<SEC-DOCUMENT>0000064803-23-000021.txt : 20230525
<SEC-HEADER>0000064803-23-000021.hdr.sgml : 20230525
<ACCEPTANCE-DATETIME>20230525063019
ACCESSION NUMBER:		0000064803-23-000021
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		147
CONFORMED PERIOD OF REPORT:	20230525
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230525
DATE AS OF CHANGE:		20230525

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01011
		FILM NUMBER:		23956143

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cvs-20230525.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:a470d627-05b8-4106-b3ee-d69f01519b0f,g:7f491b32-9056-4172-9edc-e6fc2e3bdea2,d:b58f60372ede4aa484e6883aab8684af--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:cvs="http://www.cvshealth.com/20230525" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cvs-20230525</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl80L2ZyYWc6Y2EyMWYxMDU2ZTQyNGI1ZGI2YTUzOTdlNDEwYWE0ZTUvdGFibGU6YjM2MzE4YjJlYjFjNDE3MDljYjE1ZGI4MGFlYTcxODYvdGFibGVyYW5nZTpiMzYzMThiMmViMWM0MTcwOWNiMTVkYjgwYWVhNzE4Nl8yLTEtMS0xLTI5NTk1MA_c8525f0f-55f5-487f-9d94-197de8384e84">0000064803</ix:nonNumeric><ix:nonNumeric contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl80L2ZyYWc6Y2EyMWYxMDU2ZTQyNGI1ZGI2YTUzOTdlNDEwYWE0ZTUvdGFibGU6YjM2MzE4YjJlYjFjNDE3MDljYjE1ZGI4MGFlYTcxODYvdGFibGVyYW5nZTpiMzYzMThiMmViMWM0MTcwOWNiMTVkYjgwYWVhNzE4Nl8zLTEtMS0xLTI5NTk1MA_af953528-4395-4cd9-8f87-1cf5d537c952">false</ix:nonNumeric><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzktMC0xLTEtMjY1MjQ3_12bca5b1-23af-42d6-b88c-b1f9c3ab0adf">http://fasb.org/us-gaap/2022#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzktMC0xLTEtMjY1MjQ3_37844c1d-74c5-4011-9d73-512e7f125ba5">http://fasb.org/us-gaap/2022#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzktMC0xLTEtMjY1MjQ3_ce0c18b6-7308-4640-8eef-4206af025a79">http://fasb.org/us-gaap/2022#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="i25c6ac63a35547a0892e0ad2dfe09bba_D20190101-20191231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3OA_50a38f39-24c9-439d-81f9-601a8eefa8a4">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member</ix:nonNumeric><ix:nonNumeric contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzk4OTU2MDQ2NTA5OTM_e949208d-ec5c-442c-bfb1-60608d2297f0">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201812Member</ix:nonNumeric><ix:nonNumeric contextRef="i2a0e4c7bb5f84714898af13dee589b68_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc0MDU2_6fb0217d-b4b8-4272-817b-3803971eadab">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i1940fff7a85145088d00871bcb52c604_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzYvZnJhZzo5NWM1ZDdhYWVjNTg0NzBiYWQwZWZlZWFkOWRkN2E1MS90YWJsZTowOWYzNTdmOTYwMmE0ODAyYmY3YjYzNjkyNzhmNGQ4Ny90YWJsZXJhbmdlOjA5ZjM1N2Y5NjAyYTQ4MDJiZjdiNjM2OTI3OGY0ZDg3XzEtMS0xLTEtMjY1MjQ3_d7e4a9b9-7c68-486e-bf1c-26ccfbf6a85f">0</ix:nonNumeric><ix:nonNumeric contextRef="id45be672fded459fae66de88c0ad4a5c_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzYvZnJhZzo5NWM1ZDdhYWVjNTg0NzBiYWQwZWZlZWFkOWRkN2E1MS90YWJsZTowOWYzNTdmOTYwMmE0ODAyYmY3YjYzNjkyNzhmNGQ4Ny90YWJsZXJhbmdlOjA5ZjM1N2Y5NjAyYTQ4MDJiZjdiNjM2OTI3OGY0ZDg3XzItMS0xLTEtMjY1MjQ3_5a6b0fae-c7e1-437c-bf14-3ee175daa0b7">0</ix:nonNumeric><ix:nonNumeric contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" name="us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUyLTAtMS0xLTI2NTI0Nw_1b8d2063-d583-4908-be86-f25a8a8346c8">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</ix:nonNumeric><ix:nonNumeric contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" name="us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUyLTAtMS0xLTI2NTI0Nw_d9e5828d-1d67-442b-bf21-ed9fd901073c">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</ix:nonNumeric><ix:nonNumeric contextRef="i2a0e4c7bb5f84714898af13dee589b68_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzE3Nzg_6fb0217d-b4b8-4272-817b-3803971eadab">P3Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cvs-20230525.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-25</xbrli:startDate><xbrli:endDate>2023-05-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c03b0b923c54303a8e4d6db0a6f037f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="if380faf89f3a40dbaf2259ac9b4e1da0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71272148942c413e8aff1c85d881ca42_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6714e63c7e1a4403b7da499509c4edf2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a007ee2153647ad8e132e0f3db03235_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd39a8cee1e445d2965bc047c1ffd8dd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69eed5106b194cac81e8857cca41692b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i501f291fb23d49e987222cf13c851afc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68e253af6bf3467aade09b572c1b73a6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2993c1ba25f447ab89c08c88e66aa96_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5fe3b205c444626a35463f927aa3b11_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i491a9763983d43dab185a1b3d0201cec_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe9d7c9e0fe048518f0e819acf0a59a3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief232100a20840efa196d4fd232b579f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b824a92dd1d4f39a02e0e70cc3cf6fc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4991f9a87e794b3b846aabc953f85e74_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36ab8a4da32a49829b2a533bcf21afdf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia21cb50c4e1644429c76bb8021c0abb3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6302b18a2e04d64807ebebc34715ce0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8af9823e22614548b10747e15ded15b8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65a3c1968cd74443b9c917d9cc5f64f1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72880aeb20f6446880ea5b142b21f44e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4634f40686a143b7b789e3fcc2d15bba_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i977ea8ed51c749fd9c1b5c76a2eb3053_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifedd722cb01b4162adfda8754b4a7916_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9932d12c9d66432680507bf33aaf9390_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12545f682ca84fcd8b34c17747b4d4a8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6595d99e0eca44358c06faf58aae481d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38b09f0dce8d4cb99fa27e7105e23758_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3fb716c30e94b8d9f3238fa1bdb98a0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22d6477334e54d4ebdf1f3166111f1a6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1c5ed3119a74585bf41ba0c7353c92e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22c0ec2db724456da4292af4b50c4c77_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i580e21923e444bd5aa787a3559d74a5d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i944efe0ff84e4a2d996b26b09fdc1d74_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifaccc7e6f5db47c38d9e0ea71b031391_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fffebb410fa488a9d9b0e22931e5e2c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f4bb816c26b475ea5c62611a6ca3a18_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2e98974a4f44562bfcd00c29cbe00c1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if12098c59f664975ae50e2edca80bd53_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1e89593f0c849e0b5cd198216f70015_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie82435ef167541ffb3553c4f0df32b5a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic80415c4b5d245e4a044912d0547b9bf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9dd6c6b3ecb435985256437dde936c5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91d3dea8f9bb4c86b60376ad2e8c10c7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie82959ec18904868bfd821447c031d13_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6e9f84d80be4446b8b028c6bdbc5c40_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabe48b9a3b0e43a0b640f125310e597c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8998dba726444ee9ad5bfe46a9788a1a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaeb9020504c459e87c9b9fa425f923a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i077de4b38fce45fdb34454ce78f9f9b2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i196f6e9660424434b44542b216db0270_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2b21a3fd83f44a297eaa7e45a2ba45e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfb3bacdf62f4f89858a91412d94f263_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad69a88c0d6245a29a92549e921f5e40_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bdd121bfc7c452ba215301545efe3fc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9c89dd55b72447395cf83241b9a653f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34779fb44bce4f6ba1d5a253141f3f1b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1eaf5ce6aae54524ab351f151c4c5797_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9134faa8fb4e47d780125a2ae7416a6a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bc417b7cc444506a3991b3fc859cfae_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4df9ffba7784b76a9a950adbaa557a6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i224111d466b840aebce96b61ecd97cc3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3599bd1ab9441e68ec38d940b09f7fb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25c6ac63a35547a0892e0ad2dfe09bba_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4aa93581903f4f47a9e936c93eacce46_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id114deab047e49b5a8b771195b4a54a2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="store"><xbrli:measure>cvs:store</xbrli:measure></xbrli:unit><xbrli:context id="i839a6c4fcaad4f5fa23979221c63e037_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="clinic"><xbrli:measure>cvs:clinic</xbrli:measure></xbrli:unit><xbrli:unit id="people"><xbrli:measure>cvs:people</xbrli:measure></xbrli:unit><xbrli:unit id="patient"><xbrli:measure>cvs:patient</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>cvs:Segment</xbrli:measure></xbrli:unit><xbrli:context id="if07e27d83137497c9009bcc13d88e451_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>cvs:state</xbrli:measure></xbrli:unit><xbrli:context id="ie19a1ad3f0604084922f302641035795_D20230101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida5c6a5e34da4b479b384b7941a36f63_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7176eb6123944cc09d4c6d7cc55667e2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i376bdd1660814f0c93637da644c1fc51_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cvs:FixturesEquipmentAndInternallyDevelopedSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f6f6993588e45758f3afc8079d763a1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cvs:FixturesEquipmentAndInternallyDevelopedSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10e2a519b4d24c41a2dbb11874bc1f59_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i905269377a394b08ac5584c0ccd49b20_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4aa224704f04a019a760bec8864101d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib85ef1cc5d3c496aa153d2806241d599_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2296fa243d024a1bb2396c22449c2acf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if995086e891d4d6b897fad3a54f05b27_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fa701f5944f475ba623a677b1886a1e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifacaa4d950234294b256a60719467738_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i372db3f8099544d2a643f4329a4871fe_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20100980ab444f58ab3077553ee4542c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief1dfb751b844d4bb4bbe253942b99b2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib01e468dcb8f4ca98e9b64ffb83ffbe0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i397dda43721c4f17b0cef6a6c6ee92a9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia262a9274d8f434a9a8fac8f9016ca16_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cvs:LongTermCareReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a0e4c7bb5f84714898af13dee589b68_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fdcc037f9934dcc9e2153a71efdb1ff_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherInsuranceLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i899425f497434b61be7e43e83f1ac7e5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherLongTermInsuranceLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fe9e107946a4ef9ade4731bbe54052d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherInsuranceLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8399f3149edf4edeac9228c155c337f0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherLongTermInsuranceLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd901a0e46c140848ccfebccd9919a95_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i48c79709e147425a97e76cb1ddd62633_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i862ddd84e7aa45819c8c9210518db7da_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a11ece2d2cd42918420ea7f1dd5ba50_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b20d67c786d4c91b7f3bfeff6c94528_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad2fca2727bb48aa90b14ecf9c1284f3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14e1fb81ffc34c22b66f30e2108faff0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id181fe4cc7404cdabbe77d3f7fc155e0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff2a00c33afd4f03b1e2f8fd84299373_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0ad789c62b74d228c609da2255bbaa9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife56d28f21ca44e0bc934fe219064fe1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia64bc989c4c4444ebef0e99f699fb65a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45fa51dd20a749798549f98bd1811f08_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad97b3767fd64724b1e3d77672941a0a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9d3e97b86034daf987c6fda27a02728_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3117bdb07278486084dff9ebb49a80e0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f7744badced45919f97d66a9ec50adf_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03b300885d9b456b84c6c73e4bdacfb2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i320c789c426742bfab03ca5ea3757c5f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id41082cc7c8f4e46b55567b48080c270_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if916c9222361492f8e532d2cacfc7aec_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a07c8633b37492ba109c7cd9a92299a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd57b0b73c1b4e1aa835dde2abf6925c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1d5e5a55e6f4909a1d1c3d2003ec720_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib085c0543c9d4988b6b20b9b427998b0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e79fec42f4945048db04ab6d125dac1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc35e22eaaaf4b979443a4b29ecfdb2b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib63de3071db248ca9ce666c685ac2d8a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99ffea29085e4c2bbee4c937c682d535_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dc095ba84374b6f97db2d50eca661e7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if14d784717ae45699afa13fa2039d20a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14593b1d8b2c4b0098e818ce890bc9b8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3298f299bddc4992829c48dead520fc8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07f19f7971c940519c88697285174722_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e89e68e590a458991b469aa7f41bb36_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea79f3c8d0b7431583f7968ea612fd3a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a66d7067aa7482dbb0f8422aa4c6e42_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48798a4511874c8892972dcc0082ab04_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3df790a9a364d22876a558fdc974055_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5228862959aa458aa4cf0f0ecedde213_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33b1145120c34228ad6a8552aa2ea289_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bd8d6d2503d4faebea52625423e074a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icae492ed264f4e44bfba42f67cdfceda_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30c3c2a12d62424091c32bc5d8bbb9a9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09a4ce3d435546c9b89e1b000c479765_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifeea9a469c0d4f9abb5266144d9a1b84_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i160c1d2789d34ba0bab068f3568ee908_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie73bc8fff551437d8b63b1fba165b13a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i162e562c13814497a56524c6ec2a34fd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff9fe2e514b24d7a8dea10c9425c3f0c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie09911fb17414836bb68eaeb03ab61ca_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06284eff72e64927a66522466999f6d2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1edd8caecae44ce995f38b9edd410db7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie123d487288b460289e6aaf6ae104852_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d2a7ac149f64c73a8f3b978546f2741_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0cc9849a9ff470b935a370313045788_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i977f19fae3bf4bc8963ec72c8c49ebdc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia648581c57dc457bbec0147f946c9c94_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib47b357e921d48fe83a680844e7d44d1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff457075247c43c5b18562ff48f847b4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f5aa10ed17d4bcfb6e9c9314f81c9fc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8e34b73c65d4da0ad42e0f3666f7598_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bbfa9181d494da180bb0ffaf4540e76_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie30b20aa9e074cae88b963a48417ada9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1664ef87611a43fe8c8c2e9a3c70f7f2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f342e37bfce4f6ca560a33df132c468_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17a6f560ef5640399300e7fe75e9aa5c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie743c62714f54fd4bf1245a78eee0b5b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd24d97a59214d52b3c9750f7e7d3d7d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia84c2cc8a91c4cf4aa0584d43740ee58_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i494f38c837794730a4d4ce042956fda5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5895590dd43041059596c19c70b48ee4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib399dae772f1473b882823660572095c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96881c941f4b4a52b49bb77d5efbf3d4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f0350ddd508488d8327fe9125a60729_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b31ec7f183b4cd69d634f84d8e4c94e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedc7e31aa44c40608ab490e5abeb6907_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id61b0b83a53943a09bb0a1124d0f0e47_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea9bfe47ba434e67af70f9a941c950d9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia44cce9280244cbb8b54b2754221e394_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cbdb8dae69a4ce4bcb45058e576038d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a476fae69fc4c64809902a59beedc6a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i181bfd6aedfc4e29b5b22d6b864e2ec4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ffcc008b85f412bae79b1893943f70c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia95a883374f34cadb8aba20153008269_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7a2e3c175d84b5aa44a7a859d45ad5d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ce5e18976c2489a9a964cdebbae85ac_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37c56e2626d741fc89c81191ac507cb5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1859ee0b296642ffba13a4fd14a36458_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e55817403214996b18ace12986ee657_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d3c653dcd4e4670b996e139fd812838_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife6f5f367cfd43cbb0a47919d9d3da2c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4241f3201d8548bca7574e1e0a20ac84_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb7fc09153ca404296c11711e2960b2f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92db766193ba42908696e991d4d5cd1f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6c189e7c1cd4ff9924fdcd3ca505cec_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2798658b56134273a4ae4a44406280aa_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18e1afa4d3774525860f0504f6ca19d8_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23248b4e050943bea0937b2c23a81cf0_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife99c731f49c491f9dbcec868c83f01f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01be68559ac146e1afb53160db3afdcd_D20140101-20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cvs:RedOakMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-01-01</xbrli:startDate><xbrli:endDate>2014-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf41f493187f4949ad17fce94a9132a4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cvs:RedOakMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i075db0b7afd340fa9d1cfc2f4306bf77_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5002e1bef44644008f1ddf6ef1c5be55_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69e734eb5dd74181895d964e7db3ec21_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifac339bf4b714e1782ca52ebc2be13b4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5c21594855b4f6984286b1e3809166d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic125e609219047b1851d89ba1531b87a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia67a49e920264f60b0ef8a8a7fe494fe_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1d19eaaa11f4572b405469e3348cbec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2525a9305fd84c7f917e0f50178009ca_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:HeartlandHealthcareServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8941690cb4944d199bf33e6da1cee933_I20230207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:OakStreetHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieaa2442b4a1b43c1a1e9635e5d302668_D20230207-20230207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:OakStreetHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-07</xbrli:startDate><xbrli:endDate>2023-02-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc5a99c2de364d84899668bcf7f91a6d_I20230207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:OakStreetHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:OakStreetHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65fae298043841daaccb6bbb1a996aac_I20220902"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d430fa42bb64f4cafd5196de70e0ece_D20220902-20220902"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-02</xbrli:startDate><xbrli:endDate>2022-09-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12c5778e54f64900acca49cd8d1aa3c3_I20220902"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39f6860ec9044a859b0fb2f4386504eb_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:OmnicareLongTermCareBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a1cc0d19b0548438d4b4f4e3b4d3a67_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:OmnicareLongTermCareBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16dd20d6307443f7b1496e7fd3259924_D20221101-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:BswiftLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1487797c4ed44d6ab54ae7b9970f80e0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:BswiftLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i726a3c8b7d82435e9ab454babaa43c9d_D20220601-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:PayflexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i032e70604e384dd9b7d3ebd3ff12f852_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:PayflexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90dd0fb3894941b6960bebd138f56df7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:ThailandBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="member"><xbrli:measure>cvs:member</xbrli:measure></xbrli:unit><xbrli:context id="i13c8ddf9147d44ae959fc13f26a1884f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:ThailandBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica7104e3105a418591fc79a3004a6ba4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:ThailandBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfb21d4c40684eea90662442e675b2a5_D20200731-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:CoventryHealthCareWorkersCompensationBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-31</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaa8b7f8dd3142d9a337758c8211c242_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:CoventryHealthCareWorkersCompensationBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i343759b6979e4ed18b87374d58deff9a_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:InternationalHealthCareRenewalRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13ff989d3101402c9f2d0b708fde5f39_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6007bc6f913b42eaab01b721ab83141f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04ef966a0b364268a11b39305bc55156_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f2ded7662304336a06ac9d017d04cdd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a96031559a645dc9dd2370af4f1fe81_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f484ef7e1984f9db38a5d63935d02ba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i926187f27f9143b08bebbbf8c1146300_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a316de9aa51441b93f71dad0316cb0a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fa9106e06f445a2979d054b78f571cc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf0581ceb43240768d8b04fc7ebaaa00_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb868e7bdeb94378b825d30de7838abc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc5a0a8208f2461ab82ca16442cc424c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b1a48334546440e95fe6e66cc4322ba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43efab69f7304dd1844a5ce8ac828ff2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63febf0a959b415a87f69f63c46b614d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fe88c16075341069af91ac0c4d756c4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad025fe771994e5c826f608d61d0c5f4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d60b17185a04c99a6f240935bbd2fa8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i858b216b74cc4844a1f8606b6c1545ea_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9911a4d843eb4cb1a00b136035f50e03_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bf6dd211b7f4e99ba7262cf0f3f0c19_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebf5538c68ad492782f86e19a1c4c591_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05cb6c50cba342aaadae4afcbafc5086_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="security"><xbrli:measure>cvs:security</xbrli:measure></xbrli:unit><xbrli:context id="i5cab4b0903e747b4ac60612c8fea7746_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21d50269b9b94eff85b08845bfd50cd8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9de4d4f1b014ecb98d80d1d8fd9997c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fdc07fa1fda46ea9a75488e14c8311e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5826868b7599497aaadf079b91c1ec9c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73eeedf2a9af4ccdb7f524acfbd1291d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb16d569f25741039929fe7413c06b74_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4afa3728f7a4abe948e80bf8d977e54_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if04d1680adba48cb8232ead08df7bae0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d74574442044f68b51d8276992c9058_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75980a6ff3ee49029a1d3de9bfd5c17a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90acf0fa2cef449a9a6b3fe9669194a7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie029e8df1c364a138c570492e98b3d54_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i421c93ab9ec34e0b8ad632a772e570ca_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bca51009fe7432c8013e336a1cf4350_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a6652f704234be281c7de3aaf21a926_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ea51f302c714924bc0ef9b87f297f7f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebb51e53093740178b4dba853cf3420c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12a608a6606644d88c677fd0f751bd61_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d4072e6b69341889b6e4a48f5921c8a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88a11ee9559a44de92dd80d2f5faddeb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia93b04912558443280c9e2aa952f9903_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc270e3970b14849bffe624fd7f92c5b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53ee1002dbe14d6a9a0a87c428a073fd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73d009030d3c4eb2ac0695369c7267d7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf299ad413194c68830e48ee0a189167_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91ce86bfa38a43eb82d3e5630dbb6fe0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85218d26a5ac4a8b8a791e5184f5532e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12457fd4abed4dd5810c523723b9e883_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1693d5376c24d27ae1f522504dba375_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99cea1f4247b4a72ba6ce1db47e509bc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if496ce43b9584f0cb06d921498c7a6d5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5469e56e6e2247438f23b5f4ce0fc023_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14ebe9c147f34b30afb070d4275d56be_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a42cf0d49a24a3eae7d66f7a609a49a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic39faab8b805446e8f84846e67c4a2b1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3db592d2a00948c68596b30eee11b0de_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a10358d02ce40d1ba0f351f89985dd8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9479f6e04944448fb94cd8b2ffa008ac_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i640aed5419174663a30409089c100a72_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47777d9b93154d6784b7b9f3c2f9d892_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i854bfde83a1447f4b3644fc9241f54c4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff3b89973faf410c9acb26abb292d6b2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ad5913b793d42b68d0dc23a03aeccd7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadb22641a7de480890dce9724f3d4b73_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9504148b06654a839a20790e6729610b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffa87d8a62b6424c930a0a38e3b4d729_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06832aa121f84e7d9bb9a51594f8328f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06d54096c9ef445b94dac9cf772665f9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d9407183bf04eb2817defb619e71ebd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a5c876135b74ae1838032336d64387b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ca464be42434835bf579eb85f510027_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2bf2504884d47a787c23c9e647d0278_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e057cbf62aa4488a2f57555c190f72c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4576cfca422b43d9b5a9fd4714c411f1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b33e9db5f6e4f5f9006e8393083dde3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2a5a5b141684675807f743d5fe77545_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4f98e6a0455476e9364c7c8d8ab21d8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i480128f0b108421a96f35af154e8f5f0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i014bace9b30c4dad914233baff909ea6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13320df95b974197bbb559c6f4e8dbd0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i399f816ced304ff0a68ab3aa72222b6c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9e248f337b647938c4b077be13c8a69_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4c467b53e74463fa33e728cd19c09d8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia440d58b19c54e7da108e0f4c033ea0b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecb7a9c6c43b46caa278ea7418cf1d7d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0b792007b8444fc8f042f94a615af30_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fd3a320f1354f8b810c747934dce719_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15b8ca29a4dc4503a5baf923e5290e6e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedfeeeeb01db4051a98addb83b67c636_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie44f7fadffdd49b09a635391637ef400_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9afd4ac3c27443da681cc815ff5e5c2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i739531ebbb1b4313b647d32f2141a862_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i578621c95d044984be4bc06471e111cb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i762743c83fc54d4b84a2b52a9dc069ea_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefc840c940b34ad98d700a94a9c98c36_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7f12d0216be4ec7b5b4ec403f1ac753_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i492eb4d473b8474399d0876f23723ffe_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb4f81b717c34e498a2a17bce45af326_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i369222388a054b4f8f100bd1d68da12f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i068dca23e0464c6eaf06ae53103e8ee4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9969db4222c441394605cdce7151928_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8cb3e0c3585411b8626e196b7be91ff_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i137cad6adc6f4ecb8a82de703aa13a63_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if00a9d16f4b54e3b9f6ebe547b51e58d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if19bb3693da04612931c094a9c82234d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7e14cbf58db473094f1a3a50e0e0423_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbd43a9242a0495591196ce21cc7a152_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icaf7c772d40247269c23c494f0813a7f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ada3d841105476b9dca967f07a9dee9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9bd28275ddc4fac99461d0040a82e04_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc91466b20fa43ada80738d8288e7fea_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i530204e9d197451a99415dd3717e24ac_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8990fa5e5b8a4f0f97b6e8a430a4f8cc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d16b574d8b9499db8e7d78efb965b5e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f3cd6f6ea7e499bb05f3f3288c17b03_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5c1f15313054273991533c5befb102b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d63d3b9768744a2b0dd3376b50053cc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5101082b492740a3b0895812ec43df67_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie06499b007a04690b796c75b0962751c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida238621d6c341e6a18249c65a07f582_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16e537cfafe946a1a9ae86bba72ee565_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7ab6b4e481d4957893effda1b1aa7c7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c90587389b24652b4171dd0ee88dee0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08413588348e4bebaa6e0777ce0ef468_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06e7906b8aab402c9db7df2fbd123952_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23a61fc417cb4a5cb6b648036474566b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22037852b26040388b00a9892837d2c6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29da59e3b5fa4406a9c1b13643f91b1d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f33fa4fd1b548fbbed3d1b0df48e1a0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f7c6d92a69343cba3248128978c9fee_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1764e3a27c5c4e3495ac330952dee2a7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb866ac0512442bcb82bae4443758dc2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icecd5e128c154279ad038c0b3bd207d7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25da8a3d6f6c4f1f8d90b11a666a1f83_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e6791338399461b89ecf1ab5fad5038_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea61e57b4e654ebd906d75ab95adf087_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c6d0c54222b4405b72bcbe5aab383e4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa99b9364f604126ad2513dafb044afc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b5704fae30b4a0180968bd57557cc05_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e951c3bc4d145f4a40476a3449c19ad_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief0073f279ab4af192756be0d02d4de7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc232ee5addf495c8badb0d70cc93c58_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib91aae7889074bd7a05849761119e002_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91e3342f2eda4923accdad0511bbd8ab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47cdbbca2588456f80bd73c676fe393c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf6903b55b154bf5a640326a2ba60787_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80a1fa05fa624e99a568c5d529713791_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6823ed470daa49af9254d7a5a6a31e37_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0338427c63b5451e9bbeb57e1271c8fa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib35379eff59f4c1fb2580ef9d779863d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i890e91d6254445ac8e4752816f15fc64_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ad691d08cdb4176912f4e92ea7f03db_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fdcb45e510345908f049a08f8d3ea8b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55a4eb72fc1c413382e3c1881d8197f5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8066d1e0dc94aa6b3e714bdce964759_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c74072b7da84ae7822677cfcf5afff9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe6072dccf0e4a3386213b62e3088a40_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i421fe75787694fa0a11c81717afb1439_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccca4c50d4404ba9b7e6a383314c619d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88314bd313df47c79dbba4210decb5f3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50144b06283042b2839e3602628c2e9d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31ba761daf614d80a394376a9dc8d67a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i590674c939694c899f0d33ebd89a34f9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc997bf4243447f286d22be9634f8c93_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i137db0dfee08476382f7697fd3226606_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i279e72df939f411c8a220ad40b2933ad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b4b394827a84ef89c8ad73a0012ea10_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idadd15b0bc144797998dc56ab0eea88c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09a72f728e864e3eb1d61dc884e59e71_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc633eb71dd64df8bb1f39e100cd5380_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3debe593fdae4764a4dfdb909fa118c2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if70e446705924f59820f42baab777967_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie042a85f623e47be97fb43ff84873341_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife6ed60ef9304afcbcda02067d9939e7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32a6e0424acb4626bd8a9932c7e5cf81_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2927600f263b4b33a80751d0bca72ae7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if32a2b7d26c44e27ac43f062d7bb8ce8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71dadee959a94001826c4f41df794421_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia886fe9743a34d83adeda64bfbcde12e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentShorttermDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23ea6c9d959a4be69bc036bae5151a22_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96059726faac4aa391e32ec04829a30b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee0b7f95d910427ab334b16a255c0b30_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e36e767de48460789f38c796a6e664f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentShorttermDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e8ab5d1d4da443ba302ff82ecf041dd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e02a0f8f4134b338d074df0125e76b9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4ddc4dc69fa45d7b4aabcb366bedfb2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ab04fe755eb411688cd34938017b350_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentShorttermDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefd0548132bc49fa913c97c33e550880_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35fc2780f35241c7badf4da30b423e52_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7e27a54d49940b7aef90c83ff8319a1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96d99b91ab0644839726fd9985fcf090_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentShorttermDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i935f57522466474ab5b184e68f6666bd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6589258587b4cf38304516af7c70737_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d44059ab8fa413594b33583600110ff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8eb721873e1742abb8f287c140434eb7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i770c6b93b017435188c94e8c9d24f250_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa8216683f294597bdbecb11b8d62331_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied85a7e77c3c4ba692a634daee0770fd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentShorttermDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79c89c6186094898bdeb5257ad524c9d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id25912d8f6374ed5934f4e13f688ef0f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33cbb6bd12fe4c8293ea3dde4c77e687_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5711de78e5dc4ebf9b7a6c859a134de8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if12cdf7fc62645698e90b515b611256b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i128f1c4ae2fb4204a95761f38befbbcb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib998634049ce4ca88cef9c730f1a8c88_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96ac2a40938b4452a62b6a712077bb99_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c9e1fabf93c4866832c216cd1d05ff1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06b531bb7d2c4c9fb13fbf2858aad603_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f36a954f0b04a9bba80a5b07037ee72_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21d1adae38074c42b4c3c61194cf93e0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife1fe98fbd264b5b962a3adc684d2edf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf67a70a0e4140fdafb4bfede6ecf6ab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if277087345804c939318d54c5863d3b5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie66a1446652841afb7a31c13e604633c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51e0bcd2d29b46c7aa058026dc2a2ed5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if689b204e34543fe95ac080b3debc55f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ee45bbfada1407eace8ba71e97a1529_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaad452f7bcd446778bc7ba3f4ca770d1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e061b66c25d4fd5ac6440b36c42c982_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6765b714ea5d4a02a77b602f004b5cc4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7983c2bd0c7b46a0b3bf893eec46f3de_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96c159461792475cab9a57d784186344_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05ef8fe160b24777ae8c78c62e45e2fa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49b05a6599ba4f3b8fb0296a00fc3649_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b3c1aac8a2c4908b044154620848a2f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i231179ba5b6a470c9209f71e7dbbb810_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id105f8985abf43278ce21b4eb1dbf055_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebee988b218b43188ce78e0ecf93058b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9179ad3cfa14f48a4448a5ae59ffb9e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib698372482a64b2b838c35c08acfb43b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d76414b76554feca73881ec515dcf3a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1d74124f6be475b8f9ae2f51da28944_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c13d2018e6445458a682aafc8803716_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb11f4892b1a4083a46e94dae7ceff9f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20fa3af468954aa4933d0e3030a4ae0a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10d95680a25f4275bf74bd275a219904_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3add96661c68429c98bc447aa30d7e90_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie85ddd31302d48b39bf9b6b531607b98_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i093853abc6424f1fa611b8455b524dc9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabb2b81fff06464f8b9d20abd344348b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifccbe865cbb14d2091ef941a3b9bfe9d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3517cb5c6870409aa7e4a35e9131090e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08d7c8d3b44844d9a53252e4dbcb3411_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1be8dacc0e33455686bdb32ee8a892e5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3c351bb44d34de9a79d55ff5ad02121_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i809fd6b11b2a4971a3517725cbdca04f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i473e7e5830bb4215af2dc4cfb615a70e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cfae73c894b48b3adc8ba56219aaf76_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f60137c965c405995e63ea19fbaacc4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ecc8bd5e850436fa0683a5a0e40c8c0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:SeparateAccountFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33d746c2511346dab6d70642faa03778_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:SeparateAccountFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib018c9e5213340b8a2330528464a3616_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i946281b536bd4451b3d56d4d5bcaade8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic66da0cbafad40c0b09c17c59b015bc2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a1d88c90afd4868bb3842de60276b75_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dd993afeac2436b99c2d440336ae246_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10733861aa764487bcae8d1a5debd7ab_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8885190ef7841e48df544637103ca44_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if80e6d478f774215aba1c17bfd3b0a9f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i753d74536e76447a97ef85017079a80c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe08d096357844f88d5bc75a18fcd936_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida2cad6c1b0542db87d072a6e3ffe684_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ffa35f6be0f433ea5d0c817c81cb4aa_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9bbc9d820604ed98ed4729f6b0aa8f3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb1ed30851ad423db47b88e42b33cf8f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ed4d6f5ae634f359f681dd2ea0d4e81_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cvs:LongTermCareReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icacec4d2bd5a441bb697bf94305fab43_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib59e20c5189b4f5cb592cb8f4b8324de_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib47864323cfe45848ffe84168e0f0ccb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ffa6a6d070a4dd2bdf38824f6bd5261_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9741c2be1f446a5b3e33d1093db0189_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0189be5251d42809d167551a0f5f747_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9520a4ef3083437894a7c7dde288f4c1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07f38da039c646c59f8df03b461397cc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1586ee2417bb4444a300fe3741cce552_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10166bf4bd7d4e9aa3b7ca002a1d92e7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idea4ec344a85455882460b397b94be2e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab4ce297b2134e1faac9af7fb814d1ee_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b97832079404df29d7a1346b50515c5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb9ab0a0f75a497f924ab0a5e8916bcb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia298597ebbd74213b5ccc336e308e4fb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21e3a229c93f4655982469399aecf163_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i245af29d89884e149ddc482143db7d7e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd3229b629654bf1aca3934975c2c2a2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b53ab0e06784e57adb2671c1a53ced8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:OmnicareLongTermCareBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1940fff7a85145088d00871bcb52c604_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id45be672fded459fae66de88c0ad4a5c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30716a5a00af4d6bb1f1b23cccf84c89_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64afdfad0a7c40478e14769ae335f4c8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i051a70de728945e7b41255138a99db87_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if41a3fc5ea3b4503be47a9c50af584ec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia17efad6e57f470eadf960cfb01e576d_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8537dac29594a639ef8ce90309171e8_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">us-gaap:PropertySubjectToOperatingLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f3c8c09f91f4c338d29d71777fc4bae_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b563cd5fd6444ccae80c15785db4752_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fb815e010cd42dfa706732c81d30c51_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">us-gaap:PropertySubjectToOperatingLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08b43dcea1a24bb58f5fb26ee83e336c_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcaf1a77aa6f4ad0a9316358d8fdee1d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">us-gaap:PropertySubjectToOperatingLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0abce119f76d4736a751d922587fea1e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i799291d9b4044a1d96de401f542d2dbc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i198eb6aa39444b7b9b09239c511ecfd8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97f51e7c8d364549b235af468de7d3d6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcc76cbc90f043b3a402f196167f4f72_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a2d0a34a80341588e7543f9329def49_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i070e3ddd671c465f94cda987d76035a2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c4f0b83de01479eb59aaddfa35650cd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2866ecd09514e62ba339145a6407f2d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83ae36f497504d8d90f91d0e0e6c7f9a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88f999029e8e4a6db4e05b6171f6b11d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedfef3ba5684421f9d94d0db97241826_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if153c73955f74ee79cd73647ab6d655f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bb58d471a7046db9c3cc65f4971e64f_I20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201812Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92b1a4067a7447d09ac7bb0fa978bb71_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0a700dd2b904bf5bbc0dbe22aa0bac8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bb54359e2f54f6bb88e696298a4d66a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bf2003d34b74a88a3c886d4e9d41643_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabfc58f2b34943d8a1b6af15cd233571_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20c1ca9c1b9440b994dfb835f8ea73f4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i912746c5ac72472fb68054bd160c6e6c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89b6580a77e04626a0e30a5a4fb6adc4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c5404c452ba4db28e4fbb520b402437_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1263a7bd13e6441c90af49d5dde6fbc0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i644e02c89965481d980470106777aa5c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9137fbdadfbe43f5b00bde48da98706d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie209165399db45729e89c8418744612e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c93d574c339401191a45224c5b9c45a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbfd8fdbe44c49b28f953090bd798dc8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i670b392d30e849e695e1cc46b056bb28_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f0672fcd32945aca44585b9882b4499_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i614d4d469d8542ec8ffd5f8bf31e0bef_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b99c5b96c164850bc3f80f97475b0ae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba6736243aa54f7294406b62ff339374_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i473c68aa9e4c42a8a8d365737c72ba29_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i516e66d0f707473d919c7b8251b39ca7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d569b44a37d470fadb0d1f07580eca6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i412d46651ee84600b71fc148cc986f29_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ce672bf30504e35921812d7a7fa7934_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36b9491833204d099e03fcc01e203119_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b4626daa8754d42a34f1edb762746ec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idac6af1bd4cc4ca791c3b7491cdfee7d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib04e1d5c5dc2451c8c17187d5ff131f1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d1de373967241e5bf5de600e7c144af_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6a5bdf13f3348caaae04f36dfdf1529_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1c08c444f6d46058bc3a4972bc57366_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i180b8e344c4c441c95dcb1988928fc19_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5496f38c2d14219bdf381b856591253_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountMortgageBackedSecurityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifadd8aac47504af7be902e13455b168c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountMortgageBackedSecurityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f100f6542cb4642be65ec9453938f5a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountMortgageBackedSecurityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65d11629522144ccaf2eec93210bb7ba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountMortgageBackedSecurityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3030957b790447e48affd8a2d4705582_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:SeparateAccountOtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7cd37bb88ab41ed9c765b58f78429c4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:SeparateAccountOtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadbe70c5f2f243658fd3bcc5dd8c2d3d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba813c84c6544fb990007eb39d2d1988_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i565057424b24407abbffae1c71ea0c08_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:EquitySecuritiesAndCommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fed7c25098a4dd3957760b3fa0df1c4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:EquitySecuritiesAndCommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46d398142bc14090b6efa835576c60fe_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dc40fd3418e432b9e325f5ecd1b6217_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3af420d8300b4f17a1fa385f41425a8c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12e6f7addf034c2eb5edf2df1a607732_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if443d252b4df496d80927ef019eadf74_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaabe5773025f4c2cabd69d7914e764b7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e95a5abc36e4381a98f975d83721a1c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic62f6a9337b643efa667a4246f23f5a3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bfa33d6699f4a16a614e7bb4af6003b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id32712eeb9e24f4293e053682e64d0c0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6556efb47077422bb88b269c462914c5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7f8bc3f2aea4b8490a2c00543939418_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i095b5e69420d48439f08a7fd6032e39f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i788e48585b7d4fb18382daa954eec2a2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i412829e3534d4fc095e6237114df2eaf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dd41a67d29a43c5ada1608f1dbdcca9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee8c1ff2a84748f8b1e708329c8b5afa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79ee0b15e57241c5911bf2f116f391e5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e6d6e97c2644b418692bbab3d848bbc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffb22ad240ec40d99c5b5c11c4fe3c23_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ba50b36e4af4b1aac05a10e19f622f0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i533be9b87ab747d18146404b355d4dc7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a9a8b0623524068af6014036c34e60f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b4b00758ca84efebf14e070000ab9e3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie19828a34e7c48c894138597b0f024aa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i096820313ad94c9eaf41e3a34195cf2c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie696efac889145fabb06c27642b8faab_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a9abfe3905e466f9226a7fba19a5d61_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75b0bb3f7a324df2b692b9a2d398518e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point625PercentApril2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0f1d199662c4aa1addebeb3b5240b80_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point625PercentApril2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d39dacca1a042f6b353bda666b8bda1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c95f5eb8a5e43e6b03486361d0edd35_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a911574fd4e42ccbf711bfad6c77ba7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point3PercentAugust2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0f77ee954bb4d2db587828489c53759_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point3PercentAugust2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0eb3702b560245409a4fb90d58b8cbee_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c0858694d0545f4b143004f36109ead_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f8491428a0e48e7b0b3ef58c6387fb3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b1061d1cca14c27a643cc1dd4680a00_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6973def3f8764f29984b67e00ced9e10_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point75PercentApril2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8970f954df4441f4b7ea8363b24cff7b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point75PercentApril2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb4028e415d14620a23a814353bd620f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point75PercentAugust2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88ba47fdbaa24d6183f12124cf69ae33_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point75PercentAugust2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdfec9e9766a4ff5bcabe5606e8aeec1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point875PercentFebruary2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i782152e0441e4c2a8aa5248aacc1d97e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point875PercentFebruary2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i363e35471111481bb74f8fba9324ea53_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point125PercentDueSeptember2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae612530eaf9406ca68bdc6076595a22_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point125PercentDueSeptember2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13ffe568d3ed4a168945f8b506bb89d5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i654327bfda6446f7a000b137efb56172_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26367f6403b04922b185cd41633e004b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84ed8c55fc0643daa63fac8671ac1c47_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06aeda9941724578b3400960ab91b49b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55522731fb6f4d858d93159da79516a7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab7177b9be24447698af5c299280e476_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37a3a6af561f47c5852d985e16ed71d3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia814b2597f3d40c3aa4b441a58f72382_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic986abeb083b454c96d3dc4609ec7e06_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bd24d3fc7ac43f298c824109beb8c10_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point125PercentApril2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bd579c48c854055ae2e0ed5e2761764_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point125PercentApril2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i170dc9d394554411a59b342f34d93d1a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point7PercentAugust2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f7debdac94840a4bf5279ec76e1bc30_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point7PercentAugust2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c6a0d7374684e1c95b28bb2666b8bdd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7921747c0542413d82061a71fe1c0e43_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c5ea867903e4bd98992266582152be7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i936efdc2f58c43ab85e5eb2d3d14283a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iade73b7bf7a9412cabfa7e66daa3a170_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96cf2b69c10d4cb7bbeea0f0473d095c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfef3a2b0e55448e81cc7fd8cdcefa84_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9023482dafe64c8487415d9d977873b9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30e9474ca99f4c96bd9f16e412ac3108_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id71a7150882a412185e3bc50665a4eb0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45407f38c46c4bccad465eebd0e1c1a0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d8773a95fa54a4c955ee222946850f1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6861e988cc904169ad4ce04f9a698dfb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i595551a12fa549a4b9bf4bb76c4cd9b6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84d217e379554fdc8044f794cb43db4a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c83f742d5604d34bf2d877385d1f1bf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb3abfe6fdc34a699fc61058a8ebf7fd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point25PercentApril2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d36c8bfa1e04bd1a278e34c22872187_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point25PercentApril2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e5f05c48e5f410f832224ee5b84dc43_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b89c9ecfa1844e19052dc3ccefa9571_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id47f5a8f599c4b868d0305b2456c6b4f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5d25fae6d644b13b9d7d803b1a2d336_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab1819ee2b2c48beb7a3d3480b4d3018_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7725a00fc4434458820e5285675db777_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay162025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5314895b87347ca95eb2d88cacc462b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay162025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide893c421b8b4a6bb460e90ff3db6be6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay112026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b7205dfebbd4f39b3d90a92a474a62c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay112026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f2daf0d0e1b46beb6977fe725dd8568_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay162027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58ff8eedba304dc89f24ce5bfd8071d0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay162027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53a3dea184cf43989b62efd3b338a4e4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:BackUpCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i296638e184854141a99df90a77e2a441_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:BackUpCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i096d8d3381b14ad1aa6e9c2bb706e0cd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:BackUpCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9b65b8aa3934b9e926bf1519bff738d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:FederalHomeLoanBankAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadf9ac334c4b4658ad05a02180f0b8c5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:FederalHomeLoanBankAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i364fd8c191ee4a44ba567c6975b7a46b_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70894237af7b4390b3fb413977da682d_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51ef9d9ca64a4f4287885afe3f594d9e_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fbfb24ea6744e208cb848ccde2da9e1_D20220801-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9aa5250b8a554547a64d644fea28511e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b6fb40f4dca4685b9a5bbb62b5bc3c2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3d628c3b8c14ac6864d45ff3df48167_D20220901-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7e2b901e8f64b298c94032d51d86694_D20220901-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37ff025b209247ed83d75720f35ca078_I20210818"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point125PercentDueSeptember2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifde94c7f37464b33b3e1498967849d4c_D20210818-20210818"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-18</xbrli:startDate><xbrli:endDate>2021-08-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib92c96bdb7a54505966770b11a97675d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point625PercentApril2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cd70718cc1343babbfe7bdcef36bd9a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point75PercentApril2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9544c22127144ed0964d5a4436da8785_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point125PercentApril2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0e311329095472ab7b183da066396c8_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point25PercentApril2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60425698f8a3418da11bdd624d74fae8_D20200301-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieab996d7d0884ceab3cf45494319270b_D20211201-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point70PercentDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied3ea35dfc6c47b7b9f3cc1126a9a800_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point70PercentDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2ed035e89ea4208b36e5c0321f9ff7f_D20211201-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83224dff234f476ba7ed0ccd21116967_D20210801-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4PointThreePercentDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i485c3eb16ae24960b7e3cac5ed2c512b_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4PointThreePercentDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia34bc950bc544c9382c1522adba2fb40_D20210801-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80466863c1954a5995d8cb88bd23d373_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:OutstandingSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7385c90f6eec42dbafb7d0cc760c4687_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief5a743376c14f51b6a0e836c4b51640_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf67de8907724398ac7599821631c87e_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74057c0c3792479e937638290c160b1c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d58decd879f498a93452c94fc35e626_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea5790297968453b80af10c825264b1a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f44b18f700943b2a98a19f48efe6062_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes43Due2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63e27afb0d604706bcc006002a4c8301_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes43Due2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36384f97305a4feabdce46713990833c_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d45c5eeb3784063b1f6c2bd8750adc3_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:OutstandingSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i335a47dd1b0d4b048c9088e555d579ec_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b98834372be433bb753acc0051b6968_I20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b2c782f0ddb4f47b2267b9624558fbc_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia13f558316964fe4aba42d03ed32c28a_I20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac13c74e53a64777a3a5d7e4fe3b2046_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f514b120f594513be910dc9973e11be_I20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b7fcc349cf541ddb6fa797410c0ffa1_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ae60f8a88824bf889f05cc3b51730b3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb014b08ea1a43c8bfc4d9fe2fe4cb7b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i386090869fc94797bcda9d9bd6beaaf4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf18a7ebe0824b4c9cc0c9a8db021e64_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1c28ec013bc4526b9794acd9746c77a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76a4faa3d2d7408ba85519e8aa053ec1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6f2f249637c4a7b939be9fe6d0553f0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15f18808419f492daac9928c78dfe207_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5165fa288fc140b58b3e2eb13b880dad_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i437030cc5ae74594bd99c673acc0141d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f1345bbf71048cab8ec53160a98d6e0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafecfb17bf3847a289eb418831589dd0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i393269929aa54f8d841281c28c513489_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71ffeabd45b047f7aa8093796c73ce64_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19f2f4c671e34716acf9fd0f2b572d66_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i102010332f0b40f2a4057d6bf03e8a1f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie97efbadc22e498ab09fa57a7f7a0ece_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide1653ba45f64f029e277348c07102cf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib74558535ca347569c43f5b77d45f6c5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3055783102048978188614bf9c92f67_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f0b29ec64ee405b9f397e174b416349_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f22f16c5656496881261f222143a65c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80aed82dcefc4d2c8a1b6d1666a62cc5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idecaa5de548e46198a7835338a65cfc9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb3e587df0ce4e58832ac7d14ef31287_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81a129fd9ac642898dfe6c3dbf7c13d3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07cf02d634944cfe8dec224d5af50138_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icedecd6a5d6c4cd6932eb56e5297820a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67ed1aa4b0994e08a75a11aabef0ca61_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d4ba1b4e5fd46a59de47cb57daebd43_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53d2e727f536476fb8cadfd6668d3f36_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if42d8de426004e0aa3dd6333ac3a65bd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06bd54c2ec1749b6bfe532accaddeb19_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15075758aefe43d2bf31d3cc52dcb868_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75cf4995d769495181bc451a1291d416_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6964724f64da443a8d85ef14ba9b207f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc8d04d5adea4cc4950dd1f1163a8c24_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i467dc11c176c49a494b2bfbc4ecd8d40_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4561999a767a47c9b145429b6871dada_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49acfce007b84f6a8ed646d3879a295e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47f6d39a48124eada9253e73f5eb298d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i425da7be65a34eadaf6d0d7d246f41ac_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dea2df573724790a05410f34ffcaa89_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaceec8e969924b699be4f035e5a5f056_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4bcbef4b6154d14993eefedb06e445c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d3a7dadc46046679f4259f0c2cf607b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bb67485d5704379b1a6d4da590cf813_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25c01da9448541d9a4bbe6f5bf974426_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icff5a9de270b47439f9f2e3164cdbaf1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idce9aa4064f649998284ca968ead9aeb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id88dc572d4a4463a87db8a149bc97af6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia48873c4be084823ac547c96b29588bf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i361bca717f0145f392b30b6c5842a5fb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb37318a487b4f68b2cff4e55df4fae8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i458d0bce582548dabb9da928f9be1723_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f36bf1575754528b65dba20e88e4417_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34cb265be9104204aa213bd1c51fcdbb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i859f79ed7f81424ea30511713f0e5fd7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd55208234184797b8bc48b1ab33f4f2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i047b2e5d175948e28dc1326800198805_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a9722f65b7649a0af5a40118df4c83a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fb1ff4cb6bd4a5f987eb066e1579632_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d10279e4e4240e58c58b67195918c98_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdeaeb4835884f6087e9025f4a721a0e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic03a2021968d469cafd277b1d48aeec0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e96192e9c994cc3a7cd9d3198afec11_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b84bbaf70a647149bd4230fec93c00e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i434d9033c59345d994a83769698d5f43_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8553b3aff6d249b18a9cd384b6c1a55b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82cdd943a4d64fa6817835bd3971c780_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i293cf1a1995d4e29b26bc330b1666507_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ceb26b60fcb4903b42e2e7063f9ec62_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b1cda680d3d4f8696d51e3ed6642658_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10542d46becc44c5967969f7f85f3589_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i292b96aad4ec49cdbd305facd2f76542_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f6a83783837419fbce160a80bfc2d32_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6ba387bd5784b3588f79042c1627c7c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b3fb67b13b4433fb27cf39843018e90_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ba4905b6b0747a79b11529e76f3525a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id34b6ff6eb5d4ff8b7d64f102c051a4f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f8b8e5367b4480ea7d27890901e6247_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2483b2d9ed46464386b90249127712ec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a89dc1177b443eebe04b19998c03509_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf9ceb18ea574327a935ba6e88f2287e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie38b76b68c8f4324b3b7de80321c3a38_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4c7e5e536ab42b8b050fbde07b7944b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib321cf5df709449c9ceca7c03a1a464a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5115a8b317f4f088dd39cf66bd37168_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7ca09ccbe954fe782f927e64956c241_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6de203a7cbb4d628006e35c743071f4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe3ca3dba18c491a9e22b5dec78052d1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f8b8023230e41f1a277473b8be2f39c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaac68e1f017c44aa9dd4c8012dbc3c27_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i422a5afe8aab4de28a6a361f067c59ff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55f94c0a8c604d198a8060e3981590d2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f4a9f967aaa4491ac8ac4bb55abdd08_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c682f38539f4aea97612b5c8fd96801_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad6319eb9e074402bd329fc00b71a0d4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i225a548f115e4e4cbc128578264d598f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b7f7de16d6f455b9b95fe42c0e7ddf4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic622298e7e1042bab9e914624480e3f3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice305fd722c144a8a3962bcd2d78808d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6fff6d946ac4c55bcd073422901fa74_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idec237e4913a4141abffa54109b01c5b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i424cf2f1fe794bf8b9685e626e4b60eb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92dad2a6cdd147b4a4bab53cde589c29_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i841e9a2db5bb4870b1acecc87843ca11_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i323adde47a404de6a429ebcdc6d4a624_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66bfc1b58bee484ca8439711f02fc588_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6febefab642d465386af8f7ad424e1d9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8b7ecb5ef6b4772b3207c0af0378129_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d7062cfce4d47d4950a86d0fe1a51be_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc0351d4a2c042f8ad934772134cdbd5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i588df02460dd45ebac24745a67831e0b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa15814eab354d1da0577719608c58a7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie93d0f38ac78460a8408e52712b8a9e0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62058f08b95b41b29a2bd7105c86068a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0978cb2beb54ca08a64c48351e6340d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9283234f91734e7f8067245dffa66546_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a65013be1484144aa7390d6ce8685f1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dd96e63a05b477c81a74ccccae0af1a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d58e5df6a4d4dc2b2d2020abf96dab7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30951550eb89447faeb8aed509f96d7a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5e498c9e0e949d295170b34d02f42b1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecf6ed88f0704ea1b5a17c05fba15357_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5a4161ee999468695164764689d0456_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b5516f1d83549df8e3672acb28d4018_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57859501e60645cb9752e9e1f0aaca52_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4691f1cc92b841bebd9eb3e713080db4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if380f772d15949968faea35f6c392908_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a39f01aeb134cdc96203f9fb9113b29_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib12ac2d182de47eabc00a82a798699f2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia432ea4fe3664eda9ea74cb9f5d6541e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id85fcc73165340dca7de806a6adfdfbd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06c3b035437e4295b67d73728537c87e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7760d59224714c619f74107d44fec8a9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b273fdc1bd847ed8bc54eda0343fb49_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f27f3a0ddaa4943a0a01af080cffc48_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c0c1b4aba8442ebb3315909595081fb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i606a32f530d0485e9489b153aae2186a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied58211431b74500ad5aa97b2eb41a6b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i626787e8dd8a4a428e915960b4c68a35_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ffe6c35b7494418ac8c422fd3541f2b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63c0c51144c74ed59e090814aedeff5e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63529787efd54319893b4e048ab45752_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic094ef4183de49abb0d6149a76f6e4e4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72861e7450344b1abe5a17aa6d5da491_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fb5d20c5bdd4e3c88101cecdc5afb9b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i391c77fcea114168adcefd3a368e933a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8291bfbd551444d08280efa65d088b0c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16285192a2914c1f825e830eeb4eeb4f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d3917a82295412f9c9275a317a05f05_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfd78e27e7c6482c9fc4edcc25879cfc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief0525a09e3740098895f800adaf9574_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3fd8796636345479f329fc227aac5b9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id74fa3142e884619b01040d54d501710_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc02cf1426314af28563a5e9e8a9a5e1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cdf7726148d4d678b6d37597a2aac70_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92b4331fe0364273803356e287d2561b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic928117af54f4c0892def0fc4bb4ca6f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i535c834eab7441c89aa3908b303c0da7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6621e945d6764a88aa47982bd5644a44_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if24037d3545b44d7b17124b131dcad75_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i397591891c3b446b8fe2edeab28e0a83_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd0c449a45b5463791a11ad8fb885a7f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibab30eb09068437faeb20a15dacc2fac_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i534f8d2a6659488381539213487bbba7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6f3a72a51a14616b3c062670d5dc4fa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dbb3cd21e554ebcb4cf9e874172fbff_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i384b40a0741e4d28b9e0484a44c098d9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0d860116b5a468e8949760638176508_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie948ccd30d67420f85d943d80b28ab90_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad4db4c6c00f4fadb397e0b96255d42c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb4cca5b0ebf4f3aaa50ec243577cbda_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia298adcd58b540f39bbb027f8433e7d2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvs:CVSHealth2017IncentiveCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a56dcd6eefa4635ba2a3f12f2cf62af_I20181128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvs:AetnaInc2010StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a7879ca683449ffa5da3418bf44e68d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsAndPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4b79b50a55d4d81bf3f34a3889c23df_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsAndPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if240ee4b0e0f42d0b398179a94077c59_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsAndPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i983d904f9748498597906f71baf2d240_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadd17fda7e474b46b4ac5a0ddb578ebe_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70ba7d8cc22e4bd9aed774540fbc5a2a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsAndPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84d934c3f64d4e02a86157aaa7bdff55_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsAndPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ff8661ca2c148108297d7a193977a4b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib929cd58d3cb4a4096643aeea5fb40bb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73e8856343074dedba7db4a6c8fffe3a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc7553fd8525450491acaa6901e0117c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6f1a0aed7b14023be37031ee7e6081d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f45fbcf1c62442cb073a0677f6e9707_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2310964202714b25bc144cf465c755a8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1075aa911329487a922a9ba44f7a262d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i282e236db6f547ceac0cbccfa36c5851_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c6c53ae9a7745a09f19b70ba79aa0c2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c6f50abab644dc7a7aa89e157fa28d7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3754a0a6a19e4cec89a94c39d17cded7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibad8baec27da4cd58b6724ab5ca623d2_I20221117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2022RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia92776d15fb0441ab7ac651bee86eba1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2022RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7008e24144824bc0af76d8c285ae7f14_I20211209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a3166170d724c7b97874fd6a4dd3558_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e288b240a5b4df481e15c83675a98b4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bffae2ffcf645319842b632734137ce_D20220104-20220104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-04</xbrli:startDate><xbrli:endDate>2022-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84ac2198cd22435ba1570e2db00d59e9_I20230104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:CitibankNAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25c547443c724d349e0e7af7c9e93168_D20230104-20230104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:CitibankNAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-04</xbrli:startDate><xbrli:endDate>2023-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d0b0cadc79d4115ba44a2ff3d97605e_I20220104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i094abc0cc72e4a7b9ea560f3aa3450de_I20220104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17d6d14c27bd46188dd9e2556640612b_I20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12bf05eff52b4dc7a2761da3f17bd087_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3549637e3aa64b7ca86fda506d366817_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5d6daa4ca684089955a31c220b36c14_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59704ef4a59040dea06f0021fcb06568_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc442e76415641328a8c0780c2b0fd3b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52430d6ae75d4b3fae0b76f1ae95568c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i500357364f0b4a8aa0660969b4e7e47e_I20230101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2861b22f2af148719342305921a4f8a9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHMOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3c08b2b0c4e47d4803766dfaa373def_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHMOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55bbfd8a1ccf4503a274fb9d768bf153_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHMOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10dc16dcaa2a4ba381f65a9a4a83824e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHMOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3172ad2aca194783adc959bfa45cb532_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHMOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice175d1759f24588b3cf0829061e9e44_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHMOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9ccb78a44d7465982d030ff243bbb22_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i771fadc404fa4b92b4c5f7223f25415c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88fc675ce48b4c548ef81361fcc6c9d6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dc4dc90c6c14d12b12e609426ef8a6e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcd29ef153c04215b9cfa268ba78b5f0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f0ef44e552b4f5b981adaa9006f01dc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i023f6f414fc44282a2cc8132892a707c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee8d0bfbbe9b491fb9bfa6c2b789c080_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07377a7640384b77a5031acac5ac0cff_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfb87a5b2adf46d8a1cc7648916f9ec9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifea16681bcf147688ca4766b0691becd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0883ba92f0894b389a5662952ea59782_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25433e213492429485a961cd63705c7d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0cc3bef65884acf9911dabdba462d4a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i766e456db6b04cc6983552df4d2bd677_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e7b828a30914b35b0be92961fa877cb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a4812ee71224d53b0a6f7e8aee63c1c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i598ca408d2d84a49a1bce5601d7579a1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i811c61381d624e819e35527aea6e070f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia514adc5b997452badcc59a3cef31271_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01610c9c48964170846a9803dfaae808_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5ca31cddc0e4d939c02b38a65d9a6dd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c92e83572bf462c88118f40349b2650_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb9f09a01d4b4d99b74e89116f65644f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22d7007c61d0497e98e462fffb60e872_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if125eb5e1f404115a1ed0d00ee58b816_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2aee76db1bb748378d6caddd4053ea53_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90400ed7cb0a406798d26f08b8d43428_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82369985b1244530ab5a13db891d7cb5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec1de78285984edda41f8718f4ee9eae_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb77c13970ba4503946c83a942f0b97b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f3a20682c0f4c82a18c98153f67cbfd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c4a15704cee48ee8522b657c8eb6247_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5be5c21fc6b47318e20171c1f0a645b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b84989b019a41baa48fa485b7f433eb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1aeff9cdec2548d19148b1b223aae8c8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f4df77c750240e3a41b042b6e64fc43_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b83d8d8e7104451a4bcacd3638e07ca_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if885d6ab9e204495a3e6ef113c294079_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72d609617ef245bab1355fa62da5e409_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a3276638fa043e8b7afa530e1d05bb2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fb000b6c98f4852bdadc304be11feb1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cf1c76c42274016b31466d614be3e9d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i351a28ebc5774422943a9b3793f826c0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e58ede6136947f8b425e9c08cd2ab43_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba7e0b37b090469783d9d2507887d647_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45396cadefb0439195f503c88cc4379c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2b7c36808c049e6bacef0812147f213_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibeb7c35ad88b4db086fed358829f1fca_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:StockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac8347b945e247b7ba7d5c565f033409_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:StockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5695caba25e84d32ab05654a2de0b06a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:StockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54d9d35ededb400290c122b74d7762fb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10fcd8594c7341938f00b2bcb419f4c9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic788c95fb5c54497bda6d70714f8f38b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8b5128a2a36428d980c81abdc2d74c7_D20230101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="reinsurance_agreement"><xbrli:measure>cvs:reinsurance_agreement</xbrli:measure></xbrli:unit><xbrli:context id="icfc7256b949f40db867c30ba258ef319_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:HartfordLifeAndAccidentInsuranceCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31cd59a8c7b74ded8d867dc5a415def7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:HartfordLifeAndAccidentInsuranceCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17e2ab802dda4aed8d1d06c6ae11e2f6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:LincolnLifeAnnuityCompanyOfNewYorkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67df86d1566f40d3984c59da72c03ce0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:LincolnLifeAnnuityCompanyOfNewYorkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc5740783a6940949d69470ccd32d19e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:VOYARetirementInsuranceAndAnnuityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20f471f240524ef8b98dd7b01be1b787_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:VOYARetirementInsuranceAndAnnuityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0162c987e7634f4fae5ee04958939adf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30bb205b44d94d42bbc0af842bfe1376_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2253b0fadbb64b758c7a25f141c58162_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:AllOtherReinsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91b1f9bf665d415c9bc2b9f98030d772_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:AllOtherReinsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lease"><xbrli:measure>cvs:lease</xbrli:measure></xbrli:unit><xbrli:context id="i89589b4e8c2b4f25b791df1123f534f7_D20220801-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:FederalCourtInOhioJudgmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03d4640633404e31a33fb826637ad08a_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:FederalCourtInOhioJudgmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b026ed44ce7463faf26ee5548ce9d7d_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:StateOfFloridaSettlementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaa8af588ffe417797fab6c210df9c5b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:StateOfFloridaSettlementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f9313db581d4747bb5036854512069d_D20221201-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id48716cf9312414a9271423a5fd71f20_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie67a9c6077ac426d83b2d281de921897_D20221201-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:TribalEntitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0711d6880304457da9bc46c7f815c64f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:TribalEntitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i429b564fb66a4c4db88cad8833594b8a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkAndOtherOpioidRelatedClaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i939712c24e004976bf4f03ca8692f893_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkAndOtherOpioidRelatedClaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaca84de086504e58ba6e3854de871467_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkAndOtherOpioidRelatedClaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64d6b9d0c0594df5bccc5dbc7ec5cfa6_D20230101-20231231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkAndOtherOpioidRelatedClaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if13a1b08fb134bc2819e0fbde58e3608_D20240101-20241231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkAndOtherOpioidRelatedClaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51647e75bc724c0097093f48fc959e1c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:RadcliffAndFlaimVAetnaIncEtAlMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>cvs:claim</xbrli:measure></xbrli:unit><xbrli:context id="ic57ff1de57e040e09c97cab45478a2d9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe58c09ac79e451fbfad93b9169958d4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12151a132ac84f09952fa59e048adb99_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie15ff7b3ed9249059a31d87e8221ef8d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib242b2a53204442293d0e613aa093688_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83a2435cc9ab448c913552eb356f4039_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia379beb5856c4694ac66b32c06bf2386_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1707f9f5c214463ebc3f072c05afa26e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a2425da88d34b11a7d4ed0662f4e0c0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5da73c1ec8f946c9afb45f207ff36c25_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bddb95b4cf348ec83e4a333d7575820_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b1171c68bbe4af1819c9145310c6fb8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff2a6e509d3c452fbb34c09f2c1f55ea_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf761e93be114754a9786359d43f61dd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8708367e0d6148a297ee5ca38d90794b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5e992bf9c2a499eaf6476b15ef7c5f5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc4a75422af949c2a32932d3412701db_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93f387cc7da9423da81f99d85943fc07_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia738f2f875064e3b9b39a81213de4404_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57299b3f0d29410bbd43971727bf7de2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cfee834f48c44269e6203285ea53742_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf605eb33300435fa4bb68398ee8e8db_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b8dd9bca2d845c5a94bae3567479a9e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bb91f8d55eb47ff966a699f6afb0276_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8b4d98a4ab443d1864e4785b87c3333_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebc232da670a4ceabcfa09b1f0849657_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8104c5fdfe0c4205a5f07c99c7cede7b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90b72ec258964345839ac8de15529de0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i677074299da14bd2b078357e93653928_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i114930f0b44c4d1a9f07a0c3d6dd2dd5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1b5e13d39f046e3b93ecd36eeb5ee63_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4d84170ec8e498b9520974828e0c142_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i948f596e14ee4a9d9806fb733eb3ebcd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i782729dd554e4d80bb426bea495446dd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i963c0343d69a42caadc378204229b722_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cvs:USFederalGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03d09415d2bf43b384994476ca92e168_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cvs:USFederalGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75dd5be1e137424fa4519c29f0daa19d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cvs:USFederalGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic42863604ce54004b9083c8738b254f9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a109a847174412e8d5696bab1036d5c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94f2ff5e331c4b7687981a263ec1c30d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7643d22e2ea64b119f44152086b5ef19_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28a3b9441e5e432f912162e86ac57adc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38f3804941744661bf9c3ad58fc2aad2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d20d05e0c4b4f8688a601a6a2a0b0df_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i940aaafcbe33455889e57c5de95674de_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94f36228e56d4a5e93aeacea94e8a9c3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b77d3d696ee47dba7d85700d9f05fd1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTgtMS0xLTI5MjkwOQ_c7c47afe-7c09-404c-8eab-bfc84e73f762 id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTEwLTEtMS0yOTI5MDk_54b1200e-622f-43b1-bc66-26023b61255a id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTctMS0xLTI5MjkwOQ_c6eb65b0-97a6-4658-b684-153587943450" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzk4OTU2MDQ2NTA5OTI_0918e7e7-e2f8-48f2-b797-be453d0ca700" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTQtMS0xLTI2NTI0Nw_8f1bb28a-c8a4-4c78-9ea3-af61cd28b62f id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzgtNC0xLTEtMjY1MjQ3_b3517f08-7282-4c85-8f1c-6e22b84fa874 id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI2LTQtMS0xLTI2NTI0Nw_69e345b2-8fd2-495b-b6c2-569e13e37943 id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTQtMS0xLTI2NTI0Nw_c2b5caaf-e724-468f-87e1-a662ef57b586 id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtNC0xLTEtMjY1MjQ3_335a7aa8-8c30-4b17-a5c7-4da78b6cf53b id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE3LTQtMS0xLTI2NTI0Nw_b087569e-b95a-47ca-9bcc-80b7e4472a6a id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTQtMS0xLTI2NTI0Nw_1b6f591b-bd17-46c4-9673-7791614c2538" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3Nw_ad8b6184-2d5f-4358-aca0-fe4aae4db63a" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzQtNi0xLTEtMjY1MjQ3_ff0587d7-da99-4ddb-8c92-ab01066108c2 id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzQtMTAtMS0xLTI2NTI0Nw_8ae1937e-aba3-4db1-b06b-6ea47c9a06f8 id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzQtOC0xLTEtMjY1MjQ3_a032804d-c9e5-4ea5-8b30-43a8d7915f00" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3Mw_981c78eb-618a-44f0-9a9d-80b97609c9e3" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE4LTUtMS0xLTI2NTI0Nw_b5044474-ff72-4143-a8b9-3c5839978fa9 id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzktNS0xLTEtMjY1MjQ3_d4b1cd72-a297-42b8-809c-b1f8f1c69c9f id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTItMS0xLTI2NTI0Nw_8027cace-077c-4657-b8a5-343955af68fd id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTUtMS0xLTI2NTI0Nw_fcbd8ce3-30b8-4171-8a70-7b62caa5b56e id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTUtMS0xLTI2NTI0Nw_6963df9f-0ea1-4ac6-b0b5-ec498ce9787e id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzgtMi0xLTEtMjY1MjQ3_3f1718f0-be4b-46c6-92b0-3211aa793753 id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTUtMS0xLTI2NTI0Nw_b1a6a773-e6f4-4300-9d66-479c354994aa id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTItMS0xLTI2NTI0Nw_8860a665-734e-4981-ad73-7ff28eb0e6f2 id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtNS0xLTEtMjY1MjQ3_bf3567bd-5dff-4143-aed8-f6311896e895 id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI3LTUtMS0xLTI2NTI0Nw_07c936c0-f94c-4c22-955f-5b8f2c82a300 id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtMi0xLTEtMjY1MjQ3_73897469-4aee-4b20-b92f-d8b722c9d81b id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTItMS0xLTI2NTI0Nw_acd205b2-ef06-4bc4-9857-1dae880fab11 id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI3LTItMS0xLTI2NTI0Nw_7bb20a0c-dae7-400a-932d-6273537cbc05 id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE4LTItMS0xLTI2NTI0Nw_fdb2753c-df7b-47ab-ac9e-0dd3d25a3a1f id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzktMi0xLTEtMjY1MjQ3_5d0ba310-3d35-4b81-a47c-81bd2313b35e" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3NQ_df308064-6268-4ba8-aef5-0aa63fa331d2" order="1"></ix:relationship></ix:resources></ix:header></div><div id="ib58f60372ede4aa484e6883aab8684af_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8xMzcz_377d959e-7975-457e-a178-65b3a5c0dec7">8-K</ix:nonNumeric> </span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:71.773%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.027%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date of Report (Date of earliest event reported):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGFibGU6YmRlY2RlNmM1NTU2NGM2MjkzZjcyYTVlMjc3MDc4YWMvdGFibGVyYW5nZTpiZGVjZGU2YzU1NTY0YzYyOTNmNzJhNWUyNzcwNzhhY18wLTEtMS0xLTI5NTk1MA_025cb68f-a8bb-491e-83c7-1be68f3c68e8">May 25, 2023</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><img src="cvs-20230525_g1.jpg" alt="cvshealtha38.jpg" style="height:19px;margin-bottom:5pt;vertical-align:text-bottom;width:104px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8xMzc0_8ff1357b-7175-412c-bf86-0f83bbf8bbc1">CVS HEALTH CORP</ix:nonNumeric>ORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGFibGU6MGZmODY2ZTRmNzFiNDIzYWE5NjExYTIyNTI4MjQyZTcvdGFibGVyYW5nZTowZmY4NjZlNGY3MWI0MjNhYTk2MTFhMjI1MjgyNDJlN18wLTAtMS0xLTI5NTk1MA_481e200f-541b-40ae-89b6-fd102467104a">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGFibGU6MGZmODY2ZTRmNzFiNDIzYWE5NjExYTIyNTI4MjQyZTcvdGFibGVyYW5nZTowZmY4NjZlNGY3MWI0MjNhYTk2MTFhMjI1MjgyNDJlN18wLTEtMS0xLTI5NTk1MA_2b398288-4fae-4580-90bb-0de4c61a7d62">001-01011</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGFibGU6MGZmODY2ZTRmNzFiNDIzYWE5NjExYTIyNTI4MjQyZTcvdGFibGVyYW5nZTowZmY4NjZlNGY3MWI0MjNhYTk2MTFhMjI1MjgyNDJlN18wLTItMS0xLTI5NTk1MA_e4c2b07b-30eb-4a4d-9e64-a40a9385fcd7">05-0494040</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission <br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer <br/>Identification No.)</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8xMzgw_e2a78325-653f-434c-97de-049faa58f44c">One CVS Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8xMzgx_3d7642e3-291d-4894-a91c-7d6fb8d2dc86">Woonsocket</ix:nonNumeric>, <ix:nonNumeric contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8xMzgy_2fb0e9d1-08c8-4beb-b9fd-3011f9103949">Rhode Island</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8xMzc1_43fc03e5-156a-48d6-b52f-148515c78662">02895</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(Zip Code)</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code: &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8xMzc2_2f0bd71c-bd37-4de6-9514-028c69775bec">401</ix:nonNumeric>) <ix:nonNumeric contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8xMzc3_472ab543-8518-4590-b92a-85b0ecd20c25">765-1500</ix:nonNumeric> </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Former name or former address, if changed since last report:&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525" name="dei:WrittenCommunications" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8xMzgz_c2757e3e-5a4c-479e-bfd7-3de77974f240">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8zODQ4MjkwNjk4NjAx_9a98f485-f2df-494e-a642-282fca52dba0">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8xMzc4_33f43d64-044a-4f31-812f-b3120f59a56a">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8zODQ4MjkwNjk4NjAy_b70e3d69-2328-4cdc-b8f4-3f63fca710df">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:33.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGFibGU6NGMxMzI4NzcyZmU3NDliYmEwNDhjNmRlOGE3ZGJhM2UvdGFibGVyYW5nZTo0YzEzMjg3NzJmZTc0OWJiYTA0OGM2ZGU4YTdkYmEzZV8xLTAtMS0xLTI5NTk1MA_6ddcde3e-0c0c-44bf-bc6c-add92cd9d723">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGFibGU6NGMxMzI4NzcyZmU3NDliYmEwNDhjNmRlOGE3ZGJhM2UvdGFibGVyYW5nZTo0YzEzMjg3NzJmZTc0OWJiYTA0OGM2ZGU4YTdkYmEzZV8xLTEtMS0xLTI5NTk1MA_e6a7991e-95a1-44e1-b51e-b7d8c2541836">CVS</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGFibGU6NGMxMzI4NzcyZmU3NDliYmEwNDhjNmRlOGE3ZGJhM2UvdGFibGVyYW5nZTo0YzEzMjg3NzJmZTc0OWJiYTA0OGM2ZGU4YTdkYmEzZV8xLTItMS0xLTI5NTk1MA_1f730c08-4112-4d8e-b87b-8671c171a180">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:96.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGFibGU6NTk2MzJkM2E0YWExNGQ5NzllN2U2ZGEzOGY3MDNlZGQvdGFibGVyYW5nZTo1OTYzMmQzYTRhYTE0ZDk3OWU3ZTZkYTM4ZjcwM2VkZF8wLTEtMS0xLTI5NTk1MA_19b55b93-3436-4089-bd41-aeae222e6a49">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#9744;</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ib58f60372ede4aa484e6883aab8684af_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 8 - Other Events</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.01   Other Events.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously reported, effective the first quarter of 2023, CVS Health Corporation (the &#8220;Company&#8221;) realigned the composition of its segments to correspond with changes to its operating model and reflect how its Chief Operating Decision Maker reviews information and manages the business. As a result of this realignment, the Company formed a new Health Services segment, which in addition to providing a full range of pharmacy benefit management solutions, also delivers health care services in the Company&#8217;s medical clinics, virtually, and in the home, as well as provider enablement solutions. In addition, the Company created a new Pharmacy &amp; Consumer Wellness segment, which includes its retail and long-term care pharmacy operations and related pharmacy services, as well as its retail front store operations. This segment also provides pharmacy fulfillment services to support the Health Services segment&#8217;s specialty and mail order pharmacy offerings. Following the segment realignment described above, the Company&#8217;s four reportable segments are as follows: Health Care Benefits, Health Services, Pharmacy &amp; Consumer Wellness and Corporate/Other. The Company began to report under the realigned segments effective with the filing of the Quarterly Report on Form 10-Q for the three months ended March 31, 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is filing this Current Report on Form 8-K (the &#8220;Form 8-K&#8221;) to revise the following sections: &#8220;Item 1. Business,&#8221; &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; &#8220;Item 7A. Quantitative and Qualitative Disclosures About Market Risk&#8221; and &#8220;Item 8. Financial Statements and Supplementary Data&#8221; included in its annual report on Form 10-K for the year ended December 31, 2022, which was filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on February 8, 2023 (the &#8220;2022 Form 10-K&#8221;), solely to reflect: </span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The previously reported realignment of the Company&#8217;s segments to correspond with changes made to its operating model as described in &#8220;Note 1 &#8211; Significant Accounting Policies&#8221; included in &#8220;Item 8. Financial Statements and Supplementary Data with Retrospective Adjustments&#8221; of Exhibit 99.1 of this Form 8-K, including the discontinuance of the former Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> segment reporting practice as described within the &#8220;Segment Analysis&#8221; section of &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations with Retrospective Adjustments&#8221; of Exhibit 99.1.</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The exclusion of the impact of net realized capital gains or losses from adjusted operating income, as described within the &#8220;Segment Analysis&#8221; section included in &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations with Retrospective Adjustments&#8221; of Exhibit 99.1.</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Additional disclosure in the &#8220;Medicare Update&#8221; included in &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations with Retrospective Adjustments&#8221; of Exhibit 99.1 related to the impact of the decline in the number of Medicare Advantage members in plans with star ratings of at least 4.0.</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the adoption of a new accounting standard related to the accounting for long-duration insurance contracts, which the Company adopted on January 1, 2023 using a modified retrospective transition method as of January 1, 2021, as described in &#8220;Note 8 &#8211; Other Insurance Liabilities and Separate Accounts&#8221; included in &#8220;Item 8. Financial Statements and Supplementary Data with Retrospective Adjustments&#8221; of Exhibit 99.1. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Form 8-K updates and supersedes the information in the following sections of the 2022 Form 10-K to reflect the application of the items described above:</span></div><div style="margin-top:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Item 1. Business&#8221; of the 2022 Form 10-K, which is updated and superseded by &#8220;Item 1. Business with Retrospective Adjustments&#8221; of Exhibit 99.1.</span></div><div style="margin-top:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; of the 2022 Form 10-K, which is updated and superseded by &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations with Retrospective Adjustments&#8221; of Exhibit 99.1.</span></div><div style="margin-top:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Item 7A. Quantitative and Qualitative Disclosures About Market Risk&#8221; of the 2022 Form 10-K, which is updated and superseded by &#8220;Item 7A. Quantitative and Qualitative Disclosures About Market Risk&#8221; of Exhibit 99.1.</span></div><div style="margin-top:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Item 8. Financial Statements and Supplementary Data&#8221; of the 2022 Form 10-K, which is updated and superseded by &#8220;Item 8. Financial Statements and Supplementary Data with Retrospective Adjustments&#8221; of Exhibit 99.1.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 99.1 is hereby incorporated by reference into this Item 8.01.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Company&#8217;s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023, the Company&#8217;s unaudited condensed consolidated financial statements for the three months ended March 31, 2022 reflected the application of the changes described above. The Company is filing this Form 8-K so that information reported in the Company&#8217;s 2022 Form 10-K </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">incorporated by reference in any document that the Company has filed or may file from time to time with the SEC is updated to reflect the items described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as specifically set forth above, the information in this Form 8-K does not reflect any event or development occurring after February 8, 2023, the date the Company filed the 2022 Form 10-K with the SEC. For a discussion of events and developments subsequent to the filing of the 2022 Form 10-K, please refer to the Company&#8217;s SEC filings since that date. The portions of the 2022 Form 10-K that have not been updated or superseded by the information included in Exhibit 99.1 remain effective.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 9 - Financial Statements and Exhibits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01   Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibits to this Current Report on Form 8-K are as follows: </span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO EXHIBITS</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.678%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="exhibit231-2022restated.htm">Consent of Ernst&#160;&amp; Young LLP.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="cvs-20230525_d2.htm">Excerpts from the Company&#8217;s Annual Report on Form 10-K</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="cvs-20230525_d2.htm"> for the year ended D</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="cvs-20230525_d2.htm">ecember 31, 2022</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="cvs-20230525_d2.htm"> reflecting retrospective adjustments to Part I, Item 1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="cvs-20230525_d2.htm">. Business</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="cvs-20230525_d2.htm">&#894; Part II, Item 7</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="cvs-20230525_d2.htm">. Management</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="cvs-20230525_d2.htm">&#8217;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="cvs-20230525_d2.htm">s Dis</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="cvs-20230525_d2.htm">cussion and An</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="cvs-20230525_d2.htm">alysis of Financial Condition and Re</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="cvs-20230525_d2.htm">sults of Operations</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="cvs-20230525_d2.htm">; Part II, Item 7A</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="cvs-20230525_d2.htm">. Quantitative and Qualitative Disclosures About Market Risk</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="cvs-20230525_d2.htm">&#894; and Part II, Item 8</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="cvs-20230525_d2.htm">. Financial Statements and Supplem</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="cvs-20230525_d2.htm">entary Data</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="cvs-20230525_d2.htm">.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The following excerpts from the Company&#8217;s Annual Report on Form&#160;10-K for the year ended December 31, 2022 reflecting retrospective adjustments formatted in Inline XBRL: (i)&#160;the Consolidated Statements of Operations, (ii) the Consolidated Statements of Comprehensive Income, (iii)&#160;the Consolidated Balance Sheets, (iv)&#160;the Consolidated Statements of Cash Flows, (v) the Consolidated Statements of Shareholders&#8217; Equity and (vi)&#160;the related Notes to Consolidated Financial Statements. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.709%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CVS HEALTH CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 25, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ Shawn M. Guertin</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shawn M. Guertin</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>exhibit231-2022restated.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ia49e03804f7e4c17a978224aa3ebe532_1"></div><div style="min-height:72pt;width:100%"><div style="padding-left:18pt;text-align:right"><font><br></font></div><div style="padding-left:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consent of Independent Registered Public Accounting Firm</font></div><div style="padding-left:18pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-271582, 333-270936, 333-238507, 333-230035, 333-228622, 333-167746, 333-217853, 333-208805, 333-141481, 333-139470, 333-63664, 333-91253, 333-49407, 333-34927, and 333-28043) of CVS Health Corporation of our report dated February 8, 2023 (except for Note 8 and Note 18, as to which the date is May 25, 2023), with respect to the consolidated financial statements of CVS Health Corporation and our report dated February 8, 2023, with respect to the effectiveness of internal control over financial reporting of CVS Health Corporation, included in this Current Report on Form 8-K.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston, Massachusetts</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 25, 2023</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:18pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>cvs-20230525_d2.htm
<DESCRIPTION>EX-99.1
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:a470d627-05b8-4106-b3ee-d69f01519b0f,g:7f491b32-9056-4172-9edc-e6fc2e3bdea2,d:36038907935e41eea5e9cf7cac915d44--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2022" xmlns:cvs="http://www.cvshealth.com/20230525" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cvs-20230525_d2</title></head><body><div id="i36038907935e41eea5e9cf7cac915d44_10"></div><div style="min-height:45pt;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.1</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXPLANATORY NOTE</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CVS Health Corporation, together with its subsidiaries (collectively, &#8220;CVS Health&#8221; or the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221;) is filing this Exhibit 99.1 to revise the following sections: &#8220;Item 1. Business,&#8221; &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; &#8220;Item 7A. Quantitative and Qualitative Disclosures About Market Risk&#8221; and &#8220;Item 8. Financial Statements and Supplementary Data&#8221; included in its annual report on Form 10-K for the year ended December 31, 2022, which was filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on February 8, 2023 (the &#8220;2022 Form 10-K&#8221;), solely to reflect:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">The previously reported realignment of the Company&#8217;s segments to correspond with changes made to its operating model as described in &#8220;Note 1 &#8211; Significant Accounting Policies&#8217;&#8217; included in &#8220;Item 8. Financial Statements and Supplementary Data with Retrospective Adjustments&#8221; of this Exhibit 99.1, including the discontinuance of the former Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> segment reporting practice as described within the &#8220;Segment Analysis&#8221; section of &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations with Retrospective Adjustments&#8221; of this Exhibit 99.1.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">The exclusion of the impact of net realized capital gains or losses from adjusted operating income, as described within the &#8220;Segment Analysis&#8221; section of &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations with Retrospective Adjustments&#8221; of this Exhibit 99.1.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Additional disclosure in the &#8220;Medicare Update&#8221; included in &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations with Retrospective Adjustments&#8221; of this Exhibit 99.1 related to the impact of the decline in the number of Medicare Advantage members in plans with a star rating of at least 4.0.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the adoption of a new accounting standard related to the accounting for long-duration insurance contracts, which the Company adopted on January 1, 2023 using a modified retrospective transition method as of January 1, 2021, as described in &#8220;Note 8 &#8211; Other Insurance Liabilities and Separate Accounts&#8221; included in &#8220;Item 8. Financial Statements and Supplementary Data with Retrospective Adjustments&#8221; of this Exhibit 99.1. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">These items did not have a material impact on trends in the Company&#8217;s results of operations for 2021 compared to 2020. Accordingly, for discussion of the Company&#8217;s results of operations for 2021 compared to 2020, see &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in the Company&#8217;s annual report on Form 10-K for the fiscal year ended December 31, 2021 filed with the SEC on February 9, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This information is provided solely to present recast segment reporting financial information and to reflect the other above-referenced changes. Accordingly, the following information speaks as of the original filing date of the 2022 Form 10-K, does not reflect events that may have occurred subsequent to the original filing date, and should be read in conjunction with the Company&#8217;s other filings with the SEC since the date of the 2022 Form 10-K. Except for the specific information from the 2022 Form 10-K presented herein and noted above, this Exhibit does not amend or modify any other of the disclosures made in the 2022 Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Private Securities Litigation Reform Act of 1995 (the &#8220;Reform Act&#8221;) provides a &#8220;safe harbor&#8221; for forward-looking statements, so long as (1) those statements are identified as forward-looking, and (2) the statements are accompanied by meaningful cautionary statements that identify important factors that could cause actual results to differ materially from those discussed in the statement. We want to take advantage of these safe harbor provisions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain information contained in this Exhibit is forward-looking within the meaning of the Reform Act or SEC rules. This information includes, but is not limited to the forward-looking information in &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations with Retrospective Adjustments&#8221; included in this Exhibit. In addition, throughout this Exhibit and our other reports and communications, we use the following words or variations or negatives of these words and similar expressions when we intend to identify forward-looking statements:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.354%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Anticipates</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Believes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Can</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Continue</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Could</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Estimates</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Evaluate</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Expects</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Explore</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Forecast</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Guidance</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Intends</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Likely</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">May</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Might</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Outlook</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Potential</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Predict</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Probable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Projects</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Seeks</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Should</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">View</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Will</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">All statements addressing the future operating performance of CVS Health or any segment or any subsidiary and/or future events or developments, including statements relating to the impact of coronavirus disease 2019 (&#8220;COVID-19&#8221;) and any new variants or viruses on the Company&#8217;s businesses, investment portfolio, operating results, cash flows and/or financial condition, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">statements relating to corporate strategy, statements relating to future revenue, operating income or adjusted operating income, earnings per share or adjusted earnings per share, Health Care Benefits segment business, sales results and/or trends, medical cost trends, medical membership, Medicare Part D membership, medical benefit ratios and/or operations, Health Services segment business, sales results and/or trends and/or operations, Pharmacy &amp; Consumer Wellness segment business, sales results and/or trends and/or operations, incremental investment spending, interest expense, effective tax rate, weighted-average share count, cash flow from operations, net capital expenditures, cash available for debt repayment, statements related to possible, proposed, pending or completed acquisitions, joint ventures, investments or combinations that involve, among other things, the timing or likelihood of receipt of regulatory approvals, the timing of completion, integration synergies, net synergies and integration risks and other costs, including those related to CVS Health&#8217;s acquisitions of Signify Health, Inc. and Oak Street Health, Inc., enterprise modernization, transformation, leverage ratio, cash available for enhancing shareholder value, inventory reduction, turn rate and/or loss rate, debt ratings, the Company&#8217;s ability to attract or retain customers and clients, store development and/or relocations, new product development, and the impact of industry and regulatory developments, as well as statements expressing optimism or pessimism about future operating results or events, are forward-looking statements within the meaning of the Reform Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward-looking statements rely on a number of estimates, assumptions and projections concerning future events, and are subject to a number of significant risks and uncertainties and other factors that could cause actual results to differ materially from those statements. Many of these risks and uncertainties and other factors are outside our control. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain additional risks and uncertainties and other factors are described under &#8220;Risk Factors&#8221; included in Part I, Item 1A of our 2022 Form 10-K; these are not the only risks and uncertainties we face. There can be no assurance that the Company has identified all the risks that may affect it. Additional risks and uncertainties not presently known to the Company or that the Company currently believes to be immaterial also may adversely affect the Company&#8217;s businesses. If any of those risks or uncertainties develops into actual events, those events or circumstances could have a material adverse effect on the Company&#8217;s businesses, operating results, cash flows, financial condition and/or stock price, among other effects. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should not put undue reliance on forward-looking statements. Any forward-looking statement speaks only as of the date of the 2022 Form 10-K, and we disclaim any intention or obligation to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div><span><br/></span></div><div id="i36038907935e41eea5e9cf7cac915d44_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.  Business with Retrospective Adjustments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation, together with its subsidiaries (collectively, &#8220;CVS Health,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221;), is a leading diversified health solutions company reshaping health care to help make healthier happen for more Americans. In an increasingly connected and digital world, CVS Health is meeting people wherever they are and changing health care to meet their needs. The Company has more than 9,000 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with over 110 million plan members with expanding specialty pharmacy solutions and a dedicated senior pharmacy care business serving more than one million patients per year. The Company also serves an estimated 35 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its integrated health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with its new operating model adopted in the first quarter of 2023, the Company realigned the composition of its segments to reflect how its Chief Operating Decision Maker reviews information and manages the business. As a result of this realignment, the Company formed a new Health Services segment, which in addition to providing a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, also delivers health care services in the Company&#8217;s medical clinics, virtually, and in the home, as well as provider enablement solutions. In addition, the Company created a new Pharmacy &amp; Consumer Wellness segment, which includes its retail and long-term care pharmacy operations and related pharmacy services, as well as its retail front store operations. This segment will also provide pharmacy fulfillment services to support the Health Services segment&#8217;s specialty and mail order pharmacy offerings. Segment financial information has been recast to reflect these changes. See Note 18 &#8216;&#8216;Segment Reporting&#8217;&#8217; included in Item 8 of this Exhibit 99.1 for segment financial information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the segment realignment described above, the Company has four reportable segments: Health Care Benefits, Health Services, Pharmacy &amp; Consumer Wellness and Corporate/Other.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Strategy</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company seeks to reimagine the consumer health care experience to make it easier and more affordable to live a healthier life. This means delivering solutions that are more personalized, simpler to use, and increasingly digital so that consumers can receive care when, where and how they desire. CVS Health is also shifting from transaction-based care to addressing holistic health &#8211; physical, emotional, social, economic &#8211; which will lead to higher quality care and lower medical costs. The Company is a leader in key segments of health care through its foundational businesses and is seeking to create new sources of value by expanding into next generation care delivery and health services, with a goal of improving satisfaction levels for both providers and consumers. The Company believes its consumer-centric strategy will drive sustainable long-term growth and deliver value for all stakeholders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic and its emerging new variants continue to impact the U.S. and other countries around the world. Our strong local presence and scale in communities across the country has enabled us to play an indispensable role in the national response to COVID-19, as well as provide seamless support for our customers wherever they need us: in our CVS locations, in their homes, and virtually. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offered COVID-19 diagnostic testing at more than 4,700 CVS pharmacy locations, at community-based testing sites in underserved areas and through its Return Ready</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">SM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">solution as of December&#160;31, 2022. During 2021, the Company also began selling over-the-counter (&#8220;OTC&#8221;) test kits in its retail locations and online. The Company began administering COVID-19 vaccinations in long-term care facilities and in certain of its retail pharmacies during December 2020 and February 2021, respectively, and began the administration of COVID-19 boosters and pediatric vaccines during the fourth quarter of 2021. The Company offered COVID-19 vaccinations at more than 9,000 CVS pharmacy locations as of December&#160;31, 2022. During the year ended December&#160;31, 2022, the Company administered more than 15&#160;million COVID-19 tests and nearly 28&#160;million COVID-19 vaccines and sold more than 63&#160;million OTC test kits. The Company expects to continue to play a significant role in COVID-19 testing and vaccine administration in the future, while maintaining a strong commitment to testing and vaccine equity by optimizing site locations and targeting outreach initiatives to reach vulnerable populations. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of COVID-19 on the Company&#8217;s businesses, operating results, cash flows and financial condition in the years ended December 31, 2022, 2021 and 2020, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this Exhibit 99.1.</span></div><div><span><br/></span></div><div id="i36038907935e41eea5e9cf7cac915d44_16"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment operates as one of the nation&#8217;s leading diversified health care benefits providers, serving an estimated 35 million people as of December&#160;31, 2022. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Products and Services </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk of medical and dental care costs) as &#8220;ASC.&#8221; Health Care Benefits products and services consist of the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Commercial Medical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Health Care Benefits segment offers point-of-service (&#8220;POS&#8221;), preferred provider organization (&#8220;PPO&#8221;), health maintenance organization (&#8220;HMO&#8221;) and indemnity benefit (&#8220;Indemnity&#8221;) plans. Commercial medical products also include health savings accounts (&#8220;HSAs&#8221;) and consumer-directed health plans that combine traditional POS or PPO and/or dental coverage, subject to a deductible, with an accumulating benefit account (which may be funded by the plan sponsor and/or the member in the case of HSAs). With the launch of Aetna Virtual Primary Care</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2021, eligible members now have access to health services remotely, paired with access to in-person visits with providers in the Company&#8217;s network, including at MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations. Principal products and services are targeted specifically to large multi-site national, mid-sized and small employers, individual insureds and expatriates. The Company offers medical stop loss insurance coverage for certain employers who elect to self-insure their health benefits. Under medical stop loss insurance products, the Company assumes risk for costs associated with large individual claims and/or aggregate loss experience within an employer&#8217;s plan above a pre-set annual threshold. The segment also has a portfolio of additional health products and services that complement its medical products such as dental plans, behavioral health and employee assistance products, provider network access and vision products. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Government Medical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In select geographies, the Health Care Benefits segment offers Medicare Advantage plans, Medicare Supplement plans and prescription drug coverage for Medicare beneficiaries; participates in Medicaid and subsidized Children&#8217;s Health Insurance Programs (&#8220;CHIP&#8221;); and participates in demonstration projects for members who are eligible for both Medicare and Medicaid (&#8220;Duals&#8221;). These Government Medical products are further described below:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Medicare Advantage: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through annual contracts with the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;), the Company offers HMO and PPO products for eligible individuals in certain geographic areas through the Medicare Advantage program. Members typically receive enhanced benefits over traditional fee-for-service Medicare coverage (&#8220;Original Medicare&#8221;), including reduced cost-sharing for preventive care, vision and other services. The Company offered network-based HMO and/or PPO plans in 46 states and Washington, D.C. in 2022. For certain qualifying employer groups, the Company&#160;offers Medicare PPO products nationally. When combined with the Company&#8217;s PDP product,&#160;these national PPO plans&#160;form an integrated national Insured Medicare product for employers that provides medical and pharmacy benefits.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Medicare PDP: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a national provider of drug benefits under the Medicare Part D prescription drug program. All Medicare eligible individuals are eligible to participate in this voluntary prescription drug plan. Members typically receive coverage for certain prescription drugs, usually subject to a deductible, co-insurance and/or co-payment. The Company offered PDP plans in all 50 states and Washington, D.C. in 2022.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Medicare Supplement: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For certain Medicare eligible members, the Company offers&#160;supplemental&#160;coverage for certain health care costs not covered by&#160;Original Medicare. The products included in the Medicare Supplement portfolio help to cover&#160;some of the&#160;gaps in Original Medicare, and include coverage for Medicare&#160;deductibles and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">coinsurance&#160;amounts. The Company offered a&#160;wide selection of Medicare Supplement products in 49 states and Washington, D.C. in 2022.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Medicaid and CHIP:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company offers health care management services to individuals eligible for Medicaid and CHIP under multi-year contracts with government agencies in various states that are subject to annual appropriations. CHIP are state-subsidized insurance programs that provide benefits for families with uninsured children. The Company offered these services on an Insured or ASC basis in 16 states in 2022.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Duals: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides health coverage to beneficiaries who are dually eligible for both Medicare and Medicaid coverage. These members must meet certain income and resource requirements in order to qualify for this coverage. The Company coordinates 100% of the care for these members and may provide them with additional services in order to manage their health care costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has a portfolio of transformative products and services aimed at creating a holistic and integrated approach to individual health and wellness. These products and services complement the Commercial Medical and Government Medical products and aim to provide innovative solutions, create integrated experience offerings and enable enhanced care delivery to customers. </span></div><div style="margin-bottom:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Provider Networks </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company contracts with physicians, hospitals and other providers for services they provide to the Company&#8217;s members. The Company uses a variety of techniques designed to help encourage appropriate utilization of medical services (&#8220;utilization&#8221;) and maintain affordability of quality coverage. In addition to contracts with providers for negotiated rates of reimbursement, these techniques include creating risk sharing arrangements that align economic incentives with providers, the development and implementation of guidelines for the appropriate utilization and the provision of data to providers to enable them to improve health care quality. At December&#160;31, 2022, the Company&#8217;s underlying nationwide provider network had approximately 1.6 million participating providers. Other providers in the Company&#8217;s provider networks also include laboratory, imaging, urgent care and other freestanding health facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Quality Assessment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS uses a 5-star rating system to monitor Medicare health care and drug plans and ensure that they meet CMS&#8217;s quality standards. CMS uses this rating system to provide Medicare beneficiaries with a tool that they can use to compare the overall quality of care and level of customer service of companies that provide Medicare health care and drug plans. The rating system considers a variety of measures adopted by CMS, including quality of preventative services, chronic illness management and overall customer satisfaction. See &#8220;Health Care Benefits Pricing&#8221; below in this Item 1 for further discussion of star ratings. The Company seeks Health Plan accreditation for Aetna Inc. (&#8220;Aetna&#8221;) HMO plans from the National Committee for Quality Assurance (&#8220;NCQA&#8221;), a private, not-for-profit organization that evaluates, accredits and certifies a wide range of health care organizations. Health care plans seeking accreditation must pass a rigorous, comprehensive review and must annually report on their performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aetna Life Insurance Company (&#8220;ALIC&#8221;), a wholly-owned subsidiary of the Company, has received nationwide NCQA PPO Health Plan accreditation. As of December&#160;31, 2022, all of the Company&#8217;s Commercial HMO and all of ALIC&#8217;s PPO members who were eligible participated in HMOs or PPOs that are accredited by the NCQA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s provider selection and credentialing/re-credentialing policies and procedures are consistent with NCQA and URAC, a health care accrediting organization that establishes quality standards for the health care industry, as well as state and federal, requirements. In addition, the Company is certified under the NCQA Credentials Verification Organization (&#8220;CVO&#8221;) certification program for all certification options and has URAC CVO accreditation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quality assessment programs for contracted providers who participate in the Company&#8217;s networks begin with the initial review of health care practitioners. Practitioners&#8217; licenses and education are verified, and their work history is collected by the Company or in some cases by the practitioner&#8217;s affiliated group or organization. The Company generally requires participating hospitals to be certified by CMS or accredited by The Joint Commission, the American Osteopathic Association, or Det Norske Veritas Healthcare.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also offers quality and outcome measurement programs, quality improvement programs, and health care data analysis systems to providers and purchasers of health care services.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Information Systems</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment currently operates and supports an end-to-end suite of information technology platforms to support member engagement, enrollment, health benefit administration, care management, service operations, financial reporting and analytics.&#160;The multiple platforms are supported by an integration layer to facilitate the transfer of real-time data.&#160;There is continued focus and investment in enterprise data platforms, cloud capabilities, digital products to offer innovative solutions and a seamless experience to the Company&#8217;s members through mobile and web channels.&#160;The Company is making concerted investments in emerging technology capabilities such as voice, artificial intelligence and robotics to further automate, reduce cost and improve the experience for all of its constituents. The Health Care Benefits segment is utilizing the full breadth of the Company&#8217;s assets to build enterprise technology that will help guide our members through their health care journey, provide them a high level of service, enable healthier outcomes and encourage them to take next best actions to lead healthier lives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Customers</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical membership is dispersed throughout the United States, and the Company also serves medical members in certain countries outside the United States. The Company offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, many of which are available nationwide. Depending on the product, the Company markets to a range of customers, including employer groups, individuals, college students, part-time and hourly workers, health plans, providers, governmental units, government-sponsored plans, labor groups and expatriates. For additional information on medical membership, see &#8220;Health Care Benefits Segment&#8221; in the Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (the &#8220;MD&amp;A&#8221;) included in Item 7 of this Exhibit 99.1. </span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company markets both Commercial Insured and ASC products and services primarily to employers that sponsor the Company&#8217;s products for the benefit of their employees and their employees&#8217; dependents. Frequently, larger employers offer employees a choice among coverage options from which the employee makes his or her selection during a designated annual open enrollment period. Typically, employers pay all of the monthly premiums to the Company and, through payroll deductions, obtain reimbursement from employees for a percentage of the premiums that is determined by each employer. Some Health Care Benefits products are sold directly to employees of employer groups on a fully employee-funded basis. In some cases, the Company bills the covered individual directly. In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) in eight states through which it sells Insured plans directly to individual consumers. The Company entered Public Exchanges in four additional states effective January 2023.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers Insured Medicare coverage on an individual basis as well as through employer groups to their retirees. Medicaid and CHIP members are enrolled on an individual basis. The Company also offers Insured health care coverage to members who are dually-eligible for both Medicare and Medicaid. </span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health Care Benefits products are sold through: the Company&#8217;s sales personnel; independent brokers, agents and consultants who assist in the production and servicing of business; as well as private health insurance exchanges (&#8220;Private Exchanges&#8221;) and Public Exchanges (together with Private Exchanges, &#8220;Insurance Exchanges&#8221;). For large employers or other entities that sponsor the Company&#8217;s products (&#8220;plan sponsors&#8221;), independent consultants and brokers are frequently involved in employer health plan selection decisions and sales. In some instances, the Company may pay commissions, fees and other amounts to brokers, agents, consultants and sales representatives who place business with the Company. In certain cases, the customer pays the broker for services rendered, and the Company may facilitate that arrangement by collecting the funds from the customer and transmitting them to the broker. The Company supports marketing and sales efforts with an advertising program that may include television, radio, billboards, print media and social media, supplemented by market research and direct marketing efforts.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. federal government is a significant customer of the Health Care Benefits segment through contracts with CMS for coverage of Medicare-eligible individuals and federal employee-related benefit programs. Other than the contracts with CMS, the Health Care Benefits segment is not dependent upon a single customer or a few customers the loss of which would have a significant effect on the earnings of the segment. The loss of business from any one or a few independent brokers or agents would not have a material adverse effect on the earnings of the Health Care Benefits segment. In 2022, 2021 and 2020, Health Care Benefits segment revenues from the federal government accounted for 14%, 14% and 13%, respectively, of the Company&#8217;s consolidated total revenues. Contracts with CMS for coverage of Medicare-eligible individuals in the Health Care Benefits segment accounted for approximately 74%, 79% and 78%, respectively, of the Company&#8217;s consolidated revenues from the federal government in 2022, 2021 and 2020.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Pricing</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For Commercial Insured plans, contracts containing the pricing and other terms of the relationship are generally established in advance of the policy period and typically have a duration of one year. Fees under ASC plans are generally fixed for a period of one year.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, a fixed premium rate is determined at the beginning of the policy period for Commercial Insured plans. The Company typically cannot recover unanticipated increases in health care and other benefit costs in the current policy period; however, it may consider prior experience for a product in the aggregate or for a specific customer, among other factors, in determining premium rates for future policy periods. Where required by state laws, premium rates are filed and approved by state regulators prior to contract inception. Future operating results could be adversely affected if the premium rates requested are not approved or are adjusted downward or their approval is delayed by state or federal regulators. </span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has Medicare Advantage and PDP contracts with CMS to provide HMO, PPO and prescription drug coverage to Medicare beneficiaries in certain geographic areas. Under these annual contracts, CMS pays the Company a fixed per member (or &#8220;capitation&#8221;) payment and/or a portion of the premium, both of which are based on membership and adjusted for demographic and health risk factors. CMS also considers inflation, changes in utilization patterns and average per capita fee-for-service Medicare costs in the calculation of the fixed capitation payment or premium. PDP contracts also provide a risk-sharing arrangement with CMS to limit the Company&#8217;s exposure to unfavorable expenses or benefit from favorable expenses. Amounts payable to the Company under the Medicare arrangements are subject to annual revision by CMS, and the Company elects to participate in each Medicare service area or region on an annual basis. Premiums paid to the Company for Medicare products are subject to federal government reviews and audits, which can result, and have resulted, in retroactive and prospective premium adjustments and refunds to the government and/or members. In addition to payments received from CMS, some Medicare Advantage products and all PDP products require a supplemental premium to be paid by the member or sponsoring employer. In some cases, these supplemental premiums are adjusted based on the member&#8217;s income and asset levels. Compared to Commercial Medical products, Medicare contracts generate higher per member per month revenues and higher health care and other benefit costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#8220;ACA&#8221;) ties a portion of each Medicare Advantage plan&#8217;s reimbursement to the plan&#8217;s &#8220;star ratings.&#8221; Plans must have a star rating of 4 or higher (out of 5) to qualify for bonus payments. CMS released the Company&#8217;s 2023 star ratings in October 2022. The Company&#8217;s 2023 star ratings will be used to determine which of the Company&#8217;s Medicare Advantage plans have ratings of four stars or higher and qualify for bonus payments in 2024. Based on the Company&#8217;s membership at December&#160;31, 2022, 21% of the Company&#8217;s Medicare Advantage members were in plans with 2023 star ratings of at least 4.0 stars, compared to 87% of the Company&#8217;s Medicare Advantage members being in plans with 2022 star ratings of at least 4.0 stars based on the Company&#8217;s membership at December&#160;31, 2021. Refer to &#8220;Medicare Star Ratings&#8221; within the &#8220;Government Regulation&#8221; section of this Item 1 for further discussion of the decrease in the Company&#8217;s star ratings. </span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rates for Medicare Supplement products are regulated at the state level and vary by state and plan.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Insured Medicaid contracts, state government agencies pay the Company fixed monthly rates per member that vary by state, line of business and demographics; and the Company arranges, pays for and manages the health care services provided to Medicaid beneficiaries. These rates are subject to change by each state, and, in some instances, provide for adjustment for health risk factors. CMS requires these rates to be actuarially sound. The Company also receives fees from customers where it provides services under ASC Medicaid contracts. ASC Medicaid contracts generally are for periods of more than one year, and certain of them contain performance incentives and limited financial risk sharing with respect to certain medical, financial and operational metrics. Under these arrangements, performance is evaluated annually, with associated financial incentive opportunities, and financial risk share obligations are typically limited to a percentage of the fees otherwise payable to the Company. Payments to the Company under Medicaid contracts are subject to the annual appropriation process in the applicable state.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Duals contracts, the rate setting process is generally established by CMS in partnership with the state government agency participating in the demonstration project. Both CMS and the state government agency may seek premium and other refunds under certain circumstances, including if the Company fails to comply with CMS regulations or other contractual requirements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers HMO and consumer-directed medical and dental plans to federal employees under the Federal Employees Health Benefits (&#8220;FEHB&#8221;) Program and the Federal Employees Dental and Vision Insurance Program. Premium rates and fees </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for those plans are subject to federal government review and audit, which can result, and have resulted, in retroactive and prospective premium and fee adjustments and refunds to the government and/or members. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2014, the ACA imposed significant new industry-wide fees, assessments and taxes, including an annual levy known as the health insurer fee (the &#8220;HIF&#8221;). In December 2019, the HIF was repealed for calendar years after 2020. For additional information on the ACA fees, assessments and taxes, see Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; included in Item 8 of this Exhibit 99.1. The Company&#8217;s goal is to collect premiums and fees where possible, or solve for, all of the ACA-related fees, assessments and taxes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Seasonality</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment&#8217;s quarterly operating income progression is impacted by (i) the seasonality of benefit costs which generally increase during the year as Insured members progress through their annual deductibles and out-of-pocket expense limits and (ii) the seasonality of operating expenses, which are generally the highest during the fourth quarter due primarily to spending to support readiness for the start of the upcoming plan year and marketing associated with Medicare annual enrollment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, the impact of COVID-19 within the Health Care Benefits segment has generally stabilized as a result of the Company&#8217;s ability to capture COVID-19 related medical costs in pricing, and the segment has experienced a return to a more normal seasonality pattern, as described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, the customary quarterly operating income progression was impacted by COVID-19. While overall medical costs in the first quarter were generally consistent with historical baseline levels in the aggregate, the segment experienced increased COVID-19 testing and treatment costs and lower Medicare risk-adjusted revenue. During the second quarter, COVID-19 testing and treatment costs persisted, however at levels significantly lower than those observed during the first quarter. Beginning in the third quarter, medical costs once again increased primarily driven by the spread of the emerging new variants of COVID-19, which resulted in increased testing and treatment costs that continued throughout the fourth quarter.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, the customary quarterly operating income progression was also impacted by COVID-19. Beginning in mid-March, the health care system experienced a significant reduction in utilization that is discretionary and the cancellation of elective medical procedures. Utilization remained below historical levels through April 2020, began to recover in May and June 2020 and reached more normal levels in the third and fourth quarters of 2020, with select geographies impacted by COVID-19 waves. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Competition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The health care benefits industry is highly competitive, primarily due to a large number of for-profit and not-for-profit competitors, competitors&#8217; marketing and pricing and a proliferation of competing products, including new products that are continually being introduced into the marketplace. New entrants into the marketplace, as well as consolidation within the industry, have contributed to and are expected to intensify the competitive environment. In addition, the rapid pace of change as the industry evolves towards a consumer-focused retail marketplace, including Insurance Exchanges, and the increased use of technology to interact with members, providers and customers, increase the risks the Company faces from new entrants and disruptive actions by existing competitors compared to prior periods.</span></div><div><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that the significant factors that distinguish competing health plans include the perceived overall quality (including accreditation status), quality of service, comprehensiveness of coverage, cost (including premium rates, provider discounts and member out-of-pocket costs), product design, financial stability and ratings, breadth and quality of provider networks, ability to offer different provider network options, providers available in such networks, and quality of member support and care management programs. The Company believes that it is competitive on each of these factors. The Company&#8217;s ability to increase the number of persons covered by its health plans or to increase Health Care Benefits segment revenues is affected by its ability to differentiate itself from its competitors on these factors. Competition may also affect the availability of services from providers, including primary care physicians, specialists and hospitals.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insured products compete with local and regional health care benefits plans, health care benefits and other plans sponsored by other large commercial health care benefit insurance companies, health system owned health plans, new entrants into the marketplace and numerous for-profit and not-for-profit organizations operating under licenses from the Blue Cross and Blue Shield Association. The largest competitor in Medicare products is Original Medicare. Additional Health Care Benefits </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">segment competitors include other types of medical and dental provider organizations, various specialty service providers (including pharmacy benefit management (&#8220;PBM&#8221;) services providers), health care consultants, financial services companies, integrated health care delivery organizations (networks of providers who also coordinate administrative services for and assume insurance risk of their members), third party administrators (&#8220;TPAs&#8221;) and, for certain plans, programs sponsored by the federal or state governments. Emerging competitors include start up health care benefits plans, provider-owned health plans, new joint ventures (including not-for-profit joint ventures among firms from multiple industries), financial services firms that are distributing competing products on their proprietary Private Exchanges, and consulting firms that are distributing competing products on their proprietary Private Exchanges, as well as non-traditional distributors such as retail companies. The Company&#8217;s ability to increase the number of persons enrolled in Insured Commercial Medical products also is affected by the desire and ability of employers to self-fund their health coverage.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment&#8217;s ASC plans compete primarily with other large commercial health care benefit companies, numerous for-profit and not-for-profit organizations operating under licenses from the Blue Cross and Blue Shield Association and TPAs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to competitive pressures affecting the Company&#8217;s ability to obtain new customers or retain existing customers, the Health Care Benefits segment&#8217;s medical membership has been and may continue to be adversely affected by adverse and/or uncertain economic conditions and reductions in workforce by existing customers due to adverse and/or uncertain general economic conditions, especially in the United States and industries where such membership is concentrated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Reinsurance</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">currently has</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">several reinsurance agreements with non-affiliated insurers that relate to Health Care Benefits insurance policies. The Company entered into these contracts to reduce the risk of catastrophic losses which in turn reduces capital and surplus requirements. The Company frequently evaluates reinsurance opportunities and refines its reinsurance and risk management strategies on a regular basis.</span></div><div><span><br/></span></div><div id="i36038907935e41eea5e9cf7cac915d44_19"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Services Segment (formerly Pharmacy Services Segment)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. PBM solutions include plan design offerings and administration, formulary management, retail pharmacy network management services, and specialty and mail order pharmacy services. In addition, the Company provides clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Company operates a group purchasing organization that negotiates pricing for the purchase of pharmaceuticals and rebates with pharmaceutical manufacturers on behalf of its participants and provides various administrative, management and reporting services to pharmaceutical manufacturers. The Health Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care (&#8220;Managed Medicaid&#8221;) plans, plans offered on Insurance Exchanges and other sponsors of health benefit plans throughout the United States and Covered Entities. During the year ended December&#160;31, 2022, the Company&#8217;s PBM filled or managed 2.3 billion prescriptions on a 30-day equivalent basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Services Products and Services</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PBM Solutions </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Services segment manages prescription drug distribution directly through the Company&#8217;s specialty and mail order pharmacies and through pharmacies in its retail network. All prescriptions processed by the Company are analyzed, processed and documented by the Company&#8217;s proprietary prescription management systems. These systems provide essential features and functionality to allow plan members to utilize their prescription drug benefits. These systems also streamline the process by which prescriptions are processed by staff and network pharmacists by enhancing review of various items through automation, including plan eligibility, early refills, duplicate dispensing, appropriateness of dosage, drug interactions or allergies, over-utilization and potential fraud.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plan Design Offerings and Administration</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assists its PBM clients in designing pharmacy benefit plans that help improve health outcomes while minimizing the costs to the client. The Company also assists PBM clients in monitoring the effectiveness of their plans through frequent, informal communications, the use of proprietary software, as well as through formal annual, quarterly and sometimes monthly performance reviews. The Company administers pharmacy benefit plans for clients who contract with it to facilitate </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prescription drug coverage and claims processing for their eligible plan members. The Company also provides administrative services for Covered Entities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes recommendations to help PBM clients design benefit plans that promote the use of lower cost, clinically appropriate drugs and helps its PBM clients control costs by recommending plan designs that encourage the use of generic equivalents of brand name drugs when such equivalents are available. Clients also have the option, through plan design, to further lower their pharmacy benefit plan costs by setting different member payment levels for different products on their drug lists or &#8220;formularies,&#8221; which helps guide members to choose lower cost alternatives through appropriate financial incentives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Formulary Management</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes an independent panel of doctors, pharmacists and other medical experts, referred to as the CVS Caremark National Pharmacy and Therapeutics Committee, to review and approve the selection of drugs that meet the Company&#8217;s standards of safety and efficacy for inclusion on one of the Company&#8217;s template formularies. The Company&#8217;s formularies provide recommended products in numerous drug classes to help ensure member access to clinically appropriate drugs with alternatives within a class under the client&#8217;s pharmacy benefit plan, while helping to drive the lowest net cost for clients that select one of the Company&#8217;s formularies. To help improve clinical outcomes for members and clients, the Company conducts ongoing, independent reviews of all drugs, including those appearing on the formularies and generic equivalent products. Many of the Company&#8217;s clients choose to adopt a template formulary offering as part of their plan design. PBM clients are given capabilities to offer real time benefits information for a member&#8217;s specific plan design, provided digitally at the point of prescribing, at the CVS pharmacy and directly to members.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail Pharmacy Network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management Services</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a national network of approximately 66,000 retail pharmacies, consisting of approximately 40,000 chain pharmacies (which include CVS pharmacy locations) and approximately 26,000 independent pharmacies, in the United States, including Puerto Rico, the District of Columbia, Guam and the U.S. Virgin Islands. When a customer fills a prescription in a retail pharmacy, the pharmacy sends prescription data electronically to the Company from the point-of-sale. This data interfaces with the Company&#8217;s proprietary prescription management systems, which verify relevant plan member data and eligibility, while also performing a drug utilization review to help evaluate clinical appropriateness and safety and confirming that the pharmacy will receive payment for the prescription. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Specialty and Mail Order Pharmacy Services</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates mail order pharmacies, specialty mail order pharmacies and retail specialty pharmacy stores in the United States. The mail order pharmacies are used primarily for maintenance medications, while the specialty mail order pharmacies and retail specialty pharmacy stores are used for the delivery of advanced medications to individuals with chronic or genetic diseases and disorders. The Health Services segment&#8217;s plan members or their prescribers submit prescriptions or refill requests to these pharmacies, and staff pharmacists review these prescriptions and refill requests with the assistance of the Company&#8217;s prescription management systems. This review may involve communications with the prescriber and, with the prescriber&#8217;s approval when required, can result in generic substitution, therapeutic interchange or other actions designed to help reduce cost and/or improve quality of treatment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s mail order pharmacies and specialty mail order pharmacies have been awarded Mail Service Pharmacy and Specialty Pharmacy accreditation, respectively, from URAC. Substantially all of the Company&#8217;s specialty mail order pharmacies also have been accredited by The Joint Commission and the Accreditation Commission for Health Care (&#8220;ACHC&#8221;), which are independent, not-for-profit organizations that accredit and certify health care programs and organizations in the United States. The ACHC accreditation includes an additional accreditation by the Pharmacy Compounding Accreditation Board, which certifies compliance with the highest level of pharmacy compounding standards. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with its new operating model adopted in the first quarter of 2023, the Company consolidated its specialty and mail order pharmacy fulfillment operations, which were previously included in the former Pharmacy Services segment, with its retail and long-term care pharmacy fulfillment operations in the newly formed Pharmacy &amp; Consumer Wellness segment. Under this new operating model, the Health Services segment pays an administrative service fee to the Pharmacy &amp; Consumer Wellness segment, in exchange for which the Pharmacy &amp; Consumer Wellness segment provides pharmacy fulfillment services to support the Health Services segment&#8217;s specialty and mail order pharmacy offerings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clinical Services</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers multiple clinical programs and services to help clients manage overall pharmacy and health care costs in a clinically appropriate manner. These programs are primarily designed to promote better health outcomes and to help target inappropriate medication utilization and non-adherence to medication, each of which may result in adverse medical events that </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">negatively affect member health and client pharmacy and medical spend. These programs include utilization management (&#8220;UM&#8221;), medication management, quality assurance, adherence and counseling programs to complement the client&#8217;s plan design and clinical strategies. To help address prescription opioid abuse and misuse, the Company introduced an industry-leading UM approach that limits to seven days the supply of opioids dispensed for certain acute prescriptions for patients who are new to therapy, limits the daily dosage of opioids dispensed based on the strength of the opioid and requires the use of immediate-release formulations of opioids before extended-release opioids are dispensed. The Company&#8217;s Pharmacy Advisor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> program facilitates pharmacist counseling, both face-to-face and over the telephone, to help participating plan members with certain chronic diseases, such as diabetes and cardiovascular conditions, to identify gaps in care, adhere to their prescribed medications and manage their health conditions. The Company also has digital connectivity that helps to lower drug costs for patients by providing expanded visibility to lower cost alternatives through enhanced analytics and data sharing. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disease Management Programs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s clinical programs and services utilize advanced protocols and offer clients convenience in working with providers and other third parties. The Company&#8217;s care management program covers diseases such as rheumatoid arthritis, Parkinson&#8217;s disease, epilepsy and multiple sclerosis and is accredited by the NCQA. The Company&#8217;s UM program covers similar diseases and is accredited by the NCQA and URAC. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Benefit Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s NovoLogix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">online preauthorization tool helps identify and capture cost savings opportunities for specialty drugs billed under the medical benefit by identifying outliers to appropriate dosages and costs, and helps to ensure clinically appropriate use of specialty drugs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Group Purchasing Organization Services</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates a group purchasing organization that negotiates pricing for the purchase of pharmaceuticals and rebates with pharmaceutical manufacturers on behalf of its participants. The Company also provides various administrative, management and reporting services to pharmaceutical manufacturers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MinuteClinic</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company operated more than 1,100 MinuteClinic locations in the United States. The clinics are staffed by nurse practitioners and physician assistants who utilize nationally established guidelines to deliver a variety of health care services. Payors value these clinics because they provide convenient, high-quality, cost-effective care, in many cases offering an attractive alternative to more expensive sites of care. MinuteClinic also offers virtual care services to connect customers with licensed providers to provide access to health services remotely. MinuteClinic is collaborating with the Company&#8217;s medical and pharmacy members to help meet the needs of the Company&#8217;s health plan and client plan members by offering programs that can improve member health and lower costs. MinuteClinic also maintains relationships with leading hospitals, clinics and physicians in the communities we serve to support and enhance quality, access and continuity of care. Prior to the segment realignment described previously, MinuteClinic was included in the former Retail/LTC segment.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Services Information Systems</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Services segment&#8217;s claim adjudication platform incorporates architecture that centralizes the data generated from adjudicating retail pharmacy, specialty and mail order claims and delivering other solutions to PBM clients. The Health Engagement Engine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology and proprietary clinical algorithms help connect various parts of the enterprise and serve an essential role in cost management and health improvement, leveraging cloud-native technologies and practices. This capability transforms pharmacy data into actionable interventions at key points of care, including in retail, mail and specialty pharmacies as well as in customer care call center operations, leveraging our enterprise data platform to improve the quality of care. The technology leverages assisted artificial intelligence to deliver insights to the business and bring automation to otherwise manual tasks. Specialty services also connects with our claim adjudication platform and various health plan adjudication platforms with a centralized architecture servicing many clients and members. Operating services, such as Specialty Expedite</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, provide an interconnected onboarding solution for specialty medications and branding solutions ranging from fulfillment to total patient management. These services are managed through our new innovative specialty workflow and web platform.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through the collaboration of its digital and technical teams, the Company has established critical tools which enable patients to schedule appointments through MinuteClinic.com. Key elements of the offerings include landing pages which highlight services and answer common questions, screening capabilities to determine patient eligibility, service location locator and appointment selection tools to efficiently identify the requested service on a specified date, time, and location and registration pages to collect required patient information, accelerating check-in once at the MinuteClinic. Once scheduled, the tools provide </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the user with instructions and notifications including SMS text message and email reminders, and also provide digital results and records, enabling patients to view and save their medical records for convenient access at a later point. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Services Clients</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Health Services clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Managed Medicaid plans, plans offered on Insurance Exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. Pharmaceuticals are provided to eligible members in benefit plans maintained by clients and utilize the Company&#8217;s information systems, among other things, to help perform safety checks, drug interaction screening and identify opportunities for generic substitution. Substantially all of the Health Services segment&#8217;s revenues are generated from the sale and managing of prescription drugs to eligible members in benefit plans maintained by clients. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Services Seasonality</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of Health Services segment revenues are not seasonal in nature. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Services Competition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes the primary competitive factors in the health services industry include: (i)&#160;the ability to negotiate favorable discounts from drug manufacturers as well as to negotiate favorable discounts from, and access to, retail pharmacy networks; (ii)&#160;the ability to identify and apply effective cost management programs utilizing clinical strategies, including&#160;the development and utilization of preferred formularies; (iii)&#160;the ability to market PBM and other health products and services; (iv)&#160;the commitment to provide flexible, clinically-oriented services to clients and be responsive to clients&#8217; needs; (v)&#160;the quality, scope and costs of products and services offered to clients and their members; and (vi) operational excellence in delivering services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Services segment has a significant number of competitors offering PBM services, including large, national PBM companies (e.g., Prime Therapeutics and MedImpact), PBMs owned by large national health plans (e.g., the Express Scripts business of Cigna Corporation and the OptumRx business of UnitedHealth) and smaller standalone PBMs. The Health Services segment&#8217;s MinuteClinic offerings compete with retail health clinics, urgent care and primary care offices. The Company competes for provider solutions and health information technology (&#8220;HIT&#8221;) business with other large health plans and commercial health care benefit insurance companies as well as information technology companies and companies that specialize in provider solutions and HIT.  </span></div><div><span><br/></span></div><div id="i36038907935e41eea5e9cf7cac915d44_22"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy &amp; Consumer Wellness Segment (formerly Retail/LTC Segment)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy &amp; Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise. The segment also conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and ancillary services to long-term care facilities and other care settings, and provides pharmacy fulfillment services to support the Health Services segment&#8217;s specialty and mail order pharmacy offerings. As of December&#160;31, 2022, the Pharmacy &amp; Consumer Wellness segment operated more than 9,000 retail locations, as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. During the year ended December&#160;31, 2022, the Pharmacy &amp; Consumer Wellness segment filled 1.6 billion prescriptions on a 30-day equivalent basis. For the year ended December&#160;31, 2022, the Company dispensed approximately 26.8% of the total retail pharmacy prescriptions in the United States.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy &amp; Consumer Wellness Products and Services</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A typical retail store sells prescription drugs and a wide assortment of high-quality, nationally advertised brand name and proprietary brand merchandise. Pharmacy locations may also contract with Covered Entities under the federal 340B drug pricing program. Front store categories include over-the-counter drugs, consumer health products, beauty products and personal care products. The Company purchases merchandise from numerous manufacturers and distributors. The Company believes that competitive sources are readily available for substantially all of the products carried in its retail stores and the loss of any one supplier would not likely have a material effect on the Pharmacy &amp; Consumer Wellness segment. LTC operations include distribution of prescription drugs and related consulting and ancillary services.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmacy &amp; Consumer Wellness revenues by major product group are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage&#160;of&#160;Revenues</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front store and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy includes LTC sales and sales in pharmacies within Target Corporation (&#8220;Target&#8221;) and other retail stores.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">&#8220;Other&#8221; represents less than 11% of the &#8220;Front store and other&#8221; revenue category in all periods presented.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmacy revenues represented approximately three-fourths of Pharmacy &amp; Consumer Wellness segment revenues in each of 2022, 2021 and 2020. The Company believes that retail pharmacy operations will continue to represent a critical part of the Company&#8217;s business due to industry demographics, e.g., an aging American population consuming a greater number of prescription drugs, prescription drugs being used more often as the first line of defense for managing illness, the introduction of new pharmaceutical products, the need for vaccinations, including the COVID-19 vaccination, and Medicare Part&#160;D growth. The Company believes the retail pharmacy business benefits from investment in both people and technology, as well as innovative collaborations with health plans, PBMs and providers. Given the nature of prescriptions, consumers want their prescriptions filled accurately by professional pharmacists using the latest tools and technology, and ready when promised. Consumers also need medication management programs and better information to help them get the most out of their health care dollars. To assist consumers with these needs, the Company has introduced integrated pharmacy health care services that provide an earlier, easier and more effective approach to engaging consumers in behaviors that can help lower costs, improve health and save lives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Front Store</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Front store revenues reflect the Company&#8217;s strategy of innovating with new and unique products and services, using innovative personalized marketing and adjusting the mix of merchandise to match customers&#8217; needs and preferences. A key component of the front store strategy is the ExtraCare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;card program, which is one of the largest and most successful retail loyalty programs in the United States. The ExtraCare program allows the Company to balance marketing efforts so it can reward its best customers by providing them with automatic sale prices, customized coupons, ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;rewards and other benefits. The Company also offers a subscription-based membership program, CarePass</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, under which members are entitled to a suite of benefits delivered over the course of the subscription period, as well as a promotional reward that can be redeemed for future goods and services. The Company continues to launch and enhance new and exclusive brands to create unmatched offerings in beauty products and deliver other unique product offerings, including a full range of high-quality proprietary brand products that are only available through CVS stores. The Company currently carries approximately 5,500 proprietary brand products, which accounted for approximately 21% of front store revenues during 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">On-site Pharmacies</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also operates a limited number of pharmacies located at client sites, which provide certain health plan members and customers with a convenient alternative for filling their prescriptions and receiving vaccinations, including the COVID-19 vaccination.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Specialty and Mail Order Pharmacy Fulfillment Services</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy &amp; Consumer Wellness segment provides pharmacy fulfillment services to support the Health Services segment&#8217;s specialty and mail order pharmacy offerings, in exchange for which the Health Services segment pays an administrative service fee to the Pharmacy &amp; Consumer Wellness segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Infusion and Enteral Services</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates branches for compounding, specialty infusion and enteral nutrition services in the United States. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Diagnostic Testing</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers medical diagnostic testing primarily through its testing sites located at CVS pharmacy locations, at community-based testing sites in underserved areas and through its Return Ready</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">solution.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Care Pharmacy Operations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy &amp; Consumer Wellness segment provides LTC pharmacy services through the Omnicare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> business. Omnicare&#8217;s customers consist of skilled nursing facilities, assisted living facilities, independent living communities, hospitals, correctional facilities, and other health care service providers. The Company provides pharmacy consulting, including monthly patient drug therapy evaluations, to assist in compliance with state and federal regulations and provide proprietary clinical and health management programs. It also provides pharmaceutical case management services for retirees, employees and dependents who have drug benefits under corporate-sponsored health care programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Community Location Development</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health&#8217;s community health destinations are an integral part of its ability to meet the needs of consumers and maintain its leadership position in the changing health care landscape. When paired with its rapidly expanding digital presence, the Company&#8217;s physical presence in thousands of communities across the country represents a competitive advantage by allowing it to develop deep and trusted relationships through everyday engagement in consumer health. The Company&#8217;s community health destinations have played, and will continue to play, a key role in the Company&#8217;s continued growth and success. During 2022, the Company opened approximately 40 new locations, relocated 4 locations and closed approximately 300 locations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s continuous assessment of its national footprint is an essential component of competing effectively in the current health care environment. On an ongoing basis, the Company evaluates changes in population, consumer buying patterns and future health needs to assess the ability of its existing stores and locations to meet the needs of its consumers and the business. During the fourth quarter of 2021, the Company completed a strategic review of its retail business and announced its plans to reduce store density in certain locations through the closure of approximately 900 retail stores between 2022 and 2024. As of December, 31, 2022, the Company has closed approximately 300 retail stores in connection with this strategic review.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy &amp; Consumer Wellness Information Systems</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has continued to invest in information systems to enable it to deliver exceptional customer service, enhance safety and quality, and expand patient care services while lowering operating costs. The proprietary WeCARE Workflow tool supports pharmacy teams by prioritizing work to meet customer expectations, facilitating prescriber outreach, and seamlessly integrating clinical programs. This solution delivers improved efficiency and enhances customer experience, as well as provides a framework to accommodate the evolution of pharmacy practice and the expansion of clinical programs. Our Health Engagement Engine technology and data science clinical algorithms enable the Company to help identify opportunities for pharmacists to deliver face-to-face counseling regarding patient health and safety matters, including medication adherence issues, gaps in care and management of certain chronic health conditions. The Company&#8217;s digital strategy is to empower the consumer to navigate their pharmacy experience and manage their condition through integrated online and mobile solutions that offer utility and convenience. The Company&#8217;s LTC digital technology suite, Omniview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, improves the efficiency of customers&#8217; operations with tools that include executive dashboards, pre-admission pricing, electronic ordering of prescription refills, proof-of-delivery tracking, access to patient profiles, receipt and management of facility bills, and real-time validation of Medicare Part D coverage, among other capabilities. The Company has also established tools which enable customers to schedule diagnostic testing and vaccination appointments through CVS.com, provide instructions and notifications to the customer regarding the services, and, following administration, allow customers to access digital results for tests and records for vaccinations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy &amp; Consumer Wellness Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of the Pharmacy &amp; Consumer Wellness segment&#8217;s businesses is dependent upon the Company&#8217;s ability to establish and maintain contractual relationships with pharmacy benefit managers and other payors on acceptable terms. Substantially all of the Pharmacy &amp; Consumer Wellness segment&#8217;s pharmacy revenues are derived from pharmacy benefit managers, managed care organizations (&#8220;MCOs&#8221;), government funded health care programs, commercial employers and other third-party payors. No single Pharmacy &amp; Consumer Wellness payor accounted for 10% or more of the Company&#8217;s consolidated total revenues in 2022, 2021 or 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy &amp; Consumer Wellness Seasonality</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of Pharmacy &amp; Consumer Wellness segment revenues, particularly pharmacy revenues, generally are not seasonal in nature. However, front store revenues tend to be higher during the December holiday season. In addition, both pharmacy and front store revenues are affected by the timing and severity of the cough, cold and flu season. Uncharacteristic or extreme </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">weather conditions also can adversely affect consumer shopping patterns and Pharmacy &amp; Consumer Wellness revenues, expenses and operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, the customary quarterly operating income progression in the Pharmacy &amp; Consumer Wellness segment continued to be impacted by COVID-19. During the first quarter, the Company saw high volumes of administration of COVID-19 vaccinations, as well as demand for OTC test kits in the front store, particularly in the beginning of the year when the Omicron variant incidence was high. In addition, the Company administered the highest quarterly volume of COVID-19 diagnostic tests of 2022 during the first quarter, however a decline compared to the prior year. During the second and third quarters, the Company continued to generate earnings from the sale of OTC test kits, as customers performed more in-home testing versus diagnostic testing, in addition to earnings from the continued administration of COVID-19 diagnostic testing and vaccinations, albeit at lower levels than those experienced in the first quarter. During the fourth quarter, the Company saw an increase in COVID-19 vaccine administration from the prior quarter related to the bivalent COVID-19 booster. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, the customary quarterly operating income progression was impacted by COVID-19. During the first quarter, the Company experienced reduced customer traffic in its retail pharmacies, which reflected the impact of a weaker cough, cold and flu season, while it administered the highest quarterly volume of COVID-19 diagnostic tests. During the second quarter, the segment generated earnings from COVID-19 vaccinations and saw improved customer traffic as vaccinated customers began more actively shopping in CVS locations. During the third and fourth quarters, emerging new variants drove the continued administration of COVID-19 vaccinations (including booster shots) and diagnostic testing, while the segment also generated earnings from the sale of OTC test kits in the front store. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, the customary quarterly operating income progression was impacted by COVID-19. During March 2020, the Company experienced increased prescription volume due to the greater use of 90-day prescriptions and early refills of maintenance medications, as well as increased front store volume as consumers prepared for the COVID-19 pandemic. Beginning in the second quarter and continuing throughout the remainder of the year, the Company experienced reduced customer traffic in its retail pharmacies due to shelter-in-place orders as well as reduced new therapy prescriptions and decreased long-term care prescription volume as a result of the COVID-19 pandemic. Beginning in the third quarter, the Company saw an increase in diagnostic testing related to the COVID-19 pandemic and in December 2020, the Company began administering COVID-19 vaccinations in long-term care facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy &amp; Consumer Wellness Competition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The retail pharmacy business is highly competitive. The Company believes that it competes principally on the basis of: (i)&#160;store location and convenience, (ii)&#160;customer service and satisfaction, (iii)&#160;product selection and variety, and (iv)&#160;price. In the areas it serves, the Company competes with other drugstore chains (e.g., Walgreens and Rite Aid), supermarkets, discount retailers (e.g., Walmart), independent pharmacies, restrictive pharmacy networks, internet companies (e.g., Amazon), membership clubs, as well as mail order dispensing pharmacies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LTC Health Services are highly regional or local in nature, and within a given geographic area of operation, highly competitive. The Company&#8217;s largest LTC pharmacy competitor nationally is PharMerica. The Company also competes with numerous local and regional institutional pharmacies, pharmacies owned by long-term care facilities and local retail pharmacies. Some states have enacted &#8220;freedom of choice&#8221; or &#8220;any willing provider&#8221; requirements as part of their state Medicaid programs or in separate legislation, which may increase the competition that the Company faces in providing services to long-term care facility residents in these states.</span></div><div><span><br/></span></div><div id="i36038907935e41eea5e9cf7cac915d44_25"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate/Other Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div><div id="i36038907935e41eea5e9cf7cac915d44_28"></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Generic Sourcing Venture</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and Cardinal Health, Inc. (&#8220;Cardinal&#8221;) each have a 50% ownership in Red Oak Sourcing, LLC (&#8220;Red Oak&#8221;), a generic pharmaceutical sourcing entity. Under this arrangement, the Company and Cardinal contributed their sourcing and supply chain expertise to Red Oak and agreed to source and negotiate generic pharmaceutical supply contracts for both companies through Red Oak. Red Oak does not own or hold inventory on behalf of either company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Working Capital Practices</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company funds the growth of its businesses through a combination of cash flow from operations, commercial paper and other short-term borrowings, as well as long-term borrowings. For additional information on the Company&#8217;s working capital practices, see &#8220;Liquidity and Capital Resources&#8221; in the MD&amp;A included in Item 7 of this Exhibit 99.1. Employer groups, individuals, college students, part-time and hourly workers, health plans, providers, governmental units, government-sponsored plans (with the exception of Medicare Part D services, which are described below), labor groups and expatriates, which represent the vast majority of Health Care Benefits segment revenues, typically settle in less than 30 days. As a provider of Medicare Part D services, the Company contracts annually with CMS.&#160;Utilization of services each plan year results in the accumulation of either a receivable from or a payable to CMS. The timing of settlement of the receivable or payable with CMS takes several quarters, which impacts working capital from year to year. The majority of the Pharmacy &amp; Consumer Wellness segment non-pharmacy revenues are paid in cash, or with debit or credit cards. Managed care organizations, pharmacy benefit managers, government funded health care programs, commercial employers and other third party insurance programs, which represent the vast majority of the Company&#8217;s consolidated pharmacy revenues, typically settle in less than 30 days. The remainder of the Company&#8217;s consolidated pharmacy revenues are paid in cash, or with debit or credit cards. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At CVS Health, we share a single, clear purpose: bringing our heart to every moment of your health. We devote significant time and attention to the attraction, development and retention of talent to deliver high levels of service to our customers. Our commitment to them includes a competitive rewards package and programs that support our diverse range of colleagues in rewarding and fulfilling careers. As of December&#160;31, 2022, we employed over 300,000 colleagues primarily in the United States including in all 50 states, the District of Columbia and Puerto Rico, approximately 73% of whom were full-time. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe engaged colleagues produce stronger business results and are more likely to build a career with the Company. Each year we conduct an internal engagement survey that provides colleagues with an opportunity to share their opinions and experiences with respect to their role, their team and the enterprise to help CVS Health Corporation&#8217;s Board of Directors (the &#8220;Board&#8221;) and our management identify areas where we can improve colleague experience. The survey covers a broad range of topics including development and opportunities, diversity management, recognition, performance, well-being, compliance and continuous improvement. In 2022, greater than 80% of our colleagues participated in the engagement survey, of which greater than 75% responded that they were actively engaged.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board, our Chief Executive Officer (&#8220;CEO&#8221;) and our Chief People Officer provide oversight of our human capital strategy, which consists of the following categories: total rewards; diversity, equity and inclusion; colleague development; and health and safety.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Rewards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize how vital our colleagues are to our success and strive to offer comprehensive and competitive wages and benefits to meet the varying needs of our colleagues and their families. The benefits and programs include annual bonuses, 401(k) plans, stock awards, an employee stock purchase plan, health care and insurance benefits, paid time off, flexible work schedules, family leave, dependent care resources, colleague assistance programs and tuition assistance, among many others, depending on eligibility. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recognition of the critical role that the attraction and retention of talent plays in the success of our business, during 2021, we also announced a significant investment in our employees through an increase in the Company&#8217;s minimum hourly wage to $15.00 an hour effective July 2022, with incremental increases to the Company&#8217;s competitive hourly rates beginning in August 2021. The new wage structure also incorporates additional increases beyond the $15.00 minimum, with higher starting hourly rates for roles such as pharmacy technicians and call center representatives. In addition, during 2021 we awarded incremental </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">bonuses to select colleague groups in recognition of their ongoing contributions throughout the COVID-19 pandemic, the most significant of which included bonuses to our pharmacist and distribution center colleagues. In 2022, we awarded incremental bonuses to select colleague groups including our front-line retail store, pharmacy and MinuteClinic colleagues. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diversity, Equity &amp; Inclusion</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that a diverse workforce creates a healthier, stronger and more sustainable company. We aim to attract, develop, retain and support a diverse workforce that reflects the many customers, patients, members and communities we serve. Our Diversity Management Leadership Council, a cross-functional group of senior leaders appointed by our CEO, works with our Strategic Diversity Management leadership team to intentionally embed diversity across all facets of our business. For our efforts, we have been recognized as a DiversityInc Top 50 Company, one of Seramount&#8217;s Best Companies for Multicultural Women and earned a 100 percent score on both the Human Rights Campaign Corporate Equality Index as well as the Disability Equality Index, meaning the company is recognized as a &#8220;Best Place to Work for Disability Inclusion.&#8221; The Company discloses information on our diversity, equity and inclusion strategy and programs in our annual Environmental, Social and Governance (&#8220;ESG&#8221;) Report.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a foundation of diversity and inclusion, we continuously focus on increasing underrepresented populations across our business. In 2022, 70% of our total colleague population and 55% of our colleagues at the manager level and above self-reported as female. In addition, in 2022 our colleagues reported their race/ethnicity as: White (49%), Black/African American (18%), Hispanic/Latino (16%), Asian (11%) and Other (6%). The appendix to our ESG Report, our Strategic Diversity Management Report and our EEO-1 Employer Information Report include additional information on the diversity of our workforce.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our diversity management strategy emphasizes workplace representation, inclusion and belonging, talent acquisition and management and a diverse marketplace. Beginning in 2021, we incorporated a diversity metric into our annual cash incentive program for our most senior leaders who have the greatest ability to influence the overall hiring, development and promotion of our colleagues. We also continued the deployment of conscious inclusion training for colleagues designed to enhance awareness of biases and rolled out our INCLUDE program to activate inclusive behaviors. Our ESG Report and Strategic Diversity Management Report include additional information with respect to our conscious inclusion training. We support 16 Colleague Resource Groups (&#8220;CRGs&#8221;) that include more than 28,000 colleagues across the enterprise. These groups represent a wide range of professional, cultural, ethical and personal affinities and interests, as well as formal mentoring programs. Our CRGs provide our colleagues with an opportunity to connect and network with one another through a particular affinity, culture or interest. Each of our CRGs is sponsored by a senior leader. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Colleague Development</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers a number of resources and programs that attract, engage, develop, advance and retain colleagues. Training and development provides colleagues the support they need to perform well in their current role while planning and preparing for future roles. We offer an online orientation program that pairs new hires with seasoned colleagues and the training continues throughout a colleague&#8217;s career through in-person, virtual and self-paced learning at all levels. We also provide mentoring, tools and workshops for colleagues to manage their career development. We offer a variety of management and leadership programs that develop incumbent diverse and other high potential colleagues. Our broad training practices include updated, tech-enabled tools and keep our colleagues informed of new developments in our industry that are relevant to their roles. During the year ended December&#160;31, 2022, our colleagues invested approximately 17&#160;million hours in learning and development courses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our colleague development program also promotes the importance of compliance across our business. Our colleagues demonstrate this commitment through our annual Code of Conduct training, which nearly 100% of active colleagues completed in 2022. In 2022, we launched more than 70 different training courses as part of our Enterprise Compliance Training Program.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health &amp; Safety</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a strong commitment to providing a safe working environment. We have implemented an environmental health and safety management system to support adherence and monitoring of programs designed to make our various business operations compliant with applicable occupational safety and health regulations and requirements. Our Environmental Health and Safety Department oversees the implementation and adherence to programs like Powered Industrial Truck training, materials handling and storage, selection of personal protective equipment and workplace violence prevention. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize Safety Service Plans to analyze data and concentrate on key areas of risk to reduce the chance of workplace incidents. We focus on identifying causes and improving performance when workplace incidents occur. We also engage leaders in promoting a culture of safety. With safety task forces in place at each distribution center, we empower leaders and safety business partners to identify policies, procedures and processes that could improve their own operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From the outset of the COVID-19 pandemic, we took a comprehensive approach to managing occupational health and safety challenges presented by the pandemic, including implementing facial covering requirements for our workplaces and providing face masks to colleagues, providing sick leave, implementing symptom screening measures and implementing additional protocols in accordance with applicable Occupational Safety and Health Administration (&#8220;OSHA&#8221;) requirements and guidance and Centers for Disease Control and Prevention (&#8220;CDC&#8221;) guidelines for workplaces. We have emphasized the importance of taking immediate steps toward full vaccination.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental, Social and Governance Strategy</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health believes the health of our people, communities and planet are linked to the health of our business. Our ESG strategy &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthy 2030</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is focused on achieving our economic, environmental and social imperatives and outlines how we are shaping a more equitable and sustainable future for all &#8211; across multiple dimensions of health. Designed to use our assets to transform the health care experience and invest in community health at the local level, while working to reduce the environmental impact of our operations, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthy 2030</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consists of four pillars: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthy People</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthy Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthy Community</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthy Planet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We believe this strategy is achievable without materially adversely affecting our businesses, operating results, cash flows and/or prospects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthy People</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through physical and virtual assets, we provide convenient, personalized and integrated access to health care support and services. We continue to implement and expand initiatives that build on our innovative health care model, with the ultimate aim to transform the health care experience for every person we reach to improve health outcomes. These include helping to improve chronic disease prevention and management, helping to reduce and prevent prescription drug misuse, and improving the social determinants of health, which include education, transportation and behavioral health. Through our ESG strategy we are leveraging our expertise and resources to make the health care experience simple, equitable, convenient and deeply personal for each of us. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthy Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we work to transform health care, we are committed to operating a healthy business for all our stakeholders, including our patients, customers, stockholders, clients, partners, communities and colleagues. Throughout our large operational footprint and including our supply chain, we are committed to acting responsibly with respect for human rights, privacy, information security, public policy, marketing and advertising. We focus on diversity, equity and inclusion as well as colleague development, health and safety. Through our ESG strategy, we are focused on providing people with the opportunity to be as healthy as possible by expanding community-centered solutions that advance health equity and improve outcomes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthy Community</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By working with community-focused organizations and through innovative programs that can be tailored to and executed across different communities, we are driving positive health outcomes and reducing overall health care costs. Our philanthropic strategy, which includes grants made through the CVS Health Foundation, Health Zones initiative and Project Health program, improves health outcomes and reduce health disparities in under-resourced communities. We are investing charitable resources, leveraging CVS Health assets, and working in partnership with non-profits to help our communities be as healthy as possible. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthy Planet</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are working to improve the health of our planet and make a difference in the lives of the people who live on it</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by advancing our sustainability commitments and addressing the environmental factors that contribute to health inequities. In October 2021, CVS Health&#8217;s science-based net zero greenhouse gas (&#8220;GHG&#8221;) emissions targets were validated by the Science Based Targets initiatives (&#8220;SBTi&#8221;). We continue to make meaningful progress to reduce our environmental impact across our operations and supply chain. Key priorities include the advancement of our GHG emissions-reduction targets, reduction in our energy </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consumption, the advancement of sustainability in transportation, logistics and our physical locations, which includes retrofitting community and corporate locations with LED lighting, exploring investments in renewable energy, reducing water use, focusing on smarter consumption through a &#8220;digital first&#8221; approach and the reduction of our use of paper and plastic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has registered and/or applied to register a variety of trademarks and service marks used throughout its businesses, as well as domain names, and relies on a combination of copyright, patent, trademark and trade secret laws, in addition to contractual restrictions, to establish and protect the Company&#8217;s proprietary rights. The Company regards its intellectual property as having significant value in the Health Care Benefits, Health Services and Pharmacy &amp; Consumer Wellness segments. The Company is not aware of any facts that could materially impact the continuing use of any of its intellectual property.</span></div><div><span><br/></span></div><div id="i36038907935e41eea5e9cf7cac915d44_31"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operations are subject to comprehensive federal, state and local laws and regulations and comparable multiple levels of international regulation in the jurisdictions in which it does business. There also continues to be a heightened level of review and/or audit by federal, state and international regulators of the health&#160;and related benefits industry&#8217;s business and reporting practices. In addition, many of the Company&#8217;s PBM clients and the Company&#8217;s payors in the Pharmacy &amp; Consumer Wellness segment, including insurers, Medicare plans, Managed Medicaid plans and MCOs, are themselves subject to extensive regulations that affect the design and implementation of prescription drug benefit plans that they sponsor. Similarly, the Company&#8217;s LTC clients, such as skilled nursing facilities, are subject to government regulations, including many of the same government regulations to which the Company is subject. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws and rules governing the Company&#8217;s businesses and interpretations of those laws and rules continue to expand and become more restrictive each year and are subject to frequent change. The application of these complex legal and regulatory requirements to the detailed operation of the Company&#8217;s businesses creates areas of uncertainty. Further, there are numerous proposed health care, financial services and other laws and regulations at the federal, state and international levels, some of which could adversely affect the Company&#8217;s businesses if they are enacted. The Company cannot predict whether pending or future federal or state legislation or court proceedings will change aspects of how it operates in the specific markets in which it competes or the health care industry generally, but if changes occur, the impact of any such changes could have a material adverse impact on the Company&#8217;s businesses, operating results, cash flows and/or stock price. Possible regulatory or legislative changes include the federal or one or more state governments fundamentally restructuring the Commercial, Medicare or Medicaid marketplace; reducing payments to the Company in connection with Medicare, Medicaid, dual eligible or special needs programs; increasing its involvement in drug reimbursement, pricing, purchasing, and/or importation; or changing the laws governing PBMs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has internal control policies and procedures and conducts training and compliance programs for its employees to help prevent, detect and correct prohibited practices. However, if the Company&#8217;s employees or agents fail to comply with applicable laws governing its international or other operations, it may face investigations, prosecutions and other legal proceedings and actions which could result in civil penalties, administrative remedies and criminal sanctions. Any failure or alleged failure to comply with applicable laws and regulations summarized below, or any adverse applications or interpretations of, or changes in, the laws and regulations affecting the Company and/or its businesses, could have a material adverse effect on the Company&#8217;s operating results, financial condition, cash flows and/or stock price. See Item 3 &#8220;Legal Proceedings&#8221; of the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on February 8, 2023 for further information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i) future enactment of new health care or other laws or regulations; (ii) the interpretation or application of existing laws or regulations, including the laws and regulations described in this Government Regulation section, as they may relate to one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii) pending or future federal or state governmental investigations of one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv) pending or future government audits, investigations or enforcement actions against the Company; or (v) adverse developments </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in pending or future legal proceedings against or affecting the Company, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuits, or affecting one or more of the industries in which the Company competes and/or the health care industry generally.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and Regulations Related to COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the COVID-19 pandemic, the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) put in place a public health emergency (&#8220;PHE&#8221;) in January 2020 and HHS must extend it every 90 days to maintain certain health care flexibilities and waivers. The Biden administration most recently renewed the PHE on January 11, 2023 and has indicated that they intend for the PHE to expire on May 11, 2023. The Families First Coronavirus Response Act (the &#8220;Families First Act&#8221;) and the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;) were enacted in March 2020. Each of the Families First Act and the CARES Act requires the Company to provide coverage for COVID-19 related medical services, in many cases without member cost-sharing, in its Insured Health Care Benefits products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CARES Act also provides relief funding to providers to reimburse them for health care related expenses incurred in preventing, preparing for and/or responding to COVID-19 (provided no other source is obligated to reimburse those expenses) or lost health care related revenues that are attributable to COVID-19. Under the CARES Act, the Company receives reimbursement for uninsured patients in connection with COVID-19 testing and vaccination as well as monoclonal antibody treatment. Aside from such reimbursement, the Company has not requested any funding under the CARES Act. However, in the second quarter of 2020, the Company received $43 million from the CARES Act provider relief fund, all of which was returned to the HHS during the second quarter of 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CARES Act also allows for the deferral of the payment of the employer share of Social Security taxes effective March 27, 2020 by permitting them to remit the associated payments in two equal installments on or about December 31, 2021 and December 31, 2022. The Company elected to defer approximately $670&#160;million of its Social Security tax payments during the year ended December 31, 2020. The Company paid the first of two equal installments in December 2021 and the second installment in December 2022, as required under the CARES Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Congress enacted the American Rescue Plan Act in March 2021. Among other changes, as a result of this legislation, Public Exchange plan premium subsidies increased for low-income individuals and became available to people with incomes higher than 400% of the federal poverty limit. In August 2022, the Inflation Reduction Act subsequently extended these subsidies through 2025, which could cause shifts in enrollment into Public Exchange plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the Families First Act, the CARES Act, and the American Rescue Plan Act, the Company has experienced legislation, regulation, directives, orders and other requirements from federal, state, county and municipal authorities related to the COVID-19 pandemic. These governmental actions included, but were not limited to, requirements to waive member cost-sharing associated with COVID-19 testing and treatment, provide coverage for additional COVID-19-related services, expand the use of telemedicine, extend grace periods for payments of premiums or limit coverage termination based on non-payment of premiums or fees, modify health benefits coverage eligibility rules to help maintain employee eligibility, and facilitate, accelerate or advance payments to providers, and other requirements related to the PHE. Many of these requirements remain in effect and continue to impact different areas of our business differently and may continue for different lengths of time, and present financial implications with respect to implementing and unwinding our compliance with these requirements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operations that fall within the scope of COVID-19 vaccine requirements for federal contractors, certain health care workers, and the requirements of certain jurisdictions such as New York City. Several of these are subject to judicial challenges. We are continuing to closely monitor and update our practices in response to developments or changes in the COVID-19 vaccination policies established by various federal agencies as well as the several state- and municipal-specific COVID-19 vaccine mandates that provide expanded exemptions, modifications, requirements or restrictions regarding employee vaccinations. We have a process for employees to request a reasonable accommodation if they are unable to get vaccinated due to a medical condition, sincerely held religious belief, or any other legally recognized exemption. Employees must apply and be approved for a reasonable accommodation in order to be exempt from the vaccination requirement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in January 2022, the HHS announced that commercial health insurers must cover the costs of up to eight rapid COVID-19 OTC test kits per individual per 30-day period. Coverage for COVID-19 OTC test kits has subsequently been required by Medicare and, in many states, Medicaid. These requirements may increase benefit costs in those businesses and jurisdictions, and may increase revenues in our retail business. The requirement may also result in a decrease in more expensive tests and treatments, which could partially mitigate the increase in benefit costs. These impacts will be highly dependent on the overall supply of testing products. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some activities that were suspended during the COVID-19 pandemic, such as Medicaid eligibility redeterminations, are currently scheduled to resume later this year, and many of the requirements set forth above may change once the PHE expires. The impact of this governmental activity on the U.S. economy, consumer, customer and health care provider behavior and health care utilization patterns is beyond our knowledge and control. As a result, the financial and/or operational impact these COVID-19 related governmental actions and inactions will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the collective impact could be material and adverse. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and Regulations Related to Multiple Segments of the Company&#8217;s Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Laws Related to Reimbursement by Government Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company is subject to various federal and state laws concerning its submission of claims and other information to Medicare, Medicaid and other federal and state government-sponsored health care programs. Potential sanctions for violating these laws include recoupment or reduction of government reimbursement amounts, civil penalties, treble damages, and exclusion from participation in government health care programs. Such laws include the federal False Claims Act (the &#8220;False Claims Act&#8221;), the federal anti-kickback statute (the &#8220;AKS&#8221;), state false claims acts and anti-kickback statutes in most states, the federal &#8220;Stark Law&#8221; and related state laws. In particular, the False Claims Act prohibits intentionally submitting, conspiring to submit, or causing to be submitted, false claims, records, or statements to the federal government, or intentionally failing to return overpayments, in connection with reimbursement by federal government programs. In addition, any claim for government reimbursement also violates the False Claims Act where it results from a violation of the AKS. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both federal and state false claims laws permit private individuals to file </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or &#8220;whistleblower&#8221; lawsuits on behalf of the federal or state government. Participants in the health and related benefits industry, including the Company, frequently are subject to actions under the False Claims Act or similar state laws. The federal Stark Law generally prohibits physicians from referring Medicare or Medicaid beneficiaries for certain services, including outpatient prescription drugs, to any entity with which the physician, or an immediate family member of the physician, has a financial relationship. The Stark Law further prohibits the entity receiving a prohibited referral from presenting a claim for reimbursement by Medicare or Medicaid for services furnished pursuant to the prohibited referral. Various states have enacted similar laws.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The ACA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The ACA significantly increased federal and state oversight of health plans. Among other requirements, it specifies minimum medical loss ratios (&#8220;MLRs&#8221;) for Commercial and Medicare Insured products, specifies features required to be included in commercial benefit designs, limits commercial individual and small group rating and pricing practices, encourages additional competition (including potential incentives for new participants to enter the marketplace), and includes regulations and processes that could delay or limit the Company&#8217;s ability to appropriately increase its health plan premium rates. This in turn could adversely affect the Company&#8217;s ability to continue to participate in certain product lines and/or geographies that it serves today.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the United States Supreme Court dismissed a challenge on procedural grounds that argued the ACA is unconstitutional in its entirety and issued an opinion preserving the ACA and its consumer protections in its current form. Even though the ACA was deemed constitutional, there may nevertheless be continued efforts to invalidate, modify, repeal or replace portions of it. In addition to litigation, parts of the ACA continue to evolve through the promulgation of executive orders, legislation, regulations and guidance at the federal or state level. The Company expects the ACA, including potential changes thereto, to continue to significantly impact its business operations and operating results, including pricing, medical benefit ratios (&#8220;MBRs&#8221;) and the geographies in which the Company&#8217;s products are available.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, HHS issued a new proposed rule to significantly revise the agency&#8217;s prior interpretation of Section 1557 of the ACA. Section 1557 prohibits discrimination on the basis of race, color, national origin, sex, age, and disability in certain health programs and activities, and the proposed rule specifically includes sex stereotypes, sex characteristics, sexual orientation, gender identity and pregnancy or related conditions as bases for sex discrimination. The comment period on the proposed rule has closed but to date no final rule has been released.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medicare Regulation - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Medicare Advantage products compete directly with Original Medicare and Medicare Advantage products offered by other Medicare Advantage organizations and Medicare Supplement products offered by other insurers. The Company&#8217;s Medicare PDP and Medicare Supplement products are products that Medicare beneficiaries who are enrolled in Original Medicare purchase to enhance their Original Medicare coverage.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to expand the number of counties in which it offers Medicare products. The Company has expanded its Medicare service area and products in 2022 and is seeking to substantially grow its Medicare membership, revenue and operating results over the next several years, including through growth in Medicare Supplement products. The anticipated </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">organic expansion of the Medicare service area and Medicare products offered and the Medicare-related provisions of the ACA significantly increase the Company&#8217;s exposure to funding and regulation of, and changes in government policy with respect to and/or funding or regulation of, the various Medicare programs in which the Company participates, including changes in the amounts payable to us under those programs and/or new reforms or surcharges on existing programs. For example, the ACA requires minimum MLRs for Medicare Advantage and Medicare Part D plans of 85%. If a Medicare Advantage or Medicare Part D contract pays minimum MLR rebates for three consecutive years, it will become ineligible to enroll new members. If a Medicare Advantage or Medicare Part D contract pays such rebates for five consecutive years, it will be terminated by CMS. Due to potential lower utilization of medical services by Medicare beneficiaries during the COVID-19 pandemic, it is possible certain Medicare Advantage contracts may not meet the 85% MLR for consecutive years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Medicare Advantage and PDP products are heavily regulated by CMS. The regulations and contractual requirements applicable to the Company and other private participants in Medicare programs are complex, expensive to comply with and subject to change. For example, the Medicare Advantage Overpayment Rule, issued in 2014, implemented the ACA requirements that Medicare Advantage and PDP plans report and refund to CMS overpayments that those plans receive from CMS. Failure to notify overpayments to CMS could result in liability under the False Claims Act. The precise interpretation, impact and legality of this rule are subject to pending litigation. Payments the Company receives from CMS for its Medicare Advantage and Part D businesses also are subject to risk adjustment based on the health status of the individuals enrolled. Elements of that risk adjustment mechanism continue to be challenged by the U.S. Department of Justice (the &#8220;DOJ&#8221;), the Office of the Inspector General of the HHS (the &#8220;OIG&#8221;) and CMS itself. Substantial changes in the risk adjustment mechanism, including changes that result from enforcement or audit actions, could materially affect the amount of the Company&#8217;s Medicare reimbursement, require the Company to raise prices or reduce the benefits offered to Medicare beneficiaries, and potentially limit the Company&#8217;s (and the industry&#8217;s) participation in the Medicare program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has invested significant resources to comply with Medicare standards, and its Medicare compliance efforts will continue to require significant resources. CMS may seek premium and other refunds, prohibit the Company from continuing to market and/or enroll members in or refuse to passively enroll members in one or more of the Company&#8217;s Medicare or Medicare-Medicaid demonstration (historically known as &#8220;dual eligible&#8221;) plans, exclude us from participating in one or more Medicare, dual eligible or dual eligible special needs plan programs and/or institute other sanctions and/or civil monetary penalties against the Company if it fails to comply with CMS regulations or its Medicare contractual requirements. The Company&#8217;s Medicare Supplement products are regulated at the state level and subject to similar significant compliance requirements and risks.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in November 2020, the HHS released the final Rebate Rule (the &#8220;Rebate Rule&#8221;), which eliminates the regulatory safe harbor from prosecution under the AKS for rebates from pharmaceutical companies to PBMs in Medicare Part D, replacing it with two far narrower safe harbors designed to directly benefit patients with high out-of-pocket costs and to change the way PBMs are compensated. The new safe harbors are (i) for rebates which are passed on to the patient at the point of sale and (ii) for flat service fee payments made to PBMs which cannot be tied to the list prices of drugs. It is unclear whether the Rebate Rule will be enforceable, whether pharmaceutical companies will respond by reducing list prices, whether list prices in the private market may also be reduced, and what the resulting impact will be to PBMs or the Company. The Pharmaceutical Care Management Association (the &#8220;PCMA&#8221;), which represents PBMs, has filed a suit in an effort to block the Rebate Rule, claiming that the Rebate Rule would lead to higher premiums in Medicare Part D and was adopted in an unlawful manner. The Bipartisan Infrastructure Act of 2021 delays the effective date of the rebate rule to January 2026, and the Inflation Reduction Act, enacted in August 2022, further delays the Rebate Rule through 2032.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, the 2% Medicare sequester required by the Budget Control Act of 2011 resumed, meaning that Medicare claims incur a 2% reduction in Medicare payment. The sequester had been suspended during the COVID-19 pandemic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Going forward, the Company expects CMS, the OIG, the DOJ, other federal agencies and the U.S. Congress to continue to scrutinize closely each component of the Medicare program (including Medicare Advantage, PDPs, demonstration projects such as Medicare-Medicaid plans and provider network access and adequacy), modify the terms and requirements of the program and possibly seek to recast or limit private insurers&#8217; roles. It is also possible that Congress may consider changes to Medicare Advantage payment policies due to recent recommendations by the Medicare Payment Advisory Commission and to reduce the potential added cost burden of costly new benefits, or policies that impact drug pricing such as price controls and inflationary rebates applied to pharmaceutical manufacturers. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is not possible to predict the outcome of such regulatory or Congressional activity, any of which could materially and adversely affect the Company.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medicare Audits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- CMS regularly audits the Company&#8217;s performance to determine its compliance with CMS&#8217;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare Advantage and PDP beneficiaries. For example, CMS conducts risk adjustment data validation (&#8220;RADV&#8221;) audits of a subset of Medicare Advantage contracts for each contract year. Since 2011, CMS has selected certain of the Company&#8217;s Medicare Advantage contracts for various years for RADV audit, and the number of RADV audits continues to increase. The OIG also is auditing the Company&#8217;s risk adjustment data and that of other companies, and the Company expects CMS and the OIG to continue auditing risk adjustment data. The Company also has received Civil Investigative Demands (&#8220;CIDs&#8221;) from, and provided documents and information to, the Civil Division of the DOJ in connection with a current investigation of its patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 30, 2023, CMS released the final rule concerning Part C contract-level Risk Adjustment Data Validation Audits (the &#8220;RADV Audit Rule&#8221;). The RADV Audit Rule eliminated the application of a fee-for-service adjuster (&#8220;FFS Adjuster&#8221;) in contract-level RADV audits but continued the use of extrapolation in such audits of Medicare Advantage organizations. The FFS Adjuster that was announced in 2012 was to be used by CMS to determine a permissible level of payment error. By applying the FFS Adjuster, Medicare Advantage organizations would have been liable for repayments only to the extent that their extrapolated payment errors exceeded the error rate in Original Medicare, which could have impacted the extrapolated repayments to which Medicare Advantage organizations are subject. Under the RADV Audit Rule, CMS, in most cases, will conduct RADV audits for payment year 2018 and subsequent payment years using extrapolation without the application of a FFS Adjuster. The RADV Audit Rule may have potential adverse effects, which could be material, on the Company&#8217;s operating results, financial condition, and cash flows. CMS also has announced that it will not conduct RADV audits on all contracts; instead, it will only audit contracts it believes are at the highest risk for overpayments based on its statistical modeling.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medicare Star Ratings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - A portion of each Medicare Advantage plan&#8217;s reimbursement is tied to the plan&#8217;s &#8220;star ratings.&#8221; The star rating system considers a variety of measures adopted by CMS, including quality of preventative services, chronic illness management, compliance and overall customer satisfaction. Only Medicare Advantage plans with an overall star rating of 4 or more stars (out of 5 stars) are eligible for a quality bonus in their basic premium rates. As a result, the Company&#8217;s Medicare Advantage plans&#8217; operating results in 2023 and going forward will be significantly affected by their star ratings. The Company&#8217;s star ratings and past performance scores are adversely affected by any compliance issues that may have arisen each year in its Medicare operations. CMS released the Company&#8217;s 2023 star ratings in October 2022. The Company&#8217;s 2023 star ratings will be used to determine which of its Medicare Advantage plans have ratings of 4 stars or higher and qualify for bonus payments in 2024. Based on the 2023 star ratings, the percentage of the Company&#8217;s Medicare Advantage members in 4 or more stars plans is expected to drop to 21% (based on enrollment and contract affiliation at December 31, 2022), as compared to 87% based on the 2022 star ratings. The main driver of this decrease was a 1 star decrease in the Company&#8217;s Aetna National PPO, which dropped from 4.5 to 3.5 stars, while many of the Company&#8217;s other plans remain rated at 4 or more stars. The decrease in the star rating for the Aetna National PPO will mean that it will no longer be eligible for CMS&#8217; quality bonus payments related to 2024, though the Company&#8217;s contract diversification efforts, which will partially mitigate certain adverse impacts associated with the decrease in the star rating for the Aetna National PPO, have received regulatory approval. CMS also gives PDPs star ratings that affect each PDP&#8217;s enrollment. Medicare Advantage and PDP plans that are rated less than 3 stars for three consecutive years are subject to contract termination by CMS. CMS continues to revise its star ratings system to make it harder to achieve 4 or more stars. There can be no assurances that the Company will be successful in maintaining or improving its star ratings in future years. Accordingly, the Company&#8217;s Medicare Advantage plans may not continue to be or become eligible for full level quality bonuses, which could adversely affect the benefits such plans can offer, reduce membership and/or reduce profit margins.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medicare Payment Rates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In April 2022, CMS issued its final notice detailing final 2023 Medicare Advantage payment rates. Final 2023 Medicare Advantage rates resulted in an expected average increase in revenue for the Medicare Advantage industry of 5.00%, excluding the CMS estimate of Medicare Advantage risk score trend. On February 1, 2023, CMS issued an advance notice detailing proposed 2024 Medicare Advantage payment rates. The 2024 Medicare Advantage rates, if finalized as proposed, will result in an expected average decrease in revenue for the Medicare Advantage industry of 2.27%, excluding the CMS estimate of Medicare Advantage risk score trend. CMS intends to publish the final 2024 rate announcement no later than April 3, 2023. The federal government may seek to impose restrictions on the configuration of pharmacy or other provider networks for Medicare Advantage and/or PDP plans, or otherwise restrict the ability of these plans to alter benefits, negotiate prices or establish other terms to improve affordability or maintain viability of products. The Company currently believes that the payments it has received and will receive in the near term are adequate to justify the Company&#8217;s continued participation in the Medicare Advantage and PDP programs, although there are economic and political pressures to continue to reduce spending on the program, and this outlook could change.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">340B Drug Pricing Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The 340B Drug Pricing Program allows eligible Covered Entities to purchase prescription drugs from manufacturers at a steep discount, and is overseen by the HHS and the Health Resources and Services Administration (&#8220;HRSA&#8221;). In 2020, a number of pharmaceutical manufacturers began programs that limited Covered Entities&#8217; participation in the program through contract pharmacies arrangements. In May 2021, HRSA sent enforcement letters to multiple manufacturers to curb these practices. In September 2021, HRSA forwarded the enforcement actions to the OIG for potential imposition of civil monetary penalties. Those enforcement actions are currently subject to ongoing litigation. In November 2022, HRSA issued proposed rules that would overhaul the 340B Drug Pricing Programs Administrative Dispute Resolution process. The revisions are designed to make the process more accessible by making it more expeditious and less formal, as well as more equitable by requiring fewer resources to participate. A reduction in Covered Entities&#8217; participation in contract pharmacy arrangements, as a result of the pending enforcement actions or otherwise, a reduction in the use of the Company&#8217;s administrative services by Covered Entities, or a reduction in drug manufacturers&#8217; participation in the program could materially and adversely affect the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-Remuneration Laws</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Federal law prohibits, among other things, an entity from knowingly and willfully offering, paying, soliciting or receiving, subject to certain exceptions and &#8220;safe harbors,&#8221; any remuneration to induce the referral of individuals or the purchase, lease or order of items or services for which payment may be made under Medicare, Medicaid or certain other federal and state health care programs. A number of states have similar laws, some of which are not limited to services paid for with government funds. Sanctions for violating these federal and state anti-remuneration laws may include imprisonment, criminal and civil fines, and exclusion from participation in Medicare, Medicaid and other federal and state government-sponsored health care programs. Companies involved in public health care programs such as Medicare and/or Medicaid are required to maintain compliance programs to detect and deter fraud, waste and abuse, and are often the subject of fraud, waste and abuse investigations and audits. The Company has invested significant resources to comply with Medicare and Medicaid program standards. Ongoing vigorous law enforcement and the highly technical regulatory scheme mean that the Company&#8217;s compliance efforts in this area will continue to require significant resources.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Antitrust and Unfair Competition </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The U.S. Federal Trade Commission (&#8220;FTC&#8221;) investigates and prosecutes practices that are &#8220;unfair trade practices&#8221; or &#8220;unfair methods of competition.&#8221; Numerous lawsuits have been filed throughout the United States against pharmaceutical manufacturers, retail pharmacies and/or PBMs under various federal and state antitrust and unfair competition laws challenging, among other things: (i) brand name drug pricing and rebate practices of pharmaceutical manufacturers, (ii) the maintenance of retail or specialty pharmacy networks by PBMs, and (iii) various other business practices of PBMs and retail pharmacies. In July 2021, the FTC approved several resolutions that direct agency staff to use compulsory process, such as subpoenas, to investigate seven specific enforcement priorities. Priority targets include, among other businesses, health care businesses, such as pharmaceutical companies, pharmacy benefits managers and hospitals. To the extent that the Company appears to have actual or potential market power in a relevant market or CVS pharmacy, CVS specialty or MinuteClinic plays a unique or expanded role in a Health Care Benefits or Health Services segment product offering, the Company&#8217;s business arrangements and uses of confidential information may be subject to heightened scrutiny from an anti-competitive perspective and possible challenge by state and/or federal regulators and/or private parties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Privacy and Confidentiality Requirements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Many of the Company&#8217;s activities involve the receipt, use and disclosure by the Company of personally identifiable information (&#8220;PII&#8221;) as permitted in accordance with applicable federal and state privacy and data security laws, which require organizations to provide appropriate privacy and security safeguards for such information. In addition to PII, the Company uses and discloses de-identified data for analytical and other purposes when permitted. Additionally, there are industry standards for handling credit card data known as the Payment Card Industry Data Security Standard, which are a set of requirements designed to help ensure that entities that process, store or transmit credit card information maintain a secure environment. Certain states have incorporated these requirements into state laws or enacted other requirements relating to the use and/or disclosure of PII.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal Health Insurance Portability and Accountability Act of 1996 and the regulations issued thereunder (collectively, &#8220;HIPAA&#8221;), as further modified by the American Recovery and Reinvestment Act of 2009 (&#8220;ARRA&#8221;) impose extensive requirements on the way in which health plans, providers, health care clearinghouses (known as &#8220;covered entities&#8221;) and their business associates use, disclose and safeguard protected health information (&#8220;PHI&#8221;). Further, ARRA requires the Company and other covered entities to report any breaches of PHI to impacted individuals and to the HHS and to notify the media in any states where 500 or more people are impacted by the unauthorized release or use of or access to PHI. Criminal penalties and civil sanctions may be imposed for failing to comply with HIPAA standards. The Health Information Technology for Economic and Clinical Health Act (the &#8220;HITECH Act&#8221;), enacted as part of ARRA, amended HIPAA to impose additional restrictions on third-party funded communications using PHI and the receipt of remuneration in exchange for PHI. The HITECH Act also extended HIPAA privacy and security requirements and penalties directly to business associates. HHS has begun to audit health plans, providers and other parties to enforce HIPAA compliance, including with respect to data security. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to HIPAA, state health privacy laws apply to the extent they are more protective of individual privacy than is HIPAA, including laws that place stricter controls on the release of information relating to specific diseases or conditions and requirements to notify members of unauthorized release or use of or access to PHI. States also have adopted regulations to implement provisions of the Financial Modernization Act of 1999 (also known as the Gramm-Leach-Bliley Act (&#8220;GLBA&#8221;)) which generally require insurers, including health insurers, to provide customers with notice regarding how their non-public personal health and financial information is used and the opportunity to &#8220;opt out&#8221; of certain disclosures before the insurer shares such information with a non-affiliated third party. Like HIPAA, GLBA sets a &#8220;floor&#8221; standard, allowing states to adopt more stringent requirements governing privacy protection. Complying with additional state requirements requires us to make additional investments beyond those the Company has made to comply with HIPAA and GLBA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cybersecurity Information Sharing Act of 2015 encourages organizations to share cyber threat indicators with the federal government and, among other things, directs HHS to develop a set of voluntary cybersecurity best practices for organizations in the health care industry. In addition, states have begun to enact more comprehensive privacy laws and regulations addressing consumer rights to data access, deletion, protection or transparency, such as the California Consumer Privacy Act (&#8220;CCPA&#8221;). States also are starting to issue regulations and proposed regulations specifically related to cybersecurity, such as the regulations issued by the New York Department of Financial Services. Complying with conflicting cybersecurity regulations, which may differ from state to state, requires significant resources. In addition, differing approaches to state privacy and/or cyber-security regulation and varying enforcement philosophies may materially and adversely affect the Company&#8217;s ability to standardize its products and services across state lines. Widely-reported large scale commercial data breaches in the United States and abroad increase the likelihood that additional data security legislation will be considered by additional states. These legislative and regulatory developments will impact the design and operation of the Company&#8217;s businesses, its privacy and security strategy and its web-based and mobile assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, each Public Exchange is required to adhere to privacy and security standards with respect to PII, and to impose privacy and security standards that are at least as protective of PII as those the Public Exchange has implemented for itself or non-Public Exchange entities, which include insurers offering plans through the Public Exchange and their designated downstream entities, including PBMs and other business associates. These standards may differ from, and be more stringent than, HIPAA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consumer Protection Laws</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The federal government has many consumer protection laws, such as the Federal Trade Commission Act, the Federal Postal Service Act and the Consumer Product Safety Act. Most states also have similar consumer protection laws and a growing number of states regulate subscription programs. In addition, the federal government and most states have adopted laws and/or regulations requiring places of public accommodation, health care services and other goods and services to be accessible to people with disabilities. These consumer protection and accessibility laws and regulations have been the basis for investigations, lawsuits and multistate settlements relating to, among other matters, the marketing of loyalty programs, and health care products and services, pricing accuracy, expired front store products, financial incentives provided by drug manufacturers to pharmacies in connection with therapeutic interchange programs, disclosures related to how personal data is used and protected and the accessibility of goods and services to people with disabilities. As a result of the Company&#8217;s direct-to-consumer activities, including mobile and web-based solutions offered to members and to other consumers, the Company also is subject to federal and state regulations applicable to electronic communications and to other general consumer protection laws and regulations. For example, the CCPA became effective in 2020, and additional federal and state regulation of consumer privacy protection may be proposed or enacted in the future. The Company expects these new laws and regulations to impact the design of its products and services and the management and operation of its businesses and to increase its compliance costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transparency in Coverage Rule</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In October 2020, the HHS, the U.S. Department of Labor (&#8220;DOL&#8221;) and the U.S. Internal Revenue Service (&#8220;IRS,&#8221; and together with the HHS and DOL, the &#8220;Tri-Departments&#8221;) released a final rule requiring health insurers to disclose negotiated prices of drugs, medical services, supplies and other covered items. The rule requires group health plans and health insurance issuers in the individual and group markets to disclose cost-sharing information upon request, to a participant, beneficiary, or enrollee and require plans and issuers to publicly disclose in-network provider rates, historical out-of-network allowed amounts and the associated billed charges, and negotiated rates and historical net prices for prescription drugs. Insurers are required to implement a consumer tool and disclose data in a machine readable file. In August 2021, the federal government delayed enforcement of the requirement to publish machine-readable files related to prescription drug pricing until further rulemaking occurs. The public disclosure of insurer- or PBM-negotiated price concessions may result in drug manufacturers lowering discounts or rebates, resulting in higher drug costs for patients and impacting the ability of the Company to negotiate drug prices and provide competitive products and services to consumers. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Consolidated Appropriations Act of 2021 was signed into law in December 2020 and contains further transparency provisions requiring group health plans and health insurance issuers to report certain prescription drug costs, overall spending on health services and prescription drugs, and information about premiums and the impact of rebates and other remuneration on premiums and out-of-pocket costs to the Tri-Departments. No later than 18 months after the first submission and bi-annually thereafter, the Tri-Departments will release a public report on drug pricing trends, drug reimbursement, and the impact of drug prices on premiums. The first filings of plan year data were required in December 2022 and will be required annually in June of each year on an ongoing basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Telemarketing and Other Outbound Contacts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Certain federal and state laws, such as the Telephone Consumer Protection Act and the Telemarketing Sales Rule, give the FTC, the Federal Communications Commission and state Attorneys General the ability to regulate, and bring enforcement actions relating to, telemarketing practices and certain automated outbound contacts such as phone calls, texts or emails. Under certain circumstances, these laws provide consumers with a private right of action. Violations of these laws could result in substantial statutory penalties and other sanctions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy and Professional Licensure and Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company is subject to a variety of intersecting federal and state statutes and regulations that govern the wholesale distribution of drugs; operation of retail, specialty, infusion, LTC and mail order pharmacies; licensure of facilities and professionals, including pharmacists, technicians, nurses and other health care professionals; registration of facilities with the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;) and analogous state agencies that regulate controlled substances; packaging, storing, shipping and tracking of pharmaceuticals; repackaging of drug products; labeling, medication guides and other consumer disclosures; interactions with prescribers and health care professionals; compounding of prescription medications; dispensing of controlled and non-controlled substances; counseling of patients; transfers of prescriptions; advertisement of prescription products and pharmacy services; security; inventory control; recordkeeping; reporting to Boards of Pharmacy, the U.S. Food and Drug Administration (the &#8220;FDA&#8221;), the U.S. Consumer Product Safety Commission, the DEA and related state agencies; and other elements of pharmacy practice. Pharmacies are highly regulated and have contact with a wide variety of federal, state and local agencies with various powers to investigate, inspect, audit or solicit information, including Boards of Pharmacy and Nursing, the DEA, the FDA, the DOJ, HHS and others. Many of these agencies have broad enforcement powers, conduct audits on a regular basis, can impose substantial fines and penalties, and may revoke the license, registration or program enrollment of a facility or professional. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">State Insurance, HMO and Insurance Holding Company Regulation - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of states regulate affiliated groups of insurers and HMOs such as the Company under holding company statutes. These laws may, among other things, require prior regulatory approval of dividends and material intercompany transfers of assets and transactions between the regulated companies and their affiliates, including their parent holding companies. The Company expects the states in which its insurance and HMO subsidiaries are licensed to continue to expand their regulation of the corporate governance and internal control activities of its insurance companies and HMOs. Changes to state insurance, HMO and/or insurance holding company laws or regulations or changes to the interpretation of those laws or regulations, including due to regulators&#8217; increasing concerns regarding insurance company and/or HMO solvency due, among other things, to past and expected payor insolvencies, could negatively affect the Company&#8217;s businesses in various ways, including through increases in solvency fund assessments, requirements that the Company hold greater levels of capital and/or delays in approving dividends from regulated subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PBM offerings of prescription drug coverage under certain risk arrangements may be subject to laws and regulations in various states. Such laws may require that the party at risk become licensed as an insurer, establish reserves or otherwise demonstrate financial viability. Laws that may apply in such cases include insurance laws and laws governing MCOs and limited prepaid health service plans. In addition, several states require that PBMs become directly registered or licensed with the department of insurance or similar government oversight agency regardless of any arrangements they have with clients. PBM licensure laws may include oversight of certain PBM activities and operations and may include auditing of those activities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The states of domicile of the Company&#8217;s regulated subsidiaries have statutory risk-based capital (&#8220;RBC&#8221;) requirements for health and other insurance companies and HMOs based on the National Association of Insurance Commissioners&#8217; (the &#8220;NAIC&#8221;) Risk-Based Capital for Insurers Model Act (the &#8220;RBC Model Act&#8221;). These RBC requirements are intended to assess the capital adequacy of life and health insurers and HMOs, taking into account the risk characteristics of a company&#8217;s investments and products. The RBC Model Act sets forth the formula for calculating RBC requirements, which are designed to take into account asset risks, insurance risks, interest rate risks and other relevant risks with respect to an individual company&#8217;s business. In general, under these laws, an insurance company or HMO must submit a report of its RBC level to the insurance department or insurance commissioner of its state of domicile for each calendar year. At December&#160;31, 2022, the RBC level of each of the Company&#8217;s insurance and HMO subsidiaries was above the level that would require regulatory action.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding restrictions on certain payments of dividends or other distributions by the Company&#8217;s HMO and insurance company subsidiaries, see Note 13 &#8216;&#8216;Shareholders&#8217; Equity&#8217;&#8217; included in Item 8 of this Exhibit 99.1.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holding company laws for the states of domicile of certain of the Company&#8217;s subsidiaries also restrict the ability of any person to obtain control of an insurance company or HMO without prior regulatory approval. Under those statutes, without such approval (or an exemption), no person may acquire any voting security of an insurance holding company (such as the Company&#8217;s ultimate parent company, CVS Health Corporation) that controls an insurance company or HMO, or merge with such a holding company, if as a result of such transaction such person would control the insurance holding company. Control is generally defined as the direct or indirect power to direct or cause the direction of the management and policies of a person and is presumed to exist if a person directly or indirectly owns or controls 10% or more of the voting securities of another person.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain states have laws that prohibit submitting a false claim or making a false record or statement in order to secure reimbursement from an insurance company. These state laws vary, and violation of them may lead to the imposition of civil or criminal penalties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Agreements and Mandates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - From time to time, the Company and/or its various affiliates are subject to certain consent decrees, settlement and other agreements, corrective action plans and corporate integrity agreements with various federal, state and local authorities relating to such matters as privacy practices, controlled substances, PDPs, expired products, environmental and safety matters, marketing and advertising practices, PBM, LTC and other pharmacy operations and various other business practices. Certain of these agreements contain ongoing reporting, monitoring and/or other compliance requirements for the Company. Failure to meet the Company&#8217;s obligations under these agreements could result in civil or criminal remedies, financial penalties, administrative remedies, and/or exclusion from participation in federal health care programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental and Safety Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company&#8217;s businesses are subject to various federal, state and local laws, regulations and other requirements pertaining to protection of the environment, public health and employee safety, including, for example, regulations governing the management of hazardous substances, the cleaning up of contaminated sites, and the maintenance of safe working conditions in the Company&#8217;s retail locations, distribution centers and other facilities. Governmental agencies at the federal, state and local levels continue to focus on the retail and health care sectors&#8217; compliance with such laws and regulations, and have at times pursued enforcement activities. Any failure to comply with these regulations could result in fines or other sanctions by government authorities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ERISA Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The Employee Retirement Income Security Act of 1974 (&#8220;ERISA&#8221;), provides for comprehensive federal regulation of certain employee pension and benefit plans, including private employer and union sponsored health plans and certain other plans that contract with us to provide PBM services. In general, the Company assists plan sponsors in the administration of their health benefit plans, including the prescription drug benefit portion of those plans, in accordance with the plan designs adopted by the plan sponsors. In addition, the Company may have fiduciary duties where it has specifically contracted with a plan sponsor to accept limited fiduciary responsibility, such as for the adjudication of initial prescription drug benefit claims and/or the appeals of denied claims under a plan. In addition to its fiduciary provisions, ERISA imposes civil and criminal liability on service providers to health plans and certain other persons if certain forms of illegal remuneration are made or received. These provisions of ERISA are broadly written and their application to specific business practices is often uncertain.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s health and related benefits and large case pensions products and services and related fees also are subject to potential issues raised by judicial interpretations relating to ERISA. Under those interpretations, together with DOL regulations, the Company may have ERISA fiduciary duties with respect to medical members, PBM members and/or certain general account assets held under contracts that are not guaranteed benefit policies. As a result, certain transactions related to those general account assets are subject to conflict of interest and other restrictions, and the Company must provide certain disclosures to policyholders annually. The Company must comply with these restrictions or face substantial penalties. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Preemption</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - ERISA generally preempts all state and local laws that relate to employee benefit plans, but the extent of the preemption continues to be reviewed by courts, including the U.S. Supreme Court. For example, in December 2020, the U.S. Supreme Court upheld an Arkansas law that, among other things, mandates a particular pricing methodology, establishes an appeals process for a pharmacy when the reimbursement is below the pharmacy&#8217;s acquisition cost, permits a pharmacy to reverse and rebill if they cannot procure the drug from its wholesaler at a price equal to or less than the reimbursement rate, prohibits a PBM from reimbursing a pharmacy less than the amount it reimburses an affiliate on a per unit basis, and permits a pharmacy to decline to dispense if the reimbursement is lower than the pharmacy&#8217;s acquisition cost. Subsequently, in November 2021, the U.S. Court of Appeals for the Eighth Circuit upheld a North Dakota law that regulates employer-sponsored </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ERISA health plans and certain PBM practices within Medicare and in April 2022 the U.S. District Court for the Western District of Oklahoma affirmed that the Oklahoma Insurance Department could enforce a state law against PBMs that contained provisions that alter and limit some of the options that an ERISA plan can use, because none of the provisions mandate that ERISA plans make any specific choices. Additional litigation has been filed in several states to challenge ERISA and Medicare Part D preemption.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Legislative Initiatives and Regulatory Initiatives </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The U.S. federal and state governments, as well as governments in other countries where the Company does business, continue to enact and seriously consider many broad-based legislative and regulatory proposals that have had a material impact on or could materially impact various aspects of the health care and related benefits system and the Company&#8217;s businesses, operating results and/or cash flows. For example:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Under the Budget Control Act of 2011 and the American Taxpayer Relief Act of 2012 significant, automatic across-the-board budget cuts (known as sequestration) began in March 2013, including Medicare spending cuts of not more than 2% of total program costs per year through 2024. Since then, Congress has extended and modified the Medicare sequester a number of times. The CARES Act temporarily suspended the Medicare sequester and extended mandatory sequestration to 2030. In July 2022, the 2% Medicare sequester resumed. Significant uncertainty remains as to whether and how the U.S. Congress will proceed with actions that create additional federal revenue and/or with entitlement reform. The Company cannot predict future federal Medicare or federal or state Medicaid funding levels or the impact that future federal or state budget actions or entitlement program reform, if it occurs, will have on the Company&#8217;s businesses, operations or operating results, but the effects could be materially adverse, particularly on the Company&#8217;s Medicare and/or Medicaid revenues, MBRs and operating results.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The European Union&#8217;s (&#8220;EU&#8217;s&#8221;) General Data Protection Regulation (&#8220;GDPR&#8221;) began to apply across the EU during 2018.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other significant legislative and/or regulatory measures which are or recently have been under consideration include the following:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increasing the corporate tax rate.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Eliminating payment of manufacturer&#8217;s rebates on prescription drugs to PBMs, PDPs and Managed Medicaid organizations in connection with federally funded health care programs. </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Imposing requirements and restrictions on the design and/or administration of pharmacy benefit plans offered by the Company&#8217;s and its clients&#8217; health plans and/or its PBM clients and/or the services the Company provides to those clients, including prohibiting &#8220;differential&#8221; or &#8220;spread&#8221; pricing in PBM contracts; restricting or eliminating the use of formularies for prescription drugs; restricting the Company&#8217;s ability to require members to obtain drugs through a home delivery or specialty pharmacy; restricting the Company&#8217;s ability to place certain specialty or other drugs in the higher cost tiers of its pharmacy formularies; restricting the Company&#8217;s ability to make changes to drug formularies and/or clinical programs; limiting or eliminating rebates on pharmaceuticals; requiring the use of up front purchase price discounts on pharmaceuticals in lieu of rebates; restricting the Company&#8217;s ability to configure and reimburse its health plan and retail pharmacy provider networks, including use of CVS pharmacy locations; and restricting or eliminating the use of certain drug pricing methodologies.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increasing federal or state government regulation of, or involvement in, the pricing and/or purchasing of drugs.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restricting the Company&#8217;s ability to limit providers&#8217; participation in its networks and/or remove providers from its networks by imposing network adequacy requirements or otherwise (including in its Medicare and Commercial Health Care Benefits products).</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Imposing assessments on (or to be collected by) health plans or health carriers that may or may not be passed through to their customers. These assessments may include assessments for insolvency, the uninsured, uncompensated care, Medicaid funding or defraying health care provider medical malpractice insurance costs.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mandating coverage by the Company&#8217;s and its clients&#8217; health plans for additional conditions and/or specified procedures, drugs or devices (e.g., high cost pharmaceuticals, experimental pharmaceuticals and oral chemotherapy regimens).</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Regulating electronic connectivity.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mandating or regulating the disclosure of provider fee schedules, manufacturer&#8217;s rebates and other data about the Company&#8217;s payments to providers and/or payments the Company receives from pharmaceutical manufacturers.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mandating or regulating disclosure of provider outcome and/or efficiency information.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prescribing or limiting members&#8217; financial responsibility for health care or other covered services they utilize, including restricting &#8220;surprise&#8221; bills by providers and by specifying procedures for resolving &#8220;surprise&#8221; bills.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prescribing payment levels for health care and other covered services rendered to the Company&#8217;s members by providers who do not have contracts with the Company.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assessing the medical device status of home infusion therapy products and/or solutions, mobile consumer wellness tools and clinical decision support tools, which may require compliance with FDA requirements in relation to some of these products, solutions and/or tools.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restricting the ability of employers and/or health plans to establish or impose member financial responsibility.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Proposals to expand benefits under Original Medicare.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Amending or supplementing ERISA to impose greater requirements on PBMs or the administration of employer-funded benefit plans or limit the scope of current ERISA pre-emption, which would among other things expose the Company and other health plans to expanded liability for punitive and other extra-contractual damages and additional state regulation.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is uncertain whether the Company can counter the potential adverse effects of such potential legislation or regulation on its operating results or cash flows, including whether it can recoup, through higher premium rates, expanded membership or other measures, the increased costs of mandated coverage or benefits, assessments, fees, taxes or other increased costs, including the cost of modifying its systems to implement any enacted legislation or regulations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s businesses also may be affected by other legislation and regulations. The Dodd-Frank Wall Street Reform and Consumer Protection Act creates incentives for whistleblowers to speak directly to the government rather than utilizing internal compliance programs and reduces the burden of proof under the Foreign Corrupt Practices Act of 1977 (the &#8220;FCPA&#8221;). There also are laws and regulations that set standards for the escheatment of funds to states.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health savings accounts, health reimbursement arrangements and flexible spending accounts and certain of the tax, fee and subsidy provisions of the ACA also are regulated by the U.S. Department of the Treasury and the IRS.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also may be adversely affected by court and regulatory decisions that expand or revise the interpretations of existing statutes and regulations or impose medical malpractice or bad faith liability. Federal and state courts, including the U.S. Supreme Court, continue to consider cases, and federal and state regulators continue to issue regulations and interpretations, addressing bad faith liability for denial of medical claims, the scope of ERISA&#8217;s fiduciary duty requirements, the scope of the False Claims Act and the pre-emptive effect of ERISA and Medicare Part D on state laws.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Audits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The Company is subject to audits of many of its contracts, including its PBM client contracts, its PBM rebate contracts, its PBM network contracts, its contracts relating to Medicare Advantage and/or Medicare Part D, the agreements the Company&#8217;s pharmacies enter into with other payors, its Medicaid contracts and its customer contracts. Because some of the Company&#8217;s contracts are with state or federal governments or with entities contracted with state or federal agencies, audits of these contracts are often regulated by the federal or state agencies responsible for administering federal or state benefits programs, including those which operate Medicaid fee for service plans, Managed Medicaid plans, Medicare Part D plans or Medicare Advantage organizations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Federal Employee Health Benefits Program </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The Company&#8217;s subsidiaries contract with the Office of Personnel Management (the &#8220;OPM&#8221;) to provide managed health care services under the FEHB program in their service areas. These contracts with the OPM and applicable government regulations establish premium rating arrangements for this program. In addition to other requirements, such as the Transparency in Coverage Rule note above, OPM regulations require that community-rated FEHB plans meet a FEHB program-specific minimum MLR by plan code and market. Managing to these rules is complicated by the simultaneous application of the minimum MLR standards and associated premium rebate requirements of the ACA. The Company also has a contractual arrangement with carriers for the FEHB program, such as the BlueCross BlueShield Association, to provide pharmacy services to federal employees, postal workers, annuitants, and their dependents under the Government-wide Service Benefit Plan, as authorized by the FEHB Act and as part of the FEHB program. Additionally, the Company manages certain FEHB plans on a &#8220;cost-plus&#8221; basis. These arrangements subject the Company to certain aspects of the FEHB Act, and other federal regulations, such as the FEHB Acquisition Regulation, that otherwise would not be applicable to the Company. The OPM also is auditing the Company and its other contractors to, among other things, verify that plans meet their applicable FEHB program-specific MLR and the premiums established under the OPM&#8217;s Insured contracts and costs allocated pursuant to the OPM&#8217;s cost-based contracts are in compliance with the requirements of the applicable FEHB program. The OPM may seek premium refunds or institute other sanctions against the Company if it fails to comply with the FEHB program requirements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clinical Services Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The Company provides clinical services to health plans, PBMs and providers for a variety of complex and common medical conditions, including arranging for certain members to participate in disease management programs. State laws regulate the practice of medicine, the practice of pharmacy, the practice of nursing and certain other </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">clinical activities. Clinicians engaged in a professional practice in connection with the provision of clinical services must satisfy applicable state licensing requirements and must act within their scope of practice.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Third Party Administration and Other State Licensure Laws </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Many states have licensure or registration laws governing certain types of administrative organizations, such as PPOs, TPAs and companies that provide utilization review services. Several states also have licensure or registration laws governing the organizations that provide or administer consumer card programs (also known as cash card or discount card programs).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">International Regulation - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has insurance licenses in several foreign jurisdictions and does business directly or through local affiliations in numerous countries around the world. The Company has taken steps to be able to continue to serve customers in the European Economic Area following the United Kingdom&#8217;s exit from the EU (&#8220;Brexit&#8221;).  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s international operations are subject to different, and sometimes more stringent, legal and regulatory requirements, which vary widely by jurisdiction, including anti-corruption laws; economic sanctions laws; various privacy, insurance, tax, tariff and trade laws and regulations; corporate governance, privacy, data protection (including the EU&#8217;s General Data Protection Regulation which began to apply across the EU during 2018), data mining, data transfer, labor and employment, intellectual property, consumer protection and investment laws and regulations; discriminatory licensing procedures; compulsory cessions of reinsurance; required localization of records and funds; higher premium and income taxes; limitations on dividends and repatriation of capital; and requirements for local participation in an insurer&#8217;s ownership. In addition, the presence of operations in foreign countries potentially increases the Company&#8217;s exposure to the anti-bribery, anti-corruption and anti-money laundering provisions of U.S. law, including the FCPA, and corresponding foreign laws, including the U.K. Bribery Act 2010 (the &#8220;UK Bribery Act&#8221;). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-Corruption Laws</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The FCPA prohibits offering, promising or authorizing others to give anything of value to a foreign government official to obtain or retain business or otherwise secure a business advantage. The Company also is subject to applicable anti-corruption laws of the jurisdictions in which it operates. In many countries outside the United States, health care professionals are employed by the government. Therefore, the Company&#8217;s dealings with them are subject to regulation under the FCPA. Violations of the FCPA and other anti-corruption laws may result in severe criminal and civil sanctions as well as other penalties, and there continues to be a heightened level of FCPA enforcement activity by the  SEC and the DOJ. The UK Bribery Act is an anti-corruption law that is broader in scope than the FCPA and applies to all companies with a nexus to the United Kingdom. Disclosures of FCPA violations may be shared with the UK authorities, thus potentially exposing companies to liability and potential penalties in multiple jurisdictions. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-Money Laundering Regulations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Certain lines of the Company&#8217;s businesses are subject to Treasury anti-money laundering regulations. Those lines of business have implemented anti-money laundering policies designed to ensure their compliance with the regulations. The Company also is subject to anti-money laundering laws in non-U.S. jurisdictions where it operates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Office of Foreign Assets Control</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company also is subject to regulation by the Office of Foreign Assets Control of the U.S. Department of Treasury (&#8220;OFAC&#8221;). OFAC administers and enforces economic and trade sanctions based on U.S. foreign policy and national security goals against targeted foreign countries and regimes, terrorists, international narcotics traffickers, those engaged in activities related to the proliferation of weapons of mass destruction, and other threats to the national security, foreign policy or economy of the United States. In addition, the Company is subject to similar regulations in the non-U.S. jurisdictions in which it operates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FDA Regulation - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA regulates the Company&#8217;s compounding pharmacy and clinical research operations. The FDA also generally has authority to, among other things, regulate the manufacture, distribution, sale and labeling of medical devices (including hemodialysis devices such as the device the Company is developing and mobile medical devices) and many products sold through retail pharmacies, including prescription drugs, over-the-counter medications, cosmetics, dietary supplements and certain food items. In addition, the FDA regulates the Company&#8217;s activities as a distributor of store brand products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and Regulations Related to the Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the laws and regulations discussed above that may affect multiple segments of the Company&#8217;s business, the Company is subject to federal, state, local and international statutes and regulations governing its Health Care Benefits segment specifically. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Differing approaches to state insurance regulation and varying enforcement philosophies may materially and adversely affect the Company&#8217;s ability to standardize its Health Care Benefits products and services across state lines. These laws and regulations, including the ACA, restrict how the Company conducts its business and result in additional burdens and costs to the Company. Significant areas of governmental regulation include premium rates and rating methodologies, underwriting rules and procedures, required benefits, sales and marketing activities, provider rates of payment, restrictions on health plans&#8217; ability to limit providers&#8217; participation in their networks and/or remove providers from their networks and financial condition (including reserves and minimum capital or risk based capital requirements). These laws and regulations are different in each jurisdiction and vary from product to product.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each health insurer and HMO must file periodic financial and operating reports with the states in which it does business. In addition, health insurers and HMOs are subject to state examination and periodic license renewal. Applicable laws also restrict the ability of the Company&#8217;s regulated subsidiaries to pay dividends, and certain dividends require prior regulatory approval. In addition, some of the Company&#8217;s businesses and related activities may be subject to PPO, MCO, utilization review or TPA-related licensure requirements and regulations. These licensure requirements and regulations differ from state to state, but may contain provider network, contracting, product and rate, financial and reporting requirements. There also are laws and regulations that set specific standards for the Company&#8217;s delivery of services, payment of claims, fraud prevention, protection of consumer health information, and payment for covered benefits and services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Required Regulatory Approvals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company must obtain and maintain regulatory approvals to price, market and administer many of its Health Care Benefits products. Supervisory agencies, including CMS, the Center for Consumer Information and Insurance Oversight and the DOL, as well as state health, insurance, managed care and Medicaid agencies, have broad authority to take one or more of the following actions:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Grant, suspend and revoke the Company&#8217;s licenses to transact business;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Suspend or exclude the Company from participation in government programs;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Suspend or limit the Company&#8217;s authority to market products;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Regulate many aspects of the products and services the Company offers, including the pricing and underwriting of many of its products and services;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assess damages, fines and/or penalties;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Terminate the Company&#8217;s contract with the government agency and/or withhold payments from the government agency to the Company;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Impose retroactive adjustments to premiums and require the Company to pay refunds to the government, customers and/or members;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restrict the Company&#8217;s ability to conduct acquisitions or dispositions;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Require the Company to maintain minimum capital levels in its subsidiaries and monitor its solvency and reserve adequacy;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Regulate the Company&#8217;s investment activities on the basis of quality, diversification and other quantitative criteria; and/or</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Exclude the Company&#8217;s plans from participating in Public Exchanges if they are deemed to have a history of &#8220;unreasonable&#8221; premium rate increases or fail to meet other criteria set by HHS or the applicable state.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operations, current and past business practices, current and past contracts, and accounts and other books and records are subject to routine, regular and special investigations, audits, examinations and reviews by, and from time to time the Company receives subpoenas and other requests for information from, federal, state and international supervisory and enforcement agencies, Attorneys General and other state, federal and international governmental authorities and legislators. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercial Product Pricing and Underwriting Restrictions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Pricing and underwriting regulation by states limits the Company&#8217;s underwriting and rating practices and those of other health insurers, particularly for small employer groups, and varies by state. In general, these limitations apply to certain customer segments and limit the Company&#8217;s ability to set prices for new or renewing groups, or both, based on specific characteristics of the group or the group&#8217;s prior claim experience. In some states, these laws and regulations restrict the Company&#8217;s ability to price for the risk it assumes and/or reflect reasonable costs in the Company&#8217;s pricing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA expanded the premium rate review process by, among other things, requiring the Company&#8217;s Commercial Insured rates to be reviewed for &#8220;reasonableness&#8221; at either the state or the federal level. HHS established a federal premium rate review process that generally applies to proposed premium rate increases equal to or exceeding a federally (or lower state) specified threshold. HHS&#8217;s rate review process imposes additional public disclosure requirements as well as additional review on filings </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requesting premium rate increases equal to or exceeding this &#8220;reasonableness&#8221; threshold. These combined state and federal review requirements may prevent, further delay or otherwise affect the Company&#8217;s ability to price for the risk it assumes, which could adversely affect its MBRs and operating results, particularly during periods of increased utilization of medical services and/or medical cost trend or when such utilization and/or trend exceeds the Company&#8217;s projections.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA also specifies minimum MLRs of 85% for large group Commercial products and 80% for individual and small group Commercial products. Because the ACA minimum MLRs are structured as &#8220;floors&#8221; for many of their requirements, states have the latitude to enact more stringent rules governing these restrictions. For Commercial products, states have and may adopt higher minimum MLR requirements, use more stringent definitions of &#8220;medical loss ratio,&#8221; incorporate minimum MLR requirements into prospective premium rate filings, require prior approval of premium rates or impose other requirements related to minimum MLR. Minimum MLR requirements and similar actions further limit the level of margin the Company can earn in its Insured Commercial products while leaving the Company exposed to medical costs that are higher than those reflected in its pricing. The Company also may be subject to significant fines, penalties, premium refunds and litigation if it fails to comply with minimum MLR laws and regulations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company requested increases in its premium rates in its Commercial Health Care Benefits business for 2023 and expects to request future increases in those rates in order to adequately price for projected medical cost trends, required expansions of coverage and rating limits, and significant assessments, fees and taxes imposed by the federal and state governments, including as a result of the ACA. The Company&#8217;s rates also must be adequate to reflect adverse selection in its products, particularly in small group Commercial products. These rate increases may be significant and thus heighten the risks of adverse publicity, adverse regulatory action and adverse selection and the likelihood that the Company&#8217;s requested premium rate increases will be denied, reduced or delayed, which could lead to operating margin compression.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the laws and regulations governing the Company&#8217;s pricing and underwriting practices also limit the differentials in premium rates insurers and other carriers may charge between new and renewal business, and/or between groups based on differing characteristics. They may also require that carriers disclose to customers the basis on which the carrier establishes new business and renewal premium rates and limit the ability of a carrier to terminate customers&#8217; coverage. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medicaid Regulation - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is seeking to substantially grow its Medicaid, dual eligible and dual eligible special needs plan businesses over the next several years. As a result, the Company also is increasing its exposure to changes in government policy with respect to and/or regulation of the various Medicaid, dual eligible and dual eligible special needs plan programs in which the Company participates, including changes in the amounts payable to the Company under those programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to a quality rating system that applies to Medicaid and Managed Medicaid plans, federal regulations give states the option to choose to establish a minimum MLR of at least 85% for their Managed Medicaid plans, including those offered by the Company. Regardless of whether a state establishes a minimum MLR, it must use plan-reported MLR data to set future payment rates for managed care, so that its plans will &#8220;reasonably achieve&#8221; an MLR of at least 85%. For Managed Medicaid products, states may use more stringent definitions of &#8220;medical loss ratio&#8221;, use discretion in choosing a quantitative standard for determining provider network adequacy, or impose other requirements related to minimum MLR. Minimum MLR requirements and similar actions further limit the level of margin the Company can earn in its Insured Medicaid products while leaving the Company exposed to medical costs that are higher than those reflected in its pricing. The Company also may be subject to significant fines, penalties, premium refunds and litigation if it fails to comply with minimum MLR laws and regulations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">States continue to consider Medicaid expansion; however, to date 12 states have not expanded, which will drop to 11 states once South Dakota&#8217;s expansion takes effect in July 2023. States may opt out of the elements of the ACA requiring expansion of Medicaid coverage without losing their current federal Medicaid funding. In addition, the election of new Governors and/or state legislatures may impact states&#8217; previous decisions regarding Medicaid expansion. Although Congress enacted incentives for states that had not yet done so to expand Medicaid, this incentive alone may not persuade holdout states to expand.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, Medicaid MCOs faced new requirements and state flexibility that were finalized in the 2020 Medicaid managed care final rule. States now have flexibility related to rate setting and provider network adequacy that could adversely or positively impact our Medicaid plans. Other changes related to managed care operations include beneficiary communications, appeals and grievances, and provider directories.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The economic aspects of the Medicaid, dual eligible and dual eligible special needs plan business vary from state to state and are subject to frequent change. Medicaid premiums are paid by each state and differ from state to state. The federal government and certain states also are considering proposals and legislation for Medicaid and dual eligible program reforms or redesigns, including restrictions on the collection of manufacturer&#8217;s rebates on pharmaceuticals by Medicaid MCOs and their contracted </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PBMs, further program, population and/or geographic expansions of risk-based managed care, increasing beneficiary cost-sharing or payment levels, and changes to benefits, reimbursement, eligibility criteria, provider network adequacy requirements (including requiring the inclusion of specified high cost providers in the Company&#8217;s networks) and program structure. In some states, current Medicaid and dual eligible funding and premium revenue may not be adequate for the Company to continue program participation. The Company&#8217;s Medicaid and dual eligible contracts with states (or sponsors of Medicaid managed care plans) are subject to cancellation by the state (or the sponsors of the managed care plans) after a short notice period without cause (e.g., when a state discontinues a managed care program) or in the event of insufficient state funding.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Medicaid, dual eligible and dual eligible special needs plan products also are heavily regulated by CMS and state Medicaid agencies, which have the right to audit the Company&#8217;s performance to determine compliance with CMS contracts and regulations. The Company&#8217;s Medicaid products, dual eligible products and CHIP contracts also are subject to complex federal and state regulations and oversight by state Medicaid agencies regarding the services provided to Medicaid enrollees, payment for those services, network requirements (including mandatory inclusion of specified high-cost providers), and other aspects of these programs, and by external review organizations which audit Medicaid plans on behalf of state Medicaid agencies. The laws, regulations and contractual requirements applicable to the Company and other participants in Medicaid and dual eligible programs, including requirements that the Company submit encounter data to the applicable state agency, are extensive, complex and subject to change. The Company has invested significant resources to comply with these standards, and its Medicaid and dual eligible program compliance efforts will continue to require significant resources. CMS and/or state Medicaid agencies may fine the Company, withhold payments to the Company, seek premium and other refunds, terminate the Company&#8217;s existing contracts, elect not to award the Company new contracts or not to renew the Company&#8217;s existing contracts, prohibit the Company from continuing to market and/or enroll members in or refuse to automatically assign members to one or more of the Company&#8217;s Medicaid or dual eligible products, exclude the Company from participating in one or more Medicaid or dual eligible programs and/or institute other sanctions and/or civil monetary penalties against the Company if it fails to comply with CMS or state regulations or contractual requirements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot predict whether pending or future federal or state legislation or court proceedings will change various aspects of the Medicaid program, nor can it predict the impact those changes will have on its business operations or operating results, but the effects could be materially adverse.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Federal and State Reporting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The Company is subject to extensive financial and business reporting requirements, including penalties for inaccuracies and/or omissions, at both the federal and state level. The Company&#8217;s ability to comply with certain of these requirements depends on receipt of information from third parties that may not be readily available or reliably provided in all instances. The Company is and will continue to be required to modify its information systems, dedicate significant resources and incur significant expenses to comply with these requirements. However, the Company cannot eliminate the risks of unavailability of or errors in its reports.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Design and Administration and Sales Practices</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - State and/or federal regulatory scrutiny of health care benefit product design and administration and marketing and advertising practices, including the filing of insurance policy forms, the adequacy of provider networks, the accuracy of provider directories, and the adequacy of disclosure regarding products and their administration, is increasing as are the penalties being imposed for inappropriate practices. Medicare, Medicaid and dual eligible products and products offering more limited benefits in particular continue to attract increased regulatory scrutiny.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guaranty Fund Assessments/Solvency Protection</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers as well as health insurers. The Company&#8217;s assessments generally are based on a formula relating to the Company&#8217;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer governed health plans established under the ACA. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and Regulations Related to the Health Services Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the laws and regulations discussed above that may affect multiple segments of the Company&#8217;s business, the Company is subject to federal, state and local statutes and regulations governing the operation of its Health Services segment specifically. Among these are the following:</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PBM Laws and Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Legislation and/or regulations seeking to regulate PBM activities in a comprehensive manner have been proposed or enacted in a majority of states. This legislation could adversely affect the Company&#8217;s ability to conduct business on commercially reasonable terms in states where the legislation is in effect and the Company&#8217;s ability to standardize its PBM products and services across state lines. In addition, certain quasi-regulatory organizations, including the National Association of Boards of Pharmacy and the National Council of Insurance Legislators, have issued model regulations or may propose future regulations concerning PBMs and/or PBM activities. Similarly, credentialing organizations such as URAC have established voluntary standards regarding PBM, mail order pharmacy and/or specialty pharmacy activities. While the actions of these quasi-regulatory or standard-setting organizations do not have the force of law, they may influence states to adopt their requirements or recommendations and influence client requirements for PBM, mail order pharmacy and/or specialty pharmacy services. Moreover, any standards established by these organizations could also impact the Company&#8217;s health plan clients and/or the services provided to those clients and/or the Company&#8217;s health plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s PBM activities also are regulated directly and indirectly at the federal and state levels, including being subject to the False Claims Act and state false claims acts and the AKS and state anti-kickback laws. These laws and regulations govern, and proposed legislation and regulations may govern and/or further restrict, critical PBM practices, including disclosure, receipt and retention of rebates and other payments received from pharmaceutical manufacturers; use of, administration of and/or changes to drug formularies, maximum allowable cost (&#8220;MAC&#8221;) list pricing, average wholesale prices (&#8220;AWP&#8221;) and/or clinical programs; the offering to plan sponsors of pricing that includes retail network &#8220;differential&#8221; or &#8220;spread&#8221; (i.e., a difference between the drug price charged to the plan sponsor by a PBM and the price paid by the PBM to the dispensing provider); reconciliation to pricing guarantees; disclosure of data to third parties; drug UM practices; the level of duty a PBM owes its customers; configuration of pharmacy networks; the operations of the Company&#8217;s pharmacies (including audits of its pharmacies); disclosure of negotiated provider reimbursement rates; disclosure of fees associated with administrative service agreements and patient care programs that are attributable to members&#8217; drug utilization; and registration or licensing of PBMs. Failure by the Company or one of its PBM services suppliers to comply with these laws or regulations could result in material fines and/or sanctions and could have a material adverse effect on the Company&#8217;s operating results and/or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s PBM service contracts, including those in which the Company assumes certain risks under performance guarantees or similar arrangements, are generally not subject to insurance regulation by the states. However, state departments of insurance are increasing their oversight of PBM activities due to legislation passing in a number of states requiring PBMs to register or obtain a license with the department, including through market conduct examinations and other audits our licensed entities. In addition, rulemaking is either underway or has already taken place in a number of states with the areas of focus including licensure requirements, pharmacy reimbursement, network design, cost sharing and pharmacy audits - most of which fall under the state insurance code.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy Network Access Legislation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Medicare Part D and a majority of states now have some form of legislation affecting the Company&#8217;s (and its health plans&#8217; and its health plan clients&#8217;) ability to limit access to a pharmacy provider network or remove pharmacy network providers. For example, certain &#8220;any willing provider&#8221; legislation may require the Company or its clients to admit a nonparticipating pharmacy if such pharmacy is willing and able to meet the plan&#8217;s price and other applicable terms and conditions for network participation. These laws could negatively affect the services and economic benefits achievable through a limited pharmacy provider network. Also, a majority of states now have some form of legislation affecting the Company&#8217;s ability (and the Company&#8217;s and its client health plans&#8217; ability) to conduct audits of network pharmacies regarding claims submitted to the Company for payment. These laws could negatively affect the Company&#8217;s ability to recover overpayments of claims submitted by network pharmacies that the Company identifies through pharmacy audits. Finally, several states have passed legislation that limits the ability of PBMs and health insurers to provide special benefit structures for use with affiliated pharmacies, which could result in reduced savings to clients and consumers.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy Pricing Legislation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - A number of states have passed legislation regulating the Company&#8217;s ability to manage and establish MACs for generic prescription drugs. MAC methodology is a common cost management practice used by private and public payors (including CMS) to pay pharmacies for dispensing generic prescription drugs. MAC prices specify the allowable reimbursement by a PBM for a particular strength and dosage of a generic drug that is available from multiple manufacturers but sold at different prices. State legislation can regulate the disclosure of MAC prices and MAC price methodologies, the kinds of drugs that a PBM can pay for at a MAC price, and the rights of pharmacies to appeal a MAC price established by a PBM. These laws could negatively affect the Company&#8217;s ability to establish MAC prices for generic drugs. Additionally, some states have passed legislation that would restrict certain types of retroactive reconciliation or recoupment from pharmacies in the network or create a reimbursement benchmark mandate, such as the national average drug acquisition cost and/or the wholesale acquisition cost (&#8220;WAC&#8221;), plus a set dispensing fee, for pharmacies in the network. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Formulary and Plan Design Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- A number of government entities regulate the administration of prescription drug benefits. HHS regulates how Medicare Part D formularies are developed and administered, including requiring the inclusion of all drugs in certain classes and categories, subject to limited exceptions. Under the ACA, CMS imposes drug coverage requirements for health plans required to cover essential health benefits, including plans offered through federal or state Public Exchanges. Additionally, the NAIC and health care accreditation agencies like NCQA and URAC have developed model acts and standards for formulary development that are often incorporated into government requirements. Many states regulate the scope of prescription drug coverage, as well as the delivery channels to receive prescriptions, for insurers, MCOs and Medicaid managed care plans. The increasing government regulation of formularies could significantly affect the Company&#8217;s ability to develop and administer formularies, pharmacy networks and other plan design features. Similarly, some states prohibit health plan sponsors from implementing certain restrictive pharmacy benefit plan design features. This regulation could limit or preclude (i) limited networks, (ii) a requirement to use particular providers, (iii) copayment differentials among providers and (iv) formulary tiering practices. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retail Medical Clinics </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- States regulate retail medical clinics operated by nurse practitioners or physician assistants through physician oversight, clinic and lab licensure requirements and the prohibition of the corporate practice of medicine. A number of states have implemented or proposed laws or regulations that impact certain components of retail medical clinic operations such as physician oversight, signage, third party contracting requirements, bathroom facilities, and scope of services. These laws and regulations may affect the operation and expansion of the Company&#8217;s owned and managed retail medical clinics.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and Regulations Related to the Pharmacy &amp; Consumer Wellness Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the laws and regulations discussed above that may affect multiple segments of the Company&#8217;s business, the Company is subject to federal, state and local statutes and regulations governing the operation of its Pharmacy &amp; Consumer Wellness segment specifically, including laws and regulations that limit the sale of alcohol, mandate a minimum wage, govern the practices of optometry or audiology, or impact the provision of dietician services and the sale of durable medical equipment, contact lenses, eyeglasses and hearing aids.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation was incorporated in Delaware in 1996. The corporate office is located at One CVS Drive, Woonsocket, Rhode Island 02895, telephone (401)&#160;765-1500. CVS Health Corporation&#8217;s common stock is listed on the New York Stock Exchange under the trading symbol &#8220;CVS.&#8221; General information about the Company is available through the Company&#8217;s website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">http://www.cvshealth.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company&#8217;s financial press releases and filings with the SEC are available free of charge within the Investors section of the Company&#8217;s website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">http://investors.cvshealth.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In addition, the SEC maintains an internet site that contains reports, proxy and information statements and other information regarding issuers, such as the Company, that file electronically with the SEC. The address of that website is </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">http://www.sec.gov. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information on or linked to the Company&#8217;s website is neither a part of nor incorporated by reference in this Exhibit 99.1 or any of the Company&#8217;s other SEC filings. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with guidance provided by the SEC regarding use by a company of its websites and social media channels as a means to disclose material information to investors and to comply with its disclosure obligations under SEC Regulation FD, CVS Health Corporation (the &#8220;Registrant&#8221;) hereby notifies investors, the media and other interested parties that it intends to continue to use its media and investor relations website (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">http://investors.cvshealth.com/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and its Twitter feed (@CVSHealthIR) to publish important information about the Registrant, including information that may be deemed material to investors. The list of social media channels that the Registrant uses may be updated on its media and investor relations website from time to time. The Registrant encourages investors, the media, and other interested parties to review the information the Registrant posts on its website and social media channels as described above, in addition to information announced by the Registrant through its SEC filings, press releases and public conference calls and webcasts.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_52"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:3.37pt;padding-right:3.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div><span><br/></span></div><div id="i36038907935e41eea5e9cf7cac915d44_61"></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7.  Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations with Retrospective Adjustments. (&#8220;MD&amp;A&#8221;) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis should be read in conjunction with the audited consolidated financial statements and related notes included in Item 8 of this Exhibit 99.1, &#8220;Risk Factors&#8221; included in Item 1A of the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on February 8, 2023 (the &#8220;2022 Form 10-K&#8221;) and the &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; included in this Exhibit 99.1.</span></div><div><span><br/></span></div><div id="i36038907935e41eea5e9cf7cac915d44_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation, together with its subsidiaries (collectively, &#8220;CVS Health,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221;), is a leading diversified health solutions company reshaping health care to help make healthier happen for more Americans. In an increasingly connected and digital world, CVS Health is meeting people wherever they are and changing health care to meet their needs. The Company has more than 9,000 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with over 110 million plan members with expanding specialty pharmacy solutions and a dedicated senior pharmacy care business serving more than one million patients per year. The Company also serves an estimated 35 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its integrated health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with its new operating model adopted in the first quarter of 2023, the Company realigned the composition of its segments to reflect how its Chief Operating Decision Maker (the &#8220;CODM&#8221;) reviews information and manages the business. As a result of this realignment, the Company formed a new Health Services segment, which in addition to providing a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, also delivers health care services in the Company&#8217;s medical clinics, virtually, and in the home, as well as provider enablement solutions. In addition, the Company created a new Pharmacy &amp; Consumer Wellness segment, which includes its retail and long-term care pharmacy operations and related pharmacy services, as well as its retail front store operations. This segment will also provide pharmacy fulfillment services to support the Health Services segment&#8217;s specialty and mail order pharmacy offerings. Segment financial information has been recast to reflect these changes. See Note 18 &#8216;&#8216;Segment Reporting&#8217;&#8217; included in Item 8 of this Exhibit 99.1 for segment financial information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the segment realignment described above,  the Company&#8217;s four reportable segments are as follows: Health Care Benefits, Health Services, Pharmacy &amp; Consumer Wellness and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment operates as one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) in eight states through which it sells Insured plans directly to individual consumers. The Company entered Public Exchanges in four additional states effective January 2023.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Health Services Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. PBM solutions include plan design offerings and administration, formulary management, retail pharmacy network management services, and specialty and mail order pharmacy services. In addition, the Company provides clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Company operates a group purchasing organization that negotiates pricing for the purchase of pharmaceuticals and rebates with pharmaceutical manufacturers on behalf of its participants and provides various administrative, management and reporting services to pharmaceutical manufacturers. The Health Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care (&#8220;Managed Medicaid&#8221;) plans, plans offered on Insurance Exchanges and other sponsors of health benefit plans throughout the United States and Covered Entities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Pharmacy &amp; Consumer Wellness Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy &amp; Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise. The segment also conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and ancillary services to long-term care facilities and other care settings, and provides pharmacy fulfillment services to support the Health Services segment&#8217;s specialty and mail order pharmacy offerings. As of December&#160;31, 2022, the Pharmacy &amp; Consumer Wellness segment operated more than 9,000 retail locations, as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. For the year ended December&#160;31, 2022, the Company dispensed 26.8% of the total retail pharmacy prescriptions in the United States.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Corporate/Other Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_67"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic and its emerging new variants continue to impact the economies of the U.S. and other countries around the world. Our strong local presence and scale in communities across the country has enabled us to continue to play an indispensable role in the national response to COVID-19, as well as provide seamless support for our customers wherever they need us: in our CVS locations, in their homes, and virtually. The COVID-19 pandemic had a significant impact on the Company&#8217;s operating results for the years ended December 31, 2022, 2021 and 2020, primarily in the Company&#8217;s Health Care Benefits and Pharmacy &amp; Consumer Wellness segments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in mid-March 2020, the health care system experienced a significant reduction in utilization of medical services (&#8220;utilization&#8221;) that is discretionary and the cancellation of elective medical procedures. Utilization remained below historical levels through April 2020, began to recover in May and June 2020 and reached more normal levels in the third and fourth quarters of 2020, with select geographies impacted by COVID-19 waves. In response to COVID-19, the Company provided expanded benefit coverage to its members, including cost-sharing waivers for COVID-19 related treatments, as well as assistance to members through premium credits, telehealth cost-sharing waivers and other investments. During 2020, COVID-19 also resulted in a shift in the Company&#8217;s medical membership. The Company experienced declines in Commercial membership due to reductions in workforce at our existing customers, substantially offset by increases in Medicaid membership primarily as a result of the suspension of eligibility redeterminations and increased unemployment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, overall medical costs in the first quarter were generally consistent with historical baseline levels in the aggregate, however the segment experienced increased COVID-19 testing and treatment costs and lower Medicare risk-adjusted revenue. During the second quarter, COVID-19 testing and treatment costs persisted, however at levels significantly lower than those observed during the first quarter. Beginning in the third quarter of 2021, medical costs once again increased primarily driven by the spread of emerging new variants of COVID-19, which resulted in increased testing and treatment costs throughout the remainder of the year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, the impact of COVID-19 within the Health Care Benefits segment has generally stabilized as a result of the Company&#8217;s ability to capture COVID-19 related medical costs in pricing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy &amp; Consumer Wellness Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During March 2020, the Company experienced increased prescription volume due to the greater use of 90-day prescriptions and early refills of maintenance medications, as well as increased front store volume as consumers prepared for the COVID-19 pandemic. Beginning in the second quarter and continuing throughout the remainder of the year, the Company experienced reduced customer traffic in its retail pharmacies and MinuteClinic locations due to shelter-in-place orders as well as reduced new therapy prescriptions and decreased long-term care prescription volume as a result of the COVID-19 pandemic. In addition, the Company incurred incremental operating expenses associated with the Company&#8217;s COVID-19 pandemic response efforts and waived fees associated with prescription home delivery and associated front store products. During 2020, the Company also played a key role in supporting the local communities in which it operates through the administration of diagnostic testing at its CVS pharmacy locations, as well as in long-term care facilities, at community-based testing sites in underserved areas and through its Return Ready</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">SM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">solution. The Company also began administering COVID-19 vaccinations in long-term care facilities during December 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, the Company experienced reduced customer traffic in its retail pharmacies, which reflected the impact of a weaker cough, cold and flu season, while it administered the highest quarterly volume of COVID-19 diagnostic tests. The Company began administering COVID-19 vaccines in its retail pharmacies during February 2021. During the second quarter, the segment generated earnings from COVID-19 vaccines and saw improved customer traffic as vaccinated customers began more actively shopping in CVS locations. During the third and fourth quarters, emerging new variants drove the continued administration of COVID-19 vaccinations (including boosters) and diagnostic testing, while the segment also generated earnings from the sale of over-the-counter (&#8220;OTC&#8221;) test kits in the front store. During the year ended December&#160;31, 2021, the Company administered more than 32&#160;million COVID-19 tests and more than 59&#160;million COVID-19 vaccines and sold more than 22 million OTC test kits. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the  year ended December 31, 2022, the customary quarterly operating income progression in the Pharmacy &amp; Consumer Wellness segment continued to be impacted by COVID-19. During the first quarter, the Company saw high volumes of administration of COVID-19 vaccinations, as well as demand for OTC test kits in the front store, particularly in the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">beginning of the year when the Omicron variant incidence was high. In addition, the Company administered the highest quarterly volume of COVID-19 diagnostic tests of 2022 during the first quarter, however a decline compared to the prior year. During the second and third quarters, the Company continued to generate earnings from the sale of OTC test kits, as customers performed more in-home testing versus diagnostic testing, in addition to earnings from the continued administration of COVID-19 diagnostic testing and vaccinations, albeit at lower levels than those experienced in the first quarter. During the fourth quarter, the Company saw an increase in COVID-19 vaccine administration from the prior quarter related to the bivalent COVID-19 booster. During the year ended December 31, 2022, the Company administered more than 15&#160;million COVID-19 tests and nearly 28&#160;million COVID-19 vaccines and sold more than 63&#160;million OTC test kits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. The Company believes COVID-19&#8217;s impact on its businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond the Company&#8217;s knowledge and control. As a result, the impact COVID-19 will have on the Company&#8217;s businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against the Company.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_70"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information summarizes the Company&#8217;s results of operations for 2022 compared to 2021. Financial information for the years ended December 31, 2022, 2021 and 2020 have been revised to reflect the impact of the following items, as applicable: </span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The realignment of the Company&#8217;s segments to correspond with changes made to its operating model as described in Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; included in Item 8 of this Exhibit 99.1, including the discontinuance of the former Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> segment reporting practice as described within the &#8220;Segment Analysis&#8221; section of this Item 7.</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The exclusion of the impact of net realized capital gains or losses from adjusted operating income, as described within the &#8220;Segment Analysis&#8221; section of this Item 7.</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the adoption of a new accounting standard related to the accounting for long-duration insurance contracts (the &#8220;long-duration insurance accounting standard&#8221;), which the Company adopted on January 1, 2023 using a modified retrospective transition method as of January 1, 2021, as described in Note 8 &#8220;Other Insurance Liabilities and Separate Accounts&#8221; included in Item 8 of this Exhibit 99.1. </span></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These items did not have a material impact on trends in the Company&#8217;s results of operations for 2021&#160;compared to&#160;2020. Accordingly, for discussion of the Company&#8217;s results of operations for 2021&#160;compared to&#160;2020,&#160;see &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021 filed with the SEC on February 9, 2022.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Consolidated Financial Results</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.681%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December&#160;31,&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,768&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,359)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(361)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,467&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,356&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,405&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid litigation charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store impairments </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314,513&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,801&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254,795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,712&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,954&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,310&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,911&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,356)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(601)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(404)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(452)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(988)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,836&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,537&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,770&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,701)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,039)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,327&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,989&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,201&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,662)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,327&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,989&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,192&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,662)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,311&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,001&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,179&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,690)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - 2022 compared to 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $30.4 billion, or 10.4%, in 2022 compared to 2021. The increase in total revenues was primarily driven by growth across all segments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this MD&amp;A for additional information about the revenues of the Company&#8217;s segments.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $1.2 billion, or 3.2%, in 2022 compared to 2021. The increase in operating expenses was primarily due to increased operating expenses to support growth in the business, incremental investments in business operations and decreased gains from legal settlements in 2022 compared to 2021. These increases were partially offset by a decrease in amortization of intangible assets compared to the prior year, as well as pre-tax gains of $250&#160;million on the sale of the Company&#8217;s wholly-owned subsidiary bswift LLC (&#8220;bswift&#8221;) and $225&#160;million on the sale of PayFlex Holdings, Inc. (&#8220;PayFlex&#8221;), both of which were sold during 2022.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a&#160;percentage of total revenues decreased to 11.8% in 2022 compared to 12.7% in 2021. The decrease in operating expenses as a percentage of total revenues was primarily due to the increases in total revenues described above.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this MD&amp;A for additional information about the operating expenses of the Company&#8217;s segments.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income decreased $5.4 billion, or 40.2%, in 2022 compared to 2021. The decrease in operating income was primarily driven by the $5.8 billion of opioid litigation charges and declines in the Pharmacy &amp; Consumer Wellness segment, which included a $2.5 billion loss on assets held for sale related to the write-down of the Company&#8217;s Omnicare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> long-term care business (&#8220;LTC business&#8221;) during 2022, partially offset by the absence of a store impairment charge of approximately $1.4 billion and a $431 million goodwill impairment charge on the remaining goodwill of the LTC reporting unit, both of which were recorded in the prior year. These decreases were partially offset by increases in the Health Care Benefits segment, which included the pre-tax gains of $250&#160;million on the sale of bswift and $225&#160;million on the sale of PayFlex and a decrease in amortization of intangible assets, as well as improved purchasing economics and growth in specialty pharmacy in the Health Services segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this MD&amp;A for additional information about the operating results of the Company&#8217;s segments.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interest expense decreased $216 million, or 8.6%, in 2022 compared to 2021, due to lower debt in the year ended December&#160;31, 2022. See &#8220;Liquidity and Capital Resources&#8221; later in this report for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss on early extinguishment of debt</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During 2021, the loss on early extinguishment of debt relates to the Company&#8217;s repayment of approximately </span><span style="background-color:#ffffff;color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2.3&#160;billion of its outstanding senior notes in December </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 pursuant to its early redemption make-whole provision for such senior notes, which resulted in a loss on early extinguishment of debt of $89&#160;million</span><span style="background-color:#ffffff;color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and the repayment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of approximately $2.0&#160;billion of its outstanding senior notes pursuant to its tender offer for such notes in August 2021, which resulted in a loss on early extinguishment of debt of $363&#160;million. See Note 9 &#8216;&#8216;Borrowings and Credit Agreements&#8217;&#8217; included in Item 8 of this Exhibit 99.1 for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income tax provision</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s effective income tax rate increased to 25.9% in 2022 compared to 24.2% in the prior year. The increase was primarily due to certain nondeductible legal charges and basis differences on the sale of certain subsidiaries in 2022. These increases were partially offset by the impact of certain discrete tax items concluded in the first quarter of 2022.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_73"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outlook for 2023</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to 2023, the Company believes you should consider the following important information:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Health Care Benefits segment is expected to continue to benefit from Medicare and Commercial membership growth, partially offset by declines in Medicaid due to the impact of redeterminations in 2023.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Health Services segment is expected to continue to benefit from the Company&#8217;s ability to drive further improvements in purchasing economics and strong pharmacy network volume. These increases are expected to be partially offset by continued client price improvements and regulation of pharmacy pricing.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Pharmacy &amp; Consumer Wellness segment is expected to continue to benefit from increased prescription volume and improved generic drug purchasing, partially offset by continued pharmacy reimbursement pressure and lower contributions from COVID-19 vaccinations, diagnostic testing and OTC test kits as COVID-19 transitions to the endemic stage. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company is expected to benefit from enterprise-wide cost savings initiatives, which aim to reduce the Company&#8217;s operating cost structure in a way that improves the consumer experience and is sustainable. Key drivers include:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Investments in digital, technology and analytics capabilities that will streamline processes and improve outcomes,  </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Implementing workforce and workplace strategies, and</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Deploying vendor and procurement strategies.            </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company expects changes to its business environment to continue as elected and other government officials at the national and state levels continue to propose and enact significant modifications to public policy and existing laws and regulations that govern or impact the Company&#8217;s businesses.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The COVID-19 pandemic continues to impact the economies of the U.S. and other countries around the world. The Company believes COVID-19&#8217;s impact on its businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic, as well as the pandemic&#8217;s impact on the U.S. and global economies, global supply chain, consumer behavior, and health care utilization patterns. In addition, as described in the &#8220;Government Regulation&#8221; section of this Exhibit 99.1, federal, state and local governmental policies and initiatives designed to reduce the transmission of COVID-19 and emerging new variants may not effectively combat the severity and/or duration of the COVID-19 pandemic, and have resulted in a myriad of impacts on the Company&#8217;s businesses. Those primary drivers are beyond the Company&#8217;s knowledge and control. As a result, the impact COVID-19 will have on the Company&#8217;s businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s current expectations described above are forward-looking statements. Please see &#8220;Risk Factors&#8221; included in Item 1A of the 2022 Form 10-K and the &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; in the 2022 Form 10-K for information regarding important factors that may cause the Company&#8217;s actual results to differ from those currently projected and/or otherwise materially affect the Company.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Analysis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion of segment operating results is presented based on the Company&#8217;s reportable segments in accordance with the accounting guidance for segment reporting and is consistent with the segment disclosure in Note 18 &#8216;&#8216;Segment Reporting&#8217;&#8217; included in Item 8 of this Exhibit 99.1.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has three operating segments, Health Care Benefits, Health Services and Pharmacy &amp; Consumer Wellness, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the CODM evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income. Adjusted operating income is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. Effective for the first quarter of 2023, adjusted operating income also excludes the impact of net realized capital gains or losses. See the reconciliations of operating income (GAAP measure) to adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment financial information for the years ended December 31, 2022, 2021 and 2020 has been recast, as applicable, to reflect the following items, the impact of which are reflected in the &#8220;Adjustments&#8221; lines of the table below:</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The realignment of the Company&#8217;s segments to correspond with changes made to its operating model as described in Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; included in Item 8 of this Exhibit 99.1, including the discontinuance of the former Maintenance Choice segment reporting practice as described in Note (2) of the table below.</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The exclusion of the impact of net realized capital gains or losses from adjusted operating income, as described above.</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the adoption of the long-duration insurance accounting standard, which the Company adopted on January 1, 2023 using a modified retrospective transition method as of January 1, 2021, as described in Note 8 &#8220;Other Insurance Liabilities and Separate Accounts&#8221; included in Item 8 of this Exhibit 99.1. </span></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp;<br/>Consumer <br/>Wellness</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as previously reported</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,283)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as adjusted</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,350&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,576&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,596&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,585)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,467&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as previously reported</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,984&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,356&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,705&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,785)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(728)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,532&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(575)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as adjusted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,781&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,613)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,037&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as previously reported</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,923)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,318)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as adjusted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,119&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,241)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as previously reported</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,012&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,859&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,623&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,471)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(711)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,312&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(367)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as adjusted</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,110&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,492&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,260&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,635)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,227&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as previously reported</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(584)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as adjusted</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,409&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,354&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,579&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,062)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as previously reported</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,188&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,688&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,146&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,306)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(708)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,008&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(560)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as adjusted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,135&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,128&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,012&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,319)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,956&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Health Services segment include approximately $12.6 billion, $11.6 billion and $10.9 billion of retail co-payments for 2022, 2021 and 2020, respectively. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; included in Item 8 of this Exhibit 99.1 for additional information about retail co-payments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy &amp; Consumer Wellness segment. Prior to January 1, 2023, intersegment adjusted operating income eliminations occurred when members of the Health Services segment's clients enrolled in Maintenance Choice elected to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurred, both the Health Services and Pharmacy &amp; Consumer Wellness segments recorded the adjusted operating income on a stand-alone basis.&#160;Effective January 1, 2023, the adjusted operating income associated with such transactions is reported only in the Pharmacy &amp; Consumer Wellness segment, therefore no adjusted operating income elimination is required. Segment financial information has been recast to reflect this change. </span></div><div style="padding-left:13.5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of consolidated operating income (GAAP measure) to consolidated adjusted operating income, as well as reconciliations of segment GAAP operating income to segment adjusted operating income:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp;<br/>Consumer<br/>Wellness</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,612&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,488)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office real estate optimization charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on divestiture of subsidiaries </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(475)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(475)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid litigation charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on assets held for sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,338&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,781&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,531&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,613)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,037&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp;<br/>Consumer<br/>Wellness</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,662&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,984&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,629)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store impairments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition purchase price adjustment outside of measurement period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,110&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,492&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,260&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,635)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,227&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp;<br/>Consumer<br/>Wellness</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,514&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,630)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receipt of fully reserved ACA risk corridor receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(11)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,135&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,128&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,012&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,319)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,956&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s GAAP consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s net realized capital gains and losses arise from various types of transactions, primarily in the course of managing a portfolio of assets that</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">support the payment of insurance liabilities. Net realized capital gains and losses are reflected in the consolidated statements of operations in net investment income within each segment. These capital gains and losses are the result of investment decisions, market conditions and other economic developments that are unrelated to the performance of the Company&#8217;s business, and the amount and timing of these capital gains and losses do not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Accordingly, the Company believes excluding net realized capital gains and losses enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2022, the office real estate optimization charges primarily relate to the abandonment of leased real estate and the related right-of-use assets and property and equipment in connection with the planned reduction of corporate office real estate space in response to the Company&#8217;s new flexible work arrangement. The office real estate optimization charges are reflected in the Company&#8217;s GAAP consolidated statement of operations in operating expenses within the Health Care Benefits, Corporate/Other and Health Services segments. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2022, the gain on divestiture of subsidiaries represents the pre-tax gain on the sale of bswift, which the Company sold in November 2022, and the pre-tax gain on the sale of PayFlex, which the Company sold in June 2022. In 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#8217; Compensation business, which the Company sold in July 2020. The gains on divestitures are reflected as a reduction of operating expenses in the Company&#8217;s GAAP consolidated statements of operations within the Health Care Benefits segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2022, the opioid litigation charges relate to agreements to resolve substantially all opioid claims against the Company by certain states and governmental entities. The opioid litigation charges are reflected within the Corporate/Other segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2022, the loss on assets held for sale relates to the LTC reporting unit within the Pharmacy &amp; Consumer Wellness segment. The Company continually evaluates its portfolio for non-strategic assets. The Company determined that its LTC business was no longer a strategic asset and during the third quarter of 2022 committed to a plan to sell the LTC business. As of September 30, 2022, the LTC business met the criteria for held-for-sale accounting and the net assets were accounted for as assets held for sale. The carrying value of the LTC business was determined to be greater than its estimated fair value less costs to sell and a loss on assets held for sale was recorded during the third quarter of 2022. As of December 31, 2022, the net assets of the LTC business continued to meet the criteria for held-for-sale accounting and during the fourth quarter of 2022, an incremental loss on assets held for sale was recorded to write down the carrying value of the LTC business to its estimated fair value less costs to sell. During 2022, the loss on assets held for sale also relates to the Commercial Business reporting unit within the Health Care Benefits segment. In March 2022, the Company reached an agreement to sell its international health care business domiciled in Thailand (&#8220;Thailand business&#8221;), which was included in the Commercial Business reporting unit. At that time, a portion of the Commercial Business goodwill was specifically allocated to the Thailand business. The net assets of the Thailand business were accounted for as assets held for sale at March 31, 2022. The carrying value of the Thailand business was determined to be greater than its estimated fair value less costs to sell and a loss on assets held for sale was recorded during the first quarter of 2022. The sale of the Thailand business closed in the second quarter of 2022, and the ultimate loss on the sale was not material.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2021 and 2020, acquisition-related integration costs relate to the Company&#8217;s acquisition (the &#8220;Aetna Acquisition&#8221;) of Aetna Inc. (&#8220;Aetna&#8221;). The acquisition-related integration costs are reflected in the Company&#8217;s GAAP consolidated statements of operations in operating expenses within the Corporate/Other segment.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2021, the store impairment charge relates to the write down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately 900 retail stores between 2022 and 2024. The store impairment charge is reflected within the Pharmacy &amp; Consumer Wellness segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2021, the goodwill impairment charge relates to an impairment of the remaining goodwill of the LTC reporting unit within the Pharmacy &amp; Consumer Wellness segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">In 2021, the Company received $61&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#8217;s GAAP consolidated statement of operations as a reduction of operating expenses within the Health Care Benefits segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">In 2020, the Company received $313&#160;million owed to it under the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (as amended, collectively, the &#8220;ACA&#8221;)&#8217;s risk corridor program that was previously fully reserved for as payment was uncertain. After considering offsetting items such as the ACA&#8217;s minimum medical loss ratio (&#8220;MLR&#8221;)  rebate requirements and premium taxes, the Company recognized pre-tax income of $307&#160;million in the Company&#8217;s GAAP consolidated statement of operations within the Health Care Benefits segment.</span></div><div><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-18pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Care Benefits Segment </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Health Care Benefits segment&#8217;s performance for the respective periods:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages and basis points (&#8220;bps&#8221;)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,274</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,064</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,301</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,600</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,469</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,625</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,350</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,119</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,409</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,710&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,473</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,531</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,083</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MBR (Benefit costs as a % of premium revenues)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">bps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">bps</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on assets held for sale </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,566</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,926</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,185</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,270</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,662</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,141</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,479)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,338</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,110</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,135</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,025)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium revenues (by business):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,141</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,739</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,928</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,402</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,811</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,133</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,325</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,373</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,808</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this MD&amp;A for a reconciliation of operating income (GAAP measure) to adjusted operating income for the Health Care Benefits segment, which represents the Company&#8217;s principal measure of segment performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - 2022 compared to 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $9.2 billion, or 11.2%, to $91.4 billion in 2022 compared to 2021 driven by growth across all product lines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Benefit Ratio</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical benefit ratio is calculated as benefit costs divided by premium revenues and represents the percentage of premium revenues spent on medical benefits for the Company&#8217;s Insured members. Management uses MBR to assess the underlying business performance and underwriting of its insurance products, understand variances between actual results and expected results and identify trends in period-over-period results. MBR provides management and investors with information useful in assessing the operating results of the Company&#8217;s Insured Health Care Benefits products.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The MBR decreased from 84.8% to 83.8% in 2022 compared to the prior year primarily driven by the net favorable impact of COVID-19 compared to the prior year, partially offset by the unfavorable impact of the flu compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss on assets held for sale</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During 2022, the Company recorded a $41&#160;million loss on assets held for sale on its Thailand business, which is included in the Commercial Business reporting unit within the Health Care Benefits segment. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; included in Item 8 of this Exhibit 99.1 for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Health Care Benefits segment include selling, general and administrative expenses and depreciation and amortization expenses.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $640 million, or 4.6%, in 2022 compared to 2021. The increase in operating expenses was primarily driven by increased operating expenses to support the growth across all product lines described above, incremental investments in the business, as well as office real estate optimization charges recorded in 2022 in connection with the planned reduction of corporate office real estate space. These increases were partially offset by the pre-tax gains of $250&#160;million on the sale of bswift and $225&#160;million on the sale of PayFlex.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues decreased to 15.9% in 2022 compared to 17.0% in 2021. The decrease in operating expenses as a percentage of total revenues was primarily driven by the increases in total revenues described above and the pre-tax gains on the sales of bswift and PayFlex.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income increased $1.2 billion, or 24.0%, in 2022 compared to 2021. The increase in adjusted operating income was primarily driven by the net favorable impact of COVID-19 compared to the prior year, strong underlying performance and membership growth. These increases were partially offset by incremental investments to support growth in the business and the unfavorable impact of the flu compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Health Care Benefits segment&#8217;s medical membership as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.849%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical membership:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical membership</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,003&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,393&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,396&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,847&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,001&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,848&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental membership information:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Prescription Drug Plan (standalone)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Membership</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical membership represents the number of members covered by the Company&#8217;s Insured and ASC medical products and related services at a specified point in time. Management uses this metric to understand variances between actual medical membership and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of medical membership on segment total revenues and operating results.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical membership as of December&#160;31, 2022 of 24.4 million increased 548,000 compared with December&#160;31, 2021, reflecting increases in Medicare and Commercial membership, as underlying Commercial growth more than offset the impact of international divestitures. These increases were partially offset by a decline in Medicaid membership reflecting the previously disclosed loss of a large customer in the third quarter of 2022.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare Update</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 4, 2022, the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) issued its final notice detailing final 2023 Medicare Advantage payment rates. Final 2023 Medicare Advantage rates resulted in an expected average increase in revenue for the Medicare Advantage industry of 5.00%, excluding the CMS estimate of Medicare Advantage risk score trend. On February 1, 2023, CMS issued an advance notice detailing proposed 2024 Medicare Advantage payment rates. The 2024 Medicare Advantage rates, if finalized as proposed, will result in an expected average decrease in revenue for the Medicare Advantage industry of 2.27%, excluding the CMS estimate of Medicare Advantage risk score trend. CMS intends to publish the final 2024 rate announcement no later than April 3, 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA ties a portion of each Medicare Advantage plan&#8217;s reimbursement to the plan&#8217;s &#8220;star ratings.&#8221; Plans must have a star rating of four or higher (out of five) to qualify for bonus payments. CMS released the Company&#8217;s 2023 star ratings in October 2022. The Company&#8217;s 2023 star ratings will be used to determine which of the Company&#8217;s Medicare Advantage plans have ratings of four stars or higher and qualify for bonus payments in 2024. Based on the Company&#8217;s membership at December&#160;31, 2022, 21% of the Company&#8217;s Medicare Advantage members were in plans with 2023 star ratings of at least 4.0 stars, compared to 87% of the Company&#8217;s Medicare Advantage members being in plans with 2022 star ratings of at least 4.0 stars based on the Company&#8217;s membership at December&#160;31, 2021. The estimated impact from the decline in the number of Medicare Advantage members in plans with star ratings of at least 4.0 stars, net of mitigating actions, is a reduction of the 2024 operating income of the Health Care Benefits segment of approximately $800 million to $1.0 billion.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_82"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Services Segment (formerly Pharmacy Services Segment)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Health Services segment&#8217;s performance for the respective periods:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.118%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,799</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,433</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,557</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,093</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(536)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,576</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,892</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,354</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,684&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,538&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,738</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,355</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,683</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,226</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,244</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,612</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,293</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,886</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,781</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,492</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,128</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (by distribution channel):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,968</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,834</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,740</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,094&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail &amp; specialty </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,825</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,812</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,713</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,013&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,783</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,246</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(463)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy claims processed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,335.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,242.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,110.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generic dispensing rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this MD&amp;A for a reconciliation of operating income (GAAP measure) to adjusted operating income for the Health Services segment, which represents the Company&#8217;s principal measure of segment performance.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy network revenues relate to claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies. Effective January 1, 2023, pharmacy network revenues also include activity associated with Maintenance Choice, which permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order. Maintenance Choice activity was previously reflected in mail &amp; specialty revenues. Segment financial information has been revised to reflect these changes.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Mail &amp; specialty revenues relate to specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as mail order and specialty claims fulfilled by the Pharmacy &amp; Consumer Wellness segment. Effective January 1, 2023, mail &amp; specialty revenues exclude Maintenance Choice activity, which is now reported within pharmacy network revenues. Segment financial information has been revised to reflect these changes.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes an adjustment to convert 90-day prescriptions to the equivalent of three 30-day prescriptions. This adjustment reflects the fact that these prescriptions include approximately three times the amount of product days supplied compared to a normal prescription.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - 2022 compared to 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $15.7 billion, or 10.2%, to $169.6 billion in 2022 compared to 2021. The increase was primarily driven by increased pharmacy claims volume, growth in specialty pharmacy and brand inflation, partially offset by continued client price improvements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Health Services segment include selling, general and administrative expenses; and depreciation and amortization expense.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues remained relatively consistent at 1.3% and 1.5% in 2022 and 2021, respectively. </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income increased $289 million, or 4.5%, in 2022 compared to 2021. The increase in adjusted operating income was primarily driven by improved purchasing economics, including increased contributions from the products and services of the Company&#8217;s group purchasing organization, partially offset by continued client price improvements. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As you review the Health Services segment&#8217;s performance in this area, you should consider the following important information about the business:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s efforts to (i)&#160;retain existing clients, (ii)&#160;obtain new business and (iii)&#160;maintain or improve the rebates, fees and/or discounts the Company receives from manufacturers, wholesalers and retail pharmacies continue to have an impact on adjusted operating income. In particular, competitive pressures in the PBM industry have caused the Company and other PBMs to continue to share with clients a larger portion of rebates, fees and/or discounts received from pharmaceutical manufacturers. In addition, marketplace dynamics and regulatory changes have limited the Company&#8217;s ability to offer plan sponsors pricing that includes retail network &#8220;differential&#8221; or &#8220;spread,&#8221; and the Company expects these trends to continue. The &#8220;differential&#8221; or &#8220;spread&#8221; is any difference between the drug price charged to plan sponsors, including Medicare Part&#160;D plan sponsors, by a PBM and the price paid for the drug by the PBM to the dispensing provider.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy claims processed</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pharmacy claims processed represents the number of prescription claims processed through the Company&#8217;s pharmacy benefits manager and dispensed by either its retail network pharmacies or the Company&#8217;s mail and specialty pharmacies. Management uses this metric to understand variances between actual claims processed and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of pharmacy claim volume on segment total revenues and operating results.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s pharmacy claims processed increased 4.1% on a 30-day equivalent basis in 2022 compared to 2021 primarily driven by net new business, increased utilization and the impact of an elevated cough, cold and flu season compared to the prior year. These increases were partially offset by a decrease in COVID-19 vaccinations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Excluding the impact of COVID-19 vaccinations, pharmacy claims processed increased 5.1% on a 30-day equivalent basis in 2022 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Generic dispensing rate is calculated by dividing the Health Services segment&#8217;s generic claims processed by its total claims processed. Management uses this metric to evaluate the effectiveness of the business at encouraging the use of generic drugs when they are available and clinically appropriate, which aids in decreasing costs for client members and retail customers. This metric provides management and investors with information useful in understanding trends in segment total revenues and operating results. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Health Services segment&#8217;s generic dispensing rate increased to 87.4% in 2022 compared to 86.8% in the prior year. The increase in the segment&#8217;s generic dispensing rate was primarily driven by a decrease in brand prescriptions, largely attributable to decreased COVID-19 vaccinations in 2022 compared to the prior year. Excluding the impact of COVID-19 vaccinations, the segment&#8217;s generic dispensing rate was 88.3% and 88.5% in 2022 and 2021, respectively.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy &amp; Consumer Wellness Segment (formerly Retail/LTC Segment)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Pharmacy &amp; Consumer Wellness segment&#8217;s performance for the respective periods:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.556%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,878</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,852</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,605</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,762</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,751</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,974</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(989)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,596</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,620</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,579</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,976&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,041&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,063</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,082</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,789</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on assets held for sale</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,492</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store impairments</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,481</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,765</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,276</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,560</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,984</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,514</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,424)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(530)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,531</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,260</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,012</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(729)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (by major goods/service lines):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,480</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,886</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,984</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,780</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,315</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,655</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,380</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,402</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,940</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescriptions filled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,625.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,589.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same store sales increase: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription volume </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generic dispensing rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this MD&amp;A for a reconciliation of operating income (GAAP measure) to adjusted operating income for the Pharmacy &amp; Consumer Wellness segment, which represents the Company&#8217;s principal measure of segment performance.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes an adjustment to convert 90&#8209;day prescriptions to the equivalent of three 30&#8209;day prescriptions. This adjustment reflects the fact that these prescriptions include approximately three times the amount of product&#160;days supplied compared to a normal prescription.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Same store sales and prescription volume represent the change in revenues and prescriptions filled in the Company&#8217;s retail pharmacy stores that have been operating for greater than one year, expressed as a percentage that indicates the increase or decrease relative to the comparable prior period. Same store metrics exclude revenues and prescriptions from LTC and infusion services operations. Effective January 1, 2023, same store sales also include digital sales initiated online or through mobile applications and fulfilled through the Company&#8217;s distribution centers. Segment financial information has been revised to reflect these changes. Management uses these metrics to evaluate the performance of existing stores on a comparable basis and to inform future decisions regarding existing stores and new locations. Same-store metrics provide management and investors with information useful in understanding the portion of current revenues and prescriptions resulting from organic growth in existing locations versus the portion resulting from opening new stores.</span></div><div style="padding-left:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - 2022 compared to 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $7.0 billion, or 6.9%, to $108.6 billion in 2022 compared to 2021. The increase was primarily driven by increased prescription and front store volume, including the impact of an elevated cough, cold and flu season compared to the prior year and increased sales of COVID-19 OTC test kits in 2022 compared to 2021, as well as pharmacy </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">drug mix and brand inflation. These increases were partially offset by decreased COVID-19 vaccinations and diagnostic testing, the impact of recent generic introductions and continued pharmacy reimbursement pressure.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pharmacy same store sales increased 9.5% in 2022 compared to 2021. The increase was primarily driven by the 4.0% increase in pharmacy same store prescription volume on a 30-day equivalent basis, including the impact of an elevated cough, cold and flu season compared to the prior year, pharmacy drug mix and brand inflation. These increases were partially offset by the impact of recent generic introductions and continued pharmacy reimbursement pressure.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Front store same store sales increased 7.8% in 2022 compared to 2021. The increase was primarily due to strength in consumer health, including the impact of an elevated cough, cold and flu season compared to the prior year and increased sales of COVID-19 OTC test kits in 2022 compared to 2021.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other revenues decreased 0.9% in 2022 compared to 2021. The decrease was primarily due to decreased COVID-19 diagnostic testing in 2022 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss on assets held for sale</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During 2022, the Company recorded a loss on assets held for sale of approximately $2.5 billion related to the write-down of its LTC business. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; included in Item 8 of this Exhibit 99.1 for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Store impairments</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During 2021, the Company recorded a store impairment charge of approximately $1.4 billion related to the write-down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately 900 retail stores between 2022 and 2024. See Note 6 &#8216;&#8216;Leases&#8217;&#8217; included in Item 8 of this Exhibit 99.1 for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During 2021, the Company recorded a $431 million goodwill impairment charge related to the LTC reporting unit within the Pharmacy &amp; Consumer Wellness segment. See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; included in Item 8 of this Exhibit 99.1 for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Pharmacy &amp; Consumer Wellness segment include payroll, employee benefits and occupancy costs associated with the segment&#8217;s stores and pharmacy fulfillment operations; selling expenses; advertising expenses; depreciation and amortization expense and certain administrative expenses.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $716 million, or 3.6%, in 2022 compared to 2021. The increase was primarily due to incremental costs associated with increased volume, increased investments in the segment&#8217;s operations and capabilities, as well as decreased gains from legal settlements in 2022 compared to 2021. These increases were partially offset by lower expenses associated with COVID-19 vaccination administration compared to the prior year and the favorable impact of business initiatives in 2022.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues decreased to 18.9% in 2022 compared to 19.4% in 2021. The decrease in operating expenses as a percentage of total revenues was primarily driven by the increases in total revenues described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income decreased $729 million, or 10.0%, in 2022 compared to 2021. The decrease in adjusted operating income was primarily driven by decreased COVID-19 vaccinations and diagnostic testing, continued pharmacy reimbursement pressure, increased investments in the segment&#8217;s operations and capabilities and decreased gains from legal settlements in 2022 compared to 2021. These decreases were partially offset by the increased prescription and front store volume described above, improved generic drug purchasing and the favorable impact of business initiatives in 2022. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As you review the Pharmacy &amp; Consumer Wellness segment&#8217;s performance in this area, you should consider the following important information about the business:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The segment&#8217;s adjusted operating income has been adversely affected by the efforts of managed care organizations, PBMs and governmental and other third-party payors to reduce their prescription drug costs, including the use of restrictive networks, as well as changes in the mix of business within the pharmacy portion of the Pharmacy &amp; Consumer Wellness segment. If the pharmacy reimbursement pressure accelerates, the segment may not be able to grow revenues, and its adjusted operating income could be adversely affected.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The increased use of generic drugs has positively impacted the segment&#8217;s adjusted operating income but has resulted in third-party payors augmenting their efforts to reduce reimbursement payments to retail pharmacies for prescriptions. This trend, which the Company expects to continue, reduces the benefit the segment realizes from brand-to-generic drug conversions.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prescriptions filled</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prescriptions filled represents the number of prescriptions dispensed through the Pharmacy &amp; Consumer Wellness segment&#8217;s retail and long-term care pharmacies and infusion services operations. Management uses this metric to understand variances between actual prescriptions dispensed and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of prescription volume on segment total revenues and operating results.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prescriptions filled increased 2.2% on a 30-day equivalent basis in 2022 compared to 2021 primarily driven by increased utilization and the impact of an elevated cough, cold and flu season compared to the prior year, partially offset by a decrease in COVID-19 vaccinations. Excluding the impact of COVID-19 vaccinations, prescriptions filled increased 4.4%, on a 30-day equivalent basis in 2022 compared to the prior year.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Generic dispensing rate is calculated by dividing the Pharmacy &amp; Consumer Wellness segment&#8217;s generic drug prescriptions filled by its total prescriptions filled. Management uses this metric to evaluate the effectiveness of the business at encouraging the use of generic drugs when they are available and clinically appropriate, which aids in decreasing costs for client members and retail customers. This metric provides management and investors with information useful in understanding trends in segment total revenues and operating results. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Pharmacy &amp; Consumer Wellness segment&#8217;s generic dispensing rate increased to 87.4% in 2022 compared to 85.7% in the prior year. The increase in the segment&#8217;s generic dispensing rate was primarily driven by a decrease in brand prescriptions, largely attributable to decreased COVID-19 vaccinations in 2022 compared to the prior year. Excluding the impact of COVID-19 vaccinations, the segment&#8217;s total generic dispensing rate was 88.9% and 89.0% in 2022 and 2021, respectively.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div id="i36038907935e41eea5e9cf7cac915d44_88"></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate/Other Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Corporate/Other segment&#8217;s performance for the respective periods:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.703%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid litigation charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,042</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,835</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,488)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,629)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,630)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,859)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(359.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,613)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,635)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,319)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(316)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this MD&amp;A for a reconciliation of Corporate/Other segment operating loss (GAAP measure) to adjusted operating loss, which represents the Company&#8217;s principal measure of segment performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - 2022 compared to 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues primarily relate to products for which the Company no longer solicits or accepts new customers, such as large case pensions and long-term care insurance products.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues decreased $191 million, or 26.5%, in 2022 compared to 2021. The decrease was primarily driven by net realized capital losses in 2022 compared to net realized capital gains in 2021 and lower net investment income from private equity investments, partially offset by higher average invested assets and favorable average investment yields in 2022 compared to 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opioid litigation charges</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During 2022, the Company recorded $5.8 billion of opioid litigation charges. See Note 17 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; included in Item 8 of this Exhibit 99.1 for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating loss</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating loss remained consistent at $1.6 billion in both 2022 and 2021. </span></div><div style="margin-bottom:3pt"><span><br/></span></div><div id="i36038907935e41eea5e9cf7cac915d44_91"></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a level of liquidity sufficient to allow it to meet its cash needs in the short-term. Over the long term, the Company manages its cash and capital structure to maximize shareholder return, maintain its financial condition and maintain flexibility for future strategic initiatives. The Company continuously assesses its regulatory capital requirements, working capital needs, debt and leverage levels, debt maturity schedule, capital expenditure requirements, dividend payouts, potential share repurchases and future investments or acquisitions. The Company believes its operating cash flows, commercial paper program, credit facilities, as well as any potential future borrowings, will be sufficient to fund these future payments and long-term initiatives. As of&#160;December&#160;31, 2022, the Company had approximately&#160;$12.9 billion&#160;in cash and cash equivalents, approximately&#160;$5.4 billion&#160;of which was held by the parent company or nonrestricted subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net change in cash, cash equivalents and restricted cash for the years ended December&#160;31, 2022, 2021 and 2020 was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:36.290%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,177&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,865&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,047)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,261)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,534)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,516)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,356)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,660)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents and restricted cash</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,635&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,034)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.7)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(987)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.5)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - 2022 compared to 2021</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash provided by operating activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decreased by $2.1 billion in 2022 compared to 2021 primarily due to the timing of payments and higher inventory purchases.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash used in investing activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decreased by $214 million in 2022 compared to 2021 primarily due to lower net purchases of investments and the gross proceeds from the divestitures of PayFlex and bswift, largely offset by a reduction in restricted cash as a result of the sale of health savings account funds held on behalf of customers in conjunction with the sale of PayFlex. In addition, cash used in investing activities reflected the following activity:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Gross capital expenditures remained relatively consistent at approximately $2.7 billion and $2.5 billion in 2022 and 2021, respectively. During 2022, approximately 73% of the Company&#8217;s total capital expenditures were for technology, digital and other strategic initiatives and 27% were for store, fulfillment and support facilities expansion and improvements.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash used in financing activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decreased to $10.5 billion in 2022 compared to $11.4 billion in 2021. The decrease in cash used in financing activities primarily related to lower net repayments of long-term debt during 2022 compared to the prior year, partially offset by share repurchases in 2022. </span></div><div style="margin-bottom:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in net cash used in investing activities for the years ended December&#160;31, 2022, 2021 and 2020 was the following store development activity: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stores (beginning of year)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,962&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,896&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New and acquired stores </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closed stores </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stores (end of year)</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,674&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,939&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,962&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relocated stores </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes retail drugstores and pharmacies within retail chains, primarily in Target Corporation (&#8220;Target&#8221;) stores.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Relocated stores are not included in new and acquired stores or closed stores totals.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper and Back-up Credit Facilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any commercial paper outstanding as of December 31, 2022 or 2021. In connection with its commercial paper program, the Company maintains a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 16, 2025, a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 11, 2026, and a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 16, 2027. The credit facilities allow for borrowings at various rates that are dependent, in part, on the Company&#8217;s public debt ratings and require the Company to pay a weighted average quarterly facility fee of approximately 0.03%, regardless of usage. As of December&#160;31, 2022 and 2021, there were no borrowings outstanding under any of the Company&#8217;s back-up credit facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Home Loan Bank of Boston (&#8220;FHLBB&#8221;)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A subsidiary of the Company is a member of the FHLBB. As a member, the subsidiary has the ability to obtain cash advances, subject to certain minimum collateral requirements. The maximum borrowing capacity available from the FHLBB as of December&#160;31, 2022 was approximately $915 million. At both December&#160;31, 2022 and 2021, there were no outstanding advances from the FHLBB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exercise of Par Call Redemptions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company exercised the par call redemption on its outstanding 3.5% senior notes due July 2022 to redeem for cash on hand the entire $1.5&#160;billion aggregate principal amount. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Company exercised the par call redemption on its outstanding 2.75% senior notes due November 2022 (issued by Aetna) to redeem for cash on hand the entire $1.0&#160;billion aggregate principal amount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the Company exercised the par call redemptions on its outstanding 2.75% senior notes due December 2022 and 4.75% senior notes due December 2022 (including notes issued by Omnicare, Inc.) to redeem for cash on hand the entire aggregate principal amount of $1.25&#160;billion and $399&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 18, 2021, the Company issued $1.0&#160;billion aggregate principal amount of 2.125% unsecured senior notes due September 15, 2031 for total proceeds of $987&#160;million, net of discounts, underwriting fees and offering expenses. The net proceeds of this offering were used for the purchase of senior notes in connection with the Company&#8217;s cash tender offer in August 2021 as described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During March 2020, the Company entered into several interest rate swap transactions to manage interest rate risk. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows resulting from changes in interest rates related to the anticipated issuance of $750&#160;million aggregate principal amount of 3.625% unsecured senior notes due April 1, 2027, $1.5&#160;billion aggregate principal amount of 3.75% unsecured senior notes due April 1, 2030, $1.0&#160;billion aggregate principal amount of 4.125% unsecured senior notes due April 1, 2040 and $750&#160;million aggregate principal amount of 4.25% unsecured senior notes due April 1, 2050 (collectively, the &#8220;March 2020 Notes&#8221;). In connection with the issuance of the March 2020 Notes on March 31, 2020, the Company terminated all outstanding cash flow hedges. The Company paid a net amount of $7&#160;million to the hedge counterparties upon termination, which was recorded as a loss, net of tax, of $5&#160;million in accumulated other comprehensive income and will be reclassified as interest expense over the life of the March 2020 Notes. See Note 14 &#8216;&#8216;Other Comprehensive Income (Loss)&#8217;&#8217; included in Item 8 of this Exhibit 99.1 for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Early Extinguishments of Debt</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company redeemed for cash the remaining $2.3&#160;billion of its outstanding 3.7% senior notes due 2023. In connection with the early redemption of such senior notes, the Company paid a make-whole premium of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$80 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in excess of the aggregate principal amount of the senior notes that were redeemed, wrote-off </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$8 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of unamortized deferred financing costs and incurred</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $1 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in fees, for a total loss on early extinguishment of debt of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$89&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company purchased approximately $2.0&#160;billion of its outstanding 4.3% senior notes due 2028 through a cash tender offer. In connection with the purchase of such senior notes, the Company paid a premium of $332 million&#160;in excess </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the aggregate principal amount of the senior notes that were purchased, wrote-off $26&#160;million of unamortized deferred financing costs and incurred $5&#160;million in fees, for a total loss on early extinguishment of debt of $363&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company purchased $4.5&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $113&#160;million of its 4.0% senior notes due 2023, $1.4&#160;billion of its 3.7% senior notes due 2023, $1.0&#160;billion of its 4.1% senior notes due 2025 and $2.0&#160;billion of its 4.3% senior notes due 2028. In connection with the purchase of such senior notes, the Company paid a premium of $619&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $45&#160;million of unamortized deferred financing costs and incurred $10&#160;million in fees, for a total loss on early extinguishment of debt of $674&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company purchased $6.0&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $723&#160;million of its 4.0% senior notes due 2023, $2.3&#160;billion of its 3.7% senior notes due 2023 and $3.0&#160;billion of its 4.1% senior notes due 2025. In connection with the purchase of such senior notes, the Company paid a premium of $706&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $47&#160;million of unamortized deferred financing costs and incurred $13&#160;million in fees, for a total loss on early extinguishment of debt of $766&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 9 &#8216;&#8216;Borrowings and Credit Agreements&#8217;&#8217; included in Item 8 of this Exhibit 99.1 for additional information about debt issuances and debt repayments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments in order to manage interest rate and foreign exchange risk and credit exposure. The Company&#8217;s use of these derivatives is generally limited to hedging risk and has principally consisted of using interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s back-up revolving credit facilities and unsecured senior notes (see Note 9 &#8216;&#8216;Borrowings and Credit Agreements&#8217;&#8217; included in Item 8 of this Exhibit 99.1) contain customary restrictive financial and operating covenants. These covenants do not include an acceleration of the Company&#8217;s debt maturities in the event of a downgrade in the Company&#8217;s credit ratings. The Company does not believe the restrictions contained in these covenants materially affect its financial or operating flexibility. As of December&#160;31, 2022, the Company was in compliance with all of its debt covenants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Ratings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company&#8217;s long-term debt was rated &#8220;Baa2&#8221; by Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;) and &#8220;BBB&#8221; by Standard&#160;&amp; Poor&#8217;s Financial Services LLC (&#8220;S&amp;P&#8221;), and its commercial paper program was rated &#8220;P-2&#8221; by Moody&#8217;s and &#8220;A-2&#8221; by S&amp;P. The outlook on the Company&#8217;s long-term debt is &#8220;Stable&#8221; by Moody&#8217;s. In December 2022, S&amp;P changed the outlook on the Company&#8217;s long-term debt from &#8220;Positive&#8221; to &#8220;Stable.&#8221; In assessing the Company&#8217;s credit strength, the Company believes that both Moody&#8217;s and S&amp;P considered, among other things, the Company&#8217;s capital structure and financial policies as well as its consolidated balance sheet, its historical acquisition activity and other financial information. Although the Company currently believes its long-term debt ratings will remain investment grade, it cannot guarantee the future actions of Moody&#8217;s and/or S&amp;P. The Company&#8217;s debt ratings have a direct impact on its future borrowing costs, access to capital markets and new store operating lease costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Programs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following share repurchase programs have been authorized by CVS Health Corporation&#8217;s Board of Directors (the &#8220;Board&#8221;):</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following share repurchase programs have been authorized by the Board:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In billions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Authorization&#160;Date</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Authorized</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining as of<br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 17, 2022 (&#8220;2022 Repurchase Program&#8221;)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 9, 2021 (&#8220;2021 Repurchase Program&#8221;)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the share Repurchase Programs was effective immediately and permit the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase (&#8220;ASR&#8221;) transactions, and/or other derivative transactions. Both the 2022 and 2021 Repurchase Programs can be modified or terminated by the Board at any time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, the Company repurchased an aggregate of 34.1&#160;million shares of common stock for approximately $3.5&#160;billion pursuant to the 2021 Repurchase Program, including share repurchases under the $1.5 billion fixed dollar ASR transaction described below. During the years ended December&#160;31, 2021 and 2020, the Company did not repurchase any shares of common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $2.0&#160;billion fixed dollar ASR with Citibank, N.A. (&#8220;Citibank&#8221;). Upon payment of the $2.0&#160;billion purchase price on January 4, 2023, the Company received a number of shares of CVS Health Corporation&#8217;s common stock equal to 80% of the $2.0&#160;billion notional amount of the ASR or approximately 17.4 million shares at a price of $92.19 per share, which were placed into treasury stock in January 2023. At the conclusion of the ASR, the Company may receive additional shares representing the remaining 20% of the $2.0&#160;billion notional amount. The ultimate number of shares the Company may receive will depend on the daily volume-weighted average price of the Company&#8217;s stock over an averaging period, less a discount. It is also possible, depending on such weighted average price, that the Company will have an obligation to Citibank which, at the Company&#8217;s option, could be settled in additional cash or by issuing shares. Under the terms of the ASR, the maximum number of shares that could be delivered to the Company is 43.4 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $1.5&#160;billion fixed dollar ASR with Barclays Bank PLC. Upon payment of the $1.5&#160;billion purchase price on January 4, 2022, the Company received a number of shares of CVS Health Corporation&#8217;s common stock equal to 80% of the $1.5&#160;billion notional amount of the ASR or approximately 11.6&#160;million shares at a price of $103.34 per share, which were placed into treasury stock in January 2022. The ASR was accounted for as an initial treasury stock transaction for $1.2&#160;billion and a forward contract for $0.3&#160;billion. The forward contract was classified as an equity instrument and was recorded within capital surplus. In February 2022, the Company received approximately 2.7&#160;million shares of CVS Health Corporation&#8217;s common stock, representing the remaining 20% of the $1.5&#160;billion notional amount of the ASR, thereby concluding the ASR. These shares were placed into treasury stock and the forward contract was reclassified from capital surplus to treasury stock in February 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time they were received, the initial and final receipt of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted average common shares outstanding for basic and diluted earnings per share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, 2021 and 2020 the quarterly cash dividend was $0.55, $0.50 and $0.50 per share, respectively. In December 2022, the Board authorized a 10% increase in the quarterly cash dividend to $0.605 per share effective in 2023. CVS Health Corporation has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#8217;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future Cash Requirements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes certain estimated future cash requirements under the Company&#8217;s various contractual obligations at December&#160;31, 2022, in total and disaggregated into current and long-term obligations. The table below does not include future payments of claims to health care providers or pharmacies because certain terms of these payments are not determinable at December&#160;31, 2022 (for example, the timing and volume of future services provided under fee-for-service arrangements and future membership levels for capitated arrangements). </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual lease obligations with Target </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest payments on long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid litigation settlement agreements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities on the consolidated balance sheets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Future policy benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (6) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid claims</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (6) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6) (7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,559&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,095&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,464&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Refer to Note 6 &#8216;&#8216;Leases&#8217;&#8217; included in Item 8 of this Exhibit 99.1 for additional information regarding the maturity of lease liabilities under operating and finance leases. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company leases pharmacy and clinic space from Target. See Note 6 &#8216;&#8216;Leases&#8217;&#8217; included in Item 8 of this Exhibit 99.1 for additional information regarding the lease arrangements with Target. Amounts related to such operating and finance leases are reflected within the operating lease liabilities and finance lease liabilities in the table above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings are reflected in the table above assuming equivalent stores continue to operate through the term of the arrangements. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Refer to Note 9 &#8216;&#8216;Borrowings and Credit Agreements&#8217;&#8217; included in Item 8 of this Exhibit 99.1 for additional information regarding the maturities of debt principal. Interest payments on long-term debt are calculated using outstanding balances and interest rates in effect on December&#160;31, 2022.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Refer to Note 17 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; included in Item 8 of this Exhibit 99.1 for additional information regarding the opioid litigation settlement agreements. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Payments of other long-term liabilities exclude Separate Accounts liabilities of approximately $3.2 billion because these liabilities are supported by assets that are legally segregated and are not subject to claims that arise out of the Company&#8217;s business.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total payments of future policy benefits, unpaid claims and policyholders&#8217; funds include $705 million, $1.3 billion and $170 million, respectively, of reserves for contracts subject to reinsurance. The Company expects the assuming reinsurance carrier to fund these obligations and has reflected these amounts as reinsurance recoverable assets on the consolidated balance sheets.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Customer funds associated with group life and health contracts of approximately $107 million have been excluded from the table above because such funds may be used primarily at the customer&#8217;s discretion to offset future premiums and/or for refunds, and the timing of the related cash flows cannot be determined. Additionally, net unrealized capital losses on debt securities supporting experience-rated products of $56 million, before tax, have been excluded from the table above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restrictions on Certain Payments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to general state law restrictions on payments of dividends and other distributions to stockholders applicable to all corporations, health maintenance organizations (&#8220;HMOs&#8221;) and insurance companies are subject to further regulations that, among other things, may require those companies to maintain certain levels of equity (referred to as surplus) and restrict the amount of dividends and other distributions that may be paid to their equity holders. These regulations are not directly applicable to CVS Health Corporation as a holding company, since CVS Health Corporation is not an HMO or an insurance company. In addition, in connection with the Aetna Acquisition, the Company made certain undertakings that require prior regulatory approval of dividends by certain of its HMOs and insurance companies. The additional regulations and undertakings applicable to the Company&#8217;s HMO and insurance company subsidiaries are not expected to affect the Company&#8217;s ability to service the Company&#8217;s debt, meet other financing obligations or pay dividends, or the ability of any of the Company&#8217;s subsidiaries to service their debt or other financing obligations. Under applicable regulatory requirements and undertakings, at December&#160;31, 2022, the maximum amount of dividends that may be paid by the Company&#8217;s insurance and HMO subsidiaries without prior approval by regulatory authorities was $2.7 billion in the aggregate. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains capital levels in its operating subsidiaries at or above targeted and/or required capital levels and dividends amounts in excess of these levels to meet liquidity requirements, including the payment of interest on debt and stockholder dividends. In addition, at the Company&#8217;s discretion, it uses these funds for other purposes such as funding share and debt repurchase programs, investments in new businesses and other purposes considered advisable. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 and 2021, the Company held investments of $331 million and $450 million, respectively, that are not accounted for as Separate Accounts assets but are legally segregated and are not subject to claims that arise out of the Company&#8217;s business. See Note 3 &#8216;&#8216;Investments&#8217;&#8217; included in Item 8 of this Exhibit 99.1 for additional information on investments related to the 2012 conversion of an existing group annuity contract from a participating to a non-participating contract.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Solvency Regulation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The National Association of Insurance Commissioners (the &#8220;NAIC&#8221;) utilizes risk-based capital (&#8220;RBC&#8221;) standards for insurance companies that are designed to identify weakly-capitalized companies by comparing each company&#8217;s adjusted surplus to its required surplus (the &#8220;RBC Ratio&#8221;). The RBC Ratio is designed to reflect the risk profile of insurance companies. Within certain ratio ranges, regulators have increasing authority to take action as the RBC Ratio decreases. There are four levels of regulatory action, ranging from requiring an insurer to submit a comprehensive financial plan for increasing its RBC to the state insurance commissioner to requiring the state insurance commissioner to place the insurer under regulatory control. At December&#160;31, 2022, the RBC Ratio of each of the Company&#8217;s primary insurance subsidiaries was above the level that would require regulatory action. The RBC framework described above for insurers has been extended by the NAIC to health organizations, including HMOs. Although not all states had adopted these rules at December&#160;31, 2022, at that date, each of the Company&#8217;s active HMOs had a surplus that exceeded either the applicable state net worth requirements or, where adopted, the levels that would require regulatory action under the NAIC&#8217;s RBC rules. External rating agencies use their own capital models and/or RBC standards when they determine a company&#8217;s rating.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_94"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the consolidated financial statements in conformity with generally accepted accounting principles, which require management to make certain estimates and apply judgment. Estimates and judgments are based on historical experience, current trends and other factors that management believes to be important at the time the consolidated financial statements are prepared. On a regular basis, the Company reviews its accounting policies and how they are applied and disclosed in the consolidated financial statements. While the Company believes the historical experience, current trends and other factors considered by management support the preparation of the consolidated financial statements in conformity with generally accepted accounting principles, actual results could differ from estimates, and such differences could be material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant accounting policies are discussed in Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; included in Item 8 of this Exhibit 99.1. Management believes the following accounting policies include a higher degree of judgment and/or complexity and, thus, are considered to be critical accounting policies. The Company has discussed the development and selection of these critical accounting policies with the Audit Committee of the Board (the &#8220;Audit Committee&#8221;), and the Audit Committee has reviewed the disclosures relating to them.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health Care Benefits revenue is principally derived from insurance premiums and fees billed to customers. Revenue is recognized based on customer billings, which, in the Company&#8217;s Commercial business, reflect contracted rates per member and the number of covered members recorded in the Company&#8217;s records at the time the billings are prepared. Billings are generally sent monthly for coverage during the following month. Revenue related to the Company&#8217;s Government business is collected monthly from the U.S. federal government and various government agencies based on fixed payment rates and member eligibility. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s billings may be subsequently adjusted to reflect enrollment changes due to member terminations or other factors. These adjustments are known as retroactivity adjustments. In each period, the Company estimates the amount of future retroactivity and adjusts the recorded revenue accordingly. As information regarding actual retroactivity amounts becomes known, the Company refines its estimates and records any required adjustments to revenues in the period in which they arise. A significant difference in the actual level of retroactivity compared to estimated levels would have a significant effect on the Company&#8217;s operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Premium Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums are recognized as revenue in the month in which the enrollee is entitled to receive health care services. Premiums are reported net of an allowance for estimated terminations and uncollectible amounts. Additionally, premium revenue subject to the MLR rebate requirements of the ACA is recorded net of the estimated minimum MLR rebates for the current calendar year. Premiums related to unexpired contractual coverage periods (unearned premiums) are reported as other insurance liabilities on the consolidated balance sheets and recognized as revenue when earned.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s contracts allow for premiums to be adjusted to reflect actual experience or the relative health status of Insured members. Such adjustments are reasonably estimable at the outset of the contract, and adjustments to those estimates are made based on actual experience of the customer emerging under the contract and the terms of the underlying contract.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Services Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue relates to contracts that can include various combinations of services or series of services which generally are capable of being distinct and accounted for as separate performance obligations. The Health Care Benefits segment&#8217;s services revenue primarily consists of ASC fees received in exchange for performing certain claim processing and member services for ASC members. ASC fee revenue is recognized over the period the service is provided. Some of the Company&#8217;s administrative services contracts include guarantees with respect to certain functions, such as customer service response time, claim processing accuracy and claim processing turnaround time, as well as certain guarantees that a plan sponsor&#8217;s benefit claim experience will fall within a certain range. With any of these guarantees, the Company is financially at risk if the conditions of the arrangements are not met, although the maximum amount at risk typically is limited to a percentage of the fees otherwise payable to the Company by the customer involved. Each period the Company estimates its obligations under the terms of these guarantees and records its estimate as an offset to services revenues.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting for Medicare Part D </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include insurance premiums earned by the Company&#8217;s PDPs, which are determined based on the PDP&#8217;s annual bid and related contractual arrangements with CMS. The insurance premiums include a beneficiary premium, which is the responsibility of the PDP member, and can be subsidized by CMS in the case of low-income members, and a direct premium paid by CMS. Premiums collected in advance are initially recorded within other insurance liabilities and are then recognized ratably as revenue over the period in which members are entitled to receive benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues also include a risk-sharing feature of the Medicare Part D program design referred to as the risk corridor. The Company estimates variable consideration in the form of amounts payable to, or receivable from, CMS under the risk corridor, and adjusts revenue based on calculations of additional subsidies to be received from or owed to CMS at the end of the reporting year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to Medicare Part D premiums, the Company receives additional payments each month from CMS related to catastrophic reinsurance, low-income cost-sharing subsidies and coverage gap benefits. If the subsidies received differ from the amounts earned from actual prescriptions transferred, the difference is recorded in either accounts receivable, net or accrued expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Services segment sells prescription drugs directly through its specialty and mail order pharmacy offerings and indirectly through the Company&#8217;s retail pharmacy network. The Company&#8217;s pharmacy benefit arrangements are accounted for in a manner consistent with a master supply arrangement as there are no contractual minimum volumes and each prescription is considered a separate purchasing decision and distinct performance obligation transferred at a point in time. PBM services performed in connection with each prescription claim are considered part of a single performance obligation which culminates in the fulfillment of prescription drugs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue using the gross method at the contract price negotiated with its clients when the Company has concluded it controls the prescription drug before it is transferred to the client plan members. The Company controls prescriptions fulfilled indirectly through its retail pharmacy network because it has separate contractual arrangements with those pharmacies, has discretion in setting the price for the transaction and assumes primary responsibility for fulfilling the promise to provide prescription drugs to its client plan members while also performing the related PBM services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include (i) the portion of the price the client pays directly to the Company, net of any discounts earned on brand name drugs or other discounts and refunds paid back to the client (see &#8220;Drug Discounts&#8221; and &#8220;Guarantees&#8221; below), (ii) the price paid to the Company by client plan members for mail order prescriptions and the price paid to retail network pharmacies by client plan members for retail prescriptions (&#8220;retail co-payments&#8221;), and (iii) claims based administrative fees for retail pharmacy network contracts. Sales taxes are not included in revenues. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when control of the prescription drugs is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those prescription drugs. The Company has established the following revenue recognition policies for the Health Services segment:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by third party pharmacies in the Company&#8217;s retail pharmacy network and associated administrative fees are recognized at the Company&#8217;s point-of-sale, which is when the claim is adjudicated by the Company&#8217;s online claims processing system and the Company has transferred control of the prescription drug and completed all of its performance obligations.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by specialty and mail order pharmacies are recognized when the prescription drug is delivered to the client plan member. At the time of delivery, the Company has performed substantially all of its performance obligations under its client contracts and does not experience a significant level of returns or reshipments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts under which the Company acts as an agent or does not control the prescription drugs prior to transfer to the client plan member, revenue is recognized using the net method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Drug Discounts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records revenue net of manufacturers&#8217; rebates earned by its clients based on their plan members&#8217; utilization of brand-name formulary drugs. The Company estimates these rebates at period-end based on actual and estimated claims data and its estimates of the manufacturers&#8217; rebates earned by its clients. The estimates are based on the best available data at period-end and recent history for the various factors that can affect the amount of rebates due to the client. The Company adjusts its rebates </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payable to clients to the actual amounts paid when these rebates are paid or as significant events occur. Any cumulative effect of these adjustments is recorded against revenues at the time it is identified. Adjustments generally result from contract changes with clients or manufacturers that have retroactive rebate adjustments, differences between the estimated and actual product mix subject to rebates, or whether the brand name drug was included in the applicable formulary. The effect of adjustments between estimated and actual manufacturers&#8217; rebate amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantees</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also adjusts revenues for refunds owed to clients resulting from pricing guarantees and performance against defined service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Walk-In Medical Clinics</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For services provided by the Company&#8217;s walk-in medical clinics, revenue recognition occurs for completed services provided to patients, with adjustments taken for third party payor contractual obligations and patient direct bill historical collection rates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy &amp; Consumer Wellness Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Retail Pharmacy</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s retail drugstores recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims under other retail network arrangements. Revenues are adjusted for refunds owed to third party payers resulting from pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Company gift cards purchased by customers is deferred as a contract liability until goods or services are transferred. Any amounts not expected to be redeemed by customers (i.e., breakage) are recognized based on historical redemption patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer returns are not material to the Company&#8217;s operating results or financial condition. Sales taxes are not included in revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Loyalty and Other Programs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customer loyalty program, ExtraCare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, consists of two components, ExtraSavings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Rewards. ExtraSavings are coupons that are recorded as a reduction of revenue when redeemed as the Company concluded that they do not represent a promise to the customer to deliver additional goods or services at the time of issuance because they are not tied to a specific transaction or spending level. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ExtraBucks Rewards are accumulated by customers based on their historical spending levels. Thus, the Company has determined that there is an additional performance obligation to those customers at the time of the initial transaction. The Company allocates the transaction price to the initial transaction and the ExtraBucks Rewards transaction based upon the relative standalone selling price, which considers historical redemption patterns for the rewards. Revenue allocated to ExtraBucks Rewards is recognized as those rewards are redeemed. At the end of each period, unredeemed ExtraBucks Rewards are reflected as a contract liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also offers a subscription-based membership program, CarePass</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, under which members are entitled to a suite of benefits delivered over the course of the subscription period, as well as a promotional reward that can be redeemed for future goods and services. Subscriptions are paid for on a monthly or annual basis at the time of or in advance of the Company delivering the goods and services. Revenue from these arrangements is recognized as the performance obligations are satisfied. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-term Care</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those goods or services. Each prescription claim represents a separate performance obligation of the Company, separate and distinct from other prescription claims under customer arrangements. A significant portion of long-term care revenue from sales of pharmaceutical and medical products is reimbursed by the federal Medicare Part D program and, to a lesser extent, state Medicaid programs. The Company monitors its </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revenues and receivables from these reimbursement sources, as well as long-term care facilities and other third party insurance payors, and reduces revenue at the revenue recognition date to properly account for the variable consideration due to anticipated differences between billed and reimbursed amounts. Accordingly, the total revenues and receivables reported in the Company&#8217;s consolidated financial statements are recorded at the amount expected to be ultimately received from these payors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient co-payments associated with Medicare Part D, certain state Medicaid programs, Medicare Part B and certain third party payors typically are not collected at the time products are delivered or services are rendered, but are billed to the individuals as part of normal billing procedures and subject to normal accounts receivable collections procedures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairments of Debt Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly reviews its debt securities to determine whether a decline in fair value below the cost basis or carrying value has occurred. If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related (yield-related) components. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income (loss). The Company analyzes all facts and circumstances believed to be relevant for each investment when performing this analysis, in accordance with applicable accounting guidance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principle payments; and any changes to the rating of the security by a rating agency. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among the factors considered in evaluating whether a decline in fair value below the cost basis or carrying value has occurred are whether the decline results from a change in the quality of the debt security itself, whether the decline results from a downward movement in the market as a whole, and the prospects for realizing the carrying value of the debt security based on the investment&#8217;s current and short-term prospects for recovery. For unrealized losses determined to be the result of market conditions (for example, increasing interest rates and volatility due to conditions in the overall market) or industry-related events, the Company determines whether it intends to sell the debt security or if it is more likely than not that the Company will be required to sell the debt security prior to the anticipated recovery of the debt security&#8217;s amortized cost basis. If either case is true, the Company recognizes a non-credit related impairment, and the cost basis or carrying amount of the debt security is written down to fair value.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2022, 2021 and 2020, the Company recorded yield-related impairment losses on debt securities of $143 million, $42 million and $49 million, respectively. During the year ended December&#160;31, 2022, the Company recorded credit-related losses on debt securities of $13 million. During the years ended December 31, 2021 and 2020, the Company did not record any credit-related impairment losses on debt securities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risks inherent in assessing the impairment of a debt security include the risk that market factors may differ from projections and the risk that facts and circumstances factored into the Company&#8217;s assessment may change with the passage of time. Unexpected changes to market factors and circumstances that were not present in past reporting periods are among the factors that may result in a current period decision to sell debt securities that were not impaired in prior reporting periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vendor Allowances and Purchase Discounts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vendor and manufacturer receivables were $12.4 billion and $10.6 billion as of December&#160;31, 2022 and 2021, respectively, the majority of which relate to purchase discounts and vendor allowances as described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Services segment receives purchase discounts on products purchased. Contractual arrangements with vendors, including manufacturers, wholesalers and retail pharmacies, normally provide for the Health Services segment to receive purchase discounts from established list prices in one, or a combination, of the following forms: (i)&#160;a direct discount at the time of purchase, (ii)&#160;a discount for the prompt payment of invoices or (iii)&#160;when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy), a discount (or rebate) paid subsequent to dispensing. These </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rebates are recognized when prescriptions are dispensed and are generally calculated and billed to manufacturers within 30&#160;days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Company&#8217;s operating results or financial condition. The Company accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Health Services segment also receives additional discounts under its wholesaler contracts if it exceeds contractually defined purchase volumes. In addition, the Health Services segment receives fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of products sold.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy &amp; Consumer Wellness Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vendor allowances received by the Pharmacy &amp; Consumer Wellness segment reduce the carrying cost of inventory and are recognized in cost of products sold when the related inventory is sold, unless they are specifically identified as a reimbursement of incremental costs for promotional programs and/or other services provided. Amounts that are directly linked to advertising commitments are recognized as a reduction of advertising expense (included in operating expenses) when the related advertising commitment is satisfied. Any such allowances received in excess of the actual cost incurred also reduce the carrying cost of inventory. The total value of any upfront payments received from vendors that are linked to purchase commitments is initially deferred. The deferred amounts are then amortized to reduce cost of products sold over the life of the contract based upon sales volume. The total value of any upfront payments received from vendors that are not linked to purchase commitments is also initially deferred. The deferred amounts are then amortized to reduce cost of products sold on a straight-line basis over the life of the related contract.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes a receivable for vendor income that is earned but not yet received based on historical trends and data. The majority of vendor receivables are collected within the following fiscal quarter. Historically, adjustments to the Company&#8217;s vendor receivables resulting from the reconciliation of receivables recognized to the amounts collected have not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have not been any material changes in the way the Company accounts for vendor allowances or purchase discounts during the past three&#160;years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are valued at the lower of cost or net realizable value using the weighted average cost method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The value of ending inventory is reduced for estimated inventory losses that have occurred during the interim period between physical inventory counts. Physical inventory counts are taken on a regular basis in each retail store and LTC pharmacy, and a continuous cycle count process is the primary procedure used to validate the inventory balances on hand in each distribution center and mail facility to ensure that the amounts reflected in the consolidated financial statements are properly stated. The Company&#8217;s accounting for inventory contains uncertainty since management must use judgment to estimate the inventory losses that have occurred during the interim period between physical inventory counts. When estimating these losses, a number of factors are considered which include historical physical inventory results on a location-by-location basis and current physical inventory loss trends.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total reserve for estimated inventory losses covered by this critical accounting policy was $559 million and $522 million as of December&#160;31, 2022 and 2021, respectively. Although management believes there is sufficient current and historical information available to record reasonable estimates for estimated inventory losses, it is possible that actual results could differ. In order to help investors assess the aggregate risk, if any, associated with the inventory-related uncertainties discussed above, a ten&#160;percent (10%)&#160;pre-tax change in estimated inventory losses, which is a reasonably likely change, would increase or decrease the total reserve for estimated inventory losses by approximately $56 million as of December&#160;31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although management believes that the estimates discussed above are reasonable and the related calculations conform to generally accepted accounting principles, actual results could differ from such estimates, and such differences could be material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Right-of-Use Assets and Lease Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lease, renewal date of the lease or significant remodeling of the lease space based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company&#8217;s leases is not readily determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The operating lease right-of-use assets also include lease payments made before commencement and are reduced by lease incentives. The Company evaluates the recoverability of its right-of-use assets as described in &#8220;Recoverability of Long-Lived Assets&#8221; below.  </span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s real estate leases typically contain options that permit renewals for additional periods of up to five years each. For real estate leases, the options to extend are not considered reasonably certain at lease commencement because the Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and regularly opens or closes stores to align with its operating strategy. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the right-of-use asset and lease liability. Similarly, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. Leases with an initial term of 12 months or less are not recorded on the balance sheets, and lease expense is recognized on a straight-line basis over the term of the short-term lease.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For real estate leases, the Company accounts for lease components and nonlease components as a single lease component.  Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the right-of-use assets and lease liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recoverability of Long-Lived Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recoverability of Definite-Lived Assets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the recoverability of long-lived assets, excluding goodwill and indefinite-lived intangible assets, which are tested for impairment using separate tests described below, whenever events or changes in circumstances indicate that the carrying value of such an asset may not be recoverable. The Company groups and evaluates these long-lived assets for impairment at the lowest level at which individual cash flows can be identified. If indicators of impairment are present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the asset group&#8217;s estimated future cash flows (discounted). If required, an impairment loss is recorded for the portion of the asset group&#8217;s carrying value that exceeds the asset group&#8217;s estimated future cash flows (discounted).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The long-lived asset impairment loss calculation contains uncertainty since management must use judgment to estimate each asset group&#8217;s future sales, profitability and cash flows. When preparing these estimates, the Company considers historical results and current operating trends and consolidated sales, profitability and cash flow results and forecasts. These estimates can be affected by a number of factors including general economic and regulatory conditions, efforts of third party organizations to reduce their prescription drug costs and/or increased member co-payments, the continued efforts of competitors to gain market share and consumer spending patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, the Company undertook an initiative to evaluate its corporate office real estate space in response to its new flexible work arrangement. As part of this initiative, the Company evaluated its current real estate space and changes in employee work arrangement requirements to ensure it had the appropriate space to support the business. As a result of this assessment, the Company determined that it would vacate and abandon certain leased corporate office spaces. Accordingly, in the three months ended December 31, 2022, the Company recorded office real estate optimization charges of $117 million, primarily consisting of $71&#160;million related to operating lease right-of-use assets and $44&#160;million related to property and equipment, within the Health Care Benefits, Corporate/Other and Health Services segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, the Company completed a strategic review of its retail business and announced the creation of new formats for its stores to continue to drive higher engagement with customers. As part of this review, the Company evaluated changes in population, consumer buying patterns and future health needs to ensure it has the right kinds of stores in the right locations for consumers and for the business. In connection with this initiative, on November 17, 2021, the Board authorized the closing of approximately 900 retail stores, approximately 300 stores each year, between 2022 and 2024. As a result, management determined that there were indicators of impairment with respect to the impacted stores&#8217; asset groups, including the associated operating lease right-of-use assets and property and equipment. A long-lived asset impairment test was performed during the fourth quarter of 2021 and the results of the impairment test indicated that the fair value of certain retail store asset groups was lower than their respective carrying values. Accordingly, in the three months ended December&#160;31, 2021, the Company recorded a store impairment charge of approximately $1.4 billion, consisting of a write down of approximately </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.1&#160;billion related to operating lease right-of-use assets and $261&#160;million related to property and equipment, within the Pharmacy &amp; Consumer Wellness segment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material impairment charges recognized on long-lived assets during the year ended December 31,</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recoverability of Goodwill</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of amounts paid for acquisitions over the fair value of the net identifiable assets acquired. Goodwill is subject to annual impairment reviews, or more frequent reviews if events or circumstances indicate that the carrying value may not be recoverable. Goodwill is tested for impairment on a reporting unit basis. The impairment test is performed by comparing the reporting unit&#8217;s fair value with its net book value (or carrying amount), including goodwill. The fair value of the reporting units is estimated using a combination of a discounted cash flow method and a market multiple method. If the net book value (carrying amount) of the reporting unit exceeds its fair value, the reporting unit&#8217;s goodwill is considered to be impaired, and an impairment is recognized in an amount equal to the excess.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of the fair value of the reporting units requires the Company to make significant assumptions and estimates. These assumptions and estimates primarily include the selection of appropriate peer group companies; control premiums and valuation multiples appropriate for acquisitions in the industries in which the Company competes; discount rates; terminal growth rates; and forecasts of revenue, operating income, depreciation and amortization, income taxes, capital expenditures and future working capital requirements. When determining these assumptions and preparing these estimates, the Company considers each reporting unit&#8217;s historical results and current operating trends; consolidated revenues, profitability and cash flow results and forecasts; and industry trends. The Company&#8217;s estimates can be affected by a number of factors, including general economic and regulatory conditions; the risk-free interest rate environment; the Company&#8217;s market capitalization; efforts of customers and payers to reduce costs, including their prescription drug costs, and/or increase member co-payments; the continued efforts of competitors to gain market share, consumer spending patterns and the Company&#8217;s ability to achieve its revenue growth projections and execute on its cost reduction initiatives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 Goodwill Impairment Test</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2022, the Company performed its required annual impairment test of goodwill. The results of the impairment tests indicated that there was no impairment of goodwill as of the testing date. The fair values of the reporting units with goodwill exceeded their carrying values by significant margins.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the closing date of the Aetna Acquisition in November 2018, the Company had experienced declines in its Commercial Insured medical membership. In 2022, the Company has grown its Commercial Insured medical membership, excluding the impact of the divestiture of the Thailand business described in Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; included in Item 8 of this Exhibit 99.1. Adverse economic conditions may impact medical membership in the Commercial business due to reductions in workforce at existing customers. The Company&#8217;s fair value estimate is sensitive to significant assumptions including changes in medical membership, revenue growth rate, operating income and the discount rate. The Company believes the financial projections used to determine the fair value of the Commercial Business reporting unit in the third quarter of 2022 were reasonable and achievable. As of December 31, 2022, the goodwill balance in the Commercial Business reporting unit was $25.5 billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Goodwill Impairment Test</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company performed its required annual impairment tests of goodwill. The results of the impairment tests indicated an impairment of the goodwill associated with the LTC reporting unit, as the reporting unit&#8217;s carrying value exceeded its fair value as of the testing date. The results of the impairment tests of the remaining reporting units indicated that there was no impairment of goodwill as of the testing date. The fair values of the reporting units with goodwill exceeded their carrying values by significant margins, with the exception of the Commercial Business reporting unit, which exceeded its carrying value by approximately 3%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; included in Item 8 of this Exhibit 99.1, during 2021, the LTC reporting unit has continued to face challenges that have impacted the Company&#8217;s ability to grow the LTC reporting unit&#8217;s business at the rate estimated when its 2020 goodwill impairment test was performed. These challenges include lower net facility admissions, net long-term care facility customer losses and the prolonged adverse impact of the COVID-19 pandemic and the emerging new variants, which resulted in more significant declines in occupancy rates experienced by the Company&#8217;s long-term care facility customers than previously anticipated. During the third quarter of 2021, LTC management updated their 2021 annual forecast and submitted their long-term plan which showed deterioration in the financial results for the remainder of 2021 and beyond. The Company utilized these updated projections in performing its annual impairment test, which indicated that the fair value of the LTC reporting unit was lower than its carrying value, resulting in a $431 million goodwill impairment </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">charge in the third quarter of 2021. The fair value of the LTC reporting unit was determined using a combination of a discounted cash flow method and a market multiple method. Subsequent to the impairment charge recorded in the third quarter of 2021, there is no remaining goodwill balance in the LTC reporting unit. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 Goodwill Impairment Test</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2020, the Company performed its required annual impairment test of goodwill. The results of this impairment test indicated that there was no impairment of goodwill as of the testing date. The goodwill impairment test resulted in the fair values of all of the Company&#8217;s reporting units exceeding their carrying values by significant margins, with the exception of the Commercial Business and LTC reporting units, which exceeded their carrying values by approximately 6% and 12%, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recoverability of Indefinite-Lived Intangible Assets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets are subject to annual impairment reviews, or more frequent reviews if events or circumstances indicate that their carrying value may not be recoverable. Indefinite-lived intangible assets are tested by comparing the estimated fair value of the asset to its carrying value. If the carrying value of the asset exceeds its estimated fair value, an impairment loss is recognized, and the asset is written down to its estimated fair value.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indefinite-lived intangible asset impairment loss calculation contains uncertainty since management must use judgment to estimate fair value based on the assumption that, in lieu of ownership of an intangible asset, the Company would be willing to pay a royalty in order to utilize the benefits of the asset. Fair value is estimated by discounting the hypothetical royalty payments to their present value over the estimated economic life of the asset. These estimates can be affected by a number of factors including general economic conditions, availability of market information and the profitability of the Company. There were no impairment losses recognized on indefinite-lived intangible assets in any of the years ended December&#160;31, 2022, 2021 or 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Costs Payable</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At both&#160;December&#160;31, 2022 and 2021, 77% of health care costs payable are estimates of the ultimate cost of (i) services rendered to the Company&#8217;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid (collectively, &#8220;IBNR&#8221;). Health care costs payable also include an estimate of the cost of services that will continue to be rendered after the financial statement date if the Company is obligated to pay for such services in accordance with contractual or regulatory requirements. The remainder of health care costs payable is primarily comprised of pharmacy and capitation payables, other amounts due to providers pursuant to risk sharing agreements and accruals for state assessments. The Company develops its estimate of IBNR using actuarial principles and assumptions that consider numerous factors. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; included in Item 8 of this Exhibit 99.1 for additional information on the Company&#8217;s reserving methodology.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022 and 2021, the Company observed an increase in completion factors relative to those assumed at the prior year end. After considering the claims paid in 2022 and 2021 with dates of service prior to the fourth quarter of the previous year, the Company observed assumed incurred claim weighted average completion factors that were 3 and 21 basis points higher, respectively, than previously estimated, resulting in a decrease of $32 million and $207 million in 2022 and 2021, respectively, in health care costs payable that related to the prior year. The Company has considered the pattern of changes in its completion factors when determining the completion factors used in its estimates of IBNR as of December&#160;31, 2022. However, based on historical claim experience, it is reasonably possible that the Company&#8217;s estimated weighted average completion factors may vary by plus or minus 12 basis points from the Company&#8217;s assumed rates, which could impact health care costs payable by approximately plus or minus $207 million pretax.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, during 2022 and 2021, the Company observed that health care costs for claims with claim incurred dates of three months or less before the financial statement date were lower than previously estimated. Specifically, after considering the claims paid in 2022 and 2021 with claim incurred dates for the fourth quarter of the previous year, the Company observed health care costs that were 4.8% and 5.0% lower, respectively, for each fourth quarter than previously estimated, resulting in a reduction of $622 million and $581 million in 2022 and 2021, respectively, in health care costs payable that related to prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management considers historical health care cost trend rates together with its knowledge of recent events that may impact current trends when developing estimates of current health care cost trend rates. When establishing reserves as of December&#160;31, 2022, the Company increased its assumed health care cost trend rates for the most recent three months by 4.9% from health care cost trend rates recently observed. Health care cost trend rates during the past three years have been impacted by utilization changes driven by the COVID-19 pandemic. The impact has not been uniform, with products and select geographies </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">experiencing utilization impacts due to COVID-19 waves. Based on historical claim experience, it is reasonably possible that the Company&#8217;s estimated health care cost trend rates may vary by plus or minus 3.5% from the assumed rates, which could impact health care costs payable by plus or minus $487 million pretax.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes using the asset and liability method. Deferred tax assets and liabilities are established for any temporary differences between financial and tax reporting bases and are adjusted as needed to reflect changes in the enacted tax rates expected to be in effect when the temporary differences reverse. Such adjustments are recorded in the period in which changes in tax laws are enacted, regardless of when they are effective. Deferred tax assets are reduced, if necessary, by a valuation allowance to the extent future realization of those losses, deductions or other tax benefits is sufficiently uncertain. Significant judgment is required in determining the provision for income taxes and the related taxes payable and deferred tax assets and liabilities since, in the ordinary course of business, there are transactions and calculations where the ultimate tax outcome is uncertain. Additionally, the Company&#8217;s tax returns are subject to audit by various domestic and foreign tax authorities that could result in material adjustments based on differing interpretations of the tax laws. Although management believes that its estimates are reasonable and are based on the best available information at the time the provision is prepared, actual results could differ from these estimates resulting in a final tax outcome that may be materially different from that which is reflected in the consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax benefit from an uncertain tax position is recognized only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement with the related tax authority. Interest and/or penalties related to uncertain tax positions are recognized in the income tax provision. Significant judgment is required in determining uncertain tax positions. The Company has established accruals for uncertain tax positions using its judgment and adjusts these accruals, as warranted, due to changing facts and circumstances.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8 &#8216;&#8216;Other Insurance Liabilities and Separate Accounts&#8217;&#8217; included in Item 8 of this Exhibit 99.1 for a description of recently adopted new accounting pronouncements applicable to the Company.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_97"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7A.  Quantitative and Qualitative Disclosures About Market Risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s earnings and financial condition are exposed to interest rate risk, credit quality risk, market valuation risk, foreign currency risk, commodity risk and operational risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Interest Rate and Credit Quality Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages interest rate risk by seeking to maintain a tight match between the durations of assets and liabilities when appropriate.&#160;The Company manages credit quality risk by seeking to maintain high average credit quality ratings and diversified sector exposure within its debt securities portfolio.&#160;In connection with its investment and risk management objectives, the Company also uses derivative financial instruments whose market value is at least partially determined by, among other things, levels of or changes in interest rates (short-term or long-term), duration, prepayment rates, equity markets or credit ratings/spreads.&#160;The Company&#8217;s use of these derivatives is generally limited to hedging risk and has principally consisted of using interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps.&#160;These instruments, viewed separately, subject the Company to varying degrees of interest rate, equity price and credit risk.&#160;However, when used for hedging, the Company expects these instruments to reduce overall risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investment portfolio supported the following products at December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.428%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience-rated products </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,891&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,142&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes long-term investments of $17&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; included in Item 8 of this Exhibit 99.1 for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment risks associated with experience-rated products generally do not impact the Company&#8217;s operating results. The risks associated with investments supporting experience-rated pension and annuity products in the large case pensions business in the Company&#8217;s Corporate/Other segment are assumed by the contract holders and not by the Company (subject to, among other things, certain minimum guarantees).&#160;Assets supporting experience-rated products may be subject to contract holder or participant withdrawals.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The debt securities in the Company&#8217;s investment portfolio had an average credit quality rating of A at both December&#160;31, 2022 and 2021, with a fair value of approximately $6.0 billion and $6.7 billion rated AAA at December&#160;31, 2022 and 2021, respectively.&#160;The fair value of debt securities that were rated below investment grade (that is, having a credit quality rating below BBB-/Baa3) was $1.9 billion and $2.3 billion at December&#160;31, 2022 and 2021, respectively (of which 1.6% and 2.0% at December&#160;31, 2022 and 2021, respectively, supported experience-rated products).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 and 2021, the Company held $202 million and $305 million, respectively, of municipal debt securities that were guaranteed by third parties, representing 1% of total investments at both December&#160;31, 2022 and 2021.&#160;These securities had an average credit quality rating of AA+ and AA at December&#160;31, 2022 and 2021, respectively, with the guarantee. These securities had an average credit quality rating of A at both December&#160;31, 2022 and 2021, respectively, without the guarantee.&#160;The Company does not have any significant concentration of investments with third party guarantors (either direct or indirect).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally classifies debt securities as available for sale, and carries them at fair value on the consolidated balance sheets.&#160;At both December&#160;31, 2022 and 2021, less than 1% of debt securities were valued using inputs that reflect the Company&#8217;s assumptions (categorized as Level 3 inputs in accordance with accounting principles generally accepted in the United States of America).&#160;See Note 4 &#8216;&#8216;Fair Value&#8217;&#8217; included in Item 8 of this Exhibit 99.1 for additional information on the methodologies and key assumptions used to determine the fair value of investments. For additional information related to investments, see Note 3 &#8216;&#8216;Investments&#8217;&#8217; included in Item 8 of this Exhibit 99.1.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly reviews debt securities in its portfolio to determine whether a decline in fair value below the cost basis or carrying value has occurred.&#160;If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related components. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income (loss). The impairment of debt securities is considered a critical accounting policy.&#160;See &#8216;&#8216;Critical Accounting Policies - Impairments of Debt Securities&#8221; in the MD&amp;A included in Item 7 of this Exhibit 99.1 for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Market Valuation Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly evaluates its risk from market-sensitive instruments by examining, among other things, levels of or changes in interest rates (short-term or long-term), duration, prepayment rates, equity markets and/or credit ratings/spreads. The Company also regularly evaluates the appropriateness of investments relative to management-approved investment guidelines (and operates within those guidelines) and the business objectives of its portfolios.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a quarterly basis, the Company reviews the impact of hypothetical net losses in its investment portfolio on the Company&#8217;s consolidated near-term financial condition, operating results and cash flows assuming the occurrence of certain reasonably possible changes in near-term market rates and prices. Interest rate changes (whether resulting from changes in treasury yields or credit spreads or other factors) represent the most material risk exposure category for the Company.&#160;The Company has estimated the impact on the fair value of market sensitive instruments based on the net present value of cash flows using a representative set of likely future interest rate scenarios. The assumptions used were as follows: an immediate increase of 100 basis points in interest rates (which the Company believes represents a moderately adverse scenario) for long-term debt issued by the Company, as well as its interest rate sensitive investments and an immediate decrease of 15% in prices for publicly traded domestic equity securities in the Company&#8217;s investment portfolio.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assuming an immediate increase of 100 basis points in interest rates, the theoretical decline in the fair values of market sensitive instruments at December&#160;31, 2022 is as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The fair value of long-term debt issued by the Company would decline by approximately $2.9 billion ($3.6 billion pretax). Changes in the fair value of long-term debt do not impact the Company&#8217;s operating results or financial condition.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The theoretical reduction in the fair value of interest rate sensitive investments partially offset by the theoretical reduction in the fair value of interest rate sensitive liabilities would result in a net decline in fair value of approximately $565 million ($715 million pretax) related to continuing non-experience-rated products. Net reductions in fair value would be reflected as an unrealized loss in equity, as the Company classifies these debt securities as available for sale and the effect of the interest rate on interest rate sensitive liabilities is recorded in other comprehensive income (loss).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the value of the Company&#8217;s publicly traded domestic equity securities held within its investment portfolio were to decline by 15%, this would result in a net decline in fair value of $20&#160;million ($26&#160;million pretax).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on overall exposure to interest rate risk and equity price risk, the Company believes that these changes in market rates and prices would not materially affect consolidated near-term financial condition, operating results or cash flows as of December&#160;31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Foreign Currency and Commodity Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 and 2021, the Company did not have any material foreign currency exchange rate or commodity derivative instruments in place and believes its exposure to foreign currency exchange rate risk is not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Operational Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also faces certain operational risks. Those risks include risks related to the COVID-19 pandemic and risks related to information security, including cybersecurity. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The spread of COVID-19, or actions taken to mitigate its spread, could have material and adverse effects on our ability to operate our businesses effectively, including as a result of the complete or partial closure of facilities or labor shortages. Disruptions in our supply chains, our distribution chains and/or public and private infrastructure, including communications, financial services and supply chains, could materially and adversely impact our business operations. We have transitioned a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">significant subset of our colleagues to a remote work environment in an effort to mitigate the spread of COVID-19, as have a significant number of our third-party service providers, which may amplify certain risks to our businesses, including an increased demand for information technology resources, increased risk of phishing and other cyber attacks, increased risk of unauthorized dissemination of sensitive personal information or proprietary or confidential information about us or our medical members or other third-parties and increased risk of business interruptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its vendors have experienced diverse cyber attacks and expect to continue to experience cyber attacks going forward. As examples, the Company and its vendors have experienced attempts to gain access to systems, denial of service attacks, attempted malware infections, account takeovers, scanning activity and phishing emails. Attacks can originate from external criminals, terrorists, nation states or internal actors. The Company is dedicating and will continue to dedicate significant resources and incur significant expenses to maintain and update on an ongoing basis the systems and processes that are designed to mitigate the information security risks it faces and protect the security of its computer systems, software, networks and other technology assets against attempts by unauthorized parties to obtain access to confidential information, disrupt or degrade service or cause other damage. The impact of cyber attacks has not been material to the Company&#8217;s operations or operating results through December&#160;31, 2022. The Board and its Audit Committee and Nominating and Corporate Governance Committee are regularly informed regarding the Company&#8217;s information security policies, practices and status.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_100"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.  Financial Statements and Supplementary Data with Retrospective Adjustments.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="padding-left:3.37pt;padding-right:3.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index to Consolidated Financial Statements</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i36038907935e41eea5e9cf7cac915d44_103">Consolidated Statements of Operations for the years ended December 31, 2022, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i36038907935e41eea5e9cf7cac915d44_103">76</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i36038907935e41eea5e9cf7cac915d44_106">Consolidated Statements of Comprehensive Income for the years ended December 31, 2022, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i36038907935e41eea5e9cf7cac915d44_106">77</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i36038907935e41eea5e9cf7cac915d44_109">Consolidated Balance Sheets as of December 31, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i36038907935e41eea5e9cf7cac915d44_109">78</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i36038907935e41eea5e9cf7cac915d44_112">Consolidated Statements of Cash Flows for the years ended December 31, 2022, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i36038907935e41eea5e9cf7cac915d44_112">79</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i36038907935e41eea5e9cf7cac915d44_115">Consolidated Statements of Shareholders&#8217; Equity for the years ended December 31, 2022, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i36038907935e41eea5e9cf7cac915d44_115">81</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i36038907935e41eea5e9cf7cac915d44_118">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i36038907935e41eea5e9cf7cac915d44_118">82</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i36038907935e41eea5e9cf7cac915d44_178">Reports of Independent Registered Public Accounting Firm</a></span><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(Public Company Accounting Oversight Board ID: 42)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i36038907935e41eea5e9cf7cac915d44_178">160</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_103"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i36038907935e41eea5e9cf7cac915d44_100">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Operations</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.013%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except per share amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c03b0b923c54303a8e4d6db0a6f037f_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMtMS0xLTEtMjY1MjQ3_12bc1ab6-b89a-424b-9b85-40e46c6e6d90">226,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if380faf89f3a40dbaf2259ac9b4e1da0_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMtMy0xLTEtMjY1MjQ3_16f4fb69-1845-4576-9fc3-3a49dcda6824">203,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71272148942c413e8aff1c85d881ca42_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMtNS0xLTEtMjY1MjQ3_ebbe8875-4695-4193-a591-2791affc7909">190,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzQtMS0xLTEtMjY1MjQ3_03a76e9b-208e-464f-86ca-6e4898d745b4">85,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzQtMy0xLTEtMjY1MjQ3_efcbe5b3-0694-4b2d-a619-e30445e8309a">76,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzQtNS0xLTEtMjY1MjQ3_2a98378b-433a-47fd-a361-9a88b9fb9bc3">69,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6714e63c7e1a4403b7da499509c4edf2_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzUtMS0xLTEtMjY1MjQ3_c05a1e16-a019-4ca2-bf6c-bfb9a65f5838">9,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a007ee2153647ad8e132e0f3db03235_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzUtMy0xLTEtMjY1MjQ3_0ff2a693-234d-414a-8542-aea6208134dc">11,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd39a8cee1e445d2965bc047c1ffd8dd_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzUtNS0xLTEtMjY1MjQ3_c4073a2f-536d-48b3-8a21-b416d5b26847">7,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzYtMS0xLTEtMjY1MjQ3_bad83e7d-b960-43bd-a973-649ca29804e9">838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzYtMy0xLTEtMjY1MjQ3_cee63ecd-0af9-4a32-afb0-1203079b2622">1,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzYtNS0xLTEtMjY1MjQ3_e8ff81fd-dfa7-4298-82a0-29045cca3a2b">798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzctMS0xLTEtMjY1MjQ3_ee125622-80c5-4f5b-b2d4-686056773309">322,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzctMy0xLTEtMjY1MjQ3_d18d7843-f0ce-46ce-b6e5-88247b187e19">292,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzctNS0xLTEtMjY1MjQ3_efc13146-cf71-4247-81b1-2731127b7d71">268,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzktMC0xLTEtMjY1MjQ3_12bca5b1-23af-42d6-b88c-b1f9c3ab0adf"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzktMC0xLTEtMjY1MjQ3_37844c1d-74c5-4011-9d73-512e7f125ba5"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzktMC0xLTEtMjY1MjQ3_ce0c18b6-7308-4640-8eef-4206af025a79">Cost of products sold</span></span></span></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzktMS0xLTEtMjY1MjQ3_d35eee6a-c88a-4942-a90d-fc7eb0ebc327">196,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzktMy0xLTEtMjY1MjQ3_b4a526da-9e58-4124-b6cf-35f7f01a872e">175,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzktNS0xLTEtMjY1MjQ3_4f5109eb-59f0-4cea-9ae5-ef5620a7bb17">163,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzEwLTEtMS0xLTI2NTI0Nw_821f1d87-8d20-4ea4-b5a8-315f1a718c8c">71,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzEwLTMtMS0xLTI2NTI0Nw_206963d6-7645-49bb-9209-fb628f4c7351">64,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzEwLTUtMS0xLTI2NTI0Nw_d8c9f3ec-7fcc-43e0-8e1a-a338c868956a">55,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid litigation charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzExLTEtMS0xLTI2NTI0Nw_afe0f887-8934-4c15-bb2d-dae3f1786185">5,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzExLTMtMS0xLTI2NTI0Nw_a3feceda-aa6b-4f78-8e64-ef950e0578a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzExLTUtMS0xLTI2NTI0Nw_db531c43-34f0-4165-a2f7-6bbf8e5cfc31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzEyLTEtMS0xLTI2NTI0Nw_183755dc-d615-405b-a2de-c149bb2dcc61">2,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzEyLTMtMS0xLTI2NTI0Nw_bef59f07-ef87-49ef-bf83-f7478473e0f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzEyLTUtMS0xLTI2NTI0Nw_5f51f150-786a-4c95-9c2f-d5fbee2e19d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzEzLTEtMS0xLTI2NTI0Nw_b25dcfb1-bef7-4083-87c5-0a86492b597e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzEzLTMtMS0xLTI2NTI0Nw_2f32d107-d779-4255-b558-e01aae992c9c">1,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzEzLTUtMS0xLTI2NTI0Nw_69d99d16-ec7b-4808-b790-ced92b1eb04b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE0LTEtMS0xLTI2NTI0Nw_8820923c-b3e4-4c4d-b4cb-db98ae1fc343">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE0LTMtMS0xLTI2NTI0Nw_ce500488-202d-48f6-b4cc-94790f422375">431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE0LTUtMS0xLTI2NTI0Nw_2f04a425-8ccb-4bbd-b122-8124688d91bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE1LTEtMS0xLTI2NTI0Nw_5bd20a2f-d082-419a-87c6-1fd455136c8a">38,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE1LTMtMS0xLTI2NTI0Nw_e3970a92-6280-4912-a84f-b2e9131af402">37,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="cvs:OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE1LTUtMS0xLTI2NTI0Nw_da3c3400-254a-45eb-a3e6-cf011421c4e1">35,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE2LTEtMS0xLTI2NTI0Nw_e8b07901-d5e2-47d1-b2a9-6f16dc6fdb57">314,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE2LTMtMS0xLTI2NTI0Nw_cfcb93ad-fa9a-450a-8c75-1e0a5f4c9fd8">278,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE2LTUtMS0xLTI2NTI0Nw_79632056-f8cf-4f26-8e79-bcc42d7631c1">254,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE3LTEtMS0xLTI2NTI0Nw_fce320d2-b2ab-447e-8939-6930c647c22a">7,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE3LTMtMS0xLTI2NTI0Nw_3f1231f4-a8a2-43ec-934d-77eebbcc6308">13,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE3LTUtMS0xLTI2NTI0Nw_55123b7a-c5bf-4b78-9619-cf1c177a2de1">13,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE4LTEtMS0xLTI2NTI0Nw_489f7a76-0bdf-4b6e-badc-7c774e096761">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE4LTMtMS0xLTI2NTI0Nw_685f3ddd-0176-486e-af42-6e9ce36d8f20">2,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE4LTUtMS0xLTI2NTI0Nw_90b28c09-fba8-431e-abe4-6c03e87120af">2,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE5LTEtMS0xLTI2NTI0Nw_e4b0e310-95f7-4af6-a824-6f69f837fd76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE5LTMtMS0xLTI2NTI0Nw_91d1fe28-e2f1-4141-8fa4-ca335bdf795c">452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE5LTUtMS0xLTI2NTI0Nw_fc7c1a57-60ad-4389-bd31-434e2da6a7e3">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIwLTEtMS0xLTI2NTI0Nw_7e9af490-aeb3-444d-9c20-e954bfeaf5c7">169</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIwLTMtMS0xLTI2NTI0Nw_94d28fc8-1710-479b-ad18-832adb335eb9">182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIwLTUtMS0xLTI2NTI0Nw_ed35cba5-bf06-4cf4-a28e-f1f95938f4b9">206</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIxLTEtMS0xLTI2NTI0Nw_f8bc440a-bcf5-4d51-abf7-954ab910bab4">5,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIxLTMtMS0xLTI2NTI0Nw_e4f45d5d-cacc-458a-8979-136745a4367a">10,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIxLTUtMS0xLTI2NTI0Nw_6e5cca89-f772-48d1-993d-dc59f2b5407b">9,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIyLTEtMS0xLTI2NTI0Nw_e10f6d7d-d7dd-4093-9780-7e1562c1fa34">1,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIyLTMtMS0xLTI2NTI0Nw_33477a3e-526a-4f5b-9e76-cd6f866510eb">2,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIyLTUtMS0xLTI2NTI0Nw_96b2c984-953a-445e-bab5-b57d2114155e">2,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIzLTEtMS0xLTI2NTI0Nw_084cce72-b6ad-4ba2-a7ab-1d1ef2a5d92b">4,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIzLTMtMS0xLTI2NTI0Nw_4f5ed495-9df5-4082-8b65-2634354f12b7">7,989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIzLTUtMS0xLTI2NTI0Nw_5af6bb7b-102d-4e3c-b935-5b7d300bdd40">7,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI0LTEtMS0xLTI2NTI0Nw_54aed051-7847-48af-a936-8297f73f6b26">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI0LTMtMS0xLTI2NTI0Nw_d3a42155-7ce3-47d0-8dac-38258ced872e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI0LTUtMS0xLTI2NTI0Nw_9b1bbb2b-8848-4f3d-b45c-bef4398c8c0b">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI1LTEtMS0xLTI2NTI0Nw_e8bd4930-c640-49b5-bbb1-eb1e49e2f59f">4,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI1LTMtMS0xLTI2NTI0Nw_b6b49b46-69ab-4bd8-bf5a-1e258408a55a">7,989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI1LTUtMS0xLTI2NTI0Nw_ab0da9b8-9ba6-4f5a-a595-b97615c93da3">7,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI2LTEtMS0xLTI2NTI0Nw_1ae69753-b9c0-4129-9272-8ea2b2d9b679">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI2LTMtMS0xLTI2NTI0Nw_94d4536d-4218-4d3f-9a88-155a2a439ad6">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI2LTUtMS0xLTI2NTI0Nw_ff640993-e49d-42fb-a12d-e1d9b94cf1a1">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI3LTEtMS0xLTI2NTI0Nw_adfd647c-5cc9-46c6-b369-f09204e82135">4,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI3LTMtMS0xLTI2NTI0Nw_3611468d-0bb7-4b18-ab8f-87e6dcb31acc">8,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI3LTUtMS0xLTI2NTI0Nw_887875d3-942c-4302-a6f2-718fbbbb5caf">7,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to CVS Health</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMwLTEtMS0xLTI2NTI0Nw_17352da6-8dc3-4041-a55d-f6cafb0121f0">3.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMwLTMtMS0xLTI2NTI0Nw_4cf1a58c-40ee-4fca-9b61-2ea61f9a6d4a">6.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMwLTUtMS0xLTI2NTI0Nw_c4e86d90-c873-4bee-84c8-b7f0b09deeaa">5.49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations attributable to CVS Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMxLTEtMS0xLTI2NTI0Nw_3df8b543-45eb-4d87-b699-af8c48f6e647">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMxLTMtMS0xLTI2NTI0Nw_dd945086-8be3-427d-a382-477548192e4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMxLTUtMS0xLTI2NTI0Nw_69aaa579-d5a5-4304-be3f-3f31615ec72d">0.01</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMyLTEtMS0xLTI2NTI0Nw_c11751f9-177d-4d2e-b1e6-bc79b1d8b581">3.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMyLTMtMS0xLTI2NTI0Nw_d7607d44-cbf5-4789-8733-1e8342565306">6.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMyLTUtMS0xLTI2NTI0Nw_06bf1047-025c-4de3-8c2d-1ea25db93746">5.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average basic shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMzLTEtMS0xLTI2NTI0Nw_450b527a-f5ed-47f0-ad58-658222a5332e">1,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMzLTMtMS0xLTI2NTI0Nw_410cb901-a276-4540-a05f-adaca966e7e2">1,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMzLTUtMS0xLTI2NTI0Nw_adbe30b1-2815-4882-b25e-662916e1ac03">1,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to CVS Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM1LTEtMS0xLTI2NTI0Nw_0ca71b3a-065a-4e4b-a425-715742ca2db1">3.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM1LTMtMS0xLTI2NTI0Nw_487af642-d496-4258-bb02-d74f470e7956">6.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM1LTUtMS0xLTI2NTI0Nw_05aa4ad9-acad-4e1e-afad-ab5d45e04233">5.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations attributable to CVS Health</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM2LTEtMS0xLTI2NTI0Nw_234323cc-3526-44a0-b64f-414782bf15b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM2LTMtMS0xLTI2NTI0Nw_b241d411-d900-4c45-acb0-200ba9d8cd4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM2LTUtMS0xLTI2NTI0Nw_e1dd927e-68e0-4246-b8e8-8344f540005a">0.01</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM3LTEtMS0xLTI2NTI0Nw_8f12c643-d2fc-4ecc-bae0-d6488609682b">3.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM3LTMtMS0xLTI2NTI0Nw_5aa39a51-e1ee-455b-a9d3-2bafb0b198e1">6.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM3LTUtMS0xLTI2NTI0Nw_8fb51547-64e6-4479-bb57-02dc5ec2afc7">5.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average diluted shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM4LTEtMS0xLTI2NTI0Nw_395a1153-9e73-4037-aeaf-dd666d379c16">1,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM4LTMtMS0xLTI2NTI0Nw_695da984-98fb-40be-b2e7-0d2ade8c92bf">1,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM4LTUtMS0xLTI2NTI0Nw_494a15a6-6368-45e7-85a4-57544ca0d5cd">1,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM5LTEtMS0xLTI2NTI0Nw_85c67b8d-9954-40ae-9afc-c663cbf030d3">2.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM5LTMtMS0xLTI2NTI0Nw_5e4725b2-4565-462e-981c-56ddec51e534">2.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM5LTUtMS0xLTI2NTI0Nw_5577f4fb-5a69-46d1-a86f-da73eb9f035f">2.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_106"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i36038907935e41eea5e9cf7cac915d44_100">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Income</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.013%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzItMS0xLTEtMjY1MjQ3_e8bd4930-c640-49b5-bbb1-eb1e49e2f59f">4,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzItMy0xLTEtMjY1MjQ3_b6b49b46-69ab-4bd8-bf5a-1e258408a55a">7,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzItNS0xLTEtMjY1MjQ3_ab0da9b8-9ba6-4f5a-a595-b97615c93da3">7,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized investment gains (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzQtMS0xLTEtMjY1MjQ3_b266c4fc-0cb0-4d10-8b71-c794a9da41a2">2,317</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzQtMy0xLTEtMjY1MjQ3_dc0dba75-fb09-4a74-b1a8-85c0a76f147a">556</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzQtNS0xLTEtMjY1MjQ3_129b514b-27a8-498b-b795-145e125be4a8">440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in discount rate on insurance reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzUtMS0xLTEtMjkyNzQx_662ec375-915d-4a3a-ad89-2be0b841c47b">870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzUtMy0xLTEtMjkyNzQx_80df4363-18cd-48ad-9f1f-a8d5544fbcc9">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzUtNS0xLTEtMjkyNzQx_16682873-134c-41fb-9412-ceacb2df3a04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzUtMS0xLTEtMjY1MjQ3_cd022d6e-d03e-42e4-8bf9-9bf77b5d7669">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzUtMy0xLTEtMjY1MjQ3_32406583-7e0b-422c-a471-68e254332c53">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzUtNS0xLTEtMjY1MjQ3_4e22f1b1-85d3-42d4-9a63-a479254b8018">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzYtMS0xLTEtMjY1MjQ3_91ed9ec9-3453-4b8e-be27-bbbb0a6a83e9">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzYtMy0xLTEtMjY1MjQ3_3134e664-e980-481c-b7a5-795fe46c332d">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzYtNS0xLTEtMjY1MjQ3_1f713300-333e-4ca7-8d99-0b5deebdade8">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other postretirement benefits </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzctMS0xLTEtMjY1MjQ3_e91acff6-5f85-4346-87cf-780ac8325924">168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzctMy0xLTEtMjY1MjQ3_31eaada4-b746-4c59-8258-4c466317f7ae">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzctNS0xLTEtMjY1MjQ3_1154f6fc-f87c-4194-8cbd-61b78abc1a23">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzgtMS0xLTEtMjY1MjQ3_62615017-20b8-477a-a5f6-f1be1a9cdfd0">1,598</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzgtMy0xLTEtMjY1MjQ3_08a4bb3c-d248-4268-a182-3a3d9b8cebd6">314</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzgtNS0xLTEtMjY1MjQ3_75934af2-c65c-4634-a557-bf829d2729ba">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzktMS0xLTEtMjY1MjQ3_8c3c6afc-2e1f-4bcf-b633-cdee365fdcb8">2,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzktMy0xLTEtMjY1MjQ3_e0365b35-300c-46dd-aa29-e768c0b736ae">7,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzktNS0xLTEtMjY1MjQ3_24be11be-7b99-48e2-9419-6239034b97ef">7,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzEwLTEtMS0xLTI2NTI0Nw_88f8091a-5628-4462-ba27-4695ff4f07c1">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzEwLTMtMS0xLTI2NTI0Nw_b4436f6d-7f15-46f4-adf1-1359a818fb12">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzEwLTUtMS0xLTI2NTI0Nw_bd3724aa-1da6-499e-a883-4877f33f8549">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to CVS Health</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzExLTEtMS0xLTI2NTI0Nw_ad8101b6-b9c1-44a2-b104-0f765fddc45c">2,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzExLTMtMS0xLTI2NTI0Nw_0f3f438b-1e87-4526-9710-4f196784981c">7,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzExLTUtMS0xLTI2NTI0Nw_8f7a7eac-5fab-4485-92b9-9e474c956efa">7,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_109"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i36038907935e41eea5e9cf7cac915d44_100">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except per share amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzMtMS0xLTEtMjY1MjQ3_6ed8545a-dde8-47b9-ae4f-83bdef3279fc">12,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzMtMy0xLTEtMjY1MjQ3_c9677f92-9403-4dc1-bf03-6f114341a8a3">9,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQtMS0xLTEtMjY1MjQ3_a73813dd-1d70-497f-aeef-86cd61cd17b3">2,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQtMy0xLTEtMjY1MjQ3_d4377fe5-032a-4d8e-b5dd-2fa5d57f3b97">3,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzUtMS0xLTEtMjY1MjQ3_86e0196a-53e2-453f-9aae-549fe308ff3a">27,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzUtMy0xLTEtMjY1MjQ3_eb3299fb-26b2-4ea3-9443-21e1acc46d8b">24,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzYtMS0xLTEtMjY1MjQ3_77a10297-f7ab-4aa9-8748-92d7261e3dfd">19,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzYtMy0xLTEtMjY1MjQ3_5ce32e2f-6ca7-4a88-ac45-af0fca1227f7">17,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzctMS0xLTEtMjY1MjQ3_a40aad6c-2ce7-49c8-ba35-5253d623d147">908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzctMy0xLTEtMjY1MjQ3_381b32f8-cf94-424d-b3ec-83cd17f87949">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzgtMS0xLTEtMjY1MjQ3_7252e935-6468-4ecf-9ee9-57b4fdf1561b">2,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzgtMy0xLTEtMjY1MjQ3_31b2ef04-9356-4ce1-80f3-32838ffb7b15">5,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzktMS0xLTEtMjY1MjQ3_eb18d776-69c8-4a1c-9d7f-31f32bdf5aa0">65,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzktMy0xLTEtMjY1MjQ3_51c0632b-9b56-446b-b61a-98a419bda0ca">60,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzEwLTEtMS0xLTI2NTI0Nw_4bae7218-2b9d-4d1a-9883-ece8f3276744">21,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzEwLTMtMS0xLTI2NTI0Nw_a38ca52b-b0f2-4a01-8a5c-1b6bd0753c79">23,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzExLTEtMS0xLTI2NTI0Nw_723c0ecf-2a6e-43a4-b531-8a3a9bf44a25">12,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzExLTMtMS0xLTI2NTI0Nw_2176f16a-851b-42dc-a0dd-b8c932ac6f5f">12,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzEyLTEtMS0xLTI2NTI0Nw_4d1381a6-ece0-46d5-b2b9-7abf0d9c6096">17,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzEyLTMtMS0xLTI2NTI0Nw_e25a9a2a-0f2a-4dbe-a726-8755a2478f27">19,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzEzLTEtMS0xLTI2NTI0Nw_0388c4a6-541e-4881-ab19-3251dd646447">78,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzEzLTMtMS0xLTI2NTI0Nw_8854778d-111f-47d2-80df-5f3138a58a90">79,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzE0LTEtMS0xLTI2NTI0Nw_7efc87a4-0863-43a5-a363-aa530b3923ce">24,803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzE0LTMtMS0xLTI2NTI0Nw_f965d326-5fce-4d2d-8815-d3932155a888">29,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate accounts assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzE1LTEtMS0xLTI2NTI0Nw_57dba294-450d-4742-9f54-d812d6c8a4ab">3,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzE1LTMtMS0xLTI2NTI0Nw_8c35f2e6-d233-4289-8701-9625936d79fe">5,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzE2LTEtMS0xLTI2NTI0Nw_cbe72ac6-f945-4a65-ac29-5677527496f9">4,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzE2LTMtMS0xLTI2NTI0Nw_f9d37ac9-6ce4-42b6-bf26-3e715b461d27">4,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzE3LTEtMS0xLTI2NTI0Nw_b47ba14f-d7b9-4978-8fcf-2405928e4220">228,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzE3LTMtMS0xLTI2NTI0Nw_b675832b-fafb-4570-9eb4-66b312220a92">233,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzIwLTEtMS0xLTI2NTI0Nw_0b409587-76c9-46c1-ba13-16fad3bee6a6">14,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzIwLTMtMS0xLTI2NTI0Nw_f246ce2f-b508-46a4-8060-c5989def7c80">12,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy claims and discounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:PharmacyClaimsAndDiscountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzIxLTEtMS0xLTI2NTI0Nw_f9d49257-13df-4698-9066-f9b0608dfe77">19,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:PharmacyClaimsAndDiscountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzIxLTMtMS0xLTI2NTI0Nw_dc195acd-37b8-4fe1-bcd1-8ac73a899240">17,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzIyLTEtMS0xLTI2NTI0Nw_120f9273-b6c0-4817-be6c-0993fe8ed2e1">10,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzIyLTMtMS0xLTI2NTI0Nw_906e914a-445c-42e2-b83f-7366d4eb3c97">8,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:OtherPolicyholderFunds" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzIzLTEtMS0xLTI2NTI0Nw_48fd999f-9ded-4135-88cf-a8a2724d5d4f">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:OtherPolicyholderFunds" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzIzLTMtMS0xLTI2NTI0Nw_b9997f85-4d9f-4dd3-a118-d62daa95c966">4,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzI0LTEtMS0xLTI2NTI0Nw_87af4900-9f7e-4be2-bdf7-97bcf7101a96">18,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzI0LTMtMS0xLTI2NTI0Nw_44bbb754-8eac-4cad-8df7-c705b29b946d">17,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other insurance liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzI1LTEtMS0xLTI2NTI0Nw_6a50d5b8-2ce0-4fbe-8447-f0dfebae2289">1,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzI1LTMtMS0xLTI2NTI0Nw_f268f0f6-b3cc-47bc-bf73-35ade3c94a34">1,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzI2LTEtMS0xLTI2NTI0Nw_c6416aaf-6e26-47b0-941b-bb78a0b78606">1,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzI2LTMtMS0xLTI2NTI0Nw_bcd6f059-bda9-4787-b1b8-9d33992105ee">1,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzI4LTEtMS0xLTI2NTI0Nw_74b8f36f-afbb-4fcf-a886-87ba9f3c60a4">1,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzI4LTMtMS0xLTI2NTI0Nw_d0124e25-7f26-44d6-922d-d48b881383f1">4,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzI5LTEtMS0xLTI2NTI0Nw_abc97e6a-f0b1-4b9b-83c5-a231422612aa">228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzI5LTMtMS0xLTI2NTI0Nw_a38db8af-11d7-4507-b08d-7c25d70fc7e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzMwLTEtMS0xLTI2NTI0Nw_fc4d5e1a-f646-4c60-a2b1-223be77bc113">69,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzMwLTMtMS0xLTI2NTI0Nw_a247acad-661b-4272-92c1-29a6b47303d0">67,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzMxLTEtMS0xLTI2NTI0Nw_4be25cdd-0e3a-46f5-a475-c47e47d6445c">16,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzMxLTMtMS0xLTI2NTI0Nw_fca330f6-a23d-4cc3-877e-e2df273ef6d7">18,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzMyLTEtMS0xLTI2NTI0Nw_acf69e67-f0f8-4276-b734-756402eda518">50,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzMyLTMtMS0xLTI2NTI0Nw_f362ea5a-c78f-4810-9018-6b6294356173">51,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzMzLTEtMS0xLTI2NTI0Nw_07140ed9-38fc-4eb8-a913-fd2f10f1a9ae">4,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzMzLTMtMS0xLTI2NTI0Nw_e676ed06-9879-4d57-83b7-118231753f93">6,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate accounts liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:SeparateAccountsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzM0LTEtMS0xLTI2NTI0Nw_03dedd39-737e-4ad8-82b5-02cc4c240a3d">3,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:SeparateAccountsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzM0LTMtMS0xLTI2NTI0Nw_74a41ac7-eb49-4b0a-b9a4-cc667def8d7e">5,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term insurance liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzM1LTEtMS0xLTI2NTI0Nw_589f3ef3-3cc3-463b-8050-c0e01d010dc4">5,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzM1LTMtMS0xLTI2NTI0Nw_9cc232bc-7127-4166-989f-5816a6dbd001">7,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzM2LTEtMS0xLTI2NTI0Nw_679a3fa3-cff6-40e7-baab-4d74b956f2a8">6,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzM2LTMtMS0xLTI2NTI0Nw_277830bb-63e1-4e84-a805-05a5e5a91462">1,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzM3LTEtMS0xLTI2NTI0Nw_772579f2-c030-4376-9d6a-631eea7acd55">156,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzM3LTMtMS0xLTI2NTI0Nw_3de87f1c-d325-4996-a0ea-8cc4017459e3">158,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 17)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzM4LTEtMS0xLTI2NTI0Nw_07f2908e-55b9-4d0f-87fe-12dca8f14442"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzM4LTMtMS0xLTI2NTI0Nw_e34951d3-2e09-4f51-994e-f9a6e9d25f4d"></ix:nonFraction></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjczN2E4ODAxNGUzMDQ5NjI5NGMzM2M2ZmJjYjY2Mjg4XzMx_89b2b135-7a92-40b2-a5a7-0804bda41d15"><ix:nonFraction unitRef="usdPerShare" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjczN2E4ODAxNGUzMDQ5NjI5NGMzM2M2ZmJjYjY2Mjg4XzMx_b3dfdc83-34a2-49b8-b098-ebb951e4b8e9">0.01</ix:nonFraction></ix:nonFraction>: <ix:nonFraction unitRef="shares" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjczN2E4ODAxNGUzMDQ5NjI5NGMzM2M2ZmJjYjY2Mjg4XzM1_a8c719ef-2c3d-4fca-92c7-f8da982b44a4"><ix:nonFraction unitRef="shares" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjczN2E4ODAxNGUzMDQ5NjI5NGMzM2M2ZmJjYjY2Mjg4XzM1_d9b31d07-a70d-4ac4-bd75-94bcb3f283ae">0.1</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjczN2E4ODAxNGUzMDQ5NjI5NGMzM2M2ZmJjYjY2Mjg4XzU3_0c651494-8732-4fe0-bce3-7d928fb3429d"><ix:nonFraction unitRef="shares" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjczN2E4ODAxNGUzMDQ5NjI5NGMzM2M2ZmJjYjY2Mjg4XzU3_8341babc-467e-4dd7-a622-037a7030e942"><ix:nonFraction unitRef="shares" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjczN2E4ODAxNGUzMDQ5NjI5NGMzM2M2ZmJjYjY2Mjg4XzU3_b13ea4bb-f168-48bb-bffc-59e628e89c49"><ix:nonFraction unitRef="shares" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjczN2E4ODAxNGUzMDQ5NjI5NGMzM2M2ZmJjYjY2Mjg4XzU3_f8f679eb-4058-48d0-ad1f-644717821a01">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued or outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQxLTEtMS0xLTI2NTI0Nw_21494801-ed51-42b8-81b7-b5978ee5d8f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQxLTMtMS0xLTI2NTI0Nw_a5b5dcd2-e454-4043-a47d-0b38c5577fba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjY1ZTVmZTgzNGQzZjQ5ZDliZTIzYzJlMTI4OTE4OWNiXzI4_21011cd8-cfe0-444b-8119-a482f4e63bc7"><ix:nonFraction unitRef="usdPerShare" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjY1ZTVmZTgzNGQzZjQ5ZDliZTIzYzJlMTI4OTE4OWNiXzI4_2db017b5-6c85-48c2-8784-764b5cbd513f">0.01</ix:nonFraction></ix:nonFraction>: <ix:nonFraction unitRef="shares" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjY1ZTVmZTgzNGQzZjQ5ZDliZTIzYzJlMTI4OTE4OWNiXzMy_38504e8e-e542-4045-921c-99cfb313bc3e"><ix:nonFraction unitRef="shares" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjY1ZTVmZTgzNGQzZjQ5ZDliZTIzYzJlMTI4OTE4OWNiXzMy_9d4f2ec5-609a-4310-95ef-e7dd633a3cf1">3,200</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjY1ZTVmZTgzNGQzZjQ5ZDliZTIzYzJlMTI4OTE4OWNiXzU0_84788d03-66f0-49c4-b5fd-8e19e757309c">1,758</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjY1ZTVmZTgzNGQzZjQ5ZDliZTIzYzJlMTI4OTE4OWNiXzc1_d04548d6-ef96-4074-9aac-fea44aa3fafb">1,300</ix:nonFraction> shares outstanding at December&#160;31, 2022 and <ix:nonFraction unitRef="shares" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjY1ZTVmZTgzNGQzZjQ5ZDliZTIzYzJlMTI4OTE4OWNiXzEwNw_c42db7ad-f95b-437a-a90f-1cf686a3cb90">1,744</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjY1ZTVmZTgzNGQzZjQ5ZDliZTIzYzJlMTI4OTE4OWNiXzEyOA_0e0b1815-c3be-4116-a9d1-3543365bf400">1,322</ix:nonFraction> shares outstanding at December&#160;31, 2021 and capital surplus</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:CommonStocksIncludingAdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQyLTEtMS0xLTI2NTI0Nw_984d3819-9133-4b88-923c-34909e232626">48,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:CommonStocksIncludingAdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQyLTMtMS0xLTI2NTI0Nw_42f750a7-c0a6-4fed-bb6f-7cf9d95e19d6">47,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost: <ix:nonFraction unitRef="shares" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQzLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmU4NGI4YWZiMTIxZjQ5NmI5MDhkM2NlZDljYmEwYWM5XzI5_8144cf16-daef-422c-b21a-4c3cb62b4233">458</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQzLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmU4NGI4YWZiMTIxZjQ5NmI5MDhkM2NlZDljYmEwYWM5XzM2_4bbc062c-6490-441a-905b-b28fc5236671">422</ix:nonFraction> shares at December&#160;31, 2022 and 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQzLTEtMS0xLTI2NTI0Nw_9203fa12-04dc-4ee0-94d0-50ce71e2c0e1">31,858</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQzLTMtMS0xLTI2NTI0Nw_78cf7db5-c3ad-4eb7-87a3-8aa66eba380b">28,173</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ0LTEtMS0xLTI2NTI0Nw_7ea84200-e007-453b-bcfe-62de6aa3b4b8">56,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ0LTMtMS0xLTI2NTI0Nw_fd904f06-df79-4100-8814-3adde9d3a000">54,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ1LTEtMS0xLTI2NTI0Nw_15cc7900-ebba-4dd7-9274-05f77719938a">1,264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ1LTMtMS0xLTI2NTI0Nw_afee27ff-20c2-47ce-bcfa-dfa19eb43063">334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total CVS Health shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ2LTEtMS0xLTI2NTI0Nw_0c1a912b-8e13-48a9-9c55-ea5b8a6b5329">71,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ2LTMtMS0xLTI2NTI0Nw_a6401d29-7ef8-40b9-bfa0-390d6ddcf92b">74,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ3LTEtMS0xLTI2NTI0Nw_b30dc2c8-dd1f-4248-a047-41f521acbd2d">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ3LTMtMS0xLTI2NTI0Nw_c8d84b3a-8a82-42dc-bf67-c9e7830fb565">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ4LTEtMS0xLTI2NTI0Nw_8b1650f6-bee6-4b58-bcbe-af8610fe81c8">71,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ4LTMtMS0xLTI2NTI0Nw_82ba4b24-1f35-4ff4-8667-37522b17659d">74,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ5LTEtMS0xLTI2NTI0Nw_38f66313-f70c-4ef0-a23d-416c3bda97ee">228,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ5LTMtMS0xLTI2NTI0Nw_e04e20eb-f77e-404b-9bb2-64ea325d0e71">233,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_112"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i36038907935e41eea5e9cf7cac915d44_100">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.013%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts from customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromCustomers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMtMS0xLTEtMjY1MjQ3_ace1ccd5-24d0-417e-a42f-620af15994f9">313,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromCustomers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMtMy0xLTEtMjY1MjQ3_533f1a14-2e06-4f2b-922d-35db00883e35">284,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromCustomers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMtNS0xLTEtMjY1MjQ3_992f2277-3f3e-46e1-b30c-c76cdfa9292d">264,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for inventory and prescriptions dispensed by retail network pharmacies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzQtMS0xLTEtMjY1MjQ3_e2c39a42-7c03-4a95-9ae1-de154c371598">189,766</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzQtMy0xLTEtMjY1MjQ3_499444db-e0b5-41e3-a48c-e8c1205b5894">165,783</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="cvs:PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzQtNS0xLTEtMjY1MjQ3_a30eccc8-af12-4586-9b04-10d693552604">158,636</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance benefits paid </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:PaymentsForInsuranceBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzUtMS0xLTEtMjY1MjQ3_adf41654-7d17-4a53-ba3f-fa0b1f5fbb47">69,728</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:PaymentsForInsuranceBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzUtMy0xLTEtMjY1MjQ3_761729f9-5a73-41f9-9f80-1f4c7ac1e8f6">63,598</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="cvs:PaymentsForInsuranceBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzUtNS0xLTEtMjY1MjQ3_c7b56dbf-8df8-4461-9316-8da1f1ec597d">55,124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid to other suppliers and employees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToSuppliersAndEmployees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzYtMS0xLTEtMjY1MjQ3_8ccf5597-f881-4b6e-ba37-49b4b8c718a3">32,662</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToSuppliersAndEmployees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzYtMy0xLTEtMjY1MjQ3_6f6f5f02-bcc7-483c-8689-72ed69f01122">31,652</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToSuppliersAndEmployees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzYtNS0xLTEtMjY1MjQ3_600b3916-edfd-492b-9ada-3c5eac15a2ab">29,763</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and investment income received</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromInterestAndDividendsReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzctMS0xLTEtMjY1MjQ3_1b058eaa-4c7d-491a-bcc6-0ef2870c5fa6">1,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromInterestAndDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzctMy0xLTEtMjY1MjQ3_bb235e50-7e40-4907-a1e9-82ba7ee82210">743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromInterestAndDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzctNS0xLTEtMjY1MjQ3_68c94cd9-52f9-4ae2-a1d4-4101d72f152f">894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzgtMS0xLTEtMjY1MjQ3_0aaf845a-7751-4f63-b977-46da4d563934">2,239</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzgtMy0xLTEtMjY1MjQ3_b8a43a96-3543-4cee-93d5-bc1eb1c27183">2,469</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzgtNS0xLTEtMjY1MjQ3_69bb219c-af99-40cc-86e3-cb7b1238bfa8">2,904</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzktMS0xLTEtMjY1MjQ3_d1a3c1f3-0c74-46f1-9b3d-f1b665a7efdc">4,116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzktMy0xLTEtMjY1MjQ3_65c46825-0fdc-4c14-8ef0-0de6d43abd91">3,195</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzktNS0xLTEtMjY1MjQ3_ecdf1cb2-b8a3-4990-a61b-a28355e6032c">2,929</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzEwLTEtMS0xLTI2NTI0Nw_9c8ea39c-61c0-4b65-bfd2-50b9e5db558e">16,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzEwLTMtMS0xLTI2NTI0Nw_d78f0f39-63d7-40b9-9ea4-3836b032f644">18,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzEwLTUtMS0xLTI2NTI0Nw_4169b344-6583-464e-ad34-5572282771a6">15,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales and maturities of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzEzLTEtMS0xLTI2NTI0Nw_d2b4ac95-5a55-48d7-8799-f2a4743a9e30">6,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzEzLTMtMS0xLTI2NTI0Nw_426a267f-ac3f-42f7-8cd7-6304d61ef448">7,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzEzLTUtMS0xLTI2NTI0Nw_06ce4456-528c-48a3-a9af-a90117990428">6,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE0LTEtMS0xLTI2NTI0Nw_c9eca8cc-a165-44b4-a96e-02870aec536f">7,746</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE0LTMtMS0xLTI2NTI0Nw_d31ddb67-5505-436a-b51f-547ed7ff96ca">9,963</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE0LTUtMS0xLTI2NTI0Nw_73918341-40d7-4bee-888d-27ff89e586f4">9,639</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE1LTEtMS0xLTI2NTI0Nw_cf851e89-697b-4466-abf6-78afbcccf33a">2,727</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE1LTMtMS0xLTI2NTI0Nw_73a016cc-d551-430b-b911-7dded14a54af">2,520</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE1LTUtMS0xLTI2NTI0Nw_43e50e6e-e018-44b1-b816-9763a357b59d">2,437</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale-leaseback transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE2LTEtMS0xLTI2NTI0Nw_6b051039-252c-4eaf-b10e-70bfc98a3598">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE2LTMtMS0xLTI2NTI0Nw_84bc16b4-d06c-4791-a4cb-44ae314a0950">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE2LTUtMS0xLTI2NTI0Nw_6cfda4b3-34b1-4c3d-8d34-517eff5fb2ed">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (net of cash acquired)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE3LTEtMS0xLTI2NTI0Nw_4b272c3b-4b17-41e1-ad5a-890a709bcae4">139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE3LTMtMS0xLTI2NTI0Nw_f5a7dcf4-2578-4933-8d16-30a0cf005c85">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE3LTUtMS0xLTI2NTI0Nw_dd2159ef-bafc-48fe-b2f6-d6b2181b5edd">866</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of subsidiaries (net of cash and restricted cash sold of $<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:CashDivestedFromDeconsolidation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE4LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjYxNjcwYTYzOTM5YTQ4ZGViYmYwYTYzNzYxZGY0ZWU1Xzgw_822f70d9-8db5-4ee4-a6e9-3fca56ff096f">2,854</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:CashDivestedFromDeconsolidation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE4LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjYxNjcwYTYzOTM5YTQ4ZGViYmYwYTYzNzYxZGY0ZWU1Xzg0_306b50a0-6098-4f24-bbdf-4873e8546c6b">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:CashDivestedFromDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE4LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjYxNjcwYTYzOTM5YTQ4ZGViYmYwYTYzNzYxZGY0ZWU1Xzkx_e22346e8-1681-48e6-9618-8b70da1fba6d">9</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE4LTEtMS0xLTI2NTI0Nw_03dbfc2f-bd6e-4446-8496-a4d8baff30fa">1,249</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE4LTMtMS0xLTI2NTI0Nw_14e832a4-2a77-4573-a187-465e0e67ca0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE4LTUtMS0xLTI2NTI0Nw_dcec0ff2-6b2f-454f-aeb5-c010a2422468">840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE5LTEtMS0xLTI2NTI0Nw_824a6186-40db-49d9-aa71-c5af4e1125e9">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE5LTMtMS0xLTI2NTI0Nw_41569da4-c85c-41ba-8c29-549d5d4be9aa">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE5LTUtMS0xLTI2NTI0Nw_e7c680f4-c9c6-4f26-89b9-b737a8559308">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzIwLTEtMS0xLTI2NTI0Nw_d43b38d8-fef3-4c60-a5f3-7cc522bcf8e1">5,047</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzIwLTMtMS0xLTI2NTI0Nw_76a955cf-1edf-444f-ba8b-baf439e87180">5,261</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzIwLTUtMS0xLTI2NTI0Nw_515853f2-ba45-4301-a722-1f2f57beda38">5,534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI0LTEtMS0xLTI2NTI0Nw_92f53c54-d185-4b15-9798-7d8e682f8029">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI0LTMtMS0xLTI2NTI0Nw_358d3cba-2718-4fbe-ab21-43d8a0bdd410">987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI0LTUtMS0xLTI2NTI0Nw_3234c46d-7f71-43b3-ade9-9c1efd26494e">9,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI1LTEtMS0xLTI2NTI0Nw_e7671ff8-b046-4d09-a988-a7b41452be63">4,211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI1LTMtMS0xLTI2NTI0Nw_cf249949-c179-4bdb-bbee-7fb94703d1ea">10,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI1LTUtMS0xLTI2NTI0Nw_bbc6bc54-668f-4c62-8e9a-1ea3ef29f5a0">15,631</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsForDerivativeInstrumentFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI2LTEtMS0xLTI2NTI0Nw_1b015550-b152-40e7-ae1c-fe42039b7535">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForDerivativeInstrumentFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI2LTMtMS0xLTI2NTI0Nw_1f20100d-02c8-41e0-bd89-430d3e1b4a42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForDerivativeInstrumentFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI2LTUtMS0xLTI2NTI0Nw_73ccda91-365f-4cc7-a845-8dfa6e662cea">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI3LTEtMS0xLTI2NTI0Nw_19d31bcd-7d7d-4499-8d0c-0beb09f25da7">3,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI3LTMtMS0xLTI2NTI0Nw_e4232866-2ad0-416e-a3fb-a01dbe8fad93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI3LTUtMS0xLTI2NTI0Nw_3c604836-ab12-423b-96e6-e06a3acd0417">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI4LTEtMS0xLTI2NTI0Nw_b62e59fb-e0cd-49ba-b09c-446f5a5d8c6e">2,907</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI4LTMtMS0xLTI2NTI0Nw_2940c2f2-630b-4768-9988-dd3eed329abe">2,625</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI4LTUtMS0xLTI2NTI0Nw_3ea4572e-be98-43fd-a214-9abef79bf88c">2,624</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI5LTEtMS0xLTI2NTI0Nw_e55f0b07-7093-47bd-8ad9-3bd56f1d4e78">551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI5LTMtMS0xLTI2NTI0Nw_9fe53d64-1d9d-4beb-b909-c0642fdb4f99">549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI5LTUtMS0xLTI2NTI0Nw_e970da8c-424a-4aab-bc47-bffcd3a9318c">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for taxes related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMwLTEtMS0xLTI2NTI0Nw_b7147225-8b7c-407b-be74-8fd522df531f">370</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMwLTMtMS0xLTI2NTI0Nw_5ca6c2e9-3354-42ce-9ce3-ebe5ef87372a">168</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMwLTUtMS0xLTI2NTI0Nw_04536ccd-9097-41ff-9354-465bf0b20b45">88</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMxLTEtMS0xLTI2NTI0Nw_fd486bd9-2d40-46c8-998b-79dd28d52c52">79</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMxLTMtMS0xLTI2NTI0Nw_9a75544f-8b6f-4dee-813f-e6241c765881">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMxLTUtMS0xLTI2NTI0Nw_21d3af00-d4e8-4842-bdc8-53109380c05a">432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMyLTEtMS0xLTI2NTI0Nw_a3eefb2e-e175-4486-a187-639f2284d6a2">10,516</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMyLTMtMS0xLTI2NTI0Nw_d4db6ae3-28f8-491b-a879-f4291b341fae">11,356</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMyLTUtMS0xLTI2NTI0Nw_03beedbe-0eb7-45d8-9db7-c19662f3e081">7,696</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzM0LTEtMS0xLTI2NTI0Nw_405a2418-50c0-4f0e-9fd2-567410857ec8">614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzM0LTMtMS0xLTI2NTI0Nw_64a9f4c2-9b24-4d40-bb96-358301e7c59c">1,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzM0LTUtMS0xLTI2NTI0Nw_9afea546-d437-4b0a-ae79-2eb62d85362d">2,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at the beginning of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzM1LTEtMS0xLTI2NTI0Nw_b7492f00-aef6-4c4b-a161-9f04b2d3c104">12,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501f291fb23d49e987222cf13c851afc_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzM1LTMtMS0xLTI2NTI0Nw_23c85bf7-ccb0-4b43-9c5a-b80c5cc5ad87">11,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68e253af6bf3467aade09b572c1b73a6_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzM1LTUtMS0xLTI2NTI0Nw_607d6a54-8b94-48a5-99f4-e0a6bb0b2edc">8,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzM2LTEtMS0xLTI2NTI0Nw_6e887bb0-ae6b-4a12-99d2-72b5d3b0a3c4">13,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzM2LTMtMS0xLTI2NTI0Nw_e5abcfc8-d9b4-4c59-b8c5-bc2dce65a220">12,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501f291fb23d49e987222cf13c851afc_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzM2LTUtMS0xLTI2NTI0Nw_e4736a62-a6c4-4784-adcf-828e2b404326">11,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i36038907935e41eea5e9cf7cac915d44_100">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation of net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzMtMS0xLTEtMjY1MjQ3_e8bd4930-c640-49b5-bbb1-eb1e49e2f59f">4,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzMtMy0xLTEtMjY1MjQ3_b6b49b46-69ab-4bd8-bf5a-1e258408a55a">7,989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzMtNS0xLTEtMjY1MjQ3_49b99746-953f-4682-b9ea-fb5b8d14f2ba">7,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments required to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzUtMS0xLTEtMjY1MjQ3_28520482-f167-41aa-981a-3acb426d6ec7">4,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzUtMy0xLTEtMjY1MjQ3_537ac7a5-7e99-491b-8926-8b85cf6b22bf">4,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzUtNS0xLTEtMjY1MjQ3_cc90e95e-3e98-451f-a3b4-2237fcba502e">4,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzYtMS0xLTEtMjY1MjQ3_0d5931e9-a98c-4547-9cf8-39d761ade86a">2,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzYtMy0xLTEtMjY1MjQ3_e7aa3759-7e53-44d0-82e1-50b39d181b66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzYtNS0xLTEtMjY1MjQ3_7d6821db-0c47-4e94-9fbe-0deb8244a67b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzgtMS0xLTEtMjY1MjQ3_0335c796-8a4c-4d03-b190-dc009570090c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzgtMy0xLTEtMjY1MjQ3_a1a94756-c622-4a27-946f-99a434f012f4">1,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzgtNS0xLTEtMjY1MjQ3_f8e6d30e-674c-4a85-90b7-334f03133d74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzktMS0xLTEtMjY1MjQ3_1fd7690b-7bff-45b1-a57c-4ebb26f5587c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzktMy0xLTEtMjY1MjQ3_4d968003-838c-4461-8222-c9dfd4389a80">431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzktNS0xLTEtMjY1MjQ3_b682cd6c-4015-4987-9e3e-75edbd9341d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzExLTEtMS0xLTI2NTI0Nw_ed3ff17d-2556-4a2a-b3c0-3333e7a6f70a">447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzExLTMtMS0xLTI2NTI0Nw_e4a3d88b-7dae-4b5f-90ff-3e542279e180">484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzExLTUtMS0xLTI2NTI0Nw_fb5006bb-e3bc-4d68-b6ec-a16b25f1b20a">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale of subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzEyLTEtMS0xLTI2NTI0Nw_d0c48a4e-29a8-4941-99c0-4b2b704847e0">475</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzEyLTMtMS0xLTI2NTI0Nw_95739bd2-1b86-436c-9ab6-006f51f4f989">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzEyLTUtMS0xLTI2NTI0Nw_439e0ac7-b9b7-42e2-91ed-1ef3c3618c6e">269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzEzLTEtMS0xLTI2NTI0Nw_7e390218-06d6-416f-b6a5-b4a31fed21ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzEzLTMtMS0xLTI2NTI0Nw_7dcd327c-afa3-4a65-832a-ccb726694b8c">452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzEzLTUtMS0xLTI2NTI0Nw_836df22c-d6b7-4bb1-b58f-a1c5927ef5ef">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE0LTEtMS0xLTI2NTI0Nw_5e03f754-521b-461b-b307-6df93219c662">2,029</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE0LTMtMS0xLTI2NTI0Nw_6161dfe1-185c-4acc-9429-5d8c3f168e19">402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE0LTUtMS0xLTI2NTI0Nw_b1a13440-6da1-4955-92a4-681adf4da82d">570</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other noncash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE1LTEtMS0xLTI2NTI0Nw_c5669f67-8b1f-4dc7-8370-09d6de895a60">332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE1LTMtMS0xLTI2NTI0Nw_1463987a-b5be-4232-892d-d81239724412">390</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE1LTUtMS0xLTI2NTI0Nw_2929a48d-f167-497f-98f6-14626ace75a3">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities, net of effects from acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE3LTEtMS0xLTI2NTI0Nw_d5c9ccab-e11f-4aef-82f1-6a3cd5a25690">2,971</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE3LTMtMS0xLTI2NTI0Nw_02279e7c-d849-46ed-9f65-028935994e34">2,703</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE3LTUtMS0xLTI2NTI0Nw_345d9211-be09-41ff-a5a5-d4d7357c6ee8">1,510</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE4LTEtMS0xLTI2NTI0Nw_68aa963a-f29d-44e5-9fb6-e7ca3bc606b5">1,435</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE4LTMtMS0xLTI2NTI0Nw_9a8ad06c-ecc6-49cc-98a1-adcb500dbceb">735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE4LTUtMS0xLTI2NTI0Nw_3c581def-1a9b-4fc9-a438-85a13d3923fb">973</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE5LTEtMS0xLTI2NTI0Nw_91d92750-c044-44bb-9090-346fbf5525ef">491</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE5LTMtMS0xLTI2NTI0Nw_b12d477b-9add-4fd6-b2ff-ff70a2526757">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE5LTUtMS0xLTI2NTI0Nw_bdd64bfa-4460-4d9a-b545-30601c6aeec3">364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and pharmacy claims and discounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIwLTEtMS0xLTI2NTI0Nw_55e6aca6-9b4b-4153-9db0-27d4519b52ad">4,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIwLTMtMS0xLTI2NTI0Nw_b76d3c03-ecfe-4b53-9ed6-40414698b63b">2,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIwLTUtMS0xLTI2NTI0Nw_00c0ad2c-3868-444f-82a1-37237f53391d">2,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable and other insurance liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIxLTEtMS0xLTI2NTI0Nw_a3a2d765-b6ec-4ccd-a94f-8cb5dc61c399">992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIxLTMtMS0xLTI2NTI0Nw_214d6401-3e88-4074-a305-ae2c2a9f2c3b">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIxLTUtMS0xLTI2NTI0Nw_878d8a68-15c3-4767-8195-db784930f8dd">231</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIyLTEtMS0xLTI2NTI0Nw_51bd4db5-9c3b-4790-b474-78f763164524">6,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIyLTMtMS0xLTI2NTI0Nw_35835695-fa94-4f20-8eb6-2e3e1bc46135">2,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIyLTUtMS0xLTI2NTI0Nw_3bb644ad-c7d0-4945-8e36-af885e021017">2,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIzLTEtMS0xLTI2NTI0Nw_6a2c3191-b8fd-48a0-bc65-4fd49daae3d6">16,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIzLTMtMS0xLTI2NTI0Nw_94b87c14-f2d0-42e2-903a-a3ec6499cf5b">18,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIzLTUtMS0xLTI2NTI0Nw_7c1f1bcc-3e47-47f0-8dac-8af2ba5b9d7e">15,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_115"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i36038907935e41eea5e9cf7cac915d44_100">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Shareholders&#8217; Equity</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Attributable to CVS Health</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of shares<br/>outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Surplus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>CVS Health<br/>Shareholders&#8217; <br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Shareholders&#8217;<br/>Equity</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling <br/>Interests </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic2993c1ba25f447ab89c08c88e66aa96_I20191231" decimals="-6" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtMS0xLTEtMjY1MjQ3_62c0c2a5-8697-4f9d-b667-16a7cdb49f42">1,727</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia5fe3b205c444626a35463f927aa3b11_I20191231" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtMi0xLTEtMjY1MjQ3_73897469-4aee-4b20-b92f-d8b722c9d81b">425</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491a9763983d43dab185a1b3d0201cec_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtNC0xLTEtMjY1MjQ3_335a7aa8-8c30-4b17-a5c7-4da78b6cf53b">45,972</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5fe3b205c444626a35463f927aa3b11_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtNS0xLTEtMjY1MjQ3_bf3567bd-5dff-4143-aed8-f6311896e895">28,235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe9d7c9e0fe048518f0e819acf0a59a3_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtNi0xLTEtMjY1MjQ3_1804e276-f596-4f02-86e2-46a41f50aa06">45,108</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief232100a20840efa196d4fd232b579f_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtNy0xLTEtMjY1MjQ3_1f6d998e-d6ca-464c-80c3-766ec66900bd">1,019</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b824a92dd1d4f39a02e0e70cc3cf6fc_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtOC0xLTEtMjY1MjQ3_2dc3cee4-b84c-4f6d-8924-32e122b25870">63,864</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4991f9a87e794b3b846aabc953f85e74_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtOS0xLTEtMjY1MjQ3_4f080fb7-a1cb-4690-93fc-fc467a4f2b5e">306</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68e253af6bf3467aade09b572c1b73a6_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtMTAtMS0xLTI2NTI0Nw_a249802a-5f53-4a2a-8fcb-211da0b39a56">64,170</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adoption of new accounting standard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> (3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36ab8a4da32a49829b2a533bcf21afdf_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzQtNi0xLTEtMjY1MjQ3_ff0587d7-da99-4ddb-8c92-ab01066108c2">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia21cb50c4e1644429c76bb8021c0abb3_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzQtOC0xLTEtMjY1MjQ3_a032804d-c9e5-4ea5-8b30-43a8d7915f00">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6302b18a2e04d64807ebebc34715ce0_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzQtMTAtMS0xLTI2NTI0Nw_8ae1937e-aba3-4db1-b06b-6ea47c9a06f8">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af9823e22614548b10747e15ded15b8_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzUtNi0xLTEtMjY1MjQ3_8b4519c9-4b6f-4f0b-8510-c7e755b7020f">7,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a3c1968cd74443b9c917d9cc5f64f1_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzUtOC0xLTEtMjY1MjQ3_08547a84-8a60-4cb6-9db6-8cc872ba437a">7,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72880aeb20f6446880ea5b142b21f44e_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzUtOS0xLTEtMjY1MjQ3_afc27a49-af25-4eb6-9382-d9aacaadd61f">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzUtMTAtMS0xLTI2NTI0Nw_0035b86d-735d-4095-846f-c17a2ed7c1dc">7,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive income (Note 14)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4634f40686a143b7b789e3fcc2d15bba_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzYtNy0xLTEtMjY1MjQ3_b4497dcd-35c1-47c3-b01a-9cc6067eb067">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a3c1968cd74443b9c917d9cc5f64f1_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzYtOC0xLTEtMjY1MjQ3_3d869040-b9f4-4217-9dfb-ef0929be7115">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzYtMTAtMS0xLTI2NTI0Nw_b9ea6aed-4465-4a0a-9c26-f7a95c5be508">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i977ea8ed51c749fd9c1b5c76a2eb3053_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzgtMS0xLTEtMjY1MjQ3_f2e531d7-f843-4fd2-8c30-5388f17cf4e0">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifedd722cb01b4162adfda8754b4a7916_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzgtMi0xLTEtMjY1MjQ3_3f1718f0-be4b-46c6-92b0-3211aa793753">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9932d12c9d66432680507bf33aaf9390_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzgtNC0xLTEtMjY1MjQ3_b3517f08-7282-4c85-8f1c-6e22b84fa874">541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a3c1968cd74443b9c917d9cc5f64f1_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzgtOC0xLTEtMjY1MjQ3_1c931235-5d04-4fcd-a2af-d86f9795770c">541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzgtMTAtMS0xLTI2NTI0Nw_5f2e48d3-2fcf-4617-8521-82d04ce218a4">541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">ESPP issuances, net of purchase of treasury shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifedd722cb01b4162adfda8754b4a7916_D20200101-20201231" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzktMi0xLTEtMjY1MjQ3_5d0ba310-3d35-4b81-a47c-81bd2313b35e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifedd722cb01b4162adfda8754b4a7916_D20200101-20201231" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzktNS0xLTEtMjY1MjQ3_d4b1cd72-a297-42b8-809c-b1f8f1c69c9f">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a3c1968cd74443b9c917d9cc5f64f1_D20200101-20201231" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzktOC0xLTEtMjY1MjQ3_ac1d4576-bb98-41fc-bd63-31a972a0b75f">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzktMTAtMS0xLTI2NTI0Nw_270b7622-45e2-4516-a5ec-5d0b108b8909">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8af9823e22614548b10747e15ded15b8_D20200101-20201231" decimals="-6" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEwLTYtMS0xLTI2NTI0Nw_b924bf3a-c2c3-4abe-a14f-31aa2841a7f5">2,644</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65a3c1968cd74443b9c917d9cc5f64f1_D20200101-20201231" decimals="-6" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEwLTgtMS0xLTI2NTI0Nw_bbeb7b56-979b-4a51-b3c7-2104f6229135">2,644</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEwLTEwLTEtMS0yNjUyNDc_2f3ac0a9-cd49-4379-bb74-cf7abb8bd197">2,644</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other decreases in noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72880aeb20f6446880ea5b142b21f44e_D20200101-20201231" decimals="-6" sign="-" name="cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEyLTktMS0xLTI2NTI0Nw_54b7b9c7-06a2-454b-ba1b-782918bbc08b">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" sign="-" name="cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEyLTEwLTEtMS0yNjUyNDc_42d262e3-1917-4bad-b8b0-6c742bac4903">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i12545f682ca84fcd8b34c17747b4d4a8_I20201231" decimals="-6" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTEtMS0xLTI2NTI0Nw_7d58b52d-5727-41ce-8163-0578bc598ea7">1,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6595d99e0eca44358c06faf58aae481d_I20201231" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTItMS0xLTI2NTI0Nw_acd205b2-ef06-4bc4-9857-1dae880fab11">423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38b09f0dce8d4cb99fa27e7105e23758_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTQtMS0xLTI2NTI0Nw_8f1bb28a-c8a4-4c78-9ea3-af61cd28b62f">46,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6595d99e0eca44358c06faf58aae481d_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTUtMS0xLTI2NTI0Nw_6963df9f-0ea1-4ac6-b0b5-ec498ce9787e">28,178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3fb716c30e94b8d9f3238fa1bdb98a0_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTYtMS0xLTI2NTI0Nw_b855609d-7c12-44f7-a712-0a210293357d">49,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22d6477334e54d4ebdf1f3166111f1a6_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTctMS0xLTI2NTI0Nw_8750e9c0-8913-4f8e-b3f9-d18ba4aec93e">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1c5ed3119a74585bf41ba0c7353c92e_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTgtMS0xLTI2NTI0Nw_300a56ce-6be6-4238-b335-62db36513e49">69,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22c0ec2db724456da4292af4b50c4c77_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTktMS0xLTI2NTI0Nw_09b0cc63-cd13-4ef7-955a-911c57a265e5">312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501f291fb23d49e987222cf13c851afc_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTEwLTEtMS0yNjUyNDc_d3522bab-a1b1-4b04-b565-5cd28a347d8c">69,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i580e21923e444bd5aa787a3559d74a5d_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTctMS0xLTI5MjkwOQ_c6eb65b0-97a6-4658-b684-153587943450">766</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i944efe0ff84e4a2d996b26b09fdc1d74_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTgtMS0xLTI5MjkwOQ_c7c47afe-7c09-404c-8eab-bfc84e73f762">766</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaccc7e6f5db47c38d9e0ea71b031391_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTEwLTEtMS0yOTI5MDk_54b1200e-622f-43b1-bc66-26023b61255a">766</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fffebb410fa488a9d9b0e22931e5e2c_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTYtMS0xLTI2NTI0Nw_ffa40803-e3ef-4137-a207-1ae4679aff69">8,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f4bb816c26b475ea5c62611a6ca3a18_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTgtMS0xLTI2NTI0Nw_f56d96b7-d565-401a-8518-e8e52cbe8390">8,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2e98974a4f44562bfcd00c29cbe00c1_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTktMS0xLTI2NTI0Nw_97163b83-8784-4eb5-8431-46943dd6bc02">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTEwLTEtMS0yNjUyNDc_7ce306c0-dcd4-490d-86da-cce08dc9cdd6">7,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive loss (Note 14)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if12098c59f664975ae50e2edca80bd53_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE1LTctMS0xLTI2NTI0Nw_50d35057-fe5d-49bc-86c7-f769cbfd682b">314</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f4bb816c26b475ea5c62611a6ca3a18_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE1LTgtMS0xLTI2NTI0Nw_3c1d0c19-7186-4d12-9f75-9e4fd1969225">314</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE1LTEwLTEtMS0yNjUyNDc_b6e60ef5-f1f7-4fa6-b405-09b709dc5b32">314</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1e89593f0c849e0b5cd198216f70015_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE3LTEtMS0xLTI2NTI0Nw_d359f6de-ef34-4844-913b-ebad39371d4a">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie82435ef167541ffb3553c4f0df32b5a_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE3LTQtMS0xLTI2NTI0Nw_b087569e-b95a-47ca-9bcc-80b7e4472a6a">864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f4bb816c26b475ea5c62611a6ca3a18_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE3LTgtMS0xLTI2NTI0Nw_92bb9e4c-603a-42e9-9d65-a9664561b93e">864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE3LTEwLTEtMS0yNjUyNDc_1b7d8383-da0d-4c64-8a82-c59d408a11c5">864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">ESPP issuances, net of purchase of treasury shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic80415c4b5d245e4a044912d0547b9bf_D20210101-20211231" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE4LTItMS0xLTI2NTI0Nw_fdb2753c-df7b-47ab-ac9e-0dd3d25a3a1f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic80415c4b5d245e4a044912d0547b9bf_D20210101-20211231" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE4LTUtMS0xLTI2NTI0Nw_b5044474-ff72-4143-a8b9-3c5839978fa9">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f4bb816c26b475ea5c62611a6ca3a18_D20210101-20211231" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE4LTgtMS0xLTI2NTI0Nw_71a3e098-e158-498a-b356-d75c93443e59">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE4LTEwLTEtMS0yNjUyNDc_4049d0cc-07f8-4089-ae90-14b07246d1a0">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fffebb410fa488a9d9b0e22931e5e2c_D20210101-20211231" decimals="-6" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE5LTYtMS0xLTI2NTI0Nw_9f451eec-8ead-4434-9803-5a28d4e3c422">2,644</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f4bb816c26b475ea5c62611a6ca3a18_D20210101-20211231" decimals="-6" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE5LTgtMS0xLTI2NTI0Nw_4bd9c2f3-2c4a-4af2-b19c-693dca99fd13">2,644</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE5LTEwLTEtMS0yNjUyNDc_34ecdd84-daf7-4844-8e0f-2bf9f24de94d">2,644</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other increases in noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2e98974a4f44562bfcd00c29cbe00c1_D20210101-20211231" decimals="-6" name="cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIxLTktMS0xLTI2NTI0Nw_7092639b-58a7-4fe8-86f2-edf21389d4ad">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIxLTEwLTEtMS0yNjUyNDc_007ded54-0d32-4827-b188-ae18fce32b45">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if9dd6c6b3ecb435985256437dde936c5_I20211231" decimals="-6" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTEtMS0xLTI2NTI0Nw_2c546eb7-f7f2-45e9-b064-bf7e420db91e">1,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i91d3dea8f9bb4c86b60376ad2e8c10c7_I20211231" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTItMS0xLTI2NTI0Nw_8027cace-077c-4657-b8a5-343955af68fd">422</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie82959ec18904868bfd821447c031d13_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTQtMS0xLTI2NTI0Nw_1b6f591b-bd17-46c4-9673-7791614c2538">47,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91d3dea8f9bb4c86b60376ad2e8c10c7_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTUtMS0xLTI2NTI0Nw_b1a6a773-e6f4-4300-9d66-479c354994aa">28,173</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6e9f84d80be4446b8b028c6bdbc5c40_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTYtMS0xLTI2NTI0Nw_955152e7-c818-495c-89c0-d11fc816bd39">54,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabe48b9a3b0e43a0b640f125310e597c_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTctMS0xLTI2NTI0Nw_bb35614c-9752-4d0e-ad05-48c38b0ee30b">334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8998dba726444ee9ad5bfe46a9788a1a_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTgtMS0xLTI2NTI0Nw_d1d48701-fbdc-4484-bb70-a69a8fc41bf2">74,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaeb9020504c459e87c9b9fa425f923a_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTktMS0xLTI2NTI0Nw_5278639b-1fd5-49ad-96f7-92aa13f51b35">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTEwLTEtMS0yNjUyNDc_8e4eb045-0444-47ba-b8db-11b4ab12337b">74,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077de4b38fce45fdb34454ce78f9f9b2_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI0LTYtMS0xLTI2NTI0Nw_b3d2d550-733a-4cf6-a501-fdd8c8d9e55c">4,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i196f6e9660424434b44542b216db0270_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI0LTgtMS0xLTI2NTI0Nw_71934794-479d-4d22-ae54-100073664582">4,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2b21a3fd83f44a297eaa7e45a2ba45e_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI0LTktMS0xLTI2NTI0Nw_5952dcc8-1cc4-4ef5-aaec-551b879e74cc">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI0LTEwLTEtMS0yNjUyNDc_5af039d7-bb82-452b-8f05-747b7f880e16">4,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive loss (Note 14)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icfb3bacdf62f4f89858a91412d94f263_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI1LTctMS0xLTI2NTI0Nw_6f7e9d45-a8ca-447a-af99-cf6782f92136">1,598</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i196f6e9660424434b44542b216db0270_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI1LTgtMS0xLTI2NTI0Nw_50e16ef9-aaf8-496a-a8a6-ecfaecc2bb72">1,598</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI1LTEwLTEtMS0yNjUyNDc_30906906-20a9-410c-9dfa-5e1d79dd54e1">1,598</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iad69a88c0d6245a29a92549e921f5e40_D20220101-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI2LTEtMS0xLTI2NTI0Nw_a3d30ee2-515f-4d09-9f97-2751af4c70dd">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdd121bfc7c452ba215301545efe3fc_D20220101-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI2LTQtMS0xLTI2NTI0Nw_69e345b2-8fd2-495b-b6c2-569e13e37943">816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i196f6e9660424434b44542b216db0270_D20220101-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI2LTgtMS0xLTI2NTI0Nw_c7f795be-2053-4a1d-8fe2-757f10be04fb">816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI2LTEwLTEtMS0yNjUyNDc_c9469b73-4605-4633-9c94-eb3e77e41ba6">816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Purchase of treasury shares, net of ESPP issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id9c89dd55b72447395cf83241b9a653f_D20220101-20221231" decimals="-6" name="cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI3LTItMS0xLTI2NTI0Nw_7bb20a0c-dae7-400a-932d-6273537cbc05">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9c89dd55b72447395cf83241b9a653f_D20220101-20221231" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI3LTUtMS0xLTI2NTI0Nw_07c936c0-f94c-4c22-955f-5b8f2c82a300">3,685</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i196f6e9660424434b44542b216db0270_D20220101-20221231" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI3LTgtMS0xLTI2NTI0Nw_0ecef342-15cb-4d58-9c09-52e8b8a70b3d">3,685</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI3LTEwLTEtMS0yNjUyNDc_2f409455-fd91-4725-9b67-c95982ff3730">3,685</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077de4b38fce45fdb34454ce78f9f9b2_D20220101-20221231" decimals="-6" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI4LTYtMS0xLTI2NTI0Nw_ef87e593-8c05-46dc-95b5-6cf033f88813">2,910</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i196f6e9660424434b44542b216db0270_D20220101-20221231" decimals="-6" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI4LTgtMS0xLTI2NTI0Nw_46026421-ff27-4f36-801f-9da9df6498b9">2,910</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI4LTEwLTEtMS0yNjUyNDc_f7dc2e9d-7686-4eb8-bf7f-8699e46efd12">2,910</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other decreases in noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2b21a3fd83f44a297eaa7e45a2ba45e_D20220101-20221231" decimals="-6" sign="-" name="cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI5LTktMS0xLTI2NTI0Nw_732209a4-95e6-472d-91b0-8c7507fa7572">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI5LTEwLTEtMS0yNjUyNDc_01e30dc7-952b-4edc-bbb6-b4fe4d08b652">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i34779fb44bce4f6ba1d5a253141f3f1b_I20221231" decimals="-6" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTEtMS0xLTI2NTI0Nw_4091a262-cde9-4f2f-bb1f-b63925b44a96">1,758</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1eaf5ce6aae54524ab351f151c4c5797_I20221231" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTItMS0xLTI2NTI0Nw_8860a665-734e-4981-ad73-7ff28eb0e6f2">458</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9134faa8fb4e47d780125a2ae7416a6a_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTQtMS0xLTI2NTI0Nw_c2b5caaf-e724-468f-87e1-a662ef57b586">48,193</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eaf5ce6aae54524ab351f151c4c5797_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTUtMS0xLTI2NTI0Nw_fcbd8ce3-30b8-4171-8a70-7b62caa5b56e">31,858</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc417b7cc444506a3991b3fc859cfae_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTYtMS0xLTI2NTI0Nw_cba06012-690c-4db6-ae74-42aa42771331">56,398</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4df9ffba7784b76a9a950adbaa557a6_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTctMS0xLTI2NTI0Nw_379c989b-1190-4cff-93f6-3a8a5887cc7d">1,264</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i224111d466b840aebce96b61ecd97cc3_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTgtMS0xLTI2NTI0Nw_91b40a5e-0da2-4f42-896d-d7ad635df0f9">71,469</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3599bd1ab9441e68ec38d940b09f7fb_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTktMS0xLTI2NTI0Nw_95a2bb17-2141-44d1-8a6d-aea0c37b50b0">300</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTEwLTEtMS0yNjUyNDc_d199fdde-3b9f-4fff-b1d6-6a5b93862ad9">71,769</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3NQ_df308064-6268-4ba8-aef5-0aa63fa331d2" footnoteRole="http://www.xbrl.org/2003/role/footnote">Treasury shares include <ix:nonFraction unitRef="shares" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:TreasuryStockSharesHeldinTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzEyNg_03518fa7-c535-42be-8c54-6c0b9c281e2e"><ix:nonFraction unitRef="shares" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:TreasuryStockSharesHeldinTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzEyNg_27d39d01-bc3c-42bc-aaf3-39a401618f56"><ix:nonFraction unitRef="shares" contextRef="i501f291fb23d49e987222cf13c851afc_I20201231" decimals="-6" name="cvs:TreasuryStockSharesHeldinTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzEyNg_da141e37-9311-44b8-9a92-c8a9ca8b99e2">1</ix:nonFraction></ix:nonFraction></ix:nonFraction> million shares held in trust for each of the years ended December 31, 2022, 2021 and 2020. Treasury stock includes $<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:TreasuryStockValueSharesHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzIzMA_030f2f01-c9bf-42be-8065-6287a2ffcf69"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:TreasuryStockValueSharesHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzIzMA_91eb6693-fa8a-4759-bde4-a5cf526e0d4b"><ix:nonFraction unitRef="usd" contextRef="i501f291fb23d49e987222cf13c851afc_I20201231" decimals="-6" name="cvs:TreasuryStockValueSharesHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzIzMA_b7551db1-0692-4dfe-81e9-daf3e36c93d0">29</ix:nonFraction></ix:nonFraction></ix:nonFraction> million related to shares held in trust for each of the years ended December 31, 2022, 2021 and 2020. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information.</ix:footnote></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3Nw_ad8b6184-2d5f-4358-aca0-fe4aae4db63a" footnoteRole="http://www.xbrl.org/2003/role/footnote">Common stock and capital surplus includes the par value of common stock of $<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzQzMQ_c3d9d3a3-d489-412a-8883-f2a16179a242">18</ix:nonFraction>&#160;million as of December 31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzQ2MA_44a4806e-ddb0-424f-bedb-ec2df80f1ebe"><ix:nonFraction unitRef="usd" contextRef="i501f291fb23d49e987222cf13c851afc_I20201231" decimals="-6" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzQ2MA_ac587a37-354e-42d0-9f16-ba290b78c0c3">17</ix:nonFraction></ix:nonFraction> million as of December 31, 2021 and 2020.</ix:footnote></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3Mw_981c78eb-618a-44f0-9a9d-80b97609c9e3" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3OA_50a38f39-24c9-439d-81f9-601a8eefa8a4">Accounting Standards Update (&#8220;ASU&#8221;) 2016-13</span>, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Topic 326), which resulted in a reduction to retained earnings of $<ix:nonFraction unitRef="usd" contextRef="i4aa93581903f4f47a9e936c93eacce46_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzY2OA_58862ed7-2702-4759-9495-64df01b9001d">3</ix:nonFraction>&#160;million during the year ended December 31, 2020.</span></ix:footnote></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzk4OTU2MDQ2NTA5OTI_0918e7e7-e2f8-48f2-b797-be453d0ca700" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzk4OTU2MDQ2NTA5OTM_e949208d-ec5c-442c-bfb1-60608d2297f0">ASU 2018-12</span>, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Topic 944) during the year ended December 31, 2021. See Note 8 &#8216;&#8216;Other Insurance Liabilities and Separate Accounts&#8217;&#8217; for additional information.</span></ix:footnote></div><div style="margin-bottom:3pt;text-indent:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i36038907935e41eea5e9cf7cac915d44_100">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div><div id="i36038907935e41eea5e9cf7cac915d44_121"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTM4_836c47a0-99e8-414c-a310-f8efa9b110bb" continuedAt="ib306d523a8034a2d92eeee09d799a816" escape="true">Significant Accounting Policies </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ib306d523a8034a2d92eeee09d799a816" continuedAt="i7255681a5bbf42eb96f1632c9e8f7942"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business&#160; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation, together with its subsidiaries (collectively, &#8220;CVS Health&#8221; or the &#8220;Company&#8221;), has more than <ix:nonFraction unitRef="store" contextRef="id114deab047e49b5a8b771195b4a54a2_I20221231" decimals="-2" name="us-gaap:NumberOfStores" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzE4Mw_65a3ccb9-a838-4249-9a34-5bcf2e6ef0a8">9,000</ix:nonFraction> retail locations, more than <ix:nonFraction unitRef="clinic" contextRef="i839a6c4fcaad4f5fa23979221c63e037_I20221231" decimals="-2" name="cvs:NumberOfWalkInMedicalClinics" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzIxNA_70a14e41-fe0f-4ac1-a5f9-950161935208">1,100</ix:nonFraction> walk-in medical clinics, a leading pharmacy benefits manager with over <ix:nonFraction unitRef="people" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:NumberOfPharmacyPlanMembers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzI4OA_e0fc062a-52f5-4b52-bd0b-723bbcb8e963">110</ix:nonFraction> million plan members with expanding specialty pharmacy solutions and a dedicated senior pharmacy care business serving more than <ix:nonFraction unitRef="patient" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="INF" name="cvs:NumberOfPatientsServedPerYear" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQxMg_32d26000-08d9-4426-89dd-b72978ad3d26">one million</ix:nonFraction> patients per year. The Company also serves an estimated <ix:nonFraction unitRef="people" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:NumberOfPeopleServed" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ3MQ_4b9726b9-33e0-4806-9968-630a6cca37f4">35</ix:nonFraction> million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its integrated health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The coronavirus disease 2019 (&#8220;COVID-19&#8221;) and its emerging new variants continue to impact the economies of the U.S. and other countries around the world. The impact of COVID-19 on the Company&#8217;s businesses, operating results, cash flows and financial condition in the years ended December 31, 2022, 2021 and 2020, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this Exhibit 99.1.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with its new operating model adopted in the first quarter of 2023, the Company realigned the composition of its segments to reflect how its Chief Operating Decision Maker (the &#8220;CODM&#8221;) reviews information and manages the business. As a result of this realignment, the Company formed a new Health Services segment, which in addition to providing a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, also delivers health care services in the Company&#8217;s medical clinics, virtually, and in the home, as well as provider enablement solutions. In addition, the Company created a new Pharmacy &amp; Consumer Wellness segment, which includes its retail and long-term care pharmacy operations and related pharmacy services, as well as its retail front store operations. This segment will also provide pharmacy fulfillment services to support the Health Services segment&#8217;s specialty and mail order pharmacy offerings. Segment financial information has been recast to reflect these changes.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDky_e80fb8c4-734d-4771-b8a9-5d239ee9a377" continuedAt="i31d9ffdfc186449dbd2cdfa6e7fcdd54" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the segment realignment described above, the Company&#8217;s <ix:nonFraction unitRef="segment" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzEzMzc_3a8d83e0-c590-43f4-abc9-0c2e06dce3e8">four</ix:nonFraction> reportable segments are as follows: Health Care Benefits, Health Services, Pharmacy &amp; Consumer Wellness and Corporate/Other, which are described below. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment operates as one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) in <ix:nonFraction unitRef="state" contextRef="if07e27d83137497c9009bcc13d88e451_D20220101-20221231" decimals="INF" name="cvs:IndividualPublicHealthInsuranceExchangesNumberOfStates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzMxMjg_f8d43739-05de-4dca-a039-c4ccd700f5c5">eight</ix:nonFraction> states through which it sells Insured plans directly to individual consumers. The Company entered Public Exchanges in <ix:nonFraction unitRef="state" contextRef="ie19a1ad3f0604084922f302641035795_D20230101-20230131" decimals="INF" name="cvs:IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzMyNDk_9ee504db-cb21-429f-9800-2ed279547399">four</ix:nonFraction> additional states effective January 2023. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. PBM solutions include plan design offerings and administration, formulary management, retail pharmacy network management services, and specialty and mail order pharmacy services. In addition, the Company provides clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Company operates a group purchasing organization that negotiates pricing for the purchase of pharmaceuticals and rebates with pharmaceutical manufacturers on behalf of its participants and provides various administrative, management and reporting services to pharmaceutical manufacturers. The Health Services segment&#8217;s clients are primarily employers, </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7255681a5bbf42eb96f1632c9e8f7942" continuedAt="i6ecaab9a6309474fa14d92fc1e5de91a"><ix:continuation id="i31d9ffdfc186449dbd2cdfa6e7fcdd54"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care (&#8220;Managed Medicaid&#8221;) plans, plans offered on Insurance Exchanges and other sponsors of health benefit plans throughout the United States and Covered Entities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy &amp; Consumer Wellness Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy &amp; Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise. The segment also conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and ancillary services to long-term care facilities and other care settings, and provides pharmacy fulfillment services to support the Health Services segment&#8217;s specialty and mail order pharmacy offerings. As of December&#160;31, 2022, the Pharmacy &amp; Consumer Wellness segment operated more than <ix:nonFraction unitRef="store" contextRef="id114deab047e49b5a8b771195b4a54a2_I20221231" decimals="-2" name="us-gaap:NumberOfStores" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQzOTgwNDY2MzUwNDY_6b128ae3-fb49-4179-9400-8d05aaca3add">9,000</ix:nonFraction> retail locations, as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTc4_6a5e2b53-c350-4397-9bdf-7e6f28b6ff4f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTUy_993308ea-603e-468d-94c9-9812c8a5a057" continuedAt="i61046290333f4df9af55b2fde246fb00" escape="true">Use of Estimates</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i61046290333f4df9af55b2fde246fb00">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MjAz_64507431-fd7f-4e39-9184-6db0ea1ff9a3" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of cash and temporary investments with maturities of three months or less when purchased. The Company invests in short-term money market funds, commercial paper and time deposits, as well as other debt securities that are classified as cash equivalents within the accompanying consolidated balance sheets, as these funds are highly liquid and readily convertible to known amounts of cash. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash included in other current assets on the consolidated balance sheets represents funds held on behalf of members, including health savings account (&#8220;HSA&#8221;) funds associated with high deductible health plans. Restricted cash included in other assets on the consolidated balance sheets represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits and money market funds.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6ecaab9a6309474fa14d92fc1e5de91a" continuedAt="i8e63d2bb3e304e588e4a7987d74f5b41"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDYx_c85e1e08-34d8-4f1c-919b-3462f25d068e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the consolidated balance sheets to total cash, cash equivalents and restricted cash on the consolidated statements of cash flows as of December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzEtMS0xLTEtMjY1MjQ3_6ed8545a-dde8-47b9-ae4f-83bdef3279fc">12,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzEtMy0xLTEtMjY1MjQ3_c9677f92-9403-4dc1-bf03-6f114341a8a3">9,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501f291fb23d49e987222cf13c851afc_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzEtNS0xLTEtMjY1MjQ3_b4b8a24c-6478-4662-a5ea-de9387ab5df1">7,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzItMS0xLTEtMjY1MjQ3_7fccf039-e395-4e0b-a29f-9a108c46bee2">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:RestrictedCashCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzItMy0xLTEtMjY1MjQ3_e7808734-93be-40b6-a872-bb56b42e42a2">3,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501f291fb23d49e987222cf13c851afc_I20201231" decimals="-6" name="us-gaap:RestrictedCashCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzItNS0xLTEtMjY1MjQ3_22bf26ee-6dad-48ab-9a4b-7cb07243442d">2,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzMtMS0xLTEtMjY1MjQ3_61511767-3127-4295-be62-8a963d02d542">216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzMtMy0xLTEtMjY1MjQ3_0f096794-5e46-46c9-9a45-c5ef58b53cde">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501f291fb23d49e987222cf13c851afc_I20201231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzMtNS0xLTEtMjY1MjQ3_3ba232a5-8871-4848-9de5-ad189462edfd">276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzQtMS0xLTEtMjY1MjQ3_82af95d4-7039-4585-a758-9b836f940117">13,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzQtMy0xLTEtMjY1MjQ3_c6d42984-ff82-4461-9bd0-0b3a80de3927">12,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501f291fb23d49e987222cf13c851afc_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzQtNS0xLTEtMjY1MjQ3_8e1e0bfb-3dc0-46aa-828c-3b5b13abfcf8">11,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in restricted cash included in other current assets as of December 31, 2022 compared to December 31, 2021 was primarily due to a decrease in HSA funds held on behalf of customers as a result of the sale of Payflex Holdings, Inc. (&#8220;PayFlex&#8221;). See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information on the Company&#8217;s sale of PayFlex.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTUz_a63c6fe2-0eb8-443b-b8f3-415854976e61" continuedAt="i842c180df469428d9897ec57e341c051" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Securities </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities consist primarily of U.S. Treasury and agency securities, mortgage-backed securities, corporate and foreign bonds and other debt securities. Debt securities are classified as either current or long-term investments based on their contractual maturities unless the Company intends to sell an investment within the next twelve months, in which case it is classified as current on the consolidated balance sheets. Debt securities are classified as available for sale and are carried at fair value. See Note 4 &#8216;&#8216;Fair Value&#8217;&#8217; for additional information on how the Company estimates the fair value of these investments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related (yield-related) components. In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principal payments; and any changes to the rating of the security by a rating agency. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income (loss). Interest is not accrued on debt securities when management believes the collection of interest is unlikely.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit-related component is determined by comparing the present value of cash flows expected to be collected from the security, considering all reasonably available information relevant to the collectability of the security, with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the Company records an allowance for credit losses, which is limited by the amount that the fair value is less than amortized cost basis. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For mortgage-backed and other asset-backed securities, the Company recognizes income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The Company&#8217;s investment in the security is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the security, with adjustments recognized in net income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities with readily available fair values are measured at fair value with changes in fair value recognized in net income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage Loans</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mortgage loan investments on the consolidated balance sheets are valued at the unpaid principal balance, net of an allowance for credit losses. Mortgage loans with a maturity date or a committed prepayment date within twelve months are classified as current on the consolidated balance sheets. The Company assesses whether its loans share similar risk characteristics and, if so, </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8e63d2bb3e304e588e4a7987d74f5b41" continuedAt="ifbbc10a4c1764b37831fe974366764ed"><ix:continuation id="i842c180df469428d9897ec57e341c051" continuedAt="ie199a05e255d4cc78efec81b7a79bff6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">groups such loans in a risk pool when measuring expected credit losses. The Company considers the following characteristics when evaluating whether its loans share similar risk characteristics:&#160;loan-to-value ratios, property type (e.g., office, retail, apartment, industrial), geographic location, vacancy rates and property condition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit loss reserves are determined using a loss rate method that multiplies the unpaid principal balance of each loan within a risk pool group by an estimated loss rate percentage. The loss rate percentage considers both the expected loan loss severity and the probability of loan default. For periods where the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions (e.g., gross domestic product, employment), the Company adjusts its expected loss rates to reflect these forecasted economic conditions. For periods beyond which the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions, the Company reverts to historical loss rates in determining expected credit losses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income on a potential problem loan (i.e., high probability of default) or restructured loan is accrued to the extent it is deemed to be collectible and the loan continues to perform under its original or restructured terms. Interest income on problem loans (i.e., more than 60 days delinquent, in bankruptcy or in process of foreclosure) is recognized on a cash basis. Cash payments on loans in the process of foreclosure are treated as a return of principal.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Investments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments consist primarily of the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Private equity and hedge fund limited partnerships, which are accounted for using the equity method of accounting. Under this method, the carrying value of the investment is based on the value of the Company&#8217;s equity ownership of the underlying investment funds provided by the general partner or manager of the investments, the financial statements of which generally are audited. As a result of the timing of the receipt of the valuation information provided by the fund managers, these investments are generally reported on up to a three month lag. The Company reviews investments for impairment at least quarterly and monitors their performance throughout the year through discussions with the administrators, managers and/or general partners. If the Company becomes aware of an impairment of a limited partnership&#8217;s investments through its review or prior to receiving the limited partnership&#8217;s financial statements at the financial statement date, an impairment will be recognized by recording a reduction in the carrying value of the limited partnership with a corresponding charge to net investment income. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Investment real estate, which is carried on the consolidated balance sheets at depreciated cost, including capital additions, net of write-downs for other-than-temporary declines in fair value. Depreciation is calculated using the straight-line method based on the estimated useful life of each asset. If any real estate investment is considered held-for-sale, it is carried at the lower of its carrying value or fair value less estimated selling costs. The Company generally estimates fair value using net operating income and applying a capitalization rate in conjunction with comparable sales information. At the time of the sale, the difference between the sales price and the carrying value is recorded as a realized capital gain or loss. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Privately-placed equity securities, which are carried on the consolidated balance sheets at cost less impairments, plus or minus subsequent adjustments for observable price changes. Additionally, as a member of the Federal Home Loan Bank of Boston (&#8220;FHLBB&#8221;), a subsidiary of the Company is required to purchase and hold shares of the FHLBB. These shares are restricted and carried at cost. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Income</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net investment income on the Company&#8217;s investments is recorded when earned and is reflected in the Company&#8217;s net income (other than net investment income on assets supporting experience-rated products). Experience-rated products are products in the large case pensions business where the contract holder, not the Company, assumes investment and other risks, subject to, among other things, minimum guarantees provided by the Company. The effect of investment performance on experience-rated products is allocated to contract holders&#8217; accounts daily, based on the underlying investment experience and, therefore, does not impact the Company&#8217;s net income (as long as the contract&#8217;s minimum guarantees are not triggered). Net investment income on assets supporting large case pensions&#8217; experience-rated products is included in net investment income in the consolidated statements of operations and is credited to contract holders&#8217; accounts through a charge to benefit costs. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized capital gains and losses on investments (other than realized capital gains and losses on investments supporting experience-rated products) are included as a component of net investment income in the consolidated statements of operations. Realized capital gains and losses are determined on a specific identification basis. Purchases and sales of debt and equity securities and alternative investments are reflected on the trade date. Purchases and sales of mortgage loans and investment real estate are reflected on the closing date.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ifbbc10a4c1764b37831fe974366764ed" continuedAt="i5320bf3065704f8e8589cbc40c2630fc"><ix:continuation id="ie199a05e255d4cc78efec81b7a79bff6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized capital gains and losses on investments supporting large case pensions&#8217; experience-rated products are not included in realized capital gains and losses in the consolidated statements of operations and instead are credited directly to contract holders&#8217; accounts. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized capital gains and losses on investments (other than unrealized capital gains and losses on investments supporting experience-rated products) are reflected in shareholders&#8217; equity, net of tax, as a component of accumulated other comprehensive income (loss). Unrealized capital gains and losses on investments supporting large case pensions&#8217; experience-rated products are credited directly to contract holders&#8217; accounts. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTAz_023724cd-4f75-4786-abfe-d8678615a09f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments in order to manage interest rate and foreign exchange risk and credit exposure. The Company&#8217;s use of these derivatives is generally limited to hedging risk and has principally consisted of using interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDk3_e2b25fca-0746-4deb-b027-b8b2c5bdcc75" continuedAt="i8cd3703e6e964afba66fd5e5da5a8ff7" escape="true">Accounts Receivable</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8cd3703e6e964afba66fd5e5da5a8ff7" continuedAt="i95a36e0257d045b28ec81dc662f7d4ad">Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations.</ix:continuation> <ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTA0_2eda64e3-3143-4ff4-8987-6916956929be" continuedAt="i12068ffd0fdd485c85e147955179fa5f" escape="true">Accounts receivable, net was composed of the following at December&#160;31, 2022 and 2021:</ix:nonNumeric></span></div><ix:continuation id="i12068ffd0fdd485c85e147955179fa5f"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmNTU2ZDA3YzhlYzA0Nzg2YWUyMDhhY2NhMWI4YWVlMS90YWJsZXJhbmdlOmY1NTZkMDdjOGVjMDQ3ODZhZTIwOGFjY2ExYjhhZWUxXzEtMS0xLTEtMjY1MjQ3_5f6e496b-b810-4d05-9b4a-8524d996fef7">8,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmNTU2ZDA3YzhlYzA0Nzg2YWUyMDhhY2NhMWI4YWVlMS90YWJsZXJhbmdlOmY1NTZkMDdjOGVjMDQ3ODZhZTIwOGFjY2ExYjhhZWUxXzEtMy0xLTEtMjY1MjQ3_4da43b75-0077-4b9f-8e80-9d3ff9f6e44e">7,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:VendorandManufacturerReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmNTU2ZDA3YzhlYzA0Nzg2YWUyMDhhY2NhMWI4YWVlMS90YWJsZXJhbmdlOmY1NTZkMDdjOGVjMDQ3ODZhZTIwOGFjY2ExYjhhZWUxXzItMS0xLTEtMjY1MjQ3_399dd410-43d8-41fa-b5bb-d89a863f42c1">12,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:VendorandManufacturerReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmNTU2ZDA3YzhlYzA0Nzg2YWUyMDhhY2NhMWI4YWVlMS90YWJsZXJhbmdlOmY1NTZkMDdjOGVjMDQ3ODZhZTIwOGFjY2ExYjhhZWUxXzItMy0xLTEtMjY1MjQ3_5f67b570-6229-4b09-a962-e1c6475ea6b7">10,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:PremiumsReceivableAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmNTU2ZDA3YzhlYzA0Nzg2YWUyMDhhY2NhMWI4YWVlMS90YWJsZXJhbmdlOmY1NTZkMDdjOGVjMDQ3ODZhZTIwOGFjY2ExYjhhZWUxXzMtMS0xLTEtMjY1MjQ3_8f616f81-f58d-4c3f-bc6c-6797815d6771">2,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:PremiumsReceivableAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmNTU2ZDA3YzhlYzA0Nzg2YWUyMDhhY2NhMWI4YWVlMS90YWJsZXJhbmdlOmY1NTZkMDdjOGVjMDQ3ODZhZTIwOGFjY2ExYjhhZWUxXzMtMy0xLTEtMjY1MjQ3_dd1db361-ac00-4f93-b638-254df6f36f8b">2,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmNTU2ZDA3YzhlYzA0Nzg2YWUyMDhhY2NhMWI4YWVlMS90YWJsZXJhbmdlOmY1NTZkMDdjOGVjMDQ3ODZhZTIwOGFjY2ExYjhhZWUxXzQtMS0xLTEtMjY1MjQ3_a2ad5342-fdf8-4a9b-81ee-c782d8d4172f">3,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmNTU2ZDA3YzhlYzA0Nzg2YWUyMDhhY2NhMWI4YWVlMS90YWJsZXJhbmdlOmY1NTZkMDdjOGVjMDQ3ODZhZTIwOGFjY2ExYjhhZWUxXzQtMy0xLTEtMjY1MjQ3_cde70b74-a07e-478d-aa71-ea93c10a37e3">3,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmNTU2ZDA3YzhlYzA0Nzg2YWUyMDhhY2NhMWI4YWVlMS90YWJsZXJhbmdlOmY1NTZkMDdjOGVjMDQ3ODZhZTIwOGFjY2ExYjhhZWUxXzUtMS0xLTEtMjY1MjQ3_e399175d-54a2-4f0b-a182-9ad21598e364">27,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmNTU2ZDA3YzhlYzA0Nzg2YWUyMDhhY2NhMWI4YWVlMS90YWJsZXJhbmdlOmY1NTZkMDdjOGVjMDQ3ODZhZTIwOGFjY2ExYjhhZWUxXzUtMy0xLTEtMjY1MjQ3_77283883-f4c8-4486-889e-692a99e4b1f8">24,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes accounts receivable of $<ix:nonFraction unitRef="usd" contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231" decimals="-6" name="cvs:AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzE5NTI4_463619aa-d647-4137-96ec-c64fdd508914">227</ix:nonFraction>&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div></ix:continuation><div style="text-indent:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for credit losses was $<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzE5NzY0_14cbfb21-53bd-4cae-a603-15c321108de2">333</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzE5Nzcx_63e04f7f-76ab-4933-b49b-8b2409159cc2">339</ix:nonFraction>&#160;million as of December&#160;31, 2022 and 2021, respectively. <ix:continuation id="i95a36e0257d045b28ec81dc662f7d4ad">When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTg4_1b06b627-6146-4f44-8faa-e94c35938bcf" continuedAt="i031ce2bc989f40bbbfe6a2f6d0098f2d" escape="true">Inventories </ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i031ce2bc989f40bbbfe6a2f6d0098f2d">Inventories are valued at the lower of cost or net realizable value using the weighted average cost method. Physical inventory counts are taken on a regular basis in each retail store and LTC pharmacy, and a continuous cycle count process is the primary procedure used to validate the inventory balances on hand in each distribution center and mail facility to ensure that the amounts reflected in the consolidated financial statements are properly stated. During the interim period between physical inventory counts, the Company accrues for anticipated physical inventory losses on a location-by-location basis based on historical results and current physical inventory trends.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ReinsuranceAccountingPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MjA0_3b541921-c23f-4f5e-b47a-384e6c7a9ce1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reinsurance Recoverables </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#8217;s primary liability as the direct insurer of the risks reinsured. Failure of reinsurers to indemnify the Company could result in losses; however, the Company does not expect charges for unrecoverable reinsurance to have a material effect on its consolidated operating results or financial condition. The Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk arising from similar geographic regions, activities or economic characteristics of its reinsurers. At December&#160;31, 2022, the Company&#8217;s reinsurance recoverables consisted primarily of amounts due from third parties that are rated consistent with companies that are considered to have the ability to meet their obligations. Reinsurance recoverables are recorded as other current assets or other assets on the consolidated balance sheets.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i5320bf3065704f8e8589cbc40c2630fc" continuedAt="i88fdc3ddfb304e07a8c747a3d06db5dc"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTMy_e02e6a70-3499-4063-b1be-4c1b848fe64a" continuedAt="i82d9c0686cbe49e1819b5a8b5b575511" escape="true">Health Care Contract Acquisition Costs</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i82d9c0686cbe49e1819b5a8b5b575511">Insurance products included in the Health Care Benefits segment are cancellable by either the customer or the member monthly upon written notice. Acquisition costs related to prepaid health care and health indemnity contracts are generally expensed as incurred. For certain long-duration insurance contracts, acquisition costs directly related to the successful acquisition of a new or renewal insurance contract, including commissions, are deferred and are recorded as other current assets or other assets on the consolidated balance sheets. Contracts are grouped by product and issue year into cohorts consistent with the grouping used in estimating the associated liability and are amortized on a constant level basis based on the remaining in-force policies over the estimated term of the contracts to approximate straight-line amortization. Changes to the Company&#8217;s assumptions, including assumptions related to persistency, are reflected at the cohort level at the time of change and are recognized prospectively over the estimated terms of the contract. The amortization of deferred acquisition costs is recorded in operating expenses in the consolidated statements of operations.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzk4OTU2MDQ3ODEyMDg_aff58815-d0a6-4abb-a070-1fefdb883457" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a roll forward of deferred acquisition costs for the years ended December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred acquisition costs, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DeferredPolicyAcquisitionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphY2QyOThmMWMxNmY0NmU3OTBhODg2ODAzNmZlZTc5Zi90YWJsZXJhbmdlOmFjZDI5OGYxYzE2ZjQ2ZTc5MGE4ODY4MDM2ZmVlNzlmXzItMS0xLTEtMjcyMzQ2_efe149e7-d578-449f-a1cc-79090139517d">879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501f291fb23d49e987222cf13c851afc_I20201231" decimals="-6" name="us-gaap:DeferredPolicyAcquisitionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphY2QyOThmMWMxNmY0NmU3OTBhODg2ODAzNmZlZTc5Zi90YWJsZXJhbmdlOmFjZDI5OGYxYzE2ZjQ2ZTc5MGE4ODY4MDM2ZmVlNzlmXzItMy0xLTEtMjcyMzQ2_d9f75a20-2c09-4e8f-894e-583cc07eb996">519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalizations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:DeferredPolicyAcquisitionCostsAdditions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphY2QyOThmMWMxNmY0NmU3OTBhODg2ODAzNmZlZTc5Zi90YWJsZXJhbmdlOmFjZDI5OGYxYzE2ZjQ2ZTc5MGE4ODY4MDM2ZmVlNzlmXzMtMS0xLTEtMjcyMzQ2_b9efba12-c408-4c3d-9153-a1681ad2e3a6">564</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:DeferredPolicyAcquisitionCostsAdditions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphY2QyOThmMWMxNmY0NmU3OTBhODg2ODAzNmZlZTc5Zi90YWJsZXJhbmdlOmFjZDI5OGYxYzE2ZjQ2ZTc5MGE4ODY4MDM2ZmVlNzlmXzMtMy0xLTEtMjcyMzQ2_60d946cc-e92a-4046-9be9-429a31bad73d">529</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphY2QyOThmMWMxNmY0NmU3OTBhODg2ODAzNmZlZTc5Zi90YWJsZXJhbmdlOmFjZDI5OGYxYzE2ZjQ2ZTc5MGE4ODY4MDM2ZmVlNzlmXzQtMS0xLTEtMjcyMzQ2_cde74e2f-7fc8-43e0-ae71-3f4f6e67ef76">224</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphY2QyOThmMWMxNmY0NmU3OTBhODg2ODAzNmZlZTc5Zi90YWJsZXJhbmdlOmFjZDI5OGYxYzE2ZjQ2ZTc5MGE4ODY4MDM2ZmVlNzlmXzQtMy0xLTEtMjcyMzQ2_5db0c4ff-74c2-48a0-bdaa-cb651b75e976">169</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred acquisition costs, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DeferredPolicyAcquisitionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphY2QyOThmMWMxNmY0NmU3OTBhODg2ODAzNmZlZTc5Zi90YWJsZXJhbmdlOmFjZDI5OGYxYzE2ZjQ2ZTc5MGE4ODY4MDM2ZmVlNzlmXzYtMS0xLTEtMjcyMzQ2_2a788e94-372d-4c37-b2e6-eec0937773fb">1,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DeferredPolicyAcquisitionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphY2QyOThmMWMxNmY0NmU3OTBhODg2ODAzNmZlZTc5Zi90YWJsZXJhbmdlOmFjZDI5OGYxYzE2ZjQ2ZTc5MGE4ODY4MDM2ZmVlNzlmXzYtMy0xLTEtMjcyMzQ2_0a093f15-df49-4271-a75a-a9f318123b82">879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTA3_70b668ed-9bd7-4ba8-a9d5-4f4e9381adb6" continuedAt="i656fe515bce3407191f1c1820e931e7f" escape="true">Property and Equipment</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i656fe515bce3407191f1c1820e931e7f">Property and equipment is reported at historical cost, net of accumulated depreciation. Property, equipment and improvements to leased premises are depreciated using the straight-line method over the estimated useful lives of the assets, or when applicable, the term of the lease, whichever is shorter. Estimated useful lives generally range from <ix:nonNumeric contextRef="ida5c6a5e34da4b479b384b7941a36f63_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzIzMzQz_d4a5624c-90de-4913-b0fa-074b3cc2c932">1</ix:nonNumeric> to <ix:nonNumeric contextRef="i7176eb6123944cc09d4c6d7cc55667e2_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzIzMzQ5_24b2b6e7-6614-4384-8084-82a4a0d8803e">40</ix:nonNumeric> years for buildings, building improvements and leasehold improvements and <ix:nonNumeric contextRef="i376bdd1660814f0c93637da644c1fc51_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzIzNDI2_d052495d-be3b-4e24-b721-0c1ca1828977">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i9f6f6993588e45758f3afc8079d763a1_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzIzNDMy_89bf29c8-90c6-46b8-ab98-e49f9d0231e9">10</ix:nonNumeric> years for fixtures, equipment and internally developed software. Repair and maintenance costs are charged directly to expense as incurred. Major renewals or replacements that substantially extend the useful life of an asset are capitalized and depreciated. Application development stage costs for significant internally developed software projects are capitalized and depreciated.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDk4_25156d70-15f4-4010-baa6-8fdc3dbfb482" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following at December&#160;31, 2022 and 2021: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10e2a519b4d24c41a2dbb11874bc1f59_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzEtMS0xLTEtMjY1MjQ3_6761f1fb-6815-4cad-9114-484307812d05">1,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i905269377a394b08ac5584c0ccd49b20_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzEtMy0xLTEtMjY1MjQ3_b6028bb2-afe1-4b13-8d65-056047454718">2,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4aa224704f04a019a760bec8864101d_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzItMS0xLTEtMjY1MjQ3_f4b99633-80bf-480d-add6-5b1dd65336ee">4,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib85ef1cc5d3c496aa153d2806241d599_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzItMy0xLTEtMjY1MjQ3_279cc98b-ecc1-4555-8778-f036e8644ba0">4,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixtures and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2296fa243d024a1bb2396c22449c2acf_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzMtMS0xLTEtMjY1MjQ3_102ba8be-9b56-4f54-8747-2679001a27e9">12,978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if995086e891d4d6b897fad3a54f05b27_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzMtMy0xLTEtMjY1MjQ3_bcc01772-af26-4e78-bd3e-f80cdb985dc4">13,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fa701f5944f475ba623a677b1886a1e_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzQtMS0xLTEtMjY1MjQ3_581d172a-44db-4941-b117-c429ee1f4e28">6,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifacaa4d950234294b256a60719467738_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzQtMy0xLTEtMjY1MjQ3_41a19c74-10b0-431e-b2ab-f6c89b9e5f0f">6,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i372db3f8099544d2a643f4329a4871fe_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzUtMS0xLTEtMjY1MjQ3_af8a7dfc-eaee-4ff8-a99f-214eccfbba80">8,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20100980ab444f58ab3077553ee4542c_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzUtMy0xLTEtMjY1MjQ3_3aa40b38-bb50-42b4-a409-81e496e80872">7,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzYtMS0xLTEtMjY1MjQ3_1e8635e6-51c3-44bd-83e4-b5f6d38f7737">34,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzYtMy0xLTEtMjY1MjQ3_6a243bb4-caa3-4bf1-b18c-07ecc152738c">33,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzctMS0xLTEtMjY1MjQ3_1efc0219-a2c8-4188-b84c-2e0f5175f867">21,483</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzctMy0xLTEtMjY1MjQ3_7225d506-fbea-4801-8988-29461862b326">20,654</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzgtMS0xLTEtMjY1MjQ3_45ffec43-02bb-41f0-8c56-5957dfb4b9dc">13,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzgtMy0xLTEtMjY1MjQ3_d8c1f8de-ee0c-442a-a3fb-db20a089921d">12,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes property and equipment of $<ix:nonFraction unitRef="usd" contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231" decimals="-6" name="cvs:PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzIzOTU5_aa540cf2-7876-4bb5-a907-bceb90caad00">244</ix:nonFraction>&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense (which includes the amortization of property and equipment under finance or capital leases) totaled $<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-8" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzI0Mjcw_d04d0008-f3ac-4f8d-a918-c2ff9565365c">2.4</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-8" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzI0Mjc0_96edc53c-9826-420c-9051-cce899322fe1">2.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-8" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzI0Mjgx_ad5b92e7-a4ca-4390-bce5-c48ee485151a">2.1</ix:nonFraction> billion for the years ended December&#160;31, 2022, 2021 and 2020, respectively. During the year ended December&#160;31, 2021, the Company recorded an impairment on property and equipment of $<ix:nonFraction unitRef="usd" contextRef="ief1dfb751b844d4bb4bbe253942b99b2_D20210101-20211231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzI0NDIz_c36c9f87-9c09-4b78-9a35-196c39a8a005">261</ix:nonFraction>&#160;million in connection with the planned closure of certain retail stores. See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about these impairment charges as well as the Company&#8217;s finance leases. </span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i88fdc3ddfb304e07a8c747a3d06db5dc" continuedAt="ibc3a9651f02a4a0e938aabf4c3627f76"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDcz_82b4d62c-270e-4eb2-b054-93a1ddcbcce0" continuedAt="iaf8b6aa8d55f44c0a586fea747b22f0b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Right-of-Use Assets and Lease Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the lease, renewal date of the lease or significant remodeling of the lease space based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company&#8217;s leases is not readily determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The operating lease right-of-use assets also include lease payments made before commencement and are reduced by lease incentives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s real estate leases typically contain options that permit renewals for additional periods of up to <ix:nonNumeric contextRef="ib01e468dcb8f4ca98e9b64ffb83ffbe0_D20220101-20221231" name="cvs:LesseeOperatingAndFinanceLeasesRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzI1NjI3_8ea4b452-91ad-4226-9735-0d7311c992c6">five years</ix:nonNumeric> each. For real estate leases, the options to extend are not considered reasonably certain at lease commencement because the Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and regularly opens or closes stores to align with its operating strategy. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the right-of-use asset and lease liability. Similarly, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. Leases with an initial term of 12 months or less are not recorded on the balance sheets, and lease expense is recognized on a straight-line basis over the term of the short-term lease.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For real estate leases, the Company accounts for lease components and nonlease components as a single lease component. Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the right-of-use assets and lease liabilities.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iaf8b6aa8d55f44c0a586fea747b22f0b">See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about right-of-use assets and lease liabilities.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTc0_ff1169d4-7a49-44b1-9dd7-abfdaca24db3" continuedAt="i76f3097cfe4b4af98fb11f6c4bd4a526" escape="true">Goodwill </ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i76f3097cfe4b4af98fb11f6c4bd4a526">The Company accounts for business combinations using the acquisition method of accounting, which requires the excess cost of an acquisition over the fair value of net assets acquired and identifiable intangible assets to be recorded as goodwill. Goodwill is not amortized, but is subject to impairment reviews annually, or more frequently, if necessary, as further described in &#8220;Recoverability of Long-Lived Assets&#8221; below.</ix:continuation> See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; for additional information about goodwill. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDc1_aa22a71a-0e4d-4986-b8e1-5fa108f2f5f1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s identifiable intangible assets consist primarily of trademarks, trade names, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired (&#8220;VOBA&#8221;). These intangible assets arise primarily from the determination of their respective fair market values at the date of acquisition. Amounts assigned to identifiable intangible assets, and their related useful lives, are derived from established valuation techniques and management estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s definite-lived intangible assets are amortized over their estimated useful lives based upon the pattern of future cash flows attributable to the asset. Definite-lived intangible assets are amortized using the straight-line method. VOBA is subject to loss recognition testing annually, or more frequently, if necessary. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets are not amortized but are tested for impairment annually, or more frequently, if necessary, as further described in &#8220;Recoverability of Long-Lived Assets&#8221; below.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; for additional information about intangible assets. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTY4_74be572c-b037-4fae-8f90-4a81972b55b7" continuedAt="i9c7f8727cd974aaa897281c1a8d60af7" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recoverability of Long-Lived Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the recoverability of long-lived assets, excluding goodwill and indefinite-lived intangible assets, which are tested for impairment using separate tests described below, whenever events or changes in circumstances indicate that the carrying value of such asset may not be recoverable. The Company groups and evaluates these long-lived assets for impairment at the lowest level at which individual cash flows can be identified. If indicators of impairment are present, the Company first </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ibc3a9651f02a4a0e938aabf4c3627f76" continuedAt="ib6a3440d731640bfbb37b6f576f8e817"><ix:continuation id="i9c7f8727cd974aaa897281c1a8d60af7" continuedAt="i4192159788d74c259fb37d9b96d9495f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the asset group&#8217;s estimated future cash flows (discounted). If required, an impairment loss is recorded for the portion of the asset group&#8217;s carrying value that exceeds the asset group&#8217;s estimated future cash flows (discounted). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, the Company recorded office real estate optimization charges of $<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:OfficeRealEstateOptimizationCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzMwMDkx_ff0878a8-0764-44fb-8c69-d639b11f88dd">117</ix:nonFraction>&#160;million primarily related to the abandonment of leased real estate and the related right-of-use assets and property and equipment in connection with the planned reduction of corporate office real estate space in response to its new flexible work arrangement. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, the Company recorded a store impairment charge of approximately $<ix:nonFraction unitRef="usd" contextRef="i397dda43721c4f17b0cef6a6c6ee92a9_D20210101-20211231" decimals="-8" name="cvs:StoreImpairmentCharges" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzMwNDM3_a2081250-773c-410b-873d-40da642c0b3c">1.4</ix:nonFraction>&#160;billion primarily related to the write down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately <ix:nonFraction unitRef="store" contextRef="i397dda43721c4f17b0cef6a6c6ee92a9_D20210101-20211231" decimals="-2" name="cvs:NumberOfStoresPlannedClosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzMwNTk4_75d3e422-9d43-4b75-b1a4-2387d777c48c">900</ix:nonFraction> retail stores between 2022 and 2024. There were no material impairment charges recognized on long-lived assets during the year ended December 31, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about the right-of-use asset charges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When evaluating goodwill for potential impairment, the Company compares the fair value of its reporting units to their respective carrying amounts. The Company estimates the fair value of its reporting units using a combination of a discounted cash flow method and a market multiple method. If the carrying amount of a reporting unit exceeds its estimated fair value, an impairment loss is recognized in an amount equal to that excess. During the third quarter of both 2022 and 2020, the Company performed its required annual impairment tests of goodwill and concluded there were <ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzMxNDA5_329febd1-7587-480a-8a20-76cb2e5e213f"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzMxNDA5_ee9a4de3-3021-4283-83bd-3ed464b48a5a">no</ix:nonFraction></ix:nonFraction> goodwill impairments as of the testing dates or during the years ended December 31, 2022 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company performed its required annual impairment tests of goodwill, the results of which indicated an impairment of the goodwill associated with the LTC reporting unit. Accordingly, during the third quarter of 2021, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="ia262a9274d8f434a9a8fac8f9016ca16_D20210701-20210930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzMxNzg4_fd700c44-60ab-49aa-87dc-290cf5f07383">431</ix:nonFraction>&#160;million goodwill impairment charge on the remaining goodwill of the LTC reporting unit. The results of the impairment tests indicated that there was no impairment of goodwill of the remaining reporting units as of the testing date or during the year ended December&#160;31, 2021. See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; for additional information about the goodwill impairment charge recorded during the year ended December&#160;31, 2021. </span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4192159788d74c259fb37d9b96d9495f">Indefinite-lived intangible assets are tested for impairment by comparing the estimated fair value of the asset to its carrying value. The Company estimates the fair value of its indefinite-lived trademarks using the relief from royalty method under the income approach. If the carrying value of the asset exceeds its estimated fair value, an impairment loss is recognized, and the asset is written down to its estimated fair value.</ix:continuation> There were <ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzMyNTk1_24fcd15a-e011-4803-b6b3-e1ccd75f2633"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzMyNTk1_4852358c-e298-4968-9ede-4c0f08ee2d84"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzMyNTk1_8020dde5-659e-44a8-9702-90a3e6a3cf60">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment losses recognized on indefinite-lived intangible assets in any of the years ended December&#160;31, 2022, 2021 or 2020.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:PolicyholderAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTY5_860c16aa-8624-4419-a9e7-32c15fe9b68b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets and liabilities related to large case pensions products represent funds maintained to meet specific objectives of contract holders who bear the investment risk. These assets and liabilities are carried at fair value. Net investment income (including net realized capital gains and losses) accrue directly to such contract holders. The assets of each account are legally segregated and are not subject to claims arising from the Company&#8217;s other businesses. Deposits, withdrawals and net investment income (including net realized and net unrealized capital gains and losses) on Separate Accounts assets are not reflected in the consolidated statements of operations or cash flows. Management fees charged to contract holders are included in services revenue and recognized over the period earned.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:HealthCareCostsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDkz_2553f075-1154-4bd4-bfe4-86b08be28f25" continuedAt="i2a9d2166c71747a39ced3642719f52a2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Costs Payable</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care costs payable consist principally of unpaid fee-for-service medical, dental and pharmacy claims, capitation costs, other amounts due to providers pursuant to risk-sharing arrangements related to the Health Care Benefits segment&#8217;s Insured Commercial, Medicare and Medicaid products and accruals for state assessments. Unpaid health care claims include an estimate of payments the Company will make for (i) services rendered to the Company&#8217;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid, each as of the financial statement date (collectively, &#8220;IBNR&#8221;). Health care costs payable also include an estimate of the cost of services that will continue to be rendered after the financial statement date if the Company is obligated to pay for such services in accordance with contractual or regulatory requirements. Such estimates are developed using actuarial principles and assumptions which consider, among other things, historical and projected claim submission and processing patterns, assumed and historical medical cost trends, historical utilization of medical services, claim inventory levels, changes in Insured membership and product mix, seasonality </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib6a3440d731640bfbb37b6f576f8e817" continuedAt="if33002ab5ad74dc6a76ca5eaaf5c086a"><ix:continuation id="i2a9d2166c71747a39ced3642719f52a2" continuedAt="i25d0af5fd7ad48c4b132dba12b25f857"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and other relevant factors. The Company reflects changes in these estimates in benefit costs in the Company&#8217;s consolidated operating results in the period they are determined. Capitation costs represent contractual monthly fees paid to participating physicians and other medical providers for providing medical care, regardless of the volume of medical services provided to the Insured member. Amounts due under risk-sharing arrangements are based on the terms of the underlying contracts with the providers and consider claims experience under the contracts through the financial statement date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops its estimate of IBNR using actuarial principles and assumptions that consider numerous factors. Of those factors, the Company considers the analysis of historical and projected claim payment patterns (including claims submission and processing patterns) and the assumed health care cost trend rate (the year-over-year change in per member per month health care costs) to be the most critical assumptions. In developing its IBNR estimate, the Company consistently applies these actuarial principles and assumptions each period, with consideration to the variability of related factors. There have been no significant changes to the methodologies or assumptions used to develop the Company&#8217;s estimate of IBNR in 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company analyzes historical claim payment patterns by comparing claim incurred dates (i.e., the date services were provided) to claim payment dates to estimate &#8220;completion factors.&#8221; The Company uses completion factors predominantly to estimate the ultimate cost of claims incurred more than three months before the financial statement date. The Company estimates completion factors by aggregating claim data based on the month of service and month of claim payment and estimating the percentage of claims incurred for a given month that are complete by each month thereafter. For any given month, substantially all claims are paid within <ix:nonNumeric contextRef="i2a0e4c7bb5f84714898af13dee589b68_D20220101-20221231" name="cvs:HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzM2Nzkz_1c876b1f-271b-4cdd-bbc1-181577525bb0">six months</ix:nonNumeric> of the date of service, but it can take up to <ix:nonNumeric contextRef="ib01e468dcb8f4ca98e9b64ffb83ffbe0_D20220101-20221231" name="cvs:HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzM2ODQy_a086b8cc-5d8d-490e-b0be-768369dfd887">48</ix:nonNumeric> months or longer after the date of service before all of the claims are completely resolved and paid. These historically-derived completion factors are then applied to claims paid through the financial statement date to estimate the ultimate claim cost for a given month&#8217;s incurred claim activity. The difference between the estimated ultimate claim cost and the claims paid through the financial statement date represents the Company&#8217;s estimate of claims remaining to be paid as of the financial statement date and is included in the Company&#8217;s health care costs payable. The completion factors the Company uses reflect judgments and possible adjustments based on data such as claim inventory levels, claim submission and processing patterns and, to a lesser extent, other factors such as changes in health care cost trend rates, changes in Insured membership and changes in product mix. If claims are submitted or processed on a faster (slower) pace than prior periods, the actual claims may be more (less) complete than originally estimated using the Company&#8217;s completion factors, which may result in reserves that are higher (lower) than the ultimate cost of claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because claims incurred within three months before the financial statement date are less mature, the Company uses a combination of historically-derived completion factors and the assumed health care cost trend rate to estimate the ultimate cost of claims incurred for these months. The Company applies its actuarial judgment and places a greater emphasis on the assumed health care cost trend rate for the most recent claim incurred dates as these months may be influenced by seasonal patterns and changes in membership and product mix.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s health care cost trend rate is affected by changes in per member utilization of medical services as well as changes in the unit cost of such services. Many factors influence the health care cost trend rate, including the Company&#8217;s ability to manage benefit costs through product design, negotiation of favorable provider contracts and medical management programs, as well as the mix of the Company&#8217;s business. The health status of the Company&#8217;s Insured members, aging of the population and other demographic characteristics, advances in medical technology and other factors continue to contribute to rising per member utilization and unit costs. Changes in health care practices, inflation, new technologies, increases in the cost of prescription drugs (including specialty pharmacy drugs), direct-to-consumer marketing by pharmaceutical companies, clusters of high-cost cases, claim intensity, changes in the regulatory environment, health care provider or member fraud and numerous other factors also contribute to the cost of health care and the Company&#8217;s health care cost trend rate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each reporting period, the Company uses an extensive degree of judgment in the process of estimating its health care costs payable. As a result, considerable variability and uncertainty is inherent in such estimates, particularly with respect to claims with claim incurred dates of three months or less before the financial statement date; and the adequacy of such estimates is highly sensitive to changes in assumed completion factors and the assumed health care cost trend rates. For each reporting period the Company recognizes the actuarial best estimate of health care costs payable considering the potential volatility in assumed completion factors and health care cost trend rates, as well as other factors. The Company believes its estimate of health care costs payable is reasonable and adequate to cover its obligations at December&#160;31, 2022; however, actual claim payments may differ from the Company&#8217;s estimates. A worsening (or improvement) of the Company&#8217;s health care cost trend rates or changes in completion factors from those that the Company assumed in estimating health care costs payable at December&#160;31, 2022 would cause these estimates to change in the near term, and such a change could be material.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if33002ab5ad74dc6a76ca5eaaf5c086a" continuedAt="ib4f616708cc14e418cae90179983fbdc"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i25d0af5fd7ad48c4b132dba12b25f857">Each quarter, the Company re-examines previously established health care costs payable estimates based on actual claim payments for prior periods and other changes in facts and circumstances. Given the extensive degree of judgment in this estimate, it is possible that the Company&#8217;s estimates of health care costs payable could develop either favorably (that is, its actual benefit costs for the period were less than estimated) or unfavorably. The changes in the Company&#8217;s estimate of health care costs payable may relate to a prior quarter, prior year or earlier periods. For a roll forward of the Company&#8217;s health care costs payable, see Note 7 &#8216;&#8216;Health Care Costs Payable.&#8217;&#8217; The Company&#8217;s reserving practice is to consistently recognize the actuarial best estimate of its ultimate liability for health care costs payable.</ix:continuation></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTMz_8791c36a-7b58-4075-aa81-4d3d520baa44" continuedAt="ie94fab17c0f44d60906947e31f9bcc92" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Insurance Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unpaid Claims</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unpaid claims consist primarily of reserves associated with certain short-duration group disability and term life insurance contracts, including an estimate for IBNR as of the financial statement date. Reserves associated with certain short-duration group disability and term life insurance contracts are based upon the Company&#8217;s estimate of the present value of future benefits, which is based on assumed investment yields and assumptions regarding mortality, morbidity and recoveries from the U.S. Social Security Administration. The Company develops its estimate of IBNR using actuarial principles and assumptions which consider, among other things, contractual requirements, claim incidence rates, claim recovery rates, seasonality and other relevant factors. The Company discounts certain claim liabilities related to group long-term disability and life insurance waiver of premium contracts. The discount rates generally reflect the Company&#8217;s expected investment returns for the investments supporting all incurral years of these liabilities. The discount rates for retrospectively-rated contracts are set at contractually specified levels. The Company&#8217;s estimates of unpaid claims are subject to change due to changes in the underlying experience of the insurance contracts, changes in investment yields or other factors, and these changes are recorded in current and future benefits in the consolidated statements of operations in the period they are determined. The Company estimates its reserve for claims IBNR for life products largely based on completion factors. The completion factors used are based on the Company&#8217;s historical experience and reflect judgments and possible adjustments based on data such as claim inventory levels, claim payment patterns, changes in business volume and other factors. If claims are submitted or processed on a faster (slower) pace than historical periods, the actual claims may be more (less) complete than originally estimated using completion factors, which may result in reserves that are higher (lower) than required to cover future life benefit payments. There have been no significant changes to the methodologies or assumptions used to develop the Company&#8217;s estimate of unpaid claims IBNR in 2022. As of December&#160;31, 2022, unpaid claims balances of $<ix:nonFraction unitRef="usd" contextRef="i1fdcc037f9934dcc9e2153a71efdb1ff_I20221231" decimals="-6" name="cvs:LiabilityForUnpaidClaims" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQzOTY2_06fe5b0f-4a3d-49fc-be82-6bac51136a5a">243</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i899425f497434b61be7e43e83f1ac7e5_I20221231" decimals="-8" name="cvs:LiabilityForUnpaidClaims" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQzOTcz_dbe8a488-7314-45af-976f-8653bb11d9f7">1.1</ix:nonFraction> billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2021, unpaid claims balances of $<ix:nonFraction unitRef="usd" contextRef="i2fe9e107946a4ef9ade4731bbe54052d_I20211231" decimals="-6" name="cvs:LiabilityForUnpaidClaims" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ0MTE0_c3507f7a-8219-4dee-8b8e-dcc00093281e">324</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8399f3149edf4edeac9228c155c337f0_I20211231" decimals="-8" name="cvs:LiabilityForUnpaidClaims" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ0MTIx_55437b90-ea63-4f88-92d4-b59352fdfb11">1.3</ix:nonFraction> billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all life and disability insurance liabilities have been fully ceded to unrelated third parties through indemnity reinsurance agreements; however, the Company remains directly obligated to the policyholders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Future Policy Benefits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future policy benefits consist primarily of reserves for products for which the Company no longer solicits or accepts new customers, including limited payment pension and annuity contracts and long-term care insurance contracts. Contracts are grouped into cohorts by contract type and issue year. The liability for future policy benefits is adjusted for differences between actual and expected experience. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserves for limited payment pension and annuity contracts represent the Company&#8217;s estimate of the present value of future benefits to be paid to or on behalf of policyholders and are computed using actuarial principles that consider, among other things, assumptions reflecting anticipated mortality and retirement experience. On an annual basis, or more frequently if necessary, the Company reviews mortality assumptions against both industry standards and its experience.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserves for long-term care insurance contracts represent the Company&#8217;s estimate of the present value of future benefits and settlement costs to be paid to or on behalf of policyholders less the present value of future net premiums. The Company&#8217;s estimate of the present value of future benefits under such contracts is based upon mortality, morbidity, lapse and interest rate assumptions. On an annual basis, or more frequently if necessary, the Company reviews its mortality, morbidity and lapse assumptions against its experience. Annually, or each time the assumptions are changed, the net premium ratio used to calculate the future policy benefit liability is updated to reflect actual experience, as well as the impact of any change in assumptions on the Company&#8217;s future cash flows. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company discounts its future policy benefit liability using a curve of spot rates derived from Single A rated fixed income instruments. At each reporting date, the Company will measure its liability for future policy benefits using both the current spot </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib4f616708cc14e418cae90179983fbdc" continuedAt="i7dbe14e2278a4b1983e4a600acfa73c2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie94fab17c0f44d60906947e31f9bcc92">rate curve and the locked-in discount rate at each cohort&#8217;s inception. Any difference between the measured liabilities is recorded in other comprehensive income (loss).</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, future policy benefits balances of $<ix:nonFraction unitRef="usd" contextRef="i1fdcc037f9934dcc9e2153a71efdb1ff_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ1Njkw_30d55711-452a-4675-a5d2-653608ecfcfb">334</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i899425f497434b61be7e43e83f1ac7e5_I20221231" decimals="-8" name="us-gaap:LiabilityForFuturePolicyBenefits" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ1Njk3_fc321ffd-90ca-4bf8-8eb6-b2c07acf9c88">4.7</ix:nonFraction> billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2021, future policy benefits balances of $<ix:nonFraction unitRef="usd" contextRef="i2fe9e107946a4ef9ade4731bbe54052d_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ1ODQ3_09fae4d5-bc84-451a-a3b4-96bbc1edb0c8">458</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8399f3149edf4edeac9228c155c337f0_I20211231" decimals="-8" name="us-gaap:LiabilityForFuturePolicyBenefits" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ1ODU0_a727567d-072f-4a12-9bd8-ceda9bbcde82">6.0</ix:nonFraction> billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="cvs:InsurancePremiumDeficiencyReservePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDY5_8cdf3e45-2ed3-4439-8889-559b2ada7ea2" continuedAt="i648745957170468ea636fcc786fb8da6" escape="true">Premium Deficiency Reserves</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i648745957170468ea636fcc786fb8da6">The Company evaluates its short-duration insurance contracts to determine if it is probable that a loss will be incurred. A premium deficiency loss is recognized when it is probable that expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), will exceed existing reserves plus anticipated future premiums and reinsurance recoveries. Anticipated investment income is not considered in the calculation of premium deficiency losses. For purposes of determining premium deficiency losses, contracts are grouped consistent with the Company&#8217;s method of acquiring, servicing and measuring the profitability of such contracts.</ix:continuation> The Company did <ix:nonFraction unitRef="usd" contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ2Njk2_eecf8bf7-7e03-48fa-b40e-aa7836186475">not</ix:nonFraction> have any premium deficiency reserves as of December&#160;31, 2022. As of December&#160;31, 2021, the Company established a premium deficiency reserve of $<ix:nonFraction unitRef="usd" contextRef="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ2ODEy_386f7061-ba98-4825-96c2-bb996a730f39">16</ix:nonFraction> million related to Medicaid products in the Health Care Benefits segment. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:AllocationsToPolicyholdersPolicies" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MjEw_d75a797d-d47d-4b1f-98ec-4341cd1c0e23" continuedAt="ie1d03cbd16924db59c94f7058abb6014" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policyholders&#8217; Funds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Policyholders&#8217; funds consist primarily of reserves for pension and annuity investment contracts and customer funds associated with certain health contracts. Reserves for such contracts are equal to cumulative deposits less withdrawals and charges plus interest credited thereon, net of experience-rated adjustments. In both 2022 and 2021, interest rates for pension and annuity investment contracts ranged from <ix:nonFraction unitRef="number" contextRef="i2a0e4c7bb5f84714898af13dee589b68_D20220101-20221231" decimals="3" name="cvs:PensionAndAnnuityInvestmentContractsInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ3MzEy_4dd46b09-b988-47a1-b62b-b2c19ce712bc"><ix:nonFraction unitRef="number" contextRef="i48c79709e147425a97e76cb1ddd62633_D20210101-20211231" decimals="3" name="cvs:PensionAndAnnuityInvestmentContractsInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ3MzEy_719f1c8e-9b95-443d-8c80-0ff5bee15057">3.5</ix:nonFraction></ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ib01e468dcb8f4ca98e9b64ffb83ffbe0_D20220101-20221231" decimals="3" name="cvs:PensionAndAnnuityInvestmentContractsInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ3MzE4_629f6f05-32f7-4217-aa0f-c9758f2371ca"><ix:nonFraction unitRef="number" contextRef="i862ddd84e7aa45819c8c9210518db7da_D20210101-20211231" decimals="3" name="cvs:PensionAndAnnuityInvestmentContractsInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ3MzE4_dcf4d68c-b386-480d-ae58-47c52fa1c71a">4.8</ix:nonFraction></ix:nonFraction>%. Reserves for contracts subject to experience rating reflect the Company&#8217;s rights as well as the rights of policyholders and plan participants. The Company also held funds for HSAs on behalf of members associated with high deductible health plans prior to the sale of PayFlex in June 2022. These amounts were held to pay for qualified health care expenses incurred by these members. At December&#160;31, 2022, the Company did <ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-8" name="cvs:HeathSavingsAccountBalance" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ3NzI3_55b9aa71-a175-4b7e-af57-3aec294af654">not</ix:nonFraction> hold any HSA funds as a result of the PayFlex sale. The HSA balance was approximately $<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-8" name="cvs:HeathSavingsAccountBalance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ3ODE2_4d199a71-255f-4b53-8c1d-b83508ea40f7">2.9</ix:nonFraction> billion at December 31, 2021 and was reflected in other current assets with a corresponding liability in policyholders&#8217; funds. These assets were considered restricted cash for cash flow statement purposes.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie1d03cbd16924db59c94f7058abb6014">Policyholders&#8217; funds liabilities that are expected to be paid within twelve months from the balance sheet date are classified as current on the consolidated balance sheets. Policyholders&#8217; funds liabilities that are expected to be paid greater than twelve months from the balance sheet date are included in other long-term liabilities on the consolidated balance sheets.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:SelfInsuranceReservePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDY3_df35e684-19da-4063-b6e8-51fedaf51d7e" continuedAt="i6e4ebd9126b34dc8bf62817aa624bef8" escape="true">Self-Insurance Liabilities</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6e4ebd9126b34dc8bf62817aa624bef8">The Company is self-insured for certain losses related to general liability, workers&#8217; compensation and auto liability. The Company obtains third party insurance coverage to limit exposure from these claims. The Company is also self-insured for certain losses related to health and medical liabilities. The Company&#8217;s self-insurance accruals, which include reported claims and claims incurred but not reported, are calculated using standard insurance industry actuarial assumptions and the Company&#8217;s historical claims experience.</ix:continuation> As of both December&#160;31, 2022 and 2021, self-insurance liabilities totaled $<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-8" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ5MDAx_02a6e576-d6a3-4af6-9e59-0cbd6321806f"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-8" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ5MDAx_2fc701ed-3f7b-40ba-9d45-074656ae11f6">1.1</ix:nonFraction></ix:nonFraction> billion and were recorded in accrued expenses and other long-term liabilities on the consolidated balance sheets.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTgw_72aaedac-78fc-4138-8f4d-f0060cfd14ea" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation and Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For non-U.S. dollar functional currency locations, (i) assets and liabilities are translated at end-of-period exchange rates, (ii) revenues and expenses are translated at average exchange rates in effect during the period and (iii) equity is translated at historical exchange rates. The resulting cumulative translation adjustments are included as a component of accumulated other comprehensive income (loss).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For U.S. dollar functional currency locations, foreign currency assets and liabilities are remeasured into U.S. dollars at end-of-period exchange rates, except for nonmonetary balance sheet accounts which are remeasured at historical exchange rates. Revenues and expenses are remeasured at average exchange rates in effect during each period, except for those expenses related to the nonmonetary balance sheet amounts which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in net income.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7dbe14e2278a4b1983e4a600acfa73c2" continuedAt="ica4ccb44fce34b7aa0e8ee53785e0cf4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and losses from foreign currency transactions and the effects of foreign currency remeasurements were not material in the years ended December&#160;31, 2022, 2021 or 2020. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTE0_6c3d08a5-3d7f-4b20-b918-d59bdea15e6c" continuedAt="if9c45c6d915e48bc8b49a11096d1cbf7" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health Care Benefits revenue is principally derived from insurance premiums and fees billed to customers. Revenue is recognized based on customer billings, which, in the Company&#8217;s Commercial business, reflect contracted rates per member and the number of covered members recorded in the Company&#8217;s records at the time the billings are prepared. Billings are generally sent monthly for coverage during the following month. Revenue related to the Company&#8217;s Government business is collected monthly from the U.S. federal government and various government agencies based on fixed payment rates and member eligibility. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s billings may be subsequently adjusted to reflect enrollment changes due to member terminations or other factors. These adjustments are known as retroactivity adjustments. In each period, the Company estimates the amount of future retroactivity and adjusts the recorded revenue accordingly. As information regarding actual retroactivity amounts becomes known, the Company refines its estimates and records any required adjustments to revenues in the period in which they arise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Premium Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums are recognized as revenue in the month in which the enrollee is entitled to receive health care services. Premiums are reported net of an allowance for estimated terminations and uncollectible amounts. Additionally, premium revenue subject to the minimum medical loss ratio (&#8220;MLR&#8221;) rebate requirements of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (as amended, collectively, the &#8220;ACA&#8221;) is recorded net of the estimated minimum MLR rebates for the current calendar year. Premiums related to unexpired contractual coverage periods (unearned premiums) are reported as other insurance liabilities on the consolidated balance sheets and recognized as revenue when earned.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s contracts allow for premiums to be adjusted to reflect actual experience or the relative health status of Insured members. Such adjustments are reasonably estimable at the outset of the contract, and adjustments to those estimates are made based on actual experience of the customer emerging under the contract and the terms of the underlying contract.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Services Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue relates to contracts that can include various combinations of services or series of services which generally are capable of being distinct and accounted for as separate performance obligations. The Health Care Benefits segment&#8217;s services revenue primarily consists of ASC fees received in exchange for performing certain claim processing and member services for ASC members. ASC fee revenue is recognized over the period the service is provided. Some of the Company&#8217;s administrative services contracts include guarantees with respect to certain functions, such as customer service response time, claim processing accuracy and claim processing turnaround time, as well as certain guarantees that a plan sponsor&#8217;s benefit claim experience will fall within a certain range. With any of these guarantees, the Company is financially at risk if the conditions of the arrangements are not met, although the maximum amount at risk typically is limited to a percentage of the fees otherwise payable to the Company by the customer involved. Each period the Company estimates its obligations under the terms of these guarantees and records its estimate as an offset to services revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting for Medicare Part D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include insurance premiums earned by the Company&#8217;s PDPs, which are determined based on the PDP&#8217;s annual bid and related contractual arrangements with the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;). The insurance premiums include a beneficiary premium, which is the responsibility of the PDP member, and can be subsidized by CMS in the case of low-income members, and a direct premium paid by CMS. Premiums collected in advance are initially recorded within other insurance liabilities and are then recognized ratably as revenue over the period in which members are entitled to receive benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues also include a risk-sharing feature of the Medicare Part D program design referred to as the risk corridor. The Company estimates variable consideration in the form of amounts payable to, or receivable from, CMS under the risk corridor, and adjusts revenue based on calculations of additional subsidies to be received from or owed to CMS at the end of the reporting year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to Medicare Part D premiums, the Company receives additional payments each month from CMS related to catastrophic reinsurance, low-income cost-sharing subsidies and coverage gap benefits. If the subsidies received differ from the </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ica4ccb44fce34b7aa0e8ee53785e0cf4" continuedAt="i5b732646897f45a68ec464fce4f02011"><ix:continuation id="if9c45c6d915e48bc8b49a11096d1cbf7" continuedAt="i3ce54a02377c47f98c55e254fffafb89"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amounts earned from actual prescriptions transferred, the difference is recorded in either accounts receivable, net or accrued expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Services segment sells prescription drugs directly through its specialty and mail order pharmacy offerings and indirectly through the Company&#8217;s retail pharmacy network. The Company&#8217;s pharmacy benefit arrangements are accounted for in a manner consistent with a master supply arrangement as there are no contractual minimum volumes and each prescription is considered a separate purchasing decision and distinct performance obligation transferred at a point in time. PBM services performed in connection with each prescription claim are considered part of a single performance obligation which culminates in the fulfillment of prescription drugs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue using the gross method at the contract price negotiated with its clients when the Company has concluded it controls the prescription drug before it is transferred to the client plan members. The Company controls prescriptions fulfilled indirectly through its retail pharmacy network because it has separate contractual arrangements with those pharmacies, has discretion in setting the price for the transaction and assumes primary responsibility for fulfilling the promise to provide prescription drugs to its client plan members while also performing the related PBM services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include (i) the portion of the price the client pays directly to the Company, net of any discounts earned on brand name drugs or other discounts and refunds paid back to the client (see &#8220;Drug Discounts&#8221; and &#8220;Guarantees&#8221; below), (ii) the price paid to the Company by client plan members for mail order prescriptions and the price paid to retail network pharmacies by client plan members for retail prescriptions (&#8220;retail co-payments&#8221;), and (iii) claims based administrative fees for retail pharmacy network contracts. Sales taxes are not included in revenues. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when control of the prescription drugs is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those prescription drugs. The Company has established the following revenue recognition policies for the Health Services segment:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by third party pharmacies in the Company&#8217;s retail pharmacy network and associated administrative fees are recognized at the Company&#8217;s point-of-sale, which is when the claim is adjudicated by the Company&#8217;s online claims processing system and the Company has transferred control of the prescription drug and completed all of its performance obligations.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by specialty and mail order pharmacies are recognized when the prescription drug is delivered to the client plan member. At the time of delivery, the Company has performed substantially all of its performance obligations under its client contracts and does not experience a significant level of returns or reshipments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts under which the Company acts as an agent or does not control the prescription drugs prior to transfer to the client plan member, revenue is recognized using the net method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Drug Discounts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records revenue net of manufacturers&#8217; rebates earned by its clients based on their plan members&#8217; utilization of brand-name formulary drugs. The Company estimates these rebates at period-end based on actual and estimated claims data and its estimates of the manufacturers&#8217; rebates earned by its clients. The estimates are based on the best available data at period-end and recent history for the various factors that can affect the amount of rebates due to the client. The Company adjusts its rebates payable to clients to the actual amounts paid when these rebates are paid or as significant events occur. Any cumulative effect of these adjustments is recorded against revenues at the time it is identified. Adjustments generally result from contract changes with clients or manufacturers that have retroactive rebate adjustments, differences between the estimated and actual product mix subject to rebates, or whether the brand name drug was included in the applicable formulary. The effect of adjustments between estimated and actual manufacturers&#8217; rebate amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantees</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also adjusts revenues for refunds owed to clients resulting from pricing guarantees and performance against defined service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5b732646897f45a68ec464fce4f02011" continuedAt="ib2ffec79be534b3384c787639860b559"><ix:continuation id="i3ce54a02377c47f98c55e254fffafb89" continuedAt="ia3701b7123ac4064a93c2911f011967e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Walk-In Medical Clinics</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For services provided by the Company&#8217;s walk-in medical clinics, revenue recognition occurs for completed services provided to patients, with adjustments taken for third party payor contractual obligations and patient direct bill historical collection rates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy &amp; Consumer Wellness Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Retail Pharmacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s retail drugstores recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims under other retail network arrangements. Revenues are adjusted for refunds owed to third party payers resulting from pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Company gift cards purchased by customers is deferred as a contract liability until goods or services are transferred. Any amounts not expected to be redeemed by customers (i.e., breakage) are recognized based on historical redemption patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer returns are not material to the Company&#8217;s operating results or financial condition. Sales taxes are not included in revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Loyalty and Other Programs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customer loyalty program, ExtraCare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, consists of two components, ExtraSavings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Rewards. ExtraSavings are coupons that are recorded as a reduction of revenue when redeemed as the Company concluded that they do not represent a promise to the customer to deliver additional goods or services at the time of issuance because they are not tied to a specific transaction or spending level. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ExtraBucks Rewards are accumulated by customers based on their historical spending levels. Thus, the Company has determined that there is an additional performance obligation to those customers at the time of the initial transaction. The Company allocates the transaction price to the initial transaction and the ExtraBucks Rewards transaction based upon the relative standalone selling price, which considers historical redemption patterns for the rewards. Revenue allocated to ExtraBucks Rewards is recognized as those rewards are redeemed. At the end of each period, unredeemed ExtraBucks Rewards are reflected as a contract liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also offers a subscription-based membership program, CarePass</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, under which members are entitled to a suite of benefits delivered over the course of the subscription period, as well as a promotional reward that can be redeemed for future goods and services. Subscriptions are paid for on a monthly or annual basis at the time of or in advance of the Company delivering the goods and services. Revenue from these arrangements is recognized as the performance obligations are satisfied.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-term Care</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those goods or services. Each prescription claim represents a separate performance obligation of the Company, separate and distinct from other prescription claims under customer arrangements. A significant portion of long-term care revenue from sales of pharmaceutical and medical products is reimbursed by the federal Medicare Part D program and, to a lesser extent, state Medicaid programs. The Company monitors its revenues and receivables from these reimbursement sources, as well as long-term care facilities and other third party insurance payors, and reduces revenue at the revenue recognition date to properly account for the variable consideration due to anticipated differences between billed and reimbursed amounts. Accordingly, the total revenues and receivables reported in the Company&#8217;s consolidated financial statements are recorded at the amount expected to be ultimately received from these payors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient co-payments associated with Medicare Part D, certain state Medicaid programs, Medicare Part B and certain third party payors typically are not collected at the time products are delivered or services are rendered, but are billed to the individuals as part of normal billing procedures and subject to normal accounts receivable collections procedures.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib2ffec79be534b3384c787639860b559" continuedAt="i9b8720412f3f4291afab5f48491a6240"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTc3_aae19c8f-40dc-4b09-95ea-c80829875f7c" continuedAt="ib7703dad09e541adbec11fa2ddd0d877" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company&#8217;s revenue by major source in each segment for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.334%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp;<br/>Consumer<br/>Wellness</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a11ece2d2cd42918420ea7f1dd5ba50_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMtMS0xLTEtMjY1MjQ3_9ff924cd-030a-478e-99eb-d0ce657bf6e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b20d67c786d4c91b7f3bfeff6c94528_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMtMy0xLTEtMjY1MjQ3_948a3f36-339c-4046-88f5-6276a03cd86f">166,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad2fca2727bb48aa90b14ecf9c1284f3_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMtNS0xLTEtMjY1MjQ3_6eced926-c3ed-43fe-b599-d9bd83468f6e">83,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14e1fb81ffc34c22b66f30e2108faff0_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMtNy0xLTEtMjY1MjQ3_f1844254-6583-405f-a362-57674551852e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id181fe4cc7404cdabbe77d3f7fc155e0_D20220101-20221231" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMtOS0xLTEtMjY1MjQ3_d063f2c4-b08d-4565-b830-c5ef6903b58d">45,154</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff2a00c33afd4f03b1e2f8fd84299373_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMtMTEtMS0xLTI2NTI0Nw_95b7fdf6-7bf0-4044-bea1-c3e2eb563648">205,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0ad789c62b74d228c609da2255bbaa9_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzQtMS0xLTEtMjY1MjQ3_e930c448-144c-4cde-80a5-d18aef441596">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife56d28f21ca44e0bc934fe219064fe1_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzQtMy0xLTEtMjY1MjQ3_0221b2bb-8fbf-4ac6-a0bf-4434d5e43781">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia64bc989c4c4444ebef0e99f699fb65a_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzQtNS0xLTEtMjY1MjQ3_62b5ab63-d040-425c-b3b2-c32ef67487c4">22,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45fa51dd20a749798549f98bd1811f08_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzQtNy0xLTEtMjY1MjQ3_a2ca02d7-a7d5-410d-abba-fc2048da2137">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad97b3767fd64724b1e3d77672941a0a_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzQtOS0xLTEtMjY1MjQ3_409bf9f0-b437-499b-aa99-f77c0547690d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9d3e97b86034daf987c6fda27a02728_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzQtMTEtMS0xLTI2NTI0Nw_38255c7f-03ff-4f90-ae55-b12bfa345f75">22,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3117bdb07278486084dff9ebb49a80e0_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzUtMS0xLTEtMjY1MjQ3_a4c3ed22-939b-4385-9966-d2daa65282ad">85,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f7744badced45919f97d66a9ec50adf_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzUtMy0xLTEtMjY1MjQ3_88865724-9e96-4438-a9d6-cb34fe1c37f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03b300885d9b456b84c6c73e4bdacfb2_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzUtNS0xLTEtMjY1MjQ3_20e4ef41-b9b5-481d-97c9-e19b141a96eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i320c789c426742bfab03ca5ea3757c5f_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzUtNy0xLTEtMjY1MjQ3_3128e661-a12b-4788-9cd5-0ed9a38bf0e8">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id41082cc7c8f4e46b55567b48080c270_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzUtOS0xLTEtMjY1MjQ3_dc17d240-fb03-47a9-90b8-5a7e9e06e670">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if916c9222361492f8e532d2cacfc7aec_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzUtMTEtMS0xLTI2NTI0Nw_8b7cfe26-c029-466a-8a04-401763d1eff4">85,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a07c8633b37492ba109c7cd9a92299a_D20220101-20221231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzYtMS0xLTEtMjY1MjQ3_4199b1d4-a58e-4849-b686-f786c63f3e32">476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzYtMy0xLTEtMjY1MjQ3_da508278-e23d-49e3-8bdf-38a5a1a6a50c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd57b0b73c1b4e1aa835dde2abf6925c_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzYtNS0xLTEtMjY1MjQ3_a225e3ce-b253-4697-b06f-3968e8eab82a">44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1d5e5a55e6f4909a1d1c3d2003ec720_D20220101-20221231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzYtNy0xLTEtMjY1MjQ3_b10ae807-4e93-44db-92b8-832665f6d4da">406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib085c0543c9d4988b6b20b9b427998b0_D20220101-20221231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzYtOS0xLTEtMjY1MjQ3_c5021afd-7fe8-4a3b-9b4e-72a70d70dfba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzYtMTEtMS0xLTI2NTI0Nw_a0ab76f4-e12e-4d9d-841f-9a5998d295b5">838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e79fec42f4945048db04ab6d125dac1_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzctMS0xLTEtMjY1MjQ3_f0abd834-3ec3-485e-8773-0c90a80e8e98">5,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35e22eaaaf4b979443a4b29ecfdb2b_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzctMy0xLTEtMjY1MjQ3_7f9d5195-ed42-49ac-a46d-12136cd1de11">2,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib63de3071db248ca9ce666c685ac2d8a_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzctNS0xLTEtMjY1MjQ3_c602d0b9-c4f5-411d-8d5e-193d93e84acd">2,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ffea29085e4c2bbee4c937c682d535_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzctNy0xLTEtMjY1MjQ3_bd4afe59-888c-46bc-940f-9ef431ab8e05">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dc095ba84374b6f97db2d50eca661e7_D20220101-20221231" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzctOS0xLTEtMjY1MjQ3_7e9def31-e1ba-4f1e-9d3e-714653e3d499">2,431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if14d784717ae45699afa13fa2039d20a_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzctMTEtMS0xLTI2NTI0Nw_f133c142-cc3e-45f9-b6fc-db49093d3a77">8,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a07c8633b37492ba109c7cd9a92299a_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzgtMS0xLTEtMjY1MjQ3_a966812f-fa43-45c0-b10b-4b9f9f8e6d4b">91,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzgtMy0xLTEtMjY1MjQ3_c793c5ad-79cc-4a81-b609-1e3fb46a68d1">169,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd57b0b73c1b4e1aa835dde2abf6925c_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzgtNS0xLTEtMjY1MjQ3_42c34c0f-1f54-4f1e-af5a-ac578e3a402e">108,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1d5e5a55e6f4909a1d1c3d2003ec720_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzgtNy0xLTEtMjY1MjQ3_85809ee1-905d-46b9-8f9a-addf2bff5e8b">530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib085c0543c9d4988b6b20b9b427998b0_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzgtOS0xLTEtMjY1MjQ3_fe8f76a5-0cef-4b44-80c8-3054d81a0841">47,585</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzgtMTEtMS0xLTI2NTI0Nw_35b7949d-e2fb-4400-971c-bf05c4442f76">322,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Health Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14593b1d8b2c4b0098e818ce890bc9b8_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzExLTMtMS0xLTI2NTI0Nw_0288387a-2456-4f75-85fc-f66ac3ad715b">102,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail &amp; specialty </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3298f299bddc4992829c48dead520fc8_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzEyLTMtMS0xLTI2NTI0Nw_13b45e59-5fcd-48b1-bf42-6f2b5500e2d7">63,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07f19f7971c940519c88697285174722_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzEzLTMtMS0xLTI2NTI0Nw_84faba2d-f880-4d92-b032-106cc5d39186">2,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE0LTMtMS0xLTI2NTI0Nw_2181379b-6c4c-44d3-8927-cd0a83fc310e">169,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e89e68e590a458991b469aa7f41bb36_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE4LTEtMS0xLTI2NTI0Nw_087180ef-66b4-48a8-ae52-f8d8cbd7fc32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea79f3c8d0b7431583f7968ea612fd3a_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE4LTMtMS0xLTI2NTI0Nw_6b1b73c2-a381-4390-a7e5-3f6cd1e799cc">150,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a66d7067aa7482dbb0f8422aa4c6e42_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE4LTUtMS0xLTI2NTI0Nw_6cb09cd6-5b86-4061-8e78-51b0d02ad5ee">77,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48798a4511874c8892972dcc0082ab04_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE4LTctMS0xLTI2NTI0Nw_5cfec845-37e1-4641-9052-3d52840ff45b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3df790a9a364d22876a558fdc974055_D20210101-20211231" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE4LTktMS0xLTI2NTI0Nw_9ca23eb7-f64f-45a9-89b8-60f9df60fb0e">43,913</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5228862959aa458aa4cf0f0ecedde213_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE4LTExLTEtMS0yNjUyNDc_80bd3569-6599-4ed7-902a-a45c8b884130">184,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33b1145120c34228ad6a8552aa2ea289_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE5LTEtMS0xLTI2NTI0Nw_77f62a72-9e52-4e01-9762-4c49943aec81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bd8d6d2503d4faebea52625423e074a_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE5LTMtMS0xLTI2NTI0Nw_76b6d5eb-eac6-4116-8fef-460f350a29d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae492ed264f4e44bfba42f67cdfceda_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE5LTUtMS0xLTI2NTI0Nw_d97e17cd-2c7d-4961-a992-9c3b39ffcf0a">21,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30c3c2a12d62424091c32bc5d8bbb9a9_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE5LTctMS0xLTI2NTI0Nw_3355477e-fcd2-435e-badb-3c779b651cea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09a4ce3d435546c9b89e1b000c479765_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE5LTktMS0xLTI2NTI0Nw_5154e0f2-4985-44ed-860e-729c3913248c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeea9a469c0d4f9abb5266144d9a1b84_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE5LTExLTEtMS0yNjUyNDc_dae999e0-c906-40da-8c4f-4a558b3151a6">21,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i160c1d2789d34ba0bab068f3568ee908_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIwLTEtMS0xLTI2NTI0Nw_372bdac0-1dff-487a-bba7-8b8f5cd08a05">76,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73bc8fff551437d8b63b1fba165b13a_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIwLTMtMS0xLTI2NTI0Nw_464503ee-08ae-4190-bbaa-f48bccc4da40">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i162e562c13814497a56524c6ec2a34fd_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIwLTUtMS0xLTI2NTI0Nw_35a52f87-e617-4a56-86ab-63121e6aa744">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff9fe2e514b24d7a8dea10c9425c3f0c_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIwLTctMS0xLTI2NTI0Nw_ca04d20e-3e43-4cb7-bb4c-09f4f368a4ec">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie09911fb17414836bb68eaeb03ab61ca_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIwLTktMS0xLTI2NTI0Nw_d3e9e692-85c1-4ca9-9021-309b1f8b32f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06284eff72e64927a66522466999f6d2_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIwLTExLTEtMS0yNjUyNDc_6598d7b4-016d-444e-a00c-489e43bf623f">76,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1edd8caecae44ce995f38b9edd410db7_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIxLTEtMS0xLTI2NTI0Nw_a48f5ebc-a3ba-4b1e-af18-130d4bade7c4">586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie123d487288b460289e6aaf6ae104852_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIxLTMtMS0xLTI2NTI0Nw_1b6198ad-1a9e-466d-ae00-cfec00e88f8b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d2a7ac149f64c73a8f3b978546f2741_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIxLTUtMS0xLTI2NTI0Nw_00db84ab-fd8c-4637-8a9b-b9dbc64e0c2a">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0cc9849a9ff470b935a370313045788_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIxLTctMS0xLTI2NTI0Nw_3784658d-14b2-470a-be90-944527ba0dbd">596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i977f19fae3bf4bc8963ec72c8c49ebdc_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIxLTktMS0xLTI2NTI0Nw_1ddc656d-f3ff-49ef-a6b1-3b0ea0bc2ffd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIxLTExLTEtMS0yNjUyNDc_9170ac72-b2ab-41ce-837f-b478cb91f07d">1,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia648581c57dc457bbec0147f946c9c94_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIyLTEtMS0xLTI2NTI0Nw_85d32c11-90a3-42a0-8145-b47989ff1ba5">5,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib47b357e921d48fe83a680844e7d44d1_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIyLTMtMS0xLTI2NTI0Nw_28c1fc06-9a5b-4e24-9881-c5594901b9aa">3,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff457075247c43c5b18562ff48f847b4_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIyLTUtMS0xLTI2NTI0Nw_edbf3129-e737-4138-991d-b1c15381ea7b">2,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f5aa10ed17d4bcfb6e9c9314f81c9fc_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIyLTctMS0xLTI2NTI0Nw_52767d8b-2218-4ac5-a623-141358253fc1">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8e34b73c65d4da0ad42e0f3666f7598_D20210101-20211231" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIyLTktMS0xLTI2NTI0Nw_c7ab3ff7-8712-46c3-a34d-0b2c4fcf974a">2,328</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bbfa9181d494da180bb0ffaf4540e76_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIyLTExLTEtMS0yNjUyNDc_777ab7b3-6d6e-405b-a451-fb905aaf6bd6">8,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1edd8caecae44ce995f38b9edd410db7_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIzLTEtMS0xLTI2NTI0Nw_9f46be25-fd95-49a5-9e7b-a11799a44082">82,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie123d487288b460289e6aaf6ae104852_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIzLTMtMS0xLTI2NTI0Nw_209d96c1-cddd-4836-b599-cdf97a87d677">153,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d2a7ac149f64c73a8f3b978546f2741_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIzLTUtMS0xLTI2NTI0Nw_dee77a4e-548c-4bb4-bb3a-4cecfceb4fc6">101,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0cc9849a9ff470b935a370313045788_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIzLTctMS0xLTI2NTI0Nw_745d8748-9c11-4ca5-9aed-260a812ae305">721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i977f19fae3bf4bc8963ec72c8c49ebdc_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIzLTktMS0xLTI2NTI0Nw_4c87ab3b-1105-4320-9ef1-cf78536021e0">46,241</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIzLTExLTEtMS0yNjUyNDc_e759ca0a-c930-403f-ab36-4881663f6fdf">292,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Health Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie30b20aa9e074cae88b963a48417ada9_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzI2LTMtMS0xLTI2NTI0Nw_639d609f-3f6a-4a86-a113-57aee38a6a12">96,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail &amp; specialty </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1664ef87611a43fe8c8c2e9a3c70f7f2_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzI3LTMtMS0xLTI2NTI0Nw_3ffc3578-8690-4baa-a198-cf552d62b32c">53,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f342e37bfce4f6ca560a33df132c468_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzI4LTMtMS0xLTI2NTI0Nw_77c7e653-d810-427a-8eb4-d972481f7641">3,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie123d487288b460289e6aaf6ae104852_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzI5LTMtMS0xLTI2NTI0Nw_ec9bf910-2049-48a8-bba2-3f80d5315a20">153,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a6f560ef5640399300e7fe75e9aa5c_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMzLTEtMS0xLTI2NTI0Nw_f8b6e81f-7be4-4ce6-aa6a-59bf39394889">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie743c62714f54fd4bf1245a78eee0b5b_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMzLTMtMS0xLTI2NTI0Nw_3105c8bd-4ccd-43d7-a5ef-032a4f757939">139,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd24d97a59214d52b3c9750f7e7d3d7d_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMzLTUtMS0xLTI2NTI0Nw_6f8714cf-caa3-4b4c-bb3c-646928b47ee7">71,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia84c2cc8a91c4cf4aa0584d43740ee58_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMzLTctMS0xLTI2NTI0Nw_65bcde3a-cc4c-4b9e-a220-b14107a2f2c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i494f38c837794730a4d4ce042956fda5_D20200101-20201231" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMzLTktMS0xLTI2NTI0Nw_b7a04229-17c3-4d38-80cb-3c876e475e7c">40,350</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5895590dd43041059596c19c70b48ee4_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMzLTExLTEtMS0yNjUyNDc_0228eda5-612b-4cba-9c10-4746a39b624d">171,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib399dae772f1473b882823660572095c_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM0LTEtMS0xLTI2NTI0Nw_8cde484c-024a-49c2-847a-a3507b1b13a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96881c941f4b4a52b49bb77d5efbf3d4_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM0LTMtMS0xLTI2NTI0Nw_988d7cbc-70fb-4590-b2cd-ed41118ed55e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f0350ddd508488d8327fe9125a60729_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM0LTUtMS0xLTI2NTI0Nw_b40fa473-e6d2-487f-bfdd-aec47ece1617">19,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b31ec7f183b4cd69d634f84d8e4c94e_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM0LTctMS0xLTI2NTI0Nw_f926047c-1747-435c-b7e4-1df7d0b74d90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedc7e31aa44c40608ab490e5abeb6907_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM0LTktMS0xLTI2NTI0Nw_3428540a-56d4-434e-8c5a-b995c854c7c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id61b0b83a53943a09bb0a1124d0f0e47_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM0LTExLTEtMS0yNjUyNDc_6fb35b93-e261-4aa2-a52c-c5ec47501321">19,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea9bfe47ba434e67af70f9a941c950d9_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM1LTEtMS0xLTI2NTI0Nw_c4516ca4-c30e-4a57-a747-936f8e67e86a">69,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia44cce9280244cbb8b54b2754221e394_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM1LTMtMS0xLTI2NTI0Nw_da0c7faa-1cbe-49a6-bc32-5d82c5c6d6ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cbdb8dae69a4ce4bcb45058e576038d_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM1LTUtMS0xLTI2NTI0Nw_9d6ace6f-e7d1-4931-b680-87fbb58d6dc3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a476fae69fc4c64809902a59beedc6a_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM1LTctMS0xLTI2NTI0Nw_563b3664-6c66-4cc9-a307-e8a3ab2975fe">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i181bfd6aedfc4e29b5b22d6b864e2ec4_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM1LTktMS0xLTI2NTI0Nw_30a9ad15-0a54-45b8-ac69-a6f4407a64bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ffcc008b85f412bae79b1893943f70c_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM1LTExLTEtMS0yNjUyNDc_ae57d2eb-8607-4aa0-a8c5-eb51c91d4c57">69,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95a883374f34cadb8aba20153008269_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM2LTEtMS0xLTI2NTI0Nw_07c77514-0308-40b7-a23a-c36ba226c315">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM2LTMtMS0xLTI2NTI0Nw_4113d52c-7422-429f-a999-0dc96af662df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7a2e3c175d84b5aa44a7a859d45ad5d_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM2LTUtMS0xLTI2NTI0Nw_726aeb9d-44fa-40d1-aeb6-3092c02bb7ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ce5e18976c2489a9a964cdebbae85ac_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM2LTctMS0xLTI2NTI0Nw_2ca90c32-cd20-449b-90ec-e76ebacba239">315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37c56e2626d741fc89c81191ac507cb5_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM2LTktMS0xLTI2NTI0Nw_9e05af21-0786-432e-b520-a79efef47673">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM2LTExLTEtMS0yNjUyNDc_ea43e898-4089-4012-be35-00f80cefacc8">798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1859ee0b296642ffba13a4fd14a36458_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM3LTEtMS0xLTI2NTI0Nw_6d0ef023-1641-483c-87b7-bf8d97bd2af6">5,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e55817403214996b18ace12986ee657_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM3LTMtMS0xLTI2NTI0Nw_63e0b32d-0c6b-42c4-8d55-aa8c1f5f2944">1,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3c653dcd4e4670b996e139fd812838_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM3LTUtMS0xLTI2NTI0Nw_7f330c8e-6941-4e5b-828e-90c0be9307f0">1,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife6f5f367cfd43cbb0a47919d9d3da2c_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM3LTctMS0xLTI2NTI0Nw_621f1806-6619-4315-99ff-0f0f837fd74c">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4241f3201d8548bca7574e1e0a20ac84_D20200101-20201231" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM3LTktMS0xLTI2NTI0Nw_e0465d38-9ca7-49fe-9f49-a8737b41f705">1,712</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb7fc09153ca404296c11711e2960b2f_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM3LTExLTEtMS0yNjUyNDc_7344b61b-f15f-46b6-9505-7c41c0f94e32">7,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95a883374f34cadb8aba20153008269_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM4LTEtMS0xLTI2NTI0Nw_0721aa19-2b18-4525-ad7e-d21735c8704d">75,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM4LTMtMS0xLTI2NTI0Nw_4ef18a73-b22e-4b48-8e67-47cb482c015b">141,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7a2e3c175d84b5aa44a7a859d45ad5d_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM4LTUtMS0xLTI2NTI0Nw_5508085f-b0af-4950-87e0-efb22780bdf3">93,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ce5e18976c2489a9a964cdebbae85ac_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM4LTctMS0xLTI2NTI0Nw_8cda53c0-2bdd-4b81-b15e-6c3490e36ecf">426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37c56e2626d741fc89c81191ac507cb5_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM4LTktMS0xLTI2NTI0Nw_0de3e7ae-22e9-47b5-b902-46195839f0f1">42,062</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM4LTExLTEtMS0yNjUyNDc_cde9a060-3769-4138-8dce-c8d82f157a51">268,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Health Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92db766193ba42908696e991d4d5cd1f_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzQxLTMtMS0xLTI2NTI0Nw_84f377d9-b8e6-4f2b-bec0-8f2003d440e9">89,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail &amp; specialty </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6c189e7c1cd4ff9924fdcd3ca505cec_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzQyLTMtMS0xLTI2NTI0Nw_d6a614f3-3a3e-4d13-997e-8eaa4f79b31f">49,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2798658b56134273a4ae4a44406280aa_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzQzLTMtMS0xLTI2NTI0Nw_1a253d49-251b-45cd-9c6b-96bdaaee5c09">1,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzQ0LTMtMS0xLTI2NTI0Nw_8692f558-4de0-45a2-b99b-33eaa8018e90">141,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9b8720412f3f4291afab5f48491a6240" continuedAt="i4d3b56916b844b54a098cf97c674ba2c"><ix:continuation id="ib7703dad09e541adbec11fa2ddd0d877"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Health Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies. Effective January 1, 2023, pharmacy network also includes activity associated with Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, which permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order. Maintenance Choice activity was previously reflected in mail &amp; specialty. Segment financial information has been revised to reflect these changes.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Health Services mail &amp; specialty is defined as specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as mail order and specialty claims fulfilled by the Pharmacy &amp; Consumer Wellness segment. Effective January 1, 2023, mail &amp; specialty excludes Maintenance Choice activity, which is now reflected within pharmacy network. Segment financial information has been revised to reflect these changes.</span></div></ix:continuation><div><span><br/></span></div><ix:continuation id="ia3701b7123ac4064a93c2911f011967e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDYw_270ede96-5904-4cac-87fd-332416a65a9b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmOWZmNjNkYmVjYWY0NmNlOTU2ZGFlMGM3MDRmYjQ2MC90YWJsZXJhbmdlOmY5ZmY2M2RiZWNhZjQ2Y2U5NTZkYWUwYzcwNGZiNDYwXzEtMS0xLTEtMjY1MjQ3_5f6e496b-b810-4d05-9b4a-8524d996fef7">8,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmOWZmNjNkYmVjYWY0NmNlOTU2ZGFlMGM3MDRmYjQ2MC90YWJsZXJhbmdlOmY5ZmY2M2RiZWNhZjQ2Y2U5NTZkYWUwYzcwNGZiNDYwXzEtMy0xLTEtMjY1MjQ3_4da43b75-0077-4b9f-8e80-9d3ff9f6e44e">7,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmOWZmNjNkYmVjYWY0NmNlOTU2ZGFlMGM3MDRmYjQ2MC90YWJsZXJhbmdlOmY5ZmY2M2RiZWNhZjQ2Y2U5NTZkYWUwYzcwNGZiNDYwXzItMS0xLTEtMjY1MjQ3_ea3e78ae-02cf-44c1-8c03-a9cf75ed1cdc">71</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmOWZmNjNkYmVjYWY0NmNlOTU2ZGFlMGM3MDRmYjQ2MC90YWJsZXJhbmdlOmY5ZmY2M2RiZWNhZjQ2Y2U5NTZkYWUwYzcwNGZiNDYwXzItMy0xLTEtMjY1MjQ3_25d7eaa9-7019-4e9e-b873-291a74ce948f">87</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2022 and 2021, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5NGEwZGI4ZGY0ZWY0YTExYjExYmQwNWU5N2E3ZDE2Yi90YWJsZXJhbmdlOjk0YTBkYjhkZjRlZjRhMTFiMTFiZDA1ZTk3YTdkMTZiXzEtMS0xLTEtMjY1MjQ3_f759b67e-a162-4b5f-b8e7-21f92e54aa23">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501f291fb23d49e987222cf13c851afc_I20201231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5NGEwZGI4ZGY0ZWY0YTExYjExYmQwNWU5N2E3ZDE2Yi90YWJsZXJhbmdlOjk0YTBkYjhkZjRlZjRhMTFiMTFiZDA1ZTk3YTdkMTZiXzEtMy0xLTEtMjY1MjQ3_ad0f9dd9-2090-44ce-9bd7-3cde740b9e67">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5NGEwZGI4ZGY0ZWY0YTExYjExYmQwNWU5N2E3ZDE2Yi90YWJsZXJhbmdlOjk0YTBkYjhkZjRlZjRhMTFiMTFiZDA1ZTk3YTdkMTZiXzMtMS0xLTEtMjY1MjQ3_59737380-7ccf-410f-b1c9-bb2514a71d28">340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5NGEwZGI4ZGY0ZWY0YTExYjExYmQwNWU5N2E3ZDE2Yi90YWJsZXJhbmdlOjk0YTBkYjhkZjRlZjRhMTFiMTFiZDA1ZTk3YTdkMTZiXzMtMy0xLTEtMjY1MjQ3_49cd1320-457e-491c-8769-76c5324e3d80">387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:ContractWithCustomerLiabilityRedemptionAndBreakage" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5NGEwZGI4ZGY0ZWY0YTExYjExYmQwNWU5N2E3ZDE2Yi90YWJsZXJhbmdlOjk0YTBkYjhkZjRlZjRhMTFiMTFiZDA1ZTk3YTdkMTZiXzQtMS0xLTEtMjY1MjQ3_4bfb668c-270e-40cf-b44e-e4a3a4879fe6">356</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:ContractWithCustomerLiabilityRedemptionAndBreakage" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5NGEwZGI4ZGY0ZWY0YTExYjExYmQwNWU5N2E3ZDE2Yi90YWJsZXJhbmdlOjk0YTBkYjhkZjRlZjRhMTFiMTFiZDA1ZTk3YTdkMTZiXzQtMy0xLTEtMjY1MjQ3_daa07408-117d-4704-be01-20264add5415">371</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5NGEwZGI4ZGY0ZWY0YTExYjExYmQwNWU5N2E3ZDE2Yi90YWJsZXJhbmdlOjk0YTBkYjhkZjRlZjRhMTFiMTFiZDA1ZTk3YTdkMTZiXzUtMS0xLTEtMjY1MjQ3_0d2f4dc1-4212-45dd-995c-f1935e65a8c2">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5NGEwZGI4ZGY0ZWY0YTExYjExYmQwNWU5N2E3ZDE2Yi90YWJsZXJhbmdlOjk0YTBkYjhkZjRlZjRhMTFiMTFiZDA1ZTk3YTdkMTZiXzUtMy0xLTEtMjY1MjQ3_3acd81e7-7758-4d7b-b86b-110c61dcb94c">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="padding-right:4.5pt"><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:CostOfSalesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MjEy_89567157-c662-414f-a830-8c30830b175a" continuedAt="iada7300880c9472297c3f897b5278d5b" escape="true"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products Sold</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for cost of products sold as follows:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products sold includes: (i) the cost of prescription drugs sold during the reporting period directly through the Company&#8217;s specialty and mail order pharmacies and indirectly through the Company&#8217;s retail pharmacy network, (ii) shipping and handling costs, (iii) administrative service fees paid to the Pharmacy &amp; Consumer Wellness segment for specialty and mail order pharmacy fulfillment services and (iv) the operating costs of the Company&#8217;s client service operations and related information technology support costs including depreciation and amortization. The cost of prescription drugs sold component of cost of products sold includes: (i) the cost of the prescription drugs purchased from manufacturers or distributors and shipped to members in clients&#8217; benefit plans from the Company&#8217;s mail order pharmacies, net of any volume-related or other discounts (see &#8220;Vendor Allowances and Purchase Discounts&#8221; below) and (ii) the cost of prescription drugs sold (including retail co-payments) through the Company&#8217;s retail pharmacy network under contracts where the Company is the principal, net of any volume-related or other discounts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy &amp; Consumer Wellness Segment</span></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iada7300880c9472297c3f897b5278d5b">Cost of products sold includes: the cost of merchandise sold during the reporting period, including the costs of prescription drugs sold through its retail pharmacies, net of any volume-related or other discounts, the related purchasing costs, warehousing and delivery costs (including depreciation and amortization), the operating costs of the Company&#8217;s specialty and mail order pharmacy fulfillment operations and actual and estimated inventory losses.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="cvs:VendorAllowancesAndPurchaseDiscountsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDk5_d14fd4d1-009f-4ed4-9249-4fb56fe593e3" continuedAt="i9c6282b7287547fc83c254543ffd1d23" escape="true"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vendor Allowances and Purchase Discounts </span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for vendor allowances and purchase discounts as follows: </span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4d3b56916b844b54a098cf97c674ba2c" continuedAt="ieaa525c8969447d7af30014fb9e03b8f"><ix:continuation id="i9c6282b7287547fc83c254543ffd1d23" continuedAt="i3043743f81084f19be4c4013e658c4ed"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Services segment receives purchase discounts on products purchased. Contractual arrangements with vendors, including manufacturers, wholesalers and retail pharmacies, normally provide for the Health Services segment to receive purchase discounts from established list prices in one, or a combination, of the following forms: (i) a direct discount at the time of purchase, (ii) a discount for the prompt payment of invoices or (iii) when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy), a discount (or rebate) paid subsequent to dispensing. These rebates are recognized when prescriptions are dispensed and are generally calculated and billed to manufacturers within <ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="cvs:PharmacyRebatePeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzY4ODI3_6e44dd04-b760-43df-a9ea-3c24aad9024a">30</ix:nonNumeric> days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Company&#8217;s operating results or financial condition. The Company accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Health Services segment also receives additional discounts under its wholesaler contracts if it exceeds contractually defined purchase volumes. In addition, the Health Services segment receives fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of products sold. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy &amp; Consumer Wellness Segment</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3043743f81084f19be4c4013e658c4ed">Vendor allowances received by the Pharmacy &amp; Consumer Wellness segment reduce the carrying cost of inventory and are recognized in cost of products sold when the related inventory is sold, unless they are specifically identified as a reimbursement of incremental costs for promotional programs and/or other services provided. Amounts that are directly linked to advertising commitments are recognized as a reduction of advertising expense (included in operating expenses) when the related advertising commitment is satisfied. Any amounts received in excess of the actual cost incurred also reduce the carrying cost of inventory. The total value of any upfront payments received from vendors that are linked to purchase commitments is initially deferred. The deferred amounts are then amortized to reduce cost of products sold over the life of the contract based upon sales volume. The total value of any upfront payments received from vendors that are not linked to purchase commitments is also initially deferred. The deferred amounts are then amortized to reduce cost of products sold on a straight-line basis over the life of the related contract. The total amortization of these upfront payments was not material to the Company&#8217;s consolidated financial statements in any of the periods presented.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:HealthCareEntitiesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTQ2_c445c67b-afb8-4943-8a69-9d8f516a181a" continuedAt="i094b8f941c3747729169b7dbf8b75a43" escape="true"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Reform</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Insurer Fee</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning on January 1, 2014, the ACA imposed an annual premium-based health insurer fee (&#8220;HIF&#8221;) for each calendar year, payable in September, which was not deductible for tax purposes. The Company was required to estimate a liability for the HIF at the beginning of the calendar year in which the fee was payable with a corresponding deferred asset that was amortized ratably to operating expenses over the calendar year. The Company recorded the liability for the HIF in accrued expenses and recorded the deferred asset in other current assets. In December 2019, the HIF was repealed for calendar years after 2020, therefore there was <ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="INF" name="cvs:HealthInsurerFee" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzcxNTg1_3679b5d7-eb5b-4884-afcd-ac78651288e3"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="INF" name="cvs:HealthInsurerFee" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzcxNTg1_3ada654f-7f57-499e-a0ec-d547df913470">no</ix:nonFraction></ix:nonFraction> expense related to the HIF in the years ended December&#160;31, 2022 and 2021. In the year ended December 31, 2020, operating expenses included $<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-8" name="cvs:HealthInsurerFee" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzcxNzEw_24f427c3-a8b7-4838-bebf-e4088870abc0">1.0</ix:nonFraction>&#160;billion related to the Company&#8217;s share of the HIF. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established a permanent risk adjustment program to transfer funds from qualified individual and small group insurance plans with below average risk scores to plans with above average risk scores. Based on the risk of the Company&#8217;s qualified plan members relative to the average risk of members of other qualified plans in comparable markets, as defined by the ACA, the Company estimates its ultimate risk adjustment receivable (recorded in accounts receivable) or payable (recorded in accrued expenses) for the current calendar year and reflects the pro-rata year-to-date impact as an adjustment to premium revenue. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Corridor</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established a temporary risk corridor program, which expired at the end of 2016, for qualified individual and small group health insurance plans. Under this program, health insurance companies were to make payments to, or receive payments from, the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) based on their ratio of allowable costs to target costs (as defined by the ACA). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company filed a lawsuit in August 2019 to recover the $<ix:nonFraction unitRef="usd" contextRef="i18e1afa4d3774525860f0504f6ca19d8_I20190831" decimals="-6" name="us-gaap:GainContingencyUnrecordedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzcyODY2_9da9bcbe-9fb9-4a30-9ef6-0150cd0d2a7e">313</ix:nonFraction>&#160;million it was owed under the ACA&#8217;s risk corridor program, which had been stayed pending the Supreme Court decision. In April 2020, the U.S. Supreme Court ruled that health insurance companies may sue the federal government for amounts owed as calculated under the ACA&#8217;s temporary risk corridor program. </span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ieaa525c8969447d7af30014fb9e03b8f" continuedAt="i79c4415f80074948a28bd0d3a39f844a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i094b8f941c3747729169b7dbf8b75a43">In October 2020, the Company received the $<ix:nonFraction unitRef="usd" contextRef="i23248b4e050943bea0937b2c23a81cf0_D20201001-20201031" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzczMjA5_d9872538-feb7-4c77-b3c0-5e5a6667ad74">313</ix:nonFraction>&#160;million it was owed under the ACA&#8217;s risk corridor program. The Company recorded the risk corridor payment as an increase to premium revenue in the year ended December 31, 2020. After considering offsetting items such as the ACA&#8217;s minimum MLR rebate requirements and premium taxes, the Company recorded pre-tax income of $<ix:nonFraction unitRef="usd" contextRef="ife99c731f49c491f9dbcec868c83f01f_D20200101-20201231" decimals="-6" name="cvs:FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzczNTI0_73ca4770-2eb1-43e8-9924-fce9830fbff7">307</ix:nonFraction>&#160;million and after-tax income of $<ix:nonFraction unitRef="usd" contextRef="ife99c731f49c491f9dbcec868c83f01f_D20200101-20201231" decimals="-6" name="cvs:FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzczNTUx_2ea50e65-5284-4f00-8b04-daa092590f66">223</ix:nonFraction>&#160;million during the year ended December&#160;31, 2020.</ix:continuation> </span></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTY1_db21c0a5-0069-4f12-9134-1de8d03a5c58" continuedAt="i778bd427d8db4f3b97bd901a9f66db4b" escape="true">Advertising Costs </ix:nonNumeric></span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i778bd427d8db4f3b97bd901a9f66db4b">Advertising costs, which are reduced by the portion funded by vendors, are expensed when the related advertising takes place. Net advertising costs, which are included in operating expenses, were $<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzczNzk3_77aac0da-2a42-4166-a810-3a60c9b12cff">745</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzczODAx_9c00d68f-f114-4ef0-bd9c-f11b6b513e68">707</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzczODA4_acee42b1-ff42-4c61-96d3-005f4063a9ce">613</ix:nonFraction> million in 2022, 2021 and 2020, respectively.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTkz_f8d3abb9-4a5e-4542-af2e-677c4634fd54" continuedAt="ice9e6a874aa54e39a93fd0a5398cf969" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ice9e6a874aa54e39a93fd0a5398cf969">Stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc0MDU2_6fb0217d-b4b8-4272-817b-3803971eadab">three</span> to <ix:nonNumeric contextRef="ib01e468dcb8f4ca98e9b64ffb83ffbe0_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTA2_ac7adb04-5393-41a3-b951-928227ad2fc1">five years</ix:nonNumeric>) using the straight-line method.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTEw_05dd752c-50c6-42fc-a3c0-36e9d6c110db" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year or years in which the differences are expected to reverse. The effect of a change in the tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date of such change.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, and the Company&#8217;s recent operating results. The Company establishes a valuation allowance when it does not consider it more likely than not that a deferred tax asset will be recovered.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions on the basis of a two-step process whereby (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and/or penalties related to uncertain tax positions are recognized in the income tax provision.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:PensionAndOtherPostretirementPlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTg1_b0466f56-0dc1-4ade-ba01-b1d82a00138e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit Plans</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors defined benefit pension plans (&#8220;pension plans&#8221;) and other postretirement employee benefit plans (&#8220;OPEB plans&#8221;) for its employees and retirees. The Company recognizes the funded status of its pension and OPEB plans on the consolidated balance sheets based on the year-end measurements of plan assets and benefit obligations. When the fair value of plan assets are in excess of the plan benefit obligations, the amounts are reported in other current assets and other assets. When the fair value of plan benefit obligations are in excess of plan assets, the amounts are reported in accrued expenses and other long-term liabilities based on the amount by which the actuarial present value of benefits payable in the next twelve months included in the benefit obligation exceeds the fair value of plan assets. The net periodic benefit income for the Company&#8217;s pension and OPEB plans do not contain a service cost component as these plans have been frozen for an extended period of time.&#160;Non-service cost components of pension and postretirement net periodic benefit income are included in other income in the consolidated statements of operations.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDg3_716d4ef5-4e63-4ca6-ad5a-09793902753b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is computed using the treasury stock method. The Company calculates basic earnings per share based on the weighted average number of common shares outstanding for the period. See Note 15 &#8216;&#8216;Earnings Per Share&#8217;&#8217; for additional information.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i79c4415f80074948a28bd0d3a39f844a" continuedAt="i232ca8e8c9fd48a0bcc003453e28694d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="cvs:SharesHeldInTrustPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDcx_9a5cf920-04d9-428c-b1a0-98a8fc2b50ed" continuedAt="i331ff02a79334750904b99597f194033" escape="true">Shares Held in Trust</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i331ff02a79334750904b99597f194033">The Company maintains grantor trusts, which held approximately <ix:nonFraction unitRef="shares" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:TreasuryStockSharesHeldinTrust" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc3NTcz_2e987904-d913-4ad9-959b-b0b047effdcc"><ix:nonFraction unitRef="shares" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:TreasuryStockSharesHeldinTrust" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc3NTcz_feaf49b2-23e3-4a03-b297-cb7e2f028924">one million</ix:nonFraction></ix:nonFraction> shares of its common stock at both December&#160;31, 2022 and 2021. These shares are designated for use under various employee compensation plans. Since the Company holds these shares, they are excluded from the computation of basic and diluted shares outstanding.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTk1_a59a0ca9-9420-467c-bc05-f8f09bee284c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in (i) a generic pharmaceutical sourcing entity, (ii) certain hedge fund and private equity investments and (iii) certain real estate partnerships that are considered VIEs. The Company does not have a future obligation to fund losses or debts on behalf of these investments; however, it may voluntarily contribute funds. In evaluating whether the Company is the primary beneficiary of a VIE, the Company considers several factors, including whether the Company has (a) the power to direct the activities that most significantly impact the VIE&#8217;s economic performance and (b) the obligation to absorb losses and the right to receive benefits that could potentially be significant to the VIE. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities - Primary Beneficiary</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014, the Company and Cardinal Health, Inc. (&#8220;Cardinal&#8221;) established Red Oak Sourcing, LLC (&#8220;Red Oak&#8221;), a generic pharmaceutical sourcing entity in which the Company and Cardinal each own <ix:nonFraction unitRef="number" contextRef="i01be68559ac146e1afb53160db3afdcd_D20140101-20141231" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc4ODA5_dcb23f42-d8a9-42f1-a7c8-92f9a1645fce">50</ix:nonFraction>%. The Red Oak arrangement had an initial term of <ix:nonNumeric contextRef="i01be68559ac146e1afb53160db3afdcd_D20140101-20141231" name="cvs:InitialContractualTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc4ODYw_5cd67da4-f8e7-4c57-8849-9aa7e53e9c32">ten years</ix:nonNumeric>. In 2021, the Red Oak arrangement was amended to extend the initial term an additional <ix:nonNumeric contextRef="idf41f493187f4949ad17fce94a9132a4_D20210101-20211231" name="cvs:VariableInterestEntityAmendedContractExtensionTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc4OTUw_d49bdc21-d18a-4570-b832-6c993219405b">five years</ix:nonNumeric>, for a total term of <ix:nonNumeric contextRef="idf41f493187f4949ad17fce94a9132a4_D20210101-20211231" name="cvs:VariableInterestEntityAmendedContractTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc4OTc0_59959fcb-25be-47c9-b2ad-0a05e73812e5">15</ix:nonNumeric> years. Under this arrangement, the Company and Cardinal contributed their sourcing and supply chain expertise to Red Oak and agreed to source and negotiate generic pharmaceutical supply contracts for both companies through Red Oak; however, Red Oak does not own or hold inventory on behalf of either company. No physical assets (e.g., property and equipment) were contributed to Red Oak by either company, and minimal funding was provided to capitalize Red Oak. The Company has determined that it is the primary beneficiary of this VIE because it has the ability to direct the activities of Red Oak. Consequently, the Company consolidates Red Oak in its consolidated financial statements within the Pharmacy &amp; Consumer Wellness segment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardinal is required to pay the Company quarterly payments, which began in October 2014 and will extend through June 2029. As milestones are met, the quarterly payments increase. The Company received $<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:ProceedsFromVariableInterestEntity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc5ODky_ad7dee83-706e-4707-8808-fed9c3c17c64"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:ProceedsFromVariableInterestEntity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc5ODky_b5e3fb52-36fb-48ce-be1e-6a61c1f5d4d3"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="cvs:ProceedsFromVariableInterestEntity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc5ODky_b93b13ad-c8ee-4c24-9302-2e99de07f927">183</ix:nonFraction></ix:nonFraction></ix:nonFraction> million from Cardinal during each of the years ended December&#160;31, 2022, 2021 and 2020. The payments reduce the Company&#8217;s carrying value of inventory and are recognized in cost of products sold when the related inventory is sold.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities - Other Variable Interest Holder</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has invested in certain VIEs for which it has determined that it is not the primary beneficiary, consisting of the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Hedge fund and private equity investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company invests in hedge fund and private equity investments in order to generate investment returns for its investment portfolio supporting its insurance businesses.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Real estate partnerships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company invests in various real estate partnerships, including those that construct, own and manage low-income housing developments. For the low income housing development investments, substantially all of the projected benefits to the Company are from tax credits and other tax benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not the primary beneficiary of these VIEs because the nature of the Company&#8217;s involvement with the activities of these VIEs does not give the Company the power to direct the activities that most significantly impact their economic performance. The Company records the amount of its investment in these VIEs as long-term investments on the consolidated balance sheets and recognizes its share of each VIE&#8217;s income or losses in net income.&#160;The Company&#8217;s maximum exposure to loss from these VIEs is limited to its investment balances as disclosed below and the risk of recapture of previously recognized tax credits related to the real estate partnerships, which the Company does not consider significant.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTI4_3076ee32-5b2a-4d4e-b5e7-2043020ccb0a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other variable interest holder VIE assets included in long-term investments on the consolidated balance sheets at December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedge fund investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i075db0b7afd340fa9d1cfc2f4306bf77_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5YTcxOGRkODU5ZTc0MTA3YmFiZTcyZGRiMzE2ZWMzMy90YWJsZXJhbmdlOjlhNzE4ZGQ4NTllNzQxMDdiYWJlNzJkZGIzMTZlYzMzXzEtMS0xLTEtMjY1MjQ3_7ebb88e2-aa89-4f9e-be1e-b213793ee099">589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5002e1bef44644008f1ddf6ef1c5be55_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5YTcxOGRkODU5ZTc0MTA3YmFiZTcyZGRiMzE2ZWMzMy90YWJsZXJhbmdlOjlhNzE4ZGQ4NTllNzQxMDdiYWJlNzJkZGIzMTZlYzMzXzEtMy0xLTEtMjY1MjQ3_1dc8ef29-cdf6-4cd4-9079-2ef8d6918665">463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69e734eb5dd74181895d964e7db3ec21_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5YTcxOGRkODU5ZTc0MTA3YmFiZTcyZGRiMzE2ZWMzMy90YWJsZXJhbmdlOjlhNzE4ZGQ4NTllNzQxMDdiYWJlNzJkZGIzMTZlYzMzXzItMS0xLTEtMjY1MjQ3_8f7138a1-c6da-4443-9e50-754c76ae233a">707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifac339bf4b714e1782ca52ebc2be13b4_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5YTcxOGRkODU5ZTc0MTA3YmFiZTcyZGRiMzE2ZWMzMy90YWJsZXJhbmdlOjlhNzE4ZGQ4NTllNzQxMDdiYWJlNzJkZGIzMTZlYzMzXzItMy0xLTEtMjY1MjQ3_9fbd955a-a350-404d-99b6-a420ea032fc5">601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate partnerships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c21594855b4f6984286b1e3809166d_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5YTcxOGRkODU5ZTc0MTA3YmFiZTcyZGRiMzE2ZWMzMy90YWJsZXJhbmdlOjlhNzE4ZGQ4NTllNzQxMDdiYWJlNzJkZGIzMTZlYzMzXzMtMS0xLTEtMjY1MjQ3_e810260a-8931-4e4a-97fb-8f89c4b91df4">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic125e609219047b1851d89ba1531b87a_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5YTcxOGRkODU5ZTc0MTA3YmFiZTcyZGRiMzE2ZWMzMy90YWJsZXJhbmdlOjlhNzE4ZGQ4NTllNzQxMDdiYWJlNzJkZGIzMTZlYzMzXzMtMy0xLTEtMjY1MjQ3_18092d4f-6692-4ab3-8af4-c59ef7644fcc">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia67a49e920264f60b0ef8a8a7fe494fe_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5YTcxOGRkODU5ZTc0MTA3YmFiZTcyZGRiMzE2ZWMzMy90YWJsZXJhbmdlOjlhNzE4ZGQ4NTllNzQxMDdiYWJlNzJkZGIzMTZlYzMzXzQtMS0xLTEtMjY1MjQ3_199c720b-e48d-4122-b88a-d201c737f00c">1,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1d19eaaa11f4572b405469e3348cbec_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5YTcxOGRkODU5ZTc0MTA3YmFiZTcyZGRiMzE2ZWMzMy90YWJsZXJhbmdlOjlhNzE4ZGQ4NTllNzQxMDdiYWJlNzJkZGIzMTZlYzMzXzQtMy0xLTEtMjY1MjQ3_ca99931a-b8b8-45a4-a45e-d13bea68c306">1,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i232ca8e8c9fd48a0bcc003453e28694d"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTkw_bc386297-f14a-466c-8f75-5475de48ab55" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzgyMDUw_afab40e5-2a92-4bac-a9a4-3550ff6e0721">60</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzgyMDU0_96e7dc24-b9d9-4908-91c5-b486d0232661">52</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzgyMDYx_87f7ad31-46d4-444e-9f44-63488098161b">56</ix:nonFraction> million in the years ended December&#160;31, 2022, 2021 and 2020, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in <ix:nonFraction unitRef="state" contextRef="i2525a9305fd84c7f917e0f50178009ca_I20221231" decimals="INF" name="us-gaap:NumberOfStatesInWhichEntityOperates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzgyMzY2_76076131-966b-4083-ab18-efafcf9b42a3">four</ix:nonFraction> states. Heartland paid the Company $<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzgyNDA0_9e70ec56-fad4-4145-bcfd-ffa389ab3e83">87</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzgyNDA4_4595be60-2829-4569-b8ec-fab1f284a726">79</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzgyNDE1_b0a71a08-41b8-4297-b8cd-2a3aa3c313c8">77</ix:nonFraction> million for pharmaceutical inventory purchases during the years ended December&#160;31, 2022, 2021 and 2020, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2022, 2021 and 2020, the Company made charitable contributions of&#160;$<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzgyODQ1_2a96cb70-f244-4895-9916-85523388b9df">25</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzgyODQ5_3900a6e0-f5b3-45b5-9965-882085adbe34">50</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzgyODU2_9011df77-8815-4004-b39c-5701b81d8c49">50</ix:nonFraction>&#160;million, respectively,&#160;to the CVS Health Foundation, a non-profit entity that focuses on health, education and community involvement programs. The charitable contributions were recorded as operating expenses in the consolidated statements of operations within the Corporate/Other segment for the years ended December&#160;31, 2022, 2021 and 2020.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:DiscontinuedOperationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTYw_971306ba-9111-4a92-aeff-318bf3bc5bee" continuedAt="icd2283a53f3e4502ba4020ff0f1a3d2f" escape="true">Discontinued Operations</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icd2283a53f3e4502ba4020ff0f1a3d2f">In connection with certain business dispositions completed between 1995 and 1997, the Company retained guarantees on store lease obligations for a number of former subsidiaries, including Linens &#8216;n Things and Bob&#8217;s Stores, each of which subsequently filed for bankruptcy. The Company&#8217;s loss from discontinued operations includes lease-related costs that the Company believes it will likely be required to satisfy pursuant to these lease guarantees.</ix:continuation> See &#8220;Lease Guarantees&#8221; in Note 17 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results from discontinued operations were immaterial for the years ended December 31, 2022 and 2021.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTEx_9e297525-4266-489e-b164-15ee7bf59779" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the results of discontinued operations for the year ended December 31, 2020. </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo1ZDk3NjQxNWFhZWY0ZjExYjFjZWVhZTAwNWViMGU5ZS90YWJsZXJhbmdlOjVkOTc2NDE1YWFlZjRmMTFiMWNlZWFlMDA1ZWIwZTllXzEtMS0xLTEtMjY1MjQ3_856a1b19-795d-410c-843f-fd3fc6f9197f">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo1ZDk3NjQxNWFhZWY0ZjExYjFjZWVhZTAwNWViMGU5ZS90YWJsZXJhbmdlOjVkOTc2NDE1YWFlZjRmMTFiMWNlZWFlMDA1ZWIwZTllXzItMS0xLTEtMjY1MjQ3_8a41fab5-cbca-423a-a92d-cbe62c54072e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo1ZDk3NjQxNWFhZWY0ZjExYjFjZWVhZTAwNWViMGU5ZS90YWJsZXJhbmdlOjVkOTc2NDE1YWFlZjRmMTFiMWNlZWFlMDA1ZWIwZTllXzMtMS0xLTEtMjY1MjQ3_7877b244-ef36-4f3a-aeac-69e4cf48439d">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i36038907935e41eea5e9cf7cac915d44_124"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzgyMTk_3dbe0b91-9845-4cd8-9dde-23c26d2d90d3" continuedAt="ie88631776a994ed9b0d84f4cd276985d" escape="true">Acquisitions, Divestitures and Asset Sales</ix:nonNumeric></span></div><div style="text-indent:-9pt"><span><br/></span></div><ix:continuation id="ie88631776a994ed9b0d84f4cd276985d" continuedAt="if071b430184c415796a05aa4d1fe0eba"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Oak Street Health Acquisition </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2023, the Company entered into a definitive merger agreement to acquire all of the outstanding shares of Oak Street Health, Inc. (&#8220;Oak Street Health&#8221;) for cash. Under the terms of the merger agreement, Oak Street Health stockholders will receive $<ix:nonFraction unitRef="usdPerShare" contextRef="i8941690cb4944d199bf33e6da1cee933_I20230207" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzM1Mg_838dcb35-0817-4afb-850c-3ba64d0857bc">39.00</ix:nonFraction> per share in cash. The total value of the transaction is approximately $<ix:nonFraction unitRef="usd" contextRef="ieaa2442b4a1b43c1a1e9635e5d302668_D20230207-20230207" decimals="-8" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzQyNg_183fdd6b-7430-4ba3-a05b-120ccf1112ba">10.6</ix:nonFraction>&#160;billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proposed acquisition was approved by the Board of Directors at each of the respective companies and is subject to approval by a majority of Oak Street Health stockholders, receipt of regulatory approval and satisfaction of other customary closing conditions, including the expiration of the waiting period under the federal Hart-Scott-Rodino Antitrust Improvements Act of 1976. The transaction is expected to close in 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the merger agreement is terminated under certain specified circumstances and receipt of regulatory approval has not been obtained by such time, the Company will be required to pay Oak Street Health a termination fee of approximately $<ix:nonFraction unitRef="usd" contextRef="i8941690cb4944d199bf33e6da1cee933_I20230207" decimals="-6" name="cvs:BusinessCombinationTerminationFee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzEwOTY_a25752fe-41d9-466e-a253-1d20676ea848">500</ix:nonFraction>&#160;million. If the merger agreement is terminated under other certain specified circumstances, including due to Oak Street Health accepting a superior proposal, Oak Street Health will be required to pay the Company a termination fee of approximately $<ix:nonFraction unitRef="usd" contextRef="icc5a99c2de364d84899668bcf7f91a6d_I20230207" decimals="-6" name="cvs:BusinessCombinationTerminationFee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzEzMzg_26c799c6-52b7-4175-86ef-13084585c97c">300</ix:nonFraction>&#160;million.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if071b430184c415796a05aa4d1fe0eba" continuedAt="id7875f24cc6c40c9a2a4cf6f21efa95e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pending Signify Health Acquisition </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 2, 2022, the Company entered into a definitive merger agreement to acquire all of the outstanding shares of Signify Health, Inc. (&#8220;Signify Health&#8221;) for cash. Under the terms of the merger agreement, Signify Health stockholders will receive $<ix:nonFraction unitRef="usdPerShare" contextRef="i65fae298043841daaccb6bbb1a996aac_I20220902" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzE2MzM_7f57860f-f139-46dc-9aaf-bf1cc35815a1">30.50</ix:nonFraction> per share in cash. The total value of the transaction is approximately $<ix:nonFraction unitRef="usd" contextRef="i6d430fa42bb64f4cafd5196de70e0ece_D20220902-20220902" decimals="-9" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzE3MDc_5e400290-5db8-4788-82e9-7699422bd77d">8</ix:nonFraction>&#160;billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pending acquisition was approved by the Board of Directors at each of the respective companies and the Signify Health stockholders and remains subject to receipt of regulatory approval and satisfaction of other customary closing conditions. On October 19, 2022, Signify Health and CVS Health each received a request for additional information (also known as a &#8220;second request&#8221;) from the U.S. Department of Justice (the &#8220;DOJ&#8221;) in connection with the review of the transactions contemplated by the merger agreement by the DOJ under the federal Hart-Scott-Rodino Antitrust Improvements Act of 1976. The transaction is expected to close in the second quarter of 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the merger agreement is terminated under certain specified circumstances and receipt of regulatory approval has not been obtained by such time, the Company will be required to pay Signify Health a termination fee in an amount equal to $<ix:nonFraction unitRef="usd" contextRef="i65fae298043841daaccb6bbb1a996aac_I20220902" decimals="-6" name="cvs:BusinessCombinationTerminationFee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzI2MTk_5ec446a1-3d8c-48a2-88ab-e0be5ec9fba0">380</ix:nonFraction>&#160;million. If the merger agreement is terminated under other certain specified circumstances, including due to Signify Health accepting a superior proposal, Signify Health will be required to pay the Company a termination fee in an amount equal to $<ix:nonFraction unitRef="usd" contextRef="i12c5778e54f64900acca49cd8d1aa3c3_I20220902" decimals="-6" name="cvs:BusinessCombinationTerminationFee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzI4NjA_dd36c55f-ce19-48e3-836e-c1e7682d2ea8">228</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Held For Sale</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its portfolio for non-strategic assets. The Company determined that its Omnicare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> long-term care business (&#8220;LTC business&#8221;), which is included within the Pharmacy &amp; Consumer Wellness segment, was no longer a strategic asset and during the third quarter of 2022 committed to a plan to sell the LTC business. As of September 30, 2022, the LTC business met the criteria to be classified as held for sale and the carrying value of the LTC business was determined to be greater than its estimated fair value less costs to sell. Accordingly, the Company recorded a loss on assets held for sale of $<ix:nonFraction unitRef="usd" contextRef="i39f6860ec9044a859b0fb2f4386504eb_D20220701-20220930" decimals="-8" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzM0OTM_487c254a-6676-47f7-bab9-798b0c474b05">2.5</ix:nonFraction> billion during the third quarter of 2022. As of December&#160;31, 2022, the net assets of the LTC business continued to meet the criteria for held-for-sale accounting and during the fourth quarter, an incremental loss on assets held for sale of $<ix:nonFraction unitRef="usd" contextRef="i7a1cc0d19b0548438d4b4f4e3b4d3a67_D20221001-20221231" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzM3MTM_73478eb8-821f-4714-a7c1-80a6edd5139f">12</ix:nonFraction> million was recorded to write down the carrying value of the LTC business to its estimated fair value less costs to sell. The loss on assets held for sale represents the write-down of its customer contracts/relationships intangible assets and was recorded in the Company&#8217;s consolidated statement of operations within the Pharmacy &amp; Consumer Wellness segment. The LTC business operating income was not material for the years ended December&#160;31, 2022, 2021 and 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LTC business met the criteria to be classified as held for sale at December&#160;31, 2022, but did not meet the criteria to be classified as discontinued operations. As a result, the related assets and liabilities were included in separate held-for-sale line items of the asset and liability sections of the consolidated balance sheet. As the assets held for sale are measured at fair value on a nonrecurring basis primarily using unobservable inputs as of the measurement date, they are classified in Level 3 of the fair value hierarchy. <ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzgyMTY_924b2eb6-dbc7-4b47-bb84-2eefdd88eb04" continuedAt="i51373c641d0a4cc4a15655d718a6fc33" escape="true">The following table summarizes the assets and liabilities held for sale at December&#160;31, 2022:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i51373c641d0a4cc4a15655d718a6fc33"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90YWJsZTo2NGVmMjU0YjQwZDE0YmVjOGU2NjE4ZTU4MzViM2ViYy90YWJsZXJhbmdlOjY0ZWYyNTRiNDBkMTRiZWM4ZTY2MThlNTgzNWIzZWJjXzItMS0xLTEtMjY1MjQ3_56ad0a06-6492-4ff2-8af0-c997061af542">227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90YWJsZTo2NGVmMjU0YjQwZDE0YmVjOGU2NjE4ZTU4MzViM2ViYy90YWJsZXJhbmdlOjY0ZWYyNTRiNDBkMTRiZWM4ZTY2MThlNTgzNWIzZWJjXzMtMS0xLTEtMjY1MjQ3_0966c6b0-e68f-44e2-9c57-e5b6c07bcbc5">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90YWJsZTo2NGVmMjU0YjQwZDE0YmVjOGU2NjE4ZTU4MzViM2ViYy90YWJsZXJhbmdlOjY0ZWYyNTRiNDBkMTRiZWM4ZTY2MThlNTgzNWIzZWJjXzQtMS0xLTEtMjY1MjQ3_19f396a2-efe8-43f8-aa9e-ec3285c43382">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90YWJsZTo2NGVmMjU0YjQwZDE0YmVjOGU2NjE4ZTU4MzViM2ViYy90YWJsZXJhbmdlOjY0ZWYyNTRiNDBkMTRiZWM4ZTY2MThlNTgzNWIzZWJjXzYtMS0xLTEtMjY1MjQ3_be9b5dea-b30e-40e2-a678-0751b0d93497">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90YWJsZTo2NGVmMjU0YjQwZDE0YmVjOGU2NjE4ZTU4MzViM2ViYy90YWJsZXJhbmdlOjY0ZWYyNTRiNDBkMTRiZWM4ZTY2MThlNTgzNWIzZWJjXzctMS0xLTEtMjY1MjQ3_4db242c1-0fff-480a-b5f9-41c4b07c8295">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90YWJsZTo2NGVmMjU0YjQwZDE0YmVjOGU2NjE4ZTU4MzViM2ViYy90YWJsZXJhbmdlOjY0ZWYyNTRiNDBkMTRiZWM4ZTY2MThlNTgzNWIzZWJjXzgtMS0xLTEtMjY1MjQ3_05948a77-5ebb-41f8-9a5f-1d54a9462b7d">908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90YWJsZTo2NGVmMjU0YjQwZDE0YmVjOGU2NjE4ZTU4MzViM2ViYy90YWJsZXJhbmdlOjY0ZWYyNTRiNDBkMTRiZWM4ZTY2MThlNTgzNWIzZWJjXzExLTEtMS0xLTI2NTI0Nw_cb5b171f-2eb4-41a5-afb3-f74e7c284274">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90YWJsZTo2NGVmMjU0YjQwZDE0YmVjOGU2NjE4ZTU4MzViM2ViYy90YWJsZXJhbmdlOjY0ZWYyNTRiNDBkMTRiZWM4ZTY2MThlNTgzNWIzZWJjXzEyLTEtMS0xLTI2NTI0Nw_932c60c6-77d3-40de-86bb-63663b2d684b">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90YWJsZTo2NGVmMjU0YjQwZDE0YmVjOGU2NjE4ZTU4MzViM2ViYy90YWJsZXJhbmdlOjY0ZWYyNTRiNDBkMTRiZWM4ZTY2MThlNTgzNWIzZWJjXzEzLTEtMS0xLTI2NTI0Nw_84d63087-02bd-4d41-a89c-9500e9b126b8">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90YWJsZTo2NGVmMjU0YjQwZDE0YmVjOGU2NjE4ZTU4MzViM2ViYy90YWJsZXJhbmdlOjY0ZWYyNTRiNDBkMTRiZWM4ZTY2MThlNTgzNWIzZWJjXzE0LTEtMS0xLTI2NTI0Nw_9762b334-a1be-41b1-b092-4d29f1eecce8">228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id7875f24cc6c40c9a2a4cf6f21efa95e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of bswift</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2022, the Company sold its wholly-owned subsidiary bswift LLC (&#8220;bswift&#8221;) for approximately $<ix:nonFraction unitRef="usd" contextRef="i16dd20d6307443f7b1496e7fd3259924_D20221101-20221130" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzQ4NzE_d1f8b303-0548-42e5-9b53-65963869849d">735</ix:nonFraction> million. bswift offers software and services that streamline benefits and human resource administration. The results of this business have historically been recorded within the Health Care Benefits segment. The Company recorded a pre-tax gain on the divestiture of $<ix:nonFraction unitRef="usd" contextRef="i1487797c4ed44d6ab54ae7b9970f80e0_D20220101-20221231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzUxMzE_e87afde9-a434-41c4-9730-bf3dcd0001ed">250</ix:nonFraction>&#160;million in the year ended December&#160;31, 2022, which is reflected as a reduction of operating expenses in the Company&#8217;s consolidated statement of operations within the Health Care Benefits segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of PayFlex </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company sold PayFlex for approximately $<ix:nonFraction unitRef="usd" contextRef="i726a3c8b7d82435e9ab454babaa43c9d_D20220601-20220630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzUzOTA_62d7b86f-83f1-4f91-a5eb-dbc68f21f8e7">775</ix:nonFraction>&#160;million. PayFlex provides services to employers, their employees, and their former employees in the areas of tax-advantaged account reimbursement administration (flexible spending, health reimbursement, health savings, transit and parking), Consolidated Omnibus Budget Reconciliation Act (&#8220;COBRA&#8221;) administration and special-member billing administration. The results of this business have historically been reported within the Health Care Benefits segment. The Company recorded a pre-tax gain on the divestiture of $<ix:nonFraction unitRef="usd" contextRef="i032e70604e384dd9b7d3ebd3ff12f852_D20220101-20221231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzU5MDE_b1a30fa5-71aa-4b9d-af21-2aeefa14a647">225</ix:nonFraction>&#160;million in the year ended December&#160;31, 2022, which is reflected as a reduction of operating expenses in the Company&#8217;s consolidated statement of operations within the Health Care Benefits segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of Thailand Health Care Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the Company reached an agreement to sell its international health care business domiciled in Thailand (&#8220;Thailand business&#8221;), comprised of approximately <ix:nonFraction unitRef="member" contextRef="i90dd0fb3894941b6960bebd138f56df7_I20220331" decimals="-3" name="cvs:NumberOfMedicalMembers" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzYyOTE_3279f87f-5e49-4a26-87bc-32debdadffa8">266,000</ix:nonFraction> medical members, which was included in the Commercial Business reporting unit within the Health Care Benefits segment. At that time, a portion of the Commercial Business goodwill was specifically allocated to the Thailand business. The net assets of the Thailand business were accounted for as assets held for sale at March 31, 2022. The carrying value of the Thailand business was determined to be greater than its estimated fair value less costs to sell and, accordingly, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="i13c8ddf9147d44ae959fc13f26a1884f_D20220101-20220331" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzY3OTE_be931f06-c5f8-4904-bd7f-2e2fa191826d"><ix:nonFraction unitRef="usd" contextRef="ica7104e3105a418591fc79a3004a6ba4_D20220101-20221231" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzY3OTE_c562cbbf-12a1-4915-a350-16d419811bf0">41</ix:nonFraction></ix:nonFraction> million loss on assets held for sale within the Health Care Benefits segment during the first quarter of 2022. The sale of the Thailand business closed in the second quarter of 2022, and the consideration received and ultimate loss on the sale were not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of Workers&#8217; Compensation Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2020, the Company sold its Workers&#8217; Compensation business for approximately $<ix:nonFraction unitRef="usd" contextRef="ibfb21d4c40684eea90662442e675b2a5_D20200731-20200731" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzcxODU_e1a5e008-11ee-4e3b-b0bd-0f6f215d7c8a">850</ix:nonFraction>&#160;million. The results of this business were reported within the Health Care Benefits segment. The Company recorded a pre-tax gain on the divestiture of $<ix:nonFraction unitRef="usd" contextRef="icaa8b7f8dd3142d9a337758c8211c242_D20200101-20201231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzczMzE_67c4215a-d4e1-4cc2-ab64-7a6ab7a90253">269</ix:nonFraction> million in the year ended December&#160;31, 2020, which is reflected as a reduction in operating expenses in the Company&#8217;s consolidated statement of operations within the Health Care Benefits segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International Health Care Benefits Renewal Rights Asset Sale</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company sold the renewal rights of approximately <ix:nonFraction unitRef="member" contextRef="i343759b6979e4ed18b87374d58deff9a_I20220531" decimals="-3" name="cvs:DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3Xzc2MzY_da24f82d-b56b-4656-8dc4-c1875e85b1f3">200,000</ix:nonFraction> international medical members outside of the Americas, Thailand and India in connection with an Asset Purchase Agreement. As part of this agreement, the Company will introduce and help migrate these existing international medical members to the purchaser upon renewal. The Company expects the migration process to occur between July 2022 and November 2023. The Company ceased writing any new or renewal business for international medical members outside of the Americas during the fourth quarter of 2022. The consideration received related to this agreement was not material.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_127"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzcwNDQ_2d2355a2-cab9-4552-9a9a-5a4b170047f9" continuedAt="ie50d72d0724b4c3281cd91c8201d25a3" escape="true">Investments</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie50d72d0724b4c3281cd91c8201d25a3" continuedAt="ibf74219d3e094a6cbb0cf2d4b134a4db"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="cvs:TotalInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzcwMzU_eb4d066d-dabf-46bf-8605-526045d5c88d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13ff989d3101402c9f2d0b708fde5f39_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzItMS0xLTEtMjY1MjQ3_35484196-153a-4994-b519-bc364d3b9855">2,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13ff989d3101402c9f2d0b708fde5f39_I20221231" decimals="-6" name="cvs:LongTermInvestmentsIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzItMy0xLTEtMjY1MjQ3_de827c93-f98b-4136-a89e-2c865215c85e">17,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13ff989d3101402c9f2d0b708fde5f39_I20221231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzItNS0xLTEtMjY1MjQ3_a9e64cd0-328b-4d00-ae6a-5827c4e52856">20,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6007bc6f913b42eaab01b721ab83141f_I20211231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzItNy0xLTEtMjY1MjQ3_ab69dba7-4386-486b-9547-297b1cf8237e">3,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6007bc6f913b42eaab01b721ab83141f_I20211231" decimals="-6" name="cvs:LongTermInvestmentsIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzItOS0xLTEtMjY1MjQ3_f0064ec0-08c5-431d-9cd2-4b2a6d335a45">20,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6007bc6f913b42eaab01b721ab83141f_I20211231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzItMTEtMS0xLTI2NTI0Nw_9a524317-19f0-4293-b75a-f2fec7530686">23,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04ef966a0b364268a11b39305bc55156_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzMtMS0xLTEtMjY1MjQ3_a360591f-b821-4b1a-b7e7-5c683b215221">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04ef966a0b364268a11b39305bc55156_I20221231" decimals="-6" name="cvs:LongTermInvestmentsIncludingAssetsHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzMtMy0xLTEtMjY1MjQ3_51a0b1f7-2ae8-4b78-b306-9955015a48d7">989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04ef966a0b364268a11b39305bc55156_I20221231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzMtNS0xLTEtMjY1MjQ3_c36fd263-cdc9-4c92-b85d-8aec06f4489d">1,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f2ded7662304336a06ac9d017d04cdd_I20211231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzMtNy0xLTEtMjY1MjQ3_c2e675e9-4a1b-42a4-b3fb-8d4c9effa587">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f2ded7662304336a06ac9d017d04cdd_I20211231" decimals="-6" name="cvs:LongTermInvestmentsIncludingAssetsHeldForSale" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzMtOS0xLTEtMjY1MjQ3_d67155e2-7393-4c93-8a60-9e8a8ab42ff7">844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f2ded7662304336a06ac9d017d04cdd_I20211231" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzMtMTEtMS0xLTI2NTI0Nw_ddab2736-78de-4898-acad-2bec6a80bd81">902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a96031559a645dc9dd2370af4f1fe81_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzQtMS0xLTEtMjY1MjQ3_5742e8e4-cd98-4e1c-8384-c5c02564248b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a96031559a645dc9dd2370af4f1fe81_I20221231" decimals="-6" name="cvs:LongTermInvestmentsIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzQtMy0xLTEtMjY1MjQ3_b50d8dcc-b3e5-466b-b208-c757d4e3e7b0">2,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a96031559a645dc9dd2370af4f1fe81_I20221231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzQtNS0xLTEtMjY1MjQ3_ed6a0cf0-6bfe-4b26-bb4c-0709998ca0c5">2,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f484ef7e1984f9db38a5d63935d02ba_I20211231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzQtNy0xLTEtMjY1MjQ3_e275c5c3-1f96-48da-bbdd-ac83b476e5f7">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f484ef7e1984f9db38a5d63935d02ba_I20211231" decimals="-6" name="cvs:LongTermInvestmentsIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzQtOS0xLTEtMjY1MjQ3_0697e17d-54b4-4cce-87c1-f07ad2fee27a">1,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f484ef7e1984f9db38a5d63935d02ba_I20211231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzQtMTEtMS0xLTI2NTI0Nw_b008682c-5347-45d5-b71d-92766f179344">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzUtMS0xLTEtMjY1MjQ3_14427ba2-5e95-43c8-8a1c-7d630ab0acba">2,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:LongTermInvestmentsIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzUtMy0xLTEtMjY1MjQ3_12a46925-e01c-4c1f-b63b-115a9ff891ba">21,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzUtNS0xLTEtMjY1MjQ3_a82960b4-882f-4311-9a38-f022c05bf451">23,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzUtNy0xLTEtMjY1MjQ3_40b96de7-dac0-4c29-b0ca-7878b48dab28">3,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:LongTermInvestmentsIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzUtOS0xLTEtMjY1MjQ3_b6acaa81-ec27-4338-8d3e-cf6787cc54e9">23,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzUtMTEtMS0xLTI2NTI0Nw_3c12b9d2-f4de-4f10-a3d7-493c9f3dfb38">26,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes long-term investments of $<ix:nonFraction unitRef="usd" contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231" decimals="-6" name="cvs:LongTermInvestmentsIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzE1MA_992c791f-65a1-46c6-b455-76e528bda5f2">17</ix:nonFraction>&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div></ix:nonNumeric><div style="padding-left:13.5pt;text-indent:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 and 2021, the Company held investments of $<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:RestrictedInvestmentsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzQwMw_561bf4fb-d85c-49c4-b1bc-b9fb17a252fb">331</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:RestrictedInvestmentsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzQxMA_79e08e9f-7097-4ae4-9ae1-0a92c52f6b6b">450</ix:nonFraction> million, respectively, related to the 2012 conversion of an existing group annuity contract from a participating to a non-participating contract. These investments are included in the total investments of large case pensions supporting non-experience-rated products. Although these investments are not accounted for as Separate Accounts assets, they are legally segregated and are not subject to claims that arise out of the Company&#8217;s business and only support future policy benefits obligations under that group annuity contract. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzcwNDk_8e462b33-9eb5-405a-aea5-882c62510284" continuedAt="icd2125d23a9a46589e882cd0b5a9d970" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at December&#160;31, 2022 and 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.441%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.504%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amortized <br/>Cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allowance<br/>for Credit<br/>Losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amortized<br/>Cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzMtNS0xLTEtMjY1MjQ3_68c3739a-e1bc-467a-ae4d-472717a15e74">2,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzMtNy0xLTEtMjY1MjQ3_77999e09-f828-44c0-8e85-fdfe20a2cf5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzMtOS0xLTEtMjY1MjQ3_961ed53c-ad28-4c0a-bc73-ab10d5a787f4">2,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzMtMTEtMS0xLTI2NTI0Nw_10ce8733-eeae-4954-a686-e577f64d8029">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzMtMTMtMS0xLTI2NTI0Nw_085fe3d3-aecf-4e6f-be9f-b971b322ba4c">182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzMtMTUtMS0xLTI2NTI0Nw_d8b9627c-c93b-4172-9175-e26f3d1efcc8">1,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzQtNS0xLTEtMjY1MjQ3_8efc1f0d-32ba-4e35-96bb-11b41331cccf">2,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzQtNy0xLTEtMjY1MjQ3_4f1182d8-f378-4185-a852-ce7f91cbaeee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzQtOS0xLTEtMjY1MjQ3_1836ede3-e922-4596-899a-2094508ecae3">2,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzQtMTEtMS0xLTI2NTI0Nw_4af0d2d3-8c59-4163-a965-4c765d2d249f">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzQtMTMtMS0xLTI2NTI0Nw_5db6747a-0cd7-4324-8c83-4b2c4acd4f43">129</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzQtMTUtMS0xLTI2NTI0Nw_c8480baa-10a7-4999-89d3-3c17daadd893">2,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzUtNS0xLTEtMjY1MjQ3_f3ca5c70-ed13-4041-bcac-d393392cca9a">9,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzUtNy0xLTEtMjY1MjQ3_bef86166-e104-4044-93cb-00d7f428320d">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzUtOS0xLTEtMjY1MjQ3_9fa1bf17-e86e-489a-9126-b9492ff360e7">9,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzUtMTEtMS0xLTI2NTI0Nw_4d048f2c-19e6-49c3-b8b6-2810c3f1deb4">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzUtMTMtMS0xLTI2NTI0Nw_47b24968-30ad-4db2-b439-e3f68e98e490">903</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzUtMTUtMS0xLTI2NTI0Nw_09887855-41ac-4255-b434-5adc12863e61">8,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzYtNS0xLTEtMjY1MjQ3_e21d0846-5693-4834-aa92-ec115fc62f23">2,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzYtNy0xLTEtMjY1MjQ3_a662efbd-2ec6-4190-aae1-85028e7a3b21">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzYtOS0xLTEtMjY1MjQ3_e789ec06-39ef-4770-a3e5-91d1a1932018">2,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzYtMTEtMS0xLTI2NTI0Nw_1b12706b-aaff-46ef-9867-e258db9bc30d">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzYtMTMtMS0xLTI2NTI0Nw_b0e97e95-c9a1-4ef7-97e4-a6daeb00e538">244</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzYtMTUtMS0xLTI2NTI0Nw_83245bb8-05ed-4ae2-abb3-7e16b36ae5fa">2,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzctNS0xLTEtMjY1MjQ3_e0ebcc1c-5f27-4d07-9af6-a5c39e8bcfcc">845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzctNy0xLTEtMjY1MjQ3_31e43587-b435-4462-b601-9907bb08a1a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzctOS0xLTEtMjY1MjQ3_52eae0d5-4151-469c-86c3-dede5b61b379">845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzctMTEtMS0xLTI2NTI0Nw_e1c35a99-ccd5-4d68-b8a3-465bb20e14a7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzctMTMtMS0xLTI2NTI0Nw_2ac8c49b-fd4d-4d92-80ef-0e9237a54c16">89</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzctMTUtMS0xLTI2NTI0Nw_e120d19a-7858-47d0-b2a9-1a4f485d56a9">757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzgtNS0xLTEtMjY1MjQ3_4d220599-896b-4439-b807-60701e90286c">1,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzgtNy0xLTEtMjY1MjQ3_e79fe2a0-d69d-4d26-a78b-b64f7e0cfdde">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzgtOS0xLTEtMjY1MjQ3_15388590-c14b-4007-a6cb-580449c8fe56">1,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzgtMTEtMS0xLTI2NTI0Nw_4a053f3e-1ba0-407d-b08a-ecba941c16b7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzgtMTMtMS0xLTI2NTI0Nw_f08f011a-408d-4c7a-b6f1-8bef7b69c2ff">155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzgtMTUtMS0xLTI2NTI0Nw_dd8816e0-dc97-49ac-99fd-c20216a3ced1">1,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzktNS0xLTEtMjY1MjQ3_fdd783e1-4359-4421-9e03-db6adcbd3f81">2,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzktNy0xLTEtMjY1MjQ3_950fcf02-08ec-45db-87fd-be50635ff7b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzktOS0xLTEtMjY1MjQ3_bd075dad-fd70-4c62-ac67-3e90c0d9e52e">2,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzktMTEtMS0xLTI2NTI0Nw_248121ac-3a46-4f95-81f5-94d2a21531ba">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzktMTMtMS0xLTI2NTI0Nw_9ec82bca-2f3f-4b9e-bb6a-6150463e56ec">136</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzktMTUtMS0xLTI2NTI0Nw_4dc3ba72-7ccc-4d0b-a1d8-8764912425ea">2,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzEwLTUtMS0xLTI2NTI0Nw_9f92e5e8-53c7-4a45-b8d0-8256e6f8b59a">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzEwLTctMS0xLTI2NTI0Nw_1eb4ac89-085e-4ead-b689-922982821b38">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzEwLTktMS0xLTI2NTI0Nw_66f32745-c809-4d9b-b0b1-e25604146ac6">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzEwLTExLTEtMS0yNjUyNDc_89aa3f78-5f64-4542-bfaf-2dde4fa49a6a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzEwLTEzLTEtMS0yNjUyNDc_81b32ad4-3c8e-4b23-8307-37ae4e742a1b">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzEwLTE1LTEtMS0yNjUyNDc_39d398e4-e2e2-41a1-bc78-459ae1f804ba">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzExLTUtMS0xLTI2NTI0Nw_6fb2eaf8-3005-4dbe-9d3b-a938165b229b">22,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzExLTctMS0xLTI2NTI0Nw_642fd720-e0bd-4ee3-af4d-491d255781b0">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzExLTktMS0xLTI2NTI0Nw_0ecaab70-51e6-4cf4-8e05-1572cf3a4304">22,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzExLTExLTEtMS0yNjUyNDc_557559fe-89c4-4589-8f21-f6b54a2a99bd">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzExLTEzLTEtMS0yNjUyNDc_36156edb-fbdc-495f-ab22-079e5d1d4906">1,840</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzExLTE1LTEtMS0yNjUyNDc_4b851f34-532e-4e64-ac7f-56195293429a">20,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE1LTUtMS0xLTI2NTI0Nw_fd8220d1-813c-400c-aab0-a32466a560b1">2,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE1LTctMS0xLTI2NTI0Nw_0fe34c7f-730a-4ea1-b6bc-b7dd54c1bdd0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE1LTktMS0xLTI2NTI0Nw_432cc7e6-c0e6-470f-9184-cf10d12f9e0b">2,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE1LTExLTEtMS0yNjUyNDc_97ebf8f8-b193-4676-b567-cd68a5d90d47">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE1LTEzLTEtMS0yNjUyNDc_65b14946-87d0-404d-9e4f-6287aed21a09">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE1LTE1LTEtMS0yNjUyNDc_836d4a75-da8b-447e-b3e3-a25a5d9743dc">2,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE2LTUtMS0xLTI2NTI0Nw_71d4289d-56cd-4047-92f7-25b3f34985e2">2,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE2LTctMS0xLTI2NTI0Nw_2b05c284-a1c0-4273-9aa7-03a8c907f227">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE2LTktMS0xLTI2NTI0Nw_d548777b-9318-495d-b857-3c8b01cf821e">2,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE2LTExLTEtMS0yNjUyNDc_2d13665e-1cca-48a7-a787-512315c19310">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE2LTEzLTEtMS0yNjUyNDc_5f255b0a-36d7-4d92-ba67-760080799d2e">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE2LTE1LTEtMS0yNjUyNDc_fc7ba1e8-8720-43c2-b54c-4e6e79251975">3,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE3LTUtMS0xLTI2NTI0Nw_798bce54-2193-4458-8a2b-bff96f015133">9,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE3LTctMS0xLTI2NTI0Nw_d988415e-b096-4c7c-92e3-3ec6584bc1a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE3LTktMS0xLTI2NTI0Nw_7ece3790-2636-4f5c-891b-935ead696972">9,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE3LTExLTEtMS0yNjUyNDc_f54619b4-eec3-4937-b6a1-53fdeb41e4a7">682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE3LTEzLTEtMS0yNjUyNDc_cee48b75-20b9-4644-8dcb-1e8ca4724331">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE3LTE1LTEtMS0yNjUyNDc_b0f27e62-3592-42fc-a721-37b5d915cc48">9,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE4LTUtMS0xLTI2NTI0Nw_d34679e4-ef78-4ce2-ba5f-4f2ef7923012">2,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE4LTctMS0xLTI2NTI0Nw_1dc52659-86f1-4852-9258-f4e75b3efb34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE4LTktMS0xLTI2NTI0Nw_b3d22720-07c8-4cff-b6c0-6990ae0d2c54">2,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE4LTExLTEtMS0yNjUyNDc_b2b5ba56-19fb-4d5d-8895-85a97b1af2dc">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE4LTEzLTEtMS0yNjUyNDc_27121ef0-9ed3-4257-85da-e21e78d5f75f">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE4LTE1LTEtMS0yNjUyNDc_4cc3fbaa-adc7-44fd-81c8-49d19e32747f">2,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE5LTUtMS0xLTI2NTI0Nw_ef9158e9-2bb8-4d63-8bd2-97d921d4796b">870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE5LTctMS0xLTI2NTI0Nw_29c5c1ff-bdf3-4292-87a8-5abe43c24dda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE5LTktMS0xLTI2NTI0Nw_5dd75553-a394-4829-96cd-8f21aa11b0b2">870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE5LTExLTEtMS0yNjUyNDc_3b111e22-be8a-4277-bf45-9758e21a03ea">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE5LTEzLTEtMS0yNjUyNDc_51160173-b9c7-4512-b3dd-60fb091867ec">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE5LTE1LTEtMS0yNjUyNDc_b072c729-1fcf-4d2b-a198-4eeb1c7b3c1f">875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIwLTUtMS0xLTI2NTI0Nw_e479ffe2-4022-4b91-a761-b9e85e27a95e">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIwLTctMS0xLTI2NTI0Nw_a26f169a-d0fe-4d88-aaaa-f7bb40ffa9e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIwLTktMS0xLTI2NTI0Nw_e7075483-98a6-4a39-82d2-d1e902eeb478">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIwLTExLTEtMS0yNjUyNDc_0be6f4de-ad68-49c8-8c90-f7d876670245">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIwLTEzLTEtMS0yNjUyNDc_602534e0-fe78-4ada-b49a-5d54f77997e0">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIwLTE1LTEtMS0yNjUyNDc_70ee88e9-3441-419a-b89a-7aacae3a8361">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIxLTUtMS0xLTI2NTI0Nw_0e5a62d3-2744-4579-886a-82c7182c018c">2,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIxLTctMS0xLTI2NTI0Nw_2f7488a7-a5d1-4b0f-b9bb-5c037f055066">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIxLTktMS0xLTI2NTI0Nw_6840d8db-27ff-4d46-be20-55310d6cb1f6">2,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIxLTExLTEtMS0yNjUyNDc_7d4fe187-66fd-4729-a536-842a8a4eafe5">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIxLTEzLTEtMS0yNjUyNDc_c3975c86-fa16-4060-8ea9-d649ff1d29ef">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIxLTE1LTEtMS0yNjUyNDc_8aea80ba-4d2b-406b-bc87-eac9271add87">2,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIyLTUtMS0xLTI2NTI0Nw_d7572a45-827f-438b-876b-ed4b970cd1c0">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIyLTctMS0xLTI2NTI0Nw_e1c8ae01-2d8d-423a-8c59-da5428f4c8a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIyLTktMS0xLTI2NTI0Nw_7d97877b-151c-416c-b9fe-45c5fbd3f5db">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIyLTExLTEtMS0yNjUyNDc_8f54915d-0c6a-42e4-84cc-d6cda6aeff19">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIyLTEzLTEtMS0yNjUyNDc_7bd1f3dc-2b0c-4f0e-a256-b00a4a9cff70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIyLTE1LTEtMS0yNjUyNDc_ad4a40ca-1cad-43c4-9041-18ad4f107da7">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIzLTUtMS0xLTI2NTI0Nw_1201481c-de30-4e6c-9f19-4b4ff76425d2">22,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIzLTctMS0xLTI2NTI0Nw_a6b2a810-d095-460a-b64e-eb433b23fc22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIzLTktMS0xLTI2NTI0Nw_1b57985c-dcd0-4c9b-af02-b52ac462e722">22,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIzLTExLTEtMS0yNjUyNDc_5e41f2e8-2964-46d3-8e9a-1e4f6d01fff3">1,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIzLTEzLTEtMS0yNjUyNDc_530f1c7e-b357-46a2-b7d0-9c2d1d586f20">106</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIzLTE1LTEtMS0yNjUyNDc_e6e863e8-7339-4a16-8ee7-15d05c27116c">23,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results.&#160;At December&#160;31, 2022, debt securities with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzEyNTY_b12b61a0-d3ea-458e-9647-99df37c29abd">609</ix:nonFraction> million, gross unrealized capital gains of $<ix:nonFraction unitRef="usd" contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzEyOTQ_393560a8-9d6f-497a-98e2-aa5d668a1c0c">3</ix:nonFraction> million and gross unrealized capital losses of </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ibf74219d3e094a6cbb0cf2d4b134a4db" continuedAt="i105e897054da4cb6977e1d62e251df8c"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="icd2125d23a9a46589e882cd0b5a9d970">$<ix:nonFraction unitRef="usd" contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzEzMzY_d7e6fd5b-83c3-4b82-be38-1ae228add35a">59</ix:nonFraction> million, and at December&#160;31, 2021, debt securities with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i9911a4d843eb4cb1a00b136035f50e03_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzEzODg_63ce6a28-80ad-4485-bb3d-603bab9719f7">864</ix:nonFraction> million, gross unrealized capital gains of $<ix:nonFraction unitRef="usd" contextRef="i9911a4d843eb4cb1a00b136035f50e03_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzE0MjY_0b4ce8bb-18b6-4f94-b1ff-2a17c695e1e7">94</ix:nonFraction> million and gross unrealized capital losses of $<ix:nonFraction unitRef="usd" contextRef="i9911a4d843eb4cb1a00b136035f50e03_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzE0Njg_def378da-c6fb-49d7-afaf-14c7b88036e6">2</ix:nonFraction> million were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income (loss).</ix:continuation></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzcwMzc_0ec6e7b8-d957-4874-8a51-9fa4806f299f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities at December&#160;31, 2022 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair <br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzItMS0xLTEtMjY1MjQ3_8d9ade07-845f-4bc2-bb89-655f829ebee1">1,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzItMy0xLTEtMjY1MjQ3_ddeb3208-a2ec-46de-bc3e-30f2fe8a6195">1,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzMtMS0xLTEtMjY1MjQ3_f576dd3b-f3a9-47b7-b335-717a01af1736">6,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzMtMy0xLTEtMjY1MjQ3_327e6ba5-06d1-46fb-98fd-16e6449b5f98">6,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzQtMS0xLTEtMjY1MjQ3_ab03dc0e-860a-4cf6-9002-06ea6c30e04e">4,899</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzQtMy0xLTEtMjY1MjQ3_a572df44-e5d5-4216-a7e1-4776c99f6fde">4,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzUtMS0xLTEtMjY1MjQ3_ee75900f-f61f-4816-bf29-3665cb8e3d1c">4,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzUtMy0xLTEtMjY1MjQ3_cd742b0b-ab1d-4dac-a1bc-9e299aa3294a">3,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzYtMS0xLTEtMjY1MjQ3_56f6921a-4703-411e-bbdd-31327e4f98ea">845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzYtMy0xLTEtMjY1MjQ3_1e23d77e-f1d0-4a38-a0af-c740b6526202">757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzctMS0xLTEtMjY1MjQ3_91a00c5d-62fa-4d3b-b3de-b4dc1a05670b">1,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzctMy0xLTEtMjY1MjQ3_0086d3c3-f23b-4915-af99-0ffd03fa695d">1,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzgtMS0xLTEtMjY1MjQ3_c7593d40-72ad-4dfc-91ba-c6b8d956c798">2,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzgtMy0xLTEtMjY1MjQ3_8d6767ce-fe27-4f1b-87b4-0bcce07cb03f">2,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzktMS0xLTEtMjY1MjQ3_737f2ef2-062f-4152-b110-988b787754f0">22,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzktMy0xLTEtMjY1MjQ3_57efb52a-11b2-4180-a834-0af43a3621c0">20,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage-Backed and Other Asset-Backed Securities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s residential mortgage-backed securities at December&#160;31, 2022 were issued by the Government National Mortgage Association, the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation and carry agency guarantees and explicit or implicit guarantees by the U.S. Government.&#160;At December&#160;31, 2022, the Company&#8217;s residential mortgage-backed securities had an average credit quality rating of AAA and a weighted average duration of <ix:nonNumeric contextRef="i1bf6dd211b7f4e99ba7262cf0f3f0c19_D20220101-20221231" name="cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzI0NTk_ed6564e6-1d2f-4633-88e7-d333bb9b1e7d">5.7</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s commercial mortgage-backed securities have underlying loans that are dispersed throughout the United States. Significant market observable inputs used to value these securities include loss severity and probability of default.&#160;At December&#160;31, 2022, these securities had an average credit quality rating of AAA and a weighted average duration of <ix:nonNumeric contextRef="iebf5538c68ad492782f86e19a1c4c591_D20220101-20221231" name="cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzI4MDc_c5279436-de0c-4dbf-a34e-0f0a3f8cf621">5.6</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s other asset-backed securities have a variety of underlying collateral (e.g., automobile loans, credit card receivables, home equity loans and commercial loans). Significant market observable inputs used to value these securities include the unemployment rate, loss severity and probability of default.&#160;At December&#160;31, 2022, these securities had an average credit quality rating of AA and a weighted average duration of <ix:nonNumeric contextRef="i05cb6c50cba342aaadae4afcbafc5086_D20220101-20221231" name="cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzMyMzA_e67c98e0-df6e-4ff5-a1d4-dad614e769cd">1.0</ix:nonNumeric> year.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i105e897054da4cb6977e1d62e251df8c" continuedAt="ib425cba09131412eacd8d0ad5b5077d8"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzcwNTM_b0577323-a2f7-4a25-bacd-2bf63723f606" continuedAt="iaaeb557339144461a846bfcc6a093e18" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at December&#160;31, 2022 and 2021 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>&#160;Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>&#160;Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>&#160;Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzQtMS0xLTEtMjY1MjQ3_5a059a63-4b40-4ddd-8a5e-98c9db0e8de9">519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzQtMy0xLTEtMjY1MjQ3_eb81c4b7-94e3-4599-8d4e-d6cf3b0c1d1a">1,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzQtNS0xLTEtMjY1MjQ3_aef3a6b0-3f39-40ed-8271-50cc62cdae5b">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzQtNy0xLTEtMjY1MjQ3_d15fe4f7-bb99-449c-a1f5-22129512afc8">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzQtOS0xLTEtMjY1MjQ3_723cac97-cc3a-4d34-9c80-791e2aad6007">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzQtMTEtMS0xLTI2NTI0Nw_83c0faa5-eaa3-43b1-85c3-7af04f85e8ca">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzQtMTMtMS0xLTI2NTI0Nw_5a8f22f1-64d5-4ed4-8d3c-82cf26dd8f15">554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzQtMTUtMS0xLTI2NTI0Nw_2b396535-2629-4488-84fa-5b019fdc4a36">1,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzQtMTctMS0xLTI2NTI0Nw_c847afee-7e73-4dea-bdce-8a7b81b51bf1">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzUtMS0xLTEtMjY1MjQ3_49b7c8c9-2a94-4db6-85e8-7d677f60b869">859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzUtMy0xLTEtMjY1MjQ3_684530f1-c383-43e9-853d-4b426c967512">1,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzUtNS0xLTEtMjY1MjQ3_3abc5929-d40f-4675-87a6-8c9229849b29">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzUtNy0xLTEtMjY1MjQ3_f63b95a8-bd42-49e4-b9ba-8a3f2a276a92">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzUtOS0xLTEtMjY1MjQ3_3c02a0eb-e382-4d52-bc0d-c7024e199483">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzUtMTEtMS0xLTI2NTI0Nw_afab4636-a337-4508-925a-c991c8da40d9">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzUtMTMtMS0xLTI2NTI0Nw_26d70e01-40ba-41d2-ac09-73efc366c5d9">1,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzUtMTUtMS0xLTI2NTI0Nw_1031ed90-d735-48ab-a2e6-0217b94c02e9">1,692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzUtMTctMS0xLTI2NTI0Nw_0e6060b4-0be2-4a64-a4af-8444209a8ff7">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzYtMS0xLTEtMjY1MjQ3_b86be2f6-bf32-49cc-8e06-d12c5fe6a9ff">5,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzYtMy0xLTEtMjY1MjQ3_8ad6ee05-1221-4f7e-a587-8144cea131e0">6,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzYtNS0xLTEtMjY1MjQ3_da13cb29-8342-4244-b3a3-6c50856d418d">622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzYtNy0xLTEtMjY1MjQ3_1f8fa2be-92e6-480d-8a69-859715282242">1,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzYtOS0xLTEtMjY1MjQ3_ad7b3e6d-66ec-4a41-868f-fb5fab0da80f">1,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzYtMTEtMS0xLTI2NTI0Nw_cbf09517-b482-472c-917f-e0148576c63f">281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzYtMTMtMS0xLTI2NTI0Nw_38493913-e9b5-4150-b7b3-c5ed9a999b5c">6,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzYtMTUtMS0xLTI2NTI0Nw_466ecd13-0c98-4803-aa23-97dd2f94f3b9">8,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzYtMTctMS0xLTI2NTI0Nw_ef7573e9-d7d0-40cb-b570-e8981076237e">903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzctMS0xLTEtMjY1MjQ3_54d54a7b-80f5-4449-bde6-d6e26d055e61">1,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzctMy0xLTEtMjY1MjQ3_a0e5cac0-4480-4f41-9898-adde1d410176">1,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzctNS0xLTEtMjY1MjQ3_d8671ef4-0af9-46ca-a08e-4ec5f2fe7bba">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzctNy0xLTEtMjY1MjQ3_7960c9f5-0401-4655-b6c7-7e1ebc838b78">403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzctOS0xLTEtMjY1MjQ3_73bdc579-1acb-4cd7-af84-4886de36b70a">592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzctMTEtMS0xLTI2NTI0Nw_d7582fe2-7521-4a95-8a0b-9e97c955e5cd">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzctMTMtMS0xLTI2NTI0Nw_7e4c41c1-4f99-4c74-851a-b6f69aded1a0">1,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzctMTUtMS0xLTI2NTI0Nw_7dc8ebd1-6d49-4c15-ab22-bf81be0c51b1">2,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzctMTctMS0xLTI2NTI0Nw_a53db374-39f5-43f4-ac7d-29e8a6bae67d">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzgtMS0xLTEtMjY1MjQ3_09539e92-0185-4c6e-9745-5654ab547cca">452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzgtMy0xLTEtMjY1MjQ3_9e41de07-05e5-4801-93b3-3bc6597d1524">464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzgtNS0xLTEtMjY1MjQ3_bcfdf651-f795-4885-9c02-615032575fef">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzgtNy0xLTEtMjY1MjQ3_b8dfe4c9-fe75-4deb-b297-238998935df8">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzgtOS0xLTEtMjY1MjQ3_f98cd209-dbb0-4dd9-98c4-c829e071c422">257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzgtMTEtMS0xLTI2NTI0Nw_2a051d38-a6ae-4736-bb53-c0f8adf6ebfa">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzgtMTMtMS0xLTI2NTI0Nw_755b13ab-4631-46cf-8e22-cc626016c4f5">543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzgtMTUtMS0xLTI2NTI0Nw_4de3703b-d602-4f3b-b9e5-dec594ad5049">721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzgtMTctMS0xLTI2NTI0Nw_37395b20-af25-4152-bb9a-598fbac40e63">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzktMS0xLTEtMjY1MjQ3_c297c182-29fb-4eb9-8621-1cf5da30b173">288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzktMy0xLTEtMjY1MjQ3_b18796c4-2be2-49e1-95f1-aa01b7585fe5">611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzktNS0xLTEtMjY1MjQ3_fc8cf50e-f99a-494e-b0e2-8c5ca7e9ebd8">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzktNy0xLTEtMjY1MjQ3_2e5e79db-6413-4b31-92a9-cf61edfefa91">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzktOS0xLTEtMjY1MjQ3_13b502a9-c7e4-4062-8bd4-a0fd82ea7cfa">381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzktMTEtMS0xLTI2NTI0Nw_cd7da925-23ca-409f-90e3-992fa284a297">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzktMTMtMS0xLTI2NTI0Nw_74c35bfc-f10c-4239-9fe8-d48fc780d21c">475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzktMTUtMS0xLTI2NTI0Nw_87a9d74e-8568-4829-8845-7e91f40aea73">992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzktMTctMS0xLTI2NTI0Nw_12306735-ab3a-4d94-b47a-b59d875dd00e">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEwLTEtMS0xLTI2NTI0Nw_68550e99-f13d-45c9-a0a9-681319c66095">1,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEwLTMtMS0xLTI2NTI0Nw_abac47cd-7978-4525-b99d-522b4c06675b">1,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEwLTUtMS0xLTI2NTI0Nw_f2aae01c-7f25-4af7-aa55-c8dd9f675802">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEwLTctMS0xLTI2NTI0Nw_4a744e8e-9f04-4c01-b075-b27af41e198a">391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEwLTktMS0xLTI2NTI0Nw_c4ec2375-b65b-49b2-8bf1-51ee2e8e698b">694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEwLTExLTEtMS0yNjUyNDc_ca3b1295-b0ad-477c-8cbc-2d03551a62e3">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEwLTEzLTEtMS0yNjUyNDc_d44a8c37-517d-4350-acc3-78d23e5d1a52">1,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEwLTE1LTEtMS0yNjUyNDc_aa0666ba-86cf-4be5-b931-47e385a93f9e">2,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEwLTE3LTEtMS0yNjUyNDc_2e475cdb-57e1-45c3-b0c4-ead17fd37aa0">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzExLTEtMS0xLTI2NTI0Nw_569fd3a3-fbff-4be2-aeca-656a76e66a9c">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzExLTMtMS0xLTI2NTI0Nw_c04c4f9e-571c-43e8-875c-95fba319674c">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzExLTUtMS0xLTI2NTI0Nw_1cd2198f-145a-4b4b-91c7-c82db870e141">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzExLTctMS0xLTI2NTI0Nw_95f77de7-23ed-481a-a2bc-49404c03d9bb">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzExLTktMS0xLTI2NTI0Nw_147c0482-93c5-4ebc-b1b1-31a01828f3bc">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzExLTExLTEtMS0yNjUyNDc_ef41e528-aeed-4c81-8d02-954c2a8ca65b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzExLTEzLTEtMS0yNjUyNDc_b5ce8669-25e2-4f5f-82ac-bf04337fe4ae">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzExLTE1LTEtMS0yNjUyNDc_46d8eb99-51f9-451e-bc1a-273bd1b92d26">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzExLTE3LTEtMS0yNjUyNDc_049d749c-5334-47ec-a88c-ceec28408a18">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEyLTEtMS0xLTI2NTI0Nw_4b13cc14-a6c7-449f-8ed3-cd4d437050e3">9,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEyLTMtMS0xLTI2NTI0Nw_2559339d-62d4-46cb-9931-198b4cc14c92">14,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEyLTUtMS0xLTI2NTI0Nw_2b5d478e-eb82-40df-aafc-a2e290def6a5">1,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEyLTctMS0xLTI2NTI0Nw_aa7c549d-764c-41c1-9401-c25fc56a1a77">2,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEyLTktMS0xLTI2NTI0Nw_3ccf57ca-5470-412b-8ac4-f543d4f92618">4,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEyLTExLTEtMS0yNjUyNDc_3e241be9-1405-4c7b-9c7a-1760e816fe20">614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEyLTEzLTEtMS0yNjUyNDc_34493b9e-52e9-4961-abd4-aa98ebb6b9f0">12,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEyLTE1LTEtMS0yNjUyNDc_5aec98c0-29df-4e53-b681-c4ccb31f5a8f">18,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEyLTE3LTEtMS0yNjUyNDc_2efda62e-776e-4a03-bcae-4439aa0b8742">1,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE2LTEtMS0xLTI2NTI0Nw_7b7a6d48-481d-4160-93c4-03673cdbd1b5">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE2LTMtMS0xLTI2NTI0Nw_c93108a3-2b0e-4968-843a-2a8d12be0e7a">242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE2LTUtMS0xLTI2NTI0Nw_2cb48a9b-f232-4ede-bcc6-d344ef6a04d7">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE2LTctMS0xLTI2NTI0Nw_fc014414-8ba2-49cf-a76e-8f1b1e49168f">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE2LTktMS0xLTI2NTI0Nw_fd3130a7-2c12-4924-8975-dc8c9f551f7e">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE2LTExLTEtMS0yNjUyNDc_1d72c8bf-ed65-48b9-b20c-6909ddd8db21">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE2LTEzLTEtMS0yNjUyNDc_87460276-af81-4211-9e7e-147c26c977b8">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE2LTE1LTEtMS0yNjUyNDc_09f4f581-9a85-4679-91a3-4024ae200ac4">282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE2LTE3LTEtMS0yNjUyNDc_20fdfebb-40be-42ea-bdb7-8ba95d5623fa">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE3LTEtMS0xLTI2NTI0Nw_9970c00d-e048-4b2a-91e5-82e343ced011">233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE3LTMtMS0xLTI2NTI0Nw_b9dac8b5-9976-4c2b-b650-129e0161f13a">428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE3LTUtMS0xLTI2NTI0Nw_c9046bdd-2a57-4cfd-b83c-630d892add30">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE3LTctMS0xLTI2NTI0Nw_ce17c793-720d-4ee4-8990-c087bf216438">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE3LTktMS0xLTI2NTI0Nw_d418de7b-b915-4bfa-87cf-3e098b903e8d">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE3LTExLTEtMS0yNjUyNDc_5d6889c1-16ea-440f-b5eb-c1d5a3ef99aa">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE3LTEzLTEtMS0yNjUyNDc_79ba5246-de1f-4335-8672-3be66a3381e0">246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE3LTE1LTEtMS0yNjUyNDc_a65c4e6a-69c0-4e06-af69-88e38453af50">461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE3LTE3LTEtMS0yNjUyNDc_5355b618-fd93-48b2-85ae-02b147dff3b7">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE4LTEtMS0xLTI2NTI0Nw_5d1dbb05-49d8-4ae0-9f2e-a98d6124308c">1,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE4LTMtMS0xLTI2NTI0Nw_511fa69a-f6d8-4814-849a-84733b958d93">2,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE4LTUtMS0xLTI2NTI0Nw_8a0243c2-de69-43c2-b308-68ff03f2fd6a">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE4LTctMS0xLTI2NTI0Nw_c7bb07af-fd34-492d-8d66-f9d63f9e6de7">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE4LTktMS0xLTI2NTI0Nw_4a6d8422-4c35-4dd1-877a-c0b7f8ef93c8">238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE4LTExLTEtMS0yNjUyNDc_0b3e048a-4cd2-4671-bc7c-7fdb73b006c8">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE4LTEzLTEtMS0yNjUyNDc_9e26209b-a332-4f2c-b201-46b6bacc3f3f">1,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE4LTE1LTEtMS0yNjUyNDc_2e4aea97-1c72-4eeb-b879-930c39bcd551">2,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE4LTE3LTEtMS0yNjUyNDc_3654efc2-cdf8-44f1-8897-cb5918b3ae3b">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE5LTEtMS0xLTI2NTI0Nw_8904bada-8809-488e-b344-d36d2eedb8d8">449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE5LTMtMS0xLTI2NTI0Nw_f1c2d4d6-39d4-4d5b-b982-f8f3ac4fcc95">747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE5LTUtMS0xLTI2NTI0Nw_8a181c00-6b58-4b53-82e5-8f9190f44ab5">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE5LTctMS0xLTI2NTI0Nw_d28060e9-00a6-45f2-add9-3cb153e55cd5">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE5LTktMS0xLTI2NTI0Nw_6772390a-5220-4056-9a80-f56fd0c0a369">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE5LTExLTEtMS0yNjUyNDc_e1ec4698-8322-41ad-b5b2-3ae26ac96ccc">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE5LTEzLTEtMS0yNjUyNDc_531b6a69-0833-4d81-9076-fb1c77c0b655">506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE5LTE1LTEtMS0yNjUyNDc_95b2d3a7-d4b6-45c0-91b6-986a33dc4363">838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE5LTE3LTEtMS0yNjUyNDc_57bc6a67-f99a-427f-8fce-3f8618ef0e02">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIwLTEtMS0xLTI2NTI0Nw_3c66f1b8-7188-4804-b946-8b4fdae1661a">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIwLTMtMS0xLTI2NTI0Nw_1115b336-db04-46ae-919b-fd55896f922f">593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIwLTUtMS0xLTI2NTI0Nw_b8877d56-bc66-4f66-af12-33357cd68d9f">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIwLTctMS0xLTI2NTI0Nw_fc878e73-a30c-4f23-9efa-8ae5ba2519cf">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIwLTktMS0xLTI2NTI0Nw_35be3e6a-3493-4e96-99a9-f3673bcd8af2">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIwLTExLTEtMS0yNjUyNDc_10ffd0c3-28a6-4478-84ad-7fc2191f3467">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIwLTEzLTEtMS0yNjUyNDc_6bee147f-f58e-4c86-8e16-6fba37ee9ec4">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIwLTE1LTEtMS0yNjUyNDc_a442ace6-f2e4-4df6-a577-7e2bed532360">629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIwLTE3LTEtMS0yNjUyNDc_2abfc379-0f64-4ded-9cc2-e2102e8a7f44">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIxLTEtMS0xLTI2NTI0Nw_0bee9199-8b92-4c22-915d-7fb40eb215e8">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIxLTMtMS0xLTI2NTI0Nw_dda33f87-3611-45e5-bc03-09ff2f414810">462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIxLTUtMS0xLTI2NTI0Nw_6ab5fa76-b17e-4a6c-ae33-3192c2f275ad">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIxLTctMS0xLTI2NTI0Nw_7a7a5023-475f-4fe2-b24e-b7b1c8baa818">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIxLTktMS0xLTI2NTI0Nw_ab177e8e-e67f-4cf7-949f-ed9e70c30d65">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIxLTExLTEtMS0yNjUyNDc_22162988-8117-4555-b81e-f48196bead17">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIxLTEzLTEtMS0yNjUyNDc_5f0c87c0-167c-494f-abb2-6439a6076cd5">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIxLTE1LTEtMS0yNjUyNDc_9a81cc0a-0db7-4fa2-937b-8e1cfabf6bfa">574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIxLTE3LTEtMS0yNjUyNDc_00acf3d9-88cf-4fb8-90c5-93532d1c9004">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIyLTEtMS0xLTI2NTI0Nw_6463c850-5680-4006-98b5-4f7a87f1084a">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIyLTMtMS0xLTI2NTI0Nw_469cd7ee-0048-435c-bcb9-467a58f41f05">2,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIyLTUtMS0xLTI2NTI0Nw_50b23f85-ba8e-45e5-9f9f-f58b72c07ac4">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIyLTctMS0xLTI2NTI0Nw_417eb605-5e69-456b-9b66-f02f676a1278">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIyLTktMS0xLTI2NTI0Nw_5b57acd6-637d-4d9f-8773-a39473ccd406">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIyLTExLTEtMS0yNjUyNDc_1a439bd2-d4ab-4b9c-9bcb-5a965c9096a1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIyLTEzLTEtMS0yNjUyNDc_2e2002af-5ef8-40d9-b7ea-773a0754872f">1,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIyLTE1LTEtMS0yNjUyNDc_49ce4db4-b2e2-435d-b667-1e01d46c57bc">2,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIyLTE3LTEtMS0yNjUyNDc_d0aeeb9d-335d-4c28-9d9b-785c2e6c507f">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIzLTEtMS0xLTI2NTI0Nw_3b814871-5505-47ed-8544-dc1f27609f66">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIzLTMtMS0xLTI2NTI0Nw_46287bcb-f874-45e9-a63c-3e782a854ff4">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIzLTUtMS0xLTI2NTI0Nw_e83db131-376d-427d-8aa1-ade64a5ce6b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIzLTctMS0xLTI2NTI0Nw_3a7c346e-c17e-43a9-a7d2-29919cc181a6">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIzLTktMS0xLTI2NTI0Nw_74b6dd92-eb67-4663-90d8-f6d32efaf1dc">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIzLTExLTEtMS0yNjUyNDc_73356912-66aa-4ddd-af82-9e398b392951">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIzLTEzLTEtMS0yNjUyNDc_c55ec8b0-9b6f-47c3-b273-cb7558f8066c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIzLTE1LTEtMS0yNjUyNDc_803673bf-a396-42d5-a8d5-38c2049b920d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIzLTE3LTEtMS0yNjUyNDc_cee75d45-33dd-41ab-aa02-595bc6797278">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzI0LTEtMS0xLTI2NTI0Nw_0dbd9dfe-a0ed-4a31-9156-6201fd049407">3,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzI0LTMtMS0xLTI2NTI0Nw_74ebd29b-116a-49ad-b536-86b867f4522f">6,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzI0LTUtMS0xLTI2NTI0Nw_ced372e8-a362-4b06-8d99-f250638d3fb7">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzI0LTctMS0xLTI2NTI0Nw_1f834eaa-3ea6-40a8-a551-f2703e28dafd">317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzI0LTktMS0xLTI2NTI0Nw_05ae710f-46e3-4785-afb6-0cc068b04bd0">584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzI0LTExLTEtMS0yNjUyNDc_3c2962ae-cd1e-4546-a7ea-d39d04c4bab6">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzI0LTEzLTEtMS0yNjUyNDc_21059c7b-6e44-42d8-a382-1d7283438e19">4,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzI0LTE1LTEtMS0yNjUyNDc_f54b9557-7636-4f29-b6d4-c2e4f765aa1e">7,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzI0LTE3LTEtMS0yNjUyNDc_b196d94b-ef13-45c9-b293-e2a123b05ba6">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#8217;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#8217;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#8217;s current prospects for recovery. Unrealized capital losses at December&#160;31, 2022 were generally caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities. As of December&#160;31, 2022, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib425cba09131412eacd8d0ad5b5077d8" continuedAt="ie9fbfe888d4e4a02b25a7ea0d8336313"><ix:continuation id="iaaeb557339144461a846bfcc6a093e18"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at December&#160;31, 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.432%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting experience-<br/>rated products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting remaining<br/>products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzMtMS0xLTEtMjY1MjQ3_94b97669-6fe3-4b2e-83d0-984a58b682ef">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzMtMy0xLTEtMjY1MjQ3_5cc7ace6-5b4d-40fa-b136-b7d833b67ae0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cab4b0903e747b4ac60612c8fea7746_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzMtNS0xLTEtMjY1MjQ3_bf69b3d4-73e9-47db-907b-b9144fae03b2">1,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cab4b0903e747b4ac60612c8fea7746_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzMtNy0xLTEtMjY1MjQ3_1c7dcac6-78c0-46a7-a978-04fa55d1b780">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzMtOS0xLTEtMjY1MjQ3_0ba39e93-53bc-4a4f-a7d1-dd41318a9086">1,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzMtMTEtMS0xLTI2NTI0Nw_974e9120-2a66-48cc-bb3b-5f076784eebc">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzQtMS0xLTEtMjY1MjQ3_57c39029-09ff-4b6e-b348-e5ee6226256e">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzQtMy0xLTEtMjY1MjQ3_9bb1494c-b659-492f-944e-97e6bb2e9ad7">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cab4b0903e747b4ac60612c8fea7746_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzQtNS0xLTEtMjY1MjQ3_adfbb3ba-080f-41a1-b66d-c5c603afab73">5,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cab4b0903e747b4ac60612c8fea7746_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzQtNy0xLTEtMjY1MjQ3_10c6f4fb-e575-494a-92f6-dbf9791d8bf3">398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzQtOS0xLTEtMjY1MjQ3_647f316c-2650-40a1-a8dd-4809387fb1f2">5,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzQtMTEtMS0xLTI2NTI0Nw_1aa7caa0-e66d-460c-bfac-22f530e69d02">403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzUtMS0xLTEtMjY1MjQ3_66489469-cbb4-4565-a263-a70626e18bf2">142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzUtMy0xLTEtMjY1MjQ3_446eddd8-54a8-401d-b27c-b3d24f6af7b2">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cab4b0903e747b4ac60612c8fea7746_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzUtNS0xLTEtMjY1MjQ3_96567f1f-0742-4540-85ac-8017f0b1361e">3,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cab4b0903e747b4ac60612c8fea7746_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzUtNy0xLTEtMjY1MjQ3_83509a45-0ff6-4e59-a4a2-e3f4fc38c72f">494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzUtOS0xLTEtMjY1MjQ3_fcccb011-d0ff-449b-9764-57ad9811fff2">3,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzUtMTEtMS0xLTI2NTI0Nw_ad6a9a54-cc82-459a-b874-1f7a70760d67">511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzYtMS0xLTEtMjY1MjQ3_1c819f46-4682-487e-a191-d77a1cfdc5f2">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzYtMy0xLTEtMjY1MjQ3_870b1627-3feb-4d9d-b834-7f3501c9c218">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cab4b0903e747b4ac60612c8fea7746_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzYtNS0xLTEtMjY1MjQ3_6724c7c4-783f-47a7-9fac-8ce2508d6892">3,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cab4b0903e747b4ac60612c8fea7746_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzYtNy0xLTEtMjY1MjQ3_307244d2-aef3-4b98-9c1d-1eb13d329e66">501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzYtOS0xLTEtMjY1MjQ3_cd2339cc-8358-4603-9c63-8f5bace06b38">3,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzYtMTEtMS0xLTI2NTI0Nw_799a0a1f-4de2-4562-ad03-86c97cac2794">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21d50269b9b94eff85b08845bfd50cd8_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzctMS0xLTEtMjY1MjQ3_0341dcbb-c08e-4d04-8b99-caf7655458c8">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21d50269b9b94eff85b08845bfd50cd8_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzctMy0xLTEtMjY1MjQ3_1ed2d2e8-757d-46ff-b9eb-ec7f489c85ff">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9de4d4f1b014ecb98d80d1d8fd9997c_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzctNS0xLTEtMjY1MjQ3_b81d9e11-813b-457a-9d52-c8e678d25501">710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9de4d4f1b014ecb98d80d1d8fd9997c_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzctNy0xLTEtMjY1MjQ3_216bbe23-1de2-4e9b-9863-8c92f1d8328b">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzctOS0xLTEtMjY1MjQ3_e5e08f5a-f0b6-482c-849e-162777c17d8c">721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzctMTEtMS0xLTI2NTI0Nw_a8d29941-a651-4bc7-a0e1-a0b93093311a">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fdc07fa1fda46ea9a75488e14c8311e_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzgtMS0xLTEtMjY1MjQ3_bf1a3548-f89b-48f4-a53a-3702d48ba6cc">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fdc07fa1fda46ea9a75488e14c8311e_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzgtMy0xLTEtMjY1MjQ3_3007b8c0-01a3-4e92-b3f2-c5fed11cafa5">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5826868b7599497aaadf079b91c1ec9c_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzgtNS0xLTEtMjY1MjQ3_19c4cd00-6408-4e2d-aa1f-00d8c892b3ad">960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5826868b7599497aaadf079b91c1ec9c_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzgtNy0xLTEtMjY1MjQ3_85f807ee-6fb2-41fc-8f6b-3e7e09924e37">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzgtOS0xLTEtMjY1MjQ3_ade45282-857f-4b6f-8a54-54a4ed90bf7b">992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzgtMTEtMS0xLTI2NTI0Nw_9093b158-27ee-4aab-b7e8-9fa76b1a6778">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73eeedf2a9af4ccdb7f524acfbd1291d_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzktMS0xLTEtMjY1MjQ3_86498c48-d52a-4f30-9135-05b88e2a2e36">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73eeedf2a9af4ccdb7f524acfbd1291d_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzktMy0xLTEtMjY1MjQ3_2ab734e3-fa70-4998-8b76-08f6d251e1a7">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb16d569f25741039929fe7413c06b74_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzktNS0xLTEtMjY1MjQ3_4aff3726-4627-4b9f-aae0-2efecc15b5be">2,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb16d569f25741039929fe7413c06b74_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzktNy0xLTEtMjY1MjQ3_12eee77e-cc9b-4300-8aaa-cf6c3216d8a4">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzktOS0xLTEtMjY1MjQ3_226e3478-992e-4874-b7be-2b77274a173c">2,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzktMTEtMS0xLTI2NTI0Nw_e120d870-739f-4ddc-98c1-db6d85be07e2">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzEwLTEtMS0xLTI2NTI0Nw_5ce5626b-7089-406a-bfa5-57a5d96793be">568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzEwLTMtMS0xLTI2NTI0Nw_76298b1e-f7d2-416b-8d8f-edc6e0434801">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cab4b0903e747b4ac60612c8fea7746_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzEwLTUtMS0xLTI2NTI0Nw_94cb0afc-1e76-4aca-8484-d28193492e4c">17,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cab4b0903e747b4ac60612c8fea7746_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzEwLTctMS0xLTI2NTI0Nw_83810948-dd64-4aa2-b334-54a68bed3ecb">1,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzEwLTktMS0xLTI2NTI0Nw_2a661800-b1dd-46b0-9299-04ff3584a2b9">18,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzEwLTExLTEtMS0yNjUyNDc_1e1c5e35-ea27-42d5-8d9f-3f6bfe332154">1,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mortgage Loans</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="cvs:ActivityInMortgageLoanPortfolioTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzcwNDc_0b79a579-14d6-4bd0-bbfb-cba371f16b36" continuedAt="i011c5657cbd449a1b1c6902131535648" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s mortgage loans are collateralized by commercial real estate.&#160;During the years ended December 31, 2022 and 2021, the Company had the following activity in its mortgage loan portfolio:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4afa3728f7a4abe948e80bf8d977e54_D20220101-20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo4YWMyNDAwN2YzNTM0MDdiYjVmYWIxMjAzYmY4ZjkxYS90YWJsZXJhbmdlOjhhYzI0MDA3ZjM1MzQwN2JiNWZhYjEyMDNiZjhmOTFhXzEtMS0xLTEtMjY1MjQ3_5b9b8e37-5985-42cd-9fe6-6deea8ac8d92">356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if04d1680adba48cb8232ead08df7bae0_D20210101-20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo4YWMyNDAwN2YzNTM0MDdiYjVmYWIxMjAzYmY4ZjkxYS90YWJsZXJhbmdlOjhhYzI0MDA3ZjM1MzQwN2JiNWZhYjEyMDNiZjhmOTFhXzEtMy0xLTEtMjY1MjQ3_663f5b15-84ce-4131-bcc7-705f43bebdf9">262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4afa3728f7a4abe948e80bf8d977e54_D20220101-20221231" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo4YWMyNDAwN2YzNTM0MDdiYjVmYWIxMjAzYmY4ZjkxYS90YWJsZXJhbmdlOjhhYzI0MDA3ZjM1MzQwN2JiNWZhYjEyMDNiZjhmOTFhXzItMS0xLTEtMjY1MjQ3_7d5139fe-413b-4a88-aa20-adc2c9f22037">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if04d1680adba48cb8232ead08df7bae0_D20210101-20211231" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo4YWMyNDAwN2YzNTM0MDdiYjVmYWIxMjAzYmY4ZjkxYS90YWJsZXJhbmdlOjhhYzI0MDA3ZjM1MzQwN2JiNWZhYjEyMDNiZjhmOTFhXzItMy0xLTEtMjY1MjQ3_07caf581-6646-4b66-86c5-58b0a1166286">373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4afa3728f7a4abe948e80bf8d977e54_D20220101-20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateForeclosures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo4YWMyNDAwN2YzNTM0MDdiYjVmYWIxMjAzYmY4ZjkxYS90YWJsZXJhbmdlOjhhYzI0MDA3ZjM1MzQwN2JiNWZhYjEyMDNiZjhmOTFhXzMtMS0xLTEtMjY1MjQ3_bbd93d6d-50a6-4072-9ae5-07c4ef678c69">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if04d1680adba48cb8232ead08df7bae0_D20210101-20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateForeclosures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo4YWMyNDAwN2YzNTM0MDdiYjVmYWIxMjAzYmY4ZjkxYS90YWJsZXJhbmdlOjhhYzI0MDA3ZjM1MzQwN2JiNWZhYjEyMDNiZjhmOTFhXzMtMy0xLTEtMjY1MjQ3_d62c5fbe-cc7c-4e80-812a-0c462246f503">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#8217;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 1 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents loans of superior quality.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 2 to 4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 5 and 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represent loans where credit risk is not substantial, but these loans warrant management&#8217;s close attention.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie9fbfe888d4e4a02b25a7ea0d8336313" continuedAt="ieb9cd25116fe41249fbc918db91a306e"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzcwNDg_ee6748ec-4903-4ef3-9270-57d700eb0c42" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon the Company&#8217;s assessments at December&#160;31, 2022 and 2021, the amortized cost basis of the Company&#8217;s mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.100%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.950%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d74574442044f68b51d8276992c9058_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzMtMS0xLTEtMjY1MjQ3_f58f7fed-c343-4687-b1ec-2856d21efa84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75980a6ff3ee49029a1d3de9bfd5c17a_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzMtMy0xLTEtMjY1MjQ3_91e57335-fc81-4cb8-b3bd-6b0d95d07c23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90acf0fa2cef449a9a6b3fe9669194a7_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzMtNS0xLTEtMjY1MjQ3_09eaca25-e094-4ae0-a37e-8fc82ffeefe4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie029e8df1c364a138c570492e98b3d54_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzMtNy0xLTEtMjY1MjQ3_389c55cd-a491-4983-8451-a2f4f913eea3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i421c93ab9ec34e0b8ad632a772e570ca_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzMtOS0xLTEtMjY1MjQ3_2a20a2eb-e94c-4bd3-ab16-693a02c555f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bca51009fe7432c8013e336a1cf4350_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzMtMTEtMS0xLTI2NTI0Nw_948f271d-710c-4fc4-b154-e3fc248ffcae">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a6652f704234be281c7de3aaf21a926_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzMtMTMtMS0xLTI2NTI0Nw_770aa456-3f06-4dd4-b2b8-ba55160338e7">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ea51f302c714924bc0ef9b87f297f7f_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzQtMS0xLTEtMjY1MjQ3_149a66b1-ccaa-48dd-9b4f-605f8b396f5e">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebb51e53093740178b4dba853cf3420c_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzQtMy0xLTEtMjY1MjQ3_3a1ea253-535c-4ff9-a843-b37a6f26935e">247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12a608a6606644d88c677fd0f751bd61_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzQtNS0xLTEtMjY1MjQ3_efd09981-0c88-4603-8973-b9e7a0fef918">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d4072e6b69341889b6e4a48f5921c8a_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzQtNy0xLTEtMjY1MjQ3_f3b29614-02bb-40a0-84ef-368b1860c6e0">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88a11ee9559a44de92dd80d2f5faddeb_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzQtOS0xLTEtMjY1MjQ3_b1bc7069-9e7a-4b73-bf9b-f070a4bdb503">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia93b04912558443280c9e2aa952f9903_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzQtMTEtMS0xLTI2NTI0Nw_1f97bed1-b4bc-4d73-86e9-e62ff4c933a3">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc270e3970b14849bffe624fd7f92c5b_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzQtMTMtMS0xLTI2NTI0Nw_0a2d9372-5b30-451b-9d40-2716bcdaeace">1,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53ee1002dbe14d6a9a0a87c428a073fd_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzUtMS0xLTEtMjY1MjQ3_d2eee797-cf52-43ad-a1b7-53f99cf2e70c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73d009030d3c4eb2ac0695369c7267d7_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzUtMy0xLTEtMjY1MjQ3_d7930007-53a3-4d2a-886f-7e27a111054e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf299ad413194c68830e48ee0a189167_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzUtNS0xLTEtMjY1MjQ3_9347f351-8096-4ff1-956e-f1dd6ed1f3e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91ce86bfa38a43eb82d3e5630dbb6fe0_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzUtNy0xLTEtMjY1MjQ3_d89ee4fc-f49a-4ad4-b9a3-6d1e966f3806">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85218d26a5ac4a8b8a791e5184f5532e_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzUtOS0xLTEtMjY1MjQ3_ef19e370-afa2-4ebc-b2c2-48d9ef65323e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12457fd4abed4dd5810c523723b9e883_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzUtMTEtMS0xLTI2NTI0Nw_95668ae7-ce14-493c-a52f-1ee73d778708">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1693d5376c24d27ae1f522504dba375_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzUtMTMtMS0xLTI2NTI0Nw_48b7bbd0-6c8b-4e5f-853e-23f53b876f15">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99cea1f4247b4a72ba6ce1db47e509bc_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzYtMS0xLTEtMjY1MjQ3_db2eee18-5710-4f4c-afaf-6bd2aced0419">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if496ce43b9584f0cb06d921498c7a6d5_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzYtMy0xLTEtMjY1MjQ3_fd2edb11-1448-42d3-b0ed-42618fbe5490">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5469e56e6e2247438f23b5f4ce0fc023_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzYtNS0xLTEtMjY1MjQ3_7aa0446c-6135-4b59-8b70-bda84df732ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14ebe9c147f34b30afb070d4275d56be_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzYtNy0xLTEtMjY1MjQ3_bce86214-8e9a-4b34-a4c5-8761e0a5d473">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a42cf0d49a24a3eae7d66f7a609a49a_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzYtOS0xLTEtMjY1MjQ3_bf3af794-c10a-4ada-8b9e-ddd3f9c35db9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic39faab8b805446e8f84846e67c4a2b1_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzYtMTEtMS0xLTI2NTI0Nw_1cf2159e-9f82-4e07-be51-469d48e7dcf8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db592d2a00948c68596b30eee11b0de_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzYtMTMtMS0xLTI2NTI0Nw_e8fa0f9f-9421-47f1-9de6-be6972e5b6e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a10358d02ce40d1ba0f351f89985dd8_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzctMS0xLTEtMjY1MjQ3_a6138ac7-7e51-46b8-a7c1-6a946f588c64">326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9479f6e04944448fb94cd8b2ffa008ac_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzctMy0xLTEtMjY1MjQ3_804fe699-82a2-4c6b-b1f4-2dadd5aa3e4f">247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i640aed5419174663a30409089c100a72_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzctNS0xLTEtMjY1MjQ3_62644926-2859-40b3-8ba8-7810d23dc7c1">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47777d9b93154d6784b7b9f3c2f9d892_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzctNy0xLTEtMjY1MjQ3_2b3f4b0b-cb8e-4272-824e-6ee2edcedfb8">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i854bfde83a1447f4b3644fc9241f54c4_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzctOS0xLTEtMjY1MjQ3_10587152-9c7c-46ef-84ff-45107a4f8578">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff3b89973faf410c9acb26abb292d6b2_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzctMTEtMS0xLTI2NTI0Nw_0931f920-0f6f-45ae-9b14-8ad180c2cad7">369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad5913b793d42b68d0dc23a03aeccd7_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzctMTMtMS0xLTI2NTI0Nw_7f59a024-9915-49fa-8b6e-aa49a01fb39e">1,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadb22641a7de480890dce9724f3d4b73_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEwLTMtMS0xLTI2NTI0Nw_51f37c37-20a5-407a-acdb-dca48bcc81c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9504148b06654a839a20790e6729610b_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEwLTUtMS0xLTI2NTI0Nw_cc4e7cc9-48e9-4b4d-b668-ac879f73850b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffa87d8a62b6424c930a0a38e3b4d729_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEwLTctMS0xLTI2NTI0Nw_3a037c30-7cb0-4e2d-984f-3650b567dc03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06832aa121f84e7d9bb9a51594f8328f_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEwLTktMS0xLTI2NTI0Nw_84e268a6-abcd-4e23-9bf9-415e848d494e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06d54096c9ef445b94dac9cf772665f9_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEwLTExLTEtMS0yNjUyNDc_7a683dad-f505-43c2-83ff-145b289a20b9">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9407183bf04eb2817defb619e71ebd_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEwLTEzLTEtMS0yNjUyNDc_b392e7ab-60fb-4e9b-b36c-c07205eb5fe6">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a5c876135b74ae1838032336d64387b_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzExLTMtMS0xLTI2NTI0Nw_6c986729-ec55-4d36-b087-bcb935935277">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca464be42434835bf579eb85f510027_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzExLTUtMS0xLTI2NTI0Nw_37f380e6-2679-4f7d-b9de-2eac89fec38a">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2bf2504884d47a787c23c9e647d0278_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzExLTctMS0xLTI2NTI0Nw_bbebff5b-e752-429a-a99c-01199643a7e0">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e057cbf62aa4488a2f57555c190f72c_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzExLTktMS0xLTI2NTI0Nw_96c4e10e-1dfd-44fe-a7ea-ec6e96ed91f4">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4576cfca422b43d9b5a9fd4714c411f1_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzExLTExLTEtMS0yNjUyNDc_0d49d391-04a0-4baf-a98d-397c08ab8f42">446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b33e9db5f6e4f5f9006e8393083dde3_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzExLTEzLTEtMS0yNjUyNDc_54e7e1ff-bea0-4586-a770-fe63132c383c">861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2a5a5b141684675807f743d5fe77545_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEyLTMtMS0xLTI2NTI0Nw_f37f6a5d-50ae-4268-9b69-4ecb44409155">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f98e6a0455476e9364c7c8d8ab21d8_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEyLTUtMS0xLTI2NTI0Nw_a08a3317-d434-4cc7-a10a-c919a5c46340">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i480128f0b108421a96f35af154e8f5f0_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEyLTctMS0xLTI2NTI0Nw_d8d909ac-3b46-4f5d-8243-0530e928b669">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i014bace9b30c4dad914233baff909ea6_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEyLTktMS0xLTI2NTI0Nw_86ddc6d2-244a-493f-a470-8944bb176562">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13320df95b974197bbb559c6f4e8dbd0_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEyLTExLTEtMS0yNjUyNDc_a8287ff8-12cd-4f30-bfd5-19e22d56f395">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i399f816ced304ff0a68ab3aa72222b6c_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEyLTEzLTEtMS0yNjUyNDc_8b12a70b-ef53-45bf-ae88-7d163845081a">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9e248f337b647938c4b077be13c8a69_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEzLTMtMS0xLTI2NTI0Nw_14dcc71e-2f0d-42df-873f-8ff152d7e68a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4c467b53e74463fa33e728cd19c09d8_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEzLTUtMS0xLTI2NTI0Nw_99ca23df-1a51-4062-9980-bdac175e33ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia440d58b19c54e7da108e0f4c033ea0b_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEzLTctMS0xLTI2NTI0Nw_5025d99e-3010-46a3-8203-8d104d7ba564">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb7a9c6c43b46caa278ea7418cf1d7d_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEzLTktMS0xLTI2NTI0Nw_072d2c3c-fcff-4e01-8e66-2683822924ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b792007b8444fc8f042f94a615af30_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEzLTExLTEtMS0yNjUyNDc_cf944a29-90d8-4251-9e8c-7cf2d714c02d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd3a320f1354f8b810c747934dce719_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEzLTEzLTEtMS0yNjUyNDc_5fd431a2-b865-4184-9da7-2af9d569972b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15b8ca29a4dc4503a5baf923e5290e6e_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzE0LTMtMS0xLTI2NTI0Nw_f557de2d-2171-4109-a8a7-9be00cb2b836">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedfeeeeb01db4051a98addb83b67c636_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzE0LTUtMS0xLTI2NTI0Nw_917974bd-ad07-4837-acd2-5dd3113b2743">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie44f7fadffdd49b09a635391637ef400_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzE0LTctMS0xLTI2NTI0Nw_6b44bcc3-8b85-4b02-aac8-7d81e47103a3">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9afd4ac3c27443da681cc815ff5e5c2_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzE0LTktMS0xLTI2NTI0Nw_53e91203-3306-413b-84fe-7662e2bfbb12">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739531ebbb1b4313b647d32f2141a862_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzE0LTExLTEtMS0yNjUyNDc_d129a373-4329-4364-aae2-66eff9e87bf0">484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578621c95d044984be4bc06471e111cb_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzE0LTEzLTEtMS0yNjUyNDc_c72409c6-bee5-4e48-a733-80dc970d6ba1">902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:continuation id="i011c5657cbd449a1b1c6902131535648"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 scheduled mortgage loan principal repayments were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.842%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad5913b793d42b68d0dc23a03aeccd7_I20221231" decimals="-6" name="cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo5OWQyYzgwOWQyNGE0MGRlODZmMWI4OTU4YmMwODI3Zi90YWJsZXJhbmdlOjk5ZDJjODA5ZDI0YTQwZGU4NmYxYjg5NThiYzA4MjdmXzEtMS0xLTEtMjY1MjQ3_9a11a427-06b9-4492-a84c-3909d28c44b3">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad5913b793d42b68d0dc23a03aeccd7_I20221231" decimals="-6" name="cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo5OWQyYzgwOWQyNGE0MGRlODZmMWI4OTU4YmMwODI3Zi90YWJsZXJhbmdlOjk5ZDJjODA5ZDI0YTQwZGU4NmYxYjg5NThiYzA4MjdmXzItMS0xLTEtMjY1MjQ3_c985c357-d3bd-4051-8931-dcdefbe1310e">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad5913b793d42b68d0dc23a03aeccd7_I20221231" decimals="-6" name="cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo5OWQyYzgwOWQyNGE0MGRlODZmMWI4OTU4YmMwODI3Zi90YWJsZXJhbmdlOjk5ZDJjODA5ZDI0YTQwZGU4NmYxYjg5NThiYzA4MjdmXzMtMS0xLTEtMjY1MjQ3_dabfac13-d8c6-4d67-9d28-e134421942a1">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad5913b793d42b68d0dc23a03aeccd7_I20221231" decimals="-6" name="cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo5OWQyYzgwOWQyNGE0MGRlODZmMWI4OTU4YmMwODI3Zi90YWJsZXJhbmdlOjk5ZDJjODA5ZDI0YTQwZGU4NmYxYjg5NThiYzA4MjdmXzQtMS0xLTEtMjY1MjQ3_0ce5b058-78c5-40fb-844b-694dafd9e646">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad5913b793d42b68d0dc23a03aeccd7_I20221231" decimals="-6" name="cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo5OWQyYzgwOWQyNGE0MGRlODZmMWI4OTU4YmMwODI3Zi90YWJsZXJhbmdlOjk5ZDJjODA5ZDI0YTQwZGU4NmYxYjg5NThiYzA4MjdmXzUtMS0xLTEtMjY1MjQ3_7c062d42-04b6-40e2-9b1a-3bb4c8021cb0">203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad5913b793d42b68d0dc23a03aeccd7_I20221231" decimals="-6" name="cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo5OWQyYzgwOWQyNGE0MGRlODZmMWI4OTU4YmMwODI3Zi90YWJsZXJhbmdlOjk5ZDJjODA5ZDI0YTQwZGU4NmYxYjg5NThiYzA4MjdmXzYtMS0xLTEtMjY1MjQ3_5d09b23b-648e-4c7c-ae75-317132f76a4a">376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad5913b793d42b68d0dc23a03aeccd7_I20221231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo5OWQyYzgwOWQyNGE0MGRlODZmMWI4OTU4YmMwODI3Zi90YWJsZXJhbmdlOjk5ZDJjODA5ZDI0YTQwZGU4NmYxYjg5NThiYzA4MjdmXzctMS0xLTEtMjY1MjQ3_5f907f40-95d1-4771-b291-4ab717f2a210">1,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Income</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:InvestmentIncomeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzcwMzI_fb71acb8-f123-425c-b2e9-8b5589a7b249" continuedAt="ib2a3b618eb8e41a88e499fd5b0d2f4a2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the years ended December 31, 2022, 2021 and 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i762743c83fc54d4b84a2b52a9dc069ea_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzEtMS0xLTEtMjY1MjQ3_89448dac-ff50-47c5-a497-2ca0031b477d">702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefc840c940b34ad98d700a94a9c98c36_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzEtMy0xLTEtMjY1MjQ3_ef29275a-540b-4d6d-b072-0286e07f4ffb">634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7f12d0216be4ec7b5b4ec403f1ac753_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzEtNS0xLTEtMjY1MjQ3_6cc568c5-a9ac-497b-9321-518da977872f">598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i492eb4d473b8474399d0876f23723ffe_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzItMS0xLTEtMjY1MjQ3_6f0cd5a6-7361-4f74-8c01-1c57465dbcce">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb4f81b717c34e498a2a17bce45af326_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzItMy0xLTEtMjY1MjQ3_e3a94685-be58-48ff-b32a-ac38f6969072">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369222388a054b4f8f100bd1d68da12f_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzItNS0xLTEtMjY1MjQ3_202ddd9e-af8c-47ea-8c2f-677728edf729">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i068dca23e0464c6eaf06ae53103e8ee4_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzMtMS0xLTEtMjY1MjQ3_b194294c-281d-4932-8275-928fc6498983">448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9969db4222c441394605cdce7151928_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzMtMy0xLTEtMjY1MjQ3_fdcaeeb7-36b6-4782-bbaf-a7f50c082a7a">381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8cb3e0c3585411b8626e196b7be91ff_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzMtNS0xLTEtMjY1MjQ3_c88c3a10-0503-43db-9786-c7037f8cc1ba">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzQtMS0xLTEtMjY1MjQ3_8bc50a59-3e68-4365-975d-422f8c600530">1,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzQtMy0xLTEtMjY1MjQ3_41e9e5b2-5c73-4e50-9dcf-f37cf8746a83">1,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzQtNS0xLTEtMjY1MjQ3_df9a321a-5cac-4a3b-accf-3f2e87d5fb24">781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzUtMS0xLTEtMjY1MjQ3_b60f49b4-299b-45e1-ae68-18302897f3c4">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzUtMy0xLTEtMjY1MjQ3_644801f2-8b05-41fc-b4d8-273508b03c36">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzUtNS0xLTEtMjY1MjQ3_0bf82f38-9040-4864-b79e-4d40316ba07a">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital gains or losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsOrLosses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzYtMS0xLTEtMjY1MjQ3_01329038-87cb-4757-befa-09895f5cc97b">1,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsOrLosses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzYtMy0xLTEtMjY1MjQ3_2234e4fe-9c10-435b-b649-debdf1d5fadd">1,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsOrLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzYtNS0xLTEtMjY1MjQ3_f11e065b-b7b0-49dc-bde4-d303990a5594">746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains (losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzctMS0xLTEtMjY1MjQ3_187fdbb5-a675-4451-bdd1-f97a7a906cbc">320</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzctMy0xLTEtMjY1MjQ3_fddf05e2-f49c-4ed1-afd5-e93d899d1ccb">176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzctNS0xLTEtMjY1MjQ3_62543ab4-c99f-49e3-8cb9-8fa3a9953b6d">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzgtMS0xLTEtMjY1MjQ3_ff2ccaf2-232c-46bb-954f-ff5ff0832004">838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzgtMy0xLTEtMjY1MjQ3_d1437b33-d1c0-4a65-970f-82e80da4db1f">1,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzgtNS0xLTEtMjY1MjQ3_f4e096cc-7b77-4797-b585-e9c83166acf1">798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital losses include credit-related losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzYwOTM_bfa8d9e5-dd96-443d-ba0d-56ed7bb058f9">13</ix:nonFraction> million and yield-related impairment losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzYxNTQ_ae3ef6a2-9697-47f0-bf54-86428ab4c4a2">143</ix:nonFraction> million in the year ended December 31, 2022. Net realized capital gains are net of yield-related impairment losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzYyODY_9190c9d1-0ef3-4c69-862e-27a5b347237e">42</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzYyOTM_7010e6e7-97fa-4aa7-8d00-037b942cb7a3">49</ix:nonFraction> million for the years ended December 31, 2021 and 2020, respectively. There were <ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzYzNjk_a87df1da-128f-4015-8b8f-c011b37edac3"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzYzNjk_d7c37bba-a2ad-4b70-b93f-1b7764b89798">no</ix:nonFraction></ix:nonFraction> credit-related losses on debt securities in the years ended December 31, 2021 and 2020.</span></div></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="ib2a3b618eb8e41a88e499fd5b0d2f4a2" continuedAt="i9767012e35684e728505f7b875e5a94d">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="i9767012e35684e728505f7b875e5a94d">Net investment income includes $<ix:nonFraction unitRef="usd" contextRef="i137cad6adc6f4ecb8a82de703aa13a63_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzY0OTE_5e56d2aa-f0f5-4b25-bd6f-50a7f7c364f2">35</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="if00a9d16f4b54e3b9f6ebe547b51e58d_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzY0OTU_d1a3f752-2f92-4af4-8bef-027568c44014">38</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if19bb3693da04612931c094a9c82234d_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzY1MDI_29a86f6f-086d-492d-86e6-a72644016ea8">42</ix:nonFraction> million for the years ended December 31, 2022, 2021 and 2020, respectively, related to investments supporting experience-rated products.</ix:continuation> </span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ieb9cd25116fe41249fbc918db91a306e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital gains and losses recognized during the year ended December 31, 2022 related to investments in equity securities held as of December 31, 2022 were not material.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzcwNDI_a179ace5-cd20-4d90-bbe0-bcc9c15c15f1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses in the years ended December 31, 2022, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphZDAyZTNjOGVmZGE0NmFmOTVjOGNlNmI0ZWNiNGQ0OS90YWJsZXJhbmdlOmFkMDJlM2M4ZWZkYTQ2YWY5NWM4Y2U2YjRlY2I0ZDQ5XzEtMS0xLTEtMjY1MjQ3_34c2938c-d5db-4c61-a7fb-f0bb96d9d8ce">4,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphZDAyZTNjOGVmZGE0NmFmOTVjOGNlNmI0ZWNiNGQ0OS90YWJsZXJhbmdlOmFkMDJlM2M4ZWZkYTQ2YWY5NWM4Y2U2YjRlY2I0ZDQ5XzEtMy0xLTEtMjY1MjQ3_0e33a4f5-5974-4310-9c7b-4d04a0b3fff3">3,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphZDAyZTNjOGVmZGE0NmFmOTVjOGNlNmI0ZWNiNGQ0OS90YWJsZXJhbmdlOmFkMDJlM2M4ZWZkYTQ2YWY5NWM4Y2U2YjRlY2I0ZDQ5XzEtNS0xLTEtMjY1MjQ3_93a978c9-3cde-4967-9409-634c439a17b9">3,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphZDAyZTNjOGVmZGE0NmFmOTVjOGNlNmI0ZWNiNGQ0OS90YWJsZXJhbmdlOmFkMDJlM2M4ZWZkYTQ2YWY5NWM4Y2U2YjRlY2I0ZDQ5XzItMS0xLTEtMjY1MjQ3_1b740127-74e4-4d21-ba34-c6a8a4decd11">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphZDAyZTNjOGVmZGE0NmFmOTVjOGNlNmI0ZWNiNGQ0OS90YWJsZXJhbmdlOmFkMDJlM2M4ZWZkYTQ2YWY5NWM4Y2U2YjRlY2I0ZDQ5XzItMy0xLTEtMjY1MjQ3_7e4be33b-a7de-458c-a381-42181f135a01">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphZDAyZTNjOGVmZGE0NmFmOTVjOGNlNmI0ZWNiNGQ0OS90YWJsZXJhbmdlOmFkMDJlM2M4ZWZkYTQ2YWY5NWM4Y2U2YjRlY2I0ZDQ5XzItNS0xLTEtMjY1MjQ3_7fd050ce-00ff-4132-a20c-cd4483e505c1">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphZDAyZTNjOGVmZGE0NmFmOTVjOGNlNmI0ZWNiNGQ0OS90YWJsZXJhbmdlOmFkMDJlM2M4ZWZkYTQ2YWY5NWM4Y2U2YjRlY2I0ZDQ5XzMtMS0xLTEtMjY1MjQ3_9174dc48-eeb9-4289-8d1b-0f18f69ac191">177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphZDAyZTNjOGVmZGE0NmFmOTVjOGNlNmI0ZWNiNGQ0OS90YWJsZXJhbmdlOmFkMDJlM2M4ZWZkYTQ2YWY5NWM4Y2U2YjRlY2I0ZDQ5XzMtMy0xLTEtMjY1MjQ3_cd9c28e7-a064-41ab-abe5-90728dd870f0">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphZDAyZTNjOGVmZGE0NmFmOTVjOGNlNmI0ZWNiNGQ0OS90YWJsZXJhbmdlOmFkMDJlM2M4ZWZkYTQ2YWY5NWM4Y2U2YjRlY2I0ZDQ5XzMtNS0xLTEtMjY1MjQ3_7e90cf1c-000b-4993-af47-2c67260e534f">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i36038907935e41eea5e9cf7cac915d44_130"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzEwNzIx_39cabf58-de51-44f1-9034-0a2ea3de3eb1" continuedAt="i5b852974f103438dbed2b752c534259a" escape="true">Fair Value</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i5b852974f103438dbed2b752c534259a" continuedAt="i2ef613931e914b74bc3f6b0ba9e45e9d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s consolidated financial statements requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;In this note, the Company provides details on the fair value of financial assets and liabilities and how it determines those fair values.&#160;The Company presents this information for those financial instruments that are measured at fair value for which the change in fair value impacts net income attributable to CVS Health or other comprehensive income (loss) separately from other financial assets and liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments Measured at Fair Value on the Consolidated Balance Sheets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s financial instruments are measured at fair value on the consolidated balance sheets.&#160;The fair values of these instruments are based on valuations that include inputs that can be classified within one of three levels of a hierarchy established by GAAP.&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#8220;valuation inputs&#8221;) that qualifies a financial asset or liability for each level:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Unadjusted quoted prices for identical assets or liabilities in active markets.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Valuation inputs other than Level 1 that are based on observable market data.&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Developed from unobservable data, reflecting the Company&#8217;s assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities are classified based upon the lowest level of input that is significant to the valuation.&#160;When quoted prices in active markets for identical assets and liabilities are available, the Company uses these quoted market prices to determine the fair value of financial assets and liabilities and classifies these assets and liabilities in Level 1.&#160;In other cases where a quoted market price for identical assets and liabilities in an active market is either not available or not observable, the Company estimates fair value using valuation methodologies based on available and observable market information or by using a matrix pricing model.&#160;These financial assets and liabilities are classified in Level 2.&#160;If quoted market prices are not available, the Company determines fair value using broker quotes or an internal analysis of each investment&#8217;s financial performance and cash flow projections.&#160;Thus, financial assets and liabilities may be classified in Level 3 even though there may be some significant inputs that may be observable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of the valuation methodologies used for the Company&#8217;s financial assets and liabilities that are measured at fair value, including the general classification of such assets and liabilities pursuant to the valuation hierarchy.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of cash and cash equivalents approximates fair value as maturities are less than three months. When quoted prices are available in an active market, cash equivalents are classified in Level 1 of the fair value hierarchy. Fair values of cash equivalent instruments that do not trade on a regular basis in active markets are classified as Level 2.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Where quoted prices are available in an active market, debt securities are classified in Level 1 of the fair value hierarchy.&#160;The Company&#8217;s&#160;Level 1 debt securities consist primarily of U.S. Treasury securities.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s Level 2 debt securities are obtained using models, such as matrix pricing, which use quoted market prices of debt securities with similar characteristics or discounted cash flows to estimate fair value. The </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2ef613931e914b74bc3f6b0ba9e45e9d" continuedAt="i2fcfa8afd3d2491bb1da2b99ecf02ed6"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company reviews these prices to ensure they are based on observable market inputs that include quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets and inputs that are observable that are not prices (such as interest rates and credit risks). The Company also reviews the methodologies and the assumptions used to calculate prices from these observable inputs. On a quarterly basis, the Company selects a sample of its Level 2 debt securities&#8217; prices and compares them to prices provided by a secondary source. Variances over a specified threshold are identified and reviewed to confirm the price provided by the primary source represents an appropriate estimate of fair value. In addition, the Company&#8217;s internal investment team consistently compares the prices obtained for select Level 2 debt securities to the team&#8217;s own independent estimates of fair value for those securities.&#160;The Company obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December&#160;31, 2022 or 2021. </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also values certain debt securities using Level 3 inputs.&#160;For Level 3 debt securities, fair values are determined by outside brokers or, in the case of certain private placement securities, are priced internally.&#160;Outside brokers determine the value of these debt securities through a combination of their knowledge of the current pricing environment and market flows.&#160;The Company did not have any broker quoted debt securities for the years ended December&#160;31, 2022 and 2021. For some private placement securities, the Company&#8217;s internal staff determines the value of these debt securities by analyzing spreads of corporate and sector indices as well as interest spreads of comparable public bonds.&#160;Examples of these private placement Level 3 debt securities include certain U.S. and foreign securities and certain tax-exempt municipal securities.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company currently has two classifications of equity securities:&#160;those that are publicly traded and those that are privately placed.&#160;Publicly-traded equity securities are classified in Level 1 because quoted prices are available for these securities in an active market.&#160;For privately placed equity securities, there is no active market; therefore, these securities are classified in Level 3 because the Company prices these securities through an internal analysis of each investment&#8217;s financial statements and cash flow projections. Significant unobservable inputs consist of earnings and revenue multiples, discount for lack of marketability and comparability adjustments. An increase or decrease in any of these unobservable inputs would have resulted in a change in the fair value measurement. </span></div></ix:continuation><div style="padding-left:36pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2fcfa8afd3d2491bb1da2b99ecf02ed6" continuedAt="ic7c8767bbac245b487f679aebbef57bd"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="id7e14cbf58db473094f1a3a50e0e0423_I20211231" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzY3MDM_066e31c7-da67-4393-9d77-888be4f00124"><ix:nonFraction unitRef="usd" contextRef="ibbd43a9242a0495591196ce21cc7a152_I20221231" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzY3MDM_693d61c2-bd37-486a-b36e-ff7d55115862">no</ix:nonFraction></ix:nonFraction> financial liabilities measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2022 or 2021. <ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzEwNzE0_a8d10abb-35bb-4d91-9c6e-e3cec58e97e6" continuedAt="i9f1c43e316e649278314ee117992bd4f" escape="true">Financial assets measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2022 and 2021 were as follows:</ix:nonNumeric></span></div><ix:continuation id="i9f1c43e316e649278314ee117992bd4f"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaf7c772d40247269c23c494f0813a7f_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzItMS0xLTEtMjY1MjQ3_4d82ce6c-cdd0-4bca-986b-fb53be8a407f">6,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ada3d841105476b9dca967f07a9dee9_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzItMy0xLTEtMjY1MjQ3_9f52ba04-922e-407d-8d74-cae0d5f2b770">6,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9bd28275ddc4fac99461d0040a82e04_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzItNS0xLTEtMjY1MjQ3_3ca1a275-be88-4dca-9e9d-3c299b04c403">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbd43a9242a0495591196ce21cc7a152_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzItNy0xLTEtMjY1MjQ3_78fc7efb-8e3d-44a1-843e-3b2ca8bd1333">12,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc91466b20fa43ada80738d8288e7fea_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzQtMS0xLTEtMjY1MjQ3_e22f2ef5-6d3f-4a64-bb7b-c926c4453e8d">1,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530204e9d197451a99415dd3717e24ac_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzQtMy0xLTEtMjY1MjQ3_f174d60a-4c06-4bb7-bcb8-9b7733ec4dce">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8990fa5e5b8a4f0f97b6e8a430a4f8cc_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzQtNS0xLTEtMjY1MjQ3_8e859203-3c5e-40a3-ba66-942a6cf7faf3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d16b574d8b9499db8e7d78efb965b5e_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzQtNy0xLTEtMjY1MjQ3_52202c57-51f0-4734-8d42-40c6e3fe5950">1,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f3cd6f6ea7e499bb05f3f3288c17b03_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzUtMS0xLTEtMjY1MjQ3_10e2055a-b951-4cc3-97d4-95d236c844b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5c1f15313054273991533c5befb102b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzUtMy0xLTEtMjY1MjQ3_c31c38d9-e6cb-4bf9-b1b9-1ca96c7f783a">2,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d63d3b9768744a2b0dd3376b50053cc_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzUtNS0xLTEtMjY1MjQ3_2d1974c7-fedc-4bf6-af7b-b9cef6abbd7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5101082b492740a3b0895812ec43df67_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzUtNy0xLTEtMjY1MjQ3_f7a36712-b94e-4a26-8861-04775b5165e8">2,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie06499b007a04690b796c75b0962751c_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzYtMS0xLTEtMjY1MjQ3_47d1a935-8d96-49e3-9dbf-c5b2a5e5f4b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida238621d6c341e6a18249c65a07f582_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzYtMy0xLTEtMjY1MjQ3_db86af95-34a6-4867-b5fb-0445c7abea73">8,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16e537cfafe946a1a9ae86bba72ee565_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzYtNS0xLTEtMjY1MjQ3_cfaef814-c1d7-4905-90bb-7a62f53406b1">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7ab6b4e481d4957893effda1b1aa7c7_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzYtNy0xLTEtMjY1MjQ3_5f4d9e0b-4f43-4ab5-a9d3-47299d6177eb">8,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c90587389b24652b4171dd0ee88dee0_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzctMS0xLTEtMjY1MjQ3_01f0e738-517c-4319-a5b5-a6ca717e4572">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08413588348e4bebaa6e0777ce0ef468_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzctMy0xLTEtMjY1MjQ3_f13b9a7b-59a2-4837-b814-e26b5acb8990">2,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06e7906b8aab402c9db7df2fbd123952_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzctNS0xLTEtMjY1MjQ3_aaba5a54-0c41-4b1b-aa5c-f7ec8e17fcde">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23a61fc417cb4a5cb6b648036474566b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzctNy0xLTEtMjY1MjQ3_00f7c53e-4ca1-40b0-8efe-87b6c63c34fc">2,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22037852b26040388b00a9892837d2c6_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzgtMS0xLTEtMjY1MjQ3_21f7136f-d2ce-47d0-bfd4-9505bafea9c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29da59e3b5fa4406a9c1b13643f91b1d_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzgtMy0xLTEtMjY1MjQ3_5d3fdedf-3431-4c56-a3e3-5e85c5d40d2b">757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f33fa4fd1b548fbbed3d1b0df48e1a0_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzgtNS0xLTEtMjY1MjQ3_9e6ebe59-d89b-413f-aa16-da1c9b71fbce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f7c6d92a69343cba3248128978c9fee_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzgtNy0xLTEtMjY1MjQ3_778be767-c780-4446-af9f-8a947fe7e0c5">757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1764e3a27c5c4e3495ac330952dee2a7_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzktMS0xLTEtMjY1MjQ3_361977f9-be10-4f07-8e9f-0967935c6216">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb866ac0512442bcb82bae4443758dc2_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzktMy0xLTEtMjY1MjQ3_576264ec-04c9-4e2b-b8b9-a629d068dbcc">1,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icecd5e128c154279ad038c0b3bd207d7_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzktNS0xLTEtMjY1MjQ3_a2f7f609-d7ca-4cdf-be84-c643e9445207">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25da8a3d6f6c4f1f8d90b11a666a1f83_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzktNy0xLTEtMjY1MjQ3_3491c52b-a7d3-44ae-92fa-af5dd3e769b7">1,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e6791338399461b89ecf1ab5fad5038_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEwLTEtMS0xLTI2NTI0Nw_d07e161e-b8d4-450f-9e16-62a2cc3a68b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea61e57b4e654ebd906d75ab95adf087_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEwLTMtMS0xLTI2NTI0Nw_eb6af235-d05d-44b6-9565-c8b176d69de7">2,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c6d0c54222b4405b72bcbe5aab383e4_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEwLTUtMS0xLTI2NTI0Nw_7bc7d6b3-9bb9-49aa-932c-20fbcaa1a0a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa99b9364f604126ad2513dafb044afc_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEwLTctMS0xLTI2NTI0Nw_45d64d85-6c11-4b5d-82f3-cfd766bffb15">2,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b5704fae30b4a0180968bd57557cc05_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzExLTEtMS0xLTI2NTI0Nw_5805ca3b-bd5d-433f-ae59-1f6371e002e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e951c3bc4d145f4a40476a3449c19ad_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzExLTMtMS0xLTI2NTI0Nw_45062835-8242-47c1-b355-beba7d77fbab">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief0073f279ab4af192756be0d02d4de7_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzExLTUtMS0xLTI2NTI0Nw_1cd3e473-76bb-4be2-99cd-0608513bc787">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc232ee5addf495c8badb0d70cc93c58_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzExLTctMS0xLTI2NTI0Nw_105a6b16-7067-4ca9-8d68-23bc6acf9330">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaf7c772d40247269c23c494f0813a7f_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEyLTEtMS0xLTI2NTI0Nw_27938c21-208f-4cd3-b3f7-c5215f303520">1,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ada3d841105476b9dca967f07a9dee9_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEyLTMtMS0xLTI2NTI0Nw_a57a3cd9-6825-40df-8704-790b221e51fc">18,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9bd28275ddc4fac99461d0040a82e04_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEyLTUtMS0xLTI2NTI0Nw_1b80f486-745c-4ab9-a569-4acb45a26406">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbd43a9242a0495591196ce21cc7a152_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEyLTctMS0xLTI2NTI0Nw_335f67a2-9363-4877-8d4e-c0ec7f4022db">20,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaf7c772d40247269c23c494f0813a7f_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEzLTEtMS0xLTI2NTI0Nw_51999ff2-73a6-4357-ba00-5ae0418b2358">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ada3d841105476b9dca967f07a9dee9_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEzLTMtMS0xLTI2NTI0Nw_e4f05c7d-6248-4355-8ba7-97247c69171f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9bd28275ddc4fac99461d0040a82e04_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEzLTUtMS0xLTI2NTI0Nw_5bd8dd50-867c-47a0-9265-8914da8540b9">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbd43a9242a0495591196ce21cc7a152_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEzLTctMS0xLTI2NTI0Nw_52f3e54e-3a25-48c9-a079-b3c2da49f02e">176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaf7c772d40247269c23c494f0813a7f_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE0LTEtMS0xLTI2NTI0Nw_cd23e1c5-bf1e-4fe2-97f9-91d63c976a6d">8,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ada3d841105476b9dca967f07a9dee9_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE0LTMtMS0xLTI2NTI0Nw_921c9100-8ff9-4643-ae9a-861492288830">24,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9bd28275ddc4fac99461d0040a82e04_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE0LTUtMS0xLTI2NTI0Nw_61225d9c-ad67-4b86-89a4-5aab65dd90bc">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbd43a9242a0495591196ce21cc7a152_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE0LTctMS0xLTI2NTI0Nw_a9136bb5-8ee7-4311-9982-6cc2ae610259">33,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91aae7889074bd7a05849761119e002_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE3LTEtMS0xLTI2NTI0Nw_2a4470c5-2e09-46ae-a4a4-8185080eb4c9">4,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e3342f2eda4923accdad0511bbd8ab_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE3LTMtMS0xLTI2NTI0Nw_a7aab789-faf7-4eff-93cf-e712e08a2185">4,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47cdbbca2588456f80bd73c676fe393c_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE3LTUtMS0xLTI2NTI0Nw_c29c6815-9798-4bb5-81a2-55fd2e27780e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e14cbf58db473094f1a3a50e0e0423_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE3LTctMS0xLTI2NTI0Nw_31825456-db78-4651-a3b6-7b013faa8f9b">9,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf6903b55b154bf5a640326a2ba60787_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE5LTEtMS0xLTI2NTI0Nw_4c1201eb-e84d-47fa-be57-91aaf6d56263">2,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80a1fa05fa624e99a568c5d529713791_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE5LTMtMS0xLTI2NTI0Nw_902fdc2e-59be-4452-b8c1-fbd544c8b9c7">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6823ed470daa49af9254d7a5a6a31e37_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE5LTUtMS0xLTI2NTI0Nw_868decd9-ec28-4061-b899-be83d8528cf2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0338427c63b5451e9bbeb57e1271c8fa_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE5LTctMS0xLTI2NTI0Nw_13264ba4-d018-469a-9a06-e2d7c57adeef">2,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib35379eff59f4c1fb2580ef9d779863d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIwLTEtMS0xLTI2NTI0Nw_888452b9-5758-4c15-9e17-23673f843bf4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i890e91d6254445ac8e4752816f15fc64_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIwLTMtMS0xLTI2NTI0Nw_0deadb5c-9136-4550-af49-24aea1ab968b">3,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ad691d08cdb4176912f4e92ea7f03db_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIwLTUtMS0xLTI2NTI0Nw_75c09b23-256a-4e91-9d9f-fb03081901c0">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdcb45e510345908f049a08f8d3ea8b_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIwLTctMS0xLTI2NTI0Nw_2f87d4a3-43ca-4362-bd07-73dbba1a4b8a">3,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55a4eb72fc1c413382e3c1881d8197f5_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIxLTEtMS0xLTI2NTI0Nw_1e4cb8da-f3ea-4bea-be22-a1321bb9e04f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8066d1e0dc94aa6b3e714bdce964759_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIxLTMtMS0xLTI2NTI0Nw_e83d3dee-90d5-42db-ab40-9461aad21c8e">9,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c74072b7da84ae7822677cfcf5afff9_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIxLTUtMS0xLTI2NTI0Nw_b0cc5215-5fa6-476d-ae10-cbf670ff3829">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe6072dccf0e4a3386213b62e3088a40_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIxLTctMS0xLTI2NTI0Nw_254b425b-74dc-432f-abcd-050c6846b19b">9,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i421fe75787694fa0a11c81717afb1439_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIyLTEtMS0xLTI2NTI0Nw_214134f2-c15b-496f-b883-8a1996091445">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccca4c50d4404ba9b7e6a383314c619d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIyLTMtMS0xLTI2NTI0Nw_f37e6466-c72c-46f5-882d-7693efd8c93b">2,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88314bd313df47c79dbba4210decb5f3_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIyLTUtMS0xLTI2NTI0Nw_8e0fc38b-9409-4f9f-960e-d9a7e63bb4a7">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50144b06283042b2839e3602628c2e9d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIyLTctMS0xLTI2NTI0Nw_13160547-dc02-42db-8ca6-e43151dc8057">2,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31ba761daf614d80a394376a9dc8d67a_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIzLTEtMS0xLTI2NTI0Nw_cc63c38a-1c1a-4780-8322-00d5b85f8e06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590674c939694c899f0d33ebd89a34f9_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIzLTMtMS0xLTI2NTI0Nw_7599ec99-e76e-40ad-9d5a-765ff32232c5">875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc997bf4243447f286d22be9634f8c93_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIzLTUtMS0xLTI2NTI0Nw_80180f1a-f063-4aea-8501-7a9ca74c6ca4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i137db0dfee08476382f7697fd3226606_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIzLTctMS0xLTI2NTI0Nw_bd0ba5bd-7e4f-40ae-866a-e84eac683ecf">875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i279e72df939f411c8a220ad40b2933ad_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI0LTEtMS0xLTI2NTI0Nw_b7c94c91-5c9b-491d-9e78-17d7d7f482f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b4b394827a84ef89c8ad73a0012ea10_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI0LTMtMS0xLTI2NTI0Nw_6debfc18-a116-463e-95b9-d7a58a50b41e">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idadd15b0bc144797998dc56ab0eea88c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI0LTUtMS0xLTI2NTI0Nw_5911f453-a4e0-4252-abc6-7a2cdfa5fe99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09a72f728e864e3eb1d61dc884e59e71_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI0LTctMS0xLTI2NTI0Nw_3bca0738-980a-477c-9814-cae7e32494eb">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc633eb71dd64df8bb1f39e100cd5380_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI1LTEtMS0xLTI2NTI0Nw_3d6e6b42-9991-4b88-b5b3-276a65206724">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3debe593fdae4764a4dfdb909fa118c2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI1LTMtMS0xLTI2NTI0Nw_0ca4252f-d4a3-41bb-909e-b0922a5e31da">2,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70e446705924f59820f42baab777967_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI1LTUtMS0xLTI2NTI0Nw_1554fc8a-3984-4b4b-9c7b-eb80649b020e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie042a85f623e47be97fb43ff84873341_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI1LTctMS0xLTI2NTI0Nw_f7a71d2b-0c1c-4c29-8762-3cfcc93dd8f8">2,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife6ed60ef9304afcbcda02067d9939e7_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI2LTEtMS0xLTI2NTI0Nw_c3538a32-766c-43f3-8ae1-3b714e2c6115">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a6e0424acb4626bd8a9932c7e5cf81_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI2LTMtMS0xLTI2NTI0Nw_37843aa1-ee28-4c1a-9cc8-6757ff1e5c50">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2927600f263b4b33a80751d0bca72ae7_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI2LTUtMS0xLTI2NTI0Nw_45da3090-476e-4de1-b1bd-78486b06b1c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if32a2b7d26c44e27ac43f062d7bb8ce8_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI2LTctMS0xLTI2NTI0Nw_3ef46723-0ed8-428d-9888-8f868f7aa4f0">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91aae7889074bd7a05849761119e002_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI3LTEtMS0xLTI2NTI0Nw_fd23b0da-6cca-4f56-8bb5-86c87fc47131">2,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e3342f2eda4923accdad0511bbd8ab_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI3LTMtMS0xLTI2NTI0Nw_f4757358-e104-48fc-b41e-9ff6b5d99182">20,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47cdbbca2588456f80bd73c676fe393c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI3LTUtMS0xLTI2NTI0Nw_fd517729-2c45-4044-9ae1-278648c442cf">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e14cbf58db473094f1a3a50e0e0423_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI3LTctMS0xLTI2NTI0Nw_cb20f490-2fa8-4841-92f8-9ef34b65c9da">23,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91aae7889074bd7a05849761119e002_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI4LTEtMS0xLTI2NTI0Nw_be94938b-9d0b-4940-bea5-973a22026e8a">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e3342f2eda4923accdad0511bbd8ab_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI4LTMtMS0xLTI2NTI0Nw_872d11bf-ba6f-4a64-927f-b2d0314d395b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47cdbbca2588456f80bd73c676fe393c_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI4LTUtMS0xLTI2NTI0Nw_abde000b-a61e-405e-9ed6-a577e678fbb8">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e14cbf58db473094f1a3a50e0e0423_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI4LTctMS0xLTI2NTI0Nw_2bb0e1c1-229e-4377-8624-1dbb04af4dc6">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91aae7889074bd7a05849761119e002_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI5LTEtMS0xLTI2NTI0Nw_b56c90d6-ea9c-4878-b530-a8a7270165d9">7,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e3342f2eda4923accdad0511bbd8ab_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI5LTMtMS0xLTI2NTI0Nw_2a5fbf89-a8c1-454a-bb51-5c4274717894">25,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47cdbbca2588456f80bd73c676fe393c_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI5LTUtMS0xLTI2NTI0Nw_0845e056-b7a6-4f1f-afdd-3a5339cbc9c1">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e14cbf58db473094f1a3a50e0e0423_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI5LTctMS0xLTI2NTI0Nw_3d8b1c38-ae5b-42ee-8e07-f498338ba8f6">32,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_______________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes cash and cash equivalents of $<ix:nonFraction unitRef="usd" contextRef="i71dadee959a94001826c4f41df794421_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzcwMjc_f4e38ad5-ceaf-4d4b-a577-adcbae47be47">6</ix:nonFraction>&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div></ix:continuation></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:6.75pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic7c8767bbac245b487f679aebbef57bd" continuedAt="i2d5af138402b4636a09b3b04d180c63c"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzEwNzE4_5963697b-85e6-4aa9-8e69-29d4592db241" continuedAt="i1ef20b3e4d21459091df18537affea2f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">States, <br/>municipalities<br/>&#160;and political <br/>subdivisions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.<br/>corporate<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other asset-<br/>backed<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdcb45e510345908f049a08f8d3ea8b_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzEtMS0xLTEtMjY1MjQ3_85ddb707-d271-4348-bb24-1ecb98e47ecb">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe6072dccf0e4a3386213b62e3088a40_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzEtMy0xLTEtMjY1MjQ3_5141e592-6ed6-4656-af56-8af49d416a36">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia886fe9743a34d83adeda64bfbcde12e_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzEtNS0xLTEtMjY1MjQ3_20508ec2-97fa-4600-865d-1b07e25856c0">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie042a85f623e47be97fb43ff84873341_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzEtNy0xLTEtMjY1MjQ3_fec03fa1-0266-4211-86a2-fccc0b462e27">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ea6c9d959a4be69bc036bae5151a22_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzEtMTEtMS0xLTI2NTI0Nw_c76b2ea9-e880-444a-8c8c-8bafa644a398">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e14cbf58db473094f1a3a50e0e0423_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzEtMTMtMS0xLTI2NTI0Nw_a19495e6-dd7f-4bec-8c0d-4700cfacf24c">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized capital losses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in earnings&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96059726faac4aa391e32ec04829a30b_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzMtMS0xLTEtMjY1MjQ3_fc9df44a-1406-460d-9358-b352f7deb942">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee0b7f95d910427ab334b16a255c0b30_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzMtMy0xLTEtMjY1MjQ3_aa6bb23e-6135-4bfd-9c43-ee530525b433">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e36e767de48460789f38c796a6e664f_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzMtNS0xLTEtMjY1MjQ3_e4b9aa72-ab21-457b-a42d-fbb6fe3c7841">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8ab5d1d4da443ba302ff82ecf041dd_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzMtNy0xLTEtMjY1MjQ3_822880a3-3226-44c0-9a53-c921a34a7858">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e02a0f8f4134b338d074df0125e76b9_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzMtMTEtMS0xLTI2NTI0Nw_8a9b87c0-44d3-4cab-9c8b-346dd595f189">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4ddc4dc69fa45d7b4aabcb366bedfb2_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzMtMTMtMS0xLTI2NTI0Nw_7d6579e3-0f99-415a-ac15-b54f4dd9b0fb">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96059726faac4aa391e32ec04829a30b_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzQtMS0xLTEtMjY1MjQ3_3e6c0ff9-1587-4d2b-b76f-3cdacb3963ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee0b7f95d910427ab334b16a255c0b30_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzQtMy0xLTEtMjY1MjQ3_7d24f8f5-522b-4f39-b2db-13c56284040c">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e36e767de48460789f38c796a6e664f_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzQtNS0xLTEtMjY1MjQ3_e2867a77-c366-4702-891a-164529612f74">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e8ab5d1d4da443ba302ff82ecf041dd_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzQtNy0xLTEtMjY1MjQ3_a362d978-8238-4b22-afc8-3c4d445fbb2b">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e02a0f8f4134b338d074df0125e76b9_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzQtMTEtMS0xLTI2NTI0Nw_b526974a-6f60-417a-be30-67a002fc1eb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4ddc4dc69fa45d7b4aabcb366bedfb2_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzQtMTMtMS0xLTI2NTI0Nw_298f1d00-f2f7-4da5-a654-595e3201f77a">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96059726faac4aa391e32ec04829a30b_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzUtMS0xLTEtMjY1MjQ3_ab6e9b02-10b4-4622-871f-2c09b9c72d4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee0b7f95d910427ab334b16a255c0b30_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzUtMy0xLTEtMjY1MjQ3_02c5c4c6-b036-49ef-b10a-c900d3f6b846">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e36e767de48460789f38c796a6e664f_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzUtNS0xLTEtMjY1MjQ3_996df5ba-f093-48cb-a966-3fa1db532cd7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8ab5d1d4da443ba302ff82ecf041dd_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzUtNy0xLTEtMjY1MjQ3_68b5749f-e686-42b9-8b2b-cb66094c3a1a">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e02a0f8f4134b338d074df0125e76b9_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzUtMTEtMS0xLTI2NTI0Nw_3de113a1-8a23-4ad7-b78e-b07becb9bf29">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4ddc4dc69fa45d7b4aabcb366bedfb2_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzUtMTMtMS0xLTI2NTI0Nw_a9ef66a3-f023-4b10-9243-246e19aa6a0a">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96059726faac4aa391e32ec04829a30b_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzYtMS0xLTEtMjY1MjQ3_233319f8-4ad5-4b9b-b617-e135079c2c58">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee0b7f95d910427ab334b16a255c0b30_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzYtMy0xLTEtMjY1MjQ3_c205942f-b9ce-4d7c-8355-07fde5e1b60a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e36e767de48460789f38c796a6e664f_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzYtNS0xLTEtMjY1MjQ3_12f23ad4-190a-49a0-81e2-a40a0c57832f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e8ab5d1d4da443ba302ff82ecf041dd_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzYtNy0xLTEtMjY1MjQ3_c100c382-00e8-4a90-a675-7d11a4e38639">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e02a0f8f4134b338d074df0125e76b9_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzYtMTEtMS0xLTI2NTI0Nw_3c454e76-eaff-451c-9155-691dfbd79cf7">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4ddc4dc69fa45d7b4aabcb366bedfb2_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzYtMTMtMS0xLTI2NTI0Nw_d1b565a3-c805-4cb6-a9ee-898883be1730">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96059726faac4aa391e32ec04829a30b_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzctMS0xLTEtMjY1MjQ3_0c964464-b285-41cc-9dee-107bd74a8557">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee0b7f95d910427ab334b16a255c0b30_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzctMy0xLTEtMjY1MjQ3_8612dcce-7448-4d41-a1e0-e0c47dd2d28d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e36e767de48460789f38c796a6e664f_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzctNS0xLTEtMjY1MjQ3_88f5fa1d-712d-44d4-9d40-49f7cf5d0520">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8ab5d1d4da443ba302ff82ecf041dd_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzctNy0xLTEtMjY1MjQ3_5ea1f515-e948-4d87-a903-9a053731055a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e02a0f8f4134b338d074df0125e76b9_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzctMTEtMS0xLTI2NTI0Nw_f0b43dc5-5e60-4656-870f-bfa8690fc5b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4ddc4dc69fa45d7b4aabcb366bedfb2_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzctMTMtMS0xLTI2NTI0Nw_c38d72cc-6d47-47ac-92e4-85f29a66231c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96059726faac4aa391e32ec04829a30b_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzgtMS0xLTEtMjY1MjQ3_bf90519a-786b-4da8-ae02-68bea9ddc859">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee0b7f95d910427ab334b16a255c0b30_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzgtMy0xLTEtMjY1MjQ3_f3c35f2f-00b8-400e-84e2-9ba4f9c0f830">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e36e767de48460789f38c796a6e664f_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzgtNS0xLTEtMjY1MjQ3_eb4a00d7-34e9-4c71-81d9-c8df17d6c45f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e8ab5d1d4da443ba302ff82ecf041dd_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzgtNy0xLTEtMjY1MjQ3_6b2848b9-5814-4a9b-8265-c48db2940266">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e02a0f8f4134b338d074df0125e76b9_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzgtMTEtMS0xLTI2NTI0Nw_b4433a9c-35be-497d-bb63-9881eaca0985">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4ddc4dc69fa45d7b4aabcb366bedfb2_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzgtMTMtMS0xLTI2NTI0Nw_d6ecf03d-d8df-4eab-bff9-ddb621453518">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5101082b492740a3b0895812ec43df67_I20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzktMS0xLTEtMjY1MjQ3_83de6ca0-f5ab-466a-a176-bf51ef4179f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7ab6b4e481d4957893effda1b1aa7c7_I20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzktMy0xLTEtMjY1MjQ3_3266a91a-1e78-448e-9717-cd857fbf1958">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ab04fe755eb411688cd34938017b350_I20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzktNS0xLTEtMjY1MjQ3_5313b8f6-ce04-4474-b0fd-5650787f8307">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa99b9364f604126ad2513dafb044afc_I20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzktNy0xLTEtMjY1MjQ3_2e123e33-d9ac-42a0-b12a-e2a105fd31e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefd0548132bc49fa913c97c33e550880_I20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzktMTEtMS0xLTI2NTI0Nw_9db83ca7-4a8d-4af4-90de-881e582e31af">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbd43a9242a0495591196ce21cc7a152_I20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzktMTMtMS0xLTI2NTI0Nw_f2807ef0-5e40-49f9-9a56-a40df499856d">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in net unrealized capital losses included in other comprehensive loss associated with Level 3 financial assets which were held as of December&#160;31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0Xzc0NzA_4e3b84e3-a898-4e2f-bc1b-eb2cd4ff5356">9</ix:nonFraction> million during the year ended December&#160;31, 2022.</span></div><div><span><br/></span></div><ix:continuation id="i1ef20b3e4d21459091df18537affea2f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.434%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">States, <br/>municipalities<br/>&#160;and political <br/>subdivisions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.<br/>corporate<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other asset-<br/>backed<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Redeemable<br/>preferred<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35fc2780f35241c7badf4da30b423e52_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzEtMS0xLTEtMjY1MjQ3_7bf186a9-d139-4697-b8d2-5211d37c3d46">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7e27a54d49940b7aef90c83ff8319a1_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzEtMy0xLTEtMjY1MjQ3_12642553-e465-49df-8296-765195f7c733">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d99b91ab0644839726fd9985fcf090_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzEtNS0xLTEtMjY1MjQ3_bc0a5432-b16b-4167-9fc0-d27e37c67973">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i935f57522466474ab5b184e68f6666bd_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzEtNy0xLTEtMjY1MjQ3_309c5fbd-1d82-4773-8279-eb760cc85d7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6589258587b4cf38304516af7c70737_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzEtOS0xLTEtMjY1MjQ3_91709c7f-cfe6-41a0-b5c1-e6195951d787">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d44059ab8fa413594b33583600110ff_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzEtMTEtMS0xLTI2NTI0Nw_d8e33ac0-73e4-44d7-ad51-1cbe6d5870f9">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8eb721873e1742abb8f287c140434eb7_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzEtMTMtMS0xLTI2NTI0Nw_158bfeb3-ca9b-4b7c-ab1d-ec877bc25153">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized capital gains (losses):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i770c6b93b017435188c94e8c9d24f250_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzMtMS0xLTEtMjY1MjQ3_b9560c77-63eb-4dec-95ee-0eca4cf1e20b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa8216683f294597bdbecb11b8d62331_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzMtMy0xLTEtMjY1MjQ3_d4041404-fc57-4d01-8b00-7ed5b199a03d">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied85a7e77c3c4ba692a634daee0770fd_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzMtNS0xLTEtMjY1MjQ3_d5cce525-e548-4669-a8e2-e9872bf254c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79c89c6186094898bdeb5257ad524c9d_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzMtNy0xLTEtMjY1MjQ3_8ed3e4b1-a54a-43f1-8907-eb79fb1b17df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id25912d8f6374ed5934f4e13f688ef0f_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzMtOS0xLTEtMjY1MjQ3_e8926d08-45aa-42ca-88c7-429865c5bcf4">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33cbb6bd12fe4c8293ea3dde4c77e687_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzMtMTEtMS0xLTI2NTI0Nw_d7d0a244-98f6-4109-a9e3-df671777b5e5">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5711de78e5dc4ebf9b7a6c859a134de8_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzMtMTMtMS0xLTI2NTI0Nw_9018ad8b-c169-44cc-b1d4-963e8c17ee80">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i770c6b93b017435188c94e8c9d24f250_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzQtMS0xLTEtMjY1MjQ3_f4eb8b80-f07b-4ecf-9def-b9995db51cac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa8216683f294597bdbecb11b8d62331_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzQtMy0xLTEtMjY1MjQ3_464813ca-934a-46c5-93cb-897462ccfb99">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied85a7e77c3c4ba692a634daee0770fd_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzQtNS0xLTEtMjY1MjQ3_b18df8d9-807d-4bb0-99b3-2996b5e66372">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79c89c6186094898bdeb5257ad524c9d_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzQtNy0xLTEtMjY1MjQ3_e378b734-fec2-42ca-88f2-d23ea9ff66c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id25912d8f6374ed5934f4e13f688ef0f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzQtOS0xLTEtMjY1MjQ3_3c07ee78-7a39-41a5-858e-0b0735b7f9df">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33cbb6bd12fe4c8293ea3dde4c77e687_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzQtMTEtMS0xLTI2NTI0Nw_b6b8816e-f3a3-45ea-b90b-c030430bbf71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5711de78e5dc4ebf9b7a6c859a134de8_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzQtMTMtMS0xLTI2NTI0Nw_ca7238ad-203b-4c17-86a2-7389a09379c3">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i770c6b93b017435188c94e8c9d24f250_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzUtMS0xLTEtMjY1MjQ3_55903b57-4e6e-4d0d-912c-173b20496e4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa8216683f294597bdbecb11b8d62331_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzUtMy0xLTEtMjY1MjQ3_7f2fd13b-ee23-4394-a0c9-5293760965a0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied85a7e77c3c4ba692a634daee0770fd_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzUtNS0xLTEtMjY1MjQ3_b15ed066-b8b5-4946-b73c-bac7d66394fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79c89c6186094898bdeb5257ad524c9d_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzUtNy0xLTEtMjY1MjQ3_fff546a1-ffc3-4884-858c-91177b849534">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id25912d8f6374ed5934f4e13f688ef0f_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzUtOS0xLTEtMjY1MjQ3_66d5ec8f-3a57-45e5-9d7c-b7475838866d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33cbb6bd12fe4c8293ea3dde4c77e687_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzUtMTEtMS0xLTI2NTI0Nw_2fc3b2f9-05ce-45a0-bcfd-34914e8c809d">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5711de78e5dc4ebf9b7a6c859a134de8_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzUtMTMtMS0xLTI2NTI0Nw_2ae6522e-5b3f-41bf-9954-95dc4f9dadcc">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i770c6b93b017435188c94e8c9d24f250_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzYtMS0xLTEtMjY1MjQ3_a15f6c8d-87aa-4ead-9cac-53eb64b1ff62">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa8216683f294597bdbecb11b8d62331_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzYtMy0xLTEtMjY1MjQ3_e843fdf2-2f26-4d83-bb3a-afeae18a0dca">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied85a7e77c3c4ba692a634daee0770fd_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzYtNS0xLTEtMjY1MjQ3_5a311ce0-619a-4b66-bec7-f9d0e48d6128">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79c89c6186094898bdeb5257ad524c9d_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzYtNy0xLTEtMjY1MjQ3_6e98ad85-db87-430e-bdf8-8a39dfc6d59e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id25912d8f6374ed5934f4e13f688ef0f_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzYtOS0xLTEtMjY1MjQ3_6e76b5cf-3db2-4e8b-a6bf-bcc8c5c19788">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33cbb6bd12fe4c8293ea3dde4c77e687_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzYtMTEtMS0xLTI2NTI0Nw_07215593-6944-4fb4-b419-8265b07bce00">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5711de78e5dc4ebf9b7a6c859a134de8_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzYtMTMtMS0xLTI2NTI0Nw_2d2e6705-1990-41b7-b602-3517a9f6e8d3">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i770c6b93b017435188c94e8c9d24f250_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzctMS0xLTEtMjY1MjQ3_f3880fc9-581e-4598-9109-01f63f340fe4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa8216683f294597bdbecb11b8d62331_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzctMy0xLTEtMjY1MjQ3_9c087ea1-369e-402a-b2ef-d69ca22ef294">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied85a7e77c3c4ba692a634daee0770fd_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzctNS0xLTEtMjY1MjQ3_a8d5107e-5f09-499a-85ad-e665d14b1a42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79c89c6186094898bdeb5257ad524c9d_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzctNy0xLTEtMjY1MjQ3_7962442d-de7a-491b-942b-eb0ad5b35b03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id25912d8f6374ed5934f4e13f688ef0f_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzctOS0xLTEtMjY1MjQ3_dcdcb2de-82b0-4ec0-a8db-a3c548e43a14">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33cbb6bd12fe4c8293ea3dde4c77e687_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzctMTEtMS0xLTI2NTI0Nw_2ca65b0d-8d48-490f-8394-7f2f4690e125">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5711de78e5dc4ebf9b7a6c859a134de8_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzctMTMtMS0xLTI2NTI0Nw_7b237387-86f2-4e20-adf5-8d2df399bb23">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i770c6b93b017435188c94e8c9d24f250_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzgtMS0xLTEtMjY1MjQ3_e9066851-ca4d-4225-880f-ebe064c8fa6f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa8216683f294597bdbecb11b8d62331_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzgtMy0xLTEtMjY1MjQ3_cc335814-0b87-465b-a175-6c432a6d0fd1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied85a7e77c3c4ba692a634daee0770fd_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzgtNS0xLTEtMjY1MjQ3_4647145b-5222-44b2-99f3-f4a0236867ff">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79c89c6186094898bdeb5257ad524c9d_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzgtNy0xLTEtMjY1MjQ3_d1248903-a639-48df-956f-a2055726d4d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id25912d8f6374ed5934f4e13f688ef0f_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzgtOS0xLTEtMjY1MjQ3_7586cb34-1301-447c-a6e1-b965066b2a56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33cbb6bd12fe4c8293ea3dde4c77e687_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzgtMTEtMS0xLTI2NTI0Nw_bf65fbeb-fede-4efc-acf3-c4fd72deae3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5711de78e5dc4ebf9b7a6c859a134de8_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzgtMTMtMS0xLTI2NTI0Nw_bfd5028f-38c5-49b5-be93-bb44c524e427">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fdcb45e510345908f049a08f8d3ea8b_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzktMS0xLTEtMjY1MjQ3_345ab251-e213-4d3a-8231-1ad3b15052e6">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe6072dccf0e4a3386213b62e3088a40_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzktMy0xLTEtMjY1MjQ3_322a1e15-22a6-4b75-9b56-cd4f9c018be9">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia886fe9743a34d83adeda64bfbcde12e_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzktNS0xLTEtMjY1MjQ3_0a006499-b9c0-42b4-8349-1b363416f70c">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie042a85f623e47be97fb43ff84873341_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzktNy0xLTEtMjY1MjQ3_2540c0c8-6e32-46be-ae98-2407d1adf84e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if32a2b7d26c44e27ac43f062d7bb8ce8_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzktOS0xLTEtMjY1MjQ3_e3b66908-f310-4feb-b69a-d85d51506e60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ea6c9d959a4be69bc036bae5151a22_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzktMTEtMS0xLTI2NTI0Nw_e820b121-0a76-4b0c-8bf9-514c26124706">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e14cbf58db473094f1a3a50e0e0423_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzktMTMtMS0xLTI2NTI0Nw_bedff9cd-3669-43d3-9200-dcafaa455e6c">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in net unrealized capital losses included in other comprehensive income associated with Level 3 financial assets which were held as of December&#160;31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0Xzc3NTQ_3054dbc2-0dce-4328-9cc1-56e018ab5f08">4</ix:nonFraction>&#160;million during the year ended December&#160;31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total gross transfers into (out of) Level 3 during the years ended December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross transfers into Level 3</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12cdf7fc62645698e90b515b611256b_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZToxMTA3MzBkZjBhNTM0YWM2OWVmYTAyYzMwMWQ0Y2M4ZS90YWJsZXJhbmdlOjExMDczMGRmMGE1MzRhYzY5ZWZhMDJjMzAxZDRjYzhlXzEtMS0xLTEtMjY1MjQ3_433ac9e8-9690-4bf7-bb2d-1189a1dfec8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i128f1c4ae2fb4204a95761f38befbbcb_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZToxMTA3MzBkZjBhNTM0YWM2OWVmYTAyYzMwMWQ0Y2M4ZS90YWJsZXJhbmdlOjExMDczMGRmMGE1MzRhYzY5ZWZhMDJjMzAxZDRjYzhlXzEtMy0xLTEtMjY1MjQ3_5c5aa541-e4e5-4638-81c4-3682a0bd2749">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if12cdf7fc62645698e90b515b611256b_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZToxMTA3MzBkZjBhNTM0YWM2OWVmYTAyYzMwMWQ0Y2M4ZS90YWJsZXJhbmdlOjExMDczMGRmMGE1MzRhYzY5ZWZhMDJjMzAxZDRjYzhlXzItMS0xLTEtMjY1MjQ3_848a6c2d-4231-4f03-88a9-c6320d8c9f82">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i128f1c4ae2fb4204a95761f38befbbcb_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZToxMTA3MzBkZjBhNTM0YWM2OWVmYTAyYzMwMWQ0Y2M4ZS90YWJsZXJhbmdlOjExMDczMGRmMGE1MzRhYzY5ZWZhMDJjMzAxZDRjYzhlXzItMy0xLTEtMjY1MjQ3_08dae991-2e53-449c-b747-0059989de26f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers into (out of) Level 3</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if12cdf7fc62645698e90b515b611256b_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZToxMTA3MzBkZjBhNTM0YWM2OWVmYTAyYzMwMWQ0Y2M4ZS90YWJsZXJhbmdlOjExMDczMGRmMGE1MzRhYzY5ZWZhMDJjMzAxZDRjYzhlXzMtMS0xLTEtMjY1MjQ3_9c039249-3009-4fd5-9f5c-f07095c4d771">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i128f1c4ae2fb4204a95761f38befbbcb_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZToxMTA3MzBkZjBhNTM0YWM2OWVmYTAyYzMwMWQ0Y2M4ZS90YWJsZXJhbmdlOjExMDczMGRmMGE1MzRhYzY5ZWZhMDJjMzAxZDRjYzhlXzMtMy0xLTEtMjY1MjQ3_8569120b-b176-4a7f-aa4a-85ab793d371c">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2d5af138402b4636a09b3b04d180c63c" continuedAt="ia74d07f3d29444ffabcb0d9675004bc9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments Not Measured at Fair Value on the Consolidated Balance Sheets</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzEwNzE5_bfc2e6ad-5ecc-40b5-a90a-6db33f751d2c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the consolidated balance sheets at adjusted cost or contract value at December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib998634049ce4ca88cef9c730f1a8c88_I20221231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzQtMS0xLTEtMjY1MjQ3_e35900c1-aff5-42aa-8470-920b9f23c8ef">1,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96ac2a40938b4452a62b6a712077bb99_I20221231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzQtMy0xLTEtMjY1MjQ3_c175b9e9-d000-447e-991d-256b148f7fce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c9e1fabf93c4866832c216cd1d05ff1_I20221231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzQtNS0xLTEtMjY1MjQ3_f6c9a2ad-5b9e-4b8f-b78e-d2c7fee9b6cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06b531bb7d2c4c9fb13fbf2858aad603_I20221231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzQtNy0xLTEtMjY1MjQ3_7af667c7-0099-4576-ba26-20ef81ffb7a9">978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f36a954f0b04a9bba80a5b07037ee72_I20221231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzQtOS0xLTEtMjY1MjQ3_4b3cfd7b-6e38-478d-9f99-a5a6299409b3">978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib998634049ce4ca88cef9c730f1a8c88_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzUtMS0xLTEtMjY1MjQ3_ea393b6a-f059-4e2d-ad9e-ea82031da821">411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib998634049ce4ca88cef9c730f1a8c88_I20221231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzgtMS0xLTEtMjY1MjQ3_d332a3d4-b610-4e79-b12c-f00c5b0f40a1">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96ac2a40938b4452a62b6a712077bb99_I20221231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzgtMy0xLTEtMjY1MjQ3_8f98cb2d-2a98-4bbd-b1b6-6cde2e028802">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c9e1fabf93c4866832c216cd1d05ff1_I20221231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzgtNS0xLTEtMjY1MjQ3_f55cd0e4-d73e-40c7-ab81-b8a12280e41d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06b531bb7d2c4c9fb13fbf2858aad603_I20221231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzgtNy0xLTEtMjY1MjQ3_93c32e31-ab37-4877-80d7-a078de95fcd1">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f36a954f0b04a9bba80a5b07037ee72_I20221231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzgtOS0xLTEtMjY1MjQ3_2e00a217-f82f-4f1d-9a75-ef1552b3b44a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib998634049ce4ca88cef9c730f1a8c88_I20221231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzktMS0xLTEtMjY1MjQ3_4aa117ea-0340-4ccd-8b5e-6b00121abce8">332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96ac2a40938b4452a62b6a712077bb99_I20221231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzktMy0xLTEtMjY1MjQ3_99c3b4a0-133b-448d-b49c-151fd57cfa53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c9e1fabf93c4866832c216cd1d05ff1_I20221231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzktNS0xLTEtMjY1MjQ3_bcae27e7-8432-49ab-a12f-ae290fe2ef69">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06b531bb7d2c4c9fb13fbf2858aad603_I20221231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzktNy0xLTEtMjY1MjQ3_b75bd0eb-9378-4224-9a8c-0b41b95757fd">305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f36a954f0b04a9bba80a5b07037ee72_I20221231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzktOS0xLTEtMjY1MjQ3_1b363632-3de6-4145-a9a4-515aaf2bf097">305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib998634049ce4ca88cef9c730f1a8c88_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzEwLTEtMS0xLTI2NTI0Nw_b5ebe722-5289-4a3c-88be-1eeb2db31ba1">52,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96ac2a40938b4452a62b6a712077bb99_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzEwLTMtMS0xLTI2NTI0Nw_efbb7b51-d1ab-4b7d-8230-d6d7ac109e19">47,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c9e1fabf93c4866832c216cd1d05ff1_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzEwLTUtMS0xLTI2NTI0Nw_ef044dcc-d516-40cf-b920-f0e07bd37351">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06b531bb7d2c4c9fb13fbf2858aad603_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzEwLTctMS0xLTI2NTI0Nw_51a6c8c4-4532-44fa-b18a-7b15628bf845">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f36a954f0b04a9bba80a5b07037ee72_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzEwLTktMS0xLTI2NTI0Nw_dc2fd147-ca2d-4764-b814-b279f18c8141">47,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21d1adae38074c42b4c3c61194cf93e0_I20211231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE0LTEtMS0xLTI2NTI0Nw_dce558e5-b6e4-4de6-a4be-0efa51be9314">902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife1fe98fbd264b5b962a3adc684d2edf_I20211231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE0LTMtMS0xLTI2NTI0Nw_5661814a-af8b-4d77-ba0b-77146dc4bf12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf67a70a0e4140fdafb4bfede6ecf6ab_I20211231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE0LTUtMS0xLTI2NTI0Nw_44faa783-c0a0-43e8-8a1b-3acb8fdca65b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if277087345804c939318d54c5863d3b5_I20211231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE0LTctMS0xLTI2NTI0Nw_a6add601-14fa-4757-a7aa-27d100307ab3">907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie66a1446652841afb7a31c13e604633c_I20211231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE0LTktMS0xLTI2NTI0Nw_b1c4641c-dcc9-430e-962a-fc6885b0fe83">907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21d1adae38074c42b4c3c61194cf93e0_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE1LTEtMS0xLTI2NTI0Nw_d7b3e4c0-e9c7-4b1a-a8c1-221737829eb4">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21d1adae38074c42b4c3c61194cf93e0_I20211231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE4LTEtMS0xLTI2NTI0Nw_4024aeae-1f44-4f94-83f0-508dfef6077d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife1fe98fbd264b5b962a3adc684d2edf_I20211231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE4LTMtMS0xLTI2NTI0Nw_554dc1dd-b630-4772-9781-ff9a7628bdb4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf67a70a0e4140fdafb4bfede6ecf6ab_I20211231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE4LTUtMS0xLTI2NTI0Nw_1418007b-8a37-4098-ab21-1a8c9d71f51b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if277087345804c939318d54c5863d3b5_I20211231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE4LTctMS0xLTI2NTI0Nw_4be4cd3e-ae0a-4abd-837c-f1dac878f2d7">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie66a1446652841afb7a31c13e604633c_I20211231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE4LTktMS0xLTI2NTI0Nw_6aaf3aad-fd37-418d-b508-8bf303e550ff">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21d1adae38074c42b4c3c61194cf93e0_I20211231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE5LTEtMS0xLTI2NTI0Nw_729a5572-9a74-4ecb-9638-4ae744445d0a">336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife1fe98fbd264b5b962a3adc684d2edf_I20211231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE5LTMtMS0xLTI2NTI0Nw_99e2bd58-b827-440e-805f-ce82f8d9b1eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf67a70a0e4140fdafb4bfede6ecf6ab_I20211231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE5LTUtMS0xLTI2NTI0Nw_0ec860b3-430f-4cb9-937f-dad49d593f6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if277087345804c939318d54c5863d3b5_I20211231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE5LTctMS0xLTI2NTI0Nw_bad23527-5378-429c-b556-326e13fb5a88">373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie66a1446652841afb7a31c13e604633c_I20211231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE5LTktMS0xLTI2NTI0Nw_fe69b7d0-ed64-4ad9-9f51-6fd86695526f">373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21d1adae38074c42b4c3c61194cf93e0_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzIwLTEtMS0xLTI2NTI0Nw_3b9bd029-6057-4acd-a73d-7756987bb4d7">56,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife1fe98fbd264b5b962a3adc684d2edf_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzIwLTMtMS0xLTI2NTI0Nw_19544d24-49e0-435a-8b8b-8a3ab0413e62">64,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf67a70a0e4140fdafb4bfede6ecf6ab_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzIwLTUtMS0xLTI2NTI0Nw_f16dcdfa-5afd-4186-9ea0-db3f3210fabc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if277087345804c939318d54c5863d3b5_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzIwLTctMS0xLTI2NTI0Nw_a6b508cd-b255-47f1-9a91-2b413664ead9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie66a1446652841afb7a31c13e604633c_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzIwLTktMS0xLTI2NTI0Nw_c292c376-23e9-41bb-af48-6555451f4f54">64,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">______________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information regarding the valuation of cost method investments. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes long-term debt of $<ix:nonFraction unitRef="usd" contextRef="i51e0bcd2d29b46c7aa058026dc2a2ed5_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0Xzg0Nzk_5460ba72-4c73-4a8b-aca8-b1050ef064e7">3</ix:nonFraction>&#160;million which has been accounted for as liabilities held for sale and is included in liabilities held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts Measured at Fair Value on the Consolidated Balance Sheets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets relate to the Company&#8217;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;Net investment income and capital gains and losses on Separate Accounts assets accrue directly to such contract holders.&#160;The assets of each account are legally segregated and are not subject to claims arising from the Company&#8217;s other businesses.&#160;Deposits, withdrawals, net investment income and realized and unrealized capital gains and losses on Separate Accounts assets are not reflected in the consolidated statements of operations, shareholders&#8217; equity or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets include debt and equity securities.&#160;The valuation methodologies used for these assets are similar to the methodologies described above in this Note 4 &#8216;&#8216;Fair Value.&#8217;&#8217;&#160;Separate Accounts assets also include investments in common/collective trusts that are carried at fair value. Common/collective trusts invest in other investment funds otherwise known as the underlying funds. The Separate Accounts&#8217; interests in the common/collective trust funds are based on the fair values of the investments of the underlying funds and therefore are classified in Level 2. The assets in the underlying funds primarily consist of equity securities. Investments in common/collective trust funds are valued at their respective net asset value (&#8220;NAV&#8221;) per share/unit on the valuation date.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia74d07f3d29444ffabcb0d9675004bc9"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzEwNzE2_e08fd4d7-3d76-4612-b4cc-2740d9aa2bfe" continuedAt="id20a644f5d024f59a435567ac7d1c10f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts financial assets at December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.953%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if689b204e34543fe95ac080b3debc55f_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzItMS0xLTEtMjY1MjQ3_e6d812d4-b0a9-4930-9983-2da37850f5ef">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee45bbfada1407eace8ba71e97a1529_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzItMy0xLTEtMjY1MjQ3_4b3cb33e-a9ef-421f-b467-39b46eb9f022">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaad452f7bcd446778bc7ba3f4ca770d1_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzItNS0xLTEtMjY1MjQ3_4b5c4430-90b8-4f98-a3ef-1b2446ee0aee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e061b66c25d4fd5ac6440b36c42c982_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzItNy0xLTEtMjY1MjQ3_33a2ba3b-fa8b-48db-b24b-d92f49c83a8d">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6765b714ea5d4a02a77b602f004b5cc4_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzItOS0xLTEtMjY1MjQ3_c326b0c8-8646-4db9-af8f-e0b97f7d1df2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7983c2bd0c7b46a0b3bf893eec46f3de_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzItMTEtMS0xLTI2NTI0Nw_5f26ee31-1a70-4048-9c7a-cb6375ff7534">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96c159461792475cab9a57d784186344_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzItMTMtMS0xLTI2NTI0Nw_653389a4-2f5c-4b7f-b078-27d2a709fe4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05ef8fe160b24777ae8c78c62e45e2fa_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzItMTUtMS0xLTI2NTI0Nw_f59e3b85-f6f2-4533-a6c1-49ba0a2b2005">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49b05a6599ba4f3b8fb0296a00fc3649_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzMtMS0xLTEtMjY1MjQ3_4755c6eb-5b94-4524-802b-935def0ab511">712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b3c1aac8a2c4908b044154620848a2f_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzMtMy0xLTEtMjY1MjQ3_dc4dbbf0-a164-492a-a9d3-23c161b58028">1,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231179ba5b6a470c9209f71e7dbbb810_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzMtNS0xLTEtMjY1MjQ3_9aa11dbe-7c65-43b2-a9a4-e7294d13f802">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id105f8985abf43278ce21b4eb1dbf055_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzMtNy0xLTEtMjY1MjQ3_d6740a1b-d123-420d-966a-b10542f104fb">2,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebee988b218b43188ce78e0ecf93058b_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzMtOS0xLTEtMjY1MjQ3_22b8d92b-f811-4bdc-98b2-3a46c13dcc09">1,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9179ad3cfa14f48a4448a5ae59ffb9e_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzMtMTEtMS0xLTI2NTI0Nw_eda01d76-f4a2-4a72-997e-8a9f12093c64">3,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib698372482a64b2b838c35c08acfb43b_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzMtMTMtMS0xLTI2NTI0Nw_356b0dfe-2232-4998-bb80-53dffce0d147">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d76414b76554feca73881ec515dcf3a_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzMtMTUtMS0xLTI2NTI0Nw_222ab60b-f5fe-4fbb-b16a-f6c48a46b3a5">4,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1d74124f6be475b8f9ae2f51da28944_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzQtMS0xLTEtMjY1MjQ3_ffd0e349-7f93-4c5d-bf97-f43fd434fe98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c13d2018e6445458a682aafc8803716_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzQtMy0xLTEtMjY1MjQ3_c5a21a61-0c47-4784-9f86-3bb237c11e21">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb11f4892b1a4083a46e94dae7ceff9f_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzQtNS0xLTEtMjY1MjQ3_a592d894-7e9d-4c0f-b569-a8a5562c86b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20fa3af468954aa4933d0e3030a4ae0a_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzQtNy0xLTEtMjY1MjQ3_2bee4463-5209-4092-a955-775a7cfcbb03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10d95680a25f4275bf74bd275a219904_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzQtOS0xLTEtMjY1MjQ3_efd1e819-6f5a-489e-b619-60af61075d21">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3add96661c68429c98bc447aa30d7e90_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzQtMTEtMS0xLTI2NTI0Nw_1e8f4dcb-4f32-47de-9ed0-1913b236052d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie85ddd31302d48b39bf9b6b531607b98_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzQtMTMtMS0xLTI2NTI0Nw_ae53a669-36b5-4d57-a965-fecfcc7f1e6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i093853abc6424f1fa611b8455b524dc9_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzQtMTUtMS0xLTI2NTI0Nw_df9e48e2-87bf-42b1-85c6-62c0e362ced3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabb2b81fff06464f8b9d20abd344348b_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzUtMS0xLTEtMjY1MjQ3_87ccb000-337c-4251-a689-ea4a9c7767d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccbe865cbb14d2091ef941a3b9bfe9d_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzUtMy0xLTEtMjY1MjQ3_f727e89c-63af-4ad1-9216-277fbd26e553">480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3517cb5c6870409aa7e4a35e9131090e_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzUtNS0xLTEtMjY1MjQ3_6b5e56da-13b2-4990-a824-83cdce04897c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08d7c8d3b44844d9a53252e4dbcb3411_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzUtNy0xLTEtMjY1MjQ3_d34dda55-98cb-45ac-af36-3541677c0dae">480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1be8dacc0e33455686bdb32ee8a892e5_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzUtOS0xLTEtMjY1MjQ3_d1bc8a3b-258f-42cd-97a4-1932fefce1ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3c351bb44d34de9a79d55ff5ad02121_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzUtMTEtMS0xLTI2NTI0Nw_ffd25fe7-044b-4307-8239-85e93f3b0099">547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i809fd6b11b2a4971a3517725cbdca04f_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzUtMTMtMS0xLTI2NTI0Nw_c927da4c-3a18-4661-83eb-24abea3b9298">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i473e7e5830bb4215af2dc4cfb615a70e_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzUtMTUtMS0xLTI2NTI0Nw_d355257b-a370-44ad-8dea-27d6c4d123b5">547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaf7c772d40247269c23c494f0813a7f_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzYtMS0xLTEtMjY1MjQ3_4dc02b87-4977-42ab-bec2-b3e22e779699">714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ada3d841105476b9dca967f07a9dee9_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzYtMy0xLTEtMjY1MjQ3_2b8894f2-32d4-4dd6-bad3-34e0f3290f1f">2,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9bd28275ddc4fac99461d0040a82e04_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzYtNS0xLTEtMjY1MjQ3_e2fdeda0-bbe9-42ff-883f-2d9af404e0c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbd43a9242a0495591196ce21cc7a152_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzYtNy0xLTEtMjY1MjQ3_214011f1-1fc7-4ff9-992c-14a725c4e6d0">3,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91aae7889074bd7a05849761119e002_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzYtOS0xLTEtMjY1MjQ3_ce2a9337-9c62-47fb-98db-dbf5c80db2c3">1,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e3342f2eda4923accdad0511bbd8ab_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzYtMTEtMS0xLTI2NTI0Nw_de87ab13-5bc5-434d-b992-5f483c81d31f">3,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47cdbbca2588456f80bd73c676fe393c_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzYtMTMtMS0xLTI2NTI0Nw_c1ecbea1-996c-4d33-8f9e-3050f35271aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e14cbf58db473094f1a3a50e0e0423_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzYtMTUtMS0xLTI2NTI0Nw_d54df781-7c7a-4db2-b5f5-ff60482a7f35">5,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $<ix:nonFraction unitRef="usd" contextRef="i2cfae73c894b48b3adc8ba56219aaf76_I20221231" decimals="-6" name="us-gaap:SeparateAccountsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzEwNDg3_86744857-0167-4543-9e9f-7fa4b874ec3b">85</ix:nonFraction> million of other payables and $<ix:nonFraction unitRef="usd" contextRef="i5f60137c965c405995e63ea19fbaacc4_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzEwNTEy_fc4559c1-f801-4eca-81b0-d6405308c871">70</ix:nonFraction>&#160;million of other receivables at December&#160;31, 2022 and 2021, respectively.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2022 and 2021, the Company had <ix:nonFraction unitRef="usd" contextRef="i4ecc8bd5e850436fa0683a5a0e40c8c0_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzEwNjI4_3564050e-2f78-4ce4-95d3-9facba503c89"><ix:nonFraction unitRef="usd" contextRef="i33d746c2511346dab6d70642faa03778_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzEwNjI4_52e004e8-db93-414b-b7d6-21b60e3095b1">no</ix:nonFraction></ix:nonFraction> gross transfers of Separate Accounts financial assets into or out of Level 3.</span></div></ix:continuation><div><span><br/></span></div><div id="i36038907935e41eea5e9cf7cac915d44_133"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzM0MjU_c941a55d-52c4-4a1a-8586-3f67f6b34833" continuedAt="id671de9983204ac890695e54b4f5b0e8" escape="true">Goodwill and Other Intangibles</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id671de9983204ac890695e54b4f5b0e8" continuedAt="i3fd8323b57a04747ad27b7d9fdea182c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzM0Mjc_fb10a2b0-6c3d-40d3-952d-a2e334e24db9" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the changes in the carrying amount of goodwill by segment for the&#160;years ended December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.455%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp;<br/>Consumer<br/>Wellness</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib018c9e5213340b8a2330528464a3616_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzEtMS0xLTEtMjY1MjQ3_2594c8b3-88d2-4175-942f-165bbeefc2f9">45,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946281b536bd4451b3d56d4d5bcaade8_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzEtMy0xLTEtMjY1MjQ3_cbcec989-4feb-443a-beb2-c6b9d7866486">23,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66da0cbafad40c0b09c17c59b015bc2_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzEtNS0xLTEtMjY1MjQ3_a4a0bf1f-2ed6-48af-8a0c-412d57b4fdd2">10,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501f291fb23d49e987222cf13c851afc_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzEtNy0xLTEtMjY1MjQ3_bbaa5346-8acf-4e92-a050-38ad7051429f">79,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt;padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a1d88c90afd4868bb3842de60276b75_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzUtMS0xLTEtMjY1MjQ3_bfea45a4-c512-41b4-b985-aa2c8150f2ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd993afeac2436b99c2d440336ae246_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzUtMy0xLTEtMjY1MjQ3_43f01e44-771c-4d2c-a81e-cce5853bd670">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10733861aa764487bcae8d1a5debd7ab_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzUtNS0xLTEtMjY1MjQ3_0a460040-2e3c-4e23-a022-3c354c9dd59b">431</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzUtNy0xLTEtMjY1MjQ3_685a2d35-cf38-46af-8d38-a6e2be3484b5">431</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8885190ef7841e48df544637103ca44_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzYtMS0xLTEtMjY1MjQ3_67bbc6b7-f6d4-4fb0-b6e2-8e4efeabb83c">45,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if80e6d478f774215aba1c17bfd3b0a9f_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzYtMy0xLTEtMjY1MjQ3_cfe815d5-3b89-44b1-a28d-421e73d284d9">23,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i753d74536e76447a97ef85017079a80c_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzYtNS0xLTEtMjY1MjQ3_33b37673-d0a9-4f4b-b0b5-b9699fe2cc0b">10,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzYtNy0xLTEtMjY1MjQ3_1c0edf46-53db-4fcd-b9dd-85e25334e532">79,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe08d096357844f88d5bc75a18fcd936_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzktMS0xLTEtMjY1MjQ3_d6b6c06c-e434-433a-9da3-3d1581988f91">971</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida2cad6c1b0542db87d072a6e3ffe684_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzktMy0xLTEtMjY1MjQ3_e0dec996-f947-4877-bd09-16e6a9782fd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa35f6be0f433ea5d0c817c81cb4aa_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzktNS0xLTEtMjY1MjQ3_3b13f321-33d1-4b1c-adbd-f37c4733e649">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9bbc9d820604ed98ed4729f6b0aa8f3_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzktNy0xLTEtMjY1MjQ3_6ef87f38-13be-4925-bd0c-cf07a31f03a7">971</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb1ed30851ad423db47b88e42b33cf8f_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzEyLTEtMS0xLTI2NTI0Nw_a2793c60-ff8c-4f4a-86aa-bcb52c7799f9">44,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i839a6c4fcaad4f5fa23979221c63e037_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzEyLTMtMS0xLTI2NTI0Nw_88f37c35-8972-42fa-a50f-b9488fc6c193">23,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id114deab047e49b5a8b771195b4a54a2_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzEyLTUtMS0xLTI2NTI0Nw_80fe58eb-6dcc-4bcf-9349-9e7c5dd9e09e">10,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzEyLTctMS0xLTI2NTI0Nw_52528a0a-ab32-4c8d-8efa-c0b91ad73d4a">78,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, the decrease in the carrying amount of goodwill was primarily driven by the divestitures of bswift, PayFlex and the Thailand business. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information. During the year ended December&#160;31, 2021, the decrease in the carrying amount of goodwill was primarily driven by the impairment of the remaining goodwill of the LTC reporting unit within the Pharmacy &amp; Consumer Wellness segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2022, the Company performed its required annual impairment tests of goodwill. The results of the impairment tests indicated that there was no impairment of goodwill. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company performed its required annual impairment tests of goodwill. The results of the impairment tests indicated an impairment of the goodwill associated with the LTC reporting unit, as the reporting unit&#8217;s carrying value exceeded its fair value as of the testing date. The results of the impairment tests of the remaining reporting units indicated that there was no impairment of goodwill as of the testing date. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the LTC reporting unit continued to face challenges that have impacted the Company&#8217;s ability to grow the LTC reporting unit&#8217;s business at the rate estimated when its 2020 goodwill impairment test was performed. These challenges include lower net facility admissions, net long-term care facility customer losses and the prolonged adverse impact of the COVID-19 pandemic and the emerging new variants, which resulted in more significant declines in occupancy rates experienced by the Company&#8217;s long-term care facility customers than previously anticipated. During the third quarter of 2021, LTC management updated their 2021 annual forecast and submitted their long-term plan which showed deterioration in the financial results for the remainder of 2021 and beyond. The Company utilized these updated projections in performing its annual impairment test, which indicated that the fair value of the LTC reporting unit was lower than its carrying value, resulting in a $<ix:nonFraction unitRef="usd" contextRef="ia262a9274d8f434a9a8fac8f9016ca16_D20210701-20210930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzIxODQ_fd700c44-60ab-49aa-87dc-290cf5f07383">431</ix:nonFraction>&#160;million goodwill impairment charge in the third quarter of 2021. The fair value of the LTC reporting unit was determined using a combination of a discounted cash flow method and a market multiple method. As of December&#160;31, 2021, there was <ix:nonFraction unitRef="usd" contextRef="i8ed4d6f5ae634f359f681dd2ea0d4e81_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzI0MDM_a79b650e-464f-4ab9-a2a7-70d945fcfb09">no</ix:nonFraction> remaining goodwill balance in the LTC reporting unit. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i3fd8323b57a04747ad27b7d9fdea182c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At both December&#160;31, 2022 and 2021, cumulative goodwill impairments were $<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-8" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzI1MTg_abd38a03-1e3b-4c9a-8fa5-cd8844f4f190"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-8" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzI1MTg_dbf12733-df36-4ae6-8e12-0ce489d19564">6.6</ix:nonFraction></ix:nonFraction> billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="cvs:FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzM0Mjg_f876e6c1-9099-491f-a1b6-1ef1bf7abef2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s intangible assets as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except weighted average life</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks (indefinite-lived)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzItMS0xLTEtMjY1MjQ3_5813d6ff-67a9-4451-b4d2-7704746bd7cc">10,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzItNS0xLTEtMjY1MjQ3_20a915d2-4d89-4b37-8f8c-e460e4444256">10,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/relationships and covenants not to compete</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icacec4d2bd5a441bb697bf94305fab43_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzMtMS0xLTEtMjY1MjQ3_667a2dd7-c9ce-4725-bbd5-b11dd122ea71">21,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icacec4d2bd5a441bb697bf94305fab43_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzMtMy0xLTEtMjY1MjQ3_fabd2a3d-8842-46c7-be8d-6cb0c32e262b">10,668</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icacec4d2bd5a441bb697bf94305fab43_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzMtNS0xLTEtMjY1MjQ3_5412819e-9ab8-4f61-9ffd-9c8e5015a2fb">10,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib59e20c5189b4f5cb592cb8f4b8324de_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzMtNy0xLTEtMjY1MjQ3_ae86c378-5912-461a-a705-82faf37df638">13.3</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib47864323cfe45848ffe84168e0f0ccb_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzQtMS0xLTEtMjY1MjQ3_9cb0c662-f853-4ca9-9a64-c953c8174d5c">1,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib47864323cfe45848ffe84168e0f0ccb_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzQtMy0xLTEtMjY1MjQ3_e987348c-4063-41fe-b266-35c8e6029a55">1,060</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib47864323cfe45848ffe84168e0f0ccb_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzQtNS0xLTEtMjY1MjQ3_de593692-56d7-49b4-a6c1-c875d7c5d4b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider networks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ffa6a6d070a4dd2bdf38824f6bd5261_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzUtMS0xLTEtMjY1MjQ3_b167b4f4-3b9f-4ff7-b85c-4057b9015966">4,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ffa6a6d070a4dd2bdf38824f6bd5261_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzUtMy0xLTEtMjY1MjQ3_13f08c0c-397a-4956-a8d2-f1feb546ac70">862</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ffa6a6d070a4dd2bdf38824f6bd5261_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzUtNS0xLTEtMjY1MjQ3_7e2c2248-768e-4500-8c32-e73586168db2">3,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic9741c2be1f446a5b3e33d1093db0189_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzUtNy0xLTEtMjY1MjQ3_22ef6bf3-e2c0-45f5-919b-266d76397455">20.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of Business Acquired </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0189be5251d42809d167551a0f5f747_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzYtMS0xLTEtMjY1MjQ3_0ceab40a-b940-4a95-ade1-937355120b2a">590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0189be5251d42809d167551a0f5f747_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzYtMy0xLTEtMjY1MjQ3_202b7642-7888-435b-9b89-e9eacc4d4427">174</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0189be5251d42809d167551a0f5f747_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzYtNS0xLTEtMjY1MjQ3_5442f8fb-c12e-4c7b-ac05-eae08e16e35f">416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9520a4ef3083437894a7c7dde288f4c1_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzYtNy0xLTEtMjY1MjQ3_f85875fc-ba9c-42e1-a981-53e3dec18ced">20.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07f38da039c646c59f8df03b461397cc_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzctMS0xLTEtMjY1MjQ3_d045a9a4-2720-478f-84ff-a74cbfb60593">302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07f38da039c646c59f8df03b461397cc_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzctMy0xLTEtMjY1MjQ3_cc35c429-ad61-4a82-a9e6-bafc0b2e20b7">264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07f38da039c646c59f8df03b461397cc_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzctNS0xLTEtMjY1MjQ3_155f847f-139e-42c0-b3cb-f16e73f78c19">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1586ee2417bb4444a300fe3741cce552_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzctNy0xLTEtMjY1MjQ3_76da31c9-d80f-47d5-9668-f0bd56a38291">12.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzgtMS0xLTEtMjY1MjQ3_516e8bec-1d6a-43f6-8120-7f4681a46486">37,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzgtMy0xLTEtMjY1MjQ3_340a4c1c-da91-498c-9292-305bc2b3f485">13,028</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzgtNS0xLTEtMjY1MjQ3_4c0ae01f-3601-4c1e-a765-9c35db79113e">24,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzgtNy0xLTEtMjY1MjQ3_130336d4-06f3-45d8-b19b-9921cc442d37">13.9</ix:nonNumeric></span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks (indefinite-lived)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzExLTEtMS0xLTI2NTI0Nw_f8fdaa4c-6ec7-499d-bc84-7b3539035a20">10,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzExLTUtMS0xLTI2NTI0Nw_7417bdce-9443-4f12-9234-315b88805730">10,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/relationships and covenants not to compete</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10166bf4bd7d4e9aa3b7ca002a1d92e7_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzEyLTEtMS0xLTI2NTI0Nw_d396f562-3a13-49ad-8a74-12337ac4a83b">25,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10166bf4bd7d4e9aa3b7ca002a1d92e7_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzEyLTMtMS0xLTI2NTI0Nw_fdd859b7-16e8-4648-bc36-4df892aa9502">10,564</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10166bf4bd7d4e9aa3b7ca002a1d92e7_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzEyLTUtMS0xLTI2NTI0Nw_d5b3ef8b-7711-4fc2-85cb-b1162d125adb">14,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idea4ec344a85455882460b397b94be2e_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzEyLTctMS0xLTI2NTI0Nw_b0e24b20-e97b-4c9f-99d9-96d8c1d0842f">15.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab4ce297b2134e1faac9af7fb814d1ee_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzEzLTEtMS0xLTI2NTI0Nw_30bffdd4-3bab-4ba0-8eea-8ee6d193b187">1,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab4ce297b2134e1faac9af7fb814d1ee_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzEzLTMtMS0xLTI2NTI0Nw_f3df96de-5b86-40b2-b641-b461aff9458c">1,060</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab4ce297b2134e1faac9af7fb814d1ee_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzEzLTUtMS0xLTI2NTI0Nw_457adc93-b8ff-4fc0-b60c-46c437b83487">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider networks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b97832079404df29d7a1346b50515c5_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE0LTEtMS0xLTI2NTI0Nw_0c872e4b-5687-4ba0-8012-c17de0be93e9">4,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b97832079404df29d7a1346b50515c5_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE0LTMtMS0xLTI2NTI0Nw_ddd710f4-c763-4f8c-8e54-e25d91273cb1">651</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b97832079404df29d7a1346b50515c5_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE0LTUtMS0xLTI2NTI0Nw_e8a2fe0a-57da-4ca4-a068-f0cd27487518">3,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idb9ab0a0f75a497f924ab0a5e8916bcb_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE0LTctMS0xLTI2NTI0Nw_9fa76d2b-c8dc-4409-a1d7-a19610673ca1">20.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of Business Acquired </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia298597ebbd74213b5ccc336e308e4fb_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE1LTEtMS0xLTI2NTI0Nw_d44c8e9b-1433-4910-807c-c6baae576bff">590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia298597ebbd74213b5ccc336e308e4fb_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE1LTMtMS0xLTI2NTI0Nw_4b9de16b-c286-4a3a-984a-367ffb3e8a94">147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia298597ebbd74213b5ccc336e308e4fb_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE1LTUtMS0xLTI2NTI0Nw_6e2e3274-c87c-45d6-891c-a76ae0823f73">443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i21e3a229c93f4655982469399aecf163_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE1LTctMS0xLTI2NTI0Nw_96a4aba8-95b7-440d-8128-9c79082fa3f0">20.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245af29d89884e149ddc482143db7d7e_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE2LTEtMS0xLTI2NTI0Nw_acb73316-dc77-4d2b-abdf-ec3673f95f83">318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i245af29d89884e149ddc482143db7d7e_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE2LTMtMS0xLTI2NTI0Nw_639c45d9-7ac4-4a1a-a68e-9d35383d7364">279</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245af29d89884e149ddc482143db7d7e_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE2LTUtMS0xLTI2NTI0Nw_0364da62-07ac-4f76-b52b-d86d872b1014">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifd3229b629654bf1aca3934975c2c2a2_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE2LTctMS0xLTI2NTI0Nw_7c9a2635-f9ef-4aca-abf9-f991b39f207e">8.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE3LTEtMS0xLTI2NTI0Nw_40d6d411-d3c1-425c-8416-93d95a9eb7d8">41,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE3LTMtMS0xLTI2NTI0Nw_16499af3-0e2d-4bb5-bbc3-75888d17da03">12,701</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE3LTUtMS0xLTI2NTI0Nw_934c8f98-2173-47e2-a414-dc25767b6723">29,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE3LTctMS0xLTI2NTI0Nw_423b3ab1-8fcf-4960-9945-eeda2460ab6f">15.3</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes intangible assets of $<ix:nonFraction unitRef="usd" contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231" decimals="-6" name="cvs:IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzI2OTg_04e7831b-113b-4c54-9370-cd2983509b7d">28</ix:nonFraction>&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, the reduction in the customer contracts/relationships intangible assets is primarily related to the Company&#8217;s loss on assets held for sale of $<ix:nonFraction unitRef="usd" contextRef="i8b53ab0e06784e57adb2671c1a53ced8_D20220101-20221231" decimals="-8" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzMwNTY_3098932e-292e-4912-82dc-34fab30e4035">2.5</ix:nonFraction>&#160;billion to write-down the LTC business to its estimated fair value less costs to sell. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for intangible assets totaled $<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzMyMjY_20776fc1-a1ab-4fae-a7fb-3475f4f97666">1.8</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzMyMzA_67a1bbbc-a383-4016-983d-d8ae547c0a6a">2.2</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzMyMzc_b75cdcca-84b0-41cd-acb8-a52ea441d0c3">2.3</ix:nonFraction> billion for the years ended December 31, 2022, 2021 and 2020, respectively. <ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzM0MzE_1471be74-5103-410d-9c3c-6884921ad555" continuedAt="id2c69baa696f404aa2419af84cb9d4ba" escape="true">The projected annual amortization expense for the Company&#8217;s intangible assets for the next five&#160;years is as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="id2c69baa696f404aa2419af84cb9d4ba"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.842%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTo5Yzg2ZDMwZTdmYjU0MDIyODA1NmZhZjJhNWE3ZDc4Ni90YWJsZXJhbmdlOjljODZkMzBlN2ZiNTQwMjI4MDU2ZmFmMmE1YTdkNzg2XzEtMS0xLTEtMjY1MjQ3_d2860f67-6805-4e16-9c91-3fc02d2ce2e4">1,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTo5Yzg2ZDMwZTdmYjU0MDIyODA1NmZhZjJhNWE3ZDc4Ni90YWJsZXJhbmdlOjljODZkMzBlN2ZiNTQwMjI4MDU2ZmFmMmE1YTdkNzg2XzItMS0xLTEtMjY1MjQ3_09732a67-fe4f-4e8f-b197-2da5c6a8e73f">1,562</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTo5Yzg2ZDMwZTdmYjU0MDIyODA1NmZhZjJhNWE3ZDc4Ni90YWJsZXJhbmdlOjljODZkMzBlN2ZiNTQwMjI4MDU2ZmFmMmE1YTdkNzg2XzMtMS0xLTEtMjY1MjQ3_82e084f2-470f-43dc-978c-d8e4b80d5365">1,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTo5Yzg2ZDMwZTdmYjU0MDIyODA1NmZhZjJhNWE3ZDc4Ni90YWJsZXJhbmdlOjljODZkMzBlN2ZiNTQwMjI4MDU2ZmFmMmE1YTdkNzg2XzQtMS0xLTEtMjY1MjQ3_0242602b-ea68-4233-81dc-8b9936f557a8">1,283</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTo5Yzg2ZDMwZTdmYjU0MDIyODA1NmZhZjJhNWE3ZDc4Ni90YWJsZXJhbmdlOjljODZkMzBlN2ZiNTQwMjI4MDU2ZmFmMmE1YTdkNzg2XzUtMS0xLTEtMjY1MjQ3_686b47dc-39ad-43e7-a8c2-068e6de5d40f">1,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_139"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczNDk_7683e472-1c5f-4692-acdf-8c6f5a85bb51" continuedAt="ieb8f8ab3514c44529e7882ed8f7db362" escape="true"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczNTM_da449f09-d9ee-4989-899f-1b724bff3be6" continuedAt="i71d7224d421a426cb4048aca9eccb378" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ieb8f8ab3514c44529e7882ed8f7db362" continuedAt="i82a2bdbc0c1446f59a2c5d7674562360"><ix:continuation id="i71d7224d421a426cb4048aca9eccb378" continuedAt="i8bbbca9d21374cb4a3d30c3d53f91281"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases most of its retail stores and mail order facilities and certain distribution centers and corporate offices under operating or finance leases, typically with initial terms of <ix:nonNumeric contextRef="i30716a5a00af4d6bb1f1b23cccf84c89_I20221231" name="us-gaap:LesseeFinanceLeaseTermOfContract1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzIwNw_86113f23-88c9-4b91-967b-992a52cc087b"><ix:nonNumeric contextRef="i30716a5a00af4d6bb1f1b23cccf84c89_I20221231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzIwNw_96cf93c5-6866-49e9-9346-b1854e81c22b">15</ix:nonNumeric></ix:nonNumeric> to <ix:nonNumeric contextRef="i64afdfad0a7c40478e14769ae335f4c8_I20221231" name="us-gaap:LesseeFinanceLeaseTermOfContract1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczNjI_737bdc47-b92e-4fd3-beb4-d4e7cfcfdbbb"><ix:nonNumeric contextRef="i64afdfad0a7c40478e14769ae335f4c8_I20221231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczNjI_8d967f53-a0cf-437a-90c8-9d72bce747bd">25</ix:nonNumeric></ix:nonNumeric> years. The Company also leases certain equipment and other assets under operating or finance leases, typically with initial terms of <ix:nonNumeric contextRef="i051a70de728945e7b41255138a99db87_I20221231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzM0OQ_ec47fd66-e86b-4230-b833-76ba1d58f003"><ix:nonNumeric contextRef="i051a70de728945e7b41255138a99db87_I20221231" name="us-gaap:LesseeFinanceLeaseTermOfContract1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzM0OQ_f90d141c-5541-4311-be5d-e05f300c99e6">3</ix:nonNumeric></ix:nonNumeric> to <ix:nonNumeric contextRef="if41a3fc5ea3b4503be47a9c50af584ec_I20221231" name="us-gaap:LesseeFinanceLeaseTermOfContract1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczNDU_b7a48bb0-874a-4e49-bd92-36d3918f4622"><ix:nonNumeric contextRef="if41a3fc5ea3b4503be47a9c50af584ec_I20221231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczNDU_d110ca73-603f-4a33-9a97-e4605b917330">10</ix:nonNumeric></ix:nonNumeric> years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company leases pharmacy space at the stores of another retail chain for which the noncancelable contractual term of the pharmacy lease arrangement exceeds the remaining estimated economic life of the buildings. For these pharmacy lease arrangements, the Company concluded that for accounting purposes the lease term was the remaining estimated economic life of the buildings. Consequently, most of these individual pharmacy leases are finance leases.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczNTE_b20db6e0-8f54-4380-8b5e-6d177af7315c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the components of net lease cost for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.160%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzEtMS0xLTEtMjY1MjQ3_b48f78e4-e911-4dad-9d88-b58e807c8823">2,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzEtMy0xLTEtMjY1MjQ3_e7e0d30d-5049-4fe4-a330-c358ac3fe8c3">2,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzEtNS0xLTEtMjY1MjQ3_fde459c3-7846-434f-8cbe-64a9b02ac0ca">2,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzMtMS0xLTEtMjY1MjQ3_5ae1e4b6-fc50-46b5-b63c-290a559d04b7">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzMtMy0xLTEtMjY1MjQ3_d82ce16d-0fe8-4bd6-85ec-52f96dcc7f99">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzMtNS0xLTEtMjY1MjQ3_4507ea6d-0a8e-469b-b345-1eed6a119999">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzQtMS0xLTEtMjY1MjQ3_ce0f2451-96dd-427a-8ab9-cd744f25fcf5">68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzQtMy0xLTEtMjY1MjQ3_dcce4156-f799-4c40-ab24-a0ea17638dd6">62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzQtNS0xLTEtMjY1MjQ3_e5582b1a-a731-48da-a448-b202a526593b">58</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzUtMS0xLTEtMjY1MjQ3_51d339e7-8073-4588-a3f5-6a0c412b89d5">147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzUtMy0xLTEtMjY1MjQ3_3a8975d9-96d4-4b99-8b14-221715cc87b5">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="cvs:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzUtNS0xLTEtMjY1MjQ3_8509b941-36b1-4b6e-95bf-7805ba3a0c71">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzYtMS0xLTEtMjY1MjQ3_76dac9ff-4ddd-4890-99f6-0b989c0a802d">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzYtMy0xLTEtMjY1MjQ3_2709b957-fddb-4906-b6eb-6845340843b9">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzYtNS0xLTEtMjY1MjQ3_472f6969-a95d-4c06-9277-0e1ef5caa214">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzctMS0xLTEtMjY1MjQ3_bfcbf070-04a6-41cb-be8c-e7f1a4d8842f">610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzctMy0xLTEtMjY1MjQ3_a3d6ecd2-cfcb-467d-a6e4-4ae1f6fdc1ad">604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzctNS0xLTEtMjY1MjQ3_d0621975-9273-4e0d-98a5-8671759dda59">599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: sublease income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzgtMS0xLTEtMjY1MjQ3_ab370bf5-08e0-484d-844c-5867901ced62">61</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzgtMy0xLTEtMjY1MjQ3_1a33604d-015c-45fe-bfdd-f51423b2d680">59</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzgtNS0xLTEtMjY1MjQ3_b7b7dc8b-3ead-4570-a701-bf116c8397fa">55</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzktMS0xLTEtMjY1MjQ3_687fdd38-8c38-4df8-a13b-2d106706d817">3,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzktMy0xLTEtMjY1MjQ3_a119c468-f737-4f05-827b-002c49cac421">3,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzktNS0xLTEtMjY1MjQ3_4d855a7e-d832-45ef-ab63-af78161426d5">3,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases for the years ended December&#160;31, 2022, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.160%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzItMS0xLTEtMjY1MjQ3_70e39a98-e0fc-4b0b-ba80-432b0e633349">2,689</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzItMy0xLTEtMjY1MjQ3_a6bef564-88a4-4a8b-98f1-99e01442b377">2,714</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzItNS0xLTEtMjY1MjQ3_315c0661-1349-4896-b5f6-f85cd4426ac6">2,724</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for interest portion of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzMtMS0xLTEtMjY1MjQ3_473c4078-7668-4a14-9c32-ffb10a41b92b">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzMtMy0xLTEtMjY1MjQ3_1f276192-c4ee-40d5-9960-e70fe7ea233d">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzMtNS0xLTEtMjY1MjQ3_dcd3880c-7712-4e4d-917b-75514a86d823">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows paid for principal portion of finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzQtMS0xLTEtMjY1MjQ3_dbb66765-350b-4dd0-b93d-bcc5bbf3c2da">62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzQtMy0xLTEtMjY1MjQ3_acc227f8-e197-4928-b723-ce7d79f75737">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzQtNS0xLTEtMjY1MjQ3_5a79d2cd-09a3-4f4c-8e07-45382cf44a08">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzYtMS0xLTEtMjY1MjQ3_6572b32a-a2fc-4634-8c95-76a290d0f0cc">591</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzYtMy0xLTEtMjY1MjQ3_1722966f-34ac-4cc6-b3b6-0cefdc5c0c64">1,254</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzYtNS0xLTEtMjY1MjQ3_027de2ce-e234-48b8-a69f-e46739c5f00a">1,679</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzctMS0xLTEtMjY1MjQ3_e97b337c-82d2-432b-8b32-98d9435c34d1">232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzctMy0xLTEtMjY1MjQ3_0b0e7bf0-ca58-4a9f-aa4c-401aa619f725">278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzctNS0xLTEtMjY1MjQ3_2d7fe70e-fa76-44aa-951e-ad6013ce2ac2">313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i82a2bdbc0c1446f59a2c5d7674562360" continuedAt="ie367ff7dc48e49fba21830b9352babc1"><ix:continuation id="i8bbbca9d21374cb4a3d30c3d53f91281" continuedAt="i58cb47678e684c8ab1712b716c05e121"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="cvs:LesseeLeaseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczNTU_867828e3-0804-4acd-813b-f4ee179b2f39" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases as of December&#160;31, 2022 and 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.159%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except remaining lease term and discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzItMS0xLTEtMjY1MjQ3_39fe5958-7eea-4f22-a0c0-3e0e6704efb8">17,928</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzItMy0xLTEtMjY1MjQ3_2b81beb3-2b89-46be-adc8-38bb62288a73">19,122</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzQtMS0xLTEtMjY1MjQ3_473ce030-c2d5-4769-ac4c-2bab4cec1a29">1,699</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzQtMy0xLTEtMjY1MjQ3_e2cbb7b3-390f-4b46-a766-4c85f8dc9f5f">1,646</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzUtMS0xLTEtMjY1MjQ3_2a33f224-bb3d-427c-b9fa-76e7c548e576">16,839</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzUtMy0xLTEtMjY1MjQ3_b55cb0d3-21d2-4318-91ad-9087f7ee85c9">18,177</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzYtMS0xLTEtMjY1MjQ3_cc653be2-3ddb-4903-af95-8d68413b01c3">18,538</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzYtMy0xLTEtMjY1MjQ3_2790683b-4fd8-41ba-a7a4-8ce3af50ae7f">19,823</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance leases:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:FinanceLeaseRightOfUseAssetGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzktMS0xLTEtMjY1MjQ3_b1171241-f0d5-46f9-81ca-6bde084f3259">1,608</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:FinanceLeaseRightOfUseAssetGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzktMy0xLTEtMjY1MjQ3_33990f11-b087-4aa7-bd37-2e76e63f9e38">1,375</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:FinanceLeaseRightOfUseAssetAccumulatedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzEwLTEtMS0xLTI2NTI0Nw_1855cb0e-fdb4-4dab-acc9-7ac4e5651223">284</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:FinanceLeaseRightOfUseAssetAccumulatedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzEwLTMtMS0xLTI2NTI0Nw_3f993b75-3a51-4a31-80fe-aeaae9a84159">188</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:FinanceLeaseRightOfUseAssetNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzExLTEtMS0xLTI2NTI0Nw_7424505f-525a-4a55-8163-5e2809e5e984">1,324</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:FinanceLeaseRightOfUseAssetNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzExLTMtMS0xLTI2NTI0Nw_e20dbe93-1cb7-4447-be87-5975eacad5af">1,187</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzEzLTEtMS0xLTI2NTI0Nw_0525736f-0d1c-481d-a44d-0ad215d040b1">59</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzEzLTMtMS0xLTI2NTI0Nw_867a7e46-28a5-4392-950a-195bcbdf48f1">50</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzE0LTEtMS0xLTI2NTI0Nw_cb323043-a672-4e12-9205-e6044b2e23fe">1,406</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzE0LTMtMS0xLTI2NTI0Nw_53769fdb-ece6-4ca6-9b53-3e6aaac5fe84">1,250</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzE1LTEtMS0xLTI2NTI0Nw_48abc580-feed-446d-912b-8f08f4620955">1,465</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzE1LTMtMS0xLTI2NTI0Nw_e3a33015-10db-4e71-b185-43931b14485a">1,300</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining lease term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzE4LTEtMS0xLTI2NTI0Nw_e28ec1a4-166a-4fa8-a3bc-0ab374f4e781">12.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzE4LTMtMS0xLTI2NTI0Nw_e15ffa17-dbad-4254-88d3-3723a1e084fb">12.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzE5LTEtMS0xLTI2NTI0Nw_a7f734c7-5951-462d-b6bb-ac4e3048e5e5">19.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzE5LTMtMS0xLTI2NTI0Nw_77dc05a2-af57-4f10-8e4a-193f23ebb5cc">20.0</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzIyLTEtMS0xLTI2NTI0Nw_ded6a109-d997-4490-ad7f-b5788c1c22ee">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzIyLTMtMS0xLTI2NTI0Nw_5365d245-2113-443c-85fb-50f5dc3b4383">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzIzLTEtMS0xLTI2NTI0Nw_f35d05d4-01b7-429a-9ebf-c3672e380c68">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzIzLTMtMS0xLTI2NTI0Nw_a089c66f-82ff-4243-a484-a8bac387a3e5">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes operating lease right-of-use assets of $<ix:nonFraction unitRef="usd" contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231" decimals="-6" name="cvs:OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzEyMzY_30446c3e-acd9-4ab0-8f6f-dde929f6d4e6">56</ix:nonFraction>&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes current portion of operating lease liabilities of $<ix:nonFraction unitRef="usd" contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231" decimals="-6" name="cvs:OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzE0ODQ_e549d8d6-901a-45fb-a57e-e1b021a697ad">21</ix:nonFraction>&#160;million and long-term operating lease liabilities of $<ix:nonFraction unitRef="usd" contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231" decimals="-6" name="cvs:OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzE1MzI_bf7a4fa3-9219-4ca1-af48-bff26ba9f473">39</ix:nonFraction>&#160;million which have been accounted for as liabilities held for sale and are included in liabilities held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczNTY_7d77e9cb-3ec7-4598-a946-a41bf16b94bf" escape="true"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczNjM_efce0062-7329-405a-ba7e-70230d53e43f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.453%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance<br/>Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating<br/>Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzEtMS0xLTEtMjY1MjQ3_a0adb04b-aab0-45fe-b5cc-91b9a396d7b8">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzEtMy0xLTEtMjY1MjQ3_755d2f86-ab22-4257-ab17-620674b3fe60">2,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:LesseeLiabilityPaymentsYearOne" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzEtNS0xLTEtMjY1MjQ3_03f78eb7-623c-4cc0-959e-606b396ec893">2,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzItMS0xLTEtMjY1MjQ3_105a2717-acac-43b6-8110-26c05c6edc43">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzItMy0xLTEtMjY1MjQ3_d78ab1be-08b0-441c-b222-dee9cccc4629">2,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:LesseeLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzItNS0xLTEtMjY1MjQ3_e32d3ddc-57e6-41c8-8ce0-e3c0041bc45f">2,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzMtMS0xLTEtMjY1MjQ3_78ba0530-5ef7-46c3-836e-233b178bf0f5">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzMtMy0xLTEtMjY1MjQ3_82e82d36-0c60-4d50-87a3-9a113ca05856">2,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:LesseeLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzMtNS0xLTEtMjY1MjQ3_8e1a236e-d95e-4651-bec0-489e91a7dd66">2,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzQtMS0xLTEtMjY1MjQ3_6e50fc6e-03df-4290-ac0a-1a1253308f9c">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzQtMy0xLTEtMjY1MjQ3_4de268ad-022f-4209-bddf-d78b229b0b5d">2,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:LesseeLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzQtNS0xLTEtMjY1MjQ3_32f8abb5-6712-4953-a8fc-6389fcd2cf48">2,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzUtMS0xLTEtMjY1MjQ3_524a3656-a32f-49c1-91b8-094f4a33aae1">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzUtMy0xLTEtMjY1MjQ3_a76921d3-60de-44b9-88c6-1880be786ec4">1,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:LesseeLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzUtNS0xLTEtMjY1MjQ3_4a92bdf4-8c59-424f-8baf-090ddf4fa205">2,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzYtMS0xLTEtMjY1MjQ3_4b10d17b-b83b-41a6-bde9-229dd0a1a4fc">1,640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzYtMy0xLTEtMjY1MjQ3_59aca750-3856-462a-a263-0fe00b593732">12,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:LesseeLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzYtNS0xLTEtMjY1MjQ3_65a81885-0b46-46c7-9b4f-0b77e96b2d68">14,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzctMS0xLTEtMjY1MjQ3_679d5fa4-7fc9-4bbe-b6f0-d5cf51e30027">2,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzctMy0xLTEtMjY1MjQ3_e720dbae-a200-4e26-8fcc-90b425ef686e">24,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:LesseeLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzctNS0xLTEtMjY1MjQ3_4c563171-0bbe-4d7d-b140-1aeb4a55af54">26,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzgtMS0xLTEtMjY1MjQ3_eea1707f-734e-498d-a701-a51b4dc08861">823</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzgtMy0xLTEtMjY1MjQ3_042368fb-9024-4827-8d12-3147c5d14491">5,501</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:LesseeLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzgtNS0xLTEtMjY1MjQ3_1e561bc4-f77d-4be3-9518-4c4fb11bb412">6,324</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzktMS0xLTEtMjY1MjQ3_ef9d2462-b5ef-4dd2-bf42-13e4479252ed">1,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzktMy0xLTEtMjY1MjQ3_bfaa99f2-06b4-469d-a084-8a7c8afafb7f">18,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:LeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzktNS0xLTEtMjY1MjQ3_c881b4cb-091c-43b9-bd0e-923cca6a3e2e">20,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Future operating lease payments have not been reduced by minimum sublease rentals of $<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LessorOperatingLeasePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzE5NzY_72209cdf-11f9-45fd-9e6a-40499820d6a1">290</ix:nonFraction> million due in the future under noncancelable subleases.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-8" name="cvs:OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzIyODQ_dd55c156-7ea6-4404-bf6e-a7b2435173ec">2.5</ix:nonFraction> billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.</span></div></ix:nonNumeric></ix:nonNumeric></ix:continuation></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie367ff7dc48e49fba21830b9352babc1"><ix:continuation id="i58cb47678e684c8ab1712b716c05e121"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Transactions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company finances a portion of its store development program through sale-leaseback transactions. The properties are generally sold at net book value, which generally approximates fair value, and the resulting leases generally qualify and are accounted for as operating leases. The operating leases that resulted from these transactions are included in the tables above. The Company does not have any retained or contingent interests in the stores and does not provide any guarantees, other than a guarantee of lease payments, in connection with the sale-leaseback transactions. There were no sale-leaseback transactions in 2022 or 2021. Proceeds from sale-leaseback transactions totaled $<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzMxNjA_d16ed716-13d3-4793-b356-37fea79a7e71">101</ix:nonFraction> million in the year ended December 31, 2020. Gains from sale-leaseback transactions totaled $<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:SaleAndLeasebackTransactionGainLossNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzMyNDU_2a7744f7-4825-45ae-91df-02f65ce9c02b">3</ix:nonFraction> million in the year ended December 31, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Office Real Estate Optimization Charges </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, the Company undertook an initiative to evaluate its corporate office real estate space in response to its new flexible work arrangement. As part of this initiative, the Company evaluated its current real estate space and changes in employee work arrangement requirements to ensure it had the appropriate space to support the business. As a result of this assessment, the Company determined that it would vacate and abandon certain leased corporate office spaces. Accordingly, in the three months ended December 31, 2022, the Company recorded office real estate optimization charges of $<ix:nonFraction unitRef="usd" contextRef="ia17efad6e57f470eadf960cfb01e576d_D20221001-20221231" decimals="-6" name="cvs:OfficeRealEstateOptimizationCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzM5NDY_e6fca68f-3272-41a2-8ab3-50ad4ad14048">117</ix:nonFraction>&#160;million, primarily consisting of $<ix:nonFraction unitRef="usd" contextRef="ic8537dac29594a639ef8ce90309171e8_D20221001-20221231" decimals="-6" name="cvs:OfficeRealEstateOptimizationCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzM5NzQ_c7a9b623-3107-4c28-8dc2-be48c432700f">71</ix:nonFraction>&#160;million related to operating lease right-of-use assets and $<ix:nonFraction unitRef="usd" contextRef="i5f3c8c09f91f4c338d29d71777fc4bae_D20221001-20221231" decimals="-6" name="cvs:OfficeRealEstateOptimizationCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzQwMjg_652e1b90-4074-4bd8-8536-d4340e2291dd">44</ix:nonFraction>&#160;million related to property and equipment, within the Health Care Benefits, Corporate/Other and Health Services segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Store Impairment Charges</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its retail store right-of-use and property and equipment assets for impairment at the retail store level, which is the lowest level at which cash flows can be identified. For retail stores where there is an indicator of impairment present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated undiscounted future cash flows used in the analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to its estimated fair value which is the greater of the asset group&#8217;s estimated future cash flows (discounted), or the consideration of what a market participant would pay to lease the assets, net of leasing costs. The Company&#8217;s estimate of fair value considers historical results, current operating trends, consolidated sales, profitability and cash flow results and forecasts. For assets which the Company has determined it will be able to sublease, the estimated future cash flows include the estimated sublease income, net of estimated leasing costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the carrying value of an asset group exceeds its estimated fair value, an impairment loss is recorded to reduce the value of the asset group to its estimated fair value. As the impaired assets are measured at fair value on a nonrecurring basis primarily using unobservable inputs as of the measurement date, the assets are classified in Level 3 of the fair value hierarchy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, the Company completed a strategic review of its retail business and announced the creation of new formats for its stores to continue to drive higher engagement with customers. As part of this review, the Company evaluated changes in population, consumer buying patterns and future health needs to ensure it has the right kinds of stores in the right locations for consumers and for the business. In connection with this initiative, on November 17, 2021, the Board of Directors of CVS Health Corporation (the &#8220;Board&#8221;) authorized the closing of approximately <ix:nonFraction unitRef="store" contextRef="i7b563cd5fd6444ccae80c15785db4752_D20211001-20211231" decimals="-2" name="cvs:NumberOfStoresPlannedClosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzYzNjA_ee922f3c-3948-40e7-a253-f0911c395194">900</ix:nonFraction> retail stores, approximately <ix:nonFraction unitRef="store" contextRef="i7b563cd5fd6444ccae80c15785db4752_D20211001-20211231" decimals="INF" name="cvs:NumberOfStoresAnnualPlannedClosuresForClosurePeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzYzOTI_4bbc9dff-db4d-423a-92f9-2026d0fb1533">300</ix:nonFraction> stores each year, between 2022 and 2024. As a result, management determined that there were indicators of impairment with respect to the impacted stores&#8217; asset groups, including the associated operating lease right-of-use assets and property and equipment. A long-lived asset impairment test was performed during the fourth quarter of 2021 and the results of the impairment test indicated that the fair value of certain retail store asset groups was lower than their respective carrying values. Accordingly, in the three months ended December 31, 2021, the Company recorded a store impairment charge of approximately $<ix:nonFraction unitRef="usd" contextRef="i7b563cd5fd6444ccae80c15785db4752_D20211001-20211231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzcwMTI_f89b9726-099c-45f6-abe7-7bfa6244b129">1.4</ix:nonFraction> billion, consisting of a write down of approximately $<ix:nonFraction unitRef="usd" contextRef="i7fb815e010cd42dfa706732c81d30c51_D20211001-20211231" decimals="-8" name="cvs:StoreImpairmentCharges" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzcwNjA_74bd2bd6-3606-4772-b8a3-07965b7ccc95">1.1</ix:nonFraction>&#160;billion related to operating lease right-of-use assets and $<ix:nonFraction unitRef="usd" contextRef="i08b43dcea1a24bb58f5fb26ee83e336c_D20211001-20211231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzcxMTQ_18700c76-3506-483d-a109-d6742c873a44">261</ix:nonFraction>&#160;million related to property and equipment, within the Pharmacy &amp; Consumer Wellness segment. Subsequent to the impairment loss, the fair value of the associated operating lease right-of use assets and property and equipment were $<ix:nonFraction unitRef="usd" contextRef="ibcaf1a77aa6f4ad0a9316358d8fdee1d_I20211231" decimals="-6" name="cvs:OperatingLeaseRightOfUseAssetFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczMTk_23205b38-03a0-4c73-bc9d-834f768e8754">356</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i0abce119f76d4736a751d922587fea1e_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczMjY_c883c983-ad63-41ed-839c-6d84c89b5084">185</ix:nonFraction>&#160;million, respectively.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_142"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzMzNjg_c402e61a-412c-40e4-8e41-0ce566111273" continuedAt="i58ba1450ac2543b8bfb5339c56358ca1" escape="true">Health Care Costs Payable</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i58ba1450ac2543b8bfb5339c56358ca1" continuedAt="i4d12edfee8624b1582f371430f331f09"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is information about incurred and cumulative paid health care claims development as of December&#160;31, 2022, net of reinsurance, and the total IBNR liabilities plus expected development on reported claims included within the net incurred claims amounts. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for information on how the Company estimates IBNR reserves and health care costs payable as well as changes to those methodologies, if any. The Company&#8217;s estimate of IBNR liabilities is primarily based on trend and completion factors. Claim frequency is not used in the calculation of the Company&#8217;s liability. In addition, it is impracticable to disclose claim frequency information for health care claims due to the Company&#8217;s inability to gather consistent claim frequency information across its multiple claims processing systems. Any claim frequency count disclosure would not be comparable across the Company&#8217;s different claim processing systems and would not be consistent from period to period based on the volume of claims processed through each system. As a result, health care claim count frequency is not included in the disclosures below.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzMzNjk_7d9226b9-79ce-4788-a9d8-1b611e9d74bb" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information about incurred and paid health care claims development for the year ended December&#160;31, 2021 is presented as required unaudited supplemental information.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Incurred Health Care Claims,<br/>Net of Reinsurance<br/>For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799291d9b4044a1d96de401f542d2dbc_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo3ZWVlNmY2N2I4ZTU0ZjRmYTZkZDU4ZTU2NjNjMTM3Ni90YWJsZXJhbmdlOjdlZWU2ZjY3YjhlNTRmNGZhNmRkNThlNTY2M2MxMzc2XzMtMS0xLTEtMjY1MjQ3_a798af5b-c2ee-433f-989f-9d69874bf31f">62,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i198eb6aa39444b7b9b09239c511ecfd8_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo3ZWVlNmY2N2I4ZTU0ZjRmYTZkZDU4ZTU2NjNjMTM3Ni90YWJsZXJhbmdlOjdlZWU2ZjY3YjhlNTRmNGZhNmRkNThlNTY2M2MxMzc2XzMtMy0xLTEtMjY1MjQ3_70f4ad38-1a62-440c-b12a-0c26670db19d">62,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97f51e7c8d364549b235af468de7d3d6_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo3ZWVlNmY2N2I4ZTU0ZjRmYTZkZDU4ZTU2NjNjMTM3Ni90YWJsZXJhbmdlOjdlZWU2ZjY3YjhlNTRmNGZhNmRkNThlNTY2M2MxMzc2XzQtMy0xLTEtMjY1MjQ3_14ee893f-01cb-485d-8679-347d4d1d2c05">69,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo3ZWVlNmY2N2I4ZTU0ZjRmYTZkZDU4ZTU2NjNjMTM3Ni90YWJsZXJhbmdlOjdlZWU2ZjY3YjhlNTRmNGZhNmRkNThlNTY2M2MxMzc2XzUtMy0xLTEtMjY1MjQ3_ce9f8876-e147-4a75-ba1a-14b0cb06c9ab">131,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cumulative Paid Health Care Claims,<br/>Net of Reinsurance<br/>For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799291d9b4044a1d96de401f542d2dbc_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo3ZWVlNmY2N2I4ZTU0ZjRmYTZkZDU4ZTU2NjNjMTM3Ni90YWJsZXJhbmdlOjdlZWU2ZjY3YjhlNTRmNGZhNmRkNThlNTY2M2MxMzc2XzEwLTEtMS0xLTI2NTI0Nw_9b763bf3-ff94-44b3-8ff8-ce50b983e815">54,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i198eb6aa39444b7b9b09239c511ecfd8_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo3ZWVlNmY2N2I4ZTU0ZjRmYTZkZDU4ZTU2NjNjMTM3Ni90YWJsZXJhbmdlOjdlZWU2ZjY3YjhlNTRmNGZhNmRkNThlNTY2M2MxMzc2XzEwLTMtMS0xLTI2NTI0Nw_cdeb5c74-52b6-40e9-bdd2-46ee47f152da">62,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97f51e7c8d364549b235af468de7d3d6_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo3ZWVlNmY2N2I4ZTU0ZjRmYTZkZDU4ZTU2NjNjMTM3Ni90YWJsZXJhbmdlOjdlZWU2ZjY3YjhlNTRmNGZhNmRkNThlNTY2M2MxMzc2XzExLTMtMS0xLTI2NTI0Nw_2f5d6fea-a75a-4c80-9c53-d3ce0514901c">59,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo3ZWVlNmY2N2I4ZTU0ZjRmYTZkZDU4ZTU2NjNjMTM3Ni90YWJsZXJhbmdlOjdlZWU2ZjY3YjhlNTRmNGZhNmRkNThlNTY2M2MxMzc2XzEyLTMtMS0xLTI2NTI0Nw_a615abad-60d9-475c-aaf4-5f28394ef818">121,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All outstanding liabilities for health care costs payable prior to 2021, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo3ZWVlNmY2N2I4ZTU0ZjRmYTZkZDU4ZTU2NjNjMTM3Ni90YWJsZXJhbmdlOjdlZWU2ZjY3YjhlNTRmNGZhNmRkNThlNTY2M2MxMzc2XzEzLTMtMS0xLTI2NTI0Nw_12280294-13ee-41f4-b384-9b8c04806123">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total outstanding liabilities for health care costs payable, net of reinsurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo3ZWVlNmY2N2I4ZTU0ZjRmYTZkZDU4ZTU2NjNjMTM3Ni90YWJsZXJhbmdlOjdlZWU2ZjY3YjhlNTRmNGZhNmRkNThlNTY2M2MxMzc2XzE0LTMtMS0xLTI2NTI0Nw_71f449b2-7231-4265-b9b6-5d17daee0a7f">9,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the Company&#8217;s liabilities for IBNR plus expected development on reported claims totaled approximately $<ix:nonFraction unitRef="usd" contextRef="ibb1ed30851ad423db47b88e42b33cf8f_I20221231" decimals="-8" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzE0MDg_67a11f10-a7e3-450b-8c8d-889b8b180a97">7.8</ix:nonFraction> billion. Substantially all of the Company&#8217;s liabilities for IBNR plus expected development on reported claims at December&#160;31, 2022 related to the current calendar year.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzMzNzA_88510626-d262-4f05-b6e2-ef8f5e79ffb7" continuedAt="i0726d2d99c404332bc85e04a06e55230" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the December&#160;31, 2022 health care net incurred and paid claims development tables to the health care costs payable liability on the consolidated balance sheet were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.105%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-duration health care costs payable, net of reinsurance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo1YmNiMjIyY2FjZjA0YTE1YWM5NGVlZGUyY2QzMTFmNy90YWJsZXJhbmdlOjViY2IyMjJjYWNmMDRhMTVhYzk0ZWVkZTJjZDMxMWY3XzEtMS0xLTEtMjY1MjQ3_71f449b2-7231-4265-b9b6-5d17daee0a7f">9,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo1YmNiMjIyY2FjZjA0YTE1YWM5NGVlZGUyY2QzMTFmNy90YWJsZXJhbmdlOjViY2IyMjJjYWNmMDRhMTVhYzk0ZWVkZTJjZDMxMWY3XzItMS0xLTEtMjY1MjQ3_38fe3db5-2d0f-49cf-bca0-9823426f0fdd">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance lines other than short duration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo1YmNiMjIyY2FjZjA0YTE1YWM5NGVlZGUyY2QzMTFmNy90YWJsZXJhbmdlOjViY2IyMjJjYWNmMDRhMTVhYzk0ZWVkZTJjZDMxMWY3XzQtMS0xLTEtMjY1MjQ3_01211345-4589-49c1-a231-6560eb238ac6">211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total health care costs payable</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo1YmNiMjIyY2FjZjA0YTE1YWM5NGVlZGUyY2QzMTFmNy90YWJsZXJhbmdlOjViY2IyMjJjYWNmMDRhMTVhYzk0ZWVkZTJjZDMxMWY3XzUtMS0xLTEtMjY1MjQ3_f3c2efcc-13ae-42ad-98ba-acd2e30e22a1">10,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4d12edfee8624b1582f371430f331f09"><ix:continuation id="i0726d2d99c404332bc85e04a06e55230"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in health care costs payable during the years ended December 31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.160%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of period </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzEtMS0xLTEtMjY1MjQ3_e3348c1f-8ce4-40c5-a8b7-6d16352989c0">8,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcc76cbc90f043b3a402f196167f4f72_I20201231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzEtMy0xLTEtMjY1MjQ3_9340b09c-83b4-4a5a-8811-ad4fe75e1c4b">7,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2d0a34a80341588e7543f9329def49_I20191231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzEtNS0xLTEtMjY1MjQ3_231659fa-e3e2-432f-9fa6-1ebcc03ee22c">6,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzItMS0xLTEtMjY1MjQ3_4db9ee2d-c136-4ee0-92ea-d431ab83d227">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcc76cbc90f043b3a402f196167f4f72_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzItMy0xLTEtMjY1MjQ3_cc920943-d9cd-49ff-b2e2-77e1b113830c">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2d0a34a80341588e7543f9329def49_I20191231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzItNS0xLTEtMjY1MjQ3_9318127d-64bb-4df1-bbd2-2a6116492a01">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Impact of discount rate on long-duration insurance reserves </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231" decimals="-6" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzMtMS0xLTEtMjk0MzEy_f97cf319-3b8c-483b-8b0e-742aeef9ceca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcc76cbc90f043b3a402f196167f4f72_I20201231" decimals="-6" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzMtMy0xLTEtMjk0MzEy_ff401bc6-8d09-4e7b-b717-14dae9299014">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2d0a34a80341588e7543f9329def49_I20191231" decimals="-6" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzMtNS0xLTEtMjk0MzEy_8c07ba98-b487-4583-938c-4294baaa1030">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of period, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzMtMS0xLTEtMjY1MjQ3_69bad934-7099-4af1-af55-0ea3c668753f">8,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcc76cbc90f043b3a402f196167f4f72_I20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzMtMy0xLTEtMjY1MjQ3_fd4ef38b-686e-4c86-b1d3-f6f079da6c84">7,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2d0a34a80341588e7543f9329def49_I20191231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzMtNS0xLTEtMjY1MjQ3_2b51b503-9572-4ffc-a6df-27e7aec22484">6,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i070e3ddd671c465f94cda987d76035a2_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzQtMS0xLTEtMjY1MjQ3_d05c4269-ff5a-4b43-9681-d4b7b1c81705">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f0b83de01479eb59aaddfa35650cd_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzQtMy0xLTEtMjY1MjQ3_dd4468c5-01a2-45dd-be32-589046257dfc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2866ecd09514e62ba339145a6407f2d_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzQtNS0xLTEtMjY1MjQ3_34748f86-8b2c-45f9-a0e6-6160f4e3b1b0">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i070e3ddd671c465f94cda987d76035a2_D20220101-20221231" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzctMS0xLTEtMjY1MjQ3_ad9ed27b-eb9f-46fd-94e1-33c284f919af">71,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f0b83de01479eb59aaddfa35650cd_D20210101-20211231" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzctMy0xLTEtMjY1MjQ3_e46a1f7d-46e9-45c0-a119-19301856ebff">64,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2866ecd09514e62ba339145a6407f2d_D20200101-20201231" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzctNS0xLTEtMjY1MjQ3_3dd6fc4d-22e3-489f-ae93-808f2fe67554">55,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i070e3ddd671c465f94cda987d76035a2_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzgtMS0xLTEtMjY1MjQ3_16304843-c139-4ed4-8c32-90da70a26318">654</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c4f0b83de01479eb59aaddfa35650cd_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzgtMy0xLTEtMjY1MjQ3_d5da6012-b38d-438d-8bc6-421283d92a41">788</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2866ecd09514e62ba339145a6407f2d_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzgtNS0xLTEtMjY1MjQ3_59ecda9d-84fa-4233-a4e0-ed20812a3b12">429</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i070e3ddd671c465f94cda987d76035a2_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzktMS0xLTEtMjY1MjQ3_db41bbb6-ddad-4eda-a7a4-711af2abd367">70,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f0b83de01479eb59aaddfa35650cd_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzktMy0xLTEtMjY1MjQ3_7e5aa7c7-9444-48be-b494-cd23703181be">63,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2866ecd09514e62ba339145a6407f2d_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzktNS0xLTEtMjY1MjQ3_d0ea60f4-c097-4fee-9bc1-4777b9458b0e">55,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i070e3ddd671c465f94cda987d76035a2_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzExLTEtMS0xLTI2NTI0Nw_b70388c0-31af-49bb-aaf2-9f2ebed468c0">61,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f0b83de01479eb59aaddfa35650cd_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzExLTMtMS0xLTI2NTI0Nw_3b1c9b91-6d2b-41b0-b65a-65ea0171ffda">56,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2866ecd09514e62ba339145a6407f2d_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzExLTUtMS0xLTI2NTI0Nw_8c44c49e-8989-46c9-9163-03fc0e901e47">48,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i070e3ddd671c465f94cda987d76035a2_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzEyLTEtMS0xLTI2NTI0Nw_588fa8f2-9ae6-4cdf-b858-652932e6d628">7,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f0b83de01479eb59aaddfa35650cd_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzEyLTMtMS0xLTI2NTI0Nw_9059e920-172d-4f6f-a1c3-78fb77a96886">6,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2866ecd09514e62ba339145a6407f2d_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzEyLTUtMS0xLTI2NTI0Nw_5067344b-ce7e-4f8d-a3cb-be349df2a399">6,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i070e3ddd671c465f94cda987d76035a2_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzEzLTEtMS0xLTI2NTI0Nw_a2e6b05d-31ee-46da-9b64-07bc502e1322">69,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4f0b83de01479eb59aaddfa35650cd_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzEzLTMtMS0xLTI2NTI0Nw_ba3805b1-553f-4457-a8f9-0f0eccd141ea">63,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2866ecd09514e62ba339145a6407f2d_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzEzLTUtMS0xLTI2NTI0Nw_3dacb507-c751-4180-8323-657feb7561b2">54,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE0LTEtMS0xLTI2NTI0Nw_eecf8bf7-7e03-48fa-b40e-aa7836186475">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE0LTMtMS0xLTI2NTI0Nw_386f7061-ba98-4825-96c2-bb996a730f39">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcc76cbc90f043b3a402f196167f4f72_I20201231" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE0LTUtMS0xLTI2NTI0Nw_42f6e612-b456-477c-bb5b-3db35d907a0e">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE1LTEtMS0xLTI2NTI0Nw_489bc45b-718e-4241-ab04-98b926ec8ef4">10,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE1LTMtMS0xLTI2NTI0Nw_fe7255d9-3f49-4973-8284-9e020ce63aab">8,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcc76cbc90f043b3a402f196167f4f72_I20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE1LTUtMS0xLTI2NTI0Nw_708c7103-96d8-4028-aa07-51110e210d57">7,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE2LTEtMS0xLTI2NTI0Nw_e8e5c3cf-311d-4395-b0c9-6e6659b5d6bc">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE2LTMtMS0xLTI2NTI0Nw_725461f4-1677-4bb5-a27f-8641387d1109">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcc76cbc90f043b3a402f196167f4f72_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE2LTUtMS0xLTI2NTI0Nw_02eb49cb-2e2c-49a8-a6e1-4e414bf70ccd">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Impact of discount rate on long-duration insurance reserves </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231" decimals="-6" sign="-" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE4LTEtMS0xLTI5NDMwNA_b86be63e-9b69-4ad6-b12b-b2ff445ce13f">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231" decimals="-6" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE4LTMtMS0xLTI5NDMwNA_70a9b841-c303-4049-bc8d-26e9937dea66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcc76cbc90f043b3a402f196167f4f72_I20201231" decimals="-6" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE4LTUtMS0xLTI5NDMwNA_6ff4ca69-9e1d-4453-9e1b-2f7c20f61282">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE3LTEtMS0xLTI2NTI0Nw_e80538de-2be0-4b80-bf0a-e1dc5c7ead3e">10,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE3LTMtMS0xLTI2NTI0Nw_49cf8a0e-cff1-4fd8-afd9-e46bf5630e14">8,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcc76cbc90f043b3a402f196167f4f72_I20201231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE3LTUtMS0xLTI2NTI0Nw_6c1ef8b2-299d-4117-98ed-e0140c989903">7,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the difference between the current discount rate and the locked-in discount rate on long-duration insurance reserves which is recorded within accumulated other comprehensive income (loss) on the consolidated balance sheets. Refer to Note 8 &#8216;&#8216;Other Insurance Liabilities and Separate Accounts&#8217;&#8217; for further information related to the adoption of the long-duration insurance contracts accounting standard.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total incurred health care costs for the years ended December&#160;31, 2022, 2021 and 2020 in the table above exclude $<ix:nonFraction unitRef="usd" contextRef="if07e27d83137497c9009bcc13d88e451_D20220101-20221231" decimals="-6" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzIwMTY_1bf9f124-e477-4c63-986f-e671f86b0713">79</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2a1d88c90afd4868bb3842de60276b75_D20210101-20211231" decimals="-6" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzI3NDg3NzkwNzQ0MDM_2638925c-0e02-451f-8116-957db2aeee70">58</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i83ae36f497504d8d90f91d0e0e6c7f9a_D20200101-20201231" decimals="-6" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzIwMjc_cf371d44-fdc5-4531-8159-7f147f81eefa">41</ix:nonFraction> million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the consolidated balance sheets and $<ix:nonFraction unitRef="usd" contextRef="i88f999029e8e4a6db4e05b6171f6b11d_D20220101-20221231" decimals="-6" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzIxOTU_6f4d0166-42c2-4439-98ee-dd07ac85a3a5">249</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="iedfef3ba5684421f9d94d0db97241826_D20210101-20211231" decimals="-6" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzI3NDg3NzkwNzQ0MTE_e0d07694-cbed-4cf6-adff-ff84dbf50cbb">271</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if153c73955f74ee79cd73647ab6d655f_D20200101-20201231" decimals="-6" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzIyMDY_b0940111-ecb5-4d74-a72b-96af5b6af3f5">221</ix:nonFraction> million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the consolidated balance sheets. The incurred health care costs for the years ended December 31, 2021 and 2020 also exclude $<ix:nonFraction unitRef="usd" contextRef="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzI0NTM_386f7061-ba98-4825-96c2-bb996a730f39">16</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifcc76cbc90f043b3a402f196167f4f72_I20201231" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzI0NjA_42f6e612-b456-477c-bb5b-3db35d907a0e">11</ix:nonFraction> million, respectively, for premium deficiency reserves related to the Company&#8217;s Medicaid products.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of prior years&#8217; health care costs payable decreased by $<ix:nonFraction unitRef="usd" contextRef="i070e3ddd671c465f94cda987d76035a2_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzI2MzQ_16304843-c139-4ed4-8c32-90da70a26318">654</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i6c4f0b83de01479eb59aaddfa35650cd_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzI2Mzg_d5da6012-b38d-438d-8bc6-421283d92a41">788</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if2866ecd09514e62ba339145a6407f2d_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzI2NDU_59ecda9d-84fa-4233-a4e0-ed20812a3b12">429</ix:nonFraction> million in 2022, 2021 and 2020, respectively, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#8217;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year. This development does not directly correspond to an increase in the Company&#8217;s operating results as these reductions were offset by estimated current period health care costs when the Company established the estimate of the current year health care costs payable.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_549755815784"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:InsuranceContractAcquisitionCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90ZXh0cmVnaW9uOjM3NzkzMGQ5MjBlYTRiOGE5ZTdjZDA4ODM0MzhhNjNhXzEwNDQ1MzYwNDc5MTk5_432dccf0-96b2-4e2d-921c-75f6070ea045" continuedAt="ic57cc0a5877e4d20afb425f57b32217a" escape="true">Other Insurance Liabilities and Separate Accounts</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic57cc0a5877e4d20afb425f57b32217a" continuedAt="i43a94a6676d74054b0ae396032c80c62"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the Financial Accounting Standards Board issued ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944) (the &#8220;long-duration insurance standard&#8221;). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted this accounting standard on January 1, 2023, using the modified retrospective transition method as of January 1, 2021, also referred to as the &#8220;transition date&#8221;, for changes to its liabilities for future policy benefits, deferred acquisition costs and value of business acquired intangible asset. Upon adoption, the Company recorded a transition date net adjustment to reduce accumulated other comprehensive income (loss) by $<ix:nonFraction unitRef="usd" contextRef="i5bb58d471a7046db9c3cc65f4971e64f_I20210101" decimals="-6" sign="-" name="cvs:AccumulatedOtherComprehensiveIncomeLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90ZXh0cmVnaW9uOjM3NzkzMGQ5MjBlYTRiOGE5ZTdjZDA4ODM0MzhhNjNhXzM4NDgyOTA3MTI0MzE_16e3071a-b9fa-4924-8467-21d4db81dd37"><ix:nonFraction unitRef="usd" contextRef="i5bb58d471a7046db9c3cc65f4971e64f_I20210101" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90ZXh0cmVnaW9uOjM3NzkzMGQ5MjBlYTRiOGE5ZTdjZDA4ODM0MzhhNjNhXzM4NDgyOTA3MTI0MzE_3febf128-715d-4068-a4e0-d2988c3f3479">986</ix:nonFraction></ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="i5bb58d471a7046db9c3cc65f4971e64f_I20210101" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90ZXh0cmVnaW9uOjM3NzkzMGQ5MjBlYTRiOGE5ZTdjZDA4ODM0MzhhNjNhXzM4NDgyOTA3MTI0NDU_1cdd0e35-fd2d-46a3-af47-6af719e484dc"><ix:nonFraction unitRef="usd" contextRef="i5bb58d471a7046db9c3cc65f4971e64f_I20210101" decimals="-6" name="cvs:LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90ZXh0cmVnaW9uOjM3NzkzMGQ5MjBlYTRiOGE5ZTdjZDA4ODM0MzhhNjNhXzM4NDgyOTA3MTI0NDU_8ec041bf-3fc4-48c2-803c-e79045e75254">766</ix:nonFraction></ix:nonFraction>&#160;million after-tax) with a corresponding increase to its liability for future policy benefits, the majority of which is included within other insurance liabilities and other long-term liabilities on the consolidated balance sheets. The transition date net adjustment was a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#8217;s expected investment yield under the historical guidance. The Company was not required to record an adjustment to retained earnings on the transition date. Prior period financial information subsequent to the transition date has been revised to reflect the adoption of the long-duration insurance standard.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90ZXh0cmVnaW9uOjM3NzkzMGQ5MjBlYTRiOGE5ZTdjZDA4ODM0MzhhNjNhXzEwNDQ1MzYwNDc5MjAw_bf858728-786f-4d9c-b3c3-0a47203553e5" continuedAt="if6e239110e084fe0abb801cc80b24f84" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes changes in the balances of long-duration insurance liabilities as a result of the adoption of the long-duration insurance standard effective January 1, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Large Case<br/>Pensions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term<br/>Care</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020, net of reinsurance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b1a4067a7447d09ac7bb0fa978bb71_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzEtMS0xLTEtMjk3NTAw_e251a217-8ed5-4be5-aeb7-b1af3c149b89">3,224</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a700dd2b904bf5bbc0dbe22aa0bac8_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzEtMy0xLTEtMjk3NTAw_526929bb-f378-444e-a3b9-c6fc02d9a99e">1,142</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bb54359e2f54f6bb88e696298a4d66a_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzEtNS0xLTEtMjk3NTAw_59491bc8-4407-4baa-8993-e63a1dc55781">480</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b1a4067a7447d09ac7bb0fa978bb71_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzItMS0xLTEtMjk3NTAw_deb31341-576b-433f-8025-c0f77ba1a5f9">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a700dd2b904bf5bbc0dbe22aa0bac8_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzItMy0xLTEtMjk3NTAw_106f9d14-1062-40bb-a6c2-5323982d5beb">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bb54359e2f54f6bb88e696298a4d66a_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzItNS0xLTEtMjk3NTAw_26a242fb-6259-4376-a9b6-3c2f6d3286fe">274</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b1a4067a7447d09ac7bb0fa978bb71_I20201231" decimals="-6" name="cvs:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzMtMS0xLTEtMjk3NTAw_91b692a1-4b78-49f9-8c16-d20d229c21ca">3,224</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a700dd2b904bf5bbc0dbe22aa0bac8_I20201231" decimals="-6" name="cvs:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzMtMy0xLTEtMjk3NTAw_e968ac42-c9d6-4ccd-8d91-daf4ffede76c">1,142</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bb54359e2f54f6bb88e696298a4d66a_I20201231" decimals="-6" name="cvs:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzMtNS0xLTEtMjk3NTAw_4a0d5d30-5201-4534-9b01-7b75d78f0003">754</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in discount rate assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bf2003d34b74a88a3c886d4e9d41643_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzQtMS0xLTEtMjk3NTAw_83638d85-b9c2-403d-97e7-c1fed3d8d965">604</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabfc58f2b34943d8a1b6af15cd233571_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzQtMy0xLTEtMjk3NTAw_be80fff8-953c-46a2-9c51-04f8997ad960">553</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20c1ca9c1b9440b994dfb835f8ea73f4_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzQtNS0xLTEtMjk3NTAw_144f5888-f845-470b-9259-117712a8cddd">44</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Removal of shadow adjustments in accumulated other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i912746c5ac72472fb68054bd160c6e6c_I20201231" decimals="-6" sign="-" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzUtMS0xLTEtMjk3NTAw_1fd4cfe9-415c-47ae-97f8-47a4cf0f1d35">181</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89b6580a77e04626a0e30a5a4fb6adc4_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzUtMy0xLTEtMjk3NTAw_6ed2a1bd-113e-488f-a33a-0b442c24a597">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c5404c452ba4db28e4fbb520b402437_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzUtNS0xLTEtMjk3NTAw_4c927be1-17fe-4c9f-b59f-5f02f7affb05">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted balance at January 1, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1263a7bd13e6441c90af49d5dde6fbc0_I20201231" decimals="-6" name="cvs:LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzYtMS0xLTEtMjk3NTAw_305fc4f2-74a1-469e-a649-aa96072471f5">3,647</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644e02c89965481d980470106777aa5c_I20201231" decimals="-6" name="cvs:LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzYtMy0xLTEtMjk3NTAw_62296cfa-a179-4d82-aade-9630de08c961">1,695</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9137fbdadfbe43f5b00bde48da98706d_I20201231" decimals="-6" name="cvs:LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzYtNS0xLTEtMjk3NTAw_b2aa857b-8abe-4330-9ab6-8c52327751fb">798</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1263a7bd13e6441c90af49d5dde6fbc0_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzctMS0xLTEtMjk3NTAw_4f546d2c-bb55-41ba-9a70-f65b5934b83e">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644e02c89965481d980470106777aa5c_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzctMy0xLTEtMjk3NTAw_9b32fc0b-6a12-42aa-a466-0988ab83a25d">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9137fbdadfbe43f5b00bde48da98706d_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzctNS0xLTEtMjk3NTAw_c6203b75-4dff-49a1-b0d2-e5a61764caa2">308</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted balance at January 1, 2021, net of reinsurance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1263a7bd13e6441c90af49d5dde6fbc0_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzgtMS0xLTEtMjk3NTAw_7a07a270-9392-4fb6-bec0-c8f79c27f439">3,647</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644e02c89965481d980470106777aa5c_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzgtMy0xLTEtMjk3NTAw_7952c6cc-7e9c-48ad-8540-9de1b7d28699">1,695</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9137fbdadfbe43f5b00bde48da98706d_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzgtNS0xLTEtMjk3NTAw_659f8bdc-4b05-46bc-b074-0523b51299cc">490</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i43a94a6676d74054b0ae396032c80c62" continuedAt="ic7040a31d7794b30ac1474f53742d5b9"><ix:continuation id="if6e239110e084fe0abb801cc80b24f84" continuedAt="ib213ebd44fde43a980f70573bdfa1c7b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of New Long-Duration Insurance Contracts Standard on Financial Statement Line Items</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the consolidated statement of operations for the years ended December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported<br/>December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted <br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statement of Operations:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzQtMS0xLTEtMjk3NTAw_8fdfb947-e196-42ef-919f-163766d9cded">71,281</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzQtMy0xLTEtMjk3NTAw_ef9e282a-5704-40b4-8035-3f96583d22ba">208</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzQtNS0xLTEtMjk3NTAw_bb952f02-aa53-4413-a999-aecbb3e045dd">71,073</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzUtMS0xLTEtMjk3NTAw_4d33951e-0100-4583-8b9e-f77d41d9280e">314,721</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzUtMy0xLTEtMjk3NTAw_b2508b8e-d030-43b6-a5ce-85949e3f5831">208</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzUtNS0xLTEtMjk3NTAw_5076a4f5-08f5-4970-9bbf-f96600520f8d">314,513</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzYtMS0xLTEtMjk3NTAw_e5e474ac-9d9a-4052-bc6e-a256149a4434">7,746</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzYtMy0xLTEtMjk3NTAw_89350101-6f5c-42c9-9db1-ab042c472ea4">208</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzYtNS0xLTEtMjk3NTAw_5eb8c73c-aa05-483e-8bac-c8409a98c479">7,954</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzctMS0xLTEtMjk3NTAw_2b5154cc-c8b1-4910-aa1f-21854314a67f">5,628</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzctMy0xLTEtMjk3NTAw_18ddbcc8-34ca-4c76-be69-efb12db798bb">208</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzctNS0xLTEtMjk3NTAw_d9c7ac83-f1d6-46a1-800c-2fbc4e7953b1">5,836</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzgtMS0xLTEtMjk3NTAw_decf2687-fc7a-40a9-8786-4029d19a97dd">1,463</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzgtMy0xLTEtMjk3NTAw_a02ca762-1365-4166-af0e-4b622718ac5b">46</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzgtNS0xLTEtMjk3NTAw_484d1e36-0ed8-4f16-8024-461e436544e7">1,509</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzktMS0xLTEtMjk3NTAw_355fd707-805c-4cd1-bff2-d9b64ba9938d">4,165</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzktMy0xLTEtMjk3NTAw_425c2c2b-b111-4161-8ef6-b5ecd950b66c">162</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzktNS0xLTEtMjk3NTAw_9e6982f3-c49d-430e-89eb-615a3006c752">4,327</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzEwLTEtMS0xLTI5NzUwMA_e6024b43-d8b8-48d4-9a9c-0fda0ee017ea">4,165</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzEwLTMtMS0xLTI5NzUwMA_9ab706f9-235c-4dd7-a231-ea81b87e0f80">162</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzEwLTUtMS0xLTI5NzUwMA_6dc83151-dd85-42d3-918a-e8aae83a5251">4,327</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzExLTEtMS0xLTI5NzUwMA_dd612be1-08e3-4484-be94-c7250bd3a58a">4,149</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzExLTMtMS0xLTI5NzUwMA_2e8286e0-86c7-4ee5-9fd6-7d2513a31a33">162</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzExLTUtMS0xLTI5NzUwMA_47688898-896c-4067-b08e-708a824603c1">4,311</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to CVS Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzEzLTEtMS0xLTI5NzUwMA_ab6901c9-3e82-4c1d-bd53-ccca4f94177d">3.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzEzLTMtMS0xLTI5NzUwMA_27cfaa04-2cac-4e77-b944-d45935e6e559">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzEzLTUtMS0xLTI5NzUwMA_cc332167-5e24-464d-8586-d1c8b3deec2a">3.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzE1LTEtMS0xLTMwMDYyNw_7c775963-ed41-4337-bd85-5985ffa8ad7a">3.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzE1LTMtMS0xLTMwMDYyNw_dd862997-b4f6-4e97-95b7-034771aa4874">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzE1LTUtMS0xLTMwMDYyNw_3b34dc08-1964-4731-a4e6-5d7f6587173b">3.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to CVS Health</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzE0LTEtMS0xLTI5NzUwMA_b2b7da5e-e3f9-4575-9531-7991690d8e40">3.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzE0LTMtMS0xLTI5NzUwMA_c53bab5c-5cf4-4979-93e2-5e4fdf7406a7">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzE0LTUtMS0xLTI5NzUwMA_f90fbf93-006b-402c-8bfd-8d495e80f21d">3.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzE4LTEtMS0xLTMwMDYzNQ_68c61a60-7a8e-4244-9e0c-81bb9d2ed702">3.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzE4LTMtMS0xLTMwMDYzNQ_ac4dfd7c-adcb-42b2-bf2c-eb230bfce75e">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzE4LTUtMS0xLTMwMDYzNQ_e961b03f-cf15-43e8-a383-2e9f8454fab0">3.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported<br/>December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted <br/>December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statement of Operations:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzQtMS0xLTEtMjk3NTAw_66d51f4c-ef38-400a-a651-5a3f05db26bc">64,260</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzQtMy0xLTEtMjk3NTAw_a5f8d688-1f55-4993-9c8d-51155b7f40e9">72</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzQtNS0xLTEtMjk3NTAw_ec8d1bf6-a1d6-4e1e-984e-db2b29ed0495">64,188</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231" decimals="-6" name="cvs:OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzUtMS0xLTEtMjk3NTAw_186cc182-3566-4215-b589-7cf370abc5c3">37,066</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231" decimals="-6" sign="-" name="cvs:OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzUtMy0xLTEtMjk3NTAw_1d71c034-efd8-4643-9d9f-9f8828f3a847">45</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzUtNS0xLTEtMjk3NTAw_39935027-d3be-45b0-ac6d-02d0998e05cf">37,021</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzYtMS0xLTEtMjk3NTAw_a0c6f910-f090-4944-946f-d0c0117eae75">278,918</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzYtMy0xLTEtMjk3NTAw_af37285e-97a8-4f26-b988-f0d4984e60c5">117</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzYtNS0xLTEtMjk3NTAw_300193cf-8438-4174-9e6f-f0dbd64d708d">278,801</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzctMS0xLTEtMjk3NTAw_c3b2b134-00f1-49a1-bf88-6394e4009749">13,193</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzctMy0xLTEtMjk3NTAw_347f0644-5bed-478c-8ef8-4e524dbece5b">117</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzctNS0xLTEtMjk3NTAw_3bb7dbe1-3cbe-42df-be59-72f37ee42e0c">13,310</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzgtMS0xLTEtMjk3NTAw_702ed15e-badc-48a3-b6d6-fe9d975fab41">10,420</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzgtMy0xLTEtMjk3NTAw_0a61358c-4a89-4061-9d37-b0070004baa3">117</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzgtNS0xLTEtMjk3NTAw_bd3786da-85f2-42a0-9e67-927fa8450b7a">10,537</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzktMS0xLTEtMjk3NTAw_beb7c042-9d56-44d1-87b3-1989199e8fe3">2,522</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzktMy0xLTEtMjk3NTAw_13559b8d-59bc-4821-b82a-fdcf4fb01e95">26</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzktNS0xLTEtMjk3NTAw_d0fbc512-348e-4c7e-b0eb-fe082e6b9503">2,548</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzEwLTEtMS0xLTI5NzUwMA_c5319050-3151-45af-80f0-55bd3ae0a844">7,898</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzEwLTMtMS0xLTI5NzUwMA_60b92ba4-d722-419e-b2db-9273662c0f18">91</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzEwLTUtMS0xLTI5NzUwMA_f7385650-378e-4472-b87c-8f925bf757db">7,989</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzExLTEtMS0xLTI5NzUwMA_bde6ebd4-3de5-45d9-9496-a4d394a9b9b5">7,898</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzExLTMtMS0xLTI5NzUwMA_9c4e07cc-97b5-4856-8abe-f8c3cc63edaf">91</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzExLTUtMS0xLTI5NzUwMA_07b24673-92db-4eb7-a011-a9a417a0e811">7,989</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzEyLTEtMS0xLTI5NzUwMA_71b03e63-3489-4d70-861d-0855d343f50e">7,910</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzEyLTMtMS0xLTI5NzUwMA_5c335095-dabb-49ad-b54d-b288310a8f4a">91</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzEyLTUtMS0xLTI5NzUwMA_eb75a8ab-7a43-4a97-87a2-b07cb1c8153e">8,001</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to CVS Health</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE0LTEtMS0xLTI5NzUwMA_49ea87f2-c1f4-40b0-9d72-f9ff53243968">6.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE0LTMtMS0xLTI5NzUwMA_3b8a7f39-cd78-4516-9aaa-701fa15524de">0.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE0LTUtMS0xLTI5NzUwMA_cfa857d9-c70e-493a-8e6b-3c31d2a2ca14">6.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE2LTEtMS0xLTMwMDY0Mw_a49e4015-86c7-49e7-91ba-049123eaee21">6.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE2LTMtMS0xLTMwMDY0Mw_310a7c5d-c264-4476-a964-c39056cd6f2e">0.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE2LTUtMS0xLTMwMDY0Mw_c457b784-d0e1-4fc5-8ec1-599b0ce7d5b1">6.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to CVS Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE1LTEtMS0xLTI5NzUwMA_709c6e4e-c4d9-45ba-a709-e3b35d1848e9">5.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE1LTMtMS0xLTI5NzUwMA_40c89954-ac21-4b71-8758-18e0588e2fc6">0.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE1LTUtMS0xLTI5NzUwMA_34d34504-2490-4113-9120-60026d923f4b">6.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE5LTEtMS0xLTMwMDY1MQ_fd1f258a-b7e4-4ede-9c52-1fd6e6492070">5.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE5LTMtMS0xLTMwMDY1MQ_94fdc7bc-4399-4338-a6f5-fa2e5a8413bc">0.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE5LTUtMS0xLTMwMDY1MQ_262d193f-451d-4db3-817b-214119aa4c99">6.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic7040a31d7794b30ac1474f53742d5b9" continuedAt="ic621a48062bd4e6989f157909d704f1f"><ix:continuation id="ib213ebd44fde43a980f70573bdfa1c7b" continuedAt="i5f59f57e6a63411ab9a06f8ded2cd41a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the consolidated balance sheet as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported<br/>December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted <br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Balance Sheet:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzMtMS0xLTEtMjk3NTAw_bb015e3f-d193-463d-b94d-b9c69b98cd31">2,685</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231" decimals="-6" sign="-" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzMtMy0xLTEtMjk3NTAw_ec7622bf-de9e-4197-bb5b-e42d36d51306">49</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzMtNS0xLTEtMjk3NTAw_5cb8848c-5488-4ade-bc6a-109517596d97">2,636</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzQtMS0xLTEtMjk3NTAw_4b67a753-e8c3-4c25-91d3-3939ff8917ba">65,682</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231" decimals="-6" sign="-" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzQtMy0xLTEtMjk3NTAw_6b3b2acf-f14a-486f-9b45-114fa2161b51">49</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzQtNS0xLTEtMjk3NTAw_ecfd4645-c488-4009-b6cb-a74953bd0d8d">65,633</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzUtMS0xLTEtMjk3NTAw_000cf762-a80c-498d-b30b-383fa214b21b">24,754</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzUtMy0xLTEtMjk3NTAw_8eece262-7646-4867-bd58-1e446488d2d9">49</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzUtNS0xLTEtMjk3NTAw_f9f00629-1a64-4679-a494-0f0e712ed519">24,803</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzYtMS0xLTEtMjk3NTAw_222dc4eb-984a-4dc4-97ab-6d82f515841c">228,275</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzYtMy0xLTEtMjk3NTAw_138b5473-4a48-4859-a4e2-dfdda13a0be7">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzYtNS0xLTEtMjk3NTAw_a3212982-328e-4516-a9e4-360b7151e8be">228,275</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzctMS0xLTEtMjk3NTAw_97952f8f-dfc3-471e-99cd-fbdc4cfa1721">10,406</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231" decimals="-6" sign="-" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzctMy0xLTEtMjk3NTAw_f6333f61-a760-448a-b5d6-fa1729530622">264</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzctNS0xLTEtMjk3NTAw_d89ea934-adb3-409f-8906-3d2669218466">10,142</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other insurance liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzgtMS0xLTEtMjk3NTAw_1ba056a4-0ca7-4e40-a5b4-518e486f4d25">1,140</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231" decimals="-6" sign="-" name="cvs:OtherInsuranceLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzgtMy0xLTEtMjk3NTAw_227e834c-a1ba-402c-bd4a-4a1d79e97767">51</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzgtNS0xLTEtMjk3NTAw_a51670fa-d7b7-402f-bb4f-cb3ec0f09099">1,089</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzktMS0xLTEtMjk3NTAw_f3c7d85a-a533-4a6e-997d-2204077d2a5b">69,736</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231" decimals="-6" sign="-" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzktMy0xLTEtMjk3NTAw_1848fd09-5f28-4254-944f-26c618a3e45b">315</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzktNS0xLTEtMjk3NTAw_0ed1b413-0f47-4bd6-9ad7-646cf910ac85">69,421</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzEwLTEtMS0xLTI5NzUwMA_3577bdd2-6be7-426d-9ba1-62bf0edbd546">3,880</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzEwLTMtMS0xLTI5NzUwMA_518a45b2-569f-4778-b165-134931631fd8">136</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzEwLTUtMS0xLTI5NzUwMA_c9a5cc4c-7e40-47f0-835f-6b7a21176f56">4,016</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term insurance liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzExLTEtMS0xLTI5NzUwMA_042ebf04-86a2-4d8c-80af-ae630285685f">6,108</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231" decimals="-6" sign="-" name="cvs:OtherInsuranceLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzExLTMtMS0xLTI5NzUwMA_b5ea511b-129d-45d1-a026-2fc88acbc6f2">273</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzExLTUtMS0xLTI5NzUwMA_cd8e2a15-de7c-47a1-a191-a6a73cd739da">5,835</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzEyLTEtMS0xLTI5NzUwMA_cb4ce437-995e-46ce-8cc0-c6c5c3442f57">6,732</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231" decimals="-6" sign="-" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzEyLTMtMS0xLTI5NzUwMA_980af772-b0a2-4356-8cd8-758c623d4d1a">2</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzEyLTUtMS0xLTI5NzUwMA_c3b50a1b-4933-43b0-9f02-c28ebbcdb73c">6,730</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzEzLTEtMS0xLTI5NzUwMA_1de6cebf-332a-45af-8669-cdba9d4c4218">156,960</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231" decimals="-6" sign="-" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzEzLTMtMS0xLTI5NzUwMA_8cb47a12-c9cd-49f2-8fe7-4ab2f877587d">454</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzEzLTUtMS0xLTI5NzUwMA_da9d25e0-6c8d-424e-8c12-dcb2da1673c1">156,506</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE0LTEtMS0xLTI5NzUwMA_dc08b28d-6f8e-4014-a58e-da51161cd059">56,145</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE0LTMtMS0xLTI5NzUwMA_b902c4f3-c84c-4e1a-beae-2d437fff8d2a">253</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE0LTUtMS0xLTI5NzUwMA_614ed18d-a78e-4f40-8999-a78d38dc75a1">56,398</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE1LTEtMS0xLTI5NzUwMA_88327a62-44b1-4400-83f3-281d1d0292d4">1,465</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE1LTMtMS0xLTI5NzUwMA_5280ee05-a7e1-466d-a280-d810cd8207fa">201</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE1LTUtMS0xLTI5NzUwMA_0460986f-3123-475c-b24b-ac1e46b5f433">1,264</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total CVS Health shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE2LTEtMS0xLTI5NzUwMA_c679a694-c259-47e0-8799-4cf758a17c6f">71,015</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE2LTMtMS0xLTI5NzUwMA_630242c4-541d-4afe-a7ae-f97b0009e97f">454</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE2LTUtMS0xLTI5NzUwMA_17d87c2f-df49-4f9a-a948-2b924138ae8e">71,469</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE3LTEtMS0xLTI5NzUwMA_f407eb66-a23f-4004-97e5-639b33b2c37f">71,315</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE3LTMtMS0xLTI5NzUwMA_c4f9edc9-d122-4b27-9cfa-ba7878986e62">454</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE3LTUtMS0xLTI5NzUwMA_4ed78df6-4c1a-48de-8d97-b8ad5e183f9d">71,769</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE4LTEtMS0xLTI5NzUwMA_1b1d999d-8bad-4c15-9586-0682acf7ed2d">228,275</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE4LTMtMS0xLTI5NzUwMA_237f824c-84e9-4a16-b4f8-83504b3d285b">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE4LTUtMS0xLTI5NzUwMA_928d6d5d-42d2-486b-af29-4ada5beea460">228,275</ix:nonFraction></span></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported<br/>December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted <br/>December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Balance Sheet:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzMtMS0xLTEtMjk3NTAw_b5c33c7c-2210-48bf-a8e3-ce7fcc1d3a4e">5,292</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzMtMy0xLTEtMjk3NTAw_0258e8d5-f4c4-444e-b372-8f3afde92801">27</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzMtNS0xLTEtMjk3NTAw_7eff275a-aae5-4af5-8d81-1e4dedd4e10b">5,319</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzQtMS0xLTEtMjk3NTAw_7357eb12-bdd3-4dc8-b7df-4339e52a551d">60,008</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzQtMy0xLTEtMjk3NTAw_90c888e1-a631-4b65-9034-9d07e884ade8">27</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzQtNS0xLTEtMjk3NTAw_20bbb116-9211-4775-a59f-3b8fca077d82">60,035</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzUtMS0xLTEtMjk3NTAw_c6cc17b4-d5f7-4f04-8788-6c9dd44016ef">29,026</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzUtMy0xLTEtMjk3NTAw_378a1157-6f72-4b24-a13d-2897427190df">26</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzUtNS0xLTEtMjk3NTAw_487d66c0-87be-4294-bc9f-ae6c0ecf6e8b">29,052</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzYtMS0xLTEtMjk3NTAw_6083fbee-aac6-4633-bbf1-51cebea93887">232,999</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231" decimals="-6" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzYtMy0xLTEtMjk3NTAw_bafd1b1e-9bb1-4579-a25a-9c5173ee6721">53</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzYtNS0xLTEtMjk3NTAw_10704726-6f86-47e6-b67b-3c6561875ff4">233,052</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzctMS0xLTEtMjk3NTAw_bb993a4c-7271-4659-8353-27aaa8125fbc">8,808</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231" decimals="-6" sign="-" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzctMy0xLTEtMjk3NTAw_72aba134-5057-4e03-b06b-3c91ecc8326a">130</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzctNS0xLTEtMjk3NTAw_70f35154-f943-4ef1-9802-36a83133bae3">8,678</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other insurance liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzgtMS0xLTEtMjk3NTAw_6091eb65-20ba-41ad-b040-0cd6bc47acf9">1,303</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzgtMy0xLTEtMjk3NTAw_d688402d-fdf3-4c3f-88bf-4f3b44761c9a">42</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzgtNS0xLTEtMjk3NTAw_a16c4091-2012-455b-a2f8-976488c29cb2">1,345</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzktMS0xLTEtMjk3NTAw_62020b44-b6bd-49c9-85a7-93ad3080017d">67,807</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231" decimals="-6" sign="-" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzktMy0xLTEtMjk3NTAw_59f8b5ef-ca23-4e5c-b714-7217f556b598">88</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzktNS0xLTEtMjk3NTAw_438b91f1-9544-4bcc-8fdf-f096bc241bf4">67,719</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzEwLTEtMS0xLTI5NzUwMA_888a0c01-bec8-4c73-8ffe-1cf443d4aa94">6,270</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzEwLTMtMS0xLTI5NzUwMA_e629b36f-2624-4722-a747-b7eab21a6e23">155</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzEwLTUtMS0xLTI5NzUwMA_e5da04a8-9287-4205-8d3b-22ecf6570948">6,115</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term insurance liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzExLTEtMS0xLTI5NzUwMA_4b90ad4c-faa3-4966-8678-45da78916ddf">6,402</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzExLTMtMS0xLTI5NzUwMA_9a2f1cfb-7eef-4bd0-a4b2-007471a69aaf">833</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzExLTUtMS0xLTI5NzUwMA_4cd25e39-ea2d-4f57-86f0-fc9fc19f8e71">7,235</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzEyLTEtMS0xLTI5NzUwMA_3f50c889-a3e5-4fdc-a65a-f70230c334c4">1,904</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzEyLTMtMS0xLTI5NzUwMA_92b9b957-5858-4dc5-8552-3887de9eb7ca">3</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzEyLTUtMS0xLTI5NzUwMA_8285ff39-2d37-4af5-a8ff-d93646532c28">1,907</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzEzLTEtMS0xLTI5NzUwMA_19408cc9-8ce5-4bf5-bd23-e3a45ef45437">157,618</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231" decimals="-6" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzEzLTMtMS0xLTI5NzUwMA_85505cc2-a3fa-4188-82ba-89f524d5213d">593</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzEzLTUtMS0xLTI5NzUwMA_c3afa34c-60cd-4ce6-83d6-d6a724ef2d0f">158,211</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE0LTEtMS0xLTI5NzUwMA_d9540455-8e9f-49c2-a76e-7b5906e2ea35">54,906</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE0LTMtMS0xLTI5NzUwMA_c36b6d08-55b0-4e13-aa49-4724fc884cb6">91</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE0LTUtMS0xLTI5NzUwMA_09ede65d-f480-4dd4-8e8b-42becd60de21">54,997</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE1LTEtMS0xLTI5NzUwMA_e9e22355-353a-438f-bbe8-3cda17682eca">965</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE1LTMtMS0xLTI5NzUwMA_d721ef05-bd2d-459e-8bef-ca8b6e1b0911">631</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE1LTUtMS0xLTI5NzUwMA_722820d5-ed09-4ab4-b9bf-b03fffd5e7f4">334</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total CVS Health shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE2LTEtMS0xLTI5NzUwMA_571f8703-53f0-453c-bce1-357b11f3fc89">75,075</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE2LTMtMS0xLTI5NzUwMA_cfd5688e-ad20-4e4b-a79f-80aca9a7a4df">540</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE2LTUtMS0xLTI5NzUwMA_c8a79c14-04c3-4482-a5e0-8f71bb85ef9f">74,535</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE3LTEtMS0xLTI5NzUwMA_48c958f3-aae4-44c9-84ef-397e1fe5a9be">75,381</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE3LTMtMS0xLTI5NzUwMA_705b64d1-97c3-4d14-b330-8243ae7ae9c1">540</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE3LTUtMS0xLTI5NzUwMA_d084c9e4-b623-49c2-8698-3d2d92a279c8">74,841</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE4LTEtMS0xLTI5NzUwMA_41f456f5-4785-42ee-82f2-cf690aa3ff9f">232,999</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE4LTMtMS0xLTI5NzUwMA_099c9268-1451-49e7-8daf-e0851e319511">53</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE4LTUtMS0xLTI5NzUwMA_ab9de21f-3136-49f1-af38-9a262d2195fa">233,052</ix:nonFraction></span></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic621a48062bd4e6989f157909d704f1f" continuedAt="idf53427e493e4e55a939328bd38020c4"><ix:continuation id="i5f59f57e6a63411ab9a06f8ded2cd41a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the consolidated statement of cash flows for the years ended December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported<br/>December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted <br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statement of Cash Flows:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation of net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzQtMS0xLTEtMjk3NTAw_a2653966-ab19-415a-845b-99d9fb7ab203">4,165</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzQtMy0xLTEtMjk3NTAw_7e1bf1e5-28da-4813-a07c-726d6122db9b">162</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzQtNS0xLTEtMjk3NTAw_69ebb45a-a15c-4837-be60-c93b54d00b6e">4,327</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments required to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzYtMS0xLTEtMjk3NTAw_804983cc-2b63-488c-b5e0-30f0a97c208f">4,247</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzYtMy0xLTEtMjk3NTAw_21d3bbd4-3543-4d25-ba29-afd281034aa1">23</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzYtNS0xLTEtMjk3NTAw_17e655f7-9fbc-4285-a278-e367edcaaa51">4,224</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzctMS0xLTEtMjk3NTAw_68dbb637-5a6a-43ae-b47b-906dc8705bdc">2,075</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzctMy0xLTEtMjk3NTAw_d6778312-e489-4de0-b9d9-be00ce3ac691">46</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzctNS0xLTEtMjk3NTAw_1c2b03f8-d21f-4428-a5d8-2b0744103d84">2,029</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities, net of effects from acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzktMS0xLTEtMjk3NTAw_a59cbf5d-da23-4d9b-bf57-e47aae3e3e0a">566</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzktMy0xLTEtMjk3NTAw_7abfc6bc-468a-4740-9fd8-4b3536127036">75</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzktNS0xLTEtMjk3NTAw_ecef7c22-346a-49b1-8c45-b9b30e92e7fc">491</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable and other insurance liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzEwLTEtMS0xLTI5NzUwMA_527580fd-246a-4dc1-beea-9243a3a732bf">1,247</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzEwLTMtMS0xLTI5NzUwMA_b189821c-9a85-4e21-b146-c31b7b65c897">255</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzEwLTUtMS0xLTI5NzUwMA_d97ae6d8-52f2-4810-8392-7ba5f3cfca82">992</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzExLTEtMS0xLTI5NzUwMA_dace8f06-fb43-4179-8ed5-cc7819909669">6,468</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzExLTMtMS0xLTI5NzUwMA_d86db14f-841f-4573-aa56-bec5a09fdc6b">5</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzExLTUtMS0xLTI5NzUwMA_8bb833f2-72a1-4446-8de7-c472d02706ea">6,463</ix:nonFraction></span></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported<br/>December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted <br/>December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statement of Cash Flows:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation of net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzQtMS0xLTEtMjk3NTAw_25d573cc-96ff-412b-824e-b1daec11b686">7,898</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzQtMy0xLTEtMjk3NTAw_600a89a6-4968-42de-b208-7bb9923c9304">91</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzQtNS0xLTEtMjk3NTAw_261cd721-74ee-43f3-aef1-bd608cf07d63">7,989</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments required to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzYtMS0xLTEtMjk3NTAw_9eb0efef-90b5-49d9-80cb-461200291320">4,512</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzYtMy0xLTEtMjk3NTAw_d16ac3df-1ae2-448a-ada5-a0074dd97f58">26</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzYtNS0xLTEtMjk3NTAw_a103f34e-29c1-4524-8ad8-b5ba7e0babfd">4,486</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzctMS0xLTEtMjk3NTAw_a623f0e3-638a-432e-bd9d-f0e95a714186">428</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzctMy0xLTEtMjk3NTAw_dcd0a5f6-33d8-4990-9037-315d1cc9f711">26</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzctNS0xLTEtMjk3NTAw_9a426cf4-2cdb-425f-9f37-ce101ea33af8">402</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities, net of effects from acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzktMS0xLTEtMjk3NTAw_72bba01b-b2ad-4108-8522-91b70d6f584b">3</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzktMy0xLTEtMjk3NTAw_cb84e529-2464-49b3-8ab1-12bb9fe7eac0">27</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzktNS0xLTEtMjk3NTAw_d57a9a83-e990-4eba-bd47-6fe86aa9fbdd">30</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable and other insurance liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzEwLTEtMS0xLTI5NzUwMA_71a7e55f-a4cb-4a68-8c77-4b782d469b98">169</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzEwLTMtMS0xLTI5NzUwMA_235a4346-7f23-405f-99b1-4084ecdf752d">68</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzEwLTUtMS0xLTI5NzUwMA_53a780c7-1ea9-48af-a525-debd9fdf2591">101</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzExLTEtMS0xLTI5NzUwMA_06a74340-fea4-475a-9cd9-2a56aa9eaa23">2,852</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzExLTMtMS0xLTI5NzUwMA_9ff2158a-bf9c-491b-9ff4-f47d8d61cb08">4</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzExLTUtMS0xLTI5NzUwMA_071f1bb8-616e-45b9-b903-8c499adf8fc6">2,856</ix:nonFraction></span></td></tr></table></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="idf53427e493e4e55a939328bd38020c4" continuedAt="iefc868c1967e42c09508ca3f68a940be"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future Policy Benefits</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:LiabilityForFuturePolicyBenefitActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90ZXh0cmVnaW9uOjM3NzkzMGQ5MjBlYTRiOGE5ZTdjZDA4ODM0MzhhNjNhXzEwNDQ1MzYwNDc5MjAx_af2a0b98-bd59-4665-9118-e6bf67416808" continuedAt="i917fc9ab9dad460d96a16cc95f4eeb30" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the components of the change in the liability for future policy benefits, which is included in other insurance liabilities and other long-term insurance liabilities on the consolidated balance sheets, during the years ended December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Large Case<br/>Pensions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term<br/>Care</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected net premiums </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of period - current discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzMtMy0xLTEtMjcyNDIy_0f22826f-84e6-4aee-a27b-54508c800a15">389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzQtMy0xLTEtMjcyNDIy_caf7fd55-2b81-46ca-8953-267ac77af45f">323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="-6" sign="-" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzUtMy0xLTEtMjcyNDIy_69c74234-b670-4b51-8ee0-28d4594a4edd">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzYtMy0xLTEtMjcyNDIy_84c387cd-b6f8-4e8b-8c9c-71a49a28783d">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzctMy0xLTEtMjcyNDIy_11d5ba5a-95be-46ee-b422-812465da20cf">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i614d4d469d8542ec8ffd5f8bf31e0bef_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzktMy0xLTEtMjcyNDIy_871cd501-0edf-4a55-9fb4-a35c5355f129">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums (actual)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i614d4d469d8542ec8ffd5f8bf31e0bef_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzEwLTMtMS0xLTI3MjQyMg_778510dc-1671-4145-b7d1-55ef4652f999">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzEyLTMtMS0xLTI3MjQyMg_f745d035-6947-490a-85f9-714ed20418b7">302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231" decimals="-6" sign="-" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzEzLTMtMS0xLTI3MjQyMg_67c2a4b4-fde0-439f-9c11-83356240a007">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of period - current discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzE0LTMtMS0xLTI3MjQyMg_e86e1941-e5c6-49ce-984e-5bff620585ee">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected future policy benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of period - current discount rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzE3LTEtMS0xLTI3MjQyMg_9aa472e7-6b21-4d7c-a3de-d59d31927c40">3,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzE3LTMtMS0xLTI3MjQyMg_37094bf3-43b0-45e2-883b-2d8ee12ecb02">1,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzE4LTEtMS0xLTI3MjQyMg_2c653a8b-09c2-4fdb-aa62-63cb4a914e6b">2,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzE4LTMtMS0xLTI3MjQyMg_526fbd6f-b93a-408c-9983-6c125b934782">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzE5LTEtMS0xLTI3MjQyMg_ac7bc56f-34d0-422c-a572-44d87555cdfa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzE5LTMtMS0xLTI3MjQyMg_0922297d-8a99-4f63-95d7-b7e96fecab5c">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231" decimals="-6" sign="-" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzIwLTEtMS0xLTI3MjQyMg_c3070f12-3c7b-4eec-b3a8-36dfe93919f1">44</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzIwLTMtMS0xLTI3MjQyMg_fac2e2fa-ff49-4950-9fcb-592d567947bd">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzIxLTEtMS0xLTI3MjQyMg_bd6a01ad-06b5-4d2d-af25-5ec4c6f85dd4">2,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzIxLTMtMS0xLTI3MjQyMg_b2b23d7f-e68e-4adf-b1af-f6e90efbfc55">1,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba6736243aa54f7294406b62ff339374_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzIyLTEtMS0xLTI3MjQyMg_fcdb5bcd-474f-49d0-af45-819d4d2cf413">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i614d4d469d8542ec8ffd5f8bf31e0bef_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzIyLTMtMS0xLTI3MjQyMg_3dfb76a1-bc7a-4caa-b3c7-80718b3e5757">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba6736243aa54f7294406b62ff339374_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzIzLTEtMS0xLTI3MjQyMg_9cab7718-25f6-4a5f-827c-7020fba7efa4">106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i614d4d469d8542ec8ffd5f8bf31e0bef_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzIzLTMtMS0xLTI3MjQyMg_b3e449a4-4623-462b-bd0d-5a810a1eaef5">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments (actual)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba6736243aa54f7294406b62ff339374_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzI0LTEtMS0xLTI3MjQyMg_3b36508d-2e0b-4629-b2fe-2514b359a60e">291</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i614d4d469d8542ec8ffd5f8bf31e0bef_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzI0LTMtMS0xLTI3MjQyMg_fad3793a-2fe2-4ee6-9725-7a7b816363e4">64</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i473c68aa9e4c42a8a8d365737c72ba29_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzI3LTEtMS0xLTI3MjQyMg_c8accf3e-4beb-4e86-8de5-039a9eaacf77">2,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzI3LTMtMS0xLTI3MjQyMg_1b4f1d0b-6bf5-49cb-96c2-3ea75be4bee3">1,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i473c68aa9e4c42a8a8d365737c72ba29_I20221231" decimals="-6" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzI4LTEtMS0xLTI3MjQyMg_5af67540-869a-460f-af63-fba55268431d">173</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231" decimals="-6" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzI4LTMtMS0xLTI3MjQyMg_15b905ed-d3f2-451d-9487-14fc6151d950">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of period - current discount rate</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i473c68aa9e4c42a8a8d365737c72ba29_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzI5LTEtMS0xLTI3MjQyMg_5736248f-df40-4188-be7c-df018ff161d5">2,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzI5LTMtMS0xLTI3MjQyMg_1a19431c-2ee8-4a5a-b3bc-184973a7b6d1">1,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i473c68aa9e4c42a8a8d365737c72ba29_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzMxLTEtMS0xLTI3MjQyMg_1e5707a5-8c9a-4797-b583-c2d7d2a01708">2,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzMxLTMtMS0xLTI3MjQyMg_9e8c3049-d06b-453f-8102-29a46fd4c2f0">1,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i473c68aa9e4c42a8a8d365737c72ba29_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzMyLTEtMS0xLTI3MjQyMg_9a2b0ca3-5977-45a2-ad24-a5d7f580c437">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzMyLTMtMS0xLTI3MjQyMg_ac69d4d2-629c-431f-91ef-75f1b93a0146">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits, net of reinsurance recoverable</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i473c68aa9e4c42a8a8d365737c72ba29_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzMzLTEtMS0xLTI3MjQyMg_e4a28838-64e0-4de5-b081-e8cc9a07a318">2,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzMzLTMtMS0xLTI3MjQyMg_82866a87-fca2-41cc-b631-d14c88ca3336">1,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The present value of expected net premiums is equivalent to the present value of expected gross premiums for the long-term care insurance contracts as net premiums are set equal to gross premiums.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iefc868c1967e42c09508ca3f68a940be" continuedAt="ifc466bd1ffa84fa78955ed9b1cafe773"><ix:continuation id="i917fc9ab9dad460d96a16cc95f4eeb30" continuedAt="i31cfdf7d0e0d416da80152cf88360f9c"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Large Case<br/>Pensions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term<br/>Care</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected net premiums </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of period - current discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644e02c89965481d980470106777aa5c_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzMtMy0xLTEtMjcyNDIy_2b83daf8-6f3c-445c-9778-c2afedfa370d">417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644e02c89965481d980470106777aa5c_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzQtMy0xLTEtMjcyNDIy_91699316-7adf-4d3a-858c-c163799f1693">330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644e02c89965481d980470106777aa5c_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzUtMy0xLTEtMjcyNDIy_d7324041-890f-47b3-9801-52210ceed797">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644e02c89965481d980470106777aa5c_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzYtMy0xLTEtMjcyNDIy_54e69198-3cec-4f1b-9afa-92db7fbd1cc8">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644e02c89965481d980470106777aa5c_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzctMy0xLTEtMjcyNDIy_07defbe4-2188-4854-baa1-a6bfa9915774">347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i516e66d0f707473d919c7b8251b39ca7_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzktMy0xLTEtMjcyNDIy_8383acb6-e438-4a40-bf2f-887aa5cf7c2b">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums (actual)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i516e66d0f707473d919c7b8251b39ca7_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzEwLTMtMS0xLTI3MjQyMg_56d9362d-38a3-4df3-bb69-18817660351c">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzEyLTMtMS0xLTI3MjQyMg_38cccfe2-fe7e-42a8-85cc-2781df378fb3">323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="-6" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzEzLTMtMS0xLTI3MjQyMg_d0e7628c-63ad-4f5f-8528-1a387296efc5">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of period - current discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzE0LTMtMS0xLTI3MjQyMg_e7c8ddcc-6600-4e18-91eb-7d24be723c89">389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected future policy benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of period - current discount rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1263a7bd13e6441c90af49d5dde6fbc0_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzE3LTEtMS0xLTI3MjQyMg_98bc37ff-f309-4bc4-93a3-26c94e43e911">3,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644e02c89965481d980470106777aa5c_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzE3LTMtMS0xLTI3MjQyMg_2a85beee-50a6-4865-9407-73747a5278e9">2,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1263a7bd13e6441c90af49d5dde6fbc0_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzE4LTEtMS0xLTI3MjQyMg_934d1174-ae3e-4f92-b511-011d9cb90ab9">2,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644e02c89965481d980470106777aa5c_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzE4LTMtMS0xLTI3MjQyMg_cf515781-b882-4698-abca-8ee03ffb0314">1,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1263a7bd13e6441c90af49d5dde6fbc0_I20201231" decimals="-6" sign="-" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzE5LTEtMS0xLTI3MjQyMg_95b57691-6a6e-438c-a764-9ea202531fe5">96</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644e02c89965481d980470106777aa5c_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzE5LTMtMS0xLTI3MjQyMg_bbb90261-08ac-4782-8115-7ceea55dfa5e">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1263a7bd13e6441c90af49d5dde6fbc0_I20201231" decimals="-6" sign="-" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzIwLTEtMS0xLTI3MjQyMg_2b05b309-4b13-46cb-a6f3-71cc5c731a7e">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644e02c89965481d980470106777aa5c_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzIwLTMtMS0xLTI3MjQyMg_4ab6c358-94cd-4b02-b778-55fba6d26f10">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1263a7bd13e6441c90af49d5dde6fbc0_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzIxLTEtMS0xLTI3MjQyMg_e1f927c3-488a-4b77-8d39-e6a4612a788a">2,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644e02c89965481d980470106777aa5c_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzIxLTMtMS0xLTI3MjQyMg_387cac9e-b32c-4e70-9316-c5242db48d82">1,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d569b44a37d470fadb0d1f07580eca6_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzIyLTEtMS0xLTI3MjQyMg_7e3917a6-8f66-40b1-8532-4747739ef350">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i516e66d0f707473d919c7b8251b39ca7_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzIyLTMtMS0xLTI3MjQyMg_06dac49e-ba9a-44f1-b8b9-df2903dc74e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d569b44a37d470fadb0d1f07580eca6_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzIzLTEtMS0xLTI3MjQyMg_31127889-081e-4bcf-aef7-c27091587df3">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i516e66d0f707473d919c7b8251b39ca7_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzIzLTMtMS0xLTI3MjQyMg_d411c45d-65f9-4535-8eb6-dad309db3d43">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments (actual)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d569b44a37d470fadb0d1f07580eca6_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzI0LTEtMS0xLTI3MjQyMg_4d46f0a7-66c6-4cc1-8bc3-b4404644c5fc">313</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i516e66d0f707473d919c7b8251b39ca7_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzI0LTMtMS0xLTI3MjQyMg_8d8697e5-f1f6-420e-8afe-3ba2b6f25a39">62</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzI3LTEtMS0xLTI3MjQyMg_acc0c7b6-d30b-425f-966c-1f972b67d84b">2,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzI3LTMtMS0xLTI3MjQyMg_de75d333-173f-40c5-85fe-8d9e5063e841">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231" decimals="-6" sign="-" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzI4LTEtMS0xLTI3MjQyMg_9ad376ac-d5c6-42a9-bf74-701a336b7c4c">384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="-6" sign="-" name="us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzI4LTMtMS0xLTI3MjQyMg_11f9bf2f-6d4c-4e23-883e-10543589d3cb">511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of period - current discount rate</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzI5LTEtMS0xLTI3MjQyMg_c50a3968-a917-4c6b-93fc-f55e118a30cf">3,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzI5LTMtMS0xLTI3MjQyMg_e720956f-ef2a-478b-81a2-be8632af954a">1,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzMxLTEtMS0xLTI3MjQyMg_94026e66-171a-476a-a800-f1e8626414f0">3,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzMxLTMtMS0xLTI3MjQyMg_dc298f35-4cdb-4e73-b97a-24ff7125038a">1,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzMyLTEtMS0xLTI3MjQyMg_d30877c7-1b84-4266-965d-9569047835b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzMyLTMtMS0xLTI3MjQyMg_6a61b687-7fb0-481d-8adc-f82e11c06799">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits, net of reinsurance recoverable</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzMzLTEtMS0xLTI3MjQyMg_9dfec91e-b09a-48f0-9ebc-af12977505d2">3,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzMzLTMtMS0xLTI3MjQyMg_0576f7bf-db01-4966-9fea-126676ef63eb">1,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The present value of expected net premiums is equivalent to the present value of expected gross premiums for the long-term care insurance contracts as net premiums are set equal to gross premiums.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-top:5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="ifc466bd1ffa84fa78955ed9b1cafe773" continuedAt="i9f5b473a0fed40e7b9a510ad7cc5d616"><ix:continuation id="i31cfdf7d0e0d416da80152cf88360f9c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of undiscounted expected gross premiums and expected future benefit payments for long-duration insurance liabilities as of December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Large case pensions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected future benefit payments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i473c68aa9e4c42a8a8d365737c72ba29_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo1M2ZlODhiOTUxYjc0MzkyOTFkZmQ0NzQ3OGI1YzQzNS90YWJsZXJhbmdlOjUzZmU4OGI5NTFiNzQzOTI5MWRmZDQ3NDc4YjVjNDM1XzItMS0xLTEtMjcyNDIy_d08e5f7c-4717-4dcd-bb37-02da33e96d0f">3,539</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo1M2ZlODhiOTUxYjc0MzkyOTFkZmQ0NzQ3OGI1YzQzNS90YWJsZXJhbmdlOjUzZmU4OGI5NTFiNzQzOTI5MWRmZDQ3NDc4YjVjNDM1XzItMy0xLTEtMjcyNDIy_7debdc9a-b47a-4aaf-ade6-46bf5ab77761">3,882</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected gross premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i473c68aa9e4c42a8a8d365737c72ba29_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo1M2ZlODhiOTUxYjc0MzkyOTFkZmQ0NzQ3OGI1YzQzNS90YWJsZXJhbmdlOjUzZmU4OGI5NTFiNzQzOTI5MWRmZDQ3NDc4YjVjNDM1XzMtMS0xLTEtMjcyNDIy_f2833f0b-f433-4892-9199-e1dea06b30df">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo1M2ZlODhiOTUxYjc0MzkyOTFkZmQ0NzQ3OGI1YzQzNS90YWJsZXJhbmdlOjUzZmU4OGI5NTFiNzQzOTI5MWRmZDQ3NDc4YjVjNDM1XzMtMy0xLTEtMjcyNDIy_f75b13b9-6d26-4922-b435-af0d16a656ed">&#8212;</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected future benefit payments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo1M2ZlODhiOTUxYjc0MzkyOTFkZmQ0NzQ3OGI1YzQzNS90YWJsZXJhbmdlOjUzZmU4OGI5NTFiNzQzOTI5MWRmZDQ3NDc4YjVjNDM1XzYtMS0xLTEtMjcyNDIy_938d8f28-eb8b-4e02-8cda-25f83775eaea">3,265</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo1M2ZlODhiOTUxYjc0MzkyOTFkZmQ0NzQ3OGI1YzQzNS90YWJsZXJhbmdlOjUzZmU4OGI5NTFiNzQzOTI5MWRmZDQ3NDc4YjVjNDM1XzYtMy0xLTEtMjcyNDIy_941eecb5-d98a-4e40-b444-6868774da0f0">3,115</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected gross premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo1M2ZlODhiOTUxYjc0MzkyOTFkZmQ0NzQ3OGI1YzQzNS90YWJsZXJhbmdlOjUzZmU4OGI5NTFiNzQzOTI5MWRmZDQ3NDc4YjVjNDM1XzctMS0xLTEtMjcyNDIy_0c1b5789-4eb6-406d-9b3c-c347b06b1154">437</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo1M2ZlODhiOTUxYjc0MzkyOTFkZmQ0NzQ3OGI1YzQzNS90YWJsZXJhbmdlOjUzZmU4OGI5NTFiNzQzOTI5MWRmZDQ3NDc4YjVjNDM1XzctMy0xLTEtMjcyNDIy_f89aa19d-a86c-445c-af85-73cf6ccb2cd0">478</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average interest rate used in the measurement of the long-duration insurance liabilities as of December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Large case pensions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accretion rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i473c68aa9e4c42a8a8d365737c72ba29_I20221231" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2Y4NmEzNDRkNDE0OWEyYjM3NmEyNzcxZjljNGU4YS90YWJsZXJhbmdlOmRjZjg2YTM0NGQ0MTQ5YTJiMzc2YTI3NzFmOWM0ZThhXzItMS0xLTEtMjcyNDIy_f195a017-0c0f-48dd-bfea-272eedfac4fe">4.20</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2Y4NmEzNDRkNDE0OWEyYjM3NmEyNzcxZjljNGU4YS90YWJsZXJhbmdlOmRjZjg2YTM0NGQ0MTQ5YTJiMzc2YTI3NzFmOWM0ZThhXzItMy0xLTEtMjcyNDIy_80d5b0da-e4c6-449e-992b-1d5a8d36e0db">4.20</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i473c68aa9e4c42a8a8d365737c72ba29_I20221231" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2Y4NmEzNDRkNDE0OWEyYjM3NmEyNzcxZjljNGU4YS90YWJsZXJhbmdlOmRjZjg2YTM0NGQ0MTQ5YTJiMzc2YTI3NzFmOWM0ZThhXzMtMS0xLTEtMjcyNDIy_601c80c2-a0fd-4994-bd5e-81d64f923082">5.24</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2Y4NmEzNDRkNDE0OWEyYjM3NmEyNzcxZjljNGU4YS90YWJsZXJhbmdlOmRjZjg2YTM0NGQ0MTQ5YTJiMzc2YTI3NzFmOWM0ZThhXzMtMy0xLTEtMjcyNDIy_43ba5482-b553-47bb-9394-7d8e3169c0e5">2.53</ix:nonFraction>%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accretion rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2Y4NmEzNDRkNDE0OWEyYjM3NmEyNzcxZjljNGU4YS90YWJsZXJhbmdlOmRjZjg2YTM0NGQ0MTQ5YTJiMzc2YTI3NzFmOWM0ZThhXzYtMS0xLTEtMjcyNDIy_b97eb4db-e4be-4e28-b235-49540955a21c">5.11</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2Y4NmEzNDRkNDE0OWEyYjM3NmEyNzcxZjljNGU4YS90YWJsZXJhbmdlOmRjZjg2YTM0NGQ0MTQ5YTJiMzc2YTI3NzFmOWM0ZThhXzYtMy0xLTEtMjcyNDIy_d53e2d9e-942c-4e41-8843-c153e80dfb9d">5.11</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2Y4NmEzNDRkNDE0OWEyYjM3NmEyNzcxZjljNGU4YS90YWJsZXJhbmdlOmRjZjg2YTM0NGQ0MTQ5YTJiMzc2YTI3NzFmOWM0ZThhXzctMS0xLTEtMjcyNDIy_effa0957-0fdc-4548-9b6e-bc3375c4b50e">5.39</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" decimals="4" name="us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2Y4NmEzNDRkNDE0OWEyYjM3NmEyNzcxZjljNGU4YS90YWJsZXJhbmdlOmRjZjg2YTM0NGQ0MTQ5YTJiMzc2YTI3NzFmOWM0ZThhXzctMy0xLTEtMjcyNDIy_dc863e6c-feb4-408e-a7a0-43953ec18b00">2.88</ix:nonFraction>%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average durations (in years) of the long-duration insurance liabilities as of December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large case pensions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i473c68aa9e4c42a8a8d365737c72ba29_I20221231" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTozZmFlNzQzMTc1N2E0OTFiOGJhM2MyN2FlZTA0MmZiMC90YWJsZXJhbmdlOjNmYWU3NDMxNzU3YTQ5MWI4YmEzYzI3YWVlMDQyZmIwXzEtMS0xLTEtMjcyNDIy_b0e0bfc1-94ad-4a42-a810-077009a842f2">7.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTozZmFlNzQzMTc1N2E0OTFiOGJhM2MyN2FlZTA0MmZiMC90YWJsZXJhbmdlOjNmYWU3NDMxNzU3YTQ5MWI4YmEzYzI3YWVlMDQyZmIwXzEtMy0xLTEtMjcyNDIy_9e0db425-74cc-4b1b-8eb3-a5401025d9bb">7.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term care</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTozZmFlNzQzMTc1N2E0OTFiOGJhM2MyN2FlZTA0MmZiMC90YWJsZXJhbmdlOjNmYWU3NDMxNzU3YTQ5MWI4YmEzYzI3YWVlMDQyZmIwXzItMS0xLTEtMjcyNDIy_9f6bba8c-fcb1-4841-9a86-6e8cb18f4427">12.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231" name="us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTozZmFlNzQzMTc1N2E0OTFiOGJhM2MyN2FlZTA0MmZiMC90YWJsZXJhbmdlOjNmYWU3NDMxNzU3YTQ5MWI4YmEzYzI3YWVlMDQyZmIwXzItMy0xLTEtMjcyNDIy_6bad26b1-2813-4011-98a7-5cd9254fe4a7">13.5</ix:nonNumeric></span></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any material differences between the actual experience and expected experience for the significant assumptions used in the computation of the liability for future policy benefits.</span></div></ix:continuation><div style="margin-top:5pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i9f5b473a0fed40e7b9a510ad7cc5d616" continuedAt="ie69ae0ebbf46425abcfa6ad29eaad0f0"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policyholders&#8217; Funds</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:PolicyholderAccountBalanceTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90ZXh0cmVnaW9uOjM3NzkzMGQ5MjBlYTRiOGE5ZTdjZDA4ODM0MzhhNjNhXzEwNDQ1MzYwNDc5MjA0_6b459c12-5f44-488f-8d39-158e807791f0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in policyholders&#8217; funds related to long-duration insurance contracts, which are included in policyholders&#8217; funds and other long-term liabilities on the consolidated balance sheets, during the years ended December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except weighted average crediting rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:PolicyholderFunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzItMS0xLTEtMjcyNDIy_faa663bb-f11b-4e3a-9dff-ad8271132ab4">522</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501f291fb23d49e987222cf13c851afc_I20201231" decimals="-6" name="us-gaap:PolicyholderFunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzItMy0xLTEtMjcyNDIy_e68127ba-31a7-4694-ad0b-613f071cef4a">568</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits received</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:PolicyholderAccountBalanceDepositsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzQtMS0xLTEtMjcyNDIy_fbf513e2-dece-4e72-b4fd-3c2c1cab74ac">13</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:PolicyholderAccountBalanceDepositsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzQtMy0xLTEtMjcyNDIy_0093e463-7669-4145-a08c-54a01cd14426">20</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policy charges</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:PolicyholderAccountBalancePolicyCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzUtMS0xLTEtMjcyNDIy_2959c897-25e1-42a1-89a9-a4927dd5fb6e">2</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:PolicyholderAccountBalancePolicyCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzUtMy0xLTEtMjcyNDIy_c9c004d8-99c8-4bdc-aa45-077c93cd1420">2</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surrenders and withdrawals</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:PolicyholderAccountBalanceSurrenderAndWithdrawal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzYtMS0xLTEtMjcyNDIy_9283ef9d-537b-4cbe-be5f-1c0ffecaaae6">31</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:PolicyholderAccountBalanceSurrenderAndWithdrawal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzYtMy0xLTEtMjcyNDIy_6071c358-7245-4402-8bda-c7ac4d8e00ae">21</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest credited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:InterestCreditedToPolicyholdersAccountBalances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzktMS0xLTEtMjcyNDIy_8b9932cb-4115-415d-99b8-16b00e7b85ab">11</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:InterestCreditedToPolicyholdersAccountBalances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzktMy0xLTEtMjcyNDIy_3ad01010-9612-4edf-83c2-afc063c47023">12</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in net unrealized gains (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="cvs:PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzEwLTEtMS0xLTI3MjQyMg_356feda8-305d-4c70-a34a-b2ba0e1e7283">148</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="cvs:PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzEwLTMtMS0xLTI3MjQyMg_c24b58f1-dd38-4dec-8614-316d1cb3110f">42</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzExLTEtMS0xLTI3MjQyMg_e0a095c5-7a56-489d-ad0d-121876cffa70">20</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzExLTMtMS0xLTI3MjQyMg_e0848a0c-c084-4ddf-bf3a-7166c15bbba4">13</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds, end of the period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:PolicyholderFunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzEyLTEtMS0xLTI3MjQyMg_3ed236fa-e5b2-45e4-be89-def9171e011b">345</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:PolicyholderFunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzEyLTMtMS0xLTI3MjQyMg_70e0b8f2-e81f-4b28-b839-49c0f4d19042">522</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average crediting rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="4" name="us-gaap:PolicyholderAccountBalanceWeightedAverageCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzEzLTEtMS0xLTI3MjQyMg_e966590e-fa0a-4b8b-a478-d27f4017c039">4.72</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="4" name="us-gaap:PolicyholderAccountBalanceWeightedAverageCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzEzLTMtMS0xLTI3MjQyMg_17f82ed9-1e7b-425a-98aa-0f222464fc46">4.81</ix:nonFraction>%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount at risk</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:PolicyholderAccountBalanceNetAmountAtRisk" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzE1LTEtMS0xLTI3MjQyMg_3fb9a5ca-3989-4f6e-b1f6-c50dad4e3f12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:PolicyholderAccountBalanceNetAmountAtRisk" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzE1LTMtMS0xLTI3MjQyMg_f041a4d0-3cb2-4f8a-a821-cc96aacc1d84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:CashSurrenderValueDuePolicyholdersAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzE3LTEtMS0xLTI3MjQyMg_c2fbd735-156c-413a-9c6e-e90bededa80d">339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:CashSurrenderValueDuePolicyholdersAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzE3LTMtMS0xLTI3MjQyMg_70ea13b3-5d57-40aa-81ec-7da23ec71bc8">346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts</span></div><div><span><br/></span></div><ix:continuation id="id20a644f5d024f59a435567ac7d1c10f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the fair value of assets, by major investment category, supporting Separate Accounts as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i412d46651ee84600b71fc148cc986f29_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzItMS0xLTEtMjkyMjMw_c6e04a4e-63a2-4ee7-a654-3b28eab3ec41">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ce672bf30504e35921812d7a7fa7934_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzItMy0xLTEtMjkyMjM5_f87839c9-5b4c-4f64-b159-0a220545c7ec">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36b9491833204d099e03fcc01e203119_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzQtMS0xLTEtMjkyMjMw_5bef150f-e3e0-486c-8b8b-8e299d549af6">717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b4626daa8754d42a34f1edb762746ec_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzQtMy0xLTEtMjkyMjQ1_cae4a7e4-4932-4852-8a15-e9e8f272b2e8">1,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac6af1bd4cc4ca791c3b7491cdfee7d_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzUtMS0xLTEtMjkyMjMw_3d911065-7b1d-489d-be41-56761f4cb065">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib04e1d5c5dc2451c8c17187d5ff131f1_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzUtMy0xLTEtMjkyMjQ1_80873ff8-4c97-4372-b100-0494e58729f8">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d1de373967241e5bf5de600e7c144af_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzYtMS0xLTEtMjkyMjMw_1c7da625-707b-4f61-8406-63d7e268e66c">1,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6a5bdf13f3348caaae04f36dfdf1529_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzYtMy0xLTEtMjkyMjUz_eb14b41f-e1b8-48ad-bd65-9ec14d0d3d0a">2,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1c08c444f6d46058bc3a4972bc57366_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzktMS0xLTEtMjkyMjMw_91e04cdd-a176-4306-ae47-cd166e6234ed">201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i180b8e344c4c441c95dcb1988928fc19_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzktMy0xLTEtMjkyMjYx_0ca6e4e9-eb09-425e-b798-09db1c139456">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5496f38c2d14219bdf381b856591253_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzEwLTEtMS0xLTI5MjIzMA_dba24714-72ec-44be-9b7f-a3a12c5248b1">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifadd8aac47504af7be902e13455b168c_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzEwLTMtMS0xLTI5MjI2Nw_c5d52a01-0171-4995-9ad3-50817e1261db">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f100f6542cb4642be65ec9453938f5a_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzExLTEtMS0xLTI5MjIzMA_7cc44a1d-689e-4451-ba6d-ba15fcb4d0b7">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65d11629522144ccaf2eec93210bb7ba_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzExLTMtMS0xLTI5MjI3Mw_a3072114-5461-448f-b7ae-b619b9c5ee40">57</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3030957b790447e48affd8a2d4705582_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzEyLTEtMS0xLTI5MjIzMA_9d5fb77a-3d6d-42f2-b3cf-8cf3639cdd1b">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7cd37bb88ab41ed9c765b58f78429c4_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzEyLTMtMS0xLTI5MjI3OQ_1019e84a-0b4d-40c2-ab51-d62a33b0848b">134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadbe70c5f2f243658fd3bcc5dd8c2d3d_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzEzLTEtMS0xLTI5MjIzMA_24ca22b5-720f-4117-939e-5a668c384c6b">2,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba813c84c6544fb990007eb39d2d1988_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzEzLTMtMS0xLTI5MjMxNQ_3bef1985-ac63-4520-ab0e-94939d102888">4,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities and common/collective trusts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i565057424b24407abbffae1c71ea0c08_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzE1LTEtMS0xLTI5MjIzMA_e8a46063-e526-4c34-861b-d710f7e63a7c">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fed7c25098a4dd3957760b3fa0df1c4_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzE1LTMtMS0xLTI5MjI4NQ_22e2e9d0-ae26-423a-b558-57ba6701d660">548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbd43a9242a0495591196ce21cc7a152_I20221231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzE3LTEtMS0xLTI5MjIzMA_152b64dc-08cf-4329-b474-3bfbf0c7afb7">3,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e14cbf58db473094f1a3a50e0e0423_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzE3LTMtMS0xLTI5MjMyOQ_1e56f097-4f01-46d6-8ed5-163b2fbc1bb8">5,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $<ix:nonFraction unitRef="usd" contextRef="i2cfae73c894b48b3adc8ba56219aaf76_I20221231" decimals="-6" name="us-gaap:SeparateAccountsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90ZXh0cmVnaW9uOjM3NzkzMGQ5MjBlYTRiOGE5ZTdjZDA4ODM0MzhhNjNhXzEwOTk1MTE2Mzc0OTA_86744857-0167-4543-9e9f-7fa4b874ec3b">85</ix:nonFraction> million of other payables and $<ix:nonFraction unitRef="usd" contextRef="i5f60137c965c405995e63ea19fbaacc4_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90ZXh0cmVnaW9uOjM3NzkzMGQ5MjBlYTRiOGE5ZTdjZDA4ODM0MzhhNjNhXzEwOTk1MTE2Mzc1MTY_fc4559c1-f801-4eca-81b0-d6405308c871">70</ix:nonFraction>&#160;million of other receivables at December&#160;31, 2022 and 2021, respectively.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie69ae0ebbf46425abcfa6ad29eaad0f0" continuedAt="i94360bc3d02d4874b1cb86d97e74256c"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:SeparateAccountLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90ZXh0cmVnaW9uOjM3NzkzMGQ5MjBlYTRiOGE5ZTdjZDA4ODM0MzhhNjNhXzEwNDQ1MzYwNDc5MjA2_d1ea7777-a090-4533-877d-6a3b55a2d8dc" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in Separate Accounts liabilities during the years ended December&#160;31, 2022 and 2021: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate Accounts liability, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:SeparateAccountsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzMtMS0xLTEtMjcyNDIy_b93dea82-dc9b-49e1-b16a-9868ffdd008b">5,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501f291fb23d49e987222cf13c851afc_I20201231" decimals="-6" name="us-gaap:SeparateAccountsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzMtMy0xLTEtMjcyNDIy_f5a3666f-9455-4db8-af54-518302d6deac">4,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums and deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:SeparateAccountLiabilityPremiumAndDeposit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzQtMS0xLTEtMjcyNDIy_e6b29af8-0c9f-444e-9a22-1b8f3c5b0455">853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:SeparateAccountLiabilityPremiumAndDeposit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzQtMy0xLTEtMjcyNDIy_2572c176-1e67-4594-b7f2-afa730773fb0">1,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surrenders and withdrawals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:SeparateAccountLiabilitySurrenderAndWithdrawal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzYtMS0xLTEtMjcyNDIy_02243099-3b4f-40af-b1af-cc3de3d9c960">581</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:SeparateAccountLiabilitySurrenderAndWithdrawal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzYtMy0xLTEtMjcyNDIy_8e7d783f-ac9b-43e2-aa03-079b6947258f">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:SeparateAccountLiabilityBenefitPayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzctMS0xLTEtMjcyNDIy_6b9d15d8-b278-4b02-b320-9161e65c2ed4">947</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:SeparateAccountLiabilityBenefitPayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzctMy0xLTEtMjcyNDIy_46230d8b-f346-43c3-b6e0-fd9bcd1c01ec">984</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzgtMS0xLTEtMjcyNDIy_e5c908a5-0485-428b-9287-19fe8f2a9d4b">1,130</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzgtMy0xLTEtMjcyNDIy_b1913963-cfdd-4048-9185-c96f2b2d8f9c">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers from general account</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:TransferToFromPolicyholderAccountBalanceToFromSeparateAccount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzktMS0xLTEtMjcyNDIy_4e582f0c-f303-44c5-8714-38aeefffca87">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:TransferToFromPolicyholderAccountBalanceToFromSeparateAccount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzktMy0xLTEtMjcyNDIy_199253e9-bd77-4f95-890e-cb5bc6ef1aca">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromOtherChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzEwLTEtMS0xLTI3MjQyMg_b3319684-7660-48a6-9a96-60306b0e7481">63</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromOtherChange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzEwLTMtMS0xLTI3MjQyMg_99699ebf-472d-4471-b7cc-98515a10665e">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate Accounts liability, end of the period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:SeparateAccountsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzExLTEtMS0xLTI3MjQyMg_0c0de8ce-b3e3-4ba2-ace3-1f764dd9f14a">3,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:SeparateAccountsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzExLTMtMS0xLTI3MjQyMg_dfead961-6507-4a15-ac5f-750515894f45">5,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value, end of the period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:SeparateAccountLiabilityCashSurrenderValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzEzLTEtMS0xLTI3MjQyMg_c73374b3-0f62-445c-9547-cd689be73269">2,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:SeparateAccountLiabilityCashSurrenderValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzEzLTMtMS0xLTI3MjQyMg_fafdd813-2c68-4268-b71e-27d797e717bf">3,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i94360bc3d02d4874b1cb86d97e74256c">The Company did not recognize any gains or losses on assets transferred to Separate Accounts during the years ended December&#160;31, 2022 and 2021.</ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_145"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzY3NTk_5cad6010-9b53-4b8e-8f0a-6bf740482a59" continuedAt="i2ae9e0f2a9984c65899b9043d0994c20" escape="true">Borrowings and Credit Agreements</ix:nonNumeric></span></div><ix:continuation id="i2ae9e0f2a9984c65899b9043d0994c20" continuedAt="i034b0b981a75403db5c56c6ea1bf80c3"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzY4MDE_972acc2d-106a-4921-833a-59480a4506c6" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s borrowings as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.452%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i46d398142bc14090b6efa835576c60fe_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzEyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmI3ZGI0OWQ0ZGU4ZTRjYzI5MTJhMzc1NTEyY2MxYjFiXzQ_6c391758-d492-4519-bd4e-44d34f75e130">3.5</ix:nonFraction>% senior notes due July 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46d398142bc14090b6efa835576c60fe_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzEyLTEtMS0xLTI2NTI0Nw_bbf92f4b-5bc9-44ad-af9c-aa8e33022bdf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc40fd3418e432b9e325f5ecd1b6217_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzEyLTMtMS0xLTI2NTI0Nw_627d31f5-e871-4dde-b443-757620cc232f">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3af420d8300b4f17a1fa385f41425a8c_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzEzLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjlmYWNiOWZkNmZhYzQ4ZmY4N2EzODkwZTE0MzI3ZGMxXzQ_568484ce-4844-4bcb-8096-4e3f604958bf">2.75</ix:nonFraction>% senior notes due November 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3af420d8300b4f17a1fa385f41425a8c_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzEzLTEtMS0xLTI2NTI0Nw_47d19e0e-4be4-4862-b5cd-b6a5fd303aad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12e6f7addf034c2eb5edf2df1a607732_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzEzLTMtMS0xLTI2NTI0Nw_b35410a6-c35a-48ce-ae11-698b4212ad5b">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if443d252b4df496d80927ef019eadf74_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE0LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjM0OGI4MDAzMDI4ODQ5MjU5MmQwZmY4YWY3M2I4ZGRkXzQ_75c0de00-a446-4205-a576-71304734ae45">2.75</ix:nonFraction>% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if443d252b4df496d80927ef019eadf74_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE0LTEtMS0xLTI2NTI0Nw_5b731118-8cae-4848-9304-439b17ec7800">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaabe5773025f4c2cabd69d7914e764b7_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE0LTMtMS0xLTI2NTI0Nw_dfb72fcc-1b26-4e5a-a0e3-a7696ef8df9b">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e95a5abc36e4381a98f975d83721a1c_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE1LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjVhYzAyOTI0NTlkNzRmMGU5ZGNhMWZmODkxMTBkMzEwXzQ_8c830820-1f6a-4bc9-9e1b-630685090408">4.75</ix:nonFraction>% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e95a5abc36e4381a98f975d83721a1c_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE1LTEtMS0xLTI2NTI0Nw_6cdc6b8a-9744-49b8-959f-ad9c92f17df2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic62f6a9337b643efa667a4246f23f5a3_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE1LTMtMS0xLTI2NTI0Nw_6ef58819-9f27-4b64-802f-8e62f5e7e3d9">399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0bfa33d6699f4a16a614e7bb4af6003b_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE3LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjVmNzJmOThhNTYxYzQ0NDNiNThkOTYxYzlkNjBmNjc2XzQ_f7abb898-87d4-4058-84a9-fc43a8ae3ab2">2.8</ix:nonFraction>% senior notes due June 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bfa33d6699f4a16a614e7bb4af6003b_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE3LTEtMS0xLTI2NTI0Nw_15d4bcc5-8098-467b-a293-10c859869b7f">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id32712eeb9e24f4293e053682e64d0c0_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE3LTMtMS0xLTI2NTI0Nw_0a9d5d36-7716-41d1-a8fe-b3b50fa65d31">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6556efb47077422bb88b269c462914c5_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE4LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjBjZmU1MTg3M2Q0ZDQ4ZmE4NjgyOGY3ZjhlMTVjMTRjXzQ_6e1da833-b46d-4e41-8021-bdc38fd96ceb">4</ix:nonFraction>% senior notes due December 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6556efb47077422bb88b269c462914c5_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE4LTEtMS0xLTI2NTI0Nw_fc611127-8d30-4332-b77e-25d363c2bd95">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7f8bc3f2aea4b8490a2c00543939418_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE4LTMtMS0xLTI2NTI0Nw_607f990a-251e-4bf0-897a-5e07a1fab185">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i095b5e69420d48439f08a7fd6032e39f_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE5LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmY4NmY4NWMxZGI1ZTQ2Yjg5NjYwYWQ1NDEzMjljZWI0XzQ_50e7db4d-43e6-4498-bb01-c666a48e1b85">3.375</ix:nonFraction>% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i095b5e69420d48439f08a7fd6032e39f_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE5LTEtMS0xLTI2NTI0Nw_8ef6a138-1b67-4e6b-848f-8c1614cad187">650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i788e48585b7d4fb18382daa954eec2a2_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE5LTMtMS0xLTI2NTI0Nw_c55fe9d0-3df9-425f-8b81-f295701b40ea">650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i412829e3534d4fc095e6237114df2eaf_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIwLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjdmZDZlMWUwZWIwZTQxOTA4ODE2NmQwMjhmMzQ3MDUxXzQ_529792ac-31bf-4797-a34e-f44039aa27e7">2.625</ix:nonFraction>% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i412829e3534d4fc095e6237114df2eaf_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIwLTEtMS0xLTI2NTI0Nw_8292e42c-f60c-4a6f-8eb6-2c989589b7f5">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dd41a67d29a43c5ada1608f1dbdcca9_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIwLTMtMS0xLTI2NTI0Nw_48ef9845-7aab-42aa-9900-161d0372096d">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iee8c1ff2a84748f8b1e708329c8b5afa_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmUwN2NiOWQ1YTUyYjQzZTNiY2UzMjE2NmJiZmUwNzhhXzQ_a4843f53-98b7-4299-b492-6764b27d7594">3.5</ix:nonFraction>% senior notes due November 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee8c1ff2a84748f8b1e708329c8b5afa_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIxLTEtMS0xLTI2NTI0Nw_c5d2d06d-10fc-41ba-9f1d-bbb2198ae37f">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79ee0b15e57241c5911bf2f116f391e5_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIxLTMtMS0xLTI2NTI0Nw_f837df1e-ba8d-428d-af98-34d7e35324e2">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2e6d6e97c2644b418692bbab3d848bbc_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmI5NDRiYjA4ZjlmNTQ5MzQ4MzkwNDllMWM0M2NiMGNiXzQ_0abe4d85-8766-4289-9a01-cc7909a4b45f">5</ix:nonFraction>% senior notes due December 2024 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e6d6e97c2644b418692bbab3d848bbc_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIyLTEtMS0xLTI2NTI0Nw_e38c46c1-fca9-40ee-b16a-03d45de49883">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb22ad240ec40d99c5b5c11c4fe3c23_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIyLTMtMS0xLTI2NTI0Nw_30318247-77da-4d69-8bd5-cdcb810994c0">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4ba50b36e4af4b1aac05a10e19f622f0_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIzLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjUyZTEwNzlhMDU4ZDRkN2E4MWM1ODA5YWRkNTZhZmIxXzQ_7d3763e9-db63-486c-aef3-4e9a22f3fee4">4.1</ix:nonFraction>% senior notes due March 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ba50b36e4af4b1aac05a10e19f622f0_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIzLTEtMS0xLTI2NTI0Nw_659790f2-bd33-46ce-82a3-9ae1d22b9088">950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i533be9b87ab747d18146404b355d4dc7_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIzLTMtMS0xLTI2NTI0Nw_0e2e43f6-3f24-4c35-94f8-b4142dc3d57a">950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2a9a8b0623524068af6014036c34e60f_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI0LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmE5ZTE5ODE4YTU1ODQ3NDc4YWRkZjljODIzNmUxZTA5XzQ_0147a3c8-9068-465a-9eab-e002473988c6">3.875</ix:nonFraction>% senior notes due July 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a9a8b0623524068af6014036c34e60f_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI0LTEtMS0xLTI2NTI0Nw_f680982e-187b-4273-8a36-c01cf514c2e3">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b4b00758ca84efebf14e070000ab9e3_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI0LTMtMS0xLTI2NTI0Nw_142245c1-40e0-45cb-ae8b-d4b4126cec3c">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie19828a34e7c48c894138597b0f024aa_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI1LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmQxN2Q1MGMzNGUwNzQ2OTM5NzUwMWM5ZTFhNDM5NDEwXzQ_6332999d-1cb9-4547-bdca-ff67bd814660">2.875</ix:nonFraction>% senior notes due June 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie19828a34e7c48c894138597b0f024aa_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI1LTEtMS0xLTI2NTI0Nw_d8ac6919-443f-415d-992c-40d1cd596c3f">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i096820313ad94c9eaf41e3a34195cf2c_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI1LTMtMS0xLTI2NTI0Nw_83c1535d-fb39-4c60-a3b2-825a5d8d1ed9">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie696efac889145fabb06c27642b8faab_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI2LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjVlNGU2ODU2NjNhMTRhMmNhNTA4OGUyZmI5ZjNlOWZiXzQ_38941ffa-5c2d-45c7-8da9-7d477f3958f8">3</ix:nonFraction>% senior notes due August 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie696efac889145fabb06c27642b8faab_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI2LTEtMS0xLTI2NTI0Nw_62405f6e-16d6-405b-a2de-f18cffa4e890">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a9abfe3905e466f9226a7fba19a5d61_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI2LTMtMS0xLTI2NTI0Nw_06931980-4811-4011-8220-27febc821e51">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i75b0bb3f7a324df2b692b9a2d398518e_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI3LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjhiODY2MTcyZWM1YTQ0NmM5OTlmZjZmZTVhYjZhZjI5XzQ_4c2e0a43-53a5-4a27-861b-0b2c4743f43c">3.625</ix:nonFraction>% senior notes due April 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75b0bb3f7a324df2b692b9a2d398518e_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI3LTEtMS0xLTI2NTI0Nw_06bc36ee-4936-4a7d-b84c-d55e52d024d4">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0f1d199662c4aa1addebeb3b5240b80_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI3LTMtMS0xLTI2NTI0Nw_10cedc22-fff4-4c6e-9ef5-1d138049d2ef">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9d39dacca1a042f6b353bda666b8bda1_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI4LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjgzNzRmNzZkMTI3MDQzYTdiZDMwYWYzY2I1MzQ1ODIzXzQ_a7345b72-9457-438c-8c9b-2c458dee1cd7">6.25</ix:nonFraction>% senior notes due June 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d39dacca1a042f6b353bda666b8bda1_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI4LTEtMS0xLTI2NTI0Nw_48171cd1-9876-4861-ae6d-b14cd731ea8e">372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c95f5eb8a5e43e6b03486361d0edd35_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI4LTMtMS0xLTI2NTI0Nw_06038131-e7ee-484c-8f21-52ab4cecff34">372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0a911574fd4e42ccbf711bfad6c77ba7_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI5LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjNiOGNiYjU3MzAzMDQ5YmRiZjUwM2MyNTg2YTczYzFmXzQ_be65fab1-79fe-4fed-ab1f-3a165e720388">1.3</ix:nonFraction>% senior notes due August 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a911574fd4e42ccbf711bfad6c77ba7_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI5LTEtMS0xLTI2NTI0Nw_f3f13b37-592f-487e-afe6-1953b70c44a8">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0f77ee954bb4d2db587828489c53759_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI5LTMtMS0xLTI2NTI0Nw_32615232-e3ed-4b80-81e2-6bce5cd8da13">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0eb3702b560245409a4fb90d58b8cbee_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMwLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmZlNDk5ZmRmZjRiMzQ1MDc5YjY0M2MwZjlhNmU5NjJjXzQ_09293d41-5085-4d0b-900a-2318e914096b">4.3</ix:nonFraction>% senior notes due March 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb3702b560245409a4fb90d58b8cbee_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMwLTEtMS0xLTI2NTI0Nw_a8d975e0-cf6a-4cb5-8278-ac46a32a5dfc">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c0858694d0545f4b143004f36109ead_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMwLTMtMS0xLTI2NTI0Nw_916561df-b8cb-4dbc-a74d-9698def82a79">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5f8491428a0e48e7b0b3ef58c6387fb3_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjBiZjMxNzNhODI3NzQwM2I5MDZjODVmZGMwY2NjMmEyXzQ_ed63d818-b5b4-4f44-a619-ce9a0b608004">3.25</ix:nonFraction>% senior notes due August 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f8491428a0e48e7b0b3ef58c6387fb3_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMxLTEtMS0xLTI2NTI0Nw_f86a17ec-d67c-4cfb-ab90-2473704359ae">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1061d1cca14c27a643cc1dd4680a00_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMxLTMtMS0xLTI2NTI0Nw_786cbb7c-9d74-4f89-925d-fb6efdb329f7">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6973def3f8764f29984b67e00ced9e10_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmM1N2UyNGMxN2NmYTRkYjZhOTZiMzRkODNhY2YyYzlhXzQ_01f45c79-e434-4242-a887-78932c8231bb">3.75</ix:nonFraction>% senior notes due April 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6973def3f8764f29984b67e00ced9e10_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMyLTEtMS0xLTI2NTI0Nw_2219cc6d-d101-451d-8bd5-45e2fe2e4426">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8970f954df4441f4b7ea8363b24cff7b_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMyLTMtMS0xLTI2NTI0Nw_4bc10cf8-48de-485c-9331-9798ce71bfb2">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifb4028e415d14620a23a814353bd620f_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMzLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjRjZjViMzk0MDUyZDQ1MGNhZGYwYTk4MzVjNGQ3ZDc2XzQ_c283137c-9545-485d-9139-0b8dfb2d7fae">1.75</ix:nonFraction>% senior notes due August 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb4028e415d14620a23a814353bd620f_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMzLTEtMS0xLTI2NTI0Nw_26d27ea2-ce5b-482a-9c36-89db29152218">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88ba47fdbaa24d6183f12124cf69ae33_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMzLTMtMS0xLTI2NTI0Nw_fedbeabb-af84-435f-bbd7-0917c0736d92">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibdfec9e9766a4ff5bcabe5606e8aeec1_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM0LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjBiMjJjY2VmOWRiZjQwMzVhY2Y5MjQxMGY1Y2Q5MGY5XzQ_6c957266-6914-4c7d-ab23-e70ea262ef9a">1.875</ix:nonFraction>% senior notes due February 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdfec9e9766a4ff5bcabe5606e8aeec1_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM0LTEtMS0xLTI2NTI0Nw_e1578a80-0062-438c-b982-7e833494330e">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i782152e0441e4c2a8aa5248aacc1d97e_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM0LTMtMS0xLTI2NTI0Nw_0da33f14-7cdb-4eb8-a11a-729c0f0f573d">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i363e35471111481bb74f8fba9324ea53_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM1LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjlkZmQyNmU5MWY3ODRmNjNiNzU2MGRmMmYzN2RkMjA3XzQ_39e812aa-86d5-4e97-89d9-f26c0899fa99">2.125</ix:nonFraction>% senior notes due September 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363e35471111481bb74f8fba9324ea53_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM1LTEtMS0xLTI2NTI0Nw_36bb6bbe-5f99-40d8-9ff6-7b3a1c48de9b">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae612530eaf9406ca68bdc6076595a22_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM1LTMtMS0xLTI2NTI0Nw_df1eaac3-ceaa-428e-8c48-7c4b94be43cb">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i13ffe568d3ed4a168945f8b506bb89d5_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM2LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjliMmM2YmQ2YjlkOTRkYzE4M2Q3ZGJjOTQxNGIzMzViXzQ_7b8b9f76-f038-4c1f-a058-46c90055f650">4.875</ix:nonFraction>% senior notes due July 2035</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13ffe568d3ed4a168945f8b506bb89d5_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM2LTEtMS0xLTI2NTI0Nw_60aa1d09-72f2-4419-9114-778ddc09a742">652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i654327bfda6446f7a000b137efb56172_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM2LTMtMS0xLTI2NTI0Nw_15e314a8-d4a6-4bd6-8a16-a2e4be69cbe0">652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i26367f6403b04922b185cd41633e004b_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM3LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmY0OWVhMGUwOGIzMzQ4YmNhNjM5ZDhjMGNiODljN2JlXzQ_cbba5636-8f07-45fc-9315-df87ee60ce57">6.625</ix:nonFraction>% senior notes due June 2036</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26367f6403b04922b185cd41633e004b_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM3LTEtMS0xLTI2NTI0Nw_dca4cbab-a36a-41a7-8538-31e320fb4bd9">771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84ed8c55fc0643daa63fac8671ac1c47_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM3LTMtMS0xLTI2NTI0Nw_f595d936-3636-46cf-bbf8-bf19413eb3b3">771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i06aeda9941724578b3400960ab91b49b_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM4LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjgwYTQxYTIyYzI4ZjQwNjhiNjFmNjFmMGVmZjQ0MTVhXzQ_67c39916-e6ac-47d9-9401-0c642093146c">6.75</ix:nonFraction>% senior notes due December 2037</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06aeda9941724578b3400960ab91b49b_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM4LTEtMS0xLTI2NTI0Nw_71fbad10-90bc-4b41-9f8f-c5c8e3791eba">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55522731fb6f4d858d93159da79516a7_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM4LTMtMS0xLTI2NTI0Nw_85c3affd-845f-44e5-9615-cced04c1eb80">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab7177b9be24447698af5c299280e476_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM5LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjM3YmZiYzQ3MDc2YzQ3NmU4YWY4ZTMxZWVlMjkyNDgwXzQ_83e80bdd-9b40-450c-86cc-c203c187417a">4.78</ix:nonFraction>% senior notes due March 2038</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab7177b9be24447698af5c299280e476_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM5LTEtMS0xLTI2NTI0Nw_8a0fcfcc-7075-47e6-a9c6-20317c25e742">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37a3a6af561f47c5852d985e16ed71d3_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM5LTMtMS0xLTI2NTI0Nw_3aca2313-ee7f-4d14-8514-15f32d7173b5">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia814b2597f3d40c3aa4b441a58f72382_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQwLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmM5YzJiOWI3ZGJkZjQwMWI5NDZhZTVkYWEzNWEzMzQ1XzQ_250f7ddf-73c7-4816-ac6a-48c32a5806f5">6.125</ix:nonFraction>% senior notes due September 2039</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia814b2597f3d40c3aa4b441a58f72382_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQwLTEtMS0xLTI2NTI0Nw_7522542b-8468-45fd-8219-cde6599514a4">447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic986abeb083b454c96d3dc4609ec7e06_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQwLTMtMS0xLTI2NTI0Nw_460e114d-b6b7-47a9-9936-215b657842f1">447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6bd24d3fc7ac43f298c824109beb8c10_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjFlNTYyNmZjMmE5YjQ4ZmI5YmNkYTk0ODNhYmYwZjEzXzQ_649ae688-a4a8-4780-855a-4420b86bb7bd">4.125</ix:nonFraction>% senior notes due April 2040</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bd24d3fc7ac43f298c824109beb8c10_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQxLTEtMS0xLTI2NTI0Nw_20179c0e-6938-4ec2-9b03-f1a6cedf1e84">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bd579c48c854055ae2e0ed5e2761764_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQxLTMtMS0xLTI2NTI0Nw_eb4ab346-5bb3-496c-ba8e-00b173ff4df7">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i170dc9d394554411a59b342f34d93d1a_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjhiZGRhYzZlZGRiOTRlNmE4ZmFkYzBmMzQ0ZjQxNzkyXzQ_44f8be66-2762-4376-9dd6-0f4cb3724ebf">2.7</ix:nonFraction>% senior notes due August 2040</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i170dc9d394554411a59b342f34d93d1a_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQyLTEtMS0xLTI2NTI0Nw_ab19efcd-2d29-4e92-9f03-9901f32942cb">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f7debdac94840a4bf5279ec76e1bc30_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQyLTMtMS0xLTI2NTI0Nw_56ff157e-235b-43f0-bbd5-a439a12641b2">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c6a0d7374684e1c95b28bb2666b8bdd_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQzLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjFjNGZhZjMzNTVhNjQ3Y2FiZjU0NTA3MmM1NGY0YzdjXzQ_f9e87511-3eb8-4184-9afe-9aeaeecd2099">5.75</ix:nonFraction>% senior notes due May 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c6a0d7374684e1c95b28bb2666b8bdd_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQzLTEtMS0xLTI2NTI0Nw_ec87dd9a-2551-4718-baee-2883c3841ffd">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7921747c0542413d82061a71fe1c0e43_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQzLTMtMS0xLTI2NTI0Nw_78ff36b3-6522-4fe1-8e21-3cc331eaa77b">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7c5ea867903e4bd98992266582152be7_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ0LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjVhZTdiZWUxZmU1NzQ2YmFhNWJjMDFhYWZjODdjOGJlXzQ_7bc9ae5b-6121-41a0-9970-aecc49ad07d3">4.5</ix:nonFraction>% senior notes due May 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c5ea867903e4bd98992266582152be7_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ0LTEtMS0xLTI2NTI0Nw_bbd9e162-1753-4ecf-beec-6e275728c8a3">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i936efdc2f58c43ab85e5eb2d3d14283a_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ0LTMtMS0xLTI2NTI0Nw_a52f520d-234b-450c-a03f-07132b16ede4">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iade73b7bf7a9412cabfa7e66daa3a170_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ1LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmVlZTUyZTI4ZDZiMTQ1YWU4NzUxYjExOTI5ZWIyNGJmXzQ_e82dc584-3596-4410-a5db-b8fda1480172">4.125</ix:nonFraction>% senior notes due November 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iade73b7bf7a9412cabfa7e66daa3a170_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ1LTEtMS0xLTI2NTI0Nw_e4b9d1a8-d190-4b4c-ab96-1386091b533f">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96cf2b69c10d4cb7bbeea0f0473d095c_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ1LTMtMS0xLTI2NTI0Nw_b24ab080-13d1-405a-8657-7e3f5a264e25">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibfef3a2b0e55448e81cc7fd8cdcefa84_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ2LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjVhMTUxZGI2MTU1NTQwZTRiNjc4MGEyM2I3YmJiZGE0XzQ_6c16bc2c-d425-4ef2-b9bf-2f7d9ae4f7da">5.3</ix:nonFraction>% senior notes due December 2043</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfef3a2b0e55448e81cc7fd8cdcefa84_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ2LTEtMS0xLTI2NTI0Nw_c5399daa-df1f-4505-ab4e-0fe7b0d766f9">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9023482dafe64c8487415d9d977873b9_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ2LTMtMS0xLTI2NTI0Nw_69568cda-6f01-4909-bd2d-c8250e32b5cc">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i30e9474ca99f4c96bd9f16e412ac3108_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ3LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjNmNjU2NjNhNDBiNDQyY2Q5MDlkOTg5YmFiOWY5MjkxXzQ_a5cdb2e0-d6e0-4bf6-9405-588f2ad2b755">4.75</ix:nonFraction>% senior notes due March 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30e9474ca99f4c96bd9f16e412ac3108_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ3LTEtMS0xLTI2NTI0Nw_4ef7a603-5927-4a97-b7b3-e299181057d8">375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id71a7150882a412185e3bc50665a4eb0_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ3LTMtMS0xLTI2NTI0Nw_d25950bd-5e35-4a78-85d0-3e4fb5e72e74">375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i45407f38c46c4bccad465eebd0e1c1a0_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ4LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjhhNzMxZjMyYjhmYTQ2ZGE4MDE4OWYxNDIwNjNjYmU0XzQ_d827f7f0-8290-4bd6-b419-6e194bb4aa34">5.125</ix:nonFraction>% senior notes due July 2045</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45407f38c46c4bccad465eebd0e1c1a0_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ4LTEtMS0xLTI2NTI0Nw_815c9054-9ccf-4b2d-8441-f4d77883373d">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d8773a95fa54a4c955ee222946850f1_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ4LTMtMS0xLTI2NTI0Nw_4b28c866-bc4c-4ad2-b205-879b31673b3c">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6861e988cc904169ad4ce04f9a698dfb_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ5LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjM3ZjNiYjViNTJjYjRiYTFhNDRiOGZkYjU1NjNmZDE1XzQ_ada2e5f3-b9ff-4693-a3c5-c47c8848c1fd">3.875</ix:nonFraction>% senior notes due August 2047</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6861e988cc904169ad4ce04f9a698dfb_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ5LTEtMS0xLTI2NTI0Nw_6a6fc720-f7d4-4f24-839a-d2508c94ee2e">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i595551a12fa549a4b9bf4bb76c4cd9b6_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ5LTMtMS0xLTI2NTI0Nw_4787351b-c483-4c5a-a299-a61d822fb171">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i84d217e379554fdc8044f794cb43db4a_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUwLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmE4ZGUwYjRmYzI2YjQyNTQ5MzJlMTNlNzdlOWMwNGZlXzQ_1ec7b93a-1442-457f-83d3-bd0078bc62ed">5.05</ix:nonFraction>% senior notes due March 2048</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84d217e379554fdc8044f794cb43db4a_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUwLTEtMS0xLTI2NTI0Nw_d96f4eb3-3223-470f-b298-cf15d5d27108">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c83f742d5604d34bf2d877385d1f1bf_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUwLTMtMS0xLTI2NTI0Nw_fed57a41-b664-4a35-bb70-896578b67ddf">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idb3abfe6fdc34a699fc61058a8ebf7fd_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjg0MjZiZmU0NTM5ZTRkMDg5MDg3NTNhOTFmZTFiNmJiXzQ_766d5bd9-6176-4c0e-8247-5cf71ef4fe77">4.25</ix:nonFraction>% senior notes due April 2050</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb3abfe6fdc34a699fc61058a8ebf7fd_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUxLTEtMS0xLTI2NTI0Nw_dd95886c-16c3-4796-a69b-46a6314f4b6f">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d36c8bfa1e04bd1a278e34c22872187_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUxLTMtMS0xLTI2NTI0Nw_749d261b-1978-496a-a1f7-e42b37077588">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUyLTAtMS0xLTI2NTI0Nw_1b8d2063-d583-4908-be86-f25a8a8346c8"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUyLTAtMS0xLTI2NTI0Nw_d9e5828d-1d67-442b-bf21-ed9fd901073c">Finance lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUyLTEtMS0xLTI2NTI0Nw_666b1ed8-21eb-451c-be43-f57c5070a769">1,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUyLTMtMS0xLTI2NTI0Nw_fb2ce339-1c56-4b5b-8e75-dca57b038a27">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e5f05c48e5f410f832224ee5b84dc43_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUzLTEtMS0xLTI2NTI0Nw_845e91b3-ac7c-470a-b053-985671a5eaec">314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b89c9ecfa1844e19052dc3ccefa9571_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUzLTMtMS0xLTI2NTI0Nw_aeebd652-202b-40b3-bc49-6245f71376ba">320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt principal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:LongtermDebtGrossAndLeaseObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzU0LTEtMS0xLTI2NTI0Nw_44312cdc-4ba0-4697-9f96-7a9f03c9a500">52,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:LongtermDebtGrossAndLeaseObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzU0LTMtMS0xLTI2NTI0Nw_40f6c619-333c-4902-bab1-48400cb43d3f">56,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzU1LTEtMS0xLTI2NTI0Nw_6f8a6a1d-a78e-4f01-8e0e-16dd1f3fbe05">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzU1LTMtMS0xLTI2NTI0Nw_143d4cca-88a8-413d-b09e-9f2d019ffb1a">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt discounts and deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzU2LTEtMS0xLTI2NTI0Nw_21eddf5b-c5f1-4a68-83ea-9b2e6bcd049e">696</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzU2LTMtMS0xLTI2NTI0Nw_e6e16884-7f24-4c9a-8dfe-dc495ff4f2a5">786</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzU3LTEtMS0xLTI2NTI0Nw_f3d2c110-a75e-4af1-911a-54df508315d9">52,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzU3LTMtMS0xLTI2NTI0Nw_6511ecde-ec88-43f1-84a9-05385138d91b">56,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzYwLTEtMS0xLTI2NTI0Nw_3b283fb8-61d1-4073-8a0c-29b9a28a4186">1,778</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzYwLTMtMS0xLTI2NTI0Nw_948b807e-96f2-40f9-9508-61ebbf75fa16">4,205</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzYxLTEtMS0xLTI2NTI0Nw_1d4c7952-08c6-4a00-8b33-fd71e7935ab2">50,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzYxLTMtMS0xLTI2NTI0Nw_bfb148b0-f989-47f3-b42e-49e6faa12724">51,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">__________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes long-term debt of $<ix:nonFraction unitRef="usd" contextRef="id47f5a8f599c4b868d0305b2456c6b4f_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzE5MA_79791f6e-51f0-4041-903a-2be0133c348b">3</ix:nonFraction>&#160;million which has been accounted for as liabilities held for sale and is included in liabilities held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i034b0b981a75403db5c56c6ea1bf80c3" continuedAt="icec69d83814c4b32a6877f5652223cea"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzY4MDI_f89f9692-2e6a-4bc4-8bf1-96917cbf3c28" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s required repayments of debt principal due during each of the next five&#160;years and thereafter, as of December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.842%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTo1YWY5MTQ0ZmE0NmQ0NjA1OWYwOTM4MDI1ZDQ4NWZiZi90YWJsZXJhbmdlOjVhZjkxNDRmYTQ2ZDQ2MDU5ZjA5MzgwMjVkNDg1ZmJmXzEtMS0xLTEtMjY1MjQ3_9314c789-aa72-46b9-bf4c-cb873ca40613">1,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTo1YWY5MTQ0ZmE0NmQ0NjA1OWYwOTM4MDI1ZDQ4NWZiZi90YWJsZXJhbmdlOjVhZjkxNDRmYTQ2ZDQ2MDU5ZjA5MzgwMjVkNDg1ZmJmXzItMS0xLTEtMjY1MjQ3_6d7f5413-da5d-495e-ae67-3f5799c32d1b">2,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTo1YWY5MTQ0ZmE0NmQ0NjA1OWYwOTM4MDI1ZDQ4NWZiZi90YWJsZXJhbmdlOjVhZjkxNDRmYTQ2ZDQ2MDU5ZjA5MzgwMjVkNDg1ZmJmXzMtMS0xLTEtMjY1MjQ3_c489e80d-fa0d-4c51-ae87-068a5f6e0bc5">3,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTo1YWY5MTQ0ZmE0NmQ0NjA1OWYwOTM4MDI1ZDQ4NWZiZi90YWJsZXJhbmdlOjVhZjkxNDRmYTQ2ZDQ2MDU5ZjA5MzgwMjVkNDg1ZmJmXzQtMS0xLTEtMjY1MjQ3_e00e1a89-bae1-4618-82fc-8dc5016a69a7">2,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTo1YWY5MTQ0ZmE0NmQ0NjA1OWYwOTM4MDI1ZDQ4NWZiZi90YWJsZXJhbmdlOjVhZjkxNDRmYTQ2ZDQ2MDU5ZjA5MzgwMjVkNDg1ZmJmXzUtMS0xLTEtMjY1MjQ3_1d69efaa-d974-4b81-a7d1-a4853f512f91">3,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTo1YWY5MTQ0ZmE0NmQ0NjA1OWYwOTM4MDI1ZDQ4NWZiZi90YWJsZXJhbmdlOjVhZjkxNDRmYTQ2ZDQ2MDU5ZjA5MzgwMjVkNDg1ZmJmXzYtMS0xLTEtMjY1MjQ3_82fecbe2-4472-4d71-9bcc-f2b5da32b5c8">37,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTo1YWY5MTQ0ZmE0NmQ0NjA1OWYwOTM4MDI1ZDQ4NWZiZi90YWJsZXJhbmdlOjVhZjkxNDRmYTQ2ZDQ2MDU5ZjA5MzgwMjVkNDg1ZmJmXzctMS0xLTEtMjY1MjQ3_8f499045-cccd-42fd-a977-1227b733138f">51,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTo1YWY5MTQ0ZmE0NmQ0NjA1OWYwOTM4MDI1ZDQ4NWZiZi90YWJsZXJhbmdlOjVhZjkxNDRmYTQ2ZDQ2MDU5ZjA5MzgwMjVkNDg1ZmJmXzgtMS0xLTEtMjY1MjQ3_666b1ed8-21eb-451c-be43-f57c5070a769">1,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt principal</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:LongtermDebtGrossAndLeaseObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTo1YWY5MTQ0ZmE0NmQ0NjA1OWYwOTM4MDI1ZDQ4NWZiZi90YWJsZXJhbmdlOjVhZjkxNDRmYTQ2ZDQ2MDU5ZjA5MzgwMjVkNDg1ZmJmXzktMS0xLTEtMjY1MjQ3_ab56438d-450a-4a0b-9d35-8c3b5cdfad2a">52,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for a summary of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">maturities of the Company&#8217;s finance lease liabilities.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper and Back-up Credit Facilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did <ix:nonFraction unitRef="usd" contextRef="ia5d25fae6d644b13b9d7d803b1a2d336_I20221231" decimals="INF" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3Xzc1MA_788045c6-44ba-4fd0-a42b-a9c08db857f0"><ix:nonFraction unitRef="usd" contextRef="iab1819ee2b2c48beb7a3d3480b4d3018_I20211231" decimals="INF" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3Xzc1MA_ba06b9e5-918b-4741-a6e3-02c970bf4d02">no</ix:nonFraction></ix:nonFraction>t have any commercial paper outstanding as of December 31, 2022 or 2021. In connection with its commercial paper program, the Company maintains a $<ix:nonFraction unitRef="usd" contextRef="i7725a00fc4434458820e5285675db777_I20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3Xzg5OA_7c894714-4de4-4155-8b1d-aa51c8b03f2a">2.0</ix:nonFraction> billion, <ix:nonNumeric contextRef="if5314895b87347ca95eb2d88cacc462b_D20220101-20221231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzY3MzE_a74e437a-3b71-4ccb-bd16-984e1df1124e">five-year</ix:nonNumeric> unsecured back-up revolving credit facility, which expires on May 16, 2025, a $<ix:nonFraction unitRef="usd" contextRef="ide893c421b8b4a6bb460e90ff3db6be6_I20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3Xzk4OA_21a11720-d81a-4dc7-842f-6601cc4d2c7f">2.0</ix:nonFraction> billion, <ix:nonNumeric contextRef="i9b7205dfebbd4f39b3d90a92a474a62c_D20220101-20221231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzY3NjU_be96d83d-af2a-40b8-b34d-dc4f35e44068">five-year</ix:nonNumeric> unsecured back-up revolving credit facility, which expires on May 11, 2026, and a $<ix:nonFraction unitRef="usd" contextRef="i4f2daf0d0e1b46beb6977fe725dd8568_I20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzEwODI_6c14daf3-4352-4169-8e5f-7f16e91ee291">2.0</ix:nonFraction> billion, <ix:nonNumeric contextRef="i58ff8eedba304dc89f24ce5bfd8071d0_D20220101-20221231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzY3OTU_384f3c34-ebde-41e9-bb52-3fc3d56fd6f6">five-year</ix:nonNumeric> unsecured back-up revolving credit facility, which expires on May 16, 2027. The credit facilities allow for borrowings at various rates that are dependent, in part, on the Company&#8217;s public debt ratings and require the Company to pay a weighted average quarterly facility fee of approximately <ix:nonFraction unitRef="number" contextRef="i53a3dea184cf43989b62efd3b338a4e4_D20220101-20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzEzODY_5229e210-e72b-4da7-a912-a7fc1f0b3833">0.03</ix:nonFraction>%, regardless of usage. As of December&#160;31, 2022 and 2021, there were <ix:nonFraction unitRef="usd" contextRef="i296638e184854141a99df90a77e2a441_I20221231" decimals="INF" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzE0Mzk_21d1aa6b-990b-4fcf-87da-0c9f9ad355d1"><ix:nonFraction unitRef="usd" contextRef="i096d8d3381b14ad1aa6e9c2bb706e0cd_I20211231" decimals="INF" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzE0Mzk_eb002587-d4b6-4ede-ab9d-8f662806b0a0">no</ix:nonFraction></ix:nonFraction> borrowings outstanding under any of the Company&#8217;s back-up credit facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Home Loan Bank of Boston (&#8220;FHLBB&#8221;)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A subsidiary of the Company is a member of the FHLBB. As a member, the subsidiary has the ability to obtain cash advances, subject to certain minimum collateral requirements. The maximum borrowing capacity available from the FHLBB as of December&#160;31, 2022 was approximately $<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzE4MjE_be3a6f5d-ee9d-40e4-b460-e2f9098e6c93">915</ix:nonFraction> million. At both December&#160;31, 2022 and 2021, there were <ix:nonFraction unitRef="usd" contextRef="ie9b65b8aa3934b9e926bf1519bff738d_I20211231" decimals="INF" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzE4NTU_170aaae5-5df1-4f9e-ba4e-0c50b4d33780"><ix:nonFraction unitRef="usd" contextRef="iadf9ac334c4b4658ad05a02180f0b8c5_I20221231" decimals="INF" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzE4NTU_82bd68a9-817a-4067-aa6d-40e827b0fcde">no</ix:nonFraction></ix:nonFraction> outstanding advances from the FHLBB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exercise of Par Call Redemptions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company exercised the par call redemption on its outstanding <ix:nonFraction unitRef="number" contextRef="i364fd8c191ee4a44ba567c6975b7a46b_I20220531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzIwMjk_1c4e88ec-bf66-48cb-8aa7-31434139c896">3.5</ix:nonFraction>% senior notes due July 2022 to redeem for cash on hand the entire $<ix:nonFraction unitRef="usd" contextRef="i70894237af7b4390b3fb413977da682d_D20220501-20220531" decimals="-8" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzIwOTc_bd5e8c1d-10bc-404d-b915-1a57eacc553e">1.5</ix:nonFraction>&#160;billion aggregate principal amount. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Company exercised the par call redemption on its outstanding <ix:nonFraction unitRef="number" contextRef="i51ef9d9ca64a4f4287885afe3f594d9e_I20220831" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzIyMTE_47e72464-57a1-47e4-8bef-fc1a1b099236">2.75</ix:nonFraction>% senior notes due November 2022 (issued by Aetna Inc. (&#8220;Aetna&#8221;)) to redeem for cash on hand the entire $<ix:nonFraction unitRef="usd" contextRef="i8fbfb24ea6744e208cb848ccde2da9e1_D20220801-20220831" decimals="-8" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzIzMTY_22ee5e4b-be4f-412b-a339-b49dace59c58">1.0</ix:nonFraction>&#160;billion aggregate principal amount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the Company exercised the par call redemptions on its outstanding <ix:nonFraction unitRef="number" contextRef="i9aa5250b8a554547a64d644fea28511e_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzI0MzM_4a38daf7-a3d5-41be-a685-7a24ee91db5f">2.75</ix:nonFraction>% senior notes due December 2022 and <ix:nonFraction unitRef="number" contextRef="i6b6fb40f4dca4685b9a5bbb62b5bc3c2_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzI0NzE_2afd57b5-9033-4fb5-8942-2e9214ea6fd7">4.75</ix:nonFraction>% senior notes due December 2022 (including notes issued by Omnicare, Inc.) to redeem for cash on hand the entire aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="id3d628c3b8c14ac6864d45ff3df48167_D20220901-20220930" decimals="-7" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzI2MTY_9732e853-6b7a-4330-a944-529588f49427">1.25</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="ib7e2b901e8f64b298c94032d51d86694_D20220901-20220930" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzI2MjM_4b7e2b89-2a3b-474c-ae93-291f8c8c02c4">399</ix:nonFraction>&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 18, 2021, the Company issued $<ix:nonFraction unitRef="usd" contextRef="i37ff025b209247ed83d75720f35ca078_I20210818" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzI2OTI_ffe7cbd4-e196-4dfe-b299-9f73d4132db3">1.0</ix:nonFraction>&#160;billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i37ff025b209247ed83d75720f35ca078_I20210818" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzI3MjU_0e675001-ce53-4940-abe1-afb03300c2bb">2.125</ix:nonFraction>% unsecured senior notes due September 15, 2031 for total proceeds of $<ix:nonFraction unitRef="usd" contextRef="ifde94c7f37464b33b3e1498967849d4c_D20210818-20210818" decimals="-6" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzI3OTY_ff453c2e-8a1a-4d8e-be4a-4fc75a892e02">987</ix:nonFraction>&#160;million, net of discounts, underwriting fees and offering expenses. The net proceeds of this offering were used for the purchase of senior notes in connection with the Company&#8217;s cash tender offer in August 2021 as described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During March 2020, the Company entered into several interest rate swap transactions to manage interest rate risk. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="icec69d83814c4b32a6877f5652223cea"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resulting from changes in interest rates related to the anticipated issuance of $<ix:nonFraction unitRef="usd" contextRef="ib92c96bdb7a54505966770b11a97675d_I20200331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzMzNTk_9c356ef2-b8fa-4bb8-b36b-22bff9c18395">750</ix:nonFraction>&#160;million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="ib92c96bdb7a54505966770b11a97675d_I20200331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzMzOTI_09fa5019-0062-4e91-92e3-9e442b8fe04c">3.625</ix:nonFraction>% unsecured senior notes due April 1, 2027, $<ix:nonFraction unitRef="usd" contextRef="i1cd70718cc1343babbfe7bdcef36bd9a_I20200331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzM0Mzc_0e780bd0-3eb2-4d31-86b8-2c4daea7ab6e">1.5</ix:nonFraction>&#160;billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i1cd70718cc1343babbfe7bdcef36bd9a_I20200331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzM0NzA_9dbba6f3-351a-49d9-9095-e583ccce2b6d">3.75</ix:nonFraction>% unsecured senior notes due April 1, 2030, $<ix:nonFraction unitRef="usd" contextRef="i9544c22127144ed0964d5a4436da8785_I20200331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzM1MTU_07389143-93c0-4480-b405-c9b0060b2e50">1.0</ix:nonFraction>&#160;billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i9544c22127144ed0964d5a4436da8785_I20200331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzM1NDg_8ca829b8-6206-4098-bffa-22ee150b2e3e">4.125</ix:nonFraction>% unsecured senior notes due April 1, 2040 and $<ix:nonFraction unitRef="usd" contextRef="id0e311329095472ab7b183da066396c8_I20200331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzM1OTY_9e62460b-c29e-4e39-9bfa-533fc34f6d32">750</ix:nonFraction>&#160;million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="id0e311329095472ab7b183da066396c8_I20200331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzM2Mjk_4c6ffab9-caaf-4eb1-b961-d52d8baaceb8">4.25</ix:nonFraction>% unsecured senior notes due April 1, 2050 (collectively, the &#8220;March 2020 Notes&#8221;). In connection with the issuance of the March 2020 Notes on March 31, 2020, the Company terminated all outstanding cash flow hedges. The Company paid a net amount of $<ix:nonFraction unitRef="usd" contextRef="i60425698f8a3418da11bdd624d74fae8_D20200301-20200331" decimals="-6" name="us-gaap:PaymentsForDerivativeInstrumentFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzM4Nzg_337cd6fd-95e7-44db-885d-a635d83d3db9">7</ix:nonFraction>&#160;million to the hedge counterparties upon termination, which was recorded as a loss, net of tax, of $<ix:nonFraction unitRef="usd" contextRef="i60425698f8a3418da11bdd624d74fae8_D20200301-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzM5NzI_61ab11a1-ce9c-46f7-972f-de9f48fb0222">5</ix:nonFraction>&#160;million in accumulated other comprehensive income and will be reclassified as interest expense over the life of the March 2020 Notes. See Note 14 &#8216;&#8216;Other Comprehensive Income (Loss)&#8217;&#8217; for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Early Extinguishments of Debt</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company redeemed for cash the remaining $<ix:nonFraction unitRef="usd" contextRef="ieab996d7d0884ceab3cf45494319270b_D20211201-20211231" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzQyMzA_7a74ba8c-7032-4220-ac1c-2a16267d60b1">2.3</ix:nonFraction>&#160;billion of its outstanding <ix:nonFraction unitRef="number" contextRef="ied3ea35dfc6c47b7b9f3cc1126a9a800_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzQyNTI_07ba30a4-838b-4584-8fb7-9a192a3afbca">3.7</ix:nonFraction>% senior notes due 2023. In connection with the early redemption of such senior notes, the Company paid a make-whole premium of $<ix:nonFraction unitRef="usd" contextRef="ie2ed035e89ea4208b36e5c0321f9ff7f_D20211201-20211231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzQzODE_ff9ef787-d94d-4946-98a2-400894eaa0da">80</ix:nonFraction> million in excess of the aggregate principal amount of the senior notes that were redeemed, wrote-off $<ix:nonFraction unitRef="usd" contextRef="ie2ed035e89ea4208b36e5c0321f9ff7f_D20211201-20211231" decimals="-6" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzQ0Nzg_8114239e-b039-46c7-9d92-c160d8e198ed">8</ix:nonFraction> million of unamortized deferred financing costs and incurred $<ix:nonFraction unitRef="usd" contextRef="ie2ed035e89ea4208b36e5c0321f9ff7f_D20211201-20211231" decimals="-6" name="cvs:DebtExtinguishmentFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzQ1MzQ_59000593-0ace-4b32-935d-922762eef1dc">1</ix:nonFraction> million in fees, for a total loss on early extinguishment of debt of $<ix:nonFraction unitRef="usd" contextRef="ie2ed035e89ea4208b36e5c0321f9ff7f_D20211201-20211231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzQ1OTg_265846f8-b973-4d2d-8842-dfd043f81182">89</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company purchased approximately $<ix:nonFraction unitRef="usd" contextRef="i83224dff234f476ba7ed0ccd21116967_D20210801-20210831" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzQ2NTU_27cab97d-8123-4532-bb89-3c8c155808df">2.0</ix:nonFraction>&#160;billion of its outstanding <ix:nonFraction unitRef="number" contextRef="i485c3eb16ae24960b7e3cac5ed2c512b_I20210831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzQ2Nzc_07cefd6f-6319-4e86-9af5-841575d9c5eb">4.3</ix:nonFraction>% senior notes due 2028 through a cash tender offer. In connection with the purchase of such senior notes, the Company paid a premium of $<ix:nonFraction unitRef="usd" contextRef="ia34bc950bc544c9382c1522adba2fb40_D20210801-20210831" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzQ4MTU_ffb82561-9838-486c-9966-8431bc3da9a3">332</ix:nonFraction> million&#160;in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $<ix:nonFraction unitRef="usd" contextRef="ia34bc950bc544c9382c1522adba2fb40_D20210801-20210831" decimals="-6" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzQ5MTM_e5b17402-0b7b-4774-a19c-94d64c7ea91e">26</ix:nonFraction>&#160;million of unamortized deferred financing costs and incurred $<ix:nonFraction unitRef="usd" contextRef="ia34bc950bc544c9382c1522adba2fb40_D20210801-20210831" decimals="-6" name="cvs:DebtExtinguishmentFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzQ5Njk_088e5470-fc80-4c0a-a6c0-73eb4922c6cb">5</ix:nonFraction>&#160;million in fees, for a total loss on early extinguishment of debt of $<ix:nonFraction unitRef="usd" contextRef="ia34bc950bc544c9382c1522adba2fb40_D20210801-20210831" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzUwMzM_d84b9bdb-e69d-4db1-a408-268e9e03f366">363</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company purchased $<ix:nonFraction unitRef="usd" contextRef="i80466863c1954a5995d8cb88bd23d373_D20201201-20201231" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzUwNzg_202be032-0444-4a28-a041-7e5e8c53c20e">4.5</ix:nonFraction>&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $<ix:nonFraction unitRef="usd" contextRef="i7385c90f6eec42dbafb7d0cc760c4687_D20201201-20201231" decimals="-6" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzUxOTI_da81853f-16c9-44d7-9604-05947671971a">113</ix:nonFraction>&#160;million of its <ix:nonFraction unitRef="number" contextRef="ief5a743376c14f51b6a0e836c4b51640_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzUyMDI_b9e8d41a-82f1-4a12-800a-1b31bafcfec8">4.0</ix:nonFraction>% senior notes due 2023, $<ix:nonFraction unitRef="usd" contextRef="icf67de8907724398ac7599821631c87e_D20201201-20201231" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzUyMjg_31385627-6cac-446d-988b-3f6c778b490d">1.4</ix:nonFraction>&#160;billion of its <ix:nonFraction unitRef="number" contextRef="i74057c0c3792479e937638290c160b1c_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzUyMzg_83e6c859-1c49-4abe-9036-81dd9570a8fc">3.7</ix:nonFraction>% senior notes due 2023, $<ix:nonFraction unitRef="usd" contextRef="i7d58decd879f498a93452c94fc35e626_D20201201-20201231" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzUyNjQ_f1d26e80-434b-4ce9-b2eb-5eca33925ec8">1.0</ix:nonFraction>&#160;billion of its <ix:nonFraction unitRef="number" contextRef="iea5790297968453b80af10c825264b1a_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzUyNzQ_37d02763-7ff9-4c3d-b071-9885a8515b95">4.1</ix:nonFraction>% senior notes due 2025 and $<ix:nonFraction unitRef="usd" contextRef="i7f44b18f700943b2a98a19f48efe6062_D20201201-20201231" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzUzMDM_1d36d63d-65f8-4724-8b14-510f9d4f09f3">2.0</ix:nonFraction>&#160;billion of its <ix:nonFraction unitRef="number" contextRef="i63e27afb0d604706bcc006002a4c8301_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzUzMTM_3adc2ad0-5bf4-4c49-a954-e7d7030da520">4.3</ix:nonFraction>% senior notes due 2028. In connection with the purchase of such senior notes, the Company paid a premium of $<ix:nonFraction unitRef="usd" contextRef="i36384f97305a4feabdce46713990833c_D20201201-20201231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU0MjM_125ba43a-8ec2-4e72-9907-1bd6bf76d302">619</ix:nonFraction>&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $<ix:nonFraction unitRef="usd" contextRef="i36384f97305a4feabdce46713990833c_D20201201-20201231" decimals="-6" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU1MjE_5356c4ce-a154-4362-8c18-3a1a7e6d03d1">45</ix:nonFraction>&#160;million of unamortized deferred financing costs and incurred $<ix:nonFraction unitRef="usd" contextRef="i36384f97305a4feabdce46713990833c_D20201201-20201231" decimals="-6" name="cvs:DebtExtinguishmentFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU1Nzc_fa5dad77-a135-42a8-ae0b-baa6da5d6824">10</ix:nonFraction>&#160;million in fees, for a total loss on early extinguishment of debt of $<ix:nonFraction unitRef="usd" contextRef="i36384f97305a4feabdce46713990833c_D20201201-20201231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU2NDE_82c96ff6-ee95-4bb1-9fb6-e4b15d861adc">674</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company purchased $<ix:nonFraction unitRef="usd" contextRef="i0d45c5eeb3784063b1f6c2bd8750adc3_D20200801-20200831" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU2ODQ_1bbf2620-de0c-474c-883e-583758617df1">6.0</ix:nonFraction>&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $<ix:nonFraction unitRef="usd" contextRef="i335a47dd1b0d4b048c9088e555d579ec_D20200801-20200831" decimals="-6" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU3OTg_66cd5115-5f40-4dc1-bd0e-6c72f2a4155f">723</ix:nonFraction>&#160;million of its <ix:nonFraction unitRef="number" contextRef="i3b98834372be433bb753acc0051b6968_I20200831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU4MDg_ab830396-41ed-4ff0-9ec9-a780daa1134f">4.0</ix:nonFraction>% senior notes due 2023, $<ix:nonFraction unitRef="usd" contextRef="i5b2c782f0ddb4f47b2267b9624558fbc_D20200801-20200831" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU4MzQ_1f1a11f5-3f31-4c55-80ec-6535f1213544">2.3</ix:nonFraction>&#160;billion of its <ix:nonFraction unitRef="number" contextRef="ia13f558316964fe4aba42d03ed32c28a_I20200831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU4NDQ_86bb247e-7725-497d-9b2c-2b74fe777d1f">3.7</ix:nonFraction>% senior notes due 2023 and $<ix:nonFraction unitRef="usd" contextRef="iac13c74e53a64777a3a5d7e4fe3b2046_D20200801-20200831" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU4NzM_c7a5104e-9abc-467a-a01e-dab6e6af2602">3.0</ix:nonFraction>&#160;billion of its <ix:nonFraction unitRef="number" contextRef="i4f514b120f594513be910dc9973e11be_I20200831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU4ODM_0260577d-ceec-4506-baa8-f68a704c255c">4.1</ix:nonFraction>% senior notes due 2025. In connection with the purchase of such senior notes, the Company paid a premium of $<ix:nonFraction unitRef="usd" contextRef="i2b7fcc349cf541ddb6fa797410c0ffa1_D20200801-20200831" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU5OTM_ff89a8b0-5e0a-4055-8ac2-42a7ad7ce829">706</ix:nonFraction>&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $<ix:nonFraction unitRef="usd" contextRef="i2b7fcc349cf541ddb6fa797410c0ffa1_D20200801-20200831" decimals="-6" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzYwOTE_ec20795a-c7b5-4faa-af4d-fab02ab1710a">47</ix:nonFraction>&#160;million of unamortized deferred financing costs and incurred $<ix:nonFraction unitRef="usd" contextRef="i2b7fcc349cf541ddb6fa797410c0ffa1_D20200801-20200831" decimals="-6" name="cvs:DebtExtinguishmentFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzYxNDc_9193aa96-b77d-416f-ac14-d3539041a742">13</ix:nonFraction>&#160;million in fees, for a total loss on early extinguishment of debt of $<ix:nonFraction unitRef="usd" contextRef="i2b7fcc349cf541ddb6fa797410c0ffa1_D20200801-20200831" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzYyMTE_76619254-1e84-4b19-b0c9-7b9768b3c57a">766</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s back-up revolving credit facilities and unsecured senior notes contain customary restrictive financial and operating covenants. These covenants do not include an acceleration of the Company&#8217;s debt maturities in the event of a downgrade in the Company&#8217;s credit ratings. The Company does not believe the restrictions contained in these covenants materially affect its financial or operating flexibility. As of December&#160;31, 2022, the Company was in compliance with all of its debt covenants.</span></div></ix:continuation><div><span><br/></span></div><div id="i36038907935e41eea5e9cf7cac915d44_148"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMzIz_b9a7c62d-ad64-4b60-b535-393965828051" continuedAt="ibd7f913264d34649bff3b3a745c08360" escape="true">Pension Plans and Other Postretirement Benefits</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ibd7f913264d34649bff3b3a745c08360" continuedAt="ifdb3c4450599419b9b0e02d657c91bd0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Contribution Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company sponsors several active 401(k) savings plans that cover all employees who meet plan eligibility requirements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes matching contributions consistent with the provisions of the respective plans. At the participant&#8217;s option, account balances, including the Company&#8217;s matching contribution, can be invested among various investment options under each plan. The CVS Health Future Fund 401(k) Plan offers CVS Health Corporation&#8217;s common stock fund as an investment option. The Company also maintains nonqualified, unfunded deferred compensation plans for certain key employees. The plans provide participants the opportunity to defer portions of their eligible compensation and for certain nonqualified plans, participants receive matching contributions equivalent to what they could have received under the CVS Health Future Fund 401(k) Plan absent certain restrictions and limitations under the Internal Revenue Code. The Company&#8217;s contributions under its defined contribution plans were $<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMDU_8448054a-5749-4e40-bc01-2a77d27b383d">567</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMDk_02910467-9b13-412f-b1ad-c3135a7649ba">552</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMTY_d1cd6839-fdcb-4228-a251-8b5141e7cde2">520</ix:nonFraction> million in the years ended December&#160;31, 2022, 2021 and 2020, respectively. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="ifdb3c4450599419b9b0e02d657c91bd0" continuedAt="i5f4d249e5f60451ca9184a8b66249732"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Benefit Pension Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors a tax-qualified defined benefit pension plan that was frozen in 2010 and a nonqualified supplemental pension plan that was frozen in 2007. The Company also sponsors several other defined benefit pension plans that are unfunded nonqualified supplemental retirement plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension Benefit Obligation and Plan Assets</span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMzE4_a27052b8-88c3-4231-a3a8-653e5ad7d4cd" escape="true"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMzI3_3fa95115-9aa4-4abe-aa88-a3df904989e2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables outline the change in pension benefit obligation and plan assets over the specified periods:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ae60f8a88824bf889f05cc3b51730b3_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzItMS0xLTEtMjY1MjQ3_db7cab97-e263-4a9b-a296-2985368ab33c">6,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb014b08ea1a43c8bfc4d9fe2fe4cb7b_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzItMy0xLTEtMjY1MjQ3_c9445336-9249-46fc-8d9b-50fc5cc70c2c">6,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzQtMS0xLTEtMjY1MjQ3_33fcad75-fc5d-498d-8ce8-22ffb533641a">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzQtMy0xLTEtMjY1MjQ3_0afcfdb8-e7ff-4313-9f91-38f8da344229">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzUtMS0xLTEtMjY1MjQ3_6252189e-e73a-4f43-b480-10ad2111ee32">1,011</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzUtMy0xLTEtMjY1MjQ3_b56de137-1ec1-46f8-975f-a159071fe582">102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzYtMS0xLTEtMjY1MjQ3_0cc431a4-92a2-424a-9734-f8e932c2b308">387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzYtMy0xLTEtMjY1MjQ3_2c35633e-8d99-4c86-ab42-ea3d3cf6283b">408</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzctMS0xLTEtMjY1MjQ3_f600f3e7-1632-4369-830d-cb796d667045">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzctMy0xLTEtMjY1MjQ3_312108d4-2dd7-4ab0-8f5f-967a117c76b4"><ix:nonFraction unitRef="usd" contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzctMy0xLTEtMjY1MjQ3_33027307-2ca2-4570-a210-d176e16a3626">53</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzgtMS0xLTEtMjY1MjQ3_e0fa3905-eebd-4ab5-93f5-2695a2aefd55">4,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ae60f8a88824bf889f05cc3b51730b3_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzgtMy0xLTEtMjY1MjQ3_6b2e00d7-fc3c-4065-aeac-166207d43153">6,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ae60f8a88824bf889f05cc3b51730b3_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzExLTEtMS0xLTI2NTI0Nw_d31dda76-fe10-43c3-9381-e2aa841c6b79">6,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb014b08ea1a43c8bfc4d9fe2fe4cb7b_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzExLTMtMS0xLTI2NTI0Nw_809e8766-4590-474a-8cce-8cf0e7649e54">6,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzEzLTEtMS0xLTI2NTI0Nw_42ef671b-13fa-4d64-82ff-3f504cdd67d1">968</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzEzLTMtMS0xLTI2NTI0Nw_82fe206d-dc61-4f83-985b-d6f23a867a95">215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzE0LTEtMS0xLTI2NTI0Nw_2871ed69-f457-4eaa-88fc-1352b72a751a">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzE0LTMtMS0xLTI2NTI0Nw_86882918-c0b0-4a1b-bc59-039f654e31cb">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzE1LTEtMS0xLTI2NTI0Nw_d3698ce0-6870-4782-9993-fb06e2a138a2">387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzE1LTMtMS0xLTI2NTI0Nw_70033b54-0cc3-417b-834a-3f6b3780dd37">408</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzE2LTEtMS0xLTI2NTI0Nw_71a4dadd-4cc5-4d08-958c-0cc0fa9474f7">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzE2LTMtMS0xLTI2NTI0Nw_312108d4-2dd7-4ab0-8f5f-967a117c76b4"><ix:nonFraction unitRef="usd" contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzE2LTMtMS0xLTI2NTI0Nw_33027307-2ca2-4570-a210-d176e16a3626">53</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzE3LTEtMS0xLTI2NTI0Nw_7567d22c-0f09-4db1-a689-5bbec313f86d">5,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ae60f8a88824bf889f05cc3b51730b3_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzE3LTMtMS0xLTI2NTI0Nw_7f5e8700-9e2e-4cdb-b52a-bc5abcc1e0c5">6,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzE5LTEtMS0xLTI2NTI0Nw_0f7d4085-bbb3-4ef8-8fda-1746eb5cf2da">606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ae60f8a88824bf889f05cc3b51730b3_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzE5LTMtMS0xLTI2NTI0Nw_c06eb23b-1afb-4a52-b261-ae0d0b9998ad">668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the pension benefit obligation during the years ended December&#160;31, 2022 and 2021 was primarily driven by the change in the discount rate during each respective period.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMzI4_f49e799a-3020-44ca-ba3b-a4ea57a2a5c8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets (liabilities) recognized on the consolidated balance sheets at December&#160;31, 2022 and 2021 for the defined benefit pension plans consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets reflected in other assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo3OGYzYzUwYzk1YjI0MmE1OWY2Y2FlZWMyOTMyNjkxZi90YWJsZXJhbmdlOjc4ZjNjNTBjOTViMjQyYTU5ZjZjYWVlYzI5MzI2OTFmXzEtMS0xLTEtMjY1MjQ3_e41a8eff-0386-4bc5-bfe5-7606d5edeb9c">827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ae60f8a88824bf889f05cc3b51730b3_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo3OGYzYzUwYzk1YjI0MmE1OWY2Y2FlZWMyOTMyNjkxZi90YWJsZXJhbmdlOjc4ZjNjNTBjOTViMjQyYTU5ZjZjYWVlYzI5MzI2OTFmXzEtMy0xLTEtMjY1MjQ3_f9efaead-b555-441c-b635-730486fc55df">946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities reflected in accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo3OGYzYzUwYzk1YjI0MmE1OWY2Y2FlZWMyOTMyNjkxZi90YWJsZXJhbmdlOjc4ZjNjNTBjOTViMjQyYTU5ZjZjYWVlYzI5MzI2OTFmXzItMS0xLTEtMjY1MjQ3_2926e26c-c812-42bc-87bd-fcb9abf60538">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ae60f8a88824bf889f05cc3b51730b3_I20211231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo3OGYzYzUwYzk1YjI0MmE1OWY2Y2FlZWMyOTMyNjkxZi90YWJsZXJhbmdlOjc4ZjNjNTBjOTViMjQyYTU5ZjZjYWVlYzI5MzI2OTFmXzItMy0xLTEtMjY1MjQ3_10c4ed36-532a-438f-adc1-810de2ce34ca">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities reflected in other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo3OGYzYzUwYzk1YjI0MmE1OWY2Y2FlZWMyOTMyNjkxZi90YWJsZXJhbmdlOjc4ZjNjNTBjOTViMjQyYTU5ZjZjYWVlYzI5MzI2OTFmXzMtMS0xLTEtMjY1MjQ3_12da545b-92f0-417e-b9be-42982df1c543">197</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ae60f8a88824bf889f05cc3b51730b3_I20211231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo3OGYzYzUwYzk1YjI0MmE1OWY2Y2FlZWMyOTMyNjkxZi90YWJsZXJhbmdlOjc4ZjNjNTBjOTViMjQyYTU5ZjZjYWVlYzI5MzI2OTFmXzMtMy0xLTEtMjY1MjQ3_233817cc-ac24-41e0-a385-384c27799541">250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo3OGYzYzUwYzk1YjI0MmE1OWY2Y2FlZWMyOTMyNjkxZi90YWJsZXJhbmdlOjc4ZjNjNTBjOTViMjQyYTU5ZjZjYWVlYzI5MzI2OTFmXzQtMS0xLTEtMjY1MjQ3_77385d0c-0494-4a62-9fd3-6db79e6c0465">606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ae60f8a88824bf889f05cc3b51730b3_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo3OGYzYzUwYzk1YjI0MmE1OWY2Y2FlZWMyOTMyNjkxZi90YWJsZXJhbmdlOjc4ZjNjNTBjOTViMjQyYTU5ZjZjYWVlYzI5MzI2OTFmXzQtMy0xLTEtMjY1MjQ3_c341e892-4a03-445d-9206-59d1640aeda4">668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Periodic Benefit Cost (Income)</span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMzI5_6826b17b-570b-4b9d-b1ce-6d4c40c0792b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost (income) for the years ended December&#160;31, 2022, 2021 and 2020 are shown below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Components of net periodic benefit cost (income):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzItMS0xLTEtMjY1MjQ3_82cab2de-bcda-4080-b9e0-c67ccdb1801e">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzItMy0xLTEtMjY1MjQ3_daac5459-c3bf-4337-9765-5256cad72e35">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf18a7ebe0824b4c9cc0c9a8db021e64_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzItNS0xLTEtMjY1MjQ3_8a085ed1-b089-49b0-b1bd-611eea8bbe3f">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzMtMS0xLTEtMjY1MjQ3_f4c599b6-247c-4c86-97eb-d4b9ba8df27c">309</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzMtMy0xLTEtMjY1MjQ3_a7bd3cb6-f498-4241-8318-de82d5bd6aba">317</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf18a7ebe0824b4c9cc0c9a8db021e64_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzMtNS0xLTEtMjY1MjQ3_6bf2944a-67ef-451f-8da1-c6d8441b0ce0">388</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzQtMS0xLTEtMjY1MjQ3_fdb0aa84-8b35-456d-a3e4-ed6d9f83e1bf">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzQtMy0xLTEtMjY1MjQ3_212aa6d8-1316-4f22-b083-35db13517407">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf18a7ebe0824b4c9cc0c9a8db021e64_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzQtNS0xLTEtMjY1MjQ3_2b3c3cf4-b890-4ebe-8a99-39612c3ef92d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzUtMS0xLTEtMjY1MjQ3_3f7dc3b9-70f2-4958-88b6-e6a1c7408c6b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzUtMy0xLTEtMjY1MjQ3_12aa0658-0400-44d2-be7d-e8b4cd64f747">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf18a7ebe0824b4c9cc0c9a8db021e64_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzUtNS0xLTEtMjY1MjQ3_463f5777-399f-468e-8a05-c73d214d3a36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost (income)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzYtMS0xLTEtMjY1MjQ3_122ba9b1-01bf-45f4-80c6-613bd14ee2e0">173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzYtMy0xLTEtMjY1MjQ3_cfebd8cf-718d-4913-b62e-8b8d1fffd76b">186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf18a7ebe0824b4c9cc0c9a8db021e64_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzYtNS0xLTEtMjY1MjQ3_ec2bbbb6-c898-47f8-a5ba-80e14d02343a">218</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i5f4d249e5f60451ca9184a8b66249732" continuedAt="iafc8e7cb989f44f5a665106e7cbd398b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension Plan Assumptions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a series of actuarial assumptions to determine its benefit obligation and net periodic benefit income, the most significant of which include discount rates and expected return on plan assets assumptions. </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Discount Rates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discount rate is determined using a yield curve as of the annual measurement date. The yield curve consists of a series of individual discount rates, with each discount rate corresponding to a single point in time, based on high-quality bonds. Projected benefit payments are discounted to the measurement date using the corresponding rate from the yield curve that is consistent with the maturity profile of the expected liability cash flows.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Return on Plan Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected long-term rate of return on plan assets is determined by using the plan&#8217;s target allocation and return expectations based on many factors including forecasted long-term capital market real returns and the inflationary outlook on a plan by plan basis. See &#8220;Pension Plan Assets&#8221; below for additional details regarding the pension plan assets as of December 31, 2022 and 2021.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also considers other assumptions including mortality, interest crediting rate, termination and retirement rates and cost of living adjustments. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMzE3_b2a0f9be-0e7b-4c27-9390-5050613fce4b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined its benefit obligation based on the following weighted average assumptions as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToxYjM4ODdhZTgwNTA0YmFiYjYxNmI0MWNlMWU0NTQ2YS90YWJsZXJhbmdlOjFiMzg4N2FlODA1MDRiYWJiNjE2YjQxY2UxZTQ1NDZhXzEtMS0xLTEtMjY1MjQ3_5da625d3-16c7-47ac-99f8-bce39bdcece7">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToxYjM4ODdhZTgwNTA0YmFiYjYxNmI0MWNlMWU0NTQ2YS90YWJsZXJhbmdlOjFiMzg4N2FlODA1MDRiYWJiNjE2YjQxY2UxZTQ1NDZhXzEtMy0xLTEtMjY1MjQ3_88d9042f-55ce-4ca0-ae41-e1f8172bcdef">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined its net periodic benefit cost (income) based on the following weighted average assumptions for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTphOWU1ZmEwNDA2OWM0OGY0OGRjNTM0NzA5YjU5NmVkZC90YWJsZXJhbmdlOmE5ZTVmYTA0MDY5YzQ4ZjQ4ZGM1MzQ3MDliNTk2ZWRkXzEtMS0xLTEtMjY1MjQ3_4a9ca28c-803d-481a-bc06-db622f463ef8">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTphOWU1ZmEwNDA2OWM0OGY0OGRjNTM0NzA5YjU5NmVkZC90YWJsZXJhbmdlOmE5ZTVmYTA0MDY5YzQ4ZjQ4ZGM1MzQ3MDliNTk2ZWRkXzEtMy0xLTEtMjY1MjQ3_38442119-3c66-4d90-a0b3-33f3d0ef5809">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTphOWU1ZmEwNDA2OWM0OGY0OGRjNTM0NzA5YjU5NmVkZC90YWJsZXJhbmdlOmE5ZTVmYTA0MDY5YzQ4ZjQ4ZGM1MzQ3MDliNTk2ZWRkXzEtNS0xLTEtMjY1MjQ3_b9551766-53c8-48a4-8d67-647643fcf9e8">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTphOWU1ZmEwNDA2OWM0OGY0OGRjNTM0NzA5YjU5NmVkZC90YWJsZXJhbmdlOmE5ZTVmYTA0MDY5YzQ4ZjQ4ZGM1MzQ3MDliNTk2ZWRkXzItMS0xLTEtMjY1MjQ3_070befaf-b26f-49c6-bac7-a45f0da6f76a">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTphOWU1ZmEwNDA2OWM0OGY0OGRjNTM0NzA5YjU5NmVkZC90YWJsZXJhbmdlOmE5ZTVmYTA0MDY5YzQ4ZjQ4ZGM1MzQ3MDliNTk2ZWRkXzItMy0xLTEtMjY1MjQ3_079f237b-2d93-4ea0-9c8a-2be3fce57e03">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTphOWU1ZmEwNDA2OWM0OGY0OGRjNTM0NzA5YjU5NmVkZC90YWJsZXJhbmdlOmE5ZTVmYTA0MDY5YzQ4ZjQ4ZGM1MzQ3MDliNTk2ZWRkXzItNS0xLTEtMjY1MjQ3_67233d17-7a42-4d8b-b640-227d87ef4c70">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension Plan Assets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s pension plan assets primarily include debt and equity securities held in separate accounts, common/collective trusts and real estate investments. The valuation methodologies used to value these debt and equity securities and common/collective trusts are similar to the methodologies described in Note 4 &#8220;Fair Value.&#8221; Pension plan assets also include investments in other assets that are carried at fair value. The following is a description of the valuation methodologies used to value real estate investments and these additional investments, including the general classification pursuant to the fair value hierarchy.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Real estate investments are valued by independent third party appraisers. The appraisals comply with the Uniform Standards of Professional Appraisal Practice, which include, among other things, the income, cost, and sales comparison approaches to estimating property value. Therefore, these investments are classified in Level 3.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Private equity and hedge fund limited partnerships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Private equity and hedge fund limited partnerships are carried at fair value which is estimated using the NAV per unit as reported by the administrator of the underlying investment fund as a practical expedient to fair value. Therefore, these investments have been excluded from the fair value table below.</span></div></ix:continuation><div style="padding-left:36pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iafc8e7cb989f44f5a665106e7cbd398b" continuedAt="ia159e6d9075f44458939ed7dd75c5b38"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMzEy_dc7b69bd-cbfb-4b90-b242-2f985ee252c4" continuedAt="i8ad09804079d46cea463c31ed3bee564" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2022 were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.870%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1c28ec013bc4526b9794acd9746c77a_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEtMS0xLTEtMjY1MjQ3_964ad5e7-d54e-44d1-bbf6-ad9ed1371d10">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76a4faa3d2d7408ba85519e8aa053ec1_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEtMy0xLTEtMjY1MjQ3_3487f981-3f8b-435d-a292-8774f519f4b9">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2f249637c4a7b939be9fe6d0553f0_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEtNS0xLTEtMjY1MjQ3_b2712e86-48d8-4854-a16e-1c5d6f852ca5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15f18808419f492daac9928c78dfe207_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEtNy0xLTEtMjY1MjQ3_1fa55897-136d-4aee-99c2-73b37c00de5c">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5165fa288fc140b58b3e2eb13b880dad_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzMtMS0xLTEtMjY1MjQ3_afabab94-e261-45db-a265-8c2ab76e5fcc">566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i437030cc5ae74594bd99c673acc0141d_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzMtMy0xLTEtMjY1MjQ3_811e2a0a-68d2-4238-ba11-35ce9d0af81f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f1345bbf71048cab8ec53160a98d6e0_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzMtNS0xLTEtMjY1MjQ3_f587f1bd-d6a0-4495-9116-715f6e34dcc1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafecfb17bf3847a289eb418831589dd0_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzMtNy0xLTEtMjY1MjQ3_1e0885e1-d1a1-4558-8bab-eaa297f45f9b">570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i393269929aa54f8d841281c28c513489_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzQtMS0xLTEtMjY1MjQ3_a176d079-a6e1-431c-a19a-91aab996e9dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71ffeabd45b047f7aa8093796c73ce64_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzQtMy0xLTEtMjY1MjQ3_46ba3a6e-6f4e-42ac-b367-1026dbcabf7b">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19f2f4c671e34716acf9fd0f2b572d66_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzQtNS0xLTEtMjY1MjQ3_c3b76664-d75a-4275-be9f-979e3921192b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i102010332f0b40f2a4057d6bf03e8a1f_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzQtNy0xLTEtMjY1MjQ3_938dfac4-c806-4e08-86c8-89d46868959f">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie97efbadc22e498ab09fa57a7f7a0ece_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzUtMS0xLTEtMjY1MjQ3_50d31d11-baa5-4a64-82a8-37705bdf8fc7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide1653ba45f64f029e277348c07102cf_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzUtMy0xLTEtMjY1MjQ3_02e39bc2-f7e5-4a40-9627-b0911f4cf80b">2,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib74558535ca347569c43f5b77d45f6c5_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzUtNS0xLTEtMjY1MjQ3_c8ba22b7-5439-492e-89c2-24f7b6297029">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3055783102048978188614bf9c92f67_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzUtNy0xLTEtMjY1MjQ3_b3873178-e992-4508-8bba-996136ef2357">2,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f0b29ec64ee405b9f397e174b416349_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzYtMS0xLTEtMjY1MjQ3_2eac9705-645f-4576-a056-10df957b1fe2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f22f16c5656496881261f222143a65c_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzYtMy0xLTEtMjY1MjQ3_4b470237-cde9-49da-b9a4-8bd758eaae66">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80aed82dcefc4d2c8a1b6d1666a62cc5_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzYtNS0xLTEtMjY1MjQ3_5c6a9e26-ba22-44a0-8f67-6ebc61ab7161">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idecaa5de548e46198a7835338a65cfc9_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzYtNy0xLTEtMjY1MjQ3_91930c64-4b3d-43a3-a1de-10f2d079c7de">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb3e587df0ce4e58832ac7d14ef31287_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzctMS0xLTEtMjY1MjQ3_4e2ad15c-96ba-4f86-9965-37a00d048872">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a129fd9ac642898dfe6c3dbf7c13d3_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzctMy0xLTEtMjY1MjQ3_4e42f791-448f-45f0-8056-f5d29b55666c">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07cf02d634944cfe8dec224d5af50138_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzctNS0xLTEtMjY1MjQ3_63124268-284e-45e9-a940-92c0b29ee22e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icedecd6a5d6c4cd6932eb56e5297820a_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzctNy0xLTEtMjY1MjQ3_d65e7e7d-ad1c-4934-b80a-dad6995cb280">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67ed1aa4b0994e08a75a11aabef0ca61_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzgtMS0xLTEtMjY1MjQ3_3b449831-a27c-4e8e-9a1d-fd8f86169efb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d4ba1b4e5fd46a59de47cb57daebd43_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzgtMy0xLTEtMjY1MjQ3_ac08ab17-adc0-434a-b1ce-33764e175058">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53d2e727f536476fb8cadfd6668d3f36_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzgtNS0xLTEtMjY1MjQ3_a01ab5e9-49eb-4fbc-ba81-ec0c07a19bb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if42d8de426004e0aa3dd6333ac3a65bd_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzgtNy0xLTEtMjY1MjQ3_8d20b6cd-19a9-4425-a5ca-402d0cc8bc17">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06bd54c2ec1749b6bfe532accaddeb19_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzktMS0xLTEtMjY1MjQ3_08fc3d2b-64c6-49b3-aa8c-ab0ab287d838">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15075758aefe43d2bf31d3cc52dcb868_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzktMy0xLTEtMjY1MjQ3_c7178d9d-4074-418a-ad4e-1d0c9c8773f5">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75cf4995d769495181bc451a1291d416_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzktNS0xLTEtMjY1MjQ3_03a3bef4-c323-4f7c-a299-586b2d07d7eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6964724f64da443a8d85ef14ba9b207f_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzktNy0xLTEtMjY1MjQ3_d0f8b758-d9a9-40e4-af81-3ee388a5b8e1">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8d04d5adea4cc4950dd1f1163a8c24_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEwLTEtMS0xLTI2NTI0Nw_4facc99c-13e1-4656-968a-713f5d47a821">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i467dc11c176c49a494b2bfbc4ecd8d40_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEwLTMtMS0xLTI2NTI0Nw_641e5425-960f-4e6a-8260-ec33b094fbdb">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4561999a767a47c9b145429b6871dada_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEwLTUtMS0xLTI2NTI0Nw_9fd45178-053b-4ad1-ab63-5115c7554c99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49acfce007b84f6a8ed646d3879a295e_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEwLTctMS0xLTI2NTI0Nw_d1b38e6b-9c8a-4402-8328-57892f518f86">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f6d39a48124eada9253e73f5eb298d_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzExLTEtMS0xLTI2NTI0Nw_f59f51fe-7f20-4e41-b635-783bf73a99fa">566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i425da7be65a34eadaf6d0d7d246f41ac_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzExLTMtMS0xLTI2NTI0Nw_f7272b80-a1a6-4fe5-97a2-5c1c00cefbaf">2,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dea2df573724790a05410f34ffcaa89_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzExLTUtMS0xLTI2NTI0Nw_0c0c109c-c5f0-4ec2-9a9e-d3e45e2b295f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaceec8e969924b699be4f035e5a5f056_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzExLTctMS0xLTI2NTI0Nw_0f4708ae-e7d3-45e8-a268-df7445a3bc55">3,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. domestic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bcbef4b6154d14993eefedb06e445c_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEzLTEtMS0xLTI2NTI0Nw_4a7afb81-8dc3-4ffa-9621-f3912ff25da9">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d3a7dadc46046679f4259f0c2cf607b_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEzLTMtMS0xLTI2NTI0Nw_efbeaf0e-dd8e-4358-94eb-f135cc7b1608">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb67485d5704379b1a6d4da590cf813_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEzLTUtMS0xLTI2NTI0Nw_c1eae762-1dcd-4d74-a886-6f98ebec3ec5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25c01da9448541d9a4bbe6f5bf974426_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEzLTctMS0xLTI2NTI0Nw_9ddb3527-8b22-4690-ae7f-7000b40251a7">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff5a9de270b47439f9f2e3164cdbaf1_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE0LTEtMS0xLTI2NTI0Nw_d50caba2-fe48-476f-9993-7ca8653c032b">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idce9aa4064f649998284ca968ead9aeb_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE0LTMtMS0xLTI2NTI0Nw_c052b888-5ad1-4f21-a8ec-38dffed62ec2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id88dc572d4a4463a87db8a149bc97af6_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE0LTUtMS0xLTI2NTI0Nw_29d01f3f-aafb-42dc-9303-eea6117779ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia48873c4be084823ac547c96b29588bf_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE0LTctMS0xLTI2NTI0Nw_e7de78bf-4c9c-4c41-9be8-cfb20147bcb2">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Domestic real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i361bca717f0145f392b30b6c5842a5fb_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE1LTEtMS0xLTI2NTI0Nw_7d3b83e4-2962-4230-b50b-81c9834be427">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb37318a487b4f68b2cff4e55df4fae8_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE1LTMtMS0xLTI2NTI0Nw_76271def-0a67-4f10-b8f5-9924d2743276">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i458d0bce582548dabb9da928f9be1723_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE1LTUtMS0xLTI2NTI0Nw_1dd17caa-0073-4b18-9437-e57dc7eba110">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f36bf1575754528b65dba20e88e4417_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE1LTctMS0xLTI2NTI0Nw_4666acbc-d8d2-4064-8904-e46a2e1efe30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34cb265be9104204aa213bd1c51fcdbb_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE2LTEtMS0xLTI2NTI0Nw_6637990e-0360-4da5-9b43-f7d3e1e8eb15">176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859f79ed7f81424ea30511713f0e5fd7_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE2LTMtMS0xLTI2NTI0Nw_6c367825-3787-42d0-819c-18e775ec498d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd55208234184797b8bc48b1ab33f4f2_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE2LTUtMS0xLTI2NTI0Nw_c6774677-08e0-4f00-8c50-bee1d4ab1c3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i047b2e5d175948e28dc1326800198805_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE2LTctMS0xLTI2NTI0Nw_b3b7bc6b-f966-4068-a67a-541b0e40f4fd">176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a9722f65b7649a0af5a40118df4c83a_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE4LTEtMS0xLTI2NTI0Nw_eb480895-16ba-44f3-98e6-4ed3ae9ad7d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fb1ff4cb6bd4a5f987eb066e1579632_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE4LTMtMS0xLTI2NTI0Nw_f77bd6e4-7dce-4f12-b020-1193b822d13b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d10279e4e4240e58c58b67195918c98_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE4LTUtMS0xLTI2NTI0Nw_a3d77751-f5b9-4664-9119-2308a60d5004">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdeaeb4835884f6087e9025f4a721a0e_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE4LTctMS0xLTI2NTI0Nw_3a31aeb8-eda1-4438-82d3-b838792fc0f5">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Common/collective trusts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03a2021968d469cafd277b1d48aeec0_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE5LTEtMS0xLTI2NTI0Nw_3f3aab9a-73ce-468d-8fd3-3d02b11857de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e96192e9c994cc3a7cd9d3198afec11_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE5LTMtMS0xLTI2NTI0Nw_1b0bfb3f-776c-441c-a37b-7c9b972c9c93">307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b84bbaf70a647149bd4230fec93c00e_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE5LTUtMS0xLTI2NTI0Nw_75d68c45-fc31-4365-9843-653932397f4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i434d9033c59345d994a83769698d5f43_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE5LTctMS0xLTI2NTI0Nw_64f74771-7afa-4a7c-90c3-7fbc80c5622d">307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8553b3aff6d249b18a9cd384b6c1a55b_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzIxLTEtMS0xLTI2NTI0Nw_057c061a-8a27-4892-bc42-301e6fdd511d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82cdd943a4d64fa6817835bd3971c780_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzIxLTMtMS0xLTI2NTI0Nw_4f89eee2-24e2-46bf-8e06-37d8742cc3f1">307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i293cf1a1995d4e29b26bc330b1666507_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzIxLTUtMS0xLTI2NTI0Nw_3b0aa5bb-8d42-4459-9b19-6a00b1b7ed3b">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ceb26b60fcb4903b42e2e7063f9ec62_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzIxLTctMS0xLTI2NTI0Nw_4eefb0cb-22a4-4078-83d6-963d22600e4e">632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pension investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1cda680d3d4f8696d51e3ed6642658_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzIyLTEtMS0xLTI2NTI0Nw_153c7f8e-5529-4e32-8aeb-1b0025a33126">749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10542d46becc44c5967969f7f85f3589_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzIyLTMtMS0xLTI2NTI0Nw_4fed6903-a7dd-4128-8ee7-f991f2f4d43c">3,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i292b96aad4ec49cdbd305facd2f76542_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzIyLTUtMS0xLTI2NTI0Nw_d8d999c4-ac6e-4751-9aca-9978fd6c7ec3">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f6a83783837419fbce160a80bfc2d32_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzIyLTctMS0xLTI2NTI0Nw_fd870022-4dd9-4be4-8f24-b2ed3f4418a2">4,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The assets in the underlying funds of common/collective trusts consist of $<ix:nonFraction unitRef="usd" contextRef="ie6ba387bd5784b3588f79042c1627c7c_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzUyNTc_e7271f09-a965-46c0-8dcf-591b86e78eb9">104</ix:nonFraction> million of equity securities and $<ix:nonFraction unitRef="usd" contextRef="i7b3fb67b13b4433fb27cf39843018e90_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzUyODU_0fe4a312-240f-4624-a5ba-3570f7a5cea4">203</ix:nonFraction> million of debt securities. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $<ix:nonFraction unitRef="usd" contextRef="i1ba4905b6b0747a79b11529e76f3525a_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzUzMTg_b5036d2a-dded-4240-a958-9c477c70bdc2">390</ix:nonFraction> million of other receivables as well as $<ix:nonFraction unitRef="usd" contextRef="id34b6ff6eb5d4ff8b7d64f102c051a4f_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzUzNTM_32eea42e-bd9d-4709-8f4e-868297d98e32">432</ix:nonFraction> million of private equity limited partnership investments and $<ix:nonFraction unitRef="usd" contextRef="i2f8b8e5367b4480ea7d27890901e6247_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzU0MTA_71f6cb4a-0d3a-4753-8e4d-6d43e2f14b2e">225</ix:nonFraction> million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy. </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia159e6d9075f44458939ed7dd75c5b38" continuedAt="i797e1a9f29634862bbe9fb0810db9c41"><ix:continuation id="i8ad09804079d46cea463c31ed3bee564" continuedAt="i98baa7fdf6514b63b07b2539f2646f09"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2021 were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.870%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2483b2d9ed46464386b90249127712ec_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEtMS0xLTEtMjY1MjQ3_c10fb62e-d0e4-4269-b377-31fa4032c355">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a89dc1177b443eebe04b19998c03509_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEtMy0xLTEtMjY1MjQ3_9d078728-4559-4044-b957-4bf970c59fb3">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf9ceb18ea574327a935ba6e88f2287e_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEtNS0xLTEtMjY1MjQ3_cce9ecc9-c3da-4a14-8a15-5c6a395d8bf3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie38b76b68c8f4324b3b7de80321c3a38_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEtNy0xLTEtMjY1MjQ3_7bb4cd7c-7c64-4eea-8943-328c1699ad9b">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c7e5e536ab42b8b050fbde07b7944b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzMtMS0xLTEtMjY1MjQ3_80038c60-1e5b-42b1-937c-8526cd2c04c5">1,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib321cf5df709449c9ceca7c03a1a464a_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzMtMy0xLTEtMjY1MjQ3_4243e7fb-13e1-4eb9-b57f-18a39a77dab3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5115a8b317f4f088dd39cf66bd37168_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzMtNS0xLTEtMjY1MjQ3_8344a1cc-7b89-4e6e-924e-83f8fffe464e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7ca09ccbe954fe782f927e64956c241_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzMtNy0xLTEtMjY1MjQ3_c1bade75-bb2a-4419-84e7-3e94b1c003ba">1,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6de203a7cbb4d628006e35c743071f4_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzQtMS0xLTEtMjY1MjQ3_d1c2db29-1208-4678-b271-8bd3be8f90af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe3ca3dba18c491a9e22b5dec78052d1_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzQtMy0xLTEtMjY1MjQ3_cc8b2e23-25bd-42e0-a2b8-a1fe474dd00c">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f8b8023230e41f1a277473b8be2f39c_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzQtNS0xLTEtMjY1MjQ3_36c7ffa8-7ce8-4244-b750-4189304aaab3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaac68e1f017c44aa9dd4c8012dbc3c27_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzQtNy0xLTEtMjY1MjQ3_f9f850b7-b277-47cf-9a29-d99d39720f98">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i422a5afe8aab4de28a6a361f067c59ff_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzUtMS0xLTEtMjY1MjQ3_621b2a20-3953-4871-8996-61054942eafc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55f94c0a8c604d198a8060e3981590d2_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzUtMy0xLTEtMjY1MjQ3_4b1e2477-8396-422a-8893-6f07283ed42f">2,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f4a9f967aaa4491ac8ac4bb55abdd08_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzUtNS0xLTEtMjY1MjQ3_443916d4-180b-43b0-a44b-8a56039d72a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c682f38539f4aea97612b5c8fd96801_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzUtNy0xLTEtMjY1MjQ3_1e42208b-3a49-4af6-8075-11d292c96cf8">2,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad6319eb9e074402bd329fc00b71a0d4_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzYtMS0xLTEtMjY1MjQ3_52e8a6f2-5a0d-4921-a94c-69930a632a1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225a548f115e4e4cbc128578264d598f_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzYtMy0xLTEtMjY1MjQ3_6f68e7a1-48dc-41db-a7c5-61dc67fb8c21">202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b7f7de16d6f455b9b95fe42c0e7ddf4_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzYtNS0xLTEtMjY1MjQ3_5f9df607-d311-4abb-a581-f5926769edc4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic622298e7e1042bab9e914624480e3f3_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzYtNy0xLTEtMjY1MjQ3_668aa60c-e11f-4afc-b5e2-ea8ebfef142c">202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice305fd722c144a8a3962bcd2d78808d_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzctMS0xLTEtMjY1MjQ3_65bc78f9-1525-498f-b4ad-96dd3594b964">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6fff6d946ac4c55bcd073422901fa74_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzctMy0xLTEtMjY1MjQ3_0b7209f3-f7e8-49ba-b956-0df6d1133739">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idec237e4913a4141abffa54109b01c5b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzctNS0xLTEtMjY1MjQ3_16cbf4c3-020a-4e5d-921b-98b34d411ec0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i424cf2f1fe794bf8b9685e626e4b60eb_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzctNy0xLTEtMjY1MjQ3_5d7ba3de-034b-46d5-832f-5459b6efcb7e">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92dad2a6cdd147b4a4bab53cde589c29_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzgtMS0xLTEtMjY1MjQ3_6128fcff-93d0-41ae-8052-27804172f24b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i841e9a2db5bb4870b1acecc87843ca11_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzgtMy0xLTEtMjY1MjQ3_c153db2e-65e3-488a-89b4-35c3b35d1a8e">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i323adde47a404de6a429ebcdc6d4a624_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzgtNS0xLTEtMjY1MjQ3_772204c9-e03f-452e-bf0c-a76a0d638d9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66bfc1b58bee484ca8439711f02fc588_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzgtNy0xLTEtMjY1MjQ3_2e0a3c02-f898-4672-8a1a-18cdf82c005b">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6febefab642d465386af8f7ad424e1d9_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzktMS0xLTEtMjY1MjQ3_5be4ad14-a676-48a1-8fd1-f2fc40717eae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8b7ecb5ef6b4772b3207c0af0378129_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzktMy0xLTEtMjY1MjQ3_377c6a8a-d9fa-40da-8395-f3ceda3b4715">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d7062cfce4d47d4950a86d0fe1a51be_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzktNS0xLTEtMjY1MjQ3_3f772f61-9d20-421b-ab25-462ac6f85a6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0351d4a2c042f8ad934772134cdbd5_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzktNy0xLTEtMjY1MjQ3_b60f35d7-3bbc-4884-9ccb-6ed9a50b8a35">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588df02460dd45ebac24745a67831e0b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEwLTEtMS0xLTI2NTI0Nw_32a9bd21-b6a6-436b-992a-78d9a2a0f35d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa15814eab354d1da0577719608c58a7_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEwLTMtMS0xLTI2NTI0Nw_79c30ec9-982e-440c-b25d-285cce382917">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie93d0f38ac78460a8408e52712b8a9e0_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEwLTUtMS0xLTI2NTI0Nw_9d508c4c-0b6b-4899-9e11-00cf50d25efb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62058f08b95b41b29a2bd7105c86068a_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEwLTctMS0xLTI2NTI0Nw_cd9ca3dc-254e-4429-921a-e81ede428c23">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0978cb2beb54ca08a64c48351e6340d_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzExLTEtMS0xLTI2NTI0Nw_ef4c437e-82be-4609-96bb-60354c0e1989">1,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9283234f91734e7f8067245dffa66546_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzExLTMtMS0xLTI2NTI0Nw_5475d582-e3e2-4152-82d9-b4bceb9ea0e7">3,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a65013be1484144aa7390d6ce8685f1_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzExLTUtMS0xLTI2NTI0Nw_f8d818e7-90d0-4807-ad92-f3dc7c8516b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dd96e63a05b477c81a74ccccae0af1a_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzExLTctMS0xLTI2NTI0Nw_cda26cdc-88bb-49fe-a66a-3ea2a9bb8669">4,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. domestic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d58e5df6a4d4dc2b2d2020abf96dab7_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEzLTEtMS0xLTI2NTI0Nw_57a55a8d-3de7-4360-aa77-5152d2a6a2d3">201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30951550eb89447faeb8aed509f96d7a_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEzLTMtMS0xLTI2NTI0Nw_c8afafd4-979f-4abd-a2ff-33f6e1c69e17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5e498c9e0e949d295170b34d02f42b1_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEzLTUtMS0xLTI2NTI0Nw_e4361128-b4c7-4126-80d9-8d94a6b4449d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecf6ed88f0704ea1b5a17c05fba15357_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEzLTctMS0xLTI2NTI0Nw_6e090a28-0bf6-4636-b8c2-8e1f11e85371">201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5a4161ee999468695164764689d0456_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE0LTEtMS0xLTI2NTI0Nw_d3de1d0d-a36d-483d-93f7-1cb3e8082f63">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b5516f1d83549df8e3672acb28d4018_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE0LTMtMS0xLTI2NTI0Nw_249a566d-b695-413c-a240-6d86875ffbe9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57859501e60645cb9752e9e1f0aaca52_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE0LTUtMS0xLTI2NTI0Nw_d8ff98bb-b6d2-44ea-8d3a-fd15d1265a83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4691f1cc92b841bebd9eb3e713080db4_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE0LTctMS0xLTI2NTI0Nw_d028722f-f105-482b-8d8b-b8325bb6dc07">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Domestic real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if380f772d15949968faea35f6c392908_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE1LTEtMS0xLTI2NTI0Nw_358422c7-d1d5-4900-8b91-91637b65da13">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a39f01aeb134cdc96203f9fb9113b29_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE1LTMtMS0xLTI2NTI0Nw_124ba9f6-5b92-4dc2-82b7-6cb561708883">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib12ac2d182de47eabc00a82a798699f2_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE1LTUtMS0xLTI2NTI0Nw_c192a536-d0b7-4655-ab61-331886832f33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia432ea4fe3664eda9ea74cb9f5d6541e_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE1LTctMS0xLTI2NTI0Nw_af4fa547-9a8a-4c5a-98bc-8de517335d52">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id85fcc73165340dca7de806a6adfdfbd_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE2LTEtMS0xLTI2NTI0Nw_83b4bd6f-d753-4559-9397-f90e6568b603">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06c3b035437e4295b67d73728537c87e_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE2LTMtMS0xLTI2NTI0Nw_340b6dbd-29ef-4b46-b012-f7364cced0fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7760d59224714c619f74107d44fec8a9_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE2LTUtMS0xLTI2NTI0Nw_cba0d5e9-b417-4635-9ab1-41e4c4b41de3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b273fdc1bd847ed8bc54eda0343fb49_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE2LTctMS0xLTI2NTI0Nw_b586b9bb-ba0e-4950-b4e0-cd50d07fd617">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f27f3a0ddaa4943a0a01af080cffc48_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE4LTEtMS0xLTI2NTI0Nw_e71fa8ad-d500-403d-a27b-6dc8fc74a3c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c0c1b4aba8442ebb3315909595081fb_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE4LTMtMS0xLTI2NTI0Nw_c51fce36-cbb0-42fc-ae36-6e23998dea72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i606a32f530d0485e9489b153aae2186a_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE4LTUtMS0xLTI2NTI0Nw_ff137889-4bbe-4dbe-821a-c8e7117cc388">378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied58211431b74500ad5aa97b2eb41a6b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE4LTctMS0xLTI2NTI0Nw_907b8d64-435f-4cf5-a8b4-8437430b9cef">378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Common/collective trusts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i626787e8dd8a4a428e915960b4c68a35_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE5LTEtMS0xLTI2NTI0Nw_ba6a3807-bbe0-413c-a76e-5da151e77523">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ffe6c35b7494418ac8c422fd3541f2b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE5LTMtMS0xLTI2NTI0Nw_42318a78-7225-4821-bd2a-d8ffc9b19ae1">410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63c0c51144c74ed59e090814aedeff5e_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE5LTUtMS0xLTI2NTI0Nw_54b8c3f5-de60-4783-8901-6bd3bf380b70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63529787efd54319893b4e048ab45752_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE5LTctMS0xLTI2NTI0Nw_1cd00c85-5082-4814-9410-f96a2264b088">410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic094ef4183de49abb0d6149a76f6e4e4_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzIxLTEtMS0xLTI2NTI0Nw_d9738cbd-0f99-461b-ba69-c54c3fecc25a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72861e7450344b1abe5a17aa6d5da491_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzIxLTMtMS0xLTI2NTI0Nw_ddc0676d-aa66-4da2-b1ec-65b09fd55c40">410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fb5d20c5bdd4e3c88101cecdc5afb9b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzIxLTUtMS0xLTI2NTI0Nw_e07221c3-611a-45bd-8b8c-b9f803c72fc2">378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i391c77fcea114168adcefd3a368e933a_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzIxLTctMS0xLTI2NTI0Nw_855393ae-3dd9-47d6-bd93-5d909fc96ea5">788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pension investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8291bfbd551444d08280efa65d088b0c_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzIyLTEtMS0xLTI2NTI0Nw_d6d6198d-de0b-4623-a894-1cf8c4146e59">1,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16285192a2914c1f825e830eeb4eeb4f_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzIyLTMtMS0xLTI2NTI0Nw_85893026-d281-4908-bb07-a189da6b5788">3,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d3917a82295412f9c9275a317a05f05_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzIyLTUtMS0xLTI2NTI0Nw_57e2e3e3-4b05-4f2d-b598-d99c235388af">378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfd78e27e7c6482c9fc4edcc25879cfc_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzIyLTctMS0xLTI2NTI0Nw_e34b01ff-e8ee-44e7-974d-af2b0222f661">5,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The assets in the underlying funds of common/collective trusts consist of $<ix:nonFraction unitRef="usd" contextRef="ief0525a09e3740098895f800adaf9574_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzU4MTM_59c54be4-75e2-4fdc-83c6-bdc897ff2c8b">261</ix:nonFraction> million of equity securities and $<ix:nonFraction unitRef="usd" contextRef="ib3fd8796636345479f329fc227aac5b9_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzU4NDE_d7b3a188-d441-4585-b037-f45f9c1feb4f">149</ix:nonFraction> million of debt securities. </span></div></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i98baa7fdf6514b63b07b2539f2646f09" continuedAt="i794e11cffcb04eeb89702ebaf3fee207">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="i794e11cffcb04eeb89702ebaf3fee207">Excludes $<ix:nonFraction unitRef="usd" contextRef="id74fa3142e884619b01040d54d501710_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzU4NzQ_0b184a9f-a99c-4c51-8940-a1251d0d6a2b">76</ix:nonFraction> million of other receivables as well as $<ix:nonFraction unitRef="usd" contextRef="icc02cf1426314af28563a5e9e8a9a5e1_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzU5MDk_93cc5b50-ec13-406e-b99e-0c8776437cf7">583</ix:nonFraction> million of private equity limited partnership investments and $<ix:nonFraction unitRef="usd" contextRef="i2cdf7726148d4d678b6d37597a2aac70_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzU5NjY_64491baa-e4f9-4325-8af1-c30630434efe">237</ix:nonFraction> million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:DefinedBenefitPlanPlanAssetsCategoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMzMw_6485ba20-02d2-40d1-9dce-cee9bb6744cf" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 pension plan assets during the year ended December&#160;31, 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:74.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.759%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.761%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Real estate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i606a32f530d0485e9489b153aae2186a_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmOWJhZDZiZDg3MWY0M2FhOWMwZTRhMjkzNzgzYTg3MC90YWJsZXJhbmdlOmY5YmFkNmJkODcxZjQzYWE5YzBlNGEyOTM3ODNhODcwXzEtMS0xLTEtMjY1MjQ3_75cd2aff-7492-4b29-a542-eb348d0806eb">378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d3917a82295412f9c9275a317a05f05_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmOWJhZDZiZDg3MWY0M2FhOWMwZTRhMjkzNzgzYTg3MC90YWJsZXJhbmdlOmY5YmFkNmJkODcxZjQzYWE5YzBlNGEyOTM3ODNhODcwXzEtNS0xLTEtMjY1MjQ3_96e0d96d-c7c6-4520-8242-d40fa03487e5">378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b4331fe0364273803356e287d2561b_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmOWJhZDZiZDg3MWY0M2FhOWMwZTRhMjkzNzgzYTg3MC90YWJsZXJhbmdlOmY5YmFkNmJkODcxZjQzYWE5YzBlNGEyOTM3ODNhODcwXzItMS0xLTEtMjY1MjQ3_9fd431cb-e519-4114-9ba3-25b9cc1413ff">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic928117af54f4c0892def0fc4bb4ca6f_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmOWJhZDZiZDg3MWY0M2FhOWMwZTRhMjkzNzgzYTg3MC90YWJsZXJhbmdlOmY5YmFkNmJkODcxZjQzYWE5YzBlNGEyOTM3ODNhODcwXzItNS0xLTEtMjY1MjQ3_fb2414db-9d8b-4c98-9dfe-3c412453e5a6">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92b4331fe0364273803356e287d2561b_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmOWJhZDZiZDg3MWY0M2FhOWMwZTRhMjkzNzgzYTg3MC90YWJsZXJhbmdlOmY5YmFkNmJkODcxZjQzYWE5YzBlNGEyOTM3ODNhODcwXzMtMS0xLTEtMjY1MjQ3_9d1fab41-8c87-45ff-b77c-3ebc81bc3ec9">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic928117af54f4c0892def0fc4bb4ca6f_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmOWJhZDZiZDg3MWY0M2FhOWMwZTRhMjkzNzgzYTg3MC90YWJsZXJhbmdlOmY5YmFkNmJkODcxZjQzYWE5YzBlNGEyOTM3ODNhODcwXzMtNS0xLTEtMjY1MjQ3_23f59ece-906c-4151-83b7-9abcd2820ef7">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b4331fe0364273803356e287d2561b_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmOWJhZDZiZDg3MWY0M2FhOWMwZTRhMjkzNzgzYTg3MC90YWJsZXJhbmdlOmY5YmFkNmJkODcxZjQzYWE5YzBlNGEyOTM3ODNhODcwXzQtMS0xLTEtMjY1MjQ3_4014ee79-fb55-4411-b7f0-7c73862204f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic928117af54f4c0892def0fc4bb4ca6f_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmOWJhZDZiZDg3MWY0M2FhOWMwZTRhMjkzNzgzYTg3MC90YWJsZXJhbmdlOmY5YmFkNmJkODcxZjQzYWE5YzBlNGEyOTM3ODNhODcwXzQtNS0xLTEtMjY1MjQ3_03ece846-d968-4507-a7d4-2d7316d30e88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d10279e4e4240e58c58b67195918c98_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmOWJhZDZiZDg3MWY0M2FhOWMwZTRhMjkzNzgzYTg3MC90YWJsZXJhbmdlOmY5YmFkNmJkODcxZjQzYWE5YzBlNGEyOTM3ODNhODcwXzUtMS0xLTEtMjY1MjQ3_06c32dc7-2917-4127-830c-4480d4fdb2e7">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i292b96aad4ec49cdbd305facd2f76542_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmOWJhZDZiZDg3MWY0M2FhOWMwZTRhMjkzNzgzYTg3MC90YWJsZXJhbmdlOmY5YmFkNmJkODcxZjQzYWE5YzBlNGEyOTM3ODNhODcwXzUtNS0xLTEtMjY1MjQ3_c6b7cde6-b0fb-4d78-b013-cb60d17c9af0">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 pension plan assets during the year ended December&#160;31, 2021 were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.046%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Real estate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i535c834eab7441c89aa3908b303c0da7_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmZTBhMmM4YjQ2MjM0YmQyOTdiMGMwNjFmNjQzMzBkZS90YWJsZXJhbmdlOmZlMGEyYzhiNDYyMzRiZDI5N2IwYzA2MWY2NDMzMGRlXzEtMS0xLTEtMjY1MjQ3_8d087cc0-e021-4ee6-aee9-394ae3575612">343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6621e945d6764a88aa47982bd5644a44_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmZTBhMmM4YjQ2MjM0YmQyOTdiMGMwNjFmNjQzMzBkZS90YWJsZXJhbmdlOmZlMGEyYzhiNDYyMzRiZDI5N2IwYzA2MWY2NDMzMGRlXzEtNS0xLTEtMjY1MjQ3_5510ac4b-c6ee-42ad-8e61-eb9a1adf86d9">343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if24037d3545b44d7b17124b131dcad75_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmZTBhMmM4YjQ2MjM0YmQyOTdiMGMwNjFmNjQzMzBkZS90YWJsZXJhbmdlOmZlMGEyYzhiNDYyMzRiZDI5N2IwYzA2MWY2NDMzMGRlXzItMS0xLTEtMjY1MjQ3_0a9dc0c7-42de-4e3f-a0f2-40298e3bd3f7">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i397591891c3b446b8fe2edeab28e0a83_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmZTBhMmM4YjQ2MjM0YmQyOTdiMGMwNjFmNjQzMzBkZS90YWJsZXJhbmdlOmZlMGEyYzhiNDYyMzRiZDI5N2IwYzA2MWY2NDMzMGRlXzItNS0xLTEtMjY1MjQ3_2ed4c39b-24c7-4afa-8b20-aaaea251cd39">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if24037d3545b44d7b17124b131dcad75_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmZTBhMmM4YjQ2MjM0YmQyOTdiMGMwNjFmNjQzMzBkZS90YWJsZXJhbmdlOmZlMGEyYzhiNDYyMzRiZDI5N2IwYzA2MWY2NDMzMGRlXzMtMS0xLTEtMjY1MjQ3_93e1183d-daf2-4198-b209-13bbdbbd3ce7">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i397591891c3b446b8fe2edeab28e0a83_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmZTBhMmM4YjQ2MjM0YmQyOTdiMGMwNjFmNjQzMzBkZS90YWJsZXJhbmdlOmZlMGEyYzhiNDYyMzRiZDI5N2IwYzA2MWY2NDMzMGRlXzMtNS0xLTEtMjY1MjQ3_f0a968b3-dc59-4e73-953d-45104555acf9">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if24037d3545b44d7b17124b131dcad75_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmZTBhMmM4YjQ2MjM0YmQyOTdiMGMwNjFmNjQzMzBkZS90YWJsZXJhbmdlOmZlMGEyYzhiNDYyMzRiZDI5N2IwYzA2MWY2NDMzMGRlXzQtMS0xLTEtMjY1MjQ3_646074de-4cac-42e6-a920-6fc1b33e1fa7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i397591891c3b446b8fe2edeab28e0a83_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmZTBhMmM4YjQ2MjM0YmQyOTdiMGMwNjFmNjQzMzBkZS90YWJsZXJhbmdlOmZlMGEyYzhiNDYyMzRiZDI5N2IwYzA2MWY2NDMzMGRlXzQtNS0xLTEtMjY1MjQ3_a1518ac6-1730-42a5-8eb3-e9d1b117fc2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i606a32f530d0485e9489b153aae2186a_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmZTBhMmM4YjQ2MjM0YmQyOTdiMGMwNjFmNjQzMzBkZS90YWJsZXJhbmdlOmZlMGEyYzhiNDYyMzRiZDI5N2IwYzA2MWY2NDMzMGRlXzUtMS0xLTEtMjY1MjQ3_5cbd1897-f154-44a7-91c3-d91c7bf1c593">378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d3917a82295412f9c9275a317a05f05_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmZTBhMmM4YjQ2MjM0YmQyOTdiMGMwNjFmNjQzMzBkZS90YWJsZXJhbmdlOmZlMGEyYzhiNDYyMzRiZDI5N2IwYzA2MWY2NDMzMGRlXzUtNS0xLTEtMjY1MjQ3_3d202e6d-80bc-45bb-99ae-429cea6586ec">378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s pension plan invests in a diversified mix of assets designed to generate returns that will enable the plan to meet its future benefit obligations. The risk of unexpected investment and actuarial outcomes is regularly evaluated. This evaluation </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i797e1a9f29634862bbe9fb0810db9c41" continuedAt="i3f3c23ca06094185a9878f26a1c56cea"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is performed through forecasting and assessing ranges of investment outcomes over short- and long-term horizons and by assessing the pension plan&#8217;s liability characteristics. Complementary investment styles and strategies are utilized by professional investment management firms to further improve portfolio and operational risk characteristics. Public and private equity investments are used primarily to increase overall plan returns. Real estate investments are viewed favorably for their diversification benefits and above-average dividend generation. Fixed income investments provide diversification benefits and liability hedging attributes that are desirable, especially in falling interest rate environments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, target investment allocations for the Company&#8217;s pension plan were: <ix:nonFraction unitRef="number" contextRef="idd0c449a45b5463791a11ad8fb885a7f_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzc0MDU_8acc3181-a326-47d7-8643-d2a5599a54c6">12</ix:nonFraction>% in equity securities, <ix:nonFraction unitRef="number" contextRef="ibab30eb09068437faeb20a15dacc2fac_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzc0MzA_82c1ef8d-8fc1-4b36-a297-f7e50efb757a">77</ix:nonFraction>% in fixed income and debt securities, <ix:nonFraction unitRef="number" contextRef="i534f8d2a6659488381539213487bbba7_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzc0NzA_ac2eb68f-0971-42c1-9a96-78ac2de18e67">5</ix:nonFraction>% in real estate, <ix:nonFraction unitRef="number" contextRef="ib6f3a72a51a14616b3c062670d5dc4fa_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzc0ODk_426da5ac-51bd-4309-83cc-0ba2455ef938">3</ix:nonFraction>% in private equity limited partnerships and <ix:nonFraction unitRef="number" contextRef="i8dbb3cd21e554ebcb4cf9e874172fbff_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzc1MzU_38a9cb28-3eee-4e0f-b8c7-7247db38d8fd">3</ix:nonFraction>% in hedge funds. Actual asset allocations may differ from target allocations due to tactical decisions to overweight or underweight certain assets or as a result of normal fluctuations in asset values. Asset allocations are consistent with stated investment policies and, as a general rule, periodically rebalanced back to target asset allocations. Asset allocations and investment performance are formally reviewed periodically throughout the year by the pension plan&#8217;s Investment Subcommittee. Forecasting of asset and liability growth is performed at least annually.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally contributes to its tax-qualified pension plan based on minimum funding requirements determined under applicable federal laws and regulations. Employer contributions related to the nonqualified supplemental pension plans generally represent payments to retirees for current benefits. The Company contributed $<ix:nonFraction unitRef="usd" contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzg0NDg_f86797be-17e9-4422-9556-9493826d1f12">27</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzg0NTI_118fc5e3-f2b2-4509-932a-68ead841fc0f">78</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idf18a7ebe0824b4c9cc0c9a8db021e64_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzg0NTk_a08562f5-0c7b-4aa5-a764-19d33b0e0bde">25</ix:nonFraction> million to its pension plans during 2022, 2021 and 2020, respectively. No contributions are required for the tax-qualified pension plan in 2023. The Company expects to make an immaterial amount of contributions for all other pension plans in 2023.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMzE0_031fd6d4-3fb7-4c6d-ad43-ac93790a42da" continuedAt="i6ddaf7f900df483c8429640faff20c18" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the pension benefit obligation as of December&#160;31, 2022: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo0NTAzMzM0MmYyZDA0MjE4OTE4M2IwYmRhZjA0MmE5ZS90YWJsZXJhbmdlOjQ1MDMzMzQyZjJkMDQyMTg5MTgzYjBiZGFmMDQyYTllXzEtMS0xLTEtMjY1MjQ3_e83c9dd4-cccb-4ebd-87e1-de2f3e896a5e">368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo0NTAzMzM0MmYyZDA0MjE4OTE4M2IwYmRhZjA0MmE5ZS90YWJsZXJhbmdlOjQ1MDMzMzQyZjJkMDQyMTg5MTgzYjBiZGFmMDQyYTllXzItMS0xLTEtMjY1MjQ3_62ecc2e5-d32a-4566-b50f-d0e5ccfb072b">369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo0NTAzMzM0MmYyZDA0MjE4OTE4M2IwYmRhZjA0MmE5ZS90YWJsZXJhbmdlOjQ1MDMzMzQyZjJkMDQyMTg5MTgzYjBiZGFmMDQyYTllXzMtMS0xLTEtMjY1MjQ3_d0764f77-b856-45cb-b33e-7fffdfc41c18">372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo0NTAzMzM0MmYyZDA0MjE4OTE4M2IwYmRhZjA0MmE5ZS90YWJsZXJhbmdlOjQ1MDMzMzQyZjJkMDQyMTg5MTgzYjBiZGFmMDQyYTllXzQtMS0xLTEtMjY1MjQ3_7074428a-81d4-4a21-a04b-28b6b98c6001">369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo0NTAzMzM0MmYyZDA0MjE4OTE4M2IwYmRhZjA0MmE5ZS90YWJsZXJhbmdlOjQ1MDMzMzQyZjJkMDQyMTg5MTgzYjBiZGFmMDQyYTllXzUtMS0xLTEtMjY1MjQ3_cf8063cd-991b-4f07-b188-3f3d7e73985d">367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028-2032</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo0NTAzMzM0MmYyZDA0MjE4OTE4M2IwYmRhZjA0MmE5ZS90YWJsZXJhbmdlOjQ1MDMzMzQyZjJkMDQyMTg5MTgzYjBiZGFmMDQyYTllXzYtMS0xLTEtMjY1MjQ3_fea4fea8-5adc-40d5-81e7-a5dc3bf5d252">1,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Multiemployer Pension Plans</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also contributes to a number of multiemployer pension plans under the terms of collective-bargaining agreements that cover its union-represented employees. The risks of participating in these multiemployer plans are different from single-employer pension plans in the following respects: (i) assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers, (ii) if a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers, and (iii) if the Company chooses to stop participating in some of its multiemployer plans, the Company may be required to pay those plans an amount based on the underfunded status of the applicable plan, which is referred to as a withdrawal liability. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the multiemployer pension plans in which the Company participates are individually significant to the Company. The Company&#8217;s contributions to multiemployer pension plans were $<ix:nonFraction unitRef="usd" contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231" decimals="-6" name="us-gaap:MultiemployerPlanPensionInsignificantPlanContribution" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzk5NDM_5c94be2d-76bf-422d-a0bb-d1f59cb09b82">20</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231" decimals="-6" name="us-gaap:MultiemployerPlanPensionInsignificantPlanContribution" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzk5NDc_89825b0f-b81f-44ab-9f0e-4378a73fbee9">19</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idf18a7ebe0824b4c9cc0c9a8db021e64_D20200101-20201231" decimals="-6" name="us-gaap:MultiemployerPlanPensionInsignificantPlanContribution" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzk5NTQ_ac5dae02-372a-4786-8902-b1b67f6e9718">19</ix:nonFraction> million in 2022, 2021 and 2020, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Postretirement Benefits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides postretirement health care and life insurance benefits to certain retirees who meet eligibility requirements. The Company&#8217;s funding policy is generally to pay covered expenses as they are incurred. For retiree medical plan accounting, the Company reviews external data and its own historical trends for health care costs to determine the health care cost trend rates. As of December&#160;31, 2022 and 2021, the Company&#8217;s other postretirement benefits had an accumulated postretirement benefit obligation of $<ix:nonFraction unitRef="usd" contextRef="i384b40a0741e4d28b9e0484a44c098d9_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzEwNTI4_29d66009-ef52-4365-8317-07b37396361c">159</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib0d860116b5a468e8949760638176508_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzEwNTM1_c081afdf-779c-4d21-bafd-9f35ff1346f0">207</ix:nonFraction> million, respectively. Net periodic benefit costs related to these other postretirement benefits were $<ix:nonFraction unitRef="usd" contextRef="ie948ccd30d67420f85d943d80b28ab90_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzEwNjMy_86607dab-1be1-4cfd-91c4-3179a89b83c8">4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="iad4db4c6c00f4fadb397e0b96255d42c_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzEwNjM2_1d984062-2990-4420-9632-9625507d5aff">4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idb4cca5b0ebf4f3aaa50ec243577cbda_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzEwNjQz_ac50a8bd-01af-49e3-82dd-77f0dee9f7ca">12</ix:nonFraction> million in 2022, 2021 and 2020, respectively. </span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3f3c23ca06094185a9878f26a1c56cea" continuedAt="i3fc8d13ce44748a884416467cb31734c"><ix:continuation id="i6ddaf7f900df483c8429640faff20c18"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the accumulated other postretirement benefit obligation as of December&#160;31, 2022: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:86.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i384b40a0741e4d28b9e0484a44c098d9_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo1ZTQ2ODg0OGU0OTg0NzBmOThmMDYwYWM3NzY2YzlkZC90YWJsZXJhbmdlOjVlNDY4ODQ4ZTQ5ODQ3MGY5OGYwNjBhYzc3NjZjOWRkXzEtMS0xLTEtMjY1MjQ3_ab154320-040a-4448-b9ec-920dd7274fa9">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i384b40a0741e4d28b9e0484a44c098d9_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo1ZTQ2ODg0OGU0OTg0NzBmOThmMDYwYWM3NzY2YzlkZC90YWJsZXJhbmdlOjVlNDY4ODQ4ZTQ5ODQ3MGY5OGYwNjBhYzc3NjZjOWRkXzItMS0xLTEtMjY1MjQ3_4477f9ac-e594-45f8-9c02-4a6c6242b210">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i384b40a0741e4d28b9e0484a44c098d9_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo1ZTQ2ODg0OGU0OTg0NzBmOThmMDYwYWM3NzY2YzlkZC90YWJsZXJhbmdlOjVlNDY4ODQ4ZTQ5ODQ3MGY5OGYwNjBhYzc3NjZjOWRkXzMtMS0xLTEtMjY1MjQ3_0a7aaac2-50d5-49d7-9587-2cd616a2266a">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i384b40a0741e4d28b9e0484a44c098d9_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo1ZTQ2ODg0OGU0OTg0NzBmOThmMDYwYWM3NzY2YzlkZC90YWJsZXJhbmdlOjVlNDY4ODQ4ZTQ5ODQ3MGY5OGYwNjBhYzc3NjZjOWRkXzQtMS0xLTEtMjY1MjQ3_3b7cd1d3-8272-45ad-af81-809a69d32cfc">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i384b40a0741e4d28b9e0484a44c098d9_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo1ZTQ2ODg0OGU0OTg0NzBmOThmMDYwYWM3NzY2YzlkZC90YWJsZXJhbmdlOjVlNDY4ODQ4ZTQ5ODQ3MGY5OGYwNjBhYzc3NjZjOWRkXzUtMS0xLTEtMjY1MjQ3_caaf8386-3f33-4a80-8ce0-10bf364348f3">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028-2032</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i384b40a0741e4d28b9e0484a44c098d9_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo1ZTQ2ODg0OGU0OTg0NzBmOThmMDYwYWM3NzY2YzlkZC90YWJsZXJhbmdlOjVlNDY4ODQ4ZTQ5ODQ3MGY5OGYwNjBhYzc3NjZjOWRkXzYtMS0xLTEtMjY1MjQ3_cd166acd-63de-47f7-983d-e4250dc9be41">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3fc8d13ce44748a884416467cb31734c">Pursuant to various collective bargaining agreements, the Company also contributes to multiemployer health and welfare plans that cover certain union-represented employees. The plans provide postretirement health care and life insurance benefits to certain employees who meet eligibility requirements. The Company&#8217;s contributions to multiemployer health and welfare plans totaled $<ix:nonFraction unitRef="usd" contextRef="ie948ccd30d67420f85d943d80b28ab90_D20220101-20221231" decimals="-6" name="us-gaap:MultiemployerPlanPensionInsignificantPlanContribution" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMjY2_f204d1da-32ee-43c5-b7d3-365f0019160e">62</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="iad4db4c6c00f4fadb397e0b96255d42c_D20210101-20211231" decimals="-6" name="us-gaap:MultiemployerPlanPensionInsignificantPlanContribution" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMjcw_1175fcee-c2e2-493c-8e2d-c41ed419a33e">60</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idb4cca5b0ebf4f3aaa50ec243577cbda_D20200101-20201231" decimals="-6" name="us-gaap:MultiemployerPlanPensionInsignificantPlanContribution" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMjc3_efdbcb8a-858c-4c69-8fcc-c6b4c3000038">54</ix:nonFraction> million in 2022, 2021 and 2020, respectively.</ix:continuation> </span></div><div><span><br/></span></div><div id="i36038907935e41eea5e9cf7cac915d44_154"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzM4MjU_0271e2b4-8b2f-48e9-b45c-e2f5dd013110" continuedAt="i75f1e8d8b3974e529d981c646039b301" escape="true">Income Taxes</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i75f1e8d8b3974e529d981c646039b301" continuedAt="ie1a00349ec244a97b880bfa67606efe9"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzM4MjY_a20519e4-5e20-4dce-bf02-7660b95fc6f4" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision for continuing operations consisted of the following for the&#160;years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzItMS0xLTEtMjY1MjQ3_97461a4f-c6d6-4bd3-a6b8-c3e7b5b0727c">2,803</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzItMy0xLTEtMjY1MjQ3_f65eac0d-7e9d-4ba9-91a7-fe8246aa75c6">2,285</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzItNS0xLTEtMjY1MjQ3_be673fe5-f21b-4ea7-850d-6352111ea6bd">2,615</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzMtMS0xLTEtMjY1MjQ3_d7fc216e-bc62-4fcb-b3fb-1c1272c1e9d5">735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzMtMy0xLTEtMjY1MjQ3_71c9598f-851d-455c-8c22-637a1f9c273e">665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzMtNS0xLTEtMjY1MjQ3_0630a34a-3fa7-40dc-a45f-81a5a1790c0e">518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzQtMS0xLTEtMjY1MjQ3_72c0cae2-3028-46e5-bef8-a7b81e5ea7d5">3,538</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzQtMy0xLTEtMjY1MjQ3_82df58f5-f642-4396-87f3-0d8631d39e44">2,950</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzQtNS0xLTEtMjY1MjQ3_399c9147-8669-437e-8fea-95ac79d9c754">3,133</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzYtMS0xLTEtMjY1MjQ3_ea7bc235-b71b-4757-b645-e8a2e5078306">1,526</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzYtMy0xLTEtMjY1MjQ3_1097ad0a-26e2-4f5d-9cc4-f59c9b2b6e53">282</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzYtNS0xLTEtMjY1MjQ3_bd188871-0c5f-423f-96a3-759205fbcd4d">450</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzctMS0xLTEtMjY1MjQ3_3c9a9377-537f-4124-a2c7-d4e4678bd642">503</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzctMy0xLTEtMjY1MjQ3_d0f28f05-0090-424c-b43a-81d1a03a3934">120</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzctNS0xLTEtMjY1MjQ3_0d4081d9-9422-4513-a7d3-c39213491c40">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzgtMS0xLTEtMjY1MjQ3_e54ce502-4be5-4af1-8fec-71f1eb0fe667">2,029</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzgtMy0xLTEtMjY1MjQ3_9d961814-59f7-44e1-91b6-add1b71124dd">402</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzgtNS0xLTEtMjY1MjQ3_ac709231-6ca2-4c93-9c9f-76a48b8d0037">564</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzktMS0xLTEtMjY1MjQ3_b491bf1a-2ca0-40d7-b5be-b1d348e745bb">1,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzktMy0xLTEtMjY1MjQ3_d320a149-0619-4271-90fe-624ceaedab0d">2,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzktNS0xLTEtMjY1MjQ3_a5eda19e-3c81-40d2-ab4d-8368f3996599">2,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzM4MjA_53d0acab-82b8-48fd-aab3-62c6e8190ca5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of the statutory income tax rate to the Company&#8217;s effective income tax rate for continuing operations for the&#160;years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzEtMS0xLTEtMjY1MjQ3_12ff5ea0-d5ee-4abb-a8bc-2adada387fc8">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzEtMy0xLTEtMjY1MjQ3_d2ba9324-0ba5-4471-ae07-1a7a72011c07">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzEtNS0xLTEtMjY1MjQ3_d80fdb8b-453c-4d59-bbb5-816cead2ad16">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzItMS0xLTEtMjY1MjQ3_c853fde6-0ce0-45fe-acac-c4a3d4b42eec">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzItMy0xLTEtMjY1MjQ3_904888b4-1404-4bc1-8ea8-9e3a8edfc521">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzItNS0xLTEtMjY1MjQ3_e69ae2c1-5df1-4c40-adf6-445e86e3a021">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurer fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="3" name="cvs:HealthInsurerFeeTaxEffectPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzMtMS0xLTEtMjY1MjQ3_4b77e82f-d35d-4c46-9d36-7304fcaa2441">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="3" name="cvs:HealthInsurerFeeTaxEffectPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzMtMy0xLTEtMjY1MjQ3_e8a01ac8-cd15-49f8-9e53-161f314b677d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="3" name="cvs:HealthInsurerFeeTaxEffectPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzMtNS0xLTEtMjY1MjQ3_f72d6094-d9f1-4501-a9c3-8ddbc3aa109b">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="3" name="cvs:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzQtMS0xLTEtMjY1MjQ3_de6e24b2-89a5-4fe9-83de-837acf32caa7">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="3" name="cvs:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzQtMy0xLTEtMjY1MjQ3_ecf1fbd2-29de-4827-8e1c-2066d0e206fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="3" name="cvs:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzQtNS0xLTEtMjY1MjQ3_f48fb06b-e945-437a-a7ea-2485d332eac5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basis difference upon disposition of subsidiary</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzUtMS0xLTEtMjY1MjQ3_ea0e7cd1-1fc5-4f41-b977-13e4cd05c9f6">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzUtMy0xLTEtMjY1MjQ3_d9422d91-9850-45f6-a95c-9319a65a91c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzUtNS0xLTEtMjY1MjQ3_ec15b184-4708-4b54-aeec-9329a824768b">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year refunds and unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzYtMS0xLTEtMjY1MjQ3_41771e4b-e831-477e-8f41-0d922d197627">2.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzYtMy0xLTEtMjY1MjQ3_64295b5b-de77-47cb-af75-dd28de208d08">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzYtNS0xLTEtMjY1MjQ3_9100aa5e-a688-48cd-bc77-7a3123f3ce4e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzctMS0xLTEtMjY1MjQ3_356c7d2d-c5f7-4baf-8b49-100e649dbbb7">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzctMy0xLTEtMjY1MjQ3_193a738f-bc92-4c9e-b9f7-198df7eb1c09">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzctNS0xLTEtMjY1MjQ3_79b4e352-a49a-4ec7-b06b-d5e034400353">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzgtMS0xLTEtMjY1MjQ3_0f6420c9-fc77-4885-91f9-0b1fea9e00ce">25.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzgtMy0xLTEtMjY1MjQ3_10651b68-f24a-4b67-8ea9-da2b5d5ad965">24.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzgtNS0xLTEtMjY1MjQ3_90379eed-08dc-4ab4-ac59-6481bfd35803">26.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie1a00349ec244a97b880bfa67606efe9" continuedAt="i1b87d47cc59140998ab6ee93ecd0f72f"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzM4MjE_753debfd-82cb-4189-91b8-0d29aaa2929c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the components of the Company&#8217;s deferred income tax assets and liabilities as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:78.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.711%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and rents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzItMS0xLTEtMjY1MjQ3_717eccf6-93cf-4ee1-8e8d-acccfc93afec">5,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzItMy0xLTEtMjY1MjQ3_b6680811-d82b-45bb-b9f3-4072590a9d2f">5,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzMtMS0xLTEtMjY1MjQ3_c39c5905-591d-4c0f-bf3e-d76f85f0e66a">1,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzMtMy0xLTEtMjY1MjQ3_4f62eaa7-e602-4fbc-8c27-4b7797a2ff60">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzQtMS0xLTEtMjY1MjQ3_ac00527e-fdf0-48b6-873c-73b4c5f2ca11">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzQtMy0xLTEtMjY1MjQ3_9140b92d-5ef9-4eee-ac54-9cde71a78fe1">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzUtMS0xLTEtMjY1MjQ3_98e22f49-9100-42f8-a200-9ea40f07da4b">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzUtMy0xLTEtMjY1MjQ3_e2fc95b6-3eea-4fa1-9a3e-d49081b14abb">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debts and other allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzYtMS0xLTEtMjY1MjQ3_0200e4a8-7705-417e-9744-a5031bb30e4c">480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzYtMy0xLTEtMjY1MjQ3_efc538a3-c49a-4ef3-a910-865d5ba1d1e0">489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and capital loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzgtMS0xLTEtMjY1MjQ3_68a03581-35bd-4c7d-84a9-0a3856dde6da">266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzgtMy0xLTEtMjY1MjQ3_0592eaad-104e-4108-a3a6-44aa525e7cc3">416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzktMS0xLTEtMjY1MjQ3_ba0d46e4-d9f0-485a-b289-236422e4a8dd">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzktMy0xLTEtMjY1MjQ3_2374bc94-fffc-431e-8185-f020a028cf3c">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzEwLTEtMS0xLTI2NTI0Nw_9e43bb2e-97fe-4e4a-9505-128e4879e760">319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzEwLTMtMS0xLTI2NTI0Nw_56a7664b-5505-4624-bff9-ef3e57ed317d">662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzExLTEtMS0xLTI2NTI0Nw_91a21204-59a0-473f-819b-159266bf1003">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzExLTMtMS0xLTI2NTI0Nw_f40f00a0-7268-421d-ad21-1f91ddd3ed5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll tax deferral</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:DeferredTaxAssetsPayrollTaxDeferral" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzEyLTEtMS0xLTI2NTI0Nw_84c33cbd-e438-4a15-b60e-f7d7cf285e03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:DeferredTaxAssetsPayrollTaxDeferral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzEyLTMtMS0xLTI2NTI0Nw_07e8498e-47c5-47a5-b9c9-24ef7c356d81">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzEzLTEtMS0xLTI2NTI0Nw_f3680f81-8ae7-4ce3-a164-c0c35cfb9980">335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzEzLTMtMS0xLTI2NTI0Nw_50949a09-3d3c-4987-a810-10041f7a855d">377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzE0LTEtMS0xLTI2NTI0Nw_93878fa0-f400-4ef2-9477-101f4fdcaadb">532</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzE0LTMtMS0xLTI2NTI0Nw_4c5328c7-f457-4677-9457-b1bccbb00d17">325</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzE1LTEtMS0xLTI2NTI0Nw_3b805a77-5d33-44a3-b174-ac61093d47f9">7,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzE1LTMtMS0xLTI2NTI0Nw_54ec92ea-2d7b-442e-bdd0-e63686664b5f">7,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:DeferredTaxLiabilitiesRetirementBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzE3LTEtMS0xLTI2NTI0Nw_c87b87fa-61e6-4518-9942-8ef23bc73259">92</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:DeferredTaxLiabilitiesRetirementBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzE3LTMtMS0xLTI2NTI0Nw_5cba3ac1-d2f8-4641-8a8e-a63b926bbdf6">105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzE4LTEtMS0xLTI2NTI0Nw_a2129ec7-18e8-4dc8-ac63-313501c1deb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzE4LTMtMS0xLTI2NTI0Nw_58e0c6d0-58e4-4e52-963e-425c97fe3d1d">340</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and rents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzE5LTEtMS0xLTI2NTI0Nw_9e999f30-eff6-4588-9eda-6c593cd3b8df">4,639</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzE5LTMtMS0xLTI2NTI0Nw_04c1702b-6dfa-41f6-bce4-54eeeca3bb76">4,947</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:DeferredTaxLiabilitiesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzIwLTEtMS0xLTI2NTI0Nw_7c406296-a718-47cc-ab96-cdac1c374e40">7,139</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="cvs:DeferredTaxLiabilitiesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzIwLTMtMS0xLTI2NTI0Nw_7f20dbf4-d0ea-441b-a231-972ff0fbcc11">8,381</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzIxLTEtMS0xLTI2NTI0Nw_c6e100b3-e58d-420e-9b78-e6b09cdadf8a">11,870</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzIxLTMtMS0xLTI2NTI0Nw_52d1c087-7c11-439f-8762-f88409795a1e">13,773</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzIyLTEtMS0xLTI2NTI0Nw_49cf5300-6738-466e-8345-efcff1ba3fc7">3,885</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzIyLTMtMS0xLTI2NTI0Nw_deed6f42-3bd9-4056-8720-49e0c8459560">6,115</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes deferred income tax assets of $<ix:nonFraction unitRef="usd" contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzUzMQ_7b07d3ed-b143-4d74-8ce2-452502c82bce">131</ix:nonFraction>&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When evaluating the realizability of deferred tax assets, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and the Company&#8217;s recent operating results. The Company established valuation allowances of $<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzEwNjY_93878fa0-f400-4ef2-9477-101f4fdcaadb">532</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzEwNzM_4c5328c7-f457-4677-9457-b1bccbb00d17">325</ix:nonFraction> million as of December&#160;31, 2022 and 2021, respectively, because it does not consider it more likely than not that certain deferred tax assets will be recovered.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company had net operating and capital loss carryovers of $<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzEyODQ_68a03581-35bd-4c7d-84a9-0a3856dde6da">266</ix:nonFraction> million, which expire between 2023 and 2042.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzM4MjM_22b10698-e5d4-4373-a9e1-2406c141b063" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balance of unrecognized tax benefits in 2022, 2021 and 2020 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzEtMS0xLTEtMjY1MjQ3_081e06ed-8c21-4ff7-8d82-4a76f6fc29da">782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501f291fb23d49e987222cf13c851afc_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzEtMy0xLTEtMjY1MjQ3_e677ea51-003e-4fdf-9d7a-cbe7e974546f">768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68e253af6bf3467aade09b572c1b73a6_I20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzEtNS0xLTEtMjY1MjQ3_617de75b-e7d4-4fa1-8296-9ecabef10af3">655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to the current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzItMS0xLTEtMjY1MjQ3_4bf2d8b8-f2ee-425a-ab40-4b9c53267933">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzItMy0xLTEtMjY1MjQ3_0dcc0e11-b1f1-4958-912d-21c13ee2df15">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzItNS0xLTEtMjY1MjQ3_2810c34f-1e36-4b14-8c7b-6d906d5adac1">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzMtMS0xLTEtMjY1MjQ3_490278f2-6169-446a-888c-22bf88276cb4">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzMtMy0xLTEtMjY1MjQ3_88ea395b-837b-42c3-bda4-9a25a250a780">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzMtNS0xLTEtMjY1MjQ3_634cad33-3a3f-4067-93b0-839353b01cb2">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzQtMS0xLTEtMjY1MjQ3_2a0d7ac3-6852-4f51-a086-8fe6b684a909">166</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzQtMy0xLTEtMjY1MjQ3_cfdcfffb-a09f-42c5-a558-2287c2ad5b45">33</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzQtNS0xLTEtMjY1MjQ3_cfb6434a-30f2-4a18-9433-3a6e3860f617">56</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expiration of statutes of limitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzUtMS0xLTEtMjY1MjQ3_820fea0d-ca2d-40c3-93d2-3432254c496c">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzUtMy0xLTEtMjY1MjQ3_92b53e02-9bec-4af0-a9d3-4fba115c5f65">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzUtNS0xLTEtMjY1MjQ3_fb5a58fa-aac7-4797-bf9c-ab584f5c97aa">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzYtMS0xLTEtMjY1MjQ3_54983355-b168-474b-8ed0-a7bf1ec4e856">213</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzYtMy0xLTEtMjY1MjQ3_29d29637-f40c-4714-8f42-eb4cd4d896b1">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzYtNS0xLTEtMjY1MjQ3_23a222d8-182f-4c61-821a-0e3249f3572f">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzctMS0xLTEtMjY1MjQ3_900f4175-8c77-4143-b004-a785656e49b0">446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzctMy0xLTEtMjY1MjQ3_1b671309-1a22-4380-ab0f-a0bafad60d9f">782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501f291fb23d49e987222cf13c851afc_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzctNS0xLTEtMjY1MjQ3_d08a4bd9-ae77-4b88-97b6-fb1ba234336f">768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation and most of its subsidiaries are subject to U.S. federal income tax as well as income tax of numerous state and local jurisdictions. CVS Health Corporation participated in the Compliance Assurance Process through 2019, which is </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1b87d47cc59140998ab6ee93ecd0f72f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a program made available by the U.S. Internal Revenue Service (&#8220;IRS&#8221;) to certain qualifying large taxpayers, under which participants work collaboratively with the IRS to identify and resolve potential tax issues through open, cooperative and transparent interaction prior to the annual filing of their federal income tax returns. The IRS has completed its examinations of the Company&#8217;s consolidated U.S. federal income tax returns for tax years through and including 2013 and 2018 through 2019. The IRS has substantially completed its examinations of the Company&#8217;s consolidated U.S. federal income tax returns for tax years 2014 through 2017.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation and its subsidiaries are also currently under income tax examinations by a number of state and local tax authorities. As of December&#160;31, 2022, no examination has resulted in any proposed adjustments that would result in a material change to the Company&#8217;s operating results, financial condition or liquidity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all material state and local income tax matters have been concluded for fiscal years through 2015. Certain state exams are likely to be concluded and certain state statutes of limitations will lapse in 2023, but the change in the balance of the Company&#8217;s uncertain tax positions is projected to be immaterial. In addition, it is reasonably possible that the Company&#8217;s unrecognized tax benefits could change within the next twelve months due to the anticipated conclusion of various examinations with the IRS for certain previous years. An estimate of the range of the possible change cannot be made at this time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records interest expense related to unrecognized tax benefits and penalties in the income tax provision. The Company accrued interest expense of approximately $<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzM0NTQ_4053a5b4-7e4a-441a-9ac6-858a7e80e3e0">29</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzM0NTg_d6a1a8bd-0dfe-4208-8b2b-4d4790f83548">40</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzM0NjU_bfe6bb52-5e2c-4bf3-ae72-d15437638d8b">34</ix:nonFraction> million in 2022, 2021 and 2020, respectively. The Company had approximately $<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzM1MzA_bd5a3863-84df-42fa-8e3b-5e8b44cb68a2">112</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzM1Mzc_fbf286c5-48b3-4c52-b279-32d6134e1e82">151</ix:nonFraction> million accrued for interest and penalties as of December&#160;31, 2022 and 2021, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the total amount of unrecognized tax benefits that, if recognized, would affect the Company&#8217;s effective income tax rate is approximately $<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzM3NTU_adf843b8-822c-47a2-bf02-73be4b6e7673">336</ix:nonFraction> million, after considering the federal benefit of state income taxes.</span></div></ix:continuation><div><span><br/></span></div><div id="i36038907935e41eea5e9cf7cac915d44_157"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzg0NDY_5aadccae-354c-435d-8c46-23514e5f4bb2" continuedAt="i1dad22e4b95341299806be19688ace45" escape="true">Stock Incentive Plans</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i1dad22e4b95341299806be19688ace45" continuedAt="if93a127c84dc477f8a1d32bb9a8a5fbc"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of the CVS Health 2017 Incentive Compensation Plan (&#8220;ICP&#8221;) provide for grants of annual incentive and long-term performance awards to executive officers and other officers and employees of the Company or any subsidiary of the Company, as well as equity compensation to outside directors of CVS Health Corporation. Payment of such annual incentive and long-term performance awards will be in cash, stock, other awards or other property, at the discretion of the Management Planning and Development Committee (the &#8220;MP&amp;D Committee&#8221;) of the Board. The ICP allows for a maximum of <ix:nonFraction unitRef="shares" contextRef="ia298adcd58b540f39bbb027f8433e7d2_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzYxNQ_4695b22c-d32c-4696-9f97-f576395f3c6e">58</ix:nonFraction> million shares of CVS Health Corporation common stock to be reserved and available for grants. As of December&#160;31, 2022, there were approximately <ix:nonFraction unitRef="shares" contextRef="ia298adcd58b540f39bbb027f8433e7d2_I20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzc0MA_12080a8d-45c5-4d8b-b73f-aa4ff4289996">21</ix:nonFraction> million shares of CVS Health Corporation common stock available for future grants under the ICP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the acquisition of Aetna (the &#8220;Aetna Acquisition&#8221;) on November 28, 2018, approximately <ix:nonFraction unitRef="shares" contextRef="i4a56dcd6eefa4635ba2a3f12f2cf62af_I20181128" decimals="-6" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzkyNQ_d44e8542-9180-4ef4-bc12-ff9ec232287a">22</ix:nonFraction> million shares of Aetna common stock subject to awards outstanding under the Amended Aetna Inc. 2010 Stock Incentive Plan (&#8220;SIP&#8221;) were assumed by CVS Health Corporation. In addition, in accordance with the merger agreement, shares which were available for future issuance under the SIP were converted into approximately <ix:nonFraction unitRef="shares" contextRef="i4a56dcd6eefa4635ba2a3f12f2cf62af_I20181128" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzEyNDA_dfbd30d4-73a1-4d43-9e8b-df243ed8f191">32</ix:nonFraction> million shares of CVS Health Corporation common stock reserved and available for issuance pursuant to future awards. Subsequent to the expiration of the SIP on May 21, 2020, the ICP was the only compensation plan under which the Company grants stock options, restricted stock and other stock-based awards to its employees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzE3Nzg_6fb0217d-b4b8-4272-817b-3803971eadab">three</span> to <ix:nonNumeric contextRef="ib01e468dcb8f4ca98e9b64ffb83ffbe0_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzg0NDc_f9f13996-e37e-424f-8cae-967347af9248">five years</ix:nonNumeric>) using the straight-line method. <ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzg0NDg_2734ac05-1a69-43a0-b9a2-bbf1ad901202" continuedAt="ib1e09771038e40deab5444b0f43c36c8" escape="true">The following table is a summary of stock-based compensation for the&#160;years ended December&#160;31, 2022, 2021 and 2020:</ix:nonNumeric></span></div><ix:continuation id="ib1e09771038e40deab5444b0f43c36c8"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a7879ca683449ffa5da3418bf44e68d_D20220101-20221231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTowMjJhZmFjNGVhNTQ0ZDk4YThiODIwYjM0NzEyNzYyMS90YWJsZXJhbmdlOjAyMmFmYWM0ZWE1NDRkOThhOGI4MjBiMzQ3MTI3NjIxXzEtMS0xLTEtMjY1MjQ3_68ba624d-c3c4-4f33-bc59-ab488d993160">369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b79b50a55d4d81bf3f34a3889c23df_D20210101-20211231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTowMjJhZmFjNGVhNTQ0ZDk4YThiODIwYjM0NzEyNzYyMS90YWJsZXJhbmdlOjAyMmFmYWM0ZWE1NDRkOThhOGI4MjBiMzQ3MTI3NjIxXzEtMy0xLTEtMjY1MjQ3_6d0851fd-dded-47a3-9720-cd54d8270a8e">404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if240ee4b0e0f42d0b398179a94077c59_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTowMjJhZmFjNGVhNTQ0ZDk4YThiODIwYjM0NzEyNzYyMS90YWJsZXJhbmdlOjAyMmFmYWM0ZWE1NDRkOThhOGI4MjBiMzQ3MTI3NjIxXzEtNS0xLTEtMjY1MjQ3_f49d7d92-54fa-415a-af75-747f677af70b">329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and stock appreciation rights (&#8220;SARs&#8221;) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTowMjJhZmFjNGVhNTQ0ZDk4YThiODIwYjM0NzEyNzYyMS90YWJsZXJhbmdlOjAyMmFmYWM0ZWE1NDRkOThhOGI4MjBiMzQ3MTI3NjIxXzItMS0xLTEtMjY1MjQ3_d9f0a005-e526-4b34-95ad-c318fc96197f">78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i983d904f9748498597906f71baf2d240_D20210101-20211231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTowMjJhZmFjNGVhNTQ0ZDk4YThiODIwYjM0NzEyNzYyMS90YWJsZXJhbmdlOjAyMmFmYWM0ZWE1NDRkOThhOGI4MjBiMzQ3MTI3NjIxXzItMy0xLTEtMjY1MjQ3_e35c4086-0376-4257-b19b-09b29af56cd4">80</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadd17fda7e474b46b4ac5a0ddb578ebe_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTowMjJhZmFjNGVhNTQ0ZDk4YThiODIwYjM0NzEyNzYyMS90YWJsZXJhbmdlOjAyMmFmYWM0ZWE1NDRkOThhOGI4MjBiMzQ3MTI3NjIxXzItNS0xLTEtMjY1MjQ3_08343b28-7ba7-40b1-a9b1-8b91c0cb16b7">71</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTowMjJhZmFjNGVhNTQ0ZDk4YThiODIwYjM0NzEyNzYyMS90YWJsZXJhbmdlOjAyMmFmYWM0ZWE1NDRkOThhOGI4MjBiMzQ3MTI3NjIxXzMtMS0xLTEtMjY1MjQ3_b5c1c0da-84ea-4321-8af1-807b3326754c">447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTowMjJhZmFjNGVhNTQ0ZDk4YThiODIwYjM0NzEyNzYyMS90YWJsZXJhbmdlOjAyMmFmYWM0ZWE1NDRkOThhOGI4MjBiMzQ3MTI3NjIxXzMtMy0xLTEtMjY1MjQ3_a20e2d9b-ec15-46ac-aad2-5fadb272bf5a">484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTowMjJhZmFjNGVhNTQ0ZDk4YThiODIwYjM0NzEyNzYyMS90YWJsZXJhbmdlOjAyMmFmYWM0ZWE1NDRkOThhOGI4MjBiMzQ3MTI3NjIxXzMtNS0xLTEtMjY1MjQ3_ed19b41c-8c4a-4242-9cab-f2ee65e9b385">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes the ESPP.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if93a127c84dc477f8a1d32bb9a8a5fbc" continuedAt="i09d58be685a543b5bedbc0c4ee679447"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units and Performance Stock Units</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s restricted stock units and performance stock units are considered nonvested share awards and require no payment from the employee. The fair value of the restricted stock units is based on the market price of CVS Health Corporation common stock on the grant date and is recognized on a straight-line basis over the vesting period. For each restricted stock unit granted, employees receive one share of common stock, net of taxes, at the end of the vesting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s performance stock units contain performance vesting conditions in addition to a service vesting condition. Vesting of the Company&#8217;s performance stock units is dependent upon the degree to which the Company achieves its performance goals, which are generally set for a three-year performance period and are approved at the time of grant by the MP&amp;D Committee. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of performance stock units granted with service and performance vesting conditions is based on the market price of CVS Health Corporation common stock on the grant date and is recognized over the vesting period. Certain of the performance stock units also contain a market vesting condition based on the performance of CVS Health Corporation common stock relative to a comparator group. The fair value of these performance stock units is determined using a Monte Carlo simulation as of the grant date and is recognized over the vesting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there was $<ix:nonFraction unitRef="usd" contextRef="i70ba7d8cc22e4bd9aed774540fbc5a2a_I20221231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzM0Nzk_8f9619b6-e6a1-4208-918e-83c329d59a6e">619</ix:nonFraction> million of total unrecognized compensation cost related to the Company&#8217;s restricted stock units and performance stock units that are expected to vest. These costs are expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="i8a7879ca683449ffa5da3418bf44e68d_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzM3MDE_c9fd6a44-602f-4273-a201-d20c25740c9e">2.1</ix:nonNumeric> years. The total fair value of restricted stock units vested during 2022, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i8a7879ca683449ffa5da3418bf44e68d_D20220101-20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzM3ODQ_347cd0af-abf3-4261-9251-9d1426f128a4">328</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="id4b79b50a55d4d81bf3f34a3889c23df_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzM3ODg_76b1cbc3-2c2c-4815-8341-fa18959a0341">406</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if240ee4b0e0f42d0b398179a94077c59_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzM3OTU_c0e1e199-8807-4649-aa03-db5efdbe75fa">229</ix:nonFraction> million, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzg0NDk_b2753a64-9b90-4d85-9ddd-6d69c0501fab" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the restricted stock unit and performance stock unit activity for the&#160;year ended December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In thousands, except weighted average grant date fair value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year, nonvested</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i84d934c3f64d4e02a86157aaa7bdff55_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxZjFhYmNiYTZlOWU0MTBlYmY0ZDk4YzA4ZGUzNDg5ZC90YWJsZXJhbmdlOjFmMWFiY2JhNmU5ZTQxMGViZjRkOThjMDhkZTM0ODlkXzEtMS0xLTEtMjY1MjQ3_60c2a7b5-a187-44df-b59b-7cbb5b80d67f">14,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i84d934c3f64d4e02a86157aaa7bdff55_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxZjFhYmNiYTZlOWU0MTBlYmY0ZDk4YzA4ZGUzNDg5ZC90YWJsZXJhbmdlOjFmMWFiY2JhNmU5ZTQxMGViZjRkOThjMDhkZTM0ODlkXzEtMy0xLTEtMjY1MjQ3_2034317c-02c6-4af9-9385-5e0388e5fa53">63.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8a7879ca683449ffa5da3418bf44e68d_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxZjFhYmNiYTZlOWU0MTBlYmY0ZDk4YzA4ZGUzNDg5ZC90YWJsZXJhbmdlOjFmMWFiY2JhNmU5ZTQxMGViZjRkOThjMDhkZTM0ODlkXzItMS0xLTEtMjY1MjQ3_1402b9f3-2739-4c3b-a7b8-90f202bbf3a6">5,398</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8a7879ca683449ffa5da3418bf44e68d_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxZjFhYmNiYTZlOWU0MTBlYmY0ZDk4YzA4ZGUzNDg5ZC90YWJsZXJhbmdlOjFmMWFiY2JhNmU5ZTQxMGViZjRkOThjMDhkZTM0ODlkXzItMy0xLTEtMjY1MjQ3_36332089-f797-4f16-be43-c5b8ae68a2c6">101.13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8a7879ca683449ffa5da3418bf44e68d_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxZjFhYmNiYTZlOWU0MTBlYmY0ZDk4YzA4ZGUzNDg5ZC90YWJsZXJhbmdlOjFmMWFiY2JhNmU5ZTQxMGViZjRkOThjMDhkZTM0ODlkXzMtMS0xLTEtMjY1MjQ3_1b78ea89-4836-4368-a96e-0ac8ac5d400e">5,626</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8a7879ca683449ffa5da3418bf44e68d_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxZjFhYmNiYTZlOWU0MTBlYmY0ZDk4YzA4ZGUzNDg5ZC90YWJsZXJhbmdlOjFmMWFiY2JhNmU5ZTQxMGViZjRkOThjMDhkZTM0ODlkXzMtMy0xLTEtMjY1MjQ3_60c8d0a3-e2fe-4dc8-98ed-27c50baae962">58.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8a7879ca683449ffa5da3418bf44e68d_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxZjFhYmNiYTZlOWU0MTBlYmY0ZDk4YzA4ZGUzNDg5ZC90YWJsZXJhbmdlOjFmMWFiY2JhNmU5ZTQxMGViZjRkOThjMDhkZTM0ODlkXzQtMS0xLTEtMjY1MjQ3_070a2e5d-3727-4c1f-bad5-3101d720ddd8">1,421</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8a7879ca683449ffa5da3418bf44e68d_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxZjFhYmNiYTZlOWU0MTBlYmY0ZDk4YzA4ZGUzNDg5ZC90YWJsZXJhbmdlOjFmMWFiY2JhNmU5ZTQxMGViZjRkOThjMDhkZTM0ODlkXzQtMy0xLTEtMjY1MjQ3_ed99783d-5ff0-441e-a157-b5f8124c485e">72.76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year, nonvested</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70ba7d8cc22e4bd9aed774540fbc5a2a_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxZjFhYmNiYTZlOWU0MTBlYmY0ZDk4YzA4ZGUzNDg5ZC90YWJsZXJhbmdlOjFmMWFiY2JhNmU5ZTQxMGViZjRkOThjMDhkZTM0ODlkXzUtMS0xLTEtMjY1MjQ3_51d3238b-89e9-4c1f-8897-6172058d9ba2">12,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i70ba7d8cc22e4bd9aed774540fbc5a2a_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxZjFhYmNiYTZlOWU0MTBlYmY0ZDk4YzA4ZGUzNDg5ZC90YWJsZXJhbmdlOjFmMWFiY2JhNmU5ZTQxMGViZjRkOThjMDhkZTM0ODlkXzUtMy0xLTEtMjY1MjQ3_4fc74096-3377-4cfb-ae3a-3500c3cfef77">80.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Vested performance stock units have been included at target level performance. Based on actual performance, the number of restricted stock units and performance stock units vested during the year ended December 31, 2022 was <ix:nonFraction unitRef="shares" contextRef="i8a7879ca683449ffa5da3418bf44e68d_D20220101-20221231" decimals="-5" name="cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzQyMDg_3a997f62-9526-4db6-84b0-fa7882238103">8.0</ix:nonFraction>&#160;million.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options and SARs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All stock option grants are awarded at fair value on the date of grant. The fair value of stock options is estimated using the Black-Scholes option pricing model, and stock-based compensation is recognized on a straight-line basis over the requisite service period. Stock options granted generally become exercisable over a <ix:nonNumeric contextRef="i1ff8661ca2c148108297d7a193977a4b_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzg0NTg_02d99038-f5d0-41b9-a99e-8be827a74cae">four-year</ix:nonNumeric> period from the grant date. Stock options granted through 2018 generally expire <ix:nonNumeric contextRef="ib929cd58d3cb4a4096643aeea5fb40bb_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzQ2NDk_cf22045a-d9ca-4c77-9686-097d77e08b59">seven years</ix:nonNumeric> after the grant date. Stock options granted subsequent to 2018 generally expire <ix:nonNumeric contextRef="i73e8856343074dedba7db4a6c8fffe3a_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzQ3MzI_90a7e2a2-1589-4f27-b765-10e85766b8e4">ten years</ix:nonNumeric> after the grant date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All unvested Aetna SARs outstanding upon the acquisition of Aetna were converted into replacement CVS Health Corporation SARs. The replacement SARs granted are settled in CVS Health Corporation common stock, net of taxes, based on the appreciation of the stock price on the exercise date over the market price on the date of grant. The fair value of SARs is estimated using the Black-Scholes option pricing model, and stock-based compensation is recognized on a straight-line basis over the requisite service period. SARs generally become exercisable over a <ix:nonNumeric contextRef="idc7553fd8525450491acaa6901e0117c_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzg0NDQ_fae2bcc4-b7ac-4b37-934b-9d0f9edcc022">three-year</ix:nonNumeric> period from the grant date. SARs generally expire <ix:nonNumeric contextRef="idc7553fd8525450491acaa6901e0117c_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzUzNzQ_b48862fd-4b76-4f76-baef-fd29683bb3cc">ten years</ix:nonNumeric> after the grant date. No SARs have been granted subsequent to the Aetna Acquisition.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i09d58be685a543b5bedbc0c4ee679447" continuedAt="ib163849c6e464a3d969fbd80b23a690e"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzg0NDE_d26d2760-a2b6-4752-937f-3b80b06ac5f6" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of stock option and SAR activity that occurred for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from stock options exercised (including ESPP)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzEtMS0xLTEtMjY1MjQ3_176946e1-3977-4d68-856b-43f90714daff">551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i983d904f9748498597906f71baf2d240_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzEtMy0xLTEtMjY1MjQ3_5048b118-e6f2-4e06-add5-1f7e21b31634">549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadd17fda7e474b46b4ac5a0ddb578ebe_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzEtNS0xLTEtMjY1MjQ3_64d02739-b71c-444a-86d5-be1d3e67a463">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for taxes for net share settlement of equity awards</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzItMS0xLTEtMjY1MjQ3_7e22ca14-44f2-4046-8357-7a8b84108b91">370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i983d904f9748498597906f71baf2d240_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzItMy0xLTEtMjY1MjQ3_c10885ab-d9a9-46e1-aceb-c6d16479505d">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadd17fda7e474b46b4ac5a0ddb578ebe_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzItNS0xLTEtMjY1MjQ3_aef18a5b-4433-438f-9b92-4209e61ce766">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic value of stock options and SARs exercised </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzMtMS0xLTEtMjY1MjQ3_e67cf68c-3982-484f-b62d-55a68e67e63f">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i983d904f9748498597906f71baf2d240_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzMtMy0xLTEtMjY1MjQ3_ac051961-0581-4cc6-81dc-4e23a6e1ab0a">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadd17fda7e474b46b4ac5a0ddb578ebe_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzMtNS0xLTEtMjY1MjQ3_f9571e08-cf9f-4ca0-bf83-6bcd44908347">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of stock options and SARs vested </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231" decimals="-6" name="cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzQtMS0xLTEtMjY1MjQ3_dfdcd76e-1160-4e6a-93c7-0bfed918c1a7">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i983d904f9748498597906f71baf2d240_D20210101-20211231" decimals="-6" name="cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzQtMy0xLTEtMjY1MjQ3_619762dd-1cf6-4a48-8f95-dbbb4f70fdf5">224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadd17fda7e474b46b4ac5a0ddb578ebe_D20200101-20201231" decimals="-6" name="cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzQtNS0xLTEtMjY1MjQ3_6b0fcc36-8698-44e0-90d6-702336520212">252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzg0NDI_6d87d586-8829-4f23-9395-72da7bf6189e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each stock option is estimated using the Black-Scholes option pricing model based on the following assumptions at the time of grant:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1ff8661ca2c148108297d7a193977a4b_D20220101-20221231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzEtMS0xLTEtMjY1MjQ3_8681f5d9-e4a1-4c94-bee5-6f130f3f69ab">2.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie6f1a0aed7b14023be37031ee7e6081d_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzEtMy0xLTEtMjY1MjQ3_9386cf1a-aeb6-4ff8-9afa-8b998781b7c6">2.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6f45fbcf1c62442cb073a0677f6e9707_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzEtNS0xLTEtMjY1MjQ3_48195037-356a-4637-baf3-ac691186b7e9">3.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1ff8661ca2c148108297d7a193977a4b_D20220101-20221231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzItMS0xLTEtMjY1MjQ3_8c5b67fa-d701-4aa3-bd5a-1094d06af152">27.34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie6f1a0aed7b14023be37031ee7e6081d_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzItMy0xLTEtMjY1MjQ3_9506d7c5-43df-433d-9c4a-778d82e311db">27.10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6f45fbcf1c62442cb073a0677f6e9707_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzItNS0xLTEtMjY1MjQ3_36ba0d25-6072-4bcb-806f-24849e02420d">25.22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1ff8661ca2c148108297d7a193977a4b_D20220101-20221231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzMtMS0xLTEtMjY1MjQ3_b22af4b2-c5e6-4856-a5c3-436658fc5ad2">2.46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie6f1a0aed7b14023be37031ee7e6081d_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzMtMy0xLTEtMjY1MjQ3_92f1de93-cfe5-4037-8c19-e9a69105ee68">1.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6f45fbcf1c62442cb073a0677f6e9707_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzMtNS0xLTEtMjY1MjQ3_5f06d851-1bc0-4ea1-9454-ed6722bef160">0.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1ff8661ca2c148108297d7a193977a4b_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzQtMS0xLTEtMjY1MjQ3_ea089685-cae6-4989-8945-d54ff1952aa4">6.3</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie6f1a0aed7b14023be37031ee7e6081d_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzQtMy0xLTEtMjY1MjQ3_3d72d396-2587-4519-b815-f5742b6b44a2">6.3</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6f45fbcf1c62442cb073a0677f6e9707_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzQtNS0xLTEtMjY1MjQ3_7af383a5-a83f-417b-99d6-a71b7ccd0b68">6.3</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1ff8661ca2c148108297d7a193977a4b_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzUtMS0xLTEtMjY1MjQ3_62798dbb-c1be-4fc7-90a6-dde8951509c7">24.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie6f1a0aed7b14023be37031ee7e6081d_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzUtMy0xLTEtMjY1MjQ3_ac684436-cc1e-48f1-954e-4701075c2cce">14.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6f45fbcf1c62442cb073a0677f6e9707_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzUtNS0xLTEtMjY1MjQ3_44ee2f5e-a4da-4a30-bd79-fbd02a2c628f">8.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dividend yield is based on annual dividends paid and the fair market value of CVS Health Corporation stock at the grant date.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected volatility is estimated based on the historical volatility of CVS Health Corporation&#8217;s daily stock price over a period equal to the expected life of each option grant after adjustments for infrequent events such as stock splits.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The risk-free interest rate is selected based on yields from U.S. Treasury zero-coupon issues with a remaining term equal to the expected term of the options being valued.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected life represents the number of&#160;years the options are expected to be outstanding from grant date based on historical option or SAR holder exercise experience.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, unrecognized compensation expense related to unvested stock options totaled $<ix:nonFraction unitRef="usd" contextRef="i2310964202714b25bc144cf465c755a8_I20221231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzY1ODE_fec1611e-e29c-4444-9c1b-3da802a0457d">41</ix:nonFraction> million, which the Company expects to be recognized over a weighted-average period of <ix:nonNumeric contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzY2NjI_913a1bea-4aae-4566-886e-af5ea1acc88a">1.9</ix:nonNumeric> years. After considering anticipated forfeitures, the Company expects approximately <ix:nonFraction unitRef="shares" contextRef="i2310964202714b25bc144cf465c755a8_I20221231" decimals="-6" name="cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzY3NDM_5a90d6db-207c-4f05-baba-e23307e1f1c1">7</ix:nonFraction> million of the unvested stock options to vest over the requisite service period.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzg0NTE_2e4bf05d-2e33-4703-aac5-578cce8e8574" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s stock option and SAR activity for the&#160;year ended December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.747%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;thousands, except weighted average exercise price and remaining contractual term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>&#160;Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1075aa911329487a922a9ba44f7a262d_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzEtMS0xLTEtMjY1MjQ3_ebb85acd-6307-455e-a958-7793cdc395df">19,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1075aa911329487a922a9ba44f7a262d_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzEtMy0xLTEtMjY1MjQ3_3ec1a6d7-0fa8-4cfe-83e5-27e041a2a9ea">71.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzItMS0xLTEtMjY1MjQ3_524ca5db-caaf-4b39-83d1-eb37bb916114">1,993</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzItMy0xLTEtMjY1MjQ3_d03eddbd-b70f-4445-bee2-0a6969d98f0c">101.04</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzMtMS0xLTEtMjY1MjQ3_68942663-a63c-480d-8e9f-528f668f3f63">4,921</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzMtMy0xLTEtMjY1MjQ3_47cc441d-293f-4a0f-ac01-9cf3f57a4f34">75.91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzQtMS0xLTEtMjY1MjQ3_d26b7e8f-0553-4727-91b9-f227cad0306d">478</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzQtMy0xLTEtMjY1MjQ3_60ff6d79-f317-470d-820d-ec8f4713d369">70.78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzUtMS0xLTEtMjY1MjQ3_1b8de2ce-24ea-43d8-920e-5625a4f98bff">615</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzUtMy0xLTEtMjY1MjQ3_fe9d53f1-e8c1-4f38-a130-dfddf5a6e592">99.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2310964202714b25bc144cf465c755a8_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzYtMS0xLTEtMjY1MjQ3_839f95d0-4e51-43ff-b42d-45c61b64ce94">15,040</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2310964202714b25bc144cf465c755a8_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzYtMy0xLTEtMjY1MjQ3_797efe75-6252-47f1-9bca-69253b8ede8a">73.15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzYtNS0xLTEtMjY1MjQ3_4536a8bb-3fd5-4a74-a8dd-ebe204c2269d">4.52</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2310964202714b25bc144cf465c755a8_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzYtNy0xLTEtMjY1MjQ3_fa5ba686-ee0f-4b53-a460-c05539301ca5">340,507</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2310964202714b25bc144cf465c755a8_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzctMS0xLTEtMjY1MjQ3_355d10b0-131f-4a54-8b27-926da77bdb2c">7,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2310964202714b25bc144cf465c755a8_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzctMy0xLTEtMjY1MjQ3_f1282418-c3d4-4ceb-bd1a-151c2324d9a1">72.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzctNS0xLTEtMjY1MjQ3_614ee1b8-87f2-4386-bb7a-bc8f66a54563">2.76</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2310964202714b25bc144cf465c755a8_I20221231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzctNy0xLTEtMjY1MjQ3_5121100f-067e-4e91-aefa-2ed0459ba6e6">184,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at end of year and expected to vest in the future</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2310964202714b25bc144cf465c755a8_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzgtMS0xLTEtMjY1MjQ3_64b033c5-22cb-4734-aefd-67daef038753">14,757</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2310964202714b25bc144cf465c755a8_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzgtMy0xLTEtMjY1MjQ3_b5da0fb9-c364-4bd0-a281-a66bf451e90c">72.96</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzgtNS0xLTEtMjY1MjQ3_3b719882-22b5-4f4d-900a-8d4f70bca27c">4.47</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2310964202714b25bc144cf465c755a8_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzgtNy0xLTEtMjY1MjQ3_8e874963-6100-4c1b-84d7-432c1ac936f9">336,664</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ESPP</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Employee Stock Purchase Plan (&#8220;ESPP&#8221;) provides for the purchase of up to <ix:nonFraction unitRef="shares" contextRef="i282e236db6f547ceac0cbccfa36c5851_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzcwMTg_94fc7fcd-8a2a-4950-a4f3-7dca563c684c">60</ix:nonFraction>&#160;million shares of CVS Health Corporation common stock. Under the ESPP, eligible employees may purchase common stock at the end of each six&#160;month offering period at a purchase price equal to <ix:nonFraction unitRef="number" contextRef="i5c6c53ae9a7745a09f19b70ba79aa0c2_D20220101-20221231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzcyMDI_0c7aaa00-aeba-4610-b05d-1867fc4ffc3c">90</ix:nonFraction>% of the lower of the fair market value on the first day or the last day of the offering period. During 2022, approximately <ix:nonFraction unitRef="shares" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzczMjU_9f8b6540-3968-4a1e-95b2-6f41328f325b">2</ix:nonFraction> million shares of common stock were purchased under the provisions of the ESPP at an average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="2" name="cvs:StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzc0MjI_02691822-a4fc-4f4a-a0b2-ce3d288dc9bd">78.55</ix:nonFraction> per share. As of December&#160;31, 2022, approximately <ix:nonFraction unitRef="shares" contextRef="i282e236db6f547ceac0cbccfa36c5851_I20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzc0NjA_4db07f7d-01be-4685-a378-3cfe7ad65afa">29</ix:nonFraction> million shares of common stock were available for issuance under the ESPP.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib163849c6e464a3d969fbd80b23a690e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock-based compensation associated with the ESPP is estimated on the date of grant (the first day of the six&#160;month offering period) using the Black-Scholes option pricing model.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzg0Mzc_4854b19f-8c09-49dd-99ee-a99cd1410619" continuedAt="i26592ab2787d416a8765b06eb1bbda8b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the assumptions used to value the ESPP awards for the&#160;years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5c6c53ae9a7745a09f19b70ba79aa0c2_D20220101-20221231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzEtMS0xLTEtMjY1MjQ3_e0e40cba-18c2-49f0-aa4b-30d7b2cbf9eb">1.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0c6f50abab644dc7a7aa89e157fa28d7_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzEtMy0xLTEtMjY1MjQ3_dff7497c-e212-4ac4-8ab8-eb5ffd92ab1b">1.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3754a0a6a19e4cec89a94c39d17cded7_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzEtNS0xLTEtMjY1MjQ3_e5ed53a0-6a5e-47eb-8c13-3882bb8d05e9">1.46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5c6c53ae9a7745a09f19b70ba79aa0c2_D20220101-20221231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzItMS0xLTEtMjY1MjQ3_5f4646df-fb9c-4299-b34e-6ef4682d041f">23.54</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0c6f50abab644dc7a7aa89e157fa28d7_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzItMy0xLTEtMjY1MjQ3_710db793-88d6-4ea4-8117-96b21ddc800a">25.27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3754a0a6a19e4cec89a94c39d17cded7_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzItNS0xLTEtMjY1MjQ3_cf23dbda-2349-428b-8928-00c8dc188534">37.21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5c6c53ae9a7745a09f19b70ba79aa0c2_D20220101-20221231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzMtMS0xLTEtMjY1MjQ3_70bb058d-5031-4637-bae4-4ed2699a56b3">1.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0c6f50abab644dc7a7aa89e157fa28d7_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzMtMy0xLTEtMjY1MjQ3_b3449e4d-30fd-45f6-8741-f775c715651d">0.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3754a0a6a19e4cec89a94c39d17cded7_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzMtNS0xLTEtMjY1MjQ3_0f78ab30-28f3-4426-b237-6c653f36381d">0.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5c6c53ae9a7745a09f19b70ba79aa0c2_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzQtMS0xLTEtMjY1MjQ3_978ecb92-1090-40b0-ad13-128f19cdf7d8">0.5</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0c6f50abab644dc7a7aa89e157fa28d7_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzQtMy0xLTEtMjY1MjQ3_37abc527-34a2-42b1-b914-eec760ced2d5">0.5</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3754a0a6a19e4cec89a94c39d17cded7_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzQtNS0xLTEtMjY1MjQ3_ab424b14-f18c-4545-b61b-dcdd55fad4fd">0.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5c6c53ae9a7745a09f19b70ba79aa0c2_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzUtMS0xLTEtMjY1MjQ3_fbd82b8a-ba5a-4df1-9eba-66bda944a4de">16.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0c6f50abab644dc7a7aa89e157fa28d7_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzUtMy0xLTEtMjY1MjQ3_3ce9c498-ff5a-484c-836e-7a9f2a801046">12.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3754a0a6a19e4cec89a94c39d17cded7_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzUtNS0xLTEtMjY1MjQ3_b77781a6-fe81-4075-8aeb-5332326bde70">13.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dividend yield is calculated based on semi-annual dividends paid and the fair market value of CVS Health Corporation stock at the grant date.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected volatility is estimated based on the historical volatility of CVS Health Corporation&#8217;s daily stock price over the previous six&#160;month period.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The risk-free interest rate is selected based on the Treasury constant maturity interest rate whose term is consistent with the expected term of ESPP purchases (i.e., six&#160;months).</span></div></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i26592ab2787d416a8765b06eb1bbda8b" continuedAt="if9992d8484fe496ca788dc92e155cd63">(4)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="if9992d8484fe496ca788dc92e155cd63">The expected life is based on the semi-annual purchase period</ix:continuation>.</span></div></ix:continuation><div><span><br/></span></div><div id="i36038907935e41eea5e9cf7cac915d44_160"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzUyMzg_0511226e-2156-4013-94a3-db0e1454b14d" continuedAt="i6729b86a352445d58e71186cb227d4bf" escape="true">Shareholders&#8217; Equity</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i6729b86a352445d58e71186cb227d4bf" continuedAt="i803fbba1cfb040269fbf34932b056390"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzUyNTc_4838adae-94d5-44bd-ac55-f80b33acc48e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following share repurchase programs have been authorized by the Board:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In billions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Authorization&#160;Date</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Authorized</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining as of<br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 17, 2022 (&#8220;2022 Repurchase Program&#8221;)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibad8baec27da4cd58b6724ab5ca623d2_I20221117" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZTo2MGFmMTE4MWM5YTM0M2UzYTM5Njg1YjgwZmMwNjg3Zi90YWJsZXJhbmdlOjYwYWYxMTgxYzlhMzQzZTNhMzk2ODViODBmYzA2ODdmXzEtMS0xLTEtMjY1MjQ3_01bb9a25-c8c6-4944-84a6-f70f169ec1cf">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia92776d15fb0441ab7ac651bee86eba1_I20221231" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZTo2MGFmMTE4MWM5YTM0M2UzYTM5Njg1YjgwZmMwNjg3Zi90YWJsZXJhbmdlOjYwYWYxMTgxYzlhMzQzZTNhMzk2ODViODBmYzA2ODdmXzEtMy0xLTEtMjY1MjQ3_ff7ac19b-5da6-4044-8579-c75d622300fc">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 9, 2021 (&#8220;2021 Repurchase Program&#8221;)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7008e24144824bc0af76d8c285ae7f14_I20211209" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZTo2MGFmMTE4MWM5YTM0M2UzYTM5Njg1YjgwZmMwNjg3Zi90YWJsZXJhbmdlOjYwYWYxMTgxYzlhMzQzZTNhMzk2ODViODBmYzA2ODdmXzItMS0xLTEtMjY1MjQ3_79852f7b-119e-4841-a0c7-fb5e3813241a">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a3166170d724c7b97874fd6a4dd3558_I20221231" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZTo2MGFmMTE4MWM5YTM0M2UzYTM5Njg1YjgwZmMwNjg3Zi90YWJsZXJhbmdlOjYwYWYxMTgxYzlhMzQzZTNhMzk2ODViODBmYzA2ODdmXzItMy0xLTEtMjY1MjQ3_44f281aa-1443-484a-a62c-b8d068bdc9a1">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the share Repurchase Programs was effective immediately and permit the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase (&#8220;ASR&#8221;) transactions, and/or other derivative transactions. Both the 2022 and 2021 Repurchase Programs can be modified or terminated by the Board at any time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, the Company repurchased an aggregate of <ix:nonFraction unitRef="shares" contextRef="i8e288b240a5b4df481e15c83675a98b4_D20220101-20221231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzU5Mg_fc0d1b8a-22f0-4021-91b1-2598bcccf6f2">34.1</ix:nonFraction>&#160;million shares of common stock for approximately $<ix:nonFraction unitRef="usd" contextRef="i8e288b240a5b4df481e15c83675a98b4_D20220101-20221231" decimals="-8" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzYzNg_ad26d6f8-3678-4b72-b3f1-13a5e03740f9">3.5</ix:nonFraction>&#160;billion pursuant to the 2021 Repurchase Program, including share repurchases under the $<ix:nonFraction unitRef="usd" contextRef="i1bffae2ffcf645319842b632734137ce_D20220104-20220104" decimals="-8" name="cvs:PaymentsForAcceleratedShareRepurchasesAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzcxOA_aa174b4b-db2e-4155-a5ba-027e9f71acc7">1.5</ix:nonFraction>&#160;billion fixed dollar ASR transaction described below. During the years ended December&#160;31, 2021 and 2020, the Company did <ix:nonFraction unitRef="shares" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzgxNw_bfaad557-12eb-44cb-951e-3ff482c56454"><ix:nonFraction unitRef="shares" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzgxNw_dc217d1f-9693-4b28-b959-562645bcdf43">no</ix:nonFraction></ix:nonFraction>t repurchase any shares of common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $<ix:nonFraction unitRef="usd" contextRef="i84ac2198cd22435ba1570e2db00d59e9_I20230104" decimals="-8" name="cvs:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzk1Mw_8d53bbcc-d2fd-4c9d-a881-af64e8a2cf13">2.0</ix:nonFraction>&#160;billion fixed dollar ASR with Citibank, N.A. (&#8220;Citibank&#8221;). Upon payment of the $<ix:nonFraction unitRef="usd" contextRef="i25c547443c724d349e0e7af7c9e93168_D20230104-20230104" decimals="-8" name="cvs:PaymentsForAcceleratedShareRepurchasesAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzEwMjc_ed53e341-f4c6-4753-9f9a-71f4370d5921">2.0</ix:nonFraction>&#160;billion purchase price on January 4, 2023, the Company received a number of shares of CVS Health Corporation&#8217;s common stock equal to <ix:nonFraction unitRef="number" contextRef="i84ac2198cd22435ba1570e2db00d59e9_I20230104" decimals="2" name="cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzExNTU_fdd56c26-ce83-48f0-a901-49da6fd39c89">80</ix:nonFraction>% of the $<ix:nonFraction unitRef="usd" contextRef="i84ac2198cd22435ba1570e2db00d59e9_I20230104" decimals="-8" name="cvs:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzExNjU_37d539a4-d975-4daf-ad1c-f36dfc0e1f4a">2.0</ix:nonFraction>&#160;billion notional amount of the ASR or approximately <ix:nonFraction unitRef="shares" contextRef="i84ac2198cd22435ba1570e2db00d59e9_I20230104" decimals="-5" name="cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzEyMTI_aa61363c-7c90-4284-b0b5-d9ff30396057">17.4</ix:nonFraction> million shares at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i84ac2198cd22435ba1570e2db00d59e9_I20230104" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzEyMzY_a3d1f79a-8362-42e8-82dd-651d711fd020">92.19</ix:nonFraction> per share, which were placed into treasury stock in January 2023. At the conclusion of the ASR, the Company may receive additional shares representing the remaining <ix:nonFraction unitRef="number" contextRef="i84ac2198cd22435ba1570e2db00d59e9_I20230104" decimals="2" name="cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzEzOTQ_a71e94f4-3d59-415b-9d76-709b62366367">20</ix:nonFraction>% of the $<ix:nonFraction unitRef="usd" contextRef="i84ac2198cd22435ba1570e2db00d59e9_I20230104" decimals="-8" name="cvs:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzE0MDQ_b8bfe709-39a3-4102-a218-45f9ffd01c2e">2.0</ix:nonFraction>&#160;billion notional amount. The ultimate number of shares the Company may receive will depend on the daily volume-weighted average price of the Company&#8217;s stock over an averaging period, less a discount. It is also possible, depending on such weighted average price, that the Company will have an obligation to Citibank which, at the Company&#8217;s option, could be settled in additional cash or by issuing shares. Under the terms of the ASR, the maximum number of shares that could be delivered to the Company is <ix:nonFraction unitRef="shares" contextRef="i84ac2198cd22435ba1570e2db00d59e9_I20230104" decimals="-5" name="cvs:AcceleratedShareRepurchaseProgramMaximumNumberOfShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzE5MDQ_fca64a1c-a918-4f23-81df-3ef6a6672780">43.4</ix:nonFraction> million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $<ix:nonFraction unitRef="usd" contextRef="i3d0b0cadc79d4115ba44a2ff3d97605e_I20220104" decimals="-8" name="cvs:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzIwMDE_144d1258-863d-4bef-b08a-b30f4b0777a6">1.5</ix:nonFraction>&#160;billion fixed dollar ASR with Barclays Bank PLC. Upon payment of the $<ix:nonFraction unitRef="usd" contextRef="i1bffae2ffcf645319842b632734137ce_D20220104-20220104" decimals="-8" name="cvs:PaymentsForAcceleratedShareRepurchasesAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzIwNjU_aa174b4b-db2e-4155-a5ba-027e9f71acc7">1.5</ix:nonFraction>&#160;billion purchase price on January 4, 2022, the Company received a number of shares of CVS Health Corporation&#8217;s common stock equal to <ix:nonFraction unitRef="number" contextRef="i3d0b0cadc79d4115ba44a2ff3d97605e_I20220104" decimals="2" name="cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzIxOTM_39472dde-7550-4adc-8ae9-24236514406f">80</ix:nonFraction>% of the $<ix:nonFraction unitRef="usd" contextRef="i3d0b0cadc79d4115ba44a2ff3d97605e_I20220104" decimals="-8" name="cvs:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzIyMDM_6cc3545a-9d1b-4371-b1d6-1c3decfef1c8">1.5</ix:nonFraction>&#160;billion notional amount of the ASR or approximately <ix:nonFraction unitRef="shares" contextRef="i3d0b0cadc79d4115ba44a2ff3d97605e_I20220104" decimals="-5" name="cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzIyNTA_4ab4bbe9-0b05-43ae-8f5c-201a35a7bab4">11.6</ix:nonFraction>&#160;million shares at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i3d0b0cadc79d4115ba44a2ff3d97605e_I20220104" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzIyNzQ_bad6ba74-3e7b-4192-b062-e97a19e7c9a2">103.34</ix:nonFraction> per share, which were placed into treasury stock in January 2022. The ASR was accounted for as an initial treasury stock transaction for $<ix:nonFraction unitRef="usd" contextRef="i3d0b0cadc79d4115ba44a2ff3d97605e_I20220104" decimals="-8" name="cvs:TransferOfSharesToTreasuryStockValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzI0MTQ_f265e838-6844-404e-a929-a6902a9cf73d">1.2</ix:nonFraction>&#160;billion and a forward contract for $<ix:nonFraction unitRef="usd" contextRef="i094abc0cc72e4a7b9ea560f3aa3450de_I20220104" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzI0NDQ_722670a3-f82f-4374-b6ca-814ce4d12a13">0.3</ix:nonFraction>&#160;billion. The forward contract was classified as an equity instrument and was recorded within capital surplus. In February 2022, the Company received approximately <ix:nonFraction unitRef="shares" contextRef="i17d6d14c27bd46188dd9e2556640612b_I20220228" decimals="-5" name="cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzI2MDI_d864120b-d29e-4ba5-844e-eeb91ec718cf">2.7</ix:nonFraction>&#160;million shares of CVS Health Corporation&#8217;s common stock, representing the remaining </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i803fbba1cfb040269fbf34932b056390"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i17d6d14c27bd46188dd9e2556640612b_I20220228" decimals="2" name="cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzI2ODE_7eb0d377-cdbd-4b8e-8733-79d73d24f39b">20</ix:nonFraction>% of the $<ix:nonFraction unitRef="usd" contextRef="i17d6d14c27bd46188dd9e2556640612b_I20220228" decimals="-8" name="cvs:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzI2OTE_72eb6a45-5349-437e-a45a-c8a2a57d69ab">1.5</ix:nonFraction>&#160;billion notional amount of the ASR, thereby concluding the ASR. These shares were placed into treasury stock and the forward contract was reclassified from capital surplus to treasury stock in February 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time they were received, the initial and final receipt of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted average common shares outstanding for basic and diluted earnings per share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quarterly cash dividend declared by the Board was $<ix:nonFraction unitRef="usdPerShare" contextRef="i12bf05eff52b4dc7a2761da3f17bd087_I20220630" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzMyMDE_243d068d-1828-4aed-b21f-8f5d9fd0cc1c"><ix:nonFraction unitRef="usdPerShare" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzMyMDE_a7d0b29e-84fd-4311-8377-30a50f03e45f"><ix:nonFraction unitRef="usdPerShare" contextRef="i3549637e3aa64b7ca86fda506d366817_I20220930" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzMyMDE_a9d7369a-c8bc-4203-99da-cc23c0f04a60"><ix:nonFraction unitRef="usdPerShare" contextRef="id5d6daa4ca684089955a31c220b36c14_I20220331" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzMyMDE_f10bff9a-95c0-4c89-94d5-a3cfcc01d171">0.55</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzMyMDg_30abf26d-65ea-496d-9b56-79c434802fcc"><ix:nonFraction unitRef="usdPerShare" contextRef="i59704ef4a59040dea06f0021fcb06568_I20210930" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzMyMDg_69c38f2f-8550-4f15-a2bf-372278244228"><ix:nonFraction unitRef="usdPerShare" contextRef="ifc442e76415641328a8c0780c2b0fd3b_I20210331" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzMyMDg_97a88e9b-afb1-4ba0-9de5-450256ac4078"><ix:nonFraction unitRef="usdPerShare" contextRef="i52430d6ae75d4b3fae0b76f1ae95568c_I20210630" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzMyMDg_d934200d-f7ab-4572-a15d-94037b761dd6">0.50</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> per share in 2022 and 2021, respectively. In December 2022, the Board authorized a <ix:nonFraction unitRef="number" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="2" name="cvs:DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzMyOTA_f649ce7a-f823-49f0-9b5c-6e9ac68fa430">10</ix:nonFraction>% increase in the quarterly cash dividend to $<ix:nonFraction unitRef="usdPerShare" contextRef="i500357364f0b4a8aa0660969b4e7e47e_I20230101" decimals="3" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzMzMzY_fe9ef4f2-349b-4b8f-bda6-c95a2d34add3">0.605</ix:nonFraction> per share effective in 2023. CVS Health Corporation has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#8217;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Requirements</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s insurance business operations are conducted through subsidiaries that principally consist of health maintenance organizations (&#8220;HMOs&#8221;) and insurance companies. The Company&#8217;s HMO and insurance subsidiaries report their financial statements in accordance with accounting practices prescribed by state regulatory authorities which may differ from GAAP. <ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfRegulatoryAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzUyNTU_ea8d003f-3a76-4d98-8d4e-969513588a15" continuedAt="i68ab9e2480ce470daf579c9a168fe11b" escape="true">The combined statutory net income for the years ended and estimated combined statutory and capital surplus at December&#160;31, 2022, 2021 and 2020 for the Company&#8217;s insurance and HMO subsidiaries were as follows:</ix:nonNumeric></span></div><div><ix:continuation id="i68ab9e2480ce470daf579c9a168fe11b"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory net income </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2861b22f2af148719342305921a4f8a9_D20220101-20221231" decimals="-6" name="us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZTowOGQ2ZTNiZWE2ZGI0ZjEwYWViNTdiMTY4M2U0MGYwNi90YWJsZXJhbmdlOjA4ZDZlM2JlYTZkYjRmMTBhZWI1N2IxNjgzZTQwZjA2XzEtMS0xLTEtMjY1MjQ3_9f399dd4-a6b4-4fed-81aa-e8f7a2a573d3">2,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3c08b2b0c4e47d4803766dfaa373def_D20210101-20211231" decimals="-6" name="us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZTowOGQ2ZTNiZWE2ZGI0ZjEwYWViNTdiMTY4M2U0MGYwNi90YWJsZXJhbmdlOjA4ZDZlM2JlYTZkYjRmMTBhZWI1N2IxNjgzZTQwZjA2XzEtMy0xLTEtMjY1MjQ3_96e25a39-c991-4b39-8c76-ac36908022f3">3,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55bbfd8a1ccf4503a274fb9d768bf153_D20200101-20201231" decimals="-6" name="us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZTowOGQ2ZTNiZWE2ZGI0ZjEwYWViNTdiMTY4M2U0MGYwNi90YWJsZXJhbmdlOjA4ZDZlM2JlYTZkYjRmMTBhZWI1N2IxNjgzZTQwZjA2XzEtNS0xLTEtMjY1MjQ3_87c5089c-79e1-47a6-91a9-a03ff638ada3">3,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated statutory capital and surplus</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10dc16dcaa2a4ba381f65a9a4a83824e_I20221231" decimals="-6" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZTowOGQ2ZTNiZWE2ZGI0ZjEwYWViNTdiMTY4M2U0MGYwNi90YWJsZXJhbmdlOjA4ZDZlM2JlYTZkYjRmMTBhZWI1N2IxNjgzZTQwZjA2XzItMS0xLTEtMjY1MjQ3_0b7f93f2-0eb3-40db-8e97-3b9493ccf0ef">15,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3172ad2aca194783adc959bfa45cb532_I20211231" decimals="-6" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZTowOGQ2ZTNiZWE2ZGI0ZjEwYWViNTdiMTY4M2U0MGYwNi90YWJsZXJhbmdlOjA4ZDZlM2JlYTZkYjRmMTBhZWI1N2IxNjgzZTQwZjA2XzItMy0xLTEtMjY1MjQ3_be803549-2be6-452c-b522-fc5892c1ebbf">14,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice175d1759f24588b3cf0829061e9e44_I20201231" decimals="-6" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZTowOGQ2ZTNiZWE2ZGI0ZjEwYWViNTdiMTY4M2U0MGYwNi90YWJsZXJhbmdlOjA4ZDZlM2JlYTZkYjRmMTBhZWI1N2IxNjgzZTQwZjA2XzItNS0xLTEtMjY1MjQ3_381663f2-a488-48b9-a8c1-d05e092bbbff">13,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s insurance and HMO subsidiaries paid $<ix:nonFraction unitRef="usd" contextRef="i2861b22f2af148719342305921a4f8a9_D20220101-20221231" decimals="-6" name="us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzQyNTM_ab4badd1-bbfe-453d-8c78-aed5d5d6d615">3.2</ix:nonFraction> billion of gross dividends to the Company for the year ended December&#160;31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to general state law restrictions on payments of dividends and other distributions to stockholders applicable to all corporations, HMOs and insurance companies are subject to further regulations that, among other things, may require those companies to maintain certain levels of equity and restrict the amount of dividends and other distributions that may be paid to their equity holders. In addition, in connection with the Aetna Acquisition, the Company made certain undertakings that require prior regulatory approval of dividends by certain of its HMOs and insurance companies. <ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:StatutoryAccountingPracticesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzUyNDk_6f02bfe7-8db0-41bf-8915-6d25234265e8" continuedAt="i9def0bd01b134299a2cb56b110156ab3" escape="true">At December&#160;31, 2022, these amounts were as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i9def0bd01b134299a2cb56b110156ab3"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:88.196%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.604%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated minimum statutory surplus required by regulators</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZToxMDdkMDk1NTJiNzU0NjlhYjhkNzNhODQ5MTZiODI3Yy90YWJsZXJhbmdlOjEwN2QwOTU1MmI3NTQ2OWFiOGQ3M2E4NDkxNmI4MjdjXzEtMS0xLTEtMjY1MjQ3_582bb818-e250-4d8c-89e0-cc015f0a8dab">7,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments on deposit with regulatory bodies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:AssetsHeldByInsuranceRegulators" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZToxMDdkMDk1NTJiNzU0NjlhYjhkNzNhODQ5MTZiODI3Yy90YWJsZXJhbmdlOjEwN2QwOTU1MmI3NTQ2OWFiOGQ3M2E4NDkxNmI4MjdjXzItMS0xLTEtMjY1MjQ3_65eec683-6074-463a-8c15-4045b91aafb9">652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated maximum dividend distributions permitted in 2023 without prior regulatory approval</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZToxMDdkMDk1NTJiNzU0NjlhYjhkNzNhODQ5MTZiODI3Yy90YWJsZXJhbmdlOjEwN2QwOTU1MmI3NTQ2OWFiOGQ3M2E4NDkxNmI4MjdjXzMtMS0xLTEtMjY1MjQ3_81ff9ac2-04b3-47f4-aef4-e02a9b9cc23e">2,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Noncontrolling Interests</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 and 2021, noncontrolling interests were $<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzUwMTk_b30dc2c8-dd1f-4248-a047-41f521acbd2d">300</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzUwMjY_c8d84b3a-8a82-42dc-bf67-c9e7830fb565">306</ix:nonFraction> million, respectively, primarily related to third party interests in the Company&#8217;s operating entities.&#160;The noncontrolling entities&#8217; share is included in total shareholders</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> equity on the consolidated balance sheets.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_163"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90ZXh0cmVnaW9uOjVhNmRjNDE2NzM1ZjQyNzU5YTA4YzU4MTdkYzg3ZTljXzk0Mg_376c65d2-e105-4444-901b-f586f3f7192c" continuedAt="i840a51204ade436fb23d374cce2e82e8" escape="true">Other Comprehensive Income (Loss)</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i840a51204ade436fb23d374cce2e82e8" continuedAt="i486815b9863a4f89a42fdf6853a5b45e"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90ZXh0cmVnaW9uOjVhNmRjNDE2NzM1ZjQyNzU5YTA4YzU4MTdkYzg3ZTljXzk0NA_7a66b6cf-e809-4e49-a866-68c3bf6b30bd" continuedAt="i5e72675c4d3a488782ba9dc53351d0c0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income (loss) in 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.089%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment gains (losses):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9ccb78a44d7465982d030ff243bbb22_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMtMS0xLTEtMjY1MjQ3_dd530374-e41d-4384-944e-6e698dc1d085">798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i771fadc404fa4b92b4c5f7223f25415c_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMtMy0xLTEtMjY1MjQ3_4cb80f1b-4c34-4344-aa9b-5849c415bc43">1,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88fc675ce48b4c548ef81361fcc6c9d6_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMtNS0xLTEtMjY1MjQ3_912f99cb-a945-4472-a198-a7a4245b501d">774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i1dc4dc90c6c14d12b12e609426ef8a6e_I20211231" decimals="-6" name="cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtMC0xLTEtMjk3Mjg2L3RleHRyZWdpb246ZjFmMTU0NTM4ZDJkNDMzOGE1ZTQ2YzczMDBhZDk1N2FfNTQ5NzU1ODEzOTcw_31571511-59db-48ba-a672-9784adb814ab">0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ibcd29ef153c04215b9cfa268ba78b5f0_I20201231" decimals="-6" name="cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtMC0xLTEtMjk3Mjg2L3RleHRyZWdpb246ZjFmMTU0NTM4ZDJkNDMzOGE1ZTQ2YzczMDBhZDk1N2FfNTQ5NzU1ODEzOTU1_bf29248d-72b6-4a6e-bb9a-08aa20c79883">181</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i7f0ef44e552b4f5b981adaa9006f01dc_I20191231" decimals="-6" name="cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtMC0xLTEtMjk3Mjg2L3RleHRyZWdpb246ZjFmMTU0NTM4ZDJkNDMzOGE1ZTQ2YzczMDBhZDk1N2FfNTQ5NzU1ODEzOTcz_bc3cd0a1-5d2f-4c7d-85e4-1adaf294e61e">0</ix:nonFraction> pretax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dc4dc90c6c14d12b12e609426ef8a6e_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtMS0xLTEtMjk1MDE2_7229370e-2671-4196-83a7-3d51c2cfe491">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd29ef153c04215b9cfa268ba78b5f0_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtMy0xLTEtMjk1MDE2_a2deda40-75a6-4158-b487-920e6149f8b7">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f0ef44e552b4f5b981adaa9006f01dc_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtNS0xLTEtMjk1MDE2_81fb6c61-1616-4078-9024-143c45619891">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(<ix:nonFraction unitRef="usd" contextRef="i023f6f414fc44282a2cc8132892a707c_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtMC0xLTEtMjY1MjQ3L3RleHRyZWdpb246MDE2MjhlNGE4OTYzNDYwZjk5YzA4OWVmNjkzZmVlZmRfNjQ_02af8aff-78b9-4b14-8284-9eb2ba7b2b33">3,021</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="iee8d0bfbbe9b491fb9bfa6c2b789c080_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtMC0xLTEtMjY1MjQ3L3RleHRyZWdpb246MDE2MjhlNGE4OTYzNDYwZjk5YzA4OWVmNjkzZmVlZmRfNjg_0f87383d-1999-4665-a1a8-18be797f0b6a">644</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="i07377a7640384b77a5031acac5ac0cff_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtMC0xLTEtMjY1MjQ3L3RleHRyZWdpb246MDE2MjhlNGE4OTYzNDYwZjk5YzA4OWVmNjkzZmVlZmRfNzU_b4944240-fa47-4bd5-a1a8-1f538e2108aa">497</ix:nonFraction> pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i023f6f414fc44282a2cc8132892a707c_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtMS0xLTEtMjY1MjQ3_931d08d6-4a29-4e56-b92b-7b138861d192">2,556</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee8d0bfbbe9b491fb9bfa6c2b789c080_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtMy0xLTEtMjY1MjQ3_efdd8ea6-a185-4fd7-8a65-491dedb6cd0d">530</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07377a7640384b77a5031acac5ac0cff_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtNS0xLTEtMjY1MjQ3_8072a27b-d865-4fd2-a6ba-e71bb9822465">415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="i023f6f414fc44282a2cc8132892a707c_D20220101-20221231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzUtMC0xLTEtMjY1MjQ3L3RleHRyZWdpb246ZmQ1OWVkNjFlYjg0NDM0ZDk2OTBiNmNiYWUzMDU1YzJfNzA_3c8f24b8-6e27-4f6f-ac4f-2b5503157223">315</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="iee8d0bfbbe9b491fb9bfa6c2b789c080_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzUtMC0xLTEtMjY1MjQ3L3RleHRyZWdpb246ZmQ1OWVkNjFlYjg0NDM0ZDk2OTBiNmNiYWUzMDU1YzJfNzQ_058032b3-b971-4378-847a-91c6d0225b20">32</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="i07377a7640384b77a5031acac5ac0cff_D20200101-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzUtMC0xLTEtMjY1MjQ3L3RleHRyZWdpb246ZmQ1OWVkNjFlYjg0NDM0ZDk2OTBiNmNiYWUzMDU1YzJfODE_705c6e97-071f-4b3d-a021-e36979377945">31</ix:nonFraction> pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i023f6f414fc44282a2cc8132892a707c_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzUtMS0xLTEtMjY1MjQ3_25ce6884-8281-4139-bc0d-0205c9bd8f2a">239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee8d0bfbbe9b491fb9bfa6c2b789c080_D20210101-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzUtMy0xLTEtMjY1MjQ3_6d659004-977c-44bf-80b3-fe538745d1b8">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07377a7640384b77a5031acac5ac0cff_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzUtNS0xLTEtMjY1MjQ3_03014cce-2c3d-41e2-99d3-77d55701816b">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i023f6f414fc44282a2cc8132892a707c_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzYtMS0xLTEtMjY1MjQ3_cf1d55fe-cfb3-48b5-b93d-c9a8e10a28f6">2,317</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee8d0bfbbe9b491fb9bfa6c2b789c080_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzYtMy0xLTEtMjY1MjQ3_a3bddcb0-c15d-44bf-afb5-2f21e8b2bf17">556</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07377a7640384b77a5031acac5ac0cff_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzYtNS0xLTEtMjY1MjQ3_a88d176f-ed14-4265-ae26-b1cf777b49f9">440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idfb87a5b2adf46d8a1cc7648916f9ec9_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzctMS0xLTEtMjY1MjQ3_150a0618-4c19-46e6-80bd-b117d0b761de">1,519</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9ccb78a44d7465982d030ff243bbb22_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzctMy0xLTEtMjY1MjQ3_5b6423e3-997b-4daa-aa45-e482569c1842">798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i771fadc404fa4b92b4c5f7223f25415c_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzctNS0xLTEtMjY1MjQ3_eaacee8b-e003-46ef-9ac5-8060ae974316">1,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in discount rate on long-duration insurance reserves:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifea16681bcf147688ca4766b0691becd_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzExLTEtMS0xLTI5NDk3Nw_6e86c8e1-3a6f-4206-a809-cc412ee567bf">651</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0883ba92f0894b389a5662952ea59782_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzExLTMtMS0xLTI5NDk3Nw_43d68263-3b2d-4eff-823c-b2c8b9844180">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25433e213492429485a961cd63705c7d_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzExLTUtMS0xLTI5NDk3Nw_b6eab1ee-06dd-4acd-9f0c-3cf5c994ef05">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="ib0cc3bef65884acf9911dabdba462d4a_I20211231" decimals="-6" name="cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEyLTAtMS0xLTI5NDUzNy90ZXh0cmVnaW9uOmVkZjAzMTZiMDJjNDRmOGJhY2I0YmM0YTlhYmIzMGY3XzU0OTc1NTgxMzk3NA_bdadc43d-2349-4444-b087-d01b9d2944ec">0</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="i766e456db6b04cc6983552df4d2bd677_I20201231" decimals="-6" sign="-" name="cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEyLTAtMS0xLTI5NDUzNy90ZXh0cmVnaW9uOmVkZjAzMTZiMDJjNDRmOGJhY2I0YmM0YTlhYmIzMGY3XzU0OTc1NTgxMzk4MA_39071e68-86bc-4c79-8740-981fcef88c8e">1,166</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="i5e7b828a30914b35b0be92961fa877cb_I20191231" decimals="-6" name="cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEyLTAtMS0xLTI5NDUzNy90ZXh0cmVnaW9uOmVkZjAzMTZiMDJjNDRmOGJhY2I0YmM0YTlhYmIzMGY3XzU0OTc1NTgxMzk4OA_b0e315e9-ccc1-428a-8511-c778e0462dff">0</ix:nonFraction> pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0cc3bef65884acf9911dabdba462d4a_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEyLTEtMS0xLTI5NDk3Nw_78ebd73e-9e18-4553-bf01-e84287137c4b">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766e456db6b04cc6983552df4d2bd677_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEyLTMtMS0xLTI5NDk3Nw_52cd2cde-7e15-4f35-b5a6-5c72bebadd16">906</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e7b828a30914b35b0be92961fa877cb_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEyLTUtMS0xLTI5NDk3Nw_05e574b1-0d9d-4f89-b79d-dbe624e5c732">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="i3a4812ee71224d53b0a6f7e8aee63c1c_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEzLTAtMS0xLTI5NDUzNy90ZXh0cmVnaW9uOmQ2OWU3MGMxNTI5YjQ3MjhiNmQ4ZGViMGYyYmNkYjdjXzU0OTc1NTgxMzk5Ng_0bfa342a-93bd-452b-8086-07276a99194b">1,126</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i598ca408d2d84a49a1bce5601d7579a1_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEzLTAtMS0xLTI5NDUzNy90ZXh0cmVnaW9uOmQ2OWU3MGMxNTI5YjQ3MjhiNmQ4ZGViMGYyYmNkYjdjXzU0OTc1NTgxNDAwMQ_a9254fc8-ffc7-4d8b-9cea-62a97297f31e">328</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i811c61381d624e819e35527aea6e070f_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEzLTAtMS0xLTI5NDUzNy90ZXh0cmVnaW9uOmQ2OWU3MGMxNTI5YjQ3MjhiNmQ4ZGViMGYyYmNkYjdjXzU0OTc1NTgxNDAxMA_c82d1415-cbd4-4ce8-b5bf-bcb226580ce3">0</ix:nonFraction> pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a4812ee71224d53b0a6f7e8aee63c1c_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEzLTEtMS0xLTI5NDk3Nw_599315ac-31af-4a88-af7f-468f710e8397">870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i598ca408d2d84a49a1bce5601d7579a1_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEzLTMtMS0xLTI5NDk3Nw_6e37657a-323e-4c73-aac1-632d320aa580">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i811c61381d624e819e35527aea6e070f_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEzLTUtMS0xLTI5NDk3Nw_d64af2f8-d142-44a8-bef4-a9f872ef1f94">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a4812ee71224d53b0a6f7e8aee63c1c_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE0LTEtMS0xLTI5NDk3Nw_5ca49cbd-ed3a-4de0-bd6f-4840f279ca7a">870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i598ca408d2d84a49a1bce5601d7579a1_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE0LTMtMS0xLTI5NDk3Nw_f14fcea7-41b8-4853-af8d-83df46b39c46">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i811c61381d624e819e35527aea6e070f_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE0LTUtMS0xLTI5NDk3Nw_17f7c8a5-e715-417d-ab7c-9f6ef1decd82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia514adc5b997452badcc59a3cef31271_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE1LTEtMS0xLTI5NDk3Nw_ffd42404-a6cd-4e34-82b7-44561030b166">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifea16681bcf147688ca4766b0691becd_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE1LTMtMS0xLTI5NDk3Nw_325a6951-8ad8-4377-9076-47c0d59ddf96">651</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0883ba92f0894b389a5662952ea59782_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE1LTUtMS0xLTI5NDk3Nw_78b9d122-7fa3-4a8d-b3bf-469d2e3c7fa9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01610c9c48964170846a9803dfaae808_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEwLTEtMS0xLTI2NTI0Nw_223d46d1-36c5-4012-9010-9125ed03fe43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ca31cddc0e4d939c02b38a65d9a6dd_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEwLTMtMS0xLTI2NTI0Nw_8fd74e9e-a1b9-49a8-a8ae-cd13a470cefe">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c92e83572bf462c88118f40349b2650_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEwLTUtMS0xLTI2NTI0Nw_a2387ffe-b039-4730-a420-321841e70a3d">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb9f09a01d4b4d99b74e89116f65644f_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzExLTEtMS0xLTI2NTI0Nw_f31bef0f-a484-4c7d-bd37-f29e8e582bf0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22d7007c61d0497e98e462fffb60e872_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzExLTMtMS0xLTI2NTI0Nw_099d21ec-d7b8-4a57-a5c7-0856794965ca">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if125eb5e1f404115a1ed0d00ee58b816_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzExLTUtMS0xLTI2NTI0Nw_8aac507e-d538-4de1-a595-56e3c46d591a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb9f09a01d4b4d99b74e89116f65644f_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEzLTEtMS0xLTI2NTI0Nw_ad4bd4c1-333b-48ec-8466-53e2418b7257">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22d7007c61d0497e98e462fffb60e872_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEzLTMtMS0xLTI2NTI0Nw_33001b78-4ccb-4d8a-8408-a0ba3b69d34c">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if125eb5e1f404115a1ed0d00ee58b816_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEzLTUtMS0xLTI2NTI0Nw_594153e4-65bc-4378-b230-692987217edd">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2aee76db1bb748378d6caddd4053ea53_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE0LTEtMS0xLTI2NTI0Nw_c869dfd8-fc48-4b2d-b2c7-4357b3b71779">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01610c9c48964170846a9803dfaae808_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE0LTMtMS0xLTI2NTI0Nw_e0c409c2-25fc-4551-965e-fe597a8ed185">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ca31cddc0e4d939c02b38a65d9a6dd_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE0LTUtMS0xLTI2NTI0Nw_06cd4ea6-a32c-4a6e-b561-b9e9e7098cce">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90400ed7cb0a406798d26f08b8d43428_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE3LTEtMS0xLTI2NTI0Nw_c9aadbfe-0f85-4f12-b395-89f2d634b012">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82369985b1244530ab5a13db891d7cb5_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE3LTMtMS0xLTI2NTI0Nw_e766dc4b-4c5f-43d4-bed1-5413b73d2a72">248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec1de78285984edda41f8718f4ee9eae_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE3LTUtMS0xLTI2NTI0Nw_9e9ad5e1-e261-4ece-aa5f-6972187e31a4">279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="ifb77c13970ba4503946c83a942f0b97b_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE4LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmI4NDFkYzExM2M1ZTRhODdhYjdkZjQ4MDZlZTY4MjdlXzY0_522ad5ef-53bc-4bd9-8df5-61122d9064cd">38</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i7f3a20682c0f4c82a18c98153f67cbfd_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE4LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmI4NDFkYzExM2M1ZTRhODdhYjdkZjQ4MDZlZTY4MjdlXzY4_45c0424e-2546-4e60-9325-c452621bde9e">0</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="i1c4a15704cee48ee8522b657c8eb6247_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE4LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmI4NDFkYzExM2M1ZTRhODdhYjdkZjQ4MDZlZTY4MjdlXzc1_c1dbaed8-b1eb-4e4d-807d-95cf3ed16a1f">7</ix:nonFraction>) pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb77c13970ba4503946c83a942f0b97b_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE4LTEtMS0xLTI2NTI0Nw_209efeef-df8d-43f0-b0c7-7594066178e7">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f3a20682c0f4c82a18c98153f67cbfd_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE4LTMtMS0xLTI2NTI0Nw_71b1a0b4-a602-4c30-825a-86e55ac3b9d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c4a15704cee48ee8522b657c8eb6247_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE4LTUtMS0xLTI2NTI0Nw_e86bef32-0aa0-4cee-8ca1-bcb8f61cd0d1">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(<ix:nonFraction unitRef="usd" contextRef="ifb77c13970ba4503946c83a942f0b97b_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE5LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjYwOWJmMWYwOWNhNTQzMTlhY2Q4NDdlZjgzNDA2NjQxXzcw_c02e6412-6d6d-41a1-936c-ba93588ed022">15</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="i7f3a20682c0f4c82a18c98153f67cbfd_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE5LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjYwOWJmMWYwOWNhNTQzMTlhY2Q4NDdlZjgzNDA2NjQxXzc0_396b68d8-0c5a-4c47-8bbc-10e5a6dbf75d">34</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="i1c4a15704cee48ee8522b657c8eb6247_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE5LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjYwOWJmMWYwOWNhNTQzMTlhY2Q4NDdlZjgzNDA2NjQxXzgx_54134e58-dc4a-4df1-9241-63cd5bd15fcf">35</ix:nonFraction>) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb77c13970ba4503946c83a942f0b97b_D20220101-20221231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE5LTEtMS0xLTI2NTI0Nw_0b9f2efb-1859-4752-be85-6817accff4b5">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f3a20682c0f4c82a18c98153f67cbfd_D20210101-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE5LTMtMS0xLTI2NTI0Nw_d2f24195-cc21-4dc6-9437-9b0c7d1530f9">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c4a15704cee48ee8522b657c8eb6247_D20200101-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE5LTUtMS0xLTI2NTI0Nw_09db0ece-2828-42f8-869b-bb15138e5efe">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb77c13970ba4503946c83a942f0b97b_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzIwLTEtMS0xLTI2NTI0Nw_6a5858e8-c164-4cc6-877e-f098bc986c2f">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f3a20682c0f4c82a18c98153f67cbfd_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzIwLTMtMS0xLTI2NTI0Nw_ef812152-8bc8-4ff4-8bc2-a62a08c1d3e1">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c4a15704cee48ee8522b657c8eb6247_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzIwLTUtMS0xLTI2NTI0Nw_c2522340-2c5e-4528-b13f-cef1222f301f">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5be5c21fc6b47318e20171c1f0a645b_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzIxLTEtMS0xLTI2NTI0Nw_1ca437bb-5897-41fd-9983-cd415880510a">239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90400ed7cb0a406798d26f08b8d43428_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzIxLTMtMS0xLTI2NTI0Nw_ac9a60cd-2809-4121-be46-63de0e4f3e15">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82369985b1244530ab5a13db891d7cb5_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzIxLTUtMS0xLTI2NTI0Nw_4575f35d-0b32-45f2-b99d-cc6ecfa5a483">248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84989b019a41baa48fa485b7f433eb_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI0LTEtMS0xLTI2NTI0Nw_146b6372-30c1-4795-9361-6d5428eca56d">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1aeff9cdec2548d19148b1b223aae8c8_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI0LTMtMS0xLTI2NTI0Nw_238b2e1e-5b72-4b8d-b8f5-3d07921a10e8">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f4df77c750240e3a41b042b6e64fc43_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI0LTUtMS0xLTI2NTI0Nw_108d45f9-cfd1-4578-a614-61143cfb11fc">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(<ix:nonFraction unitRef="usd" contextRef="i0b83d8d8e7104451a4bcacd3638e07ca_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI1LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmZmOTU2ODE5MmZmZDRkZTY4MmVjODFlM2E5YTg2M2RiXzY0_de731057-1cc2-4c1b-8b16-666877904416">229</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="if885d6ab9e204495a3e6ef113c294079_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI1LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmZmOTU2ODE5MmZmZDRkZTY4MmVjODFlM2E5YTg2M2RiXzY4_e907c823-6791-4a5d-9df9-5fd841a8d94a">20</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="i72d609617ef245bab1355fa62da5e409_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI1LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmZmOTU2ODE5MmZmZDRkZTY4MmVjODFlM2E5YTg2M2RiXzc1_e4748540-584f-444d-bccc-27928b6fe836">30</ix:nonFraction>) pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b83d8d8e7104451a4bcacd3638e07ca_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI1LTEtMS0xLTI2NTI0Nw_ce840fd8-0b34-4b00-9f0c-f8417407b528">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if885d6ab9e204495a3e6ef113c294079_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI1LTMtMS0xLTI2NTI0Nw_d6c7b091-2624-4109-9e4b-6350b93e816b">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72d609617ef245bab1355fa62da5e409_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI1LTUtMS0xLTI2NTI0Nw_5bdf208b-5eef-46ba-9be5-dc2c96bc10c0">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="i0b83d8d8e7104451a4bcacd3638e07ca_D20220101-20221231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI2LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjZhNzA3YjE4OTJiNjRmMzE4Njc4YTQ1YjUwMzRjMjcyXzY4_cd18eeda-294c-4ed4-8648-2e161ff7a0a9">3</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="if885d6ab9e204495a3e6ef113c294079_D20210101-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI2LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjZhNzA3YjE4OTJiNjRmMzE4Njc4YTQ1YjUwMzRjMjcyXzcy_078097cc-8f4d-4fd0-b80a-762c28e00560">6</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i72d609617ef245bab1355fa62da5e409_D20200101-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI2LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjZhNzA3YjE4OTJiNjRmMzE4Njc4YTQ1YjUwMzRjMjcyXzc5_9d9b4ee7-d7b4-49d7-ae29-46799e6331fc">7</ix:nonFraction> pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b83d8d8e7104451a4bcacd3638e07ca_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI2LTEtMS0xLTI2NTI0Nw_92f172d6-3eef-4be3-8ba5-23b681e848b9">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if885d6ab9e204495a3e6ef113c294079_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI2LTMtMS0xLTI2NTI0Nw_30dd1797-726b-47c2-9c97-90a6c5638f41">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72d609617ef245bab1355fa62da5e409_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI2LTUtMS0xLTI2NTI0Nw_26266acb-6127-4a84-adcf-8661f78469ac">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b83d8d8e7104451a4bcacd3638e07ca_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI3LTEtMS0xLTI2NTI0Nw_896c55d2-df88-41c5-bbde-807880bfecc3">168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if885d6ab9e204495a3e6ef113c294079_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI3LTMtMS0xLTI2NTI0Nw_0f09f4ec-7ee6-408f-9f1d-309e98241aea">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72d609617ef245bab1355fa62da5e409_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI3LTUtMS0xLTI2NTI0Nw_526e2fee-7d60-4288-b988-87a29608a8e5">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a3276638fa043e8b7afa530e1d05bb2_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI4LTEtMS0xLTI2NTI0Nw_8c153557-d948-40bd-a5ce-b926ec411369">203</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b84989b019a41baa48fa485b7f433eb_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI4LTMtMS0xLTI2NTI0Nw_2ad8afda-0455-4d60-a1e4-649444566d72">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1aeff9cdec2548d19148b1b223aae8c8_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI4LTUtMS0xLTI2NTI0Nw_9c59bb95-cc35-404f-b600-0dd1258b6c72">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of year accumulated other comprehensive income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fb000b6c98f4852bdadc304be11feb1_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMwLTEtMS0xLTI2NTI0Nw_9f08eb71-89df-4e78-b429-9878aaec5478">334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cf1c76c42274016b31466d614be3e9d_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMwLTMtMS0xLTI2NTI0Nw_d5ace3fb-97d4-432a-a2b4-6be79ab68e4e">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i351a28ebc5774422943a9b3793f826c0_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMwLTUtMS0xLTI2NTI0Nw_88b2ca44-ffd2-43d8-8104-5d2fe4649708">1,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e58ede6136947f8b425e9c08cd2ab43_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzM5LTEtMS0xLTI5NTAyOQ_8bc8fb9e-6080-436c-8b3a-8eb7ce88ee89">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba7e0b37b090469783d9d2507887d647_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzM5LTMtMS0xLTI5NTAyOQ_ae7ef70d-e1e4-4a64-a655-4b439e017d6c">766</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45396cadefb0439195f503c88cc4379c_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzM5LTUtMS0xLTI5NTAyOQ_223a7454-860c-4c64-b75e-107716448a97">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMxLTEtMS0xLTI2NTI0Nw_62615017-20b8-477a-a5f6-f1be1a9cdfd0">1,598</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMxLTMtMS0xLTI2NTI0Nw_08a4bb3c-d248-4268-a182-3a3d9b8cebd6">314</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMxLTUtMS0xLTI2NTI0Nw_75934af2-c65c-4634-a557-bf829d2729ba">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of year accumulated other comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic2b7c36808c049e6bacef0812147f213_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMyLTEtMS0xLTI2NTI0Nw_c1363ea5-aae0-42ff-a242-2b08be224026">1,264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fb000b6c98f4852bdadc304be11feb1_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMyLTMtMS0xLTI2NTI0Nw_4ad050a5-fc61-45f5-af40-a4ee32d2205d">334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cf1c76c42274016b31466d614be3e9d_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMyLTUtMS0xLTI2NTI0Nw_44b0118f-51e2-441e-8830-7439a2628dbf">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_______________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"> Reflects the adoption of ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 944) during the year ended December 31, 2021. See Note 8 &#8216;&#8216;Other Insurance Liabilities and Separate Accounts&#8217;&#8217; for additional information.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i486815b9863a4f89a42fdf6853a5b45e"><ix:continuation id="i5e72675c4d3a488782ba9dc53351d0c0"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the consolidated statements of operations. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included within interest expense in the consolidated statements of operations. The Company expects to reclassify $<ix:nonFraction unitRef="usd" contextRef="if5be5c21fc6b47318e20171c1f0a645b_I20221231" decimals="-6" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90ZXh0cmVnaW9uOjVhNmRjNDE2NzM1ZjQyNzU5YTA4YzU4MTdkYzg3ZTljXzYyNQ_5a4d5c89-01bb-4718-b5b0-d26fd684162d">11</ix:nonFraction> million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the consolidated statements of operations.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_166"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90ZXh0cmVnaW9uOjlhMTYzNDUyMjI0ODQxZTE4ZDFkMDY2ODhjZTQ2YTljXzU4Ng_426c207a-9c77-4044-9a66-45daedd6746f" continuedAt="i5158b4a79d614c92b512ad9aff8459f3" escape="true">Earnings Per Share</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i5158b4a79d614c92b512ad9aff8459f3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is computed using the treasury stock method. Stock options and SARs to purchase <ix:nonFraction unitRef="shares" contextRef="ibeb7c35ad88b4db086fed358829f1fca_D20220101-20221231" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90ZXh0cmVnaW9uOjlhMTYzNDUyMjI0ODQxZTE4ZDFkMDY2ODhjZTQ2YTljXzEyNQ_1b922398-1f83-44a4-bf92-6a25d80dcb9c">4</ix:nonFraction> million, <ix:nonFraction unitRef="shares" contextRef="iac8347b945e247b7ba7d5c565f033409_D20210101-20211231" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90ZXh0cmVnaW9uOjlhMTYzNDUyMjI0ODQxZTE4ZDFkMDY2ODhjZTQ2YTljXzEyOQ_867415fd-11e8-4257-8fd7-2455a01c8944">7</ix:nonFraction>&#160;million, and <ix:nonFraction unitRef="shares" contextRef="i5695caba25e84d32ab05654a2de0b06a_D20200101-20201231" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90ZXh0cmVnaW9uOjlhMTYzNDUyMjI0ODQxZTE4ZDFkMDY2ODhjZTQ2YTljXzEzNw_a5a184b8-69f5-430b-807c-93659ba77fa1">15</ix:nonFraction>&#160;million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the years ended December&#160;31, 2022, 2021 and 2020, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90ZXh0cmVnaW9uOjlhMTYzNDUyMjI0ODQxZTE4ZDFkMDY2ODhjZTQ2YTljXzU4Mw_5189cb9f-d521-4984-a2d3-e49552dc9d97" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings per share from continuing operations for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzItMS0xLTEtMjY1MjQ3_084cce72-b6ad-4ba2-a7ab-1d1ef2a5d92b">4,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzItMy0xLTEtMjY1MjQ3_4f5ed495-9df5-4082-8b65-2634354f12b7">7,989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzItNS0xLTEtMjY1MjQ3_c8393fa4-7981-48af-996e-e16f32e7611e">7,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzQtMS0xLTEtMjY1MjQ3_62aba313-32c8-468b-8b2c-e8459e3d521c">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzQtMy0xLTEtMjY1MjQ3_343cbf7e-1077-45f6-aad0-3a648d46de03">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzQtNS0xLTEtMjY1MjQ3_85bea384-405d-423e-b5a5-31b3313c7aa4">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to CVS Health</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzUtMS0xLTEtMjY1MjQ3_8e1dea99-1f38-4f92-ad23-fd3b2e9afcc4">4,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzUtMy0xLTEtMjY1MjQ3_a6987219-7d26-4304-93b4-67eb8ded7bdc">8,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzUtNS0xLTEtMjY1MjQ3_7eebebdf-059b-45b8-9d48-00ab4fb34414">7,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzgtMS0xLTEtMjY1MjQ3_450b527a-f5ed-47f0-ad58-658222a5332e">1,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzgtMy0xLTEtMjY1MjQ3_410cb901-a276-4540-a05f-adaca966e7e2">1,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzgtNS0xLTEtMjY1MjQ3_adbe30b1-2815-4882-b25e-662916e1ac03">1,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i54d9d35ededb400290c122b74d7762fb_D20220101-20221231" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzktMS0xLTEtMjY1MjQ3_61f7244f-0aa6-470f-9d51-ccf96bd9fdbe">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10fcd8594c7341938f00b2bcb419f4c9_D20210101-20211231" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzktMy0xLTEtMjY1MjQ3_61655990-bd61-4a7f-a489-64b89cd0f6e5">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic788c95fb5c54497bda6d70714f8f38b_D20200101-20201231" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzktNS0xLTEtMjY1MjQ3_cd6db099-b06b-447b-8d22-c078b3636a20">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and SARs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibeb7c35ad88b4db086fed358829f1fca_D20220101-20221231" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzEwLTEtMS0xLTI2NTI0Nw_c2a79a7b-442f-4e30-a8b1-02942cb2d22f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac8347b945e247b7ba7d5c565f033409_D20210101-20211231" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzEwLTMtMS0xLTI2NTI0Nw_6ca5a660-4e97-4712-9de9-85b6d50f0514">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5695caba25e84d32ab05654a2de0b06a_D20200101-20201231" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzEwLTUtMS0xLTI2NTI0Nw_5177bc5b-ceb8-4e93-812c-f07fc7e97681">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzExLTEtMS0xLTI2NTI0Nw_395a1153-9e73-4037-aeaf-dd666d379c16">1,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzExLTMtMS0xLTI2NTI0Nw_695da984-98fb-40be-b2e7-0d2ade8c92bf">1,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzExLTUtMS0xLTI2NTI0Nw_494a15a6-6368-45e7-85a4-57544ca0d5cd">1,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share from continuing operations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzE0LTEtMS0xLTI2NTI0Nw_17352da6-8dc3-4041-a55d-f6cafb0121f0">3.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzE0LTMtMS0xLTI2NTI0Nw_4cf1a58c-40ee-4fca-9b61-2ea61f9a6d4a">6.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzE0LTUtMS0xLTI2NTI0Nw_c4e86d90-c873-4bee-84c8-b7f0b09deeaa">5.49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzE1LTEtMS0xLTI2NTI0Nw_0ca71b3a-065a-4e4b-a425-715742ca2db1">3.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzE1LTMtMS0xLTI2NTI0Nw_487af642-d496-4258-bb02-d74f470e7956">6.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzE1LTUtMS0xLTI2NTI0Nw_05aa4ad9-acad-4e1e-afad-ab5d45e04233">5.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i36038907935e41eea5e9cf7cac915d44_169"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ReinsuranceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90ZXh0cmVnaW9uOjBjMzVkODgxNjEwMjQwYmZhMGNkODlmOWU4YzZhN2M1XzE2NDA_5ccaf8ba-2295-427a-b058-db8eb5dbee91" continuedAt="i845a7d3e8e11452ca880afae078731ca" escape="true">Reinsurance</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i845a7d3e8e11452ca880afae078731ca" continuedAt="ibcbfbfb67ce040318d93e910b5847bda"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#8217;s primary liability as the direct insurer of the risks reinsured.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, the Company entered into <ix:nonFraction unitRef="reinsurance_agreement" contextRef="if8b5128a2a36428d980c81abdc2d74c7_D20230101-20230131" decimals="INF" name="cvs:NumberofReinsuranceContractsEnteredInto" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90ZXh0cmVnaW9uOjBjMzVkODgxNjEwMjQwYmZhMGNkODlmOWU4YzZhN2M1XzQzOQ_65a04a9f-3c2e-4770-afcd-d17262fc8d1d">two</ix:nonFraction> <ix:nonNumeric contextRef="if8b5128a2a36428d980c81abdc2d74c7_D20230101-20230131" name="cvs:FourYearsReinsuranceAgreementWithUnrelatedInsurer" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90ZXh0cmVnaW9uOjBjMzVkODgxNjEwMjQwYmZhMGNkODlmOWU4YzZhN2M1XzE2MzA_c78a2a14-c43e-4dc7-8e63-982faaf6bf35">four-year</ix:nonNumeric> reinsurance agreements with an unrelated reinsurer that allow it to reduce required capital and provide collateralized excess of loss reinsurance coverage on a portion of the Health Care Benefits segment&#8217;s group Commercial Insured business.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90ZXh0cmVnaW9uOjBjMzVkODgxNjEwMjQwYmZhMGNkODlmOWU4YzZhN2M1XzE2MzE_0c2e5801-8bd2-4fce-ab81-0f27f3e26cc0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance recoverables (recorded as other current assets or other assets on the consolidated balance sheets) at December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reinsurer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hartford Life and Accident Insurance Company</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfc7256b949f40db867c30ba258ef319_I20221231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzItMS0xLTEtMjY1MjQ3_dcceaed2-a3e8-45d3-9382-d8c839089e92">1,549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31cd59a8c7b74ded8d867dc5a415def7_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzItMy0xLTEtMjY1MjQ3_dcd432b7-860a-4989-bbbf-0274c44363c1">1,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lincoln Life &amp; Annuity Company of New York</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17e2ab802dda4aed8d1d06c6ae11e2f6_I20221231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzMtMS0xLTEtMjY1MjQ3_0a46f51d-75c8-4a72-9ba4-8243fb41925f">385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67df86d1566f40d3984c59da72c03ce0_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzMtMy0xLTEtMjY1MjQ3_6bec00c9-1bd5-4430-9ff7-d1943276de6f">395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VOYA Retirement Insurance and Annuity Company </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc5740783a6940949d69470ccd32d19e_I20221231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzQtMS0xLTEtMjY1MjQ3_9270201c-ccfc-4e8e-803d-cb6aa974c8da">159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20f471f240524ef8b98dd7b01be1b787_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzQtMy0xLTEtMjY1MjQ3_2ee32f4c-25c2-448e-9e55-4bdba93b85fc">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fresenius Medical Care Reinsurance Company (Cayman) Ltd. </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0162c987e7634f4fae5ee04958939adf_I20221231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzUtMS0xLTEtMjY1MjQ3_5aa6996f-742b-47df-b447-121939e85e48">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30bb205b44d94d42bbc0af842bfe1376_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzUtMy0xLTEtMjY1MjQ3_103dda1c-79d6-481c-bd3d-1147784f5443">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2253b0fadbb64b758c7a25f141c58162_I20221231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzYtMS0xLTEtMjY1MjQ3_5557d051-835b-47ef-8630-b1715bcfe2a9">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91b1f9bf665d415c9bc2b9f98030d772_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzYtMy0xLTEtMjY1MjQ3_ac11718b-156b-492e-b1d1-4f66b8046b12">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzctMS0xLTEtMjY1MjQ3_938f3e29-73a4-479d-a8da-e7a4baa96233">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzctMy0xLTEtMjY1MjQ3_f231c935-13d4-4a93-a289-c4297e6c1e77">2,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ibcbfbfb67ce040318d93e910b5847bda"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90ZXh0cmVnaW9uOjBjMzVkODgxNjEwMjQwYmZhMGNkODlmOWU4YzZhN2M1XzE2Mzc_471454a3-b9ed-4d20-8c32-bc1e96f9c80e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct, assumed and ceded premiums earned for the years ended December&#160;31, 2022, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:DirectPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzEtMS0xLTEtMjY1MjQ3_ae1230f3-754a-4b12-bffa-315abc9e3139">85,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:DirectPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzEtMy0xLTEtMjY1MjQ3_f6abc7fe-a20f-4aa2-840b-eb9af1a73e54">76,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:DirectPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzEtNS0xLTEtMjY1MjQ3_9b7b83af-f25d-42a7-a571-ae265aa2f3f0">69,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:AssumedPremiumsEarned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzItMS0xLTEtMjY1MjQ3_f146b953-ef1c-4233-88c8-00d908a3972e">432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:AssumedPremiumsEarned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzItMy0xLTEtMjY1MjQ3_22c41934-8cff-4f3d-a15a-a277324ab242">492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:AssumedPremiumsEarned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzItNS0xLTEtMjY1MjQ3_d8a4af36-9347-4ff1-a2c3-7739cf8fa6ce">478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:CededPremiumsEarned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzMtMS0xLTEtMjY1MjQ3_cb89cc1c-7618-4750-992e-feb08867807e">772</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:CededPremiumsEarned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzMtMy0xLTEtMjY1MjQ3_d7f2a736-92ab-4fa7-8774-a007fd730205">680</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:CededPremiumsEarned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzMtNS0xLTEtMjY1MjQ3_b6877afe-7643-4c3b-8394-2ee3e1a4a9d1">825</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzQtMS0xLTEtMjY1MjQ3_e9a73867-5ec7-4290-9518-b9ea5508e89e">85,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzQtMy0xLTEtMjY1MjQ3_489b9bac-1890-42f7-9d5f-c8e7ff943d90">76,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzQtNS0xLTEtMjY1MjQ3_a26a4cee-b47a-4877-b95a-6c7e507b5553">69,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:EffectsOfReinsuranceTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90ZXh0cmVnaW9uOjBjMzVkODgxNjEwMjQwYmZhMGNkODlmOWU4YzZhN2M1XzE2NDE_958390a5-d922-4108-9cdd-41cf6be436a8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of reinsurance on benefit costs for the years ended December&#160;31, 2022, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzEtMS0xLTEtMjY1MjQ3_aadb0066-0949-4844-a063-5f5d4e275ea8">71,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzEtMy0xLTEtMjY1MjQ3_98360cb9-1afe-4619-bd5f-29818807357b">64,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzEtNS0xLTEtMjY1MjQ3_9960c023-d871-4f89-b74a-c1f0725118e4">56,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzItMS0xLTEtMjY1MjQ3_0b285fad-e653-4916-b259-e6deb7836012">379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzItMy0xLTEtMjY1MjQ3_8c670be9-75e1-4a1c-93b6-5a6f08e96b01">398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzItNS0xLTEtMjY1MjQ3_d0809bf3-0cea-4c31-bcc2-0628ee96b2dc">329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzMtMS0xLTEtMjY1MjQ3_475d751e-89bd-4b02-b40d-6a4ffe6dbe1a">663</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzMtMy0xLTEtMjY1MjQ3_cbdef83c-8519-4c4c-a873-ea880c7f681a">549</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzMtNS0xLTEtMjY1MjQ3_e6d09eeb-e6ba-4bda-b853-ee453fe6cfd0">727</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net benefit costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzQtMS0xLTEtMjY1MjQ3_b124332c-e362-4077-a62a-d7ef1637b987">71,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzQtMy0xLTEtMjY1MjQ3_57df6b2c-473b-4c93-b125-2c6b64a85de9">64,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzQtNS0xLTEtMjY1MjQ3_c4413009-8188-4719-8784-92ecddc074d7">55,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is not a material difference between premiums on a written basis versus an earned basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has various agreements with unrelated reinsurers that do not qualify for reinsurance accounting under GAAP, and consequently are accounted for using deposit accounting. The Company entered into these contracts to reduce the risk of catastrophic loss which in turn reduces the Company&#8217;s capital and surplus requirements. Total deposit assets and liabilities related to reinsurance agreements that do not qualify for reinsurance accounting under GAAP were not material as of December&#160;31, 2022 or 2021.</span></div></ix:continuation><div><span><br/></span></div><div id="i36038907935e41eea5e9cf7cac915d44_172"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzM4NjI0_2039491c-4701-4470-819c-f55b5f4c2c07" continuedAt="ic6dee39987d4491d9e327d694432fd35" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic6dee39987d4491d9e327d694432fd35" continuedAt="i5dc7b5c605fc4127b5f7967e6bbfdcaf"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. The Company believes COVID-19&#8217;s impact on its businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond the Company&#8217;s knowledge and control. As a result, the impact COVID-19 will have on the Company&#8217;s businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has the following significant guarantee arrangements at December&#160;31, 2022:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ASC Claim Funding Accounts - The Company has arrangements with certain banks for the processing of claim payments for its ASC customers. The banks maintain accounts to fund claims of the Company&#8217;s ASC customers. The customer is responsible for funding the amount paid by the bank each day. In these arrangements, the Company guarantees that the banks will not sustain losses if the responsible ASC customer does not properly fund its account. The aggregate maximum exposure under these arrangements is generally limited to $<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="us-gaap:GuaranteeObligationsMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE1Mjg_0cfdb3c8-178f-491a-b4dc-08ce4ddc767b">250</ix:nonFraction> million. The Company can limit its exposure to these guarantees by suspending the payment of claims for ASC customers that have not adequately funded the amount paid by the bank. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Separate Accounts Assets - Certain Separate Accounts assets associated with the large case pensions business in the Corporate/Other segment represent funds maintained as a contractual requirement to fund specific pension annuities that the Company has guaranteed. Minimum contractual obligations underlying the guaranteed benefits in these Separate Accounts were approximately $<ix:nonFraction unitRef="usd" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="-6" name="cvs:ContractualObligationsToMaintainLevelsOfSeparateAccounts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzIwODA_73d178d2-3ba3-4d6b-834a-a7e0ca00c863">941</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i69eed5106b194cac81e8857cca41692b_I20211231" decimals="-8" name="cvs:ContractualObligationsToMaintainLevelsOfSeparateAccounts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzIwODc_df6f9e64-0621-4d13-b181-e6b33b195f13">1.3</ix:nonFraction> billion at December&#160;31, 2022 and 2021, respectively. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information on Separate Accounts. Contract holders assume all investment and mortality risk and are required to maintain Separate Accounts balances at or above a specified level. The level of required funds is a function of the risk underlying the Separate Account&#8217;s investment strategy. If contract holders do not maintain the required level of Separate Accounts assets to meet the annuity guarantees, the Company would establish an additional liability. Contract holders&#8217; balances in the Separate Accounts at December&#160;31, 2022 exceeded the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">148</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5dc7b5c605fc4127b5f7967e6bbfdcaf" continuedAt="i68b232e85241477bac4abcc5ccfcfe8e"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">value of the guaranteed benefit obligation. As a result, the Company was not required to maintain any additional liability for its related guarantees at December&#160;31, 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Guarantees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#8217;s Stores and Linens &#8216;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#8217;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#8217;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations, and any significant adverse impact of COVID-19 on such purchasers and/or former subsidiaries increases the risk that the Company will be required to satisfy those obligations. As of December&#160;31, 2022, the Company guaranteed <ix:nonFraction unitRef="lease" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="INF" name="cvs:GuarantorObligationsNumberOfLeases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzM5NTE_26d38a46-b29d-47ec-a30f-78eb2008ab0b">67</ix:nonFraction> such store leases (excluding the lease guarantees related to Linens &#8216;n Things, which have been recorded as a liability on the consolidated balance sheets), with the maximum remaining lease term extending through 2034.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#8217;s assessments generally are based on a formula relating to the Company&#8217;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the ACA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#8220;Penn Treaty&#8221;) in rehabilitation, an intermediate action before insolvency, and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#8217;s operating results, financial condition and cash flows, and the risk is heightened by any significant adverse impact of the COVID-19 pandemic on the solvency of other insurers, including long-term care and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#8217;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s total guaranty fund assessments liability was immaterial at both December&#160;31, 2022 and 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been involved or is currently involved in numerous legal proceedings, including litigation, arbitration, government investigations, audits, reviews and claims. These include routine, regular and special investigations, audits and reviews by</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> CMS, state insurance and health and welfare departments, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the U.S. Department of Justice (the &#8220;DOJ&#8221;), </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">state Attorneys General, the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;), the U.S. Federal Trade Commission (the &#8220;FTC&#8221;) and other governmental authorities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings, in general, and securities, class action and multi-district litigation, in particular, and governmental special investigations, audits and reviews can be expensive and disruptive. Some of the litigation matters may purport or be determined </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i68b232e85241477bac4abcc5ccfcfe8e" continuedAt="ia0a4cfadf5be4f38850149678b1111f6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years. The Company also may be named from time to time in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions initiated by private third parties that could also be separately pursued by a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs incurred in these matters can be substantial, regardless of the outcome.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. None of the Company&#8217;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#8217;s financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses and assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and rights to indemnification, will have a material adverse effect on the Company&#8217;s financial position. Substantial unanticipated verdicts, fines and rulings, however, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on its results of operations. In addition, as a result of governmental investigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or loss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be material to the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Usual and Customary Pricing Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and certain current and former directors and officers are named as a defendant in a number of lawsuits that allege that the Company&#8217;s retail pharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions are brought by a number of different types of plaintiffs, including plan members, private payors, government payors, and shareholders based on different legal theories. Some of these cases are brought as putative class actions, and in some instances, classes have been certified. In October 2022, one of the litigating shareholders made a litigation demand to the Board related to these and other issues after his amended derivative complaint was dismissed for failing to demonstrate demand futility. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PBM Litigation and Investigations</span></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is facing multiple lawsuits, including by state Attorneys General, governmental subdivisions and several putative class actions, regarding drug pricing and its rebate arrangements with drug manufacturers. These complaints, brought by a number of different types of plaintiffs under a variety of legal theories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is defending itself against these claims. The Company has also received subpoenas, civil investigative demands (&#8220;CIDs&#8221;), and other requests for documents and information from, and is being investigated by, the FTC and Attorneys General of several states and the District of Columbia regarding its PBM practices, including pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs, and requests for information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Behnke v. CVS Caremark Corporation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#8217;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#8217;s PBM. The Company is defending itself against these claims.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia0a4cfadf5be4f38850149678b1111f6" continuedAt="i1ca7a926881c43be834694216ad7f3b0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Controlled Substances Litigation, Audits and Subpoenas</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims beginning as far back as the early 2000s generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned In re National Prescription Opiate Litigation (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs, and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas, CIDs, and other requests for information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Company was among the chain pharmacies found liable by a jury in a trial in federal court in Ohio; in August 2022, the court issued a judgment jointly against the three defendants in the amount of $<ix:nonFraction unitRef="usd" contextRef="i89589b4e8c2b4f25b791df1123f534f7_D20220801-20220831" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE0NzE3_ea8b2669-700f-479a-aeeb-628ea041f654">651</ix:nonFraction>&#160;million to be paid over <ix:nonNumeric contextRef="i03d4640633404e31a33fb826637ad08a_I20220831" name="cvs:LegalSettlementPeriodOfPayment" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzM4NjI2_72a23869-fdd2-4f82-8bf8-cb8747c2edd4">15</ix:nonNumeric> years, and also ordered certain injunctive relief. The Company is appealing the judgment and has not accrued a liability for this matter. In March 2022, CVS Health Corporation and CVS Pharmacy, Inc. entered into a settlement agreement with the State of Florida to resolve claims related to opioid medications dating back more than a decade. Under the terms of the settlement agreement, CVS Health Corporation settled all opioid claims against it and its subsidiaries by the State of Florida for $<ix:nonFraction unitRef="usd" contextRef="i3b026ed44ce7463faf26ee5548ce9d7d_D20220301-20220331" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE1MjM0_188da8bb-3524-4392-8e26-b2e0f8a01abf">484</ix:nonFraction>&#160;million, which is to be paid over a period of <ix:nonNumeric contextRef="ibaa8af588ffe417797fab6c210df9c5b_I20220331" name="cvs:LegalSettlementPeriodOfPayment" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzM4NjI4_97bc8789-3167-442f-9031-2e9f164d43bc">18</ix:nonNumeric> years. During the three months ended March 31, 2022, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="ibaa8af588ffe417797fab6c210df9c5b_I20220331" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE1MzU0_be71a958-4680-40f6-b29e-dfe86334eac7">484</ix:nonFraction>&#160;million liability associated with this legal settlement. In August 2022, CVS Pharmacy, Inc. entered into an agreement with the State of New Mexico to settle all opioid claims against it and its parents and subsidiaries by the State of New Mexico and participating subdivisions. In September 2022, CVS Pharmacy, Inc. entered into an agreement with the State of West Virginia to settle all opioid claims against it and its parents and subsidiaries by the State of West Virginia and participating subdivisions. Also in September 2022, CVS Pharmacy, Inc. entered into an agreement with the Cherokee Nation to settle all opioid claims against it and its parents and subsidiaries by the Cherokee Nation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company agreed to a formal settlement agreement, the financial amounts of which were agreed to in principle in October 2022, with a leadership group of a number of state Attorneys General and the Plaintiffs&#8217; Executive Committee (&#8220;PEC&#8221;). The agreement would resolve substantially all opioid claims against Company entities by states and political subdivisions, but not private plaintiffs. The maximum amount payable by the Company under the settlement would be approximately $<ix:nonFraction unitRef="usd" contextRef="i8f9313db581d4747bb5036854512069d_D20221201-20221231" decimals="-8" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE2NTQ0_d002ffaa-9eaf-4b16-a887-8b33b93db8a1">4.3</ix:nonFraction>&#160;billion in opioid remediation and $<ix:nonFraction unitRef="usd" contextRef="i8f9313db581d4747bb5036854512069d_D20221201-20221231" decimals="-6" name="us-gaap:LegalFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE2NTcz_b261039a-ba48-451c-8b4d-982f9222e94b">625</ix:nonFraction>&#160;million in attorneys&#8217; fees and costs and additional remediation. The amounts would be payable over <ix:nonNumeric contextRef="id48716cf9312414a9271423a5fd71f20_I20221231" name="cvs:LegalSettlementPeriodOfPayment" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzM4NjQw_44169448-63b9-48cf-9e0d-afaeed512a92">10</ix:nonNumeric> years, beginning in 2023. The agreement also contains injunctive terms relating to the dispensing of opioid medications. The settlement agreement is available at nationalopioidsettlement.com.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the settlement agreement, before the Company determines whether to enter into any final settlement, it will assess the number and identities of the governmental entities that will participate in any such settlement. The settlement agreement contemplates that if certain governmental entities do not agree to the settlement, but the Company nonetheless concludes that there is sufficient participation to warrant going forward with the settlement, there would be a corresponding reduction in the amount due from the Company to account for the governmental entities that did not agree. Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants. Private plaintiff litigation will also continue.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been informed that <ix:nonFraction unitRef="state" contextRef="id48716cf9312414a9271423a5fd71f20_I20221231" decimals="0" name="cvs:LitigationSettlementNumberOfStatesElectedToJoin" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE3NjY5_ce695466-45a6-4890-8934-4070ffb8e188">45</ix:nonFraction> states, the District of Columbia, and all eligible United States territories have elected to join the settlement. <ix:nonFraction unitRef="state" contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231" decimals="0" name="cvs:LitigationSettlementNumberOfStatesSubjectToEarlierSettlements" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE3Nzg2_81c3e2b1-0821-485a-8cc3-a2ff9d87e388">Three</ix:nonFraction> states were the subject of earlier settlements. The Company has elected to proceed with the settlement process based on that level of participation. The settlement process will progress to the period during which subdivisions may elect to join.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company also agreed to a formal settlement agreement with a leadership group representing tribes throughout the United States. The agreement would resolve substantially all opioid claims against Company entities by such tribes. The maximum amount payable by the Company under the settlement would be $<ix:nonFraction unitRef="usd" contextRef="ie67a9c6077ac426d83b2d281de921897_D20221201-20221231" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE4MzU3_acace28d-5c38-4427-836a-80dc1f21abee">113</ix:nonFraction>&#160;million in opioid remediation and $<ix:nonFraction unitRef="usd" contextRef="ie67a9c6077ac426d83b2d281de921897_D20221201-20221231" decimals="-6" name="us-gaap:LegalFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE4Mzg2_88faac5d-395f-4cd2-b7de-cb7f4e200dfe">18</ix:nonFraction>&#160;million in attorneys&#8217; fees and costs. The amounts would be payable over <ix:nonNumeric contextRef="i0711d6880304457da9bc46c7f815c64f_I20221231" name="cvs:LegalSettlementPeriodOfPayment" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzM4NjI3_5c1cb053-f7e9-4462-84b4-12990b1b091b">10</ix:nonNumeric> years, beginning in 2023. The agreement is contingent upon sufficient participation by tribes.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">151</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1ca7a926881c43be834694216ad7f3b0" continuedAt="ia1537fc90b404aecb129ad1049e07094"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has concluded that settlement of opioid claims by governmental entities and tribes is probable, and the loss related thereto could be reasonably estimated. As a result of that conclusion, and its assessment of certain other opioid-related claims including those for which the Company reached agreement in August and September 2022, the Company recorded pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="i429b564fb66a4c4db88cad8833594b8a_D20220701-20220930" decimals="-8" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE4OTM2_049147f0-4827-45a0-9f06-ea744365c17f">5.2</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i939712c24e004976bf4f03ca8692f893_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE4OTQz_ab58e063-0baa-451b-a8de-8601dc7da5f9">99</ix:nonFraction> million during the three months ended September 30, 2022 and the three months ended December&#160;31, 2022, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="iaca84de086504e58ba6e3854de871467_I20221231" decimals="-8" name="us-gaap:LossContingencyAccrualCarryingValueNoncurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE5MDQ5_4a3533ff-a787-4655-b82c-2f8e273a1c8c">4.8</ix:nonFraction>&#160;billion was recorded in other long-term liabilities on the consolidated balance sheet. In addition, the Company expects the cash impact in 2023 and 2024 to be less than $<ix:nonFraction unitRef="usd" contextRef="i64d6b9d0c0594df5bccc5dbc7ec5cfa6_D20230101-20231231" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE5MjEz_3aab4bfc-ebc7-4880-a1a6-e2251de55573"><ix:nonFraction unitRef="usd" contextRef="if13a1b08fb134bc2819e0fbde58e3608_D20240101-20241231" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE5MjEz_ef2dc150-cf26-40fb-ae4e-756d55ec9a79">500</ix:nonFraction></ix:nonFraction>&#160;million in each year. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment requires judgments about future events. Moreover, the settlement is in its early phases, and there is no assurance that contingencies will be satisfied. The amount of ultimate loss may differ materially from this accrual.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the many uncertainties associated with any settlement arrangement or other resolution of all opioid-related litigation matters, including the uncertain scope of participation by governmental entities, and given that the Company continues to actively defend ongoing litigation for which it believes it has defenses and assertions that have merit, the Company is not able to reasonably estimate the range of ultimate possible loss for all opioid-related litigation matters at this time. The outcome of these legal matters could have a material effect on the Company&#8217;s business, financial condition, operating results and/or cash flows.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the DOJ served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS pharmacy locations concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. In January 2022, the DOJ served the Company with a CID regarding similar subjects, and the Company is providing documents and information in response to these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prescription Processing Litigation and Investigations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its prescription processing practices, including the following:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ex rel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Bassan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> v. Omnicare, Inc. and CVS Health Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#8217;s Office for the Southern District of New York (the &#8220;SDNY&#8221;) filed a complaint-in-intervention in this previously sealed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case. The complaint alleges that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Gill et al. v. CVS Health Corp. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (U.S. District Court for the Northern District of Illinois). In July 2022, the Delaware Attorney General&#8217;s Office moved for partial intervention as to allegations under the Delaware false claims act related to not escheating alleged overpayments in this previously sealed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case. The federal government and the remaining states declined to intervene on other additional theories in the relator&#8217;s complaint. The Company is defending itself against all of the claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#8217;s Omnicare pharmacies&#8217; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2016, the Company received a CID from the U.S. Attorney&#8217;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#8217;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Provider Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by providers with whom the Company has a contract and with whom the Company does not have a contract (&#8220;out-of-network providers&#8221;).&#160;Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for out-of-network services (including COVID-19 testing) and/or otherwise allege that the Company failed to timely or appropriately pay or administer claims and benefits (including the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia1537fc90b404aecb129ad1049e07094" continuedAt="ied4d8b7dc83441d6a3953e95f57bb2b1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company&#8217;s post payment audit and collection practices). Other major health insurers are the subject of similar litigation or have settled similar litigation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CMS Actions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS regularly audits the Company&#8217;s performance to determine its compliance with CMS&#8217;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#8217;s and other companies&#8217; Medicare plans by considering the applicable health status of Medicare members as supported by information prepared, maintained and provided by providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#8217; medical records to determine whether those records support the related diagnosis codes that determine the members&#8217; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#8220;RADV&#8221;) audits of various Medicare Advantage plans, including certain of the Company&#8217;s plans, to validate coding practices and supporting medical record documentation maintained by providers and the resulting risk-adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#8217;s risk-adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of the HHS (the &#8220;OIG&#8221;) also is auditing the Company&#8217;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, in the &#8220;Notice of Final Payment Error Calculation for Part C Medicare Advantage Risk Adjustment Validation Data (RADV) Contract-Level Audits,&#8221; CMS revised its audit methodology for RADV contract-level audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS announced extrapolation of the error rate identified in the audit sample along with the application of a process to account for errors in the government&#8217;s traditional fee-for-service Medicare program (&#8220;FFS Adjuster&#8221;). For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract, nor did CMS propose to apply a FFS adjuster. By applying the FFS Adjuster, Medicare Advantage organizations would have been liable for repayments only to the extent that their extrapolated payment errors exceeded the error rate in Original Medicare, which could have impacted the extrapolated repayments to which Medicare Advantage organizations are subject. This revised contract-level audit methodology increased the Company&#8217;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. In the RADV audit methodology CMS used from 2011-2013, CMS selected only a few of the Company&#8217;s Medicare Advantage contracts for various contract years for contract-level RADV audits. In October 2018, CMS in the proposed rule (&#8220;Proposed Rule&#8221;) announced a new methodology for RADV audits targeting certain health conditions and members with many diagnostic conditions along with extrapolation for the error rates identified without use of a FFS Adjuster. While the rule was under proposal, CMS initiated contract-level RADV audits for the years 2014 and 2015 with this new RADV methodology without a final rule. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 30, 2023, CMS released the final rule (&#8220;RADV Audit Rule&#8221;), announcing it may use extrapolation for payment years 2018 forward, for both RADV audits and OIG audits and eliminated the application of a FFS Adjuster in Part C contract-level RADV audits of Medicare Advantage organizations. In the RADV Audit Rule, CMS indicated that it will use more than one audit methodology going forward and indicated CMS will audit contracts it believes are at the highest risk for overpayments based on its statistical modeling, citing a 2016 Governmental Accountability Office report that recommended selection of contract-level RADV audits with a focus on contracts likely to have high rates of improper payment, the highest coding intensity scores, and contracts with high levels of unsupported diagnoses from prior RADV audits.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive refunds for years prior to 2018 or prospective adjustments to Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#8217;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#8217;s bids </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">153</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ied4d8b7dc83441d6a3953e95f57bb2b1" continuedAt="i2d0455f4a929436480fef7f9a288667b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of RADV, Public Exchange related or other audits by CMS, the OIG or otherwise, including audits of the Company&#8217;s MLR rebates, methodology and/or reports, could be material and could adversely affect the Company&#8217;s operating results, cash flows and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RADV Audit Rule does not apply to the CMS Part C Improper Payment Measures audits nor the HHS-RADV programs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicare and Medicaid CIDs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#8217;s patient chart review processes related to risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company received a CID from the SDNY requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stockholder Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in February 2019, multiple class action complaints, as well as a derivative complaint, were filed by putative plaintiffs against the Company and certain current and former officers and directors. The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#8217;s LTC business unit. The Company and its current and former officers and directors are defending themselves against these claims. Since filing, several of the cases have been consolidated, and the first-filed federal case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Miami Fire Fighters&#8217; and Police Officers&#8217; Retirement Trust, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anarkat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), was dismissed with prejudice in February 2021. Plaintiffs appealed that decision to the First Circuit after their motion for reconsideration was denied, and in August 2022 the First Circuit affirmed the dismissal. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re CVS Health Corp. Securities Act Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Waterford</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re CVS Health Corp. Securities Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Warren</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Freundlich</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) have been stayed pending the outcome of the First Circuit appeal. Plaintiffs in both cases have since filed amended complaints, which the Company has moved to dismiss. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August and September 2020, <ix:nonFraction unitRef="claim" contextRef="i51647e75bc724c0097093f48fc959e1c_I20200930" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzMyMTA2_95fa4004-948c-4d70-baf2-a3799aa5b9bd">two</ix:nonFraction> class actions under the Employee Retirement Income Security Act of 1974 (&#8220;ERISA&#8221;) were filed in the U.S. District Court for the District of Connecticut against CVS Health, Aetna, and several current and former executives, directors and/or members of Aetna&#8217;s Compensation and Talent Management Committee: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Radcliffe v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flaim v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. The plaintiffs in these cases assert a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) Plan&#8217;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#8217;s LTC business unit. The district court consolidated the actions, and in October 2021, dismissed the consolidated action without prejudice. Plaintiffs filed an amended consolidated complaint, which the Company moved to dismiss. In October 2022, the court granted the Company&#8217;s motion to dismiss with prejudice. Plaintiffs have appealed this decision to the Second Circuit.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also received a related document request pursuant to ERISA &#167; 104(b), to which the Company has responded. The Company and its current and former officers and directors are defending themselves against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company received a demand for inspection of books and records pursuant to Delaware Corporation Law Section 220 (the &#8220;Demand&#8221;). The Demand purports to be related to potential breaches of fiduciary duties by the Board in relation to certain matters concerning opioids.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Legal and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas, or similar process from various governmental agencies requesting information. These other legal proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, breach of fiduciary duty, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, denial of or failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, product liability, intellectual property litigation, and employment litigation. Some of </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">154</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2d0455f4a929436480fef7f9a288667b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#8217;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed, or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#8217;s operating results. The Company will continue to defend contract awards it receives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#8217;s and the rest of the health care and related benefits industry&#8217;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#8217; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight, and claim payment practices (including payments to out-of-network providers).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a leading national health solutions company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#8217;s businesses, changes to or clarifications of the Company&#8217;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the federal government, withholding of premium payments to the Company by government agencies,&#160;assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i)&#160;future enactment of new health care or other laws or regulations; (ii)&#160;the interpretation or application of existing laws or regulations as they may relate to one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii)&#160;pending or future federal or state government investigations of one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv)&#160;pending or future government audits, investigations or enforcement actions against the Company; (v)&#160;adverse developments in any pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit against the Company, whether sealed or unsealed, or in any future </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit that may be filed against the Company; or (vi)&#160;adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.</span></div></ix:continuation><div><span><br/></span></div><div id="i36038907935e41eea5e9cf7cac915d44_175"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzk1Nzg_8987fe4e-3aaa-4000-8299-81db8f619f5e" continuedAt="i19eb841b622c4c638116f0853265436d" escape="true">Segment Reporting</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i19eb841b622c4c638116f0853265436d" continuedAt="i6b2ab65f26754d558e8c190a9bcedffd"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="segment" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzQx_fa859048-6363-4a0c-95fe-87f634745abb">three</ix:nonFraction> operating segments, Health Care Benefits, Health Services and Pharmacy &amp; Consumer Wellness, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the CODM evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income. Adjusted operating income is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. Effective for the first quarter of 2023, adjusted operating income also excludes the impact of net realized capital gains or losses. See the reconciliation of consolidated operating income (GAAP measure) to consolidated adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzEwNDQ1MzYwNDc4NTYw_1e39b294-8494-45c5-8d44-7d39cfaedd65" continuedAt="i91081b9f3c9e4bf6a3ec76591fe76fd9" escape="true">Segment financial information for the years ended December 31, 2022, 2021 and 2020 has been recast, as applicable, to reflect the following items, the impact of which are reflected in the &#8220;Adjustments&#8221; lines of the table below:</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">155</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6b2ab65f26754d558e8c190a9bcedffd" continuedAt="if022d36396bc4481adfc6facb6d1e031"><ix:continuation id="i91081b9f3c9e4bf6a3ec76591fe76fd9" continuedAt="i04cea70ba1d541eba9996cc565e63e45"><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The realignment of the Company&#8217;s segments to correspond with changes made to its operating model as described in Note 1 &#8220;Significant Accounting Policies,&#8221; including the discontinuance of the former Maintenance Choice segment reporting practice as described in Note (1) of the table below.</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The exclusion of the impact of net realized capital gains or losses from adjusted operating income, as described above.</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the adoption of the long-duration insurance accounting standard, which the Company adopted on January 1, 2023 using a modified retrospective transition method as of January 1, 2021, as described in Note 8 &#8220;Other Insurance Liabilities and Separate Accounts.&#8221; </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care <br/>Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp; <br/>Consumer <br/>Wellness</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as previously reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic57ff1de57e040e09c97cab45478a2d9_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzItMS0xLTEtMjk1NzYw_94e5483a-aa39-4b0f-946e-b0708285f2c5">91,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe58c09ac79e451fbfad93b9169958d4_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzItMy0xLTEtMjk1Nzcw_b5c6e16b-fffc-49c3-802a-cc4d5f8ca2e0">169,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12151a132ac84f09952fa59e048adb99_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzItNS0xLTEtMjk1Nzcw_1422e17c-e173-490e-bd0f-cc126af141f6">106,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie15ff7b3ed9249059a31d87e8221ef8d_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzItNy0xLTEtMjk1Nzgz_c3bdf2d4-ac61-4d51-b4eb-de3d6f651a6d">530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib242b2a53204442293d0e613aa093688_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzItOS0xLTEtMjk1Nzgz_e27f4b53-227f-46be-b783-165b4cdc8f02">45,302</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzItMTEtMS0xLTI5NTc4Mw_b5e11396-7468-4606-8fd7-d89705dd6d09">322,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83a2435cc9ab448c913552eb356f4039_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzMtMS0xLTEtMjk1NzYw_a00a2747-305c-427b-9793-c3e86365497f">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia379beb5856c4694ac66b32c06bf2386_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzMtMy0xLTEtMjk1Nzcw_574276d1-f013-4812-ade6-1b5533380cc0">340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1707f9f5c214463ebc3f072c05afa26e_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzMtNS0xLTEtMjk1Nzcw_b5779d15-c3aa-4e1b-af8c-53423b6cb758">2,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2425da88d34b11a7d4ed0662f4e0c0_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzMtNy0xLTEtMjk1Nzgz_c174b722-28ba-43d3-8983-e47982d43403">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5da73c1ec8f946c9afb45f207ff36c25_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzMtOS0xLTEtMjk1Nzgz_ac169bb0-039f-41b3-8ff9-b81c335d58ed">2,283</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bddb95b4cf348ec83e4a333d7575820_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzMtMTEtMS0xLTI5NTc4Mw_59a71902-cee6-474b-85a7-d332949fa3b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as adjusted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a07c8633b37492ba109c7cd9a92299a_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzQtMS0xLTEtMjk1NzYw_b4632974-bdf8-49e3-b3bf-f198b0714633">91,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzQtMy0xLTEtMjk1Nzcw_4a1f46f9-5a9a-4170-b540-32bfada031a3">169,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd57b0b73c1b4e1aa835dde2abf6925c_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzQtNS0xLTEtMjk1Nzcw_ff52248b-d569-4f83-870d-3c71263c4507">108,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1d5e5a55e6f4909a1d1c3d2003ec720_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzQtNy0xLTEtMjk1Nzgz_940d306d-fb3e-4f9d-a9d7-00164ebeda74">530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib085c0543c9d4988b6b20b9b427998b0_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzQtOS0xLTEtMjk1Nzgz_d02050ad-68b5-45d7-8fd2-15934b7d7d75">47,585</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzQtMTEtMS0xLTI5NTc4Mw_1a4e248d-d54a-4278-9f3a-aa0049c7baf7">322,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 1.75pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as previously reported</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic57ff1de57e040e09c97cab45478a2d9_D20220101-20221231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzYtMS0xLTEtMjk1NzYw_7f4ce0f1-7c3c-4b9f-92a5-d9062c02a666">5,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe58c09ac79e451fbfad93b9169958d4_D20220101-20221231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzYtMy0xLTEtMjk1Nzcw_13787311-09cd-46d8-b351-17ed06349887">7,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12151a132ac84f09952fa59e048adb99_D20220101-20221231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzYtNS0xLTEtMjk1Nzcw_b1f56496-616c-47c3-8642-fa8f35835f7d">6,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie15ff7b3ed9249059a31d87e8221ef8d_D20220101-20221231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzYtNy0xLTEtMjk1Nzgz_12bbc945-a475-4d83-94af-4507857ec16b">1,785</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib242b2a53204442293d0e613aa093688_D20220101-20221231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzYtOS0xLTEtMjk1Nzgz_dffe3e8c-dbfb-4799-bbe3-caa3a3542ce9">728</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzYtMTEtMS0xLTI5NTc4Mw_3f8e58a1-fc46-40a3-b287-1a8feb8610e5">17,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83a2435cc9ab448c913552eb356f4039_D20220101-20221231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzctMS0xLTEtMjk1NzYw_abc7a159-17ac-4f94-b3b2-b24163d0c958">354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia379beb5856c4694ac66b32c06bf2386_D20220101-20221231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzctMy0xLTEtMjk1Nzcw_6b5ef661-f8b9-4154-b0f2-38414eba5a2e">575</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1707f9f5c214463ebc3f072c05afa26e_D20220101-20221231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzctNS0xLTEtMjk1Nzcw_d1d10fa2-b1d9-4778-8cd6-62d1a72fa0df">174</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2425da88d34b11a7d4ed0662f4e0c0_D20220101-20221231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzctNy0xLTEtMjk1Nzgz_1ad54460-15df-4c5b-a49b-0dc1a622704d">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5da73c1ec8f946c9afb45f207ff36c25_D20220101-20221231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzctOS0xLTEtMjk1Nzgz_bd2c3f4a-01c5-408c-8a2c-65efc5d9eda8">728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bddb95b4cf348ec83e4a333d7575820_D20220101-20221231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzctMTEtMS0xLTI5NTc4Mw_4a7206c4-335a-4336-8f88-7755d68faf33">505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as adjusted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a07c8633b37492ba109c7cd9a92299a_D20220101-20221231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzgtMS0xLTEtMjk1NzYw_3f8d027a-f539-476e-9290-6b6c5ace2e87">6,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzgtMy0xLTEtMjk1Nzcw_a1d3240a-4f86-413b-9130-37ecb0ae6924">6,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd57b0b73c1b4e1aa835dde2abf6925c_D20220101-20221231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzgtNS0xLTEtMjk1Nzcw_ae299878-0b27-42bc-a94b-a3d57ba6e723">6,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1d5e5a55e6f4909a1d1c3d2003ec720_D20220101-20221231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzgtNy0xLTEtMjk1Nzgz_f6f2d0c2-ae1c-475a-9368-dd0c5dd4a931">1,613</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib085c0543c9d4988b6b20b9b427998b0_D20220101-20221231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzgtOS0xLTEtMjk1Nzgz_235c4daf-1d99-4f94-91ed-5e3515d76ca7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzgtMTEtMS0xLTI5NTc4Mw_57c2ee37-a64b-4ea2-8917-c01289584621">18,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care <br/>Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp; <br/>Consumer <br/>Wellness</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as previously reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b1171c68bbe4af1819c9145310c6fb8_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzItMS0xLTEtMjk1ODIz_79e29adc-d64c-49ad-a48a-720a5380f794">82,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff2a6e509d3c452fbb34c09f2c1f55ea_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzItMy0xLTEtMjk1ODMx_07842be9-d22c-48fc-b772-169cec94cc86">153,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf761e93be114754a9786359d43f61dd_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzItNS0xLTEtMjk1ODMx_8b748aff-4925-4ccb-8efc-18b4751de963">100,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8708367e0d6148a297ee5ca38d90794b_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzItNy0xLTEtMjk1ODQx_959e27a0-347d-4d60-95bf-44219312fdb1">721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5e992bf9c2a499eaf6476b15ef7c5f5_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzItOS0xLTEtMjk1ODQx_4fe7bdb8-e38b-4dff-948c-178958ac6b6b">43,923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzItMTEtMS0xLTI5NTg0MQ_dfb38e1a-1e95-4dd3-b305-2f67fe38ee38">292,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc4a75422af949c2a32932d3412701db_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzMtMS0xLTEtMjk1ODIz_66cd9efe-7037-4514-b308-1cac8693bb04">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93f387cc7da9423da81f99d85943fc07_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzMtMy0xLTEtMjk1ODMx_ab0bb960-5198-4691-a4b6-529ecb1deba3">870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia738f2f875064e3b9b39a81213de4404_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzMtNS0xLTEtMjk1ODMx_bdf0db85-7d48-426f-b0b1-519fda520105">1,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57299b3f0d29410bbd43971727bf7de2_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzMtNy0xLTEtMjk1ODQx_9016e7b5-93c4-44a4-98c6-35ba5e9fa193">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cfee834f48c44269e6203285ea53742_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzMtOS0xLTEtMjk1ODQx_f58b821f-b6ee-4986-982d-259b4c5b6368">2,318</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf605eb33300435fa4bb68398ee8e8db_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzMtMTEtMS0xLTI5NTg0MQ_14114d2a-e488-40a4-99bd-15d62868ac45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as adjusted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1edd8caecae44ce995f38b9edd410db7_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzQtMS0xLTEtMjk1ODIz_72d024ba-d546-496b-ac77-c6c183485969">82,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie123d487288b460289e6aaf6ae104852_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzQtMy0xLTEtMjk1ODMx_6a78d5b1-6570-429f-b4fd-f6d69bc86aa6">153,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d2a7ac149f64c73a8f3b978546f2741_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzQtNS0xLTEtMjk1ODMx_0e15b6f1-985c-47fa-8a1c-60faac40b302">101,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0cc9849a9ff470b935a370313045788_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzQtNy0xLTEtMjk1ODQx_dcb65765-0133-43e3-bcc9-3bbb056671c0">721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i977f19fae3bf4bc8963ec72c8c49ebdc_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzQtOS0xLTEtMjk1ODQx_7ce39c46-1dc3-4889-ad00-624ec8e4ad39">46,241</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzQtMTEtMS0xLTI5NTg0MQ_73fc4a3f-16f5-42cf-90c4-6bfe13cacb48">292,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 1.75pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as previously reported</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b1171c68bbe4af1819c9145310c6fb8_D20210101-20211231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzYtMS0xLTEtMjk1ODIz_accc191b-c311-4360-9be9-b6058f38a3aa">5,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff2a6e509d3c452fbb34c09f2c1f55ea_D20210101-20211231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzYtMy0xLTEtMjk1ODMx_cdd6efd8-6974-40ec-bbf4-a0e2a9f125ca">6,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf761e93be114754a9786359d43f61dd_D20210101-20211231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzYtNS0xLTEtMjk1ODMx_3775962f-1127-4b6c-be94-a944a120e8fe">7,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8708367e0d6148a297ee5ca38d90794b_D20210101-20211231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzYtNy0xLTEtMjk1ODQx_6494723f-1d99-4962-9cc8-d0bef6266497">1,471</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5e992bf9c2a499eaf6476b15ef7c5f5_D20210101-20211231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzYtOS0xLTEtMjk1ODQx_f5996a34-9cdb-45a5-9d42-ecd3a0efa2c9">711</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzYtMTEtMS0xLTI5NTg0MQ_04696530-3f8e-4720-b15e-8f8a58b5c6f2">17,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc4a75422af949c2a32932d3412701db_D20210101-20211231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzctMS0xLTEtMjk1ODIz_03ef32f2-1cbc-4375-b9f3-6bb3967bfb03">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93f387cc7da9423da81f99d85943fc07_D20210101-20211231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzctMy0xLTEtMjk1ODMx_7e9074e8-398c-456d-b32f-cf97363c9af0">367</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia738f2f875064e3b9b39a81213de4404_D20210101-20211231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzctNS0xLTEtMjk1ODMx_8970a4e1-8c4a-4188-982f-809fdb6bb671">363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57299b3f0d29410bbd43971727bf7de2_D20210101-20211231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzctNy0xLTEtMjk1ODQx_c39abcc4-9876-41e6-89cc-3f2cf0b8951d">164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cfee834f48c44269e6203285ea53742_D20210101-20211231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzctOS0xLTEtMjk1ODQx_be791f1f-e195-4a30-a0cf-ea9cb3ba6410">711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf605eb33300435fa4bb68398ee8e8db_D20210101-20211231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzctMTEtMS0xLTI5NTg0MQ_9a50a34b-cdf4-4359-a0b6-a81e328fcb64">85</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as adjusted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1edd8caecae44ce995f38b9edd410db7_D20210101-20211231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzgtMS0xLTEtMjk1ODIz_a11daad6-ee3f-4ea1-ab34-3c6176598ddb">5,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie123d487288b460289e6aaf6ae104852_D20210101-20211231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzgtMy0xLTEtMjk1ODMx_2be06524-e985-467e-a272-2d0c3bb004da">6,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d2a7ac149f64c73a8f3b978546f2741_D20210101-20211231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzgtNS0xLTEtMjk1ODMx_2d0be0f4-cd98-472d-b1a4-13ea6a6926ba">7,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0cc9849a9ff470b935a370313045788_D20210101-20211231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzgtNy0xLTEtMjk1ODQx_bb0cd847-650d-4384-acaf-3b76b589c488">1,635</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i977f19fae3bf4bc8963ec72c8c49ebdc_D20210101-20211231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzgtOS0xLTEtMjk1ODQx_762ab4ee-9863-4988-b1a6-9652b02471b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzgtMTEtMS0xLTI5NTg0MQ_ac4061b5-720d-4b3e-8c3c-0f78589ce781">17,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care <br/>Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp; <br/>Consumer <br/>Wellness</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as previously reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b8dd9bca2d845c5a94bae3567479a9e_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzItMS0xLTEtMjk1ODUw_b9ed6b01-9a4c-4953-8694-7d6557da1318">75,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb91f8d55eb47ff966a699f6afb0276_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzItMy0xLTEtMjk1ODU4_49aeacc2-cd67-4564-9665-65ce40f12247">141,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8b4d98a4ab443d1864e4785b87c3333_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzItNS0xLTEtMjk1ODU4_72b88bfb-e5ec-4711-9102-aade4e267c27">91,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebc232da670a4ceabcfa09b1f0849657_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzItNy0xLTEtMjk1ODY2_e0bd79c2-cf05-4970-9d96-7e5bbd49dc7c">426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8104c5fdfe0c4205a5f07c99c7cede7b_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzItOS0xLTEtMjk1ODY2_a6a48410-9d3d-4a25-b4d3-32364f1ea915">40,323</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90b72ec258964345839ac8de15529de0_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzItMTEtMS0xLTI5NTg2Ng_e660498b-1899-449d-aef6-dec11e8d0837">268,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i677074299da14bd2b078357e93653928_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzMtMS0xLTEtMjk1ODUw_3dbbd5a4-8e0e-4cad-9329-e87ca4c8480d">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i114930f0b44c4d1a9f07a0c3d6dd2dd5_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzMtMy0xLTEtMjk1ODU4_a8b5b16c-ebd2-49fa-a86d-e4e484723fca">584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b5e13d39f046e3b93ecd36eeb5ee63_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzMtNS0xLTEtMjk1ODU4_0ac919b0-82aa-4868-b12a-e1bf013c6ce0">2,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4d84170ec8e498b9520974828e0c142_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzMtNy0xLTEtMjk1ODY2_06b4a680-3106-4401-9af3-6f3baea0065f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i948f596e14ee4a9d9806fb733eb3ebcd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzMtOS0xLTEtMjk1ODY2_e66a0018-21a7-430c-8134-0a21f79fed9d">1,739</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i782729dd554e4d80bb426bea495446dd_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzMtMTEtMS0xLTI5NTg2Ng_cbc1ec5c-99b7-4169-874f-9afb13f055bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as adjusted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95a883374f34cadb8aba20153008269_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzQtMS0xLTEtMjk1ODUw_c99c2156-d325-41ad-8a4b-9ee6f093a4ab">75,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzQtMy0xLTEtMjk1ODU4_07694566-f2bf-47a8-baae-98940a1481ef">141,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7a2e3c175d84b5aa44a7a859d45ad5d_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzQtNS0xLTEtMjk1ODU4_47bd928a-20ba-4008-ba57-444d42ad8cf5">93,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ce5e18976c2489a9a964cdebbae85ac_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzQtNy0xLTEtMjk1ODY2_9e9a751f-fc60-4be5-afef-f9cce3e88a15">426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37c56e2626d741fc89c81191ac507cb5_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzQtOS0xLTEtMjk1ODY2_15dbc8a3-8df9-40bb-9aac-6bf3ccb75277">42,062</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzQtMTEtMS0xLTI5NTg2Ng_46a0fffd-116f-4ab2-b31a-815ddfd4a2f5">268,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 1.75pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as previously reported</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b8dd9bca2d845c5a94bae3567479a9e_D20200101-20201231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzYtMS0xLTEtMjk1ODUw_4a9fd6b9-8901-401d-85fc-adef684ef22c">6,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb91f8d55eb47ff966a699f6afb0276_D20200101-20201231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzYtMy0xLTEtMjk1ODU4_55a38be8-b077-44cc-a4e4-d8929036d36d">5,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8b4d98a4ab443d1864e4785b87c3333_D20200101-20201231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzYtNS0xLTEtMjk1ODU4_9812415e-65a4-452f-9ea1-c3063a5e2eac">6,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebc232da670a4ceabcfa09b1f0849657_D20200101-20201231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzYtNy0xLTEtMjk1ODY2_ec6099b5-143f-47c2-8b6c-2c5b0d8b3fab">1,306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8104c5fdfe0c4205a5f07c99c7cede7b_D20200101-20201231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzYtOS0xLTEtMjk1ODY2_784afe5e-8212-4392-8b98-f08c85d5cc2d">708</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90b72ec258964345839ac8de15529de0_D20200101-20201231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzYtMTEtMS0xLTI5NTg2Ng_6138cc6d-999a-40b3-b81d-a0026abf030f">16,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i677074299da14bd2b078357e93653928_D20200101-20201231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzctMS0xLTEtMjk1ODUw_25a059d8-a31a-4180-bc04-47b7b662fa82">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i114930f0b44c4d1a9f07a0c3d6dd2dd5_D20200101-20201231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzctMy0xLTEtMjk1ODU4_b6779e6e-04cc-4e81-851e-4fcc050da882">560</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1b5e13d39f046e3b93ecd36eeb5ee63_D20200101-20201231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzctNS0xLTEtMjk1ODU4_e9192310-c83f-4600-bfd6-b6a50b067f55">134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4d84170ec8e498b9520974828e0c142_D20200101-20201231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzctNy0xLTEtMjk1ODY2_3f1be299-6603-4fae-bfc3-eeb5660baaea">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i948f596e14ee4a9d9806fb733eb3ebcd_D20200101-20201231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzctOS0xLTEtMjk1ODY2_5c9a290c-861c-4eab-95e6-589b6d35fa77">708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i782729dd554e4d80bb426bea495446dd_D20200101-20201231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzctMTEtMS0xLTI5NTg2Ng_10977b12-d8ab-405c-a538-f1b056be7ac3">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as adjusted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95a883374f34cadb8aba20153008269_D20200101-20201231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzgtMS0xLTEtMjk1ODUw_0866585c-1373-4afb-aa8b-18c1b96e3332">6,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzgtMy0xLTEtMjk1ODU4_1bf9af24-1f84-4a9b-916f-62a480c2425a">5,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7a2e3c175d84b5aa44a7a859d45ad5d_D20200101-20201231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzgtNS0xLTEtMjk1ODU4_5413fd0f-49d3-4b7d-b823-665ca72fd032">6,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ce5e18976c2489a9a964cdebbae85ac_D20200101-20201231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzgtNy0xLTEtMjk1ODY2_14df488e-b533-45c3-b5e2-d07e238dc73c">1,319</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37c56e2626d741fc89c81191ac507cb5_D20200101-20201231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzgtOS0xLTEtMjk1ODY2_fbfa57e5-c630-4b58-9f1a-46796686b630">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzgtMTEtMS0xLTI5NTg2Ng_b39326a1-72ae-4102-b4ec-f366a29560ab">15,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy &amp; Consumer Wellness segment. Prior to January 1, 2023, intersegment adjusted operating income eliminations occurred when members of the Health Services segment's clients enrolled in Maintenance Choice elected to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurred, both the Health Services and Pharmacy &amp; Consumer Wellness segments recorded the adjusted operating income on a stand-alone basis.&#160;Effective January 1, 2023, the adjusted operating income associated with such transactions is reported only in the Pharmacy &amp; Consumer Wellness segment, therefore no adjusted operating income elimination is required. Segment financial information has been recast to reflect this change. </span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if022d36396bc4481adfc6facb6d1e031" continuedAt="i25d895361fdb4e30a58cc1ee1c989627"><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, 2021 and 2020, revenues from the federal government accounted for <ix:nonFraction unitRef="number" contextRef="i963c0343d69a42caadc378204229b722_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzE1NzY_bf2a85fd-807e-4289-aaa0-27a8089f4a18">18</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i03d09415d2bf43b384994476ca92e168_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzE1ODA_293e98f6-d25f-400f-85d5-274b03dcb1e7">17</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i75dd5be1e137424fa4519c29f0daa19d_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzE1ODc_69f3e2ff-2c23-436d-877b-8eb977508a61">16</ix:nonFraction>%, respectively, of the Company&#8217;s consolidated total revenues, primarily related to contracts with CMS for coverage of Medicare-eligible individuals within the Health Care Benefits segment.</span></div><div><span><br/></span></div><ix:continuation id="i04cea70ba1d541eba9996cc565e63e45"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:29.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.092%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.914%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.860%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.096%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp;<br/>Consumer<br/>Wellness</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a07c8633b37492ba109c7cd9a92299a_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzItMS0xLTEtMjY1MjQ3_83f44f28-d971-43ec-b9ff-00ff4dfb251f">90,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzItMy0xLTEtMjY1MjQ3_454e0810-8529-45f0-816a-1bd9503dd715">157,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd57b0b73c1b4e1aa835dde2abf6925c_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzItNS0xLTEtMjY1MjQ3_0159e2c6-9b83-4b75-8e2a-136f2c0d6f42">72,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1d5e5a55e6f4909a1d1c3d2003ec720_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzItNy0xLTEtMjY1MjQ3_b1a60eee-503a-48d6-a7ae-5c835c26594c">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzItMTEtMS0xLTI2NTI0Nw_7010ea6e-6c19-4f10-b520-e3cadc44f24f">321,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic42863604ce54004b9083c8738b254f9_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzMtMS0xLTEtMjY1MjQ3_b6838953-4ddf-4779-a8fc-9c15ccc9c43d">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a109a847174412e8d5696bab1036d5c_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzMtMy0xLTEtMjY1MjQ3_5b1cfc3c-b36f-4106-ab53-3dcc3d022f8f">11,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94f2ff5e331c4b7687981a263ec1c30d_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzMtNS0xLTEtMjY1MjQ3_d4ff09b7-dc0a-4a9d-8c67-1f5b5326e5c2">35,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib085c0543c9d4988b6b20b9b427998b0_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzMtOS0xLTEtMjY1MjQ3_af9af881-8372-444c-82a2-3f568ea64951">47,585</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a07c8633b37492ba109c7cd9a92299a_D20220101-20221231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzQtMS0xLTEtMjY1MjQ3_4199b1d4-a58e-4849-b686-f786c63f3e32">476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzQtMy0xLTEtMjY1MjQ3_da508278-e23d-49e3-8bdf-38a5a1a6a50c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd57b0b73c1b4e1aa835dde2abf6925c_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzQtNS0xLTEtMjY1MjQ3_a225e3ce-b253-4697-b06f-3968e8eab82a">44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1d5e5a55e6f4909a1d1c3d2003ec720_D20220101-20221231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzQtNy0xLTEtMjY1MjQ3_b10ae807-4e93-44db-92b8-832665f6d4da">406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib085c0543c9d4988b6b20b9b427998b0_D20220101-20221231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzQtOS0xLTEtMjY1MjQ3_c5021afd-7fe8-4a3b-9b4e-72a70d70dfba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzQtMTEtMS0xLTI2NTI0Nw_e8d0088c-4b52-446c-baa7-ff7671ed649c">838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a07c8633b37492ba109c7cd9a92299a_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzUtMS0xLTEtMjY1MjQ3_a966812f-fa43-45c0-b10b-4b9f9f8e6d4b">91,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzUtMy0xLTEtMjY1MjQ3_c793c5ad-79cc-4a81-b609-1e3fb46a68d1">169,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd57b0b73c1b4e1aa835dde2abf6925c_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzUtNS0xLTEtMjY1MjQ3_42c34c0f-1f54-4f1e-af5a-ac578e3a402e">108,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1d5e5a55e6f4909a1d1c3d2003ec720_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzUtNy0xLTEtMjY1MjQ3_85809ee1-905d-46b9-8f9a-addf2bff5e8b">530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib085c0543c9d4988b6b20b9b427998b0_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzUtOS0xLTEtMjY1MjQ3_fe8f76a5-0cef-4b44-80c8-3054d81a0841">47,585</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzUtMTEtMS0xLTI2NTI0Nw_9d8fd173-e13b-4998-9eb4-3137136a367e">322,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a07c8633b37492ba109c7cd9a92299a_D20220101-20221231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzYtMS0xLTEtMjY1MjQ3_8c306227-28a1-4912-9795-8009b965e1a0">6,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzYtMy0xLTEtMjY1MjQ3_8de61937-951c-469f-b7e4-0e4677a1913a">6,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd57b0b73c1b4e1aa835dde2abf6925c_D20220101-20221231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzYtNS0xLTEtMjY1MjQ3_9ae65da4-1e5a-4d20-8517-54089a73a16e">6,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1d5e5a55e6f4909a1d1c3d2003ec720_D20220101-20221231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzYtNy0xLTEtMjY1MjQ3_a99bafa5-e796-4b7c-a564-2080f3cbfcd0">1,613</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib085c0543c9d4988b6b20b9b427998b0_D20220101-20221231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzYtOS0xLTEtMjY1MjQ3_0ce4d25b-3969-4424-8981-f781720561ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzYtMTEtMS0xLTI2NTI0Nw_236f6fc2-2e5c-433d-94db-28c0739ef699">18,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a07c8633b37492ba109c7cd9a92299a_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzctMS0xLTEtMjY1MjQ3_53da3428-e994-4e2d-bcce-4bf5bf252532">1,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzctMy0xLTEtMjY1MjQ3_b390faed-f41f-4ec2-9d00-920019dce87d">519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd57b0b73c1b4e1aa835dde2abf6925c_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzctNS0xLTEtMjY1MjQ3_143480b3-5016-4b3f-b1ef-401d739cfea4">1,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1d5e5a55e6f4909a1d1c3d2003ec720_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzctNy0xLTEtMjY1MjQ3_66af34ff-43e9-42b3-8bb1-2618efeb6e86">237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib085c0543c9d4988b6b20b9b427998b0_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzctOS0xLTEtMjY1MjQ3_aef69d73-46a6-42f8-8e9e-41cd2f2268ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzctMTEtMS0xLTI2NTI0Nw_b4236dfc-78bb-4349-bf44-65c59fbc7d89">4,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1edd8caecae44ce995f38b9edd410db7_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzktMS0xLTEtMjY1MjQ3_a954d703-eb51-475d-8893-090990d22cb5">81,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie123d487288b460289e6aaf6ae104852_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzktMy0xLTEtMjY1MjQ3_fde97451-b1d5-4c39-968f-0fda8b82b19b">143,912</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d2a7ac149f64c73a8f3b978546f2741_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzktNS0xLTEtMjY1MjQ3_f618da02-2829-4ee8-9134-87c4be01fcef">65,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0cc9849a9ff470b935a370313045788_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzktNy0xLTEtMjY1MjQ3_daaf8a90-5235-4d45-af31-03735ac1cc0c">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzktMTEtMS0xLTI2NTI0Nw_238d4908-b682-478e-a822-2ef48fe4efc9">290,912</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7643d22e2ea64b119f44152086b5ef19_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEwLTEtMS0xLTI2NTI0Nw_a1cce818-1f8e-4ebc-98e1-d388feb7d60e">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a3b9441e5e432f912162e86ac57adc_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEwLTMtMS0xLTI2NTI0Nw_cfeb8964-e3e5-4629-aa6a-833322d400ce">9,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38f3804941744661bf9c3ad58fc2aad2_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEwLTUtMS0xLTI2NTI0Nw_64faa80c-e321-40bf-abc0-a8bff0951dbc">36,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i977f19fae3bf4bc8963ec72c8c49ebdc_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEwLTktMS0xLTI2NTI0Nw_52c8b0a0-3603-4784-81a9-b9ed8675d19a">46,241</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1edd8caecae44ce995f38b9edd410db7_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzExLTEtMS0xLTI2NTI0Nw_2d1bbab6-861a-4579-8855-c6e504080318">586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie123d487288b460289e6aaf6ae104852_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzExLTMtMS0xLTI2NTI0Nw_f16c3334-85bc-44bc-8fa0-46101fa00710">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d2a7ac149f64c73a8f3b978546f2741_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzExLTUtMS0xLTI2NTI0Nw_292422b6-44e0-4d3b-b617-01c416f7b832">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0cc9849a9ff470b935a370313045788_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzExLTctMS0xLTI2NTI0Nw_aa162488-fa95-406e-896a-6cede36fbd2d">596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i977f19fae3bf4bc8963ec72c8c49ebdc_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzExLTktMS0xLTI2NTI0Nw_2371b9d7-fa30-4a05-8f46-7ba8c2a16799">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzExLTExLTEtMS0yNjUyNDc_b89f3cd6-4318-411b-ad9c-7f8f271c4974">1,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1edd8caecae44ce995f38b9edd410db7_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEyLTEtMS0xLTI2NTI0Nw_5c609e77-78dc-4852-bbcf-cddfa4a0b730">82,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie123d487288b460289e6aaf6ae104852_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEyLTMtMS0xLTI2NTI0Nw_2d21931a-f463-475d-a68f-073ff92b7f07">153,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d2a7ac149f64c73a8f3b978546f2741_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEyLTUtMS0xLTI2NTI0Nw_b26a61d9-f108-4651-a90b-00dd4d7d1dcd">101,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0cc9849a9ff470b935a370313045788_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEyLTctMS0xLTI2NTI0Nw_1a3b1900-5e7a-42ce-8a46-622f7e97c1e2">721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i977f19fae3bf4bc8963ec72c8c49ebdc_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEyLTktMS0xLTI2NTI0Nw_be8cf1f0-1099-4bbb-a78b-94477fcea6b6">46,241</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEyLTExLTEtMS0yNjUyNDc_4665fbb6-7a9e-443a-8c21-7257eea39848">292,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1edd8caecae44ce995f38b9edd410db7_D20210101-20211231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEzLTEtMS0xLTI2NTI0Nw_b183d0ea-65ad-4b5b-beb8-bf65bc06488e">5,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie123d487288b460289e6aaf6ae104852_D20210101-20211231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEzLTMtMS0xLTI2NTI0Nw_d270c999-9ac4-41a6-ba30-fe1f8533b4ea">6,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d2a7ac149f64c73a8f3b978546f2741_D20210101-20211231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEzLTUtMS0xLTI2NTI0Nw_65418399-d39d-401c-b4ba-c4b57d8f0101">7,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0cc9849a9ff470b935a370313045788_D20210101-20211231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEzLTctMS0xLTI2NTI0Nw_0de8703d-439e-449b-908e-bb200ca69aea">1,635</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i977f19fae3bf4bc8963ec72c8c49ebdc_D20210101-20211231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEzLTktMS0xLTI2NTI0Nw_a3c7e330-a6d2-497d-8452-445d6f92b046">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEzLTExLTEtMS0yNjUyNDc_ea3a5053-80de-4d77-8607-996f141fd88d">17,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1edd8caecae44ce995f38b9edd410db7_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE0LTEtMS0xLTI2NTI0Nw_790838dd-9a41-4ce1-ab3b-e38eef5257c0">1,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie123d487288b460289e6aaf6ae104852_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE0LTMtMS0xLTI2NTI0Nw_ff651c09-0cbc-4033-8753-77ada7047805">505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d2a7ac149f64c73a8f3b978546f2741_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE0LTUtMS0xLTI2NTI0Nw_72d05b06-4127-4a5c-92f8-0be6d69a1dd8">1,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0cc9849a9ff470b935a370313045788_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE0LTctMS0xLTI2NTI0Nw_65ebf1e8-b9dc-486e-89b3-e4bc990b981a">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i977f19fae3bf4bc8963ec72c8c49ebdc_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE0LTktMS0xLTI2NTI0Nw_aab4346a-1665-4075-a3d3-8d16fa8bb563">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE0LTExLTEtMS0yNjUyNDc_6d1d1ceb-4185-4e99-8d6e-8effd335dbaf">4,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95a883374f34cadb8aba20153008269_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE2LTEtMS0xLTI2NTI0Nw_f6366d0a-3ec3-4834-94cd-ecefb6ff9976">74,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE2LTMtMS0xLTI2NTI0Nw_5f55cebe-0aa7-48d7-b638-456b5d94f9cb">131,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7a2e3c175d84b5aa44a7a859d45ad5d_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE2LTUtMS0xLTI2NTI0Nw_a7ee22bc-d95d-480f-90b4-d15e1cc81754">60,990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ce5e18976c2489a9a964cdebbae85ac_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE2LTctMS0xLTI2NTI0Nw_59cffc73-04cc-4b21-b614-d1c92d2860f9">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE2LTExLTEtMS0yNjUyNDc_e3c4c5ae-4177-4f55-aed3-d49d0e8e95ba">267,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d20d05e0c4b4f8688a601a6a2a0b0df_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE3LTEtMS0xLTI2NTI0Nw_0f5b715e-4fa2-453a-9889-949d36fca3af">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i940aaafcbe33455889e57c5de95674de_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE3LTMtMS0xLTI2NTI0Nw_623b36ce-a6c2-43c1-94a2-df71a93a7ec0">9,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94f36228e56d4a5e93aeacea94e8a9c3_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE3LTUtMS0xLTI2NTI0Nw_bf9004dc-e05d-44bf-8ec4-1f241a67d087">32,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37c56e2626d741fc89c81191ac507cb5_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE3LTktMS0xLTI2NTI0Nw_472a38b0-dfd0-4ca4-ae1a-7d500c3d5bdd">42,062</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95a883374f34cadb8aba20153008269_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE4LTEtMS0xLTI2NTI0Nw_8c20b6f3-f2d7-45d0-af3b-b337f9332654">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE4LTMtMS0xLTI2NTI0Nw_0c99b574-2d6b-4ea4-9ab0-93c55bc8ba8b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7a2e3c175d84b5aa44a7a859d45ad5d_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE4LTUtMS0xLTI2NTI0Nw_5ab983c6-304f-419c-87bd-62b5cd66d3ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ce5e18976c2489a9a964cdebbae85ac_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE4LTctMS0xLTI2NTI0Nw_8360eb67-b26d-43bb-bb16-48a085fe10ab">315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37c56e2626d741fc89c81191ac507cb5_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE4LTktMS0xLTI2NTI0Nw_4b205542-4732-48c4-b0ac-e40c7293c65e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE4LTExLTEtMS0yNjUyNDc_af174843-df5a-4290-a9c3-3a2fbcf08593">798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95a883374f34cadb8aba20153008269_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE5LTEtMS0xLTI2NTI0Nw_30cd394c-46bd-4dff-bf47-827a46e2daf4">75,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE5LTMtMS0xLTI2NTI0Nw_134a29de-b74d-4ba1-bcab-22f3dc2d27b3">141,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7a2e3c175d84b5aa44a7a859d45ad5d_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE5LTUtMS0xLTI2NTI0Nw_d336e130-059b-45f7-9611-d8beec75e9a8">93,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ce5e18976c2489a9a964cdebbae85ac_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE5LTctMS0xLTI2NTI0Nw_75a896ee-a486-4bf8-9cdb-d4211c2b8f00">426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37c56e2626d741fc89c81191ac507cb5_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE5LTktMS0xLTI2NTI0Nw_28d5d323-2833-4b07-8491-7257e91ec63e">42,062</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE5LTExLTEtMS0yNjUyNDc_5a53774a-2ca1-4dd3-b693-01f3d4f459e6">268,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95a883374f34cadb8aba20153008269_D20200101-20201231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIwLTEtMS0xLTI2NTI0Nw_a46619f2-3594-4fd5-91c1-95ffdf4b31eb">6,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIwLTMtMS0xLTI2NTI0Nw_3ca3a510-f3f6-4f49-ba9c-1ef705f4202e">5,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7a2e3c175d84b5aa44a7a859d45ad5d_D20200101-20201231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIwLTUtMS0xLTI2NTI0Nw_dc007215-5452-4d55-aea7-cbfb22c71de5">6,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ce5e18976c2489a9a964cdebbae85ac_D20200101-20201231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIwLTctMS0xLTI2NTI0Nw_c1b1eac3-b38b-492f-865a-34be428b0dea">1,319</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37c56e2626d741fc89c81191ac507cb5_D20200101-20201231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIwLTktMS0xLTI2NTI0Nw_5593b242-e5aa-48f2-a3fb-545f51501dca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIwLTExLTEtMS0yNjUyNDc_734f096a-f5f0-44d8-a386-186e90a6aafe">15,956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95a883374f34cadb8aba20153008269_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIxLTEtMS0xLTI2NTI0Nw_84188b74-5dae-44a7-b0f7-288eadfd4267">1,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIxLTMtMS0xLTI2NTI0Nw_2642a680-384b-4362-b42b-b2dd4729cf06">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7a2e3c175d84b5aa44a7a859d45ad5d_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIxLTUtMS0xLTI2NTI0Nw_0887fa46-c859-4b04-9dc9-9bf80d1a60cd">1,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ce5e18976c2489a9a964cdebbae85ac_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIxLTctMS0xLTI2NTI0Nw_9a01ff3c-752d-4b1b-be91-d2eca412f82e">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37c56e2626d741fc89c81191ac507cb5_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIxLTktMS0xLTI2NTI0Nw_fd036ece-cc7b-4cf0-b662-c396310c0afe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIxLTExLTEtMS0yNjUyNDc_dd413ea3-449b-499a-9fe9-685d42ba1c79">4,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Health Services segment include approximately $<ix:nonFraction unitRef="usd" contextRef="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231" decimals="-8" name="cvs:NetRevenuesRetailCoPayments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzIwMDg_7b7be722-e1b8-4b01-b8bb-f1e09ead5386">12.6</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="ie123d487288b460289e6aaf6ae104852_D20210101-20211231" decimals="-8" name="cvs:NetRevenuesRetailCoPayments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzIwMTI_a7484713-5069-42fb-adee-2eadfa6611f7">11.6</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231" decimals="-8" name="cvs:NetRevenuesRetailCoPayments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzIwMTk_e50e172c-fac4-4728-bb9f-8dd24b8baea9">10.9</ix:nonFraction> billion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">of retail co-payments for 2022, 2021 and 2020, respectively. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information about retail co-payments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy &amp; Consumer Wellness segment.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">157</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i25d895361fdb4e30a58cc1ee1c989627" continuedAt="i4bb5bf58cc6f4327b330c099d083f5a7"><ix:nonNumeric contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzk1NzA_af936993-fbf4-46ee-89f9-a02684560912" continuedAt="i4e0f4b78e682450a95386e770018cfbc" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of consolidated operating income to adjusted operating income for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzEtMS0xLTEtMjY1MjQ3_0fc638b5-85e0-4e33-8ef8-f5559a5652ca">7,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzEtMy0xLTEtMjY1MjQ3_4ba1f4ec-ae63-42cc-a03e-9edbec336961">13,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzEtNS0xLTEtMjY1MjQ3_4a80a8a5-f6b7-484c-a5dc-8a650c5c4813">13,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzItMS0xLTEtMjY1MjQ3_ad46c72b-5d76-4812-9147-c36626c420f4">1,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzItMy0xLTEtMjY1MjQ3_a703a58b-a512-453f-a0f1-09ed7e1ac324">2,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzItNS0xLTEtMjY1MjQ3_d96f76e2-dcc3-4ef8-bde7-29b94f297fd2">2,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital (gains) losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzMtMS0xLTEtMjc0MjU2_3e50b947-6017-408b-8225-bf4fe7bd214d">320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzMtMy0xLTEtMjk3ODI2_7745deb5-f038-4b21-b432-ae275be42a0c">176</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzMtNS0xLTEtMjk3Nzcw_98113fc6-5c92-4c5f-9b77-3ea31a5c74dd">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office real estate optimization charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:OfficeRealEstateOptimizationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzMtMS0xLTEtMjY1MjQ3_19f1ac17-e6b4-4e12-a2b5-07e6f1ed8493">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:OfficeRealEstateOptimizationCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzMtMy0xLTEtMjY1MjQ3_61c1e153-7bdd-4253-881a-16c163e73e2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="cvs:OfficeRealEstateOptimizationCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzMtNS0xLTEtMjY1MjQ3_688faa29-f2e5-4b18-8116-6a0cf90348ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on divestiture of subsidiaries </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzQtMS0xLTEtMjY1MjQ3_326428dc-1c19-4089-a22e-ff42f612e48e">475</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzQtMy0xLTEtMjY1MjQ3_04567596-4a66-48cb-b0eb-a59f2d1ef15a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzQtNS0xLTEtMjY1MjQ3_d1d14fc3-e6c9-4fb7-9422-ab4dad947f3e">269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid litigation charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzUtMS0xLTEtMjY1MjQ3_631aa56e-bff9-459e-81fe-1b1393ecf5e3">5,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzUtMy0xLTEtMjY1MjQ3_a52bc16d-b09c-4881-b826-2647b857b69c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzUtNS0xLTEtMjY1MjQ3_595aab16-3468-4d44-b2fd-8d5f6793cebf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on assets held for sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzYtMS0xLTEtMjY1MjQ3_c8490829-e4b9-4b6f-82e8-9ef00b0865f5">2,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzYtMy0xLTEtMjY1MjQ3_e1f5f709-af58-409e-848e-72cec6ca5fed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzYtNS0xLTEtMjY1MjQ3_2e69e937-6b61-4c8e-b037-007ff9782271">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzctMS0xLTEtMjY1MjQ3_d3892c31-4ee3-444b-b4b1-73b94b511fcc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzctMy0xLTEtMjY1MjQ3_9ad8b749-384b-4af6-9d5c-c4de9f18cb6e">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzctNS0xLTEtMjY1MjQ3_0d015b13-4e66-4bd3-a689-d385c10d7b74">332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store impairments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzgtMS0xLTEtMjY1MjQ3_796e4153-9d26-4171-ab3d-f8d1801cac1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzgtMy0xLTEtMjY1MjQ3_c6534885-8d45-4e30-a29b-59019cbee4b7">1,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzgtNS0xLTEtMjY1MjQ3_8bb40884-79f4-417e-8cbc-05532ee71525">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzktMS0xLTEtMjY1MjQ3_5d1acc0a-8e6b-499f-a799-66572fe7c1ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzktMy0xLTEtMjY1MjQ3_a352766a-a78c-498a-b126-8e88fe7fd900">431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzktNS0xLTEtMjY1MjQ3_5b22d887-fcc6-46e6-b30b-426fe89b87ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition purchase price adjustment outside of measurement period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzEwLTEtMS0xLTI2NTI0Nw_3e37eb22-ee2b-4e08-8094-dbc8591168b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzEwLTMtMS0xLTI2NTI0Nw_6025ff19-8f73-44c5-9d1e-2991d83fa4b7">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzEwLTUtMS0xLTI2NTI0Nw_b7c2afee-485e-44b8-91ca-34ec4f9327b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receipt of fully reserved ACA risk corridor receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(11)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzExLTEtMS0xLTI2NTI0Nw_77488797-5e19-4b8a-afbd-e1660beb1382">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzExLTMtMS0xLTI2NTI0Nw_49fbc226-0003-4bee-804a-b5b49836be68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzExLTUtMS0xLTI2NTI0Nw_6f9496b1-6af6-4c0b-9475-451e301556cd">307</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzEyLTEtMS0xLTI2NTI0Nw_435e2fce-aa36-4101-a927-4896e595c2f1">18,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzEyLTMtMS0xLTI2NTI0Nw_ea3a5053-80de-4d77-8607-996f141fd88d">17,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzEyLTUtMS0xLTI2NTI0Nw_734f096a-f5f0-44d8-a386-186e90a6aafe">15,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s GAAP consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s net realized capital gains and losses arise from various types of transactions, primarily in the course of managing a portfolio of assets that support the payment of insurance liabilities. Net realized capital gains and losses are reflected in the consolidated statements of operations in net investment income within each segment. These capital gains and losses are the result of investment decisions, market conditions and other economic developments that are unrelated to the performance of the Company&#8217;s business, and the amount and timing of these capital gains and losses do not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Accordingly, the Company believes excluding net realized capital gains and losses enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2022, the office real estate optimization charges primarily relate to the abandonment of leased real estate and the related right-of-use assets and property and equipment in connection with the planned reduction of corporate office real estate space in response to the Company&#8217;s new flexible work arrangement. The office real estate optimization charges are reflected in the Company&#8217;s GAAP consolidated statement of operations in operating expenses within the Health Care Benefits, Corporate/Other and Health Services segments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2022, the gain on divestiture of subsidiaries represents the pre-tax gain on the sale of bswift, which the Company sold in November 2022, and the pre-tax gain on the sale of PayFlex, which the Company sold in June 2022. In 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#8217; Compensation business, which the Company sold in July 2020. The gains on divestitures are reflected as a reduction of operating expenses in the Company&#8217;s GAAP consolidated statements of operations within the Health Care Benefits segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2022, the opioid litigation charges relate to agreements to resolve substantially all opioid claims against the Company by certain states and governmental entities. The opioid litigation charges are reflected within the Corporate/Other segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2022, the loss on assets held for sale relates to the LTC reporting unit within the Pharmacy &amp; Consumer Wellness segment. The Company continually evaluates its portfolio for non-strategic assets. The Company determined that its LTC business was no longer a strategic asset and during the third quarter of 2022 committed to a plan to sell the LTC business. As of September 30, 2022, the LTC business met the criteria for held-for-sale accounting and its net assets were accounted for as assets held for sale. The carrying value of the LTC business was determined to be greater than its estimated fair value less costs to sell and a loss on assets held for sale was recorded during the third quarter of 2022. As of December 31, 2022, the net assets of the LTC business continued to meet the criteria for held-for-sale accounting and during the fourth quarter of 2022, an incremental loss on assets held for sale was recorded to write down the carrying value of the LTC business to its estimated fair value less costs to sell. During 2022, the loss on assets held for sale also relates to the Commercial Business reporting unit within the Health Care Benefits segment. In March 2022, the Company reached an agreement to sell its Thailand business, which was included in the Commercial Business reporting unit. At that time, a portion of the Commercial Business goodwill was specifically allocated to the Thailand business. The net assets of the Thailand business were accounted for as assets held for sale at March 31, 2022. The carrying value of the Thailand business was determined to be greater than its estimated fair value less costs to sell and a loss on assets held for sale was recorded during the first quarter of 2022. The sale of the Thailand business closed in the second quarter of 2022, and the ultimate loss on the sale was not material.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">158</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4bb5bf58cc6f4327b330c099d083f5a7"><ix:continuation id="i4e0f4b78e682450a95386e770018cfbc"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2021 and 2020, acquisition-related integration costs relate to the acquisition of Aetna. The acquisition-related integration costs are reflected in the Company&#8217;s GAAP consolidated statements of operations in operating expenses within the Corporate/Other segment.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2021, the store impairment charge relates to the write down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately <ix:nonFraction unitRef="store" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="INF" name="cvs:NumberOfStoresPlannedClosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzg1MDM_cf9d7259-6aa8-460d-838a-eab44dda9e56">900</ix:nonFraction> retail stores between 2022 and 2024. The store impairment charge is reflected within the Pharmacy &amp; Consumer Wellness segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2021, the goodwill impairment charge relates to an impairment of the remaining goodwill of the LTC reporting unit within the Pharmacy &amp; Consumer Wellness segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">In 2021, the Company received $<ix:nonFraction unitRef="usd" contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231" decimals="-6" name="cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzg3OTU_94d7866e-eb05-41be-8efe-af9d6fd259e2">61</ix:nonFraction>&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#8217;s GAAP consolidated statement of operations as a reduction of operating expenses within the Health Care Benefits segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">In 2020, the Company received $<ix:nonFraction unitRef="usd" contextRef="i8b77d3d696ee47dba7d85700d9f05fd1_I20201231" decimals="-6" name="us-gaap:GainContingencyUnrecordedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzkyMDA_63329f75-33bb-4970-9d66-d63bc8b0ae47">313</ix:nonFraction>&#160;million owed to it under the ACA&#8217;s risk corridor program that was previously fully reserved for as payment was uncertain. After considering offsetting items such as the ACA&#8217;s minimum MLR rebate requirements and premium taxes, the Company recognized pre-tax income of $<ix:nonFraction unitRef="usd" contextRef="ife99c731f49c491f9dbcec868c83f01f_D20200101-20201231" decimals="-6" name="cvs:FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzk0NjI_93ada995-7177-4e84-8740-f29ab2ea93f2">307</ix:nonFraction>&#160;million in the Company&#8217;s GAAP consolidated statement of operations within the Health Care Benefits segment.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_178"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i36038907935e41eea5e9cf7cac915d44_100">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of CVS Health Corporation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited CVS Health Corporation&#8217;s internal control over financial reporting as of December&#160;31, 2022, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, CVS Health Corporation (the Company) maintained, in all material respects, effective internal control over financial reporting as of December&#160;31, 2022, based on the COSO criteria.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the 2022 consolidated financial statements of the Company and our report dated February&#160;8, 2023, expressed an unqualified opinion thereon.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston, Massachusetts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;8, 2023 </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">160</span></div></div></div><div id="i36038907935e41eea5e9cf7cac915d44_181"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of CVS Health Corporation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of CVS Health Corporation (the Company) as of December&#160;31, 2022 and 2021, the related consolidated statements of operations, comprehensive income, shareholders&#8217; equity and cash flows for each of the three years in the period ended December&#160;31, 2022, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December&#160;31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December&#160;31, 2022, in conformity with U.S. generally accepted accounting principles. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of December&#160;31, 2022, based on criteria established in Internal Control-Integrated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated February&#160;8, 2023, expressed an unqualified opinion thereon.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adoption of ASU No. 2018-12</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 8 to the consolidated financial statements, the Company changed its method of accounting for long-duration contracts in 2023 due to the adoption of ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">161</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.305%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%">Valuation of health care costs payable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2022, the incurred but not reported (&#8220;IBNR&#8221;) liabilities represented $7.8 billion of $10.1 billion of health care costs payable. As discussed in Note 1 to the consolidated financial statements, the Company&#8217;s liability for health care costs payable includes estimated payments for (1) services rendered to members but not yet reported and (2) claims that have been reported but not yet paid, each as of the financial statement date (collectively, &#8220;IBNR&#8221;). The estimated IBNR liability is developed utilizing actuarial principles and assumptions that include historical and projected claim submission and processing patterns, historical and assumed medical cost trends, historical utilization of medical services, claim inventory levels, changes in membership and product mix, seasonality and other relevant factors to record the actuarial best estimate of health care costs payable. There is significant uncertainty inherent in determining management&#8217;s actuarial best estimate of health care costs payable. In particular, the estimate is sensitive to the assumed completion factors and the assumed health care cost trend rates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Auditing management&#8217;s actuarial best estimate of IBNR reserves for health care costs payable for its products and services involved a high degree of subjectivity in evaluating management&#8217;s assumptions used in the valuation process.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the process for estimating IBNR reserves. This included, among others, controls over the completeness and accuracy of data used in the actuarial projections, the transfer of data between underlying source systems, and the review and approval processes that management has in place for the actuarial principles and assumptions used in estimating the health care costs payable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To test IBNR reserves, our audit procedures included, among others, testing the completeness and accuracy of the underlying claim and membership data used in the calculation of IBNR reserves. We involved actuarial specialists to assist with our audit procedures, which included, among others, evaluating the methodologies applied by the Company in determining the actuarially determined liability, evaluating management&#8217;s actuarial principles and assumptions used in their analysis based on historical claim experience, and independently calculating a range of reserve estimates for comparison to management&#8217;s actuarial best estimate of the liability for health care costs payable. Additionally, we performed a review of the prior period liabilities for incurred but not paid claims to subsequent claims development.</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2007.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston, Massachusetts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;8, 2023, except for Note 8 and Note 18, as to which the date is May 25, 2023</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">162</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>cvs-20230525.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:a470d627-05b8-4106-b3ee-d69f01519b0f,g:7f491b32-9056-4172-9edc-e6fc2e3bdea2-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cvs="http://www.cvshealth.com/20230525" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cvshealth.com/20230525">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20230525_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20230525_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20230525_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20230525_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.cvshealth.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofOperations">
        <link:definition>0000002 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>0000003 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.cvshealth.com/role/ConsolidatedBalanceSheets">
        <link:definition>0000004 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000005 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>0000006 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows_1" roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1">
        <link:definition>0000006 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofShareholdersEquity" roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity">
        <link:definition>0000007 - Statement - Consolidated Statements of Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofShareholdersEquityParentheticals" roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals">
        <link:definition>0000008 - Statement - Consolidated Statements of Shareholders' Equity (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlowsParenthetical" roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlowsParenthetical">
        <link:definition>0000009 - Statement - Consolidated Statements of Cash Flows (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://www.cvshealth.com/role/SignificantAccountingPolicies">
        <link:definition>0000010 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsDivestituresandAssetSales" roleURI="http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSales">
        <link:definition>0000011 - Disclosure - Acquisitions, Divestitures and Asset Sales</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.cvshealth.com/role/Investments">
        <link:definition>0000012 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValue" roleURI="http://www.cvshealth.com/role/FairValue">
        <link:definition>0000013 - Disclosure - Fair Value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibles" roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangibles">
        <link:definition>0000014 - Disclosure - Goodwill and Other Intangibles</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.cvshealth.com/role/Leases">
        <link:definition>0000015 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayable" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayable">
        <link:definition>0000016 - Disclosure - Health Care Costs Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInsuranceLiabilitiesandSeparateAccounts" roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccounts">
        <link:definition>0000017 - Disclosure - Other Insurance Liabilities and Separate Accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditAgreements" roleURI="http://www.cvshealth.com/role/BorrowingsandCreditAgreements">
        <link:definition>0000018 - Disclosure - Borrowings and Credit Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefits" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits">
        <link:definition>0000019 - Disclosure - Pension Plans and Other Postretirement Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.cvshealth.com/role/IncomeTaxes">
        <link:definition>0000020 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlans" roleURI="http://www.cvshealth.com/role/StockIncentivePlans">
        <link:definition>0000021 - Disclosure - Stock Incentive Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://www.cvshealth.com/role/ShareholdersEquity">
        <link:definition>0000022 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncomeLoss" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeLoss">
        <link:definition>0000023 - Disclosure - Other Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.cvshealth.com/role/EarningsPerShare">
        <link:definition>0000024 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Reinsurance" roleURI="http://www.cvshealth.com/role/Reinsurance">
        <link:definition>0000025 - Disclosure - Reinsurance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.cvshealth.com/role/CommitmentsandContingencies">
        <link:definition>0000026 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.cvshealth.com/role/SegmentReporting">
        <link:definition>0000027 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>0000028 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesTables" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables">
        <link:definition>0000029 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsDivestituresandAssetSalesTables" roleURI="http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesTables">
        <link:definition>0000030 - Disclosure - Acquisitions, Divestitures and Asset Sales (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.cvshealth.com/role/InvestmentsTables">
        <link:definition>0000031 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueTables" roleURI="http://www.cvshealth.com/role/FairValueTables">
        <link:definition>0000032 - Disclosure - Fair Value (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangiblesTables" roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables">
        <link:definition>0000033 - Disclosure - Goodwill and Other Intangibles (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.cvshealth.com/role/LeasesTables">
        <link:definition>0000034 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableTables" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableTables">
        <link:definition>0000035 - Disclosure - Health Care Costs Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInsuranceLiabilitiesandSeparateAccountsTables" roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsTables">
        <link:definition>0000036 - Disclosure - Other Insurance Liabilities and Separate Accounts (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditAgreementsTables" roleURI="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsTables">
        <link:definition>0000037 - Disclosure - Borrowings and Credit Agreements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsTables" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables">
        <link:definition>0000038 - Disclosure - Pension Plans and Other Postretirement Benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.cvshealth.com/role/IncomeTaxesTables">
        <link:definition>0000039 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansTables" roleURI="http://www.cvshealth.com/role/StockIncentivePlansTables">
        <link:definition>0000040 - Disclosure - Stock Incentive Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://www.cvshealth.com/role/ShareholdersEquityTables">
        <link:definition>0000041 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncomeTables" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables">
        <link:definition>0000042 - Disclosure - Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.cvshealth.com/role/EarningsPerShareTables">
        <link:definition>0000043 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceTables" roleURI="http://www.cvshealth.com/role/ReinsuranceTables">
        <link:definition>0000044 - Disclosure - Reinsurance (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.cvshealth.com/role/SegmentReportingTables">
        <link:definition>0000045 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0000046 - Disclosure - Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails">
        <link:definition>0000047 - Disclosure - Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesAccountsReceivableDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails">
        <link:definition>0000048 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDeferredAcquisitionCostsDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDeferredAcquisitionCostsDetails">
        <link:definition>0000049 - Disclosure - Significant Accounting Policies - Deferred Acquisition Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPropertyandEquipmentDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails">
        <link:definition>0000050 - Disclosure - Significant Accounting Policies - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDisaggregationofRevenueDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails">
        <link:definition>0000051 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails">
        <link:definition>0000052 - Disclosure - Significant Accounting Policies - Receivables and Contracted Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesContractBalancesDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails">
        <link:definition>0000053 - Disclosure - Significant Accounting Policies - Contract Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesVariableInterestEntitiesDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails">
        <link:definition>0000054 - Disclosure - Significant Accounting Policies - Variable Interest Entities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDiscontinuedOperationsDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails">
        <link:definition>0000055 - Disclosure - Significant Accounting Policies - Discontinued Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsDivestituresandAssetSalesNarrativeDetails" roleURI="http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails">
        <link:definition>0000056 - Disclosure - Acquisitions, Divestitures and Asset Sales - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails" roleURI="http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails">
        <link:definition>0000057 - Disclosure - Acquisitions, Divestitures and Asset Sales - Summary of Assets and Liabilities Held for Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsScheduleofTotalInvestmentsDetails" roleURI="http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails">
        <link:definition>0000058 - Disclosure - Investments - Schedule of Total Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNarrativeDetails" roleURI="http://www.cvshealth.com/role/InvestmentsNarrativeDetails">
        <link:definition>0000059 - Disclosure - Investments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDebtSecuritiesDetails" roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails">
        <link:definition>0000060 - Disclosure - Investments - Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDebtSecuritiesDetails_1" roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1">
        <link:definition>0000060 - Disclosure - Investments - Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDebtSecuritiesbyMaturityDetails" roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails">
        <link:definition>0000061 - Disclosure - Investments - Debt Securities by Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsUnrealizedLossPositionDetails" roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails">
        <link:definition>0000062 - Disclosure - Investments - Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsUnrealizedLossPositionMaturitiesDetails" roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails">
        <link:definition>0000063 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsMortgageLoansDetails" roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails">
        <link:definition>0000064 - Disclosure - Investments - Mortgage Loans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsMortgageLoansCreditRatingsIndicatorDetails" roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails">
        <link:definition>0000065 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsMortgageLoanPrincipalRepaymentsDetails" roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails">
        <link:definition>0000066 - Disclosure - Investments - Mortgage Loan Principal Repayments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNetInvestmentIncomeDetails" roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails">
        <link:definition>0000067 - Disclosure - Investments - Net Investment Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsRealizedGainsDetails" roleURI="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails">
        <link:definition>0000068 - Disclosure - Investments - Realized Gains (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueFairValueMeasurementsDetails" roleURI="http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails">
        <link:definition>0000069 - Disclosure - Fair Value - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueChangesinLevel3FinancialAssetsDetails" roleURI="http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails">
        <link:definition>0000070 - Disclosure - Fair Value - Changes in Level 3 Financial Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueGrossTransfersIntoOutOfLevel3Details" roleURI="http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details">
        <link:definition>0000071 - Disclosure - Fair Value - Gross Transfers Into (Out Of) Level 3 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueCarryingValueandFairValueClassifiedbyLevelDetails" roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails">
        <link:definition>0000072 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueSeparateAccountsFairValueDetails" roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails">
        <link:definition>0000073 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueNarrativeDetails" roleURI="http://www.cvshealth.com/role/FairValueNarrativeDetails">
        <link:definition>0000074 - Disclosure - Fair Value - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangiblesGoodwillDetails" roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails">
        <link:definition>0000075 - Disclosure - Goodwill and Other Intangibles - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangiblesNarrativeDetails" roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails">
        <link:definition>0000076 - Disclosure - Goodwill and Other Intangibles - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangiblesIntangibleAssetsDetails" roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails">
        <link:definition>0000077 - Disclosure - Goodwill and Other Intangibles - Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails" roleURI="http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails">
        <link:definition>0000078 - Disclosure - Goodwill and Other Acquired Intangibles - Future Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.cvshealth.com/role/LeasesNarrativeDetails">
        <link:definition>0000079 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSummaryoftheComponentsofNetLeaseCostDetails" roleURI="http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails">
        <link:definition>0000080 - Disclosure - Leases - Summary of the Components of Net Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalCashFlowInformationDetails" roleURI="http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails">
        <link:definition>0000081 - Disclosure - Leases - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationDetails" roleURI="http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails">
        <link:definition>0000082 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" roleURI="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails">
        <link:definition>0000083 - Disclosure - Leases - Maturities of Operating and Finance Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" roleURI="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1">
        <link:definition>0000083 - Disclosure - Leases - Maturities of Operating and Finance Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails">
        <link:definition>0000084 - Disclosure - Health Care Costs Payable - Incurred and Paid Health Care Claims Development (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableNarrativeDetails" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails">
        <link:definition>0000085 - Disclosure - Health Care Costs Payable - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails">
        <link:definition>0000086 - Disclosure - Health Care Costs Payable - Liability for Unpaid Claims and Claims Adjustment Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails">
        <link:definition>0000087 - Disclosure - Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails" roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails">
        <link:definition>0000088 - Disclosure - Other Insurance Liabilities and Separate Accounts - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails" roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails">
        <link:definition>0000089 - Disclosure - Other Insurance Liabilities and Separate Accounts - Changes in Balances of Long-Duration Insurance Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails" roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails">
        <link:definition>0000090 - Disclosure - Other Insurance Liabilities and Separate Accounts - Adjustments Resulting From Applying New Accounting Standard (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails" roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails">
        <link:definition>0000091 - Disclosure - Other Insurance Liabilities and Separate Accounts - Changes in Liability for Future Policy Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails" roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails">
        <link:definition>0000092 - Disclosure - Other Insurance Liabilities and Separate Accounts - Undiscounted Expected Gross Premiums and Expected Future Benefit Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails" roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails">
        <link:definition>0000093 - Disclosure - Other Insurance Liabilities and Separate Accounts - Weighted-average Interest Rates and Durations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails" roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails">
        <link:definition>0000094 - Disclosure - Other Insurance Liabilities and Separate Accounts - Roll Forward of Policyholders' Funds (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails" roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails">
        <link:definition>0000095 - Disclosure - Other Insurance Liabilities and Separate Accounts - Separate Account Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails" roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails">
        <link:definition>0000096 - Disclosure - Other Insurance Liabilities and Separate Accounts - Roll Forward of Separate Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditAgreementsScheduleofBorrowingsDetails" roleURI="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails">
        <link:definition>0000097 - Disclosure - Borrowings and Credit Agreements - Schedule of Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditAgreementsDebtMaturitiesDetails" roleURI="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails">
        <link:definition>0000098 - Disclosure - Borrowings and Credit Agreements - Debt Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditAgreementsShorttermBorrowingsDetails" roleURI="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails">
        <link:definition>0000099 - Disclosure - Borrowings and Credit Agreements - Short-term Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditAgreementsLongtermBorrowingsDetails" roleURI="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails">
        <link:definition>0000100 - Disclosure - Borrowings and Credit Agreements - Long-term Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsNarrativeDetails" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails">
        <link:definition>0000101 - Disclosure - Pension Plans and Other Postretirement Benefits - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails">
        <link:definition>0000102 - Disclosure - Pension Plans and Other Postretirement Benefits - Benefit Obligations and Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails">
        <link:definition>0000103 - Disclosure - Pension Plans and Other Postretirement Benefits - Net Periodic Benefit Cost (Income) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails">
        <link:definition>0000104 - Disclosure - Pension Plans and Other Postretirement Benefits - Weighted Average Assumptions Used (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails">
        <link:definition>0000105 - Disclosure - Pension Plans and Other Postretirement Benefits - Fair Value of Pension Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails">
        <link:definition>0000106 - Disclosure - Pension Plans and Other Postretirement Benefits - Changes in Level 3 Pension Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails">
        <link:definition>0000107 - Disclosure - Pension Plans and Other Postretirement Benefits - Defined Benefit Plans Expected Benefit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxProvisionDetails" roleURI="http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails">
        <link:definition>0000108 - Disclosure - Income Taxes - Income Tax Provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesEffectiveTaxRateReconciliationDetails" roleURI="http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails">
        <link:definition>0000109 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>0000110 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>0000111 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesUnrecognizedTaxBenefitsDetails" roleURI="http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails">
        <link:definition>0000112 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansStockBasedCompensationExpenseandESPPDetails" roleURI="http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails">
        <link:definition>0000113 - Disclosure - Stock Incentive Plans - Stock-Based Compensation Expense and ESPP (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansRestrictedStockActivityDetails" roleURI="http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails">
        <link:definition>0000114 - Disclosure - Stock Incentive Plans - Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansStockOptionandSARActivityDetails" roleURI="http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails">
        <link:definition>0000115 - Disclosure - Stock Incentive Plans - Stock Option and SAR Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansValuationAssumptionsDetails" roleURI="http://www.cvshealth.com/role/StockIncentivePlansValuationAssumptionsDetails">
        <link:definition>0000116 - Disclosure - Stock Incentive Plans - Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityShareRepurchasesDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails">
        <link:definition>0000117 - Disclosure - Shareholders' Equity - Share Repurchases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityAcceleratedShareRepurchasesDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails">
        <link:definition>0000118 - Disclosure - Shareholders' Equity - Accelerated Share Repurchases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityDividendsDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails">
        <link:definition>0000119 - Disclosure - Shareholders' Equity - Dividends (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityRegulatoryRequirementsDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails">
        <link:definition>0000120 - Disclosure - Shareholders' Equity - Regulatory Requirements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityNoncontrollingInterestsDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityNoncontrollingInterestsDetails">
        <link:definition>0000121 - Disclosure - Shareholders' Equity - Noncontrolling Interests (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncomeLossDetails" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails">
        <link:definition>0000122 - Disclosure - Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareDetails" roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails">
        <link:definition>0000123 - Disclosure - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceNarrativeDetails" roleURI="http://www.cvshealth.com/role/ReinsuranceNarrativeDetails">
        <link:definition>0000124 - Disclosure - Reinsurance - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceReinsuranceRecoverablesDetails" roleURI="http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails">
        <link:definition>0000125 - Disclosure - Reinsurance - Reinsurance Recoverables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceEffectsofReinsuranceDetails" roleURI="http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails">
        <link:definition>0000126 - Disclosure - Reinsurance - Effects of Reinsurance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails">
        <link:definition>0000127 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails">
        <link:definition>0000128 - Disclosure - Segment Reporting - Retrospective Adjustments to Segment Composition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingNarrativeDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails">
        <link:definition>0000129 - Disclosure - Segment Reporting - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails">
        <link:definition>0000130 - Disclosure - Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails">
        <link:definition>0000131 - Disclosure - Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember" abstract="true" name="EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PharmacyRevenueMember" abstract="true" name="PharmacyRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.75DueDecember2022Member" abstract="true" name="SeniorNotes4.75DueDecember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PremiumDeficiencyReserveLiability" abstract="false" name="PremiumDeficiencyReserveLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale" abstract="false" name="OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NumberOfPatientsServedPerYear" abstract="false" name="NumberOfPatientsServedPerYear" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_USFederalGovernmentMember" abstract="true" name="USFederalGovernmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2Point7PercentAugust2040Member" abstract="true" name="SeniorNotes2Point7PercentAugust2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_NumberOfPharmacyPlanMembers" abstract="false" name="NumberOfPharmacyPlanMembers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_SupportingExperienceRatedProductsMember" abstract="true" name="SupportingExperienceRatedProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember" abstract="true" name="AOCIChangeInDiscountRateOnInsuranceReservesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_VOYARetirementInsuranceAndAnnuityCompanyMember" abstract="true" name="VOYARetirementInsuranceAndAnnuityCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_RedeemablePreferredSecuritiesMember" abstract="true" name="RedeemablePreferredSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares" abstract="false" name="AcceleratedShareRepurchaseProgramMaximumNumberOfShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_CashFlowLesseeAbstract" abstract="true" name="CashFlowLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_LesseeLiabilityPaymentsDueAfterYearFive" abstract="false" name="LesseeLiabilityPaymentsDueAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold" abstract="false" name="DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" abstract="false" name="YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses" abstract="false" name="PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_Categories5And6Member" abstract="true" name="Categories5And6Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3Point70PercentDue2023Member" abstract="true" name="SeniorNotes3Point70PercentDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.7DueMarch2023Member" abstract="true" name="SeniorNotes3.7DueMarch2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SalesChannelOtherMember" abstract="true" name="SalesChannelOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodThreeMember" abstract="true" name="YearOfOriginationPeriodThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LesseeLiabilityPaymentsDue" abstract="false" name="LesseeLiabilityPaymentsDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember" abstract="true" name="EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" abstract="false" name="HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_ProviderNetworksMember" abstract="true" name="ProviderNetworksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.125DueNovember2042Member" abstract="true" name="SeniorNotes4.125DueNovember2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" abstract="false" name="PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LongTermInvestmentsIncludingAssetsHeldForSale" abstract="false" name="LongTermInvestmentsIncludingAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" abstract="false" name="CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_HeartlandHealthcareServicesMember" abstract="true" name="HeartlandHealthcareServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" abstract="false" name="BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_StoreImpairmentCharges" abstract="false" name="StoreImpairmentCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_A2022RepurchaseProgramMember" abstract="true" name="A2022RepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_PharmacyClaimsAndDiscountsPayableCurrent" abstract="false" name="PharmacyClaimsAndDiscountsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" abstract="false" name="InvestmentContractsWithoutFixedMaturityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_OmnicareLongTermCareBusinessMember" abstract="true" name="OmnicareLongTermCareBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_BarclaysBankMember" abstract="true" name="BarclaysBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_RadcliffAndFlaimVAetnaIncEtAlMember" abstract="true" name="RadcliffAndFlaimVAetnaIncEtAlMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TreasuryStockValueSharesHeldInTrust" abstract="false" name="TreasuryStockValueSharesHeldInTrust" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LargeCasePensionsMember" abstract="true" name="LargeCasePensionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_AcceleratedShareRepurchasesAgreementAmount" abstract="false" name="AcceleratedShareRepurchasesAgreementAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ContractWithCustomerLiabilityRedemptionAndBreakage" abstract="false" name="ContractWithCustomerLiabilityRedemptionAndBreakage" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_AdjustedOperatingIncomeLoss" abstract="false" name="AdjustedOperatingIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" abstract="false" name="ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes6.25DueJune2027Member" abstract="true" name="SeniorNotes6.25DueJune2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity" abstract="false" name="RelatedPartyTransactionCharitableContributionToNonProfitEntity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_FinanceLeaseRightOfUseAssetGross" abstract="false" name="FinanceLeaseRightOfUseAssetGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateLoansFullyRepaid" abstract="false" name="MortgageLoansOnRealEstateLoansFullyRepaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" abstract="false" name="OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_BswiftLLCMember" abstract="true" name="BswiftLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock" abstract="false" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember" abstract="true" name="RestrictedStockUnitsAndPerformanceShareUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2.75DueDecember2022Member" abstract="true" name="SeniorNotes2.75DueDecember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease" abstract="false" name="NoncontrollingInterestOtherPeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_OtherInsuranceLiabilitiesMember" abstract="true" name="OtherInsuranceLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.875DueAugust2047Member" abstract="true" name="SeniorNotes3.875DueAugust2047Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" abstract="false" name="FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DeferredTaxLiabilitiesRetirementBenefits" abstract="false" name="DeferredTaxLiabilitiesRetirementBenefits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet" abstract="false" name="DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TotalInvestmentsDomain" abstract="true" name="TotalInvestmentsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_VariableInterestEntityAmendedContractTerm" abstract="false" name="VariableInterestEntityAmendedContractTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_SeniorNotes5.75DueMay2041Member" abstract="true" name="SeniorNotes5.75DueMay2041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" abstract="true" name="RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation" abstract="false" name="FinanceLeaseRightOfUseAssetAccumulatedDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_BusinessCombinationTerminationFee" abstract="false" name="BusinessCombinationTerminationFee" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" abstract="false" name="DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_DeferredTaxAssetsPayrollTaxDeferral" abstract="false" name="DeferredTaxAssetsPayrollTaxDeferral" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" abstract="false" name="OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member" abstract="true" name="ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LesseeLiabilityPaymentsDueYearThree" abstract="false" name="LesseeLiabilityPaymentsDueYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" abstract="true" name="MortgageLoansOnRealEstateYearOfOriginationDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_EquitySecuritiesDomesticRealEstateMember" abstract="true" name="EquitySecuritiesDomesticRealEstateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.75DueMarch2044Member" abstract="true" name="SeniorNotes4.75DueMarch2044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PharmacyAndConsumerHealthSegmentMember" abstract="true" name="PharmacyAndConsumerHealthSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_WeightedAverageRemainingLeaseTermAbstract" abstract="true" name="WeightedAverageRemainingLeaseTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes1Point3PercentAugust2027Member" abstract="true" name="SeniorNotes1Point3PercentAugust2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates" abstract="false" name="IndividualPublicHealthInsuranceExchangesNumberOfStates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_StockOptionsAndStockAppreciationRightsMember" abstract="true" name="StockOptionsAndStockAppreciationRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4PointThreePercentDue2028Member" abstract="true" name="SeniorNotes4PointThreePercentDue2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased" abstract="false" name="AcceleratedShareRepurchasesNumberOfSharesRepurchased" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" abstract="true" name="DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ThailandBusinessMember" abstract="true" name="ThailandBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" abstract="false" name="MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TotalInvestmentsAxis" abstract="true" name="TotalInvestmentsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract" abstract="true" name="HealthCareAndOtherInsuranceLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" abstract="false" name="LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_RetailLongTermCareSegmentMember" abstract="true" name="RetailLongTermCareSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes6.625DueJune2036Member" abstract="true" name="SeniorNotes6.625DueJune2036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_InvestmentIncomeExcludingCapitalGainsOrLosses" abstract="false" name="InvestmentIncomeExcludingCapitalGainsOrLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_PensionAndAnnuityInvestmentContractsInterest" abstract="false" name="PensionAndAnnuityInvestmentContractsInterest" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cvs_SeniorNotes3Point75PercentApril2030Member" abstract="true" name="SeniorNotes3Point75PercentApril2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OfficeRealEstateOptimizationCharges" abstract="false" name="OfficeRealEstateOptimizationCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes2.75DueNovember2022Member" abstract="true" name="SeniorNotes2.75DueNovember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_CitibankNAMember" abstract="true" name="CitibankNAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" abstract="true" name="MortgageLoansOnRealEstateYearOfOriginationAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract" abstract="true" name="ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_NumberOfMedicalMembers" abstract="false" name="NumberOfMedicalMembers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" abstract="false" name="MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_InternationalHealthCareRenewalRightsMember" abstract="true" name="InternationalHealthCareRenewalRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TribalEntitiesMember" abstract="true" name="TribalEntitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_HealthCareBenefitsSegmentMember" abstract="true" name="HealthCareBenefitsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TotalInvestmentsTable" abstract="true" name="TotalInvestmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_EmployeeStockOptionsAndStockAppreciationRightsMember" abstract="true" name="EmployeeStockOptionsAndStockAppreciationRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes6.125DueSeptember2039Member" abstract="true" name="SeniorNotes6.125DueSeptember2039Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember" abstract="true" name="SettlementFrameworkAndOtherOpioidRelatedClaimsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_EarningsPerShareBasicAndDilutedEPSAbstract" abstract="true" name="EarningsPerShareBasicAndDilutedEPSAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes4.875DueJuly2035Member" abstract="true" name="SeniorNotes4.875DueJuly2035Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2Point125PercentDueSeptember2031Member" abstract="true" name="SeniorNotes2Point125PercentDueSeptember2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NumeratorForEarningsPerShareCalculationAbstract" abstract="true" name="NumeratorForEarningsPerShareCalculationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure" abstract="false" name="OperatingLeaseRightOfUseAssetFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodFourMember" abstract="true" name="YearOfOriginationPeriodFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_HealthInsurerFeeTaxEffectPercent" abstract="false" name="HealthInsurerFeeTaxEffectPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cvs_SeniorNotes3.875DueJuly2025Member" abstract="true" name="SeniorNotes3.875DueJuly2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LesseeLiabilityPaymentsDueYearFive" abstract="false" name="LesseeLiabilityPaymentsDueYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LongTermCareReportingUnitMember" abstract="true" name="LongTermCareReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DeferredTaxLiabilitiesDepreciationAndAmortization" abstract="false" name="DeferredTaxLiabilitiesDepreciationAndAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes5.125DueJuly2045Member" abstract="true" name="SeniorNotes5.125DueJuly2045Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_OtherAcquiredIntangibleAssetsLineItems" abstract="true" name="OtherAcquiredIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_FederalCourtInOhioJudgmentMember" abstract="true" name="FederalCourtInOhioJudgmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.1DueMarch2025Member" abstract="true" name="SeniorNotes4.1DueMarch2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NumberofReinsuranceContractsEnteredInto" abstract="false" name="NumberofReinsuranceContractsEnteredInto" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_LegalSettlementPeriodOfPayment" abstract="false" name="LegalSettlementPeriodOfPayment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_GuarantorObligationsNumberOfLeases" abstract="false" name="GuarantorObligationsNumberOfLeases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_SeparateAccountFinancialAssetsMember" abstract="true" name="SeparateAccountFinancialAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" abstract="false" name="LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LongTermCareMember" abstract="true" name="LongTermCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.375DueAugust2024Member" abstract="true" name="SeniorNotes3.375DueAugust2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_RedOakMember" abstract="true" name="RedOakMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" abstract="false" name="MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent" abstract="false" name="DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member" abstract="true" name="ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OtherInsuranceLiabilitiesCurrent" abstract="false" name="OtherInsuranceLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_PaymentsForInsuranceBenefits" abstract="false" name="PaymentsForInsuranceBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_OtherInsuranceLiabilitiesNoncurrent" abstract="false" name="OtherInsuranceLiabilitiesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LesseeLiabilityPaymentsDueYearTwo" abstract="false" name="LesseeLiabilityPaymentsDueYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" abstract="false" name="ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" abstract="true" name="RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_NetRevenuesRetailCoPayments" abstract="false" name="NetRevenuesRetailCoPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" abstract="false" name="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_Category2To4Member" abstract="true" name="Category2To4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.5DueMay2042Member" abstract="true" name="SeniorNotes4.5DueMay2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SettlementFrameworkMember" abstract="true" name="SettlementFrameworkMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PayflexMember" abstract="true" name="PayflexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtExtinguishmentFees" abstract="false" name="DebtExtinguishmentFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LeaseLiability" abstract="false" name="LeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes3DueAugust2026Member" abstract="true" name="SeniorNotes3DueAugust2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" abstract="false" name="ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_AllOtherReinsurersMember" abstract="true" name="AllOtherReinsurersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LongtermDebtGrossAndLeaseObligation" abstract="false" name="LongtermDebtGrossAndLeaseObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale" abstract="false" name="IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_CommonAndCollectiveTrustsMember" abstract="true" name="CommonAndCollectiveTrustsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OtherAssetBackedSecuritiesMember" abstract="true" name="OtherAssetBackedSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodTwoMember" abstract="true" name="YearOfOriginationPeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.5DueNovember2024Member" abstract="true" name="SeniorNotes3.5DueNovember2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LitigationSettlementNumberOfStatesElectedToJoin" abstract="false" name="LitigationSettlementNumberOfStatesElectedToJoin" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" abstract="true" name="DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_NumberOfStoresPlannedClosure" abstract="false" name="NumberOfStoresPlannedClosure" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_InitialContractualTerm" abstract="false" name="InitialContractualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies" abstract="false" name="PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" abstract="true" name="USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" abstract="false" name="MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax" abstract="false" name="AccumulatedOtherComprehensiveIncomeLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" abstract="false" name="ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4DueDecember2023Member" abstract="true" name="SeniorNotes4DueDecember2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.3DueMarch2028Member" abstract="true" name="SeniorNotes4.3DueMarch2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TotalInvestmentsTableTextBlock" abstract="false" name="TotalInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer" abstract="false" name="FourYearsReinsuranceAgreementWithUnrelatedInsurer" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_EquitySecuritiesAndCommonAndCollectiveTrustsMember" abstract="true" name="EquitySecuritiesAndCommonAndCollectiveTrustsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeparateAccountOtherAssetBackedSecuritiesMember" abstract="true" name="SeparateAccountOtherAssetBackedSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TotalInvestmentsLineItems" abstract="true" name="TotalInvestmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_YearOfOriginationPriorToPeriodFiveMember" abstract="true" name="YearOfOriginationPriorToPeriodFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes5.05DueMarch2048Member" abstract="true" name="SeniorNotes5.05DueMarch2048Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LiabilityForUnpaidClaims" abstract="false" name="LiabilityForUnpaidClaims" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4Point25PercentApril2050Member" abstract="true" name="SeniorNotes4Point25PercentApril2050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SharesHeldInTrustPolicyTextBlock" abstract="false" name="SharesHeldInTrustPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" abstract="false" name="ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_SeniorNotes6.75DueDecember2037Member" abstract="true" name="SeniorNotes6.75DueDecember2037Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TransferOfSharesToTreasuryStockValue" abstract="false" name="TransferOfSharesToTreasuryStockValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtAndEquitySecuritiesAvailableForSaleMember" abstract="true" name="DebtAndEquitySecuritiesAvailableForSaleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DenominatorForEarningsPerShareCalculationAbstract" abstract="true" name="DenominatorForEarningsPerShareCalculationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" abstract="false" name="AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_HartfordLifeAndAccidentInsuranceCompanyMember" abstract="true" name="HartfordLifeAndAccidentInsuranceCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale" abstract="false" name="OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes2.625DueAugust2024Member" abstract="true" name="SeniorNotes2.625DueAugust2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2.875DueJune2026Member" abstract="true" name="SeniorNotes2.875DueJune2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes5.3DueDecember2043Member" abstract="true" name="SeniorNotes5.3DueDecember2043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_AetnaInc2010StockIncentivePlanMember" abstract="true" name="AetnaInc2010StockIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LeasesWeightedAverageDiscountRateAbstract" abstract="true" name="LeasesWeightedAverageDiscountRateAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_PaymentsForAcceleratedShareRepurchasesAmount" abstract="false" name="PaymentsForAcceleratedShareRepurchasesAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TreasuryStockSharesHeldinTrust" abstract="false" name="TreasuryStockSharesHeldinTrust" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember" abstract="true" name="FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" abstract="false" name="AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cvs_CoventryHealthCareWorkersCompensationBusinessMember" abstract="true" name="CoventryHealthCareWorkersCompensationBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" abstract="false" name="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes43Due2028Member" abstract="true" name="SeniorNotes43Due2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_A2021RepurchaseProgramMember" abstract="true" name="A2021RepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock" abstract="false" name="VendorAllowancesAndPurchaseDiscountsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates" abstract="false" name="IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_ValueOfBusinessAcquiredMember" abstract="true" name="ValueOfBusinessAcquiredMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LesseeLeaseTableTextBlock" abstract="false" name="LesseeLeaseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodFiveMember" abstract="true" name="YearOfOriginationPeriodFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" abstract="false" name="MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansMember" abstract="true" name="MortgageLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" abstract="false" name="InvestmentContractsWithFixedMaturityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SignifyHealthIncMember" abstract="true" name="SignifyHealthIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OutstandingSeniorNotesMember" abstract="true" name="OutstandingSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LesseeLiabilityUndiscountedExcessAmount" abstract="false" name="LesseeLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_FinanceLeaseRightOfUseAssetNet" abstract="false" name="FinanceLeaseRightOfUseAssetNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes1Point875PercentFebruary2031Member" abstract="true" name="SeniorNotes1Point875PercentFebruary2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodOneMember" abstract="true" name="YearOfOriginationPeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_NumberOfWalkInMedicalClinics" abstract="false" name="NumberOfWalkInMedicalClinics" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod" abstract="false" name="NumberOfStoresAnnualPlannedClosuresForClosurePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale" abstract="false" name="OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SupportingRemainingProductsMember" abstract="true" name="SupportingRemainingProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange" abstract="false" name="LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_PolicyholderAccountBalanceDepositsReceived" abstract="false" name="PolicyholderAccountBalanceDepositsReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_HealthInsurerFee" abstract="false" name="HealthInsurerFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NumberOfPeopleServed" abstract="false" name="NumberOfPeopleServed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" abstract="false" name="TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LesseeOperatingAndFinanceLeasesRenewalTerm" abstract="false" name="LesseeOperatingAndFinanceLeasesRenewalTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_OtherAcquiredIntangibleAssetsTable" abstract="true" name="OtherAcquiredIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_PharmacyRebatePeriod" abstract="false" name="PharmacyRebatePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_LesseeLiabilityPaymentsDueYearFour" abstract="false" name="LesseeLiabilityPaymentsDueYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" abstract="true" name="DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_BackUpCreditFacilitiesMember" abstract="true" name="BackUpCreditFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PremiumsMember" abstract="true" name="PremiumsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_FrontStoreRevenueMember" abstract="true" name="FrontStoreRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ProceedsFromVariableInterestEntity" abstract="false" name="ProceedsFromVariableInterestEntity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_CVSHealth2017IncentiveCompensationPlanMember" abstract="true" name="CVSHealth2017IncentiveCompensationPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2.8DueJune2023Member" abstract="true" name="SeniorNotes2.8DueJune2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes5DueDecember2024Member" abstract="true" name="SeniorNotes5DueDecember2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OakStreetHealthIncMember" abstract="true" name="OakStreetHealthIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_RevolvingCreditFacilityExpiringMay162025Member" abstract="true" name="RevolvingCreditFacilityExpiringMay162025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_HeathSavingsAccountBalance" abstract="false" name="HeathSavingsAccountBalance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_VendorandManufacturerReceivables" abstract="false" name="VendorandManufacturerReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" abstract="false" name="AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cvs_LesseeLiabilityPaymentsYearOne" abstract="false" name="LesseeLiabilityPaymentsYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LitigationSettlementNumberOfStatesSubjectToEarlierSettlements" abstract="false" name="LitigationSettlementNumberOfStatesSubjectToEarlierSettlements" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_OtherLongTermInsuranceLiabilitiesMember" abstract="true" name="OtherLongTermInsuranceLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_RevolvingCreditFacilityExpiringMay112026Member" abstract="true" name="RevolvingCreditFacilityExpiringMay112026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale" abstract="false" name="PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_Category7Member" abstract="true" name="Category7Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_VariableInterestEntityAmendedContractExtensionTerm" abstract="false" name="VariableInterestEntityAmendedContractExtensionTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_StateOfFloridaSettlementMember" abstract="true" name="StateOfFloridaSettlementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" abstract="false" name="FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_InsurancePremiumDeficiencyReservePolicyTextBlock" abstract="false" name="InsurancePremiumDeficiencyReservePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts" abstract="false" name="ContractualObligationsToMaintainLevelsOfSeparateAccounts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ActivityInMortgageLoanPortfolioTableTextBlock" abstract="false" name="ActivityInMortgageLoanPortfolioTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_SeniorNotes3Point625PercentApril2027Member" abstract="true" name="SeniorNotes3Point625PercentApril2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.78DueMarch2038Member" abstract="true" name="SeniorNotes4.78DueMarch2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" abstract="false" name="TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember" abstract="true" name="FixturesEquipmentAndInternallyDevelopedSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.5DueJuly2022Member" abstract="true" name="SeniorNotes3.5DueJuly2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_RevolvingCreditFacilityExpiringMay162027Member" abstract="true" name="RevolvingCreditFacilityExpiringMay162027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract" abstract="true" name="LesseeLeasesLiabilitiesPaymentsDueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes1Point75PercentAugust2030Member" abstract="true" name="SeniorNotes1Point75PercentAugust2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax" abstract="false" name="LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LincolnLifeAnnuityCompanyOfNewYorkMember" abstract="true" name="LincolnLifeAnnuityCompanyOfNewYorkMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4Point125PercentApril2040Member" abstract="true" name="SeniorNotes4Point125PercentApril2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" abstract="true" name="FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" abstract="false" name="StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale" abstract="false" name="LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_InsuranceAndHMOMember" abstract="true" name="InsuranceAndHMOMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_Category1Member" abstract="true" name="Category1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.25DueAugust2029Member" abstract="true" name="SeniorNotes3.25DueAugust2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" abstract="false" name="MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_HealthServicesSegmentMember" abstract="true" name="HealthServicesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ChangeInContractWithCustomerLiabilityRollForward" abstract="true" name="ChangeInContractWithCustomerLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>5
<FILENAME>cvs-20230525_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:a470d627-05b8-4106-b3ee-d69f01519b0f,g:7f491b32-9056-4172-9edc-e6fc2e3bdea2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="cvs-20230525.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d6c46050-7659-4576-bfa0-83ce3d8145f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7149725f-7f80-4cee-90b6-2c1130059543" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d6c46050-7659-4576-bfa0-83ce3d8145f0" xlink:to="loc_us-gaap_OperatingIncomeLoss_7149725f-7f80-4cee-90b6-2c1130059543" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_92f0073a-a1f9-47f4-be65-78f07b00213e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d6c46050-7659-4576-bfa0-83ce3d8145f0" xlink:to="loc_us-gaap_InterestExpense_92f0073a-a1f9-47f4-be65-78f07b00213e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7d70e8ef-a364-46dc-95b0-e61553c7380e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d6c46050-7659-4576-bfa0-83ce3d8145f0" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7d70e8ef-a364-46dc-95b0-e61553c7380e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_14766f7d-121c-496a-aebc-616bfa0feba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d6c46050-7659-4576-bfa0-83ce3d8145f0" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_14766f7d-121c-496a-aebc-616bfa0feba3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ea323331-dbd4-4c62-8267-0a60f34d35d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_d446b6f7-d063-4344-a075-cad522e23d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_ea323331-dbd4-4c62-8267-0a60f34d35d0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_d446b6f7-d063-4344-a075-cad522e23d5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_14c7edc1-4e8f-45fc-9e67-dcec6b348db8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_ea323331-dbd4-4c62-8267-0a60f34d35d0" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_14c7edc1-4e8f-45fc-9e67-dcec6b348db8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_29de198c-137f-4104-90d1-0a789ed6b0ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_7c86fc8c-e71b-4e74-965c-2b3751684c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_29de198c-137f-4104-90d1-0a789ed6b0ab" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_7c86fc8c-e71b-4e74-965c-2b3751684c6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_33b46052-a1f2-4784-8d27-6eaa79267df9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_29de198c-137f-4104-90d1-0a789ed6b0ab" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_33b46052-a1f2-4784-8d27-6eaa79267df9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_7d8bfbd9-9d2e-4579-ba3f-6e3b0bd3e93e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_29de198c-137f-4104-90d1-0a789ed6b0ab" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_7d8bfbd9-9d2e-4579-ba3f-6e3b0bd3e93e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_67eaeb02-789a-4afa-aea5-280989b7fc6a" xlink:href="cvs-20230525.xsd#cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_29de198c-137f-4104-90d1-0a789ed6b0ab" xlink:to="loc_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_67eaeb02-789a-4afa-aea5-280989b7fc6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_8d4b689c-ca31-4262-b4fa-4c339537743b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_29de198c-137f-4104-90d1-0a789ed6b0ab" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_8d4b689c-ca31-4262-b4fa-4c339537743b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges_72ed1cc0-2481-4c0f-9cb9-4faf910d63e5" xlink:href="cvs-20230525.xsd#cvs_StoreImpairmentCharges"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_29de198c-137f-4104-90d1-0a789ed6b0ab" xlink:to="loc_cvs_StoreImpairmentCharges_72ed1cc0-2481-4c0f-9cb9-4faf910d63e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_5294af9c-3141-4bd5-b8b2-bf0a1912bc89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_29de198c-137f-4104-90d1-0a789ed6b0ab" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_5294af9c-3141-4bd5-b8b2-bf0a1912bc89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7215d88d-2452-46a4-b93a-4383f1993d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_84c31d5f-1bc2-4321-aa8d-6157717a63f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7215d88d-2452-46a4-b93a-4383f1993d92" xlink:to="loc_us-gaap_ProfitLoss_84c31d5f-1bc2-4321-aa8d-6157717a63f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_844551c6-e4d0-4cf5-8107-aca4116f9a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7215d88d-2452-46a4-b93a-4383f1993d92" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_844551c6-e4d0-4cf5-8107-aca4116f9a7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4873d9d2-6612-4987-879e-db6bdf7b66d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_7ea5759e-78dd-4994-a810-74cb08b89795" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_4873d9d2-6612-4987-879e-db6bdf7b66d4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_7ea5759e-78dd-4994-a810-74cb08b89795" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_bea41971-2424-4338-8ddd-1781a5a08bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_4873d9d2-6612-4987-879e-db6bdf7b66d4" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_bea41971-2424-4338-8ddd-1781a5a08bc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_43dd1eb3-3481-4b8a-9c11-fcf4766ede45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_288532b3-d9e3-4681-8936-067447466cee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_43dd1eb3-3481-4b8a-9c11-fcf4766ede45" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_288532b3-d9e3-4681-8936-067447466cee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b3e20c5f-1a38-4b82-9234-cdea817496df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_43dd1eb3-3481-4b8a-9c11-fcf4766ede45" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b3e20c5f-1a38-4b82-9234-cdea817496df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f448b324-1e44-4d4d-a387-30f9bc2c9dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_b09b3b3f-a237-43c9-9649-a7560b5b7181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_f448b324-1e44-4d4d-a387-30f9bc2c9dfc" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_b09b3b3f-a237-43c9-9649-a7560b5b7181" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_5ff1b361-1786-47be-8ace-5628e0460a38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_f448b324-1e44-4d4d-a387-30f9bc2c9dfc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_5ff1b361-1786-47be-8ace-5628e0460a38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_97a5bf64-43ed-4521-aad6-33269ad72f07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_11e6b60f-82d7-4b22-9a2b-e8bed6381866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_97a5bf64-43ed-4521-aad6-33269ad72f07" xlink:to="loc_us-gaap_CostsAndExpenses_11e6b60f-82d7-4b22-9a2b-e8bed6381866" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_c354a782-6cf4-41f0-b5d6-6eb853014a09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_97a5bf64-43ed-4521-aad6-33269ad72f07" xlink:to="loc_us-gaap_Revenues_c354a782-6cf4-41f0-b5d6-6eb853014a09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_76cc5087-7ab5-4765-b2ac-c3e88a5ef96b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_104a0337-247c-4caf-9bff-5d16fb255f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_76cc5087-7ab5-4765-b2ac-c3e88a5ef96b" xlink:to="loc_us-gaap_NetInvestmentIncome_104a0337-247c-4caf-9bff-5d16fb255f9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_ba000e4c-8c3b-4d39-9e4b-dc118d70e624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_76cc5087-7ab5-4765-b2ac-c3e88a5ef96b" xlink:to="loc_us-gaap_PremiumsEarnedNet_ba000e4c-8c3b-4d39-9e4b-dc118d70e624" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_603bf2b9-674f-4440-8c9e-75d41a325623" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_76cc5087-7ab5-4765-b2ac-c3e88a5ef96b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_603bf2b9-674f-4440-8c9e-75d41a325623" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="cvs-20230525.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_178727eb-c5cf-4ed4-a114-33f0af3dc0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_303debe0-e001-4a04-9d1d-932e5027b3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_178727eb-c5cf-4ed4-a114-33f0af3dc0b1" xlink:to="loc_us-gaap_ProfitLoss_303debe0-e001-4a04-9d1d-932e5027b3d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d54d903d-e132-4dde-8b88-2fa3c8e78350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_178727eb-c5cf-4ed4-a114-33f0af3dc0b1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d54d903d-e132-4dde-8b88-2fa3c8e78350" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_add94021-8dbe-4f58-b07d-e4e8ef7d6ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_5bd04472-6b78-471c-80ab-b4bc6682bffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_add94021-8dbe-4f58-b07d-e4e8ef7d6ddf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_5bd04472-6b78-471c-80ab-b4bc6682bffc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_122e0a16-5617-448a-9849-2ea3185dad56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_add94021-8dbe-4f58-b07d-e4e8ef7d6ddf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_122e0a16-5617-448a-9849-2ea3185dad56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax_bcb2b7e7-8bfe-4765-9048-d40d557dc560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_add94021-8dbe-4f58-b07d-e4e8ef7d6ddf" xlink:to="loc_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax_bcb2b7e7-8bfe-4765-9048-d40d557dc560" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_bcd8211d-4e14-49f1-b4f8-05eb747bf088" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_add94021-8dbe-4f58-b07d-e4e8ef7d6ddf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_bcd8211d-4e14-49f1-b4f8-05eb747bf088" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_eb133b3c-92ea-42d0-9b9a-c4035bbf0486" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_add94021-8dbe-4f58-b07d-e4e8ef7d6ddf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_eb133b3c-92ea-42d0-9b9a-c4035bbf0486" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_fb7dff5e-4017-4ce9-a5ef-e11a635bcdc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8ddb15db-1af9-4d2c-aa77-d47cdc9cf55e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_fb7dff5e-4017-4ce9-a5ef-e11a635bcdc2" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8ddb15db-1af9-4d2c-aa77-d47cdc9cf55e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_78e03104-2172-45f1-b15c-79ada61ab6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_fb7dff5e-4017-4ce9-a5ef-e11a635bcdc2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_78e03104-2172-45f1-b15c-79ada61ab6a8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cvs-20230525.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_399485f5-c528-478c-b8d9-c5a2844970ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_5f3ab58e-c3b4-4a60-a9ca-e80ffb2d1b17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_399485f5-c528-478c-b8d9-c5a2844970ca" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_5f3ab58e-c3b4-4a60-a9ca-e80ffb2d1b17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_3dcc5e66-765f-424b-b013-00f4c58c99db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_399485f5-c528-478c-b8d9-c5a2844970ca" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_3dcc5e66-765f-424b-b013-00f4c58c99db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_fdce9ad5-908b-4f6d-b167-9432a88f611b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_399485f5-c528-478c-b8d9-c5a2844970ca" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_fdce9ad5-908b-4f6d-b167-9432a88f611b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_9482f510-fc37-4c88-a4ea-d8e10f3f6619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_399485f5-c528-478c-b8d9-c5a2844970ca" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_9482f510-fc37-4c88-a4ea-d8e10f3f6619" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e4209202-5eb8-4a80-a45d-562995ead589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_399485f5-c528-478c-b8d9-c5a2844970ca" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e4209202-5eb8-4a80-a45d-562995ead589" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_01d401ff-45b0-4456-bad9-b0b2e9d994bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_399485f5-c528-478c-b8d9-c5a2844970ca" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_01d401ff-45b0-4456-bad9-b0b2e9d994bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent_2513f39f-1268-4d1a-8ea6-6443120640fb" xlink:href="cvs-20230525.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_399485f5-c528-478c-b8d9-c5a2844970ca" xlink:to="loc_cvs_OtherInsuranceLiabilitiesCurrent_2513f39f-1268-4d1a-8ea6-6443120640fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsAndDiscountsPayableCurrent_02ad3d3a-376b-400a-b5e0-a7c195e34f18" xlink:href="cvs-20230525.xsd#cvs_PharmacyClaimsAndDiscountsPayableCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_399485f5-c528-478c-b8d9-c5a2844970ca" xlink:to="loc_cvs_PharmacyClaimsAndDiscountsPayableCurrent_02ad3d3a-376b-400a-b5e0-a7c195e34f18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds_ceedf945-e9ab-4bbc-9115-a2b5754aab3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_399485f5-c528-478c-b8d9-c5a2844970ca" xlink:to="loc_us-gaap_OtherPolicyholderFunds_ceedf945-e9ab-4bbc-9115-a2b5754aab3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4a087a0e-4e0d-48c0-b9de-259b2fb1360c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c879746f-88a1-4acf-8971-9baf0ba75997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4a087a0e-4e0d-48c0-b9de-259b2fb1360c" xlink:to="loc_us-gaap_StockholdersEquity_c879746f-88a1-4acf-8971-9baf0ba75997" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_eb006ec6-ac59-42cb-bec5-41f446ef56fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4a087a0e-4e0d-48c0-b9de-259b2fb1360c" xlink:to="loc_us-gaap_MinorityInterest_eb006ec6-ac59-42cb-bec5-41f446ef56fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d3418e01-1ef2-4438-b06a-90548996d595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_de3bbddb-2ea8-4abd-8322-8404426c2a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d3418e01-1ef2-4438-b06a-90548996d595" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_de3bbddb-2ea8-4abd-8322-8404426c2a5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e3145f4a-3b1e-4c3f-a060-591dcab6febd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d3418e01-1ef2-4438-b06a-90548996d595" xlink:to="loc_us-gaap_Goodwill_e3145f4a-3b1e-4c3f-a060-591dcab6febd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_10ef333f-ef71-4fad-b31c-1238d63ffed3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d3418e01-1ef2-4438-b06a-90548996d595" xlink:to="loc_us-gaap_SeparateAccountAssets_10ef333f-ef71-4fad-b31c-1238d63ffed3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e9026d7c-98c8-4ab0-bbd0-e4c27e7e1181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d3418e01-1ef2-4438-b06a-90548996d595" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e9026d7c-98c8-4ab0-bbd0-e4c27e7e1181" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_11970506-7452-401f-82a1-a2946c6f66a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d3418e01-1ef2-4438-b06a-90548996d595" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_11970506-7452-401f-82a1-a2946c6f66a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_777ff076-b79f-49fb-954f-98cdf77ac970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d3418e01-1ef2-4438-b06a-90548996d595" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_777ff076-b79f-49fb-954f-98cdf77ac970" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_cb530e15-4cc9-4fb8-9a38-ee9113470878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d3418e01-1ef2-4438-b06a-90548996d595" xlink:to="loc_us-gaap_LongTermInvestments_cb530e15-4cc9-4fb8-9a38-ee9113470878" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ec634889-f6c6-4afe-9270-9d447c74fb77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d3418e01-1ef2-4438-b06a-90548996d595" xlink:to="loc_us-gaap_AssetsCurrent_ec634889-f6c6-4afe-9270-9d447c74fb77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e9edf4ee-0397-4c4a-92ef-5943b60f4191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1cf2820a-bc34-4584-b5db-118188024827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e9edf4ee-0397-4c4a-92ef-5943b60f4191" xlink:to="loc_us-gaap_Liabilities_1cf2820a-bc34-4584-b5db-118188024827" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_a329c441-77c6-465f-903d-61332c12f81e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e9edf4ee-0397-4c4a-92ef-5943b60f4191" xlink:to="loc_us-gaap_CommitmentsAndContingencies_a329c441-77c6-465f-903d-61332c12f81e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8345a390-2da4-40bb-8e4a-36a205d42b07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e9edf4ee-0397-4c4a-92ef-5943b60f4191" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8345a390-2da4-40bb-8e4a-36a205d42b07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ab6c6a04-630f-4ef0-8f5c-a1c994d2f64f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_52b481bf-94f1-4355-b08e-1723217ad100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ab6c6a04-630f-4ef0-8f5c-a1c994d2f64f" xlink:to="loc_us-gaap_OtherAssetsCurrent_52b481bf-94f1-4355-b08e-1723217ad100" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_9311e63a-ea5f-4c43-a40a-8964f5a2422f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ab6c6a04-630f-4ef0-8f5c-a1c994d2f64f" xlink:to="loc_us-gaap_InventoryNet_9311e63a-ea5f-4c43-a40a-8964f5a2422f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_4b99e56d-4858-484f-84ee-f5c241c33d02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ab6c6a04-630f-4ef0-8f5c-a1c994d2f64f" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_4b99e56d-4858-484f-84ee-f5c241c33d02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1386a9a1-ee79-4ece-8cc2-f1708b282d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ab6c6a04-630f-4ef0-8f5c-a1c994d2f64f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1386a9a1-ee79-4ece-8cc2-f1708b282d3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_9877ba53-556b-49e8-8ba6-7b5cc76f2f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ab6c6a04-630f-4ef0-8f5c-a1c994d2f64f" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_9877ba53-556b-49e8-8ba6-7b5cc76f2f5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_253f3335-e18c-4be2-b13a-04fe956d361c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ab6c6a04-630f-4ef0-8f5c-a1c994d2f64f" xlink:to="loc_us-gaap_ShortTermInvestments_253f3335-e18c-4be2-b13a-04fe956d361c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cd9f3117-b5e3-477f-8af3-d5e50ea834a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_bd4a9a6f-d49a-421f-9c13-9b273c616d06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cd9f3117-b5e3-477f-8af3-d5e50ea834a7" xlink:to="loc_us-gaap_PreferredStockValue_bd4a9a6f-d49a-421f-9c13-9b273c616d06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_8add0efc-9af5-4d09-a606-5a66c8acfcf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cd9f3117-b5e3-477f-8af3-d5e50ea834a7" xlink:to="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_8add0efc-9af5-4d09-a606-5a66c8acfcf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_d9f52a21-2936-4374-be58-aa71892aeb25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cd9f3117-b5e3-477f-8af3-d5e50ea834a7" xlink:to="loc_us-gaap_TreasuryStockValue_d9f52a21-2936-4374-be58-aa71892aeb25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6e006111-fd53-464e-a19e-c5a8f6b4e248" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cd9f3117-b5e3-477f-8af3-d5e50ea834a7" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6e006111-fd53-464e-a19e-c5a8f6b4e248" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f5544159-d1bf-441c-a5ad-da9d664b0863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cd9f3117-b5e3-477f-8af3-d5e50ea834a7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f5544159-d1bf-441c-a5ad-da9d664b0863" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0aa68a4a-341b-494a-9b75-b89f17904373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1d7c0f77-82f2-4340-b917-10a7139438fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0aa68a4a-341b-494a-9b75-b89f17904373" xlink:to="loc_us-gaap_LiabilitiesCurrent_1d7c0f77-82f2-4340-b917-10a7139438fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e8f07835-f135-4dab-a061-5a5172278f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0aa68a4a-341b-494a-9b75-b89f17904373" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e8f07835-f135-4dab-a061-5a5172278f0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d0ec96a1-2c68-4a9e-b9b3-599e4dccd5c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0aa68a4a-341b-494a-9b75-b89f17904373" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d0ec96a1-2c68-4a9e-b9b3-599e4dccd5c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_7353e52f-d23e-4b34-9ffa-125ce2ad14a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0aa68a4a-341b-494a-9b75-b89f17904373" xlink:to="loc_us-gaap_SeparateAccountsLiability_7353e52f-d23e-4b34-9ffa-125ce2ad14a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_c69cc1b7-6692-4e63-929b-ad68e644f31d" xlink:href="cvs-20230525.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0aa68a4a-341b-494a-9b75-b89f17904373" xlink:to="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_c69cc1b7-6692-4e63-929b-ad68e644f31d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b39c4edb-db16-41a5-bfe8-c103e3c1df6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0aa68a4a-341b-494a-9b75-b89f17904373" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b39c4edb-db16-41a5-bfe8-c103e3c1df6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6eb22186-e463-4ff2-baa9-11261731eff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0aa68a4a-341b-494a-9b75-b89f17904373" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6eb22186-e463-4ff2-baa9-11261731eff1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cvs-20230525.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1cf4c0ab-ab71-4c3a-bf3b-e63a102b9694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_b8bac66f-54db-4948-85c6-117edb6ff1c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1cf4c0ab-ab71-4c3a-bf3b-e63a102b9694" xlink:to="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_b8bac66f-54db-4948-85c6-117edb6ff1c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_8e0c3a02-e8e1-4412-ac0b-838e734685f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1cf4c0ab-ab71-4c3a-bf3b-e63a102b9694" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_8e0c3a02-e8e1-4412-ac0b-838e734685f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers_554790b9-2807-48f7-a095-5db1710a97e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1cf4c0ab-ab71-4c3a-bf3b-e63a102b9694" xlink:to="loc_us-gaap_ProceedsFromCustomers_554790b9-2807-48f7-a095-5db1710a97e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForInsuranceBenefits_847a6775-03e9-430a-9068-1fcaadaa56e5" xlink:href="cvs-20230525.xsd#cvs_PaymentsForInsuranceBenefits"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1cf4c0ab-ab71-4c3a-bf3b-e63a102b9694" xlink:to="loc_cvs_PaymentsForInsuranceBenefits_847a6775-03e9-430a-9068-1fcaadaa56e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees_92c96ea3-c112-4c27-b9a8-438ce14b5af7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1cf4c0ab-ab71-4c3a-bf3b-e63a102b9694" xlink:to="loc_us-gaap_PaymentsToSuppliersAndEmployees_92c96ea3-c112-4c27-b9a8-438ce14b5af7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_6469930b-3b05-4ce9-acf6-b7e62a4abbb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1cf4c0ab-ab71-4c3a-bf3b-e63a102b9694" xlink:to="loc_us-gaap_InterestPaidNet_6469930b-3b05-4ce9-acf6-b7e62a4abbb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies_0d8ab2b3-ed42-486c-a9a2-676e6389b485" xlink:href="cvs-20230525.xsd#cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1cf4c0ab-ab71-4c3a-bf3b-e63a102b9694" xlink:to="loc_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies_0d8ab2b3-ed42-486c-a9a2-676e6389b485" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c6ba6ac1-1b5b-4459-baf8-a3ac03b4c53a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0b77cdce-393c-48e3-accb-65db1302d096" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c6ba6ac1-1b5b-4459-baf8-a3ac03b4c53a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0b77cdce-393c-48e3-accb-65db1302d096" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e1b771a2-d6a2-4b76-9cc9-46a2bd61862c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c6ba6ac1-1b5b-4459-baf8-a3ac03b4c53a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e1b771a2-d6a2-4b76-9cc9-46a2bd61862c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4f82535b-d27d-44c9-87d9-238bf6754458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c6ba6ac1-1b5b-4459-baf8-a3ac03b4c53a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4f82535b-d27d-44c9-87d9-238bf6754458" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_566e5d9b-d23f-417e-8011-acf3c81dc2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_58b3e508-6e37-4585-86d6-dfeeb5778979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_566e5d9b-d23f-417e-8011-acf3c81dc2f0" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_58b3e508-6e37-4585-86d6-dfeeb5778979" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_43841c6f-231a-44c9-93c1-4d94bc289b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_566e5d9b-d23f-417e-8011-acf3c81dc2f0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_43841c6f-231a-44c9-93c1-4d94bc289b0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_be3d2b1a-5839-4dd9-966d-8c20b9ae9ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_566e5d9b-d23f-417e-8011-acf3c81dc2f0" xlink:to="loc_us-gaap_PaymentsOfDividends_be3d2b1a-5839-4dd9-966d-8c20b9ae9ea7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_caf00920-e008-43ef-9033-e2b4becba105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_566e5d9b-d23f-417e-8011-acf3c81dc2f0" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_caf00920-e008-43ef-9033-e2b4becba105" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_4c60b770-b5e1-42b0-8fab-17654374a009" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_566e5d9b-d23f-417e-8011-acf3c81dc2f0" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_4c60b770-b5e1-42b0-8fab-17654374a009" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_44c34c6e-fc92-44b3-9331-13749fb2dbd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_566e5d9b-d23f-417e-8011-acf3c81dc2f0" xlink:to="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_44c34c6e-fc92-44b3-9331-13749fb2dbd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_bfabbccb-5b68-4d78-8327-fe19652e9424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_566e5d9b-d23f-417e-8011-acf3c81dc2f0" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_bfabbccb-5b68-4d78-8327-fe19652e9424" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1ab22448-e0c7-428f-9893-b18cf834c5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_566e5d9b-d23f-417e-8011-acf3c81dc2f0" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1ab22448-e0c7-428f-9893-b18cf834c5f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_646dd165-51c7-49d9-b2ce-eed8eb143c56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_68502a98-f8b3-4d5c-8a30-17c4f985375a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_646dd165-51c7-49d9-b2ce-eed8eb143c56" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_68502a98-f8b3-4d5c-8a30-17c4f985375a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_ff0c9d00-7736-4432-aaf3-e823fc05de2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_646dd165-51c7-49d9-b2ce-eed8eb143c56" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_ff0c9d00-7736-4432-aaf3-e823fc05de2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_403aca91-3464-47f8-bf56-98ddbb60ced4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_646dd165-51c7-49d9-b2ce-eed8eb143c56" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_403aca91-3464-47f8-bf56-98ddbb60ced4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_6f216a5a-9d72-405a-9162-498f20510b71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_646dd165-51c7-49d9-b2ce-eed8eb143c56" xlink:to="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_6f216a5a-9d72-405a-9162-498f20510b71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5d14670a-63af-4c34-8838-66b8ebf240b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_646dd165-51c7-49d9-b2ce-eed8eb143c56" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5d14670a-63af-4c34-8838-66b8ebf240b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_488e76fd-345c-4a6e-8b27-503e16cefad0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_646dd165-51c7-49d9-b2ce-eed8eb143c56" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_488e76fd-345c-4a6e-8b27-503e16cefad0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_9b07232d-1eed-40de-8d63-7f7959e4fbb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_646dd165-51c7-49d9-b2ce-eed8eb143c56" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_9b07232d-1eed-40de-8d63-7f7959e4fbb5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1" xlink:type="simple" xlink:href="cvs-20230525.xsd#ConsolidatedStatementsofCashFlows_1"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4e45edc0-75eb-4f9e-a7ac-b4166776af7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_13bc2e0b-79cf-49cb-ae64-4df881816a52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4e45edc0-75eb-4f9e-a7ac-b4166776af7a" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_13bc2e0b-79cf-49cb-ae64-4df881816a52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_691eb004-c358-41aa-a7d7-e1f90d388f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4e45edc0-75eb-4f9e-a7ac-b4166776af7a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_691eb004-c358-41aa-a7d7-e1f90d388f0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_ad1bb064-6ace-4360-8222-193151befbb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4e45edc0-75eb-4f9e-a7ac-b4166776af7a" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_ad1bb064-6ace-4360-8222-193151befbb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ceecaf3a-cfd0-4cd0-b6fd-fd7a9da10eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4e45edc0-75eb-4f9e-a7ac-b4166776af7a" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ceecaf3a-cfd0-4cd0-b6fd-fd7a9da10eb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_2b9e70b4-b303-4541-a918-f6df7826de0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4e45edc0-75eb-4f9e-a7ac-b4166776af7a" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_2b9e70b4-b303-4541-a918-f6df7826de0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e2fbea68-bb8d-485f-b2f1-85a881297c00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4e45edc0-75eb-4f9e-a7ac-b4166776af7a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e2fbea68-bb8d-485f-b2f1-85a881297c00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_4eb87579-d75d-46de-b6ee-cc4401b389a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4e45edc0-75eb-4f9e-a7ac-b4166776af7a" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_4eb87579-d75d-46de-b6ee-cc4401b389a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_e43f0a28-5b52-429e-b238-4b28ff65dd3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4e45edc0-75eb-4f9e-a7ac-b4166776af7a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_e43f0a28-5b52-429e-b238-4b28ff65dd3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a395a168-e6dc-46a3-8103-9702766b9325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4e45edc0-75eb-4f9e-a7ac-b4166776af7a" xlink:to="loc_us-gaap_ProfitLoss_a395a168-e6dc-46a3-8103-9702766b9325" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_47c04d0d-d94e-431e-b79b-c70b081c9937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4e45edc0-75eb-4f9e-a7ac-b4166776af7a" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_47c04d0d-d94e-431e-b79b-c70b081c9937" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges_a87bcd02-516d-461f-b7fa-38f3f458c2d0" xlink:href="cvs-20230525.xsd#cvs_StoreImpairmentCharges"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4e45edc0-75eb-4f9e-a7ac-b4166776af7a" xlink:to="loc_cvs_StoreImpairmentCharges_a87bcd02-516d-461f-b7fa-38f3f458c2d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_1de0f6fe-7f2c-4ea0-b8d6-8cc10bc8949b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4e45edc0-75eb-4f9e-a7ac-b4166776af7a" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_1de0f6fe-7f2c-4ea0-b8d6-8cc10bc8949b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_4fad6fa6-0adb-4b8d-911a-9570f9df4f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4e45edc0-75eb-4f9e-a7ac-b4166776af7a" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_4fad6fa6-0adb-4b8d-911a-9570f9df4f6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_2f12e632-7636-49c8-8967-014277bfd4e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4e45edc0-75eb-4f9e-a7ac-b4166776af7a" xlink:to="loc_us-gaap_ShareBasedCompensation_2f12e632-7636-49c8-8967-014277bfd4e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1fe7d368-f68a-4c30-91b5-cb7b0530fd13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4e45edc0-75eb-4f9e-a7ac-b4166776af7a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1fe7d368-f68a-4c30-91b5-cb7b0530fd13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_6ff75ba8-6761-46cf-be46-bbf9b336dd9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4e45edc0-75eb-4f9e-a7ac-b4166776af7a" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_6ff75ba8-6761-46cf-be46-bbf9b336dd9e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_71b28691-df9f-4f6f-9afb-093409f2bf0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_84936911-c5a2-4706-a99e-241e9ec91ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_71b28691-df9f-4f6f-9afb-093409f2bf0c" xlink:to="loc_us-gaap_RestrictedCashCurrent_84936911-c5a2-4706-a99e-241e9ec91ce7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_5a3655ed-7afd-4dbb-8d21-d4eb376567a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_71b28691-df9f-4f6f-9afb-093409f2bf0c" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_5a3655ed-7afd-4dbb-8d21-d4eb376567a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_92dc5ee6-f3b1-4a19-b438-ab6c8b718258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_71b28691-df9f-4f6f-9afb-093409f2bf0c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_92dc5ee6-f3b1-4a19-b438-ab6c8b718258" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SignificantAccountingPoliciesAccountsReceivableDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_c838c356-9080-4044-be36-d3c51178d701" xlink:href="cvs-20230525.xsd#cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorandManufacturerReceivables_a04efe92-dc0a-4b81-a2fb-7b8711bf896f" xlink:href="cvs-20230525.xsd#cvs_VendorandManufacturerReceivables"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_c838c356-9080-4044-be36-d3c51178d701" xlink:to="loc_cvs_VendorandManufacturerReceivables_a04efe92-dc0a-4b81-a2fb-7b8711bf896f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_bf7629d8-3ecf-454b-8169-19388a60ba9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_c838c356-9080-4044-be36-d3c51178d701" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_bf7629d8-3ecf-454b-8169-19388a60ba9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_59ccc511-6bef-49be-8ab7-9b5dc705dff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_c838c356-9080-4044-be36-d3c51178d701" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_59ccc511-6bef-49be-8ab7-9b5dc705dff6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_4a6bbb24-d4ac-486a-937e-954c52b899e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_c838c356-9080-4044-be36-d3c51178d701" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_4a6bbb24-d4ac-486a-937e-954c52b899e8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SignificantAccountingPoliciesPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale_f343ed32-5c4b-48a7-a584-585adf8e1b98" xlink:href="cvs-20230525.xsd#cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c86eaac8-0cba-4891-9016-2e1e7cf06c46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale_f343ed32-5c4b-48a7-a584-585adf8e1b98" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c86eaac8-0cba-4891-9016-2e1e7cf06c46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ec7f3440-d4e1-4331-82c6-c3473ba624c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale_f343ed32-5c4b-48a7-a584-585adf8e1b98" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ec7f3440-d4e1-4331-82c6-c3473ba624c6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SignificantAccountingPoliciesDiscontinuedOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2be9f40b-e504-4fa3-a6c0-4a01dbb24a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_11d8cbe5-e8a2-42c4-97d3-2962733874f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2be9f40b-e504-4fa3-a6c0-4a01dbb24a0e" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_11d8cbe5-e8a2-42c4-97d3-2962733874f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_c7ea88f5-e95c-467e-a5dd-1cebb02b54fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2be9f40b-e504-4fa3-a6c0-4a01dbb24a0e" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_c7ea88f5-e95c-467e-a5dd-1cebb02b54fd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8067b8d1-c2c0-4ba8-9bab-57d78cc13590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_d4e7d4e7-7d7c-4741-b2ed-c6f2164687f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8067b8d1-c2c0-4ba8-9bab-57d78cc13590" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_d4e7d4e7-7d7c-4741-b2ed-c6f2164687f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_51c28bf1-ba07-4153-8997-f88584882c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8067b8d1-c2c0-4ba8-9bab-57d78cc13590" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_51c28bf1-ba07-4153-8997-f88584882c3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_36c24903-0f1d-497c-a993-91943d3084d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8067b8d1-c2c0-4ba8-9bab-57d78cc13590" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_36c24903-0f1d-497c-a993-91943d3084d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_9c16127a-33fe-4992-abbb-f894686b1597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8067b8d1-c2c0-4ba8-9bab-57d78cc13590" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_9c16127a-33fe-4992-abbb-f894686b1597" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_03eb544c-7405-472a-add4-e1b308f735ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8067b8d1-c2c0-4ba8-9bab-57d78cc13590" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_03eb544c-7405-472a-add4-e1b308f735ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fdff3b3c-19ed-41ef-a1c5-76fa35f84700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_3109e0c8-b09b-4bdc-a22a-78cd54131588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fdff3b3c-19ed-41ef-a1c5-76fa35f84700" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_3109e0c8-b09b-4bdc-a22a-78cd54131588" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_3300fb7d-3989-4aeb-91a2-fa976d6314de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fdff3b3c-19ed-41ef-a1c5-76fa35f84700" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_3300fb7d-3989-4aeb-91a2-fa976d6314de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_22bc9435-c12c-4025-9c2b-7e1d4d10156b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fdff3b3c-19ed-41ef-a1c5-76fa35f84700" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_22bc9435-c12c-4025-9c2b-7e1d4d10156b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsScheduleofTotalInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_c02c6a2f-d240-4f92-96b5-10b80a77b5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermInvestmentsIncludingAssetsHeldForSale_0fd02ffd-4af2-4b67-8346-43d9da32df16" xlink:href="cvs-20230525.xsd#cvs_LongTermInvestmentsIncludingAssetsHeldForSale"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_c02c6a2f-d240-4f92-96b5-10b80a77b5e3" xlink:to="loc_cvs_LongTermInvestmentsIncludingAssetsHeldForSale_0fd02ffd-4af2-4b67-8346-43d9da32df16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_6097807b-a0d5-4593-8c97-645b7b320f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_c02c6a2f-d240-4f92-96b5-10b80a77b5e3" xlink:to="loc_us-gaap_ShortTermInvestments_6097807b-a0d5-4593-8c97-645b7b320f1e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_8fa49082-d462-4196-a2ac-d1d93f358e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ed6b9333-5d45-4d96-b576-72c4b40d1af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_8fa49082-d462-4196-a2ac-d1d93f358e8b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ed6b9333-5d45-4d96-b576-72c4b40d1af9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_d8ae15c5-0a11-4f38-a26c-fa46d31bd58e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_8fa49082-d462-4196-a2ac-d1d93f358e8b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_d8ae15c5-0a11-4f38-a26c-fa46d31bd58e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsDebtSecuritiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_91064c04-cfaf-42c5-8dba-5e5ef80a867e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_794b2135-04df-4058-98bf-a79d067d4f51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_91064c04-cfaf-42c5-8dba-5e5ef80a867e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_794b2135-04df-4058-98bf-a79d067d4f51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d3104b76-3819-42c8-9bea-501961177c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_91064c04-cfaf-42c5-8dba-5e5ef80a867e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d3104b76-3819-42c8-9bea-501961177c9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_064d4d94-daf3-4943-9f1a-a9f4e68656bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_91064c04-cfaf-42c5-8dba-5e5ef80a867e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_064d4d94-daf3-4943-9f1a-a9f4e68656bd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_b686c459-0f83-40af-85a9-82046ad16b22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_72598e1e-7046-4e47-b2d1-1a7f62f76823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_b686c459-0f83-40af-85a9-82046ad16b22" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_72598e1e-7046-4e47-b2d1-1a7f62f76823" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_f0046c50-0412-4346-8732-13874f769409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_b686c459-0f83-40af-85a9-82046ad16b22" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_f0046c50-0412-4346-8732-13874f769409" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_6bdcf56b-5f46-4dd3-a238-63478e21667a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_b686c459-0f83-40af-85a9-82046ad16b22" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_6bdcf56b-5f46-4dd3-a238-63478e21667a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_fcc55123-cb56-4f9b-858a-4f50b492bcb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_b686c459-0f83-40af-85a9-82046ad16b22" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_fcc55123-cb56-4f9b-858a-4f50b492bcb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_a00e1582-e910-4f0f-b8ad-78b6e0f24faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_b686c459-0f83-40af-85a9-82046ad16b22" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_a00e1582-e910-4f0f-b8ad-78b6e0f24faf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1230eb03-f506-4262-a27f-40521f2379ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_5ed8587b-7837-48be-9c73-410688c9e8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1230eb03-f506-4262-a27f-40521f2379ef" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_5ed8587b-7837-48be-9c73-410688c9e8ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_6d9a93c2-b939-4713-9ed0-28fbd273509c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1230eb03-f506-4262-a27f-40521f2379ef" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_6d9a93c2-b939-4713-9ed0-28fbd273509c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_8ebf0d47-01a3-4b46-b920-ea7a58a03883" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1230eb03-f506-4262-a27f-40521f2379ef" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_8ebf0d47-01a3-4b46-b920-ea7a58a03883" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_2bcc61e6-82df-4d66-94fe-e9c21a95a5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1230eb03-f506-4262-a27f-40521f2379ef" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_2bcc61e6-82df-4d66-94fe-e9c21a95a5a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_4566bb95-213e-4207-8cc9-43890037321a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1230eb03-f506-4262-a27f-40521f2379ef" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_4566bb95-213e-4207-8cc9-43890037321a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_893c8934-f184-4aaa-a7df-e228f2621de6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_6c13855c-24bc-4be5-942d-8333910dcece" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_893c8934-f184-4aaa-a7df-e228f2621de6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_6c13855c-24bc-4be5-942d-8333910dcece" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_abfd5700-6faa-4da7-b6ae-28f278ab79cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_893c8934-f184-4aaa-a7df-e228f2621de6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_abfd5700-6faa-4da7-b6ae-28f278ab79cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_22643763-824b-4fc5-8c50-e998288d6c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_f265ebc7-256b-4c28-9aaa-83b936a778b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_22643763-824b-4fc5-8c50-e998288d6c3d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_f265ebc7-256b-4c28-9aaa-83b936a778b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_20e87a86-6170-4238-a4a0-af28f36d9eed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_22643763-824b-4fc5-8c50-e998288d6c3d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_20e87a86-6170-4238-a4a0-af28f36d9eed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_ad4a6539-dc86-4597-acef-0c9d7dee92ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0df9509b-998a-4a4d-8825-a717bdc845e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_ad4a6539-dc86-4597-acef-0c9d7dee92ab" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0df9509b-998a-4a4d-8825-a717bdc845e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_884c7b33-1367-464c-85fe-8a6df3d46b47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_ad4a6539-dc86-4597-acef-0c9d7dee92ab" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_884c7b33-1367-464c-85fe-8a6df3d46b47" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_dfa454e9-becb-4a0e-a369-71049013ce61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_b1cbaf3b-d9f3-40d9-9c3c-b2ae4935c2ea" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_dfa454e9-becb-4a0e-a369-71049013ce61" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_b1cbaf3b-d9f3-40d9-9c3c-b2ae4935c2ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_47f81cfb-a8bb-4d6e-8580-ac3fe229c015" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_dfa454e9-becb-4a0e-a369-71049013ce61" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_47f81cfb-a8bb-4d6e-8580-ac3fe229c015" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_55166a41-b024-4e84-a945-e7658d894598" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_dfa454e9-becb-4a0e-a369-71049013ce61" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_55166a41-b024-4e84-a945-e7658d894598" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_640b0d72-eb9a-488e-831a-024f8b3a6f2b" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_dfa454e9-becb-4a0e-a369-71049013ce61" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_640b0d72-eb9a-488e-831a-024f8b3a6f2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue_b3f620ad-b7d8-4cad-9935-355b0742ae47" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_dfa454e9-becb-4a0e-a369-71049013ce61" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue_b3f620ad-b7d8-4cad-9935-355b0742ae47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5895be3e-d00e-4dc7-91c6-58c90b02e5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_8832a722-5182-47b6-8ea0-bdb08a515b14" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5895be3e-d00e-4dc7-91c6-58c90b02e5fe" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_8832a722-5182-47b6-8ea0-bdb08a515b14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_3bb87338-2ee0-4333-9aa0-b3f60944b021" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5895be3e-d00e-4dc7-91c6-58c90b02e5fe" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_3bb87338-2ee0-4333-9aa0-b3f60944b021" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_8d6424bf-4493-4ea2-86c1-34b7ab9cc0dd" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5895be3e-d00e-4dc7-91c6-58c90b02e5fe" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_8d6424bf-4493-4ea2-86c1-34b7ab9cc0dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_8a85ed63-2185-47c3-beea-7de1d36c95c2" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5895be3e-d00e-4dc7-91c6-58c90b02e5fe" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_8a85ed63-2185-47c3-beea-7de1d36c95c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss_8727b963-5fcc-4e52-8c99-7daa63a0f6b2" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5895be3e-d00e-4dc7-91c6-58c90b02e5fe" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss_8727b963-5fcc-4e52-8c99-7daa63a0f6b2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsMortgageLoanPrincipalRepaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_bbd077f8-cf42-4de3-8266-0d42815a64a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_ac9d9176-e3bd-4606-b9dd-d1b0dcf889c0" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_bbd077f8-cf42-4de3-8266-0d42815a64a5" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_ac9d9176-e3bd-4606-b9dd-d1b0dcf889c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_4e8891a3-e8f2-4869-8905-451ba23bc87e" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_bbd077f8-cf42-4de3-8266-0d42815a64a5" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_4e8891a3-e8f2-4869-8905-451ba23bc87e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_3ae290b5-1ddb-4c5b-a5c5-21c7f163c823" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_bbd077f8-cf42-4de3-8266-0d42815a64a5" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_3ae290b5-1ddb-4c5b-a5c5-21c7f163c823" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_64c3820a-837e-4f2e-9bcf-89eba8652433" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_bbd077f8-cf42-4de3-8266-0d42815a64a5" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_64c3820a-837e-4f2e-9bcf-89eba8652433" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_4f8a4db1-c668-4ea0-bc88-c20f7832c844" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_bbd077f8-cf42-4de3-8266-0d42815a64a5" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_4f8a4db1-c668-4ea0-bc88-c20f7832c844" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_88e06bbb-4628-40e1-82da-f4cf24713735" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_bbd077f8-cf42-4de3-8266-0d42815a64a5" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_88e06bbb-4628-40e1-82da-f4cf24713735" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_47d1ec09-9392-4fa5-9ff3-41f7baaddf6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_ee7c2f2b-d9c2-49c0-b10a-17e4a1b05024" xlink:href="cvs-20230525.xsd#cvs_InvestmentIncomeExcludingCapitalGainsOrLosses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeNet_47d1ec09-9392-4fa5-9ff3-41f7baaddf6d" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_ee7c2f2b-d9c2-49c0-b10a-17e4a1b05024" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_2a53a662-5a9d-4cf5-9fa1-f467239f3e35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeNet_47d1ec09-9392-4fa5-9ff3-41f7baaddf6d" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_2a53a662-5a9d-4cf5-9fa1-f467239f3e35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_672b9334-a5cd-46a7-8fcb-0708009fe47e" xlink:href="cvs-20230525.xsd#cvs_InvestmentIncomeExcludingCapitalGainsOrLosses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_15f77efe-b6b4-49d1-8da8-4258475da0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_672b9334-a5cd-46a7-8fcb-0708009fe47e" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_15f77efe-b6b4-49d1-8da8-4258475da0c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_22d2f293-6daa-4c4d-b344-7b6f64873c15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_672b9334-a5cd-46a7-8fcb-0708009fe47e" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_22d2f293-6daa-4c4d-b344-7b6f64873c15" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#FairValueFairValueMeasurementsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_77e6fbb2-9b03-4709-8d22-db6877fe97dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_c08af76a-660f-4f4d-9a29-a2635d062988" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_77e6fbb2-9b03-4709-8d22-db6877fe97dd" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_c08af76a-660f-4f4d-9a29-a2635d062988" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_16cceb02-e903-4081-a047-7a2c5f51f5af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_77e6fbb2-9b03-4709-8d22-db6877fe97dd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_16cceb02-e903-4081-a047-7a2c5f51f5af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_260d55d3-1bf2-4068-a897-563350cc2530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_77e6fbb2-9b03-4709-8d22-db6877fe97dd" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_260d55d3-1bf2-4068-a897-563350cc2530" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details" xlink:type="simple" xlink:href="cvs-20230525.xsd#FairValueGrossTransfersIntoOutOfLevel3Details"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_8810bfa8-d0cb-4766-a207-a305493e9d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_d74e7690-1d79-428f-a7ab-cc896877dd7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_8810bfa8-d0cb-4766-a207-a305493e9d8a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_d74e7690-1d79-428f-a7ab-cc896877dd7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_54d8eefe-ae38-4198-bc99-51122a2179b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_8810bfa8-d0cb-4766-a207-a305493e9d8a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_54d8eefe-ae38-4198-bc99-51122a2179b4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#GoodwillandOtherIntangiblesIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_150e829e-587e-421b-ac83-d8e1c355e75b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b071f590-88c9-4cb7-a73b-96ea5e5b9bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_150e829e-587e-421b-ac83-d8e1c355e75b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b071f590-88c9-4cb7-a73b-96ea5e5b9bfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2c350f79-c693-4a6b-a0f3-ca08769f9e24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_150e829e-587e-421b-ac83-d8e1c355e75b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2c350f79-c693-4a6b-a0f3-ca08769f9e24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0c0704b0-5581-4613-9a47-42245890b240" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_fef6fa59-1624-4b78-8a2d-c43b18f0e7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0c0704b0-5581-4613-9a47-42245890b240" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_fef6fa59-1624-4b78-8a2d-c43b18f0e7c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_de31fdde-0b43-4bf4-8b3b-576e644f6cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0c0704b0-5581-4613-9a47-42245890b240" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_de31fdde-0b43-4bf4-8b3b-576e644f6cb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale_30b81de5-3005-4ffd-8b27-5063fcb0899f" xlink:href="cvs-20230525.xsd#cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6a6445ed-4c73-4dce-ac37-01ce310edd65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale_30b81de5-3005-4ffd-8b27-5063fcb0899f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6a6445ed-4c73-4dce-ac37-01ce310edd65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_1307fe4a-69a0-4b78-a94b-560ae1735be5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale_30b81de5-3005-4ffd-8b27-5063fcb0899f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_1307fe4a-69a0-4b78-a94b-560ae1735be5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#LeasesSummaryoftheComponentsofNetLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_271505f5-fc5d-49fc-90f2-bbc85d7e89fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_43b61270-290a-4bc4-b432-8e90c2c59316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_271505f5-fc5d-49fc-90f2-bbc85d7e89fd" xlink:to="loc_us-gaap_SubleaseIncome_43b61270-290a-4bc4-b432-8e90c2c59316" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_7a439b5c-aa60-4095-874f-c1d64cb12b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_271505f5-fc5d-49fc-90f2-bbc85d7e89fd" xlink:to="loc_us-gaap_VariableLeaseCost_7a439b5c-aa60-4095-874f-c1d64cb12b1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_c5fdb1ab-dc84-4dbe-8de7-9a903bff5ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_271505f5-fc5d-49fc-90f2-bbc85d7e89fd" xlink:to="loc_us-gaap_OperatingLeaseCost_c5fdb1ab-dc84-4dbe-8de7-9a903bff5ad3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseCost_67111166-73cd-422d-a40e-ec17b95591fc" xlink:href="cvs-20230525.xsd#cvs_FinanceLeaseCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_271505f5-fc5d-49fc-90f2-bbc85d7e89fd" xlink:to="loc_cvs_FinanceLeaseCost_67111166-73cd-422d-a40e-ec17b95591fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_31d7cc67-68d4-4000-aea2-6f22ddc4f3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_271505f5-fc5d-49fc-90f2-bbc85d7e89fd" xlink:to="loc_us-gaap_ShortTermLeaseCost_31d7cc67-68d4-4000-aea2-6f22ddc4f3c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseCost_a8f27ee7-39ea-4a93-a59d-5cc5c51a1716" xlink:href="cvs-20230525.xsd#cvs_FinanceLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_91cc7228-7518-43a7-82b4-4f646cd9ba51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_FinanceLeaseCost_a8f27ee7-39ea-4a93-a59d-5cc5c51a1716" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_91cc7228-7518-43a7-82b4-4f646cd9ba51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_399f1608-5291-4640-9eaa-e1431389fb13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_FinanceLeaseCost_a8f27ee7-39ea-4a93-a59d-5cc5c51a1716" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_399f1608-5291-4640-9eaa-e1431389fb13" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_980d003f-073e-40fe-9651-d7a965091603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale_9f2f18aa-e837-413b-8858-c7c7cca5b49e" xlink:href="cvs-20230525.xsd#cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_980d003f-073e-40fe-9651-d7a965091603" xlink:to="loc_cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale_9f2f18aa-e837-413b-8858-c7c7cca5b49e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale_60fb938d-9076-4aaa-a240-31218ae0c6b1" xlink:href="cvs-20230525.xsd#cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_980d003f-073e-40fe-9651-d7a965091603" xlink:to="loc_cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale_60fb938d-9076-4aaa-a240-31218ae0c6b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetNet_d60c7c9e-e2a5-4fcf-8380-dccea16f31c1" xlink:href="cvs-20230525.xsd#cvs_FinanceLeaseRightOfUseAssetNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetGross_2d5e00c1-4a92-4018-8f9f-e19cdc5bd31f" xlink:href="cvs-20230525.xsd#cvs_FinanceLeaseRightOfUseAssetGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_FinanceLeaseRightOfUseAssetNet_d60c7c9e-e2a5-4fcf-8380-dccea16f31c1" xlink:to="loc_cvs_FinanceLeaseRightOfUseAssetGross_2d5e00c1-4a92-4018-8f9f-e19cdc5bd31f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_1ccd83b4-19f1-4cf6-8cd6-a950641b2b3e" xlink:href="cvs-20230525.xsd#cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_FinanceLeaseRightOfUseAssetNet_d60c7c9e-e2a5-4fcf-8380-dccea16f31c1" xlink:to="loc_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_1ccd83b4-19f1-4cf6-8cd6-a950641b2b3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_90eda14e-c597-4bce-9955-b370b84b8a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_f7eb206d-4294-474d-b6e8-3d9893883570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_90eda14e-c597-4bce-9955-b370b84b8a2b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_f7eb206d-4294-474d-b6e8-3d9893883570" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_07b2037b-9f2c-409d-b5b9-6f4e707ad474" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_90eda14e-c597-4bce-9955-b370b84b8a2b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_07b2037b-9f2c-409d-b5b9-6f4e707ad474" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityUndiscountedExcessAmount_c8d16f84-8f70-4bb8-857e-b4022f826986" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_4973944f-044d-4dd0-8a2e-2d6ed9e85d87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityUndiscountedExcessAmount_c8d16f84-8f70-4bb8-857e-b4022f826986" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_4973944f-044d-4dd0-8a2e-2d6ed9e85d87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_c43de6bd-cd93-404c-989e-29d4815ba0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityUndiscountedExcessAmount_c8d16f84-8f70-4bb8-857e-b4022f826986" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_c43de6bd-cd93-404c-989e-29d4815ba0eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_435284ed-c80c-47ba-b162-26709c2ede48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_300618fb-476b-4e2d-ae05-1cfb5462b705" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_435284ed-c80c-47ba-b162-26709c2ede48" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_300618fb-476b-4e2d-ae05-1cfb5462b705" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_3d67c3c8-d0ba-41f5-ab5a-d548928433f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_435284ed-c80c-47ba-b162-26709c2ede48" xlink:to="loc_us-gaap_OperatingLeaseLiability_3d67c3c8-d0ba-41f5-ab5a-d548928433f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDue_9c4f40b8-f122-407f-b396-0a0ca34b87fa" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityUndiscountedExcessAmount_15610758-6730-4eb3-a990-bc8d7e41af3d" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_9c4f40b8-f122-407f-b396-0a0ca34b87fa" xlink:to="loc_cvs_LesseeLiabilityUndiscountedExcessAmount_15610758-6730-4eb3-a990-bc8d7e41af3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LeaseLiability_231ce2bd-3f35-43db-9d7c-c7bf76edb0a8" xlink:href="cvs-20230525.xsd#cvs_LeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_9c4f40b8-f122-407f-b396-0a0ca34b87fa" xlink:to="loc_cvs_LeaseLiability_231ce2bd-3f35-43db-9d7c-c7bf76edb0a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFour_07f1db2d-6139-4f87-8ee2-05a4bd3b2f7c" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_76e3ad50-03bf-4b61-bfa4-7b996aeac0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearFour_07f1db2d-6139-4f87-8ee2-05a4bd3b2f7c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_76e3ad50-03bf-4b61-bfa4-7b996aeac0b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8266833a-d51c-42b9-a428-ae93e23d4213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearFour_07f1db2d-6139-4f87-8ee2-05a4bd3b2f7c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8266833a-d51c-42b9-a428-ae93e23d4213" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1152a004-31f9-4317-b784-bbfa8d531d86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_c0a17c59-342a-4618-a6b5-caa26c158f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1152a004-31f9-4317-b784-bbfa8d531d86" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_c0a17c59-342a-4618-a6b5-caa26c158f3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_3da4b8e9-c952-4133-acb4-5418402d47f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1152a004-31f9-4317-b784-bbfa8d531d86" xlink:to="loc_us-gaap_FinanceLeaseLiability_3da4b8e9-c952-4133-acb4-5418402d47f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFive_442095f8-20d7-4e13-8d86-c50b1aa9c195" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_bcfb2d3d-cbf3-4010-88bf-793deaaad908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearFive_442095f8-20d7-4e13-8d86-c50b1aa9c195" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_bcfb2d3d-cbf3-4010-88bf-793deaaad908" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_284849c6-82a1-4c69-a385-9549a6f345b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearFive_442095f8-20d7-4e13-8d86-c50b1aa9c195" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_284849c6-82a1-4c69-a385-9549a6f345b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearThree_4e206902-1b24-436b-91d5-55448c5da789" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_4d33c8e0-8d38-4ab3-98c8-8f7998b612aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearThree_4e206902-1b24-436b-91d5-55448c5da789" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_4d33c8e0-8d38-4ab3-98c8-8f7998b612aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_760903a9-bfa3-4534-9be6-e3b4c3a1515c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearThree_4e206902-1b24-436b-91d5-55448c5da789" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_760903a9-bfa3-4534-9be6-e3b4c3a1515c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive_a6f9d295-5983-4fad-9009-b107253a5d35" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDueAfterYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_58b7d125-7739-4d57-98ac-fcb2461feefc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive_a6f9d295-5983-4fad-9009-b107253a5d35" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_58b7d125-7739-4d57-98ac-fcb2461feefc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_be22f104-1b4c-44e5-95c7-9db416c2fd1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive_a6f9d295-5983-4fad-9009-b107253a5d35" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_be22f104-1b4c-44e5-95c7-9db416c2fd1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LeaseLiability_46de15eb-b37d-49df-bf9c-60080b443cb5" xlink:href="cvs-20230525.xsd#cvs_LeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_b53a732d-38a2-4180-a41e-bccd8c4d389c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LeaseLiability_46de15eb-b37d-49df-bf9c-60080b443cb5" xlink:to="loc_us-gaap_FinanceLeaseLiability_b53a732d-38a2-4180-a41e-bccd8c4d389c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_15a29d74-8fd5-4312-82ae-aa6a0dcd9a72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LeaseLiability_46de15eb-b37d-49df-bf9c-60080b443cb5" xlink:to="loc_us-gaap_OperatingLeaseLiability_15a29d74-8fd5-4312-82ae-aa6a0dcd9a72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearTwo_0040c8b2-813b-4118-983d-5da61fdb9654" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_8f5b6e0a-bd73-40d7-9215-336a84280f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearTwo_0040c8b2-813b-4118-983d-5da61fdb9654" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_8f5b6e0a-bd73-40d7-9215-336a84280f89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3b76ab61-db18-480a-b237-b07b0caaf2eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearTwo_0040c8b2-813b-4118-983d-5da61fdb9654" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3b76ab61-db18-480a-b237-b07b0caaf2eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsYearOne_63908962-56b1-4822-9bce-184d897fbb46" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsYearOne"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7299ddd5-f285-4b89-8070-b6937f41f3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsYearOne_63908962-56b1-4822-9bce-184d897fbb46" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7299ddd5-f285-4b89-8070-b6937f41f3f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d8c02b36-4f39-433c-91db-3acdaa4ed744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsYearOne_63908962-56b1-4822-9bce-184d897fbb46" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d8c02b36-4f39-433c-91db-3acdaa4ed744" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="cvs-20230525.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_679c39d9-332f-44d6-a3b3-d8c1d7fe1512" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2fac8d5b-9477-4192-a064-2e679ae82a78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_679c39d9-332f-44d6-a3b3-d8c1d7fe1512" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2fac8d5b-9477-4192-a064-2e679ae82a78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_0d7a59fe-c336-4116-9e32-0d0b684a63dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_679c39d9-332f-44d6-a3b3-d8c1d7fe1512" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_0d7a59fe-c336-4116-9e32-0d0b684a63dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_029f3996-a66e-4d10-9541-73966d0fd9df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_679c39d9-332f-44d6-a3b3-d8c1d7fe1512" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_029f3996-a66e-4d10-9541-73966d0fd9df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_ce6185de-f931-48d7-8fe7-0e0d3c82c696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_679c39d9-332f-44d6-a3b3-d8c1d7fe1512" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_ce6185de-f931-48d7-8fe7-0e0d3c82c696" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_ebdde486-2228-45ef-81f8-54dad38262de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_679c39d9-332f-44d6-a3b3-d8c1d7fe1512" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_ebdde486-2228-45ef-81f8-54dad38262de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_2f099ef6-d5e7-44b8-bbf7-9e0a0b4a97c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_679c39d9-332f-44d6-a3b3-d8c1d7fe1512" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_2f099ef6-d5e7-44b8-bbf7-9e0a0b4a97c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_96e7dee3-54c2-4d7f-8d34-670a6c39449f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_514be9c0-b969-4dc8-9a85-c3aaa900c88a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_96e7dee3-54c2-4d7f-8d34-670a6c39449f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_514be9c0-b969-4dc8-9a85-c3aaa900c88a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_37aafd78-5f87-4c33-b49e-6b89441fdad0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_96e7dee3-54c2-4d7f-8d34-670a6c39449f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_37aafd78-5f87-4c33-b49e-6b89441fdad0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b86fdf83-4a82-4172-b13c-0c2327452991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_96e7dee3-54c2-4d7f-8d34-670a6c39449f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b86fdf83-4a82-4172-b13c-0c2327452991" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a0e57f5f-a107-41df-a698-bb467e314f45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_96e7dee3-54c2-4d7f-8d34-670a6c39449f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a0e57f5f-a107-41df-a698-bb467e314f45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_7315e476-7404-40c3-8ac5-957eaea4a299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_96e7dee3-54c2-4d7f-8d34-670a6c39449f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_7315e476-7404-40c3-8ac5-957eaea4a299" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_55aa6828-d380-49d5-98bb-28eca95e91f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_96e7dee3-54c2-4d7f-8d34-670a6c39449f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_55aa6828-d380-49d5-98bb-28eca95e91f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDue_2e677cd2-6564-4e52-b7a8-a141e4c9347a" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsYearOne_f8186b23-4638-457b-aadc-518ccf982f5e" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsYearOne"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_2e677cd2-6564-4e52-b7a8-a141e4c9347a" xlink:to="loc_cvs_LesseeLiabilityPaymentsYearOne_f8186b23-4638-457b-aadc-518ccf982f5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearTwo_0f6f2dc1-c1dd-4273-a0e0-ee6a138c16cf" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_2e677cd2-6564-4e52-b7a8-a141e4c9347a" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearTwo_0f6f2dc1-c1dd-4273-a0e0-ee6a138c16cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearThree_cc4a6971-62e5-4600-9ed9-ed496c34d2d2" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_2e677cd2-6564-4e52-b7a8-a141e4c9347a" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearThree_cc4a6971-62e5-4600-9ed9-ed496c34d2d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFour_1b82e37d-c2db-414e-bc23-b83ee9565b96" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_2e677cd2-6564-4e52-b7a8-a141e4c9347a" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearFour_1b82e37d-c2db-414e-bc23-b83ee9565b96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFive_873b57f5-49ab-4685-92ae-3a04fccb5b9e" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_2e677cd2-6564-4e52-b7a8-a141e4c9347a" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearFive_873b57f5-49ab-4685-92ae-3a04fccb5b9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive_c9db543a-2dfc-4306-89ae-30c542594f78" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_2e677cd2-6564-4e52-b7a8-a141e4c9347a" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive_c9db543a-2dfc-4306-89ae-30c542594f78" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_ec9056d6-7750-4eff-8c87-d0c0b5607d28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_cdde7850-6025-4c24-baca-8d551b70c04a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_ec9056d6-7750-4eff-8c87-d0c0b5607d28" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_cdde7850-6025-4c24-baca-8d551b70c04a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_f50222bf-7d7a-4de4-a794-00cd614d16d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_ec9056d6-7750-4eff-8c87-d0c0b5607d28" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_f50222bf-7d7a-4de4-a794-00cd614d16d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_833e4d78-cc64-4965-9e5b-d69ba8b41021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_ec9056d6-7750-4eff-8c87-d0c0b5607d28" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_833e4d78-cc64-4965-9e5b-d69ba8b41021" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_02f67122-f7d7-4735-a660-6e05d5379b92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_09d08051-de9a-4965-bfbc-87951030d407" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_02f67122-f7d7-4735-a660-6e05d5379b92" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_09d08051-de9a-4965-bfbc-87951030d407" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_4b265d89-4dc2-407c-9349-2562dec4879b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_02f67122-f7d7-4735-a660-6e05d5379b92" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_4b265d89-4dc2-407c-9349-2562dec4879b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_7394ede8-6842-4608-9303-cda69fc31ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_02f67122-f7d7-4735-a660-6e05d5379b92" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_7394ede8-6842-4608-9303-cda69fc31ec5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_ca235fd7-e600-404c-80a7-0abfe5f8f6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_81053d8c-9e93-441c-ace2-82d49a84bf2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_ca235fd7-e600-404c-80a7-0abfe5f8f6e6" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_81053d8c-9e93-441c-ace2-82d49a84bf2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_d93ae702-f9c8-4557-9af6-b88d1c2b1c75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_ca235fd7-e600-404c-80a7-0abfe5f8f6e6" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_d93ae702-f9c8-4557-9af6-b88d1c2b1c75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_a186d524-5384-4f84-a747-5707b2992ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_8b78454f-62cf-470c-bd65-fbf9663faa4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_a186d524-5384-4f84-a747-5707b2992ae0" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_8b78454f-62cf-470c-bd65-fbf9663faa4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_c87ac34d-7849-4f51-a6a0-523191c136c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_a186d524-5384-4f84-a747-5707b2992ae0" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_c87ac34d-7849-4f51-a6a0-523191c136c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_586af4c0-c77e-42ff-8322-128d5b168dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_2bb1abed-bef2-453e-8cc3-30121b2da04f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_586af4c0-c77e-42ff-8322-128d5b168dc0" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_2bb1abed-bef2-453e-8cc3-30121b2da04f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_5e9f18ae-a3cb-4fcd-b782-0d04b5748d09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_586af4c0-c77e-42ff-8322-128d5b168dc0" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_5e9f18ae-a3cb-4fcd-b782-0d04b5748d09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b126f74f-c7e2-4bfe-9529-a51409a6bdc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_586af4c0-c77e-42ff-8322-128d5b168dc0" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b126f74f-c7e2-4bfe-9529-a51409a6bdc3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_402b03f4-cb44-4a7a-a326-a4320a732af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_25942ff6-0e2f-4b09-a58e-65062c2ce8d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_402b03f4-cb44-4a7a-a326-a4320a732af8" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_25942ff6-0e2f-4b09-a58e-65062c2ce8d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_1431e0db-293f-4b2f-ac6c-1afd4b507ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_402b03f4-cb44-4a7a-a326-a4320a732af8" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_1431e0db-293f-4b2f-ac6c-1afd4b507ff9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_bf50138b-1978-4bc0-a9fb-55e97b002314" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_aa42b07c-cd79-4470-a272-af8f99d51052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_bf50138b-1978-4bc0-a9fb-55e97b002314" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_aa42b07c-cd79-4470-a272-af8f99d51052" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_e452047e-cba0-415a-96b0-5c5dd1ed77f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_bf50138b-1978-4bc0-a9fb-55e97b002314" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefits_e452047e-cba0-415a-96b0-5c5dd1ed77f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_0c548da8-5bb4-45b7-be9c-b65ae1d3febd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_86b5c587-4b09-4ad7-a55b-92c8e841a1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_0c548da8-5bb4-45b7-be9c-b65ae1d3febd" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_86b5c587-4b09-4ad7-a55b-92c8e841a1c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_555c3c72-9285-4347-99dd-01511d02f41b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_0c548da8-5bb4-45b7-be9c-b65ae1d3febd" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_555c3c72-9285-4347-99dd-01511d02f41b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_42cd3283-af34-44f7-99db-c8f9bccd4783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_d0bce3d0-8061-4723-af5c-21e23f3013cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefits_42cd3283-af34-44f7-99db-c8f9bccd4783" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_d0bce3d0-8061-4723-af5c-21e23f3013cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_32a331d5-b68c-4d52-b9c4-79279c0fb5da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefits_42cd3283-af34-44f7-99db-c8f9bccd4783" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_32a331d5-b68c-4d52-b9c4-79279c0fb5da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_4a2b8749-ca36-41d3-932c-c3179582e793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_08762c89-fed4-423c-9215-7428912c889d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_4a2b8749-ca36-41d3-932c-c3179582e793" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_08762c89-fed4-423c-9215-7428912c889d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_13913e49-aed4-4f4a-a76c-6cb19a8352a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_4a2b8749-ca36-41d3-932c-c3179582e793" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_13913e49-aed4-4f4a-a76c-6cb19a8352a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange_8d604889-cca2-40c6-9a95-ccc31ca22d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_4a2b8749-ca36-41d3-932c-c3179582e793" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange_8d604889-cca2-40c6-9a95-ccc31ca22d3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_672ec4c9-4bf6-452b-b857-e24bcecddab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_e1db933d-2624-477b-b43b-2ae2e121a59a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_672ec4c9-4bf6-452b-b857-e24bcecddab1" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_e1db933d-2624-477b-b43b-2ae2e121a59a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_e76e3e0a-d626-4cc8-993e-c01fd14ee028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_672ec4c9-4bf6-452b-b857-e24bcecddab1" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_e76e3e0a-d626-4cc8-993e-c01fd14ee028" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_7b81e815-c9de-4468-b60a-52fc20636b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_672ec4c9-4bf6-452b-b857-e24bcecddab1" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_7b81e815-c9de-4468-b60a-52fc20636b38" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_ebf36ca3-0611-4ceb-8c20-3cc8e85c987f" xlink:href="cvs-20230525.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_da07f902-d114-4ccd-be71-945eb67a6618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LongtermDebtGrossAndLeaseObligation_ebf36ca3-0611-4ceb-8c20-3cc8e85c987f" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_da07f902-d114-4ccd-be71-945eb67a6618" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_5b430fdc-a2bd-4d9b-88d6-f93cda416e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LongtermDebtGrossAndLeaseObligation_ebf36ca3-0611-4ceb-8c20-3cc8e85c987f" xlink:to="loc_us-gaap_FinanceLeaseLiability_5b430fdc-a2bd-4d9b-88d6-f93cda416e3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_e3df081b-4e30-4a81-9e2a-5622474c8075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_0572bb87-5474-44b6-8d75-8067862ddc9d" xlink:href="cvs-20230525.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_e3df081b-4e30-4a81-9e2a-5622474c8075" xlink:to="loc_cvs_LongtermDebtGrossAndLeaseObligation_0572bb87-5474-44b6-8d75-8067862ddc9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet_38596e71-cbde-4f67-9601-15ae0f76de0c" xlink:href="cvs-20230525.xsd#cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_e3df081b-4e30-4a81-9e2a-5622474c8075" xlink:to="loc_cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet_38596e71-cbde-4f67-9601-15ae0f76de0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_a02c0783-9c3a-4352-b098-acaad4c64600" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_e3df081b-4e30-4a81-9e2a-5622474c8075" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_a02c0783-9c3a-4352-b098-acaad4c64600" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#BorrowingsandCreditAgreementsDebtMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_9b2c534e-b79a-4762-bfdf-3a895d5144d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_564618aa-933f-4421-b1cb-15837434498a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_9b2c534e-b79a-4762-bfdf-3a895d5144d5" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_564618aa-933f-4421-b1cb-15837434498a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2f93f831-f320-4323-9e31-9f747c7fee0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_9b2c534e-b79a-4762-bfdf-3a895d5144d5" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2f93f831-f320-4323-9e31-9f747c7fee0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_58a2945a-6a28-42a1-912e-be179f8e5f26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_9b2c534e-b79a-4762-bfdf-3a895d5144d5" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_58a2945a-6a28-42a1-912e-be179f8e5f26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_8add7176-e83c-43cf-9cbb-ff038a96580b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_9b2c534e-b79a-4762-bfdf-3a895d5144d5" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_8add7176-e83c-43cf-9cbb-ff038a96580b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_cd95a579-a71a-460c-94ae-95509e9b73ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_9b2c534e-b79a-4762-bfdf-3a895d5144d5" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_cd95a579-a71a-460c-94ae-95509e9b73ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_c3d6fe36-f5ef-4d8e-8fc6-651f69628818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_9b2c534e-b79a-4762-bfdf-3a895d5144d5" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_c3d6fe36-f5ef-4d8e-8fc6-651f69628818" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_7291f44f-cc6d-4ce7-87af-6c7f238d63b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_2d49402e-6d32-4fa5-bd1a-e4e7226b384e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_7291f44f-cc6d-4ce7-87af-6c7f238d63b9" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_2d49402e-6d32-4fa5-bd1a-e4e7226b384e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_3ca02552-8124-4291-b986-99fdc0b6c2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_7291f44f-cc6d-4ce7-87af-6c7f238d63b9" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_3ca02552-8124-4291-b986-99fdc0b6c2cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_cf41686e-e117-45cf-9e21-9be86090c09f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_7291f44f-cc6d-4ce7-87af-6c7f238d63b9" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_cf41686e-e117-45cf-9e21-9be86090c09f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_8b4fc080-f4ce-4421-a723-2d44600a65d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_1b2e5b7f-53ad-4095-b5c3-0150bae40166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_8b4fc080-f4ce-4421-a723-2d44600a65d3" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_1b2e5b7f-53ad-4095-b5c3-0150bae40166" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5c4c046f-c32f-4431-bd70-869905cd998f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_8b4fc080-f4ce-4421-a723-2d44600a65d3" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5c4c046f-c32f-4431-bd70-869905cd998f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_8c1561a9-a89b-43d1-9295-894a8b8a1030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ef98216a-6ad1-4320-8523-ed27e0c2a9cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_8c1561a9-a89b-43d1-9295-894a8b8a1030" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ef98216a-6ad1-4320-8523-ed27e0c2a9cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_a6650578-3df4-4495-b17e-ad945ef1f1ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_8c1561a9-a89b-43d1-9295-894a8b8a1030" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_a6650578-3df4-4495-b17e-ad945ef1f1ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_8c018bf9-253a-4f82-989d-6c89530dcabb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_8c1561a9-a89b-43d1-9295-894a8b8a1030" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_8c018bf9-253a-4f82-989d-6c89530dcabb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_72d3bac7-3a40-4cc4-9a8d-2ff4f52e8fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_8c1561a9-a89b-43d1-9295-894a8b8a1030" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_72d3bac7-3a40-4cc4-9a8d-2ff4f52e8fb3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#IncomeTaxesIncomeTaxProvisionDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ff1f59de-eab0-4bf5-97cb-2c210cce7adc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3c8c7eff-e641-4e23-967f-4c72b4fce296" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ff1f59de-eab0-4bf5-97cb-2c210cce7adc" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3c8c7eff-e641-4e23-967f-4c72b4fce296" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_30cdcc52-8bc2-4347-a367-d7a00fd6a92e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ff1f59de-eab0-4bf5-97cb-2c210cce7adc" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_30cdcc52-8bc2-4347-a367-d7a00fd6a92e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8b1beecf-c79b-43aa-8a6e-b9830a853a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a228f41f-50ed-481a-a02a-011e4e98b3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8b1beecf-c79b-43aa-8a6e-b9830a853a6b" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a228f41f-50ed-481a-a02a-011e4e98b3c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_6f6124af-6aae-48ed-8c2c-76fe03ffdf01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8b1beecf-c79b-43aa-8a6e-b9830a853a6b" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_6f6124af-6aae-48ed-8c2c-76fe03ffdf01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e7c08b73-5ab6-4ed8-a70d-13f34c718471" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_f81385dc-145d-4057-b458-f40f99bc550a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e7c08b73-5ab6-4ed8-a70d-13f34c718471" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_f81385dc-145d-4057-b458-f40f99bc550a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_290edd6e-a7f1-4a33-93d8-f07b93997a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e7c08b73-5ab6-4ed8-a70d-13f34c718471" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_290edd6e-a7f1-4a33-93d8-f07b93997a07" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#IncomeTaxesEffectiveTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7d707310-2e90-435c-a21e-7f17b069b4d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_0d2dc746-d0de-4239-81b0-715ce1975b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7d707310-2e90-435c-a21e-7f17b069b4d4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_0d2dc746-d0de-4239-81b0-715ce1975b4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_2451a00f-018b-4f99-a30f-f1b138c6a568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7d707310-2e90-435c-a21e-7f17b069b4d4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_2451a00f-018b-4f99-a30f-f1b138c6a568" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_780378e3-24d2-4612-9b93-3d74af23e78f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7d707310-2e90-435c-a21e-7f17b069b4d4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_780378e3-24d2-4612-9b93-3d74af23e78f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent_d8f7480a-8737-4ea6-b7d1-949809316bb8" xlink:href="cvs-20230525.xsd#cvs_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7d707310-2e90-435c-a21e-7f17b069b4d4" xlink:to="loc_cvs_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent_d8f7480a-8737-4ea6-b7d1-949809316bb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_eefafbc7-beff-45ee-a0ca-ec768cc30592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7d707310-2e90-435c-a21e-7f17b069b4d4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_eefafbc7-beff-45ee-a0ca-ec768cc30592" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFeeTaxEffectPercent_a5a756c7-92d1-4ade-9295-74d858759117" xlink:href="cvs-20230525.xsd#cvs_HealthInsurerFeeTaxEffectPercent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7d707310-2e90-435c-a21e-7f17b069b4d4" xlink:to="loc_cvs_HealthInsurerFeeTaxEffectPercent_a5a756c7-92d1-4ade-9295-74d858759117" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_b3c7e654-63f5-46d3-8ee5-77d4ad8ac4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7d707310-2e90-435c-a21e-7f17b069b4d4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_b3c7e654-63f5-46d3-8ee5-77d4ad8ac4ec" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_3d49a9a8-da08-4b19-ad8e-5bcbb9406464" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_3ff3d43d-e52f-40a8-b8fa-a22ee785404e" xlink:href="cvs-20230525.xsd#cvs_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_3d49a9a8-da08-4b19-ad8e-5bcbb9406464" xlink:to="loc_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_3ff3d43d-e52f-40a8-b8fa-a22ee785404e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_073f6800-bcb5-4669-a4ef-857abb6babfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_3d49a9a8-da08-4b19-ad8e-5bcbb9406464" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_073f6800-bcb5-4669-a4ef-857abb6babfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments_22b76787-e467-4c2e-b592-1de805908d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_3d49a9a8-da08-4b19-ad8e-5bcbb9406464" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestments_22b76787-e467-4c2e-b592-1de805908d7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxLiabilitiesRetirementBenefits_7a983984-f164-470c-aae7-824cb81be6d1" xlink:href="cvs-20230525.xsd#cvs_DeferredTaxLiabilitiesRetirementBenefits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_3d49a9a8-da08-4b19-ad8e-5bcbb9406464" xlink:to="loc_cvs_DeferredTaxLiabilitiesRetirementBenefits_7a983984-f164-470c-aae7-824cb81be6d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_b0c57a2e-1e61-4d81-b9b2-3b0cd8dd83de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_bd624860-2482-4709-986e-59d37c69ce7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_b0c57a2e-1e61-4d81-b9b2-3b0cd8dd83de" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_bd624860-2482-4709-986e-59d37c69ce7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_356fb0d2-13ae-4496-a64a-3726fb4175fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_b0c57a2e-1e61-4d81-b9b2-3b0cd8dd83de" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_356fb0d2-13ae-4496-a64a-3726fb4175fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_118ef806-a029-4da5-8548-a3e057b88410" xlink:href="cvs-20230525.xsd#cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_b0c57a2e-1e61-4d81-b9b2-3b0cd8dd83de" xlink:to="loc_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_118ef806-a029-4da5-8548-a3e057b88410" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_ecb5eafb-a46b-4365-82b5-3519cc9d5b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_b0c57a2e-1e61-4d81-b9b2-3b0cd8dd83de" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_ecb5eafb-a46b-4365-82b5-3519cc9d5b4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxAssetsPayrollTaxDeferral_fd410526-5519-4249-a0a5-3bbf8d13dbbc" xlink:href="cvs-20230525.xsd#cvs_DeferredTaxAssetsPayrollTaxDeferral"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_b0c57a2e-1e61-4d81-b9b2-3b0cd8dd83de" xlink:to="loc_cvs_DeferredTaxAssetsPayrollTaxDeferral_fd410526-5519-4249-a0a5-3bbf8d13dbbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_6ee44749-432e-4f3b-87fb-e4069d1a5617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_b0c57a2e-1e61-4d81-b9b2-3b0cd8dd83de" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_6ee44749-432e-4f3b-87fb-e4069d1a5617" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_4d289034-2da5-4e0d-9ba6-2d21109342ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_b0c57a2e-1e61-4d81-b9b2-3b0cd8dd83de" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_4d289034-2da5-4e0d-9ba6-2d21109342ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_f6ee83de-6a30-4231-a984-7cd33f4b4ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_b0c57a2e-1e61-4d81-b9b2-3b0cd8dd83de" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_f6ee83de-6a30-4231-a984-7cd33f4b4ab4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_1169d5e5-d839-44a0-ae16-9b50cc778076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_b0c57a2e-1e61-4d81-b9b2-3b0cd8dd83de" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_1169d5e5-d839-44a0-ae16-9b50cc778076" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements_a2445628-cb46-4388-90d6-02fcb7c0c1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_b0c57a2e-1e61-4d81-b9b2-3b0cd8dd83de" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements_a2445628-cb46-4388-90d6-02fcb7c0c1ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_b78969f2-ed85-4731-bc84-1a7a7e884638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_b0c57a2e-1e61-4d81-b9b2-3b0cd8dd83de" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_b78969f2-ed85-4731-bc84-1a7a7e884638" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments_a8c8f1f6-b96e-47b5-be33-0935719ba9b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_b0c57a2e-1e61-4d81-b9b2-3b0cd8dd83de" xlink:to="loc_us-gaap_DeferredTaxAssetsInvestments_a8c8f1f6-b96e-47b5-be33-0935719ba9b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_3d56b543-5ede-4a54-9d9f-3e4c91545489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_48443a54-78aa-446d-80dc-fa77fbb35f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_3d56b543-5ede-4a54-9d9f-3e4c91545489" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_48443a54-78aa-446d-80dc-fa77fbb35f0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_1a0312a1-6bf3-4161-b520-73c38242501c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_3d56b543-5ede-4a54-9d9f-3e4c91545489" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_1a0312a1-6bf3-4161-b520-73c38242501c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ddfece07-75b6-435d-a24e-90ee3bf8b955" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_92dc1c9e-6f1c-40c9-93b6-50c8b41fa9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ddfece07-75b6-435d-a24e-90ee3bf8b955" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_92dc1c9e-6f1c-40c9-93b6-50c8b41fa9e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_04a942a1-4fb2-4bad-9929-e59c6025b7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ddfece07-75b6-435d-a24e-90ee3bf8b955" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_04a942a1-4fb2-4bad-9929-e59c6025b7b4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#EarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_adc39a49-f601-4ee7-82ce-c13a06c97787" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5115a1e0-b050-4aac-89c3-78ac35b066a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_adc39a49-f601-4ee7-82ce-c13a06c97787" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5115a1e0-b050-4aac-89c3-78ac35b066a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_37747fba-9923-4f6a-aaf3-fa061e0345f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_adc39a49-f601-4ee7-82ce-c13a06c97787" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_37747fba-9923-4f6a-aaf3-fa061e0345f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_aeb45911-aa5c-4f6d-a877-14a91fba4e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_12988980-8245-49d5-a4b9-812c5535ffa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_aeb45911-aa5c-4f6d-a877-14a91fba4e9d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_12988980-8245-49d5-a4b9-812c5535ffa0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6e93d769-7c89-45f1-9e71-89c43df993bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_aeb45911-aa5c-4f6d-a877-14a91fba4e9d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6e93d769-7c89-45f1-9e71-89c43df993bb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#ReinsuranceEffectsofReinsuranceDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_b97415f0-eebc-481e-9bc6-271b24d9a3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectPremiumsEarned_7af6f542-d9d9-4239-baea-e98980f05330" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectPremiumsEarned"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PremiumsEarnedNet_b97415f0-eebc-481e-9bc6-271b24d9a3eb" xlink:to="loc_us-gaap_DirectPremiumsEarned_7af6f542-d9d9-4239-baea-e98980f05330" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssumedPremiumsEarned_f7bd04aa-4ec1-467c-9ddb-8d7d3de9f281" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssumedPremiumsEarned"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PremiumsEarnedNet_b97415f0-eebc-481e-9bc6-271b24d9a3eb" xlink:to="loc_us-gaap_AssumedPremiumsEarned_f7bd04aa-4ec1-467c-9ddb-8d7d3de9f281" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededPremiumsEarned_9d3b6592-da05-49df-9675-18d3cbfab91b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededPremiumsEarned"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PremiumsEarnedNet_b97415f0-eebc-481e-9bc6-271b24d9a3eb" xlink:to="loc_us-gaap_CededPremiumsEarned_9d3b6592-da05-49df-9675-18d3cbfab91b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_edaea309-6ee8-4f28-8564-5864c844894f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_4076b2d1-d020-416e-bb32-aeb30ba96820" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_edaea309-6ee8-4f28-8564-5864c844894f" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_4076b2d1-d020-416e-bb32-aeb30ba96820" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_9e2621a9-7408-460c-8316-48429340ce97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_edaea309-6ee8-4f28-8564-5864c844894f" xlink:to="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_9e2621a9-7408-460c-8316-48429340ce97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_6db76611-6a0e-4145-8707-cc9e9706066a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_edaea309-6ee8-4f28-8564-5864c844894f" xlink:to="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_6db76611-6a0e-4145-8707-cc9e9706066a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0cf40917-259e-457f-9aed-5653a3dc5b68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_44338b02-df11-405a-9c6e-360fdf96fc50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_0cf40917-259e-457f-9aed-5653a3dc5b68" xlink:to="loc_us-gaap_NetInvestmentIncome_44338b02-df11-405a-9c6e-360fdf96fc50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_d154a696-029d-4f27-96b4-922edb6750c8" xlink:href="cvs-20230525.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_0cf40917-259e-457f-9aed-5653a3dc5b68" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_d154a696-029d-4f27-96b4-922edb6750c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b1df3eac-1e18-4bb1-8079-5cd0eb5cf515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_0cf40917-259e-457f-9aed-5653a3dc5b68" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b1df3eac-1e18-4bb1-8079-5cd0eb5cf515" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>cvs-20230525_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:a470d627-05b8-4106-b3ee-d69f01519b0f,g:7f491b32-9056-4172-9edc-e6fc2e3bdea2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="cvs-20230525.xsd#ConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofOperations" xlink:type="extended" id="i81378fd5f0844956a549607464d4a2df_ConsolidatedStatementsofOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_201ac5df-2eb0-400f-a37a-184b25148669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_RevenuesAbstract_201ac5df-2eb0-400f-a37a-184b25148669" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a8be9c0c-2f5a-4487-bfa3-560cc02f7517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_201ac5df-2eb0-400f-a37a-184b25148669" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a8be9c0c-2f5a-4487-bfa3-560cc02f7517" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_add55321-0ec2-411d-b889-76e9e689984c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_201ac5df-2eb0-400f-a37a-184b25148669" xlink:to="loc_us-gaap_PremiumsEarnedNet_add55321-0ec2-411d-b889-76e9e689984c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_5dc05c37-7982-4a66-b976-d1a7be4ab60e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_201ac5df-2eb0-400f-a37a-184b25148669" xlink:to="loc_us-gaap_NetInvestmentIncome_5dc05c37-7982-4a66-b976-d1a7be4ab60e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7aa33272-ae71-4b1e-976a-f00f75436d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_201ac5df-2eb0-400f-a37a-184b25148669" xlink:to="loc_us-gaap_Revenues_7aa33272-ae71-4b1e-976a-f00f75436d08" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_e8594484-fe05-4bbc-b9ac-668c3b3ae802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_OperatingExpensesAbstract_e8594484-fe05-4bbc-b9ac-668c3b3ae802" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ecbe02ba-a230-4eec-9ae8-bee91b35a0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e8594484-fe05-4bbc-b9ac-668c3b3ae802" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ecbe02ba-a230-4eec-9ae8-bee91b35a0ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_c84204b0-2fa7-40a8-92d9-e3166cbcf486" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e8594484-fe05-4bbc-b9ac-668c3b3ae802" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_c84204b0-2fa7-40a8-92d9-e3166cbcf486" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_fb31a6a5-9c7f-460c-831d-cd26fc4c57be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e8594484-fe05-4bbc-b9ac-668c3b3ae802" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_fb31a6a5-9c7f-460c-831d-cd26fc4c57be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_ae294930-839d-430a-b9e0-bdb8967407fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e8594484-fe05-4bbc-b9ac-668c3b3ae802" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_ae294930-839d-430a-b9e0-bdb8967407fa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges_0283f8e1-8c74-410c-a122-315dd5906ec1" xlink:href="cvs-20230525.xsd#cvs_StoreImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e8594484-fe05-4bbc-b9ac-668c3b3ae802" xlink:to="loc_cvs_StoreImpairmentCharges_0283f8e1-8c74-410c-a122-315dd5906ec1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_e2027844-6313-493e-8d68-9e80144f9980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e8594484-fe05-4bbc-b9ac-668c3b3ae802" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_e2027844-6313-493e-8d68-9e80144f9980" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_34b20d78-8011-4c2a-ba8c-88023abdd981" xlink:href="cvs-20230525.xsd#cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e8594484-fe05-4bbc-b9ac-668c3b3ae802" xlink:to="loc_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_34b20d78-8011-4c2a-ba8c-88023abdd981" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_df9be296-071e-4066-8a74-31a4b92c34b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e8594484-fe05-4bbc-b9ac-668c3b3ae802" xlink:to="loc_us-gaap_CostsAndExpenses_df9be296-071e-4066-8a74-31a4b92c34b3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_12679ff8-fb7a-49cb-9550-103931ac1f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_OperatingIncomeLoss_12679ff8-fb7a-49cb-9550-103931ac1f5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_398ded2c-2e6a-4475-89e9-31910acd1929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_InterestExpense_398ded2c-2e6a-4475-89e9-31910acd1929" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_93a4d5d5-22e2-41af-912a-9c2c049b9810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_93a4d5d5-22e2-41af-912a-9c2c049b9810" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_38a988b7-fd8d-4f7e-b08c-32bf35e99bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_38a988b7-fd8d-4f7e-b08c-32bf35e99bd6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fa00e726-3fff-4180-9764-99e28fe5b82e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fa00e726-3fff-4180-9764-99e28fe5b82e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3a6ede67-212f-45c3-b8e6-8ccd791a9499" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3a6ede67-212f-45c3-b8e6-8ccd791a9499" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1675406d-d0b4-4232-8a3a-0c56aef34ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1675406d-d0b4-4232-8a3a-0c56aef34ab1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_abcb2e80-7615-4532-a6f2-1165ca9c8289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_abcb2e80-7615-4532-a6f2-1165ca9c8289" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_13b63cfe-abd9-473c-a2df-5a6cc10aa9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_ProfitLoss_13b63cfe-abd9-473c-a2df-5a6cc10aa9d8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_363d88a1-f93e-4e21-a8b4-bd381ab0af9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_363d88a1-f93e-4e21-a8b4-bd381ab0af9e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6d3414fa-97b3-42e0-b13f-9c561c7083ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_NetIncomeLoss_6d3414fa-97b3-42e0-b13f-9c561c7083ea" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_814f3854-8ea6-4c72-825e-e258d27272c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_814f3854-8ea6-4c72-825e-e258d27272c8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_80d07fe7-1ec3-461c-b6da-7a352cd59d65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_814f3854-8ea6-4c72-825e-e258d27272c8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_80d07fe7-1ec3-461c-b6da-7a352cd59d65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_8584d074-f178-43f4-a48f-5f78cfc886bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_814f3854-8ea6-4c72-825e-e258d27272c8" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_8584d074-f178-43f4-a48f-5f78cfc886bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_132f76c5-0b76-4d61-9e8f-11c8fc8a4009" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_814f3854-8ea6-4c72-825e-e258d27272c8" xlink:to="loc_us-gaap_EarningsPerShareBasic_132f76c5-0b76-4d61-9e8f-11c8fc8a4009" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_910dc2b3-1bb2-4605-bea2-12ae66d91eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_814f3854-8ea6-4c72-825e-e258d27272c8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_910dc2b3-1bb2-4605-bea2-12ae66d91eba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_3c2746d6-c014-4134-afe3-3fc8e47add7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_3c2746d6-c014-4134-afe3-3fc8e47add7b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_189b5c4d-cfda-46c4-977e-d8ff5b9f4bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_3c2746d6-c014-4134-afe3-3fc8e47add7b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_189b5c4d-cfda-46c4-977e-d8ff5b9f4bf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_868b2244-8676-4cfd-86eb-467c04de145b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_3c2746d6-c014-4134-afe3-3fc8e47add7b" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_868b2244-8676-4cfd-86eb-467c04de145b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a980d4f2-42ea-44f3-9024-52aeec28cc36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_3c2746d6-c014-4134-afe3-3fc8e47add7b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a980d4f2-42ea-44f3-9024-52aeec28cc36" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_53075c97-2a96-4f9a-b4da-6abcfc25862f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_3c2746d6-c014-4134-afe3-3fc8e47add7b" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_53075c97-2a96-4f9a-b4da-6abcfc25862f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_ea501cdb-fef5-43c6-9d20-d9138a95992c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_ea501cdb-fef5-43c6-9d20-d9138a95992c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_bd41e505-963a-4cb8-b8a9-4d608d17b664" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_bd41e505-963a-4cb8-b8a9-4d608d17b664" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6482774b-a47e-460a-958e-8b3ad9bd547a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_StatementTable_6482774b-a47e-460a-958e-8b3ad9bd547a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f208da14-c14b-4e63-9c5f-8f2ebb1ed505" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6482774b-a47e-460a-958e-8b3ad9bd547a" xlink:to="loc_srt_ProductOrServiceAxis_f208da14-c14b-4e63-9c5f-8f2ebb1ed505" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f208da14-c14b-4e63-9c5f-8f2ebb1ed505_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f208da14-c14b-4e63-9c5f-8f2ebb1ed505" xlink:to="loc_srt_ProductsAndServicesDomain_f208da14-c14b-4e63-9c5f-8f2ebb1ed505_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_37af55a0-b4ca-4b9f-b775-ff00a7a44ad1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f208da14-c14b-4e63-9c5f-8f2ebb1ed505" xlink:to="loc_srt_ProductsAndServicesDomain_37af55a0-b4ca-4b9f-b775-ff00a7a44ad1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_c32d1b5d-cd44-418f-abe5-99e376a5bc4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_37af55a0-b4ca-4b9f-b775-ff00a7a44ad1" xlink:to="loc_us-gaap_ProductMember_c32d1b5d-cd44-418f-abe5-99e376a5bc4e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_959c5e6f-1064-4bd6-abce-d090470b6717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_37af55a0-b4ca-4b9f-b775-ff00a7a44ad1" xlink:to="loc_us-gaap_ServiceMember_959c5e6f-1064-4bd6-abce-d090470b6717" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="cvs-20230525.xsd#ConsolidatedStatementsofShareholdersEquity"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="extended" id="iac17cdf01744451db64b8951cb51ef75_ConsolidatedStatementsofShareholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c0ce9fdf-98cc-407d-a45b-1d717fc16111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c0ce9fdf-98cc-407d-a45b-1d717fc16111" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_5224ddf6-4b9b-4059-a389-4a8394f33222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_us-gaap_SharesOutstanding_5224ddf6-4b9b-4059-a389-4a8394f33222" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_3b5401ac-ebbc-4f4e-9fd4-076ebd0e6d04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_us-gaap_TreasuryStockCommonShares_3b5401ac-ebbc-4f4e-9fd4-076ebd0e6d04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_adc99c47-be88-4d5a-b118-95ebdab43366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_adc99c47-be88-4d5a-b118-95ebdab43366" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_00dc9d15-7928-4abd-8201-1ab73ac200f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_us-gaap_ProfitLoss_00dc9d15-7928-4abd-8201-1ab73ac200f9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ac71ea40-f23e-4fb4-b393-862b72791284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ac71ea40-f23e-4fb4-b393-862b72791284" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a1ef2e2d-24cf-4cae-b8b9-1b7b569ffc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a1ef2e2d-24cf-4cae-b8b9-1b7b569ffc5f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_4931c87f-b2af-4e6f-86f3-07aa269e9587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_4931c87f-b2af-4e6f-86f3-07aa269e9587" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_fd9bcf77-7e12-4c21-9ac5-73b90052e9a5" xlink:href="cvs-20230525.xsd#cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_fd9bcf77-7e12-4c21-9ac5-73b90052e9a5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_b66d23a4-df18-4035-99c9-e595eafec390" xlink:href="cvs-20230525.xsd#cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_b66d23a4-df18-4035-99c9-e595eafec390" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_9c613355-6426-40d2-8750-5d3427e2ca70" xlink:href="cvs-20230525.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_9c613355-6426-40d2-8750-5d3427e2ca70" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_99560956-5321-462d-ab42-f47f6660c39f" xlink:href="cvs-20230525.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_99560956-5321-462d-ab42-f47f6660c39f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_f8d333bc-caf9-4428-b1ad-f1e1676891af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_us-gaap_DividendsCommonStock_f8d333bc-caf9-4428-b1ad-f1e1676891af" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease_dc009f32-9a4b-45c7-b3c3-9ed09ced77ce" xlink:href="cvs-20230525.xsd#cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease_dc009f32-9a4b-45c7-b3c3-9ed09ced77ce" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_2dc3584f-5724-400c-a261-612f3316a7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_085bd1af-1943-4bd5-8fb2-826c4ad041a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3833a210-946e-4fc5-b284-574bcc6dd799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7f0fcce8-5d16-43e2-a99c-33403e7e386f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c0ce9fdf-98cc-407d-a45b-1d717fc16111" xlink:to="loc_us-gaap_StatementTable_7f0fcce8-5d16-43e2-a99c-33403e7e386f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9388894e-fb32-46b7-ac07-3990d8deb61e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7f0fcce8-5d16-43e2-a99c-33403e7e386f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9388894e-fb32-46b7-ac07-3990d8deb61e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9388894e-fb32-46b7-ac07-3990d8deb61e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9388894e-fb32-46b7-ac07-3990d8deb61e" xlink:to="loc_us-gaap_EquityComponentDomain_9388894e-fb32-46b7-ac07-3990d8deb61e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6af026f1-ea5f-4615-a0e1-46dd35f5d707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9388894e-fb32-46b7-ac07-3990d8deb61e" xlink:to="loc_us-gaap_EquityComponentDomain_6af026f1-ea5f-4615-a0e1-46dd35f5d707" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_afe6ad0a-b8cf-407a-aff2-f2d084200570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6af026f1-ea5f-4615-a0e1-46dd35f5d707" xlink:to="loc_us-gaap_ParentMember_afe6ad0a-b8cf-407a-aff2-f2d084200570" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4129b0aa-5c85-4370-94d8-3b0b5c751bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_afe6ad0a-b8cf-407a-aff2-f2d084200570" xlink:to="loc_us-gaap_CommonStockMember_4129b0aa-5c85-4370-94d8-3b0b5c751bd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_ad908af1-c51e-41e4-b809-9af59cc9609a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_afe6ad0a-b8cf-407a-aff2-f2d084200570" xlink:to="loc_us-gaap_TreasuryStockCommonMember_ad908af1-c51e-41e4-b809-9af59cc9609a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_2ec5c89d-cf81-4c17-bc90-26bf25c29195" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_afe6ad0a-b8cf-407a-aff2-f2d084200570" xlink:to="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_2ec5c89d-cf81-4c17-bc90-26bf25c29195" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_15c8cf1f-e67e-40c9-8489-803cd43db86d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_afe6ad0a-b8cf-407a-aff2-f2d084200570" xlink:to="loc_us-gaap_RetainedEarningsMember_15c8cf1f-e67e-40c9-8489-803cd43db86d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5612610a-e3da-4fb8-b7d0-8b37fc6f2a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_afe6ad0a-b8cf-407a-aff2-f2d084200570" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5612610a-e3da-4fb8-b7d0-8b37fc6f2a6b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_31f69299-ad74-439d-87c8-0d23a5003bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6af026f1-ea5f-4615-a0e1-46dd35f5d707" xlink:to="loc_us-gaap_NoncontrollingInterestMember_31f69299-ad74-439d-87c8-0d23a5003bbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0ad170de-3fbe-4397-8ae7-a2f207b65f2b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7f0fcce8-5d16-43e2-a99c-33403e7e386f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0ad170de-3fbe-4397-8ae7-a2f207b65f2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0ad170de-3fbe-4397-8ae7-a2f207b65f2b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0ad170de-3fbe-4397-8ae7-a2f207b65f2b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0ad170de-3fbe-4397-8ae7-a2f207b65f2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ad126088-9985-4120-9e18-fd47cc3c3206" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0ad170de-3fbe-4397-8ae7-a2f207b65f2b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ad126088-9985-4120-9e18-fd47cc3c3206" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_0b315c43-9447-4293-9bb1-e299441e0caf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ad126088-9985-4120-9e18-fd47cc3c3206" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_0b315c43-9447-4293-9bb1-e299441e0caf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="simple" xlink:href="cvs-20230525.xsd#ConsolidatedStatementsofShareholdersEquityParentheticals"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="extended" id="i64941df1297149829b8704513a0253bd_ConsolidatedStatementsofShareholdersEquityParentheticals">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_023a743c-1bb3-42ca-919c-0b69ee280f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust_b51d0dd0-4f72-4353-bc3a-6601a42a5cbb" xlink:href="cvs-20230525.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_023a743c-1bb3-42ca-919c-0b69ee280f6f" xlink:to="loc_cvs_TreasuryStockSharesHeldinTrust_b51d0dd0-4f72-4353-bc3a-6601a42a5cbb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueSharesHeldInTrust_ce54cf8d-7fec-4b9f-81da-2cef5210fb73" xlink:href="cvs-20230525.xsd#cvs_TreasuryStockValueSharesHeldInTrust"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_023a743c-1bb3-42ca-919c-0b69ee280f6f" xlink:to="loc_cvs_TreasuryStockValueSharesHeldInTrust_ce54cf8d-7fec-4b9f-81da-2cef5210fb73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_0f3f0d42-514d-468b-b2a2-7872b12cbca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_023a743c-1bb3-42ca-919c-0b69ee280f6f" xlink:to="loc_us-gaap_CommonStockValue_0f3f0d42-514d-468b-b2a2-7872b12cbca8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_28de27d7-9d14-4a82-85b3-81ddaa25619b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_023a743c-1bb3-42ca-919c-0b69ee280f6f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_28de27d7-9d14-4a82-85b3-81ddaa25619b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_c5a8e14a-a457-46b7-967f-b3e78be7faa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_023a743c-1bb3-42ca-919c-0b69ee280f6f" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_c5a8e14a-a457-46b7-967f-b3e78be7faa8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_03f50f70-d24f-4a41-92fa-9a1efdd2d77d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_023a743c-1bb3-42ca-919c-0b69ee280f6f" xlink:to="loc_us-gaap_StatementTable_03f50f70-d24f-4a41-92fa-9a1efdd2d77d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f41059d8-a413-494d-9c29-8d073ec6631d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_03f50f70-d24f-4a41-92fa-9a1efdd2d77d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f41059d8-a413-494d-9c29-8d073ec6631d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f41059d8-a413-494d-9c29-8d073ec6631d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f41059d8-a413-494d-9c29-8d073ec6631d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f41059d8-a413-494d-9c29-8d073ec6631d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d6eaa515-39ff-4d06-a9de-d7fe1f296d0d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f41059d8-a413-494d-9c29-8d073ec6631d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d6eaa515-39ff-4d06-a9de-d7fe1f296d0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_57c74817-4641-4fbf-a5d5-ffc8d1a327ba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d6eaa515-39ff-4d06-a9de-d7fe1f296d0d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_57c74817-4641-4fbf-a5d5-ffc8d1a327ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c3117a44-1609-4f92-81a2-82d3ab0773dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_03f50f70-d24f-4a41-92fa-9a1efdd2d77d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c3117a44-1609-4f92-81a2-82d3ab0773dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c3117a44-1609-4f92-81a2-82d3ab0773dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c3117a44-1609-4f92-81a2-82d3ab0773dc" xlink:to="loc_us-gaap_EquityComponentDomain_c3117a44-1609-4f92-81a2-82d3ab0773dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8c5cb3dd-8942-4f53-abf9-1d202a683cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c3117a44-1609-4f92-81a2-82d3ab0773dc" xlink:to="loc_us-gaap_EquityComponentDomain_8c5cb3dd-8942-4f53-abf9-1d202a683cf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6e079a5b-1b25-4061-8690-ecae41a8882d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8c5cb3dd-8942-4f53-abf9-1d202a683cf7" xlink:to="loc_us-gaap_RetainedEarningsMember_6e079a5b-1b25-4061-8690-ecae41a8882d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_3ed0ae4b-a8a2-449c-9fec-34f2934f34f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_03f50f70-d24f-4a41-92fa-9a1efdd2d77d" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_3ed0ae4b-a8a2-449c-9fec-34f2934f34f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_3ed0ae4b-a8a2-449c-9fec-34f2934f34f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_3ed0ae4b-a8a2-449c-9fec-34f2934f34f8" xlink:to="loc_us-gaap_TypeOfAdoptionMember_3ed0ae4b-a8a2-449c-9fec-34f2934f34f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_6cb26cc3-c580-4232-8d15-5d29c97726f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_3ed0ae4b-a8a2-449c-9fec-34f2934f34f8" xlink:to="loc_us-gaap_TypeOfAdoptionMember_6cb26cc3-c580-4232-8d15-5d29c97726f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_db6d36f5-a3c3-4297-be36-6c977107b07d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_6cb26cc3-c580-4232-8d15-5d29c97726f7" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_db6d36f5-a3c3-4297-be36-6c977107b07d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="ie472554dd68c43d7a8fc7a7436ef0a44_SignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_c963c2af-f772-468a-b830-19aa252c007d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStores"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_NumberOfStores_c963c2af-f772-468a-b830-19aa252c007d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfWalkInMedicalClinics_e8093fbb-bc27-4f80-8667-b817e4563841" xlink:href="cvs-20230525.xsd#cvs_NumberOfWalkInMedicalClinics"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_NumberOfWalkInMedicalClinics_e8093fbb-bc27-4f80-8667-b817e4563841" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPharmacyPlanMembers_d0e627a4-3fb3-4ca8-9bb0-ce0733813720" xlink:href="cvs-20230525.xsd#cvs_NumberOfPharmacyPlanMembers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_NumberOfPharmacyPlanMembers_d0e627a4-3fb3-4ca8-9bb0-ce0733813720" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPatientsServedPerYear_0af0185a-6e11-43b0-badb-bd8c17bb2002" xlink:href="cvs-20230525.xsd#cvs_NumberOfPatientsServedPerYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_NumberOfPatientsServedPerYear_0af0185a-6e11-43b0-badb-bd8c17bb2002" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPeopleServed_396c5217-6995-464f-9ee5-59842152b4e1" xlink:href="cvs-20230525.xsd#cvs_NumberOfPeopleServed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_NumberOfPeopleServed_396c5217-6995-464f-9ee5-59842152b4e1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_7e532698-2038-4f64-94c9-7fa408efea5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_NumberOfReportableSegments_7e532698-2038-4f64-94c9-7fa408efea5b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates_6d53a5f2-cf59-413d-866b-0d2123c97d28" xlink:href="cvs-20230525.xsd#cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates_6d53a5f2-cf59-413d-866b-0d2123c97d28" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates_9b05650f-26c5-42c8-81da-00d205edf7a3" xlink:href="cvs-20230525.xsd#cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates_9b05650f-26c5-42c8-81da-00d205edf7a3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts_a1e2959f-cd66-4c76-a521-939eced662c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCosts_a1e2959f-cd66-4c76-a521-939eced662c3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_28c89e08-32f6-4c25-a4cf-53c9053ef477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_28c89e08-32f6-4c25-a4cf-53c9053ef477" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_819959e0-bbff-4244-be38-da69341be3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_Depreciation_819959e0-bbff-4244-be38-da69341be3a8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OfficeRealEstateOptimizationCharges_a2f2b8a9-65e9-47d7-99c2-31e41d97ad07" xlink:href="cvs-20230525.xsd#cvs_OfficeRealEstateOptimizationCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_OfficeRealEstateOptimizationCharges_a2f2b8a9-65e9-47d7-99c2-31e41d97ad07" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges_782e8684-16b3-47ba-8093-9843e75a89a5" xlink:href="cvs-20230525.xsd#cvs_StoreImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_StoreImpairmentCharges_782e8684-16b3-47ba-8093-9843e75a89a5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm_209d4615-8da1-4425-bf57-b98153a9295d" xlink:href="cvs-20230525.xsd#cvs_LesseeOperatingAndFinanceLeasesRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm_209d4615-8da1-4425-bf57-b98153a9295d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresPlannedClosure_9b944101-ba4f-4712-94cc-ec99202499d6" xlink:href="cvs-20230525.xsd#cvs_NumberOfStoresPlannedClosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_NumberOfStoresPlannedClosure_9b944101-ba4f-4712-94cc-ec99202499d6" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_0697e07e-b1a2-4c2a-8826-728513572571" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_0697e07e-b1a2-4c2a-8826-728513572571" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_3b267562-b69a-4562-8b42-3e58b7d42135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_3b267562-b69a-4562-8b42-3e58b7d42135" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid_56a475d0-6d6d-44fd-882c-0e090d8e63b0" xlink:href="cvs-20230525.xsd#cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid_56a475d0-6d6d-44fd-882c-0e090d8e63b0" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaims_892b880b-e298-47c0-b3eb-d2b9b95982b7" xlink:href="cvs-20230525.xsd#cvs_LiabilityForUnpaidClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_LiabilityForUnpaidClaims_892b880b-e298-47c0-b3eb-d2b9b95982b7" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_a30ac392-e4f1-4e52-bf08-4fb883545158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefits_a30ac392-e4f1-4e52-bf08-4fb883545158" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_d86032df-ffeb-410c-adda-4db664b38212" xlink:href="cvs-20230525.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_d86032df-ffeb-410c-adda-4db664b38212" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PensionAndAnnuityInvestmentContractsInterest_a6d9333c-db4a-4a7c-80a3-c99e16f54c5b" xlink:href="cvs-20230525.xsd#cvs_PensionAndAnnuityInvestmentContractsInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_PensionAndAnnuityInvestmentContractsInterest_a6d9333c-db4a-4a7c-80a3-c99e16f54c5b" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeathSavingsAccountBalance_9ee085fa-6bc0-432e-8cdd-e94df7b6f859" xlink:href="cvs-20230525.xsd#cvs_HeathSavingsAccountBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_HeathSavingsAccountBalance_9ee085fa-6bc0-432e-8cdd-e94df7b6f859" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_e3c1b170-d066-4edb-809f-e4ef62321d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_SelfInsuranceReserve_e3c1b170-d066-4edb-809f-e4ef62321d4f" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRebatePeriod_5b98493d-cf82-4564-ace3-39c000c94923" xlink:href="cvs-20230525.xsd#cvs_PharmacyRebatePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_PharmacyRebatePeriod_5b98493d-cf82-4564-ace3-39c000c94923" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFee_cb3fd5b3-7c42-4674-88fa-285db8ba85fb" xlink:href="cvs-20230525.xsd#cvs_HealthInsurerFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_HealthInsurerFee_cb3fd5b3-7c42-4674-88fa-285db8ba85fb" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyUnrecordedAmount_942f5d54-e864-4710-82d8-85269a363e88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainContingencyUnrecordedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_GainContingencyUnrecordedAmount_942f5d54-e864-4710-82d8-85269a363e88" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_00290522-faa5-485c-9666-d55e6d3e4c55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_00290522-faa5-485c-9666-d55e6d3e4c55" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_89f5ad20-4638-4f4c-bd6d-f37d3784170e" xlink:href="cvs-20230525.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_89f5ad20-4638-4f4c-bd6d-f37d3784170e" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_74032544-6ca0-445b-aab1-acc1b515f144" xlink:href="cvs-20230525.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_74032544-6ca0-445b-aab1-acc1b515f144" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_2aab7a0e-ee63-46a8-af90-370342e8d516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_AdvertisingExpense_2aab7a0e-ee63-46a8-af90-370342e8d516" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_63541884-3618-4b78-b548-944838b27a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_63541884-3618-4b78-b548-944838b27a6d" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust_90b37b21-67ec-4636-89da-64251f3625e4" xlink:href="cvs-20230525.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_TreasuryStockSharesHeldinTrust_90b37b21-67ec-4636-89da-64251f3625e4" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_ed019fd6-5c90-4bff-ba07-65ac4d4e389d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_ed019fd6-5c90-4bff-ba07-65ac4d4e389d" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_1123dd70-586e-4bba-afa8-8c84ca146f39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_1123dd70-586e-4bba-afa8-8c84ca146f39" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_25045f37-210f-4900-bce3-fdc02171bff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_25045f37-210f-4900-bce3-fdc02171bff2" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity_80836ec7-827e-4aac-9022-f2ff719ea279" xlink:href="cvs-20230525.xsd#cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity_80836ec7-827e-4aac-9022-f2ff719ea279" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_cba5583b-e7ff-4a03-90a8-77242be348d9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:to="loc_srt_ProductOrServiceAxis_cba5583b-e7ff-4a03-90a8-77242be348d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cba5583b-e7ff-4a03-90a8-77242be348d9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_cba5583b-e7ff-4a03-90a8-77242be348d9" xlink:to="loc_srt_ProductsAndServicesDomain_cba5583b-e7ff-4a03-90a8-77242be348d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_26e081a3-18e5-490b-9870-365f0887eaea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_cba5583b-e7ff-4a03-90a8-77242be348d9" xlink:to="loc_srt_ProductsAndServicesDomain_26e081a3-18e5-490b-9870-365f0887eaea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_cbdfefd7-3b43-49c8-a7d2-6834fd4b8093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_26e081a3-18e5-490b-9870-365f0887eaea" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_cbdfefd7-3b43-49c8-a7d2-6834fd4b8093" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c9b67edf-49e4-44c9-8284-ddc8507d3d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c9b67edf-49e4-44c9-8284-ddc8507d3d10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c9b67edf-49e4-44c9-8284-ddc8507d3d10_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c9b67edf-49e4-44c9-8284-ddc8507d3d10" xlink:to="loc_us-gaap_SegmentDomain_c9b67edf-49e4-44c9-8284-ddc8507d3d10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_de1bc7d8-fd96-4857-a942-3e4985f78353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c9b67edf-49e4-44c9-8284-ddc8507d3d10" xlink:to="loc_us-gaap_SegmentDomain_de1bc7d8-fd96-4857-a942-3e4985f78353" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_e0570a4e-50ac-47e2-aa43-07e44db56941" xlink:href="cvs-20230525.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_de1bc7d8-fd96-4857-a942-3e4985f78353" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_e0570a4e-50ac-47e2-aa43-07e44db56941" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthServicesSegmentMember_1dd12d54-9e1a-4ac3-b590-eb7ff8803bf1" xlink:href="cvs-20230525.xsd#cvs_HealthServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_de1bc7d8-fd96-4857-a942-3e4985f78353" xlink:to="loc_cvs_HealthServicesSegmentMember_1dd12d54-9e1a-4ac3-b590-eb7ff8803bf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_3b1377f6-679a-42ca-981e-95c422aec030" xlink:href="cvs-20230525.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_de1bc7d8-fd96-4857-a942-3e4985f78353" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_3b1377f6-679a-42ca-981e-95c422aec030" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_735981d2-0a4e-4a3f-b2cc-a44724b58507" xlink:href="cvs-20230525.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_de1bc7d8-fd96-4857-a942-3e4985f78353" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_735981d2-0a4e-4a3f-b2cc-a44724b58507" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d057c69d-8f43-4946-828c-e19ccf963199" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:to="loc_srt_RangeAxis_d057c69d-8f43-4946-828c-e19ccf963199" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d057c69d-8f43-4946-828c-e19ccf963199_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d057c69d-8f43-4946-828c-e19ccf963199" xlink:to="loc_srt_RangeMember_d057c69d-8f43-4946-828c-e19ccf963199_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cc5bcf85-a198-4584-a292-95d3723227bc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d057c69d-8f43-4946-828c-e19ccf963199" xlink:to="loc_srt_RangeMember_cc5bcf85-a198-4584-a292-95d3723227bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a6b498fa-e326-43b3-87ca-96980a744d34" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cc5bcf85-a198-4584-a292-95d3723227bc" xlink:to="loc_srt_MinimumMember_a6b498fa-e326-43b3-87ca-96980a744d34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a5e057e9-b270-494b-b675-30e1d2389996" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cc5bcf85-a198-4584-a292-95d3723227bc" xlink:to="loc_srt_MaximumMember_a5e057e9-b270-494b-b675-30e1d2389996" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_add3a55d-a8bf-4c25-88c3-0dc2b77feb6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_add3a55d-a8bf-4c25-88c3-0dc2b77feb6d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_add3a55d-a8bf-4c25-88c3-0dc2b77feb6d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_add3a55d-a8bf-4c25-88c3-0dc2b77feb6d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_add3a55d-a8bf-4c25-88c3-0dc2b77feb6d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7632625d-1fd6-40fc-883a-9036c21b7c02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_add3a55d-a8bf-4c25-88c3-0dc2b77feb6d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7632625d-1fd6-40fc-883a-9036c21b7c02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_cc4d39c0-6c47-4708-92d0-df3b1b2502c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7632625d-1fd6-40fc-883a-9036c21b7c02" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_cc4d39c0-6c47-4708-92d0-df3b1b2502c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember_8daccd79-7af6-488e-b2ee-54bc382ba598" xlink:href="cvs-20230525.xsd#cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7632625d-1fd6-40fc-883a-9036c21b7c02" xlink:to="loc_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember_8daccd79-7af6-488e-b2ee-54bc382ba598" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_255b078e-f91e-4ffc-97ce-e9c4a9977f78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7632625d-1fd6-40fc-883a-9036c21b7c02" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_255b078e-f91e-4ffc-97ce-e9c4a9977f78" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_bcf9ca9f-22aa-4374-8bb0-48513a16ac50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_bcf9ca9f-22aa-4374-8bb0-48513a16ac50" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_bcf9ca9f-22aa-4374-8bb0-48513a16ac50_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_bcf9ca9f-22aa-4374-8bb0-48513a16ac50" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_bcf9ca9f-22aa-4374-8bb0-48513a16ac50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_cc878043-2e15-49f0-bfd5-737443b78c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_bcf9ca9f-22aa-4374-8bb0-48513a16ac50" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_cc878043-2e15-49f0-bfd5-737443b78c33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesMember_abe462d7-72e7-4da8-a453-08ede7ee2b83" xlink:href="cvs-20230525.xsd#cvs_OtherInsuranceLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_cc878043-2e15-49f0-bfd5-737443b78c33" xlink:to="loc_cvs_OtherInsuranceLiabilitiesMember_abe462d7-72e7-4da8-a453-08ede7ee2b83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherLongTermInsuranceLiabilitiesMember_2b0b0800-967e-4c1f-a626-c0aec527db5a" xlink:href="cvs-20230525.xsd#cvs_OtherLongTermInsuranceLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_cc878043-2e15-49f0-bfd5-737443b78c33" xlink:to="loc_cvs_OtherLongTermInsuranceLiabilitiesMember_2b0b0800-967e-4c1f-a626-c0aec527db5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_04a94295-8405-4ad8-8d71-d20bddc22df8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:to="loc_dei_LegalEntityAxis_04a94295-8405-4ad8-8d71-d20bddc22df8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_04a94295-8405-4ad8-8d71-d20bddc22df8_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_04a94295-8405-4ad8-8d71-d20bddc22df8" xlink:to="loc_dei_EntityDomain_04a94295-8405-4ad8-8d71-d20bddc22df8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_15112133-8845-4927-aeeb-a5074212690f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_04a94295-8405-4ad8-8d71-d20bddc22df8" xlink:to="loc_dei_EntityDomain_15112133-8845-4927-aeeb-a5074212690f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember_cee7df7d-a287-4363-a468-61da725bf085" xlink:href="cvs-20230525.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_15112133-8845-4927-aeeb-a5074212690f" xlink:to="loc_cvs_HeartlandHealthcareServicesMember_cee7df7d-a287-4363-a468-61da725bf085" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_51b0622d-59eb-4e66-9113-e7ac404b14d1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:to="loc_srt_LitigationCaseAxis_51b0622d-59eb-4e66-9113-e7ac404b14d1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_51b0622d-59eb-4e66-9113-e7ac404b14d1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_51b0622d-59eb-4e66-9113-e7ac404b14d1" xlink:to="loc_srt_LitigationCaseTypeDomain_51b0622d-59eb-4e66-9113-e7ac404b14d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_18c1bc26-115c-4f51-9548-811f2aafb0d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_51b0622d-59eb-4e66-9113-e7ac404b14d1" xlink:to="loc_srt_LitigationCaseTypeDomain_18c1bc26-115c-4f51-9548-811f2aafb0d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_13245d85-e308-4893-a93b-d452edbdd0ff" xlink:href="cvs-20230525.xsd#cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_18c1bc26-115c-4f51-9548-811f2aafb0d4" xlink:to="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_13245d85-e308-4893-a93b-d452edbdd0ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_4ea5bd0e-3dc1-4892-86de-ce65d27a9e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:to="loc_us-gaap_LitigationStatusAxis_4ea5bd0e-3dc1-4892-86de-ce65d27a9e2d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_4ea5bd0e-3dc1-4892-86de-ce65d27a9e2d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_4ea5bd0e-3dc1-4892-86de-ce65d27a9e2d" xlink:to="loc_us-gaap_LitigationStatusDomain_4ea5bd0e-3dc1-4892-86de-ce65d27a9e2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_dc58352c-4ebd-40fe-87f1-2ff87e17a899" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_4ea5bd0e-3dc1-4892-86de-ce65d27a9e2d" xlink:to="loc_us-gaap_LitigationStatusDomain_dc58352c-4ebd-40fe-87f1-2ff87e17a899" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_78f33e80-918a-452f-aff5-dc8b88d924aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_dc58352c-4ebd-40fe-87f1-2ff87e17a899" xlink:to="loc_us-gaap_SettledLitigationMember_78f33e80-918a-452f-aff5-dc8b88d924aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a6723ea6-4180-42e8-8ddf-d07dee4d54d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:to="loc_srt_StatementScenarioAxis_a6723ea6-4180-42e8-8ddf-d07dee4d54d4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a6723ea6-4180-42e8-8ddf-d07dee4d54d4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_a6723ea6-4180-42e8-8ddf-d07dee4d54d4" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a6723ea6-4180-42e8-8ddf-d07dee4d54d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f15c94eb-38de-4ea8-a590-8a0580874658" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_a6723ea6-4180-42e8-8ddf-d07dee4d54d4" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f15c94eb-38de-4ea8-a590-8a0580874658" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_06c6befc-d2c5-4f0b-bdf6-ae2a3cffe9bd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_f15c94eb-38de-4ea8-a590-8a0580874658" xlink:to="loc_srt_ScenarioForecastMember_06c6befc-d2c5-4f0b-bdf6-ae2a3cffe9bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_319aeca1-1b2a-4462-88b9-892b68ab6ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:to="loc_us-gaap_ReportingUnitAxis_319aeca1-1b2a-4462-88b9-892b68ab6ff7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_319aeca1-1b2a-4462-88b9-892b68ab6ff7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_319aeca1-1b2a-4462-88b9-892b68ab6ff7" xlink:to="loc_us-gaap_ReportingUnitDomain_319aeca1-1b2a-4462-88b9-892b68ab6ff7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_2c42eaff-4f11-4bde-9c76-a25e2dd6e87b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_319aeca1-1b2a-4462-88b9-892b68ab6ff7" xlink:to="loc_us-gaap_ReportingUnitDomain_2c42eaff-4f11-4bde-9c76-a25e2dd6e87b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareReportingUnitMember_2895e687-634b-49d0-9035-5d8657650509" xlink:href="cvs-20230525.xsd#cvs_LongTermCareReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_2c42eaff-4f11-4bde-9c76-a25e2dd6e87b" xlink:to="loc_cvs_LongTermCareReportingUnitMember_2895e687-634b-49d0-9035-5d8657650509" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SignificantAccountingPoliciesAccountsReceivableDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="extended" id="if766715515e0470c8ed70d00d84d8230_SignificantAccountingPoliciesAccountsReceivableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_24fed575-05f6-46ff-b447-6960568aa88b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_246a12ab-d05f-4585-a1f4-2395d56e4e93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_24fed575-05f6-46ff-b447-6960568aa88b" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_246a12ab-d05f-4585-a1f4-2395d56e4e93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorandManufacturerReceivables_fb2d764a-1987-4f51-9b25-e34325a1f955" xlink:href="cvs-20230525.xsd#cvs_VendorandManufacturerReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_24fed575-05f6-46ff-b447-6960568aa88b" xlink:to="loc_cvs_VendorandManufacturerReceivables_fb2d764a-1987-4f51-9b25-e34325a1f955" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_060a9566-066c-4548-81de-fe5392f4cf59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_24fed575-05f6-46ff-b447-6960568aa88b" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_060a9566-066c-4548-81de-fe5392f4cf59" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_c802a440-3bd3-4ba5-98b7-cbde9eca5ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_24fed575-05f6-46ff-b447-6960568aa88b" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_c802a440-3bd3-4ba5-98b7-cbde9eca5ea6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_da0e3caf-6e2d-4763-8bc9-8f02598266d7" xlink:href="cvs-20230525.xsd#cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_24fed575-05f6-46ff-b447-6960568aa88b" xlink:to="loc_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_da0e3caf-6e2d-4763-8bc9-8f02598266d7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_413202ef-0091-4222-bae0-1fe4fc210209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_24fed575-05f6-46ff-b447-6960568aa88b" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_413202ef-0091-4222-bae0-1fe4fc210209" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_e595722a-d676-4194-9c0c-b1d1899055e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_24fed575-05f6-46ff-b447-6960568aa88b" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_e595722a-d676-4194-9c0c-b1d1899055e5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d91a5d81-3dba-4750-bc6a-da08de419a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_e595722a-d676-4194-9c0c-b1d1899055e5" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d91a5d81-3dba-4750-bc6a-da08de419a7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d91a5d81-3dba-4750-bc6a-da08de419a7c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d91a5d81-3dba-4750-bc6a-da08de419a7c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d91a5d81-3dba-4750-bc6a-da08de419a7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_282ae83a-411b-4f9b-acc9-ca151c2aeac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d91a5d81-3dba-4750-bc6a-da08de419a7c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_282ae83a-411b-4f9b-acc9-ca151c2aeac3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_88c1bd76-dc5c-4247-acec-b91198d7e945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_282ae83a-411b-4f9b-acc9-ca151c2aeac3" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_88c1bd76-dc5c-4247-acec-b91198d7e945" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SignificantAccountingPoliciesPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="extended" id="ib1418e30c43b43699ffb5f9f9acf0944_SignificantAccountingPoliciesPropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_07768f12-bcfb-4d59-a855-d1a37918b79f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_b5ca1fe6-3d46-4287-808e-91e39ab9a0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_07768f12-bcfb-4d59-a855-d1a37918b79f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_b5ca1fe6-3d46-4287-808e-91e39ab9a0c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ca520f4c-e792-4390-8808-2e99bab0713d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_07768f12-bcfb-4d59-a855-d1a37918b79f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ca520f4c-e792-4390-8808-2e99bab0713d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale_5bf021e9-bef4-4e6c-85d3-800d9abed819" xlink:href="cvs-20230525.xsd#cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_07768f12-bcfb-4d59-a855-d1a37918b79f" xlink:to="loc_cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale_5bf021e9-bef4-4e6c-85d3-800d9abed819" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3d08204e-91f5-4660-973b-a52b1b904c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_07768f12-bcfb-4d59-a855-d1a37918b79f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3d08204e-91f5-4660-973b-a52b1b904c2e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6c30287f-c4f4-444f-8d26-624f7f9e71c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3d08204e-91f5-4660-973b-a52b1b904c2e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6c30287f-c4f4-444f-8d26-624f7f9e71c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6c30287f-c4f4-444f-8d26-624f7f9e71c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6c30287f-c4f4-444f-8d26-624f7f9e71c2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6c30287f-c4f4-444f-8d26-624f7f9e71c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_86baff2e-51e4-4c9c-ad69-63a45832883f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6c30287f-c4f4-444f-8d26-624f7f9e71c2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_86baff2e-51e4-4c9c-ad69-63a45832883f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_34369bff-8082-45af-ae96-b41abb8cf92d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_86baff2e-51e4-4c9c-ad69-63a45832883f" xlink:to="loc_us-gaap_LandMember_34369bff-8082-45af-ae96-b41abb8cf92d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_f57099da-1178-4be6-ae51-715759191cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_86baff2e-51e4-4c9c-ad69-63a45832883f" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_f57099da-1178-4be6-ae51-715759191cb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_23f63bb5-2274-46a9-90ca-a2e4a58adcdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_86baff2e-51e4-4c9c-ad69-63a45832883f" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_23f63bb5-2274-46a9-90ca-a2e4a58adcdf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_cdfa7bde-fbeb-4257-9fe7-c840315850c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_86baff2e-51e4-4c9c-ad69-63a45832883f" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_cdfa7bde-fbeb-4257-9fe7-c840315850c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_c77c1724-0be4-4b3b-a87e-8f159cbad9a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_86baff2e-51e4-4c9c-ad69-63a45832883f" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_c77c1724-0be4-4b3b-a87e-8f159cbad9a3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_c5a62e73-75b2-454a-ac55-60fb86c3bcd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3d08204e-91f5-4660-973b-a52b1b904c2e" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_c5a62e73-75b2-454a-ac55-60fb86c3bcd4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c5a62e73-75b2-454a-ac55-60fb86c3bcd4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c5a62e73-75b2-454a-ac55-60fb86c3bcd4" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c5a62e73-75b2-454a-ac55-60fb86c3bcd4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_49123996-e8a3-4c5a-ae65-245a72638581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c5a62e73-75b2-454a-ac55-60fb86c3bcd4" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_49123996-e8a3-4c5a-ae65-245a72638581" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_99fd869d-ded7-43e0-a469-d77e820d5395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_49123996-e8a3-4c5a-ae65-245a72638581" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_99fd869d-ded7-43e0-a469-d77e820d5395" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SignificantAccountingPoliciesDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="extended" id="i5e4b3a930ebf43d0972cef49affb2a6d_SignificantAccountingPoliciesDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_55eb9b3f-4820-4a24-91e1-6ec2eeb8c6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_a2e08417-cbd1-4410-90df-ebc5212675b1" xlink:href="cvs-20230525.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_55eb9b3f-4820-4a24-91e1-6ec2eeb8c6f3" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_a2e08417-cbd1-4410-90df-ebc5212675b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_4fd857ad-9e23-4fdc-b6a8-1d22d9f4168b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_55eb9b3f-4820-4a24-91e1-6ec2eeb8c6f3" xlink:to="loc_us-gaap_NetInvestmentIncome_4fd857ad-9e23-4fdc-b6a8-1d22d9f4168b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_97b7f485-386a-45cb-a077-5f62a457d591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_55eb9b3f-4820-4a24-91e1-6ec2eeb8c6f3" xlink:to="loc_us-gaap_Revenues_97b7f485-386a-45cb-a077-5f62a457d591" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ef8837ac-4960-4b6a-b2e8-71ea77cb90f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_55eb9b3f-4820-4a24-91e1-6ec2eeb8c6f3" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ef8837ac-4960-4b6a-b2e8-71ea77cb90f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_0a7e09d6-1ca7-4ee1-a06b-432b50f4b4ea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ef8837ac-4960-4b6a-b2e8-71ea77cb90f1" xlink:to="loc_srt_ConsolidationItemsAxis_0a7e09d6-1ca7-4ee1-a06b-432b50f4b4ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_0a7e09d6-1ca7-4ee1-a06b-432b50f4b4ea_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_0a7e09d6-1ca7-4ee1-a06b-432b50f4b4ea" xlink:to="loc_srt_ConsolidationItemsDomain_0a7e09d6-1ca7-4ee1-a06b-432b50f4b4ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_904a96df-cb7e-4a7d-a049-ce05df4aee8c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_0a7e09d6-1ca7-4ee1-a06b-432b50f4b4ea" xlink:to="loc_srt_ConsolidationItemsDomain_904a96df-cb7e-4a7d-a049-ce05df4aee8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_2f99b999-5a88-4212-9f88-80c456d1909d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_904a96df-cb7e-4a7d-a049-ce05df4aee8c" xlink:to="loc_us-gaap_OperatingSegmentsMember_2f99b999-5a88-4212-9f88-80c456d1909d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_deabb206-1df6-4029-b21c-cc491d50fb93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_904a96df-cb7e-4a7d-a049-ce05df4aee8c" xlink:to="loc_us-gaap_CorporateNonSegmentMember_deabb206-1df6-4029-b21c-cc491d50fb93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_9cbd58ac-a724-4807-aa9b-9225252324d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_904a96df-cb7e-4a7d-a049-ce05df4aee8c" xlink:to="loc_us-gaap_IntersegmentEliminationMember_9cbd58ac-a724-4807-aa9b-9225252324d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7f2709aa-a8cf-4990-bc85-5c869143a0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ef8837ac-4960-4b6a-b2e8-71ea77cb90f1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7f2709aa-a8cf-4990-bc85-5c869143a0dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7f2709aa-a8cf-4990-bc85-5c869143a0dd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7f2709aa-a8cf-4990-bc85-5c869143a0dd" xlink:to="loc_us-gaap_SegmentDomain_7f2709aa-a8cf-4990-bc85-5c869143a0dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2abd309a-781b-45ef-97b2-99694a214759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7f2709aa-a8cf-4990-bc85-5c869143a0dd" xlink:to="loc_us-gaap_SegmentDomain_2abd309a-781b-45ef-97b2-99694a214759" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_8479c731-607c-4019-95b2-4b06e17c31a3" xlink:href="cvs-20230525.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2abd309a-781b-45ef-97b2-99694a214759" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_8479c731-607c-4019-95b2-4b06e17c31a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthServicesSegmentMember_e658cad2-b3cf-4b96-8f73-245b7889952f" xlink:href="cvs-20230525.xsd#cvs_HealthServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2abd309a-781b-45ef-97b2-99694a214759" xlink:to="loc_cvs_HealthServicesSegmentMember_e658cad2-b3cf-4b96-8f73-245b7889952f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_35c7198d-58db-4547-aff4-e5f264fb1174" xlink:href="cvs-20230525.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2abd309a-781b-45ef-97b2-99694a214759" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_35c7198d-58db-4547-aff4-e5f264fb1174" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_99cdc4a0-3d26-43b5-9ace-1d50e2b3ba89" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ef8837ac-4960-4b6a-b2e8-71ea77cb90f1" xlink:to="loc_srt_ProductOrServiceAxis_99cdc4a0-3d26-43b5-9ace-1d50e2b3ba89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_99cdc4a0-3d26-43b5-9ace-1d50e2b3ba89_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_99cdc4a0-3d26-43b5-9ace-1d50e2b3ba89" xlink:to="loc_srt_ProductsAndServicesDomain_99cdc4a0-3d26-43b5-9ace-1d50e2b3ba89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5d3d65cf-c918-413a-b152-09fcfe2272a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_99cdc4a0-3d26-43b5-9ace-1d50e2b3ba89" xlink:to="loc_srt_ProductsAndServicesDomain_5d3d65cf-c918-413a-b152-09fcfe2272a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember_7b8f40de-db29-4a09-abb4-be141e472615" xlink:href="cvs-20230525.xsd#cvs_PharmacyRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5d3d65cf-c918-413a-b152-09fcfe2272a9" xlink:to="loc_cvs_PharmacyRevenueMember_7b8f40de-db29-4a09-abb4-be141e472615" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember_f08b0b7a-e9c5-4531-b14e-8ded69f24631" xlink:href="cvs-20230525.xsd#cvs_FrontStoreRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5d3d65cf-c918-413a-b152-09fcfe2272a9" xlink:to="loc_cvs_FrontStoreRevenueMember_f08b0b7a-e9c5-4531-b14e-8ded69f24631" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember_e37893d0-bdfb-4b9c-80aa-1ccf794f59dc" xlink:href="cvs-20230525.xsd#cvs_PremiumsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5d3d65cf-c918-413a-b152-09fcfe2272a9" xlink:to="loc_cvs_PremiumsMember_e37893d0-bdfb-4b9c-80aa-1ccf794f59dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_075e2757-7aa9-4e3c-907e-7e17814616b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5d3d65cf-c918-413a-b152-09fcfe2272a9" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_075e2757-7aa9-4e3c-907e-7e17814616b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_03e11827-5487-4adb-91ff-81e48779709b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ef8837ac-4960-4b6a-b2e8-71ea77cb90f1" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_03e11827-5487-4adb-91ff-81e48779709b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_03e11827-5487-4adb-91ff-81e48779709b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_03e11827-5487-4adb-91ff-81e48779709b" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_03e11827-5487-4adb-91ff-81e48779709b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_d8909628-18fd-4103-bc00-8dec6119fea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_03e11827-5487-4adb-91ff-81e48779709b" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_d8909628-18fd-4103-bc00-8dec6119fea6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_90cbd969-de03-41c6-932e-c6841d34ff16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_d8909628-18fd-4103-bc00-8dec6119fea6" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_90cbd969-de03-41c6-932e-c6841d34ff16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_da363181-6a1c-4cbc-b661-7d16aebd8209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_d8909628-18fd-4103-bc00-8dec6119fea6" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_da363181-6a1c-4cbc-b661-7d16aebd8209" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember_2b138fc2-b3c3-4333-876d-fe5b2ecb7828" xlink:href="cvs-20230525.xsd#cvs_SalesChannelOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_d8909628-18fd-4103-bc00-8dec6119fea6" xlink:to="loc_cvs_SalesChannelOtherMember_2b138fc2-b3c3-4333-876d-fe5b2ecb7828" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SignificantAccountingPoliciesVariableInterestEntitiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails" xlink:type="extended" id="i2bcbedfb982e449ea0335b0948e2705f_SignificantAccountingPoliciesVariableInterestEntitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_4b9e0c3e-2362-4d93-acb6-e85349fa10d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_f57d045f-54c0-45df-a777-aa595c781e68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4b9e0c3e-2362-4d93-acb6-e85349fa10d2" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_f57d045f-54c0-45df-a777-aa595c781e68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InitialContractualTerm_10edacb8-cbda-44c4-bead-6cbd57b7887f" xlink:href="cvs-20230525.xsd#cvs_InitialContractualTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4b9e0c3e-2362-4d93-acb6-e85349fa10d2" xlink:to="loc_cvs_InitialContractualTerm_10edacb8-cbda-44c4-bead-6cbd57b7887f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VariableInterestEntityAmendedContractExtensionTerm_50eff438-d6d6-4031-94ad-1d50f8c02bb1" xlink:href="cvs-20230525.xsd#cvs_VariableInterestEntityAmendedContractExtensionTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4b9e0c3e-2362-4d93-acb6-e85349fa10d2" xlink:to="loc_cvs_VariableInterestEntityAmendedContractExtensionTerm_50eff438-d6d6-4031-94ad-1d50f8c02bb1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VariableInterestEntityAmendedContractTerm_9642ad55-240a-4162-96f1-404eca23691e" xlink:href="cvs-20230525.xsd#cvs_VariableInterestEntityAmendedContractTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4b9e0c3e-2362-4d93-acb6-e85349fa10d2" xlink:to="loc_cvs_VariableInterestEntityAmendedContractTerm_9642ad55-240a-4162-96f1-404eca23691e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsFromVariableInterestEntity_b09e1d56-2cbe-4faa-b477-bd9736c18081" xlink:href="cvs-20230525.xsd#cvs_ProceedsFromVariableInterestEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4b9e0c3e-2362-4d93-acb6-e85349fa10d2" xlink:to="loc_cvs_ProceedsFromVariableInterestEntity_b09e1d56-2cbe-4faa-b477-bd9736c18081" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_b6662f8a-8b0c-4fd4-ba1c-c66ce73fd239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4b9e0c3e-2362-4d93-acb6-e85349fa10d2" xlink:to="loc_us-gaap_LongTermInvestments_b6662f8a-8b0c-4fd4-ba1c-c66ce73fd239" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_910fdf21-ec6b-457a-aa81-1077e942f591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4b9e0c3e-2362-4d93-acb6-e85349fa10d2" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_910fdf21-ec6b-457a-aa81-1077e942f591" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_4d4dfe47-eb11-414c-ae93-2595d9f14b57" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_910fdf21-ec6b-457a-aa81-1077e942f591" xlink:to="loc_srt_ConsolidatedEntitiesAxis_4d4dfe47-eb11-414c-ae93-2595d9f14b57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_4d4dfe47-eb11-414c-ae93-2595d9f14b57_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_4d4dfe47-eb11-414c-ae93-2595d9f14b57" xlink:to="loc_srt_ConsolidatedEntitiesDomain_4d4dfe47-eb11-414c-ae93-2595d9f14b57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_f69b781a-795d-4231-9758-625fac6f3381" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_4d4dfe47-eb11-414c-ae93-2595d9f14b57" xlink:to="loc_srt_ConsolidatedEntitiesDomain_f69b781a-795d-4231-9758-625fac6f3381" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_0aec513e-a0e4-4bcf-b1be-77b2b8632eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_f69b781a-795d-4231-9758-625fac6f3381" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_0aec513e-a0e4-4bcf-b1be-77b2b8632eb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_4b5ce650-9a5b-4c7a-ae05-d4e1dcd26961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_910fdf21-ec6b-457a-aa81-1077e942f591" xlink:to="loc_us-gaap_InvestmentTypeAxis_4b5ce650-9a5b-4c7a-ae05-d4e1dcd26961" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_4b5ce650-9a5b-4c7a-ae05-d4e1dcd26961_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_4b5ce650-9a5b-4c7a-ae05-d4e1dcd26961" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_4b5ce650-9a5b-4c7a-ae05-d4e1dcd26961_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_69265252-656f-46cd-b8d0-706b7ee92ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_4b5ce650-9a5b-4c7a-ae05-d4e1dcd26961" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_69265252-656f-46cd-b8d0-706b7ee92ce3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_2da894e2-ddcb-4139-9e7e-6be76fc64d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_69265252-656f-46cd-b8d0-706b7ee92ce3" xlink:to="loc_us-gaap_HedgeFundsMember_2da894e2-ddcb-4139-9e7e-6be76fc64d54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_2a4bd00f-85ac-4480-aef6-04bccf08c0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_69265252-656f-46cd-b8d0-706b7ee92ce3" xlink:to="loc_us-gaap_PrivateEquityFundsMember_2a4bd00f-85ac-4480-aef6-04bccf08c0c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_60092cb6-f21f-477f-9b91-3fa81fb8a713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_69265252-656f-46cd-b8d0-706b7ee92ce3" xlink:to="loc_us-gaap_RealEstateFundsMember_60092cb6-f21f-477f-9b91-3fa81fb8a713" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2fa8e192-016c-4c1c-af04-8dce424f27bf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_910fdf21-ec6b-457a-aa81-1077e942f591" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2fa8e192-016c-4c1c-af04-8dce424f27bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_2fa8e192-016c-4c1c-af04-8dce424f27bf_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2fa8e192-016c-4c1c-af04-8dce424f27bf" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_2fa8e192-016c-4c1c-af04-8dce424f27bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_b76c0fd4-45ef-4563-904d-875bbaceff47" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2fa8e192-016c-4c1c-af04-8dce424f27bf" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_b76c0fd4-45ef-4563-904d-875bbaceff47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RedOakMember_3e67847b-c4f5-449e-a195-76d1e6661e4b" xlink:href="cvs-20230525.xsd#cvs_RedOakMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b76c0fd4-45ef-4563-904d-875bbaceff47" xlink:to="loc_cvs_RedOakMember_3e67847b-c4f5-449e-a195-76d1e6661e4b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#AcquisitionsDivestituresandAssetSalesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails" xlink:type="extended" id="id3987025b2264d90b920b819095bc148_AcquisitionsDivestituresandAssetSalesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2865625c-c58d-4422-9430-d7bb34cda5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_f9cb0ae3-7d79-48e2-af7c-8402e350aded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2865625c-c58d-4422-9430-d7bb34cda5b3" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_f9cb0ae3-7d79-48e2-af7c-8402e350aded" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2a47d5b6-7b68-47bb-ad4d-842b5969316b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2865625c-c58d-4422-9430-d7bb34cda5b3" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2a47d5b6-7b68-47bb-ad4d-842b5969316b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationTerminationFee_d2c027c2-77ed-448c-b299-a5d4cb59e09a" xlink:href="cvs-20230525.xsd#cvs_BusinessCombinationTerminationFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2865625c-c58d-4422-9430-d7bb34cda5b3" xlink:to="loc_cvs_BusinessCombinationTerminationFee_d2c027c2-77ed-448c-b299-a5d4cb59e09a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_55db10e8-55b3-4c42-8c94-f98e8aec49d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2865625c-c58d-4422-9430-d7bb34cda5b3" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_55db10e8-55b3-4c42-8c94-f98e8aec49d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_90711b0d-a591-4f2e-aa43-ab0cd4271842" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2865625c-c58d-4422-9430-d7bb34cda5b3" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_90711b0d-a591-4f2e-aa43-ab0cd4271842" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_01da86c0-0f24-4811-a1c9-c2395f56eff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2865625c-c58d-4422-9430-d7bb34cda5b3" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_01da86c0-0f24-4811-a1c9-c2395f56eff3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfMedicalMembers_2213c738-aba7-4631-a6c6-f0022316e037" xlink:href="cvs-20230525.xsd#cvs_NumberOfMedicalMembers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2865625c-c58d-4422-9430-d7bb34cda5b3" xlink:to="loc_cvs_NumberOfMedicalMembers_2213c738-aba7-4631-a6c6-f0022316e037" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold_3e173003-3b7f-434d-89d6-3ef8cb6cd67a" xlink:href="cvs-20230525.xsd#cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2865625c-c58d-4422-9430-d7bb34cda5b3" xlink:to="loc_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold_3e173003-3b7f-434d-89d6-3ef8cb6cd67a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_11007a8a-ed43-4630-a00c-a98646f45e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2865625c-c58d-4422-9430-d7bb34cda5b3" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_11007a8a-ed43-4630-a00c-a98646f45e6d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_c3e46b1b-b329-4585-b93a-10a91c433a10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_11007a8a-ed43-4630-a00c-a98646f45e6d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_c3e46b1b-b329-4585-b93a-10a91c433a10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c3e46b1b-b329-4585-b93a-10a91c433a10_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c3e46b1b-b329-4585-b93a-10a91c433a10" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c3e46b1b-b329-4585-b93a-10a91c433a10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_707b17de-39a4-474e-8af0-19cd5038732a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c3e46b1b-b329-4585-b93a-10a91c433a10" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_707b17de-39a4-474e-8af0-19cd5038732a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_26e30191-e02b-44fb-bd2e-59a632486d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_707b17de-39a4-474e-8af0-19cd5038732a" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_26e30191-e02b-44fb-bd2e-59a632486d88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_ae2be565-b0ca-4531-8e3d-2799482df6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_707b17de-39a4-474e-8af0-19cd5038732a" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_ae2be565-b0ca-4531-8e3d-2799482df6b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_8e7fd6af-704b-4a8a-91ca-fc26612c861f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_707b17de-39a4-474e-8af0-19cd5038732a" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_8e7fd6af-704b-4a8a-91ca-fc26612c861f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b81fc0bf-1881-4b49-9c30-2e9bafbea35b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_11007a8a-ed43-4630-a00c-a98646f45e6d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b81fc0bf-1881-4b49-9c30-2e9bafbea35b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b81fc0bf-1881-4b49-9c30-2e9bafbea35b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b81fc0bf-1881-4b49-9c30-2e9bafbea35b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b81fc0bf-1881-4b49-9c30-2e9bafbea35b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5554a952-d8c1-4732-a3b4-46b22be364e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b81fc0bf-1881-4b49-9c30-2e9bafbea35b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5554a952-d8c1-4732-a3b4-46b22be364e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OmnicareLongTermCareBusinessMember_6b15825d-2ea5-49dc-be3b-4ccb5d4f16d9" xlink:href="cvs-20230525.xsd#cvs_OmnicareLongTermCareBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5554a952-d8c1-4732-a3b4-46b22be364e6" xlink:to="loc_cvs_OmnicareLongTermCareBusinessMember_6b15825d-2ea5-49dc-be3b-4ccb5d4f16d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BswiftLLCMember_cc28bfd4-d666-435d-8f50-706c296cc846" xlink:href="cvs-20230525.xsd#cvs_BswiftLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5554a952-d8c1-4732-a3b4-46b22be364e6" xlink:to="loc_cvs_BswiftLLCMember_cc28bfd4-d666-435d-8f50-706c296cc846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PayflexMember_df6c1e21-fa46-4211-9308-cf4097c67cdb" xlink:href="cvs-20230525.xsd#cvs_PayflexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5554a952-d8c1-4732-a3b4-46b22be364e6" xlink:to="loc_cvs_PayflexMember_df6c1e21-fa46-4211-9308-cf4097c67cdb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ThailandBusinessMember_97cf4604-ed8c-41e4-957b-a3b1c5a8299c" xlink:href="cvs-20230525.xsd#cvs_ThailandBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5554a952-d8c1-4732-a3b4-46b22be364e6" xlink:to="loc_cvs_ThailandBusinessMember_97cf4604-ed8c-41e4-957b-a3b1c5a8299c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InternationalHealthCareRenewalRightsMember_2193c2c0-9eb3-4884-9105-588fd6373609" xlink:href="cvs-20230525.xsd#cvs_InternationalHealthCareRenewalRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5554a952-d8c1-4732-a3b4-46b22be364e6" xlink:to="loc_cvs_InternationalHealthCareRenewalRightsMember_2193c2c0-9eb3-4884-9105-588fd6373609" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_ebe41db0-736f-49cf-becb-6b7a6c24d719" xlink:href="cvs-20230525.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5554a952-d8c1-4732-a3b4-46b22be364e6" xlink:to="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_ebe41db0-736f-49cf-becb-6b7a6c24d719" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b842d651-b3aa-452c-8fda-066403438eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_11007a8a-ed43-4630-a00c-a98646f45e6d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b842d651-b3aa-452c-8fda-066403438eca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b842d651-b3aa-452c-8fda-066403438eca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b842d651-b3aa-452c-8fda-066403438eca" xlink:to="loc_us-gaap_SegmentDomain_b842d651-b3aa-452c-8fda-066403438eca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ae887bd7-6514-441f-a730-790e7caa32cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b842d651-b3aa-452c-8fda-066403438eca" xlink:to="loc_us-gaap_SegmentDomain_ae887bd7-6514-441f-a730-790e7caa32cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_524be901-d451-4501-8747-b3b454db7076" xlink:href="cvs-20230525.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ae887bd7-6514-441f-a730-790e7caa32cf" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_524be901-d451-4501-8747-b3b454db7076" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_eb6cf5bc-0198-45a6-a6b6-d1c373641259" xlink:href="cvs-20230525.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ae887bd7-6514-441f-a730-790e7caa32cf" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_eb6cf5bc-0198-45a6-a6b6-d1c373641259" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_81a64940-2011-4d34-bad1-f4bcc4c1b07d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_11007a8a-ed43-4630-a00c-a98646f45e6d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_81a64940-2011-4d34-bad1-f4bcc4c1b07d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81a64940-2011-4d34-bad1-f4bcc4c1b07d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_81a64940-2011-4d34-bad1-f4bcc4c1b07d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81a64940-2011-4d34-bad1-f4bcc4c1b07d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_548fa04c-b7bd-42f1-a9b1-5e01951aed66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_81a64940-2011-4d34-bad1-f4bcc4c1b07d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_548fa04c-b7bd-42f1-a9b1-5e01951aed66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OakStreetHealthIncMember_142b5b1d-6ef9-4211-8d94-f46402a1ee7b" xlink:href="cvs-20230525.xsd#cvs_OakStreetHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_548fa04c-b7bd-42f1-a9b1-5e01951aed66" xlink:to="loc_cvs_OakStreetHealthIncMember_142b5b1d-6ef9-4211-8d94-f46402a1ee7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SignifyHealthIncMember_0d71205f-fca7-43fb-8381-6bfac68305a3" xlink:href="cvs-20230525.xsd#cvs_SignifyHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_548fa04c-b7bd-42f1-a9b1-5e01951aed66" xlink:to="loc_cvs_SignifyHealthIncMember_0d71205f-fca7-43fb-8381-6bfac68305a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8e97c8e3-7ed8-44c3-a110-4bbe959e39ba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_11007a8a-ed43-4630-a00c-a98646f45e6d" xlink:to="loc_dei_LegalEntityAxis_8e97c8e3-7ed8-44c3-a110-4bbe959e39ba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8e97c8e3-7ed8-44c3-a110-4bbe959e39ba_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_8e97c8e3-7ed8-44c3-a110-4bbe959e39ba" xlink:to="loc_dei_EntityDomain_8e97c8e3-7ed8-44c3-a110-4bbe959e39ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_83ef9ada-127b-4d10-927b-1558c5bce997" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_8e97c8e3-7ed8-44c3-a110-4bbe959e39ba" xlink:to="loc_dei_EntityDomain_83ef9ada-127b-4d10-927b-1558c5bce997" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OakStreetHealthIncMember_778b215e-f220-4a98-8e17-b033a1933c22" xlink:href="cvs-20230525.xsd#cvs_OakStreetHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_83ef9ada-127b-4d10-927b-1558c5bce997" xlink:to="loc_cvs_OakStreetHealthIncMember_778b215e-f220-4a98-8e17-b033a1933c22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SignifyHealthIncMember_1e14dd25-d41d-4b03-8afc-277dc137079d" xlink:href="cvs-20230525.xsd#cvs_SignifyHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_83ef9ada-127b-4d10-927b-1558c5bce997" xlink:to="loc_cvs_SignifyHealthIncMember_1e14dd25-d41d-4b03-8afc-277dc137079d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1182f6d6-5c77-44c3-95dc-2b601aed4fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_11007a8a-ed43-4630-a00c-a98646f45e6d" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1182f6d6-5c77-44c3-95dc-2b601aed4fa6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1182f6d6-5c77-44c3-95dc-2b601aed4fa6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1182f6d6-5c77-44c3-95dc-2b601aed4fa6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1182f6d6-5c77-44c3-95dc-2b601aed4fa6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ebc4b665-c7e2-46ea-a99b-cf1e62e54103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1182f6d6-5c77-44c3-95dc-2b601aed4fa6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ebc4b665-c7e2-46ea-a99b-cf1e62e54103" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e1532592-ce3a-4b7d-973f-16c6262c25a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ebc4b665-c7e2-46ea-a99b-cf1e62e54103" xlink:to="loc_us-gaap_SubsequentEventMember_e1532592-ce3a-4b7d-973f-16c6262c25a2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended" id="i9bfed62b49cf41748fd817104f9978f3_AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd70c76d-a599-4961-97c4-0bb2e5f68caa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_56a36696-d4de-4484-9203-11fc59373a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd70c76d-a599-4961-97c4-0bb2e5f68caa" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_56a36696-d4de-4484-9203-11fc59373a3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_bcb54996-a4be-44cd-96f1-dec1dd13e3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_56a36696-d4de-4484-9203-11fc59373a3f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_bcb54996-a4be-44cd-96f1-dec1dd13e3ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_f8c27b71-0c66-46de-bafa-03f28307b5c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_56a36696-d4de-4484-9203-11fc59373a3f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_f8c27b71-0c66-46de-bafa-03f28307b5c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_7437e5f8-a7b2-46f1-9828-895ef6b37383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_56a36696-d4de-4484-9203-11fc59373a3f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_7437e5f8-a7b2-46f1-9828-895ef6b37383" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_443b1c54-5ffe-4f0e-8ebf-484eb0c56960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_56a36696-d4de-4484-9203-11fc59373a3f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_443b1c54-5ffe-4f0e-8ebf-484eb0c56960" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_332b360e-ab13-403c-8104-1d1342e5f639" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_56a36696-d4de-4484-9203-11fc59373a3f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_332b360e-ab13-403c-8104-1d1342e5f639" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_bc7a7fde-4e71-4144-8ae4-23828262db3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_56a36696-d4de-4484-9203-11fc59373a3f" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_bc7a7fde-4e71-4144-8ae4-23828262db3b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_e60ec96a-34ec-4ff0-bc8c-08bd89067796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd70c76d-a599-4961-97c4-0bb2e5f68caa" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_e60ec96a-34ec-4ff0-bc8c-08bd89067796" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_ef8ec4ba-015d-47a0-bad2-b582baf9e193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_e60ec96a-34ec-4ff0-bc8c-08bd89067796" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_ef8ec4ba-015d-47a0-bad2-b582baf9e193" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_c53fecd8-766a-4607-83d9-118510b1d00f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_e60ec96a-34ec-4ff0-bc8c-08bd89067796" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_c53fecd8-766a-4607-83d9-118510b1d00f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_1bfc194d-dfa4-4d9f-b937-3d2ecd7c30cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_e60ec96a-34ec-4ff0-bc8c-08bd89067796" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_1bfc194d-dfa4-4d9f-b937-3d2ecd7c30cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_42854162-5b0c-4580-814a-a61569b9d1b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_e60ec96a-34ec-4ff0-bc8c-08bd89067796" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_42854162-5b0c-4580-814a-a61569b9d1b8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6a20e4e5-a255-40aa-86d4-302b4eb3a9c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd70c76d-a599-4961-97c4-0bb2e5f68caa" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6a20e4e5-a255-40aa-86d4-302b4eb3a9c0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b9accb82-cde8-47ab-98ee-0d4ce899be5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6a20e4e5-a255-40aa-86d4-302b4eb3a9c0" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b9accb82-cde8-47ab-98ee-0d4ce899be5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b9accb82-cde8-47ab-98ee-0d4ce899be5c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b9accb82-cde8-47ab-98ee-0d4ce899be5c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b9accb82-cde8-47ab-98ee-0d4ce899be5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e967e6ef-af2c-4159-948d-5064494f7099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b9accb82-cde8-47ab-98ee-0d4ce899be5c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e967e6ef-af2c-4159-948d-5064494f7099" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_33545e9e-6cef-48c7-b9ad-dffef3cc2014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_e967e6ef-af2c-4159-948d-5064494f7099" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_33545e9e-6cef-48c7-b9ad-dffef3cc2014" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsScheduleofTotalInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails" xlink:type="extended" id="i89e77e40a83a41c1bdd1eebad105569b_InvestmentsScheduleofTotalInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems_a01847f3-4925-4a84-ae81-bc754af1431d" xlink:href="cvs-20230525.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_bfe3a03a-7586-429b-864f-8f352131906e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_a01847f3-4925-4a84-ae81-bc754af1431d" xlink:to="loc_us-gaap_ShortTermInvestments_bfe3a03a-7586-429b-864f-8f352131906e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermInvestmentsIncludingAssetsHeldForSale_de44943f-3b1c-44cf-87e5-129ca394fc8f" xlink:href="cvs-20230525.xsd#cvs_LongTermInvestmentsIncludingAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_a01847f3-4925-4a84-ae81-bc754af1431d" xlink:to="loc_cvs_LongTermInvestmentsIncludingAssetsHeldForSale_de44943f-3b1c-44cf-87e5-129ca394fc8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_8cefa8a5-7529-46f7-8fbf-47587fedb29d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_a01847f3-4925-4a84-ae81-bc754af1431d" xlink:to="loc_us-gaap_Investments_8cefa8a5-7529-46f7-8fbf-47587fedb29d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable_8af37927-9eea-45d6-b405-517053a7d398" xlink:href="cvs-20230525.xsd#cvs_TotalInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cvs_TotalInvestmentsLineItems_a01847f3-4925-4a84-ae81-bc754af1431d" xlink:to="loc_cvs_TotalInvestmentsTable_8af37927-9eea-45d6-b405-517053a7d398" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis_742a5a99-10e2-4eb4-9b73-48deff57895d" xlink:href="cvs-20230525.xsd#cvs_TotalInvestmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cvs_TotalInvestmentsTable_8af37927-9eea-45d6-b405-517053a7d398" xlink:to="loc_cvs_TotalInvestmentsAxis_742a5a99-10e2-4eb4-9b73-48deff57895d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_742a5a99-10e2-4eb4-9b73-48deff57895d_default" xlink:href="cvs-20230525.xsd#cvs_TotalInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cvs_TotalInvestmentsAxis_742a5a99-10e2-4eb4-9b73-48deff57895d" xlink:to="loc_cvs_TotalInvestmentsDomain_742a5a99-10e2-4eb4-9b73-48deff57895d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_a9a777de-3ec4-4b2b-aa15-227c003c100a" xlink:href="cvs-20230525.xsd#cvs_TotalInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cvs_TotalInvestmentsAxis_742a5a99-10e2-4eb4-9b73-48deff57895d" xlink:to="loc_cvs_TotalInvestmentsDomain_a9a777de-3ec4-4b2b-aa15-227c003c100a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_005f758f-bdf3-4421-8087-5204eb2e0996" xlink:href="cvs-20230525.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_a9a777de-3ec4-4b2b-aa15-227c003c100a" xlink:to="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_005f758f-bdf3-4421-8087-5204eb2e0996" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_782a0311-9fe8-4c56-a0cb-d021b4500832" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_a9a777de-3ec4-4b2b-aa15-227c003c100a" xlink:to="loc_cvs_MortgageLoansMember_782a0311-9fe8-4c56-a0cb-d021b4500832" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_1caf05ae-4c12-4e7a-8add-9aaf604e5ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_a9a777de-3ec4-4b2b-aa15-227c003c100a" xlink:to="loc_us-gaap_OtherInvestmentsMember_1caf05ae-4c12-4e7a-8add-9aaf604e5ee3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b4808d91-f71c-47e7-a93a-315532907cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cvs_TotalInvestmentsTable_8af37927-9eea-45d6-b405-517053a7d398" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b4808d91-f71c-47e7-a93a-315532907cec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b4808d91-f71c-47e7-a93a-315532907cec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b4808d91-f71c-47e7-a93a-315532907cec" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b4808d91-f71c-47e7-a93a-315532907cec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_881dd869-a78c-4e10-a1fb-33058a2d6572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b4808d91-f71c-47e7-a93a-315532907cec" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_881dd869-a78c-4e10-a1fb-33058a2d6572" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_6818c559-9bb7-407b-a2b2-26068424ba00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_881dd869-a78c-4e10-a1fb-33058a2d6572" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_6818c559-9bb7-407b-a2b2-26068424ba00" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsNarrativeDetails" xlink:type="extended" id="ie9d7dfcc6d324e30a2b8fe7b3964ff55_InvestmentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1e3f2050-c358-41ee-869d-b20971da069d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedInvestmentsAtFairValue_17f64c0b-aaff-45a9-a80f-83b650467fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedInvestmentsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1e3f2050-c358-41ee-869d-b20971da069d" xlink:to="loc_us-gaap_RestrictedInvestmentsAtFairValue_17f64c0b-aaff-45a9-a80f-83b650467fb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities_0810a428-88a3-414f-b4ef-14b02e2a4dbe" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1e3f2050-c358-41ee-869d-b20971da069d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities_0810a428-88a3-414f-b4ef-14b02e2a4dbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a67f6608-4500-435f-ab17-1a0fbb54284b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1e3f2050-c358-41ee-869d-b20971da069d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a67f6608-4500-435f-ab17-1a0fbb54284b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_766c955f-3dbd-4f45-b046-2865d83d7218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a67f6608-4500-435f-ab17-1a0fbb54284b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_766c955f-3dbd-4f45-b046-2865d83d7218" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_766c955f-3dbd-4f45-b046-2865d83d7218_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_766c955f-3dbd-4f45-b046-2865d83d7218" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_766c955f-3dbd-4f45-b046-2865d83d7218_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63c19042-bee3-4f78-89f2-a3a64297b6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_766c955f-3dbd-4f45-b046-2865d83d7218" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63c19042-bee3-4f78-89f2-a3a64297b6a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_3e706585-9c44-4e6b-b6d2-6663052a83f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63c19042-bee3-4f78-89f2-a3a64297b6a4" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_3e706585-9c44-4e6b-b6d2-6663052a83f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_59e7e3ea-6792-43a4-b416-7c9e718c70cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63c19042-bee3-4f78-89f2-a3a64297b6a4" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_59e7e3ea-6792-43a4-b416-7c9e718c70cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_4280b4b3-0351-49b4-880a-7f101950fc51" xlink:href="cvs-20230525.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63c19042-bee3-4f78-89f2-a3a64297b6a4" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_4280b4b3-0351-49b4-880a-7f101950fc51" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended" id="id9113f80bddd4babb3fc13c6a1aaf6e0_InvestmentsDebtSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5a6a5272-de43-47b2-aee2-47d16df8d691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_248d6d68-a398-418b-addd-ec693f04591f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5a6a5272-de43-47b2-aee2-47d16df8d691" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_248d6d68-a398-418b-addd-ec693f04591f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_9fa86398-800e-418f-9733-13aecc1de1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5a6a5272-de43-47b2-aee2-47d16df8d691" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_9fa86398-800e-418f-9733-13aecc1de1d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_3b8f82fa-f2a4-4016-b6f4-5ba0d44f74f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5a6a5272-de43-47b2-aee2-47d16df8d691" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_3b8f82fa-f2a4-4016-b6f4-5ba0d44f74f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_30bc3596-48c0-469d-9bf4-e21140bcb14c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5a6a5272-de43-47b2-aee2-47d16df8d691" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_30bc3596-48c0-469d-9bf4-e21140bcb14c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_173f3af3-9250-4b59-a04e-509444f13bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5a6a5272-de43-47b2-aee2-47d16df8d691" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_173f3af3-9250-4b59-a04e-509444f13bed" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e817cf9a-97fa-498d-af2a-06a581aed5be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5a6a5272-de43-47b2-aee2-47d16df8d691" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e817cf9a-97fa-498d-af2a-06a581aed5be" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8b328dd1-4393-4a09-b9f0-c814b4ac56cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5a6a5272-de43-47b2-aee2-47d16df8d691" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8b328dd1-4393-4a09-b9f0-c814b4ac56cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a74884f2-573d-460e-a22c-f128237bb56b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8b328dd1-4393-4a09-b9f0-c814b4ac56cd" xlink:to="loc_srt_ProductOrServiceAxis_a74884f2-573d-460e-a22c-f128237bb56b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a74884f2-573d-460e-a22c-f128237bb56b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a74884f2-573d-460e-a22c-f128237bb56b" xlink:to="loc_srt_ProductsAndServicesDomain_a74884f2-573d-460e-a22c-f128237bb56b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_926716ff-da6b-4762-b66c-f7d26e993ca7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a74884f2-573d-460e-a22c-f128237bb56b" xlink:to="loc_srt_ProductsAndServicesDomain_926716ff-da6b-4762-b66c-f7d26e993ca7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_8ee3e2c0-0f35-4411-83bf-ae49d89bf231" xlink:href="cvs-20230525.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_926716ff-da6b-4762-b66c-f7d26e993ca7" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_8ee3e2c0-0f35-4411-83bf-ae49d89bf231" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2cc64349-0985-40f4-96bd-e9d2ce57dd58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8b328dd1-4393-4a09-b9f0-c814b4ac56cd" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2cc64349-0985-40f4-96bd-e9d2ce57dd58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2cc64349-0985-40f4-96bd-e9d2ce57dd58_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2cc64349-0985-40f4-96bd-e9d2ce57dd58" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2cc64349-0985-40f4-96bd-e9d2ce57dd58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ccb4783-e60c-4e12-a63a-dbb70f34e383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2cc64349-0985-40f4-96bd-e9d2ce57dd58" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ccb4783-e60c-4e12-a63a-dbb70f34e383" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_800e8298-e262-4f45-83ea-84bb78425cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ccb4783-e60c-4e12-a63a-dbb70f34e383" xlink:to="loc_us-gaap_DebtSecuritiesMember_800e8298-e262-4f45-83ea-84bb78425cfb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_b9ac6ab5-8ffe-43d9-ba80-d796c3079f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_800e8298-e262-4f45-83ea-84bb78425cfb" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_b9ac6ab5-8ffe-43d9-ba80-d796c3079f4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_89321d17-329c-441d-ba72-35b2a8d6a511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_800e8298-e262-4f45-83ea-84bb78425cfb" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_89321d17-329c-441d-ba72-35b2a8d6a511" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_95aad425-0479-4d40-96be-e5ce50b2837c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_800e8298-e262-4f45-83ea-84bb78425cfb" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_95aad425-0479-4d40-96be-e5ce50b2837c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_3596e3bd-8dcd-400b-b225-07e0886c307a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_800e8298-e262-4f45-83ea-84bb78425cfb" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_3596e3bd-8dcd-400b-b225-07e0886c307a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_52fdc3e9-29e8-4e1f-bfdf-96a258255794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_800e8298-e262-4f45-83ea-84bb78425cfb" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_52fdc3e9-29e8-4e1f-bfdf-96a258255794" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_e7a736af-4e3e-4ab4-b71f-ac673711d9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_800e8298-e262-4f45-83ea-84bb78425cfb" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_e7a736af-4e3e-4ab4-b71f-ac673711d9c8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_5b75d70c-8632-46c8-a178-0d5627e72704" xlink:href="cvs-20230525.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_800e8298-e262-4f45-83ea-84bb78425cfb" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_5b75d70c-8632-46c8-a178-0d5627e72704" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_efe20b4f-2496-4043-9c9f-f7c1979d48e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_800e8298-e262-4f45-83ea-84bb78425cfb" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_efe20b4f-2496-4043-9c9f-f7c1979d48e9" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended" id="idccdbb3a5d2f4ff6ab69bb9a5411e85d_InvestmentsDebtSecuritiesbyMaturityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c5c3d2dc-5127-4fe4-9e3f-4ba465682e98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_48797424-2a2d-455a-8be3-b4a4f3e0865c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c5c3d2dc-5127-4fe4-9e3f-4ba465682e98" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_48797424-2a2d-455a-8be3-b4a4f3e0865c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_68cf3368-9e08-436e-b134-dd5f2611e88d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_48797424-2a2d-455a-8be3-b4a4f3e0865c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_68cf3368-9e08-436e-b134-dd5f2611e88d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_2981a2ac-4d52-4d58-8a84-5c381af9571f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_48797424-2a2d-455a-8be3-b4a4f3e0865c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_2981a2ac-4d52-4d58-8a84-5c381af9571f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_53b38328-a8c0-4b16-b7ef-004a5e1eabb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_48797424-2a2d-455a-8be3-b4a4f3e0865c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_53b38328-a8c0-4b16-b7ef-004a5e1eabb0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_f8e9aa95-5476-40d3-8a57-438f84e4709f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_48797424-2a2d-455a-8be3-b4a4f3e0865c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_f8e9aa95-5476-40d3-8a57-438f84e4709f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_5d8c754b-cc12-4423-ae15-78992c95b429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_48797424-2a2d-455a-8be3-b4a4f3e0865c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_5d8c754b-cc12-4423-ae15-78992c95b429" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_e587bdc1-5829-4ce4-ae3f-416aee323f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_48797424-2a2d-455a-8be3-b4a4f3e0865c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_e587bdc1-5829-4ce4-ae3f-416aee323f5e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_6aca95e4-8bc0-4e37-aaab-2745ea1133a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c5c3d2dc-5127-4fe4-9e3f-4ba465682e98" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_6aca95e4-8bc0-4e37-aaab-2745ea1133a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_a101d6d7-d404-4e62-887a-3c21722315ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_6aca95e4-8bc0-4e37-aaab-2745ea1133a8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_a101d6d7-d404-4e62-887a-3c21722315ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_2a64f248-750b-42d9-a724-bdf43e3e8315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_6aca95e4-8bc0-4e37-aaab-2745ea1133a8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_2a64f248-750b-42d9-a724-bdf43e3e8315" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_6abc8627-f4ae-4bd1-8400-3e60800a394c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_6aca95e4-8bc0-4e37-aaab-2745ea1133a8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_6abc8627-f4ae-4bd1-8400-3e60800a394c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_c7db15ce-47bc-47e9-acfa-4d627962172e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_6aca95e4-8bc0-4e37-aaab-2745ea1133a8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_c7db15ce-47bc-47e9-acfa-4d627962172e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_20459287-7ed7-42af-b9f8-04bd53f4058b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_6aca95e4-8bc0-4e37-aaab-2745ea1133a8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_20459287-7ed7-42af-b9f8-04bd53f4058b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0e88e5f3-00c4-43be-90ee-6e50a1cbbe89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_6aca95e4-8bc0-4e37-aaab-2745ea1133a8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0e88e5f3-00c4-43be-90ee-6e50a1cbbe89" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_60d7202d-3072-4ed9-867c-58ed568d3d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c5c3d2dc-5127-4fe4-9e3f-4ba465682e98" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_60d7202d-3072-4ed9-867c-58ed568d3d5f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_fb99b13a-bc57-41b4-8eed-58861b6aa784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_60d7202d-3072-4ed9-867c-58ed568d3d5f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_fb99b13a-bc57-41b4-8eed-58861b6aa784" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fb99b13a-bc57-41b4-8eed-58861b6aa784_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_fb99b13a-bc57-41b4-8eed-58861b6aa784" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fb99b13a-bc57-41b4-8eed-58861b6aa784_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d4bf23b5-400a-4d60-9c07-80a063fa4a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_fb99b13a-bc57-41b4-8eed-58861b6aa784" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d4bf23b5-400a-4d60-9c07-80a063fa4a99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_088604b1-734f-45ac-97a4-4f00e2ba4d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d4bf23b5-400a-4d60-9c07-80a063fa4a99" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_088604b1-734f-45ac-97a4-4f00e2ba4d2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_64eb9838-10df-44ae-a8ee-85b8e852ed5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d4bf23b5-400a-4d60-9c07-80a063fa4a99" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_64eb9838-10df-44ae-a8ee-85b8e852ed5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_b40e3bf8-5841-459b-9bdc-fd93d567f573" xlink:href="cvs-20230525.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d4bf23b5-400a-4d60-9c07-80a063fa4a99" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_b40e3bf8-5841-459b-9bdc-fd93d567f573" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended" id="i0c2456986fef454198407ac7c387b4c6_InvestmentsUnrealizedLossPositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_87582c03-7a50-48cb-9a01-5e880503470d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_324ac0c5-2f7e-4121-bae4-ea4828f3e497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_87582c03-7a50-48cb-9a01-5e880503470d" xlink:to="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_324ac0c5-2f7e-4121-bae4-ea4828f3e497" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_94d95906-b7b7-481b-aecf-edd99584188e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_324ac0c5-2f7e-4121-bae4-ea4828f3e497" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_94d95906-b7b7-481b-aecf-edd99584188e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_c3e0127e-e506-4f71-988d-146dd69a09d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_324ac0c5-2f7e-4121-bae4-ea4828f3e497" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_c3e0127e-e506-4f71-988d-146dd69a09d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_1f9485cb-ded4-432a-80d0-c8f05dd8abe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_324ac0c5-2f7e-4121-bae4-ea4828f3e497" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_1f9485cb-ded4-432a-80d0-c8f05dd8abe9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_2515f3c0-33a2-4a3f-98ea-f4e1a96d25a1" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_87582c03-7a50-48cb-9a01-5e880503470d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_2515f3c0-33a2-4a3f-98ea-f4e1a96d25a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_f95634d8-6b10-4890-8f56-19f43c1c6a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_2515f3c0-33a2-4a3f-98ea-f4e1a96d25a1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_f95634d8-6b10-4890-8f56-19f43c1c6a0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0ef76b2a-f3b9-4712-866b-0086d43e0a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_2515f3c0-33a2-4a3f-98ea-f4e1a96d25a1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0ef76b2a-f3b9-4712-866b-0086d43e0a47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_d0a71bf1-0c37-41c7-83b2-7a2f755c5d31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_2515f3c0-33a2-4a3f-98ea-f4e1a96d25a1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_d0a71bf1-0c37-41c7-83b2-7a2f755c5d31" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ec28e96-03e8-4f79-a030-31d1e6e3da8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_87582c03-7a50-48cb-9a01-5e880503470d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ec28e96-03e8-4f79-a030-31d1e6e3da8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_f9812877-61bb-46c4-824f-81e225fa5e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ec28e96-03e8-4f79-a030-31d1e6e3da8b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_f9812877-61bb-46c4-824f-81e225fa5e2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_f2bdef69-2a22-41b1-a350-813df3fafbb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ec28e96-03e8-4f79-a030-31d1e6e3da8b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_f2bdef69-2a22-41b1-a350-813df3fafbb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_b592f97c-a4bf-4023-b30f-b1afe68984d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ec28e96-03e8-4f79-a030-31d1e6e3da8b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_b592f97c-a4bf-4023-b30f-b1afe68984d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_7e9c76f2-3811-4f53-9615-f9a3fb9cb6f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_87582c03-7a50-48cb-9a01-5e880503470d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_7e9c76f2-3811-4f53-9615-f9a3fb9cb6f2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ee290eb9-6514-473a-96a3-e0d346ece9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_7e9c76f2-3811-4f53-9615-f9a3fb9cb6f2" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ee290eb9-6514-473a-96a3-e0d346ece9a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ee290eb9-6514-473a-96a3-e0d346ece9a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ee290eb9-6514-473a-96a3-e0d346ece9a1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ee290eb9-6514-473a-96a3-e0d346ece9a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3b251320-d020-4fff-a501-e13b7c7ae8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ee290eb9-6514-473a-96a3-e0d346ece9a1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3b251320-d020-4fff-a501-e13b7c7ae8b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_7667fb0b-efc7-46ba-a008-d5dd35b13b88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3b251320-d020-4fff-a501-e13b7c7ae8b4" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_7667fb0b-efc7-46ba-a008-d5dd35b13b88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_a2eb6f90-d91e-4cfe-b532-602ae44b9e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3b251320-d020-4fff-a501-e13b7c7ae8b4" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_a2eb6f90-d91e-4cfe-b532-602ae44b9e4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_57080d1c-523d-482d-ae84-9c85a68732e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3b251320-d020-4fff-a501-e13b7c7ae8b4" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_57080d1c-523d-482d-ae84-9c85a68732e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_23bb9bee-47fd-4f8b-a39c-de965a244396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3b251320-d020-4fff-a501-e13b7c7ae8b4" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_23bb9bee-47fd-4f8b-a39c-de965a244396" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_e12fae56-0d38-4b27-84d3-52ba5a86fb36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3b251320-d020-4fff-a501-e13b7c7ae8b4" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_e12fae56-0d38-4b27-84d3-52ba5a86fb36" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_4821ab5e-547c-451d-8005-0cca9a33a3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3b251320-d020-4fff-a501-e13b7c7ae8b4" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_4821ab5e-547c-451d-8005-0cca9a33a3f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_e0c88387-a8be-4471-a3fc-455fdb55c0df" xlink:href="cvs-20230525.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3b251320-d020-4fff-a501-e13b7c7ae8b4" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_e0c88387-a8be-4471-a3fc-455fdb55c0df" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_e5ae29f9-f08b-4ad6-93ef-a12a23ce5bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3b251320-d020-4fff-a501-e13b7c7ae8b4" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_e5ae29f9-f08b-4ad6-93ef-a12a23ce5bef" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended" id="idb38f3e8ff4e4bb181edad2838782fc1_InvestmentsUnrealizedLossPositionMaturitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5c2aa0-9bdb-42d9-b9a2-145b61501db4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_385044e2-36db-4b01-b520-1f5364f5fabc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5c2aa0-9bdb-42d9-b9a2-145b61501db4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_385044e2-36db-4b01-b520-1f5364f5fabc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_88097e7f-6b32-4828-a3b5-82f08ec76f41" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_385044e2-36db-4b01-b520-1f5364f5fabc" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_88097e7f-6b32-4828-a3b5-82f08ec76f41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_7e030ed8-4bd9-4fe4-aeb8-80a97c6cb692" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_385044e2-36db-4b01-b520-1f5364f5fabc" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_7e030ed8-4bd9-4fe4-aeb8-80a97c6cb692" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_22e4d810-31e0-4c7e-a363-829264c15946" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_385044e2-36db-4b01-b520-1f5364f5fabc" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_22e4d810-31e0-4c7e-a363-829264c15946" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_150149e4-6580-4313-9ced-fb6df5b3dbee" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_385044e2-36db-4b01-b520-1f5364f5fabc" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_150149e4-6580-4313-9ced-fb6df5b3dbee" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue_38b6f4de-167e-4764-a7cb-9704666befa6" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_385044e2-36db-4b01-b520-1f5364f5fabc" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue_38b6f4de-167e-4764-a7cb-9704666befa6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_df4e125a-d9ab-4bfd-a25a-f6544d34af1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_385044e2-36db-4b01-b520-1f5364f5fabc" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_df4e125a-d9ab-4bfd-a25a-f6544d34af1e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f5c98f89-a579-4d50-8d21-9b0e02399fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5c2aa0-9bdb-42d9-b9a2-145b61501db4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f5c98f89-a579-4d50-8d21-9b0e02399fd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_705ee089-2e17-4895-9ecb-b9ff94980b0b" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f5c98f89-a579-4d50-8d21-9b0e02399fd4" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_705ee089-2e17-4895-9ecb-b9ff94980b0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_84c2f960-f68a-4187-ad1a-d7ca9523c47c" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f5c98f89-a579-4d50-8d21-9b0e02399fd4" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_84c2f960-f68a-4187-ad1a-d7ca9523c47c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_c5783752-f663-4d80-b062-8ace2c136120" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f5c98f89-a579-4d50-8d21-9b0e02399fd4" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_c5783752-f663-4d80-b062-8ace2c136120" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_c186961f-ddae-4220-a862-cbc2daeb963c" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f5c98f89-a579-4d50-8d21-9b0e02399fd4" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_c186961f-ddae-4220-a862-cbc2daeb963c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss_66516966-7c38-4ecd-8315-eaf1b13d75df" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f5c98f89-a579-4d50-8d21-9b0e02399fd4" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss_66516966-7c38-4ecd-8315-eaf1b13d75df" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_41e2ae5b-8d61-4c3f-91c8-b9c8b013549b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f5c98f89-a579-4d50-8d21-9b0e02399fd4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_41e2ae5b-8d61-4c3f-91c8-b9c8b013549b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a3bc0d84-cf5b-420c-bfef-bd2e46474cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5c2aa0-9bdb-42d9-b9a2-145b61501db4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a3bc0d84-cf5b-420c-bfef-bd2e46474cb8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e15532fe-964e-4cda-900a-d80ca362ddf3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a3bc0d84-cf5b-420c-bfef-bd2e46474cb8" xlink:to="loc_srt_ProductOrServiceAxis_e15532fe-964e-4cda-900a-d80ca362ddf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e15532fe-964e-4cda-900a-d80ca362ddf3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_e15532fe-964e-4cda-900a-d80ca362ddf3" xlink:to="loc_srt_ProductsAndServicesDomain_e15532fe-964e-4cda-900a-d80ca362ddf3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9a54819b-2491-4631-aa8b-bd58cce44afc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_e15532fe-964e-4cda-900a-d80ca362ddf3" xlink:to="loc_srt_ProductsAndServicesDomain_9a54819b-2491-4631-aa8b-bd58cce44afc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_f665eab5-8f6f-4973-a79b-6d826f8565f6" xlink:href="cvs-20230525.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9a54819b-2491-4631-aa8b-bd58cce44afc" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_f665eab5-8f6f-4973-a79b-6d826f8565f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember_7910b36b-03b0-40ba-a2ac-2fd7374ce10e" xlink:href="cvs-20230525.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9a54819b-2491-4631-aa8b-bd58cce44afc" xlink:to="loc_cvs_SupportingRemainingProductsMember_7910b36b-03b0-40ba-a2ac-2fd7374ce10e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6457fb42-6b9c-4077-8bc8-cc8763b288d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a3bc0d84-cf5b-420c-bfef-bd2e46474cb8" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6457fb42-6b9c-4077-8bc8-cc8763b288d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6457fb42-6b9c-4077-8bc8-cc8763b288d6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6457fb42-6b9c-4077-8bc8-cc8763b288d6" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6457fb42-6b9c-4077-8bc8-cc8763b288d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8607275-4d96-4f39-a1d4-a8d4f107353f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6457fb42-6b9c-4077-8bc8-cc8763b288d6" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8607275-4d96-4f39-a1d4-a8d4f107353f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_c6f01c89-f7fe-4e88-adde-9f37e40622b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8607275-4d96-4f39-a1d4-a8d4f107353f" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_c6f01c89-f7fe-4e88-adde-9f37e40622b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_17f18ff7-e904-47b7-bbfc-337c257619cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8607275-4d96-4f39-a1d4-a8d4f107353f" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_17f18ff7-e904-47b7-bbfc-337c257619cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_9e393402-72e9-45a4-b8fb-deb1d20c2fde" xlink:href="cvs-20230525.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8607275-4d96-4f39-a1d4-a8d4f107353f" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_9e393402-72e9-45a4-b8fb-deb1d20c2fde" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsMortgageLoansDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="extended" id="i1487794e4ad84dd1a0bdb7aee50d50b5_InvestmentsMortgageLoansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_3ec53b1b-0902-4906-8f3a-ff7ed940e356" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_f2c8a8db-1c2e-43c5-993d-dbd824b46b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_3ec53b1b-0902-4906-8f3a-ff7ed940e356" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_f2c8a8db-1c2e-43c5-993d-dbd824b46b5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_16f47922-ed8f-442f-9648-3fbb51e6b1f2" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_3ec53b1b-0902-4906-8f3a-ff7ed940e356" xlink:to="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_16f47922-ed8f-442f-9648-3fbb51e6b1f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_86c4ed9f-f135-4186-8c3b-30775ffb2c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_3ec53b1b-0902-4906-8f3a-ff7ed940e356" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_86c4ed9f-f135-4186-8c3b-30775ffb2c33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_6c189417-d3fd-4d31-96bb-fcbab41fa842" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_3ec53b1b-0902-4906-8f3a-ff7ed940e356" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_6c189417-d3fd-4d31-96bb-fcbab41fa842" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_16a498a9-8cf5-4962-859b-17edbd16bb5a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_6c189417-d3fd-4d31-96bb-fcbab41fa842" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_16a498a9-8cf5-4962-859b-17edbd16bb5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_16a498a9-8cf5-4962-859b-17edbd16bb5a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_16a498a9-8cf5-4962-859b-17edbd16bb5a" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_16a498a9-8cf5-4962-859b-17edbd16bb5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_1d7065ac-7ab0-477c-afae-815c6600b12c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_16a498a9-8cf5-4962-859b-17edbd16bb5a" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_1d7065ac-7ab0-477c-afae-815c6600b12c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_bbaa5f42-5b97-465d-b43a-dfbcd35a2929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_1d7065ac-7ab0-477c-afae-815c6600b12c" xlink:to="loc_us-gaap_CommercialRealEstateMember_bbaa5f42-5b97-465d-b43a-dfbcd35a2929" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsMortgageLoansCreditRatingsIndicatorDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="extended" id="i99f7a1e522084dc3b410be7a374f70b4_InvestmentsMortgageLoansCreditRatingsIndicatorDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_fb7911a9-1fd3-4c02-8cf7-78f933c60ef3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate_cad3a1a9-a1b7-4853-a555-c806303da533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_fb7911a9-1fd3-4c02-8cf7-78f933c60ef3" xlink:to="loc_us-gaap_MortgageLoansOnRealEstate_cad3a1a9-a1b7-4853-a555-c806303da533" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_ef36fd79-1dd5-486c-bc26-4d2ce2741ee7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_fb7911a9-1fd3-4c02-8cf7-78f933c60ef3" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_ef36fd79-1dd5-486c-bc26-4d2ce2741ee7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_88ed3127-2a39-4c34-8d7d-00f9ab4e75cd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_ef36fd79-1dd5-486c-bc26-4d2ce2741ee7" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_88ed3127-2a39-4c34-8d7d-00f9ab4e75cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_88ed3127-2a39-4c34-8d7d-00f9ab4e75cd_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_88ed3127-2a39-4c34-8d7d-00f9ab4e75cd" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_88ed3127-2a39-4c34-8d7d-00f9ab4e75cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_703560c0-305c-4381-90fc-1d056047f21e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_88ed3127-2a39-4c34-8d7d-00f9ab4e75cd" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_703560c0-305c-4381-90fc-1d056047f21e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_016d3440-b710-4f38-9faa-cdbd7e32353a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_703560c0-305c-4381-90fc-1d056047f21e" xlink:to="loc_us-gaap_CommercialRealEstateMember_016d3440-b710-4f38-9faa-cdbd7e32353a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentAxis_44b044c2-a43a-4f94-82bf-648ed07ce3ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalCreditAssessmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_ef36fd79-1dd5-486c-bc26-4d2ce2741ee7" xlink:to="loc_us-gaap_InternalCreditAssessmentAxis_44b044c2-a43a-4f94-82bf-648ed07ce3ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentDomain_44b044c2-a43a-4f94-82bf-648ed07ce3ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalCreditAssessmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InternalCreditAssessmentAxis_44b044c2-a43a-4f94-82bf-648ed07ce3ac" xlink:to="loc_us-gaap_InternalCreditAssessmentDomain_44b044c2-a43a-4f94-82bf-648ed07ce3ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentDomain_5e4d635a-297f-4cf3-b513-6a11460998b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalCreditAssessmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InternalCreditAssessmentAxis_44b044c2-a43a-4f94-82bf-648ed07ce3ac" xlink:to="loc_us-gaap_InternalCreditAssessmentDomain_5e4d635a-297f-4cf3-b513-6a11460998b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member_2c5746f2-3f1f-46c2-8946-656fea93ea0a" xlink:href="cvs-20230525.xsd#cvs_Category1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_5e4d635a-297f-4cf3-b513-6a11460998b4" xlink:to="loc_cvs_Category1Member_2c5746f2-3f1f-46c2-8946-656fea93ea0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member_266ea780-7152-49a3-b823-4b16bebe4efa" xlink:href="cvs-20230525.xsd#cvs_Category2To4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_5e4d635a-297f-4cf3-b513-6a11460998b4" xlink:to="loc_cvs_Category2To4Member_266ea780-7152-49a3-b823-4b16bebe4efa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5And6Member_9f0f98c0-f5c0-49a7-a37a-b87ece1e429e" xlink:href="cvs-20230525.xsd#cvs_Categories5And6Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_5e4d635a-297f-4cf3-b513-6a11460998b4" xlink:to="loc_cvs_Categories5And6Member_9f0f98c0-f5c0-49a7-a37a-b87ece1e429e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member_baac87da-e659-46c1-8a9e-bf48cd36a2cb" xlink:href="cvs-20230525.xsd#cvs_Category7Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_5e4d635a-297f-4cf3-b513-6a11460998b4" xlink:to="loc_cvs_Category7Member_baac87da-e659-46c1-8a9e-bf48cd36a2cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_17861d07-cc3d-44fa-9667-3024f4c0e8da" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_ef36fd79-1dd5-486c-bc26-4d2ce2741ee7" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_17861d07-cc3d-44fa-9667-3024f4c0e8da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_17861d07-cc3d-44fa-9667-3024f4c0e8da_default" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_17861d07-cc3d-44fa-9667-3024f4c0e8da" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_17861d07-cc3d-44fa-9667-3024f4c0e8da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_38bdf1b5-8084-4df9-8d22-e92d13cebf43" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_17861d07-cc3d-44fa-9667-3024f4c0e8da" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_38bdf1b5-8084-4df9-8d22-e92d13cebf43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember_4e13aa48-f30c-48d3-b1cd-15137d7eb4a4" xlink:href="cvs-20230525.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_38bdf1b5-8084-4df9-8d22-e92d13cebf43" xlink:to="loc_cvs_YearOfOriginationPeriodOneMember_4e13aa48-f30c-48d3-b1cd-15137d7eb4a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember_e7a6ee60-ae61-49a5-9e9e-f169b2f2fac9" xlink:href="cvs-20230525.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_38bdf1b5-8084-4df9-8d22-e92d13cebf43" xlink:to="loc_cvs_YearOfOriginationPeriodTwoMember_e7a6ee60-ae61-49a5-9e9e-f169b2f2fac9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember_7e432b57-93be-435f-88a2-72d6fe11c5bf" xlink:href="cvs-20230525.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_38bdf1b5-8084-4df9-8d22-e92d13cebf43" xlink:to="loc_cvs_YearOfOriginationPeriodThreeMember_7e432b57-93be-435f-88a2-72d6fe11c5bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember_731102b2-c8da-4ed3-af25-4a547424a1bb" xlink:href="cvs-20230525.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_38bdf1b5-8084-4df9-8d22-e92d13cebf43" xlink:to="loc_cvs_YearOfOriginationPeriodFourMember_731102b2-c8da-4ed3-af25-4a547424a1bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember_b674f20c-9b09-431b-8123-5efe7553c8e9" xlink:href="cvs-20230525.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_38bdf1b5-8084-4df9-8d22-e92d13cebf43" xlink:to="loc_cvs_YearOfOriginationPeriodFiveMember_b674f20c-9b09-431b-8123-5efe7553c8e9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_ea55d938-06f5-48b3-a91f-b5750e442d2a" xlink:href="cvs-20230525.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_38bdf1b5-8084-4df9-8d22-e92d13cebf43" xlink:to="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_ea55d938-06f5-48b3-a91f-b5750e442d2a" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsMortgageLoanPrincipalRepaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails" xlink:type="extended" id="i14d5f53dfa5b451abd58ed78a24e8863_InvestmentsMortgageLoanPrincipalRepaymentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_482595a2-e60b-4d5b-b047-81ebedc8d6d7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_6c8b3c88-e4ee-4829-9a79-c60ea14efadc" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_482595a2-e60b-4d5b-b047-81ebedc8d6d7" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_6c8b3c88-e4ee-4829-9a79-c60ea14efadc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_ad180bb7-0ac2-4338-af04-a10d9f27d5e7" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_482595a2-e60b-4d5b-b047-81ebedc8d6d7" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_ad180bb7-0ac2-4338-af04-a10d9f27d5e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_4a19e077-f912-4472-b1f1-a751a8bbc23d" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_482595a2-e60b-4d5b-b047-81ebedc8d6d7" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_4a19e077-f912-4472-b1f1-a751a8bbc23d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_2085e14a-5181-4a55-9fc5-17f7964dbcbb" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_482595a2-e60b-4d5b-b047-81ebedc8d6d7" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_2085e14a-5181-4a55-9fc5-17f7964dbcbb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_7cd10b26-82f7-44dc-8f01-8efbccad2228" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_482595a2-e60b-4d5b-b047-81ebedc8d6d7" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_7cd10b26-82f7-44dc-8f01-8efbccad2228" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_a8d064b7-c4a0-49da-8678-fcac56d9ac5b" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_482595a2-e60b-4d5b-b047-81ebedc8d6d7" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_a8d064b7-c4a0-49da-8678-fcac56d9ac5b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_15abf5f5-0ccf-4985-b2c5-b35be2814c71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_482595a2-e60b-4d5b-b047-81ebedc8d6d7" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_15abf5f5-0ccf-4985-b2c5-b35be2814c71" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_9b148a73-63a2-4f99-8d4b-b276fc5b4ec7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_482595a2-e60b-4d5b-b047-81ebedc8d6d7" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_9b148a73-63a2-4f99-8d4b-b276fc5b4ec7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_7e366328-0d11-445c-b932-c32cf3d075bd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_9b148a73-63a2-4f99-8d4b-b276fc5b4ec7" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_7e366328-0d11-445c-b932-c32cf3d075bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_7e366328-0d11-445c-b932-c32cf3d075bd_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_7e366328-0d11-445c-b932-c32cf3d075bd" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_7e366328-0d11-445c-b932-c32cf3d075bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_96bcbbce-e843-4734-8581-5f005e913b61" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_7e366328-0d11-445c-b932-c32cf3d075bd" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_96bcbbce-e843-4734-8581-5f005e913b61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_f19a36d1-3053-4abe-882f-03a59d10deb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_96bcbbce-e843-4734-8581-5f005e913b61" xlink:to="loc_us-gaap_CommercialRealEstateMember_f19a36d1-3053-4abe-882f-03a59d10deb7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended" id="i300e44c77d6d465fbb210a4640a8933f_InvestmentsNetInvestmentIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_59fd2704-ab9e-4250-9a96-acfe1f56ca33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_35863e88-0556-4164-959e-828090b9dcc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_59fd2704-ab9e-4250-9a96-acfe1f56ca33" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_35863e88-0556-4164-959e-828090b9dcc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_516640e9-d90f-416b-8f37-6aba073feac6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_59fd2704-ab9e-4250-9a96-acfe1f56ca33" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_516640e9-d90f-416b-8f37-6aba073feac6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_ad3d0549-c18a-49ec-a32d-7ed8a4cea4e0" xlink:href="cvs-20230525.xsd#cvs_InvestmentIncomeExcludingCapitalGainsOrLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_59fd2704-ab9e-4250-9a96-acfe1f56ca33" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_ad3d0549-c18a-49ec-a32d-7ed8a4cea4e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_955dc1ec-d3bd-4dd0-999d-83b0dda9f43d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_59fd2704-ab9e-4250-9a96-acfe1f56ca33" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_955dc1ec-d3bd-4dd0-999d-83b0dda9f43d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_822e5afc-3806-41db-9b02-9c7f84be7a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_59fd2704-ab9e-4250-9a96-acfe1f56ca33" xlink:to="loc_us-gaap_InvestmentIncomeNet_822e5afc-3806-41db-9b02-9c7f84be7a47" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_fb742b5c-8c7c-4b4b-951f-febd5ea742dc" xlink:href="cvs-20230525.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_59fd2704-ab9e-4250-9a96-acfe1f56ca33" xlink:to="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_fb742b5c-8c7c-4b4b-951f-febd5ea742dc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_a4698037-d195-48e2-a2fe-c5a274ffc5dd" xlink:href="cvs-20230525.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_59fd2704-ab9e-4250-9a96-acfe1f56ca33" xlink:to="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_a4698037-d195-48e2-a2fe-c5a274ffc5dd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_d35dde92-f818-4d91-b861-e10a73a989ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_59fd2704-ab9e-4250-9a96-acfe1f56ca33" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_d35dde92-f818-4d91-b861-e10a73a989ec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_7c62c8a8-b46d-4248-bf3c-d4f95177480b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_d35dde92-f818-4d91-b861-e10a73a989ec" xlink:to="loc_us-gaap_InvestmentTypeAxis_7c62c8a8-b46d-4248-bf3c-d4f95177480b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_7c62c8a8-b46d-4248-bf3c-d4f95177480b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_7c62c8a8-b46d-4248-bf3c-d4f95177480b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_7c62c8a8-b46d-4248-bf3c-d4f95177480b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_75d39fcd-75e8-4732-a9cd-7fb0305dde50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_7c62c8a8-b46d-4248-bf3c-d4f95177480b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_75d39fcd-75e8-4732-a9cd-7fb0305dde50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_7ffc5643-036d-47ff-b647-9c6e5bdf9c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_75d39fcd-75e8-4732-a9cd-7fb0305dde50" xlink:to="loc_us-gaap_DebtSecuritiesMember_7ffc5643-036d-47ff-b647-9c6e5bdf9c35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_c7194637-b83e-4f23-8801-3f4ccd846cdd" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_75d39fcd-75e8-4732-a9cd-7fb0305dde50" xlink:to="loc_cvs_MortgageLoansMember_c7194637-b83e-4f23-8801-3f4ccd846cdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_a7f1d262-2a69-47e1-a698-32ff6168435b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_75d39fcd-75e8-4732-a9cd-7fb0305dde50" xlink:to="loc_us-gaap_OtherInvestmentsMember_a7f1d262-2a69-47e1-a698-32ff6168435b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3b649bd4-1780-4cbe-8b74-13080d58e914" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_d35dde92-f818-4d91-b861-e10a73a989ec" xlink:to="loc_srt_ProductOrServiceAxis_3b649bd4-1780-4cbe-8b74-13080d58e914" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3b649bd4-1780-4cbe-8b74-13080d58e914_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_3b649bd4-1780-4cbe-8b74-13080d58e914" xlink:to="loc_srt_ProductsAndServicesDomain_3b649bd4-1780-4cbe-8b74-13080d58e914_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2fd2f433-50a0-4629-9f43-81b1f72e3eda" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_3b649bd4-1780-4cbe-8b74-13080d58e914" xlink:to="loc_srt_ProductsAndServicesDomain_2fd2f433-50a0-4629-9f43-81b1f72e3eda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_768d3a2c-c1db-4534-8a55-ed68c31ef120" xlink:href="cvs-20230525.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2fd2f433-50a0-4629-9f43-81b1f72e3eda" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_768d3a2c-c1db-4534-8a55-ed68c31ef120" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#FairValueFairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails" xlink:type="extended" id="i2672babcc7de4e8c927555f40d5a23c7_FairValueFairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97662cc5-8f83-4804-9f86-3410b4a0c7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_eb992abd-66bb-44be-a2a5-60d1113c9079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97662cc5-8f83-4804-9f86-3410b4a0c7b8" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_eb992abd-66bb-44be-a2a5-60d1113c9079" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b5f64fb5-9ac4-4b77-969f-1cb5dcf17710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97662cc5-8f83-4804-9f86-3410b4a0c7b8" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b5f64fb5-9ac4-4b77-969f-1cb5dcf17710" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_743b75ee-d3ca-45f5-a320-50c8b3cba96f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97662cc5-8f83-4804-9f86-3410b4a0c7b8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_743b75ee-d3ca-45f5-a320-50c8b3cba96f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_435953a7-d57a-49fb-9464-f3797be567f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97662cc5-8f83-4804-9f86-3410b4a0c7b8" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_435953a7-d57a-49fb-9464-f3797be567f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_983184a3-41ec-4516-a277-000eee1f4626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97662cc5-8f83-4804-9f86-3410b4a0c7b8" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_983184a3-41ec-4516-a277-000eee1f4626" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e3182d81-ac7f-4be9-907a-68d109c7f6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97662cc5-8f83-4804-9f86-3410b4a0c7b8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e3182d81-ac7f-4be9-907a-68d109c7f6c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cdfda536-4c7f-4846-bc8a-d4a8e481df1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e3182d81-ac7f-4be9-907a-68d109c7f6c3" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cdfda536-4c7f-4846-bc8a-d4a8e481df1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_cdfda536-4c7f-4846-bc8a-d4a8e481df1e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cdfda536-4c7f-4846-bc8a-d4a8e481df1e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_cdfda536-4c7f-4846-bc8a-d4a8e481df1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b969431a-8fb2-48a1-a27b-5e0cbd17de04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cdfda536-4c7f-4846-bc8a-d4a8e481df1e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b969431a-8fb2-48a1-a27b-5e0cbd17de04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_404e4d91-69df-4352-89cd-5ee303dffd88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_b969431a-8fb2-48a1-a27b-5e0cbd17de04" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_404e4d91-69df-4352-89cd-5ee303dffd88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1617e752-2ba5-4fa4-a9a6-fdd3978896bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e3182d81-ac7f-4be9-907a-68d109c7f6c3" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1617e752-2ba5-4fa4-a9a6-fdd3978896bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1617e752-2ba5-4fa4-a9a6-fdd3978896bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1617e752-2ba5-4fa4-a9a6-fdd3978896bd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1617e752-2ba5-4fa4-a9a6-fdd3978896bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a6bf0ca-c266-4b48-829a-16c0c72a2c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1617e752-2ba5-4fa4-a9a6-fdd3978896bd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a6bf0ca-c266-4b48-829a-16c0c72a2c76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_b49d3302-126a-456c-9cfc-01ed347e7590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a6bf0ca-c266-4b48-829a-16c0c72a2c76" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_b49d3302-126a-456c-9cfc-01ed347e7590" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_c4bf2e37-745f-4d1a-9819-e19eb176c137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a6bf0ca-c266-4b48-829a-16c0c72a2c76" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_c4bf2e37-745f-4d1a-9819-e19eb176c137" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_5b2093e0-3527-40bb-a008-e45a1d1ea2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a6bf0ca-c266-4b48-829a-16c0c72a2c76" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_5b2093e0-3527-40bb-a008-e45a1d1ea2cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_aa573cde-463f-4ad8-8a03-d3f139e979e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a6bf0ca-c266-4b48-829a-16c0c72a2c76" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_aa573cde-463f-4ad8-8a03-d3f139e979e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_bf1026a8-a3ab-43aa-8537-dd7e795c43a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a6bf0ca-c266-4b48-829a-16c0c72a2c76" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_bf1026a8-a3ab-43aa-8537-dd7e795c43a7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c408545b-65ac-402e-84c0-601e7aad0410" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a6bf0ca-c266-4b48-829a-16c0c72a2c76" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c408545b-65ac-402e-84c0-601e7aad0410" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_4fe1fb95-a6a7-4b65-ab65-95be95c2e66b" xlink:href="cvs-20230525.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a6bf0ca-c266-4b48-829a-16c0c72a2c76" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_4fe1fb95-a6a7-4b65-ab65-95be95c2e66b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_58d49bb3-3c6f-44c5-a1dc-418dba390ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a6bf0ca-c266-4b48-829a-16c0c72a2c76" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_58d49bb3-3c6f-44c5-a1dc-418dba390ae5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ee4df8f1-f800-4908-848d-91a1286c9412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e3182d81-ac7f-4be9-907a-68d109c7f6c3" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ee4df8f1-f800-4908-848d-91a1286c9412" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ee4df8f1-f800-4908-848d-91a1286c9412_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ee4df8f1-f800-4908-848d-91a1286c9412" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ee4df8f1-f800-4908-848d-91a1286c9412_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9b0ec7af-9ccb-4ed1-b088-cd4084843f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ee4df8f1-f800-4908-848d-91a1286c9412" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9b0ec7af-9ccb-4ed1-b088-cd4084843f9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_06ff3e28-bec4-4090-a9da-19ad33ddbda6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9b0ec7af-9ccb-4ed1-b088-cd4084843f9e" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_06ff3e28-bec4-4090-a9da-19ad33ddbda6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_69265ae8-f6ac-4971-8727-5ff9c228e575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9b0ec7af-9ccb-4ed1-b088-cd4084843f9e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_69265ae8-f6ac-4971-8727-5ff9c228e575" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4c8a1f2e-1611-4a42-ac2e-652841a2264d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9b0ec7af-9ccb-4ed1-b088-cd4084843f9e" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4c8a1f2e-1611-4a42-ac2e-652841a2264d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4ecdd0f7-4ce7-49cc-9a33-0fd0a63fec34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e3182d81-ac7f-4be9-907a-68d109c7f6c3" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4ecdd0f7-4ce7-49cc-9a33-0fd0a63fec34" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4ecdd0f7-4ce7-49cc-9a33-0fd0a63fec34_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4ecdd0f7-4ce7-49cc-9a33-0fd0a63fec34" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4ecdd0f7-4ce7-49cc-9a33-0fd0a63fec34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ae27d438-319d-4352-a7f4-f05686fd645f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4ecdd0f7-4ce7-49cc-9a33-0fd0a63fec34" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ae27d438-319d-4352-a7f4-f05686fd645f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_5ea486a7-1ff6-4fdf-80a4-211141e2a484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_ae27d438-319d-4352-a7f4-f05686fd645f" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_5ea486a7-1ff6-4fdf-80a4-211141e2a484" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#FairValueChangesinLevel3FinancialAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails" xlink:type="extended" id="ied952d3efc3243fda87c34ada7d719b5_FairValueChangesinLevel3FinancialAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f9edbec0-06de-42f3-8d10-1ac7f9b918a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8d35a0c9-8238-4534-851c-4ceaf4f2cbb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f9edbec0-06de-42f3-8d10-1ac7f9b918a9" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8d35a0c9-8238-4534-851c-4ceaf4f2cbb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_29d452ea-4b7c-461d-affa-1eb7d0d45edb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8d35a0c9-8238-4534-851c-4ceaf4f2cbb6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_29d452ea-4b7c-461d-affa-1eb7d0d45edb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_009a7c15-50f0-4b40-bcec-792d44ff794d" xlink:href="cvs-20230525.xsd#cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8d35a0c9-8238-4534-851c-4ceaf4f2cbb6" xlink:to="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_009a7c15-50f0-4b40-bcec-792d44ff794d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_d168299a-61d3-4646-b065-27c130578d91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_009a7c15-50f0-4b40-bcec-792d44ff794d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_d168299a-61d3-4646-b065-27c130578d91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_2e94a2b7-0987-43a5-b5c9-b85a7bc1253a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_009a7c15-50f0-4b40-bcec-792d44ff794d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_2e94a2b7-0987-43a5-b5c9-b85a7bc1253a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_247da247-0559-44cc-a10e-8ebfedf9ad07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8d35a0c9-8238-4534-851c-4ceaf4f2cbb6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_247da247-0559-44cc-a10e-8ebfedf9ad07" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_5c35fcf7-a243-4eb4-900f-fcde4cb95633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8d35a0c9-8238-4534-851c-4ceaf4f2cbb6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_5c35fcf7-a243-4eb4-900f-fcde4cb95633" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_aedae1e9-9ffb-4f1c-963f-a70ee122abdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8d35a0c9-8238-4534-851c-4ceaf4f2cbb6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_aedae1e9-9ffb-4f1c-963f-a70ee122abdc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_457cb7fb-e7fe-44cf-ab3c-fddda70508c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8d35a0c9-8238-4534-851c-4ceaf4f2cbb6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_457cb7fb-e7fe-44cf-ab3c-fddda70508c8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_1823eaa7-8799-4758-884a-4ed12d7200f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci_c9d05377-0830-4a52-b2c2-0ef6cf8383a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f9edbec0-06de-42f3-8d10-1ac7f9b918a9" xlink:to="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci_c9d05377-0830-4a52-b2c2-0ef6cf8383a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0acbbfdc-76fd-491b-b8e3-aba4c09c4ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f9edbec0-06de-42f3-8d10-1ac7f9b918a9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0acbbfdc-76fd-491b-b8e3-aba4c09c4ab5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e15cd4c5-744b-43a8-a640-23c2078c6e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0acbbfdc-76fd-491b-b8e3-aba4c09c4ab5" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e15cd4c5-744b-43a8-a640-23c2078c6e8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e15cd4c5-744b-43a8-a640-23c2078c6e8c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e15cd4c5-744b-43a8-a640-23c2078c6e8c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e15cd4c5-744b-43a8-a640-23c2078c6e8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e6572c08-0b9c-489f-b979-63e5c00e9242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e15cd4c5-744b-43a8-a640-23c2078c6e8c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e6572c08-0b9c-489f-b979-63e5c00e9242" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_503e8f02-a0c8-4fd6-a642-901afa1fe08c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e6572c08-0b9c-489f-b979-63e5c00e9242" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_503e8f02-a0c8-4fd6-a642-901afa1fe08c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_66fd9135-e4fb-4df8-9b3d-8ed729109c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e6572c08-0b9c-489f-b979-63e5c00e9242" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_66fd9135-e4fb-4df8-9b3d-8ed729109c59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember_aa672c7f-272a-41e0-8ce5-49c4e93dbc48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e6572c08-0b9c-489f-b979-63e5c00e9242" xlink:to="loc_us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember_aa672c7f-272a-41e0-8ce5-49c4e93dbc48" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_eaaf22c5-e68d-43de-a3ee-de61c6afcbb5" xlink:href="cvs-20230525.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e6572c08-0b9c-489f-b979-63e5c00e9242" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_eaaf22c5-e68d-43de-a3ee-de61c6afcbb5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_35c5709d-f713-47f9-adf5-9001a55f1140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e6572c08-0b9c-489f-b979-63e5c00e9242" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_35c5709d-f713-47f9-adf5-9001a55f1140" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_a730dc9c-e869-4089-ac33-c6f615498add" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e6572c08-0b9c-489f-b979-63e5c00e9242" xlink:to="loc_us-gaap_EquitySecuritiesMember_a730dc9c-e869-4089-ac33-c6f615498add" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7ecec4d3-4a24-4f13-867a-1fb774fd13f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0acbbfdc-76fd-491b-b8e3-aba4c09c4ab5" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7ecec4d3-4a24-4f13-867a-1fb774fd13f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_7ecec4d3-4a24-4f13-867a-1fb774fd13f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7ecec4d3-4a24-4f13-867a-1fb774fd13f2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_7ecec4d3-4a24-4f13-867a-1fb774fd13f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_8e87bb38-8990-4b9c-8114-d4213787c8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7ecec4d3-4a24-4f13-867a-1fb774fd13f2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_8e87bb38-8990-4b9c-8114-d4213787c8eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_779aba2c-8824-4632-8439-7e4e1695577c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_8e87bb38-8990-4b9c-8114-d4213787c8eb" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_779aba2c-8824-4632-8439-7e4e1695577c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details" xlink:type="simple" xlink:href="cvs-20230525.xsd#FairValueGrossTransfersIntoOutOfLevel3Details"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details" xlink:type="extended" id="i98ff4de1eba84cfe985dd4e4ba877c38_FairValueGrossTransfersIntoOutOfLevel3Details">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_185a5bd6-6e0c-4bfd-b092-81fb6b8627cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_10596465-f504-4625-b6fb-1bba7f7edc80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_185a5bd6-6e0c-4bfd-b092-81fb6b8627cb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_10596465-f504-4625-b6fb-1bba7f7edc80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_daea1570-eda5-469f-808f-fc3f7ea2b630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_185a5bd6-6e0c-4bfd-b092-81fb6b8627cb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_daea1570-eda5-469f-808f-fc3f7ea2b630" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_3355ea82-34b9-4e3d-8912-c4fec4bb8b49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_185a5bd6-6e0c-4bfd-b092-81fb6b8627cb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_3355ea82-34b9-4e3d-8912-c4fec4bb8b49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bae62b1c-08cf-4df1-995b-81399846189b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_185a5bd6-6e0c-4bfd-b092-81fb6b8627cb" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bae62b1c-08cf-4df1-995b-81399846189b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_94877fb8-d399-4152-b884-08fa9f6c4438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bae62b1c-08cf-4df1-995b-81399846189b" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_94877fb8-d399-4152-b884-08fa9f6c4438" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_94877fb8-d399-4152-b884-08fa9f6c4438_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_94877fb8-d399-4152-b884-08fa9f6c4438" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_94877fb8-d399-4152-b884-08fa9f6c4438_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b86cad98-c687-4d4d-9bd2-09cd6da86e36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_94877fb8-d399-4152-b884-08fa9f6c4438" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b86cad98-c687-4d4d-9bd2-09cd6da86e36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_9ee4d77d-e4d4-4fa0-b7d4-1b5f20b6faaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_b86cad98-c687-4d4d-9bd2-09cd6da86e36" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_9ee4d77d-e4d4-4fa0-b7d4-1b5f20b6faaa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ede8915f-a798-41db-b0fc-9cea3e35d7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bae62b1c-08cf-4df1-995b-81399846189b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ede8915f-a798-41db-b0fc-9cea3e35d7bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ede8915f-a798-41db-b0fc-9cea3e35d7bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ede8915f-a798-41db-b0fc-9cea3e35d7bc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ede8915f-a798-41db-b0fc-9cea3e35d7bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_efe8a7c9-87a0-41a6-b6d5-87e5b8d170cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ede8915f-a798-41db-b0fc-9cea3e35d7bc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_efe8a7c9-87a0-41a6-b6d5-87e5b8d170cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a19bce6c-de74-451e-8588-59382bf79741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_efe8a7c9-87a0-41a6-b6d5-87e5b8d170cc" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a19bce6c-de74-451e-8588-59382bf79741" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#FairValueCarryingValueandFairValueClassifiedbyLevelDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="extended" id="i130bbd1cc66f416388acdceb19436f6e_FairValueCarryingValueandFairValueClassifiedbyLevelDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7bc60663-ce41-4caf-905f-585e461a41fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1a097ad6-68fc-4736-a0d6-d29acaab362d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7bc60663-ce41-4caf-905f-585e461a41fc" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1a097ad6-68fc-4736-a0d6-d29acaab362d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_73b42e7c-802d-4252-8197-3a76725cacc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1a097ad6-68fc-4736-a0d6-d29acaab362d" xlink:to="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_73b42e7c-802d-4252-8197-3a76725cacc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_91b20b67-c39c-446e-b035-4902828e44d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1a097ad6-68fc-4736-a0d6-d29acaab362d" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_91b20b67-c39c-446e-b035-4902828e44d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_92d2d1ff-4e5d-4abe-9f14-5d0ddd4684e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7bc60663-ce41-4caf-905f-585e461a41fc" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_92d2d1ff-4e5d-4abe-9f14-5d0ddd4684e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_009ee356-9180-43ed-a485-1db5a3efaa93" xlink:href="cvs-20230525.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_92d2d1ff-4e5d-4abe-9f14-5d0ddd4684e2" xlink:to="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_009ee356-9180-43ed-a485-1db5a3efaa93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_e3985356-cc2d-441a-907a-24ab37708b40" xlink:href="cvs-20230525.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_92d2d1ff-4e5d-4abe-9f14-5d0ddd4684e2" xlink:to="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_e3985356-cc2d-441a-907a-24ab37708b40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_615350d9-da81-4aa0-a117-75333aeff8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_92d2d1ff-4e5d-4abe-9f14-5d0ddd4684e2" xlink:to="loc_us-gaap_DebtInstrumentFairValue_615350d9-da81-4aa0-a117-75333aeff8b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4988a284-9841-4ade-88c6-c955c4fee603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7bc60663-ce41-4caf-905f-585e461a41fc" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4988a284-9841-4ade-88c6-c955c4fee603" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8490135b-db9e-49e4-b125-63f832c09977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4988a284-9841-4ade-88c6-c955c4fee603" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8490135b-db9e-49e4-b125-63f832c09977" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_8490135b-db9e-49e4-b125-63f832c09977_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8490135b-db9e-49e4-b125-63f832c09977" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_8490135b-db9e-49e4-b125-63f832c09977_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f83e6a2f-2d56-44c0-9b6a-727ff4b348ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8490135b-db9e-49e4-b125-63f832c09977" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f83e6a2f-2d56-44c0-9b6a-727ff4b348ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_e0d03415-5ff8-452a-816b-b1fb763b3e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f83e6a2f-2d56-44c0-9b6a-727ff4b348ee" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_e0d03415-5ff8-452a-816b-b1fb763b3e45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bdd807a7-3ef0-4276-83d1-34c5c75e4c58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4988a284-9841-4ade-88c6-c955c4fee603" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bdd807a7-3ef0-4276-83d1-34c5c75e4c58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bdd807a7-3ef0-4276-83d1-34c5c75e4c58_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bdd807a7-3ef0-4276-83d1-34c5c75e4c58" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bdd807a7-3ef0-4276-83d1-34c5c75e4c58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e5096aa4-9440-4b2e-99af-9273a3d67385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bdd807a7-3ef0-4276-83d1-34c5c75e4c58" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e5096aa4-9440-4b2e-99af-9273a3d67385" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_476d4ae2-b010-4617-9dc4-6c51b91597b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e5096aa4-9440-4b2e-99af-9273a3d67385" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_476d4ae2-b010-4617-9dc4-6c51b91597b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_766109d0-e18a-4bf2-b685-b73cb7098774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e5096aa4-9440-4b2e-99af-9273a3d67385" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_766109d0-e18a-4bf2-b685-b73cb7098774" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8dca7909-254a-4f09-8113-17f5f94b4a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e5096aa4-9440-4b2e-99af-9273a3d67385" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8dca7909-254a-4f09-8113-17f5f94b4a4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_9a0a955c-c8cc-4b26-9ea9-a60d0a7c6558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4988a284-9841-4ade-88c6-c955c4fee603" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_9a0a955c-c8cc-4b26-9ea9-a60d0a7c6558" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9a0a955c-c8cc-4b26-9ea9-a60d0a7c6558_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_9a0a955c-c8cc-4b26-9ea9-a60d0a7c6558" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9a0a955c-c8cc-4b26-9ea9-a60d0a7c6558_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_4df462f3-e90e-4e3c-8ab8-7b2f62bafaf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_9a0a955c-c8cc-4b26-9ea9-a60d0a7c6558" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_4df462f3-e90e-4e3c-8ab8-7b2f62bafaf2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ff377d74-1b01-4fa5-bbd1-17c11ffd3692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_4df462f3-e90e-4e3c-8ab8-7b2f62bafaf2" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ff377d74-1b01-4fa5-bbd1-17c11ffd3692" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_ddf377fb-6207-4cdc-a11b-079ce8c29f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ff377d74-1b01-4fa5-bbd1-17c11ffd3692" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_ddf377fb-6207-4cdc-a11b-079ce8c29f9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1af71818-785d-4b07-b30a-e7377aa31c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ff377d74-1b01-4fa5-bbd1-17c11ffd3692" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1af71818-785d-4b07-b30a-e7377aa31c27" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_638ef3f7-4475-47c4-967f-400730f57e38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4988a284-9841-4ade-88c6-c955c4fee603" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_638ef3f7-4475-47c4-967f-400730f57e38" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_638ef3f7-4475-47c4-967f-400730f57e38_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_638ef3f7-4475-47c4-967f-400730f57e38" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_638ef3f7-4475-47c4-967f-400730f57e38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_edd4b3e2-6113-4d26-86a4-42423836c0bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_638ef3f7-4475-47c4-967f-400730f57e38" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_edd4b3e2-6113-4d26-86a4-42423836c0bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_a9f77a39-6d21-414a-9e6e-3394bf687988" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_edd4b3e2-6113-4d26-86a4-42423836c0bb" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_a9f77a39-6d21-414a-9e6e-3394bf687988" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#FairValueSeparateAccountsFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="extended" id="i6ae9dfeeff72402bb78109af74515207_FairValueSeparateAccountsFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_4362cd64-2fd8-4667-936b-cc07ed612d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_955a220b-a181-4547-9483-019c3fb94096" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_4362cd64-2fd8-4667-936b-cc07ed612d1b" xlink:to="loc_us-gaap_SeparateAccountAssets_955a220b-a181-4547-9483-019c3fb94096" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_d97aff01-5c48-4b43-bb55-de22c9962d75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_4362cd64-2fd8-4667-936b-cc07ed612d1b" xlink:to="loc_us-gaap_SeparateAccountsLiability_d97aff01-5c48-4b43-bb55-de22c9962d75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_45056b96-da49-45ba-847c-b3897ada11d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_4362cd64-2fd8-4667-936b-cc07ed612d1b" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_45056b96-da49-45ba-847c-b3897ada11d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a72fe254-f7af-4407-ade9-ddbbfd668099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_45056b96-da49-45ba-847c-b3897ada11d3" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a72fe254-f7af-4407-ade9-ddbbfd668099" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_a72fe254-f7af-4407-ade9-ddbbfd668099_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a72fe254-f7af-4407-ade9-ddbbfd668099" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_a72fe254-f7af-4407-ade9-ddbbfd668099_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_5d49b6f3-bf43-4f0a-9052-5a5d049fcf29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a72fe254-f7af-4407-ade9-ddbbfd668099" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_5d49b6f3-bf43-4f0a-9052-5a5d049fcf29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_1fabe650-5029-45b9-a0e2-0d39362e4460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_5d49b6f3-bf43-4f0a-9052-5a5d049fcf29" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_1fabe650-5029-45b9-a0e2-0d39362e4460" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_98d16e4f-455a-4a8b-86c3-d93f157fdddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_45056b96-da49-45ba-847c-b3897ada11d3" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_98d16e4f-455a-4a8b-86c3-d93f157fdddb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98d16e4f-455a-4a8b-86c3-d93f157fdddb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_98d16e4f-455a-4a8b-86c3-d93f157fdddb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98d16e4f-455a-4a8b-86c3-d93f157fdddb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a4843508-f745-4bb7-ab96-5fa47884edaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_98d16e4f-455a-4a8b-86c3-d93f157fdddb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a4843508-f745-4bb7-ab96-5fa47884edaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3511dcfd-a79f-4f7c-a9b2-31f0066f3d44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a4843508-f745-4bb7-ab96-5fa47884edaf" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3511dcfd-a79f-4f7c-a9b2-31f0066f3d44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_23da7cbd-da06-420b-99d5-692fc60943dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a4843508-f745-4bb7-ab96-5fa47884edaf" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_23da7cbd-da06-420b-99d5-692fc60943dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_dc9b03ad-3822-4171-909b-3452dcf59550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a4843508-f745-4bb7-ab96-5fa47884edaf" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_dc9b03ad-3822-4171-909b-3452dcf59550" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryAxis_bb230441-4bd3-45ee-b14c-efadb5c6f79d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_45056b96-da49-45ba-847c-b3897ada11d3" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryAxis_bb230441-4bd3-45ee-b14c-efadb5c6f79d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain_bb230441-4bd3-45ee-b14c-efadb5c6f79d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis_bb230441-4bd3-45ee-b14c-efadb5c6f79d" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryDomain_bb230441-4bd3-45ee-b14c-efadb5c6f79d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain_17fcc7fa-fb35-49c1-b4ee-7351aad440f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis_bb230441-4bd3-45ee-b14c-efadb5c6f79d" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryDomain_17fcc7fa-fb35-49c1-b4ee-7351aad440f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_9975738f-46ba-4fb4-8c96-ee764af01e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_17fcc7fa-fb35-49c1-b4ee-7351aad440f1" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_9975738f-46ba-4fb4-8c96-ee764af01e32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_18628b28-4eb2-473e-9fcc-1c65fc463fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_17fcc7fa-fb35-49c1-b4ee-7351aad440f1" xlink:to="loc_us-gaap_DebtSecuritiesMember_18628b28-4eb2-473e-9fcc-1c65fc463fcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_181a1bc0-7056-465d-8d80-046b8e4f6c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_17fcc7fa-fb35-49c1-b4ee-7351aad440f1" xlink:to="loc_us-gaap_EquitySecuritiesMember_181a1bc0-7056-465d-8d80-046b8e4f6c3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember_d6638370-9a00-415e-ac79-ddfc33b3ef6e" xlink:href="cvs-20230525.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_17fcc7fa-fb35-49c1-b4ee-7351aad440f1" xlink:to="loc_cvs_CommonAndCollectiveTrustsMember_d6638370-9a00-415e-ac79-ddfc33b3ef6e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f398df29-32f5-467a-beac-8e6cf9a86bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_45056b96-da49-45ba-847c-b3897ada11d3" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f398df29-32f5-467a-beac-8e6cf9a86bb7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f398df29-32f5-467a-beac-8e6cf9a86bb7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f398df29-32f5-467a-beac-8e6cf9a86bb7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f398df29-32f5-467a-beac-8e6cf9a86bb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_65c6a791-a719-46cb-8bbd-06c643bff21c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f398df29-32f5-467a-beac-8e6cf9a86bb7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_65c6a791-a719-46cb-8bbd-06c643bff21c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableMember_6d4d3f03-5ee0-49ec-8d18-0ce3e232aeb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_65c6a791-a719-46cb-8bbd-06c643bff21c" xlink:to="loc_us-gaap_AccountsPayableMember_6d4d3f03-5ee0-49ec-8d18-0ce3e232aeb3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_11152f17-bb0f-4f5b-a76e-4a902ddc5cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_65c6a791-a719-46cb-8bbd-06c643bff21c" xlink:to="loc_us-gaap_AccountsReceivableMember_11152f17-bb0f-4f5b-a76e-4a902ddc5cd3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#FairValueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueNarrativeDetails" xlink:type="extended" id="if6fed7077e4d4175a39eb884a5e319af_FairValueNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fa78913a-1bfb-43b4-91ba-1adb7dd8f5aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_e9c19885-c8e5-458e-bd03-f63c1cb07d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fa78913a-1bfb-43b4-91ba-1adb7dd8f5aa" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_e9c19885-c8e5-458e-bd03-f63c1cb07d1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efc2ab6b-c3ec-4ba0-8fbd-ff95ee4fcc60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fa78913a-1bfb-43b4-91ba-1adb7dd8f5aa" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efc2ab6b-c3ec-4ba0-8fbd-ff95ee4fcc60" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_96c661c8-033f-48e0-8496-4ab068fde369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efc2ab6b-c3ec-4ba0-8fbd-ff95ee4fcc60" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_96c661c8-033f-48e0-8496-4ab068fde369" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_96c661c8-033f-48e0-8496-4ab068fde369_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_96c661c8-033f-48e0-8496-4ab068fde369" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_96c661c8-033f-48e0-8496-4ab068fde369_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5e3f8467-0d7c-4b3d-a25f-09ae3fcd3517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_96c661c8-033f-48e0-8496-4ab068fde369" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5e3f8467-0d7c-4b3d-a25f-09ae3fcd3517" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_85ebea83-ddaa-424a-9275-6b871a196d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5e3f8467-0d7c-4b3d-a25f-09ae3fcd3517" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_85ebea83-ddaa-424a-9275-6b871a196d23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c155e5ca-5ed3-4bb5-8daf-5927884b4a58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efc2ab6b-c3ec-4ba0-8fbd-ff95ee4fcc60" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c155e5ca-5ed3-4bb5-8daf-5927884b4a58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c155e5ca-5ed3-4bb5-8daf-5927884b4a58_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c155e5ca-5ed3-4bb5-8daf-5927884b4a58" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c155e5ca-5ed3-4bb5-8daf-5927884b4a58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_8da729fc-1662-43b1-8629-198a74954675" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c155e5ca-5ed3-4bb5-8daf-5927884b4a58" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_8da729fc-1662-43b1-8629-198a74954675" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_4896b7f6-b876-4ecc-ba41-c7a5491050cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_8da729fc-1662-43b1-8629-198a74954675" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_4896b7f6-b876-4ecc-ba41-c7a5491050cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryAxis_479b2289-88e6-4411-8600-91e414fded6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efc2ab6b-c3ec-4ba0-8fbd-ff95ee4fcc60" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryAxis_479b2289-88e6-4411-8600-91e414fded6b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain_479b2289-88e6-4411-8600-91e414fded6b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis_479b2289-88e6-4411-8600-91e414fded6b" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryDomain_479b2289-88e6-4411-8600-91e414fded6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain_2b26fb6a-ffe5-44ff-9d99-b2837d092652" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis_479b2289-88e6-4411-8600-91e414fded6b" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryDomain_2b26fb6a-ffe5-44ff-9d99-b2837d092652" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeparateAccountFinancialAssetsMember_51d6814a-d26a-4b3f-ad8f-da6d5e25daf9" xlink:href="cvs-20230525.xsd#cvs_SeparateAccountFinancialAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_2b26fb6a-ffe5-44ff-9d99-b2837d092652" xlink:to="loc_cvs_SeparateAccountFinancialAssetsMember_51d6814a-d26a-4b3f-ad8f-da6d5e25daf9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#GoodwillandOtherIntangiblesGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails" xlink:type="extended" id="i5f4fbc58f4704160933ae635dcd3917d_GoodwillandOtherIntangiblesGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_bd648948-e8e6-449a-abf3-aeee4fa90e42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_303b91e2-f152-404e-bea2-4b97bc145b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_bd648948-e8e6-449a-abf3-aeee4fa90e42" xlink:to="loc_us-gaap_GoodwillRollForward_303b91e2-f152-404e-bea2-4b97bc145b45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e29a7020-0aeb-4b5f-8c89-379db0c72fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_303b91e2-f152-404e-bea2-4b97bc145b45" xlink:to="loc_us-gaap_Goodwill_e29a7020-0aeb-4b5f-8c89-379db0c72fbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_e26f1183-fe72-4e42-ab37-3b1102351457" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_303b91e2-f152-404e-bea2-4b97bc145b45" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_e26f1183-fe72-4e42-ab37-3b1102351457" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_1395c056-b838-47bc-81d1-d33d789ae322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_303b91e2-f152-404e-bea2-4b97bc145b45" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_1395c056-b838-47bc-81d1-d33d789ae322" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3e3f8fb3-0536-413f-a638-6985bb96b648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_c91ad25f-09f7-488e-9f12-8f8434aefd7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_bd648948-e8e6-449a-abf3-aeee4fa90e42" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_c91ad25f-09f7-488e-9f12-8f8434aefd7f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_24614034-2c2e-443b-81f0-4c8bc055193b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c91ad25f-09f7-488e-9f12-8f8434aefd7f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_24614034-2c2e-443b-81f0-4c8bc055193b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_24614034-2c2e-443b-81f0-4c8bc055193b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_24614034-2c2e-443b-81f0-4c8bc055193b" xlink:to="loc_us-gaap_SegmentDomain_24614034-2c2e-443b-81f0-4c8bc055193b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d3a6a00a-072d-489f-bef9-1907238386f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_24614034-2c2e-443b-81f0-4c8bc055193b" xlink:to="loc_us-gaap_SegmentDomain_d3a6a00a-072d-489f-bef9-1907238386f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_08bc1ad9-f366-4c5c-ba3a-00fa545050ea" xlink:href="cvs-20230525.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d3a6a00a-072d-489f-bef9-1907238386f1" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_08bc1ad9-f366-4c5c-ba3a-00fa545050ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthServicesSegmentMember_e07e2173-8ed1-4411-8816-b077b7ce556a" xlink:href="cvs-20230525.xsd#cvs_HealthServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d3a6a00a-072d-489f-bef9-1907238386f1" xlink:to="loc_cvs_HealthServicesSegmentMember_e07e2173-8ed1-4411-8816-b077b7ce556a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_6632c304-41a2-4faf-952e-86d6a822d70a" xlink:href="cvs-20230525.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d3a6a00a-072d-489f-bef9-1907238386f1" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_6632c304-41a2-4faf-952e-86d6a822d70a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_1f0157cb-761a-4e73-a82b-af59f11afccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c91ad25f-09f7-488e-9f12-8f8434aefd7f" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_1f0157cb-761a-4e73-a82b-af59f11afccf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1f0157cb-761a-4e73-a82b-af59f11afccf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1f0157cb-761a-4e73-a82b-af59f11afccf" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1f0157cb-761a-4e73-a82b-af59f11afccf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6e7d243a-8613-4e04-819a-b77adc2d999f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1f0157cb-761a-4e73-a82b-af59f11afccf" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6e7d243a-8613-4e04-819a-b77adc2d999f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_4616a64a-f511-4100-ad04-addb0cd8879e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_6e7d243a-8613-4e04-819a-b77adc2d999f" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_4616a64a-f511-4100-ad04-addb0cd8879e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#GoodwillandOtherIntangiblesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails" xlink:type="extended" id="if98828fbbf9345da9dcf1a089eca5713_GoodwillandOtherIntangiblesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_e5460f41-8582-4f16-9e32-e13935289b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_2e2b965c-0dce-4cfb-bf89-08084d1a4584" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_e5460f41-8582-4f16-9e32-e13935289b0e" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_2e2b965c-0dce-4cfb-bf89-08084d1a4584" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_56dd089f-c178-425d-8507-31790d3d8dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_e5460f41-8582-4f16-9e32-e13935289b0e" xlink:to="loc_us-gaap_Goodwill_56dd089f-c178-425d-8507-31790d3d8dc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_23b635f4-f28e-457a-ae61-8e3953e476c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_e5460f41-8582-4f16-9e32-e13935289b0e" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_23b635f4-f28e-457a-ae61-8e3953e476c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_d809f5fc-ebaa-47e7-b80c-48f5b434ef8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_e5460f41-8582-4f16-9e32-e13935289b0e" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_d809f5fc-ebaa-47e7-b80c-48f5b434ef8a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_5c2089fe-9fba-4fc3-a748-ea1d713b545f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d809f5fc-ebaa-47e7-b80c-48f5b434ef8a" xlink:to="loc_us-gaap_ReportingUnitAxis_5c2089fe-9fba-4fc3-a748-ea1d713b545f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_5c2089fe-9fba-4fc3-a748-ea1d713b545f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_5c2089fe-9fba-4fc3-a748-ea1d713b545f" xlink:to="loc_us-gaap_ReportingUnitDomain_5c2089fe-9fba-4fc3-a748-ea1d713b545f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_d6e84444-82f2-4f53-b7c2-b778ce4bd28f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_5c2089fe-9fba-4fc3-a748-ea1d713b545f" xlink:to="loc_us-gaap_ReportingUnitDomain_d6e84444-82f2-4f53-b7c2-b778ce4bd28f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareReportingUnitMember_44d6a4b7-c4e4-4cf8-a444-2cc3de37a045" xlink:href="cvs-20230525.xsd#cvs_LongTermCareReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_d6e84444-82f2-4f53-b7c2-b778ce4bd28f" xlink:to="loc_cvs_LongTermCareReportingUnitMember_44d6a4b7-c4e4-4cf8-a444-2cc3de37a045" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#GoodwillandOtherIntangiblesIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails" xlink:type="extended" id="i2a02db4736de4bd890cc9889bd5a9950_GoodwillandOtherIntangiblesIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_a819ed2e-08bf-4d0e-9fab-60248dbe3786" xlink:href="cvs-20230525.xsd#cvs_OtherAcquiredIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0cc260d7-1861-4778-9c4f-0e8b58c471ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_a819ed2e-08bf-4d0e-9fab-60248dbe3786" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0cc260d7-1861-4778-9c4f-0e8b58c471ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ba5c1379-841b-4646-8cab-f2962f856a65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_a819ed2e-08bf-4d0e-9fab-60248dbe3786" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ba5c1379-841b-4646-8cab-f2962f856a65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6707f873-8bac-48db-9376-e144dba577ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_a819ed2e-08bf-4d0e-9fab-60248dbe3786" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6707f873-8bac-48db-9376-e144dba577ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_51ef6d5a-a7f7-44f4-b0e2-86349a57812e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_a819ed2e-08bf-4d0e-9fab-60248dbe3786" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_51ef6d5a-a7f7-44f4-b0e2-86349a57812e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_8a745664-b1f7-4cdc-a5c2-de9571f7c9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_a819ed2e-08bf-4d0e-9fab-60248dbe3786" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_8a745664-b1f7-4cdc-a5c2-de9571f7c9e1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale_1dade402-45f9-4289-afc5-2f0490d16562" xlink:href="cvs-20230525.xsd#cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_a819ed2e-08bf-4d0e-9fab-60248dbe3786" xlink:to="loc_cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale_1dade402-45f9-4289-afc5-2f0490d16562" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension_7d91c5dd-8b43-4b97-8daf-4cc76374fa6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_a819ed2e-08bf-4d0e-9fab-60248dbe3786" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension_7d91c5dd-8b43-4b97-8daf-4cc76374fa6e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_db2bd7b7-952c-4b0a-8445-03e7457c5783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_a819ed2e-08bf-4d0e-9fab-60248dbe3786" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_db2bd7b7-952c-4b0a-8445-03e7457c5783" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_01e1a2c4-6f8c-46fb-b022-d0929dcae6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_a819ed2e-08bf-4d0e-9fab-60248dbe3786" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_01e1a2c4-6f8c-46fb-b022-d0929dcae6cf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAcquiredIntangibleAssetsTable_44e4927f-8cc7-4a6e-bf9a-29dc35850b8e" xlink:href="cvs-20230525.xsd#cvs_OtherAcquiredIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_a819ed2e-08bf-4d0e-9fab-60248dbe3786" xlink:to="loc_cvs_OtherAcquiredIntangibleAssetsTable_44e4927f-8cc7-4a6e-bf9a-29dc35850b8e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fa29f923-c376-44c3-bfe8-f2aa417620ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsTable_44e4927f-8cc7-4a6e-bf9a-29dc35850b8e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fa29f923-c376-44c3-bfe8-f2aa417620ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fa29f923-c376-44c3-bfe8-f2aa417620ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fa29f923-c376-44c3-bfe8-f2aa417620ff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fa29f923-c376-44c3-bfe8-f2aa417620ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_784d841f-ece2-4ef8-8dee-6eaeda5da0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fa29f923-c376-44c3-bfe8-f2aa417620ff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_784d841f-ece2-4ef8-8dee-6eaeda5da0b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_425235a3-4c3d-4865-a0aa-281d7315ac17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_784d841f-ece2-4ef8-8dee-6eaeda5da0b8" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_425235a3-4c3d-4865-a0aa-281d7315ac17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_6640f0da-48bd-4bd5-a299-0607905f0cee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_784d841f-ece2-4ef8-8dee-6eaeda5da0b8" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_6640f0da-48bd-4bd5-a299-0607905f0cee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProviderNetworksMember_15c34fd0-be1c-4178-8746-9526cedc7374" xlink:href="cvs-20230525.xsd#cvs_ProviderNetworksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_784d841f-ece2-4ef8-8dee-6eaeda5da0b8" xlink:to="loc_cvs_ProviderNetworksMember_15c34fd0-be1c-4178-8746-9526cedc7374" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ValueOfBusinessAcquiredMember_9b4b09ae-1176-433e-9ccd-4d59b8acdd1d" xlink:href="cvs-20230525.xsd#cvs_ValueOfBusinessAcquiredMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_784d841f-ece2-4ef8-8dee-6eaeda5da0b8" xlink:to="loc_cvs_ValueOfBusinessAcquiredMember_9b4b09ae-1176-433e-9ccd-4d59b8acdd1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_36bc5342-9a8f-43a4-b451-ed3e593f771e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_784d841f-ece2-4ef8-8dee-6eaeda5da0b8" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_36bc5342-9a8f-43a4-b451-ed3e593f771e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_ea7967fe-3ebf-4c58-b8db-771122e34735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsTable_44e4927f-8cc7-4a6e-bf9a-29dc35850b8e" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_ea7967fe-3ebf-4c58-b8db-771122e34735" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ea7967fe-3ebf-4c58-b8db-771122e34735_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ea7967fe-3ebf-4c58-b8db-771122e34735" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ea7967fe-3ebf-4c58-b8db-771122e34735_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ef14c2c4-e72c-48f8-af49-4f625477ef65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ea7967fe-3ebf-4c58-b8db-771122e34735" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ef14c2c4-e72c-48f8-af49-4f625477ef65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_5da8697f-f098-4faa-a887-fb7fdc1730b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_ef14c2c4-e72c-48f8-af49-4f625477ef65" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_5da8697f-f098-4faa-a887-fb7fdc1730b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5dfe5f31-a678-4bd7-8a3d-a6420df4adcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsTable_44e4927f-8cc7-4a6e-bf9a-29dc35850b8e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5dfe5f31-a678-4bd7-8a3d-a6420df4adcf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5dfe5f31-a678-4bd7-8a3d-a6420df4adcf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5dfe5f31-a678-4bd7-8a3d-a6420df4adcf" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5dfe5f31-a678-4bd7-8a3d-a6420df4adcf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c1fa3550-c09c-46b8-983b-ecc2060128a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5dfe5f31-a678-4bd7-8a3d-a6420df4adcf" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c1fa3550-c09c-46b8-983b-ecc2060128a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OmnicareLongTermCareBusinessMember_c41bd869-1721-4454-a5fb-530a603ea4f6" xlink:href="cvs-20230525.xsd#cvs_OmnicareLongTermCareBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c1fa3550-c09c-46b8-983b-ecc2060128a0" xlink:to="loc_cvs_OmnicareLongTermCareBusinessMember_c41bd869-1721-4454-a5fb-530a603ea4f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_dc9fe2de-53e6-4417-947d-002e5a9228d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsTable_44e4927f-8cc7-4a6e-bf9a-29dc35850b8e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_dc9fe2de-53e6-4417-947d-002e5a9228d6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_dc9fe2de-53e6-4417-947d-002e5a9228d6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_dc9fe2de-53e6-4417-947d-002e5a9228d6" xlink:to="loc_us-gaap_SegmentDomain_dc9fe2de-53e6-4417-947d-002e5a9228d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7df82a83-ee75-4700-8c6f-398accd6c095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_dc9fe2de-53e6-4417-947d-002e5a9228d6" xlink:to="loc_us-gaap_SegmentDomain_7df82a83-ee75-4700-8c6f-398accd6c095" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_67ba641e-a602-404b-a94f-d7038c7594ae" xlink:href="cvs-20230525.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7df82a83-ee75-4700-8c6f-398accd6c095" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_67ba641e-a602-404b-a94f-d7038c7594ae" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i9ad2a4a4256e46518312e3df58c5d286_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_fcc2136c-4fac-4bb9-a5f9-2715a48cc045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_fcc2136c-4fac-4bb9-a5f9-2715a48cc045" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_bec5b57e-40ec-4746-9306-1b4ef230dc1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeaseTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:to="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_bec5b57e-40ec-4746-9306-1b4ef230dc1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_5153fb41-02da-4f4e-854b-09079026aa97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:to="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_5153fb41-02da-4f4e-854b-09079026aa97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_587e9b6f-4d02-40a4-b621-c1f99084e969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:to="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_587e9b6f-4d02-40a4-b621-c1f99084e969" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OfficeRealEstateOptimizationCharges_eff06434-7b95-4881-a928-570c66f5704a" xlink:href="cvs-20230525.xsd#cvs_OfficeRealEstateOptimizationCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:to="loc_cvs_OfficeRealEstateOptimizationCharges_eff06434-7b95-4881-a928-570c66f5704a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresPlannedClosure_2a59190b-2ee3-4621-bd9e-cb774fbd566e" xlink:href="cvs-20230525.xsd#cvs_NumberOfStoresPlannedClosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:to="loc_cvs_NumberOfStoresPlannedClosure_2a59190b-2ee3-4621-bd9e-cb774fbd566e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod_91ccfee3-46e3-46fa-8d33-73799065e28b" xlink:href="cvs-20230525.xsd#cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:to="loc_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod_91ccfee3-46e3-46fa-8d33-73799065e28b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges_719a6f59-e305-488d-a857-fd977f835337" xlink:href="cvs-20230525.xsd#cvs_StoreImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:to="loc_cvs_StoreImpairmentCharges_719a6f59-e305-488d-a857-fd977f835337" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure_cbad544e-921e-4392-bac6-9ac8ea02cf58" xlink:href="cvs-20230525.xsd#cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:to="loc_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure_cbad544e-921e-4392-bac6-9ac8ea02cf58" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure_b9bc468b-2002-44d3-b92d-a320cc9acc55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure_b9bc468b-2002-44d3-b92d-a320cc9acc55" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d393af01-4228-48f9-ace0-912eb0784d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d393af01-4228-48f9-ace0-912eb0784d54" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_748f94c9-3aa6-46d4-8ef0-f7285834378b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d393af01-4228-48f9-ace0-912eb0784d54" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_748f94c9-3aa6-46d4-8ef0-f7285834378b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_748f94c9-3aa6-46d4-8ef0-f7285834378b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_748f94c9-3aa6-46d4-8ef0-f7285834378b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_748f94c9-3aa6-46d4-8ef0-f7285834378b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_51ad748d-e1a6-4b18-a5f6-96c07f8bbf54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_748f94c9-3aa6-46d4-8ef0-f7285834378b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_51ad748d-e1a6-4b18-a5f6-96c07f8bbf54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_4f52fd0d-d635-41ff-a5ce-a3ee20b61a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_51ad748d-e1a6-4b18-a5f6-96c07f8bbf54" xlink:to="loc_us-gaap_BuildingMember_4f52fd0d-d635-41ff-a5ce-a3ee20b61a1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_a7363ca1-8833-4ee7-8f09-7ae0fa2b936a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_51ad748d-e1a6-4b18-a5f6-96c07f8bbf54" xlink:to="loc_us-gaap_EquipmentMember_a7363ca1-8833-4ee7-8f09-7ae0fa2b936a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_94c6ed4e-ebff-4744-a126-bf971d688a95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_51ad748d-e1a6-4b18-a5f6-96c07f8bbf54" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_94c6ed4e-ebff-4744-a126-bf971d688a95" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a4189db1-d5da-43e4-9499-81f516ad7bf2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d393af01-4228-48f9-ace0-912eb0784d54" xlink:to="loc_srt_RangeAxis_a4189db1-d5da-43e4-9499-81f516ad7bf2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a4189db1-d5da-43e4-9499-81f516ad7bf2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a4189db1-d5da-43e4-9499-81f516ad7bf2" xlink:to="loc_srt_RangeMember_a4189db1-d5da-43e4-9499-81f516ad7bf2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bc84ed54-09b3-485b-ba5a-3c58fc5b889c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a4189db1-d5da-43e4-9499-81f516ad7bf2" xlink:to="loc_srt_RangeMember_bc84ed54-09b3-485b-ba5a-3c58fc5b889c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2abfe3b7-09a5-46b1-b620-0456466f0e6e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bc84ed54-09b3-485b-ba5a-3c58fc5b889c" xlink:to="loc_srt_MinimumMember_2abfe3b7-09a5-46b1-b620-0456466f0e6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b7510f55-9991-4662-a2d0-4d6870c5c911" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bc84ed54-09b3-485b-ba5a-3c58fc5b889c" xlink:to="loc_srt_MaximumMember_b7510f55-9991-4662-a2d0-4d6870c5c911" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2f7de22d-e2f4-403c-9c6d-79e69692adc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d393af01-4228-48f9-ace0-912eb0784d54" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2f7de22d-e2f4-403c-9c6d-79e69692adc9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2f7de22d-e2f4-403c-9c6d-79e69692adc9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2f7de22d-e2f4-403c-9c6d-79e69692adc9" xlink:to="loc_us-gaap_SegmentDomain_2f7de22d-e2f4-403c-9c6d-79e69692adc9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_be897984-124a-4b85-b55c-1281e48c7592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2f7de22d-e2f4-403c-9c6d-79e69692adc9" xlink:to="loc_us-gaap_SegmentDomain_be897984-124a-4b85-b55c-1281e48c7592" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_70e373da-914d-43f7-9807-c9903542e59d" xlink:href="cvs-20230525.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_be897984-124a-4b85-b55c-1281e48c7592" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_70e373da-914d-43f7-9807-c9903542e59d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_4c3771c2-d4dc-4d9c-a2bc-30de646cb25d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d393af01-4228-48f9-ace0-912eb0784d54" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_4c3771c2-d4dc-4d9c-a2bc-30de646cb25d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_4c3771c2-d4dc-4d9c-a2bc-30de646cb25d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_4c3771c2-d4dc-4d9c-a2bc-30de646cb25d" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_4c3771c2-d4dc-4d9c-a2bc-30de646cb25d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_f31e3e9a-2867-4d2c-acd0-e86fcf7dd505" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_4c3771c2-d4dc-4d9c-a2bc-30de646cb25d" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_f31e3e9a-2867-4d2c-acd0-e86fcf7dd505" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOperatingLeaseMember_2f09a629-d591-4089-ac15-b3fbf9ea1d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertySubjectToOperatingLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_f31e3e9a-2867-4d2c-acd0-e86fcf7dd505" xlink:to="loc_us-gaap_PropertySubjectToOperatingLeaseMember_2f09a629-d591-4089-ac15-b3fbf9ea1d0b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended" id="i2fe2c8a80d1d46d3ada6e4d53a3128f6_LeasesSupplementalBalanceSheetInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_4ef4171f-b074-46ca-a84a-2ada326e4f11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_72f242e1-7f34-4e9f-a243-d573ff76aa6c" xlink:href="cvs-20230525.xsd#cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4ef4171f-b074-46ca-a84a-2ada326e4f11" xlink:to="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_72f242e1-7f34-4e9f-a243-d573ff76aa6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale_71c11f7a-9593-4f51-8c3f-3dd377aad4ff" xlink:href="cvs-20230525.xsd#cvs_OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_72f242e1-7f34-4e9f-a243-d573ff76aa6c" xlink:to="loc_cvs_OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale_71c11f7a-9593-4f51-8c3f-3dd377aad4ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale_d482df62-9235-4c56-888e-2797bef3679c" xlink:href="cvs-20230525.xsd#cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_72f242e1-7f34-4e9f-a243-d573ff76aa6c" xlink:to="loc_cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale_d482df62-9235-4c56-888e-2797bef3679c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale_7ac0a6a8-38b5-4ce3-b9fc-7aaabcde12a4" xlink:href="cvs-20230525.xsd#cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_72f242e1-7f34-4e9f-a243-d573ff76aa6c" xlink:to="loc_cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale_7ac0a6a8-38b5-4ce3-b9fc-7aaabcde12a4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_bc53f3ed-f75a-44c6-a315-49ce06a1639c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_72f242e1-7f34-4e9f-a243-d573ff76aa6c" xlink:to="loc_us-gaap_OperatingLeaseLiability_bc53f3ed-f75a-44c6-a315-49ce06a1639c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_65b9ecaa-a88b-4ea6-bc40-327f9b8261f0" xlink:href="cvs-20230525.xsd#cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4ef4171f-b074-46ca-a84a-2ada326e4f11" xlink:to="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_65b9ecaa-a88b-4ea6-bc40-327f9b8261f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetGross_9fd163d8-81e7-4d09-991b-2a96331359e1" xlink:href="cvs-20230525.xsd#cvs_FinanceLeaseRightOfUseAssetGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_65b9ecaa-a88b-4ea6-bc40-327f9b8261f0" xlink:to="loc_cvs_FinanceLeaseRightOfUseAssetGross_9fd163d8-81e7-4d09-991b-2a96331359e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_fef3fdee-7398-4f09-9b72-7e0dbce15b3b" xlink:href="cvs-20230525.xsd#cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_65b9ecaa-a88b-4ea6-bc40-327f9b8261f0" xlink:to="loc_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_fef3fdee-7398-4f09-9b72-7e0dbce15b3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetNet_8a73f1f6-b464-4316-b261-ab8c0b3b4ed0" xlink:href="cvs-20230525.xsd#cvs_FinanceLeaseRightOfUseAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_65b9ecaa-a88b-4ea6-bc40-327f9b8261f0" xlink:to="loc_cvs_FinanceLeaseRightOfUseAssetNet_8a73f1f6-b464-4316-b261-ab8c0b3b4ed0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_0c0eea24-1bf5-4f65-94fa-80b2f0bdebc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_65b9ecaa-a88b-4ea6-bc40-327f9b8261f0" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_0c0eea24-1bf5-4f65-94fa-80b2f0bdebc4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_a2adc07c-34fd-470a-8fe3-fa8f83429cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_65b9ecaa-a88b-4ea6-bc40-327f9b8261f0" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_a2adc07c-34fd-470a-8fe3-fa8f83429cf7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_d908ff09-8481-46de-9262-c09f97aff47f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_65b9ecaa-a88b-4ea6-bc40-327f9b8261f0" xlink:to="loc_us-gaap_FinanceLeaseLiability_d908ff09-8481-46de-9262-c09f97aff47f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_WeightedAverageRemainingLeaseTermAbstract_bb9b85c6-e2e0-4493-a375-8974fe66f210" xlink:href="cvs-20230525.xsd#cvs_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4ef4171f-b074-46ca-a84a-2ada326e4f11" xlink:to="loc_cvs_WeightedAverageRemainingLeaseTermAbstract_bb9b85c6-e2e0-4493-a375-8974fe66f210" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_87c69be5-d6c1-4349-9643-7dde19be0bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_WeightedAverageRemainingLeaseTermAbstract_bb9b85c6-e2e0-4493-a375-8974fe66f210" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_87c69be5-d6c1-4349-9643-7dde19be0bc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_dba0a9de-3d8d-42c0-b6b8-b3b5026ad526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_WeightedAverageRemainingLeaseTermAbstract_bb9b85c6-e2e0-4493-a375-8974fe66f210" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_dba0a9de-3d8d-42c0-b6b8-b3b5026ad526" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LeasesWeightedAverageDiscountRateAbstract_17615fd7-3c3a-4fc6-bcbe-7612a85b7b49" xlink:href="cvs-20230525.xsd#cvs_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4ef4171f-b074-46ca-a84a-2ada326e4f11" xlink:to="loc_cvs_LeasesWeightedAverageDiscountRateAbstract_17615fd7-3c3a-4fc6-bcbe-7612a85b7b49" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ea575f5c-467f-4067-b5a6-245c1c98a26a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_LeasesWeightedAverageDiscountRateAbstract_17615fd7-3c3a-4fc6-bcbe-7612a85b7b49" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ea575f5c-467f-4067-b5a6-245c1c98a26a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_a059d91f-f677-43f6-8a49-cce5e5456d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_LeasesWeightedAverageDiscountRateAbstract_17615fd7-3c3a-4fc6-bcbe-7612a85b7b49" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_a059d91f-f677-43f6-8a49-cce5e5456d3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_94575104-e169-4131-b3dc-a12fbc03fb6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4ef4171f-b074-46ca-a84a-2ada326e4f11" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_94575104-e169-4131-b3dc-a12fbc03fb6c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_66ef04d5-7722-4b73-baee-b125d48079a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_94575104-e169-4131-b3dc-a12fbc03fb6c" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_66ef04d5-7722-4b73-baee-b125d48079a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_66ef04d5-7722-4b73-baee-b125d48079a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_66ef04d5-7722-4b73-baee-b125d48079a1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_66ef04d5-7722-4b73-baee-b125d48079a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_44017f1f-1c58-45d1-91ff-ed8aa125f78a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_66ef04d5-7722-4b73-baee-b125d48079a1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_44017f1f-1c58-45d1-91ff-ed8aa125f78a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_b9536ee2-0278-4fa4-85ab-72b2bd3e9582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_44017f1f-1c58-45d1-91ff-ed8aa125f78a" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_b9536ee2-0278-4fa4-85ab-72b2bd3e9582" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails" xlink:type="extended" id="i96a7e38f90a74e3d89bf408d3dbe94bb_HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems_e219be68-795a-4066-bb48-a1822d2553cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_5233b78a-ed1c-44a3-882e-41f3c8a9079b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e219be68-795a-4066-bb48-a1822d2553cd" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_5233b78a-ed1c-44a3-882e-41f3c8a9079b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_633e307d-032d-4ec6-a8c6-a290b2ee57cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e219be68-795a-4066-bb48-a1822d2553cd" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_633e307d-032d-4ec6-a8c6-a290b2ee57cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_bab1596c-54c2-4d09-b42e-ec43ebb96cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e219be68-795a-4066-bb48-a1822d2553cd" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_bab1596c-54c2-4d09-b42e-ec43ebb96cdd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_482f759c-371d-46b7-90a3-a7dbba992d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e219be68-795a-4066-bb48-a1822d2553cd" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_482f759c-371d-46b7-90a3-a7dbba992d9a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_69b0e51d-f70f-4ac5-9d83-f22ec55c3f04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e219be68-795a-4066-bb48-a1822d2553cd" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_69b0e51d-f70f-4ac5-9d83-f22ec55c3f04" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9b46a18a-b169-40e3-9be9-a70a67e305f9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_69b0e51d-f70f-4ac5-9d83-f22ec55c3f04" xlink:to="loc_srt_ProductOrServiceAxis_9b46a18a-b169-40e3-9be9-a70a67e305f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9b46a18a-b169-40e3-9be9-a70a67e305f9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_9b46a18a-b169-40e3-9be9-a70a67e305f9" xlink:to="loc_srt_ProductsAndServicesDomain_9b46a18a-b169-40e3-9be9-a70a67e305f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_133c571f-e1d0-4f30-a54a-27b9f8f90b1f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_9b46a18a-b169-40e3-9be9-a70a67e305f9" xlink:to="loc_srt_ProductsAndServicesDomain_133c571f-e1d0-4f30-a54a-27b9f8f90b1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_56bd457d-f552-49cf-acdc-941b01cde052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_133c571f-e1d0-4f30-a54a-27b9f8f90b1f" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_56bd457d-f552-49cf-acdc-941b01cde052" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_baeac436-f5b8-4776-8e36-607809a5393a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_69b0e51d-f70f-4ac5-9d83-f22ec55c3f04" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_baeac436-f5b8-4776-8e36-607809a5393a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_baeac436-f5b8-4776-8e36-607809a5393a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_baeac436-f5b8-4776-8e36-607809a5393a" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_baeac436-f5b8-4776-8e36-607809a5393a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_1571f8b6-b911-45b3-b1f3-e3de5eb19329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_baeac436-f5b8-4776-8e36-607809a5393a" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_1571f8b6-b911-45b3-b1f3-e3de5eb19329" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_46e0a5d0-7db8-43bc-bc8a-b0c741d72fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_1571f8b6-b911-45b3-b1f3-e3de5eb19329" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_46e0a5d0-7db8-43bc-bc8a-b0c741d72fbb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_1cacc487-00a3-496c-9f0e-500eee8504d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_1571f8b6-b911-45b3-b1f3-e3de5eb19329" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_1cacc487-00a3-496c-9f0e-500eee8504d0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#HealthCareCostsPayableNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="extended" id="iad25f2bcc3c84e228ad9a1d3fc7c53b5_HealthCareCostsPayableNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_396006d4-ad55-44e9-9817-213840b1f09e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_57bbc1bd-2a8d-49cb-bb64-62d42f0148e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_396006d4-ad55-44e9-9817-213840b1f09e" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_57bbc1bd-2a8d-49cb-bb64-62d42f0148e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_c1530b43-47de-4ee8-b1df-dc1ed449c2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_396006d4-ad55-44e9-9817-213840b1f09e" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_c1530b43-47de-4ee8-b1df-dc1ed449c2b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_2b580ee6-d393-4193-b795-4d5324a90983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_396006d4-ad55-44e9-9817-213840b1f09e" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_2b580ee6-d393-4193-b795-4d5324a90983" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_14794889-3d95-4be6-87a7-b3892799d325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_2b580ee6-d393-4193-b795-4d5324a90983" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_14794889-3d95-4be6-87a7-b3892799d325" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_14794889-3d95-4be6-87a7-b3892799d325_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_14794889-3d95-4be6-87a7-b3892799d325" xlink:to="loc_us-gaap_SegmentDomain_14794889-3d95-4be6-87a7-b3892799d325_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e88ed8ca-a395-4eb8-b205-9a1ec5335476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_14794889-3d95-4be6-87a7-b3892799d325" xlink:to="loc_us-gaap_SegmentDomain_e88ed8ca-a395-4eb8-b205-9a1ec5335476" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_ce616074-014f-4405-947d-9aa3cf3501eb" xlink:href="cvs-20230525.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e88ed8ca-a395-4eb8-b205-9a1ec5335476" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_ce616074-014f-4405-947d-9aa3cf3501eb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" xlink:type="extended" id="idded90ee002c4134832f67b576e338c3_HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_2e79c50f-083c-4421-99fb-d7817ed15f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_5584ffb1-1551-4d0c-896e-0da4d8ac951a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_2e79c50f-083c-4421-99fb-d7817ed15f3e" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_5584ffb1-1551-4d0c-896e-0da4d8ac951a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_1db3de11-1f0c-42d4-8fa1-f7e01fe7ea3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_2e79c50f-083c-4421-99fb-d7817ed15f3e" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_1db3de11-1f0c-42d4-8fa1-f7e01fe7ea3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_695bb91e-fc72-4ada-83e3-3ba225136281" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_2e79c50f-083c-4421-99fb-d7817ed15f3e" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_695bb91e-fc72-4ada-83e3-3ba225136281" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b59424ea-a3aa-4d2e-b167-9b4f7dfda631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_2e79c50f-083c-4421-99fb-d7817ed15f3e" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b59424ea-a3aa-4d2e-b167-9b4f7dfda631" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_9e5c40c2-5221-46ac-990c-61b447a3689b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_2e79c50f-083c-4421-99fb-d7817ed15f3e" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_9e5c40c2-5221-46ac-990c-61b447a3689b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0441356c-6972-447a-b670-de8f9388db4c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_9e5c40c2-5221-46ac-990c-61b447a3689b" xlink:to="loc_srt_ProductOrServiceAxis_0441356c-6972-447a-b670-de8f9388db4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0441356c-6972-447a-b670-de8f9388db4c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_0441356c-6972-447a-b670-de8f9388db4c" xlink:to="loc_srt_ProductsAndServicesDomain_0441356c-6972-447a-b670-de8f9388db4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fe68c404-cb6b-4c79-bcf0-d4fc0f02a876" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_0441356c-6972-447a-b670-de8f9388db4c" xlink:to="loc_srt_ProductsAndServicesDomain_fe68c404-cb6b-4c79-bcf0-d4fc0f02a876" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_bb27deab-17f2-48a5-a95d-a5bcc1326644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_fe68c404-cb6b-4c79-bcf0-d4fc0f02a876" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_bb27deab-17f2-48a5-a95d-a5bcc1326644" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="extended" id="i7901a14359bf4d9ea5f30cfe2f4613ad_HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_7b088bf2-ff98-423e-88d8-2b413c048d02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_7b088bf2-ff98-423e-88d8-2b413c048d02" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_1b8a4405-1ff9-4be1-aca8-7931ca07f4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_1b8a4405-1ff9-4be1-aca8-7931ca07f4ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_3ff79bdc-ade3-490b-ad51-f7dcfece2159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_3ff79bdc-ade3-490b-ad51-f7dcfece2159" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_575fe8b7-cdf1-412d-95f7-0cc9ea44e9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_575fe8b7-cdf1-412d-95f7-0cc9ea44e9e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_848f62dd-1b61-48a6-8051-a688d141f910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_848f62dd-1b61-48a6-8051-a688d141f910" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_b00e08e8-3a95-4ee4-92a7-592bc3af8530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_b00e08e8-3a95-4ee4-92a7-592bc3af8530" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_67c7f454-62a2-4f7a-800d-282546ffba7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_67c7f454-62a2-4f7a-800d-282546ffba7f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_311ae66a-e7f6-47a8-bea6-41edbcda6aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_67c7f454-62a2-4f7a-800d-282546ffba7f" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_311ae66a-e7f6-47a8-bea6-41edbcda6aa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_d319a67b-9585-4179-973e-a5cd44423306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_67c7f454-62a2-4f7a-800d-282546ffba7f" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_d319a67b-9585-4179-973e-a5cd44423306" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_64c909e9-44e0-4ff1-99c3-c6294bbea967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_67c7f454-62a2-4f7a-800d-282546ffba7f" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_64c909e9-44e0-4ff1-99c3-c6294bbea967" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_2677f2b0-37b9-4ec5-ae55-8dd25f176c99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_2677f2b0-37b9-4ec5-ae55-8dd25f176c99" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_8e676366-6980-4b30-a9fa-316e40c4652e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_2677f2b0-37b9-4ec5-ae55-8dd25f176c99" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_8e676366-6980-4b30-a9fa-316e40c4652e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_2ef7b087-ac17-4a7d-a15c-e84a026c7912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_2677f2b0-37b9-4ec5-ae55-8dd25f176c99" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_2ef7b087-ac17-4a7d-a15c-e84a026c7912" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_13d3ea4e-2d9a-48c8-bb1a-83551f6804fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_2677f2b0-37b9-4ec5-ae55-8dd25f176c99" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_13d3ea4e-2d9a-48c8-bb1a-83551f6804fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_28c32619-b9ca-48c4-b1e6-b3e8f8e61afd" xlink:href="cvs-20230525.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_28c32619-b9ca-48c4-b1e6-b3e8f8e61afd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_33c09d18-d6e3-4458-bd86-807f58f9e823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_11b14fae-778e-4d32-b5e7-1329a411d73f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_e1a69b42-cfd1-43e0-8a99-7828c7975bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_c78850f7-2e37-4dff-b28c-bffe51dd0027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_5a491027-a24f-4fb2-8c8e-1d1a215b00f5" xlink:href="cvs-20230525.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_7b088bf2-ff98-423e-88d8-2b413c048d02" xlink:to="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_5a491027-a24f-4fb2-8c8e-1d1a215b00f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_ebf83a2b-bcbb-4c46-8fdc-fe45b118d9b3" xlink:href="cvs-20230525.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_b3018195-1891-4c51-a631-a8cdbe3bec96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_7b088bf2-ff98-423e-88d8-2b413c048d02" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_b3018195-1891-4c51-a631-a8cdbe3bec96" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c5aadb29-b48a-46fb-8211-8e7d9d9b8b06" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_b3018195-1891-4c51-a631-a8cdbe3bec96" xlink:to="loc_srt_ProductOrServiceAxis_c5aadb29-b48a-46fb-8211-8e7d9d9b8b06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c5aadb29-b48a-46fb-8211-8e7d9d9b8b06_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c5aadb29-b48a-46fb-8211-8e7d9d9b8b06" xlink:to="loc_srt_ProductsAndServicesDomain_c5aadb29-b48a-46fb-8211-8e7d9d9b8b06_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_492e7472-6b01-4f6a-b6f7-f2d597d33253" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c5aadb29-b48a-46fb-8211-8e7d9d9b8b06" xlink:to="loc_srt_ProductsAndServicesDomain_492e7472-6b01-4f6a-b6f7-f2d597d33253" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_afa9c096-8a04-4526-8c80-254ecae54dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_492e7472-6b01-4f6a-b6f7-f2d597d33253" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_afa9c096-8a04-4526-8c80-254ecae54dc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a7aa44f1-2b75-493e-938f-1b25d396c7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_b3018195-1891-4c51-a631-a8cdbe3bec96" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a7aa44f1-2b75-493e-938f-1b25d396c7f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a7aa44f1-2b75-493e-938f-1b25d396c7f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a7aa44f1-2b75-493e-938f-1b25d396c7f3" xlink:to="loc_us-gaap_SegmentDomain_a7aa44f1-2b75-493e-938f-1b25d396c7f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9f3264a2-1ddc-4c93-aa03-99c8a8a34bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a7aa44f1-2b75-493e-938f-1b25d396c7f3" xlink:to="loc_us-gaap_SegmentDomain_9f3264a2-1ddc-4c93-aa03-99c8a8a34bc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_e7a278e5-3e17-4dad-8a55-eaad70baffda" xlink:href="cvs-20230525.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9f3264a2-1ddc-4c93-aa03-99c8a8a34bc3" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_e7a278e5-3e17-4dad-8a55-eaad70baffda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_4009397a-155f-4917-b60a-dd50e1954958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9f3264a2-1ddc-4c93-aa03-99c8a8a34bc3" xlink:to="loc_us-gaap_CorporateAndOtherMember_4009397a-155f-4917-b60a-dd50e1954958" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails" xlink:type="extended" id="ie918f1e091644b4e90f499bbc3ae7432_OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_251e8458-5462-4e66-b150-e067b76f9049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_ea993245-e42c-48aa-8c73-0f0d706055c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_251e8458-5462-4e66-b150-e067b76f9049" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_ea993245-e42c-48aa-8c73-0f0d706055c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax_9a09946f-f2e5-4d7d-936e-799ffca826ff" xlink:href="cvs-20230525.xsd#cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_251e8458-5462-4e66-b150-e067b76f9049" xlink:to="loc_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax_9a09946f-f2e5-4d7d-936e-799ffca826ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax_22a9b192-1647-4aac-bfbe-63823e257aa2" xlink:href="cvs-20230525.xsd#cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_251e8458-5462-4e66-b150-e067b76f9049" xlink:to="loc_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax_22a9b192-1647-4aac-bfbe-63823e257aa2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e59e6c84-bc94-4391-8dfd-f29f291d44aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_251e8458-5462-4e66-b150-e067b76f9049" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e59e6c84-bc94-4391-8dfd-f29f291d44aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_bd5f28b6-fa11-4a61-b614-cd251448d983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_251e8458-5462-4e66-b150-e067b76f9049" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_bd5f28b6-fa11-4a61-b614-cd251448d983" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8fe18626-b097-422e-baae-7d62aaced8cd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_bd5f28b6-fa11-4a61-b614-cd251448d983" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8fe18626-b097-422e-baae-7d62aaced8cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8fe18626-b097-422e-baae-7d62aaced8cd_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8fe18626-b097-422e-baae-7d62aaced8cd" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8fe18626-b097-422e-baae-7d62aaced8cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_379eb212-bbac-4eaa-993d-f2b5fc9ec7ef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8fe18626-b097-422e-baae-7d62aaced8cd" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_379eb212-bbac-4eaa-993d-f2b5fc9ec7ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_312accfa-c8e8-4f6d-b0ee-1572eef13ec6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_379eb212-bbac-4eaa-993d-f2b5fc9ec7ef" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_312accfa-c8e8-4f6d-b0ee-1572eef13ec6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_731dc374-150b-4cda-a27d-d4630b239244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_bd5f28b6-fa11-4a61-b614-cd251448d983" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_731dc374-150b-4cda-a27d-d4630b239244" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_731dc374-150b-4cda-a27d-d4630b239244_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_731dc374-150b-4cda-a27d-d4630b239244" xlink:to="loc_us-gaap_TypeOfAdoptionMember_731dc374-150b-4cda-a27d-d4630b239244_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_f879368f-030f-430a-a35f-4582800ca7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_731dc374-150b-4cda-a27d-d4630b239244" xlink:to="loc_us-gaap_TypeOfAdoptionMember_f879368f-030f-430a-a35f-4582800ca7c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201812Member_6397df03-268e-4753-93ef-c55b4f0ccec8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201812Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_f879368f-030f-430a-a35f-4582800ca7c9" xlink:to="loc_us-gaap_AccountingStandardsUpdate201812Member_6397df03-268e-4753-93ef-c55b4f0ccec8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails" xlink:type="extended" id="i73e377d929ba44b5889e6dc9f466febd_OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_784ba8d0-b820-40e8-9d81-1701c1b3b259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_044de45b-0d99-4865-a553-e50f94d4ae9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_784ba8d0-b820-40e8-9d81-1701c1b3b259" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_044de45b-0d99-4865-a553-e50f94d4ae9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_136d3bec-1b44-4cfc-92a9-f122a6e13ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_044de45b-0d99-4865-a553-e50f94d4ae9e" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_136d3bec-1b44-4cfc-92a9-f122a6e13ecf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_ee63ffde-0918-4709-8be6-f95da08450c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_044de45b-0d99-4865-a553-e50f94d4ae9e" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_ee63ffde-0918-4709-8be6-f95da08450c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange_3df23893-bcf5-4dd1-9aac-f8630fbbb843" xlink:href="cvs-20230525.xsd#cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_044de45b-0d99-4865-a553-e50f94d4ae9e" xlink:to="loc_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange_3df23893-bcf5-4dd1-9aac-f8630fbbb843" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_1b112fa8-0e87-46a4-8884-cd7d9150d2e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_044de45b-0d99-4865-a553-e50f94d4ae9e" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_1b112fa8-0e87-46a4-8884-cd7d9150d2e6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_22f86739-e10a-48c8-8629-0ba0a792e4f8" xlink:href="cvs-20230525.xsd#cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_044de45b-0d99-4865-a553-e50f94d4ae9e" xlink:to="loc_cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_22f86739-e10a-48c8-8629-0ba0a792e4f8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_006048a0-39b1-42b1-9397-34c117c98988" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_5f647777-91bd-49f8-8c54-c633bfd09581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1273f52c-837b-460c-8a85-8d3c439cd109" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_784ba8d0-b820-40e8-9d81-1701c1b3b259" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1273f52c-837b-460c-8a85-8d3c439cd109" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_7e1abb83-3a32-4ab8-8882-8ba6d9287d2a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1273f52c-837b-460c-8a85-8d3c439cd109" xlink:to="loc_srt_ProductOrServiceAxis_7e1abb83-3a32-4ab8-8882-8ba6d9287d2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7e1abb83-3a32-4ab8-8882-8ba6d9287d2a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_7e1abb83-3a32-4ab8-8882-8ba6d9287d2a" xlink:to="loc_srt_ProductsAndServicesDomain_7e1abb83-3a32-4ab8-8882-8ba6d9287d2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ac69142d-656b-4ace-90c2-e1be1b121324" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_7e1abb83-3a32-4ab8-8882-8ba6d9287d2a" xlink:to="loc_srt_ProductsAndServicesDomain_ac69142d-656b-4ace-90c2-e1be1b121324" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LargeCasePensionsMember_d077ac4f-813c-430a-a5fd-282b83d32819" xlink:href="cvs-20230525.xsd#cvs_LargeCasePensionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ac69142d-656b-4ace-90c2-e1be1b121324" xlink:to="loc_cvs_LargeCasePensionsMember_d077ac4f-813c-430a-a5fd-282b83d32819" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareMember_53145400-3770-4e9f-8737-871bcd5341e6" xlink:href="cvs-20230525.xsd#cvs_LongTermCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ac69142d-656b-4ace-90c2-e1be1b121324" xlink:to="loc_cvs_LongTermCareMember_53145400-3770-4e9f-8737-871bcd5341e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_7bbc1103-9d0b-4bb4-8fd4-c7bb1f702d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ac69142d-656b-4ace-90c2-e1be1b121324" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_7bbc1103-9d0b-4bb4-8fd4-c7bb1f702d4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_819b4fcb-b117-427a-b117-02a91f1db0ef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1273f52c-837b-460c-8a85-8d3c439cd109" xlink:to="loc_srt_RestatementAxis_819b4fcb-b117-427a-b117-02a91f1db0ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_819b4fcb-b117-427a-b117-02a91f1db0ef_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_819b4fcb-b117-427a-b117-02a91f1db0ef" xlink:to="loc_srt_RestatementDomain_819b4fcb-b117-427a-b117-02a91f1db0ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_7dc87430-ef4d-4e9c-83cc-1fea41abb8fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_819b4fcb-b117-427a-b117-02a91f1db0ef" xlink:to="loc_srt_RestatementDomain_7dc87430-ef4d-4e9c-83cc-1fea41abb8fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_5228a1b6-bdfc-4498-8554-43160b3f6eab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_7dc87430-ef4d-4e9c-83cc-1fea41abb8fe" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_5228a1b6-bdfc-4498-8554-43160b3f6eab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember_aa657e6e-cc86-4c6c-9993-1e152e9475f2" xlink:href="cvs-20230525.xsd#cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_7dc87430-ef4d-4e9c-83cc-1fea41abb8fe" xlink:to="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember_aa657e6e-cc86-4c6c-9993-1e152e9475f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember_6a4e700c-f9a3-4db4-b563-b15e2dab77a3" xlink:href="cvs-20230525.xsd#cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_7dc87430-ef4d-4e9c-83cc-1fea41abb8fe" xlink:to="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember_6a4e700c-f9a3-4db4-b563-b15e2dab77a3" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails" xlink:type="extended" id="if1e2584ff2a2405986199a83b7268cd1_OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c4be9b82-495e-4e9f-9515-b53e2355fb72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalIncomeStatementElementsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c4be9b82-495e-4e9f-9515-b53e2355fb72" xlink:to="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_edc1839c-eab4-4d10-88d8-3078644df69c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_edc1839c-eab4-4d10-88d8-3078644df69c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_0ef87cf8-4ba6-4fad-8ecd-d5d5cb9967f7" xlink:href="cvs-20230525.xsd#cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:to="loc_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_0ef87cf8-4ba6-4fad-8ecd-d5d5cb9967f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_3300cb68-3004-48c3-bd75-25d5b5583423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:to="loc_us-gaap_CostsAndExpenses_3300cb68-3004-48c3-bd75-25d5b5583423" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_eeba11a1-736c-4aea-b871-ba01dfbef76f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:to="loc_us-gaap_OperatingIncomeLoss_eeba11a1-736c-4aea-b871-ba01dfbef76f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c3a5e508-bb53-4d9e-b185-f56ccf96575d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c3a5e508-bb53-4d9e-b185-f56ccf96575d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ef6f7616-b748-46b8-a965-4ca9b0e8406e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ef6f7616-b748-46b8-a965-4ca9b0e8406e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f006808f-a2f8-4f08-9d4a-1ce15e984376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f006808f-a2f8-4f08-9d4a-1ce15e984376" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_feeba0bd-bd1a-4512-8733-6193b6ba60d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:to="loc_us-gaap_ProfitLoss_feeba0bd-bd1a-4512-8733-6193b6ba60d1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9e1cf7b2-d2a3-4e4c-999c-b296d1c7623f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:to="loc_us-gaap_NetIncomeLoss_9e1cf7b2-d2a3-4e4c-999c-b296d1c7623f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_871c089e-c456-405b-8e5b-bdc34f8f1450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_871c089e-c456-405b-8e5b-bdc34f8f1450" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_4094d93d-d9ef-45ca-8164-5cd892e8ea96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_871c089e-c456-405b-8e5b-bdc34f8f1450" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_4094d93d-d9ef-45ca-8164-5cd892e8ea96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_84cff813-ee34-43d8-be18-5914bfc6fe1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_871c089e-c456-405b-8e5b-bdc34f8f1450" xlink:to="loc_us-gaap_EarningsPerShareBasic_84cff813-ee34-43d8-be18-5914bfc6fe1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_5f0dbb8f-54a0-4ead-b303-31eb9ffbd9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_5f0dbb8f-54a0-4ead-b303-31eb9ffbd9dc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_1962da56-8579-417f-80cf-1f61bedb9867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_5f0dbb8f-54a0-4ead-b303-31eb9ffbd9dc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_1962da56-8579-417f-80cf-1f61bedb9867" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_cd958321-3ebd-4e41-b22a-e17390c29df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_5f0dbb8f-54a0-4ead-b303-31eb9ffbd9dc" xlink:to="loc_us-gaap_EarningsPerShareDiluted_cd958321-3ebd-4e41-b22a-e17390c29df2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c4be9b82-495e-4e9f-9515-b53e2355fb72" xlink:to="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_41ef1192-0242-4b69-8c03-8f701d37c82b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_OtherAssetsCurrent_41ef1192-0242-4b69-8c03-8f701d37c82b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a6dbff7a-5313-4434-b7a8-62627a73601f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_AssetsCurrent_a6dbff7a-5313-4434-b7a8-62627a73601f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_211d3cf2-fa46-471a-8434-48ea388c46a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_211d3cf2-fa46-471a-8434-48ea388c46a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0710962e-33a5-4a25-b60d-e6b8ed19bda1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_Assets_0710962e-33a5-4a25-b60d-e6b8ed19bda1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_c4e26f80-ecdc-46e5-878e-1ed8634da47b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_c4e26f80-ecdc-46e5-878e-1ed8634da47b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent_70a5a618-3c3b-4fb7-a1c9-b4bcb8b723ae" xlink:href="cvs-20230525.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_cvs_OtherInsuranceLiabilitiesCurrent_70a5a618-3c3b-4fb7-a1c9-b4bcb8b723ae" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_cd759e59-8c9e-4c89-935e-2b9a35942efa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_LiabilitiesCurrent_cd759e59-8c9e-4c89-935e-2b9a35942efa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4ef463d9-1572-4da8-8cff-de3c896d26a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4ef463d9-1572-4da8-8cff-de3c896d26a9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_105f843c-ceb5-4789-b47b-3717ec082701" xlink:href="cvs-20230525.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_105f843c-ceb5-4789-b47b-3717ec082701" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_a73e7fba-1838-452c-bebe-7a10ceef21f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_a73e7fba-1838-452c-bebe-7a10ceef21f5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e113d30c-e7f0-4e07-90f7-8c7fa99cdc58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_Liabilities_e113d30c-e7f0-4e07-90f7-8c7fa99cdc58" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2c088eae-99d1-446f-b78a-a7db009839a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2c088eae-99d1-446f-b78a-a7db009839a4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d9588fe5-6fa8-4754-8a70-6cab4ac61dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d9588fe5-6fa8-4754-8a70-6cab4ac61dc0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2ca56dca-8a8c-4198-924f-4dcf909b094a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_StockholdersEquity_2ca56dca-8a8c-4198-924f-4dcf909b094a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0c4851ba-6631-4b8c-b707-0563174d1e11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0c4851ba-6631-4b8c-b707-0563174d1e11" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_570374a0-be86-41cf-bedb-ac5f89d509b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_570374a0-be86-41cf-bedb-ac5f89d509b4" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_7f752e8b-d80e-4903-b858-ee2843072340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c4be9b82-495e-4e9f-9515-b53e2355fb72" xlink:to="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_7f752e8b-d80e-4903-b858-ee2843072340" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_446197b5-0dd5-4298-84a6-815ef006420a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_7f752e8b-d80e-4903-b858-ee2843072340" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_446197b5-0dd5-4298-84a6-815ef006420a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_0f6bbef6-8a32-494a-a67d-620524e0e9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_7f752e8b-d80e-4903-b858-ee2843072340" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_0f6bbef6-8a32-494a-a67d-620524e0e9fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_a6474194-069b-4e18-a449-f560da610b36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_7f752e8b-d80e-4903-b858-ee2843072340" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_a6474194-069b-4e18-a449-f560da610b36" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_137e574a-733d-4fac-b165-9509196a4127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_7f752e8b-d80e-4903-b858-ee2843072340" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_137e574a-733d-4fac-b165-9509196a4127" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_5d076bfa-e3e6-4044-959f-5bbf21b77107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_7f752e8b-d80e-4903-b858-ee2843072340" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_5d076bfa-e3e6-4044-959f-5bbf21b77107" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e37c0328-c6ab-4329-814a-6d55ac8fd813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c4be9b82-495e-4e9f-9515-b53e2355fb72" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e37c0328-c6ab-4329-814a-6d55ac8fd813" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_ffe039d9-e7fa-423c-8f9a-8ec6f79ffed2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e37c0328-c6ab-4329-814a-6d55ac8fd813" xlink:to="loc_srt_RestatementAxis_ffe039d9-e7fa-423c-8f9a-8ec6f79ffed2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_ffe039d9-e7fa-423c-8f9a-8ec6f79ffed2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_ffe039d9-e7fa-423c-8f9a-8ec6f79ffed2" xlink:to="loc_srt_RestatementDomain_ffe039d9-e7fa-423c-8f9a-8ec6f79ffed2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_f69d3079-a4de-4c10-bdad-6019c15c8543" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_ffe039d9-e7fa-423c-8f9a-8ec6f79ffed2" xlink:to="loc_srt_RestatementDomain_f69d3079-a4de-4c10-bdad-6019c15c8543" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_519e5283-92d8-4547-a5ac-de1c80754d27" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_f69d3079-a4de-4c10-bdad-6019c15c8543" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_519e5283-92d8-4547-a5ac-de1c80754d27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_1df2a13a-e06d-4f30-acab-b4c6b90c0134" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_f69d3079-a4de-4c10-bdad-6019c15c8543" xlink:to="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_1df2a13a-e06d-4f30-acab-b4c6b90c0134" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails" xlink:type="extended" id="i13e83756aa674681b632c9be07bbc856_OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_cb94bb5d-2900-4b52-9200-471ffbd1f179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8b726a30-5dd1-44a9-9cb9-544bc2cb824c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_cb94bb5d-2900-4b52-9200-471ffbd1f179" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8b726a30-5dd1-44a9-9cb9-544bc2cb824c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_8f771006-6878-4591-8126-03fac58da233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8b726a30-5dd1-44a9-9cb9-544bc2cb824c" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_8f771006-6878-4591-8126-03fac58da233" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_dfa1f0c7-1cf3-4222-9dfa-6f844c5e8d97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8b726a30-5dd1-44a9-9cb9-544bc2cb824c" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_dfa1f0c7-1cf3-4222-9dfa-6f844c5e8d97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange_b07daa2e-7b8f-466d-991c-06370e96bc14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8b726a30-5dd1-44a9-9cb9-544bc2cb824c" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange_b07daa2e-7b8f-466d-991c-06370e96bc14" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_df486b18-f899-483a-82e3-64586bc7d249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8b726a30-5dd1-44a9-9cb9-544bc2cb824c" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_df486b18-f899-483a-82e3-64586bc7d249" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_300283a5-b8fd-46e0-87b7-13e896982184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8b726a30-5dd1-44a9-9cb9-544bc2cb824c" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_300283a5-b8fd-46e0-87b7-13e896982184" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome_2264f5d1-ea47-4509-89f6-73440356ebd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8b726a30-5dd1-44a9-9cb9-544bc2cb824c" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome_2264f5d1-ea47-4509-89f6-73440356ebd6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected_0ac0b451-8eed-4f39-8fdf-de1d38058592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8b726a30-5dd1-44a9-9cb9-544bc2cb824c" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected_0ac0b451-8eed-4f39-8fdf-de1d38058592" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_c372cfb3-5f43-4863-a0d6-ba5e28632090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_c58fdd92-7227-4e97-b70e-4c8d0c5652be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8b726a30-5dd1-44a9-9cb9-544bc2cb824c" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_c58fdd92-7227-4e97-b70e-4c8d0c5652be" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_ad05ce93-ae0b-4f6c-b83a-4866af266f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_cb94bb5d-2900-4b52-9200-471ffbd1f179" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_f833e003-b0e4-4189-98cd-e5e81e82ed62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_f833e003-b0e4-4189-98cd-e5e81e82ed62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_1f9d9273-ad1b-49ac-a304-d705c71b25ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_1f9d9273-ad1b-49ac-a304-d705c71b25ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_ef215d09-33bc-4bfe-90b4-180dfe4a28c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_ef215d09-33bc-4bfe-90b4-180dfe4a28c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_87b3e623-cc8a-4a5f-9f25-49eedb8607cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_87b3e623-cc8a-4a5f-9f25-49eedb8607cb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_35d6ff22-3f6e-4a7c-b9c5-234d0b2a3aae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_35d6ff22-3f6e-4a7c-b9c5-234d0b2a3aae" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance_5f984d33-b636-444d-b33d-178a886af972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance_5f984d33-b636-444d-b33d-178a886af972" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense_9939f4bf-2feb-49e8-87d2-eda2574532a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense_9939f4bf-2feb-49e8-87d2-eda2574532a3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits_dc6ce28e-e31d-4ad2-aa8e-f761ae099312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits_dc6ce28e-e31d-4ad2-aa8e-f761ae099312" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_777ce1b5-a995-4a63-bbb1-fd3315c44910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_4ee8d5df-db3a-4d7b-ba09-73121fd23edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_4ee8d5df-db3a-4d7b-ba09-73121fd23edc" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_d2dab6a5-c00d-40c2-a112-79e731e7e84c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_b8eac47a-9963-4ea7-b6b3-3eff6c3d4d18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_cb94bb5d-2900-4b52-9200-471ffbd1f179" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefits_b8eac47a-9963-4ea7-b6b3-3eff6c3d4d18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_fb4b4fd7-b220-412e-b423-d579fe4af24a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_cb94bb5d-2900-4b52-9200-471ffbd1f179" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_fb4b4fd7-b220-412e-b423-d579fe4af24a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_144a0943-475d-401b-89b6-9846349ec6de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_cb94bb5d-2900-4b52-9200-471ffbd1f179" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_144a0943-475d-401b-89b6-9846349ec6de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_1590843b-73b4-4510-9776-b3ede2c68691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_cb94bb5d-2900-4b52-9200-471ffbd1f179" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_1590843b-73b4-4510-9776-b3ede2c68691" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_67707cdf-1b2f-47fe-a547-f30a3bd0c4b8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_1590843b-73b4-4510-9776-b3ede2c68691" xlink:to="loc_srt_ProductOrServiceAxis_67707cdf-1b2f-47fe-a547-f30a3bd0c4b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_67707cdf-1b2f-47fe-a547-f30a3bd0c4b8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_67707cdf-1b2f-47fe-a547-f30a3bd0c4b8" xlink:to="loc_srt_ProductsAndServicesDomain_67707cdf-1b2f-47fe-a547-f30a3bd0c4b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_74b154f5-18e8-490c-b383-f412f25aad7c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_67707cdf-1b2f-47fe-a547-f30a3bd0c4b8" xlink:to="loc_srt_ProductsAndServicesDomain_74b154f5-18e8-490c-b383-f412f25aad7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LargeCasePensionsMember_d89fc320-06aa-4872-b19b-6a12407910dd" xlink:href="cvs-20230525.xsd#cvs_LargeCasePensionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_74b154f5-18e8-490c-b383-f412f25aad7c" xlink:to="loc_cvs_LargeCasePensionsMember_d89fc320-06aa-4872-b19b-6a12407910dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareMember_5e6bde6d-f29b-4fec-8b1b-98edbfa72f0b" xlink:href="cvs-20230525.xsd#cvs_LongTermCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_74b154f5-18e8-490c-b383-f412f25aad7c" xlink:to="loc_cvs_LongTermCareMember_5e6bde6d-f29b-4fec-8b1b-98edbfa72f0b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails" xlink:type="extended" id="i7cd59ee4c9594da5a52ef9fc3796ba7b_OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_35557d22-db58-4425-9c24-92711aa1f9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance_c32cce4e-b144-400a-b951-e8f44bb0d1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_35557d22-db58-4425-9c24-92711aa1f9d7" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance_c32cce4e-b144-400a-b951-e8f44bb0d1b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance_77b82cba-523e-46ab-b41c-abafadb36394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_35557d22-db58-4425-9c24-92711aa1f9d7" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance_77b82cba-523e-46ab-b41c-abafadb36394" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_6f2f780e-92ed-41d3-b779-356d8204c699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_35557d22-db58-4425-9c24-92711aa1f9d7" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_6f2f780e-92ed-41d3-b779-356d8204c699" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_19950527-c03d-4514-8566-477d00386056" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_6f2f780e-92ed-41d3-b779-356d8204c699" xlink:to="loc_srt_ProductOrServiceAxis_19950527-c03d-4514-8566-477d00386056" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_19950527-c03d-4514-8566-477d00386056_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_19950527-c03d-4514-8566-477d00386056" xlink:to="loc_srt_ProductsAndServicesDomain_19950527-c03d-4514-8566-477d00386056_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_32a4b8e3-167f-455a-a9ec-587c663b70a7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_19950527-c03d-4514-8566-477d00386056" xlink:to="loc_srt_ProductsAndServicesDomain_32a4b8e3-167f-455a-a9ec-587c663b70a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LargeCasePensionsMember_00a95001-8242-4c61-adbc-4f7360549a06" xlink:href="cvs-20230525.xsd#cvs_LargeCasePensionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_32a4b8e3-167f-455a-a9ec-587c663b70a7" xlink:to="loc_cvs_LargeCasePensionsMember_00a95001-8242-4c61-adbc-4f7360549a06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareMember_dfc2b38c-384d-4a42-85fa-0fbb8b535783" xlink:href="cvs-20230525.xsd#cvs_LongTermCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_32a4b8e3-167f-455a-a9ec-587c663b70a7" xlink:to="loc_cvs_LongTermCareMember_dfc2b38c-384d-4a42-85fa-0fbb8b535783" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails" xlink:type="extended" id="i60b605eae5394eb29515d8f82337aeef_OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_d161db9e-da5e-4e53-96b0-42447eaaebbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate_d0f9dd77-24ac-4d04-8f7b-daf4e9ca20b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_d161db9e-da5e-4e53-96b0-42447eaaebbc" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate_d0f9dd77-24ac-4d04-8f7b-daf4e9ca20b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate_9e6bc965-af1a-49de-aea0-5aa399c5ff32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_d161db9e-da5e-4e53-96b0-42447eaaebbc" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate_9e6bc965-af1a-49de-aea0-5aa399c5ff32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration_dc533d3f-4a9f-44dc-a8e9-e6547ef7684f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_d161db9e-da5e-4e53-96b0-42447eaaebbc" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration_dc533d3f-4a9f-44dc-a8e9-e6547ef7684f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_f5390bc5-916f-4c37-a8d2-903042debf6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_d161db9e-da5e-4e53-96b0-42447eaaebbc" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_f5390bc5-916f-4c37-a8d2-903042debf6e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_37ae6c6f-3f54-415f-a39c-74910b0224cd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_f5390bc5-916f-4c37-a8d2-903042debf6e" xlink:to="loc_srt_ProductOrServiceAxis_37ae6c6f-3f54-415f-a39c-74910b0224cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_37ae6c6f-3f54-415f-a39c-74910b0224cd_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_37ae6c6f-3f54-415f-a39c-74910b0224cd" xlink:to="loc_srt_ProductsAndServicesDomain_37ae6c6f-3f54-415f-a39c-74910b0224cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_68b84026-a5b5-4f35-932e-6808ca0a87fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_37ae6c6f-3f54-415f-a39c-74910b0224cd" xlink:to="loc_srt_ProductsAndServicesDomain_68b84026-a5b5-4f35-932e-6808ca0a87fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LargeCasePensionsMember_94a598af-910e-47f8-9706-81bcf608b6ea" xlink:href="cvs-20230525.xsd#cvs_LargeCasePensionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_68b84026-a5b5-4f35-932e-6808ca0a87fb" xlink:to="loc_cvs_LargeCasePensionsMember_94a598af-910e-47f8-9706-81bcf608b6ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareMember_7655d419-82bb-47e5-b7f3-05fd34bb0d85" xlink:href="cvs-20230525.xsd#cvs_LongTermCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_68b84026-a5b5-4f35-932e-6808ca0a87fb" xlink:to="loc_cvs_LongTermCareMember_7655d419-82bb-47e5-b7f3-05fd34bb0d85" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails" xlink:type="extended" id="i97ccc5dce8d04e85b3ed9e416cf14660_OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_951d3e91-d216-4623-9b59-799017c16b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_fbf81efe-6005-4ebf-bd57-ccea066f1299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_951d3e91-d216-4623-9b59-799017c16b1b" xlink:to="loc_us-gaap_SeparateAccountAssets_fbf81efe-6005-4ebf-bd57-ccea066f1299" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_1bc4c142-0912-4db9-b518-865b5849b8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_951d3e91-d216-4623-9b59-799017c16b1b" xlink:to="loc_us-gaap_SeparateAccountsLiability_1bc4c142-0912-4db9-b518-865b5849b8dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_217f09ad-330e-4d9a-93fd-c1c07cfda290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_951d3e91-d216-4623-9b59-799017c16b1b" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_217f09ad-330e-4d9a-93fd-c1c07cfda290" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryAxis_10d488e0-a545-46c6-af85-2bcfa3291935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_217f09ad-330e-4d9a-93fd-c1c07cfda290" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryAxis_10d488e0-a545-46c6-af85-2bcfa3291935" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain_10d488e0-a545-46c6-af85-2bcfa3291935_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis_10d488e0-a545-46c6-af85-2bcfa3291935" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryDomain_10d488e0-a545-46c6-af85-2bcfa3291935_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain_cec306f1-6b37-4bf8-9791-537c218add8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis_10d488e0-a545-46c6-af85-2bcfa3291935" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryDomain_cec306f1-6b37-4bf8-9791-537c218add8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountCashAndCashEquivalentsMember_a8224668-d115-4f3b-a23f-1ab6d0023418" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_cec306f1-6b37-4bf8-9791-537c218add8b" xlink:to="loc_us-gaap_SeparateAccountCashAndCashEquivalentsMember_a8224668-d115-4f3b-a23f-1ab6d0023418" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountDebtSecurityMember_fad6c6e3-d544-4760-b68a-da99822c65a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountDebtSecurityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_cec306f1-6b37-4bf8-9791-537c218add8b" xlink:to="loc_us-gaap_SeparateAccountDebtSecurityMember_fad6c6e3-d544-4760-b68a-da99822c65a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountMortgageBackedSecurityMember_03fc03c4-acba-47ab-a2b0-fd34370dabf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountMortgageBackedSecurityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_cec306f1-6b37-4bf8-9791-537c218add8b" xlink:to="loc_us-gaap_SeparateAccountMortgageBackedSecurityMember_03fc03c4-acba-47ab-a2b0-fd34370dabf8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeparateAccountOtherAssetBackedSecuritiesMember_5974546d-b733-4c66-a2b1-fd45e67c84e3" xlink:href="cvs-20230525.xsd#cvs_SeparateAccountOtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_cec306f1-6b37-4bf8-9791-537c218add8b" xlink:to="loc_cvs_SeparateAccountOtherAssetBackedSecuritiesMember_5974546d-b733-4c66-a2b1-fd45e67c84e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EquitySecuritiesAndCommonAndCollectiveTrustsMember_7b342f5d-fd31-4c76-83b8-062e43fbb76f" xlink:href="cvs-20230525.xsd#cvs_EquitySecuritiesAndCommonAndCollectiveTrustsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_cec306f1-6b37-4bf8-9791-537c218add8b" xlink:to="loc_cvs_EquitySecuritiesAndCommonAndCollectiveTrustsMember_7b342f5d-fd31-4c76-83b8-062e43fbb76f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_640dac4f-2b64-476b-aefe-1aee3a5b421a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_217f09ad-330e-4d9a-93fd-c1c07cfda290" xlink:to="loc_us-gaap_FinancialInstrumentAxis_640dac4f-2b64-476b-aefe-1aee3a5b421a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_640dac4f-2b64-476b-aefe-1aee3a5b421a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_640dac4f-2b64-476b-aefe-1aee3a5b421a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_640dac4f-2b64-476b-aefe-1aee3a5b421a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019c4024-166a-4a82-a5da-9dd747215f58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_640dac4f-2b64-476b-aefe-1aee3a5b421a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019c4024-166a-4a82-a5da-9dd747215f58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_2e6fd784-3f42-4643-830c-702a0f5a2651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019c4024-166a-4a82-a5da-9dd747215f58" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_2e6fd784-3f42-4643-830c-702a0f5a2651" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_87bd9082-11b5-4587-b4b9-db7cdf366582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019c4024-166a-4a82-a5da-9dd747215f58" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_87bd9082-11b5-4587-b4b9-db7cdf366582" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_42d1e7e8-1194-44c3-80ac-f27a6295f442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019c4024-166a-4a82-a5da-9dd747215f58" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_42d1e7e8-1194-44c3-80ac-f27a6295f442" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_94ed179c-8616-4b51-ab2f-1743ad2bf7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019c4024-166a-4a82-a5da-9dd747215f58" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_94ed179c-8616-4b51-ab2f-1743ad2bf7a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_de828727-176e-4aef-88bd-7320b25cb0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019c4024-166a-4a82-a5da-9dd747215f58" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_de828727-176e-4aef-88bd-7320b25cb0f4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_42c44adc-7108-43f7-a988-fda75b6c384c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019c4024-166a-4a82-a5da-9dd747215f58" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_42c44adc-7108-43f7-a988-fda75b6c384c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_41df7142-9ed1-407e-b9cd-fb84e4e3c72b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_217f09ad-330e-4d9a-93fd-c1c07cfda290" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_41df7142-9ed1-407e-b9cd-fb84e4e3c72b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_41df7142-9ed1-407e-b9cd-fb84e4e3c72b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_41df7142-9ed1-407e-b9cd-fb84e4e3c72b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_41df7142-9ed1-407e-b9cd-fb84e4e3c72b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_85a99596-d0cc-4cc2-bbfc-31158920d2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_41df7142-9ed1-407e-b9cd-fb84e4e3c72b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_85a99596-d0cc-4cc2-bbfc-31158920d2cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableMember_08d9494a-277c-4870-b2c3-ac90ffd0f5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_85a99596-d0cc-4cc2-bbfc-31158920d2cd" xlink:to="loc_us-gaap_AccountsPayableMember_08d9494a-277c-4870-b2c3-ac90ffd0f5c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_992c3bb3-e934-4013-8de8-c58a175e80da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_85a99596-d0cc-4cc2-bbfc-31158920d2cd" xlink:to="loc_us-gaap_AccountsReceivableMember_992c3bb3-e934-4013-8de8-c58a175e80da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fbb71837-1119-4ce1-a585-b54b696b5f95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_217f09ad-330e-4d9a-93fd-c1c07cfda290" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fbb71837-1119-4ce1-a585-b54b696b5f95" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_fbb71837-1119-4ce1-a585-b54b696b5f95_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fbb71837-1119-4ce1-a585-b54b696b5f95" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_fbb71837-1119-4ce1-a585-b54b696b5f95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_744c9b1d-f3df-4e42-b8b3-5f377f80343f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fbb71837-1119-4ce1-a585-b54b696b5f95" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_744c9b1d-f3df-4e42-b8b3-5f377f80343f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_a8c4e9a9-55eb-46df-ae45-29b64178ec91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_744c9b1d-f3df-4e42-b8b3-5f377f80343f" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_a8c4e9a9-55eb-46df-ae45-29b64178ec91" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails" xlink:type="extended" id="icfc9829353cf406bb7ddaa73f7952c47_BorrowingsandCreditAgreementsScheduleofBorrowingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_be14ce74-514c-4860-b4a6-1e29e4fc2fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_be14ce74-514c-4860-b4a6-1e29e4fc2fe0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_7793fbb9-a625-40e2-91ba-a11b20cf012e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_7793fbb9-a625-40e2-91ba-a11b20cf012e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_d78d2d1c-e166-4156-a0ac-64a9471d1f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:to="loc_us-gaap_FinanceLeaseLiability_d78d2d1c-e166-4156-a0ac-64a9471d1f98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_5576c1dd-5207-4faf-8cf4-bbc5e48d6fcd" xlink:href="cvs-20230525.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:to="loc_cvs_LongtermDebtGrossAndLeaseObligation_5576c1dd-5207-4faf-8cf4-bbc5e48d6fcd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_13dcc97a-9bad-40e8-bd5e-8a7c5d5e7102" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_13dcc97a-9bad-40e8-bd5e-8a7c5d5e7102" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet_b4a3f29f-40a0-47a3-be08-8c1e81225917" xlink:href="cvs-20230525.xsd#cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:to="loc_cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet_b4a3f29f-40a0-47a3-be08-8c1e81225917" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_d90ae8f2-dbaa-46d0-93fa-d42663591c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_d90ae8f2-dbaa-46d0-93fa-d42663591c4d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2f8850e0-fea3-49a9-9824-ce6aa9b2f632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2f8850e0-fea3-49a9-9824-ce6aa9b2f632" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale_7be11b2f-cd93-41b8-97b2-aafdf84eb2f8" xlink:href="cvs-20230525.xsd#cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:to="loc_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale_7be11b2f-cd93-41b8-97b2-aafdf84eb2f8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_b4d8b93b-2fcf-4559-94e0-24296beba532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:to="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_b4d8b93b-2fcf-4559-94e0-24296beba532" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_bfb0588d-e9ad-44db-9075-de600d0d607a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:to="loc_us-gaap_DebtInstrumentTable_bfb0588d-e9ad-44db-9075-de600d0d607a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2a2eec38-bb71-486c-b136-be17ef202355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bfb0588d-e9ad-44db-9075-de600d0d607a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2a2eec38-bb71-486c-b136-be17ef202355" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2a2eec38-bb71-486c-b136-be17ef202355_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2a2eec38-bb71-486c-b136-be17ef202355" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2a2eec38-bb71-486c-b136-be17ef202355_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6efdce76-0c62-4e2e-ad8d-bde7b6f4ae2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2a2eec38-bb71-486c-b136-be17ef202355" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6efdce76-0c62-4e2e-ad8d-bde7b6f4ae2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_8a3346e6-cbc2-48b6-9248-a72542015d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6efdce76-0c62-4e2e-ad8d-bde7b6f4ae2d" xlink:to="loc_us-gaap_SeniorNotesMember_8a3346e6-cbc2-48b6-9248-a72542015d96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_c26ee550-0fd0-41ac-9e0e-4bafcfa141d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6efdce76-0c62-4e2e-ad8d-bde7b6f4ae2d" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_c26ee550-0fd0-41ac-9e0e-4bafcfa141d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a9f587b4-6c41-4aa6-b75b-42cd0b21291d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bfb0588d-e9ad-44db-9075-de600d0d607a" xlink:to="loc_us-gaap_DebtInstrumentAxis_a9f587b4-6c41-4aa6-b75b-42cd0b21291d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a9f587b4-6c41-4aa6-b75b-42cd0b21291d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a9f587b4-6c41-4aa6-b75b-42cd0b21291d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a9f587b4-6c41-4aa6-b75b-42cd0b21291d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a9f587b4-6c41-4aa6-b75b-42cd0b21291d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueJuly2022Member_f828b743-639a-4cd2-bcb8-66f0de28c3f1" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.5DueJuly2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes3.5DueJuly2022Member_f828b743-639a-4cd2-bcb8-66f0de28c3f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueNovember2022Member_ea798657-30d1-429c-91dc-45d131811040" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2.75DueNovember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes2.75DueNovember2022Member_ea798657-30d1-429c-91dc-45d131811040" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueDecember2022Member_44126120-6062-43f3-aed5-ac0c4bd36c00" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2.75DueDecember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes2.75DueDecember2022Member_44126120-6062-43f3-aed5-ac0c4bd36c00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueDecember2022Member_25f524b8-0efc-4a9a-a512-d97d00a0e602" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.75DueDecember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes4.75DueDecember2022Member_25f524b8-0efc-4a9a-a512-d97d00a0e602" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJune2023Member_ef1d9820-ee36-42d6-8e0a-ab2d1f1fe70d" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2.8DueJune2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes2.8DueJune2023Member_ef1d9820-ee36-42d6-8e0a-ab2d1f1fe70d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_01255528-121b-4f83-a1ad-753aac8fb39b" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_01255528-121b-4f83-a1ad-753aac8fb39b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.375DueAugust2024Member_8da80df9-5c32-48dc-bcd0-70fe72bf753d" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.375DueAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes3.375DueAugust2024Member_8da80df9-5c32-48dc-bcd0-70fe72bf753d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member_c13d7ad2-dab2-4cac-a345-9977bb0d2d27" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes2.625DueAugust2024Member_c13d7ad2-dab2-4cac-a345-9977bb0d2d27" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueNovember2024Member_72205d46-98a3-4e27-9269-79b91a131d92" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.5DueNovember2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes3.5DueNovember2024Member_72205d46-98a3-4e27-9269-79b91a131d92" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5DueDecember2024Member_fde3bccc-3d1b-4cfd-b626-bb43d7ce4cff" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes5DueDecember2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes5DueDecember2024Member_fde3bccc-3d1b-4cfd-b626-bb43d7ce4cff" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_e5fe3c0a-7eef-494e-a8a2-946b72b45fad" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_e5fe3c0a-7eef-494e-a8a2-946b72b45fad" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueJuly2025Member_0acd0c86-ef79-41d2-b6e0-a8e8ea76b86d" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.875DueJuly2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes3.875DueJuly2025Member_0acd0c86-ef79-41d2-b6e0-a8e8ea76b86d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.875DueJune2026Member_390a8a8d-1543-4f62-8deb-e9cd014d7b87" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2.875DueJune2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes2.875DueJune2026Member_390a8a8d-1543-4f62-8deb-e9cd014d7b87" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member_ac35427b-3eb1-4ea0-9d51-76746ded9617" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes3DueAugust2026Member_ac35427b-3eb1-4ea0-9d51-76746ded9617" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point625PercentApril2027Member_78e14be2-b407-42aa-af91-bfc2dbc55063" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3Point625PercentApril2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes3Point625PercentApril2027Member_78e14be2-b407-42aa-af91-bfc2dbc55063" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.25DueJune2027Member_c52201fe-75ab-4716-a301-c09ca668189a" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes6.25DueJune2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes6.25DueJune2027Member_c52201fe-75ab-4716-a301-c09ca668189a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point3PercentAugust2027Member_20168257-a547-4d2a-b218-d6790d4a892c" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes1Point3PercentAugust2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes1Point3PercentAugust2027Member_20168257-a547-4d2a-b218-d6790d4a892c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.3DueMarch2028Member_c03e7244-2097-43b8-97b6-8ba1e8f9868f" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.3DueMarch2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes4.3DueMarch2028Member_c03e7244-2097-43b8-97b6-8ba1e8f9868f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member_fa853b52-ad4d-46c2-9510-a5b4e83c66ef" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes3.25DueAugust2029Member_fa853b52-ad4d-46c2-9510-a5b4e83c66ef" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point75PercentApril2030Member_14a72112-c220-4cda-8c4f-b0f65caa8f3c" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3Point75PercentApril2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes3Point75PercentApril2030Member_14a72112-c220-4cda-8c4f-b0f65caa8f3c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point75PercentAugust2030Member_0570d141-abfd-4b8f-80f5-e301748ececa" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes1Point75PercentAugust2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes1Point75PercentAugust2030Member_0570d141-abfd-4b8f-80f5-e301748ececa" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point875PercentFebruary2031Member_e15ad2ee-5810-48aa-b61a-0c07807e7d9a" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes1Point875PercentFebruary2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes1Point875PercentFebruary2031Member_e15ad2ee-5810-48aa-b61a-0c07807e7d9a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2Point125PercentDueSeptember2031Member_acbd0a78-5554-4e64-b520-a266278a4c61" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2Point125PercentDueSeptember2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes2Point125PercentDueSeptember2031Member_acbd0a78-5554-4e64-b520-a266278a4c61" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.875DueJuly2035Member_d7a96fe4-3f79-424f-a331-c0c4b12ae90e" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.875DueJuly2035Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes4.875DueJuly2035Member_d7a96fe4-3f79-424f-a331-c0c4b12ae90e" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.625DueJune2036Member_e7a5e504-cc37-4521-b7e9-46b4fe256fac" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes6.625DueJune2036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes6.625DueJune2036Member_e7a5e504-cc37-4521-b7e9-46b4fe256fac" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.75DueDecember2037Member_535c3b8f-789d-4c88-a84f-0ae028206c4e" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes6.75DueDecember2037Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes6.75DueDecember2037Member_535c3b8f-789d-4c88-a84f-0ae028206c4e" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.78DueMarch2038Member_0abcfba1-52a0-4f33-93b4-c832991c9a40" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.78DueMarch2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes4.78DueMarch2038Member_0abcfba1-52a0-4f33-93b4-c832991c9a40" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.125DueSeptember2039Member_17db61f8-295c-4b85-9844-14ae5fc1b7eb" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes6.125DueSeptember2039Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes6.125DueSeptember2039Member_17db61f8-295c-4b85-9844-14ae5fc1b7eb" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4Point125PercentApril2040Member_a5d42aac-d952-4835-ab0e-34bb1f3109ff" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4Point125PercentApril2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes4Point125PercentApril2040Member_a5d42aac-d952-4835-ab0e-34bb1f3109ff" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2Point7PercentAugust2040Member_236334a9-3591-4a16-a738-e4fc324de2f8" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2Point7PercentAugust2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes2Point7PercentAugust2040Member_236334a9-3591-4a16-a738-e4fc324de2f8" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.75DueMay2041Member_952f921d-7d48-4ff8-8baa-8162aa016a4d" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes5.75DueMay2041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes5.75DueMay2041Member_952f921d-7d48-4ff8-8baa-8162aa016a4d" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.5DueMay2042Member_66f5cd2d-af18-4c26-9daf-092e157a70d4" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.5DueMay2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes4.5DueMay2042Member_66f5cd2d-af18-4c26-9daf-092e157a70d4" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueNovember2042Member_48f6b297-6274-4285-ac82-2677ea124317" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.125DueNovember2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes4.125DueNovember2042Member_48f6b297-6274-4285-ac82-2677ea124317" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.3DueDecember2043Member_35c23235-afdd-49a0-87e9-4fc8d0b406a6" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes5.3DueDecember2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes5.3DueDecember2043Member_35c23235-afdd-49a0-87e9-4fc8d0b406a6" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueMarch2044Member_d2a3a4c2-4526-43f9-93aa-5cea755eff5d" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.75DueMarch2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes4.75DueMarch2044Member_d2a3a4c2-4526-43f9-93aa-5cea755eff5d" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.125DueJuly2045Member_52a98338-7535-4964-886b-017879d9afdf" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes5.125DueJuly2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes5.125DueJuly2045Member_52a98338-7535-4964-886b-017879d9afdf" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueAugust2047Member_20a675f1-4b54-4f4d-a6e8-bdbaf9ff2b5d" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.875DueAugust2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes3.875DueAugust2047Member_20a675f1-4b54-4f4d-a6e8-bdbaf9ff2b5d" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.05DueMarch2048Member_8f0cc8b3-5b45-4d99-b754-28abe6cf10c8" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes5.05DueMarch2048Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes5.05DueMarch2048Member_8f0cc8b3-5b45-4d99-b754-28abe6cf10c8" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4Point25PercentApril2050Member_70a51bcf-cef4-426f-9541-a42fc3425289" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4Point25PercentApril2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes4Point25PercentApril2050Member_70a51bcf-cef4-426f-9541-a42fc3425289" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_5516a597-0ae3-4925-a557-028906205330" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bfb0588d-e9ad-44db-9075-de600d0d607a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_5516a597-0ae3-4925-a557-028906205330" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_5516a597-0ae3-4925-a557-028906205330_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_5516a597-0ae3-4925-a557-028906205330" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_5516a597-0ae3-4925-a557-028906205330_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_128732ed-b8e9-45e4-a1ce-b16fa4464060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_5516a597-0ae3-4925-a557-028906205330" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_128732ed-b8e9-45e4-a1ce-b16fa4464060" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_e79c9572-e9bd-4b1c-8d79-09b171dedde6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_128732ed-b8e9-45e4-a1ce-b16fa4464060" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_e79c9572-e9bd-4b1c-8d79-09b171dedde6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#BorrowingsandCreditAgreementsShorttermBorrowingsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails" xlink:type="extended" id="ic521ad4b2c604157941d0c8d98587220_BorrowingsandCreditAgreementsShorttermBorrowingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_d7047061-4903-4f61-aa99-86cbfd8f16f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_e745c8d7-d3f2-4823-b371-15367e453a54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_d7047061-4903-4f61-aa99-86cbfd8f16f2" xlink:to="loc_us-gaap_ShortTermBorrowings_e745c8d7-d3f2-4823-b371-15367e453a54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_afbce53d-4fc1-4504-b854-10b4658de166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_d7047061-4903-4f61-aa99-86cbfd8f16f2" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_afbce53d-4fc1-4504-b854-10b4658de166" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_b719fadc-7253-4785-8682-9ad35277c381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_d7047061-4903-4f61-aa99-86cbfd8f16f2" xlink:to="loc_us-gaap_DebtInstrumentTerm_b719fadc-7253-4785-8682-9ad35277c381" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_f6edb778-d01f-49c6-a002-0abe5126efa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_d7047061-4903-4f61-aa99-86cbfd8f16f2" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_f6edb778-d01f-49c6-a002-0abe5126efa2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable_68dfd301-2803-4afa-9c30-40272622d24b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_d7047061-4903-4f61-aa99-86cbfd8f16f2" xlink:to="loc_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable_68dfd301-2803-4afa-9c30-40272622d24b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_6623491d-d714-451e-bdce-63241d29204b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_d7047061-4903-4f61-aa99-86cbfd8f16f2" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_6623491d-d714-451e-bdce-63241d29204b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_ac403f6b-f60b-4ec7-88d3-636bcdb4e077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_6623491d-d714-451e-bdce-63241d29204b" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_ac403f6b-f60b-4ec7-88d3-636bcdb4e077" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_ac403f6b-f60b-4ec7-88d3-636bcdb4e077_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_ac403f6b-f60b-4ec7-88d3-636bcdb4e077" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_ac403f6b-f60b-4ec7-88d3-636bcdb4e077_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_6e80ad40-dc80-4da0-b068-42f27e7c8ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_ac403f6b-f60b-4ec7-88d3-636bcdb4e077" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_6e80ad40-dc80-4da0-b068-42f27e7c8ffc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_6d7efc94-eddf-48ef-9fe5-2a608067c23d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_6e80ad40-dc80-4da0-b068-42f27e7c8ffc" xlink:to="loc_us-gaap_CommercialPaperMember_6d7efc94-eddf-48ef-9fe5-2a608067c23d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_b5b08d5f-7f35-41d3-9304-56901556dc67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_6e80ad40-dc80-4da0-b068-42f27e7c8ffc" xlink:to="loc_us-gaap_LineOfCreditMember_b5b08d5f-7f35-41d3-9304-56901556dc67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesMember_e47db3b9-a3c4-410e-9d45-1dd8faa5444e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalHomeLoanBankAdvancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_6e80ad40-dc80-4da0-b068-42f27e7c8ffc" xlink:to="loc_us-gaap_FederalHomeLoanBankAdvancesMember_e47db3b9-a3c4-410e-9d45-1dd8faa5444e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_88a6bdc7-6714-4a3d-8ac1-27ac2dd6a4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_6623491d-d714-451e-bdce-63241d29204b" xlink:to="loc_us-gaap_DebtInstrumentAxis_88a6bdc7-6714-4a3d-8ac1-27ac2dd6a4dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_88a6bdc7-6714-4a3d-8ac1-27ac2dd6a4dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_88a6bdc7-6714-4a3d-8ac1-27ac2dd6a4dc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_88a6bdc7-6714-4a3d-8ac1-27ac2dd6a4dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_643dcf26-5dad-4015-b126-dcb21ea4301a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_88a6bdc7-6714-4a3d-8ac1-27ac2dd6a4dc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_643dcf26-5dad-4015-b126-dcb21ea4301a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BackUpCreditFacilitiesMember_eb59bf4a-8450-42d8-916a-c09519698cc4" xlink:href="cvs-20230525.xsd#cvs_BackUpCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_643dcf26-5dad-4015-b126-dcb21ea4301a" xlink:to="loc_cvs_BackUpCreditFacilitiesMember_eb59bf4a-8450-42d8-916a-c09519698cc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay162025Member_aece11bc-6aa0-4fd3-a38f-7ce0efb7b6c8" xlink:href="cvs-20230525.xsd#cvs_RevolvingCreditFacilityExpiringMay162025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_BackUpCreditFacilitiesMember_eb59bf4a-8450-42d8-916a-c09519698cc4" xlink:to="loc_cvs_RevolvingCreditFacilityExpiringMay162025Member_aece11bc-6aa0-4fd3-a38f-7ce0efb7b6c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay112026Member_0bfd02d0-1cfc-46f1-b09a-d84859ca946f" xlink:href="cvs-20230525.xsd#cvs_RevolvingCreditFacilityExpiringMay112026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_BackUpCreditFacilitiesMember_eb59bf4a-8450-42d8-916a-c09519698cc4" xlink:to="loc_cvs_RevolvingCreditFacilityExpiringMay112026Member_0bfd02d0-1cfc-46f1-b09a-d84859ca946f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay162027Member_7d348854-91cc-4402-91a6-5f4a6b74f23e" xlink:href="cvs-20230525.xsd#cvs_RevolvingCreditFacilityExpiringMay162027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_BackUpCreditFacilitiesMember_eb59bf4a-8450-42d8-916a-c09519698cc4" xlink:to="loc_cvs_RevolvingCreditFacilityExpiringMay162027Member_7d348854-91cc-4402-91a6-5f4a6b74f23e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#BorrowingsandCreditAgreementsLongtermBorrowingsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails" xlink:type="extended" id="ic25b8d4b535e48adaf4f6645e31aed43_BorrowingsandCreditAgreementsLongtermBorrowingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_81f84aa4-1f9d-43e8-98cc-8f740e4ae23b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_81f84aa4-1f9d-43e8-98cc-8f740e4ae23b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_a5261345-2f86-419b-86ed-2c1d63adffe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_a5261345-2f86-419b-86ed-2c1d63adffe7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_c6a97247-0d6f-4dfa-8c52-af8e07b86561" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_c6a97247-0d6f-4dfa-8c52-af8e07b86561" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_c0f5dcea-1cee-4df0-a659-17baa80be61b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_c0f5dcea-1cee-4df0-a659-17baa80be61b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_f1bd356b-156b-43a8-8dfc-0a28ad117d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_f1bd356b-156b-43a8-8dfc-0a28ad117d7b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_a214a3ac-beb7-4f07-b765-b15a2b8d547a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_a214a3ac-beb7-4f07-b765-b15a2b8d547a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_31c5d8f6-a784-44b5-9d76-821dcc9fadd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_31c5d8f6-a784-44b5-9d76-821dcc9fadd2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_6a095f47-9049-4cf3-9660-0d46d08807bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_6a095f47-9049-4cf3-9660-0d46d08807bb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_ea89579c-e475-434f-9555-c6a564d82697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_ea89579c-e475-434f-9555-c6a564d82697" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtExtinguishmentFees_526f1524-d040-4fc3-9d0f-6b2f8e7de216" xlink:href="cvs-20230525.xsd#cvs_DebtExtinguishmentFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_cvs_DebtExtinguishmentFees_526f1524-d040-4fc3-9d0f-6b2f8e7de216" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9f150c92-4499-4289-8a2d-741751da5563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9f150c92-4499-4289-8a2d-741751da5563" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d3c1339d-9a0a-407a-a48f-7c5904a45388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_us-gaap_DebtInstrumentTable_d3c1339d-9a0a-407a-a48f-7c5904a45388" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_557f72a2-402b-44c9-9892-4832ed99e566" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d3c1339d-9a0a-407a-a48f-7c5904a45388" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_557f72a2-402b-44c9-9892-4832ed99e566" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_557f72a2-402b-44c9-9892-4832ed99e566_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_557f72a2-402b-44c9-9892-4832ed99e566" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_557f72a2-402b-44c9-9892-4832ed99e566_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f1b4ca88-42be-40a0-890a-cc770fed8e80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_557f72a2-402b-44c9-9892-4832ed99e566" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f1b4ca88-42be-40a0-890a-cc770fed8e80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_18f25344-55a6-4136-9f2e-fb33e6df6139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f1b4ca88-42be-40a0-890a-cc770fed8e80" xlink:to="loc_us-gaap_SeniorNotesMember_18f25344-55a6-4136-9f2e-fb33e6df6139" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_24347707-472b-4d8e-b3fd-5b372d5dc5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d3c1339d-9a0a-407a-a48f-7c5904a45388" xlink:to="loc_us-gaap_DebtInstrumentAxis_24347707-472b-4d8e-b3fd-5b372d5dc5ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_24347707-472b-4d8e-b3fd-5b372d5dc5ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_24347707-472b-4d8e-b3fd-5b372d5dc5ee" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_24347707-472b-4d8e-b3fd-5b372d5dc5ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_24347707-472b-4d8e-b3fd-5b372d5dc5ee" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueJuly2022Member_479f1bd5-f5d6-46a7-8c60-c564047db829" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.5DueJuly2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes3.5DueJuly2022Member_479f1bd5-f5d6-46a7-8c60-c564047db829" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueNovember2022Member_fcb67ff4-1cc8-4d37-b4f2-981933c37d3b" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2.75DueNovember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes2.75DueNovember2022Member_fcb67ff4-1cc8-4d37-b4f2-981933c37d3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueDecember2022Member_486d2d45-62ce-4506-bb8f-626f10269b07" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2.75DueDecember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes2.75DueDecember2022Member_486d2d45-62ce-4506-bb8f-626f10269b07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueDecember2022Member_b94d6202-b114-4720-8935-35b30f20c78a" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.75DueDecember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes4.75DueDecember2022Member_b94d6202-b114-4720-8935-35b30f20c78a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2Point125PercentDueSeptember2031Member_2421f6ed-8a65-43a6-9d01-2c3bb1bf5baf" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2Point125PercentDueSeptember2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes2Point125PercentDueSeptember2031Member_2421f6ed-8a65-43a6-9d01-2c3bb1bf5baf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point625PercentApril2027Member_d9e0c9b4-70c7-47f3-93df-fa41e8af6b55" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3Point625PercentApril2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes3Point625PercentApril2027Member_d9e0c9b4-70c7-47f3-93df-fa41e8af6b55" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point75PercentApril2030Member_bccbc98a-0267-452e-a5e0-a6126fd78f18" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3Point75PercentApril2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes3Point75PercentApril2030Member_bccbc98a-0267-452e-a5e0-a6126fd78f18" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4Point125PercentApril2040Member_5d61754e-836c-4ede-8678-9d9881a494af" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4Point125PercentApril2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes4Point125PercentApril2040Member_5d61754e-836c-4ede-8678-9d9881a494af" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4Point25PercentApril2050Member_211d92e2-129b-4549-937f-ea9839aeedfc" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4Point25PercentApril2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes4Point25PercentApril2050Member_211d92e2-129b-4549-937f-ea9839aeedfc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point70PercentDue2023Member_5c5f8b09-a944-4db5-80cb-95927f861534" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3Point70PercentDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes3Point70PercentDue2023Member_5c5f8b09-a944-4db5-80cb-95927f861534" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4PointThreePercentDue2028Member_2ea91f73-8cc0-4846-be2d-44349977d2fb" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4PointThreePercentDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes4PointThreePercentDue2028Member_2ea91f73-8cc0-4846-be2d-44349977d2fb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OutstandingSeniorNotesMember_f934a803-e544-471a-a9fa-9fee0856a26f" xlink:href="cvs-20230525.xsd#cvs_OutstandingSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_OutstandingSeniorNotesMember_f934a803-e544-471a-a9fa-9fee0856a26f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_6b31c5ea-94f1-4d50-a448-894d500ea1f1" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_6b31c5ea-94f1-4d50-a448-894d500ea1f1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member_6fa4d242-42ca-47a2-ba48-debad3a8b024" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes3.7DueMarch2023Member_6fa4d242-42ca-47a2-ba48-debad3a8b024" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_3e76eb26-58b0-44f1-b848-c931be8adceb" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_3e76eb26-58b0-44f1-b848-c931be8adceb" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes43Due2028Member_c2e9e5e0-2dbf-4714-89f2-60f5a0e8a4b2" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes43Due2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes43Due2028Member_c2e9e5e0-2dbf-4714-89f2-60f5a0e8a4b2" xlink:type="arc" order="15"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#PensionPlansandOtherPostretirementBenefitsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails" xlink:type="extended" id="i3a3aadb0a0774d64b341a60473e9f4f4_PensionPlansandOtherPostretirementBenefitsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_52934ee6-a83c-4497-92b2-3909b31aeba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_1e5a5bae-12ce-4e2c-b862-3a70cd8a9bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_52934ee6-a83c-4497-92b2-3909b31aeba1" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_1e5a5bae-12ce-4e2c-b862-3a70cd8a9bf5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_4b37c830-a9be-455e-b7d7-7e055aad08fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_52934ee6-a83c-4497-92b2-3909b31aeba1" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_4b37c830-a9be-455e-b7d7-7e055aad08fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_c74b3395-5332-4540-9ddf-f9aea1f8b063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_52934ee6-a83c-4497-92b2-3909b31aeba1" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_c74b3395-5332-4540-9ddf-f9aea1f8b063" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution_cc4f8f04-c741-4a79-97d6-c9acf12ad8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MultiemployerPlanPensionInsignificantPlanContribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_52934ee6-a83c-4497-92b2-3909b31aeba1" xlink:to="loc_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution_cc4f8f04-c741-4a79-97d6-c9acf12ad8a4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_9152ec12-7049-4142-a5f7-d3aff312b81e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_52934ee6-a83c-4497-92b2-3909b31aeba1" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_9152ec12-7049-4142-a5f7-d3aff312b81e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ce198234-560e-4b52-a800-1282c5f1da6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_52934ee6-a83c-4497-92b2-3909b31aeba1" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ce198234-560e-4b52-a800-1282c5f1da6b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5ac7493c-2347-44c9-87ee-e1c9ed2142d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_52934ee6-a83c-4497-92b2-3909b31aeba1" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5ac7493c-2347-44c9-87ee-e1c9ed2142d9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_9816a57c-9534-4918-8bd8-1a9372cba62c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5ac7493c-2347-44c9-87ee-e1c9ed2142d9" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_9816a57c-9534-4918-8bd8-1a9372cba62c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_9816a57c-9534-4918-8bd8-1a9372cba62c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_9816a57c-9534-4918-8bd8-1a9372cba62c" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_9816a57c-9534-4918-8bd8-1a9372cba62c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_504b2c11-11e1-4600-a701-ce0734f3c4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_9816a57c-9534-4918-8bd8-1a9372cba62c" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_504b2c11-11e1-4600-a701-ce0734f3c4f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_bde5f348-5849-46dc-b8e0-e53bec25cc9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_504b2c11-11e1-4600-a701-ce0734f3c4f9" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_bde5f348-5849-46dc-b8e0-e53bec25cc9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_293a4b3c-b8e0-4860-94ca-5056ffe11d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_504b2c11-11e1-4600-a701-ce0734f3c4f9" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_293a4b3c-b8e0-4860-94ca-5056ffe11d3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_8d986a76-700f-4eff-bf82-1ac75ffe0b28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5ac7493c-2347-44c9-87ee-e1c9ed2142d9" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_8d986a76-700f-4eff-bf82-1ac75ffe0b28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_8d986a76-700f-4eff-bf82-1ac75ffe0b28_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_8d986a76-700f-4eff-bf82-1ac75ffe0b28" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_8d986a76-700f-4eff-bf82-1ac75ffe0b28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_f2d2993e-a117-4dd3-a660-b0ae278fdf87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_8d986a76-700f-4eff-bf82-1ac75ffe0b28" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_f2d2993e-a117-4dd3-a660-b0ae278fdf87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_d9c566a3-603e-4ac5-bdb0-5add38ba9069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f2d2993e-a117-4dd3-a660-b0ae278fdf87" xlink:to="loc_us-gaap_EquitySecuritiesMember_d9c566a3-603e-4ac5-bdb0-5add38ba9069" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_524b3258-56c9-4f5a-8497-6ebaf3daa47b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f2d2993e-a117-4dd3-a660-b0ae278fdf87" xlink:to="loc_us-gaap_DebtSecuritiesMember_524b3258-56c9-4f5a-8497-6ebaf3daa47b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentMember_140b45a8-4462-4679-af88-a492368239dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f2d2993e-a117-4dd3-a660-b0ae278fdf87" xlink:to="loc_us-gaap_RealEstateInvestmentMember_140b45a8-4462-4679-af88-a492368239dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_4675630a-2294-4bee-bfa2-7d284165711f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f2d2993e-a117-4dd3-a660-b0ae278fdf87" xlink:to="loc_us-gaap_PrivateEquityFundsMember_4675630a-2294-4bee-bfa2-7d284165711f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_ee608f6c-c426-47d6-ba53-0d590be28dab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f2d2993e-a117-4dd3-a660-b0ae278fdf87" xlink:to="loc_us-gaap_HedgeFundsMember_ee608f6c-c426-47d6-ba53-0d590be28dab" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails" xlink:type="extended" id="i830a74ffd7714dec92de018e50b603f5_PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c94f94e1-5f73-4054-879e-497e2169ea90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3bba235b-50bd-438e-b498-a8fc86d87bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c94f94e1-5f73-4054-879e-497e2169ea90" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3bba235b-50bd-438e-b498-a8fc86d87bb3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_e47e6ae7-e125-4280-8a06-cf0f4481b7da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3bba235b-50bd-438e-b498-a8fc86d87bb3" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_e47e6ae7-e125-4280-8a06-cf0f4481b7da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_7db03e4e-2c21-48b7-9219-288ea9198a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3bba235b-50bd-438e-b498-a8fc86d87bb3" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_7db03e4e-2c21-48b7-9219-288ea9198a9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_b33b7c61-2113-47e2-a23b-a6d688f37870" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3bba235b-50bd-438e-b498-a8fc86d87bb3" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_b33b7c61-2113-47e2-a23b-a6d688f37870" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_7c286b5e-7666-4b1a-a4f0-dbaadbcceabf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3bba235b-50bd-438e-b498-a8fc86d87bb3" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_7c286b5e-7666-4b1a-a4f0-dbaadbcceabf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_ca7cb7c1-7e93-49a0-bc70-81612472de90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3bba235b-50bd-438e-b498-a8fc86d87bb3" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_ca7cb7c1-7e93-49a0-bc70-81612472de90" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_5ae75812-016b-445c-be91-d6997358884b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b3152f47-63ae-4908-beb5-e71ef9aa8fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c94f94e1-5f73-4054-879e-497e2169ea90" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b3152f47-63ae-4908-beb5-e71ef9aa8fa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_99237824-51ae-4bf7-a762-2bd60670286a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b3152f47-63ae-4908-beb5-e71ef9aa8fa7" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_99237824-51ae-4bf7-a762-2bd60670286a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_a172f5be-f332-4abb-89b5-e8231c472de7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b3152f47-63ae-4908-beb5-e71ef9aa8fa7" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_a172f5be-f332-4abb-89b5-e8231c472de7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_b724bfca-bfa6-4685-b63f-c1ec1224bf8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b3152f47-63ae-4908-beb5-e71ef9aa8fa7" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_b724bfca-bfa6-4685-b63f-c1ec1224bf8c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_e27d0609-24c5-4d99-8460-5e9a00feed08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b3152f47-63ae-4908-beb5-e71ef9aa8fa7" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_e27d0609-24c5-4d99-8460-5e9a00feed08" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_45350ac9-f9ae-4865-aab5-3dd2f95ebf9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b3152f47-63ae-4908-beb5-e71ef9aa8fa7" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_45350ac9-f9ae-4865-aab5-3dd2f95ebf9f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_26d169a9-d601-431c-8d83-ca17b39d52d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_15f18dd1-94f4-4df6-8fa2-7d40501bd26b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c94f94e1-5f73-4054-879e-497e2169ea90" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_15f18dd1-94f4-4df6-8fa2-7d40501bd26b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a95f4bde-a9b0-48a9-82d1-24e3bee9e0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c94f94e1-5f73-4054-879e-497e2169ea90" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a95f4bde-a9b0-48a9-82d1-24e3bee9e0c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_7decb353-fedb-47b0-abb8-173baadcc866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a95f4bde-a9b0-48a9-82d1-24e3bee9e0c0" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_7decb353-fedb-47b0-abb8-173baadcc866" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_774a1ad3-6eb5-4b57-b875-6442322e8f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a95f4bde-a9b0-48a9-82d1-24e3bee9e0c0" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_774a1ad3-6eb5-4b57-b875-6442322e8f5e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_776ff4bb-b4ea-4fe8-9067-5a8706a3d450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a95f4bde-a9b0-48a9-82d1-24e3bee9e0c0" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_776ff4bb-b4ea-4fe8-9067-5a8706a3d450" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_a285600b-0d2e-46fb-bc45-4c7fce0b1d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a95f4bde-a9b0-48a9-82d1-24e3bee9e0c0" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_a285600b-0d2e-46fb-bc45-4c7fce0b1d4a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df60ecf0-7e51-4b3e-abd7-7f59203d28e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c94f94e1-5f73-4054-879e-497e2169ea90" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df60ecf0-7e51-4b3e-abd7-7f59203d28e5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_2c94f72e-17b6-47d5-93be-17cf8e37eeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df60ecf0-7e51-4b3e-abd7-7f59203d28e5" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_2c94f72e-17b6-47d5-93be-17cf8e37eeb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_2c94f72e-17b6-47d5-93be-17cf8e37eeb7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_2c94f72e-17b6-47d5-93be-17cf8e37eeb7" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_2c94f72e-17b6-47d5-93be-17cf8e37eeb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_cc0fd86b-3641-4ab0-8978-65f5b5ad525e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_2c94f72e-17b6-47d5-93be-17cf8e37eeb7" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_cc0fd86b-3641-4ab0-8978-65f5b5ad525e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_f83b4dbe-69fd-497b-8760-2444e861f895" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_cc0fd86b-3641-4ab0-8978-65f5b5ad525e" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_f83b4dbe-69fd-497b-8760-2444e861f895" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails" xlink:type="extended" id="i4ef598a3104a40b1b9cef285b0ec846f_PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_44c4f3e9-cc3f-4bff-a87e-1625707d6ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_01adf912-f383-443a-aa10-f5a1d0a44116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_44c4f3e9-cc3f-4bff-a87e-1625707d6ae1" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_01adf912-f383-443a-aa10-f5a1d0a44116" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_1126fb84-7fe7-4bfe-9110-111a1683e680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_01adf912-f383-443a-aa10-f5a1d0a44116" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_1126fb84-7fe7-4bfe-9110-111a1683e680" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e5c82794-d904-4d24-88cd-9a3c32fc6175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_01adf912-f383-443a-aa10-f5a1d0a44116" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e5c82794-d904-4d24-88cd-9a3c32fc6175" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_66e51c3e-ee69-40e3-957b-bab59957d262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_01adf912-f383-443a-aa10-f5a1d0a44116" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_66e51c3e-ee69-40e3-957b-bab59957d262" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_dfb86463-a7ac-4f56-8c19-eb8bda1ebfa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_01adf912-f383-443a-aa10-f5a1d0a44116" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_dfb86463-a7ac-4f56-8c19-eb8bda1ebfa4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_76194acf-9bb2-4284-9583-1798edb5cb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_01adf912-f383-443a-aa10-f5a1d0a44116" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_76194acf-9bb2-4284-9583-1798edb5cb4b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a6e9f1a7-d114-40e9-97f5-5815bcb89d29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_44c4f3e9-cc3f-4bff-a87e-1625707d6ae1" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a6e9f1a7-d114-40e9-97f5-5815bcb89d29" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d1ec1c68-696f-4181-ad08-7e5329b85b01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a6e9f1a7-d114-40e9-97f5-5815bcb89d29" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d1ec1c68-696f-4181-ad08-7e5329b85b01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_d1ec1c68-696f-4181-ad08-7e5329b85b01_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d1ec1c68-696f-4181-ad08-7e5329b85b01" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_d1ec1c68-696f-4181-ad08-7e5329b85b01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f05e98f5-7a11-4d93-bd1d-b68c5ff6329c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d1ec1c68-696f-4181-ad08-7e5329b85b01" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f05e98f5-7a11-4d93-bd1d-b68c5ff6329c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_01d16a75-7c9b-4383-a27d-5fed7a320a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f05e98f5-7a11-4d93-bd1d-b68c5ff6329c" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_01d16a75-7c9b-4383-a27d-5fed7a320a7b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails" xlink:type="extended" id="icbadc7b7953246c5bd4275cb46d9f147_PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_41d80d6f-749d-41b7-bb9a-3f3c13df6bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_3f30103b-aebe-42a4-b590-e6078dbb4e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_41d80d6f-749d-41b7-bb9a-3f3c13df6bdc" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_3f30103b-aebe-42a4-b590-e6078dbb4e7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount_6fd0c80d-4a4a-423d-886e-d5fdfdb4b08e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_41d80d6f-749d-41b7-bb9a-3f3c13df6bdc" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount_6fd0c80d-4a4a-423d-886e-d5fdfdb4b08e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eca33ce3-d8c4-49de-b3e6-91ee4f3d4a85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_41d80d6f-749d-41b7-bb9a-3f3c13df6bdc" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eca33ce3-d8c4-49de-b3e6-91ee4f3d4a85" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_8b1a7f07-f127-4c5e-aeb3-09cf7f445fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eca33ce3-d8c4-49de-b3e6-91ee4f3d4a85" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_8b1a7f07-f127-4c5e-aeb3-09cf7f445fa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_8b1a7f07-f127-4c5e-aeb3-09cf7f445fa3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_8b1a7f07-f127-4c5e-aeb3-09cf7f445fa3" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_8b1a7f07-f127-4c5e-aeb3-09cf7f445fa3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_2745b38f-f10f-47c9-a227-453f1da4e4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_8b1a7f07-f127-4c5e-aeb3-09cf7f445fa3" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_2745b38f-f10f-47c9-a227-453f1da4e4f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_c11c3bb6-7361-4e6b-baf9-901ff4ecfb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_2745b38f-f10f-47c9-a227-453f1da4e4f1" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_c11c3bb6-7361-4e6b-baf9-901ff4ecfb4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_827c1450-d4c5-4332-b54d-6329b887f264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eca33ce3-d8c4-49de-b3e6-91ee4f3d4a85" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_827c1450-d4c5-4332-b54d-6329b887f264" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_827c1450-d4c5-4332-b54d-6329b887f264_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_827c1450-d4c5-4332-b54d-6329b887f264" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_827c1450-d4c5-4332-b54d-6329b887f264_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_fa0fe1b8-9bfa-4eda-abcd-db35f0dcd93c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_827c1450-d4c5-4332-b54d-6329b887f264" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_fa0fe1b8-9bfa-4eda-abcd-db35f0dcd93c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_75eeff39-5ba1-4787-a8e7-c042b1332633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_fa0fe1b8-9bfa-4eda-abcd-db35f0dcd93c" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_75eeff39-5ba1-4787-a8e7-c042b1332633" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_3f82800c-3d7c-4574-9f22-ddc33b8dd092" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_fa0fe1b8-9bfa-4eda-abcd-db35f0dcd93c" xlink:to="loc_us-gaap_DebtSecuritiesMember_3f82800c-3d7c-4574-9f22-ddc33b8dd092" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_01d151e6-cdfd-488d-b8ae-0f0e249b2648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_3f82800c-3d7c-4574-9f22-ddc33b8dd092" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_01d151e6-cdfd-488d-b8ae-0f0e249b2648" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_b414c89c-2fb6-4811-98e8-a18e7472aef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_3f82800c-3d7c-4574-9f22-ddc33b8dd092" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_b414c89c-2fb6-4811-98e8-a18e7472aef1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_b41ef9ff-d2e6-4731-88eb-bbba6ebc8054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_3f82800c-3d7c-4574-9f22-ddc33b8dd092" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_b41ef9ff-d2e6-4731-88eb-bbba6ebc8054" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_bd94d120-b6cb-4c9b-8442-1de4de5e5fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_3f82800c-3d7c-4574-9f22-ddc33b8dd092" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_bd94d120-b6cb-4c9b-8442-1de4de5e5fc4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_4b3c18f8-6468-4153-a189-f5b010d8209e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_3f82800c-3d7c-4574-9f22-ddc33b8dd092" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_4b3c18f8-6468-4153-a189-f5b010d8209e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_79b0b4a5-5fb7-4f64-8c04-1d42f93515fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_3f82800c-3d7c-4574-9f22-ddc33b8dd092" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_79b0b4a5-5fb7-4f64-8c04-1d42f93515fe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_377cf202-1307-4690-9c0d-3dd45405d413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_3f82800c-3d7c-4574-9f22-ddc33b8dd092" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_377cf202-1307-4690-9c0d-3dd45405d413" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RedeemablePreferredSecuritiesMember_fb65611b-e2e6-4a3e-b06d-4a95c8ea9f13" xlink:href="cvs-20230525.xsd#cvs_RedeemablePreferredSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_3f82800c-3d7c-4574-9f22-ddc33b8dd092" xlink:to="loc_cvs_RedeemablePreferredSecuritiesMember_fb65611b-e2e6-4a3e-b06d-4a95c8ea9f13" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_8972d154-5aed-4abc-8b44-36d0ed8db071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_fa0fe1b8-9bfa-4eda-abcd-db35f0dcd93c" xlink:to="loc_us-gaap_EquitySecuritiesMember_8972d154-5aed-4abc-8b44-36d0ed8db071" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_5f0b274e-af63-4923-8863-4804229197bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesMember_8972d154-5aed-4abc-8b44-36d0ed8db071" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_5f0b274e-af63-4923-8863-4804229197bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_adcaabed-5b00-4612-ab10-e09af822056f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesMember_8972d154-5aed-4abc-8b44-36d0ed8db071" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_adcaabed-5b00-4612-ab10-e09af822056f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EquitySecuritiesDomesticRealEstateMember_b016d843-f70e-4a1e-a8b7-1d7a66742d7d" xlink:href="cvs-20230525.xsd#cvs_EquitySecuritiesDomesticRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesMember_8972d154-5aed-4abc-8b44-36d0ed8db071" xlink:to="loc_cvs_EquitySecuritiesDomesticRealEstateMember_b016d843-f70e-4a1e-a8b7-1d7a66742d7d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_a8f0a8a3-d64c-4cf5-823c-e8e9d4d2d668" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_fa0fe1b8-9bfa-4eda-abcd-db35f0dcd93c" xlink:to="loc_us-gaap_OtherInvestmentsMember_a8f0a8a3-d64c-4cf5-823c-e8e9d4d2d668" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRealEstateMember_da2023bb-25cd-4600-8f73-298f695befce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherInvestmentsMember_a8f0a8a3-d64c-4cf5-823c-e8e9d4d2d668" xlink:to="loc_us-gaap_DefinedBenefitPlanRealEstateMember_da2023bb-25cd-4600-8f73-298f695befce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_697a27a4-4c0b-4119-a98a-3748e6286b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherInvestmentsMember_a8f0a8a3-d64c-4cf5-823c-e8e9d4d2d668" xlink:to="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_697a27a4-4c0b-4119-a98a-3748e6286b8a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember_c4b6cd81-8a53-4539-9019-56a6c25c2116" xlink:href="cvs-20230525.xsd#cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_fa0fe1b8-9bfa-4eda-abcd-db35f0dcd93c" xlink:to="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember_c4b6cd81-8a53-4539-9019-56a6c25c2116" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember_1a1cd24e-5b74-4d20-abc9-d2196d6242fe" xlink:href="cvs-20230525.xsd#cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_fa0fe1b8-9bfa-4eda-abcd-db35f0dcd93c" xlink:to="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember_1a1cd24e-5b74-4d20-abc9-d2196d6242fe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_e34bfea1-be81-444d-a269-483ea62dc2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_fa0fe1b8-9bfa-4eda-abcd-db35f0dcd93c" xlink:to="loc_us-gaap_AccountsReceivableMember_e34bfea1-be81-444d-a269-483ea62dc2e3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_aa1158ee-be57-4805-bf3f-75fddd298dda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_fa0fe1b8-9bfa-4eda-abcd-db35f0dcd93c" xlink:to="loc_us-gaap_PrivateEquityFundsMember_aa1158ee-be57-4805-bf3f-75fddd298dda" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_fcc15ee2-36af-42a8-9521-d0680481ee18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_fa0fe1b8-9bfa-4eda-abcd-db35f0dcd93c" xlink:to="loc_us-gaap_HedgeFundsMember_fcc15ee2-36af-42a8-9521-d0680481ee18" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6e654342-f10b-4a3f-8fe0-3d283ad30888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eca33ce3-d8c4-49de-b3e6-91ee4f3d4a85" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6e654342-f10b-4a3f-8fe0-3d283ad30888" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6e654342-f10b-4a3f-8fe0-3d283ad30888_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6e654342-f10b-4a3f-8fe0-3d283ad30888" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6e654342-f10b-4a3f-8fe0-3d283ad30888_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d9f703a-62e7-4947-9920-bb206605f252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6e654342-f10b-4a3f-8fe0-3d283ad30888" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d9f703a-62e7-4947-9920-bb206605f252" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_f68d0297-21c4-4098-a3fa-2966eb3a363d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d9f703a-62e7-4947-9920-bb206605f252" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_f68d0297-21c4-4098-a3fa-2966eb3a363d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_df794c2e-3d6b-4a76-b4dd-26f8b52a9fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_f68d0297-21c4-4098-a3fa-2966eb3a363d" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_df794c2e-3d6b-4a76-b4dd-26f8b52a9fd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_711da380-4fec-40d1-805b-9f34565b22db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_f68d0297-21c4-4098-a3fa-2966eb3a363d" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_711da380-4fec-40d1-805b-9f34565b22db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3ae1e252-321e-4e04-b035-90c21e044c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_f68d0297-21c4-4098-a3fa-2966eb3a363d" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3ae1e252-321e-4e04-b035-90c21e044c3f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_56d338e2-cc3e-4dd9-ad60-67cc79e636ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d9f703a-62e7-4947-9920-bb206605f252" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_56d338e2-cc3e-4dd9-ad60-67cc79e636ea" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails" xlink:type="extended" id="i2d518d6e090b46c78da68f3ae22c844c_PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a8892fbb-4798-487d-a450-f907db178f03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f8a2f08d-7c77-4a07-8a54-bc3701f38f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a8892fbb-4798-487d-a450-f907db178f03" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f8a2f08d-7c77-4a07-8a54-bc3701f38f69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_0f2e5aa5-c206-4919-9987-713286def3a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f8a2f08d-7c77-4a07-8a54-bc3701f38f69" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_0f2e5aa5-c206-4919-9987-713286def3a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_c2242224-0794-4c9e-9145-8dfbee696b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f8a2f08d-7c77-4a07-8a54-bc3701f38f69" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_c2242224-0794-4c9e-9145-8dfbee696b2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_085814eb-ee68-4c77-8e91-b92dfe8523fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f8a2f08d-7c77-4a07-8a54-bc3701f38f69" xlink:to="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_085814eb-ee68-4c77-8e91-b92dfe8523fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels_0b43e96a-eb44-4f4b-892e-25fb1288df16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f8a2f08d-7c77-4a07-8a54-bc3701f38f69" xlink:to="loc_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels_0b43e96a-eb44-4f4b-892e-25fb1288df16" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_66e0b658-9046-4953-bcb3-745ad957cd81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_2d6bdce5-8127-439f-bc58-6ac99b3ffe3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a8892fbb-4798-487d-a450-f907db178f03" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_2d6bdce5-8127-439f-bc58-6ac99b3ffe3f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_19930d7c-7498-4ff4-8042-1a5ab0500812" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_2d6bdce5-8127-439f-bc58-6ac99b3ffe3f" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_19930d7c-7498-4ff4-8042-1a5ab0500812" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_19930d7c-7498-4ff4-8042-1a5ab0500812_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_19930d7c-7498-4ff4-8042-1a5ab0500812" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_19930d7c-7498-4ff4-8042-1a5ab0500812_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_2961a1db-46d7-4b35-a9a7-1afb076bf7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_19930d7c-7498-4ff4-8042-1a5ab0500812" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_2961a1db-46d7-4b35-a9a7-1afb076bf7ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRealEstateMember_156cb3ac-14c6-4e41-84d4-07d1a8ad3cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2961a1db-46d7-4b35-a9a7-1afb076bf7ff" xlink:to="loc_us-gaap_DefinedBenefitPlanRealEstateMember_156cb3ac-14c6-4e41-84d4-07d1a8ad3cbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a40d0e2c-fc25-4686-9d2a-3084bf747839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_2d6bdce5-8127-439f-bc58-6ac99b3ffe3f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a40d0e2c-fc25-4686-9d2a-3084bf747839" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a40d0e2c-fc25-4686-9d2a-3084bf747839_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a40d0e2c-fc25-4686-9d2a-3084bf747839" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a40d0e2c-fc25-4686-9d2a-3084bf747839_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_15159647-fa31-4c06-aba3-0a4631594cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a40d0e2c-fc25-4686-9d2a-3084bf747839" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_15159647-fa31-4c06-aba3-0a4631594cc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_6551dfd7-fcd2-474a-b594-ade2d6e8ec23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_15159647-fa31-4c06-aba3-0a4631594cc7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_6551dfd7-fcd2-474a-b594-ade2d6e8ec23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_4200183c-07de-4bae-81d8-e65218fc4408" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_2d6bdce5-8127-439f-bc58-6ac99b3ffe3f" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_4200183c-07de-4bae-81d8-e65218fc4408" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_4200183c-07de-4bae-81d8-e65218fc4408_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_4200183c-07de-4bae-81d8-e65218fc4408" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_4200183c-07de-4bae-81d8-e65218fc4408_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0964474c-b639-4881-a08b-b0864aeb2086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_4200183c-07de-4bae-81d8-e65218fc4408" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0964474c-b639-4881-a08b-b0864aeb2086" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_af62c427-4d76-45d7-8938-70ab05184650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_0964474c-b639-4881-a08b-b0864aeb2086" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_af62c427-4d76-45d7-8938-70ab05184650" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails" xlink:type="extended" id="ia6d3cba4f81b42bda8479939bd324d65_PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb8de277-8100-4387-a5a4-0f2db1e2b9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_dea8a566-9181-4321-a8ad-4c70c0148bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb8de277-8100-4387-a5a4-0f2db1e2b9a2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_dea8a566-9181-4321-a8ad-4c70c0148bc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_34635227-b6d1-4be3-8884-511b74ea3068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb8de277-8100-4387-a5a4-0f2db1e2b9a2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_34635227-b6d1-4be3-8884-511b74ea3068" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_b7b77696-1c5c-474c-a1cd-15711fdd1346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb8de277-8100-4387-a5a4-0f2db1e2b9a2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_b7b77696-1c5c-474c-a1cd-15711fdd1346" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_78d8a02b-647c-4674-914c-083d0fc7dfb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb8de277-8100-4387-a5a4-0f2db1e2b9a2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_78d8a02b-647c-4674-914c-083d0fc7dfb2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_f31d0af0-5a95-4d51-9c64-df4e4fd94727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb8de277-8100-4387-a5a4-0f2db1e2b9a2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_f31d0af0-5a95-4d51-9c64-df4e4fd94727" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_1f9a3ffd-4783-45ea-acfe-02227202c0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb8de277-8100-4387-a5a4-0f2db1e2b9a2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_1f9a3ffd-4783-45ea-acfe-02227202c0c7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4226cfc3-28f4-4351-87b1-a8a9b200136f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb8de277-8100-4387-a5a4-0f2db1e2b9a2" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4226cfc3-28f4-4351-87b1-a8a9b200136f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_864bda9c-11fd-4113-b17a-a39d61bca528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4226cfc3-28f4-4351-87b1-a8a9b200136f" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_864bda9c-11fd-4113-b17a-a39d61bca528" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_864bda9c-11fd-4113-b17a-a39d61bca528_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_864bda9c-11fd-4113-b17a-a39d61bca528" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_864bda9c-11fd-4113-b17a-a39d61bca528_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_fadbd8fb-0c4b-4751-920f-c7e3c0672767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_864bda9c-11fd-4113-b17a-a39d61bca528" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_fadbd8fb-0c4b-4751-920f-c7e3c0672767" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_3d1c9b01-fdc5-4f3e-8cd8-b9eec8377dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_fadbd8fb-0c4b-4751-920f-c7e3c0672767" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_3d1c9b01-fdc5-4f3e-8cd8-b9eec8377dd9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e6891d6b-38e9-4246-8448-8bfc855538db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_fadbd8fb-0c4b-4751-920f-c7e3c0672767" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e6891d6b-38e9-4246-8448-8bfc855538db" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended" id="i8f52722240b74da48573e9ad6c21a579_IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceLineItems_7f6dfd77-8fdc-491b-9aec-dfcaa109716e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_7f6dfd77-8fdc-491b-9aec-dfcaa109716e" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_83ac6362-1619-473e-8791-ee3f8ea538da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_83ac6362-1619-473e-8791-ee3f8ea538da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements_525ab7e3-c23f-454c-acdc-2e597b88f154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements_525ab7e3-c23f-454c-acdc-2e597b88f154" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_49abc900-a1e3-4036-adfc-f2c8d43db533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_49abc900-a1e3-4036-adfc-f2c8d43db533" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_c9a17226-dd90-4854-a77a-4c8c9d392dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_c9a17226-dd90-4854-a77a-4c8c9d392dd8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_0ee586af-245e-431a-a25a-468b484a832c" xlink:href="cvs-20230525.xsd#cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_0ee586af-245e-431a-a25a-468b484a832c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_385b2e7d-871f-44bc-b965-01a42d6d5d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_385b2e7d-871f-44bc-b965-01a42d6d5d85" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_9a2518c0-9300-4009-a3dc-7a10310e2b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_9a2518c0-9300-4009-a3dc-7a10310e2b8f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_e76ec482-04ee-4037-9aaf-389611941d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_e76ec482-04ee-4037-9aaf-389611941d2f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments_3962f039-4558-40b6-8ea7-39c1f65be552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_us-gaap_DeferredTaxAssetsInvestments_3962f039-4558-40b6-8ea7-39c1f65be552" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxAssetsPayrollTaxDeferral_ccee8a78-9bf7-4b2d-a1ab-99485a38e171" xlink:href="cvs-20230525.xsd#cvs_DeferredTaxAssetsPayrollTaxDeferral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_cvs_DeferredTaxAssetsPayrollTaxDeferral_ccee8a78-9bf7-4b2d-a1ab-99485a38e171" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_424b1746-ec76-43a0-9eb6-5aea9a899862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_424b1746-ec76-43a0-9eb6-5aea9a899862" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_6b439642-4028-45ef-81fa-ebfd6c15a790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_6b439642-4028-45ef-81fa-ebfd6c15a790" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_34f546bd-3146-4ea7-9694-7c57dc370a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_34f546bd-3146-4ea7-9694-7c57dc370a99" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_74ed2a32-49b8-4cdb-90ca-3447eb7561d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_7f6dfd77-8fdc-491b-9aec-dfcaa109716e" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_74ed2a32-49b8-4cdb-90ca-3447eb7561d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxLiabilitiesRetirementBenefits_393e28dd-c13f-47d3-b0f5-224556f3582b" xlink:href="cvs-20230525.xsd#cvs_DeferredTaxLiabilitiesRetirementBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_74ed2a32-49b8-4cdb-90ca-3447eb7561d8" xlink:to="loc_cvs_DeferredTaxLiabilitiesRetirementBenefits_393e28dd-c13f-47d3-b0f5-224556f3582b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments_010f2e9e-d274-40aa-953f-6400419ee9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_74ed2a32-49b8-4cdb-90ca-3447eb7561d8" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestments_010f2e9e-d274-40aa-953f-6400419ee9fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_0dccd7fe-177e-458b-9be0-a335a35f52c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_74ed2a32-49b8-4cdb-90ca-3447eb7561d8" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_0dccd7fe-177e-458b-9be0-a335a35f52c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_1cd0badd-eea5-4294-82ed-db179e162956" xlink:href="cvs-20230525.xsd#cvs_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_74ed2a32-49b8-4cdb-90ca-3447eb7561d8" xlink:to="loc_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_1cd0badd-eea5-4294-82ed-db179e162956" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_02520713-ba8a-4286-86f0-e9941b455b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_7f6dfd77-8fdc-491b-9aec-dfcaa109716e" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_02520713-ba8a-4286-86f0-e9941b455b7e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_3d60fe33-6069-4f26-b037-450ab8b9cbf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_7f6dfd77-8fdc-491b-9aec-dfcaa109716e" xlink:to="loc_us-gaap_DeferredTaxLiabilities_3d60fe33-6069-4f26-b037-450ab8b9cbf5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceTable_50501960-f30d-4d44-8f7b-9bb7c4b2df78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_7f6dfd77-8fdc-491b-9aec-dfcaa109716e" xlink:to="loc_us-gaap_ValuationAllowanceTable_50501960-f30d-4d44-8f7b-9bb7c4b2df78" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b28111d6-da3e-4568-8cef-de94afb1ca82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ValuationAllowanceTable_50501960-f30d-4d44-8f7b-9bb7c4b2df78" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b28111d6-da3e-4568-8cef-de94afb1ca82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b28111d6-da3e-4568-8cef-de94afb1ca82_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b28111d6-da3e-4568-8cef-de94afb1ca82" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b28111d6-da3e-4568-8cef-de94afb1ca82_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3d3a8bec-1ce5-4480-b9af-cc012b221262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b28111d6-da3e-4568-8cef-de94afb1ca82" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3d3a8bec-1ce5-4480-b9af-cc012b221262" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_e6b633fd-b9df-42b4-9677-3f40ff03be49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_3d3a8bec-1ce5-4480-b9af-cc012b221262" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_e6b633fd-b9df-42b4-9677-3f40ff03be49" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails" xlink:type="extended" id="ibde86123b02d48b699869bcbc687ea27_StockIncentivePlansStockBasedCompensationExpenseandESPPDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_72a01520-36c2-4e9e-9799-13b9dd78dda7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_72a01520-36c2-4e9e-9799-13b9dd78dda7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_7f0f4616-4812-42c3-9c7b-5d2b27c44bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_7f0f4616-4812-42c3-9c7b-5d2b27c44bbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_d14208b9-685a-4135-b25c-09a463b02dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_d14208b9-685a-4135-b25c-09a463b02dd4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_fa495c64-c323-4626-be0e-ec1dfaea0dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_fa495c64-c323-4626-be0e-ec1dfaea0dc0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_854e9560-5c03-47de-af8f-3923449c3ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_854e9560-5c03-47de-af8f-3923449c3ad9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_bd0feb1c-4338-4719-9499-1b23674a2da7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_bd0feb1c-4338-4719-9499-1b23674a2da7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8a096eb7-e3fd-4b8f-9625-58048e62f4da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8a096eb7-e3fd-4b8f-9625-58048e62f4da" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_fab8829e-6699-4f91-92da-e5184d3ea737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_fab8829e-6699-4f91-92da-e5184d3ea737" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_6bbc6482-bc07-4f1a-90b1-a17412483022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_6bbc6482-bc07-4f1a-90b1-a17412483022" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_c1a6b5de-c624-4d71-9304-6eeec7e8ba9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_c1a6b5de-c624-4d71-9304-6eeec7e8ba9c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber_c43a3bcc-533d-4d81-bdeb-4068b505de95" xlink:href="cvs-20230525.xsd#cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber_c43a3bcc-533d-4d81-bdeb-4068b505de95" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_a09328fd-b276-4360-bf2a-4dc06bff9d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_a09328fd-b276-4360-bf2a-4dc06bff9d54" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_4097e186-ed78-4e5d-8128-6a0fd37eb960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_4097e186-ed78-4e5d-8128-6a0fd37eb960" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased_2d619802-39eb-4184-9276-e7f4a5f2fc35" xlink:href="cvs-20230525.xsd#cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased_2d619802-39eb-4184-9276-e7f4a5f2fc35" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f3ce5aa6-0fb0-46c4-8096-81f233e02155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f3ce5aa6-0fb0-46c4-8096-81f233e02155" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_adc97a18-d932-4ac9-8eef-7db28389a41e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f3ce5aa6-0fb0-46c4-8096-81f233e02155" xlink:to="loc_us-gaap_PlanNameAxis_adc97a18-d932-4ac9-8eef-7db28389a41e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_adc97a18-d932-4ac9-8eef-7db28389a41e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_adc97a18-d932-4ac9-8eef-7db28389a41e" xlink:to="loc_us-gaap_PlanNameDomain_adc97a18-d932-4ac9-8eef-7db28389a41e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_0b24281e-2963-4693-8c67-a22e9f33f93f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_adc97a18-d932-4ac9-8eef-7db28389a41e" xlink:to="loc_us-gaap_PlanNameDomain_0b24281e-2963-4693-8c67-a22e9f33f93f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CVSHealth2017IncentiveCompensationPlanMember_dbbd007e-7437-45fb-bfc5-8fb59e7a996c" xlink:href="cvs-20230525.xsd#cvs_CVSHealth2017IncentiveCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_0b24281e-2963-4693-8c67-a22e9f33f93f" xlink:to="loc_cvs_CVSHealth2017IncentiveCompensationPlanMember_dbbd007e-7437-45fb-bfc5-8fb59e7a996c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AetnaInc2010StockIncentivePlanMember_2fe00791-af4a-4790-8f96-ea7e5bd2c4ec" xlink:href="cvs-20230525.xsd#cvs_AetnaInc2010StockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_0b24281e-2963-4693-8c67-a22e9f33f93f" xlink:to="loc_cvs_AetnaInc2010StockIncentivePlanMember_2fe00791-af4a-4790-8f96-ea7e5bd2c4ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_248b2646-38c1-42d2-88ea-b2e2682ca862" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f3ce5aa6-0fb0-46c4-8096-81f233e02155" xlink:to="loc_srt_RangeAxis_248b2646-38c1-42d2-88ea-b2e2682ca862" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_248b2646-38c1-42d2-88ea-b2e2682ca862_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_248b2646-38c1-42d2-88ea-b2e2682ca862" xlink:to="loc_srt_RangeMember_248b2646-38c1-42d2-88ea-b2e2682ca862_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dab15b30-8bd9-4c5c-b67f-0128dafe84fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_248b2646-38c1-42d2-88ea-b2e2682ca862" xlink:to="loc_srt_RangeMember_dab15b30-8bd9-4c5c-b67f-0128dafe84fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6f26dbd6-ad50-4d83-9408-be49f51276f7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dab15b30-8bd9-4c5c-b67f-0128dafe84fe" xlink:to="loc_srt_MinimumMember_6f26dbd6-ad50-4d83-9408-be49f51276f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4855f56f-e859-45ba-bfdf-a485a3e4f9a7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dab15b30-8bd9-4c5c-b67f-0128dafe84fe" xlink:to="loc_srt_MaximumMember_4855f56f-e859-45ba-bfdf-a485a3e4f9a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e94c0a55-2d23-43f1-955b-6fc31ac3d8da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f3ce5aa6-0fb0-46c4-8096-81f233e02155" xlink:to="loc_us-gaap_AwardTypeAxis_e94c0a55-2d23-43f1-955b-6fc31ac3d8da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e94c0a55-2d23-43f1-955b-6fc31ac3d8da_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e94c0a55-2d23-43f1-955b-6fc31ac3d8da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e94c0a55-2d23-43f1-955b-6fc31ac3d8da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ba541d6-f293-4fed-9554-62a2b5a3fe30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e94c0a55-2d23-43f1-955b-6fc31ac3d8da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ba541d6-f293-4fed-9554-62a2b5a3fe30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember_350d9ed5-5bea-4387-bdaf-cfe8d7cc361e" xlink:href="cvs-20230525.xsd#cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ba541d6-f293-4fed-9554-62a2b5a3fe30" xlink:to="loc_cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember_350d9ed5-5bea-4387-bdaf-cfe8d7cc361e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EmployeeStockOptionsAndStockAppreciationRightsMember_6011d75d-ea9c-44d1-94da-4cc81381f807" xlink:href="cvs-20230525.xsd#cvs_EmployeeStockOptionsAndStockAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ba541d6-f293-4fed-9554-62a2b5a3fe30" xlink:to="loc_cvs_EmployeeStockOptionsAndStockAppreciationRightsMember_6011d75d-ea9c-44d1-94da-4cc81381f807" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_addd2432-5ade-4298-be85-f57a0166bfef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ba541d6-f293-4fed-9554-62a2b5a3fe30" xlink:to="loc_us-gaap_EmployeeStockMember_addd2432-5ade-4298-be85-f57a0166bfef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_85027d20-0617-4426-a85c-635a1fa3aac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ba541d6-f293-4fed-9554-62a2b5a3fe30" xlink:to="loc_us-gaap_EmployeeStockOptionMember_85027d20-0617-4426-a85c-635a1fa3aac5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_2c493691-7216-426c-97d8-a235bced8240" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ba541d6-f293-4fed-9554-62a2b5a3fe30" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_2c493691-7216-426c-97d8-a235bced8240" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#StockIncentivePlansRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails" xlink:type="extended" id="ia3d581d9f87b44d597829e410acd1860_StockIncentivePlansRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_711d6b8d-9ce9-42b9-aca9-cb207f327966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b4d56344-78cc-4068-a180-7687b7448048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_711d6b8d-9ce9-42b9-aca9-cb207f327966" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b4d56344-78cc-4068-a180-7687b7448048" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a568a74f-1e8a-4b0a-b217-8c37b7b3ea8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b4d56344-78cc-4068-a180-7687b7448048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a568a74f-1e8a-4b0a-b217-8c37b7b3ea8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1e6efe08-186b-4e26-a9d8-c27bff2a6fed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b4d56344-78cc-4068-a180-7687b7448048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1e6efe08-186b-4e26-a9d8-c27bff2a6fed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1c518307-60ee-4cac-8d13-af734a543c68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b4d56344-78cc-4068-a180-7687b7448048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1c518307-60ee-4cac-8d13-af734a543c68" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2758e616-4672-4b64-8838-9e4afb3c4a86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b4d56344-78cc-4068-a180-7687b7448048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2758e616-4672-4b64-8838-9e4afb3c4a86" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_695fe9cd-cf71-482a-9624-97cd05dc43da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69a13c9d-d522-48ea-b888-b255adf6a908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_711d6b8d-9ce9-42b9-aca9-cb207f327966" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69a13c9d-d522-48ea-b888-b255adf6a908" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5ef6a27f-8297-4de2-8449-684b6cb152ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69a13c9d-d522-48ea-b888-b255adf6a908" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5ef6a27f-8297-4de2-8449-684b6cb152ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_943ca40b-ab38-4d7a-9b91-bf50b985dc3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69a13c9d-d522-48ea-b888-b255adf6a908" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_943ca40b-ab38-4d7a-9b91-bf50b985dc3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c776c53c-110e-4a4b-b9f0-a72c193e13a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69a13c9d-d522-48ea-b888-b255adf6a908" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c776c53c-110e-4a4b-b9f0-a72c193e13a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_09c6c10a-c8cc-44ed-a23c-be5e1bcffda0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69a13c9d-d522-48ea-b888-b255adf6a908" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_09c6c10a-c8cc-44ed-a23c-be5e1bcffda0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_16b2dba4-b295-4980-ab59-f66fc4bb63f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates_25dbccf6-802f-4bc5-a843-9463c1fed13d" xlink:href="cvs-20230525.xsd#cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_711d6b8d-9ce9-42b9-aca9-cb207f327966" xlink:to="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates_25dbccf6-802f-4bc5-a843-9463c1fed13d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2a3fac-597c-47e4-bed3-b20de3567c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_711d6b8d-9ce9-42b9-aca9-cb207f327966" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2a3fac-597c-47e4-bed3-b20de3567c96" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_de636a23-c120-47b0-a994-1f5aa3af17fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2a3fac-597c-47e4-bed3-b20de3567c96" xlink:to="loc_us-gaap_AwardTypeAxis_de636a23-c120-47b0-a994-1f5aa3af17fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_de636a23-c120-47b0-a994-1f5aa3af17fb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_de636a23-c120-47b0-a994-1f5aa3af17fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_de636a23-c120-47b0-a994-1f5aa3af17fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c3ccaa66-fd94-455d-b47d-5879fc24d9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_de636a23-c120-47b0-a994-1f5aa3af17fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c3ccaa66-fd94-455d-b47d-5879fc24d9a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember_ac4b580b-5066-42fd-b93b-1a09ec39af7c" xlink:href="cvs-20230525.xsd#cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c3ccaa66-fd94-455d-b47d-5879fc24d9a5" xlink:to="loc_cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember_ac4b580b-5066-42fd-b93b-1a09ec39af7c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#StockIncentivePlansStockOptionandSARActivityDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails" xlink:type="extended" id="i82b33e7bf35f4662ae1f811111f9898e_StockIncentivePlansStockOptionandSARActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b0e982c5-6f30-4a36-943c-395a45387af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_4f05dc54-8235-4f6d-a3a1-d2a60566bfd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b0e982c5-6f30-4a36-943c-395a45387af9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_4f05dc54-8235-4f6d-a3a1-d2a60566bfd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_18b6da20-f23c-416c-a126-3af06639dc16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b0e982c5-6f30-4a36-943c-395a45387af9" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_18b6da20-f23c-416c-a126-3af06639dc16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c0aafbb2-4ae7-488b-8cbb-2a0e140b1cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b0e982c5-6f30-4a36-943c-395a45387af9" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c0aafbb2-4ae7-488b-8cbb-2a0e140b1cc0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_414aa0ae-ff2e-44b5-a9e8-cc94fcd7336d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b0e982c5-6f30-4a36-943c-395a45387af9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_414aa0ae-ff2e-44b5-a9e8-cc94fcd7336d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue_eb7f829d-98a8-417c-9577-8bae999f38b6" xlink:href="cvs-20230525.xsd#cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b0e982c5-6f30-4a36-943c-395a45387af9" xlink:to="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue_eb7f829d-98a8-417c-9577-8bae999f38b6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1a24c4d9-2ee1-4375-bd53-7e87200d8aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b0e982c5-6f30-4a36-943c-395a45387af9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1a24c4d9-2ee1-4375-bd53-7e87200d8aea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6394bf00-b6b8-473b-b79a-3f79f88e823a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1a24c4d9-2ee1-4375-bd53-7e87200d8aea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6394bf00-b6b8-473b-b79a-3f79f88e823a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_af2c1e73-9f13-45cc-af97-3245c9fe6e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1a24c4d9-2ee1-4375-bd53-7e87200d8aea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_af2c1e73-9f13-45cc-af97-3245c9fe6e70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0dd71e51-2c79-4b4b-b350-61404a9d62cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1a24c4d9-2ee1-4375-bd53-7e87200d8aea" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0dd71e51-2c79-4b4b-b350-61404a9d62cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_b4e22651-02c7-49ae-9727-8668735a2e24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1a24c4d9-2ee1-4375-bd53-7e87200d8aea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_b4e22651-02c7-49ae-9727-8668735a2e24" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_bedb5d90-7e60-4a6c-9a7a-3b147d7adb1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1a24c4d9-2ee1-4375-bd53-7e87200d8aea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_bedb5d90-7e60-4a6c-9a7a-3b147d7adb1e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8bd7dd0f-3749-498e-875a-942de58d9d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d0e1c945-8cde-4594-b440-d5e5ed6f9a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b0e982c5-6f30-4a36-943c-395a45387af9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d0e1c945-8cde-4594-b440-d5e5ed6f9a7e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_92008ed7-506a-4147-b136-95b9065c2596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d0e1c945-8cde-4594-b440-d5e5ed6f9a7e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_92008ed7-506a-4147-b136-95b9065c2596" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_285df79e-75bd-47eb-a327-2ade2d64ca9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d0e1c945-8cde-4594-b440-d5e5ed6f9a7e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_285df79e-75bd-47eb-a327-2ade2d64ca9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_23510773-a82d-4bb9-a670-c071462f9196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d0e1c945-8cde-4594-b440-d5e5ed6f9a7e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_23510773-a82d-4bb9-a670-c071462f9196" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_a5f3efe8-b263-4add-aa0f-2be22eaf3ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d0e1c945-8cde-4594-b440-d5e5ed6f9a7e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_a5f3efe8-b263-4add-aa0f-2be22eaf3ec3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_ec9eae40-425b-4e9c-9a18-56b2dafad336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d0e1c945-8cde-4594-b440-d5e5ed6f9a7e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_ec9eae40-425b-4e9c-9a18-56b2dafad336" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b2823aac-ead0-41bb-96a0-9b7b7c68e794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b0e982c5-6f30-4a36-943c-395a45387af9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5dbd6ecd-c560-43b8-b229-0ccf06e359ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5dbd6ecd-c560-43b8-b229-0ccf06e359ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_bd1367b7-7bd6-4013-8819-2c0c510dc84a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_bd1367b7-7bd6-4013-8819-2c0c510dc84a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_86f4efb9-028a-4b3c-ae0b-450c7035db8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_86f4efb9-028a-4b3c-ae0b-450c7035db8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_5f07b445-a08d-4662-b338-c6d551885f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_5f07b445-a08d-4662-b338-c6d551885f5e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_fef8d7ee-9ce5-4d47-b8e3-0ccdcf508163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_fef8d7ee-9ce5-4d47-b8e3-0ccdcf508163" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_d24d972b-82e6-47db-b25a-3b15a0fac6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_d24d972b-82e6-47db-b25a-3b15a0fac6dc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_081fcb1c-30b7-4949-bc7d-78e1db91ce11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_081fcb1c-30b7-4949-bc7d-78e1db91ce11" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_4666126a-14dd-436b-a0d7-c8c59960a13d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_4666126a-14dd-436b-a0d7-c8c59960a13d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ae0c99de-8378-4009-bcf3-51d8480622b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ae0c99de-8378-4009-bcf3-51d8480622b4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_92912d7e-3692-4338-a519-2c7ada94b279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_92912d7e-3692-4338-a519-2c7ada94b279" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b625123f-6ab1-4c89-a563-c4c5a27334f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b0e982c5-6f30-4a36-943c-395a45387af9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b625123f-6ab1-4c89-a563-c4c5a27334f4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_58047db9-9613-4a75-90d5-3089f3883aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b625123f-6ab1-4c89-a563-c4c5a27334f4" xlink:to="loc_us-gaap_AwardTypeAxis_58047db9-9613-4a75-90d5-3089f3883aed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58047db9-9613-4a75-90d5-3089f3883aed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_58047db9-9613-4a75-90d5-3089f3883aed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58047db9-9613-4a75-90d5-3089f3883aed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1eef0f54-21fc-4acf-a693-8656e494c94c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_58047db9-9613-4a75-90d5-3089f3883aed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1eef0f54-21fc-4acf-a693-8656e494c94c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member_a4235ad9-670b-4141-a911-403363aeb3b8" xlink:href="cvs-20230525.xsd#cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1eef0f54-21fc-4acf-a693-8656e494c94c" xlink:to="loc_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member_a4235ad9-670b-4141-a911-403363aeb3b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member_26c83fef-4989-4b24-9554-4df170792c76" xlink:href="cvs-20230525.xsd#cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1eef0f54-21fc-4acf-a693-8656e494c94c" xlink:to="loc_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member_26c83fef-4989-4b24-9554-4df170792c76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_944ef21c-a4ba-4de4-acc4-f50198c76eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1eef0f54-21fc-4acf-a693-8656e494c94c" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_944ef21c-a4ba-4de4-acc4-f50198c76eaf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EmployeeStockOptionsAndStockAppreciationRightsMember_4cb1a611-acc2-4488-a323-e97ac2ead76c" xlink:href="cvs-20230525.xsd#cvs_EmployeeStockOptionsAndStockAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1eef0f54-21fc-4acf-a693-8656e494c94c" xlink:to="loc_cvs_EmployeeStockOptionsAndStockAppreciationRightsMember_4cb1a611-acc2-4488-a323-e97ac2ead76c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansValuationAssumptionsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#StockIncentivePlansValuationAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansValuationAssumptionsDetails" xlink:type="extended" id="ifdb65d378ef743f9977433c0f143a6cc_StockIncentivePlansValuationAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e17e6f8c-c4e2-46bc-a7f1-f83f068e6505" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7a26f35c-da10-4a78-a6b9-9224a045960d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e17e6f8c-c4e2-46bc-a7f1-f83f068e6505" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7a26f35c-da10-4a78-a6b9-9224a045960d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_5063bd5c-a4f7-4f2b-a5e3-6109edc756e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e17e6f8c-c4e2-46bc-a7f1-f83f068e6505" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_5063bd5c-a4f7-4f2b-a5e3-6109edc756e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_b6c37225-b4e8-4411-8cec-c0e466ac3c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e17e6f8c-c4e2-46bc-a7f1-f83f068e6505" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_b6c37225-b4e8-4411-8cec-c0e466ac3c2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_86dfe06c-546f-4f76-a777-4bd86c3a13ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e17e6f8c-c4e2-46bc-a7f1-f83f068e6505" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_86dfe06c-546f-4f76-a777-4bd86c3a13ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a0990db3-d107-4c90-926d-b84170322637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e17e6f8c-c4e2-46bc-a7f1-f83f068e6505" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a0990db3-d107-4c90-926d-b84170322637" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_89043152-8375-426c-a5b3-15cae9f3aac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e17e6f8c-c4e2-46bc-a7f1-f83f068e6505" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_89043152-8375-426c-a5b3-15cae9f3aac5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4da9badb-c09d-4c24-8fdd-c5e4536da36e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_89043152-8375-426c-a5b3-15cae9f3aac5" xlink:to="loc_us-gaap_AwardTypeAxis_4da9badb-c09d-4c24-8fdd-c5e4536da36e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4da9badb-c09d-4c24-8fdd-c5e4536da36e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_4da9badb-c09d-4c24-8fdd-c5e4536da36e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4da9badb-c09d-4c24-8fdd-c5e4536da36e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d7b35e57-cf98-43c2-8b80-05f9d6f6ab44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_4da9badb-c09d-4c24-8fdd-c5e4536da36e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d7b35e57-cf98-43c2-8b80-05f9d6f6ab44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_9fabc564-bcef-487f-b0d6-dc7da9aafef8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d7b35e57-cf98-43c2-8b80-05f9d6f6ab44" xlink:to="loc_us-gaap_EmployeeStockMember_9fabc564-bcef-487f-b0d6-dc7da9aafef8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_330370be-c39e-400e-80a8-85b5d5f7ac50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d7b35e57-cf98-43c2-8b80-05f9d6f6ab44" xlink:to="loc_us-gaap_EmployeeStockOptionMember_330370be-c39e-400e-80a8-85b5d5f7ac50" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#ShareholdersEquityShareRepurchasesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails" xlink:type="extended" id="ia706a5198f264dd09d1f22cd746ec55a_ShareholdersEquityShareRepurchasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_472c9d23-daaa-4d7c-b50c-dc555c4c2341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_aa4e7c22-df30-47a6-99fc-5655e945595b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_472c9d23-daaa-4d7c-b50c-dc555c4c2341" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_aa4e7c22-df30-47a6-99fc-5655e945595b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_8b8d676d-d723-4d6d-a32b-25bceb1dc2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_472c9d23-daaa-4d7c-b50c-dc555c4c2341" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_8b8d676d-d723-4d6d-a32b-25bceb1dc2a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_cd09b701-48de-4b36-94d3-278fa06eba3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_472c9d23-daaa-4d7c-b50c-dc555c4c2341" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_cd09b701-48de-4b36-94d3-278fa06eba3c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_96e01975-4993-4ece-b4a6-a91161889de6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_472c9d23-daaa-4d7c-b50c-dc555c4c2341" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_96e01975-4993-4ece-b4a6-a91161889de6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_f44706b6-d675-42ba-b0ba-9d85d3513ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_472c9d23-daaa-4d7c-b50c-dc555c4c2341" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_f44706b6-d675-42ba-b0ba-9d85d3513ccf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_130a0864-2c96-4ff8-a789-63e0a61e9e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_f44706b6-d675-42ba-b0ba-9d85d3513ccf" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_130a0864-2c96-4ff8-a789-63e0a61e9e3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_130a0864-2c96-4ff8-a789-63e0a61e9e3d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_130a0864-2c96-4ff8-a789-63e0a61e9e3d" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_130a0864-2c96-4ff8-a789-63e0a61e9e3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_392d0214-d868-4776-b547-1803e5ae63de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_130a0864-2c96-4ff8-a789-63e0a61e9e3d" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_392d0214-d868-4776-b547-1803e5ae63de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2022RepurchaseProgramMember_d4a8d06b-99bc-42be-8384-e7bc997c1b05" xlink:href="cvs-20230525.xsd#cvs_A2022RepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_392d0214-d868-4776-b547-1803e5ae63de" xlink:to="loc_cvs_A2022RepurchaseProgramMember_d4a8d06b-99bc-42be-8384-e7bc997c1b05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2021RepurchaseProgramMember_4b398169-fcbb-442d-9458-9df6a520f7d0" xlink:href="cvs-20230525.xsd#cvs_A2021RepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_392d0214-d868-4776-b547-1803e5ae63de" xlink:to="loc_cvs_A2021RepurchaseProgramMember_4b398169-fcbb-442d-9458-9df6a520f7d0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#ShareholdersEquityAcceleratedShareRepurchasesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails" xlink:type="extended" id="i59fc1b89e74e45f3ae1c4735611edc14_ShareholdersEquityAcceleratedShareRepurchasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f747c4eb-cbf0-4aee-b291-794796129052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesAgreementAmount_657101a3-22b9-472d-b798-22738eb14df4" xlink:href="cvs-20230525.xsd#cvs_AcceleratedShareRepurchasesAgreementAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f747c4eb-cbf0-4aee-b291-794796129052" xlink:to="loc_cvs_AcceleratedShareRepurchasesAgreementAmount_657101a3-22b9-472d-b798-22738eb14df4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount_d190c140-53e6-4639-8844-f037fdbbaac8" xlink:href="cvs-20230525.xsd#cvs_PaymentsForAcceleratedShareRepurchasesAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f747c4eb-cbf0-4aee-b291-794796129052" xlink:to="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount_d190c140-53e6-4639-8844-f037fdbbaac8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_10d43a1c-b18f-4ed1-8122-c337ba73f832" xlink:href="cvs-20230525.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f747c4eb-cbf0-4aee-b291-794796129052" xlink:to="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_10d43a1c-b18f-4ed1-8122-c337ba73f832" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased_58e62dd4-3007-49a6-967f-46156b158d13" xlink:href="cvs-20230525.xsd#cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f747c4eb-cbf0-4aee-b291-794796129052" xlink:to="loc_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased_58e62dd4-3007-49a6-967f-46156b158d13" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_c8dfba20-f136-4fc5-958d-a190b27d7b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f747c4eb-cbf0-4aee-b291-794796129052" xlink:to="loc_us-gaap_SharePrice_c8dfba20-f136-4fc5-958d-a190b27d7b0c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_f651c17c-86a7-483e-9299-ea6a024a3986" xlink:href="cvs-20230525.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f747c4eb-cbf0-4aee-b291-794796129052" xlink:to="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_f651c17c-86a7-483e-9299-ea6a024a3986" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares_1447f497-0a45-414f-9da5-8d07984990ca" xlink:href="cvs-20230525.xsd#cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f747c4eb-cbf0-4aee-b291-794796129052" xlink:to="loc_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares_1447f497-0a45-414f-9da5-8d07984990ca" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TransferOfSharesToTreasuryStockValue_4b83ee4d-55c7-46a9-a8e4-400cdf71c92b" xlink:href="cvs-20230525.xsd#cvs_TransferOfSharesToTreasuryStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f747c4eb-cbf0-4aee-b291-794796129052" xlink:to="loc_cvs_TransferOfSharesToTreasuryStockValue_4b83ee4d-55c7-46a9-a8e4-400cdf71c92b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_b2cc38c4-6694-407c-93cb-416537715fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f747c4eb-cbf0-4aee-b291-794796129052" xlink:to="loc_us-gaap_DerivativeNotionalAmount_b2cc38c4-6694-407c-93cb-416537715fb8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_09ac8ce0-e083-45dc-be02-3e839984ffd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f747c4eb-cbf0-4aee-b291-794796129052" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_09ac8ce0-e083-45dc-be02-3e839984ffd1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_e1bf708f-138c-498a-bdc7-11c378e94f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_09ac8ce0-e083-45dc-be02-3e839984ffd1" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_e1bf708f-138c-498a-bdc7-11c378e94f5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_e1bf708f-138c-498a-bdc7-11c378e94f5c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_e1bf708f-138c-498a-bdc7-11c378e94f5c" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_e1bf708f-138c-498a-bdc7-11c378e94f5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_58934f3a-b391-4c47-b1b1-86610ddf9879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_e1bf708f-138c-498a-bdc7-11c378e94f5c" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_58934f3a-b391-4c47-b1b1-86610ddf9879" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2021RepurchaseProgramMember_979a92df-6871-4b79-9be0-90f09152ca7c" xlink:href="cvs-20230525.xsd#cvs_A2021RepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_58934f3a-b391-4c47-b1b1-86610ddf9879" xlink:to="loc_cvs_A2021RepurchaseProgramMember_979a92df-6871-4b79-9be0-90f09152ca7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_0d07d903-4907-4938-bda7-34cb1475e8c7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_09ac8ce0-e083-45dc-be02-3e839984ffd1" xlink:to="loc_srt_CounterpartyNameAxis_0d07d903-4907-4938-bda7-34cb1475e8c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0d07d903-4907-4938-bda7-34cb1475e8c7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_0d07d903-4907-4938-bda7-34cb1475e8c7" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0d07d903-4907-4938-bda7-34cb1475e8c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ee382254-3448-475c-a0fb-f290e13a1e04" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_0d07d903-4907-4938-bda7-34cb1475e8c7" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ee382254-3448-475c-a0fb-f290e13a1e04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CitibankNAMember_d49389e4-fbe0-4612-8044-76b7669309fa" xlink:href="cvs-20230525.xsd#cvs_CitibankNAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ee382254-3448-475c-a0fb-f290e13a1e04" xlink:to="loc_cvs_CitibankNAMember_d49389e4-fbe0-4612-8044-76b7669309fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BarclaysBankMember_44f600e4-a830-4292-ad77-28f5702fd796" xlink:href="cvs-20230525.xsd#cvs_BarclaysBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ee382254-3448-475c-a0fb-f290e13a1e04" xlink:to="loc_cvs_BarclaysBankMember_44f600e4-a830-4292-ad77-28f5702fd796" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8b793ddc-6175-4fc1-9988-fc472b2d1d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_09ac8ce0-e083-45dc-be02-3e839984ffd1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8b793ddc-6175-4fc1-9988-fc472b2d1d0b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8b793ddc-6175-4fc1-9988-fc472b2d1d0b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8b793ddc-6175-4fc1-9988-fc472b2d1d0b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8b793ddc-6175-4fc1-9988-fc472b2d1d0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ff6df604-c024-4a0a-a500-96fe60225d09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8b793ddc-6175-4fc1-9988-fc472b2d1d0b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ff6df604-c024-4a0a-a500-96fe60225d09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_5d5717dc-35c6-40f7-a7e0-0a3da51f1670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ff6df604-c024-4a0a-a500-96fe60225d09" xlink:to="loc_us-gaap_ForwardContractsMember_5d5717dc-35c6-40f7-a7e0-0a3da51f1670" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_df53d9e2-b571-4fd1-9869-9c5660862d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_09ac8ce0-e083-45dc-be02-3e839984ffd1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_df53d9e2-b571-4fd1-9869-9c5660862d08" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_df53d9e2-b571-4fd1-9869-9c5660862d08_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_df53d9e2-b571-4fd1-9869-9c5660862d08" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_df53d9e2-b571-4fd1-9869-9c5660862d08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8eaaf420-1973-46a5-a1a6-1baa9fe6de4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_df53d9e2-b571-4fd1-9869-9c5660862d08" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8eaaf420-1973-46a5-a1a6-1baa9fe6de4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_84d34a6f-9c6d-42d3-be70-c144004dddd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_8eaaf420-1973-46a5-a1a6-1baa9fe6de4a" xlink:to="loc_us-gaap_SubsequentEventMember_84d34a6f-9c6d-42d3-be70-c144004dddd5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#ShareholdersEquityDividendsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails" xlink:type="extended" id="i02249c8ea11140d98dd4d1c474b71c85_ShareholdersEquityDividendsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems_fe89aa9d-5748-42e7-9675-d06ea2754d21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_408b92c1-4ba8-4c8c-ad9d-a9c1ab562121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_fe89aa9d-5748-42e7-9675-d06ea2754d21" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_408b92c1-4ba8-4c8c-ad9d-a9c1ab562121" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent_9f4118fc-5671-4206-b38a-72142b4790fa" xlink:href="cvs-20230525.xsd#cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_fe89aa9d-5748-42e7-9675-d06ea2754d21" xlink:to="loc_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent_9f4118fc-5671-4206-b38a-72142b4790fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable_09aabce2-e97f-4661-892d-3b7dc1a26648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DividendsPayableLineItems_fe89aa9d-5748-42e7-9675-d06ea2754d21" xlink:to="loc_us-gaap_DividendsPayableTable_09aabce2-e97f-4661-892d-3b7dc1a26648" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_154f6de9-354c-43ab-b874-471b1f31804f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_09aabce2-e97f-4661-892d-3b7dc1a26648" xlink:to="loc_srt_StatementScenarioAxis_154f6de9-354c-43ab-b874-471b1f31804f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_154f6de9-354c-43ab-b874-471b1f31804f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_154f6de9-354c-43ab-b874-471b1f31804f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_154f6de9-354c-43ab-b874-471b1f31804f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_745d3c93-3179-4642-ae70-70b2f7dae22d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_154f6de9-354c-43ab-b874-471b1f31804f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_745d3c93-3179-4642-ae70-70b2f7dae22d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_c46de05d-2a42-4d87-87df-d1c97ce42847" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_745d3c93-3179-4642-ae70-70b2f7dae22d" xlink:to="loc_srt_ScenarioForecastMember_c46de05d-2a42-4d87-87df-d1c97ce42847" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#ShareholdersEquityRegulatoryRequirementsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails" xlink:type="extended" id="id9a0f51274ad43f9b3667826bf782726_ShareholdersEquityRegulatoryRequirementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesLineItems_95cece72-8153-4196-a5b9-30678045a8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount_9c2358d1-d273-4659-9983-f023824d30af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_95cece72-8153-4196-a5b9-30678045a8c8" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount_9c2358d1-d273-4659-9983-f023824d30af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_ea95f7a3-ad2b-4848-9cc9-fbf7b30d9ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_95cece72-8153-4196-a5b9-30678045a8c8" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_ea95f7a3-ad2b-4848-9cc9-fbf7b30d9ec8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_cc2a2c6c-98f8-4f99-90e0-a5c45fefb9e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_95cece72-8153-4196-a5b9-30678045a8c8" xlink:to="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_cc2a2c6c-98f8-4f99-90e0-a5c45fefb9e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_3129edc4-00bd-4f89-a09e-df312dd16da1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_95cece72-8153-4196-a5b9-30678045a8c8" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_3129edc4-00bd-4f89-a09e-df312dd16da1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldByInsuranceRegulators_fea54fea-0cd7-48d8-83ef-2a3ceecdfa35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldByInsuranceRegulators"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_95cece72-8153-4196-a5b9-30678045a8c8" xlink:to="loc_us-gaap_AssetsHeldByInsuranceRegulators_fea54fea-0cd7-48d8-83ef-2a3ceecdfa35" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_f5e9e66b-37a8-4b20-9742-9d1f1d140a86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_95cece72-8153-4196-a5b9-30678045a8c8" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_f5e9e66b-37a8-4b20-9742-9d1f1d140a86" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesTable_f6e15d9c-79cd-4ad8-89e5-0e290b172e36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_95cece72-8153-4196-a5b9-30678045a8c8" xlink:to="loc_us-gaap_StatutoryAccountingPracticesTable_f6e15d9c-79cd-4ad8-89e5-0e290b172e36" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_4c9ec428-1008-437e-8330-f861db766c1c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatutoryAccountingPracticesTable_f6e15d9c-79cd-4ad8-89e5-0e290b172e36" xlink:to="loc_dei_LegalEntityAxis_4c9ec428-1008-437e-8330-f861db766c1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4c9ec428-1008-437e-8330-f861db766c1c_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_4c9ec428-1008-437e-8330-f861db766c1c" xlink:to="loc_dei_EntityDomain_4c9ec428-1008-437e-8330-f861db766c1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ac0c8a69-1b5c-4deb-bdcd-551deda311a3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_4c9ec428-1008-437e-8330-f861db766c1c" xlink:to="loc_dei_EntityDomain_ac0c8a69-1b5c-4deb-bdcd-551deda311a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InsuranceAndHMOMember_05af8859-33e4-4570-a18d-3a4cf7f420f2" xlink:href="cvs-20230525.xsd#cvs_InsuranceAndHMOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_ac0c8a69-1b5c-4deb-bdcd-551deda311a3" xlink:to="loc_cvs_InsuranceAndHMOMember_05af8859-33e4-4570-a18d-3a4cf7f420f2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i93fc78ef2bc94f428fddeab294423d6f_OtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6e9b2bb8-5329-4039-8d26-c3627b60f1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_a853b0de-4ba3-4890-ad75-8db2ddc65476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6e9b2bb8-5329-4039-8d26-c3627b60f1e6" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_a853b0de-4ba3-4890-ad75-8db2ddc65476" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_68f9e4a5-e2d6-456a-9a6f-8170b17ad77d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_a853b0de-4ba3-4890-ad75-8db2ddc65476" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_68f9e4a5-e2d6-456a-9a6f-8170b17ad77d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_006e0ce5-5660-40e4-b0cc-e2a37d02ad9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_a853b0de-4ba3-4890-ad75-8db2ddc65476" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_006e0ce5-5660-40e4-b0cc-e2a37d02ad9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5ac3d934-89a5-42be-be14-a2d55a4b68bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_a853b0de-4ba3-4890-ad75-8db2ddc65476" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5ac3d934-89a5-42be-be14-a2d55a4b68bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3ba94dbd-f446-4c71-a699-5c60063f29d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_a853b0de-4ba3-4890-ad75-8db2ddc65476" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3ba94dbd-f446-4c71-a699-5c60063f29d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f6ff2758-87ca-431d-be55-e7e938ce909c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax_466ca850-49f3-43db-aa45-4fec467b4fe3" xlink:href="cvs-20230525.xsd#cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6e9b2bb8-5329-4039-8d26-c3627b60f1e6" xlink:to="loc_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax_466ca850-49f3-43db-aa45-4fec467b4fe3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_03badaeb-ac35-48fd-9843-27de20b241a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6e9b2bb8-5329-4039-8d26-c3627b60f1e6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_03badaeb-ac35-48fd-9843-27de20b241a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_3f10b6bd-1119-47a5-9aa4-5b18437b4118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6e9b2bb8-5329-4039-8d26-c3627b60f1e6" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_3f10b6bd-1119-47a5-9aa4-5b18437b4118" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_8c70179f-fbcb-41ee-9822-3439fb7e727e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6e9b2bb8-5329-4039-8d26-c3627b60f1e6" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_8c70179f-fbcb-41ee-9822-3439fb7e727e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_e03e043c-ebc1-4fa8-9b7f-67f83f0d6bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6e9b2bb8-5329-4039-8d26-c3627b60f1e6" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_e03e043c-ebc1-4fa8-9b7f-67f83f0d6bc7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b678d9d1-2655-4628-b090-f8e8082f476a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_e03e043c-ebc1-4fa8-9b7f-67f83f0d6bc7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b678d9d1-2655-4628-b090-f8e8082f476a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b678d9d1-2655-4628-b090-f8e8082f476a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b678d9d1-2655-4628-b090-f8e8082f476a" xlink:to="loc_us-gaap_EquityComponentDomain_b678d9d1-2655-4628-b090-f8e8082f476a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_08640a28-f4e0-427c-ba0e-9f565f8c4426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b678d9d1-2655-4628-b090-f8e8082f476a" xlink:to="loc_us-gaap_EquityComponentDomain_08640a28-f4e0-427c-ba0e-9f565f8c4426" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_cb91c2bd-c441-423b-a502-640004bdd8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_08640a28-f4e0-427c-ba0e-9f565f8c4426" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_cb91c2bd-c441-423b-a502-640004bdd8a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember_03bdcf68-57d1-4911-9c31-9795fdfd9783" xlink:href="cvs-20230525.xsd#cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_08640a28-f4e0-427c-ba0e-9f565f8c4426" xlink:to="loc_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember_03bdcf68-57d1-4911-9c31-9795fdfd9783" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_403c2d66-378e-40ee-86cf-6eccf5091f09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_08640a28-f4e0-427c-ba0e-9f565f8c4426" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_403c2d66-378e-40ee-86cf-6eccf5091f09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_5621cd4c-22b6-4810-bf26-9a9f4e0ed2fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_08640a28-f4e0-427c-ba0e-9f565f8c4426" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_5621cd4c-22b6-4810-bf26-9a9f4e0ed2fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_1fdf12d3-7c89-4d55-91ef-b4e41f958c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_08640a28-f4e0-427c-ba0e-9f565f8c4426" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_1fdf12d3-7c89-4d55-91ef-b4e41f958c48" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_02f5233f-2640-4e86-85ad-f70a7d3adde0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_08640a28-f4e0-427c-ba0e-9f565f8c4426" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_02f5233f-2640-4e86-85ad-f70a7d3adde0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_71896a87-a95b-4e62-8408-cd78c8f3fa97" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_e03e043c-ebc1-4fa8-9b7f-67f83f0d6bc7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_71896a87-a95b-4e62-8408-cd78c8f3fa97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_71896a87-a95b-4e62-8408-cd78c8f3fa97_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_71896a87-a95b-4e62-8408-cd78c8f3fa97" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_71896a87-a95b-4e62-8408-cd78c8f3fa97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_5ada4e43-76b5-4702-8d6b-86f5be61b865" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_71896a87-a95b-4e62-8408-cd78c8f3fa97" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_5ada4e43-76b5-4702-8d6b-86f5be61b865" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_964bbe8a-fc36-460d-ad57-3daa9622bb6e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_5ada4e43-76b5-4702-8d6b-86f5be61b865" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_964bbe8a-fc36-460d-ad57-3daa9622bb6e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#EarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="extended" id="ic32b073b155e426888cac6ed6f30d198_EarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_89f89e8f-12c4-420e-97da-ff4e5490992d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b0ba6da4-5fbb-49d6-96d2-1fbd6234ea40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_89f89e8f-12c4-420e-97da-ff4e5490992d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b0ba6da4-5fbb-49d6-96d2-1fbd6234ea40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_b3e623c1-d92d-4e10-a63a-773ee5a8e1ef" xlink:href="cvs-20230525.xsd#cvs_NumeratorForEarningsPerShareCalculationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_89f89e8f-12c4-420e-97da-ff4e5490992d" xlink:to="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_b3e623c1-d92d-4e10-a63a-773ee5a8e1ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_cda9ebec-a06e-4738-9adc-9156a7cdec47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_b3e623c1-d92d-4e10-a63a-773ee5a8e1ef" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_cda9ebec-a06e-4738-9adc-9156a7cdec47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_51920ee9-bfbc-4d15-8ba6-2895fc6a14fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_b3e623c1-d92d-4e10-a63a-773ee5a8e1ef" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_51920ee9-bfbc-4d15-8ba6-2895fc6a14fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_8d279739-de09-4abf-b232-a1f8d30f32a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_b3e623c1-d92d-4e10-a63a-773ee5a8e1ef" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_8d279739-de09-4abf-b232-a1f8d30f32a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_c5ee6c81-c4ee-4d29-9c3c-c9c60c240732" xlink:href="cvs-20230525.xsd#cvs_DenominatorForEarningsPerShareCalculationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_89f89e8f-12c4-420e-97da-ff4e5490992d" xlink:to="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_c5ee6c81-c4ee-4d29-9c3c-c9c60c240732" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e5e8a449-cf7c-47b5-8ee8-33ffaf193ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_c5ee6c81-c4ee-4d29-9c3c-c9c60c240732" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e5e8a449-cf7c-47b5-8ee8-33ffaf193ad8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2120ee6a-c3fe-469e-aff6-ff97155836da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_c5ee6c81-c4ee-4d29-9c3c-c9c60c240732" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2120ee6a-c3fe-469e-aff6-ff97155836da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_98474cad-5f3d-452d-8288-d264bfb4cb42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_c5ee6c81-c4ee-4d29-9c3c-c9c60c240732" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_98474cad-5f3d-452d-8288-d264bfb4cb42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_1639dddc-8b10-4821-b6ab-380ac4320dc6" xlink:href="cvs-20230525.xsd#cvs_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_89f89e8f-12c4-420e-97da-ff4e5490992d" xlink:to="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_1639dddc-8b10-4821-b6ab-380ac4320dc6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_bbad3f90-a396-4a72-90fe-d6920b2cc37f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_1639dddc-8b10-4821-b6ab-380ac4320dc6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_bbad3f90-a396-4a72-90fe-d6920b2cc37f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_a7b9c25d-566e-40eb-9bf2-59eb25dede28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_1639dddc-8b10-4821-b6ab-380ac4320dc6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_a7b9c25d-566e-40eb-9bf2-59eb25dede28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_31a98b23-c346-4303-a683-832c068ce814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_89f89e8f-12c4-420e-97da-ff4e5490992d" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_31a98b23-c346-4303-a683-832c068ce814" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f9e7969d-20c2-4c1f-afc2-9b0fe810a342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_31a98b23-c346-4303-a683-832c068ce814" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f9e7969d-20c2-4c1f-afc2-9b0fe810a342" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f9e7969d-20c2-4c1f-afc2-9b0fe810a342_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f9e7969d-20c2-4c1f-afc2-9b0fe810a342" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f9e7969d-20c2-4c1f-afc2-9b0fe810a342_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3798bc16-f617-42bb-9fb5-8264c99f71dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f9e7969d-20c2-4c1f-afc2-9b0fe810a342" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3798bc16-f617-42bb-9fb5-8264c99f71dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockOptionsAndStockAppreciationRightsMember_da53c063-b18a-4426-94a4-787ffa249cd7" xlink:href="cvs-20230525.xsd#cvs_StockOptionsAndStockAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3798bc16-f617-42bb-9fb5-8264c99f71dc" xlink:to="loc_cvs_StockOptionsAndStockAppreciationRightsMember_da53c063-b18a-4426-94a4-787ffa249cd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember_c287fc45-f6fc-4286-840a-9f1878109ee7" xlink:href="cvs-20230525.xsd#cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3798bc16-f617-42bb-9fb5-8264c99f71dc" xlink:to="loc_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember_c287fc45-f6fc-4286-840a-9f1878109ee7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#ReinsuranceNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ReinsuranceNarrativeDetails" xlink:type="extended" id="iba0c410211df4f49913638b0218e1b71_ReinsuranceNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskLineItems_f656c079-2e8b-4ecb-b3c7-ac1b49b66318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer_88968da9-be1d-4c0f-a192-fc2c65332dd0" xlink:href="cvs-20230525.xsd#cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskLineItems_f656c079-2e8b-4ecb-b3c7-ac1b49b66318" xlink:to="loc_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer_88968da9-be1d-4c0f-a192-fc2c65332dd0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofReinsuranceContractsEnteredInto_4f6190ed-0024-48d9-9250-16597835e18b" xlink:href="cvs-20230525.xsd#cvs_NumberofReinsuranceContractsEnteredInto"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskLineItems_f656c079-2e8b-4ecb-b3c7-ac1b49b66318" xlink:to="loc_cvs_NumberofReinsuranceContractsEnteredInto_4f6190ed-0024-48d9-9250-16597835e18b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskTable_0ae4c5c2-a3aa-454a-b29b-3a589fa3c773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CededCreditRiskLineItems_f656c079-2e8b-4ecb-b3c7-ac1b49b66318" xlink:to="loc_us-gaap_CededCreditRiskTable_0ae4c5c2-a3aa-454a-b29b-3a589fa3c773" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_c596b847-3d61-4bee-9188-137682fbfeeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_CededCreditRiskTable_0ae4c5c2-a3aa-454a-b29b-3a589fa3c773" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_c596b847-3d61-4bee-9188-137682fbfeeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c596b847-3d61-4bee-9188-137682fbfeeb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c596b847-3d61-4bee-9188-137682fbfeeb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c596b847-3d61-4bee-9188-137682fbfeeb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2b213505-9b16-4e14-9330-ecb257567d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c596b847-3d61-4bee-9188-137682fbfeeb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2b213505-9b16-4e14-9330-ecb257567d8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4d159ef0-8ad1-478e-a638-b56f81ad34a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_2b213505-9b16-4e14-9330-ecb257567d8e" xlink:to="loc_us-gaap_SubsequentEventMember_4d159ef0-8ad1-478e-a638-b56f81ad34a0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#ReinsuranceReinsuranceRecoverablesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails" xlink:type="extended" id="ia2b3953e24a54d5d9499ce347f027fd4_ReinsuranceReinsuranceRecoverablesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskLineItems_be306cf6-724e-4451-93fe-9ce3d969c33e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_5a0b4ffc-293c-4d57-932a-89175dd488cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskLineItems_be306cf6-724e-4451-93fe-9ce3d969c33e" xlink:to="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_5a0b4ffc-293c-4d57-932a-89175dd488cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskTable_58230106-f5a6-4129-8f01-73bd268b216b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CededCreditRiskLineItems_be306cf6-724e-4451-93fe-9ce3d969c33e" xlink:to="loc_us-gaap_CededCreditRiskTable_58230106-f5a6-4129-8f01-73bd268b216b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskAxis_0e616dd5-81c8-4598-bbc6-658b304bf691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_CededCreditRiskTable_58230106-f5a6-4129-8f01-73bd268b216b" xlink:to="loc_us-gaap_CededCreditRiskAxis_0e616dd5-81c8-4598-bbc6-658b304bf691" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskReinsurerDomain_0e616dd5-81c8-4598-bbc6-658b304bf691_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskReinsurerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CededCreditRiskAxis_0e616dd5-81c8-4598-bbc6-658b304bf691" xlink:to="loc_us-gaap_CededCreditRiskReinsurerDomain_0e616dd5-81c8-4598-bbc6-658b304bf691_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskReinsurerDomain_bac29c10-ee92-4598-b742-85952f20a217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskReinsurerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CededCreditRiskAxis_0e616dd5-81c8-4598-bbc6-658b304bf691" xlink:to="loc_us-gaap_CededCreditRiskReinsurerDomain_bac29c10-ee92-4598-b742-85952f20a217" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HartfordLifeAndAccidentInsuranceCompanyMember_85b12201-4f49-4454-a89b-e8c22ff64b19" xlink:href="cvs-20230525.xsd#cvs_HartfordLifeAndAccidentInsuranceCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_bac29c10-ee92-4598-b742-85952f20a217" xlink:to="loc_cvs_HartfordLifeAndAccidentInsuranceCompanyMember_85b12201-4f49-4454-a89b-e8c22ff64b19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember_458b4a8c-2ffb-4429-85d5-45d3312d53b3" xlink:href="cvs-20230525.xsd#cvs_LincolnLifeAnnuityCompanyOfNewYorkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_bac29c10-ee92-4598-b742-85952f20a217" xlink:to="loc_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember_458b4a8c-2ffb-4429-85d5-45d3312d53b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember_4b42c350-088b-4030-8d29-16b19cfc4a73" xlink:href="cvs-20230525.xsd#cvs_VOYARetirementInsuranceAndAnnuityCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_bac29c10-ee92-4598-b742-85952f20a217" xlink:to="loc_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember_4b42c350-088b-4030-8d29-16b19cfc4a73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember_42d8158a-d50e-411e-9815-9984419857e0" xlink:href="cvs-20230525.xsd#cvs_FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_bac29c10-ee92-4598-b742-85952f20a217" xlink:to="loc_cvs_FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember_42d8158a-d50e-411e-9815-9984419857e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AllOtherReinsurersMember_1358fcc5-7ef4-4aba-85da-54fef8324124" xlink:href="cvs-20230525.xsd#cvs_AllOtherReinsurersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_bac29c10-ee92-4598-b742-85952f20a217" xlink:to="loc_cvs_AllOtherReinsurersMember_1358fcc5-7ef4-4aba-85da-54fef8324124" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="i6d8bcd4f3286467aa84ec779c9723437_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_1ed4c74f-5d14-4a46-9287-2ec22728952c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_1ed4c74f-5d14-4a46-9287-2ec22728952c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LegalSettlementPeriodOfPayment_0b4a49e6-d1e0-4c66-9ccf-0ec840ce21c7" xlink:href="cvs-20230525.xsd#cvs_LegalSettlementPeriodOfPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:to="loc_cvs_LegalSettlementPeriodOfPayment_0b4a49e6-d1e0-4c66-9ccf-0ec840ce21c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_a2654def-3b1f-4a38-b979-c060e78d7617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_a2654def-3b1f-4a38-b979-c060e78d7617" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_77861eb9-d0a2-4551-8036-df0c9d0358e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_77861eb9-d0a2-4551-8036-df0c9d0358e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_8cf62b9b-8998-4cfb-b6bc-230fdfe50b40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:to="loc_us-gaap_LegalFees_8cf62b9b-8998-4cfb-b6bc-230fdfe50b40" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LitigationSettlementNumberOfStatesElectedToJoin_84156c3b-6a65-4337-9ddf-413f3cce824c" xlink:href="cvs-20230525.xsd#cvs_LitigationSettlementNumberOfStatesElectedToJoin"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:to="loc_cvs_LitigationSettlementNumberOfStatesElectedToJoin_84156c3b-6a65-4337-9ddf-413f3cce824c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LitigationSettlementNumberOfStatesSubjectToEarlierSettlements_69f76168-f938-47f0-9d1f-ad7a59a4cf02" xlink:href="cvs-20230525.xsd#cvs_LitigationSettlementNumberOfStatesSubjectToEarlierSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:to="loc_cvs_LitigationSettlementNumberOfStatesSubjectToEarlierSettlements_69f76168-f938-47f0-9d1f-ad7a59a4cf02" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_df14425c-583e-4f50-8b10-b7d3b3ec9142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_df14425c-583e-4f50-8b10-b7d3b3ec9142" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_96b66611-d023-4729-bc4d-6769a1bb94ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_96b66611-d023-4729-bc4d-6769a1bb94ac" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_a80fdf34-1206-405e-9b6c-33639e018648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_a80fdf34-1206-405e-9b6c-33639e018648" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_38c546f5-47cf-4164-9a94-3a3a7e10d09e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:to="loc_us-gaap_LossContingenciesTable_38c546f5-47cf-4164-9a94-3a3a7e10d09e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_56aec07d-3791-49ce-824a-69cd061ba389" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_38c546f5-47cf-4164-9a94-3a3a7e10d09e" xlink:to="loc_srt_LitigationCaseAxis_56aec07d-3791-49ce-824a-69cd061ba389" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_56aec07d-3791-49ce-824a-69cd061ba389_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_56aec07d-3791-49ce-824a-69cd061ba389" xlink:to="loc_srt_LitigationCaseTypeDomain_56aec07d-3791-49ce-824a-69cd061ba389_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_2c7052d1-60dc-45a6-89f6-9fa42f357a4c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_56aec07d-3791-49ce-824a-69cd061ba389" xlink:to="loc_srt_LitigationCaseTypeDomain_2c7052d1-60dc-45a6-89f6-9fa42f357a4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FederalCourtInOhioJudgmentMember_591290b7-9c92-4507-a463-15cc2a8924e5" xlink:href="cvs-20230525.xsd#cvs_FederalCourtInOhioJudgmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_2c7052d1-60dc-45a6-89f6-9fa42f357a4c" xlink:to="loc_cvs_FederalCourtInOhioJudgmentMember_591290b7-9c92-4507-a463-15cc2a8924e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StateOfFloridaSettlementMember_5b858a85-49cf-4378-be58-91c460da929f" xlink:href="cvs-20230525.xsd#cvs_StateOfFloridaSettlementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_2c7052d1-60dc-45a6-89f6-9fa42f357a4c" xlink:to="loc_cvs_StateOfFloridaSettlementMember_5b858a85-49cf-4378-be58-91c460da929f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SettlementFrameworkMember_6d8aff9e-1698-471a-872a-8bf32e334317" xlink:href="cvs-20230525.xsd#cvs_SettlementFrameworkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_2c7052d1-60dc-45a6-89f6-9fa42f357a4c" xlink:to="loc_cvs_SettlementFrameworkMember_6d8aff9e-1698-471a-872a-8bf32e334317" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember_da53467d-97c1-44b3-9929-5cb89883792c" xlink:href="cvs-20230525.xsd#cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_2c7052d1-60dc-45a6-89f6-9fa42f357a4c" xlink:to="loc_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember_da53467d-97c1-44b3-9929-5cb89883792c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RadcliffAndFlaimVAetnaIncEtAlMember_b53fd551-51c1-43bd-9a94-3aa7bb08b5b2" xlink:href="cvs-20230525.xsd#cvs_RadcliffAndFlaimVAetnaIncEtAlMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_2c7052d1-60dc-45a6-89f6-9fa42f357a4c" xlink:to="loc_cvs_RadcliffAndFlaimVAetnaIncEtAlMember_b53fd551-51c1-43bd-9a94-3aa7bb08b5b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_9b10373a-b854-4d5a-8339-8d96fe47a609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_38c546f5-47cf-4164-9a94-3a3a7e10d09e" xlink:to="loc_us-gaap_LitigationStatusAxis_9b10373a-b854-4d5a-8339-8d96fe47a609" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_9b10373a-b854-4d5a-8339-8d96fe47a609_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_9b10373a-b854-4d5a-8339-8d96fe47a609" xlink:to="loc_us-gaap_LitigationStatusDomain_9b10373a-b854-4d5a-8339-8d96fe47a609_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_f28aac7d-fc06-4537-b1e6-f94d101a3d39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_9b10373a-b854-4d5a-8339-8d96fe47a609" xlink:to="loc_us-gaap_LitigationStatusDomain_f28aac7d-fc06-4537-b1e6-f94d101a3d39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_f524ebda-fd4d-40b1-b51b-c9f338b9d621" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_f28aac7d-fc06-4537-b1e6-f94d101a3d39" xlink:to="loc_us-gaap_PendingLitigationMember_f524ebda-fd4d-40b1-b51b-c9f338b9d621" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_876c44cc-0ffe-468b-930f-3795f7a5b19c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_38c546f5-47cf-4164-9a94-3a3a7e10d09e" xlink:to="loc_srt_CounterpartyNameAxis_876c44cc-0ffe-468b-930f-3795f7a5b19c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_876c44cc-0ffe-468b-930f-3795f7a5b19c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_876c44cc-0ffe-468b-930f-3795f7a5b19c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_876c44cc-0ffe-468b-930f-3795f7a5b19c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_67f861aa-6782-4353-84da-12eb3c9aacbf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_876c44cc-0ffe-468b-930f-3795f7a5b19c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_67f861aa-6782-4353-84da-12eb3c9aacbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TribalEntitiesMember_69a7d40d-5b57-4fd8-bb7a-a9a706780c53" xlink:href="cvs-20230525.xsd#cvs_TribalEntitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_67f861aa-6782-4353-84da-12eb3c9aacbf" xlink:to="loc_cvs_TribalEntitiesMember_69a7d40d-5b57-4fd8-bb7a-a9a706780c53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_90cd1a54-8137-4cc2-b71e-d4c779029b66" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_38c546f5-47cf-4164-9a94-3a3a7e10d09e" xlink:to="loc_srt_RangeAxis_90cd1a54-8137-4cc2-b71e-d4c779029b66" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_90cd1a54-8137-4cc2-b71e-d4c779029b66_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_90cd1a54-8137-4cc2-b71e-d4c779029b66" xlink:to="loc_srt_RangeMember_90cd1a54-8137-4cc2-b71e-d4c779029b66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0191697b-a591-49df-9f3a-f7973aad3878" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_90cd1a54-8137-4cc2-b71e-d4c779029b66" xlink:to="loc_srt_RangeMember_0191697b-a591-49df-9f3a-f7973aad3878" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6daf596f-0e15-45f1-9570-77474b998563" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0191697b-a591-49df-9f3a-f7973aad3878" xlink:to="loc_srt_MaximumMember_6daf596f-0e15-45f1-9570-77474b998563" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_9fdc6d65-cefd-47db-be80-243789784e76" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_38c546f5-47cf-4164-9a94-3a3a7e10d09e" xlink:to="loc_srt_StatementScenarioAxis_9fdc6d65-cefd-47db-be80-243789784e76" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9fdc6d65-cefd-47db-be80-243789784e76_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_9fdc6d65-cefd-47db-be80-243789784e76" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9fdc6d65-cefd-47db-be80-243789784e76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9c1751df-9be8-4db2-901d-f895d74d915e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_9fdc6d65-cefd-47db-be80-243789784e76" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9c1751df-9be8-4db2-901d-f895d74d915e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_302ee1c5-a5bd-4361-8201-b6616fce54f9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_9c1751df-9be8-4db2-901d-f895d74d915e" xlink:to="loc_srt_ScenarioForecastMember_302ee1c5-a5bd-4361-8201-b6616fce54f9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails" xlink:type="extended" id="ibfa61eb064d648efae587002a4b8f972_SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_ab2a9141-7ec6-480d-a8a2-ed662a5e5d73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fb382c48-b7d6-47e3-9432-a8e7cc85c58d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_ab2a9141-7ec6-480d-a8a2-ed662a5e5d73" xlink:to="loc_us-gaap_Revenues_fb382c48-b7d6-47e3-9432-a8e7cc85c58d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_b3a49d35-385a-4e41-93aa-a15a19fba85d" xlink:href="cvs-20230525.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_ab2a9141-7ec6-480d-a8a2-ed662a5e5d73" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_b3a49d35-385a-4e41-93aa-a15a19fba85d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_9437e761-72a2-4dcc-b186-f0398a4c37c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_ab2a9141-7ec6-480d-a8a2-ed662a5e5d73" xlink:to="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_9437e761-72a2-4dcc-b186-f0398a4c37c2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_0cf1aaaa-56b9-4abe-88fb-bb75ec719db2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_9437e761-72a2-4dcc-b186-f0398a4c37c2" xlink:to="loc_srt_RestatementAxis_0cf1aaaa-56b9-4abe-88fb-bb75ec719db2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_0cf1aaaa-56b9-4abe-88fb-bb75ec719db2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_0cf1aaaa-56b9-4abe-88fb-bb75ec719db2" xlink:to="loc_srt_RestatementDomain_0cf1aaaa-56b9-4abe-88fb-bb75ec719db2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_e6bdb87f-d419-42b5-b0a8-972c02490e4a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_0cf1aaaa-56b9-4abe-88fb-bb75ec719db2" xlink:to="loc_srt_RestatementDomain_e6bdb87f-d419-42b5-b0a8-972c02490e4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_201c0600-7229-4a26-868e-28d4e7a45698" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_e6bdb87f-d419-42b5-b0a8-972c02490e4a" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_201c0600-7229-4a26-868e-28d4e7a45698" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_68c1b4ab-8bf0-4065-b571-114c214e15e2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_e6bdb87f-d419-42b5-b0a8-972c02490e4a" xlink:to="loc_srt_RestatementAdjustmentMember_68c1b4ab-8bf0-4065-b571-114c214e15e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bb867823-c668-4540-bf6d-ccea61f3c939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_9437e761-72a2-4dcc-b186-f0398a4c37c2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bb867823-c668-4540-bf6d-ccea61f3c939" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bb867823-c668-4540-bf6d-ccea61f3c939_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bb867823-c668-4540-bf6d-ccea61f3c939" xlink:to="loc_us-gaap_SegmentDomain_bb867823-c668-4540-bf6d-ccea61f3c939_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ea0c6cf0-9330-4d79-9e3b-e48c841a4aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bb867823-c668-4540-bf6d-ccea61f3c939" xlink:to="loc_us-gaap_SegmentDomain_ea0c6cf0-9330-4d79-9e3b-e48c841a4aa9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_bee5cbfd-4f4f-461a-94aa-6170169bade3" xlink:href="cvs-20230525.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ea0c6cf0-9330-4d79-9e3b-e48c841a4aa9" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_bee5cbfd-4f4f-461a-94aa-6170169bade3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthServicesSegmentMember_d43453fc-3a55-46b5-bf44-9db68b3df4d9" xlink:href="cvs-20230525.xsd#cvs_HealthServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ea0c6cf0-9330-4d79-9e3b-e48c841a4aa9" xlink:to="loc_cvs_HealthServicesSegmentMember_d43453fc-3a55-46b5-bf44-9db68b3df4d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_a292e2b8-5e8c-43d8-837b-02587c85126f" xlink:href="cvs-20230525.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ea0c6cf0-9330-4d79-9e3b-e48c841a4aa9" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_a292e2b8-5e8c-43d8-837b-02587c85126f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5f5608b8-ce62-4d55-a82d-494487bc0dba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_9437e761-72a2-4dcc-b186-f0398a4c37c2" xlink:to="loc_srt_ConsolidationItemsAxis_5f5608b8-ce62-4d55-a82d-494487bc0dba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5f5608b8-ce62-4d55-a82d-494487bc0dba_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_5f5608b8-ce62-4d55-a82d-494487bc0dba" xlink:to="loc_srt_ConsolidationItemsDomain_5f5608b8-ce62-4d55-a82d-494487bc0dba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d3015d8e-08da-469a-86e3-deb36f63ee28" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_5f5608b8-ce62-4d55-a82d-494487bc0dba" xlink:to="loc_srt_ConsolidationItemsDomain_d3015d8e-08da-469a-86e3-deb36f63ee28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_5300630f-0b70-4168-a992-01ac4ccd007c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d3015d8e-08da-469a-86e3-deb36f63ee28" xlink:to="loc_us-gaap_OperatingSegmentsMember_5300630f-0b70-4168-a992-01ac4ccd007c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_b999e716-c790-45d1-bc3a-1784d67189fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d3015d8e-08da-469a-86e3-deb36f63ee28" xlink:to="loc_us-gaap_CorporateNonSegmentMember_b999e716-c790-45d1-bc3a-1784d67189fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_f93db431-4f8b-4e0c-b09e-fd63d9403a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d3015d8e-08da-469a-86e3-deb36f63ee28" xlink:to="loc_us-gaap_IntersegmentEliminationMember_f93db431-4f8b-4e0c-b09e-fd63d9403a5c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SegmentReportingNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="extended" id="iaca4709a841c40bab875cff153aabc0c_SegmentReportingNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_f22a049b-9ca0-4c22-9ae0-e5d68088916a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_e44facb8-fdae-4216-99a8-2e11761aec1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_f22a049b-9ca0-4c22-9ae0-e5d68088916a" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_e44facb8-fdae-4216-99a8-2e11761aec1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_47ac3c90-790c-47c4-be50-aaa6f8195c34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_f22a049b-9ca0-4c22-9ae0-e5d68088916a" xlink:to="loc_us-gaap_ConcentrationRiskTable_47ac3c90-790c-47c4-be50-aaa6f8195c34" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_333fc9ed-b46e-4e0e-a338-c2a84a6453a0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_47ac3c90-790c-47c4-be50-aaa6f8195c34" xlink:to="loc_srt_MajorCustomersAxis_333fc9ed-b46e-4e0e-a338-c2a84a6453a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_333fc9ed-b46e-4e0e-a338-c2a84a6453a0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_333fc9ed-b46e-4e0e-a338-c2a84a6453a0" xlink:to="loc_srt_NameOfMajorCustomerDomain_333fc9ed-b46e-4e0e-a338-c2a84a6453a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_b6cdc649-3f28-40de-8417-7b5ed2264245" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_333fc9ed-b46e-4e0e-a338-c2a84a6453a0" xlink:to="loc_srt_NameOfMajorCustomerDomain_b6cdc649-3f28-40de-8417-7b5ed2264245" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USFederalGovernmentMember_5a707596-f1e1-45a1-8df6-04b54c4523cc" xlink:href="cvs-20230525.xsd#cvs_USFederalGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_b6cdc649-3f28-40de-8417-7b5ed2264245" xlink:to="loc_cvs_USFederalGovernmentMember_5a707596-f1e1-45a1-8df6-04b54c4523cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_2cff30a6-1581-430a-b373-b37a02fb5f84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_47ac3c90-790c-47c4-be50-aaa6f8195c34" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_2cff30a6-1581-430a-b373-b37a02fb5f84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_2cff30a6-1581-430a-b373-b37a02fb5f84_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_2cff30a6-1581-430a-b373-b37a02fb5f84" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_2cff30a6-1581-430a-b373-b37a02fb5f84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_2ab0d8f8-0283-431e-a33b-219884e4620b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_2cff30a6-1581-430a-b373-b37a02fb5f84" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_2ab0d8f8-0283-431e-a33b-219884e4620b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_dbcfd238-d864-4caa-b58c-30b38d184997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_2ab0d8f8-0283-431e-a33b-219884e4620b" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_dbcfd238-d864-4caa-b58c-30b38d184997" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_83705841-d47f-4085-94aa-434740104682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_47ac3c90-790c-47c4-be50-aaa6f8195c34" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_83705841-d47f-4085-94aa-434740104682" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_83705841-d47f-4085-94aa-434740104682_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_83705841-d47f-4085-94aa-434740104682" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_83705841-d47f-4085-94aa-434740104682_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_eb7c348f-32e8-432a-bd99-60f7d7c159c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_83705841-d47f-4085-94aa-434740104682" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_eb7c348f-32e8-432a-bd99-60f7d7c159c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_759e5808-6f94-4818-85fd-96eec63073df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_eb7c348f-32e8-432a-bd99-60f7d7c159c7" xlink:to="loc_us-gaap_SalesRevenueNetMember_759e5808-6f94-4818-85fd-96eec63073df" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="extended" id="i1c248de6d9f44e0d95396e2009283aad_SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_9ded2c28-74e0-4486-b6f5-afa59cde3249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_2401bd02-db9f-4248-b100-50f0cf3f011f" xlink:href="cvs-20230525.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9ded2c28-74e0-4486-b6f5-afa59cde3249" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_2401bd02-db9f-4248-b100-50f0cf3f011f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_83753c13-1b29-4d0e-be31-76a6eb9a995d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9ded2c28-74e0-4486-b6f5-afa59cde3249" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_83753c13-1b29-4d0e-be31-76a6eb9a995d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_eb13ca64-547d-40bb-aba8-3a34cd3697e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9ded2c28-74e0-4486-b6f5-afa59cde3249" xlink:to="loc_us-gaap_NetInvestmentIncome_eb13ca64-547d-40bb-aba8-3a34cd3697e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_d53460cf-471a-4a43-8ed7-ccbc5f50ff61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9ded2c28-74e0-4486-b6f5-afa59cde3249" xlink:to="loc_us-gaap_Revenues_d53460cf-471a-4a43-8ed7-ccbc5f50ff61" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_2aadfb86-567f-47a2-9c89-27b7a84efeb1" xlink:href="cvs-20230525.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9ded2c28-74e0-4486-b6f5-afa59cde3249" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_2aadfb86-567f-47a2-9c89-27b7a84efeb1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_d323b9cc-70b7-4bf9-b4ac-f32669c0fd87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9ded2c28-74e0-4486-b6f5-afa59cde3249" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_d323b9cc-70b7-4bf9-b4ac-f32669c0fd87" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments_3d7485d7-d861-411d-9a8f-00892041ada4" xlink:href="cvs-20230525.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9ded2c28-74e0-4486-b6f5-afa59cde3249" xlink:to="loc_cvs_NetRevenuesRetailCoPayments_3d7485d7-d861-411d-9a8f-00892041ada4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b0e0a511-2e62-41e8-aeb6-f769e71877ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9ded2c28-74e0-4486-b6f5-afa59cde3249" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b0e0a511-2e62-41e8-aeb6-f769e71877ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b0007f08-2328-45b5-ab40-1522b8cbe664" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b0e0a511-2e62-41e8-aeb6-f769e71877ff" xlink:to="loc_srt_ConsolidationItemsAxis_b0007f08-2328-45b5-ab40-1522b8cbe664" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b0007f08-2328-45b5-ab40-1522b8cbe664_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_b0007f08-2328-45b5-ab40-1522b8cbe664" xlink:to="loc_srt_ConsolidationItemsDomain_b0007f08-2328-45b5-ab40-1522b8cbe664_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_adda3a84-8a90-40c5-830e-d9ebef5578b4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_b0007f08-2328-45b5-ab40-1522b8cbe664" xlink:to="loc_srt_ConsolidationItemsDomain_adda3a84-8a90-40c5-830e-d9ebef5578b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_0fc0a064-2f3d-4792-ba18-3be9e7a65ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_adda3a84-8a90-40c5-830e-d9ebef5578b4" xlink:to="loc_us-gaap_OperatingSegmentsMember_0fc0a064-2f3d-4792-ba18-3be9e7a65ea2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_e58d3cf7-fe83-47aa-a468-b8408de5cad6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_adda3a84-8a90-40c5-830e-d9ebef5578b4" xlink:to="loc_us-gaap_IntersegmentEliminationMember_e58d3cf7-fe83-47aa-a468-b8408de5cad6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_7b167b8e-305f-44eb-9b51-388bd16301dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_adda3a84-8a90-40c5-830e-d9ebef5578b4" xlink:to="loc_us-gaap_CorporateNonSegmentMember_7b167b8e-305f-44eb-9b51-388bd16301dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_52f4093b-2e8b-46d1-9734-e5d260ddb2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b0e0a511-2e62-41e8-aeb6-f769e71877ff" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_52f4093b-2e8b-46d1-9734-e5d260ddb2d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_52f4093b-2e8b-46d1-9734-e5d260ddb2d9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_52f4093b-2e8b-46d1-9734-e5d260ddb2d9" xlink:to="loc_us-gaap_SegmentDomain_52f4093b-2e8b-46d1-9734-e5d260ddb2d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5c613b16-b3fd-4c05-9306-27d5615a119f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_52f4093b-2e8b-46d1-9734-e5d260ddb2d9" xlink:to="loc_us-gaap_SegmentDomain_5c613b16-b3fd-4c05-9306-27d5615a119f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_27c9f097-fdfc-4a96-80ff-30675ff8d430" xlink:href="cvs-20230525.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5c613b16-b3fd-4c05-9306-27d5615a119f" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_27c9f097-fdfc-4a96-80ff-30675ff8d430" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthServicesSegmentMember_9a03330f-c866-4e76-886f-78538f4b5a0a" xlink:href="cvs-20230525.xsd#cvs_HealthServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5c613b16-b3fd-4c05-9306-27d5615a119f" xlink:to="loc_cvs_HealthServicesSegmentMember_9a03330f-c866-4e76-886f-78538f4b5a0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_549fa2f3-a998-4dbe-8615-6107983b24c7" xlink:href="cvs-20230525.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5c613b16-b3fd-4c05-9306-27d5615a119f" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_549fa2f3-a998-4dbe-8615-6107983b24c7" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="extended" id="i45428a1359054cc99fc52c807cc36a03_SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e6c04529-201d-48b0-9844-a144aada9ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_us-gaap_OperatingIncomeLoss_e6c04529-201d-48b0-9844-a144aada9ec1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a4b4f4a5-1592-4b4d-a03e-14e1a0338d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a4b4f4a5-1592-4b4d-a03e-14e1a0338d19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_cd1949c1-968a-468d-9fe9-fced685bacda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_cd1949c1-968a-468d-9fe9-fced685bacda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OfficeRealEstateOptimizationCharges_c06c445c-e8fa-46ed-a83a-5dddd8332adc" xlink:href="cvs-20230525.xsd#cvs_OfficeRealEstateOptimizationCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_cvs_OfficeRealEstateOptimizationCharges_c06c445c-e8fa-46ed-a83a-5dddd8332adc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_f8dc6d86-3b3e-444e-98bd-3544a447c9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_f8dc6d86-3b3e-444e-98bd-3544a447c9e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_aa5a415f-f281-41fc-9340-00e81de9a981" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_aa5a415f-f281-41fc-9340-00e81de9a981" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_5d4f3fce-123c-4a74-8298-8fb82b9cbc90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_5d4f3fce-123c-4a74-8298-8fb82b9cbc90" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_185f4217-677a-412f-bcd8-fedb33b71a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_185f4217-677a-412f-bcd8-fedb33b71a0e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges_9c3b434e-a59d-4019-a3a3-4fbee87ac3b8" xlink:href="cvs-20230525.xsd#cvs_StoreImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_cvs_StoreImpairmentCharges_9c3b434e-a59d-4019-a3a3-4fbee87ac3b8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_62b303d9-7c90-4ebf-b01b-f3e8536f9efb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_62b303d9-7c90-4ebf-b01b-f3e8536f9efb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_077113a8-2090-4705-8339-5f5a9097bbf9" xlink:href="cvs-20230525.xsd#cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_077113a8-2090-4705-8339-5f5a9097bbf9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_38c9b845-a451-4abd-a285-74f32277b72b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_38c9b845-a451-4abd-a285-74f32277b72b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_6ac1d9dc-9cbd-49ec-bb19-705ed225ee90" xlink:href="cvs-20230525.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_6ac1d9dc-9cbd-49ec-bb19-705ed225ee90" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresPlannedClosure_b2dfcb4b-88c8-465e-ab16-ce4ec7f27c57" xlink:href="cvs-20230525.xsd#cvs_NumberOfStoresPlannedClosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_cvs_NumberOfStoresPlannedClosure_b2dfcb4b-88c8-465e-ab16-ce4ec7f27c57" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyUnrecordedAmount_8ddac9ad-f8de-42c3-9f92-b4002edf881a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainContingencyUnrecordedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_us-gaap_GainContingencyUnrecordedAmount_8ddac9ad-f8de-42c3-9f92-b4002edf881a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_7b044adf-40b2-444e-8f11-4409b53f17e0" xlink:href="cvs-20230525.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_7b044adf-40b2-444e-8f11-4409b53f17e0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_44ae7478-32a3-4837-8c40-0870d3cf90d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_44ae7478-32a3-4837-8c40-0870d3cf90d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_9a7cfaa1-409d-469d-a198-547d01fd8db0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_44ae7478-32a3-4837-8c40-0870d3cf90d2" xlink:to="loc_srt_LitigationCaseAxis_9a7cfaa1-409d-469d-a198-547d01fd8db0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_9a7cfaa1-409d-469d-a198-547d01fd8db0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_9a7cfaa1-409d-469d-a198-547d01fd8db0" xlink:to="loc_srt_LitigationCaseTypeDomain_9a7cfaa1-409d-469d-a198-547d01fd8db0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8368f43f-01c8-440d-b541-71f1964fc5b1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_9a7cfaa1-409d-469d-a198-547d01fd8db0" xlink:to="loc_srt_LitigationCaseTypeDomain_8368f43f-01c8-440d-b541-71f1964fc5b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_de700fd6-5269-49cb-bc3f-89e2630545ef" xlink:href="cvs-20230525.xsd#cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_8368f43f-01c8-440d-b541-71f1964fc5b1" xlink:to="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_de700fd6-5269-49cb-bc3f-89e2630545ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_37b9c7bb-1b8a-4bb8-99fb-07a2366f317c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_44ae7478-32a3-4837-8c40-0870d3cf90d2" xlink:to="loc_us-gaap_LitigationStatusAxis_37b9c7bb-1b8a-4bb8-99fb-07a2366f317c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_37b9c7bb-1b8a-4bb8-99fb-07a2366f317c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_37b9c7bb-1b8a-4bb8-99fb-07a2366f317c" xlink:to="loc_us-gaap_LitigationStatusDomain_37b9c7bb-1b8a-4bb8-99fb-07a2366f317c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_c3c2e980-a0e8-43a5-9b9d-ac9bebb751af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_37b9c7bb-1b8a-4bb8-99fb-07a2366f317c" xlink:to="loc_us-gaap_LitigationStatusDomain_c3c2e980-a0e8-43a5-9b9d-ac9bebb751af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_af2b6c55-bad9-47c1-a365-e9692eeb4ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_c3c2e980-a0e8-43a5-9b9d-ac9bebb751af" xlink:to="loc_us-gaap_SettledLitigationMember_af2b6c55-bad9-47c1-a365-e9692eeb4ecf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>cvs-20230525_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:a470d627-05b8-4106-b3ee-d69f01519b0f,g:7f491b32-9056-4172-9edc-e6fc2e3bdea2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_15869429-e89d-4f38-b6d9-77854863f06a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRealEstateMember_23e422dd-fee7-44eb-a1e0-519d11acfd81_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRealEstateMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Real Estate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:to="lab_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_cf479116-da16-4919-8fda-6e74c4982967_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_1fad7fe4-f63a-4f13-b9b7-1de0abc7dbd8_terseLabel_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other asset-backed securities</link:label>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_label_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asset-Backed Securities [Member]</link:label>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_documentation_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities collateralized by a variety of assets such as automobile loans, credit card receivables, home equity loans, etc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember" xlink:href="cvs-20230525.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherAssetBackedSecuritiesMember" xlink:to="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_3aaa0ab6-7793-43b4-8139-81720e2c2723_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation and Transactions</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_d3cff14c-adf6-4ec2-900d-6f2045b5f94b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_d86b8fd7-9424-4994-b308-5f24cb4670a3_totalLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net benefit costs</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_b0768280-36be-4f06-a30b-9d5d4714386f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_4d218c9c-5d21-4720-8378-9f034ad300a0_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_c65ae052-69d1-4c48-b115-a0a1e68de562_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_0ada38f2-08c2-4107-99ce-6fd111d5506f_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Impact of discount rate on long-duration insurance reserves</link:label>
    <link:label id="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_8161bb9c-57ff-44a3-bb4e-db75eefcb36b_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Impact of discount rate on long-duration insurance reserves</link:label>
    <link:label id="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_9ee4467a-8344-4747-adc8-e9e64514d26c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of changes in discount rate assumptions</link:label>
    <link:label id="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_label_en-US" xlink:label="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" xlink:to="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FinanceLeaseCost_ccc46e31-e370-438e-a94e-1c3569b25e33_totalLabel_en-US" xlink:label="lab_cvs_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease costs</link:label>
    <link:label id="lab_cvs_FinanceLeaseCost_label_en-US" xlink:label="lab_cvs_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Cost</link:label>
    <link:label id="lab_cvs_FinanceLeaseCost_documentation_en-US" xlink:label="lab_cvs_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseCost" xlink:href="cvs-20230525.xsd#cvs_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FinanceLeaseCost" xlink:to="lab_cvs_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocationsToPolicyholdersPolicies_150aae67-6a36-4d0d-a5df-dcc7afcdae7e_terseLabel_en-US" xlink:label="lab_us-gaap_AllocationsToPolicyholdersPolicies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholders' Funds</link:label>
    <link:label id="lab_us-gaap_AllocationsToPolicyholdersPolicies_label_en-US" xlink:label="lab_us-gaap_AllocationsToPolicyholdersPolicies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocations to Policyholders, Policies [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocationsToPolicyholdersPolicies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocationsToPolicyholdersPolicies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocationsToPolicyholdersPolicies" xlink:to="lab_us-gaap_AllocationsToPolicyholdersPolicies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_db188494-f81c-49ac-ba48-833cb9e144c7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_4593107a-c383-4de4-93a1-7bae77ed9202_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_5376bbef-6a52-4c4a-8f73-d63c4a9b462b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized investment gains (losses)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_d1018a46-6dd0-4c2c-b85a-1b44d699db84_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense and Components of Change in Health Care Costs Payable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_0f41bb9e-0028-4e33-9766-badd0bc501fc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember_31fca28f-a154-4879-a530-81ad413174bf_terseLabel_en-US" xlink:label="lab_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement Framework and Other Opioid-Related Claims</link:label>
    <link:label id="lab_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember_label_en-US" xlink:label="lab_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement Framework And Other Opioid-Related Claims [Member]</link:label>
    <link:label id="lab_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember_documentation_en-US" xlink:label="lab_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement Framework And Other Opioid-Related Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember" xlink:href="cvs-20230525.xsd#cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember" xlink:to="lab_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_5a34c173-e508-4185-923f-423408031a03_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_0468b0a4-d392-4ad4-a547-dec72f50eb85_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_56f269bc-dce9-4986-9fe5-a8143b50b249_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_26f938c2-ff31-42e2-b5d1-92bad51fbe4f_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage_c26ae759-ebe3-40ac-9df1-b705ffaf250f_negatedTerseLabel_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption and breakage</link:label>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage_label_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Redemption And Breakage</link:label>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage_documentation_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Redemption And Breakage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage" xlink:href="cvs-20230525.xsd#cvs_ContractWithCustomerLiabilityRedemptionAndBreakage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage" xlink:to="lab_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_307d8567-8862-49c3-8f3b-a1d43b3ab610_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_8906b3c8-daf3-4246-bec2-4b9f300c1ec9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.05DueMarch2048Member_badd9775-722d-42c3-a812-a824dca1f1cc_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.05% senior notes due March 2048</link:label>
    <link:label id="lab_cvs_SeniorNotes5.05DueMarch2048Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.05%, Due March 2048 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.05DueMarch2048Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.05%, Due March 2048 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.05DueMarch2048Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes5.05DueMarch2048Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.05DueMarch2048Member" xlink:to="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_2debb9ef-dddf-40a8-b787-582851ef8924_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_d54a83c9-44ed-400f-9af4-1872ea5c8c69_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Activity [Line Items]</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Activity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal_4817147c-7227-49d9-aac5-52c33073119c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surrenders and withdrawals</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Surrender and Withdrawal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal" xlink:to="lab_us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_95eb8c96-a3ab-491a-be91-ba14744bd833_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b9e923c8-f1a9-4904-8733-4f813f3b6190_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total health care costs payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_2cf60bbb-5dd4-46be-8da6-30404aa03b70_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, beginning of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_6948ce83-dd34-4634-893a-dc33c4c1e07d_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, end of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_ca59cc38-743b-4105-bfb8-798cebdfdf6e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax_613f5fd2-99f0-411d-86ea-2724261696e3_terseLabel_en-US" xlink:label="lab_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in discount rate on insurance reserves</link:label>
    <link:label id="lab_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax_label_en-US" xlink:label="lab_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Liability for Future Policy Benefit, Gain (Loss), after Reclassification Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax" xlink:to="lab_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.5DueJuly2022Member_390ce2c5-148f-46f7-944c-bad0172d90f7_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% senior notes due July 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueJuly2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due July 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueJuly2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due July 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueJuly2022Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.5DueJuly2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.5DueJuly2022Member" xlink:to="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_b9e126c3-795b-4dd5-ad56-c83ac4eeb05b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_9d7933e5-4654-48c2-b761-a229e72b34fd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e74de0bf-ec1d-46fc-b146-eda0be1dd850_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category7Member_3dd8ddfe-b429-4003-8a84-5388d11bd819_terseLabel_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7</link:label>
    <link:label id="lab_cvs_Category7Member_label_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 7 [Member]</link:label>
    <link:label id="lab_cvs_Category7Member_documentation_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loan credit quality indicator - Category 7</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member" xlink:href="cvs-20230525.xsd#cvs_Category7Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category7Member" xlink:to="lab_cvs_Category7Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_17126ab6-f8c6-4cf0-9f89-dd2981073086_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_8a553448-e711-4532-930e-2b23bc67754b_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2d5efff0-758f-4a2f-be06-7b19cb32f362_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option activity, stock awards and other (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1d35665e-4728-48cd-a4be-227eeb7870d1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2Point7PercentAugust2040Member_1ea3e15c-1570-4592-a407-9b06830df31b_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2Point7PercentAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.7% senior notes due August 2040</link:label>
    <link:label id="lab_cvs_SeniorNotes2Point7PercentAugust2040Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2Point7PercentAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2 Point 7 Percent, August 2040 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2Point7PercentAugust2040Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2Point7PercentAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2 Point 7 Percent, August 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2Point7PercentAugust2040Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2Point7PercentAugust2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2Point7PercentAugust2040Member" xlink:to="lab_cvs_SeniorNotes2Point7PercentAugust2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_8f1cc1ae-add1-405c-ac75-f989a9bc05c0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9c9388b6-ecd2-4a88-9b36-22e186f063af_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_3de75ccc-652d-4ca7-bfe6-055c9dff34ef_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common/collective trusts</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Common Collective Trust [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember" xlink:to="lab_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_0e2c7476-f068-496d-bb78-fcc9dcbd8c8a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_158467bb-0aec-41b9-a366-a1d32c30b047_terseLabel_en-US" xlink:label="lab_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized and unrealized capital gains (losses):</link:label>
    <link:label id="lab_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_label_en-US" xlink:label="lab_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured On Recurring Basis, Unobservable Unput Reconciliation, Net Realized And Unrealized Capital Gaines (Losses) [Abstract]</link:label>
    <link:label id="lab_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_documentation_en-US" xlink:label="lab_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured On Recurring Basis, Unobservable Unput Reconciliation, Net Realized And Unrealized Capital Gaines (Losses) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" xlink:href="cvs-20230525.xsd#cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" xlink:to="lab_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_807d501f-f15d-4071-a95e-463795e107e0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsYearOne_492ee77e-f770-459b-8c87-ca10b1264051_totalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsYearOne" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsYearOne_label_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Year One</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsYearOne_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsYearOne" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityPaymentsYearOne" xlink:to="lab_cvs_LesseeLiabilityPaymentsYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_9c6f5aa8-7ff4-4078-983a-0ee2d6b0c97c_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale_51540431-618a-4404-b262-c219a66c5912_totalLabel_en-US" xlink:label="lab_cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale_label_en-US" xlink:label="lab_cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill), Including Assets Held For Sale</link:label>
    <link:label id="lab_cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale_documentation_en-US" xlink:label="lab_cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill), Including Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale" xlink:href="cvs-20230525.xsd#cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale" xlink:to="lab_cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_e1cc7131-fe98-4017-85a8-ffe1a02c5b22_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_835353d4-8887-45c5-a972-76a2c25bc084_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_40ac68b6-a2dc-4c0f-997d-f32711e19145_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f0247d05-80c4-4423-ac0f-274b50080ae1_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_bbca258d-872f-45a4-86e7-fcfd2d7c1dd2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_7d8ded8a-5961-490a-bf87-ca38f2df118d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_9a4462cd-cbc1-46a7-a073-f702f59bd913_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_e9d04797-fa20-4470-811c-b05bc6164d98_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_ba64eed3-24cb-44d0-9122-1cc01b942659_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_a2c8edcf-7d88-45c5-8a53-ab3fce1965e5_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which entity operates</link:label>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of States in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BswiftLLCMember_66d39727-ab58-4c4c-b52f-075df4f9e535_terseLabel_en-US" xlink:label="lab_cvs_BswiftLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">bswift LLC</link:label>
    <link:label id="lab_cvs_BswiftLLCMember_label_en-US" xlink:label="lab_cvs_BswiftLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">bswift LLC [Member]</link:label>
    <link:label id="lab_cvs_BswiftLLCMember_documentation_en-US" xlink:label="lab_cvs_BswiftLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">bswift LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BswiftLLCMember" xlink:href="cvs-20230525.xsd#cvs_BswiftLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BswiftLLCMember" xlink:to="lab_cvs_BswiftLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentIncome_d8624a1a-75bd-4a83-89ce-182bba380b86_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_9221ece1-5d52-4c66-9eba-215cca95270d_verboseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income (loss)</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_label_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentIncome" xlink:to="lab_us-gaap_NetInvestmentIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_c8073ad1-8759-4c5f-a209-2783267526b1_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_af5b1a8a-5aca-4b8e-8d88-07a6e71e63dd_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term liability recorded in association with legal settlement</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Accrual, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay112026Member_5d365074-0ff9-4c36-b845-7a5690b34cc1_terseLabel_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay112026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 11, 2026</link:label>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay112026Member_label_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay112026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 11, 2026 [Member]</link:label>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay112026Member_documentation_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay112026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 11, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay112026Member" xlink:href="cvs-20230525.xsd#cvs_RevolvingCreditFacilityExpiringMay112026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RevolvingCreditFacilityExpiringMay112026Member" xlink:to="lab_cvs_RevolvingCreditFacilityExpiringMay112026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_ea59ad9b-0492-4647-9cc7-adcb6673e008_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_03dd7a9a-5d8d-4b86-bc72-6977ba315135_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_9dad1a32-502a-41f4-b215-9b14a44d2382_terseLabel_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator for earnings per share calculation:</link:label>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_label_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_documentation_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:href="cvs-20230525.xsd#cvs_NumeratorForEarningsPerShareCalculationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:to="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1330e9af-50b7-41b3-84dd-8383da15b85d_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions based on tax positions related to the current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_0d274dc5-edac-4f3c-a250-33af8c2f5827_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_920b7b22-3e3f-46da-9dfd-b65e91037562_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_729e24b6-9569-4352-a3ff-48de6bdd7b3a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for future policy benefits</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_cf64d90e-2d4e-4ee3-9f20-6633e52dcb8b_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted balance at January 1, 2021, net of reinsurance</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_08c601b6-a183-404d-9551-2aad251116f6_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net liability for future policy benefits, net of reinsurance recoverable</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, after Reinsurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_83a790f4-4596-41f9-b439-1e985f9b1dae_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_cc35e863-e5bb-4c85-8084-f9d2ad861484_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate accounts liabilities</link:label>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_365cafb3-ac8e-438f-843a-799e8615aca0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate accounts liabilities</link:label>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_0ff98228-270a-4f22-a36b-6517437a02c4_periodStartLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Accounts liability, beginning of the period</link:label>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_5fc4bf0f-23a5-4391-96e7-1ff208691c32_periodEndLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Accounts liability, end of the period</link:label>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_label_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountsLiability" xlink:to="lab_us-gaap_SeparateAccountsLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4de7ac9f-33e3-4bd8-9bc4-d2260c180c1f_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d9282439-27e7-419d-a4bc-8bae14c5de86_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e69875e3-dfc4-4f11-9481-5ab90a3c8844_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_f8095e10-df6b-4c3b-bf6a-bb55359c28ad_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash to be received by shareholders in proposed/pending acquisition (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_d1dda912-a3db-4d6c-a063-bdbd09c69bcf_terseLabel_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment contracts liabilities without a fixed maturity</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_label_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts Without A Fixed Maturity, Fair Value Disclosure</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_documentation_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:href="cvs-20230525.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:to="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_742a71a9-6bfa-4479-ba45-cd0f1e7d67bc_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_1049c0e6-b310-49df-a028-5339e30d37c5_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_cf9c558e-ae41-49a1-9eca-a251d74ad1d2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_c3cb857e-12db-4d53-8e33-f05fc8671fdd_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_4e05a2b4-9bfe-4528-ab15-80c3ad67de87_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, forfeited ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance_26ee551e-4f36-41ef-9779-9e381dcce9ff_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected gross premiums</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Gross Premium, Undiscounted, before Reinsurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_adf8c1a7-1033-4d91-90c5-07f9c1fa620a_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_label_en-US" xlink:label="lab_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract" xlink:to="lab_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_5e69fbe6-90a1-4be2-bae4-6e6cbaac1785_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation not yet recognized, other than options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_d5d31808-a3be-46af-9477-777204adac85_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember_b989d94d-be8e-4201-942c-bf35db273a29_terseLabel_en-US" xlink:label="lab_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) and Performance Stock Units (PSUs)</link:label>
    <link:label id="lab_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember_label_en-US" xlink:label="lab_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) And Performance Stock Units (PSUs) [Member]</link:label>
    <link:label id="lab_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember_documentation_en-US" xlink:label="lab_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) And Performance Stock Units (PSUs)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" xlink:href="cvs-20230525.xsd#cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" xlink:to="lab_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SettlementFrameworkMember_ce83a4ff-d3dd-4acf-ad0c-42ddce2a760a_terseLabel_en-US" xlink:label="lab_cvs_SettlementFrameworkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement Framework</link:label>
    <link:label id="lab_cvs_SettlementFrameworkMember_label_en-US" xlink:label="lab_cvs_SettlementFrameworkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement Framework [Member]</link:label>
    <link:label id="lab_cvs_SettlementFrameworkMember_documentation_en-US" xlink:label="lab_cvs_SettlementFrameworkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement Framework</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SettlementFrameworkMember" xlink:href="cvs-20230525.xsd#cvs_SettlementFrameworkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SettlementFrameworkMember" xlink:to="lab_cvs_SettlementFrameworkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_acb025e8-41ef-446d-98f8-f95fbeeadeb9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_72586577-bd24-4e75-b84d-33870865b75c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross transfers out of Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_b1eac62f-6198-49bc-850d-5e75a8f1b8e9_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a69bc374-13f0-41bd-bd72-d0372f047301_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_4c40769e-310a-4676-9906-e4c7ddb8cc7c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average contractual term, outstanding at end of year</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_de24098f-43fa-4312-8254-30d437407efd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_66ca7689-7d1c-4ec1-b191-34c2f7828121_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_5c5f6d26-b98b-44c3-ba6f-8c7dc4a5c22d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_231ab82e-b643-44d7-bdda-12aaba1ba9d2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_78ca7701-0511-4bf5-8f11-a2083bd0e2db_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_ea2b8b4a-5c3a-48d0-8b61-2c6216246f9c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.01: 3,200 shares authorized; 1,758 shares issued and 1,300 shares outstanding at December&#160;31, 2022 and 1,744 shares issued and 1,322 shares outstanding at December&#160;31, 2021 and capital surplus</link:label>
    <link:label id="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stocks, Including Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:to="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure_6e8144bf-1c14-40e3-9bcb-c2694bc17038_terseLabel_en-US" xlink:label="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgages Held-for-sale, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:to="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_8169802e-74ed-4ce3-b94c-b3824e186325_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_102f4003-e09d-4c9c-a85a-50f14d5ce905_terseLabel_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit-related impairment loss</link:label>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_label_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</link:label>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_documentation_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:href="cvs-20230525.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_4bc1964f-a71d-466d-92ce-e8ca2620d018_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_07d40dca-c824-4b59-8660-d6ad05e9439e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember_9e6d5c39-52e1-48f6-8bec-2c6c02de1aee_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign securities</link:label>
    <link:label id="lab_us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Government Short-Term Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember" xlink:to="lab_us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_3832efc6-2366-4218-8760-a81fa81d6d6f_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost:</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_0de04c07-6276-4d77-820d-c117538bd2e5_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from divestiture of subsidiary</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category2To4Member_7c28b0cc-00c4-4587-8fdc-4fc301d7779c_terseLabel_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2 to 4</link:label>
    <link:label id="lab_cvs_Category2To4Member_label_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 2 To 4 [Member]</link:label>
    <link:label id="lab_cvs_Category2To4Member_documentation_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Credit Quality Indicator - Category 2 to 4 [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member" xlink:href="cvs-20230525.xsd#cvs_Category2To4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category2To4Member" xlink:to="lab_cvs_Category2To4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.3DueDecember2043Member_d9e1c18e-9cbe-481b-b5d1-4e71c13da8a4_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.3% senior notes due December 2043</link:label>
    <link:label id="lab_cvs_SeniorNotes5.3DueDecember2043Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.3%, Due December 2043 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.3DueDecember2043Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.3%, Due December 2043 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.3DueDecember2043Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes5.3DueDecember2043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.3DueDecember2043Member" xlink:to="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_e38c6b68-c470-4436-94e9-73754558812d_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Three</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" xlink:to="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToSuppliersAndEmployees_c08c0aed-c74d-433c-a268-1315598aade0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid to other suppliers and employees</link:label>
    <link:label id="lab_us-gaap_PaymentsToSuppliersAndEmployees_label_en-US" xlink:label="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Suppliers and Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToSuppliersAndEmployees" xlink:to="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_7de1644f-91a8-4b64-b5fc-78d453456509_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_f6d651c3-0eb7-45a9-8a0f-56e91b617d12_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_fc31494f-2b49-4ab6-92a1-8cc9e46d58a0_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_0ac83eb0-d170-4d25-83e9-655ee36eea61_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_A2021RepurchaseProgramMember_27722829-8f69-4b1d-bae9-d8afc08dc50c_terseLabel_en-US" xlink:label="lab_cvs_A2021RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Repurchase Program</link:label>
    <link:label id="lab_cvs_A2021RepurchaseProgramMember_label_en-US" xlink:label="lab_cvs_A2021RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Repurchase Program [Member]</link:label>
    <link:label id="lab_cvs_A2021RepurchaseProgramMember_documentation_en-US" xlink:label="lab_cvs_A2021RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2021RepurchaseProgramMember" xlink:href="cvs-20230525.xsd#cvs_A2021RepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_A2021RepurchaseProgramMember" xlink:to="lab_cvs_A2021RepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_9b2b0e1f-3a69-4332-9496-58ddde69232d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease and rents</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_f28f3f99-84ac-4149-b0a4-ea0c77f03bb7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6e505310-8250-4abc-a3f0-a2e21a43c4be_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_102ee422-2e81-42b3-ae32-2f06fe68fe6a_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_269a7a17-247a-4d4a-8240-ee62871029e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Future Benefits Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_b4d1f4cf-3605-4a7c-87a7-e08f98064738_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Benefit Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Projected Benefit Obligations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_65a0c1a7-bce3-42b8-9c1c-4a56b406ca6a_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Year Of Origination [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Year Of Origination [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Year Of Origination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:to="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_ada13350-e98e-41a3-ad6c-3b53e149cb3b_totalLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total outstanding liabilities for health care costs payable, net of reinsurance</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_48f475c1-e325-41bb-96dd-d721ffb698e2_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration health care costs payable, net of reinsurance</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_7f2ba890-8b0b-4a81-a253-776feea34ef6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_1bf60779-5368-4f00-8bd1-1c0d964dec9b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Claims Development [Table]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Claims Development [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1166b1ad-5ba9-447d-84d5-e5d21319fc9e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_ebb59c28-6c0b-413d-b31c-10b4897ee9ee_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_5988c3a4-05b7-4cb0-a07f-595ea96b79a8_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_a8354a90-a287-4260-815d-7641ad2ff82e_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale_499db991-2d87-4d5a-8cfb-71249e611d71_terseLabel_en-US" xlink:label="lab_cvs_OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_cvs_OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale_label_en-US" xlink:label="lab_cvs_OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Including Assets Held For Sale</link:label>
    <link:label id="lab_cvs_OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale_documentation_en-US" xlink:label="lab_cvs_OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Including Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale" xlink:href="cvs-20230525.xsd#cvs_OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale" xlink:to="lab_cvs_OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_516f0f9a-a911-4ec3-9670-8365a783f6e7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_aa7cd6c5-adf6-4944-bf9a-9e50e5c0c1bc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful life of property plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_229997c6-696d-4144-85eb-a6ff845888a4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of net periodic benefit cost (income):</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsDomain_5429b571-a786-4764-b242-f290f8f2c38c_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Domain]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsDomain_label_en-US" xlink:label="lab_cvs_TotalInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain" xlink:href="cvs-20230525.xsd#cvs_TotalInvestmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsDomain" xlink:to="lab_cvs_TotalInvestmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock_d28e6a3c-b841-4f67-82ac-ab909e412946_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rollforward of deferred acquisition costs</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock" xlink:to="lab_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_43ef9fd8-9876-46a9-9d3b-ece0831ed7af_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_078991b9-8444-4f05-b941-21ad113d7d7e_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior</link:label>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Prior To Period Five [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Prior To Period Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:href="cvs-20230525.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:to="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_bfc9fbfe-d3ed-41df-bc5f-f977ee69737e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at beginning of year (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3b53f5aa-0539-4786-bb02-52f67c6a1ca2_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at end of year (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3f473da8-a0b3-4c6c-b27c-ece84e13e84b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_d8f0de02-7b81-4224-a6e9-a461306480ec_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_04ebbd30-61b8-420f-826e-53fa7be5831c_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_b9281d95-0537-4c4f-a697-f8a3b5ae9619_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_6c9215e6-686a-4a79-91b9-afc444ba798a_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_837d7dcd-88aa-4419-9109-7922e482694a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent assets reflected in other assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_8f75c977-cd7f-4e74-bd63-ca4be19ff07a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment Income, Reported Amounts, by Category [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_bce3ca3b-4d7e-4025-9d96-b446daafed41_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative settlements</link:label>
    <link:label id="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_10ca4c9e-b5c1-4e05-93b4-22cd09d1111a_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for derivative instruments</link:label>
    <link:label id="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Derivative Instrument, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:to="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3DueAugust2026Member_d19f06f1-3ae6-4668-ae69-a25fd9c3b174_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3% senior notes due August 2026</link:label>
    <link:label id="lab_cvs_SeniorNotes3DueAugust2026Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3%, Due August 2026 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3DueAugust2026Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3%, Due August 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3DueAugust2026Member" xlink:to="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityUndiscountedExcessAmount_96deae9b-5af7-407f-b5e4-dd4965210afb_negatedTotalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_cvs_LesseeLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_cvs_LesseeLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_cvs_LesseeLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityUndiscountedExcessAmount" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityUndiscountedExcessAmount" xlink:to="lab_cvs_LesseeLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_264982dc-8b32-48b8-ae66-643ee445b578_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Included in earnings</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_1b50511d-6091-4ed7-8537-6ebee5e92e39_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of receivables and contract liabilities from contracts with customers</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_6be4f9fb-0c92-4f8e-b043-c5d95c7d34f2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentsMember" xlink:to="lab_us-gaap_OtherInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_USFederalGovernmentMember_5c0cb7c8-0e9e-4a14-977b-087842ca1114_terseLabel_en-US" xlink:label="lab_cvs_USFederalGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Federal Government</link:label>
    <link:label id="lab_cvs_USFederalGovernmentMember_label_en-US" xlink:label="lab_cvs_USFederalGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Federal Government [Member]</link:label>
    <link:label id="lab_cvs_USFederalGovernmentMember_documentation_en-US" xlink:label="lab_cvs_USFederalGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Federal Government</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USFederalGovernmentMember" xlink:href="cvs-20230525.xsd#cvs_USFederalGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_USFederalGovernmentMember" xlink:to="lab_cvs_USFederalGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci_0a06bd69-e3fb-4e6d-9e88-be4f59169979_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrealized capital losses included in OCI associated with Level 3 financial assets</link:label>
    <link:label id="lab_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci_label_en-US" xlink:label="lab_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci" xlink:to="lab_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_b722d9c0-871d-453b-8689-2201ace7900a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_23e12abc-27ff-400d-bfcf-c2fb6e00158a_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Contract Acquisition Costs</link:label>
    <link:label id="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_label_en-US" xlink:label="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:to="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_GuarantorObligationsNumberOfLeases_96165f55-c397-466b-8d8e-378cf29c4784_terseLabel_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberOfLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor obligations, number of leases</link:label>
    <link:label id="lab_cvs_GuarantorObligationsNumberOfLeases_label_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberOfLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Number Of Leases</link:label>
    <link:label id="lab_cvs_GuarantorObligationsNumberOfLeases_documentation_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberOfLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Number Of Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_GuarantorObligationsNumberOfLeases" xlink:href="cvs-20230525.xsd#cvs_GuarantorObligationsNumberOfLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_GuarantorObligationsNumberOfLeases" xlink:to="lab_cvs_GuarantorObligationsNumberOfLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_aed12508-9087-47b9-b2a2-d2bf2138f275_totalLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total claims paid</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_65920b16-0c76-4b6b-aa95-91d0d2ac482f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateInvestmentMember_64757ae3-1259-4000-ae06-e6927e9698cc_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate investment</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentMember_label_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateInvestmentMember" xlink:to="lab_us-gaap_RealEstateInvestmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalHomeLoanBankAdvancesMember_f3652c18-8987-4fd3-9ea0-45e8313453cb_terseLabel_en-US" xlink:label="lab_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Home Loan Bank Advances</link:label>
    <link:label id="lab_us-gaap_FederalHomeLoanBankAdvancesMember_label_en-US" xlink:label="lab_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Home Loan Bank Advances [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalHomeLoanBankAdvancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:to="lab_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_5f0298ff-b50d-48c0-b300-01b1e4a271d6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_ef84d992-fb90-4250-8257-67c2f77a9359_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_6eb7eea2-cf5e-47a6-8bc7-511417071751_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_5ff0116e-835a-4385-9b5c-43b5c054d8ce_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FrontStoreRevenueMember_08b67429-9980-4dd5-8081-186b51763742_terseLabel_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store</link:label>
    <link:label id="lab_cvs_FrontStoreRevenueMember_label_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store Revenue [Member]</link:label>
    <link:label id="lab_cvs_FrontStoreRevenueMember_documentation_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember" xlink:href="cvs-20230525.xsd#cvs_FrontStoreRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FrontStoreRevenueMember" xlink:to="lab_cvs_FrontStoreRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_5937139d-ab34-4b39-bf78-da6ce76c5711_totalLabel_en-US" xlink:label="lab_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accounts receivable, net</link:label>
    <link:label id="lab_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_label_en-US" xlink:label="lab_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, After Allowance For Credit Loss, Current, Including Assets Held For Sale</link:label>
    <link:label id="lab_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_documentation_en-US" xlink:label="lab_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, After Allowance For Credit Loss, Current, Including Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" xlink:href="cvs-20230525.xsd#cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" xlink:to="lab_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_3e393aee-4daf-4653-b884-40bcb85a8419_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer_e2ae8ffa-98ad-4dad-ae5f-f3e9b4ef8f4d_terseLabel_en-US" xlink:label="lab_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of reinsurance agreements with unrelated issuer</link:label>
    <link:label id="lab_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer_label_en-US" xlink:label="lab_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Years Reinsurance Agreement With Unrelated Insurer</link:label>
    <link:label id="lab_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer_documentation_en-US" xlink:label="lab_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This line item represents the four years of a reinsurance agreement with an unrelated insurer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer" xlink:href="cvs-20230525.xsd#cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer" xlink:to="lab_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_8aeee48c-12b7-4848-b620-257ffa4b2fa5_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_7ffa72f7-047b-48d0-930b-ce8f67f23acb_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease costs</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_6cd36075-37f5-4726-a77a-ce1a08c72507_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of subsidiaries</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_007d2ecf-56ba-4c2a-8db0-292a933779e7_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on sale of subsidiaries</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_515030c5-514e-498b-8fee-1003ed8e6816_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on divestiture of subsidiaries</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_6ece4069-89c8-4481-ba4b-c3a595c1c76f_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_fe62a54b-343d-49c8-82da-ed87135d9dd5_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_0a8de406-8cc6-403f-84a5-e85ab5310a71_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_88a613a8-b72b-4d78-92be-db1338fd5e55_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_7d4ec106-ac78-4e9b-960c-859b70500464_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_e6f1c1ae-5ef9-4c04-9249-8cb3099e0429_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrivateEquityFundsMember_071e5b94-2d66-4dbb-9d13-52d0e4f8f7c5_verboseLabel_en-US" xlink:label="lab_us-gaap_PrivateEquityFundsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private equity investments</link:label>
    <link:label id="lab_us-gaap_PrivateEquityFundsMember_label_en-US" xlink:label="lab_us-gaap_PrivateEquityFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Equity Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivateEquityFundsMember" xlink:to="lab_us-gaap_PrivateEquityFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_b2ab3306-bc23-4cdc-915e-0b1640fd0eae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_4da8571e-1c17-42f7-a4fd-b1829b165d4f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Provision</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_cd5db2b4-cda6-463e-b092-754a004b90f9_terseLabel_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential Mortgage-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthInsurerFee_6be89455-e35d-493c-a7d4-c886f4a0fd9a_terseLabel_en-US" xlink:label="lab_cvs_HealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health insurer fee</link:label>
    <link:label id="lab_cvs_HealthInsurerFee_label_en-US" xlink:label="lab_cvs_HealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurer Fee</link:label>
    <link:label id="lab_cvs_HealthInsurerFee_documentation_en-US" xlink:label="lab_cvs_HealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the estimated amount of the health insurer fee accrued during the reporting period, as required by Health Care Reform.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFee" xlink:href="cvs-20230525.xsd#cvs_HealthInsurerFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthInsurerFee" xlink:to="lab_cvs_HealthInsurerFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9ac3bd89-4fc5-4f8f-aafa-7bb40aa5cb3f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation not yet recognized, period for recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_8a2acb80-4556-4ad2-a63c-6fbbe93848b8_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_77535bc4-08d3-4297-9aac-e127027ea2d2_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual term exercisable at end of year</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityPremiumAndDeposit_765f957d-1889-4662-b7a9-1fc7c4ef5675_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityPremiumAndDeposit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums and deposits</link:label>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityPremiumAndDeposit_label_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityPremiumAndDeposit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability, Premium and Deposit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityPremiumAndDeposit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityPremiumAndDeposit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountLiabilityPremiumAndDeposit" xlink:to="lab_us-gaap_SeparateAccountLiabilityPremiumAndDeposit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_8e2dcf69-c71b-4266-8850-3165f42d6645_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on net cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_d8676987-cb04-44a6-ba73-9764fccd78a0_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_f52cca46-e3d4-4bed-acda-af37c78579b0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Value and Fair Value By Level of Fair Value Hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_7773b887-72af-4eea-9d22-97594af76a58_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_dddd0742-14a1-42b8-a872-083cc692b540_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium paid in excess of debt principal</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_5b62a984-eb5a-4d05-bcfb-d28a3d2a2e48_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee benefits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_cf515d18-1ae1-4a24-86fa-cc50ed80ee6a_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCorporateDebtSecuritiesMember_a76fc0c4-b90b-423c-a421-c8e840fed694_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign securities</link:label>
    <link:label id="lab_us-gaap_ForeignCorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Corporate, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_c26c5fd0-acb5-4d35-b6d5-53c08f622f4f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance_5c63482f-5067-4039-a887-cbf289c7570e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit, Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_521cd7f7-6f72-4fbc-97d3-c05a1ec8c854_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_e0763228-7d58-4514-acf2-ea45a6030a9a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9507561c-5c1f-41e5-9731-ef09bc2967cf_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_3894aa78-eae0-4a47-a207-65fb46a5cda5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit payments</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_18733f11-d426-4668-8fe4-e8f4db000b24_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred Health Care Claims, Net of Reinsurance</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_bc2e4967-3553-4bed-9787-2ba25ebfed97_verboseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plans and Other Postretirement Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_3e26a185-c5b2-4adf-82e6-958a0aa6221d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_8be97682-0521-40eb-a8fe-9d29846dafa6_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a3ad8131-a2b6-4969-8261-2118b72bad1f_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_29e49885-5184-46b0-9d3c-39a646737c3c_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of year balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c8d46273-b0bc-4531-882f-9b0916e34a23_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of year balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9a9d930c-9556-44fc-a758-5704375b837e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction to retained earnings as a result of new accounting standard adoption</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4aa3d3d2-9585-41c7-8cac-dea246d8c95c_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember_2fce1e4b-d55f-4ce7-97aa-421ac9eb10c4_terseLabel_en-US" xlink:label="lab_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lincoln Life &amp; Annuity Company of New York</link:label>
    <link:label id="lab_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember_label_en-US" xlink:label="lab_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lincoln Life &amp; Annuity Company Of New York [Member]</link:label>
    <link:label id="lab_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember_documentation_en-US" xlink:label="lab_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lincoln Life &amp; Annuity Company Of New York [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember" xlink:href="cvs-20230525.xsd#cvs_LincolnLifeAnnuityCompanyOfNewYorkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember" xlink:to="lab_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_fa8e6c76-0537-4cb3-8e4d-dfb6dfca2a72_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss and capital loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_8c76a547-3685-4cdc-bd76-2b7068c26f3b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_81ba0b41-8e6e-4fe4-8a7a-9987a25e98ae_terseLabel_en-US" xlink:label="lab_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for lease obligations:</link:label>
    <link:label id="lab_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_label_en-US" xlink:label="lab_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:label id="lab_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_documentation_en-US" xlink:label="lab_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:href="cvs-20230525.xsd#cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:to="lab_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_54c3f58c-b84f-4277-ab16-f6d9b1c8a75c_terseLabel_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield-related impairment loss</link:label>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_label_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings</link:label>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_documentation_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:href="cvs-20230525.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_fde9ab11-8a8f-487d-a11f-6d274f61ac3e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_302efd29-1b61-48d5-af41-9d373419b844_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Two</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" xlink:to="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LongTermInvestmentsIncludingAssetsHeldForSale_6917f12a-e082-4fc3-a77e-2abed3a6c66f_terseLabel_en-US" xlink:label="lab_cvs_LongTermInvestmentsIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term</link:label>
    <link:label id="lab_cvs_LongTermInvestmentsIncludingAssetsHeldForSale_label_en-US" xlink:label="lab_cvs_LongTermInvestmentsIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments, Including Assets Held For Sale</link:label>
    <link:label id="lab_cvs_LongTermInvestmentsIncludingAssetsHeldForSale_documentation_en-US" xlink:label="lab_cvs_LongTermInvestmentsIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments, Including Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermInvestmentsIncludingAssetsHeldForSale" xlink:href="cvs-20230525.xsd#cvs_LongTermInvestmentsIncludingAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LongTermInvestmentsIncludingAssetsHeldForSale" xlink:to="lab_cvs_LongTermInvestmentsIncludingAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_5b45bc8a-24fc-4fbd-b53a-118b207aedf1_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_f36aa542-8844-4dda-9727-c97473d89c90_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_7347a3a8-4678-4c5c-90fc-271261d30921_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_fd02b6c0-9874-473b-baa7-b3d7a8c8276e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_9168892b-2847-4a18-ab7e-2c68e2b832c5_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations attributable to CVS Health (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4PointThreePercentDue2028Member_fd34973e-fdbb-42fa-95c3-f2c3b929c733_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4PointThreePercentDue2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.3% senior notes due 2028</link:label>
    <link:label id="lab_cvs_SeniorNotes4PointThreePercentDue2028Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4PointThreePercentDue2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4 Point Three Percent, Due 2028 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4PointThreePercentDue2028Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4PointThreePercentDue2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4 Point Three Percent, Due 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4PointThreePercentDue2028Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4PointThreePercentDue2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4PointThreePercentDue2028Member" xlink:to="lab_cvs_SeniorNotes4PointThreePercentDue2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b71e4373-9bf6-469f-a80c-d0cdb8c7f92c_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.875DueAugust2047Member_d981d25e-a13c-4200-8365-c2c3a826e351_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% senior notes due August 2047</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueAugust2047Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due August 2047 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueAugust2047Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due August 2047 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueAugust2047Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.875DueAugust2047Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.875DueAugust2047Member" xlink:to="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fcf251a4-d2df-4802-b868-0e8901ce69e3_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_c267c88d-1054-4785-b618-605babb62643_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_cccb94d1-9c59-4dfa-a077-0e390bdba744_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_693ba09b-e8c3-4005-89c9-9648649de624_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_908d053a-8cbb-471a-a2ae-df8f094c9bd7_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_c6f99004-58ae-4a9d-9b40-d785cc34fe7e_terseLabel_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments</link:label>
    <link:label id="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_label_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Accounting Standards Update, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:to="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededCreditRiskReinsurerDomain_956853e5-2301-48aa-9138-cb4ec7a28805_terseLabel_en-US" xlink:label="lab_us-gaap_CededCreditRiskReinsurerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk, Reinsurer [Domain]</link:label>
    <link:label id="lab_us-gaap_CededCreditRiskReinsurerDomain_label_en-US" xlink:label="lab_us-gaap_CededCreditRiskReinsurerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurer, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskReinsurerDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskReinsurerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain" xlink:to="lab_us-gaap_CededCreditRiskReinsurerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.125DueJuly2045Member_c2fcc416-ca8d-4b61-a044-da329e3ae325_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.125% senior notes due July 2045</link:label>
    <link:label id="lab_cvs_SeniorNotes5.125DueJuly2045Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.125%, Due July 2045 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.125DueJuly2045Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.125%, Due July 2045 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.125DueJuly2045Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes5.125DueJuly2045Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.125DueJuly2045Member" xlink:to="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_3db4213c-333c-4195-9ae6-05dae9a92ed3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock_8d872d37-f507-4a8b-afe1-c2d269d03a94_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices Disclosure</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock" xlink:to="lab_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FederalCourtInOhioJudgmentMember_10f087e0-ff42-49c2-a070-0fbaef230b75_terseLabel_en-US" xlink:label="lab_cvs_FederalCourtInOhioJudgmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Court in Ohio Judgment</link:label>
    <link:label id="lab_cvs_FederalCourtInOhioJudgmentMember_label_en-US" xlink:label="lab_cvs_FederalCourtInOhioJudgmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Court In Ohio Judgment [Member]</link:label>
    <link:label id="lab_cvs_FederalCourtInOhioJudgmentMember_documentation_en-US" xlink:label="lab_cvs_FederalCourtInOhioJudgmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Court In Ohio Judgment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FederalCourtInOhioJudgmentMember" xlink:href="cvs-20230525.xsd#cvs_FederalCourtInOhioJudgmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FederalCourtInOhioJudgmentMember" xlink:to="lab_cvs_FederalCourtInOhioJudgmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_ef9b8900-d6f5-4072-9147-41c534330145_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment Income, Reported Amounts, by Category [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_957a7b76-5ee2-4377-b2b4-8522655e9bad_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a152b960-1ff0-4bbe-8721-d2069ee58ed1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_58f4fceb-4a7f-417c-9868-9ed67790e41a_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure_397d7d22-1209-4065-984b-ab6408e60039_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, fair value</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_6c40bbf7-3a2a-4776-a8a1-2120cb7b7599_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Reinsurance recoverable</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_8750e474-43f7-4381-9f9d-a2d31bd72e30_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Reinsurance recoverable</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_8c80a628-15c8-4150-a3a5-7978c81f0c1d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Reinsurance recoverable</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Reinsurance Recoverable, after Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_cdc51bf6-89e2-4ecf-9c58-8c3120ff8226_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceTableTextBlock_0562742d-e46b-4f17-ad48-676caee2625a_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Roll Forward of Policyholders' Funds</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceTableTextBlock_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountBalanceTableTextBlock" xlink:to="lab_us-gaap_PolicyholderAccountBalanceTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_a69a8857-947e-4ec4-aa98-16d22f3b84cc_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssumedPremiumsEarned_7e5c9f43-49bd-410c-a471-90b524f3a530_terseLabel_en-US" xlink:label="lab_us-gaap_AssumedPremiumsEarned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed</link:label>
    <link:label id="lab_us-gaap_AssumedPremiumsEarned_label_en-US" xlink:label="lab_us-gaap_AssumedPremiumsEarned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed Premiums Earned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssumedPremiumsEarned" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssumedPremiumsEarned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssumedPremiumsEarned" xlink:to="lab_us-gaap_AssumedPremiumsEarned" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale_ee9a8938-3ef7-420a-8030-80552820ee46_terseLabel_en-US" xlink:label="lab_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale_label_en-US" xlink:label="lab_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt And Lease Obligation, Including Liabilities Held For Sale</link:label>
    <link:label id="lab_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale_documentation_en-US" xlink:label="lab_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of long-term debt and lease obligation, including liabilities held for sale, classified as noncurrent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale" xlink:href="cvs-20230525.xsd#cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale" xlink:to="lab_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_78074c83-df1f-496b-8c7f-1871c72b1875_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and pharmacy claims and discounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeparateAccountOtherAssetBackedSecuritiesMember_97d6e738-dcea-46ff-b249-269d9d577918_terseLabel_en-US" xlink:label="lab_cvs_SeparateAccountOtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other asset-backed securities</link:label>
    <link:label id="lab_cvs_SeparateAccountOtherAssetBackedSecuritiesMember_label_en-US" xlink:label="lab_cvs_SeparateAccountOtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Other Asset-Backed Securities [Member]</link:label>
    <link:label id="lab_cvs_SeparateAccountOtherAssetBackedSecuritiesMember_documentation_en-US" xlink:label="lab_cvs_SeparateAccountOtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Other Asset-Backed Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeparateAccountOtherAssetBackedSecuritiesMember" xlink:href="cvs-20230525.xsd#cvs_SeparateAccountOtherAssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeparateAccountOtherAssetBackedSecuritiesMember" xlink:to="lab_cvs_SeparateAccountOtherAssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_9b5754c9-088d-4739-9e0c-19805a22f0bb_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues from transactions with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Other Revenues from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_97032bfa-f552-4a25-83be-24ab8c2636ac_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Paid Health Care Claims, Net of Reinsurance</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_68d4ea29-1453-4d6d-b34d-ff878279db1a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_be12608f-2691-4a9c-8e3e-91903bee5738_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percent</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_c479d8cf-8e00-4388-afaa-7c1db8cd557f_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Other Significant Reconciling Item [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Other Significant Reconciling Item [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceAccountingPolicy_69c389ce-1709-4763-a05e-31a7f8ee7208_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceAccountingPolicy_label_en-US" xlink:label="lab_us-gaap_ReinsuranceAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Accounting Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceAccountingPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceAccountingPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceAccountingPolicy" xlink:to="lab_us-gaap_ReinsuranceAccountingPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3Point625PercentApril2027Member_4f3e7b7c-a8c7-4ba0-9e2f-d0e0153fbf46_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3Point625PercentApril2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.625% senior notes due April 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes3Point625PercentApril2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3Point625PercentApril2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3 Point 625 Percent, April 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3Point625PercentApril2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3Point625PercentApril2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3 Point 625 Percent, April 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point625PercentApril2027Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3Point625PercentApril2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3Point625PercentApril2027Member" xlink:to="lab_cvs_SeniorNotes3Point625PercentApril2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.625DueJune2036Member_e4c3ea23-e9da-476e-9e41-8cba62f5e74e_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.625% senior notes due June 2036</link:label>
    <link:label id="lab_cvs_SeniorNotes6.625DueJune2036Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.625%, Due June 2036 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.625DueJune2036Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.625%, Due June 2036 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.625DueJune2036Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes6.625DueJune2036Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.625DueJune2036Member" xlink:to="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_40c77f63-593a-4308-9f25-155e64979ecc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_564e85bc-94f7-492a-8792-859774eb02d6_terseLabel_en-US" xlink:label="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Department of Health and Human Services, ACA Risk Corridor Receivables</link:label>
    <link:label id="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_label_en-US" xlink:label="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Department Of Health And Human Services, ACA Risk Corridor Receivables [Member]</link:label>
    <link:label id="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_documentation_en-US" xlink:label="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Department Of Health And Human Services, ACA Risk Corridor Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:href="cvs-20230525.xsd#cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:to="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_d7366707-4916-49a5-8cc7-5caea6baacd9_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Next Twelve Months</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" xlink:to="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates_c468b0f0-9d34-4773-957f-b74eff1530ea_terseLabel_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which the Company has entered the individual public health insurance exchange</link:label>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates_label_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Public Health Insurance Exchanges, Number Of States</link:label>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates_documentation_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Public Health Insurance Exchanges, Number Of States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates" xlink:href="cvs-20230525.xsd#cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates" xlink:to="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherLongTermInsuranceLiabilitiesMember_6170b4ed-624c-40a3-b517-91d85300e8aa_terseLabel_en-US" xlink:label="lab_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Insurance Liabilities</link:label>
    <link:label id="lab_cvs_OtherLongTermInsuranceLiabilitiesMember_label_en-US" xlink:label="lab_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Insurance Liabilities [Member]</link:label>
    <link:label id="lab_cvs_OtherLongTermInsuranceLiabilitiesMember_documentation_en-US" xlink:label="lab_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Insurance Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:href="cvs-20230525.xsd#cvs_OtherLongTermInsuranceLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:to="lab_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_bca543b7-833f-476d-876b-b2e4c912d88d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration_f299677b-a2e0-46cd-b612-bd0bcbaf4126_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average duration of long-duration insurance liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Weighted-Average Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1b4219e5-0400-464e-9bdb-9d76297a87b1_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, gross</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_58e3c5eb-9694-4cb4-8254-cb83e51133a2_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_6028c9ca-3033-4135-a703-94d7a68740e6_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to CVS Health (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_5cf58b77-de6a-4b61-ab67-c46eb2c7faab_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to CVS Health (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DeferredTaxLiabilitiesRetirementBenefits_04576193-0902-4523-a06a-bafcd09c1d8a_negatedTerseLabel_en-US" xlink:label="lab_cvs_DeferredTaxLiabilitiesRetirementBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement benefits</link:label>
    <link:label id="lab_cvs_DeferredTaxLiabilitiesRetirementBenefits_label_en-US" xlink:label="lab_cvs_DeferredTaxLiabilitiesRetirementBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Retirement Benefits</link:label>
    <link:label id="lab_cvs_DeferredTaxLiabilitiesRetirementBenefits_documentation_en-US" xlink:label="lab_cvs_DeferredTaxLiabilitiesRetirementBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Retirement Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxLiabilitiesRetirementBenefits" xlink:href="cvs-20230525.xsd#cvs_DeferredTaxLiabilitiesRetirementBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DeferredTaxLiabilitiesRetirementBenefits" xlink:to="lab_cvs_DeferredTaxLiabilitiesRetirementBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate_8da3c663-3f0d-4ad4-94ee-4ccf0d4f9ec0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest accretion rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Weighted-Average Interest Accretion Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockSharesHeldinTrust_cac9d965-1767-4f9c-abf4-6414dcbbdff2_terseLabel_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares held in trust (in shares)</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesHeldinTrust_label_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Held in Trust</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesHeldinTrust_documentation_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Held in Trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust" xlink:href="cvs-20230525.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockSharesHeldinTrust" xlink:to="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember_979d4c74-9751-4108-8079-4802dba3323a_terseLabel_en-US" xlink:label="lab_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VOYA Retirement Insurance and Annuity Company</link:label>
    <link:label id="lab_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember_label_en-US" xlink:label="lab_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VOYA Retirement Insurance And Annuity Company [Member]</link:label>
    <link:label id="lab_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember_documentation_en-US" xlink:label="lab_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VOYA Retirement Insurance And Annuity Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember" xlink:href="cvs-20230525.xsd#cvs_VOYARetirementInsuranceAndAnnuityCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember" xlink:to="lab_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_ba22429f-d2cc-4bc8-8ff7-287ab1c76d05_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified, pre-tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3784e541-e1f8-450d-8eff-c799577a9f1b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested in period, fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_4540a69b-b5d8-4b79-a1b3-48b6d0b8e220_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_aa16231a-2b1f-4202-b299-c9794f398129_verboseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f5542ff3-8b26-41cb-adb4-029f6a0961a7_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_c9f71540-adb7-4e5f-9e1a-3a37e6f1829a_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate/ Other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountBalancePolicyCharge_7cfa7e68-42c6-4d32-b1b0-f31f2eaaa2ee_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalancePolicyCharge" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policy charges</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountBalancePolicyCharge_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalancePolicyCharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Policy Charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalancePolicyCharge" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalancePolicyCharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountBalancePolicyCharge" xlink:to="lab_us-gaap_PolicyholderAccountBalancePolicyCharge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_6f5ef9cd-a167-4d65-b60a-c8c6265c985b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_50ee8a55-b404-4478-9408-4e17a8228321_terseLabel_en-US" xlink:label="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Subject to or Available for Operating Lease [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_label_en-US" xlink:label="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Subject to or Available for Operating Lease [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_927baad5-b746-48d9-9a23-59e1214f37c5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale-leaseback transactions</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lease Payment, Sales-Type and Direct Financing Leases, Investing Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" xlink:to="lab_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_ae1f5e36-b888-48d5-a197-aef142e3000d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_7916ab2c-ee8c-4c8f-ba54-009a3ee9ee06_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract_a1a58054-b8f9-48b1-a597-7b908cdc78ba_terseLabel_en-US" xlink:label="lab_cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions:</link:label>
    <link:label id="lab_cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract_label_en-US" xlink:label="lab_cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]</link:label>
    <link:label id="lab_cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract_documentation_en-US" xlink:label="lab_cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions:</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract" xlink:href="cvs-20230525.xsd#cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract" xlink:to="lab_cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_745b0d0a-bbd8-400b-bdbb-a08c19d6a712_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit Activity [Table]</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit Activity [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CashFlowLesseeAbstract_f6061da9-c14e-464e-b1e9-1b06d91a27f8_terseLabel_en-US" xlink:label="lab_cvs_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_cvs_CashFlowLesseeAbstract_label_en-US" xlink:label="lab_cvs_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Abstract]</link:label>
    <link:label id="lab_cvs_CashFlowLesseeAbstract_documentation_en-US" xlink:label="lab_cvs_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CashFlowLesseeAbstract" xlink:href="cvs-20230525.xsd#cvs_CashFlowLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CashFlowLesseeAbstract" xlink:to="lab_cvs_CashFlowLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_41f7f063-b9aa-4c94-a75e-5956911ef655_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededPremiumsEarned_6e0b94b0-5868-42dd-9619-2442eb474703_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CededPremiumsEarned" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded</link:label>
    <link:label id="lab_us-gaap_CededPremiumsEarned_label_en-US" xlink:label="lab_us-gaap_CededPremiumsEarned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Premiums Earned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededPremiumsEarned" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededPremiumsEarned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededPremiumsEarned" xlink:to="lab_us-gaap_CededPremiumsEarned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_226d4758-e011-4d14-8dfe-e19507c3373c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_d9d401f4-1a31-438a-9b8f-41f0b4d60f9e_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceContractAcquisitionCostTextBlock_4d84fd86-4817-45d2-80fc-f6eef73e8d3d_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceContractAcquisitionCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities and Separate Accounts</link:label>
    <link:label id="lab_us-gaap_InsuranceContractAcquisitionCostTextBlock_label_en-US" xlink:label="lab_us-gaap_InsuranceContractAcquisitionCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Contract, Acquisition Cost [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceContractAcquisitionCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceContractAcquisitionCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceContractAcquisitionCostTextBlock" xlink:to="lab_us-gaap_InsuranceContractAcquisitionCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LitigationSettlementNumberOfStatesElectedToJoin_fe3b7606-a4c8-4087-a133-8aa9156b7396_terseLabel_en-US" xlink:label="lab_cvs_LitigationSettlementNumberOfStatesElectedToJoin" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states that elected to join the settlement</link:label>
    <link:label id="lab_cvs_LitigationSettlementNumberOfStatesElectedToJoin_label_en-US" xlink:label="lab_cvs_LitigationSettlementNumberOfStatesElectedToJoin" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Number Of States Elected To Join</link:label>
    <link:label id="lab_cvs_LitigationSettlementNumberOfStatesElectedToJoin_documentation_en-US" xlink:label="lab_cvs_LitigationSettlementNumberOfStatesElectedToJoin" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Number Of States Elected To Join</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LitigationSettlementNumberOfStatesElectedToJoin" xlink:href="cvs-20230525.xsd#cvs_LitigationSettlementNumberOfStatesElectedToJoin"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LitigationSettlementNumberOfStatesElectedToJoin" xlink:to="lab_cvs_LitigationSettlementNumberOfStatesElectedToJoin" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_ff3b43c8-ff60-4573-91b6-5ac71ec852e5_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_49cb5330-66a8-48ad-b78d-199acc7f4c29_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalCreditAssessmentDomain_65d9dc31-7f81-4f03-bebe-98852ea12f60_terseLabel_en-US" xlink:label="lab_us-gaap_InternalCreditAssessmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Credit Assessment [Domain]</link:label>
    <link:label id="lab_us-gaap_InternalCreditAssessmentDomain_label_en-US" xlink:label="lab_us-gaap_InternalCreditAssessmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Credit Assessment [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalCreditAssessmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain" xlink:to="lab_us-gaap_InternalCreditAssessmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_888fd460-8ddf-4597-8e9b-a8c3277d814e_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_c3988bde-8918-4706-a9c0-d9ff9dd3bc40_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock_8fe26501-a400-4b33-aa76-fefb81c45013_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:to="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount_89c9fc8f-fbf9-4814-aa19-24067965367d_terseLabel_en-US" xlink:label="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for ASR, amount</link:label>
    <link:label id="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount_label_en-US" xlink:label="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Accelerated Share Repurchases, Amount</link:label>
    <link:label id="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount_documentation_en-US" xlink:label="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Accelerated Share Repurchases, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:href="cvs-20230525.xsd#cvs_PaymentsForAcceleratedShareRepurchasesAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:to="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_192e2433-4c99-483d-bf75-a93af6796eaa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OmnicareLongTermCareBusinessMember_1b8993af-c020-4b75-b2a8-cc4699e803d7_terseLabel_en-US" xlink:label="lab_cvs_OmnicareLongTermCareBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Omnicare Long-Term Care Business</link:label>
    <link:label id="lab_cvs_OmnicareLongTermCareBusinessMember_label_en-US" xlink:label="lab_cvs_OmnicareLongTermCareBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Omnicare Long-Term Care Business [Member]</link:label>
    <link:label id="lab_cvs_OmnicareLongTermCareBusinessMember_documentation_en-US" xlink:label="lab_cvs_OmnicareLongTermCareBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Omnicare Long-Term Care Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OmnicareLongTermCareBusinessMember" xlink:href="cvs-20230525.xsd#cvs_OmnicareLongTermCareBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OmnicareLongTermCareBusinessMember" xlink:to="lab_cvs_OmnicareLongTermCareBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_abb5cb55-89a1-459a-8b6b-dccad0ee1a2b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_0dbe8f69-27e0-4527-8c2e-7d8afe76d987_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstate_1079ce95-4923-4011-8095-c08219f623e4_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstate_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstate" xlink:to="lab_us-gaap_MortgageLoansOnRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_e47e92c6-546d-4e38-a583-fdd74fc76e0d_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax penalties and interest expense</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_bafeb5b4-ae51-4826-ac1b-9553f3a33032_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BackUpCreditFacilitiesMember_76f923b9-0e2f-4f50-bcfc-87a3f0a01bf5_terseLabel_en-US" xlink:label="lab_cvs_BackUpCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Back-Up Credit Facilities</link:label>
    <link:label id="lab_cvs_BackUpCreditFacilitiesMember_label_en-US" xlink:label="lab_cvs_BackUpCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Back-Up Credit Facilities [Member]</link:label>
    <link:label id="lab_cvs_BackUpCreditFacilitiesMember_documentation_en-US" xlink:label="lab_cvs_BackUpCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Back-Up Credit Facilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BackUpCreditFacilitiesMember" xlink:href="cvs-20230525.xsd#cvs_BackUpCreditFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BackUpCreditFacilitiesMember" xlink:to="lab_cvs_BackUpCreditFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_a11e9caf-44c3-4fcc-bf4d-22d6faf75fa6_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_c6937c3b-5369-45fb-ab9c-77646d1ff9bb_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCreditedToPolicyholdersAccountBalances_70ebe0fc-2622-476a-987a-1fb9494fa321_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCreditedToPolicyholdersAccountBalances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest credited</link:label>
    <link:label id="lab_us-gaap_InterestCreditedToPolicyholdersAccountBalances_label_en-US" xlink:label="lab_us-gaap_InterestCreditedToPolicyholdersAccountBalances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCreditedToPolicyholdersAccountBalances" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCreditedToPolicyholdersAccountBalances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCreditedToPolicyholdersAccountBalances" xlink:to="lab_us-gaap_InterestCreditedToPolicyholdersAccountBalances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_b5119821-b9d5-44c4-8db2-64dbcee706c3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross transfers into Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_13c623e6-4b9a-4482-9f59-87966b4d8e55_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_3e5622b1-1259-4d86-b999-74d00c7cc211_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement losses</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LongTermCareReportingUnitMember_013155b7-a239-474b-9e48-bd5acfab6040_terseLabel_en-US" xlink:label="lab_cvs_LongTermCareReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Care Reporting Unit</link:label>
    <link:label id="lab_cvs_LongTermCareReportingUnitMember_label_en-US" xlink:label="lab_cvs_LongTermCareReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Care Reporting Unit [Member]</link:label>
    <link:label id="lab_cvs_LongTermCareReportingUnitMember_documentation_en-US" xlink:label="lab_cvs_LongTermCareReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Care Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareReportingUnitMember" xlink:href="cvs-20230525.xsd#cvs_LongTermCareReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LongTermCareReportingUnitMember" xlink:to="lab_cvs_LongTermCareReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_7e5b82ef-c8ce-4add-9f04-182c43d3ef47_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_7e90d39b-5338-41ce-a4d7-b3ad50e94bfc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ec9aea08-52be-4238-af45-135813f81140_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price exercisable at end of year ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueDuePolicyholdersAmount_e8e98033-34b0-4e39-a048-f6d99b726a7f_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueDuePolicyholdersAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash surrender value</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueDuePolicyholdersAmount_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueDuePolicyholdersAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Cash Surrender Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueDuePolicyholdersAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueDuePolicyholdersAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueDuePolicyholdersAmount" xlink:to="lab_us-gaap_CashSurrenderValueDuePolicyholdersAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_480268c7-a50a-416e-bdfc-e131c4c18b01_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_9bf1f62e-0df3-4dee-ae54-f63ffd50ad6e_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_18a24402-27d4-48ce-8710-b8a19206b342_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_059f2c31-2dd5-4dcb-9dd2-e4eb15e2337a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows paid for principal portion of finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements_26c51b5f-ba61-4ba9-80a4-e27415a82212_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal charges</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PaymentsForInsuranceBenefits_354deda3-00b8-43a6-a152-d757f9c14041_negatedTerseLabel_en-US" xlink:label="lab_cvs_PaymentsForInsuranceBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance benefits paid</link:label>
    <link:label id="lab_cvs_PaymentsForInsuranceBenefits_label_en-US" xlink:label="lab_cvs_PaymentsForInsuranceBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Insurance Benefits</link:label>
    <link:label id="lab_cvs_PaymentsForInsuranceBenefits_documentation_en-US" xlink:label="lab_cvs_PaymentsForInsuranceBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Insurance Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForInsuranceBenefits" xlink:href="cvs-20230525.xsd#cvs_PaymentsForInsuranceBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PaymentsForInsuranceBenefits" xlink:to="lab_cvs_PaymentsForInsuranceBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale_65277f26-91cf-4f51-b4a7-26a4cb77c26f_totalLabel_en-US" xlink:label="lab_cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale_label_en-US" xlink:label="lab_cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant And Equipment, Net, Including Assets Held For Sale</link:label>
    <link:label id="lab_cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale_documentation_en-US" xlink:label="lab_cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant And Equipment, Net, Including Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale" xlink:href="cvs-20230525.xsd#cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale" xlink:to="lab_cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount_abe53d27-a873-4c56-aa40-0ec573fb5e88_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash surrender value, end of the period</link:label>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount_label_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability, Cash Surrender Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount" xlink:to="lab_us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_ed10d5c1-ae43-4667-830a-a29b6d66dd94_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity_d8584956-996f-4820-aab6-8044fdf9a210_terseLabel_en-US" xlink:label="lab_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charitable contribution to CVS Health Foundation</link:label>
    <link:label id="lab_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity_label_en-US" xlink:label="lab_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Charitable Contribution To Non-Profit Entity</link:label>
    <link:label id="lab_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity_documentation_en-US" xlink:label="lab_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Charitable Contribution To Non-Profit Entity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity" xlink:href="cvs-20230525.xsd#cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity" xlink:to="lab_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_96c0f579-53c4-4dbb-bf18-4911552da0da_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_bc858928-e930-431e-a6a6-7ac53130a026_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current taxes</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_ff21e546-e3ea-45b2-8a41-f9acc9ea59cf_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate_f677cd59-4a9a-4d78-857e-373c350c370b_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average crediting rate</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Weighted Average Crediting Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate" xlink:to="lab_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember_cadc6b3d-e1b1-4375-a21d-e8e36c71c56b_terseLabel_en-US" xlink:label="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common/collective trusts, Equity Securities</link:label>
    <link:label id="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember_label_en-US" xlink:label="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Common Collective Trust, Equity Securities [Member]</link:label>
    <link:label id="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember_documentation_en-US" xlink:label="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Common Collective Trust, Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" xlink:href="cvs-20230525.xsd#cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" xlink:to="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearTwo_3b5260de-ca8d-4a01-99eb-272844cf8538_totalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearTwo_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearTwo" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearTwo" xlink:to="lab_cvs_LesseeLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_a998e571-a3fe-46f3-a340-52877f40f331_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_9d46b91f-646c-4052-bfb7-9fb5aa7d423a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price vested at end of year and expected to vest in the future ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HeathSavingsAccountBalance_a4909416-f255-4c57-9617-d5dbd4c6c2e0_terseLabel_en-US" xlink:label="lab_cvs_HeathSavingsAccountBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HSA balances</link:label>
    <link:label id="lab_cvs_HeathSavingsAccountBalance_label_en-US" xlink:label="lab_cvs_HeathSavingsAccountBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heath Savings Account Balance</link:label>
    <link:label id="lab_cvs_HeathSavingsAccountBalance_documentation_en-US" xlink:label="lab_cvs_HeathSavingsAccountBalance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heath Savings Account Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeathSavingsAccountBalance" xlink:href="cvs-20230525.xsd#cvs_HeathSavingsAccountBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HeathSavingsAccountBalance" xlink:to="lab_cvs_HeathSavingsAccountBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.75DueNovember2022Member_aa3fc3d6-d9fb-401a-aed5-fa2d16bcb643_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.75% senior notes due November 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueNovember2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due November 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueNovember2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due November 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueNovember2022Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2.75DueNovember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.75DueNovember2022Member" xlink:to="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RedeemablePreferredSecuritiesMember_5bfbd697-b0d8-48f0-9f4c-04b30dbfaf95_terseLabel_en-US" xlink:label="lab_cvs_RedeemablePreferredSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable preferred securities</link:label>
    <link:label id="lab_cvs_RedeemablePreferredSecuritiesMember_label_en-US" xlink:label="lab_cvs_RedeemablePreferredSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Securities [Member]</link:label>
    <link:label id="lab_cvs_RedeemablePreferredSecuritiesMember_documentation_en-US" xlink:label="lab_cvs_RedeemablePreferredSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RedeemablePreferredSecuritiesMember" xlink:href="cvs-20230525.xsd#cvs_RedeemablePreferredSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RedeemablePreferredSecuritiesMember" xlink:to="lab_cvs_RedeemablePreferredSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_0aded29f-1985-496b-ac34-f03f28f81fdf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_f36c24a7-d934-48a1-9081-cef67d25e483_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPolicyholderFunds_6d0f2e7a-6cd5-457f-8de6-400250906dd2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholders&#8217; funds</link:label>
    <link:label id="lab_us-gaap_OtherPolicyholderFunds_label_en-US" xlink:label="lab_us-gaap_OtherPolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Policyholder Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPolicyholderFunds" xlink:to="lab_us-gaap_OtherPolicyholderFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_ccfff218-a6b2-4ca1-8b68-7d8b75726c45_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_78c4bdd5-c61f-4625-a57b-717fb00dfd32_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_70b15c01-4889-4a16-a805-622a883ce178_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_23b0ab47-fbed-4115-b8bd-29b1fee12d7e_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of the period</link:label>
    <link:label id="lab_us-gaap_Goodwill_b093105e-03c9-4489-b1e3-be0099a9d6be_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of the period</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_5f15c833-bc47-495f-82cd-794198cb641e_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Balance Sheet:</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract_label_en-US" xlink:label="lab_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care and Other Insurance Liabilities [Abstract]</link:label>
    <link:label id="lab_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract_documentation_en-US" xlink:label="lab_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care and Other Insurance Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract" xlink:href="cvs-20230525.xsd#cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract" xlink:to="lab_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_fbde64b6-8b3c-4a2c-abd7-4605196036d6_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bef12133-94a1-47f5-ac77-773fb4a319cc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_ccaff516-19e2-411f-a43a-ea08faa49a45_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_453a5a6b-7114-432e-a09d-ff50bc83df1d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized investment gains (losses)</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_ac755c59-fb6f-4b39-a05d-24932be377cc_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_e449b11e-e1c4-4721-8724-4d6aedf42d10_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_d71c00a6-7c80-4f15-8227-d333ff4d9903_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_2fa4f7b8-76b6-4523-b2c6-bfde5a580b5d_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_db580817-6411-4e0c-8075-2f7b5551a0e5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_4bfcba58-cb8d-4a17-acbf-21444e78f5cd_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_9c978f09-b315-4dca-a95e-289bd891bcb3_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d763fe3b-b0ca-4ce2-9eb5-2bca0dc981aa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_0d668eab-724b-4a80-aeb7-ce73c929d746_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange_a7693d3b-4eb8-41c7-aedd-d0916a5ab15d_terseLabel_en-US" xlink:label="lab_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for future policy benefits, beginning of period - current discount rate</link:label>
    <link:label id="lab_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange_label_en-US" xlink:label="lab_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Expected Future Policy Benefit, Before Reinsurance, Before Discount Rate Change</link:label>
    <link:label id="lab_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange_documentation_en-US" xlink:label="lab_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Expected Future Policy Benefit, Before Reinsurance, Before Discount Rate Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange" xlink:href="cvs-20230525.xsd#cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange" xlink:to="lab_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BusinessCombinationTerminationFee_2a5f950c-8f42-45be-9a9c-0281ba1a0942_terseLabel_en-US" xlink:label="lab_cvs_BusinessCombinationTerminationFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination fee</link:label>
    <link:label id="lab_cvs_BusinessCombinationTerminationFee_label_en-US" xlink:label="lab_cvs_BusinessCombinationTerminationFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Termination Fee</link:label>
    <link:label id="lab_cvs_BusinessCombinationTerminationFee_documentation_en-US" xlink:label="lab_cvs_BusinessCombinationTerminationFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Termination Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationTerminationFee" xlink:href="cvs-20230525.xsd#cvs_BusinessCombinationTerminationFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BusinessCombinationTerminationFee" xlink:to="lab_cvs_BusinessCombinationTerminationFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_bb954640-391e-4f88-a33b-eacb34152949_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_82d6ca92-dc3c-42b6-ab78-1d85230028a1_terseLabel_en-US" xlink:label="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of changes in discount rate assumptions</link:label>
    <link:label id="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_label_en-US" xlink:label="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Liability for Future Policy Benefit, Expected Net Premium, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" xlink:to="lab_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_9b77e638-81c8-49eb-9ab3-bb049c4257b1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_705754c0-cc3d-489c-a7bb-c8bff7781b42_totalLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_b9d05c28-bbe1-4623-ba11-0cdc8cbecef1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_8acaf4d7-83bf-4df5-9c84-3cb7d22c2278_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_64408b7d-5ef4-41d0-b3b2-5d544a23f6f4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4DueDecember2023Member_1e09b1c8-e140-45a0-b05e-eba918064973_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4% senior notes due December 2023</link:label>
    <link:label id="lab_cvs_SeniorNotes4DueDecember2023Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4%, Due December 2023 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4DueDecember2023Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4%, Due December 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4DueDecember2023Member" xlink:to="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_2afe7db0-8182-45a8-9c3f-1eb48094e2e8_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related integration costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_73ed1876-8491-4a8d-bb2f-309248f5e1c2_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_f5996d55-d0ce-4a70-abda-7355a6c0396c_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, New Mortgage Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_df3c56d2-1648-40fa-98cf-76ef1d1e5973_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning liability for future policy benefits at original (locked-in) discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_90a8e562-ab4d-4ef1-8e9a-a3bbf569e7ee_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending liability for future policy benefits at original (locked-in) discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Cash Flow and Reinsurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_6b28be83-e3e9-46a7-8ff5-8cb5ea9b6d75_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities reflected in accrued expenses</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_13c38623-cc30-4baa-baa8-70b19b0f6948_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c1b2fbab-bb7b-4a68-b09e-73bd402b88a2_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_38c92272-47bf-4e6c-b297-3d7cab0bfb76_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at the end of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_706dd349-e29d-4c62-bd67-5915afa3e7f5_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f00760cb-103f-4b12-b1ea-74750bc07aac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.375DueAugust2024Member_44c4ff3c-e8b3-4d25-a093-0296da545e23_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% senior notes due August 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes3.375DueAugust2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.375%, Due August 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.375DueAugust2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.375%, Due August 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.375DueAugust2024Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.375DueAugust2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.375DueAugust2024Member" xlink:to="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectsOfReinsuranceTableTextBlock_a624855c-b333-47bb-bf69-2d3ef394c853_terseLabel_en-US" xlink:label="lab_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Impact of Reinsurance on Benefit Costs</link:label>
    <link:label id="lab_us-gaap_EffectsOfReinsuranceTableTextBlock_label_en-US" xlink:label="lab_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of Reinsurance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectsOfReinsuranceTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:to="lab_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LongTermCareMember_8d28de3e-b8e9-4e5c-afa8-5bd5508a010a_terseLabel_en-US" xlink:label="lab_cvs_LongTermCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Care</link:label>
    <link:label id="lab_cvs_LongTermCareMember_label_en-US" xlink:label="lab_cvs_LongTermCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Care [Member]</link:label>
    <link:label id="lab_cvs_LongTermCareMember_documentation_en-US" xlink:label="lab_cvs_LongTermCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Care</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareMember" xlink:href="cvs-20230525.xsd#cvs_LongTermCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LongTermCareMember" xlink:to="lab_cvs_LongTermCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_96075106-1465-4992-974b-6021b51e6681_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_2ff71355-50af-4f6b-b7bc-a3192820aadd_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash received from stock options exercised (including ESPP)</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ffede14d-00e1-4327-8657-9c1cb813045f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual term vested at end of year and expected to vest in the future</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ChangeInContractWithCustomerLiabilityRollForward_b95c9b40-96fa-42c4-8ad0-0581e21604e1_terseLabel_en-US" xlink:label="lab_cvs_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_cvs_ChangeInContractWithCustomerLiabilityRollForward_label_en-US" xlink:label="lab_cvs_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract With Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_cvs_ChangeInContractWithCustomerLiabilityRollForward_documentation_en-US" xlink:label="lab_cvs_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract With Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeInContractWithCustomerLiabilityRollForward" xlink:href="cvs-20230525.xsd#cvs_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ChangeInContractWithCustomerLiabilityRollForward" xlink:to="lab_cvs_ChangeInContractWithCustomerLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_4ed33dde-ca08-44c9-8f94-58f376633443_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities (included in accrued expenses)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_f3f01016-4aaa-48ac-a349-36ca654d7b12_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities, beginning of period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_f2bb7416-6660-4181-ac66-f8e5e9baa819_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities, end of period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.75DueMarch2044Member_36809c1d-ac50-4b54-8d7f-4a8839b58c7d_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% senior notes due March 2044</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueMarch2044Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due March 2044 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueMarch2044Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due March 2044 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueMarch2044Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.75DueMarch2044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.75DueMarch2044Member" xlink:to="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_a0c1896f-a6c7-4e22-8323-763ce35cec29_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_f5196208-e0f2-4167-a13f-72604e301cb7_terseLabel_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP issuances, net of purchase of treasury shares</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net Of Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_documentation_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net Of Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:href="cvs-20230525.xsd#cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:to="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_4730ed9b-a7b4-4299-829f-fa2f25b1c27b_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total CVS Health Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_145da95a-a837-4bcb-be0a-5d78d3cfbe01_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_c15b78db-c008-4aa1-a95b-db170782d7d0_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_4711040a-cc7f-47df-9845-dbe54a26db05_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_2891108a-c3c4-4bba-b3d6-18bedd5478b9_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_490ecc95-5029-40f5-a086-69dc936f629d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of actual variances from expected experience</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) of Actual Variance from Expected Experience</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_eb84eb3e-4dab-464d-a48b-6df4a12b99b7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDue_fc7147af-775e-4744-81e3-a63a98a15b52_totalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDue_label_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDue_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDue" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue" xlink:to="lab_cvs_LesseeLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansMember_4f147e29-f766-405b-8966-d44bb67966e6_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_cvs_MortgageLoansMember_label_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans [Member]</link:label>
    <link:label id="lab_cvs_MortgageLoansMember_documentation_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents mortgage loans for the reporting period measured at carrying value. We carry the value of our mortgage loan investments on our balance sheet at the unpaid principal balance, net of impairment reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansMember" xlink:to="lab_cvs_MortgageLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_2a42b2c8-eee8-42ae-8aa3-067b81a81b96_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4affe400-b318-4883-9340-5d2c58a2e782_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_dc59fe94-261b-40f4-81df-648e09fcaa8d_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearThree_7d674113-6e9c-4af5-a9f2-4eb9f47de39a_totalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearThree_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearThree" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearThree" xlink:to="lab_cvs_LesseeLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange_d5991326-c9d1-4c65-a2a4-ccebe3a6027f_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange_label_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability, Increase (Decrease) from Other Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange" xlink:to="lab_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet_0d160e7e-ee8d-4673-8f95-7fe967fef953_terseLabel_en-US" xlink:label="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains from sale-leaseback transactions</link:label>
    <link:label id="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet_label_en-US" xlink:label="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale and Leaseback Transaction, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:to="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_4f36aa8d-dcef-4e4c-a3e0-6681403ac085_verboseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, Divestitures and Asset Sales</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_166821c8-d979-429f-8cc8-1e6552b3678e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_352c036b-7642-44f1-b2b1-fa403bc4f8f9_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_cdbc70a6-3d14-45ce-bd9a-f8a6fc742183_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis difference upon disposition of subsidiary</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposition of Business, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_36727368-fa09-447e-9d69-ea2bc9b8e149_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_aee4253b-cf89-4c60-a8a1-e1020dcc81dc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ProceedsFromVariableInterestEntity_89c923fc-3ade-44bb-8415-5ebb1e4f3bbe_terseLabel_en-US" xlink:label="lab_cvs_ProceedsFromVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from VIE</link:label>
    <link:label id="lab_cvs_ProceedsFromVariableInterestEntity_label_en-US" xlink:label="lab_cvs_ProceedsFromVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Variable Interest Entity</link:label>
    <link:label id="lab_cvs_ProceedsFromVariableInterestEntity_documentation_en-US" xlink:label="lab_cvs_ProceedsFromVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Variable Interest Entity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsFromVariableInterestEntity" xlink:href="cvs-20230525.xsd#cvs_ProceedsFromVariableInterestEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ProceedsFromVariableInterestEntity" xlink:to="lab_cvs_ProceedsFromVariableInterestEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes43Due2028Member_34cc0c56-dff8-4a45-bcc2-facb16b705ab_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes43Due2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.3% senior notes due 2028</link:label>
    <link:label id="lab_cvs_SeniorNotes43Due2028Member_label_en-US" xlink:label="lab_cvs_SeniorNotes43Due2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due 2028 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes43Due2028Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes43Due2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes43Due2028Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes43Due2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes43Due2028Member" xlink:to="lab_cvs_SeniorNotes43Due2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_7e660006-fb5e-4dbc-bc81-1e4fc51050e6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares exercisable at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3caa643f-9137-4c3c-a733-cd9f64200027_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsLineItems_18d76804-e034-48f1-a506-69b41855c7d2_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Line Items]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsLineItems_label_en-US" xlink:label="lab_cvs_TotalInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems" xlink:href="cvs-20230525.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsLineItems" xlink:to="lab_cvs_TotalInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_868d1720-e82d-4000-a0b3-6cbcf0882b06_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1b98522b-3f91-4d4c-8fab-069dc50ef990_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of common stock percent</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_12eda71e-b32f-42d2-8486-58a6648c3061_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Claims paid</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesMember_8e3f377a-6797-4322-bc64-75dab21863b2_terseLabel_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesMember_label_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities [Member]</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesMember_documentation_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesMember" xlink:href="cvs-20230525.xsd#cvs_OtherInsuranceLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherInsuranceLiabilitiesMember" xlink:to="lab_cvs_OtherInsuranceLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_e43b8398-ce3a-4015-98e6-d3226d14a151_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_257e9b30-4af5-4ad0-a515-ecc9a8dcc3b4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate_de6f3085-370e-4df4-a105-28a5ea9207a3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Current Weighted-Average Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_a74fd6cd-6857-401a-9818-16f6f7752456_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_f5ba34c6-0818-4c4d-a1d6-38e3bf3c987f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease term (in years)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BarclaysBankMember_f2a93db4-064e-40fe-a107-3a2b6936c964_terseLabel_en-US" xlink:label="lab_cvs_BarclaysBankMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays Bank</link:label>
    <link:label id="lab_cvs_BarclaysBankMember_label_en-US" xlink:label="lab_cvs_BarclaysBankMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays Bank [Member]</link:label>
    <link:label id="lab_cvs_BarclaysBankMember_documentation_en-US" xlink:label="lab_cvs_BarclaysBankMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays Bank</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BarclaysBankMember" xlink:href="cvs-20230525.xsd#cvs_BarclaysBankMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BarclaysBankMember" xlink:to="lab_cvs_BarclaysBankMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_619c81de-e7e7-487d-bdb3-9d3307203723_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_b7473c14-1a34-41d2-8962-afff7b54d3f4_terseLabel_en-US" xlink:label="lab_cvs_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share from continuing operations:</link:label>
    <link:label id="lab_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_label_en-US" xlink:label="lab_cvs_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic And Diluted EPS [Abstract]</link:label>
    <link:label id="lab_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_documentation_en-US" xlink:label="lab_cvs_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic And Diluted EPS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:href="cvs-20230525.xsd#cvs_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:to="lab_cvs_EarningsPerShareBasicAndDilutedEPSAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_3005dc4b-8c55-4670-af96-52c1ad7db969_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities_9ba659e4-1054-475f-b083-377070554910_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable and other insurance liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Insurance Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_f9b3dbb0-8b7e-47bb-97dd-e9539f09cfd6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_f4dce979-f88b-41ac-b6ee-df55094e54ed_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected_dd602554-e23d-4c0a-862a-8377f93735ce_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net premiums (actual)</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Net Premium, Net Premium Collected</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_b112d485-5dd7-4734-89d9-ba20aec7fc7f_terseLabel_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities available for sale</link:label>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_label_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt And Equity Securities Available For Sale [Member]</link:label>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_documentation_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in debt and equity securities which are categorized neither as trading securities nor held-to-maturity securities. Such securities are reported at fair value; unrealized gains and losses related to Available-for-sale securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:href="cvs-20230525.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:to="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_222626e5-78d2-44d8-9bdc-97659d8b3e06_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows paid for operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateForeclosures_f599f186-6e4e-4013-bde6-476621d69ed4_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans foreclosed</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateForeclosures_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Foreclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8ade2170-15b3-4958-af37-ffa69342718c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of expected net premiums</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_a1506bc3-d05f-47ff-be79-b4130b33f925_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_b1ac48c8-9418-448c-b1ed-94fd584fd11c_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemed principal amount</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_e2a17a94-1a39-48e3-bf68-8d1f6c1ba98d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_4660c240-ac0a-4cc1-b186-67873995774a_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_b35bf137-7882-4f23-a7a0-7b245c098562_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumptions used to determine benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_c3c5a79d-180f-4567-8157-e3724dea5e09_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost: 458 and 422 shares at December&#160;31, 2022 and 2021</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_467e312d-483f-46df-bda7-234706c79570_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f0023963-eb6c-4bc2-9f9f-24daa6eb0c66_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_4133bc60-cbcc-4072-b156-068c59e4251d_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated statutory capital and surplus</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Capital and Surplus, Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_34905d31-a795-42b1-8730-00df6f702904_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale_f2ae97b8-4734-476b-ab4d-0b8b07d5de21_terseLabel_en-US" xlink:label="lab_cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale_label_en-US" xlink:label="lab_cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Including Liabilities Held For Sale</link:label>
    <link:label id="lab_cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale_documentation_en-US" xlink:label="lab_cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Including Liabilities Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale" xlink:href="cvs-20230525.xsd#cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale" xlink:to="lab_cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_e59c1715-3fc9-4fcd-ae4d-3570ca58e614_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option activity, stock awards and other</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_5cf2d5dd-f7c0-4321-868f-3597497d15f6_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self insurance liabilities</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self Insurance Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReserve" xlink:to="lab_us-gaap_SelfInsuranceReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_27a865da-8919-4aea-9963-6a0b60c8b130_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TransferOfSharesToTreasuryStockValue_0919a247-58b9-44b6-baf8-d986fe3fecc8_terseLabel_en-US" xlink:label="lab_cvs_TransferOfSharesToTreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of shares to treasury stock value</link:label>
    <link:label id="lab_cvs_TransferOfSharesToTreasuryStockValue_label_en-US" xlink:label="lab_cvs_TransferOfSharesToTreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer Of Shares To Treasury Stock Value</link:label>
    <link:label id="lab_cvs_TransferOfSharesToTreasuryStockValue_documentation_en-US" xlink:label="lab_cvs_TransferOfSharesToTreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer Of Shares To Treasury Stock Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TransferOfSharesToTreasuryStockValue" xlink:href="cvs-20230525.xsd#cvs_TransferOfSharesToTreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TransferOfSharesToTreasuryStockValue" xlink:to="lab_cvs_TransferOfSharesToTreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_37adf700-f22a-4ce2-b6bf-848f6755e95c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_eb70690f-bcad-4d3f-86a1-9e5ebcba6153_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_b874ee77-da53-4e2a-984b-557786a4aadf_negatedTerseLabel_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_label_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, Accumulated Depreciation</link:label>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_documentation_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, Accumulated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation" xlink:href="cvs-20230525.xsd#cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation" xlink:to="lab_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_51d0c122-4f89-4bf6-b2cf-56a800a84736_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax_41ef0a6f-2632-44ac-8c73-b9d4f488c19a_negatedTerseLabel_en-US" xlink:label="lab_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction to accumulated other comprehensive income (loss), before tax</link:label>
    <link:label id="lab_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Before Tax</link:label>
    <link:label id="lab_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax_documentation_en-US" xlink:label="lab_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax" xlink:href="cvs-20230525.xsd#cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_77dd3bfb-d01d-4851-99b3-d2472be2c474_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold_61acddf3-2bd6-40ce-92b8-b5bfe68390ca_terseLabel_en-US" xlink:label="lab_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of international health care members, renewal rights sold</link:label>
    <link:label id="lab_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold_label_en-US" xlink:label="lab_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Number Of International Health Care Members, Renewal Rights Sold</link:label>
    <link:label id="lab_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold_documentation_en-US" xlink:label="lab_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Number Of International Health Care Members, Renewal Rights Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold" xlink:href="cvs-20230525.xsd#cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold" xlink:to="lab_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.75DueDecember2037Member_76de9c25-c80c-41ae-8fbf-05ed9e30ee9d_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.75% senior notes due December 2037</link:label>
    <link:label id="lab_cvs_SeniorNotes6.75DueDecember2037Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.75%, Due December 2037 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.75DueDecember2037Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.75%, Due December 2037 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.75DueDecember2037Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes6.75DueDecember2037Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.75DueDecember2037Member" xlink:to="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_8720c6e5-5c29-4977-8d2f-cc004767805e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableLineItems_8351f1b8-03d0-4dc3-9747-7475f0a933f4_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Line Items]</link:label>
    <link:label id="lab_us-gaap_DividendsPayableLineItems_label_en-US" xlink:label="lab_us-gaap_DividendsPayableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableLineItems" xlink:to="lab_us-gaap_DividendsPayableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange_297a3ec4-9585-4823-8fdd-f362f431b79a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of changes in cash flow assumptions</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) from Cash Flow Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_3cab5dec-dae1-4677-a31d-f135172ac5b4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6aaf96d2-be13-4ab2-9223-34de28d17030_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_d242cd9a-395e-43df-a383-6d880f4d3c27_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Periodic Benefit Cost (Income)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountsPolicy_8142875e-6b0c-486b-8be4-438d71147c8a_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Accounts</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountsPolicy" xlink:to="lab_us-gaap_PolicyholderAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefits_00bcaad8-0dea-41a4-ab41-293e2a0e1b12_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for future policy benefits</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefits_f4a9e5f4-9381-42f1-a89f-fd12d0a28562_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net liability for future policy benefits</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefits_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, before Reinsurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefits" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_592f2283-a8bc-4023-b30a-0ece65783ebc_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_be36c704-ebc8-4912-a583-fd60a2ca88ab_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_d685cad5-afbf-4a82-9d6d-569f71a5887f_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ValueOfBusinessAcquiredMember_53a4b62b-45c8-4638-8db5-67a65ce61957_terseLabel_en-US" xlink:label="lab_cvs_ValueOfBusinessAcquiredMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Business Acquired</link:label>
    <link:label id="lab_cvs_ValueOfBusinessAcquiredMember_label_en-US" xlink:label="lab_cvs_ValueOfBusinessAcquiredMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Of Business Acquired [Member]</link:label>
    <link:label id="lab_cvs_ValueOfBusinessAcquiredMember_documentation_en-US" xlink:label="lab_cvs_ValueOfBusinessAcquiredMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Of Business Acquired [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ValueOfBusinessAcquiredMember" xlink:href="cvs-20230525.xsd#cvs_ValueOfBusinessAcquiredMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ValueOfBusinessAcquiredMember" xlink:to="lab_cvs_ValueOfBusinessAcquiredMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.875DueJuly2025Member_e63ec7b9-1278-4ba3-8df8-58774d226575_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% senior notes due July 2025</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueJuly2025Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due July 2025 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueJuly2025Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due July 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueJuly2025Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.875DueJuly2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.875DueJuly2025Member" xlink:to="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_f3673c35-f24b-4560-9f31-de5c5ebd06be_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Products Sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueAfterYearFive_621b0be9-4d31-4a57-86be-d2f67b30ae04_totalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due After Year Five</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueAfterYearFive_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due After Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive" xlink:to="lab_cvs_LesseeLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_f571d6ed-3b3e-401d-9f2a-ec708084a002_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LeasesWeightedAverageDiscountRateAbstract_4191d94a-2627-4a3d-b1fa-a0a6be2cdbdf_terseLabel_en-US" xlink:label="lab_cvs_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_cvs_LeasesWeightedAverageDiscountRateAbstract_label_en-US" xlink:label="lab_cvs_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Weighted Average Discount Rate [Abstract]</link:label>
    <link:label id="lab_cvs_LeasesWeightedAverageDiscountRateAbstract_documentation_en-US" xlink:label="lab_cvs_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Weighted Average Discount Rate [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LeasesWeightedAverageDiscountRateAbstract" xlink:href="cvs-20230525.xsd#cvs_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LeasesWeightedAverageDiscountRateAbstract" xlink:to="lab_cvs_LeasesWeightedAverageDiscountRateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_38f41c1f-d98f-4580-aa13-7869a5e8a970_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reconciliation of cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_7f877235-76ff-4ca3-b93c-4a592a15a7ee_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_08353b55-07c1-4947-840d-ec2c36ce05fe_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_3ea0d8c7-fbe1-42ae-9489-bba19a672d63_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_9a5a8bfd-c8af-4ffb-b648-b03c5b69957c_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStores_2583c3fe-8e1b-4241-9d41-29cfd864ecaf_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStores" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of retail locations (more than)</link:label>
    <link:label id="lab_us-gaap_NumberOfStores_label_en-US" xlink:label="lab_us-gaap_NumberOfStores" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Stores</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStores"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStores" xlink:to="lab_us-gaap_NumberOfStores" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2Point125PercentDueSeptember2031Member_9fd95e44-d28d-448d-aae8-b6293c1d8a20_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2Point125PercentDueSeptember2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% senior notes due September 2031</link:label>
    <link:label id="lab_cvs_SeniorNotes2Point125PercentDueSeptember2031Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2Point125PercentDueSeptember2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2 Point 125 Percent, Due September 2031 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2Point125PercentDueSeptember2031Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2Point125PercentDueSeptember2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2 Point 125 Percent, Due September 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2Point125PercentDueSeptember2031Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2Point125PercentDueSeptember2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2Point125PercentDueSeptember2031Member" xlink:to="lab_cvs_SeniorNotes2Point125PercentDueSeptember2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_d555f61a-e772-42f4-9ad5-551ce6ad4c60_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_4956ab33-cfb9-4460-bebb-be0a9d0d76b9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_9fc58d2b-d57e-435d-a75b-dc49cce8832b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased_a1f91228-494c-49fd-99b5-67029d565b19_terseLabel_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased under ASR agreement (in shares)</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased_label_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Number Of Shares Repurchased</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased_documentation_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Number Of Shares Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased" xlink:href="cvs-20230525.xsd#cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased" xlink:to="lab_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_51f35001-dc74-4f14-abfb-3b8158fa638f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_ab15f108-9649-449b-a003-830d59747931_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededCreditRiskAxis_52c6f549-68a6-4685-9ed6-f91a79567609_terseLabel_en-US" xlink:label="lab_us-gaap_CededCreditRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk, Reinsurer [Axis]</link:label>
    <link:label id="lab_us-gaap_CededCreditRiskAxis_label_en-US" xlink:label="lab_us-gaap_CededCreditRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurer, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededCreditRiskAxis" xlink:to="lab_us-gaap_CededCreditRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesTable_ff8845f5-3fa9-40f5-af61-984c9d59426a_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices [Table]</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesTable_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesTable" xlink:to="lab_us-gaap_StatutoryAccountingPracticesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfPeopleServed_4566fa14-b6cf-4f56-8910-e5e86eabb17b_terseLabel_en-US" xlink:label="lab_cvs_NumberOfPeopleServed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of people served</link:label>
    <link:label id="lab_cvs_NumberOfPeopleServed_label_en-US" xlink:label="lab_cvs_NumberOfPeopleServed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of People Served</link:label>
    <link:label id="lab_cvs_NumberOfPeopleServed_documentation_en-US" xlink:label="lab_cvs_NumberOfPeopleServed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of People Served</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPeopleServed" xlink:href="cvs-20230525.xsd#cvs_NumberOfPeopleServed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfPeopleServed" xlink:to="lab_cvs_NumberOfPeopleServed" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfWalkInMedicalClinics_ce41ebbb-ffe7-49a4-a084-ef0e533c5a1c_terseLabel_en-US" xlink:label="lab_cvs_NumberOfWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of walk-in medical clinics (more than)</link:label>
    <link:label id="lab_cvs_NumberOfWalkInMedicalClinics_label_en-US" xlink:label="lab_cvs_NumberOfWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Walk In Medical Clinics</link:label>
    <link:label id="lab_cvs_NumberOfWalkInMedicalClinics_documentation_en-US" xlink:label="lab_cvs_NumberOfWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Walk In Medical Clinics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfWalkInMedicalClinics" xlink:href="cvs-20230525.xsd#cvs_NumberOfWalkInMedicalClinics"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfWalkInMedicalClinics" xlink:to="lab_cvs_NumberOfWalkInMedicalClinics" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_6af44d59-75ed-4aa7-9474-007fc0b961bf_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases, sales and settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:to="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_853ab9f6-994f-49ac-ad87-70e3d3778c74_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_664c02aa-0f4e-4250-a89b-058ba43adaec_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_354a26fd-962a-4b7c-9c0e-db5ec63eed61_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Rollforward</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_0690ae8e-6710-4f2f-9704-506c70ae08f7_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_174b8942-7c63-45b1-9c8d-4827afeba7d6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers into (out of) Level 3, net</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_1b5918e0-a6fd-45c9-bc68-31534e226f39_totalLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net transfers into (out of) Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_7cf00d31-21df-44bf-9b39-f14c10ce8a06_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities_e42ec89d-5cda-4ef6-aeb7-aa35161ef628_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average duration of securities</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Weighted Average Duration Of Securities</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Weighted Average Duration Of Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_f804b734-db64-4012-b741-f4779585d5e4_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Separate Accounts by Major Category of Investment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_a328c700-e196-4c83-aba2-407fcc5491db_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Separate Account Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeparateAccountFinancialAssetsMember_3f2f965c-fdeb-4800-93d3-498ed00d18b7_terseLabel_en-US" xlink:label="lab_cvs_SeparateAccountFinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Accounts, financial assets</link:label>
    <link:label id="lab_cvs_SeparateAccountFinancialAssetsMember_label_en-US" xlink:label="lab_cvs_SeparateAccountFinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Financial Assets [Member]</link:label>
    <link:label id="lab_cvs_SeparateAccountFinancialAssetsMember_documentation_en-US" xlink:label="lab_cvs_SeparateAccountFinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Financial Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeparateAccountFinancialAssetsMember" xlink:href="cvs-20230525.xsd#cvs_SeparateAccountFinancialAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeparateAccountFinancialAssetsMember" xlink:to="lab_cvs_SeparateAccountFinancialAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_a19b0da4-9426-4e3f-9227-df0ddbdd3edd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Assumptions Used in Determining Benefit Obligations and Net Benefit Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_0a850761-de0c-45fa-9252-ec40f0e7d0f2_terseLabel_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment contract liabilities with a fixed maturity</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_label_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts With Fixed Maturity, Fair Value Disclosure</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_documentation_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts With Fixed Maturity, Fair Value Disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:href="cvs-20230525.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:to="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_bd5f0f1e-086c-4e4d-be15-0440680f320c_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.5DueNovember2024Member_6707acb7-99b6-4dca-b2a6-27fa4c92f874_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% senior notes due November 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueNovember2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due November 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueNovember2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due November 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueNovember2024Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.5DueNovember2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.5DueNovember2024Member" xlink:to="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss_90310d29-94d9-4e1c-bb1b-3fcb9e2243df_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date, unrealized losses</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Without Single Maturity Date, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Without Single Maturity Date, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_242c002d-8b2b-4bfd-b809-461e82d77af2_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_30e5a2dd-b43c-4049-92a6-5b1e9b600d45_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">As Reported</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_dfc3aa8f-1f25-4d6a-b98c-e16f4f7d3a59_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_f7a932b3-78e1-4c76-8ac0-9e33a041c8fe_terseLabel_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former gain contingency, recognized in current period, net of tax</link:label>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Gain Contingency, Recognized In Current Period, Net of Tax</link:label>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_documentation_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Gain Contingency, Recognized In Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:href="cvs-20230525.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:to="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_04a24273-ed60-42f5-af7e-051c0f893c37_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_378a0930-af3b-4b73-b503-74ec8ec3e6e1_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_153ae33d-36a1-4063-bb49-ce9742cc60a0_terseLabel_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other insurance liabilities</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_label_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Current</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_documentation_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent" xlink:href="cvs-20230525.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherInsuranceLiabilitiesCurrent" xlink:to="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.75DueDecember2022Member_52d1ebf9-7d55-44d8-9c9a-93baae6771ef_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.75% senior notes due December 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueDecember2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due December 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueDecember2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due December 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueDecember2022Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2.75DueDecember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.75DueDecember2022Member" xlink:to="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_32d63231-105e-47c2-85b0-e5f5b202511b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_336133a4-7eca-43bf-822c-52d6feb84c8e_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal settlement awarded to other party</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_889c72a9-5696-490a-9e80-21e276810f84_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_b956cfb8-76f9-4ffd-b63d-a6731d66ca41_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_ca9f81cf-39bf-475b-ad4a-e6b7bc3108f2_verboseLabel_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium deficiency reserve</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_c75552e3-07f5-4f6d-9ba1-6995cc4c51eb_terseLabel_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Premium deficiency reserve</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_label_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Deficiency Reserve Liability</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_documentation_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability" xlink:href="cvs-20230525.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumDeficiencyReserveLiability" xlink:to="lab_cvs_PremiumDeficiencyReserveLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_6d615c82-03c9-46f3-817b-54d3f5a3e4de_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value vested at end of year and expected to vest in the future</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes1Point875PercentFebruary2031Member_8d5b3ea2-d989-4eba-8d7f-12b0ca2aede3_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes1Point875PercentFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.875% senior notes due February 2031</link:label>
    <link:label id="lab_cvs_SeniorNotes1Point875PercentFebruary2031Member_label_en-US" xlink:label="lab_cvs_SeniorNotes1Point875PercentFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1 Point 875 Percent, February 2031 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes1Point875PercentFebruary2031Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes1Point875PercentFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1 Point 875 Percent, February 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point875PercentFebruary2031Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes1Point875PercentFebruary2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes1Point875PercentFebruary2031Member" xlink:to="lab_cvs_SeniorNotes1Point875PercentFebruary2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_5395dd20-18ec-46ab-baf2-a05f5dc259bc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations attributable to CVS Health (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_285be9a2-331a-4ee2-8f05-0d1de4fd80b7_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share from continuing operations, basic (USD per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LeaseLiability_2064fc14-1974-4302-b9b2-ac194104b42d_totalLabel_en-US" xlink:label="lab_cvs_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_cvs_LeaseLiability_label_en-US" xlink:label="lab_cvs_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:label id="lab_cvs_LeaseLiability_documentation_en-US" xlink:label="lab_cvs_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LeaseLiability" xlink:href="cvs-20230525.xsd#cvs_LeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LeaseLiability" xlink:to="lab_cvs_LeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_94c3eeb1-2c07-44af-be7b-6451554c77a1_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average basic shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a1eefa4f-d940-4efd-95a1-9edea80850a4_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_e07302b4-3483-46f8-91a8-e95fee26a6e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of variable interest entities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearFour_a392c172-4935-4059-9ba8-01687c41b3b4_totalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearFour_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFour" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearFour" xlink:to="lab_cvs_LesseeLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_b3149a39-80dc-48c2-97cc-a2c86e33067d_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_f9f47b98-f371-4f47-9936-39865f449551_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability recorded in association with legal settlement</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AetnaInc2010StockIncentivePlanMember_166806ea-76b8-4171-8df1-0ce90cacbaa0_terseLabel_en-US" xlink:label="lab_cvs_AetnaInc2010StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aetna Inc 2010 Stock Incentive Plan</link:label>
    <link:label id="lab_cvs_AetnaInc2010StockIncentivePlanMember_label_en-US" xlink:label="lab_cvs_AetnaInc2010StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aetna Inc 2010 Stock Incentive Plan [Member]</link:label>
    <link:label id="lab_cvs_AetnaInc2010StockIncentivePlanMember_documentation_en-US" xlink:label="lab_cvs_AetnaInc2010StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aetna Inc 2010 Stock Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AetnaInc2010StockIncentivePlanMember" xlink:href="cvs-20230525.xsd#cvs_AetnaInc2010StockIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AetnaInc2010StockIncentivePlanMember" xlink:to="lab_cvs_AetnaInc2010StockIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.125DueNovember2042Member_669dd269-0cd7-406e-b55c-e91a7d71755b_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due November 2042</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueNovember2042Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due November 2042 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueNovember2042Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item represents senior notes due 2042 with a coupon rate of 4.125%.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueNovember2042Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.125DueNovember2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.125DueNovember2042Member" xlink:to="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_60dabde9-48df-4f92-b2bd-bb43e8283345_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in prior years' healthcare costs payable</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_7baad13a-3dba-47fa-9bf8-0d4b60f4778f_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_6a7153ee-fab8-4efe-afe5-f4d974c6bc2e_terseLabel_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Copayments</link:label>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_label_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues, Retail CoPayments</link:label>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_documentation_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues, Retail CoPayments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments" xlink:href="cvs-20230525.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NetRevenuesRetailCoPayments" xlink:to="lab_cvs_NetRevenuesRetailCoPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_e4a83ecd-31ea-4221-a5f7-d053a8552af2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in plan assets:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_1dc4b8e5-0a64-4c47-bc79-d5288980213b_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning liability for future policy benefits at original (locked-in) discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_ffb49eeb-9ec1-426c-8c88-9ad78420c0ac_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending liability for future policy benefits at original (locked-in) discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit, Original Discount Rate, before Cash Flow and Reinsurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue_3159a3d3-4347-4dc8-998d-29843c1a49aa_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date, fair value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Without Single Maturity Date, Fair Value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_900e37bb-438d-4a50-9f52-68c91f6c7efe_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target investment allocations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_1c85d47b-a848-4df3-993a-ec5855367393_terseLabel_en-US" xlink:label="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_label_en-US" xlink:label="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Consolidated Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:to="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountAssetCategoryDomain_41786a11-7a77-4edc-a19f-ff5430d7cd15_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountAssetCategoryDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset Category [Domain]</link:label>
    <link:label id="lab_us-gaap_SeparateAccountAssetCategoryDomain_label_en-US" xlink:label="lab_us-gaap_SeparateAccountAssetCategoryDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain" xlink:to="lab_us-gaap_SeparateAccountAssetCategoryDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_f21a1f65-e0a5-4888-b139-bee5f251c41c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward contract, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_9e2e731c-05d0-48d0-aa13-ce7d28f9cea2_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_8db4214e-3b27-4f03-9941-ecf06aaebc47_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash (included in other current assets)</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember_0ae0e410-b16e-426d-ba17-ddd5f19e3007_terseLabel_en-US" xlink:label="lab_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixtures, equipment and internally developed software</link:label>
    <link:label id="lab_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember_label_en-US" xlink:label="lab_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixtures, Equipment And Internally Developed Software [Member]</link:label>
    <link:label id="lab_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember_documentation_en-US" xlink:label="lab_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixtures, Equipment And Internally Developed Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember" xlink:href="cvs-20230525.xsd#cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember" xlink:to="lab_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_ad4702af-e53b-4d85-84d3-ab1af5d22afc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_d269e39b-9606-4d7e-ab31-b87a06b21e34_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_e7a288d6-6db6-4ecc-8918-cc2b3848d3ac_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_f9d352e5-f3fb-4ca7-b8d6-07c8d1773ddf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_e3b7ec85-06ae-4334-a3ee-d34db2bf9b65_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Included in other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_20f7c2a4-2b3d-41f2-9509-999d2c8773e5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Level 3 Financial Assets</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_aedcdb3d-9b93-4364-ad99-75991233ad78_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_92644cf9-e621-4a9c-8308-a9e04bad81dd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_ae90268f-7912-47da-ac84-d022f0080066_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Assets and Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_1d5e0e53-2791-4a64-926a-a8105445b011_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses_15d1a3b1-6a98-4a46-b86f-eefcba281fb5_terseLabel_en-US" xlink:label="lab_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in net unrealized gains (losses)</link:label>
    <link:label id="lab_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses_label_en-US" xlink:label="lab_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Change In Net Unrealized Gains (Losses)</link:label>
    <link:label id="lab_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses_documentation_en-US" xlink:label="lab_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Change In Net Unrealized Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses" xlink:href="cvs-20230525.xsd#cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses" xlink:to="lab_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_56720abe-7433-4a8c-9336-db6aca59e7f0_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_62934bd0-7516-4ed1-9f5c-4e909834899f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plans</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountCashAndCashEquivalentsMember_35d16293-80a0-4c48-847f-fd68ea9f4415_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_SeparateAccountCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_SeparateAccountCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_SeparateAccountCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_cb521dd8-4617-427e-a83f-7c543df32d5a_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock_4ff434a9-efad-4e75-8d2a-dd1c635918be_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Assets and Liabilities Held for Sale</link:label>
    <link:label id="lab_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Long-Lived Assets Held-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock" xlink:to="lab_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareCostsPolicyPolicyTextBlock_877f7e0a-8abb-4b78-860f-29329166cd38_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Costs Payable</link:label>
    <link:label id="lab_us-gaap_HealthCareCostsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_HealthCareCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareCostsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareCostsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareCostsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_HealthCareCostsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_99c83dcf-1e67-4c54-b0e8-a9299226a6f6_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_47611949-5d32-4b3e-816c-199efc62cef6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestitures</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_73fc5968-832d-4dda-a7de-dc60710c7555_negatedTerseLabel_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury shares, net of ESPP issuances</link:label>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_label_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_documentation_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:href="cvs-20230525.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:to="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_350595b9-4a17-4ea0-94ec-ca9e3728a2a3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_44ee289e-6ec8-47d3-bd04-454194492ed5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_0111d381-0d92-4b9b-96c8-2f94298a8283_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Product and Service [Extensible List]</link:label>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_label_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Product and Service [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:to="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_1dbaf830-cbec-4849-b93d-212a329a5798_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_cb8eb752-2643-4337-bef3-e1c047b2a0ff_verboseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal of debt extinguished</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_6a23e9d3-6eeb-424c-b627-372d805b2c93_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_46b8cbf6-9fea-49c6-b5dd-bdd296a82859_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_06babb80-eace-432c-ad1f-28b05a746fdd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_0409fb16-b48c-4d4f-b471-e7348ff105ea_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_27e7ffa9-9687-4cf7-8cac-28e72f64bec1_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ebc389dc-cedb-4305-9d03-9bdb4fe92cb2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions (net of cash acquired)</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_0a09d480-6dc4-4ac5-a3c8-b542077b0180_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_2a56a0a4-fda0-439c-aea7-ac7877bdfac3_terseLabel_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting remaining products</link:label>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_label_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting Remaining Products [Member]</link:label>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_documentation_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities in an unrealized capital loss position supporting remaining products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember" xlink:href="cvs-20230525.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SupportingRemainingProductsMember" xlink:to="lab_cvs_SupportingRemainingProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_0a1cb985-aa70-4785-8f23-e8162d7ee186_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit costs</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_94da72df-e572-44e8-8eb7-eb9708510aaf_verboseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit costs</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net, Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalIncomeStatementElementsAbstract_4181dcf3-275d-40dc-a576-940be35c7dc2_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalIncomeStatementElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Statement of Operations:</link:label>
    <link:label id="lab_us-gaap_SupplementalIncomeStatementElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalIncomeStatementElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Income Statement Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalIncomeStatementElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalIncomeStatementElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract" xlink:to="lab_us-gaap_SupplementalIncomeStatementElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_59e25aa7-3788-41be-ae2d-cdc32193efc4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_4f3abfec-fa2e-4722-9ba5-dd0445f8e310_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_7819756d-849f-4f49-a872-2417cb51ea37_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumsMember_5c38722b-2943-4472-8df6-093f262c7ab6_terseLabel_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_cvs_PremiumsMember_label_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums [Member]</link:label>
    <link:label id="lab_cvs_PremiumsMember_documentation_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember" xlink:href="cvs-20230525.xsd#cvs_PremiumsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumsMember" xlink:to="lab_cvs_PremiumsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.75DueMay2041Member_89f4ab29-437f-4646-8984-9185e99bba66_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.75% senior notes due May 2041</link:label>
    <link:label id="lab_cvs_SeniorNotes5.75DueMay2041Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.75%, Due May 2041 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.75DueMay2041Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.75%, Due May 2041 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.75DueMay2041Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes5.75DueMay2041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.75DueMay2041Member" xlink:to="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife_d360e0f2-6dd8-4dcb-9830-27b673bb0166_terseLabel_en-US" xlink:label="lab_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, amount due in excess of remaining estimated economic life</link:label>
    <link:label id="lab_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife_label_en-US" xlink:label="lab_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Capital Leases, Amount Due In Excess Of Remaining Estimated Economic Life</link:label>
    <link:label id="lab_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife_documentation_en-US" xlink:label="lab_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Capital Leases, Amount Due In Excess Of Remaining Estimated Economic Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" xlink:href="cvs-20230525.xsd#cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" xlink:to="lab_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_bd4de91a-0646-4f9b-a117-8b074531d530_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_5abd106b-39c5-4451-82ab-d02365611523_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior year refunds and unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Settlement, Domestic, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_c3a4e894-8f8f-416d-933d-43dd251faa6f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_553124b4-03a0-4ca2-9402-f65d276bb841_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_2a734351-4578-442d-b7ff-5ef78994ea48_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_7886cba5-5b99-4fb4-8a2b-7662c74f2ad0_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_037cab8e-e26c-4188-a713-78ff02f6ce06_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_7a24a0e1-39bb-4fb1-a32f-43034bd664fb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Subject to or Available for Operating Lease [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_label_en-US" xlink:label="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Subject to or Available for Operating Lease [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReservePolicyTextBlock_0b1383cf-2c2c-482f-99ab-9fd7c8faf3c7_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-Insurance Liabilities</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReservePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self Insurance Reserve [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfInsuranceReservePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:to="lab_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_bf12e638-578b-4c03-9d79-2db8f6211fcb_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_2dfe29b2-88d8-48e6-b739-40f7066cc232_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, beginning of period, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_627f4520-b8aa-44b5-94b9-d3b89c754f4a_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, end of period, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_c16a1478-4532-472c-ae80-0c4b943dfe25_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c25b26bb-ce26-4eb3-b5fc-259e9772fe5f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_677d43b1-6a44-4582-8515-559328e6c46f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceTextBlock_df28cf7d-61a2-44a3-881d-f658d8f8d4b5_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance</link:label>
    <link:label id="lab_us-gaap_ReinsuranceTextBlock_label_en-US" xlink:label="lab_us-gaap_ReinsuranceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceTextBlock" xlink:to="lab_us-gaap_ReinsuranceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_6c40b683-36c8-4c30-ab5a-8ce79defa7bc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_5e0fa0f6-56c0-4e10-b49f-aee92a591741_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for future policy benefits, beginning of period - current discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_2fbdefce-5d62-414e-828d-a61710ebff0f_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for future policy benefits, end of period - current discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_85280875-53f9-4dfb-a192-24ff9fb72761_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets, indefinite-lived</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock_026eb706-5b4e-40d9-965d-6a083bdc1bb8_terseLabel_en-US" xlink:label="lab_cvs_FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Intangible Assets</link:label>
    <link:label id="lab_cvs_FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_cvs_FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived And Indefinite Lived Intangible Assets [Table Text Block]</link:label>
    <link:label id="lab_cvs_FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock_documentation_en-US" xlink:label="lab_cvs_FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the cost, accumulated amortization and net balance of intangibles assets and amortization period, in total and by major class. Finite-lived intangible assets have a stated useful life over which their gross carrying value is amortized. Indefinite intangible assets have a projected indefinite period of benefit (hence are not amortized).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="cvs-20230525.xsd#cvs_FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_cvs_FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_cbcc68c5-3483-4cef-ab99-514cce791310_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm_8722ebd8-731e-4a9d-9c06-fb606569a307_terseLabel_en-US" xlink:label="lab_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease renewal term</link:label>
    <link:label id="lab_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm_label_en-US" xlink:label="lab_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Leases, Renewal Term</link:label>
    <link:label id="lab_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm_documentation_en-US" xlink:label="lab_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Leases, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm" xlink:href="cvs-20230525.xsd#cvs_LesseeOperatingAndFinanceLeasesRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm" xlink:to="lab_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RadcliffAndFlaimVAetnaIncEtAlMember_6b4d118f-a5bc-4a83-9350-3e63b5f729d3_terseLabel_en-US" xlink:label="lab_cvs_RadcliffAndFlaimVAetnaIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radcliff and Flaim v Aetna Inc., et al</link:label>
    <link:label id="lab_cvs_RadcliffAndFlaimVAetnaIncEtAlMember_label_en-US" xlink:label="lab_cvs_RadcliffAndFlaimVAetnaIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radcliff and Flaim v Aetna Inc., et al [Member]</link:label>
    <link:label id="lab_cvs_RadcliffAndFlaimVAetnaIncEtAlMember_documentation_en-US" xlink:label="lab_cvs_RadcliffAndFlaimVAetnaIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radcliff and Flaim v Aetna Inc., et al</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RadcliffAndFlaimVAetnaIncEtAlMember" xlink:href="cvs-20230525.xsd#cvs_RadcliffAndFlaimVAetnaIncEtAlMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RadcliffAndFlaimVAetnaIncEtAlMember" xlink:to="lab_cvs_RadcliffAndFlaimVAetnaIncEtAlMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3Point75PercentApril2030Member_cf1b5e7d-bc16-4571-9a02-0524ed5324a4_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3Point75PercentApril2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.75% senior notes due April 2030</link:label>
    <link:label id="lab_cvs_SeniorNotes3Point75PercentApril2030Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3Point75PercentApril2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3 Point 75 Percent, April 2030 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3Point75PercentApril2030Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3Point75PercentApril2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3 Point 75 Percent, April 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point75PercentApril2030Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3Point75PercentApril2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3Point75PercentApril2030Member" xlink:to="lab_cvs_SeniorNotes3Point75PercentApril2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_6f8ad382-47f7-4813-89e8-1d13750092c3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_32b62ac7-3a53-45a7-8a1b-195abb51a2cf_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_d5014b18-2d23-4511-894f-7aefc12f241a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_a7d1c5f9-0b9a-4d1c-993f-e608b9fe56c2_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total incurred health care costs</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_31e2a35d-68fd-4953-bf3f-5922695a7655_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthServicesSegmentMember_08ab9941-3e53-4c8f-87df-3f929e479e04_terseLabel_en-US" xlink:label="lab_cvs_HealthServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Services</link:label>
    <link:label id="lab_cvs_HealthServicesSegmentMember_label_en-US" xlink:label="lab_cvs_HealthServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Services Segment [Member]</link:label>
    <link:label id="lab_cvs_HealthServicesSegmentMember_documentation_en-US" xlink:label="lab_cvs_HealthServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Services Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthServicesSegmentMember" xlink:href="cvs-20230525.xsd#cvs_HealthServicesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthServicesSegmentMember" xlink:to="lab_cvs_HealthServicesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_32af7396-ceb4-41a6-bf61-982a8a7767a1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt (1)</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsAxis_802dae55-91ef-4dbb-b5d0-40cb02c9448e_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Axis]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsAxis_label_en-US" xlink:label="lab_cvs_TotalInvestmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis" xlink:href="cvs-20230525.xsd#cvs_TotalInvestmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsAxis" xlink:to="lab_cvs_TotalInvestmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_7083f1bc-e82e-4974-8dc6-e53b17ad2a56_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_608fbed4-1677-4eaf-8bf1-e484791e9196_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_70da1f5b-d7ba-4645-a204-94a51a5e3bcb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_58c3fbbf-8f1a-42b3-b8de-780d1457ef85_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_09b705f2-ff38-4738-8973-4c2796a0be1e_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0feae31c-d020-4a68-b624-048538bf5677_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_VariableInterestEntityAmendedContractTerm_c78c9187-0a80-4397-a7ed-abeaaed5ba31_terseLabel_en-US" xlink:label="lab_cvs_VariableInterestEntityAmendedContractTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended contract term (in years)</link:label>
    <link:label id="lab_cvs_VariableInterestEntityAmendedContractTerm_label_en-US" xlink:label="lab_cvs_VariableInterestEntityAmendedContractTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Amended Contract Term</link:label>
    <link:label id="lab_cvs_VariableInterestEntityAmendedContractTerm_documentation_en-US" xlink:label="lab_cvs_VariableInterestEntityAmendedContractTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Amended Contract Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VariableInterestEntityAmendedContractTerm" xlink:href="cvs-20230525.xsd#cvs_VariableInterestEntityAmendedContractTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_VariableInterestEntityAmendedContractTerm" xlink:to="lab_cvs_VariableInterestEntityAmendedContractTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_9bff5245-e000-4e59-ab9a-6d3e53c60f34_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Costs Payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_2d094be6-f90c-4b67-8bb2-584afa15aacb_terseLabel_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term insurance liabilities</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_label_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Noncurrent</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_documentation_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:href="cvs-20230525.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:to="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_c9bdd098-1fcc-4cde-aeda-a038f803c7bc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU and Performance Share Unit Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Share Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceDisclosuresAbstract_6b5a0269-8b6f-4527-9869-3e433f5b268f_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReinsuranceDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ReinsuranceDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract" xlink:to="lab_us-gaap_ReinsuranceDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_810a5e8f-8df8-4ad6-b61a-293bd8e1c656_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_ed8b6977-7f00-4206-a15b-214ebf46c4d8_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure_ff0069ff-89dc-4ae3-beb4-e6ba0cdbc2e5_terseLabel_en-US" xlink:label="lab_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, right-of-use asset, fair value</link:label>
    <link:label id="lab_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure_label_en-US" xlink:label="lab_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, Right-of-Use Asset, Fair Value Disclosure</link:label>
    <link:label id="lab_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure_documentation_en-US" xlink:label="lab_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, Right-of-Use Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure" xlink:href="cvs-20230525.xsd#cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure" xlink:to="lab_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_VariableInterestEntityAmendedContractExtensionTerm_efec141d-5d98-45cd-96bf-824294f2d144_terseLabel_en-US" xlink:label="lab_cvs_VariableInterestEntityAmendedContractExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended contract extension term</link:label>
    <link:label id="lab_cvs_VariableInterestEntityAmendedContractExtensionTerm_label_en-US" xlink:label="lab_cvs_VariableInterestEntityAmendedContractExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Amended Contract Extension Term</link:label>
    <link:label id="lab_cvs_VariableInterestEntityAmendedContractExtensionTerm_documentation_en-US" xlink:label="lab_cvs_VariableInterestEntityAmendedContractExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Amended Contract Extension Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VariableInterestEntityAmendedContractExtensionTerm" xlink:href="cvs-20230525.xsd#cvs_VariableInterestEntityAmendedContractExtensionTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_VariableInterestEntityAmendedContractExtensionTerm" xlink:to="lab_cvs_VariableInterestEntityAmendedContractExtensionTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_b4dfa778-1ce1-4604-8eae-bedbc0815736_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor obligations, maximum exposure</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Maximum Exposure, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:to="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock_b3e3a1de-6d24-4f6b-812b-a19c57770765_terseLabel_en-US" xlink:label="lab_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Deficiency Reserves</link:label>
    <link:label id="lab_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock_label_en-US" xlink:label="lab_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Premium Deficiency Reserve [Policy Text Block]</link:label>
    <link:label id="lab_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock_documentation_en-US" xlink:label="lab_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Premium Deficiency Reserve [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock" xlink:href="cvs-20230525.xsd#cvs_InsurancePremiumDeficiencyReservePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock" xlink:to="lab_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_4dec222d-3ee9-4f94-89e7-d2a754417f9c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_713d1f4f-e937-43e0-8b6f-882db910db41_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange_82542c64-29bb-46cb-94ba-91e56a95e499_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Increase (Decrease) from Other Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange" xlink:to="lab_us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_0a18df10-b378-4263-ab35-574a99522b08_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_93ca7629-968d-4f3a-a87d-eb6467153d45_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_998de9aa-e925-4439-ba88-1868452966b6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_593a5b7c-c6e6-448b-98fa-4aa5fb900383_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Two [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember" xlink:href="cvs-20230525.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodTwoMember" xlink:to="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_33928a9b-70be-44e4-b8a4-30ee1bbb0bd3_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Accident Year [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution_61636f08-7dcb-40d3-a680-1306b2d12723_terseLabel_en-US" xlink:label="lab_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer plans, plan contributions</link:label>
    <link:label id="lab_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution_label_en-US" xlink:label="lab_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer Plan, Pension, Insignificant, Plan Contribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MultiemployerPlanPensionInsignificantPlanContribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution" xlink:to="lab_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e7f136f4-2665-4f62-b416-3880ca290f6b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4d1ab014-229b-4092-88d3-9ee83a0ff58b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_f183e901-532e-47c0-94fa-574690a5335c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total value of proposed/pending acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LegalSettlementPeriodOfPayment_241cafde-6483-4445-8dd6-13feb21a9f01_terseLabel_en-US" xlink:label="lab_cvs_LegalSettlementPeriodOfPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal settlement, period of payment</link:label>
    <link:label id="lab_cvs_LegalSettlementPeriodOfPayment_label_en-US" xlink:label="lab_cvs_LegalSettlementPeriodOfPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Settlement, Period Of Payment</link:label>
    <link:label id="lab_cvs_LegalSettlementPeriodOfPayment_documentation_en-US" xlink:label="lab_cvs_LegalSettlementPeriodOfPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Settlement, Period Of Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LegalSettlementPeriodOfPayment" xlink:href="cvs-20230525.xsd#cvs_LegalSettlementPeriodOfPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LegalSettlementPeriodOfPayment" xlink:to="lab_cvs_LegalSettlementPeriodOfPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_c9ba9983-b6f0-43ef-8668-941eebc9b7d1_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Number of Positions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:to="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_5b6120c6-f5a0-4095-b736-2fc71bb09c22_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_7c32270c-483c-46a0-9cb4-cc1678fff502_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_61c70d97-7e04-4e27-8432-2430ab65d0b2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalFees_3b630283-f63b-4ccd-bfbc-51e6fd293430_terseLabel_en-US" xlink:label="lab_us-gaap_LegalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Attorneys' fees and costs</link:label>
    <link:label id="lab_us-gaap_LegalFees_label_en-US" xlink:label="lab_us-gaap_LegalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalFees" xlink:to="lab_us-gaap_LegalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAdjustmentMember_edd53d80-f672-49f8-b9a5-c5d5855dc156_terseLabel_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments</link:label>
    <link:label id="lab_srt_RestatementAdjustmentMember_label_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAdjustmentMember" xlink:to="lab_srt_RestatementAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_77bd2f51-d931-4d11-929e-693193a699b8_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_45440889-e4ce-487e-b6c1-cd7788f84a22_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Securities In An Unrealized Capital Loss Position</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrealized Loss on Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_442d0d38-2014-4cd3-bd63-d62cf5db2820_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_7d42c317-b96e-487e-9ef6-354fe1a4849c_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.5DueMay2042Member_2b19d049-b678-45fd-9318-0ab384aa375f_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.5% senior notes due May 2042</link:label>
    <link:label id="lab_cvs_SeniorNotes4.5DueMay2042Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.5%, Due May 2042 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.5DueMay2042Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.5%, Due May 2042 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.5DueMay2042Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.5DueMay2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.5DueMay2042Member" xlink:to="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromInterestAndDividendsReceived_680d1435-246c-4ef3-8213-27754599774c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and investment income received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromInterestAndDividendsReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Interest and Dividends Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:to="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_015cfe2d-c14d-43fa-8a26-28d101c647a4_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial liabilities measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_49e918dd-1625-433a-9320-6bf821741400_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_dd139b89-9921-48f9-b008-60287782855d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_d6adcb1c-09d3-449c-8f6b-3a13e93bee56_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HartfordLifeAndAccidentInsuranceCompanyMember_cdb6a795-3c59-4dc1-aa77-587ea0946359_terseLabel_en-US" xlink:label="lab_cvs_HartfordLifeAndAccidentInsuranceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hartford Life and Accident Insurance Company</link:label>
    <link:label id="lab_cvs_HartfordLifeAndAccidentInsuranceCompanyMember_label_en-US" xlink:label="lab_cvs_HartfordLifeAndAccidentInsuranceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hartford Life And Accident Insurance Company [Member]</link:label>
    <link:label id="lab_cvs_HartfordLifeAndAccidentInsuranceCompanyMember_documentation_en-US" xlink:label="lab_cvs_HartfordLifeAndAccidentInsuranceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hartford Life And Accident Insurance Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HartfordLifeAndAccidentInsuranceCompanyMember" xlink:href="cvs-20230525.xsd#cvs_HartfordLifeAndAccidentInsuranceCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HartfordLifeAndAccidentInsuranceCompanyMember" xlink:to="lab_cvs_HartfordLifeAndAccidentInsuranceCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_c5d782db-20f4-4c21-8fea-26234d56925f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherAcquiredIntangibleAssetsLineItems_7a84aac6-0236-4381-bc31-2cdc58fcfbce_terseLabel_en-US" xlink:label="lab_cvs_OtherAcquiredIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets[Line Items]</link:label>
    <link:label id="lab_cvs_OtherAcquiredIntangibleAssetsLineItems_label_en-US" xlink:label="lab_cvs_OtherAcquiredIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Acquired Intangible Assets [Line Items]</link:label>
    <link:label id="lab_cvs_OtherAcquiredIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_cvs_OtherAcquiredIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAcquiredIntangibleAssetsLineItems" xlink:href="cvs-20230525.xsd#cvs_OtherAcquiredIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems" xlink:to="lab_cvs_OtherAcquiredIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_c8a7f2b6-f0af-4555-a4cc-a2daaa0520b1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0c932296-6f00-4077-a5be-311d869d1e8c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits_d6ba6b7a-0c87-446b-9f16-5d0069a105cf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit payments (actual)</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_5b07a5de-0d8a-49cd-99b4-b87fdc60395f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_9a365e50-4ad2-47aa-92de-72f32327c58c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_cccbd47f-928e-4740-8fbb-0e3b44dfc532_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_5f9f65bb-6868-4b3c-91a5-e6d6cde8fccc_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_343a82e3-5629-4d8b-b58f-36f5dfc47047_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c5869562-303c-48ea-a826-1dde270ea1bb_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Basic and Diluted Earnings (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_f7c909e0-dbd3-410d-aa8d-c491bcb219ff_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_a0b62b72-0fb8-492a-964f-78a448ecd5e8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized capital losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_6c2113ec-68aa-434a-a354-3adac7273de8_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:to="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_823136a9-4562-4b1d-998f-efdb32708d90_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_18961773-5e28-4090-a60a-903da29ef8aa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_ae8decbe-525d-4cd5-97d2-5dfe9588cbfc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome_ec06d7e7-c448-4e87-9e68-94294a8e6a82_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest accrual (using locked-in discount rate)</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Net Premium, Interest Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_EmployeeStockOptionsAndStockAppreciationRightsMember_67cb8ceb-1a8e-458d-ac87-38c3bbd82f21_terseLabel_en-US" xlink:label="lab_cvs_EmployeeStockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Options and Stock Appreciation Rights</link:label>
    <link:label id="lab_cvs_EmployeeStockOptionsAndStockAppreciationRightsMember_label_en-US" xlink:label="lab_cvs_EmployeeStockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Options And Stock Appreciation Rights [Member]</link:label>
    <link:label id="lab_cvs_EmployeeStockOptionsAndStockAppreciationRightsMember_documentation_en-US" xlink:label="lab_cvs_EmployeeStockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Options and Stock Appreciation Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EmployeeStockOptionsAndStockAppreciationRightsMember" xlink:href="cvs-20230525.xsd#cvs_EmployeeStockOptionsAndStockAppreciationRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_EmployeeStockOptionsAndStockAppreciationRightsMember" xlink:to="lab_cvs_EmployeeStockOptionsAndStockAppreciationRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_7e51900b-cbcc-4039-8534-8f133c31e7fc_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_24c1e951-9cc0-4bd7-98f9-6889df3cc26e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5e627b81-a9b4-4061-be34-a81469c13cb3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_97d51754-8885-4897-ba84-9b72bedf0c48_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_3cfa39bf-56ac-43da-9688-0ac2e93b41a8_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_cd6ad900-e445-47d8-8258-56a7c2046aef_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_87ec7bac-06e0-4cc5-ac81-2e9f873b83da_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance lines other than short duration</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Liability for Unpaid Claims and Claim Adjustment Expense, Other Reconciling Item</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount_5ad87b03-46a0-46bf-ba62-1ca85ca9408b_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory net income</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Net Income Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_0be7b05e-f5fd-4edc-9594-8c50d4ef0bf4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountAssetCategoryAxis_6255bc38-fec3-4b40-bb76-7319940c040c_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountAssetCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset Category [Axis]</link:label>
    <link:label id="lab_us-gaap_SeparateAccountAssetCategoryAxis_label_en-US" xlink:label="lab_us-gaap_SeparateAccountAssetCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis" xlink:to="lab_us-gaap_SeparateAccountAssetCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b4562235-8b8c-4f6e-bdd8-eeca4a2defa3_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_91b55a1e-64cc-47f8-9973-8a507a5901f0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DeferredTaxAssetsPayrollTaxDeferral_8496c844-44d9-4234-9016-1bc35bc0b305_terseLabel_en-US" xlink:label="lab_cvs_DeferredTaxAssetsPayrollTaxDeferral" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll tax deferral</link:label>
    <link:label id="lab_cvs_DeferredTaxAssetsPayrollTaxDeferral_label_en-US" xlink:label="lab_cvs_DeferredTaxAssetsPayrollTaxDeferral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Payroll Tax Deferral</link:label>
    <link:label id="lab_cvs_DeferredTaxAssetsPayrollTaxDeferral_documentation_en-US" xlink:label="lab_cvs_DeferredTaxAssetsPayrollTaxDeferral" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Payroll Tax Deferral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxAssetsPayrollTaxDeferral" xlink:href="cvs-20230525.xsd#cvs_DeferredTaxAssetsPayrollTaxDeferral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DeferredTaxAssetsPayrollTaxDeferral" xlink:to="lab_cvs_DeferredTaxAssetsPayrollTaxDeferral" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ProviderNetworksMember_0120445c-e56d-49d1-b95e-b3c5daafd651_terseLabel_en-US" xlink:label="lab_cvs_ProviderNetworksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider networks</link:label>
    <link:label id="lab_cvs_ProviderNetworksMember_label_en-US" xlink:label="lab_cvs_ProviderNetworksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider Networks [Member]</link:label>
    <link:label id="lab_cvs_ProviderNetworksMember_documentation_en-US" xlink:label="lab_cvs_ProviderNetworksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired in a business combination or other transaction. This item represents the value ascribed to the relationships with the acquiree's physicians, hospitals and other health care providers network.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProviderNetworksMember" xlink:href="cvs-20230525.xsd#cvs_ProviderNetworksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ProviderNetworksMember" xlink:to="lab_cvs_ProviderNetworksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b40ef74b-efa2-4563-bc53-f48de83d322a_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceLineItems_71a76c6c-f832-47c8-af73-42fe7c49f75a_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance [Line Items]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceLineItems_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceLineItems" xlink:to="lab_us-gaap_ValuationAllowanceLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_521122dd-d05c-48bd-8302-87e924c4f1e7_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_bb55536e-c1ea-418e-bed0-5442b75f394d_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses from transactions with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_7d474870-2355-40b7-bb01-9ff3e9480367_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2316bb04-47fc-4432-8216-a7f91cc9ef13_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_c9657a0f-d8f7-4336-b7bb-b50e6af770a1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased_f1082233-7568-4e6e-922a-9b4db18d6cb3_terseLabel_en-US" xlink:label="lab_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average purchase price of shares purchased (in dollars per share)</link:label>
    <link:label id="lab_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased_label_en-US" xlink:label="lab_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Employee Stock Purchase Plan, Average Purchase Price of Shares Purchased</link:label>
    <link:label id="lab_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased_documentation_en-US" xlink:label="lab_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Employee Stock Purchase Plan, Average Purchase Price of Shares Purchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" xlink:href="cvs-20230525.xsd#cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" xlink:to="lab_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_9522267d-c63a-4503-91dc-f5dd2ec90afe_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. domestic</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities, US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_cee88825-e85c-40de-91e1-3acf4642d043_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_label_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SharesHeldInTrustPolicyTextBlock_9369f051-d9ae-45f7-a60e-77793b8cd0f0_terseLabel_en-US" xlink:label="lab_cvs_SharesHeldInTrustPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Held in Trust</link:label>
    <link:label id="lab_cvs_SharesHeldInTrustPolicyTextBlock_label_en-US" xlink:label="lab_cvs_SharesHeldInTrustPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Held In Trust [Policy Text Block]</link:label>
    <link:label id="lab_cvs_SharesHeldInTrustPolicyTextBlock_documentation_en-US" xlink:label="lab_cvs_SharesHeldInTrustPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Held In Trust [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SharesHeldInTrustPolicyTextBlock" xlink:href="cvs-20230525.xsd#cvs_SharesHeldInTrustPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SharesHeldInTrustPolicyTextBlock" xlink:to="lab_cvs_SharesHeldInTrustPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldByInsuranceRegulators_a159333f-9935-4705-bb7a-0d31c4427dd0_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldByInsuranceRegulators" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments on deposit with regulatory bodies</link:label>
    <link:label id="lab_us-gaap_AssetsHeldByInsuranceRegulators_label_en-US" xlink:label="lab_us-gaap_AssetsHeldByInsuranceRegulators" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held by Insurance Regulators</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldByInsuranceRegulators" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldByInsuranceRegulators"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldByInsuranceRegulators" xlink:to="lab_us-gaap_AssetsHeldByInsuranceRegulators" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares_121c9142-d5cf-45b3-be6f-bef5b2ea60dd_terseLabel_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR, maximum amount of shares received or delivered</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares_label_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Program, Maximum Number Of Shares</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares_documentation_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Program, Maximum Number Of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares" xlink:href="cvs-20230525.xsd#cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares" xlink:to="lab_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_cdfb2a2e-0560-4a9c-8c7f-3e381267711f_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Four</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" xlink:to="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1234fdd2-3072-4ffe-903d-db5f20bab682_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_6dab0ae0-9c6f-4746-a5a0-3f9f990871b4_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3Point70PercentDue2023Member_067e466e-2e81-4a78-b053-a50c0b9d3ceb_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3Point70PercentDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.7% senior notes due 2023</link:label>
    <link:label id="lab_cvs_SeniorNotes3Point70PercentDue2023Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3Point70PercentDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3 Point 70 Percent, Due 2023 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3Point70PercentDue2023Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3Point70PercentDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3 Point 70 Percent, Due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point70PercentDue2023Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3Point70PercentDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3Point70PercentDue2023Member" xlink:to="lab_cvs_SeniorNotes3Point70PercentDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ThailandBusinessMember_605cd386-b603-4017-9637-38a89e4f1c7d_terseLabel_en-US" xlink:label="lab_cvs_ThailandBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thailand Business</link:label>
    <link:label id="lab_cvs_ThailandBusinessMember_label_en-US" xlink:label="lab_cvs_ThailandBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thailand Business [Member]</link:label>
    <link:label id="lab_cvs_ThailandBusinessMember_documentation_en-US" xlink:label="lab_cvs_ThailandBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thailand Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ThailandBusinessMember" xlink:href="cvs-20230525.xsd#cvs_ThailandBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ThailandBusinessMember" xlink:to="lab_cvs_ThailandBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InitialContractualTerm_9b4e5ec5-430c-4535-8851-2c8f34d9bf03_terseLabel_en-US" xlink:label="lab_cvs_InitialContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial contractual term (in years)</link:label>
    <link:label id="lab_cvs_InitialContractualTerm_label_en-US" xlink:label="lab_cvs_InitialContractualTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Contractual Term</link:label>
    <link:label id="lab_cvs_InitialContractualTerm_documentation_en-US" xlink:label="lab_cvs_InitialContractualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Initial Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InitialContractualTerm" xlink:href="cvs-20230525.xsd#cvs_InitialContractualTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InitialContractualTerm" xlink:to="lab_cvs_InitialContractualTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountDebtSecurityMember_1a752a43-6d8e-49e7-bc21-358675c83399_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountDebtSecurityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_SeparateAccountDebtSecurityMember_label_en-US" xlink:label="lab_us-gaap_SeparateAccountDebtSecurityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Debt Security [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountDebtSecurityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountDebtSecurityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountDebtSecurityMember" xlink:to="lab_us-gaap_SeparateAccountDebtSecurityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_61038c0e-7357-4385-ac4b-41c8733c5ba9_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_8742f9d3-2cae-46b0-93d9-44d6a01766c9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales and maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0c574f4a-1a19-4be0-a57f-4b7aca3779e8_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_f139091c-03de-4941-979a-84e8fc3c13f7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration of statutes of limitation</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_4146640a-7419-453e-808e-e1e6fa2091da_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1542c416-cbe7-47c3-9c4f-f64f689ed6f5_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost (income)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_73288295-0566-4ca6-8c5d-9165e8205581_terseLabel_en-US" xlink:label="lab_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases Liabilities Payments Due [Abstract]</link:label>
    <link:label id="lab_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_documentation_en-US" xlink:label="lab_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases Liabilities Payments Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract" xlink:href="cvs-20230525.xsd#cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract" xlink:to="lab_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_4b6e0925-4258-44d9-99c4-d07411968e65_terseLabel_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP issuances, net of purchase of treasury shares (in shares)</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_label_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net Of Treasury Stock, Shares, Acquired, Cost Method</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_documentation_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net Of Treasury Stock, Shares, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:href="cvs-20230525.xsd#cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:to="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies_2d2642ea-e638-4b01-9363-dc89bede0d57_negatedTerseLabel_en-US" xlink:label="lab_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for inventory and prescriptions dispensed by retail network pharmacies</link:label>
    <link:label id="lab_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies_label_en-US" xlink:label="lab_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Inventory And Prescriptions Dispensed By Retail Network Pharmacies</link:label>
    <link:label id="lab_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies_documentation_en-US" xlink:label="lab_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Inventory And Prescriptions Dispensed By Retail Network Pharmacies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies" xlink:href="cvs-20230525.xsd#cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies" xlink:to="lab_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_a54e481d-1a0b-488c-a59f-9c8b3ffaab6d_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_b2498ab8-09e9-4aad-9778-3f119408b4f9_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_665be993-8c11-4792-aa55-67ce7bf45a16_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule ESPP Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_5fc8a5bf-a13f-491c-abea-25789b002dd3_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_9531ebd9-71da-4215-812a-28d545d94406_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_4c473edc-dc49-4fe1-b605-04a918a87ec7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_07b5d8f4-a233-4ba6-908d-246e74ad6ba7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_0c75ebb5-567c-4091-a377-6b75a0ed5a37_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_31f0c8e9-1ddb-4da7-a877-c0801ae50a92_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_c35dfdc8-93ef-41e6-a1dd-bf8e2247c2da_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RetailLongTermCareSegmentMember_1c2242d0-633c-4570-9a91-f5b9bfe8f71b_terseLabel_en-US" xlink:label="lab_cvs_RetailLongTermCareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail LTC</link:label>
    <link:label id="lab_cvs_RetailLongTermCareSegmentMember_label_en-US" xlink:label="lab_cvs_RetailLongTermCareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Long-Term Care Segment [Member]</link:label>
    <link:label id="lab_cvs_RetailLongTermCareSegmentMember_documentation_en-US" xlink:label="lab_cvs_RetailLongTermCareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Long-Term Care Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember" xlink:href="cvs-20230525.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RetailLongTermCareSegmentMember" xlink:to="lab_cvs_RetailLongTermCareSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_638d2274-b2a3-4432-8bf2-084a51463e23_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRegulatoryAssetsTextBlock_65c3b17e-e3ae-42ad-a146-25aa0c02ba46_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRegulatoryAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Regulatory Requirements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRegulatoryAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRegulatoryAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Regulatory Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRegulatoryAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRegulatoryAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRegulatoryAssetsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRegulatoryAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk_fd73d9cc-0d77-4ba5-bd26-3c9d6d5f5193_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amount at risk</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Net Amount at Risk</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceNetAmountAtRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk" xlink:to="lab_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f0bdfc6c-ad39-4976-8b39-5fb1cca0ab98_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_f4cc71bf-eb6a-4ba7-9946-6822d339c8e4_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_d4e9c3a3-4940-46ff-b7a9-d1d8f02da3de_terseLabel_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR percent of notional amount received in shares</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_label_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percent Of Notional Amount Received In Shares</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_documentation_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percent Of Notional Amount Received In Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:href="cvs-20230525.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:to="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.75DueDecember2022Member_ff076841-65c3-461f-b274-d94cd948385a_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% senior notes due December 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueDecember2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due December 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueDecember2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due December 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueDecember2022Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.75DueDecember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.75DueDecember2022Member" xlink:to="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_219e2bf5-b247-4df2-958e-807e0aba74c1_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for future policy benefits, beginning of period - current discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_da9acdca-a8be-44bc-9aed-5778891d9319_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for future policy benefits, end of period - current discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Net Premium, before Reinsurance, after Discount Rate Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_a59876ed-0cd1-41c8-8a4a-b2efbcc97711_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest and Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_289f0e90-0296-43a6-9d29-b30b4433ae2d_terseLabel_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator for earnings per share calculation:</link:label>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_label_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_documentation_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:href="cvs-20230525.xsd#cvs_DenominatorForEarningsPerShareCalculationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:to="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_f5cd8b35-a30e-4931-b152-489f23f18a8e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.125DueSeptember2039Member_2d22d304-5e40-4dff-8c67-1aeed007488c_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.125% senior notes due September 2039</link:label>
    <link:label id="lab_cvs_SeniorNotes6.125DueSeptember2039Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.125%, Due September 2039 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.125DueSeptember2039Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.125%, Due September 2039 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes6.125DueSeptember2039Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:to="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_2b692658-c211-4380-8e40-e88191faee30_terseLabel_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">States, municipalities and political subdivisions</link:label>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_5e2d7303-6cd0-4b75-a4fc-1ad2b36fb747_verboseLabel_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">States, municipalities and political subdivisions</link:label>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_label_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US States and Political Subdivisions Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:to="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_a9ed75ee-89e1-48e7-84c1-1199ccf33969_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_6aa5b346-cf1e-4248-9f73-fccc515790d4_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and lease obligation</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation, Including Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_0e8d5347-9edd-4204-b7ea-e1a36ebaf458_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_3f47b01e-2972-46f2-8d72-3d4831612140_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations attributable to CVS Health (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_608f2301-d66a-48ab-8a19-3923b14245e4_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share from continuing operations, diluted (USD per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_85dea189-3f3b-4290-9417-b2142cf51b0f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesAgreementAmount_fc6e8fbb-5002-402f-92a2-a5ec8b920b2e_terseLabel_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR agreement, amount</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesAgreementAmount_label_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases Agreement, Amount</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesAgreementAmount_documentation_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases Agreement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:href="cvs-20230525.xsd#cvs_AcceleratedShareRepurchasesAgreementAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:to="lab_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SignifyHealthIncMember_17d8ab9c-c6cb-4b89-830b-e07a8d4e15b1_terseLabel_en-US" xlink:label="lab_cvs_SignifyHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Signify Health, Inc.</link:label>
    <link:label id="lab_cvs_SignifyHealthIncMember_label_en-US" xlink:label="lab_cvs_SignifyHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Signify Health, Inc. [Member]</link:label>
    <link:label id="lab_cvs_SignifyHealthIncMember_documentation_en-US" xlink:label="lab_cvs_SignifyHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Signify Health, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SignifyHealthIncMember" xlink:href="cvs-20230525.xsd#cvs_SignifyHealthIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SignifyHealthIncMember" xlink:to="lab_cvs_SignifyHealthIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_dac73409-805a-4802-aa8a-14fc48214303_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_be8e5087-0d1a-4a33-acf3-ed2f39dddb6e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_d6da91dc-22e6-481f-ba76-a4bcbbce971a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_f0a4ca12-92ab-45d6-aa83-c3ad692768ce_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_StockOptionsAndStockAppreciationRightsMember_dbefaf91-5e95-4da9-96de-71c20ff23120_terseLabel_en-US" xlink:label="lab_cvs_StockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options and Stock Appreciation Rights</link:label>
    <link:label id="lab_cvs_StockOptionsAndStockAppreciationRightsMember_label_en-US" xlink:label="lab_cvs_StockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options And Stock Appreciation Rights [Member]</link:label>
    <link:label id="lab_cvs_StockOptionsAndStockAppreciationRightsMember_documentation_en-US" xlink:label="lab_cvs_StockOptionsAndStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options And Stock Appreciation Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockOptionsAndStockAppreciationRightsMember" xlink:href="cvs-20230525.xsd#cvs_StockOptionsAndStockAppreciationRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_StockOptionsAndStockAppreciationRightsMember" xlink:to="lab_cvs_StockOptionsAndStockAppreciationRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock_28ec2b9b-fd8a-457e-b474-0c81fc13f6e2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Change in Level 3 Plan Assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_c3c70aa1-17bc-4a7b-ae13-681461ef532b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance_73073f82-9108-412d-a05d-8032420ec75c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected future benefit payments</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted, before Reinsurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance_e22745fc-efd6-4c32-bb78-fca723b819f6_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment earnings</link:label>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance_label_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability, Increase (Decrease) from Invested Performance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance" xlink:to="lab_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_dbde03c6-601c-4beb-955d-bdd9c38b37f8_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_6bc9bc11-e6a6-4765-9028-31b731a5c0c9_verboseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_1e09813d-10ad-4b3e-9871-0e6a77ba7fe4_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_4cfe5ac7-0028-400d-951f-226e7ed9c28c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_51d76651-f0c1-489b-83f5-ca1522698b58_terseLabel_en-US" xlink:label="lab_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bad debts and other allowances</link:label>
    <link:label id="lab_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_label_en-US" xlink:label="lab_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Bad Debts And Other Allowances</link:label>
    <link:label id="lab_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_documentation_en-US" xlink:label="lab_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Bad Debts And Other Allowances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" xlink:href="cvs-20230525.xsd#cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" xlink:to="lab_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_1406605b-8009-4d39-b297-4d2147990f41_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_d2c735d0-731f-45d6-95d3-e95bd75300c2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Securities Available For Sale</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_c79b8d63-1728-4b96-84a8-426588b076ca_terseLabel_en-US" xlink:label="lab_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases:</link:label>
    <link:label id="lab_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Assets And Liabilities, Lessee [Abstract]</link:label>
    <link:label id="lab_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Assets And Liabilities, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="cvs-20230525.xsd#cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_8c6fd517-d47f-49f3-831f-d57d63bd273d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_fc8081cd-3591-41f7-b38b-33933d8ec870_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information about Incurred and Paid Health Care Claims Development</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Claims Development [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyClaimsAndDiscountsPayableCurrent_ba353e00-e731-4ee6-9615-9cbb0fb09104_terseLabel_en-US" xlink:label="lab_cvs_PharmacyClaimsAndDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy claims and discounts payable</link:label>
    <link:label id="lab_cvs_PharmacyClaimsAndDiscountsPayableCurrent_label_en-US" xlink:label="lab_cvs_PharmacyClaimsAndDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Claims And Discounts Payable, Current</link:label>
    <link:label id="lab_cvs_PharmacyClaimsAndDiscountsPayableCurrent_documentation_en-US" xlink:label="lab_cvs_PharmacyClaimsAndDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Claims And Discounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsAndDiscountsPayableCurrent" xlink:href="cvs-20230525.xsd#cvs_PharmacyClaimsAndDiscountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyClaimsAndDiscountsPayableCurrent" xlink:to="lab_cvs_PharmacyClaimsAndDiscountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.25DueAugust2029Member_9db075b3-848b-4892-8323-8b050bd506c3_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.25% senior notes due August 2029</link:label>
    <link:label id="lab_cvs_SeniorNotes3.25DueAugust2029Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.25%, Due August 2029 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.25DueAugust2029Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.25%, Due August 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.25DueAugust2029Member" xlink:to="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_b0b133d9-c2cc-45c2-a2e6-fdac6cd1107c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount expected to be reclassified</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityTableTextBlock_6b693510-e586-4189-b6a3-ffd68ffac270_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Roll Forward of Separate Accounts</link:label>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountLiabilityTableTextBlock" xlink:to="lab_us-gaap_SeparateAccountLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5DueDecember2024Member_07c105ef-4aaa-4ba9-9b1b-4e9762095259_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5% senior notes due December 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes5DueDecember2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5%, Due December 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5DueDecember2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5%, Due December 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5DueDecember2024Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes5DueDecember2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5DueDecember2024Member" xlink:to="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_44470cfb-bd8f-4780-ba47-63722779bda5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_9840b281-6ff8-4d0e-a8c6-2985b7150a3e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receipt of fully reserved ACA risk corridor receivable</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Recovery</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_f6d9d3c6-90b6-4e84-9f5a-c3adde4f5551_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_97825154-a3cf-416c-a905-8fd2303242b7_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy network</link:label>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Through Intermediary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:to="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_5e7da38e-8200-471f-9d66-01cc37cde27f_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberofReinsuranceContractsEnteredInto_602e53e6-f688-451d-99e7-a1ab45800b62_terseLabel_en-US" xlink:label="lab_cvs_NumberofReinsuranceContractsEnteredInto" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reinsurance contracts entered into</link:label>
    <link:label id="lab_cvs_NumberofReinsuranceContractsEnteredInto_label_en-US" xlink:label="lab_cvs_NumberofReinsuranceContractsEnteredInto" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reinsurance Contracts Entered Into</link:label>
    <link:label id="lab_cvs_NumberofReinsuranceContractsEnteredInto_documentation_en-US" xlink:label="lab_cvs_NumberofReinsuranceContractsEnteredInto" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reinsurance contracts entered into with an unrelated insurer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofReinsuranceContractsEnteredInto" xlink:href="cvs-20230525.xsd#cvs_NumberofReinsuranceContractsEnteredInto"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberofReinsuranceContractsEnteredInto" xlink:to="lab_cvs_NumberofReinsuranceContractsEnteredInto" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_f7b0cdc2-b1a4-48b2-8021-05b3e95a22f9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities reflected in other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_f081c15f-74b3-4d0b-b446-e5223999eb88_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_e5329f17-a01a-4d5f-9854-f1daca261000_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_5ef8592b-79fa-4d2a-b1e6-ca1aab9dcce5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_6b5dd63f-91c9-4fdb-b92e-515cc9cd6fe1_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations attributable to CVS Health (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_e7d13e56-d485-4d8b-b1e6-995f0e798281_terseLabel_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former gain contingency, recognized in current period, before tax</link:label>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Gain Contingency, Recognized In Current Period, Before Tax</link:label>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_documentation_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Gain Contingency, Recognized In Current Period, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:href="cvs-20230525.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:to="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_161895cf-d536-47cc-ad0b-e11087b63376_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_129658d6-6d2c-4fcd-9b2b-a672eafe7582_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_52701c84-fb1b-4a6e-b71e-632f24683547_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_8e823c3c-744c-4e06-9b55-11984c0884a6_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Statement of Cash Flows:</link:label>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_cad8a4bc-8a58-4061-a878-e7de18a87595_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededCreditRiskLineItems_3bea7c36-d88f-4e83-854c-233fc99f588b_terseLabel_en-US" xlink:label="lab_us-gaap_CededCreditRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_CededCreditRiskLineItems_label_en-US" xlink:label="lab_us-gaap_CededCreditRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededCreditRiskLineItems" xlink:to="lab_us-gaap_CededCreditRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_c436898e-f8f9-44eb-a596-185e58034755_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_8ef8d924-db23-405b-81a5-80df6b89064a_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings and Credit Agreements</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashDivestedFromDeconsolidation_b05c0119-7491-42c7-9d8c-24d11990400b_terseLabel_en-US" xlink:label="lab_us-gaap_CashDivestedFromDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and restricted cash sold</link:label>
    <link:label id="lab_us-gaap_CashDivestedFromDeconsolidation_label_en-US" xlink:label="lab_us-gaap_CashDivestedFromDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Divested from Deconsolidation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDivestedFromDeconsolidation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashDivestedFromDeconsolidation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashDivestedFromDeconsolidation" xlink:to="lab_us-gaap_CashDivestedFromDeconsolidation" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_cb84d2cf-c740-4bd1-b7ae-ef08bb51703c_negatedTerseLabel_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury shares, net of ESPP issuances (in shares)</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_label_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_documentation_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:href="cvs-20230525.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:to="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_958285f7-a7e9-44c6-9ae2-581e7f87d94a_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_dbb29fe2-8d7a-4ae0-b450-1076a94b21a1_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_5ed1dec1-63f7-485e-9959-9d5d4189dd0d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions for tax positions of prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DirectPremiumsEarned_ceb7c334-1ecb-4f02-8f96-f729f1cee644_terseLabel_en-US" xlink:label="lab_us-gaap_DirectPremiumsEarned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct</link:label>
    <link:label id="lab_us-gaap_DirectPremiumsEarned_label_en-US" xlink:label="lab_us-gaap_DirectPremiumsEarned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Premiums Earned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectPremiumsEarned" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectPremiumsEarned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectPremiumsEarned" xlink:to="lab_us-gaap_DirectPremiumsEarned" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes1Point75PercentAugust2030Member_1880110f-e7c8-4daa-a823-0bce4d82c698_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes1Point75PercentAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.75% senior notes due August 2030</link:label>
    <link:label id="lab_cvs_SeniorNotes1Point75PercentAugust2030Member_label_en-US" xlink:label="lab_cvs_SeniorNotes1Point75PercentAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1 Point 75 Percent, August 2030 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes1Point75PercentAugust2030Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes1Point75PercentAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1 Point 75 Percent, August 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point75PercentAugust2030Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes1Point75PercentAugust2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes1Point75PercentAugust2030Member" xlink:to="lab_cvs_SeniorNotes1Point75PercentAugust2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeTextBlock_6bb2859d-dac4-44c3-9f62-ed1455d2dd50_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeTextBlock" xlink:to="lab_us-gaap_InvestmentIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_0cf9ef77-4023-48b3-8d18-52acf84c6dd3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_8bf9cd1e-94c4-42e8-aa99-440ed450072c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1fd2ded0-7887-4c47-b21d-b5d0a54ecc42_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetNet_8229147f-886f-4645-8ee0-a9d8823efcab_totalLabel_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetNet_label_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, Net</link:label>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetNet_documentation_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetNet" xlink:href="cvs-20230525.xsd#cvs_FinanceLeaseRightOfUseAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FinanceLeaseRightOfUseAssetNet" xlink:to="lab_cvs_FinanceLeaseRightOfUseAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.875DueJuly2035Member_a54e7349-6b15-4571-9ef9-dac77cee9e74_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.875% senior notes due July 2035</link:label>
    <link:label id="lab_cvs_SeniorNotes4.875DueJuly2035Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.875%, Due July 2035 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.875DueJuly2035Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.875%, Due July 2035 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.875DueJuly2035Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.875DueJuly2035Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.875DueJuly2035Member" xlink:to="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_8ac9eb6c-ea29-4b42-8f55-3de720fae12c_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2003f714-65bc-4ade-b789-53e4e784b261_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_b8f7ca7e-0197-4ea7-bccb-67f6ed42a094_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_3b395ed4-9ea9-4e4e-b6df-33d23da47be9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_25ed6910-6102-4a56-aea9-1204ee4ed03b_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_6759ac86-1a63-4d0c-bb7f-0e06e337f64c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_f3444937-3054-45c4-a196-39d1b5989f69_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_a552bda7-28dc-47ba-8228-bbab17c3301b_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.25DueJune2027Member_9989d9b5-2ad7-46d7-a037-f0e1f6628502_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.25% senior notes due June 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes6.25DueJune2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.25%, Due June 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.25DueJune2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.25%, Due June 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.25DueJune2027Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes6.25DueJune2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.25DueJune2027Member" xlink:to="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax_d490ff67-222b-494f-900d-2b7bf8edee0c_terseLabel_en-US" xlink:label="lab_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption of new accounting standard, pre-tax</link:label>
    <link:label id="lab_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax_label_en-US" xlink:label="lab_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable To Noncontrolling Interest, Pretax</link:label>
    <link:label id="lab_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax_documentation_en-US" xlink:label="lab_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable To Noncontrolling Interest, Pretax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" xlink:href="cvs-20230525.xsd#cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" xlink:to="lab_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RedOakMember_14cbd647-890d-4b81-8167-c99175489744_terseLabel_en-US" xlink:label="lab_cvs_RedOakMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Red Oak</link:label>
    <link:label id="lab_cvs_RedOakMember_label_en-US" xlink:label="lab_cvs_RedOakMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Red Oak [Member]</link:label>
    <link:label id="lab_cvs_RedOakMember_documentation_en-US" xlink:label="lab_cvs_RedOakMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Red Oak</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RedOakMember" xlink:href="cvs-20230525.xsd#cvs_RedOakMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RedOakMember" xlink:to="lab_cvs_RedOakMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountAssets_4a34b6bc-4d4b-428d-845b-e79b9a03c2d4_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate accounts assets</link:label>
    <link:label id="lab_us-gaap_SeparateAccountAssets_label_en-US" xlink:label="lab_us-gaap_SeparateAccountAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountAssets" xlink:to="lab_us-gaap_SeparateAccountAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_0ecf9f00-6756-41a2-be74-b206ad7f58b2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_0a0e614e-0a07-42a4-9ae9-4d17d9204e67_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_d47bcfb8-e064-4e5d-9df1-51dc72ca21a1_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyRevenueMember_139513b5-fccf-42e6-acb9-3fbea9f3ff59_terseLabel_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy</link:label>
    <link:label id="lab_cvs_PharmacyRevenueMember_label_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Revenue [Member]</link:label>
    <link:label id="lab_cvs_PharmacyRevenueMember_documentation_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember" xlink:href="cvs-20230525.xsd#cvs_PharmacyRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyRevenueMember" xlink:to="lab_cvs_PharmacyRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_ef25ab43-19b2-4a14-ab57-6f3e04ae6a78_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to CVS Health:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_79dabcf1-098b-4713-ab6a-a6e06c2a8f3a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt premiums</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_e039eb9f-01eb-4d5a-affe-d7e545563766_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount awarded from other party</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded from Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes1Point3PercentAugust2027Member_dedd904e-b9da-440e-adbd-973405e94e63_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes1Point3PercentAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% senior notes due August 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes1Point3PercentAugust2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes1Point3PercentAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1 Point 3 Percent, August 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes1Point3PercentAugust2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes1Point3PercentAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1 Point 3 Percent, August 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point3PercentAugust2027Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes1Point3PercentAugust2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes1Point3PercentAugust2027Member" xlink:to="lab_cvs_SeniorNotes1Point3PercentAugust2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a8386a04-0dbd-45dc-955a-87042d66ad84_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.7DueMarch2023Member_c2b08cd0-3837-4fe1-b156-c4ca0ba04162_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.7DueMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.7% senior notes due March 2023</link:label>
    <link:label id="lab_cvs_SeniorNotes3.7DueMarch2023Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.7DueMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.7%, Due March 2023 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.7DueMarch2023Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.7DueMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.7%, Due March 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.7DueMarch2023Member" xlink:to="lab_cvs_SeniorNotes3.7DueMarch2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_159256e2-2f23-4072-ad12-ab792e916d8e_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_WeightedAverageRemainingLeaseTermAbstract_38532ad8-95a1-4b22-b797-0612076dcfab_terseLabel_en-US" xlink:label="lab_cvs_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_cvs_WeightedAverageRemainingLeaseTermAbstract_label_en-US" xlink:label="lab_cvs_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:label id="lab_cvs_WeightedAverageRemainingLeaseTermAbstract_documentation_en-US" xlink:label="lab_cvs_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_WeightedAverageRemainingLeaseTermAbstract" xlink:href="cvs-20230525.xsd#cvs_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_WeightedAverageRemainingLeaseTermAbstract" xlink:to="lab_cvs_WeightedAverageRemainingLeaseTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount_b7692eba-a43b-470f-8a53-cec4b96e4744_terseLabel_en-US" xlink:label="lab_us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net transfers from general account</link:label>
    <link:label id="lab_us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount_label_en-US" xlink:label="lab_us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer to (from) Policyholder Account Balance (to) from Separate Account</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount" xlink:to="lab_us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet_2a373efa-988a-4013-92c9-d73aa7e07799_negatedTerseLabel_en-US" xlink:label="lab_cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discounts and deferred financing costs</link:label>
    <link:label id="lab_cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount And Debt Issuance Costs, Net</link:label>
    <link:label id="lab_cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet_documentation_en-US" xlink:label="lab_cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount And Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet" xlink:href="cvs-20230525.xsd#cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet" xlink:to="lab_cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4Point25PercentApril2050Member_5d47435d-75ef-485e-84ef-db93c9cf534c_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4Point25PercentApril2050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.25% senior notes due April 2050</link:label>
    <link:label id="lab_cvs_SeniorNotes4Point25PercentApril2050Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4Point25PercentApril2050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4 Point 25 Percent, April 2050 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4Point25PercentApril2050Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4Point25PercentApril2050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4 Point 25 Percent, April 2050</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4Point25PercentApril2050Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4Point25PercentApril2050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4Point25PercentApril2050Member" xlink:to="lab_cvs_SeniorNotes4Point25PercentApril2050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5549c826-8894-41a7-a4c1-e80f5d063d09_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, exercised ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_55448381-acc2-4a43-b190-a4b78c88d929_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_5acb1365-a24f-4bf4-98c7-b072c8858382_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3b6dd3bd-4550-4cfa-9f6f-844300c195df_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_635fe2b1-a002-402f-bbd1-d16227a3e578_terseLabel_en-US" xlink:label="lab_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases:</link:label>
    <link:label id="lab_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Assets And Liabilities, Lessee [Abstract]</link:label>
    <link:label id="lab_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Assets And Liabilities, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="cvs-20230525.xsd#cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_6b24ceb4-d6ca-4eaf-a82b-8afa0e2739b6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod_85b59160-9092-4b2d-b6c5-262edb482765_terseLabel_en-US" xlink:label="lab_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of stores, annual planned closures for closure period</link:label>
    <link:label id="lab_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod_label_en-US" xlink:label="lab_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Stores, Annual Planned Closures For Closure Period</link:label>
    <link:label id="lab_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod_documentation_en-US" xlink:label="lab_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Stores, Annual Planned Closures For Closure Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod" xlink:href="cvs-20230525.xsd#cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod" xlink:to="lab_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2d251613-f9cc-44f4-89a4-1b95bb7f5226_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_19f16384-6f32-4a74-840b-abebb5bb6580_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates_304527c0-53a4-40c9-927c-eb7a8b85b2c9_terseLabel_en-US" xlink:label="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units and performance stock units vested if actual payout rates are applied (in shares)</link:label>
    <link:label id="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates_label_en-US" xlink:label="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested In Period, Actual Payout Rates</link:label>
    <link:label id="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates_documentation_en-US" xlink:label="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested In Period, Actual Payout Rates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates" xlink:href="cvs-20230525.xsd#cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates" xlink:to="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_0911e144-28d4-410b-b1ce-44f0469f703e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_fecf7f97-25a8-48fa-b24d-81b76af8d71c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_2c357c8f-80ec-47ad-9871-350870bd719d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingencyUnrecordedAmount_e2717b9e-80dd-43ed-9653-e7808ccfa5e2_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingencyUnrecordedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain contingency, unrecorded amount</link:label>
    <link:label id="lab_us-gaap_GainContingencyUnrecordedAmount_label_en-US" xlink:label="lab_us-gaap_GainContingencyUnrecordedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingency, Unrecorded Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyUnrecordedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainContingencyUnrecordedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingencyUnrecordedAmount" xlink:to="lab_us-gaap_GainContingencyUnrecordedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_3f7f9155-362f-44ca-878b-cbb0e5f37613_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts_f427cbf8-caa4-4b3c-bc96-8e7ce95a1db5_terseLabel_en-US" xlink:label="lab_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual obligations underlying the guaranteed benefits</link:label>
    <link:label id="lab_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts_label_en-US" xlink:label="lab_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligations To Maintain Levels Of Separate Accounts</link:label>
    <link:label id="lab_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts_documentation_en-US" xlink:label="lab_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the contractual obligation to maintain the required level of funding in Separate Accounts necessary to fund specific guaranteed pensions annuities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts" xlink:href="cvs-20230525.xsd#cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts" xlink:to="lab_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForwardContractsMember_8784ff6e-b951-4d95-b502-15bb675f5a0c_terseLabel_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts</link:label>
    <link:label id="lab_us-gaap_ForwardContractsMember_label_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractsMember" xlink:to="lab_us-gaap_ForwardContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_2ff12fc8-36a1-4444-8a9f-199421d132e9_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_5ffd0f16-8e4a-48b3-8871-c2dc79ad66e1_periodStartLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_6f0a384c-b670-44f6-8064-76eead2cfb1f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable for Unpaid Claims and Claims Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:to="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_15c79d56-2458-4f5a-80b7-a15d277f6fd7_terseLabel_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting experience- rated products</link:label>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_label_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting Experience Rated Products [Member]</link:label>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_documentation_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting discontinued and experience-rated products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember" xlink:href="cvs-20230525.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SupportingExperienceRatedProductsMember" xlink:to="lab_cvs_SupportingExperienceRatedProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_5cabb840-80eb-4c79-901d-845e5cc15c12_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_fc1b9e51-163c-4bd2-81a1-b7bbb17fd377_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_25adceb7-b252-42f1-bdbd-273e3d0c1b21_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_83a79d40-62f5-48b2-825a-8935fd7a3ce7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on early extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_f9cc1d7c-4314-4e66-b6fe-12ba2212c23d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of changes in cash flow assumptions</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) from Cash Flow Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_18efee4f-137b-4af0-9570-bf80bcc14043_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_3b2954bf-f370-4619-b91c-80536d4037d1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded</link:label>
    <link:label id="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_label_en-US" xlink:label="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Ceded</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:to="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_30df8596-efde-4ed0-8fc7-8d41d23dc5c0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets (liabilities) recognized on the consolidated balance sheet</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_7d2af5a9-bcc1-48d5-8311-294c107e24b6_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_5a0988d9-3c14-4992-885f-ca07d2daf09a_negatedTerseLabel_en-US" xlink:label="lab_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_label_en-US" xlink:label="lab_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Depreciation And Amortization</link:label>
    <link:label id="lab_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_documentation_en-US" xlink:label="lab_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Depreciation and Amortization - Amount of deferred tax liability attributable to taxable temporary differences from depreciation and amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:href="cvs-20230525.xsd#cvs_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:to="lab_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_97e54799-41a2-4ade-a167-28a0b1cb287d_verboseLabel_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Proceeds and Related Gross Realized Capital Gains and Losses From the Sale of Debt Securities</link:label>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_label_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds And Related Gross Realized Capital Gains Losses From Sale Of Debt Securities [Table Text Block]</link:label>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:href="cvs-20230525.xsd#cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:to="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_ebd30d25-ab31-4210-952b-96057f78ddd0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceAbstract_64e2b7eb-7db2-4347-b052-43b0d3c2703a_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:label id="lab_us-gaap_InsuranceAbstract_label_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceAbstract" xlink:to="lab_us-gaap_InsuranceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.875DueJune2026Member_4a2e50ef-97e8-4508-9bcc-d2a1bdc767fe_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% senior notes due June 2026</link:label>
    <link:label id="lab_cvs_SeniorNotes2.875DueJune2026Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.875%, Due June 2026 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.875DueJune2026Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.875%, Due June 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.875DueJune2026Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2.875DueJune2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.875DueJune2026Member" xlink:to="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_abe4f9f3-320d-47e1-830b-e0e53eb751a4_totalLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Commercial and Consumer, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_498d8ec5-208b-4497-aaf7-a26edd4b7c08_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_266f66d4-891b-470d-985a-99f7084d00f5_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal After Year Five</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal After Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" xlink:to="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialRealEstateMember_5487fbe2-8ed4-4952-b393-6fc179ae022f_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Real Estate</link:label>
    <link:label id="lab_us-gaap_CommercialRealEstateMember_label_en-US" xlink:label="lab_us-gaap_CommercialRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Real Estate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialRealEstateMember" xlink:to="lab_us-gaap_CommercialRealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostsAdditions_fbc679e9-6552-4629-a47f-16d6091f4c21_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostsAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalizations</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostsAdditions_label_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostsAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Cost, Capitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostsAdditions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostsAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredPolicyAcquisitionCostsAdditions" xlink:to="lab_us-gaap_DeferredPolicyAcquisitionCostsAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_320762b1-8ba6-4d0b-af2d-72e016c70bf0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_15ae0fca-b0fc-4cc5-950c-76e5b8f75d5e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) claims liability, net</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_ea6cf253-4ee6-43d0-b91b-b647de2e6339_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated minimum statutory surplus required by regulators</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Capital and Surplus Required</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_2d4474f4-b985-4756-a66b-0982f17fb591_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_877cb6f7-2ca3-405f-994a-58eb291f07d1_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_ae0cb55e-5b52-4d40-9aa6-c0f6ef0c2916_terseLabel_en-US" xlink:label="lab_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_label_en-US" xlink:label="lab_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses, Excluding Store Impairments, Goodwill Impairments, Loss On Assets Held For Sale, And Loss On Litigation Settlement</link:label>
    <link:label id="lab_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_documentation_en-US" xlink:label="lab_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses, Excluding Store Impairments, Goodwill Impairments, Loss On Assets Held For Sale, And Loss On Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" xlink:href="cvs-20230525.xsd#cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" xlink:to="lab_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_34c88131-7250-4539-90fc-71bfe3b81b20_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028-2032</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AllOtherReinsurersMember_f2904444-4043-4d36-989e-2a17879fd17d_terseLabel_en-US" xlink:label="lab_cvs_AllOtherReinsurersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other</link:label>
    <link:label id="lab_cvs_AllOtherReinsurersMember_label_en-US" xlink:label="lab_cvs_AllOtherReinsurersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other Reinsurers [Member]</link:label>
    <link:label id="lab_cvs_AllOtherReinsurersMember_documentation_en-US" xlink:label="lab_cvs_AllOtherReinsurersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other Reinsurers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AllOtherReinsurersMember" xlink:href="cvs-20230525.xsd#cvs_AllOtherReinsurersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AllOtherReinsurersMember" xlink:to="lab_cvs_AllOtherReinsurersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.3DueMarch2028Member_08028550-0110-4b41-8051-a72fd6c55c0b_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.3% senior notes due March 2028</link:label>
    <link:label id="lab_cvs_SeniorNotes4.3DueMarch2028Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due March 2028 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.3DueMarch2028Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due March 2028 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.3DueMarch2028Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.3DueMarch2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.3DueMarch2028Member" xlink:to="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_cd5a7cee-8988-4bdb-8ed6-65cca7f842b3_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_8d767288-b57b-4ed1-aa94-de2a9df64b1a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClaimsDevelopmentLineItems_f99e2a82-db1d-466e-9f04-b6908126b408_terseLabel_en-US" xlink:label="lab_us-gaap_ClaimsDevelopmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims Development [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClaimsDevelopmentLineItems_label_en-US" xlink:label="lab_us-gaap_ClaimsDevelopmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims Development [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems" xlink:to="lab_us-gaap_ClaimsDevelopmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCosts_19b16416-27c3-436d-8bd4-95eb5980a8d0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred acquisition costs</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCosts_e757b53b-c91a-4ee6-bded-9ecaac13bbb1_periodStartLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred acquisition costs, beginning of the period</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCosts_bb5a6838-7212-464a-8a3c-2c954d14d1c6_periodEndLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred acquisition costs, end of the period</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCosts_label_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredPolicyAcquisitionCosts" xlink:to="lab_us-gaap_DeferredPolicyAcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_20046bf9-3a2d-4c0d-ad43-89efcbee8959_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_bddbbd9f-ebc0-47e7-bb79-0b0215bdacee_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_5aaab598-3753-4b66-a7c7-ffd4ae04d23d_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_a5880421-44e3-47e1-8e58-499cf5f80c63_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_d677a1d4-f088-4a34-8c44-a5d5a28b1a12_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Accumulated Other Comprehensive Income (Loss) by Component</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_699df07b-e351-4be6-927d-33a1a62833f3_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue_362b7e98-2da3-4d1f-bcc0-49c1ab324eca_terseLabel_en-US" xlink:label="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of stock options and SARs vested</link:label>
    <link:label id="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue_label_en-US" xlink:label="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Equity Instruments Other Than Options, Vested In Period, Fair Value</link:label>
    <link:label id="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue_documentation_en-US" xlink:label="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Equity Instruments Other Than Options, Vested In Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" xlink:href="cvs-20230525.xsd#cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" xlink:to="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_6512fb2f-ac18-477d-ab38-a2881f1f392f_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares outstanding, beginning of year balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_fc73c287-8b30-44f4-b9c4-16d6771652d1_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares outstanding, end of year balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LongtermDebtGrossAndLeaseObligation_8e64b76b-1e0b-438b-99aa-2216ab33842c_totalLabel_en-US" xlink:label="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt principal</link:label>
    <link:label id="lab_cvs_LongtermDebtGrossAndLeaseObligation_label_en-US" xlink:label="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross And Lease Obligation</link:label>
    <link:label id="lab_cvs_LongtermDebtGrossAndLeaseObligation_documentation_en-US" xlink:label="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross And Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation" xlink:href="cvs-20230525.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LongtermDebtGrossAndLeaseObligation" xlink:to="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_611e24a4-396e-4729-92bb-e2b756900b3e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_b6d38200-d4b2-4a46-bc54-0228df6055a4_terseLabel_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits</link:label>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_label_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits Segment [Member]</link:label>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_documentation_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember" xlink:href="cvs-20230525.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthCareBenefitsSegmentMember" xlink:to="lab_cvs_HealthCareBenefitsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLeaseTableTextBlock_3757c9d0-3098-45e1-8b66-726f58a84611_terseLabel_en-US" xlink:label="lab_cvs_LesseeLeaseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_cvs_LesseeLeaseTableTextBlock_label_en-US" xlink:label="lab_cvs_LesseeLeaseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease [Table Text Block]</link:label>
    <link:label id="lab_cvs_LesseeLeaseTableTextBlock_documentation_en-US" xlink:label="lab_cvs_LesseeLeaseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLeaseTableTextBlock" xlink:href="cvs-20230525.xsd#cvs_LesseeLeaseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLeaseTableTextBlock" xlink:to="lab_cvs_LesseeLeaseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfPatientsServedPerYear_55ca3902-20d2-4fc0-ad27-bcc847c76094_terseLabel_en-US" xlink:label="lab_cvs_NumberOfPatientsServedPerYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patients served per year (more than)</link:label>
    <link:label id="lab_cvs_NumberOfPatientsServedPerYear_label_en-US" xlink:label="lab_cvs_NumberOfPatientsServedPerYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Patients Served Per Year</link:label>
    <link:label id="lab_cvs_NumberOfPatientsServedPerYear_documentation_en-US" xlink:label="lab_cvs_NumberOfPatientsServedPerYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Patients Served Per Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPatientsServedPerYear" xlink:href="cvs-20230525.xsd#cvs_NumberOfPatientsServedPerYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfPatientsServedPerYear" xlink:to="lab_cvs_NumberOfPatientsServedPerYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_74ce4cf9-27a9-4fb5-8303-ec2e519bed6a_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions based on tax positions related to prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_adb36382-bed8-48dd-a6f0-f5014d34ba48_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measured at Net Asset Value Per Share</link:label>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measured at Net Asset Value Per Share [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:to="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_14cf6ca1-4098-4414-b38a-4e95027810ef_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_A2022RepurchaseProgramMember_fbdd3bdc-00ab-4543-a047-4a09a4eac755_terseLabel_en-US" xlink:label="lab_cvs_A2022RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Repurchase Program</link:label>
    <link:label id="lab_cvs_A2022RepurchaseProgramMember_label_en-US" xlink:label="lab_cvs_A2022RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Repurchase Program [Member]</link:label>
    <link:label id="lab_cvs_A2022RepurchaseProgramMember_documentation_en-US" xlink:label="lab_cvs_A2022RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2022RepurchaseProgramMember" xlink:href="cvs-20230525.xsd#cvs_A2022RepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_A2022RepurchaseProgramMember" xlink:to="lab_cvs_A2022RepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_446a940a-7573-4a8e-a897-744ee6a5ee22_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_4880ebf0-326b-4e8c-8990-feecc6da6dc6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PolicyholderAccountBalanceDepositsReceived_f670b1fc-6370-4539-9aac-c3b8f1cae640_terseLabel_en-US" xlink:label="lab_cvs_PolicyholderAccountBalanceDepositsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits received</link:label>
    <link:label id="lab_cvs_PolicyholderAccountBalanceDepositsReceived_label_en-US" xlink:label="lab_cvs_PolicyholderAccountBalanceDepositsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Deposits Received</link:label>
    <link:label id="lab_cvs_PolicyholderAccountBalanceDepositsReceived_documentation_en-US" xlink:label="lab_cvs_PolicyholderAccountBalanceDepositsReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance, Deposits Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PolicyholderAccountBalanceDepositsReceived" xlink:href="cvs-20230525.xsd#cvs_PolicyholderAccountBalanceDepositsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PolicyholderAccountBalanceDepositsReceived" xlink:to="lab_cvs_PolicyholderAccountBalanceDepositsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_781acea8-8e4e-4db7-beeb-554dc52df46e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares vested at end of year and expected to vest in the future (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable_ef1f5dbb-c799-4c8c-bbdd-32425e950a70_terseLabel_en-US" xlink:label="lab_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal home loan bank advances maximum amount available</link:label>
    <link:label id="lab_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable_label_en-US" xlink:label="lab_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Home Loan Bank, Advances, General Debt Obligations, Maximum Amount Available</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable" xlink:to="lab_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4285d14e-d5d9-43fa-962d-6bbc9b1353ae_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_cf6ed13a-8eca-417b-bf28-48587d293d72_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_3d557236-cdf1-46ad-8f7a-2e1ac4725943_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_28539e93-ea1d-4aa4-a936-f8298cf4b151_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b95c7f7b-6448-4262-ae47-46d359ea1869_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent_ba156ed7-7429-4a54-8163-bc2234965974_terseLabel_en-US" xlink:label="lab_cvs_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal charges</link:label>
    <link:label id="lab_cvs_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent_label_en-US" xlink:label="lab_cvs_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal Charges, Percent</link:label>
    <link:label id="lab_cvs_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent_documentation_en-US" xlink:label="lab_cvs_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal Charges, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent" xlink:href="cvs-20230525.xsd#cvs_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent" xlink:to="lab_cvs_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_46488d8c-0607-49d0-966d-6260ae2767fd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_0249658c-2362-4075-b8b4-c66dc7faebca_totalLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_d2fe1958-a37b-43f5-a414-784be74302ed_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_b6bb44c9-b2b7-44a8-9f64-90d2c5cf2b0c_terseLabel_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common/collective trusts</link:label>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_label_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common And Collective Trusts [Member]</link:label>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_documentation_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The total amount of Common/Collective Trusts held by the company, primarily related to investment funds otherwise known as underlying funds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember" xlink:href="cvs-20230525.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CommonAndCollectiveTrustsMember" xlink:to="lab_cvs_CommonAndCollectiveTrustsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertySubjectToOperatingLeaseMember_baa4aa2a-9953-4732-86e7-a438110a130f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertySubjectToOperatingLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_PropertySubjectToOperatingLeaseMember_label_en-US" xlink:label="lab_us-gaap_PropertySubjectToOperatingLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Subject to Operating Lease [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOperatingLeaseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertySubjectToOperatingLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertySubjectToOperatingLeaseMember" xlink:to="lab_us-gaap_PropertySubjectToOperatingLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_c3394c05-b85d-432c-8121-71a6c8f0d120_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetGross_f90c3aa9-90a9-474c-a5c0-f06df0dd2c52_terseLabel_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetGross_label_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, Gross</link:label>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetGross_documentation_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetGross" xlink:href="cvs-20230525.xsd#cvs_FinanceLeaseRightOfUseAssetGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FinanceLeaseRightOfUseAssetGross" xlink:to="lab_cvs_FinanceLeaseRightOfUseAssetGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_cacac1ab-57ca-456d-be1f-925343a95027_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_f95a10dd-7e11-4d8f-a4b2-3a5b60c7103d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfMedicalMembers_cf60c967-0065-402e-ab7c-5a36c19952f0_terseLabel_en-US" xlink:label="lab_cvs_NumberOfMedicalMembers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of medical members</link:label>
    <link:label id="lab_cvs_NumberOfMedicalMembers_label_en-US" xlink:label="lab_cvs_NumberOfMedicalMembers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Medical Members</link:label>
    <link:label id="lab_cvs_NumberOfMedicalMembers_documentation_en-US" xlink:label="lab_cvs_NumberOfMedicalMembers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Medical Members</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfMedicalMembers" xlink:href="cvs-20230525.xsd#cvs_NumberOfMedicalMembers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfMedicalMembers" xlink:to="lab_cvs_NumberOfMedicalMembers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_98320fa7-2c69-41fc-a0e3-2a6047a63468_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_46724e95-3a45-42b4-9d7a-86d617acb423_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Changes in Carrying Amount of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_49d004e9-015d-44c1-bc78-95dad715a08b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_3419c712-f346-4257-beef-4db4fe1ec32b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2717fd50-6d25-4969-b4e3-c710fcaa7ad2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_6fb3704a-53e8-435e-9bfb-93620867aaac_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_b1b8561c-62f0-4759-96e1-3c44e7c1bb8b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableMember_254c2b33-52a4-461a-b31f-07893ecc8fd1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other payables</link:label>
    <link:label id="lab_us-gaap_AccountsPayableMember_label_en-US" xlink:label="lab_us-gaap_AccountsPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableMember" xlink:to="lab_us-gaap_AccountsPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CVSHealth2017IncentiveCompensationPlanMember_9f18bc58-2242-4517-8ef5-d86e54350ed3_terseLabel_en-US" xlink:label="lab_cvs_CVSHealth2017IncentiveCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CVS Health 2017 Incentive Compensation Plan</link:label>
    <link:label id="lab_cvs_CVSHealth2017IncentiveCompensationPlanMember_label_en-US" xlink:label="lab_cvs_CVSHealth2017IncentiveCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CVS Health 2017 Incentive Compensation Plan [Member]</link:label>
    <link:label id="lab_cvs_CVSHealth2017IncentiveCompensationPlanMember_documentation_en-US" xlink:label="lab_cvs_CVSHealth2017IncentiveCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CVS Health 2017 Incentive Compensation Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CVSHealth2017IncentiveCompensationPlanMember" xlink:href="cvs-20230525.xsd#cvs_CVSHealth2017IncentiveCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CVSHealth2017IncentiveCompensationPlanMember" xlink:to="lab_cvs_CVSHealth2017IncentiveCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_332d4573-b3d2-4870-9f77-1cbafbfffada_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_44a747ce-7ee1-463d-9343-2e46eb2312ca_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_d76b77a3-d1de-4a47-9fa9-9a0fefa88c85_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_3b9df17b-ad79-41e2-b565-09fa1dd5daf4_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total CVS Health shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_0f7b8de0-7a86-48e0-b457-e0a742193e89_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total CVS Health shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_34e86eb5-ec29-4c81-a88c-7ecf7f4c57d1_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Reform</link:label>
    <link:label id="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareEntitiesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:to="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_7c860516-aeb3-45b5-a250-7108962a067d_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_58b47e66-36d8-4c2a-88f4-049061000f2c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_cb4cfb2a-3f25-41cf-9f0e-780abb7b7ebb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock dividends</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesLineItems_184c27a9-e3b9-4f53-b076-dc39d6df7a41_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesLineItems_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems" xlink:to="lab_us-gaap_StatutoryAccountingPracticesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_76106de6-7823-44b3-90f5-3b46cf272170_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OutstandingSeniorNotesMember_f08d1f6d-be5b-49a2-9609-fa3f6aa3e2da_terseLabel_en-US" xlink:label="lab_cvs_OutstandingSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Senior Notes</link:label>
    <link:label id="lab_cvs_OutstandingSeniorNotesMember_label_en-US" xlink:label="lab_cvs_OutstandingSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Senior Notes [Member]</link:label>
    <link:label id="lab_cvs_OutstandingSeniorNotesMember_documentation_en-US" xlink:label="lab_cvs_OutstandingSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OutstandingSeniorNotesMember" xlink:href="cvs-20230525.xsd#cvs_OutstandingSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OutstandingSeniorNotesMember" xlink:to="lab_cvs_OutstandingSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_e1f687b8-a671-4410-ba00-a472f4cda0be_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Mortgage-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_6c4615e1-71a5-40b8-8269-2b94fe890503_totalLabel_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income (excluding net realized capital gains or losses)</link:label>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_label_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Excluding Capital Gains Or Losses</link:label>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_documentation_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Excluding Capital Gains Or Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses" xlink:href="cvs-20230525.xsd#cvs_InvestmentIncomeExcludingCapitalGainsOrLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses" xlink:to="lab_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_f8e8b84b-b33c-48e7-a6c3-3ad260f97e04_terseLabel_en-US" xlink:label="lab_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Stock Option and SAR Activity</link:label>
    <link:label id="lab_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Proceeds Received and Tax Benefit from Share-Based Payment Awards [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:to="lab_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b72c6a68-c5f3-488b-8b0a-30927eacb694_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_77b74bda-b15d-4088-9be9-d4543a2e9479_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityBenefitPayment_1e865ef9-c1bc-4e48-9760-1beacc0f3667_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityBenefitPayment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit payments</link:label>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityBenefitPayment_label_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityBenefitPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability, Benefit Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityBenefitPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityBenefitPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountLiabilityBenefitPayment" xlink:to="lab_us-gaap_SeparateAccountLiabilityBenefitPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_4a1cc036-fa5f-40a7-b89c-e3c8214daa13_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_ac5d9a12-b610-4078-be20-936f89eb6cec_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearFive_39e3093b-f143-4fe3-9548-54a7f1256a6e_totalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Five</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearFive_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFive" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearFive" xlink:to="lab_cvs_LesseeLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_37ca0170-ff41-4d6c-8804-6ceb8aacd0a8_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_4ce0b1c7-3eef-4cd2-8f93-d52ddfca3c80_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_7c42618d-2237-4e94-9d6c-47a45bc0f01a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_4d4bbb82-ff5a-476d-98d2-969d2705418d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation not yet recognized, options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_e89b7c16-00d4-4803-93a0-aa2308a43293_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid litigation charges</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock_bca62052-e5e8-444d-a425-877c090593e5_terseLabel_en-US" xlink:label="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Direct, Assumed and Ceded Premiums Earned</link:label>
    <link:label id="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock_label_en-US" xlink:label="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-17, Insurance Companies, Reinsurance [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" xlink:to="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_c416a9b2-9fb2-4be8-9b7d-afc2eac6e111_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_4146e58c-59ad-419c-89f3-2adfe1c91e5d_verboseLabel_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_16e9ff6d-81bb-400a-b89f-e1fc7081e584_terseLabel_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from external customers</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_documentation_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="cvs-20230525.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_b333a8a3-ba8e-4dfb-bcb0-2f36f91c9984_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceTable_e92d32fb-f4d8-423f-905d-75f32f36f8f4_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance [Table]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceTable_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceTable" xlink:to="lab_us-gaap_ValuationAllowanceTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsReceivableAtCarryingValue_f37709be-bfc0-4030-aa72-a79c9346b17e_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium receivables</link:label>
    <link:label id="lab_us-gaap_PremiumsReceivableAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsReceivableAtCarryingValue" xlink:to="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_e6513d7b-ac25-4646-8c03-c1c703e8329b_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_92e92fa2-f190-4471-8f8b-f3a69e525941_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of the Components of Net Lease Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_ba64f928-c6fd-4c77-9d87-5fe6e6c74e3f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_8ebda5a7-c12a-441c-b0c9-dc7e4da5b217_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_6c890eb5-253c-4015-b8ce-ea6928421ef0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of discontinued operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_3bc3117c-3cea-4db5-b41f-b05ea3927dae_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LargeCasePensionsMember_5c486c1c-9cb4-4f59-879b-f2b92b1f654a_terseLabel_en-US" xlink:label="lab_cvs_LargeCasePensionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Large Case Pensions</link:label>
    <link:label id="lab_cvs_LargeCasePensionsMember_label_en-US" xlink:label="lab_cvs_LargeCasePensionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Large Case Pensions [Member]</link:label>
    <link:label id="lab_cvs_LargeCasePensionsMember_documentation_en-US" xlink:label="lab_cvs_LargeCasePensionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Large Case Pensions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LargeCasePensionsMember" xlink:href="cvs-20230525.xsd#cvs_LargeCasePensionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LargeCasePensionsMember" xlink:to="lab_cvs_LargeCasePensionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestments_b859fdc2-ac11-48cb-9da7-7a65b20ec3f5_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestments_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_ecf5518e-d758-4a2d-ba36-22c20ba54fa5_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixtures and equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_668f6a19-b6aa-4be9-82d9-7ebdcf9362bc_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateLineItems_63175c70-c7f5-4798-856c-cda66a1156e2_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate [Line Items]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateLineItems_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems" xlink:to="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_b64fd18e-d852-4b2c-bcc5-57b9842b1168_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Programs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_da38fec7-e215-4cf3-a5d0-21383ad14ab6_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_ef35ec43-1a66-46e3-b25b-fbc564b8ab26_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Fair Value, Inputs, Level 1, 2 and 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1, Level 2, and Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:to="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_76da8277-3f3c-42e3-b9e0-976baf24807e_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible assets, Trademarks</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_768df334-e63c-4efc-a52e-7981790e43fb_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7500e627-7e63-4a92-9478-542618e61dcb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_d1e4e2a5-38d3-4482-868e-94d34bd42ff7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_ee75abb7-f9e1-4f63-81cc-aaafca7b1eef_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government securities</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_a2b03994-cc7d-4016-803d-596ad11c85f4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_b102ee5a-da01-42d5-9f4f-f57ee8e060c4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets (Liabilities) Recognized in Balance Sheet</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableTable_45c14714-45a8-4122-ac38-9ab623967e32_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Table]</link:label>
    <link:label id="lab_us-gaap_DividendsPayableTable_label_en-US" xlink:label="lab_us-gaap_DividendsPayableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableTable" xlink:to="lab_us-gaap_DividendsPayableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_738be7e6-63b3-46bc-9568-dd6eeb20ab51_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Accident Year [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_85988b41-df7e-4977-8ede-52d4feac7191_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_d8d6b01b-07a6-47a8-8765-e2bdb89f7453_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_f13af6fa-4b7c-4579-b408-d71693913581_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, expired ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_a54d8cc6-15f0-4260-a1b1-5af4e1cf87a0_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_26ba6d51-89cc-4117-9664-38fe88ccd48c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_8d430409-2dd3-47d6-9eb1-40af58823717_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Direct</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_64ca2e52-51e0-466e-aeb3-6ce861500b30_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0b51793c-1b5c-472c-87e6-df15be6489f8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_5de8cd71-1748-4d58-991e-29f82bf06660_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, gross carrying amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_7700e396-4eed-4973-8a55-e556a57fb004_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of expected future policy benefits</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_4d58421d-77a9-43a1-851b-62979a16b42b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2019 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_38be4169-7e87-4da3-854e-492b8440cc09_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Year Of Origination [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Year Of Origination [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Year Of Origination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:to="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_efcb3c84-497f-4700-98eb-6c4fc4d9f3f3_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_bba74fe0-557e-4f21-96f7-78a3decb9eb3_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_e9b623bf-3cf6-4aec-8b83-8a36e9818c90_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period, value</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4Point125PercentApril2040Member_849b0aa7-e3b7-4df3-9bfd-640c703d476d_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4Point125PercentApril2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due April 2040</link:label>
    <link:label id="lab_cvs_SeniorNotes4Point125PercentApril2040Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4Point125PercentApril2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4 Point 125 Percent, April 2040 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4Point125PercentApril2040Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4Point125PercentApril2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4 Point 125 Percent, April 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4Point125PercentApril2040Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4Point125PercentApril2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4Point125PercentApril2040Member" xlink:to="lab_cvs_SeniorNotes4Point125PercentApril2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_17420257-fb30-4606-a10f-ce4f31a07e06_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_21f47ef3-ccc1-49fe-9ad4-8ffd961a24b4_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Three [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember" xlink:href="cvs-20230525.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodThreeMember" xlink:to="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_6ca4de7e-a0ed-4837-99f7-d6373b8a231d_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_ca836c42-aa90-471c-a3fb-705e9440a686_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_e18aea6c-ae2c-4030-9a54-3f8a1ed30ef2_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember_54f41c47-4b83-4f8a-bde8-4603266726d1_terseLabel_en-US" xlink:label="lab_cvs_FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fresenius Medical Care Reinsurance Company (Cayman) Ltd.</link:label>
    <link:label id="lab_cvs_FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember_label_en-US" xlink:label="lab_cvs_FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fresenius Medical Care Reinsurance Company (Cayman) Ltd. [Member]</link:label>
    <link:label id="lab_cvs_FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember_documentation_en-US" xlink:label="lab_cvs_FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fresenius Medical Care Reinsurance Company (Cayman) Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember" xlink:href="cvs-20230525.xsd#cvs_FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember" xlink:to="lab_cvs_FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyAndConsumerHealthSegmentMember_e5aa1a01-25f7-42b0-bda4-0be225425d35_terseLabel_en-US" xlink:label="lab_cvs_PharmacyAndConsumerHealthSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy &amp; Consumer Wellness</link:label>
    <link:label id="lab_cvs_PharmacyAndConsumerHealthSegmentMember_label_en-US" xlink:label="lab_cvs_PharmacyAndConsumerHealthSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy And Consumer Health Segment [Member]</link:label>
    <link:label id="lab_cvs_PharmacyAndConsumerHealthSegmentMember_documentation_en-US" xlink:label="lab_cvs_PharmacyAndConsumerHealthSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy And Consumer Health Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember" xlink:href="cvs-20230525.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyAndConsumerHealthSegmentMember" xlink:to="lab_cvs_PharmacyAndConsumerHealthSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_8a142cc5-1610-4fc1-9c01-af10cc96d40e_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_9b1f9483-53a4-44c1-9a16-4d46798f895f_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_f5133696-b207-4a4d-b5f8-438f93de2c39_netLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (GAAP measure)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_61fd8404-2480-4b47-8278-d09385745b08_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TribalEntitiesMember_fd5b647d-aadd-4605-9fa2-fc3949e1cdd0_terseLabel_en-US" xlink:label="lab_cvs_TribalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tribal Entities</link:label>
    <link:label id="lab_cvs_TribalEntitiesMember_label_en-US" xlink:label="lab_cvs_TribalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tribal Entities [Member]</link:label>
    <link:label id="lab_cvs_TribalEntitiesMember_documentation_en-US" xlink:label="lab_cvs_TribalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tribal Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TribalEntitiesMember" xlink:href="cvs-20230525.xsd#cvs_TribalEntitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TribalEntitiesMember" xlink:to="lab_cvs_TribalEntitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_fc9036e0-e153-4abe-a7d0-94791af477fc_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201812Member_2349b93c-05f7-42de-ba9c-676d9509d8cf_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201812Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2018-12</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201812Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201812Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2018-12 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201812Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201812Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201812Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201812Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_0bbdfbfc-d735-4e45-b899-d136992b5931_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_fe6ce1d0-f21b-419e-a8bf-ae0165826060_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Tax Effect of Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:to="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LitigationSettlementNumberOfStatesSubjectToEarlierSettlements_a30e8144-7406-463e-b0e5-0aa115482628_terseLabel_en-US" xlink:label="lab_cvs_LitigationSettlementNumberOfStatesSubjectToEarlierSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states subject to earlier settlements</link:label>
    <link:label id="lab_cvs_LitigationSettlementNumberOfStatesSubjectToEarlierSettlements_label_en-US" xlink:label="lab_cvs_LitigationSettlementNumberOfStatesSubjectToEarlierSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Number Of States Subject To Earlier Settlements</link:label>
    <link:label id="lab_cvs_LitigationSettlementNumberOfStatesSubjectToEarlierSettlements_documentation_en-US" xlink:label="lab_cvs_LitigationSettlementNumberOfStatesSubjectToEarlierSettlements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Number Of States Subject To Earlier Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LitigationSettlementNumberOfStatesSubjectToEarlierSettlements" xlink:href="cvs-20230525.xsd#cvs_LitigationSettlementNumberOfStatesSubjectToEarlierSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LitigationSettlementNumberOfStatesSubjectToEarlierSettlements" xlink:to="lab_cvs_LitigationSettlementNumberOfStatesSubjectToEarlierSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_2d658c31-7f0c-4b7a-a86d-d89e5800ad74_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during the period (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_d2046eea-177a-4101-9186-40c4230c41e5_terseLabel_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rewards earnings and gift card issuances</link:label>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_label_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Loyalty Program Earnings And Gift Card Issuance</link:label>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_documentation_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:href="cvs-20230525.xsd#cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:to="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a20854f4-769a-40dc-ba3a-ec7503abdf34_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments required to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_b29ae771-2845-4368-95f3-6f8948b7488e_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangibles</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_548c1c2e-97ed-4bda-83ae-d3626525fa29_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_57cee73c-235b-4675-8364-e5de650df1a3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4289280a-865b-42aa-9c22-ad5871256d1b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_0e3e5e18-6c2e-416d-ba64-2d133902188c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8a46b0bd-2f07-4e00-bf4d-972a988f333d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_27f6a036-af4a-4960-95f9-3e0edd676fa8_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Reinsurance, after Cash Flow Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_de2a2b8d-264c-4dae-9d19-6aa0142eebd3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Options and Stock Appreciation Rights Award Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option and Stock Appreciation Rights, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_4da3c383-f240-4368-a161-976b336352b7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock_e52a9442-76ca-4807-a124-f56a92df44e3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Liability for Future Policy Benefits</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LiabilityForUnpaidClaims_bc35e8b7-ca3c-4fbd-b583-995cc575d48d_terseLabel_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for unpaid claims</link:label>
    <link:label id="lab_cvs_LiabilityForUnpaidClaims_label_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims</link:label>
    <link:label id="lab_cvs_LiabilityForUnpaidClaims_documentation_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the total liability on the balance sheet for unpaid claims for both short-duration and long-duration insurance contracts after reinsurance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaims" xlink:href="cvs-20230525.xsd#cvs_LiabilityForUnpaidClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LiabilityForUnpaidClaims" xlink:to="lab_cvs_LiabilityForUnpaidClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_11ae8d30-140a-4139-bda4-e1c018bdb876_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash (included in other assets)</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_3a0cad3b-be85-452a-9616-701ceb1cf62d_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_6e67b34f-a82b-42c2-ab22-7b4912765d14_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of stock options and SARs exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_48be90bf-46f9-467f-9209-1964439f955a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average diluted shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_90e179f4-cccb-4816-a7be-86eb555baa66_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_26e1557f-3a41-412a-b434-2c17f27f83b9_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4958a37d-ccfe-4a3c-ad79-1d59c76576f2_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_817d044d-ce89-45c5-bbd6-fc3ad6934cd2_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:label id="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_8234fa4c-0ef7-4316-9dc9-6ef0049634ce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Adjustments Resulting From Applying New Accounting Standard</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2f0f6c38-b304-4933-b125-209d9073b4cd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_c7ba80d1-d9be-4942-857d-3a8a4701cbed_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings, building improvements and leasehold improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_0758a8f8-14fb-4274-9ff9-432c58a723e4_verboseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember_7fd8e6de-d193-44ca-aab3-82fb9926c078_terseLabel_en-US" xlink:label="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common/collective trusts, Debt Securities</link:label>
    <link:label id="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember_label_en-US" xlink:label="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Common Collective Trust, Debt Securities [Member]</link:label>
    <link:label id="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember_documentation_en-US" xlink:label="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Common Collective Trust, Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" xlink:href="cvs-20230525.xsd#cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" xlink:to="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member_c3f7f900-57b1-4409-bd4a-c9719a935925_terseLabel_en-US" xlink:label="lab_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options granted subsequent to 2018</link:label>
    <link:label id="lab_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member_label_en-US" xlink:label="lab_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Granted Subsequent to 2018 [Member]</link:label>
    <link:label id="lab_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member_documentation_en-US" xlink:label="lab_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Granted Subsequent to 2018</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member" xlink:href="cvs-20230525.xsd#cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member" xlink:to="lab_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_623654d1-6e6f-457c-bb79-3cfff07b5a7d_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfPharmacyPlanMembers_5ac7553e-7fa6-4bfd-8d9a-db9f2ecc5335_terseLabel_en-US" xlink:label="lab_cvs_NumberOfPharmacyPlanMembers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of pharmacy plan members</link:label>
    <link:label id="lab_cvs_NumberOfPharmacyPlanMembers_label_en-US" xlink:label="lab_cvs_NumberOfPharmacyPlanMembers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Pharmacy Plan Members</link:label>
    <link:label id="lab_cvs_NumberOfPharmacyPlanMembers_documentation_en-US" xlink:label="lab_cvs_NumberOfPharmacyPlanMembers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Pharmacy Plan Members</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPharmacyPlanMembers" xlink:href="cvs-20230525.xsd#cvs_NumberOfPharmacyPlanMembers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfPharmacyPlanMembers" xlink:to="lab_cvs_NumberOfPharmacyPlanMembers" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category1Member_a62a2f24-8aa1-410a-b8bd-309afe53bd18_terseLabel_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1</link:label>
    <link:label id="lab_cvs_Category1Member_label_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 1 [Member]</link:label>
    <link:label id="lab_cvs_Category1Member_documentation_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Credit Quality Indicator - Category 1 [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member" xlink:href="cvs-20230525.xsd#cvs_Category1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category1Member" xlink:to="lab_cvs_Category1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c4368a79-a1b2-4c2f-a5e6-746824ebaa40_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_adb1de8a-5f8b-425c-bd14-d9401d208dd9_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_8d094a17-fbe2-45d9-ba1f-8745c6bbb11b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_707fcc3c-df35-4892-a755-dd45be0c38ad_terseLabel_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized capital gains (losses)</link:label>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_fc596f27-f755-4145-82a7-d3de047a1738_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized capital (gains) losses</link:label>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_label_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Investment Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:to="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_7db57914-6bb6-4d3f-9b03-71fc81aa3920_terseLabel_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit costs recorded in other insurance liabilities</link:label>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_label_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</link:label>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_documentation_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:href="cvs-20230525.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:to="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_b9b8b2cf-cf81-4edc-bc52-e8548256e9ac_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mail choice</link:label>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Directly to Consumer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:to="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OakStreetHealthIncMember_b6677cb7-888f-4f0b-8e0a-01fb71407c0d_terseLabel_en-US" xlink:label="lab_cvs_OakStreetHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oak Street Health Inc.</link:label>
    <link:label id="lab_cvs_OakStreetHealthIncMember_label_en-US" xlink:label="lab_cvs_OakStreetHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oak Street Health Inc. [Member]</link:label>
    <link:label id="lab_cvs_OakStreetHealthIncMember_documentation_en-US" xlink:label="lab_cvs_OakStreetHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oak Street Health Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OakStreetHealthIncMember" xlink:href="cvs-20230525.xsd#cvs_OakStreetHealthIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OakStreetHealthIncMember" xlink:to="lab_cvs_OakStreetHealthIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PensionAndAnnuityInvestmentContractsInterest_ef2af752-f087-405e-a969-e57a6a2884db_terseLabel_en-US" xlink:label="lab_cvs_PensionAndAnnuityInvestmentContractsInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate for pension and annuity investment contracts</link:label>
    <link:label id="lab_cvs_PensionAndAnnuityInvestmentContractsInterest_label_en-US" xlink:label="lab_cvs_PensionAndAnnuityInvestmentContractsInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension And Annuity Investment Contracts Interest</link:label>
    <link:label id="lab_cvs_PensionAndAnnuityInvestmentContractsInterest_documentation_en-US" xlink:label="lab_cvs_PensionAndAnnuityInvestmentContractsInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension And Annuity Investment Contracts Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PensionAndAnnuityInvestmentContractsInterest" xlink:href="cvs-20230525.xsd#cvs_PensionAndAnnuityInvestmentContractsInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PensionAndAnnuityInvestmentContractsInterest" xlink:to="lab_cvs_PensionAndAnnuityInvestmentContractsInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_370eebe0-82d8-4ee6-99e8-0dd09f5826fa_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_bc04e89f-b9c1-4448-819b-027c82b2453a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_94e28f31-e821-4957-aa71-006c203a3129_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_db1521d3-7aac-483f-b0fe-1e5d64d8d436_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value exercisable at end of year</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember_d61f27e1-6706-4ce8-9df3-8683a8df4793_terseLabel_en-US" xlink:label="lab_cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units and Performance Share Units</link:label>
    <link:label id="lab_cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember_label_en-US" xlink:label="lab_cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units And Performance Share Units [Member]</link:label>
    <link:label id="lab_cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember_documentation_en-US" xlink:label="lab_cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units and Performance Share Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:href="cvs-20230525.xsd#cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:to="lab_cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_7264c30e-4881-482b-9cc3-045f80d4d6c6_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term lease costs</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_8ec2baee-1b91-4298-8caa-b31282cde5d6_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_e306829d-a963-4d25-8a12-472b2ee230d3_terseLabel_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR, shares to be received at the end of program as a percent of notional amount</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_label_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percent Of Notional Amount In Shares To Be Received At End Of Program</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_documentation_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percent Of Notional Amount In Shares To Be Received At End Of Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:href="cvs-20230525.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:to="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_fbb6eb0e-9aea-4e58-a320-4bbcb0ed8437_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (income) loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_53258c68-b8ca-49a6-8117-358e689fce60_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive (income) loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1fefa329-9417-4fb1-b46a-f1eb7729ef67_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_5b115273-9608-4fab-b2ee-39d03d8438c5_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative goodwill impairments</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_6f6b7785-c9cb-45a9-96e5-6479d0848815_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_080473a5-46f8-456a-bf02-a965abd58391_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_7408d095-dc39-43ea-b4df-5373e30cd151_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_cb875ca2-5b95-4af3-925f-0316c503bb0a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_250c83ad-481f-435c-9403-d399f8c71fc7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock and Capital Surplus</link:label>
    <link:label id="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Including Additional Paid in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_ba3c9f27-5e83-4b87-b09a-0c68db9dd2b3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fffecf04-2eda-4456-a181-f530401f4099_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_1d20a2ec-db67-4771-87e2-aa2010548b61_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_437af950-dc52-470e-8311-b9ae0d9dc049_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_d1e8c98f-16c3-49c8-bfd5-8ac8d17ca0f1_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateAndOtherMember_331c34c7-50e4-4e61-b876-c809170e6110_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate/ Other</link:label>
    <link:label id="lab_us-gaap_CorporateAndOtherMember_label_en-US" xlink:label="lab_us-gaap_CorporateAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateAndOtherMember" xlink:to="lab_us-gaap_CorporateAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_51dce3d7-fefc-4bee-a31b-a8e6c9d2ba46_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_a7f7a5ba-a92f-4499-870f-b88fa6d37681_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_f1c86e82-ed70-4b00-8c4b-f60a95fbb4a2_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember_ddfb98a7-b613-44fa-910c-cc8399476fba_terseLabel_en-US" xlink:label="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in discount rate assumptions</link:label>
    <link:label id="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember_label_en-US" xlink:label="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect Of Application Of Accounting Standards Update 2018-12, Adjustments For Change In Discount Rate Assumptions [Member]</link:label>
    <link:label id="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember_documentation_en-US" xlink:label="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect Of Application Of Accounting Standards Update 2018-12, Adjustments For Change In Discount Rate Assumptions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember" xlink:href="cvs-20230525.xsd#cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember" xlink:to="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_f4684a8a-fc1a-4cfd-9fd7-377ebe005728_terseLabel_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted operating income</link:label>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_e2eb9294-e92f-4c26-9dd1-d074bf31b91b_verboseLabel_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted operating income (loss)</link:label>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_label_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Operating Income (Loss)</link:label>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_documentation_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss" xlink:href="cvs-20230525.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AdjustedOperatingIncomeLoss" xlink:to="lab_cvs_AdjustedOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_2e4d6acc-8b66-4778-9ea7-884b9358b20a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summarized Financial Information Of Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_0e3ff639-7095-47e3-9f07-d305fe3c3fd5_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on assets held for sale</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_42e1e275-6912-4949-b541-b331f0be3d16_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:to="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2d54b122-d999-4709-a09c-3f766730e41b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_d2c39b06-eca5-4825-97e5-745d7b7a36e4_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_6ccc53a8-9e26-4d41-9bf3-19e4733b75bc_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_85f4a3d9-8ba9-44a5-8766-9d8f7bfe4461_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividend declared (USD per share)</link:label>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_label_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Amount Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableAmountPerShare" xlink:to="lab_us-gaap_DividendsPayableAmountPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_9b3b5d29-65dd-440c-b6d8-f91b41d5524a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e70b61a0-514f-41cc-a0a6-3b876fcedd76_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding at beginning of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1ba17b74-9745-45e2-b1f7-92c1f313366d_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_3207968d-94c2-4407-9b7f-d9ffc69349ae_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Five</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" xlink:to="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_VendorandManufacturerReceivables_217367db-ab16-4760-a0a9-d50c75d49d7a_terseLabel_en-US" xlink:label="lab_cvs_VendorandManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor and manufacturer receivables</link:label>
    <link:label id="lab_cvs_VendorandManufacturerReceivables_label_en-US" xlink:label="lab_cvs_VendorandManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor and Manufacturer Receivables</link:label>
    <link:label id="lab_cvs_VendorandManufacturerReceivables_documentation_en-US" xlink:label="lab_cvs_VendorandManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor and Manufacturer Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorandManufacturerReceivables" xlink:href="cvs-20230525.xsd#cvs_VendorandManufacturerReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_VendorandManufacturerReceivables" xlink:to="lab_cvs_VendorandManufacturerReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease_20e61e75-e308-4568-a57b-dd77c0ad9cbe_terseLabel_en-US" xlink:label="lab_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other increases (decreases) in noncontrolling interests</link:label>
    <link:label id="lab_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease_label_en-US" xlink:label="lab_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Other Period Increase (Decrease)</link:label>
    <link:label id="lab_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Other Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease" xlink:href="cvs-20230525.xsd#cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease" xlink:to="lab_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_96f4c942-44f7-483a-b601-c09268f38e75_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal tax benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_c576030b-3fff-4db2-8b07-3ea8e651803f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_5e920281-d8ee-442b-8d35-e3ed4f12fd36_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_33f8d81d-9f04-4102-beb5-a0cff9212590_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c3775c57-7fa1-4177-aab1-f1f62d5573d6_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_5ede3df4-d869-408d-aa6d-84282da2de8c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_16e8561d-273a-466f-961e-0db491b13163_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_a6f4d920-c3ad-430a-9ab4-71bf8fe4cc5d_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Projected Annual Amortization Expense for Intangible Assets for Next Five Years</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_052a3619-85c1-4fe1-8114-546c6832fe11_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_c1ca9df2-5b8d-4833-b882-63f940dc6e58_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_98247d8a-4c8a-4a9a-9003-40b5d7087d6d_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.625DueAugust2024Member_ec862413-e302-4ab2-bbdc-dc135fb088c6_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625% senior notes due August 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes2.625DueAugust2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.625%, Due August 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.625DueAugust2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.625%, Due August 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.625DueAugust2024Member" xlink:to="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_de1a63ab-1748-450c-9125-fa4b0e562948_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b6966af9-64b0-4cc7-8f50-527f1a113087_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction to accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_EquitySecuritiesAndCommonAndCollectiveTrustsMember_6e0b697b-165a-4c60-8768-3754c2b641c2_terseLabel_en-US" xlink:label="lab_cvs_EquitySecuritiesAndCommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities and common/collective trusts</link:label>
    <link:label id="lab_cvs_EquitySecuritiesAndCommonAndCollectiveTrustsMember_label_en-US" xlink:label="lab_cvs_EquitySecuritiesAndCommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities And Common And Collective Trusts [Member]</link:label>
    <link:label id="lab_cvs_EquitySecuritiesAndCommonAndCollectiveTrustsMember_documentation_en-US" xlink:label="lab_cvs_EquitySecuritiesAndCommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities And Common And Collective Trusts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EquitySecuritiesAndCommonAndCollectiveTrustsMember" xlink:href="cvs-20230525.xsd#cvs_EquitySecuritiesAndCommonAndCollectiveTrustsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_EquitySecuritiesAndCommonAndCollectiveTrustsMember" xlink:to="lab_cvs_EquitySecuritiesAndCommonAndCollectiveTrustsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_4808ac7d-2a7a-455d-9884-f56732fa0977_terseLabel_en-US" xlink:label="lab_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_label_en-US" xlink:label="lab_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward" xlink:to="lab_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderFunds_5a428c73-44be-45f7-993f-89d908ae64fe_periodStartLabel_en-US" xlink:label="lab_us-gaap_PolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholders&#8217; funds, beginning of the period</link:label>
    <link:label id="lab_us-gaap_PolicyholderFunds_0be2f77b-3499-4534-a277-83982e2a8ed2_periodEndLabel_en-US" xlink:label="lab_us-gaap_PolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholders&#8217; funds, end of the period</link:label>
    <link:label id="lab_us-gaap_PolicyholderFunds_label_en-US" xlink:label="lab_us-gaap_PolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderFunds" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderFunds" xlink:to="lab_us-gaap_PolicyholderFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_b86b1359-9fe4-4233-a637-802ee9259cfc_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected long-term rate of return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_3b202137-b302-42a1-9582-a600fadd4ced_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_75a1e69d-cee5-4c14-bba6-a8416c892d00_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_fc1ae3fe-2eba-411f-bacd-99d4e7041126_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_a11c9bd5-490f-47bf-bfcc-e5329c473f7b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_4b6bb90b-4c5f-4f38-b236-72d162e53ccf_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash impact of litigation settlement</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_f1710cde-c39a-4a18-a26b-776fa5e766ba_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.8DueJune2023Member_f63a0c15-fbe5-414c-8c0d-395934337675_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.8% senior notes due June 2023</link:label>
    <link:label id="lab_cvs_SeniorNotes2.8DueJune2023Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.8%, Due June 2023 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.8DueJune2023Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.8%, Due June 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJune2023Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2.8DueJune2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.8DueJune2023Member" xlink:to="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_101df499-1c90-4d4f-8dbb-32bb97d6c224_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OfficeRealEstateOptimizationCharges_bea7b836-8675-4cd2-a696-b40c925ed8b0_terseLabel_en-US" xlink:label="lab_cvs_OfficeRealEstateOptimizationCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office real estate optimization charges</link:label>
    <link:label id="lab_cvs_OfficeRealEstateOptimizationCharges_label_en-US" xlink:label="lab_cvs_OfficeRealEstateOptimizationCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Real Estate Optimization Charges</link:label>
    <link:label id="lab_cvs_OfficeRealEstateOptimizationCharges_documentation_en-US" xlink:label="lab_cvs_OfficeRealEstateOptimizationCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Real Estate Optimization Charges - Related to the abandonment of leased real estate and the related right-of-use assets and property and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OfficeRealEstateOptimizationCharges" xlink:href="cvs-20230525.xsd#cvs_OfficeRealEstateOptimizationCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OfficeRealEstateOptimizationCharges" xlink:to="lab_cvs_OfficeRealEstateOptimizationCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_df3edb40-ce93-4f32-890f-43e0f6feab94_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding, beginning of year balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_b5ccb3d4-d3c8-4efb-a0d8-4928be2e5cc4_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding, end of year balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_f37fc956-f2da-417b-b959-58ec95b32458_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of actual variances from expected experience</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) of Actual Variance from Expected Experience</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_22c039ab-f259-4a84-bf38-a323d120e105_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_b412b361-a6e3-49b4-8ef6-39cb9723f877_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_bb9ca3a7-eb49-4c5d-b6b9-fca71dd34fbe_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, net carrying amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_b270f7ac-4b64-4eb7-b4f3-e0de443abe8b_terseLabel_en-US" xlink:label="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities</link:label>
    <link:label id="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid Policy Claims and Claims Adjustment Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:to="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherAcquiredIntangibleAssetsTable_062c124b-78f0-4b30-8d4e-49fbbaaa9a1f_terseLabel_en-US" xlink:label="lab_cvs_OtherAcquiredIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Table]</link:label>
    <link:label id="lab_cvs_OtherAcquiredIntangibleAssetsTable_label_en-US" xlink:label="lab_cvs_OtherAcquiredIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Acquired Intangible Assets [Table]</link:label>
    <link:label id="lab_cvs_OtherAcquiredIntangibleAssetsTable_documentation_en-US" xlink:label="lab_cvs_OtherAcquiredIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAcquiredIntangibleAssetsTable" xlink:href="cvs-20230525.xsd#cvs_OtherAcquiredIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsTable" xlink:to="lab_cvs_OtherAcquiredIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_5c5b3725-fbbc-48ca-b161-c13c59544e54_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_b03039fe-8097-41ce-bfd5-da128b72c6de_totalLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net premiums</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_label_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsEarnedNet" xlink:to="lab_us-gaap_PremiumsEarnedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInvestments_6ddf894a-f70f-4717-b184-ae672efbb8af_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInvestments_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInvestments" xlink:to="lab_us-gaap_DeferredTaxAssetsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCorporateDebtSecuritiesMember_0118aa0d-d8a2-4417-8ad9-1005b4a58751_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. corporate securities</link:label>
    <link:label id="lab_us-gaap_DomesticCorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Corporate, US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_2fcc8b4b-f790-4bb3-be42-475b6716435f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Benefit, Original Discount Rate, before Reinsurance, after Cash Flow Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb3df319-af51-4430-b320-069e4d064e3f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_9e4596fe-8c7b-4b7b-8359-aa4a6a51d38e_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans fully repaid</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Loans Fully Repaid</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pertains to amount of mortgage loans fully repaid.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:to="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_6f0f8fe7-d86f-458e-afb7-154905b69e04_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable preferred securities</link:label>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemablePreferredStockMember" xlink:to="lab_us-gaap_RedeemablePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_d9f6612e-a573-45c8-ba62-963279d1c751_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All outstanding liabilities for health care costs payable prior to 2021, net of reinsurance</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net, Not Separately Presented</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_1a6ffbb8-54c9-4ac6-af23-9d50b0674c6c_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Four [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember" xlink:href="cvs-20230525.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodFourMember" xlink:to="lab_cvs_YearOfOriginationPeriodFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ea47d84d-0cda-4c33-8d26-32bff6f54861_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic value outstanding at end of year</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_d53a6e05-c142-48db-b599-c6dde10b5abf_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember_a264dfab-1cdf-44f0-bf72-74bc46301d5f_terseLabel_en-US" xlink:label="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Removal of shadow adjustments in accumulated other comprehensive income</link:label>
    <link:label id="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect Of Application Of Accounting Standards Update 2018-12, Adjustments For Removal Of Shadow Adjustments In Accumulated Other Comprehensive Income [Member]</link:label>
    <link:label id="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember_documentation_en-US" xlink:label="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect Of Application Of Accounting Standards Update 2018-12, Adjustments For Removal Of Shadow Adjustments In Accumulated Other Comprehensive Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember" xlink:href="cvs-20230525.xsd#cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_4c68ad02-9670-4bbd-81a0-771d8e9f6b90_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_de24f7a0-3f19-4471-94d4-a4f4447e39a8_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_0223a7a9-4912-4b00-879b-742e82e9b791_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededCreditRiskTable_bafabf19-5dbf-496e-9ffe-012b7fde6408_terseLabel_en-US" xlink:label="lab_us-gaap_CededCreditRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk [Table]</link:label>
    <link:label id="lab_us-gaap_CededCreditRiskTable_label_en-US" xlink:label="lab_us-gaap_CededCreditRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededCreditRiskTable" xlink:to="lab_us-gaap_CededCreditRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_c6da3da3-764c-438e-9319-0b34725e2ac2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateScheduleTable_1ab3859a-4074-42c7-822b-851534c768fe_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate [Table]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateScheduleTable_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable" xlink:to="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedInvestmentsAtFairValue_c94e0a7a-3547-4470-9053-a0e1a0d54eb6_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedInvestmentsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments related to 2012 contract conversion</link:label>
    <link:label id="lab_us-gaap_RestrictedInvestmentsAtFairValue_label_en-US" xlink:label="lab_us-gaap_RestrictedInvestmentsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Investments, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedInvestmentsAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedInvestmentsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedInvestmentsAtFairValue" xlink:to="lab_us-gaap_RestrictedInvestmentsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_9ed91986-5838-4009-984d-6a70cc70ef4f_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock_bd510bba-f5d2-4ec3-84d8-77d588bf6018_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reinsurance Recoverables</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock" xlink:to="lab_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfStoresPlannedClosure_f415bdc8-224b-4fa1-a051-52fefc706d13_terseLabel_en-US" xlink:label="lab_cvs_NumberOfStoresPlannedClosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of stores, planned closure</link:label>
    <link:label id="lab_cvs_NumberOfStoresPlannedClosure_label_en-US" xlink:label="lab_cvs_NumberOfStoresPlannedClosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Stores, Planned Closure</link:label>
    <link:label id="lab_cvs_NumberOfStoresPlannedClosure_documentation_en-US" xlink:label="lab_cvs_NumberOfStoresPlannedClosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Stores, Planned Closure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresPlannedClosure" xlink:href="cvs-20230525.xsd#cvs_NumberOfStoresPlannedClosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfStoresPlannedClosure" xlink:to="lab_cvs_NumberOfStoresPlannedClosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_c0eca7f4-267c-4aab-910a-226d816941b8_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable for Paid and Unpaid Claims and Claims Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses" xlink:to="lab_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_2606f112-f415-4eb4-9964-4e0fceb02a55_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_163084c9-57b3-41fa-9810-7eaa33a76930_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_c804ccae-ef51-4641-b7a0-72a967dba108_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_f53ad050-4629-4327-b949-8340a3fb6f69_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_287bb009-9ccf-46a8-896b-bd9a0e13d393_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_fdf189b5-b31c-4319-9d11-c6de123fecf8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Finance Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.1DueMarch2025Member_70428046-0dec-42bc-8961-a1e30d14f61c_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.1% senior notes due March 2025</link:label>
    <link:label id="lab_cvs_SeniorNotes4.1DueMarch2025Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.1%, Due March 2025 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.1DueMarch2025Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.1%, Due March 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.1DueMarch2025Member" xlink:to="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_dc224008-cefa-4896-9fcd-cc8654398075_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_d7a5fd74-140f-4f16-b8a1-f4189b8d2917_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future noncancelable subleases, future minimum payments</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payments to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseTermOfContract1_edb60959-4aa9-42ae-8b23-775b1ae1aa60_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease term (in years)</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeaseTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:to="lab_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalCreditAssessmentAxis_de28c836-2e0f-4776-946c-1348ef4304e1_terseLabel_en-US" xlink:label="lab_us-gaap_InternalCreditAssessmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Credit Assessment [Axis]</link:label>
    <link:label id="lab_us-gaap_InternalCreditAssessmentAxis_label_en-US" xlink:label="lab_us-gaap_InternalCreditAssessmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Credit Assessment [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalCreditAssessmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalCreditAssessmentAxis" xlink:to="lab_us-gaap_InternalCreditAssessmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1d2b0590-cd30-4bf4-9400-1961b8e7da9a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, granted ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_f1c3f6d5-63e3-44f6-a17b-466b60bb8bb9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit payments</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b36add95-4525-4168-9a3e-d074e424698d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_6dfff702-eeac-4eba-9948-4a7624b9d823_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceRollForward_d7f24f0f-1e7c-40b2-bff8-9b24fe73b4fb_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountBalanceRollForward_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountBalanceRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Account Balance [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountBalanceRollForward" xlink:to="lab_us-gaap_PolicyholderAccountBalanceRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_c743eb22-47c2-4fa2-8c25-b1a4b7ae40b7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_85459f7e-8e3c-4f18-afb2-b07836412a69_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_25719f08-d179-4ee1-8ba6-0732a5165cdd_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amortized Cost and Fair Value of Debt Securities by Contractual Maturity</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension_f3c11d2c-a404-4ee6-b747-3ea3b86ee064_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Life (years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Weighted Average Period before Next Renewal or Extension</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyRebatePeriod_35072c00-01d7-4875-906a-eff2d7db49e9_terseLabel_en-US" xlink:label="lab_cvs_PharmacyRebatePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy rebate period</link:label>
    <link:label id="lab_cvs_PharmacyRebatePeriod_label_en-US" xlink:label="lab_cvs_PharmacyRebatePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Rebate Period</link:label>
    <link:label id="lab_cvs_PharmacyRebatePeriod_documentation_en-US" xlink:label="lab_cvs_PharmacyRebatePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Rebate Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRebatePeriod" xlink:href="cvs-20230525.xsd#cvs_PharmacyRebatePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyRebatePeriod" xlink:to="lab_cvs_PharmacyRebatePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_03ea6aec-b054-4b53-bd1a-3cc4875fb883_terseLabel_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of deferred debt issuance cost</link:label>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of Deferred Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f21246d1-1ed8-4ab5-b9fe-0d1b46ce8c6c_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_5c60fdab-7f66-4aef-a519-9ad02425666d_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_eb9e9ff9-5ba8-4b3b-9526-c98d6ff1555f_terseLabel_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares held in trust</link:label>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_label_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Shares Held In Trust</link:label>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_documentation_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Shares Held In Trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueSharesHeldInTrust" xlink:href="cvs-20230525.xsd#cvs_TreasuryStockValueSharesHeldInTrust"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockValueSharesHeldInTrust" xlink:to="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_fd8faa16-1222-4102-a705-2b5aec881b3e_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_9e5f1c11-cc37-4f6b-8578-212b876c0798_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 17)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_f3badddf-d31b-438c-a634-2fce0c7993af_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6214d541-4fea-4b61-b850-efb7f4ff0cd9_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, outstanding at beginning of year ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_79d638f9-0553-4c39-877e-d98990466c75_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, outstanding at end of year ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax_4c82c8a1-ac12-4db0-8cbc-475c31a45b5e_terseLabel_en-US" xlink:label="lab_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for future policy benefits, after tax</link:label>
    <link:label id="lab_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax_label_en-US" xlink:label="lab_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, After Reinsurance, Net Of Tax</link:label>
    <link:label id="lab_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax_documentation_en-US" xlink:label="lab_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, After Reinsurance, Net Of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax" xlink:href="cvs-20230525.xsd#cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax" xlink:to="lab_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_f7eec9eb-792c-42d7-a16b-720a29caa69d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Costs, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense" xlink:to="lab_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent_5ef66d0e-3672-47a1-b676-6ba56944d05a_terseLabel_en-US" xlink:label="lab_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly dividends declared, percent increase</link:label>
    <link:label id="lab_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent_label_en-US" xlink:label="lab_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Quarterly Dividends Declared, Increase Amount, Percent</link:label>
    <link:label id="lab_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent_documentation_en-US" xlink:label="lab_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Quarterly Dividends Declared, Increase Amount, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent" xlink:href="cvs-20230525.xsd#cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent" xlink:to="lab_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_dd65772d-c715-451f-87f2-9444e700ce4a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SalesChannelOtherMember_d42e8db8-97b5-467a-8f06-1666f089e749_terseLabel_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_cvs_SalesChannelOtherMember_label_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Other [Member]</link:label>
    <link:label id="lab_cvs_SalesChannelOtherMember_documentation_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember" xlink:href="cvs-20230525.xsd#cvs_SalesChannelOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SalesChannelOtherMember" xlink:to="lab_cvs_SalesChannelOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_6cbc3626-b94a-421f-9e6c-80b631f79212_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_4abc67c6-4392-4da1-8b66-40189db72a0a_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f52a20c5-86b7-4162-911a-1c74a3b1a4fe_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_89bf79d3-5e74-4ed9-a9c7-a7c3b765c77d_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_87b51666-fb2c-4c94-829e-98516aa1e767_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_8d41fd87-e4cd-48e5-8bce-3d7b5a6cc40e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital shares reserved for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_ecf9149f-4186-4f8c-8afa-0a18ca243b6e_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_192f9523-4833-43d8-8ef3-327ffd66829c_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_f54f2a3d-1165-4b99-a817-96ee10da2592_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_a53c35c9-9c86-4260-b56f-48bc019e35a2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_fd5dfdb6-83cc-4be2-82b5-fc9d8a04cac6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f0175796-6332-4c78-a361-5b18bd4f0d92_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_e4935051-36a3-4668-b9bd-4d2fdf35c913_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_28fe93d3-558f-4172-8f92-d777c0d789dc_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates_669d56d7-fb58-4cdb-9516-583d06eff95c_terseLabel_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional number of states in which the Company entered the individual public health insurance exchange</link:label>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates_label_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Public Health Insurance Exchanges, Number Of Additional States</link:label>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates_documentation_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Public Health Insurance Exchanges, Number Of Additional States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates" xlink:href="cvs-20230525.xsd#cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates" xlink:to="lab_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_6d0c9e4f-9f1a-40df-bab7-e28dc99538c6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Deferred Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1ad0cfeb-da93-4f26-a4c8-affd2e328629_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in benefit obligation:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_ca23933f-e94d-4a36-84eb-edc5d528c820_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Components of incurred health care costs</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_fd54e09f-3c4c-483b-9a8a-1567fa697c1f_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_f2cec994-d58c-484c-a18d-b7f5b007517d_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7a4b8dd8-d907-4204-b867-bb64d6fedebd_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_57e56bca-d690-4d7c-a5fa-3bb9d1913252_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_4dc9ec1e-7ba0-4a5e-be9b-45ab0ed60404_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_7652eb26-0072-4910-abaa-823e77f23b9f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of net actuarial loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e5b92ba5-cab1-4f0e-b682-fa4646769bca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for taxes related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_60ecffa4-fa0a-447a-a736-1ceadfea4a93_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for taxes for net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_7f6a3bfa-2893-4b76-9e9f-d0cb9b80944f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_a7fcd4b0-1e7d-4c86-8fd4-96b58003acbd_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member_44043635-3f71-4ac3-a7b3-17948c882e29_terseLabel_en-US" xlink:label="lab_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options granted through 2018</link:label>
    <link:label id="lab_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member_label_en-US" xlink:label="lab_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Granted Prior Through 2018 [Member]</link:label>
    <link:label id="lab_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member_documentation_en-US" xlink:label="lab_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Granted Prior Through 2018</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member" xlink:href="cvs-20230525.xsd#cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member" xlink:to="lab_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay162025Member_4b4c3ef7-ad15-496b-9caf-77d10daf96c7_terseLabel_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay162025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 16, 2025</link:label>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay162025Member_label_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay162025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 16, 2025 [Member]</link:label>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay162025Member_documentation_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay162025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 16, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay162025Member" xlink:href="cvs-20230525.xsd#cvs_RevolvingCreditFacilityExpiringMay162025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RevolvingCreditFacilityExpiringMay162025Member" xlink:to="lab_cvs_RevolvingCreditFacilityExpiringMay162025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_97077db3-d65e-48d2-a095-f0c05ec5e318_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_c52b2baa-f4ed-4f9a-8912-6cbc35579acc_terseLabel_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Product Line</link:label>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_label_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Product Line [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthInsuranceProductLineMember" xlink:to="lab_us-gaap_HealthInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_82550b6e-ba87-4d47-80d2-88b7056b5250_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_da23c493-3eda-42b3-b69e-62831e1550dd_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal_75e2e283-b09b-498d-a2ca-5ebe42bf5ed3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surrenders and withdrawals</link:label>
    <link:label id="lab_us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal_label_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability, Surrender and Withdrawal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal" xlink:to="lab_us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_EquitySecuritiesDomesticRealEstateMember_6b724bd3-d6d3-4c2f-9349-6e3e757ba42a_terseLabel_en-US" xlink:label="lab_cvs_EquitySecuritiesDomesticRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic real estate</link:label>
    <link:label id="lab_cvs_EquitySecuritiesDomesticRealEstateMember_label_en-US" xlink:label="lab_cvs_EquitySecuritiesDomesticRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Domestic Real Estate [Member]</link:label>
    <link:label id="lab_cvs_EquitySecuritiesDomesticRealEstateMember_documentation_en-US" xlink:label="lab_cvs_EquitySecuritiesDomesticRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This category includes information about ownership interests or the right to acquire ownership interests in domestic real estate whose ownership interest is represented by shares of common or preferred stock (which is neither mandatorily redeemable no redeemable at the option of the holder), convertible securities, stock rights, or stock warrants categorized by other type.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EquitySecuritiesDomesticRealEstateMember" xlink:href="cvs-20230525.xsd#cvs_EquitySecuritiesDomesticRealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_EquitySecuritiesDomesticRealEstateMember" xlink:to="lab_cvs_EquitySecuritiesDomesticRealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_dffe344e-8f1d-499f-8c28-9ca12d216bb1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_be452466-e2af-4112-bfca-ead30a1000bc_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Consolidated Operating Income to Adjusted Operating Income</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtExtinguishmentFees_2eb13d1f-6a65-48f8-8f3b-4a46e18e08de_terseLabel_en-US" xlink:label="lab_cvs_DebtExtinguishmentFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment fees</link:label>
    <link:label id="lab_cvs_DebtExtinguishmentFees_label_en-US" xlink:label="lab_cvs_DebtExtinguishmentFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Extinguishment Fees</link:label>
    <link:label id="lab_cvs_DebtExtinguishmentFees_documentation_en-US" xlink:label="lab_cvs_DebtExtinguishmentFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Extinguishment Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtExtinguishmentFees" xlink:href="cvs-20230525.xsd#cvs_DebtExtinguishmentFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtExtinguishmentFees" xlink:to="lab_cvs_DebtExtinguishmentFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_02f8a902-3a5c-4c59-b596-be74fc161684_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InsuranceAndHMOMember_13f528b3-4ba1-4b0a-8433-fa0a039f6d66_terseLabel_en-US" xlink:label="lab_cvs_InsuranceAndHMOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance and HMO</link:label>
    <link:label id="lab_cvs_InsuranceAndHMOMember_label_en-US" xlink:label="lab_cvs_InsuranceAndHMOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance And HMO [Member]</link:label>
    <link:label id="lab_cvs_InsuranceAndHMOMember_documentation_en-US" xlink:label="lab_cvs_InsuranceAndHMOMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance and HMO subsidiaries [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InsuranceAndHMOMember" xlink:href="cvs-20230525.xsd#cvs_InsuranceAndHMOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InsuranceAndHMOMember" xlink:to="lab_cvs_InsuranceAndHMOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_StateOfFloridaSettlementMember_0511b493-74e0-4007-abb9-42e3ede84bf7_terseLabel_en-US" xlink:label="lab_cvs_StateOfFloridaSettlementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Florida Settlement</link:label>
    <link:label id="lab_cvs_StateOfFloridaSettlementMember_label_en-US" xlink:label="lab_cvs_StateOfFloridaSettlementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State Of Florida Settlement [Member]</link:label>
    <link:label id="lab_cvs_StateOfFloridaSettlementMember_documentation_en-US" xlink:label="lab_cvs_StateOfFloridaSettlementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State Of Florida Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StateOfFloridaSettlementMember" xlink:href="cvs-20230525.xsd#cvs_StateOfFloridaSettlementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_StateOfFloridaSettlementMember" xlink:to="lab_cvs_StateOfFloridaSettlementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_adc19c55-92a8-428a-9e6d-96d96e4a70c1_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax penalties and interest accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_19746908-978b-4e6b-9ab5-a76f67b5aa70_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized capital gains</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_a720057d-3e31-44b2-86f9-dfa8366d37ab_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2b3a0052-7329-41e6-87ff-6760e4bb9957_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_c2df4049-4776-452c-9f1e-cfbeb6ebd981_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to CVS Health (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_cb0b2383-6953-43b2-a66b-b38d06b0d27a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to CVS Health (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber_e6739e88-3505-42ef-a255-bb91b8419e33_terseLabel_en-US" xlink:label="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected to vest (in shares)</link:label>
    <link:label id="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Number</link:label>
    <link:label id="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber_documentation_en-US" xlink:label="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" xlink:href="cvs-20230525.xsd#cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" xlink:to="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_294d302c-c637-4b22-9713-48980cbc79e9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance reserves</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_b019cf7b-f2d7-4544-96b9-18e4cfc90440_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period One [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember" xlink:href="cvs-20230525.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodOneMember" xlink:to="lab_cvs_YearOfOriginationPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b7e27adb-512f-4cc5-b402-0d402f12d18a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_eac6ab1c-df7e-465d-9f78-78c530c0448d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASU 2016-13</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_bcf51ccb-bf67-42d1-855d-2982a66b45fb_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0ced682c-c669-455a-a5ec-9380d2216029_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_157fc96e-0a38-424a-82c8-22f1cb817778_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_bccf62dd-725b-4b27-920d-aeab5451ed88_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense_27e014f4-20db-45b0-bd01-7894284857e7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest accrual (using locked-in discount rate)</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthInsurerFeeTaxEffectPercent_a9b99c35-9a60-4d0f-8718-d3bd72ab8d53_terseLabel_en-US" xlink:label="lab_cvs_HealthInsurerFeeTaxEffectPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health insurer fee</link:label>
    <link:label id="lab_cvs_HealthInsurerFeeTaxEffectPercent_label_en-US" xlink:label="lab_cvs_HealthInsurerFeeTaxEffectPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurer Fee Tax Effect, Percent</link:label>
    <link:label id="lab_cvs_HealthInsurerFeeTaxEffectPercent_documentation_en-US" xlink:label="lab_cvs_HealthInsurerFeeTaxEffectPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the tax effect of the health care reform's non-tax deductible health insurer fee.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFeeTaxEffectPercent" xlink:href="cvs-20230525.xsd#cvs_HealthInsurerFeeTaxEffectPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthInsurerFeeTaxEffectPercent" xlink:to="lab_cvs_HealthInsurerFeeTaxEffectPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_4cbfa571-f8de-455b-bf61-694d1892949b_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_96c00707-0a30-4e9b-b35b-30811c8eeefe_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_c8229859-81dd-4a53-bf52-932623be4b69_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_1f09c988-5fb3-4c2e-83a4-033c42475931_terseLabel_en-US" xlink:label="lab_cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for future policy benefits, end of period - current discount rate</link:label>
    <link:label id="lab_cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_label_en-US" xlink:label="lab_cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Including Deferred Profit Liability, Expected Future Policy Benefit, Before Reinsurance, After Discount Rate Change</link:label>
    <link:label id="lab_cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_documentation_en-US" xlink:label="lab_cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Future Policy Benefit, Including Deferred Profit Liability, Expected Future Policy Benefit, Before Reinsurance, After Discount Rate Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:href="cvs-20230525.xsd#cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:to="lab_cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_9a85cb3d-bb18-4afa-bf0c-534e6cadf3d8_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_5b86f171-64b4-476c-b408-9295d163a972_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_2be3373b-2d5f-4d0d-bd1c-13674458716b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInvestmentExpense_08e7c338-ae3a-49c8-8809-c5d8cf6d7c55_negatedLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment expenses</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInvestmentExpense_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Investment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInvestmentExpense" xlink:to="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_7d62759d-aec5-49ab-b0c2-52e37937210b_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_841bfe80-f15c-4fd0-9843-925ff07083c5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_27a6b226-8011-4692-9feb-891e6f460ac1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI before reclassifications, pre-tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_9f84266e-a4b9-4ccd-a0c6-859e241c507c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_069c2b59-9ecb-4e7a-ba69-0929ef925833_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock_37c4454b-33c3-4db7-9ae4-eda9b2cbda1e_terseLabel_en-US" xlink:label="lab_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor Allowances and Purchase Discounts</link:label>
    <link:label id="lab_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock_label_en-US" xlink:label="lab_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor Allowances And Purchase Discounts [Policy Text Block]</link:label>
    <link:label id="lab_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock_documentation_en-US" xlink:label="lab_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor Allowances And Purchase Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock" xlink:href="cvs-20230525.xsd#cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock" xlink:to="lab_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_961aafec-47c1-48e7-b425-b6c159e8b2d0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_c108a16e-1af1-44fc-bf0c-28906b6094d9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Operating Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_e4c6bb88-3750-4298-8630-ce6212dbc22a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.78DueMarch2038Member_113d921e-278c-447d-9af9-473dd9e9a5a6_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.78% senior notes due March 2038</link:label>
    <link:label id="lab_cvs_SeniorNotes4.78DueMarch2038Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.78%, Due March 2038 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.78DueMarch2038Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.78%, Due March 2038 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.78DueMarch2038Member" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.78DueMarch2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.78DueMarch2038Member" xlink:to="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateFundsMember_9bb2951d-9db2-4cb3-b16d-8bcf740ee86d_verboseLabel_en-US" xlink:label="lab_us-gaap_RealEstateFundsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate partnerships</link:label>
    <link:label id="lab_us-gaap_RealEstateFundsMember_label_en-US" xlink:label="lab_us-gaap_RealEstateFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateFundsMember" xlink:to="lab_us-gaap_RealEstateFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCustomers_903f99ed-6429-472b-bde1-05a6701db04b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash receipts from customers</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCustomers_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCustomers" xlink:to="lab_us-gaap_ProceedsFromCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_a9f952e5-125a-4770-9b79-d7e117e3ef34_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgeFundsMember_4d9eed79-40ee-48a1-9301-b9af28cf0a57_verboseLabel_en-US" xlink:label="lab_us-gaap_HedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge fund investments</link:label>
    <link:label id="lab_us-gaap_HedgeFundsMember_label_en-US" xlink:label="lab_us-gaap_HedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgeFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgeFundsMember" xlink:to="lab_us-gaap_HedgeFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_964bb894-6cc4-49a1-87cc-9b000cc7ee7a_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Categories5And6Member_835532f7-be50-446d-96d2-cca31f35ac3b_terseLabel_en-US" xlink:label="lab_cvs_Categories5And6Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5 and 6</link:label>
    <link:label id="lab_cvs_Categories5And6Member_label_en-US" xlink:label="lab_cvs_Categories5And6Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Categories 5 And 6 [Member]</link:label>
    <link:label id="lab_cvs_Categories5And6Member_documentation_en-US" xlink:label="lab_cvs_Categories5And6Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loan credit quality indicator - Categories 5 and 6</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5And6Member" xlink:href="cvs-20230525.xsd#cvs_Categories5And6Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Categories5And6Member" xlink:to="lab_cvs_Categories5And6Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_1d7eda6f-3c62-43eb-8f24-a940695e9f3d_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_9a0dd06a-101b-4c1f-b6fe-5780ada4ce10_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_fbd326c7-2cae-4e5a-8bc8-ac2f35d4b2b9_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_2eaebbe9-c430-4dd3-a3bc-b14e2dabd0b8_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_344fd9e2-6047-4e8e-a05a-cc9a68ae7dfc_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated maximum dividend distributions permitted in 2023 without prior regulatory approval</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember_7e145567-de2c-4bc0-819e-9470d0551093_terseLabel_en-US" xlink:label="lab_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in discount rate on long-duration insurance reserves</link:label>
    <link:label id="lab_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember_label_en-US" xlink:label="lab_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Change In Discount Rate On Insurance Reserves [Member]</link:label>
    <link:label id="lab_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember_documentation_en-US" xlink:label="lab_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Change In Discount Rate On Insurance Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember" xlink:href="cvs-20230525.xsd#cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember" xlink:to="lab_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_83482373-0e5c-4a8d-bc28-6b771eae4966_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Company's Borrowings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_f3b323d6-c5ea-4f32-8749-d8e4928cab02_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease and rents</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_d115b848-21a4-4821-9584-8ca07baca299_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution centers and Corporate offices</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_730e38dc-3f6b-484e-ac35-20b6d726f8c3_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_f1081e48-21e9-4bca-bb62-9a22e72262fe_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed</link:label>
    <link:label id="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_label_en-US" xlink:label="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" xlink:to="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_c1993db5-2f57-48d4-a8ff-95496e0a7c01_verboseLabel_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity in Mortgage Loan Portfolio</link:label>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_label_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity In Mortgage Loan Portfolio [Table Text Block]</link:label>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Table representing activities in mortgage loan portfolio during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:href="cvs-20230525.xsd#cvs_ActivityInMortgageLoanPortfolioTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:to="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_979a5e8a-c7cd-44b5-987c-6825144cfa90_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_534f8994-5ed5-4161-90a4-32186f24cd25_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_04654593-3028-4d06-94cf-b714d0fed3ed_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of disaggregation of revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_258b4ca8-dc6b-429a-bd86-0eecf83415ff_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid_7c2eb946-3c6e-495f-b23e-748fcb24574f_terseLabel_en-US" xlink:label="lab_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period after date of service a claim is paid</link:label>
    <link:label id="lab_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid_label_en-US" xlink:label="lab_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Costs Payable, Period After Date Of Services Claims Are Paid</link:label>
    <link:label id="lab_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid_documentation_en-US" xlink:label="lab_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Costs Payable, Period After Date Of Services Claims Are Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" xlink:href="cvs-20230525.xsd#cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" xlink:to="lab_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_612edcb2-1d51-4883-a67c-1c42dec5b1a0_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_293bb198-9df3-41c2-8812-f0d7d566f75a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables (included in accounts receivable, net)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountMortgageBackedSecurityMember_e17a51bf-510f-4048-b007-81a10b8d17ad_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountMortgageBackedSecurityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_SeparateAccountMortgageBackedSecurityMember_label_en-US" xlink:label="lab_us-gaap_SeparateAccountMortgageBackedSecurityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Mortgage-Backed Security [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountMortgageBackedSecurityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountMortgageBackedSecurityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountMortgageBackedSecurityMember" xlink:to="lab_us-gaap_SeparateAccountMortgageBackedSecurityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_010e6c30-e50e-46a2-ac48-6bd2ba68802b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VIE, ownership percentage</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_133fedbd-199b-433a-90d7-0cd3460db984_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows paid for interest portion of finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_4e292c26-22fe-4971-872c-58efb1f0c534_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer contracts/relationships and covenants not to compete</link:label>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:to="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_f8d9c2c9-b87c-4777-a451-0f45750583ca_verboseLabel_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Mortgage Loan Amortized Cost and Credit Quality Indicator</link:label>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_label_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Mortgage Loan Internal Credit Ratings [Table Text Block]</link:label>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:href="cvs-20230525.xsd#cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:to="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_9774bfe8-47af-429a-9340-79e703c95aa2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumptions used to determine net benefit costs</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_e7f211f9-53c0-4bf1-8756-3b31401fb187_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recoverability of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_702beffb-ca1f-456b-a6e8-9e8769121271_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_ffeef543-50a3-45fe-b879-614e231d5925_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsTable_be83bc2b-56e5-4ffc-a81b-1185067dd392_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTable_label_en-US" xlink:label="lab_cvs_TotalInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable" xlink:href="cvs-20230525.xsd#cvs_TotalInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsTable" xlink:to="lab_cvs_TotalInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityRollForward_88cd6b96-b301-4f2c-8dff-0cdee6c11d4b_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_SeparateAccountLiabilityRollForward_label_en-US" xlink:label="lab_us-gaap_SeparateAccountLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountLiabilityRollForward" xlink:to="lab_us-gaap_SeparateAccountLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_165cc51c-fc68-452f-a73c-9937b416b655_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_b3e406cc-072b-4327-a2d9-c490fc87317c_verboseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Total Investments</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_label_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table Text Block]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item includes total investments, both current and long-term.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTableTextBlock" xlink:href="cvs-20230525.xsd#cvs_TotalInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsTableTextBlock" xlink:to="lab_cvs_TotalInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_c55c3d8a-1202-4581-9dfc-48f34e0fdcbe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_4241c7ae-58bc-452c-994e-2966f16155f2_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CitibankNAMember_87520fb9-1c17-4e5a-8f2a-6214733de2dd_terseLabel_en-US" xlink:label="lab_cvs_CitibankNAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Citibank, N.A.</link:label>
    <link:label id="lab_cvs_CitibankNAMember_label_en-US" xlink:label="lab_cvs_CitibankNAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Citibank, N.A. [Member]</link:label>
    <link:label id="lab_cvs_CitibankNAMember_documentation_en-US" xlink:label="lab_cvs_CitibankNAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Citibank, N.A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CitibankNAMember" xlink:href="cvs-20230525.xsd#cvs_CitibankNAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CitibankNAMember" xlink:to="lab_cvs_CitibankNAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_51421000-c48c-4538-aee0-8eca47b4f106_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember_472849bc-7449-4477-b5cc-6b8dd9b17aec_terseLabel_en-US" xlink:label="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coventry Health Care Workers Compensation Business</link:label>
    <link:label id="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember_label_en-US" xlink:label="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coventry Health Care Workers Compensation Business [Member]</link:label>
    <link:label id="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember_documentation_en-US" xlink:label="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coventry Health Care Workers Compensation Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:href="cvs-20230525.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:to="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_fab16594-33f1-4189-b3a4-4260447d1042_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_60aecc45-4cd0-4160-a169-f1c9ca31555a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations</link:label>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDebtSecuritiesMember" xlink:to="lab_us-gaap_OtherDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale_1c788ae2-ec03-40df-b76f-210c0b52ea10_terseLabel_en-US" xlink:label="lab_cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale_label_en-US" xlink:label="lab_cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Including Liabilities Held For Sale</link:label>
    <link:label id="lab_cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale_documentation_en-US" xlink:label="lab_cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Including Liabilities Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale" xlink:href="cvs-20230525.xsd#cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale" xlink:to="lab_cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels_064a8706-3de5-46b6-b19b-b5f8cc3255b0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers out of Level 3</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Assets Transferred into (out of) Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels" xlink:to="lab_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_95a30f9f-dc65-49a4-aa64-2d974770243a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_a8338640-a7af-4db3-88a6-276e952b3024_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_af0e7c3e-9cc7-4582-888e-0c76f9d548c7_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_663c5f40-3a4e-4fc9-942a-887a1ea11cac_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_1aa90b08-b1a1-4d29-be59-8f680ac5a092_terseLabel_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services</link:label>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_label_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services [Member]</link:label>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_documentation_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember" xlink:href="cvs-20230525.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HeartlandHealthcareServicesMember" xlink:to="lab_cvs_HeartlandHealthcareServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_d644a661-5adb-41ec-ae72-9ec988143036_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7b9d39be-ec86-424b-a6da-7156021ce67e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_c02b0def-351a-4bde-9896-7abd1690031d_negatedTerseLabel_en-US" xlink:label="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition purchase price adjustments outside of measurement period</link:label>
    <link:label id="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_label_en-US" xlink:label="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Purchase Price Adjustment, Outside Of Measurement Period</link:label>
    <link:label id="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_documentation_en-US" xlink:label="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Purchase Price Adjustment, Outside Of Measurement Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:href="cvs-20230525.xsd#cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:to="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_7d6f87d0-0a5f-4cc2-93df-b2d87b892b0e_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_cc6c98d9-da72-4f71-8d62-bfcdb6cd43a6_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:to="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_c4c45699-05f8-43b9-a93b-c356ba8e0f70_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Five [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember" xlink:href="cvs-20230525.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodFiveMember" xlink:to="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_cb3294c4-a3b8-4873-8a27-0fcf22a5d54a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_StoreImpairmentCharges_6bc97653-b6f4-4289-a1f4-77f90db2841e_terseLabel_en-US" xlink:label="lab_cvs_StoreImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Store impairments</link:label>
    <link:label id="lab_cvs_StoreImpairmentCharges_25592721-0cc5-4f08-b8c0-6a6a8c0e910f_verboseLabel_en-US" xlink:label="lab_cvs_StoreImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Store impairment charges</link:label>
    <link:label id="lab_cvs_StoreImpairmentCharges_label_en-US" xlink:label="lab_cvs_StoreImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Store Impairment Charges</link:label>
    <link:label id="lab_cvs_StoreImpairmentCharges_documentation_en-US" xlink:label="lab_cvs_StoreImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Store Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges" xlink:href="cvs-20230525.xsd#cvs_StoreImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_StoreImpairmentCharges" xlink:to="lab_cvs_StoreImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_e86f1a0c-d9d4-4c5b-9d9d-f7f98daf5eb1_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PayflexMember_91ddffd5-92de-4584-ae70-035b38e707de_terseLabel_en-US" xlink:label="lab_cvs_PayflexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payflex</link:label>
    <link:label id="lab_cvs_PayflexMember_label_en-US" xlink:label="lab_cvs_PayflexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payflex [Member]</link:label>
    <link:label id="lab_cvs_PayflexMember_documentation_en-US" xlink:label="lab_cvs_PayflexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payflex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PayflexMember" xlink:href="cvs-20230525.xsd#cvs_PayflexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PayflexMember" xlink:to="lab_cvs_PayflexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_26901e09-07bb-4006-82a4-79c3def86354_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_529c6c3e-768f-4550-9050-32218c2d2ecb_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of subsidiaries (net of cash and restricted cash sold of $2,854, $0 and $9)</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InternationalHealthCareRenewalRightsMember_6160f390-652e-485a-acbe-54b4c2cfddd6_terseLabel_en-US" xlink:label="lab_cvs_InternationalHealthCareRenewalRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Health Care Renewal Rights</link:label>
    <link:label id="lab_cvs_InternationalHealthCareRenewalRightsMember_label_en-US" xlink:label="lab_cvs_InternationalHealthCareRenewalRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Health Care Renewal Rights [Member]</link:label>
    <link:label id="lab_cvs_InternationalHealthCareRenewalRightsMember_documentation_en-US" xlink:label="lab_cvs_InternationalHealthCareRenewalRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Health Care Renewal Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InternationalHealthCareRenewalRightsMember" xlink:href="cvs-20230525.xsd#cvs_InternationalHealthCareRenewalRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InternationalHealthCareRenewalRightsMember" xlink:to="lab_cvs_InternationalHealthCareRenewalRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_9a4c46db-df83-4e40-afcb-ea9f524630a9_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount_fb0483ab-ddcb-4c1c-8258-8188d7663e5f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan assets, investment within plan asset category, amount</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay162027Member_70227fbe-4ea2-4882-b098-dd26da0cb88d_terseLabel_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay162027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 16, 2027</link:label>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay162027Member_label_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay162027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 16, 2027 [Member]</link:label>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay162027Member_documentation_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay162027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 16, 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay162027Member" xlink:href="cvs-20230525.xsd#cvs_RevolvingCreditFacilityExpiringMay162027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RevolvingCreditFacilityExpiringMay162027Member" xlink:to="lab_cvs_RevolvingCreditFacilityExpiringMay162027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_386057a7-7970-43db-8f39-7a4720e769e2_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>cvs-20230525_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:a470d627-05b8-4106-b3ee-d69f01519b0f,g:7f491b32-9056-4172-9edc-e6fc2e3bdea2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com/role/CoverPage" xlink:type="simple" xlink:href="cvs-20230525.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_adbdb139-f50d-44fa-a2e3-46418d033bfa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:to="loc_dei_DocumentType_adbdb139-f50d-44fa-a2e3-46418d033bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d52a7ca6-90da-4ae4-8ff0-2156a85be3c3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:to="loc_dei_DocumentPeriodEndDate_d52a7ca6-90da-4ae4-8ff0-2156a85be3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b76501ff-524b-4da2-882a-0d36e6990124" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:to="loc_dei_EntityRegistrantName_b76501ff-524b-4da2-882a-0d36e6990124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_eff7206c-23a0-4a5f-854f-49f6fd8a6dc1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:to="loc_dei_EntityCentralIndexKey_eff7206c-23a0-4a5f-854f-49f6fd8a6dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_e98172e3-474a-46ca-9f57-f4864e404666" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:to="loc_dei_AmendmentFlag_e98172e3-474a-46ca-9f57-f4864e404666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_572f59f8-be4a-4f92-a207-d26bc91c4cc0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:to="loc_dei_EntityIncorporationStateCountryCode_572f59f8-be4a-4f92-a207-d26bc91c4cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0b8262b6-a9c6-419e-a9b4-3d4ed5b8b508" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:to="loc_dei_EntityFileNumber_0b8262b6-a9c6-419e-a9b4-3d4ed5b8b508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_3b1b300d-a0f0-4d25-9eae-2255f6033ffb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:to="loc_dei_EntityTaxIdentificationNumber_3b1b300d-a0f0-4d25-9eae-2255f6033ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7ae81175-b302-4b99-86a8-af79bef4c264" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:to="loc_dei_EntityAddressAddressLine1_7ae81175-b302-4b99-86a8-af79bef4c264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_91c80e84-b8b8-4161-a922-9d21348663cc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:to="loc_dei_EntityAddressCityOrTown_91c80e84-b8b8-4161-a922-9d21348663cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_cd450058-72de-4c75-8621-5e67e6910118" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:to="loc_dei_EntityAddressStateOrProvince_cd450058-72de-4c75-8621-5e67e6910118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_505ed68c-f96a-46b8-9b9d-bc8b7979a015" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:to="loc_dei_EntityAddressPostalZipCode_505ed68c-f96a-46b8-9b9d-bc8b7979a015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_05312382-ea25-42b4-8390-c7d52474cce5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:to="loc_dei_CityAreaCode_05312382-ea25-42b4-8390-c7d52474cce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b9c8951b-2b64-427b-af27-47585167159c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:to="loc_dei_LocalPhoneNumber_b9c8951b-2b64-427b-af27-47585167159c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_d904e53a-a9e6-42b3-bbda-d7b716e0fdba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:to="loc_dei_WrittenCommunications_d904e53a-a9e6-42b3-bbda-d7b716e0fdba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_53ea35f1-0e7d-4571-83f8-856b17ea558b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:to="loc_dei_SolicitingMaterial_53ea35f1-0e7d-4571-83f8-856b17ea558b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_c76f04f0-031e-4979-af4c-51fd8c925a1f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:to="loc_dei_PreCommencementTenderOffer_c76f04f0-031e-4979-af4c-51fd8c925a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_f011e1ce-0e6a-4f94-a4f1-2c40eeb53490" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_f011e1ce-0e6a-4f94-a4f1-2c40eeb53490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_d7a72a65-6f28-4b59-8055-af02822b7f17" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:to="loc_dei_Security12bTitle_d7a72a65-6f28-4b59-8055-af02822b7f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_47cdbb97-4f4d-4dca-b825-3350640cd5b4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:to="loc_dei_TradingSymbol_47cdbb97-4f4d-4dca-b825-3350640cd5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_902421f8-a521-49bb-9a90-ed8d8676f1ff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:to="loc_dei_SecurityExchangeName_902421f8-a521-49bb-9a90-ed8d8676f1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_6ea46757-dd1c-4cd3-a46e-cdbd6d567a44" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a88c1ff3-4538-4e57-b334-73ed33a5126f" xlink:to="loc_dei_EntityEmergingGrowthCompany_6ea46757-dd1c-4cd3-a46e-cdbd6d567a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="cvs-20230525.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_2040996c-6b5d-4000-a75e-2cd308df9f48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6482774b-a47e-460a-958e-8b3ad9bd547a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2040996c-6b5d-4000-a75e-2cd308df9f48" xlink:to="loc_us-gaap_StatementTable_6482774b-a47e-460a-958e-8b3ad9bd547a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f208da14-c14b-4e63-9c5f-8f2ebb1ed505" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6482774b-a47e-460a-958e-8b3ad9bd547a" xlink:to="loc_srt_ProductOrServiceAxis_f208da14-c14b-4e63-9c5f-8f2ebb1ed505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_37af55a0-b4ca-4b9f-b775-ff00a7a44ad1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f208da14-c14b-4e63-9c5f-8f2ebb1ed505" xlink:to="loc_srt_ProductsAndServicesDomain_37af55a0-b4ca-4b9f-b775-ff00a7a44ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_c32d1b5d-cd44-418f-abe5-99e376a5bc4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_37af55a0-b4ca-4b9f-b775-ff00a7a44ad1" xlink:to="loc_us-gaap_ProductMember_c32d1b5d-cd44-418f-abe5-99e376a5bc4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_959c5e6f-1064-4bd6-abce-d090470b6717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_37af55a0-b4ca-4b9f-b775-ff00a7a44ad1" xlink:to="loc_us-gaap_ServiceMember_959c5e6f-1064-4bd6-abce-d090470b6717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6482774b-a47e-460a-958e-8b3ad9bd547a" xlink:to="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_201ac5df-2eb0-400f-a37a-184b25148669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_RevenuesAbstract_201ac5df-2eb0-400f-a37a-184b25148669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a8be9c0c-2f5a-4487-bfa3-560cc02f7517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_201ac5df-2eb0-400f-a37a-184b25148669" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a8be9c0c-2f5a-4487-bfa3-560cc02f7517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_add55321-0ec2-411d-b889-76e9e689984c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_201ac5df-2eb0-400f-a37a-184b25148669" xlink:to="loc_us-gaap_PremiumsEarnedNet_add55321-0ec2-411d-b889-76e9e689984c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_5dc05c37-7982-4a66-b976-d1a7be4ab60e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_201ac5df-2eb0-400f-a37a-184b25148669" xlink:to="loc_us-gaap_NetInvestmentIncome_5dc05c37-7982-4a66-b976-d1a7be4ab60e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7aa33272-ae71-4b1e-976a-f00f75436d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_201ac5df-2eb0-400f-a37a-184b25148669" xlink:to="loc_us-gaap_Revenues_7aa33272-ae71-4b1e-976a-f00f75436d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_e8594484-fe05-4bbc-b9ac-668c3b3ae802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_OperatingExpensesAbstract_e8594484-fe05-4bbc-b9ac-668c3b3ae802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ecbe02ba-a230-4eec-9ae8-bee91b35a0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e8594484-fe05-4bbc-b9ac-668c3b3ae802" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ecbe02ba-a230-4eec-9ae8-bee91b35a0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_c84204b0-2fa7-40a8-92d9-e3166cbcf486" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e8594484-fe05-4bbc-b9ac-668c3b3ae802" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_c84204b0-2fa7-40a8-92d9-e3166cbcf486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_fb31a6a5-9c7f-460c-831d-cd26fc4c57be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e8594484-fe05-4bbc-b9ac-668c3b3ae802" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_fb31a6a5-9c7f-460c-831d-cd26fc4c57be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_ae294930-839d-430a-b9e0-bdb8967407fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e8594484-fe05-4bbc-b9ac-668c3b3ae802" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_ae294930-839d-430a-b9e0-bdb8967407fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges_0283f8e1-8c74-410c-a122-315dd5906ec1" xlink:href="cvs-20230525.xsd#cvs_StoreImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e8594484-fe05-4bbc-b9ac-668c3b3ae802" xlink:to="loc_cvs_StoreImpairmentCharges_0283f8e1-8c74-410c-a122-315dd5906ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_e2027844-6313-493e-8d68-9e80144f9980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e8594484-fe05-4bbc-b9ac-668c3b3ae802" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_e2027844-6313-493e-8d68-9e80144f9980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_34b20d78-8011-4c2a-ba8c-88023abdd981" xlink:href="cvs-20230525.xsd#cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e8594484-fe05-4bbc-b9ac-668c3b3ae802" xlink:to="loc_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_34b20d78-8011-4c2a-ba8c-88023abdd981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_df9be296-071e-4066-8a74-31a4b92c34b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e8594484-fe05-4bbc-b9ac-668c3b3ae802" xlink:to="loc_us-gaap_CostsAndExpenses_df9be296-071e-4066-8a74-31a4b92c34b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_12679ff8-fb7a-49cb-9550-103931ac1f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_OperatingIncomeLoss_12679ff8-fb7a-49cb-9550-103931ac1f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_398ded2c-2e6a-4475-89e9-31910acd1929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_InterestExpense_398ded2c-2e6a-4475-89e9-31910acd1929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_93a4d5d5-22e2-41af-912a-9c2c049b9810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_93a4d5d5-22e2-41af-912a-9c2c049b9810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_38a988b7-fd8d-4f7e-b08c-32bf35e99bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_38a988b7-fd8d-4f7e-b08c-32bf35e99bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fa00e726-3fff-4180-9764-99e28fe5b82e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fa00e726-3fff-4180-9764-99e28fe5b82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3a6ede67-212f-45c3-b8e6-8ccd791a9499" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3a6ede67-212f-45c3-b8e6-8ccd791a9499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1675406d-d0b4-4232-8a3a-0c56aef34ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1675406d-d0b4-4232-8a3a-0c56aef34ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_abcb2e80-7615-4532-a6f2-1165ca9c8289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_abcb2e80-7615-4532-a6f2-1165ca9c8289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_13b63cfe-abd9-473c-a2df-5a6cc10aa9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_ProfitLoss_13b63cfe-abd9-473c-a2df-5a6cc10aa9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_363d88a1-f93e-4e21-a8b4-bd381ab0af9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_363d88a1-f93e-4e21-a8b4-bd381ab0af9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6d3414fa-97b3-42e0-b13f-9c561c7083ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_NetIncomeLoss_6d3414fa-97b3-42e0-b13f-9c561c7083ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_814f3854-8ea6-4c72-825e-e258d27272c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_814f3854-8ea6-4c72-825e-e258d27272c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_80d07fe7-1ec3-461c-b6da-7a352cd59d65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_814f3854-8ea6-4c72-825e-e258d27272c8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_80d07fe7-1ec3-461c-b6da-7a352cd59d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_8584d074-f178-43f4-a48f-5f78cfc886bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_814f3854-8ea6-4c72-825e-e258d27272c8" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_8584d074-f178-43f4-a48f-5f78cfc886bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_132f76c5-0b76-4d61-9e8f-11c8fc8a4009" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_814f3854-8ea6-4c72-825e-e258d27272c8" xlink:to="loc_us-gaap_EarningsPerShareBasic_132f76c5-0b76-4d61-9e8f-11c8fc8a4009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_910dc2b3-1bb2-4605-bea2-12ae66d91eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_814f3854-8ea6-4c72-825e-e258d27272c8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_910dc2b3-1bb2-4605-bea2-12ae66d91eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_3c2746d6-c014-4134-afe3-3fc8e47add7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_3c2746d6-c014-4134-afe3-3fc8e47add7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_189b5c4d-cfda-46c4-977e-d8ff5b9f4bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_3c2746d6-c014-4134-afe3-3fc8e47add7b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_189b5c4d-cfda-46c4-977e-d8ff5b9f4bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_868b2244-8676-4cfd-86eb-467c04de145b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_3c2746d6-c014-4134-afe3-3fc8e47add7b" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_868b2244-8676-4cfd-86eb-467c04de145b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a980d4f2-42ea-44f3-9024-52aeec28cc36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_3c2746d6-c014-4134-afe3-3fc8e47add7b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a980d4f2-42ea-44f3-9024-52aeec28cc36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_53075c97-2a96-4f9a-b4da-6abcfc25862f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_3c2746d6-c014-4134-afe3-3fc8e47add7b" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_53075c97-2a96-4f9a-b4da-6abcfc25862f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_ea501cdb-fef5-43c6-9d20-d9138a95992c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_ea501cdb-fef5-43c6-9d20-d9138a95992c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_bd41e505-963a-4cb8-b8a9-4d608d17b664" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30d29476-7ca1-4fbc-8069-86f09fa15670" xlink:to="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_bd41e505-963a-4cb8-b8a9-4d608d17b664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="cvs-20230525.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7b53b229-70d5-4cb1-9678-07af95036f22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d382bde0-5b8f-42e1-9a59-62ef2dd574d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7b53b229-70d5-4cb1-9678-07af95036f22" xlink:to="loc_us-gaap_ProfitLoss_d382bde0-5b8f-42e1-9a59-62ef2dd574d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_23626945-dc53-4991-9980-a779015dbf39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7b53b229-70d5-4cb1-9678-07af95036f22" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_23626945-dc53-4991-9980-a779015dbf39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3349555d-e4f2-4168-9332-e4180df7a93f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_23626945-dc53-4991-9980-a779015dbf39" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3349555d-e4f2-4168-9332-e4180df7a93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax_db6ec651-a87f-4ba4-9248-c93a73ec5a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_23626945-dc53-4991-9980-a779015dbf39" xlink:to="loc_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax_db6ec651-a87f-4ba4-9248-c93a73ec5a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_cd3188b2-ab75-4631-9dd8-91a175e3ebb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_23626945-dc53-4991-9980-a779015dbf39" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_cd3188b2-ab75-4631-9dd8-91a175e3ebb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_29d3b0b3-fd7b-4663-a7d1-bec25b0470d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_23626945-dc53-4991-9980-a779015dbf39" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_29d3b0b3-fd7b-4663-a7d1-bec25b0470d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f4f9769e-d55a-468f-aa40-1689a7794d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_23626945-dc53-4991-9980-a779015dbf39" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f4f9769e-d55a-468f-aa40-1689a7794d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_96b53bb9-0e4c-4559-afdf-0c518315d928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_23626945-dc53-4991-9980-a779015dbf39" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_96b53bb9-0e4c-4559-afdf-0c518315d928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4eb21bb5-8a9f-40a8-a80a-967aae87be24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7b53b229-70d5-4cb1-9678-07af95036f22" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4eb21bb5-8a9f-40a8-a80a-967aae87be24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_cde023f9-5283-4387-bc77-96594727713d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7b53b229-70d5-4cb1-9678-07af95036f22" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_cde023f9-5283-4387-bc77-96594727713d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_38e4e2ab-2f09-45ea-b7fd-bfe9f54c6cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7b53b229-70d5-4cb1-9678-07af95036f22" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_38e4e2ab-2f09-45ea-b7fd-bfe9f54c6cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cvs-20230525.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_c2562477-2c87-4bdf-9f18-78f466df5d94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_4850c578-3a5e-4e8c-b45a-5d87cf79071e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c2562477-2c87-4bdf-9f18-78f466df5d94" xlink:to="loc_us-gaap_AssetsAbstract_4850c578-3a5e-4e8c-b45a-5d87cf79071e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a884feed-ac38-46e5-955d-8f110884a277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4850c578-3a5e-4e8c-b45a-5d87cf79071e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a884feed-ac38-46e5-955d-8f110884a277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_c380a7a4-fdd2-462c-918f-6a5e7a3cd763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4850c578-3a5e-4e8c-b45a-5d87cf79071e" xlink:to="loc_us-gaap_ShortTermInvestments_c380a7a4-fdd2-462c-918f-6a5e7a3cd763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_dc0f7004-0f09-4aa6-8939-bbc17d0238a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4850c578-3a5e-4e8c-b45a-5d87cf79071e" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_dc0f7004-0f09-4aa6-8939-bbc17d0238a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_967aa736-f959-4a4d-a72f-76e158ee0b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4850c578-3a5e-4e8c-b45a-5d87cf79071e" xlink:to="loc_us-gaap_InventoryNet_967aa736-f959-4a4d-a72f-76e158ee0b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_3c8f889e-2cf7-4ebe-b5c6-810217f8e6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4850c578-3a5e-4e8c-b45a-5d87cf79071e" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_3c8f889e-2cf7-4ebe-b5c6-810217f8e6a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_e2153ab1-2a4a-49cb-89e5-c43094b58820" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4850c578-3a5e-4e8c-b45a-5d87cf79071e" xlink:to="loc_us-gaap_OtherAssetsCurrent_e2153ab1-2a4a-49cb-89e5-c43094b58820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6c7f28c0-2bd1-4842-b43b-437f583953d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4850c578-3a5e-4e8c-b45a-5d87cf79071e" xlink:to="loc_us-gaap_AssetsCurrent_6c7f28c0-2bd1-4842-b43b-437f583953d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_d266f9ef-2fef-4c18-bf32-bd8ec79228c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4850c578-3a5e-4e8c-b45a-5d87cf79071e" xlink:to="loc_us-gaap_LongTermInvestments_d266f9ef-2fef-4c18-bf32-bd8ec79228c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1d46f59b-0364-48b9-a4d1-db9190dea226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4850c578-3a5e-4e8c-b45a-5d87cf79071e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1d46f59b-0364-48b9-a4d1-db9190dea226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_5e340688-5e07-41ca-84d9-54c4a1c4895f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4850c578-3a5e-4e8c-b45a-5d87cf79071e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_5e340688-5e07-41ca-84d9-54c4a1c4895f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d67a6c25-a501-4f20-a31d-4138fc9bc099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4850c578-3a5e-4e8c-b45a-5d87cf79071e" xlink:to="loc_us-gaap_Goodwill_d67a6c25-a501-4f20-a31d-4138fc9bc099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5ee7cbac-7a3f-4b85-bc6e-efe49c9daeaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4850c578-3a5e-4e8c-b45a-5d87cf79071e" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5ee7cbac-7a3f-4b85-bc6e-efe49c9daeaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_99101e4a-8856-4e6a-8213-bd2cc43d99f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4850c578-3a5e-4e8c-b45a-5d87cf79071e" xlink:to="loc_us-gaap_SeparateAccountAssets_99101e4a-8856-4e6a-8213-bd2cc43d99f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c3a699e6-5c5d-4a19-8c8f-afde1ba65cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4850c578-3a5e-4e8c-b45a-5d87cf79071e" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c3a699e6-5c5d-4a19-8c8f-afde1ba65cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6a9e5cc5-57c0-409d-beda-8d3636e7e0df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4850c578-3a5e-4e8c-b45a-5d87cf79071e" xlink:to="loc_us-gaap_Assets_6a9e5cc5-57c0-409d-beda-8d3636e7e0df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_789c1489-9a67-40ff-a257-7d2a40360a37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c2562477-2c87-4bdf-9f18-78f466df5d94" xlink:to="loc_us-gaap_LiabilitiesAbstract_789c1489-9a67-40ff-a257-7d2a40360a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_29c24810-8e03-4823-9e54-58928514ec92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_789c1489-9a67-40ff-a257-7d2a40360a37" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_29c24810-8e03-4823-9e54-58928514ec92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsAndDiscountsPayableCurrent_d4c1306a-172b-4872-ab9c-55df2f62bc3b" xlink:href="cvs-20230525.xsd#cvs_PharmacyClaimsAndDiscountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_789c1489-9a67-40ff-a257-7d2a40360a37" xlink:to="loc_cvs_PharmacyClaimsAndDiscountsPayableCurrent_d4c1306a-172b-4872-ab9c-55df2f62bc3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_1a2ef0cd-6d85-4815-92cb-ba69245198b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_789c1489-9a67-40ff-a257-7d2a40360a37" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_1a2ef0cd-6d85-4815-92cb-ba69245198b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds_53837f6b-512f-4c95-a750-243a2532414f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_789c1489-9a67-40ff-a257-7d2a40360a37" xlink:to="loc_us-gaap_OtherPolicyholderFunds_53837f6b-512f-4c95-a750-243a2532414f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_bb2ca1c8-97cc-432b-9e5a-6046bf7c3bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_789c1489-9a67-40ff-a257-7d2a40360a37" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_bb2ca1c8-97cc-432b-9e5a-6046bf7c3bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent_666dab5c-3dec-4d69-9642-6795747dea1e" xlink:href="cvs-20230525.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_789c1489-9a67-40ff-a257-7d2a40360a37" xlink:to="loc_cvs_OtherInsuranceLiabilitiesCurrent_666dab5c-3dec-4d69-9642-6795747dea1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8a1a54e7-eb1d-4d9d-9f41-822498088329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_789c1489-9a67-40ff-a257-7d2a40360a37" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8a1a54e7-eb1d-4d9d-9f41-822498088329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f9a2b403-195d-474f-8469-545cb5e3c052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_789c1489-9a67-40ff-a257-7d2a40360a37" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f9a2b403-195d-474f-8469-545cb5e3c052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_d4e49b87-ae84-4f4e-8ad4-5bc734b0f5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_789c1489-9a67-40ff-a257-7d2a40360a37" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_d4e49b87-ae84-4f4e-8ad4-5bc734b0f5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_493fe7a0-82d8-443f-a345-4df164239f90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_789c1489-9a67-40ff-a257-7d2a40360a37" xlink:to="loc_us-gaap_LiabilitiesCurrent_493fe7a0-82d8-443f-a345-4df164239f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b7e6e643-6bb1-4ed2-a10a-1052c2ab474e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_789c1489-9a67-40ff-a257-7d2a40360a37" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b7e6e643-6bb1-4ed2-a10a-1052c2ab474e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_8c26ac2a-3724-442e-a61e-a3c766d759a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_789c1489-9a67-40ff-a257-7d2a40360a37" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_8c26ac2a-3724-442e-a61e-a3c766d759a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5a523a42-95a1-4bc5-a0d2-aa9534228929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_789c1489-9a67-40ff-a257-7d2a40360a37" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5a523a42-95a1-4bc5-a0d2-aa9534228929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_6cf0f3a6-0476-4f17-b1c0-daad4affce72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_789c1489-9a67-40ff-a257-7d2a40360a37" xlink:to="loc_us-gaap_SeparateAccountsLiability_6cf0f3a6-0476-4f17-b1c0-daad4affce72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_0775b003-ded3-4945-b30b-90c4fca0425e" xlink:href="cvs-20230525.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_789c1489-9a67-40ff-a257-7d2a40360a37" xlink:to="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_0775b003-ded3-4945-b30b-90c4fca0425e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e8dc992b-eb62-447e-9a37-65dd6767b4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_789c1489-9a67-40ff-a257-7d2a40360a37" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e8dc992b-eb62-447e-9a37-65dd6767b4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_27a8c9d6-62f6-4ca6-a237-3597a5373336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_789c1489-9a67-40ff-a257-7d2a40360a37" xlink:to="loc_us-gaap_Liabilities_27a8c9d6-62f6-4ca6-a237-3597a5373336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_47dd1270-8dcf-4f25-af7c-d864f4d62b53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c2562477-2c87-4bdf-9f18-78f466df5d94" xlink:to="loc_us-gaap_CommitmentsAndContingencies_47dd1270-8dcf-4f25-af7c-d864f4d62b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_956a809f-e5f3-4718-95b4-42e7413e0010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c2562477-2c87-4bdf-9f18-78f466df5d94" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_956a809f-e5f3-4718-95b4-42e7413e0010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_c9caf91d-9d03-4301-ac2e-71fbefe0bcc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_956a809f-e5f3-4718-95b4-42e7413e0010" xlink:to="loc_us-gaap_PreferredStockValue_c9caf91d-9d03-4301-ac2e-71fbefe0bcc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_58c3d9a5-933a-4e85-b4ab-4c8643f6c8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_956a809f-e5f3-4718-95b4-42e7413e0010" xlink:to="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_58c3d9a5-933a-4e85-b4ab-4c8643f6c8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_397bfe10-f62e-4f1e-bedf-4e415b5ff738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_956a809f-e5f3-4718-95b4-42e7413e0010" xlink:to="loc_us-gaap_TreasuryStockValue_397bfe10-f62e-4f1e-bedf-4e415b5ff738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_dbc4e6f7-5739-4805-af0a-d77e1d478615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_956a809f-e5f3-4718-95b4-42e7413e0010" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_dbc4e6f7-5739-4805-af0a-d77e1d478615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8bc1bf29-2934-425d-8b6f-b0508f3060f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_956a809f-e5f3-4718-95b4-42e7413e0010" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8bc1bf29-2934-425d-8b6f-b0508f3060f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1eca8aa8-a765-455b-adee-f948cb3f81cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_956a809f-e5f3-4718-95b4-42e7413e0010" xlink:to="loc_us-gaap_StockholdersEquity_1eca8aa8-a765-455b-adee-f948cb3f81cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_76adc83d-e446-4f9c-a7f4-8b71994ff292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_956a809f-e5f3-4718-95b4-42e7413e0010" xlink:to="loc_us-gaap_MinorityInterest_76adc83d-e446-4f9c-a7f4-8b71994ff292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a657eb7e-ea0d-45e9-8692-5d96ae7ef2e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_956a809f-e5f3-4718-95b4-42e7413e0010" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a657eb7e-ea0d-45e9-8692-5d96ae7ef2e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d7f4b064-f594-4ce2-b015-a9f936f392f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c2562477-2c87-4bdf-9f18-78f466df5d94" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_d7f4b064-f594-4ce2-b015-a9f936f392f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="cvs-20230525.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_63baaa54-a05b-4ff7-89ea-6119c0ecec36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_95f885d8-24a4-4196-95cd-0ec1b404497b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_63baaa54-a05b-4ff7-89ea-6119c0ecec36" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_95f885d8-24a4-4196-95cd-0ec1b404497b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_5dbcd876-0615-4053-93fa-67dec93ae070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_63baaa54-a05b-4ff7-89ea-6119c0ecec36" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_5dbcd876-0615-4053-93fa-67dec93ae070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_accef449-6a70-41fb-b304-bce6328ba2da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_63baaa54-a05b-4ff7-89ea-6119c0ecec36" xlink:to="loc_us-gaap_PreferredStockSharesIssued_accef449-6a70-41fb-b304-bce6328ba2da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_5594afa7-6b17-48d9-adbc-6d85379ec39f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_63baaa54-a05b-4ff7-89ea-6119c0ecec36" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_5594afa7-6b17-48d9-adbc-6d85379ec39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_40d13f51-c6c2-4b07-8316-ed684594c64c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_63baaa54-a05b-4ff7-89ea-6119c0ecec36" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_40d13f51-c6c2-4b07-8316-ed684594c64c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_e88d1b6f-c628-4bfb-97a9-7f7fbbd3db12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_63baaa54-a05b-4ff7-89ea-6119c0ecec36" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_e88d1b6f-c628-4bfb-97a9-7f7fbbd3db12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ae196b70-72f5-4fb4-a2b2-0def6214ac9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_63baaa54-a05b-4ff7-89ea-6119c0ecec36" xlink:to="loc_us-gaap_CommonStockSharesIssued_ae196b70-72f5-4fb4-a2b2-0def6214ac9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d0678e02-249f-4b32-affa-8bc8b4c6221d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_63baaa54-a05b-4ff7-89ea-6119c0ecec36" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d0678e02-249f-4b32-affa-8bc8b4c6221d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_9a5871c5-e39c-4847-bdfa-4dc7c8168738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_63baaa54-a05b-4ff7-89ea-6119c0ecec36" xlink:to="loc_us-gaap_TreasuryStockShares_9a5871c5-e39c-4847-bdfa-4dc7c8168738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cvs-20230525.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_b867f377-125d-4b9b-835a-83d63a4db3f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_88b76558-48b2-405d-b1ea-7a755a45137f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b867f377-125d-4b9b-835a-83d63a4db3f4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_88b76558-48b2-405d-b1ea-7a755a45137f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers_78de0254-35b5-4df5-a957-5d875bb2d750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_88b76558-48b2-405d-b1ea-7a755a45137f" xlink:to="loc_us-gaap_ProceedsFromCustomers_78de0254-35b5-4df5-a957-5d875bb2d750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies_0a9102e3-4989-444d-887b-96a41dfb2687" xlink:href="cvs-20230525.xsd#cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_88b76558-48b2-405d-b1ea-7a755a45137f" xlink:to="loc_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies_0a9102e3-4989-444d-887b-96a41dfb2687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForInsuranceBenefits_aee9444c-3a9f-45ee-b1f8-1720bda677f6" xlink:href="cvs-20230525.xsd#cvs_PaymentsForInsuranceBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_88b76558-48b2-405d-b1ea-7a755a45137f" xlink:to="loc_cvs_PaymentsForInsuranceBenefits_aee9444c-3a9f-45ee-b1f8-1720bda677f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees_44953992-8581-4955-8b4e-871e07ba6581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_88b76558-48b2-405d-b1ea-7a755a45137f" xlink:to="loc_us-gaap_PaymentsToSuppliersAndEmployees_44953992-8581-4955-8b4e-871e07ba6581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_9cda7bf9-5058-49da-af3f-5e997e169766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_88b76558-48b2-405d-b1ea-7a755a45137f" xlink:to="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_9cda7bf9-5058-49da-af3f-5e997e169766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_00345684-0b38-44e6-a40d-951b3eb1bf2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_88b76558-48b2-405d-b1ea-7a755a45137f" xlink:to="loc_us-gaap_InterestPaidNet_00345684-0b38-44e6-a40d-951b3eb1bf2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_b2f37422-0b52-415d-a0d4-72de7cf1755e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_88b76558-48b2-405d-b1ea-7a755a45137f" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_b2f37422-0b52-415d-a0d4-72de7cf1755e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4cae65f5-a50c-440c-b4e2-5247fd559f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_88b76558-48b2-405d-b1ea-7a755a45137f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4cae65f5-a50c-440c-b4e2-5247fd559f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5fbf4068-d3e4-4404-a964-e851793869d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b867f377-125d-4b9b-835a-83d63a4db3f4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5fbf4068-d3e4-4404-a964-e851793869d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_12a40191-1eba-4659-bb05-6e475b558d07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5fbf4068-d3e4-4404-a964-e851793869d9" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_12a40191-1eba-4659-bb05-6e475b558d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_2e624da1-129f-4e04-b396-758154547009" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5fbf4068-d3e4-4404-a964-e851793869d9" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_2e624da1-129f-4e04-b396-758154547009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_74639ffc-7609-4c10-9848-0c3784e85b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5fbf4068-d3e4-4404-a964-e851793869d9" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_74639ffc-7609-4c10-9848-0c3784e85b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_10eebb81-b20f-4aca-8841-7626ee2c9f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5fbf4068-d3e4-4404-a964-e851793869d9" xlink:to="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_10eebb81-b20f-4aca-8841-7626ee2c9f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ac3f22b5-d67c-43e3-b55e-10938c4e7253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5fbf4068-d3e4-4404-a964-e851793869d9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ac3f22b5-d67c-43e3-b55e-10938c4e7253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_358eb57c-d340-4729-a662-f7e6655dc6ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5fbf4068-d3e4-4404-a964-e851793869d9" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_358eb57c-d340-4729-a662-f7e6655dc6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ba7fff41-1215-43fc-9076-edc9256a640f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5fbf4068-d3e4-4404-a964-e851793869d9" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ba7fff41-1215-43fc-9076-edc9256a640f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_821de8cd-6daf-4371-bbb7-e20e1f2fa8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5fbf4068-d3e4-4404-a964-e851793869d9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_821de8cd-6daf-4371-bbb7-e20e1f2fa8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c436e6b-ee76-4e05-bf4a-ebdfc0a2ce73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b867f377-125d-4b9b-835a-83d63a4db3f4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c436e6b-ee76-4e05-bf4a-ebdfc0a2ce73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_5e4e9081-eaa4-4e56-aecc-9fc3b931c1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c436e6b-ee76-4e05-bf4a-ebdfc0a2ce73" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_5e4e9081-eaa4-4e56-aecc-9fc3b931c1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_642557e8-8e9c-40a4-9933-b57106625ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c436e6b-ee76-4e05-bf4a-ebdfc0a2ce73" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_642557e8-8e9c-40a4-9933-b57106625ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_4a903317-fb55-406b-a257-c168e18d1f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c436e6b-ee76-4e05-bf4a-ebdfc0a2ce73" xlink:to="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_4a903317-fb55-406b-a257-c168e18d1f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_46b2096c-e711-4ea4-91e2-f5982396fd8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c436e6b-ee76-4e05-bf4a-ebdfc0a2ce73" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_46b2096c-e711-4ea4-91e2-f5982396fd8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_d7cdfa5a-ec87-43bb-b106-9759a960b97e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c436e6b-ee76-4e05-bf4a-ebdfc0a2ce73" xlink:to="loc_us-gaap_PaymentsOfDividends_d7cdfa5a-ec87-43bb-b106-9759a960b97e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_92d48b6a-cac2-437c-8371-cd4814bb11c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c436e6b-ee76-4e05-bf4a-ebdfc0a2ce73" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_92d48b6a-cac2-437c-8371-cd4814bb11c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_63efc27f-58f0-430e-b8cd-38bc95d66005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c436e6b-ee76-4e05-bf4a-ebdfc0a2ce73" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_63efc27f-58f0-430e-b8cd-38bc95d66005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_1b88c59d-7e1a-408a-9259-5f8b29650f58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c436e6b-ee76-4e05-bf4a-ebdfc0a2ce73" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_1b88c59d-7e1a-408a-9259-5f8b29650f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_88458259-ba1d-4f85-a3de-1d070c54111c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9c436e6b-ee76-4e05-bf4a-ebdfc0a2ce73" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_88458259-ba1d-4f85-a3de-1d070c54111c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_29846b64-1a0d-4bc2-9726-7997af36075d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b867f377-125d-4b9b-835a-83d63a4db3f4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_29846b64-1a0d-4bc2-9726-7997af36075d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d2efadf4-4eaa-4964-8a52-6386d242e83a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b867f377-125d-4b9b-835a-83d63a4db3f4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d2efadf4-4eaa-4964-8a52-6386d242e83a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b7ac0e64-605e-45ff-aeee-094cd0a3fa40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b867f377-125d-4b9b-835a-83d63a4db3f4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b7ac0e64-605e-45ff-aeee-094cd0a3fa40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_edfc101e-e802-4168-bc21-062651252950" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b867f377-125d-4b9b-835a-83d63a4db3f4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_edfc101e-e802-4168-bc21-062651252950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7df60439-0bd6-4ff9-9e89-f4601c70598b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_edfc101e-e802-4168-bc21-062651252950" xlink:to="loc_us-gaap_ProfitLoss_7df60439-0bd6-4ff9-9e89-f4601c70598b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee5fa7e2-b341-4cbe-a4c2-9b7f2f8a49f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_edfc101e-e802-4168-bc21-062651252950" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee5fa7e2-b341-4cbe-a4c2-9b7f2f8a49f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_e26932a9-5143-458b-a3e4-56477f5c4f73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee5fa7e2-b341-4cbe-a4c2-9b7f2f8a49f1" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_e26932a9-5143-458b-a3e4-56477f5c4f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_a5c6a86e-c3f5-4d85-922c-63146a3bbcb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee5fa7e2-b341-4cbe-a4c2-9b7f2f8a49f1" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_a5c6a86e-c3f5-4d85-922c-63146a3bbcb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges_5590fc67-8688-49da-9922-ae87b04dc06e" xlink:href="cvs-20230525.xsd#cvs_StoreImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee5fa7e2-b341-4cbe-a4c2-9b7f2f8a49f1" xlink:to="loc_cvs_StoreImpairmentCharges_5590fc67-8688-49da-9922-ae87b04dc06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_14bb40c8-7790-4154-ba31-ffc852e9ff96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee5fa7e2-b341-4cbe-a4c2-9b7f2f8a49f1" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_14bb40c8-7790-4154-ba31-ffc852e9ff96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_97de0fa8-9888-4f14-a33a-adeeeda2f6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee5fa7e2-b341-4cbe-a4c2-9b7f2f8a49f1" xlink:to="loc_us-gaap_ShareBasedCompensation_97de0fa8-9888-4f14-a33a-adeeeda2f6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_2c65f51c-97c6-4905-89ab-228b62ae3606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee5fa7e2-b341-4cbe-a4c2-9b7f2f8a49f1" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_2c65f51c-97c6-4905-89ab-228b62ae3606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5ef62d06-d2d3-4fb8-8e2a-ade25ba9cd44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee5fa7e2-b341-4cbe-a4c2-9b7f2f8a49f1" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5ef62d06-d2d3-4fb8-8e2a-ade25ba9cd44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_cb127888-bdf7-4819-8acc-3127ecc66100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee5fa7e2-b341-4cbe-a4c2-9b7f2f8a49f1" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_cb127888-bdf7-4819-8acc-3127ecc66100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_30b0d97e-bd6e-4a0f-8cc8-df34005445fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee5fa7e2-b341-4cbe-a4c2-9b7f2f8a49f1" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_30b0d97e-bd6e-4a0f-8cc8-df34005445fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract_34ef00c2-fdd4-429e-8336-ed721dccd524" xlink:href="cvs-20230525.xsd#cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_edfc101e-e802-4168-bc21-062651252950" xlink:to="loc_cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract_34ef00c2-fdd4-429e-8336-ed721dccd524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a02fc05d-7953-4925-982a-6d9ce3d7a8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract_34ef00c2-fdd4-429e-8336-ed721dccd524" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a02fc05d-7953-4925-982a-6d9ce3d7a8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_0f17dd6c-4b50-4603-9e87-3dc815164e17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract_34ef00c2-fdd4-429e-8336-ed721dccd524" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_0f17dd6c-4b50-4603-9e87-3dc815164e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_96546c30-14d1-441f-917f-ef7d717fb5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract_34ef00c2-fdd4-429e-8336-ed721dccd524" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_96546c30-14d1-441f-917f-ef7d717fb5c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_7f576e15-8037-45cf-8d8f-c829bcde8d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract_34ef00c2-fdd4-429e-8336-ed721dccd524" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_7f576e15-8037-45cf-8d8f-c829bcde8d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_56f21a63-6918-4627-8b50-a25ddf8bb00c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract_34ef00c2-fdd4-429e-8336-ed721dccd524" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_56f21a63-6918-4627-8b50-a25ddf8bb00c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_0dd7b2e7-fa0d-40bd-8eea-491516d83afc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract_34ef00c2-fdd4-429e-8336-ed721dccd524" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_0dd7b2e7-fa0d-40bd-8eea-491516d83afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_285dbe86-8a8e-4458-91aa-90a7ad32cb2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract_34ef00c2-fdd4-429e-8336-ed721dccd524" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_285dbe86-8a8e-4458-91aa-90a7ad32cb2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1" xlink:type="simple" xlink:href="cvs-20230525.xsd#ConsolidatedStatementsofCashFlows_1"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="cvs-20230525.xsd#ConsolidatedStatementsofShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_22003717-b71a-4656-954e-e1d689504ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7f0fcce8-5d16-43e2-a99c-33403e7e386f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_22003717-b71a-4656-954e-e1d689504ea7" xlink:to="loc_us-gaap_StatementTable_7f0fcce8-5d16-43e2-a99c-33403e7e386f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9388894e-fb32-46b7-ac07-3990d8deb61e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7f0fcce8-5d16-43e2-a99c-33403e7e386f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9388894e-fb32-46b7-ac07-3990d8deb61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6af026f1-ea5f-4615-a0e1-46dd35f5d707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9388894e-fb32-46b7-ac07-3990d8deb61e" xlink:to="loc_us-gaap_EquityComponentDomain_6af026f1-ea5f-4615-a0e1-46dd35f5d707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_afe6ad0a-b8cf-407a-aff2-f2d084200570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6af026f1-ea5f-4615-a0e1-46dd35f5d707" xlink:to="loc_us-gaap_ParentMember_afe6ad0a-b8cf-407a-aff2-f2d084200570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4129b0aa-5c85-4370-94d8-3b0b5c751bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_afe6ad0a-b8cf-407a-aff2-f2d084200570" xlink:to="loc_us-gaap_CommonStockMember_4129b0aa-5c85-4370-94d8-3b0b5c751bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_ad908af1-c51e-41e4-b809-9af59cc9609a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_afe6ad0a-b8cf-407a-aff2-f2d084200570" xlink:to="loc_us-gaap_TreasuryStockCommonMember_ad908af1-c51e-41e4-b809-9af59cc9609a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_2ec5c89d-cf81-4c17-bc90-26bf25c29195" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_afe6ad0a-b8cf-407a-aff2-f2d084200570" xlink:to="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_2ec5c89d-cf81-4c17-bc90-26bf25c29195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_15c8cf1f-e67e-40c9-8489-803cd43db86d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_afe6ad0a-b8cf-407a-aff2-f2d084200570" xlink:to="loc_us-gaap_RetainedEarningsMember_15c8cf1f-e67e-40c9-8489-803cd43db86d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5612610a-e3da-4fb8-b7d0-8b37fc6f2a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_afe6ad0a-b8cf-407a-aff2-f2d084200570" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5612610a-e3da-4fb8-b7d0-8b37fc6f2a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_31f69299-ad74-439d-87c8-0d23a5003bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6af026f1-ea5f-4615-a0e1-46dd35f5d707" xlink:to="loc_us-gaap_NoncontrollingInterestMember_31f69299-ad74-439d-87c8-0d23a5003bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0ad170de-3fbe-4397-8ae7-a2f207b65f2b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7f0fcce8-5d16-43e2-a99c-33403e7e386f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0ad170de-3fbe-4397-8ae7-a2f207b65f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ad126088-9985-4120-9e18-fd47cc3c3206" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0ad170de-3fbe-4397-8ae7-a2f207b65f2b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ad126088-9985-4120-9e18-fd47cc3c3206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_0b315c43-9447-4293-9bb1-e299441e0caf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ad126088-9985-4120-9e18-fd47cc3c3206" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_0b315c43-9447-4293-9bb1-e299441e0caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c0ce9fdf-98cc-407d-a45b-1d717fc16111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7f0fcce8-5d16-43e2-a99c-33403e7e386f" xlink:to="loc_us-gaap_StatementLineItems_c0ce9fdf-98cc-407d-a45b-1d717fc16111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c0ce9fdf-98cc-407d-a45b-1d717fc16111" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_5224ddf6-4b9b-4059-a389-4a8394f33222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_us-gaap_SharesOutstanding_5224ddf6-4b9b-4059-a389-4a8394f33222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_3b5401ac-ebbc-4f4e-9fd4-076ebd0e6d04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_us-gaap_TreasuryStockCommonShares_3b5401ac-ebbc-4f4e-9fd4-076ebd0e6d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_adc99c47-be88-4d5a-b118-95ebdab43366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_adc99c47-be88-4d5a-b118-95ebdab43366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_00dc9d15-7928-4abd-8201-1ab73ac200f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_us-gaap_ProfitLoss_00dc9d15-7928-4abd-8201-1ab73ac200f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ac71ea40-f23e-4fb4-b393-862b72791284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ac71ea40-f23e-4fb4-b393-862b72791284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a1ef2e2d-24cf-4cae-b8b9-1b7b569ffc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a1ef2e2d-24cf-4cae-b8b9-1b7b569ffc5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_4931c87f-b2af-4e6f-86f3-07aa269e9587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_4931c87f-b2af-4e6f-86f3-07aa269e9587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_fd9bcf77-7e12-4c21-9ac5-73b90052e9a5" xlink:href="cvs-20230525.xsd#cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_fd9bcf77-7e12-4c21-9ac5-73b90052e9a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_b66d23a4-df18-4035-99c9-e595eafec390" xlink:href="cvs-20230525.xsd#cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_b66d23a4-df18-4035-99c9-e595eafec390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_9c613355-6426-40d2-8750-5d3427e2ca70" xlink:href="cvs-20230525.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_9c613355-6426-40d2-8750-5d3427e2ca70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_99560956-5321-462d-ab42-f47f6660c39f" xlink:href="cvs-20230525.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_99560956-5321-462d-ab42-f47f6660c39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_f8d333bc-caf9-4428-b1ad-f1e1676891af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_us-gaap_DividendsCommonStock_f8d333bc-caf9-4428-b1ad-f1e1676891af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease_dc009f32-9a4b-45c7-b3c3-9ed09ced77ce" xlink:href="cvs-20230525.xsd#cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease_dc009f32-9a4b-45c7-b3c3-9ed09ced77ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_2dc3584f-5724-400c-a261-612f3316a7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_us-gaap_SharesOutstanding_2dc3584f-5724-400c-a261-612f3316a7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_085bd1af-1943-4bd5-8fb2-826c4ad041a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_us-gaap_TreasuryStockCommonShares_085bd1af-1943-4bd5-8fb2-826c4ad041a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3833a210-946e-4fc5-b284-574bcc6dd799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_15c7607e-8171-47f3-8517-4d5fe5c04b1e" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3833a210-946e-4fc5-b284-574bcc6dd799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="simple" xlink:href="cvs-20230525.xsd#ConsolidatedStatementsofShareholdersEquityParentheticals"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_1bd5ae87-1967-44cf-95c7-9a30f5e636be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_03f50f70-d24f-4a41-92fa-9a1efdd2d77d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_1bd5ae87-1967-44cf-95c7-9a30f5e636be" xlink:to="loc_us-gaap_StatementTable_03f50f70-d24f-4a41-92fa-9a1efdd2d77d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f41059d8-a413-494d-9c29-8d073ec6631d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_03f50f70-d24f-4a41-92fa-9a1efdd2d77d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f41059d8-a413-494d-9c29-8d073ec6631d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d6eaa515-39ff-4d06-a9de-d7fe1f296d0d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f41059d8-a413-494d-9c29-8d073ec6631d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d6eaa515-39ff-4d06-a9de-d7fe1f296d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_57c74817-4641-4fbf-a5d5-ffc8d1a327ba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d6eaa515-39ff-4d06-a9de-d7fe1f296d0d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_57c74817-4641-4fbf-a5d5-ffc8d1a327ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c3117a44-1609-4f92-81a2-82d3ab0773dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_03f50f70-d24f-4a41-92fa-9a1efdd2d77d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c3117a44-1609-4f92-81a2-82d3ab0773dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8c5cb3dd-8942-4f53-abf9-1d202a683cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c3117a44-1609-4f92-81a2-82d3ab0773dc" xlink:to="loc_us-gaap_EquityComponentDomain_8c5cb3dd-8942-4f53-abf9-1d202a683cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6e079a5b-1b25-4061-8690-ecae41a8882d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8c5cb3dd-8942-4f53-abf9-1d202a683cf7" xlink:to="loc_us-gaap_RetainedEarningsMember_6e079a5b-1b25-4061-8690-ecae41a8882d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_3ed0ae4b-a8a2-449c-9fec-34f2934f34f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_03f50f70-d24f-4a41-92fa-9a1efdd2d77d" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_3ed0ae4b-a8a2-449c-9fec-34f2934f34f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_6cb26cc3-c580-4232-8d15-5d29c97726f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_3ed0ae4b-a8a2-449c-9fec-34f2934f34f8" xlink:to="loc_us-gaap_TypeOfAdoptionMember_6cb26cc3-c580-4232-8d15-5d29c97726f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_db6d36f5-a3c3-4297-be36-6c977107b07d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_6cb26cc3-c580-4232-8d15-5d29c97726f7" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_db6d36f5-a3c3-4297-be36-6c977107b07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_023a743c-1bb3-42ca-919c-0b69ee280f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_03f50f70-d24f-4a41-92fa-9a1efdd2d77d" xlink:to="loc_us-gaap_StatementLineItems_023a743c-1bb3-42ca-919c-0b69ee280f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust_b51d0dd0-4f72-4353-bc3a-6601a42a5cbb" xlink:href="cvs-20230525.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_023a743c-1bb3-42ca-919c-0b69ee280f6f" xlink:to="loc_cvs_TreasuryStockSharesHeldinTrust_b51d0dd0-4f72-4353-bc3a-6601a42a5cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueSharesHeldInTrust_ce54cf8d-7fec-4b9f-81da-2cef5210fb73" xlink:href="cvs-20230525.xsd#cvs_TreasuryStockValueSharesHeldInTrust"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_023a743c-1bb3-42ca-919c-0b69ee280f6f" xlink:to="loc_cvs_TreasuryStockValueSharesHeldInTrust_ce54cf8d-7fec-4b9f-81da-2cef5210fb73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_0f3f0d42-514d-468b-b2a2-7872b12cbca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_023a743c-1bb3-42ca-919c-0b69ee280f6f" xlink:to="loc_us-gaap_CommonStockValue_0f3f0d42-514d-468b-b2a2-7872b12cbca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_28de27d7-9d14-4a82-85b3-81ddaa25619b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_023a743c-1bb3-42ca-919c-0b69ee280f6f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_28de27d7-9d14-4a82-85b3-81ddaa25619b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_c5a8e14a-a457-46b7-967f-b3e78be7faa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_023a743c-1bb3-42ca-919c-0b69ee280f6f" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_c5a8e14a-a457-46b7-967f-b3e78be7faa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlowsParenthetical" xlink:type="simple" xlink:href="cvs-20230525.xsd#ConsolidatedStatementsofCashFlowsParenthetical"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlowsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_a14f7958-2e0a-44d8-a4a6-733f800afdde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDivestedFromDeconsolidation_19591d47-5a8f-4fbf-bfc8-744d12227893" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashDivestedFromDeconsolidation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a14f7958-2e0a-44d8-a4a6-733f800afdde" xlink:to="loc_us-gaap_CashDivestedFromDeconsolidation_19591d47-5a8f-4fbf-bfc8-744d12227893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="cvs-20230525.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9fa3cc04-fc78-41f2-acbc-d93d2e033159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_ce218676-6b98-4bc8-9d87-ea41af10e6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9fa3cc04-fc78-41f2-acbc-d93d2e033159" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_ce218676-6b98-4bc8-9d87-ea41af10e6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSales" xlink:type="simple" xlink:href="cvs-20230525.xsd#AcquisitionsDivestituresandAssetSales"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSales" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b75c1e94-457b-4589-9b65-81333d11827d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_c24b9956-5cbe-4b70-a321-5c7eee714006" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b75c1e94-457b-4589-9b65-81333d11827d" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_c24b9956-5cbe-4b70-a321-5c7eee714006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Investments" xlink:type="simple" xlink:href="cvs-20230525.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_d9b04409-50f2-4e3d-be01-663fc6a23f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_7dff4960-0005-4742-a6fe-dfd5651bedb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_d9b04409-50f2-4e3d-be01-663fc6a23f4c" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_7dff4960-0005-4742-a6fe-dfd5651bedb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValue" xlink:type="simple" xlink:href="cvs-20230525.xsd#FairValue"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d28ba7f9-a815-4996-a582-7c22e8245e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_4288b4e1-ced7-47fa-b8ab-5a19ce232ead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d28ba7f9-a815-4996-a582-7c22e8245e9a" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_4288b4e1-ced7-47fa-b8ab-5a19ce232ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangibles" xlink:type="simple" xlink:href="cvs-20230525.xsd#GoodwillandOtherIntangibles"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangibles" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6d150db7-3bcf-428d-a0d0-a9cd686c8928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e4e45f14-b480-4e16-8756-d8dbe7f52c62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6d150db7-3bcf-428d-a0d0-a9cd686c8928" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e4e45f14-b480-4e16-8756-d8dbe7f52c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Leases" xlink:type="simple" xlink:href="cvs-20230525.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ebc113f0-a0a7-484a-aa64-48cc0d492aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_a5803c42-2924-40ee-888e-93a69b750c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ebc113f0-a0a7-484a-aa64-48cc0d492aa3" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_a5803c42-2924-40ee-888e-93a69b750c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_c63dd67b-d35b-4d92-aee3-9b3c2c25e3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ebc113f0-a0a7-484a-aa64-48cc0d492aa3" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_c63dd67b-d35b-4d92-aee3-9b3c2c25e3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="simple" xlink:href="cvs-20230525.xsd#HealthCareCostsPayable"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract_93f1b7e7-3bb4-4d07-ad3d-f57cb7e3e716" xlink:href="cvs-20230525.xsd#cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_68ea9bd3-4fc6-43ee-8fa3-96998963bd10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract_93f1b7e7-3bb4-4d07-ad3d-f57cb7e3e716" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_68ea9bd3-4fc6-43ee-8fa3-96998963bd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccounts" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherInsuranceLiabilitiesandSeparateAccounts"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccounts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_266a51f0-71e5-4801-aa7f-60fea6d344f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceContractAcquisitionCostTextBlock_78c8faea-6281-462b-973f-931c1e595eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceContractAcquisitionCostTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_266a51f0-71e5-4801-aa7f-60fea6d344f0" xlink:to="loc_us-gaap_InsuranceContractAcquisitionCostTextBlock_78c8faea-6281-462b-973f-931c1e595eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditAgreements" xlink:type="simple" xlink:href="cvs-20230525.xsd#BorrowingsandCreditAgreements"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_35cff589-2ce1-4621-85c3-4d120890f4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_8539cd5a-a3c6-44fd-b996-9795fb73b861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_35cff589-2ce1-4621-85c3-4d120890f4e9" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_8539cd5a-a3c6-44fd-b996-9795fb73b861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits" xlink:type="simple" xlink:href="cvs-20230525.xsd#PensionPlansandOtherPostretirementBenefits"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8142413d-b9e0-4147-9350-6ab0b6b1dff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_ff561d00-6579-42a6-9328-a6acf717e127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8142413d-b9e0-4147-9350-6ab0b6b1dff1" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_ff561d00-6579-42a6-9328-a6acf717e127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxes" xlink:type="simple" xlink:href="cvs-20230525.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1b1c20b9-60b4-49fe-8925-a8f6b9805705" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_f55fa4f1-734c-49de-8645-71bad8b8c5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b1c20b9-60b4-49fe-8925-a8f6b9805705" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_f55fa4f1-734c-49de-8645-71bad8b8c5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlans" xlink:type="simple" xlink:href="cvs-20230525.xsd#StockIncentivePlans"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3969bf80-d33c-4f5c-9c97-069177349d49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_f2214ed5-a7cb-49f6-9aaa-2065b288213c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3969bf80-d33c-4f5c-9c97-069177349d49" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_f2214ed5-a7cb-49f6-9aaa-2065b288213c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="cvs-20230525.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f83c0ada-22ed-4452-8cf4-a8e0c107b24b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1253b656-b8e4-4619-bf46-581a76278445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f83c0ada-22ed-4452-8cf4-a8e0c107b24b" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1253b656-b8e4-4619-bf46-581a76278445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b86a1adc-8983-4edb-943e-682e16025838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_49a0b395-dbee-4145-9ba9-13e7b83ad9a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b86a1adc-8983-4edb-943e-682e16025838" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_49a0b395-dbee-4145-9ba9-13e7b83ad9a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShare" xlink:type="simple" xlink:href="cvs-20230525.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_10f9329f-406c-429f-afcd-b36a972e7d13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_da138e08-ec29-404d-a46d-3759d45f796d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_10f9329f-406c-429f-afcd-b36a972e7d13" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_da138e08-ec29-404d-a46d-3759d45f796d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Reinsurance" xlink:type="simple" xlink:href="cvs-20230525.xsd#Reinsurance"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/Reinsurance" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_e6b25b78-460c-466c-8006-17f67e620635" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceTextBlock_35ec05a1-7af6-4133-ae76-1bd53dbd3af2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_e6b25b78-460c-466c-8006-17f67e620635" xlink:to="loc_us-gaap_ReinsuranceTextBlock_35ec05a1-7af6-4133-ae76-1bd53dbd3af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="cvs-20230525.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7ef539d1-5b6f-4fa8-a8c1-575e32f42c15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e2c40e32-8171-4a0d-9b99-e24bb570e21b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7ef539d1-5b6f-4fa8-a8c1-575e32f42c15" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e2c40e32-8171-4a0d-9b99-e24bb570e21b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReporting" xlink:type="simple" xlink:href="cvs-20230525.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_8a12159e-b31d-436d-8900-296dc2b4c12b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_feededcd-00b4-4a01-915a-1f0d12150b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8a12159e-b31d-436d-8900-296dc2b4c12b" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_feededcd-00b4-4a01-915a-1f0d12150b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cvs-20230525.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_99c83cbb-1ef7-49d9-8cfb-3068cdb60678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_99c83cbb-1ef7-49d9-8cfb-3068cdb60678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_96adc52a-758d-4b3b-b5c4-2dd2af28880c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_96adc52a-758d-4b3b-b5c4-2dd2af28880c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_494ca481-1a7c-43aa-aa22-207411450d65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_UseOfEstimates_494ca481-1a7c-43aa-aa22-207411450d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_fde96b6c-83ec-4f44-bc46-2e55999b6c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_fde96b6c-83ec-4f44-bc46-2e55999b6c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_d8620be1-3675-40fe-a298-eec777a07cce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_d8620be1-3675-40fe-a298-eec777a07cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_cb55ed0f-34b6-4978-8a11-6dedeaa6afe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_cb55ed0f-34b6-4978-8a11-6dedeaa6afe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_f7e64d08-51f4-47d4-874c-700f4b0cc656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_f7e64d08-51f4-47d4-874c-700f4b0cc656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_3bc52c30-8875-4654-b605-a15b88656083" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_3bc52c30-8875-4654-b605-a15b88656083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceAccountingPolicy_020a88ca-c84e-479e-941e-c869851a9a19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceAccountingPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_ReinsuranceAccountingPolicy_020a88ca-c84e-479e-941e-c869851a9a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_90a26d66-407b-4230-bae2-0047e19452fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_90a26d66-407b-4230-bae2-0047e19452fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_11c6f760-02d0-443e-b3f2-e981b0143f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_11c6f760-02d0-443e-b3f2-e981b0143f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_151ba32f-9236-4085-b069-075c9fb815d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_151ba32f-9236-4085-b069-075c9fb815d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_7e8ba0b0-8505-4883-9539-8924601cfe7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_7e8ba0b0-8505-4883-9539-8924601cfe7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_81fdeaeb-fd36-452a-bebc-a9cb6291ae50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_81fdeaeb-fd36-452a-bebc-a9cb6291ae50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_54ceba4c-0355-489a-9dcd-4068037b8f27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_54ceba4c-0355-489a-9dcd-4068037b8f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountsPolicy_b8496fa1-4a12-46ab-920b-17de3f0f0f73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountsPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_PolicyholderAccountsPolicy_b8496fa1-4a12-46ab-920b-17de3f0f0f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareCostsPolicyPolicyTextBlock_043521a7-b960-4e92-889e-44a21eecaf17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareCostsPolicyPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_HealthCareCostsPolicyPolicyTextBlock_043521a7-b960-4e92-889e-44a21eecaf17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_a027fd41-d9e5-4706-87ac-bf1f3a1ab37d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_a027fd41-d9e5-4706-87ac-bf1f3a1ab37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock_c7819cea-d206-4dab-88c3-54a6b01b36f5" xlink:href="cvs-20230525.xsd#cvs_InsurancePremiumDeficiencyReservePolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock_c7819cea-d206-4dab-88c3-54a6b01b36f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocationsToPolicyholdersPolicies_dccf0966-4c72-439d-9d63-a62370f6fc20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocationsToPolicyholdersPolicies"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_AllocationsToPolicyholdersPolicies_dccf0966-4c72-439d-9d63-a62370f6fc20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReservePolicyTextBlock_b2fdef57-2622-4f6f-a98b-27f304efbebe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfInsuranceReservePolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_SelfInsuranceReservePolicyTextBlock_b2fdef57-2622-4f6f-a98b-27f304efbebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_0796aaa9-bb2a-4c33-9bcb-00a3437cc700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_0796aaa9-bb2a-4c33-9bcb-00a3437cc700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_6cce1e07-c469-4153-a91b-2f18e2371d13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_6cce1e07-c469-4153-a91b-2f18e2371d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_13886f0c-3201-484e-a335-2811e956e534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_13886f0c-3201-484e-a335-2811e956e534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock_226da222-5adc-404d-8c65-7b6635e837bb" xlink:href="cvs-20230525.xsd#cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock_226da222-5adc-404d-8c65-7b6635e837bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_0a5d5c41-d75f-42f1-adda-e6780de18c01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareEntitiesPolicyPolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_0a5d5c41-d75f-42f1-adda-e6780de18c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_7d4ecd76-2f86-4702-a452-a4494112bf52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_7d4ecd76-2f86-4702-a452-a4494112bf52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_837c0691-6893-4ae4-b6f2-712b86c0cde9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_837c0691-6893-4ae4-b6f2-712b86c0cde9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_5cae219d-c85d-4823-975f-b18a7ca755df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_5cae219d-c85d-4823-975f-b18a7ca755df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_5cac3d53-6e98-4ed4-9caf-c4eb7e1ceb03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_5cac3d53-6e98-4ed4-9caf-c4eb7e1ceb03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_230e3ea3-04c0-4d97-aab3-72df63e85c37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_230e3ea3-04c0-4d97-aab3-72df63e85c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SharesHeldInTrustPolicyTextBlock_497dcee5-40ad-4263-8443-c7bd7cda29d7" xlink:href="cvs-20230525.xsd#cvs_SharesHeldInTrustPolicyTextBlock"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_cvs_SharesHeldInTrustPolicyTextBlock_497dcee5-40ad-4263-8443-c7bd7cda29d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_5f2204f4-860b-4bc3-ae35-a9f99254f6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_5f2204f4-860b-4bc3-ae35-a9f99254f6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_a1717802-3dde-48d6-a096-15f2223e387c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_a1717802-3dde-48d6-a096-15f2223e387c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock_b7a2f585-7b7a-4bc8-9735-422d645bc15c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsPolicyTextBlock"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_74a86b1f-bc3d-481c-8d78-5ba75fbb6331" xlink:to="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock_b7a2f585-7b7a-4bc8-9735-422d645bc15c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cvs-20230525.xsd#SignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5895a5cc-69da-470b-8824-558cf7e9429a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_1bfcf0b9-07a4-4dca-a2c2-1e522e639d75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5895a5cc-69da-470b-8824-558cf7e9429a" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_1bfcf0b9-07a4-4dca-a2c2-1e522e639d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_b3112b25-a463-46d8-a603-7304446026b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5895a5cc-69da-470b-8824-558cf7e9429a" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_b3112b25-a463-46d8-a603-7304446026b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock_07556497-ff16-4aad-a37c-4217867b5317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5895a5cc-69da-470b-8824-558cf7e9429a" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock_07556497-ff16-4aad-a37c-4217867b5317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_f8d91f57-5458-489d-bafe-233d25b207a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5895a5cc-69da-470b-8824-558cf7e9429a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_f8d91f57-5458-489d-bafe-233d25b207a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_280ca4c5-5f80-49c6-aee5-1ffe81d33e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5895a5cc-69da-470b-8824-558cf7e9429a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_280ca4c5-5f80-49c6-aee5-1ffe81d33e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_61ba85eb-b5fa-4640-ae88-21a46637fed8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5895a5cc-69da-470b-8824-558cf7e9429a" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_61ba85eb-b5fa-4640-ae88-21a46637fed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_3081b307-efd3-4df2-b67d-e9af9d79f9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5895a5cc-69da-470b-8824-558cf7e9429a" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_3081b307-efd3-4df2-b67d-e9af9d79f9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_3f86051e-180d-4103-a9f9-cf2d0c9ebe9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5895a5cc-69da-470b-8824-558cf7e9429a" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_3f86051e-180d-4103-a9f9-cf2d0c9ebe9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesTables" xlink:type="simple" xlink:href="cvs-20230525.xsd#AcquisitionsDivestituresandAssetSalesTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_66d111c0-eaad-42a5-96ed-53e09e24a7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock_112d1edf-6437-4105-b4e1-fdb1ca4e69b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_66d111c0-eaad-42a5-96ed-53e09e24a7ee" xlink:to="loc_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock_112d1edf-6437-4105-b4e1-fdb1ca4e69b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_b548a86e-9f49-43c1-ad84-7567413f718b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTableTextBlock_52a9a608-dae3-4890-ab6b-b07e917a8a83" xlink:href="cvs-20230525.xsd#cvs_TotalInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_b548a86e-9f49-43c1-ad84-7567413f718b" xlink:to="loc_cvs_TotalInvestmentsTableTextBlock_52a9a608-dae3-4890-ab6b-b07e917a8a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_869cb62b-1ffd-42b5-bdd1-3f90fba164ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_b548a86e-9f49-43c1-ad84-7567413f718b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_869cb62b-1ffd-42b5-bdd1-3f90fba164ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_869635cb-2a16-46d8-b599-41a960e70826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_b548a86e-9f49-43c1-ad84-7567413f718b" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_869635cb-2a16-46d8-b599-41a960e70826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_e8525622-08d1-4ced-83a7-e3f5f21f527b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_b548a86e-9f49-43c1-ad84-7567413f718b" xlink:to="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_e8525622-08d1-4ced-83a7-e3f5f21f527b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_97efb920-92d1-4bfe-a589-fc82a52d96b2" xlink:href="cvs-20230525.xsd#cvs_ActivityInMortgageLoanPortfolioTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_b548a86e-9f49-43c1-ad84-7567413f718b" xlink:to="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_97efb920-92d1-4bfe-a589-fc82a52d96b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_deb509fe-8829-445a-9fb0-5d64bffe9597" xlink:href="cvs-20230525.xsd#cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_b548a86e-9f49-43c1-ad84-7567413f718b" xlink:to="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_deb509fe-8829-445a-9fb0-5d64bffe9597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeTextBlock_94326c1b-3376-45d6-aef1-f8540609c53f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_b548a86e-9f49-43c1-ad84-7567413f718b" xlink:to="loc_us-gaap_InvestmentIncomeTextBlock_94326c1b-3376-45d6-aef1-f8540609c53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_07808f7a-5ac4-481b-8ef7-187206888507" xlink:href="cvs-20230525.xsd#cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_b548a86e-9f49-43c1-ad84-7567413f718b" xlink:to="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_07808f7a-5ac4-481b-8ef7-187206888507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueTables" xlink:type="simple" xlink:href="cvs-20230525.xsd#FairValueTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6a1e3c0a-6cd1-4e3a-9ec3-9c5b417b8852" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_1e5efccd-7197-4f71-81b9-3eff4ab30f04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6a1e3c0a-6cd1-4e3a-9ec3-9c5b417b8852" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_1e5efccd-7197-4f71-81b9-3eff4ab30f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_54355b54-c8b0-456e-9c60-d0b4fe087d86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6a1e3c0a-6cd1-4e3a-9ec3-9c5b417b8852" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_54355b54-c8b0-456e-9c60-d0b4fe087d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_a80fd107-5996-471b-8091-94117315177e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6a1e3c0a-6cd1-4e3a-9ec3-9c5b417b8852" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_a80fd107-5996-471b-8091-94117315177e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_6b584c6e-7e36-4ce9-9f0d-3d809de1134b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6a1e3c0a-6cd1-4e3a-9ec3-9c5b417b8852" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_6b584c6e-7e36-4ce9-9f0d-3d809de1134b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables" xlink:type="simple" xlink:href="cvs-20230525.xsd#GoodwillandOtherIntangiblesTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_aa5b0c7a-309a-475f-8dc4-e21945681c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_4f0be1ea-2f62-40ae-9838-7fef26256875" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_aa5b0c7a-309a-475f-8dc4-e21945681c35" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_4f0be1ea-2f62-40ae-9838-7fef26256875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock_e032bd5d-6833-446e-be22-b2c2ea6f228d" xlink:href="cvs-20230525.xsd#cvs_FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_aa5b0c7a-309a-475f-8dc4-e21945681c35" xlink:to="loc_cvs_FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock_e032bd5d-6833-446e-be22-b2c2ea6f228d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_0f53e8f9-1d8a-4f02-862f-a01b5c9e76e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_aa5b0c7a-309a-475f-8dc4-e21945681c35" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_0f53e8f9-1d8a-4f02-862f-a01b5c9e76e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesTables" xlink:type="simple" xlink:href="cvs-20230525.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_17df7b0a-ecbc-4774-a535-1af1ef4c9ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_72a1ce76-b4ec-44f8-8d83-c8c274e114f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_17df7b0a-ecbc-4774-a535-1af1ef4c9ed1" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_72a1ce76-b4ec-44f8-8d83-c8c274e114f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLeaseTableTextBlock_ef294be8-7228-4da1-9a98-f2599428af87" xlink:href="cvs-20230525.xsd#cvs_LesseeLeaseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_17df7b0a-ecbc-4774-a535-1af1ef4c9ed1" xlink:to="loc_cvs_LesseeLeaseTableTextBlock_ef294be8-7228-4da1-9a98-f2599428af87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_27eb0280-9a37-4e13-b184-f0812a784bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_17df7b0a-ecbc-4774-a535-1af1ef4c9ed1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_27eb0280-9a37-4e13-b184-f0812a784bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_7cf61d1f-9f14-4594-9ddd-3f8bf00d4dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_17df7b0a-ecbc-4774-a535-1af1ef4c9ed1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_7cf61d1f-9f14-4594-9ddd-3f8bf00d4dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="simple" xlink:href="cvs-20230525.xsd#HealthCareCostsPayableTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract_b7b28aec-c092-4872-a230-c152b678c94f" xlink:href="cvs-20230525.xsd#cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_70eaecb9-6cf6-4d59-80f9-e2e11318051a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract_b7b28aec-c092-4872-a230-c152b678c94f" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_70eaecb9-6cf6-4d59-80f9-e2e11318051a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_b5870261-78a0-4342-94e3-ca1fcf6b6b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract_b7b28aec-c092-4872-a230-c152b678c94f" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_b5870261-78a0-4342-94e3-ca1fcf6b6b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsTables" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherInsuranceLiabilitiesandSeparateAccountsTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_c05802b1-bbab-4793-b4fa-768deb5870ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_1f92b3e6-c1d4-455a-9605-586cfd85881f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_c05802b1-bbab-4793-b4fa-768deb5870ff" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_1f92b3e6-c1d4-455a-9605-586cfd85881f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock_d9019d44-d5ed-4de5-8b3e-2f6996f83050" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_c05802b1-bbab-4793-b4fa-768deb5870ff" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock_d9019d44-d5ed-4de5-8b3e-2f6996f83050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceTableTextBlock_72550728-9cd3-4d51-a2e6-8196a6a06fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_c05802b1-bbab-4793-b4fa-768deb5870ff" xlink:to="loc_us-gaap_PolicyholderAccountBalanceTableTextBlock_72550728-9cd3-4d51-a2e6-8196a6a06fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_024fc19f-30ee-4264-af99-f5611551506f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_c05802b1-bbab-4793-b4fa-768deb5870ff" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_024fc19f-30ee-4264-af99-f5611551506f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityTableTextBlock_ecc6b219-99ef-47b3-ab92-d5a485f48b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_c05802b1-bbab-4793-b4fa-768deb5870ff" xlink:to="loc_us-gaap_SeparateAccountLiabilityTableTextBlock_ecc6b219-99ef-47b3-ab92-d5a485f48b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsTables" xlink:type="simple" xlink:href="cvs-20230525.xsd#BorrowingsandCreditAgreementsTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f244411b-7399-4b35-ac8d-0315b03a8b04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_5ccb427b-e1dd-431b-8f40-3604f280c5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f244411b-7399-4b35-ac8d-0315b03a8b04" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_5ccb427b-e1dd-431b-8f40-3604f280c5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_b11f116b-5cd2-46a3-945b-a6d3a1bbaa6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f244411b-7399-4b35-ac8d-0315b03a8b04" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_b11f116b-5cd2-46a3-945b-a6d3a1bbaa6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables" xlink:type="simple" xlink:href="cvs-20230525.xsd#PensionPlansandOtherPostretirementBenefitsTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9bd82587-a49a-4c4e-afef-e4c7d0e9ae65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_a1de007a-24bd-403e-871c-955a9821f9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9bd82587-a49a-4c4e-afef-e4c7d0e9ae65" xlink:to="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_a1de007a-24bd-403e-871c-955a9821f9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_af722c71-4d04-4a9f-ba91-60ca71c1be74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9bd82587-a49a-4c4e-afef-e4c7d0e9ae65" xlink:to="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_af722c71-4d04-4a9f-ba91-60ca71c1be74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_9cf098db-be8c-457b-a643-f11e6bc3b4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9bd82587-a49a-4c4e-afef-e4c7d0e9ae65" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_9cf098db-be8c-457b-a643-f11e6bc3b4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_82bf95e7-774a-44be-ae47-90005afb9ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9bd82587-a49a-4c4e-afef-e4c7d0e9ae65" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_82bf95e7-774a-44be-ae47-90005afb9ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_7b542bf6-f35c-48eb-8d88-d1628fbe9793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9bd82587-a49a-4c4e-afef-e4c7d0e9ae65" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_7b542bf6-f35c-48eb-8d88-d1628fbe9793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_9a88a580-2469-441a-8837-bea2cdadd312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9bd82587-a49a-4c4e-afef-e4c7d0e9ae65" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_9a88a580-2469-441a-8837-bea2cdadd312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock_cc83d918-8d18-4029-8ad9-3bed51f59c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9bd82587-a49a-4c4e-afef-e4c7d0e9ae65" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock_cc83d918-8d18-4029-8ad9-3bed51f59c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_e5f6c1e0-ae5b-4070-b2b6-a31205f610f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9bd82587-a49a-4c4e-afef-e4c7d0e9ae65" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_e5f6c1e0-ae5b-4070-b2b6-a31205f610f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="cvs-20230525.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f1c58118-f851-474c-8ad2-075c18e16c08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_7444da66-6449-462f-b854-da4818411616" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f1c58118-f851-474c-8ad2-075c18e16c08" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_7444da66-6449-462f-b854-da4818411616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_a0f0f111-f30b-415f-9ab1-d320cc12e76b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f1c58118-f851-474c-8ad2-075c18e16c08" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_a0f0f111-f30b-415f-9ab1-d320cc12e76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_d083f675-2d77-44f0-ac35-0a9f0c1b1ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f1c58118-f851-474c-8ad2-075c18e16c08" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_d083f675-2d77-44f0-ac35-0a9f0c1b1ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_9cec47e5-ae89-422e-a18c-78bf1ee7a7b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f1c58118-f851-474c-8ad2-075c18e16c08" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_9cec47e5-ae89-422e-a18c-78bf1ee7a7b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansTables" xlink:type="simple" xlink:href="cvs-20230525.xsd#StockIncentivePlansTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f7fddcd9-ee15-4fa7-be04-d37bb9588686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_d2f6cabc-6a34-48d0-8f66-783572eda934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f7fddcd9-ee15-4fa7-be04-d37bb9588686" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_d2f6cabc-6a34-48d0-8f66-783572eda934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_3ee21790-3e49-4991-8a12-480954e428e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f7fddcd9-ee15-4fa7-be04-d37bb9588686" xlink:to="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_3ee21790-3e49-4991-8a12-480954e428e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_9b485d6f-631c-48d9-bfd3-62c066a011f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f7fddcd9-ee15-4fa7-be04-d37bb9588686" xlink:to="loc_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_9b485d6f-631c-48d9-bfd3-62c066a011f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_affd40c2-7ca5-4a25-94a4-d0c2c1448f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f7fddcd9-ee15-4fa7-be04-d37bb9588686" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_affd40c2-7ca5-4a25-94a4-d0c2c1448f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_3fbc2aac-59ea-4ac9-9100-c16e15cb8b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f7fddcd9-ee15-4fa7-be04-d37bb9588686" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_3fbc2aac-59ea-4ac9-9100-c16e15cb8b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_0066ee93-f9a8-4790-9e87-643aa86da16f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f7fddcd9-ee15-4fa7-be04-d37bb9588686" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_0066ee93-f9a8-4790-9e87-643aa86da16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="cvs-20230525.xsd#ShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_09b125b2-1e82-4186-92d7-5d7404fa5df1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_8252b963-8909-4fa1-a55b-3c635af672e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_09b125b2-1e82-4186-92d7-5d7404fa5df1" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_8252b963-8909-4fa1-a55b-3c635af672e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRegulatoryAssetsTextBlock_61bc8d75-97fa-4abb-a9ca-c6b3e6957ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRegulatoryAssetsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_09b125b2-1e82-4186-92d7-5d7404fa5df1" xlink:to="loc_us-gaap_ScheduleOfRegulatoryAssetsTextBlock_61bc8d75-97fa-4abb-a9ca-c6b3e6957ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock_356996bb-6dee-43b8-8c10-85d9a8d7b532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesDisclosureTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_09b125b2-1e82-4186-92d7-5d7404fa5df1" xlink:to="loc_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock_356996bb-6dee-43b8-8c10-85d9a8d7b532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherComprehensiveIncomeTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5d013315-3a37-455d-9166-f67ebac75d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_836d50c9-5d7b-4561-8d4c-7ccc28818df8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5d013315-3a37-455d-9166-f67ebac75d6f" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_836d50c9-5d7b-4561-8d4c-7ccc28818df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="cvs-20230525.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2265888c-bfa6-431f-aeb0-74236ccc1af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_052cd921-2adb-4dac-a59a-da0d83ed6e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2265888c-bfa6-431f-aeb0-74236ccc1af0" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_052cd921-2adb-4dac-a59a-da0d83ed6e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceTables" xlink:type="simple" xlink:href="cvs-20230525.xsd#ReinsuranceTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ReinsuranceTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_e7f22590-b719-4f20-abe9-e03e2e5459fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock_8dcc6dbd-7aec-41de-8eff-baa18da96fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_e7f22590-b719-4f20-abe9-e03e2e5459fc" xlink:to="loc_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock_8dcc6dbd-7aec-41de-8eff-baa18da96fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock_f8eeab2b-1f41-4ffa-8dcd-b1423a38d550" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_e7f22590-b719-4f20-abe9-e03e2e5459fc" xlink:to="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock_f8eeab2b-1f41-4ffa-8dcd-b1423a38d550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectsOfReinsuranceTableTextBlock_da99fbc4-fa76-4437-af19-ac2b7384c87f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectsOfReinsuranceTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_e7f22590-b719-4f20-abe9-e03e2e5459fc" xlink:to="loc_us-gaap_EffectsOfReinsuranceTableTextBlock_da99fbc4-fa76-4437-af19-ac2b7384c87f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="cvs-20230525.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ea18b6f0-a446-4605-98a2-c981e8389e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_7c81b008-3892-4f44-b652-da6290bab7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ea18b6f0-a446-4605-98a2-c981e8389e8c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_7c81b008-3892-4f44-b652-da6290bab7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_da101710-2fae-4de6-9340-066d8c6e2951" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ea18b6f0-a446-4605-98a2-c981e8389e8c" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_da101710-2fae-4de6-9340-066d8c6e2951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bdd0eec3-dcd6-41a0-aa43-b0a0d5461ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bdd0eec3-dcd6-41a0-aa43-b0a0d5461ea8" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_cba5583b-e7ff-4a03-90a8-77242be348d9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:to="loc_srt_ProductOrServiceAxis_cba5583b-e7ff-4a03-90a8-77242be348d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_26e081a3-18e5-490b-9870-365f0887eaea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_cba5583b-e7ff-4a03-90a8-77242be348d9" xlink:to="loc_srt_ProductsAndServicesDomain_26e081a3-18e5-490b-9870-365f0887eaea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_cbdfefd7-3b43-49c8-a7d2-6834fd4b8093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_26e081a3-18e5-490b-9870-365f0887eaea" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_cbdfefd7-3b43-49c8-a7d2-6834fd4b8093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c9b67edf-49e4-44c9-8284-ddc8507d3d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c9b67edf-49e4-44c9-8284-ddc8507d3d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_de1bc7d8-fd96-4857-a942-3e4985f78353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c9b67edf-49e4-44c9-8284-ddc8507d3d10" xlink:to="loc_us-gaap_SegmentDomain_de1bc7d8-fd96-4857-a942-3e4985f78353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_e0570a4e-50ac-47e2-aa43-07e44db56941" xlink:href="cvs-20230525.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_de1bc7d8-fd96-4857-a942-3e4985f78353" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_e0570a4e-50ac-47e2-aa43-07e44db56941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthServicesSegmentMember_1dd12d54-9e1a-4ac3-b590-eb7ff8803bf1" xlink:href="cvs-20230525.xsd#cvs_HealthServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_de1bc7d8-fd96-4857-a942-3e4985f78353" xlink:to="loc_cvs_HealthServicesSegmentMember_1dd12d54-9e1a-4ac3-b590-eb7ff8803bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_3b1377f6-679a-42ca-981e-95c422aec030" xlink:href="cvs-20230525.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_de1bc7d8-fd96-4857-a942-3e4985f78353" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_3b1377f6-679a-42ca-981e-95c422aec030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_735981d2-0a4e-4a3f-b2cc-a44724b58507" xlink:href="cvs-20230525.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_de1bc7d8-fd96-4857-a942-3e4985f78353" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_735981d2-0a4e-4a3f-b2cc-a44724b58507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d057c69d-8f43-4946-828c-e19ccf963199" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:to="loc_srt_RangeAxis_d057c69d-8f43-4946-828c-e19ccf963199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cc5bcf85-a198-4584-a292-95d3723227bc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d057c69d-8f43-4946-828c-e19ccf963199" xlink:to="loc_srt_RangeMember_cc5bcf85-a198-4584-a292-95d3723227bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a6b498fa-e326-43b3-87ca-96980a744d34" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cc5bcf85-a198-4584-a292-95d3723227bc" xlink:to="loc_srt_MinimumMember_a6b498fa-e326-43b3-87ca-96980a744d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a5e057e9-b270-494b-b675-30e1d2389996" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cc5bcf85-a198-4584-a292-95d3723227bc" xlink:to="loc_srt_MaximumMember_a5e057e9-b270-494b-b675-30e1d2389996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_add3a55d-a8bf-4c25-88c3-0dc2b77feb6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_add3a55d-a8bf-4c25-88c3-0dc2b77feb6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7632625d-1fd6-40fc-883a-9036c21b7c02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_add3a55d-a8bf-4c25-88c3-0dc2b77feb6d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7632625d-1fd6-40fc-883a-9036c21b7c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_cc4d39c0-6c47-4708-92d0-df3b1b2502c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7632625d-1fd6-40fc-883a-9036c21b7c02" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_cc4d39c0-6c47-4708-92d0-df3b1b2502c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember_8daccd79-7af6-488e-b2ee-54bc382ba598" xlink:href="cvs-20230525.xsd#cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7632625d-1fd6-40fc-883a-9036c21b7c02" xlink:to="loc_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember_8daccd79-7af6-488e-b2ee-54bc382ba598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_255b078e-f91e-4ffc-97ce-e9c4a9977f78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7632625d-1fd6-40fc-883a-9036c21b7c02" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_255b078e-f91e-4ffc-97ce-e9c4a9977f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_bcf9ca9f-22aa-4374-8bb0-48513a16ac50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_bcf9ca9f-22aa-4374-8bb0-48513a16ac50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_cc878043-2e15-49f0-bfd5-737443b78c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_bcf9ca9f-22aa-4374-8bb0-48513a16ac50" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_cc878043-2e15-49f0-bfd5-737443b78c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesMember_abe462d7-72e7-4da8-a453-08ede7ee2b83" xlink:href="cvs-20230525.xsd#cvs_OtherInsuranceLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_cc878043-2e15-49f0-bfd5-737443b78c33" xlink:to="loc_cvs_OtherInsuranceLiabilitiesMember_abe462d7-72e7-4da8-a453-08ede7ee2b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherLongTermInsuranceLiabilitiesMember_2b0b0800-967e-4c1f-a626-c0aec527db5a" xlink:href="cvs-20230525.xsd#cvs_OtherLongTermInsuranceLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_cc878043-2e15-49f0-bfd5-737443b78c33" xlink:to="loc_cvs_OtherLongTermInsuranceLiabilitiesMember_2b0b0800-967e-4c1f-a626-c0aec527db5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_04a94295-8405-4ad8-8d71-d20bddc22df8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:to="loc_dei_LegalEntityAxis_04a94295-8405-4ad8-8d71-d20bddc22df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_15112133-8845-4927-aeeb-a5074212690f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_04a94295-8405-4ad8-8d71-d20bddc22df8" xlink:to="loc_dei_EntityDomain_15112133-8845-4927-aeeb-a5074212690f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember_cee7df7d-a287-4363-a468-61da725bf085" xlink:href="cvs-20230525.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_15112133-8845-4927-aeeb-a5074212690f" xlink:to="loc_cvs_HeartlandHealthcareServicesMember_cee7df7d-a287-4363-a468-61da725bf085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_51b0622d-59eb-4e66-9113-e7ac404b14d1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:to="loc_srt_LitigationCaseAxis_51b0622d-59eb-4e66-9113-e7ac404b14d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_18c1bc26-115c-4f51-9548-811f2aafb0d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_51b0622d-59eb-4e66-9113-e7ac404b14d1" xlink:to="loc_srt_LitigationCaseTypeDomain_18c1bc26-115c-4f51-9548-811f2aafb0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_13245d85-e308-4893-a93b-d452edbdd0ff" xlink:href="cvs-20230525.xsd#cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_18c1bc26-115c-4f51-9548-811f2aafb0d4" xlink:to="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_13245d85-e308-4893-a93b-d452edbdd0ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_4ea5bd0e-3dc1-4892-86de-ce65d27a9e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:to="loc_us-gaap_LitigationStatusAxis_4ea5bd0e-3dc1-4892-86de-ce65d27a9e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_dc58352c-4ebd-40fe-87f1-2ff87e17a899" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_4ea5bd0e-3dc1-4892-86de-ce65d27a9e2d" xlink:to="loc_us-gaap_LitigationStatusDomain_dc58352c-4ebd-40fe-87f1-2ff87e17a899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_78f33e80-918a-452f-aff5-dc8b88d924aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_dc58352c-4ebd-40fe-87f1-2ff87e17a899" xlink:to="loc_us-gaap_SettledLitigationMember_78f33e80-918a-452f-aff5-dc8b88d924aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a6723ea6-4180-42e8-8ddf-d07dee4d54d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:to="loc_srt_StatementScenarioAxis_a6723ea6-4180-42e8-8ddf-d07dee4d54d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f15c94eb-38de-4ea8-a590-8a0580874658" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_a6723ea6-4180-42e8-8ddf-d07dee4d54d4" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f15c94eb-38de-4ea8-a590-8a0580874658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_06c6befc-d2c5-4f0b-bdf6-ae2a3cffe9bd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_f15c94eb-38de-4ea8-a590-8a0580874658" xlink:to="loc_srt_ScenarioForecastMember_06c6befc-d2c5-4f0b-bdf6-ae2a3cffe9bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_319aeca1-1b2a-4462-88b9-892b68ab6ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:to="loc_us-gaap_ReportingUnitAxis_319aeca1-1b2a-4462-88b9-892b68ab6ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_2c42eaff-4f11-4bde-9c76-a25e2dd6e87b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_319aeca1-1b2a-4462-88b9-892b68ab6ff7" xlink:to="loc_us-gaap_ReportingUnitDomain_2c42eaff-4f11-4bde-9c76-a25e2dd6e87b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareReportingUnitMember_2895e687-634b-49d0-9035-5d8657650509" xlink:href="cvs-20230525.xsd#cvs_LongTermCareReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_2c42eaff-4f11-4bde-9c76-a25e2dd6e87b" xlink:to="loc_cvs_LongTermCareReportingUnitMember_2895e687-634b-49d0-9035-5d8657650509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_01276cce-77dd-4efb-8e28-95e9796c3e76" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_c963c2af-f772-468a-b830-19aa252c007d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStores"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_NumberOfStores_c963c2af-f772-468a-b830-19aa252c007d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfWalkInMedicalClinics_e8093fbb-bc27-4f80-8667-b817e4563841" xlink:href="cvs-20230525.xsd#cvs_NumberOfWalkInMedicalClinics"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_NumberOfWalkInMedicalClinics_e8093fbb-bc27-4f80-8667-b817e4563841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPharmacyPlanMembers_d0e627a4-3fb3-4ca8-9bb0-ce0733813720" xlink:href="cvs-20230525.xsd#cvs_NumberOfPharmacyPlanMembers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_NumberOfPharmacyPlanMembers_d0e627a4-3fb3-4ca8-9bb0-ce0733813720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPatientsServedPerYear_0af0185a-6e11-43b0-badb-bd8c17bb2002" xlink:href="cvs-20230525.xsd#cvs_NumberOfPatientsServedPerYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_NumberOfPatientsServedPerYear_0af0185a-6e11-43b0-badb-bd8c17bb2002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPeopleServed_396c5217-6995-464f-9ee5-59842152b4e1" xlink:href="cvs-20230525.xsd#cvs_NumberOfPeopleServed"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_NumberOfPeopleServed_396c5217-6995-464f-9ee5-59842152b4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_7e532698-2038-4f64-94c9-7fa408efea5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_NumberOfReportableSegments_7e532698-2038-4f64-94c9-7fa408efea5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates_6d53a5f2-cf59-413d-866b-0d2123c97d28" xlink:href="cvs-20230525.xsd#cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates_6d53a5f2-cf59-413d-866b-0d2123c97d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates_9b05650f-26c5-42c8-81da-00d205edf7a3" xlink:href="cvs-20230525.xsd#cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates_9b05650f-26c5-42c8-81da-00d205edf7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts_a1e2959f-cd66-4c76-a521-939eced662c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCosts_a1e2959f-cd66-4c76-a521-939eced662c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_28c89e08-32f6-4c25-a4cf-53c9053ef477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_28c89e08-32f6-4c25-a4cf-53c9053ef477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_819959e0-bbff-4244-be38-da69341be3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_Depreciation_819959e0-bbff-4244-be38-da69341be3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OfficeRealEstateOptimizationCharges_a2f2b8a9-65e9-47d7-99c2-31e41d97ad07" xlink:href="cvs-20230525.xsd#cvs_OfficeRealEstateOptimizationCharges"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_OfficeRealEstateOptimizationCharges_a2f2b8a9-65e9-47d7-99c2-31e41d97ad07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges_782e8684-16b3-47ba-8093-9843e75a89a5" xlink:href="cvs-20230525.xsd#cvs_StoreImpairmentCharges"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_StoreImpairmentCharges_782e8684-16b3-47ba-8093-9843e75a89a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm_209d4615-8da1-4425-bf57-b98153a9295d" xlink:href="cvs-20230525.xsd#cvs_LesseeOperatingAndFinanceLeasesRenewalTerm"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm_209d4615-8da1-4425-bf57-b98153a9295d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresPlannedClosure_9b944101-ba4f-4712-94cc-ec99202499d6" xlink:href="cvs-20230525.xsd#cvs_NumberOfStoresPlannedClosure"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_NumberOfStoresPlannedClosure_9b944101-ba4f-4712-94cc-ec99202499d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_0697e07e-b1a2-4c2a-8826-728513572571" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_0697e07e-b1a2-4c2a-8826-728513572571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_3b267562-b69a-4562-8b42-3e58b7d42135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_3b267562-b69a-4562-8b42-3e58b7d42135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid_56a475d0-6d6d-44fd-882c-0e090d8e63b0" xlink:href="cvs-20230525.xsd#cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid_56a475d0-6d6d-44fd-882c-0e090d8e63b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaims_892b880b-e298-47c0-b3eb-d2b9b95982b7" xlink:href="cvs-20230525.xsd#cvs_LiabilityForUnpaidClaims"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_LiabilityForUnpaidClaims_892b880b-e298-47c0-b3eb-d2b9b95982b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_a30ac392-e4f1-4e52-bf08-4fb883545158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefits_a30ac392-e4f1-4e52-bf08-4fb883545158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_d86032df-ffeb-410c-adda-4db664b38212" xlink:href="cvs-20230525.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_d86032df-ffeb-410c-adda-4db664b38212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PensionAndAnnuityInvestmentContractsInterest_a6d9333c-db4a-4a7c-80a3-c99e16f54c5b" xlink:href="cvs-20230525.xsd#cvs_PensionAndAnnuityInvestmentContractsInterest"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_PensionAndAnnuityInvestmentContractsInterest_a6d9333c-db4a-4a7c-80a3-c99e16f54c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeathSavingsAccountBalance_9ee085fa-6bc0-432e-8cdd-e94df7b6f859" xlink:href="cvs-20230525.xsd#cvs_HeathSavingsAccountBalance"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_HeathSavingsAccountBalance_9ee085fa-6bc0-432e-8cdd-e94df7b6f859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_e3c1b170-d066-4edb-809f-e4ef62321d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_SelfInsuranceReserve_e3c1b170-d066-4edb-809f-e4ef62321d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRebatePeriod_5b98493d-cf82-4564-ace3-39c000c94923" xlink:href="cvs-20230525.xsd#cvs_PharmacyRebatePeriod"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_PharmacyRebatePeriod_5b98493d-cf82-4564-ace3-39c000c94923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFee_cb3fd5b3-7c42-4674-88fa-285db8ba85fb" xlink:href="cvs-20230525.xsd#cvs_HealthInsurerFee"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_HealthInsurerFee_cb3fd5b3-7c42-4674-88fa-285db8ba85fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyUnrecordedAmount_942f5d54-e864-4710-82d8-85269a363e88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainContingencyUnrecordedAmount"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_GainContingencyUnrecordedAmount_942f5d54-e864-4710-82d8-85269a363e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_00290522-faa5-485c-9666-d55e6d3e4c55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_00290522-faa5-485c-9666-d55e6d3e4c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_89f5ad20-4638-4f4c-bd6d-f37d3784170e" xlink:href="cvs-20230525.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_89f5ad20-4638-4f4c-bd6d-f37d3784170e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_74032544-6ca0-445b-aab1-acc1b515f144" xlink:href="cvs-20230525.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_74032544-6ca0-445b-aab1-acc1b515f144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_2aab7a0e-ee63-46a8-af90-370342e8d516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_AdvertisingExpense_2aab7a0e-ee63-46a8-af90-370342e8d516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_63541884-3618-4b78-b548-944838b27a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_63541884-3618-4b78-b548-944838b27a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust_90b37b21-67ec-4636-89da-64251f3625e4" xlink:href="cvs-20230525.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_TreasuryStockSharesHeldinTrust_90b37b21-67ec-4636-89da-64251f3625e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_ed019fd6-5c90-4bff-ba07-65ac4d4e389d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_ed019fd6-5c90-4bff-ba07-65ac4d4e389d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_1123dd70-586e-4bba-afa8-8c84ca146f39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_1123dd70-586e-4bba-afa8-8c84ca146f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_25045f37-210f-4900-bce3-fdc02171bff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_25045f37-210f-4900-bce3-fdc02171bff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity_80836ec7-827e-4aac-9022-f2ff719ea279" xlink:href="cvs-20230525.xsd#cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7a281918-60df-42a1-b1e3-bd40f166337c" xlink:to="loc_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity_80836ec7-827e-4aac-9022-f2ff719ea279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f598573c-1eeb-4cde-befe-441da4e788bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5f6f2118-f4e6-4ce8-8c74-15e48bf32385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f598573c-1eeb-4cde-befe-441da4e788bd" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5f6f2118-f4e6-4ce8-8c74-15e48bf32385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_2cf64baf-0105-4aa7-89c3-2bbdb016aee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f598573c-1eeb-4cde-befe-441da4e788bd" xlink:to="loc_us-gaap_RestrictedCashCurrent_2cf64baf-0105-4aa7-89c3-2bbdb016aee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_9642f2fc-0b27-4b9a-aae1-73ffe0c26acd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f598573c-1eeb-4cde-befe-441da4e788bd" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_9642f2fc-0b27-4b9a-aae1-73ffe0c26acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_104a38a2-9133-43b9-a06a-b51c432d289e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f598573c-1eeb-4cde-befe-441da4e788bd" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_104a38a2-9133-43b9-a06a-b51c432d289e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SignificantAccountingPoliciesAccountsReceivableDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6a47da28-fa0d-4e5a-ac0b-aa16d9ca32cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_e595722a-d676-4194-9c0c-b1d1899055e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6a47da28-fa0d-4e5a-ac0b-aa16d9ca32cc" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_e595722a-d676-4194-9c0c-b1d1899055e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d91a5d81-3dba-4750-bc6a-da08de419a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_e595722a-d676-4194-9c0c-b1d1899055e5" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d91a5d81-3dba-4750-bc6a-da08de419a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_282ae83a-411b-4f9b-acc9-ca151c2aeac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d91a5d81-3dba-4750-bc6a-da08de419a7c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_282ae83a-411b-4f9b-acc9-ca151c2aeac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_88c1bd76-dc5c-4247-acec-b91198d7e945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_282ae83a-411b-4f9b-acc9-ca151c2aeac3" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_88c1bd76-dc5c-4247-acec-b91198d7e945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_24fed575-05f6-46ff-b447-6960568aa88b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_e595722a-d676-4194-9c0c-b1d1899055e5" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_24fed575-05f6-46ff-b447-6960568aa88b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_246a12ab-d05f-4585-a1f4-2395d56e4e93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_24fed575-05f6-46ff-b447-6960568aa88b" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_246a12ab-d05f-4585-a1f4-2395d56e4e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorandManufacturerReceivables_fb2d764a-1987-4f51-9b25-e34325a1f955" xlink:href="cvs-20230525.xsd#cvs_VendorandManufacturerReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_24fed575-05f6-46ff-b447-6960568aa88b" xlink:to="loc_cvs_VendorandManufacturerReceivables_fb2d764a-1987-4f51-9b25-e34325a1f955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_060a9566-066c-4548-81de-fe5392f4cf59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_24fed575-05f6-46ff-b447-6960568aa88b" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_060a9566-066c-4548-81de-fe5392f4cf59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_c802a440-3bd3-4ba5-98b7-cbde9eca5ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_24fed575-05f6-46ff-b447-6960568aa88b" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_c802a440-3bd3-4ba5-98b7-cbde9eca5ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_da0e3caf-6e2d-4763-8bc9-8f02598266d7" xlink:href="cvs-20230525.xsd#cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_24fed575-05f6-46ff-b447-6960568aa88b" xlink:to="loc_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale_da0e3caf-6e2d-4763-8bc9-8f02598266d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_413202ef-0091-4222-bae0-1fe4fc210209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_24fed575-05f6-46ff-b447-6960568aa88b" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_413202ef-0091-4222-bae0-1fe4fc210209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDeferredAcquisitionCostsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SignificantAccountingPoliciesDeferredAcquisitionCostsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDeferredAcquisitionCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_295fee1a-77df-41e8-81d3-ea43c99e5cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_93a2ccc5-2fef-47cc-bd27-98cff0b6a2ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_295fee1a-77df-41e8-81d3-ea43c99e5cc6" xlink:to="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_93a2ccc5-2fef-47cc-bd27-98cff0b6a2ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts_10f5a2cd-0093-42b9-b54a-883c0b29eb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_93a2ccc5-2fef-47cc-bd27-98cff0b6a2ce" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCosts_10f5a2cd-0093-42b9-b54a-883c0b29eb3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostsAdditions_c5346f4f-7b82-4ce3-b8af-3c7b6b02665f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostsAdditions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_93a2ccc5-2fef-47cc-bd27-98cff0b6a2ce" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostsAdditions_c5346f4f-7b82-4ce3-b8af-3c7b6b02665f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_040bb9e4-3cd7-4255-8eb6-f1f03ca5cb1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_93a2ccc5-2fef-47cc-bd27-98cff0b6a2ce" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense_040bb9e4-3cd7-4255-8eb6-f1f03ca5cb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts_1055199c-e848-463b-bc73-81c07e69c23e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward_93a2ccc5-2fef-47cc-bd27-98cff0b6a2ce" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCosts_1055199c-e848-463b-bc73-81c07e69c23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SignificantAccountingPoliciesPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_32ae0a4e-4a70-4250-9ea6-eb94ea128aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3d08204e-91f5-4660-973b-a52b1b904c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_32ae0a4e-4a70-4250-9ea6-eb94ea128aa3" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3d08204e-91f5-4660-973b-a52b1b904c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6c30287f-c4f4-444f-8d26-624f7f9e71c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3d08204e-91f5-4660-973b-a52b1b904c2e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6c30287f-c4f4-444f-8d26-624f7f9e71c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_86baff2e-51e4-4c9c-ad69-63a45832883f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6c30287f-c4f4-444f-8d26-624f7f9e71c2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_86baff2e-51e4-4c9c-ad69-63a45832883f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_34369bff-8082-45af-ae96-b41abb8cf92d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_86baff2e-51e4-4c9c-ad69-63a45832883f" xlink:to="loc_us-gaap_LandMember_34369bff-8082-45af-ae96-b41abb8cf92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_f57099da-1178-4be6-ae51-715759191cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_86baff2e-51e4-4c9c-ad69-63a45832883f" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_f57099da-1178-4be6-ae51-715759191cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_23f63bb5-2274-46a9-90ca-a2e4a58adcdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_86baff2e-51e4-4c9c-ad69-63a45832883f" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_23f63bb5-2274-46a9-90ca-a2e4a58adcdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_cdfa7bde-fbeb-4257-9fe7-c840315850c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_86baff2e-51e4-4c9c-ad69-63a45832883f" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_cdfa7bde-fbeb-4257-9fe7-c840315850c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_c77c1724-0be4-4b3b-a87e-8f159cbad9a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_86baff2e-51e4-4c9c-ad69-63a45832883f" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_c77c1724-0be4-4b3b-a87e-8f159cbad9a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_c5a62e73-75b2-454a-ac55-60fb86c3bcd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3d08204e-91f5-4660-973b-a52b1b904c2e" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_c5a62e73-75b2-454a-ac55-60fb86c3bcd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_49123996-e8a3-4c5a-ae65-245a72638581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c5a62e73-75b2-454a-ac55-60fb86c3bcd4" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_49123996-e8a3-4c5a-ae65-245a72638581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_99fd869d-ded7-43e0-a469-d77e820d5395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_49123996-e8a3-4c5a-ae65-245a72638581" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_99fd869d-ded7-43e0-a469-d77e820d5395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_07768f12-bcfb-4d59-a855-d1a37918b79f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3d08204e-91f5-4660-973b-a52b1b904c2e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_07768f12-bcfb-4d59-a855-d1a37918b79f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_b5ca1fe6-3d46-4287-808e-91e39ab9a0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_07768f12-bcfb-4d59-a855-d1a37918b79f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_b5ca1fe6-3d46-4287-808e-91e39ab9a0c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ca520f4c-e792-4390-8808-2e99bab0713d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_07768f12-bcfb-4d59-a855-d1a37918b79f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ca520f4c-e792-4390-8808-2e99bab0713d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale_5bf021e9-bef4-4e6c-85d3-800d9abed819" xlink:href="cvs-20230525.xsd#cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_07768f12-bcfb-4d59-a855-d1a37918b79f" xlink:to="loc_cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale_5bf021e9-bef4-4e6c-85d3-800d9abed819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SignificantAccountingPoliciesDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d304304a-2873-4a86-ba4a-692ef969a796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ef8837ac-4960-4b6a-b2e8-71ea77cb90f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d304304a-2873-4a86-ba4a-692ef969a796" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ef8837ac-4960-4b6a-b2e8-71ea77cb90f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_0a7e09d6-1ca7-4ee1-a06b-432b50f4b4ea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ef8837ac-4960-4b6a-b2e8-71ea77cb90f1" xlink:to="loc_srt_ConsolidationItemsAxis_0a7e09d6-1ca7-4ee1-a06b-432b50f4b4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_904a96df-cb7e-4a7d-a049-ce05df4aee8c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_0a7e09d6-1ca7-4ee1-a06b-432b50f4b4ea" xlink:to="loc_srt_ConsolidationItemsDomain_904a96df-cb7e-4a7d-a049-ce05df4aee8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_2f99b999-5a88-4212-9f88-80c456d1909d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_904a96df-cb7e-4a7d-a049-ce05df4aee8c" xlink:to="loc_us-gaap_OperatingSegmentsMember_2f99b999-5a88-4212-9f88-80c456d1909d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_deabb206-1df6-4029-b21c-cc491d50fb93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_904a96df-cb7e-4a7d-a049-ce05df4aee8c" xlink:to="loc_us-gaap_CorporateNonSegmentMember_deabb206-1df6-4029-b21c-cc491d50fb93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_9cbd58ac-a724-4807-aa9b-9225252324d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_904a96df-cb7e-4a7d-a049-ce05df4aee8c" xlink:to="loc_us-gaap_IntersegmentEliminationMember_9cbd58ac-a724-4807-aa9b-9225252324d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7f2709aa-a8cf-4990-bc85-5c869143a0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ef8837ac-4960-4b6a-b2e8-71ea77cb90f1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7f2709aa-a8cf-4990-bc85-5c869143a0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2abd309a-781b-45ef-97b2-99694a214759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7f2709aa-a8cf-4990-bc85-5c869143a0dd" xlink:to="loc_us-gaap_SegmentDomain_2abd309a-781b-45ef-97b2-99694a214759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_8479c731-607c-4019-95b2-4b06e17c31a3" xlink:href="cvs-20230525.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2abd309a-781b-45ef-97b2-99694a214759" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_8479c731-607c-4019-95b2-4b06e17c31a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthServicesSegmentMember_e658cad2-b3cf-4b96-8f73-245b7889952f" xlink:href="cvs-20230525.xsd#cvs_HealthServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2abd309a-781b-45ef-97b2-99694a214759" xlink:to="loc_cvs_HealthServicesSegmentMember_e658cad2-b3cf-4b96-8f73-245b7889952f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_35c7198d-58db-4547-aff4-e5f264fb1174" xlink:href="cvs-20230525.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2abd309a-781b-45ef-97b2-99694a214759" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_35c7198d-58db-4547-aff4-e5f264fb1174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_99cdc4a0-3d26-43b5-9ace-1d50e2b3ba89" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ef8837ac-4960-4b6a-b2e8-71ea77cb90f1" xlink:to="loc_srt_ProductOrServiceAxis_99cdc4a0-3d26-43b5-9ace-1d50e2b3ba89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5d3d65cf-c918-413a-b152-09fcfe2272a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_99cdc4a0-3d26-43b5-9ace-1d50e2b3ba89" xlink:to="loc_srt_ProductsAndServicesDomain_5d3d65cf-c918-413a-b152-09fcfe2272a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember_7b8f40de-db29-4a09-abb4-be141e472615" xlink:href="cvs-20230525.xsd#cvs_PharmacyRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5d3d65cf-c918-413a-b152-09fcfe2272a9" xlink:to="loc_cvs_PharmacyRevenueMember_7b8f40de-db29-4a09-abb4-be141e472615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember_f08b0b7a-e9c5-4531-b14e-8ded69f24631" xlink:href="cvs-20230525.xsd#cvs_FrontStoreRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5d3d65cf-c918-413a-b152-09fcfe2272a9" xlink:to="loc_cvs_FrontStoreRevenueMember_f08b0b7a-e9c5-4531-b14e-8ded69f24631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember_e37893d0-bdfb-4b9c-80aa-1ccf794f59dc" xlink:href="cvs-20230525.xsd#cvs_PremiumsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5d3d65cf-c918-413a-b152-09fcfe2272a9" xlink:to="loc_cvs_PremiumsMember_e37893d0-bdfb-4b9c-80aa-1ccf794f59dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_075e2757-7aa9-4e3c-907e-7e17814616b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5d3d65cf-c918-413a-b152-09fcfe2272a9" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_075e2757-7aa9-4e3c-907e-7e17814616b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_03e11827-5487-4adb-91ff-81e48779709b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ef8837ac-4960-4b6a-b2e8-71ea77cb90f1" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_03e11827-5487-4adb-91ff-81e48779709b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_d8909628-18fd-4103-bc00-8dec6119fea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_03e11827-5487-4adb-91ff-81e48779709b" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_d8909628-18fd-4103-bc00-8dec6119fea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_90cbd969-de03-41c6-932e-c6841d34ff16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_d8909628-18fd-4103-bc00-8dec6119fea6" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_90cbd969-de03-41c6-932e-c6841d34ff16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_da363181-6a1c-4cbc-b661-7d16aebd8209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_d8909628-18fd-4103-bc00-8dec6119fea6" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_da363181-6a1c-4cbc-b661-7d16aebd8209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember_2b138fc2-b3c3-4333-876d-fe5b2ecb7828" xlink:href="cvs-20230525.xsd#cvs_SalesChannelOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_d8909628-18fd-4103-bc00-8dec6119fea6" xlink:to="loc_cvs_SalesChannelOtherMember_2b138fc2-b3c3-4333-876d-fe5b2ecb7828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_55eb9b3f-4820-4a24-91e1-6ec2eeb8c6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ef8837ac-4960-4b6a-b2e8-71ea77cb90f1" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_55eb9b3f-4820-4a24-91e1-6ec2eeb8c6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_a2e08417-cbd1-4410-90df-ebc5212675b1" xlink:href="cvs-20230525.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_55eb9b3f-4820-4a24-91e1-6ec2eeb8c6f3" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_a2e08417-cbd1-4410-90df-ebc5212675b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_4fd857ad-9e23-4fdc-b6a8-1d22d9f4168b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_55eb9b3f-4820-4a24-91e1-6ec2eeb8c6f3" xlink:to="loc_us-gaap_NetInvestmentIncome_4fd857ad-9e23-4fdc-b6a8-1d22d9f4168b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_97b7f485-386a-45cb-a077-5f62a457d591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_55eb9b3f-4820-4a24-91e1-6ec2eeb8c6f3" xlink:to="loc_us-gaap_Revenues_97b7f485-386a-45cb-a077-5f62a457d591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_287b34f4-4231-4fbf-be59-7cad30f30e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_e597ecec-8a67-4a87-b4ff-f0762cb60442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_287b34f4-4231-4fbf-be59-7cad30f30e6d" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_e597ecec-8a67-4a87-b4ff-f0762cb60442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_72317858-6d5d-490b-a74e-dfa105611c21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_287b34f4-4231-4fbf-be59-7cad30f30e6d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_72317858-6d5d-490b-a74e-dfa105611c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SignificantAccountingPoliciesContractBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1a391014-8a69-480f-9003-6e7d032e4a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_a6bf3859-74e2-4add-93f4-e46d835fb236" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1a391014-8a69-480f-9003-6e7d032e4a6c" xlink:to="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_a6bf3859-74e2-4add-93f4-e46d835fb236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeInContractWithCustomerLiabilityRollForward_d499c500-9176-45b5-b11a-bd64bbbc6196" xlink:href="cvs-20230525.xsd#cvs_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_a6bf3859-74e2-4add-93f4-e46d835fb236" xlink:to="loc_cvs_ChangeInContractWithCustomerLiabilityRollForward_d499c500-9176-45b5-b11a-bd64bbbc6196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_178203b2-ecf6-47f3-bf97-7b1a89e4e0da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeInContractWithCustomerLiabilityRollForward_d499c500-9176-45b5-b11a-bd64bbbc6196" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_178203b2-ecf6-47f3-bf97-7b1a89e4e0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_0666717f-c00e-4b68-a81a-156e526496c0" xlink:href="cvs-20230525.xsd#cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeInContractWithCustomerLiabilityRollForward_d499c500-9176-45b5-b11a-bd64bbbc6196" xlink:to="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_0666717f-c00e-4b68-a81a-156e526496c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage_869337d4-aa54-446b-80f5-bed6c76db6c5" xlink:href="cvs-20230525.xsd#cvs_ContractWithCustomerLiabilityRedemptionAndBreakage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeInContractWithCustomerLiabilityRollForward_d499c500-9176-45b5-b11a-bd64bbbc6196" xlink:to="loc_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage_869337d4-aa54-446b-80f5-bed6c76db6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_fa7ce900-6df5-4f14-9126-a27ce6aaafd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeInContractWithCustomerLiabilityRollForward_d499c500-9176-45b5-b11a-bd64bbbc6196" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_fa7ce900-6df5-4f14-9126-a27ce6aaafd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SignificantAccountingPoliciesVariableInterestEntitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3eb4624e-049b-435a-92ac-fd92d006c5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_910fdf21-ec6b-457a-aa81-1077e942f591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3eb4624e-049b-435a-92ac-fd92d006c5fb" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_910fdf21-ec6b-457a-aa81-1077e942f591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_4d4dfe47-eb11-414c-ae93-2595d9f14b57" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_910fdf21-ec6b-457a-aa81-1077e942f591" xlink:to="loc_srt_ConsolidatedEntitiesAxis_4d4dfe47-eb11-414c-ae93-2595d9f14b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_f69b781a-795d-4231-9758-625fac6f3381" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_4d4dfe47-eb11-414c-ae93-2595d9f14b57" xlink:to="loc_srt_ConsolidatedEntitiesDomain_f69b781a-795d-4231-9758-625fac6f3381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_0aec513e-a0e4-4bcf-b1be-77b2b8632eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_f69b781a-795d-4231-9758-625fac6f3381" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_0aec513e-a0e4-4bcf-b1be-77b2b8632eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_4b5ce650-9a5b-4c7a-ae05-d4e1dcd26961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_910fdf21-ec6b-457a-aa81-1077e942f591" xlink:to="loc_us-gaap_InvestmentTypeAxis_4b5ce650-9a5b-4c7a-ae05-d4e1dcd26961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_69265252-656f-46cd-b8d0-706b7ee92ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_4b5ce650-9a5b-4c7a-ae05-d4e1dcd26961" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_69265252-656f-46cd-b8d0-706b7ee92ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_2da894e2-ddcb-4139-9e7e-6be76fc64d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgeFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_69265252-656f-46cd-b8d0-706b7ee92ce3" xlink:to="loc_us-gaap_HedgeFundsMember_2da894e2-ddcb-4139-9e7e-6be76fc64d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_2a4bd00f-85ac-4480-aef6-04bccf08c0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_69265252-656f-46cd-b8d0-706b7ee92ce3" xlink:to="loc_us-gaap_PrivateEquityFundsMember_2a4bd00f-85ac-4480-aef6-04bccf08c0c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_60092cb6-f21f-477f-9b91-3fa81fb8a713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_69265252-656f-46cd-b8d0-706b7ee92ce3" xlink:to="loc_us-gaap_RealEstateFundsMember_60092cb6-f21f-477f-9b91-3fa81fb8a713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2fa8e192-016c-4c1c-af04-8dce424f27bf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_910fdf21-ec6b-457a-aa81-1077e942f591" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2fa8e192-016c-4c1c-af04-8dce424f27bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_b76c0fd4-45ef-4563-904d-875bbaceff47" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2fa8e192-016c-4c1c-af04-8dce424f27bf" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_b76c0fd4-45ef-4563-904d-875bbaceff47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RedOakMember_3e67847b-c4f5-449e-a195-76d1e6661e4b" xlink:href="cvs-20230525.xsd#cvs_RedOakMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b76c0fd4-45ef-4563-904d-875bbaceff47" xlink:to="loc_cvs_RedOakMember_3e67847b-c4f5-449e-a195-76d1e6661e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_4b9e0c3e-2362-4d93-acb6-e85349fa10d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_910fdf21-ec6b-457a-aa81-1077e942f591" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_4b9e0c3e-2362-4d93-acb6-e85349fa10d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_f57d045f-54c0-45df-a777-aa595c781e68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4b9e0c3e-2362-4d93-acb6-e85349fa10d2" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_f57d045f-54c0-45df-a777-aa595c781e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InitialContractualTerm_10edacb8-cbda-44c4-bead-6cbd57b7887f" xlink:href="cvs-20230525.xsd#cvs_InitialContractualTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4b9e0c3e-2362-4d93-acb6-e85349fa10d2" xlink:to="loc_cvs_InitialContractualTerm_10edacb8-cbda-44c4-bead-6cbd57b7887f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VariableInterestEntityAmendedContractExtensionTerm_50eff438-d6d6-4031-94ad-1d50f8c02bb1" xlink:href="cvs-20230525.xsd#cvs_VariableInterestEntityAmendedContractExtensionTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4b9e0c3e-2362-4d93-acb6-e85349fa10d2" xlink:to="loc_cvs_VariableInterestEntityAmendedContractExtensionTerm_50eff438-d6d6-4031-94ad-1d50f8c02bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VariableInterestEntityAmendedContractTerm_9642ad55-240a-4162-96f1-404eca23691e" xlink:href="cvs-20230525.xsd#cvs_VariableInterestEntityAmendedContractTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4b9e0c3e-2362-4d93-acb6-e85349fa10d2" xlink:to="loc_cvs_VariableInterestEntityAmendedContractTerm_9642ad55-240a-4162-96f1-404eca23691e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsFromVariableInterestEntity_b09e1d56-2cbe-4faa-b477-bd9736c18081" xlink:href="cvs-20230525.xsd#cvs_ProceedsFromVariableInterestEntity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4b9e0c3e-2362-4d93-acb6-e85349fa10d2" xlink:to="loc_cvs_ProceedsFromVariableInterestEntity_b09e1d56-2cbe-4faa-b477-bd9736c18081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_b6662f8a-8b0c-4fd4-ba1c-c66ce73fd239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4b9e0c3e-2362-4d93-acb6-e85349fa10d2" xlink:to="loc_us-gaap_LongTermInvestments_b6662f8a-8b0c-4fd4-ba1c-c66ce73fd239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SignificantAccountingPoliciesDiscontinuedOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_099a12f6-71fb-4c98-933f-60c683fbdaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_e46b384e-b58d-407d-bd0c-4164285ce9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_099a12f6-71fb-4c98-933f-60c683fbdaa6" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_e46b384e-b58d-407d-bd0c-4164285ce9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_6f3cf878-f8da-4d8c-a94c-d0f933b78da8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_099a12f6-71fb-4c98-933f-60c683fbdaa6" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_6f3cf878-f8da-4d8c-a94c-d0f933b78da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_e2e90b2b-6ad3-4f15-8c34-86e109f43aae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_099a12f6-71fb-4c98-933f-60c683fbdaa6" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_e2e90b2b-6ad3-4f15-8c34-86e109f43aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#AcquisitionsDivestituresandAssetSalesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f07244c0-4a41-4285-a8de-37975bd7c0de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_11007a8a-ed43-4630-a00c-a98646f45e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f07244c0-4a41-4285-a8de-37975bd7c0de" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_11007a8a-ed43-4630-a00c-a98646f45e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_c3e46b1b-b329-4585-b93a-10a91c433a10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_11007a8a-ed43-4630-a00c-a98646f45e6d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_c3e46b1b-b329-4585-b93a-10a91c433a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_707b17de-39a4-474e-8af0-19cd5038732a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c3e46b1b-b329-4585-b93a-10a91c433a10" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_707b17de-39a4-474e-8af0-19cd5038732a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_26e30191-e02b-44fb-bd2e-59a632486d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_707b17de-39a4-474e-8af0-19cd5038732a" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_26e30191-e02b-44fb-bd2e-59a632486d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_ae2be565-b0ca-4531-8e3d-2799482df6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_707b17de-39a4-474e-8af0-19cd5038732a" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_ae2be565-b0ca-4531-8e3d-2799482df6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_8e7fd6af-704b-4a8a-91ca-fc26612c861f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_707b17de-39a4-474e-8af0-19cd5038732a" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_8e7fd6af-704b-4a8a-91ca-fc26612c861f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b81fc0bf-1881-4b49-9c30-2e9bafbea35b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_11007a8a-ed43-4630-a00c-a98646f45e6d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b81fc0bf-1881-4b49-9c30-2e9bafbea35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5554a952-d8c1-4732-a3b4-46b22be364e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b81fc0bf-1881-4b49-9c30-2e9bafbea35b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5554a952-d8c1-4732-a3b4-46b22be364e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OmnicareLongTermCareBusinessMember_6b15825d-2ea5-49dc-be3b-4ccb5d4f16d9" xlink:href="cvs-20230525.xsd#cvs_OmnicareLongTermCareBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5554a952-d8c1-4732-a3b4-46b22be364e6" xlink:to="loc_cvs_OmnicareLongTermCareBusinessMember_6b15825d-2ea5-49dc-be3b-4ccb5d4f16d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BswiftLLCMember_cc28bfd4-d666-435d-8f50-706c296cc846" xlink:href="cvs-20230525.xsd#cvs_BswiftLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5554a952-d8c1-4732-a3b4-46b22be364e6" xlink:to="loc_cvs_BswiftLLCMember_cc28bfd4-d666-435d-8f50-706c296cc846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PayflexMember_df6c1e21-fa46-4211-9308-cf4097c67cdb" xlink:href="cvs-20230525.xsd#cvs_PayflexMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5554a952-d8c1-4732-a3b4-46b22be364e6" xlink:to="loc_cvs_PayflexMember_df6c1e21-fa46-4211-9308-cf4097c67cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ThailandBusinessMember_97cf4604-ed8c-41e4-957b-a3b1c5a8299c" xlink:href="cvs-20230525.xsd#cvs_ThailandBusinessMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5554a952-d8c1-4732-a3b4-46b22be364e6" xlink:to="loc_cvs_ThailandBusinessMember_97cf4604-ed8c-41e4-957b-a3b1c5a8299c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InternationalHealthCareRenewalRightsMember_2193c2c0-9eb3-4884-9105-588fd6373609" xlink:href="cvs-20230525.xsd#cvs_InternationalHealthCareRenewalRightsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5554a952-d8c1-4732-a3b4-46b22be364e6" xlink:to="loc_cvs_InternationalHealthCareRenewalRightsMember_2193c2c0-9eb3-4884-9105-588fd6373609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_ebe41db0-736f-49cf-becb-6b7a6c24d719" xlink:href="cvs-20230525.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5554a952-d8c1-4732-a3b4-46b22be364e6" xlink:to="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_ebe41db0-736f-49cf-becb-6b7a6c24d719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b842d651-b3aa-452c-8fda-066403438eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_11007a8a-ed43-4630-a00c-a98646f45e6d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b842d651-b3aa-452c-8fda-066403438eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ae887bd7-6514-441f-a730-790e7caa32cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b842d651-b3aa-452c-8fda-066403438eca" xlink:to="loc_us-gaap_SegmentDomain_ae887bd7-6514-441f-a730-790e7caa32cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_524be901-d451-4501-8747-b3b454db7076" xlink:href="cvs-20230525.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ae887bd7-6514-441f-a730-790e7caa32cf" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_524be901-d451-4501-8747-b3b454db7076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_eb6cf5bc-0198-45a6-a6b6-d1c373641259" xlink:href="cvs-20230525.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ae887bd7-6514-441f-a730-790e7caa32cf" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_eb6cf5bc-0198-45a6-a6b6-d1c373641259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_81a64940-2011-4d34-bad1-f4bcc4c1b07d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_11007a8a-ed43-4630-a00c-a98646f45e6d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_81a64940-2011-4d34-bad1-f4bcc4c1b07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_548fa04c-b7bd-42f1-a9b1-5e01951aed66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_81a64940-2011-4d34-bad1-f4bcc4c1b07d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_548fa04c-b7bd-42f1-a9b1-5e01951aed66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OakStreetHealthIncMember_142b5b1d-6ef9-4211-8d94-f46402a1ee7b" xlink:href="cvs-20230525.xsd#cvs_OakStreetHealthIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_548fa04c-b7bd-42f1-a9b1-5e01951aed66" xlink:to="loc_cvs_OakStreetHealthIncMember_142b5b1d-6ef9-4211-8d94-f46402a1ee7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SignifyHealthIncMember_0d71205f-fca7-43fb-8381-6bfac68305a3" xlink:href="cvs-20230525.xsd#cvs_SignifyHealthIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_548fa04c-b7bd-42f1-a9b1-5e01951aed66" xlink:to="loc_cvs_SignifyHealthIncMember_0d71205f-fca7-43fb-8381-6bfac68305a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8e97c8e3-7ed8-44c3-a110-4bbe959e39ba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_11007a8a-ed43-4630-a00c-a98646f45e6d" xlink:to="loc_dei_LegalEntityAxis_8e97c8e3-7ed8-44c3-a110-4bbe959e39ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_83ef9ada-127b-4d10-927b-1558c5bce997" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_8e97c8e3-7ed8-44c3-a110-4bbe959e39ba" xlink:to="loc_dei_EntityDomain_83ef9ada-127b-4d10-927b-1558c5bce997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OakStreetHealthIncMember_778b215e-f220-4a98-8e17-b033a1933c22" xlink:href="cvs-20230525.xsd#cvs_OakStreetHealthIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_83ef9ada-127b-4d10-927b-1558c5bce997" xlink:to="loc_cvs_OakStreetHealthIncMember_778b215e-f220-4a98-8e17-b033a1933c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SignifyHealthIncMember_1e14dd25-d41d-4b03-8afc-277dc137079d" xlink:href="cvs-20230525.xsd#cvs_SignifyHealthIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_83ef9ada-127b-4d10-927b-1558c5bce997" xlink:to="loc_cvs_SignifyHealthIncMember_1e14dd25-d41d-4b03-8afc-277dc137079d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1182f6d6-5c77-44c3-95dc-2b601aed4fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_11007a8a-ed43-4630-a00c-a98646f45e6d" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1182f6d6-5c77-44c3-95dc-2b601aed4fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ebc4b665-c7e2-46ea-a99b-cf1e62e54103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1182f6d6-5c77-44c3-95dc-2b601aed4fa6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ebc4b665-c7e2-46ea-a99b-cf1e62e54103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e1532592-ce3a-4b7d-973f-16c6262c25a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ebc4b665-c7e2-46ea-a99b-cf1e62e54103" xlink:to="loc_us-gaap_SubsequentEventMember_e1532592-ce3a-4b7d-973f-16c6262c25a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2865625c-c58d-4422-9430-d7bb34cda5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_11007a8a-ed43-4630-a00c-a98646f45e6d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2865625c-c58d-4422-9430-d7bb34cda5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_f9cb0ae3-7d79-48e2-af7c-8402e350aded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2865625c-c58d-4422-9430-d7bb34cda5b3" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_f9cb0ae3-7d79-48e2-af7c-8402e350aded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2a47d5b6-7b68-47bb-ad4d-842b5969316b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2865625c-c58d-4422-9430-d7bb34cda5b3" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2a47d5b6-7b68-47bb-ad4d-842b5969316b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationTerminationFee_d2c027c2-77ed-448c-b299-a5d4cb59e09a" xlink:href="cvs-20230525.xsd#cvs_BusinessCombinationTerminationFee"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2865625c-c58d-4422-9430-d7bb34cda5b3" xlink:to="loc_cvs_BusinessCombinationTerminationFee_d2c027c2-77ed-448c-b299-a5d4cb59e09a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_55db10e8-55b3-4c42-8c94-f98e8aec49d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2865625c-c58d-4422-9430-d7bb34cda5b3" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_55db10e8-55b3-4c42-8c94-f98e8aec49d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_90711b0d-a591-4f2e-aa43-ab0cd4271842" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2865625c-c58d-4422-9430-d7bb34cda5b3" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_90711b0d-a591-4f2e-aa43-ab0cd4271842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_01da86c0-0f24-4811-a1c9-c2395f56eff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2865625c-c58d-4422-9430-d7bb34cda5b3" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_01da86c0-0f24-4811-a1c9-c2395f56eff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfMedicalMembers_2213c738-aba7-4631-a6c6-f0022316e037" xlink:href="cvs-20230525.xsd#cvs_NumberOfMedicalMembers"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2865625c-c58d-4422-9430-d7bb34cda5b3" xlink:to="loc_cvs_NumberOfMedicalMembers_2213c738-aba7-4631-a6c6-f0022316e037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold_3e173003-3b7f-434d-89d6-3ef8cb6cd67a" xlink:href="cvs-20230525.xsd#cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2865625c-c58d-4422-9430-d7bb34cda5b3" xlink:to="loc_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold_3e173003-3b7f-434d-89d6-3ef8cb6cd67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6f18d445-e2f7-46f4-b195-102b9caf4754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6a20e4e5-a255-40aa-86d4-302b4eb3a9c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6f18d445-e2f7-46f4-b195-102b9caf4754" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6a20e4e5-a255-40aa-86d4-302b4eb3a9c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b9accb82-cde8-47ab-98ee-0d4ce899be5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6a20e4e5-a255-40aa-86d4-302b4eb3a9c0" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b9accb82-cde8-47ab-98ee-0d4ce899be5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e967e6ef-af2c-4159-948d-5064494f7099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b9accb82-cde8-47ab-98ee-0d4ce899be5c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e967e6ef-af2c-4159-948d-5064494f7099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_33545e9e-6cef-48c7-b9ad-dffef3cc2014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_e967e6ef-af2c-4159-948d-5064494f7099" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_33545e9e-6cef-48c7-b9ad-dffef3cc2014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd70c76d-a599-4961-97c4-0bb2e5f68caa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6a20e4e5-a255-40aa-86d4-302b4eb3a9c0" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd70c76d-a599-4961-97c4-0bb2e5f68caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_56a36696-d4de-4484-9203-11fc59373a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd70c76d-a599-4961-97c4-0bb2e5f68caa" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_56a36696-d4de-4484-9203-11fc59373a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_bcb54996-a4be-44cd-96f1-dec1dd13e3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_56a36696-d4de-4484-9203-11fc59373a3f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_bcb54996-a4be-44cd-96f1-dec1dd13e3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_f8c27b71-0c66-46de-bafa-03f28307b5c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_56a36696-d4de-4484-9203-11fc59373a3f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_f8c27b71-0c66-46de-bafa-03f28307b5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_7437e5f8-a7b2-46f1-9828-895ef6b37383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_56a36696-d4de-4484-9203-11fc59373a3f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_7437e5f8-a7b2-46f1-9828-895ef6b37383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_443b1c54-5ffe-4f0e-8ebf-484eb0c56960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_56a36696-d4de-4484-9203-11fc59373a3f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_443b1c54-5ffe-4f0e-8ebf-484eb0c56960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_332b360e-ab13-403c-8104-1d1342e5f639" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_56a36696-d4de-4484-9203-11fc59373a3f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_332b360e-ab13-403c-8104-1d1342e5f639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_bc7a7fde-4e71-4144-8ae4-23828262db3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_56a36696-d4de-4484-9203-11fc59373a3f" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_bc7a7fde-4e71-4144-8ae4-23828262db3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_e60ec96a-34ec-4ff0-bc8c-08bd89067796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd70c76d-a599-4961-97c4-0bb2e5f68caa" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_e60ec96a-34ec-4ff0-bc8c-08bd89067796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_ef8ec4ba-015d-47a0-bad2-b582baf9e193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_e60ec96a-34ec-4ff0-bc8c-08bd89067796" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable_ef8ec4ba-015d-47a0-bad2-b582baf9e193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_c53fecd8-766a-4607-83d9-118510b1d00f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_e60ec96a-34ec-4ff0-bc8c-08bd89067796" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities_c53fecd8-766a-4607-83d9-118510b1d00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_1bfc194d-dfa4-4d9f-b937-3d2ecd7c30cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_e60ec96a-34ec-4ff0-bc8c-08bd89067796" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_1bfc194d-dfa4-4d9f-b937-3d2ecd7c30cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_42854162-5b0c-4580-814a-a61569b9d1b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_e60ec96a-34ec-4ff0-bc8c-08bd89067796" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_42854162-5b0c-4580-814a-a61569b9d1b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsScheduleofTotalInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_3334b00f-25eb-4bdc-bf53-50c45f6e8ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable_8af37927-9eea-45d6-b405-517053a7d398" xlink:href="cvs-20230525.xsd#cvs_TotalInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_3334b00f-25eb-4bdc-bf53-50c45f6e8ef4" xlink:to="loc_cvs_TotalInvestmentsTable_8af37927-9eea-45d6-b405-517053a7d398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis_742a5a99-10e2-4eb4-9b73-48deff57895d" xlink:href="cvs-20230525.xsd#cvs_TotalInvestmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsTable_8af37927-9eea-45d6-b405-517053a7d398" xlink:to="loc_cvs_TotalInvestmentsAxis_742a5a99-10e2-4eb4-9b73-48deff57895d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_a9a777de-3ec4-4b2b-aa15-227c003c100a" xlink:href="cvs-20230525.xsd#cvs_TotalInvestmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsAxis_742a5a99-10e2-4eb4-9b73-48deff57895d" xlink:to="loc_cvs_TotalInvestmentsDomain_a9a777de-3ec4-4b2b-aa15-227c003c100a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_005f758f-bdf3-4421-8087-5204eb2e0996" xlink:href="cvs-20230525.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_a9a777de-3ec4-4b2b-aa15-227c003c100a" xlink:to="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_005f758f-bdf3-4421-8087-5204eb2e0996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_782a0311-9fe8-4c56-a0cb-d021b4500832" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_a9a777de-3ec4-4b2b-aa15-227c003c100a" xlink:to="loc_cvs_MortgageLoansMember_782a0311-9fe8-4c56-a0cb-d021b4500832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_1caf05ae-4c12-4e7a-8add-9aaf604e5ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_a9a777de-3ec4-4b2b-aa15-227c003c100a" xlink:to="loc_us-gaap_OtherInvestmentsMember_1caf05ae-4c12-4e7a-8add-9aaf604e5ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b4808d91-f71c-47e7-a93a-315532907cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsTable_8af37927-9eea-45d6-b405-517053a7d398" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b4808d91-f71c-47e7-a93a-315532907cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_881dd869-a78c-4e10-a1fb-33058a2d6572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b4808d91-f71c-47e7-a93a-315532907cec" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_881dd869-a78c-4e10-a1fb-33058a2d6572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_6818c559-9bb7-407b-a2b2-26068424ba00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_881dd869-a78c-4e10-a1fb-33058a2d6572" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_6818c559-9bb7-407b-a2b2-26068424ba00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems_a01847f3-4925-4a84-ae81-bc754af1431d" xlink:href="cvs-20230525.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsTable_8af37927-9eea-45d6-b405-517053a7d398" xlink:to="loc_cvs_TotalInvestmentsLineItems_a01847f3-4925-4a84-ae81-bc754af1431d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_bfe3a03a-7586-429b-864f-8f352131906e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_a01847f3-4925-4a84-ae81-bc754af1431d" xlink:to="loc_us-gaap_ShortTermInvestments_bfe3a03a-7586-429b-864f-8f352131906e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermInvestmentsIncludingAssetsHeldForSale_de44943f-3b1c-44cf-87e5-129ca394fc8f" xlink:href="cvs-20230525.xsd#cvs_LongTermInvestmentsIncludingAssetsHeldForSale"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_a01847f3-4925-4a84-ae81-bc754af1431d" xlink:to="loc_cvs_LongTermInvestmentsIncludingAssetsHeldForSale_de44943f-3b1c-44cf-87e5-129ca394fc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_8cefa8a5-7529-46f7-8fbf-47587fedb29d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_a01847f3-4925-4a84-ae81-bc754af1431d" xlink:to="loc_us-gaap_Investments_8cefa8a5-7529-46f7-8fbf-47587fedb29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_4c2a5725-211d-4275-8e5e-b0ce62d161c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a67f6608-4500-435f-ab17-1a0fbb54284b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_4c2a5725-211d-4275-8e5e-b0ce62d161c4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a67f6608-4500-435f-ab17-1a0fbb54284b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_766c955f-3dbd-4f45-b046-2865d83d7218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a67f6608-4500-435f-ab17-1a0fbb54284b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_766c955f-3dbd-4f45-b046-2865d83d7218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63c19042-bee3-4f78-89f2-a3a64297b6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_766c955f-3dbd-4f45-b046-2865d83d7218" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63c19042-bee3-4f78-89f2-a3a64297b6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_3e706585-9c44-4e6b-b6d2-6663052a83f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63c19042-bee3-4f78-89f2-a3a64297b6a4" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_3e706585-9c44-4e6b-b6d2-6663052a83f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_59e7e3ea-6792-43a4-b416-7c9e718c70cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63c19042-bee3-4f78-89f2-a3a64297b6a4" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_59e7e3ea-6792-43a4-b416-7c9e718c70cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_4280b4b3-0351-49b4-880a-7f101950fc51" xlink:href="cvs-20230525.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63c19042-bee3-4f78-89f2-a3a64297b6a4" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_4280b4b3-0351-49b4-880a-7f101950fc51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1e3f2050-c358-41ee-869d-b20971da069d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a67f6608-4500-435f-ab17-1a0fbb54284b" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1e3f2050-c358-41ee-869d-b20971da069d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedInvestmentsAtFairValue_17f64c0b-aaff-45a9-a80f-83b650467fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedInvestmentsAtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1e3f2050-c358-41ee-869d-b20971da069d" xlink:to="loc_us-gaap_RestrictedInvestmentsAtFairValue_17f64c0b-aaff-45a9-a80f-83b650467fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities_0810a428-88a3-414f-b4ef-14b02e2a4dbe" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1e3f2050-c358-41ee-869d-b20971da069d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities_0810a428-88a3-414f-b4ef-14b02e2a4dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_87cb04ab-8e76-448e-9733-bc8cb3df6871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8b328dd1-4393-4a09-b9f0-c814b4ac56cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_87cb04ab-8e76-448e-9733-bc8cb3df6871" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8b328dd1-4393-4a09-b9f0-c814b4ac56cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a74884f2-573d-460e-a22c-f128237bb56b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8b328dd1-4393-4a09-b9f0-c814b4ac56cd" xlink:to="loc_srt_ProductOrServiceAxis_a74884f2-573d-460e-a22c-f128237bb56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_926716ff-da6b-4762-b66c-f7d26e993ca7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a74884f2-573d-460e-a22c-f128237bb56b" xlink:to="loc_srt_ProductsAndServicesDomain_926716ff-da6b-4762-b66c-f7d26e993ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_8ee3e2c0-0f35-4411-83bf-ae49d89bf231" xlink:href="cvs-20230525.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_926716ff-da6b-4762-b66c-f7d26e993ca7" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_8ee3e2c0-0f35-4411-83bf-ae49d89bf231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2cc64349-0985-40f4-96bd-e9d2ce57dd58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8b328dd1-4393-4a09-b9f0-c814b4ac56cd" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2cc64349-0985-40f4-96bd-e9d2ce57dd58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ccb4783-e60c-4e12-a63a-dbb70f34e383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2cc64349-0985-40f4-96bd-e9d2ce57dd58" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ccb4783-e60c-4e12-a63a-dbb70f34e383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_800e8298-e262-4f45-83ea-84bb78425cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6ccb4783-e60c-4e12-a63a-dbb70f34e383" xlink:to="loc_us-gaap_DebtSecuritiesMember_800e8298-e262-4f45-83ea-84bb78425cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_b9ac6ab5-8ffe-43d9-ba80-d796c3079f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_800e8298-e262-4f45-83ea-84bb78425cfb" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_b9ac6ab5-8ffe-43d9-ba80-d796c3079f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_89321d17-329c-441d-ba72-35b2a8d6a511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_800e8298-e262-4f45-83ea-84bb78425cfb" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_89321d17-329c-441d-ba72-35b2a8d6a511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_95aad425-0479-4d40-96be-e5ce50b2837c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_800e8298-e262-4f45-83ea-84bb78425cfb" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_95aad425-0479-4d40-96be-e5ce50b2837c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_3596e3bd-8dcd-400b-b225-07e0886c307a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_800e8298-e262-4f45-83ea-84bb78425cfb" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_3596e3bd-8dcd-400b-b225-07e0886c307a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_52fdc3e9-29e8-4e1f-bfdf-96a258255794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_800e8298-e262-4f45-83ea-84bb78425cfb" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_52fdc3e9-29e8-4e1f-bfdf-96a258255794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_e7a736af-4e3e-4ab4-b71f-ac673711d9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_800e8298-e262-4f45-83ea-84bb78425cfb" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_e7a736af-4e3e-4ab4-b71f-ac673711d9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_5b75d70c-8632-46c8-a178-0d5627e72704" xlink:href="cvs-20230525.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_800e8298-e262-4f45-83ea-84bb78425cfb" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_5b75d70c-8632-46c8-a178-0d5627e72704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_efe20b4f-2496-4043-9c9f-f7c1979d48e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_800e8298-e262-4f45-83ea-84bb78425cfb" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_efe20b4f-2496-4043-9c9f-f7c1979d48e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5a6a5272-de43-47b2-aee2-47d16df8d691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8b328dd1-4393-4a09-b9f0-c814b4ac56cd" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5a6a5272-de43-47b2-aee2-47d16df8d691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_248d6d68-a398-418b-addd-ec693f04591f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5a6a5272-de43-47b2-aee2-47d16df8d691" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_248d6d68-a398-418b-addd-ec693f04591f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_9fa86398-800e-418f-9733-13aecc1de1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5a6a5272-de43-47b2-aee2-47d16df8d691" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_9fa86398-800e-418f-9733-13aecc1de1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_3b8f82fa-f2a4-4016-b6f4-5ba0d44f74f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5a6a5272-de43-47b2-aee2-47d16df8d691" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_3b8f82fa-f2a4-4016-b6f4-5ba0d44f74f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_30bc3596-48c0-469d-9bf4-e21140bcb14c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5a6a5272-de43-47b2-aee2-47d16df8d691" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_30bc3596-48c0-469d-9bf4-e21140bcb14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_173f3af3-9250-4b59-a04e-509444f13bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5a6a5272-de43-47b2-aee2-47d16df8d691" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_173f3af3-9250-4b59-a04e-509444f13bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e817cf9a-97fa-498d-af2a-06a581aed5be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5a6a5272-de43-47b2-aee2-47d16df8d691" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e817cf9a-97fa-498d-af2a-06a581aed5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsDebtSecuritiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_1bd9408f-d7d4-412e-875c-c7229be49b70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_60d7202d-3072-4ed9-867c-58ed568d3d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_1bd9408f-d7d4-412e-875c-c7229be49b70" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_60d7202d-3072-4ed9-867c-58ed568d3d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_fb99b13a-bc57-41b4-8eed-58861b6aa784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_60d7202d-3072-4ed9-867c-58ed568d3d5f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_fb99b13a-bc57-41b4-8eed-58861b6aa784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d4bf23b5-400a-4d60-9c07-80a063fa4a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_fb99b13a-bc57-41b4-8eed-58861b6aa784" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d4bf23b5-400a-4d60-9c07-80a063fa4a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_088604b1-734f-45ac-97a4-4f00e2ba4d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d4bf23b5-400a-4d60-9c07-80a063fa4a99" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_088604b1-734f-45ac-97a4-4f00e2ba4d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_64eb9838-10df-44ae-a8ee-85b8e852ed5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d4bf23b5-400a-4d60-9c07-80a063fa4a99" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_64eb9838-10df-44ae-a8ee-85b8e852ed5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_b40e3bf8-5841-459b-9bdc-fd93d567f573" xlink:href="cvs-20230525.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d4bf23b5-400a-4d60-9c07-80a063fa4a99" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_b40e3bf8-5841-459b-9bdc-fd93d567f573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c5c3d2dc-5127-4fe4-9e3f-4ba465682e98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_60d7202d-3072-4ed9-867c-58ed568d3d5f" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c5c3d2dc-5127-4fe4-9e3f-4ba465682e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_48797424-2a2d-455a-8be3-b4a4f3e0865c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c5c3d2dc-5127-4fe4-9e3f-4ba465682e98" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_48797424-2a2d-455a-8be3-b4a4f3e0865c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_68cf3368-9e08-436e-b134-dd5f2611e88d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_48797424-2a2d-455a-8be3-b4a4f3e0865c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_68cf3368-9e08-436e-b134-dd5f2611e88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_2981a2ac-4d52-4d58-8a84-5c381af9571f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_48797424-2a2d-455a-8be3-b4a4f3e0865c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_2981a2ac-4d52-4d58-8a84-5c381af9571f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_53b38328-a8c0-4b16-b7ef-004a5e1eabb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_48797424-2a2d-455a-8be3-b4a4f3e0865c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_53b38328-a8c0-4b16-b7ef-004a5e1eabb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_f8e9aa95-5476-40d3-8a57-438f84e4709f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_48797424-2a2d-455a-8be3-b4a4f3e0865c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_f8e9aa95-5476-40d3-8a57-438f84e4709f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_5d8c754b-cc12-4423-ae15-78992c95b429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_48797424-2a2d-455a-8be3-b4a4f3e0865c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_5d8c754b-cc12-4423-ae15-78992c95b429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_e587bdc1-5829-4ce4-ae3f-416aee323f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_48797424-2a2d-455a-8be3-b4a4f3e0865c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_e587bdc1-5829-4ce4-ae3f-416aee323f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_6aca95e4-8bc0-4e37-aaab-2745ea1133a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c5c3d2dc-5127-4fe4-9e3f-4ba465682e98" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_6aca95e4-8bc0-4e37-aaab-2745ea1133a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_a101d6d7-d404-4e62-887a-3c21722315ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_6aca95e4-8bc0-4e37-aaab-2745ea1133a8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_a101d6d7-d404-4e62-887a-3c21722315ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_2a64f248-750b-42d9-a724-bdf43e3e8315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_6aca95e4-8bc0-4e37-aaab-2745ea1133a8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_2a64f248-750b-42d9-a724-bdf43e3e8315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_6abc8627-f4ae-4bd1-8400-3e60800a394c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_6aca95e4-8bc0-4e37-aaab-2745ea1133a8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_6abc8627-f4ae-4bd1-8400-3e60800a394c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_c7db15ce-47bc-47e9-acfa-4d627962172e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_6aca95e4-8bc0-4e37-aaab-2745ea1133a8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_c7db15ce-47bc-47e9-acfa-4d627962172e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_20459287-7ed7-42af-b9f8-04bd53f4058b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_6aca95e4-8bc0-4e37-aaab-2745ea1133a8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_20459287-7ed7-42af-b9f8-04bd53f4058b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0e88e5f3-00c4-43be-90ee-6e50a1cbbe89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_6aca95e4-8bc0-4e37-aaab-2745ea1133a8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0e88e5f3-00c4-43be-90ee-6e50a1cbbe89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_75500bbf-e4db-4a70-88b3-5acb48782bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_7e9c76f2-3811-4f53-9615-f9a3fb9cb6f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_75500bbf-e4db-4a70-88b3-5acb48782bbe" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_7e9c76f2-3811-4f53-9615-f9a3fb9cb6f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ee290eb9-6514-473a-96a3-e0d346ece9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_7e9c76f2-3811-4f53-9615-f9a3fb9cb6f2" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ee290eb9-6514-473a-96a3-e0d346ece9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3b251320-d020-4fff-a501-e13b7c7ae8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ee290eb9-6514-473a-96a3-e0d346ece9a1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3b251320-d020-4fff-a501-e13b7c7ae8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_7667fb0b-efc7-46ba-a008-d5dd35b13b88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3b251320-d020-4fff-a501-e13b7c7ae8b4" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_7667fb0b-efc7-46ba-a008-d5dd35b13b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_a2eb6f90-d91e-4cfe-b532-602ae44b9e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3b251320-d020-4fff-a501-e13b7c7ae8b4" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_a2eb6f90-d91e-4cfe-b532-602ae44b9e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_57080d1c-523d-482d-ae84-9c85a68732e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3b251320-d020-4fff-a501-e13b7c7ae8b4" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_57080d1c-523d-482d-ae84-9c85a68732e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_23bb9bee-47fd-4f8b-a39c-de965a244396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3b251320-d020-4fff-a501-e13b7c7ae8b4" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_23bb9bee-47fd-4f8b-a39c-de965a244396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_e12fae56-0d38-4b27-84d3-52ba5a86fb36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3b251320-d020-4fff-a501-e13b7c7ae8b4" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_e12fae56-0d38-4b27-84d3-52ba5a86fb36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_4821ab5e-547c-451d-8005-0cca9a33a3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3b251320-d020-4fff-a501-e13b7c7ae8b4" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_4821ab5e-547c-451d-8005-0cca9a33a3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_e0c88387-a8be-4471-a3fc-455fdb55c0df" xlink:href="cvs-20230525.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3b251320-d020-4fff-a501-e13b7c7ae8b4" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_e0c88387-a8be-4471-a3fc-455fdb55c0df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_e5ae29f9-f08b-4ad6-93ef-a12a23ce5bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3b251320-d020-4fff-a501-e13b7c7ae8b4" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_e5ae29f9-f08b-4ad6-93ef-a12a23ce5bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_87582c03-7a50-48cb-9a01-5e880503470d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_7e9c76f2-3811-4f53-9615-f9a3fb9cb6f2" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_87582c03-7a50-48cb-9a01-5e880503470d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_324ac0c5-2f7e-4121-bae4-ea4828f3e497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_87582c03-7a50-48cb-9a01-5e880503470d" xlink:to="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_324ac0c5-2f7e-4121-bae4-ea4828f3e497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_94d95906-b7b7-481b-aecf-edd99584188e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_324ac0c5-2f7e-4121-bae4-ea4828f3e497" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_94d95906-b7b7-481b-aecf-edd99584188e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_c3e0127e-e506-4f71-988d-146dd69a09d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_324ac0c5-2f7e-4121-bae4-ea4828f3e497" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_c3e0127e-e506-4f71-988d-146dd69a09d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_1f9485cb-ded4-432a-80d0-c8f05dd8abe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_324ac0c5-2f7e-4121-bae4-ea4828f3e497" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_1f9485cb-ded4-432a-80d0-c8f05dd8abe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_2515f3c0-33a2-4a3f-98ea-f4e1a96d25a1" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_87582c03-7a50-48cb-9a01-5e880503470d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_2515f3c0-33a2-4a3f-98ea-f4e1a96d25a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_f95634d8-6b10-4890-8f56-19f43c1c6a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_2515f3c0-33a2-4a3f-98ea-f4e1a96d25a1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_f95634d8-6b10-4890-8f56-19f43c1c6a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0ef76b2a-f3b9-4712-866b-0086d43e0a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_2515f3c0-33a2-4a3f-98ea-f4e1a96d25a1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0ef76b2a-f3b9-4712-866b-0086d43e0a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_d0a71bf1-0c37-41c7-83b2-7a2f755c5d31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_2515f3c0-33a2-4a3f-98ea-f4e1a96d25a1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_d0a71bf1-0c37-41c7-83b2-7a2f755c5d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ec28e96-03e8-4f79-a030-31d1e6e3da8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_87582c03-7a50-48cb-9a01-5e880503470d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ec28e96-03e8-4f79-a030-31d1e6e3da8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_f9812877-61bb-46c4-824f-81e225fa5e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ec28e96-03e8-4f79-a030-31d1e6e3da8b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_f9812877-61bb-46c4-824f-81e225fa5e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_f2bdef69-2a22-41b1-a350-813df3fafbb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ec28e96-03e8-4f79-a030-31d1e6e3da8b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_f2bdef69-2a22-41b1-a350-813df3fafbb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_b592f97c-a4bf-4023-b30f-b1afe68984d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ec28e96-03e8-4f79-a030-31d1e6e3da8b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_b592f97c-a4bf-4023-b30f-b1afe68984d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_7a7f1d00-8948-4f67-93a7-0119bae35ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a3bc0d84-cf5b-420c-bfef-bd2e46474cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_7a7f1d00-8948-4f67-93a7-0119bae35ab1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a3bc0d84-cf5b-420c-bfef-bd2e46474cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e15532fe-964e-4cda-900a-d80ca362ddf3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a3bc0d84-cf5b-420c-bfef-bd2e46474cb8" xlink:to="loc_srt_ProductOrServiceAxis_e15532fe-964e-4cda-900a-d80ca362ddf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9a54819b-2491-4631-aa8b-bd58cce44afc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e15532fe-964e-4cda-900a-d80ca362ddf3" xlink:to="loc_srt_ProductsAndServicesDomain_9a54819b-2491-4631-aa8b-bd58cce44afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_f665eab5-8f6f-4973-a79b-6d826f8565f6" xlink:href="cvs-20230525.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9a54819b-2491-4631-aa8b-bd58cce44afc" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_f665eab5-8f6f-4973-a79b-6d826f8565f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember_7910b36b-03b0-40ba-a2ac-2fd7374ce10e" xlink:href="cvs-20230525.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9a54819b-2491-4631-aa8b-bd58cce44afc" xlink:to="loc_cvs_SupportingRemainingProductsMember_7910b36b-03b0-40ba-a2ac-2fd7374ce10e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6457fb42-6b9c-4077-8bc8-cc8763b288d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a3bc0d84-cf5b-420c-bfef-bd2e46474cb8" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6457fb42-6b9c-4077-8bc8-cc8763b288d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8607275-4d96-4f39-a1d4-a8d4f107353f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6457fb42-6b9c-4077-8bc8-cc8763b288d6" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8607275-4d96-4f39-a1d4-a8d4f107353f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_c6f01c89-f7fe-4e88-adde-9f37e40622b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8607275-4d96-4f39-a1d4-a8d4f107353f" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_c6f01c89-f7fe-4e88-adde-9f37e40622b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_17f18ff7-e904-47b7-bbfc-337c257619cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8607275-4d96-4f39-a1d4-a8d4f107353f" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_17f18ff7-e904-47b7-bbfc-337c257619cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_9e393402-72e9-45a4-b8fb-deb1d20c2fde" xlink:href="cvs-20230525.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8607275-4d96-4f39-a1d4-a8d4f107353f" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_9e393402-72e9-45a4-b8fb-deb1d20c2fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5c2aa0-9bdb-42d9-b9a2-145b61501db4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a3bc0d84-cf5b-420c-bfef-bd2e46474cb8" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5c2aa0-9bdb-42d9-b9a2-145b61501db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_385044e2-36db-4b01-b520-1f5364f5fabc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5c2aa0-9bdb-42d9-b9a2-145b61501db4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_385044e2-36db-4b01-b520-1f5364f5fabc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_88097e7f-6b32-4828-a3b5-82f08ec76f41" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_385044e2-36db-4b01-b520-1f5364f5fabc" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_88097e7f-6b32-4828-a3b5-82f08ec76f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_7e030ed8-4bd9-4fe4-aeb8-80a97c6cb692" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_385044e2-36db-4b01-b520-1f5364f5fabc" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_7e030ed8-4bd9-4fe4-aeb8-80a97c6cb692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_22e4d810-31e0-4c7e-a363-829264c15946" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_385044e2-36db-4b01-b520-1f5364f5fabc" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_22e4d810-31e0-4c7e-a363-829264c15946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_150149e4-6580-4313-9ced-fb6df5b3dbee" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_385044e2-36db-4b01-b520-1f5364f5fabc" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_150149e4-6580-4313-9ced-fb6df5b3dbee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue_38b6f4de-167e-4764-a7cb-9704666befa6" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_385044e2-36db-4b01-b520-1f5364f5fabc" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue_38b6f4de-167e-4764-a7cb-9704666befa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_df4e125a-d9ab-4bfd-a25a-f6544d34af1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_385044e2-36db-4b01-b520-1f5364f5fabc" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_df4e125a-d9ab-4bfd-a25a-f6544d34af1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f5c98f89-a579-4d50-8d21-9b0e02399fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7d5c2aa0-9bdb-42d9-b9a2-145b61501db4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f5c98f89-a579-4d50-8d21-9b0e02399fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_705ee089-2e17-4895-9ecb-b9ff94980b0b" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f5c98f89-a579-4d50-8d21-9b0e02399fd4" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_705ee089-2e17-4895-9ecb-b9ff94980b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_84c2f960-f68a-4187-ad1a-d7ca9523c47c" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f5c98f89-a579-4d50-8d21-9b0e02399fd4" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_84c2f960-f68a-4187-ad1a-d7ca9523c47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_c5783752-f663-4d80-b062-8ace2c136120" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f5c98f89-a579-4d50-8d21-9b0e02399fd4" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_c5783752-f663-4d80-b062-8ace2c136120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_c186961f-ddae-4220-a862-cbc2daeb963c" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f5c98f89-a579-4d50-8d21-9b0e02399fd4" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_c186961f-ddae-4220-a862-cbc2daeb963c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss_66516966-7c38-4ecd-8315-eaf1b13d75df" xlink:href="cvs-20230525.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f5c98f89-a579-4d50-8d21-9b0e02399fd4" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss_66516966-7c38-4ecd-8315-eaf1b13d75df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_41e2ae5b-8d61-4c3f-91c8-b9c8b013549b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f5c98f89-a579-4d50-8d21-9b0e02399fd4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_41e2ae5b-8d61-4c3f-91c8-b9c8b013549b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsMortgageLoansDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_40e23e34-3c3b-48fa-bfa8-83dd2f35a47e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_6c189417-d3fd-4d31-96bb-fcbab41fa842" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_40e23e34-3c3b-48fa-bfa8-83dd2f35a47e" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_6c189417-d3fd-4d31-96bb-fcbab41fa842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_16a498a9-8cf5-4962-859b-17edbd16bb5a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_6c189417-d3fd-4d31-96bb-fcbab41fa842" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_16a498a9-8cf5-4962-859b-17edbd16bb5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_1d7065ac-7ab0-477c-afae-815c6600b12c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_16a498a9-8cf5-4962-859b-17edbd16bb5a" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_1d7065ac-7ab0-477c-afae-815c6600b12c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_bbaa5f42-5b97-465d-b43a-dfbcd35a2929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_1d7065ac-7ab0-477c-afae-815c6600b12c" xlink:to="loc_us-gaap_CommercialRealEstateMember_bbaa5f42-5b97-465d-b43a-dfbcd35a2929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_3ec53b1b-0902-4906-8f3a-ff7ed940e356" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_6c189417-d3fd-4d31-96bb-fcbab41fa842" xlink:to="loc_srt_MortgageLoansOnRealEstateLineItems_3ec53b1b-0902-4906-8f3a-ff7ed940e356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_f2c8a8db-1c2e-43c5-993d-dbd824b46b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_3ec53b1b-0902-4906-8f3a-ff7ed940e356" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_f2c8a8db-1c2e-43c5-993d-dbd824b46b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_16f47922-ed8f-442f-9648-3fbb51e6b1f2" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_3ec53b1b-0902-4906-8f3a-ff7ed940e356" xlink:to="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_16f47922-ed8f-442f-9648-3fbb51e6b1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_86c4ed9f-f135-4186-8c3b-30775ffb2c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_3ec53b1b-0902-4906-8f3a-ff7ed940e356" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_86c4ed9f-f135-4186-8c3b-30775ffb2c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsMortgageLoansCreditRatingsIndicatorDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_e0a22bc1-d98c-44dd-8e89-a3c8fdc9e2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_ef36fd79-1dd5-486c-bc26-4d2ce2741ee7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_e0a22bc1-d98c-44dd-8e89-a3c8fdc9e2c7" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_ef36fd79-1dd5-486c-bc26-4d2ce2741ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_88ed3127-2a39-4c34-8d7d-00f9ab4e75cd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_ef36fd79-1dd5-486c-bc26-4d2ce2741ee7" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_88ed3127-2a39-4c34-8d7d-00f9ab4e75cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_703560c0-305c-4381-90fc-1d056047f21e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_88ed3127-2a39-4c34-8d7d-00f9ab4e75cd" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_703560c0-305c-4381-90fc-1d056047f21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_016d3440-b710-4f38-9faa-cdbd7e32353a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_703560c0-305c-4381-90fc-1d056047f21e" xlink:to="loc_us-gaap_CommercialRealEstateMember_016d3440-b710-4f38-9faa-cdbd7e32353a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentAxis_44b044c2-a43a-4f94-82bf-648ed07ce3ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalCreditAssessmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_ef36fd79-1dd5-486c-bc26-4d2ce2741ee7" xlink:to="loc_us-gaap_InternalCreditAssessmentAxis_44b044c2-a43a-4f94-82bf-648ed07ce3ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentDomain_5e4d635a-297f-4cf3-b513-6a11460998b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalCreditAssessmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentAxis_44b044c2-a43a-4f94-82bf-648ed07ce3ac" xlink:to="loc_us-gaap_InternalCreditAssessmentDomain_5e4d635a-297f-4cf3-b513-6a11460998b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member_2c5746f2-3f1f-46c2-8946-656fea93ea0a" xlink:href="cvs-20230525.xsd#cvs_Category1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_5e4d635a-297f-4cf3-b513-6a11460998b4" xlink:to="loc_cvs_Category1Member_2c5746f2-3f1f-46c2-8946-656fea93ea0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member_266ea780-7152-49a3-b823-4b16bebe4efa" xlink:href="cvs-20230525.xsd#cvs_Category2To4Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_5e4d635a-297f-4cf3-b513-6a11460998b4" xlink:to="loc_cvs_Category2To4Member_266ea780-7152-49a3-b823-4b16bebe4efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5And6Member_9f0f98c0-f5c0-49a7-a37a-b87ece1e429e" xlink:href="cvs-20230525.xsd#cvs_Categories5And6Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_5e4d635a-297f-4cf3-b513-6a11460998b4" xlink:to="loc_cvs_Categories5And6Member_9f0f98c0-f5c0-49a7-a37a-b87ece1e429e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member_baac87da-e659-46c1-8a9e-bf48cd36a2cb" xlink:href="cvs-20230525.xsd#cvs_Category7Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_5e4d635a-297f-4cf3-b513-6a11460998b4" xlink:to="loc_cvs_Category7Member_baac87da-e659-46c1-8a9e-bf48cd36a2cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_17861d07-cc3d-44fa-9667-3024f4c0e8da" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_ef36fd79-1dd5-486c-bc26-4d2ce2741ee7" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_17861d07-cc3d-44fa-9667-3024f4c0e8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_38bdf1b5-8084-4df9-8d22-e92d13cebf43" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_17861d07-cc3d-44fa-9667-3024f4c0e8da" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_38bdf1b5-8084-4df9-8d22-e92d13cebf43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember_4e13aa48-f30c-48d3-b1cd-15137d7eb4a4" xlink:href="cvs-20230525.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_38bdf1b5-8084-4df9-8d22-e92d13cebf43" xlink:to="loc_cvs_YearOfOriginationPeriodOneMember_4e13aa48-f30c-48d3-b1cd-15137d7eb4a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember_e7a6ee60-ae61-49a5-9e9e-f169b2f2fac9" xlink:href="cvs-20230525.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_38bdf1b5-8084-4df9-8d22-e92d13cebf43" xlink:to="loc_cvs_YearOfOriginationPeriodTwoMember_e7a6ee60-ae61-49a5-9e9e-f169b2f2fac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember_7e432b57-93be-435f-88a2-72d6fe11c5bf" xlink:href="cvs-20230525.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_38bdf1b5-8084-4df9-8d22-e92d13cebf43" xlink:to="loc_cvs_YearOfOriginationPeriodThreeMember_7e432b57-93be-435f-88a2-72d6fe11c5bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember_731102b2-c8da-4ed3-af25-4a547424a1bb" xlink:href="cvs-20230525.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_38bdf1b5-8084-4df9-8d22-e92d13cebf43" xlink:to="loc_cvs_YearOfOriginationPeriodFourMember_731102b2-c8da-4ed3-af25-4a547424a1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember_b674f20c-9b09-431b-8123-5efe7553c8e9" xlink:href="cvs-20230525.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_38bdf1b5-8084-4df9-8d22-e92d13cebf43" xlink:to="loc_cvs_YearOfOriginationPeriodFiveMember_b674f20c-9b09-431b-8123-5efe7553c8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_ea55d938-06f5-48b3-a91f-b5750e442d2a" xlink:href="cvs-20230525.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_38bdf1b5-8084-4df9-8d22-e92d13cebf43" xlink:to="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_ea55d938-06f5-48b3-a91f-b5750e442d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_fb7911a9-1fd3-4c02-8cf7-78f933c60ef3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_ef36fd79-1dd5-486c-bc26-4d2ce2741ee7" xlink:to="loc_srt_MortgageLoansOnRealEstateLineItems_fb7911a9-1fd3-4c02-8cf7-78f933c60ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate_cad3a1a9-a1b7-4853-a555-c806303da533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_fb7911a9-1fd3-4c02-8cf7-78f933c60ef3" xlink:to="loc_us-gaap_MortgageLoansOnRealEstate_cad3a1a9-a1b7-4853-a555-c806303da533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsMortgageLoanPrincipalRepaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_d497b691-6ea2-43c4-9267-697e851b858a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_9b148a73-63a2-4f99-8d4b-b276fc5b4ec7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_d497b691-6ea2-43c4-9267-697e851b858a" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_9b148a73-63a2-4f99-8d4b-b276fc5b4ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_7e366328-0d11-445c-b932-c32cf3d075bd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_9b148a73-63a2-4f99-8d4b-b276fc5b4ec7" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_7e366328-0d11-445c-b932-c32cf3d075bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_96bcbbce-e843-4734-8581-5f005e913b61" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_7e366328-0d11-445c-b932-c32cf3d075bd" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_96bcbbce-e843-4734-8581-5f005e913b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_f19a36d1-3053-4abe-882f-03a59d10deb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_96bcbbce-e843-4734-8581-5f005e913b61" xlink:to="loc_us-gaap_CommercialRealEstateMember_f19a36d1-3053-4abe-882f-03a59d10deb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_482595a2-e60b-4d5b-b047-81ebedc8d6d7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_9b148a73-63a2-4f99-8d4b-b276fc5b4ec7" xlink:to="loc_srt_MortgageLoansOnRealEstateLineItems_482595a2-e60b-4d5b-b047-81ebedc8d6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_6c8b3c88-e4ee-4829-9a79-c60ea14efadc" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_482595a2-e60b-4d5b-b047-81ebedc8d6d7" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_6c8b3c88-e4ee-4829-9a79-c60ea14efadc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_ad180bb7-0ac2-4338-af04-a10d9f27d5e7" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_482595a2-e60b-4d5b-b047-81ebedc8d6d7" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_ad180bb7-0ac2-4338-af04-a10d9f27d5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_4a19e077-f912-4472-b1f1-a751a8bbc23d" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_482595a2-e60b-4d5b-b047-81ebedc8d6d7" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_4a19e077-f912-4472-b1f1-a751a8bbc23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_2085e14a-5181-4a55-9fc5-17f7964dbcbb" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_482595a2-e60b-4d5b-b047-81ebedc8d6d7" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_2085e14a-5181-4a55-9fc5-17f7964dbcbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_7cd10b26-82f7-44dc-8f01-8efbccad2228" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_482595a2-e60b-4d5b-b047-81ebedc8d6d7" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_7cd10b26-82f7-44dc-8f01-8efbccad2228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_a8d064b7-c4a0-49da-8678-fcac56d9ac5b" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_482595a2-e60b-4d5b-b047-81ebedc8d6d7" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_a8d064b7-c4a0-49da-8678-fcac56d9ac5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_15abf5f5-0ccf-4985-b2c5-b35be2814c71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_482595a2-e60b-4d5b-b047-81ebedc8d6d7" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_15abf5f5-0ccf-4985-b2c5-b35be2814c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_2cab5d2c-9b7f-4029-b553-14aa3093236d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_d35dde92-f818-4d91-b861-e10a73a989ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_2cab5d2c-9b7f-4029-b553-14aa3093236d" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_d35dde92-f818-4d91-b861-e10a73a989ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_7c62c8a8-b46d-4248-bf3c-d4f95177480b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_d35dde92-f818-4d91-b861-e10a73a989ec" xlink:to="loc_us-gaap_InvestmentTypeAxis_7c62c8a8-b46d-4248-bf3c-d4f95177480b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_75d39fcd-75e8-4732-a9cd-7fb0305dde50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_7c62c8a8-b46d-4248-bf3c-d4f95177480b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_75d39fcd-75e8-4732-a9cd-7fb0305dde50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_7ffc5643-036d-47ff-b647-9c6e5bdf9c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_75d39fcd-75e8-4732-a9cd-7fb0305dde50" xlink:to="loc_us-gaap_DebtSecuritiesMember_7ffc5643-036d-47ff-b647-9c6e5bdf9c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_c7194637-b83e-4f23-8801-3f4ccd846cdd" xlink:href="cvs-20230525.xsd#cvs_MortgageLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_75d39fcd-75e8-4732-a9cd-7fb0305dde50" xlink:to="loc_cvs_MortgageLoansMember_c7194637-b83e-4f23-8801-3f4ccd846cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_a7f1d262-2a69-47e1-a698-32ff6168435b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_75d39fcd-75e8-4732-a9cd-7fb0305dde50" xlink:to="loc_us-gaap_OtherInvestmentsMember_a7f1d262-2a69-47e1-a698-32ff6168435b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3b649bd4-1780-4cbe-8b74-13080d58e914" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_d35dde92-f818-4d91-b861-e10a73a989ec" xlink:to="loc_srt_ProductOrServiceAxis_3b649bd4-1780-4cbe-8b74-13080d58e914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2fd2f433-50a0-4629-9f43-81b1f72e3eda" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_3b649bd4-1780-4cbe-8b74-13080d58e914" xlink:to="loc_srt_ProductsAndServicesDomain_2fd2f433-50a0-4629-9f43-81b1f72e3eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_768d3a2c-c1db-4534-8a55-ed68c31ef120" xlink:href="cvs-20230525.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2fd2f433-50a0-4629-9f43-81b1f72e3eda" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_768d3a2c-c1db-4534-8a55-ed68c31ef120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_59fd2704-ab9e-4250-9a96-acfe1f56ca33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_d35dde92-f818-4d91-b861-e10a73a989ec" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_59fd2704-ab9e-4250-9a96-acfe1f56ca33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_35863e88-0556-4164-959e-828090b9dcc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_59fd2704-ab9e-4250-9a96-acfe1f56ca33" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_35863e88-0556-4164-959e-828090b9dcc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_516640e9-d90f-416b-8f37-6aba073feac6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_59fd2704-ab9e-4250-9a96-acfe1f56ca33" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_516640e9-d90f-416b-8f37-6aba073feac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_ad3d0549-c18a-49ec-a32d-7ed8a4cea4e0" xlink:href="cvs-20230525.xsd#cvs_InvestmentIncomeExcludingCapitalGainsOrLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_59fd2704-ab9e-4250-9a96-acfe1f56ca33" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses_ad3d0549-c18a-49ec-a32d-7ed8a4cea4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_955dc1ec-d3bd-4dd0-999d-83b0dda9f43d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_59fd2704-ab9e-4250-9a96-acfe1f56ca33" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_955dc1ec-d3bd-4dd0-999d-83b0dda9f43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_822e5afc-3806-41db-9b02-9c7f84be7a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_59fd2704-ab9e-4250-9a96-acfe1f56ca33" xlink:to="loc_us-gaap_InvestmentIncomeNet_822e5afc-3806-41db-9b02-9c7f84be7a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_fb742b5c-8c7c-4b4b-951f-febd5ea742dc" xlink:href="cvs-20230525.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_59fd2704-ab9e-4250-9a96-acfe1f56ca33" xlink:to="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_fb742b5c-8c7c-4b4b-951f-febd5ea742dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_a4698037-d195-48e2-a2fe-c5a274ffc5dd" xlink:href="cvs-20230525.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_59fd2704-ab9e-4250-9a96-acfe1f56ca33" xlink:to="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_a4698037-d195-48e2-a2fe-c5a274ffc5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#InvestmentsRealizedGainsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_f05c49dc-a964-459b-87b8-164322f1ec68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_1b6f70a3-9b72-449b-8913-9780951e8b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_f05c49dc-a964-459b-87b8-164322f1ec68" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_1b6f70a3-9b72-449b-8913-9780951e8b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_a0d5fdf4-d2e4-4ec3-a302-a3f73cd64be9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_f05c49dc-a964-459b-87b8-164322f1ec68" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_a0d5fdf4-d2e4-4ec3-a302-a3f73cd64be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_53bd49d7-64f5-48fe-90c7-622809548306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_f05c49dc-a964-459b-87b8-164322f1ec68" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_53bd49d7-64f5-48fe-90c7-622809548306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#FairValueFairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4b4e6268-92b0-421e-bc9a-d1ed3c377c72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e3182d81-ac7f-4be9-907a-68d109c7f6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4b4e6268-92b0-421e-bc9a-d1ed3c377c72" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e3182d81-ac7f-4be9-907a-68d109c7f6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cdfda536-4c7f-4846-bc8a-d4a8e481df1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e3182d81-ac7f-4be9-907a-68d109c7f6c3" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cdfda536-4c7f-4846-bc8a-d4a8e481df1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b969431a-8fb2-48a1-a27b-5e0cbd17de04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cdfda536-4c7f-4846-bc8a-d4a8e481df1e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b969431a-8fb2-48a1-a27b-5e0cbd17de04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_404e4d91-69df-4352-89cd-5ee303dffd88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_b969431a-8fb2-48a1-a27b-5e0cbd17de04" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_404e4d91-69df-4352-89cd-5ee303dffd88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1617e752-2ba5-4fa4-a9a6-fdd3978896bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e3182d81-ac7f-4be9-907a-68d109c7f6c3" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1617e752-2ba5-4fa4-a9a6-fdd3978896bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a6bf0ca-c266-4b48-829a-16c0c72a2c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1617e752-2ba5-4fa4-a9a6-fdd3978896bd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a6bf0ca-c266-4b48-829a-16c0c72a2c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_b49d3302-126a-456c-9cfc-01ed347e7590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a6bf0ca-c266-4b48-829a-16c0c72a2c76" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_b49d3302-126a-456c-9cfc-01ed347e7590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_c4bf2e37-745f-4d1a-9819-e19eb176c137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a6bf0ca-c266-4b48-829a-16c0c72a2c76" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_c4bf2e37-745f-4d1a-9819-e19eb176c137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_5b2093e0-3527-40bb-a008-e45a1d1ea2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a6bf0ca-c266-4b48-829a-16c0c72a2c76" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_5b2093e0-3527-40bb-a008-e45a1d1ea2cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_aa573cde-463f-4ad8-8a03-d3f139e979e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a6bf0ca-c266-4b48-829a-16c0c72a2c76" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_aa573cde-463f-4ad8-8a03-d3f139e979e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_bf1026a8-a3ab-43aa-8537-dd7e795c43a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a6bf0ca-c266-4b48-829a-16c0c72a2c76" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_bf1026a8-a3ab-43aa-8537-dd7e795c43a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c408545b-65ac-402e-84c0-601e7aad0410" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a6bf0ca-c266-4b48-829a-16c0c72a2c76" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c408545b-65ac-402e-84c0-601e7aad0410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_4fe1fb95-a6a7-4b65-ab65-95be95c2e66b" xlink:href="cvs-20230525.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a6bf0ca-c266-4b48-829a-16c0c72a2c76" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_4fe1fb95-a6a7-4b65-ab65-95be95c2e66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_58d49bb3-3c6f-44c5-a1dc-418dba390ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6a6bf0ca-c266-4b48-829a-16c0c72a2c76" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_58d49bb3-3c6f-44c5-a1dc-418dba390ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ee4df8f1-f800-4908-848d-91a1286c9412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e3182d81-ac7f-4be9-907a-68d109c7f6c3" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ee4df8f1-f800-4908-848d-91a1286c9412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9b0ec7af-9ccb-4ed1-b088-cd4084843f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ee4df8f1-f800-4908-848d-91a1286c9412" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9b0ec7af-9ccb-4ed1-b088-cd4084843f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_06ff3e28-bec4-4090-a9da-19ad33ddbda6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9b0ec7af-9ccb-4ed1-b088-cd4084843f9e" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_06ff3e28-bec4-4090-a9da-19ad33ddbda6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_69265ae8-f6ac-4971-8727-5ff9c228e575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9b0ec7af-9ccb-4ed1-b088-cd4084843f9e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_69265ae8-f6ac-4971-8727-5ff9c228e575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4c8a1f2e-1611-4a42-ac2e-652841a2264d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9b0ec7af-9ccb-4ed1-b088-cd4084843f9e" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4c8a1f2e-1611-4a42-ac2e-652841a2264d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4ecdd0f7-4ce7-49cc-9a33-0fd0a63fec34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e3182d81-ac7f-4be9-907a-68d109c7f6c3" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4ecdd0f7-4ce7-49cc-9a33-0fd0a63fec34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ae27d438-319d-4352-a7f4-f05686fd645f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4ecdd0f7-4ce7-49cc-9a33-0fd0a63fec34" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ae27d438-319d-4352-a7f4-f05686fd645f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_5ea486a7-1ff6-4fdf-80a4-211141e2a484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_ae27d438-319d-4352-a7f4-f05686fd645f" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_5ea486a7-1ff6-4fdf-80a4-211141e2a484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97662cc5-8f83-4804-9f86-3410b4a0c7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e3182d81-ac7f-4be9-907a-68d109c7f6c3" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97662cc5-8f83-4804-9f86-3410b4a0c7b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_eb992abd-66bb-44be-a2a5-60d1113c9079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97662cc5-8f83-4804-9f86-3410b4a0c7b8" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_eb992abd-66bb-44be-a2a5-60d1113c9079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b5f64fb5-9ac4-4b77-969f-1cb5dcf17710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97662cc5-8f83-4804-9f86-3410b4a0c7b8" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b5f64fb5-9ac4-4b77-969f-1cb5dcf17710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_743b75ee-d3ca-45f5-a320-50c8b3cba96f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97662cc5-8f83-4804-9f86-3410b4a0c7b8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_743b75ee-d3ca-45f5-a320-50c8b3cba96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_435953a7-d57a-49fb-9464-f3797be567f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97662cc5-8f83-4804-9f86-3410b4a0c7b8" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_435953a7-d57a-49fb-9464-f3797be567f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_983184a3-41ec-4516-a277-000eee1f4626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_97662cc5-8f83-4804-9f86-3410b4a0c7b8" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_983184a3-41ec-4516-a277-000eee1f4626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#FairValueChangesinLevel3FinancialAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_72dfbb49-53a3-470f-817a-125c54f5516b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0acbbfdc-76fd-491b-b8e3-aba4c09c4ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_72dfbb49-53a3-470f-817a-125c54f5516b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0acbbfdc-76fd-491b-b8e3-aba4c09c4ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e15cd4c5-744b-43a8-a640-23c2078c6e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0acbbfdc-76fd-491b-b8e3-aba4c09c4ab5" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e15cd4c5-744b-43a8-a640-23c2078c6e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e6572c08-0b9c-489f-b979-63e5c00e9242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e15cd4c5-744b-43a8-a640-23c2078c6e8c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e6572c08-0b9c-489f-b979-63e5c00e9242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_503e8f02-a0c8-4fd6-a642-901afa1fe08c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e6572c08-0b9c-489f-b979-63e5c00e9242" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_503e8f02-a0c8-4fd6-a642-901afa1fe08c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_66fd9135-e4fb-4df8-9b3d-8ed729109c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e6572c08-0b9c-489f-b979-63e5c00e9242" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_66fd9135-e4fb-4df8-9b3d-8ed729109c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember_aa672c7f-272a-41e0-8ce5-49c4e93dbc48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e6572c08-0b9c-489f-b979-63e5c00e9242" xlink:to="loc_us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember_aa672c7f-272a-41e0-8ce5-49c4e93dbc48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_eaaf22c5-e68d-43de-a3ee-de61c6afcbb5" xlink:href="cvs-20230525.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e6572c08-0b9c-489f-b979-63e5c00e9242" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_eaaf22c5-e68d-43de-a3ee-de61c6afcbb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_35c5709d-f713-47f9-adf5-9001a55f1140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e6572c08-0b9c-489f-b979-63e5c00e9242" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_35c5709d-f713-47f9-adf5-9001a55f1140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_a730dc9c-e869-4089-ac33-c6f615498add" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e6572c08-0b9c-489f-b979-63e5c00e9242" xlink:to="loc_us-gaap_EquitySecuritiesMember_a730dc9c-e869-4089-ac33-c6f615498add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7ecec4d3-4a24-4f13-867a-1fb774fd13f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0acbbfdc-76fd-491b-b8e3-aba4c09c4ab5" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7ecec4d3-4a24-4f13-867a-1fb774fd13f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_8e87bb38-8990-4b9c-8114-d4213787c8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7ecec4d3-4a24-4f13-867a-1fb774fd13f2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_8e87bb38-8990-4b9c-8114-d4213787c8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_779aba2c-8824-4632-8439-7e4e1695577c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_8e87bb38-8990-4b9c-8114-d4213787c8eb" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_779aba2c-8824-4632-8439-7e4e1695577c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f9edbec0-06de-42f3-8d10-1ac7f9b918a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0acbbfdc-76fd-491b-b8e3-aba4c09c4ab5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f9edbec0-06de-42f3-8d10-1ac7f9b918a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8d35a0c9-8238-4534-851c-4ceaf4f2cbb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f9edbec0-06de-42f3-8d10-1ac7f9b918a9" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8d35a0c9-8238-4534-851c-4ceaf4f2cbb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_29d452ea-4b7c-461d-affa-1eb7d0d45edb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8d35a0c9-8238-4534-851c-4ceaf4f2cbb6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_29d452ea-4b7c-461d-affa-1eb7d0d45edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_009a7c15-50f0-4b40-bcec-792d44ff794d" xlink:href="cvs-20230525.xsd#cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8d35a0c9-8238-4534-851c-4ceaf4f2cbb6" xlink:to="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_009a7c15-50f0-4b40-bcec-792d44ff794d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_d168299a-61d3-4646-b065-27c130578d91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_009a7c15-50f0-4b40-bcec-792d44ff794d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_d168299a-61d3-4646-b065-27c130578d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_2e94a2b7-0987-43a5-b5c9-b85a7bc1253a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_009a7c15-50f0-4b40-bcec-792d44ff794d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_2e94a2b7-0987-43a5-b5c9-b85a7bc1253a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_247da247-0559-44cc-a10e-8ebfedf9ad07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8d35a0c9-8238-4534-851c-4ceaf4f2cbb6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_247da247-0559-44cc-a10e-8ebfedf9ad07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_5c35fcf7-a243-4eb4-900f-fcde4cb95633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8d35a0c9-8238-4534-851c-4ceaf4f2cbb6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_5c35fcf7-a243-4eb4-900f-fcde4cb95633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_aedae1e9-9ffb-4f1c-963f-a70ee122abdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8d35a0c9-8238-4534-851c-4ceaf4f2cbb6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_aedae1e9-9ffb-4f1c-963f-a70ee122abdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_457cb7fb-e7fe-44cf-ab3c-fddda70508c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8d35a0c9-8238-4534-851c-4ceaf4f2cbb6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_457cb7fb-e7fe-44cf-ab3c-fddda70508c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_1823eaa7-8799-4758-884a-4ed12d7200f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8d35a0c9-8238-4534-851c-4ceaf4f2cbb6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_1823eaa7-8799-4758-884a-4ed12d7200f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci_c9d05377-0830-4a52-b2c2-0ef6cf8383a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f9edbec0-06de-42f3-8d10-1ac7f9b918a9" xlink:to="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci_c9d05377-0830-4a52-b2c2-0ef6cf8383a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details" xlink:type="simple" xlink:href="cvs-20230525.xsd#FairValueGrossTransfersIntoOutOfLevel3Details"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a5835bfe-081f-4570-b9a6-805f319c0ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bae62b1c-08cf-4df1-995b-81399846189b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a5835bfe-081f-4570-b9a6-805f319c0ea9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bae62b1c-08cf-4df1-995b-81399846189b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_94877fb8-d399-4152-b884-08fa9f6c4438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bae62b1c-08cf-4df1-995b-81399846189b" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_94877fb8-d399-4152-b884-08fa9f6c4438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b86cad98-c687-4d4d-9bd2-09cd6da86e36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_94877fb8-d399-4152-b884-08fa9f6c4438" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b86cad98-c687-4d4d-9bd2-09cd6da86e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_9ee4d77d-e4d4-4fa0-b7d4-1b5f20b6faaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_b86cad98-c687-4d4d-9bd2-09cd6da86e36" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_9ee4d77d-e4d4-4fa0-b7d4-1b5f20b6faaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ede8915f-a798-41db-b0fc-9cea3e35d7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bae62b1c-08cf-4df1-995b-81399846189b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ede8915f-a798-41db-b0fc-9cea3e35d7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_efe8a7c9-87a0-41a6-b6d5-87e5b8d170cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ede8915f-a798-41db-b0fc-9cea3e35d7bc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_efe8a7c9-87a0-41a6-b6d5-87e5b8d170cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a19bce6c-de74-451e-8588-59382bf79741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_efe8a7c9-87a0-41a6-b6d5-87e5b8d170cc" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a19bce6c-de74-451e-8588-59382bf79741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_185a5bd6-6e0c-4bfd-b092-81fb6b8627cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bae62b1c-08cf-4df1-995b-81399846189b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_185a5bd6-6e0c-4bfd-b092-81fb6b8627cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_10596465-f504-4625-b6fb-1bba7f7edc80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_185a5bd6-6e0c-4bfd-b092-81fb6b8627cb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_10596465-f504-4625-b6fb-1bba7f7edc80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_daea1570-eda5-469f-808f-fc3f7ea2b630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_185a5bd6-6e0c-4bfd-b092-81fb6b8627cb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_daea1570-eda5-469f-808f-fc3f7ea2b630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_3355ea82-34b9-4e3d-8912-c4fec4bb8b49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_185a5bd6-6e0c-4bfd-b092-81fb6b8627cb" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_3355ea82-34b9-4e3d-8912-c4fec4bb8b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#FairValueCarryingValueandFairValueClassifiedbyLevelDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6ca7752a-1a45-4b49-b6b0-35650a69f685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4988a284-9841-4ade-88c6-c955c4fee603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6ca7752a-1a45-4b49-b6b0-35650a69f685" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4988a284-9841-4ade-88c6-c955c4fee603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8490135b-db9e-49e4-b125-63f832c09977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4988a284-9841-4ade-88c6-c955c4fee603" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8490135b-db9e-49e4-b125-63f832c09977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f83e6a2f-2d56-44c0-9b6a-727ff4b348ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8490135b-db9e-49e4-b125-63f832c09977" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f83e6a2f-2d56-44c0-9b6a-727ff4b348ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_e0d03415-5ff8-452a-816b-b1fb763b3e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f83e6a2f-2d56-44c0-9b6a-727ff4b348ee" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_e0d03415-5ff8-452a-816b-b1fb763b3e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bdd807a7-3ef0-4276-83d1-34c5c75e4c58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4988a284-9841-4ade-88c6-c955c4fee603" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bdd807a7-3ef0-4276-83d1-34c5c75e4c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e5096aa4-9440-4b2e-99af-9273a3d67385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bdd807a7-3ef0-4276-83d1-34c5c75e4c58" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e5096aa4-9440-4b2e-99af-9273a3d67385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_476d4ae2-b010-4617-9dc4-6c51b91597b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e5096aa4-9440-4b2e-99af-9273a3d67385" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_476d4ae2-b010-4617-9dc4-6c51b91597b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_766109d0-e18a-4bf2-b685-b73cb7098774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e5096aa4-9440-4b2e-99af-9273a3d67385" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_766109d0-e18a-4bf2-b685-b73cb7098774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8dca7909-254a-4f09-8113-17f5f94b4a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e5096aa4-9440-4b2e-99af-9273a3d67385" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8dca7909-254a-4f09-8113-17f5f94b4a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_9a0a955c-c8cc-4b26-9ea9-a60d0a7c6558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4988a284-9841-4ade-88c6-c955c4fee603" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_9a0a955c-c8cc-4b26-9ea9-a60d0a7c6558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_4df462f3-e90e-4e3c-8ab8-7b2f62bafaf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_9a0a955c-c8cc-4b26-9ea9-a60d0a7c6558" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_4df462f3-e90e-4e3c-8ab8-7b2f62bafaf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ff377d74-1b01-4fa5-bbd1-17c11ffd3692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_4df462f3-e90e-4e3c-8ab8-7b2f62bafaf2" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ff377d74-1b01-4fa5-bbd1-17c11ffd3692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_ddf377fb-6207-4cdc-a11b-079ce8c29f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ff377d74-1b01-4fa5-bbd1-17c11ffd3692" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_ddf377fb-6207-4cdc-a11b-079ce8c29f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1af71818-785d-4b07-b30a-e7377aa31c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ff377d74-1b01-4fa5-bbd1-17c11ffd3692" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1af71818-785d-4b07-b30a-e7377aa31c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_638ef3f7-4475-47c4-967f-400730f57e38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4988a284-9841-4ade-88c6-c955c4fee603" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_638ef3f7-4475-47c4-967f-400730f57e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_edd4b3e2-6113-4d26-86a4-42423836c0bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_638ef3f7-4475-47c4-967f-400730f57e38" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_edd4b3e2-6113-4d26-86a4-42423836c0bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_a9f77a39-6d21-414a-9e6e-3394bf687988" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_edd4b3e2-6113-4d26-86a4-42423836c0bb" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_a9f77a39-6d21-414a-9e6e-3394bf687988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7bc60663-ce41-4caf-905f-585e461a41fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_4988a284-9841-4ade-88c6-c955c4fee603" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7bc60663-ce41-4caf-905f-585e461a41fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1a097ad6-68fc-4736-a0d6-d29acaab362d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7bc60663-ce41-4caf-905f-585e461a41fc" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1a097ad6-68fc-4736-a0d6-d29acaab362d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_73b42e7c-802d-4252-8197-3a76725cacc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1a097ad6-68fc-4736-a0d6-d29acaab362d" xlink:to="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_73b42e7c-802d-4252-8197-3a76725cacc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_91b20b67-c39c-446e-b035-4902828e44d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1a097ad6-68fc-4736-a0d6-d29acaab362d" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_91b20b67-c39c-446e-b035-4902828e44d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_92d2d1ff-4e5d-4abe-9f14-5d0ddd4684e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7bc60663-ce41-4caf-905f-585e461a41fc" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_92d2d1ff-4e5d-4abe-9f14-5d0ddd4684e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_009ee356-9180-43ed-a485-1db5a3efaa93" xlink:href="cvs-20230525.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_92d2d1ff-4e5d-4abe-9f14-5d0ddd4684e2" xlink:to="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_009ee356-9180-43ed-a485-1db5a3efaa93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_e3985356-cc2d-441a-907a-24ab37708b40" xlink:href="cvs-20230525.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_92d2d1ff-4e5d-4abe-9f14-5d0ddd4684e2" xlink:to="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_e3985356-cc2d-441a-907a-24ab37708b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_615350d9-da81-4aa0-a117-75333aeff8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_92d2d1ff-4e5d-4abe-9f14-5d0ddd4684e2" xlink:to="loc_us-gaap_DebtInstrumentFairValue_615350d9-da81-4aa0-a117-75333aeff8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#FairValueSeparateAccountsFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_be3e538c-2c2a-4eef-ba16-8ff8766a6402" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_45056b96-da49-45ba-847c-b3897ada11d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_be3e538c-2c2a-4eef-ba16-8ff8766a6402" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_45056b96-da49-45ba-847c-b3897ada11d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a72fe254-f7af-4407-ade9-ddbbfd668099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_45056b96-da49-45ba-847c-b3897ada11d3" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a72fe254-f7af-4407-ade9-ddbbfd668099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_5d49b6f3-bf43-4f0a-9052-5a5d049fcf29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a72fe254-f7af-4407-ade9-ddbbfd668099" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_5d49b6f3-bf43-4f0a-9052-5a5d049fcf29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_1fabe650-5029-45b9-a0e2-0d39362e4460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_5d49b6f3-bf43-4f0a-9052-5a5d049fcf29" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_1fabe650-5029-45b9-a0e2-0d39362e4460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_98d16e4f-455a-4a8b-86c3-d93f157fdddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_45056b96-da49-45ba-847c-b3897ada11d3" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_98d16e4f-455a-4a8b-86c3-d93f157fdddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a4843508-f745-4bb7-ab96-5fa47884edaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_98d16e4f-455a-4a8b-86c3-d93f157fdddb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a4843508-f745-4bb7-ab96-5fa47884edaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3511dcfd-a79f-4f7c-a9b2-31f0066f3d44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a4843508-f745-4bb7-ab96-5fa47884edaf" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3511dcfd-a79f-4f7c-a9b2-31f0066f3d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_23da7cbd-da06-420b-99d5-692fc60943dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a4843508-f745-4bb7-ab96-5fa47884edaf" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_23da7cbd-da06-420b-99d5-692fc60943dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_dc9b03ad-3822-4171-909b-3452dcf59550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a4843508-f745-4bb7-ab96-5fa47884edaf" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_dc9b03ad-3822-4171-909b-3452dcf59550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryAxis_bb230441-4bd3-45ee-b14c-efadb5c6f79d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_45056b96-da49-45ba-847c-b3897ada11d3" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryAxis_bb230441-4bd3-45ee-b14c-efadb5c6f79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain_17fcc7fa-fb35-49c1-b4ee-7351aad440f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis_bb230441-4bd3-45ee-b14c-efadb5c6f79d" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryDomain_17fcc7fa-fb35-49c1-b4ee-7351aad440f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_9975738f-46ba-4fb4-8c96-ee764af01e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_17fcc7fa-fb35-49c1-b4ee-7351aad440f1" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_9975738f-46ba-4fb4-8c96-ee764af01e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_18628b28-4eb2-473e-9fcc-1c65fc463fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_17fcc7fa-fb35-49c1-b4ee-7351aad440f1" xlink:to="loc_us-gaap_DebtSecuritiesMember_18628b28-4eb2-473e-9fcc-1c65fc463fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_181a1bc0-7056-465d-8d80-046b8e4f6c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_17fcc7fa-fb35-49c1-b4ee-7351aad440f1" xlink:to="loc_us-gaap_EquitySecuritiesMember_181a1bc0-7056-465d-8d80-046b8e4f6c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember_d6638370-9a00-415e-ac79-ddfc33b3ef6e" xlink:href="cvs-20230525.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_17fcc7fa-fb35-49c1-b4ee-7351aad440f1" xlink:to="loc_cvs_CommonAndCollectiveTrustsMember_d6638370-9a00-415e-ac79-ddfc33b3ef6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f398df29-32f5-467a-beac-8e6cf9a86bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_45056b96-da49-45ba-847c-b3897ada11d3" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f398df29-32f5-467a-beac-8e6cf9a86bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_65c6a791-a719-46cb-8bbd-06c643bff21c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f398df29-32f5-467a-beac-8e6cf9a86bb7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_65c6a791-a719-46cb-8bbd-06c643bff21c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableMember_6d4d3f03-5ee0-49ec-8d18-0ce3e232aeb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_65c6a791-a719-46cb-8bbd-06c643bff21c" xlink:to="loc_us-gaap_AccountsPayableMember_6d4d3f03-5ee0-49ec-8d18-0ce3e232aeb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_11152f17-bb0f-4f5b-a76e-4a902ddc5cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_65c6a791-a719-46cb-8bbd-06c643bff21c" xlink:to="loc_us-gaap_AccountsReceivableMember_11152f17-bb0f-4f5b-a76e-4a902ddc5cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_4362cd64-2fd8-4667-936b-cc07ed612d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_45056b96-da49-45ba-847c-b3897ada11d3" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_4362cd64-2fd8-4667-936b-cc07ed612d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_955a220b-a181-4547-9483-019c3fb94096" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_4362cd64-2fd8-4667-936b-cc07ed612d1b" xlink:to="loc_us-gaap_SeparateAccountAssets_955a220b-a181-4547-9483-019c3fb94096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_d97aff01-5c48-4b43-bb55-de22c9962d75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_4362cd64-2fd8-4667-936b-cc07ed612d1b" xlink:to="loc_us-gaap_SeparateAccountsLiability_d97aff01-5c48-4b43-bb55-de22c9962d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#FairValueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ec63c772-c51d-44fe-aad4-ec66d54fb413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efc2ab6b-c3ec-4ba0-8fbd-ff95ee4fcc60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ec63c772-c51d-44fe-aad4-ec66d54fb413" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efc2ab6b-c3ec-4ba0-8fbd-ff95ee4fcc60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_96c661c8-033f-48e0-8496-4ab068fde369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efc2ab6b-c3ec-4ba0-8fbd-ff95ee4fcc60" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_96c661c8-033f-48e0-8496-4ab068fde369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5e3f8467-0d7c-4b3d-a25f-09ae3fcd3517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_96c661c8-033f-48e0-8496-4ab068fde369" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5e3f8467-0d7c-4b3d-a25f-09ae3fcd3517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_85ebea83-ddaa-424a-9275-6b871a196d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5e3f8467-0d7c-4b3d-a25f-09ae3fcd3517" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_85ebea83-ddaa-424a-9275-6b871a196d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c155e5ca-5ed3-4bb5-8daf-5927884b4a58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efc2ab6b-c3ec-4ba0-8fbd-ff95ee4fcc60" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c155e5ca-5ed3-4bb5-8daf-5927884b4a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_8da729fc-1662-43b1-8629-198a74954675" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c155e5ca-5ed3-4bb5-8daf-5927884b4a58" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_8da729fc-1662-43b1-8629-198a74954675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_4896b7f6-b876-4ecc-ba41-c7a5491050cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_8da729fc-1662-43b1-8629-198a74954675" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_4896b7f6-b876-4ecc-ba41-c7a5491050cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryAxis_479b2289-88e6-4411-8600-91e414fded6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efc2ab6b-c3ec-4ba0-8fbd-ff95ee4fcc60" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryAxis_479b2289-88e6-4411-8600-91e414fded6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain_2b26fb6a-ffe5-44ff-9d99-b2837d092652" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis_479b2289-88e6-4411-8600-91e414fded6b" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryDomain_2b26fb6a-ffe5-44ff-9d99-b2837d092652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeparateAccountFinancialAssetsMember_51d6814a-d26a-4b3f-ad8f-da6d5e25daf9" xlink:href="cvs-20230525.xsd#cvs_SeparateAccountFinancialAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_2b26fb6a-ffe5-44ff-9d99-b2837d092652" xlink:to="loc_cvs_SeparateAccountFinancialAssetsMember_51d6814a-d26a-4b3f-ad8f-da6d5e25daf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fa78913a-1bfb-43b4-91ba-1adb7dd8f5aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_efc2ab6b-c3ec-4ba0-8fbd-ff95ee4fcc60" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fa78913a-1bfb-43b4-91ba-1adb7dd8f5aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_e9c19885-c8e5-458e-bd03-f63c1cb07d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fa78913a-1bfb-43b4-91ba-1adb7dd8f5aa" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_e9c19885-c8e5-458e-bd03-f63c1cb07d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#GoodwillandOtherIntangiblesGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8da17d8a-fa10-4bf5-939c-b8bb80ac1afd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_c91ad25f-09f7-488e-9f12-8f8434aefd7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8da17d8a-fa10-4bf5-939c-b8bb80ac1afd" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_c91ad25f-09f7-488e-9f12-8f8434aefd7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_24614034-2c2e-443b-81f0-4c8bc055193b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c91ad25f-09f7-488e-9f12-8f8434aefd7f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_24614034-2c2e-443b-81f0-4c8bc055193b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d3a6a00a-072d-489f-bef9-1907238386f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_24614034-2c2e-443b-81f0-4c8bc055193b" xlink:to="loc_us-gaap_SegmentDomain_d3a6a00a-072d-489f-bef9-1907238386f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_08bc1ad9-f366-4c5c-ba3a-00fa545050ea" xlink:href="cvs-20230525.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d3a6a00a-072d-489f-bef9-1907238386f1" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_08bc1ad9-f366-4c5c-ba3a-00fa545050ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthServicesSegmentMember_e07e2173-8ed1-4411-8816-b077b7ce556a" xlink:href="cvs-20230525.xsd#cvs_HealthServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d3a6a00a-072d-489f-bef9-1907238386f1" xlink:to="loc_cvs_HealthServicesSegmentMember_e07e2173-8ed1-4411-8816-b077b7ce556a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_6632c304-41a2-4faf-952e-86d6a822d70a" xlink:href="cvs-20230525.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d3a6a00a-072d-489f-bef9-1907238386f1" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_6632c304-41a2-4faf-952e-86d6a822d70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_1f0157cb-761a-4e73-a82b-af59f11afccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c91ad25f-09f7-488e-9f12-8f8434aefd7f" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_1f0157cb-761a-4e73-a82b-af59f11afccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6e7d243a-8613-4e04-819a-b77adc2d999f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1f0157cb-761a-4e73-a82b-af59f11afccf" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6e7d243a-8613-4e04-819a-b77adc2d999f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_4616a64a-f511-4100-ad04-addb0cd8879e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_6e7d243a-8613-4e04-819a-b77adc2d999f" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_4616a64a-f511-4100-ad04-addb0cd8879e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_bd648948-e8e6-449a-abf3-aeee4fa90e42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c91ad25f-09f7-488e-9f12-8f8434aefd7f" xlink:to="loc_us-gaap_GoodwillLineItems_bd648948-e8e6-449a-abf3-aeee4fa90e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_303b91e2-f152-404e-bea2-4b97bc145b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_bd648948-e8e6-449a-abf3-aeee4fa90e42" xlink:to="loc_us-gaap_GoodwillRollForward_303b91e2-f152-404e-bea2-4b97bc145b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e29a7020-0aeb-4b5f-8c89-379db0c72fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_303b91e2-f152-404e-bea2-4b97bc145b45" xlink:to="loc_us-gaap_Goodwill_e29a7020-0aeb-4b5f-8c89-379db0c72fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_e26f1183-fe72-4e42-ab37-3b1102351457" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_303b91e2-f152-404e-bea2-4b97bc145b45" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_e26f1183-fe72-4e42-ab37-3b1102351457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_1395c056-b838-47bc-81d1-d33d789ae322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_303b91e2-f152-404e-bea2-4b97bc145b45" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_1395c056-b838-47bc-81d1-d33d789ae322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3e3f8fb3-0536-413f-a638-6985bb96b648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_303b91e2-f152-404e-bea2-4b97bc145b45" xlink:to="loc_us-gaap_Goodwill_3e3f8fb3-0536-413f-a638-6985bb96b648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#GoodwillandOtherIntangiblesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9a50ba75-2e4f-4d1e-a8fc-4a3c350dfc0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_d809f5fc-ebaa-47e7-b80c-48f5b434ef8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9a50ba75-2e4f-4d1e-a8fc-4a3c350dfc0a" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_d809f5fc-ebaa-47e7-b80c-48f5b434ef8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_5c2089fe-9fba-4fc3-a748-ea1d713b545f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d809f5fc-ebaa-47e7-b80c-48f5b434ef8a" xlink:to="loc_us-gaap_ReportingUnitAxis_5c2089fe-9fba-4fc3-a748-ea1d713b545f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_d6e84444-82f2-4f53-b7c2-b778ce4bd28f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_5c2089fe-9fba-4fc3-a748-ea1d713b545f" xlink:to="loc_us-gaap_ReportingUnitDomain_d6e84444-82f2-4f53-b7c2-b778ce4bd28f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareReportingUnitMember_44d6a4b7-c4e4-4cf8-a444-2cc3de37a045" xlink:href="cvs-20230525.xsd#cvs_LongTermCareReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_d6e84444-82f2-4f53-b7c2-b778ce4bd28f" xlink:to="loc_cvs_LongTermCareReportingUnitMember_44d6a4b7-c4e4-4cf8-a444-2cc3de37a045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_e5460f41-8582-4f16-9e32-e13935289b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d809f5fc-ebaa-47e7-b80c-48f5b434ef8a" xlink:to="loc_us-gaap_GoodwillLineItems_e5460f41-8582-4f16-9e32-e13935289b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_2e2b965c-0dce-4cfb-bf89-08084d1a4584" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_e5460f41-8582-4f16-9e32-e13935289b0e" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_2e2b965c-0dce-4cfb-bf89-08084d1a4584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_56dd089f-c178-425d-8507-31790d3d8dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_e5460f41-8582-4f16-9e32-e13935289b0e" xlink:to="loc_us-gaap_Goodwill_56dd089f-c178-425d-8507-31790d3d8dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_23b635f4-f28e-457a-ae61-8e3953e476c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_e5460f41-8582-4f16-9e32-e13935289b0e" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_23b635f4-f28e-457a-ae61-8e3953e476c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#GoodwillandOtherIntangiblesIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2b532965-ed5f-4641-9119-25dca12a9ead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAcquiredIntangibleAssetsTable_44e4927f-8cc7-4a6e-bf9a-29dc35850b8e" xlink:href="cvs-20230525.xsd#cvs_OtherAcquiredIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2b532965-ed5f-4641-9119-25dca12a9ead" xlink:to="loc_cvs_OtherAcquiredIntangibleAssetsTable_44e4927f-8cc7-4a6e-bf9a-29dc35850b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fa29f923-c376-44c3-bfe8-f2aa417620ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsTable_44e4927f-8cc7-4a6e-bf9a-29dc35850b8e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fa29f923-c376-44c3-bfe8-f2aa417620ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_784d841f-ece2-4ef8-8dee-6eaeda5da0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fa29f923-c376-44c3-bfe8-f2aa417620ff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_784d841f-ece2-4ef8-8dee-6eaeda5da0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_425235a3-4c3d-4865-a0aa-281d7315ac17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_784d841f-ece2-4ef8-8dee-6eaeda5da0b8" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_425235a3-4c3d-4865-a0aa-281d7315ac17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_6640f0da-48bd-4bd5-a299-0607905f0cee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_784d841f-ece2-4ef8-8dee-6eaeda5da0b8" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_6640f0da-48bd-4bd5-a299-0607905f0cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProviderNetworksMember_15c34fd0-be1c-4178-8746-9526cedc7374" xlink:href="cvs-20230525.xsd#cvs_ProviderNetworksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_784d841f-ece2-4ef8-8dee-6eaeda5da0b8" xlink:to="loc_cvs_ProviderNetworksMember_15c34fd0-be1c-4178-8746-9526cedc7374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ValueOfBusinessAcquiredMember_9b4b09ae-1176-433e-9ccd-4d59b8acdd1d" xlink:href="cvs-20230525.xsd#cvs_ValueOfBusinessAcquiredMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_784d841f-ece2-4ef8-8dee-6eaeda5da0b8" xlink:to="loc_cvs_ValueOfBusinessAcquiredMember_9b4b09ae-1176-433e-9ccd-4d59b8acdd1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_36bc5342-9a8f-43a4-b451-ed3e593f771e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_784d841f-ece2-4ef8-8dee-6eaeda5da0b8" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_36bc5342-9a8f-43a4-b451-ed3e593f771e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_ea7967fe-3ebf-4c58-b8db-771122e34735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsTable_44e4927f-8cc7-4a6e-bf9a-29dc35850b8e" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_ea7967fe-3ebf-4c58-b8db-771122e34735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ef14c2c4-e72c-48f8-af49-4f625477ef65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ea7967fe-3ebf-4c58-b8db-771122e34735" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ef14c2c4-e72c-48f8-af49-4f625477ef65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_5da8697f-f098-4faa-a887-fb7fdc1730b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_ef14c2c4-e72c-48f8-af49-4f625477ef65" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_5da8697f-f098-4faa-a887-fb7fdc1730b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5dfe5f31-a678-4bd7-8a3d-a6420df4adcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsTable_44e4927f-8cc7-4a6e-bf9a-29dc35850b8e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5dfe5f31-a678-4bd7-8a3d-a6420df4adcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c1fa3550-c09c-46b8-983b-ecc2060128a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5dfe5f31-a678-4bd7-8a3d-a6420df4adcf" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c1fa3550-c09c-46b8-983b-ecc2060128a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OmnicareLongTermCareBusinessMember_c41bd869-1721-4454-a5fb-530a603ea4f6" xlink:href="cvs-20230525.xsd#cvs_OmnicareLongTermCareBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c1fa3550-c09c-46b8-983b-ecc2060128a0" xlink:to="loc_cvs_OmnicareLongTermCareBusinessMember_c41bd869-1721-4454-a5fb-530a603ea4f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_dc9fe2de-53e6-4417-947d-002e5a9228d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsTable_44e4927f-8cc7-4a6e-bf9a-29dc35850b8e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_dc9fe2de-53e6-4417-947d-002e5a9228d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7df82a83-ee75-4700-8c6f-398accd6c095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_dc9fe2de-53e6-4417-947d-002e5a9228d6" xlink:to="loc_us-gaap_SegmentDomain_7df82a83-ee75-4700-8c6f-398accd6c095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_67ba641e-a602-404b-a94f-d7038c7594ae" xlink:href="cvs-20230525.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7df82a83-ee75-4700-8c6f-398accd6c095" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_67ba641e-a602-404b-a94f-d7038c7594ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_a819ed2e-08bf-4d0e-9fab-60248dbe3786" xlink:href="cvs-20230525.xsd#cvs_OtherAcquiredIntangibleAssetsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsTable_44e4927f-8cc7-4a6e-bf9a-29dc35850b8e" xlink:to="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_a819ed2e-08bf-4d0e-9fab-60248dbe3786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0cc260d7-1861-4778-9c4f-0e8b58c471ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_a819ed2e-08bf-4d0e-9fab-60248dbe3786" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0cc260d7-1861-4778-9c4f-0e8b58c471ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ba5c1379-841b-4646-8cab-f2962f856a65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_a819ed2e-08bf-4d0e-9fab-60248dbe3786" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ba5c1379-841b-4646-8cab-f2962f856a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6707f873-8bac-48db-9376-e144dba577ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_a819ed2e-08bf-4d0e-9fab-60248dbe3786" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6707f873-8bac-48db-9376-e144dba577ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_51ef6d5a-a7f7-44f4-b0e2-86349a57812e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_a819ed2e-08bf-4d0e-9fab-60248dbe3786" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_51ef6d5a-a7f7-44f4-b0e2-86349a57812e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_8a745664-b1f7-4cdc-a5c2-de9571f7c9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_a819ed2e-08bf-4d0e-9fab-60248dbe3786" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_8a745664-b1f7-4cdc-a5c2-de9571f7c9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale_1dade402-45f9-4289-afc5-2f0490d16562" xlink:href="cvs-20230525.xsd#cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_a819ed2e-08bf-4d0e-9fab-60248dbe3786" xlink:to="loc_cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale_1dade402-45f9-4289-afc5-2f0490d16562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension_7d91c5dd-8b43-4b97-8daf-4cc76374fa6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_a819ed2e-08bf-4d0e-9fab-60248dbe3786" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension_7d91c5dd-8b43-4b97-8daf-4cc76374fa6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_db2bd7b7-952c-4b0a-8445-03e7457c5783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_a819ed2e-08bf-4d0e-9fab-60248dbe3786" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_db2bd7b7-952c-4b0a-8445-03e7457c5783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_01e1a2c4-6f8c-46fb-b022-d0929dcae6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_a819ed2e-08bf-4d0e-9fab-60248dbe3786" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_01e1a2c4-6f8c-46fb-b022-d0929dcae6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1f9240b6-253b-4b2b-9204-582c87dc1ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_099ac1b5-d756-4392-a1f1-d57e208f787a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1f9240b6-253b-4b2b-9204-582c87dc1ddd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_099ac1b5-d756-4392-a1f1-d57e208f787a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_8a10ce3b-0602-4a1e-8fe0-9378c07a8512" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_099ac1b5-d756-4392-a1f1-d57e208f787a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_8a10ce3b-0602-4a1e-8fe0-9378c07a8512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_e27fbc20-7ed4-4cac-b92f-8015b985529f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_099ac1b5-d756-4392-a1f1-d57e208f787a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_e27fbc20-7ed4-4cac-b92f-8015b985529f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_fb6bfa41-22f2-468f-b99d-35f966a30f12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_099ac1b5-d756-4392-a1f1-d57e208f787a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_fb6bfa41-22f2-468f-b99d-35f966a30f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_92361f4a-3b4a-40b3-a647-e5d794654559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_099ac1b5-d756-4392-a1f1-d57e208f787a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_92361f4a-3b4a-40b3-a647-e5d794654559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_f90f2661-16ee-4a44-a5e5-aefee877c2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_099ac1b5-d756-4392-a1f1-d57e208f787a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_f90f2661-16ee-4a44-a5e5-aefee877c2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_db2dbf26-4f83-4f98-8543-46f5f2397a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d393af01-4228-48f9-ace0-912eb0784d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_db2dbf26-4f83-4f98-8543-46f5f2397a06" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d393af01-4228-48f9-ace0-912eb0784d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_748f94c9-3aa6-46d4-8ef0-f7285834378b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d393af01-4228-48f9-ace0-912eb0784d54" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_748f94c9-3aa6-46d4-8ef0-f7285834378b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_51ad748d-e1a6-4b18-a5f6-96c07f8bbf54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_748f94c9-3aa6-46d4-8ef0-f7285834378b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_51ad748d-e1a6-4b18-a5f6-96c07f8bbf54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_4f52fd0d-d635-41ff-a5ce-a3ee20b61a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_51ad748d-e1a6-4b18-a5f6-96c07f8bbf54" xlink:to="loc_us-gaap_BuildingMember_4f52fd0d-d635-41ff-a5ce-a3ee20b61a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_a7363ca1-8833-4ee7-8f09-7ae0fa2b936a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_51ad748d-e1a6-4b18-a5f6-96c07f8bbf54" xlink:to="loc_us-gaap_EquipmentMember_a7363ca1-8833-4ee7-8f09-7ae0fa2b936a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_94c6ed4e-ebff-4744-a126-bf971d688a95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_51ad748d-e1a6-4b18-a5f6-96c07f8bbf54" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_94c6ed4e-ebff-4744-a126-bf971d688a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a4189db1-d5da-43e4-9499-81f516ad7bf2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d393af01-4228-48f9-ace0-912eb0784d54" xlink:to="loc_srt_RangeAxis_a4189db1-d5da-43e4-9499-81f516ad7bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bc84ed54-09b3-485b-ba5a-3c58fc5b889c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a4189db1-d5da-43e4-9499-81f516ad7bf2" xlink:to="loc_srt_RangeMember_bc84ed54-09b3-485b-ba5a-3c58fc5b889c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2abfe3b7-09a5-46b1-b620-0456466f0e6e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bc84ed54-09b3-485b-ba5a-3c58fc5b889c" xlink:to="loc_srt_MinimumMember_2abfe3b7-09a5-46b1-b620-0456466f0e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b7510f55-9991-4662-a2d0-4d6870c5c911" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bc84ed54-09b3-485b-ba5a-3c58fc5b889c" xlink:to="loc_srt_MaximumMember_b7510f55-9991-4662-a2d0-4d6870c5c911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2f7de22d-e2f4-403c-9c6d-79e69692adc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d393af01-4228-48f9-ace0-912eb0784d54" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2f7de22d-e2f4-403c-9c6d-79e69692adc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_be897984-124a-4b85-b55c-1281e48c7592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2f7de22d-e2f4-403c-9c6d-79e69692adc9" xlink:to="loc_us-gaap_SegmentDomain_be897984-124a-4b85-b55c-1281e48c7592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_70e373da-914d-43f7-9807-c9903542e59d" xlink:href="cvs-20230525.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_be897984-124a-4b85-b55c-1281e48c7592" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_70e373da-914d-43f7-9807-c9903542e59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_4c3771c2-d4dc-4d9c-a2bc-30de646cb25d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d393af01-4228-48f9-ace0-912eb0784d54" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_4c3771c2-d4dc-4d9c-a2bc-30de646cb25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_f31e3e9a-2867-4d2c-acd0-e86fcf7dd505" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_4c3771c2-d4dc-4d9c-a2bc-30de646cb25d" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_f31e3e9a-2867-4d2c-acd0-e86fcf7dd505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOperatingLeaseMember_2f09a629-d591-4089-ac15-b3fbf9ea1d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertySubjectToOperatingLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_f31e3e9a-2867-4d2c-acd0-e86fcf7dd505" xlink:to="loc_us-gaap_PropertySubjectToOperatingLeaseMember_2f09a629-d591-4089-ac15-b3fbf9ea1d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_d393af01-4228-48f9-ace0-912eb0784d54" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_fcc2136c-4fac-4bb9-a5f9-2715a48cc045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_fcc2136c-4fac-4bb9-a5f9-2715a48cc045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_bec5b57e-40ec-4746-9306-1b4ef230dc1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeaseTermOfContract1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:to="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_bec5b57e-40ec-4746-9306-1b4ef230dc1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_5153fb41-02da-4f4e-854b-09079026aa97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:to="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_5153fb41-02da-4f4e-854b-09079026aa97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_587e9b6f-4d02-40a4-b621-c1f99084e969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:to="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_587e9b6f-4d02-40a4-b621-c1f99084e969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OfficeRealEstateOptimizationCharges_eff06434-7b95-4881-a928-570c66f5704a" xlink:href="cvs-20230525.xsd#cvs_OfficeRealEstateOptimizationCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:to="loc_cvs_OfficeRealEstateOptimizationCharges_eff06434-7b95-4881-a928-570c66f5704a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresPlannedClosure_2a59190b-2ee3-4621-bd9e-cb774fbd566e" xlink:href="cvs-20230525.xsd#cvs_NumberOfStoresPlannedClosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:to="loc_cvs_NumberOfStoresPlannedClosure_2a59190b-2ee3-4621-bd9e-cb774fbd566e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod_91ccfee3-46e3-46fa-8d33-73799065e28b" xlink:href="cvs-20230525.xsd#cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:to="loc_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod_91ccfee3-46e3-46fa-8d33-73799065e28b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges_719a6f59-e305-488d-a857-fd977f835337" xlink:href="cvs-20230525.xsd#cvs_StoreImpairmentCharges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:to="loc_cvs_StoreImpairmentCharges_719a6f59-e305-488d-a857-fd977f835337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure_cbad544e-921e-4392-bac6-9ac8ea02cf58" xlink:href="cvs-20230525.xsd#cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:to="loc_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure_cbad544e-921e-4392-bac6-9ac8ea02cf58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure_b9bc468b-2002-44d3-b92d-a320cc9acc55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentFairValueDisclosure"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3bd9679a-e45b-4f38-8fc9-d6d925b77cb0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure_b9bc468b-2002-44d3-b92d-a320cc9acc55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#LeasesSummaryoftheComponentsofNetLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0d525aad-0b4e-47df-a2d5-fd59ca3f1a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_ba3514c8-850e-4e38-b3a6-c9e3d68405cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0d525aad-0b4e-47df-a2d5-fd59ca3f1a8c" xlink:to="loc_us-gaap_OperatingLeaseCost_ba3514c8-850e-4e38-b3a6-c9e3d68405cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_8c4b80d2-8e9b-42b0-a5e1-057585a0fb9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0d525aad-0b4e-47df-a2d5-fd59ca3f1a8c" xlink:to="loc_us-gaap_LeaseCostAbstract_8c4b80d2-8e9b-42b0-a5e1-057585a0fb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_2caeda00-48fb-4770-9025-49e69b8f3295" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_8c4b80d2-8e9b-42b0-a5e1-057585a0fb9a" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_2caeda00-48fb-4770-9025-49e69b8f3295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_bc364f36-1aaf-4f7a-a9ec-391c88a3cd3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_8c4b80d2-8e9b-42b0-a5e1-057585a0fb9a" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_bc364f36-1aaf-4f7a-a9ec-391c88a3cd3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseCost_f991f21c-7ebd-48ad-9356-69628164d891" xlink:href="cvs-20230525.xsd#cvs_FinanceLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_8c4b80d2-8e9b-42b0-a5e1-057585a0fb9a" xlink:to="loc_cvs_FinanceLeaseCost_f991f21c-7ebd-48ad-9356-69628164d891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_4302dbd3-70ef-48e5-939b-5273ae60678b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_8c4b80d2-8e9b-42b0-a5e1-057585a0fb9a" xlink:to="loc_us-gaap_ShortTermLeaseCost_4302dbd3-70ef-48e5-939b-5273ae60678b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_083f858d-51e4-4ed5-a0fb-f3689ea8befc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_8c4b80d2-8e9b-42b0-a5e1-057585a0fb9a" xlink:to="loc_us-gaap_VariableLeaseCost_083f858d-51e4-4ed5-a0fb-f3689ea8befc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_cb6e4475-bd53-414f-b62f-d7257638b91a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_8c4b80d2-8e9b-42b0-a5e1-057585a0fb9a" xlink:to="loc_us-gaap_SubleaseIncome_cb6e4475-bd53-414f-b62f-d7257638b91a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_f3e737c6-8f2d-4ab4-82fd-cd51cad6a7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_8c4b80d2-8e9b-42b0-a5e1-057585a0fb9a" xlink:to="loc_us-gaap_LeaseCost_f3e737c6-8f2d-4ab4-82fd-cd51cad6a7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#LeasesSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_16316b77-97f5-4a3f-aa21-f85d4e04b265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CashFlowLesseeAbstract_b4ab973d-4e2f-46d3-bde9-7968dc93677b" xlink:href="cvs-20230525.xsd#cvs_CashFlowLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_16316b77-97f5-4a3f-aa21-f85d4e04b265" xlink:to="loc_cvs_CashFlowLesseeAbstract_b4ab973d-4e2f-46d3-bde9-7968dc93677b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_7b622688-ba6f-4a53-8ffb-93f17bf9ad46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_CashFlowLesseeAbstract_b4ab973d-4e2f-46d3-bde9-7968dc93677b" xlink:to="loc_us-gaap_OperatingLeasePayments_7b622688-ba6f-4a53-8ffb-93f17bf9ad46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_92425bb2-1954-4525-af7a-edc5be2b717a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_CashFlowLesseeAbstract_b4ab973d-4e2f-46d3-bde9-7968dc93677b" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_92425bb2-1954-4525-af7a-edc5be2b717a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_41f6bd33-8fc7-41aa-970c-72cc31ddbb33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_CashFlowLesseeAbstract_b4ab973d-4e2f-46d3-bde9-7968dc93677b" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_41f6bd33-8fc7-41aa-970c-72cc31ddbb33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_ab263777-d401-4f50-988a-a6ae00ff503d" xlink:href="cvs-20230525.xsd#cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_CashFlowLesseeAbstract_b4ab973d-4e2f-46d3-bde9-7968dc93677b" xlink:to="loc_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_ab263777-d401-4f50-988a-a6ae00ff503d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_394908e3-1de0-4b5a-8f24-0aa3216568ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_ab263777-d401-4f50-988a-a6ae00ff503d" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_394908e3-1de0-4b5a-8f24-0aa3216568ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_505bd72a-97e4-49a4-b55c-c9fb81b12ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_ab263777-d401-4f50-988a-a6ae00ff503d" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_505bd72a-97e4-49a4-b55c-c9fb81b12ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_bd0067ae-1945-40a8-b3f6-e81f4a180ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_94575104-e169-4131-b3dc-a12fbc03fb6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bd0067ae-1945-40a8-b3f6-e81f4a180ba9" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_94575104-e169-4131-b3dc-a12fbc03fb6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_66ef04d5-7722-4b73-baee-b125d48079a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_94575104-e169-4131-b3dc-a12fbc03fb6c" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_66ef04d5-7722-4b73-baee-b125d48079a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_44017f1f-1c58-45d1-91ff-ed8aa125f78a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_66ef04d5-7722-4b73-baee-b125d48079a1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_44017f1f-1c58-45d1-91ff-ed8aa125f78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_b9536ee2-0278-4fa4-85ab-72b2bd3e9582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_44017f1f-1c58-45d1-91ff-ed8aa125f78a" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_b9536ee2-0278-4fa4-85ab-72b2bd3e9582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_4ef4171f-b074-46ca-a84a-2ada326e4f11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_94575104-e169-4131-b3dc-a12fbc03fb6c" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_4ef4171f-b074-46ca-a84a-2ada326e4f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_72f242e1-7f34-4e9f-a243-d573ff76aa6c" xlink:href="cvs-20230525.xsd#cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4ef4171f-b074-46ca-a84a-2ada326e4f11" xlink:to="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_72f242e1-7f34-4e9f-a243-d573ff76aa6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale_71c11f7a-9593-4f51-8c3f-3dd377aad4ff" xlink:href="cvs-20230525.xsd#cvs_OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_72f242e1-7f34-4e9f-a243-d573ff76aa6c" xlink:to="loc_cvs_OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale_71c11f7a-9593-4f51-8c3f-3dd377aad4ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale_d482df62-9235-4c56-888e-2797bef3679c" xlink:href="cvs-20230525.xsd#cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_72f242e1-7f34-4e9f-a243-d573ff76aa6c" xlink:to="loc_cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale_d482df62-9235-4c56-888e-2797bef3679c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale_7ac0a6a8-38b5-4ce3-b9fc-7aaabcde12a4" xlink:href="cvs-20230525.xsd#cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_72f242e1-7f34-4e9f-a243-d573ff76aa6c" xlink:to="loc_cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale_7ac0a6a8-38b5-4ce3-b9fc-7aaabcde12a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_bc53f3ed-f75a-44c6-a315-49ce06a1639c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_72f242e1-7f34-4e9f-a243-d573ff76aa6c" xlink:to="loc_us-gaap_OperatingLeaseLiability_bc53f3ed-f75a-44c6-a315-49ce06a1639c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_65b9ecaa-a88b-4ea6-bc40-327f9b8261f0" xlink:href="cvs-20230525.xsd#cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4ef4171f-b074-46ca-a84a-2ada326e4f11" xlink:to="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_65b9ecaa-a88b-4ea6-bc40-327f9b8261f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetGross_9fd163d8-81e7-4d09-991b-2a96331359e1" xlink:href="cvs-20230525.xsd#cvs_FinanceLeaseRightOfUseAssetGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_65b9ecaa-a88b-4ea6-bc40-327f9b8261f0" xlink:to="loc_cvs_FinanceLeaseRightOfUseAssetGross_9fd163d8-81e7-4d09-991b-2a96331359e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_fef3fdee-7398-4f09-9b72-7e0dbce15b3b" xlink:href="cvs-20230525.xsd#cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_65b9ecaa-a88b-4ea6-bc40-327f9b8261f0" xlink:to="loc_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_fef3fdee-7398-4f09-9b72-7e0dbce15b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetNet_8a73f1f6-b464-4316-b261-ab8c0b3b4ed0" xlink:href="cvs-20230525.xsd#cvs_FinanceLeaseRightOfUseAssetNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_65b9ecaa-a88b-4ea6-bc40-327f9b8261f0" xlink:to="loc_cvs_FinanceLeaseRightOfUseAssetNet_8a73f1f6-b464-4316-b261-ab8c0b3b4ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_0c0eea24-1bf5-4f65-94fa-80b2f0bdebc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_65b9ecaa-a88b-4ea6-bc40-327f9b8261f0" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_0c0eea24-1bf5-4f65-94fa-80b2f0bdebc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_a2adc07c-34fd-470a-8fe3-fa8f83429cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_65b9ecaa-a88b-4ea6-bc40-327f9b8261f0" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_a2adc07c-34fd-470a-8fe3-fa8f83429cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_d908ff09-8481-46de-9262-c09f97aff47f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_65b9ecaa-a88b-4ea6-bc40-327f9b8261f0" xlink:to="loc_us-gaap_FinanceLeaseLiability_d908ff09-8481-46de-9262-c09f97aff47f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_WeightedAverageRemainingLeaseTermAbstract_bb9b85c6-e2e0-4493-a375-8974fe66f210" xlink:href="cvs-20230525.xsd#cvs_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4ef4171f-b074-46ca-a84a-2ada326e4f11" xlink:to="loc_cvs_WeightedAverageRemainingLeaseTermAbstract_bb9b85c6-e2e0-4493-a375-8974fe66f210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_87c69be5-d6c1-4349-9643-7dde19be0bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_WeightedAverageRemainingLeaseTermAbstract_bb9b85c6-e2e0-4493-a375-8974fe66f210" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_87c69be5-d6c1-4349-9643-7dde19be0bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_dba0a9de-3d8d-42c0-b6b8-b3b5026ad526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_WeightedAverageRemainingLeaseTermAbstract_bb9b85c6-e2e0-4493-a375-8974fe66f210" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_dba0a9de-3d8d-42c0-b6b8-b3b5026ad526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LeasesWeightedAverageDiscountRateAbstract_17615fd7-3c3a-4fc6-bcbe-7612a85b7b49" xlink:href="cvs-20230525.xsd#cvs_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4ef4171f-b074-46ca-a84a-2ada326e4f11" xlink:to="loc_cvs_LeasesWeightedAverageDiscountRateAbstract_17615fd7-3c3a-4fc6-bcbe-7612a85b7b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ea575f5c-467f-4067-b5a6-245c1c98a26a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LeasesWeightedAverageDiscountRateAbstract_17615fd7-3c3a-4fc6-bcbe-7612a85b7b49" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ea575f5c-467f-4067-b5a6-245c1c98a26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_a059d91f-f677-43f6-8a49-cce5e5456d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LeasesWeightedAverageDiscountRateAbstract_17615fd7-3c3a-4fc6-bcbe-7612a85b7b49" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_a059d91f-f677-43f6-8a49-cce5e5456d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6490d251-24cf-4572-9be1-f500cc9ab958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_c40afe4f-413d-4718-98c6-2adfb733abe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6490d251-24cf-4572-9be1-f500cc9ab958" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_c40afe4f-413d-4718-98c6-2adfb733abe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_855f6fd2-2689-46ae-b505-3bfba5e60328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_c40afe4f-413d-4718-98c6-2adfb733abe5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_855f6fd2-2689-46ae-b505-3bfba5e60328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_e6ce2c49-cc49-49d8-9ce6-9699452143c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_c40afe4f-413d-4718-98c6-2adfb733abe5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_e6ce2c49-cc49-49d8-9ce6-9699452143c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_d123bdf7-674e-4acd-9dab-b4b3bbc6f792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_c40afe4f-413d-4718-98c6-2adfb733abe5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_d123bdf7-674e-4acd-9dab-b4b3bbc6f792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_6e5148fe-4fbc-4bea-91a2-464155d1d698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_c40afe4f-413d-4718-98c6-2adfb733abe5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_6e5148fe-4fbc-4bea-91a2-464155d1d698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_f8b5a96c-55e6-44e4-a5e2-2a05466bc349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_c40afe4f-413d-4718-98c6-2adfb733abe5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_f8b5a96c-55e6-44e4-a5e2-2a05466bc349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_bc5b43cf-e929-4f66-8d27-480c4dd04057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_c40afe4f-413d-4718-98c6-2adfb733abe5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_bc5b43cf-e929-4f66-8d27-480c4dd04057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_b348723d-e417-4239-be02-fcdcb0ba3065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_c40afe4f-413d-4718-98c6-2adfb733abe5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_b348723d-e417-4239-be02-fcdcb0ba3065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_677b0d23-2285-438e-aab3-a7ad04e6f751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_c40afe4f-413d-4718-98c6-2adfb733abe5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_677b0d23-2285-438e-aab3-a7ad04e6f751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_78231f97-4a34-4380-8582-ea101d01294b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_c40afe4f-413d-4718-98c6-2adfb733abe5" xlink:to="loc_us-gaap_FinanceLeaseLiability_78231f97-4a34-4380-8582-ea101d01294b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_49ec26c5-654e-4a32-a36d-3defe21e7cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6490d251-24cf-4572-9be1-f500cc9ab958" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_49ec26c5-654e-4a32-a36d-3defe21e7cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9b0e160f-7afc-40ab-ac92-a943c2cddba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_49ec26c5-654e-4a32-a36d-3defe21e7cdb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9b0e160f-7afc-40ab-ac92-a943c2cddba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e59b5187-323b-49a3-b882-218b4fbda25e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_49ec26c5-654e-4a32-a36d-3defe21e7cdb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e59b5187-323b-49a3-b882-218b4fbda25e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a75875f5-124f-4b62-8431-9630c6039381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_49ec26c5-654e-4a32-a36d-3defe21e7cdb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a75875f5-124f-4b62-8431-9630c6039381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8890f437-2a74-4b78-a594-5ad23b75a995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_49ec26c5-654e-4a32-a36d-3defe21e7cdb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8890f437-2a74-4b78-a594-5ad23b75a995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_e4bee355-6232-40f8-92e0-4f66a922be96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_49ec26c5-654e-4a32-a36d-3defe21e7cdb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_e4bee355-6232-40f8-92e0-4f66a922be96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_446f3834-6372-4c3e-a7ad-1489743fe060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_49ec26c5-654e-4a32-a36d-3defe21e7cdb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_446f3834-6372-4c3e-a7ad-1489743fe060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_038d798b-523f-4cf6-a7c4-a9a14281ef30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_49ec26c5-654e-4a32-a36d-3defe21e7cdb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_038d798b-523f-4cf6-a7c4-a9a14281ef30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_daaf41e4-4c5e-48e0-93d9-4fa8a0ece52a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_49ec26c5-654e-4a32-a36d-3defe21e7cdb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_daaf41e4-4c5e-48e0-93d9-4fa8a0ece52a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_77e44514-133e-4154-aea2-803bf49b87ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_49ec26c5-654e-4a32-a36d-3defe21e7cdb" xlink:to="loc_us-gaap_OperatingLeaseLiability_77e44514-133e-4154-aea2-803bf49b87ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_8867e69f-a22e-44bc-8365-0db2695af2e8" xlink:href="cvs-20230525.xsd#cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6490d251-24cf-4572-9be1-f500cc9ab958" xlink:to="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_8867e69f-a22e-44bc-8365-0db2695af2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsYearOne_e30b810f-62c1-4b50-8b5d-265c7ec68640" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsYearOne"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_8867e69f-a22e-44bc-8365-0db2695af2e8" xlink:to="loc_cvs_LesseeLiabilityPaymentsYearOne_e30b810f-62c1-4b50-8b5d-265c7ec68640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearTwo_32dc716d-517b-4b89-af44-2898d3169756" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_8867e69f-a22e-44bc-8365-0db2695af2e8" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearTwo_32dc716d-517b-4b89-af44-2898d3169756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearThree_f96ef6be-7942-471e-906a-fc28a3fb604c" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_8867e69f-a22e-44bc-8365-0db2695af2e8" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearThree_f96ef6be-7942-471e-906a-fc28a3fb604c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFour_5c63fc7d-7475-4f9a-82db-a0041cf3d991" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_8867e69f-a22e-44bc-8365-0db2695af2e8" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearFour_5c63fc7d-7475-4f9a-82db-a0041cf3d991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFive_96cc754c-01f9-49f6-934c-314d4525f424" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_8867e69f-a22e-44bc-8365-0db2695af2e8" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearFive_96cc754c-01f9-49f6-934c-314d4525f424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive_499703c4-0551-4302-807f-6e85a9a9bbf7" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_8867e69f-a22e-44bc-8365-0db2695af2e8" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive_499703c4-0551-4302-807f-6e85a9a9bbf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDue_d2a5f65c-0e5e-45fc-b6b8-bf4e6f29e839" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_8867e69f-a22e-44bc-8365-0db2695af2e8" xlink:to="loc_cvs_LesseeLiabilityPaymentsDue_d2a5f65c-0e5e-45fc-b6b8-bf4e6f29e839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityUndiscountedExcessAmount_b610c6fb-c2f1-4492-8d32-cb04b988e995" xlink:href="cvs-20230525.xsd#cvs_LesseeLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_8867e69f-a22e-44bc-8365-0db2695af2e8" xlink:to="loc_cvs_LesseeLiabilityUndiscountedExcessAmount_b610c6fb-c2f1-4492-8d32-cb04b988e995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LeaseLiability_d17989c7-55ee-49fa-9970-620183a78bc7" xlink:href="cvs-20230525.xsd#cvs_LeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_8867e69f-a22e-44bc-8365-0db2695af2e8" xlink:to="loc_cvs_LeaseLiability_d17989c7-55ee-49fa-9970-620183a78bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_918de2ca-3023-4994-926f-7539eed91a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6490d251-24cf-4572-9be1-f500cc9ab958" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_918de2ca-3023-4994-926f-7539eed91a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife_2cdec330-91bc-4e3e-9d73-1867bf21345f" xlink:href="cvs-20230525.xsd#cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6490d251-24cf-4572-9be1-f500cc9ab958" xlink:to="loc_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife_2cdec330-91bc-4e3e-9d73-1867bf21345f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="cvs-20230525.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract_1f5da0df-5d6c-4e4a-b100-536ed232eb80" xlink:href="cvs-20230525.xsd#cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_69b0e51d-f70f-4ac5-9d83-f22ec55c3f04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract_1f5da0df-5d6c-4e4a-b100-536ed232eb80" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_69b0e51d-f70f-4ac5-9d83-f22ec55c3f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9b46a18a-b169-40e3-9be9-a70a67e305f9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_69b0e51d-f70f-4ac5-9d83-f22ec55c3f04" xlink:to="loc_srt_ProductOrServiceAxis_9b46a18a-b169-40e3-9be9-a70a67e305f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_133c571f-e1d0-4f30-a54a-27b9f8f90b1f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_9b46a18a-b169-40e3-9be9-a70a67e305f9" xlink:to="loc_srt_ProductsAndServicesDomain_133c571f-e1d0-4f30-a54a-27b9f8f90b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_56bd457d-f552-49cf-acdc-941b01cde052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_133c571f-e1d0-4f30-a54a-27b9f8f90b1f" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_56bd457d-f552-49cf-acdc-941b01cde052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_baeac436-f5b8-4776-8e36-607809a5393a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_69b0e51d-f70f-4ac5-9d83-f22ec55c3f04" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_baeac436-f5b8-4776-8e36-607809a5393a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_1571f8b6-b911-45b3-b1f3-e3de5eb19329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_baeac436-f5b8-4776-8e36-607809a5393a" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_1571f8b6-b911-45b3-b1f3-e3de5eb19329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_46e0a5d0-7db8-43bc-bc8a-b0c741d72fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2019Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_1571f8b6-b911-45b3-b1f3-e3de5eb19329" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_46e0a5d0-7db8-43bc-bc8a-b0c741d72fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_1cacc487-00a3-496c-9f0e-500eee8504d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_1571f8b6-b911-45b3-b1f3-e3de5eb19329" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_1cacc487-00a3-496c-9f0e-500eee8504d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems_e219be68-795a-4066-bb48-a1822d2553cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_69b0e51d-f70f-4ac5-9d83-f22ec55c3f04" xlink:to="loc_us-gaap_ClaimsDevelopmentLineItems_e219be68-795a-4066-bb48-a1822d2553cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_5233b78a-ed1c-44a3-882e-41f3c8a9079b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e219be68-795a-4066-bb48-a1822d2553cd" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_5233b78a-ed1c-44a3-882e-41f3c8a9079b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_633e307d-032d-4ec6-a8c6-a290b2ee57cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e219be68-795a-4066-bb48-a1822d2553cd" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_633e307d-032d-4ec6-a8c6-a290b2ee57cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_bab1596c-54c2-4d09-b42e-ec43ebb96cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e219be68-795a-4066-bb48-a1822d2553cd" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_bab1596c-54c2-4d09-b42e-ec43ebb96cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_482f759c-371d-46b7-90a3-a7dbba992d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_e219be68-795a-4066-bb48-a1822d2553cd" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_482f759c-371d-46b7-90a3-a7dbba992d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#HealthCareCostsPayableNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract_68783c9a-2f37-4ae3-b396-725acdfd0a94" xlink:href="cvs-20230525.xsd#cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_2b580ee6-d393-4193-b795-4d5324a90983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract_68783c9a-2f37-4ae3-b396-725acdfd0a94" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_2b580ee6-d393-4193-b795-4d5324a90983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_14794889-3d95-4be6-87a7-b3892799d325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_2b580ee6-d393-4193-b795-4d5324a90983" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_14794889-3d95-4be6-87a7-b3892799d325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e88ed8ca-a395-4eb8-b205-9a1ec5335476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_14794889-3d95-4be6-87a7-b3892799d325" xlink:to="loc_us-gaap_SegmentDomain_e88ed8ca-a395-4eb8-b205-9a1ec5335476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_ce616074-014f-4405-947d-9aa3cf3501eb" xlink:href="cvs-20230525.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e88ed8ca-a395-4eb8-b205-9a1ec5335476" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_ce616074-014f-4405-947d-9aa3cf3501eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_396006d4-ad55-44e9-9817-213840b1f09e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_2b580ee6-d393-4193-b795-4d5324a90983" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_396006d4-ad55-44e9-9817-213840b1f09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_57bbc1bd-2a8d-49cb-bb64-62d42f0148e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_396006d4-ad55-44e9-9817-213840b1f09e" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_57bbc1bd-2a8d-49cb-bb64-62d42f0148e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_c1530b43-47de-4ee8-b1df-dc1ed449c2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_396006d4-ad55-44e9-9817-213840b1f09e" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_c1530b43-47de-4ee8-b1df-dc1ed449c2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract_0074a3bc-90d5-47bc-840f-7687c5c570a0" xlink:href="cvs-20230525.xsd#cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_9e5c40c2-5221-46ac-990c-61b447a3689b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract_0074a3bc-90d5-47bc-840f-7687c5c570a0" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_9e5c40c2-5221-46ac-990c-61b447a3689b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0441356c-6972-447a-b670-de8f9388db4c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_9e5c40c2-5221-46ac-990c-61b447a3689b" xlink:to="loc_srt_ProductOrServiceAxis_0441356c-6972-447a-b670-de8f9388db4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fe68c404-cb6b-4c79-bcf0-d4fc0f02a876" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_0441356c-6972-447a-b670-de8f9388db4c" xlink:to="loc_srt_ProductsAndServicesDomain_fe68c404-cb6b-4c79-bcf0-d4fc0f02a876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_bb27deab-17f2-48a5-a95d-a5bcc1326644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_fe68c404-cb6b-4c79-bcf0-d4fc0f02a876" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_bb27deab-17f2-48a5-a95d-a5bcc1326644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_2e79c50f-083c-4421-99fb-d7817ed15f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_9e5c40c2-5221-46ac-990c-61b447a3689b" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_2e79c50f-083c-4421-99fb-d7817ed15f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_5584ffb1-1551-4d0c-896e-0da4d8ac951a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_2e79c50f-083c-4421-99fb-d7817ed15f3e" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_5584ffb1-1551-4d0c-896e-0da4d8ac951a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_1db3de11-1f0c-42d4-8fa1-f7e01fe7ea3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_2e79c50f-083c-4421-99fb-d7817ed15f3e" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_1db3de11-1f0c-42d4-8fa1-f7e01fe7ea3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_695bb91e-fc72-4ada-83e3-3ba225136281" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_2e79c50f-083c-4421-99fb-d7817ed15f3e" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_695bb91e-fc72-4ada-83e3-3ba225136281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b59424ea-a3aa-4d2e-b167-9b4f7dfda631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_2e79c50f-083c-4421-99fb-d7817ed15f3e" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b59424ea-a3aa-4d2e-b167-9b4f7dfda631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract_3a2cc4c9-abc0-49b6-98c5-e98b3516e7d2" xlink:href="cvs-20230525.xsd#cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_b3018195-1891-4c51-a631-a8cdbe3bec96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract_3a2cc4c9-abc0-49b6-98c5-e98b3516e7d2" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_b3018195-1891-4c51-a631-a8cdbe3bec96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c5aadb29-b48a-46fb-8211-8e7d9d9b8b06" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_b3018195-1891-4c51-a631-a8cdbe3bec96" xlink:to="loc_srt_ProductOrServiceAxis_c5aadb29-b48a-46fb-8211-8e7d9d9b8b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_492e7472-6b01-4f6a-b6f7-f2d597d33253" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c5aadb29-b48a-46fb-8211-8e7d9d9b8b06" xlink:to="loc_srt_ProductsAndServicesDomain_492e7472-6b01-4f6a-b6f7-f2d597d33253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_afa9c096-8a04-4526-8c80-254ecae54dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_492e7472-6b01-4f6a-b6f7-f2d597d33253" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_afa9c096-8a04-4526-8c80-254ecae54dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a7aa44f1-2b75-493e-938f-1b25d396c7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_b3018195-1891-4c51-a631-a8cdbe3bec96" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a7aa44f1-2b75-493e-938f-1b25d396c7f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9f3264a2-1ddc-4c93-aa03-99c8a8a34bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a7aa44f1-2b75-493e-938f-1b25d396c7f3" xlink:to="loc_us-gaap_SegmentDomain_9f3264a2-1ddc-4c93-aa03-99c8a8a34bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_e7a278e5-3e17-4dad-8a55-eaad70baffda" xlink:href="cvs-20230525.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9f3264a2-1ddc-4c93-aa03-99c8a8a34bc3" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_e7a278e5-3e17-4dad-8a55-eaad70baffda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_4009397a-155f-4917-b60a-dd50e1954958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9f3264a2-1ddc-4c93-aa03-99c8a8a34bc3" xlink:to="loc_us-gaap_CorporateAndOtherMember_4009397a-155f-4917-b60a-dd50e1954958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_7b088bf2-ff98-423e-88d8-2b413c048d02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_b3018195-1891-4c51-a631-a8cdbe3bec96" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_7b088bf2-ff98-423e-88d8-2b413c048d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_7b088bf2-ff98-423e-88d8-2b413c048d02" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_1b8a4405-1ff9-4be1-aca8-7931ca07f4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_1b8a4405-1ff9-4be1-aca8-7931ca07f4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_3ff79bdc-ade3-490b-ad51-f7dcfece2159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_3ff79bdc-ade3-490b-ad51-f7dcfece2159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_575fe8b7-cdf1-412d-95f7-0cc9ea44e9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_575fe8b7-cdf1-412d-95f7-0cc9ea44e9e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_848f62dd-1b61-48a6-8051-a688d141f910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_848f62dd-1b61-48a6-8051-a688d141f910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_b00e08e8-3a95-4ee4-92a7-592bc3af8530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_b00e08e8-3a95-4ee4-92a7-592bc3af8530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_67c7f454-62a2-4f7a-800d-282546ffba7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_67c7f454-62a2-4f7a-800d-282546ffba7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_311ae66a-e7f6-47a8-bea6-41edbcda6aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_67c7f454-62a2-4f7a-800d-282546ffba7f" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_311ae66a-e7f6-47a8-bea6-41edbcda6aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_d319a67b-9585-4179-973e-a5cd44423306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_67c7f454-62a2-4f7a-800d-282546ffba7f" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_d319a67b-9585-4179-973e-a5cd44423306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_64c909e9-44e0-4ff1-99c3-c6294bbea967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_67c7f454-62a2-4f7a-800d-282546ffba7f" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_64c909e9-44e0-4ff1-99c3-c6294bbea967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_2677f2b0-37b9-4ec5-ae55-8dd25f176c99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_2677f2b0-37b9-4ec5-ae55-8dd25f176c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_8e676366-6980-4b30-a9fa-316e40c4652e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_2677f2b0-37b9-4ec5-ae55-8dd25f176c99" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_8e676366-6980-4b30-a9fa-316e40c4652e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_2ef7b087-ac17-4a7d-a15c-e84a026c7912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_2677f2b0-37b9-4ec5-ae55-8dd25f176c99" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_2ef7b087-ac17-4a7d-a15c-e84a026c7912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_13d3ea4e-2d9a-48c8-bb1a-83551f6804fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_2677f2b0-37b9-4ec5-ae55-8dd25f176c99" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_13d3ea4e-2d9a-48c8-bb1a-83551f6804fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_28c32619-b9ca-48c4-b1e6-b3e8f8e61afd" xlink:href="cvs-20230525.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_28c32619-b9ca-48c4-b1e6-b3e8f8e61afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_33c09d18-d6e3-4458-bd86-807f58f9e823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_33c09d18-d6e3-4458-bd86-807f58f9e823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_11b14fae-778e-4d32-b5e7-1329a411d73f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_11b14fae-778e-4d32-b5e7-1329a411d73f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_e1a69b42-cfd1-43e0-8a99-7828c7975bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_e1a69b42-cfd1-43e0-8a99-7828c7975bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_c78850f7-2e37-4dff-b28c-bffe51dd0027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_f01c886a-2a3c-4462-b55f-c5ceb75692e7" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_c78850f7-2e37-4dff-b28c-bffe51dd0027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_5a491027-a24f-4fb2-8c8e-1d1a215b00f5" xlink:href="cvs-20230525.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_7b088bf2-ff98-423e-88d8-2b413c048d02" xlink:to="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_5a491027-a24f-4fb2-8c8e-1d1a215b00f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_ebf83a2b-bcbb-4c46-8fdc-fe45b118d9b3" xlink:href="cvs-20230525.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_7b088bf2-ff98-423e-88d8-2b413c048d02" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_ebf83a2b-bcbb-4c46-8fdc-fe45b118d9b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_e867d698-f976-42a1-8478-1a05e998b3a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_bd5f28b6-fa11-4a61-b614-cd251448d983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_e867d698-f976-42a1-8478-1a05e998b3a4" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_bd5f28b6-fa11-4a61-b614-cd251448d983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8fe18626-b097-422e-baae-7d62aaced8cd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_bd5f28b6-fa11-4a61-b614-cd251448d983" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8fe18626-b097-422e-baae-7d62aaced8cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_379eb212-bbac-4eaa-993d-f2b5fc9ec7ef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8fe18626-b097-422e-baae-7d62aaced8cd" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_379eb212-bbac-4eaa-993d-f2b5fc9ec7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_312accfa-c8e8-4f6d-b0ee-1572eef13ec6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_379eb212-bbac-4eaa-993d-f2b5fc9ec7ef" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_312accfa-c8e8-4f6d-b0ee-1572eef13ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_731dc374-150b-4cda-a27d-d4630b239244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_bd5f28b6-fa11-4a61-b614-cd251448d983" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_731dc374-150b-4cda-a27d-d4630b239244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_f879368f-030f-430a-a35f-4582800ca7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_731dc374-150b-4cda-a27d-d4630b239244" xlink:to="loc_us-gaap_TypeOfAdoptionMember_f879368f-030f-430a-a35f-4582800ca7c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201812Member_6397df03-268e-4753-93ef-c55b4f0ccec8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201812Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_f879368f-030f-430a-a35f-4582800ca7c9" xlink:to="loc_us-gaap_AccountingStandardsUpdate201812Member_6397df03-268e-4753-93ef-c55b4f0ccec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_251e8458-5462-4e66-b150-e067b76f9049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_bd5f28b6-fa11-4a61-b614-cd251448d983" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_251e8458-5462-4e66-b150-e067b76f9049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_ea993245-e42c-48aa-8c73-0f0d706055c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_251e8458-5462-4e66-b150-e067b76f9049" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_ea993245-e42c-48aa-8c73-0f0d706055c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax_9a09946f-f2e5-4d7d-936e-799ffca826ff" xlink:href="cvs-20230525.xsd#cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_251e8458-5462-4e66-b150-e067b76f9049" xlink:to="loc_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax_9a09946f-f2e5-4d7d-936e-799ffca826ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax_22a9b192-1647-4aac-bfbe-63823e257aa2" xlink:href="cvs-20230525.xsd#cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_251e8458-5462-4e66-b150-e067b76f9049" xlink:to="loc_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax_22a9b192-1647-4aac-bfbe-63823e257aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e59e6c84-bc94-4391-8dfd-f29f291d44aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_251e8458-5462-4e66-b150-e067b76f9049" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e59e6c84-bc94-4391-8dfd-f29f291d44aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_1efdb4ae-cd2a-4946-8db5-5f070e16a78c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1273f52c-837b-460c-8a85-8d3c439cd109" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_1efdb4ae-cd2a-4946-8db5-5f070e16a78c" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1273f52c-837b-460c-8a85-8d3c439cd109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_7e1abb83-3a32-4ab8-8882-8ba6d9287d2a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1273f52c-837b-460c-8a85-8d3c439cd109" xlink:to="loc_srt_ProductOrServiceAxis_7e1abb83-3a32-4ab8-8882-8ba6d9287d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ac69142d-656b-4ace-90c2-e1be1b121324" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_7e1abb83-3a32-4ab8-8882-8ba6d9287d2a" xlink:to="loc_srt_ProductsAndServicesDomain_ac69142d-656b-4ace-90c2-e1be1b121324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LargeCasePensionsMember_d077ac4f-813c-430a-a5fd-282b83d32819" xlink:href="cvs-20230525.xsd#cvs_LargeCasePensionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ac69142d-656b-4ace-90c2-e1be1b121324" xlink:to="loc_cvs_LargeCasePensionsMember_d077ac4f-813c-430a-a5fd-282b83d32819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareMember_53145400-3770-4e9f-8737-871bcd5341e6" xlink:href="cvs-20230525.xsd#cvs_LongTermCareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ac69142d-656b-4ace-90c2-e1be1b121324" xlink:to="loc_cvs_LongTermCareMember_53145400-3770-4e9f-8737-871bcd5341e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_7bbc1103-9d0b-4bb4-8fd4-c7bb1f702d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ac69142d-656b-4ace-90c2-e1be1b121324" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_7bbc1103-9d0b-4bb4-8fd4-c7bb1f702d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_819b4fcb-b117-427a-b117-02a91f1db0ef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1273f52c-837b-460c-8a85-8d3c439cd109" xlink:to="loc_srt_RestatementAxis_819b4fcb-b117-427a-b117-02a91f1db0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_7dc87430-ef4d-4e9c-83cc-1fea41abb8fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_819b4fcb-b117-427a-b117-02a91f1db0ef" xlink:to="loc_srt_RestatementDomain_7dc87430-ef4d-4e9c-83cc-1fea41abb8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_5228a1b6-bdfc-4498-8554-43160b3f6eab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_7dc87430-ef4d-4e9c-83cc-1fea41abb8fe" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_5228a1b6-bdfc-4498-8554-43160b3f6eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember_aa657e6e-cc86-4c6c-9993-1e152e9475f2" xlink:href="cvs-20230525.xsd#cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_7dc87430-ef4d-4e9c-83cc-1fea41abb8fe" xlink:to="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember_aa657e6e-cc86-4c6c-9993-1e152e9475f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember_6a4e700c-f9a3-4db4-b563-b15e2dab77a3" xlink:href="cvs-20230525.xsd#cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_7dc87430-ef4d-4e9c-83cc-1fea41abb8fe" xlink:to="loc_cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember_6a4e700c-f9a3-4db4-b563-b15e2dab77a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_784ba8d0-b820-40e8-9d81-1701c1b3b259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1273f52c-837b-460c-8a85-8d3c439cd109" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_784ba8d0-b820-40e8-9d81-1701c1b3b259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_044de45b-0d99-4865-a553-e50f94d4ae9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_784ba8d0-b820-40e8-9d81-1701c1b3b259" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_044de45b-0d99-4865-a553-e50f94d4ae9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_136d3bec-1b44-4cfc-92a9-f122a6e13ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_044de45b-0d99-4865-a553-e50f94d4ae9e" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_136d3bec-1b44-4cfc-92a9-f122a6e13ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_ee63ffde-0918-4709-8be6-f95da08450c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_044de45b-0d99-4865-a553-e50f94d4ae9e" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_ee63ffde-0918-4709-8be6-f95da08450c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange_3df23893-bcf5-4dd1-9aac-f8630fbbb843" xlink:href="cvs-20230525.xsd#cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_044de45b-0d99-4865-a553-e50f94d4ae9e" xlink:to="loc_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange_3df23893-bcf5-4dd1-9aac-f8630fbbb843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_1b112fa8-0e87-46a4-8884-cd7d9150d2e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_044de45b-0d99-4865-a553-e50f94d4ae9e" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_1b112fa8-0e87-46a4-8884-cd7d9150d2e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_22f86739-e10a-48c8-8629-0ba0a792e4f8" xlink:href="cvs-20230525.xsd#cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_044de45b-0d99-4865-a553-e50f94d4ae9e" xlink:to="loc_cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_22f86739-e10a-48c8-8629-0ba0a792e4f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_006048a0-39b1-42b1-9397-34c117c98988" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_044de45b-0d99-4865-a553-e50f94d4ae9e" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_006048a0-39b1-42b1-9397-34c117c98988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_5f647777-91bd-49f8-8c54-c633bfd09581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_044de45b-0d99-4865-a553-e50f94d4ae9e" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_5f647777-91bd-49f8-8c54-c633bfd09581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_e72ceeaf-9b80-449f-b14f-2c80bb952223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e37c0328-c6ab-4329-814a-6d55ac8fd813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_e72ceeaf-9b80-449f-b14f-2c80bb952223" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e37c0328-c6ab-4329-814a-6d55ac8fd813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_ffe039d9-e7fa-423c-8f9a-8ec6f79ffed2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e37c0328-c6ab-4329-814a-6d55ac8fd813" xlink:to="loc_srt_RestatementAxis_ffe039d9-e7fa-423c-8f9a-8ec6f79ffed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_f69d3079-a4de-4c10-bdad-6019c15c8543" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_ffe039d9-e7fa-423c-8f9a-8ec6f79ffed2" xlink:to="loc_srt_RestatementDomain_f69d3079-a4de-4c10-bdad-6019c15c8543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_519e5283-92d8-4547-a5ac-de1c80754d27" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_f69d3079-a4de-4c10-bdad-6019c15c8543" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_519e5283-92d8-4547-a5ac-de1c80754d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_1df2a13a-e06d-4f30-acab-b4c6b90c0134" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_f69d3079-a4de-4c10-bdad-6019c15c8543" xlink:to="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_1df2a13a-e06d-4f30-acab-b4c6b90c0134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c4be9b82-495e-4e9f-9515-b53e2355fb72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e37c0328-c6ab-4329-814a-6d55ac8fd813" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c4be9b82-495e-4e9f-9515-b53e2355fb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalIncomeStatementElementsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c4be9b82-495e-4e9f-9515-b53e2355fb72" xlink:to="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_edc1839c-eab4-4d10-88d8-3078644df69c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_edc1839c-eab4-4d10-88d8-3078644df69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_0ef87cf8-4ba6-4fad-8ecd-d5d5cb9967f7" xlink:href="cvs-20230525.xsd#cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:to="loc_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement_0ef87cf8-4ba6-4fad-8ecd-d5d5cb9967f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_3300cb68-3004-48c3-bd75-25d5b5583423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:to="loc_us-gaap_CostsAndExpenses_3300cb68-3004-48c3-bd75-25d5b5583423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_eeba11a1-736c-4aea-b871-ba01dfbef76f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:to="loc_us-gaap_OperatingIncomeLoss_eeba11a1-736c-4aea-b871-ba01dfbef76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c3a5e508-bb53-4d9e-b185-f56ccf96575d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c3a5e508-bb53-4d9e-b185-f56ccf96575d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ef6f7616-b748-46b8-a965-4ca9b0e8406e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ef6f7616-b748-46b8-a965-4ca9b0e8406e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f006808f-a2f8-4f08-9d4a-1ce15e984376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f006808f-a2f8-4f08-9d4a-1ce15e984376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_feeba0bd-bd1a-4512-8733-6193b6ba60d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:to="loc_us-gaap_ProfitLoss_feeba0bd-bd1a-4512-8733-6193b6ba60d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9e1cf7b2-d2a3-4e4c-999c-b296d1c7623f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:to="loc_us-gaap_NetIncomeLoss_9e1cf7b2-d2a3-4e4c-999c-b296d1c7623f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_871c089e-c456-405b-8e5b-bdc34f8f1450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_871c089e-c456-405b-8e5b-bdc34f8f1450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_4094d93d-d9ef-45ca-8164-5cd892e8ea96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_871c089e-c456-405b-8e5b-bdc34f8f1450" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_4094d93d-d9ef-45ca-8164-5cd892e8ea96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_84cff813-ee34-43d8-be18-5914bfc6fe1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_871c089e-c456-405b-8e5b-bdc34f8f1450" xlink:to="loc_us-gaap_EarningsPerShareBasic_84cff813-ee34-43d8-be18-5914bfc6fe1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_5f0dbb8f-54a0-4ead-b303-31eb9ffbd9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_9a91e5c2-ce7c-4192-9d2e-64c63f86e4a4" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_5f0dbb8f-54a0-4ead-b303-31eb9ffbd9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_1962da56-8579-417f-80cf-1f61bedb9867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_5f0dbb8f-54a0-4ead-b303-31eb9ffbd9dc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_1962da56-8579-417f-80cf-1f61bedb9867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_cd958321-3ebd-4e41-b22a-e17390c29df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_5f0dbb8f-54a0-4ead-b303-31eb9ffbd9dc" xlink:to="loc_us-gaap_EarningsPerShareDiluted_cd958321-3ebd-4e41-b22a-e17390c29df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c4be9b82-495e-4e9f-9515-b53e2355fb72" xlink:to="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_41ef1192-0242-4b69-8c03-8f701d37c82b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_OtherAssetsCurrent_41ef1192-0242-4b69-8c03-8f701d37c82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a6dbff7a-5313-4434-b7a8-62627a73601f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_AssetsCurrent_a6dbff7a-5313-4434-b7a8-62627a73601f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_211d3cf2-fa46-471a-8434-48ea388c46a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_211d3cf2-fa46-471a-8434-48ea388c46a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0710962e-33a5-4a25-b60d-e6b8ed19bda1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_Assets_0710962e-33a5-4a25-b60d-e6b8ed19bda1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_c4e26f80-ecdc-46e5-878e-1ed8634da47b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_c4e26f80-ecdc-46e5-878e-1ed8634da47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent_70a5a618-3c3b-4fb7-a1c9-b4bcb8b723ae" xlink:href="cvs-20230525.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_cvs_OtherInsuranceLiabilitiesCurrent_70a5a618-3c3b-4fb7-a1c9-b4bcb8b723ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_cd759e59-8c9e-4c89-935e-2b9a35942efa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_LiabilitiesCurrent_cd759e59-8c9e-4c89-935e-2b9a35942efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4ef463d9-1572-4da8-8cff-de3c896d26a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4ef463d9-1572-4da8-8cff-de3c896d26a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_105f843c-ceb5-4789-b47b-3717ec082701" xlink:href="cvs-20230525.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_105f843c-ceb5-4789-b47b-3717ec082701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_a73e7fba-1838-452c-bebe-7a10ceef21f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_a73e7fba-1838-452c-bebe-7a10ceef21f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e113d30c-e7f0-4e07-90f7-8c7fa99cdc58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_Liabilities_e113d30c-e7f0-4e07-90f7-8c7fa99cdc58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2c088eae-99d1-446f-b78a-a7db009839a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2c088eae-99d1-446f-b78a-a7db009839a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d9588fe5-6fa8-4754-8a70-6cab4ac61dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d9588fe5-6fa8-4754-8a70-6cab4ac61dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2ca56dca-8a8c-4198-924f-4dcf909b094a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_StockholdersEquity_2ca56dca-8a8c-4198-924f-4dcf909b094a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0c4851ba-6631-4b8c-b707-0563174d1e11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0c4851ba-6631-4b8c-b707-0563174d1e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_570374a0-be86-41cf-bedb-ac5f89d509b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_7aa20de4-c2b2-4075-b273-aeb50a2c63a9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_570374a0-be86-41cf-bedb-ac5f89d509b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_7f752e8b-d80e-4903-b858-ee2843072340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c4be9b82-495e-4e9f-9515-b53e2355fb72" xlink:to="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_7f752e8b-d80e-4903-b858-ee2843072340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_446197b5-0dd5-4298-84a6-815ef006420a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_7f752e8b-d80e-4903-b858-ee2843072340" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_446197b5-0dd5-4298-84a6-815ef006420a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_0f6bbef6-8a32-494a-a67d-620524e0e9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_7f752e8b-d80e-4903-b858-ee2843072340" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_0f6bbef6-8a32-494a-a67d-620524e0e9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_a6474194-069b-4e18-a449-f560da610b36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_7f752e8b-d80e-4903-b858-ee2843072340" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_a6474194-069b-4e18-a449-f560da610b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_137e574a-733d-4fac-b165-9509196a4127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_7f752e8b-d80e-4903-b858-ee2843072340" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_137e574a-733d-4fac-b165-9509196a4127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_5d076bfa-e3e6-4044-959f-5bbf21b77107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_7f752e8b-d80e-4903-b858-ee2843072340" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_5d076bfa-e3e6-4044-959f-5bbf21b77107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_dbc5989c-77af-45d5-8e11-f659b8f35386" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_1590843b-73b4-4510-9776-b3ede2c68691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_dbc5989c-77af-45d5-8e11-f659b8f35386" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_1590843b-73b4-4510-9776-b3ede2c68691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_67707cdf-1b2f-47fe-a547-f30a3bd0c4b8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_1590843b-73b4-4510-9776-b3ede2c68691" xlink:to="loc_srt_ProductOrServiceAxis_67707cdf-1b2f-47fe-a547-f30a3bd0c4b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_74b154f5-18e8-490c-b383-f412f25aad7c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_67707cdf-1b2f-47fe-a547-f30a3bd0c4b8" xlink:to="loc_srt_ProductsAndServicesDomain_74b154f5-18e8-490c-b383-f412f25aad7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LargeCasePensionsMember_d89fc320-06aa-4872-b19b-6a12407910dd" xlink:href="cvs-20230525.xsd#cvs_LargeCasePensionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_74b154f5-18e8-490c-b383-f412f25aad7c" xlink:to="loc_cvs_LargeCasePensionsMember_d89fc320-06aa-4872-b19b-6a12407910dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareMember_5e6bde6d-f29b-4fec-8b1b-98edbfa72f0b" xlink:href="cvs-20230525.xsd#cvs_LongTermCareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_74b154f5-18e8-490c-b383-f412f25aad7c" xlink:to="loc_cvs_LongTermCareMember_5e6bde6d-f29b-4fec-8b1b-98edbfa72f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_cb94bb5d-2900-4b52-9200-471ffbd1f179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_1590843b-73b4-4510-9776-b3ede2c68691" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_cb94bb5d-2900-4b52-9200-471ffbd1f179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8b726a30-5dd1-44a9-9cb9-544bc2cb824c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_cb94bb5d-2900-4b52-9200-471ffbd1f179" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8b726a30-5dd1-44a9-9cb9-544bc2cb824c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_8f771006-6878-4591-8126-03fac58da233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8b726a30-5dd1-44a9-9cb9-544bc2cb824c" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_8f771006-6878-4591-8126-03fac58da233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_dfa1f0c7-1cf3-4222-9dfa-6f844c5e8d97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8b726a30-5dd1-44a9-9cb9-544bc2cb824c" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_dfa1f0c7-1cf3-4222-9dfa-6f844c5e8d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange_b07daa2e-7b8f-466d-991c-06370e96bc14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8b726a30-5dd1-44a9-9cb9-544bc2cb824c" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange_b07daa2e-7b8f-466d-991c-06370e96bc14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_df486b18-f899-483a-82e3-64586bc7d249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8b726a30-5dd1-44a9-9cb9-544bc2cb824c" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_df486b18-f899-483a-82e3-64586bc7d249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_300283a5-b8fd-46e0-87b7-13e896982184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8b726a30-5dd1-44a9-9cb9-544bc2cb824c" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_300283a5-b8fd-46e0-87b7-13e896982184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome_2264f5d1-ea47-4509-89f6-73440356ebd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8b726a30-5dd1-44a9-9cb9-544bc2cb824c" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome_2264f5d1-ea47-4509-89f6-73440356ebd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected_0ac0b451-8eed-4f39-8fdf-de1d38058592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8b726a30-5dd1-44a9-9cb9-544bc2cb824c" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected_0ac0b451-8eed-4f39-8fdf-de1d38058592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_c372cfb3-5f43-4863-a0d6-ba5e28632090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8b726a30-5dd1-44a9-9cb9-544bc2cb824c" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance_c372cfb3-5f43-4863-a0d6-ba5e28632090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_c58fdd92-7227-4e97-b70e-4c8d0c5652be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8b726a30-5dd1-44a9-9cb9-544bc2cb824c" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax_c58fdd92-7227-4e97-b70e-4c8d0c5652be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_ad05ce93-ae0b-4f6c-b83a-4866af266f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward_8b726a30-5dd1-44a9-9cb9-544bc2cb824c" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange_ad05ce93-ae0b-4f6c-b83a-4866af266f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_cb94bb5d-2900-4b52-9200-471ffbd1f179" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_f833e003-b0e4-4189-98cd-e5e81e82ed62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_f833e003-b0e4-4189-98cd-e5e81e82ed62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_1f9d9273-ad1b-49ac-a304-d705c71b25ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_1f9d9273-ad1b-49ac-a304-d705c71b25ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_ef215d09-33bc-4bfe-90b4-180dfe4a28c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange_ef215d09-33bc-4bfe-90b4-180dfe4a28c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_87b3e623-cc8a-4a5f-9f25-49eedb8607cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience_87b3e623-cc8a-4a5f-9f25-49eedb8607cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_35d6ff22-3f6e-4a7c-b9c5-234d0b2a3aae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange_35d6ff22-3f6e-4a7c-b9c5-234d0b2a3aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance_5f984d33-b636-444d-b33d-178a886af972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance_5f984d33-b636-444d-b33d-178a886af972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense_9939f4bf-2feb-49e8-87d2-eda2574532a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense_9939f4bf-2feb-49e8-87d2-eda2574532a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits_dc6ce28e-e31d-4ad2-aa8e-f761ae099312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits_dc6ce28e-e31d-4ad2-aa8e-f761ae099312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_777ce1b5-a995-4a63-bbb1-fd3315c44910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance_777ce1b5-a995-4a63-bbb1-fd3315c44910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_4ee8d5df-db3a-4d7b-ba09-73121fd23edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:to="loc_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax_4ee8d5df-db3a-4d7b-ba09-73121fd23edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_d2dab6a5-c00d-40c2-a112-79e731e7e84c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward_eebc2518-2d94-4385-b400-beb6146daa49" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange_d2dab6a5-c00d-40c2-a112-79e731e7e84c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_b8eac47a-9963-4ea7-b6b3-3eff6c3d4d18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_cb94bb5d-2900-4b52-9200-471ffbd1f179" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefits_b8eac47a-9963-4ea7-b6b3-3eff6c3d4d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_fb4b4fd7-b220-412e-b423-d579fe4af24a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_cb94bb5d-2900-4b52-9200-471ffbd1f179" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance_fb4b4fd7-b220-412e-b423-d579fe4af24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_144a0943-475d-401b-89b6-9846349ec6de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_cb94bb5d-2900-4b52-9200-471ffbd1f179" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance_144a0943-475d-401b-89b6-9846349ec6de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_c247d21b-2d9a-4770-8882-1248b0cca208" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_6f2f780e-92ed-41d3-b779-356d8204c699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_c247d21b-2d9a-4770-8882-1248b0cca208" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_6f2f780e-92ed-41d3-b779-356d8204c699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_19950527-c03d-4514-8566-477d00386056" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_6f2f780e-92ed-41d3-b779-356d8204c699" xlink:to="loc_srt_ProductOrServiceAxis_19950527-c03d-4514-8566-477d00386056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_32a4b8e3-167f-455a-a9ec-587c663b70a7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_19950527-c03d-4514-8566-477d00386056" xlink:to="loc_srt_ProductsAndServicesDomain_32a4b8e3-167f-455a-a9ec-587c663b70a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LargeCasePensionsMember_00a95001-8242-4c61-adbc-4f7360549a06" xlink:href="cvs-20230525.xsd#cvs_LargeCasePensionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_32a4b8e3-167f-455a-a9ec-587c663b70a7" xlink:to="loc_cvs_LargeCasePensionsMember_00a95001-8242-4c61-adbc-4f7360549a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareMember_dfc2b38c-384d-4a42-85fa-0fbb8b535783" xlink:href="cvs-20230525.xsd#cvs_LongTermCareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_32a4b8e3-167f-455a-a9ec-587c663b70a7" xlink:to="loc_cvs_LongTermCareMember_dfc2b38c-384d-4a42-85fa-0fbb8b535783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_35557d22-db58-4425-9c24-92711aa1f9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_6f2f780e-92ed-41d3-b779-356d8204c699" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_35557d22-db58-4425-9c24-92711aa1f9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance_c32cce4e-b144-400a-b951-e8f44bb0d1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_35557d22-db58-4425-9c24-92711aa1f9d7" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance_c32cce4e-b144-400a-b951-e8f44bb0d1b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance_77b82cba-523e-46ab-b41c-abafadb36394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_35557d22-db58-4425-9c24-92711aa1f9d7" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance_77b82cba-523e-46ab-b41c-abafadb36394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_687cb10d-8b3e-4958-a272-f9d2bef9a7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_f5390bc5-916f-4c37-a8d2-903042debf6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_687cb10d-8b3e-4958-a272-f9d2bef9a7a8" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_f5390bc5-916f-4c37-a8d2-903042debf6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_37ae6c6f-3f54-415f-a39c-74910b0224cd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_f5390bc5-916f-4c37-a8d2-903042debf6e" xlink:to="loc_srt_ProductOrServiceAxis_37ae6c6f-3f54-415f-a39c-74910b0224cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_68b84026-a5b5-4f35-932e-6808ca0a87fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_37ae6c6f-3f54-415f-a39c-74910b0224cd" xlink:to="loc_srt_ProductsAndServicesDomain_68b84026-a5b5-4f35-932e-6808ca0a87fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LargeCasePensionsMember_94a598af-910e-47f8-9706-81bcf608b6ea" xlink:href="cvs-20230525.xsd#cvs_LargeCasePensionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_68b84026-a5b5-4f35-932e-6808ca0a87fb" xlink:to="loc_cvs_LargeCasePensionsMember_94a598af-910e-47f8-9706-81bcf608b6ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareMember_7655d419-82bb-47e5-b7f3-05fd34bb0d85" xlink:href="cvs-20230525.xsd#cvs_LongTermCareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_68b84026-a5b5-4f35-932e-6808ca0a87fb" xlink:to="loc_cvs_LongTermCareMember_7655d419-82bb-47e5-b7f3-05fd34bb0d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_d161db9e-da5e-4e53-96b0-42447eaaebbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTable_f5390bc5-916f-4c37-a8d2-903042debf6e" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_d161db9e-da5e-4e53-96b0-42447eaaebbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate_d0f9dd77-24ac-4d04-8f7b-daf4e9ca20b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_d161db9e-da5e-4e53-96b0-42447eaaebbc" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate_d0f9dd77-24ac-4d04-8f7b-daf4e9ca20b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate_9e6bc965-af1a-49de-aea0-5aa399c5ff32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_d161db9e-da5e-4e53-96b0-42447eaaebbc" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate_9e6bc965-af1a-49de-aea0-5aa399c5ff32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration_dc533d3f-4a9f-44dc-a8e9-e6547ef7684f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems_d161db9e-da5e-4e53-96b0-42447eaaebbc" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration_dc533d3f-4a9f-44dc-a8e9-e6547ef7684f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_785f67b9-6660-46a0-840e-d8289422ae56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceRollForward_d8c21d98-3c06-4043-b8f9-a46218fe7ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_785f67b9-6660-46a0-840e-d8289422ae56" xlink:to="loc_us-gaap_PolicyholderAccountBalanceRollForward_d8c21d98-3c06-4043-b8f9-a46218fe7ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderFunds_aa688fb3-5fd7-4c2f-b8da-6b195f660760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderFunds"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderAccountBalanceRollForward_d8c21d98-3c06-4043-b8f9-a46218fe7ccf" xlink:to="loc_us-gaap_PolicyholderFunds_aa688fb3-5fd7-4c2f-b8da-6b195f660760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PolicyholderAccountBalanceDepositsReceived_00e75cd5-09de-467b-b68f-2d05dc12b17d" xlink:href="cvs-20230525.xsd#cvs_PolicyholderAccountBalanceDepositsReceived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderAccountBalanceRollForward_d8c21d98-3c06-4043-b8f9-a46218fe7ccf" xlink:to="loc_cvs_PolicyholderAccountBalanceDepositsReceived_00e75cd5-09de-467b-b68f-2d05dc12b17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalancePolicyCharge_27a58079-8a9b-4f59-879a-eb60634b489b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalancePolicyCharge"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderAccountBalanceRollForward_d8c21d98-3c06-4043-b8f9-a46218fe7ccf" xlink:to="loc_us-gaap_PolicyholderAccountBalancePolicyCharge_27a58079-8a9b-4f59-879a-eb60634b489b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal_ce0ed3e9-fb45-4531-b354-ca3d7627ab83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderAccountBalanceRollForward_d8c21d98-3c06-4043-b8f9-a46218fe7ccf" xlink:to="loc_us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal_ce0ed3e9-fb45-4531-b354-ca3d7627ab83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCreditedToPolicyholdersAccountBalances_12ecbdef-3972-40c3-9cf4-70c4cdbfbd6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestCreditedToPolicyholdersAccountBalances"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderAccountBalanceRollForward_d8c21d98-3c06-4043-b8f9-a46218fe7ccf" xlink:to="loc_us-gaap_InterestCreditedToPolicyholdersAccountBalances_12ecbdef-3972-40c3-9cf4-70c4cdbfbd6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses_299310bd-d909-437b-95d7-edf3d7433051" xlink:href="cvs-20230525.xsd#cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderAccountBalanceRollForward_d8c21d98-3c06-4043-b8f9-a46218fe7ccf" xlink:to="loc_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses_299310bd-d909-437b-95d7-edf3d7433051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange_c5222c7e-60b5-4d0a-851b-144cdcb5df08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderAccountBalanceRollForward_d8c21d98-3c06-4043-b8f9-a46218fe7ccf" xlink:to="loc_us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange_c5222c7e-60b5-4d0a-851b-144cdcb5df08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderFunds_8e0eabdf-241b-4140-813b-3b3a40f28b89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderFunds"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderAccountBalanceRollForward_d8c21d98-3c06-4043-b8f9-a46218fe7ccf" xlink:to="loc_us-gaap_PolicyholderFunds_8e0eabdf-241b-4140-813b-3b3a40f28b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate_1c02b482-490e-40b8-b7ea-a28ffef6ebb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_785f67b9-6660-46a0-840e-d8289422ae56" xlink:to="loc_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate_1c02b482-490e-40b8-b7ea-a28ffef6ebb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk_aebf97a1-699a-4d8e-a85d-f2d20f7aec1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderAccountBalanceNetAmountAtRisk"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_785f67b9-6660-46a0-840e-d8289422ae56" xlink:to="loc_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk_aebf97a1-699a-4d8e-a85d-f2d20f7aec1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueDuePolicyholdersAmount_36c95e73-0d27-4b35-9189-a56598b2fa94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueDuePolicyholdersAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_785f67b9-6660-46a0-840e-d8289422ae56" xlink:to="loc_us-gaap_CashSurrenderValueDuePolicyholdersAmount_36c95e73-0d27-4b35-9189-a56598b2fa94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_93643109-465e-4f6a-ad47-c760010459e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_217f09ad-330e-4d9a-93fd-c1c07cfda290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_93643109-465e-4f6a-ad47-c760010459e8" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_217f09ad-330e-4d9a-93fd-c1c07cfda290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryAxis_10d488e0-a545-46c6-af85-2bcfa3291935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_217f09ad-330e-4d9a-93fd-c1c07cfda290" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryAxis_10d488e0-a545-46c6-af85-2bcfa3291935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain_cec306f1-6b37-4bf8-9791-537c218add8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis_10d488e0-a545-46c6-af85-2bcfa3291935" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryDomain_cec306f1-6b37-4bf8-9791-537c218add8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountCashAndCashEquivalentsMember_a8224668-d115-4f3b-a23f-1ab6d0023418" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_cec306f1-6b37-4bf8-9791-537c218add8b" xlink:to="loc_us-gaap_SeparateAccountCashAndCashEquivalentsMember_a8224668-d115-4f3b-a23f-1ab6d0023418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountDebtSecurityMember_fad6c6e3-d544-4760-b68a-da99822c65a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountDebtSecurityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_cec306f1-6b37-4bf8-9791-537c218add8b" xlink:to="loc_us-gaap_SeparateAccountDebtSecurityMember_fad6c6e3-d544-4760-b68a-da99822c65a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountMortgageBackedSecurityMember_03fc03c4-acba-47ab-a2b0-fd34370dabf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountMortgageBackedSecurityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_cec306f1-6b37-4bf8-9791-537c218add8b" xlink:to="loc_us-gaap_SeparateAccountMortgageBackedSecurityMember_03fc03c4-acba-47ab-a2b0-fd34370dabf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeparateAccountOtherAssetBackedSecuritiesMember_5974546d-b733-4c66-a2b1-fd45e67c84e3" xlink:href="cvs-20230525.xsd#cvs_SeparateAccountOtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_cec306f1-6b37-4bf8-9791-537c218add8b" xlink:to="loc_cvs_SeparateAccountOtherAssetBackedSecuritiesMember_5974546d-b733-4c66-a2b1-fd45e67c84e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EquitySecuritiesAndCommonAndCollectiveTrustsMember_7b342f5d-fd31-4c76-83b8-062e43fbb76f" xlink:href="cvs-20230525.xsd#cvs_EquitySecuritiesAndCommonAndCollectiveTrustsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_cec306f1-6b37-4bf8-9791-537c218add8b" xlink:to="loc_cvs_EquitySecuritiesAndCommonAndCollectiveTrustsMember_7b342f5d-fd31-4c76-83b8-062e43fbb76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_640dac4f-2b64-476b-aefe-1aee3a5b421a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_217f09ad-330e-4d9a-93fd-c1c07cfda290" xlink:to="loc_us-gaap_FinancialInstrumentAxis_640dac4f-2b64-476b-aefe-1aee3a5b421a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019c4024-166a-4a82-a5da-9dd747215f58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_640dac4f-2b64-476b-aefe-1aee3a5b421a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019c4024-166a-4a82-a5da-9dd747215f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_2e6fd784-3f42-4643-830c-702a0f5a2651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019c4024-166a-4a82-a5da-9dd747215f58" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_2e6fd784-3f42-4643-830c-702a0f5a2651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_87bd9082-11b5-4587-b4b9-db7cdf366582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019c4024-166a-4a82-a5da-9dd747215f58" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_87bd9082-11b5-4587-b4b9-db7cdf366582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_42d1e7e8-1194-44c3-80ac-f27a6295f442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019c4024-166a-4a82-a5da-9dd747215f58" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_42d1e7e8-1194-44c3-80ac-f27a6295f442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_94ed179c-8616-4b51-ab2f-1743ad2bf7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019c4024-166a-4a82-a5da-9dd747215f58" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_94ed179c-8616-4b51-ab2f-1743ad2bf7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_de828727-176e-4aef-88bd-7320b25cb0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019c4024-166a-4a82-a5da-9dd747215f58" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_de828727-176e-4aef-88bd-7320b25cb0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_42c44adc-7108-43f7-a988-fda75b6c384c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019c4024-166a-4a82-a5da-9dd747215f58" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_42c44adc-7108-43f7-a988-fda75b6c384c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_41df7142-9ed1-407e-b9cd-fb84e4e3c72b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_217f09ad-330e-4d9a-93fd-c1c07cfda290" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_41df7142-9ed1-407e-b9cd-fb84e4e3c72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_85a99596-d0cc-4cc2-bbfc-31158920d2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_41df7142-9ed1-407e-b9cd-fb84e4e3c72b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_85a99596-d0cc-4cc2-bbfc-31158920d2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableMember_08d9494a-277c-4870-b2c3-ac90ffd0f5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_85a99596-d0cc-4cc2-bbfc-31158920d2cd" xlink:to="loc_us-gaap_AccountsPayableMember_08d9494a-277c-4870-b2c3-ac90ffd0f5c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_992c3bb3-e934-4013-8de8-c58a175e80da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_85a99596-d0cc-4cc2-bbfc-31158920d2cd" xlink:to="loc_us-gaap_AccountsReceivableMember_992c3bb3-e934-4013-8de8-c58a175e80da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fbb71837-1119-4ce1-a585-b54b696b5f95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_217f09ad-330e-4d9a-93fd-c1c07cfda290" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fbb71837-1119-4ce1-a585-b54b696b5f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_744c9b1d-f3df-4e42-b8b3-5f377f80343f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_fbb71837-1119-4ce1-a585-b54b696b5f95" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_744c9b1d-f3df-4e42-b8b3-5f377f80343f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_a8c4e9a9-55eb-46df-ae45-29b64178ec91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_744c9b1d-f3df-4e42-b8b3-5f377f80343f" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_a8c4e9a9-55eb-46df-ae45-29b64178ec91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_951d3e91-d216-4623-9b59-799017c16b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_217f09ad-330e-4d9a-93fd-c1c07cfda290" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_951d3e91-d216-4623-9b59-799017c16b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_fbf81efe-6005-4ebf-bd57-ccea066f1299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_951d3e91-d216-4623-9b59-799017c16b1b" xlink:to="loc_us-gaap_SeparateAccountAssets_fbf81efe-6005-4ebf-bd57-ccea066f1299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_1bc4c142-0912-4db9-b518-865b5849b8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_951d3e91-d216-4623-9b59-799017c16b1b" xlink:to="loc_us-gaap_SeparateAccountsLiability_1bc4c142-0912-4db9-b518-865b5849b8dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_b1b2a054-9bad-4613-bb67-7fcf53ab5ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityRollForward_4ce232f7-9303-4fa0-b59d-e35024b99bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_b1b2a054-9bad-4613-bb67-7fcf53ab5ae5" xlink:to="loc_us-gaap_SeparateAccountLiabilityRollForward_4ce232f7-9303-4fa0-b59d-e35024b99bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_6201651f-8ec5-47b9-9ad9-28887271731f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountLiabilityRollForward_4ce232f7-9303-4fa0-b59d-e35024b99bb4" xlink:to="loc_us-gaap_SeparateAccountsLiability_6201651f-8ec5-47b9-9ad9-28887271731f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityPremiumAndDeposit_1a1b1c6d-a875-4f51-bef5-e1eb8f908172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityPremiumAndDeposit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountLiabilityRollForward_4ce232f7-9303-4fa0-b59d-e35024b99bb4" xlink:to="loc_us-gaap_SeparateAccountLiabilityPremiumAndDeposit_1a1b1c6d-a875-4f51-bef5-e1eb8f908172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal_4bf2e017-f6ef-456f-8d2c-c5a357c2ab86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountLiabilityRollForward_4ce232f7-9303-4fa0-b59d-e35024b99bb4" xlink:to="loc_us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal_4bf2e017-f6ef-456f-8d2c-c5a357c2ab86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityBenefitPayment_785ba8c3-4fea-4172-8c81-ddf4044ddb81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityBenefitPayment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountLiabilityRollForward_4ce232f7-9303-4fa0-b59d-e35024b99bb4" xlink:to="loc_us-gaap_SeparateAccountLiabilityBenefitPayment_785ba8c3-4fea-4172-8c81-ddf4044ddb81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance_4b35ba61-c5e2-4439-8dd5-67ef449e99b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountLiabilityRollForward_4ce232f7-9303-4fa0-b59d-e35024b99bb4" xlink:to="loc_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance_4b35ba61-c5e2-4439-8dd5-67ef449e99b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount_08c153fe-0d2e-4b90-94fe-88c3d2c6271c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountLiabilityRollForward_4ce232f7-9303-4fa0-b59d-e35024b99bb4" xlink:to="loc_us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount_08c153fe-0d2e-4b90-94fe-88c3d2c6271c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange_09c52cfe-320d-49b1-873a-41823dc89af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountLiabilityRollForward_4ce232f7-9303-4fa0-b59d-e35024b99bb4" xlink:to="loc_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange_09c52cfe-320d-49b1-873a-41823dc89af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_3e91de8e-6586-44f3-81f6-a6641aa3ef6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountLiabilityRollForward_4ce232f7-9303-4fa0-b59d-e35024b99bb4" xlink:to="loc_us-gaap_SeparateAccountsLiability_3e91de8e-6586-44f3-81f6-a6641aa3ef6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount_2cd11973-5e23-4165-8ade-cc5fa501b7f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_b1b2a054-9bad-4613-bb67-7fcf53ab5ae5" xlink:to="loc_us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount_2cd11973-5e23-4165-8ade-cc5fa501b7f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1b86041b-f89a-4983-866a-df971e3d3e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_bfb0588d-e9ad-44db-9075-de600d0d607a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1b86041b-f89a-4983-866a-df971e3d3e4b" xlink:to="loc_us-gaap_DebtInstrumentTable_bfb0588d-e9ad-44db-9075-de600d0d607a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2a2eec38-bb71-486c-b136-be17ef202355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bfb0588d-e9ad-44db-9075-de600d0d607a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2a2eec38-bb71-486c-b136-be17ef202355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6efdce76-0c62-4e2e-ad8d-bde7b6f4ae2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2a2eec38-bb71-486c-b136-be17ef202355" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6efdce76-0c62-4e2e-ad8d-bde7b6f4ae2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_8a3346e6-cbc2-48b6-9248-a72542015d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6efdce76-0c62-4e2e-ad8d-bde7b6f4ae2d" xlink:to="loc_us-gaap_SeniorNotesMember_8a3346e6-cbc2-48b6-9248-a72542015d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_c26ee550-0fd0-41ac-9e0e-4bafcfa141d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6efdce76-0c62-4e2e-ad8d-bde7b6f4ae2d" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_c26ee550-0fd0-41ac-9e0e-4bafcfa141d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a9f587b4-6c41-4aa6-b75b-42cd0b21291d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bfb0588d-e9ad-44db-9075-de600d0d607a" xlink:to="loc_us-gaap_DebtInstrumentAxis_a9f587b4-6c41-4aa6-b75b-42cd0b21291d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a9f587b4-6c41-4aa6-b75b-42cd0b21291d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueJuly2022Member_f828b743-639a-4cd2-bcb8-66f0de28c3f1" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.5DueJuly2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes3.5DueJuly2022Member_f828b743-639a-4cd2-bcb8-66f0de28c3f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueNovember2022Member_ea798657-30d1-429c-91dc-45d131811040" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2.75DueNovember2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes2.75DueNovember2022Member_ea798657-30d1-429c-91dc-45d131811040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueDecember2022Member_44126120-6062-43f3-aed5-ac0c4bd36c00" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2.75DueDecember2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes2.75DueDecember2022Member_44126120-6062-43f3-aed5-ac0c4bd36c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueDecember2022Member_25f524b8-0efc-4a9a-a512-d97d00a0e602" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.75DueDecember2022Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes4.75DueDecember2022Member_25f524b8-0efc-4a9a-a512-d97d00a0e602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJune2023Member_ef1d9820-ee36-42d6-8e0a-ab2d1f1fe70d" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2.8DueJune2023Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes2.8DueJune2023Member_ef1d9820-ee36-42d6-8e0a-ab2d1f1fe70d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_01255528-121b-4f83-a1ad-753aac8fb39b" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_01255528-121b-4f83-a1ad-753aac8fb39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.375DueAugust2024Member_8da80df9-5c32-48dc-bcd0-70fe72bf753d" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.375DueAugust2024Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes3.375DueAugust2024Member_8da80df9-5c32-48dc-bcd0-70fe72bf753d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member_c13d7ad2-dab2-4cac-a345-9977bb0d2d27" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes2.625DueAugust2024Member_c13d7ad2-dab2-4cac-a345-9977bb0d2d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueNovember2024Member_72205d46-98a3-4e27-9269-79b91a131d92" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.5DueNovember2024Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes3.5DueNovember2024Member_72205d46-98a3-4e27-9269-79b91a131d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5DueDecember2024Member_fde3bccc-3d1b-4cfd-b626-bb43d7ce4cff" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes5DueDecember2024Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes5DueDecember2024Member_fde3bccc-3d1b-4cfd-b626-bb43d7ce4cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_e5fe3c0a-7eef-494e-a8a2-946b72b45fad" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_e5fe3c0a-7eef-494e-a8a2-946b72b45fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueJuly2025Member_0acd0c86-ef79-41d2-b6e0-a8e8ea76b86d" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.875DueJuly2025Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes3.875DueJuly2025Member_0acd0c86-ef79-41d2-b6e0-a8e8ea76b86d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.875DueJune2026Member_390a8a8d-1543-4f62-8deb-e9cd014d7b87" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2.875DueJune2026Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes2.875DueJune2026Member_390a8a8d-1543-4f62-8deb-e9cd014d7b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member_ac35427b-3eb1-4ea0-9d51-76746ded9617" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes3DueAugust2026Member_ac35427b-3eb1-4ea0-9d51-76746ded9617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point625PercentApril2027Member_78e14be2-b407-42aa-af91-bfc2dbc55063" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3Point625PercentApril2027Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes3Point625PercentApril2027Member_78e14be2-b407-42aa-af91-bfc2dbc55063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.25DueJune2027Member_c52201fe-75ab-4716-a301-c09ca668189a" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes6.25DueJune2027Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes6.25DueJune2027Member_c52201fe-75ab-4716-a301-c09ca668189a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point3PercentAugust2027Member_20168257-a547-4d2a-b218-d6790d4a892c" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes1Point3PercentAugust2027Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes1Point3PercentAugust2027Member_20168257-a547-4d2a-b218-d6790d4a892c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.3DueMarch2028Member_c03e7244-2097-43b8-97b6-8ba1e8f9868f" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.3DueMarch2028Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes4.3DueMarch2028Member_c03e7244-2097-43b8-97b6-8ba1e8f9868f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member_fa853b52-ad4d-46c2-9510-a5b4e83c66ef" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes3.25DueAugust2029Member_fa853b52-ad4d-46c2-9510-a5b4e83c66ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point75PercentApril2030Member_14a72112-c220-4cda-8c4f-b0f65caa8f3c" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3Point75PercentApril2030Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes3Point75PercentApril2030Member_14a72112-c220-4cda-8c4f-b0f65caa8f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point75PercentAugust2030Member_0570d141-abfd-4b8f-80f5-e301748ececa" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes1Point75PercentAugust2030Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes1Point75PercentAugust2030Member_0570d141-abfd-4b8f-80f5-e301748ececa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point875PercentFebruary2031Member_e15ad2ee-5810-48aa-b61a-0c07807e7d9a" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes1Point875PercentFebruary2031Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes1Point875PercentFebruary2031Member_e15ad2ee-5810-48aa-b61a-0c07807e7d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2Point125PercentDueSeptember2031Member_acbd0a78-5554-4e64-b520-a266278a4c61" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2Point125PercentDueSeptember2031Member"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes2Point125PercentDueSeptember2031Member_acbd0a78-5554-4e64-b520-a266278a4c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.875DueJuly2035Member_d7a96fe4-3f79-424f-a331-c0c4b12ae90e" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.875DueJuly2035Member"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes4.875DueJuly2035Member_d7a96fe4-3f79-424f-a331-c0c4b12ae90e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.625DueJune2036Member_e7a5e504-cc37-4521-b7e9-46b4fe256fac" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes6.625DueJune2036Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes6.625DueJune2036Member_e7a5e504-cc37-4521-b7e9-46b4fe256fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.75DueDecember2037Member_535c3b8f-789d-4c88-a84f-0ae028206c4e" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes6.75DueDecember2037Member"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes6.75DueDecember2037Member_535c3b8f-789d-4c88-a84f-0ae028206c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.78DueMarch2038Member_0abcfba1-52a0-4f33-93b4-c832991c9a40" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.78DueMarch2038Member"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes4.78DueMarch2038Member_0abcfba1-52a0-4f33-93b4-c832991c9a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.125DueSeptember2039Member_17db61f8-295c-4b85-9844-14ae5fc1b7eb" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes6.125DueSeptember2039Member"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes6.125DueSeptember2039Member_17db61f8-295c-4b85-9844-14ae5fc1b7eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4Point125PercentApril2040Member_a5d42aac-d952-4835-ab0e-34bb1f3109ff" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4Point125PercentApril2040Member"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes4Point125PercentApril2040Member_a5d42aac-d952-4835-ab0e-34bb1f3109ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2Point7PercentAugust2040Member_236334a9-3591-4a16-a738-e4fc324de2f8" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2Point7PercentAugust2040Member"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes2Point7PercentAugust2040Member_236334a9-3591-4a16-a738-e4fc324de2f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.75DueMay2041Member_952f921d-7d48-4ff8-8baa-8162aa016a4d" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes5.75DueMay2041Member"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes5.75DueMay2041Member_952f921d-7d48-4ff8-8baa-8162aa016a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.5DueMay2042Member_66f5cd2d-af18-4c26-9daf-092e157a70d4" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.5DueMay2042Member"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes4.5DueMay2042Member_66f5cd2d-af18-4c26-9daf-092e157a70d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueNovember2042Member_48f6b297-6274-4285-ac82-2677ea124317" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.125DueNovember2042Member"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes4.125DueNovember2042Member_48f6b297-6274-4285-ac82-2677ea124317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.3DueDecember2043Member_35c23235-afdd-49a0-87e9-4fc8d0b406a6" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes5.3DueDecember2043Member"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes5.3DueDecember2043Member_35c23235-afdd-49a0-87e9-4fc8d0b406a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueMarch2044Member_d2a3a4c2-4526-43f9-93aa-5cea755eff5d" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.75DueMarch2044Member"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes4.75DueMarch2044Member_d2a3a4c2-4526-43f9-93aa-5cea755eff5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.125DueJuly2045Member_52a98338-7535-4964-886b-017879d9afdf" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes5.125DueJuly2045Member"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes5.125DueJuly2045Member_52a98338-7535-4964-886b-017879d9afdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueAugust2047Member_20a675f1-4b54-4f4d-a6e8-bdbaf9ff2b5d" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.875DueAugust2047Member"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes3.875DueAugust2047Member_20a675f1-4b54-4f4d-a6e8-bdbaf9ff2b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.05DueMarch2048Member_8f0cc8b3-5b45-4d99-b754-28abe6cf10c8" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes5.05DueMarch2048Member"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes5.05DueMarch2048Member_8f0cc8b3-5b45-4d99-b754-28abe6cf10c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4Point25PercentApril2050Member_70a51bcf-cef4-426f-9541-a42fc3425289" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4Point25PercentApril2050Member"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ebd1897f-fe49-48e2-acc5-a3987fa4cb5b" xlink:to="loc_cvs_SeniorNotes4Point25PercentApril2050Member_70a51bcf-cef4-426f-9541-a42fc3425289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_5516a597-0ae3-4925-a557-028906205330" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bfb0588d-e9ad-44db-9075-de600d0d607a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_5516a597-0ae3-4925-a557-028906205330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_128732ed-b8e9-45e4-a1ce-b16fa4464060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_5516a597-0ae3-4925-a557-028906205330" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_128732ed-b8e9-45e4-a1ce-b16fa4464060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_e79c9572-e9bd-4b1c-8d79-09b171dedde6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_128732ed-b8e9-45e4-a1ce-b16fa4464060" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_e79c9572-e9bd-4b1c-8d79-09b171dedde6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bfb0588d-e9ad-44db-9075-de600d0d607a" xlink:to="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_be14ce74-514c-4860-b4a6-1e29e4fc2fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_be14ce74-514c-4860-b4a6-1e29e4fc2fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_7793fbb9-a625-40e2-91ba-a11b20cf012e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_7793fbb9-a625-40e2-91ba-a11b20cf012e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_d78d2d1c-e166-4156-a0ac-64a9471d1f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:to="loc_us-gaap_FinanceLeaseLiability_d78d2d1c-e166-4156-a0ac-64a9471d1f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_5576c1dd-5207-4faf-8cf4-bbc5e48d6fcd" xlink:href="cvs-20230525.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:to="loc_cvs_LongtermDebtGrossAndLeaseObligation_5576c1dd-5207-4faf-8cf4-bbc5e48d6fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_13dcc97a-9bad-40e8-bd5e-8a7c5d5e7102" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_13dcc97a-9bad-40e8-bd5e-8a7c5d5e7102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet_b4a3f29f-40a0-47a3-be08-8c1e81225917" xlink:href="cvs-20230525.xsd#cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:to="loc_cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet_b4a3f29f-40a0-47a3-be08-8c1e81225917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_d90ae8f2-dbaa-46d0-93fa-d42663591c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_d90ae8f2-dbaa-46d0-93fa-d42663591c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2f8850e0-fea3-49a9-9824-ce6aa9b2f632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2f8850e0-fea3-49a9-9824-ce6aa9b2f632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale_7be11b2f-cd93-41b8-97b2-aafdf84eb2f8" xlink:href="cvs-20230525.xsd#cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:to="loc_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale_7be11b2f-cd93-41b8-97b2-aafdf84eb2f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_b4d8b93b-2fcf-4559-94e0-24296beba532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ebc1c74e-0745-4050-b11e-ce1bfe5fb825" xlink:to="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_b4d8b93b-2fcf-4559-94e0-24296beba532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#BorrowingsandCreditAgreementsDebtMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_989ce21a-127b-4d1a-9050-f68cc3ee0178" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_6b3e5cb9-38a6-4e27-b260-5d7298abcf14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_989ce21a-127b-4d1a-9050-f68cc3ee0178" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_6b3e5cb9-38a6-4e27-b260-5d7298abcf14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_60a8f057-1ac1-4539-b11e-03d3ee2949a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_6b3e5cb9-38a6-4e27-b260-5d7298abcf14" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_60a8f057-1ac1-4539-b11e-03d3ee2949a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_714988b1-b865-4229-ac02-9007ab5f6c23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_6b3e5cb9-38a6-4e27-b260-5d7298abcf14" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_714988b1-b865-4229-ac02-9007ab5f6c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_38799dfb-4a36-4fcc-8d15-18bdca34e9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_6b3e5cb9-38a6-4e27-b260-5d7298abcf14" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_38799dfb-4a36-4fcc-8d15-18bdca34e9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_73c43cb2-1d46-47e9-9f3c-e905136c69da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_6b3e5cb9-38a6-4e27-b260-5d7298abcf14" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_73c43cb2-1d46-47e9-9f3c-e905136c69da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_f001f671-b50d-494e-8a4c-d544bc6cea08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_6b3e5cb9-38a6-4e27-b260-5d7298abcf14" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_f001f671-b50d-494e-8a4c-d544bc6cea08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_32791614-2a3e-44e3-9183-de66ee43004e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_6b3e5cb9-38a6-4e27-b260-5d7298abcf14" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_32791614-2a3e-44e3-9183-de66ee43004e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_f2ba6455-dc62-415e-bc4c-00a7c9362720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_6b3e5cb9-38a6-4e27-b260-5d7298abcf14" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_f2ba6455-dc62-415e-bc4c-00a7c9362720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_01056246-f2c0-4ff6-b219-c13ceeb82543" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_989ce21a-127b-4d1a-9050-f68cc3ee0178" xlink:to="loc_us-gaap_FinanceLeaseLiability_01056246-f2c0-4ff6-b219-c13ceeb82543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_8b16bdcf-f24c-4802-95cc-5b7559e41931" xlink:href="cvs-20230525.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_989ce21a-127b-4d1a-9050-f68cc3ee0178" xlink:to="loc_cvs_LongtermDebtGrossAndLeaseObligation_8b16bdcf-f24c-4802-95cc-5b7559e41931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#BorrowingsandCreditAgreementsShorttermBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5918180c-7372-4299-aac8-225cf7ebdf07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_6623491d-d714-451e-bdce-63241d29204b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5918180c-7372-4299-aac8-225cf7ebdf07" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_6623491d-d714-451e-bdce-63241d29204b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_ac403f6b-f60b-4ec7-88d3-636bcdb4e077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_6623491d-d714-451e-bdce-63241d29204b" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_ac403f6b-f60b-4ec7-88d3-636bcdb4e077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_6e80ad40-dc80-4da0-b068-42f27e7c8ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_ac403f6b-f60b-4ec7-88d3-636bcdb4e077" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_6e80ad40-dc80-4da0-b068-42f27e7c8ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_6d7efc94-eddf-48ef-9fe5-2a608067c23d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_6e80ad40-dc80-4da0-b068-42f27e7c8ffc" xlink:to="loc_us-gaap_CommercialPaperMember_6d7efc94-eddf-48ef-9fe5-2a608067c23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_b5b08d5f-7f35-41d3-9304-56901556dc67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_6e80ad40-dc80-4da0-b068-42f27e7c8ffc" xlink:to="loc_us-gaap_LineOfCreditMember_b5b08d5f-7f35-41d3-9304-56901556dc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesMember_e47db3b9-a3c4-410e-9d45-1dd8faa5444e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalHomeLoanBankAdvancesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_6e80ad40-dc80-4da0-b068-42f27e7c8ffc" xlink:to="loc_us-gaap_FederalHomeLoanBankAdvancesMember_e47db3b9-a3c4-410e-9d45-1dd8faa5444e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_88a6bdc7-6714-4a3d-8ac1-27ac2dd6a4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_6623491d-d714-451e-bdce-63241d29204b" xlink:to="loc_us-gaap_DebtInstrumentAxis_88a6bdc7-6714-4a3d-8ac1-27ac2dd6a4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_643dcf26-5dad-4015-b126-dcb21ea4301a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_88a6bdc7-6714-4a3d-8ac1-27ac2dd6a4dc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_643dcf26-5dad-4015-b126-dcb21ea4301a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BackUpCreditFacilitiesMember_eb59bf4a-8450-42d8-916a-c09519698cc4" xlink:href="cvs-20230525.xsd#cvs_BackUpCreditFacilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_643dcf26-5dad-4015-b126-dcb21ea4301a" xlink:to="loc_cvs_BackUpCreditFacilitiesMember_eb59bf4a-8450-42d8-916a-c09519698cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay162025Member_aece11bc-6aa0-4fd3-a38f-7ce0efb7b6c8" xlink:href="cvs-20230525.xsd#cvs_RevolvingCreditFacilityExpiringMay162025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_BackUpCreditFacilitiesMember_eb59bf4a-8450-42d8-916a-c09519698cc4" xlink:to="loc_cvs_RevolvingCreditFacilityExpiringMay162025Member_aece11bc-6aa0-4fd3-a38f-7ce0efb7b6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay112026Member_0bfd02d0-1cfc-46f1-b09a-d84859ca946f" xlink:href="cvs-20230525.xsd#cvs_RevolvingCreditFacilityExpiringMay112026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_BackUpCreditFacilitiesMember_eb59bf4a-8450-42d8-916a-c09519698cc4" xlink:to="loc_cvs_RevolvingCreditFacilityExpiringMay112026Member_0bfd02d0-1cfc-46f1-b09a-d84859ca946f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay162027Member_7d348854-91cc-4402-91a6-5f4a6b74f23e" xlink:href="cvs-20230525.xsd#cvs_RevolvingCreditFacilityExpiringMay162027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_BackUpCreditFacilitiesMember_eb59bf4a-8450-42d8-916a-c09519698cc4" xlink:to="loc_cvs_RevolvingCreditFacilityExpiringMay162027Member_7d348854-91cc-4402-91a6-5f4a6b74f23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_d7047061-4903-4f61-aa99-86cbfd8f16f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_6623491d-d714-451e-bdce-63241d29204b" xlink:to="loc_us-gaap_ShortTermDebtLineItems_d7047061-4903-4f61-aa99-86cbfd8f16f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_e745c8d7-d3f2-4823-b371-15367e453a54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_d7047061-4903-4f61-aa99-86cbfd8f16f2" xlink:to="loc_us-gaap_ShortTermBorrowings_e745c8d7-d3f2-4823-b371-15367e453a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_afbce53d-4fc1-4504-b854-10b4658de166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_d7047061-4903-4f61-aa99-86cbfd8f16f2" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_afbce53d-4fc1-4504-b854-10b4658de166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_b719fadc-7253-4785-8682-9ad35277c381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_d7047061-4903-4f61-aa99-86cbfd8f16f2" xlink:to="loc_us-gaap_DebtInstrumentTerm_b719fadc-7253-4785-8682-9ad35277c381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_f6edb778-d01f-49c6-a002-0abe5126efa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_d7047061-4903-4f61-aa99-86cbfd8f16f2" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_f6edb778-d01f-49c6-a002-0abe5126efa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable_68dfd301-2803-4afa-9c30-40272622d24b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_d7047061-4903-4f61-aa99-86cbfd8f16f2" xlink:to="loc_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable_68dfd301-2803-4afa-9c30-40272622d24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#BorrowingsandCreditAgreementsLongtermBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ece8b36b-71b2-4899-9084-5328c134ec71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d3c1339d-9a0a-407a-a48f-7c5904a45388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ece8b36b-71b2-4899-9084-5328c134ec71" xlink:to="loc_us-gaap_DebtInstrumentTable_d3c1339d-9a0a-407a-a48f-7c5904a45388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_557f72a2-402b-44c9-9892-4832ed99e566" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d3c1339d-9a0a-407a-a48f-7c5904a45388" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_557f72a2-402b-44c9-9892-4832ed99e566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f1b4ca88-42be-40a0-890a-cc770fed8e80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_557f72a2-402b-44c9-9892-4832ed99e566" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f1b4ca88-42be-40a0-890a-cc770fed8e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_18f25344-55a6-4136-9f2e-fb33e6df6139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f1b4ca88-42be-40a0-890a-cc770fed8e80" xlink:to="loc_us-gaap_SeniorNotesMember_18f25344-55a6-4136-9f2e-fb33e6df6139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_24347707-472b-4d8e-b3fd-5b372d5dc5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d3c1339d-9a0a-407a-a48f-7c5904a45388" xlink:to="loc_us-gaap_DebtInstrumentAxis_24347707-472b-4d8e-b3fd-5b372d5dc5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_24347707-472b-4d8e-b3fd-5b372d5dc5ee" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueJuly2022Member_479f1bd5-f5d6-46a7-8c60-c564047db829" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.5DueJuly2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes3.5DueJuly2022Member_479f1bd5-f5d6-46a7-8c60-c564047db829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueNovember2022Member_fcb67ff4-1cc8-4d37-b4f2-981933c37d3b" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2.75DueNovember2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes2.75DueNovember2022Member_fcb67ff4-1cc8-4d37-b4f2-981933c37d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueDecember2022Member_486d2d45-62ce-4506-bb8f-626f10269b07" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2.75DueDecember2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes2.75DueDecember2022Member_486d2d45-62ce-4506-bb8f-626f10269b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueDecember2022Member_b94d6202-b114-4720-8935-35b30f20c78a" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.75DueDecember2022Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes4.75DueDecember2022Member_b94d6202-b114-4720-8935-35b30f20c78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2Point125PercentDueSeptember2031Member_2421f6ed-8a65-43a6-9d01-2c3bb1bf5baf" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes2Point125PercentDueSeptember2031Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes2Point125PercentDueSeptember2031Member_2421f6ed-8a65-43a6-9d01-2c3bb1bf5baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point625PercentApril2027Member_d9e0c9b4-70c7-47f3-93df-fa41e8af6b55" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3Point625PercentApril2027Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes3Point625PercentApril2027Member_d9e0c9b4-70c7-47f3-93df-fa41e8af6b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point75PercentApril2030Member_bccbc98a-0267-452e-a5e0-a6126fd78f18" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3Point75PercentApril2030Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes3Point75PercentApril2030Member_bccbc98a-0267-452e-a5e0-a6126fd78f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4Point125PercentApril2040Member_5d61754e-836c-4ede-8678-9d9881a494af" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4Point125PercentApril2040Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes4Point125PercentApril2040Member_5d61754e-836c-4ede-8678-9d9881a494af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4Point25PercentApril2050Member_211d92e2-129b-4549-937f-ea9839aeedfc" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4Point25PercentApril2050Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes4Point25PercentApril2050Member_211d92e2-129b-4549-937f-ea9839aeedfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point70PercentDue2023Member_5c5f8b09-a944-4db5-80cb-95927f861534" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3Point70PercentDue2023Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes3Point70PercentDue2023Member_5c5f8b09-a944-4db5-80cb-95927f861534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4PointThreePercentDue2028Member_2ea91f73-8cc0-4846-be2d-44349977d2fb" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4PointThreePercentDue2028Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes4PointThreePercentDue2028Member_2ea91f73-8cc0-4846-be2d-44349977d2fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OutstandingSeniorNotesMember_f934a803-e544-471a-a9fa-9fee0856a26f" xlink:href="cvs-20230525.xsd#cvs_OutstandingSeniorNotesMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_OutstandingSeniorNotesMember_f934a803-e544-471a-a9fa-9fee0856a26f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_6b31c5ea-94f1-4d50-a448-894d500ea1f1" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_6b31c5ea-94f1-4d50-a448-894d500ea1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member_6fa4d242-42ca-47a2-ba48-debad3a8b024" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes3.7DueMarch2023Member_6fa4d242-42ca-47a2-ba48-debad3a8b024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_3e76eb26-58b0-44f1-b848-c931be8adceb" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_3e76eb26-58b0-44f1-b848-c931be8adceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes43Due2028Member_c2e9e5e0-2dbf-4714-89f2-60f5a0e8a4b2" xlink:href="cvs-20230525.xsd#cvs_SeniorNotes43Due2028Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bba55c7-abbf-4554-9875-afb0c7a64ec0" xlink:to="loc_cvs_SeniorNotes43Due2028Member_c2e9e5e0-2dbf-4714-89f2-60f5a0e8a4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d3c1339d-9a0a-407a-a48f-7c5904a45388" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_81f84aa4-1f9d-43e8-98cc-8f740e4ae23b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_81f84aa4-1f9d-43e8-98cc-8f740e4ae23b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_a5261345-2f86-419b-86ed-2c1d63adffe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_a5261345-2f86-419b-86ed-2c1d63adffe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_c6a97247-0d6f-4dfa-8c52-af8e07b86561" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_c6a97247-0d6f-4dfa-8c52-af8e07b86561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_c0f5dcea-1cee-4df0-a659-17baa80be61b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_c0f5dcea-1cee-4df0-a659-17baa80be61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_f1bd356b-156b-43a8-8dfc-0a28ad117d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_f1bd356b-156b-43a8-8dfc-0a28ad117d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_a214a3ac-beb7-4f07-b765-b15a2b8d547a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_a214a3ac-beb7-4f07-b765-b15a2b8d547a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_31c5d8f6-a784-44b5-9d76-821dcc9fadd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_31c5d8f6-a784-44b5-9d76-821dcc9fadd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_6a095f47-9049-4cf3-9660-0d46d08807bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_6a095f47-9049-4cf3-9660-0d46d08807bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_ea89579c-e475-434f-9555-c6a564d82697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_ea89579c-e475-434f-9555-c6a564d82697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtExtinguishmentFees_526f1524-d040-4fc3-9d0f-6b2f8e7de216" xlink:href="cvs-20230525.xsd#cvs_DebtExtinguishmentFees"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_cvs_DebtExtinguishmentFees_526f1524-d040-4fc3-9d0f-6b2f8e7de216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9f150c92-4499-4289-8a2d-741751da5563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2bad04ef-fe7b-45a4-b597-52ca7f277f00" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9f150c92-4499-4289-8a2d-741751da5563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#PensionPlansandOtherPostretirementBenefitsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_de534ee7-8663-405d-a989-ec67ff641249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5ac7493c-2347-44c9-87ee-e1c9ed2142d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_de534ee7-8663-405d-a989-ec67ff641249" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5ac7493c-2347-44c9-87ee-e1c9ed2142d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_9816a57c-9534-4918-8bd8-1a9372cba62c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5ac7493c-2347-44c9-87ee-e1c9ed2142d9" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_9816a57c-9534-4918-8bd8-1a9372cba62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_504b2c11-11e1-4600-a701-ce0734f3c4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_9816a57c-9534-4918-8bd8-1a9372cba62c" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_504b2c11-11e1-4600-a701-ce0734f3c4f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_bde5f348-5849-46dc-b8e0-e53bec25cc9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_504b2c11-11e1-4600-a701-ce0734f3c4f9" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_bde5f348-5849-46dc-b8e0-e53bec25cc9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_293a4b3c-b8e0-4860-94ca-5056ffe11d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_504b2c11-11e1-4600-a701-ce0734f3c4f9" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_293a4b3c-b8e0-4860-94ca-5056ffe11d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_8d986a76-700f-4eff-bf82-1ac75ffe0b28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5ac7493c-2347-44c9-87ee-e1c9ed2142d9" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_8d986a76-700f-4eff-bf82-1ac75ffe0b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_f2d2993e-a117-4dd3-a660-b0ae278fdf87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_8d986a76-700f-4eff-bf82-1ac75ffe0b28" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_f2d2993e-a117-4dd3-a660-b0ae278fdf87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_d9c566a3-603e-4ac5-bdb0-5add38ba9069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f2d2993e-a117-4dd3-a660-b0ae278fdf87" xlink:to="loc_us-gaap_EquitySecuritiesMember_d9c566a3-603e-4ac5-bdb0-5add38ba9069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_524b3258-56c9-4f5a-8497-6ebaf3daa47b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f2d2993e-a117-4dd3-a660-b0ae278fdf87" xlink:to="loc_us-gaap_DebtSecuritiesMember_524b3258-56c9-4f5a-8497-6ebaf3daa47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentMember_140b45a8-4462-4679-af88-a492368239dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateInvestmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f2d2993e-a117-4dd3-a660-b0ae278fdf87" xlink:to="loc_us-gaap_RealEstateInvestmentMember_140b45a8-4462-4679-af88-a492368239dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_4675630a-2294-4bee-bfa2-7d284165711f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f2d2993e-a117-4dd3-a660-b0ae278fdf87" xlink:to="loc_us-gaap_PrivateEquityFundsMember_4675630a-2294-4bee-bfa2-7d284165711f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_ee608f6c-c426-47d6-ba53-0d590be28dab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgeFundsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f2d2993e-a117-4dd3-a660-b0ae278fdf87" xlink:to="loc_us-gaap_HedgeFundsMember_ee608f6c-c426-47d6-ba53-0d590be28dab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_52934ee6-a83c-4497-92b2-3909b31aeba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5ac7493c-2347-44c9-87ee-e1c9ed2142d9" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_52934ee6-a83c-4497-92b2-3909b31aeba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_1e5a5bae-12ce-4e2c-b862-3a70cd8a9bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_52934ee6-a83c-4497-92b2-3909b31aeba1" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_1e5a5bae-12ce-4e2c-b862-3a70cd8a9bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_4b37c830-a9be-455e-b7d7-7e055aad08fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_52934ee6-a83c-4497-92b2-3909b31aeba1" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_4b37c830-a9be-455e-b7d7-7e055aad08fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_c74b3395-5332-4540-9ddf-f9aea1f8b063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_52934ee6-a83c-4497-92b2-3909b31aeba1" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_c74b3395-5332-4540-9ddf-f9aea1f8b063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution_cc4f8f04-c741-4a79-97d6-c9acf12ad8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MultiemployerPlanPensionInsignificantPlanContribution"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_52934ee6-a83c-4497-92b2-3909b31aeba1" xlink:to="loc_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution_cc4f8f04-c741-4a79-97d6-c9acf12ad8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_9152ec12-7049-4142-a5f7-d3aff312b81e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_52934ee6-a83c-4497-92b2-3909b31aeba1" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_9152ec12-7049-4142-a5f7-d3aff312b81e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ce198234-560e-4b52-a800-1282c5f1da6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_52934ee6-a83c-4497-92b2-3909b31aeba1" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ce198234-560e-4b52-a800-1282c5f1da6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9622c5c8-3c7d-416e-97a5-215a65fc99b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df60ecf0-7e51-4b3e-abd7-7f59203d28e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9622c5c8-3c7d-416e-97a5-215a65fc99b7" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df60ecf0-7e51-4b3e-abd7-7f59203d28e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_2c94f72e-17b6-47d5-93be-17cf8e37eeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df60ecf0-7e51-4b3e-abd7-7f59203d28e5" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_2c94f72e-17b6-47d5-93be-17cf8e37eeb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_cc0fd86b-3641-4ab0-8978-65f5b5ad525e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_2c94f72e-17b6-47d5-93be-17cf8e37eeb7" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_cc0fd86b-3641-4ab0-8978-65f5b5ad525e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_f83b4dbe-69fd-497b-8760-2444e861f895" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_cc0fd86b-3641-4ab0-8978-65f5b5ad525e" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_f83b4dbe-69fd-497b-8760-2444e861f895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c94f94e1-5f73-4054-879e-497e2169ea90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_df60ecf0-7e51-4b3e-abd7-7f59203d28e5" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c94f94e1-5f73-4054-879e-497e2169ea90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3bba235b-50bd-438e-b498-a8fc86d87bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c94f94e1-5f73-4054-879e-497e2169ea90" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3bba235b-50bd-438e-b498-a8fc86d87bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_e47e6ae7-e125-4280-8a06-cf0f4481b7da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3bba235b-50bd-438e-b498-a8fc86d87bb3" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_e47e6ae7-e125-4280-8a06-cf0f4481b7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_7db03e4e-2c21-48b7-9219-288ea9198a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3bba235b-50bd-438e-b498-a8fc86d87bb3" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_7db03e4e-2c21-48b7-9219-288ea9198a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_b33b7c61-2113-47e2-a23b-a6d688f37870" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3bba235b-50bd-438e-b498-a8fc86d87bb3" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_b33b7c61-2113-47e2-a23b-a6d688f37870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_7c286b5e-7666-4b1a-a4f0-dbaadbcceabf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3bba235b-50bd-438e-b498-a8fc86d87bb3" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_7c286b5e-7666-4b1a-a4f0-dbaadbcceabf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_ca7cb7c1-7e93-49a0-bc70-81612472de90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3bba235b-50bd-438e-b498-a8fc86d87bb3" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_ca7cb7c1-7e93-49a0-bc70-81612472de90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_5ae75812-016b-445c-be91-d6997358884b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_3bba235b-50bd-438e-b498-a8fc86d87bb3" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_5ae75812-016b-445c-be91-d6997358884b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b3152f47-63ae-4908-beb5-e71ef9aa8fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c94f94e1-5f73-4054-879e-497e2169ea90" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b3152f47-63ae-4908-beb5-e71ef9aa8fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_99237824-51ae-4bf7-a762-2bd60670286a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b3152f47-63ae-4908-beb5-e71ef9aa8fa7" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_99237824-51ae-4bf7-a762-2bd60670286a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_a172f5be-f332-4abb-89b5-e8231c472de7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b3152f47-63ae-4908-beb5-e71ef9aa8fa7" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_a172f5be-f332-4abb-89b5-e8231c472de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_b724bfca-bfa6-4685-b63f-c1ec1224bf8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b3152f47-63ae-4908-beb5-e71ef9aa8fa7" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_b724bfca-bfa6-4685-b63f-c1ec1224bf8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_e27d0609-24c5-4d99-8460-5e9a00feed08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b3152f47-63ae-4908-beb5-e71ef9aa8fa7" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_e27d0609-24c5-4d99-8460-5e9a00feed08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_45350ac9-f9ae-4865-aab5-3dd2f95ebf9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b3152f47-63ae-4908-beb5-e71ef9aa8fa7" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_45350ac9-f9ae-4865-aab5-3dd2f95ebf9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_26d169a9-d601-431c-8d83-ca17b39d52d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b3152f47-63ae-4908-beb5-e71ef9aa8fa7" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_26d169a9-d601-431c-8d83-ca17b39d52d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_15f18dd1-94f4-4df6-8fa2-7d40501bd26b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c94f94e1-5f73-4054-879e-497e2169ea90" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_15f18dd1-94f4-4df6-8fa2-7d40501bd26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a95f4bde-a9b0-48a9-82d1-24e3bee9e0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_c94f94e1-5f73-4054-879e-497e2169ea90" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a95f4bde-a9b0-48a9-82d1-24e3bee9e0c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_7decb353-fedb-47b0-abb8-173baadcc866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a95f4bde-a9b0-48a9-82d1-24e3bee9e0c0" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_7decb353-fedb-47b0-abb8-173baadcc866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_774a1ad3-6eb5-4b57-b875-6442322e8f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a95f4bde-a9b0-48a9-82d1-24e3bee9e0c0" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_774a1ad3-6eb5-4b57-b875-6442322e8f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_776ff4bb-b4ea-4fe8-9067-5a8706a3d450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a95f4bde-a9b0-48a9-82d1-24e3bee9e0c0" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_776ff4bb-b4ea-4fe8-9067-5a8706a3d450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_a285600b-0d2e-46fb-bc45-4c7fce0b1d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_a95f4bde-a9b0-48a9-82d1-24e3bee9e0c0" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_a285600b-0d2e-46fb-bc45-4c7fce0b1d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d969bd35-ff2d-4c7b-ba64-76fb31a72beb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a6e9f1a7-d114-40e9-97f5-5815bcb89d29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d969bd35-ff2d-4c7b-ba64-76fb31a72beb" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a6e9f1a7-d114-40e9-97f5-5815bcb89d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d1ec1c68-696f-4181-ad08-7e5329b85b01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a6e9f1a7-d114-40e9-97f5-5815bcb89d29" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d1ec1c68-696f-4181-ad08-7e5329b85b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f05e98f5-7a11-4d93-bd1d-b68c5ff6329c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d1ec1c68-696f-4181-ad08-7e5329b85b01" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f05e98f5-7a11-4d93-bd1d-b68c5ff6329c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_01d16a75-7c9b-4383-a27d-5fed7a320a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f05e98f5-7a11-4d93-bd1d-b68c5ff6329c" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_01d16a75-7c9b-4383-a27d-5fed7a320a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_44c4f3e9-cc3f-4bff-a87e-1625707d6ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a6e9f1a7-d114-40e9-97f5-5815bcb89d29" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_44c4f3e9-cc3f-4bff-a87e-1625707d6ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_01adf912-f383-443a-aa10-f5a1d0a44116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_44c4f3e9-cc3f-4bff-a87e-1625707d6ae1" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_01adf912-f383-443a-aa10-f5a1d0a44116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_1126fb84-7fe7-4bfe-9110-111a1683e680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_01adf912-f383-443a-aa10-f5a1d0a44116" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_1126fb84-7fe7-4bfe-9110-111a1683e680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e5c82794-d904-4d24-88cd-9a3c32fc6175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_01adf912-f383-443a-aa10-f5a1d0a44116" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e5c82794-d904-4d24-88cd-9a3c32fc6175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_66e51c3e-ee69-40e3-957b-bab59957d262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_01adf912-f383-443a-aa10-f5a1d0a44116" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_66e51c3e-ee69-40e3-957b-bab59957d262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_dfb86463-a7ac-4f56-8c19-eb8bda1ebfa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_01adf912-f383-443a-aa10-f5a1d0a44116" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_dfb86463-a7ac-4f56-8c19-eb8bda1ebfa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_76194acf-9bb2-4284-9583-1798edb5cb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_01adf912-f383-443a-aa10-f5a1d0a44116" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_76194acf-9bb2-4284-9583-1798edb5cb4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_95968289-5498-4e41-84be-a8205cb6d1c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_480c08c4-e822-4a5e-bae0-34d9be62c4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_95968289-5498-4e41-84be-a8205cb6d1c9" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_480c08c4-e822-4a5e-bae0-34d9be62c4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_45c45f68-54d6-4567-aea2-d33a7ef7f153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_480c08c4-e822-4a5e-bae0-34d9be62c4d6" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_45c45f68-54d6-4567-aea2-d33a7ef7f153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_28128331-b4ce-44b9-9a53-c5270635ee8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_95968289-5498-4e41-84be-a8205cb6d1c9" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_28128331-b4ce-44b9-9a53-c5270635ee8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_070cac81-e2b7-4e57-9525-541d94721ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_28128331-b4ce-44b9-9a53-c5270635ee8b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_070cac81-e2b7-4e57-9525-541d94721ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_05e904bf-baab-4f42-ac71-1ff1c9a9f0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_28128331-b4ce-44b9-9a53-c5270635ee8b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_05e904bf-baab-4f42-ac71-1ff1c9a9f0ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_620d2f64-7f31-4c20-8c83-60d165c12107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eca33ce3-d8c4-49de-b3e6-91ee4f3d4a85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_620d2f64-7f31-4c20-8c83-60d165c12107" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eca33ce3-d8c4-49de-b3e6-91ee4f3d4a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_8b1a7f07-f127-4c5e-aeb3-09cf7f445fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eca33ce3-d8c4-49de-b3e6-91ee4f3d4a85" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_8b1a7f07-f127-4c5e-aeb3-09cf7f445fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_2745b38f-f10f-47c9-a227-453f1da4e4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_8b1a7f07-f127-4c5e-aeb3-09cf7f445fa3" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_2745b38f-f10f-47c9-a227-453f1da4e4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_c11c3bb6-7361-4e6b-baf9-901ff4ecfb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_2745b38f-f10f-47c9-a227-453f1da4e4f1" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_c11c3bb6-7361-4e6b-baf9-901ff4ecfb4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_827c1450-d4c5-4332-b54d-6329b887f264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eca33ce3-d8c4-49de-b3e6-91ee4f3d4a85" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_827c1450-d4c5-4332-b54d-6329b887f264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_fa0fe1b8-9bfa-4eda-abcd-db35f0dcd93c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_827c1450-d4c5-4332-b54d-6329b887f264" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_fa0fe1b8-9bfa-4eda-abcd-db35f0dcd93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_75eeff39-5ba1-4787-a8e7-c042b1332633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_fa0fe1b8-9bfa-4eda-abcd-db35f0dcd93c" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_75eeff39-5ba1-4787-a8e7-c042b1332633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_3f82800c-3d7c-4574-9f22-ddc33b8dd092" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_fa0fe1b8-9bfa-4eda-abcd-db35f0dcd93c" xlink:to="loc_us-gaap_DebtSecuritiesMember_3f82800c-3d7c-4574-9f22-ddc33b8dd092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_01d151e6-cdfd-488d-b8ae-0f0e249b2648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_3f82800c-3d7c-4574-9f22-ddc33b8dd092" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_01d151e6-cdfd-488d-b8ae-0f0e249b2648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_b414c89c-2fb6-4811-98e8-a18e7472aef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_3f82800c-3d7c-4574-9f22-ddc33b8dd092" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_b414c89c-2fb6-4811-98e8-a18e7472aef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_b41ef9ff-d2e6-4731-88eb-bbba6ebc8054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_3f82800c-3d7c-4574-9f22-ddc33b8dd092" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_b41ef9ff-d2e6-4731-88eb-bbba6ebc8054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_bd94d120-b6cb-4c9b-8442-1de4de5e5fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_3f82800c-3d7c-4574-9f22-ddc33b8dd092" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_bd94d120-b6cb-4c9b-8442-1de4de5e5fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_4b3c18f8-6468-4153-a189-f5b010d8209e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_3f82800c-3d7c-4574-9f22-ddc33b8dd092" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_4b3c18f8-6468-4153-a189-f5b010d8209e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_79b0b4a5-5fb7-4f64-8c04-1d42f93515fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_3f82800c-3d7c-4574-9f22-ddc33b8dd092" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_79b0b4a5-5fb7-4f64-8c04-1d42f93515fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_377cf202-1307-4690-9c0d-3dd45405d413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_3f82800c-3d7c-4574-9f22-ddc33b8dd092" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_377cf202-1307-4690-9c0d-3dd45405d413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RedeemablePreferredSecuritiesMember_fb65611b-e2e6-4a3e-b06d-4a95c8ea9f13" xlink:href="cvs-20230525.xsd#cvs_RedeemablePreferredSecuritiesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_3f82800c-3d7c-4574-9f22-ddc33b8dd092" xlink:to="loc_cvs_RedeemablePreferredSecuritiesMember_fb65611b-e2e6-4a3e-b06d-4a95c8ea9f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_8972d154-5aed-4abc-8b44-36d0ed8db071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_fa0fe1b8-9bfa-4eda-abcd-db35f0dcd93c" xlink:to="loc_us-gaap_EquitySecuritiesMember_8972d154-5aed-4abc-8b44-36d0ed8db071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_5f0b274e-af63-4923-8863-4804229197bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesMember_8972d154-5aed-4abc-8b44-36d0ed8db071" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_5f0b274e-af63-4923-8863-4804229197bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_adcaabed-5b00-4612-ab10-e09af822056f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesMember_8972d154-5aed-4abc-8b44-36d0ed8db071" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_adcaabed-5b00-4612-ab10-e09af822056f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EquitySecuritiesDomesticRealEstateMember_b016d843-f70e-4a1e-a8b7-1d7a66742d7d" xlink:href="cvs-20230525.xsd#cvs_EquitySecuritiesDomesticRealEstateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesMember_8972d154-5aed-4abc-8b44-36d0ed8db071" xlink:to="loc_cvs_EquitySecuritiesDomesticRealEstateMember_b016d843-f70e-4a1e-a8b7-1d7a66742d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_a8f0a8a3-d64c-4cf5-823c-e8e9d4d2d668" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_fa0fe1b8-9bfa-4eda-abcd-db35f0dcd93c" xlink:to="loc_us-gaap_OtherInvestmentsMember_a8f0a8a3-d64c-4cf5-823c-e8e9d4d2d668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRealEstateMember_da2023bb-25cd-4600-8f73-298f695befce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentsMember_a8f0a8a3-d64c-4cf5-823c-e8e9d4d2d668" xlink:to="loc_us-gaap_DefinedBenefitPlanRealEstateMember_da2023bb-25cd-4600-8f73-298f695befce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_697a27a4-4c0b-4119-a98a-3748e6286b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentsMember_a8f0a8a3-d64c-4cf5-823c-e8e9d4d2d668" xlink:to="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_697a27a4-4c0b-4119-a98a-3748e6286b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember_c4b6cd81-8a53-4539-9019-56a6c25c2116" xlink:href="cvs-20230525.xsd#cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_fa0fe1b8-9bfa-4eda-abcd-db35f0dcd93c" xlink:to="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember_c4b6cd81-8a53-4539-9019-56a6c25c2116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember_1a1cd24e-5b74-4d20-abc9-d2196d6242fe" xlink:href="cvs-20230525.xsd#cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_fa0fe1b8-9bfa-4eda-abcd-db35f0dcd93c" xlink:to="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember_1a1cd24e-5b74-4d20-abc9-d2196d6242fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_e34bfea1-be81-444d-a269-483ea62dc2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_fa0fe1b8-9bfa-4eda-abcd-db35f0dcd93c" xlink:to="loc_us-gaap_AccountsReceivableMember_e34bfea1-be81-444d-a269-483ea62dc2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_aa1158ee-be57-4805-bf3f-75fddd298dda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_fa0fe1b8-9bfa-4eda-abcd-db35f0dcd93c" xlink:to="loc_us-gaap_PrivateEquityFundsMember_aa1158ee-be57-4805-bf3f-75fddd298dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_fcc15ee2-36af-42a8-9521-d0680481ee18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgeFundsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_fa0fe1b8-9bfa-4eda-abcd-db35f0dcd93c" xlink:to="loc_us-gaap_HedgeFundsMember_fcc15ee2-36af-42a8-9521-d0680481ee18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6e654342-f10b-4a3f-8fe0-3d283ad30888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eca33ce3-d8c4-49de-b3e6-91ee4f3d4a85" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6e654342-f10b-4a3f-8fe0-3d283ad30888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d9f703a-62e7-4947-9920-bb206605f252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6e654342-f10b-4a3f-8fe0-3d283ad30888" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d9f703a-62e7-4947-9920-bb206605f252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_f68d0297-21c4-4098-a3fa-2966eb3a363d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d9f703a-62e7-4947-9920-bb206605f252" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_f68d0297-21c4-4098-a3fa-2966eb3a363d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_df794c2e-3d6b-4a76-b4dd-26f8b52a9fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_f68d0297-21c4-4098-a3fa-2966eb3a363d" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_df794c2e-3d6b-4a76-b4dd-26f8b52a9fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_711da380-4fec-40d1-805b-9f34565b22db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_f68d0297-21c4-4098-a3fa-2966eb3a363d" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_711da380-4fec-40d1-805b-9f34565b22db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3ae1e252-321e-4e04-b035-90c21e044c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_f68d0297-21c4-4098-a3fa-2966eb3a363d" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3ae1e252-321e-4e04-b035-90c21e044c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_56d338e2-cc3e-4dd9-ad60-67cc79e636ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d9f703a-62e7-4947-9920-bb206605f252" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_56d338e2-cc3e-4dd9-ad60-67cc79e636ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_41d80d6f-749d-41b7-bb9a-3f3c13df6bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eca33ce3-d8c4-49de-b3e6-91ee4f3d4a85" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_41d80d6f-749d-41b7-bb9a-3f3c13df6bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_3f30103b-aebe-42a4-b590-e6078dbb4e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_41d80d6f-749d-41b7-bb9a-3f3c13df6bdc" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_3f30103b-aebe-42a4-b590-e6078dbb4e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount_6fd0c80d-4a4a-423d-886e-d5fdfdb4b08e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_41d80d6f-749d-41b7-bb9a-3f3c13df6bdc" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount_6fd0c80d-4a4a-423d-886e-d5fdfdb4b08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_db177d93-289d-46cf-bbbb-727d11d70dba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_2d6bdce5-8127-439f-bc58-6ac99b3ffe3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_db177d93-289d-46cf-bbbb-727d11d70dba" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_2d6bdce5-8127-439f-bc58-6ac99b3ffe3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_19930d7c-7498-4ff4-8042-1a5ab0500812" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_2d6bdce5-8127-439f-bc58-6ac99b3ffe3f" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_19930d7c-7498-4ff4-8042-1a5ab0500812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_2961a1db-46d7-4b35-a9a7-1afb076bf7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_19930d7c-7498-4ff4-8042-1a5ab0500812" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_2961a1db-46d7-4b35-a9a7-1afb076bf7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRealEstateMember_156cb3ac-14c6-4e41-84d4-07d1a8ad3cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2961a1db-46d7-4b35-a9a7-1afb076bf7ff" xlink:to="loc_us-gaap_DefinedBenefitPlanRealEstateMember_156cb3ac-14c6-4e41-84d4-07d1a8ad3cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a40d0e2c-fc25-4686-9d2a-3084bf747839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_2d6bdce5-8127-439f-bc58-6ac99b3ffe3f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a40d0e2c-fc25-4686-9d2a-3084bf747839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_15159647-fa31-4c06-aba3-0a4631594cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a40d0e2c-fc25-4686-9d2a-3084bf747839" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_15159647-fa31-4c06-aba3-0a4631594cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_6551dfd7-fcd2-474a-b594-ade2d6e8ec23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_15159647-fa31-4c06-aba3-0a4631594cc7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_6551dfd7-fcd2-474a-b594-ade2d6e8ec23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_4200183c-07de-4bae-81d8-e65218fc4408" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_2d6bdce5-8127-439f-bc58-6ac99b3ffe3f" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_4200183c-07de-4bae-81d8-e65218fc4408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0964474c-b639-4881-a08b-b0864aeb2086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_4200183c-07de-4bae-81d8-e65218fc4408" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0964474c-b639-4881-a08b-b0864aeb2086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_af62c427-4d76-45d7-8938-70ab05184650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_0964474c-b639-4881-a08b-b0864aeb2086" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_af62c427-4d76-45d7-8938-70ab05184650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a8892fbb-4798-487d-a450-f907db178f03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_2d6bdce5-8127-439f-bc58-6ac99b3ffe3f" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a8892fbb-4798-487d-a450-f907db178f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f8a2f08d-7c77-4a07-8a54-bc3701f38f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_a8892fbb-4798-487d-a450-f907db178f03" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f8a2f08d-7c77-4a07-8a54-bc3701f38f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_0f2e5aa5-c206-4919-9987-713286def3a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f8a2f08d-7c77-4a07-8a54-bc3701f38f69" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_0f2e5aa5-c206-4919-9987-713286def3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_c2242224-0794-4c9e-9145-8dfbee696b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f8a2f08d-7c77-4a07-8a54-bc3701f38f69" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_c2242224-0794-4c9e-9145-8dfbee696b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_085814eb-ee68-4c77-8e91-b92dfe8523fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f8a2f08d-7c77-4a07-8a54-bc3701f38f69" xlink:to="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_085814eb-ee68-4c77-8e91-b92dfe8523fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels_0b43e96a-eb44-4f4b-892e-25fb1288df16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f8a2f08d-7c77-4a07-8a54-bc3701f38f69" xlink:to="loc_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels_0b43e96a-eb44-4f4b-892e-25fb1288df16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_66e0b658-9046-4953-bcb3-745ad957cd81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_f8a2f08d-7c77-4a07-8a54-bc3701f38f69" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_66e0b658-9046-4953-bcb3-745ad957cd81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ee164ae8-1766-4a66-b9e5-ae3d381bc52c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4226cfc3-28f4-4351-87b1-a8a9b200136f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ee164ae8-1766-4a66-b9e5-ae3d381bc52c" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4226cfc3-28f4-4351-87b1-a8a9b200136f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_864bda9c-11fd-4113-b17a-a39d61bca528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4226cfc3-28f4-4351-87b1-a8a9b200136f" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_864bda9c-11fd-4113-b17a-a39d61bca528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_fadbd8fb-0c4b-4751-920f-c7e3c0672767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_864bda9c-11fd-4113-b17a-a39d61bca528" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_fadbd8fb-0c4b-4751-920f-c7e3c0672767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_3d1c9b01-fdc5-4f3e-8cd8-b9eec8377dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_fadbd8fb-0c4b-4751-920f-c7e3c0672767" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_3d1c9b01-fdc5-4f3e-8cd8-b9eec8377dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e6891d6b-38e9-4246-8448-8bfc855538db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_fadbd8fb-0c4b-4751-920f-c7e3c0672767" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e6891d6b-38e9-4246-8448-8bfc855538db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb8de277-8100-4387-a5a4-0f2db1e2b9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4226cfc3-28f4-4351-87b1-a8a9b200136f" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb8de277-8100-4387-a5a4-0f2db1e2b9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_dea8a566-9181-4321-a8ad-4c70c0148bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb8de277-8100-4387-a5a4-0f2db1e2b9a2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_dea8a566-9181-4321-a8ad-4c70c0148bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_34635227-b6d1-4be3-8884-511b74ea3068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb8de277-8100-4387-a5a4-0f2db1e2b9a2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_34635227-b6d1-4be3-8884-511b74ea3068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_b7b77696-1c5c-474c-a1cd-15711fdd1346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb8de277-8100-4387-a5a4-0f2db1e2b9a2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_b7b77696-1c5c-474c-a1cd-15711fdd1346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_78d8a02b-647c-4674-914c-083d0fc7dfb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb8de277-8100-4387-a5a4-0f2db1e2b9a2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_78d8a02b-647c-4674-914c-083d0fc7dfb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_f31d0af0-5a95-4d51-9c64-df4e4fd94727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb8de277-8100-4387-a5a4-0f2db1e2b9a2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_f31d0af0-5a95-4d51-9c64-df4e4fd94727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_1f9a3ffd-4783-45ea-acfe-02227202c0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eb8de277-8100-4387-a5a4-0f2db1e2b9a2" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_1f9a3ffd-4783-45ea-acfe-02227202c0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#IncomeTaxesIncomeTaxProvisionDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2a83eced-f410-46b8-86e7-4dbd67f77f29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_bb1592ad-d3c2-4b48-a8ac-690358b6722c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2a83eced-f410-46b8-86e7-4dbd67f77f29" xlink:to="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_bb1592ad-d3c2-4b48-a8ac-690358b6722c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7ea37265-ddc8-4027-b889-8af776716e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_bb1592ad-d3c2-4b48-a8ac-690358b6722c" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7ea37265-ddc8-4027-b889-8af776716e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_fb157289-4c2a-49f9-8b8a-6c9e27dd5785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7ea37265-ddc8-4027-b889-8af776716e08" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_fb157289-4c2a-49f9-8b8a-6c9e27dd5785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_5a8c4294-3d01-4310-93a4-a20249d95480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7ea37265-ddc8-4027-b889-8af776716e08" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_5a8c4294-3d01-4310-93a4-a20249d95480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e5dd124f-4220-4f69-8eb9-51adb6b6c3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7ea37265-ddc8-4027-b889-8af776716e08" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e5dd124f-4220-4f69-8eb9-51adb6b6c3fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_229ca095-4d5f-41e1-bae8-aa048a585d87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_bb1592ad-d3c2-4b48-a8ac-690358b6722c" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_229ca095-4d5f-41e1-bae8-aa048a585d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_be7d81bf-732d-47c7-8e50-64d3de4d23a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_229ca095-4d5f-41e1-bae8-aa048a585d87" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_be7d81bf-732d-47c7-8e50-64d3de4d23a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_264695ef-414e-44ce-8a27-62aebba64cce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_229ca095-4d5f-41e1-bae8-aa048a585d87" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_264695ef-414e-44ce-8a27-62aebba64cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_affedf59-bc1c-4610-b9d7-f14ae914d69c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_229ca095-4d5f-41e1-bae8-aa048a585d87" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_affedf59-bc1c-4610-b9d7-f14ae914d69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_54488884-3a19-433d-bcee-63b3862ee29f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_bb1592ad-d3c2-4b48-a8ac-690358b6722c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_54488884-3a19-433d-bcee-63b3862ee29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#IncomeTaxesEffectiveTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_67e25533-cca2-46c8-b8ce-ae13c43e7722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_bdc8911e-26eb-4b49-83c7-26ea71164768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_67e25533-cca2-46c8-b8ce-ae13c43e7722" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_bdc8911e-26eb-4b49-83c7-26ea71164768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_fad97f0d-2034-44ba-9cac-f4f5266697c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_bdc8911e-26eb-4b49-83c7-26ea71164768" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_fad97f0d-2034-44ba-9cac-f4f5266697c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_f044e549-314c-4e48-9448-b12114bb78da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_bdc8911e-26eb-4b49-83c7-26ea71164768" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_f044e549-314c-4e48-9448-b12114bb78da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFeeTaxEffectPercent_32a3c1c6-0e3f-4a29-b58d-8837aebf6f89" xlink:href="cvs-20230525.xsd#cvs_HealthInsurerFeeTaxEffectPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_bdc8911e-26eb-4b49-83c7-26ea71164768" xlink:to="loc_cvs_HealthInsurerFeeTaxEffectPercent_32a3c1c6-0e3f-4a29-b58d-8837aebf6f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent_cb6998f2-185a-4316-9ff4-2a216e210fcd" xlink:href="cvs-20230525.xsd#cvs_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_bdc8911e-26eb-4b49-83c7-26ea71164768" xlink:to="loc_cvs_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent_cb6998f2-185a-4316-9ff4-2a216e210fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_2c556138-e678-47a7-be50-8ef648bb62bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_bdc8911e-26eb-4b49-83c7-26ea71164768" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_2c556138-e678-47a7-be50-8ef648bb62bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_788179a4-5ca6-4ec8-912d-69d3f11eff72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_bdc8911e-26eb-4b49-83c7-26ea71164768" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_788179a4-5ca6-4ec8-912d-69d3f11eff72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_b8dd353a-a791-4836-bcfb-5310205220ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_bdc8911e-26eb-4b49-83c7-26ea71164768" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_b8dd353a-a791-4836-bcfb-5310205220ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_547ba46e-d857-45eb-92ef-0b62cb1962bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_bdc8911e-26eb-4b49-83c7-26ea71164768" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_547ba46e-d857-45eb-92ef-0b62cb1962bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4be0260f-a110-48c6-8356-97af27cb362a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_655b9779-f68e-4c07-8687-abdf19693450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4be0260f-a110-48c6-8356-97af27cb362a" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_655b9779-f68e-4c07-8687-abdf19693450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceTable_50501960-f30d-4d44-8f7b-9bb7c4b2df78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_655b9779-f68e-4c07-8687-abdf19693450" xlink:to="loc_us-gaap_ValuationAllowanceTable_50501960-f30d-4d44-8f7b-9bb7c4b2df78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b28111d6-da3e-4568-8cef-de94afb1ca82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceTable_50501960-f30d-4d44-8f7b-9bb7c4b2df78" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b28111d6-da3e-4568-8cef-de94afb1ca82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3d3a8bec-1ce5-4480-b9af-cc012b221262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b28111d6-da3e-4568-8cef-de94afb1ca82" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3d3a8bec-1ce5-4480-b9af-cc012b221262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_e6b633fd-b9df-42b4-9677-3f40ff03be49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_3d3a8bec-1ce5-4480-b9af-cc012b221262" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_e6b633fd-b9df-42b4-9677-3f40ff03be49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceLineItems_7f6dfd77-8fdc-491b-9aec-dfcaa109716e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceTable_50501960-f30d-4d44-8f7b-9bb7c4b2df78" xlink:to="loc_us-gaap_ValuationAllowanceLineItems_7f6dfd77-8fdc-491b-9aec-dfcaa109716e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_7f6dfd77-8fdc-491b-9aec-dfcaa109716e" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_83ac6362-1619-473e-8791-ee3f8ea538da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_83ac6362-1619-473e-8791-ee3f8ea538da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements_525ab7e3-c23f-454c-acdc-2e597b88f154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements_525ab7e3-c23f-454c-acdc-2e597b88f154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_49abc900-a1e3-4036-adfc-f2c8d43db533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_49abc900-a1e3-4036-adfc-f2c8d43db533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_c9a17226-dd90-4854-a77a-4c8c9d392dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_c9a17226-dd90-4854-a77a-4c8c9d392dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_0ee586af-245e-431a-a25a-468b484a832c" xlink:href="cvs-20230525.xsd#cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_0ee586af-245e-431a-a25a-468b484a832c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_385b2e7d-871f-44bc-b965-01a42d6d5d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_385b2e7d-871f-44bc-b965-01a42d6d5d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_9a2518c0-9300-4009-a3dc-7a10310e2b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_9a2518c0-9300-4009-a3dc-7a10310e2b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_e76ec482-04ee-4037-9aaf-389611941d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_e76ec482-04ee-4037-9aaf-389611941d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments_3962f039-4558-40b6-8ea7-39c1f65be552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_us-gaap_DeferredTaxAssetsInvestments_3962f039-4558-40b6-8ea7-39c1f65be552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxAssetsPayrollTaxDeferral_ccee8a78-9bf7-4b2d-a1ab-99485a38e171" xlink:href="cvs-20230525.xsd#cvs_DeferredTaxAssetsPayrollTaxDeferral"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_cvs_DeferredTaxAssetsPayrollTaxDeferral_ccee8a78-9bf7-4b2d-a1ab-99485a38e171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_424b1746-ec76-43a0-9eb6-5aea9a899862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_424b1746-ec76-43a0-9eb6-5aea9a899862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_6b439642-4028-45ef-81fa-ebfd6c15a790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_6b439642-4028-45ef-81fa-ebfd6c15a790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_34f546bd-3146-4ea7-9694-7c57dc370a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_217ebfa5-821d-462d-90f9-f263839d7e08" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_34f546bd-3146-4ea7-9694-7c57dc370a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_74ed2a32-49b8-4cdb-90ca-3447eb7561d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_7f6dfd77-8fdc-491b-9aec-dfcaa109716e" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_74ed2a32-49b8-4cdb-90ca-3447eb7561d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxLiabilitiesRetirementBenefits_393e28dd-c13f-47d3-b0f5-224556f3582b" xlink:href="cvs-20230525.xsd#cvs_DeferredTaxLiabilitiesRetirementBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_74ed2a32-49b8-4cdb-90ca-3447eb7561d8" xlink:to="loc_cvs_DeferredTaxLiabilitiesRetirementBenefits_393e28dd-c13f-47d3-b0f5-224556f3582b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments_010f2e9e-d274-40aa-953f-6400419ee9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_74ed2a32-49b8-4cdb-90ca-3447eb7561d8" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestments_010f2e9e-d274-40aa-953f-6400419ee9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_0dccd7fe-177e-458b-9be0-a335a35f52c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_74ed2a32-49b8-4cdb-90ca-3447eb7561d8" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_0dccd7fe-177e-458b-9be0-a335a35f52c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_1cd0badd-eea5-4294-82ed-db179e162956" xlink:href="cvs-20230525.xsd#cvs_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_74ed2a32-49b8-4cdb-90ca-3447eb7561d8" xlink:to="loc_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_1cd0badd-eea5-4294-82ed-db179e162956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_02520713-ba8a-4286-86f0-e9941b455b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_7f6dfd77-8fdc-491b-9aec-dfcaa109716e" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_02520713-ba8a-4286-86f0-e9941b455b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_3d60fe33-6069-4f26-b037-450ab8b9cbf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_7f6dfd77-8fdc-491b-9aec-dfcaa109716e" xlink:to="loc_us-gaap_DeferredTaxLiabilities_3d60fe33-6069-4f26-b037-450ab8b9cbf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_237a6194-860e-45ff-bce3-44ad7821a66f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_563f7698-09f0-40d3-82a9-e48ed6fb1a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_237a6194-860e-45ff-bce3-44ad7821a66f" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_563f7698-09f0-40d3-82a9-e48ed6fb1a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_182a1ec6-b6b4-4548-927a-2b8cd14c006e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_237a6194-860e-45ff-bce3-44ad7821a66f" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_182a1ec6-b6b4-4548-927a-2b8cd14c006e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_5ea0ab20-2c8e-4bc1-8cb3-2bebaa2404c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_237a6194-860e-45ff-bce3-44ad7821a66f" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_5ea0ab20-2c8e-4bc1-8cb3-2bebaa2404c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_8285e07f-61dd-4dcb-820a-a0ad5c8e13be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_237a6194-860e-45ff-bce3-44ad7821a66f" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_8285e07f-61dd-4dcb-820a-a0ad5c8e13be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_8c95b2b3-98e0-49f0-a185-6193d8490ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_237a6194-860e-45ff-bce3-44ad7821a66f" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_8c95b2b3-98e0-49f0-a185-6193d8490ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9992d8b9-6f3b-49d9-aaa0-26aa33f13153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a05d7101-1115-41dc-a77e-5624c8574f36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9992d8b9-6f3b-49d9-aaa0-26aa33f13153" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a05d7101-1115-41dc-a77e-5624c8574f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_7ef08d0c-7eda-4535-9518-b9769194c082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a05d7101-1115-41dc-a77e-5624c8574f36" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_7ef08d0c-7eda-4535-9518-b9769194c082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_62bbcb32-ffa1-4422-bbd9-68b09af8562c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a05d7101-1115-41dc-a77e-5624c8574f36" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_62bbcb32-ffa1-4422-bbd9-68b09af8562c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_0fc4de97-23a7-4bdd-b6c2-be0f8e5ff687" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a05d7101-1115-41dc-a77e-5624c8574f36" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_0fc4de97-23a7-4bdd-b6c2-be0f8e5ff687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_8b811f1e-7610-4c5a-a8e1-439f5ad3c25e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a05d7101-1115-41dc-a77e-5624c8574f36" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_8b811f1e-7610-4c5a-a8e1-439f5ad3c25e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_e4f3bfe6-5133-4aef-8746-d3dfac85a485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a05d7101-1115-41dc-a77e-5624c8574f36" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_e4f3bfe6-5133-4aef-8746-d3dfac85a485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_15634281-783c-42cc-ab25-30b6849e6abf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a05d7101-1115-41dc-a77e-5624c8574f36" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_15634281-783c-42cc-ab25-30b6849e6abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_9a72dce6-bbb7-49bd-be89-b0053417939b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a05d7101-1115-41dc-a77e-5624c8574f36" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_9a72dce6-bbb7-49bd-be89-b0053417939b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_07d39ec9-2d20-48a6-b7d5-9e438f739c66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f3ce5aa6-0fb0-46c4-8096-81f233e02155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_07d39ec9-2d20-48a6-b7d5-9e438f739c66" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f3ce5aa6-0fb0-46c4-8096-81f233e02155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_adc97a18-d932-4ac9-8eef-7db28389a41e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f3ce5aa6-0fb0-46c4-8096-81f233e02155" xlink:to="loc_us-gaap_PlanNameAxis_adc97a18-d932-4ac9-8eef-7db28389a41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_0b24281e-2963-4693-8c67-a22e9f33f93f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_adc97a18-d932-4ac9-8eef-7db28389a41e" xlink:to="loc_us-gaap_PlanNameDomain_0b24281e-2963-4693-8c67-a22e9f33f93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CVSHealth2017IncentiveCompensationPlanMember_dbbd007e-7437-45fb-bfc5-8fb59e7a996c" xlink:href="cvs-20230525.xsd#cvs_CVSHealth2017IncentiveCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_0b24281e-2963-4693-8c67-a22e9f33f93f" xlink:to="loc_cvs_CVSHealth2017IncentiveCompensationPlanMember_dbbd007e-7437-45fb-bfc5-8fb59e7a996c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AetnaInc2010StockIncentivePlanMember_2fe00791-af4a-4790-8f96-ea7e5bd2c4ec" xlink:href="cvs-20230525.xsd#cvs_AetnaInc2010StockIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_0b24281e-2963-4693-8c67-a22e9f33f93f" xlink:to="loc_cvs_AetnaInc2010StockIncentivePlanMember_2fe00791-af4a-4790-8f96-ea7e5bd2c4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_248b2646-38c1-42d2-88ea-b2e2682ca862" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f3ce5aa6-0fb0-46c4-8096-81f233e02155" xlink:to="loc_srt_RangeAxis_248b2646-38c1-42d2-88ea-b2e2682ca862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dab15b30-8bd9-4c5c-b67f-0128dafe84fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_248b2646-38c1-42d2-88ea-b2e2682ca862" xlink:to="loc_srt_RangeMember_dab15b30-8bd9-4c5c-b67f-0128dafe84fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6f26dbd6-ad50-4d83-9408-be49f51276f7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dab15b30-8bd9-4c5c-b67f-0128dafe84fe" xlink:to="loc_srt_MinimumMember_6f26dbd6-ad50-4d83-9408-be49f51276f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4855f56f-e859-45ba-bfdf-a485a3e4f9a7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dab15b30-8bd9-4c5c-b67f-0128dafe84fe" xlink:to="loc_srt_MaximumMember_4855f56f-e859-45ba-bfdf-a485a3e4f9a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e94c0a55-2d23-43f1-955b-6fc31ac3d8da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f3ce5aa6-0fb0-46c4-8096-81f233e02155" xlink:to="loc_us-gaap_AwardTypeAxis_e94c0a55-2d23-43f1-955b-6fc31ac3d8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ba541d6-f293-4fed-9554-62a2b5a3fe30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e94c0a55-2d23-43f1-955b-6fc31ac3d8da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ba541d6-f293-4fed-9554-62a2b5a3fe30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember_350d9ed5-5bea-4387-bdaf-cfe8d7cc361e" xlink:href="cvs-20230525.xsd#cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ba541d6-f293-4fed-9554-62a2b5a3fe30" xlink:to="loc_cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember_350d9ed5-5bea-4387-bdaf-cfe8d7cc361e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EmployeeStockOptionsAndStockAppreciationRightsMember_6011d75d-ea9c-44d1-94da-4cc81381f807" xlink:href="cvs-20230525.xsd#cvs_EmployeeStockOptionsAndStockAppreciationRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ba541d6-f293-4fed-9554-62a2b5a3fe30" xlink:to="loc_cvs_EmployeeStockOptionsAndStockAppreciationRightsMember_6011d75d-ea9c-44d1-94da-4cc81381f807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_addd2432-5ade-4298-be85-f57a0166bfef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ba541d6-f293-4fed-9554-62a2b5a3fe30" xlink:to="loc_us-gaap_EmployeeStockMember_addd2432-5ade-4298-be85-f57a0166bfef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_85027d20-0617-4426-a85c-635a1fa3aac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ba541d6-f293-4fed-9554-62a2b5a3fe30" xlink:to="loc_us-gaap_EmployeeStockOptionMember_85027d20-0617-4426-a85c-635a1fa3aac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_2c493691-7216-426c-97d8-a235bced8240" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ba541d6-f293-4fed-9554-62a2b5a3fe30" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_2c493691-7216-426c-97d8-a235bced8240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f3ce5aa6-0fb0-46c4-8096-81f233e02155" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_72a01520-36c2-4e9e-9799-13b9dd78dda7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_72a01520-36c2-4e9e-9799-13b9dd78dda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_7f0f4616-4812-42c3-9c7b-5d2b27c44bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_7f0f4616-4812-42c3-9c7b-5d2b27c44bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_d14208b9-685a-4135-b25c-09a463b02dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_d14208b9-685a-4135-b25c-09a463b02dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_fa495c64-c323-4626-be0e-ec1dfaea0dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_fa495c64-c323-4626-be0e-ec1dfaea0dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_854e9560-5c03-47de-af8f-3923449c3ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_854e9560-5c03-47de-af8f-3923449c3ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_bd0feb1c-4338-4719-9499-1b23674a2da7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_bd0feb1c-4338-4719-9499-1b23674a2da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8a096eb7-e3fd-4b8f-9625-58048e62f4da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8a096eb7-e3fd-4b8f-9625-58048e62f4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_fab8829e-6699-4f91-92da-e5184d3ea737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_fab8829e-6699-4f91-92da-e5184d3ea737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_6bbc6482-bc07-4f1a-90b1-a17412483022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_6bbc6482-bc07-4f1a-90b1-a17412483022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_c1a6b5de-c624-4d71-9304-6eeec7e8ba9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_c1a6b5de-c624-4d71-9304-6eeec7e8ba9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber_c43a3bcc-533d-4d81-bdeb-4068b505de95" xlink:href="cvs-20230525.xsd#cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber_c43a3bcc-533d-4d81-bdeb-4068b505de95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_a09328fd-b276-4360-bf2a-4dc06bff9d54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_a09328fd-b276-4360-bf2a-4dc06bff9d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_4097e186-ed78-4e5d-8128-6a0fd37eb960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_4097e186-ed78-4e5d-8128-6a0fd37eb960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased_2d619802-39eb-4184-9276-e7f4a5f2fc35" xlink:href="cvs-20230525.xsd#cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d88d916d-addb-4f91-9e5e-8dadb3d25362" xlink:to="loc_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased_2d619802-39eb-4184-9276-e7f4a5f2fc35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#StockIncentivePlansRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8d5a0c0d-e109-4336-bf60-2fcc8cfc027c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2a3fac-597c-47e4-bed3-b20de3567c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8d5a0c0d-e109-4336-bf60-2fcc8cfc027c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2a3fac-597c-47e4-bed3-b20de3567c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_de636a23-c120-47b0-a994-1f5aa3af17fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2a3fac-597c-47e4-bed3-b20de3567c96" xlink:to="loc_us-gaap_AwardTypeAxis_de636a23-c120-47b0-a994-1f5aa3af17fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c3ccaa66-fd94-455d-b47d-5879fc24d9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_de636a23-c120-47b0-a994-1f5aa3af17fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c3ccaa66-fd94-455d-b47d-5879fc24d9a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember_ac4b580b-5066-42fd-b93b-1a09ec39af7c" xlink:href="cvs-20230525.xsd#cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c3ccaa66-fd94-455d-b47d-5879fc24d9a5" xlink:to="loc_cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember_ac4b580b-5066-42fd-b93b-1a09ec39af7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_711d6b8d-9ce9-42b9-aca9-cb207f327966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2f2a3fac-597c-47e4-bed3-b20de3567c96" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_711d6b8d-9ce9-42b9-aca9-cb207f327966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b4d56344-78cc-4068-a180-7687b7448048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_711d6b8d-9ce9-42b9-aca9-cb207f327966" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b4d56344-78cc-4068-a180-7687b7448048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a568a74f-1e8a-4b0a-b217-8c37b7b3ea8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b4d56344-78cc-4068-a180-7687b7448048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a568a74f-1e8a-4b0a-b217-8c37b7b3ea8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1e6efe08-186b-4e26-a9d8-c27bff2a6fed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b4d56344-78cc-4068-a180-7687b7448048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1e6efe08-186b-4e26-a9d8-c27bff2a6fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1c518307-60ee-4cac-8d13-af734a543c68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b4d56344-78cc-4068-a180-7687b7448048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1c518307-60ee-4cac-8d13-af734a543c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2758e616-4672-4b64-8838-9e4afb3c4a86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b4d56344-78cc-4068-a180-7687b7448048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2758e616-4672-4b64-8838-9e4afb3c4a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_695fe9cd-cf71-482a-9624-97cd05dc43da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b4d56344-78cc-4068-a180-7687b7448048" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_695fe9cd-cf71-482a-9624-97cd05dc43da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69a13c9d-d522-48ea-b888-b255adf6a908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_711d6b8d-9ce9-42b9-aca9-cb207f327966" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69a13c9d-d522-48ea-b888-b255adf6a908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5ef6a27f-8297-4de2-8449-684b6cb152ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69a13c9d-d522-48ea-b888-b255adf6a908" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5ef6a27f-8297-4de2-8449-684b6cb152ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_943ca40b-ab38-4d7a-9b91-bf50b985dc3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69a13c9d-d522-48ea-b888-b255adf6a908" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_943ca40b-ab38-4d7a-9b91-bf50b985dc3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c776c53c-110e-4a4b-b9f0-a72c193e13a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69a13c9d-d522-48ea-b888-b255adf6a908" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c776c53c-110e-4a4b-b9f0-a72c193e13a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_09c6c10a-c8cc-44ed-a23c-be5e1bcffda0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69a13c9d-d522-48ea-b888-b255adf6a908" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_09c6c10a-c8cc-44ed-a23c-be5e1bcffda0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_16b2dba4-b295-4980-ab59-f66fc4bb63f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69a13c9d-d522-48ea-b888-b255adf6a908" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_16b2dba4-b295-4980-ab59-f66fc4bb63f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates_25dbccf6-802f-4bc5-a843-9463c1fed13d" xlink:href="cvs-20230525.xsd#cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_711d6b8d-9ce9-42b9-aca9-cb207f327966" xlink:to="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates_25dbccf6-802f-4bc5-a843-9463c1fed13d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#StockIncentivePlansStockOptionandSARActivityDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1d2b7d53-62ea-4a49-9497-cc8b459c58eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b625123f-6ab1-4c89-a563-c4c5a27334f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1d2b7d53-62ea-4a49-9497-cc8b459c58eb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b625123f-6ab1-4c89-a563-c4c5a27334f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_58047db9-9613-4a75-90d5-3089f3883aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b625123f-6ab1-4c89-a563-c4c5a27334f4" xlink:to="loc_us-gaap_AwardTypeAxis_58047db9-9613-4a75-90d5-3089f3883aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1eef0f54-21fc-4acf-a693-8656e494c94c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_58047db9-9613-4a75-90d5-3089f3883aed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1eef0f54-21fc-4acf-a693-8656e494c94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member_a4235ad9-670b-4141-a911-403363aeb3b8" xlink:href="cvs-20230525.xsd#cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1eef0f54-21fc-4acf-a693-8656e494c94c" xlink:to="loc_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member_a4235ad9-670b-4141-a911-403363aeb3b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member_26c83fef-4989-4b24-9554-4df170792c76" xlink:href="cvs-20230525.xsd#cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1eef0f54-21fc-4acf-a693-8656e494c94c" xlink:to="loc_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member_26c83fef-4989-4b24-9554-4df170792c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_944ef21c-a4ba-4de4-acc4-f50198c76eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1eef0f54-21fc-4acf-a693-8656e494c94c" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_944ef21c-a4ba-4de4-acc4-f50198c76eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EmployeeStockOptionsAndStockAppreciationRightsMember_4cb1a611-acc2-4488-a323-e97ac2ead76c" xlink:href="cvs-20230525.xsd#cvs_EmployeeStockOptionsAndStockAppreciationRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1eef0f54-21fc-4acf-a693-8656e494c94c" xlink:to="loc_cvs_EmployeeStockOptionsAndStockAppreciationRightsMember_4cb1a611-acc2-4488-a323-e97ac2ead76c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b0e982c5-6f30-4a36-943c-395a45387af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b625123f-6ab1-4c89-a563-c4c5a27334f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b0e982c5-6f30-4a36-943c-395a45387af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_4f05dc54-8235-4f6d-a3a1-d2a60566bfd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b0e982c5-6f30-4a36-943c-395a45387af9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_4f05dc54-8235-4f6d-a3a1-d2a60566bfd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_18b6da20-f23c-416c-a126-3af06639dc16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b0e982c5-6f30-4a36-943c-395a45387af9" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_18b6da20-f23c-416c-a126-3af06639dc16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c0aafbb2-4ae7-488b-8cbb-2a0e140b1cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b0e982c5-6f30-4a36-943c-395a45387af9" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c0aafbb2-4ae7-488b-8cbb-2a0e140b1cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_414aa0ae-ff2e-44b5-a9e8-cc94fcd7336d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b0e982c5-6f30-4a36-943c-395a45387af9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_414aa0ae-ff2e-44b5-a9e8-cc94fcd7336d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue_eb7f829d-98a8-417c-9577-8bae999f38b6" xlink:href="cvs-20230525.xsd#cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b0e982c5-6f30-4a36-943c-395a45387af9" xlink:to="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue_eb7f829d-98a8-417c-9577-8bae999f38b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1a24c4d9-2ee1-4375-bd53-7e87200d8aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b0e982c5-6f30-4a36-943c-395a45387af9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1a24c4d9-2ee1-4375-bd53-7e87200d8aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6394bf00-b6b8-473b-b79a-3f79f88e823a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1a24c4d9-2ee1-4375-bd53-7e87200d8aea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6394bf00-b6b8-473b-b79a-3f79f88e823a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_af2c1e73-9f13-45cc-af97-3245c9fe6e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1a24c4d9-2ee1-4375-bd53-7e87200d8aea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_af2c1e73-9f13-45cc-af97-3245c9fe6e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0dd71e51-2c79-4b4b-b350-61404a9d62cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1a24c4d9-2ee1-4375-bd53-7e87200d8aea" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0dd71e51-2c79-4b4b-b350-61404a9d62cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_b4e22651-02c7-49ae-9727-8668735a2e24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1a24c4d9-2ee1-4375-bd53-7e87200d8aea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_b4e22651-02c7-49ae-9727-8668735a2e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_bedb5d90-7e60-4a6c-9a7a-3b147d7adb1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1a24c4d9-2ee1-4375-bd53-7e87200d8aea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_bedb5d90-7e60-4a6c-9a7a-3b147d7adb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8bd7dd0f-3749-498e-875a-942de58d9d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1a24c4d9-2ee1-4375-bd53-7e87200d8aea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8bd7dd0f-3749-498e-875a-942de58d9d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d0e1c945-8cde-4594-b440-d5e5ed6f9a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b0e982c5-6f30-4a36-943c-395a45387af9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d0e1c945-8cde-4594-b440-d5e5ed6f9a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_92008ed7-506a-4147-b136-95b9065c2596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d0e1c945-8cde-4594-b440-d5e5ed6f9a7e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_92008ed7-506a-4147-b136-95b9065c2596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_285df79e-75bd-47eb-a327-2ade2d64ca9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d0e1c945-8cde-4594-b440-d5e5ed6f9a7e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_285df79e-75bd-47eb-a327-2ade2d64ca9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_23510773-a82d-4bb9-a670-c071462f9196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d0e1c945-8cde-4594-b440-d5e5ed6f9a7e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_23510773-a82d-4bb9-a670-c071462f9196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_a5f3efe8-b263-4add-aa0f-2be22eaf3ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d0e1c945-8cde-4594-b440-d5e5ed6f9a7e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_a5f3efe8-b263-4add-aa0f-2be22eaf3ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_ec9eae40-425b-4e9c-9a18-56b2dafad336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d0e1c945-8cde-4594-b440-d5e5ed6f9a7e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_ec9eae40-425b-4e9c-9a18-56b2dafad336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b2823aac-ead0-41bb-96a0-9b7b7c68e794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d0e1c945-8cde-4594-b440-d5e5ed6f9a7e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b2823aac-ead0-41bb-96a0-9b7b7c68e794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b0e982c5-6f30-4a36-943c-395a45387af9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5dbd6ecd-c560-43b8-b229-0ccf06e359ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5dbd6ecd-c560-43b8-b229-0ccf06e359ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_bd1367b7-7bd6-4013-8819-2c0c510dc84a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_bd1367b7-7bd6-4013-8819-2c0c510dc84a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_86f4efb9-028a-4b3c-ae0b-450c7035db8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_86f4efb9-028a-4b3c-ae0b-450c7035db8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_5f07b445-a08d-4662-b338-c6d551885f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_5f07b445-a08d-4662-b338-c6d551885f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_fef8d7ee-9ce5-4d47-b8e3-0ccdcf508163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_fef8d7ee-9ce5-4d47-b8e3-0ccdcf508163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_d24d972b-82e6-47db-b25a-3b15a0fac6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_d24d972b-82e6-47db-b25a-3b15a0fac6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_081fcb1c-30b7-4949-bc7d-78e1db91ce11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_081fcb1c-30b7-4949-bc7d-78e1db91ce11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_4666126a-14dd-436b-a0d7-c8c59960a13d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_4666126a-14dd-436b-a0d7-c8c59960a13d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ae0c99de-8378-4009-bcf3-51d8480622b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ae0c99de-8378-4009-bcf3-51d8480622b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_92912d7e-3692-4338-a519-2c7ada94b279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ece3e6e9-279c-4bbc-b6fc-20562faa6b86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_92912d7e-3692-4338-a519-2c7ada94b279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansValuationAssumptionsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#StockIncentivePlansValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0dd2201e-be19-4eb9-b5b6-f2df3d964144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_89043152-8375-426c-a5b3-15cae9f3aac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0dd2201e-be19-4eb9-b5b6-f2df3d964144" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_89043152-8375-426c-a5b3-15cae9f3aac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4da9badb-c09d-4c24-8fdd-c5e4536da36e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_89043152-8375-426c-a5b3-15cae9f3aac5" xlink:to="loc_us-gaap_AwardTypeAxis_4da9badb-c09d-4c24-8fdd-c5e4536da36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d7b35e57-cf98-43c2-8b80-05f9d6f6ab44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_4da9badb-c09d-4c24-8fdd-c5e4536da36e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d7b35e57-cf98-43c2-8b80-05f9d6f6ab44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_9fabc564-bcef-487f-b0d6-dc7da9aafef8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d7b35e57-cf98-43c2-8b80-05f9d6f6ab44" xlink:to="loc_us-gaap_EmployeeStockMember_9fabc564-bcef-487f-b0d6-dc7da9aafef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_330370be-c39e-400e-80a8-85b5d5f7ac50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d7b35e57-cf98-43c2-8b80-05f9d6f6ab44" xlink:to="loc_us-gaap_EmployeeStockOptionMember_330370be-c39e-400e-80a8-85b5d5f7ac50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e17e6f8c-c4e2-46bc-a7f1-f83f068e6505" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_89043152-8375-426c-a5b3-15cae9f3aac5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e17e6f8c-c4e2-46bc-a7f1-f83f068e6505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7a26f35c-da10-4a78-a6b9-9224a045960d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e17e6f8c-c4e2-46bc-a7f1-f83f068e6505" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7a26f35c-da10-4a78-a6b9-9224a045960d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_5063bd5c-a4f7-4f2b-a5e3-6109edc756e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e17e6f8c-c4e2-46bc-a7f1-f83f068e6505" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_5063bd5c-a4f7-4f2b-a5e3-6109edc756e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_b6c37225-b4e8-4411-8cec-c0e466ac3c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e17e6f8c-c4e2-46bc-a7f1-f83f068e6505" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_b6c37225-b4e8-4411-8cec-c0e466ac3c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_86dfe06c-546f-4f76-a777-4bd86c3a13ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e17e6f8c-c4e2-46bc-a7f1-f83f068e6505" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_86dfe06c-546f-4f76-a777-4bd86c3a13ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a0990db3-d107-4c90-926d-b84170322637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e17e6f8c-c4e2-46bc-a7f1-f83f068e6505" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a0990db3-d107-4c90-926d-b84170322637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#ShareholdersEquityShareRepurchasesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_41c83b8d-d5d4-4575-9f6c-9cd16e539b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_f44706b6-d675-42ba-b0ba-9d85d3513ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_41c83b8d-d5d4-4575-9f6c-9cd16e539b8b" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_f44706b6-d675-42ba-b0ba-9d85d3513ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_130a0864-2c96-4ff8-a789-63e0a61e9e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_f44706b6-d675-42ba-b0ba-9d85d3513ccf" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_130a0864-2c96-4ff8-a789-63e0a61e9e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_392d0214-d868-4776-b547-1803e5ae63de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_130a0864-2c96-4ff8-a789-63e0a61e9e3d" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_392d0214-d868-4776-b547-1803e5ae63de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2022RepurchaseProgramMember_d4a8d06b-99bc-42be-8384-e7bc997c1b05" xlink:href="cvs-20230525.xsd#cvs_A2022RepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_392d0214-d868-4776-b547-1803e5ae63de" xlink:to="loc_cvs_A2022RepurchaseProgramMember_d4a8d06b-99bc-42be-8384-e7bc997c1b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2021RepurchaseProgramMember_4b398169-fcbb-442d-9458-9df6a520f7d0" xlink:href="cvs-20230525.xsd#cvs_A2021RepurchaseProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_392d0214-d868-4776-b547-1803e5ae63de" xlink:to="loc_cvs_A2021RepurchaseProgramMember_4b398169-fcbb-442d-9458-9df6a520f7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_472c9d23-daaa-4d7c-b50c-dc555c4c2341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_f44706b6-d675-42ba-b0ba-9d85d3513ccf" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_472c9d23-daaa-4d7c-b50c-dc555c4c2341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_aa4e7c22-df30-47a6-99fc-5655e945595b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_472c9d23-daaa-4d7c-b50c-dc555c4c2341" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_aa4e7c22-df30-47a6-99fc-5655e945595b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_8b8d676d-d723-4d6d-a32b-25bceb1dc2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_472c9d23-daaa-4d7c-b50c-dc555c4c2341" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_8b8d676d-d723-4d6d-a32b-25bceb1dc2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_cd09b701-48de-4b36-94d3-278fa06eba3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_472c9d23-daaa-4d7c-b50c-dc555c4c2341" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_cd09b701-48de-4b36-94d3-278fa06eba3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_96e01975-4993-4ece-b4a6-a91161889de6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_472c9d23-daaa-4d7c-b50c-dc555c4c2341" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_96e01975-4993-4ece-b4a6-a91161889de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#ShareholdersEquityAcceleratedShareRepurchasesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_82c7dbd2-ccd8-40eb-a205-acd9bf017209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_09ac8ce0-e083-45dc-be02-3e839984ffd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_82c7dbd2-ccd8-40eb-a205-acd9bf017209" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_09ac8ce0-e083-45dc-be02-3e839984ffd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_e1bf708f-138c-498a-bdc7-11c378e94f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_09ac8ce0-e083-45dc-be02-3e839984ffd1" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_e1bf708f-138c-498a-bdc7-11c378e94f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_58934f3a-b391-4c47-b1b1-86610ddf9879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_e1bf708f-138c-498a-bdc7-11c378e94f5c" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_58934f3a-b391-4c47-b1b1-86610ddf9879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2021RepurchaseProgramMember_979a92df-6871-4b79-9be0-90f09152ca7c" xlink:href="cvs-20230525.xsd#cvs_A2021RepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_58934f3a-b391-4c47-b1b1-86610ddf9879" xlink:to="loc_cvs_A2021RepurchaseProgramMember_979a92df-6871-4b79-9be0-90f09152ca7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_0d07d903-4907-4938-bda7-34cb1475e8c7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_09ac8ce0-e083-45dc-be02-3e839984ffd1" xlink:to="loc_srt_CounterpartyNameAxis_0d07d903-4907-4938-bda7-34cb1475e8c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ee382254-3448-475c-a0fb-f290e13a1e04" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_0d07d903-4907-4938-bda7-34cb1475e8c7" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ee382254-3448-475c-a0fb-f290e13a1e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CitibankNAMember_d49389e4-fbe0-4612-8044-76b7669309fa" xlink:href="cvs-20230525.xsd#cvs_CitibankNAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ee382254-3448-475c-a0fb-f290e13a1e04" xlink:to="loc_cvs_CitibankNAMember_d49389e4-fbe0-4612-8044-76b7669309fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BarclaysBankMember_44f600e4-a830-4292-ad77-28f5702fd796" xlink:href="cvs-20230525.xsd#cvs_BarclaysBankMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ee382254-3448-475c-a0fb-f290e13a1e04" xlink:to="loc_cvs_BarclaysBankMember_44f600e4-a830-4292-ad77-28f5702fd796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8b793ddc-6175-4fc1-9988-fc472b2d1d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_09ac8ce0-e083-45dc-be02-3e839984ffd1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8b793ddc-6175-4fc1-9988-fc472b2d1d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ff6df604-c024-4a0a-a500-96fe60225d09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8b793ddc-6175-4fc1-9988-fc472b2d1d0b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ff6df604-c024-4a0a-a500-96fe60225d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_5d5717dc-35c6-40f7-a7e0-0a3da51f1670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ff6df604-c024-4a0a-a500-96fe60225d09" xlink:to="loc_us-gaap_ForwardContractsMember_5d5717dc-35c6-40f7-a7e0-0a3da51f1670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_df53d9e2-b571-4fd1-9869-9c5660862d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_09ac8ce0-e083-45dc-be02-3e839984ffd1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_df53d9e2-b571-4fd1-9869-9c5660862d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8eaaf420-1973-46a5-a1a6-1baa9fe6de4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_df53d9e2-b571-4fd1-9869-9c5660862d08" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8eaaf420-1973-46a5-a1a6-1baa9fe6de4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_84d34a6f-9c6d-42d3-be70-c144004dddd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_8eaaf420-1973-46a5-a1a6-1baa9fe6de4a" xlink:to="loc_us-gaap_SubsequentEventMember_84d34a6f-9c6d-42d3-be70-c144004dddd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f747c4eb-cbf0-4aee-b291-794796129052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_09ac8ce0-e083-45dc-be02-3e839984ffd1" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f747c4eb-cbf0-4aee-b291-794796129052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesAgreementAmount_657101a3-22b9-472d-b798-22738eb14df4" xlink:href="cvs-20230525.xsd#cvs_AcceleratedShareRepurchasesAgreementAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f747c4eb-cbf0-4aee-b291-794796129052" xlink:to="loc_cvs_AcceleratedShareRepurchasesAgreementAmount_657101a3-22b9-472d-b798-22738eb14df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount_d190c140-53e6-4639-8844-f037fdbbaac8" xlink:href="cvs-20230525.xsd#cvs_PaymentsForAcceleratedShareRepurchasesAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f747c4eb-cbf0-4aee-b291-794796129052" xlink:to="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount_d190c140-53e6-4639-8844-f037fdbbaac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_10d43a1c-b18f-4ed1-8122-c337ba73f832" xlink:href="cvs-20230525.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f747c4eb-cbf0-4aee-b291-794796129052" xlink:to="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_10d43a1c-b18f-4ed1-8122-c337ba73f832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased_58e62dd4-3007-49a6-967f-46156b158d13" xlink:href="cvs-20230525.xsd#cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f747c4eb-cbf0-4aee-b291-794796129052" xlink:to="loc_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased_58e62dd4-3007-49a6-967f-46156b158d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_c8dfba20-f136-4fc5-958d-a190b27d7b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f747c4eb-cbf0-4aee-b291-794796129052" xlink:to="loc_us-gaap_SharePrice_c8dfba20-f136-4fc5-958d-a190b27d7b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_f651c17c-86a7-483e-9299-ea6a024a3986" xlink:href="cvs-20230525.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f747c4eb-cbf0-4aee-b291-794796129052" xlink:to="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_f651c17c-86a7-483e-9299-ea6a024a3986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares_1447f497-0a45-414f-9da5-8d07984990ca" xlink:href="cvs-20230525.xsd#cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f747c4eb-cbf0-4aee-b291-794796129052" xlink:to="loc_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares_1447f497-0a45-414f-9da5-8d07984990ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TransferOfSharesToTreasuryStockValue_4b83ee4d-55c7-46a9-a8e4-400cdf71c92b" xlink:href="cvs-20230525.xsd#cvs_TransferOfSharesToTreasuryStockValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f747c4eb-cbf0-4aee-b291-794796129052" xlink:to="loc_cvs_TransferOfSharesToTreasuryStockValue_4b83ee4d-55c7-46a9-a8e4-400cdf71c92b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_b2cc38c4-6694-407c-93cb-416537715fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_f747c4eb-cbf0-4aee-b291-794796129052" xlink:to="loc_us-gaap_DerivativeNotionalAmount_b2cc38c4-6694-407c-93cb-416537715fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#ShareholdersEquityDividendsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_fdc79842-ecff-45fb-89be-1ef8b78cf16a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable_09aabce2-e97f-4661-892d-3b7dc1a26648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_fdc79842-ecff-45fb-89be-1ef8b78cf16a" xlink:to="loc_us-gaap_DividendsPayableTable_09aabce2-e97f-4661-892d-3b7dc1a26648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_154f6de9-354c-43ab-b874-471b1f31804f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_09aabce2-e97f-4661-892d-3b7dc1a26648" xlink:to="loc_srt_StatementScenarioAxis_154f6de9-354c-43ab-b874-471b1f31804f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_745d3c93-3179-4642-ae70-70b2f7dae22d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_154f6de9-354c-43ab-b874-471b1f31804f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_745d3c93-3179-4642-ae70-70b2f7dae22d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_c46de05d-2a42-4d87-87df-d1c97ce42847" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_745d3c93-3179-4642-ae70-70b2f7dae22d" xlink:to="loc_srt_ScenarioForecastMember_c46de05d-2a42-4d87-87df-d1c97ce42847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems_fe89aa9d-5748-42e7-9675-d06ea2754d21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_09aabce2-e97f-4661-892d-3b7dc1a26648" xlink:to="loc_us-gaap_DividendsPayableLineItems_fe89aa9d-5748-42e7-9675-d06ea2754d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_408b92c1-4ba8-4c8c-ad9d-a9c1ab562121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_fe89aa9d-5748-42e7-9675-d06ea2754d21" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_408b92c1-4ba8-4c8c-ad9d-a9c1ab562121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent_9f4118fc-5671-4206-b38a-72142b4790fa" xlink:href="cvs-20230525.xsd#cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_fe89aa9d-5748-42e7-9675-d06ea2754d21" xlink:to="loc_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent_9f4118fc-5671-4206-b38a-72142b4790fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#ShareholdersEquityRegulatoryRequirementsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3d5445a6-09d3-4189-a13b-47a0cfa68ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesTable_f6e15d9c-79cd-4ad8-89e5-0e290b172e36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3d5445a6-09d3-4189-a13b-47a0cfa68ea5" xlink:to="loc_us-gaap_StatutoryAccountingPracticesTable_f6e15d9c-79cd-4ad8-89e5-0e290b172e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_4c9ec428-1008-437e-8330-f861db766c1c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesTable_f6e15d9c-79cd-4ad8-89e5-0e290b172e36" xlink:to="loc_dei_LegalEntityAxis_4c9ec428-1008-437e-8330-f861db766c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ac0c8a69-1b5c-4deb-bdcd-551deda311a3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_4c9ec428-1008-437e-8330-f861db766c1c" xlink:to="loc_dei_EntityDomain_ac0c8a69-1b5c-4deb-bdcd-551deda311a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InsuranceAndHMOMember_05af8859-33e4-4570-a18d-3a4cf7f420f2" xlink:href="cvs-20230525.xsd#cvs_InsuranceAndHMOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ac0c8a69-1b5c-4deb-bdcd-551deda311a3" xlink:to="loc_cvs_InsuranceAndHMOMember_05af8859-33e4-4570-a18d-3a4cf7f420f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesLineItems_95cece72-8153-4196-a5b9-30678045a8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesTable_f6e15d9c-79cd-4ad8-89e5-0e290b172e36" xlink:to="loc_us-gaap_StatutoryAccountingPracticesLineItems_95cece72-8153-4196-a5b9-30678045a8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount_9c2358d1-d273-4659-9983-f023824d30af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_95cece72-8153-4196-a5b9-30678045a8c8" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount_9c2358d1-d273-4659-9983-f023824d30af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_ea95f7a3-ad2b-4848-9cc9-fbf7b30d9ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_95cece72-8153-4196-a5b9-30678045a8c8" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_ea95f7a3-ad2b-4848-9cc9-fbf7b30d9ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_cc2a2c6c-98f8-4f99-90e0-a5c45fefb9e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_95cece72-8153-4196-a5b9-30678045a8c8" xlink:to="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_cc2a2c6c-98f8-4f99-90e0-a5c45fefb9e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_3129edc4-00bd-4f89-a09e-df312dd16da1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_95cece72-8153-4196-a5b9-30678045a8c8" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_3129edc4-00bd-4f89-a09e-df312dd16da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldByInsuranceRegulators_fea54fea-0cd7-48d8-83ef-2a3ceecdfa35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldByInsuranceRegulators"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_95cece72-8153-4196-a5b9-30678045a8c8" xlink:to="loc_us-gaap_AssetsHeldByInsuranceRegulators_fea54fea-0cd7-48d8-83ef-2a3ceecdfa35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_f5e9e66b-37a8-4b20-9742-9d1f1d140a86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_95cece72-8153-4196-a5b9-30678045a8c8" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_f5e9e66b-37a8-4b20-9742-9d1f1d140a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#ShareholdersEquityNoncontrollingInterestsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityNoncontrollingInterestsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0511c41c-bf99-45d2-81ff-1977ead7a35e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_246a4344-2da9-411a-99c3-2487b20355e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0511c41c-bf99-45d2-81ff-1977ead7a35e" xlink:to="loc_us-gaap_MinorityInterest_246a4344-2da9-411a-99c3-2487b20355e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#OtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a4549b04-2df1-4221-a94b-f75407f1cd87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_e03e043c-ebc1-4fa8-9b7f-67f83f0d6bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a4549b04-2df1-4221-a94b-f75407f1cd87" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_e03e043c-ebc1-4fa8-9b7f-67f83f0d6bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b678d9d1-2655-4628-b090-f8e8082f476a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_e03e043c-ebc1-4fa8-9b7f-67f83f0d6bc7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b678d9d1-2655-4628-b090-f8e8082f476a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_08640a28-f4e0-427c-ba0e-9f565f8c4426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b678d9d1-2655-4628-b090-f8e8082f476a" xlink:to="loc_us-gaap_EquityComponentDomain_08640a28-f4e0-427c-ba0e-9f565f8c4426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_cb91c2bd-c441-423b-a502-640004bdd8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_08640a28-f4e0-427c-ba0e-9f565f8c4426" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_cb91c2bd-c441-423b-a502-640004bdd8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember_03bdcf68-57d1-4911-9c31-9795fdfd9783" xlink:href="cvs-20230525.xsd#cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_08640a28-f4e0-427c-ba0e-9f565f8c4426" xlink:to="loc_cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember_03bdcf68-57d1-4911-9c31-9795fdfd9783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_403c2d66-378e-40ee-86cf-6eccf5091f09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_08640a28-f4e0-427c-ba0e-9f565f8c4426" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_403c2d66-378e-40ee-86cf-6eccf5091f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_5621cd4c-22b6-4810-bf26-9a9f4e0ed2fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_08640a28-f4e0-427c-ba0e-9f565f8c4426" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_5621cd4c-22b6-4810-bf26-9a9f4e0ed2fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_1fdf12d3-7c89-4d55-91ef-b4e41f958c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_08640a28-f4e0-427c-ba0e-9f565f8c4426" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_1fdf12d3-7c89-4d55-91ef-b4e41f958c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_02f5233f-2640-4e86-85ad-f70a7d3adde0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_08640a28-f4e0-427c-ba0e-9f565f8c4426" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_02f5233f-2640-4e86-85ad-f70a7d3adde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_71896a87-a95b-4e62-8408-cd78c8f3fa97" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_e03e043c-ebc1-4fa8-9b7f-67f83f0d6bc7" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_71896a87-a95b-4e62-8408-cd78c8f3fa97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_5ada4e43-76b5-4702-8d6b-86f5be61b865" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_71896a87-a95b-4e62-8408-cd78c8f3fa97" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_5ada4e43-76b5-4702-8d6b-86f5be61b865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_964bbe8a-fc36-460d-ad57-3daa9622bb6e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_5ada4e43-76b5-4702-8d6b-86f5be61b865" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_964bbe8a-fc36-460d-ad57-3daa9622bb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6e9b2bb8-5329-4039-8d26-c3627b60f1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_e03e043c-ebc1-4fa8-9b7f-67f83f0d6bc7" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6e9b2bb8-5329-4039-8d26-c3627b60f1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_a853b0de-4ba3-4890-ad75-8db2ddc65476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6e9b2bb8-5329-4039-8d26-c3627b60f1e6" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_a853b0de-4ba3-4890-ad75-8db2ddc65476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_68f9e4a5-e2d6-456a-9a6f-8170b17ad77d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_a853b0de-4ba3-4890-ad75-8db2ddc65476" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_68f9e4a5-e2d6-456a-9a6f-8170b17ad77d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_006e0ce5-5660-40e4-b0cc-e2a37d02ad9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_a853b0de-4ba3-4890-ad75-8db2ddc65476" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_006e0ce5-5660-40e4-b0cc-e2a37d02ad9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5ac3d934-89a5-42be-be14-a2d55a4b68bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_a853b0de-4ba3-4890-ad75-8db2ddc65476" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5ac3d934-89a5-42be-be14-a2d55a4b68bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3ba94dbd-f446-4c71-a699-5c60063f29d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_a853b0de-4ba3-4890-ad75-8db2ddc65476" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3ba94dbd-f446-4c71-a699-5c60063f29d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f6ff2758-87ca-431d-be55-e7e938ce909c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_a853b0de-4ba3-4890-ad75-8db2ddc65476" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f6ff2758-87ca-431d-be55-e7e938ce909c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax_466ca850-49f3-43db-aa45-4fec467b4fe3" xlink:href="cvs-20230525.xsd#cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6e9b2bb8-5329-4039-8d26-c3627b60f1e6" xlink:to="loc_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax_466ca850-49f3-43db-aa45-4fec467b4fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_03badaeb-ac35-48fd-9843-27de20b241a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6e9b2bb8-5329-4039-8d26-c3627b60f1e6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_03badaeb-ac35-48fd-9843-27de20b241a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_3f10b6bd-1119-47a5-9aa4-5b18437b4118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6e9b2bb8-5329-4039-8d26-c3627b60f1e6" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_3f10b6bd-1119-47a5-9aa4-5b18437b4118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_8c70179f-fbcb-41ee-9822-3439fb7e727e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_6e9b2bb8-5329-4039-8d26-c3627b60f1e6" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_8c70179f-fbcb-41ee-9822-3439fb7e727e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#EarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b335fc67-691b-4c9f-b8db-609f0335a29f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_31a98b23-c346-4303-a683-832c068ce814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b335fc67-691b-4c9f-b8db-609f0335a29f" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_31a98b23-c346-4303-a683-832c068ce814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f9e7969d-20c2-4c1f-afc2-9b0fe810a342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_31a98b23-c346-4303-a683-832c068ce814" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f9e7969d-20c2-4c1f-afc2-9b0fe810a342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3798bc16-f617-42bb-9fb5-8264c99f71dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f9e7969d-20c2-4c1f-afc2-9b0fe810a342" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3798bc16-f617-42bb-9fb5-8264c99f71dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockOptionsAndStockAppreciationRightsMember_da53c063-b18a-4426-94a4-787ffa249cd7" xlink:href="cvs-20230525.xsd#cvs_StockOptionsAndStockAppreciationRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3798bc16-f617-42bb-9fb5-8264c99f71dc" xlink:to="loc_cvs_StockOptionsAndStockAppreciationRightsMember_da53c063-b18a-4426-94a4-787ffa249cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember_c287fc45-f6fc-4286-840a-9f1878109ee7" xlink:href="cvs-20230525.xsd#cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3798bc16-f617-42bb-9fb5-8264c99f71dc" xlink:to="loc_cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember_c287fc45-f6fc-4286-840a-9f1878109ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_89f89e8f-12c4-420e-97da-ff4e5490992d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_31a98b23-c346-4303-a683-832c068ce814" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_89f89e8f-12c4-420e-97da-ff4e5490992d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b0ba6da4-5fbb-49d6-96d2-1fbd6234ea40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_89f89e8f-12c4-420e-97da-ff4e5490992d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b0ba6da4-5fbb-49d6-96d2-1fbd6234ea40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_b3e623c1-d92d-4e10-a63a-773ee5a8e1ef" xlink:href="cvs-20230525.xsd#cvs_NumeratorForEarningsPerShareCalculationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_89f89e8f-12c4-420e-97da-ff4e5490992d" xlink:to="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_b3e623c1-d92d-4e10-a63a-773ee5a8e1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_cda9ebec-a06e-4738-9adc-9156a7cdec47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_b3e623c1-d92d-4e10-a63a-773ee5a8e1ef" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_cda9ebec-a06e-4738-9adc-9156a7cdec47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_51920ee9-bfbc-4d15-8ba6-2895fc6a14fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_b3e623c1-d92d-4e10-a63a-773ee5a8e1ef" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_51920ee9-bfbc-4d15-8ba6-2895fc6a14fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_8d279739-de09-4abf-b232-a1f8d30f32a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_b3e623c1-d92d-4e10-a63a-773ee5a8e1ef" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_8d279739-de09-4abf-b232-a1f8d30f32a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_c5ee6c81-c4ee-4d29-9c3c-c9c60c240732" xlink:href="cvs-20230525.xsd#cvs_DenominatorForEarningsPerShareCalculationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_89f89e8f-12c4-420e-97da-ff4e5490992d" xlink:to="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_c5ee6c81-c4ee-4d29-9c3c-c9c60c240732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e5e8a449-cf7c-47b5-8ee8-33ffaf193ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_c5ee6c81-c4ee-4d29-9c3c-c9c60c240732" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e5e8a449-cf7c-47b5-8ee8-33ffaf193ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2120ee6a-c3fe-469e-aff6-ff97155836da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_c5ee6c81-c4ee-4d29-9c3c-c9c60c240732" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2120ee6a-c3fe-469e-aff6-ff97155836da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_98474cad-5f3d-452d-8288-d264bfb4cb42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_c5ee6c81-c4ee-4d29-9c3c-c9c60c240732" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_98474cad-5f3d-452d-8288-d264bfb4cb42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_1639dddc-8b10-4821-b6ab-380ac4320dc6" xlink:href="cvs-20230525.xsd#cvs_EarningsPerShareBasicAndDilutedEPSAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_89f89e8f-12c4-420e-97da-ff4e5490992d" xlink:to="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_1639dddc-8b10-4821-b6ab-380ac4320dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_bbad3f90-a396-4a72-90fe-d6920b2cc37f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_1639dddc-8b10-4821-b6ab-380ac4320dc6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_bbad3f90-a396-4a72-90fe-d6920b2cc37f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_a7b9c25d-566e-40eb-9bf2-59eb25dede28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_EarningsPerShareBasicAndDilutedEPSAbstract_1639dddc-8b10-4821-b6ab-380ac4320dc6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_a7b9c25d-566e-40eb-9bf2-59eb25dede28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#ReinsuranceNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ReinsuranceNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_1a45de74-a32a-4d3f-aa1a-62b47dba98fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskTable_0ae4c5c2-a3aa-454a-b29b-3a589fa3c773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_1a45de74-a32a-4d3f-aa1a-62b47dba98fc" xlink:to="loc_us-gaap_CededCreditRiskTable_0ae4c5c2-a3aa-454a-b29b-3a589fa3c773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_c596b847-3d61-4bee-9188-137682fbfeeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskTable_0ae4c5c2-a3aa-454a-b29b-3a589fa3c773" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_c596b847-3d61-4bee-9188-137682fbfeeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2b213505-9b16-4e14-9330-ecb257567d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c596b847-3d61-4bee-9188-137682fbfeeb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2b213505-9b16-4e14-9330-ecb257567d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4d159ef0-8ad1-478e-a638-b56f81ad34a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_2b213505-9b16-4e14-9330-ecb257567d8e" xlink:to="loc_us-gaap_SubsequentEventMember_4d159ef0-8ad1-478e-a638-b56f81ad34a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskLineItems_f656c079-2e8b-4ecb-b3c7-ac1b49b66318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskTable_0ae4c5c2-a3aa-454a-b29b-3a589fa3c773" xlink:to="loc_us-gaap_CededCreditRiskLineItems_f656c079-2e8b-4ecb-b3c7-ac1b49b66318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer_88968da9-be1d-4c0f-a192-fc2c65332dd0" xlink:href="cvs-20230525.xsd#cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskLineItems_f656c079-2e8b-4ecb-b3c7-ac1b49b66318" xlink:to="loc_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer_88968da9-be1d-4c0f-a192-fc2c65332dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofReinsuranceContractsEnteredInto_4f6190ed-0024-48d9-9250-16597835e18b" xlink:href="cvs-20230525.xsd#cvs_NumberofReinsuranceContractsEnteredInto"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskLineItems_f656c079-2e8b-4ecb-b3c7-ac1b49b66318" xlink:to="loc_cvs_NumberofReinsuranceContractsEnteredInto_4f6190ed-0024-48d9-9250-16597835e18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#ReinsuranceReinsuranceRecoverablesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_54dd5cb4-10c0-443a-8bd5-f41812f9602f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskTable_58230106-f5a6-4129-8f01-73bd268b216b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_54dd5cb4-10c0-443a-8bd5-f41812f9602f" xlink:to="loc_us-gaap_CededCreditRiskTable_58230106-f5a6-4129-8f01-73bd268b216b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskAxis_0e616dd5-81c8-4598-bbc6-658b304bf691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskTable_58230106-f5a6-4129-8f01-73bd268b216b" xlink:to="loc_us-gaap_CededCreditRiskAxis_0e616dd5-81c8-4598-bbc6-658b304bf691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskReinsurerDomain_bac29c10-ee92-4598-b742-85952f20a217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskReinsurerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskAxis_0e616dd5-81c8-4598-bbc6-658b304bf691" xlink:to="loc_us-gaap_CededCreditRiskReinsurerDomain_bac29c10-ee92-4598-b742-85952f20a217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HartfordLifeAndAccidentInsuranceCompanyMember_85b12201-4f49-4454-a89b-e8c22ff64b19" xlink:href="cvs-20230525.xsd#cvs_HartfordLifeAndAccidentInsuranceCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_bac29c10-ee92-4598-b742-85952f20a217" xlink:to="loc_cvs_HartfordLifeAndAccidentInsuranceCompanyMember_85b12201-4f49-4454-a89b-e8c22ff64b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember_458b4a8c-2ffb-4429-85d5-45d3312d53b3" xlink:href="cvs-20230525.xsd#cvs_LincolnLifeAnnuityCompanyOfNewYorkMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_bac29c10-ee92-4598-b742-85952f20a217" xlink:to="loc_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember_458b4a8c-2ffb-4429-85d5-45d3312d53b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember_4b42c350-088b-4030-8d29-16b19cfc4a73" xlink:href="cvs-20230525.xsd#cvs_VOYARetirementInsuranceAndAnnuityCompanyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_bac29c10-ee92-4598-b742-85952f20a217" xlink:to="loc_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember_4b42c350-088b-4030-8d29-16b19cfc4a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember_42d8158a-d50e-411e-9815-9984419857e0" xlink:href="cvs-20230525.xsd#cvs_FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_bac29c10-ee92-4598-b742-85952f20a217" xlink:to="loc_cvs_FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember_42d8158a-d50e-411e-9815-9984419857e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AllOtherReinsurersMember_1358fcc5-7ef4-4aba-85da-54fef8324124" xlink:href="cvs-20230525.xsd#cvs_AllOtherReinsurersMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_bac29c10-ee92-4598-b742-85952f20a217" xlink:to="loc_cvs_AllOtherReinsurersMember_1358fcc5-7ef4-4aba-85da-54fef8324124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskLineItems_be306cf6-724e-4451-93fe-9ce3d969c33e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededCreditRiskLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskTable_58230106-f5a6-4129-8f01-73bd268b216b" xlink:to="loc_us-gaap_CededCreditRiskLineItems_be306cf6-724e-4451-93fe-9ce3d969c33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_5a0b4ffc-293c-4d57-932a-89175dd488cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskLineItems_be306cf6-724e-4451-93fe-9ce3d969c33e" xlink:to="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_5a0b4ffc-293c-4d57-932a-89175dd488cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#ReinsuranceEffectsofReinsuranceDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_06f8f2a9-0e58-47d9-bab3-e44886cc01d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_99ae289d-8747-4c4f-8718-4c4bea4c5197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_06f8f2a9-0e58-47d9-bab3-e44886cc01d9" xlink:to="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_99ae289d-8747-4c4f-8718-4c4bea4c5197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectPremiumsEarned_c1cb537b-3507-42b3-988a-5b300390412e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectPremiumsEarned"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_99ae289d-8747-4c4f-8718-4c4bea4c5197" xlink:to="loc_us-gaap_DirectPremiumsEarned_c1cb537b-3507-42b3-988a-5b300390412e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssumedPremiumsEarned_fa08d8b9-78d8-4562-bce4-00c87ed33c73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssumedPremiumsEarned"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_99ae289d-8747-4c4f-8718-4c4bea4c5197" xlink:to="loc_us-gaap_AssumedPremiumsEarned_fa08d8b9-78d8-4562-bce4-00c87ed33c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededPremiumsEarned_f7f5efa8-c9b5-4e4b-91a1-fe784b253f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededPremiumsEarned"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_99ae289d-8747-4c4f-8718-4c4bea4c5197" xlink:to="loc_us-gaap_CededPremiumsEarned_f7f5efa8-c9b5-4e4b-91a1-fe784b253f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_c4a856b2-5be7-4560-914d-c84aa2783997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_99ae289d-8747-4c4f-8718-4c4bea4c5197" xlink:to="loc_us-gaap_PremiumsEarnedNet_c4a856b2-5be7-4560-914d-c84aa2783997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_39a1881d-5e05-4fab-b7e2-492c4ed170bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_06f8f2a9-0e58-47d9-bab3-e44886cc01d9" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_39a1881d-5e05-4fab-b7e2-492c4ed170bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_9be8df37-ded7-45c4-b020-db94d733e6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_39a1881d-5e05-4fab-b7e2-492c4ed170bf" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_9be8df37-ded7-45c4-b020-db94d733e6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_2d0a533e-aba7-4182-b54b-0a5f4b132fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_39a1881d-5e05-4fab-b7e2-492c4ed170bf" xlink:to="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_2d0a533e-aba7-4182-b54b-0a5f4b132fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_e1af0272-0b43-4bdd-8d9a-5f8c913de62b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_39a1881d-5e05-4fab-b7e2-492c4ed170bf" xlink:to="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_e1af0272-0b43-4bdd-8d9a-5f8c913de62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_02cbbaa3-0727-4046-ab0b-c55febb6645a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_39a1881d-5e05-4fab-b7e2-492c4ed170bf" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_02cbbaa3-0727-4046-ab0b-c55febb6645a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1ceee8d2-b052-4cc9-9480-99dfdc240647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_b9ec8f95-10db-4ccf-af9b-ac4e0009fbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1ceee8d2-b052-4cc9-9480-99dfdc240647" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_b9ec8f95-10db-4ccf-af9b-ac4e0009fbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts_8a0d184a-512c-4356-bf4d-02c20c0d0e47" xlink:href="cvs-20230525.xsd#cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1ceee8d2-b052-4cc9-9480-99dfdc240647" xlink:to="loc_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts_8a0d184a-512c-4356-bf4d-02c20c0d0e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_GuarantorObligationsNumberOfLeases_3d1f2d51-dbd0-4804-85bb-c6dbca15478f" xlink:href="cvs-20230525.xsd#cvs_GuarantorObligationsNumberOfLeases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1ceee8d2-b052-4cc9-9480-99dfdc240647" xlink:to="loc_cvs_GuarantorObligationsNumberOfLeases_3d1f2d51-dbd0-4804-85bb-c6dbca15478f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_38c546f5-47cf-4164-9a94-3a3a7e10d09e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1ceee8d2-b052-4cc9-9480-99dfdc240647" xlink:to="loc_us-gaap_LossContingenciesTable_38c546f5-47cf-4164-9a94-3a3a7e10d09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_56aec07d-3791-49ce-824a-69cd061ba389" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_38c546f5-47cf-4164-9a94-3a3a7e10d09e" xlink:to="loc_srt_LitigationCaseAxis_56aec07d-3791-49ce-824a-69cd061ba389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_2c7052d1-60dc-45a6-89f6-9fa42f357a4c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_56aec07d-3791-49ce-824a-69cd061ba389" xlink:to="loc_srt_LitigationCaseTypeDomain_2c7052d1-60dc-45a6-89f6-9fa42f357a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FederalCourtInOhioJudgmentMember_591290b7-9c92-4507-a463-15cc2a8924e5" xlink:href="cvs-20230525.xsd#cvs_FederalCourtInOhioJudgmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_2c7052d1-60dc-45a6-89f6-9fa42f357a4c" xlink:to="loc_cvs_FederalCourtInOhioJudgmentMember_591290b7-9c92-4507-a463-15cc2a8924e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StateOfFloridaSettlementMember_5b858a85-49cf-4378-be58-91c460da929f" xlink:href="cvs-20230525.xsd#cvs_StateOfFloridaSettlementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_2c7052d1-60dc-45a6-89f6-9fa42f357a4c" xlink:to="loc_cvs_StateOfFloridaSettlementMember_5b858a85-49cf-4378-be58-91c460da929f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SettlementFrameworkMember_6d8aff9e-1698-471a-872a-8bf32e334317" xlink:href="cvs-20230525.xsd#cvs_SettlementFrameworkMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_2c7052d1-60dc-45a6-89f6-9fa42f357a4c" xlink:to="loc_cvs_SettlementFrameworkMember_6d8aff9e-1698-471a-872a-8bf32e334317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember_da53467d-97c1-44b3-9929-5cb89883792c" xlink:href="cvs-20230525.xsd#cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_2c7052d1-60dc-45a6-89f6-9fa42f357a4c" xlink:to="loc_cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember_da53467d-97c1-44b3-9929-5cb89883792c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RadcliffAndFlaimVAetnaIncEtAlMember_b53fd551-51c1-43bd-9a94-3aa7bb08b5b2" xlink:href="cvs-20230525.xsd#cvs_RadcliffAndFlaimVAetnaIncEtAlMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_2c7052d1-60dc-45a6-89f6-9fa42f357a4c" xlink:to="loc_cvs_RadcliffAndFlaimVAetnaIncEtAlMember_b53fd551-51c1-43bd-9a94-3aa7bb08b5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_9b10373a-b854-4d5a-8339-8d96fe47a609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_38c546f5-47cf-4164-9a94-3a3a7e10d09e" xlink:to="loc_us-gaap_LitigationStatusAxis_9b10373a-b854-4d5a-8339-8d96fe47a609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_f28aac7d-fc06-4537-b1e6-f94d101a3d39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_9b10373a-b854-4d5a-8339-8d96fe47a609" xlink:to="loc_us-gaap_LitigationStatusDomain_f28aac7d-fc06-4537-b1e6-f94d101a3d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_f524ebda-fd4d-40b1-b51b-c9f338b9d621" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_f28aac7d-fc06-4537-b1e6-f94d101a3d39" xlink:to="loc_us-gaap_PendingLitigationMember_f524ebda-fd4d-40b1-b51b-c9f338b9d621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_876c44cc-0ffe-468b-930f-3795f7a5b19c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_38c546f5-47cf-4164-9a94-3a3a7e10d09e" xlink:to="loc_srt_CounterpartyNameAxis_876c44cc-0ffe-468b-930f-3795f7a5b19c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_67f861aa-6782-4353-84da-12eb3c9aacbf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_876c44cc-0ffe-468b-930f-3795f7a5b19c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_67f861aa-6782-4353-84da-12eb3c9aacbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TribalEntitiesMember_69a7d40d-5b57-4fd8-bb7a-a9a706780c53" xlink:href="cvs-20230525.xsd#cvs_TribalEntitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_67f861aa-6782-4353-84da-12eb3c9aacbf" xlink:to="loc_cvs_TribalEntitiesMember_69a7d40d-5b57-4fd8-bb7a-a9a706780c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_90cd1a54-8137-4cc2-b71e-d4c779029b66" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_38c546f5-47cf-4164-9a94-3a3a7e10d09e" xlink:to="loc_srt_RangeAxis_90cd1a54-8137-4cc2-b71e-d4c779029b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0191697b-a591-49df-9f3a-f7973aad3878" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_90cd1a54-8137-4cc2-b71e-d4c779029b66" xlink:to="loc_srt_RangeMember_0191697b-a591-49df-9f3a-f7973aad3878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6daf596f-0e15-45f1-9570-77474b998563" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0191697b-a591-49df-9f3a-f7973aad3878" xlink:to="loc_srt_MaximumMember_6daf596f-0e15-45f1-9570-77474b998563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_9fdc6d65-cefd-47db-be80-243789784e76" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_38c546f5-47cf-4164-9a94-3a3a7e10d09e" xlink:to="loc_srt_StatementScenarioAxis_9fdc6d65-cefd-47db-be80-243789784e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9c1751df-9be8-4db2-901d-f895d74d915e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_9fdc6d65-cefd-47db-be80-243789784e76" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9c1751df-9be8-4db2-901d-f895d74d915e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_302ee1c5-a5bd-4361-8201-b6616fce54f9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_9c1751df-9be8-4db2-901d-f895d74d915e" xlink:to="loc_srt_ScenarioForecastMember_302ee1c5-a5bd-4361-8201-b6616fce54f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_38c546f5-47cf-4164-9a94-3a3a7e10d09e" xlink:to="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_1ed4c74f-5d14-4a46-9287-2ec22728952c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_1ed4c74f-5d14-4a46-9287-2ec22728952c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LegalSettlementPeriodOfPayment_0b4a49e6-d1e0-4c66-9ccf-0ec840ce21c7" xlink:href="cvs-20230525.xsd#cvs_LegalSettlementPeriodOfPayment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:to="loc_cvs_LegalSettlementPeriodOfPayment_0b4a49e6-d1e0-4c66-9ccf-0ec840ce21c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_a2654def-3b1f-4a38-b979-c060e78d7617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_a2654def-3b1f-4a38-b979-c060e78d7617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_77861eb9-d0a2-4551-8036-df0c9d0358e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_77861eb9-d0a2-4551-8036-df0c9d0358e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_8cf62b9b-8998-4cfb-b6bc-230fdfe50b40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalFees"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:to="loc_us-gaap_LegalFees_8cf62b9b-8998-4cfb-b6bc-230fdfe50b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LitigationSettlementNumberOfStatesElectedToJoin_84156c3b-6a65-4337-9ddf-413f3cce824c" xlink:href="cvs-20230525.xsd#cvs_LitigationSettlementNumberOfStatesElectedToJoin"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:to="loc_cvs_LitigationSettlementNumberOfStatesElectedToJoin_84156c3b-6a65-4337-9ddf-413f3cce824c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LitigationSettlementNumberOfStatesSubjectToEarlierSettlements_69f76168-f938-47f0-9d1f-ad7a59a4cf02" xlink:href="cvs-20230525.xsd#cvs_LitigationSettlementNumberOfStatesSubjectToEarlierSettlements"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:to="loc_cvs_LitigationSettlementNumberOfStatesSubjectToEarlierSettlements_69f76168-f938-47f0-9d1f-ad7a59a4cf02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_df14425c-583e-4f50-8b10-b7d3b3ec9142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_df14425c-583e-4f50-8b10-b7d3b3ec9142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_96b66611-d023-4729-bc4d-6769a1bb94ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_96b66611-d023-4729-bc4d-6769a1bb94ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_a80fdf34-1206-405e-9b6c-33639e018648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e5586708-9f1b-487f-9afc-207d1b3cb133" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_a80fdf34-1206-405e-9b6c-33639e018648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_fa2d3916-411b-4687-a2c4-62fb073d1b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_9437e761-72a2-4dcc-b186-f0398a4c37c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fa2d3916-411b-4687-a2c4-62fb073d1b1d" xlink:to="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_9437e761-72a2-4dcc-b186-f0398a4c37c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_0cf1aaaa-56b9-4abe-88fb-bb75ec719db2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_9437e761-72a2-4dcc-b186-f0398a4c37c2" xlink:to="loc_srt_RestatementAxis_0cf1aaaa-56b9-4abe-88fb-bb75ec719db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_e6bdb87f-d419-42b5-b0a8-972c02490e4a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_0cf1aaaa-56b9-4abe-88fb-bb75ec719db2" xlink:to="loc_srt_RestatementDomain_e6bdb87f-d419-42b5-b0a8-972c02490e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_201c0600-7229-4a26-868e-28d4e7a45698" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_e6bdb87f-d419-42b5-b0a8-972c02490e4a" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_201c0600-7229-4a26-868e-28d4e7a45698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_68c1b4ab-8bf0-4065-b571-114c214e15e2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_e6bdb87f-d419-42b5-b0a8-972c02490e4a" xlink:to="loc_srt_RestatementAdjustmentMember_68c1b4ab-8bf0-4065-b571-114c214e15e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bb867823-c668-4540-bf6d-ccea61f3c939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_9437e761-72a2-4dcc-b186-f0398a4c37c2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bb867823-c668-4540-bf6d-ccea61f3c939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ea0c6cf0-9330-4d79-9e3b-e48c841a4aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bb867823-c668-4540-bf6d-ccea61f3c939" xlink:to="loc_us-gaap_SegmentDomain_ea0c6cf0-9330-4d79-9e3b-e48c841a4aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_bee5cbfd-4f4f-461a-94aa-6170169bade3" xlink:href="cvs-20230525.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ea0c6cf0-9330-4d79-9e3b-e48c841a4aa9" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_bee5cbfd-4f4f-461a-94aa-6170169bade3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthServicesSegmentMember_d43453fc-3a55-46b5-bf44-9db68b3df4d9" xlink:href="cvs-20230525.xsd#cvs_HealthServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ea0c6cf0-9330-4d79-9e3b-e48c841a4aa9" xlink:to="loc_cvs_HealthServicesSegmentMember_d43453fc-3a55-46b5-bf44-9db68b3df4d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_a292e2b8-5e8c-43d8-837b-02587c85126f" xlink:href="cvs-20230525.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ea0c6cf0-9330-4d79-9e3b-e48c841a4aa9" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_a292e2b8-5e8c-43d8-837b-02587c85126f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5f5608b8-ce62-4d55-a82d-494487bc0dba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_9437e761-72a2-4dcc-b186-f0398a4c37c2" xlink:to="loc_srt_ConsolidationItemsAxis_5f5608b8-ce62-4d55-a82d-494487bc0dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d3015d8e-08da-469a-86e3-deb36f63ee28" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_5f5608b8-ce62-4d55-a82d-494487bc0dba" xlink:to="loc_srt_ConsolidationItemsDomain_d3015d8e-08da-469a-86e3-deb36f63ee28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_5300630f-0b70-4168-a992-01ac4ccd007c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d3015d8e-08da-469a-86e3-deb36f63ee28" xlink:to="loc_us-gaap_OperatingSegmentsMember_5300630f-0b70-4168-a992-01ac4ccd007c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_b999e716-c790-45d1-bc3a-1784d67189fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d3015d8e-08da-469a-86e3-deb36f63ee28" xlink:to="loc_us-gaap_CorporateNonSegmentMember_b999e716-c790-45d1-bc3a-1784d67189fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_f93db431-4f8b-4e0c-b09e-fd63d9403a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d3015d8e-08da-469a-86e3-deb36f63ee28" xlink:to="loc_us-gaap_IntersegmentEliminationMember_f93db431-4f8b-4e0c-b09e-fd63d9403a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_ab2a9141-7ec6-480d-a8a2-ed662a5e5d73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable_9437e761-72a2-4dcc-b186-f0398a4c37c2" xlink:to="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_ab2a9141-7ec6-480d-a8a2-ed662a5e5d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fb382c48-b7d6-47e3-9432-a8e7cc85c58d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_ab2a9141-7ec6-480d-a8a2-ed662a5e5d73" xlink:to="loc_us-gaap_Revenues_fb382c48-b7d6-47e3-9432-a8e7cc85c58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_b3a49d35-385a-4e41-93aa-a15a19fba85d" xlink:href="cvs-20230525.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems_ab2a9141-7ec6-480d-a8a2-ed662a5e5d73" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_b3a49d35-385a-4e41-93aa-a15a19fba85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SegmentReportingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_cf1d2aa8-d507-48a3-8cd9-4f13f85e3a57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_9e3890c1-8d99-44b2-8389-bc57dbc7704c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cf1d2aa8-d507-48a3-8cd9-4f13f85e3a57" xlink:to="loc_us-gaap_NumberOfOperatingSegments_9e3890c1-8d99-44b2-8389-bc57dbc7704c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_47ac3c90-790c-47c4-be50-aaa6f8195c34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cf1d2aa8-d507-48a3-8cd9-4f13f85e3a57" xlink:to="loc_us-gaap_ConcentrationRiskTable_47ac3c90-790c-47c4-be50-aaa6f8195c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_333fc9ed-b46e-4e0e-a338-c2a84a6453a0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_47ac3c90-790c-47c4-be50-aaa6f8195c34" xlink:to="loc_srt_MajorCustomersAxis_333fc9ed-b46e-4e0e-a338-c2a84a6453a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_b6cdc649-3f28-40de-8417-7b5ed2264245" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_333fc9ed-b46e-4e0e-a338-c2a84a6453a0" xlink:to="loc_srt_NameOfMajorCustomerDomain_b6cdc649-3f28-40de-8417-7b5ed2264245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USFederalGovernmentMember_5a707596-f1e1-45a1-8df6-04b54c4523cc" xlink:href="cvs-20230525.xsd#cvs_USFederalGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_b6cdc649-3f28-40de-8417-7b5ed2264245" xlink:to="loc_cvs_USFederalGovernmentMember_5a707596-f1e1-45a1-8df6-04b54c4523cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_2cff30a6-1581-430a-b373-b37a02fb5f84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_47ac3c90-790c-47c4-be50-aaa6f8195c34" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_2cff30a6-1581-430a-b373-b37a02fb5f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_2ab0d8f8-0283-431e-a33b-219884e4620b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_2cff30a6-1581-430a-b373-b37a02fb5f84" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_2ab0d8f8-0283-431e-a33b-219884e4620b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_dbcfd238-d864-4caa-b58c-30b38d184997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_2ab0d8f8-0283-431e-a33b-219884e4620b" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_dbcfd238-d864-4caa-b58c-30b38d184997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_83705841-d47f-4085-94aa-434740104682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_47ac3c90-790c-47c4-be50-aaa6f8195c34" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_83705841-d47f-4085-94aa-434740104682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_eb7c348f-32e8-432a-bd99-60f7d7c159c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_83705841-d47f-4085-94aa-434740104682" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_eb7c348f-32e8-432a-bd99-60f7d7c159c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_759e5808-6f94-4818-85fd-96eec63073df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_eb7c348f-32e8-432a-bd99-60f7d7c159c7" xlink:to="loc_us-gaap_SalesRevenueNetMember_759e5808-6f94-4818-85fd-96eec63073df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_f22a049b-9ca0-4c22-9ae0-e5d68088916a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_47ac3c90-790c-47c4-be50-aaa6f8195c34" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_f22a049b-9ca0-4c22-9ae0-e5d68088916a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_e44facb8-fdae-4216-99a8-2e11761aec1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_f22a049b-9ca0-4c22-9ae0-e5d68088916a" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_e44facb8-fdae-4216-99a8-2e11761aec1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ab8ad558-6659-49b3-bc40-f60767be388f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b0e0a511-2e62-41e8-aeb6-f769e71877ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ab8ad558-6659-49b3-bc40-f60767be388f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b0e0a511-2e62-41e8-aeb6-f769e71877ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b0007f08-2328-45b5-ab40-1522b8cbe664" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b0e0a511-2e62-41e8-aeb6-f769e71877ff" xlink:to="loc_srt_ConsolidationItemsAxis_b0007f08-2328-45b5-ab40-1522b8cbe664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_adda3a84-8a90-40c5-830e-d9ebef5578b4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_b0007f08-2328-45b5-ab40-1522b8cbe664" xlink:to="loc_srt_ConsolidationItemsDomain_adda3a84-8a90-40c5-830e-d9ebef5578b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_0fc0a064-2f3d-4792-ba18-3be9e7a65ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_adda3a84-8a90-40c5-830e-d9ebef5578b4" xlink:to="loc_us-gaap_OperatingSegmentsMember_0fc0a064-2f3d-4792-ba18-3be9e7a65ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_e58d3cf7-fe83-47aa-a468-b8408de5cad6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_adda3a84-8a90-40c5-830e-d9ebef5578b4" xlink:to="loc_us-gaap_IntersegmentEliminationMember_e58d3cf7-fe83-47aa-a468-b8408de5cad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_7b167b8e-305f-44eb-9b51-388bd16301dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_adda3a84-8a90-40c5-830e-d9ebef5578b4" xlink:to="loc_us-gaap_CorporateNonSegmentMember_7b167b8e-305f-44eb-9b51-388bd16301dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_52f4093b-2e8b-46d1-9734-e5d260ddb2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b0e0a511-2e62-41e8-aeb6-f769e71877ff" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_52f4093b-2e8b-46d1-9734-e5d260ddb2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5c613b16-b3fd-4c05-9306-27d5615a119f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_52f4093b-2e8b-46d1-9734-e5d260ddb2d9" xlink:to="loc_us-gaap_SegmentDomain_5c613b16-b3fd-4c05-9306-27d5615a119f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_27c9f097-fdfc-4a96-80ff-30675ff8d430" xlink:href="cvs-20230525.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5c613b16-b3fd-4c05-9306-27d5615a119f" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_27c9f097-fdfc-4a96-80ff-30675ff8d430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthServicesSegmentMember_9a03330f-c866-4e76-886f-78538f4b5a0a" xlink:href="cvs-20230525.xsd#cvs_HealthServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5c613b16-b3fd-4c05-9306-27d5615a119f" xlink:to="loc_cvs_HealthServicesSegmentMember_9a03330f-c866-4e76-886f-78538f4b5a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyAndConsumerHealthSegmentMember_549fa2f3-a998-4dbe-8615-6107983b24c7" xlink:href="cvs-20230525.xsd#cvs_PharmacyAndConsumerHealthSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5c613b16-b3fd-4c05-9306-27d5615a119f" xlink:to="loc_cvs_PharmacyAndConsumerHealthSegmentMember_549fa2f3-a998-4dbe-8615-6107983b24c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_9ded2c28-74e0-4486-b6f5-afa59cde3249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b0e0a511-2e62-41e8-aeb6-f769e71877ff" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_9ded2c28-74e0-4486-b6f5-afa59cde3249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_2401bd02-db9f-4248-b100-50f0cf3f011f" xlink:href="cvs-20230525.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9ded2c28-74e0-4486-b6f5-afa59cde3249" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_2401bd02-db9f-4248-b100-50f0cf3f011f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_83753c13-1b29-4d0e-be31-76a6eb9a995d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9ded2c28-74e0-4486-b6f5-afa59cde3249" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_83753c13-1b29-4d0e-be31-76a6eb9a995d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_eb13ca64-547d-40bb-aba8-3a34cd3697e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9ded2c28-74e0-4486-b6f5-afa59cde3249" xlink:to="loc_us-gaap_NetInvestmentIncome_eb13ca64-547d-40bb-aba8-3a34cd3697e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_d53460cf-471a-4a43-8ed7-ccbc5f50ff61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9ded2c28-74e0-4486-b6f5-afa59cde3249" xlink:to="loc_us-gaap_Revenues_d53460cf-471a-4a43-8ed7-ccbc5f50ff61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_2aadfb86-567f-47a2-9c89-27b7a84efeb1" xlink:href="cvs-20230525.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9ded2c28-74e0-4486-b6f5-afa59cde3249" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_2aadfb86-567f-47a2-9c89-27b7a84efeb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_d323b9cc-70b7-4bf9-b4ac-f32669c0fd87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9ded2c28-74e0-4486-b6f5-afa59cde3249" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_d323b9cc-70b7-4bf9-b4ac-f32669c0fd87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments_3d7485d7-d861-411d-9a8f-00892041ada4" xlink:href="cvs-20230525.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9ded2c28-74e0-4486-b6f5-afa59cde3249" xlink:to="loc_cvs_NetRevenuesRetailCoPayments_3d7485d7-d861-411d-9a8f-00892041ada4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="simple" xlink:href="cvs-20230525.xsd#SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_dd0790f4-6d72-4338-9d84-f99ef7c52205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_44ae7478-32a3-4837-8c40-0870d3cf90d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_dd0790f4-6d72-4338-9d84-f99ef7c52205" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_44ae7478-32a3-4837-8c40-0870d3cf90d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_9a7cfaa1-409d-469d-a198-547d01fd8db0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_44ae7478-32a3-4837-8c40-0870d3cf90d2" xlink:to="loc_srt_LitigationCaseAxis_9a7cfaa1-409d-469d-a198-547d01fd8db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8368f43f-01c8-440d-b541-71f1964fc5b1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_9a7cfaa1-409d-469d-a198-547d01fd8db0" xlink:to="loc_srt_LitigationCaseTypeDomain_8368f43f-01c8-440d-b541-71f1964fc5b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_de700fd6-5269-49cb-bc3f-89e2630545ef" xlink:href="cvs-20230525.xsd#cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_8368f43f-01c8-440d-b541-71f1964fc5b1" xlink:to="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_de700fd6-5269-49cb-bc3f-89e2630545ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_37b9c7bb-1b8a-4bb8-99fb-07a2366f317c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_44ae7478-32a3-4837-8c40-0870d3cf90d2" xlink:to="loc_us-gaap_LitigationStatusAxis_37b9c7bb-1b8a-4bb8-99fb-07a2366f317c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_c3c2e980-a0e8-43a5-9b9d-ac9bebb751af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_37b9c7bb-1b8a-4bb8-99fb-07a2366f317c" xlink:to="loc_us-gaap_LitigationStatusDomain_c3c2e980-a0e8-43a5-9b9d-ac9bebb751af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_af2b6c55-bad9-47c1-a365-e9692eeb4ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_c3c2e980-a0e8-43a5-9b9d-ac9bebb751af" xlink:to="loc_us-gaap_SettledLitigationMember_af2b6c55-bad9-47c1-a365-e9692eeb4ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_44ae7478-32a3-4837-8c40-0870d3cf90d2" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e6c04529-201d-48b0-9844-a144aada9ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_us-gaap_OperatingIncomeLoss_e6c04529-201d-48b0-9844-a144aada9ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a4b4f4a5-1592-4b4d-a03e-14e1a0338d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a4b4f4a5-1592-4b4d-a03e-14e1a0338d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_cd1949c1-968a-468d-9fe9-fced685bacda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_cd1949c1-968a-468d-9fe9-fced685bacda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OfficeRealEstateOptimizationCharges_c06c445c-e8fa-46ed-a83a-5dddd8332adc" xlink:href="cvs-20230525.xsd#cvs_OfficeRealEstateOptimizationCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_cvs_OfficeRealEstateOptimizationCharges_c06c445c-e8fa-46ed-a83a-5dddd8332adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_f8dc6d86-3b3e-444e-98bd-3544a447c9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_f8dc6d86-3b3e-444e-98bd-3544a447c9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_aa5a415f-f281-41fc-9340-00e81de9a981" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_aa5a415f-f281-41fc-9340-00e81de9a981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_5d4f3fce-123c-4a74-8298-8fb82b9cbc90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_5d4f3fce-123c-4a74-8298-8fb82b9cbc90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_185f4217-677a-412f-bcd8-fedb33b71a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_185f4217-677a-412f-bcd8-fedb33b71a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges_9c3b434e-a59d-4019-a3a3-4fbee87ac3b8" xlink:href="cvs-20230525.xsd#cvs_StoreImpairmentCharges"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_cvs_StoreImpairmentCharges_9c3b434e-a59d-4019-a3a3-4fbee87ac3b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_62b303d9-7c90-4ebf-b01b-f3e8536f9efb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_62b303d9-7c90-4ebf-b01b-f3e8536f9efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_077113a8-2090-4705-8339-5f5a9097bbf9" xlink:href="cvs-20230525.xsd#cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_077113a8-2090-4705-8339-5f5a9097bbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_38c9b845-a451-4abd-a285-74f32277b72b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_38c9b845-a451-4abd-a285-74f32277b72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_6ac1d9dc-9cbd-49ec-bb19-705ed225ee90" xlink:href="cvs-20230525.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_6ac1d9dc-9cbd-49ec-bb19-705ed225ee90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresPlannedClosure_b2dfcb4b-88c8-465e-ab16-ce4ec7f27c57" xlink:href="cvs-20230525.xsd#cvs_NumberOfStoresPlannedClosure"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_cvs_NumberOfStoresPlannedClosure_b2dfcb4b-88c8-465e-ab16-ce4ec7f27c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyUnrecordedAmount_8ddac9ad-f8de-42c3-9f92-b4002edf881a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainContingencyUnrecordedAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_us-gaap_GainContingencyUnrecordedAmount_8ddac9ad-f8de-42c3-9f92-b4002edf881a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_7b044adf-40b2-444e-8f11-4409b53f17e0" xlink:href="cvs-20230525.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_609a8ca6-2f8f-4477-a57a-fd3ec1d62f0c" xlink:to="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_7b044adf-40b2-444e-8f11-4409b53f17e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>cvs-20230525_g1.jpg
<DESCRIPTION>CVS HEALTH LOGO
<TEXT>
begin 644 cvs-20230525_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  < )T# 2(  A$! Q$!_\0
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M>(O@BW@63PU_PLX3?\([?_V@?#O]N&P_L[S/M.S[=Y()\[9Y>[G;CY3\[?\
M! #X'?M5>,O^"27PGU+X;?'KX=^"_!=U_;!T[1M2^'?]K7=IMUJ^67?<_:X_
M,WS"1Q\@VJRKR5R?0/V=/#OQ/^$G_!QY=?\ "Y_'WA_XAZ];_LT3WB:GHWAP
MZ)#!8CQ*-L+0>;,7=765MX9<AU&!LRWUA_+9^KB_+[#WIQ;!QW]/\_6OY[?V
M;OVJ_P!C_P#X*)>#M0^+7[;WC_XA>+OB%XMUB[O-*\%V]AXMC\/_  ZL(KAX
MK6TL3I4*PRN8T21YMS,Q9=P$JRM)W'P;_P""O^L?L<_LH_MF:9\-/''B_P"+
M?@#X3:7H^J?"3Q+XKT^^35-+75;B'3I+.X:_BC>>.QNKB)H5=#N2-QN*LJ1@
M'[M#FOFC_@KA\;/BE^S3^PSXP^)'PEU#P78ZY\/[6;Q!J,?B739[ZWO["WMI
MWD@B6*6,I,T@A*NQ*@*P(R01\_?#+_@W<\ Q?"VQ\0^*O'7Q7OOVEKG3UFO?
MBS!XWU)=8L=3*J7:WC$PMS;(X*)%)$^8OE+$_/7QW^QC\-]8_P"'!O[<?C;Q
MWK&L>(?BE?3^+O#WB'4)]6N)K23[%&6VP6[-Y$($TTQ!CB0E6"] H !^G&E_
M\%(M%^&?[.G[+_B+XA66I2>(OVC9/#^AVG]A60-I;:MJ5BEQEP\H:.WW[P#F
M1E!'!P2.+_:0_:[^,7P$_P""P'[//PK:\\!WOPB^.XUY([<:3.-<TY])TE;E
M]]QYWE,LD\J%0L0VJI!R3D_#7[>W['O@KXH?!'_@F;XDU9/$+:EXRUKP#X,U
M/[+KU[:0OI[::93Y4<4JK!/N8_OX@LV, .!7JO\ P5C_ &0+37O^"A'_  3E
M^#?A7Q1XN\#Z+%#XVTI-5TW5IVUB'3H=*T]KF);N1FF$D]LDT!E+%AYQ;)(Y
M /UF3CKG/H?6G9S7Y/?M7?L8>#?^"*WQ_P#V;?B-^SRWB7P38?$KXN:/\./&
M_AF7Q#J.K:5XGL]4$X:YE2[GD(NH!"3$ZL "YSD##?J_'N ^:@".6 RQ[3T/
M%?E7^W5_P;TW'Q._:+TO7OA+?:-X9\+>++PCQ)I\X*Q>'R07>ZM(E&'1\$?9
MP5"RLFUEC8F']6J*Y<5@Z6(AR55='U'"O&.;<.XF6*RJKR2DFGU33[IZ.VZ[
M,\S_ &5?V5/!_P"QW\'M/\%>"=-^PZ79?O)I9<-<W\YQON)W &^5\#)X  55
M"JJJ/&O^"JO_  3,L?\ @H?\+-/6QOH-#\=>%7EFT34)T9K9Q(%\RVG"_-Y3
ME(SN +(R*P##<C?6-%54PM*=+V#7NVM8X\OXDS+!YFLXH57[=/FYF[MM[WOO
M?5.^]S\'S_P2 _;*T?PY-\.K>XNF\$7$VZ6SA\9[="F)?>7-N6!.7^<Y@!+9
M."V,_HU_P2:_X)<_\.]_A[KTWB#5+'7O'/BXQ#4KFS5_LEG#$'\N"$N S -(
M[,Y5"^X?* B@?8U%<.%R>A0J>TC=OI?6WH?:<3>+F>9W@I9?75.G3G+FG[."
MBYM6UD^NJ1^'WQA_X-V?C%?_ !L\2+X3D\%6O@N\UF=](DFU%Q+:6,DK-$K1
M^426BC8*?F.2@K]#/^"@'_!+G1?VNOV.M!^&^@SVOAV^\!I;OX6EECWV]N88
M#"+>7 W")XSM+*"58(^U]FQOK6BJHY1AJ2FH+26YSYQXK<0YE4PE;$5%S87X
M&EUTUE_,[*VO2_<_"FP_X)/?MJ> _!&H?#/2;B=/ NH2.MS9V'BV./2+D.<R
M'RV>.54DR2R>6 V3N!).?L_]@G_@FU\3/^":G[,GCW7/#%KX/\>_'#Q6UDL6
MEWFHRV.AP013[3%]J\HREA%+-(7\L!F2) N$WO\ H/12PN3T*%158MMK:[V-
MN)?%K.\ZP,\NKJG3IS:E/V<%%S:U]Y]=5<^'_P#@@O\ LL?&S]AC]BG3?@U\
M7/#_ (,TVS\"F7^PM2T/6I-0FU7[7?WMY<>?&T*+"8S-"B%6?<"Q.TC!X:;]
MFK]J:7_@MK'\?O\ A7_PJ_X5^GA;_A5A4^+)FO/[!.NF].J"+[-C[7Y!/^C$
M^7GCS.<U^C-%>J?F)^;W[.7[._[5'_!(K0]8^%OPE^''@G]H3X%_VQ=7_@F&
MZ\9CPOKW@ZVNIFGELKIIX)HKJ&.61RDB_O&)=FP&2*/TV/\ 8.^+G[;O[&GQ
MD\#_ +57C'P_<W'QAC6/3?#GA6R1M(^'<4.)+3[/.T<=S>7"SI#/*T[&,O"$
MC"IN+_:E% 'YY_#36?\ @H=\//A)9_".Z\ _!G7?$6EV4>E6GQEG\82_V>\*
M(B)=7&D-;FYFO-@+/ATB>7MLR&\Z_82_X))_'+X/?\$S?VCOV8?&UQX5:U\>
M)K<OA;QBNK27$^JW-_&T0>^M_*)@'[J%V*R2G]ZX&64,?U1HH _+KXA_L)?M
M/?%[]@O]F^QO/"/PYT?XK?LL^.]"U;3=&/B>2?3/%VFZ38);K)]H$.;>>:4L
M1&P941"2S$A:V?VLO@#^UY\=?VX?V9_C-H_PJ^$]O_PH^PU6YGTF[\=SK]KO
M-9TR"VN[=I%LSM6UD1]LBA_-Z[5'%?I910!\'_\ !:3]EWX]?M9:K\$[/X2^
M$_ NL:3\,?B!I/Q)N;G7/$<NFRW%WISS[+$1K!(/+D64$R[\J5QL/!'VO\.[
MS7-1\!Z+<>)=/L=)\17%A;R:I965V;NUM+MHU,T<4K(C2(LA95<HI8*&VJ20
&-FB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224244469088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>May 25, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 25,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CVS HEALTH CORP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000064803<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-01011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">05-0494040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One CVS Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Woonsocket<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">RI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-1500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CVS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224244056304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">$ 85,330<span></span>
</td>
<td class="nump">$ 76,132<span></span>
</td>
<td class="nump">$ 69,364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">838<span></span>
</td>
<td class="nump">1,199<span></span>
</td>
<td class="nump">798<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">322,467<span></span>
</td>
<td class="nump">292,111<span></span>
</td>
<td class="nump">268,706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">196,892<span></span>
</td>
<td class="nump">175,803<span></span>
</td>
<td class="nump">163,981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefit costs</a></td>
<td class="nump">71,073<span></span>
</td>
<td class="nump">64,188<span></span>
</td>
<td class="nump">55,679<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Opioid litigation charges</a></td>
<td class="nump">5,803<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Loss on assets held for sale</a></td>
<td class="nump">2,533<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_StoreImpairmentCharges', window );">Store impairments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,358<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">431<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement', window );">Operating expenses</a></td>
<td class="nump">38,212<span></span>
</td>
<td class="nump">37,021<span></span>
</td>
<td class="nump">35,135<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs</a></td>
<td class="nump">314,513<span></span>
</td>
<td class="nump">278,801<span></span>
</td>
<td class="nump">254,795<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">7,954<span></span>
</td>
<td class="nump">13,310<span></span>
</td>
<td class="nump">13,911<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">2,287<span></span>
</td>
<td class="nump">2,503<span></span>
</td>
<td class="nump">2,907<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">452<span></span>
</td>
<td class="nump">1,440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="num">(169)<span></span>
</td>
<td class="num">(182)<span></span>
</td>
<td class="num">(206)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income tax provision</a></td>
<td class="nump">5,836<span></span>
</td>
<td class="nump">10,537<span></span>
</td>
<td class="nump">9,770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">1,509<span></span>
</td>
<td class="nump">2,548<span></span>
</td>
<td class="nump">2,569<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income from continuing operations</a></td>
<td class="nump">4,327<span></span>
</td>
<td class="nump">7,989<span></span>
</td>
<td class="nump">7,201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">4,327<span></span>
</td>
<td class="nump">7,989<span></span>
</td>
<td class="nump">7,192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net (income) loss attributable to noncontrolling interests</a></td>
<td class="num">(16)<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to CVS Health</a></td>
<td class="nump">$ 4,311<span></span>
</td>
<td class="nump">$ 8,001<span></span>
</td>
<td class="nump">$ 7,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Income from continuing operations attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">$ 3.29<span></span>
</td>
<td class="nump">$ 6.07<span></span>
</td>
<td class="nump">$ 5.49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare', window );">Loss from discontinued operations attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">$ 3.29<span></span>
</td>
<td class="nump">$ 6.07<span></span>
</td>
<td class="nump">$ 5.48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average basic shares outstanding (in shares)</a></td>
<td class="nump">1,312<span></span>
</td>
<td class="nump">1,319<span></span>
</td>
<td class="nump">1,309<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Income from continuing operations attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">$ 3.26<span></span>
</td>
<td class="nump">$ 6.02<span></span>
</td>
<td class="nump">$ 5.47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare', window );">Loss from discontinued operations attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">$ 3.26<span></span>
</td>
<td class="nump">$ 6.02<span></span>
</td>
<td class="nump">$ 5.46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average diluted shares outstanding (in shares)</a></td>
<td class="nump">1,323<span></span>
</td>
<td class="nump">1,329<span></span>
</td>
<td class="nump">1,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 2.20<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList', window );">Cost, Product and Service [Extensible List]</a></td>
<td class="text">Products<span></span>
</td>
<td class="text">Products<span></span>
</td>
<td class="text">Products<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 226,616<span></span>
</td>
<td class="nump">$ 203,738<span></span>
</td>
<td class="nump">$ 190,688<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 9,683<span></span>
</td>
<td class="nump">$ 11,042<span></span>
</td>
<td class="nump">$ 7,856<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Expenses, Excluding Store Impairments, Goodwill Impairments, Loss On Assets Held For Sale, And Loss On Litigation Settlement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_StoreImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Store Impairment Charges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_StoreImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates type of cost from product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920602&amp;loc=SL49130690-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfCostGoodOrServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224245359648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 4,327<span></span>
</td>
<td class="nump">$ 7,989<span></span>
</td>
<td class="nump">$ 7,192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Net unrealized investment gains (losses)</a></td>
<td class="num">(2,317)<span></span>
</td>
<td class="num">(556)<span></span>
</td>
<td class="nump">440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax', window );">Change in discount rate on insurance reserves</a></td>
<td class="nump">870<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net cash flow hedges</a></td>
<td class="nump">17<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and other postretirement benefits</a></td>
<td class="num">(168)<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(1,598)<span></span>
</td>
<td class="num">(314)<span></span>
</td>
<td class="nump">395<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">2,729<span></span>
</td>
<td class="nump">7,675<span></span>
</td>
<td class="nump">7,587<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Comprehensive (income) loss attributable to noncontrolling interests</a></td>
<td class="num">(16)<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to CVS Health</a></td>
<td class="nump">$ 2,713<span></span>
</td>
<td class="nump">$ 7,687<span></span>
</td>
<td class="nump">$ 7,574<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of unrealized gain (loss) from (increase) decrease in liability for future policy benefit from change in discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (m)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224243067760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 12,945<span></span>
</td>
<td class="nump">$ 9,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments</a></td>
<td class="nump">2,778<span></span>
</td>
<td class="nump">3,117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">27,276<span></span>
</td>
<td class="nump">24,431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">19,090<span></span>
</td>
<td class="nump">17,760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">908<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">2,636<span></span>
</td>
<td class="nump">5,319<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">65,633<span></span>
</td>
<td class="nump">60,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">21,096<span></span>
</td>
<td class="nump">23,025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">12,873<span></span>
</td>
<td class="nump">12,896<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">17,872<span></span>
</td>
<td class="nump">19,122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">78,150<span></span>
</td>
<td class="nump">79,121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">24,803<span></span>
</td>
<td class="nump">29,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">3,228<span></span>
</td>
<td class="nump">5,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">4,620<span></span>
</td>
<td class="nump">4,714<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">228,275<span></span>
</td>
<td class="nump">233,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable</a></td>
<td class="nump">14,838<span></span>
</td>
<td class="nump">12,544<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PharmacyClaimsAndDiscountsPayableCurrent', window );">Pharmacy claims and discounts payable</a></td>
<td class="nump">19,423<span></span>
</td>
<td class="nump">17,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable</a></td>
<td class="nump">10,142<span></span>
</td>
<td class="nump">8,678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPolicyholderFunds', window );">Policyholders&#8217; funds</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">4,301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">18,745<span></span>
</td>
<td class="nump">17,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesCurrent', window );">Other insurance liabilities</a></td>
<td class="nump">1,089<span></span>
</td>
<td class="nump">1,345<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">1,678<span></span>
</td>
<td class="nump">1,646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">1,778<span></span>
</td>
<td class="nump">4,205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">228<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">69,421<span></span>
</td>
<td class="nump">67,719<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">16,800<span></span>
</td>
<td class="nump">18,177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt (1)</a></td>
<td class="nump">50,476<span></span>
</td>
<td class="nump">51,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">4,016<span></span>
</td>
<td class="nump">6,115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountsLiability', window );">Separate accounts liabilities</a></td>
<td class="nump">3,228<span></span>
</td>
<td class="nump">5,087<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesNoncurrent', window );">Other long-term insurance liabilities</a></td>
<td class="nump">5,835<span></span>
</td>
<td class="nump">7,235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">6,730<span></span>
</td>
<td class="nump">1,907<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">156,506<span></span>
</td>
<td class="nump">158,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 17)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital', window );">Common stock, par value $0.01: 3,200 shares authorized; 1,758 shares issued and 1,300 shares outstanding at December&#160;31, 2022 and 1,744 shares issued and 1,322 shares outstanding at December&#160;31, 2021 and capital surplus</a></td>
<td class="nump">48,193<span></span>
</td>
<td class="nump">47,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost: 458 and 422 shares at December&#160;31, 2022 and 2021</a></td>
<td class="num">(31,858)<span></span>
</td>
<td class="num">(28,173)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">56,398<span></span>
</td>
<td class="nump">54,997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="num">(1,264)<span></span>
</td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total CVS Health shareholders&#8217; equity</a></td>
<td class="nump">71,469<span></span>
</td>
<td class="nump">74,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">71,769<span></span>
</td>
<td class="nump">74,841<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 228,275<span></span>
</td>
<td class="nump">$ 233,052<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherInsuranceLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Insurance Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherInsuranceLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherInsuranceLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Insurance Liabilities, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherInsuranceLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PharmacyClaimsAndDiscountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pharmacy Claims And Discounts Payable, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PharmacyClaimsAndDiscountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of par value plus amounts in excess of par value or issuance value for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStocksIncludingAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPolicyholderFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due to policyholders for funds held that are returnable under the terms of insurance contracts, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.14)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPolicyholderFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset at fair value held for benefit of separate account policyholder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224244034144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">3,200,000,000<span></span>
</td>
<td class="nump">3,200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">1,758,000,000<span></span>
</td>
<td class="nump">1,744,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">1,300,000,000<span></span>
</td>
<td class="nump">1,322,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">458,000,000<span></span>
</td>
<td class="nump">422,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224244803184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCustomers', window );">Cash receipts from customers</a></td>
<td class="nump">$ 313,662<span></span>
</td>
<td class="nump">$ 284,219<span></span>
</td>
<td class="nump">$ 264,327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies', window );">Cash paid for inventory and prescriptions dispensed by retail network pharmacies</a></td>
<td class="num">(189,766)<span></span>
</td>
<td class="num">(165,783)<span></span>
</td>
<td class="num">(158,636)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PaymentsForInsuranceBenefits', window );">Insurance benefits paid</a></td>
<td class="num">(69,728)<span></span>
</td>
<td class="num">(63,598)<span></span>
</td>
<td class="num">(55,124)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToSuppliersAndEmployees', window );">Cash paid to other suppliers and employees</a></td>
<td class="num">(32,662)<span></span>
</td>
<td class="num">(31,652)<span></span>
</td>
<td class="num">(29,763)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromInterestAndDividendsReceived', window );">Interest and investment income received</a></td>
<td class="nump">1,026<span></span>
</td>
<td class="nump">743<span></span>
</td>
<td class="nump">894<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="num">(2,239)<span></span>
</td>
<td class="num">(2,469)<span></span>
</td>
<td class="num">(2,904)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="num">(4,116)<span></span>
</td>
<td class="num">(3,195)<span></span>
</td>
<td class="num">(2,929)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">16,177<span></span>
</td>
<td class="nump">18,265<span></span>
</td>
<td class="nump">15,865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sales and maturities of investments</a></td>
<td class="nump">6,729<span></span>
</td>
<td class="nump">7,246<span></span>
</td>
<td class="nump">6,467<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(7,746)<span></span>
</td>
<td class="num">(9,963)<span></span>
</td>
<td class="num">(9,639)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(2,727)<span></span>
</td>
<td class="num">(2,520)<span></span>
</td>
<td class="num">(2,437)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity', window );">Proceeds from sale-leaseback transactions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions (net of cash acquired)</a></td>
<td class="num">(139)<span></span>
</td>
<td class="num">(146)<span></span>
</td>
<td class="num">(866)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from sale of subsidiaries (net of cash and restricted cash sold of $2,854, $0 and $9)</a></td>
<td class="num">(1,249)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(5,047)<span></span>
</td>
<td class="num">(5,261)<span></span>
</td>
<td class="num">(5,534)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">987<span></span>
</td>
<td class="nump">9,958<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(4,211)<span></span>
</td>
<td class="num">(10,254)<span></span>
</td>
<td class="num">(15,631)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities', window );">Derivative settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(3,500)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid</a></td>
<td class="num">(2,907)<span></span>
</td>
<td class="num">(2,625)<span></span>
</td>
<td class="num">(2,624)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">551<span></span>
</td>
<td class="nump">549<span></span>
</td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for taxes related to net share settlement of equity awards</a></td>
<td class="num">(370)<span></span>
</td>
<td class="num">(168)<span></span>
</td>
<td class="num">(88)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(79)<span></span>
</td>
<td class="nump">155<span></span>
</td>
<td class="nump">432<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(10,516)<span></span>
</td>
<td class="num">(11,356)<span></span>
</td>
<td class="num">(7,696)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents and restricted cash</a></td>
<td class="nump">614<span></span>
</td>
<td class="nump">1,648<span></span>
</td>
<td class="nump">2,635<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the beginning of the period</a></td>
<td class="nump">12,691<span></span>
</td>
<td class="nump">11,043<span></span>
</td>
<td class="nump">8,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the end of the period</a></td>
<td class="nump">13,305<span></span>
</td>
<td class="nump">12,691<span></span>
</td>
<td class="nump">11,043<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Reconciliation of net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">4,327<span></span>
</td>
<td class="nump">7,989<span></span>
</td>
<td class="nump">7,192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments required to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,224<span></span>
</td>
<td class="nump">4,486<span></span>
</td>
<td class="nump">4,441<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Loss on assets held for sale</a></td>
<td class="nump">2,533<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_StoreImpairmentCharges', window );">Store impairments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,358<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">431<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">447<span></span>
</td>
<td class="nump">484<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of subsidiaries</a></td>
<td class="num">(475)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(269)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">452<span></span>
</td>
<td class="nump">1,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income taxes</a></td>
<td class="num">(2,029)<span></span>
</td>
<td class="num">(402)<span></span>
</td>
<td class="num">(570)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other noncash items</a></td>
<td class="nump">332<span></span>
</td>
<td class="num">(390)<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract', window );"><strong>Change in operating assets and liabilities, net of effects from acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(2,971)<span></span>
</td>
<td class="num">(2,703)<span></span>
</td>
<td class="num">(1,510)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(1,435)<span></span>
</td>
<td class="nump">735<span></span>
</td>
<td class="num">(973)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(491)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="nump">364<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable and pharmacy claims and discounts payable</a></td>
<td class="nump">4,260<span></span>
</td>
<td class="nump">2,898<span></span>
</td>
<td class="nump">2,769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities', window );">Health care costs payable and other insurance liabilities</a></td>
<td class="nump">992<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="num">(231)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">6,463<span></span>
</td>
<td class="nump">2,856<span></span>
</td>
<td class="nump">2,740<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">$ 16,177<span></span>
</td>
<td class="nump">$ 18,265<span></span>
</td>
<td class="nump">$ 15,865<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in operating assets and liabilities, net of effects from acquisitions:</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PaymentsForInsuranceBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Insurance Benefits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PaymentsForInsuranceBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Inventory And Prescriptions Dispensed By Retail Network Pharmacies</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_StoreImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Store Impairment Charges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_StoreImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in insurance liability balances during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3505-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForDerivativeInstrumentFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToSuppliersAndEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash payments to suppliers for goods and services provided and to employees for services provided.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToSuppliersAndEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash receipts from customers during the current period which are usually for sales of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromInterestAndDividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received for dividends and interest on the entity's equity and debt investments during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3337-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromInterestAndDividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from principal payment received from sales-type and direct financing leases classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 230<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123398031&amp;loc=SL120154370-112784<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224239988880">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Shareholders' Equity - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th" colspan="2"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Total CVS Health Shareholders&#8217; Equity</div></th>
<th class="th" colspan="2">
<div>Total CVS Health Shareholders&#8217; Equity </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Common Shares</div></th>
<th class="th" colspan="2"><div>Treasury Shares</div></th>
<th class="th"><div>Common Stock and Capital Surplus</div></th>
<th class="th"><sup>[3]</sup></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th">
<div>Retained Earnings </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><sup>[2]</sup></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th">
<div>Accumulated Other Comprehensive Income (Loss) </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><sup>[4]</sup></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, beginning of year balance (in shares) at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares outstanding, beginning of year balance (in shares) at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 64,170<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 63,864<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,235)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="nump">$ 45,972<span></span>
</td>
<td class="nump">$ 45,108<span></span>
</td>
<td colspan="2" class="num">$ (3)<span></span>
</td>
<td class="nump">$ 1,019<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">$ 306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">7,179<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="nump">541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,644)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,644)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(2,644)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, end of year balance (in shares) at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares outstanding, end of year balance (in shares) at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(423)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">69,701<span></span>
</td>
<td class="num">$ (766)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">69,389<span></span>
</td>
<td class="num">$ (766)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,178)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="nump">46,513<span></span>
</td>
<td class="nump">49,640<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
<td colspan="2" class="num">$ (766)<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">8,001<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(314)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(314)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(314)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="nump">864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,644)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,644)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(2,644)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, end of year balance (in shares) at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares outstanding, end of year balance (in shares) at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(422)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">74,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">74,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,173)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="nump">47,377<span></span>
</td>
<td class="nump">54,997<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">334<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">4,311<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,598)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,598)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(1,598)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="nump">816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance', window );">Purchase of treasury shares, net of ESPP issuances (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance', window );">Purchase of treasury shares, net of ESPP issuances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,685)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,685)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,685)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,910)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,910)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(2,910)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, end of year balance (in shares) at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury shares outstanding, end of year balance (in shares) at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(458)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 71,769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 71,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (31,858)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="nump">$ 48,193<span></span>
</td>
<td class="nump">$ 56,398<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">$ (1,264)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr><td colspan="19"></td></tr>
<tr><td colspan="19"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Treasury shares include 1 million shares held in trust for each of the years ended December 31, 2022, 2021 and 2020. Treasury stock includes $29 million related to shares held in trust for each of the years ended December 31, 2022, 2021 and 2020. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3OA_50a38f39-24c9-439d-81f9-601a8eefa8a4">Accounting Standards Update (&#8220;ASU&#8221;) 2016-13</span>, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Topic 326), which resulted in a reduction to retained earnings of $3&#160;million during the year ended December 31, 2020.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Common stock and capital surplus includes the par value of common stock of $18&#160;million as of December 31, 2022 and $17 million as of December 31, 2021 and 2020.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzk4OTU2MDQ2NTA5OTM_e949208d-ec5c-442c-bfb1-60608d2297f0">ASU 2018-12</span>, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Topic 944) during the year ended December 31, 2021. See Note 8 &#8216;&#8216;Other Insurance Liabilities and Separate Accounts&#8217;&#8217; for additional information.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ESPP Issuance, Net Of Treasury Stock, Shares, Acquired, Cost Method</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ESPP Issuance, Net Of Treasury Stock, Value, Acquired, Cost Method</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Other Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224239021184">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Shareholders' Equity (Parentheticals) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TreasuryStockSharesHeldinTrust', window );">Treasury shares held in trust (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TreasuryStockValueSharesHeldInTrust', window );">Treasury shares held in trust</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 29<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">18<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Reduction to retained earnings as a result of new accounting standard adoption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (69,701)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (64,170)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(71,769)<span></span>
</td>
<td class="num">(74,841)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Accounting Standards Update 2018-12<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">ASU 2016-13<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Reduction to retained earnings as a result of new accounting standard adoption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (49,640)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (45,108)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (56,398)<span></span>
</td>
<td class="num">$ (54,997)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Reduction to retained earnings as a result of new accounting standard adoption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 766<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Retained Earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Reduction to retained earnings as a result of new accounting standard adoption</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Retained Earnings | ASU 2016-13</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Reduction to retained earnings as a result of new accounting standard adoption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzk4OTU2MDQ2NTA5OTM_e949208d-ec5c-442c-bfb1-60608d2297f0">ASU 2018-12</span>, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Topic 944) during the year ended December 31, 2021. See Note 8 &#8216;&#8216;Other Insurance Liabilities and Separate Accounts&#8217;&#8217; for additional information.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3OA_50a38f39-24c9-439d-81f9-601a8eefa8a4">Accounting Standards Update (&#8220;ASU&#8221;) 2016-13</span>, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Topic 326), which resulted in a reduction to retained earnings of $3&#160;million during the year ended December 31, 2020.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockSharesHeldinTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares, Held in Trust</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockSharesHeldinTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockValueSharesHeldInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Shares Held In Trust</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockValueSharesHeldInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224248766880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Statement of Cash Flows [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashDivestedFromDeconsolidation', window );">Cash and restricted cash sold</a></td>
<td class="nump">$ 2,854<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashDivestedFromDeconsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reduction in cash due to no longer including the former subsidiary's cash in the consolidated entity's cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashDivestedFromDeconsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224251916896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business&#160; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation, together with its subsidiaries (collectively, &#8220;CVS Health&#8221; or the &#8220;Company&#8221;), has more than 9,000 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with over 110 million plan members with expanding specialty pharmacy solutions and a dedicated senior pharmacy care business serving more than one million patients per year. The Company also serves an estimated 35 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its integrated health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The coronavirus disease 2019 (&#8220;COVID-19&#8221;) and its emerging new variants continue to impact the economies of the U.S. and other countries around the world. The impact of COVID-19 on the Company&#8217;s businesses, operating results, cash flows and financial condition in the years ended December 31, 2022, 2021 and 2020, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this Exhibit 99.1.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with its new operating model adopted in the first quarter of 2023, the Company realigned the composition of its segments to reflect how its Chief Operating Decision Maker (the &#8220;CODM&#8221;) reviews information and manages the business. As a result of this realignment, the Company formed a new Health Services segment, which in addition to providing a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, also delivers health care services in the Company&#8217;s medical clinics, virtually, and in the home, as well as provider enablement solutions. In addition, the Company created a new Pharmacy &amp; Consumer Wellness segment, which includes its retail and long-term care pharmacy operations and related pharmacy services, as well as its retail front store operations. This segment will also provide pharmacy fulfillment services to support the Health Services segment&#8217;s specialty and mail order pharmacy offerings. Segment financial information has been recast to reflect these changes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the segment realignment described above, the Company&#8217;s four reportable segments are as follows: Health Care Benefits, Health Services, Pharmacy &amp; Consumer Wellness and Corporate/Other, which are described below. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment operates as one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) in eight states through which it sells Insured plans directly to individual consumers. The Company entered Public Exchanges in four additional states effective January 2023. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. PBM solutions include plan design offerings and administration, formulary management, retail pharmacy network management services, and specialty and mail order pharmacy services. In addition, the Company provides clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Company operates a group purchasing organization that negotiates pricing for the purchase of pharmaceuticals and rebates with pharmaceutical manufacturers on behalf of its participants and provides various administrative, management and reporting services to pharmaceutical manufacturers. The Health Services segment&#8217;s clients are primarily employers, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care (&#8220;Managed Medicaid&#8221;) plans, plans offered on Insurance Exchanges and other sponsors of health benefit plans throughout the United States and Covered Entities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy &amp; Consumer Wellness Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy &amp; Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise. The segment also conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and ancillary services to long-term care facilities and other care settings, and provides pharmacy fulfillment services to support the Health Services segment&#8217;s specialty and mail order pharmacy offerings. As of December&#160;31, 2022, the Pharmacy &amp; Consumer Wellness segment operated more than 9,000 retail locations, as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of cash and temporary investments with maturities of three months or less when purchased. The Company invests in short-term money market funds, commercial paper and time deposits, as well as other debt securities that are classified as cash equivalents within the accompanying consolidated balance sheets, as these funds are highly liquid and readily convertible to known amounts of cash. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash included in other current assets on the consolidated balance sheets represents funds held on behalf of members, including health savings account (&#8220;HSA&#8221;) funds associated with high deductible health plans. Restricted cash included in other assets on the consolidated balance sheets represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits and money market funds.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the consolidated balance sheets to total cash, cash equivalents and restricted cash on the consolidated statements of cash flows as of December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,305&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,691&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,043&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in restricted cash included in other current assets as of December 31, 2022 compared to December 31, 2021 was primarily due to a decrease in HSA funds held on behalf of customers as a result of the sale of Payflex Holdings, Inc. (&#8220;PayFlex&#8221;). See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information on the Company&#8217;s sale of PayFlex.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Securities </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities consist primarily of U.S. Treasury and agency securities, mortgage-backed securities, corporate and foreign bonds and other debt securities. Debt securities are classified as either current or long-term investments based on their contractual maturities unless the Company intends to sell an investment within the next twelve months, in which case it is classified as current on the consolidated balance sheets. Debt securities are classified as available for sale and are carried at fair value. See Note 4 &#8216;&#8216;Fair Value&#8217;&#8217; for additional information on how the Company estimates the fair value of these investments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related (yield-related) components. In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principal payments; and any changes to the rating of the security by a rating agency. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income (loss). Interest is not accrued on debt securities when management believes the collection of interest is unlikely.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit-related component is determined by comparing the present value of cash flows expected to be collected from the security, considering all reasonably available information relevant to the collectability of the security, with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the Company records an allowance for credit losses, which is limited by the amount that the fair value is less than amortized cost basis. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For mortgage-backed and other asset-backed securities, the Company recognizes income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The Company&#8217;s investment in the security is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the security, with adjustments recognized in net income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities with readily available fair values are measured at fair value with changes in fair value recognized in net income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage Loans</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mortgage loan investments on the consolidated balance sheets are valued at the unpaid principal balance, net of an allowance for credit losses. Mortgage loans with a maturity date or a committed prepayment date within twelve months are classified as current on the consolidated balance sheets. The Company assesses whether its loans share similar risk characteristics and, if so, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">groups such loans in a risk pool when measuring expected credit losses. The Company considers the following characteristics when evaluating whether its loans share similar risk characteristics:&#160;loan-to-value ratios, property type (e.g., office, retail, apartment, industrial), geographic location, vacancy rates and property condition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit loss reserves are determined using a loss rate method that multiplies the unpaid principal balance of each loan within a risk pool group by an estimated loss rate percentage. The loss rate percentage considers both the expected loan loss severity and the probability of loan default. For periods where the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions (e.g., gross domestic product, employment), the Company adjusts its expected loss rates to reflect these forecasted economic conditions. For periods beyond which the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions, the Company reverts to historical loss rates in determining expected credit losses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income on a potential problem loan (i.e., high probability of default) or restructured loan is accrued to the extent it is deemed to be collectible and the loan continues to perform under its original or restructured terms. Interest income on problem loans (i.e., more than 60 days delinquent, in bankruptcy or in process of foreclosure) is recognized on a cash basis. Cash payments on loans in the process of foreclosure are treated as a return of principal.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Investments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments consist primarily of the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Private equity and hedge fund limited partnerships, which are accounted for using the equity method of accounting. Under this method, the carrying value of the investment is based on the value of the Company&#8217;s equity ownership of the underlying investment funds provided by the general partner or manager of the investments, the financial statements of which generally are audited. As a result of the timing of the receipt of the valuation information provided by the fund managers, these investments are generally reported on up to a three month lag. The Company reviews investments for impairment at least quarterly and monitors their performance throughout the year through discussions with the administrators, managers and/or general partners. If the Company becomes aware of an impairment of a limited partnership&#8217;s investments through its review or prior to receiving the limited partnership&#8217;s financial statements at the financial statement date, an impairment will be recognized by recording a reduction in the carrying value of the limited partnership with a corresponding charge to net investment income. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Investment real estate, which is carried on the consolidated balance sheets at depreciated cost, including capital additions, net of write-downs for other-than-temporary declines in fair value. Depreciation is calculated using the straight-line method based on the estimated useful life of each asset. If any real estate investment is considered held-for-sale, it is carried at the lower of its carrying value or fair value less estimated selling costs. The Company generally estimates fair value using net operating income and applying a capitalization rate in conjunction with comparable sales information. At the time of the sale, the difference between the sales price and the carrying value is recorded as a realized capital gain or loss. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Privately-placed equity securities, which are carried on the consolidated balance sheets at cost less impairments, plus or minus subsequent adjustments for observable price changes. Additionally, as a member of the Federal Home Loan Bank of Boston (&#8220;FHLBB&#8221;), a subsidiary of the Company is required to purchase and hold shares of the FHLBB. These shares are restricted and carried at cost. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Income</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net investment income on the Company&#8217;s investments is recorded when earned and is reflected in the Company&#8217;s net income (other than net investment income on assets supporting experience-rated products). Experience-rated products are products in the large case pensions business where the contract holder, not the Company, assumes investment and other risks, subject to, among other things, minimum guarantees provided by the Company. The effect of investment performance on experience-rated products is allocated to contract holders&#8217; accounts daily, based on the underlying investment experience and, therefore, does not impact the Company&#8217;s net income (as long as the contract&#8217;s minimum guarantees are not triggered). Net investment income on assets supporting large case pensions&#8217; experience-rated products is included in net investment income in the consolidated statements of operations and is credited to contract holders&#8217; accounts through a charge to benefit costs. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized capital gains and losses on investments (other than realized capital gains and losses on investments supporting experience-rated products) are included as a component of net investment income in the consolidated statements of operations. Realized capital gains and losses are determined on a specific identification basis. Purchases and sales of debt and equity securities and alternative investments are reflected on the trade date. Purchases and sales of mortgage loans and investment real estate are reflected on the closing date.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized capital gains and losses on investments supporting large case pensions&#8217; experience-rated products are not included in realized capital gains and losses in the consolidated statements of operations and instead are credited directly to contract holders&#8217; accounts. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized capital gains and losses on investments (other than unrealized capital gains and losses on investments supporting experience-rated products) are reflected in shareholders&#8217; equity, net of tax, as a component of accumulated other comprehensive income (loss). Unrealized capital gains and losses on investments supporting large case pensions&#8217; experience-rated products are credited directly to contract holders&#8217; accounts. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments in order to manage interest rate and foreign exchange risk and credit exposure. The Company&#8217;s use of these derivatives is generally limited to hedging risk and has principally consisted of using interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations. Accounts receivable, net was composed of the following at December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,503&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,431&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes accounts receivable of $227&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><div style="text-indent:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for credit losses was $333&#160;million and $339&#160;million as of December&#160;31, 2022 and 2021, respectively. When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are valued at the lower of cost or net realizable value using the weighted average cost method. Physical inventory counts are taken on a regular basis in each retail store and LTC pharmacy, and a continuous cycle count process is the primary procedure used to validate the inventory balances on hand in each distribution center and mail facility to ensure that the amounts reflected in the consolidated financial statements are properly stated. During the interim period between physical inventory counts, the Company accrues for anticipated physical inventory losses on a location-by-location basis based on historical results and current physical inventory trends. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reinsurance Recoverables </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#8217;s primary liability as the direct insurer of the risks reinsured. Failure of reinsurers to indemnify the Company could result in losses; however, the Company does not expect charges for unrecoverable reinsurance to have a material effect on its consolidated operating results or financial condition. The Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk arising from similar geographic regions, activities or economic characteristics of its reinsurers. At December&#160;31, 2022, the Company&#8217;s reinsurance recoverables consisted primarily of amounts due from third parties that are rated consistent with companies that are considered to have the ability to meet their obligations. Reinsurance recoverables are recorded as other current assets or other assets on the consolidated balance sheets.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Contract Acquisition Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance products included in the Health Care Benefits segment are cancellable by either the customer or the member monthly upon written notice. Acquisition costs related to prepaid health care and health indemnity contracts are generally expensed as incurred. For certain long-duration insurance contracts, acquisition costs directly related to the successful acquisition of a new or renewal insurance contract, including commissions, are deferred and are recorded as other current assets or other assets on the consolidated balance sheets. Contracts are grouped by product and issue year into cohorts consistent with the grouping used in estimating the associated liability and are amortized on a constant level basis based on the remaining in-force policies over the estimated term of the contracts to approximate straight-line amortization. Changes to the Company&#8217;s assumptions, including assumptions related to persistency, are reflected at the cohort level at the time of change and are recognized prospectively over the estimated terms of the contract. The amortization of deferred acquisition costs is recorded in operating expenses in the consolidated statements of operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a roll forward of deferred acquisition costs for the years ended December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred acquisition costs, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalizations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred acquisition costs, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is reported at historical cost, net of accumulated depreciation. Property, equipment and improvements to leased premises are depreciated using the straight-line method over the estimated useful lives of the assets, or when applicable, the term of the lease, whichever is shorter. Estimated useful lives generally range from 1 to 40 years for buildings, building improvements and leasehold improvements and 3 to 10 years for fixtures, equipment and internally developed software. Repair and maintenance costs are charged directly to expense as incurred. Major renewals or replacements that substantially extend the useful life of an asset are capitalized and depreciated. Application development stage costs for significant internally developed software projects are capitalized and depreciated. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following at December&#160;31, 2022 and 2021: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.990%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,996&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixtures and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,978&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,843&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,600&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,550&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,117&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,896&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes property and equipment of $244&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense (which includes the amortization of property and equipment under finance or capital leases) totaled $2.4 billion, $2.3 billion and $2.1 billion for the years ended December&#160;31, 2022, 2021 and 2020, respectively. During the year ended December&#160;31, 2021, the Company recorded an impairment on property and equipment of $261&#160;million in connection with the planned closure of certain retail stores. See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about these impairment charges as well as the Company&#8217;s finance leases. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Right-of-Use Assets and Lease Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the lease, renewal date of the lease or significant remodeling of the lease space based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company&#8217;s leases is not readily determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The operating lease right-of-use assets also include lease payments made before commencement and are reduced by lease incentives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s real estate leases typically contain options that permit renewals for additional periods of up to five years each. For real estate leases, the options to extend are not considered reasonably certain at lease commencement because the Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and regularly opens or closes stores to align with its operating strategy. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the right-of-use asset and lease liability. Similarly, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. Leases with an initial term of 12 months or less are not recorded on the balance sheets, and lease expense is recognized on a straight-line basis over the term of the short-term lease.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For real estate leases, the Company accounts for lease components and nonlease components as a single lease component. Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the right-of-use assets and lease liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about right-of-use assets and lease liabilities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for business combinations using the acquisition method of accounting, which requires the excess cost of an acquisition over the fair value of net assets acquired and identifiable intangible assets to be recorded as goodwill. Goodwill is not amortized, but is subject to impairment reviews annually, or more frequently, if necessary, as further described in &#8220;Recoverability of Long-Lived Assets&#8221; below. See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; for additional information about goodwill. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s identifiable intangible assets consist primarily of trademarks, trade names, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired (&#8220;VOBA&#8221;). These intangible assets arise primarily from the determination of their respective fair market values at the date of acquisition. Amounts assigned to identifiable intangible assets, and their related useful lives, are derived from established valuation techniques and management estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s definite-lived intangible assets are amortized over their estimated useful lives based upon the pattern of future cash flows attributable to the asset. Definite-lived intangible assets are amortized using the straight-line method. VOBA is subject to loss recognition testing annually, or more frequently, if necessary. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets are not amortized but are tested for impairment annually, or more frequently, if necessary, as further described in &#8220;Recoverability of Long-Lived Assets&#8221; below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; for additional information about intangible assets. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recoverability of Long-Lived Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the recoverability of long-lived assets, excluding goodwill and indefinite-lived intangible assets, which are tested for impairment using separate tests described below, whenever events or changes in circumstances indicate that the carrying value of such asset may not be recoverable. The Company groups and evaluates these long-lived assets for impairment at the lowest level at which individual cash flows can be identified. If indicators of impairment are present, the Company first </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the asset group&#8217;s estimated future cash flows (discounted). If required, an impairment loss is recorded for the portion of the asset group&#8217;s carrying value that exceeds the asset group&#8217;s estimated future cash flows (discounted). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, the Company recorded office real estate optimization charges of $117&#160;million primarily related to the abandonment of leased real estate and the related right-of-use assets and property and equipment in connection with the planned reduction of corporate office real estate space in response to its new flexible work arrangement. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, the Company recorded a store impairment charge of approximately $1.4&#160;billion primarily related to the write down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately 900 retail stores between 2022 and 2024. There were no material impairment charges recognized on long-lived assets during the year ended December 31, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about the right-of-use asset charges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When evaluating goodwill for potential impairment, the Company compares the fair value of its reporting units to their respective carrying amounts. The Company estimates the fair value of its reporting units using a combination of a discounted cash flow method and a market multiple method. If the carrying amount of a reporting unit exceeds its estimated fair value, an impairment loss is recognized in an amount equal to that excess. During the third quarter of both 2022 and 2020, the Company performed its required annual impairment tests of goodwill and concluded there were no goodwill impairments as of the testing dates or during the years ended December 31, 2022 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company performed its required annual impairment tests of goodwill, the results of which indicated an impairment of the goodwill associated with the LTC reporting unit. Accordingly, during the third quarter of 2021, the Company recorded a $431&#160;million goodwill impairment charge on the remaining goodwill of the LTC reporting unit. The results of the impairment tests indicated that there was no impairment of goodwill of the remaining reporting units as of the testing date or during the year ended December&#160;31, 2021. See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; for additional information about the goodwill impairment charge recorded during the year ended December&#160;31, 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets are tested for impairment by comparing the estimated fair value of the asset to its carrying value. The Company estimates the fair value of its indefinite-lived trademarks using the relief from royalty method under the income approach. If the carrying value of the asset exceeds its estimated fair value, an impairment loss is recognized, and the asset is written down to its estimated fair value. There were no impairment losses recognized on indefinite-lived intangible assets in any of the years ended December&#160;31, 2022, 2021 or 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets and liabilities related to large case pensions products represent funds maintained to meet specific objectives of contract holders who bear the investment risk. These assets and liabilities are carried at fair value. Net investment income (including net realized capital gains and losses) accrue directly to such contract holders. The assets of each account are legally segregated and are not subject to claims arising from the Company&#8217;s other businesses. Deposits, withdrawals and net investment income (including net realized and net unrealized capital gains and losses) on Separate Accounts assets are not reflected in the consolidated statements of operations or cash flows. Management fees charged to contract holders are included in services revenue and recognized over the period earned.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Costs Payable</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care costs payable consist principally of unpaid fee-for-service medical, dental and pharmacy claims, capitation costs, other amounts due to providers pursuant to risk-sharing arrangements related to the Health Care Benefits segment&#8217;s Insured Commercial, Medicare and Medicaid products and accruals for state assessments. Unpaid health care claims include an estimate of payments the Company will make for (i) services rendered to the Company&#8217;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid, each as of the financial statement date (collectively, &#8220;IBNR&#8221;). Health care costs payable also include an estimate of the cost of services that will continue to be rendered after the financial statement date if the Company is obligated to pay for such services in accordance with contractual or regulatory requirements. Such estimates are developed using actuarial principles and assumptions which consider, among other things, historical and projected claim submission and processing patterns, assumed and historical medical cost trends, historical utilization of medical services, claim inventory levels, changes in Insured membership and product mix, seasonality </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and other relevant factors. The Company reflects changes in these estimates in benefit costs in the Company&#8217;s consolidated operating results in the period they are determined. Capitation costs represent contractual monthly fees paid to participating physicians and other medical providers for providing medical care, regardless of the volume of medical services provided to the Insured member. Amounts due under risk-sharing arrangements are based on the terms of the underlying contracts with the providers and consider claims experience under the contracts through the financial statement date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops its estimate of IBNR using actuarial principles and assumptions that consider numerous factors. Of those factors, the Company considers the analysis of historical and projected claim payment patterns (including claims submission and processing patterns) and the assumed health care cost trend rate (the year-over-year change in per member per month health care costs) to be the most critical assumptions. In developing its IBNR estimate, the Company consistently applies these actuarial principles and assumptions each period, with consideration to the variability of related factors. There have been no significant changes to the methodologies or assumptions used to develop the Company&#8217;s estimate of IBNR in 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company analyzes historical claim payment patterns by comparing claim incurred dates (i.e., the date services were provided) to claim payment dates to estimate &#8220;completion factors.&#8221; The Company uses completion factors predominantly to estimate the ultimate cost of claims incurred more than three months before the financial statement date. The Company estimates completion factors by aggregating claim data based on the month of service and month of claim payment and estimating the percentage of claims incurred for a given month that are complete by each month thereafter. For any given month, substantially all claims are paid within six months of the date of service, but it can take up to 48 months or longer after the date of service before all of the claims are completely resolved and paid. These historically-derived completion factors are then applied to claims paid through the financial statement date to estimate the ultimate claim cost for a given month&#8217;s incurred claim activity. The difference between the estimated ultimate claim cost and the claims paid through the financial statement date represents the Company&#8217;s estimate of claims remaining to be paid as of the financial statement date and is included in the Company&#8217;s health care costs payable. The completion factors the Company uses reflect judgments and possible adjustments based on data such as claim inventory levels, claim submission and processing patterns and, to a lesser extent, other factors such as changes in health care cost trend rates, changes in Insured membership and changes in product mix. If claims are submitted or processed on a faster (slower) pace than prior periods, the actual claims may be more (less) complete than originally estimated using the Company&#8217;s completion factors, which may result in reserves that are higher (lower) than the ultimate cost of claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because claims incurred within three months before the financial statement date are less mature, the Company uses a combination of historically-derived completion factors and the assumed health care cost trend rate to estimate the ultimate cost of claims incurred for these months. The Company applies its actuarial judgment and places a greater emphasis on the assumed health care cost trend rate for the most recent claim incurred dates as these months may be influenced by seasonal patterns and changes in membership and product mix.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s health care cost trend rate is affected by changes in per member utilization of medical services as well as changes in the unit cost of such services. Many factors influence the health care cost trend rate, including the Company&#8217;s ability to manage benefit costs through product design, negotiation of favorable provider contracts and medical management programs, as well as the mix of the Company&#8217;s business. The health status of the Company&#8217;s Insured members, aging of the population and other demographic characteristics, advances in medical technology and other factors continue to contribute to rising per member utilization and unit costs. Changes in health care practices, inflation, new technologies, increases in the cost of prescription drugs (including specialty pharmacy drugs), direct-to-consumer marketing by pharmaceutical companies, clusters of high-cost cases, claim intensity, changes in the regulatory environment, health care provider or member fraud and numerous other factors also contribute to the cost of health care and the Company&#8217;s health care cost trend rate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each reporting period, the Company uses an extensive degree of judgment in the process of estimating its health care costs payable. As a result, considerable variability and uncertainty is inherent in such estimates, particularly with respect to claims with claim incurred dates of three months or less before the financial statement date; and the adequacy of such estimates is highly sensitive to changes in assumed completion factors and the assumed health care cost trend rates. For each reporting period the Company recognizes the actuarial best estimate of health care costs payable considering the potential volatility in assumed completion factors and health care cost trend rates, as well as other factors. The Company believes its estimate of health care costs payable is reasonable and adequate to cover its obligations at December&#160;31, 2022; however, actual claim payments may differ from the Company&#8217;s estimates. A worsening (or improvement) of the Company&#8217;s health care cost trend rates or changes in completion factors from those that the Company assumed in estimating health care costs payable at December&#160;31, 2022 would cause these estimates to change in the near term, and such a change could be material.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each quarter, the Company re-examines previously established health care costs payable estimates based on actual claim payments for prior periods and other changes in facts and circumstances. Given the extensive degree of judgment in this estimate, it is possible that the Company&#8217;s estimates of health care costs payable could develop either favorably (that is, its actual benefit costs for the period were less than estimated) or unfavorably. The changes in the Company&#8217;s estimate of health care costs payable may relate to a prior quarter, prior year or earlier periods. For a roll forward of the Company&#8217;s health care costs payable, see Note 7 &#8216;&#8216;Health Care Costs Payable.&#8217;&#8217; The Company&#8217;s reserving practice is to consistently recognize the actuarial best estimate of its ultimate liability for health care costs payable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Insurance Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unpaid Claims</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unpaid claims consist primarily of reserves associated with certain short-duration group disability and term life insurance contracts, including an estimate for IBNR as of the financial statement date. Reserves associated with certain short-duration group disability and term life insurance contracts are based upon the Company&#8217;s estimate of the present value of future benefits, which is based on assumed investment yields and assumptions regarding mortality, morbidity and recoveries from the U.S. Social Security Administration. The Company develops its estimate of IBNR using actuarial principles and assumptions which consider, among other things, contractual requirements, claim incidence rates, claim recovery rates, seasonality and other relevant factors. The Company discounts certain claim liabilities related to group long-term disability and life insurance waiver of premium contracts. The discount rates generally reflect the Company&#8217;s expected investment returns for the investments supporting all incurral years of these liabilities. The discount rates for retrospectively-rated contracts are set at contractually specified levels. The Company&#8217;s estimates of unpaid claims are subject to change due to changes in the underlying experience of the insurance contracts, changes in investment yields or other factors, and these changes are recorded in current and future benefits in the consolidated statements of operations in the period they are determined. The Company estimates its reserve for claims IBNR for life products largely based on completion factors. The completion factors used are based on the Company&#8217;s historical experience and reflect judgments and possible adjustments based on data such as claim inventory levels, claim payment patterns, changes in business volume and other factors. If claims are submitted or processed on a faster (slower) pace than historical periods, the actual claims may be more (less) complete than originally estimated using completion factors, which may result in reserves that are higher (lower) than required to cover future life benefit payments. There have been no significant changes to the methodologies or assumptions used to develop the Company&#8217;s estimate of unpaid claims IBNR in 2022. As of December&#160;31, 2022, unpaid claims balances of $243 million and $1.1 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2021, unpaid claims balances of $324 million and $1.3 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all life and disability insurance liabilities have been fully ceded to unrelated third parties through indemnity reinsurance agreements; however, the Company remains directly obligated to the policyholders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Future Policy Benefits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future policy benefits consist primarily of reserves for products for which the Company no longer solicits or accepts new customers, including limited payment pension and annuity contracts and long-term care insurance contracts. Contracts are grouped into cohorts by contract type and issue year. The liability for future policy benefits is adjusted for differences between actual and expected experience. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserves for limited payment pension and annuity contracts represent the Company&#8217;s estimate of the present value of future benefits to be paid to or on behalf of policyholders and are computed using actuarial principles that consider, among other things, assumptions reflecting anticipated mortality and retirement experience. On an annual basis, or more frequently if necessary, the Company reviews mortality assumptions against both industry standards and its experience.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserves for long-term care insurance contracts represent the Company&#8217;s estimate of the present value of future benefits and settlement costs to be paid to or on behalf of policyholders less the present value of future net premiums. The Company&#8217;s estimate of the present value of future benefits under such contracts is based upon mortality, morbidity, lapse and interest rate assumptions. On an annual basis, or more frequently if necessary, the Company reviews its mortality, morbidity and lapse assumptions against its experience. Annually, or each time the assumptions are changed, the net premium ratio used to calculate the future policy benefit liability is updated to reflect actual experience, as well as the impact of any change in assumptions on the Company&#8217;s future cash flows. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company discounts its future policy benefit liability using a curve of spot rates derived from Single A rated fixed income instruments. At each reporting date, the Company will measure its liability for future policy benefits using both the current spot </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rate curve and the locked-in discount rate at each cohort&#8217;s inception. Any difference between the measured liabilities is recorded in other comprehensive income (loss).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, future policy benefits balances of $334 million and $4.7 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2021, future policy benefits balances of $458 million and $6.0 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Premium Deficiency Reserves</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its short-duration insurance contracts to determine if it is probable that a loss will be incurred. A premium deficiency loss is recognized when it is probable that expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), will exceed existing reserves plus anticipated future premiums and reinsurance recoveries. Anticipated investment income is not considered in the calculation of premium deficiency losses. For purposes of determining premium deficiency losses, contracts are grouped consistent with the Company&#8217;s method of acquiring, servicing and measuring the profitability of such contracts. The Company did not have any premium deficiency reserves as of December&#160;31, 2022. As of December&#160;31, 2021, the Company established a premium deficiency reserve of $16 million related to Medicaid products in the Health Care Benefits segment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policyholders&#8217; Funds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Policyholders&#8217; funds consist primarily of reserves for pension and annuity investment contracts and customer funds associated with certain health contracts. Reserves for such contracts are equal to cumulative deposits less withdrawals and charges plus interest credited thereon, net of experience-rated adjustments. In both 2022 and 2021, interest rates for pension and annuity investment contracts ranged from 3.5% to 4.8%. Reserves for contracts subject to experience rating reflect the Company&#8217;s rights as well as the rights of policyholders and plan participants. The Company also held funds for HSAs on behalf of members associated with high deductible health plans prior to the sale of PayFlex in June 2022. These amounts were held to pay for qualified health care expenses incurred by these members. At December&#160;31, 2022, the Company did not hold any HSA funds as a result of the PayFlex sale. The HSA balance was approximately $2.9 billion at December 31, 2021 and was reflected in other current assets with a corresponding liability in policyholders&#8217; funds. These assets were considered restricted cash for cash flow statement purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Policyholders&#8217; funds liabilities that are expected to be paid within twelve months from the balance sheet date are classified as current on the consolidated balance sheets. Policyholders&#8217; funds liabilities that are expected to be paid greater than twelve months from the balance sheet date are included in other long-term liabilities on the consolidated balance sheets. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Self-Insurance Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is self-insured for certain losses related to general liability, workers&#8217; compensation and auto liability. The Company obtains third party insurance coverage to limit exposure from these claims. The Company is also self-insured for certain losses related to health and medical liabilities. The Company&#8217;s self-insurance accruals, which include reported claims and claims incurred but not reported, are calculated using standard insurance industry actuarial assumptions and the Company&#8217;s historical claims experience. As of both December&#160;31, 2022 and 2021, self-insurance liabilities totaled $1.1 billion and were recorded in accrued expenses and other long-term liabilities on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation and Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For non-U.S. dollar functional currency locations, (i) assets and liabilities are translated at end-of-period exchange rates, (ii) revenues and expenses are translated at average exchange rates in effect during the period and (iii) equity is translated at historical exchange rates. The resulting cumulative translation adjustments are included as a component of accumulated other comprehensive income (loss).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For U.S. dollar functional currency locations, foreign currency assets and liabilities are remeasured into U.S. dollars at end-of-period exchange rates, except for nonmonetary balance sheet accounts which are remeasured at historical exchange rates. Revenues and expenses are remeasured at average exchange rates in effect during each period, except for those expenses related to the nonmonetary balance sheet amounts which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in net income.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and losses from foreign currency transactions and the effects of foreign currency remeasurements were not material in the years ended December&#160;31, 2022, 2021 or 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health Care Benefits revenue is principally derived from insurance premiums and fees billed to customers. Revenue is recognized based on customer billings, which, in the Company&#8217;s Commercial business, reflect contracted rates per member and the number of covered members recorded in the Company&#8217;s records at the time the billings are prepared. Billings are generally sent monthly for coverage during the following month. Revenue related to the Company&#8217;s Government business is collected monthly from the U.S. federal government and various government agencies based on fixed payment rates and member eligibility. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s billings may be subsequently adjusted to reflect enrollment changes due to member terminations or other factors. These adjustments are known as retroactivity adjustments. In each period, the Company estimates the amount of future retroactivity and adjusts the recorded revenue accordingly. As information regarding actual retroactivity amounts becomes known, the Company refines its estimates and records any required adjustments to revenues in the period in which they arise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Premium Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums are recognized as revenue in the month in which the enrollee is entitled to receive health care services. Premiums are reported net of an allowance for estimated terminations and uncollectible amounts. Additionally, premium revenue subject to the minimum medical loss ratio (&#8220;MLR&#8221;) rebate requirements of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (as amended, collectively, the &#8220;ACA&#8221;) is recorded net of the estimated minimum MLR rebates for the current calendar year. Premiums related to unexpired contractual coverage periods (unearned premiums) are reported as other insurance liabilities on the consolidated balance sheets and recognized as revenue when earned.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s contracts allow for premiums to be adjusted to reflect actual experience or the relative health status of Insured members. Such adjustments are reasonably estimable at the outset of the contract, and adjustments to those estimates are made based on actual experience of the customer emerging under the contract and the terms of the underlying contract.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Services Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue relates to contracts that can include various combinations of services or series of services which generally are capable of being distinct and accounted for as separate performance obligations. The Health Care Benefits segment&#8217;s services revenue primarily consists of ASC fees received in exchange for performing certain claim processing and member services for ASC members. ASC fee revenue is recognized over the period the service is provided. Some of the Company&#8217;s administrative services contracts include guarantees with respect to certain functions, such as customer service response time, claim processing accuracy and claim processing turnaround time, as well as certain guarantees that a plan sponsor&#8217;s benefit claim experience will fall within a certain range. With any of these guarantees, the Company is financially at risk if the conditions of the arrangements are not met, although the maximum amount at risk typically is limited to a percentage of the fees otherwise payable to the Company by the customer involved. Each period the Company estimates its obligations under the terms of these guarantees and records its estimate as an offset to services revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting for Medicare Part D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include insurance premiums earned by the Company&#8217;s PDPs, which are determined based on the PDP&#8217;s annual bid and related contractual arrangements with the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;). The insurance premiums include a beneficiary premium, which is the responsibility of the PDP member, and can be subsidized by CMS in the case of low-income members, and a direct premium paid by CMS. Premiums collected in advance are initially recorded within other insurance liabilities and are then recognized ratably as revenue over the period in which members are entitled to receive benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues also include a risk-sharing feature of the Medicare Part D program design referred to as the risk corridor. The Company estimates variable consideration in the form of amounts payable to, or receivable from, CMS under the risk corridor, and adjusts revenue based on calculations of additional subsidies to be received from or owed to CMS at the end of the reporting year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to Medicare Part D premiums, the Company receives additional payments each month from CMS related to catastrophic reinsurance, low-income cost-sharing subsidies and coverage gap benefits. If the subsidies received differ from the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amounts earned from actual prescriptions transferred, the difference is recorded in either accounts receivable, net or accrued expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Services segment sells prescription drugs directly through its specialty and mail order pharmacy offerings and indirectly through the Company&#8217;s retail pharmacy network. The Company&#8217;s pharmacy benefit arrangements are accounted for in a manner consistent with a master supply arrangement as there are no contractual minimum volumes and each prescription is considered a separate purchasing decision and distinct performance obligation transferred at a point in time. PBM services performed in connection with each prescription claim are considered part of a single performance obligation which culminates in the fulfillment of prescription drugs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue using the gross method at the contract price negotiated with its clients when the Company has concluded it controls the prescription drug before it is transferred to the client plan members. The Company controls prescriptions fulfilled indirectly through its retail pharmacy network because it has separate contractual arrangements with those pharmacies, has discretion in setting the price for the transaction and assumes primary responsibility for fulfilling the promise to provide prescription drugs to its client plan members while also performing the related PBM services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include (i) the portion of the price the client pays directly to the Company, net of any discounts earned on brand name drugs or other discounts and refunds paid back to the client (see &#8220;Drug Discounts&#8221; and &#8220;Guarantees&#8221; below), (ii) the price paid to the Company by client plan members for mail order prescriptions and the price paid to retail network pharmacies by client plan members for retail prescriptions (&#8220;retail co-payments&#8221;), and (iii) claims based administrative fees for retail pharmacy network contracts. Sales taxes are not included in revenues. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when control of the prescription drugs is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those prescription drugs. The Company has established the following revenue recognition policies for the Health Services segment:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by third party pharmacies in the Company&#8217;s retail pharmacy network and associated administrative fees are recognized at the Company&#8217;s point-of-sale, which is when the claim is adjudicated by the Company&#8217;s online claims processing system and the Company has transferred control of the prescription drug and completed all of its performance obligations.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by specialty and mail order pharmacies are recognized when the prescription drug is delivered to the client plan member. At the time of delivery, the Company has performed substantially all of its performance obligations under its client contracts and does not experience a significant level of returns or reshipments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts under which the Company acts as an agent or does not control the prescription drugs prior to transfer to the client plan member, revenue is recognized using the net method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Drug Discounts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records revenue net of manufacturers&#8217; rebates earned by its clients based on their plan members&#8217; utilization of brand-name formulary drugs. The Company estimates these rebates at period-end based on actual and estimated claims data and its estimates of the manufacturers&#8217; rebates earned by its clients. The estimates are based on the best available data at period-end and recent history for the various factors that can affect the amount of rebates due to the client. The Company adjusts its rebates payable to clients to the actual amounts paid when these rebates are paid or as significant events occur. Any cumulative effect of these adjustments is recorded against revenues at the time it is identified. Adjustments generally result from contract changes with clients or manufacturers that have retroactive rebate adjustments, differences between the estimated and actual product mix subject to rebates, or whether the brand name drug was included in the applicable formulary. The effect of adjustments between estimated and actual manufacturers&#8217; rebate amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantees</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also adjusts revenues for refunds owed to clients resulting from pricing guarantees and performance against defined service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Walk-In Medical Clinics</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For services provided by the Company&#8217;s walk-in medical clinics, revenue recognition occurs for completed services provided to patients, with adjustments taken for third party payor contractual obligations and patient direct bill historical collection rates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy &amp; Consumer Wellness Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Retail Pharmacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s retail drugstores recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims under other retail network arrangements. Revenues are adjusted for refunds owed to third party payers resulting from pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Company gift cards purchased by customers is deferred as a contract liability until goods or services are transferred. Any amounts not expected to be redeemed by customers (i.e., breakage) are recognized based on historical redemption patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer returns are not material to the Company&#8217;s operating results or financial condition. Sales taxes are not included in revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Loyalty and Other Programs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customer loyalty program, ExtraCare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, consists of two components, ExtraSavings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Rewards. ExtraSavings are coupons that are recorded as a reduction of revenue when redeemed as the Company concluded that they do not represent a promise to the customer to deliver additional goods or services at the time of issuance because they are not tied to a specific transaction or spending level. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ExtraBucks Rewards are accumulated by customers based on their historical spending levels. Thus, the Company has determined that there is an additional performance obligation to those customers at the time of the initial transaction. The Company allocates the transaction price to the initial transaction and the ExtraBucks Rewards transaction based upon the relative standalone selling price, which considers historical redemption patterns for the rewards. Revenue allocated to ExtraBucks Rewards is recognized as those rewards are redeemed. At the end of each period, unredeemed ExtraBucks Rewards are reflected as a contract liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also offers a subscription-based membership program, CarePass</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, under which members are entitled to a suite of benefits delivered over the course of the subscription period, as well as a promotional reward that can be redeemed for future goods and services. Subscriptions are paid for on a monthly or annual basis at the time of or in advance of the Company delivering the goods and services. Revenue from these arrangements is recognized as the performance obligations are satisfied.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-term Care</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those goods or services. Each prescription claim represents a separate performance obligation of the Company, separate and distinct from other prescription claims under customer arrangements. A significant portion of long-term care revenue from sales of pharmaceutical and medical products is reimbursed by the federal Medicare Part D program and, to a lesser extent, state Medicaid programs. The Company monitors its revenues and receivables from these reimbursement sources, as well as long-term care facilities and other third party insurance payors, and reduces revenue at the revenue recognition date to properly account for the variable consideration due to anticipated differences between billed and reimbursed amounts. Accordingly, the total revenues and receivables reported in the Company&#8217;s consolidated financial statements are recorded at the amount expected to be ultimately received from these payors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient co-payments associated with Medicare Part D, certain state Medicaid programs, Medicare Part B and certain third party payors typically are not collected at the time products are delivered or services are rendered, but are billed to the individuals as part of normal billing procedures and subject to normal accounts receivable collections procedures.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company&#8217;s revenue by major source in each segment for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.701%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.334%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp;<br/>Consumer<br/>Wellness</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">166,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">83,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(45,154)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">205,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">85,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">85,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91,350&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">169,576&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">108,596&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(47,585)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">322,467&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Health Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">102,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail &amp; specialty </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">169,576&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">150,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">77,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43,913)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">184,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">76,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">76,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,328)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,846&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">82,119&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">153,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">101,620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(46,241)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">292,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Health Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail &amp; specialty </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">153,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">139,453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">71,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(40,350)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">171,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,712)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">75,409&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,354&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">93,579&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(42,062)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Health Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail &amp; specialty </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Health Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies. Effective January 1, 2023, pharmacy network also includes activity associated with Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, which permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order. Maintenance Choice activity was previously reflected in mail &amp; specialty. Segment financial information has been revised to reflect these changes.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Health Services mail &amp; specialty is defined as specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as mail order and specialty claims fulfilled by the Pharmacy &amp; Consumer Wellness segment. Effective January 1, 2023, mail &amp; specialty excludes Maintenance Choice activity, which is now reflected within pharmacy network. Segment financial information has been revised to reflect these changes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2022 and 2021, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(371)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products Sold</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for cost of products sold as follows:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products sold includes: (i) the cost of prescription drugs sold during the reporting period directly through the Company&#8217;s specialty and mail order pharmacies and indirectly through the Company&#8217;s retail pharmacy network, (ii) shipping and handling costs, (iii) administrative service fees paid to the Pharmacy &amp; Consumer Wellness segment for specialty and mail order pharmacy fulfillment services and (iv) the operating costs of the Company&#8217;s client service operations and related information technology support costs including depreciation and amortization. The cost of prescription drugs sold component of cost of products sold includes: (i) the cost of the prescription drugs purchased from manufacturers or distributors and shipped to members in clients&#8217; benefit plans from the Company&#8217;s mail order pharmacies, net of any volume-related or other discounts (see &#8220;Vendor Allowances and Purchase Discounts&#8221; below) and (ii) the cost of prescription drugs sold (including retail co-payments) through the Company&#8217;s retail pharmacy network under contracts where the Company is the principal, net of any volume-related or other discounts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy &amp; Consumer Wellness Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products sold includes: the cost of merchandise sold during the reporting period, including the costs of prescription drugs sold through its retail pharmacies, net of any volume-related or other discounts, the related purchasing costs, warehousing and delivery costs (including depreciation and amortization), the operating costs of the Company&#8217;s specialty and mail order pharmacy fulfillment operations and actual and estimated inventory losses. </span></div><div><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vendor Allowances and Purchase Discounts </span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for vendor allowances and purchase discounts as follows: </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Services segment receives purchase discounts on products purchased. Contractual arrangements with vendors, including manufacturers, wholesalers and retail pharmacies, normally provide for the Health Services segment to receive purchase discounts from established list prices in one, or a combination, of the following forms: (i) a direct discount at the time of purchase, (ii) a discount for the prompt payment of invoices or (iii) when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy), a discount (or rebate) paid subsequent to dispensing. These rebates are recognized when prescriptions are dispensed and are generally calculated and billed to manufacturers within 30 days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Company&#8217;s operating results or financial condition. The Company accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Health Services segment also receives additional discounts under its wholesaler contracts if it exceeds contractually defined purchase volumes. In addition, the Health Services segment receives fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of products sold. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy &amp; Consumer Wellness Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vendor allowances received by the Pharmacy &amp; Consumer Wellness segment reduce the carrying cost of inventory and are recognized in cost of products sold when the related inventory is sold, unless they are specifically identified as a reimbursement of incremental costs for promotional programs and/or other services provided. Amounts that are directly linked to advertising commitments are recognized as a reduction of advertising expense (included in operating expenses) when the related advertising commitment is satisfied. Any amounts received in excess of the actual cost incurred also reduce the carrying cost of inventory. The total value of any upfront payments received from vendors that are linked to purchase commitments is initially deferred. The deferred amounts are then amortized to reduce cost of products sold over the life of the contract based upon sales volume. The total value of any upfront payments received from vendors that are not linked to purchase commitments is also initially deferred. The deferred amounts are then amortized to reduce cost of products sold on a straight-line basis over the life of the related contract. The total amortization of these upfront payments was not material to the Company&#8217;s consolidated financial statements in any of the periods presented. </span></div><div><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Reform</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Insurer Fee</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning on January 1, 2014, the ACA imposed an annual premium-based health insurer fee (&#8220;HIF&#8221;) for each calendar year, payable in September, which was not deductible for tax purposes. The Company was required to estimate a liability for the HIF at the beginning of the calendar year in which the fee was payable with a corresponding deferred asset that was amortized ratably to operating expenses over the calendar year. The Company recorded the liability for the HIF in accrued expenses and recorded the deferred asset in other current assets. In December 2019, the HIF was repealed for calendar years after 2020, therefore there was no expense related to the HIF in the years ended December&#160;31, 2022 and 2021. In the year ended December 31, 2020, operating expenses included $1.0&#160;billion related to the Company&#8217;s share of the HIF. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established a permanent risk adjustment program to transfer funds from qualified individual and small group insurance plans with below average risk scores to plans with above average risk scores. Based on the risk of the Company&#8217;s qualified plan members relative to the average risk of members of other qualified plans in comparable markets, as defined by the ACA, the Company estimates its ultimate risk adjustment receivable (recorded in accounts receivable) or payable (recorded in accrued expenses) for the current calendar year and reflects the pro-rata year-to-date impact as an adjustment to premium revenue. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Corridor</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established a temporary risk corridor program, which expired at the end of 2016, for qualified individual and small group health insurance plans. Under this program, health insurance companies were to make payments to, or receive payments from, the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) based on their ratio of allowable costs to target costs (as defined by the ACA). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company filed a lawsuit in August 2019 to recover the $313&#160;million it was owed under the ACA&#8217;s risk corridor program, which had been stayed pending the Supreme Court decision. In April 2020, the U.S. Supreme Court ruled that health insurance companies may sue the federal government for amounts owed as calculated under the ACA&#8217;s temporary risk corridor program. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company received the $313&#160;million it was owed under the ACA&#8217;s risk corridor program. The Company recorded the risk corridor payment as an increase to premium revenue in the year ended December 31, 2020. After considering offsetting items such as the ACA&#8217;s minimum MLR rebate requirements and premium taxes, the Company recorded pre-tax income of $307&#160;million and after-tax income of $223&#160;million during the year ended December&#160;31, 2020. </span></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Costs </span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs, which are reduced by the portion funded by vendors, are expensed when the related advertising takes place. Net advertising costs, which are included in operating expenses, were $745 million, $707 million and $613 million in 2022, 2021 and 2020, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc0MDU2_6fb0217d-b4b8-4272-817b-3803971eadab">three</span> to five years) using the straight-line method. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year or years in which the differences are expected to reverse. The effect of a change in the tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date of such change.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, and the Company&#8217;s recent operating results. The Company establishes a valuation allowance when it does not consider it more likely than not that a deferred tax asset will be recovered.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions on the basis of a two-step process whereby (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and/or penalties related to uncertain tax positions are recognized in the income tax provision.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit Plans</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors defined benefit pension plans (&#8220;pension plans&#8221;) and other postretirement employee benefit plans (&#8220;OPEB plans&#8221;) for its employees and retirees. The Company recognizes the funded status of its pension and OPEB plans on the consolidated balance sheets based on the year-end measurements of plan assets and benefit obligations. When the fair value of plan assets are in excess of the plan benefit obligations, the amounts are reported in other current assets and other assets. When the fair value of plan benefit obligations are in excess of plan assets, the amounts are reported in accrued expenses and other long-term liabilities based on the amount by which the actuarial present value of benefits payable in the next twelve months included in the benefit obligation exceeds the fair value of plan assets. The net periodic benefit income for the Company&#8217;s pension and OPEB plans do not contain a service cost component as these plans have been frozen for an extended period of time.&#160;Non-service cost components of pension and postretirement net periodic benefit income are included in other income in the consolidated statements of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is computed using the treasury stock method. The Company calculates basic earnings per share based on the weighted average number of common shares outstanding for the period. See Note 15 &#8216;&#8216;Earnings Per Share&#8217;&#8217; for additional information.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shares Held in Trust</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains grantor trusts, which held approximately one million shares of its common stock at both December&#160;31, 2022 and 2021. These shares are designated for use under various employee compensation plans. Since the Company holds these shares, they are excluded from the computation of basic and diluted shares outstanding. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in (i) a generic pharmaceutical sourcing entity, (ii) certain hedge fund and private equity investments and (iii) certain real estate partnerships that are considered VIEs. The Company does not have a future obligation to fund losses or debts on behalf of these investments; however, it may voluntarily contribute funds. In evaluating whether the Company is the primary beneficiary of a VIE, the Company considers several factors, including whether the Company has (a) the power to direct the activities that most significantly impact the VIE&#8217;s economic performance and (b) the obligation to absorb losses and the right to receive benefits that could potentially be significant to the VIE. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities - Primary Beneficiary</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014, the Company and Cardinal Health, Inc. (&#8220;Cardinal&#8221;) established Red Oak Sourcing, LLC (&#8220;Red Oak&#8221;), a generic pharmaceutical sourcing entity in which the Company and Cardinal each own 50%. The Red Oak arrangement had an initial term of ten years. In 2021, the Red Oak arrangement was amended to extend the initial term an additional five years, for a total term of 15 years. Under this arrangement, the Company and Cardinal contributed their sourcing and supply chain expertise to Red Oak and agreed to source and negotiate generic pharmaceutical supply contracts for both companies through Red Oak; however, Red Oak does not own or hold inventory on behalf of either company. No physical assets (e.g., property and equipment) were contributed to Red Oak by either company, and minimal funding was provided to capitalize Red Oak. The Company has determined that it is the primary beneficiary of this VIE because it has the ability to direct the activities of Red Oak. Consequently, the Company consolidates Red Oak in its consolidated financial statements within the Pharmacy &amp; Consumer Wellness segment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardinal is required to pay the Company quarterly payments, which began in October 2014 and will extend through June 2029. As milestones are met, the quarterly payments increase. The Company received $183 million from Cardinal during each of the years ended December&#160;31, 2022, 2021 and 2020. The payments reduce the Company&#8217;s carrying value of inventory and are recognized in cost of products sold when the related inventory is sold.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities - Other Variable Interest Holder</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has invested in certain VIEs for which it has determined that it is not the primary beneficiary, consisting of the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Hedge fund and private equity investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company invests in hedge fund and private equity investments in order to generate investment returns for its investment portfolio supporting its insurance businesses.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Real estate partnerships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company invests in various real estate partnerships, including those that construct, own and manage low-income housing developments. For the low income housing development investments, substantially all of the projected benefits to the Company are from tax credits and other tax benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not the primary beneficiary of these VIEs because the nature of the Company&#8217;s involvement with the activities of these VIEs does not give the Company the power to direct the activities that most significantly impact their economic performance. The Company records the amount of its investment in these VIEs as long-term investments on the consolidated balance sheets and recognizes its share of each VIE&#8217;s income or losses in net income.&#160;The Company&#8217;s maximum exposure to loss from these VIEs is limited to its investment balances as disclosed below and the risk of recapture of previously recognized tax credits related to the real estate partnerships, which the Company does not consider significant.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other variable interest holder VIE assets included in long-term investments on the consolidated balance sheets at December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedge fund investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate partnerships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,289&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $60 million, $52 million and $56 million in the years ended December&#160;31, 2022, 2021 and 2020, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $87 million, $79 million and $77 million for pharmaceutical inventory purchases during the years ended December&#160;31, 2022, 2021 and 2020, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2022, 2021 and 2020, the Company made charitable contributions of&#160;$25&#160;million, $50 million and $50&#160;million, respectively,&#160;to the CVS Health Foundation, a non-profit entity that focuses on health, education and community involvement programs. The charitable contributions were recorded as operating expenses in the consolidated statements of operations within the Corporate/Other segment for the years ended December&#160;31, 2022, 2021 and 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Discontinued Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with certain business dispositions completed between 1995 and 1997, the Company retained guarantees on store lease obligations for a number of former subsidiaries, including Linens &#8216;n Things and Bob&#8217;s Stores, each of which subsequently filed for bankruptcy. The Company&#8217;s loss from discontinued operations includes lease-related costs that the Company believes it will likely be required to satisfy pursuant to these lease guarantees. See &#8220;Lease Guarantees&#8221; in Note 17 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results from discontinued operations were immaterial for the years ended December 31, 2022 and 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the results of discontinued operations for the year ended December 31, 2020. </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224251683632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions, Divestitures and Asset Sales<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Acquisitions, Divestitures and Asset Sales</a></td>
<td class="text">Acquisitions, Divestitures and Asset Sales<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed Oak Street Health Acquisition </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2023, the Company entered into a definitive merger agreement to acquire all of the outstanding shares of Oak Street Health, Inc. (&#8220;Oak Street Health&#8221;) for cash. Under the terms of the merger agreement, Oak Street Health stockholders will receive $39.00 per share in cash. The total value of the transaction is approximately $10.6&#160;billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proposed acquisition was approved by the Board of Directors at each of the respective companies and is subject to approval by a majority of Oak Street Health stockholders, receipt of regulatory approval and satisfaction of other customary closing conditions, including the expiration of the waiting period under the federal Hart-Scott-Rodino Antitrust Improvements Act of 1976. The transaction is expected to close in 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the merger agreement is terminated under certain specified circumstances and receipt of regulatory approval has not been obtained by such time, the Company will be required to pay Oak Street Health a termination fee of approximately $500&#160;million. If the merger agreement is terminated under other certain specified circumstances, including due to Oak Street Health accepting a superior proposal, Oak Street Health will be required to pay the Company a termination fee of approximately $300&#160;million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pending Signify Health Acquisition </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 2, 2022, the Company entered into a definitive merger agreement to acquire all of the outstanding shares of Signify Health, Inc. (&#8220;Signify Health&#8221;) for cash. Under the terms of the merger agreement, Signify Health stockholders will receive $30.50 per share in cash. The total value of the transaction is approximately $8&#160;billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pending acquisition was approved by the Board of Directors at each of the respective companies and the Signify Health stockholders and remains subject to receipt of regulatory approval and satisfaction of other customary closing conditions. On October 19, 2022, Signify Health and CVS Health each received a request for additional information (also known as a &#8220;second request&#8221;) from the U.S. Department of Justice (the &#8220;DOJ&#8221;) in connection with the review of the transactions contemplated by the merger agreement by the DOJ under the federal Hart-Scott-Rodino Antitrust Improvements Act of 1976. The transaction is expected to close in the second quarter of 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the merger agreement is terminated under certain specified circumstances and receipt of regulatory approval has not been obtained by such time, the Company will be required to pay Signify Health a termination fee in an amount equal to $380&#160;million. If the merger agreement is terminated under other certain specified circumstances, including due to Signify Health accepting a superior proposal, Signify Health will be required to pay the Company a termination fee in an amount equal to $228&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Held For Sale</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its portfolio for non-strategic assets. The Company determined that its Omnicare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> long-term care business (&#8220;LTC business&#8221;), which is included within the Pharmacy &amp; Consumer Wellness segment, was no longer a strategic asset and during the third quarter of 2022 committed to a plan to sell the LTC business. As of September 30, 2022, the LTC business met the criteria to be classified as held for sale and the carrying value of the LTC business was determined to be greater than its estimated fair value less costs to sell. Accordingly, the Company recorded a loss on assets held for sale of $2.5 billion during the third quarter of 2022. As of December&#160;31, 2022, the net assets of the LTC business continued to meet the criteria for held-for-sale accounting and during the fourth quarter, an incremental loss on assets held for sale of $12 million was recorded to write down the carrying value of the LTC business to its estimated fair value less costs to sell. The loss on assets held for sale represents the write-down of its customer contracts/relationships intangible assets and was recorded in the Company&#8217;s consolidated statement of operations within the Pharmacy &amp; Consumer Wellness segment. The LTC business operating income was not material for the years ended December&#160;31, 2022, 2021 and 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LTC business met the criteria to be classified as held for sale at December&#160;31, 2022, but did not meet the criteria to be classified as discontinued operations. As a result, the related assets and liabilities were included in separate held-for-sale line items of the asset and liability sections of the consolidated balance sheet. As the assets held for sale are measured at fair value on a nonrecurring basis primarily using unobservable inputs as of the measurement date, they are classified in Level 3 of the fair value hierarchy. The following table summarizes the assets and liabilities held for sale at December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">908&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of bswift</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2022, the Company sold its wholly-owned subsidiary bswift LLC (&#8220;bswift&#8221;) for approximately $735 million. bswift offers software and services that streamline benefits and human resource administration. The results of this business have historically been recorded within the Health Care Benefits segment. The Company recorded a pre-tax gain on the divestiture of $250&#160;million in the year ended December&#160;31, 2022, which is reflected as a reduction of operating expenses in the Company&#8217;s consolidated statement of operations within the Health Care Benefits segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of PayFlex </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company sold PayFlex for approximately $775&#160;million. PayFlex provides services to employers, their employees, and their former employees in the areas of tax-advantaged account reimbursement administration (flexible spending, health reimbursement, health savings, transit and parking), Consolidated Omnibus Budget Reconciliation Act (&#8220;COBRA&#8221;) administration and special-member billing administration. The results of this business have historically been reported within the Health Care Benefits segment. The Company recorded a pre-tax gain on the divestiture of $225&#160;million in the year ended December&#160;31, 2022, which is reflected as a reduction of operating expenses in the Company&#8217;s consolidated statement of operations within the Health Care Benefits segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of Thailand Health Care Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the Company reached an agreement to sell its international health care business domiciled in Thailand (&#8220;Thailand business&#8221;), comprised of approximately 266,000 medical members, which was included in the Commercial Business reporting unit within the Health Care Benefits segment. At that time, a portion of the Commercial Business goodwill was specifically allocated to the Thailand business. The net assets of the Thailand business were accounted for as assets held for sale at March 31, 2022. The carrying value of the Thailand business was determined to be greater than its estimated fair value less costs to sell and, accordingly, the Company recorded a $41 million loss on assets held for sale within the Health Care Benefits segment during the first quarter of 2022. The sale of the Thailand business closed in the second quarter of 2022, and the consideration received and ultimate loss on the sale were not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of Workers&#8217; Compensation Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2020, the Company sold its Workers&#8217; Compensation business for approximately $850&#160;million. The results of this business were reported within the Health Care Benefits segment. The Company recorded a pre-tax gain on the divestiture of $269 million in the year ended December&#160;31, 2020, which is reflected as a reduction in operating expenses in the Company&#8217;s consolidated statement of operations within the Health Care Benefits segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International Health Care Benefits Renewal Rights Asset Sale</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company sold the renewal rights of approximately 200,000 international medical members outside of the Americas, Thailand and India in connection with an Asset Purchase Agreement. As part of this agreement, the Company will introduce and help migrate these existing international medical members to the purchaser upon renewal. The Company expects the migration process to occur between July 2022 and November 2023. The Company ceased writing any new or renewal business for international medical members outside of the Americas during the fourth quarter of 2022. The consideration received related to this agreement was not material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224248846720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">Investments<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.016%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,778&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,113&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,891&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,117&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,025&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,142&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes long-term investments of $17&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><div style="padding-left:13.5pt;text-indent:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 and 2021, the Company held investments of $331 million and $450 million, respectively, related to the 2012 conversion of an existing group annuity contract from a participating to a non-participating contract. These investments are included in the total investments of large case pensions supporting non-experience-rated products. Although these investments are not accounted for as Separate Accounts assets, they are legally segregated and are not subject to claims that arise out of the Company&#8217;s business and only support future policy benefits obligations under that group annuity contract. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at December&#160;31, 2022 and 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.441%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.504%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amortized <br/>Cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allowance<br/>for Credit<br/>Losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amortized<br/>Cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,067&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,840)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,174&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,174&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,240&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results.&#160;At December&#160;31, 2022, debt securities with a fair value of $609 million, gross unrealized capital gains of $3 million and gross unrealized capital losses of </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$59 million, and at December&#160;31, 2021, debt securities with a fair value of $864 million, gross unrealized capital gains of $94 million and gross unrealized capital losses of $2 million were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income (loss).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities at December&#160;31, 2022 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair <br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,899&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,063&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,280&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage-Backed and Other Asset-Backed Securities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s residential mortgage-backed securities at December&#160;31, 2022 were issued by the Government National Mortgage Association, the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation and carry agency guarantees and explicit or implicit guarantees by the U.S. Government.&#160;At December&#160;31, 2022, the Company&#8217;s residential mortgage-backed securities had an average credit quality rating of AAA and a weighted average duration of 5.7 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s commercial mortgage-backed securities have underlying loans that are dispersed throughout the United States. Significant market observable inputs used to value these securities include loss severity and probability of default.&#160;At December&#160;31, 2022, these securities had an average credit quality rating of AAA and a weighted average duration of 5.6 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s other asset-backed securities have a variety of underlying collateral (e.g., automobile loans, credit card receivables, home equity loans and commercial loans). Significant market observable inputs used to value these securities include the unemployment rate, loss severity and probability of default.&#160;At December&#160;31, 2022, these securities had an average credit quality rating of AA and a weighted average duration of 1.0 year.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at December&#160;31, 2022 and 2021 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>&#160;Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>&#160;Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>&#160;Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,692&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,700&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,800&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,017&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,384&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#8217;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#8217;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#8217;s current prospects for recovery. Unrealized capital losses at December&#160;31, 2022 were generally caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities. As of December&#160;31, 2022, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at December&#160;31, 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting experience-<br/>rated products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting remaining<br/>products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,709&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,924&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,781&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,492&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mortgage Loans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s mortgage loans are collateralized by commercial real estate.&#160;During the years ended December 31, 2022 and 2021, the Company had the following activity in its mortgage loan portfolio:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#8217;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 1 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents loans of superior quality.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 2 to 4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 5 and 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represent loans where credit risk is not substantial, but these loans warrant management&#8217;s close attention.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon the Company&#8217;s assessments at December&#160;31, 2022 and 2021, the amortized cost basis of the Company&#8217;s mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.100%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.950%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 scheduled mortgage loan principal repayments were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Income</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the years ended December 31, 2022, 2021 and 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,201&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital gains or losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,158&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains (losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(320)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital losses include credit-related losses on debt securities of $13 million and yield-related impairment losses on debt securities of $143 million in the year ended December 31, 2022. Net realized capital gains are net of yield-related impairment losses on debt securities of $42 million and $49 million for the years ended December 31, 2021 and 2020, respectively. There were no credit-related losses on debt securities in the years ended December 31, 2021 and 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net investment income includes $35 million, $38 million and $42 million for the years ended December 31, 2022, 2021 and 2020, respectively, related to investments supporting experience-rated products. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital gains and losses recognized during the year ended December 31, 2022 related to investments in equity securities held as of December 31, 2022 were not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses in the years ended December 31, 2022, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,913&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224248845840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value</a></td>
<td class="text">Fair Value<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s consolidated financial statements requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;In this note, the Company provides details on the fair value of financial assets and liabilities and how it determines those fair values.&#160;The Company presents this information for those financial instruments that are measured at fair value for which the change in fair value impacts net income attributable to CVS Health or other comprehensive income (loss) separately from other financial assets and liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments Measured at Fair Value on the Consolidated Balance Sheets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s financial instruments are measured at fair value on the consolidated balance sheets.&#160;The fair values of these instruments are based on valuations that include inputs that can be classified within one of three levels of a hierarchy established by GAAP.&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#8220;valuation inputs&#8221;) that qualifies a financial asset or liability for each level:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Unadjusted quoted prices for identical assets or liabilities in active markets.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Valuation inputs other than Level 1 that are based on observable market data.&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Developed from unobservable data, reflecting the Company&#8217;s assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities are classified based upon the lowest level of input that is significant to the valuation.&#160;When quoted prices in active markets for identical assets and liabilities are available, the Company uses these quoted market prices to determine the fair value of financial assets and liabilities and classifies these assets and liabilities in Level 1.&#160;In other cases where a quoted market price for identical assets and liabilities in an active market is either not available or not observable, the Company estimates fair value using valuation methodologies based on available and observable market information or by using a matrix pricing model.&#160;These financial assets and liabilities are classified in Level 2.&#160;If quoted market prices are not available, the Company determines fair value using broker quotes or an internal analysis of each investment&#8217;s financial performance and cash flow projections.&#160;Thus, financial assets and liabilities may be classified in Level 3 even though there may be some significant inputs that may be observable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of the valuation methodologies used for the Company&#8217;s financial assets and liabilities that are measured at fair value, including the general classification of such assets and liabilities pursuant to the valuation hierarchy.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of cash and cash equivalents approximates fair value as maturities are less than three months. When quoted prices are available in an active market, cash equivalents are classified in Level 1 of the fair value hierarchy. Fair values of cash equivalent instruments that do not trade on a regular basis in active markets are classified as Level 2.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Where quoted prices are available in an active market, debt securities are classified in Level 1 of the fair value hierarchy.&#160;The Company&#8217;s&#160;Level 1 debt securities consist primarily of U.S. Treasury securities.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s Level 2 debt securities are obtained using models, such as matrix pricing, which use quoted market prices of debt securities with similar characteristics or discounted cash flows to estimate fair value. The </span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company reviews these prices to ensure they are based on observable market inputs that include quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets and inputs that are observable that are not prices (such as interest rates and credit risks). The Company also reviews the methodologies and the assumptions used to calculate prices from these observable inputs. On a quarterly basis, the Company selects a sample of its Level 2 debt securities&#8217; prices and compares them to prices provided by a secondary source. Variances over a specified threshold are identified and reviewed to confirm the price provided by the primary source represents an appropriate estimate of fair value. In addition, the Company&#8217;s internal investment team consistently compares the prices obtained for select Level 2 debt securities to the team&#8217;s own independent estimates of fair value for those securities.&#160;The Company obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December&#160;31, 2022 or 2021. </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also values certain debt securities using Level 3 inputs.&#160;For Level 3 debt securities, fair values are determined by outside brokers or, in the case of certain private placement securities, are priced internally.&#160;Outside brokers determine the value of these debt securities through a combination of their knowledge of the current pricing environment and market flows.&#160;The Company did not have any broker quoted debt securities for the years ended December&#160;31, 2022 and 2021. For some private placement securities, the Company&#8217;s internal staff determines the value of these debt securities by analyzing spreads of corporate and sector indices as well as interest spreads of comparable public bonds.&#160;Examples of these private placement Level 3 debt securities include certain U.S. and foreign securities and certain tax-exempt municipal securities.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company currently has two classifications of equity securities:&#160;those that are publicly traded and those that are privately placed.&#160;Publicly-traded equity securities are classified in Level 1 because quoted prices are available for these securities in an active market.&#160;For privately placed equity securities, there is no active market; therefore, these securities are classified in Level 3 because the Company prices these securities through an internal analysis of each investment&#8217;s financial statements and cash flow projections. Significant unobservable inputs consist of earnings and revenue multiples, discount for lack of marketability and comparability adjustments. An increase or decrease in any of these unobservable inputs would have resulted in a change in the fair value measurement. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no financial liabilities measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2022 or 2021. Financial assets measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,860&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,860&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,351&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,280&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,878&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,400&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,407&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,954&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,440&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,266&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,817&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_______________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes cash and cash equivalents of $6&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">States, <br/>municipalities<br/>&#160;and political <br/>subdivisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.<br/>corporate<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other asset-<br/>backed<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized capital losses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in earnings&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in net unrealized capital losses included in other comprehensive loss associated with Level 3 financial assets which were held as of December&#160;31, 2022 was $9 million during the year ended December&#160;31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.434%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">States, <br/>municipalities<br/>&#160;and political <br/>subdivisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.<br/>corporate<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other asset-<br/>backed<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Redeemable<br/>preferred<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized capital gains (losses):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in net unrealized capital losses included in other comprehensive income associated with Level 3 financial assets which were held as of December&#160;31, 2021 was $4&#160;million during the year ended December&#160;31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total gross transfers into (out of) Level 3 during the years ended December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross transfers into Level 3</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers into (out of) Level 3</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments Not Measured at Fair Value on the Consolidated Balance Sheets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the consolidated balance sheets at adjusted cost or contract value at December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">978&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">978&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">______________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information regarding the valuation of cost method investments. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes long-term debt of $3&#160;million which has been accounted for as liabilities held for sale and is included in liabilities held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts Measured at Fair Value on the Consolidated Balance Sheets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets relate to the Company&#8217;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;Net investment income and capital gains and losses on Separate Accounts assets accrue directly to such contract holders.&#160;The assets of each account are legally segregated and are not subject to claims arising from the Company&#8217;s other businesses.&#160;Deposits, withdrawals, net investment income and realized and unrealized capital gains and losses on Separate Accounts assets are not reflected in the consolidated statements of operations, shareholders&#8217; equity or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets include debt and equity securities.&#160;The valuation methodologies used for these assets are similar to the methodologies described above in this Note 4 &#8216;&#8216;Fair Value.&#8217;&#8217;&#160;Separate Accounts assets also include investments in common/collective trusts that are carried at fair value. Common/collective trusts invest in other investment funds otherwise known as the underlying funds. The Separate Accounts&#8217; interests in the common/collective trust funds are based on the fair values of the investments of the underlying funds and therefore are classified in Level 2. The assets in the underlying funds primarily consist of equity securities. Investments in common/collective trust funds are valued at their respective net asset value (&#8220;NAV&#8221;) per share/unit on the valuation date.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts financial assets at December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.953%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,048&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,599&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,782&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,017&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $85 million of other payables and $70&#160;million of other receivables at December&#160;31, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2022 and 2021, the Company had no gross transfers of Separate Accounts financial assets into or out of Level 3.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224240261840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangibles<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangibles</a></td>
<td class="text">Goodwill and Other Intangibles<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the changes in the carrying amount of goodwill by segment for the&#160;years ended December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.455%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp;<br/>Consumer<br/>Wellness</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt;padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,376&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(971)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(971)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,159&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,615&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,376&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,150&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, the decrease in the carrying amount of goodwill was primarily driven by the divestitures of bswift, PayFlex and the Thailand business. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information. During the year ended December&#160;31, 2021, the decrease in the carrying amount of goodwill was primarily driven by the impairment of the remaining goodwill of the LTC reporting unit within the Pharmacy &amp; Consumer Wellness segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2022, the Company performed its required annual impairment tests of goodwill. The results of the impairment tests indicated that there was no impairment of goodwill. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company performed its required annual impairment tests of goodwill. The results of the impairment tests indicated an impairment of the goodwill associated with the LTC reporting unit, as the reporting unit&#8217;s carrying value exceeded its fair value as of the testing date. The results of the impairment tests of the remaining reporting units indicated that there was no impairment of goodwill as of the testing date. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the LTC reporting unit continued to face challenges that have impacted the Company&#8217;s ability to grow the LTC reporting unit&#8217;s business at the rate estimated when its 2020 goodwill impairment test was performed. These challenges include lower net facility admissions, net long-term care facility customer losses and the prolonged adverse impact of the COVID-19 pandemic and the emerging new variants, which resulted in more significant declines in occupancy rates experienced by the Company&#8217;s long-term care facility customers than previously anticipated. During the third quarter of 2021, LTC management updated their 2021 annual forecast and submitted their long-term plan which showed deterioration in the financial results for the remainder of 2021 and beyond. The Company utilized these updated projections in performing its annual impairment test, which indicated that the fair value of the LTC reporting unit was lower than its carrying value, resulting in a $431&#160;million goodwill impairment charge in the third quarter of 2021. The fair value of the LTC reporting unit was determined using a combination of a discounted cash flow method and a market multiple method. As of December&#160;31, 2021, there was no remaining goodwill balance in the LTC reporting unit. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At both December&#160;31, 2022 and 2021, cumulative goodwill impairments were $6.6 billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s intangible assets as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except weighted average life</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks (indefinite-lived)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/relationships and covenants not to compete</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,668)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,060)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider networks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(862)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of Business Acquired </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,859&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,028)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,831&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks (indefinite-lived)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/relationships and covenants not to compete</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,564)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider networks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(651)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of Business Acquired </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,753&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,701)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,052&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes intangible assets of $28&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, the reduction in the customer contracts/relationships intangible assets is primarily related to the Company&#8217;s loss on assets held for sale of $2.5&#160;billion to write-down the LTC business to its estimated fair value less costs to sell. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for intangible assets totaled $1.8 billion, $2.2 billion and $2.3 billion for the years ended December 31, 2022, 2021 and 2020, respectively. The projected annual amortization expense for the Company&#8217;s intangible assets for the next five&#160;years is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,283&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224249130064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases most of its retail stores and mail order facilities and certain distribution centers and corporate offices under operating or finance leases, typically with initial terms of 15 to 25 years. The Company also leases certain equipment and other assets under operating or finance leases, typically with initial terms of 3 to 10 years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company leases pharmacy space at the stores of another retail chain for which the noncancelable contractual term of the pharmacy lease arrangement exceeds the remaining estimated economic life of the buildings. For these pharmacy lease arrangements, the Company concluded that for accounting purposes the lease term was the remaining estimated economic life of the buildings. Consequently, most of these individual pharmacy leases are finance leases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the components of net lease cost for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.160%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,633&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: sublease income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,302&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,327&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,350&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases for the years ended December&#160;31, 2022, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.160%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,689&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,714&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,724&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for interest portion of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows paid for principal portion of finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,679&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases as of December&#160;31, 2022 and 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except remaining lease term and discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,928</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,122</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,699</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,839</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,177</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,538</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,823</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance leases:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,608</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,375</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(284)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,406</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining lease term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes operating lease right-of-use assets of $56&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes current portion of operating lease liabilities of $21&#160;million and long-term operating lease liabilities of $39&#160;million which have been accounted for as liabilities held for sale and are included in liabilities held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance<br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating<br/>Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,640&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(823)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,501)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,324)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,538&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,003&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Future operating lease payments have not been reduced by minimum sublease rentals of $290 million due in the future under noncancelable subleases.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.5 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Transactions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company finances a portion of its store development program through sale-leaseback transactions. The properties are generally sold at net book value, which generally approximates fair value, and the resulting leases generally qualify and are accounted for as operating leases. The operating leases that resulted from these transactions are included in the tables above. The Company does not have any retained or contingent interests in the stores and does not provide any guarantees, other than a guarantee of lease payments, in connection with the sale-leaseback transactions. There were no sale-leaseback transactions in 2022 or 2021. Proceeds from sale-leaseback transactions totaled $101 million in the year ended December 31, 2020. Gains from sale-leaseback transactions totaled $3 million in the year ended December 31, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Office Real Estate Optimization Charges </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, the Company undertook an initiative to evaluate its corporate office real estate space in response to its new flexible work arrangement. As part of this initiative, the Company evaluated its current real estate space and changes in employee work arrangement requirements to ensure it had the appropriate space to support the business. As a result of this assessment, the Company determined that it would vacate and abandon certain leased corporate office spaces. Accordingly, in the three months ended December 31, 2022, the Company recorded office real estate optimization charges of $117&#160;million, primarily consisting of $71&#160;million related to operating lease right-of-use assets and $44&#160;million related to property and equipment, within the Health Care Benefits, Corporate/Other and Health Services segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Store Impairment Charges</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its retail store right-of-use and property and equipment assets for impairment at the retail store level, which is the lowest level at which cash flows can be identified. For retail stores where there is an indicator of impairment present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated undiscounted future cash flows used in the analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to its estimated fair value which is the greater of the asset group&#8217;s estimated future cash flows (discounted), or the consideration of what a market participant would pay to lease the assets, net of leasing costs. The Company&#8217;s estimate of fair value considers historical results, current operating trends, consolidated sales, profitability and cash flow results and forecasts. For assets which the Company has determined it will be able to sublease, the estimated future cash flows include the estimated sublease income, net of estimated leasing costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the carrying value of an asset group exceeds its estimated fair value, an impairment loss is recorded to reduce the value of the asset group to its estimated fair value. As the impaired assets are measured at fair value on a nonrecurring basis primarily using unobservable inputs as of the measurement date, the assets are classified in Level 3 of the fair value hierarchy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, the Company completed a strategic review of its retail business and announced the creation of new formats for its stores to continue to drive higher engagement with customers. As part of this review, the Company evaluated changes in population, consumer buying patterns and future health needs to ensure it has the right kinds of stores in the right locations for consumers and for the business. In connection with this initiative, on November 17, 2021, the Board of Directors of CVS Health Corporation (the &#8220;Board&#8221;) authorized the closing of approximately 900 retail stores, approximately 300 stores each year, between 2022 and 2024. As a result, management determined that there were indicators of impairment with respect to the impacted stores&#8217; asset groups, including the associated operating lease right-of-use assets and property and equipment. A long-lived asset impairment test was performed during the fourth quarter of 2021 and the results of the impairment test indicated that the fair value of certain retail store asset groups was lower than their respective carrying values. Accordingly, in the three months ended December 31, 2021, the Company recorded a store impairment charge of approximately $1.4 billion, consisting of a write down of approximately $1.1&#160;billion related to operating lease right-of-use assets and $261&#160;million related to property and equipment, within the Pharmacy &amp; Consumer Wellness segment. Subsequent to the impairment loss, the fair value of the associated operating lease right-of use assets and property and equipment were $356&#160;million and $185&#160;million, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases most of its retail stores and mail order facilities and certain distribution centers and corporate offices under operating or finance leases, typically with initial terms of 15 to 25 years. The Company also leases certain equipment and other assets under operating or finance leases, typically with initial terms of 3 to 10 years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company leases pharmacy space at the stores of another retail chain for which the noncancelable contractual term of the pharmacy lease arrangement exceeds the remaining estimated economic life of the buildings. For these pharmacy lease arrangements, the Company concluded that for accounting purposes the lease term was the remaining estimated economic life of the buildings. Consequently, most of these individual pharmacy leases are finance leases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the components of net lease cost for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.160%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,633&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: sublease income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,302&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,327&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,350&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases for the years ended December&#160;31, 2022, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.160%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,689&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,714&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,724&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for interest portion of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows paid for principal portion of finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,679&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases as of December&#160;31, 2022 and 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except remaining lease term and discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,928</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,122</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,699</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,839</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,177</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,538</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,823</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance leases:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,608</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,375</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(284)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,406</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining lease term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes operating lease right-of-use assets of $56&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes current portion of operating lease liabilities of $21&#160;million and long-term operating lease liabilities of $39&#160;million which have been accounted for as liabilities held for sale and are included in liabilities held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance<br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating<br/>Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,640&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(823)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,501)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,324)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,538&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,003&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Future operating lease payments have not been reduced by minimum sublease rentals of $290 million due in the future under noncancelable subleases.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.5 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Transactions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company finances a portion of its store development program through sale-leaseback transactions. The properties are generally sold at net book value, which generally approximates fair value, and the resulting leases generally qualify and are accounted for as operating leases. The operating leases that resulted from these transactions are included in the tables above. The Company does not have any retained or contingent interests in the stores and does not provide any guarantees, other than a guarantee of lease payments, in connection with the sale-leaseback transactions. There were no sale-leaseback transactions in 2022 or 2021. Proceeds from sale-leaseback transactions totaled $101 million in the year ended December 31, 2020. Gains from sale-leaseback transactions totaled $3 million in the year ended December 31, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Office Real Estate Optimization Charges </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, the Company undertook an initiative to evaluate its corporate office real estate space in response to its new flexible work arrangement. As part of this initiative, the Company evaluated its current real estate space and changes in employee work arrangement requirements to ensure it had the appropriate space to support the business. As a result of this assessment, the Company determined that it would vacate and abandon certain leased corporate office spaces. Accordingly, in the three months ended December 31, 2022, the Company recorded office real estate optimization charges of $117&#160;million, primarily consisting of $71&#160;million related to operating lease right-of-use assets and $44&#160;million related to property and equipment, within the Health Care Benefits, Corporate/Other and Health Services segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Store Impairment Charges</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its retail store right-of-use and property and equipment assets for impairment at the retail store level, which is the lowest level at which cash flows can be identified. For retail stores where there is an indicator of impairment present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated undiscounted future cash flows used in the analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to its estimated fair value which is the greater of the asset group&#8217;s estimated future cash flows (discounted), or the consideration of what a market participant would pay to lease the assets, net of leasing costs. The Company&#8217;s estimate of fair value considers historical results, current operating trends, consolidated sales, profitability and cash flow results and forecasts. For assets which the Company has determined it will be able to sublease, the estimated future cash flows include the estimated sublease income, net of estimated leasing costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the carrying value of an asset group exceeds its estimated fair value, an impairment loss is recorded to reduce the value of the asset group to its estimated fair value. As the impaired assets are measured at fair value on a nonrecurring basis primarily using unobservable inputs as of the measurement date, the assets are classified in Level 3 of the fair value hierarchy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, the Company completed a strategic review of its retail business and announced the creation of new formats for its stores to continue to drive higher engagement with customers. As part of this review, the Company evaluated changes in population, consumer buying patterns and future health needs to ensure it has the right kinds of stores in the right locations for consumers and for the business. In connection with this initiative, on November 17, 2021, the Board of Directors of CVS Health Corporation (the &#8220;Board&#8221;) authorized the closing of approximately 900 retail stores, approximately 300 stores each year, between 2022 and 2024. As a result, management determined that there were indicators of impairment with respect to the impacted stores&#8217; asset groups, including the associated operating lease right-of-use assets and property and equipment. A long-lived asset impairment test was performed during the fourth quarter of 2021 and the results of the impairment test indicated that the fair value of certain retail store asset groups was lower than their respective carrying values. Accordingly, in the three months ended December 31, 2021, the Company recorded a store impairment charge of approximately $1.4 billion, consisting of a write down of approximately $1.1&#160;billion related to operating lease right-of-use assets and $261&#160;million related to property and equipment, within the Pharmacy &amp; Consumer Wellness segment. Subsequent to the impairment loss, the fair value of the associated operating lease right-of use assets and property and equipment were $356&#160;million and $185&#160;million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224403316512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract', window );"><strong>Health Care and Other Insurance Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock', window );">Health Care Costs Payable</a></td>
<td class="text">Health Care Costs Payable<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is information about incurred and cumulative paid health care claims development as of December&#160;31, 2022, net of reinsurance, and the total IBNR liabilities plus expected development on reported claims included within the net incurred claims amounts. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for information on how the Company estimates IBNR reserves and health care costs payable as well as changes to those methodologies, if any. The Company&#8217;s estimate of IBNR liabilities is primarily based on trend and completion factors. Claim frequency is not used in the calculation of the Company&#8217;s liability. In addition, it is impracticable to disclose claim frequency information for health care claims due to the Company&#8217;s inability to gather consistent claim frequency information across its multiple claims processing systems. Any claim frequency count disclosure would not be comparable across the Company&#8217;s different claim processing systems and would not be consistent from period to period based on the volume of claims processed through each system. As a result, health care claim count frequency is not included in the disclosures below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information about incurred and paid health care claims development for the year ended December&#160;31, 2021 is presented as required unaudited supplemental information.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Incurred Health Care Claims,<br/>Net of Reinsurance<br/>For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,444&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cumulative Paid Health Care Claims,<br/>Net of Reinsurance<br/>For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,714&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All outstanding liabilities for health care costs payable prior to 2021, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total outstanding liabilities for health care costs payable, net of reinsurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,926&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the Company&#8217;s liabilities for IBNR plus expected development on reported claims totaled approximately $7.8 billion. Substantially all of the Company&#8217;s liabilities for IBNR plus expected development on reported claims at December&#160;31, 2022 related to the current calendar year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the December&#160;31, 2022 health care net incurred and paid claims development tables to the health care costs payable liability on the consolidated balance sheet were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.105%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-duration health care costs payable, net of reinsurance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance lines other than short duration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total health care costs payable</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,142&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in health care costs payable during the years ended December 31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.160%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of period </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,678&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Impact of discount rate on long-duration insurance reserves </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of period, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,670&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,926&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,874&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(654)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(788)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(429)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,745&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,406&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,115&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,129&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Impact of discount rate on long-duration insurance reserves </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,142&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,678&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,936&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the difference between the current discount rate and the locked-in discount rate on long-duration insurance reserves which is recorded within accumulated other comprehensive income (loss) on the consolidated balance sheets. Refer to Note 8 &#8216;&#8216;Other Insurance Liabilities and Separate Accounts&#8217;&#8217; for further information related to the adoption of the long-duration insurance contracts accounting standard.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total incurred health care costs for the years ended December&#160;31, 2022, 2021 and 2020 in the table above exclude $79 million, $58 million and $41 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the consolidated balance sheets and $249 million, $271 million and $221 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the consolidated balance sheets. The incurred health care costs for the years ended December 31, 2021 and 2020 also exclude $16 million and $11 million, respectively, for premium deficiency reserves related to the Company&#8217;s Medicaid products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of prior years&#8217; health care costs payable decreased by $654 million, $788 million and $429 million in 2022, 2021 and 2020, respectively, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#8217;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year. This development does not directly correspond to an increase in the Company&#8217;s operating results as these reductions were offset by estimated current period health care costs when the Company established the estimate of the current year health care costs payable.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Health Care and Other Insurance Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -URI https://asc.fasb.org/subtopic&amp;trid=2560295<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224240356416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Insurance Liabilities and Separate Accounts<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceContractAcquisitionCostTextBlock', window );">Other Insurance Liabilities and Separate Accounts</a></td>
<td class="text">Other Insurance Liabilities and Separate Accounts<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the Financial Accounting Standards Board issued ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944) (the &#8220;long-duration insurance standard&#8221;). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted this accounting standard on January 1, 2023, using the modified retrospective transition method as of January 1, 2021, also referred to as the &#8220;transition date&#8221;, for changes to its liabilities for future policy benefits, deferred acquisition costs and value of business acquired intangible asset. Upon adoption, the Company recorded a transition date net adjustment to reduce accumulated other comprehensive income (loss) by $986&#160;million ($766&#160;million after-tax) with a corresponding increase to its liability for future policy benefits, the majority of which is included within other insurance liabilities and other long-term liabilities on the consolidated balance sheets. The transition date net adjustment was a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#8217;s expected investment yield under the historical guidance. The Company was not required to record an adjustment to retained earnings on the transition date. Prior period financial information subsequent to the transition date has been revised to reflect the adoption of the long-duration insurance standard.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes changes in the balances of long-duration insurance liabilities as a result of the adoption of the long-duration insurance standard effective January 1, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Large Case<br/>Pensions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term<br/>Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020, net of reinsurance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,142</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,142</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in discount rate assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Removal of shadow adjustments in accumulated other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted balance at January 1, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,647</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,695</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted balance at January 1, 2021, net of reinsurance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,647</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,695</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of New Long-Duration Insurance Contracts Standard on Financial Statement Line Items</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the consolidated statement of operations for the years ended December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported<br/>December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted <br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statement of Operations:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,281</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,073</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314,721</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314,513</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,746</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,954</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,628</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,836</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,165</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,327</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,165</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,327</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,149</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,311</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to CVS Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to CVS Health</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported<br/>December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted <br/>December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statement of Operations:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,260</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,188</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,066</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,918</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,801</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,193</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,310</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,420</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,537</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,522</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,548</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,898</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,989</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,898</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,989</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,910</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,001</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to CVS Health</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to CVS Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the consolidated balance sheet as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.716%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported<br/>December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted <br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Balance Sheet:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,685</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,636</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,682</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,633</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,754</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,803</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,275</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,275</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,406</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,142</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other insurance liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,736</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(315)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,421</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,880</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term insurance liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,108</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(273)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,835</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,732</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,730</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,960</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(454)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,506</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,145</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,398</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,465)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,264)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total CVS Health shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,469</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,315</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,769</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,275</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,275</span></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.716%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported<br/>December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted <br/>December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Balance Sheet:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,292</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,319</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,008</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,035</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,052</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,999</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,052</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,808</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,678</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other insurance liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,303</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,807</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,719</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,270</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,115</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term insurance liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,402</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">833</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,235</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,904</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,907</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,618</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,211</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,906</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,997</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">965</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(631)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total CVS Health shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,075</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(540)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,535</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,381</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(540)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,841</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,999</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,052</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the consolidated statement of cash flows for the years ended December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported<br/>December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted <br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statement of Cash Flows:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation of net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,165</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,327</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments required to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,247</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,224</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,075)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,029)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities, net of effects from acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(566)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(491)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable and other insurance liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,247</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,468</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,463</span></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported<br/>December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted <br/>December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statement of Cash Flows:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation of net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,898</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,989</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments required to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,512</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,486</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(428)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(402)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities, net of effects from acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable and other insurance liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,852</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,856</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future Policy Benefits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the components of the change in the liability for future policy benefits, which is included in other insurance liabilities and other long-term insurance liabilities on the consolidated balance sheets, during the years ended December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Large Case<br/>Pensions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term<br/>Care</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected net premiums </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of period - current discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums (actual)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of period - current discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected future policy benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of period - current discount rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,606&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments (actual)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,425&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of period - current discount rate</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,252&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits, net of reinsurance recoverable</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,252&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The present value of expected net premiums is equivalent to the present value of expected gross premiums for the long-term care insurance contracts as net premiums are set equal to gross premiums.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Large Case<br/>Pensions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term<br/>Care</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected net premiums </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of period - current discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums (actual)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of period - current discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected future policy benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of period - current discount rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,844&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,468&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments (actual)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(313)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of period - current discount rate</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,991&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits, net of reinsurance recoverable</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,602&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The present value of expected net premiums is equivalent to the present value of expected gross premiums for the long-term care insurance contracts as net premiums are set equal to gross premiums.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of undiscounted expected gross premiums and expected future benefit payments for long-duration insurance liabilities as of December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Large case pensions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected future benefit payments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,539</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,882</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected gross premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected future benefit payments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,265</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,115</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected gross premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average interest rate used in the measurement of the long-duration insurance liabilities as of December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Large case pensions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accretion rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.24%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.53%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accretion rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.11%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.11%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.39%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.88%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average durations (in years) of the long-duration insurance liabilities as of December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large case pensions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term care</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any material differences between the actual experience and expected experience for the significant assumptions used in the computation of the liability for future policy benefits.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policyholders&#8217; Funds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in policyholders&#8217; funds related to long-duration insurance contracts, which are included in policyholders&#8217; funds and other long-term liabilities on the consolidated balance sheets, during the years ended December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except weighted average crediting rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits received</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policy charges</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surrenders and withdrawals</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest credited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in net unrealized gains (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds, end of the period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average crediting rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.72%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.81%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount at risk</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the fair value of assets, by major investment category, supporting Separate Accounts as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,677&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,281&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities and common/collective trusts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,017&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $85 million of other payables and $70&#160;million of other receivables at December&#160;31, 2022 and 2021, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in Separate Accounts liabilities during the years ended December&#160;31, 2022 and 2021: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate Accounts liability, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,087&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,881&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums and deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surrenders and withdrawals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(581)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(947)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(984)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,130)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers from general account</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate Accounts liability, end of the period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,087&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value, end of the period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The Company did not recognize any gains or losses on assets transferred to Separate Accounts during the years ended December&#160;31, 2022 and 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceContractAcquisitionCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for cost related directly to successful acquisition of new and renewal of insurance contract. Includes, but is not limited to, deferred policy acquisition cost, deferred sale inducement cost, and present value of future profit of insurance contract acquired in business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=4737841<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceContractAcquisitionCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224251908176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Borrowings and Credit Agreements</a></td>
<td class="text">Borrowings and Credit Agreements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s borrowings as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.452%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5% senior notes due July 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.75% senior notes due November 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8% senior notes due June 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4% senior notes due December 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.375% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.625% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5% senior notes due November 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5% senior notes due December 2024 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1% senior notes due March 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.875% senior notes due July 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875% senior notes due June 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3% senior notes due August 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.625% senior notes due April 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.25% senior notes due June 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3% senior notes due August 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3% senior notes due March 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.25% senior notes due August 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.75% senior notes due April 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.75% senior notes due August 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.875% senior notes due February 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.125% senior notes due September 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.875% senior notes due July 2035</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.625% senior notes due June 2036</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.75% senior notes due December 2037</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.78% senior notes due March 2038</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.125% senior notes due September 2039</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.125% senior notes due April 2040</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7% senior notes due August 2040</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.75% senior notes due May 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5% senior notes due May 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.125% senior notes due November 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3% senior notes due December 2043</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.75% senior notes due March 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.125% senior notes due July 2045</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.875% senior notes due August 2047</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.05% senior notes due March 2048</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.25% senior notes due April 2050</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUyLTAtMS0xLTI2NTI0Nw_1b8d2063-d583-4908-be86-f25a8a8346c8"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUyLTAtMS0xLTI2NTI0Nw_d9e5828d-1d67-442b-bf21-ed9fd901073c">Finance lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt principal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,753&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,743&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt discounts and deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(786)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,257&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,778)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,479&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,971&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">__________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes long-term debt of $3&#160;million which has been accounted for as liabilities held for sale and is included in liabilities held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s required repayments of debt principal due during each of the next five&#160;years and thereafter, as of December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt principal</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,753&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for a summary of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">maturities of the Company&#8217;s finance lease liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper and Back-up Credit Facilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any commercial paper outstanding as of December 31, 2022 or 2021. In connection with its commercial paper program, the Company maintains a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 16, 2025, a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 11, 2026, and a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 16, 2027. The credit facilities allow for borrowings at various rates that are dependent, in part, on the Company&#8217;s public debt ratings and require the Company to pay a weighted average quarterly facility fee of approximately 0.03%, regardless of usage. As of December&#160;31, 2022 and 2021, there were no borrowings outstanding under any of the Company&#8217;s back-up credit facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Home Loan Bank of Boston (&#8220;FHLBB&#8221;)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A subsidiary of the Company is a member of the FHLBB. As a member, the subsidiary has the ability to obtain cash advances, subject to certain minimum collateral requirements. The maximum borrowing capacity available from the FHLBB as of December&#160;31, 2022 was approximately $915 million. At both December&#160;31, 2022 and 2021, there were no outstanding advances from the FHLBB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exercise of Par Call Redemptions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company exercised the par call redemption on its outstanding 3.5% senior notes due July 2022 to redeem for cash on hand the entire $1.5&#160;billion aggregate principal amount. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Company exercised the par call redemption on its outstanding 2.75% senior notes due November 2022 (issued by Aetna Inc. (&#8220;Aetna&#8221;)) to redeem for cash on hand the entire $1.0&#160;billion aggregate principal amount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the Company exercised the par call redemptions on its outstanding 2.75% senior notes due December 2022 and 4.75% senior notes due December 2022 (including notes issued by Omnicare, Inc.) to redeem for cash on hand the entire aggregate principal amount of $1.25&#160;billion and $399&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 18, 2021, the Company issued $1.0&#160;billion aggregate principal amount of 2.125% unsecured senior notes due September 15, 2031 for total proceeds of $987&#160;million, net of discounts, underwriting fees and offering expenses. The net proceeds of this offering were used for the purchase of senior notes in connection with the Company&#8217;s cash tender offer in August 2021 as described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During March 2020, the Company entered into several interest rate swap transactions to manage interest rate risk. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resulting from changes in interest rates related to the anticipated issuance of $750&#160;million aggregate principal amount of 3.625% unsecured senior notes due April 1, 2027, $1.5&#160;billion aggregate principal amount of 3.75% unsecured senior notes due April 1, 2030, $1.0&#160;billion aggregate principal amount of 4.125% unsecured senior notes due April 1, 2040 and $750&#160;million aggregate principal amount of 4.25% unsecured senior notes due April 1, 2050 (collectively, the &#8220;March 2020 Notes&#8221;). In connection with the issuance of the March 2020 Notes on March 31, 2020, the Company terminated all outstanding cash flow hedges. The Company paid a net amount of $7&#160;million to the hedge counterparties upon termination, which was recorded as a loss, net of tax, of $5&#160;million in accumulated other comprehensive income and will be reclassified as interest expense over the life of the March 2020 Notes. See Note 14 &#8216;&#8216;Other Comprehensive Income (Loss)&#8217;&#8217; for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Early Extinguishments of Debt</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company redeemed for cash the remaining $2.3&#160;billion of its outstanding 3.7% senior notes due 2023. In connection with the early redemption of such senior notes, the Company paid a make-whole premium of $80 million in excess of the aggregate principal amount of the senior notes that were redeemed, wrote-off $8 million of unamortized deferred financing costs and incurred $1 million in fees, for a total loss on early extinguishment of debt of $89&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company purchased approximately $2.0&#160;billion of its outstanding 4.3% senior notes due 2028 through a cash tender offer. In connection with the purchase of such senior notes, the Company paid a premium of $332 million&#160;in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $26&#160;million of unamortized deferred financing costs and incurred $5&#160;million in fees, for a total loss on early extinguishment of debt of $363&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company purchased $4.5&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $113&#160;million of its 4.0% senior notes due 2023, $1.4&#160;billion of its 3.7% senior notes due 2023, $1.0&#160;billion of its 4.1% senior notes due 2025 and $2.0&#160;billion of its 4.3% senior notes due 2028. In connection with the purchase of such senior notes, the Company paid a premium of $619&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $45&#160;million of unamortized deferred financing costs and incurred $10&#160;million in fees, for a total loss on early extinguishment of debt of $674&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company purchased $6.0&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $723&#160;million of its 4.0% senior notes due 2023, $2.3&#160;billion of its 3.7% senior notes due 2023 and $3.0&#160;billion of its 4.1% senior notes due 2025. In connection with the purchase of such senior notes, the Company paid a premium of $706&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $47&#160;million of unamortized deferred financing costs and incurred $13&#160;million in fees, for a total loss on early extinguishment of debt of $766&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s back-up revolving credit facilities and unsecured senior notes contain customary restrictive financial and operating covenants. These covenants do not include an acceleration of the Company&#8217;s debt maturities in the event of a downgrade in the Company&#8217;s credit ratings. The Company does not believe the restrictions contained in these covenants materially affect its financial or operating flexibility. As of December&#160;31, 2022, the Company was in compliance with all of its debt covenants.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224248390320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pension Plans and Other Postretirement Benefits</a></td>
<td class="text">Pension Plans and Other Postretirement Benefits<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Contribution Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company sponsors several active 401(k) savings plans that cover all employees who meet plan eligibility requirements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes matching contributions consistent with the provisions of the respective plans. At the participant&#8217;s option, account balances, including the Company&#8217;s matching contribution, can be invested among various investment options under each plan. The CVS Health Future Fund 401(k) Plan offers CVS Health Corporation&#8217;s common stock fund as an investment option. The Company also maintains nonqualified, unfunded deferred compensation plans for certain key employees. The plans provide participants the opportunity to defer portions of their eligible compensation and for certain nonqualified plans, participants receive matching contributions equivalent to what they could have received under the CVS Health Future Fund 401(k) Plan absent certain restrictions and limitations under the Internal Revenue Code. The Company&#8217;s contributions under its defined contribution plans were $567 million, $552 million and $520 million in the years ended December&#160;31, 2022, 2021 and 2020, respectively. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Benefit Pension Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors a tax-qualified defined benefit pension plan that was frozen in 2010 and a nonqualified supplemental pension plan that was frozen in 2007. The Company also sponsors several other defined benefit pension plans that are unfunded nonqualified supplemental retirement plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension Benefit Obligation and Plan Assets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables outline the change in pension benefit obligation and plan assets over the specified periods:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,011)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(387)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,740&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(968)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(387)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the pension benefit obligation during the years ended December&#160;31, 2022 and 2021 was primarily driven by the change in the discount rate during each respective period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets (liabilities) recognized on the consolidated balance sheets at December&#160;31, 2022 and 2021 for the defined benefit pension plans consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets reflected in other assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">827&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities reflected in accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities reflected in other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(197)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Periodic Benefit Cost (Income)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost (income) for the years ended December&#160;31, 2022, 2021 and 2020 are shown below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Components of net periodic benefit cost (income):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(309)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost (income)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension Plan Assumptions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a series of actuarial assumptions to determine its benefit obligation and net periodic benefit income, the most significant of which include discount rates and expected return on plan assets assumptions. </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Discount Rates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discount rate is determined using a yield curve as of the annual measurement date. The yield curve consists of a series of individual discount rates, with each discount rate corresponding to a single point in time, based on high-quality bonds. Projected benefit payments are discounted to the measurement date using the corresponding rate from the yield curve that is consistent with the maturity profile of the expected liability cash flows.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Return on Plan Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected long-term rate of return on plan assets is determined by using the plan&#8217;s target allocation and return expectations based on many factors including forecasted long-term capital market real returns and the inflationary outlook on a plan by plan basis. See &#8220;Pension Plan Assets&#8221; below for additional details regarding the pension plan assets as of December 31, 2022 and 2021.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also considers other assumptions including mortality, interest crediting rate, termination and retirement rates and cost of living adjustments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined its benefit obligation based on the following weighted average assumptions as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined its net periodic benefit cost (income) based on the following weighted average assumptions for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension Plan Assets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s pension plan assets primarily include debt and equity securities held in separate accounts, common/collective trusts and real estate investments. The valuation methodologies used to value these debt and equity securities and common/collective trusts are similar to the methodologies described in Note 4 &#8220;Fair Value.&#8221; Pension plan assets also include investments in other assets that are carried at fair value. The following is a description of the valuation methodologies used to value real estate investments and these additional investments, including the general classification pursuant to the fair value hierarchy.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Real estate investments are valued by independent third party appraisers. The appraisals comply with the Uniform Standards of Professional Appraisal Practice, which include, among other things, the income, cost, and sales comparison approaches to estimating property value. Therefore, these investments are classified in Level 3.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Private equity and hedge fund limited partnerships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Private equity and hedge fund limited partnerships are carried at fair value which is estimated using the NAV per unit as reported by the administrator of the underlying investment fund as a practical expedient to fair value. Therefore, these investments have been excluded from the fair value table below.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2022 were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,837&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. domestic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Domestic real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Common/collective trusts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pension investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,225&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,299&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The assets in the underlying funds of common/collective trusts consist of $104 million of equity securities and $203 million of debt securities. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $390 million of other receivables as well as $432 million of private equity limited partnership investments and $225 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2021 were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,553&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. domestic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Domestic real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Common/collective trusts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pension investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,837&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,781&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The assets in the underlying funds of common/collective trusts consist of $261 million of equity securities and $149 million of debt securities. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $76 million of other receivables as well as $583 million of private equity limited partnership investments and $237 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 pension plan assets during the year ended December&#160;31, 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:74.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.759%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.761%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Real estate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 pension plan assets during the year ended December&#160;31, 2021 were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.046%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Real estate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s pension plan invests in a diversified mix of assets designed to generate returns that will enable the plan to meet its future benefit obligations. The risk of unexpected investment and actuarial outcomes is regularly evaluated. This evaluation </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is performed through forecasting and assessing ranges of investment outcomes over short- and long-term horizons and by assessing the pension plan&#8217;s liability characteristics. Complementary investment styles and strategies are utilized by professional investment management firms to further improve portfolio and operational risk characteristics. Public and private equity investments are used primarily to increase overall plan returns. Real estate investments are viewed favorably for their diversification benefits and above-average dividend generation. Fixed income investments provide diversification benefits and liability hedging attributes that are desirable, especially in falling interest rate environments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, target investment allocations for the Company&#8217;s pension plan were: 12% in equity securities, 77% in fixed income and debt securities, 5% in real estate, 3% in private equity limited partnerships and 3% in hedge funds. Actual asset allocations may differ from target allocations due to tactical decisions to overweight or underweight certain assets or as a result of normal fluctuations in asset values. Asset allocations are consistent with stated investment policies and, as a general rule, periodically rebalanced back to target asset allocations. Asset allocations and investment performance are formally reviewed periodically throughout the year by the pension plan&#8217;s Investment Subcommittee. Forecasting of asset and liability growth is performed at least annually.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally contributes to its tax-qualified pension plan based on minimum funding requirements determined under applicable federal laws and regulations. Employer contributions related to the nonqualified supplemental pension plans generally represent payments to retirees for current benefits. The Company contributed $27 million, $78 million and $25 million to its pension plans during 2022, 2021 and 2020, respectively. No contributions are required for the tax-qualified pension plan in 2023. The Company expects to make an immaterial amount of contributions for all other pension plans in 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the pension benefit obligation as of December&#160;31, 2022: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028-2032</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Multiemployer Pension Plans</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also contributes to a number of multiemployer pension plans under the terms of collective-bargaining agreements that cover its union-represented employees. The risks of participating in these multiemployer plans are different from single-employer pension plans in the following respects: (i) assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers, (ii) if a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers, and (iii) if the Company chooses to stop participating in some of its multiemployer plans, the Company may be required to pay those plans an amount based on the underfunded status of the applicable plan, which is referred to as a withdrawal liability. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the multiemployer pension plans in which the Company participates are individually significant to the Company. The Company&#8217;s contributions to multiemployer pension plans were $20 million, $19 million and $19 million in 2022, 2021 and 2020, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Postretirement Benefits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides postretirement health care and life insurance benefits to certain retirees who meet eligibility requirements. The Company&#8217;s funding policy is generally to pay covered expenses as they are incurred. For retiree medical plan accounting, the Company reviews external data and its own historical trends for health care costs to determine the health care cost trend rates. As of December&#160;31, 2022 and 2021, the Company&#8217;s other postretirement benefits had an accumulated postretirement benefit obligation of $159 million and $207 million, respectively. Net periodic benefit costs related to these other postretirement benefits were $4 million, $4 million and $12 million in 2022, 2021 and 2020, respectively. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the accumulated other postretirement benefit obligation as of December&#160;31, 2022: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:86.105%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028-2032</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Pursuant to various collective bargaining agreements, the Company also contributes to multiemployer health and welfare plans that cover certain union-represented employees. The plans provide postretirement health care and life insurance benefits to certain employees who meet eligibility requirements. The Company&#8217;s contributions to multiemployer health and welfare plans totaled $62 million, $60 million and $54 million in 2022, 2021 and 2020, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224248390608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision for continuing operations consisted of the following for the&#160;years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,803&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,615&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,538&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,950&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,133&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,526)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(503)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,029)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(402)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(564)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,548&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of the statutory income tax rate to the Company&#8217;s effective income tax rate for continuing operations for the&#160;years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurer fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basis difference upon disposition of subsidiary</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year refunds and unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the components of the Company&#8217;s deferred income tax assets and liabilities as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.711%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and rents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debts and other allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and capital loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll tax deferral</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(532)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,985&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,658&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and rents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,639)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,947)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,139)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,381)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,870)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,773)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,885)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,115)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes deferred income tax assets of $131&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When evaluating the realizability of deferred tax assets, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and the Company&#8217;s recent operating results. The Company established valuation allowances of $532 million and $325 million as of December&#160;31, 2022 and 2021, respectively, because it does not consider it more likely than not that certain deferred tax assets will be recovered.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company had net operating and capital loss carryovers of $266 million, which expire between 2023 and 2042.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balance of unrecognized tax benefits in 2022, 2021 and 2020 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to the current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expiration of statutes of limitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation and most of its subsidiaries are subject to U.S. federal income tax as well as income tax of numerous state and local jurisdictions. CVS Health Corporation participated in the Compliance Assurance Process through 2019, which is </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a program made available by the U.S. Internal Revenue Service (&#8220;IRS&#8221;) to certain qualifying large taxpayers, under which participants work collaboratively with the IRS to identify and resolve potential tax issues through open, cooperative and transparent interaction prior to the annual filing of their federal income tax returns. The IRS has completed its examinations of the Company&#8217;s consolidated U.S. federal income tax returns for tax years through and including 2013 and 2018 through 2019. The IRS has substantially completed its examinations of the Company&#8217;s consolidated U.S. federal income tax returns for tax years 2014 through 2017.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation and its subsidiaries are also currently under income tax examinations by a number of state and local tax authorities. As of December&#160;31, 2022, no examination has resulted in any proposed adjustments that would result in a material change to the Company&#8217;s operating results, financial condition or liquidity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all material state and local income tax matters have been concluded for fiscal years through 2015. Certain state exams are likely to be concluded and certain state statutes of limitations will lapse in 2023, but the change in the balance of the Company&#8217;s uncertain tax positions is projected to be immaterial. In addition, it is reasonably possible that the Company&#8217;s unrecognized tax benefits could change within the next twelve months due to the anticipated conclusion of various examinations with the IRS for certain previous years. An estimate of the range of the possible change cannot be made at this time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records interest expense related to unrecognized tax benefits and penalties in the income tax provision. The Company accrued interest expense of approximately $29 million, $40 million and $34 million in 2022, 2021 and 2020, respectively. The Company had approximately $112 million and $151 million accrued for interest and penalties as of December&#160;31, 2022 and 2021, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the total amount of unrecognized tax benefits that, if recognized, would affect the Company&#8217;s effective income tax rate is approximately $336 million, after considering the federal benefit of state income taxes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224251822704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Incentive Plans</a></td>
<td class="text">Stock Incentive Plans<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of the CVS Health 2017 Incentive Compensation Plan (&#8220;ICP&#8221;) provide for grants of annual incentive and long-term performance awards to executive officers and other officers and employees of the Company or any subsidiary of the Company, as well as equity compensation to outside directors of CVS Health Corporation. Payment of such annual incentive and long-term performance awards will be in cash, stock, other awards or other property, at the discretion of the Management Planning and Development Committee (the &#8220;MP&amp;D Committee&#8221;) of the Board. The ICP allows for a maximum of 58 million shares of CVS Health Corporation common stock to be reserved and available for grants. As of December&#160;31, 2022, there were approximately 21 million shares of CVS Health Corporation common stock available for future grants under the ICP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the acquisition of Aetna (the &#8220;Aetna Acquisition&#8221;) on November 28, 2018, approximately 22 million shares of Aetna common stock subject to awards outstanding under the Amended Aetna Inc. 2010 Stock Incentive Plan (&#8220;SIP&#8221;) were assumed by CVS Health Corporation. In addition, in accordance with the merger agreement, shares which were available for future issuance under the SIP were converted into approximately 32 million shares of CVS Health Corporation common stock reserved and available for issuance pursuant to future awards. Subsequent to the expiration of the SIP on May 21, 2020, the ICP was the only compensation plan under which the Company grants stock options, restricted stock and other stock-based awards to its employees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzE3Nzg_6fb0217d-b4b8-4272-817b-3803971eadab">three</span> to five years) using the straight-line method. The following table is a summary of stock-based compensation for the&#160;years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and stock appreciation rights (&#8220;SARs&#8221;) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes the ESPP.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units and Performance Stock Units</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s restricted stock units and performance stock units are considered nonvested share awards and require no payment from the employee. The fair value of the restricted stock units is based on the market price of CVS Health Corporation common stock on the grant date and is recognized on a straight-line basis over the vesting period. For each restricted stock unit granted, employees receive one share of common stock, net of taxes, at the end of the vesting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s performance stock units contain performance vesting conditions in addition to a service vesting condition. Vesting of the Company&#8217;s performance stock units is dependent upon the degree to which the Company achieves its performance goals, which are generally set for a three-year performance period and are approved at the time of grant by the MP&amp;D Committee. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of performance stock units granted with service and performance vesting conditions is based on the market price of CVS Health Corporation common stock on the grant date and is recognized over the vesting period. Certain of the performance stock units also contain a market vesting condition based on the performance of CVS Health Corporation common stock relative to a comparator group. The fair value of these performance stock units is determined using a Monte Carlo simulation as of the grant date and is recognized over the vesting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there was $619 million of total unrecognized compensation cost related to the Company&#8217;s restricted stock units and performance stock units that are expected to vest. These costs are expected to be recognized over a weighted-average period of 2.1 years. The total fair value of restricted stock units vested during 2022, 2021 and 2020 was $328 million, $406 million and $229 million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the restricted stock unit and performance stock unit activity for the&#160;year ended December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In thousands, except weighted average grant date fair value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year, nonvested</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.02&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,398&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,626)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,421)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year, nonvested</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,681&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Vested performance stock units have been included at target level performance. Based on actual performance, the number of restricted stock units and performance stock units vested during the year ended December 31, 2022 was 8.0&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options and SARs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All stock option grants are awarded at fair value on the date of grant. The fair value of stock options is estimated using the Black-Scholes option pricing model, and stock-based compensation is recognized on a straight-line basis over the requisite service period. Stock options granted generally become exercisable over a four-year period from the grant date. Stock options granted through 2018 generally expire seven years after the grant date. Stock options granted subsequent to 2018 generally expire ten years after the grant date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All unvested Aetna SARs outstanding upon the acquisition of Aetna were converted into replacement CVS Health Corporation SARs. The replacement SARs granted are settled in CVS Health Corporation common stock, net of taxes, based on the appreciation of the stock price on the exercise date over the market price on the date of grant. The fair value of SARs is estimated using the Black-Scholes option pricing model, and stock-based compensation is recognized on a straight-line basis over the requisite service period. SARs generally become exercisable over a three-year period from the grant date. SARs generally expire ten years after the grant date. No SARs have been granted subsequent to the Aetna Acquisition.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of stock option and SAR activity that occurred for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from stock options exercised (including ESPP)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for taxes for net share settlement of equity awards</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic value of stock options and SARs exercised </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of stock options and SARs vested </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each stock option is estimated using the Black-Scholes option pricing model based on the following assumptions at the time of grant:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dividend yield is based on annual dividends paid and the fair market value of CVS Health Corporation stock at the grant date.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected volatility is estimated based on the historical volatility of CVS Health Corporation&#8217;s daily stock price over a period equal to the expected life of each option grant after adjustments for infrequent events such as stock splits.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The risk-free interest rate is selected based on yields from U.S. Treasury zero-coupon issues with a remaining term equal to the expected term of the options being valued.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected life represents the number of&#160;years the options are expected to be outstanding from grant date based on historical option or SAR holder exercise experience.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, unrecognized compensation expense related to unvested stock options totaled $41 million, which the Company expects to be recognized over a weighted-average period of 1.9 years. After considering anticipated forfeitures, the Company expects approximately 7 million of the unvested stock options to vest over the requisite service period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s stock option and SAR activity for the&#160;year ended December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.747%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;thousands, except weighted average exercise price and remaining contractual term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.74&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,993&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.04&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,921)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(478)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(615)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,040&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.52</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340,507&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,730&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.76</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,904&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at end of year and expected to vest in the future</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,757&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.47</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336,664&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ESPP</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Employee Stock Purchase Plan (&#8220;ESPP&#8221;) provides for the purchase of up to 60&#160;million shares of CVS Health Corporation common stock. Under the ESPP, eligible employees may purchase common stock at the end of each six&#160;month offering period at a purchase price equal to 90% of the lower of the fair market value on the first day or the last day of the offering period. During 2022, approximately 2 million shares of common stock were purchased under the provisions of the ESPP at an average price of $78.55 per share. As of December&#160;31, 2022, approximately 29 million shares of common stock were available for issuance under the ESPP.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock-based compensation associated with the ESPP is estimated on the date of grant (the first day of the six&#160;month offering period) using the Black-Scholes option pricing model.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the assumptions used to value the ESPP awards for the&#160;years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dividend yield is calculated based on semi-annual dividends paid and the fair market value of CVS Health Corporation stock at the grant date.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected volatility is estimated based on the historical volatility of CVS Health Corporation&#8217;s daily stock price over the previous six&#160;month period.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The risk-free interest rate is selected based on the Treasury constant maturity interest rate whose term is consistent with the expected term of ESPP purchases (i.e., six&#160;months).</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected life is based on the semi-annual purchase period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224251725280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text">Shareholders&#8217; Equity<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following share repurchase programs have been authorized by the Board:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In billions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Authorization&#160;Date</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Authorized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining as of<br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 17, 2022 (&#8220;2022 Repurchase Program&#8221;)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 9, 2021 (&#8220;2021 Repurchase Program&#8221;)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the share Repurchase Programs was effective immediately and permit the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase (&#8220;ASR&#8221;) transactions, and/or other derivative transactions. Both the 2022 and 2021 Repurchase Programs can be modified or terminated by the Board at any time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, the Company repurchased an aggregate of 34.1&#160;million shares of common stock for approximately $3.5&#160;billion pursuant to the 2021 Repurchase Program, including share repurchases under the $1.5&#160;billion fixed dollar ASR transaction described below. During the years ended December&#160;31, 2021 and 2020, the Company did not repurchase any shares of common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $2.0&#160;billion fixed dollar ASR with Citibank, N.A. (&#8220;Citibank&#8221;). Upon payment of the $2.0&#160;billion purchase price on January 4, 2023, the Company received a number of shares of CVS Health Corporation&#8217;s common stock equal to 80% of the $2.0&#160;billion notional amount of the ASR or approximately 17.4 million shares at a price of $92.19 per share, which were placed into treasury stock in January 2023. At the conclusion of the ASR, the Company may receive additional shares representing the remaining 20% of the $2.0&#160;billion notional amount. The ultimate number of shares the Company may receive will depend on the daily volume-weighted average price of the Company&#8217;s stock over an averaging period, less a discount. It is also possible, depending on such weighted average price, that the Company will have an obligation to Citibank which, at the Company&#8217;s option, could be settled in additional cash or by issuing shares. Under the terms of the ASR, the maximum number of shares that could be delivered to the Company is 43.4 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $1.5&#160;billion fixed dollar ASR with Barclays Bank PLC. Upon payment of the $1.5&#160;billion purchase price on January 4, 2022, the Company received a number of shares of CVS Health Corporation&#8217;s common stock equal to 80% of the $1.5&#160;billion notional amount of the ASR or approximately 11.6&#160;million shares at a price of $103.34 per share, which were placed into treasury stock in January 2022. The ASR was accounted for as an initial treasury stock transaction for $1.2&#160;billion and a forward contract for $0.3&#160;billion. The forward contract was classified as an equity instrument and was recorded within capital surplus. In February 2022, the Company received approximately 2.7&#160;million shares of CVS Health Corporation&#8217;s common stock, representing the remaining </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20% of the $1.5&#160;billion notional amount of the ASR, thereby concluding the ASR. These shares were placed into treasury stock and the forward contract was reclassified from capital surplus to treasury stock in February 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time they were received, the initial and final receipt of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted average common shares outstanding for basic and diluted earnings per share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quarterly cash dividend declared by the Board was $0.55 and $0.50 per share in 2022 and 2021, respectively. In December 2022, the Board authorized a 10% increase in the quarterly cash dividend to $0.605 per share effective in 2023. CVS Health Corporation has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#8217;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Requirements</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s insurance business operations are conducted through subsidiaries that principally consist of health maintenance organizations (&#8220;HMOs&#8221;) and insurance companies. The Company&#8217;s HMO and insurance subsidiaries report their financial statements in accordance with accounting practices prescribed by state regulatory authorities which may differ from GAAP. The combined statutory net income for the years ended and estimated combined statutory and capital surplus at December&#160;31, 2022, 2021 and 2020 for the Company&#8217;s insurance and HMO subsidiaries were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory net income </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,851&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,302&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,667&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated statutory capital and surplus</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s insurance and HMO subsidiaries paid $3.2 billion of gross dividends to the Company for the year ended December&#160;31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to general state law restrictions on payments of dividends and other distributions to stockholders applicable to all corporations, HMOs and insurance companies are subject to further regulations that, among other things, may require those companies to maintain certain levels of equity and restrict the amount of dividends and other distributions that may be paid to their equity holders. In addition, in connection with the Aetna Acquisition, the Company made certain undertakings that require prior regulatory approval of dividends by certain of its HMOs and insurance companies. At December&#160;31, 2022, these amounts were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:88.196%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated minimum statutory surplus required by regulators</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments on deposit with regulatory bodies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated maximum dividend distributions permitted in 2023 without prior regulatory approval</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,706&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Noncontrolling Interests</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 and 2021, noncontrolling interests were $300 million and $306 million, respectively, primarily related to third party interests in the Company&#8217;s operating entities.&#160;The noncontrolling entities&#8217; share is included in total shareholders</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> equity on the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224251628656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income (Loss)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Other Comprehensive Income (Loss)</a></td>
<td class="text">Other Comprehensive Income (Loss)<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income (loss) in 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.089%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment gains (losses):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$0, $181 and $0 pretax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(3,021), $(644) and $497 pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,556)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(530)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($315, $(32) and $31 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,317)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(556)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,519)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in discount rate on long-duration insurance reserves:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(651)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($0, $(1,166) and $0 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(906)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($1,126, $328, and $0 pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(651)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($38, $0 and $(7) pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(15), $(34) and $(35) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(229), $20 and $(30) pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($3, $6 and $7 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of year accumulated other comprehensive income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(766)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,598)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of year accumulated other comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,264)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_______________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"> Reflects the adoption of ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 944) during the year ended December 31, 2021. See Note 8 &#8216;&#8216;Other Insurance Liabilities and Separate Accounts&#8217;&#8217; for additional information.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the consolidated statements of operations. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included within interest expense in the consolidated statements of operations. The Company expects to reclassify $11 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the consolidated statements of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224248802896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per Share<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is computed using the treasury stock method. Stock options and SARs to purchase 4 million, 7&#160;million, and 15&#160;million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the years ended December&#160;31, 2022, 2021 and 2020, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings per share from continuing operations for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to CVS Health</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,311&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,001&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,188&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and SARs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share from continuing operations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224251664592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reinsurance<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceDisclosuresAbstract', window );"><strong>Reinsurance Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceTextBlock', window );">Reinsurance</a></td>
<td class="text">Reinsurance<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#8217;s primary liability as the direct insurer of the risks reinsured.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, the Company entered into two four-year reinsurance agreements with an unrelated reinsurer that allow it to reduce required capital and provide collateralized excess of loss reinsurance coverage on a portion of the Health Care Benefits segment&#8217;s group Commercial Insured business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance recoverables (recorded as other current assets or other assets on the consolidated balance sheets) at December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reinsurer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hartford Life and Accident Insurance Company</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lincoln Life &amp; Annuity Company of New York</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VOYA Retirement Insurance and Annuity Company </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fresenius Medical Care Reinsurance Company (Cayman) Ltd. </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,564&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct, assumed and ceded premiums earned for the years ended December&#160;31, 2022, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(772)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(680)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(825)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,330&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,132&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,364&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of reinsurance on benefit costs for the years ended December&#160;31, 2022, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(663)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(549)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net benefit costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,073&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,188&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,679&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is not a material difference between premiums on a written basis versus an earned basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has various agreements with unrelated reinsurers that do not qualify for reinsurance accounting under GAAP, and consequently are accounted for using deposit accounting. The Company entered into these contracts to reduce the risk of catastrophic loss which in turn reduces the Company&#8217;s capital and surplus requirements. Total deposit assets and liabilities related to reinsurance agreements that do not qualify for reinsurance accounting under GAAP were not material as of December&#160;31, 2022 or 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure pertaining to the existence, magnitude and information about insurance that has been ceded to or assumed from another insurance company, including the methodologies and assumptions used in determining recorded amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=99379264&amp;loc=d3e27830-158548<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6811-158387<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -URI https://asc.fasb.org/topic&amp;trid=2303980<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6816-158387<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99379264&amp;loc=d3e27758-158548<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224239582176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. The Company believes COVID-19&#8217;s impact on its businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond the Company&#8217;s knowledge and control. As a result, the impact COVID-19 will have on the Company&#8217;s businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has the following significant guarantee arrangements at December&#160;31, 2022:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ASC Claim Funding Accounts - The Company has arrangements with certain banks for the processing of claim payments for its ASC customers. The banks maintain accounts to fund claims of the Company&#8217;s ASC customers. The customer is responsible for funding the amount paid by the bank each day. In these arrangements, the Company guarantees that the banks will not sustain losses if the responsible ASC customer does not properly fund its account. The aggregate maximum exposure under these arrangements is generally limited to $250 million. The Company can limit its exposure to these guarantees by suspending the payment of claims for ASC customers that have not adequately funded the amount paid by the bank. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Separate Accounts Assets - Certain Separate Accounts assets associated with the large case pensions business in the Corporate/Other segment represent funds maintained as a contractual requirement to fund specific pension annuities that the Company has guaranteed. Minimum contractual obligations underlying the guaranteed benefits in these Separate Accounts were approximately $941&#160;million and $1.3 billion at December&#160;31, 2022 and 2021, respectively. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information on Separate Accounts. Contract holders assume all investment and mortality risk and are required to maintain Separate Accounts balances at or above a specified level. The level of required funds is a function of the risk underlying the Separate Account&#8217;s investment strategy. If contract holders do not maintain the required level of Separate Accounts assets to meet the annuity guarantees, the Company would establish an additional liability. Contract holders&#8217; balances in the Separate Accounts at December&#160;31, 2022 exceeded the </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">value of the guaranteed benefit obligation. As a result, the Company was not required to maintain any additional liability for its related guarantees at December&#160;31, 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Guarantees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#8217;s Stores and Linens &#8216;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#8217;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#8217;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations, and any significant adverse impact of COVID-19 on such purchasers and/or former subsidiaries increases the risk that the Company will be required to satisfy those obligations. As of December&#160;31, 2022, the Company guaranteed 67 such store leases (excluding the lease guarantees related to Linens &#8216;n Things, which have been recorded as a liability on the consolidated balance sheets), with the maximum remaining lease term extending through 2034.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#8217;s assessments generally are based on a formula relating to the Company&#8217;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the ACA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#8220;Penn Treaty&#8221;) in rehabilitation, an intermediate action before insolvency, and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#8217;s operating results, financial condition and cash flows, and the risk is heightened by any significant adverse impact of the COVID-19 pandemic on the solvency of other insurers, including long-term care and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#8217;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s total guaranty fund assessments liability was immaterial at both December&#160;31, 2022 and 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been involved or is currently involved in numerous legal proceedings, including litigation, arbitration, government investigations, audits, reviews and claims. These include routine, regular and special investigations, audits and reviews by</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> CMS, state insurance and health and welfare departments, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the U.S. Department of Justice (the &#8220;DOJ&#8221;), </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">state Attorneys General, the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;), the U.S. Federal Trade Commission (the &#8220;FTC&#8221;) and other governmental authorities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings, in general, and securities, class action and multi-district litigation, in particular, and governmental special investigations, audits and reviews can be expensive and disruptive. Some of the litigation matters may purport or be determined </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years. The Company also may be named from time to time in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions initiated by private third parties that could also be separately pursued by a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs incurred in these matters can be substantial, regardless of the outcome.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. None of the Company&#8217;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#8217;s financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses and assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and rights to indemnification, will have a material adverse effect on the Company&#8217;s financial position. Substantial unanticipated verdicts, fines and rulings, however, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on its results of operations. In addition, as a result of governmental investigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or loss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be material to the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Usual and Customary Pricing Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and certain current and former directors and officers are named as a defendant in a number of lawsuits that allege that the Company&#8217;s retail pharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions are brought by a number of different types of plaintiffs, including plan members, private payors, government payors, and shareholders based on different legal theories. Some of these cases are brought as putative class actions, and in some instances, classes have been certified. In October 2022, one of the litigating shareholders made a litigation demand to the Board related to these and other issues after his amended derivative complaint was dismissed for failing to demonstrate demand futility. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PBM Litigation and Investigations</span></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is facing multiple lawsuits, including by state Attorneys General, governmental subdivisions and several putative class actions, regarding drug pricing and its rebate arrangements with drug manufacturers. These complaints, brought by a number of different types of plaintiffs under a variety of legal theories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is defending itself against these claims. The Company has also received subpoenas, civil investigative demands (&#8220;CIDs&#8221;), and other requests for documents and information from, and is being investigated by, the FTC and Attorneys General of several states and the District of Columbia regarding its PBM practices, including pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs, and requests for information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Behnke v. CVS Caremark Corporation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#8217;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#8217;s PBM. The Company is defending itself against these claims.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Controlled Substances Litigation, Audits and Subpoenas</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims beginning as far back as the early 2000s generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned In re National Prescription Opiate Litigation (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs, and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas, CIDs, and other requests for information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Company was among the chain pharmacies found liable by a jury in a trial in federal court in Ohio; in August 2022, the court issued a judgment jointly against the three defendants in the amount of $651&#160;million to be paid over 15 years, and also ordered certain injunctive relief. The Company is appealing the judgment and has not accrued a liability for this matter. In March 2022, CVS Health Corporation and CVS Pharmacy, Inc. entered into a settlement agreement with the State of Florida to resolve claims related to opioid medications dating back more than a decade. Under the terms of the settlement agreement, CVS Health Corporation settled all opioid claims against it and its subsidiaries by the State of Florida for $484&#160;million, which is to be paid over a period of 18 years. During the three months ended March 31, 2022, the Company recorded a $484&#160;million liability associated with this legal settlement. In August 2022, CVS Pharmacy, Inc. entered into an agreement with the State of New Mexico to settle all opioid claims against it and its parents and subsidiaries by the State of New Mexico and participating subdivisions. In September 2022, CVS Pharmacy, Inc. entered into an agreement with the State of West Virginia to settle all opioid claims against it and its parents and subsidiaries by the State of West Virginia and participating subdivisions. Also in September 2022, CVS Pharmacy, Inc. entered into an agreement with the Cherokee Nation to settle all opioid claims against it and its parents and subsidiaries by the Cherokee Nation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company agreed to a formal settlement agreement, the financial amounts of which were agreed to in principle in October 2022, with a leadership group of a number of state Attorneys General and the Plaintiffs&#8217; Executive Committee (&#8220;PEC&#8221;). The agreement would resolve substantially all opioid claims against Company entities by states and political subdivisions, but not private plaintiffs. The maximum amount payable by the Company under the settlement would be approximately $4.3&#160;billion in opioid remediation and $625&#160;million in attorneys&#8217; fees and costs and additional remediation. The amounts would be payable over 10 years, beginning in 2023. The agreement also contains injunctive terms relating to the dispensing of opioid medications. The settlement agreement is available at nationalopioidsettlement.com.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the settlement agreement, before the Company determines whether to enter into any final settlement, it will assess the number and identities of the governmental entities that will participate in any such settlement. The settlement agreement contemplates that if certain governmental entities do not agree to the settlement, but the Company nonetheless concludes that there is sufficient participation to warrant going forward with the settlement, there would be a corresponding reduction in the amount due from the Company to account for the governmental entities that did not agree. Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants. Private plaintiff litigation will also continue.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been informed that 45 states, the District of Columbia, and all eligible United States territories have elected to join the settlement. Three states were the subject of earlier settlements. The Company has elected to proceed with the settlement process based on that level of participation. The settlement process will progress to the period during which subdivisions may elect to join.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company also agreed to a formal settlement agreement with a leadership group representing tribes throughout the United States. The agreement would resolve substantially all opioid claims against Company entities by such tribes. The maximum amount payable by the Company under the settlement would be $113&#160;million in opioid remediation and $18&#160;million in attorneys&#8217; fees and costs. The amounts would be payable over 10 years, beginning in 2023. The agreement is contingent upon sufficient participation by tribes.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has concluded that settlement of opioid claims by governmental entities and tribes is probable, and the loss related thereto could be reasonably estimated. As a result of that conclusion, and its assessment of certain other opioid-related claims including those for which the Company reached agreement in August and September 2022, the Company recorded pre-tax charges of $5.2&#160;billion and $99 million during the three months ended September 30, 2022 and the three months ended December&#160;31, 2022, respectively, of which $4.8&#160;billion was recorded in other long-term liabilities on the consolidated balance sheet. In addition, the Company expects the cash impact in 2023 and 2024 to be less than $500&#160;million in each year. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment requires judgments about future events. Moreover, the settlement is in its early phases, and there is no assurance that contingencies will be satisfied. The amount of ultimate loss may differ materially from this accrual.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the many uncertainties associated with any settlement arrangement or other resolution of all opioid-related litigation matters, including the uncertain scope of participation by governmental entities, and given that the Company continues to actively defend ongoing litigation for which it believes it has defenses and assertions that have merit, the Company is not able to reasonably estimate the range of ultimate possible loss for all opioid-related litigation matters at this time. The outcome of these legal matters could have a material effect on the Company&#8217;s business, financial condition, operating results and/or cash flows.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the DOJ served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS pharmacy locations concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. In January 2022, the DOJ served the Company with a CID regarding similar subjects, and the Company is providing documents and information in response to these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prescription Processing Litigation and Investigations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its prescription processing practices, including the following:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ex rel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Bassan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> v. Omnicare, Inc. and CVS Health Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#8217;s Office for the Southern District of New York (the &#8220;SDNY&#8221;) filed a complaint-in-intervention in this previously sealed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case. The complaint alleges that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Gill et al. v. CVS Health Corp. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (U.S. District Court for the Northern District of Illinois). In July 2022, the Delaware Attorney General&#8217;s Office moved for partial intervention as to allegations under the Delaware false claims act related to not escheating alleged overpayments in this previously sealed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case. The federal government and the remaining states declined to intervene on other additional theories in the relator&#8217;s complaint. The Company is defending itself against all of the claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#8217;s Omnicare pharmacies&#8217; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2016, the Company received a CID from the U.S. Attorney&#8217;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#8217;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Provider Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by providers with whom the Company has a contract and with whom the Company does not have a contract (&#8220;out-of-network providers&#8221;).&#160;Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for out-of-network services (including COVID-19 testing) and/or otherwise allege that the Company failed to timely or appropriately pay or administer claims and benefits (including the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company&#8217;s post payment audit and collection practices). Other major health insurers are the subject of similar litigation or have settled similar litigation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CMS Actions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS regularly audits the Company&#8217;s performance to determine its compliance with CMS&#8217;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#8217;s and other companies&#8217; Medicare plans by considering the applicable health status of Medicare members as supported by information prepared, maintained and provided by providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#8217; medical records to determine whether those records support the related diagnosis codes that determine the members&#8217; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#8220;RADV&#8221;) audits of various Medicare Advantage plans, including certain of the Company&#8217;s plans, to validate coding practices and supporting medical record documentation maintained by providers and the resulting risk-adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#8217;s risk-adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of the HHS (the &#8220;OIG&#8221;) also is auditing the Company&#8217;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, in the &#8220;Notice of Final Payment Error Calculation for Part C Medicare Advantage Risk Adjustment Validation Data (RADV) Contract-Level Audits,&#8221; CMS revised its audit methodology for RADV contract-level audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS announced extrapolation of the error rate identified in the audit sample along with the application of a process to account for errors in the government&#8217;s traditional fee-for-service Medicare program (&#8220;FFS Adjuster&#8221;). For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract, nor did CMS propose to apply a FFS adjuster. By applying the FFS Adjuster, Medicare Advantage organizations would have been liable for repayments only to the extent that their extrapolated payment errors exceeded the error rate in Original Medicare, which could have impacted the extrapolated repayments to which Medicare Advantage organizations are subject. This revised contract-level audit methodology increased the Company&#8217;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. In the RADV audit methodology CMS used from 2011-2013, CMS selected only a few of the Company&#8217;s Medicare Advantage contracts for various contract years for contract-level RADV audits. In October 2018, CMS in the proposed rule (&#8220;Proposed Rule&#8221;) announced a new methodology for RADV audits targeting certain health conditions and members with many diagnostic conditions along with extrapolation for the error rates identified without use of a FFS Adjuster. While the rule was under proposal, CMS initiated contract-level RADV audits for the years 2014 and 2015 with this new RADV methodology without a final rule. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 30, 2023, CMS released the final rule (&#8220;RADV Audit Rule&#8221;), announcing it may use extrapolation for payment years 2018 forward, for both RADV audits and OIG audits and eliminated the application of a FFS Adjuster in Part C contract-level RADV audits of Medicare Advantage organizations. In the RADV Audit Rule, CMS indicated that it will use more than one audit methodology going forward and indicated CMS will audit contracts it believes are at the highest risk for overpayments based on its statistical modeling, citing a 2016 Governmental Accountability Office report that recommended selection of contract-level RADV audits with a focus on contracts likely to have high rates of improper payment, the highest coding intensity scores, and contracts with high levels of unsupported diagnoses from prior RADV audits.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive refunds for years prior to 2018 or prospective adjustments to Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#8217;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#8217;s bids </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of RADV, Public Exchange related or other audits by CMS, the OIG or otherwise, including audits of the Company&#8217;s MLR rebates, methodology and/or reports, could be material and could adversely affect the Company&#8217;s operating results, cash flows and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RADV Audit Rule does not apply to the CMS Part C Improper Payment Measures audits nor the HHS-RADV programs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicare and Medicaid CIDs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#8217;s patient chart review processes related to risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company received a CID from the SDNY requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stockholder Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in February 2019, multiple class action complaints, as well as a derivative complaint, were filed by putative plaintiffs against the Company and certain current and former officers and directors. The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#8217;s LTC business unit. The Company and its current and former officers and directors are defending themselves against these claims. Since filing, several of the cases have been consolidated, and the first-filed federal case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Miami Fire Fighters&#8217; and Police Officers&#8217; Retirement Trust, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anarkat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), was dismissed with prejudice in February 2021. Plaintiffs appealed that decision to the First Circuit after their motion for reconsideration was denied, and in August 2022 the First Circuit affirmed the dismissal. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re CVS Health Corp. Securities Act Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Waterford</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re CVS Health Corp. Securities Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Warren</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Freundlich</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) have been stayed pending the outcome of the First Circuit appeal. Plaintiffs in both cases have since filed amended complaints, which the Company has moved to dismiss. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August and September 2020, two class actions under the Employee Retirement Income Security Act of 1974 (&#8220;ERISA&#8221;) were filed in the U.S. District Court for the District of Connecticut against CVS Health, Aetna, and several current and former executives, directors and/or members of Aetna&#8217;s Compensation and Talent Management Committee: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Radcliffe v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flaim v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. The plaintiffs in these cases assert a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) Plan&#8217;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#8217;s LTC business unit. The district court consolidated the actions, and in October 2021, dismissed the consolidated action without prejudice. Plaintiffs filed an amended consolidated complaint, which the Company moved to dismiss. In October 2022, the court granted the Company&#8217;s motion to dismiss with prejudice. Plaintiffs have appealed this decision to the Second Circuit.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also received a related document request pursuant to ERISA &#167; 104(b), to which the Company has responded. The Company and its current and former officers and directors are defending themselves against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company received a demand for inspection of books and records pursuant to Delaware Corporation Law Section 220 (the &#8220;Demand&#8221;). The Demand purports to be related to potential breaches of fiduciary duties by the Board in relation to certain matters concerning opioids.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Legal and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas, or similar process from various governmental agencies requesting information. These other legal proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, breach of fiduciary duty, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, denial of or failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, product liability, intellectual property litigation, and employment litigation. Some of </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#8217;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed, or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#8217;s operating results. The Company will continue to defend contract awards it receives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#8217;s and the rest of the health care and related benefits industry&#8217;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#8217; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight, and claim payment practices (including payments to out-of-network providers).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a leading national health solutions company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#8217;s businesses, changes to or clarifications of the Company&#8217;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the federal government, withholding of premium payments to the Company by government agencies,&#160;assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i)&#160;future enactment of new health care or other laws or regulations; (ii)&#160;the interpretation or application of existing laws or regulations as they may relate to one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii)&#160;pending or future federal or state government investigations of one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv)&#160;pending or future government audits, investigations or enforcement actions against the Company; (v)&#160;adverse developments in any pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit against the Company, whether sealed or unsealed, or in any future </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit that may be filed against the Company; or (vi)&#160;adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224251679376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment Reporting<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has three operating segments, Health Care Benefits, Health Services and Pharmacy &amp; Consumer Wellness, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the CODM evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income. Adjusted operating income is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. Effective for the first quarter of 2023, adjusted operating income also excludes the impact of net realized capital gains or losses. See the reconciliation of consolidated operating income (GAAP measure) to consolidated adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment financial information for the years ended December 31, 2022, 2021 and 2020 has been recast, as applicable, to reflect the following items, the impact of which are reflected in the &#8220;Adjustments&#8221; lines of the table below:</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The realignment of the Company&#8217;s segments to correspond with changes made to its operating model as described in Note 1 &#8220;Significant Accounting Policies,&#8221; including the discontinuance of the former Maintenance Choice segment reporting practice as described in Note (1) of the table below.</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The exclusion of the impact of net realized capital gains or losses from adjusted operating income, as described above.</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the adoption of the long-duration insurance accounting standard, which the Company adopted on January 1, 2023 using a modified retrospective transition method as of January 1, 2021, as described in Note 8 &#8220;Other Insurance Liabilities and Separate Accounts.&#8221; </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care <br/>Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp; <br/>Consumer <br/>Wellness</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as previously reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,594&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,302)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,283)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as adjusted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,576&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,596&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,585)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 1.75pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as previously reported</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,785)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(728)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(575)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as adjusted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,338&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,781&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,531&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,613)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,037&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care <br/>Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp; <br/>Consumer <br/>Wellness</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as previously reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,923)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,318)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as adjusted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,119&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,241)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 1.75pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as previously reported</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,471)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as adjusted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,110&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,492&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,260&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,635)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,227&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care <br/>Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp; <br/>Consumer <br/>Wellness</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as previously reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,198&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,323)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(584)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,739)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as adjusted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,062)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 1.75pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as previously reported</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(708)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(560)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as adjusted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,135&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,128&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,012&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,319)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,956&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy &amp; Consumer Wellness segment. Prior to January 1, 2023, intersegment adjusted operating income eliminations occurred when members of the Health Services segment's clients enrolled in Maintenance Choice elected to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurred, both the Health Services and Pharmacy &amp; Consumer Wellness segments recorded the adjusted operating income on a stand-alone basis.&#160;Effective January 1, 2023, the adjusted operating income associated with such transactions is reported only in the Pharmacy &amp; Consumer Wellness segment, therefore no adjusted operating income elimination is required. Segment financial information has been recast to reflect this change. </span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, 2021 and 2020, revenues from the federal government accounted for 18%, 17% and 16%, respectively, of the Company&#8217;s consolidated total revenues, primarily related to contracts with CMS for coverage of Medicare-eligible individuals within the Health Care Benefits segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:29.091%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.092%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.914%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.860%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp;<br/>Consumer<br/>Wellness</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,585)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,576&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,596&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,585)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,613)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,241)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,119&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,892&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,620&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,241)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,635)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,062)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,062)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,319)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Health Services segment include approximately $12.6 billion, $11.6 billion and $10.9 billion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">of retail co-payments for 2022, 2021 and 2020, respectively. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information about retail co-payments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy &amp; Consumer Wellness segment.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of consolidated operating income to adjusted operating income for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital (gains) losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office real estate optimization charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on divestiture of subsidiaries </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(475)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid litigation charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on assets held for sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store impairments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition purchase price adjustment outside of measurement period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receipt of fully reserved ACA risk corridor receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(11)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,037&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,227&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,956&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s GAAP consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s net realized capital gains and losses arise from various types of transactions, primarily in the course of managing a portfolio of assets that support the payment of insurance liabilities. Net realized capital gains and losses are reflected in the consolidated statements of operations in net investment income within each segment. These capital gains and losses are the result of investment decisions, market conditions and other economic developments that are unrelated to the performance of the Company&#8217;s business, and the amount and timing of these capital gains and losses do not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Accordingly, the Company believes excluding net realized capital gains and losses enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2022, the office real estate optimization charges primarily relate to the abandonment of leased real estate and the related right-of-use assets and property and equipment in connection with the planned reduction of corporate office real estate space in response to the Company&#8217;s new flexible work arrangement. The office real estate optimization charges are reflected in the Company&#8217;s GAAP consolidated statement of operations in operating expenses within the Health Care Benefits, Corporate/Other and Health Services segments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2022, the gain on divestiture of subsidiaries represents the pre-tax gain on the sale of bswift, which the Company sold in November 2022, and the pre-tax gain on the sale of PayFlex, which the Company sold in June 2022. In 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#8217; Compensation business, which the Company sold in July 2020. The gains on divestitures are reflected as a reduction of operating expenses in the Company&#8217;s GAAP consolidated statements of operations within the Health Care Benefits segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2022, the opioid litigation charges relate to agreements to resolve substantially all opioid claims against the Company by certain states and governmental entities. The opioid litigation charges are reflected within the Corporate/Other segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2022, the loss on assets held for sale relates to the LTC reporting unit within the Pharmacy &amp; Consumer Wellness segment. The Company continually evaluates its portfolio for non-strategic assets. The Company determined that its LTC business was no longer a strategic asset and during the third quarter of 2022 committed to a plan to sell the LTC business. As of September 30, 2022, the LTC business met the criteria for held-for-sale accounting and its net assets were accounted for as assets held for sale. The carrying value of the LTC business was determined to be greater than its estimated fair value less costs to sell and a loss on assets held for sale was recorded during the third quarter of 2022. As of December 31, 2022, the net assets of the LTC business continued to meet the criteria for held-for-sale accounting and during the fourth quarter of 2022, an incremental loss on assets held for sale was recorded to write down the carrying value of the LTC business to its estimated fair value less costs to sell. During 2022, the loss on assets held for sale also relates to the Commercial Business reporting unit within the Health Care Benefits segment. In March 2022, the Company reached an agreement to sell its Thailand business, which was included in the Commercial Business reporting unit. At that time, a portion of the Commercial Business goodwill was specifically allocated to the Thailand business. The net assets of the Thailand business were accounted for as assets held for sale at March 31, 2022. The carrying value of the Thailand business was determined to be greater than its estimated fair value less costs to sell and a loss on assets held for sale was recorded during the first quarter of 2022. The sale of the Thailand business closed in the second quarter of 2022, and the ultimate loss on the sale was not material.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2021 and 2020, acquisition-related integration costs relate to the acquisition of Aetna. The acquisition-related integration costs are reflected in the Company&#8217;s GAAP consolidated statements of operations in operating expenses within the Corporate/Other segment.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2021, the store impairment charge relates to the write down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately 900 retail stores between 2022 and 2024. The store impairment charge is reflected within the Pharmacy &amp; Consumer Wellness segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2021, the goodwill impairment charge relates to an impairment of the remaining goodwill of the LTC reporting unit within the Pharmacy &amp; Consumer Wellness segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">In 2021, the Company received $61&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#8217;s GAAP consolidated statement of operations as a reduction of operating expenses within the Health Care Benefits segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">In 2020, the Company received $313&#160;million owed to it under the ACA&#8217;s risk corridor program that was previously fully reserved for as payment was uncertain. After considering offsetting items such as the ACA&#8217;s minimum MLR rebate requirements and premium taxes, the Company recognized pre-tax income of $307&#160;million in the Company&#8217;s GAAP consolidated statement of operations within the Health Care Benefits segment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224240345040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the segment realignment described above, the Company&#8217;s four reportable segments are as follows: Health Care Benefits, Health Services, Pharmacy &amp; Consumer Wellness and Corporate/Other, which are described below. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment operates as one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) in eight states through which it sells Insured plans directly to individual consumers. The Company entered Public Exchanges in four additional states effective January 2023. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. PBM solutions include plan design offerings and administration, formulary management, retail pharmacy network management services, and specialty and mail order pharmacy services. In addition, the Company provides clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Company operates a group purchasing organization that negotiates pricing for the purchase of pharmaceuticals and rebates with pharmaceutical manufacturers on behalf of its participants and provides various administrative, management and reporting services to pharmaceutical manufacturers. The Health Services segment&#8217;s clients are primarily employers, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care (&#8220;Managed Medicaid&#8221;) plans, plans offered on Insurance Exchanges and other sponsors of health benefit plans throughout the United States and Covered Entities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy &amp; Consumer Wellness Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy &amp; Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise. The segment also conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and ancillary services to long-term care facilities and other care settings, and provides pharmacy fulfillment services to support the Health Services segment&#8217;s specialty and mail order pharmacy offerings. As of December&#160;31, 2022, the Pharmacy &amp; Consumer Wellness segment operated more than 9,000 retail locations, as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">Use of EstimatesThe preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash and Cash Equivalents and Restricted Cash</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of cash and temporary investments with maturities of three months or less when purchased. The Company invests in short-term money market funds, commercial paper and time deposits, as well as other debt securities that are classified as cash equivalents within the accompanying consolidated balance sheets, as these funds are highly liquid and readily convertible to known amounts of cash. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash included in other current assets on the consolidated balance sheets represents funds held on behalf of members, including health savings account (&#8220;HSA&#8221;) funds associated with high deductible health plans. Restricted cash included in other assets on the consolidated balance sheets represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits and money market funds.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Securities </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities consist primarily of U.S. Treasury and agency securities, mortgage-backed securities, corporate and foreign bonds and other debt securities. Debt securities are classified as either current or long-term investments based on their contractual maturities unless the Company intends to sell an investment within the next twelve months, in which case it is classified as current on the consolidated balance sheets. Debt securities are classified as available for sale and are carried at fair value. See Note 4 &#8216;&#8216;Fair Value&#8217;&#8217; for additional information on how the Company estimates the fair value of these investments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related (yield-related) components. In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principal payments; and any changes to the rating of the security by a rating agency. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income (loss). Interest is not accrued on debt securities when management believes the collection of interest is unlikely.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit-related component is determined by comparing the present value of cash flows expected to be collected from the security, considering all reasonably available information relevant to the collectability of the security, with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the Company records an allowance for credit losses, which is limited by the amount that the fair value is less than amortized cost basis. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For mortgage-backed and other asset-backed securities, the Company recognizes income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The Company&#8217;s investment in the security is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the security, with adjustments recognized in net income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities with readily available fair values are measured at fair value with changes in fair value recognized in net income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage Loans</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mortgage loan investments on the consolidated balance sheets are valued at the unpaid principal balance, net of an allowance for credit losses. Mortgage loans with a maturity date or a committed prepayment date within twelve months are classified as current on the consolidated balance sheets. The Company assesses whether its loans share similar risk characteristics and, if so, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">groups such loans in a risk pool when measuring expected credit losses. The Company considers the following characteristics when evaluating whether its loans share similar risk characteristics:&#160;loan-to-value ratios, property type (e.g., office, retail, apartment, industrial), geographic location, vacancy rates and property condition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit loss reserves are determined using a loss rate method that multiplies the unpaid principal balance of each loan within a risk pool group by an estimated loss rate percentage. The loss rate percentage considers both the expected loan loss severity and the probability of loan default. For periods where the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions (e.g., gross domestic product, employment), the Company adjusts its expected loss rates to reflect these forecasted economic conditions. For periods beyond which the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions, the Company reverts to historical loss rates in determining expected credit losses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income on a potential problem loan (i.e., high probability of default) or restructured loan is accrued to the extent it is deemed to be collectible and the loan continues to perform under its original or restructured terms. Interest income on problem loans (i.e., more than 60 days delinquent, in bankruptcy or in process of foreclosure) is recognized on a cash basis. Cash payments on loans in the process of foreclosure are treated as a return of principal.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Investments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments consist primarily of the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Private equity and hedge fund limited partnerships, which are accounted for using the equity method of accounting. Under this method, the carrying value of the investment is based on the value of the Company&#8217;s equity ownership of the underlying investment funds provided by the general partner or manager of the investments, the financial statements of which generally are audited. As a result of the timing of the receipt of the valuation information provided by the fund managers, these investments are generally reported on up to a three month lag. The Company reviews investments for impairment at least quarterly and monitors their performance throughout the year through discussions with the administrators, managers and/or general partners. If the Company becomes aware of an impairment of a limited partnership&#8217;s investments through its review or prior to receiving the limited partnership&#8217;s financial statements at the financial statement date, an impairment will be recognized by recording a reduction in the carrying value of the limited partnership with a corresponding charge to net investment income. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Investment real estate, which is carried on the consolidated balance sheets at depreciated cost, including capital additions, net of write-downs for other-than-temporary declines in fair value. Depreciation is calculated using the straight-line method based on the estimated useful life of each asset. If any real estate investment is considered held-for-sale, it is carried at the lower of its carrying value or fair value less estimated selling costs. The Company generally estimates fair value using net operating income and applying a capitalization rate in conjunction with comparable sales information. At the time of the sale, the difference between the sales price and the carrying value is recorded as a realized capital gain or loss. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Privately-placed equity securities, which are carried on the consolidated balance sheets at cost less impairments, plus or minus subsequent adjustments for observable price changes. Additionally, as a member of the Federal Home Loan Bank of Boston (&#8220;FHLBB&#8221;), a subsidiary of the Company is required to purchase and hold shares of the FHLBB. These shares are restricted and carried at cost. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Income</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net investment income on the Company&#8217;s investments is recorded when earned and is reflected in the Company&#8217;s net income (other than net investment income on assets supporting experience-rated products). Experience-rated products are products in the large case pensions business where the contract holder, not the Company, assumes investment and other risks, subject to, among other things, minimum guarantees provided by the Company. The effect of investment performance on experience-rated products is allocated to contract holders&#8217; accounts daily, based on the underlying investment experience and, therefore, does not impact the Company&#8217;s net income (as long as the contract&#8217;s minimum guarantees are not triggered). Net investment income on assets supporting large case pensions&#8217; experience-rated products is included in net investment income in the consolidated statements of operations and is credited to contract holders&#8217; accounts through a charge to benefit costs. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized capital gains and losses on investments (other than realized capital gains and losses on investments supporting experience-rated products) are included as a component of net investment income in the consolidated statements of operations. Realized capital gains and losses are determined on a specific identification basis. Purchases and sales of debt and equity securities and alternative investments are reflected on the trade date. Purchases and sales of mortgage loans and investment real estate are reflected on the closing date.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized capital gains and losses on investments supporting large case pensions&#8217; experience-rated products are not included in realized capital gains and losses in the consolidated statements of operations and instead are credited directly to contract holders&#8217; accounts. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized capital gains and losses on investments (other than unrealized capital gains and losses on investments supporting experience-rated products) are reflected in shareholders&#8217; equity, net of tax, as a component of accumulated other comprehensive income (loss). Unrealized capital gains and losses on investments supporting large case pensions&#8217; experience-rated products are credited directly to contract holders&#8217; accounts. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments in order to manage interest rate and foreign exchange risk and credit exposure. The Company&#8217;s use of these derivatives is generally limited to hedging risk and has principally consisted of using interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text">Accounts ReceivableAccounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations.When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">Inventories Inventories are valued at the lower of cost or net realizable value using the weighted average cost method. Physical inventory counts are taken on a regular basis in each retail store and LTC pharmacy, and a continuous cycle count process is the primary procedure used to validate the inventory balances on hand in each distribution center and mail facility to ensure that the amounts reflected in the consolidated financial statements are properly stated. During the interim period between physical inventory counts, the Company accrues for anticipated physical inventory losses on a location-by-location basis based on historical results and current physical inventory trends.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceAccountingPolicy', window );">Reinsurance Recoverables</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reinsurance Recoverables </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#8217;s primary liability as the direct insurer of the risks reinsured. Failure of reinsurers to indemnify the Company could result in losses; however, the Company does not expect charges for unrecoverable reinsurance to have a material effect on its consolidated operating results or financial condition. The Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk arising from similar geographic regions, activities or economic characteristics of its reinsurers. At December&#160;31, 2022, the Company&#8217;s reinsurance recoverables consisted primarily of amounts due from third parties that are rated consistent with companies that are considered to have the ability to meet their obligations. Reinsurance recoverables are recorded as other current assets or other assets on the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy', window );">Health Care Contract Acquisition Costs</a></td>
<td class="text">Health Care Contract Acquisition CostsInsurance products included in the Health Care Benefits segment are cancellable by either the customer or the member monthly upon written notice. Acquisition costs related to prepaid health care and health indemnity contracts are generally expensed as incurred. For certain long-duration insurance contracts, acquisition costs directly related to the successful acquisition of a new or renewal insurance contract, including commissions, are deferred and are recorded as other current assets or other assets on the consolidated balance sheets. Contracts are grouped by product and issue year into cohorts consistent with the grouping used in estimating the associated liability and are amortized on a constant level basis based on the remaining in-force policies over the estimated term of the contracts to approximate straight-line amortization. Changes to the Company&#8217;s assumptions, including assumptions related to persistency, are reflected at the cohort level at the time of change and are recognized prospectively over the estimated terms of the contract. The amortization of deferred acquisition costs is recorded in operating expenses in the consolidated statements of operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text">Property and EquipmentProperty and equipment is reported at historical cost, net of accumulated depreciation. Property, equipment and improvements to leased premises are depreciated using the straight-line method over the estimated useful lives of the assets, or when applicable, the term of the lease, whichever is shorter. Estimated useful lives generally range from 1 to 40 years for buildings, building improvements and leasehold improvements and 3 to 10 years for fixtures, equipment and internally developed software. Repair and maintenance costs are charged directly to expense as incurred. Major renewals or replacements that substantially extend the useful life of an asset are capitalized and depreciated. Application development stage costs for significant internally developed software projects are capitalized and depreciated.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Right-of-Use Assets and Lease Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Right-of-Use Assets and Lease Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the lease, renewal date of the lease or significant remodeling of the lease space based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company&#8217;s leases is not readily determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The operating lease right-of-use assets also include lease payments made before commencement and are reduced by lease incentives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s real estate leases typically contain options that permit renewals for additional periods of up to five years each. For real estate leases, the options to extend are not considered reasonably certain at lease commencement because the Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and regularly opens or closes stores to align with its operating strategy. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the right-of-use asset and lease liability. Similarly, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. Leases with an initial term of 12 months or less are not recorded on the balance sheets, and lease expense is recognized on a straight-line basis over the term of the short-term lease.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For real estate leases, the Company accounts for lease components and nonlease components as a single lease component. Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the right-of-use assets and lease liabilities.</span></div>See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about right-of-use assets and lease liabilities.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text">Goodwill The Company accounts for business combinations using the acquisition method of accounting, which requires the excess cost of an acquisition over the fair value of net assets acquired and identifiable intangible assets to be recorded as goodwill. Goodwill is not amortized, but is subject to impairment reviews annually, or more frequently, if necessary, as further described in &#8220;Recoverability of Long-Lived Assets&#8221; below.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s identifiable intangible assets consist primarily of trademarks, trade names, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired (&#8220;VOBA&#8221;). These intangible assets arise primarily from the determination of their respective fair market values at the date of acquisition. Amounts assigned to identifiable intangible assets, and their related useful lives, are derived from established valuation techniques and management estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s definite-lived intangible assets are amortized over their estimated useful lives based upon the pattern of future cash flows attributable to the asset. Definite-lived intangible assets are amortized using the straight-line method. VOBA is subject to loss recognition testing annually, or more frequently, if necessary. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets are not amortized but are tested for impairment annually, or more frequently, if necessary, as further described in &#8220;Recoverability of Long-Lived Assets&#8221; below.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Recoverability of Long-Lived Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recoverability of Long-Lived Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the recoverability of long-lived assets, excluding goodwill and indefinite-lived intangible assets, which are tested for impairment using separate tests described below, whenever events or changes in circumstances indicate that the carrying value of such asset may not be recoverable. The Company groups and evaluates these long-lived assets for impairment at the lowest level at which individual cash flows can be identified. If indicators of impairment are present, the Company first </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the asset group&#8217;s estimated future cash flows (discounted). If required, an impairment loss is recorded for the portion of the asset group&#8217;s carrying value that exceeds the asset group&#8217;s estimated future cash flows (discounted). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, the Company recorded office real estate optimization charges of $117&#160;million primarily related to the abandonment of leased real estate and the related right-of-use assets and property and equipment in connection with the planned reduction of corporate office real estate space in response to its new flexible work arrangement. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, the Company recorded a store impairment charge of approximately $1.4&#160;billion primarily related to the write down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately 900 retail stores between 2022 and 2024. There were no material impairment charges recognized on long-lived assets during the year ended December 31, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about the right-of-use asset charges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When evaluating goodwill for potential impairment, the Company compares the fair value of its reporting units to their respective carrying amounts. The Company estimates the fair value of its reporting units using a combination of a discounted cash flow method and a market multiple method. If the carrying amount of a reporting unit exceeds its estimated fair value, an impairment loss is recognized in an amount equal to that excess. During the third quarter of both 2022 and 2020, the Company performed its required annual impairment tests of goodwill and concluded there were no goodwill impairments as of the testing dates or during the years ended December 31, 2022 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company performed its required annual impairment tests of goodwill, the results of which indicated an impairment of the goodwill associated with the LTC reporting unit. Accordingly, during the third quarter of 2021, the Company recorded a $431&#160;million goodwill impairment charge on the remaining goodwill of the LTC reporting unit. The results of the impairment tests indicated that there was no impairment of goodwill of the remaining reporting units as of the testing date or during the year ended December&#160;31, 2021. See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; for additional information about the goodwill impairment charge recorded during the year ended December&#160;31, 2021. </span></div>Indefinite-lived intangible assets are tested for impairment by comparing the estimated fair value of the asset to its carrying value. The Company estimates the fair value of its indefinite-lived trademarks using the relief from royalty method under the income approach. If the carrying value of the asset exceeds its estimated fair value, an impairment loss is recognized, and the asset is written down to its estimated fair value.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountsPolicy', window );">Separate Accounts</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets and liabilities related to large case pensions products represent funds maintained to meet specific objectives of contract holders who bear the investment risk. These assets and liabilities are carried at fair value. Net investment income (including net realized capital gains and losses) accrue directly to such contract holders. The assets of each account are legally segregated and are not subject to claims arising from the Company&#8217;s other businesses. Deposits, withdrawals and net investment income (including net realized and net unrealized capital gains and losses) on Separate Accounts assets are not reflected in the consolidated statements of operations or cash flows. Management fees charged to contract holders are included in services revenue and recognized over the period earned.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareCostsPolicyPolicyTextBlock', window );">Health Care Costs Payable</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Costs Payable</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care costs payable consist principally of unpaid fee-for-service medical, dental and pharmacy claims, capitation costs, other amounts due to providers pursuant to risk-sharing arrangements related to the Health Care Benefits segment&#8217;s Insured Commercial, Medicare and Medicaid products and accruals for state assessments. Unpaid health care claims include an estimate of payments the Company will make for (i) services rendered to the Company&#8217;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid, each as of the financial statement date (collectively, &#8220;IBNR&#8221;). Health care costs payable also include an estimate of the cost of services that will continue to be rendered after the financial statement date if the Company is obligated to pay for such services in accordance with contractual or regulatory requirements. Such estimates are developed using actuarial principles and assumptions which consider, among other things, historical and projected claim submission and processing patterns, assumed and historical medical cost trends, historical utilization of medical services, claim inventory levels, changes in Insured membership and product mix, seasonality </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and other relevant factors. The Company reflects changes in these estimates in benefit costs in the Company&#8217;s consolidated operating results in the period they are determined. Capitation costs represent contractual monthly fees paid to participating physicians and other medical providers for providing medical care, regardless of the volume of medical services provided to the Insured member. Amounts due under risk-sharing arrangements are based on the terms of the underlying contracts with the providers and consider claims experience under the contracts through the financial statement date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops its estimate of IBNR using actuarial principles and assumptions that consider numerous factors. Of those factors, the Company considers the analysis of historical and projected claim payment patterns (including claims submission and processing patterns) and the assumed health care cost trend rate (the year-over-year change in per member per month health care costs) to be the most critical assumptions. In developing its IBNR estimate, the Company consistently applies these actuarial principles and assumptions each period, with consideration to the variability of related factors. There have been no significant changes to the methodologies or assumptions used to develop the Company&#8217;s estimate of IBNR in 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company analyzes historical claim payment patterns by comparing claim incurred dates (i.e., the date services were provided) to claim payment dates to estimate &#8220;completion factors.&#8221; The Company uses completion factors predominantly to estimate the ultimate cost of claims incurred more than three months before the financial statement date. The Company estimates completion factors by aggregating claim data based on the month of service and month of claim payment and estimating the percentage of claims incurred for a given month that are complete by each month thereafter. For any given month, substantially all claims are paid within six months of the date of service, but it can take up to 48 months or longer after the date of service before all of the claims are completely resolved and paid. These historically-derived completion factors are then applied to claims paid through the financial statement date to estimate the ultimate claim cost for a given month&#8217;s incurred claim activity. The difference between the estimated ultimate claim cost and the claims paid through the financial statement date represents the Company&#8217;s estimate of claims remaining to be paid as of the financial statement date and is included in the Company&#8217;s health care costs payable. The completion factors the Company uses reflect judgments and possible adjustments based on data such as claim inventory levels, claim submission and processing patterns and, to a lesser extent, other factors such as changes in health care cost trend rates, changes in Insured membership and changes in product mix. If claims are submitted or processed on a faster (slower) pace than prior periods, the actual claims may be more (less) complete than originally estimated using the Company&#8217;s completion factors, which may result in reserves that are higher (lower) than the ultimate cost of claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because claims incurred within three months before the financial statement date are less mature, the Company uses a combination of historically-derived completion factors and the assumed health care cost trend rate to estimate the ultimate cost of claims incurred for these months. The Company applies its actuarial judgment and places a greater emphasis on the assumed health care cost trend rate for the most recent claim incurred dates as these months may be influenced by seasonal patterns and changes in membership and product mix.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s health care cost trend rate is affected by changes in per member utilization of medical services as well as changes in the unit cost of such services. Many factors influence the health care cost trend rate, including the Company&#8217;s ability to manage benefit costs through product design, negotiation of favorable provider contracts and medical management programs, as well as the mix of the Company&#8217;s business. The health status of the Company&#8217;s Insured members, aging of the population and other demographic characteristics, advances in medical technology and other factors continue to contribute to rising per member utilization and unit costs. Changes in health care practices, inflation, new technologies, increases in the cost of prescription drugs (including specialty pharmacy drugs), direct-to-consumer marketing by pharmaceutical companies, clusters of high-cost cases, claim intensity, changes in the regulatory environment, health care provider or member fraud and numerous other factors also contribute to the cost of health care and the Company&#8217;s health care cost trend rate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each reporting period, the Company uses an extensive degree of judgment in the process of estimating its health care costs payable. As a result, considerable variability and uncertainty is inherent in such estimates, particularly with respect to claims with claim incurred dates of three months or less before the financial statement date; and the adequacy of such estimates is highly sensitive to changes in assumed completion factors and the assumed health care cost trend rates. For each reporting period the Company recognizes the actuarial best estimate of health care costs payable considering the potential volatility in assumed completion factors and health care cost trend rates, as well as other factors. The Company believes its estimate of health care costs payable is reasonable and adequate to cover its obligations at December&#160;31, 2022; however, actual claim payments may differ from the Company&#8217;s estimates. A worsening (or improvement) of the Company&#8217;s health care cost trend rates or changes in completion factors from those that the Company assumed in estimating health care costs payable at December&#160;31, 2022 would cause these estimates to change in the near term, and such a change could be material.</span></div>Each quarter, the Company re-examines previously established health care costs payable estimates based on actual claim payments for prior periods and other changes in facts and circumstances. Given the extensive degree of judgment in this estimate, it is possible that the Company&#8217;s estimates of health care costs payable could develop either favorably (that is, its actual benefit costs for the period were less than estimated) or unfavorably. The changes in the Company&#8217;s estimate of health care costs payable may relate to a prior quarter, prior year or earlier periods. For a roll forward of the Company&#8217;s health care costs payable, see Note 7 &#8216;&#8216;Health Care Costs Payable.&#8217;&#8217; The Company&#8217;s reserving practice is to consistently recognize the actuarial best estimate of its ultimate liability for health care costs payable.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy', window );">Other Insurance Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Insurance Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unpaid Claims</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unpaid claims consist primarily of reserves associated with certain short-duration group disability and term life insurance contracts, including an estimate for IBNR as of the financial statement date. Reserves associated with certain short-duration group disability and term life insurance contracts are based upon the Company&#8217;s estimate of the present value of future benefits, which is based on assumed investment yields and assumptions regarding mortality, morbidity and recoveries from the U.S. Social Security Administration. The Company develops its estimate of IBNR using actuarial principles and assumptions which consider, among other things, contractual requirements, claim incidence rates, claim recovery rates, seasonality and other relevant factors. The Company discounts certain claim liabilities related to group long-term disability and life insurance waiver of premium contracts. The discount rates generally reflect the Company&#8217;s expected investment returns for the investments supporting all incurral years of these liabilities. The discount rates for retrospectively-rated contracts are set at contractually specified levels. The Company&#8217;s estimates of unpaid claims are subject to change due to changes in the underlying experience of the insurance contracts, changes in investment yields or other factors, and these changes are recorded in current and future benefits in the consolidated statements of operations in the period they are determined. The Company estimates its reserve for claims IBNR for life products largely based on completion factors. The completion factors used are based on the Company&#8217;s historical experience and reflect judgments and possible adjustments based on data such as claim inventory levels, claim payment patterns, changes in business volume and other factors. If claims are submitted or processed on a faster (slower) pace than historical periods, the actual claims may be more (less) complete than originally estimated using completion factors, which may result in reserves that are higher (lower) than required to cover future life benefit payments. There have been no significant changes to the methodologies or assumptions used to develop the Company&#8217;s estimate of unpaid claims IBNR in 2022. As of December&#160;31, 2022, unpaid claims balances of $243 million and $1.1 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2021, unpaid claims balances of $324 million and $1.3 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all life and disability insurance liabilities have been fully ceded to unrelated third parties through indemnity reinsurance agreements; however, the Company remains directly obligated to the policyholders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Future Policy Benefits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future policy benefits consist primarily of reserves for products for which the Company no longer solicits or accepts new customers, including limited payment pension and annuity contracts and long-term care insurance contracts. Contracts are grouped into cohorts by contract type and issue year. The liability for future policy benefits is adjusted for differences between actual and expected experience. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserves for limited payment pension and annuity contracts represent the Company&#8217;s estimate of the present value of future benefits to be paid to or on behalf of policyholders and are computed using actuarial principles that consider, among other things, assumptions reflecting anticipated mortality and retirement experience. On an annual basis, or more frequently if necessary, the Company reviews mortality assumptions against both industry standards and its experience.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserves for long-term care insurance contracts represent the Company&#8217;s estimate of the present value of future benefits and settlement costs to be paid to or on behalf of policyholders less the present value of future net premiums. The Company&#8217;s estimate of the present value of future benefits under such contracts is based upon mortality, morbidity, lapse and interest rate assumptions. On an annual basis, or more frequently if necessary, the Company reviews its mortality, morbidity and lapse assumptions against its experience. Annually, or each time the assumptions are changed, the net premium ratio used to calculate the future policy benefit liability is updated to reflect actual experience, as well as the impact of any change in assumptions on the Company&#8217;s future cash flows. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company discounts its future policy benefit liability using a curve of spot rates derived from Single A rated fixed income instruments. At each reporting date, the Company will measure its liability for future policy benefits using both the current spot </span></div>rate curve and the locked-in discount rate at each cohort&#8217;s inception. Any difference between the measured liabilities is recorded in other comprehensive income (loss).<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock', window );">Premium Deficiency Reserves</a></td>
<td class="text">Premium Deficiency ReservesThe Company evaluates its short-duration insurance contracts to determine if it is probable that a loss will be incurred. A premium deficiency loss is recognized when it is probable that expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), will exceed existing reserves plus anticipated future premiums and reinsurance recoveries. Anticipated investment income is not considered in the calculation of premium deficiency losses. For purposes of determining premium deficiency losses, contracts are grouped consistent with the Company&#8217;s method of acquiring, servicing and measuring the profitability of such contracts.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocationsToPolicyholdersPolicies', window );">Policyholders' Funds</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policyholders&#8217; Funds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Policyholders&#8217; funds consist primarily of reserves for pension and annuity investment contracts and customer funds associated with certain health contracts. Reserves for such contracts are equal to cumulative deposits less withdrawals and charges plus interest credited thereon, net of experience-rated adjustments. In both 2022 and 2021, interest rates for pension and annuity investment contracts ranged from 3.5% to 4.8%. Reserves for contracts subject to experience rating reflect the Company&#8217;s rights as well as the rights of policyholders and plan participants. The Company also held funds for HSAs on behalf of members associated with high deductible health plans prior to the sale of PayFlex in June 2022. These amounts were held to pay for qualified health care expenses incurred by these members. At December&#160;31, 2022, the Company did not hold any HSA funds as a result of the PayFlex sale. The HSA balance was approximately $2.9 billion at December 31, 2021 and was reflected in other current assets with a corresponding liability in policyholders&#8217; funds. These assets were considered restricted cash for cash flow statement purposes.</span></div>Policyholders&#8217; funds liabilities that are expected to be paid within twelve months from the balance sheet date are classified as current on the consolidated balance sheets. Policyholders&#8217; funds liabilities that are expected to be paid greater than twelve months from the balance sheet date are included in other long-term liabilities on the consolidated balance sheets.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReservePolicyTextBlock', window );">Self-Insurance Liabilities</a></td>
<td class="text">Self-Insurance LiabilitiesThe Company is self-insured for certain losses related to general liability, workers&#8217; compensation and auto liability. The Company obtains third party insurance coverage to limit exposure from these claims. The Company is also self-insured for certain losses related to health and medical liabilities. The Company&#8217;s self-insurance accruals, which include reported claims and claims incurred but not reported, are calculated using standard insurance industry actuarial assumptions and the Company&#8217;s historical claims experience.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation and Transactions</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation and Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For non-U.S. dollar functional currency locations, (i) assets and liabilities are translated at end-of-period exchange rates, (ii) revenues and expenses are translated at average exchange rates in effect during the period and (iii) equity is translated at historical exchange rates. The resulting cumulative translation adjustments are included as a component of accumulated other comprehensive income (loss).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For U.S. dollar functional currency locations, foreign currency assets and liabilities are remeasured into U.S. dollars at end-of-period exchange rates, except for nonmonetary balance sheet accounts which are remeasured at historical exchange rates. Revenues and expenses are remeasured at average exchange rates in effect during each period, except for those expenses related to the nonmonetary balance sheet amounts which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in net income.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health Care Benefits revenue is principally derived from insurance premiums and fees billed to customers. Revenue is recognized based on customer billings, which, in the Company&#8217;s Commercial business, reflect contracted rates per member and the number of covered members recorded in the Company&#8217;s records at the time the billings are prepared. Billings are generally sent monthly for coverage during the following month. Revenue related to the Company&#8217;s Government business is collected monthly from the U.S. federal government and various government agencies based on fixed payment rates and member eligibility. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s billings may be subsequently adjusted to reflect enrollment changes due to member terminations or other factors. These adjustments are known as retroactivity adjustments. In each period, the Company estimates the amount of future retroactivity and adjusts the recorded revenue accordingly. As information regarding actual retroactivity amounts becomes known, the Company refines its estimates and records any required adjustments to revenues in the period in which they arise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Premium Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums are recognized as revenue in the month in which the enrollee is entitled to receive health care services. Premiums are reported net of an allowance for estimated terminations and uncollectible amounts. Additionally, premium revenue subject to the minimum medical loss ratio (&#8220;MLR&#8221;) rebate requirements of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (as amended, collectively, the &#8220;ACA&#8221;) is recorded net of the estimated minimum MLR rebates for the current calendar year. Premiums related to unexpired contractual coverage periods (unearned premiums) are reported as other insurance liabilities on the consolidated balance sheets and recognized as revenue when earned.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s contracts allow for premiums to be adjusted to reflect actual experience or the relative health status of Insured members. Such adjustments are reasonably estimable at the outset of the contract, and adjustments to those estimates are made based on actual experience of the customer emerging under the contract and the terms of the underlying contract.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Services Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue relates to contracts that can include various combinations of services or series of services which generally are capable of being distinct and accounted for as separate performance obligations. The Health Care Benefits segment&#8217;s services revenue primarily consists of ASC fees received in exchange for performing certain claim processing and member services for ASC members. ASC fee revenue is recognized over the period the service is provided. Some of the Company&#8217;s administrative services contracts include guarantees with respect to certain functions, such as customer service response time, claim processing accuracy and claim processing turnaround time, as well as certain guarantees that a plan sponsor&#8217;s benefit claim experience will fall within a certain range. With any of these guarantees, the Company is financially at risk if the conditions of the arrangements are not met, although the maximum amount at risk typically is limited to a percentage of the fees otherwise payable to the Company by the customer involved. Each period the Company estimates its obligations under the terms of these guarantees and records its estimate as an offset to services revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting for Medicare Part D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include insurance premiums earned by the Company&#8217;s PDPs, which are determined based on the PDP&#8217;s annual bid and related contractual arrangements with the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;). The insurance premiums include a beneficiary premium, which is the responsibility of the PDP member, and can be subsidized by CMS in the case of low-income members, and a direct premium paid by CMS. Premiums collected in advance are initially recorded within other insurance liabilities and are then recognized ratably as revenue over the period in which members are entitled to receive benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues also include a risk-sharing feature of the Medicare Part D program design referred to as the risk corridor. The Company estimates variable consideration in the form of amounts payable to, or receivable from, CMS under the risk corridor, and adjusts revenue based on calculations of additional subsidies to be received from or owed to CMS at the end of the reporting year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to Medicare Part D premiums, the Company receives additional payments each month from CMS related to catastrophic reinsurance, low-income cost-sharing subsidies and coverage gap benefits. If the subsidies received differ from the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amounts earned from actual prescriptions transferred, the difference is recorded in either accounts receivable, net or accrued expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Services segment sells prescription drugs directly through its specialty and mail order pharmacy offerings and indirectly through the Company&#8217;s retail pharmacy network. The Company&#8217;s pharmacy benefit arrangements are accounted for in a manner consistent with a master supply arrangement as there are no contractual minimum volumes and each prescription is considered a separate purchasing decision and distinct performance obligation transferred at a point in time. PBM services performed in connection with each prescription claim are considered part of a single performance obligation which culminates in the fulfillment of prescription drugs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue using the gross method at the contract price negotiated with its clients when the Company has concluded it controls the prescription drug before it is transferred to the client plan members. The Company controls prescriptions fulfilled indirectly through its retail pharmacy network because it has separate contractual arrangements with those pharmacies, has discretion in setting the price for the transaction and assumes primary responsibility for fulfilling the promise to provide prescription drugs to its client plan members while also performing the related PBM services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include (i) the portion of the price the client pays directly to the Company, net of any discounts earned on brand name drugs or other discounts and refunds paid back to the client (see &#8220;Drug Discounts&#8221; and &#8220;Guarantees&#8221; below), (ii) the price paid to the Company by client plan members for mail order prescriptions and the price paid to retail network pharmacies by client plan members for retail prescriptions (&#8220;retail co-payments&#8221;), and (iii) claims based administrative fees for retail pharmacy network contracts. Sales taxes are not included in revenues. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when control of the prescription drugs is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those prescription drugs. The Company has established the following revenue recognition policies for the Health Services segment:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by third party pharmacies in the Company&#8217;s retail pharmacy network and associated administrative fees are recognized at the Company&#8217;s point-of-sale, which is when the claim is adjudicated by the Company&#8217;s online claims processing system and the Company has transferred control of the prescription drug and completed all of its performance obligations.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by specialty and mail order pharmacies are recognized when the prescription drug is delivered to the client plan member. At the time of delivery, the Company has performed substantially all of its performance obligations under its client contracts and does not experience a significant level of returns or reshipments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts under which the Company acts as an agent or does not control the prescription drugs prior to transfer to the client plan member, revenue is recognized using the net method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Drug Discounts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records revenue net of manufacturers&#8217; rebates earned by its clients based on their plan members&#8217; utilization of brand-name formulary drugs. The Company estimates these rebates at period-end based on actual and estimated claims data and its estimates of the manufacturers&#8217; rebates earned by its clients. The estimates are based on the best available data at period-end and recent history for the various factors that can affect the amount of rebates due to the client. The Company adjusts its rebates payable to clients to the actual amounts paid when these rebates are paid or as significant events occur. Any cumulative effect of these adjustments is recorded against revenues at the time it is identified. Adjustments generally result from contract changes with clients or manufacturers that have retroactive rebate adjustments, differences between the estimated and actual product mix subject to rebates, or whether the brand name drug was included in the applicable formulary. The effect of adjustments between estimated and actual manufacturers&#8217; rebate amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantees</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also adjusts revenues for refunds owed to clients resulting from pricing guarantees and performance against defined service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Walk-In Medical Clinics</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For services provided by the Company&#8217;s walk-in medical clinics, revenue recognition occurs for completed services provided to patients, with adjustments taken for third party payor contractual obligations and patient direct bill historical collection rates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy &amp; Consumer Wellness Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Retail Pharmacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s retail drugstores recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims under other retail network arrangements. Revenues are adjusted for refunds owed to third party payers resulting from pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Company gift cards purchased by customers is deferred as a contract liability until goods or services are transferred. Any amounts not expected to be redeemed by customers (i.e., breakage) are recognized based on historical redemption patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer returns are not material to the Company&#8217;s operating results or financial condition. Sales taxes are not included in revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Loyalty and Other Programs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customer loyalty program, ExtraCare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, consists of two components, ExtraSavings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Rewards. ExtraSavings are coupons that are recorded as a reduction of revenue when redeemed as the Company concluded that they do not represent a promise to the customer to deliver additional goods or services at the time of issuance because they are not tied to a specific transaction or spending level. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ExtraBucks Rewards are accumulated by customers based on their historical spending levels. Thus, the Company has determined that there is an additional performance obligation to those customers at the time of the initial transaction. The Company allocates the transaction price to the initial transaction and the ExtraBucks Rewards transaction based upon the relative standalone selling price, which considers historical redemption patterns for the rewards. Revenue allocated to ExtraBucks Rewards is recognized as those rewards are redeemed. At the end of each period, unredeemed ExtraBucks Rewards are reflected as a contract liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also offers a subscription-based membership program, CarePass</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, under which members are entitled to a suite of benefits delivered over the course of the subscription period, as well as a promotional reward that can be redeemed for future goods and services. Subscriptions are paid for on a monthly or annual basis at the time of or in advance of the Company delivering the goods and services. Revenue from these arrangements is recognized as the performance obligations are satisfied.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-term Care</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those goods or services. Each prescription claim represents a separate performance obligation of the Company, separate and distinct from other prescription claims under customer arrangements. A significant portion of long-term care revenue from sales of pharmaceutical and medical products is reimbursed by the federal Medicare Part D program and, to a lesser extent, state Medicaid programs. The Company monitors its revenues and receivables from these reimbursement sources, as well as long-term care facilities and other third party insurance payors, and reduces revenue at the revenue recognition date to properly account for the variable consideration due to anticipated differences between billed and reimbursed amounts. Accordingly, the total revenues and receivables reported in the Company&#8217;s consolidated financial statements are recorded at the amount expected to be ultimately received from these payors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient co-payments associated with Medicare Part D, certain state Medicaid programs, Medicare Part B and certain third party payors typically are not collected at the time products are delivered or services are rendered, but are billed to the individuals as part of normal billing procedures and subject to normal accounts receivable collections procedures.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Products Sold</a></td>
<td class="text"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products Sold</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for cost of products sold as follows:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products sold includes: (i) the cost of prescription drugs sold during the reporting period directly through the Company&#8217;s specialty and mail order pharmacies and indirectly through the Company&#8217;s retail pharmacy network, (ii) shipping and handling costs, (iii) administrative service fees paid to the Pharmacy &amp; Consumer Wellness segment for specialty and mail order pharmacy fulfillment services and (iv) the operating costs of the Company&#8217;s client service operations and related information technology support costs including depreciation and amortization. The cost of prescription drugs sold component of cost of products sold includes: (i) the cost of the prescription drugs purchased from manufacturers or distributors and shipped to members in clients&#8217; benefit plans from the Company&#8217;s mail order pharmacies, net of any volume-related or other discounts (see &#8220;Vendor Allowances and Purchase Discounts&#8221; below) and (ii) the cost of prescription drugs sold (including retail co-payments) through the Company&#8217;s retail pharmacy network under contracts where the Company is the principal, net of any volume-related or other discounts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy &amp; Consumer Wellness Segment</span></div>Cost of products sold includes: the cost of merchandise sold during the reporting period, including the costs of prescription drugs sold through its retail pharmacies, net of any volume-related or other discounts, the related purchasing costs, warehousing and delivery costs (including depreciation and amortization), the operating costs of the Company&#8217;s specialty and mail order pharmacy fulfillment operations and actual and estimated inventory losses.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock', window );">Vendor Allowances and Purchase Discounts</a></td>
<td class="text"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vendor Allowances and Purchase Discounts </span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for vendor allowances and purchase discounts as follows: </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Services segment receives purchase discounts on products purchased. Contractual arrangements with vendors, including manufacturers, wholesalers and retail pharmacies, normally provide for the Health Services segment to receive purchase discounts from established list prices in one, or a combination, of the following forms: (i) a direct discount at the time of purchase, (ii) a discount for the prompt payment of invoices or (iii) when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy), a discount (or rebate) paid subsequent to dispensing. These rebates are recognized when prescriptions are dispensed and are generally calculated and billed to manufacturers within 30 days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Company&#8217;s operating results or financial condition. The Company accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Health Services segment also receives additional discounts under its wholesaler contracts if it exceeds contractually defined purchase volumes. In addition, the Health Services segment receives fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of products sold. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy &amp; Consumer Wellness Segment</span></div>Vendor allowances received by the Pharmacy &amp; Consumer Wellness segment reduce the carrying cost of inventory and are recognized in cost of products sold when the related inventory is sold, unless they are specifically identified as a reimbursement of incremental costs for promotional programs and/or other services provided. Amounts that are directly linked to advertising commitments are recognized as a reduction of advertising expense (included in operating expenses) when the related advertising commitment is satisfied. Any amounts received in excess of the actual cost incurred also reduce the carrying cost of inventory. The total value of any upfront payments received from vendors that are linked to purchase commitments is initially deferred. The deferred amounts are then amortized to reduce cost of products sold over the life of the contract based upon sales volume. The total value of any upfront payments received from vendors that are not linked to purchase commitments is also initially deferred. The deferred amounts are then amortized to reduce cost of products sold on a straight-line basis over the life of the related contract. The total amortization of these upfront payments was not material to the Company&#8217;s consolidated financial statements in any of the periods presented.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock', window );">Health Care Reform</a></td>
<td class="text"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Reform</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Insurer Fee</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning on January 1, 2014, the ACA imposed an annual premium-based health insurer fee (&#8220;HIF&#8221;) for each calendar year, payable in September, which was not deductible for tax purposes. The Company was required to estimate a liability for the HIF at the beginning of the calendar year in which the fee was payable with a corresponding deferred asset that was amortized ratably to operating expenses over the calendar year. The Company recorded the liability for the HIF in accrued expenses and recorded the deferred asset in other current assets. In December 2019, the HIF was repealed for calendar years after 2020, therefore there was no expense related to the HIF in the years ended December&#160;31, 2022 and 2021. In the year ended December 31, 2020, operating expenses included $1.0&#160;billion related to the Company&#8217;s share of the HIF. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established a permanent risk adjustment program to transfer funds from qualified individual and small group insurance plans with below average risk scores to plans with above average risk scores. Based on the risk of the Company&#8217;s qualified plan members relative to the average risk of members of other qualified plans in comparable markets, as defined by the ACA, the Company estimates its ultimate risk adjustment receivable (recorded in accounts receivable) or payable (recorded in accrued expenses) for the current calendar year and reflects the pro-rata year-to-date impact as an adjustment to premium revenue. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Corridor</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established a temporary risk corridor program, which expired at the end of 2016, for qualified individual and small group health insurance plans. Under this program, health insurance companies were to make payments to, or receive payments from, the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) based on their ratio of allowable costs to target costs (as defined by the ACA). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company filed a lawsuit in August 2019 to recover the $313&#160;million it was owed under the ACA&#8217;s risk corridor program, which had been stayed pending the Supreme Court decision. In April 2020, the U.S. Supreme Court ruled that health insurance companies may sue the federal government for amounts owed as calculated under the ACA&#8217;s temporary risk corridor program. </span></div>In October 2020, the Company received the $313&#160;million it was owed under the ACA&#8217;s risk corridor program. The Company recorded the risk corridor payment as an increase to premium revenue in the year ended December 31, 2020. After considering offsetting items such as the ACA&#8217;s minimum MLR rebate requirements and premium taxes, the Company recorded pre-tax income of $307&#160;million and after-tax income of $223&#160;million during the year ended December&#160;31, 2020.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text">Advertising Costs Advertising costs, which are reduced by the portion funded by vendors, are expensed when the related advertising takes place. Net advertising costs, which are included in operating expenses, were $745 million, $707 million and $613 million in 2022, 2021 and 2020, respectively.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based CompensationStock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc0MDU2_6fb0217d-b4b8-4272-817b-3803971eadab">three</span> to five years) using the straight-line method.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year or years in which the differences are expected to reverse. The effect of a change in the tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date of such change.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, and the Company&#8217;s recent operating results. The Company establishes a valuation allowance when it does not consider it more likely than not that a deferred tax asset will be recovered.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions on the basis of a two-step process whereby (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and/or penalties related to uncertain tax positions are recognized in the income tax provision.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPolicy', window );">Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit Plans</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit Plans</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors defined benefit pension plans (&#8220;pension plans&#8221;) and other postretirement employee benefit plans (&#8220;OPEB plans&#8221;) for its employees and retirees. The Company recognizes the funded status of its pension and OPEB plans on the consolidated balance sheets based on the year-end measurements of plan assets and benefit obligations. When the fair value of plan assets are in excess of the plan benefit obligations, the amounts are reported in other current assets and other assets. When the fair value of plan benefit obligations are in excess of plan assets, the amounts are reported in accrued expenses and other long-term liabilities based on the amount by which the actuarial present value of benefits payable in the next twelve months included in the benefit obligation exceeds the fair value of plan assets. The net periodic benefit income for the Company&#8217;s pension and OPEB plans do not contain a service cost component as these plans have been frozen for an extended period of time.&#160;Non-service cost components of pension and postretirement net periodic benefit income are included in other income in the consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is computed using the treasury stock method. The Company calculates basic earnings per share based on the weighted average number of common shares outstanding for the period. See Note 15 &#8216;&#8216;Earnings Per Share&#8217;&#8217; for additional information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_SharesHeldInTrustPolicyTextBlock', window );">Shares Held in Trust</a></td>
<td class="text">Shares Held in TrustThe Company maintains grantor trusts, which held approximately one million shares of its common stock at both December&#160;31, 2022 and 2021. These shares are designated for use under various employee compensation plans. Since the Company holds these shares, they are excluded from the computation of basic and diluted shares outstanding.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in (i) a generic pharmaceutical sourcing entity, (ii) certain hedge fund and private equity investments and (iii) certain real estate partnerships that are considered VIEs. The Company does not have a future obligation to fund losses or debts on behalf of these investments; however, it may voluntarily contribute funds. In evaluating whether the Company is the primary beneficiary of a VIE, the Company considers several factors, including whether the Company has (a) the power to direct the activities that most significantly impact the VIE&#8217;s economic performance and (b) the obligation to absorb losses and the right to receive benefits that could potentially be significant to the VIE. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities - Primary Beneficiary</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014, the Company and Cardinal Health, Inc. (&#8220;Cardinal&#8221;) established Red Oak Sourcing, LLC (&#8220;Red Oak&#8221;), a generic pharmaceutical sourcing entity in which the Company and Cardinal each own 50%. The Red Oak arrangement had an initial term of ten years. In 2021, the Red Oak arrangement was amended to extend the initial term an additional five years, for a total term of 15 years. Under this arrangement, the Company and Cardinal contributed their sourcing and supply chain expertise to Red Oak and agreed to source and negotiate generic pharmaceutical supply contracts for both companies through Red Oak; however, Red Oak does not own or hold inventory on behalf of either company. No physical assets (e.g., property and equipment) were contributed to Red Oak by either company, and minimal funding was provided to capitalize Red Oak. The Company has determined that it is the primary beneficiary of this VIE because it has the ability to direct the activities of Red Oak. Consequently, the Company consolidates Red Oak in its consolidated financial statements within the Pharmacy &amp; Consumer Wellness segment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardinal is required to pay the Company quarterly payments, which began in October 2014 and will extend through June 2029. As milestones are met, the quarterly payments increase. The Company received $183 million from Cardinal during each of the years ended December&#160;31, 2022, 2021 and 2020. The payments reduce the Company&#8217;s carrying value of inventory and are recognized in cost of products sold when the related inventory is sold.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities - Other Variable Interest Holder</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has invested in certain VIEs for which it has determined that it is not the primary beneficiary, consisting of the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Hedge fund and private equity investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company invests in hedge fund and private equity investments in order to generate investment returns for its investment portfolio supporting its insurance businesses.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Real estate partnerships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company invests in various real estate partnerships, including those that construct, own and manage low-income housing developments. For the low income housing development investments, substantially all of the projected benefits to the Company are from tax credits and other tax benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not the primary beneficiary of these VIEs because the nature of the Company&#8217;s involvement with the activities of these VIEs does not give the Company the power to direct the activities that most significantly impact their economic performance. The Company records the amount of its investment in these VIEs as long-term investments on the consolidated balance sheets and recognizes its share of each VIE&#8217;s income or losses in net income.&#160;The Company&#8217;s maximum exposure to loss from these VIEs is limited to its investment balances as disclosed below and the risk of recapture of previously recognized tax credits related to the real estate partnerships, which the Company does not consider significant.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Related Party Transactions</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $60 million, $52 million and $56 million in the years ended December&#160;31, 2022, 2021 and 2020, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $87 million, $79 million and $77 million for pharmaceutical inventory purchases during the years ended December&#160;31, 2022, 2021 and 2020, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2022, 2021 and 2020, the Company made charitable contributions of&#160;$25&#160;million, $50 million and $50&#160;million, respectively,&#160;to the CVS Health Foundation, a non-profit entity that focuses on health, education and community involvement programs. The charitable contributions were recorded as operating expenses in the consolidated statements of operations within the Corporate/Other segment for the years ended December&#160;31, 2022, 2021 and 2020.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsPolicyTextBlock', window );">Discontinued Operations</a></td>
<td class="text">Discontinued OperationsIn connection with certain business dispositions completed between 1995 and 1997, the Company retained guarantees on store lease obligations for a number of former subsidiaries, including Linens &#8216;n Things and Bob&#8217;s Stores, each of which subsequently filed for bankruptcy. The Company&#8217;s loss from discontinued operations includes lease-related costs that the Company believes it will likely be required to satisfy pursuant to these lease guarantees.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Insurance Premium Deficiency Reserve [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InsurancePremiumDeficiencyReservePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_SharesHeldInTrustPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Held In Trust [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_SharesHeldInTrustPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vendor Allowances And Purchase Discounts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocationsToPolicyholdersPolicies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining amounts of income and expenses allocated to policyholders and contract holders, excluding the method for determining dividends payable to policyholders and accounting policies pertaining to separate accounts for variable annuity contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6483535&amp;loc=d3e16392-158451<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocationsToPolicyholdersPolicies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferred policy acquisition costs, including the nature, type, and amount of capitalized costs incurred to write or acquire insurance contracts, and the basis for and methodologies applied in capitalizing and amortizing such costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=35755530&amp;loc=d3e11264-158415<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759068-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI https://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section S99<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=26872618&amp;loc=d3e7436-122677<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144439<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareCostsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accruing health care costs for a prepaid health care service provider.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 405<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6491204&amp;loc=d3e4879-115612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 720<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=49178521&amp;loc=d3e9162-115647<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareCostsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for all health care policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareEntitiesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66047640&amp;loc=d3e39622-114963<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=d3e29149-114947<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6412939&amp;loc=d3e15145-114933<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for contracts reported in separate accounts, including the extent and terms of minimum guarantees, basis of presentation for separate account assets and liabilities and related separate account activity, the liability valuation method and assumptions used in valuing each type of policyholder and contract holder account maintained by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceAccountingPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of reinsurance accounting policy, for example, but not limited to, description of the methodologies and assumptions underlying determination of reinsurance recoverables, reinsurance payables and retention policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=99379264&amp;loc=d3e27830-158548<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99379264&amp;loc=d3e27758-158548<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -URI https://asc.fasb.org/topic&amp;trid=2303980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceAccountingPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReservePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for self-insurance reserves, including, but not limited to incurred but not reported reserves (IBNR).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReservePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for estimating the ultimate cost of settling insurance claims relating to insured events that have occurred on or before a particular date (ordinarily, the statement of financial position date). The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claims adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14754-158437<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14784-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224239426384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of reconciliation of cash and cash equivalents</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the consolidated balance sheets to total cash, cash equivalents and restricted cash on the consolidated statements of cash flows as of December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,305&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,691&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,043&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of accounts receivable, net</a></td>
<td class="text">Accounts receivable, net was composed of the following at December&#160;31, 2022 and 2021:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,503&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,431&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes accounts receivable of $227&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock', window );">Rollforward of deferred acquisition costs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a roll forward of deferred acquisition costs for the years ended December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred acquisition costs, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalizations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred acquisition costs, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following at December&#160;31, 2022 and 2021: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.990%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,996&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixtures and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,978&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,843&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,600&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,550&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,117&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,896&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes property and equipment of $244&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of disaggregation of revenue</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company&#8217;s revenue by major source in each segment for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.701%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.334%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp;<br/>Consumer<br/>Wellness</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">166,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">83,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(45,154)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">205,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">85,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">85,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91,350&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">169,576&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">108,596&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(47,585)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">322,467&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Health Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">102,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail &amp; specialty </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">169,576&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">150,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">77,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43,913)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">184,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">76,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">76,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,328)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,846&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">82,119&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">153,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">101,620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(46,241)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">292,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Health Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail &amp; specialty </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">153,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">139,453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">71,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(40,350)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">171,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,712)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">75,409&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,354&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">93,579&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(42,062)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Health Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail &amp; specialty </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Health Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies. Effective January 1, 2023, pharmacy network also includes activity associated with Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, which permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order. Maintenance Choice activity was previously reflected in mail &amp; specialty. Segment financial information has been revised to reflect these changes.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Health Services mail &amp; specialty is defined as specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as mail order and specialty claims fulfilled by the Pharmacy &amp; Consumer Wellness segment. Effective January 1, 2023, mail &amp; specialty excludes Maintenance Choice activity, which is now reflected within pharmacy network. Segment financial information has been revised to reflect these changes.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of receivables and contract liabilities from contracts with customers</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2022 and 2021, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(371)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock', window );">Schedule of variable interest entities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other variable interest holder VIE assets included in long-term investments on the consolidated balance sheets at December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedge fund investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate partnerships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,289&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of discontinued operations</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the results of discontinued operations for the year ended December 31, 2020. </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the movement in deferred policy acquisition costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=35755530&amp;loc=d3e11264-158415<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2B<br> -URI https://asc.fasb.org/extlink&amp;oid=124505477&amp;loc=SL117422543-158416<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 55<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124504731&amp;loc=d3e11522-158419<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6228884-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfVariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224251714688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions, Divestitures and Asset Sales (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock', window );">Summary of Assets and Liabilities Held for Sale</a></td>
<td class="text">The following table summarizes the assets and liabilities held for sale at December&#160;31, 2022:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">908&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long lived assets held for sale. Disclosure may include the description of the facts and circumstances leading to the expected disposal, manner and timing of disposal, the carrying value of the assets held for sale, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224239435840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TotalInvestmentsTableTextBlock', window );">Schedule of Total Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.016%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,778&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,113&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,891&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,117&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,025&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,142&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes long-term investments of $17&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Debt Securities Available For Sale</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at December&#160;31, 2022 and 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.441%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.504%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Amortized <br/>Cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allowance<br/>for Credit<br/>Losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Amortized<br/>Cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,067&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,840)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,174&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,174&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,240&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results.&#160;At December&#160;31, 2022, debt securities with a fair value of $609 million, gross unrealized capital gains of $3 million and gross unrealized capital losses of </span></div>$59 million, and at December&#160;31, 2021, debt securities with a fair value of $864 million, gross unrealized capital gains of $94 million and gross unrealized capital losses of $2 million were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income (loss).<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Amortized Cost and Fair Value of Debt Securities by Contractual Maturity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities at December&#160;31, 2022 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair <br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,899&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,063&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,280&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock', window );">Schedule of Debt Securities In An Unrealized Capital Loss Position</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at December&#160;31, 2022 and 2021 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>&#160;Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>&#160;Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>&#160;Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,692&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,700&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,800&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,017&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,384&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at December&#160;31, 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting experience-<br/>rated products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting remaining<br/>products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,709&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,924&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,781&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,492&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ActivityInMortgageLoanPortfolioTableTextBlock', window );">Schedule of Activity in Mortgage Loan Portfolio</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s mortgage loans are collateralized by commercial real estate.&#160;During the years ended December 31, 2022 and 2021, the Company had the following activity in its mortgage loan portfolio:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 scheduled mortgage loan principal repayments were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock', window );">Schedule of Mortgage Loan Amortized Cost and Credit Quality Indicator</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon the Company&#8217;s assessments at December&#160;31, 2022 and 2021, the amortized cost basis of the Company&#8217;s mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.100%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.950%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeTextBlock', window );">Schedule of Net Investment Income</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the years ended December 31, 2022, 2021 and 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,201&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital gains or losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,158&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains (losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(320)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital losses include credit-related losses on debt securities of $13 million and yield-related impairment losses on debt securities of $143 million in the year ended December 31, 2022. Net realized capital gains are net of yield-related impairment losses on debt securities of $42 million and $49 million for the years ended December 31, 2021 and 2020, respectively. There were no credit-related losses on debt securities in the years ended December 31, 2021 and 2020.</span></div>(2)Net investment income includes $35 million, $38 million and $42 million for the years ended December 31, 2022, 2021 and 2020, respectively, related to investments supporting experience-rated products.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock', window );">Schedule of Proceeds and Related Gross Realized Capital Gains and Losses From the Sale of Debt Securities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses in the years ended December 31, 2022, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,913&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ActivityInMortgageLoanPortfolioTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Table representing activities in mortgage loan portfolio during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ActivityInMortgageLoanPortfolioTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item includes total investments, both current and long-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224239056464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text">Financial assets measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2022 and 2021 were as follows:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,860&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,860&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,351&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,280&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,878&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,400&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,407&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,954&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,440&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,266&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,817&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_______________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes cash and cash equivalents of $6&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Changes in Level 3 Financial Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">States, <br/>municipalities<br/>&#160;and political <br/>subdivisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.<br/>corporate<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other asset-<br/>backed<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized capital losses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in earnings&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.434%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">States, <br/>municipalities<br/>&#160;and political <br/>subdivisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.<br/>corporate<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other asset-<br/>backed<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Redeemable<br/>preferred<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized capital gains (losses):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in net unrealized capital losses included in other comprehensive income associated with Level 3 financial assets which were held as of December&#160;31, 2021 was $4&#160;million during the year ended December&#160;31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total gross transfers into (out of) Level 3 during the years ended December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross transfers into Level 3</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers into (out of) Level 3</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of Carrying Value and Fair Value By Level of Fair Value Hierarchy</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the consolidated balance sheets at adjusted cost or contract value at December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">978&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">978&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">______________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information regarding the valuation of cost method investments. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes long-term debt of $3&#160;million which has been accounted for as liabilities held for sale and is included in liabilities held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock', window );">Schedule of Fair Value of Separate Accounts by Major Category of Investment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts financial assets at December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.953%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,048&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,599&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,782&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,017&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $85 million of other payables and $70&#160;million of other receivables at December&#160;31, 2022 and 2021, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the fair value of assets, by major investment category, supporting Separate Accounts as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,677&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,281&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities and common/collective trusts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,017&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $85 million of other payables and $70&#160;million of other receivables at December&#160;31, 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of asset supporting separate account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124504833&amp;loc=d3e7104-158389<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224248174032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangibles (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Summary of Changes in Carrying Amount of Goodwill</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the changes in the carrying amount of goodwill by segment for the&#160;years ended December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.455%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp;<br/>Consumer<br/>Wellness</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt;padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,376&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(971)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(971)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,159&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,615&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,376&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,150&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Summary of Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s intangible assets as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except weighted average life</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks (indefinite-lived)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/relationships and covenants not to compete</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,668)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,060)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider networks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(862)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of Business Acquired </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,859&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,028)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,831&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks (indefinite-lived)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/relationships and covenants not to compete</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,564)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider networks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(651)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of Business Acquired </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,753&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,701)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,052&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes intangible assets of $28&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Projected Annual Amortization Expense for Intangible Assets for Next Five Years</a></td>
<td class="text">The projected annual amortization expense for the Company&#8217;s intangible assets for the next five&#160;years is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,283&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the cost, accumulated amortization and net balance of intangibles assets and amortization period, in total and by major class. Finite-lived intangible assets have a stated useful life over which their gross carrying value is amortized. Indefinite intangible assets have a projected indefinite period of benefit (hence are not amortized).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224244859024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Summary of the Components of Net Lease Cost</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the components of net lease cost for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.160%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,633&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: sublease income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,302&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,327&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,350&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases for the years ended December&#160;31, 2022, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.160%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,689&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,714&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,724&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for interest portion of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows paid for principal portion of finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,679&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LesseeLeaseTableTextBlock', window );">Supplemental Balance Sheet Information</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases as of December&#160;31, 2022 and 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except remaining lease term and discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,928</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,122</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,699</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,839</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,177</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,538</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,823</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance leases:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,608</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,375</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(284)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,406</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining lease term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes operating lease right-of-use assets of $56&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes current portion of operating lease liabilities of $21&#160;million and long-term operating lease liabilities of $39&#160;million which have been accounted for as liabilities held for sale and are included in liabilities held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of Operating Lease Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance<br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating<br/>Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,640&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(823)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,501)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,324)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,538&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,003&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Future operating lease payments have not been reduced by minimum sublease rentals of $290 million due in the future under noncancelable subleases.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.5 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Maturities of Finance Lease Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance<br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating<br/>Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,640&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(823)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,501)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,324)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,538&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,003&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Future operating lease payments have not been reduced by minimum sublease rentals of $290 million due in the future under noncancelable subleases.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.5 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLeaseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Lease [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLeaseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224251712080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract', window );"><strong>Health Care and Other Insurance Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock', window );">Information about Incurred and Paid Health Care Claims Development</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information about incurred and paid health care claims development for the year ended December&#160;31, 2021 is presented as required unaudited supplemental information.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Incurred Health Care Claims,<br/>Net of Reinsurance<br/>For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,444&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cumulative Paid Health Care Claims,<br/>Net of Reinsurance<br/>For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,714&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All outstanding liabilities for health care costs payable prior to 2021, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total outstanding liabilities for health care costs payable, net of reinsurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,926&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense and Components of Change in Health Care Costs Payable</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the December&#160;31, 2022 health care net incurred and paid claims development tables to the health care costs payable liability on the consolidated balance sheet were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.105%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-duration health care costs payable, net of reinsurance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance lines other than short duration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total health care costs payable</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,142&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in health care costs payable during the years ended December 31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.160%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of period </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,678&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Impact of discount rate on long-duration insurance reserves </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of period, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,670&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,926&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,874&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(654)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(788)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(429)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,745&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,406&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,115&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,129&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Impact of discount rate on long-duration insurance reserves </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,142&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,678&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,936&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the difference between the current discount rate and the locked-in discount rate on long-duration insurance reserves which is recorded within accumulated other comprehensive income (loss) on the consolidated balance sheets. Refer to Note 8 &#8216;&#8216;Other Insurance Liabilities and Separate Accounts&#8217;&#8217; for further information related to the adoption of the long-duration insurance contracts accounting standard.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total incurred health care costs for the years ended December&#160;31, 2022, 2021 and 2020 in the table above exclude $79 million, $58 million and $41 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the consolidated balance sheets and $249 million, $271 million and $221 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the consolidated balance sheets. The incurred health care costs for the years ended December 31, 2021 and 2020 also exclude $16 million and $11 million, respectively, for premium deficiency reserves related to the Company&#8217;s Medicaid products.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Health Care and Other Insurance Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted information about claims development by accident year for short-duration insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224245767584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Insurance Liabilities and Separate Accounts (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Schedule of Adjustments Resulting From Applying New Accounting Standard</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes changes in the balances of long-duration insurance liabilities as a result of the adoption of the long-duration insurance standard effective January 1, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Large Case<br/>Pensions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term<br/>Care</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020, net of reinsurance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,142</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,142</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in discount rate assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Removal of shadow adjustments in accumulated other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted balance at January 1, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,647</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,695</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted balance at January 1, 2021, net of reinsurance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,647</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,695</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of New Long-Duration Insurance Contracts Standard on Financial Statement Line Items</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the consolidated statement of operations for the years ended December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported<br/>December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted <br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statement of Operations:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,281</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,073</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314,721</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314,513</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,746</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,954</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,628</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,836</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,165</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,327</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,165</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,327</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,149</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,311</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to CVS Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to CVS Health</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported<br/>December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted <br/>December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statement of Operations:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,260</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,188</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,066</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,918</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,801</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,193</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,310</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,420</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,537</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,522</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,548</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,898</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,989</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,898</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,989</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,910</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,001</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to CVS Health</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to CVS Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the consolidated balance sheet as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.716%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported<br/>December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted <br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Balance Sheet:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,685</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,636</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,682</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,633</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,754</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,803</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,275</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,275</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,406</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,142</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other insurance liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,736</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(315)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,421</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,880</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term insurance liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,108</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(273)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,835</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,732</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,730</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,960</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(454)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,506</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,145</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,398</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,465)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,264)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total CVS Health shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,469</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,315</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,769</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,275</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,275</span></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.716%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported<br/>December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted <br/>December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Balance Sheet:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,292</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,319</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,008</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,035</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,052</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,999</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,052</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,808</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,678</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other insurance liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,303</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,807</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,719</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,270</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,115</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term insurance liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,402</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">833</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,235</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,904</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,907</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,618</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,211</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,906</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,997</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">965</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(631)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total CVS Health shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,075</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(540)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,535</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,381</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(540)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,841</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,999</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,052</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the consolidated statement of cash flows for the years ended December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported<br/>December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted <br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statement of Cash Flows:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation of net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,165</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,327</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments required to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,247</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,224</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,075)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,029)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities, net of effects from acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(566)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(491)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable and other insurance liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,247</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,468</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,463</span></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Impact of Change in Accounting Policy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported<br/>December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted <br/>December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statement of Cash Flows:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation of net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,898</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,989</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments required to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,512</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,486</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(428)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(402)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities, net of effects from acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable and other insurance liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,852</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,856</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock', window );">Schedule of Changes in Liability for Future Policy Benefits</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the components of the change in the liability for future policy benefits, which is included in other insurance liabilities and other long-term insurance liabilities on the consolidated balance sheets, during the years ended December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Large Case<br/>Pensions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term<br/>Care</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected net premiums </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of period - current discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums (actual)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of period - current discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected future policy benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of period - current discount rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,606&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments (actual)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,425&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of period - current discount rate</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,252&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits, net of reinsurance recoverable</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,252&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The present value of expected net premiums is equivalent to the present value of expected gross premiums for the long-term care insurance contracts as net premiums are set equal to gross premiums.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Large Case<br/>Pensions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term<br/>Care</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected net premiums </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of period - current discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums (actual)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of period - current discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of expected future policy benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, beginning of period - current discount rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning liability for future policy benefits at original (locked-in) discount rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in cash flow assumptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of actual variances from expected experience</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,844&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,468&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accrual (using locked-in discount rate)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments (actual)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(313)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending liability for future policy benefits at original (locked-in) discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of changes in discount rate assumptions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability for future policy benefits, end of period - current discount rate</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,991&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net liability for future policy benefits, net of reinsurance recoverable</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,602&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The present value of expected net premiums is equivalent to the present value of expected gross premiums for the long-term care insurance contracts as net premiums are set equal to gross premiums.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of undiscounted expected gross premiums and expected future benefit payments for long-duration insurance liabilities as of December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Large case pensions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected future benefit payments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,539</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,882</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected gross premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected future benefit payments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,265</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,115</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected gross premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average interest rate used in the measurement of the long-duration insurance liabilities as of December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Large case pensions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accretion rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.24%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.53%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest accretion rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.11%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.11%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.39%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.88%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average durations (in years) of the long-duration insurance liabilities as of December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large case pensions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term care</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceTableTextBlock', window );">Roll Forward of Policyholders' Funds</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in policyholders&#8217; funds related to long-duration insurance contracts, which are included in policyholders&#8217; funds and other long-term liabilities on the consolidated balance sheets, during the years ended December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except weighted average crediting rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits received</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policy charges</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surrenders and withdrawals</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest credited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in net unrealized gains (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds, end of the period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average crediting rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.72%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.81%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount at risk</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock', window );">Summary of Separate Account Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts financial assets at December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.953%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,048&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,599&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,782&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,017&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $85 million of other payables and $70&#160;million of other receivables at December&#160;31, 2022 and 2021, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the fair value of assets, by major investment category, supporting Separate Accounts as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,677&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,281&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities and common/collective trusts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,017&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $85 million of other payables and $70&#160;million of other receivables at December&#160;31, 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountLiabilityTableTextBlock', window );">Roll Forward of Separate Accounts</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in Separate Accounts liabilities during the years ended December&#160;31, 2022 and 2021: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate Accounts liability, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,087&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,881&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums and deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surrenders and withdrawals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(581)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(947)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(984)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,130)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers from general account</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate Accounts liability, end of the period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,087&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value, end of the period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of beginning balance to ending balance for liability for future policy benefit, with separate presentation of expected future net premium and expected future benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountBalanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about policyholder account balance, including, but not limited to change in liability and related cash surrender value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountBalanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of asset supporting separate account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124504833&amp;loc=d3e7104-158389<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e765-108305<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e725-108305<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about separate account liability, including, but not limited to change in liability and related cash surrender value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224245365936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Agreements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Summary of Company's Borrowings</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s borrowings as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.452%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5% senior notes due July 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.75% senior notes due November 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8% senior notes due June 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4% senior notes due December 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.375% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.625% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5% senior notes due November 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5% senior notes due December 2024 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1% senior notes due March 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.875% senior notes due July 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875% senior notes due June 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3% senior notes due August 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.625% senior notes due April 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.25% senior notes due June 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3% senior notes due August 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3% senior notes due March 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.25% senior notes due August 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.75% senior notes due April 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.75% senior notes due August 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.875% senior notes due February 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.125% senior notes due September 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.875% senior notes due July 2035</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.625% senior notes due June 2036</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.75% senior notes due December 2037</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.78% senior notes due March 2038</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.125% senior notes due September 2039</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.125% senior notes due April 2040</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7% senior notes due August 2040</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.75% senior notes due May 2041</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5% senior notes due May 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.125% senior notes due November 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3% senior notes due December 2043</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.75% senior notes due March 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.125% senior notes due July 2045</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.875% senior notes due August 2047</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.05% senior notes due March 2048</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.25% senior notes due April 2050</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUyLTAtMS0xLTI2NTI0Nw_1b8d2063-d583-4908-be86-f25a8a8346c8"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUyLTAtMS0xLTI2NTI0Nw_d9e5828d-1d67-442b-bf21-ed9fd901073c">Finance lease liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt principal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,753&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,743&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt discounts and deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(786)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,257&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,778)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,479&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,971&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">__________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes long-term debt of $3&#160;million which has been accounted for as liabilities held for sale and is included in liabilities held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-Term Debt</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s required repayments of debt principal due during each of the next five&#160;years and thereafter, as of December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt principal</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,753&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for a summary of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">maturities of the Company&#8217;s finance lease liabilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224240017792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock', window );">Schedule of Changes in Benefit Obligations</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables outline the change in pension benefit obligation and plan assets over the specified periods:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,011)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(387)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,740&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(968)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(387)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock', window );">Schedule of Changes in Plan Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables outline the change in pension benefit obligation and plan assets over the specified periods:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,011)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(387)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,740&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(968)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(387)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock', window );">Schedule of Assets (Liabilities) Recognized in Balance Sheet</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets (liabilities) recognized on the consolidated balance sheets at December&#160;31, 2022 and 2021 for the defined benefit pension plans consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets reflected in other assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">827&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities reflected in accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities reflected in other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(197)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of Net Periodic Benefit Cost (Income)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost (income) for the years ended December&#160;31, 2022, 2021 and 2020 are shown below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Components of net periodic benefit cost (income):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(309)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost (income)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Weighted Average Assumptions Used in Determining Benefit Obligations and Net Benefit Costs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined its benefit obligation based on the following weighted average assumptions as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined its net periodic benefit cost (income) based on the following weighted average assumptions for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Schedule of Changes in Fair Value of Plan Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2022 were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,837&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. domestic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Domestic real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Common/collective trusts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pension investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,225&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,299&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The assets in the underlying funds of common/collective trusts consist of $104 million of equity securities and $203 million of debt securities. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $390 million of other receivables as well as $432 million of private equity limited partnership investments and $225 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2021 were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,553&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. domestic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Domestic real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Common/collective trusts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pension investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,837&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,781&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The assets in the underlying funds of common/collective trusts consist of $261 million of equity securities and $149 million of debt securities. </span></div>(2)Excludes $76 million of other receivables as well as $583 million of private equity limited partnership investments and $237 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock', window );">Schedule of Change in Level 3 Plan Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 pension plan assets during the year ended December&#160;31, 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:74.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.759%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.761%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Real estate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 pension plan assets during the year ended December&#160;31, 2021 were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.046%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Real estate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of Expected Future Benefits Payments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the pension benefit obligation as of December&#160;31, 2022: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028-2032</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the accumulated other postretirement benefit obligation as of December&#160;31, 2022: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:86.105%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028-2032</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of defined benefit plan asset investment. Includes, but is not limited to, fair value of category of plan asset and its level within fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224244454144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Income Tax Provision</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision for continuing operations consisted of the following for the&#160;years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,803&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,615&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,538&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,950&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,133&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,526)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(503)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,029)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(402)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(564)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,548&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of the statutory income tax rate to the Company&#8217;s effective income tax rate for continuing operations for the&#160;years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurer fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basis difference upon disposition of subsidiary</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year refunds and unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the components of the Company&#8217;s deferred income tax assets and liabilities as of December&#160;31, 2022 and 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.711%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and rents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debts and other allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and capital loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll tax deferral</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(532)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,985&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,658&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and rents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,639)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,947)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,139)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,381)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,870)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,773)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,885)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,115)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes deferred income tax assets of $131&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#8216;&#8216;Acquisitions, Divestitures and Asset Sales&#8217;&#8217; for additional information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits Rollforward</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balance of unrecognized tax benefits in 2022, 2021 and 2020 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to the current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expiration of statutes of limitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI https://asc.fasb.org/extlink&amp;oid=126976462&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224245296672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Stock-Based Compensation</a></td>
<td class="text">The following table is a summary of stock-based compensation for the&#160;years ended December&#160;31, 2022, 2021 and 2020:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and stock appreciation rights (&#8220;SARs&#8221;) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes the ESPP.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">RSU and Performance Share Unit Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the restricted stock unit and performance stock unit activity for the&#160;year ended December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In thousands, except weighted average grant date fair value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year, nonvested</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.02&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,398&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,626)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,421)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year, nonvested</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,681&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Vested performance stock units have been included at target level performance. Based on actual performance, the number of restricted stock units and performance stock units vested during the year ended December 31, 2022 was 8.0&#160;million.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock', window );">Summary of Stock Option and SAR Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of stock option and SAR activity that occurred for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from stock options exercised (including ESPP)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for taxes for net share settlement of equity awards</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic value of stock options and SARs exercised </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of stock options and SARs vested </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Valuation Assumptions</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each stock option is estimated using the Black-Scholes option pricing model based on the following assumptions at the time of grant:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dividend yield is based on annual dividends paid and the fair market value of CVS Health Corporation stock at the grant date.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected volatility is estimated based on the historical volatility of CVS Health Corporation&#8217;s daily stock price over a period equal to the expected life of each option grant after adjustments for infrequent events such as stock splits.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The risk-free interest rate is selected based on yields from U.S. Treasury zero-coupon issues with a remaining term equal to the expected term of the options being valued.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected life represents the number of&#160;years the options are expected to be outstanding from grant date based on historical option or SAR holder exercise experience.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock', window );">Schedule of Stock Options and Stock Appreciation Rights Award Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s stock option and SAR activity for the&#160;year ended December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.747%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;thousands, except weighted average exercise price and remaining contractual term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.74&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,993&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.04&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,921)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(478)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(615)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,040&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.52</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340,507&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,730&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.76</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,904&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at end of year and expected to vest in the future</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,757&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.47</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336,664&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule ESPP Valuation Assumptions</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the assumptions used to value the ESPP awards for the&#160;years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dividend yield is calculated based on semi-annual dividends paid and the fair market value of CVS Health Corporation stock at the grant date.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected volatility is estimated based on the historical volatility of CVS Health Corporation&#8217;s daily stock price over the previous six&#160;month period.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The risk-free interest rate is selected based on the Treasury constant maturity interest rate whose term is consistent with the expected term of ESPP purchases (i.e., six&#160;months).</span></div>(4)The expected life is based on the semi-annual purchase period<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash received from exercise of stock options and similar instruments granted under share-based payment arrangements and tax benefit from exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224251651648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Share Repurchase Programs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following share repurchase programs have been authorized by the Board:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In billions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Authorization&#160;Date</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Authorized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining as of<br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 17, 2022 (&#8220;2022 Repurchase Program&#8221;)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 9, 2021 (&#8220;2021 Repurchase Program&#8221;)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRegulatoryAssetsTextBlock', window );">Schedule of Regulatory Requirements</a></td>
<td class="text">The combined statutory net income for the years ended and estimated combined statutory and capital surplus at December&#160;31, 2022, 2021 and 2020 for the Company&#8217;s insurance and HMO subsidiaries were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory net income </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,851&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,302&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,667&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated statutory capital and surplus</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock', window );">Statutory Accounting Practices Disclosure</a></td>
<td class="text">At December&#160;31, 2022, these amounts were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:88.196%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated minimum statutory surplus required by regulators</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments on deposit with regulatory bodies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated maximum dividend distributions permitted in 2023 without prior regulatory approval</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,706&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRegulatoryAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets that are created when regulatory agencies permit public utilities to defer certain costs included in rate-setting to the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 980<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6499975&amp;loc=d3e44250-110382<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 980<br> -SubTopic 715<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501251&amp;loc=d3e52485-110419<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 980<br> -SubTopic 340<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6499975&amp;loc=d3e44264-110382<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRegulatoryAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of how the entity's reporting under GAAP as of the balance sheet date differs from the results based on prescribed and permitted accounting practices of the state or country of domicile in which a relevant statutory filing is made, or differences in results based on the National Association of Insurance Commissioners (NAIC) prescribed practices, or a combination thereof. Describes the accounting practices used and the related monetary effect on statutory surplus, net income, and risk-based capital. If an insurance enterprise's risk-based capital would have triggered a regulatory event had it not used a permitted practice, that fact is disclosed in the financial statements. Permitted statutory accounting practices include practices not prescribed but allowed by the domiciliary state insurance department regulatory authority.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.23(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24708-158529<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24790-158529<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24746-158529<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 55<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=82848697&amp;loc=d3e24959-158530<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 55<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=82848697&amp;loc=d3e24938-158530<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224251692896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income (loss) in 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.089%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment gains (losses):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$0, $181 and $0 pretax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(3,021), $(644) and $497 pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,556)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(530)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($315, $(32) and $31 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,317)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(556)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,519)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in discount rate on long-duration insurance reserves:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(651)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($0, $(1,166) and $0 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(906)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($1,126, $328, and $0 pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(651)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($38, $0 and $(7) pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(15), $(34) and $(35) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(229), $20 and $(30) pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($3, $6 and $7 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of year accumulated other comprehensive income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(766)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,598)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of year accumulated other comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,264)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_______________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"> Reflects the adoption of ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 944) during the year ended December 31, 2021. See Note 8 &#8216;&#8216;Other Insurance Liabilities and Separate Accounts&#8217;&#8217; for additional information.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the consolidated statements of operations. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included within interest expense in the consolidated statements of operations. The Company expects to reclassify $11 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the consolidated statements of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224251592512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of Basic and Diluted Earnings (Loss) Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings per share from continuing operations for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to CVS Health</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,311&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,001&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,188&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and SARs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share from continuing operations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224251622080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reinsurance (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceDisclosuresAbstract', window );"><strong>Reinsurance Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock', window );">Schedule of Reinsurance Recoverables</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance recoverables (recorded as other current assets or other assets on the consolidated balance sheets) at December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reinsurer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hartford Life and Accident Insurance Company</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lincoln Life &amp; Annuity Company of New York</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VOYA Retirement Insurance and Annuity Company </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fresenius Medical Care Reinsurance Company (Cayman) Ltd. </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,564&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock', window );">Schedule of Direct, Assumed and Ceded Premiums Earned</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct, assumed and ceded premiums earned for the years ended December&#160;31, 2022, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(772)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(680)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(825)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,330&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,132&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,364&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectsOfReinsuranceTableTextBlock', window );">Schedule of Impact of Reinsurance on Benefit Costs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of reinsurance on benefit costs for the years ended December&#160;31, 2022, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(663)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(549)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net benefit costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,073&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,188&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,679&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the supplemental schedule of reinsurance information. Reinsurance schedule includes, but is not limited to, the type of insurance, gross amount of premiums, premiums ceded to other entities, premiums assumed from other entities, net amount of premium revenue, and the percentage of the premiums assumed to net premium revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17)<br> -URI https://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectsOfReinsuranceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effects of reinsurance, for example, but not limited to, disclosure of direct, assumed, and ceded insurance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectsOfReinsuranceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of reinsurer or group of reinsurers for whom the entity has a concentration of credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123600520&amp;loc=SL75241803-196195<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224245956416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summarized Financial Information Of Segments</a></td>
<td class="text">Segment financial information for the years ended December 31, 2022, 2021 and 2020 has been recast, as applicable, to reflect the following items, the impact of which are reflected in the &#8220;Adjustments&#8221; lines of the table below:<div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The realignment of the Company&#8217;s segments to correspond with changes made to its operating model as described in Note 1 &#8220;Significant Accounting Policies,&#8221; including the discontinuance of the former Maintenance Choice segment reporting practice as described in Note (1) of the table below.</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The exclusion of the impact of net realized capital gains or losses from adjusted operating income, as described above.</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the adoption of the long-duration insurance accounting standard, which the Company adopted on January 1, 2023 using a modified retrospective transition method as of January 1, 2021, as described in Note 8 &#8220;Other Insurance Liabilities and Separate Accounts.&#8221; </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care <br/>Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp; <br/>Consumer <br/>Wellness</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as previously reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,594&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,302)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,283)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as adjusted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,576&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,596&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,585)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 1.75pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as previously reported</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,785)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(728)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(575)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as adjusted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,338&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,781&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,531&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,613)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,037&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care <br/>Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp; <br/>Consumer <br/>Wellness</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as previously reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,923)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,318)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as adjusted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,119&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,241)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 1.75pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as previously reported</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,471)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as adjusted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,110&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,492&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,260&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,635)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,227&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care <br/>Benefits</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health<br/>Services</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp; <br/>Consumer <br/>Wellness</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as previously reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,198&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,323)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(584)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,739)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, as adjusted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,062)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 1.75pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as previously reported</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(708)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(560)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss), as adjusted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,135&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,128&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,012&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,319)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,956&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy &amp; Consumer Wellness segment. Prior to January 1, 2023, intersegment adjusted operating income eliminations occurred when members of the Health Services segment's clients enrolled in Maintenance Choice elected to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurred, both the Health Services and Pharmacy &amp; Consumer Wellness segments recorded the adjusted operating income on a stand-alone basis.&#160;Effective January 1, 2023, the adjusted operating income associated with such transactions is reported only in the Pharmacy &amp; Consumer Wellness segment, therefore no adjusted operating income elimination is required. Segment financial information has been recast to reflect this change. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:29.091%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.651%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.092%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.914%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.860%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy &amp;<br/>Consumer<br/>Wellness</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,585)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,576&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,596&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,585)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,613)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,241)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,119&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,892&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,620&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,241)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,635)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,062)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,062)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,319)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Health Services segment include approximately $12.6 billion, $11.6 billion and $10.9 billion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">of retail co-payments for 2022, 2021 and 2020, respectively. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information about retail co-payments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy &amp; Consumer Wellness segment.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation Of Consolidated Operating Income to Adjusted Operating Income</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of consolidated operating income to adjusted operating income for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital (gains) losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office real estate optimization charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on divestiture of subsidiaries </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(475)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid litigation charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on assets held for sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store impairments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition purchase price adjustment outside of measurement period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receipt of fully reserved ACA risk corridor receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(11)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,037&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,227&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,956&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s GAAP consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s net realized capital gains and losses arise from various types of transactions, primarily in the course of managing a portfolio of assets that support the payment of insurance liabilities. Net realized capital gains and losses are reflected in the consolidated statements of operations in net investment income within each segment. These capital gains and losses are the result of investment decisions, market conditions and other economic developments that are unrelated to the performance of the Company&#8217;s business, and the amount and timing of these capital gains and losses do not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Accordingly, the Company believes excluding net realized capital gains and losses enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2022, the office real estate optimization charges primarily relate to the abandonment of leased real estate and the related right-of-use assets and property and equipment in connection with the planned reduction of corporate office real estate space in response to the Company&#8217;s new flexible work arrangement. The office real estate optimization charges are reflected in the Company&#8217;s GAAP consolidated statement of operations in operating expenses within the Health Care Benefits, Corporate/Other and Health Services segments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2022, the gain on divestiture of subsidiaries represents the pre-tax gain on the sale of bswift, which the Company sold in November 2022, and the pre-tax gain on the sale of PayFlex, which the Company sold in June 2022. In 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#8217; Compensation business, which the Company sold in July 2020. The gains on divestitures are reflected as a reduction of operating expenses in the Company&#8217;s GAAP consolidated statements of operations within the Health Care Benefits segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2022, the opioid litigation charges relate to agreements to resolve substantially all opioid claims against the Company by certain states and governmental entities. The opioid litigation charges are reflected within the Corporate/Other segment.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2022, the loss on assets held for sale relates to the LTC reporting unit within the Pharmacy &amp; Consumer Wellness segment. The Company continually evaluates its portfolio for non-strategic assets. The Company determined that its LTC business was no longer a strategic asset and during the third quarter of 2022 committed to a plan to sell the LTC business. As of September 30, 2022, the LTC business met the criteria for held-for-sale accounting and its net assets were accounted for as assets held for sale. The carrying value of the LTC business was determined to be greater than its estimated fair value less costs to sell and a loss on assets held for sale was recorded during the third quarter of 2022. As of December 31, 2022, the net assets of the LTC business continued to meet the criteria for held-for-sale accounting and during the fourth quarter of 2022, an incremental loss on assets held for sale was recorded to write down the carrying value of the LTC business to its estimated fair value less costs to sell. During 2022, the loss on assets held for sale also relates to the Commercial Business reporting unit within the Health Care Benefits segment. In March 2022, the Company reached an agreement to sell its Thailand business, which was included in the Commercial Business reporting unit. At that time, a portion of the Commercial Business goodwill was specifically allocated to the Thailand business. The net assets of the Thailand business were accounted for as assets held for sale at March 31, 2022. The carrying value of the Thailand business was determined to be greater than its estimated fair value less costs to sell and a loss on assets held for sale was recorded during the first quarter of 2022. The sale of the Thailand business closed in the second quarter of 2022, and the ultimate loss on the sale was not material.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2021 and 2020, acquisition-related integration costs relate to the acquisition of Aetna. The acquisition-related integration costs are reflected in the Company&#8217;s GAAP consolidated statements of operations in operating expenses within the Corporate/Other segment.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2021, the store impairment charge relates to the write down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately 900 retail stores between 2022 and 2024. The store impairment charge is reflected within the Pharmacy &amp; Consumer Wellness segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In 2021, the goodwill impairment charge relates to an impairment of the remaining goodwill of the LTC reporting unit within the Pharmacy &amp; Consumer Wellness segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">In 2021, the Company received $61&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#8217;s GAAP consolidated statement of operations as a reduction of operating expenses within the Health Care Benefits segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">In 2020, the Company received $313&#160;million owed to it under the ACA&#8217;s risk corridor program that was previously fully reserved for as payment was uncertain. After considering offsetting items such as the ACA&#8217;s minimum MLR rebate requirements and premium taxes, the Company recognized pre-tax income of $307&#160;million in the Company&#8217;s GAAP consolidated statement of operations within the Health Care Benefits segment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224236193104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Narrative (Details)<br> shares in Millions, people in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2023 </div>
<div>state</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>people </div>
<div>store </div>
<div>clinic </div>
<div>patient </div>
<div>state </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>store </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>state </div>
<div>people </div>
<div>store </div>
<div>clinic </div>
<div>patient </div>
<div>Segment </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>store </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NumberOfPharmacyPlanMembers', window );">Number of pharmacy plan members | people</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NumberOfPatientsServedPerYear', window );">Number of patients served per year (more than) | patient</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NumberOfPeopleServed', window );">Number of people served | people</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredPolicyAcquisitionCosts', window );">Deferred acquisition costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,219,000,000<span></span>
</td>
<td class="nump">$ 879,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,219,000,000<span></span>
</td>
<td class="nump">$ 879,000,000<span></span>
</td>
<td class="nump">$ 519,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400,000,000<span></span>
</td>
<td class="nump">2,300,000,000<span></span>
</td>
<td class="nump">2,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OfficeRealEstateOptimizationCharges', window );">Office real estate optimization charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_StoreImpairmentCharges', window );">Store impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1,358,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NumberOfStoresPlannedClosure', window );">Number of stores, planned closure | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 431,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangible assets, indefinite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_HeathSavingsAccountBalance', window );">HSA balances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000,000<span></span>
</td>
<td class="nump">$ 1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000,000<span></span>
</td>
<td class="nump">1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PharmacyRebatePeriod', window );">Pharmacy rebate period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_HealthInsurerFee', window );">Health insurer fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 745,000,000<span></span>
</td>
<td class="nump">$ 707,000,000<span></span>
</td>
<td class="nump">$ 613,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TreasuryStockSharesHeldinTrust', window );">Treasury shares held in trust (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Expenses from transactions with related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="nump">$ 52,000,000<span></span>
</td>
<td class="nump">$ 56,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty', window );">Other revenues from transactions with related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,000,000<span></span>
</td>
<td class="nump">79,000,000<span></span>
</td>
<td class="nump">77,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity', window );">Charitable contribution to CVS Health Foundation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=cvs_LongTermCareReportingUnitMember', window );">Long-Term Care Reporting Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 431,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember', window );">U.S. Department of Health and Human Services, ACA Risk Corridor Receivables | Settled Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainContingencyUnrecordedAmount', window );">Gain contingency, unrecorded amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,000,000<span></span>
</td>
<td class="nump">$ 313,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty', window );">Amount awarded from other party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 313,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax', window );">Former gain contingency, recognized in current period, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax', window );">Former gain contingency, recognized in current period, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=cvs_HeartlandHealthcareServicesMember', window );">Heartland Healthcare Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfStatesInWhichEntityOperates', window );">Number of states in which entity operates | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherInsuranceLiabilitiesMember', window );">Other Insurance Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LiabilityForUnpaidClaims', window );">Liability for unpaid claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 243,000,000<span></span>
</td>
<td class="nump">$ 324,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 243,000,000<span></span>
</td>
<td class="nump">324,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefits', window );">Liability for future policy benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">334,000,000<span></span>
</td>
<td class="nump">458,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">334,000,000<span></span>
</td>
<td class="nump">458,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherLongTermInsuranceLiabilitiesMember', window );">Other Long-Term Insurance Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LiabilityForUnpaidClaims', window );">Liability for unpaid claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000,000<span></span>
</td>
<td class="nump">1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000,000<span></span>
</td>
<td class="nump">1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefits', window );">Liability for future policy benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,700,000,000<span></span>
</td>
<td class="nump">6,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,700,000,000<span></span>
</td>
<td class="nump">$ 6,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OfficeRealEstateOptimizationCharges', window );">Office real estate optimization charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid', window );">Period after date of service a claim is paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PensionAndAnnuityInvestmentContractsInterest', window );">Interest rate for pension and annuity investment contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Buildings, building improvements and leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Fixtures, equipment and internally developed software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm', window );">Lease renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid', window );">Period after date of service a claim is paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">48 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PensionAndAnnuityInvestmentContractsInterest', window );">Interest rate for pension and annuity investment contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.80%<span></span>
</td>
<td class="nump">4.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Buildings, building improvements and leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Fixtures, equipment and internally developed software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember', window );">Pharmacy &amp; Consumer Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of retail locations (more than) | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 431,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember', window );">Health Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NumberOfWalkInMedicalClinics', window );">Number of walk-in medical clinics (more than) | clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates', window );">Number of states in which the Company has entered the individual public health insurance exchange | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates', window );">Additional number of states in which the Company entered the individual public health insurance exchange | state</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_StoreImpairmentCharges', window );">Store impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NumberOfStoresPlannedClosure', window );">Number of stores, planned closure | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail LTC | Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_StoreImpairmentCharges', window );">Store impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 261,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 261,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Health Insurance Product Line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumDeficiencyReserveLiability', window );">Premium deficiency reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16,000,000<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Gain Contingency, Recognized In Current Period, Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Gain Contingency, Recognized In Current Period, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Health Care Costs Payable, Period After Date Of Services Claims Are Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthInsurerFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the estimated amount of the health insurer fee accrued during the reporting period, as required by Health Care Reform.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthInsurerFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HeathSavingsAccountBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Heath Savings Account Balance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HeathSavingsAccountBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Individual Public Health Insurance Exchanges, Number Of Additional States</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Individual Public Health Insurance Exchanges, Number Of States</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating And Finance Leases, Renewal Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeOperatingAndFinanceLeasesRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LiabilityForUnpaidClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the total liability on the balance sheet for unpaid claims for both short-duration and long-duration insurance contracts after reinsurance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LiabilityForUnpaidClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfPatientsServedPerYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Patients Served Per Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfPatientsServedPerYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfPeopleServed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of People Served</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfPeopleServed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfPharmacyPlanMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Pharmacy Plan Members</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfPharmacyPlanMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfStoresPlannedClosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Stores, Planned Closure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfStoresPlannedClosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfWalkInMedicalClinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Walk In Medical Clinics</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfWalkInMedicalClinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OfficeRealEstateOptimizationCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Office Real Estate Optimization Charges - Related to the abandonment of leased real estate and the related right-of-use assets and property and equipment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OfficeRealEstateOptimizationCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PensionAndAnnuityInvestmentContractsInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pension And Annuity Investment Contracts Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PensionAndAnnuityInvestmentContractsInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PharmacyRebatePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pharmacy Rebate Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PharmacyRebatePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumDeficiencyReserveLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumDeficiencyReserveLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Charitable Contribution To Non-Profit Entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_StoreImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Store Impairment Charges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_StoreImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockSharesHeldinTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares, Held in Trust</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockSharesHeldinTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredPolicyAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred policy acquisition cost capitalized on contract remaining in force.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124505477&amp;loc=SL117422543-158416<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124505477&amp;loc=SL117422543-158416<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124506110&amp;loc=d3e32546-158582<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 55<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124504731&amp;loc=d3e11522-158419<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredPolicyAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingencyUnrecordedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount or range of possible amounts of gain that could be realized upon the resolution of a contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6397426&amp;loc=d3e17499-108355<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingencyUnrecordedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance, of present value of future benefit to be paid to or on behalf of policyholder and related expense less present value of future net premium receivable under insurance contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded from other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedFromOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStatesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of states the entity operates in as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStatesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStores">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of stores.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStores</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=cvs_LongTermCareReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=cvs_LongTermCareReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cvs_HeartlandHealthcareServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cvs_HeartlandHealthcareServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherInsuranceLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=cvs_OtherInsuranceLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherLongTermInsuranceLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=cvs_OtherLongTermInsuranceLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224240332128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 12,945<span></span>
</td>
<td class="nump">$ 9,408<span></span>
</td>
<td class="nump">$ 7,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash (included in other current assets)</a></td>
<td class="nump">144<span></span>
</td>
<td class="nump">3,065<span></span>
</td>
<td class="nump">2,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash (included in other assets)</a></td>
<td class="nump">216<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="nump">276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows</a></td>
<td class="nump">$ 13,305<span></span>
</td>
<td class="nump">$ 12,691<span></span>
</td>
<td class="nump">$ 11,043<span></span>
</td>
<td class="nump">$ 8,408<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224243003056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Accounts Receivable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Trade receivables</a></td>
<td class="nump">$ 8,983<span></span>
</td>
<td class="nump">$ 7,932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_VendorandManufacturerReceivables', window );">Vendor and manufacturer receivables</a></td>
<td class="nump">12,395<span></span>
</td>
<td class="nump">10,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsReceivableAtCarryingValue', window );">Premium receivables</a></td>
<td class="nump">2,676<span></span>
</td>
<td class="nump">2,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">3,449<span></span>
</td>
<td class="nump">3,389<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale', window );">Total accounts receivable, net</a></td>
<td class="nump">27,503<span></span>
</td>
<td class="nump">24,431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit losses</a></td>
<td class="nump">333<span></span>
</td>
<td class="nump">$ 339<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale', window );">Total accounts receivable, net</a></td>
<td class="nump">$ 227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, After Allowance For Credit Loss, Current, Including Assets Held For Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_VendorandManufacturerReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vendor and Manufacturer Receivables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_VendorandManufacturerReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsReceivableAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),5)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsReceivableAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224240343600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Deferred Acquisition Costs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward', window );"><strong>Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredPolicyAcquisitionCosts', window );">Deferred acquisition costs, beginning of the period</a></td>
<td class="nump">$ 879<span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredPolicyAcquisitionCostsAdditions', window );">Capitalizations</a></td>
<td class="nump">564<span></span>
</td>
<td class="nump">529<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense', window );">Amortization expense</a></td>
<td class="num">(224)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredPolicyAcquisitionCosts', window );">Deferred acquisition costs, end of the period</a></td>
<td class="nump">$ 1,219<span></span>
</td>
<td class="nump">$ 879<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense (reversal of expense) for deferred policy acquisition costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 55<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124504731&amp;loc=d3e11522-158419<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6480726&amp;loc=d3e6691-158385<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(7)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124505477&amp;loc=SL117422543-158416<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=35755530&amp;loc=d3e11264-158415<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredPolicyAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred policy acquisition cost capitalized on contract remaining in force.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124505477&amp;loc=SL117422543-158416<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124505477&amp;loc=SL117422543-158416<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124506110&amp;loc=d3e32546-158582<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 55<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124504731&amp;loc=d3e11522-158419<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredPolicyAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredPolicyAcquisitionCostsAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred policy acquisition cost capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124505477&amp;loc=SL117422543-158416<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 55<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124504731&amp;loc=d3e11522-158419<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredPolicyAcquisitionCostsAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224246644320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Property and Equipment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 34,600<span></span>
</td>
<td class="nump">$ 33,550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(21,483)<span></span>
</td>
<td class="num">(20,654)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale', window );">Property and equipment, net</a></td>
<td class="nump">13,117<span></span>
</td>
<td class="nump">12,896<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale', window );">Property and equipment, net</a></td>
<td class="nump">244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">1,996<span></span>
</td>
<td class="nump">2,038<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">4,545<span></span>
</td>
<td class="nump">4,225<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Fixtures and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">12,978<span></span>
</td>
<td class="nump">13,619<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">6,238<span></span>
</td>
<td class="nump">6,242<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 8,843<span></span>
</td>
<td class="nump">$ 7,426<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property, Plant And Equipment, Net, Including Assets Held For Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224246313792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 321,629<span></span>
</td>
<td class="nump">$ 290,912<span></span>
</td>
<td class="nump">$ 267,908<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">838<span></span>
</td>
<td class="nump">1,199<span></span>
</td>
<td class="nump">798<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">322,467<span></span>
</td>
<td class="nump">292,111<span></span>
</td>
<td class="nump">268,706<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember', window );">Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">205,119<span></span>
</td>
<td class="nump">184,619<span></span>
</td>
<td class="nump">171,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember', window );">Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">22,780<span></span>
</td>
<td class="nump">21,315<span></span>
</td>
<td class="nump">19,655<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_PremiumsMember', window );">Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">85,330<span></span>
</td>
<td class="nump">76,132<span></span>
</td>
<td class="nump">69,364<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">8,400<span></span>
</td>
<td class="nump">8,846<span></span>
</td>
<td class="nump">7,802<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">90,798<span></span>
</td>
<td class="nump">81,457<span></span>
</td>
<td class="nump">74,871<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">476<span></span>
</td>
<td class="nump">586<span></span>
</td>
<td class="nump">483<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">91,350<span></span>
</td>
<td class="nump">82,119<span></span>
</td>
<td class="nump">75,409<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">85,274<span></span>
</td>
<td class="nump">76,064<span></span>
</td>
<td class="nump">69,301<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">5,600<span></span>
</td>
<td class="nump">5,469<span></span>
</td>
<td class="nump">5,625<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">157,968<span></span>
</td>
<td class="nump">143,912<span></span>
</td>
<td class="nump">131,936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">169,576<span></span>
</td>
<td class="nump">153,892<span></span>
</td>
<td class="nump">141,354<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Services | Pharmacy network</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">102,968<span></span>
</td>
<td class="nump">96,834<span></span>
</td>
<td class="nump">89,740<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Services | Mail choice</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">63,825<span></span>
</td>
<td class="nump">53,812<span></span>
</td>
<td class="nump">49,713<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Services | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,783<span></span>
</td>
<td class="nump">3,246<span></span>
</td>
<td class="nump">1,901<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Services | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">166,793<span></span>
</td>
<td class="nump">150,646<span></span>
</td>
<td class="nump">139,453<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Services | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Services | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Services | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">2,783<span></span>
</td>
<td class="nump">3,246<span></span>
</td>
<td class="nump">1,901<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy &amp; Consumer Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">72,739<span></span>
</td>
<td class="nump">65,418<span></span>
</td>
<td class="nump">60,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="num">(44)<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">108,596<span></span>
</td>
<td class="nump">101,620<span></span>
</td>
<td class="nump">93,579<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy &amp; Consumer Wellness | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">83,480<span></span>
</td>
<td class="nump">77,886<span></span>
</td>
<td class="nump">71,984<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy &amp; Consumer Wellness | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">22,780<span></span>
</td>
<td class="nump">21,315<span></span>
</td>
<td class="nump">19,655<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy &amp; Consumer Wellness | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy &amp; Consumer Wellness | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">2,380<span></span>
</td>
<td class="nump">2,402<span></span>
</td>
<td class="nump">1,940<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">406<span></span>
</td>
<td class="nump">596<span></span>
</td>
<td class="nump">315<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">530<span></span>
</td>
<td class="nump">721<span></span>
</td>
<td class="nump">426<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(47,585)<span></span>
</td>
<td class="num">(46,241)<span></span>
</td>
<td class="num">(42,062)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">(45,154)<span></span>
</td>
<td class="num">(43,913)<span></span>
</td>
<td class="num">(40,350)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">$ (2,431)<span></span>
</td>
<td class="num">$ (2,328)<span></span>
</td>
<td class="num">$ (1,712)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_PremiumsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_PremiumsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=cvs_SalesChannelOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=cvs_SalesChannelOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224247801664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Receivables and Contracted Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Trade receivables (included in accounts receivable, net)</a></td>
<td class="nump">$ 8,983<span></span>
</td>
<td class="nump">$ 7,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities (included in accrued expenses)</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224238932400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Contract Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ChangeInContractWithCustomerLiabilityRollForward', window );"><strong>Change in Contract with Customer, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities, beginning of period</a></td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance', window );">Rewards earnings and gift card issuances</a></td>
<td class="nump">340<span></span>
</td>
<td class="nump">387<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage', window );">Redemption and breakage</a></td>
<td class="num">(356)<span></span>
</td>
<td class="num">(371)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities, end of period</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ChangeInContractWithCustomerLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In Contract With Customer, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ChangeInContractWithCustomerLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer Liability Redemption And Breakage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ContractWithCustomerLiabilityRedemptionAndBreakage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224240003952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Variable Interest Entities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ProceedsFromVariableInterestEntity', window );">Proceeds from VIE</a></td>
<td class="nump">$ 183<span></span>
</td>
<td class="nump">$ 183<span></span>
</td>
<td class="nump">$ 183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">21,096<span></span>
</td>
<td class="nump">$ 23,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cvs_RedOakMember', window );">Red Oak</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">VIE, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InitialContractualTerm', window );">Initial contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_VariableInterestEntityAmendedContractExtensionTerm', window );">Amended contract extension term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_VariableInterestEntityAmendedContractTerm', window );">Amended contract term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">1,537<span></span>
</td>
<td class="nump">$ 1,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary | Hedge fund investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">589<span></span>
</td>
<td class="nump">463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary | Private equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">707<span></span>
</td>
<td class="nump">601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary | Real estate partnerships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">$ 241<span></span>
</td>
<td class="nump">$ 225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InitialContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Variable Interest Entity, Initial Contractual Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InitialContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ProceedsFromVariableInterestEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Variable Interest Entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ProceedsFromVariableInterestEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_VariableInterestEntityAmendedContractExtensionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Variable Interest Entity, Amended Contract Extension Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_VariableInterestEntityAmendedContractExtensionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_VariableInterestEntityAmendedContractTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Variable Interest Entity, Amended Contract Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_VariableInterestEntityAmendedContractTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cvs_RedOakMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cvs_RedOakMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_HedgeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_HedgeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_PrivateEquityFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_PrivateEquityFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_RealEstateFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_RealEstateFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224245372432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Discontinued Operations (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Loss from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Income tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations, net of tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (9)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224244137344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions, Divestitures and Asset Sales - Narrative (Details)<br> $ / shares in Units, member in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 07, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 02, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>member</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2022 </div>
<div>member</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Loss on assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,533<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on sale of subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">475<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cvs_OakStreetHealthIncMember', window );">Oak Street Health Inc. | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Cash to be received by shareholders in proposed/pending acquisition (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 39.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total value of proposed/pending acquisition</a></td>
<td class="nump">$ 10,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_BusinessCombinationTerminationFee', window );">Termination fee</a></td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cvs_OakStreetHealthIncMember', window );">Oak Street Health Inc. | Oak Street Health Inc. | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_BusinessCombinationTerminationFee', window );">Termination fee</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cvs_SignifyHealthIncMember', window );">Signify Health, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Cash to be received by shareholders in proposed/pending acquisition (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total value of proposed/pending acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_BusinessCombinationTerminationFee', window );">Termination fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cvs_SignifyHealthIncMember', window );">Signify Health, Inc. | Signify Health, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_BusinessCombinationTerminationFee', window );">Termination fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations | Omnicare Long-Term Care Business | Pharmacy &amp; Consumer Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Loss on assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | bswift LLC | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestiture of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on sale of subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Payflex | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestiture of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on sale of subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Thailand Business | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Loss on assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NumberOfMedicalMembers', window );">Number of medical members | member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | International Health Care Renewal Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold', window );">Number of international health care members, renewal rights sold | member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale | Coventry Health Care Workers Compensation Business | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestiture of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on sale of subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_BusinessCombinationTerminationFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Termination Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_BusinessCombinationTerminationFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Number Of International Health Care Members, Renewal Rights Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfMedicalMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Medical Members</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfMedicalMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cvs_OakStreetHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cvs_OakStreetHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cvs_OakStreetHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cvs_OakStreetHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cvs_SignifyHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cvs_SignifyHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cvs_SignifyHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cvs_SignifyHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_OmnicareLongTermCareBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_OmnicareLongTermCareBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_BswiftLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_BswiftLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_PayflexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_PayflexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_ThailandBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_ThailandBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_InternationalHealthCareRenewalRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_InternationalHealthCareRenewalRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_CoventryHealthCareWorkersCompensationBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_CoventryHealthCareWorkersCompensationBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224246750496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions, Divestitures and Asset Sales - Summary of Assets and Liabilities Held for Sale (Details) - Disposal Group, Held-for-sale, Not Discontinued Operations<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Accounts receivable, net</a></td>
<td class="nump">$ 227<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1', window );">Inventories</a></td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets', window );">Deferred income taxes</a></td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets', window );">Other</a></td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Total assets held for sale</a></td>
<td class="nump">908<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities', window );">Other</a></td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Total liabilities held for sale</a></td>
<td class="nump">$ 228<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as deferred tax assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224236085424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Schedule of Total Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">$ 2,778<span></span>
</td>
<td class="nump">$ 3,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LongTermInvestmentsIncludingAssetsHeldForSale', window );">Long-term</a></td>
<td class="nump">21,113<span></span>
</td>
<td class="nump">23,025<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">23,891<span></span>
</td>
<td class="nump">26,142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LongTermInvestmentsIncludingAssetsHeldForSale', window );">Long-term</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember', window );">Debt securities available for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">2,718<span></span>
</td>
<td class="nump">3,009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LongTermInvestmentsIncludingAssetsHeldForSale', window );">Long-term</a></td>
<td class="nump">17,562<span></span>
</td>
<td class="nump">20,231<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">20,280<span></span>
</td>
<td class="nump">23,240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember', window );">Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LongTermInvestmentsIncludingAssetsHeldForSale', window );">Long-term</a></td>
<td class="nump">989<span></span>
</td>
<td class="nump">844<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">1,044<span></span>
</td>
<td class="nump">902<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LongTermInvestmentsIncludingAssetsHeldForSale', window );">Long-term</a></td>
<td class="nump">2,562<span></span>
</td>
<td class="nump">1,950<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">$ 2,567<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LongTermInvestmentsIncludingAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-Term Investments, Including Assets Held For Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LongTermInvestmentsIncludingAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224243933184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedInvestmentsAtFairValue', window );">Investments related to 2012 contract conversion</a></td>
<td class="nump">$ 331<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities', window );">Weighted average duration of securities</a></td>
<td class="text">5 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities', window );">Weighted average duration of securities</a></td>
<td class="text">5 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities', window );">Weighted average duration of securities</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Weighted Average Duration Of Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedInvestmentsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate value of all restricted investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12.6(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611133-123010<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Footnote 11(c)))<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedInvestmentsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224245897872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Debt Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">$ 22,067<span></span>
</td>
<td class="nump">$ 22,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">22,063<span></span>
</td>
<td class="nump">22,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">1,172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1,840)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">20,280<span></span>
</td>
<td class="nump">23,240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">2,074<span></span>
</td>
<td class="nump">2,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">2,074<span></span>
</td>
<td class="nump">2,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(182)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,892<span></span>
</td>
<td class="nump">2,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">2,393<span></span>
</td>
<td class="nump">2,947<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">2,393<span></span>
</td>
<td class="nump">2,947<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(129)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,272<span></span>
</td>
<td class="nump">3,091<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">9,838<span></span>
</td>
<td class="nump">9,093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">9,835<span></span>
</td>
<td class="nump">9,093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">682<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(903)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">8,958<span></span>
</td>
<td class="nump">9,735<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">2,780<span></span>
</td>
<td class="nump">2,821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">2,779<span></span>
</td>
<td class="nump">2,821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(244)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,550<span></span>
</td>
<td class="nump">2,993<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">845<span></span>
</td>
<td class="nump">870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">845<span></span>
</td>
<td class="nump">870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(89)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">757<span></span>
</td>
<td class="nump">875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">1,172<span></span>
</td>
<td class="nump">1,278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">1,172<span></span>
</td>
<td class="nump">1,278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(155)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,018<span></span>
</td>
<td class="nump">1,310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">2,940<span></span>
</td>
<td class="nump">2,791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">2,940<span></span>
</td>
<td class="nump">2,791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(136)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,810<span></span>
</td>
<td class="nump">2,792<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Gross Amortized Cost</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience- rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(59)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 609<span></span>
</td>
<td class="nump">$ 864<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224243861376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Debt Securities by Maturity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Less than one year</a></td>
<td class="nump">$ 1,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">One year through five years</a></td>
<td class="nump">6,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost', window );">After five years through ten years</a></td>
<td class="nump">4,899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost', window );">Greater than ten years</a></td>
<td class="nump">4,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">22,063<span></span>
</td>
<td class="nump">$ 22,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than one year</a></td>
<td class="nump">1,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">One year through five years</a></td>
<td class="nump">6,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">After five years through ten years</a></td>
<td class="nump">4,401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Greater than ten years</a></td>
<td class="nump">3,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">20,280<span></span>
</td>
<td class="nump">23,240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">845<span></span>
</td>
<td class="nump">870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">757<span></span>
</td>
<td class="nump">875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">1,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">1,172<span></span>
</td>
<td class="nump">1,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">1,018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">1,018<span></span>
</td>
<td class="nump">1,310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">2,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Net Amortized Cost</a></td>
<td class="nump">2,940<span></span>
</td>
<td class="nump">2,791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">2,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">$ 2,810<span></span>
</td>
<td class="nump">$ 2,792<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224244227984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Unrealized Loss Position (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>security</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>security</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">9,500<span></span>
</td>
<td class="nump">3,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">2,784<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">12,284<span></span>
</td>
<td class="nump">4,017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 14,228<span></span>
</td>
<td class="nump">$ 6,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">4,264<span></span>
</td>
<td class="nump">584<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">18,492<span></span>
</td>
<td class="nump">7,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">1,226<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">614<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 1,840<span></span>
</td>
<td class="nump">$ 106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">519<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">554<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 1,620<span></span>
</td>
<td class="nump">$ 242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">191<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">1,811<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">164<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 182<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">859<span></span>
</td>
<td class="nump">233<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">196<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">1,055<span></span>
</td>
<td class="nump">246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 1,370<span></span>
</td>
<td class="nump">$ 428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">322<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">1,692<span></span>
</td>
<td class="nump">461<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 129<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">5,193<span></span>
</td>
<td class="nump">1,610<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">1,479<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">6,672<span></span>
</td>
<td class="nump">1,775<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 6,537<span></span>
</td>
<td class="nump">$ 2,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">1,822<span></span>
</td>
<td class="nump">238<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">8,359<span></span>
</td>
<td class="nump">2,534<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">622<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">281<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 903<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">1,168<span></span>
</td>
<td class="nump">449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">403<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">1,571<span></span>
</td>
<td class="nump">506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 1,715<span></span>
</td>
<td class="nump">$ 747<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">592<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">2,307<span></span>
</td>
<td class="nump">838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">147<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 244<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">452<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">543<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 464<span></span>
</td>
<td class="nump">$ 593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">257<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">721<span></span>
</td>
<td class="nump">629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 89<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">288<span></span>
</td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">187<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">475<span></span>
</td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 611<span></span>
</td>
<td class="nump">$ 462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">381<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">992<span></span>
</td>
<td class="nump">574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 155<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">1,008<span></span>
</td>
<td class="nump">1,011<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">391<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">1,399<span></span>
</td>
<td class="nump">1,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 1,893<span></span>
</td>
<td class="nump">$ 2,030<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">694<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">2,587<span></span>
</td>
<td class="nump">2,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 136<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224239896784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Unrealized Loss Position Maturities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">$ 1,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">5,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">3,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">3,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">18,492<span></span>
</td>
<td class="nump">$ 7,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">1,840<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">721<span></span>
</td>
<td class="nump">629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">89<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">992<span></span>
</td>
<td class="nump">574<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">2,587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">2,587<span></span>
</td>
<td class="nump">2,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">136<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience- rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience- rated products | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience- rated products | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience- rated products | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">1,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">5,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">3,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">3,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">17,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">1,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">2,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">$ 134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Without Single Maturity Date, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Without Single Maturity Date, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224248528832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Mortgage Loans (Details) - Commercial Real Estate - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans', window );">New mortgage loans</a></td>
<td class="nump">$ 356<span></span>
</td>
<td class="nump">$ 262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateLoansFullyRepaid', window );">Mortgage loans fully repaid</a></td>
<td class="nump">178<span></span>
</td>
<td class="nump">373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateForeclosures', window );">Mortgage loans foreclosed</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateLoansFullyRepaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pertains to amount of mortgage loans fully repaid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateLoansFullyRepaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateForeclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from foreclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Footnote 6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateForeclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from new investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Footnote 6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateNewMortgageLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224246143792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Mortgage Loans Credit Ratings Indicator (Details) - Commercial Real Estate - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">$ 1,044<span></span>
</td>
<td class="nump">$ 902<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">247<span></span>
</td>
<td class="nump">255<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">369<span></span>
</td>
<td class="nump">484<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1 | 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1 | 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1 | 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1 | 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1 | 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1 | Prior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">1,022<span></span>
</td>
<td class="nump">861<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4 | 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4 | 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">247<span></span>
</td>
<td class="nump">255<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4 | 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4 | 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4 | 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4 | Prior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">350<span></span>
</td>
<td class="nump">446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6 | 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6 | 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6 | 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6 | 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6 | 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6 | Prior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7 | 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7 | 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7 | 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7 | 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7 | 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7 | Prior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Column G))<br> -URI https://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPriorToPeriodFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPriorToPeriodFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalCreditAssessmentAxis=cvs_Category1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalCreditAssessmentAxis=cvs_Category1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalCreditAssessmentAxis=cvs_Category2To4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalCreditAssessmentAxis=cvs_Category2To4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalCreditAssessmentAxis=cvs_Categories5And6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalCreditAssessmentAxis=cvs_Categories5And6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalCreditAssessmentAxis=cvs_Category7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalCreditAssessmentAxis=cvs_Category7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224245975328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Mortgage Loan Principal Repayments (Details) - Commercial Real Estate<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive', window );">2027</a></td>
<td class="nump">203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">376<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet', window );">Total</a></td>
<td class="nump">$ 1,044<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Mortgage Loans On Real Estate Collections Of Principal After Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Mortgage Loans On Real Estate Collections Of Principal In Next Twelve Months</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Mortgage Loans On Real Estate Collections Of Principal In Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Mortgage Loans On Real Estate Collections Of Principal In Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Mortgage Loans On Real Estate Collections Of Principal In Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Mortgage Loans On Real Estate Collections Of Principal In Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224243202176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Net Investment Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">$ 1,201<span></span>
</td>
<td class="nump">$ 1,070<span></span>
</td>
<td class="nump">$ 781<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInvestmentExpense', window );">Investment expenses</a></td>
<td class="num">(43)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses', window );">Net investment income (excluding net realized capital gains or losses)</a></td>
<td class="nump">1,158<span></span>
</td>
<td class="nump">1,023<span></span>
</td>
<td class="nump">746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Net realized capital gains (losses)</a></td>
<td class="num">(320)<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Net investment income</a></td>
<td class="nump">838<span></span>
</td>
<td class="nump">1,199<span></span>
</td>
<td class="nump">798<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">Credit-related impairment loss</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">Yield-related impairment loss</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience- rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Net investment income</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember', window );">Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">702<span></span>
</td>
<td class="nump">634<span></span>
</td>
<td class="nump">598<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember', window );">Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">$ 448<span></span>
</td>
<td class="nump">$ 381<span></span>
</td>
<td class="nump">$ 123<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentIncomeExcludingCapitalGainsOrLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Income, Excluding Capital Gains Or Losses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentIncomeExcludingCapitalGainsOrLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Yield Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInvestmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses related to the generation of investment income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInvestmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224239056304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Realized Gains (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sales</a></td>
<td class="nump">$ 4,243<span></span>
</td>
<td class="nump">$ 3,572<span></span>
</td>
<td class="nump">$ 3,913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain', window );">Gross realized capital gains</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss', window );">Gross realized capital losses</a></td>
<td class="nump">$ 177<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224236527584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Fair Value Measurements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">$ 20,280<span></span>
</td>
<td class="nump">$ 23,240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,892<span></span>
</td>
<td class="nump">2,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,272<span></span>
</td>
<td class="nump">3,091<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">8,958<span></span>
</td>
<td class="nump">9,735<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,550<span></span>
</td>
<td class="nump">2,993<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">757<span></span>
</td>
<td class="nump">875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,018<span></span>
</td>
<td class="nump">1,310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,810<span></span>
</td>
<td class="nump">2,792<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">12,951<span></span>
</td>
<td class="nump">9,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">20,280<span></span>
</td>
<td class="nump">23,240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">169<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">33,407<span></span>
</td>
<td class="nump">32,817<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Disposal Group, Held-for-sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">6,902<span></span>
</td>
<td class="nump">4,954<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,860<span></span>
</td>
<td class="nump">2,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">114<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">8,878<span></span>
</td>
<td class="nump">7,440<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">6,049<span></span>
</td>
<td class="nump">4,454<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">18,351<span></span>
</td>
<td class="nump">20,812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">24,400<span></span>
</td>
<td class="nump">25,266<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,892<span></span>
</td>
<td class="nump">2,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,860<span></span>
</td>
<td class="nump">2,372<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,272<span></span>
</td>
<td class="nump">3,091<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,272<span></span>
</td>
<td class="nump">3,086<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">8,958<span></span>
</td>
<td class="nump">9,735<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">8,897<span></span>
</td>
<td class="nump">9,697<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,550<span></span>
</td>
<td class="nump">2,993<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,542<span></span>
</td>
<td class="nump">2,983<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">757<span></span>
</td>
<td class="nump">875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">757<span></span>
</td>
<td class="nump">875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,018<span></span>
</td>
<td class="nump">1,310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,018<span></span>
</td>
<td class="nump">1,310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,810<span></span>
</td>
<td class="nump">2,792<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,810<span></span>
</td>
<td class="nump">2,789<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224244183600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value - Changes in Level 3 Financial Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci', window );">Change in unrealized capital losses included in OCI associated with Level 3 financial assets</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Included in earnings</a></td>
<td class="num">(9)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Included in other comprehensive income (loss)</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="num">(30)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers into (out of) Level 3, net</a></td>
<td class="num">(29)<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Included in earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Included in other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers into (out of) Level 3, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Included in earnings</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Included in other comprehensive income (loss)</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers into (out of) Level 3, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember', window );">Foreign securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Included in earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Included in other comprehensive income (loss)</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers into (out of) Level 3, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Included in earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Included in other comprehensive income (loss)</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers into (out of) Level 3, net</a></td>
<td class="num">(29)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Included in earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Included in other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers into (out of) Level 3, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Equity securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Included in earnings</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Included in other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers into (out of) Level 3, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Assets Measured On Recurring Basis, Unobservable Unput Reconciliation, Net Realized And Unrealized Capital Gaines (Losses) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3) and still held.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224248465648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value - Gross Transfers Into (Out Of) Level 3 (Details) - Recurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Net transfers into (out of) Level 3</a></td>
<td class="num">$ (29)<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Gross transfers into Level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Gross transfers out of Level 3</a></td>
<td class="num">(29)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Net transfers into (out of) Level 3</a></td>
<td class="num">$ (29)<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224246107968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Carrying Value and Fair Value Classified by Level (Details) - Nonrecurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">$ 1,044<span></span>
</td>
<td class="nump">$ 902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity securities</a></td>
<td class="nump">411<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contract liabilities with a fixed maturity</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">332<span></span>
</td>
<td class="nump">336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">52,257<span></span>
</td>
<td class="nump">56,176<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Carrying Value | Disposal Group, Held-for-sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">978<span></span>
</td>
<td class="nump">907<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contract liabilities with a fixed maturity</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">305<span></span>
</td>
<td class="nump">373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">47,653<span></span>
</td>
<td class="nump">64,157<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Level 1 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contract liabilities with a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">47,653<span></span>
</td>
<td class="nump">64,157<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Level 2 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contract liabilities with a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Level 3 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">978<span></span>
</td>
<td class="nump">907<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contract liabilities with a fixed maturity</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">305<span></span>
</td>
<td class="nump">373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Contracts With Fixed Maturity, Fair Value Disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of mortgage loans held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgagesHeldForSaleFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224243150032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Separate Accounts Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">$ 3,228<span></span>
</td>
<td class="nump">$ 5,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountsLiability', window );">Separate accounts liabilities</a></td>
<td class="num">(3,228)<span></span>
</td>
<td class="num">(5,087)<span></span>
</td>
<td class="num">$ (4,881)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">3,313<span></span>
</td>
<td class="nump">5,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountsLiability', window );">Separate accounts liabilities</a></td>
<td class="num">(85)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2,677<span></span>
</td>
<td class="nump">4,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">480<span></span>
</td>
<td class="nump">547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">714<span></span>
</td>
<td class="nump">1,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">712<span></span>
</td>
<td class="nump">1,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2,599<span></span>
</td>
<td class="nump">3,782<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">154<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">1,965<span></span>
</td>
<td class="nump">3,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">480<span></span>
</td>
<td class="nump">547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset at fair value held for benefit of separate account policyholder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=cvs_CommonAndCollectiveTrustsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=cvs_CommonAndCollectiveTrustsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224247993360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value - Narrative (Details) - Recurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers into (out of) Level 3, net</a></td>
<td class="num">$ (29)<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers into (out of) Level 3, net</a></td>
<td class="num">(29)<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Separate Accounts, financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers into (out of) Level 3, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=cvs_SeparateAccountFinancialAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=cvs_SeparateAccountFinancialAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224247861728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangibles - Goodwill (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning of the period</a></td>
<td class="nump">$ 79,121<span></span>
</td>
<td class="nump">$ 79,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(431)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, end of the period</a></td>
<td class="nump">78,150<span></span>
</td>
<td class="nump">79,121<span></span>
</td>
<td class="nump">79,552<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestitures</a></td>
<td class="num">(971)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning of the period</a></td>
<td class="nump">45,130<span></span>
</td>
<td class="nump">45,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, end of the period</a></td>
<td class="nump">44,159<span></span>
</td>
<td class="nump">45,130<span></span>
</td>
<td class="nump">45,130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits | Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestitures</a></td>
<td class="num">(971)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember', window );">Health Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning of the period</a></td>
<td class="nump">23,615<span></span>
</td>
<td class="nump">23,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, end of the period</a></td>
<td class="nump">23,615<span></span>
</td>
<td class="nump">23,615<span></span>
</td>
<td class="nump">23,615<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember', window );">Health Services | Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestitures</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember', window );">Pharmacy &amp; Consumer Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning of the period</a></td>
<td class="nump">10,376<span></span>
</td>
<td class="nump">10,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(431)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, end of the period</a></td>
<td class="nump">10,376<span></span>
</td>
<td class="nump">$ 10,376<span></span>
</td>
<td class="nump">$ 10,807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember', window );">Pharmacy &amp; Consumer Wellness | Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestitures</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224237809968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangibles - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 431<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,150<span></span>
</td>
<td class="nump">79,121<span></span>
</td>
<td class="nump">$ 79,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Cumulative goodwill impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,600<span></span>
</td>
<td class="nump">6,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=cvs_LongTermCareReportingUnitMember', window );">Long-Term Care Reporting Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=cvs_LongTermCareReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=cvs_LongTermCareReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224244114928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangibles - Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherAcquiredIntangibleAssetsLineItems', window );"><strong>Other Intangible Assets[Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets, Trademarks</a></td>
<td class="nump">$ 10,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,498<span></span>
</td>
<td class="nump">$ 10,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(13,028)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,028)<span></span>
</td>
<td class="num">(12,701)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross</a></td>
<td class="nump">37,859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,859<span></span>
</td>
<td class="nump">41,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale', window );">Intangible assets, net</a></td>
<td class="nump">24,831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,831<span></span>
</td>
<td class="nump">$ 29,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension', window );">Weighted Average Life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">13 years 10 months 24 days<span></span>
</td>
<td class="text">15 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Loss on assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,533<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,785<span></span>
</td>
<td class="nump">2,233<span></span>
</td>
<td class="nump">$ 2,341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherAcquiredIntangibleAssetsLineItems', window );"><strong>Other Intangible Assets[Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale', window );">Intangible assets, net</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations | Omnicare Long-Term Care Business | Pharmacy &amp; Consumer Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherAcquiredIntangibleAssetsLineItems', window );"><strong>Other Intangible Assets[Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Loss on assets held for sale</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember', window );">Customer contracts/relationships and covenants not to compete</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherAcquiredIntangibleAssetsLineItems', window );"><strong>Other Intangible Assets[Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross carrying amount</a></td>
<td class="nump">21,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,206<span></span>
</td>
<td class="nump">25,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(10,668)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,668)<span></span>
</td>
<td class="num">(10,564)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net carrying amount</a></td>
<td class="nump">10,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,538<span></span>
</td>
<td class="nump">$ 14,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension', window );">Weighted Average Life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">13 years 3 months 18 days<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherAcquiredIntangibleAssetsLineItems', window );"><strong>Other Intangible Assets[Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross carrying amount</a></td>
<td class="nump">1,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,060<span></span>
</td>
<td class="nump">$ 1,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(1,060)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,060)<span></span>
</td>
<td class="num">(1,060)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net carrying amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension', window );">Weighted Average Life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">0 years<span></span>
</td>
<td class="text">0 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cvs_ProviderNetworksMember', window );">Provider networks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherAcquiredIntangibleAssetsLineItems', window );"><strong>Other Intangible Assets[Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross carrying amount</a></td>
<td class="nump">4,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,203<span></span>
</td>
<td class="nump">$ 4,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(862)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(862)<span></span>
</td>
<td class="num">(651)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net carrying amount</a></td>
<td class="nump">3,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,341<span></span>
</td>
<td class="nump">$ 3,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension', window );">Weighted Average Life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cvs_ValueOfBusinessAcquiredMember', window );">Value of Business Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherAcquiredIntangibleAssetsLineItems', window );"><strong>Other Intangible Assets[Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross carrying amount</a></td>
<td class="nump">590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 590<span></span>
</td>
<td class="nump">$ 590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(174)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(174)<span></span>
</td>
<td class="num">(147)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net carrying amount</a></td>
<td class="nump">416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 416<span></span>
</td>
<td class="nump">$ 443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension', window );">Weighted Average Life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherAcquiredIntangibleAssetsLineItems', window );"><strong>Other Intangible Assets[Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross carrying amount</a></td>
<td class="nump">302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 302<span></span>
</td>
<td class="nump">$ 318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(264)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(264)<span></span>
</td>
<td class="num">(279)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net carrying amount</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension', window );">Weighted Average Life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years 4 months 24 days<span></span>
</td>
<td class="text">8 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets, Net (Excluding Goodwill), Including Assets Held For Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherAcquiredIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherAcquiredIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average period before the next renewal or extension (both explicit and implicit) for intangible assets that have been renewed or extended, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_OmnicareLongTermCareBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_OmnicareLongTermCareBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cvs_ProviderNetworksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cvs_ProviderNetworksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cvs_ValueOfBusinessAcquiredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cvs_ValueOfBusinessAcquiredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224246684832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Acquired Intangibles - Future Amortization Expense (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 1,601<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">1,562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">1,515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">1,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">2027</a></td>
<td class="nump">$ 1,196<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224239912064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>store</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>store</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity', window );">Proceeds from sale-leaseback transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 101.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleAndLeasebackTransactionGainLossNet', window );">Gains from sale-leaseback transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OfficeRealEstateOptimizationCharges', window );">Office real estate optimization charges</a></td>
<td class="nump">$ 117.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NumberOfStoresPlannedClosure', window );">Number of stores, planned closure | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_StoreImpairmentCharges', window );">Store impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 1,358.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=us-gaap_PropertySubjectToOperatingLeaseMember', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OfficeRealEstateOptimizationCharges', window );">Office real estate optimization charges</a></td>
<td class="nump">$ 71.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NumberOfStoresPlannedClosure', window );">Number of stores, planned closure | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod', window );">Number of stores, annual planned closures for closure period | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_StoreImpairmentCharges', window );">Store impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail LTC | Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_StoreImpairmentCharges', window );">Store impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure', window );">Operating lease, right-of-use asset, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">356.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">356.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Distribution centers and Corporate offices | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease term (in years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseTermOfContract1', window );">Finance lease term (in years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Distribution centers and Corporate offices | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease term (in years)</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseTermOfContract1', window );">Finance lease term (in years)</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease term (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseTermOfContract1', window );">Finance lease term (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease term (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseTermOfContract1', window );">Finance lease term (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OfficeRealEstateOptimizationCharges', window );">Office real estate optimization charges</a></td>
<td class="nump">$ 44.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property and equipment | Retail LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_StoreImpairmentCharges', window );">Store impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">261.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">261.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure', window );">Property and equipment, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 185.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 185.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Stores, Annual Planned Closures For Closure Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfStoresPlannedClosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Stores, Planned Closure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfStoresPlannedClosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OfficeRealEstateOptimizationCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Office Real Estate Optimization Charges - Related to the abandonment of leased real estate and the related right-of-use assets and property and equipment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OfficeRealEstateOptimizationCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating lease, Right-of-Use Asset, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_StoreImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Store Impairment Charges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_StoreImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from principal payment received from sales-type and direct financing leases classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 230<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123398031&amp;loc=SL120154370-112784<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleAndLeasebackTransactionGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128295416&amp;loc=SL77919786-209982<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleAndLeasebackTransactionGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=us-gaap_PropertySubjectToOperatingLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=us-gaap_PropertySubjectToOperatingLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224237810000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Summary of the Components of Net Lease Cost (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 2,579<span></span>
</td>
<td class="nump">$ 2,633<span></span>
</td>
<td class="nump">$ 2,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Finance lease cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_FinanceLeaseCost', window );">Total finance lease costs</a></td>
<td class="nump">147<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="nump">114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease costs</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease costs</a></td>
<td class="nump">610<span></span>
</td>
<td class="nump">604<span></span>
</td>
<td class="nump">599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Less: sublease income</a></td>
<td class="num">(61)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net lease cost</a></td>
<td class="nump">$ 3,302<span></span>
</td>
<td class="nump">$ 3,327<span></span>
</td>
<td class="nump">$ 3,350<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224243858672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_CashFlowLesseeAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows paid for operating leases</a></td>
<td class="nump">$ 2,689<span></span>
</td>
<td class="nump">$ 2,714<span></span>
</td>
<td class="nump">$ 2,724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows paid for interest portion of finance leases</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows paid for principal portion of finance leases</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract', window );"><strong>Right-of-use assets obtained in exchange for lease obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating leases</a></td>
<td class="nump">591<span></span>
</td>
<td class="nump">1,254<span></span>
</td>
<td class="nump">1,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Finance leases</a></td>
<td class="nump">$ 232<span></span>
</td>
<td class="nump">$ 278<span></span>
</td>
<td class="nump">$ 313<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_CashFlowLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Flow, Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_CashFlowLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224247721456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Operating leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 17,928<span></span>
</td>
<td class="nump">$ 19,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">1,699<span></span>
</td>
<td class="nump">1,646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale', window );">Long-term operating lease liabilities</a></td>
<td class="nump">16,839<span></span>
</td>
<td class="nump">18,177<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">18,538<span></span>
</td>
<td class="nump">19,823<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Finance leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_FinanceLeaseRightOfUseAssetGross', window );">Property and equipment, gross</a></td>
<td class="nump">1,608<span></span>
</td>
<td class="nump">1,375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation', window );">Accumulated depreciation</a></td>
<td class="num">(284)<span></span>
</td>
<td class="num">(188)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_FinanceLeaseRightOfUseAssetNet', window );">Property and equipment, net</a></td>
<td class="nump">1,324<span></span>
</td>
<td class="nump">1,187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term debt</a></td>
<td class="nump">1,406<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">$ 1,465<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_WeightedAverageRemainingLeaseTermAbstract', window );"><strong>Weighted average remaining lease term (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases</a></td>
<td class="text">12 years 2 months 12 days<span></span>
</td>
<td class="text">12 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance leases</a></td>
<td class="text">19 years 4 months 24 days<span></span>
</td>
<td class="text">20 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LeasesWeightedAverageDiscountRateAbstract', window );"><strong>Weighted average discount rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance leases</a></td>
<td class="nump">4.90%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Operating leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale', window );">Long-term operating lease liabilities</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Assets And Liabilities, Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Right-Of-Use Asset, Accumulated Depreciation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FinanceLeaseRightOfUseAssetGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Right-Of-Use Asset, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FinanceLeaseRightOfUseAssetGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FinanceLeaseRightOfUseAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Right-Of-Use Asset, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FinanceLeaseRightOfUseAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LeasesWeightedAverageDiscountRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Leases, Weighted Average Discount Rate [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LeasesWeightedAverageDiscountRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Assets And Liabilities, Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Liability, Current, Including Liabilities Held For Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Liability, Noncurrent, Including Liabilities Held For Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-Of-Use Asset, Including Assets Held For Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_WeightedAverageRemainingLeaseTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Lease Term [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_WeightedAverageRemainingLeaseTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224239121408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of Operating and Finance Lease Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">1,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">2,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(823)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">1,465<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">2,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">2,499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">2,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">2,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">1,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">12,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">24,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(5,501)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">18,538<span></span>
</td>
<td class="nump">$ 19,823<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LesseeLiabilityPaymentsYearOne', window );">2023</a></td>
<td class="nump">2,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LesseeLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">2,629<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LesseeLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">2,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LesseeLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">2,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LesseeLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">2,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LesseeLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">14,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LesseeLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">26,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LesseeLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(6,324)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">20,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived', window );">Future noncancelable subleases, future minimum payments</a></td>
<td class="nump">290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife', window );">Leases, amount due in excess of remaining estimated economic life</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Leases Liabilities Payments Due [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Payments, Due</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Payments, Due After Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Payments, Due Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Payments, Due Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Payments, Due Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Payments, Due Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityPaymentsYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Payments, Year One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityPaymentsYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating And Capital Leases, Amount Due In Excess Of Remaining Estimated Economic Life</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payments to be received by lessor for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224245821200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Health Care Costs Payable - Incurred and Paid Health Care Claims Development (Details) - Health Insurance Product Line - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Incurred Health Care Claims, Net of Reinsurance</a></td>
<td class="nump">$ 131,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Cumulative Paid Health Care Claims, Net of Reinsurance</a></td>
<td class="nump">121,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented', window );">All outstanding liabilities for health care costs payable prior to 2021, net of reinsurance</a></td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Total outstanding liabilities for health care costs payable, net of reinsurance</a></td>
<td class="nump">9,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Incurred Health Care Claims, Net of Reinsurance</a></td>
<td class="nump">62,259<span></span>
</td>
<td class="nump">$ 62,830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Cumulative Paid Health Care Claims, Net of Reinsurance</a></td>
<td class="nump">62,144<span></span>
</td>
<td class="nump">$ 54,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Incurred Health Care Claims, Net of Reinsurance</a></td>
<td class="nump">69,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Cumulative Paid Health Care Claims, Net of Reinsurance</a></td>
<td class="nump">$ 59,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClaimsDevelopmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClaimsDevelopmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reinsurance, of paid claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of incurred claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671315-158438<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts for accident years not separately presented in claim development information. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224243929408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Health Care Costs Payable - Narrative (Details)<br> $ in Billions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet', window );">Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) claims liability, net</a></td>
<td class="nump">$ 7.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671321-158438<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671317-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224244182800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Health Care Costs Payable - Liability for Unpaid Claims and Claims Adjustment Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems', window );"><strong>Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Total health care costs payable</a></td>
<td class="nump">$ 10,142<span></span>
</td>
<td class="nump">$ 8,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Health Insurance Product Line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems', window );"><strong>Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Short-duration health care costs payable, net of reinsurance</a></td>
<td class="nump">9,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Reinsurance recoverables</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem', window );">Insurance lines other than short duration</a></td>
<td class="nump">211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Total health care costs payable</a></td>
<td class="nump">$ 10,142<span></span>
</td>
<td class="nump">$ 8,678<span></span>
</td>
<td class="nump">$ 7,936<span></span>
</td>
<td class="nump">$ 6,879<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671315-158438<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reconciling item for the reconciliation of the liability in the disclosure of claims development (in excess of) less than the liability for unpaid claims and claims adjustment expense for short-duration insurance contracts, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671315-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224245779360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable, beginning of period</a></td>
<td class="nump">$ 8,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable, end of period</a></td>
<td class="nump">10,142<span></span>
</td>
<td class="nump">$ 8,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts', window );">Benefit costs recorded in other insurance liabilities</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember', window );">Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts', window );">Benefit costs recorded in other insurance liabilities</a></td>
<td class="nump">249<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="nump">221<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Health Insurance Product Line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable, beginning of period</a></td>
<td class="nump">8,678<span></span>
</td>
<td class="nump">7,936<span></span>
</td>
<td class="nump">6,879<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Less: Reinsurance recoverables</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax', window );">Less: Impact of discount rate on long-duration insurance reserves</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, beginning of period, net</a></td>
<td class="nump">8,670<span></span>
</td>
<td class="nump">7,926<span></span>
</td>
<td class="nump">6,874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions', window );">Acquisitions, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract', window );"><strong>Add: Components of incurred health care costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current year</a></td>
<td class="nump">71,399<span></span>
</td>
<td class="nump">64,631<span></span>
</td>
<td class="nump">55,835<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior years</a></td>
<td class="num">(654)<span></span>
</td>
<td class="num">(788)<span></span>
</td>
<td class="num">(429)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total incurred health care costs</a></td>
<td class="nump">70,745<span></span>
</td>
<td class="nump">63,843<span></span>
</td>
<td class="nump">55,406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Current year</a></td>
<td class="nump">61,640<span></span>
</td>
<td class="nump">56,323<span></span>
</td>
<td class="nump">48,770<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Prior years</a></td>
<td class="nump">7,646<span></span>
</td>
<td class="nump">6,792<span></span>
</td>
<td class="nump">6,009<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total claims paid</a></td>
<td class="nump">69,286<span></span>
</td>
<td class="nump">63,115<span></span>
</td>
<td class="nump">54,779<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumDeficiencyReserveLiability', window );">Add: Premium deficiency reserve</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, end of period, net</a></td>
<td class="nump">10,129<span></span>
</td>
<td class="nump">8,670<span></span>
</td>
<td class="nump">7,926<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Add: Reinsurance recoverables</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax', window );">Add: Impact of discount rate on long-duration insurance reserves</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable, end of period</a></td>
<td class="nump">10,142<span></span>
</td>
<td class="nump">8,678<span></span>
</td>
<td class="nump">7,936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumDeficiencyReserveLiability', window );">Premium deficiency reserve</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumDeficiencyReserveLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumDeficiencyReserveLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) (AOCI) from (increase) decrease in expected future policy benefit component of liability for future policy benefit from change in discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLossesAndLossAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224247811488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Insurance Liabilities and Separate Accounts - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Reduction to accumulated other comprehensive income (loss)</a></td>
<td class="nump">$ 1,264<span></span>
</td>
<td class="num">$ (334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2018-12</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance', window );">Liability for future policy benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax', window );">Reduction to accumulated other comprehensive income (loss), before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">986<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax', window );">Liability for future policy benefits, after tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Reduction to accumulated other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 766<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income (Loss), Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Future Policy Benefit, After Reinsurance, Net Of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of reinsurance, of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201812Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201812Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224236525680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Insurance Liabilities and Separate Accounts - Changes in Balances of Long-Duration Insurance Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember', window );">Large Case Pensions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance', window );">Liability for future policy benefits</a></td>
<td class="nump">$ 2,252<span></span>
</td>
<td class="nump">$ 3,034<span></span>
</td>
<td class="nump">$ 3,647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance', window );">Add: Reinsurance recoverable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange', window );">Effect of changes in cash flow assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(96)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange', window );">Liability for future policy benefits, end of period - current discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,647<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember', window );">Large Case Pensions | As Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance', window );">Liability for future policy benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance', window );">Add: Reinsurance recoverable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange', window );">Liability for future policy benefits, beginning of period - current discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,224<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember', window );">Large Case Pensions | Change in discount rate assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange', window );">Effect of changes in cash flow assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">604<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember', window );">Large Case Pensions | Removal of shadow adjustments in accumulated other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange', window );">Effect of changes in cash flow assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(181)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LongTermCareMember', window );">Long-Term Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance', window );">Liability for future policy benefits</a></td>
<td class="nump">1,266<span></span>
</td>
<td class="nump">1,602<span></span>
</td>
<td class="nump">1,695<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance', window );">Add: Reinsurance recoverable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange', window );">Effect of changes in cash flow assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange', window );">Liability for future policy benefits, end of period - current discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,695<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LongTermCareMember', window );">Long-Term Care | As Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance', window );">Liability for future policy benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance', window );">Add: Reinsurance recoverable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange', window );">Liability for future policy benefits, beginning of period - current discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LongTermCareMember', window );">Long-Term Care | Change in discount rate assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange', window );">Effect of changes in cash flow assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">553<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LongTermCareMember', window );">Long-Term Care | Removal of shadow adjustments in accumulated other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange', window );">Effect of changes in cash flow assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance', window );">Liability for future policy benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">490<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance', window );">Add: Reinsurance recoverable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange', window );">Liability for future policy benefits, end of period - current discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">798<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other | As Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance', window );">Liability for future policy benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance', window );">Add: Reinsurance recoverable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange', window );">Liability for future policy benefits, beginning of period - current discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">754<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other | Change in discount rate assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange', window );">Effect of changes in cash flow assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other | Removal of shadow adjustments in accumulated other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange', window );">Effect of changes in cash flow assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Future Policy Benefit, Expected Future Policy Benefit, Before Reinsurance, Before Discount Rate Change</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Future Policy Benefit, Including Deferred Profit Liability, Expected Future Policy Benefit, Before Reinsurance, After Discount Rate Change</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of reinsurance, of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in expected future policy benefit and expense component for liability of future policy benefit from cash flow assumption change for future cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, recoverable under reinsurance of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_LongTermCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_LongTermCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224238058480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Insurance Liabilities and Separate Accounts - Adjustments Resulting From Applying New Accounting Standard (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalIncomeStatementElementsAbstract', window );"><strong>Condensed Consolidated Statement of Operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefit costs</a></td>
<td class="nump">$ 71,073<span></span>
</td>
<td class="nump">$ 64,188<span></span>
</td>
<td class="nump">$ 55,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement', window );">Operating expenses</a></td>
<td class="nump">38,212<span></span>
</td>
<td class="nump">37,021<span></span>
</td>
<td class="nump">35,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs</a></td>
<td class="nump">314,513<span></span>
</td>
<td class="nump">278,801<span></span>
</td>
<td class="nump">254,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">7,954<span></span>
</td>
<td class="nump">13,310<span></span>
</td>
<td class="nump">13,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income tax provision</a></td>
<td class="nump">5,836<span></span>
</td>
<td class="nump">10,537<span></span>
</td>
<td class="nump">9,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">1,509<span></span>
</td>
<td class="nump">2,548<span></span>
</td>
<td class="nump">2,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income from continuing operations</a></td>
<td class="nump">4,327<span></span>
</td>
<td class="nump">7,989<span></span>
</td>
<td class="nump">7,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">4,327<span></span>
</td>
<td class="nump">7,989<span></span>
</td>
<td class="nump">7,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to CVS Health</a></td>
<td class="nump">$ 4,311<span></span>
</td>
<td class="nump">$ 8,001<span></span>
</td>
<td class="nump">$ 7,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Income from continuing operations attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">$ 3.29<span></span>
</td>
<td class="nump">$ 6.07<span></span>
</td>
<td class="nump">$ 5.49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">3.29<span></span>
</td>
<td class="nump">6.07<span></span>
</td>
<td class="nump">5.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Income from continuing operations attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">3.26<span></span>
</td>
<td class="nump">6.02<span></span>
</td>
<td class="nump">5.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">$ 3.26<span></span>
</td>
<td class="nump">$ 6.02<span></span>
</td>
<td class="nump">$ 5.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Condensed Consolidated Balance Sheet:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">$ 2,636<span></span>
</td>
<td class="nump">$ 5,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">65,633<span></span>
</td>
<td class="nump">60,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">24,803<span></span>
</td>
<td class="nump">29,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">228,275<span></span>
</td>
<td class="nump">233,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable</a></td>
<td class="nump">10,142<span></span>
</td>
<td class="nump">8,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesCurrent', window );">Other insurance liabilities</a></td>
<td class="nump">1,089<span></span>
</td>
<td class="nump">1,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">69,421<span></span>
</td>
<td class="nump">67,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">4,016<span></span>
</td>
<td class="nump">6,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesNoncurrent', window );">Other long-term insurance liabilities</a></td>
<td class="nump">5,835<span></span>
</td>
<td class="nump">7,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">6,730<span></span>
</td>
<td class="nump">1,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">156,506<span></span>
</td>
<td class="nump">158,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">56,398<span></span>
</td>
<td class="nump">54,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="num">(1,264)<span></span>
</td>
<td class="nump">334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total CVS Health shareholders&#8217; equity</a></td>
<td class="nump">71,469<span></span>
</td>
<td class="nump">74,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">71,769<span></span>
</td>
<td class="nump">74,841<span></span>
</td>
<td class="nump">$ 69,701<span></span>
</td>
<td class="nump">$ 64,170<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">228,275<span></span>
</td>
<td class="nump">233,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract', window );"><strong>Condensed Consolidated Statement of Cash Flows:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,224<span></span>
</td>
<td class="nump">4,486<span></span>
</td>
<td class="nump">4,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income taxes</a></td>
<td class="num">(2,029)<span></span>
</td>
<td class="num">(402)<span></span>
</td>
<td class="num">(570)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(491)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="nump">364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities', window );">Health care costs payable and other insurance liabilities</a></td>
<td class="nump">992<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="num">(231)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">6,463<span></span>
</td>
<td class="nump">2,856<span></span>
</td>
<td class="nump">$ 2,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalIncomeStatementElementsAbstract', window );"><strong>Condensed Consolidated Statement of Operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefit costs</a></td>
<td class="nump">71,281<span></span>
</td>
<td class="nump">64,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs</a></td>
<td class="nump">314,721<span></span>
</td>
<td class="nump">278,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">7,746<span></span>
</td>
<td class="nump">13,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income tax provision</a></td>
<td class="nump">5,628<span></span>
</td>
<td class="nump">10,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">1,463<span></span>
</td>
<td class="nump">2,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income from continuing operations</a></td>
<td class="nump">4,165<span></span>
</td>
<td class="nump">7,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">4,165<span></span>
</td>
<td class="nump">7,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to CVS Health</a></td>
<td class="nump">$ 4,149<span></span>
</td>
<td class="nump">$ 7,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Income from continuing operations attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">$ 3.16<span></span>
</td>
<td class="nump">$ 6.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">3.16<span></span>
</td>
<td class="nump">6.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Income from continuing operations attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">3.14<span></span>
</td>
<td class="nump">5.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">$ 3.14<span></span>
</td>
<td class="nump">$ 5.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Condensed Consolidated Balance Sheet:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">$ 2,685<span></span>
</td>
<td class="nump">$ 5,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">65,682<span></span>
</td>
<td class="nump">60,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">24,754<span></span>
</td>
<td class="nump">29,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">228,275<span></span>
</td>
<td class="nump">232,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable</a></td>
<td class="nump">10,406<span></span>
</td>
<td class="nump">8,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesCurrent', window );">Other insurance liabilities</a></td>
<td class="nump">1,140<span></span>
</td>
<td class="nump">1,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">69,736<span></span>
</td>
<td class="nump">67,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">3,880<span></span>
</td>
<td class="nump">6,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesNoncurrent', window );">Other long-term insurance liabilities</a></td>
<td class="nump">6,108<span></span>
</td>
<td class="nump">6,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">6,732<span></span>
</td>
<td class="nump">1,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">156,960<span></span>
</td>
<td class="nump">157,618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">56,145<span></span>
</td>
<td class="nump">54,906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="num">(1,465)<span></span>
</td>
<td class="nump">965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total CVS Health shareholders&#8217; equity</a></td>
<td class="nump">71,015<span></span>
</td>
<td class="nump">75,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">71,315<span></span>
</td>
<td class="nump">75,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">228,275<span></span>
</td>
<td class="nump">232,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract', window );"><strong>Condensed Consolidated Statement of Cash Flows:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,247<span></span>
</td>
<td class="nump">4,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income taxes</a></td>
<td class="num">(2,075)<span></span>
</td>
<td class="num">(428)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(566)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities', window );">Health care costs payable and other insurance liabilities</a></td>
<td class="nump">1,247<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">6,468<span></span>
</td>
<td class="nump">2,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember', window );">Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalIncomeStatementElementsAbstract', window );"><strong>Condensed Consolidated Statement of Operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefit costs</a></td>
<td class="num">(208)<span></span>
</td>
<td class="num">(72)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs</a></td>
<td class="num">(208)<span></span>
</td>
<td class="num">(117)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">208<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income tax provision</a></td>
<td class="nump">208<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income from continuing operations</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to CVS Health</a></td>
<td class="nump">$ 162<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Income from continuing operations attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">0.13<span></span>
</td>
<td class="nump">0.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Income from continuing operations attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">0.12<span></span>
</td>
<td class="nump">0.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Condensed Consolidated Balance Sheet:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="num">$ (49)<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="num">(49)<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable</a></td>
<td class="num">(264)<span></span>
</td>
<td class="num">(130)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesCurrent', window );">Other insurance liabilities</a></td>
<td class="num">(51)<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="num">(315)<span></span>
</td>
<td class="num">(88)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">136<span></span>
</td>
<td class="num">(155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesNoncurrent', window );">Other long-term insurance liabilities</a></td>
<td class="num">(273)<span></span>
</td>
<td class="nump">833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="num">(454)<span></span>
</td>
<td class="nump">593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">253<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="nump">201<span></span>
</td>
<td class="num">(631)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total CVS Health shareholders&#8217; equity</a></td>
<td class="nump">454<span></span>
</td>
<td class="num">(540)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">454<span></span>
</td>
<td class="num">(540)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract', window );"><strong>Condensed Consolidated Statement of Cash Flows:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income taxes</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">75<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities', window );">Health care costs payable and other insurance liabilities</a></td>
<td class="num">(255)<span></span>
</td>
<td class="num">(68)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="num">$ (5)<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Expenses, Excluding Store Impairments, Goodwill Impairments, Loss On Assets Held For Sale, And Loss On Litigation Settlement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherInsuranceLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Insurance Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherInsuranceLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherInsuranceLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Insurance Liabilities, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherInsuranceLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in insurance liability balances during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalIncomeStatementElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalIncomeStatementElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224246098816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Insurance Liabilities and Separate Accounts - Changes in Liability for Future Policy Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember', window );">Large Case Pensions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange', window );">Liability for future policy benefits, beginning of period - current discount rate</a></td>
<td class="nump">$ 3,034<span></span>
</td>
<td class="nump">$ 3,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance', window );">Beginning liability for future policy benefits at original (locked-in) discount rate</a></td>
<td class="nump">2,650<span></span>
</td>
<td class="nump">2,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange', window );">Effect of changes in cash flow assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">$ (96)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience', window );">Effect of actual variances from expected experience</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange', window );">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,606<span></span>
</td>
<td class="nump">2,844<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance', window );">Issuances</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense', window );">Interest accrual (using locked-in discount rate)</a></td>
<td class="nump">106<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits', window );">Benefit payments (actual)</a></td>
<td class="num">(291)<span></span>
</td>
<td class="num">(313)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance', window );">Ending liability for future policy benefits at original (locked-in) discount rate</a></td>
<td class="nump">2,425<span></span>
</td>
<td class="nump">2,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax', window );">Effect of changes in discount rate assumptions</a></td>
<td class="num">(173)<span></span>
</td>
<td class="nump">384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange', window );">Liability for future policy benefits, end of period - current discount rate</a></td>
<td class="nump">2,252<span></span>
</td>
<td class="nump">3,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefits', window );">Net liability for future policy benefits</a></td>
<td class="nump">2,252<span></span>
</td>
<td class="nump">3,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance', window );">Less: Reinsurance recoverable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance', window );">Net liability for future policy benefits, net of reinsurance recoverable</a></td>
<td class="nump">2,252<span></span>
</td>
<td class="nump">3,034<span></span>
</td>
<td class="nump">3,647<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LongTermCareMember', window );">Long-Term Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward', window );"><strong>Present value of expected net premiums</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange', window );">Liability for future policy benefits, beginning of period - current discount rate</a></td>
<td class="nump">389<span></span>
</td>
<td class="nump">417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance', window );">Beginning liability for future policy benefits at original (locked-in) discount rate</a></td>
<td class="nump">323<span></span>
</td>
<td class="nump">330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange', window );">Effect of changes in cash flow assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience', window );">Effect of actual variances from expected experience</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange', window );">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">326<span></span>
</td>
<td class="nump">347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome', window );">Interest accrual (using locked-in discount rate)</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected', window );">Net premiums (actual)</a></td>
<td class="num">(40)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance', window );">Ending liability for future policy benefits at original (locked-in) discount rate</a></td>
<td class="nump">302<span></span>
</td>
<td class="nump">323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax', window );">Effect of changes in discount rate assumptions</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange', window );">Liability for future policy benefits, end of period - current discount rate</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward', window );"><strong>Present value of expected future policy benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange', window );">Liability for future policy benefits, beginning of period - current discount rate</a></td>
<td class="nump">1,991<span></span>
</td>
<td class="nump">2,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance', window );">Beginning liability for future policy benefits at original (locked-in) discount rate</a></td>
<td class="nump">1,480<span></span>
</td>
<td class="nump">1,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange', window );">Effect of changes in cash flow assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience', window );">Effect of actual variances from expected experience</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange', window );">Adjusted beginning liability for future policy benefits - original (locked-in) discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,597<span></span>
</td>
<td class="nump">1,468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance', window );">Issuances</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense', window );">Interest accrual (using locked-in discount rate)</a></td>
<td class="nump">80<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits', window );">Benefit payments (actual)</a></td>
<td class="num">(64)<span></span>
</td>
<td class="num">(62)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance', window );">Ending liability for future policy benefits at original (locked-in) discount rate</a></td>
<td class="nump">1,613<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax', window );">Effect of changes in discount rate assumptions</a></td>
<td class="num">(47)<span></span>
</td>
<td class="nump">511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange', window );">Liability for future policy benefits, end of period - current discount rate</a></td>
<td class="nump">1,566<span></span>
</td>
<td class="nump">1,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefits', window );">Net liability for future policy benefits</a></td>
<td class="nump">1,266<span></span>
</td>
<td class="nump">1,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance', window );">Less: Reinsurance recoverable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance', window );">Net liability for future policy benefits, net of reinsurance recoverable</a></td>
<td class="nump">$ 1,266<span></span>
</td>
<td class="nump">$ 1,602<span></span>
</td>
<td class="nump">$ 1,695<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) (AOCI) from (increase) decrease in expected future policy benefit component of liability for future policy benefit from change in discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) (AOCI) from increase (decrease) in expected net premium component of liability for future policy benefit from change in discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of reinsurance, of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance and after current period update of cash flow assumption, of expected future benefit and expense component for liability for future policy benefit, discounted at original rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance and after current period update of cash flow assumption and discount rate change, of expected future policy benefit and expense component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in expected future policy benefit and expense component for liability of future policy benefit from cash flow assumption change for future cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in expected future policy benefit and expense component for liability of future policy benefit from effect of variance from cash flow assumption change for actual experience.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense for expected future policy benefit and expense component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in expected future policy benefit and expense component of liability for future policy benefit from contract issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance and current period update of cash flow assumption, of expected future policy benefit and expense component of liability for future policy benefit, discounted at original rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance and after current period update of cash flow assumption and discount rate change, of expected net premium component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in expected net premium component of liability for future policy benefit from cash flow assumption change for future cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in expected net premium component for liability of future policy benefit from effect of variance from cash flow assumption change for actual experience.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income for expected net premium component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of premium collected from policyholder to fund expected benefit payment for expected net premium component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance and current period update of cash flow assumption, of expected net premium component of liability for future policy benefit, discounted at original rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance and after current period update of cash flow assumption, of expected net premium component for liability for future policy benefit, discounted at original rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, recoverable under reinsurance of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance, of present value of future benefit to be paid to or on behalf of policyholder and related expense less present value of future net premium receivable under insurance contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to policyholder from benefit payment for expected future policy benefit and expense component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783724-158441<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_LongTermCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_LongTermCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224243885248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Insurance Liabilities and Separate Accounts - Undiscounted Expected Gross Premiums and Expected Future Benefit Payments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember', window );">Large Case Pensions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems', window );"><strong>Liability for Future Policy Benefit, Activity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance', window );">Expected future benefit payments</a></td>
<td class="nump">$ 3,539<span></span>
</td>
<td class="nump">$ 3,882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance', window );">Expected gross premiums</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LongTermCareMember', window );">Long-Term Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems', window );"><strong>Liability for Future Policy Benefit, Activity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance', window );">Expected future benefit payments</a></td>
<td class="nump">3,265<span></span>
</td>
<td class="nump">3,115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance', window );">Expected gross premiums</a></td>
<td class="nump">$ 437<span></span>
</td>
<td class="nump">$ 478<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance, of undiscounted balance for expected future gross premium component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance, of undiscounted balance for expected future policy benefit and expense component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_LongTermCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_LongTermCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224243072304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Insurance Liabilities and Separate Accounts - Weighted-average Interest Rates and Durations (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember', window );">Large Case Pensions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems', window );"><strong>Liability for Future Policy Benefit, Activity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate', window );">Interest accretion rate</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate', window );">Current discount rate</a></td>
<td class="nump">5.24%<span></span>
</td>
<td class="nump">2.53%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration', window );">Weighted-average duration of long-duration insurance liabilities</a></td>
<td class="text">7 years 4 months 24 days<span></span>
</td>
<td class="text">7 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_LongTermCareMember', window );">Long-Term Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems', window );"><strong>Liability for Future Policy Benefit, Activity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate', window );">Interest accretion rate</a></td>
<td class="nump">5.11%<span></span>
</td>
<td class="nump">5.11%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate', window );">Current discount rate</a></td>
<td class="nump">5.39%<span></span>
</td>
<td class="nump">2.88%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration', window );">Weighted-average duration of long-duration insurance liabilities</a></td>
<td class="text">12 years 7 months 6 days<span></span>
</td>
<td class="text">13 years 6 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current weighted-average discount rate used to measure liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(6)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average duration of liability for future policy benefit, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Original weighted-average discount rate at contract issue date used to measure liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819541-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(6)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_LargeCasePensionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_LongTermCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_LongTermCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224240165632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Insurance Liabilities and Separate Accounts - Roll Forward of Policyholders' Funds (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceRollForward', window );"><strong>Policyholder Account Balance [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderFunds', window );">Policyholders&#8217; funds, beginning of the period</a></td>
<td class="nump">$ 522<span></span>
</td>
<td class="nump">$ 568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PolicyholderAccountBalanceDepositsReceived', window );">Deposits received</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalancePolicyCharge', window );">Policy charges</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal', window );">Surrenders and withdrawals</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestCreditedToPolicyholdersAccountBalances', window );">Interest credited</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses', window );">Change in net unrealized gains (losses)</a></td>
<td class="num">(148)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange', window );">Other</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderFunds', window );">Policyholders&#8217; funds, end of the period</a></td>
<td class="nump">$ 345<span></span>
</td>
<td class="nump">$ 522<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate', window );">Weighted average crediting rate</a></td>
<td class="nump">4.72%<span></span>
</td>
<td class="nump">4.81%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk', window );">Net amount at risk</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueDuePolicyholdersAmount', window );">Cash surrender value</a></td>
<td class="nump">$ 339<span></span>
</td>
<td class="nump">$ 346<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Policyholder Account Balance, Change In Net Unrealized Gains (Losses)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PolicyholderAccountBalanceDepositsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Policyholder Account Balance, Deposits Received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PolicyholderAccountBalanceDepositsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueDuePolicyholdersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash to be paid to policyholder upon termination and surrender of long-duration contract issued by insurance entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueDuePolicyholdersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCreditedToPolicyholdersAccountBalances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense for allocation to policyholder account balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13J<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783734-158441<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6480726&amp;loc=d3e6691-158385<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCreditedToPolicyholdersAccountBalances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in liability for policyholder account balance from change, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountBalanceNetAmountAtRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of guaranteed benefit in excess of current account balance of policyholder account balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountBalanceNetAmountAtRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountBalancePolicyCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in liability for policyholder account balance from policy charge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13J<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783734-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountBalancePolicyCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountBalanceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountBalanceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in liability for policyholder account balance from contract redemption and withdrawal of funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average crediting rate for liability for policyholder account balance, calculated at a point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due to policyholder. Includes, but is not limited to, unpaid policy dividend, retrospective refund, and undistributed earnings on participating business. Excludes future policy benefit and claim expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224246274944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Insurance Liabilities and Separate Accounts - Separate Account Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">$ 3,228<span></span>
</td>
<td class="nump">$ 5,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountsLiability', window );">Separate accounts liabilities</a></td>
<td class="nump">3,228<span></span>
</td>
<td class="nump">5,087<span></span>
</td>
<td class="nump">$ 4,881<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">3,313<span></span>
</td>
<td class="nump">5,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableMember', window );">Other payables | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountsLiability', window );">Separate accounts liabilities</a></td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember', window );">Other receivables | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountCashAndCashEquivalentsMember', window );">Cash and cash equivalents | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountDebtSecurityMember', window );">Debt securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2,677<span></span>
</td>
<td class="nump">4,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountDebtSecurityMember', window );">Debt securities | U.S. government securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">717<span></span>
</td>
<td class="nump">1,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountDebtSecurityMember', window );">Debt securities | States, municipalities and political subdivisions | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountDebtSecurityMember', window );">Debt securities | U.S. corporate securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">1,667<span></span>
</td>
<td class="nump">2,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountDebtSecurityMember', window );">Debt securities | Foreign securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountMortgageBackedSecurityMember', window );">Mortgage-backed securities | Residential mortgage-backed securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountMortgageBackedSecurityMember', window );">Mortgage-backed securities | Commercial mortgage-backed securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssetCategoryAxis=cvs_SeparateAccountOtherAssetBackedSecuritiesMember', window );">Other asset-backed securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssetCategoryAxis=cvs_EquitySecuritiesAndCommonAndCollectiveTrustsMember', window );">Equity securities and common/collective trusts | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">$ 480<span></span>
</td>
<td class="nump">$ 548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset at fair value held for benefit of separate account policyholder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountDebtSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountDebtSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountMortgageBackedSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_SeparateAccountMortgageBackedSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=cvs_SeparateAccountOtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=cvs_SeparateAccountOtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=cvs_EquitySecuritiesAndCommonAndCollectiveTrustsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=cvs_EquitySecuritiesAndCommonAndCollectiveTrustsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224245975072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Insurance Liabilities and Separate Accounts - Roll Forward of Separate Accounts (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountLiabilityRollForward', window );"><strong>Separate Account, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountsLiability', window );">Separate Accounts liability, beginning of the period</a></td>
<td class="nump">$ 5,087<span></span>
</td>
<td class="nump">$ 4,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountLiabilityPremiumAndDeposit', window );">Premiums and deposits</a></td>
<td class="nump">853<span></span>
</td>
<td class="nump">1,118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal', window );">Surrenders and withdrawals</a></td>
<td class="num">(581)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountLiabilityBenefitPayment', window );">Benefit payments</a></td>
<td class="num">(947)<span></span>
</td>
<td class="num">(984)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance', window );">Investment earnings</a></td>
<td class="num">(1,130)<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount', window );">Net transfers from general account</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange', window );">Other</a></td>
<td class="num">(63)<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountsLiability', window );">Separate Accounts liability, end of the period</a></td>
<td class="nump">3,228<span></span>
</td>
<td class="nump">5,087<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount', window );">Cash surrender value, end of the period</a></td>
<td class="nump">$ 2,087<span></span>
</td>
<td class="nump">$ 3,513<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountLiabilityBenefitPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to separate account policyholder from benefit payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountLiabilityBenefitPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of separate account liability payable to policyholder upon surrender of contract before maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in separate account liability from performance of investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount increase (decrease) in separate account liability from change, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountLiabilityPremiumAndDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow to separate account liability from premium and deposit from cash received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountLiabilityPremiumAndDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in separate account liability from contract redemption and withdrawal of funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer to (from) liability for policyholder account balance (to) from liability for separate account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29F<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117819544-158441<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=SL117782755-158439<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 13J<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126561865&amp;loc=SL117783734-158441<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224232720432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings and Credit Agreements - Schedule of Borrowings (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Aug. 18, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 51,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease liabilities</a></td>
<td class="nump">1,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LongtermDebtGrossAndLeaseObligation', window );">Total debt principal</a></td>
<td class="nump">52,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premiums</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet', window );">Debt discounts and deferred financing costs</a></td>
<td class="num">(696)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(786)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities', window );">Long-term debt and lease obligation</a></td>
<td class="nump">52,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="num">(1,778)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,205)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale', window );">Long-term debt</a></td>
<td class="nump">$ 50,479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Long-term debt (1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Long-term debt (1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.5% senior notes due July 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.75% senior notes due November 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.75% senior notes due December 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.75% senior notes due December 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.8% senior notes due June 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4% senior notes due December 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.375% senior notes due August 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.625% senior notes due August 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.5% senior notes due November 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5% senior notes due December 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5% senior notes due December 2024 | Disposal Group, Held-for-sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.1% senior notes due March 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.875% senior notes due July 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 2,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.875% senior notes due June 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3% senior notes due August 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.625% senior notes due April 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.625%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.25% senior notes due June 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.3% senior notes due August 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.3% senior notes due March 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.25% senior notes due August 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.75% senior notes due April 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.75% senior notes due August 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.875% senior notes due February 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.125% senior notes due September 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.875% senior notes due July 2035</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.625% senior notes due June 2036</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.75% senior notes due December 2037</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.78% senior notes due March 2038</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.78%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.125% senior notes due September 2039</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due April 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.7% senior notes due August 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.75% senior notes due May 2041</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.5% senior notes due May 2042</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due November 2042</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.3% senior notes due December 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.75% senior notes due March 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.125% senior notes due July 2045</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.875% senior notes due August 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.05% senior notes due March 2048</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.25% senior notes due April 2050</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other Debt Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Unamortized Discount And Debt Issuance Costs, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, including liabilities held for sale, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LongtermDebtGrossAndLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Gross And Lease Obligation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LongtermDebtGrossAndLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, including portion classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueJuly2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueJuly2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueNovember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueNovember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueDecember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueDecember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueDecember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueDecember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.8DueJune2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.8DueJune2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.375DueAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.375DueAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.625DueAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.625DueAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueNovember2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueNovember2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5DueDecember2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5DueDecember2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueJuly2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueJuly2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.875DueJune2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.875DueJune2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3DueAugust2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3DueAugust2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3Point625PercentApril2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3Point625PercentApril2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.25DueJune2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.25DueJune2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1Point3PercentAugust2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1Point3PercentAugust2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.3DueMarch2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.3DueMarch2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.25DueAugust2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.25DueAugust2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3Point75PercentApril2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3Point75PercentApril2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1Point75PercentAugust2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1Point75PercentAugust2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1Point875PercentFebruary2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1Point875PercentFebruary2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2Point125PercentDueSeptember2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2Point125PercentDueSeptember2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.875DueJuly2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.875DueJuly2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.625DueJune2036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.625DueJune2036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.75DueDecember2037Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.75DueDecember2037Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.78DueMarch2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.78DueMarch2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.125DueSeptember2039Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.125DueSeptember2039Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4Point125PercentApril2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4Point125PercentApril2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2Point7PercentAugust2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2Point7PercentAugust2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.75DueMay2041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.75DueMay2041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.5DueMay2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.5DueMay2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueNovember2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueNovember2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.3DueDecember2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.3DueDecember2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueMarch2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueMarch2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.125DueJuly2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.125DueJuly2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueAugust2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueAugust2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.05DueMarch2048Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.05DueMarch2048Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4Point25PercentApril2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4Point25PercentApril2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224248181760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings and Credit Agreements - Debt Maturities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Long-term Debt, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 1,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">2,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">3,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">2,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2027</a></td>
<td class="nump">3,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">37,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Subtotal</a></td>
<td class="nump">51,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease liabilities</a></td>
<td class="nump">1,465<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LongtermDebtGrossAndLeaseObligation', window );">Total debt principal</a></td>
<td class="nump">$ 52,753<span></span>
</td>
<td class="nump">$ 56,743<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LongtermDebtGrossAndLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Gross And Lease Obligation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LongtermDebtGrossAndLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224239457040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Agreements - Short-term Borrowings (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable', window );">Federal home loan bank advances maximum amount available</a></td>
<td class="nump">$ 915,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Back-Up Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.03%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility, Expiring May 16, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility, Expiring May 11, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility, Expiring May 16, 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_FederalHomeLoanBankAdvancesMember', window );">Federal Home Loan Bank Advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of maximum advances or credit lines available from the Federal Home Loan Bank (FHLB).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13(3)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6479118&amp;loc=d3e64650-112822<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22 (b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_BackUpCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_BackUpCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_RevolvingCreditFacilityExpiringMay162025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_RevolvingCreditFacilityExpiringMay162025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_RevolvingCreditFacilityExpiringMay112026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_RevolvingCreditFacilityExpiringMay112026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_RevolvingCreditFacilityExpiringMay162027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_RevolvingCreditFacilityExpiringMay162027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_FederalHomeLoanBankAdvancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_FederalHomeLoanBankAdvancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224238167152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Agreements - Long-term Borrowings (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="8">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 18, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Redeemed principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,211,000,000<span></span>
</td>
<td class="nump">$ 10,254,000,000<span></span>
</td>
<td class="nump">$ 15,631,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from debt</a></td>
<td class="nump">$ 987,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities', window );">Payments for derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Loss on net cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost', window );">Premium paid in excess of debt principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000,000<span></span>
</td>
<td class="nump">$ 332,000,000<span></span>
</td>
<td class="nump">$ 619,000,000<span></span>
</td>
<td class="nump">$ 706,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Write off of deferred debt issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="nump">26,000,000<span></span>
</td>
<td class="nump">45,000,000<span></span>
</td>
<td class="nump">47,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DebtExtinguishmentFees', window );">Debt extinguishment fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 89,000,000<span></span>
</td>
<td class="nump">$ 363,000,000<span></span>
</td>
<td class="nump">674,000,000<span></span>
</td>
<td class="nump">766,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 452,000,000<span></span>
</td>
<td class="nump">$ 1,440,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.5% senior notes due July 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Redeemed principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.75% senior notes due November 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Redeemed principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.75% senior notes due December 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Redeemed principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.75% senior notes due December 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Redeemed principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 399,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.125% senior notes due September 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.625% senior notes due April 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.625%<span></span>
</td>
<td class="nump">3.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.75% senior notes due April 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due April 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.25% senior notes due April 2050</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.7% senior notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.3% senior notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Outstanding Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000,000<span></span>
</td>
<td class="nump">$ 6,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4% senior notes due December 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,000,000<span></span>
</td>
<td class="nump">$ 723,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.7% senior notes due March 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000,000<span></span>
</td>
<td class="nump">$ 2,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.1% senior notes due March 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.3% senior notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtExtinguishmentFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Extinguishment Fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtExtinguishmentFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3505-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForDerivativeInstrumentFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueJuly2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueJuly2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueNovember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueNovember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueDecember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueDecember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueDecember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueDecember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2Point125PercentDueSeptember2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2Point125PercentDueSeptember2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3Point625PercentApril2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3Point625PercentApril2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3Point75PercentApril2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3Point75PercentApril2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4Point125PercentApril2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4Point125PercentApril2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4Point25PercentApril2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4Point25PercentApril2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3Point70PercentDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3Point70PercentDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4PointThreePercentDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4PointThreePercentDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_OutstandingSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_OutstandingSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.7DueMarch2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.7DueMarch2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes43Due2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes43Due2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224247542560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Defined contribution plan, employer contributions</a></td>
<td class="nump">$ 567<span></span>
</td>
<td class="nump">$ 552<span></span>
</td>
<td class="nump">$ 520<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution', window );">Multiemployer plans, plan contributions</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation</a></td>
<td class="nump">4,740<span></span>
</td>
<td class="nump">6,009<span></span>
</td>
<td class="nump">6,462<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="num">$ (173)<span></span>
</td>
<td class="num">(186)<span></span>
</td>
<td class="num">(218)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target investment allocations</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target investment allocations</a></td>
<td class="nump">77.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Real estate investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target investment allocations</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Private equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target investment allocations</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Hedge fund investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target investment allocations</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution', window );">Multiemployer plans, plan contributions</a></td>
<td class="nump">$ 62<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation</a></td>
<td class="nump">159<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by multiemployer pension plan from all employers participating in multiemployer pension plan determined to be individually insignificant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=SL14450678-114947<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MultiemployerPlanPensionInsignificantPlanContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_PrivateEquityFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_PrivateEquityFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224247569328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits - Benefit Obligations and Plan Assets (Details) - Pension Plan - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in benefit obligation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation, beginning of year</a></td>
<td class="nump">$ 6,009<span></span>
</td>
<td class="nump">$ 6,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="nump">$ 168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial gain</a></td>
<td class="num">(1,011)<span></span>
</td>
<td class="num">(102)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefit payments</a></td>
<td class="num">(387)<span></span>
</td>
<td class="num">(408)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement', window );">Settlements</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation, end of year</a></td>
<td class="nump">4,740<span></span>
</td>
<td class="nump">6,009<span></span>
</td>
<td class="nump">6,462<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Beginning balance</a></td>
<td class="nump">6,677<span></span>
</td>
<td class="nump">6,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="num">(968)<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefit payments</a></td>
<td class="num">(387)<span></span>
</td>
<td class="num">(408)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlements</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Ending balance</a></td>
<td class="nump">5,346<span></span>
</td>
<td class="nump">6,677<span></span>
</td>
<td class="nump">$ 6,845<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="nump">606<span></span>
</td>
<td class="nump">668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract', window );"><strong>Assets (liabilities) recognized on the consolidated balance sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Noncurrent assets reflected in other assets</a></td>
<td class="nump">827<span></span>
</td>
<td class="nump">946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities reflected in accrued expenses</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Noncurrent liabilities reflected in other long-term liabilities</a></td>
<td class="num">(197)<span></span>
</td>
<td class="num">(250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Net assets</a></td>
<td class="nump">$ 606<span></span>
</td>
<td class="nump">$ 668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases benefit obligation of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract. Excludes decreases to benefit obligation for remeasurement due to settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(8)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224238996528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits - Net Periodic Benefit Cost (Income) (Details) - Pension Plan - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Components of net periodic benefit cost (income):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">$ 132<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
<td class="nump">$ 168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(309)<span></span>
</td>
<td class="num">(317)<span></span>
</td>
<td class="num">(388)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of net actuarial loss</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlement losses</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost (income)</a></td>
<td class="num">$ (173)<span></span>
</td>
<td class="num">$ (186)<span></span>
</td>
<td class="num">$ (218)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224249409504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits - Weighted Average Assumptions Used (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract', window );"><strong>Assumptions used to determine benefit obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">5.20%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Assumptions used to determine net benefit costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.30%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected long-term rate of return on plan assets</a></td>
<td class="nump">4.80%<span></span>
</td>
<td class="nump">4.80%<span></span>
</td>
<td class="nump">6.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224236592192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits - Fair Value of Pension Plan Assets (Details) - Pension Plan - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 5,346<span></span>
</td>
<td class="nump">$ 6,677<span></span>
</td>
<td class="nump">$ 6,845<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">4,299<span></span>
</td>
<td class="nump">5,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">749<span></span>
</td>
<td class="nump">1,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">3,225<span></span>
</td>
<td class="nump">3,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">325<span></span>
</td>
<td class="nump">378<span></span>
</td>
<td class="nump">343<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Cash and cash equivalents | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Cash and cash equivalents | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Cash and cash equivalents | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Cash and cash equivalents | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Debt securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">3,403<span></span>
</td>
<td class="nump">4,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Debt securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">566<span></span>
</td>
<td class="nump">1,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Debt securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2,837<span></span>
</td>
<td class="nump">3,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Debt securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. government securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">570<span></span>
</td>
<td class="nump">1,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. government securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">566<span></span>
</td>
<td class="nump">1,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. government securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. government securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">States, municipalities and political subdivisions | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">States, municipalities and political subdivisions | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">States, municipalities and political subdivisions | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">States, municipalities and political subdivisions | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. corporate securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2,611<span></span>
</td>
<td class="nump">2,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. corporate securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. corporate securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2,611<span></span>
</td>
<td class="nump">2,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. corporate securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Residential mortgage-backed securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Residential mortgage-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Residential mortgage-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Residential mortgage-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Commercial mortgage-backed securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Commercial mortgage-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Commercial mortgage-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Commercial mortgage-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other asset-backed securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other asset-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other asset-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other asset-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Redeemable preferred securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Redeemable preferred securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Redeemable preferred securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Redeemable preferred securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Equity securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Equity securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Equity securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Equity securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. domestic | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. domestic | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. domestic | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. domestic | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">International | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">International | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">International | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">International | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Domestic real estate | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Domestic real estate | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Domestic real estate | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Domestic real estate | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other investments | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">632<span></span>
</td>
<td class="nump">788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other investments | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other investments | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other investments | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">325<span></span>
</td>
<td class="nump">378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Real estate | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">325<span></span>
</td>
<td class="nump">378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Real estate | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Real estate | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Real estate | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">325<span></span>
</td>
<td class="nump">378<span></span>
</td>
<td class="nump">$ 343<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Common/collective trusts | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Common/collective trusts | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Common/collective trusts | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Common/collective trusts | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Common/collective trusts, Equity Securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount', window );">Plan assets, investment within plan asset category, amount</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Common/collective trusts, Debt Securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount', window );">Plan assets, investment within plan asset category, amount</a></td>
<td class="nump">203<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other receivables | Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">390<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Private equity investments | Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">432<span></span>
</td>
<td class="nump">583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Hedge fund investments | Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 225<span></span>
</td>
<td class="nump">$ 237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment within defined benefit plan asset category.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_RedeemablePreferredSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_RedeemablePreferredSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_EquitySecuritiesDomesticRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_EquitySecuritiesDomesticRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_PrivateEquityFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_PrivateEquityFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224248761216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits - Changes in Level 3 Pension Plan Assets (Details) - Pension Plan - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Beginning balance</a></td>
<td class="nump">$ 6,677<span></span>
</td>
<td class="nump">$ 6,845<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Ending balance</a></td>
<td class="nump">5,346<span></span>
</td>
<td class="nump">6,677<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Beginning balance</a></td>
<td class="nump">378<span></span>
</td>
<td class="nump">343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld', window );">Actual return on plan assets</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements', window );">Purchases, sales and settlements</a></td>
<td class="num">(74)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels', window );">Transfers out of Level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Ending balance</a></td>
<td class="nump">325<span></span>
</td>
<td class="nump">378<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanRealEstateMember', window );">Real estate | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Beginning balance</a></td>
<td class="nump">378<span></span>
</td>
<td class="nump">343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld', window );">Actual return on plan assets</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements', window );">Purchases, sales and settlements</a></td>
<td class="num">(74)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels', window );">Transfers out of Level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Ending balance</a></td>
<td class="nump">$ 325<span></span>
</td>
<td class="nump">$ 378<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan from actual return (loss) on assets still held.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)(A)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, measured using unobservable input, of increase (decrease) in plan asset of defined benefit plan from purchase, sale and settlement of trade associated with underlying investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)(B)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan, for assets transferred into (out of) Level 3 of fair value hierarchy. Includes, but is not limited to, transfer due to change in observability of significant inputs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)(C)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224248802784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits - Defined Benefit Plans Expected Benefit (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2024</a></td>
<td class="nump">369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2025</a></td>
<td class="nump">372<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2026</a></td>
<td class="nump">369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2027</a></td>
<td class="nump">367<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2028-2032</a></td>
<td class="nump">1,776<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2023</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2024</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2025</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2026</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2027</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2028-2032</a></td>
<td class="nump">$ 59<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224243241648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Tax Provision (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 2,803<span></span>
</td>
<td class="nump">$ 2,285<span></span>
</td>
<td class="nump">$ 2,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">735<span></span>
</td>
<td class="nump">665<span></span>
</td>
<td class="nump">518<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current taxes</a></td>
<td class="nump">3,538<span></span>
</td>
<td class="nump">2,950<span></span>
</td>
<td class="nump">3,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(1,526)<span></span>
</td>
<td class="num">(282)<span></span>
</td>
<td class="num">(450)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(503)<span></span>
</td>
<td class="num">(120)<span></span>
</td>
<td class="num">(114)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred income taxes</a></td>
<td class="num">(2,029)<span></span>
</td>
<td class="num">(402)<span></span>
</td>
<td class="num">(564)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">$ 1,509<span></span>
</td>
<td class="nump">$ 2,548<span></span>
</td>
<td class="nump">$ 2,569<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224236073392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Effective Tax Rate Reconciliation (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Effective Income Tax Rate Reconciliation, Amount [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal tax benefit</a></td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_HealthInsurerFeeTaxEffectPercent', window );">Health insurer fee</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent', window );">Legal charges</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness', window );">Basis difference upon disposition of subsidiary</a></td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(1.20%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic', window );">Prior year refunds and unrecognized tax benefits</a></td>
<td class="num">(2.60%)<span></span>
</td>
<td class="num">(1.20%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(0.70%)<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">25.90%<span></span>
</td>
<td class="nump">24.20%<span></span>
</td>
<td class="nump">26.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal Charges, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthInsurerFeeTaxEffectPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the tax effect of the health care reform's non-tax deductible health insurer fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthInsurerFeeTaxEffectPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to disposition of a business not qualifying as a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to domestic income tax settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224239370864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred income tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent', window );">Lease and rents</a></td>
<td class="nump">$ 5,242<span></span>
</td>
<td class="nump">$ 5,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements', window );">Legal charges</a></td>
<td class="nump">1,260<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation', window );">Employee benefits</a></td>
<td class="nump">153<span></span>
</td>
<td class="nump">193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances', window );">Bad debts and other allowances</a></td>
<td class="nump">480<span></span>
</td>
<td class="nump">489<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss and capital loss carryforwards</a></td>
<td class="nump">266<span></span>
</td>
<td class="nump">416<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred income</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves', window );">Insurance reserves</a></td>
<td class="nump">319<span></span>
</td>
<td class="nump">662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInvestments', window );">Investments</a></td>
<td class="nump">293<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DeferredTaxAssetsPayrollTaxDeferral', window );">Payroll tax deferral</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">335<span></span>
</td>
<td class="nump">377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(532)<span></span>
</td>
<td class="num">(325)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred income tax assets</a></td>
<td class="nump">7,985<span></span>
</td>
<td class="nump">7,658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred income tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DeferredTaxLiabilitiesRetirementBenefits', window );">Retirement benefits</a></td>
<td class="num">(92)<span></span>
</td>
<td class="num">(105)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesInvestments', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(340)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Lease and rents</a></td>
<td class="num">(4,639)<span></span>
</td>
<td class="num">(4,947)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(7,139)<span></span>
</td>
<td class="num">(8,381)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred income tax liabilities</a></td>
<td class="num">(11,870)<span></span>
</td>
<td class="num">(13,773)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred income tax liabilities</a></td>
<td class="num">(3,885)<span></span>
</td>
<td class="num">$ (6,115)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred income tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred income tax assets</a></td>
<td class="nump">$ 131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DeferredTaxAssetsPayrollTaxDeferral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Payroll Tax Deferral</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DeferredTaxAssetsPayrollTaxDeferral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Bad Debts And Other Allowances</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Depreciation and Amortization - Amount of deferred tax liability attributable to taxable temporary differences from depreciation and amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DeferredTaxLiabilitiesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DeferredTaxLiabilitiesRetirementBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Retirement Benefits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DeferredTaxLiabilitiesRetirementBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred rent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the estimated loss from legal settlements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224239355040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">$ 532<span></span>
</td>
<td class="nump">$ 325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss and capital loss carryforwards</a></td>
<td class="nump">266<span></span>
</td>
<td class="nump">416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Income tax penalties and interest expense</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Income tax penalties and interest accrued</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">$ 151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">$ 336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224248856704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning balance</a></td>
<td class="nump">$ 782<span></span>
</td>
<td class="nump">$ 768<span></span>
</td>
<td class="nump">$ 655<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions based on tax positions related to the current year</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions based on tax positions related to prior years</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Reductions for tax positions of prior years</a></td>
<td class="num">(166)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Expiration of statutes of limitation</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements</a></td>
<td class="num">(213)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending balance</a></td>
<td class="nump">$ 446<span></span>
</td>
<td class="nump">$ 782<span></span>
</td>
<td class="nump">$ 768<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224246032912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans - Stock-Based Compensation Expense and ESPP (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 28, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 447<span></span>
</td>
<td class="nump">$ 484<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued employee stock purchase plan (in shares)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased', window );">Average purchase price of shares purchased (in dollars per share)</a></td>
<td class="nump">$ 78.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember', window );">Restricted Stock Units and Performance Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 369<span></span>
</td>
<td class="nump">404<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Compensation not yet recognized, other than options</a></td>
<td class="nump">$ 619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation not yet recognized, period for recognition</a></td>
<td class="text">2 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Vested in period, fair value</a></td>
<td class="nump">$ 328<span></span>
</td>
<td class="nump">406<span></span>
</td>
<td class="nump">229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cvs_EmployeeStockOptionsAndStockAppreciationRightsMember', window );">Employee Stock Options and Stock Appreciation Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 78<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation not yet recognized, period for recognition</a></td>
<td class="text">1 year 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Compensation not yet recognized, options</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber', window );">Expected to vest (in shares)</a></td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="nump">60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares)</a></td>
<td class="nump">29,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock percent</a></td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">Stock Appreciation Rights (SARs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cvs_CVSHealth2017IncentiveCompensationPlanMember', window );">CVS Health 2017 Incentive Compensation Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="nump">58,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares)</a></td>
<td class="nump">21,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cvs_AetnaInc2010StockIncentivePlanMember', window );">Aetna Inc 2010 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Capital shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Employee Stock Purchase Plan, Average Purchase Price of Shares Purchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cvs_EmployeeStockOptionsAndStockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cvs_EmployeeStockOptionsAndStockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cvs_CVSHealth2017IncentiveCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cvs_CVSHealth2017IncentiveCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cvs_AetnaInc2010StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cvs_AetnaInc2010StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224244560768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans - Restricted Stock Activity (Details) - Restricted Stock Units and Performance Share Units<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at beginning of period (in shares)</a></td>
<td class="nump">14,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">5,398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(5,626)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(1,421)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at end of period (in shares)</a></td>
<td class="nump">12,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted average grant date fair value (in dollars per share)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at beginning of year (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 63.02<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">101.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">58.28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">72.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at end of year (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 80.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates', window );">Restricted stock units and performance stock units vested if actual payout rates are applied (in shares)</a></td>
<td class="nump">8,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested In Period, Actual Payout Rates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224252714192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans - Stock Option and SAR Activity (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Cash received from stock options exercised (including ESPP)</a></td>
<td class="nump">$ 551,000<span></span>
</td>
<td class="nump">$ 549,000<span></span>
</td>
<td class="nump">$ 264,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for taxes for net share settlement of equity awards</a></td>
<td class="nump">$ 370,000<span></span>
</td>
<td class="nump">168,000<span></span>
</td>
<td class="nump">88,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member', window );">Stock options granted through 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member', window );">Stock options granted subsequent to 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">Stock Appreciation Rights (SARs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cvs_EmployeeStockOptionsAndStockAppreciationRightsMember', window );">Employee Stock Options and Stock Appreciation Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Cash received from stock options exercised (including ESPP)</a></td>
<td class="nump">$ 551,000<span></span>
</td>
<td class="nump">549,000<span></span>
</td>
<td class="nump">264,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for taxes for net share settlement of equity awards</a></td>
<td class="nump">370,000<span></span>
</td>
<td class="nump">168,000<span></span>
</td>
<td class="nump">88,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of stock options and SARs exercised</a></td>
<td class="nump">118,000<span></span>
</td>
<td class="nump">105,000<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue', window );">Fair value of stock options and SARs vested</a></td>
<td class="nump">$ 219,000<span></span>
</td>
<td class="nump">$ 224,000<span></span>
</td>
<td class="nump">$ 252,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares, Outstanding at beginning of year (in shares)</a></td>
<td class="nump">19,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares granted (in shares)</a></td>
<td class="nump">1,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares exercised (in shares)</a></td>
<td class="num">(4,921)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Shares forfeited (in shares)</a></td>
<td class="num">(478)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Shares expired (in shares)</a></td>
<td class="num">(615)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares, Outstanding at end of year (in shares)</a></td>
<td class="nump">15,040<span></span>
</td>
<td class="nump">19,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, outstanding at beginning of year ($ per share)</a></td>
<td class="nump">$ 71.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, granted ($ per share)</a></td>
<td class="nump">101.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, exercised ($ per share)</a></td>
<td class="nump">75.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, forfeited ($ per share)</a></td>
<td class="nump">70.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, expired ($ per share)</a></td>
<td class="nump">99.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, outstanding at end of year ($ per share)</a></td>
<td class="nump">$ 73.15<span></span>
</td>
<td class="nump">$ 71.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average contractual term, outstanding at end of year</a></td>
<td class="text">4 years 6 months 7 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic value outstanding at end of year</a></td>
<td class="nump">$ 340,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Shares exercisable at end of year (in shares)</a></td>
<td class="nump">7,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price exercisable at end of year ($ per share)</a></td>
<td class="nump">$ 72.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term exercisable at end of year</a></td>
<td class="text">2 years 9 months 3 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value exercisable at end of year</a></td>
<td class="nump">$ 184,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Shares vested at end of year and expected to vest in the future (in shares)</a></td>
<td class="nump">14,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price vested at end of year and expected to vest in the future ($ per share)</a></td>
<td class="nump">$ 72.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term vested at end of year and expected to vest in the future</a></td>
<td class="text">4 years 5 months 19 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value vested at end of year and expected to vest in the future</a></td>
<td class="nump">$ 336,664<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Equity Instruments Other Than Options, Vested In Period, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cvs_EmployeeStockOptionsAndStockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cvs_EmployeeStockOptionsAndStockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224239195424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans - Valuation Assumptions (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">1.12%<span></span>
</td>
<td class="nump">1.34%<span></span>
</td>
<td class="nump">1.46%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">23.54%<span></span>
</td>
<td class="nump">25.27%<span></span>
</td>
<td class="nump">37.21%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.42%<span></span>
</td>
<td class="nump">0.08%<span></span>
</td>
<td class="nump">0.81%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 16.25<span></span>
</td>
<td class="nump">$ 12.55<span></span>
</td>
<td class="nump">$ 13.85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">2.18%<span></span>
</td>
<td class="nump">2.68%<span></span>
</td>
<td class="nump">3.42%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">27.34%<span></span>
</td>
<td class="nump">27.10%<span></span>
</td>
<td class="nump">25.22%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">2.46%<span></span>
</td>
<td class="nump">1.13%<span></span>
</td>
<td class="nump">0.61%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 24.15<span></span>
</td>
<td class="nump">$ 14.57<span></span>
</td>
<td class="nump">$ 8.78<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224247607568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Share Repurchases (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 17, 2022</div></th>
<th class="th"><div>Dec. 09, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchased during the period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2022RepurchaseProgramMember', window );">2022 Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount</a></td>
<td class="nump">$ 10,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember', window );">2021 Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount</a></td>
<td class="nump">$ 6,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchased during the period (in shares)</a></td>
<td class="nump">34,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock repurchased during period, value</a></td>
<td class="nump">$ 3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2022RepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=cvs_A2022RepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224245899760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders' Equity - Accelerated Share Repurchases (Details) - 2021 Repurchase Program - USD ($)<br> $ / shares in Units, shares in Millions, $ in Billions</strong></div></th>
<th class="th"><div>Jan. 04, 2023</div></th>
<th class="th"><div>Jan. 04, 2022</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember', window );">Citibank, N.A. | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesAgreementAmount', window );">ASR agreement, amount</a></td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PaymentsForAcceleratedShareRepurchasesAmount', window );">Payments for ASR, amount</a></td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares', window );">ASR percent of notional amount received in shares</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased', window );">Shares repurchased under ASR agreement (in shares)</a></td>
<td class="nump">17.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share)</a></td>
<td class="nump">$ 92.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram', window );">ASR, shares to be received at the end of program as a percent of notional amount</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares', window );">ASR, maximum amount of shares received or delivered</a></td>
<td class="nump">43.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember', window );">Barclays Bank</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesAgreementAmount', window );">ASR agreement, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PaymentsForAcceleratedShareRepurchasesAmount', window );">Payments for ASR, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares', window );">ASR percent of notional amount received in shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased', window );">Shares repurchased under ASR agreement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.6<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 103.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram', window );">ASR, shares to be received at the end of program as a percent of notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_TransferOfSharesToTreasuryStockValue', window );">Transfer of shares to treasury stock value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember', window );">Barclays Bank | Forward Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Forward contract, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchase Program, Maximum Number Of Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AcceleratedShareRepurchasesAgreementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases Agreement, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AcceleratedShareRepurchasesAgreementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Number Of Shares Repurchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Percent Of Notional Amount In Shares To Be Received At End Of Program</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Percent Of Notional Amount Received In Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PaymentsForAcceleratedShareRepurchasesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Accelerated Share Repurchases, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PaymentsForAcceleratedShareRepurchasesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TransferOfSharesToTreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transfer Of Shares To Treasury Stock Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TransferOfSharesToTreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cvs_CitibankNAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cvs_CitibankNAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cvs_BarclaysBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cvs_BarclaysBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224246023952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders' Equity - Dividends (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Cash dividend declared (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent', window );">Quarterly dividends declared, percent increase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Cash dividend declared (USD per share)</a></td>
<td class="nump">$ 0.605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dividends Payable, Quarterly Dividends Declared, Increase Amount, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share amount of a dividend declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224246640112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Regulatory Requirements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesLineItems', window );"><strong>Statutory Accounting Practices [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired', window );">Estimated minimum statutory surplus required by regulators</a></td>
<td class="nump">$ 7,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldByInsuranceRegulators', window );">Investments on deposit with regulatory bodies</a></td>
<td class="nump">652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval', window );">Estimated maximum dividend distributions permitted in 2023 without prior regulatory approval</a></td>
<td class="nump">2,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=cvs_InsuranceAndHMOMember', window );">Insurance and HMO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesLineItems', window );"><strong>Statutory Accounting Practices [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount', window );">Statutory net income</a></td>
<td class="nump">2,851<span></span>
</td>
<td class="nump">$ 3,302<span></span>
</td>
<td class="nump">$ 3,667<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance', window );">Estimated statutory capital and surplus</a></td>
<td class="nump">15,503<span></span>
</td>
<td class="nump">$ 14,879<span></span>
</td>
<td class="nump">$ 13,238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries', window );">Dividends paid</a></td>
<td class="nump">$ 3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldByInsuranceRegulators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of cash and investment securities on deposit with state regulatory authorities in connection with capital requirements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123600598&amp;loc=SL75763979-209797<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldByInsuranceRegulators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents disclosure of the aggregate cash dividends paid to the entity by consolidated subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of dividends that can be declared or paid without approval of regulatory agency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24708-158529<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24708-158529<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net income for the period determined using accounting principles prescribed or permitted by insurance regulators.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cvs_InsuranceAndHMOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cvs_InsuranceAndHMOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R121.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224332587520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders' Equity - Noncontrolling Interests (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 306<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R122.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224246350672">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,841<span></span>
</td>
<td class="nump">$ 69,701<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 64,170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,598)<span></span>
</td>
<td class="num">(314)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">395<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,769<span></span>
</td>
<td class="nump">74,841<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">69,701<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(766)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(766)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Net unrealized investment gains (losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">798<span></span>
</td>
<td class="nump">1,214<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">774<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,556)<span></span>
</td>
<td class="num">(530)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">415<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss), net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,317)<span></span>
</td>
<td class="num">(556)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">440<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,519)<span></span>
</td>
<td class="nump">798<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,214<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before reclassifications, pre-tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,021)<span></span>
</td>
<td class="num">(644)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">497<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">31<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Net unrealized investment gains (losses) | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">140<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax', window );">Adoption of new accounting standard, pre-tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">181<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember', window );">Change in discount rate on long-duration insurance reserves</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(651)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">870<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">870<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="num">(651)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before reclassifications, pre-tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,126<span></span>
</td>
<td class="nump">328<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember', window );">Change in discount rate on long-duration insurance reserves | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(906)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(906)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax', window );">Adoption of new accounting standard, pre-tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,166)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign currency translation adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember', window );">Net cash flow hedges</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">279<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss), net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(26)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(31)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">248<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before reclassifications, pre-tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(35)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Amount expected to be reclassified</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Pension and other postretirement benefits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(38)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(170)<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(22)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss), net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(168)<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(17)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(203)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(55)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before reclassifications, pre-tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(229)<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(30)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">AOCI Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">334<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,019<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,264)<span></span>
</td>
<td class="nump">334<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,414<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">AOCI Including Portion Attributable to Noncontrolling Interest | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(766)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (766)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzk4OTU2MDQ2NTA5OTM_e949208d-ec5c-442c-bfb1-60608d2297f0">ASU 2018-12</span>, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Topic 944) during the year ended December 31, 2021. See Note 8 &#8216;&#8216;Other Insurance Liabilities and Separate Accounts&#8217;&#8217; for additional information.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3OA_50a38f39-24c9-439d-81f9-601a8eefa8a4">Accounting Standards Update (&#8220;ASU&#8221;) 2016-13</span>, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Topic 326), which resulted in a reduction to retained earnings of $3&#160;million during the year ended December 31, 2020.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stockholders' Equity, Including Portion Attributable To Noncontrolling Interest, Pretax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R123.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224242986336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NumeratorForEarningsPerShareCalculationAbstract', window );"><strong>Numerator for earnings per share calculation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income from continuing operations</a></td>
<td class="nump">$ 4,327<span></span>
</td>
<td class="nump">$ 7,989<span></span>
</td>
<td class="nump">$ 7,201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net (income) loss attributable to noncontrolling interests</a></td>
<td class="num">(16)<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income from continuing operations attributable to CVS Health</a></td>
<td class="nump">$ 4,311<span></span>
</td>
<td class="nump">$ 8,001<span></span>
</td>
<td class="nump">$ 7,188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DenominatorForEarningsPerShareCalculationAbstract', window );"><strong>Denominator for earnings per share calculation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares, basic (in shares)</a></td>
<td class="nump">1,312<span></span>
</td>
<td class="nump">1,319<span></span>
</td>
<td class="nump">1,309<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares, diluted (in shares)</a></td>
<td class="nump">1,323<span></span>
</td>
<td class="nump">1,329<span></span>
</td>
<td class="nump">1,314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_EarningsPerShareBasicAndDilutedEPSAbstract', window );"><strong>Earnings per share from continuing operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Earnings per share from continuing operations, basic (USD per share)</a></td>
<td class="nump">$ 3.29<span></span>
</td>
<td class="nump">$ 6.07<span></span>
</td>
<td class="nump">$ 5.49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Earnings per share from continuing operations, diluted (USD per share)</a></td>
<td class="nump">$ 3.26<span></span>
</td>
<td class="nump">$ 6.02<span></span>
</td>
<td class="nump">$ 5.47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvs_StockOptionsAndStockAppreciationRightsMember', window );">Stock Options and Stock Appreciation Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of EPS (in shares)</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DenominatorForEarningsPerShareCalculationAbstract', window );"><strong>Denominator for earnings per share calculation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember', window );">Restricted Stock Units (RSUs) and Performance Stock Units (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_DenominatorForEarningsPerShareCalculationAbstract', window );"><strong>Denominator for earnings per share calculation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DenominatorForEarningsPerShareCalculationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Denominator For Earnings Per Share Calculation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DenominatorForEarningsPerShareCalculationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_EarningsPerShareBasicAndDilutedEPSAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share, Basic And Diluted EPS</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_EarningsPerShareBasicAndDilutedEPSAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumeratorForEarningsPerShareCalculationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Numerator For Earnings Per Share Calculation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumeratorForEarningsPerShareCalculationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvs_StockOptionsAndStockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvs_StockOptionsAndStockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R124.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224251875248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reinsurance - Narrative (Details) - Subsequent Event<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jan. 31, 2023 </div>
<div>reinsurance_agreement</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer', window );">Term of reinsurance agreements with unrelated issuer</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NumberofReinsuranceContractsEnteredInto', window );">Number of reinsurance contracts entered into</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This line item represents the four years of a reinsurance agreement with an unrelated insurer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberofReinsuranceContractsEnteredInto">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of reinsurance contracts entered into with an unrelated insurer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberofReinsuranceContractsEnteredInto</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R125.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224243247440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Reinsurance - Reinsurance Recoverables (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses', window );">Total reinsurance recoverables</a></td>
<td class="nump">$ 2,250<span></span>
</td>
<td class="nump">$ 2,564<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskAxis=cvs_HartfordLifeAndAccidentInsuranceCompanyMember', window );">Hartford Life and Accident Insurance Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses', window );">Total reinsurance recoverables</a></td>
<td class="nump">1,549<span></span>
</td>
<td class="nump">1,902<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskAxis=cvs_LincolnLifeAnnuityCompanyOfNewYorkMember', window );">Lincoln Life &amp; Annuity Company of New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses', window );">Total reinsurance recoverables</a></td>
<td class="nump">385<span></span>
</td>
<td class="nump">395<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskAxis=cvs_VOYARetirementInsuranceAndAnnuityCompanyMember', window );">VOYA Retirement Insurance and Annuity Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses', window );">Total reinsurance recoverables</a></td>
<td class="nump">159<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskAxis=cvs_FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember', window );">Fresenius Medical Care Reinsurance Company (Cayman) Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses', window );">Total reinsurance recoverables</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskAxis=cvs_AllOtherReinsurersMember', window );">All Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses', window );">Total reinsurance recoverables</a></td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, policy benefits and policy reserves. Excludes premiums paid under reinsurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21409-158489<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123600520&amp;loc=SL75241803-196195<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=cvs_HartfordLifeAndAccidentInsuranceCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=cvs_HartfordLifeAndAccidentInsuranceCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=cvs_LincolnLifeAnnuityCompanyOfNewYorkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=cvs_LincolnLifeAnnuityCompanyOfNewYorkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=cvs_VOYARetirementInsuranceAndAnnuityCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=cvs_VOYARetirementInsuranceAndAnnuityCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=cvs_FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=cvs_FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=cvs_AllOtherReinsurersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=cvs_AllOtherReinsurersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R126.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224243867472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reinsurance - Effects of Reinsurance (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract', window );"><strong>Premiums Earned, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DirectPremiumsEarned', window );">Direct</a></td>
<td class="nump">$ 85,670<span></span>
</td>
<td class="nump">$ 76,320<span></span>
</td>
<td class="nump">$ 69,711<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssumedPremiumsEarned', window );">Assumed</a></td>
<td class="nump">432<span></span>
</td>
<td class="nump">492<span></span>
</td>
<td class="nump">478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededPremiumsEarned', window );">Ceded</a></td>
<td class="num">(772)<span></span>
</td>
<td class="num">(680)<span></span>
</td>
<td class="num">(825)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Net premiums</a></td>
<td class="nump">85,330<span></span>
</td>
<td class="nump">76,132<span></span>
</td>
<td class="nump">69,364<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract', window );"><strong>Policyholder Benefits and Claims Incurred, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross', window );">Direct</a></td>
<td class="nump">71,357<span></span>
</td>
<td class="nump">64,339<span></span>
</td>
<td class="nump">56,077<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed', window );">Assumed</a></td>
<td class="nump">379<span></span>
</td>
<td class="nump">398<span></span>
</td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded', window );">Ceded</a></td>
<td class="num">(663)<span></span>
</td>
<td class="num">(549)<span></span>
</td>
<td class="num">(727)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet', window );">Net benefit costs</a></td>
<td class="nump">$ 71,073<span></span>
</td>
<td class="nump">$ 64,188<span></span>
</td>
<td class="nump">$ 55,679<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssumedPremiumsEarned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of earned premiums assumed from other entities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column D))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssumedPremiumsEarned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededPremiumsEarned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of earned premiums ceded to other entities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column C))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84167274&amp;loc=d3e27175-158546<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededPremiumsEarned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectPremiumsEarned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DirectPremiumsEarned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6811-158387<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of policy benefits and costs incurred for policies assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6811-158387<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reduction of provision for policy benefits and costs incurred for policies ceded.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6811-158387<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R127.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224236143232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>lease </div>
<div>state</div>
</th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>lease </div>
<div>state</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>lease </div>
<div>state</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>claim</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsMaximumExposure', window );">Guarantor obligations, maximum exposure</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts', window );">Contractual obligations underlying the guaranteed benefits</a></td>
<td class="nump">$ 941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 941<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_GuarantorObligationsNumberOfLeases', window );">Guarantor obligations, number of leases | lease</a></td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Opioid litigation charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,803<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LitigationSettlementNumberOfStatesSubjectToEarlierSettlements', window );">Number of states subject to earlier settlements | state</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_FederalCourtInOhioJudgmentMember', window );">Federal Court in Ohio Judgment | Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Legal settlement awarded to other party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LegalSettlementPeriodOfPayment', window );">Legal settlement, period of payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_StateOfFloridaSettlementMember', window );">State of Florida Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LegalSettlementPeriodOfPayment', window );">Legal settlement, period of payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Opioid litigation charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Liability recorded in association with legal settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_SettlementFrameworkMember', window );">Settlement Framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Legal settlement awarded to other party</a></td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LegalSettlementPeriodOfPayment', window );">Legal settlement, period of payment</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Attorneys' fees and costs</a></td>
<td class="nump">$ 625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LitigationSettlementNumberOfStatesElectedToJoin', window );">Number of states that elected to join the settlement | state</a></td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_SettlementFrameworkMember', window );">Settlement Framework | Tribal Entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Legal settlement awarded to other party</a></td>
<td class="nump">$ 113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_LegalSettlementPeriodOfPayment', window );">Legal settlement, period of payment</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Attorneys' fees and costs</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember', window );">Settlement Framework and Other Opioid-Related Claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Opioid litigation charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
<td class="nump">$ 5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent', window );">Long-term liability recorded in association with legal settlement</a></td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember', window );">Settlement Framework and Other Opioid-Related Claims | Maximum | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Cash impact of litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_RadcliffAndFlaimVAetnaIncEtAlMember', window );">Radcliff and Flaim v Aetna Inc., et al | Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of claims | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the contractual obligation to maintain the required level of funding in Separate Accounts necessary to fund specific guaranteed pensions annuities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_GuarantorObligationsNumberOfLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guarantor Obligations, Number Of Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_GuarantorObligationsNumberOfLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LegalSettlementPeriodOfPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Legal Settlement, Period Of Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LegalSettlementPeriodOfPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LitigationSettlementNumberOfStatesElectedToJoin">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Number Of States Elected To Join</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LitigationSettlementNumberOfStatesElectedToJoin</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LitigationSettlementNumberOfStatesSubjectToEarlierSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Number Of States Subject To Earlier Settlements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LitigationSettlementNumberOfStatesSubjectToEarlierSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12069-110248<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_FederalCourtInOhioJudgmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_FederalCourtInOhioJudgmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_StateOfFloridaSettlementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_StateOfFloridaSettlementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_SettlementFrameworkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_SettlementFrameworkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cvs_TribalEntitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cvs_TribalEntitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_RadcliffAndFlaimVAetnaIncEtAlMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_RadcliffAndFlaimVAetnaIncEtAlMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R128.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224239519792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Retrospective Adjustments to Segment Composition (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 322,467<span></span>
</td>
<td class="nump">$ 292,111<span></span>
</td>
<td class="nump">$ 268,706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="nump">18,037<span></span>
</td>
<td class="nump">17,227<span></span>
</td>
<td class="nump">15,956<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">530<span></span>
</td>
<td class="nump">721<span></span>
</td>
<td class="nump">426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="num">(1,613)<span></span>
</td>
<td class="num">(1,635)<span></span>
</td>
<td class="num">(1,319)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(47,585)<span></span>
</td>
<td class="num">(46,241)<span></span>
</td>
<td class="num">(42,062)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">91,350<span></span>
</td>
<td class="nump">82,119<span></span>
</td>
<td class="nump">75,409<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="nump">6,338<span></span>
</td>
<td class="nump">5,110<span></span>
</td>
<td class="nump">6,135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember', window );">Health Services | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">169,576<span></span>
</td>
<td class="nump">153,892<span></span>
</td>
<td class="nump">141,354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="nump">6,781<span></span>
</td>
<td class="nump">6,492<span></span>
</td>
<td class="nump">5,128<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember', window );">Pharmacy &amp; Consumer Wellness | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">108,596<span></span>
</td>
<td class="nump">101,620<span></span>
</td>
<td class="nump">93,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="nump">6,531<span></span>
</td>
<td class="nump">7,260<span></span>
</td>
<td class="nump">6,012<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">322,467<span></span>
</td>
<td class="nump">292,111<span></span>
</td>
<td class="nump">268,706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="nump">17,532<span></span>
</td>
<td class="nump">17,312<span></span>
</td>
<td class="nump">16,008<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Reported | Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">530<span></span>
</td>
<td class="nump">721<span></span>
</td>
<td class="nump">426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="num">(1,785)<span></span>
</td>
<td class="num">(1,471)<span></span>
</td>
<td class="num">(1,306)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Reported | Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(45,302)<span></span>
</td>
<td class="num">(43,923)<span></span>
</td>
<td class="num">(40,323)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="num">(728)<span></span>
</td>
<td class="num">(711)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Reported | Health Care Benefits | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">91,409<span></span>
</td>
<td class="nump">82,186<span></span>
</td>
<td class="nump">75,467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="nump">5,984<span></span>
</td>
<td class="nump">5,012<span></span>
</td>
<td class="nump">6,188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Reported | Health Services | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">169,236<span></span>
</td>
<td class="nump">153,022<span></span>
</td>
<td class="nump">141,938<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="nump">7,356<span></span>
</td>
<td class="nump">6,859<span></span>
</td>
<td class="nump">5,688<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Reported | Pharmacy &amp; Consumer Wellness | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">106,594<span></span>
</td>
<td class="nump">100,105<span></span>
</td>
<td class="nump">91,198<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="nump">6,705<span></span>
</td>
<td class="nump">7,623<span></span>
</td>
<td class="nump">6,146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="nump">505<span></span>
</td>
<td class="num">(85)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustments | Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="nump">172<span></span>
</td>
<td class="num">(164)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustments | Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(2,283)<span></span>
</td>
<td class="num">(2,318)<span></span>
</td>
<td class="num">(1,739)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="nump">728<span></span>
</td>
<td class="nump">711<span></span>
</td>
<td class="nump">708<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustments | Health Care Benefits | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(59)<span></span>
</td>
<td class="num">(67)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="nump">354<span></span>
</td>
<td class="nump">98<span></span>
</td>
<td class="num">(53)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustments | Health Services | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">340<span></span>
</td>
<td class="nump">870<span></span>
</td>
<td class="num">(584)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="num">(575)<span></span>
</td>
<td class="num">(367)<span></span>
</td>
<td class="num">(560)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustments | Pharmacy &amp; Consumer Wellness | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems', window );"><strong>Segment Reporting, Other Significant Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,002<span></span>
</td>
<td class="nump">1,515<span></span>
</td>
<td class="nump">2,381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="num">$ (174)<span></span>
</td>
<td class="num">$ (363)<span></span>
</td>
<td class="num">$ (134)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AdjustedOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjusted Operating Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AdjustedOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R129.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224248048992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Narrative (Details) - Segment<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=cvs_USFederalGovernmentMember', window );">US Federal Government | Customer Concentration Risk | Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percent</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cvs_USFederalGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cvs_USFederalGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R130.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224243151136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">$ 321,629<span></span>
</td>
<td class="nump">$ 290,912<span></span>
</td>
<td class="nump">$ 267,908<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">838<span></span>
</td>
<td class="nump">1,199<span></span>
</td>
<td class="nump">798<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">322,467<span></span>
</td>
<td class="nump">292,111<span></span>
</td>
<td class="nump">268,706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">18,037<span></span>
</td>
<td class="nump">17,227<span></span>
</td>
<td class="nump">15,956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,224<span></span>
</td>
<td class="nump">4,486<span></span>
</td>
<td class="nump">4,441<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">90,798<span></span>
</td>
<td class="nump">81,457<span></span>
</td>
<td class="nump">74,871<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">476<span></span>
</td>
<td class="nump">586<span></span>
</td>
<td class="nump">483<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">91,350<span></span>
</td>
<td class="nump">82,119<span></span>
</td>
<td class="nump">75,409<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">6,338<span></span>
</td>
<td class="nump">5,110<span></span>
</td>
<td class="nump">6,135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,579<span></span>
</td>
<td class="nump">1,811<span></span>
</td>
<td class="nump">1,832<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">157,968<span></span>
</td>
<td class="nump">143,912<span></span>
</td>
<td class="nump">131,936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">169,576<span></span>
</td>
<td class="nump">153,892<span></span>
</td>
<td class="nump">141,354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">6,781<span></span>
</td>
<td class="nump">6,492<span></span>
</td>
<td class="nump">5,128<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">519<span></span>
</td>
<td class="nump">505<span></span>
</td>
<td class="nump">532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NetRevenuesRetailCoPayments', window );">Copayments</a></td>
<td class="nump">12,600<span></span>
</td>
<td class="nump">11,600<span></span>
</td>
<td class="nump">10,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy &amp; Consumer Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">72,739<span></span>
</td>
<td class="nump">65,418<span></span>
</td>
<td class="nump">60,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="num">(44)<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">108,596<span></span>
</td>
<td class="nump">101,620<span></span>
</td>
<td class="nump">93,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">6,531<span></span>
</td>
<td class="nump">7,260<span></span>
</td>
<td class="nump">6,012<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,889<span></span>
</td>
<td class="nump">1,955<span></span>
</td>
<td class="nump">1,881<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Intersegment revenues</a></td>
<td class="num">(47,585)<span></span>
</td>
<td class="num">(46,241)<span></span>
</td>
<td class="num">(42,062)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(47,585)<span></span>
</td>
<td class="num">(46,241)<span></span>
</td>
<td class="num">(42,062)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Intersegment revenues</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Health Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Intersegment revenues</a></td>
<td class="nump">11,608<span></span>
</td>
<td class="nump">9,980<span></span>
</td>
<td class="nump">9,418<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Pharmacy &amp; Consumer Wellness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Intersegment revenues</a></td>
<td class="nump">35,901<span></span>
</td>
<td class="nump">36,185<span></span>
</td>
<td class="nump">32,589<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income (loss)</a></td>
<td class="nump">406<span></span>
</td>
<td class="nump">596<span></span>
</td>
<td class="nump">315<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">530<span></span>
</td>
<td class="nump">721<span></span>
</td>
<td class="nump">426<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="num">(1,613)<span></span>
</td>
<td class="num">(1,635)<span></span>
</td>
<td class="num">(1,319)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 237<span></span>
</td>
<td class="nump">$ 215<span></span>
</td>
<td class="nump">$ 196<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AdjustedOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjusted Operating Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AdjustedOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NetRevenuesRetailCoPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Revenues, Retail CoPayments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NetRevenuesRetailCoPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R131.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140224252210656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>store</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (GAAP measure)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,954<span></span>
</td>
<td class="nump">$ 13,310<span></span>
</td>
<td class="nump">$ 13,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,785<span></span>
</td>
<td class="nump">2,233<span></span>
</td>
<td class="nump">2,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Net realized capital (gains) losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">320<span></span>
</td>
<td class="num">(176)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_OfficeRealEstateOptimizationCharges', window );">Office real estate optimization charges</a></td>
<td class="nump">$ 117<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on divestiture of subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(475)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(269)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Opioid litigation charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,803<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Loss on assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,533<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Acquisition-related integration costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="nump">332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_StoreImpairmentCharges', window );">Store impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,358<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">431<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod', window );">Acquisition purchase price adjustments outside of measurement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries', window );">Receipt of fully reserved ACA risk corridor receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(307)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,037<span></span>
</td>
<td class="nump">$ 17,227<span></span>
</td>
<td class="nump">15,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_NumberOfStoresPlannedClosure', window );">Number of stores, planned closure | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember', window );">U.S. Department of Health and Human Services, ACA Risk Corridor Receivables | Settled Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainContingencyUnrecordedAmount', window );">Gain contingency, unrecorded amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313<span></span>
</td>
<td class="nump">$ 313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax', window );">Former gain contingency, recognized in current period, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AdjustedOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjusted Operating Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AdjustedOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Purchase Price Adjustment, Outside Of Measurement Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Gain Contingency, Recognized In Current Period, Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfStoresPlannedClosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Stores, Planned Closure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfStoresPlannedClosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OfficeRealEstateOptimizationCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Office Real Estate Optimization Charges - Related to the abandonment of leased real estate and the related right-of-use assets and property and equipment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OfficeRealEstateOptimizationCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_StoreImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Store Impairment Charges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_StoreImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in allowance for credit loss on accounts receivable, from recovery.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingencyUnrecordedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount or range of possible amounts of gain that could be realized upon the resolution of a contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6397426&amp;loc=d3e17499-108355<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingencyUnrecordedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>cvs-20230525_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cvs="http://www.cvshealth.com/20230525"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cvs-20230525.xsd" xlink:type="simple"/>
    <context id="i3fdad821325f486399d0038fd579bc16_D20230525-20230525">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2023-05-25</startDate>
            <endDate>2023-05-25</endDate>
        </period>
    </context>
    <context id="i1c03b0b923c54303a8e4d6db0a6f037f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if380faf89f3a40dbaf2259ac9b4e1da0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i71272148942c413e8aff1c85d881ca42_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6714e63c7e1a4403b7da499509c4edf2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7a007ee2153647ad8e132e0f3db03235_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifd39a8cee1e445d2965bc047c1ffd8dd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i656c8f23bf884eb99730c0e0ceed03bb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i69eed5106b194cac81e8857cca41692b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i501f291fb23d49e987222cf13c851afc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i68e253af6bf3467aade09b572c1b73a6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic2993c1ba25f447ab89c08c88e66aa96_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia5fe3b205c444626a35463f927aa3b11_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i491a9763983d43dab185a1b3d0201cec_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibe9d7c9e0fe048518f0e819acf0a59a3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ief232100a20840efa196d4fd232b579f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4b824a92dd1d4f39a02e0e70cc3cf6fc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4991f9a87e794b3b846aabc953f85e74_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i36ab8a4da32a49829b2a533bcf21afdf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia21cb50c4e1644429c76bb8021c0abb3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia6302b18a2e04d64807ebebc34715ce0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8af9823e22614548b10747e15ded15b8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i65a3c1968cd74443b9c917d9cc5f64f1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i72880aeb20f6446880ea5b142b21f44e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4634f40686a143b7b789e3fcc2d15bba_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i977ea8ed51c749fd9c1b5c76a2eb3053_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifedd722cb01b4162adfda8754b4a7916_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9932d12c9d66432680507bf33aaf9390_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i12545f682ca84fcd8b34c17747b4d4a8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6595d99e0eca44358c06faf58aae481d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i38b09f0dce8d4cb99fa27e7105e23758_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie3fb716c30e94b8d9f3238fa1bdb98a0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i22d6477334e54d4ebdf1f3166111f1a6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia1c5ed3119a74585bf41ba0c7353c92e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i22c0ec2db724456da4292af4b50c4c77_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i580e21923e444bd5aa787a3559d74a5d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i944efe0ff84e4a2d996b26b09fdc1d74_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifaccc7e6f5db47c38d9e0ea71b031391_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6fffebb410fa488a9d9b0e22931e5e2c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3f4bb816c26b475ea5c62611a6ca3a18_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie2e98974a4f44562bfcd00c29cbe00c1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if12098c59f664975ae50e2edca80bd53_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib1e89593f0c849e0b5cd198216f70015_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie82435ef167541ffb3553c4f0df32b5a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic80415c4b5d245e4a044912d0547b9bf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if9dd6c6b3ecb435985256437dde936c5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i91d3dea8f9bb4c86b60376ad2e8c10c7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie82959ec18904868bfd821447c031d13_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib6e9f84d80be4446b8b028c6bdbc5c40_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iabe48b9a3b0e43a0b640f125310e597c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8998dba726444ee9ad5bfe46a9788a1a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibaeb9020504c459e87c9b9fa425f923a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i077de4b38fce45fdb34454ce78f9f9b2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i196f6e9660424434b44542b216db0270_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib2b21a3fd83f44a297eaa7e45a2ba45e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icfb3bacdf62f4f89858a91412d94f263_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iad69a88c0d6245a29a92549e921f5e40_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3bdd121bfc7c452ba215301545efe3fc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id9c89dd55b72447395cf83241b9a653f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i34779fb44bce4f6ba1d5a253141f3f1b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1eaf5ce6aae54524ab351f151c4c5797_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9134faa8fb4e47d780125a2ae7416a6a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1bc417b7cc444506a3991b3fc859cfae_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib4df9ffba7784b76a9a950adbaa557a6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i224111d466b840aebce96b61ecd97cc3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id3599bd1ab9441e68ec38d940b09f7fb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i25c6ac63a35547a0892e0ad2dfe09bba_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4aa93581903f4f47a9e936c93eacce46_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id114deab047e49b5a8b771195b4a54a2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i839a6c4fcaad4f5fa23979221c63e037_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if07e27d83137497c9009bcc13d88e451_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie19a1ad3f0604084922f302641035795_D20230101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ida5c6a5e34da4b479b384b7941a36f63_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7176eb6123944cc09d4c6d7cc55667e2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i376bdd1660814f0c93637da644c1fc51_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cvs:FixturesEquipmentAndInternallyDevelopedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9f6f6993588e45758f3afc8079d763a1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cvs:FixturesEquipmentAndInternallyDevelopedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i10e2a519b4d24c41a2dbb11874bc1f59_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i905269377a394b08ac5584c0ccd49b20_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie4aa224704f04a019a760bec8864101d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib85ef1cc5d3c496aa153d2806241d599_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2296fa243d024a1bb2396c22449c2acf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if995086e891d4d6b897fad3a54f05b27_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7fa701f5944f475ba623a677b1886a1e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifacaa4d950234294b256a60719467738_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i372db3f8099544d2a643f4329a4871fe_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i20100980ab444f58ab3077553ee4542c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ief1dfb751b844d4bb4bbe253942b99b2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib01e468dcb8f4ca98e9b64ffb83ffbe0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i397dda43721c4f17b0cef6a6c6ee92a9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia262a9274d8f434a9a8fac8f9016ca16_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cvs:LongTermCareReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2a0e4c7bb5f84714898af13dee589b68_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1fdcc037f9934dcc9e2153a71efdb1ff_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherInsuranceLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i899425f497434b61be7e43e83f1ac7e5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherLongTermInsuranceLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2fe9e107946a4ef9ade4731bbe54052d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherInsuranceLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8399f3149edf4edeac9228c155c337f0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherLongTermInsuranceLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibd901a0e46c140848ccfebccd9919a95_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i48c79709e147425a97e76cb1ddd62633_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i862ddd84e7aa45819c8c9210518db7da_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1a11ece2d2cd42918420ea7f1dd5ba50_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8b20d67c786d4c91b7f3bfeff6c94528_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iad2fca2727bb48aa90b14ecf9c1284f3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i14e1fb81ffc34c22b66f30e2108faff0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id181fe4cc7404cdabbe77d3f7fc155e0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iff2a00c33afd4f03b1e2f8fd84299373_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib0ad789c62b74d228c609da2255bbaa9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ife56d28f21ca44e0bc934fe219064fe1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia64bc989c4c4444ebef0e99f699fb65a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i45fa51dd20a749798549f98bd1811f08_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iad97b3767fd64724b1e3d77672941a0a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id9d3e97b86034daf987c6fda27a02728_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3117bdb07278486084dff9ebb49a80e0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7f7744badced45919f97d66a9ec50adf_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i03b300885d9b456b84c6c73e4bdacfb2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i320c789c426742bfab03ca5ea3757c5f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id41082cc7c8f4e46b55567b48080c270_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if916c9222361492f8e532d2cacfc7aec_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2a07c8633b37492ba109c7cd9a92299a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icd57b0b73c1b4e1aa835dde2abf6925c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie1d5e5a55e6f4909a1d1c3d2003ec720_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib085c0543c9d4988b6b20b9b427998b0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4e79fec42f4945048db04ab6d125dac1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifc35e22eaaaf4b979443a4b29ecfdb2b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib63de3071db248ca9ce666c685ac2d8a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i99ffea29085e4c2bbee4c937c682d535_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2dc095ba84374b6f97db2d50eca661e7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if14d784717ae45699afa13fa2039d20a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i14593b1d8b2c4b0098e818ce890bc9b8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3298f299bddc4992829c48dead520fc8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i07f19f7971c940519c88697285174722_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2e89e68e590a458991b469aa7f41bb36_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iea79f3c8d0b7431583f7968ea612fd3a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8a66d7067aa7482dbb0f8422aa4c6e42_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i48798a4511874c8892972dcc0082ab04_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie3df790a9a364d22876a558fdc974055_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5228862959aa458aa4cf0f0ecedde213_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i33b1145120c34228ad6a8552aa2ea289_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1bd8d6d2503d4faebea52625423e074a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icae492ed264f4e44bfba42f67cdfceda_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i30c3c2a12d62424091c32bc5d8bbb9a9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i09a4ce3d435546c9b89e1b000c479765_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifeea9a469c0d4f9abb5266144d9a1b84_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i160c1d2789d34ba0bab068f3568ee908_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie73bc8fff551437d8b63b1fba165b13a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i162e562c13814497a56524c6ec2a34fd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iff9fe2e514b24d7a8dea10c9425c3f0c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie09911fb17414836bb68eaeb03ab61ca_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i06284eff72e64927a66522466999f6d2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1edd8caecae44ce995f38b9edd410db7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie123d487288b460289e6aaf6ae104852_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0d2a7ac149f64c73a8f3b978546f2741_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia0cc9849a9ff470b935a370313045788_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i977f19fae3bf4bc8963ec72c8c49ebdc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia648581c57dc457bbec0147f946c9c94_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib47b357e921d48fe83a680844e7d44d1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iff457075247c43c5b18562ff48f847b4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1f5aa10ed17d4bcfb6e9c9314f81c9fc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id8e34b73c65d4da0ad42e0f3666f7598_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4bbfa9181d494da180bb0ffaf4540e76_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie30b20aa9e074cae88b963a48417ada9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1664ef87611a43fe8c8c2e9a3c70f7f2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8f342e37bfce4f6ca560a33df132c468_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i17a6f560ef5640399300e7fe75e9aa5c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie743c62714f54fd4bf1245a78eee0b5b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifd24d97a59214d52b3c9750f7e7d3d7d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia84c2cc8a91c4cf4aa0584d43740ee58_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i494f38c837794730a4d4ce042956fda5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5895590dd43041059596c19c70b48ee4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib399dae772f1473b882823660572095c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i96881c941f4b4a52b49bb77d5efbf3d4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3f0350ddd508488d8327fe9125a60729_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0b31ec7f183b4cd69d634f84d8e4c94e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iedc7e31aa44c40608ab490e5abeb6907_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id61b0b83a53943a09bb0a1124d0f0e47_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iea9bfe47ba434e67af70f9a941c950d9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia44cce9280244cbb8b54b2754221e394_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4cbdb8dae69a4ce4bcb45058e576038d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6a476fae69fc4c64809902a59beedc6a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i181bfd6aedfc4e29b5b22d6b864e2ec4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2ffcc008b85f412bae79b1893943f70c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia95a883374f34cadb8aba20153008269_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if7a2e3c175d84b5aa44a7a859d45ad5d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2ce5e18976c2489a9a964cdebbae85ac_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i37c56e2626d741fc89c81191ac507cb5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1859ee0b296642ffba13a4fd14a36458_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3e55817403214996b18ace12986ee657_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6d3c653dcd4e4670b996e139fd812838_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ife6f5f367cfd43cbb0a47919d9d3da2c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4241f3201d8548bca7574e1e0a20ac84_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icb7fc09153ca404296c11711e2960b2f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i92db766193ba42908696e991d4d5cd1f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie6c189e7c1cd4ff9924fdcd3ca505cec_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2798658b56134273a4ae4a44406280aa_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i18e1afa4d3774525860f0504f6ca19d8_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="i23248b4e050943bea0937b2c23a81cf0_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ife99c731f49c491f9dbcec868c83f01f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i01be68559ac146e1afb53160db3afdcd_D20140101-20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cvs:RedOakMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-01-01</startDate>
            <endDate>2014-12-31</endDate>
        </period>
    </context>
    <context id="idf41f493187f4949ad17fce94a9132a4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cvs:RedOakMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i075db0b7afd340fa9d1cfc2f4306bf77_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5002e1bef44644008f1ddf6ef1c5be55_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i69e734eb5dd74181895d964e7db3ec21_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifac339bf4b714e1782ca52ebc2be13b4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia5c21594855b4f6984286b1e3809166d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic125e609219047b1851d89ba1531b87a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia67a49e920264f60b0ef8a8a7fe494fe_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id1d19eaaa11f4572b405469e3348cbec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2525a9305fd84c7f917e0f50178009ca_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:HeartlandHealthcareServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8941690cb4944d199bf33e6da1cee933_I20230207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:OakStreetHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-07</instant>
        </period>
    </context>
    <context id="ieaa2442b4a1b43c1a1e9635e5d302668_D20230207-20230207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:OakStreetHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-07</startDate>
            <endDate>2023-02-07</endDate>
        </period>
    </context>
    <context id="icc5a99c2de364d84899668bcf7f91a6d_I20230207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:OakStreetHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:OakStreetHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-07</instant>
        </period>
    </context>
    <context id="i65fae298043841daaccb6bbb1a996aac_I20220902">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-02</instant>
        </period>
    </context>
    <context id="i6d430fa42bb64f4cafd5196de70e0ece_D20220902-20220902">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-02</startDate>
            <endDate>2022-09-02</endDate>
        </period>
    </context>
    <context id="i12c5778e54f64900acca49cd8d1aa3c3_I20220902">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:SignifyHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-02</instant>
        </period>
    </context>
    <context id="i39f6860ec9044a859b0fb2f4386504eb_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:OmnicareLongTermCareBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7a1cc0d19b0548438d4b4f4e3b4d3a67_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:OmnicareLongTermCareBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i16dd20d6307443f7b1496e7fd3259924_D20221101-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:BswiftLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i1487797c4ed44d6ab54ae7b9970f80e0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:BswiftLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i726a3c8b7d82435e9ab454babaa43c9d_D20220601-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:PayflexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i032e70604e384dd9b7d3ebd3ff12f852_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:PayflexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i90dd0fb3894941b6960bebd138f56df7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:ThailandBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i13c8ddf9147d44ae959fc13f26a1884f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:ThailandBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ica7104e3105a418591fc79a3004a6ba4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:ThailandBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibfb21d4c40684eea90662442e675b2a5_D20200731-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:CoventryHealthCareWorkersCompensationBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-31</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="icaa8b7f8dd3142d9a337758c8211c242_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:CoventryHealthCareWorkersCompensationBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i343759b6979e4ed18b87374d58deff9a_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:InternationalHealthCareRenewalRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i13ff989d3101402c9f2d0b708fde5f39_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6007bc6f913b42eaab01b721ab83141f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i04ef966a0b364268a11b39305bc55156_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4f2ded7662304336a06ac9d017d04cdd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8a96031559a645dc9dd2370af4f1fe81_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3f484ef7e1984f9db38a5d63935d02ba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i926187f27f9143b08bebbbf8c1146300_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7a316de9aa51441b93f71dad0316cb0a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7fa9106e06f445a2979d054b78f571cc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icf0581ceb43240768d8b04fc7ebaaa00_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icb868e7bdeb94378b825d30de7838abc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibc5a0a8208f2461ab82ca16442cc424c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0b1a48334546440e95fe6e66cc4322ba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i43efab69f7304dd1844a5ce8ac828ff2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i63febf0a959b415a87f69f63c46b614d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3fe88c16075341069af91ac0c4d756c4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iad025fe771994e5c826f608d61d0c5f4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5d60b17185a04c99a6f240935bbd2fa8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i858b216b74cc4844a1f8606b6c1545ea_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9911a4d843eb4cb1a00b136035f50e03_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1bf6dd211b7f4e99ba7262cf0f3f0c19_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iebf5538c68ad492782f86e19a1c4c591_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i05cb6c50cba342aaadae4afcbafc5086_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5cab4b0903e747b4ac60612c8fea7746_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i21d50269b9b94eff85b08845bfd50cd8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib9de4d4f1b014ecb98d80d1d8fd9997c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9fdc07fa1fda46ea9a75488e14c8311e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5826868b7599497aaadf079b91c1ec9c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i73eeedf2a9af4ccdb7f524acfbd1291d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibb16d569f25741039929fe7413c06b74_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia4afa3728f7a4abe948e80bf8d977e54_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if04d1680adba48cb8232ead08df7bae0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2d74574442044f68b51d8276992c9058_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i75980a6ff3ee49029a1d3de9bfd5c17a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i90acf0fa2cef449a9a6b3fe9669194a7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie029e8df1c364a138c570492e98b3d54_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i421c93ab9ec34e0b8ad632a772e570ca_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2bca51009fe7432c8013e336a1cf4350_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3a6652f704234be281c7de3aaf21a926_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0ea51f302c714924bc0ef9b87f297f7f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iebb51e53093740178b4dba853cf3420c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i12a608a6606644d88c677fd0f751bd61_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3d4072e6b69341889b6e4a48f5921c8a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i88a11ee9559a44de92dd80d2f5faddeb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia93b04912558443280c9e2aa952f9903_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibc270e3970b14849bffe624fd7f92c5b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i53ee1002dbe14d6a9a0a87c428a073fd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i73d009030d3c4eb2ac0695369c7267d7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idf299ad413194c68830e48ee0a189167_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i91ce86bfa38a43eb82d3e5630dbb6fe0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i85218d26a5ac4a8b8a791e5184f5532e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i12457fd4abed4dd5810c523723b9e883_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib1693d5376c24d27ae1f522504dba375_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i99cea1f4247b4a72ba6ce1db47e509bc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if496ce43b9584f0cb06d921498c7a6d5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5469e56e6e2247438f23b5f4ce0fc023_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i14ebe9c147f34b30afb070d4275d56be_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2a42cf0d49a24a3eae7d66f7a609a49a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic39faab8b805446e8f84846e67c4a2b1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3db592d2a00948c68596b30eee11b0de_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3a10358d02ce40d1ba0f351f89985dd8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9479f6e04944448fb94cd8b2ffa008ac_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i640aed5419174663a30409089c100a72_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i47777d9b93154d6784b7b9f3c2f9d892_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i854bfde83a1447f4b3644fc9241f54c4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iff3b89973faf410c9acb26abb292d6b2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9ad5913b793d42b68d0dc23a03aeccd7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iadb22641a7de480890dce9724f3d4b73_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9504148b06654a839a20790e6729610b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iffa87d8a62b6424c930a0a38e3b4d729_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i06832aa121f84e7d9bb9a51594f8328f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i06d54096c9ef445b94dac9cf772665f9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0d9407183bf04eb2817defb619e71ebd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6a5c876135b74ae1838032336d64387b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0ca464be42434835bf579eb85f510027_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id2bf2504884d47a787c23c9e647d0278_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9e057cbf62aa4488a2f57555c190f72c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4576cfca422b43d9b5a9fd4714c411f1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3b33e9db5f6e4f5f9006e8393083dde3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie2a5a5b141684675807f743d5fe77545_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie4f98e6a0455476e9364c7c8d8ab21d8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i480128f0b108421a96f35af154e8f5f0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i014bace9b30c4dad914233baff909ea6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i13320df95b974197bbb559c6f4e8dbd0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i399f816ced304ff0a68ab3aa72222b6c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5And6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id9e248f337b647938c4b077be13c8a69_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie4c467b53e74463fa33e728cd19c09d8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia440d58b19c54e7da108e0f4c033ea0b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iecb7a9c6c43b46caa278ea7418cf1d7d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib0b792007b8444fc8f042f94a615af30_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8fd3a320f1354f8b810c747934dce719_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i15b8ca29a4dc4503a5baf923e5290e6e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iedfeeeeb01db4051a98addb83b67c636_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie44f7fadffdd49b09a635391637ef400_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie9afd4ac3c27443da681cc815ff5e5c2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i739531ebbb1b4313b647d32f2141a862_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i578621c95d044984be4bc06471e111cb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i762743c83fc54d4b84a2b52a9dc069ea_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iefc840c940b34ad98d700a94a9c98c36_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic7f12d0216be4ec7b5b4ec403f1ac753_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i492eb4d473b8474399d0876f23723ffe_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icb4f81b717c34e498a2a17bce45af326_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i369222388a054b4f8f100bd1d68da12f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i068dca23e0464c6eaf06ae53103e8ee4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic9969db4222c441394605cdce7151928_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib8cb3e0c3585411b8626e196b7be91ff_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i137cad6adc6f4ecb8a82de703aa13a63_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if00a9d16f4b54e3b9f6ebe547b51e58d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if19bb3693da04612931c094a9c82234d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id7e14cbf58db473094f1a3a50e0e0423_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibbd43a9242a0495591196ce21cc7a152_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icaf7c772d40247269c23c494f0813a7f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0ada3d841105476b9dca967f07a9dee9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie9bd28275ddc4fac99461d0040a82e04_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idc91466b20fa43ada80738d8288e7fea_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i530204e9d197451a99415dd3717e24ac_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8990fa5e5b8a4f0f97b6e8a430a4f8cc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8d16b574d8b9499db8e7d78efb965b5e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6f3cd6f6ea7e499bb05f3f3288c17b03_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie5c1f15313054273991533c5befb102b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9d63d3b9768744a2b0dd3376b50053cc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5101082b492740a3b0895812ec43df67_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie06499b007a04690b796c75b0962751c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ida238621d6c341e6a18249c65a07f582_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i16e537cfafe946a1a9ae86bba72ee565_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id7ab6b4e481d4957893effda1b1aa7c7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1c90587389b24652b4171dd0ee88dee0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i08413588348e4bebaa6e0777ce0ef468_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i06e7906b8aab402c9db7df2fbd123952_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i23a61fc417cb4a5cb6b648036474566b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i22037852b26040388b00a9892837d2c6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i29da59e3b5fa4406a9c1b13643f91b1d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7f33fa4fd1b548fbbed3d1b0df48e1a0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2f7c6d92a69343cba3248128978c9fee_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1764e3a27c5c4e3495ac330952dee2a7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieb866ac0512442bcb82bae4443758dc2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icecd5e128c154279ad038c0b3bd207d7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i25da8a3d6f6c4f1f8d90b11a666a1f83_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9e6791338399461b89ecf1ab5fad5038_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iea61e57b4e654ebd906d75ab95adf087_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9c6d0c54222b4405b72bcbe5aab383e4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifa99b9364f604126ad2513dafb044afc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8b5704fae30b4a0180968bd57557cc05_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8e951c3bc4d145f4a40476a3449c19ad_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ief0073f279ab4af192756be0d02d4de7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibc232ee5addf495c8badb0d70cc93c58_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib91aae7889074bd7a05849761119e002_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i91e3342f2eda4923accdad0511bbd8ab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i47cdbbca2588456f80bd73c676fe393c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaf6903b55b154bf5a640326a2ba60787_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i80a1fa05fa624e99a568c5d529713791_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6823ed470daa49af9254d7a5a6a31e37_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0338427c63b5451e9bbeb57e1271c8fa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib35379eff59f4c1fb2580ef9d779863d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i890e91d6254445ac8e4752816f15fc64_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1ad691d08cdb4176912f4e92ea7f03db_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2fdcb45e510345908f049a08f8d3ea8b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i55a4eb72fc1c413382e3c1881d8197f5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic8066d1e0dc94aa6b3e714bdce964759_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2c74072b7da84ae7822677cfcf5afff9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibe6072dccf0e4a3386213b62e3088a40_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i421fe75787694fa0a11c81717afb1439_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iccca4c50d4404ba9b7e6a383314c619d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i88314bd313df47c79dbba4210decb5f3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i50144b06283042b2839e3602628c2e9d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i31ba761daf614d80a394376a9dc8d67a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i590674c939694c899f0d33ebd89a34f9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibc997bf4243447f286d22be9634f8c93_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i137db0dfee08476382f7697fd3226606_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i279e72df939f411c8a220ad40b2933ad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7b4b394827a84ef89c8ad73a0012ea10_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idadd15b0bc144797998dc56ab0eea88c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i09a72f728e864e3eb1d61dc884e59e71_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibc633eb71dd64df8bb1f39e100cd5380_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3debe593fdae4764a4dfdb909fa118c2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if70e446705924f59820f42baab777967_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie042a85f623e47be97fb43ff84873341_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ife6ed60ef9304afcbcda02067d9939e7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i32a6e0424acb4626bd8a9932c7e5cf81_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2927600f263b4b33a80751d0bca72ae7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if32a2b7d26c44e27ac43f062d7bb8ce8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i71dadee959a94001826c4f41df794421_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia886fe9743a34d83adeda64bfbcde12e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i23ea6c9d959a4be69bc036bae5151a22_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i96059726faac4aa391e32ec04829a30b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iee0b7f95d910427ab334b16a255c0b30_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1e36e767de48460789f38c796a6e664f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6e8ab5d1d4da443ba302ff82ecf041dd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5e02a0f8f4134b338d074df0125e76b9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia4ddc4dc69fa45d7b4aabcb366bedfb2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1ab04fe755eb411688cd34938017b350_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iefd0548132bc49fa913c97c33e550880_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i35fc2780f35241c7badf4da30b423e52_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic7e27a54d49940b7aef90c83ff8319a1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i96d99b91ab0644839726fd9985fcf090_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i935f57522466474ab5b184e68f6666bd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic6589258587b4cf38304516af7c70737_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4d44059ab8fa413594b33583600110ff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8eb721873e1742abb8f287c140434eb7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i770c6b93b017435188c94e8c9d24f250_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaa8216683f294597bdbecb11b8d62331_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ied85a7e77c3c4ba692a634daee0770fd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i79c89c6186094898bdeb5257ad524c9d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id25912d8f6374ed5934f4e13f688ef0f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i33cbb6bd12fe4c8293ea3dde4c77e687_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5711de78e5dc4ebf9b7a6c859a134de8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if12cdf7fc62645698e90b515b611256b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i128f1c4ae2fb4204a95761f38befbbcb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib998634049ce4ca88cef9c730f1a8c88_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i96ac2a40938b4452a62b6a712077bb99_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9c9e1fabf93c4866832c216cd1d05ff1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i06b531bb7d2c4c9fb13fbf2858aad603_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3f36a954f0b04a9bba80a5b07037ee72_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i21d1adae38074c42b4c3c61194cf93e0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ife1fe98fbd264b5b962a3adc684d2edf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idf67a70a0e4140fdafb4bfede6ecf6ab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if277087345804c939318d54c5863d3b5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie66a1446652841afb7a31c13e604633c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i51e0bcd2d29b46c7aa058026dc2a2ed5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if689b204e34543fe95ac080b3debc55f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2ee45bbfada1407eace8ba71e97a1529_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaad452f7bcd446778bc7ba3f4ca770d1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5e061b66c25d4fd5ac6440b36c42c982_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6765b714ea5d4a02a77b602f004b5cc4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7983c2bd0c7b46a0b3bf893eec46f3de_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i96c159461792475cab9a57d784186344_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i05ef8fe160b24777ae8c78c62e45e2fa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i49b05a6599ba4f3b8fb0296a00fc3649_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3b3c1aac8a2c4908b044154620848a2f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i231179ba5b6a470c9209f71e7dbbb810_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id105f8985abf43278ce21b4eb1dbf055_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iebee988b218b43188ce78e0ecf93058b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic9179ad3cfa14f48a4448a5ae59ffb9e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib698372482a64b2b838c35c08acfb43b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4d76414b76554feca73881ec515dcf3a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic1d74124f6be475b8f9ae2f51da28944_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1c13d2018e6445458a682aafc8803716_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifb11f4892b1a4083a46e94dae7ceff9f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i20fa3af468954aa4933d0e3030a4ae0a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i10d95680a25f4275bf74bd275a219904_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3add96661c68429c98bc447aa30d7e90_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie85ddd31302d48b39bf9b6b531607b98_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i093853abc6424f1fa611b8455b524dc9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iabb2b81fff06464f8b9d20abd344348b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifccbe865cbb14d2091ef941a3b9bfe9d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3517cb5c6870409aa7e4a35e9131090e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i08d7c8d3b44844d9a53252e4dbcb3411_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1be8dacc0e33455686bdb32ee8a892e5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic3c351bb44d34de9a79d55ff5ad02121_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i809fd6b11b2a4971a3517725cbdca04f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i473e7e5830bb4215af2dc4cfb615a70e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2cfae73c894b48b3adc8ba56219aaf76_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5f60137c965c405995e63ea19fbaacc4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4ecc8bd5e850436fa0683a5a0e40c8c0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:SeparateAccountFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i33d746c2511346dab6d70642faa03778_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:SeparateAccountFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib018c9e5213340b8a2330528464a3616_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i946281b536bd4451b3d56d4d5bcaade8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic66da0cbafad40c0b09c17c59b015bc2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2a1d88c90afd4868bb3842de60276b75_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2dd993afeac2436b99c2d440336ae246_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i10733861aa764487bcae8d1a5debd7ab_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic8885190ef7841e48df544637103ca44_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if80e6d478f774215aba1c17bfd3b0a9f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i753d74536e76447a97ef85017079a80c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibe08d096357844f88d5bc75a18fcd936_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ida2cad6c1b0542db87d072a6e3ffe684_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3ffa35f6be0f433ea5d0c817c81cb4aa_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic9bbc9d820604ed98ed4729f6b0aa8f3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibb1ed30851ad423db47b88e42b33cf8f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8ed4d6f5ae634f359f681dd2ea0d4e81_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cvs:LongTermCareReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icacec4d2bd5a441bb697bf94305fab43_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib59e20c5189b4f5cb592cb8f4b8324de_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib47864323cfe45848ffe84168e0f0ccb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6ffa6a6d070a4dd2bdf38824f6bd5261_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic9741c2be1f446a5b3e33d1093db0189_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie0189be5251d42809d167551a0f5f747_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9520a4ef3083437894a7c7dde288f4c1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i07f38da039c646c59f8df03b461397cc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1586ee2417bb4444a300fe3741cce552_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i10166bf4bd7d4e9aa3b7ca002a1d92e7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idea4ec344a85455882460b397b94be2e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iab4ce297b2134e1faac9af7fb814d1ee_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4b97832079404df29d7a1346b50515c5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idb9ab0a0f75a497f924ab0a5e8916bcb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia298597ebbd74213b5ccc336e308e4fb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i21e3a229c93f4655982469399aecf163_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i245af29d89884e149ddc482143db7d7e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifd3229b629654bf1aca3934975c2c2a2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8b53ab0e06784e57adb2671c1a53ced8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:OmnicareLongTermCareBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1940fff7a85145088d00871bcb52c604_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id45be672fded459fae66de88c0ad4a5c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i30716a5a00af4d6bb1f1b23cccf84c89_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i64afdfad0a7c40478e14769ae335f4c8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i051a70de728945e7b41255138a99db87_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if41a3fc5ea3b4503be47a9c50af584ec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia17efad6e57f470eadf960cfb01e576d_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic8537dac29594a639ef8ce90309171e8_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">us-gaap:PropertySubjectToOperatingLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5f3c8c09f91f4c338d29d71777fc4bae_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7b563cd5fd6444ccae80c15785db4752_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7fb815e010cd42dfa706732c81d30c51_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">us-gaap:PropertySubjectToOperatingLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i08b43dcea1a24bb58f5fb26ee83e336c_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibcaf1a77aa6f4ad0a9316358d8fdee1d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">us-gaap:PropertySubjectToOperatingLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0abce119f76d4736a751d922587fea1e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i799291d9b4044a1d96de401f542d2dbc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i198eb6aa39444b7b9b09239c511ecfd8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i97f51e7c8d364549b235af468de7d3d6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifcc76cbc90f043b3a402f196167f4f72_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0a2d0a34a80341588e7543f9329def49_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i070e3ddd671c465f94cda987d76035a2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6c4f0b83de01479eb59aaddfa35650cd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if2866ecd09514e62ba339145a6407f2d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i83ae36f497504d8d90f91d0e0e6c7f9a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i88f999029e8e4a6db4e05b6171f6b11d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iedfef3ba5684421f9d94d0db97241826_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if153c73955f74ee79cd73647ab6d655f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5bb58d471a7046db9c3cc65f4971e64f_I20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201812Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="i92b1a4067a7447d09ac7bb0fa978bb71_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if0a700dd2b904bf5bbc0dbe22aa0bac8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1bb54359e2f54f6bb88e696298a4d66a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6bf2003d34b74a88a3c886d4e9d41643_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iabfc58f2b34943d8a1b6af15cd233571_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i20c1ca9c1b9440b994dfb835f8ea73f4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i912746c5ac72472fb68054bd160c6e6c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i89b6580a77e04626a0e30a5a4fb6adc4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8c5404c452ba4db28e4fbb520b402437_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">cvs:EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1263a7bd13e6441c90af49d5dde6fbc0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i644e02c89965481d980470106777aa5c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9137fbdadfbe43f5b00bde48da98706d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie209165399db45729e89c8418744612e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3c93d574c339401191a45224c5b9c45a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icbfd8fdbe44c49b28f953090bd798dc8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i670b392d30e849e695e1cc46b056bb28_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f0672fcd32945aca44585b9882b4499_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i614d4d469d8542ec8ffd5f8bf31e0bef_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0b99c5b96c164850bc3f80f97475b0ae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iba6736243aa54f7294406b62ff339374_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i473c68aa9e4c42a8a8d365737c72ba29_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i516e66d0f707473d919c7b8251b39ca7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LongTermCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6d569b44a37d470fadb0d1f07580eca6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:LargeCasePensionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i412d46651ee84600b71fc148cc986f29_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8ce672bf30504e35921812d7a7fa7934_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i36b9491833204d099e03fcc01e203119_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4b4626daa8754d42a34f1edb762746ec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idac6af1bd4cc4ca791c3b7491cdfee7d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib04e1d5c5dc2451c8c17187d5ff131f1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8d1de373967241e5bf5de600e7c144af_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if6a5bdf13f3348caaae04f36dfdf1529_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib1c08c444f6d46058bc3a4972bc57366_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i180b8e344c4c441c95dcb1988928fc19_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie5496f38c2d14219bdf381b856591253_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountMortgageBackedSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifadd8aac47504af7be902e13455b168c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountMortgageBackedSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5f100f6542cb4642be65ec9453938f5a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountMortgageBackedSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i65d11629522144ccaf2eec93210bb7ba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountMortgageBackedSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3030957b790447e48affd8a2d4705582_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:SeparateAccountOtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia7cd37bb88ab41ed9c765b58f78429c4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:SeparateAccountOtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iadbe70c5f2f243658fd3bcc5dd8c2d3d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iba813c84c6544fb990007eb39d2d1988_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:SeparateAccountDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i565057424b24407abbffae1c71ea0c08_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:EquitySecuritiesAndCommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9fed7c25098a4dd3957760b3fa0df1c4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:EquitySecuritiesAndCommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i46d398142bc14090b6efa835576c60fe_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6dc40fd3418e432b9e325f5ecd1b6217_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3af420d8300b4f17a1fa385f41425a8c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i12e6f7addf034c2eb5edf2df1a607732_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if443d252b4df496d80927ef019eadf74_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaabe5773025f4c2cabd69d7914e764b7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3e95a5abc36e4381a98f975d83721a1c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic62f6a9337b643efa667a4246f23f5a3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0bfa33d6699f4a16a614e7bb4af6003b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id32712eeb9e24f4293e053682e64d0c0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6556efb47077422bb88b269c462914c5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic7f8bc3f2aea4b8490a2c00543939418_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i095b5e69420d48439f08a7fd6032e39f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i788e48585b7d4fb18382daa954eec2a2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i412829e3534d4fc095e6237114df2eaf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4dd41a67d29a43c5ada1608f1dbdcca9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iee8c1ff2a84748f8b1e708329c8b5afa_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i79ee0b15e57241c5911bf2f116f391e5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2e6d6e97c2644b418692bbab3d848bbc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iffb22ad240ec40d99c5b5c11c4fe3c23_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4ba50b36e4af4b1aac05a10e19f622f0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i533be9b87ab747d18146404b355d4dc7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2a9a8b0623524068af6014036c34e60f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8b4b00758ca84efebf14e070000ab9e3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie19828a34e7c48c894138597b0f024aa_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i096820313ad94c9eaf41e3a34195cf2c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie696efac889145fabb06c27642b8faab_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6a9abfe3905e466f9226a7fba19a5d61_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i75b0bb3f7a324df2b692b9a2d398518e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point625PercentApril2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie0f1d199662c4aa1addebeb3b5240b80_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point625PercentApril2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9d39dacca1a042f6b353bda666b8bda1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5c95f5eb8a5e43e6b03486361d0edd35_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0a911574fd4e42ccbf711bfad6c77ba7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point3PercentAugust2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib0f77ee954bb4d2db587828489c53759_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point3PercentAugust2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0eb3702b560245409a4fb90d58b8cbee_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8c0858694d0545f4b143004f36109ead_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5f8491428a0e48e7b0b3ef58c6387fb3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8b1061d1cca14c27a643cc1dd4680a00_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6973def3f8764f29984b67e00ced9e10_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point75PercentApril2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8970f954df4441f4b7ea8363b24cff7b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point75PercentApril2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifb4028e415d14620a23a814353bd620f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point75PercentAugust2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i88ba47fdbaa24d6183f12124cf69ae33_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point75PercentAugust2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibdfec9e9766a4ff5bcabe5606e8aeec1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point875PercentFebruary2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i782152e0441e4c2a8aa5248aacc1d97e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point875PercentFebruary2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i363e35471111481bb74f8fba9324ea53_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point125PercentDueSeptember2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iae612530eaf9406ca68bdc6076595a22_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point125PercentDueSeptember2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i13ffe568d3ed4a168945f8b506bb89d5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i654327bfda6446f7a000b137efb56172_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i26367f6403b04922b185cd41633e004b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i84ed8c55fc0643daa63fac8671ac1c47_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i06aeda9941724578b3400960ab91b49b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i55522731fb6f4d858d93159da79516a7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iab7177b9be24447698af5c299280e476_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i37a3a6af561f47c5852d985e16ed71d3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia814b2597f3d40c3aa4b441a58f72382_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic986abeb083b454c96d3dc4609ec7e06_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6bd24d3fc7ac43f298c824109beb8c10_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point125PercentApril2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7bd579c48c854055ae2e0ed5e2761764_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point125PercentApril2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i170dc9d394554411a59b342f34d93d1a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point7PercentAugust2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8f7debdac94840a4bf5279ec76e1bc30_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point7PercentAugust2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2c6a0d7374684e1c95b28bb2666b8bdd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7921747c0542413d82061a71fe1c0e43_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7c5ea867903e4bd98992266582152be7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i936efdc2f58c43ab85e5eb2d3d14283a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iade73b7bf7a9412cabfa7e66daa3a170_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i96cf2b69c10d4cb7bbeea0f0473d095c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibfef3a2b0e55448e81cc7fd8cdcefa84_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9023482dafe64c8487415d9d977873b9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i30e9474ca99f4c96bd9f16e412ac3108_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id71a7150882a412185e3bc50665a4eb0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i45407f38c46c4bccad465eebd0e1c1a0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3d8773a95fa54a4c955ee222946850f1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6861e988cc904169ad4ce04f9a698dfb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i595551a12fa549a4b9bf4bb76c4cd9b6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i84d217e379554fdc8044f794cb43db4a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5c83f742d5604d34bf2d877385d1f1bf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idb3abfe6fdc34a699fc61058a8ebf7fd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point25PercentApril2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7d36c8bfa1e04bd1a278e34c22872187_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point25PercentApril2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3e5f05c48e5f410f832224ee5b84dc43_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1b89c9ecfa1844e19052dc3ccefa9571_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id47f5a8f599c4b868d0305b2456c6b4f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia5d25fae6d644b13b9d7d803b1a2d336_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iab1819ee2b2c48beb7a3d3480b4d3018_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7725a00fc4434458820e5285675db777_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay162025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if5314895b87347ca95eb2d88cacc462b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay162025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ide893c421b8b4a6bb460e90ff3db6be6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay112026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9b7205dfebbd4f39b3d90a92a474a62c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay112026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4f2daf0d0e1b46beb6977fe725dd8568_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay162027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i58ff8eedba304dc89f24ce5bfd8071d0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay162027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i53a3dea184cf43989b62efd3b338a4e4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:BackUpCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i296638e184854141a99df90a77e2a441_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:BackUpCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i096d8d3381b14ad1aa6e9c2bb706e0cd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:BackUpCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie9b65b8aa3934b9e926bf1519bff738d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:FederalHomeLoanBankAdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iadf9ac334c4b4658ad05a02180f0b8c5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:FederalHomeLoanBankAdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i364fd8c191ee4a44ba567c6975b7a46b_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i70894237af7b4390b3fb413977da682d_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i51ef9d9ca64a4f4287885afe3f594d9e_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="i8fbfb24ea6744e208cb848ccde2da9e1_D20220801-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="i9aa5250b8a554547a64d644fea28511e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6b6fb40f4dca4685b9a5bbb62b5bc3c2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id3d628c3b8c14ac6864d45ff3df48167_D20220901-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib7e2b901e8f64b298c94032d51d86694_D20220901-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i37ff025b209247ed83d75720f35ca078_I20210818">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point125PercentDueSeptember2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-18</instant>
        </period>
    </context>
    <context id="ifde94c7f37464b33b3e1498967849d4c_D20210818-20210818">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2021-08-18</startDate>
            <endDate>2021-08-18</endDate>
        </period>
    </context>
    <context id="ib92c96bdb7a54505966770b11a97675d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point625PercentApril2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1cd70718cc1343babbfe7bdcef36bd9a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point75PercentApril2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i9544c22127144ed0964d5a4436da8785_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point125PercentApril2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id0e311329095472ab7b183da066396c8_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point25PercentApril2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i60425698f8a3418da11bdd624d74fae8_D20200301-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ieab996d7d0884ceab3cf45494319270b_D20211201-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point70PercentDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ied3ea35dfc6c47b7b9f3cc1126a9a800_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point70PercentDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie2ed035e89ea4208b36e5c0321f9ff7f_D20211201-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i83224dff234f476ba7ed0ccd21116967_D20210801-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4PointThreePercentDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i485c3eb16ae24960b7e3cac5ed2c512b_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4PointThreePercentDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="ia34bc950bc544c9382c1522adba2fb40_D20210801-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i80466863c1954a5995d8cb88bd23d373_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:OutstandingSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7385c90f6eec42dbafb7d0cc760c4687_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ief5a743376c14f51b6a0e836c4b51640_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icf67de8907724398ac7599821631c87e_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i74057c0c3792479e937638290c160b1c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7d58decd879f498a93452c94fc35e626_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iea5790297968453b80af10c825264b1a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7f44b18f700943b2a98a19f48efe6062_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes43Due2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i63e27afb0d604706bcc006002a4c8301_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes43Due2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i36384f97305a4feabdce46713990833c_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0d45c5eeb3784063b1f6c2bd8750adc3_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:OutstandingSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i335a47dd1b0d4b048c9088e555d579ec_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i3b98834372be433bb753acc0051b6968_I20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="i5b2c782f0ddb4f47b2267b9624558fbc_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="ia13f558316964fe4aba42d03ed32c28a_I20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="iac13c74e53a64777a3a5d7e4fe3b2046_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i4f514b120f594513be910dc9973e11be_I20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="i2b7fcc349cf541ddb6fa797410c0ffa1_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i6ae60f8a88824bf889f05cc3b51730b3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idb014b08ea1a43c8bfc4d9fe2fe4cb7b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i386090869fc94797bcda9d9bd6beaaf4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idf18a7ebe0824b4c9cc0c9a8db021e64_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib1c28ec013bc4526b9794acd9746c77a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i76a4faa3d2d7408ba85519e8aa053ec1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib6f2f249637c4a7b939be9fe6d0553f0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i15f18808419f492daac9928c78dfe207_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5165fa288fc140b58b3e2eb13b880dad_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i437030cc5ae74594bd99c673acc0141d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9f1345bbf71048cab8ec53160a98d6e0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iafecfb17bf3847a289eb418831589dd0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i393269929aa54f8d841281c28c513489_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i71ffeabd45b047f7aa8093796c73ce64_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i19f2f4c671e34716acf9fd0f2b572d66_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i102010332f0b40f2a4057d6bf03e8a1f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie97efbadc22e498ab09fa57a7f7a0ece_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ide1653ba45f64f029e277348c07102cf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib74558535ca347569c43f5b77d45f6c5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic3055783102048978188614bf9c92f67_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9f0b29ec64ee405b9f397e174b416349_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8f22f16c5656496881261f222143a65c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i80aed82dcefc4d2c8a1b6d1666a62cc5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idecaa5de548e46198a7835338a65cfc9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifb3e587df0ce4e58832ac7d14ef31287_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i81a129fd9ac642898dfe6c3dbf7c13d3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i07cf02d634944cfe8dec224d5af50138_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icedecd6a5d6c4cd6932eb56e5297820a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i67ed1aa4b0994e08a75a11aabef0ca61_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2d4ba1b4e5fd46a59de47cb57daebd43_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i53d2e727f536476fb8cadfd6668d3f36_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if42d8de426004e0aa3dd6333ac3a65bd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i06bd54c2ec1749b6bfe532accaddeb19_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i15075758aefe43d2bf31d3cc52dcb868_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i75cf4995d769495181bc451a1291d416_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6964724f64da443a8d85ef14ba9b207f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibc8d04d5adea4cc4950dd1f1163a8c24_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i467dc11c176c49a494b2bfbc4ecd8d40_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4561999a767a47c9b145429b6871dada_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i49acfce007b84f6a8ed646d3879a295e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i47f6d39a48124eada9253e73f5eb298d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i425da7be65a34eadaf6d0d7d246f41ac_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6dea2df573724790a05410f34ffcaa89_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaceec8e969924b699be4f035e5a5f056_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if4bcbef4b6154d14993eefedb06e445c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1d3a7dadc46046679f4259f0c2cf607b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3bb67485d5704379b1a6d4da590cf813_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i25c01da9448541d9a4bbe6f5bf974426_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icff5a9de270b47439f9f2e3164cdbaf1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idce9aa4064f649998284ca968ead9aeb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id88dc572d4a4463a87db8a149bc97af6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia48873c4be084823ac547c96b29588bf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i361bca717f0145f392b30b6c5842a5fb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieb37318a487b4f68b2cff4e55df4fae8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i458d0bce582548dabb9da928f9be1723_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2f36bf1575754528b65dba20e88e4417_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i34cb265be9104204aa213bd1c51fcdbb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i859f79ed7f81424ea30511713f0e5fd7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icd55208234184797b8bc48b1ab33f4f2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i047b2e5d175948e28dc1326800198805_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3a9722f65b7649a0af5a40118df4c83a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0fb1ff4cb6bd4a5f987eb066e1579632_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3d10279e4e4240e58c58b67195918c98_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icdeaeb4835884f6087e9025f4a721a0e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic03a2021968d469cafd277b1d48aeec0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4e96192e9c994cc3a7cd9d3198afec11_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1b84bbaf70a647149bd4230fec93c00e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i434d9033c59345d994a83769698d5f43_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8553b3aff6d249b18a9cd384b6c1a55b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i82cdd943a4d64fa6817835bd3971c780_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i293cf1a1995d4e29b26bc330b1666507_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6ceb26b60fcb4903b42e2e7063f9ec62_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1b1cda680d3d4f8696d51e3ed6642658_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i10542d46becc44c5967969f7f85f3589_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i292b96aad4ec49cdbd305facd2f76542_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5f6a83783837419fbce160a80bfc2d32_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie6ba387bd5784b3588f79042c1627c7c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7b3fb67b13b4433fb27cf39843018e90_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1ba4905b6b0747a79b11529e76f3525a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id34b6ff6eb5d4ff8b7d64f102c051a4f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2f8b8e5367b4480ea7d27890901e6247_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2483b2d9ed46464386b90249127712ec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5a89dc1177b443eebe04b19998c03509_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibf9ceb18ea574327a935ba6e88f2287e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie38b76b68c8f4324b3b7de80321c3a38_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib4c7e5e536ab42b8b050fbde07b7944b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib321cf5df709449c9ceca7c03a1a464a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie5115a8b317f4f088dd39cf66bd37168_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia7ca09ccbe954fe782f927e64956c241_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia6de203a7cbb4d628006e35c743071f4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibe3ca3dba18c491a9e22b5dec78052d1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4f8b8023230e41f1a277473b8be2f39c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaac68e1f017c44aa9dd4c8012dbc3c27_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i422a5afe8aab4de28a6a361f067c59ff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i55f94c0a8c604d198a8060e3981590d2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3f4a9f967aaa4491ac8ac4bb55abdd08_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4c682f38539f4aea97612b5c8fd96801_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iad6319eb9e074402bd329fc00b71a0d4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i225a548f115e4e4cbc128578264d598f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1b7f7de16d6f455b9b95fe42c0e7ddf4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic622298e7e1042bab9e914624480e3f3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ice305fd722c144a8a3962bcd2d78808d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic6fff6d946ac4c55bcd073422901fa74_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idec237e4913a4141abffa54109b01c5b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i424cf2f1fe794bf8b9685e626e4b60eb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i92dad2a6cdd147b4a4bab53cde589c29_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i841e9a2db5bb4870b1acecc87843ca11_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i323adde47a404de6a429ebcdc6d4a624_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i66bfc1b58bee484ca8439711f02fc588_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6febefab642d465386af8f7ad424e1d9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia8b7ecb5ef6b4772b3207c0af0378129_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5d7062cfce4d47d4950a86d0fe1a51be_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icc0351d4a2c042f8ad934772134cdbd5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i588df02460dd45ebac24745a67831e0b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaa15814eab354d1da0577719608c58a7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie93d0f38ac78460a8408e52712b8a9e0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i62058f08b95b41b29a2bd7105c86068a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib0978cb2beb54ca08a64c48351e6340d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9283234f91734e7f8067245dffa66546_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4a65013be1484144aa7390d6ce8685f1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0dd96e63a05b477c81a74ccccae0af1a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7d58e5df6a4d4dc2b2d2020abf96dab7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i30951550eb89447faeb8aed509f96d7a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib5e498c9e0e949d295170b34d02f42b1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iecf6ed88f0704ea1b5a17c05fba15357_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie5a4161ee999468695164764689d0456_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4b5516f1d83549df8e3672acb28d4018_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i57859501e60645cb9752e9e1f0aaca52_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4691f1cc92b841bebd9eb3e713080db4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if380f772d15949968faea35f6c392908_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9a39f01aeb134cdc96203f9fb9113b29_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib12ac2d182de47eabc00a82a798699f2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia432ea4fe3664eda9ea74cb9f5d6541e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id85fcc73165340dca7de806a6adfdfbd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i06c3b035437e4295b67d73728537c87e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7760d59224714c619f74107d44fec8a9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9b273fdc1bd847ed8bc54eda0343fb49_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f27f3a0ddaa4943a0a01af080cffc48_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9c0c1b4aba8442ebb3315909595081fb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i606a32f530d0485e9489b153aae2186a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ied58211431b74500ad5aa97b2eb41a6b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i626787e8dd8a4a428e915960b4c68a35_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4ffe6c35b7494418ac8c422fd3541f2b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i63c0c51144c74ed59e090814aedeff5e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i63529787efd54319893b4e048ab45752_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic094ef4183de49abb0d6149a76f6e4e4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i72861e7450344b1abe5a17aa6d5da491_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2fb5d20c5bdd4e3c88101cecdc5afb9b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i391c77fcea114168adcefd3a368e933a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8291bfbd551444d08280efa65d088b0c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i16285192a2914c1f825e830eeb4eeb4f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9d3917a82295412f9c9275a317a05f05_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idfd78e27e7c6482c9fc4edcc25879cfc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ief0525a09e3740098895f800adaf9574_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib3fd8796636345479f329fc227aac5b9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id74fa3142e884619b01040d54d501710_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icc02cf1426314af28563a5e9e8a9a5e1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2cdf7726148d4d678b6d37597a2aac70_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i92b4331fe0364273803356e287d2561b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic928117af54f4c0892def0fc4bb4ca6f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i535c834eab7441c89aa3908b303c0da7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6621e945d6764a88aa47982bd5644a44_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if24037d3545b44d7b17124b131dcad75_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i397591891c3b446b8fe2edeab28e0a83_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idd0c449a45b5463791a11ad8fb885a7f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibab30eb09068437faeb20a15dacc2fac_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i534f8d2a6659488381539213487bbba7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateInvestmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib6f3a72a51a14616b3c062670d5dc4fa_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8dbb3cd21e554ebcb4cf9e874172fbff_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i384b40a0741e4d28b9e0484a44c098d9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib0d860116b5a468e8949760638176508_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie948ccd30d67420f85d943d80b28ab90_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iad4db4c6c00f4fadb397e0b96255d42c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idb4cca5b0ebf4f3aaa50ec243577cbda_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia298adcd58b540f39bbb027f8433e7d2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvs:CVSHealth2017IncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4a56dcd6eefa4635ba2a3f12f2cf62af_I20181128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvs:AetnaInc2010StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-28</instant>
        </period>
    </context>
    <context id="i8a7879ca683449ffa5da3418bf44e68d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsAndPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id4b79b50a55d4d81bf3f34a3889c23df_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsAndPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if240ee4b0e0f42d0b398179a94077c59_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsAndPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i983d904f9748498597906f71baf2d240_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iadd17fda7e474b46b4ac5a0ddb578ebe_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i70ba7d8cc22e4bd9aed774540fbc5a2a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsAndPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i84d934c3f64d4e02a86157aaa7bdff55_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsAndPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1ff8661ca2c148108297d7a193977a4b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib929cd58d3cb4a4096643aeea5fb40bb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i73e8856343074dedba7db4a6c8fffe3a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idc7553fd8525450491acaa6901e0117c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie6f1a0aed7b14023be37031ee7e6081d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6f45fbcf1c62442cb073a0677f6e9707_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2310964202714b25bc144cf465c755a8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1075aa911329487a922a9ba44f7a262d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i282e236db6f547ceac0cbccfa36c5851_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5c6c53ae9a7745a09f19b70ba79aa0c2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0c6f50abab644dc7a7aa89e157fa28d7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3754a0a6a19e4cec89a94c39d17cded7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibad8baec27da4cd58b6724ab5ca623d2_I20221117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2022RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-17</instant>
        </period>
    </context>
    <context id="ia92776d15fb0441ab7ac651bee86eba1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2022RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7008e24144824bc0af76d8c285ae7f14_I20211209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-09</instant>
        </period>
    </context>
    <context id="i5a3166170d724c7b97874fd6a4dd3558_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8e288b240a5b4df481e15c83675a98b4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1bffae2ffcf645319842b632734137ce_D20220104-20220104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-04</startDate>
            <endDate>2022-01-04</endDate>
        </period>
    </context>
    <context id="i84ac2198cd22435ba1570e2db00d59e9_I20230104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:CitibankNAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-04</instant>
        </period>
    </context>
    <context id="i25c547443c724d349e0e7af7c9e93168_D20230104-20230104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:CitibankNAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-04</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="i3d0b0cadc79d4115ba44a2ff3d97605e_I20220104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-04</instant>
        </period>
    </context>
    <context id="i094abc0cc72e4a7b9ea560f3aa3450de_I20220104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-04</instant>
        </period>
    </context>
    <context id="i17d6d14c27bd46188dd9e2556640612b_I20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="i12bf05eff52b4dc7a2761da3f17bd087_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3549637e3aa64b7ca86fda506d366817_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id5d6daa4ca684089955a31c220b36c14_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i59704ef4a59040dea06f0021fcb06568_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifc442e76415641328a8c0780c2b0fd3b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i52430d6ae75d4b3fae0b76f1ae95568c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i500357364f0b4a8aa0660969b4e7e47e_I20230101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="i2861b22f2af148719342305921a4f8a9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHMOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib3c08b2b0c4e47d4803766dfaa373def_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHMOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i55bbfd8a1ccf4503a274fb9d768bf153_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHMOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i10dc16dcaa2a4ba381f65a9a4a83824e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHMOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3172ad2aca194783adc959bfa45cb532_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHMOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ice175d1759f24588b3cf0829061e9e44_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHMOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic9ccb78a44d7465982d030ff243bbb22_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i771fadc404fa4b92b4c5f7223f25415c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i88fc675ce48b4c548ef81361fcc6c9d6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1dc4dc90c6c14d12b12e609426ef8a6e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibcd29ef153c04215b9cfa268ba78b5f0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7f0ef44e552b4f5b981adaa9006f01dc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i023f6f414fc44282a2cc8132892a707c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iee8d0bfbbe9b491fb9bfa6c2b789c080_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i07377a7640384b77a5031acac5ac0cff_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idfb87a5b2adf46d8a1cc7648916f9ec9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifea16681bcf147688ca4766b0691becd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0883ba92f0894b389a5662952ea59782_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i25433e213492429485a961cd63705c7d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib0cc3bef65884acf9911dabdba462d4a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i766e456db6b04cc6983552df4d2bd677_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5e7b828a30914b35b0be92961fa877cb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3a4812ee71224d53b0a6f7e8aee63c1c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i598ca408d2d84a49a1bce5601d7579a1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i811c61381d624e819e35527aea6e070f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia514adc5b997452badcc59a3cef31271_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cvs:AOCIChangeInDiscountRateOnInsuranceReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i01610c9c48964170846a9803dfaae808_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic5ca31cddc0e4d939c02b38a65d9a6dd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8c92e83572bf462c88118f40349b2650_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icb9f09a01d4b4d99b74e89116f65644f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i22d7007c61d0497e98e462fffb60e872_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if125eb5e1f404115a1ed0d00ee58b816_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2aee76db1bb748378d6caddd4053ea53_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i90400ed7cb0a406798d26f08b8d43428_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i82369985b1244530ab5a13db891d7cb5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iec1de78285984edda41f8718f4ee9eae_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifb77c13970ba4503946c83a942f0b97b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7f3a20682c0f4c82a18c98153f67cbfd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1c4a15704cee48ee8522b657c8eb6247_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if5be5c21fc6b47318e20171c1f0a645b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6b84989b019a41baa48fa485b7f433eb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1aeff9cdec2548d19148b1b223aae8c8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6f4df77c750240e3a41b042b6e64fc43_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0b83d8d8e7104451a4bcacd3638e07ca_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if885d6ab9e204495a3e6ef113c294079_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i72d609617ef245bab1355fa62da5e409_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7a3276638fa043e8b7afa530e1d05bb2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4fb000b6c98f4852bdadc304be11feb1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8cf1c76c42274016b31466d614be3e9d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i351a28ebc5774422943a9b3793f826c0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9e58ede6136947f8b425e9c08cd2ab43_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iba7e0b37b090469783d9d2507887d647_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i45396cadefb0439195f503c88cc4379c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic2b7c36808c049e6bacef0812147f213_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibeb7c35ad88b4db086fed358829f1fca_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:StockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iac8347b945e247b7ba7d5c565f033409_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:StockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5695caba25e84d32ab05654a2de0b06a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:StockOptionsAndStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i54d9d35ededb400290c122b74d7762fb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i10fcd8594c7341938f00b2bcb419f4c9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic788c95fb5c54497bda6d70714f8f38b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if8b5128a2a36428d980c81abdc2d74c7_D20230101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="icfc7256b949f40db867c30ba258ef319_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:HartfordLifeAndAccidentInsuranceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i31cd59a8c7b74ded8d867dc5a415def7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:HartfordLifeAndAccidentInsuranceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i17e2ab802dda4aed8d1d06c6ae11e2f6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:LincolnLifeAnnuityCompanyOfNewYorkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i67df86d1566f40d3984c59da72c03ce0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:LincolnLifeAnnuityCompanyOfNewYorkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibc5740783a6940949d69470ccd32d19e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:VOYARetirementInsuranceAndAnnuityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i20f471f240524ef8b98dd7b01be1b787_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:VOYARetirementInsuranceAndAnnuityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0162c987e7634f4fae5ee04958939adf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i30bb205b44d94d42bbc0af842bfe1376_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2253b0fadbb64b758c7a25f141c58162_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:AllOtherReinsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i91b1f9bf665d415c9bc2b9f98030d772_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:AllOtherReinsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i89589b4e8c2b4f25b791df1123f534f7_D20220801-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:FederalCourtInOhioJudgmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="i03d4640633404e31a33fb826637ad08a_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:FederalCourtInOhioJudgmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="i3b026ed44ce7463faf26ee5548ce9d7d_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:StateOfFloridaSettlementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibaa8af588ffe417797fab6c210df9c5b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:StateOfFloridaSettlementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8f9313db581d4747bb5036854512069d_D20221201-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id48716cf9312414a9271423a5fd71f20_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie67a9c6077ac426d83b2d281de921897_D20221201-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:TribalEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0711d6880304457da9bc46c7f815c64f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:TribalEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i429b564fb66a4c4db88cad8833594b8a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkAndOtherOpioidRelatedClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i939712c24e004976bf4f03ca8692f893_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkAndOtherOpioidRelatedClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaca84de086504e58ba6e3854de871467_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkAndOtherOpioidRelatedClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i64d6b9d0c0594df5bccc5dbc7ec5cfa6_D20230101-20231231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkAndOtherOpioidRelatedClaimsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="if13a1b08fb134bc2819e0fbde58e3608_D20240101-20241231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:SettlementFrameworkAndOtherOpioidRelatedClaimsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="i51647e75bc724c0097093f48fc959e1c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:RadcliffAndFlaimVAetnaIncEtAlMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic57ff1de57e040e09c97cab45478a2d9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibe58c09ac79e451fbfad93b9169958d4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i12151a132ac84f09952fa59e048adb99_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie15ff7b3ed9249059a31d87e8221ef8d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib242b2a53204442293d0e613aa093688_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i83a2435cc9ab448c913552eb356f4039_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia379beb5856c4694ac66b32c06bf2386_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1707f9f5c214463ebc3f072c05afa26e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0a2425da88d34b11a7d4ed0662f4e0c0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5da73c1ec8f946c9afb45f207ff36c25_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3bddb95b4cf348ec83e4a333d7575820_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2b1171c68bbe4af1819c9145310c6fb8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iff2a6e509d3c452fbb34c09f2c1f55ea_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaf761e93be114754a9786359d43f61dd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8708367e0d6148a297ee5ca38d90794b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if5e992bf9c2a499eaf6476b15ef7c5f5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifc4a75422af949c2a32932d3412701db_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i93f387cc7da9423da81f99d85943fc07_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia738f2f875064e3b9b39a81213de4404_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i57299b3f0d29410bbd43971727bf7de2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5cfee834f48c44269e6203285ea53742_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icf605eb33300435fa4bb68398ee8e8db_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3b8dd9bca2d845c5a94bae3567479a9e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4bb91f8d55eb47ff966a699f6afb0276_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic8b4d98a4ab443d1864e4785b87c3333_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iebc232da670a4ceabcfa09b1f0849657_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8104c5fdfe0c4205a5f07c99c7cede7b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i90b72ec258964345839ac8de15529de0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i677074299da14bd2b078357e93653928_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i114930f0b44c4d1a9f07a0c3d6dd2dd5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia1b5e13d39f046e3b93ecd36eeb5ee63_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib4d84170ec8e498b9520974828e0c142_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i948f596e14ee4a9d9806fb733eb3ebcd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i782729dd554e4d80bb426bea495446dd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i963c0343d69a42caadc378204229b722_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cvs:USFederalGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i03d09415d2bf43b384994476ca92e168_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cvs:USFederalGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i75dd5be1e137424fa4519c29f0daa19d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cvs:USFederalGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic42863604ce54004b9083c8738b254f9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5a109a847174412e8d5696bab1036d5c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i94f2ff5e331c4b7687981a263ec1c30d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7643d22e2ea64b119f44152086b5ef19_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i28a3b9441e5e432f912162e86ac57adc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i38f3804941744661bf9c3ad58fc2aad2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9d20d05e0c4b4f8688a601a6a2a0b0df_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i940aaafcbe33455889e57c5de95674de_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i94f36228e56d4a5e93aeacea94e8a9c3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyAndConsumerHealthSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8b77d3d696ee47dba7d85700d9f05fd1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="store">
        <measure>cvs:store</measure>
    </unit>
    <unit id="clinic">
        <measure>cvs:clinic</measure>
    </unit>
    <unit id="people">
        <measure>cvs:people</measure>
    </unit>
    <unit id="patient">
        <measure>cvs:patient</measure>
    </unit>
    <unit id="segment">
        <measure>cvs:Segment</measure>
    </unit>
    <unit id="state">
        <measure>cvs:state</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="member">
        <measure>cvs:member</measure>
    </unit>
    <unit id="security">
        <measure>cvs:security</measure>
    </unit>
    <unit id="reinsurance_agreement">
        <measure>cvs:reinsurance_agreement</measure>
    </unit>
    <unit id="lease">
        <measure>cvs:lease</measure>
    </unit>
    <unit id="claim">
        <measure>cvs:claim</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl80L2ZyYWc6Y2EyMWYxMDU2ZTQyNGI1ZGI2YTUzOTdlNDEwYWE0ZTUvdGFibGU6YjM2MzE4YjJlYjFjNDE3MDljYjE1ZGI4MGFlYTcxODYvdGFibGVyYW5nZTpiMzYzMThiMmViMWM0MTcwOWNiMTVkYjgwYWVhNzE4Nl8yLTEtMS0xLTI5NTk1MA_c8525f0f-55f5-487f-9d94-197de8384e84">0000064803</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl80L2ZyYWc6Y2EyMWYxMDU2ZTQyNGI1ZGI2YTUzOTdlNDEwYWE0ZTUvdGFibGU6YjM2MzE4YjJlYjFjNDE3MDljYjE1ZGI4MGFlYTcxODYvdGFibGVyYW5nZTpiMzYzMThiMmViMWM0MTcwOWNiMTVkYjgwYWVhNzE4Nl8zLTEtMS0xLTI5NTk1MA_af953528-4395-4cd9-8f87-1cf5d537c952">false</dei:AmendmentFlag>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzktMC0xLTEtMjY1MjQ3_12bca5b1-23af-42d6-b88c-b1f9c3ab0adf">http://fasb.org/us-gaap/2022#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzktMC0xLTEtMjY1MjQ3_37844c1d-74c5-4011-9d73-512e7f125ba5">http://fasb.org/us-gaap/2022#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzktMC0xLTEtMjY1MjQ3_ce0c18b6-7308-4640-8eef-4206af025a79">http://fasb.org/us-gaap/2022#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i25c6ac63a35547a0892e0ad2dfe09bba_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3OA_50a38f39-24c9-439d-81f9-601a8eefa8a4">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzk4OTU2MDQ2NTA5OTM_e949208d-ec5c-442c-bfb1-60608d2297f0">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201812Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i2a0e4c7bb5f84714898af13dee589b68_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc0MDU2_6fb0217d-b4b8-4272-817b-3803971eadab">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i1940fff7a85145088d00871bcb52c604_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzYvZnJhZzo5NWM1ZDdhYWVjNTg0NzBiYWQwZWZlZWFkOWRkN2E1MS90YWJsZTowOWYzNTdmOTYwMmE0ODAyYmY3YjYzNjkyNzhmNGQ4Ny90YWJsZXJhbmdlOjA5ZjM1N2Y5NjAyYTQ4MDJiZjdiNjM2OTI3OGY0ZDg3XzEtMS0xLTEtMjY1MjQ3_d7e4a9b9-7c68-486e-bf1c-26ccfbf6a85f">P0Y</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="id45be672fded459fae66de88c0ad4a5c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzYvZnJhZzo5NWM1ZDdhYWVjNTg0NzBiYWQwZWZlZWFkOWRkN2E1MS90YWJsZTowOWYzNTdmOTYwMmE0ODAyYmY3YjYzNjkyNzhmNGQ4Ny90YWJsZXJhbmdlOjA5ZjM1N2Y5NjAyYTQ4MDJiZjdiNjM2OTI3OGY0ZDg3XzItMS0xLTEtMjY1MjQ3_5a6b0fae-c7e1-437c-bf14-3ee175daa0b7">P0Y</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUyLTAtMS0xLTI2NTI0Nw_1b8d2063-d583-4908-be86-f25a8a8346c8">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUyLTAtMS0xLTI2NTI0Nw_d9e5828d-1d67-442b-bf21-ed9fd901073c">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i2a0e4c7bb5f84714898af13dee589b68_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzE3Nzg_6fb0217d-b4b8-4272-817b-3803971eadab">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType
      contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8xMzcz_377d959e-7975-457e-a178-65b3a5c0dec7">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGFibGU6YmRlY2RlNmM1NTU2NGM2MjkzZjcyYTVlMjc3MDc4YWMvdGFibGVyYW5nZTpiZGVjZGU2YzU1NTY0YzYyOTNmNzJhNWUyNzcwNzhhY18wLTEtMS0xLTI5NTk1MA_025cb68f-a8bb-491e-83c7-1be68f3c68e8">2023-05-25</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8xMzc0_8ff1357b-7175-412c-bf86-0f83bbf8bbc1">CVS HEALTH CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGFibGU6MGZmODY2ZTRmNzFiNDIzYWE5NjExYTIyNTI4MjQyZTcvdGFibGVyYW5nZTowZmY4NjZlNGY3MWI0MjNhYTk2MTFhMjI1MjgyNDJlN18wLTAtMS0xLTI5NTk1MA_481e200f-541b-40ae-89b6-fd102467104a">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGFibGU6MGZmODY2ZTRmNzFiNDIzYWE5NjExYTIyNTI4MjQyZTcvdGFibGVyYW5nZTowZmY4NjZlNGY3MWI0MjNhYTk2MTFhMjI1MjgyNDJlN18wLTEtMS0xLTI5NTk1MA_2b398288-4fae-4580-90bb-0de4c61a7d62">001-01011</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGFibGU6MGZmODY2ZTRmNzFiNDIzYWE5NjExYTIyNTI4MjQyZTcvdGFibGVyYW5nZTowZmY4NjZlNGY3MWI0MjNhYTk2MTFhMjI1MjgyNDJlN18wLTItMS0xLTI5NTk1MA_e4c2b07b-30eb-4a4d-9e64-a40a9385fcd7">05-0494040</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8xMzgw_e2a78325-653f-434c-97de-049faa58f44c">One CVS Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8xMzgx_3d7642e3-291d-4894-a91c-7d6fb8d2dc86">Woonsocket</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8xMzgy_2fb0e9d1-08c8-4beb-b9fd-3011f9103949">RI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8xMzc1_43fc03e5-156a-48d6-b52f-148515c78662">02895</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8xMzc2_2f0bd71c-bd37-4de6-9514-028c69775bec">401</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8xMzc3_472ab543-8518-4590-b92a-85b0ecd20c25">765-1500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8xMzgz_c2757e3e-5a4c-479e-bfd7-3de77974f240">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8zODQ4MjkwNjk4NjAx_9a98f485-f2df-494e-a642-282fca52dba0">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8xMzc4_33f43d64-044a-4f31-812f-b3120f59a56a">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGV4dHJlZ2lvbjo3ZTcwNGU3Nzk4Yzc0MWY2OTJjYjA1MDA3YzIxYTdiYV8zODQ4MjkwNjk4NjAy_b70e3d69-2328-4cdc-b8f4-3f63fca710df">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGFibGU6NGMxMzI4NzcyZmU3NDliYmEwNDhjNmRlOGE3ZGJhM2UvdGFibGVyYW5nZTo0YzEzMjg3NzJmZTc0OWJiYTA0OGM2ZGU4YTdkYmEzZV8xLTAtMS0xLTI5NTk1MA_6ddcde3e-0c0c-44bf-bc6c-add92cd9d723">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGFibGU6NGMxMzI4NzcyZmU3NDliYmEwNDhjNmRlOGE3ZGJhM2UvdGFibGVyYW5nZTo0YzEzMjg3NzJmZTc0OWJiYTA0OGM2ZGU4YTdkYmEzZV8xLTEtMS0xLTI5NTk1MA_e6a7991e-95a1-44e1-b51e-b7d8c2541836">CVS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGFibGU6NGMxMzI4NzcyZmU3NDliYmEwNDhjNmRlOGE3ZGJhM2UvdGFibGVyYW5nZTo0YzEzMjg3NzJmZTc0OWJiYTA0OGM2ZGU4YTdkYmEzZV8xLTItMS0xLTI5NTk1MA_1f730c08-4112-4d8e-b87b-8671c171a180">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i3fdad821325f486399d0038fd579bc16_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmI1OGY2MDM3MmVkZTRhYTQ4NGU2ODgzYWFiODY4NGFmL3NlYzpiNThmNjAzNzJlZGU0YWE0ODRlNjg4M2FhYjg2ODRhZl8xL2ZyYWc6N2U3MDRlNzc5OGM3NDFmNjkyY2IwNTAwN2MyMWE3YmEvdGFibGU6NTk2MzJkM2E0YWExNGQ5NzllN2U2ZGEzOGY3MDNlZGQvdGFibGVyYW5nZTo1OTYzMmQzYTRhYTE0ZDk3OWU3ZTZkYTM4ZjcwM2VkZF8wLTEtMS0xLTI5NTk1MA_19b55b93-3436-4089-bd41-aeae222e6a49">false</dei:EntityEmergingGrowthCompany>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c03b0b923c54303a8e4d6db0a6f037f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMtMS0xLTEtMjY1MjQ3_12bc1ab6-b89a-424b-9b85-40e46c6e6d90"
      unitRef="usd">226616000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if380faf89f3a40dbaf2259ac9b4e1da0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMtMy0xLTEtMjY1MjQ3_16f4fb69-1845-4576-9fc3-3a49dcda6824"
      unitRef="usd">203738000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i71272148942c413e8aff1c85d881ca42_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMtNS0xLTEtMjY1MjQ3_ebbe8875-4695-4193-a591-2791affc7909"
      unitRef="usd">190688000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:PremiumsEarnedNet
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzQtMS0xLTEtMjY1MjQ3_03a76e9b-208e-464f-86ca-6e4898d745b4"
      unitRef="usd">85330000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzQtMy0xLTEtMjY1MjQ3_efcbe5b3-0694-4b2d-a619-e30445e8309a"
      unitRef="usd">76132000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzQtNS0xLTEtMjY1MjQ3_2a98378b-433a-47fd-a361-9a88b9fb9bc3"
      unitRef="usd">69364000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6714e63c7e1a4403b7da499509c4edf2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzUtMS0xLTEtMjY1MjQ3_c05a1e16-a019-4ca2-bf6c-bfb9a65f5838"
      unitRef="usd">9683000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a007ee2153647ad8e132e0f3db03235_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzUtMy0xLTEtMjY1MjQ3_0ff2a693-234d-414a-8542-aea6208134dc"
      unitRef="usd">11042000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd39a8cee1e445d2965bc047c1ffd8dd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzUtNS0xLTEtMjY1MjQ3_c4073a2f-536d-48b3-8a21-b416d5b26847"
      unitRef="usd">7856000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzYtMS0xLTEtMjY1MjQ3_bad83e7d-b960-43bd-a973-649ca29804e9"
      unitRef="usd">838000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzYtMy0xLTEtMjY1MjQ3_cee63ecd-0af9-4a32-afb0-1203079b2622"
      unitRef="usd">1199000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzYtNS0xLTEtMjY1MjQ3_e8ff81fd-dfa7-4298-82a0-29045cca3a2b"
      unitRef="usd">798000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzctMS0xLTEtMjY1MjQ3_ee125622-80c5-4f5b-b2d4-686056773309"
      unitRef="usd">322467000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzctMy0xLTEtMjY1MjQ3_d18d7843-f0ce-46ce-b6e5-88247b187e19"
      unitRef="usd">292111000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzctNS0xLTEtMjY1MjQ3_efc13146-cf71-4247-81b1-2731127b7d71"
      unitRef="usd">268706000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzktMS0xLTEtMjY1MjQ3_d35eee6a-c88a-4942-a90d-fc7eb0ebc327"
      unitRef="usd">196892000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzktMy0xLTEtMjY1MjQ3_b4a526da-9e58-4124-b6cf-35f7f01a872e"
      unitRef="usd">175803000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzktNS0xLTEtMjY1MjQ3_4f5109eb-59f0-4cea-9ae5-ef5620a7bb17"
      unitRef="usd">163981000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzEwLTEtMS0xLTI2NTI0Nw_821f1d87-8d20-4ea4-b5a8-315f1a718c8c"
      unitRef="usd">71073000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzEwLTMtMS0xLTI2NTI0Nw_206963d6-7645-49bb-9209-fb628f4c7351"
      unitRef="usd">64188000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzEwLTUtMS0xLTI2NTI0Nw_d8c9f3ec-7fcc-43e0-8e1a-a338c868956a"
      unitRef="usd">55679000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzExLTEtMS0xLTI2NTI0Nw_afe0f887-8934-4c15-bb2d-dae3f1786185"
      unitRef="usd">-5803000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzExLTMtMS0xLTI2NTI0Nw_a3feceda-aa6b-4f78-8e64-ef950e0578a4"
      unitRef="usd">0</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzExLTUtMS0xLTI2NTI0Nw_db531c43-34f0-4165-a2f7-6bbf8e5cfc31"
      unitRef="usd">0</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzEyLTEtMS0xLTI2NTI0Nw_183755dc-d615-405b-a2de-c149bb2dcc61"
      unitRef="usd">2533000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzEyLTMtMS0xLTI2NTI0Nw_bef59f07-ef87-49ef-bf83-f7478473e0f0"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzEyLTUtMS0xLTI2NTI0Nw_5f51f150-786a-4c95-9c2f-d5fbee2e19d2"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <cvs:StoreImpairmentCharges
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzEzLTEtMS0xLTI2NTI0Nw_b25dcfb1-bef7-4083-87c5-0a86492b597e"
      unitRef="usd">0</cvs:StoreImpairmentCharges>
    <cvs:StoreImpairmentCharges
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzEzLTMtMS0xLTI2NTI0Nw_2f32d107-d779-4255-b558-e01aae992c9c"
      unitRef="usd">1358000000</cvs:StoreImpairmentCharges>
    <cvs:StoreImpairmentCharges
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzEzLTUtMS0xLTI2NTI0Nw_69d99d16-ec7b-4808-b790-ced92b1eb04b"
      unitRef="usd">0</cvs:StoreImpairmentCharges>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE0LTEtMS0xLTI2NTI0Nw_8820923c-b3e4-4c4d-b4cb-db98ae1fc343"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE0LTMtMS0xLTI2NTI0Nw_ce500488-202d-48f6-b4cc-94790f422375"
      unitRef="usd">431000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE0LTUtMS0xLTI2NTI0Nw_2f04a425-8ccb-4bbd-b122-8124688d91bb"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <cvs:OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE1LTEtMS0xLTI2NTI0Nw_5bd20a2f-d082-419a-87c6-1fd455136c8a"
      unitRef="usd">38212000000</cvs:OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement>
    <cvs:OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE1LTMtMS0xLTI2NTI0Nw_e3970a92-6280-4912-a84f-b2e9131af402"
      unitRef="usd">37021000000</cvs:OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement>
    <cvs:OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE1LTUtMS0xLTI2NTI0Nw_da3c3400-254a-45eb-a3e6-cf011421c4e1"
      unitRef="usd">35135000000</cvs:OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement>
    <us-gaap:CostsAndExpenses
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE2LTEtMS0xLTI2NTI0Nw_e8b07901-d5e2-47d1-b2a9-6f16dc6fdb57"
      unitRef="usd">314513000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE2LTMtMS0xLTI2NTI0Nw_cfcb93ad-fa9a-450a-8c75-1e0a5f4c9fd8"
      unitRef="usd">278801000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE2LTUtMS0xLTI2NTI0Nw_79632056-f8cf-4f26-8e79-bcc42d7631c1"
      unitRef="usd">254795000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE3LTEtMS0xLTI2NTI0Nw_fce320d2-b2ab-447e-8939-6930c647c22a"
      unitRef="usd">7954000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE3LTMtMS0xLTI2NTI0Nw_3f1231f4-a8a2-43ec-934d-77eebbcc6308"
      unitRef="usd">13310000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE3LTUtMS0xLTI2NTI0Nw_55123b7a-c5bf-4b78-9619-cf1c177a2de1"
      unitRef="usd">13911000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE4LTEtMS0xLTI2NTI0Nw_489f7a76-0bdf-4b6e-badc-7c774e096761"
      unitRef="usd">2287000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE4LTMtMS0xLTI2NTI0Nw_685f3ddd-0176-486e-af42-6e9ce36d8f20"
      unitRef="usd">2503000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE4LTUtMS0xLTI2NTI0Nw_90b28c09-fba8-431e-abe4-6c03e87120af"
      unitRef="usd">2907000000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE5LTEtMS0xLTI2NTI0Nw_e4b0e310-95f7-4af6-a824-6f69f837fd76"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE5LTMtMS0xLTI2NTI0Nw_91d1fe28-e2f1-4141-8fa4-ca335bdf795c"
      unitRef="usd">-452000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzE5LTUtMS0xLTI2NTI0Nw_fc7c1a57-60ad-4389-bd31-434e2da6a7e3"
      unitRef="usd">-1440000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIwLTEtMS0xLTI2NTI0Nw_7e9af490-aeb3-444d-9c20-e954bfeaf5c7"
      unitRef="usd">169000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIwLTMtMS0xLTI2NTI0Nw_94d28fc8-1710-479b-ad18-832adb335eb9"
      unitRef="usd">182000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIwLTUtMS0xLTI2NTI0Nw_ed35cba5-bf06-4cf4-a28e-f1f95938f4b9"
      unitRef="usd">206000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIxLTEtMS0xLTI2NTI0Nw_f8bc440a-bcf5-4d51-abf7-954ab910bab4"
      unitRef="usd">5836000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIxLTMtMS0xLTI2NTI0Nw_e4f45d5d-cacc-458a-8979-136745a4367a"
      unitRef="usd">10537000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIxLTUtMS0xLTI2NTI0Nw_6e5cca89-f772-48d1-993d-dc59f2b5407b"
      unitRef="usd">9770000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIyLTEtMS0xLTI2NTI0Nw_e10f6d7d-d7dd-4093-9780-7e1562c1fa34"
      unitRef="usd">1509000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIyLTMtMS0xLTI2NTI0Nw_33477a3e-526a-4f5b-9e76-cd6f866510eb"
      unitRef="usd">2548000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIyLTUtMS0xLTI2NTI0Nw_96b2c984-953a-445e-bab5-b57d2114155e"
      unitRef="usd">2569000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIzLTEtMS0xLTI2NTI0Nw_084cce72-b6ad-4ba2-a7ab-1d1ef2a5d92b"
      unitRef="usd">4327000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIzLTMtMS0xLTI2NTI0Nw_4f5ed495-9df5-4082-8b65-2634354f12b7"
      unitRef="usd">7989000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzIzLTUtMS0xLTI2NTI0Nw_5af6bb7b-102d-4e3c-b935-5b7d300bdd40"
      unitRef="usd">7201000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI0LTEtMS0xLTI2NTI0Nw_54aed051-7847-48af-a936-8297f73f6b26"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI0LTMtMS0xLTI2NTI0Nw_d3a42155-7ce3-47d0-8dac-38258ced872e"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI0LTUtMS0xLTI2NTI0Nw_9b1bbb2b-8848-4f3d-b45c-bef4398c8c0b"
      unitRef="usd">-9000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI1LTEtMS0xLTI2NTI0Nw_e8bd4930-c640-49b5-bbb1-eb1e49e2f59f"
      unitRef="usd">4327000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI1LTMtMS0xLTI2NTI0Nw_b6b49b46-69ab-4bd8-bf5a-1e258408a55a"
      unitRef="usd">7989000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI1LTUtMS0xLTI2NTI0Nw_ab0da9b8-9ba6-4f5a-a595-b97615c93da3"
      unitRef="usd">7192000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI2LTEtMS0xLTI2NTI0Nw_1ae69753-b9c0-4129-9272-8ea2b2d9b679"
      unitRef="usd">16000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI2LTMtMS0xLTI2NTI0Nw_94d4536d-4218-4d3f-9a88-155a2a439ad6"
      unitRef="usd">-12000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI2LTUtMS0xLTI2NTI0Nw_ff640993-e49d-42fb-a12d-e1d9b94cf1a1"
      unitRef="usd">13000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI3LTEtMS0xLTI2NTI0Nw_adfd647c-5cc9-46c6-b369-f09204e82135"
      unitRef="usd">4311000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI3LTMtMS0xLTI2NTI0Nw_3611468d-0bb7-4b18-ab8f-87e6dcb31acc"
      unitRef="usd">8001000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzI3LTUtMS0xLTI2NTI0Nw_887875d3-942c-4302-a6f2-718fbbbb5caf"
      unitRef="usd">7179000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMwLTEtMS0xLTI2NTI0Nw_17352da6-8dc3-4041-a55d-f6cafb0121f0"
      unitRef="usdPerShare">3.29</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMwLTMtMS0xLTI2NTI0Nw_4cf1a58c-40ee-4fca-9b61-2ea61f9a6d4a"
      unitRef="usdPerShare">6.07</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMwLTUtMS0xLTI2NTI0Nw_c4e86d90-c873-4bee-84c8-b7f0b09deeaa"
      unitRef="usdPerShare">5.49</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMxLTEtMS0xLTI2NTI0Nw_3df8b543-45eb-4d87-b699-af8c48f6e647"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMxLTMtMS0xLTI2NTI0Nw_dd945086-8be3-427d-a382-477548192e4f"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMxLTUtMS0xLTI2NTI0Nw_69aaa579-d5a5-4304-be3f-3f31615ec72d"
      unitRef="usdPerShare">-0.01</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMyLTEtMS0xLTI2NTI0Nw_c11751f9-177d-4d2e-b1e6-bc79b1d8b581"
      unitRef="usdPerShare">3.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMyLTMtMS0xLTI2NTI0Nw_d7607d44-cbf5-4789-8733-1e8342565306"
      unitRef="usdPerShare">6.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMyLTUtMS0xLTI2NTI0Nw_06bf1047-025c-4de3-8c2d-1ea25db93746"
      unitRef="usdPerShare">5.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMzLTEtMS0xLTI2NTI0Nw_450b527a-f5ed-47f0-ad58-658222a5332e"
      unitRef="shares">1312000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMzLTMtMS0xLTI2NTI0Nw_410cb901-a276-4540-a05f-adaca966e7e2"
      unitRef="shares">1319000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzMzLTUtMS0xLTI2NTI0Nw_adbe30b1-2815-4882-b25e-662916e1ac03"
      unitRef="shares">1309000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM1LTEtMS0xLTI2NTI0Nw_0ca71b3a-065a-4e4b-a425-715742ca2db1"
      unitRef="usdPerShare">3.26</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM1LTMtMS0xLTI2NTI0Nw_487af642-d496-4258-bb02-d74f470e7956"
      unitRef="usdPerShare">6.02</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM1LTUtMS0xLTI2NTI0Nw_05aa4ad9-acad-4e1e-afad-ab5d45e04233"
      unitRef="usdPerShare">5.47</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM2LTEtMS0xLTI2NTI0Nw_234323cc-3526-44a0-b64f-414782bf15b5"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM2LTMtMS0xLTI2NTI0Nw_b241d411-d900-4c45-acb0-200ba9d8cd4f"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM2LTUtMS0xLTI2NTI0Nw_e1dd927e-68e0-4246-b8e8-8344f540005a"
      unitRef="usdPerShare">-0.01</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM3LTEtMS0xLTI2NTI0Nw_8f12c643-d2fc-4ecc-bae0-d6488609682b"
      unitRef="usdPerShare">3.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM3LTMtMS0xLTI2NTI0Nw_5aa39a51-e1ee-455b-a9d3-2bafb0b198e1"
      unitRef="usdPerShare">6.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM3LTUtMS0xLTI2NTI0Nw_8fb51547-64e6-4479-bb57-02dc5ec2afc7"
      unitRef="usdPerShare">5.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM4LTEtMS0xLTI2NTI0Nw_395a1153-9e73-4037-aeaf-dd666d379c16"
      unitRef="shares">1323000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM4LTMtMS0xLTI2NTI0Nw_695da984-98fb-40be-b2e7-0d2ade8c92bf"
      unitRef="shares">1329000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM4LTUtMS0xLTI2NTI0Nw_494a15a6-6368-45e7-85a4-57544ca0d5cd"
      unitRef="shares">1314000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM5LTEtMS0xLTI2NTI0Nw_85c67b8d-9954-40ae-9afc-c663cbf030d3"
      unitRef="usdPerShare">2.20</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM5LTMtMS0xLTI2NTI0Nw_5e4725b2-4565-462e-981c-56ddec51e534"
      unitRef="usdPerShare">2.00</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDMvZnJhZzowYTE2MGE4YTRkODU0YWM3OWNkMWM1NjgxYWM4YWNiNS90YWJsZTo0Y2YxZGM0ZDU4MDE0NTc0YjliZGJlMzY4NWJjZmNkNS90YWJsZXJhbmdlOjRjZjFkYzRkNTgwMTQ1NzRiOWJkYmUzNjg1YmNmY2Q1XzM5LTUtMS0xLTI2NTI0Nw_5577f4fb-5a69-46d1-a86f-da73eb9f035f"
      unitRef="usdPerShare">2.00</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ProfitLoss
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzItMS0xLTEtMjY1MjQ3_e8bd4930-c640-49b5-bbb1-eb1e49e2f59f"
      unitRef="usd">4327000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzItMy0xLTEtMjY1MjQ3_b6b49b46-69ab-4bd8-bf5a-1e258408a55a"
      unitRef="usd">7989000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzItNS0xLTEtMjY1MjQ3_ab0da9b8-9ba6-4f5a-a595-b97615c93da3"
      unitRef="usd">7192000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzQtMS0xLTEtMjY1MjQ3_b266c4fc-0cb0-4d10-8b71-c794a9da41a2"
      unitRef="usd">-2317000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzQtMy0xLTEtMjY1MjQ3_dc0dba75-fb09-4a74-b1a8-85c0a76f147a"
      unitRef="usd">-556000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzQtNS0xLTEtMjY1MjQ3_129b514b-27a8-498b-b795-145e125be4a8"
      unitRef="usd">440000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzUtMS0xLTEtMjkyNzQx_662ec375-915d-4a3a-ad89-2be0b841c47b"
      unitRef="usd">870000000</us-gaap:OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax>
    <us-gaap:OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzUtMy0xLTEtMjkyNzQx_80df4363-18cd-48ad-9f1f-a8d5544fbcc9"
      unitRef="usd">255000000</us-gaap:OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax>
    <us-gaap:OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzUtNS0xLTEtMjkyNzQx_16682873-134c-41fb-9412-ceacb2df3a04"
      unitRef="usd">0</us-gaap:OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzUtMS0xLTEtMjY1MjQ3_cd022d6e-d03e-42e4-8bf9-9bf77b5d7669"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzUtMy0xLTEtMjY1MjQ3_32406583-7e0b-422c-a471-68e254332c53"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzUtNS0xLTEtMjY1MjQ3_4e22f1b1-85d3-42d4-9a63-a479254b8018"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzYtMS0xLTEtMjY1MjQ3_91ed9ec9-3453-4b8e-be27-bbbb0a6a83e9"
      unitRef="usd">17000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzYtMy0xLTEtMjY1MjQ3_3134e664-e980-481c-b7a5-795fe46c332d"
      unitRef="usd">-26000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzYtNS0xLTEtMjY1MjQ3_1f713300-333e-4ca7-8d99-0b5deebdade8"
      unitRef="usd">-31000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzctMS0xLTEtMjY1MjQ3_e91acff6-5f85-4346-87cf-780ac8325924"
      unitRef="usd">168000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzctMy0xLTEtMjY1MjQ3_31eaada4-b746-4c59-8258-4c466317f7ae"
      unitRef="usd">-20000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzctNS0xLTEtMjY1MjQ3_1154f6fc-f87c-4194-8cbd-61b78abc1a23"
      unitRef="usd">17000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzgtMS0xLTEtMjY1MjQ3_62615017-20b8-477a-a5f6-f1be1a9cdfd0"
      unitRef="usd">-1598000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzgtMy0xLTEtMjY1MjQ3_08a4bb3c-d248-4268-a182-3a3d9b8cebd6"
      unitRef="usd">-314000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzgtNS0xLTEtMjY1MjQ3_75934af2-c65c-4634-a557-bf829d2729ba"
      unitRef="usd">395000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzktMS0xLTEtMjY1MjQ3_8c3c6afc-2e1f-4bcf-b633-cdee365fdcb8"
      unitRef="usd">2729000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzktMy0xLTEtMjY1MjQ3_e0365b35-300c-46dd-aa29-e768c0b736ae"
      unitRef="usd">7675000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzktNS0xLTEtMjY1MjQ3_24be11be-7b99-48e2-9419-6239034b97ef"
      unitRef="usd">7587000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzEwLTEtMS0xLTI2NTI0Nw_88f8091a-5628-4462-ba27-4695ff4f07c1"
      unitRef="usd">16000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzEwLTMtMS0xLTI2NTI0Nw_b4436f6d-7f15-46f4-adf1-1359a818fb12"
      unitRef="usd">-12000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzEwLTUtMS0xLTI2NTI0Nw_bd3724aa-1da6-499e-a883-4877f33f8549"
      unitRef="usd">13000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzExLTEtMS0xLTI2NTI0Nw_ad8101b6-b9c1-44a2-b104-0f765fddc45c"
      unitRef="usd">2713000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzExLTMtMS0xLTI2NTI0Nw_0f3f438b-1e87-4526-9710-4f196784981c"
      unitRef="usd">7687000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDYvZnJhZzpiMTM1YTkwOGI2MTE0ZmI3OGQ1ZDA5MzA0MjE4ZTRmMS90YWJsZToyZTY0MGQzNGU4MjM0ODY5OTQ0ZjkyYWQ3MzA0MTc2Ny90YWJsZXJhbmdlOjJlNjQwZDM0ZTgyMzQ4Njk5NDRmOTJhZDczMDQxNzY3XzExLTUtMS0xLTI2NTI0Nw_8f7a7eac-5fab-4485-92b9-9e474c956efa"
      unitRef="usd">7574000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzMtMS0xLTEtMjY1MjQ3_6ed8545a-dde8-47b9-ae4f-83bdef3279fc"
      unitRef="usd">12945000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzMtMy0xLTEtMjY1MjQ3_c9677f92-9403-4dc1-bf03-6f114341a8a3"
      unitRef="usd">9408000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQtMS0xLTEtMjY1MjQ3_a73813dd-1d70-497f-aeef-86cd61cd17b3"
      unitRef="usd">2778000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQtMy0xLTEtMjY1MjQ3_d4377fe5-032a-4d8e-b5dd-2fa5d57f3b97"
      unitRef="usd">3117000000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzUtMS0xLTEtMjY1MjQ3_86e0196a-53e2-453f-9aae-549fe308ff3a"
      unitRef="usd">27276000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzUtMy0xLTEtMjY1MjQ3_eb3299fb-26b2-4ea3-9443-21e1acc46d8b"
      unitRef="usd">24431000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzYtMS0xLTEtMjY1MjQ3_77a10297-f7ab-4aa9-8748-92d7261e3dfd"
      unitRef="usd">19090000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzYtMy0xLTEtMjY1MjQ3_5ce32e2f-6ca7-4a88-ac45-af0fca1227f7"
      unitRef="usd">17760000000</us-gaap:InventoryNet>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzctMS0xLTEtMjY1MjQ3_a40aad6c-2ce7-49c8-ba35-5253d623d147"
      unitRef="usd">908000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzctMy0xLTEtMjY1MjQ3_381b32f8-cf94-424d-b3ec-83cd17f87949"
      unitRef="usd">0</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzgtMS0xLTEtMjY1MjQ3_7252e935-6468-4ecf-9ee9-57b4fdf1561b"
      unitRef="usd">2636000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzgtMy0xLTEtMjY1MjQ3_31b2ef04-9356-4ce1-80f3-32838ffb7b15"
      unitRef="usd">5319000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzktMS0xLTEtMjY1MjQ3_eb18d776-69c8-4a1c-9d7f-31f32bdf5aa0"
      unitRef="usd">65633000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzktMy0xLTEtMjY1MjQ3_51c0632b-9b56-446b-b61a-98a419bda0ca"
      unitRef="usd">60035000000</us-gaap:AssetsCurrent>
    <us-gaap:LongTermInvestments
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzEwLTEtMS0xLTI2NTI0Nw_4bae7218-2b9d-4d1a-9883-ece8f3276744"
      unitRef="usd">21096000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzEwLTMtMS0xLTI2NTI0Nw_a38ca52b-b0f2-4a01-8a5c-1b6bd0753c79"
      unitRef="usd">23025000000</us-gaap:LongTermInvestments>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzExLTEtMS0xLTI2NTI0Nw_723c0ecf-2a6e-43a4-b531-8a3a9bf44a25"
      unitRef="usd">12873000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzExLTMtMS0xLTI2NTI0Nw_2176f16a-851b-42dc-a0dd-b8c932ac6f5f"
      unitRef="usd">12896000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzEyLTEtMS0xLTI2NTI0Nw_4d1381a6-ece0-46d5-b2b9-7abf0d9c6096"
      unitRef="usd">17872000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzEyLTMtMS0xLTI2NTI0Nw_e25a9a2a-0f2a-4dbe-a726-8755a2478f27"
      unitRef="usd">19122000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzEzLTEtMS0xLTI2NTI0Nw_0388c4a6-541e-4881-ab19-3251dd646447"
      unitRef="usd">78150000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzEzLTMtMS0xLTI2NTI0Nw_8854778d-111f-47d2-80df-5f3138a58a90"
      unitRef="usd">79121000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzE0LTEtMS0xLTI2NTI0Nw_7efc87a4-0863-43a5-a363-aa530b3923ce"
      unitRef="usd">24803000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzE0LTMtMS0xLTI2NTI0Nw_f965d326-5fce-4d2d-8815-d3932155a888"
      unitRef="usd">29052000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:SeparateAccountAssets
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzE1LTEtMS0xLTI2NTI0Nw_57dba294-450d-4742-9f54-d812d6c8a4ab"
      unitRef="usd">3228000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzE1LTMtMS0xLTI2NTI0Nw_8c35f2e6-d233-4289-8701-9625936d79fe"
      unitRef="usd">5087000000</us-gaap:SeparateAccountAssets>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzE2LTEtMS0xLTI2NTI0Nw_cbe72ac6-f945-4a65-ac29-5677527496f9"
      unitRef="usd">4620000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzE2LTMtMS0xLTI2NTI0Nw_f9d37ac9-6ce4-42b6-bf26-3e715b461d27"
      unitRef="usd">4714000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzE3LTEtMS0xLTI2NTI0Nw_b47ba14f-d7b9-4978-8fcf-2405928e4220"
      unitRef="usd">228275000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzE3LTMtMS0xLTI2NTI0Nw_b675832b-fafb-4570-9eb4-66b312220a92"
      unitRef="usd">233052000000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzIwLTEtMS0xLTI2NTI0Nw_0b409587-76c9-46c1-ba13-16fad3bee6a6"
      unitRef="usd">14838000000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzIwLTMtMS0xLTI2NTI0Nw_f246ce2f-b508-46a4-8060-c5989def7c80"
      unitRef="usd">12544000000</us-gaap:AccountsPayableTradeCurrent>
    <cvs:PharmacyClaimsAndDiscountsPayableCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzIxLTEtMS0xLTI2NTI0Nw_f9d49257-13df-4698-9066-f9b0608dfe77"
      unitRef="usd">19423000000</cvs:PharmacyClaimsAndDiscountsPayableCurrent>
    <cvs:PharmacyClaimsAndDiscountsPayableCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzIxLTMtMS0xLTI2NTI0Nw_dc195acd-37b8-4fe1-bcd1-8ac73a899240"
      unitRef="usd">17330000000</cvs:PharmacyClaimsAndDiscountsPayableCurrent>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzIyLTEtMS0xLTI2NTI0Nw_120f9273-b6c0-4817-be6c-0993fe8ed2e1"
      unitRef="usd">10142000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzIyLTMtMS0xLTI2NTI0Nw_906e914a-445c-42e2-b83f-7366d4eb3c97"
      unitRef="usd">8678000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:OtherPolicyholderFunds
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzIzLTEtMS0xLTI2NTI0Nw_48fd999f-9ded-4135-88cf-a8a2724d5d4f"
      unitRef="usd">1500000000</us-gaap:OtherPolicyholderFunds>
    <us-gaap:OtherPolicyholderFunds
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzIzLTMtMS0xLTI2NTI0Nw_b9997f85-4d9f-4dd3-a118-d62daa95c966"
      unitRef="usd">4301000000</us-gaap:OtherPolicyholderFunds>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzI0LTEtMS0xLTI2NTI0Nw_87af4900-9f7e-4be2-bdf7-97bcf7101a96"
      unitRef="usd">18745000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzI0LTMtMS0xLTI2NTI0Nw_44bbb754-8eac-4cad-8df7-c705b29b946d"
      unitRef="usd">17670000000</us-gaap:AccruedLiabilitiesCurrent>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzI1LTEtMS0xLTI2NTI0Nw_6a50d5b8-2ce0-4fbe-8447-f0dfebae2289"
      unitRef="usd">1089000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzI1LTMtMS0xLTI2NTI0Nw_f268f0f6-b3cc-47bc-bf73-35ade3c94a34"
      unitRef="usd">1345000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzI2LTEtMS0xLTI2NTI0Nw_c6416aaf-6e26-47b0-941b-bb78a0b78606"
      unitRef="usd">1678000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzI2LTMtMS0xLTI2NTI0Nw_bcd6f059-bda9-4787-b1b8-9d33992105ee"
      unitRef="usd">1646000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzI4LTEtMS0xLTI2NTI0Nw_74b8f36f-afbb-4fcf-a886-87ba9f3c60a4"
      unitRef="usd">1778000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzI4LTMtMS0xLTI2NTI0Nw_d0124e25-7f26-44d6-922d-d48b881383f1"
      unitRef="usd">4205000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzI5LTEtMS0xLTI2NTI0Nw_abc97e6a-f0b1-4b9b-83c5-a231422612aa"
      unitRef="usd">228000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzI5LTMtMS0xLTI2NTI0Nw_a38db8af-11d7-4507-b08d-7c25d70fc7e5"
      unitRef="usd">0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzMwLTEtMS0xLTI2NTI0Nw_fc4d5e1a-f646-4c60-a2b1-223be77bc113"
      unitRef="usd">69421000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzMwLTMtMS0xLTI2NTI0Nw_a247acad-661b-4272-92c1-29a6b47303d0"
      unitRef="usd">67719000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzMxLTEtMS0xLTI2NTI0Nw_4be25cdd-0e3a-46f5-a475-c47e47d6445c"
      unitRef="usd">16800000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzMxLTMtMS0xLTI2NTI0Nw_fca330f6-a23d-4cc3-877e-e2df273ef6d7"
      unitRef="usd">18177000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzMyLTEtMS0xLTI2NTI0Nw_acf69e67-f0f8-4276-b734-756402eda518"
      unitRef="usd">50476000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzMyLTMtMS0xLTI2NTI0Nw_f362ea5a-c78f-4810-9018-6b6294356173"
      unitRef="usd">51971000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzMzLTEtMS0xLTI2NTI0Nw_07140ed9-38fc-4eb8-a913-fd2f10f1a9ae"
      unitRef="usd">4016000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzMzLTMtMS0xLTI2NTI0Nw_e676ed06-9879-4d57-83b7-118231753f93"
      unitRef="usd">6115000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:SeparateAccountsLiability
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzM0LTEtMS0xLTI2NTI0Nw_03dedd39-737e-4ad8-82b5-02cc4c240a3d"
      unitRef="usd">3228000000</us-gaap:SeparateAccountsLiability>
    <us-gaap:SeparateAccountsLiability
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzM0LTMtMS0xLTI2NTI0Nw_74a41ac7-eb49-4b0a-b9a4-cc667def8d7e"
      unitRef="usd">5087000000</us-gaap:SeparateAccountsLiability>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzM1LTEtMS0xLTI2NTI0Nw_589f3ef3-3cc3-463b-8050-c0e01d010dc4"
      unitRef="usd">5835000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzM1LTMtMS0xLTI2NTI0Nw_9cc232bc-7127-4166-989f-5816a6dbd001"
      unitRef="usd">7235000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzM2LTEtMS0xLTI2NTI0Nw_679a3fa3-cff6-40e7-baab-4d74b956f2a8"
      unitRef="usd">6730000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzM2LTMtMS0xLTI2NTI0Nw_277830bb-63e1-4e84-a805-05a5e5a91462"
      unitRef="usd">1907000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzM3LTEtMS0xLTI2NTI0Nw_772579f2-c030-4376-9d6a-631eea7acd55"
      unitRef="usd">156506000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzM3LTMtMS0xLTI2NTI0Nw_3de87f1c-d325-4996-a0ea-8cc4017459e3"
      unitRef="usd">158211000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzM4LTEtMS0xLTI2NTI0Nw_07f2908e-55b9-4d0f-87fe-12dca8f14442"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzM4LTMtMS0xLTI2NTI0Nw_e34951d3-2e09-4f51-994e-f9a6e9d25f4d"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjczN2E4ODAxNGUzMDQ5NjI5NGMzM2M2ZmJjYjY2Mjg4XzMx_89b2b135-7a92-40b2-a5a7-0804bda41d15"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjczN2E4ODAxNGUzMDQ5NjI5NGMzM2M2ZmJjYjY2Mjg4XzMx_b3dfdc83-34a2-49b8-b098-ebb951e4b8e9"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjczN2E4ODAxNGUzMDQ5NjI5NGMzM2M2ZmJjYjY2Mjg4XzM1_a8c719ef-2c3d-4fca-92c7-f8da982b44a4"
      unitRef="shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjczN2E4ODAxNGUzMDQ5NjI5NGMzM2M2ZmJjYjY2Mjg4XzM1_d9b31d07-a70d-4ac4-bd75-94bcb3f283ae"
      unitRef="shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjczN2E4ODAxNGUzMDQ5NjI5NGMzM2M2ZmJjYjY2Mjg4XzU3_0c651494-8732-4fe0-bce3-7d928fb3429d"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjczN2E4ODAxNGUzMDQ5NjI5NGMzM2M2ZmJjYjY2Mjg4XzU3_8341babc-467e-4dd7-a622-037a7030e942"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjczN2E4ODAxNGUzMDQ5NjI5NGMzM2M2ZmJjYjY2Mjg4XzU3_b13ea4bb-f168-48bb-bffc-59e628e89c49"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjczN2E4ODAxNGUzMDQ5NjI5NGMzM2M2ZmJjYjY2Mjg4XzU3_f8f679eb-4058-48d0-ad1f-644717821a01"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQxLTEtMS0xLTI2NTI0Nw_21494801-ed51-42b8-81b7-b5978ee5d8f8"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQxLTMtMS0xLTI2NTI0Nw_a5b5dcd2-e454-4043-a47d-0b38c5577fba"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjY1ZTVmZTgzNGQzZjQ5ZDliZTIzYzJlMTI4OTE4OWNiXzI4_21011cd8-cfe0-444b-8119-a482f4e63bc7"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjY1ZTVmZTgzNGQzZjQ5ZDliZTIzYzJlMTI4OTE4OWNiXzI4_2db017b5-6c85-48c2-8784-764b5cbd513f"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjY1ZTVmZTgzNGQzZjQ5ZDliZTIzYzJlMTI4OTE4OWNiXzMy_38504e8e-e542-4045-921c-99cfb313bc3e"
      unitRef="shares">3200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjY1ZTVmZTgzNGQzZjQ5ZDliZTIzYzJlMTI4OTE4OWNiXzMy_9d4f2ec5-609a-4310-95ef-e7dd633a3cf1"
      unitRef="shares">3200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjY1ZTVmZTgzNGQzZjQ5ZDliZTIzYzJlMTI4OTE4OWNiXzU0_84788d03-66f0-49c4-b5fd-8e19e757309c"
      unitRef="shares">1758000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjY1ZTVmZTgzNGQzZjQ5ZDliZTIzYzJlMTI4OTE4OWNiXzc1_d04548d6-ef96-4074-9aac-fea44aa3fafb"
      unitRef="shares">1300000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjY1ZTVmZTgzNGQzZjQ5ZDliZTIzYzJlMTI4OTE4OWNiXzEwNw_c42db7ad-f95b-437a-a90f-1cf686a3cb90"
      unitRef="shares">1744000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjY1ZTVmZTgzNGQzZjQ5ZDliZTIzYzJlMTI4OTE4OWNiXzEyOA_0e0b1815-c3be-4116-a9d1-3543365bf400"
      unitRef="shares">1322000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQyLTEtMS0xLTI2NTI0Nw_984d3819-9133-4b88-923c-34909e232626"
      unitRef="usd">48193000000</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQyLTMtMS0xLTI2NTI0Nw_42f750a7-c0a6-4fed-bb6f-7cf9d95e19d6"
      unitRef="usd">47377000000</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:TreasuryStockShares
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQzLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmU4NGI4YWZiMTIxZjQ5NmI5MDhkM2NlZDljYmEwYWM5XzI5_8144cf16-daef-422c-b21a-4c3cb62b4233"
      unitRef="shares">458000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQzLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmU4NGI4YWZiMTIxZjQ5NmI5MDhkM2NlZDljYmEwYWM5XzM2_4bbc062c-6490-441a-905b-b28fc5236671"
      unitRef="shares">422000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQzLTEtMS0xLTI2NTI0Nw_9203fa12-04dc-4ee0-94d0-50ce71e2c0e1"
      unitRef="usd">31858000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQzLTMtMS0xLTI2NTI0Nw_78cf7db5-c3ad-4eb7-87a3-8aa66eba380b"
      unitRef="usd">28173000000</us-gaap:TreasuryStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ0LTEtMS0xLTI2NTI0Nw_7ea84200-e007-453b-bcfe-62de6aa3b4b8"
      unitRef="usd">56398000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ0LTMtMS0xLTI2NTI0Nw_fd904f06-df79-4100-8814-3adde9d3a000"
      unitRef="usd">54997000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ1LTEtMS0xLTI2NTI0Nw_15cc7900-ebba-4dd7-9274-05f77719938a"
      unitRef="usd">-1264000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ1LTMtMS0xLTI2NTI0Nw_afee27ff-20c2-47ce-bcfa-dfa19eb43063"
      unitRef="usd">334000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ2LTEtMS0xLTI2NTI0Nw_0c1a912b-8e13-48a9-9c55-ea5b8a6b5329"
      unitRef="usd">71469000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ2LTMtMS0xLTI2NTI0Nw_a6401d29-7ef8-40b9-bfa0-390d6ddcf92b"
      unitRef="usd">74535000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ3LTEtMS0xLTI2NTI0Nw_b30dc2c8-dd1f-4248-a047-41f521acbd2d"
      unitRef="usd">300000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ3LTMtMS0xLTI2NTI0Nw_c8d84b3a-8a82-42dc-bf67-c9e7830fb565"
      unitRef="usd">306000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ4LTEtMS0xLTI2NTI0Nw_8b1650f6-bee6-4b58-bcbe-af8610fe81c8"
      unitRef="usd">71769000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ4LTMtMS0xLTI2NTI0Nw_82ba4b24-1f35-4ff4-8667-37522b17659d"
      unitRef="usd">74841000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ5LTEtMS0xLTI2NTI0Nw_38f66313-f70c-4ef0-a23d-416c3bda97ee"
      unitRef="usd">228275000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMDkvZnJhZzpiOTk3YzY2OTZjYWM0MDczYmFlZTZmZTAzMjkxMDdhOC90YWJsZTpjNDgzMzY1MmZkOGQ0MjYzYTEzOThlYzM0MTFkYWQ3ZS90YWJsZXJhbmdlOmM0ODMzNjUyZmQ4ZDQyNjNhMTM5OGVjMzQxMWRhZDdlXzQ5LTMtMS0xLTI2NTI0Nw_e04e20eb-f77e-404b-9bb2-64ea325d0e71"
      unitRef="usd">233052000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProceedsFromCustomers
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMtMS0xLTEtMjY1MjQ3_ace1ccd5-24d0-417e-a42f-620af15994f9"
      unitRef="usd">313662000000</us-gaap:ProceedsFromCustomers>
    <us-gaap:ProceedsFromCustomers
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMtMy0xLTEtMjY1MjQ3_533f1a14-2e06-4f2b-922d-35db00883e35"
      unitRef="usd">284219000000</us-gaap:ProceedsFromCustomers>
    <us-gaap:ProceedsFromCustomers
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMtNS0xLTEtMjY1MjQ3_992f2277-3f3e-46e1-b30c-c76cdfa9292d"
      unitRef="usd">264327000000</us-gaap:ProceedsFromCustomers>
    <cvs:PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzQtMS0xLTEtMjY1MjQ3_e2c39a42-7c03-4a95-9ae1-de154c371598"
      unitRef="usd">189766000000</cvs:PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies>
    <cvs:PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzQtMy0xLTEtMjY1MjQ3_499444db-e0b5-41e3-a48c-e8c1205b5894"
      unitRef="usd">165783000000</cvs:PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies>
    <cvs:PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzQtNS0xLTEtMjY1MjQ3_a30eccc8-af12-4586-9b04-10d693552604"
      unitRef="usd">158636000000</cvs:PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies>
    <cvs:PaymentsForInsuranceBenefits
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzUtMS0xLTEtMjY1MjQ3_adf41654-7d17-4a53-ba3f-fa0b1f5fbb47"
      unitRef="usd">69728000000</cvs:PaymentsForInsuranceBenefits>
    <cvs:PaymentsForInsuranceBenefits
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzUtMy0xLTEtMjY1MjQ3_761729f9-5a73-41f9-9f80-1f4c7ac1e8f6"
      unitRef="usd">63598000000</cvs:PaymentsForInsuranceBenefits>
    <cvs:PaymentsForInsuranceBenefits
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzUtNS0xLTEtMjY1MjQ3_c7b56dbf-8df8-4461-9316-8da1f1ec597d"
      unitRef="usd">55124000000</cvs:PaymentsForInsuranceBenefits>
    <us-gaap:PaymentsToSuppliersAndEmployees
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzYtMS0xLTEtMjY1MjQ3_8ccf5597-f881-4b6e-ba37-49b4b8c718a3"
      unitRef="usd">32662000000</us-gaap:PaymentsToSuppliersAndEmployees>
    <us-gaap:PaymentsToSuppliersAndEmployees
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzYtMy0xLTEtMjY1MjQ3_6f6f5f02-bcc7-483c-8689-72ed69f01122"
      unitRef="usd">31652000000</us-gaap:PaymentsToSuppliersAndEmployees>
    <us-gaap:PaymentsToSuppliersAndEmployees
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzYtNS0xLTEtMjY1MjQ3_600b3916-edfd-492b-9ada-3c5eac15a2ab"
      unitRef="usd">29763000000</us-gaap:PaymentsToSuppliersAndEmployees>
    <us-gaap:ProceedsFromInterestAndDividendsReceived
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzctMS0xLTEtMjY1MjQ3_1b058eaa-4c7d-491a-bcc6-0ef2870c5fa6"
      unitRef="usd">1026000000</us-gaap:ProceedsFromInterestAndDividendsReceived>
    <us-gaap:ProceedsFromInterestAndDividendsReceived
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzctMy0xLTEtMjY1MjQ3_bb235e50-7e40-4907-a1e9-82ba7ee82210"
      unitRef="usd">743000000</us-gaap:ProceedsFromInterestAndDividendsReceived>
    <us-gaap:ProceedsFromInterestAndDividendsReceived
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzctNS0xLTEtMjY1MjQ3_68c94cd9-52f9-4ae2-a1d4-4101d72f152f"
      unitRef="usd">894000000</us-gaap:ProceedsFromInterestAndDividendsReceived>
    <us-gaap:InterestPaidNet
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzgtMS0xLTEtMjY1MjQ3_0aaf845a-7751-4f63-b977-46da4d563934"
      unitRef="usd">2239000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzgtMy0xLTEtMjY1MjQ3_b8a43a96-3543-4cee-93d5-bc1eb1c27183"
      unitRef="usd">2469000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzgtNS0xLTEtMjY1MjQ3_69bb219c-af99-40cc-86e3-cb7b1238bfa8"
      unitRef="usd">2904000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzktMS0xLTEtMjY1MjQ3_d1a3c1f3-0c74-46f1-9b3d-f1b665a7efdc"
      unitRef="usd">4116000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzktMy0xLTEtMjY1MjQ3_65c46825-0fdc-4c14-8ef0-0de6d43abd91"
      unitRef="usd">3195000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzktNS0xLTEtMjY1MjQ3_ecdf1cb2-b8a3-4990-a61b-a28355e6032c"
      unitRef="usd">2929000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzEwLTEtMS0xLTI2NTI0Nw_9c8ea39c-61c0-4b65-bfd2-50b9e5db558e"
      unitRef="usd">16177000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzEwLTMtMS0xLTI2NTI0Nw_d78f0f39-63d7-40b9-9ea4-3836b032f644"
      unitRef="usd">18265000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzEwLTUtMS0xLTI2NTI0Nw_4169b344-6583-464e-ad34-5572282771a6"
      unitRef="usd">15865000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzEzLTEtMS0xLTI2NTI0Nw_d2b4ac95-5a55-48d7-8799-f2a4743a9e30"
      unitRef="usd">6729000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzEzLTMtMS0xLTI2NTI0Nw_426a267f-ac3f-42f7-8cd7-6304d61ef448"
      unitRef="usd">7246000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzEzLTUtMS0xLTI2NTI0Nw_06ce4456-528c-48a3-a9af-a90117990428"
      unitRef="usd">6467000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE0LTEtMS0xLTI2NTI0Nw_c9eca8cc-a165-44b4-a96e-02870aec536f"
      unitRef="usd">7746000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE0LTMtMS0xLTI2NTI0Nw_d31ddb67-5505-436a-b51f-547ed7ff96ca"
      unitRef="usd">9963000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE0LTUtMS0xLTI2NTI0Nw_73918341-40d7-4bee-888d-27ff89e586f4"
      unitRef="usd">9639000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE1LTEtMS0xLTI2NTI0Nw_cf851e89-697b-4466-abf6-78afbcccf33a"
      unitRef="usd">2727000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE1LTMtMS0xLTI2NTI0Nw_73a016cc-d551-430b-b911-7dded14a54af"
      unitRef="usd">2520000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE1LTUtMS0xLTI2NTI0Nw_43e50e6e-e018-44b1-b816-9763a357b59d"
      unitRef="usd">2437000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE2LTEtMS0xLTI2NTI0Nw_6b051039-252c-4eaf-b10e-70bfc98a3598"
      unitRef="usd">0</us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity>
    <us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE2LTMtMS0xLTI2NTI0Nw_84bc16b4-d06c-4791-a4cb-44ae314a0950"
      unitRef="usd">0</us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity>
    <us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE2LTUtMS0xLTI2NTI0Nw_6cfda4b3-34b1-4c3d-8d34-517eff5fb2ed"
      unitRef="usd">101000000</us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE3LTEtMS0xLTI2NTI0Nw_4b272c3b-4b17-41e1-ad5a-890a709bcae4"
      unitRef="usd">139000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE3LTMtMS0xLTI2NTI0Nw_f5a7dcf4-2578-4933-8d16-30a0cf005c85"
      unitRef="usd">146000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE3LTUtMS0xLTI2NTI0Nw_dd2159ef-bafc-48fe-b2f6-d6b2181b5edd"
      unitRef="usd">866000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:CashDivestedFromDeconsolidation
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE4LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjYxNjcwYTYzOTM5YTQ4ZGViYmYwYTYzNzYxZGY0ZWU1Xzgw_822f70d9-8db5-4ee4-a6e9-3fca56ff096f"
      unitRef="usd">2854000000</us-gaap:CashDivestedFromDeconsolidation>
    <us-gaap:CashDivestedFromDeconsolidation
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE4LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjYxNjcwYTYzOTM5YTQ4ZGViYmYwYTYzNzYxZGY0ZWU1Xzg0_306b50a0-6098-4f24-bbdf-4873e8546c6b"
      unitRef="usd">0</us-gaap:CashDivestedFromDeconsolidation>
    <us-gaap:CashDivestedFromDeconsolidation
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE4LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjYxNjcwYTYzOTM5YTQ4ZGViYmYwYTYzNzYxZGY0ZWU1Xzkx_e22346e8-1681-48e6-9618-8b70da1fba6d"
      unitRef="usd">9000000</us-gaap:CashDivestedFromDeconsolidation>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE4LTEtMS0xLTI2NTI0Nw_03dbfc2f-bd6e-4446-8496-a4d8baff30fa"
      unitRef="usd">-1249000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE4LTMtMS0xLTI2NTI0Nw_14e832a4-2a77-4573-a187-465e0e67ca0e"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE4LTUtMS0xLTI2NTI0Nw_dcec0ff2-6b2f-454f-aeb5-c010a2422468"
      unitRef="usd">840000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE5LTEtMS0xLTI2NTI0Nw_824a6186-40db-49d9-aa71-c5af4e1125e9"
      unitRef="usd">-85000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE5LTMtMS0xLTI2NTI0Nw_41569da4-c85c-41ba-8c29-549d5d4be9aa"
      unitRef="usd">-122000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzE5LTUtMS0xLTI2NTI0Nw_e7c680f4-c9c6-4f26-89b9-b737a8559308"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzIwLTEtMS0xLTI2NTI0Nw_d43b38d8-fef3-4c60-a5f3-7cc522bcf8e1"
      unitRef="usd">-5047000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzIwLTMtMS0xLTI2NTI0Nw_76a955cf-1edf-444f-ba8b-baf439e87180"
      unitRef="usd">-5261000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzIwLTUtMS0xLTI2NTI0Nw_515853f2-ba45-4301-a722-1f2f57beda38"
      unitRef="usd">-5534000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI0LTEtMS0xLTI2NTI0Nw_92f53c54-d185-4b15-9798-7d8e682f8029"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI0LTMtMS0xLTI2NTI0Nw_358d3cba-2718-4fbe-ab21-43d8a0bdd410"
      unitRef="usd">987000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI0LTUtMS0xLTI2NTI0Nw_3234c46d-7f71-43b3-ade9-9c1efd26494e"
      unitRef="usd">9958000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI1LTEtMS0xLTI2NTI0Nw_e7671ff8-b046-4d09-a988-a7b41452be63"
      unitRef="usd">4211000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI1LTMtMS0xLTI2NTI0Nw_cf249949-c179-4bdb-bbee-7fb94703d1ea"
      unitRef="usd">10254000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI1LTUtMS0xLTI2NTI0Nw_bbc6bc54-668f-4c62-8e9a-1ea3ef29f5a0"
      unitRef="usd">15631000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForDerivativeInstrumentFinancingActivities
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI2LTEtMS0xLTI2NTI0Nw_1b015550-b152-40e7-ae1c-fe42039b7535"
      unitRef="usd">0</us-gaap:PaymentsForDerivativeInstrumentFinancingActivities>
    <us-gaap:PaymentsForDerivativeInstrumentFinancingActivities
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI2LTMtMS0xLTI2NTI0Nw_1f20100d-02c8-41e0-bd89-430d3e1b4a42"
      unitRef="usd">0</us-gaap:PaymentsForDerivativeInstrumentFinancingActivities>
    <us-gaap:PaymentsForDerivativeInstrumentFinancingActivities
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI2LTUtMS0xLTI2NTI0Nw_73ccda91-365f-4cc7-a845-8dfa6e662cea"
      unitRef="usd">7000000</us-gaap:PaymentsForDerivativeInstrumentFinancingActivities>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI3LTEtMS0xLTI2NTI0Nw_19d31bcd-7d7d-4499-8d0c-0beb09f25da7"
      unitRef="usd">3500000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI3LTMtMS0xLTI2NTI0Nw_e4232866-2ad0-416e-a3fb-a01dbe8fad93"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI3LTUtMS0xLTI2NTI0Nw_3c604836-ab12-423b-96e6-e06a3acd0417"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividends
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI4LTEtMS0xLTI2NTI0Nw_b62e59fb-e0cd-49ba-b09c-446f5a5d8c6e"
      unitRef="usd">2907000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI4LTMtMS0xLTI2NTI0Nw_2940c2f2-630b-4768-9988-dd3eed329abe"
      unitRef="usd">2625000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI4LTUtMS0xLTI2NTI0Nw_3ea4572e-be98-43fd-a214-9abef79bf88c"
      unitRef="usd">2624000000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI5LTEtMS0xLTI2NTI0Nw_e55f0b07-7093-47bd-8ad9-3bd56f1d4e78"
      unitRef="usd">551000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI5LTMtMS0xLTI2NTI0Nw_9fe53d64-1d9d-4beb-b909-c0642fdb4f99"
      unitRef="usd">549000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzI5LTUtMS0xLTI2NTI0Nw_e970da8c-424a-4aab-bc47-bffcd3a9318c"
      unitRef="usd">264000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMwLTEtMS0xLTI2NTI0Nw_b7147225-8b7c-407b-be74-8fd522df531f"
      unitRef="usd">370000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMwLTMtMS0xLTI2NTI0Nw_5ca6c2e9-3354-42ce-9ce3-ebe5ef87372a"
      unitRef="usd">168000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMwLTUtMS0xLTI2NTI0Nw_04536ccd-9097-41ff-9354-465bf0b20b45"
      unitRef="usd">88000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMxLTEtMS0xLTI2NTI0Nw_fd486bd9-2d40-46c8-998b-79dd28d52c52"
      unitRef="usd">-79000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMxLTMtMS0xLTI2NTI0Nw_9a75544f-8b6f-4dee-813f-e6241c765881"
      unitRef="usd">155000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMxLTUtMS0xLTI2NTI0Nw_21d3af00-d4e8-4842-bdc8-53109380c05a"
      unitRef="usd">432000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMyLTEtMS0xLTI2NTI0Nw_a3eefb2e-e175-4486-a187-639f2284d6a2"
      unitRef="usd">-10516000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMyLTMtMS0xLTI2NTI0Nw_d4db6ae3-28f8-491b-a879-f4291b341fae"
      unitRef="usd">-11356000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzMyLTUtMS0xLTI2NTI0Nw_03beedbe-0eb7-45d8-9db7-c19662f3e081"
      unitRef="usd">-7696000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzM0LTEtMS0xLTI2NTI0Nw_405a2418-50c0-4f0e-9fd2-567410857ec8"
      unitRef="usd">614000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzM0LTMtMS0xLTI2NTI0Nw_64a9f4c2-9b24-4d40-bb96-358301e7c59c"
      unitRef="usd">1648000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzM0LTUtMS0xLTI2NTI0Nw_9afea546-d437-4b0a-ae79-2eb62d85362d"
      unitRef="usd">2635000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzM1LTEtMS0xLTI2NTI0Nw_b7492f00-aef6-4c4b-a161-9f04b2d3c104"
      unitRef="usd">12691000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i501f291fb23d49e987222cf13c851afc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzM1LTMtMS0xLTI2NTI0Nw_23c85bf7-ccb0-4b43-9c5a-b80c5cc5ad87"
      unitRef="usd">11043000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i68e253af6bf3467aade09b572c1b73a6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzM1LTUtMS0xLTI2NTI0Nw_607d6a54-8b94-48a5-99f4-e0a6bb0b2edc"
      unitRef="usd">8408000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzM2LTEtMS0xLTI2NTI0Nw_6e887bb0-ae6b-4a12-99d2-72b5d3b0a3c4"
      unitRef="usd">13305000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzM2LTMtMS0xLTI2NTI0Nw_e5abcfc8-d9b4-4c59-b8c5-bc2dce65a220"
      unitRef="usd">12691000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i501f291fb23d49e987222cf13c851afc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZTpmMDA3ZjRhZjUwNzc0M2I2Yjc4ZmFiY2QyMTUwMjU2Mi90YWJsZXJhbmdlOmYwMDdmNGFmNTA3NzQzYjZiNzhmYWJjZDIxNTAyNTYyXzM2LTUtMS0xLTI2NTI0Nw_e4736a62-a6c4-4784-adcf-828e2b404326"
      unitRef="usd">11043000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ProfitLoss
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzMtMS0xLTEtMjY1MjQ3_e8bd4930-c640-49b5-bbb1-eb1e49e2f59f"
      unitRef="usd">4327000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzMtMy0xLTEtMjY1MjQ3_b6b49b46-69ab-4bd8-bf5a-1e258408a55a"
      unitRef="usd">7989000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzMtNS0xLTEtMjY1MjQ3_49b99746-953f-4682-b9ea-fb5b8d14f2ba"
      unitRef="usd">7192000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzUtMS0xLTEtMjY1MjQ3_28520482-f167-41aa-981a-3acb426d6ec7"
      unitRef="usd">4224000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzUtMy0xLTEtMjY1MjQ3_537ac7a5-7e99-491b-8926-8b85cf6b22bf"
      unitRef="usd">4486000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzUtNS0xLTEtMjY1MjQ3_cc90e95e-3e98-451f-a3b4-2237fcba502e"
      unitRef="usd">4441000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzYtMS0xLTEtMjY1MjQ3_0d5931e9-a98c-4547-9cf8-39d761ade86a"
      unitRef="usd">2533000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzYtMy0xLTEtMjY1MjQ3_e7aa3759-7e53-44d0-82e1-50b39d181b66"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzYtNS0xLTEtMjY1MjQ3_7d6821db-0c47-4e94-9fbe-0deb8244a67b"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <cvs:StoreImpairmentCharges
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzgtMS0xLTEtMjY1MjQ3_0335c796-8a4c-4d03-b190-dc009570090c"
      unitRef="usd">0</cvs:StoreImpairmentCharges>
    <cvs:StoreImpairmentCharges
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzgtMy0xLTEtMjY1MjQ3_a1a94756-c622-4a27-946f-99a434f012f4"
      unitRef="usd">1358000000</cvs:StoreImpairmentCharges>
    <cvs:StoreImpairmentCharges
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzgtNS0xLTEtMjY1MjQ3_f8e6d30e-674c-4a85-90b7-334f03133d74"
      unitRef="usd">0</cvs:StoreImpairmentCharges>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzktMS0xLTEtMjY1MjQ3_1fd7690b-7bff-45b1-a57c-4ebb26f5587c"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzktMy0xLTEtMjY1MjQ3_4d968003-838c-4461-8222-c9dfd4389a80"
      unitRef="usd">431000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzktNS0xLTEtMjY1MjQ3_b682cd6c-4015-4987-9e3e-75edbd9341d8"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzExLTEtMS0xLTI2NTI0Nw_ed3ff17d-2556-4a2a-b3c0-3333e7a6f70a"
      unitRef="usd">447000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzExLTMtMS0xLTI2NTI0Nw_e4a3d88b-7dae-4b5f-90ff-3e542279e180"
      unitRef="usd">484000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzExLTUtMS0xLTI2NTI0Nw_fb5006bb-e3bc-4d68-b6ec-a16b25f1b20a"
      unitRef="usd">400000000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzEyLTEtMS0xLTI2NTI0Nw_d0c48a4e-29a8-4941-99c0-4b2b704847e0"
      unitRef="usd">475000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzEyLTMtMS0xLTI2NTI0Nw_95739bd2-1b86-436c-9ab6-006f51f4f989"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzEyLTUtMS0xLTI2NTI0Nw_439e0ac7-b9b7-42e2-91ed-1ef3c3618c6e"
      unitRef="usd">269000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzEzLTEtMS0xLTI2NTI0Nw_7e390218-06d6-416f-b6a5-b4a31fed21ed"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzEzLTMtMS0xLTI2NTI0Nw_7dcd327c-afa3-4a65-832a-ccb726694b8c"
      unitRef="usd">-452000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzEzLTUtMS0xLTI2NTI0Nw_836df22c-d6b7-4bb1-b58f-a1c5927ef5ef"
      unitRef="usd">-1440000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE0LTEtMS0xLTI2NTI0Nw_5e03f754-521b-461b-b307-6df93219c662"
      unitRef="usd">-2029000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE0LTMtMS0xLTI2NTI0Nw_6161dfe1-185c-4acc-9429-5d8c3f168e19"
      unitRef="usd">-402000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE0LTUtMS0xLTI2NTI0Nw_b1a13440-6da1-4955-92a4-681adf4da82d"
      unitRef="usd">-570000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE1LTEtMS0xLTI2NTI0Nw_c5669f67-8b1f-4dc7-8370-09d6de895a60"
      unitRef="usd">-332000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE1LTMtMS0xLTI2NTI0Nw_1463987a-b5be-4232-892d-d81239724412"
      unitRef="usd">390000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE1LTUtMS0xLTI2NTI0Nw_2929a48d-f167-497f-98f6-14626ace75a3"
      unitRef="usd">-72000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE3LTEtMS0xLTI2NTI0Nw_d5c9ccab-e11f-4aef-82f1-6a3cd5a25690"
      unitRef="usd">2971000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE3LTMtMS0xLTI2NTI0Nw_02279e7c-d849-46ed-9f65-028935994e34"
      unitRef="usd">2703000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE3LTUtMS0xLTI2NTI0Nw_345d9211-be09-41ff-a5a5-d4d7357c6ee8"
      unitRef="usd">1510000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE4LTEtMS0xLTI2NTI0Nw_68aa963a-f29d-44e5-9fb6-e7ca3bc606b5"
      unitRef="usd">1435000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE4LTMtMS0xLTI2NTI0Nw_9a8ad06c-ecc6-49cc-98a1-adcb500dbceb"
      unitRef="usd">-735000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE4LTUtMS0xLTI2NTI0Nw_3c581def-1a9b-4fc9-a438-85a13d3923fb"
      unitRef="usd">973000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE5LTEtMS0xLTI2NTI0Nw_91d92750-c044-44bb-9090-346fbf5525ef"
      unitRef="usd">491000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE5LTMtMS0xLTI2NTI0Nw_b12d477b-9add-4fd6-b2ff-ff70a2526757"
      unitRef="usd">30000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzE5LTUtMS0xLTI2NTI0Nw_bdd64bfa-4460-4d9a-b545-30601c6aeec3"
      unitRef="usd">-364000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIwLTEtMS0xLTI2NTI0Nw_55e6aca6-9b4b-4153-9db0-27d4519b52ad"
      unitRef="usd">4260000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIwLTMtMS0xLTI2NTI0Nw_b76d3c03-ecfe-4b53-9ed6-40414698b63b"
      unitRef="usd">2898000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIwLTUtMS0xLTI2NTI0Nw_00c0ad2c-3868-444f-82a1-37237f53391d"
      unitRef="usd">2769000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIxLTEtMS0xLTI2NTI0Nw_a3a2d765-b6ec-4ccd-a94f-8cb5dc61c399"
      unitRef="usd">992000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIxLTMtMS0xLTI2NTI0Nw_214d6401-3e88-4074-a305-ae2c2a9f2c3b"
      unitRef="usd">101000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIxLTUtMS0xLTI2NTI0Nw_878d8a68-15c3-4767-8195-db784930f8dd"
      unitRef="usd">-231000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIyLTEtMS0xLTI2NTI0Nw_51bd4db5-9c3b-4790-b474-78f763164524"
      unitRef="usd">6463000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIyLTMtMS0xLTI2NTI0Nw_35835695-fa94-4f20-8eb6-2e3e1bc46135"
      unitRef="usd">2856000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIyLTUtMS0xLTI2NTI0Nw_3bb644ad-c7d0-4945-8e36-af885e021017"
      unitRef="usd">2740000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIzLTEtMS0xLTI2NTI0Nw_6a2c3191-b8fd-48a0-bc65-4fd49daae3d6"
      unitRef="usd">16177000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIzLTMtMS0xLTI2NTI0Nw_94b87c14-f2d0-42e2-903a-a3ec6499cf5b"
      unitRef="usd">18265000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTIvZnJhZzpkYTI5YWNjNTliNTU0OGIxYTU0YjNhMzI1YWZhMjM0NC90YWJsZToxNjMyMjE0MzIxNGY0MTQ2YmJmNzFhMTAzOWJlM2E5Yi90YWJsZXJhbmdlOjE2MzIyMTQzMjE0ZjQxNDZiYmY3MWExMDM5YmUzYTliXzIzLTUtMS0xLTI2NTI0Nw_7c1f1bcc-3e47-47f0-8dac-8af2ba5b9d7e"
      unitRef="usd">15865000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:SharesOutstanding
      contextRef="ic2993c1ba25f447ab89c08c88e66aa96_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtMS0xLTEtMjY1MjQ3_62c0c2a5-8697-4f9d-b667-16a7cdb49f42"
      unitRef="shares">1727000000</us-gaap:SharesOutstanding>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ia5fe3b205c444626a35463f927aa3b11_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtMi0xLTEtMjY1MjQ3_73897469-4aee-4b20-b92f-d8b722c9d81b"
      unitRef="shares">425000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i491a9763983d43dab185a1b3d0201cec_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtNC0xLTEtMjY1MjQ3_335a7aa8-8c30-4b17-a5c7-4da78b6cf53b"
      unitRef="usd">45972000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia5fe3b205c444626a35463f927aa3b11_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtNS0xLTEtMjY1MjQ3_bf3567bd-5dff-4143-aed8-f6311896e895"
      unitRef="usd">-28235000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibe9d7c9e0fe048518f0e819acf0a59a3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtNi0xLTEtMjY1MjQ3_1804e276-f596-4f02-86e2-46a41f50aa06"
      unitRef="usd">45108000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ief232100a20840efa196d4fd232b579f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtNy0xLTEtMjY1MjQ3_1f6d998e-d6ca-464c-80c3-766ec66900bd"
      unitRef="usd">1019000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4b824a92dd1d4f39a02e0e70cc3cf6fc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtOC0xLTEtMjY1MjQ3_2dc3cee4-b84c-4f6d-8924-32e122b25870"
      unitRef="usd">63864000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4991f9a87e794b3b846aabc953f85e74_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtOS0xLTEtMjY1MjQ3_4f080fb7-a1cb-4690-93fc-fc467a4f2b5e"
      unitRef="usd">306000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i68e253af6bf3467aade09b572c1b73a6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtMTAtMS0xLTI2NTI0Nw_a249802a-5f53-4a2a-8fcb-211da0b39a56"
      unitRef="usd">64170000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36ab8a4da32a49829b2a533bcf21afdf_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzQtNi0xLTEtMjY1MjQ3_ff0587d7-da99-4ddb-8c92-ab01066108c2"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia21cb50c4e1644429c76bb8021c0abb3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzQtOC0xLTEtMjY1MjQ3_a032804d-c9e5-4ea5-8b30-43a8d7915f00"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia6302b18a2e04d64807ebebc34715ce0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzQtMTAtMS0xLTI2NTI0Nw_8ae1937e-aba3-4db1-b06b-6ea47c9a06f8"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i8af9823e22614548b10747e15ded15b8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzUtNi0xLTEtMjY1MjQ3_8b4519c9-4b6f-4f0b-8510-c7e755b7020f"
      unitRef="usd">7179000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i65a3c1968cd74443b9c917d9cc5f64f1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzUtOC0xLTEtMjY1MjQ3_08547a84-8a60-4cb6-9db6-8cc872ba437a"
      unitRef="usd">7179000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i72880aeb20f6446880ea5b142b21f44e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzUtOS0xLTEtMjY1MjQ3_afc27a49-af25-4eb6-9382-d9aacaadd61f"
      unitRef="usd">13000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzUtMTAtMS0xLTI2NTI0Nw_0035b86d-735d-4095-846f-c17a2ed7c1dc"
      unitRef="usd">7192000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4634f40686a143b7b789e3fcc2d15bba_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzYtNy0xLTEtMjY1MjQ3_b4497dcd-35c1-47c3-b01a-9cc6067eb067"
      unitRef="usd">395000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i65a3c1968cd74443b9c917d9cc5f64f1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzYtOC0xLTEtMjY1MjQ3_3d869040-b9f4-4217-9dfb-ef0929be7115"
      unitRef="usd">395000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzYtMTAtMS0xLTI2NTI0Nw_b9ea6aed-4465-4a0a-9c26-f7a95c5be508"
      unitRef="usd">395000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i977ea8ed51c749fd9c1b5c76a2eb3053_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzgtMS0xLTEtMjY1MjQ3_f2e531d7-f843-4fd2-8c30-5388f17cf4e0"
      unitRef="shares">6000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ifedd722cb01b4162adfda8754b4a7916_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzgtMi0xLTEtMjY1MjQ3_3f1718f0-be4b-46c6-92b0-3211aa793753"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i9932d12c9d66432680507bf33aaf9390_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzgtNC0xLTEtMjY1MjQ3_b3517f08-7282-4c85-8f1c-6e22b84fa874"
      unitRef="usd">541000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i65a3c1968cd74443b9c917d9cc5f64f1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzgtOC0xLTEtMjY1MjQ3_1c931235-5d04-4fcd-a2af-d86f9795770c"
      unitRef="usd">541000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzgtMTAtMS0xLTI2NTI0Nw_5f2e48d3-2fcf-4617-8521-82d04ce218a4"
      unitRef="usd">541000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod
      contextRef="ifedd722cb01b4162adfda8754b4a7916_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzktMi0xLTEtMjY1MjQ3_5d0ba310-3d35-4b81-a47c-81bd2313b35e"
      unitRef="shares">2000000</cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="ifedd722cb01b4162adfda8754b4a7916_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzktNS0xLTEtMjY1MjQ3_d4b1cd72-a297-42b8-809c-b1f8f1c69c9f"
      unitRef="usd">57000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i65a3c1968cd74443b9c917d9cc5f64f1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzktOC0xLTEtMjY1MjQ3_ac1d4576-bb98-41fc-bd63-31a972a0b75f"
      unitRef="usd">57000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzktMTAtMS0xLTI2NTI0Nw_270b7622-45e2-4516-a5ec-5d0b108b8909"
      unitRef="usd">57000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStock
      contextRef="i8af9823e22614548b10747e15ded15b8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEwLTYtMS0xLTI2NTI0Nw_b924bf3a-c2c3-4abe-a14f-31aa2841a7f5"
      unitRef="usd">2644000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i65a3c1968cd74443b9c917d9cc5f64f1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEwLTgtMS0xLTI2NTI0Nw_bbeb7b56-979b-4a51-b3c7-2104f6229135"
      unitRef="usd">2644000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEwLTEwLTEtMS0yNjUyNDc_2f3ac0a9-cd49-4379-bb74-cf7abb8bd197"
      unitRef="usd">2644000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease
      contextRef="i72880aeb20f6446880ea5b142b21f44e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEyLTktMS0xLTI2NTI0Nw_54b7b9c7-06a2-454b-ba1b-782918bbc08b"
      unitRef="usd">-7000000</cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEyLTEwLTEtMS0yNjUyNDc_42d262e3-1917-4bad-b8b0-6c742bac4903"
      unitRef="usd">-7000000</cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="i12545f682ca84fcd8b34c17747b4d4a8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTEtMS0xLTI2NTI0Nw_7d58b52d-5727-41ce-8163-0578bc598ea7"
      unitRef="shares">1733000000</us-gaap:SharesOutstanding>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i6595d99e0eca44358c06faf58aae481d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTItMS0xLTI2NTI0Nw_acd205b2-ef06-4bc4-9857-1dae880fab11"
      unitRef="shares">423000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i38b09f0dce8d4cb99fa27e7105e23758_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTQtMS0xLTI2NTI0Nw_8f1bb28a-c8a4-4c78-9ea3-af61cd28b62f"
      unitRef="usd">46513000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6595d99e0eca44358c06faf58aae481d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTUtMS0xLTI2NTI0Nw_6963df9f-0ea1-4ac6-b0b5-ec498ce9787e"
      unitRef="usd">-28178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie3fb716c30e94b8d9f3238fa1bdb98a0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTYtMS0xLTI2NTI0Nw_b855609d-7c12-44f7-a712-0a210293357d"
      unitRef="usd">49640000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i22d6477334e54d4ebdf1f3166111f1a6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTctMS0xLTI2NTI0Nw_8750e9c0-8913-4f8e-b3f9-d18ba4aec93e"
      unitRef="usd">1414000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1c5ed3119a74585bf41ba0c7353c92e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTgtMS0xLTI2NTI0Nw_300a56ce-6be6-4238-b335-62db36513e49"
      unitRef="usd">69389000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i22c0ec2db724456da4292af4b50c4c77_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTktMS0xLTI2NTI0Nw_09b0cc63-cd13-4ef7-955a-911c57a265e5"
      unitRef="usd">312000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i501f291fb23d49e987222cf13c851afc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTEwLTEtMS0yNjUyNDc_d3522bab-a1b1-4b04-b565-5cd28a347d8c"
      unitRef="usd">69701000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i580e21923e444bd5aa787a3559d74a5d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTctMS0xLTI5MjkwOQ_c6eb65b0-97a6-4658-b684-153587943450"
      unitRef="usd">-766000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i944efe0ff84e4a2d996b26b09fdc1d74_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTgtMS0xLTI5MjkwOQ_c7c47afe-7c09-404c-8eab-bfc84e73f762"
      unitRef="usd">-766000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifaccc7e6f5db47c38d9e0ea71b031391_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTEwLTEtMS0yOTI5MDk_54b1200e-622f-43b1-bc66-26023b61255a"
      unitRef="usd">-766000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i6fffebb410fa488a9d9b0e22931e5e2c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTYtMS0xLTI2NTI0Nw_ffa40803-e3ef-4137-a207-1ae4679aff69"
      unitRef="usd">8001000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3f4bb816c26b475ea5c62611a6ca3a18_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTgtMS0xLTI2NTI0Nw_f56d96b7-d565-401a-8518-e8e52cbe8390"
      unitRef="usd">8001000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie2e98974a4f44562bfcd00c29cbe00c1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTktMS0xLTI2NTI0Nw_97163b83-8784-4eb5-8431-46943dd6bc02"
      unitRef="usd">-12000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTEwLTEtMS0yNjUyNDc_7ce306c0-dcd4-490d-86da-cce08dc9cdd6"
      unitRef="usd">7989000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if12098c59f664975ae50e2edca80bd53_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE1LTctMS0xLTI2NTI0Nw_50d35057-fe5d-49bc-86c7-f769cbfd682b"
      unitRef="usd">-314000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3f4bb816c26b475ea5c62611a6ca3a18_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE1LTgtMS0xLTI2NTI0Nw_3c1d0c19-7186-4d12-9f75-9e4fd1969225"
      unitRef="usd">-314000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE1LTEwLTEtMS0yNjUyNDc_b6e60ef5-f1f7-4fa6-b405-09b709dc5b32"
      unitRef="usd">-314000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ib1e89593f0c849e0b5cd198216f70015_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE3LTEtMS0xLTI2NTI0Nw_d359f6de-ef34-4844-913b-ebad39371d4a"
      unitRef="shares">11000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie82435ef167541ffb3553c4f0df32b5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE3LTQtMS0xLTI2NTI0Nw_b087569e-b95a-47ca-9bcc-80b7e4472a6a"
      unitRef="usd">864000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i3f4bb816c26b475ea5c62611a6ca3a18_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE3LTgtMS0xLTI2NTI0Nw_92bb9e4c-603a-42e9-9d65-a9664561b93e"
      unitRef="usd">864000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE3LTEwLTEtMS0yNjUyNDc_1b7d8383-da0d-4c64-8a82-c59d408a11c5"
      unitRef="usd">864000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod
      contextRef="ic80415c4b5d245e4a044912d0547b9bf_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE4LTItMS0xLTI2NTI0Nw_fdb2753c-df7b-47ab-ac9e-0dd3d25a3a1f"
      unitRef="shares">1000000</cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="ic80415c4b5d245e4a044912d0547b9bf_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE4LTUtMS0xLTI2NTI0Nw_b5044474-ff72-4143-a8b9-3c5839978fa9"
      unitRef="usd">5000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i3f4bb816c26b475ea5c62611a6ca3a18_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE4LTgtMS0xLTI2NTI0Nw_71a3e098-e158-498a-b356-d75c93443e59"
      unitRef="usd">5000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE4LTEwLTEtMS0yNjUyNDc_4049d0cc-07f8-4089-ae90-14b07246d1a0"
      unitRef="usd">5000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStock
      contextRef="i6fffebb410fa488a9d9b0e22931e5e2c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE5LTYtMS0xLTI2NTI0Nw_9f451eec-8ead-4434-9803-5a28d4e3c422"
      unitRef="usd">2644000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i3f4bb816c26b475ea5c62611a6ca3a18_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE5LTgtMS0xLTI2NTI0Nw_4bd9c2f3-2c4a-4af2-b19c-693dca99fd13"
      unitRef="usd">2644000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE5LTEwLTEtMS0yNjUyNDc_34ecdd84-daf7-4844-8e0f-2bf9f24de94d"
      unitRef="usd">2644000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease
      contextRef="ie2e98974a4f44562bfcd00c29cbe00c1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIxLTktMS0xLTI2NTI0Nw_7092639b-58a7-4fe8-86f2-edf21389d4ad"
      unitRef="usd">6000000</cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIxLTEwLTEtMS0yNjUyNDc_007ded54-0d32-4827-b188-ae18fce32b45"
      unitRef="usd">6000000</cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="if9dd6c6b3ecb435985256437dde936c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTEtMS0xLTI2NTI0Nw_2c546eb7-f7f2-45e9-b064-bf7e420db91e"
      unitRef="shares">1744000000</us-gaap:SharesOutstanding>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i91d3dea8f9bb4c86b60376ad2e8c10c7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTItMS0xLTI2NTI0Nw_8027cace-077c-4657-b8a5-343955af68fd"
      unitRef="shares">422000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie82959ec18904868bfd821447c031d13_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTQtMS0xLTI2NTI0Nw_1b6f591b-bd17-46c4-9673-7791614c2538"
      unitRef="usd">47377000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i91d3dea8f9bb4c86b60376ad2e8c10c7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTUtMS0xLTI2NTI0Nw_b1a6a773-e6f4-4300-9d66-479c354994aa"
      unitRef="usd">-28173000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib6e9f84d80be4446b8b028c6bdbc5c40_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTYtMS0xLTI2NTI0Nw_955152e7-c818-495c-89c0-d11fc816bd39"
      unitRef="usd">54997000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iabe48b9a3b0e43a0b640f125310e597c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTctMS0xLTI2NTI0Nw_bb35614c-9752-4d0e-ad05-48c38b0ee30b"
      unitRef="usd">334000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8998dba726444ee9ad5bfe46a9788a1a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTgtMS0xLTI2NTI0Nw_d1d48701-fbdc-4484-bb70-a69a8fc41bf2"
      unitRef="usd">74535000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibaeb9020504c459e87c9b9fa425f923a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTktMS0xLTI2NTI0Nw_5278639b-1fd5-49ad-96f7-92aa13f51b35"
      unitRef="usd">306000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTEwLTEtMS0yNjUyNDc_8e4eb045-0444-47ba-b8db-11b4ab12337b"
      unitRef="usd">74841000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i077de4b38fce45fdb34454ce78f9f9b2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI0LTYtMS0xLTI2NTI0Nw_b3d2d550-733a-4cf6-a501-fdd8c8d9e55c"
      unitRef="usd">4311000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i196f6e9660424434b44542b216db0270_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI0LTgtMS0xLTI2NTI0Nw_71934794-479d-4d22-ae54-100073664582"
      unitRef="usd">4311000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib2b21a3fd83f44a297eaa7e45a2ba45e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI0LTktMS0xLTI2NTI0Nw_5952dcc8-1cc4-4ef5-aaec-551b879e74cc"
      unitRef="usd">16000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI0LTEwLTEtMS0yNjUyNDc_5af039d7-bb82-452b-8f05-747b7f880e16"
      unitRef="usd">4327000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icfb3bacdf62f4f89858a91412d94f263_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI1LTctMS0xLTI2NTI0Nw_6f7e9d45-a8ca-447a-af99-cf6782f92136"
      unitRef="usd">-1598000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i196f6e9660424434b44542b216db0270_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI1LTgtMS0xLTI2NTI0Nw_50e16ef9-aaf8-496a-a8a6-ecfaecc2bb72"
      unitRef="usd">-1598000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI1LTEwLTEtMS0yNjUyNDc_30906906-20a9-410c-9dfa-5e1d79dd54e1"
      unitRef="usd">-1598000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="iad69a88c0d6245a29a92549e921f5e40_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI2LTEtMS0xLTI2NTI0Nw_a3d30ee2-515f-4d09-9f97-2751af4c70dd"
      unitRef="shares">14000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i3bdd121bfc7c452ba215301545efe3fc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI2LTQtMS0xLTI2NTI0Nw_69e345b2-8fd2-495b-b6c2-569e13e37943"
      unitRef="usd">816000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i196f6e9660424434b44542b216db0270_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI2LTgtMS0xLTI2NTI0Nw_c7f795be-2053-4a1d-8fe2-757f10be04fb"
      unitRef="usd">816000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI2LTEwLTEtMS0yNjUyNDc_c9469b73-4605-4633-9c94-eb3e77e41ba6"
      unitRef="usd">816000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance
      contextRef="id9c89dd55b72447395cf83241b9a653f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI3LTItMS0xLTI2NTI0Nw_7bb20a0c-dae7-400a-932d-6273537cbc05"
      unitRef="shares">36000000</cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="id9c89dd55b72447395cf83241b9a653f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI3LTUtMS0xLTI2NTI0Nw_07c936c0-f94c-4c22-955f-5b8f2c82a300"
      unitRef="usd">3685000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i196f6e9660424434b44542b216db0270_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI3LTgtMS0xLTI2NTI0Nw_0ecef342-15cb-4d58-9c09-52e8b8a70b3d"
      unitRef="usd">3685000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI3LTEwLTEtMS0yNjUyNDc_2f409455-fd91-4725-9b67-c95982ff3730"
      unitRef="usd">3685000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <us-gaap:DividendsCommonStock
      contextRef="i077de4b38fce45fdb34454ce78f9f9b2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI4LTYtMS0xLTI2NTI0Nw_ef87e593-8c05-46dc-95b5-6cf033f88813"
      unitRef="usd">2910000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i196f6e9660424434b44542b216db0270_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI4LTgtMS0xLTI2NTI0Nw_46026421-ff27-4f36-801f-9da9df6498b9"
      unitRef="usd">2910000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI4LTEwLTEtMS0yNjUyNDc_f7dc2e9d-7686-4eb8-bf7f-8699e46efd12"
      unitRef="usd">2910000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease
      contextRef="ib2b21a3fd83f44a297eaa7e45a2ba45e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI5LTktMS0xLTI2NTI0Nw_732209a4-95e6-472d-91b0-8c7507fa7572"
      unitRef="usd">-22000000</cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI5LTEwLTEtMS0yNjUyNDc_01e30dc7-952b-4edc-bbb6-b4fe4d08b652"
      unitRef="usd">-22000000</cvs:NoncontrollingInterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="i34779fb44bce4f6ba1d5a253141f3f1b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTEtMS0xLTI2NTI0Nw_4091a262-cde9-4f2f-bb1f-b63925b44a96"
      unitRef="shares">1758000000</us-gaap:SharesOutstanding>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i1eaf5ce6aae54524ab351f151c4c5797_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTItMS0xLTI2NTI0Nw_8860a665-734e-4981-ad73-7ff28eb0e6f2"
      unitRef="shares">458000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9134faa8fb4e47d780125a2ae7416a6a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTQtMS0xLTI2NTI0Nw_c2b5caaf-e724-468f-87e1-a662ef57b586"
      unitRef="usd">48193000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1eaf5ce6aae54524ab351f151c4c5797_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTUtMS0xLTI2NTI0Nw_fcbd8ce3-30b8-4171-8a70-7b62caa5b56e"
      unitRef="usd">-31858000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1bc417b7cc444506a3991b3fc859cfae_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTYtMS0xLTI2NTI0Nw_cba06012-690c-4db6-ae74-42aa42771331"
      unitRef="usd">56398000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib4df9ffba7784b76a9a950adbaa557a6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTctMS0xLTI2NTI0Nw_379c989b-1190-4cff-93f6-3a8a5887cc7d"
      unitRef="usd">-1264000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i224111d466b840aebce96b61ecd97cc3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTgtMS0xLTI2NTI0Nw_91b40a5e-0da2-4f42-896d-d7ad635df0f9"
      unitRef="usd">71469000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id3599bd1ab9441e68ec38d940b09f7fb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTktMS0xLTI2NTI0Nw_95a2bb17-2141-44d1-8a6d-aea0c37b50b0"
      unitRef="usd">300000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTEwLTEtMS0yNjUyNDc_d199fdde-3b9f-4fff-b1d6-6a5b93862ad9"
      unitRef="usd">71769000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzEyNg_03518fa7-c535-42be-8c54-6c0b9c281e2e"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzEyNg_27d39d01-bc3c-42bc-aaf3-39a401618f56"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i501f291fb23d49e987222cf13c851afc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzEyNg_da141e37-9311-44b8-9a92-c8a9ca8b99e2"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzIzMA_030f2f01-c9bf-42be-8065-6287a2ffcf69"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzIzMA_91eb6693-fa8a-4759-bde4-a5cf526e0d4b"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i501f291fb23d49e987222cf13c851afc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzIzMA_b7551db1-0692-4dfe-81e9-daf3e36c93d0"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <us-gaap:CommonStockValue
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzQzMQ_c3d9d3a3-d489-412a-8883-f2a16179a242"
      unitRef="usd">18000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzQ2MA_44a4806e-ddb0-424f-bedb-ec2df80f1ebe"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i501f291fb23d49e987222cf13c851afc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzQ2MA_ac587a37-354e-42d0-9f16-ba290b78c0c3"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4aa93581903f4f47a9e936c93eacce46_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzY2OA_58862ed7-2702-4759-9495-64df01b9001d"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTM4_836c47a0-99e8-414c-a310-f8efa9b110bb">Significant Accounting Policies &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Business&#160; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CVS Health Corporation, together with its subsidiaries (collectively, &#x201c;CVS Health&#x201d; or the &#x201c;Company&#x201d;), has more than 9,000 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with over 110 million plan members with expanding specialty pharmacy solutions and a dedicated senior pharmacy care business serving more than one million patients per year. The Company also serves an estimated 35 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#x201c;PDP&#x201d;). The Company believes its integrated health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The coronavirus disease 2019 (&#x201c;COVID-19&#x201d;) and its emerging new variants continue to impact the economies of the U.S. and other countries around the world. The impact of COVID-19 on the Company&#x2019;s businesses, operating results, cash flows and financial condition in the years ended December 31, 2022, 2021 and 2020, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this Exhibit 99.1.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with its new operating model adopted in the first quarter of 2023, the Company realigned the composition of its segments to reflect how its Chief Operating Decision Maker (the &#x201c;CODM&#x201d;) reviews information and manages the business. As a result of this realignment, the Company formed a new Health Services segment, which in addition to providing a full range of pharmacy benefit management (&#x201c;PBM&#x201d;) solutions, also delivers health care services in the Company&#x2019;s medical clinics, virtually, and in the home, as well as provider enablement solutions. In addition, the Company created a new Pharmacy &amp;amp; Consumer Wellness segment, which includes its retail and long-term care pharmacy operations and related pharmacy services, as well as its retail front store operations. This segment will also provide pharmacy fulfillment services to support the Health Services segment&#x2019;s specialty and mail order pharmacy offerings. Segment financial information has been recast to reflect these changes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the segment realignment described above, the Company&#x2019;s four reportable segments are as follows: Health Care Benefits, Health Services, Pharmacy &amp;amp; Consumer Wellness and Corporate/Other, which are described below. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Benefits Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Health Care Benefits segment operates as one of the nation&#x2019;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. The Health Care Benefits segment also provided workers&#x2019; compensation administrative services through its Coventry Health Care Workers&#x2019; Compensation business (&#x201c;Workers&#x2019; Compensation business&#x201d;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#x2019;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#x201c;providers&#x201d;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#x201c;Insured&#x201d; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#x201c;ASC.&#x201d; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#x201c;Public Exchanges&#x201d;) in eight states through which it sells Insured plans directly to individual consumers. The Company entered Public Exchanges in four additional states effective January 2023. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. PBM solutions include plan design offerings and administration, formulary management, retail pharmacy network management services, and specialty and mail order pharmacy services. In addition, the Company provides clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#x201c;Covered Entities&#x201d;). The Company operates a group purchasing organization that negotiates pricing for the purchase of pharmaceuticals and rebates with pharmaceutical manufacturers on behalf of its participants and provides various administrative, management and reporting services to pharmaceutical manufacturers. The Health Services segment&#x2019;s clients are primarily employers, &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care (&#x201c;Managed Medicaid&#x201d;) plans, plans offered on Insurance Exchanges and other sponsors of health benefit plans throughout the United States and Covered Entities. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy &amp;amp; Consumer Wellness Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy &amp;amp; Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise. The segment also conducts long-term care pharmacy (&#x201c;LTC&#x201d;) operations, which distribute prescription drugs and provide related pharmacy consulting and ancillary services to long-term care facilities and other care settings, and provides pharmacy fulfillment services to support the Health Services segment&#x2019;s specialty and mail order pharmacy offerings. As of December&#160;31, 2022, the Pharmacy &amp;amp; Consumer Wellness segment operated more than 9,000 retail locations, as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Corporate/Other Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Management and administrative expenses to support the Company&#x2019;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#x2019;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;). The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#x201c;VIEs&#x201d;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents consist of cash and temporary investments with maturities of three months or less when purchased. The Company invests in short-term money market funds, commercial paper and time deposits, as well as other debt securities that are classified as cash equivalents within the accompanying consolidated balance sheets, as these funds are highly liquid and readily convertible to known amounts of cash. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash included in other current assets on the consolidated balance sheets represents funds held on behalf of members, including health savings account (&#x201c;HSA&#x201d;) funds associated with high deductible health plans. Restricted cash included in other assets on the consolidated balance sheets represents amounts held in a trust in one of the Company&#x2019;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits and money market funds.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of cash and cash equivalents on the consolidated balance sheets to total cash, cash equivalents and restricted cash on the consolidated statements of cash flows as of December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other current assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The decrease in restricted cash included in other current assets as of December 31, 2022 compared to December 31, 2021 was primarily due to a decrease in HSA funds held on behalf of customers as a result of the sale of Payflex Holdings, Inc. (&#x201c;PayFlex&#x201d;). See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information on the Company&#x2019;s sale of PayFlex.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt Securities &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities consist primarily of U.S. Treasury and agency securities, mortgage-backed securities, corporate and foreign bonds and other debt securities. Debt securities are classified as either current or long-term investments based on their contractual maturities unless the Company intends to sell an investment within the next twelve months, in which case it is classified as current on the consolidated balance sheets. Debt securities are classified as available for sale and are carried at fair value. See Note 4 &#x2018;&#x2018;Fair Value&#x2019;&#x2019; for additional information on how the Company estimates the fair value of these investments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related (yield-related) components. In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principal payments; and any changes to the rating of the security by a rating agency. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income (loss). Interest is not accrued on debt securities when management believes the collection of interest is unlikely.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The credit-related component is determined by comparing the present value of cash flows expected to be collected from the security, considering all reasonably available information relevant to the collectability of the security, with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the Company records an allowance for credit losses, which is limited by the amount that the fair value is less than amortized cost basis. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For mortgage-backed and other asset-backed securities, the Company recognizes income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The Company&#x2019;s investment in the security is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the security, with adjustments recognized in net income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities with readily available fair values are measured at fair value with changes in fair value recognized in net income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mortgage Loans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mortgage loan investments on the consolidated balance sheets are valued at the unpaid principal balance, net of an allowance for credit losses. Mortgage loans with a maturity date or a committed prepayment date within twelve months are classified as current on the consolidated balance sheets. The Company assesses whether its loans share similar risk characteristics and, if so, &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;groups such loans in a risk pool when measuring expected credit losses. The Company considers the following characteristics when evaluating whether its loans share similar risk characteristics:&#160;loan-to-value ratios, property type (e.g., office, retail, apartment, industrial), geographic location, vacancy rates and property condition. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Credit loss reserves are determined using a loss rate method that multiplies the unpaid principal balance of each loan within a risk pool group by an estimated loss rate percentage. The loss rate percentage considers both the expected loan loss severity and the probability of loan default. For periods where the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions (e.g., gross domestic product, employment), the Company adjusts its expected loss rates to reflect these forecasted economic conditions. For periods beyond which the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions, the Company reverts to historical loss rates in determining expected credit losses. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest income on a potential problem loan (i.e., high probability of default) or restructured loan is accrued to the extent it is deemed to be collectible and the loan continues to perform under its original or restructured terms. Interest income on problem loans (i.e., more than 60 days delinquent, in bankruptcy or in process of foreclosure) is recognized on a cash basis. Cash payments on loans in the process of foreclosure are treated as a return of principal.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other investments consist primarily of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Private equity and hedge fund limited partnerships, which are accounted for using the equity method of accounting. Under this method, the carrying value of the investment is based on the value of the Company&#x2019;s equity ownership of the underlying investment funds provided by the general partner or manager of the investments, the financial statements of which generally are audited. As a result of the timing of the receipt of the valuation information provided by the fund managers, these investments are generally reported on up to a three month lag. The Company reviews investments for impairment at least quarterly and monitors their performance throughout the year through discussions with the administrators, managers and/or general partners. If the Company becomes aware of an impairment of a limited partnership&#x2019;s investments through its review or prior to receiving the limited partnership&#x2019;s financial statements at the financial statement date, an impairment will be recognized by recording a reduction in the carrying value of the limited partnership with a corresponding charge to net investment income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Investment real estate, which is carried on the consolidated balance sheets at depreciated cost, including capital additions, net of write-downs for other-than-temporary declines in fair value. Depreciation is calculated using the straight-line method based on the estimated useful life of each asset. If any real estate investment is considered held-for-sale, it is carried at the lower of its carrying value or fair value less estimated selling costs. The Company generally estimates fair value using net operating income and applying a capitalization rate in conjunction with comparable sales information. At the time of the sale, the difference between the sales price and the carrying value is recorded as a realized capital gain or loss. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Privately-placed equity securities, which are carried on the consolidated balance sheets at cost less impairments, plus or minus subsequent adjustments for observable price changes. Additionally, as a member of the Federal Home Loan Bank of Boston (&#x201c;FHLBB&#x201d;), a subsidiary of the Company is required to purchase and hold shares of the FHLBB. These shares are restricted and carried at cost. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Investment Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net investment income on the Company&#x2019;s investments is recorded when earned and is reflected in the Company&#x2019;s net income (other than net investment income on assets supporting experience-rated products). Experience-rated products are products in the large case pensions business where the contract holder, not the Company, assumes investment and other risks, subject to, among other things, minimum guarantees provided by the Company. The effect of investment performance on experience-rated products is allocated to contract holders&#x2019; accounts daily, based on the underlying investment experience and, therefore, does not impact the Company&#x2019;s net income (as long as the contract&#x2019;s minimum guarantees are not triggered). Net investment income on assets supporting large case pensions&#x2019; experience-rated products is included in net investment income in the consolidated statements of operations and is credited to contract holders&#x2019; accounts through a charge to benefit costs. The contract holders&#x2019; accounts are reflected in policyholders&#x2019; funds on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realized capital gains and losses on investments (other than realized capital gains and losses on investments supporting experience-rated products) are included as a component of net investment income in the consolidated statements of operations. Realized capital gains and losses are determined on a specific identification basis. Purchases and sales of debt and equity securities and alternative investments are reflected on the trade date. Purchases and sales of mortgage loans and investment real estate are reflected on the closing date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realized capital gains and losses on investments supporting large case pensions&#x2019; experience-rated products are not included in realized capital gains and losses in the consolidated statements of operations and instead are credited directly to contract holders&#x2019; accounts. The contract holders&#x2019; accounts are reflected in policyholders&#x2019; funds on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrealized capital gains and losses on investments (other than unrealized capital gains and losses on investments supporting experience-rated products) are reflected in shareholders&#x2019; equity, net of tax, as a component of accumulated other comprehensive income (loss). Unrealized capital gains and losses on investments supporting large case pensions&#x2019; experience-rated products are credited directly to contract holders&#x2019; accounts. The contract holders&#x2019; accounts are reflected in policyholders&#x2019; funds on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses derivative financial instruments in order to manage interest rate and foreign exchange risk and credit exposure. The Company&#x2019;s use of these derivatives is generally limited to hedging risk and has principally consisted of using interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations. Accounts receivable, net was composed of the following at December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vendor and manufacturer receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total accounts receivable, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes accounts receivable of $227&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:6.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s allowance for credit losses was $333&#160;million and $339&#160;million as of December&#160;31, 2022 and 2021, respectively. When developing an estimate of the Company&#x2019;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#x2019;s accounts receivable are short duration in nature and typically settle in less than 30 days. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are valued at the lower of cost or net realizable value using the weighted average cost method. Physical inventory counts are taken on a regular basis in each retail store and LTC pharmacy, and a continuous cycle count process is the primary procedure used to validate the inventory balances on hand in each distribution center and mail facility to ensure that the amounts reflected in the consolidated financial statements are properly stated. During the interim period between physical inventory counts, the Company accrues for anticipated physical inventory losses on a location-by-location basis based on historical results and current physical inventory trends. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reinsurance Recoverables &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#x2019;s primary liability as the direct insurer of the risks reinsured. Failure of reinsurers to indemnify the Company could result in losses; however, the Company does not expect charges for unrecoverable reinsurance to have a material effect on its consolidated operating results or financial condition. The Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk arising from similar geographic regions, activities or economic characteristics of its reinsurers. At December&#160;31, 2022, the Company&#x2019;s reinsurance recoverables consisted primarily of amounts due from third parties that are rated consistent with companies that are considered to have the ability to meet their obligations. Reinsurance recoverables are recorded as other current assets or other assets on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Health Care Contract Acquisition Costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Insurance products included in the Health Care Benefits segment are cancellable by either the customer or the member monthly upon written notice. Acquisition costs related to prepaid health care and health indemnity contracts are generally expensed as incurred. For certain long-duration insurance contracts, acquisition costs directly related to the successful acquisition of a new or renewal insurance contract, including commissions, are deferred and are recorded as other current assets or other assets on the consolidated balance sheets. Contracts are grouped by product and issue year into cohorts consistent with the grouping used in estimating the associated liability and are amortized on a constant level basis based on the remaining in-force policies over the estimated term of the contracts to approximate straight-line amortization. Changes to the Company&#x2019;s assumptions, including assumptions related to persistency, are reflected at the cohort level at the time of change and are recognized prospectively over the estimated terms of the contract. The amortization of deferred acquisition costs is recorded in operating expenses in the consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a roll forward of deferred acquisition costs for the years ended December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred acquisition costs, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalizations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred acquisition costs, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment is reported at historical cost, net of accumulated depreciation. Property, equipment and improvements to leased premises are depreciated using the straight-line method over the estimated useful lives of the assets, or when applicable, the term of the lease, whichever is shorter. Estimated useful lives generally range from 1 to 40 years for buildings, building improvements and leasehold improvements and 3 to 10 years for fixtures, equipment and internally developed software. Repair and maintenance costs are charged directly to expense as incurred. Major renewals or replacements that substantially extend the useful life of an asset are capitalized and depreciated. Application development stage costs for significant internally developed software projects are capitalized and depreciated. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consisted of the following at December&#160;31, 2022 and 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixtures and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes property and equipment of $244&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense (which includes the amortization of property and equipment under finance or capital leases) totaled $2.4 billion, $2.3 billion and $2.1 billion for the years ended December&#160;31, 2022, 2021 and 2020, respectively. During the year ended December&#160;31, 2021, the Company recorded an impairment on property and equipment of $261&#160;million in connection with the planned closure of certain retail stores. See Note 6 &#x2018;&#x2018;Leases&#x2019;&#x2019; for additional information about these impairment charges as well as the Company&#x2019;s finance leases. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Right-of-Use Assets and Lease Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the lease, renewal date of the lease or significant remodeling of the lease space based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company&#x2019;s leases is not readily determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The operating lease right-of-use assets also include lease payments made before commencement and are reduced by lease incentives. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s real estate leases typically contain options that permit renewals for additional periods of up to five years each. For real estate leases, the options to extend are not considered reasonably certain at lease commencement because the Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and regularly opens or closes stores to align with its operating strategy. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the right-of-use asset and lease liability. Similarly, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. Leases with an initial term of 12 months or less are not recorded on the balance sheets, and lease expense is recognized on a straight-line basis over the term of the short-term lease.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For real estate leases, the Company accounts for lease components and nonlease components as a single lease component. Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the right-of-use assets and lease liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 6 &#x2018;&#x2018;Leases&#x2019;&#x2019; for additional information about right-of-use assets and lease liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for business combinations using the acquisition method of accounting, which requires the excess cost of an acquisition over the fair value of net assets acquired and identifiable intangible assets to be recorded as goodwill. Goodwill is not amortized, but is subject to impairment reviews annually, or more frequently, if necessary, as further described in &#x201c;Recoverability of Long-Lived Assets&#x201d; below. See Note 5 &#x2018;&#x2018;Goodwill and Other Intangibles&#x2019;&#x2019; for additional information about goodwill. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s identifiable intangible assets consist primarily of trademarks, trade names, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired (&#x201c;VOBA&#x201d;). These intangible assets arise primarily from the determination of their respective fair market values at the date of acquisition. Amounts assigned to identifiable intangible assets, and their related useful lives, are derived from established valuation techniques and management estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s definite-lived intangible assets are amortized over their estimated useful lives based upon the pattern of future cash flows attributable to the asset. Definite-lived intangible assets are amortized using the straight-line method. VOBA is subject to loss recognition testing annually, or more frequently, if necessary. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite-lived intangible assets are not amortized but are tested for impairment annually, or more frequently, if necessary, as further described in &#x201c;Recoverability of Long-Lived Assets&#x201d; below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 5 &#x2018;&#x2018;Goodwill and Other Intangibles&#x2019;&#x2019; for additional information about intangible assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recoverability of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates the recoverability of long-lived assets, excluding goodwill and indefinite-lived intangible assets, which are tested for impairment using separate tests described below, whenever events or changes in circumstances indicate that the carrying value of such asset may not be recoverable. The Company groups and evaluates these long-lived assets for impairment at the lowest level at which individual cash flows can be identified. If indicators of impairment are present, the Company first &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the asset group&#x2019;s estimated future cash flows (discounted). If required, an impairment loss is recorded for the portion of the asset group&#x2019;s carrying value that exceeds the asset group&#x2019;s estimated future cash flows (discounted). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2022, the Company recorded office real estate optimization charges of $117&#160;million primarily related to the abandonment of leased real estate and the related right-of-use assets and property and equipment in connection with the planned reduction of corporate office real estate space in response to its new flexible work arrangement. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2021, the Company recorded a store impairment charge of approximately $1.4&#160;billion primarily related to the write down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately 900 retail stores between 2022 and 2024. There were no material impairment charges recognized on long-lived assets during the year ended December 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 6 &#x2018;&#x2018;Leases&#x2019;&#x2019; for additional information about the right-of-use asset charges. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When evaluating goodwill for potential impairment, the Company compares the fair value of its reporting units to their respective carrying amounts. The Company estimates the fair value of its reporting units using a combination of a discounted cash flow method and a market multiple method. If the carrying amount of a reporting unit exceeds its estimated fair value, an impairment loss is recognized in an amount equal to that excess. During the third quarter of both 2022 and 2020, the Company performed its required annual impairment tests of goodwill and concluded there were no goodwill impairments as of the testing dates or during the years ended December 31, 2022 and 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2021, the Company performed its required annual impairment tests of goodwill, the results of which indicated an impairment of the goodwill associated with the LTC reporting unit. Accordingly, during the third quarter of 2021, the Company recorded a $431&#160;million goodwill impairment charge on the remaining goodwill of the LTC reporting unit. The results of the impairment tests indicated that there was no impairment of goodwill of the remaining reporting units as of the testing date or during the year ended December&#160;31, 2021. See Note 5 &#x2018;&#x2018;Goodwill and Other Intangibles&#x2019;&#x2019; for additional information about the goodwill impairment charge recorded during the year ended December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite-lived intangible assets are tested for impairment by comparing the estimated fair value of the asset to its carrying value. The Company estimates the fair value of its indefinite-lived trademarks using the relief from royalty method under the income approach. If the carrying value of the asset exceeds its estimated fair value, an impairment loss is recognized, and the asset is written down to its estimated fair value. There were no impairment losses recognized on indefinite-lived intangible assets in any of the years ended December&#160;31, 2022, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Separate Accounts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts assets and liabilities related to large case pensions products represent funds maintained to meet specific objectives of contract holders who bear the investment risk. These assets and liabilities are carried at fair value. Net investment income (including net realized capital gains and losses) accrue directly to such contract holders. The assets of each account are legally segregated and are not subject to claims arising from the Company&#x2019;s other businesses. Deposits, withdrawals and net investment income (including net realized and net unrealized capital gains and losses) on Separate Accounts assets are not reflected in the consolidated statements of operations or cash flows. Management fees charged to contract holders are included in services revenue and recognized over the period earned.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Health Care Costs Payable&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Health care costs payable consist principally of unpaid fee-for-service medical, dental and pharmacy claims, capitation costs, other amounts due to providers pursuant to risk-sharing arrangements related to the Health Care Benefits segment&#x2019;s Insured Commercial, Medicare and Medicaid products and accruals for state assessments. Unpaid health care claims include an estimate of payments the Company will make for (i) services rendered to the Company&#x2019;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid, each as of the financial statement date (collectively, &#x201c;IBNR&#x201d;). Health care costs payable also include an estimate of the cost of services that will continue to be rendered after the financial statement date if the Company is obligated to pay for such services in accordance with contractual or regulatory requirements. Such estimates are developed using actuarial principles and assumptions which consider, among other things, historical and projected claim submission and processing patterns, assumed and historical medical cost trends, historical utilization of medical services, claim inventory levels, changes in Insured membership and product mix, seasonality &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and other relevant factors. The Company reflects changes in these estimates in benefit costs in the Company&#x2019;s consolidated operating results in the period they are determined. Capitation costs represent contractual monthly fees paid to participating physicians and other medical providers for providing medical care, regardless of the volume of medical services provided to the Insured member. Amounts due under risk-sharing arrangements are based on the terms of the underlying contracts with the providers and consider claims experience under the contracts through the financial statement date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company develops its estimate of IBNR using actuarial principles and assumptions that consider numerous factors. Of those factors, the Company considers the analysis of historical and projected claim payment patterns (including claims submission and processing patterns) and the assumed health care cost trend rate (the year-over-year change in per member per month health care costs) to be the most critical assumptions. In developing its IBNR estimate, the Company consistently applies these actuarial principles and assumptions each period, with consideration to the variability of related factors. There have been no significant changes to the methodologies or assumptions used to develop the Company&#x2019;s estimate of IBNR in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company analyzes historical claim payment patterns by comparing claim incurred dates (i.e., the date services were provided) to claim payment dates to estimate &#x201c;completion factors.&#x201d; The Company uses completion factors predominantly to estimate the ultimate cost of claims incurred more than three months before the financial statement date. The Company estimates completion factors by aggregating claim data based on the month of service and month of claim payment and estimating the percentage of claims incurred for a given month that are complete by each month thereafter. For any given month, substantially all claims are paid within six months of the date of service, but it can take up to 48 months or longer after the date of service before all of the claims are completely resolved and paid. These historically-derived completion factors are then applied to claims paid through the financial statement date to estimate the ultimate claim cost for a given month&#x2019;s incurred claim activity. The difference between the estimated ultimate claim cost and the claims paid through the financial statement date represents the Company&#x2019;s estimate of claims remaining to be paid as of the financial statement date and is included in the Company&#x2019;s health care costs payable. The completion factors the Company uses reflect judgments and possible adjustments based on data such as claim inventory levels, claim submission and processing patterns and, to a lesser extent, other factors such as changes in health care cost trend rates, changes in Insured membership and changes in product mix. If claims are submitted or processed on a faster (slower) pace than prior periods, the actual claims may be more (less) complete than originally estimated using the Company&#x2019;s completion factors, which may result in reserves that are higher (lower) than the ultimate cost of claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because claims incurred within three months before the financial statement date are less mature, the Company uses a combination of historically-derived completion factors and the assumed health care cost trend rate to estimate the ultimate cost of claims incurred for these months. The Company applies its actuarial judgment and places a greater emphasis on the assumed health care cost trend rate for the most recent claim incurred dates as these months may be influenced by seasonal patterns and changes in membership and product mix.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s health care cost trend rate is affected by changes in per member utilization of medical services as well as changes in the unit cost of such services. Many factors influence the health care cost trend rate, including the Company&#x2019;s ability to manage benefit costs through product design, negotiation of favorable provider contracts and medical management programs, as well as the mix of the Company&#x2019;s business. The health status of the Company&#x2019;s Insured members, aging of the population and other demographic characteristics, advances in medical technology and other factors continue to contribute to rising per member utilization and unit costs. Changes in health care practices, inflation, new technologies, increases in the cost of prescription drugs (including specialty pharmacy drugs), direct-to-consumer marketing by pharmaceutical companies, clusters of high-cost cases, claim intensity, changes in the regulatory environment, health care provider or member fraud and numerous other factors also contribute to the cost of health care and the Company&#x2019;s health care cost trend rate.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For each reporting period, the Company uses an extensive degree of judgment in the process of estimating its health care costs payable. As a result, considerable variability and uncertainty is inherent in such estimates, particularly with respect to claims with claim incurred dates of three months or less before the financial statement date; and the adequacy of such estimates is highly sensitive to changes in assumed completion factors and the assumed health care cost trend rates. For each reporting period the Company recognizes the actuarial best estimate of health care costs payable considering the potential volatility in assumed completion factors and health care cost trend rates, as well as other factors. The Company believes its estimate of health care costs payable is reasonable and adequate to cover its obligations at December&#160;31, 2022; however, actual claim payments may differ from the Company&#x2019;s estimates. A worsening (or improvement) of the Company&#x2019;s health care cost trend rates or changes in completion factors from those that the Company assumed in estimating health care costs payable at December&#160;31, 2022 would cause these estimates to change in the near term, and such a change could be material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each quarter, the Company re-examines previously established health care costs payable estimates based on actual claim payments for prior periods and other changes in facts and circumstances. Given the extensive degree of judgment in this estimate, it is possible that the Company&#x2019;s estimates of health care costs payable could develop either favorably (that is, its actual benefit costs for the period were less than estimated) or unfavorably. The changes in the Company&#x2019;s estimate of health care costs payable may relate to a prior quarter, prior year or earlier periods. For a roll forward of the Company&#x2019;s health care costs payable, see Note 7 &#x2018;&#x2018;Health Care Costs Payable.&#x2019;&#x2019; The Company&#x2019;s reserving practice is to consistently recognize the actuarial best estimate of its ultimate liability for health care costs payable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Insurance Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unpaid Claims&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unpaid claims consist primarily of reserves associated with certain short-duration group disability and term life insurance contracts, including an estimate for IBNR as of the financial statement date. Reserves associated with certain short-duration group disability and term life insurance contracts are based upon the Company&#x2019;s estimate of the present value of future benefits, which is based on assumed investment yields and assumptions regarding mortality, morbidity and recoveries from the U.S. Social Security Administration. The Company develops its estimate of IBNR using actuarial principles and assumptions which consider, among other things, contractual requirements, claim incidence rates, claim recovery rates, seasonality and other relevant factors. The Company discounts certain claim liabilities related to group long-term disability and life insurance waiver of premium contracts. The discount rates generally reflect the Company&#x2019;s expected investment returns for the investments supporting all incurral years of these liabilities. The discount rates for retrospectively-rated contracts are set at contractually specified levels. The Company&#x2019;s estimates of unpaid claims are subject to change due to changes in the underlying experience of the insurance contracts, changes in investment yields or other factors, and these changes are recorded in current and future benefits in the consolidated statements of operations in the period they are determined. The Company estimates its reserve for claims IBNR for life products largely based on completion factors. The completion factors used are based on the Company&#x2019;s historical experience and reflect judgments and possible adjustments based on data such as claim inventory levels, claim payment patterns, changes in business volume and other factors. If claims are submitted or processed on a faster (slower) pace than historical periods, the actual claims may be more (less) complete than originally estimated using completion factors, which may result in reserves that are higher (lower) than required to cover future life benefit payments. There have been no significant changes to the methodologies or assumptions used to develop the Company&#x2019;s estimate of unpaid claims IBNR in 2022. As of December&#160;31, 2022, unpaid claims balances of $243 million and $1.1 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2021, unpaid claims balances of $324 million and $1.3 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all life and disability insurance liabilities have been fully ceded to unrelated third parties through indemnity reinsurance agreements; however, the Company remains directly obligated to the policyholders.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Future Policy Benefits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future policy benefits consist primarily of reserves for products for which the Company no longer solicits or accepts new customers, including limited payment pension and annuity contracts and long-term care insurance contracts. Contracts are grouped into cohorts by contract type and issue year. The liability for future policy benefits is adjusted for differences between actual and expected experience. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reserves for limited payment pension and annuity contracts represent the Company&#x2019;s estimate of the present value of future benefits to be paid to or on behalf of policyholders and are computed using actuarial principles that consider, among other things, assumptions reflecting anticipated mortality and retirement experience. On an annual basis, or more frequently if necessary, the Company reviews mortality assumptions against both industry standards and its experience.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reserves for long-term care insurance contracts represent the Company&#x2019;s estimate of the present value of future benefits and settlement costs to be paid to or on behalf of policyholders less the present value of future net premiums. The Company&#x2019;s estimate of the present value of future benefits under such contracts is based upon mortality, morbidity, lapse and interest rate assumptions. On an annual basis, or more frequently if necessary, the Company reviews its mortality, morbidity and lapse assumptions against its experience. Annually, or each time the assumptions are changed, the net premium ratio used to calculate the future policy benefit liability is updated to reflect actual experience, as well as the impact of any change in assumptions on the Company&#x2019;s future cash flows. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company discounts its future policy benefit liability using a curve of spot rates derived from Single A rated fixed income instruments. At each reporting date, the Company will measure its liability for future policy benefits using both the current spot &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;rate curve and the locked-in discount rate at each cohort&#x2019;s inception. Any difference between the measured liabilities is recorded in other comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, future policy benefits balances of $334 million and $4.7 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2021, future policy benefits balances of $458 million and $6.0 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Premium Deficiency Reserves&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates its short-duration insurance contracts to determine if it is probable that a loss will be incurred. A premium deficiency loss is recognized when it is probable that expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), will exceed existing reserves plus anticipated future premiums and reinsurance recoveries. Anticipated investment income is not considered in the calculation of premium deficiency losses. For purposes of determining premium deficiency losses, contracts are grouped consistent with the Company&#x2019;s method of acquiring, servicing and measuring the profitability of such contracts. The Company did not have any premium deficiency reserves as of December&#160;31, 2022. As of December&#160;31, 2021, the Company established a premium deficiency reserve of $16 million related to Medicaid products in the Health Care Benefits segment. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Policyholders&#x2019; Funds&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Policyholders&#x2019; funds consist primarily of reserves for pension and annuity investment contracts and customer funds associated with certain health contracts. Reserves for such contracts are equal to cumulative deposits less withdrawals and charges plus interest credited thereon, net of experience-rated adjustments. In both 2022 and 2021, interest rates for pension and annuity investment contracts ranged from 3.5% to 4.8%. Reserves for contracts subject to experience rating reflect the Company&#x2019;s rights as well as the rights of policyholders and plan participants. The Company also held funds for HSAs on behalf of members associated with high deductible health plans prior to the sale of PayFlex in June 2022. These amounts were held to pay for qualified health care expenses incurred by these members. At December&#160;31, 2022, the Company did not hold any HSA funds as a result of the PayFlex sale. The HSA balance was approximately $2.9 billion at December 31, 2021 and was reflected in other current assets with a corresponding liability in policyholders&#x2019; funds. These assets were considered restricted cash for cash flow statement purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Policyholders&#x2019; funds liabilities that are expected to be paid within twelve months from the balance sheet date are classified as current on the consolidated balance sheets. Policyholders&#x2019; funds liabilities that are expected to be paid greater than twelve months from the balance sheet date are included in other long-term liabilities on the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Self-Insurance Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is self-insured for certain losses related to general liability, workers&#x2019; compensation and auto liability. The Company obtains third party insurance coverage to limit exposure from these claims. The Company is also self-insured for certain losses related to health and medical liabilities. The Company&#x2019;s self-insurance accruals, which include reported claims and claims incurred but not reported, are calculated using standard insurance industry actuarial assumptions and the Company&#x2019;s historical claims experience. As of both December&#160;31, 2022 and 2021, self-insurance liabilities totaled $1.1 billion and were recorded in accrued expenses and other long-term liabilities on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Translation and Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For non-U.S. dollar functional currency locations, (i) assets and liabilities are translated at end-of-period exchange rates, (ii) revenues and expenses are translated at average exchange rates in effect during the period and (iii) equity is translated at historical exchange rates. The resulting cumulative translation adjustments are included as a component of accumulated other comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For U.S. dollar functional currency locations, foreign currency assets and liabilities are remeasured into U.S. dollars at end-of-period exchange rates, except for nonmonetary balance sheet accounts which are remeasured at historical exchange rates. Revenues and expenses are remeasured at average exchange rates in effect during each period, except for those expenses related to the nonmonetary balance sheet amounts which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in net income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains and losses from foreign currency transactions and the effects of foreign currency remeasurements were not material in the years ended December&#160;31, 2022, 2021 or 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Benefits Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Health Care Benefits revenue is principally derived from insurance premiums and fees billed to customers. Revenue is recognized based on customer billings, which, in the Company&#x2019;s Commercial business, reflect contracted rates per member and the number of covered members recorded in the Company&#x2019;s records at the time the billings are prepared. Billings are generally sent monthly for coverage during the following month. Revenue related to the Company&#x2019;s Government business is collected monthly from the U.S. federal government and various government agencies based on fixed payment rates and member eligibility. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s billings may be subsequently adjusted to reflect enrollment changes due to member terminations or other factors. These adjustments are known as retroactivity adjustments. In each period, the Company estimates the amount of future retroactivity and adjusts the recorded revenue accordingly. As information regarding actual retroactivity amounts becomes known, the Company refines its estimates and records any required adjustments to revenues in the period in which they arise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Premium Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premiums are recognized as revenue in the month in which the enrollee is entitled to receive health care services. Premiums are reported net of an allowance for estimated terminations and uncollectible amounts. Additionally, premium revenue subject to the minimum medical loss ratio (&#x201c;MLR&#x201d;) rebate requirements of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (as amended, collectively, the &#x201c;ACA&#x201d;) is recorded net of the estimated minimum MLR rebates for the current calendar year. Premiums related to unexpired contractual coverage periods (unearned premiums) are reported as other insurance liabilities on the consolidated balance sheets and recognized as revenue when earned.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of the Company&#x2019;s contracts allow for premiums to be adjusted to reflect actual experience or the relative health status of Insured members. Such adjustments are reasonably estimable at the outset of the contract, and adjustments to those estimates are made based on actual experience of the customer emerging under the contract and the terms of the underlying contract.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Services Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services revenue relates to contracts that can include various combinations of services or series of services which generally are capable of being distinct and accounted for as separate performance obligations. The Health Care Benefits segment&#x2019;s services revenue primarily consists of ASC fees received in exchange for performing certain claim processing and member services for ASC members. ASC fee revenue is recognized over the period the service is provided. Some of the Company&#x2019;s administrative services contracts include guarantees with respect to certain functions, such as customer service response time, claim processing accuracy and claim processing turnaround time, as well as certain guarantees that a plan sponsor&#x2019;s benefit claim experience will fall within a certain range. With any of these guarantees, the Company is financially at risk if the conditions of the arrangements are not met, although the maximum amount at risk typically is limited to a percentage of the fees otherwise payable to the Company by the customer involved. Each period the Company estimates its obligations under the terms of these guarantees and records its estimate as an offset to services revenues.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accounting for Medicare Part D&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues include insurance premiums earned by the Company&#x2019;s PDPs, which are determined based on the PDP&#x2019;s annual bid and related contractual arrangements with the U.S. Centers for Medicare &amp;amp; Medicaid Services (&#x201c;CMS&#x201d;). The insurance premiums include a beneficiary premium, which is the responsibility of the PDP member, and can be subsidized by CMS in the case of low-income members, and a direct premium paid by CMS. Premiums collected in advance are initially recorded within other insurance liabilities and are then recognized ratably as revenue over the period in which members are entitled to receive benefits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues also include a risk-sharing feature of the Medicare Part D program design referred to as the risk corridor. The Company estimates variable consideration in the form of amounts payable to, or receivable from, CMS under the risk corridor, and adjusts revenue based on calculations of additional subsidies to be received from or owed to CMS at the end of the reporting year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to Medicare Part D premiums, the Company receives additional payments each month from CMS related to catastrophic reinsurance, low-income cost-sharing subsidies and coverage gap benefits. If the subsidies received differ from the &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;amounts earned from actual prescriptions transferred, the difference is recorded in either accounts receivable, net or accrued expenses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Health Services segment sells prescription drugs directly through its specialty and mail order pharmacy offerings and indirectly through the Company&#x2019;s retail pharmacy network. The Company&#x2019;s pharmacy benefit arrangements are accounted for in a manner consistent with a master supply arrangement as there are no contractual minimum volumes and each prescription is considered a separate purchasing decision and distinct performance obligation transferred at a point in time. PBM services performed in connection with each prescription claim are considered part of a single performance obligation which culminates in the fulfillment of prescription drugs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue using the gross method at the contract price negotiated with its clients when the Company has concluded it controls the prescription drug before it is transferred to the client plan members. The Company controls prescriptions fulfilled indirectly through its retail pharmacy network because it has separate contractual arrangements with those pharmacies, has discretion in setting the price for the transaction and assumes primary responsibility for fulfilling the promise to provide prescription drugs to its client plan members while also performing the related PBM services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues include (i) the portion of the price the client pays directly to the Company, net of any discounts earned on brand name drugs or other discounts and refunds paid back to the client (see &#x201c;Drug Discounts&#x201d; and &#x201c;Guarantees&#x201d; below), (ii) the price paid to the Company by client plan members for mail order prescriptions and the price paid to retail network pharmacies by client plan members for retail prescriptions (&#x201c;retail co-payments&#x201d;), and (iii) claims based administrative fees for retail pharmacy network contracts. Sales taxes are not included in revenues. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue when control of the prescription drugs is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those prescription drugs. The Company has established the following revenue recognition policies for the Health Services segment:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Revenues generated from prescription drugs sold by third party pharmacies in the Company&#x2019;s retail pharmacy network and associated administrative fees are recognized at the Company&#x2019;s point-of-sale, which is when the claim is adjudicated by the Company&#x2019;s online claims processing system and the Company has transferred control of the prescription drug and completed all of its performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Revenues generated from prescription drugs sold by specialty and mail order pharmacies are recognized when the prescription drug is delivered to the client plan member. At the time of delivery, the Company has performed substantially all of its performance obligations under its client contracts and does not experience a significant level of returns or reshipments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For contracts under which the Company acts as an agent or does not control the prescription drugs prior to transfer to the client plan member, revenue is recognized using the net method.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Drug Discounts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records revenue net of manufacturers&#x2019; rebates earned by its clients based on their plan members&#x2019; utilization of brand-name formulary drugs. The Company estimates these rebates at period-end based on actual and estimated claims data and its estimates of the manufacturers&#x2019; rebates earned by its clients. The estimates are based on the best available data at period-end and recent history for the various factors that can affect the amount of rebates due to the client. The Company adjusts its rebates payable to clients to the actual amounts paid when these rebates are paid or as significant events occur. Any cumulative effect of these adjustments is recorded against revenues at the time it is identified. Adjustments generally result from contract changes with clients or manufacturers that have retroactive rebate adjustments, differences between the estimated and actual product mix subject to rebates, or whether the brand name drug was included in the applicable formulary. The effect of adjustments between estimated and actual manufacturers&#x2019; rebate amounts has not been material to the Company&#x2019;s operating results or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also adjusts revenues for refunds owed to clients resulting from pricing guarantees and performance against defined service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#x2019;s operating results or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Walk-In Medical Clinics&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For services provided by the Company&#x2019;s walk-in medical clinics, revenue recognition occurs for completed services provided to patients, with adjustments taken for third party payor contractual obligations and patient direct bill historical collection rates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy &amp;amp; Consumer Wellness Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Retail Pharmacy&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s retail drugstores recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims under other retail network arrangements. Revenues are adjusted for refunds owed to third party payers resulting from pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#x2019;s operating results or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from Company gift cards purchased by customers is deferred as a contract liability until goods or services are transferred. Any amounts not expected to be redeemed by customers (i.e., breakage) are recognized based on historical redemption patterns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer returns are not material to the Company&#x2019;s operating results or financial condition. Sales taxes are not included in revenues.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Loyalty and Other Programs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s customer loyalty program, ExtraCare&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, consists of two components, ExtraSavings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Rewards. ExtraSavings are coupons that are recorded as a reduction of revenue when redeemed as the Company concluded that they do not represent a promise to the customer to deliver additional goods or services at the time of issuance because they are not tied to a specific transaction or spending level. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ExtraBucks Rewards are accumulated by customers based on their historical spending levels. Thus, the Company has determined that there is an additional performance obligation to those customers at the time of the initial transaction. The Company allocates the transaction price to the initial transaction and the ExtraBucks Rewards transaction based upon the relative standalone selling price, which considers historical redemption patterns for the rewards. Revenue allocated to ExtraBucks Rewards is recognized as those rewards are redeemed. At the end of each period, unredeemed ExtraBucks Rewards are reflected as a contract liability.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also offers a subscription-based membership program, CarePass&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, under which members are entitled to a suite of benefits delivered over the course of the subscription period, as well as a promotional reward that can be redeemed for future goods and services. Subscriptions are paid for on a monthly or annual basis at the time of or in advance of the Company delivering the goods and services. Revenue from these arrangements is recognized as the performance obligations are satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Long-term Care&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those goods or services. Each prescription claim represents a separate performance obligation of the Company, separate and distinct from other prescription claims under customer arrangements. A significant portion of long-term care revenue from sales of pharmaceutical and medical products is reimbursed by the federal Medicare Part D program and, to a lesser extent, state Medicaid programs. The Company monitors its revenues and receivables from these reimbursement sources, as well as long-term care facilities and other third party insurance payors, and reduces revenue at the revenue recognition date to properly account for the variable consideration due to anticipated differences between billed and reimbursed amounts. Accordingly, the total revenues and receivables reported in the Company&#x2019;s consolidated financial statements are recorded at the amount expected to be ultimately received from these payors. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patient co-payments associated with Medicare Part D, certain state Medicaid programs, Medicare Part B and certain third party payors typically are not collected at the time products are delivered or services are rendered, but are billed to the individuals as part of normal billing procedures and subject to normal accounts receivable collections procedures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table disaggregates the Company&#x2019;s revenue by major source in each segment for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy &amp;amp;&lt;br/&gt;Consumer&lt;br/&gt;Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;166,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;83,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(45,154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;205,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;22,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;22,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;85,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;85,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;91,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;169,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;108,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(47,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;322,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Health Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;102,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail &amp;amp; specialty &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;63,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;169,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;150,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;77,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(43,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;184,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;76,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;76,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;82,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;153,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;101,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(46,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;292,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Health Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail &amp;amp; specialty &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;153,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;139,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;71,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(40,350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;171,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,712)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;75,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;93,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(42,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;268,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Health Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail &amp;amp; specialty &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Health Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#x2019;s retail pharmacies and LTC pharmacies. Effective January 1, 2023, pharmacy network also includes activity associated with Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;, which permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order. Maintenance Choice activity was previously reflected in mail &amp;amp; specialty. Segment financial information has been revised to reflect these changes.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Health Services mail &amp;amp; specialty is defined as specialty mail claims inclusive of Specialty Connect&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; claims picked up at a retail pharmacy, as well as mail order and specialty claims fulfilled by the Pharmacy &amp;amp; Consumer Wellness segment. Effective January 1, 2023, mail &amp;amp; specialty excludes Maintenance Choice activity, which is now reflected within pharmacy network. Segment financial information has been revised to reflect these changes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities primarily represent the Company&#x2019;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about receivables and contract liabilities from contracts with customers as of December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables (included in accounts receivable, net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities (included in accrued expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2022 and 2021, the contract liabilities balance includes increases related to customers&#x2019; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rewards earnings and gift card issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemption and breakage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Products Sold&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for cost of products sold as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of products sold includes: (i) the cost of prescription drugs sold during the reporting period directly through the Company&#x2019;s specialty and mail order pharmacies and indirectly through the Company&#x2019;s retail pharmacy network, (ii) shipping and handling costs, (iii) administrative service fees paid to the Pharmacy &amp;amp; Consumer Wellness segment for specialty and mail order pharmacy fulfillment services and (iv) the operating costs of the Company&#x2019;s client service operations and related information technology support costs including depreciation and amortization. The cost of prescription drugs sold component of cost of products sold includes: (i) the cost of the prescription drugs purchased from manufacturers or distributors and shipped to members in clients&#x2019; benefit plans from the Company&#x2019;s mail order pharmacies, net of any volume-related or other discounts (see &#x201c;Vendor Allowances and Purchase Discounts&#x201d; below) and (ii) the cost of prescription drugs sold (including retail co-payments) through the Company&#x2019;s retail pharmacy network under contracts where the Company is the principal, net of any volume-related or other discounts. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy &amp;amp; Consumer Wellness Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of products sold includes: the cost of merchandise sold during the reporting period, including the costs of prescription drugs sold through its retail pharmacies, net of any volume-related or other discounts, the related purchasing costs, warehousing and delivery costs (including depreciation and amortization), the operating costs of the Company&#x2019;s specialty and mail order pharmacy fulfillment operations and actual and estimated inventory losses. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Vendor Allowances and Purchase Discounts &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for vendor allowances and purchase discounts as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Health Services segment receives purchase discounts on products purchased. Contractual arrangements with vendors, including manufacturers, wholesalers and retail pharmacies, normally provide for the Health Services segment to receive purchase discounts from established list prices in one, or a combination, of the following forms: (i) a direct discount at the time of purchase, (ii) a discount for the prompt payment of invoices or (iii) when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy), a discount (or rebate) paid subsequent to dispensing. These rebates are recognized when prescriptions are dispensed and are generally calculated and billed to manufacturers within 30 days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Company&#x2019;s operating results or financial condition. The Company accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Health Services segment also receives additional discounts under its wholesaler contracts if it exceeds contractually defined purchase volumes. In addition, the Health Services segment receives fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of products sold. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy &amp;amp; Consumer Wellness Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vendor allowances received by the Pharmacy &amp;amp; Consumer Wellness segment reduce the carrying cost of inventory and are recognized in cost of products sold when the related inventory is sold, unless they are specifically identified as a reimbursement of incremental costs for promotional programs and/or other services provided. Amounts that are directly linked to advertising commitments are recognized as a reduction of advertising expense (included in operating expenses) when the related advertising commitment is satisfied. Any amounts received in excess of the actual cost incurred also reduce the carrying cost of inventory. The total value of any upfront payments received from vendors that are linked to purchase commitments is initially deferred. The deferred amounts are then amortized to reduce cost of products sold over the life of the contract based upon sales volume. The total value of any upfront payments received from vendors that are not linked to purchase commitments is also initially deferred. The deferred amounts are then amortized to reduce cost of products sold on a straight-line basis over the life of the related contract. The total amortization of these upfront payments was not material to the Company&#x2019;s consolidated financial statements in any of the periods presented. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Health Care Reform&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Insurer Fee&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning on January 1, 2014, the ACA imposed an annual premium-based health insurer fee (&#x201c;HIF&#x201d;) for each calendar year, payable in September, which was not deductible for tax purposes. The Company was required to estimate a liability for the HIF at the beginning of the calendar year in which the fee was payable with a corresponding deferred asset that was amortized ratably to operating expenses over the calendar year. The Company recorded the liability for the HIF in accrued expenses and recorded the deferred asset in other current assets. In December 2019, the HIF was repealed for calendar years after 2020, therefore there was no expense related to the HIF in the years ended December&#160;31, 2022 and 2021. In the year ended December 31, 2020, operating expenses included $1.0&#160;billion related to the Company&#x2019;s share of the HIF. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Adjustment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ACA established a permanent risk adjustment program to transfer funds from qualified individual and small group insurance plans with below average risk scores to plans with above average risk scores. Based on the risk of the Company&#x2019;s qualified plan members relative to the average risk of members of other qualified plans in comparable markets, as defined by the ACA, the Company estimates its ultimate risk adjustment receivable (recorded in accounts receivable) or payable (recorded in accrued expenses) for the current calendar year and reflects the pro-rata year-to-date impact as an adjustment to premium revenue. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Corridor&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ACA established a temporary risk corridor program, which expired at the end of 2016, for qualified individual and small group health insurance plans. Under this program, health insurance companies were to make payments to, or receive payments from, the U.S. Department of Health and Human Services (&#x201c;HHS&#x201d;) based on their ratio of allowable costs to target costs (as defined by the ACA). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company filed a lawsuit in August 2019 to recover the $313&#160;million it was owed under the ACA&#x2019;s risk corridor program, which had been stayed pending the Supreme Court decision. In April 2020, the U.S. Supreme Court ruled that health insurance companies may sue the federal government for amounts owed as calculated under the ACA&#x2019;s temporary risk corridor program. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the Company received the $313&#160;million it was owed under the ACA&#x2019;s risk corridor program. The Company recorded the risk corridor payment as an increase to premium revenue in the year ended December 31, 2020. After considering offsetting items such as the ACA&#x2019;s minimum MLR rebate requirements and premium taxes, the Company recorded pre-tax income of $307&#160;million and after-tax income of $223&#160;million during the year ended December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising Costs &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising costs, which are reduced by the portion funded by vendors, are expensed when the related advertising takes place. Net advertising costs, which are included in operating expenses, were $745 million, $707 million and $613 million in 2022, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc0MDU2_6fb0217d-b4b8-4272-817b-3803971eadab"&gt;three&lt;/span&gt; to five years) using the straight-line method. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year or years in which the differences are expected to reverse. The effect of a change in the tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date of such change.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, and the Company&#x2019;s recent operating results. The Company establishes a valuation allowance when it does not consider it more likely than not that a deferred tax asset will be recovered.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records uncertain tax positions on the basis of a two-step process whereby (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest and/or penalties related to uncertain tax positions are recognized in the income tax provision.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sponsors defined benefit pension plans (&#x201c;pension plans&#x201d;) and other postretirement employee benefit plans (&#x201c;OPEB plans&#x201d;) for its employees and retirees. The Company recognizes the funded status of its pension and OPEB plans on the consolidated balance sheets based on the year-end measurements of plan assets and benefit obligations. When the fair value of plan assets are in excess of the plan benefit obligations, the amounts are reported in other current assets and other assets. When the fair value of plan benefit obligations are in excess of plan assets, the amounts are reported in accrued expenses and other long-term liabilities based on the amount by which the actuarial present value of benefits payable in the next twelve months included in the benefit obligation exceeds the fair value of plan assets. The net periodic benefit income for the Company&#x2019;s pension and OPEB plans do not contain a service cost component as these plans have been frozen for an extended period of time.&#160;Non-service cost components of pension and postretirement net periodic benefit income are included in other income in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share is computed using the treasury stock method. The Company calculates basic earnings per share based on the weighted average number of common shares outstanding for the period. See Note 15 &#x2018;&#x2018;Earnings Per Share&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shares Held in Trust&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains grantor trusts, which held approximately one million shares of its common stock at both December&#160;31, 2022 and 2021. These shares are designated for use under various employee compensation plans. Since the Company holds these shares, they are excluded from the computation of basic and diluted shares outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has investments in (i) a generic pharmaceutical sourcing entity, (ii) certain hedge fund and private equity investments and (iii) certain real estate partnerships that are considered VIEs. The Company does not have a future obligation to fund losses or debts on behalf of these investments; however, it may voluntarily contribute funds. In evaluating whether the Company is the primary beneficiary of a VIE, the Company considers several factors, including whether the Company has (a) the power to direct the activities that most significantly impact the VIE&#x2019;s economic performance and (b) the obligation to absorb losses and the right to receive benefits that could potentially be significant to the VIE. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Interest Entities - Primary Beneficiary&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2014, the Company and Cardinal Health, Inc. (&#x201c;Cardinal&#x201d;) established Red Oak Sourcing, LLC (&#x201c;Red Oak&#x201d;), a generic pharmaceutical sourcing entity in which the Company and Cardinal each own 50%. The Red Oak arrangement had an initial term of ten years. In 2021, the Red Oak arrangement was amended to extend the initial term an additional five years, for a total term of 15 years. Under this arrangement, the Company and Cardinal contributed their sourcing and supply chain expertise to Red Oak and agreed to source and negotiate generic pharmaceutical supply contracts for both companies through Red Oak; however, Red Oak does not own or hold inventory on behalf of either company. No physical assets (e.g., property and equipment) were contributed to Red Oak by either company, and minimal funding was provided to capitalize Red Oak. The Company has determined that it is the primary beneficiary of this VIE because it has the ability to direct the activities of Red Oak. Consequently, the Company consolidates Red Oak in its consolidated financial statements within the Pharmacy &amp;amp; Consumer Wellness segment. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cardinal is required to pay the Company quarterly payments, which began in October 2014 and will extend through June 2029. As milestones are met, the quarterly payments increase. The Company received $183 million from Cardinal during each of the years ended December&#160;31, 2022, 2021 and 2020. The payments reduce the Company&#x2019;s carrying value of inventory and are recognized in cost of products sold when the related inventory is sold.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Interest Entities - Other Variable Interest Holder&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has invested in certain VIEs for which it has determined that it is not the primary beneficiary, consisting of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Hedge fund and private equity investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The Company invests in hedge fund and private equity investments in order to generate investment returns for its investment portfolio supporting its insurance businesses.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Real estate partnerships&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The Company invests in various real estate partnerships, including those that construct, own and manage low-income housing developments. For the low income housing development investments, substantially all of the projected benefits to the Company are from tax credits and other tax benefits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is not the primary beneficiary of these VIEs because the nature of the Company&#x2019;s involvement with the activities of these VIEs does not give the Company the power to direct the activities that most significantly impact their economic performance. The Company records the amount of its investment in these VIEs as long-term investments on the consolidated balance sheets and recognizes its share of each VIE&#x2019;s income or losses in net income.&#160;The Company&#x2019;s maximum exposure to loss from these VIEs is limited to its investment balances as disclosed below and the risk of recapture of previously recognized tax credits related to the real estate partnerships, which the Company does not consider significant.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other variable interest holder VIE assets included in long-term investments on the consolidated balance sheets at December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedge fund investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in SureScripts, LLC (&#x201c;SureScripts&#x201d;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $60 million, $52 million and $56 million in the years ended December&#160;31, 2022, 2021 and 2020, respectively. The Company&#x2019;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in Heartland Healthcare Services, LLC (&#x201c;Heartland&#x201d;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $87 million, $79 million and $77 million for pharmaceutical inventory purchases during the years ended December&#160;31, 2022, 2021 and 2020, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#x2019;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2022, 2021 and 2020, the Company made charitable contributions of&#160;$25&#160;million, $50 million and $50&#160;million, respectively,&#160;to the CVS Health Foundation, a non-profit entity that focuses on health, education and community involvement programs. The charitable contributions were recorded as operating expenses in the consolidated statements of operations within the Corporate/Other segment for the years ended December&#160;31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Discontinued Operations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with certain business dispositions completed between 1995 and 1997, the Company retained guarantees on store lease obligations for a number of former subsidiaries, including Linens &#x2018;n Things and Bob&#x2019;s Stores, each of which subsequently filed for bankruptcy. The Company&#x2019;s loss from discontinued operations includes lease-related costs that the Company believes it will likely be required to satisfy pursuant to these lease guarantees. See &#x201c;Lease Guarantees&#x201d; in Note 17 &#x2018;&#x2018;Commitments and Contingencies&#x2019;&#x2019; for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Results from discontinued operations were immaterial for the years ended December 31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of the results of discontinued operations for the year ended December 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NumberOfStores
      contextRef="id114deab047e49b5a8b771195b4a54a2_I20221231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzE4Mw_65a3ccb9-a838-4249-9a34-5bcf2e6ef0a8"
      unitRef="store">9000</us-gaap:NumberOfStores>
    <cvs:NumberOfWalkInMedicalClinics
      contextRef="i839a6c4fcaad4f5fa23979221c63e037_I20221231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzIxNA_70a14e41-fe0f-4ac1-a5f9-950161935208"
      unitRef="clinic">1100</cvs:NumberOfWalkInMedicalClinics>
    <cvs:NumberOfPharmacyPlanMembers
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzI4OA_e0fc062a-52f5-4b52-bd0b-723bbcb8e963"
      unitRef="people">110000000</cvs:NumberOfPharmacyPlanMembers>
    <cvs:NumberOfPatientsServedPerYear
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQxMg_32d26000-08d9-4426-89dd-b72978ad3d26"
      unitRef="patient">1000000</cvs:NumberOfPatientsServedPerYear>
    <cvs:NumberOfPeopleServed
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ3MQ_4b9726b9-33e0-4806-9968-630a6cca37f4"
      unitRef="people">35000000</cvs:NumberOfPeopleServed>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDky_e80fb8c4-734d-4771-b8a9-5d239ee9a377">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the segment realignment described above, the Company&#x2019;s four reportable segments are as follows: Health Care Benefits, Health Services, Pharmacy &amp;amp; Consumer Wellness and Corporate/Other, which are described below. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Benefits Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Health Care Benefits segment operates as one of the nation&#x2019;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. The Health Care Benefits segment also provided workers&#x2019; compensation administrative services through its Coventry Health Care Workers&#x2019; Compensation business (&#x201c;Workers&#x2019; Compensation business&#x201d;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#x2019;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#x201c;providers&#x201d;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#x201c;Insured&#x201d; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#x201c;ASC.&#x201d; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#x201c;Public Exchanges&#x201d;) in eight states through which it sells Insured plans directly to individual consumers. The Company entered Public Exchanges in four additional states effective January 2023. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. PBM solutions include plan design offerings and administration, formulary management, retail pharmacy network management services, and specialty and mail order pharmacy services. In addition, the Company provides clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#x201c;Covered Entities&#x201d;). The Company operates a group purchasing organization that negotiates pricing for the purchase of pharmaceuticals and rebates with pharmaceutical manufacturers on behalf of its participants and provides various administrative, management and reporting services to pharmaceutical manufacturers. The Health Services segment&#x2019;s clients are primarily employers, &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care (&#x201c;Managed Medicaid&#x201d;) plans, plans offered on Insurance Exchanges and other sponsors of health benefit plans throughout the United States and Covered Entities. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy &amp;amp; Consumer Wellness Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy &amp;amp; Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise. The segment also conducts long-term care pharmacy (&#x201c;LTC&#x201d;) operations, which distribute prescription drugs and provide related pharmacy consulting and ancillary services to long-term care facilities and other care settings, and provides pharmacy fulfillment services to support the Health Services segment&#x2019;s specialty and mail order pharmacy offerings. As of December&#160;31, 2022, the Pharmacy &amp;amp; Consumer Wellness segment operated more than 9,000 retail locations, as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Corporate/Other Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Management and administrative expenses to support the Company&#x2019;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#x2019;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzEzMzc_3a8d83e0-c590-43f4-abc9-0c2e06dce3e8"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <cvs:IndividualPublicHealthInsuranceExchangesNumberOfStates
      contextRef="if07e27d83137497c9009bcc13d88e451_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzMxMjg_f8d43739-05de-4dca-a039-c4ccd700f5c5"
      unitRef="state">8</cvs:IndividualPublicHealthInsuranceExchangesNumberOfStates>
    <cvs:IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates
      contextRef="ie19a1ad3f0604084922f302641035795_D20230101-20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzMyNDk_9ee504db-cb21-429f-9800-2ed279547399"
      unitRef="state">4</cvs:IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates>
    <us-gaap:NumberOfStores
      contextRef="id114deab047e49b5a8b771195b4a54a2_I20221231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQzOTgwNDY2MzUwNDY_6b128ae3-fb49-4179-9400-8d05aaca3add"
      unitRef="store">9000</us-gaap:NumberOfStores>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTc4_6a5e2b53-c350-4397-9bdf-7e6f28b6ff4f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;). The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#x201c;VIEs&#x201d;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTUy_993308ea-603e-468d-94c9-9812c8a5a057">Use of EstimatesThe preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MjAz_64507431-fd7f-4e39-9184-6db0ea1ff9a3">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents consist of cash and temporary investments with maturities of three months or less when purchased. The Company invests in short-term money market funds, commercial paper and time deposits, as well as other debt securities that are classified as cash equivalents within the accompanying consolidated balance sheets, as these funds are highly liquid and readily convertible to known amounts of cash. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash included in other current assets on the consolidated balance sheets represents funds held on behalf of members, including health savings account (&#x201c;HSA&#x201d;) funds associated with high deductible health plans. Restricted cash included in other assets on the consolidated balance sheets represents amounts held in a trust in one of the Company&#x2019;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits and money market funds.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDYx_c85e1e08-34d8-4f1c-919b-3462f25d068e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of cash and cash equivalents on the consolidated balance sheets to total cash, cash equivalents and restricted cash on the consolidated statements of cash flows as of December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other current assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzEtMS0xLTEtMjY1MjQ3_6ed8545a-dde8-47b9-ae4f-83bdef3279fc"
      unitRef="usd">12945000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzEtMy0xLTEtMjY1MjQ3_c9677f92-9403-4dc1-bf03-6f114341a8a3"
      unitRef="usd">9408000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i501f291fb23d49e987222cf13c851afc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzEtNS0xLTEtMjY1MjQ3_b4b8a24c-6478-4662-a5ea-de9387ab5df1"
      unitRef="usd">7854000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzItMS0xLTEtMjY1MjQ3_7fccf039-e395-4e0b-a29f-9a108c46bee2"
      unitRef="usd">144000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzItMy0xLTEtMjY1MjQ3_e7808734-93be-40b6-a872-bb56b42e42a2"
      unitRef="usd">3065000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i501f291fb23d49e987222cf13c851afc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzItNS0xLTEtMjY1MjQ3_22bf26ee-6dad-48ab-9a4b-7cb07243442d"
      unitRef="usd">2913000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzMtMS0xLTEtMjY1MjQ3_61511767-3127-4295-be62-8a963d02d542"
      unitRef="usd">216000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzMtMy0xLTEtMjY1MjQ3_0f096794-5e46-46c9-9a45-c5ef58b53cde"
      unitRef="usd">218000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i501f291fb23d49e987222cf13c851afc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzMtNS0xLTEtMjY1MjQ3_3ba232a5-8871-4848-9de5-ad189462edfd"
      unitRef="usd">276000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzQtMS0xLTEtMjY1MjQ3_82af95d4-7039-4585-a758-9b836f940117"
      unitRef="usd">13305000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzQtMy0xLTEtMjY1MjQ3_c6d42984-ff82-4461-9bd0-0b3a80de3927"
      unitRef="usd">12691000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i501f291fb23d49e987222cf13c851afc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowOGMxZjQ4MTk3MTU0OWRmYTEzOThiZjRkN2Q2ZTM2NS90YWJsZXJhbmdlOjA4YzFmNDgxOTcxNTQ5ZGZhMTM5OGJmNGQ3ZDZlMzY1XzQtNS0xLTEtMjY1MjQ3_8e1e0bfb-3dc0-46aa-828c-3b5b13abfcf8"
      unitRef="usd">11043000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTUz_a63c6fe2-0eb8-443b-b8f3-415854976e61">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt Securities &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities consist primarily of U.S. Treasury and agency securities, mortgage-backed securities, corporate and foreign bonds and other debt securities. Debt securities are classified as either current or long-term investments based on their contractual maturities unless the Company intends to sell an investment within the next twelve months, in which case it is classified as current on the consolidated balance sheets. Debt securities are classified as available for sale and are carried at fair value. See Note 4 &#x2018;&#x2018;Fair Value&#x2019;&#x2019; for additional information on how the Company estimates the fair value of these investments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related (yield-related) components. In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principal payments; and any changes to the rating of the security by a rating agency. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income (loss). Interest is not accrued on debt securities when management believes the collection of interest is unlikely.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The credit-related component is determined by comparing the present value of cash flows expected to be collected from the security, considering all reasonably available information relevant to the collectability of the security, with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the Company records an allowance for credit losses, which is limited by the amount that the fair value is less than amortized cost basis. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For mortgage-backed and other asset-backed securities, the Company recognizes income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The Company&#x2019;s investment in the security is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the security, with adjustments recognized in net income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities with readily available fair values are measured at fair value with changes in fair value recognized in net income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mortgage Loans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mortgage loan investments on the consolidated balance sheets are valued at the unpaid principal balance, net of an allowance for credit losses. Mortgage loans with a maturity date or a committed prepayment date within twelve months are classified as current on the consolidated balance sheets. The Company assesses whether its loans share similar risk characteristics and, if so, &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;groups such loans in a risk pool when measuring expected credit losses. The Company considers the following characteristics when evaluating whether its loans share similar risk characteristics:&#160;loan-to-value ratios, property type (e.g., office, retail, apartment, industrial), geographic location, vacancy rates and property condition. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Credit loss reserves are determined using a loss rate method that multiplies the unpaid principal balance of each loan within a risk pool group by an estimated loss rate percentage. The loss rate percentage considers both the expected loan loss severity and the probability of loan default. For periods where the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions (e.g., gross domestic product, employment), the Company adjusts its expected loss rates to reflect these forecasted economic conditions. For periods beyond which the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions, the Company reverts to historical loss rates in determining expected credit losses. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest income on a potential problem loan (i.e., high probability of default) or restructured loan is accrued to the extent it is deemed to be collectible and the loan continues to perform under its original or restructured terms. Interest income on problem loans (i.e., more than 60 days delinquent, in bankruptcy or in process of foreclosure) is recognized on a cash basis. Cash payments on loans in the process of foreclosure are treated as a return of principal.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other investments consist primarily of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Private equity and hedge fund limited partnerships, which are accounted for using the equity method of accounting. Under this method, the carrying value of the investment is based on the value of the Company&#x2019;s equity ownership of the underlying investment funds provided by the general partner or manager of the investments, the financial statements of which generally are audited. As a result of the timing of the receipt of the valuation information provided by the fund managers, these investments are generally reported on up to a three month lag. The Company reviews investments for impairment at least quarterly and monitors their performance throughout the year through discussions with the administrators, managers and/or general partners. If the Company becomes aware of an impairment of a limited partnership&#x2019;s investments through its review or prior to receiving the limited partnership&#x2019;s financial statements at the financial statement date, an impairment will be recognized by recording a reduction in the carrying value of the limited partnership with a corresponding charge to net investment income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Investment real estate, which is carried on the consolidated balance sheets at depreciated cost, including capital additions, net of write-downs for other-than-temporary declines in fair value. Depreciation is calculated using the straight-line method based on the estimated useful life of each asset. If any real estate investment is considered held-for-sale, it is carried at the lower of its carrying value or fair value less estimated selling costs. The Company generally estimates fair value using net operating income and applying a capitalization rate in conjunction with comparable sales information. At the time of the sale, the difference between the sales price and the carrying value is recorded as a realized capital gain or loss. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Privately-placed equity securities, which are carried on the consolidated balance sheets at cost less impairments, plus or minus subsequent adjustments for observable price changes. Additionally, as a member of the Federal Home Loan Bank of Boston (&#x201c;FHLBB&#x201d;), a subsidiary of the Company is required to purchase and hold shares of the FHLBB. These shares are restricted and carried at cost. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Investment Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net investment income on the Company&#x2019;s investments is recorded when earned and is reflected in the Company&#x2019;s net income (other than net investment income on assets supporting experience-rated products). Experience-rated products are products in the large case pensions business where the contract holder, not the Company, assumes investment and other risks, subject to, among other things, minimum guarantees provided by the Company. The effect of investment performance on experience-rated products is allocated to contract holders&#x2019; accounts daily, based on the underlying investment experience and, therefore, does not impact the Company&#x2019;s net income (as long as the contract&#x2019;s minimum guarantees are not triggered). Net investment income on assets supporting large case pensions&#x2019; experience-rated products is included in net investment income in the consolidated statements of operations and is credited to contract holders&#x2019; accounts through a charge to benefit costs. The contract holders&#x2019; accounts are reflected in policyholders&#x2019; funds on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realized capital gains and losses on investments (other than realized capital gains and losses on investments supporting experience-rated products) are included as a component of net investment income in the consolidated statements of operations. Realized capital gains and losses are determined on a specific identification basis. Purchases and sales of debt and equity securities and alternative investments are reflected on the trade date. Purchases and sales of mortgage loans and investment real estate are reflected on the closing date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realized capital gains and losses on investments supporting large case pensions&#x2019; experience-rated products are not included in realized capital gains and losses in the consolidated statements of operations and instead are credited directly to contract holders&#x2019; accounts. The contract holders&#x2019; accounts are reflected in policyholders&#x2019; funds on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrealized capital gains and losses on investments (other than unrealized capital gains and losses on investments supporting experience-rated products) are reflected in shareholders&#x2019; equity, net of tax, as a component of accumulated other comprehensive income (loss). Unrealized capital gains and losses on investments supporting large case pensions&#x2019; experience-rated products are credited directly to contract holders&#x2019; accounts. The contract holders&#x2019; accounts are reflected in policyholders&#x2019; funds on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTAz_023724cd-4f75-4786-abfe-d8678615a09f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses derivative financial instruments in order to manage interest rate and foreign exchange risk and credit exposure. The Company&#x2019;s use of these derivatives is generally limited to hedging risk and has principally consisted of using interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDk3_e2b25fca-0746-4deb-b027-b8b2c5bdcc75">Accounts ReceivableAccounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations.When developing an estimate of the Company&#x2019;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#x2019;s accounts receivable are short duration in nature and typically settle in less than 30 days.</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTA0_2eda64e3-3143-4ff4-8987-6916956929be">Accounts receivable, net was composed of the following at December&#160;31, 2022 and 2021:&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vendor and manufacturer receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total accounts receivable, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes accounts receivable of $227&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmNTU2ZDA3YzhlYzA0Nzg2YWUyMDhhY2NhMWI4YWVlMS90YWJsZXJhbmdlOmY1NTZkMDdjOGVjMDQ3ODZhZTIwOGFjY2ExYjhhZWUxXzEtMS0xLTEtMjY1MjQ3_5f6e496b-b810-4d05-9b4a-8524d996fef7"
      unitRef="usd">8983000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmNTU2ZDA3YzhlYzA0Nzg2YWUyMDhhY2NhMWI4YWVlMS90YWJsZXJhbmdlOmY1NTZkMDdjOGVjMDQ3ODZhZTIwOGFjY2ExYjhhZWUxXzEtMy0xLTEtMjY1MjQ3_4da43b75-0077-4b9f-8e80-9d3ff9f6e44e"
      unitRef="usd">7932000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <cvs:VendorandManufacturerReceivables
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmNTU2ZDA3YzhlYzA0Nzg2YWUyMDhhY2NhMWI4YWVlMS90YWJsZXJhbmdlOmY1NTZkMDdjOGVjMDQ3ODZhZTIwOGFjY2ExYjhhZWUxXzItMS0xLTEtMjY1MjQ3_399dd410-43d8-41fa-b5bb-d89a863f42c1"
      unitRef="usd">12395000000</cvs:VendorandManufacturerReceivables>
    <cvs:VendorandManufacturerReceivables
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmNTU2ZDA3YzhlYzA0Nzg2YWUyMDhhY2NhMWI4YWVlMS90YWJsZXJhbmdlOmY1NTZkMDdjOGVjMDQ3ODZhZTIwOGFjY2ExYjhhZWUxXzItMy0xLTEtMjY1MjQ3_5f67b570-6229-4b09-a962-e1c6475ea6b7"
      unitRef="usd">10573000000</cvs:VendorandManufacturerReceivables>
    <us-gaap:PremiumsReceivableAtCarryingValue
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmNTU2ZDA3YzhlYzA0Nzg2YWUyMDhhY2NhMWI4YWVlMS90YWJsZXJhbmdlOmY1NTZkMDdjOGVjMDQ3ODZhZTIwOGFjY2ExYjhhZWUxXzMtMS0xLTEtMjY1MjQ3_8f616f81-f58d-4c3f-bc6c-6797815d6771"
      unitRef="usd">2676000000</us-gaap:PremiumsReceivableAtCarryingValue>
    <us-gaap:PremiumsReceivableAtCarryingValue
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmNTU2ZDA3YzhlYzA0Nzg2YWUyMDhhY2NhMWI4YWVlMS90YWJsZXJhbmdlOmY1NTZkMDdjOGVjMDQ3ODZhZTIwOGFjY2ExYjhhZWUxXzMtMy0xLTEtMjY1MjQ3_dd1db361-ac00-4f93-b638-254df6f36f8b"
      unitRef="usd">2537000000</us-gaap:PremiumsReceivableAtCarryingValue>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmNTU2ZDA3YzhlYzA0Nzg2YWUyMDhhY2NhMWI4YWVlMS90YWJsZXJhbmdlOmY1NTZkMDdjOGVjMDQ3ODZhZTIwOGFjY2ExYjhhZWUxXzQtMS0xLTEtMjY1MjQ3_a2ad5342-fdf8-4a9b-81ee-c782d8d4172f"
      unitRef="usd">3449000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmNTU2ZDA3YzhlYzA0Nzg2YWUyMDhhY2NhMWI4YWVlMS90YWJsZXJhbmdlOmY1NTZkMDdjOGVjMDQ3ODZhZTIwOGFjY2ExYjhhZWUxXzQtMy0xLTEtMjY1MjQ3_cde70b74-a07e-478d-aa71-ea93c10a37e3"
      unitRef="usd">3389000000</us-gaap:OtherReceivablesNetCurrent>
    <cvs:AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmNTU2ZDA3YzhlYzA0Nzg2YWUyMDhhY2NhMWI4YWVlMS90YWJsZXJhbmdlOmY1NTZkMDdjOGVjMDQ3ODZhZTIwOGFjY2ExYjhhZWUxXzUtMS0xLTEtMjY1MjQ3_e399175d-54a2-4f0b-a182-9ad21598e364"
      unitRef="usd">27503000000</cvs:AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale>
    <cvs:AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmNTU2ZDA3YzhlYzA0Nzg2YWUyMDhhY2NhMWI4YWVlMS90YWJsZXJhbmdlOmY1NTZkMDdjOGVjMDQ3ODZhZTIwOGFjY2ExYjhhZWUxXzUtMy0xLTEtMjY1MjQ3_77283883-f4c8-4486-889e-692a99e4b1f8"
      unitRef="usd">24431000000</cvs:AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale>
    <cvs:AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale
      contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzE5NTI4_463619aa-d647-4137-96ec-c64fdd508914"
      unitRef="usd">227000000</cvs:AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzE5NzY0_14cbfb21-53bd-4cae-a603-15c321108de2"
      unitRef="usd">333000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzE5Nzcx_63e04f7f-76ab-4933-b49b-8b2409159cc2"
      unitRef="usd">339000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTg4_1b06b627-6146-4f44-8faa-e94c35938bcf">Inventories Inventories are valued at the lower of cost or net realizable value using the weighted average cost method. Physical inventory counts are taken on a regular basis in each retail store and LTC pharmacy, and a continuous cycle count process is the primary procedure used to validate the inventory balances on hand in each distribution center and mail facility to ensure that the amounts reflected in the consolidated financial statements are properly stated. During the interim period between physical inventory counts, the Company accrues for anticipated physical inventory losses on a location-by-location basis based on historical results and current physical inventory trends.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ReinsuranceAccountingPolicy
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MjA0_3b541921-c23f-4f5e-b47a-384e6c7a9ce1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reinsurance Recoverables &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#x2019;s primary liability as the direct insurer of the risks reinsured. Failure of reinsurers to indemnify the Company could result in losses; however, the Company does not expect charges for unrecoverable reinsurance to have a material effect on its consolidated operating results or financial condition. The Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk arising from similar geographic regions, activities or economic characteristics of its reinsurers. At December&#160;31, 2022, the Company&#x2019;s reinsurance recoverables consisted primarily of amounts due from third parties that are rated consistent with companies that are considered to have the ability to meet their obligations. Reinsurance recoverables are recorded as other current assets or other assets on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReinsuranceAccountingPolicy>
    <us-gaap:CapitalizationOfDeferredPolicyAcquisitionCostsPolicy
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTMy_e02e6a70-3499-4063-b1be-4c1b848fe64a">Health Care Contract Acquisition CostsInsurance products included in the Health Care Benefits segment are cancellable by either the customer or the member monthly upon written notice. Acquisition costs related to prepaid health care and health indemnity contracts are generally expensed as incurred. For certain long-duration insurance contracts, acquisition costs directly related to the successful acquisition of a new or renewal insurance contract, including commissions, are deferred and are recorded as other current assets or other assets on the consolidated balance sheets. Contracts are grouped by product and issue year into cohorts consistent with the grouping used in estimating the associated liability and are amortized on a constant level basis based on the remaining in-force policies over the estimated term of the contracts to approximate straight-line amortization. Changes to the Company&#x2019;s assumptions, including assumptions related to persistency, are reflected at the cohort level at the time of change and are recognized prospectively over the estimated terms of the contract. The amortization of deferred acquisition costs is recorded in operating expenses in the consolidated statements of operations.</us-gaap:CapitalizationOfDeferredPolicyAcquisitionCostsPolicy>
    <us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzk4OTU2MDQ3ODEyMDg_aff58815-d0a6-4abb-a070-1fefdb883457">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a roll forward of deferred acquisition costs for the years ended December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred acquisition costs, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalizations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred acquisition costs, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock>
    <us-gaap:DeferredPolicyAcquisitionCosts
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphY2QyOThmMWMxNmY0NmU3OTBhODg2ODAzNmZlZTc5Zi90YWJsZXJhbmdlOmFjZDI5OGYxYzE2ZjQ2ZTc5MGE4ODY4MDM2ZmVlNzlmXzItMS0xLTEtMjcyMzQ2_efe149e7-d578-449f-a1cc-79090139517d"
      unitRef="usd">879000000</us-gaap:DeferredPolicyAcquisitionCosts>
    <us-gaap:DeferredPolicyAcquisitionCosts
      contextRef="i501f291fb23d49e987222cf13c851afc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphY2QyOThmMWMxNmY0NmU3OTBhODg2ODAzNmZlZTc5Zi90YWJsZXJhbmdlOmFjZDI5OGYxYzE2ZjQ2ZTc5MGE4ODY4MDM2ZmVlNzlmXzItMy0xLTEtMjcyMzQ2_d9f75a20-2c09-4e8f-894e-583cc07eb996"
      unitRef="usd">519000000</us-gaap:DeferredPolicyAcquisitionCosts>
    <us-gaap:DeferredPolicyAcquisitionCostsAdditions
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphY2QyOThmMWMxNmY0NmU3OTBhODg2ODAzNmZlZTc5Zi90YWJsZXJhbmdlOmFjZDI5OGYxYzE2ZjQ2ZTc5MGE4ODY4MDM2ZmVlNzlmXzMtMS0xLTEtMjcyMzQ2_b9efba12-c408-4c3d-9153-a1681ad2e3a6"
      unitRef="usd">564000000</us-gaap:DeferredPolicyAcquisitionCostsAdditions>
    <us-gaap:DeferredPolicyAcquisitionCostsAdditions
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphY2QyOThmMWMxNmY0NmU3OTBhODg2ODAzNmZlZTc5Zi90YWJsZXJhbmdlOmFjZDI5OGYxYzE2ZjQ2ZTc5MGE4ODY4MDM2ZmVlNzlmXzMtMy0xLTEtMjcyMzQ2_60d946cc-e92a-4046-9be9-429a31bad73d"
      unitRef="usd">529000000</us-gaap:DeferredPolicyAcquisitionCostsAdditions>
    <us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphY2QyOThmMWMxNmY0NmU3OTBhODg2ODAzNmZlZTc5Zi90YWJsZXJhbmdlOmFjZDI5OGYxYzE2ZjQ2ZTc5MGE4ODY4MDM2ZmVlNzlmXzQtMS0xLTEtMjcyMzQ2_cde74e2f-7fc8-43e0-ae71-3f4f6e67ef76"
      unitRef="usd">224000000</us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense>
    <us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphY2QyOThmMWMxNmY0NmU3OTBhODg2ODAzNmZlZTc5Zi90YWJsZXJhbmdlOmFjZDI5OGYxYzE2ZjQ2ZTc5MGE4ODY4MDM2ZmVlNzlmXzQtMy0xLTEtMjcyMzQ2_5db0c4ff-74c2-48a0-bdaa-cb651b75e976"
      unitRef="usd">169000000</us-gaap:DeferredPolicyAcquisitionCostAmortizationExpense>
    <us-gaap:DeferredPolicyAcquisitionCosts
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphY2QyOThmMWMxNmY0NmU3OTBhODg2ODAzNmZlZTc5Zi90YWJsZXJhbmdlOmFjZDI5OGYxYzE2ZjQ2ZTc5MGE4ODY4MDM2ZmVlNzlmXzYtMS0xLTEtMjcyMzQ2_2a788e94-372d-4c37-b2e6-eec0937773fb"
      unitRef="usd">1219000000</us-gaap:DeferredPolicyAcquisitionCosts>
    <us-gaap:DeferredPolicyAcquisitionCosts
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphY2QyOThmMWMxNmY0NmU3OTBhODg2ODAzNmZlZTc5Zi90YWJsZXJhbmdlOmFjZDI5OGYxYzE2ZjQ2ZTc5MGE4ODY4MDM2ZmVlNzlmXzYtMy0xLTEtMjcyMzQ2_0a093f15-df49-4271-a75a-a9f318123b82"
      unitRef="usd">879000000</us-gaap:DeferredPolicyAcquisitionCosts>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTA3_70b668ed-9bd7-4ba8-a9d5-4f4e9381adb6">Property and EquipmentProperty and equipment is reported at historical cost, net of accumulated depreciation. Property, equipment and improvements to leased premises are depreciated using the straight-line method over the estimated useful lives of the assets, or when applicable, the term of the lease, whichever is shorter. Estimated useful lives generally range from 1 to 40 years for buildings, building improvements and leasehold improvements and 3 to 10 years for fixtures, equipment and internally developed software. Repair and maintenance costs are charged directly to expense as incurred. Major renewals or replacements that substantially extend the useful life of an asset are capitalized and depreciated. Application development stage costs for significant internally developed software projects are capitalized and depreciated.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ida5c6a5e34da4b479b384b7941a36f63_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzIzMzQz_d4a5624c-90de-4913-b0fa-074b3cc2c932">P1Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i7176eb6123944cc09d4c6d7cc55667e2_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzIzMzQ5_24b2b6e7-6614-4384-8084-82a4a0d8803e">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i376bdd1660814f0c93637da644c1fc51_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzIzNDI2_d052495d-be3b-4e24-b721-0c1ca1828977">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i9f6f6993588e45758f3afc8079d763a1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzIzNDMy_89bf29c8-90c6-46b8-ab98-e49f9d0231e9">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDk4_25156d70-15f4-4010-baa6-8fdc3dbfb482">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consisted of the following at December&#160;31, 2022 and 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixtures and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes property and equipment of $244&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i10e2a519b4d24c41a2dbb11874bc1f59_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzEtMS0xLTEtMjY1MjQ3_6761f1fb-6815-4cad-9114-484307812d05"
      unitRef="usd">1996000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i905269377a394b08ac5584c0ccd49b20_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzEtMy0xLTEtMjY1MjQ3_b6028bb2-afe1-4b13-8d65-056047454718"
      unitRef="usd">2038000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie4aa224704f04a019a760bec8864101d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzItMS0xLTEtMjY1MjQ3_f4b99633-80bf-480d-add6-5b1dd65336ee"
      unitRef="usd">4545000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib85ef1cc5d3c496aa153d2806241d599_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzItMy0xLTEtMjY1MjQ3_279cc98b-ecc1-4555-8778-f036e8644ba0"
      unitRef="usd">4225000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2296fa243d024a1bb2396c22449c2acf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzMtMS0xLTEtMjY1MjQ3_102ba8be-9b56-4f54-8747-2679001a27e9"
      unitRef="usd">12978000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if995086e891d4d6b897fad3a54f05b27_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzMtMy0xLTEtMjY1MjQ3_bcc01772-af26-4e78-bd3e-f80cdb985dc4"
      unitRef="usd">13619000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7fa701f5944f475ba623a677b1886a1e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzQtMS0xLTEtMjY1MjQ3_581d172a-44db-4941-b117-c429ee1f4e28"
      unitRef="usd">6238000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ifacaa4d950234294b256a60719467738_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzQtMy0xLTEtMjY1MjQ3_41a19c74-10b0-431e-b2ab-f6c89b9e5f0f"
      unitRef="usd">6242000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i372db3f8099544d2a643f4329a4871fe_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzUtMS0xLTEtMjY1MjQ3_af8a7dfc-eaee-4ff8-a99f-214eccfbba80"
      unitRef="usd">8843000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i20100980ab444f58ab3077553ee4542c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzUtMy0xLTEtMjY1MjQ3_3aa40b38-bb50-42b4-a409-81e496e80872"
      unitRef="usd">7426000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzYtMS0xLTEtMjY1MjQ3_1e8635e6-51c3-44bd-83e4-b5f6d38f7737"
      unitRef="usd">34600000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzYtMy0xLTEtMjY1MjQ3_6a243bb4-caa3-4bf1-b18c-07ecc152738c"
      unitRef="usd">33550000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzctMS0xLTEtMjY1MjQ3_1efc0219-a2c8-4188-b84c-2e0f5175f867"
      unitRef="usd">21483000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzctMy0xLTEtMjY1MjQ3_7225d506-fbea-4801-8988-29461862b326"
      unitRef="usd">20654000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <cvs:PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzgtMS0xLTEtMjY1MjQ3_45ffec43-02bb-41f0-8c56-5957dfb4b9dc"
      unitRef="usd">13117000000</cvs:PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale>
    <cvs:PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTowZDkzNDBhYzYyNTc0NWNhYWY0ODM2YWEyYjY5NTFjNC90YWJsZXJhbmdlOjBkOTM0MGFjNjI1NzQ1Y2FhZjQ4MzZhYTJiNjk1MWM0XzgtMy0xLTEtMjY1MjQ3_d8c1f8de-ee0c-442a-a3fb-db20a089921d"
      unitRef="usd">12896000000</cvs:PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale>
    <cvs:PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale
      contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzIzOTU5_aa540cf2-7876-4bb5-a907-bceb90caad00"
      unitRef="usd">244000000</cvs:PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale>
    <us-gaap:Depreciation
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzI0Mjcw_d04d0008-f3ac-4f8d-a918-c2ff9565365c"
      unitRef="usd">2400000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzI0Mjc0_96edc53c-9826-420c-9051-cce899322fe1"
      unitRef="usd">2300000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzI0Mjgx_ad5b92e7-a4ca-4390-bce5-c48ee485151a"
      unitRef="usd">2100000000</us-gaap:Depreciation>
    <cvs:StoreImpairmentCharges
      contextRef="ief1dfb751b844d4bb4bbe253942b99b2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzI0NDIz_c36c9f87-9c09-4b78-9a35-196c39a8a005"
      unitRef="usd">261000000</cvs:StoreImpairmentCharges>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDcz_82b4d62c-270e-4eb2-b054-93a1ddcbcce0">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Right-of-Use Assets and Lease Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the lease, renewal date of the lease or significant remodeling of the lease space based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company&#x2019;s leases is not readily determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The operating lease right-of-use assets also include lease payments made before commencement and are reduced by lease incentives. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s real estate leases typically contain options that permit renewals for additional periods of up to five years each. For real estate leases, the options to extend are not considered reasonably certain at lease commencement because the Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and regularly opens or closes stores to align with its operating strategy. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the right-of-use asset and lease liability. Similarly, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. Leases with an initial term of 12 months or less are not recorded on the balance sheets, and lease expense is recognized on a straight-line basis over the term of the short-term lease.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For real estate leases, the Company accounts for lease components and nonlease components as a single lease component. Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the right-of-use assets and lease liabilities.&lt;/span&gt;&lt;/div&gt;See Note 6 &#x2018;&#x2018;Leases&#x2019;&#x2019; for additional information about right-of-use assets and lease liabilities.</us-gaap:LesseeLeasesPolicyTextBlock>
    <cvs:LesseeOperatingAndFinanceLeasesRenewalTerm
      contextRef="ib01e468dcb8f4ca98e9b64ffb83ffbe0_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzI1NjI3_8ea4b452-91ad-4226-9735-0d7311c992c6">P5Y</cvs:LesseeOperatingAndFinanceLeasesRenewalTerm>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTc0_ff1169d4-7a49-44b1-9dd7-abfdaca24db3">Goodwill The Company accounts for business combinations using the acquisition method of accounting, which requires the excess cost of an acquisition over the fair value of net assets acquired and identifiable intangible assets to be recorded as goodwill. Goodwill is not amortized, but is subject to impairment reviews annually, or more frequently, if necessary, as further described in &#x201c;Recoverability of Long-Lived Assets&#x201d; below.</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDc1_aa22a71a-0e4d-4986-b8e1-5fa108f2f5f1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s identifiable intangible assets consist primarily of trademarks, trade names, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired (&#x201c;VOBA&#x201d;). These intangible assets arise primarily from the determination of their respective fair market values at the date of acquisition. Amounts assigned to identifiable intangible assets, and their related useful lives, are derived from established valuation techniques and management estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s definite-lived intangible assets are amortized over their estimated useful lives based upon the pattern of future cash flows attributable to the asset. Definite-lived intangible assets are amortized using the straight-line method. VOBA is subject to loss recognition testing annually, or more frequently, if necessary. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite-lived intangible assets are not amortized but are tested for impairment annually, or more frequently, if necessary, as further described in &#x201c;Recoverability of Long-Lived Assets&#x201d; below.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTY4_74be572c-b037-4fae-8f90-4a81972b55b7">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recoverability of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates the recoverability of long-lived assets, excluding goodwill and indefinite-lived intangible assets, which are tested for impairment using separate tests described below, whenever events or changes in circumstances indicate that the carrying value of such asset may not be recoverable. The Company groups and evaluates these long-lived assets for impairment at the lowest level at which individual cash flows can be identified. If indicators of impairment are present, the Company first &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the asset group&#x2019;s estimated future cash flows (discounted). If required, an impairment loss is recorded for the portion of the asset group&#x2019;s carrying value that exceeds the asset group&#x2019;s estimated future cash flows (discounted). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2022, the Company recorded office real estate optimization charges of $117&#160;million primarily related to the abandonment of leased real estate and the related right-of-use assets and property and equipment in connection with the planned reduction of corporate office real estate space in response to its new flexible work arrangement. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2021, the Company recorded a store impairment charge of approximately $1.4&#160;billion primarily related to the write down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately 900 retail stores between 2022 and 2024. There were no material impairment charges recognized on long-lived assets during the year ended December 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 6 &#x2018;&#x2018;Leases&#x2019;&#x2019; for additional information about the right-of-use asset charges. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When evaluating goodwill for potential impairment, the Company compares the fair value of its reporting units to their respective carrying amounts. The Company estimates the fair value of its reporting units using a combination of a discounted cash flow method and a market multiple method. If the carrying amount of a reporting unit exceeds its estimated fair value, an impairment loss is recognized in an amount equal to that excess. During the third quarter of both 2022 and 2020, the Company performed its required annual impairment tests of goodwill and concluded there were no goodwill impairments as of the testing dates or during the years ended December 31, 2022 and 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2021, the Company performed its required annual impairment tests of goodwill, the results of which indicated an impairment of the goodwill associated with the LTC reporting unit. Accordingly, during the third quarter of 2021, the Company recorded a $431&#160;million goodwill impairment charge on the remaining goodwill of the LTC reporting unit. The results of the impairment tests indicated that there was no impairment of goodwill of the remaining reporting units as of the testing date or during the year ended December&#160;31, 2021. See Note 5 &#x2018;&#x2018;Goodwill and Other Intangibles&#x2019;&#x2019; for additional information about the goodwill impairment charge recorded during the year ended December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;Indefinite-lived intangible assets are tested for impairment by comparing the estimated fair value of the asset to its carrying value. The Company estimates the fair value of its indefinite-lived trademarks using the relief from royalty method under the income approach. If the carrying value of the asset exceeds its estimated fair value, an impairment loss is recognized, and the asset is written down to its estimated fair value.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <cvs:OfficeRealEstateOptimizationCharges
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzMwMDkx_ff0878a8-0764-44fb-8c69-d639b11f88dd"
      unitRef="usd">117000000</cvs:OfficeRealEstateOptimizationCharges>
    <cvs:StoreImpairmentCharges
      contextRef="i397dda43721c4f17b0cef6a6c6ee92a9_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzMwNDM3_a2081250-773c-410b-873d-40da642c0b3c"
      unitRef="usd">1400000000</cvs:StoreImpairmentCharges>
    <cvs:NumberOfStoresPlannedClosure
      contextRef="i397dda43721c4f17b0cef6a6c6ee92a9_D20210101-20211231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzMwNTk4_75d3e422-9d43-4b75-b1a4-2387d777c48c"
      unitRef="store">900</cvs:NumberOfStoresPlannedClosure>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzMxNDA5_329febd1-7587-480a-8a20-76cb2e5e213f"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzMxNDA5_ee9a4de3-3021-4283-83bd-3ed464b48a5a"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ia262a9274d8f434a9a8fac8f9016ca16_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzMxNzg4_fd700c44-60ab-49aa-87dc-290cf5f07383"
      unitRef="usd">431000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzMyNTk1_24fcd15a-e011-4803-b6b3-e1ccd75f2633"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzMyNTk1_4852358c-e298-4968-9ede-4c0f08ee2d84"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzMyNTk1_8020dde5-659e-44a8-9702-90a3e6a3cf60"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:PolicyholderAccountsPolicy
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTY5_860c16aa-8624-4419-a9e7-32c15fe9b68b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Separate Accounts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts assets and liabilities related to large case pensions products represent funds maintained to meet specific objectives of contract holders who bear the investment risk. These assets and liabilities are carried at fair value. Net investment income (including net realized capital gains and losses) accrue directly to such contract holders. The assets of each account are legally segregated and are not subject to claims arising from the Company&#x2019;s other businesses. Deposits, withdrawals and net investment income (including net realized and net unrealized capital gains and losses) on Separate Accounts assets are not reflected in the consolidated statements of operations or cash flows. Management fees charged to contract holders are included in services revenue and recognized over the period earned.&lt;/span&gt;&lt;/div&gt;</us-gaap:PolicyholderAccountsPolicy>
    <us-gaap:HealthCareCostsPolicyPolicyTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDkz_2553f075-1154-4bd4-bfe4-86b08be28f25">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Health Care Costs Payable&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Health care costs payable consist principally of unpaid fee-for-service medical, dental and pharmacy claims, capitation costs, other amounts due to providers pursuant to risk-sharing arrangements related to the Health Care Benefits segment&#x2019;s Insured Commercial, Medicare and Medicaid products and accruals for state assessments. Unpaid health care claims include an estimate of payments the Company will make for (i) services rendered to the Company&#x2019;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid, each as of the financial statement date (collectively, &#x201c;IBNR&#x201d;). Health care costs payable also include an estimate of the cost of services that will continue to be rendered after the financial statement date if the Company is obligated to pay for such services in accordance with contractual or regulatory requirements. Such estimates are developed using actuarial principles and assumptions which consider, among other things, historical and projected claim submission and processing patterns, assumed and historical medical cost trends, historical utilization of medical services, claim inventory levels, changes in Insured membership and product mix, seasonality &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and other relevant factors. The Company reflects changes in these estimates in benefit costs in the Company&#x2019;s consolidated operating results in the period they are determined. Capitation costs represent contractual monthly fees paid to participating physicians and other medical providers for providing medical care, regardless of the volume of medical services provided to the Insured member. Amounts due under risk-sharing arrangements are based on the terms of the underlying contracts with the providers and consider claims experience under the contracts through the financial statement date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company develops its estimate of IBNR using actuarial principles and assumptions that consider numerous factors. Of those factors, the Company considers the analysis of historical and projected claim payment patterns (including claims submission and processing patterns) and the assumed health care cost trend rate (the year-over-year change in per member per month health care costs) to be the most critical assumptions. In developing its IBNR estimate, the Company consistently applies these actuarial principles and assumptions each period, with consideration to the variability of related factors. There have been no significant changes to the methodologies or assumptions used to develop the Company&#x2019;s estimate of IBNR in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company analyzes historical claim payment patterns by comparing claim incurred dates (i.e., the date services were provided) to claim payment dates to estimate &#x201c;completion factors.&#x201d; The Company uses completion factors predominantly to estimate the ultimate cost of claims incurred more than three months before the financial statement date. The Company estimates completion factors by aggregating claim data based on the month of service and month of claim payment and estimating the percentage of claims incurred for a given month that are complete by each month thereafter. For any given month, substantially all claims are paid within six months of the date of service, but it can take up to 48 months or longer after the date of service before all of the claims are completely resolved and paid. These historically-derived completion factors are then applied to claims paid through the financial statement date to estimate the ultimate claim cost for a given month&#x2019;s incurred claim activity. The difference between the estimated ultimate claim cost and the claims paid through the financial statement date represents the Company&#x2019;s estimate of claims remaining to be paid as of the financial statement date and is included in the Company&#x2019;s health care costs payable. The completion factors the Company uses reflect judgments and possible adjustments based on data such as claim inventory levels, claim submission and processing patterns and, to a lesser extent, other factors such as changes in health care cost trend rates, changes in Insured membership and changes in product mix. If claims are submitted or processed on a faster (slower) pace than prior periods, the actual claims may be more (less) complete than originally estimated using the Company&#x2019;s completion factors, which may result in reserves that are higher (lower) than the ultimate cost of claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because claims incurred within three months before the financial statement date are less mature, the Company uses a combination of historically-derived completion factors and the assumed health care cost trend rate to estimate the ultimate cost of claims incurred for these months. The Company applies its actuarial judgment and places a greater emphasis on the assumed health care cost trend rate for the most recent claim incurred dates as these months may be influenced by seasonal patterns and changes in membership and product mix.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s health care cost trend rate is affected by changes in per member utilization of medical services as well as changes in the unit cost of such services. Many factors influence the health care cost trend rate, including the Company&#x2019;s ability to manage benefit costs through product design, negotiation of favorable provider contracts and medical management programs, as well as the mix of the Company&#x2019;s business. The health status of the Company&#x2019;s Insured members, aging of the population and other demographic characteristics, advances in medical technology and other factors continue to contribute to rising per member utilization and unit costs. Changes in health care practices, inflation, new technologies, increases in the cost of prescription drugs (including specialty pharmacy drugs), direct-to-consumer marketing by pharmaceutical companies, clusters of high-cost cases, claim intensity, changes in the regulatory environment, health care provider or member fraud and numerous other factors also contribute to the cost of health care and the Company&#x2019;s health care cost trend rate.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For each reporting period, the Company uses an extensive degree of judgment in the process of estimating its health care costs payable. As a result, considerable variability and uncertainty is inherent in such estimates, particularly with respect to claims with claim incurred dates of three months or less before the financial statement date; and the adequacy of such estimates is highly sensitive to changes in assumed completion factors and the assumed health care cost trend rates. For each reporting period the Company recognizes the actuarial best estimate of health care costs payable considering the potential volatility in assumed completion factors and health care cost trend rates, as well as other factors. The Company believes its estimate of health care costs payable is reasonable and adequate to cover its obligations at December&#160;31, 2022; however, actual claim payments may differ from the Company&#x2019;s estimates. A worsening (or improvement) of the Company&#x2019;s health care cost trend rates or changes in completion factors from those that the Company assumed in estimating health care costs payable at December&#160;31, 2022 would cause these estimates to change in the near term, and such a change could be material.&lt;/span&gt;&lt;/div&gt;Each quarter, the Company re-examines previously established health care costs payable estimates based on actual claim payments for prior periods and other changes in facts and circumstances. Given the extensive degree of judgment in this estimate, it is possible that the Company&#x2019;s estimates of health care costs payable could develop either favorably (that is, its actual benefit costs for the period were less than estimated) or unfavorably. The changes in the Company&#x2019;s estimate of health care costs payable may relate to a prior quarter, prior year or earlier periods. For a roll forward of the Company&#x2019;s health care costs payable, see Note 7 &#x2018;&#x2018;Health Care Costs Payable.&#x2019;&#x2019; The Company&#x2019;s reserving practice is to consistently recognize the actuarial best estimate of its ultimate liability for health care costs payable.</us-gaap:HealthCareCostsPolicyPolicyTextBlock>
    <cvs:HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid
      contextRef="i2a0e4c7bb5f84714898af13dee589b68_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzM2Nzkz_1c876b1f-271b-4cdd-bbc1-181577525bb0">P6M</cvs:HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid>
    <cvs:HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid
      contextRef="ib01e468dcb8f4ca98e9b64ffb83ffbe0_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzM2ODQy_a086b8cc-5d8d-490e-b0be-768369dfd887">P48M</cvs:HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid>
    <us-gaap:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTMz_8791c36a-7b58-4075-aa81-4d3d520baa44">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Insurance Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unpaid Claims&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unpaid claims consist primarily of reserves associated with certain short-duration group disability and term life insurance contracts, including an estimate for IBNR as of the financial statement date. Reserves associated with certain short-duration group disability and term life insurance contracts are based upon the Company&#x2019;s estimate of the present value of future benefits, which is based on assumed investment yields and assumptions regarding mortality, morbidity and recoveries from the U.S. Social Security Administration. The Company develops its estimate of IBNR using actuarial principles and assumptions which consider, among other things, contractual requirements, claim incidence rates, claim recovery rates, seasonality and other relevant factors. The Company discounts certain claim liabilities related to group long-term disability and life insurance waiver of premium contracts. The discount rates generally reflect the Company&#x2019;s expected investment returns for the investments supporting all incurral years of these liabilities. The discount rates for retrospectively-rated contracts are set at contractually specified levels. The Company&#x2019;s estimates of unpaid claims are subject to change due to changes in the underlying experience of the insurance contracts, changes in investment yields or other factors, and these changes are recorded in current and future benefits in the consolidated statements of operations in the period they are determined. The Company estimates its reserve for claims IBNR for life products largely based on completion factors. The completion factors used are based on the Company&#x2019;s historical experience and reflect judgments and possible adjustments based on data such as claim inventory levels, claim payment patterns, changes in business volume and other factors. If claims are submitted or processed on a faster (slower) pace than historical periods, the actual claims may be more (less) complete than originally estimated using completion factors, which may result in reserves that are higher (lower) than required to cover future life benefit payments. There have been no significant changes to the methodologies or assumptions used to develop the Company&#x2019;s estimate of unpaid claims IBNR in 2022. As of December&#160;31, 2022, unpaid claims balances of $243 million and $1.1 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2021, unpaid claims balances of $324 million and $1.3 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all life and disability insurance liabilities have been fully ceded to unrelated third parties through indemnity reinsurance agreements; however, the Company remains directly obligated to the policyholders.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Future Policy Benefits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future policy benefits consist primarily of reserves for products for which the Company no longer solicits or accepts new customers, including limited payment pension and annuity contracts and long-term care insurance contracts. Contracts are grouped into cohorts by contract type and issue year. The liability for future policy benefits is adjusted for differences between actual and expected experience. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reserves for limited payment pension and annuity contracts represent the Company&#x2019;s estimate of the present value of future benefits to be paid to or on behalf of policyholders and are computed using actuarial principles that consider, among other things, assumptions reflecting anticipated mortality and retirement experience. On an annual basis, or more frequently if necessary, the Company reviews mortality assumptions against both industry standards and its experience.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reserves for long-term care insurance contracts represent the Company&#x2019;s estimate of the present value of future benefits and settlement costs to be paid to or on behalf of policyholders less the present value of future net premiums. The Company&#x2019;s estimate of the present value of future benefits under such contracts is based upon mortality, morbidity, lapse and interest rate assumptions. On an annual basis, or more frequently if necessary, the Company reviews its mortality, morbidity and lapse assumptions against its experience. Annually, or each time the assumptions are changed, the net premium ratio used to calculate the future policy benefit liability is updated to reflect actual experience, as well as the impact of any change in assumptions on the Company&#x2019;s future cash flows. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company discounts its future policy benefit liability using a curve of spot rates derived from Single A rated fixed income instruments. At each reporting date, the Company will measure its liability for future policy benefits using both the current spot &lt;/span&gt;&lt;/div&gt;rate curve and the locked-in discount rate at each cohort&#x2019;s inception. Any difference between the measured liabilities is recorded in other comprehensive income (loss).</us-gaap:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy>
    <cvs:LiabilityForUnpaidClaims
      contextRef="i1fdcc037f9934dcc9e2153a71efdb1ff_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQzOTY2_06fe5b0f-4a3d-49fc-be82-6bac51136a5a"
      unitRef="usd">243000000</cvs:LiabilityForUnpaidClaims>
    <cvs:LiabilityForUnpaidClaims
      contextRef="i899425f497434b61be7e43e83f1ac7e5_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQzOTcz_dbe8a488-7314-45af-976f-8653bb11d9f7"
      unitRef="usd">1100000000</cvs:LiabilityForUnpaidClaims>
    <cvs:LiabilityForUnpaidClaims
      contextRef="i2fe9e107946a4ef9ade4731bbe54052d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ0MTE0_c3507f7a-8219-4dee-8b8e-dcc00093281e"
      unitRef="usd">324000000</cvs:LiabilityForUnpaidClaims>
    <cvs:LiabilityForUnpaidClaims
      contextRef="i8399f3149edf4edeac9228c155c337f0_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ0MTIx_55437b90-ea63-4f88-92d4-b59352fdfb11"
      unitRef="usd">1300000000</cvs:LiabilityForUnpaidClaims>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="i1fdcc037f9934dcc9e2153a71efdb1ff_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ1Njkw_30d55711-452a-4675-a5d2-653608ecfcfb"
      unitRef="usd">334000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="i899425f497434b61be7e43e83f1ac7e5_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ1Njk3_fc321ffd-90ca-4bf8-8eb6-b2c07acf9c88"
      unitRef="usd">4700000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="i2fe9e107946a4ef9ade4731bbe54052d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ1ODQ3_09fae4d5-bc84-451a-a3b4-96bbc1edb0c8"
      unitRef="usd">458000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="i8399f3149edf4edeac9228c155c337f0_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ1ODU0_a727567d-072f-4a12-9bd8-ceda9bbcde82"
      unitRef="usd">6000000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <cvs:InsurancePremiumDeficiencyReservePolicyTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDY5_8cdf3e45-2ed3-4439-8889-559b2ada7ea2">Premium Deficiency ReservesThe Company evaluates its short-duration insurance contracts to determine if it is probable that a loss will be incurred. A premium deficiency loss is recognized when it is probable that expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), will exceed existing reserves plus anticipated future premiums and reinsurance recoveries. Anticipated investment income is not considered in the calculation of premium deficiency losses. For purposes of determining premium deficiency losses, contracts are grouped consistent with the Company&#x2019;s method of acquiring, servicing and measuring the profitability of such contracts.</cvs:InsurancePremiumDeficiencyReservePolicyTextBlock>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ2Njk2_eecf8bf7-7e03-48fa-b40e-aa7836186475"
      unitRef="usd">0</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ2ODEy_386f7061-ba98-4825-96c2-bb996a730f39"
      unitRef="usd">16000000</cvs:PremiumDeficiencyReserveLiability>
    <us-gaap:AllocationsToPolicyholdersPolicies
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MjEw_d75a797d-d47d-4b1f-98ec-4341cd1c0e23">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Policyholders&#x2019; Funds&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Policyholders&#x2019; funds consist primarily of reserves for pension and annuity investment contracts and customer funds associated with certain health contracts. Reserves for such contracts are equal to cumulative deposits less withdrawals and charges plus interest credited thereon, net of experience-rated adjustments. In both 2022 and 2021, interest rates for pension and annuity investment contracts ranged from 3.5% to 4.8%. Reserves for contracts subject to experience rating reflect the Company&#x2019;s rights as well as the rights of policyholders and plan participants. The Company also held funds for HSAs on behalf of members associated with high deductible health plans prior to the sale of PayFlex in June 2022. These amounts were held to pay for qualified health care expenses incurred by these members. At December&#160;31, 2022, the Company did not hold any HSA funds as a result of the PayFlex sale. The HSA balance was approximately $2.9 billion at December 31, 2021 and was reflected in other current assets with a corresponding liability in policyholders&#x2019; funds. These assets were considered restricted cash for cash flow statement purposes.&lt;/span&gt;&lt;/div&gt;Policyholders&#x2019; funds liabilities that are expected to be paid within twelve months from the balance sheet date are classified as current on the consolidated balance sheets. Policyholders&#x2019; funds liabilities that are expected to be paid greater than twelve months from the balance sheet date are included in other long-term liabilities on the consolidated balance sheets.</us-gaap:AllocationsToPolicyholdersPolicies>
    <cvs:PensionAndAnnuityInvestmentContractsInterest
      contextRef="i2a0e4c7bb5f84714898af13dee589b68_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ3MzEy_4dd46b09-b988-47a1-b62b-b2c19ce712bc"
      unitRef="number">0.035</cvs:PensionAndAnnuityInvestmentContractsInterest>
    <cvs:PensionAndAnnuityInvestmentContractsInterest
      contextRef="i48c79709e147425a97e76cb1ddd62633_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ3MzEy_719f1c8e-9b95-443d-8c80-0ff5bee15057"
      unitRef="number">0.035</cvs:PensionAndAnnuityInvestmentContractsInterest>
    <cvs:PensionAndAnnuityInvestmentContractsInterest
      contextRef="ib01e468dcb8f4ca98e9b64ffb83ffbe0_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ3MzE4_629f6f05-32f7-4217-aa0f-c9758f2371ca"
      unitRef="number">0.048</cvs:PensionAndAnnuityInvestmentContractsInterest>
    <cvs:PensionAndAnnuityInvestmentContractsInterest
      contextRef="i862ddd84e7aa45819c8c9210518db7da_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ3MzE4_dcf4d68c-b386-480d-ae58-47c52fa1c71a"
      unitRef="number">0.048</cvs:PensionAndAnnuityInvestmentContractsInterest>
    <cvs:HeathSavingsAccountBalance
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ3NzI3_55b9aa71-a175-4b7e-af57-3aec294af654"
      unitRef="usd">0</cvs:HeathSavingsAccountBalance>
    <cvs:HeathSavingsAccountBalance
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ3ODE2_4d199a71-255f-4b53-8c1d-b83508ea40f7"
      unitRef="usd">2900000000</cvs:HeathSavingsAccountBalance>
    <us-gaap:SelfInsuranceReservePolicyTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDY3_df35e684-19da-4063-b6e8-51fedaf51d7e">Self-Insurance LiabilitiesThe Company is self-insured for certain losses related to general liability, workers&#x2019; compensation and auto liability. The Company obtains third party insurance coverage to limit exposure from these claims. The Company is also self-insured for certain losses related to health and medical liabilities. The Company&#x2019;s self-insurance accruals, which include reported claims and claims incurred but not reported, are calculated using standard insurance industry actuarial assumptions and the Company&#x2019;s historical claims experience.</us-gaap:SelfInsuranceReservePolicyTextBlock>
    <us-gaap:SelfInsuranceReserve
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ5MDAx_02a6e576-d6a3-4af6-9e59-0cbd6321806f"
      unitRef="usd">1100000000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzQ5MDAx_2fc701ed-3f7b-40ba-9d45-074656ae11f6"
      unitRef="usd">1100000000</us-gaap:SelfInsuranceReserve>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTgw_72aaedac-78fc-4138-8f4d-f0060cfd14ea">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Translation and Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For non-U.S. dollar functional currency locations, (i) assets and liabilities are translated at end-of-period exchange rates, (ii) revenues and expenses are translated at average exchange rates in effect during the period and (iii) equity is translated at historical exchange rates. The resulting cumulative translation adjustments are included as a component of accumulated other comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For U.S. dollar functional currency locations, foreign currency assets and liabilities are remeasured into U.S. dollars at end-of-period exchange rates, except for nonmonetary balance sheet accounts which are remeasured at historical exchange rates. Revenues and expenses are remeasured at average exchange rates in effect during each period, except for those expenses related to the nonmonetary balance sheet amounts which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in net income.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTE0_6c3d08a5-3d7f-4b20-b918-d59bdea15e6c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Benefits Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Health Care Benefits revenue is principally derived from insurance premiums and fees billed to customers. Revenue is recognized based on customer billings, which, in the Company&#x2019;s Commercial business, reflect contracted rates per member and the number of covered members recorded in the Company&#x2019;s records at the time the billings are prepared. Billings are generally sent monthly for coverage during the following month. Revenue related to the Company&#x2019;s Government business is collected monthly from the U.S. federal government and various government agencies based on fixed payment rates and member eligibility. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s billings may be subsequently adjusted to reflect enrollment changes due to member terminations or other factors. These adjustments are known as retroactivity adjustments. In each period, the Company estimates the amount of future retroactivity and adjusts the recorded revenue accordingly. As information regarding actual retroactivity amounts becomes known, the Company refines its estimates and records any required adjustments to revenues in the period in which they arise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Premium Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premiums are recognized as revenue in the month in which the enrollee is entitled to receive health care services. Premiums are reported net of an allowance for estimated terminations and uncollectible amounts. Additionally, premium revenue subject to the minimum medical loss ratio (&#x201c;MLR&#x201d;) rebate requirements of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (as amended, collectively, the &#x201c;ACA&#x201d;) is recorded net of the estimated minimum MLR rebates for the current calendar year. Premiums related to unexpired contractual coverage periods (unearned premiums) are reported as other insurance liabilities on the consolidated balance sheets and recognized as revenue when earned.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of the Company&#x2019;s contracts allow for premiums to be adjusted to reflect actual experience or the relative health status of Insured members. Such adjustments are reasonably estimable at the outset of the contract, and adjustments to those estimates are made based on actual experience of the customer emerging under the contract and the terms of the underlying contract.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Services Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services revenue relates to contracts that can include various combinations of services or series of services which generally are capable of being distinct and accounted for as separate performance obligations. The Health Care Benefits segment&#x2019;s services revenue primarily consists of ASC fees received in exchange for performing certain claim processing and member services for ASC members. ASC fee revenue is recognized over the period the service is provided. Some of the Company&#x2019;s administrative services contracts include guarantees with respect to certain functions, such as customer service response time, claim processing accuracy and claim processing turnaround time, as well as certain guarantees that a plan sponsor&#x2019;s benefit claim experience will fall within a certain range. With any of these guarantees, the Company is financially at risk if the conditions of the arrangements are not met, although the maximum amount at risk typically is limited to a percentage of the fees otherwise payable to the Company by the customer involved. Each period the Company estimates its obligations under the terms of these guarantees and records its estimate as an offset to services revenues.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accounting for Medicare Part D&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues include insurance premiums earned by the Company&#x2019;s PDPs, which are determined based on the PDP&#x2019;s annual bid and related contractual arrangements with the U.S. Centers for Medicare &amp;amp; Medicaid Services (&#x201c;CMS&#x201d;). The insurance premiums include a beneficiary premium, which is the responsibility of the PDP member, and can be subsidized by CMS in the case of low-income members, and a direct premium paid by CMS. Premiums collected in advance are initially recorded within other insurance liabilities and are then recognized ratably as revenue over the period in which members are entitled to receive benefits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues also include a risk-sharing feature of the Medicare Part D program design referred to as the risk corridor. The Company estimates variable consideration in the form of amounts payable to, or receivable from, CMS under the risk corridor, and adjusts revenue based on calculations of additional subsidies to be received from or owed to CMS at the end of the reporting year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to Medicare Part D premiums, the Company receives additional payments each month from CMS related to catastrophic reinsurance, low-income cost-sharing subsidies and coverage gap benefits. If the subsidies received differ from the &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;amounts earned from actual prescriptions transferred, the difference is recorded in either accounts receivable, net or accrued expenses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Health Services segment sells prescription drugs directly through its specialty and mail order pharmacy offerings and indirectly through the Company&#x2019;s retail pharmacy network. The Company&#x2019;s pharmacy benefit arrangements are accounted for in a manner consistent with a master supply arrangement as there are no contractual minimum volumes and each prescription is considered a separate purchasing decision and distinct performance obligation transferred at a point in time. PBM services performed in connection with each prescription claim are considered part of a single performance obligation which culminates in the fulfillment of prescription drugs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue using the gross method at the contract price negotiated with its clients when the Company has concluded it controls the prescription drug before it is transferred to the client plan members. The Company controls prescriptions fulfilled indirectly through its retail pharmacy network because it has separate contractual arrangements with those pharmacies, has discretion in setting the price for the transaction and assumes primary responsibility for fulfilling the promise to provide prescription drugs to its client plan members while also performing the related PBM services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues include (i) the portion of the price the client pays directly to the Company, net of any discounts earned on brand name drugs or other discounts and refunds paid back to the client (see &#x201c;Drug Discounts&#x201d; and &#x201c;Guarantees&#x201d; below), (ii) the price paid to the Company by client plan members for mail order prescriptions and the price paid to retail network pharmacies by client plan members for retail prescriptions (&#x201c;retail co-payments&#x201d;), and (iii) claims based administrative fees for retail pharmacy network contracts. Sales taxes are not included in revenues. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue when control of the prescription drugs is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those prescription drugs. The Company has established the following revenue recognition policies for the Health Services segment:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Revenues generated from prescription drugs sold by third party pharmacies in the Company&#x2019;s retail pharmacy network and associated administrative fees are recognized at the Company&#x2019;s point-of-sale, which is when the claim is adjudicated by the Company&#x2019;s online claims processing system and the Company has transferred control of the prescription drug and completed all of its performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Revenues generated from prescription drugs sold by specialty and mail order pharmacies are recognized when the prescription drug is delivered to the client plan member. At the time of delivery, the Company has performed substantially all of its performance obligations under its client contracts and does not experience a significant level of returns or reshipments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For contracts under which the Company acts as an agent or does not control the prescription drugs prior to transfer to the client plan member, revenue is recognized using the net method.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Drug Discounts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records revenue net of manufacturers&#x2019; rebates earned by its clients based on their plan members&#x2019; utilization of brand-name formulary drugs. The Company estimates these rebates at period-end based on actual and estimated claims data and its estimates of the manufacturers&#x2019; rebates earned by its clients. The estimates are based on the best available data at period-end and recent history for the various factors that can affect the amount of rebates due to the client. The Company adjusts its rebates payable to clients to the actual amounts paid when these rebates are paid or as significant events occur. Any cumulative effect of these adjustments is recorded against revenues at the time it is identified. Adjustments generally result from contract changes with clients or manufacturers that have retroactive rebate adjustments, differences between the estimated and actual product mix subject to rebates, or whether the brand name drug was included in the applicable formulary. The effect of adjustments between estimated and actual manufacturers&#x2019; rebate amounts has not been material to the Company&#x2019;s operating results or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also adjusts revenues for refunds owed to clients resulting from pricing guarantees and performance against defined service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#x2019;s operating results or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Walk-In Medical Clinics&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For services provided by the Company&#x2019;s walk-in medical clinics, revenue recognition occurs for completed services provided to patients, with adjustments taken for third party payor contractual obligations and patient direct bill historical collection rates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy &amp;amp; Consumer Wellness Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Retail Pharmacy&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s retail drugstores recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims under other retail network arrangements. Revenues are adjusted for refunds owed to third party payers resulting from pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#x2019;s operating results or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from Company gift cards purchased by customers is deferred as a contract liability until goods or services are transferred. Any amounts not expected to be redeemed by customers (i.e., breakage) are recognized based on historical redemption patterns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer returns are not material to the Company&#x2019;s operating results or financial condition. Sales taxes are not included in revenues.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Loyalty and Other Programs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s customer loyalty program, ExtraCare&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, consists of two components, ExtraSavings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Rewards. ExtraSavings are coupons that are recorded as a reduction of revenue when redeemed as the Company concluded that they do not represent a promise to the customer to deliver additional goods or services at the time of issuance because they are not tied to a specific transaction or spending level. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ExtraBucks Rewards are accumulated by customers based on their historical spending levels. Thus, the Company has determined that there is an additional performance obligation to those customers at the time of the initial transaction. The Company allocates the transaction price to the initial transaction and the ExtraBucks Rewards transaction based upon the relative standalone selling price, which considers historical redemption patterns for the rewards. Revenue allocated to ExtraBucks Rewards is recognized as those rewards are redeemed. At the end of each period, unredeemed ExtraBucks Rewards are reflected as a contract liability.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also offers a subscription-based membership program, CarePass&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, under which members are entitled to a suite of benefits delivered over the course of the subscription period, as well as a promotional reward that can be redeemed for future goods and services. Subscriptions are paid for on a monthly or annual basis at the time of or in advance of the Company delivering the goods and services. Revenue from these arrangements is recognized as the performance obligations are satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Long-term Care&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those goods or services. Each prescription claim represents a separate performance obligation of the Company, separate and distinct from other prescription claims under customer arrangements. A significant portion of long-term care revenue from sales of pharmaceutical and medical products is reimbursed by the federal Medicare Part D program and, to a lesser extent, state Medicaid programs. The Company monitors its revenues and receivables from these reimbursement sources, as well as long-term care facilities and other third party insurance payors, and reduces revenue at the revenue recognition date to properly account for the variable consideration due to anticipated differences between billed and reimbursed amounts. Accordingly, the total revenues and receivables reported in the Company&#x2019;s consolidated financial statements are recorded at the amount expected to be ultimately received from these payors. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patient co-payments associated with Medicare Part D, certain state Medicaid programs, Medicare Part B and certain third party payors typically are not collected at the time products are delivered or services are rendered, but are billed to the individuals as part of normal billing procedures and subject to normal accounts receivable collections procedures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities primarily represent the Company&#x2019;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTc3_aae19c8f-40dc-4b09-95ea-c80829875f7c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table disaggregates the Company&#x2019;s revenue by major source in each segment for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy &amp;amp;&lt;br/&gt;Consumer&lt;br/&gt;Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;166,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;83,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(45,154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;205,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;22,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;22,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;85,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;85,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;91,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;169,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;108,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(47,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;322,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Health Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;102,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail &amp;amp; specialty &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;63,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;169,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;150,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;77,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(43,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;184,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;76,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;76,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;3,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;82,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;153,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;101,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(46,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;292,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Health Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail &amp;amp; specialty &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;153,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;139,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;71,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(40,350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;171,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,712)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;75,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;93,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(42,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;268,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Health Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail &amp;amp; specialty &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Health Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#x2019;s retail pharmacies and LTC pharmacies. Effective January 1, 2023, pharmacy network also includes activity associated with Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;, which permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order. Maintenance Choice activity was previously reflected in mail &amp;amp; specialty. Segment financial information has been revised to reflect these changes.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Health Services mail &amp;amp; specialty is defined as specialty mail claims inclusive of Specialty Connect&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; claims picked up at a retail pharmacy, as well as mail order and specialty claims fulfilled by the Pharmacy &amp;amp; Consumer Wellness segment. Effective January 1, 2023, mail &amp;amp; specialty excludes Maintenance Choice activity, which is now reflected within pharmacy network. Segment financial information has been revised to reflect these changes.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a11ece2d2cd42918420ea7f1dd5ba50_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMtMS0xLTEtMjY1MjQ3_9ff924cd-030a-478e-99eb-d0ce657bf6e7"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b20d67c786d4c91b7f3bfeff6c94528_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMtMy0xLTEtMjY1MjQ3_948a3f36-339c-4046-88f5-6276a03cd86f"
      unitRef="usd">166793000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad2fca2727bb48aa90b14ecf9c1284f3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMtNS0xLTEtMjY1MjQ3_6eced926-c3ed-43fe-b599-d9bd83468f6e"
      unitRef="usd">83480000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i14e1fb81ffc34c22b66f30e2108faff0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMtNy0xLTEtMjY1MjQ3_f1844254-6583-405f-a362-57674551852e"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id181fe4cc7404cdabbe77d3f7fc155e0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMtOS0xLTEtMjY1MjQ3_d063f2c4-b08d-4565-b830-c5ef6903b58d"
      unitRef="usd">-45154000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iff2a00c33afd4f03b1e2f8fd84299373_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMtMTEtMS0xLTI2NTI0Nw_95b7fdf6-7bf0-4044-bea1-c3e2eb563648"
      unitRef="usd">205119000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib0ad789c62b74d228c609da2255bbaa9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzQtMS0xLTEtMjY1MjQ3_e930c448-144c-4cde-80a5-d18aef441596"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife56d28f21ca44e0bc934fe219064fe1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzQtMy0xLTEtMjY1MjQ3_0221b2bb-8fbf-4ac6-a0bf-4434d5e43781"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia64bc989c4c4444ebef0e99f699fb65a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzQtNS0xLTEtMjY1MjQ3_62b5ab63-d040-425c-b3b2-c32ef67487c4"
      unitRef="usd">22780000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45fa51dd20a749798549f98bd1811f08_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzQtNy0xLTEtMjY1MjQ3_a2ca02d7-a7d5-410d-abba-fc2048da2137"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad97b3767fd64724b1e3d77672941a0a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzQtOS0xLTEtMjY1MjQ3_409bf9f0-b437-499b-aa99-f77c0547690d"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9d3e97b86034daf987c6fda27a02728_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzQtMTEtMS0xLTI2NTI0Nw_38255c7f-03ff-4f90-ae55-b12bfa345f75"
      unitRef="usd">22780000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3117bdb07278486084dff9ebb49a80e0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzUtMS0xLTEtMjY1MjQ3_a4c3ed22-939b-4385-9966-d2daa65282ad"
      unitRef="usd">85274000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7f7744badced45919f97d66a9ec50adf_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzUtMy0xLTEtMjY1MjQ3_88865724-9e96-4438-a9d6-cb34fe1c37f9"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03b300885d9b456b84c6c73e4bdacfb2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzUtNS0xLTEtMjY1MjQ3_20e4ef41-b9b5-481d-97c9-e19b141a96eb"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i320c789c426742bfab03ca5ea3757c5f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzUtNy0xLTEtMjY1MjQ3_3128e661-a12b-4788-9cd5-0ed9a38bf0e8"
      unitRef="usd">56000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id41082cc7c8f4e46b55567b48080c270_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzUtOS0xLTEtMjY1MjQ3_dc17d240-fb03-47a9-90b8-5a7e9e06e670"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if916c9222361492f8e532d2cacfc7aec_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzUtMTEtMS0xLTI2NTI0Nw_8b7cfe26-c029-466a-8a04-401763d1eff4"
      unitRef="usd">85330000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i2a07c8633b37492ba109c7cd9a92299a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzYtMS0xLTEtMjY1MjQ3_4199b1d4-a58e-4849-b686-f786c63f3e32"
      unitRef="usd">476000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzYtMy0xLTEtMjY1MjQ3_da508278-e23d-49e3-8bdf-38a5a1a6a50c"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="icd57b0b73c1b4e1aa835dde2abf6925c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzYtNS0xLTEtMjY1MjQ3_a225e3ce-b253-4697-b06f-3968e8eab82a"
      unitRef="usd">-44000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ie1d5e5a55e6f4909a1d1c3d2003ec720_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzYtNy0xLTEtMjY1MjQ3_b10ae807-4e93-44db-92b8-832665f6d4da"
      unitRef="usd">406000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ib085c0543c9d4988b6b20b9b427998b0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzYtOS0xLTEtMjY1MjQ3_c5021afd-7fe8-4a3b-9b4e-72a70d70dfba"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzYtMTEtMS0xLTI2NTI0Nw_a0ab76f4-e12e-4d9d-841f-9a5998d295b5"
      unitRef="usd">838000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e79fec42f4945048db04ab6d125dac1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzctMS0xLTEtMjY1MjQ3_f0abd834-3ec3-485e-8773-0c90a80e8e98"
      unitRef="usd">5600000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc35e22eaaaf4b979443a4b29ecfdb2b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzctMy0xLTEtMjY1MjQ3_7f9d5195-ed42-49ac-a46d-12136cd1de11"
      unitRef="usd">2783000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib63de3071db248ca9ce666c685ac2d8a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzctNS0xLTEtMjY1MjQ3_c602d0b9-c4f5-411d-8d5e-193d93e84acd"
      unitRef="usd">2380000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i99ffea29085e4c2bbee4c937c682d535_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzctNy0xLTEtMjY1MjQ3_bd4afe59-888c-46bc-940f-9ef431ab8e05"
      unitRef="usd">68000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2dc095ba84374b6f97db2d50eca661e7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzctOS0xLTEtMjY1MjQ3_7e9def31-e1ba-4f1e-9d3e-714653e3d499"
      unitRef="usd">-2431000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if14d784717ae45699afa13fa2039d20a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzctMTEtMS0xLTI2NTI0Nw_f133c142-cc3e-45f9-b6fc-db49093d3a77"
      unitRef="usd">8400000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i2a07c8633b37492ba109c7cd9a92299a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzgtMS0xLTEtMjY1MjQ3_a966812f-fa43-45c0-b10b-4b9f9f8e6d4b"
      unitRef="usd">91350000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzgtMy0xLTEtMjY1MjQ3_c793c5ad-79cc-4a81-b609-1e3fb46a68d1"
      unitRef="usd">169576000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icd57b0b73c1b4e1aa835dde2abf6925c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzgtNS0xLTEtMjY1MjQ3_42c34c0f-1f54-4f1e-af5a-ac578e3a402e"
      unitRef="usd">108596000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie1d5e5a55e6f4909a1d1c3d2003ec720_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzgtNy0xLTEtMjY1MjQ3_85809ee1-905d-46b9-8f9a-addf2bff5e8b"
      unitRef="usd">530000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib085c0543c9d4988b6b20b9b427998b0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzgtOS0xLTEtMjY1MjQ3_fe8f76a5-0cef-4b44-80c8-3054d81a0841"
      unitRef="usd">-47585000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzgtMTEtMS0xLTI2NTI0Nw_35b7949d-e2fb-4400-971c-bf05c4442f76"
      unitRef="usd">322467000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i14593b1d8b2c4b0098e818ce890bc9b8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzExLTMtMS0xLTI2NTI0Nw_0288387a-2456-4f75-85fc-f66ac3ad715b"
      unitRef="usd">102968000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3298f299bddc4992829c48dead520fc8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzEyLTMtMS0xLTI2NTI0Nw_13b45e59-5fcd-48b1-bf42-6f2b5500e2d7"
      unitRef="usd">63825000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i07f19f7971c940519c88697285174722_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzEzLTMtMS0xLTI2NTI0Nw_84faba2d-f880-4d92-b032-106cc5d39186"
      unitRef="usd">2783000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE0LTMtMS0xLTI2NTI0Nw_2181379b-6c4c-44d3-8927-cd0a83fc310e"
      unitRef="usd">169576000000</us-gaap:Revenues>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e89e68e590a458991b469aa7f41bb36_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE4LTEtMS0xLTI2NTI0Nw_087180ef-66b4-48a8-ae52-f8d8cbd7fc32"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea79f3c8d0b7431583f7968ea612fd3a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE4LTMtMS0xLTI2NTI0Nw_6b1b73c2-a381-4390-a7e5-3f6cd1e799cc"
      unitRef="usd">150646000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8a66d7067aa7482dbb0f8422aa4c6e42_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE4LTUtMS0xLTI2NTI0Nw_6cb09cd6-5b86-4061-8e78-51b0d02ad5ee"
      unitRef="usd">77886000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48798a4511874c8892972dcc0082ab04_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE4LTctMS0xLTI2NTI0Nw_5cfec845-37e1-4641-9052-3d52840ff45b"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie3df790a9a364d22876a558fdc974055_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE4LTktMS0xLTI2NTI0Nw_9ca23eb7-f64f-45a9-89b8-60f9df60fb0e"
      unitRef="usd">-43913000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5228862959aa458aa4cf0f0ecedde213_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE4LTExLTEtMS0yNjUyNDc_80bd3569-6599-4ed7-902a-a45c8b884130"
      unitRef="usd">184619000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i33b1145120c34228ad6a8552aa2ea289_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE5LTEtMS0xLTI2NTI0Nw_77f62a72-9e52-4e01-9762-4c49943aec81"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1bd8d6d2503d4faebea52625423e074a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE5LTMtMS0xLTI2NTI0Nw_76b6d5eb-eac6-4116-8fef-460f350a29d1"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icae492ed264f4e44bfba42f67cdfceda_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE5LTUtMS0xLTI2NTI0Nw_d97e17cd-2c7d-4961-a992-9c3b39ffcf0a"
      unitRef="usd">21315000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i30c3c2a12d62424091c32bc5d8bbb9a9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE5LTctMS0xLTI2NTI0Nw_3355477e-fcd2-435e-badb-3c779b651cea"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09a4ce3d435546c9b89e1b000c479765_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE5LTktMS0xLTI2NTI0Nw_5154e0f2-4985-44ed-860e-729c3913248c"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifeea9a469c0d4f9abb5266144d9a1b84_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzE5LTExLTEtMS0yNjUyNDc_dae999e0-c906-40da-8c4f-4a558b3151a6"
      unitRef="usd">21315000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i160c1d2789d34ba0bab068f3568ee908_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIwLTEtMS0xLTI2NTI0Nw_372bdac0-1dff-487a-bba7-8b8f5cd08a05"
      unitRef="usd">76064000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie73bc8fff551437d8b63b1fba165b13a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIwLTMtMS0xLTI2NTI0Nw_464503ee-08ae-4190-bbaa-f48bccc4da40"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i162e562c13814497a56524c6ec2a34fd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIwLTUtMS0xLTI2NTI0Nw_35a52f87-e617-4a56-86ab-63121e6aa744"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iff9fe2e514b24d7a8dea10c9425c3f0c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIwLTctMS0xLTI2NTI0Nw_ca04d20e-3e43-4cb7-bb4c-09f4f368a4ec"
      unitRef="usd">68000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie09911fb17414836bb68eaeb03ab61ca_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIwLTktMS0xLTI2NTI0Nw_d3e9e692-85c1-4ca9-9021-309b1f8b32f1"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i06284eff72e64927a66522466999f6d2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIwLTExLTEtMS0yNjUyNDc_6598d7b4-016d-444e-a00c-489e43bf623f"
      unitRef="usd">76132000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i1edd8caecae44ce995f38b9edd410db7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIxLTEtMS0xLTI2NTI0Nw_a48f5ebc-a3ba-4b1e-af18-130d4bade7c4"
      unitRef="usd">586000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ie123d487288b460289e6aaf6ae104852_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIxLTMtMS0xLTI2NTI0Nw_1b6198ad-1a9e-466d-ae00-cfec00e88f8b"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i0d2a7ac149f64c73a8f3b978546f2741_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIxLTUtMS0xLTI2NTI0Nw_00db84ab-fd8c-4637-8a9b-b9dbc64e0c2a"
      unitRef="usd">17000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ia0cc9849a9ff470b935a370313045788_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIxLTctMS0xLTI2NTI0Nw_3784658d-14b2-470a-be90-944527ba0dbd"
      unitRef="usd">596000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i977f19fae3bf4bc8963ec72c8c49ebdc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIxLTktMS0xLTI2NTI0Nw_1ddc656d-f3ff-49ef-a6b1-3b0ea0bc2ffd"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIxLTExLTEtMS0yNjUyNDc_9170ac72-b2ab-41ce-837f-b478cb91f07d"
      unitRef="usd">1199000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia648581c57dc457bbec0147f946c9c94_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIyLTEtMS0xLTI2NTI0Nw_85d32c11-90a3-42a0-8145-b47989ff1ba5"
      unitRef="usd">5469000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib47b357e921d48fe83a680844e7d44d1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIyLTMtMS0xLTI2NTI0Nw_28c1fc06-9a5b-4e24-9881-c5594901b9aa"
      unitRef="usd">3246000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iff457075247c43c5b18562ff48f847b4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIyLTUtMS0xLTI2NTI0Nw_edbf3129-e737-4138-991d-b1c15381ea7b"
      unitRef="usd">2402000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1f5aa10ed17d4bcfb6e9c9314f81c9fc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIyLTctMS0xLTI2NTI0Nw_52767d8b-2218-4ac5-a623-141358253fc1"
      unitRef="usd">57000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id8e34b73c65d4da0ad42e0f3666f7598_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIyLTktMS0xLTI2NTI0Nw_c7ab3ff7-8712-46c3-a34d-0b2c4fcf974a"
      unitRef="usd">-2328000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4bbfa9181d494da180bb0ffaf4540e76_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIyLTExLTEtMS0yNjUyNDc_777ab7b3-6d6e-405b-a451-fb905aaf6bd6"
      unitRef="usd">8846000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i1edd8caecae44ce995f38b9edd410db7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIzLTEtMS0xLTI2NTI0Nw_9f46be25-fd95-49a5-9e7b-a11799a44082"
      unitRef="usd">82119000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie123d487288b460289e6aaf6ae104852_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIzLTMtMS0xLTI2NTI0Nw_209d96c1-cddd-4836-b599-cdf97a87d677"
      unitRef="usd">153892000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0d2a7ac149f64c73a8f3b978546f2741_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIzLTUtMS0xLTI2NTI0Nw_dee77a4e-548c-4bb4-bb3a-4cecfceb4fc6"
      unitRef="usd">101620000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia0cc9849a9ff470b935a370313045788_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIzLTctMS0xLTI2NTI0Nw_745d8748-9c11-4ca5-9aed-260a812ae305"
      unitRef="usd">721000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i977f19fae3bf4bc8963ec72c8c49ebdc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIzLTktMS0xLTI2NTI0Nw_4c87ab3b-1105-4320-9ef1-cf78536021e0"
      unitRef="usd">-46241000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzIzLTExLTEtMS0yNjUyNDc_e759ca0a-c930-403f-ab36-4881663f6fdf"
      unitRef="usd">292111000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie30b20aa9e074cae88b963a48417ada9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzI2LTMtMS0xLTI2NTI0Nw_639d609f-3f6a-4a86-a113-57aee38a6a12"
      unitRef="usd">96834000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1664ef87611a43fe8c8c2e9a3c70f7f2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzI3LTMtMS0xLTI2NTI0Nw_3ffc3578-8690-4baa-a198-cf552d62b32c"
      unitRef="usd">53812000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8f342e37bfce4f6ca560a33df132c468_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzI4LTMtMS0xLTI2NTI0Nw_77c7e653-d810-427a-8eb4-d972481f7641"
      unitRef="usd">3246000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie123d487288b460289e6aaf6ae104852_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzI5LTMtMS0xLTI2NTI0Nw_ec9bf910-2049-48a8-bba2-3f80d5315a20"
      unitRef="usd">153892000000</us-gaap:Revenues>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i17a6f560ef5640399300e7fe75e9aa5c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMzLTEtMS0xLTI2NTI0Nw_f8b6e81f-7be4-4ce6-aa6a-59bf39394889"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie743c62714f54fd4bf1245a78eee0b5b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMzLTMtMS0xLTI2NTI0Nw_3105c8bd-4ccd-43d7-a5ef-032a4f757939"
      unitRef="usd">139453000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd24d97a59214d52b3c9750f7e7d3d7d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMzLTUtMS0xLTI2NTI0Nw_6f8714cf-caa3-4b4c-bb3c-646928b47ee7"
      unitRef="usd">71984000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia84c2cc8a91c4cf4aa0584d43740ee58_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMzLTctMS0xLTI2NTI0Nw_65bcde3a-cc4c-4b9e-a220-b14107a2f2c9"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i494f38c837794730a4d4ce042956fda5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMzLTktMS0xLTI2NTI0Nw_b7a04229-17c3-4d38-80cb-3c876e475e7c"
      unitRef="usd">-40350000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5895590dd43041059596c19c70b48ee4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzMzLTExLTEtMS0yNjUyNDc_0228eda5-612b-4cba-9c10-4746a39b624d"
      unitRef="usd">171087000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib399dae772f1473b882823660572095c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM0LTEtMS0xLTI2NTI0Nw_8cde484c-024a-49c2-847a-a3507b1b13a5"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i96881c941f4b4a52b49bb77d5efbf3d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM0LTMtMS0xLTI2NTI0Nw_988d7cbc-70fb-4590-b2cd-ed41118ed55e"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f0350ddd508488d8327fe9125a60729_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM0LTUtMS0xLTI2NTI0Nw_b40fa473-e6d2-487f-bfdd-aec47ece1617"
      unitRef="usd">19655000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0b31ec7f183b4cd69d634f84d8e4c94e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM0LTctMS0xLTI2NTI0Nw_f926047c-1747-435c-b7e4-1df7d0b74d90"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iedc7e31aa44c40608ab490e5abeb6907_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM0LTktMS0xLTI2NTI0Nw_3428540a-56d4-434e-8c5a-b995c854c7c3"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id61b0b83a53943a09bb0a1124d0f0e47_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM0LTExLTEtMS0yNjUyNDc_6fb35b93-e261-4aa2-a52c-c5ec47501321"
      unitRef="usd">19655000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea9bfe47ba434e67af70f9a941c950d9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM1LTEtMS0xLTI2NTI0Nw_c4516ca4-c30e-4a57-a747-936f8e67e86a"
      unitRef="usd">69301000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia44cce9280244cbb8b54b2754221e394_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM1LTMtMS0xLTI2NTI0Nw_da0c7faa-1cbe-49a6-bc32-5d82c5c6d6ea"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4cbdb8dae69a4ce4bcb45058e576038d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM1LTUtMS0xLTI2NTI0Nw_9d6ace6f-e7d1-4931-b680-87fbb58d6dc3"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6a476fae69fc4c64809902a59beedc6a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM1LTctMS0xLTI2NTI0Nw_563b3664-6c66-4cc9-a307-e8a3ab2975fe"
      unitRef="usd">63000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i181bfd6aedfc4e29b5b22d6b864e2ec4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM1LTktMS0xLTI2NTI0Nw_30a9ad15-0a54-45b8-ac69-a6f4407a64bd"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ffcc008b85f412bae79b1893943f70c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM1LTExLTEtMS0yNjUyNDc_ae57d2eb-8607-4aa0-a8c5-eb51c91d4c57"
      unitRef="usd">69364000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="ia95a883374f34cadb8aba20153008269_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM2LTEtMS0xLTI2NTI0Nw_07c77514-0308-40b7-a23a-c36ba226c315"
      unitRef="usd">483000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM2LTMtMS0xLTI2NTI0Nw_4113d52c-7422-429f-a999-0dc96af662df"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if7a2e3c175d84b5aa44a7a859d45ad5d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM2LTUtMS0xLTI2NTI0Nw_726aeb9d-44fa-40d1-aeb6-3092c02bb7ce"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i2ce5e18976c2489a9a964cdebbae85ac_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM2LTctMS0xLTI2NTI0Nw_2ca90c32-cd20-449b-90ec-e76ebacba239"
      unitRef="usd">315000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i37c56e2626d741fc89c81191ac507cb5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM2LTktMS0xLTI2NTI0Nw_9e05af21-0786-432e-b520-a79efef47673"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM2LTExLTEtMS0yNjUyNDc_ea43e898-4089-4012-be35-00f80cefacc8"
      unitRef="usd">798000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1859ee0b296642ffba13a4fd14a36458_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM3LTEtMS0xLTI2NTI0Nw_6d0ef023-1641-483c-87b7-bf8d97bd2af6"
      unitRef="usd">5625000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e55817403214996b18ace12986ee657_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM3LTMtMS0xLTI2NTI0Nw_63e0b32d-0c6b-42c4-8d55-aa8c1f5f2944"
      unitRef="usd">1901000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d3c653dcd4e4670b996e139fd812838_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM3LTUtMS0xLTI2NTI0Nw_7f330c8e-6941-4e5b-828e-90c0be9307f0"
      unitRef="usd">1940000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife6f5f367cfd43cbb0a47919d9d3da2c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM3LTctMS0xLTI2NTI0Nw_621f1806-6619-4315-99ff-0f0f837fd74c"
      unitRef="usd">48000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4241f3201d8548bca7574e1e0a20ac84_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM3LTktMS0xLTI2NTI0Nw_e0465d38-9ca7-49fe-9f49-a8737b41f705"
      unitRef="usd">-1712000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb7fc09153ca404296c11711e2960b2f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM3LTExLTEtMS0yNjUyNDc_7344b61b-f15f-46b6-9505-7c41c0f94e32"
      unitRef="usd">7802000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="ia95a883374f34cadb8aba20153008269_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM4LTEtMS0xLTI2NTI0Nw_0721aa19-2b18-4525-ad7e-d21735c8704d"
      unitRef="usd">75409000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM4LTMtMS0xLTI2NTI0Nw_4ef18a73-b22e-4b48-8e67-47cb482c015b"
      unitRef="usd">141354000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if7a2e3c175d84b5aa44a7a859d45ad5d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM4LTUtMS0xLTI2NTI0Nw_5508085f-b0af-4950-87e0-efb22780bdf3"
      unitRef="usd">93579000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2ce5e18976c2489a9a964cdebbae85ac_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM4LTctMS0xLTI2NTI0Nw_8cda53c0-2bdd-4b81-b15e-6c3490e36ecf"
      unitRef="usd">426000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i37c56e2626d741fc89c81191ac507cb5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM4LTktMS0xLTI2NTI0Nw_0de3e7ae-22e9-47b5-b902-46195839f0f1"
      unitRef="usd">-42062000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzM4LTExLTEtMS0yNjUyNDc_cde9a060-3769-4138-8dce-c8d82f157a51"
      unitRef="usd">268706000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i92db766193ba42908696e991d4d5cd1f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzQxLTMtMS0xLTI2NTI0Nw_84f377d9-b8e6-4f2b-bec0-8f2003d440e9"
      unitRef="usd">89740000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie6c189e7c1cd4ff9924fdcd3ca505cec_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzQyLTMtMS0xLTI2NTI0Nw_d6a614f3-3a3e-4d13-997e-8eaa4f79b31f"
      unitRef="usd">49713000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2798658b56134273a4ae4a44406280aa_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzQzLTMtMS0xLTI2NTI0Nw_1a253d49-251b-45cd-9c6b-96bdaaee5c09"
      unitRef="usd">1901000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTphMTY1MjBjODgzYTg0YjJmOTQ5Y2QyYmJiZTZiOTAyZC90YWJsZXJhbmdlOmExNjUyMGM4ODNhODRiMmY5NDljZDJiYmJlNmI5MDJkXzQ0LTMtMS0xLTI2NTI0Nw_8692f558-4de0-45a2-b99b-33eaa8018e90"
      unitRef="usd">141354000000</us-gaap:Revenues>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDYw_270ede96-5904-4cac-87fd-332416a65a9b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about receivables and contract liabilities from contracts with customers as of December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables (included in accounts receivable, net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities (included in accrued expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2022 and 2021, the contract liabilities balance includes increases related to customers&#x2019; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rewards earnings and gift card issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemption and breakage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmOWZmNjNkYmVjYWY0NmNlOTU2ZGFlMGM3MDRmYjQ2MC90YWJsZXJhbmdlOmY5ZmY2M2RiZWNhZjQ2Y2U5NTZkYWUwYzcwNGZiNDYwXzEtMS0xLTEtMjY1MjQ3_5f6e496b-b810-4d05-9b4a-8524d996fef7"
      unitRef="usd">8983000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmOWZmNjNkYmVjYWY0NmNlOTU2ZGFlMGM3MDRmYjQ2MC90YWJsZXJhbmdlOmY5ZmY2M2RiZWNhZjQ2Y2U5NTZkYWUwYzcwNGZiNDYwXzEtMy0xLTEtMjY1MjQ3_4da43b75-0077-4b9f-8e80-9d3ff9f6e44e"
      unitRef="usd">7932000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmOWZmNjNkYmVjYWY0NmNlOTU2ZGFlMGM3MDRmYjQ2MC90YWJsZXJhbmdlOmY5ZmY2M2RiZWNhZjQ2Y2U5NTZkYWUwYzcwNGZiNDYwXzItMS0xLTEtMjY1MjQ3_ea3e78ae-02cf-44c1-8c03-a9cf75ed1cdc"
      unitRef="usd">71000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTpmOWZmNjNkYmVjYWY0NmNlOTU2ZGFlMGM3MDRmYjQ2MC90YWJsZXJhbmdlOmY5ZmY2M2RiZWNhZjQ2Y2U5NTZkYWUwYzcwNGZiNDYwXzItMy0xLTEtMjY1MjQ3_25d7eaa9-7019-4e9e-b873-291a74ce948f"
      unitRef="usd">87000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5NGEwZGI4ZGY0ZWY0YTExYjExYmQwNWU5N2E3ZDE2Yi90YWJsZXJhbmdlOjk0YTBkYjhkZjRlZjRhMTFiMTFiZDA1ZTk3YTdkMTZiXzEtMS0xLTEtMjY1MjQ3_f759b67e-a162-4b5f-b8e7-21f92e54aa23"
      unitRef="usd">87000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i501f291fb23d49e987222cf13c851afc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5NGEwZGI4ZGY0ZWY0YTExYjExYmQwNWU5N2E3ZDE2Yi90YWJsZXJhbmdlOjk0YTBkYjhkZjRlZjRhMTFiMTFiZDA1ZTk3YTdkMTZiXzEtMy0xLTEtMjY1MjQ3_ad0f9dd9-2090-44ce-9bd7-3cde740b9e67"
      unitRef="usd">71000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5NGEwZGI4ZGY0ZWY0YTExYjExYmQwNWU5N2E3ZDE2Yi90YWJsZXJhbmdlOjk0YTBkYjhkZjRlZjRhMTFiMTFiZDA1ZTk3YTdkMTZiXzMtMS0xLTEtMjY1MjQ3_59737380-7ccf-410f-b1c9-bb2514a71d28"
      unitRef="usd">340000000</cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance>
    <cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5NGEwZGI4ZGY0ZWY0YTExYjExYmQwNWU5N2E3ZDE2Yi90YWJsZXJhbmdlOjk0YTBkYjhkZjRlZjRhMTFiMTFiZDA1ZTk3YTdkMTZiXzMtMy0xLTEtMjY1MjQ3_49cd1320-457e-491c-8769-76c5324e3d80"
      unitRef="usd">387000000</cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance>
    <cvs:ContractWithCustomerLiabilityRedemptionAndBreakage
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5NGEwZGI4ZGY0ZWY0YTExYjExYmQwNWU5N2E3ZDE2Yi90YWJsZXJhbmdlOjk0YTBkYjhkZjRlZjRhMTFiMTFiZDA1ZTk3YTdkMTZiXzQtMS0xLTEtMjY1MjQ3_4bfb668c-270e-40cf-b44e-e4a3a4879fe6"
      unitRef="usd">356000000</cvs:ContractWithCustomerLiabilityRedemptionAndBreakage>
    <cvs:ContractWithCustomerLiabilityRedemptionAndBreakage
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5NGEwZGI4ZGY0ZWY0YTExYjExYmQwNWU5N2E3ZDE2Yi90YWJsZXJhbmdlOjk0YTBkYjhkZjRlZjRhMTFiMTFiZDA1ZTk3YTdkMTZiXzQtMy0xLTEtMjY1MjQ3_daa07408-117d-4704-be01-20264add5415"
      unitRef="usd">371000000</cvs:ContractWithCustomerLiabilityRedemptionAndBreakage>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5NGEwZGI4ZGY0ZWY0YTExYjExYmQwNWU5N2E3ZDE2Yi90YWJsZXJhbmdlOjk0YTBkYjhkZjRlZjRhMTFiMTFiZDA1ZTk3YTdkMTZiXzUtMS0xLTEtMjY1MjQ3_0d2f4dc1-4212-45dd-995c-f1935e65a8c2"
      unitRef="usd">71000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5NGEwZGI4ZGY0ZWY0YTExYjExYmQwNWU5N2E3ZDE2Yi90YWJsZXJhbmdlOjk0YTBkYjhkZjRlZjRhMTFiMTFiZDA1ZTk3YTdkMTZiXzUtMy0xLTEtMjY1MjQ3_3acd81e7-7758-4d7b-b86b-110c61dcb94c"
      unitRef="usd">87000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MjEy_89567157-c662-414f-a830-8c30830b175a">&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Products Sold&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for cost of products sold as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of products sold includes: (i) the cost of prescription drugs sold during the reporting period directly through the Company&#x2019;s specialty and mail order pharmacies and indirectly through the Company&#x2019;s retail pharmacy network, (ii) shipping and handling costs, (iii) administrative service fees paid to the Pharmacy &amp;amp; Consumer Wellness segment for specialty and mail order pharmacy fulfillment services and (iv) the operating costs of the Company&#x2019;s client service operations and related information technology support costs including depreciation and amortization. The cost of prescription drugs sold component of cost of products sold includes: (i) the cost of the prescription drugs purchased from manufacturers or distributors and shipped to members in clients&#x2019; benefit plans from the Company&#x2019;s mail order pharmacies, net of any volume-related or other discounts (see &#x201c;Vendor Allowances and Purchase Discounts&#x201d; below) and (ii) the cost of prescription drugs sold (including retail co-payments) through the Company&#x2019;s retail pharmacy network under contracts where the Company is the principal, net of any volume-related or other discounts. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy &amp;amp; Consumer Wellness Segment&lt;/span&gt;&lt;/div&gt;Cost of products sold includes: the cost of merchandise sold during the reporting period, including the costs of prescription drugs sold through its retail pharmacies, net of any volume-related or other discounts, the related purchasing costs, warehousing and delivery costs (including depreciation and amortization), the operating costs of the Company&#x2019;s specialty and mail order pharmacy fulfillment operations and actual and estimated inventory losses.</us-gaap:CostOfSalesPolicyTextBlock>
    <cvs:VendorAllowancesAndPurchaseDiscountsPolicyTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDk5_d14fd4d1-009f-4ed4-9249-4fb56fe593e3">&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Vendor Allowances and Purchase Discounts &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for vendor allowances and purchase discounts as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Health Services segment receives purchase discounts on products purchased. Contractual arrangements with vendors, including manufacturers, wholesalers and retail pharmacies, normally provide for the Health Services segment to receive purchase discounts from established list prices in one, or a combination, of the following forms: (i) a direct discount at the time of purchase, (ii) a discount for the prompt payment of invoices or (iii) when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy), a discount (or rebate) paid subsequent to dispensing. These rebates are recognized when prescriptions are dispensed and are generally calculated and billed to manufacturers within 30 days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Company&#x2019;s operating results or financial condition. The Company accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Health Services segment also receives additional discounts under its wholesaler contracts if it exceeds contractually defined purchase volumes. In addition, the Health Services segment receives fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of products sold. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy &amp;amp; Consumer Wellness Segment&lt;/span&gt;&lt;/div&gt;Vendor allowances received by the Pharmacy &amp;amp; Consumer Wellness segment reduce the carrying cost of inventory and are recognized in cost of products sold when the related inventory is sold, unless they are specifically identified as a reimbursement of incremental costs for promotional programs and/or other services provided. Amounts that are directly linked to advertising commitments are recognized as a reduction of advertising expense (included in operating expenses) when the related advertising commitment is satisfied. Any amounts received in excess of the actual cost incurred also reduce the carrying cost of inventory. The total value of any upfront payments received from vendors that are linked to purchase commitments is initially deferred. The deferred amounts are then amortized to reduce cost of products sold over the life of the contract based upon sales volume. The total value of any upfront payments received from vendors that are not linked to purchase commitments is also initially deferred. The deferred amounts are then amortized to reduce cost of products sold on a straight-line basis over the life of the related contract. The total amortization of these upfront payments was not material to the Company&#x2019;s consolidated financial statements in any of the periods presented.</cvs:VendorAllowancesAndPurchaseDiscountsPolicyTextBlock>
    <cvs:PharmacyRebatePeriod
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzY4ODI3_6e44dd04-b760-43df-a9ea-3c24aad9024a">P30D</cvs:PharmacyRebatePeriod>
    <us-gaap:HealthCareEntitiesPolicyPolicyTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTQ2_c445c67b-afb8-4943-8a69-9d8f516a181a">&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Health Care Reform&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Insurer Fee&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning on January 1, 2014, the ACA imposed an annual premium-based health insurer fee (&#x201c;HIF&#x201d;) for each calendar year, payable in September, which was not deductible for tax purposes. The Company was required to estimate a liability for the HIF at the beginning of the calendar year in which the fee was payable with a corresponding deferred asset that was amortized ratably to operating expenses over the calendar year. The Company recorded the liability for the HIF in accrued expenses and recorded the deferred asset in other current assets. In December 2019, the HIF was repealed for calendar years after 2020, therefore there was no expense related to the HIF in the years ended December&#160;31, 2022 and 2021. In the year ended December 31, 2020, operating expenses included $1.0&#160;billion related to the Company&#x2019;s share of the HIF. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Adjustment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ACA established a permanent risk adjustment program to transfer funds from qualified individual and small group insurance plans with below average risk scores to plans with above average risk scores. Based on the risk of the Company&#x2019;s qualified plan members relative to the average risk of members of other qualified plans in comparable markets, as defined by the ACA, the Company estimates its ultimate risk adjustment receivable (recorded in accounts receivable) or payable (recorded in accrued expenses) for the current calendar year and reflects the pro-rata year-to-date impact as an adjustment to premium revenue. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Corridor&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ACA established a temporary risk corridor program, which expired at the end of 2016, for qualified individual and small group health insurance plans. Under this program, health insurance companies were to make payments to, or receive payments from, the U.S. Department of Health and Human Services (&#x201c;HHS&#x201d;) based on their ratio of allowable costs to target costs (as defined by the ACA). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company filed a lawsuit in August 2019 to recover the $313&#160;million it was owed under the ACA&#x2019;s risk corridor program, which had been stayed pending the Supreme Court decision. In April 2020, the U.S. Supreme Court ruled that health insurance companies may sue the federal government for amounts owed as calculated under the ACA&#x2019;s temporary risk corridor program. &lt;/span&gt;&lt;/div&gt;In October 2020, the Company received the $313&#160;million it was owed under the ACA&#x2019;s risk corridor program. The Company recorded the risk corridor payment as an increase to premium revenue in the year ended December 31, 2020. After considering offsetting items such as the ACA&#x2019;s minimum MLR rebate requirements and premium taxes, the Company recorded pre-tax income of $307&#160;million and after-tax income of $223&#160;million during the year ended December&#160;31, 2020.</us-gaap:HealthCareEntitiesPolicyPolicyTextBlock>
    <cvs:HealthInsurerFee
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzcxNTg1_3679b5d7-eb5b-4884-afcd-ac78651288e3"
      unitRef="usd">0</cvs:HealthInsurerFee>
    <cvs:HealthInsurerFee
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzcxNTg1_3ada654f-7f57-499e-a0ec-d547df913470"
      unitRef="usd">0</cvs:HealthInsurerFee>
    <cvs:HealthInsurerFee
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzcxNzEw_24f427c3-a8b7-4838-bebf-e4088870abc0"
      unitRef="usd">1000000000</cvs:HealthInsurerFee>
    <us-gaap:GainContingencyUnrecordedAmount
      contextRef="i18e1afa4d3774525860f0504f6ca19d8_I20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzcyODY2_9da9bcbe-9fb9-4a30-9ef6-0150cd0d2a7e"
      unitRef="usd">313000000</us-gaap:GainContingencyUnrecordedAmount>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty
      contextRef="i23248b4e050943bea0937b2c23a81cf0_D20201001-20201031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzczMjA5_d9872538-feb7-4c77-b3c0-5e5a6667ad74"
      unitRef="usd">313000000</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <cvs:FormerGainContingencyRecognizedInCurrentPeriodBeforeTax
      contextRef="ife99c731f49c491f9dbcec868c83f01f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzczNTI0_73ca4770-2eb1-43e8-9924-fce9830fbff7"
      unitRef="usd">307000000</cvs:FormerGainContingencyRecognizedInCurrentPeriodBeforeTax>
    <cvs:FormerGainContingencyRecognizedInCurrentPeriodNetOfTax
      contextRef="ife99c731f49c491f9dbcec868c83f01f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzczNTUx_2ea50e65-5284-4f00-8b04-daa092590f66"
      unitRef="usd">223000000</cvs:FormerGainContingencyRecognizedInCurrentPeriodNetOfTax>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTY1_db21c0a5-0069-4f12-9134-1de8d03a5c58">Advertising Costs Advertising costs, which are reduced by the portion funded by vendors, are expensed when the related advertising takes place. Net advertising costs, which are included in operating expenses, were $745 million, $707 million and $613 million in 2022, 2021 and 2020, respectively.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzczNzk3_77aac0da-2a42-4166-a810-3a60c9b12cff"
      unitRef="usd">745000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzczODAx_9c00d68f-f114-4ef0-bd9c-f11b6b513e68"
      unitRef="usd">707000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzczODA4_acee42b1-ff42-4c61-96d3-005f4063a9ce"
      unitRef="usd">613000000</us-gaap:AdvertisingExpense>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTkz_f8d3abb9-4a5e-4542-af2e-677c4634fd54">Stock-Based CompensationStock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc0MDU2_6fb0217d-b4b8-4272-817b-3803971eadab"&gt;three&lt;/span&gt; to five years) using the straight-line method.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ib01e468dcb8f4ca98e9b64ffb83ffbe0_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTA2_ac7adb04-5393-41a3-b951-928227ad2fc1">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTEw_05dd752c-50c6-42fc-a3c0-36e9d6c110db">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year or years in which the differences are expected to reverse. The effect of a change in the tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date of such change.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, and the Company&#x2019;s recent operating results. The Company establishes a valuation allowance when it does not consider it more likely than not that a deferred tax asset will be recovered.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records uncertain tax positions on the basis of a two-step process whereby (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest and/or penalties related to uncertain tax positions are recognized in the income tax provision.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:PensionAndOtherPostretirementPlansPolicy
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTg1_b0466f56-0dc1-4ade-ba01-b1d82a00138e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sponsors defined benefit pension plans (&#x201c;pension plans&#x201d;) and other postretirement employee benefit plans (&#x201c;OPEB plans&#x201d;) for its employees and retirees. The Company recognizes the funded status of its pension and OPEB plans on the consolidated balance sheets based on the year-end measurements of plan assets and benefit obligations. When the fair value of plan assets are in excess of the plan benefit obligations, the amounts are reported in other current assets and other assets. When the fair value of plan benefit obligations are in excess of plan assets, the amounts are reported in accrued expenses and other long-term liabilities based on the amount by which the actuarial present value of benefits payable in the next twelve months included in the benefit obligation exceeds the fair value of plan assets. The net periodic benefit income for the Company&#x2019;s pension and OPEB plans do not contain a service cost component as these plans have been frozen for an extended period of time.&#160;Non-service cost components of pension and postretirement net periodic benefit income are included in other income in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementPlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDg3_716d4ef5-4e63-4ca6-ad5a-09793902753b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share is computed using the treasury stock method. The Company calculates basic earnings per share based on the weighted average number of common shares outstanding for the period. See Note 15 &#x2018;&#x2018;Earnings Per Share&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <cvs:SharesHeldInTrustPolicyTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MDcx_9a5cf920-04d9-428c-b1a0-98a8fc2b50ed">Shares Held in TrustThe Company maintains grantor trusts, which held approximately one million shares of its common stock at both December&#160;31, 2022 and 2021. These shares are designated for use under various employee compensation plans. Since the Company holds these shares, they are excluded from the computation of basic and diluted shares outstanding.</cvs:SharesHeldInTrustPolicyTextBlock>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc3NTcz_2e987904-d913-4ad9-959b-b0b047effdcc"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc3NTcz_feaf49b2-23e3-4a03-b297-cb7e2f028924"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <us-gaap:ConsolidationVariableInterestEntityPolicy
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTk1_a59a0ca9-9420-467c-bc05-f8f09bee284c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has investments in (i) a generic pharmaceutical sourcing entity, (ii) certain hedge fund and private equity investments and (iii) certain real estate partnerships that are considered VIEs. The Company does not have a future obligation to fund losses or debts on behalf of these investments; however, it may voluntarily contribute funds. In evaluating whether the Company is the primary beneficiary of a VIE, the Company considers several factors, including whether the Company has (a) the power to direct the activities that most significantly impact the VIE&#x2019;s economic performance and (b) the obligation to absorb losses and the right to receive benefits that could potentially be significant to the VIE. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Interest Entities - Primary Beneficiary&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2014, the Company and Cardinal Health, Inc. (&#x201c;Cardinal&#x201d;) established Red Oak Sourcing, LLC (&#x201c;Red Oak&#x201d;), a generic pharmaceutical sourcing entity in which the Company and Cardinal each own 50%. The Red Oak arrangement had an initial term of ten years. In 2021, the Red Oak arrangement was amended to extend the initial term an additional five years, for a total term of 15 years. Under this arrangement, the Company and Cardinal contributed their sourcing and supply chain expertise to Red Oak and agreed to source and negotiate generic pharmaceutical supply contracts for both companies through Red Oak; however, Red Oak does not own or hold inventory on behalf of either company. No physical assets (e.g., property and equipment) were contributed to Red Oak by either company, and minimal funding was provided to capitalize Red Oak. The Company has determined that it is the primary beneficiary of this VIE because it has the ability to direct the activities of Red Oak. Consequently, the Company consolidates Red Oak in its consolidated financial statements within the Pharmacy &amp;amp; Consumer Wellness segment. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cardinal is required to pay the Company quarterly payments, which began in October 2014 and will extend through June 2029. As milestones are met, the quarterly payments increase. The Company received $183 million from Cardinal during each of the years ended December&#160;31, 2022, 2021 and 2020. The payments reduce the Company&#x2019;s carrying value of inventory and are recognized in cost of products sold when the related inventory is sold.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Interest Entities - Other Variable Interest Holder&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has invested in certain VIEs for which it has determined that it is not the primary beneficiary, consisting of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Hedge fund and private equity investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The Company invests in hedge fund and private equity investments in order to generate investment returns for its investment portfolio supporting its insurance businesses.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Real estate partnerships&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The Company invests in various real estate partnerships, including those that construct, own and manage low-income housing developments. For the low income housing development investments, substantially all of the projected benefits to the Company are from tax credits and other tax benefits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is not the primary beneficiary of these VIEs because the nature of the Company&#x2019;s involvement with the activities of these VIEs does not give the Company the power to direct the activities that most significantly impact their economic performance. The Company records the amount of its investment in these VIEs as long-term investments on the consolidated balance sheets and recognizes its share of each VIE&#x2019;s income or losses in net income.&#160;The Company&#x2019;s maximum exposure to loss from these VIEs is limited to its investment balances as disclosed below and the risk of recapture of previously recognized tax credits related to the real estate partnerships, which the Company does not consider significant.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i01be68559ac146e1afb53160db3afdcd_D20140101-20141231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc4ODA5_dcb23f42-d8a9-42f1-a7c8-92f9a1645fce"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <cvs:InitialContractualTerm
      contextRef="i01be68559ac146e1afb53160db3afdcd_D20140101-20141231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc4ODYw_5cd67da4-f8e7-4c57-8849-9aa7e53e9c32">P10Y</cvs:InitialContractualTerm>
    <cvs:VariableInterestEntityAmendedContractExtensionTerm
      contextRef="idf41f493187f4949ad17fce94a9132a4_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc4OTUw_d49bdc21-d18a-4570-b832-6c993219405b">P5Y</cvs:VariableInterestEntityAmendedContractExtensionTerm>
    <cvs:VariableInterestEntityAmendedContractTerm
      contextRef="idf41f493187f4949ad17fce94a9132a4_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc4OTc0_59959fcb-25be-47c9-b2ad-0a05e73812e5">P15Y</cvs:VariableInterestEntityAmendedContractTerm>
    <cvs:ProceedsFromVariableInterestEntity
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc5ODky_ad7dee83-706e-4707-8808-fed9c3c17c64"
      unitRef="usd">183000000</cvs:ProceedsFromVariableInterestEntity>
    <cvs:ProceedsFromVariableInterestEntity
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc5ODky_b5e3fb52-36fb-48ce-be1e-6a61c1f5d4d3"
      unitRef="usd">183000000</cvs:ProceedsFromVariableInterestEntity>
    <cvs:ProceedsFromVariableInterestEntity
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzc5ODky_b93b13ad-c8ee-4c24-9302-2e99de07f927"
      unitRef="usd">183000000</cvs:ProceedsFromVariableInterestEntity>
    <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTI4_3076ee32-5b2a-4d4e-b5e7-2043020ccb0a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other variable interest holder VIE assets included in long-term investments on the consolidated balance sheets at December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedge fund investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
    <us-gaap:LongTermInvestments
      contextRef="i075db0b7afd340fa9d1cfc2f4306bf77_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5YTcxOGRkODU5ZTc0MTA3YmFiZTcyZGRiMzE2ZWMzMy90YWJsZXJhbmdlOjlhNzE4ZGQ4NTllNzQxMDdiYWJlNzJkZGIzMTZlYzMzXzEtMS0xLTEtMjY1MjQ3_7ebb88e2-aa89-4f9e-be1e-b213793ee099"
      unitRef="usd">589000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i5002e1bef44644008f1ddf6ef1c5be55_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5YTcxOGRkODU5ZTc0MTA3YmFiZTcyZGRiMzE2ZWMzMy90YWJsZXJhbmdlOjlhNzE4ZGQ4NTllNzQxMDdiYWJlNzJkZGIzMTZlYzMzXzEtMy0xLTEtMjY1MjQ3_1dc8ef29-cdf6-4cd4-9079-2ef8d6918665"
      unitRef="usd">463000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i69e734eb5dd74181895d964e7db3ec21_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5YTcxOGRkODU5ZTc0MTA3YmFiZTcyZGRiMzE2ZWMzMy90YWJsZXJhbmdlOjlhNzE4ZGQ4NTllNzQxMDdiYWJlNzJkZGIzMTZlYzMzXzItMS0xLTEtMjY1MjQ3_8f7138a1-c6da-4443-9e50-754c76ae233a"
      unitRef="usd">707000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ifac339bf4b714e1782ca52ebc2be13b4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5YTcxOGRkODU5ZTc0MTA3YmFiZTcyZGRiMzE2ZWMzMy90YWJsZXJhbmdlOjlhNzE4ZGQ4NTllNzQxMDdiYWJlNzJkZGIzMTZlYzMzXzItMy0xLTEtMjY1MjQ3_9fbd955a-a350-404d-99b6-a420ea032fc5"
      unitRef="usd">601000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ia5c21594855b4f6984286b1e3809166d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5YTcxOGRkODU5ZTc0MTA3YmFiZTcyZGRiMzE2ZWMzMy90YWJsZXJhbmdlOjlhNzE4ZGQ4NTllNzQxMDdiYWJlNzJkZGIzMTZlYzMzXzMtMS0xLTEtMjY1MjQ3_e810260a-8931-4e4a-97fb-8f89c4b91df4"
      unitRef="usd">241000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ic125e609219047b1851d89ba1531b87a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5YTcxOGRkODU5ZTc0MTA3YmFiZTcyZGRiMzE2ZWMzMy90YWJsZXJhbmdlOjlhNzE4ZGQ4NTllNzQxMDdiYWJlNzJkZGIzMTZlYzMzXzMtMy0xLTEtMjY1MjQ3_18092d4f-6692-4ab3-8af4-c59ef7644fcc"
      unitRef="usd">225000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ia67a49e920264f60b0ef8a8a7fe494fe_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5YTcxOGRkODU5ZTc0MTA3YmFiZTcyZGRiMzE2ZWMzMy90YWJsZXJhbmdlOjlhNzE4ZGQ4NTllNzQxMDdiYWJlNzJkZGIzMTZlYzMzXzQtMS0xLTEtMjY1MjQ3_199c720b-e48d-4122-b88a-d201c737f00c"
      unitRef="usd">1537000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="id1d19eaaa11f4572b405469e3348cbec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo5YTcxOGRkODU5ZTc0MTA3YmFiZTcyZGRiMzE2ZWMzMy90YWJsZXJhbmdlOjlhNzE4ZGQ4NTllNzQxMDdiYWJlNzJkZGIzMTZlYzMzXzQtMy0xLTEtMjY1MjQ3_ca99931a-b8b8-45a4-a45e-d13bea68c306"
      unitRef="usd">1289000000</us-gaap:LongTermInvestments>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTkw_bc386297-f14a-466c-8f75-5475de48ab55">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in SureScripts, LLC (&#x201c;SureScripts&#x201d;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $60 million, $52 million and $56 million in the years ended December&#160;31, 2022, 2021 and 2020, respectively. The Company&#x2019;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in Heartland Healthcare Services, LLC (&#x201c;Heartland&#x201d;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $87 million, $79 million and $77 million for pharmaceutical inventory purchases during the years ended December&#160;31, 2022, 2021 and 2020, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#x2019;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2022, 2021 and 2020, the Company made charitable contributions of&#160;$25&#160;million, $50 million and $50&#160;million, respectively,&#160;to the CVS Health Foundation, a non-profit entity that focuses on health, education and community involvement programs. The charitable contributions were recorded as operating expenses in the consolidated statements of operations within the Corporate/Other segment for the years ended December&#160;31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzgyMDUw_afab40e5-2a92-4bac-a9a4-3550ff6e0721"
      unitRef="usd">60000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzgyMDU0_96e7dc24-b9d9-4908-91c5-b486d0232661"
      unitRef="usd">52000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzgyMDYx_87f7ad31-46d4-444e-9f44-63488098161b"
      unitRef="usd">56000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:NumberOfStatesInWhichEntityOperates
      contextRef="i2525a9305fd84c7f917e0f50178009ca_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzgyMzY2_76076131-966b-4083-ab18-efafcf9b42a3"
      unitRef="state">4</us-gaap:NumberOfStatesInWhichEntityOperates>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzgyNDA0_9e70ec56-fad4-4145-bcfd-ffa389ab3e83"
      unitRef="usd">87000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzgyNDA4_4595be60-2829-4569-b8ec-fab1f284a726"
      unitRef="usd">79000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzgyNDE1_b0a71a08-41b8-4297-b8cd-2a3aa3c313c8"
      unitRef="usd">77000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzgyODQ1_2a96cb70-f244-4895-9916-85523388b9df"
      unitRef="usd">25000000</cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity>
    <cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzgyODQ5_3900a6e0-f5b3-45b5-9965-882085adbe34"
      unitRef="usd">50000000</cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity>
    <cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzgyODU2_9011df77-8815-4004-b39c-5701b81d8c49"
      unitRef="usd">50000000</cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity>
    <us-gaap:DiscontinuedOperationsPolicyTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTYw_971306ba-9111-4a92-aeff-318bf3bc5bee">Discontinued OperationsIn connection with certain business dispositions completed between 1995 and 1997, the Company retained guarantees on store lease obligations for a number of former subsidiaries, including Linens &#x2018;n Things and Bob&#x2019;s Stores, each of which subsequently filed for bankruptcy. The Company&#x2019;s loss from discontinued operations includes lease-related costs that the Company believes it will likely be required to satisfy pursuant to these lease guarantees.</us-gaap:DiscontinuedOperationsPolicyTextBlock>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90ZXh0cmVnaW9uOjQxNDYyMGE5OWNiMDRmMjI4ZjJlNjlhMGI0NTJkMzcyXzg2MTEx_9e297525-4266-489e-b164-15ee7bf59779">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of the results of discontinued operations for the year ended December 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo1ZDk3NjQxNWFhZWY0ZjExYjFjZWVhZTAwNWViMGU5ZS90YWJsZXJhbmdlOjVkOTc2NDE1YWFlZjRmMTFiMWNlZWFlMDA1ZWIwZTllXzEtMS0xLTEtMjY1MjQ3_856a1b19-795d-410c-843f-fd3fc6f9197f"
      unitRef="usd">-12000000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo1ZDk3NjQxNWFhZWY0ZjExYjFjZWVhZTAwNWViMGU5ZS90YWJsZXJhbmdlOjVkOTc2NDE1YWFlZjRmMTFiMWNlZWFlMDA1ZWIwZTllXzItMS0xLTEtMjY1MjQ3_8a41fab5-cbca-423a-a92d-cbe62c54072e"
      unitRef="usd">-3000000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjEvZnJhZzo0MTQ2MjBhOTljYjA0ZjIyOGYyZTY5YTBiNDUyZDM3Mi90YWJsZTo1ZDk3NjQxNWFhZWY0ZjExYjFjZWVhZTAwNWViMGU5ZS90YWJsZXJhbmdlOjVkOTc2NDE1YWFlZjRmMTFiMWNlZWFlMDA1ZWIwZTllXzMtMS0xLTEtMjY1MjQ3_7877b244-ef36-4f3a-aeac-69e4cf48439d"
      unitRef="usd">-9000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzgyMTk_3dbe0b91-9845-4cd8-9dde-23c26d2d90d3">Acquisitions, Divestitures and Asset Sales&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Proposed Oak Street Health Acquisition &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 7, 2023, the Company entered into a definitive merger agreement to acquire all of the outstanding shares of Oak Street Health, Inc. (&#x201c;Oak Street Health&#x201d;) for cash. Under the terms of the merger agreement, Oak Street Health stockholders will receive $39.00 per share in cash. The total value of the transaction is approximately $10.6&#160;billion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The proposed acquisition was approved by the Board of Directors at each of the respective companies and is subject to approval by a majority of Oak Street Health stockholders, receipt of regulatory approval and satisfaction of other customary closing conditions, including the expiration of the waiting period under the federal Hart-Scott-Rodino Antitrust Improvements Act of 1976. The transaction is expected to close in 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the merger agreement is terminated under certain specified circumstances and receipt of regulatory approval has not been obtained by such time, the Company will be required to pay Oak Street Health a termination fee of approximately $500&#160;million. If the merger agreement is terminated under other certain specified circumstances, including due to Oak Street Health accepting a superior proposal, Oak Street Health will be required to pay the Company a termination fee of approximately $300&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pending Signify Health Acquisition &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 2, 2022, the Company entered into a definitive merger agreement to acquire all of the outstanding shares of Signify Health, Inc. (&#x201c;Signify Health&#x201d;) for cash. Under the terms of the merger agreement, Signify Health stockholders will receive $30.50 per share in cash. The total value of the transaction is approximately $8&#160;billion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The pending acquisition was approved by the Board of Directors at each of the respective companies and the Signify Health stockholders and remains subject to receipt of regulatory approval and satisfaction of other customary closing conditions. On October 19, 2022, Signify Health and CVS Health each received a request for additional information (also known as a &#x201c;second request&#x201d;) from the U.S. Department of Justice (the &#x201c;DOJ&#x201d;) in connection with the review of the transactions contemplated by the merger agreement by the DOJ under the federal Hart-Scott-Rodino Antitrust Improvements Act of 1976. The transaction is expected to close in the second quarter of 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the merger agreement is terminated under certain specified circumstances and receipt of regulatory approval has not been obtained by such time, the Company will be required to pay Signify Health a termination fee in an amount equal to $380&#160;million. If the merger agreement is terminated under other certain specified circumstances, including due to Signify Health accepting a superior proposal, Signify Health will be required to pay the Company a termination fee in an amount equal to $228&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets Held For Sale&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continually evaluates its portfolio for non-strategic assets. The Company determined that its Omnicare&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; long-term care business (&#x201c;LTC business&#x201d;), which is included within the Pharmacy &amp;amp; Consumer Wellness segment, was no longer a strategic asset and during the third quarter of 2022 committed to a plan to sell the LTC business. As of September 30, 2022, the LTC business met the criteria to be classified as held for sale and the carrying value of the LTC business was determined to be greater than its estimated fair value less costs to sell. Accordingly, the Company recorded a loss on assets held for sale of $2.5 billion during the third quarter of 2022. As of December&#160;31, 2022, the net assets of the LTC business continued to meet the criteria for held-for-sale accounting and during the fourth quarter, an incremental loss on assets held for sale of $12 million was recorded to write down the carrying value of the LTC business to its estimated fair value less costs to sell. The loss on assets held for sale represents the write-down of its customer contracts/relationships intangible assets and was recorded in the Company&#x2019;s consolidated statement of operations within the Pharmacy &amp;amp; Consumer Wellness segment. The LTC business operating income was not material for the years ended December&#160;31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The LTC business met the criteria to be classified as held for sale at December&#160;31, 2022, but did not meet the criteria to be classified as discontinued operations. As a result, the related assets and liabilities were included in separate held-for-sale line items of the asset and liability sections of the consolidated balance sheet. As the assets held for sale are measured at fair value on a nonrecurring basis primarily using unobservable inputs as of the measurement date, they are classified in Level 3 of the fair value hierarchy. The following table summarizes the assets and liabilities held for sale at December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.789%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Divestiture of bswift&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2022, the Company sold its wholly-owned subsidiary bswift LLC (&#x201c;bswift&#x201d;) for approximately $735 million. bswift offers software and services that streamline benefits and human resource administration. The results of this business have historically been recorded within the Health Care Benefits segment. The Company recorded a pre-tax gain on the divestiture of $250&#160;million in the year ended December&#160;31, 2022, which is reflected as a reduction of operating expenses in the Company&#x2019;s consolidated statement of operations within the Health Care Benefits segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Divestiture of PayFlex &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Company sold PayFlex for approximately $775&#160;million. PayFlex provides services to employers, their employees, and their former employees in the areas of tax-advantaged account reimbursement administration (flexible spending, health reimbursement, health savings, transit and parking), Consolidated Omnibus Budget Reconciliation Act (&#x201c;COBRA&#x201d;) administration and special-member billing administration. The results of this business have historically been reported within the Health Care Benefits segment. The Company recorded a pre-tax gain on the divestiture of $225&#160;million in the year ended December&#160;31, 2022, which is reflected as a reduction of operating expenses in the Company&#x2019;s consolidated statement of operations within the Health Care Benefits segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Divestiture of Thailand Health Care Business&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, the Company reached an agreement to sell its international health care business domiciled in Thailand (&#x201c;Thailand business&#x201d;), comprised of approximately 266,000 medical members, which was included in the Commercial Business reporting unit within the Health Care Benefits segment. At that time, a portion of the Commercial Business goodwill was specifically allocated to the Thailand business. The net assets of the Thailand business were accounted for as assets held for sale at March 31, 2022. The carrying value of the Thailand business was determined to be greater than its estimated fair value less costs to sell and, accordingly, the Company recorded a $41 million loss on assets held for sale within the Health Care Benefits segment during the first quarter of 2022. The sale of the Thailand business closed in the second quarter of 2022, and the consideration received and ultimate loss on the sale were not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Divestiture of Workers&#x2019; Compensation Business&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 31, 2020, the Company sold its Workers&#x2019; Compensation business for approximately $850&#160;million. The results of this business were reported within the Health Care Benefits segment. The Company recorded a pre-tax gain on the divestiture of $269 million in the year ended December&#160;31, 2020, which is reflected as a reduction in operating expenses in the Company&#x2019;s consolidated statement of operations within the Health Care Benefits segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;International Health Care Benefits Renewal Rights Asset Sale&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2022, the Company sold the renewal rights of approximately 200,000 international medical members outside of the Americas, Thailand and India in connection with an Asset Purchase Agreement. As part of this agreement, the Company will introduce and help migrate these existing international medical members to the purchaser upon renewal. The Company expects the migration process to occur between July 2022 and November 2023. The Company ceased writing any new or renewal business for international medical members outside of the Americas during the fourth quarter of 2022. The consideration received related to this agreement was not material.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i8941690cb4944d199bf33e6da1cee933_I20230207"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzM1Mg_838dcb35-0817-4afb-850c-3ba64d0857bc"
      unitRef="usdPerShare">39.00</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ieaa2442b4a1b43c1a1e9635e5d302668_D20230207-20230207"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzQyNg_183fdd6b-7430-4ba3-a05b-120ccf1112ba"
      unitRef="usd">10600000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <cvs:BusinessCombinationTerminationFee
      contextRef="i8941690cb4944d199bf33e6da1cee933_I20230207"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzEwOTY_a25752fe-41d9-466e-a253-1d20676ea848"
      unitRef="usd">500000000</cvs:BusinessCombinationTerminationFee>
    <cvs:BusinessCombinationTerminationFee
      contextRef="icc5a99c2de364d84899668bcf7f91a6d_I20230207"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzEzMzg_26c799c6-52b7-4175-86ef-13084585c97c"
      unitRef="usd">300000000</cvs:BusinessCombinationTerminationFee>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i65fae298043841daaccb6bbb1a996aac_I20220902"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzE2MzM_7f57860f-f139-46dc-9aaf-bf1cc35815a1"
      unitRef="usdPerShare">30.50</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i6d430fa42bb64f4cafd5196de70e0ece_D20220902-20220902"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzE3MDc_5e400290-5db8-4788-82e9-7699422bd77d"
      unitRef="usd">8000000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <cvs:BusinessCombinationTerminationFee
      contextRef="i65fae298043841daaccb6bbb1a996aac_I20220902"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzI2MTk_5ec446a1-3d8c-48a2-88ab-e0be5ec9fba0"
      unitRef="usd">380000000</cvs:BusinessCombinationTerminationFee>
    <cvs:BusinessCombinationTerminationFee
      contextRef="i12c5778e54f64900acca49cd8d1aa3c3_I20220902"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzI4NjA_dd36c55f-ce19-48e3-836e-c1e7682d2ea8"
      unitRef="usd">228000000</cvs:BusinessCombinationTerminationFee>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i39f6860ec9044a859b0fb2f4386504eb_D20220701-20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzM0OTM_487c254a-6676-47f7-bab9-798b0c474b05"
      unitRef="usd">2500000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i7a1cc0d19b0548438d4b4f4e3b4d3a67_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzM3MTM_73478eb8-821f-4714-a7c1-80a6edd5139f"
      unitRef="usd">12000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzgyMTY_924b2eb6-dbc7-4b47-bb84-2eefdd88eb04">The following table summarizes the assets and liabilities held for sale at December&#160;31, 2022:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.789%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90YWJsZTo2NGVmMjU0YjQwZDE0YmVjOGU2NjE4ZTU4MzViM2ViYy90YWJsZXJhbmdlOjY0ZWYyNTRiNDBkMTRiZWM4ZTY2MThlNTgzNWIzZWJjXzItMS0xLTEtMjY1MjQ3_56ad0a06-6492-4ff2-8af0-c997061af542"
      unitRef="usd">227000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1
      contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90YWJsZTo2NGVmMjU0YjQwZDE0YmVjOGU2NjE4ZTU4MzViM2ViYy90YWJsZXJhbmdlOjY0ZWYyNTRiNDBkMTRiZWM4ZTY2MThlNTgzNWIzZWJjXzMtMS0xLTEtMjY1MjQ3_0966c6b0-e68f-44e2-9c57-e5b6c07bcbc5"
      unitRef="usd">188000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
      contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90YWJsZTo2NGVmMjU0YjQwZDE0YmVjOGU2NjE4ZTU4MzViM2ViYy90YWJsZXJhbmdlOjY0ZWYyNTRiNDBkMTRiZWM4ZTY2MThlNTgzNWIzZWJjXzQtMS0xLTEtMjY1MjQ3_19f396a2-efe8-43f8-aa9e-ec3285c43382"
      unitRef="usd">244000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets
      contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90YWJsZTo2NGVmMjU0YjQwZDE0YmVjOGU2NjE4ZTU4MzViM2ViYy90YWJsZXJhbmdlOjY0ZWYyNTRiNDBkMTRiZWM4ZTY2MThlNTgzNWIzZWJjXzYtMS0xLTEtMjY1MjQ3_be9b5dea-b30e-40e2-a678-0751b0d93497"
      unitRef="usd">131000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets
      contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90YWJsZTo2NGVmMjU0YjQwZDE0YmVjOGU2NjE4ZTU4MzViM2ViYy90YWJsZXJhbmdlOjY0ZWYyNTRiNDBkMTRiZWM4ZTY2MThlNTgzNWIzZWJjXzctMS0xLTEtMjY1MjQ3_4db242c1-0fff-480a-b5f9-41c4b07c8295"
      unitRef="usd">118000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90YWJsZTo2NGVmMjU0YjQwZDE0YmVjOGU2NjE4ZTU4MzViM2ViYy90YWJsZXJhbmdlOjY0ZWYyNTRiNDBkMTRiZWM4ZTY2MThlNTgzNWIzZWJjXzgtMS0xLTEtMjY1MjQ3_05948a77-5ebb-41f8-9a5f-1d54a9462b7d"
      unitRef="usd">908000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable
      contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90YWJsZTo2NGVmMjU0YjQwZDE0YmVjOGU2NjE4ZTU4MzViM2ViYy90YWJsZXJhbmdlOjY0ZWYyNTRiNDBkMTRiZWM4ZTY2MThlNTgzNWIzZWJjXzExLTEtMS0xLTI2NTI0Nw_cb5b171f-2eb4-41a5-afb3-f74e7c284274"
      unitRef="usd">86000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayable>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities
      contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90YWJsZTo2NGVmMjU0YjQwZDE0YmVjOGU2NjE4ZTU4MzViM2ViYy90YWJsZXJhbmdlOjY0ZWYyNTRiNDBkMTRiZWM4ZTY2MThlNTgzNWIzZWJjXzEyLTEtMS0xLTI2NTI0Nw_932c60c6-77d3-40de-86bb-63663b2d684b"
      unitRef="usd">71000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
      contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90YWJsZTo2NGVmMjU0YjQwZDE0YmVjOGU2NjE4ZTU4MzViM2ViYy90YWJsZXJhbmdlOjY0ZWYyNTRiNDBkMTRiZWM4ZTY2MThlNTgzNWIzZWJjXzEzLTEtMS0xLTI2NTI0Nw_84d63087-02bd-4d41-a89c-9500e9b126b8"
      unitRef="usd">71000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90YWJsZTo2NGVmMjU0YjQwZDE0YmVjOGU2NjE4ZTU4MzViM2ViYy90YWJsZXJhbmdlOjY0ZWYyNTRiNDBkMTRiZWM4ZTY2MThlNTgzNWIzZWJjXzE0LTEtMS0xLTI2NTI0Nw_9762b334-a1be-41b1-b092-4d29f1eecce8"
      unitRef="usd">228000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i16dd20d6307443f7b1496e7fd3259924_D20221101-20221130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzQ4NzE_d1f8b303-0548-42e5-9b53-65963869849d"
      unitRef="usd">735000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i1487797c4ed44d6ab54ae7b9970f80e0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzUxMzE_e87afde9-a434-41c4-9730-bf3dcd0001ed"
      unitRef="usd">250000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i726a3c8b7d82435e9ab454babaa43c9d_D20220601-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzUzOTA_62d7b86f-83f1-4f91-a5eb-dbc68f21f8e7"
      unitRef="usd">775000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i032e70604e384dd9b7d3ebd3ff12f852_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzU5MDE_b1a30fa5-71aa-4b9d-af21-2aeefa14a647"
      unitRef="usd">225000000</us-gaap:GainLossOnSaleOfBusiness>
    <cvs:NumberOfMedicalMembers
      contextRef="i90dd0fb3894941b6960bebd138f56df7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzYyOTE_3279f87f-5e49-4a26-87bc-32debdadffa8"
      unitRef="member">266000</cvs:NumberOfMedicalMembers>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i13c8ddf9147d44ae959fc13f26a1884f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzY3OTE_be931f06-c5f8-4904-bd7f-2e2fa191826d"
      unitRef="usd">41000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="ica7104e3105a418591fc79a3004a6ba4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzY3OTE_c562cbbf-12a1-4915-a350-16d419811bf0"
      unitRef="usd">41000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ibfb21d4c40684eea90662442e675b2a5_D20200731-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzcxODU_e1a5e008-11ee-4e3b-b0bd-0f6f215d7c8a"
      unitRef="usd">850000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="icaa8b7f8dd3142d9a337758c8211c242_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3XzczMzE_67c4215a-d4e1-4cc2-ab64-7a6ab7a90253"
      unitRef="usd">269000000</us-gaap:GainLossOnSaleOfBusiness>
    <cvs:DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold
      contextRef="i343759b6979e4ed18b87374d58deff9a_I20220531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjQvZnJhZzo3OWQwNWI3M2EyNDM0ZGE3ODMxMjczMWZhZTUwZmE1Ny90ZXh0cmVnaW9uOjc5ZDA1YjczYTI0MzRkYTc4MzEyNzMxZmFlNTBmYTU3Xzc2MzY_da24f82d-b56b-4656-8dc4-c1875e85b1f3"
      unitRef="member">200000</cvs:DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzcwNDQ_2d2355a2-cab9-4552-9a9a-5a4b170047f9">Investments&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total investments at December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities available for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes long-term investments of $17&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:6.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022 and 2021, the Company held investments of $331 million and $450 million, respectively, related to the 2012 conversion of an existing group annuity contract from a participating to a non-participating contract. These investments are included in the total investments of large case pensions supporting non-experience-rated products. Although these investments are not accounted for as Separate Accounts assets, they are legally segregated and are not subject to claims that arise out of the Company&#x2019;s business and only support future policy benefits obligations under that group annuity contract. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities available for sale at December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.504%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Amortized &lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Allowance&lt;br/&gt;for Credit&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Investment risks associated with the Company&#x2019;s experience-rated products generally do not impact the Company&#x2019;s consolidated operating results.&#160;At December&#160;31, 2022, debt securities with a fair value of $609 million, gross unrealized capital gains of $3 million and gross unrealized capital losses of &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$59 million, and at December&#160;31, 2021, debt securities with a fair value of $864 million, gross unrealized capital gains of $94 million and gross unrealized capital losses of $2 million were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost and fair value of debt securities at December&#160;31, 2022 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mortgage-Backed and Other Asset-Backed Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company&#x2019;s residential mortgage-backed securities at December&#160;31, 2022 were issued by the Government National Mortgage Association, the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation and carry agency guarantees and explicit or implicit guarantees by the U.S. Government.&#160;At December&#160;31, 2022, the Company&#x2019;s residential mortgage-backed securities had an average credit quality rating of AAA and a weighted average duration of 5.7 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s commercial mortgage-backed securities have underlying loans that are dispersed throughout the United States. Significant market observable inputs used to value these securities include loss severity and probability of default.&#160;At December&#160;31, 2022, these securities had an average credit quality rating of AAA and a weighted average duration of 5.6 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s other asset-backed securities have a variety of underlying collateral (e.g., automobile loans, credit card receivables, home equity loans and commercial loans). Significant market observable inputs used to value these securities include the unemployment rate, loss severity and probability of default.&#160;At December&#160;31, 2022, these securities had an average credit quality rating of AA and a weighted average duration of 1.0 year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summarized below are the debt securities the Company held at December&#160;31, 2022 and 2021 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Greater than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except number of securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;&#160;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;&#160;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;&#160;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#x2019;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#x2019;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#x2019;s current prospects for recovery. Unrealized capital losses at December&#160;31, 2022 were generally caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities. As of December&#160;31, 2022, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturity dates for debt securities in an unrealized capital loss position at December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting experience-&lt;br/&gt;rated products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting remaining&lt;br/&gt;products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Mortgage Loans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s mortgage loans are collateralized by commercial real estate.&#160;During the years ended December 31, 2022 and 2021, the Company had the following activity in its mortgage loan portfolio:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans fully repaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans foreclosed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#x2019;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Category 1 - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Represents loans of superior quality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Categories 2 to 4 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Categories 5 and 6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Represent loans where credit risk is not substantial, but these loans warrant management&#x2019;s close attention.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Category 7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based upon the Company&#x2019;s assessments at December&#160;31, 2022 and 2021, the amortized cost basis of the Company&#x2019;s mortgage loans within each credit quality indicator by year of origination was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.950%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost Basis by Year of Origination&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except credit quality indicator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022 scheduled mortgage loan principal repayments were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Investment Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sources of net investment income for the years ended December 31, 2022, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (excluding net realized capital gains or losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized capital gains (losses) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net realized capital losses include credit-related losses on debt securities of $13 million and yield-related impairment losses on debt securities of $143 million in the year ended December 31, 2022. Net realized capital gains are net of yield-related impairment losses on debt securities of $42 million and $49 million for the years ended December 31, 2021 and 2020, respectively. There were no credit-related losses on debt securities in the years ended December 31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net investment income includes $35 million, $38 million and $42 million for the years ended December 31, 2022, 2021 and 2020, respectively, related to investments supporting experience-rated products. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capital gains and losses recognized during the year ended December 31, 2022 related to investments in equity securities held as of December 31, 2022 were not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses in the years ended December 31, 2022, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <cvs:TotalInvestmentsTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzcwMzU_eb4d066d-dabf-46bf-8605-526045d5c88d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total investments at December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities available for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes long-term investments of $17&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;</cvs:TotalInvestmentsTableTextBlock>
    <us-gaap:ShortTermInvestments
      contextRef="i13ff989d3101402c9f2d0b708fde5f39_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzItMS0xLTEtMjY1MjQ3_35484196-153a-4994-b519-bc364d3b9855"
      unitRef="usd">2718000000</us-gaap:ShortTermInvestments>
    <cvs:LongTermInvestmentsIncludingAssetsHeldForSale
      contextRef="i13ff989d3101402c9f2d0b708fde5f39_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzItMy0xLTEtMjY1MjQ3_de827c93-f98b-4136-a89e-2c865215c85e"
      unitRef="usd">17562000000</cvs:LongTermInvestmentsIncludingAssetsHeldForSale>
    <us-gaap:Investments
      contextRef="i13ff989d3101402c9f2d0b708fde5f39_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzItNS0xLTEtMjY1MjQ3_a9e64cd0-328b-4d00-ae6a-5827c4e52856"
      unitRef="usd">20280000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i6007bc6f913b42eaab01b721ab83141f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzItNy0xLTEtMjY1MjQ3_ab69dba7-4386-486b-9547-297b1cf8237e"
      unitRef="usd">3009000000</us-gaap:ShortTermInvestments>
    <cvs:LongTermInvestmentsIncludingAssetsHeldForSale
      contextRef="i6007bc6f913b42eaab01b721ab83141f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzItOS0xLTEtMjY1MjQ3_f0064ec0-08c5-431d-9cd2-4b2a6d335a45"
      unitRef="usd">20231000000</cvs:LongTermInvestmentsIncludingAssetsHeldForSale>
    <us-gaap:Investments
      contextRef="i6007bc6f913b42eaab01b721ab83141f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzItMTEtMS0xLTI2NTI0Nw_9a524317-19f0-4293-b75a-f2fec7530686"
      unitRef="usd">23240000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i04ef966a0b364268a11b39305bc55156_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzMtMS0xLTEtMjY1MjQ3_a360591f-b821-4b1a-b7e7-5c683b215221"
      unitRef="usd">55000000</us-gaap:ShortTermInvestments>
    <cvs:LongTermInvestmentsIncludingAssetsHeldForSale
      contextRef="i04ef966a0b364268a11b39305bc55156_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzMtMy0xLTEtMjY1MjQ3_51a0b1f7-2ae8-4b78-b306-9955015a48d7"
      unitRef="usd">989000000</cvs:LongTermInvestmentsIncludingAssetsHeldForSale>
    <us-gaap:Investments
      contextRef="i04ef966a0b364268a11b39305bc55156_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzMtNS0xLTEtMjY1MjQ3_c36fd263-cdc9-4c92-b85d-8aec06f4489d"
      unitRef="usd">1044000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i4f2ded7662304336a06ac9d017d04cdd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzMtNy0xLTEtMjY1MjQ3_c2e675e9-4a1b-42a4-b3fb-8d4c9effa587"
      unitRef="usd">58000000</us-gaap:ShortTermInvestments>
    <cvs:LongTermInvestmentsIncludingAssetsHeldForSale
      contextRef="i4f2ded7662304336a06ac9d017d04cdd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzMtOS0xLTEtMjY1MjQ3_d67155e2-7393-4c93-8a60-9e8a8ab42ff7"
      unitRef="usd">844000000</cvs:LongTermInvestmentsIncludingAssetsHeldForSale>
    <us-gaap:Investments
      contextRef="i4f2ded7662304336a06ac9d017d04cdd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzMtMTEtMS0xLTI2NTI0Nw_ddab2736-78de-4898-acad-2bec6a80bd81"
      unitRef="usd">902000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i8a96031559a645dc9dd2370af4f1fe81_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzQtMS0xLTEtMjY1MjQ3_5742e8e4-cd98-4e1c-8384-c5c02564248b"
      unitRef="usd">5000000</us-gaap:ShortTermInvestments>
    <cvs:LongTermInvestmentsIncludingAssetsHeldForSale
      contextRef="i8a96031559a645dc9dd2370af4f1fe81_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzQtMy0xLTEtMjY1MjQ3_b50d8dcc-b3e5-466b-b208-c757d4e3e7b0"
      unitRef="usd">2562000000</cvs:LongTermInvestmentsIncludingAssetsHeldForSale>
    <us-gaap:Investments
      contextRef="i8a96031559a645dc9dd2370af4f1fe81_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzQtNS0xLTEtMjY1MjQ3_ed6a0cf0-6bfe-4b26-bb4c-0709998ca0c5"
      unitRef="usd">2567000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i3f484ef7e1984f9db38a5d63935d02ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzQtNy0xLTEtMjY1MjQ3_e275c5c3-1f96-48da-bbdd-ac83b476e5f7"
      unitRef="usd">50000000</us-gaap:ShortTermInvestments>
    <cvs:LongTermInvestmentsIncludingAssetsHeldForSale
      contextRef="i3f484ef7e1984f9db38a5d63935d02ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzQtOS0xLTEtMjY1MjQ3_0697e17d-54b4-4cce-87c1-f07ad2fee27a"
      unitRef="usd">1950000000</cvs:LongTermInvestmentsIncludingAssetsHeldForSale>
    <us-gaap:Investments
      contextRef="i3f484ef7e1984f9db38a5d63935d02ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzQtMTEtMS0xLTI2NTI0Nw_b008682c-5347-45d5-b71d-92766f179344"
      unitRef="usd">2000000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzUtMS0xLTEtMjY1MjQ3_14427ba2-5e95-43c8-8a1c-7d630ab0acba"
      unitRef="usd">2778000000</us-gaap:ShortTermInvestments>
    <cvs:LongTermInvestmentsIncludingAssetsHeldForSale
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzUtMy0xLTEtMjY1MjQ3_12a46925-e01c-4c1f-b63b-115a9ff891ba"
      unitRef="usd">21113000000</cvs:LongTermInvestmentsIncludingAssetsHeldForSale>
    <us-gaap:Investments
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzUtNS0xLTEtMjY1MjQ3_a82960b4-882f-4311-9a38-f022c05bf451"
      unitRef="usd">23891000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzUtNy0xLTEtMjY1MjQ3_40b96de7-dac0-4c29-b0ca-7878b48dab28"
      unitRef="usd">3117000000</us-gaap:ShortTermInvestments>
    <cvs:LongTermInvestmentsIncludingAssetsHeldForSale
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzUtOS0xLTEtMjY1MjQ3_b6acaa81-ec27-4338-8d3e-cf6787cc54e9"
      unitRef="usd">23025000000</cvs:LongTermInvestmentsIncludingAssetsHeldForSale>
    <us-gaap:Investments
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTplODNjN2Y5YWViN2I0OTg3YTI0ZTliZDUzODY3MDM0Mi90YWJsZXJhbmdlOmU4M2M3ZjlhZWI3YjQ5ODdhMjRlOWJkNTM4NjcwMzQyXzUtMTEtMS0xLTI2NTI0Nw_3c12b9d2-f4de-4f10-a3d7-493c9f3dfb38"
      unitRef="usd">26142000000</us-gaap:Investments>
    <cvs:LongTermInvestmentsIncludingAssetsHeldForSale
      contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzE1MA_992c791f-65a1-46c6-b455-76e528bda5f2"
      unitRef="usd">17000000</cvs:LongTermInvestmentsIncludingAssetsHeldForSale>
    <us-gaap:RestrictedInvestmentsAtFairValue
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzQwMw_561bf4fb-d85c-49c4-b1bc-b9fb17a252fb"
      unitRef="usd">331000000</us-gaap:RestrictedInvestmentsAtFairValue>
    <us-gaap:RestrictedInvestmentsAtFairValue
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzQxMA_79e08e9f-7097-4ae4-9ae1-0a92c52f6b6b"
      unitRef="usd">450000000</us-gaap:RestrictedInvestmentsAtFairValue>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzcwNDk_8e462b33-9eb5-405a-aea5-882c62510284">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities available for sale at December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.504%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Amortized &lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Allowance&lt;br/&gt;for Credit&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Investment risks associated with the Company&#x2019;s experience-rated products generally do not impact the Company&#x2019;s consolidated operating results.&#160;At December&#160;31, 2022, debt securities with a fair value of $609 million, gross unrealized capital gains of $3 million and gross unrealized capital losses of &lt;/span&gt;&lt;/div&gt;$59 million, and at December&#160;31, 2021, debt securities with a fair value of $864 million, gross unrealized capital gains of $94 million and gross unrealized capital losses of $2 million were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income (loss).</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzMtNS0xLTEtMjY1MjQ3_68c3739a-e1bc-467a-ae4d-472717a15e74"
      unitRef="usd">2074000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzMtNy0xLTEtMjY1MjQ3_77999e09-f828-44c0-8e85-fdfe20a2cf5d"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzMtOS0xLTEtMjY1MjQ3_961ed53c-ad28-4c0a-bc73-ab10d5a787f4"
      unitRef="usd">2074000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzMtMTEtMS0xLTI2NTI0Nw_10ce8733-eeae-4954-a686-e577f64d8029"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzMtMTMtMS0xLTI2NTI0Nw_085fe3d3-aecf-4e6f-be9f-b971b322ba4c"
      unitRef="usd">182000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzMtMTUtMS0xLTI2NTI0Nw_d8b9627c-c93b-4172-9175-e26f3d1efcc8"
      unitRef="usd">1892000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzQtNS0xLTEtMjY1MjQ3_8efc1f0d-32ba-4e35-96bb-11b41331cccf"
      unitRef="usd">2393000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzQtNy0xLTEtMjY1MjQ3_4f1182d8-f378-4185-a852-ce7f91cbaeee"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzQtOS0xLTEtMjY1MjQ3_1836ede3-e922-4596-899a-2094508ecae3"
      unitRef="usd">2393000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzQtMTEtMS0xLTI2NTI0Nw_4af0d2d3-8c59-4163-a965-4c765d2d249f"
      unitRef="usd">8000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzQtMTMtMS0xLTI2NTI0Nw_5db6747a-0cd7-4324-8c83-4b2c4acd4f43"
      unitRef="usd">129000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzQtMTUtMS0xLTI2NTI0Nw_c8480baa-10a7-4999-89d3-3c17daadd893"
      unitRef="usd">2272000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzUtNS0xLTEtMjY1MjQ3_f3ca5c70-ed13-4041-bcac-d393392cca9a"
      unitRef="usd">9838000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzUtNy0xLTEtMjY1MjQ3_bef86166-e104-4044-93cb-00d7f428320d"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzUtOS0xLTEtMjY1MjQ3_9fa1bf17-e86e-489a-9126-b9492ff360e7"
      unitRef="usd">9835000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzUtMTEtMS0xLTI2NTI0Nw_4d048f2c-19e6-49c3-b8b6-2810c3f1deb4"
      unitRef="usd">26000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzUtMTMtMS0xLTI2NTI0Nw_47b24968-30ad-4db2-b439-e3f68e98e490"
      unitRef="usd">903000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzUtMTUtMS0xLTI2NTI0Nw_09887855-41ac-4255-b434-5adc12863e61"
      unitRef="usd">8958000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzYtNS0xLTEtMjY1MjQ3_e21d0846-5693-4834-aa92-ec115fc62f23"
      unitRef="usd">2780000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzYtNy0xLTEtMjY1MjQ3_a662efbd-2ec6-4190-aae1-85028e7a3b21"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzYtOS0xLTEtMjY1MjQ3_e789ec06-39ef-4770-a3e5-91d1a1932018"
      unitRef="usd">2779000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzYtMTEtMS0xLTI2NTI0Nw_1b12706b-aaff-46ef-9867-e258db9bc30d"
      unitRef="usd">15000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzYtMTMtMS0xLTI2NTI0Nw_b0e97e95-c9a1-4ef7-97e4-a6daeb00e538"
      unitRef="usd">244000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzYtMTUtMS0xLTI2NTI0Nw_83245bb8-05ed-4ae2-abb3-7e16b36ae5fa"
      unitRef="usd">2550000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzctNS0xLTEtMjY1MjQ3_e0ebcc1c-5f27-4d07-9af6-a5c39e8bcfcc"
      unitRef="usd">845000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzctNy0xLTEtMjY1MjQ3_31e43587-b435-4462-b601-9907bb08a1a8"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzctOS0xLTEtMjY1MjQ3_52eae0d5-4151-469c-86c3-dede5b61b379"
      unitRef="usd">845000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzctMTEtMS0xLTI2NTI0Nw_e1c35a99-ccd5-4d68-b8a3-465bb20e14a7"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzctMTMtMS0xLTI2NTI0Nw_2ac8c49b-fd4d-4d92-80ef-0e9237a54c16"
      unitRef="usd">89000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzctMTUtMS0xLTI2NTI0Nw_e120d19a-7858-47d0-b2a9-1a4f485d56a9"
      unitRef="usd">757000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzgtNS0xLTEtMjY1MjQ3_4d220599-896b-4439-b807-60701e90286c"
      unitRef="usd">1172000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzgtNy0xLTEtMjY1MjQ3_e79fe2a0-d69d-4d26-a78b-b64f7e0cfdde"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzgtOS0xLTEtMjY1MjQ3_15388590-c14b-4007-a6cb-580449c8fe56"
      unitRef="usd">1172000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzgtMTEtMS0xLTI2NTI0Nw_4a053f3e-1ba0-407d-b08a-ecba941c16b7"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzgtMTMtMS0xLTI2NTI0Nw_f08f011a-408d-4c7a-b6f1-8bef7b69c2ff"
      unitRef="usd">155000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzgtMTUtMS0xLTI2NTI0Nw_dd8816e0-dc97-49ac-99fd-c20216a3ced1"
      unitRef="usd">1018000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzktNS0xLTEtMjY1MjQ3_fdd783e1-4359-4421-9e03-db6adcbd3f81"
      unitRef="usd">2940000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzktNy0xLTEtMjY1MjQ3_950fcf02-08ec-45db-87fd-be50635ff7b6"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzktOS0xLTEtMjY1MjQ3_bd075dad-fd70-4c62-ac67-3e90c0d9e52e"
      unitRef="usd">2940000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzktMTEtMS0xLTI2NTI0Nw_248121ac-3a46-4f95-81f5-94d2a21531ba"
      unitRef="usd">6000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzktMTMtMS0xLTI2NTI0Nw_9ec82bca-2f3f-4b9e-bb6a-6150463e56ec"
      unitRef="usd">136000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzktMTUtMS0xLTI2NTI0Nw_4dc3ba72-7ccc-4d0b-a1d8-8764912425ea"
      unitRef="usd">2810000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzEwLTUtMS0xLTI2NTI0Nw_9f92e5e8-53c7-4a45-b8d0-8256e6f8b59a"
      unitRef="usd">25000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzEwLTctMS0xLTI2NTI0Nw_1eb4ac89-085e-4ead-b689-922982821b38"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzEwLTktMS0xLTI2NTI0Nw_66f32745-c809-4d9b-b0b1-e25604146ac6"
      unitRef="usd">25000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzEwLTExLTEtMS0yNjUyNDc_89aa3f78-5f64-4542-bfaf-2dde4fa49a6a"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzEwLTEzLTEtMS0yNjUyNDc_81b32ad4-3c8e-4b23-8307-37ae4e742a1b"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzEwLTE1LTEtMS0yNjUyNDc_39d398e4-e2e2-41a1-bc78-459ae1f804ba"
      unitRef="usd">23000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzExLTUtMS0xLTI2NTI0Nw_6fb2eaf8-3005-4dbe-9d3b-a938165b229b"
      unitRef="usd">22067000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzExLTctMS0xLTI2NTI0Nw_642fd720-e0bd-4ee3-af4d-491d255781b0"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzExLTktMS0xLTI2NTI0Nw_0ecaab70-51e6-4cf4-8e05-1572cf3a4304"
      unitRef="usd">22063000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzExLTExLTEtMS0yNjUyNDc_557559fe-89c4-4589-8f21-f6b54a2a99bd"
      unitRef="usd">57000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzExLTEzLTEtMS0yNjUyNDc_36156edb-fbdc-495f-ab22-079e5d1d4906"
      unitRef="usd">1840000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzExLTE1LTEtMS0yNjUyNDc_4b851f34-532e-4e64-ac7f-56195293429a"
      unitRef="usd">20280000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE1LTUtMS0xLTI2NTI0Nw_fd8220d1-813c-400c-aab0-a32466a560b1"
      unitRef="usd">2349000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE1LTctMS0xLTI2NTI0Nw_0fe34c7f-730a-4ea1-b6bc-b7dd54c1bdd0"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE1LTktMS0xLTI2NTI0Nw_432cc7e6-c0e6-470f-9184-cf10d12f9e0b"
      unitRef="usd">2349000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE1LTExLTEtMS0yNjUyNDc_97ebf8f8-b193-4676-b567-cd68a5d90d47"
      unitRef="usd">70000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE1LTEzLTEtMS0yNjUyNDc_65b14946-87d0-404d-9e4f-6287aed21a09"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE1LTE1LTEtMS0yNjUyNDc_836d4a75-da8b-447e-b3e3-a25a5d9743dc"
      unitRef="usd">2416000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE2LTUtMS0xLTI2NTI0Nw_71d4289d-56cd-4047-92f7-25b3f34985e2"
      unitRef="usd">2947000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE2LTctMS0xLTI2NTI0Nw_2b05c284-a1c0-4273-9aa7-03a8c907f227"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE2LTktMS0xLTI2NTI0Nw_d548777b-9318-495d-b857-3c8b01cf821e"
      unitRef="usd">2947000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE2LTExLTEtMS0yNjUyNDc_2d13665e-1cca-48a7-a787-512315c19310"
      unitRef="usd">148000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE2LTEzLTEtMS0yNjUyNDc_5f255b0a-36d7-4d92-ba67-760080799d2e"
      unitRef="usd">4000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE2LTE1LTEtMS0yNjUyNDc_fc7ba1e8-8720-43c2-b54c-4e6e79251975"
      unitRef="usd">3091000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE3LTUtMS0xLTI2NTI0Nw_798bce54-2193-4458-8a2b-bff96f015133"
      unitRef="usd">9093000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE3LTctMS0xLTI2NTI0Nw_d988415e-b096-4c7c-92e3-3ec6584bc1a8"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE3LTktMS0xLTI2NTI0Nw_7ece3790-2636-4f5c-891b-935ead696972"
      unitRef="usd">9093000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE3LTExLTEtMS0yNjUyNDc_f54619b4-eec3-4937-b6a1-53fdeb41e4a7"
      unitRef="usd">682000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE3LTEzLTEtMS0yNjUyNDc_cee48b75-20b9-4644-8dcb-1e8ca4724331"
      unitRef="usd">40000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE3LTE1LTEtMS0yNjUyNDc_b0f27e62-3592-42fc-a721-37b5d915cc48"
      unitRef="usd">9735000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE4LTUtMS0xLTI2NTI0Nw_d34679e4-ef78-4ce2-ba5f-4f2ef7923012"
      unitRef="usd">2821000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE4LTctMS0xLTI2NTI0Nw_1dc52659-86f1-4852-9258-f4e75b3efb34"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE4LTktMS0xLTI2NTI0Nw_b3d22720-07c8-4cff-b6c0-6990ae0d2c54"
      unitRef="usd">2821000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE4LTExLTEtMS0yNjUyNDc_b2b5ba56-19fb-4d5d-8895-85a97b1af2dc"
      unitRef="usd">196000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE4LTEzLTEtMS0yNjUyNDc_27121ef0-9ed3-4257-85da-e21e78d5f75f"
      unitRef="usd">24000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE4LTE1LTEtMS0yNjUyNDc_4cc3fbaa-adc7-44fd-81c8-49d19e32747f"
      unitRef="usd">2993000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE5LTUtMS0xLTI2NTI0Nw_ef9158e9-2bb8-4d63-8bd2-97d921d4796b"
      unitRef="usd">870000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE5LTctMS0xLTI2NTI0Nw_29c5c1ff-bdf3-4292-87a8-5abe43c24dda"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE5LTktMS0xLTI2NTI0Nw_5dd75553-a394-4829-96cd-8f21aa11b0b2"
      unitRef="usd">870000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE5LTExLTEtMS0yNjUyNDc_3b111e22-be8a-4277-bf45-9758e21a03ea"
      unitRef="usd">15000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE5LTEzLTEtMS0yNjUyNDc_51160173-b9c7-4512-b3dd-60fb091867ec"
      unitRef="usd">10000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzE5LTE1LTEtMS0yNjUyNDc_b072c729-1fcf-4d2b-a198-4eeb1c7b3c1f"
      unitRef="usd">875000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIwLTUtMS0xLTI2NTI0Nw_e479ffe2-4022-4b91-a761-b9e85e27a95e"
      unitRef="usd">1278000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIwLTctMS0xLTI2NTI0Nw_a26f169a-d0fe-4d88-aaaa-f7bb40ffa9e0"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIwLTktMS0xLTI2NTI0Nw_e7075483-98a6-4a39-82d2-d1e902eeb478"
      unitRef="usd">1278000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIwLTExLTEtMS0yNjUyNDc_0be6f4de-ad68-49c8-8c90-f7d876670245"
      unitRef="usd">44000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIwLTEzLTEtMS0yNjUyNDc_602534e0-fe78-4ada-b49a-5d54f77997e0"
      unitRef="usd">12000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIwLTE1LTEtMS0yNjUyNDc_70ee88e9-3441-419a-b89a-7aacae3a8361"
      unitRef="usd">1310000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIxLTUtMS0xLTI2NTI0Nw_0e5a62d3-2744-4579-886a-82c7182c018c"
      unitRef="usd">2791000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIxLTctMS0xLTI2NTI0Nw_2f7488a7-a5d1-4b0f-b9bb-5c037f055066"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIxLTktMS0xLTI2NTI0Nw_6840d8db-27ff-4d46-be20-55310d6cb1f6"
      unitRef="usd">2791000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIxLTExLTEtMS0yNjUyNDc_7d4fe187-66fd-4729-a536-842a8a4eafe5"
      unitRef="usd">14000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIxLTEzLTEtMS0yNjUyNDc_c3975c86-fa16-4060-8ea9-d649ff1d29ef"
      unitRef="usd">13000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIxLTE1LTEtMS0yNjUyNDc_8aea80ba-4d2b-406b-bc87-eac9271add87"
      unitRef="usd">2792000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIyLTUtMS0xLTI2NTI0Nw_d7572a45-827f-438b-876b-ed4b970cd1c0"
      unitRef="usd">25000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIyLTctMS0xLTI2NTI0Nw_e1c8ae01-2d8d-423a-8c59-da5428f4c8a0"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIyLTktMS0xLTI2NTI0Nw_7d97877b-151c-416c-b9fe-45c5fbd3f5db"
      unitRef="usd">25000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIyLTExLTEtMS0yNjUyNDc_8f54915d-0c6a-42e4-84cc-d6cda6aeff19"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIyLTEzLTEtMS0yNjUyNDc_7bd1f3dc-2b0c-4f0e-a256-b00a4a9cff70"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIyLTE1LTEtMS0yNjUyNDc_ad4a40ca-1cad-43c4-9041-18ad4f107da7"
      unitRef="usd">28000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIzLTUtMS0xLTI2NTI0Nw_1201481c-de30-4e6c-9f19-4b4ff76425d2"
      unitRef="usd">22174000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIzLTctMS0xLTI2NTI0Nw_a6b2a810-d095-460a-b64e-eb433b23fc22"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIzLTktMS0xLTI2NTI0Nw_1b57985c-dcd0-4c9b-af02-b52ac462e722"
      unitRef="usd">22174000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIzLTExLTEtMS0yNjUyNDc_5e41f2e8-2964-46d3-8e9a-1e4f6d01fff3"
      unitRef="usd">1172000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIzLTEzLTEtMS0yNjUyNDc_530f1c7e-b357-46a2-b7d0-9c2d1d586f20"
      unitRef="usd">106000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToyMDNjODQ5NGRjODY0MDExOGFhYmZmODhkMTQ1Y2VlMi90YWJsZXJhbmdlOjIwM2M4NDk0ZGM4NjQwMTE4YWFiZmY4OGQxNDVjZWUyXzIzLTE1LTEtMS0yNjUyNDc_e6e863e8-7339-4a16-8ee7-15d05c27116c"
      unitRef="usd">23240000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzEyNTY_b12b61a0-d3ea-458e-9647-99df37c29abd"
      unitRef="usd">609000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzEyOTQ_393560a8-9d6f-497a-98e2-aa5d668a1c0c"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzEzMzY_d7e6fd5b-83c3-4b82-be38-1ae228add35a"
      unitRef="usd">59000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9911a4d843eb4cb1a00b136035f50e03_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzEzODg_63ce6a28-80ad-4485-bb3d-603bab9719f7"
      unitRef="usd">864000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9911a4d843eb4cb1a00b136035f50e03_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzE0MjY_0b4ce8bb-18b6-4f94-b1ff-2a17c695e1e7"
      unitRef="usd">94000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9911a4d843eb4cb1a00b136035f50e03_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzE0Njg_def378da-c6fb-49d7-afaf-14c7b88036e6"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzcwMzc_0ec6e7b8-d957-4874-8a51-9fa4806f299f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost and fair value of debt securities at December&#160;31, 2022 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzItMS0xLTEtMjY1MjQ3_8d9ade07-845f-4bc2-bb89-655f829ebee1"
      unitRef="usd">1315000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzItMy0xLTEtMjY1MjQ3_ddeb3208-a2ec-46de-bc3e-30f2fe8a6195"
      unitRef="usd">1305000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzMtMS0xLTEtMjY1MjQ3_f576dd3b-f3a9-47b7-b335-717a01af1736"
      unitRef="usd">6596000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzMtMy0xLTEtMjY1MjQ3_327e6ba5-06d1-46fb-98fd-16e6449b5f98"
      unitRef="usd">6206000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzQtMS0xLTEtMjY1MjQ3_ab03dc0e-860a-4cf6-9002-06ea6c30e04e"
      unitRef="usd">4899000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzQtMy0xLTEtMjY1MjQ3_a572df44-e5d5-4216-a7e1-4776c99f6fde"
      unitRef="usd">4401000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzUtMS0xLTEtMjY1MjQ3_ee75900f-f61f-4816-bf29-3665cb8e3d1c"
      unitRef="usd">4296000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzUtMy0xLTEtMjY1MjQ3_cd742b0b-ab1d-4dac-a1bc-9e299aa3294a"
      unitRef="usd">3783000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
      contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzYtMS0xLTEtMjY1MjQ3_56f6921a-4703-411e-bbdd-31327e4f98ea"
      unitRef="usd">845000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzYtMy0xLTEtMjY1MjQ3_1e23d77e-f1d0-4a38-a0af-c740b6526202"
      unitRef="usd">757000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
      contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzctMS0xLTEtMjY1MjQ3_91a00c5d-62fa-4d3b-b3de-b4dc1a05670b"
      unitRef="usd">1172000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzctMy0xLTEtMjY1MjQ3_0086d3c3-f23b-4915-af99-0ffd03fa695d"
      unitRef="usd">1018000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
      contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzgtMS0xLTEtMjY1MjQ3_c7593d40-72ad-4dfc-91ba-c6b8d956c798"
      unitRef="usd">2940000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzgtMy0xLTEtMjY1MjQ3_8d6767ce-fe27-4f1b-87b4-0bcce07cb03f"
      unitRef="usd">2810000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzktMS0xLTEtMjY1MjQ3_737f2ef2-062f-4152-b110-988b787754f0"
      unitRef="usd">22063000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZToxOWJkODEzNTFhMmI0NWNiOTk2OThhMGQ4ODUxZGMwNS90YWJsZXJhbmdlOjE5YmQ4MTM1MWEyYjQ1Y2I5OTY5OGEwZDg4NTFkYzA1XzktMy0xLTEtMjY1MjQ3_57efb52a-11b2-4180-a834-0af43a3621c0"
      unitRef="usd">20280000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities
      contextRef="i1bf6dd211b7f4e99ba7262cf0f3f0c19_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzI0NTk_ed6564e6-1d2f-4633-88e7-d333bb9b1e7d">P5Y8M12D</cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities>
    <cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities
      contextRef="iebf5538c68ad492782f86e19a1c4c591_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzI4MDc_c5279436-de0c-4dbf-a34e-0f0a3f8cf621">P5Y7M6D</cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities>
    <cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities
      contextRef="i05cb6c50cba342aaadae4afcbafc5086_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzMyMzA_e67c98e0-df6e-4ff5-a1d4-dad614e769cd">P1Y</cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities>
    <us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzcwNTM_b0577323-a2f7-4a25-bacd-2bf63723f606">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summarized below are the debt securities the Company held at December&#160;31, 2022 and 2021 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Greater than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except number of securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;&#160;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;&#160;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;&#160;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturity dates for debt securities in an unrealized capital loss position at December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting experience-&lt;br/&gt;rated products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting remaining&lt;br/&gt;products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzQtMS0xLTEtMjY1MjQ3_5a059a63-4b40-4ddd-8a5e-98c9db0e8de9"
      unitRef="security">519</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzQtMy0xLTEtMjY1MjQ3_eb81c4b7-94e3-4599-8d4e-d6cf3b0c1d1a"
      unitRef="usd">1620000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzQtNS0xLTEtMjY1MjQ3_aef3a6b0-3f39-40ed-8271-50cc62cdae5b"
      unitRef="usd">164000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzQtNy0xLTEtMjY1MjQ3_d15fe4f7-bb99-449c-a1f5-22129512afc8"
      unitRef="security">35</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzQtOS0xLTEtMjY1MjQ3_723cac97-cc3a-4d34-9c80-791e2aad6007"
      unitRef="usd">191000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzQtMTEtMS0xLTI2NTI0Nw_83c0faa5-eaa3-43b1-85c3-7af04f85e8ca"
      unitRef="usd">18000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzQtMTMtMS0xLTI2NTI0Nw_5a8f22f1-64d5-4ed4-8d3c-82cf26dd8f15"
      unitRef="security">554</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzQtMTUtMS0xLTI2NTI0Nw_2b396535-2629-4488-84fa-5b019fdc4a36"
      unitRef="usd">1811000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i926187f27f9143b08bebbbf8c1146300_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzQtMTctMS0xLTI2NTI0Nw_c847afee-7e73-4dea-bdce-8a7b81b51bf1"
      unitRef="usd">182000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzUtMS0xLTEtMjY1MjQ3_49b7c8c9-2a94-4db6-85e8-7d677f60b869"
      unitRef="security">859</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzUtMy0xLTEtMjY1MjQ3_684530f1-c383-43e9-853d-4b426c967512"
      unitRef="usd">1370000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzUtNS0xLTEtMjY1MjQ3_3abc5929-d40f-4675-87a6-8c9229849b29"
      unitRef="usd">95000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzUtNy0xLTEtMjY1MjQ3_f63b95a8-bd42-49e4-b9ba-8a3f2a276a92"
      unitRef="security">196</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzUtOS0xLTEtMjY1MjQ3_3c02a0eb-e382-4d52-bc0d-c7024e199483"
      unitRef="usd">322000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzUtMTEtMS0xLTI2NTI0Nw_afab4636-a337-4508-925a-c991c8da40d9"
      unitRef="usd">34000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzUtMTMtMS0xLTI2NTI0Nw_26d70e01-40ba-41d2-ac09-73efc366c5d9"
      unitRef="security">1055</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzUtMTUtMS0xLTI2NTI0Nw_1031ed90-d735-48ab-a2e6-0217b94c02e9"
      unitRef="usd">1692000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i7a316de9aa51441b93f71dad0316cb0a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzUtMTctMS0xLTI2NTI0Nw_0e6060b4-0be2-4a64-a4af-8444209a8ff7"
      unitRef="usd">129000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzYtMS0xLTEtMjY1MjQ3_b86be2f6-bf32-49cc-8e06-d12c5fe6a9ff"
      unitRef="security">5193</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzYtMy0xLTEtMjY1MjQ3_8ad6ee05-1221-4f7e-a587-8144cea131e0"
      unitRef="usd">6537000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzYtNS0xLTEtMjY1MjQ3_da13cb29-8342-4244-b3a3-6c50856d418d"
      unitRef="usd">622000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzYtNy0xLTEtMjY1MjQ3_1f8fa2be-92e6-480d-8a69-859715282242"
      unitRef="security">1479</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzYtOS0xLTEtMjY1MjQ3_ad7b3e6d-66ec-4a41-868f-fb5fab0da80f"
      unitRef="usd">1822000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzYtMTEtMS0xLTI2NTI0Nw_cbf09517-b482-472c-917f-e0148576c63f"
      unitRef="usd">281000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzYtMTMtMS0xLTI2NTI0Nw_38493913-e9b5-4150-b7b3-c5ed9a999b5c"
      unitRef="security">6672</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzYtMTUtMS0xLTI2NTI0Nw_466ecd13-0c98-4803-aa23-97dd2f94f3b9"
      unitRef="usd">8359000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i7fa9106e06f445a2979d054b78f571cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzYtMTctMS0xLTI2NTI0Nw_ef7573e9-d7d0-40cb-b570-e8981076237e"
      unitRef="usd">903000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzctMS0xLTEtMjY1MjQ3_54d54a7b-80f5-4449-bde6-d6e26d055e61"
      unitRef="security">1168</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzctMy0xLTEtMjY1MjQ3_a0e5cac0-4480-4f41-9898-adde1d410176"
      unitRef="usd">1715000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzctNS0xLTEtMjY1MjQ3_d8671ef4-0af9-46ca-a08e-4ec5f2fe7bba"
      unitRef="usd">147000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzctNy0xLTEtMjY1MjQ3_7960c9f5-0401-4655-b6c7-7e1ebc838b78"
      unitRef="security">403</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzctOS0xLTEtMjY1MjQ3_73bdc579-1acb-4cd7-af84-4886de36b70a"
      unitRef="usd">592000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzctMTEtMS0xLTI2NTI0Nw_d7582fe2-7521-4a95-8a0b-9e97c955e5cd"
      unitRef="usd">97000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzctMTMtMS0xLTI2NTI0Nw_7e4c41c1-4f99-4c74-851a-b6f69aded1a0"
      unitRef="security">1571</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzctMTUtMS0xLTI2NTI0Nw_7dc8ebd1-6d49-4c15-ab22-bf81be0c51b1"
      unitRef="usd">2307000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i3c204b317c7d44a9be3b5ea3f10fe0b4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzctMTctMS0xLTI2NTI0Nw_a53db374-39f5-43f4-ac7d-29e8a6bae67d"
      unitRef="usd">244000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzgtMS0xLTEtMjY1MjQ3_09539e92-0185-4c6e-9745-5654ab547cca"
      unitRef="security">452</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzgtMy0xLTEtMjY1MjQ3_9e41de07-05e5-4801-93b3-3bc6597d1524"
      unitRef="usd">464000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzgtNS0xLTEtMjY1MjQ3_bcfdf651-f795-4885-9c02-615032575fef"
      unitRef="usd">39000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzgtNy0xLTEtMjY1MjQ3_b8dfe4c9-fe75-4deb-b297-238998935df8"
      unitRef="security">91</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzgtOS0xLTEtMjY1MjQ3_f98cd209-dbb0-4dd9-98c4-c829e071c422"
      unitRef="usd">257000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzgtMTEtMS0xLTI2NTI0Nw_2a051d38-a6ae-4736-bb53-c0f8adf6ebfa"
      unitRef="usd">50000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzgtMTMtMS0xLTI2NTI0Nw_755b13ab-4631-46cf-8e22-cc626016c4f5"
      unitRef="security">543</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzgtMTUtMS0xLTI2NTI0Nw_4de3703b-d602-4f3b-b9e5-dec594ad5049"
      unitRef="usd">721000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzgtMTctMS0xLTI2NTI0Nw_37395b20-af25-4152-bb9a-598fbac40e63"
      unitRef="usd">89000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzktMS0xLTEtMjY1MjQ3_c297c182-29fb-4eb9-8621-1cf5da30b173"
      unitRef="security">288</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzktMy0xLTEtMjY1MjQ3_b18796c4-2be2-49e1-95f1-aa01b7585fe5"
      unitRef="usd">611000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzktNS0xLTEtMjY1MjQ3_fc8cf50e-f99a-494e-b0e2-8c5ca7e9ebd8"
      unitRef="usd">69000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzktNy0xLTEtMjY1MjQ3_2e5e79db-6413-4b31-92a9-cf61edfefa91"
      unitRef="security">187</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzktOS0xLTEtMjY1MjQ3_13b502a9-c7e4-4062-8bd4-a0fd82ea7cfa"
      unitRef="usd">381000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzktMTEtMS0xLTI2NTI0Nw_cd7da925-23ca-409f-90e3-992fa284a297"
      unitRef="usd">86000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzktMTMtMS0xLTI2NTI0Nw_74c35bfc-f10c-4239-9fe8-d48fc780d21c"
      unitRef="security">475</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzktMTUtMS0xLTI2NTI0Nw_87a9d74e-8568-4829-8845-7e91f40aea73"
      unitRef="usd">992000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzktMTctMS0xLTI2NTI0Nw_12306735-ab3a-4d94-b47a-b59d875dd00e"
      unitRef="usd">155000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEwLTEtMS0xLTI2NTI0Nw_68550e99-f13d-45c9-a0a9-681319c66095"
      unitRef="security">1008</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEwLTMtMS0xLTI2NTI0Nw_abac47cd-7978-4525-b99d-522b4c06675b"
      unitRef="usd">1893000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEwLTUtMS0xLTI2NTI0Nw_f2aae01c-7f25-4af7-aa55-c8dd9f675802"
      unitRef="usd">88000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEwLTctMS0xLTI2NTI0Nw_4a744e8e-9f04-4c01-b075-b27af41e198a"
      unitRef="security">391</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEwLTktMS0xLTI2NTI0Nw_c4ec2375-b65b-49b2-8bf1-51ee2e8e698b"
      unitRef="usd">694000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEwLTExLTEtMS0yNjUyNDc_ca3b1295-b0ad-477c-8cbc-2d03551a62e3"
      unitRef="usd">48000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEwLTEzLTEtMS0yNjUyNDc_d44a8c37-517d-4350-acc3-78d23e5d1a52"
      unitRef="security">1399</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEwLTE1LTEtMS0yNjUyNDc_aa0666ba-86cf-4be5-b931-47e385a93f9e"
      unitRef="usd">2587000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEwLTE3LTEtMS0yNjUyNDc_2e475cdb-57e1-45c3-b0c4-ead17fd37aa0"
      unitRef="usd">136000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzExLTEtMS0xLTI2NTI0Nw_569fd3a3-fbff-4be2-aeca-656a76e66a9c"
      unitRef="security">13</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzExLTMtMS0xLTI2NTI0Nw_c04c4f9e-571c-43e8-875c-95fba319674c"
      unitRef="usd">18000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzExLTUtMS0xLTI2NTI0Nw_1cd2198f-145a-4b4b-91c7-c82db870e141"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzExLTctMS0xLTI2NTI0Nw_95f77de7-23ed-481a-a2bc-49404c03d9bb"
      unitRef="security">2</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzExLTktMS0xLTI2NTI0Nw_147c0482-93c5-4ebc-b1b1-31a01828f3bc"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzExLTExLTEtMS0yNjUyNDc_ef41e528-aeed-4c81-8d02-954c2a8ca65b"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzExLTEzLTEtMS0yNjUyNDc_b5ce8669-25e2-4f5f-82ac-bf04337fe4ae"
      unitRef="security">15</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzExLTE1LTEtMS0yNjUyNDc_46d8eb99-51f9-451e-bc1a-273bd1b92d26"
      unitRef="usd">23000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ibc5a0a8208f2461ab82ca16442cc424c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzExLTE3LTEtMS0yNjUyNDc_049d749c-5334-47ec-a88c-ceec28408a18"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEyLTEtMS0xLTI2NTI0Nw_4b13cc14-a6c7-449f-8ed3-cd4d437050e3"
      unitRef="security">9500</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEyLTMtMS0xLTI2NTI0Nw_2559339d-62d4-46cb-9931-198b4cc14c92"
      unitRef="usd">14228000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEyLTUtMS0xLTI2NTI0Nw_2b5d478e-eb82-40df-aafc-a2e290def6a5"
      unitRef="usd">1226000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEyLTctMS0xLTI2NTI0Nw_aa7c549d-764c-41c1-9401-c25fc56a1a77"
      unitRef="security">2784</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEyLTktMS0xLTI2NTI0Nw_3ccf57ca-5470-412b-8ac4-f543d4f92618"
      unitRef="usd">4264000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEyLTExLTEtMS0yNjUyNDc_3e241be9-1405-4c7b-9c7a-1760e816fe20"
      unitRef="usd">614000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEyLTEzLTEtMS0yNjUyNDc_34493b9e-52e9-4961-abd4-aa98ebb6b9f0"
      unitRef="security">12284</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEyLTE1LTEtMS0yNjUyNDc_5aec98c0-29df-4e53-b681-c4ccb31f5a8f"
      unitRef="usd">18492000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzEyLTE3LTEtMS0yNjUyNDc_2efda62e-776e-4a03-bcae-4439aa0b8742"
      unitRef="usd">1840000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE2LTEtMS0xLTI2NTI0Nw_7b7a6d48-481d-4160-93c4-03673cdbd1b5"
      unitRef="security">43</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE2LTMtMS0xLTI2NTI0Nw_c93108a3-2b0e-4968-843a-2a8d12be0e7a"
      unitRef="usd">242000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE2LTUtMS0xLTI2NTI0Nw_2cb48a9b-f232-4ede-bcc6-d344ef6a04d7"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE2LTctMS0xLTI2NTI0Nw_fc014414-8ba2-49cf-a76e-8f1b1e49168f"
      unitRef="security">10</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE2LTktMS0xLTI2NTI0Nw_fd3130a7-2c12-4924-8975-dc8c9f551f7e"
      unitRef="usd">40000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE2LTExLTEtMS0yNjUyNDc_1d72c8bf-ed65-48b9-b20c-6909ddd8db21"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE2LTEzLTEtMS0yNjUyNDc_87460276-af81-4211-9e7e-147c26c977b8"
      unitRef="security">53</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE2LTE1LTEtMS0yNjUyNDc_09f4f581-9a85-4679-91a3-4024ae200ac4"
      unitRef="usd">282000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i0b1a48334546440e95fe6e66cc4322ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE2LTE3LTEtMS0yNjUyNDc_20fdfebb-40be-42ea-bdb7-8ba95d5623fa"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE3LTEtMS0xLTI2NTI0Nw_9970c00d-e048-4b2a-91e5-82e343ced011"
      unitRef="security">233</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE3LTMtMS0xLTI2NTI0Nw_b9dac8b5-9976-4c2b-b650-129e0161f13a"
      unitRef="usd">428000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE3LTUtMS0xLTI2NTI0Nw_c9046bdd-2a57-4cfd-b83c-630d892add30"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE3LTctMS0xLTI2NTI0Nw_ce17c793-720d-4ee4-8990-c087bf216438"
      unitRef="security">13</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE3LTktMS0xLTI2NTI0Nw_d418de7b-b915-4bfa-87cf-3e098b903e8d"
      unitRef="usd">33000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE3LTExLTEtMS0yNjUyNDc_5d6889c1-16ea-440f-b5eb-c1d5a3ef99aa"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE3LTEzLTEtMS0yNjUyNDc_79ba5246-de1f-4335-8672-3be66a3381e0"
      unitRef="security">246</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE3LTE1LTEtMS0yNjUyNDc_a65c4e6a-69c0-4e06-af69-88e38453af50"
      unitRef="usd">461000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ie13308fa2c9f4cb696615b34b5cce4ee_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE3LTE3LTEtMS0yNjUyNDc_5355b618-fd93-48b2-85ae-02b147dff3b7"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE4LTEtMS0xLTI2NTI0Nw_5d1dbb05-49d8-4ae0-9f2e-a98d6124308c"
      unitRef="security">1610</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE4LTMtMS0xLTI2NTI0Nw_511fa69a-f6d8-4814-849a-84733b958d93"
      unitRef="usd">2296000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE4LTUtMS0xLTI2NTI0Nw_8a0243c2-de69-43c2-b308-68ff03f2fd6a"
      unitRef="usd">31000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE4LTctMS0xLTI2NTI0Nw_c7bb07af-fd34-492d-8d66-f9d63f9e6de7"
      unitRef="security">165</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE4LTktMS0xLTI2NTI0Nw_4a6d8422-4c35-4dd1-877a-c0b7f8ef93c8"
      unitRef="usd">238000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE4LTExLTEtMS0yNjUyNDc_0b3e048a-4cd2-4671-bc7c-7fdb73b006c8"
      unitRef="usd">9000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE4LTEzLTEtMS0yNjUyNDc_9e26209b-a332-4f2c-b201-46b6bacc3f3f"
      unitRef="security">1775</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE4LTE1LTEtMS0yNjUyNDc_2e4aea97-1c72-4eeb-b879-930c39bcd551"
      unitRef="usd">2534000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i43efab69f7304dd1844a5ce8ac828ff2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE4LTE3LTEtMS0yNjUyNDc_3654efc2-cdf8-44f1-8897-cb5918b3ae3b"
      unitRef="usd">40000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE5LTEtMS0xLTI2NTI0Nw_8904bada-8809-488e-b344-d36d2eedb8d8"
      unitRef="security">449</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE5LTMtMS0xLTI2NTI0Nw_f1c2d4d6-39d4-4d5b-b982-f8f3ac4fcc95"
      unitRef="usd">747000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE5LTUtMS0xLTI2NTI0Nw_8a181c00-6b58-4b53-82e5-8f9190f44ab5"
      unitRef="usd">20000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE5LTctMS0xLTI2NTI0Nw_d28060e9-00a6-45f2-add9-3cb153e55cd5"
      unitRef="security">57</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE5LTktMS0xLTI2NTI0Nw_6772390a-5220-4056-9a80-f56fd0c0a369"
      unitRef="usd">91000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE5LTExLTEtMS0yNjUyNDc_e1ec4698-8322-41ad-b5b2-3ae26ac96ccc"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE5LTEzLTEtMS0yNjUyNDc_531b6a69-0833-4d81-9076-fb1c77c0b655"
      unitRef="security">506</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE5LTE1LTEtMS0yNjUyNDc_95b2d3a7-d4b6-45c0-91b6-986a33dc4363"
      unitRef="usd">838000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i63febf0a959b415a87f69f63c46b614d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzE5LTE3LTEtMS0yNjUyNDc_57bc6a67-f99a-427f-8fce-3f8618ef0e02"
      unitRef="usd">24000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIwLTEtMS0xLTI2NTI0Nw_3c66f1b8-7188-4804-b946-8b4fdae1661a"
      unitRef="security">165</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIwLTMtMS0xLTI2NTI0Nw_1115b336-db04-46ae-919b-fd55896f922f"
      unitRef="usd">593000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIwLTUtMS0xLTI2NTI0Nw_b8877d56-bc66-4f66-af12-33357cd68d9f"
      unitRef="usd">9000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIwLTctMS0xLTI2NTI0Nw_fc878e73-a30c-4f23-9efa-8ae5ba2519cf"
      unitRef="security">10</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIwLTktMS0xLTI2NTI0Nw_35be3e6a-3493-4e96-99a9-f3673bcd8af2"
      unitRef="usd">36000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIwLTExLTEtMS0yNjUyNDc_10ffd0c3-28a6-4478-84ad-7fc2191f3467"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIwLTEzLTEtMS0yNjUyNDc_6bee147f-f58e-4c86-8e16-6fba37ee9ec4"
      unitRef="security">175</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIwLTE1LTEtMS0yNjUyNDc_a442ace6-f2e4-4df6-a577-7e2bed532360"
      unitRef="usd">629000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i7bb5f4ee66f04a6a9c6a5f82acebfd00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIwLTE3LTEtMS0yNjUyNDc_2abfc379-0f64-4ded-9cc2-e2102e8a7f44"
      unitRef="usd">10000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIxLTEtMS0xLTI2NTI0Nw_0bee9199-8b92-4c22-915d-7fb40eb215e8"
      unitRef="security">188</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIxLTMtMS0xLTI2NTI0Nw_dda33f87-3611-45e5-bc03-09ff2f414810"
      unitRef="usd">462000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIxLTUtMS0xLTI2NTI0Nw_6ab5fa76-b17e-4a6c-ae33-3192c2f275ad"
      unitRef="usd">7000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIxLTctMS0xLTI2NTI0Nw_7a7a5023-475f-4fe2-b24e-b7b1c8baa818"
      unitRef="security">35</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIxLTktMS0xLTI2NTI0Nw_ab177e8e-e67f-4cf7-949f-ed9e70c30d65"
      unitRef="usd">112000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIxLTExLTEtMS0yNjUyNDc_22162988-8117-4555-b81e-f48196bead17"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIxLTEzLTEtMS0yNjUyNDc_5f0c87c0-167c-494f-abb2-6439a6076cd5"
      unitRef="security">223</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIxLTE1LTEtMS0yNjUyNDc_9a81cc0a-0db7-4fa2-937b-8e1cfabf6bfa"
      unitRef="usd">574000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i3fe88c16075341069af91ac0c4d756c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIxLTE3LTEtMS0yNjUyNDc_00acf3d9-88cf-4fb8-90c5-93532d1c9004"
      unitRef="usd">12000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIyLTEtMS0xLTI2NTI0Nw_6463c850-5680-4006-98b5-4f7a87f1084a"
      unitRef="security">1011</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIyLTMtMS0xLTI2NTI0Nw_469cd7ee-0048-435c-bcb9-467a58f41f05"
      unitRef="usd">2030000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIyLTUtMS0xLTI2NTI0Nw_50b23f85-ba8e-45e5-9f9f-f58b72c07ac4"
      unitRef="usd">12000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIyLTctMS0xLTI2NTI0Nw_417eb605-5e69-456b-9b66-f02f676a1278"
      unitRef="security">26</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIyLTktMS0xLTI2NTI0Nw_5b57acd6-637d-4d9f-8773-a39473ccd406"
      unitRef="usd">31000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIyLTExLTEtMS0yNjUyNDc_1a439bd2-d4ab-4b9c-9bcb-5a965c9096a1"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIyLTEzLTEtMS0yNjUyNDc_2e2002af-5ef8-40d9-b7ea-773a0754872f"
      unitRef="security">1037</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIyLTE1LTEtMS0yNjUyNDc_49ce4db4-b2e2-435d-b667-1e01d46c57bc"
      unitRef="usd">2061000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="iad025fe771994e5c826f608d61d0c5f4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIyLTE3LTEtMS0yNjUyNDc_d0aeeb9d-335d-4c28-9d9b-785c2e6c507f"
      unitRef="usd">13000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIzLTEtMS0xLTI2NTI0Nw_3b814871-5505-47ed-8544-dc1f27609f66"
      unitRef="security">1</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIzLTMtMS0xLTI2NTI0Nw_46287bcb-f874-45e9-a63c-3e782a854ff4"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIzLTUtMS0xLTI2NTI0Nw_e83db131-376d-427d-8aa1-ade64a5ce6b5"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIzLTctMS0xLTI2NTI0Nw_3a7c346e-c17e-43a9-a7d2-29919cc181a6"
      unitRef="security">1</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIzLTktMS0xLTI2NTI0Nw_74b6dd92-eb67-4663-90d8-f6d32efaf1dc"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIzLTExLTEtMS0yNjUyNDc_73356912-66aa-4ddd-af82-9e398b392951"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIzLTEzLTEtMS0yNjUyNDc_c55ec8b0-9b6f-47c3-b273-cb7558f8066c"
      unitRef="security">2</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIzLTE1LTEtMS0yNjUyNDc_803673bf-a396-42d5-a8d5-38c2049b920d"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i5d60b17185a04c99a6f240935bbd2fa8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzIzLTE3LTEtMS0yNjUyNDc_cee75d45-33dd-41ab-aa02-595bc6797278"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzI0LTEtMS0xLTI2NTI0Nw_0dbd9dfe-a0ed-4a31-9156-6201fd049407"
      unitRef="security">3700</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzI0LTMtMS0xLTI2NTI0Nw_74ebd29b-116a-49ad-b536-86b867f4522f"
      unitRef="usd">6800000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzI0LTUtMS0xLTI2NTI0Nw_ced372e8-a362-4b06-8d99-f250638d3fb7"
      unitRef="usd">84000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzI0LTctMS0xLTI2NTI0Nw_1f834eaa-3ea6-40a8-a551-f2703e28dafd"
      unitRef="security">317</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzI0LTktMS0xLTI2NTI0Nw_05ae710f-46e3-4785-afb6-0cc068b04bd0"
      unitRef="usd">584000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzI0LTExLTEtMS0yNjUyNDc_3c2962ae-cd1e-4546-a7ea-d39d04c4bab6"
      unitRef="usd">22000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzI0LTEzLTEtMS0yNjUyNDc_21059c7b-6e44-42d8-a382-1d7283438e19"
      unitRef="security">4017</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzI0LTE1LTEtMS0yNjUyNDc_f54b9557-7636-4f29-b6d4-c2e4f765aa1e"
      unitRef="usd">7384000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphYTY3YzgzMzQwODA0NmMxYTM4ZTM4ZThiZThlMTc2YS90YWJsZXJhbmdlOmFhNjdjODMzNDA4MDQ2YzFhMzhlMzhlOGJlOGUxNzZhXzI0LTE3LTEtMS0yNjUyNDc_b196d94b-ef13-45c9-b293-e2a123b05ba6"
      unitRef="usd">106000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzMtMS0xLTEtMjY1MjQ3_94b97669-6fe3-4b2e-83d0-984a58b682ef"
      unitRef="usd">33000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzMtMy0xLTEtMjY1MjQ3_5cc7ace6-5b4d-40fa-b136-b7d833b67ae0"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="i5cab4b0903e747b4ac60612c8fea7746_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzMtNS0xLTEtMjY1MjQ3_bf69b3d4-73e9-47db-907b-b9144fae03b2"
      unitRef="usd">1161000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="i5cab4b0903e747b4ac60612c8fea7746_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzMtNy0xLTEtMjY1MjQ3_1c7dcac6-78c0-46a7-a978-04fa55d1b780"
      unitRef="usd">14000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzMtOS0xLTEtMjY1MjQ3_0ba39e93-53bc-4a4f-a7d1-dd41318a9086"
      unitRef="usd">1194000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzMtMTEtMS0xLTI2NTI0Nw_974e9120-2a66-48cc-bb3b-5f076784eebc"
      unitRef="usd">14000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzQtMS0xLTEtMjY1MjQ3_57c39029-09ff-4b6e-b348-e5ee6226256e"
      unitRef="usd">126000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzQtMy0xLTEtMjY1MjQ3_9bb1494c-b659-492f-944e-97e6bb2e9ad7"
      unitRef="usd">5000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="i5cab4b0903e747b4ac60612c8fea7746_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzQtNS0xLTEtMjY1MjQ3_adfbb3ba-080f-41a1-b66d-c5c603afab73"
      unitRef="usd">5583000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="i5cab4b0903e747b4ac60612c8fea7746_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzQtNy0xLTEtMjY1MjQ3_10c6f4fb-e575-494a-92f6-dbf9791d8bf3"
      unitRef="usd">398000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzQtOS0xLTEtMjY1MjQ3_647f316c-2650-40a1-a8dd-4809387fb1f2"
      unitRef="usd">5709000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzQtMTEtMS0xLTI2NTI0Nw_1aa7caa0-e66d-460c-bfac-22f530e69d02"
      unitRef="usd">403000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzUtMS0xLTEtMjY1MjQ3_66489469-cbb4-4565-a263-a70626e18bf2"
      unitRef="usd">142000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzUtMy0xLTEtMjY1MjQ3_446eddd8-54a8-401d-b27c-b3d24f6af7b2"
      unitRef="usd">17000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="i5cab4b0903e747b4ac60612c8fea7746_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzUtNS0xLTEtMjY1MjQ3_96567f1f-0742-4540-85ac-8017f0b1361e"
      unitRef="usd">3787000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="i5cab4b0903e747b4ac60612c8fea7746_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzUtNy0xLTEtMjY1MjQ3_83509a45-0ff6-4e59-a4a2-e3f4fc38c72f"
      unitRef="usd">494000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzUtOS0xLTEtMjY1MjQ3_fcccb011-d0ff-449b-9764-57ad9811fff2"
      unitRef="usd">3929000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzUtMTEtMS0xLTI2NTI0Nw_ad6a9a54-cc82-459a-b874-1f7a70760d67"
      unitRef="usd">511000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzYtMS0xLTEtMjY1MjQ3_1c819f46-4682-487e-a191-d77a1cfdc5f2"
      unitRef="usd">207000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzYtMy0xLTEtMjY1MjQ3_870b1627-3feb-4d9d-b834-7f3501c9c218"
      unitRef="usd">31000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="i5cab4b0903e747b4ac60612c8fea7746_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzYtNS0xLTEtMjY1MjQ3_6724c7c4-783f-47a7-9fac-8ce2508d6892"
      unitRef="usd">3153000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="i5cab4b0903e747b4ac60612c8fea7746_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzYtNy0xLTEtMjY1MjQ3_307244d2-aef3-4b98-9c1d-1eb13d329e66"
      unitRef="usd">501000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzYtOS0xLTEtMjY1MjQ3_cd2339cc-8358-4603-9c63-8f5bace06b38"
      unitRef="usd">3360000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzYtMTEtMS0xLTI2NTI0Nw_799a0a1f-4de2-4562-ad03-86c97cac2794"
      unitRef="usd">532000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue
      contextRef="i21d50269b9b94eff85b08845bfd50cd8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzctMS0xLTEtMjY1MjQ3_0341dcbb-c08e-4d04-8b99-caf7655458c8"
      unitRef="usd">11000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss
      contextRef="i21d50269b9b94eff85b08845bfd50cd8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzctMy0xLTEtMjY1MjQ3_1ed2d2e8-757d-46ff-b9eb-ec7f489c85ff"
      unitRef="usd">1000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue
      contextRef="ib9de4d4f1b014ecb98d80d1d8fd9997c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzctNS0xLTEtMjY1MjQ3_b81d9e11-813b-457a-9d52-c8e678d25501"
      unitRef="usd">710000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss
      contextRef="ib9de4d4f1b014ecb98d80d1d8fd9997c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzctNy0xLTEtMjY1MjQ3_216bbe23-1de2-4e9b-9863-8c92f1d8328b"
      unitRef="usd">88000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue
      contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzctOS0xLTEtMjY1MjQ3_e5e08f5a-f0b6-482c-849e-162777c17d8c"
      unitRef="usd">721000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss
      contextRef="i9eb094c2aa9b4c3b8c5e58fbf5d3d768_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzctMTEtMS0xLTI2NTI0Nw_a8d29941-a651-4bc7-a0e1-a0b93093311a"
      unitRef="usd">89000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue
      contextRef="i9fdc07fa1fda46ea9a75488e14c8311e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzgtMS0xLTEtMjY1MjQ3_bf1a3548-f89b-48f4-a53a-3702d48ba6cc"
      unitRef="usd">32000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss
      contextRef="i9fdc07fa1fda46ea9a75488e14c8311e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzgtMy0xLTEtMjY1MjQ3_3007b8c0-01a3-4e92-b3f2-c5fed11cafa5"
      unitRef="usd">3000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue
      contextRef="i5826868b7599497aaadf079b91c1ec9c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzgtNS0xLTEtMjY1MjQ3_19c4cd00-6408-4e2d-aa1f-00d8c892b3ad"
      unitRef="usd">960000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss
      contextRef="i5826868b7599497aaadf079b91c1ec9c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzgtNy0xLTEtMjY1MjQ3_85f807ee-6fb2-41fc-8f6b-3e7e09924e37"
      unitRef="usd">152000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue
      contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzgtOS0xLTEtMjY1MjQ3_ade45282-857f-4b6f-8a54-54a4ed90bf7b"
      unitRef="usd">992000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss
      contextRef="icf0581ceb43240768d8b04fc7ebaaa00_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzgtMTEtMS0xLTI2NTI0Nw_9093b158-27ee-4aab-b7e8-9fa76b1a6778"
      unitRef="usd">155000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue
      contextRef="i73eeedf2a9af4ccdb7f524acfbd1291d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzktMS0xLTEtMjY1MjQ3_86498c48-d52a-4f30-9135-05b88e2a2e36"
      unitRef="usd">17000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss
      contextRef="i73eeedf2a9af4ccdb7f524acfbd1291d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzktMy0xLTEtMjY1MjQ3_2ab734e3-fa70-4998-8b76-08f6d251e1a7"
      unitRef="usd">2000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue
      contextRef="ibb16d569f25741039929fe7413c06b74_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzktNS0xLTEtMjY1MjQ3_4aff3726-4627-4b9f-aae0-2efecc15b5be"
      unitRef="usd">2570000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss
      contextRef="ibb16d569f25741039929fe7413c06b74_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzktNy0xLTEtMjY1MjQ3_12eee77e-cc9b-4300-8aaa-cf6c3216d8a4"
      unitRef="usd">134000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue
      contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzktOS0xLTEtMjY1MjQ3_226e3478-992e-4874-b7be-2b77274a173c"
      unitRef="usd">2587000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss
      contextRef="icb868e7bdeb94378b825d30de7838abc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzktMTEtMS0xLTI2NTI0Nw_e120d870-739f-4ddc-98c1-db6d85be07e2"
      unitRef="usd">136000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzEwLTEtMS0xLTI2NTI0Nw_5ce5626b-7089-406a-bfa5-57a5d96793be"
      unitRef="usd">568000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i858b216b74cc4844a1f8606b6c1545ea_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzEwLTMtMS0xLTI2NTI0Nw_76298b1e-f7d2-416b-8d8f-edc6e0434801"
      unitRef="usd">59000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i5cab4b0903e747b4ac60612c8fea7746_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzEwLTUtMS0xLTI2NTI0Nw_94cb0afc-1e76-4aca-8484-d28193492e4c"
      unitRef="usd">17924000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i5cab4b0903e747b4ac60612c8fea7746_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzEwLTctMS0xLTI2NTI0Nw_83810948-dd64-4aa2-b334-54a68bed3ecb"
      unitRef="usd">1781000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzEwLTktMS0xLTI2NTI0Nw_2a661800-b1dd-46b0-9299-04ff3584a2b9"
      unitRef="usd">18492000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTpkNDBhNmY2YzA1MDk0NmRjOTIxNmQzM2Q2ZGM5NDlmMy90YWJsZXJhbmdlOmQ0MGE2ZjZjMDUwOTQ2ZGM5MjE2ZDMzZDZkYzk0OWYzXzEwLTExLTEtMS0yNjUyNDc_1e1c5e35-ea27-42d5-8d9f-3f6bfe332154"
      unitRef="usd">1840000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <cvs:ActivityInMortgageLoanPortfolioTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzcwNDc_0b79a579-14d6-4bd0-bbfb-cba371f16b36">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s mortgage loans are collateralized by commercial real estate.&#160;During the years ended December 31, 2022 and 2021, the Company had the following activity in its mortgage loan portfolio:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans fully repaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans foreclosed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022 scheduled mortgage loan principal repayments were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:ActivityInMortgageLoanPortfolioTableTextBlock>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="ia4afa3728f7a4abe948e80bf8d977e54_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo4YWMyNDAwN2YzNTM0MDdiYjVmYWIxMjAzYmY4ZjkxYS90YWJsZXJhbmdlOjhhYzI0MDA3ZjM1MzQwN2JiNWZhYjEyMDNiZjhmOTFhXzEtMS0xLTEtMjY1MjQ3_5b9b8e37-5985-42cd-9fe6-6deea8ac8d92"
      unitRef="usd">356000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="if04d1680adba48cb8232ead08df7bae0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo4YWMyNDAwN2YzNTM0MDdiYjVmYWIxMjAzYmY4ZjkxYS90YWJsZXJhbmdlOjhhYzI0MDA3ZjM1MzQwN2JiNWZhYjEyMDNiZjhmOTFhXzEtMy0xLTEtMjY1MjQ3_663f5b15-84ce-4131-bcc7-705f43bebdf9"
      unitRef="usd">262000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="ia4afa3728f7a4abe948e80bf8d977e54_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo4YWMyNDAwN2YzNTM0MDdiYjVmYWIxMjAzYmY4ZjkxYS90YWJsZXJhbmdlOjhhYzI0MDA3ZjM1MzQwN2JiNWZhYjEyMDNiZjhmOTFhXzItMS0xLTEtMjY1MjQ3_7d5139fe-413b-4a88-aa20-adc2c9f22037"
      unitRef="usd">178000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="if04d1680adba48cb8232ead08df7bae0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo4YWMyNDAwN2YzNTM0MDdiYjVmYWIxMjAzYmY4ZjkxYS90YWJsZXJhbmdlOjhhYzI0MDA3ZjM1MzQwN2JiNWZhYjEyMDNiZjhmOTFhXzItMy0xLTEtMjY1MjQ3_07caf581-6646-4b66-86c5-58b0a1166286"
      unitRef="usd">373000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="ia4afa3728f7a4abe948e80bf8d977e54_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo4YWMyNDAwN2YzNTM0MDdiYjVmYWIxMjAzYmY4ZjkxYS90YWJsZXJhbmdlOjhhYzI0MDA3ZjM1MzQwN2JiNWZhYjEyMDNiZjhmOTFhXzMtMS0xLTEtMjY1MjQ3_bbd93d6d-50a6-4072-9ae5-07c4ef678c69"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="if04d1680adba48cb8232ead08df7bae0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo4YWMyNDAwN2YzNTM0MDdiYjVmYWIxMjAzYmY4ZjkxYS90YWJsZXJhbmdlOjhhYzI0MDA3ZjM1MzQwN2JiNWZhYjEyMDNiZjhmOTFhXzMtMy0xLTEtMjY1MjQ3_d62c5fbe-cc7c-4e80-812a-0c462246f503"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzcwNDg_ee6748ec-4903-4ef3-9270-57d700eb0c42">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based upon the Company&#x2019;s assessments at December&#160;31, 2022 and 2021, the amortized cost basis of the Company&#x2019;s mortgage loans within each credit quality indicator by year of origination was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.950%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost Basis by Year of Origination&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except credit quality indicator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i2d74574442044f68b51d8276992c9058_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzMtMS0xLTEtMjY1MjQ3_f58f7fed-c343-4687-b1ec-2856d21efa84"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i75980a6ff3ee49029a1d3de9bfd5c17a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzMtMy0xLTEtMjY1MjQ3_91e57335-fc81-4cb8-b3bd-6b0d95d07c23"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i90acf0fa2cef449a9a6b3fe9669194a7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzMtNS0xLTEtMjY1MjQ3_09eaca25-e094-4ae0-a37e-8fc82ffeefe4"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie029e8df1c364a138c570492e98b3d54_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzMtNy0xLTEtMjY1MjQ3_389c55cd-a491-4983-8451-a2f4f913eea3"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i421c93ab9ec34e0b8ad632a772e570ca_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzMtOS0xLTEtMjY1MjQ3_2a20a2eb-e94c-4bd3-ab16-693a02c555f2"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i2bca51009fe7432c8013e336a1cf4350_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzMtMTEtMS0xLTI2NTI0Nw_948f271d-710c-4fc4-b154-e3fc248ffcae"
      unitRef="usd">15000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i3a6652f704234be281c7de3aaf21a926_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzMtMTMtMS0xLTI2NTI0Nw_770aa456-3f06-4dd4-b2b8-ba55160338e7"
      unitRef="usd">15000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i0ea51f302c714924bc0ef9b87f297f7f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzQtMS0xLTEtMjY1MjQ3_149a66b1-ccaa-48dd-9b4f-605f8b396f5e"
      unitRef="usd">326000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iebb51e53093740178b4dba853cf3420c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzQtMy0xLTEtMjY1MjQ3_3a1ea253-535c-4ff9-a843-b37a6f26935e"
      unitRef="usd">247000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i12a608a6606644d88c677fd0f751bd61_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzQtNS0xLTEtMjY1MjQ3_efd09981-0c88-4603-8973-b9e7a0fef918"
      unitRef="usd">36000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i3d4072e6b69341889b6e4a48f5921c8a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzQtNy0xLTEtMjY1MjQ3_f3b29614-02bb-40a0-84ef-368b1860c6e0"
      unitRef="usd">11000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i88a11ee9559a44de92dd80d2f5faddeb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzQtOS0xLTEtMjY1MjQ3_b1bc7069-9e7a-4b73-bf9b-f070a4bdb503"
      unitRef="usd">52000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ia93b04912558443280c9e2aa952f9903_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzQtMTEtMS0xLTI2NTI0Nw_1f97bed1-b4bc-4d73-86e9-e62ff4c933a3"
      unitRef="usd">350000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ibc270e3970b14849bffe624fd7f92c5b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzQtMTMtMS0xLTI2NTI0Nw_0a2d9372-5b30-451b-9d40-2716bcdaeace"
      unitRef="usd">1022000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i53ee1002dbe14d6a9a0a87c428a073fd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzUtMS0xLTEtMjY1MjQ3_d2eee797-cf52-43ad-a1b7-53f99cf2e70c"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i73d009030d3c4eb2ac0695369c7267d7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzUtMy0xLTEtMjY1MjQ3_d7930007-53a3-4d2a-886f-7e27a111054e"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="idf299ad413194c68830e48ee0a189167_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzUtNS0xLTEtMjY1MjQ3_9347f351-8096-4ff1-956e-f1dd6ed1f3e5"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i91ce86bfa38a43eb82d3e5630dbb6fe0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzUtNy0xLTEtMjY1MjQ3_d89ee4fc-f49a-4ad4-b9a3-6d1e966f3806"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i85218d26a5ac4a8b8a791e5184f5532e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzUtOS0xLTEtMjY1MjQ3_ef19e370-afa2-4ebc-b2c2-48d9ef65323e"
      unitRef="usd">3000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i12457fd4abed4dd5810c523723b9e883_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzUtMTEtMS0xLTI2NTI0Nw_95668ae7-ce14-493c-a52f-1ee73d778708"
      unitRef="usd">4000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib1693d5376c24d27ae1f522504dba375_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzUtMTMtMS0xLTI2NTI0Nw_48b7bbd0-6c8b-4e5f-853e-23f53b876f15"
      unitRef="usd">7000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i99cea1f4247b4a72ba6ce1db47e509bc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzYtMS0xLTEtMjY1MjQ3_db2eee18-5710-4f4c-afaf-6bd2aced0419"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="if496ce43b9584f0cb06d921498c7a6d5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzYtMy0xLTEtMjY1MjQ3_fd2edb11-1448-42d3-b0ed-42618fbe5490"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i5469e56e6e2247438f23b5f4ce0fc023_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzYtNS0xLTEtMjY1MjQ3_7aa0446c-6135-4b59-8b70-bda84df732ad"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i14ebe9c147f34b30afb070d4275d56be_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzYtNy0xLTEtMjY1MjQ3_bce86214-8e9a-4b34-a4c5-8761e0a5d473"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i2a42cf0d49a24a3eae7d66f7a609a49a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzYtOS0xLTEtMjY1MjQ3_bf3af794-c10a-4ada-8b9e-ddd3f9c35db9"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ic39faab8b805446e8f84846e67c4a2b1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzYtMTEtMS0xLTI2NTI0Nw_1cf2159e-9f82-4e07-be51-469d48e7dcf8"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i3db592d2a00948c68596b30eee11b0de_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzYtMTMtMS0xLTI2NTI0Nw_e8fa0f9f-9421-47f1-9de6-be6972e5b6e4"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i3a10358d02ce40d1ba0f351f89985dd8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzctMS0xLTEtMjY1MjQ3_a6138ac7-7e51-46b8-a7c1-6a946f588c64"
      unitRef="usd">326000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i9479f6e04944448fb94cd8b2ffa008ac_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzctMy0xLTEtMjY1MjQ3_804fe699-82a2-4c6b-b1f4-2dadd5aa3e4f"
      unitRef="usd">247000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i640aed5419174663a30409089c100a72_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzctNS0xLTEtMjY1MjQ3_62644926-2859-40b3-8ba8-7810d23dc7c1"
      unitRef="usd">36000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i47777d9b93154d6784b7b9f3c2f9d892_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzctNy0xLTEtMjY1MjQ3_2b3f4b0b-cb8e-4272-824e-6ee2edcedfb8"
      unitRef="usd">11000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i854bfde83a1447f4b3644fc9241f54c4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzctOS0xLTEtMjY1MjQ3_10587152-9c7c-46ef-84ff-45107a4f8578"
      unitRef="usd">55000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iff3b89973faf410c9acb26abb292d6b2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzctMTEtMS0xLTI2NTI0Nw_0931f920-0f6f-45ae-9b14-8ad180c2cad7"
      unitRef="usd">369000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i9ad5913b793d42b68d0dc23a03aeccd7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzctMTMtMS0xLTI2NTI0Nw_7f59a024-9915-49fa-8b6e-aa49a01fb39e"
      unitRef="usd">1044000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iadb22641a7de480890dce9724f3d4b73_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEwLTMtMS0xLTI2NTI0Nw_51f37c37-20a5-407a-acdb-dca48bcc81c2"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i9504148b06654a839a20790e6729610b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEwLTUtMS0xLTI2NTI0Nw_cc4e7cc9-48e9-4b4d-b668-ac879f73850b"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iffa87d8a62b6424c930a0a38e3b4d729_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEwLTctMS0xLTI2NTI0Nw_3a037c30-7cb0-4e2d-984f-3650b567dc03"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i06832aa121f84e7d9bb9a51594f8328f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEwLTktMS0xLTI2NTI0Nw_84e268a6-abcd-4e23-9bf9-415e848d494e"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i06d54096c9ef445b94dac9cf772665f9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEwLTExLTEtMS0yNjUyNDc_7a683dad-f505-43c2-83ff-145b289a20b9"
      unitRef="usd">28000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i0d9407183bf04eb2817defb619e71ebd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEwLTEzLTEtMS0yNjUyNDc_b392e7ab-60fb-4e9b-b36c-c07205eb5fe6"
      unitRef="usd">28000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i6a5c876135b74ae1838032336d64387b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzExLTMtMS0xLTI2NTI0Nw_6c986729-ec55-4d36-b087-bcb935935277"
      unitRef="usd">255000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i0ca464be42434835bf579eb85f510027_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzExLTUtMS0xLTI2NTI0Nw_37f380e6-2679-4f7d-b9de-2eac89fec38a"
      unitRef="usd">48000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="id2bf2504884d47a787c23c9e647d0278_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzExLTctMS0xLTI2NTI0Nw_bbebff5b-e752-429a-a99c-01199643a7e0"
      unitRef="usd">40000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i9e057cbf62aa4488a2f57555c190f72c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzExLTktMS0xLTI2NTI0Nw_96c4e10e-1dfd-44fe-a7ea-ec6e96ed91f4"
      unitRef="usd">72000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i4576cfca422b43d9b5a9fd4714c411f1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzExLTExLTEtMS0yNjUyNDc_0d49d391-04a0-4baf-a98d-397c08ab8f42"
      unitRef="usd">446000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i3b33e9db5f6e4f5f9006e8393083dde3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzExLTEzLTEtMS0yNjUyNDc_54e7e1ff-bea0-4586-a770-fe63132c383c"
      unitRef="usd">861000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie2a5a5b141684675807f743d5fe77545_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEyLTMtMS0xLTI2NTI0Nw_f37f6a5d-50ae-4268-9b69-4ecb44409155"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie4f98e6a0455476e9364c7c8d8ab21d8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEyLTUtMS0xLTI2NTI0Nw_a08a3317-d434-4cc7-a10a-c919a5c46340"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i480128f0b108421a96f35af154e8f5f0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEyLTctMS0xLTI2NTI0Nw_d8d909ac-3b46-4f5d-8243-0530e928b669"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i014bace9b30c4dad914233baff909ea6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEyLTktMS0xLTI2NTI0Nw_86ddc6d2-244a-493f-a470-8944bb176562"
      unitRef="usd">3000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i13320df95b974197bbb559c6f4e8dbd0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEyLTExLTEtMS0yNjUyNDc_a8287ff8-12cd-4f30-bfd5-19e22d56f395"
      unitRef="usd">10000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i399f816ced304ff0a68ab3aa72222b6c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEyLTEzLTEtMS0yNjUyNDc_8b12a70b-ef53-45bf-ae88-7d163845081a"
      unitRef="usd">13000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="id9e248f337b647938c4b077be13c8a69_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEzLTMtMS0xLTI2NTI0Nw_14dcc71e-2f0d-42df-873f-8ff152d7e68a"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie4c467b53e74463fa33e728cd19c09d8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEzLTUtMS0xLTI2NTI0Nw_99ca23df-1a51-4062-9980-bdac175e33ab"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ia440d58b19c54e7da108e0f4c033ea0b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEzLTctMS0xLTI2NTI0Nw_5025d99e-3010-46a3-8203-8d104d7ba564"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iecb7a9c6c43b46caa278ea7418cf1d7d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEzLTktMS0xLTI2NTI0Nw_072d2c3c-fcff-4e01-8e66-2683822924ca"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib0b792007b8444fc8f042f94a615af30_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEzLTExLTEtMS0yNjUyNDc_cf944a29-90d8-4251-9e8c-7cf2d714c02d"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i8fd3a320f1354f8b810c747934dce719_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzEzLTEzLTEtMS0yNjUyNDc_5fd431a2-b865-4184-9da7-2af9d569972b"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i15b8ca29a4dc4503a5baf923e5290e6e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzE0LTMtMS0xLTI2NTI0Nw_f557de2d-2171-4109-a8a7-9be00cb2b836"
      unitRef="usd">255000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iedfeeeeb01db4051a98addb83b67c636_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzE0LTUtMS0xLTI2NTI0Nw_917974bd-ad07-4837-acd2-5dd3113b2743"
      unitRef="usd">48000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie44f7fadffdd49b09a635391637ef400_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzE0LTctMS0xLTI2NTI0Nw_6b44bcc3-8b85-4b02-aac8-7d81e47103a3"
      unitRef="usd">40000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie9afd4ac3c27443da681cc815ff5e5c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzE0LTktMS0xLTI2NTI0Nw_53e91203-3306-413b-84fe-7662e2bfbb12"
      unitRef="usd">75000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i739531ebbb1b4313b647d32f2141a862_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzE0LTExLTEtMS0yNjUyNDc_d129a373-4329-4364-aae2-66eff9e87bf0"
      unitRef="usd">484000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i578621c95d044984be4bc06471e111cb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTozYjQ0ZmU3ZDg0YTY0Yjg2YTk5ZWIyNzBmNTYyOTM1MC90YWJsZXJhbmdlOjNiNDRmZTdkODRhNjRiODZhOTllYjI3MGY1NjI5MzUwXzE0LTEzLTEtMS0yNjUyNDc_c72409c6-bee5-4e48-a733-80dc970d6ba1"
      unitRef="usd">902000000</us-gaap:MortgageLoansOnRealEstate>
    <cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths
      contextRef="i9ad5913b793d42b68d0dc23a03aeccd7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo5OWQyYzgwOWQyNGE0MGRlODZmMWI4OTU4YmMwODI3Zi90YWJsZXJhbmdlOjk5ZDJjODA5ZDI0YTQwZGU4NmYxYjg5NThiYzA4MjdmXzEtMS0xLTEtMjY1MjQ3_9a11a427-06b9-4492-a84c-3909d28c44b3"
      unitRef="usd">55000000</cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths>
    <cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo
      contextRef="i9ad5913b793d42b68d0dc23a03aeccd7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo5OWQyYzgwOWQyNGE0MGRlODZmMWI4OTU4YmMwODI3Zi90YWJsZXJhbmdlOjk5ZDJjODA5ZDI0YTQwZGU4NmYxYjg5NThiYzA4MjdmXzItMS0xLTEtMjY1MjQ3_c985c357-d3bd-4051-8931-dcdefbe1310e"
      unitRef="usd">152000000</cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo>
    <cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree
      contextRef="i9ad5913b793d42b68d0dc23a03aeccd7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo5OWQyYzgwOWQyNGE0MGRlODZmMWI4OTU4YmMwODI3Zi90YWJsZXJhbmdlOjk5ZDJjODA5ZDI0YTQwZGU4NmYxYjg5NThiYzA4MjdmXzMtMS0xLTEtMjY1MjQ3_dabfac13-d8c6-4d67-9d28-e134421942a1"
      unitRef="usd">90000000</cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree>
    <cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour
      contextRef="i9ad5913b793d42b68d0dc23a03aeccd7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo5OWQyYzgwOWQyNGE0MGRlODZmMWI4OTU4YmMwODI3Zi90YWJsZXJhbmdlOjk5ZDJjODA5ZDI0YTQwZGU4NmYxYjg5NThiYzA4MjdmXzQtMS0xLTEtMjY1MjQ3_0ce5b058-78c5-40fb-844b-694dafd9e646"
      unitRef="usd">168000000</cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour>
    <cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive
      contextRef="i9ad5913b793d42b68d0dc23a03aeccd7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo5OWQyYzgwOWQyNGE0MGRlODZmMWI4OTU4YmMwODI3Zi90YWJsZXJhbmdlOjk5ZDJjODA5ZDI0YTQwZGU4NmYxYjg5NThiYzA4MjdmXzUtMS0xLTEtMjY1MjQ3_7c062d42-04b6-40e2-9b1a-3bb4c8021cb0"
      unitRef="usd">203000000</cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive>
    <cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive
      contextRef="i9ad5913b793d42b68d0dc23a03aeccd7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo5OWQyYzgwOWQyNGE0MGRlODZmMWI4OTU4YmMwODI3Zi90YWJsZXJhbmdlOjk5ZDJjODA5ZDI0YTQwZGU4NmYxYjg5NThiYzA4MjdmXzYtMS0xLTEtMjY1MjQ3_5d09b23b-648e-4c7c-ae75-317132f76a4a"
      unitRef="usd">376000000</cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive>
    <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet
      contextRef="i9ad5913b793d42b68d0dc23a03aeccd7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo5OWQyYzgwOWQyNGE0MGRlODZmMWI4OTU4YmMwODI3Zi90YWJsZXJhbmdlOjk5ZDJjODA5ZDI0YTQwZGU4NmYxYjg5NThiYzA4MjdmXzctMS0xLTEtMjY1MjQ3_5f907f40-95d1-4771-b291-4ab717f2a210"
      unitRef="usd">1044000000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
    <us-gaap:InvestmentIncomeTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzcwMzI_fb71acb8-f123-425c-b2e9-8b5589a7b249">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sources of net investment income for the years ended December 31, 2022, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (excluding net realized capital gains or losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized capital gains (losses) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net realized capital losses include credit-related losses on debt securities of $13 million and yield-related impairment losses on debt securities of $143 million in the year ended December 31, 2022. Net realized capital gains are net of yield-related impairment losses on debt securities of $42 million and $49 million for the years ended December 31, 2021 and 2020, respectively. There were no credit-related losses on debt securities in the years ended December 31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;(2)Net investment income includes $35 million, $38 million and $42 million for the years ended December 31, 2022, 2021 and 2020, respectively, related to investments supporting experience-rated products.</us-gaap:InvestmentIncomeTextBlock>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i762743c83fc54d4b84a2b52a9dc069ea_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzEtMS0xLTEtMjY1MjQ3_89448dac-ff50-47c5-a497-2ca0031b477d"
      unitRef="usd">702000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="iefc840c940b34ad98d700a94a9c98c36_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzEtMy0xLTEtMjY1MjQ3_ef29275a-540b-4d6d-b072-0286e07f4ffb"
      unitRef="usd">634000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ic7f12d0216be4ec7b5b4ec403f1ac753_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzEtNS0xLTEtMjY1MjQ3_6cc568c5-a9ac-497b-9321-518da977872f"
      unitRef="usd">598000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i492eb4d473b8474399d0876f23723ffe_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzItMS0xLTEtMjY1MjQ3_6f0cd5a6-7361-4f74-8c01-1c57465dbcce"
      unitRef="usd">51000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="icb4f81b717c34e498a2a17bce45af326_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzItMy0xLTEtMjY1MjQ3_e3a94685-be58-48ff-b32a-ac38f6969072"
      unitRef="usd">55000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i369222388a054b4f8f100bd1d68da12f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzItNS0xLTEtMjY1MjQ3_202ddd9e-af8c-47ea-8c2f-677728edf729"
      unitRef="usd">60000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i068dca23e0464c6eaf06ae53103e8ee4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzMtMS0xLTEtMjY1MjQ3_b194294c-281d-4932-8275-928fc6498983"
      unitRef="usd">448000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ic9969db4222c441394605cdce7151928_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzMtMy0xLTEtMjY1MjQ3_fdcaeeb7-36b6-4782-bbaf-a7f50c082a7a"
      unitRef="usd">381000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ib8cb3e0c3585411b8626e196b7be91ff_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzMtNS0xLTEtMjY1MjQ3_c88c3a10-0503-43db-9786-c7037f8cc1ba"
      unitRef="usd">123000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzQtMS0xLTEtMjY1MjQ3_8bc50a59-3e68-4365-975d-422f8c600530"
      unitRef="usd">1201000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzQtMy0xLTEtMjY1MjQ3_41e9e5b2-5c73-4e50-9dcf-f37cf8746a83"
      unitRef="usd">1070000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzQtNS0xLTEtMjY1MjQ3_df9a321a-5cac-4a3b-accf-3f2e87d5fb24"
      unitRef="usd">781000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzUtMS0xLTEtMjY1MjQ3_b60f49b4-299b-45e1-ae68-18302897f3c4"
      unitRef="usd">43000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzUtMy0xLTEtMjY1MjQ3_644801f2-8b05-41fc-b4d8-273508b03c36"
      unitRef="usd">47000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzUtNS0xLTEtMjY1MjQ3_0bf82f38-9040-4864-b79e-4d40316ba07a"
      unitRef="usd">35000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <cvs:InvestmentIncomeExcludingCapitalGainsOrLosses
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzYtMS0xLTEtMjY1MjQ3_01329038-87cb-4757-befa-09895f5cc97b"
      unitRef="usd">1158000000</cvs:InvestmentIncomeExcludingCapitalGainsOrLosses>
    <cvs:InvestmentIncomeExcludingCapitalGainsOrLosses
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzYtMy0xLTEtMjY1MjQ3_2234e4fe-9c10-435b-b649-debdf1d5fadd"
      unitRef="usd">1023000000</cvs:InvestmentIncomeExcludingCapitalGainsOrLosses>
    <cvs:InvestmentIncomeExcludingCapitalGainsOrLosses
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzYtNS0xLTEtMjY1MjQ3_f11e065b-b7b0-49dc-bde4-d303990a5594"
      unitRef="usd">746000000</cvs:InvestmentIncomeExcludingCapitalGainsOrLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzctMS0xLTEtMjY1MjQ3_187fdbb5-a675-4451-bdd1-f97a7a906cbc"
      unitRef="usd">-320000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzctMy0xLTEtMjY1MjQ3_fddf05e2-f49c-4ed1-afd5-e93d899d1ccb"
      unitRef="usd">176000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzctNS0xLTEtMjY1MjQ3_62543ab4-c99f-49e3-8cb9-8fa3a9953b6d"
      unitRef="usd">52000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:InvestmentIncomeNet
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzgtMS0xLTEtMjY1MjQ3_ff2ccaf2-232c-46bb-954f-ff5ff0832004"
      unitRef="usd">838000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzgtMy0xLTEtMjY1MjQ3_d1437b33-d1c0-4a65-970f-82e80da4db1f"
      unitRef="usd">1199000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTo1M2QxYzQ1ZGZiMGI0MTljYjIyMjgwOGRhZDQxY2FjMC90YWJsZXJhbmdlOjUzZDFjNDVkZmIwYjQxOWNiMjIyODA4ZGFkNDFjYWMwXzgtNS0xLTEtMjY1MjQ3_f4e096cc-7b77-4797-b585-e9c83166acf1"
      unitRef="usd">798000000</us-gaap:InvestmentIncomeNet>
    <cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzYwOTM_bfa8d9e5-dd96-443d-ba0d-56ed7bb058f9"
      unitRef="usd">13000000</cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzYxNTQ_ae3ef6a2-9697-47f0-bf54-86428ab4c4a2"
      unitRef="usd">143000000</cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzYyODY_9190c9d1-0ef3-4c69-862e-27a5b347237e"
      unitRef="usd">42000000</cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzYyOTM_7010e6e7-97fa-4aa7-8d00-037b942cb7a3"
      unitRef="usd">49000000</cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzYzNjk_a87df1da-128f-4015-8b8f-c011b37edac3"
      unitRef="usd">0</cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzYzNjk_d7c37bba-a2ad-4b70-b93f-1b7764b89798"
      unitRef="usd">0</cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:InvestmentIncomeNet
      contextRef="i137cad6adc6f4ecb8a82de703aa13a63_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzY0OTE_5e56d2aa-f0f5-4b25-bd6f-50a7f7c364f2"
      unitRef="usd">35000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="if00a9d16f4b54e3b9f6ebe547b51e58d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzY0OTU_d1a3f752-2f92-4af4-8bef-027568c44014"
      unitRef="usd">38000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="if19bb3693da04612931c094a9c82234d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzY1MDI_29a86f6f-086d-492d-86e6-a72644016ea8"
      unitRef="usd">42000000</us-gaap:InvestmentIncomeNet>
    <cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90ZXh0cmVnaW9uOjIxMDk1ZTBlNzE3NDQ4MTA5ZGRhNjA1YWM0YmI2ZDg5XzcwNDI_a179ace5-cd20-4d90-bbe0-bcc9c15c15f1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses in the years ended December 31, 2022, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphZDAyZTNjOGVmZGE0NmFmOTVjOGNlNmI0ZWNiNGQ0OS90YWJsZXJhbmdlOmFkMDJlM2M4ZWZkYTQ2YWY5NWM4Y2U2YjRlY2I0ZDQ5XzEtMS0xLTEtMjY1MjQ3_34c2938c-d5db-4c61-a7fb-f0bb96d9d8ce"
      unitRef="usd">4243000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphZDAyZTNjOGVmZGE0NmFmOTVjOGNlNmI0ZWNiNGQ0OS90YWJsZXJhbmdlOmFkMDJlM2M4ZWZkYTQ2YWY5NWM4Y2U2YjRlY2I0ZDQ5XzEtMy0xLTEtMjY1MjQ3_0e33a4f5-5974-4310-9c7b-4d04a0b3fff3"
      unitRef="usd">3572000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphZDAyZTNjOGVmZGE0NmFmOTVjOGNlNmI0ZWNiNGQ0OS90YWJsZXJhbmdlOmFkMDJlM2M4ZWZkYTQ2YWY5NWM4Y2U2YjRlY2I0ZDQ5XzEtNS0xLTEtMjY1MjQ3_93a978c9-3cde-4967-9409-634c439a17b9"
      unitRef="usd">3913000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphZDAyZTNjOGVmZGE0NmFmOTVjOGNlNmI0ZWNiNGQ0OS90YWJsZXJhbmdlOmFkMDJlM2M4ZWZkYTQ2YWY5NWM4Y2U2YjRlY2I0ZDQ5XzItMS0xLTEtMjY1MjQ3_1b740127-74e4-4d21-ba34-c6a8a4decd11"
      unitRef="usd">24000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphZDAyZTNjOGVmZGE0NmFmOTVjOGNlNmI0ZWNiNGQ0OS90YWJsZXJhbmdlOmFkMDJlM2M4ZWZkYTQ2YWY5NWM4Y2U2YjRlY2I0ZDQ5XzItMy0xLTEtMjY1MjQ3_7e4be33b-a7de-458c-a381-42181f135a01"
      unitRef="usd">72000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphZDAyZTNjOGVmZGE0NmFmOTVjOGNlNmI0ZWNiNGQ0OS90YWJsZXJhbmdlOmFkMDJlM2M4ZWZkYTQ2YWY5NWM4Y2U2YjRlY2I0ZDQ5XzItNS0xLTEtMjY1MjQ3_7fd050ce-00ff-4132-a20c-cd4483e505c1"
      unitRef="usd">80000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphZDAyZTNjOGVmZGE0NmFmOTVjOGNlNmI0ZWNiNGQ0OS90YWJsZXJhbmdlOmFkMDJlM2M4ZWZkYTQ2YWY5NWM4Y2U2YjRlY2I0ZDQ5XzMtMS0xLTEtMjY1MjQ3_9174dc48-eeb9-4289-8d1b-0f18f69ac191"
      unitRef="usd">177000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphZDAyZTNjOGVmZGE0NmFmOTVjOGNlNmI0ZWNiNGQ0OS90YWJsZXJhbmdlOmFkMDJlM2M4ZWZkYTQ2YWY5NWM4Y2U2YjRlY2I0ZDQ5XzMtMy0xLTEtMjY1MjQ3_cd9c28e7-a064-41ab-abe5-90728dd870f0"
      unitRef="usd">14000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMjcvZnJhZzoyMTA5NWUwZTcxNzQ0ODEwOWRkYTYwNWFjNGJiNmQ4OS90YWJsZTphZDAyZTNjOGVmZGE0NmFmOTVjOGNlNmI0ZWNiNGQ0OS90YWJsZXJhbmdlOmFkMDJlM2M4ZWZkYTQ2YWY5NWM4Y2U2YjRlY2I0ZDQ5XzMtNS0xLTEtMjY1MjQ3_7e90cf1c-000b-4993-af47-2c67260e534f"
      unitRef="usd">62000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzEwNzIx_39cabf58-de51-44f1-9034-0a2ea3de3eb1">Fair Value&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the Company&#x2019;s consolidated financial statements requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;In this note, the Company provides details on the fair value of financial assets and liabilities and how it determines those fair values.&#160;The Company presents this information for those financial instruments that are measured at fair value for which the change in fair value impacts net income attributable to CVS Health or other comprehensive income (loss) separately from other financial assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instruments Measured at Fair Value on the Consolidated Balance Sheets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company&#x2019;s financial instruments are measured at fair value on the consolidated balance sheets.&#160;The fair values of these instruments are based on valuations that include inputs that can be classified within one of three levels of a hierarchy established by GAAP.&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#x201c;valuation inputs&#x201d;) that qualifies a financial asset or liability for each level:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2013; Unadjusted quoted prices for identical assets or liabilities in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2013; Valuation inputs other than Level 1 that are based on observable market data.&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2013; Developed from unobservable data, reflecting the Company&#x2019;s assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities are classified based upon the lowest level of input that is significant to the valuation.&#160;When quoted prices in active markets for identical assets and liabilities are available, the Company uses these quoted market prices to determine the fair value of financial assets and liabilities and classifies these assets and liabilities in Level 1.&#160;In other cases where a quoted market price for identical assets and liabilities in an active market is either not available or not observable, the Company estimates fair value using valuation methodologies based on available and observable market information or by using a matrix pricing model.&#160;These financial assets and liabilities are classified in Level 2.&#160;If quoted market prices are not available, the Company determines fair value using broker quotes or an internal analysis of each investment&#x2019;s financial performance and cash flow projections.&#160;Thus, financial assets and liabilities may be classified in Level 3 even though there may be some significant inputs that may be observable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a description of the valuation methodologies used for the Company&#x2019;s financial assets and liabilities that are measured at fair value, including the general classification of such assets and liabilities pursuant to the valuation hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and Cash Equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of cash and cash equivalents approximates fair value as maturities are less than three months. When quoted prices are available in an active market, cash equivalents are classified in Level 1 of the fair value hierarchy. Fair values of cash equivalent instruments that do not trade on a regular basis in active markets are classified as Level 2.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Where quoted prices are available in an active market, debt securities are classified in Level 1 of the fair value hierarchy.&#160;The Company&#x2019;s&#160;Level 1 debt securities consist primarily of U.S. Treasury securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the Company&#x2019;s Level 2 debt securities are obtained using models, such as matrix pricing, which use quoted market prices of debt securities with similar characteristics or discounted cash flows to estimate fair value. The &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company reviews these prices to ensure they are based on observable market inputs that include quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets and inputs that are observable that are not prices (such as interest rates and credit risks). The Company also reviews the methodologies and the assumptions used to calculate prices from these observable inputs. On a quarterly basis, the Company selects a sample of its Level 2 debt securities&#x2019; prices and compares them to prices provided by a secondary source. Variances over a specified threshold are identified and reviewed to confirm the price provided by the primary source represents an appropriate estimate of fair value. In addition, the Company&#x2019;s internal investment team consistently compares the prices obtained for select Level 2 debt securities to the team&#x2019;s own independent estimates of fair value for those securities.&#160;The Company obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December&#160;31, 2022 or 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also values certain debt securities using Level 3 inputs.&#160;For Level 3 debt securities, fair values are determined by outside brokers or, in the case of certain private placement securities, are priced internally.&#160;Outside brokers determine the value of these debt securities through a combination of their knowledge of the current pricing environment and market flows.&#160;The Company did not have any broker quoted debt securities for the years ended December&#160;31, 2022 and 2021. For some private placement securities, the Company&#x2019;s internal staff determines the value of these debt securities by analyzing spreads of corporate and sector indices as well as interest spreads of comparable public bonds.&#160;Examples of these private placement Level 3 debt securities include certain U.S. and foreign securities and certain tax-exempt municipal securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company currently has two classifications of equity securities:&#160;those that are publicly traded and those that are privately placed.&#160;Publicly-traded equity securities are classified in Level 1 because quoted prices are available for these securities in an active market.&#160;For privately placed equity securities, there is no active market; therefore, these securities are classified in Level 3 because the Company prices these securities through an internal analysis of each investment&#x2019;s financial statements and cash flow projections. Significant unobservable inputs consist of earnings and revenue multiples, discount for lack of marketability and comparability adjustments. An increase or decrease in any of these unobservable inputs would have resulted in a change in the fair value measurement. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no financial liabilities measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2022 or 2021. Financial assets measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes cash and cash equivalents of $6&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;States, &lt;br/&gt;municipalities&lt;br/&gt;&#160;and political &lt;br/&gt;subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S.&lt;br/&gt;corporate&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other asset-&lt;br/&gt;backed&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized and unrealized capital losses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in earnings&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in net unrealized capital losses included in other comprehensive loss associated with Level 3 financial assets which were held as of December&#160;31, 2022 was $9 million during the year ended December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;States, &lt;br/&gt;municipalities&lt;br/&gt;&#160;and political &lt;br/&gt;subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S.&lt;br/&gt;corporate&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other asset-&lt;br/&gt;backed&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Redeemable&lt;br/&gt;preferred&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized and unrealized capital gains (losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers into Level 3, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in net unrealized capital losses included in other comprehensive income associated with Level 3 financial assets which were held as of December&#160;31, 2021 was $4&#160;million during the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total gross transfers into (out of) Level 3 during the years ended December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross transfers into Level 3&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net transfers into (out of) Level 3&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instruments Not Measured at Fair Value on the Consolidated Balance Sheets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the consolidated balance sheets at adjusted cost or contract value at December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for additional information regarding the valuation of cost method investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes long-term debt of $3&#160;million which has been accounted for as liabilities held for sale and is included in liabilities held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Separate Accounts Measured at Fair Value on the Consolidated Balance Sheets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts assets relate to the Company&#x2019;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;Net investment income and capital gains and losses on Separate Accounts assets accrue directly to such contract holders.&#160;The assets of each account are legally segregated and are not subject to claims arising from the Company&#x2019;s other businesses.&#160;Deposits, withdrawals, net investment income and realized and unrealized capital gains and losses on Separate Accounts assets are not reflected in the consolidated statements of operations, shareholders&#x2019; equity or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts assets include debt and equity securities.&#160;The valuation methodologies used for these assets are similar to the methodologies described above in this Note 4 &#x2018;&#x2018;Fair Value.&#x2019;&#x2019;&#160;Separate Accounts assets also include investments in common/collective trusts that are carried at fair value. Common/collective trusts invest in other investment funds otherwise known as the underlying funds. The Separate Accounts&#x2019; interests in the common/collective trust funds are based on the fair values of the investments of the underlying funds and therefore are classified in Level 2. The assets in the underlying funds primarily consist of equity securities. Investments in common/collective trust funds are valued at their respective net asset value (&#x201c;NAV&#x201d;) per share/unit on the valuation date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts financial assets at December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common/collective trusts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $85 million of other payables and $70&#160;million of other receivables at December&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December 31, 2022 and 2021, the Company had no gross transfers of Separate Accounts financial assets into or out of Level 3.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="id7e14cbf58db473094f1a3a50e0e0423_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzY3MDM_066e31c7-da67-4393-9d77-888be4f00124"
      unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="ibbd43a9242a0495591196ce21cc7a152_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzY3MDM_693d61c2-bd37-486a-b36e-ff7d55115862"
      unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzEwNzE0_a8d10abb-35bb-4d91-9c6e-e3cec58e97e6">Financial assets measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2022 and 2021 were as follows:&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes cash and cash equivalents of $6&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="icaf7c772d40247269c23c494f0813a7f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzItMS0xLTEtMjY1MjQ3_4d82ce6c-cdd0-4bca-986b-fb53be8a407f"
      unitRef="usd">6902000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i0ada3d841105476b9dca967f07a9dee9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzItMy0xLTEtMjY1MjQ3_9f52ba04-922e-407d-8d74-cae0d5f2b770"
      unitRef="usd">6049000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ie9bd28275ddc4fac99461d0040a82e04_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzItNS0xLTEtMjY1MjQ3_3ca1a275-be88-4dca-9e9d-3c299b04c403"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ibbd43a9242a0495591196ce21cc7a152_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzItNy0xLTEtMjY1MjQ3_78fc7efb-8e3d-44a1-843e-3b2ca8bd1333"
      unitRef="usd">12951000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idc91466b20fa43ada80738d8288e7fea_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzQtMS0xLTEtMjY1MjQ3_e22f2ef5-6d3f-4a64-bb7b-c926c4453e8d"
      unitRef="usd">1860000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i530204e9d197451a99415dd3717e24ac_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzQtMy0xLTEtMjY1MjQ3_f174d60a-4c06-4bb7-bcb8-9b7733ec4dce"
      unitRef="usd">32000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8990fa5e5b8a4f0f97b6e8a430a4f8cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzQtNS0xLTEtMjY1MjQ3_8e859203-3c5e-40a3-ba66-942a6cf7faf3"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8d16b574d8b9499db8e7d78efb965b5e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzQtNy0xLTEtMjY1MjQ3_52202c57-51f0-4734-8d42-40c6e3fe5950"
      unitRef="usd">1892000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6f3cd6f6ea7e499bb05f3f3288c17b03_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzUtMS0xLTEtMjY1MjQ3_10e2055a-b951-4cc3-97d4-95d236c844b8"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie5c1f15313054273991533c5befb102b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzUtMy0xLTEtMjY1MjQ3_c31c38d9-e6cb-4bf9-b1b9-1ca96c7f783a"
      unitRef="usd">2272000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9d63d3b9768744a2b0dd3376b50053cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzUtNS0xLTEtMjY1MjQ3_2d1974c7-fedc-4bf6-af7b-b9cef6abbd7b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5101082b492740a3b0895812ec43df67_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzUtNy0xLTEtMjY1MjQ3_f7a36712-b94e-4a26-8861-04775b5165e8"
      unitRef="usd">2272000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie06499b007a04690b796c75b0962751c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzYtMS0xLTEtMjY1MjQ3_47d1a935-8d96-49e3-9dbf-c5b2a5e5f4b8"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ida238621d6c341e6a18249c65a07f582_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzYtMy0xLTEtMjY1MjQ3_db86af95-34a6-4867-b5fb-0445c7abea73"
      unitRef="usd">8897000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i16e537cfafe946a1a9ae86bba72ee565_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzYtNS0xLTEtMjY1MjQ3_cfaef814-c1d7-4905-90bb-7a62f53406b1"
      unitRef="usd">61000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id7ab6b4e481d4957893effda1b1aa7c7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzYtNy0xLTEtMjY1MjQ3_5f4d9e0b-4f43-4ab5-a9d3-47299d6177eb"
      unitRef="usd">8958000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1c90587389b24652b4171dd0ee88dee0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzctMS0xLTEtMjY1MjQ3_01f0e738-517c-4319-a5b5-a6ca717e4572"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i08413588348e4bebaa6e0777ce0ef468_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzctMy0xLTEtMjY1MjQ3_f13b9a7b-59a2-4837-b814-e26b5acb8990"
      unitRef="usd">2542000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i06e7906b8aab402c9db7df2fbd123952_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzctNS0xLTEtMjY1MjQ3_aaba5a54-0c41-4b1b-aa5c-f7ec8e17fcde"
      unitRef="usd">8000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i23a61fc417cb4a5cb6b648036474566b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzctNy0xLTEtMjY1MjQ3_00f7c53e-4ca1-40b0-8efe-87b6c63c34fc"
      unitRef="usd">2550000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i22037852b26040388b00a9892837d2c6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzgtMS0xLTEtMjY1MjQ3_21f7136f-d2ce-47d0-bfd4-9505bafea9c8"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i29da59e3b5fa4406a9c1b13643f91b1d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzgtMy0xLTEtMjY1MjQ3_5d3fdedf-3431-4c56-a3e3-5e85c5d40d2b"
      unitRef="usd">757000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7f33fa4fd1b548fbbed3d1b0df48e1a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzgtNS0xLTEtMjY1MjQ3_9e6ebe59-d89b-413f-aa16-da1c9b71fbce"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2f7c6d92a69343cba3248128978c9fee_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzgtNy0xLTEtMjY1MjQ3_778be767-c780-4446-af9f-8a947fe7e0c5"
      unitRef="usd">757000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1764e3a27c5c4e3495ac330952dee2a7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzktMS0xLTEtMjY1MjQ3_361977f9-be10-4f07-8e9f-0967935c6216"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ieb866ac0512442bcb82bae4443758dc2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzktMy0xLTEtMjY1MjQ3_576264ec-04c9-4e2b-b8b9-a629d068dbcc"
      unitRef="usd">1018000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icecd5e128c154279ad038c0b3bd207d7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzktNS0xLTEtMjY1MjQ3_a2f7f609-d7ca-4cdf-be84-c643e9445207"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i25da8a3d6f6c4f1f8d90b11a666a1f83_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzktNy0xLTEtMjY1MjQ3_3491c52b-a7d3-44ae-92fa-af5dd3e769b7"
      unitRef="usd">1018000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9e6791338399461b89ecf1ab5fad5038_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEwLTEtMS0xLTI2NTI0Nw_d07e161e-b8d4-450f-9e16-62a2cc3a68b3"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iea61e57b4e654ebd906d75ab95adf087_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEwLTMtMS0xLTI2NTI0Nw_eb6af235-d05d-44b6-9565-c8b176d69de7"
      unitRef="usd">2810000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9c6d0c54222b4405b72bcbe5aab383e4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEwLTUtMS0xLTI2NTI0Nw_7bc7d6b3-9bb9-49aa-932c-20fbcaa1a0a2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifa99b9364f604126ad2513dafb044afc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEwLTctMS0xLTI2NTI0Nw_45d64d85-6c11-4b5d-82f3-cfd766bffb15"
      unitRef="usd">2810000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8b5704fae30b4a0180968bd57557cc05_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzExLTEtMS0xLTI2NTI0Nw_5805ca3b-bd5d-433f-ae59-1f6371e002e1"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8e951c3bc4d145f4a40476a3449c19ad_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzExLTMtMS0xLTI2NTI0Nw_45062835-8242-47c1-b355-beba7d77fbab"
      unitRef="usd">23000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ief0073f279ab4af192756be0d02d4de7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzExLTUtMS0xLTI2NTI0Nw_1cd3e473-76bb-4be2-99cd-0608513bc787"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibc232ee5addf495c8badb0d70cc93c58_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzExLTctMS0xLTI2NTI0Nw_105a6b16-7067-4ca9-8d68-23bc6acf9330"
      unitRef="usd">23000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icaf7c772d40247269c23c494f0813a7f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEyLTEtMS0xLTI2NTI0Nw_27938c21-208f-4cd3-b3f7-c5215f303520"
      unitRef="usd">1860000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0ada3d841105476b9dca967f07a9dee9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEyLTMtMS0xLTI2NTI0Nw_a57a3cd9-6825-40df-8704-790b221e51fc"
      unitRef="usd">18351000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie9bd28275ddc4fac99461d0040a82e04_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEyLTUtMS0xLTI2NTI0Nw_1b80f486-745c-4ab9-a569-4acb45a26406"
      unitRef="usd">69000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibbd43a9242a0495591196ce21cc7a152_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEyLTctMS0xLTI2NTI0Nw_335f67a2-9363-4877-8d4e-c0ec7f4022db"
      unitRef="usd">20280000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="icaf7c772d40247269c23c494f0813a7f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEzLTEtMS0xLTI2NTI0Nw_51999ff2-73a6-4357-ba00-5ae0418b2358"
      unitRef="usd">116000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i0ada3d841105476b9dca967f07a9dee9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEzLTMtMS0xLTI2NTI0Nw_e4f05c7d-6248-4355-8ba7-97247c69171f"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ie9bd28275ddc4fac99461d0040a82e04_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEzLTUtMS0xLTI2NTI0Nw_5bd8dd50-867c-47a0-9265-8914da8540b9"
      unitRef="usd">60000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ibbd43a9242a0495591196ce21cc7a152_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzEzLTctMS0xLTI2NTI0Nw_52f3e54e-3a25-48c9-a079-b3c2da49f02e"
      unitRef="usd">176000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="icaf7c772d40247269c23c494f0813a7f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE0LTEtMS0xLTI2NTI0Nw_cd23e1c5-bf1e-4fe2-97f9-91d63c976a6d"
      unitRef="usd">8878000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0ada3d841105476b9dca967f07a9dee9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE0LTMtMS0xLTI2NTI0Nw_921c9100-8ff9-4643-ae9a-861492288830"
      unitRef="usd">24400000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie9bd28275ddc4fac99461d0040a82e04_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE0LTUtMS0xLTI2NTI0Nw_61225d9c-ad67-4b86-89a4-5aab65dd90bc"
      unitRef="usd">129000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibbd43a9242a0495591196ce21cc7a152_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE0LTctMS0xLTI2NTI0Nw_a9136bb5-8ee7-4311-9982-6cc2ae610259"
      unitRef="usd">33407000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib91aae7889074bd7a05849761119e002_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE3LTEtMS0xLTI2NTI0Nw_2a4470c5-2e09-46ae-a4a4-8185080eb4c9"
      unitRef="usd">4954000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i91e3342f2eda4923accdad0511bbd8ab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE3LTMtMS0xLTI2NTI0Nw_a7aab789-faf7-4eff-93cf-e712e08a2185"
      unitRef="usd">4454000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i47cdbbca2588456f80bd73c676fe393c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE3LTUtMS0xLTI2NTI0Nw_c29c6815-9798-4bb5-81a2-55fd2e27780e"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="id7e14cbf58db473094f1a3a50e0e0423_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE3LTctMS0xLTI2NTI0Nw_31825456-db78-4651-a3b6-7b013faa8f9b"
      unitRef="usd">9408000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaf6903b55b154bf5a640326a2ba60787_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE5LTEtMS0xLTI2NTI0Nw_4c1201eb-e84d-47fa-be57-91aaf6d56263"
      unitRef="usd">2372000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i80a1fa05fa624e99a568c5d529713791_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE5LTMtMS0xLTI2NTI0Nw_902fdc2e-59be-4452-b8c1-fbd544c8b9c7"
      unitRef="usd">44000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6823ed470daa49af9254d7a5a6a31e37_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE5LTUtMS0xLTI2NTI0Nw_868decd9-ec28-4061-b899-be83d8528cf2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0338427c63b5451e9bbeb57e1271c8fa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzE5LTctMS0xLTI2NTI0Nw_13264ba4-d018-469a-9a06-e2d7c57adeef"
      unitRef="usd">2416000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib35379eff59f4c1fb2580ef9d779863d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIwLTEtMS0xLTI2NTI0Nw_888452b9-5758-4c15-9e17-23673f843bf4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i890e91d6254445ac8e4752816f15fc64_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIwLTMtMS0xLTI2NTI0Nw_0deadb5c-9136-4550-af49-24aea1ab968b"
      unitRef="usd">3086000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1ad691d08cdb4176912f4e92ea7f03db_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIwLTUtMS0xLTI2NTI0Nw_75c09b23-256a-4e91-9d9f-fb03081901c0"
      unitRef="usd">5000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2fdcb45e510345908f049a08f8d3ea8b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIwLTctMS0xLTI2NTI0Nw_2f87d4a3-43ca-4362-bd07-73dbba1a4b8a"
      unitRef="usd">3091000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i55a4eb72fc1c413382e3c1881d8197f5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIxLTEtMS0xLTI2NTI0Nw_1e4cb8da-f3ea-4bea-be22-a1321bb9e04f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic8066d1e0dc94aa6b3e714bdce964759_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIxLTMtMS0xLTI2NTI0Nw_e83d3dee-90d5-42db-ab40-9461aad21c8e"
      unitRef="usd">9697000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2c74072b7da84ae7822677cfcf5afff9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIxLTUtMS0xLTI2NTI0Nw_b0cc5215-5fa6-476d-ae10-cbf670ff3829"
      unitRef="usd">38000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibe6072dccf0e4a3386213b62e3088a40_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIxLTctMS0xLTI2NTI0Nw_254b425b-74dc-432f-abcd-050c6846b19b"
      unitRef="usd">9735000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i421fe75787694fa0a11c81717afb1439_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIyLTEtMS0xLTI2NTI0Nw_214134f2-c15b-496f-b883-8a1996091445"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iccca4c50d4404ba9b7e6a383314c619d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIyLTMtMS0xLTI2NTI0Nw_f37e6466-c72c-46f5-882d-7693efd8c93b"
      unitRef="usd">2983000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i88314bd313df47c79dbba4210decb5f3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIyLTUtMS0xLTI2NTI0Nw_8e0fc38b-9409-4f9f-960e-d9a7e63bb4a7"
      unitRef="usd">10000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i50144b06283042b2839e3602628c2e9d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIyLTctMS0xLTI2NTI0Nw_13160547-dc02-42db-8ca6-e43151dc8057"
      unitRef="usd">2993000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i31ba761daf614d80a394376a9dc8d67a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIzLTEtMS0xLTI2NTI0Nw_cc63c38a-1c1a-4780-8322-00d5b85f8e06"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i590674c939694c899f0d33ebd89a34f9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIzLTMtMS0xLTI2NTI0Nw_7599ec99-e76e-40ad-9d5a-765ff32232c5"
      unitRef="usd">875000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibc997bf4243447f286d22be9634f8c93_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIzLTUtMS0xLTI2NTI0Nw_80180f1a-f063-4aea-8501-7a9ca74c6ca4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i137db0dfee08476382f7697fd3226606_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzIzLTctMS0xLTI2NTI0Nw_bd0ba5bd-7e4f-40ae-866a-e84eac683ecf"
      unitRef="usd">875000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i279e72df939f411c8a220ad40b2933ad_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI0LTEtMS0xLTI2NTI0Nw_b7c94c91-5c9b-491d-9e78-17d7d7f482f6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7b4b394827a84ef89c8ad73a0012ea10_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI0LTMtMS0xLTI2NTI0Nw_6debfc18-a116-463e-95b9-d7a58a50b41e"
      unitRef="usd">1310000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idadd15b0bc144797998dc56ab0eea88c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI0LTUtMS0xLTI2NTI0Nw_5911f453-a4e0-4252-abc6-7a2cdfa5fe99"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i09a72f728e864e3eb1d61dc884e59e71_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI0LTctMS0xLTI2NTI0Nw_3bca0738-980a-477c-9814-cae7e32494eb"
      unitRef="usd">1310000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibc633eb71dd64df8bb1f39e100cd5380_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI1LTEtMS0xLTI2NTI0Nw_3d6e6b42-9991-4b88-b5b3-276a65206724"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3debe593fdae4764a4dfdb909fa118c2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI1LTMtMS0xLTI2NTI0Nw_0ca4252f-d4a3-41bb-909e-b0922a5e31da"
      unitRef="usd">2789000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if70e446705924f59820f42baab777967_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI1LTUtMS0xLTI2NTI0Nw_1554fc8a-3984-4b4b-9c7b-eb80649b020e"
      unitRef="usd">3000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie042a85f623e47be97fb43ff84873341_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI1LTctMS0xLTI2NTI0Nw_f7a71d2b-0c1c-4c29-8762-3cfcc93dd8f8"
      unitRef="usd">2792000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ife6ed60ef9304afcbcda02067d9939e7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI2LTEtMS0xLTI2NTI0Nw_c3538a32-766c-43f3-8ae1-3b714e2c6115"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i32a6e0424acb4626bd8a9932c7e5cf81_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI2LTMtMS0xLTI2NTI0Nw_37843aa1-ee28-4c1a-9cc8-6757ff1e5c50"
      unitRef="usd">28000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2927600f263b4b33a80751d0bca72ae7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI2LTUtMS0xLTI2NTI0Nw_45da3090-476e-4de1-b1bd-78486b06b1c6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if32a2b7d26c44e27ac43f062d7bb8ce8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI2LTctMS0xLTI2NTI0Nw_3ef46723-0ed8-428d-9888-8f868f7aa4f0"
      unitRef="usd">28000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib91aae7889074bd7a05849761119e002_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI3LTEtMS0xLTI2NTI0Nw_fd23b0da-6cca-4f56-8bb5-86c87fc47131"
      unitRef="usd">2372000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i91e3342f2eda4923accdad0511bbd8ab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI3LTMtMS0xLTI2NTI0Nw_f4757358-e104-48fc-b41e-9ff6b5d99182"
      unitRef="usd">20812000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i47cdbbca2588456f80bd73c676fe393c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI3LTUtMS0xLTI2NTI0Nw_fd517729-2c45-4044-9ae1-278648c442cf"
      unitRef="usd">56000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id7e14cbf58db473094f1a3a50e0e0423_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI3LTctMS0xLTI2NTI0Nw_cb20f490-2fa8-4841-92f8-9ef34b65c9da"
      unitRef="usd">23240000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib91aae7889074bd7a05849761119e002_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI4LTEtMS0xLTI2NTI0Nw_be94938b-9d0b-4940-bea5-973a22026e8a"
      unitRef="usd">114000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i91e3342f2eda4923accdad0511bbd8ab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI4LTMtMS0xLTI2NTI0Nw_872d11bf-ba6f-4a64-927f-b2d0314d395b"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i47cdbbca2588456f80bd73c676fe393c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI4LTUtMS0xLTI2NTI0Nw_abde000b-a61e-405e-9ed6-a577e678fbb8"
      unitRef="usd">55000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id7e14cbf58db473094f1a3a50e0e0423_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI4LTctMS0xLTI2NTI0Nw_2bb0e1c1-229e-4377-8624-1dbb04af4dc6"
      unitRef="usd">169000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib91aae7889074bd7a05849761119e002_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI5LTEtMS0xLTI2NTI0Nw_b56c90d6-ea9c-4878-b530-a8a7270165d9"
      unitRef="usd">7440000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i91e3342f2eda4923accdad0511bbd8ab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI5LTMtMS0xLTI2NTI0Nw_2a5fbf89-a8c1-454a-bb51-5c4274717894"
      unitRef="usd">25266000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i47cdbbca2588456f80bd73c676fe393c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI5LTUtMS0xLTI2NTI0Nw_0845e056-b7a6-4f1f-afdd-3a5339cbc9c1"
      unitRef="usd">111000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id7e14cbf58db473094f1a3a50e0e0423_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTplZWE1Y2U2ZjUzYzQ0MzU5YmQzM2M3M2VmNTkwZTVlMy90YWJsZXJhbmdlOmVlYTVjZTZmNTNjNDQzNTliZDMzYzczZWY1OTBlNWUzXzI5LTctMS0xLTI2NTI0Nw_3d8b1c38-ae5b-42ee-8e07-f498338ba8f6"
      unitRef="usd">32817000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i71dadee959a94001826c4f41df794421_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzcwMjc_f4e38ad5-ceaf-4d4b-a577-adcbae47be47"
      unitRef="usd">6000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzEwNzE4_5963697b-85e6-4aa9-8e69-29d4592db241">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;States, &lt;br/&gt;municipalities&lt;br/&gt;&#160;and political &lt;br/&gt;subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S.&lt;br/&gt;corporate&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other asset-&lt;br/&gt;backed&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized and unrealized capital losses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in earnings&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;States, &lt;br/&gt;municipalities&lt;br/&gt;&#160;and political &lt;br/&gt;subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S.&lt;br/&gt;corporate&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other asset-&lt;br/&gt;backed&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Redeemable&lt;br/&gt;preferred&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized and unrealized capital gains (losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers into Level 3, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in net unrealized capital losses included in other comprehensive income associated with Level 3 financial assets which were held as of December&#160;31, 2021 was $4&#160;million during the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total gross transfers into (out of) Level 3 during the years ended December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross transfers into Level 3&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net transfers into (out of) Level 3&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i2fdcb45e510345908f049a08f8d3ea8b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzEtMS0xLTEtMjY1MjQ3_85ddb707-d271-4348-bb24-1ecb98e47ecb"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ibe6072dccf0e4a3386213b62e3088a40_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzEtMy0xLTEtMjY1MjQ3_5141e592-6ed6-4656-af56-8af49d416a36"
      unitRef="usd">38000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ia886fe9743a34d83adeda64bfbcde12e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzEtNS0xLTEtMjY1MjQ3_20508ec2-97fa-4600-865d-1b07e25856c0"
      unitRef="usd">10000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ie042a85f623e47be97fb43ff84873341_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzEtNy0xLTEtMjY1MjQ3_fec03fa1-0266-4211-86a2-fccc0b462e27"
      unitRef="usd">3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i23ea6c9d959a4be69bc036bae5151a22_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzEtMTEtMS0xLTI2NTI0Nw_c76b2ea9-e880-444a-8c8c-8bafa644a398"
      unitRef="usd">55000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="id7e14cbf58db473094f1a3a50e0e0423_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzEtMTMtMS0xLTI2NTI0Nw_a19495e6-dd7f-4bec-8c0d-4700cfacf24c"
      unitRef="usd">111000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i96059726faac4aa391e32ec04829a30b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzMtMS0xLTEtMjY1MjQ3_fc9df44a-1406-460d-9358-b352f7deb942"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="iee0b7f95d910427ab334b16a255c0b30_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzMtMy0xLTEtMjY1MjQ3_aa6bb23e-6135-4bfd-9c43-ee530525b433"
      unitRef="usd">-8000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i1e36e767de48460789f38c796a6e664f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzMtNS0xLTEtMjY1MjQ3_e4b9aa72-ab21-457b-a42d-fbb6fe3c7841"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i6e8ab5d1d4da443ba302ff82ecf041dd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzMtNy0xLTEtMjY1MjQ3_822880a3-3226-44c0-9a53-c921a34a7858"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i5e02a0f8f4134b338d074df0125e76b9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzMtMTEtMS0xLTI2NTI0Nw_8a9b87c0-44d3-4cab-9c8b-346dd595f189"
      unitRef="usd">-1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="ia4ddc4dc69fa45d7b4aabcb366bedfb2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzMtMTMtMS0xLTI2NTI0Nw_7d6579e3-0f99-415a-ac15-b54f4dd9b0fb"
      unitRef="usd">-9000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i96059726faac4aa391e32ec04829a30b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzQtMS0xLTEtMjY1MjQ3_3e6c0ff9-1587-4d2b-b76f-3cdacb3963ff"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="iee0b7f95d910427ab334b16a255c0b30_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzQtMy0xLTEtMjY1MjQ3_7d24f8f5-522b-4f39-b2db-13c56284040c"
      unitRef="usd">-5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i1e36e767de48460789f38c796a6e664f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzQtNS0xLTEtMjY1MjQ3_e2867a77-c366-4702-891a-164529612f74"
      unitRef="usd">-2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i6e8ab5d1d4da443ba302ff82ecf041dd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzQtNy0xLTEtMjY1MjQ3_a362d978-8238-4b22-afc8-3c4d445fbb2b"
      unitRef="usd">-2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i5e02a0f8f4134b338d074df0125e76b9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzQtMTEtMS0xLTI2NTI0Nw_b526974a-6f60-417a-be30-67a002fc1eb2"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="ia4ddc4dc69fa45d7b4aabcb366bedfb2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzQtMTMtMS0xLTI2NTI0Nw_298f1d00-f2f7-4da5-a654-595e3201f77a"
      unitRef="usd">-9000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i96059726faac4aa391e32ec04829a30b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzUtMS0xLTEtMjY1MjQ3_ab6e9b02-10b4-4622-871f-2c09b9c72d4d"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="iee0b7f95d910427ab334b16a255c0b30_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzUtMy0xLTEtMjY1MjQ3_02c5c4c6-b036-49ef-b10a-c900d3f6b846"
      unitRef="usd">36000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i1e36e767de48460789f38c796a6e664f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzUtNS0xLTEtMjY1MjQ3_996df5ba-f093-48cb-a966-3fa1db532cd7"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i6e8ab5d1d4da443ba302ff82ecf041dd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzUtNy0xLTEtMjY1MjQ3_68b5749f-e686-42b9-8b2b-cb66094c3a1a"
      unitRef="usd">30000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i5e02a0f8f4134b338d074df0125e76b9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzUtMTEtMS0xLTI2NTI0Nw_3de113a1-8a23-4ad7-b78e-b07becb9bf29"
      unitRef="usd">29000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="ia4ddc4dc69fa45d7b4aabcb366bedfb2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzUtMTMtMS0xLTI2NTI0Nw_a9ef66a3-f023-4b10-9243-246e19aa6a0a"
      unitRef="usd">95000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i96059726faac4aa391e32ec04829a30b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzYtMS0xLTEtMjY1MjQ3_233319f8-4ad5-4b9b-b617-e135079c2c58"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="iee0b7f95d910427ab334b16a255c0b30_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzYtMy0xLTEtMjY1MjQ3_c205942f-b9ce-4d7c-8355-07fde5e1b60a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i1e36e767de48460789f38c796a6e664f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzYtNS0xLTEtMjY1MjQ3_12f23ad4-190a-49a0-81e2-a40a0c57832f"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i6e8ab5d1d4da443ba302ff82ecf041dd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzYtNy0xLTEtMjY1MjQ3_c100c382-00e8-4a90-a675-7d11a4e38639"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i5e02a0f8f4134b338d074df0125e76b9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzYtMTEtMS0xLTI2NTI0Nw_3c454e76-eaff-451c-9155-691dfbd79cf7"
      unitRef="usd">23000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="ia4ddc4dc69fa45d7b4aabcb366bedfb2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzYtMTMtMS0xLTI2NTI0Nw_d1b565a3-c805-4cb6-a9ee-898883be1730"
      unitRef="usd">30000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i96059726faac4aa391e32ec04829a30b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzctMS0xLTEtMjY1MjQ3_0c964464-b285-41cc-9dee-107bd74a8557"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="iee0b7f95d910427ab334b16a255c0b30_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzctMy0xLTEtMjY1MjQ3_8612dcce-7448-4d41-a1e0-e0c47dd2d28d"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i1e36e767de48460789f38c796a6e664f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzctNS0xLTEtMjY1MjQ3_88f5fa1d-712d-44d4-9d40-49f7cf5d0520"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i6e8ab5d1d4da443ba302ff82ecf041dd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzctNy0xLTEtMjY1MjQ3_5ea1f515-e948-4d87-a903-9a053731055a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i5e02a0f8f4134b338d074df0125e76b9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzctMTEtMS0xLTI2NTI0Nw_f0b43dc5-5e60-4656-870f-bfa8690fc5b7"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="ia4ddc4dc69fa45d7b4aabcb366bedfb2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzctMTMtMS0xLTI2NTI0Nw_c38d72cc-6d47-47ac-92e4-85f29a66231c"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i96059726faac4aa391e32ec04829a30b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzgtMS0xLTEtMjY1MjQ3_bf90519a-786b-4da8-ae02-68bea9ddc859"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="iee0b7f95d910427ab334b16a255c0b30_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzgtMy0xLTEtMjY1MjQ3_f3c35f2f-00b8-400e-84e2-9ba4f9c0f830"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i1e36e767de48460789f38c796a6e664f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzgtNS0xLTEtMjY1MjQ3_eb4a00d7-34e9-4c71-81d9-c8df17d6c45f"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i6e8ab5d1d4da443ba302ff82ecf041dd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzgtNy0xLTEtMjY1MjQ3_6b2848b9-5814-4a9b-8265-c48db2940266"
      unitRef="usd">-29000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i5e02a0f8f4134b338d074df0125e76b9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzgtMTEtMS0xLTI2NTI0Nw_b4433a9c-35be-497d-bb63-9881eaca0985"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="ia4ddc4dc69fa45d7b4aabcb366bedfb2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzgtMTMtMS0xLTI2NTI0Nw_d6ecf03d-d8df-4eab-bff9-ddb621453518"
      unitRef="usd">-29000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i5101082b492740a3b0895812ec43df67_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzktMS0xLTEtMjY1MjQ3_83de6ca0-f5ab-466a-a176-bf51ef4179f9"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="id7ab6b4e481d4957893effda1b1aa7c7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzktMy0xLTEtMjY1MjQ3_3266a91a-1e78-448e-9717-cd857fbf1958"
      unitRef="usd">61000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i1ab04fe755eb411688cd34938017b350_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzktNS0xLTEtMjY1MjQ3_5313b8f6-ce04-4474-b0fd-5650787f8307"
      unitRef="usd">8000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ifa99b9364f604126ad2513dafb044afc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzktNy0xLTEtMjY1MjQ3_2e123e33-d9ac-42a0-b12a-e2a105fd31e9"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="iefd0548132bc49fa913c97c33e550880_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzktMTEtMS0xLTI2NTI0Nw_9db83ca7-4a8d-4af4-90de-881e582e31af"
      unitRef="usd">60000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ibbd43a9242a0495591196ce21cc7a152_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo3MDZmNzIzNzZlMjk0NWM0OWYxODBkNGQ3YzY3MjlhZS90YWJsZXJhbmdlOjcwNmY3MjM3NmUyOTQ1YzQ5ZjE4MGQ0ZDdjNjcyOWFlXzktMTMtMS0xLTI2NTI0Nw_f2807ef0-5e40-49f9-9a56-a40df499856d"
      unitRef="usd">129000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0Xzc0NzA_4e3b84e3-a898-4e2f-bc1b-eb2cd4ff5356"
      unitRef="usd">-9000000</us-gaap:FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i35fc2780f35241c7badf4da30b423e52_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzEtMS0xLTEtMjY1MjQ3_7bf186a9-d139-4697-b8d2-5211d37c3d46"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ic7e27a54d49940b7aef90c83ff8319a1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzEtMy0xLTEtMjY1MjQ3_12642553-e465-49df-8296-765195f7c733"
      unitRef="usd">52000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i96d99b91ab0644839726fd9985fcf090_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzEtNS0xLTEtMjY1MjQ3_bc0a5432-b16b-4167-9fc0-d27e37c67973"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i935f57522466474ab5b184e68f6666bd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzEtNy0xLTEtMjY1MjQ3_309c5fbd-1d82-4773-8279-eb760cc85d7e"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ic6589258587b4cf38304516af7c70737_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzEtOS0xLTEtMjY1MjQ3_91709c7f-cfe6-41a0-b5c1-e6195951d787"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i4d44059ab8fa413594b33583600110ff_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzEtMTEtMS0xLTI2NTI0Nw_d8e33ac0-73e4-44d7-ad51-1cbe6d5870f9"
      unitRef="usd">30000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i8eb721873e1742abb8f287c140434eb7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzEtMTMtMS0xLTI2NTI0Nw_158bfeb3-ca9b-4b7c-ab1d-ec877bc25153"
      unitRef="usd">84000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i770c6b93b017435188c94e8c9d24f250_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzMtMS0xLTEtMjY1MjQ3_b9560c77-63eb-4dec-95ee-0eca4cf1e20b"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="iaa8216683f294597bdbecb11b8d62331_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzMtMy0xLTEtMjY1MjQ3_d4041404-fc57-4d01-8b00-7ed5b199a03d"
      unitRef="usd">-10000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="ied85a7e77c3c4ba692a634daee0770fd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzMtNS0xLTEtMjY1MjQ3_d5cce525-e548-4669-a8e2-e9872bf254c8"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i79c89c6186094898bdeb5257ad524c9d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzMtNy0xLTEtMjY1MjQ3_8ed3e4b1-a54a-43f1-8907-eb79fb1b17df"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="id25912d8f6374ed5934f4e13f688ef0f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzMtOS0xLTEtMjY1MjQ3_e8926d08-45aa-42ca-88c7-429865c5bcf4"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i33cbb6bd12fe4c8293ea3dde4c77e687_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzMtMTEtMS0xLTI2NTI0Nw_d7d0a244-98f6-4109-a9e3-df671777b5e5"
      unitRef="usd">13000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i5711de78e5dc4ebf9b7a6c859a134de8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzMtMTMtMS0xLTI2NTI0Nw_9018ad8b-c169-44cc-b1d4-963e8c17ee80"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i770c6b93b017435188c94e8c9d24f250_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzQtMS0xLTEtMjY1MjQ3_f4eb8b80-f07b-4ecf-9def-b9995db51cac"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="iaa8216683f294597bdbecb11b8d62331_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzQtMy0xLTEtMjY1MjQ3_464813ca-934a-46c5-93cb-897462ccfb99"
      unitRef="usd">-3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="ied85a7e77c3c4ba692a634daee0770fd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzQtNS0xLTEtMjY1MjQ3_b18df8d9-807d-4bb0-99b3-2996b5e66372"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i79c89c6186094898bdeb5257ad524c9d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzQtNy0xLTEtMjY1MjQ3_e378b734-fec2-42ca-88f2-d23ea9ff66c3"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="id25912d8f6374ed5934f4e13f688ef0f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzQtOS0xLTEtMjY1MjQ3_3c07ee78-7a39-41a5-858e-0b0735b7f9df"
      unitRef="usd">-1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i33cbb6bd12fe4c8293ea3dde4c77e687_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzQtMTEtMS0xLTI2NTI0Nw_b6b8816e-f3a3-45ea-b90b-c030430bbf71"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i5711de78e5dc4ebf9b7a6c859a134de8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzQtMTMtMS0xLTI2NTI0Nw_ca7238ad-203b-4c17-86a2-7389a09379c3"
      unitRef="usd">-4000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i770c6b93b017435188c94e8c9d24f250_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzUtMS0xLTEtMjY1MjQ3_55903b57-4e6e-4d0d-912c-173b20496e4b"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="iaa8216683f294597bdbecb11b8d62331_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzUtMy0xLTEtMjY1MjQ3_7f2fd13b-ee23-4394-a0c9-5293760965a0"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="ied85a7e77c3c4ba692a634daee0770fd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzUtNS0xLTEtMjY1MjQ3_b15ed066-b8b5-4946-b73c-bac7d66394fe"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i79c89c6186094898bdeb5257ad524c9d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzUtNy0xLTEtMjY1MjQ3_fff546a1-ffc3-4884-858c-91177b849534"
      unitRef="usd">3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="id25912d8f6374ed5934f4e13f688ef0f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzUtOS0xLTEtMjY1MjQ3_66d5ec8f-3a57-45e5-9d7c-b7475838866d"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i33cbb6bd12fe4c8293ea3dde4c77e687_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzUtMTEtMS0xLTI2NTI0Nw_2fc3b2f9-05ce-45a0-bcfd-34914e8c809d"
      unitRef="usd">13000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i5711de78e5dc4ebf9b7a6c859a134de8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzUtMTMtMS0xLTI2NTI0Nw_2ae6522e-5b3f-41bf-9954-95dc4f9dadcc"
      unitRef="usd">17000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i770c6b93b017435188c94e8c9d24f250_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzYtMS0xLTEtMjY1MjQ3_a15f6c8d-87aa-4ead-9cac-53eb64b1ff62"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="iaa8216683f294597bdbecb11b8d62331_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzYtMy0xLTEtMjY1MjQ3_e843fdf2-2f26-4d83-bb3a-afeae18a0dca"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="ied85a7e77c3c4ba692a634daee0770fd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzYtNS0xLTEtMjY1MjQ3_5a311ce0-619a-4b66-bec7-f9d0e48d6128"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i79c89c6186094898bdeb5257ad524c9d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzYtNy0xLTEtMjY1MjQ3_6e98ad85-db87-430e-bdf8-8a39dfc6d59e"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="id25912d8f6374ed5934f4e13f688ef0f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzYtOS0xLTEtMjY1MjQ3_6e76b5cf-3db2-4e8b-a6bf-bcc8c5c19788"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i33cbb6bd12fe4c8293ea3dde4c77e687_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzYtMTEtMS0xLTI2NTI0Nw_07215593-6944-4fb4-b419-8265b07bce00"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i5711de78e5dc4ebf9b7a6c859a134de8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzYtMTMtMS0xLTI2NTI0Nw_2d2e6705-1990-41b7-b602-3517a9f6e8d3"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i770c6b93b017435188c94e8c9d24f250_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzctMS0xLTEtMjY1MjQ3_f3880fc9-581e-4598-9109-01f63f340fe4"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="iaa8216683f294597bdbecb11b8d62331_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzctMy0xLTEtMjY1MjQ3_9c087ea1-369e-402a-b2ef-d69ca22ef294"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="ied85a7e77c3c4ba692a634daee0770fd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzctNS0xLTEtMjY1MjQ3_a8d5107e-5f09-499a-85ad-e665d14b1a42"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i79c89c6186094898bdeb5257ad524c9d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzctNy0xLTEtMjY1MjQ3_7962442d-de7a-491b-942b-eb0ad5b35b03"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="id25912d8f6374ed5934f4e13f688ef0f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzctOS0xLTEtMjY1MjQ3_dcdcb2de-82b0-4ec0-a8db-a3c548e43a14"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i33cbb6bd12fe4c8293ea3dde4c77e687_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzctMTEtMS0xLTI2NTI0Nw_2ca65b0d-8d48-490f-8394-7f2f4690e125"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i5711de78e5dc4ebf9b7a6c859a134de8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzctMTMtMS0xLTI2NTI0Nw_7b237387-86f2-4e20-adf5-8d2df399bb23"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i770c6b93b017435188c94e8c9d24f250_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzgtMS0xLTEtMjY1MjQ3_e9066851-ca4d-4225-880f-ebe064c8fa6f"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="iaa8216683f294597bdbecb11b8d62331_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzgtMy0xLTEtMjY1MjQ3_cc335814-0b87-465b-a175-6c432a6d0fd1"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="ied85a7e77c3c4ba692a634daee0770fd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzgtNS0xLTEtMjY1MjQ3_4647145b-5222-44b2-99f3-f4a0236867ff"
      unitRef="usd">10000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i79c89c6186094898bdeb5257ad524c9d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzgtNy0xLTEtMjY1MjQ3_d1248903-a639-48df-956f-a2055726d4d4"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="id25912d8f6374ed5934f4e13f688ef0f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzgtOS0xLTEtMjY1MjQ3_7586cb34-1301-447c-a6e1-b965066b2a56"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i33cbb6bd12fe4c8293ea3dde4c77e687_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzgtMTEtMS0xLTI2NTI0Nw_bf65fbeb-fede-4efc-acf3-c4fd72deae3c"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i5711de78e5dc4ebf9b7a6c859a134de8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzgtMTMtMS0xLTI2NTI0Nw_bfd5028f-38c5-49b5-be93-bb44c524e427"
      unitRef="usd">15000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i2fdcb45e510345908f049a08f8d3ea8b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzktMS0xLTEtMjY1MjQ3_345ab251-e213-4d3a-8231-1ad3b15052e6"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ibe6072dccf0e4a3386213b62e3088a40_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzktMy0xLTEtMjY1MjQ3_322a1e15-22a6-4b75-9b56-cd4f9c018be9"
      unitRef="usd">38000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ia886fe9743a34d83adeda64bfbcde12e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzktNS0xLTEtMjY1MjQ3_0a006499-b9c0-42b4-8349-1b363416f70c"
      unitRef="usd">10000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ie042a85f623e47be97fb43ff84873341_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzktNy0xLTEtMjY1MjQ3_2540c0c8-6e32-46be-ae98-2407d1adf84e"
      unitRef="usd">3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="if32a2b7d26c44e27ac43f062d7bb8ce8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzktOS0xLTEtMjY1MjQ3_e3b66908-f310-4feb-b69a-d85d51506e60"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i23ea6c9d959a4be69bc036bae5151a22_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzktMTEtMS0xLTI2NTI0Nw_e820b121-0a76-4b0c-8bf9-514c26124706"
      unitRef="usd">55000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="id7e14cbf58db473094f1a3a50e0e0423_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTphZGVmNjlmZDkzYTY0ZDYyOWJkNmQxMGI1NGZjYjFiMS90YWJsZXJhbmdlOmFkZWY2OWZkOTNhNjRkNjI5YmQ2ZDEwYjU0ZmNiMWIxXzktMTMtMS0xLTI2NTI0Nw_bedff9cd-3669-43d3-9200-dcafaa455e6c"
      unitRef="usd">111000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0Xzc3NTQ_3054dbc2-0dce-4328-9cc1-56e018ab5f08"
      unitRef="usd">-4000000</us-gaap:FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="if12cdf7fc62645698e90b515b611256b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZToxMTA3MzBkZjBhNTM0YWM2OWVmYTAyYzMwMWQ0Y2M4ZS90YWJsZXJhbmdlOjExMDczMGRmMGE1MzRhYzY5ZWZhMDJjMzAxZDRjYzhlXzEtMS0xLTEtMjY1MjQ3_433ac9e8-9690-4bf7-bb2d-1189a1dfec8a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="i128f1c4ae2fb4204a95761f38befbbcb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZToxMTA3MzBkZjBhNTM0YWM2OWVmYTAyYzMwMWQ0Y2M4ZS90YWJsZXJhbmdlOjExMDczMGRmMGE1MzRhYzY5ZWZhMDJjMzAxZDRjYzhlXzEtMy0xLTEtMjY1MjQ3_5c5aa541-e4e5-4638-81c4-3682a0bd2749"
      unitRef="usd">15000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="if12cdf7fc62645698e90b515b611256b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZToxMTA3MzBkZjBhNTM0YWM2OWVmYTAyYzMwMWQ0Y2M4ZS90YWJsZXJhbmdlOjExMDczMGRmMGE1MzRhYzY5ZWZhMDJjMzAxZDRjYzhlXzItMS0xLTEtMjY1MjQ3_848a6c2d-4231-4f03-88a9-c6320d8c9f82"
      unitRef="usd">29000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i128f1c4ae2fb4204a95761f38befbbcb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZToxMTA3MzBkZjBhNTM0YWM2OWVmYTAyYzMwMWQ0Y2M4ZS90YWJsZXJhbmdlOjExMDczMGRmMGE1MzRhYzY5ZWZhMDJjMzAxZDRjYzhlXzItMy0xLTEtMjY1MjQ3_08dae991-2e53-449c-b747-0059989de26f"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="if12cdf7fc62645698e90b515b611256b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZToxMTA3MzBkZjBhNTM0YWM2OWVmYTAyYzMwMWQ0Y2M4ZS90YWJsZXJhbmdlOjExMDczMGRmMGE1MzRhYzY5ZWZhMDJjMzAxZDRjYzhlXzMtMS0xLTEtMjY1MjQ3_9c039249-3009-4fd5-9f5c-f07095c4d771"
      unitRef="usd">-29000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i128f1c4ae2fb4204a95761f38befbbcb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZToxMTA3MzBkZjBhNTM0YWM2OWVmYTAyYzMwMWQ0Y2M4ZS90YWJsZXJhbmdlOjExMDczMGRmMGE1MzRhYzY5ZWZhMDJjMzAxZDRjYzhlXzMtMy0xLTEtMjY1MjQ3_8569120b-b176-4a7f-aa4a-85ab793d371c"
      unitRef="usd">15000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzEwNzE5_bfc2e6ad-5ecc-40b5-a90a-6db33f751d2c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the consolidated balance sheets at adjusted cost or contract value at December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for additional information regarding the valuation of cost method investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes long-term debt of $3&#160;million which has been accounted for as liabilities held for sale and is included in liabilities held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="ib998634049ce4ca88cef9c730f1a8c88_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzQtMS0xLTEtMjY1MjQ3_e35900c1-aff5-42aa-8470-920b9f23c8ef"
      unitRef="usd">1044000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i96ac2a40938b4452a62b6a712077bb99_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzQtMy0xLTEtMjY1MjQ3_c175b9e9-d000-447e-991d-256b148f7fce"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i9c9e1fabf93c4866832c216cd1d05ff1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzQtNS0xLTEtMjY1MjQ3_f6c9a2ad-5b9e-4b8f-b78e-d2c7fee9b6cb"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i06b531bb7d2c4c9fb13fbf2858aad603_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzQtNy0xLTEtMjY1MjQ3_7af667c7-0099-4576-ba26-20ef81ffb7a9"
      unitRef="usd">978000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i3f36a954f0b04a9bba80a5b07037ee72_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzQtOS0xLTEtMjY1MjQ3_4b3cfd7b-6e38-478d-9f99-a5a6299409b3"
      unitRef="usd">978000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="ib998634049ce4ca88cef9c730f1a8c88_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzUtMS0xLTEtMjY1MjQ3_ea393b6a-f059-4e2d-ad9e-ea82031da821"
      unitRef="usd">411000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="ib998634049ce4ca88cef9c730f1a8c88_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzgtMS0xLTEtMjY1MjQ3_d332a3d4-b610-4e79-b12c-f00c5b0f40a1"
      unitRef="usd">3000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i96ac2a40938b4452a62b6a712077bb99_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzgtMy0xLTEtMjY1MjQ3_8f98cb2d-2a98-4bbd-b1b6-6cde2e028802"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i9c9e1fabf93c4866832c216cd1d05ff1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzgtNS0xLTEtMjY1MjQ3_f55cd0e4-d73e-40c7-ab81-b8a12280e41d"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i06b531bb7d2c4c9fb13fbf2858aad603_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzgtNy0xLTEtMjY1MjQ3_93c32e31-ab37-4877-80d7-a078de95fcd1"
      unitRef="usd">3000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i3f36a954f0b04a9bba80a5b07037ee72_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzgtOS0xLTEtMjY1MjQ3_2e00a217-f82f-4f1d-9a75-ef1552b3b44a"
      unitRef="usd">3000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="ib998634049ce4ca88cef9c730f1a8c88_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzktMS0xLTEtMjY1MjQ3_4aa117ea-0340-4ccd-8b5e-6b00121abce8"
      unitRef="usd">332000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i96ac2a40938b4452a62b6a712077bb99_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzktMy0xLTEtMjY1MjQ3_99c3b4a0-133b-448d-b49c-151fd57cfa53"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i9c9e1fabf93c4866832c216cd1d05ff1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzktNS0xLTEtMjY1MjQ3_bcae27e7-8432-49ab-a12f-ae290fe2ef69"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i06b531bb7d2c4c9fb13fbf2858aad603_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzktNy0xLTEtMjY1MjQ3_b75bd0eb-9378-4224-9a8c-0b41b95757fd"
      unitRef="usd">305000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i3f36a954f0b04a9bba80a5b07037ee72_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzktOS0xLTEtMjY1MjQ3_1b363632-3de6-4145-a9a4-515aaf2bf097"
      unitRef="usd">305000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib998634049ce4ca88cef9c730f1a8c88_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzEwLTEtMS0xLTI2NTI0Nw_b5ebe722-5289-4a3c-88be-1eeb2db31ba1"
      unitRef="usd">52257000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i96ac2a40938b4452a62b6a712077bb99_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzEwLTMtMS0xLTI2NTI0Nw_efbb7b51-d1ab-4b7d-8230-d6d7ac109e19"
      unitRef="usd">47653000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i9c9e1fabf93c4866832c216cd1d05ff1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzEwLTUtMS0xLTI2NTI0Nw_ef044dcc-d516-40cf-b920-f0e07bd37351"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i06b531bb7d2c4c9fb13fbf2858aad603_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzEwLTctMS0xLTI2NTI0Nw_51a6c8c4-4532-44fa-b18a-7b15628bf845"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i3f36a954f0b04a9bba80a5b07037ee72_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzEwLTktMS0xLTI2NTI0Nw_dc2fd147-ca2d-4764-b814-b279f18c8141"
      unitRef="usd">47653000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i21d1adae38074c42b4c3c61194cf93e0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE0LTEtMS0xLTI2NTI0Nw_dce558e5-b6e4-4de6-a4be-0efa51be9314"
      unitRef="usd">902000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="ife1fe98fbd264b5b962a3adc684d2edf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE0LTMtMS0xLTI2NTI0Nw_5661814a-af8b-4d77-ba0b-77146dc4bf12"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="idf67a70a0e4140fdafb4bfede6ecf6ab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE0LTUtMS0xLTI2NTI0Nw_44faa783-c0a0-43e8-8a1b-3acb8fdca65b"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="if277087345804c939318d54c5863d3b5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE0LTctMS0xLTI2NTI0Nw_a6add601-14fa-4757-a7aa-27d100307ab3"
      unitRef="usd">907000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="ie66a1446652841afb7a31c13e604633c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE0LTktMS0xLTI2NTI0Nw_b1c4641c-dcc9-430e-962a-fc6885b0fe83"
      unitRef="usd">907000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i21d1adae38074c42b4c3c61194cf93e0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE1LTEtMS0xLTI2NTI0Nw_d7b3e4c0-e9c7-4b1a-a8c1-221737829eb4"
      unitRef="usd">126000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i21d1adae38074c42b4c3c61194cf93e0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE4LTEtMS0xLTI2NTI0Nw_4024aeae-1f44-4f94-83f0-508dfef6077d"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="ife1fe98fbd264b5b962a3adc684d2edf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE4LTMtMS0xLTI2NTI0Nw_554dc1dd-b630-4772-9781-ff9a7628bdb4"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="idf67a70a0e4140fdafb4bfede6ecf6ab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE4LTUtMS0xLTI2NTI0Nw_1418007b-8a37-4098-ab21-1a8c9d71f51b"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="if277087345804c939318d54c5863d3b5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE4LTctMS0xLTI2NTI0Nw_4be4cd3e-ae0a-4abd-837c-f1dac878f2d7"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="ie66a1446652841afb7a31c13e604633c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE4LTktMS0xLTI2NTI0Nw_6aaf3aad-fd37-418d-b508-8bf303e550ff"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i21d1adae38074c42b4c3c61194cf93e0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE5LTEtMS0xLTI2NTI0Nw_729a5572-9a74-4ecb-9638-4ae744445d0a"
      unitRef="usd">336000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="ife1fe98fbd264b5b962a3adc684d2edf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE5LTMtMS0xLTI2NTI0Nw_99e2bd58-b827-440e-805f-ce82f8d9b1eb"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="idf67a70a0e4140fdafb4bfede6ecf6ab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE5LTUtMS0xLTI2NTI0Nw_0ec860b3-430f-4cb9-937f-dad49d593f6f"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="if277087345804c939318d54c5863d3b5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE5LTctMS0xLTI2NTI0Nw_bad23527-5378-429c-b556-326e13fb5a88"
      unitRef="usd">373000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="ie66a1446652841afb7a31c13e604633c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzE5LTktMS0xLTI2NTI0Nw_fe69b7d0-ed64-4ad9-9f51-6fd86695526f"
      unitRef="usd">373000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i21d1adae38074c42b4c3c61194cf93e0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzIwLTEtMS0xLTI2NTI0Nw_3b9bd029-6057-4acd-a73d-7756987bb4d7"
      unitRef="usd">56176000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ife1fe98fbd264b5b962a3adc684d2edf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzIwLTMtMS0xLTI2NTI0Nw_19544d24-49e0-435a-8b8b-8a3ab0413e62"
      unitRef="usd">64157000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="idf67a70a0e4140fdafb4bfede6ecf6ab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzIwLTUtMS0xLTI2NTI0Nw_f16dcdfa-5afd-4186-9ea0-db3f3210fabc"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="if277087345804c939318d54c5863d3b5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzIwLTctMS0xLTI2NTI0Nw_a6b508cd-b255-47f1-9a91-2b413664ead9"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ie66a1446652841afb7a31c13e604633c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo4ZDJjMWQ4MmI0YTM0YzJiYTBjNTZmZGY2OTgyNjdjMi90YWJsZXJhbmdlOjhkMmMxZDgyYjRhMzRjMmJhMGM1NmZkZjY5ODI2N2MyXzIwLTktMS0xLTI2NTI0Nw_c292c376-23e9-41bb-af48-6555451f4f54"
      unitRef="usd">64157000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i51e0bcd2d29b46c7aa058026dc2a2ed5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0Xzg0Nzk_5460ba72-4c73-4a8b-aca8-b1050ef064e7"
      unitRef="usd">3000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzEwNzE2_e08fd4d7-3d76-4612-b4cc-2740d9aa2bfe">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts financial assets at December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common/collective trusts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $85 million of other payables and $70&#160;million of other receivables at December&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the fair value of assets, by major investment category, supporting Separate Accounts as of December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities and common/collective trusts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $85 million of other payables and $70&#160;million of other receivables at December&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock>
    <us-gaap:SeparateAccountAssets
      contextRef="if689b204e34543fe95ac080b3debc55f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzItMS0xLTEtMjY1MjQ3_e6d812d4-b0a9-4930-9983-2da37850f5ef"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i2ee45bbfada1407eace8ba71e97a1529_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzItMy0xLTEtMjY1MjQ3_4b3cb33e-a9ef-421f-b467-39b46eb9f022"
      unitRef="usd">154000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="iaad452f7bcd446778bc7ba3f4ca770d1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzItNS0xLTEtMjY1MjQ3_4b5c4430-90b8-4f98-a3ef-1b2446ee0aee"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i5e061b66c25d4fd5ac6440b36c42c982_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzItNy0xLTEtMjY1MjQ3_33a2ba3b-fa8b-48db-b24b-d92f49c83a8d"
      unitRef="usd">156000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i6765b714ea5d4a02a77b602f004b5cc4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzItOS0xLTEtMjY1MjQ3_c326b0c8-8646-4db9-af8f-e0b97f7d1df2"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i7983c2bd0c7b46a0b3bf893eec46f3de_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzItMTEtMS0xLTI2NTI0Nw_5f26ee31-1a70-4048-9c7a-cb6375ff7534"
      unitRef="usd">186000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i96c159461792475cab9a57d784186344_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzItMTMtMS0xLTI2NTI0Nw_653389a4-2f5c-4b7f-b078-27d2a709fe4d"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i05ef8fe160b24777ae8c78c62e45e2fa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzItMTUtMS0xLTI2NTI0Nw_f59e3b85-f6f2-4533-a6c1-49ba0a2b2005"
      unitRef="usd">188000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i49b05a6599ba4f3b8fb0296a00fc3649_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzMtMS0xLTEtMjY1MjQ3_4755c6eb-5b94-4524-802b-935def0ab511"
      unitRef="usd">712000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i3b3c1aac8a2c4908b044154620848a2f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzMtMy0xLTEtMjY1MjQ3_dc4dbbf0-a164-492a-a9d3-23c161b58028"
      unitRef="usd">1965000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i231179ba5b6a470c9209f71e7dbbb810_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzMtNS0xLTEtMjY1MjQ3_9aa11dbe-7c65-43b2-a9a4-e7294d13f802"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="id105f8985abf43278ce21b4eb1dbf055_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzMtNy0xLTEtMjY1MjQ3_d6740a1b-d123-420d-966a-b10542f104fb"
      unitRef="usd">2677000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="iebee988b218b43188ce78e0ecf93058b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzMtOS0xLTEtMjY1MjQ3_22b8d92b-f811-4bdc-98b2-3a46c13dcc09"
      unitRef="usd">1233000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ic9179ad3cfa14f48a4448a5ae59ffb9e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzMtMTEtMS0xLTI2NTI0Nw_eda01d76-f4a2-4a72-997e-8a9f12093c64"
      unitRef="usd">3048000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ib698372482a64b2b838c35c08acfb43b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzMtMTMtMS0xLTI2NTI0Nw_356b0dfe-2232-4998-bb80-53dffce0d147"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i4d76414b76554feca73881ec515dcf3a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzMtMTUtMS0xLTI2NTI0Nw_222ab60b-f5fe-4fbb-b16a-f6c48a46b3a5"
      unitRef="usd">4281000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ic1d74124f6be475b8f9ae2f51da28944_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzQtMS0xLTEtMjY1MjQ3_ffd0e349-7f93-4c5d-bf97-f43fd434fe98"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i1c13d2018e6445458a682aafc8803716_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzQtMy0xLTEtMjY1MjQ3_c5a21a61-0c47-4784-9f86-3bb237c11e21"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ifb11f4892b1a4083a46e94dae7ceff9f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzQtNS0xLTEtMjY1MjQ3_a592d894-7e9d-4c0f-b569-a8a5562c86b7"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i20fa3af468954aa4933d0e3030a4ae0a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzQtNy0xLTEtMjY1MjQ3_2bee4463-5209-4092-a955-775a7cfcbb03"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i10d95680a25f4275bf74bd275a219904_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzQtOS0xLTEtMjY1MjQ3_efd1e819-6f5a-489e-b619-60af61075d21"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i3add96661c68429c98bc447aa30d7e90_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzQtMTEtMS0xLTI2NTI0Nw_1e8f4dcb-4f32-47de-9ed0-1913b236052d"
      unitRef="usd">1000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ie85ddd31302d48b39bf9b6b531607b98_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzQtMTMtMS0xLTI2NTI0Nw_ae53a669-36b5-4d57-a965-fecfcc7f1e6d"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i093853abc6424f1fa611b8455b524dc9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzQtMTUtMS0xLTI2NTI0Nw_df9e48e2-87bf-42b1-85c6-62c0e362ced3"
      unitRef="usd">1000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="iabb2b81fff06464f8b9d20abd344348b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzUtMS0xLTEtMjY1MjQ3_87ccb000-337c-4251-a689-ea4a9c7767d3"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ifccbe865cbb14d2091ef941a3b9bfe9d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzUtMy0xLTEtMjY1MjQ3_f727e89c-63af-4ad1-9216-277fbd26e553"
      unitRef="usd">480000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i3517cb5c6870409aa7e4a35e9131090e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzUtNS0xLTEtMjY1MjQ3_6b5e56da-13b2-4990-a824-83cdce04897c"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i08d7c8d3b44844d9a53252e4dbcb3411_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzUtNy0xLTEtMjY1MjQ3_d34dda55-98cb-45ac-af36-3541677c0dae"
      unitRef="usd">480000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i1be8dacc0e33455686bdb32ee8a892e5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzUtOS0xLTEtMjY1MjQ3_d1bc8a3b-258f-42cd-97a4-1932fefce1ca"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ic3c351bb44d34de9a79d55ff5ad02121_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzUtMTEtMS0xLTI2NTI0Nw_ffd25fe7-044b-4307-8239-85e93f3b0099"
      unitRef="usd">547000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i809fd6b11b2a4971a3517725cbdca04f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzUtMTMtMS0xLTI2NTI0Nw_c927da4c-3a18-4661-83eb-24abea3b9298"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i473e7e5830bb4215af2dc4cfb615a70e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzUtMTUtMS0xLTI2NTI0Nw_d355257b-a370-44ad-8dea-27d6c4d123b5"
      unitRef="usd">547000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="icaf7c772d40247269c23c494f0813a7f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzYtMS0xLTEtMjY1MjQ3_4dc02b87-4977-42ab-bec2-b3e22e779699"
      unitRef="usd">714000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i0ada3d841105476b9dca967f07a9dee9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzYtMy0xLTEtMjY1MjQ3_2b8894f2-32d4-4dd6-bad3-34e0f3290f1f"
      unitRef="usd">2599000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ie9bd28275ddc4fac99461d0040a82e04_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzYtNS0xLTEtMjY1MjQ3_e2fdeda0-bbe9-42ff-883f-2d9af404e0c0"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ibbd43a9242a0495591196ce21cc7a152_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzYtNy0xLTEtMjY1MjQ3_214011f1-1fc7-4ff9-992c-14a725c4e6d0"
      unitRef="usd">3313000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ib91aae7889074bd7a05849761119e002_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzYtOS0xLTEtMjY1MjQ3_ce2a9337-9c62-47fb-98db-dbf5c80db2c3"
      unitRef="usd">1235000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i91e3342f2eda4923accdad0511bbd8ab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzYtMTEtMS0xLTI2NTI0Nw_de87ab13-5bc5-434d-b992-5f483c81d31f"
      unitRef="usd">3782000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i47cdbbca2588456f80bd73c676fe393c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzYtMTMtMS0xLTI2NTI0Nw_c1ecbea1-996c-4d33-8f9e-3050f35271aa"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="id7e14cbf58db473094f1a3a50e0e0423_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90YWJsZTo0YjI0YTRlYTM1YTY0MzI1OTA0YjEzMGQwOWE3YTE0Ni90YWJsZXJhbmdlOjRiMjRhNGVhMzVhNjQzMjU5MDRiMTMwZDA5YTdhMTQ2XzYtMTUtMS0xLTI2NTI0Nw_d54df781-7c7a-4db2-b5f5-ff60482a7f35"
      unitRef="usd">5017000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountsLiability
      contextRef="i2cfae73c894b48b3adc8ba56219aaf76_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzEwNDg3_86744857-0167-4543-9e9f-7fa4b874ec3b"
      unitRef="usd">85000000</us-gaap:SeparateAccountsLiability>
    <us-gaap:SeparateAccountAssets
      contextRef="i5f60137c965c405995e63ea19fbaacc4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzEwNTEy_fc4559c1-f801-4eca-81b0-d6405308c871"
      unitRef="usd">70000000</us-gaap:SeparateAccountAssets>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i4ecc8bd5e850436fa0683a5a0e40c8c0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzEwNjI4_3564050e-2f78-4ce4-95d3-9facba503c89"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i33d746c2511346dab6d70642faa03778_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzAvZnJhZzo4NTljMzhiMGFkNjQ0Nzc0OWI0NzAzM2M5OTRmODdjNC90ZXh0cmVnaW9uOjg1OWMzOGIwYWQ2NDQ3NzQ5YjQ3MDMzYzk5NGY4N2M0XzEwNjI4_52e004e8-db93-414b-b7d6-21b60e3095b1"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzM0MjU_c941a55d-52c4-4a1a-8586-3f67f6b34833">Goodwill and Other Intangibles&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of the changes in the carrying amount of goodwill by segment for the&#160;years ended December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy &amp;amp;&lt;br/&gt;Consumer&lt;br/&gt;Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt;padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(971)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(971)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2022, the decrease in the carrying amount of goodwill was primarily driven by the divestitures of bswift, PayFlex and the Thailand business. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information. During the year ended December&#160;31, 2021, the decrease in the carrying amount of goodwill was primarily driven by the impairment of the remaining goodwill of the LTC reporting unit within the Pharmacy &amp;amp; Consumer Wellness segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2022, the Company performed its required annual impairment tests of goodwill. The results of the impairment tests indicated that there was no impairment of goodwill. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2021, the Company performed its required annual impairment tests of goodwill. The results of the impairment tests indicated an impairment of the goodwill associated with the LTC reporting unit, as the reporting unit&#x2019;s carrying value exceeded its fair value as of the testing date. The results of the impairment tests of the remaining reporting units indicated that there was no impairment of goodwill as of the testing date. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2021, the LTC reporting unit continued to face challenges that have impacted the Company&#x2019;s ability to grow the LTC reporting unit&#x2019;s business at the rate estimated when its 2020 goodwill impairment test was performed. These challenges include lower net facility admissions, net long-term care facility customer losses and the prolonged adverse impact of the COVID-19 pandemic and the emerging new variants, which resulted in more significant declines in occupancy rates experienced by the Company&#x2019;s long-term care facility customers than previously anticipated. During the third quarter of 2021, LTC management updated their 2021 annual forecast and submitted their long-term plan which showed deterioration in the financial results for the remainder of 2021 and beyond. The Company utilized these updated projections in performing its annual impairment test, which indicated that the fair value of the LTC reporting unit was lower than its carrying value, resulting in a $431&#160;million goodwill impairment charge in the third quarter of 2021. The fair value of the LTC reporting unit was determined using a combination of a discounted cash flow method and a market multiple method. As of December&#160;31, 2021, there was no remaining goodwill balance in the LTC reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At both December&#160;31, 2022 and 2021, cumulative goodwill impairments were $6.6 billion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s intangible assets as of December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions, except weighted average life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks (indefinite-lived)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts/relationships and covenants not to compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,668)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(862)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value of Business Acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks (indefinite-lived)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts/relationships and covenants not to compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value of Business Acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes intangible assets of $28&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2022, the reduction in the customer contracts/relationships intangible assets is primarily related to the Company&#x2019;s loss on assets held for sale of $2.5&#160;billion to write-down the LTC business to its estimated fair value less costs to sell. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense for intangible assets totaled $1.8 billion, $2.2 billion and $2.3 billion for the years ended December 31, 2022, 2021 and 2020, respectively. The projected annual amortization expense for the Company&#x2019;s intangible assets for the next five&#160;years is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzM0Mjc_fb10a2b0-6c3d-40d3-952d-a2e334e24db9">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of the changes in the carrying amount of goodwill by segment for the&#160;years ended December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy &amp;amp;&lt;br/&gt;Consumer&lt;br/&gt;Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt;padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(971)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(971)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ib018c9e5213340b8a2330528464a3616_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzEtMS0xLTEtMjY1MjQ3_2594c8b3-88d2-4175-942f-165bbeefc2f9"
      unitRef="usd">45130000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i946281b536bd4451b3d56d4d5bcaade8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzEtMy0xLTEtMjY1MjQ3_cbcec989-4feb-443a-beb2-c6b9d7866486"
      unitRef="usd">23615000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic66da0cbafad40c0b09c17c59b015bc2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzEtNS0xLTEtMjY1MjQ3_a4a0bf1f-2ed6-48af-8a0c-412d57b4fdd2"
      unitRef="usd">10807000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i501f291fb23d49e987222cf13c851afc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzEtNy0xLTEtMjY1MjQ3_bbaa5346-8acf-4e92-a050-38ad7051429f"
      unitRef="usd">79552000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i2a1d88c90afd4868bb3842de60276b75_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzUtMS0xLTEtMjY1MjQ3_bfea45a4-c512-41b4-b985-aa2c8150f2ce"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i2dd993afeac2436b99c2d440336ae246_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzUtMy0xLTEtMjY1MjQ3_43f01e44-771c-4d2c-a81e-cce5853bd670"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i10733861aa764487bcae8d1a5debd7ab_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzUtNS0xLTEtMjY1MjQ3_0a460040-2e3c-4e23-a022-3c354c9dd59b"
      unitRef="usd">431000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzUtNy0xLTEtMjY1MjQ3_685a2d35-cf38-46af-8d38-a6e2be3484b5"
      unitRef="usd">431000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="ic8885190ef7841e48df544637103ca44_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzYtMS0xLTEtMjY1MjQ3_67bbc6b7-f6d4-4fb0-b6e2-8e4efeabb83c"
      unitRef="usd">45130000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if80e6d478f774215aba1c17bfd3b0a9f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzYtMy0xLTEtMjY1MjQ3_cfe815d5-3b89-44b1-a28d-421e73d284d9"
      unitRef="usd">23615000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i753d74536e76447a97ef85017079a80c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzYtNS0xLTEtMjY1MjQ3_33b37673-d0a9-4f4b-b0b5-b9699fe2cc0b"
      unitRef="usd">10376000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzYtNy0xLTEtMjY1MjQ3_1c0edf46-53db-4fcd-b9dd-85e25334e532"
      unitRef="usd">79121000000</us-gaap:Goodwill>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="ibe08d096357844f88d5bc75a18fcd936_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzktMS0xLTEtMjY1MjQ3_d6b6c06c-e434-433a-9da3-3d1581988f91"
      unitRef="usd">971000000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="ida2cad6c1b0542db87d072a6e3ffe684_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzktMy0xLTEtMjY1MjQ3_e0dec996-f947-4877-bd09-16e6a9782fd5"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i3ffa35f6be0f433ea5d0c817c81cb4aa_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzktNS0xLTEtMjY1MjQ3_3b13f321-33d1-4b1c-adbd-f37c4733e649"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="ic9bbc9d820604ed98ed4729f6b0aa8f3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzktNy0xLTEtMjY1MjQ3_6ef87f38-13be-4925-bd0c-cf07a31f03a7"
      unitRef="usd">971000000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:Goodwill
      contextRef="ibb1ed30851ad423db47b88e42b33cf8f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzEyLTEtMS0xLTI2NTI0Nw_a2793c60-ff8c-4f4a-86aa-bcb52c7799f9"
      unitRef="usd">44159000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i839a6c4fcaad4f5fa23979221c63e037_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzEyLTMtMS0xLTI2NTI0Nw_88f37c35-8972-42fa-a50f-b9488fc6c193"
      unitRef="usd">23615000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id114deab047e49b5a8b771195b4a54a2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzEyLTUtMS0xLTI2NTI0Nw_80fe58eb-6dcc-4bcf-9349-9e7c5dd9e09e"
      unitRef="usd">10376000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTphYzZhZmM1YTNmNDA0YWJiOGM1NDFjZTQ0MTgwODhlZS90YWJsZXJhbmdlOmFjNmFmYzVhM2Y0MDRhYmI4YzU0MWNlNDQxODA4OGVlXzEyLTctMS0xLTI2NTI0Nw_52528a0a-ab32-4c8d-8efa-c0b91ad73d4a"
      unitRef="usd">78150000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ia262a9274d8f434a9a8fac8f9016ca16_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzIxODQ_fd700c44-60ab-49aa-87dc-290cf5f07383"
      unitRef="usd">431000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="i8ed4d6f5ae634f359f681dd2ea0d4e81_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzI0MDM_a79b650e-464f-4ab9-a2a7-70d945fcfb09"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzI1MTg_abd38a03-1e3b-4c9a-8fa5-cd8844f4f190"
      unitRef="usd">6600000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzI1MTg_dbf12733-df36-4ae6-8e12-0ce489d19564"
      unitRef="usd">6600000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <cvs:FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzM0Mjg_f876e6c1-9099-491f-a1b6-1ef1bf7abef2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s intangible assets as of December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions, except weighted average life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks (indefinite-lived)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts/relationships and covenants not to compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,668)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(862)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value of Business Acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks (indefinite-lived)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts/relationships and covenants not to compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value of Business Acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes intangible assets of $28&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;</cvs:FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzItMS0xLTEtMjY1MjQ3_5813d6ff-67a9-4451-b4d2-7704746bd7cc"
      unitRef="usd">10498000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzItNS0xLTEtMjY1MjQ3_20a915d2-4d89-4b37-8f8c-e460e4444256"
      unitRef="usd">10498000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="icacec4d2bd5a441bb697bf94305fab43_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzMtMS0xLTEtMjY1MjQ3_667a2dd7-c9ce-4725-bbd5-b11dd122ea71"
      unitRef="usd">21206000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="icacec4d2bd5a441bb697bf94305fab43_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzMtMy0xLTEtMjY1MjQ3_fabd2a3d-8842-46c7-be8d-6cb0c32e262b"
      unitRef="usd">10668000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="icacec4d2bd5a441bb697bf94305fab43_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzMtNS0xLTEtMjY1MjQ3_5412819e-9ab8-4f61-9ffd-9c8e5015a2fb"
      unitRef="usd">10538000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="ib59e20c5189b4f5cb592cb8f4b8324de_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzMtNy0xLTEtMjY1MjQ3_ae86c378-5912-461a-a705-82faf37df638">P13Y3M18D</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib47864323cfe45848ffe84168e0f0ccb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzQtMS0xLTEtMjY1MjQ3_9cb0c662-f853-4ca9-9a64-c953c8174d5c"
      unitRef="usd">1060000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib47864323cfe45848ffe84168e0f0ccb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzQtMy0xLTEtMjY1MjQ3_e987348c-4063-41fe-b266-35c8e6029a55"
      unitRef="usd">1060000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib47864323cfe45848ffe84168e0f0ccb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzQtNS0xLTEtMjY1MjQ3_de593692-56d7-49b4-a6c1-c875d7c5d4b9"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6ffa6a6d070a4dd2bdf38824f6bd5261_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzUtMS0xLTEtMjY1MjQ3_b167b4f4-3b9f-4ff7-b85c-4057b9015966"
      unitRef="usd">4203000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6ffa6a6d070a4dd2bdf38824f6bd5261_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzUtMy0xLTEtMjY1MjQ3_13f08c0c-397a-4956-a8d2-f1feb546ac70"
      unitRef="usd">862000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6ffa6a6d070a4dd2bdf38824f6bd5261_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzUtNS0xLTEtMjY1MjQ3_7e2c2248-768e-4500-8c32-e73586168db2"
      unitRef="usd">3341000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="ic9741c2be1f446a5b3e33d1093db0189_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzUtNy0xLTEtMjY1MjQ3_22ef6bf3-e2c0-45f5-919b-266d76397455">P20Y</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie0189be5251d42809d167551a0f5f747_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzYtMS0xLTEtMjY1MjQ3_0ceab40a-b940-4a95-ade1-937355120b2a"
      unitRef="usd">590000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie0189be5251d42809d167551a0f5f747_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzYtMy0xLTEtMjY1MjQ3_202b7642-7888-435b-9b89-e9eacc4d4427"
      unitRef="usd">174000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie0189be5251d42809d167551a0f5f747_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzYtNS0xLTEtMjY1MjQ3_5442f8fb-c12e-4c7b-ac05-eae08e16e35f"
      unitRef="usd">416000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i9520a4ef3083437894a7c7dde288f4c1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzYtNy0xLTEtMjY1MjQ3_f85875fc-ba9c-42e1-a981-53e3dec18ced">P20Y</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i07f38da039c646c59f8df03b461397cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzctMS0xLTEtMjY1MjQ3_d045a9a4-2720-478f-84ff-a74cbfb60593"
      unitRef="usd">302000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i07f38da039c646c59f8df03b461397cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzctMy0xLTEtMjY1MjQ3_cc35c429-ad61-4a82-a9e6-bafc0b2e20b7"
      unitRef="usd">264000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i07f38da039c646c59f8df03b461397cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzctNS0xLTEtMjY1MjQ3_155f847f-139e-42c0-b3cb-f16e73f78c19"
      unitRef="usd">38000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i1586ee2417bb4444a300fe3741cce552_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzctNy0xLTEtMjY1MjQ3_76da31c9-d80f-47d5-9668-f0bd56a38291">P12Y4M24D</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzgtMS0xLTEtMjY1MjQ3_516e8bec-1d6a-43f6-8120-7f4681a46486"
      unitRef="usd">37859000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzgtMy0xLTEtMjY1MjQ3_340a4c1c-da91-498c-9292-305bc2b3f485"
      unitRef="usd">13028000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <cvs:IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzgtNS0xLTEtMjY1MjQ3_4c0ae01f-3601-4c1e-a765-9c35db79113e"
      unitRef="usd">24831000000</cvs:IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzgtNy0xLTEtMjY1MjQ3_130336d4-06f3-45d8-b19b-9921cc442d37">P13Y10M24D</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzExLTEtMS0xLTI2NTI0Nw_f8fdaa4c-6ec7-499d-bc84-7b3539035a20"
      unitRef="usd">10498000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzExLTUtMS0xLTI2NTI0Nw_7417bdce-9443-4f12-9234-315b88805730"
      unitRef="usd">10498000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i10166bf4bd7d4e9aa3b7ca002a1d92e7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzEyLTEtMS0xLTI2NTI0Nw_d396f562-3a13-49ad-8a74-12337ac4a83b"
      unitRef="usd">25084000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i10166bf4bd7d4e9aa3b7ca002a1d92e7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzEyLTMtMS0xLTI2NTI0Nw_fdd859b7-16e8-4648-bc36-4df892aa9502"
      unitRef="usd">10564000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i10166bf4bd7d4e9aa3b7ca002a1d92e7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzEyLTUtMS0xLTI2NTI0Nw_d5b3ef8b-7711-4fc2-85cb-b1162d125adb"
      unitRef="usd">14520000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="idea4ec344a85455882460b397b94be2e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzEyLTctMS0xLTI2NTI0Nw_b0e24b20-e97b-4c9f-99d9-96d8c1d0842f">P15Y</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iab4ce297b2134e1faac9af7fb814d1ee_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzEzLTEtMS0xLTI2NTI0Nw_30bffdd4-3bab-4ba0-8eea-8ee6d193b187"
      unitRef="usd">1060000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iab4ce297b2134e1faac9af7fb814d1ee_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzEzLTMtMS0xLTI2NTI0Nw_f3df96de-5b86-40b2-b641-b461aff9458c"
      unitRef="usd">1060000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iab4ce297b2134e1faac9af7fb814d1ee_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzEzLTUtMS0xLTI2NTI0Nw_457adc93-b8ff-4fc0-b60c-46c437b83487"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4b97832079404df29d7a1346b50515c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE0LTEtMS0xLTI2NTI0Nw_0c872e4b-5687-4ba0-8012-c17de0be93e9"
      unitRef="usd">4203000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4b97832079404df29d7a1346b50515c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE0LTMtMS0xLTI2NTI0Nw_ddd710f4-c763-4f8c-8e54-e25d91273cb1"
      unitRef="usd">651000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4b97832079404df29d7a1346b50515c5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE0LTUtMS0xLTI2NTI0Nw_e8a2fe0a-57da-4ca4-a068-f0cd27487518"
      unitRef="usd">3552000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="idb9ab0a0f75a497f924ab0a5e8916bcb_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE0LTctMS0xLTI2NTI0Nw_9fa76d2b-c8dc-4409-a1d7-a19610673ca1">P20Y</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia298597ebbd74213b5ccc336e308e4fb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE1LTEtMS0xLTI2NTI0Nw_d44c8e9b-1433-4910-807c-c6baae576bff"
      unitRef="usd">590000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia298597ebbd74213b5ccc336e308e4fb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE1LTMtMS0xLTI2NTI0Nw_4b9de16b-c286-4a3a-984a-367ffb3e8a94"
      unitRef="usd">147000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia298597ebbd74213b5ccc336e308e4fb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE1LTUtMS0xLTI2NTI0Nw_6e2e3274-c87c-45d6-891c-a76ae0823f73"
      unitRef="usd">443000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i21e3a229c93f4655982469399aecf163_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE1LTctMS0xLTI2NTI0Nw_96a4aba8-95b7-440d-8128-9c79082fa3f0">P20Y</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i245af29d89884e149ddc482143db7d7e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE2LTEtMS0xLTI2NTI0Nw_acb73316-dc77-4d2b-abdf-ec3673f95f83"
      unitRef="usd">318000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i245af29d89884e149ddc482143db7d7e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE2LTMtMS0xLTI2NTI0Nw_639c45d9-7ac4-4a1a-a68e-9d35383d7364"
      unitRef="usd">279000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i245af29d89884e149ddc482143db7d7e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE2LTUtMS0xLTI2NTI0Nw_0364da62-07ac-4f76-b52b-d86d872b1014"
      unitRef="usd">39000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="ifd3229b629654bf1aca3934975c2c2a2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE2LTctMS0xLTI2NTI0Nw_7c9a2635-f9ef-4aca-abf9-f991b39f207e">P8Y4M24D</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE3LTEtMS0xLTI2NTI0Nw_40d6d411-d3c1-425c-8416-93d95a9eb7d8"
      unitRef="usd">41753000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE3LTMtMS0xLTI2NTI0Nw_16499af3-0e2d-4bb5-bbc3-75888d17da03"
      unitRef="usd">12701000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <cvs:IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE3LTUtMS0xLTI2NTI0Nw_934c8f98-2173-47e2-a414-dc25767b6723"
      unitRef="usd">29052000000</cvs:IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTowZjgxZjdiZTA0NjE0OWVjYmY0ZDAzZGM0YmY4ZjEzYy90YWJsZXJhbmdlOjBmODFmN2JlMDQ2MTQ5ZWNiZjRkMDNkYzRiZjhmMTNjXzE3LTctMS0xLTI2NTI0Nw_423b3ab1-8fcf-4960-9945-eeda2460ab6f">P15Y3M18D</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <cvs:IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale
      contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzI2OTg_04e7831b-113b-4c54-9370-cd2983509b7d"
      unitRef="usd">28000000</cvs:IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i8b53ab0e06784e57adb2671c1a53ced8_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzMwNTY_3098932e-292e-4912-82dc-34fab30e4035"
      unitRef="usd">2500000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzMyMjY_20776fc1-a1ab-4fae-a7fb-3475f4f97666"
      unitRef="usd">1800000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzMyMzA_67a1bbbc-a383-4016-983d-d8ae547c0a6a"
      unitRef="usd">2200000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzMyMzc_b75cdcca-84b0-41cd-acb8-a52ea441d0c3"
      unitRef="usd">2300000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90ZXh0cmVnaW9uOmM5MDg3M2IwNGM5YjQ3MmFiY2YxODBlNWIzZmUyMjQzXzM0MzE_1471be74-5103-410d-9c3c-6884921ad555">The projected annual amortization expense for the Company&#x2019;s intangible assets for the next five&#160;years is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTo5Yzg2ZDMwZTdmYjU0MDIyODA1NmZhZjJhNWE3ZDc4Ni90YWJsZXJhbmdlOjljODZkMzBlN2ZiNTQwMjI4MDU2ZmFmMmE1YTdkNzg2XzEtMS0xLTEtMjY1MjQ3_d2860f67-6805-4e16-9c91-3fc02d2ce2e4"
      unitRef="usd">1601000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTo5Yzg2ZDMwZTdmYjU0MDIyODA1NmZhZjJhNWE3ZDc4Ni90YWJsZXJhbmdlOjljODZkMzBlN2ZiNTQwMjI4MDU2ZmFmMmE1YTdkNzg2XzItMS0xLTEtMjY1MjQ3_09732a67-fe4f-4e8f-b197-2da5c6a8e73f"
      unitRef="usd">1562000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTo5Yzg2ZDMwZTdmYjU0MDIyODA1NmZhZjJhNWE3ZDc4Ni90YWJsZXJhbmdlOjljODZkMzBlN2ZiNTQwMjI4MDU2ZmFmMmE1YTdkNzg2XzMtMS0xLTEtMjY1MjQ3_82e084f2-470f-43dc-978c-d8e4b80d5365"
      unitRef="usd">1515000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTo5Yzg2ZDMwZTdmYjU0MDIyODA1NmZhZjJhNWE3ZDc4Ni90YWJsZXJhbmdlOjljODZkMzBlN2ZiNTQwMjI4MDU2ZmFmMmE1YTdkNzg2XzQtMS0xLTEtMjY1MjQ3_0242602b-ea68-4233-81dc-8b9936f557a8"
      unitRef="usd">1283000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzMvZnJhZzpjOTA4NzNiMDRjOWI0NzJhYmNmMTgwZTViM2ZlMjI0My90YWJsZTo5Yzg2ZDMwZTdmYjU0MDIyODA1NmZhZjJhNWE3ZDc4Ni90YWJsZXJhbmdlOjljODZkMzBlN2ZiNTQwMjI4MDU2ZmFmMmE1YTdkNzg2XzUtMS0xLTEtMjY1MjQ3_686b47dc-39ad-43e7-a8c2-068e6de5d40f"
      unitRef="usd">1196000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczNDk_7683e472-1c5f-4692-acdf-8c6f5a85bb51">Leases&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases most of its retail stores and mail order facilities and certain distribution centers and corporate offices under operating or finance leases, typically with initial terms of 15 to 25 years. The Company also leases certain equipment and other assets under operating or finance leases, typically with initial terms of 3 to 10 years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company leases pharmacy space at the stores of another retail chain for which the noncancelable contractual term of the pharmacy lease arrangement exceeds the remaining estimated economic life of the buildings. For these pharmacy lease arrangements, the Company concluded that for accounting purposes the lease term was the remaining estimated economic life of the buildings. Consequently, most of these individual pharmacy leases are finance leases.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the components of net lease cost for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases for the years ended December&#160;31, 2022, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows paid for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows paid for interest portion of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows paid for principal portion of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases as of December&#160;31, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except remaining lease term and discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,928&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,122&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,699&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,839&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,177&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,538&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,823&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance leases:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,608&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,375&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(284)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,406&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining lease term &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes operating lease right-of-use assets of $56&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes current portion of operating lease liabilities of $21&#160;million and long-term operating lease liabilities of $39&#160;million which have been accounted for as liabilities held for sale and are included in liabilities held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Operating&lt;br/&gt;Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,501)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Future operating lease payments have not been reduced by minimum sublease rentals of $290 million due in the future under noncancelable subleases.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.5 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sale-Leaseback Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company finances a portion of its store development program through sale-leaseback transactions. The properties are generally sold at net book value, which generally approximates fair value, and the resulting leases generally qualify and are accounted for as operating leases. The operating leases that resulted from these transactions are included in the tables above. The Company does not have any retained or contingent interests in the stores and does not provide any guarantees, other than a guarantee of lease payments, in connection with the sale-leaseback transactions. There were no sale-leaseback transactions in 2022 or 2021. Proceeds from sale-leaseback transactions totaled $101 million in the year ended December 31, 2020. Gains from sale-leaseback transactions totaled $3 million in the year ended December 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Office Real Estate Optimization Charges &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2022, the Company undertook an initiative to evaluate its corporate office real estate space in response to its new flexible work arrangement. As part of this initiative, the Company evaluated its current real estate space and changes in employee work arrangement requirements to ensure it had the appropriate space to support the business. As a result of this assessment, the Company determined that it would vacate and abandon certain leased corporate office spaces. Accordingly, in the three months ended December 31, 2022, the Company recorded office real estate optimization charges of $117&#160;million, primarily consisting of $71&#160;million related to operating lease right-of-use assets and $44&#160;million related to property and equipment, within the Health Care Benefits, Corporate/Other and Health Services segments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Store Impairment Charges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates its retail store right-of-use and property and equipment assets for impairment at the retail store level, which is the lowest level at which cash flows can be identified. For retail stores where there is an indicator of impairment present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated undiscounted future cash flows used in the analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to its estimated fair value which is the greater of the asset group&#x2019;s estimated future cash flows (discounted), or the consideration of what a market participant would pay to lease the assets, net of leasing costs. The Company&#x2019;s estimate of fair value considers historical results, current operating trends, consolidated sales, profitability and cash flow results and forecasts. For assets which the Company has determined it will be able to sublease, the estimated future cash flows include the estimated sublease income, net of estimated leasing costs. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When the carrying value of an asset group exceeds its estimated fair value, an impairment loss is recorded to reduce the value of the asset group to its estimated fair value. As the impaired assets are measured at fair value on a nonrecurring basis primarily using unobservable inputs as of the measurement date, the assets are classified in Level 3 of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2021, the Company completed a strategic review of its retail business and announced the creation of new formats for its stores to continue to drive higher engagement with customers. As part of this review, the Company evaluated changes in population, consumer buying patterns and future health needs to ensure it has the right kinds of stores in the right locations for consumers and for the business. In connection with this initiative, on November 17, 2021, the Board of Directors of CVS Health Corporation (the &#x201c;Board&#x201d;) authorized the closing of approximately 900 retail stores, approximately 300 stores each year, between 2022 and 2024. As a result, management determined that there were indicators of impairment with respect to the impacted stores&#x2019; asset groups, including the associated operating lease right-of-use assets and property and equipment. A long-lived asset impairment test was performed during the fourth quarter of 2021 and the results of the impairment test indicated that the fair value of certain retail store asset groups was lower than their respective carrying values. Accordingly, in the three months ended December 31, 2021, the Company recorded a store impairment charge of approximately $1.4 billion, consisting of a write down of approximately $1.1&#160;billion related to operating lease right-of-use assets and $261&#160;million related to property and equipment, within the Pharmacy &amp;amp; Consumer Wellness segment. Subsequent to the impairment loss, the fair value of the associated operating lease right-of use assets and property and equipment were $356&#160;million and $185&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczNTM_da449f09-d9ee-4989-899f-1b724bff3be6">Leases&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases most of its retail stores and mail order facilities and certain distribution centers and corporate offices under operating or finance leases, typically with initial terms of 15 to 25 years. The Company also leases certain equipment and other assets under operating or finance leases, typically with initial terms of 3 to 10 years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company leases pharmacy space at the stores of another retail chain for which the noncancelable contractual term of the pharmacy lease arrangement exceeds the remaining estimated economic life of the buildings. For these pharmacy lease arrangements, the Company concluded that for accounting purposes the lease term was the remaining estimated economic life of the buildings. Consequently, most of these individual pharmacy leases are finance leases.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the components of net lease cost for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases for the years ended December&#160;31, 2022, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows paid for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows paid for interest portion of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows paid for principal portion of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases as of December&#160;31, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except remaining lease term and discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,928&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,122&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,699&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,839&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,177&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,538&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,823&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance leases:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,608&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,375&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(284)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,406&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining lease term &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes operating lease right-of-use assets of $56&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes current portion of operating lease liabilities of $21&#160;million and long-term operating lease liabilities of $39&#160;million which have been accounted for as liabilities held for sale and are included in liabilities held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Operating&lt;br/&gt;Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,501)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Future operating lease payments have not been reduced by minimum sublease rentals of $290 million due in the future under noncancelable subleases.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.5 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sale-Leaseback Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company finances a portion of its store development program through sale-leaseback transactions. The properties are generally sold at net book value, which generally approximates fair value, and the resulting leases generally qualify and are accounted for as operating leases. The operating leases that resulted from these transactions are included in the tables above. The Company does not have any retained or contingent interests in the stores and does not provide any guarantees, other than a guarantee of lease payments, in connection with the sale-leaseback transactions. There were no sale-leaseback transactions in 2022 or 2021. Proceeds from sale-leaseback transactions totaled $101 million in the year ended December 31, 2020. Gains from sale-leaseback transactions totaled $3 million in the year ended December 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Office Real Estate Optimization Charges &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2022, the Company undertook an initiative to evaluate its corporate office real estate space in response to its new flexible work arrangement. As part of this initiative, the Company evaluated its current real estate space and changes in employee work arrangement requirements to ensure it had the appropriate space to support the business. As a result of this assessment, the Company determined that it would vacate and abandon certain leased corporate office spaces. Accordingly, in the three months ended December 31, 2022, the Company recorded office real estate optimization charges of $117&#160;million, primarily consisting of $71&#160;million related to operating lease right-of-use assets and $44&#160;million related to property and equipment, within the Health Care Benefits, Corporate/Other and Health Services segments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Store Impairment Charges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates its retail store right-of-use and property and equipment assets for impairment at the retail store level, which is the lowest level at which cash flows can be identified. For retail stores where there is an indicator of impairment present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated undiscounted future cash flows used in the analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to its estimated fair value which is the greater of the asset group&#x2019;s estimated future cash flows (discounted), or the consideration of what a market participant would pay to lease the assets, net of leasing costs. The Company&#x2019;s estimate of fair value considers historical results, current operating trends, consolidated sales, profitability and cash flow results and forecasts. For assets which the Company has determined it will be able to sublease, the estimated future cash flows include the estimated sublease income, net of estimated leasing costs. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When the carrying value of an asset group exceeds its estimated fair value, an impairment loss is recorded to reduce the value of the asset group to its estimated fair value. As the impaired assets are measured at fair value on a nonrecurring basis primarily using unobservable inputs as of the measurement date, the assets are classified in Level 3 of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2021, the Company completed a strategic review of its retail business and announced the creation of new formats for its stores to continue to drive higher engagement with customers. As part of this review, the Company evaluated changes in population, consumer buying patterns and future health needs to ensure it has the right kinds of stores in the right locations for consumers and for the business. In connection with this initiative, on November 17, 2021, the Board of Directors of CVS Health Corporation (the &#x201c;Board&#x201d;) authorized the closing of approximately 900 retail stores, approximately 300 stores each year, between 2022 and 2024. As a result, management determined that there were indicators of impairment with respect to the impacted stores&#x2019; asset groups, including the associated operating lease right-of-use assets and property and equipment. A long-lived asset impairment test was performed during the fourth quarter of 2021 and the results of the impairment test indicated that the fair value of certain retail store asset groups was lower than their respective carrying values. Accordingly, in the three months ended December 31, 2021, the Company recorded a store impairment charge of approximately $1.4 billion, consisting of a write down of approximately $1.1&#160;billion related to operating lease right-of-use assets and $261&#160;million related to property and equipment, within the Pharmacy &amp;amp; Consumer Wellness segment. Subsequent to the impairment loss, the fair value of the associated operating lease right-of use assets and property and equipment were $356&#160;million and $185&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeaseTermOfContract1
      contextRef="i30716a5a00af4d6bb1f1b23cccf84c89_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzIwNw_86113f23-88c9-4b91-967b-992a52cc087b">P15Y</us-gaap:LesseeFinanceLeaseTermOfContract1>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i30716a5a00af4d6bb1f1b23cccf84c89_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzIwNw_96cf93c5-6866-49e9-9346-b1854e81c22b">P15Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeFinanceLeaseTermOfContract1
      contextRef="i64afdfad0a7c40478e14769ae335f4c8_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczNjI_737bdc47-b92e-4fd3-beb4-d4e7cfcfdbbb">P25Y</us-gaap:LesseeFinanceLeaseTermOfContract1>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i64afdfad0a7c40478e14769ae335f4c8_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczNjI_8d967f53-a0cf-437a-90c8-9d72bce747bd">P25Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i051a70de728945e7b41255138a99db87_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzM0OQ_ec47fd66-e86b-4230-b833-76ba1d58f003">P3Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeFinanceLeaseTermOfContract1
      contextRef="i051a70de728945e7b41255138a99db87_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzM0OQ_f90d141c-5541-4311-be5d-e05f300c99e6">P3Y</us-gaap:LesseeFinanceLeaseTermOfContract1>
    <us-gaap:LesseeFinanceLeaseTermOfContract1
      contextRef="if41a3fc5ea3b4503be47a9c50af584ec_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczNDU_b7a48bb0-874a-4e49-bd92-36d3918f4622">P10Y</us-gaap:LesseeFinanceLeaseTermOfContract1>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="if41a3fc5ea3b4503be47a9c50af584ec_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczNDU_d110ca73-603f-4a33-9a97-e4605b917330">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczNTE_b20db6e0-8f54-4380-8b5e-6d177af7315c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the components of net lease cost for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases for the years ended December&#160;31, 2022, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows paid for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows paid for interest portion of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows paid for principal portion of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzEtMS0xLTEtMjY1MjQ3_b48f78e4-e911-4dad-9d88-b58e807c8823"
      unitRef="usd">2579000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzEtMy0xLTEtMjY1MjQ3_e7e0d30d-5049-4fe4-a330-c358ac3fe8c3"
      unitRef="usd">2633000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzEtNS0xLTEtMjY1MjQ3_fde459c3-7846-434f-8cbe-64a9b02ac0ca"
      unitRef="usd">2670000000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzMtMS0xLTEtMjY1MjQ3_5ae1e4b6-fc50-46b5-b63c-290a559d04b7"
      unitRef="usd">79000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzMtMy0xLTEtMjY1MjQ3_d82ce16d-0fe8-4bd6-85ec-52f96dcc7f99"
      unitRef="usd">62000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzMtNS0xLTEtMjY1MjQ3_4507ea6d-0a8e-469b-b345-1eed6a119999"
      unitRef="usd">56000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzQtMS0xLTEtMjY1MjQ3_ce0f2451-96dd-427a-8ab9-cd744f25fcf5"
      unitRef="usd">68000000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzQtMy0xLTEtMjY1MjQ3_dcce4156-f799-4c40-ab24-a0ea17638dd6"
      unitRef="usd">62000000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzQtNS0xLTEtMjY1MjQ3_e5582b1a-a731-48da-a448-b202a526593b"
      unitRef="usd">58000000</us-gaap:FinanceLeaseInterestExpense>
    <cvs:FinanceLeaseCost
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzUtMS0xLTEtMjY1MjQ3_51d339e7-8073-4588-a3f5-6a0c412b89d5"
      unitRef="usd">147000000</cvs:FinanceLeaseCost>
    <cvs:FinanceLeaseCost
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzUtMy0xLTEtMjY1MjQ3_3a8975d9-96d4-4b99-8b14-221715cc87b5"
      unitRef="usd">124000000</cvs:FinanceLeaseCost>
    <cvs:FinanceLeaseCost
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzUtNS0xLTEtMjY1MjQ3_8509b941-36b1-4b6e-95bf-7805ba3a0c71"
      unitRef="usd">114000000</cvs:FinanceLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzYtMS0xLTEtMjY1MjQ3_76dac9ff-4ddd-4890-99f6-0b989c0a802d"
      unitRef="usd">27000000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzYtMy0xLTEtMjY1MjQ3_2709b957-fddb-4906-b6eb-6845340843b9"
      unitRef="usd">25000000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzYtNS0xLTEtMjY1MjQ3_472f6969-a95d-4c06-9277-0e1ef5caa214"
      unitRef="usd">22000000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzctMS0xLTEtMjY1MjQ3_bfcbf070-04a6-41cb-be8c-e7f1a4d8842f"
      unitRef="usd">610000000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzctMy0xLTEtMjY1MjQ3_a3d6ecd2-cfcb-467d-a6e4-4ae1f6fdc1ad"
      unitRef="usd">604000000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzctNS0xLTEtMjY1MjQ3_d0621975-9273-4e0d-98a5-8671759dda59"
      unitRef="usd">599000000</us-gaap:VariableLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzgtMS0xLTEtMjY1MjQ3_ab370bf5-08e0-484d-844c-5867901ced62"
      unitRef="usd">61000000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzgtMy0xLTEtMjY1MjQ3_1a33604d-015c-45fe-bfdd-f51423b2d680"
      unitRef="usd">59000000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzgtNS0xLTEtMjY1MjQ3_b7b7dc8b-3ead-4570-a701-bf116c8397fa"
      unitRef="usd">55000000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzktMS0xLTEtMjY1MjQ3_687fdd38-8c38-4df8-a13b-2d106706d817"
      unitRef="usd">3302000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzktMy0xLTEtMjY1MjQ3_a119c468-f737-4f05-827b-002c49cac421"
      unitRef="usd">3327000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo0M2Q0MWIyZWNhZjc0N2Q1ODQ1MTg1YTE0YjJiNzJhZS90YWJsZXJhbmdlOjQzZDQxYjJlY2FmNzQ3ZDU4NDUxODVhMTRiMmI3MmFlXzktNS0xLTEtMjY1MjQ3_4d855a7e-d832-45ef-ab63-af78161426d5"
      unitRef="usd">3350000000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzItMS0xLTEtMjY1MjQ3_70e39a98-e0fc-4b0b-ba80-432b0e633349"
      unitRef="usd">2689000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzItMy0xLTEtMjY1MjQ3_a6bef564-88a4-4a8b-98f1-99e01442b377"
      unitRef="usd">2714000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzItNS0xLTEtMjY1MjQ3_315c0661-1349-4896-b5f6-f85cd4426ac6"
      unitRef="usd">2724000000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzMtMS0xLTEtMjY1MjQ3_473c4078-7668-4a14-9c32-ffb10a41b92b"
      unitRef="usd">68000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzMtMy0xLTEtMjY1MjQ3_1f276192-c4ee-40d5-9960-e70fe7ea233d"
      unitRef="usd">62000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzMtNS0xLTEtMjY1MjQ3_dcd3880c-7712-4e4d-917b-75514a86d823"
      unitRef="usd">58000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzQtMS0xLTEtMjY1MjQ3_dbb66765-350b-4dd0-b93d-bcc5bbf3c2da"
      unitRef="usd">62000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzQtMy0xLTEtMjY1MjQ3_acc227f8-e197-4928-b723-ce7d79f75737"
      unitRef="usd">50000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzQtNS0xLTEtMjY1MjQ3_5a79d2cd-09a3-4f4c-8e07-45382cf44a08"
      unitRef="usd">34000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzYtMS0xLTEtMjY1MjQ3_6572b32a-a2fc-4634-8c95-76a290d0f0cc"
      unitRef="usd">591000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzYtMy0xLTEtMjY1MjQ3_1722966f-34ac-4cc6-b3b6-0cefdc5c0c64"
      unitRef="usd">1254000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzYtNS0xLTEtMjY1MjQ3_027de2ce-e234-48b8-a69f-e46739c5f00a"
      unitRef="usd">1679000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzctMS0xLTEtMjY1MjQ3_e97b337c-82d2-432b-8b32-98d9435c34d1"
      unitRef="usd">232000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzctMy0xLTEtMjY1MjQ3_0b0e7bf0-ca58-4a9f-aa4c-401aa619f725"
      unitRef="usd">278000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTozOGUyM2ExZDI4MDg0MTE1OTgzMjFiZjgxOGE4ODI4NC90YWJsZXJhbmdlOjM4ZTIzYTFkMjgwODQxMTU5ODMyMWJmODE4YTg4Mjg0XzctNS0xLTEtMjY1MjQ3_2d7fe70e-fa76-44aa-951e-ad6013ce2ac2"
      unitRef="usd">313000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <cvs:LesseeLeaseTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczNTU_867828e3-0804-4acd-813b-f4ee179b2f39">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases as of December&#160;31, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except remaining lease term and discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,928&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,122&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,699&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,839&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,177&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,538&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,823&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance leases:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,608&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,375&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(284)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,406&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining lease term &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes operating lease right-of-use assets of $56&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes current portion of operating lease liabilities of $21&#160;million and long-term operating lease liabilities of $39&#160;million which have been accounted for as liabilities held for sale and are included in liabilities held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;</cvs:LesseeLeaseTableTextBlock>
    <cvs:OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzItMS0xLTEtMjY1MjQ3_39fe5958-7eea-4f22-a0c0-3e0e6704efb8"
      unitRef="usd">17928000000</cvs:OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale>
    <cvs:OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzItMy0xLTEtMjY1MjQ3_2b81beb3-2b89-46be-adc8-38bb62288a73"
      unitRef="usd">19122000000</cvs:OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale>
    <cvs:OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzQtMS0xLTEtMjY1MjQ3_473ce030-c2d5-4769-ac4c-2bab4cec1a29"
      unitRef="usd">1699000000</cvs:OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale>
    <cvs:OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzQtMy0xLTEtMjY1MjQ3_e2cbb7b3-390f-4b46-a766-4c85f8dc9f5f"
      unitRef="usd">1646000000</cvs:OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale>
    <cvs:OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzUtMS0xLTEtMjY1MjQ3_2a33f224-bb3d-427c-b9fa-76e7c548e576"
      unitRef="usd">16839000000</cvs:OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale>
    <cvs:OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzUtMy0xLTEtMjY1MjQ3_b55cb0d3-21d2-4318-91ad-9087f7ee85c9"
      unitRef="usd">18177000000</cvs:OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale>
    <us-gaap:OperatingLeaseLiability
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzYtMS0xLTEtMjY1MjQ3_cc653be2-3ddb-4903-af95-8d68413b01c3"
      unitRef="usd">18538000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzYtMy0xLTEtMjY1MjQ3_2790683b-4fd8-41ba-a7a4-8ce3af50ae7f"
      unitRef="usd">19823000000</us-gaap:OperatingLeaseLiability>
    <cvs:FinanceLeaseRightOfUseAssetGross
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzktMS0xLTEtMjY1MjQ3_b1171241-f0d5-46f9-81ca-6bde084f3259"
      unitRef="usd">1608000000</cvs:FinanceLeaseRightOfUseAssetGross>
    <cvs:FinanceLeaseRightOfUseAssetGross
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzktMy0xLTEtMjY1MjQ3_33990f11-b087-4aa7-bd37-2e76e63f9e38"
      unitRef="usd">1375000000</cvs:FinanceLeaseRightOfUseAssetGross>
    <cvs:FinanceLeaseRightOfUseAssetAccumulatedDepreciation
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzEwLTEtMS0xLTI2NTI0Nw_1855cb0e-fdb4-4dab-acc9-7ac4e5651223"
      unitRef="usd">284000000</cvs:FinanceLeaseRightOfUseAssetAccumulatedDepreciation>
    <cvs:FinanceLeaseRightOfUseAssetAccumulatedDepreciation
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzEwLTMtMS0xLTI2NTI0Nw_3f993b75-3a51-4a31-80fe-aeaae9a84159"
      unitRef="usd">188000000</cvs:FinanceLeaseRightOfUseAssetAccumulatedDepreciation>
    <cvs:FinanceLeaseRightOfUseAssetNet
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzExLTEtMS0xLTI2NTI0Nw_7424505f-525a-4a55-8163-5e2809e5e984"
      unitRef="usd">1324000000</cvs:FinanceLeaseRightOfUseAssetNet>
    <cvs:FinanceLeaseRightOfUseAssetNet
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzExLTMtMS0xLTI2NTI0Nw_e20dbe93-1cb7-4447-be87-5975eacad5af"
      unitRef="usd">1187000000</cvs:FinanceLeaseRightOfUseAssetNet>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzEzLTEtMS0xLTI2NTI0Nw_0525736f-0d1c-481d-a44d-0ad215d040b1"
      unitRef="usd">59000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzEzLTMtMS0xLTI2NTI0Nw_867a7e46-28a5-4392-950a-195bcbdf48f1"
      unitRef="usd">50000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzE0LTEtMS0xLTI2NTI0Nw_cb323043-a672-4e12-9205-e6044b2e23fe"
      unitRef="usd">1406000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzE0LTMtMS0xLTI2NTI0Nw_53769fdb-ece6-4ca6-9b53-3e6aaac5fe84"
      unitRef="usd">1250000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzE1LTEtMS0xLTI2NTI0Nw_48abc580-feed-446d-912b-8f08f4620955"
      unitRef="usd">1465000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzE1LTMtMS0xLTI2NTI0Nw_e3a33015-10db-4e71-b185-43931b14485a"
      unitRef="usd">1300000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzE4LTEtMS0xLTI2NTI0Nw_e28ec1a4-166a-4fa8-a3bc-0ab374f4e781">P12Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzE4LTMtMS0xLTI2NTI0Nw_e15ffa17-dbad-4254-88d3-3723a1e084fb">P12Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzE5LTEtMS0xLTI2NTI0Nw_a7f734c7-5951-462d-b6bb-ac4e3048e5e5">P19Y4M24D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzE5LTMtMS0xLTI2NTI0Nw_77dc05a2-af57-4f10-8e4a-193f23ebb5cc">P20Y</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzIyLTEtMS0xLTI2NTI0Nw_ded6a109-d997-4490-ad7f-b5788c1c22ee"
      unitRef="number">0.044</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzIyLTMtMS0xLTI2NTI0Nw_5365d245-2113-443c-85fb-50f5dc3b4383"
      unitRef="number">0.044</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzIzLTEtMS0xLTI2NTI0Nw_f35d05d4-01b7-429a-9ebf-c3672e380c68"
      unitRef="number">0.049</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTo5OGZkZGQ4YTZiZWM0MmMzOWYyODlkNmQ0ZjI2N2NkYy90YWJsZXJhbmdlOjk4ZmRkZDhhNmJlYzQyYzM5ZjI4OWQ2ZDRmMjY3Y2RjXzIzLTMtMS0xLTI2NTI0Nw_a089c66f-82ff-4243-a484-a8bac387a3e5"
      unitRef="number">0.050</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <cvs:OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale
      contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzEyMzY_30446c3e-acd9-4ab0-8f6f-dde929f6d4e6"
      unitRef="usd">56000000</cvs:OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale>
    <cvs:OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale
      contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzE0ODQ_e549d8d6-901a-45fb-a57e-e1b021a697ad"
      unitRef="usd">21000000</cvs:OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale>
    <cvs:OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale
      contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzE1MzI_bf7a4fa3-9219-4ca1-af48-bff26ba9f473"
      unitRef="usd">39000000</cvs:OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczNTY_7d77e9cb-3ec7-4598-a946-a41bf16b94bf">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Operating&lt;br/&gt;Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,501)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Future operating lease payments have not been reduced by minimum sublease rentals of $290 million due in the future under noncancelable subleases.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.5 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczNjM_efce0062-7329-405a-ba7e-70230d53e43f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Operating&lt;br/&gt;Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,501)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Future operating lease payments have not been reduced by minimum sublease rentals of $290 million due in the future under noncancelable subleases.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.5 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.&lt;/span&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzEtMS0xLTEtMjY1MjQ3_a0adb04b-aab0-45fe-b5cc-91b9a396d7b8"
      unitRef="usd">139000000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzEtMy0xLTEtMjY1MjQ3_755d2f86-ab22-4257-ab17-620674b3fe60"
      unitRef="usd">2685000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <cvs:LesseeLiabilityPaymentsYearOne
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzEtNS0xLTEtMjY1MjQ3_03f78eb7-623c-4cc0-959e-606b396ec893"
      unitRef="usd">2824000000</cvs:LesseeLiabilityPaymentsYearOne>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzItMS0xLTEtMjY1MjQ3_105a2717-acac-43b6-8110-26c05c6edc43"
      unitRef="usd">130000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzItMy0xLTEtMjY1MjQ3_d78ab1be-08b0-441c-b222-dee9cccc4629"
      unitRef="usd">2499000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <cvs:LesseeLiabilityPaymentsDueYearTwo
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzItNS0xLTEtMjY1MjQ3_e32d3ddc-57e6-41c8-8ce0-e3c0041bc45f"
      unitRef="usd">2629000000</cvs:LesseeLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzMtMS0xLTEtMjY1MjQ3_78ba0530-5ef7-46c3-836e-233b178bf0f5"
      unitRef="usd">128000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzMtMy0xLTEtMjY1MjQ3_82e82d36-0c60-4d50-87a3-9a113ca05856"
      unitRef="usd">2313000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <cvs:LesseeLiabilityPaymentsDueYearThree
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzMtNS0xLTEtMjY1MjQ3_8e1a236e-d95e-4651-bec0-489e91a7dd66"
      unitRef="usd">2441000000</cvs:LesseeLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzQtMS0xLTEtMjY1MjQ3_6e50fc6e-03df-4290-ac0a-1a1253308f9c"
      unitRef="usd">127000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzQtMy0xLTEtMjY1MjQ3_4de268ad-022f-4209-bddf-d78b229b0b5d"
      unitRef="usd">2142000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <cvs:LesseeLiabilityPaymentsDueYearFour
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzQtNS0xLTEtMjY1MjQ3_32f8abb5-6712-4953-a8fc-6389fcd2cf48"
      unitRef="usd">2269000000</cvs:LesseeLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzUtMS0xLTEtMjY1MjQ3_524a3656-a32f-49c1-91b8-094f4a33aae1"
      unitRef="usd">124000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzUtMy0xLTEtMjY1MjQ3_a76921d3-60de-44b9-88c6-1880be786ec4"
      unitRef="usd">1989000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <cvs:LesseeLiabilityPaymentsDueYearFive
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzUtNS0xLTEtMjY1MjQ3_4a92bdf4-8c59-424f-8baf-090ddf4fa205"
      unitRef="usd">2113000000</cvs:LesseeLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzYtMS0xLTEtMjY1MjQ3_4b10d17b-b83b-41a6-bde9-229dd0a1a4fc"
      unitRef="usd">1640000000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzYtMy0xLTEtMjY1MjQ3_59aca750-3856-462a-a263-0fe00b593732"
      unitRef="usd">12411000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <cvs:LesseeLiabilityPaymentsDueAfterYearFive
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzYtNS0xLTEtMjY1MjQ3_65a81885-0b46-46c7-9b4f-0b77e96b2d68"
      unitRef="usd">14051000000</cvs:LesseeLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzctMS0xLTEtMjY1MjQ3_679d5fa4-7fc9-4bbe-b6f0-d5cf51e30027"
      unitRef="usd">2288000000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzctMy0xLTEtMjY1MjQ3_e720dbae-a200-4e26-8fcc-90b425ef686e"
      unitRef="usd">24039000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <cvs:LesseeLiabilityPaymentsDue
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzctNS0xLTEtMjY1MjQ3_4c563171-0bbe-4d7d-b140-1aeb4a55af54"
      unitRef="usd">26327000000</cvs:LesseeLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzgtMS0xLTEtMjY1MjQ3_eea1707f-734e-498d-a701-a51b4dc08861"
      unitRef="usd">823000000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzgtMy0xLTEtMjY1MjQ3_042368fb-9024-4827-8d12-3147c5d14491"
      unitRef="usd">5501000000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <cvs:LesseeLiabilityUndiscountedExcessAmount
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzgtNS0xLTEtMjY1MjQ3_1e561bc4-f77d-4be3-9518-4c4fb11bb412"
      unitRef="usd">6324000000</cvs:LesseeLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzktMS0xLTEtMjY1MjQ3_ef9d2462-b5ef-4dd2-bf42-13e4479252ed"
      unitRef="usd">1465000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzktMy0xLTEtMjY1MjQ3_bfaa99f2-06b4-469d-a084-8a7c8afafb7f"
      unitRef="usd">18538000000</us-gaap:OperatingLeaseLiability>
    <cvs:LeaseLiability
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90YWJsZTplMzA1MTcyMjgwNWQ0OThhYWQzMWM0ZDkzYTE2YzdlMi90YWJsZXJhbmdlOmUzMDUxNzIyODA1ZDQ5OGFhZDMxYzRkOTNhMTZjN2UyXzktNS0xLTEtMjY1MjQ3_c881b4cb-091c-43b9-bd0e-923cca6a3e2e"
      unitRef="usd">20003000000</cvs:LeaseLiability>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceived
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzE5NzY_72209cdf-11f9-45fd-9e6a-40499820d6a1"
      unitRef="usd">290000000</us-gaap:LessorOperatingLeasePaymentsToBeReceived>
    <cvs:OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzIyODQ_dd55c156-7ea6-4404-bf6e-a7b2435173ec"
      unitRef="usd">2500000000</cvs:OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife>
    <us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzMxNjA_d16ed716-13d3-4793-b356-37fea79a7e71"
      unitRef="usd">101000000</us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity>
    <us-gaap:SaleAndLeasebackTransactionGainLossNet
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzMyNDU_2a7744f7-4825-45ae-91df-02f65ce9c02b"
      unitRef="usd">3000000</us-gaap:SaleAndLeasebackTransactionGainLossNet>
    <cvs:OfficeRealEstateOptimizationCharges
      contextRef="ia17efad6e57f470eadf960cfb01e576d_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzM5NDY_e6fca68f-3272-41a2-8ab3-50ad4ad14048"
      unitRef="usd">117000000</cvs:OfficeRealEstateOptimizationCharges>
    <cvs:OfficeRealEstateOptimizationCharges
      contextRef="ic8537dac29594a639ef8ce90309171e8_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzM5NzQ_c7a9b623-3107-4c28-8dc2-be48c432700f"
      unitRef="usd">71000000</cvs:OfficeRealEstateOptimizationCharges>
    <cvs:OfficeRealEstateOptimizationCharges
      contextRef="i5f3c8c09f91f4c338d29d71777fc4bae_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzQwMjg_652e1b90-4074-4bd8-8536-d4340e2291dd"
      unitRef="usd">44000000</cvs:OfficeRealEstateOptimizationCharges>
    <cvs:NumberOfStoresPlannedClosure
      contextRef="i7b563cd5fd6444ccae80c15785db4752_D20211001-20211231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzYzNjA_ee922f3c-3948-40e7-a253-f0911c395194"
      unitRef="store">900</cvs:NumberOfStoresPlannedClosure>
    <cvs:NumberOfStoresAnnualPlannedClosuresForClosurePeriod
      contextRef="i7b563cd5fd6444ccae80c15785db4752_D20211001-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzYzOTI_4bbc9dff-db4d-423a-92f9-2026d0fb1533"
      unitRef="store">300</cvs:NumberOfStoresAnnualPlannedClosuresForClosurePeriod>
    <cvs:StoreImpairmentCharges
      contextRef="i7b563cd5fd6444ccae80c15785db4752_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzcwMTI_f89b9726-099c-45f6-abe7-7bfa6244b129"
      unitRef="usd">1400000000</cvs:StoreImpairmentCharges>
    <cvs:StoreImpairmentCharges
      contextRef="i7fb815e010cd42dfa706732c81d30c51_D20211001-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzcwNjA_74bd2bd6-3606-4772-b8a3-07965b7ccc95"
      unitRef="usd">1100000000</cvs:StoreImpairmentCharges>
    <cvs:StoreImpairmentCharges
      contextRef="i08b43dcea1a24bb58f5fb26ee83e336c_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzcxMTQ_18700c76-3506-483d-a109-d6742c873a44"
      unitRef="usd">261000000</cvs:StoreImpairmentCharges>
    <cvs:OperatingLeaseRightOfUseAssetFairValueDisclosure
      contextRef="ibcaf1a77aa6f4ad0a9316358d8fdee1d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczMTk_23205b38-03a0-4c73-bc9d-834f768e8754"
      unitRef="usd">356000000</cvs:OperatingLeaseRightOfUseAssetFairValueDisclosure>
    <us-gaap:PropertyPlantAndEquipmentFairValueDisclosure
      contextRef="i0abce119f76d4736a751d922587fea1e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMzkvZnJhZzpiZTYxMWU2NzYzNWQ0YTViYTVlNDAwZWVjNzA2ZmZlNy90ZXh0cmVnaW9uOmJlNjExZTY3NjM1ZDRhNWJhNWU0MDBlZWM3MDZmZmU3XzczMjY_c883c983-ad63-41ed-839c-6d84c89b5084"
      unitRef="usd">185000000</us-gaap:PropertyPlantAndEquipmentFairValueDisclosure>
    <us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzMzNjg_c402e61a-412c-40e4-8e41-0ce566111273">Health Care Costs Payable&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is information about incurred and cumulative paid health care claims development as of December&#160;31, 2022, net of reinsurance, and the total IBNR liabilities plus expected development on reported claims included within the net incurred claims amounts. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for information on how the Company estimates IBNR reserves and health care costs payable as well as changes to those methodologies, if any. The Company&#x2019;s estimate of IBNR liabilities is primarily based on trend and completion factors. Claim frequency is not used in the calculation of the Company&#x2019;s liability. In addition, it is impracticable to disclose claim frequency information for health care claims due to the Company&#x2019;s inability to gather consistent claim frequency information across its multiple claims processing systems. Any claim frequency count disclosure would not be comparable across the Company&#x2019;s different claim processing systems and would not be consistent from period to period based on the volume of claims processed through each system. As a result, health care claim count frequency is not included in the disclosures below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The information about incurred and paid health care claims development for the year ended December&#160;31, 2021 is presented as required unaudited supplemental information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Incurred Health Care Claims,&lt;br/&gt;Net of Reinsurance&lt;br/&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Date of Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cumulative Paid Health Care Claims,&lt;br/&gt;Net of Reinsurance&lt;br/&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Date of Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All outstanding liabilities for health care costs payable prior to 2021, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total outstanding liabilities for health care costs payable, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, the Company&#x2019;s liabilities for IBNR plus expected development on reported claims totaled approximately $7.8 billion. Substantially all of the Company&#x2019;s liabilities for IBNR plus expected development on reported claims at December&#160;31, 2022 related to the current calendar year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of the December&#160;31, 2022 health care net incurred and paid claims development tables to the health care costs payable liability on the consolidated balance sheet were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-duration health care costs payable, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance lines other than short duration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total health care costs payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in health care costs payable during the years ended December 31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of period &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Impact of discount rate on long-duration insurance reserves &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Components of incurred health care costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(788)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred health care costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Premium deficiency reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Impact of discount rate on long-duration insurance reserves &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Reflects the difference between the current discount rate and the locked-in discount rate on long-duration insurance reserves which is recorded within accumulated other comprehensive income (loss) on the consolidated balance sheets. Refer to Note 8 &#x2018;&#x2018;Other Insurance Liabilities and Separate Accounts&#x2019;&#x2019; for further information related to the adoption of the long-duration insurance contracts accounting standard.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total incurred health care costs for the years ended December&#160;31, 2022, 2021 and 2020 in the table above exclude $79 million, $58 million and $41 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the consolidated balance sheets and $249 million, $271 million and $221 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the consolidated balance sheets. The incurred health care costs for the years ended December 31, 2021 and 2020 also exclude $16 million and $11 million, respectively, for premium deficiency reserves related to the Company&#x2019;s Medicaid products.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimates of prior years&#x2019; health care costs payable decreased by $654 million, $788 million and $429 million in 2022, 2021 and 2020, respectively, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#x2019;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year. This development does not directly correspond to an increase in the Company&#x2019;s operating results as these reductions were offset by estimated current period health care costs when the Company established the estimate of the current year health care costs payable.&lt;/span&gt;&lt;/div&gt;</us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock>
    <us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzMzNjk_7d9226b9-79ce-4788-a9d8-1b611e9d74bb">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The information about incurred and paid health care claims development for the year ended December&#160;31, 2021 is presented as required unaudited supplemental information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Incurred Health Care Claims,&lt;br/&gt;Net of Reinsurance&lt;br/&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Date of Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cumulative Paid Health Care Claims,&lt;br/&gt;Net of Reinsurance&lt;br/&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Date of Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All outstanding liabilities for health care costs payable prior to 2021, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total outstanding liabilities for health care costs payable, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i799291d9b4044a1d96de401f542d2dbc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo3ZWVlNmY2N2I4ZTU0ZjRmYTZkZDU4ZTU2NjNjMTM3Ni90YWJsZXJhbmdlOjdlZWU2ZjY3YjhlNTRmNGZhNmRkNThlNTY2M2MxMzc2XzMtMS0xLTEtMjY1MjQ3_a798af5b-c2ee-433f-989f-9d69874bf31f"
      unitRef="usd">62830000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i198eb6aa39444b7b9b09239c511ecfd8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo3ZWVlNmY2N2I4ZTU0ZjRmYTZkZDU4ZTU2NjNjMTM3Ni90YWJsZXJhbmdlOjdlZWU2ZjY3YjhlNTRmNGZhNmRkNThlNTY2M2MxMzc2XzMtMy0xLTEtMjY1MjQ3_70f4ad38-1a62-440c-b12a-0c26670db19d"
      unitRef="usd">62259000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i97f51e7c8d364549b235af468de7d3d6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo3ZWVlNmY2N2I4ZTU0ZjRmYTZkZDU4ZTU2NjNjMTM3Ni90YWJsZXJhbmdlOjdlZWU2ZjY3YjhlNTRmNGZhNmRkNThlNTY2M2MxMzc2XzQtMy0xLTEtMjY1MjQ3_14ee893f-01cb-485d-8679-347d4d1d2c05"
      unitRef="usd">69185000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo3ZWVlNmY2N2I4ZTU0ZjRmYTZkZDU4ZTU2NjNjMTM3Ni90YWJsZXJhbmdlOjdlZWU2ZjY3YjhlNTRmNGZhNmRkNThlNTY2M2MxMzc2XzUtMy0xLTEtMjY1MjQ3_ce9f8876-e147-4a75-ba1a-14b0cb06c9ab"
      unitRef="usd">131444000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i799291d9b4044a1d96de401f542d2dbc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo3ZWVlNmY2N2I4ZTU0ZjRmYTZkZDU4ZTU2NjNjMTM3Ni90YWJsZXJhbmdlOjdlZWU2ZjY3YjhlNTRmNGZhNmRkNThlNTY2M2MxMzc2XzEwLTEtMS0xLTI2NTI0Nw_9b763bf3-ff94-44b3-8ff8-ce50b983e815"
      unitRef="usd">54600000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i198eb6aa39444b7b9b09239c511ecfd8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo3ZWVlNmY2N2I4ZTU0ZjRmYTZkZDU4ZTU2NjNjMTM3Ni90YWJsZXJhbmdlOjdlZWU2ZjY3YjhlNTRmNGZhNmRkNThlNTY2M2MxMzc2XzEwLTMtMS0xLTI2NTI0Nw_cdeb5c74-52b6-40e9-bdd2-46ee47f152da"
      unitRef="usd">62144000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i97f51e7c8d364549b235af468de7d3d6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo3ZWVlNmY2N2I4ZTU0ZjRmYTZkZDU4ZTU2NjNjMTM3Ni90YWJsZXJhbmdlOjdlZWU2ZjY3YjhlNTRmNGZhNmRkNThlNTY2M2MxMzc2XzExLTMtMS0xLTI2NTI0Nw_2f5d6fea-a75a-4c80-9c53-d3ce0514901c"
      unitRef="usd">59570000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo3ZWVlNmY2N2I4ZTU0ZjRmYTZkZDU4ZTU2NjNjMTM3Ni90YWJsZXJhbmdlOjdlZWU2ZjY3YjhlNTRmNGZhNmRkNThlNTY2M2MxMzc2XzEyLTMtMS0xLTI2NTI0Nw_a615abad-60d9-475c-aaf4-5f28394ef818"
      unitRef="usd">121714000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented
      contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo3ZWVlNmY2N2I4ZTU0ZjRmYTZkZDU4ZTU2NjNjMTM3Ni90YWJsZXJhbmdlOjdlZWU2ZjY3YjhlNTRmNGZhNmRkNThlNTY2M2MxMzc2XzEzLTMtMS0xLTI2NTI0Nw_12280294-13ee-41f4-b384-9b8c04806123"
      unitRef="usd">196000000</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo3ZWVlNmY2N2I4ZTU0ZjRmYTZkZDU4ZTU2NjNjMTM3Ni90YWJsZXJhbmdlOjdlZWU2ZjY3YjhlNTRmNGZhNmRkNThlNTY2M2MxMzc2XzE0LTMtMS0xLTI2NTI0Nw_71f449b2-7231-4265-b9b6-5d17daee0a7f"
      unitRef="usd">9926000000</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet
      contextRef="ibb1ed30851ad423db47b88e42b33cf8f_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzE0MDg_67a11f10-a7e3-450b-8c8d-889b8b180a97"
      unitRef="usd">7800000000</us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet>
    <us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzMzNzA_88510626-d262-4f05-b6e2-ef8f5e79ffb7">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of the December&#160;31, 2022 health care net incurred and paid claims development tables to the health care costs payable liability on the consolidated balance sheet were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-duration health care costs payable, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance lines other than short duration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total health care costs payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in health care costs payable during the years ended December 31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of period &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Impact of discount rate on long-duration insurance reserves &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Components of incurred health care costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(788)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred health care costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Premium deficiency reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Impact of discount rate on long-duration insurance reserves &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Reflects the difference between the current discount rate and the locked-in discount rate on long-duration insurance reserves which is recorded within accumulated other comprehensive income (loss) on the consolidated balance sheets. Refer to Note 8 &#x2018;&#x2018;Other Insurance Liabilities and Separate Accounts&#x2019;&#x2019; for further information related to the adoption of the long-duration insurance contracts accounting standard.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total incurred health care costs for the years ended December&#160;31, 2022, 2021 and 2020 in the table above exclude $79 million, $58 million and $41 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the consolidated balance sheets and $249 million, $271 million and $221 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the consolidated balance sheets. The incurred health care costs for the years ended December 31, 2021 and 2020 also exclude $16 million and $11 million, respectively, for premium deficiency reserves related to the Company&#x2019;s Medicaid products.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo1YmNiMjIyY2FjZjA0YTE1YWM5NGVlZGUyY2QzMTFmNy90YWJsZXJhbmdlOjViY2IyMjJjYWNmMDRhMTVhYzk0ZWVkZTJjZDMxMWY3XzEtMS0xLTEtMjY1MjQ3_71f449b2-7231-4265-b9b6-5d17daee0a7f"
      unitRef="usd">9926000000</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo1YmNiMjIyY2FjZjA0YTE1YWM5NGVlZGUyY2QzMTFmNy90YWJsZXJhbmdlOjViY2IyMjJjYWNmMDRhMTVhYzk0ZWVkZTJjZDMxMWY3XzItMS0xLTEtMjY1MjQ3_38fe3db5-2d0f-49cf-bca0-9823426f0fdd"
      unitRef="usd">5000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem
      contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo1YmNiMjIyY2FjZjA0YTE1YWM5NGVlZGUyY2QzMTFmNy90YWJsZXJhbmdlOjViY2IyMjJjYWNmMDRhMTVhYzk0ZWVkZTJjZDMxMWY3XzQtMS0xLTEtMjY1MjQ3_01211345-4589-49c1-a231-6560eb238ac6"
      unitRef="usd">211000000</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTo1YmNiMjIyY2FjZjA0YTE1YWM5NGVlZGUyY2QzMTFmNy90YWJsZXJhbmdlOjViY2IyMjJjYWNmMDRhMTVhYzk0ZWVkZTJjZDMxMWY3XzUtMS0xLTEtMjY1MjQ3_f3c2efcc-13ae-42ad-98ba-acd2e30e22a1"
      unitRef="usd">10142000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzEtMS0xLTEtMjY1MjQ3_e3348c1f-8ce4-40c5-a8b7-6d16352989c0"
      unitRef="usd">8678000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ifcc76cbc90f043b3a402f196167f4f72_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzEtMy0xLTEtMjY1MjQ3_9340b09c-83b4-4a5a-8811-ad4fe75e1c4b"
      unitRef="usd">7936000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i0a2d0a34a80341588e7543f9329def49_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzEtNS0xLTEtMjY1MjQ3_231659fa-e3e2-432f-9fa6-1ebcc03ee22c"
      unitRef="usd">6879000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzItMS0xLTEtMjY1MjQ3_4db9ee2d-c136-4ee0-92ea-d431ab83d227"
      unitRef="usd">8000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ifcc76cbc90f043b3a402f196167f4f72_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzItMy0xLTEtMjY1MjQ3_cc920943-d9cd-49ff-b2e2-77e1b113830c"
      unitRef="usd">10000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i0a2d0a34a80341588e7543f9329def49_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzItNS0xLTEtMjY1MjQ3_9318127d-64bb-4df1-bbd2-2a6116492a01"
      unitRef="usd">5000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax
      contextRef="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzMtMS0xLTEtMjk0MzEy_f97cf319-3b8c-483b-8b0e-742aeef9ceca"
      unitRef="usd">0</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax
      contextRef="ifcc76cbc90f043b3a402f196167f4f72_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzMtMy0xLTEtMjk0MzEy_ff401bc6-8d09-4e7b-b717-14dae9299014"
      unitRef="usd">0</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax
      contextRef="i0a2d0a34a80341588e7543f9329def49_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzMtNS0xLTEtMjk0MzEy_8c07ba98-b487-4583-938c-4294baaa1030"
      unitRef="usd">0</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzMtMS0xLTEtMjY1MjQ3_69bad934-7099-4af1-af55-0ea3c668753f"
      unitRef="usd">8670000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ifcc76cbc90f043b3a402f196167f4f72_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzMtMy0xLTEtMjY1MjQ3_fd4ef38b-686e-4c86-b1d3-f6f079da6c84"
      unitRef="usd">7926000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i0a2d0a34a80341588e7543f9329def49_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzMtNS0xLTEtMjY1MjQ3_2b51b503-9572-4ffc-a6df-27e7aec22484"
      unitRef="usd">6874000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="i070e3ddd671c465f94cda987d76035a2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzQtMS0xLTEtMjY1MjQ3_d05c4269-ff5a-4b43-9681-d4b7b1c81705"
      unitRef="usd">0</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="i6c4f0b83de01479eb59aaddfa35650cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzQtMy0xLTEtMjY1MjQ3_dd4468c5-01a2-45dd-be32-589046257dfc"
      unitRef="usd">0</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="if2866ecd09514e62ba339145a6407f2d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzQtNS0xLTEtMjY1MjQ3_34748f86-8b2c-45f9-a0e6-6160f4e3b1b0"
      unitRef="usd">414000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i070e3ddd671c465f94cda987d76035a2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzctMS0xLTEtMjY1MjQ3_ad9ed27b-eb9f-46fd-94e1-33c284f919af"
      unitRef="usd">71399000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i6c4f0b83de01479eb59aaddfa35650cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzctMy0xLTEtMjY1MjQ3_e46a1f7d-46e9-45c0-a119-19301856ebff"
      unitRef="usd">64631000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="if2866ecd09514e62ba339145a6407f2d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzctNS0xLTEtMjY1MjQ3_3dd6fc4d-22e3-489f-ae93-808f2fe67554"
      unitRef="usd">55835000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i070e3ddd671c465f94cda987d76035a2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzgtMS0xLTEtMjY1MjQ3_16304843-c139-4ed4-8c32-90da70a26318"
      unitRef="usd">-654000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i6c4f0b83de01479eb59aaddfa35650cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzgtMy0xLTEtMjY1MjQ3_d5da6012-b38d-438d-8bc6-421283d92a41"
      unitRef="usd">-788000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="if2866ecd09514e62ba339145a6407f2d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzgtNS0xLTEtMjY1MjQ3_59ecda9d-84fa-4233-a4e0-ed20812a3b12"
      unitRef="usd">-429000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i070e3ddd671c465f94cda987d76035a2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzktMS0xLTEtMjY1MjQ3_db41bbb6-ddad-4eda-a7a4-711af2abd367"
      unitRef="usd">70745000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i6c4f0b83de01479eb59aaddfa35650cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzktMy0xLTEtMjY1MjQ3_7e5aa7c7-9444-48be-b494-cd23703181be"
      unitRef="usd">63843000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="if2866ecd09514e62ba339145a6407f2d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzktNS0xLTEtMjY1MjQ3_d0ea60f4-c097-4fee-9bc1-4777b9458b0e"
      unitRef="usd">55406000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i070e3ddd671c465f94cda987d76035a2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzExLTEtMS0xLTI2NTI0Nw_b70388c0-31af-49bb-aaf2-9f2ebed468c0"
      unitRef="usd">61640000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i6c4f0b83de01479eb59aaddfa35650cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzExLTMtMS0xLTI2NTI0Nw_3b1c9b91-6d2b-41b0-b65a-65ea0171ffda"
      unitRef="usd">56323000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="if2866ecd09514e62ba339145a6407f2d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzExLTUtMS0xLTI2NTI0Nw_8c44c49e-8989-46c9-9163-03fc0e901e47"
      unitRef="usd">48770000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i070e3ddd671c465f94cda987d76035a2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzEyLTEtMS0xLTI2NTI0Nw_588fa8f2-9ae6-4cdf-b858-652932e6d628"
      unitRef="usd">7646000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i6c4f0b83de01479eb59aaddfa35650cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzEyLTMtMS0xLTI2NTI0Nw_9059e920-172d-4f6f-a1c3-78fb77a96886"
      unitRef="usd">6792000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="if2866ecd09514e62ba339145a6407f2d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzEyLTUtMS0xLTI2NTI0Nw_5067344b-ce7e-4f8d-a3cb-be349df2a399"
      unitRef="usd">6009000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i070e3ddd671c465f94cda987d76035a2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzEzLTEtMS0xLTI2NTI0Nw_a2e6b05d-31ee-46da-9b64-07bc502e1322"
      unitRef="usd">69286000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i6c4f0b83de01479eb59aaddfa35650cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzEzLTMtMS0xLTI2NTI0Nw_ba3805b1-553f-4457-a8f9-0f0eccd141ea"
      unitRef="usd">63115000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="if2866ecd09514e62ba339145a6407f2d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzEzLTUtMS0xLTI2NTI0Nw_3dacb507-c751-4180-8323-657feb7561b2"
      unitRef="usd">54779000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE0LTEtMS0xLTI2NTI0Nw_eecf8bf7-7e03-48fa-b40e-aa7836186475"
      unitRef="usd">0</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE0LTMtMS0xLTI2NTI0Nw_386f7061-ba98-4825-96c2-bb996a730f39"
      unitRef="usd">16000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="ifcc76cbc90f043b3a402f196167f4f72_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE0LTUtMS0xLTI2NTI0Nw_42f6e612-b456-477c-bb5b-3db35d907a0e"
      unitRef="usd">11000000</cvs:PremiumDeficiencyReserveLiability>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE1LTEtMS0xLTI2NTI0Nw_489bc45b-718e-4241-ab04-98b926ec8ef4"
      unitRef="usd">10129000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE1LTMtMS0xLTI2NTI0Nw_fe7255d9-3f49-4973-8284-9e020ce63aab"
      unitRef="usd">8670000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ifcc76cbc90f043b3a402f196167f4f72_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE1LTUtMS0xLTI2NTI0Nw_708c7103-96d8-4028-aa07-51110e210d57"
      unitRef="usd">7926000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE2LTEtMS0xLTI2NTI0Nw_e8e5c3cf-311d-4395-b0c9-6e6659b5d6bc"
      unitRef="usd">5000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE2LTMtMS0xLTI2NTI0Nw_725461f4-1677-4bb5-a27f-8641387d1109"
      unitRef="usd">8000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ifcc76cbc90f043b3a402f196167f4f72_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE2LTUtMS0xLTI2NTI0Nw_02eb49cb-2e2c-49a8-a6e1-4e414bf70ccd"
      unitRef="usd">10000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax
      contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE4LTEtMS0xLTI5NDMwNA_b86be63e-9b69-4ad6-b12b-b2ff445ce13f"
      unitRef="usd">-8000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax
      contextRef="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE4LTMtMS0xLTI5NDMwNA_70a9b841-c303-4049-bc8d-26e9937dea66"
      unitRef="usd">0</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax
      contextRef="ifcc76cbc90f043b3a402f196167f4f72_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE4LTUtMS0xLTI5NDMwNA_6ff4ca69-9e1d-4453-9e1b-2f7c20f61282"
      unitRef="usd">0</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ibd901a0e46c140848ccfebccd9919a95_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE3LTEtMS0xLTI2NTI0Nw_e80538de-2be0-4b80-bf0a-e1dc5c7ead3e"
      unitRef="usd">10142000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE3LTMtMS0xLTI2NTI0Nw_49cf8a0e-cff1-4fd8-afd9-e46bf5630e14"
      unitRef="usd">8678000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ifcc76cbc90f043b3a402f196167f4f72_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90YWJsZTpiODJhZDA5YmYyNmM0MjNiOThjODUyZGIyMDE4MmYxNS90YWJsZXJhbmdlOmI4MmFkMDliZjI2YzQyM2I5OGM4NTJkYjIwMTgyZjE1XzE3LTUtMS0xLTI2NTI0Nw_6c1ef8b2-299d-4117-98ed-e0140c989903"
      unitRef="usd">7936000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="if07e27d83137497c9009bcc13d88e451_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzIwMTY_1bf9f124-e477-4c63-986f-e671f86b0713"
      unitRef="usd">79000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="i2a1d88c90afd4868bb3842de60276b75_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzI3NDg3NzkwNzQ0MDM_2638925c-0e02-451f-8116-957db2aeee70"
      unitRef="usd">58000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="i83ae36f497504d8d90f91d0e0e6c7f9a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzIwMjc_cf371d44-fdc5-4531-8159-7f147f81eefa"
      unitRef="usd">41000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="i88f999029e8e4a6db4e05b6171f6b11d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzIxOTU_6f4d0166-42c2-4439-98ee-dd07ac85a3a5"
      unitRef="usd">249000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="iedfef3ba5684421f9d94d0db97241826_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzI3NDg3NzkwNzQ0MTE_e0d07694-cbed-4cf6-adff-ff84dbf50cbb"
      unitRef="usd">271000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="if153c73955f74ee79cd73647ab6d655f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzIyMDY_b0940111-ecb5-4d74-a72b-96af5b6af3f5"
      unitRef="usd">221000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i11cabe5a61f44dbfb4c5d12e6e7f1e74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzI0NTM_386f7061-ba98-4825-96c2-bb996a730f39"
      unitRef="usd">16000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="ifcc76cbc90f043b3a402f196167f4f72_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzI0NjA_42f6e612-b456-477c-bb5b-3db35d907a0e"
      unitRef="usd">11000000</cvs:PremiumDeficiencyReserveLiability>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i070e3ddd671c465f94cda987d76035a2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzI2MzQ_16304843-c139-4ed4-8c32-90da70a26318"
      unitRef="usd">-654000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i6c4f0b83de01479eb59aaddfa35650cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzI2Mzg_d5da6012-b38d-438d-8bc6-421283d92a41"
      unitRef="usd">-788000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="if2866ecd09514e62ba339145a6407f2d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDIvZnJhZzpiZTkwYTQyMmJiODU0OTA5OGUwMTk4NzI1ZDFjM2Q0Zi90ZXh0cmVnaW9uOmJlOTBhNDIyYmI4NTQ5MDk4ZTAxOTg3MjVkMWMzZDRmXzI2NDU_59ecda9d-84fa-4233-a4e0-ed20812a3b12"
      unitRef="usd">-429000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:InsuranceContractAcquisitionCostTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90ZXh0cmVnaW9uOjM3NzkzMGQ5MjBlYTRiOGE5ZTdjZDA4ODM0MzhhNjNhXzEwNDQ1MzYwNDc5MTk5_432dccf0-96b2-4e2d-921c-75f6070ea045">Other Insurance Liabilities and Separate Accounts&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Insurance Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the Financial Accounting Standards Board issued ASU 2018-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 944) (the &#x201c;long-duration insurance standard&#x201d;). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#x2019;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#x2019;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#x2019;s interim and annual financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted this accounting standard on January 1, 2023, using the modified retrospective transition method as of January 1, 2021, also referred to as the &#x201c;transition date&#x201d;, for changes to its liabilities for future policy benefits, deferred acquisition costs and value of business acquired intangible asset. Upon adoption, the Company recorded a transition date net adjustment to reduce accumulated other comprehensive income (loss) by $986&#160;million ($766&#160;million after-tax) with a corresponding increase to its liability for future policy benefits, the majority of which is included within other insurance liabilities and other long-term liabilities on the consolidated balance sheets. The transition date net adjustment was a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#x2019;s expected investment yield under the historical guidance. The Company was not required to record an adjustment to retained earnings on the transition date. Prior period financial information subsequent to the transition date has been revised to reflect the adoption of the long-duration insurance standard.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes changes in the balances of long-duration insurance liabilities as a result of the adoption of the long-duration insurance standard effective January 1, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Large Case&lt;br/&gt;Pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-Term&lt;br/&gt;Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,224&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,142&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,224&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,142&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Removal of shadow adjustments in accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,647&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,695&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted balance at January 1, 2021, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,647&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,695&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impact of New Long-Duration Insurance Contracts Standard on Financial Statement Line Items&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the consolidated statement of operations for the years ended December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Impact of Change in Accounting Policy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted &lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated Statement of Operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,281&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,073&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314,721&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314,513&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,746&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,954&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,628&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,836&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,463&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,509&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,165&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,327&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,165&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,327&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,149&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,311&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Impact of Change in Accounting Policy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;br/&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted &lt;br/&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated Statement of Operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,260&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,188&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,066&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278,918&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278,801&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,193&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,310&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,420&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,537&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,522&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,548&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,898&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,989&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,898&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,989&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,910&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,001&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the consolidated balance sheet as of December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Impact of Change in Accounting Policy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted &lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated Balance Sheet:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,685&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,636&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,682&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,633&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,754&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,803&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,275&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,275&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,406&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,142&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other insurance liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,140&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,736&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(315)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,421&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,880&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,016&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term insurance liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,108&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(273)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,835&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,732&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,730&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156,960&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(454)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156,506&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retained earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,145&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,398&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,465)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,264)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total CVS Health shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,469&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,315&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,769&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities and shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,275&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,275&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Impact of Change in Accounting Policy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;br/&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted &lt;br/&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated Balance Sheet:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,292&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,319&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,008&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,035&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,052&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,999&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233,052&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,808&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,678&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other insurance liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,303&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,345&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,807&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,719&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,270&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,115&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term insurance liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,402&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;833&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,235&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,904&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,907&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,618&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;593&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158,211&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retained earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,906&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,997&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;965&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(631)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total CVS Health shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,075&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(540)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,535&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,381&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(540)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,841&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities and shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,999&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233,052&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the consolidated statement of cash flows for the years ended December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Impact of Change in Accounting Policy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted &lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated Statement of Cash Flows:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reconciliation of net income to net cash provided by operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,165&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,327&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments required to reconcile net income to net cash provided by operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,247&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,224&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,075)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,029)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in operating assets and liabilities, net of effects from acquisitions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(566)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(491)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable and other insurance liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,247&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(255)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,468&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,463&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Impact of Change in Accounting Policy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;br/&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted &lt;br/&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated Statement of Cash Flows:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reconciliation of net income to net cash provided by operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,898&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,989&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments required to reconcile net income to net cash provided by operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,512&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,486&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(428)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in operating assets and liabilities, net of effects from acquisitions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable and other insurance liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,852&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,856&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Future Policy Benefits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables show the components of the change in the liability for future policy benefits, which is included in other insurance liabilities and other long-term insurance liabilities on the consolidated balance sheets, during the years ended December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Large Case&lt;br/&gt;Pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-Term&lt;br/&gt;Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of expected net premiums &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, beginning of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in cash flow assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of actual variances from expected experience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted beginning liability for future policy benefits - original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accrual (using locked-in discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net premiums (actual)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, end of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of expected future policy benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, beginning of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in cash flow assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of actual variances from expected experience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted beginning liability for future policy benefits - original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accrual (using locked-in discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments (actual)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, end of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net liability for future policy benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net liability for future policy benefits, net of reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The present value of expected net premiums is equivalent to the present value of expected gross premiums for the long-term care insurance contracts as net premiums are set equal to gross premiums.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Large Case&lt;br/&gt;Pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-Term&lt;br/&gt;Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of expected net premiums &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, beginning of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in cash flow assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of actual variances from expected experience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted beginning liability for future policy benefits - original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accrual (using locked-in discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net premiums (actual)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, end of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of expected future policy benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, beginning of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in cash flow assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of actual variances from expected experience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted beginning liability for future policy benefits - original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accrual (using locked-in discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments (actual)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(313)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, end of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net liability for future policy benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net liability for future policy benefits, net of reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The present value of expected net premiums is equivalent to the present value of expected gross premiums for the long-term care insurance contracts as net premiums are set equal to gross premiums.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of undiscounted expected gross premiums and expected future benefit payments for long-duration insurance liabilities as of December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Large case pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected future benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,539&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,882&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected gross premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected future benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,265&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,115&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected gross premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average interest rate used in the measurement of the long-duration insurance liabilities as of December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Large case pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accretion rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.24%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.53%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accretion rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.11%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.11%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.39%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.88%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average durations (in years) of the long-duration insurance liabilities as of December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Large case pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not have any material differences between the actual experience and expected experience for the significant assumptions used in the computation of the liability for future policy benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Policyholders&#x2019; Funds&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in policyholders&#x2019; funds related to long-duration insurance contracts, which are included in policyholders&#x2019; funds and other long-term liabilities on the consolidated balance sheets, during the years ended December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except weighted average crediting rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Policyholders&#x2019; funds, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deposits received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Policy charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surrenders and withdrawals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest credited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in net unrealized gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Policyholders&#x2019; funds, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average crediting rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.72%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.81%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amount at risk&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Separate Accounts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the fair value of assets, by major investment category, supporting Separate Accounts as of December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities and common/collective trusts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $85 million of other payables and $70&#160;million of other receivables at December&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in Separate Accounts liabilities during the years ended December&#160;31, 2022 and 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Separate Accounts liability, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums and deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surrenders and withdrawals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(581)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(984)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net transfers from general account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Separate Accounts liability, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The Company did not recognize any gains or losses on assets transferred to Separate Accounts during the years ended December&#160;31, 2022 and 2021.</us-gaap:InsuranceContractAcquisitionCostTextBlock>
    <cvs:AccumulatedOtherComprehensiveIncomeLossBeforeTax
      contextRef="i5bb58d471a7046db9c3cc65f4971e64f_I20210101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90ZXh0cmVnaW9uOjM3NzkzMGQ5MjBlYTRiOGE5ZTdjZDA4ODM0MzhhNjNhXzM4NDgyOTA3MTI0MzE_16e3071a-b9fa-4924-8467-21d4db81dd37"
      unitRef="usd">-986000000</cvs:AccumulatedOtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="i5bb58d471a7046db9c3cc65f4971e64f_I20210101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90ZXh0cmVnaW9uOjM3NzkzMGQ5MjBlYTRiOGE5ZTdjZDA4ODM0MzhhNjNhXzM4NDgyOTA3MTI0MzE_3febf128-715d-4068-a4e0-d2988c3f3479"
      unitRef="usd">986000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5bb58d471a7046db9c3cc65f4971e64f_I20210101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90ZXh0cmVnaW9uOjM3NzkzMGQ5MjBlYTRiOGE5ZTdjZDA4ODM0MzhhNjNhXzM4NDgyOTA3MTI0NDU_1cdd0e35-fd2d-46a3-af47-6af719e484dc"
      unitRef="usd">-766000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <cvs:LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax
      contextRef="i5bb58d471a7046db9c3cc65f4971e64f_I20210101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90ZXh0cmVnaW9uOjM3NzkzMGQ5MjBlYTRiOGE5ZTdjZDA4ODM0MzhhNjNhXzM4NDgyOTA3MTI0NDU_8ec041bf-3fc4-48c2-803c-e79045e75254"
      unitRef="usd">766000000</cvs:LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax>
    <us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90ZXh0cmVnaW9uOjM3NzkzMGQ5MjBlYTRiOGE5ZTdjZDA4ODM0MzhhNjNhXzEwNDQ1MzYwNDc5MjAw_bf858728-786f-4d9c-b3c3-0a47203553e5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes changes in the balances of long-duration insurance liabilities as a result of the adoption of the long-duration insurance standard effective January 1, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Large Case&lt;br/&gt;Pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-Term&lt;br/&gt;Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,224&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,142&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,224&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,142&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Removal of shadow adjustments in accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,647&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,695&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted balance at January 1, 2021, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,647&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,695&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impact of New Long-Duration Insurance Contracts Standard on Financial Statement Line Items&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the consolidated statement of operations for the years ended December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Impact of Change in Accounting Policy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted &lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated Statement of Operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,281&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,073&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314,721&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314,513&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,746&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,954&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,628&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,836&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,463&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,509&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,165&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,327&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,165&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,327&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,149&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,311&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Impact of Change in Accounting Policy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;br/&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted &lt;br/&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated Statement of Operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,260&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,188&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,066&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278,918&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278,801&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,193&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,310&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,420&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,537&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,522&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,548&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,898&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,989&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,898&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,989&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,910&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,001&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the consolidated balance sheet as of December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Impact of Change in Accounting Policy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted &lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated Balance Sheet:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,685&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,636&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,682&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,633&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,754&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,803&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,275&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,275&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,406&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,142&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other insurance liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,140&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,736&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(315)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,421&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,880&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,016&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term insurance liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,108&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(273)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,835&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,732&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,730&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156,960&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(454)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156,506&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retained earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,145&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,398&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,465)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,264)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total CVS Health shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,469&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,315&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,769&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities and shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,275&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,275&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Impact of Change in Accounting Policy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;br/&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted &lt;br/&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated Balance Sheet:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,292&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,319&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,008&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,035&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,052&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,999&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233,052&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,808&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,678&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other insurance liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,303&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,345&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,807&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,719&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,270&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,115&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term insurance liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,402&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;833&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,235&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,904&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,907&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,618&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;593&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158,211&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retained earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,906&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,997&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;965&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(631)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total CVS Health shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,075&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(540)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,535&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,381&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(540)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,841&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities and shareholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,999&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233,052&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of applying the long-duration insurance standard using a modified retrospective method, the following adjustments were made to amounts reported in the consolidated statement of cash flows for the years ended December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Impact of Change in Accounting Policy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted &lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated Statement of Cash Flows:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reconciliation of net income to net cash provided by operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,165&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,327&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments required to reconcile net income to net cash provided by operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,247&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,224&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,075)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,029)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in operating assets and liabilities, net of effects from acquisitions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(566)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(491)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable and other insurance liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,247&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(255)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,468&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,463&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Impact of Change in Accounting Policy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;br/&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted &lt;br/&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated Statement of Cash Flows:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reconciliation of net income to net cash provided by operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,898&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,989&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments required to reconcile net income to net cash provided by operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,512&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,486&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(428)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in operating assets and liabilities, net of effects from acquisitions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable and other insurance liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,852&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,856&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="i92b1a4067a7447d09ac7bb0fa978bb71_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzEtMS0xLTEtMjk3NTAw_e251a217-8ed5-4be5-aeb7-b1af3c149b89"
      unitRef="usd">3224000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="if0a700dd2b904bf5bbc0dbe22aa0bac8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzEtMy0xLTEtMjk3NTAw_526929bb-f378-444e-a3b9-c6fc02d9a99e"
      unitRef="usd">1142000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="i1bb54359e2f54f6bb88e696298a4d66a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzEtNS0xLTEtMjk3NTAw_59491bc8-4407-4baa-8993-e63a1dc55781"
      unitRef="usd">480000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="i92b1a4067a7447d09ac7bb0fa978bb71_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzItMS0xLTEtMjk3NTAw_deb31341-576b-433f-8025-c0f77ba1a5f9"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="if0a700dd2b904bf5bbc0dbe22aa0bac8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzItMy0xLTEtMjk3NTAw_106f9d14-1062-40bb-a6c2-5323982d5beb"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="i1bb54359e2f54f6bb88e696298a4d66a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzItNS0xLTEtMjk3NTAw_26a242fb-6259-4376-a9b6-3c2f6d3286fe"
      unitRef="usd">274000000</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <cvs:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange
      contextRef="i92b1a4067a7447d09ac7bb0fa978bb71_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzMtMS0xLTEtMjk3NTAw_91b692a1-4b78-49f9-8c16-d20d229c21ca"
      unitRef="usd">3224000000</cvs:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange>
    <cvs:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange
      contextRef="if0a700dd2b904bf5bbc0dbe22aa0bac8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzMtMy0xLTEtMjk3NTAw_e968ac42-c9d6-4ccd-8d91-daf4ffede76c"
      unitRef="usd">1142000000</cvs:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange>
    <cvs:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange
      contextRef="i1bb54359e2f54f6bb88e696298a4d66a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzMtNS0xLTEtMjk3NTAw_4a0d5d30-5201-4534-9b01-7b75d78f0003"
      unitRef="usd">754000000</cvs:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="i6bf2003d34b74a88a3c886d4e9d41643_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzQtMS0xLTEtMjk3NTAw_83638d85-b9c2-403d-97e7-c1fed3d8d965"
      unitRef="usd">604000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="iabfc58f2b34943d8a1b6af15cd233571_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzQtMy0xLTEtMjk3NTAw_be80fff8-953c-46a2-9c51-04f8997ad960"
      unitRef="usd">553000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="i20c1ca9c1b9440b994dfb835f8ea73f4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzQtNS0xLTEtMjk3NTAw_144f5888-f845-470b-9259-117712a8cddd"
      unitRef="usd">44000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="i912746c5ac72472fb68054bd160c6e6c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzUtMS0xLTEtMjk3NTAw_1fd4cfe9-415c-47ae-97f8-47a4cf0f1d35"
      unitRef="usd">-181000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="i89b6580a77e04626a0e30a5a4fb6adc4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzUtMy0xLTEtMjk3NTAw_6ed2a1bd-113e-488f-a33a-0b442c24a597"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="i8c5404c452ba4db28e4fbb520b402437_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzUtNS0xLTEtMjk3NTAw_4c927be1-17fe-4c9f-b59f-5f02f7affb05"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange>
    <cvs:LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="i1263a7bd13e6441c90af49d5dde6fbc0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzYtMS0xLTEtMjk3NTAw_305fc4f2-74a1-469e-a649-aa96072471f5"
      unitRef="usd">3647000000</cvs:LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <cvs:LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="i644e02c89965481d980470106777aa5c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzYtMy0xLTEtMjk3NTAw_62296cfa-a179-4d82-aade-9630de08c961"
      unitRef="usd">1695000000</cvs:LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <cvs:LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="i9137fbdadfbe43f5b00bde48da98706d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzYtNS0xLTEtMjk3NTAw_b2aa857b-8abe-4330-9ab6-8c52327751fb"
      unitRef="usd">798000000</cvs:LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="i1263a7bd13e6441c90af49d5dde6fbc0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzctMS0xLTEtMjk3NTAw_4f546d2c-bb55-41ba-9a70-f65b5934b83e"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="i644e02c89965481d980470106777aa5c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzctMy0xLTEtMjk3NTAw_9b32fc0b-6a12-42aa-a466-0988ab83a25d"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="i9137fbdadfbe43f5b00bde48da98706d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzctNS0xLTEtMjk3NTAw_c6203b75-4dff-49a1-b0d2-e5a61764caa2"
      unitRef="usd">308000000</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="i1263a7bd13e6441c90af49d5dde6fbc0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzgtMS0xLTEtMjk3NTAw_7a07a270-9392-4fb6-bec0-c8f79c27f439"
      unitRef="usd">3647000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="i644e02c89965481d980470106777aa5c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzgtMy0xLTEtMjk3NTAw_7952c6cc-7e9c-48ad-8540-9de1b7d28699"
      unitRef="usd">1695000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="i9137fbdadfbe43f5b00bde48da98706d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo0Mzg1YzE1ZWNhZTk0MTYzOTU2MDlmMmZlYjMwZmQyZS90YWJsZXJhbmdlOjQzODVjMTVlY2FlOTQxNjM5NTYwOWYyZmViMzBmZDJlXzgtNS0xLTEtMjk3NTAw_659f8bdc-4b05-46bc-b074-0523b51299cc"
      unitRef="usd">490000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzQtMS0xLTEtMjk3NTAw_8fdfb947-e196-42ef-919f-163766d9cded"
      unitRef="usd">71281000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzQtMy0xLTEtMjk3NTAw_ef9e282a-5704-40b4-8035-3f96583d22ba"
      unitRef="usd">-208000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzQtNS0xLTEtMjk3NTAw_bb952f02-aa53-4413-a999-aecbb3e045dd"
      unitRef="usd">71073000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:CostsAndExpenses
      contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzUtMS0xLTEtMjk3NTAw_4d33951e-0100-4583-8b9e-f77d41d9280e"
      unitRef="usd">314721000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzUtMy0xLTEtMjk3NTAw_b2508b8e-d030-43b6-a5ce-85949e3f5831"
      unitRef="usd">-208000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzUtNS0xLTEtMjk3NTAw_5076a4f5-08f5-4970-9bbf-f96600520f8d"
      unitRef="usd">314513000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzYtMS0xLTEtMjk3NTAw_e5e474ac-9d9a-4052-bc6e-a256149a4434"
      unitRef="usd">7746000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzYtMy0xLTEtMjk3NTAw_89350101-6f5c-42c9-9db1-ab042c472ea4"
      unitRef="usd">208000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzYtNS0xLTEtMjk3NTAw_5eb8c73c-aa05-483e-8bac-c8409a98c479"
      unitRef="usd">7954000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzctMS0xLTEtMjk3NTAw_2b5154cc-c8b1-4910-aa1f-21854314a67f"
      unitRef="usd">5628000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzctMy0xLTEtMjk3NTAw_18ddbcc8-34ca-4c76-be69-efb12db798bb"
      unitRef="usd">208000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzctNS0xLTEtMjk3NTAw_d9c7ac83-f1d6-46a1-800c-2fbc4e7953b1"
      unitRef="usd">5836000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzgtMS0xLTEtMjk3NTAw_decf2687-fc7a-40a9-8786-4029d19a97dd"
      unitRef="usd">1463000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzgtMy0xLTEtMjk3NTAw_a02ca762-1365-4166-af0e-4b622718ac5b"
      unitRef="usd">46000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzgtNS0xLTEtMjk3NTAw_484d1e36-0ed8-4f16-8024-461e436544e7"
      unitRef="usd">1509000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzktMS0xLTEtMjk3NTAw_355fd707-805c-4cd1-bff2-d9b64ba9938d"
      unitRef="usd">4165000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzktMy0xLTEtMjk3NTAw_425c2c2b-b111-4161-8ef6-b5ecd950b66c"
      unitRef="usd">162000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzktNS0xLTEtMjk3NTAw_9e6982f3-c49d-430e-89eb-615a3006c752"
      unitRef="usd">4327000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzEwLTEtMS0xLTI5NzUwMA_e6024b43-d8b8-48d4-9a9c-0fda0ee017ea"
      unitRef="usd">4165000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzEwLTMtMS0xLTI5NzUwMA_9ab706f9-235c-4dd7-a231-ea81b87e0f80"
      unitRef="usd">162000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzEwLTUtMS0xLTI5NzUwMA_6dc83151-dd85-42d3-918a-e8aae83a5251"
      unitRef="usd">4327000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzExLTEtMS0xLTI5NzUwMA_dd612be1-08e3-4484-be94-c7250bd3a58a"
      unitRef="usd">4149000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzExLTMtMS0xLTI5NzUwMA_2e8286e0-86c7-4ee5-9fd6-7d2513a31a33"
      unitRef="usd">162000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzExLTUtMS0xLTI5NzUwMA_47688898-896c-4067-b08e-708a824603c1"
      unitRef="usd">4311000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzEzLTEtMS0xLTI5NzUwMA_ab6901c9-3e82-4c1d-bd53-ccca4f94177d"
      unitRef="usdPerShare">3.16</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzEzLTMtMS0xLTI5NzUwMA_27cfaa04-2cac-4e77-b944-d45935e6e559"
      unitRef="usdPerShare">0.13</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzEzLTUtMS0xLTI5NzUwMA_cc332167-5e24-464d-8586-d1c8b3deec2a"
      unitRef="usdPerShare">3.29</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzE1LTEtMS0xLTMwMDYyNw_7c775963-ed41-4337-bd85-5985ffa8ad7a"
      unitRef="usdPerShare">3.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzE1LTMtMS0xLTMwMDYyNw_dd862997-b4f6-4e97-95b7-034771aa4874"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzE1LTUtMS0xLTMwMDYyNw_3b34dc08-1964-4731-a4e6-5d7f6587173b"
      unitRef="usdPerShare">3.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzE0LTEtMS0xLTI5NzUwMA_b2b7da5e-e3f9-4575-9531-7991690d8e40"
      unitRef="usdPerShare">3.14</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzE0LTMtMS0xLTI5NzUwMA_c53bab5c-5cf4-4979-93e2-5e4fdf7406a7"
      unitRef="usdPerShare">0.12</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzE0LTUtMS0xLTI5NzUwMA_f90fbf93-006b-402c-8bfd-8d495e80f21d"
      unitRef="usdPerShare">3.26</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzE4LTEtMS0xLTMwMDYzNQ_68c61a60-7a8e-4244-9e0c-81bb9d2ed702"
      unitRef="usdPerShare">3.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzE4LTMtMS0xLTMwMDYzNQ_ac4dfd7c-adcb-42b2-bf2c-eb230bfce75e"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyNGM0NjcwNjQ4YWY0NmYxYTRlYmRiMzAzNzU3ZTYzMC90YWJsZXJhbmdlOjI0YzQ2NzA2NDhhZjQ2ZjFhNGViZGIzMDM3NTdlNjMwXzE4LTUtMS0xLTMwMDYzNQ_e961b03f-cf15-43e8-a383-2e9f8454fab0"
      unitRef="usdPerShare">3.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzQtMS0xLTEtMjk3NTAw_66d51f4c-ef38-400a-a651-5a3f05db26bc"
      unitRef="usd">64260000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzQtMy0xLTEtMjk3NTAw_a5f8d688-1f55-4993-9c8d-51155b7f40e9"
      unitRef="usd">-72000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzQtNS0xLTEtMjk3NTAw_ec8d1bf6-a1d6-4e1e-984e-db2b29ed0495"
      unitRef="usd">64188000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <cvs:OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement
      contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzUtMS0xLTEtMjk3NTAw_186cc182-3566-4215-b589-7cf370abc5c3"
      unitRef="usd">37066000000</cvs:OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement>
    <cvs:OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement
      contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzUtMy0xLTEtMjk3NTAw_1d71c034-efd8-4643-9d9f-9f8828f3a847"
      unitRef="usd">-45000000</cvs:OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement>
    <cvs:OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzUtNS0xLTEtMjk3NTAw_39935027-d3be-45b0-ac6d-02d0998e05cf"
      unitRef="usd">37021000000</cvs:OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement>
    <us-gaap:CostsAndExpenses
      contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzYtMS0xLTEtMjk3NTAw_a0c6f910-f090-4944-946f-d0c0117eae75"
      unitRef="usd">278918000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzYtMy0xLTEtMjk3NTAw_af37285e-97a8-4f26-b988-f0d4984e60c5"
      unitRef="usd">-117000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzYtNS0xLTEtMjk3NTAw_300193cf-8438-4174-9e6f-f0dbd64d708d"
      unitRef="usd">278801000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzctMS0xLTEtMjk3NTAw_c3b2b134-00f1-49a1-bf88-6394e4009749"
      unitRef="usd">13193000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzctMy0xLTEtMjk3NTAw_347f0644-5bed-478c-8ef8-4e524dbece5b"
      unitRef="usd">117000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzctNS0xLTEtMjk3NTAw_3bb7dbe1-3cbe-42df-be59-72f37ee42e0c"
      unitRef="usd">13310000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzgtMS0xLTEtMjk3NTAw_702ed15e-badc-48a3-b6d6-fe9d975fab41"
      unitRef="usd">10420000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzgtMy0xLTEtMjk3NTAw_0a61358c-4a89-4061-9d37-b0070004baa3"
      unitRef="usd">117000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzgtNS0xLTEtMjk3NTAw_bd3786da-85f2-42a0-9e67-927fa8450b7a"
      unitRef="usd">10537000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzktMS0xLTEtMjk3NTAw_beb7c042-9d56-44d1-87b3-1989199e8fe3"
      unitRef="usd">2522000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzktMy0xLTEtMjk3NTAw_13559b8d-59bc-4821-b82a-fdcf4fb01e95"
      unitRef="usd">26000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzktNS0xLTEtMjk3NTAw_d0fbc512-348e-4c7e-b0eb-fe082e6b9503"
      unitRef="usd">2548000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzEwLTEtMS0xLTI5NzUwMA_c5319050-3151-45af-80f0-55bd3ae0a844"
      unitRef="usd">7898000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzEwLTMtMS0xLTI5NzUwMA_60b92ba4-d722-419e-b2db-9273662c0f18"
      unitRef="usd">91000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzEwLTUtMS0xLTI5NzUwMA_f7385650-378e-4472-b87c-8f925bf757db"
      unitRef="usd">7989000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzExLTEtMS0xLTI5NzUwMA_bde6ebd4-3de5-45d9-9496-a4d394a9b9b5"
      unitRef="usd">7898000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzExLTMtMS0xLTI5NzUwMA_9c4e07cc-97b5-4856-8abe-f8c3cc63edaf"
      unitRef="usd">91000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzExLTUtMS0xLTI5NzUwMA_07b24673-92db-4eb7-a011-a9a417a0e811"
      unitRef="usd">7989000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzEyLTEtMS0xLTI5NzUwMA_71b03e63-3489-4d70-861d-0855d343f50e"
      unitRef="usd">7910000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzEyLTMtMS0xLTI5NzUwMA_5c335095-dabb-49ad-b54d-b288310a8f4a"
      unitRef="usd">91000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzEyLTUtMS0xLTI5NzUwMA_eb75a8ab-7a43-4a97-87a2-b07cb1c8153e"
      unitRef="usd">8001000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE0LTEtMS0xLTI5NzUwMA_49ea87f2-c1f4-40b0-9d72-f9ff53243968"
      unitRef="usdPerShare">6.00</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE0LTMtMS0xLTI5NzUwMA_3b8a7f39-cd78-4516-9aaa-701fa15524de"
      unitRef="usdPerShare">0.07</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE0LTUtMS0xLTI5NzUwMA_cfa857d9-c70e-493a-8e6b-3c31d2a2ca14"
      unitRef="usdPerShare">6.07</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE2LTEtMS0xLTMwMDY0Mw_a49e4015-86c7-49e7-91ba-049123eaee21"
      unitRef="usdPerShare">6.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE2LTMtMS0xLTMwMDY0Mw_310a7c5d-c264-4476-a964-c39056cd6f2e"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE2LTUtMS0xLTMwMDY0Mw_c457b784-d0e1-4fc5-8ec1-599b0ce7d5b1"
      unitRef="usdPerShare">6.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE1LTEtMS0xLTI5NzUwMA_709c6e4e-c4d9-45ba-a709-e3b35d1848e9"
      unitRef="usdPerShare">5.95</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE1LTMtMS0xLTI5NzUwMA_40c89954-ac21-4b71-8758-18e0588e2fc6"
      unitRef="usdPerShare">0.07</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE1LTUtMS0xLTI5NzUwMA_34d34504-2490-4113-9120-60026d923f4b"
      unitRef="usdPerShare">6.02</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE5LTEtMS0xLTMwMDY1MQ_fd1f258a-b7e4-4ede-9c52-1fd6e6492070"
      unitRef="usdPerShare">5.95</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE5LTMtMS0xLTMwMDY1MQ_94fdc7bc-4399-4338-a6f5-fa2e5a8413bc"
      unitRef="usdPerShare">0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZTllZjM0MzYzMmE0ZjQ0ODE5NGIyOTAzYzQ3ZjFmYS90YWJsZXJhbmdlOmJlOWVmMzQzNjMyYTRmNDQ4MTk0YjI5MDNjNDdmMWZhXzE5LTUtMS0xLTMwMDY1MQ_262d193f-451d-4db3-817b-214119aa4c99"
      unitRef="usdPerShare">6.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:OtherAssetsCurrent
      contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzMtMS0xLTEtMjk3NTAw_bb015e3f-d193-463d-b94d-b9c69b98cd31"
      unitRef="usd">2685000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzMtMy0xLTEtMjk3NTAw_ec7622bf-de9e-4197-bb5b-e42d36d51306"
      unitRef="usd">-49000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzMtNS0xLTEtMjk3NTAw_5cb8848c-5488-4ade-bc6a-109517596d97"
      unitRef="usd">2636000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzQtMS0xLTEtMjk3NTAw_4b67a753-e8c3-4c25-91d3-3939ff8917ba"
      unitRef="usd">65682000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzQtMy0xLTEtMjk3NTAw_6b3b2acf-f14a-486f-9b45-114fa2161b51"
      unitRef="usd">-49000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzQtNS0xLTEtMjk3NTAw_ecfd4645-c488-4009-b6cb-a74953bd0d8d"
      unitRef="usd">65633000000</us-gaap:AssetsCurrent>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzUtMS0xLTEtMjk3NTAw_000cf762-a80c-498d-b30b-383fa214b21b"
      unitRef="usd">24754000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzUtMy0xLTEtMjk3NTAw_8eece262-7646-4867-bd58-1e446488d2d9"
      unitRef="usd">49000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzUtNS0xLTEtMjk3NTAw_f9f00629-1a64-4679-a494-0f0e712ed519"
      unitRef="usd">24803000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Assets
      contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzYtMS0xLTEtMjk3NTAw_222dc4eb-984a-4dc4-97ab-6d82f515841c"
      unitRef="usd">228275000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzYtMy0xLTEtMjk3NTAw_138b5473-4a48-4859-a4e2-dfdda13a0be7"
      unitRef="usd">0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzYtNS0xLTEtMjk3NTAw_a3212982-328e-4516-a9e4-360b7151e8be"
      unitRef="usd">228275000000</us-gaap:Assets>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzctMS0xLTEtMjk3NTAw_97952f8f-dfc3-471e-99cd-fbdc4cfa1721"
      unitRef="usd">10406000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzctMy0xLTEtMjk3NTAw_f6333f61-a760-448a-b5d6-fa1729530622"
      unitRef="usd">-264000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzctNS0xLTEtMjk3NTAw_d89ea934-adb3-409f-8906-3d2669218466"
      unitRef="usd">10142000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzgtMS0xLTEtMjk3NTAw_1ba056a4-0ca7-4e40-a5b4-518e486f4d25"
      unitRef="usd">1140000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzgtMy0xLTEtMjk3NTAw_227e834c-a1ba-402c-bd4a-4a1d79e97767"
      unitRef="usd">-51000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzgtNS0xLTEtMjk3NTAw_a51670fa-d7b7-402f-bb4f-cb3ec0f09099"
      unitRef="usd">1089000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzktMS0xLTEtMjk3NTAw_f3c7d85a-a533-4a6e-997d-2204077d2a5b"
      unitRef="usd">69736000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzktMy0xLTEtMjk3NTAw_1848fd09-5f28-4254-944f-26c618a3e45b"
      unitRef="usd">-315000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzktNS0xLTEtMjk3NTAw_0ed1b413-0f47-4bd6-9ad7-646cf910ac85"
      unitRef="usd">69421000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzEwLTEtMS0xLTI5NzUwMA_3577bdd2-6be7-426d-9ba1-62bf0edbd546"
      unitRef="usd">3880000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzEwLTMtMS0xLTI5NzUwMA_518a45b2-569f-4778-b165-134931631fd8"
      unitRef="usd">136000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzEwLTUtMS0xLTI5NzUwMA_c9a5cc4c-7e40-47f0-835f-6b7a21176f56"
      unitRef="usd">4016000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzExLTEtMS0xLTI5NzUwMA_042ebf04-86a2-4d8c-80af-ae630285685f"
      unitRef="usd">6108000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzExLTMtMS0xLTI5NzUwMA_b5ea511b-129d-45d1-a026-2fc88acbc6f2"
      unitRef="usd">-273000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzExLTUtMS0xLTI5NzUwMA_cd8e2a15-de7c-47a1-a191-a6a73cd739da"
      unitRef="usd">5835000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzEyLTEtMS0xLTI5NzUwMA_cb4ce437-995e-46ce-8cc0-c6c5c3442f57"
      unitRef="usd">6732000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzEyLTMtMS0xLTI5NzUwMA_980af772-b0a2-4356-8cd8-758c623d4d1a"
      unitRef="usd">-2000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzEyLTUtMS0xLTI5NzUwMA_c3b50a1b-4933-43b0-9f02-c28ebbcdb73c"
      unitRef="usd">6730000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzEzLTEtMS0xLTI5NzUwMA_1de6cebf-332a-45af-8669-cdba9d4c4218"
      unitRef="usd">156960000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzEzLTMtMS0xLTI5NzUwMA_8cb47a12-c9cd-49f2-8fe7-4ab2f877587d"
      unitRef="usd">-454000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzEzLTUtMS0xLTI5NzUwMA_da9d25e0-6c8d-424e-8c12-dcb2da1673c1"
      unitRef="usd">156506000000</us-gaap:Liabilities>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE0LTEtMS0xLTI5NzUwMA_dc08b28d-6f8e-4014-a58e-da51161cd059"
      unitRef="usd">56145000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE0LTMtMS0xLTI5NzUwMA_b902c4f3-c84c-4e1a-beae-2d437fff8d2a"
      unitRef="usd">253000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE0LTUtMS0xLTI5NzUwMA_614ed18d-a78e-4f40-8999-a78d38dc75a1"
      unitRef="usd">56398000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE1LTEtMS0xLTI5NzUwMA_88327a62-44b1-4400-83f3-281d1d0292d4"
      unitRef="usd">-1465000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE1LTMtMS0xLTI5NzUwMA_5280ee05-a7e1-466d-a280-d810cd8207fa"
      unitRef="usd">201000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE1LTUtMS0xLTI5NzUwMA_0460986f-3123-475c-b24b-ac1e46b5f433"
      unitRef="usd">-1264000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE2LTEtMS0xLTI5NzUwMA_c679a694-c259-47e0-8799-4cf758a17c6f"
      unitRef="usd">71015000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE2LTMtMS0xLTI5NzUwMA_630242c4-541d-4afe-a7ae-f97b0009e97f"
      unitRef="usd">454000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE2LTUtMS0xLTI5NzUwMA_17d87c2f-df49-4f9a-a948-2b924138ae8e"
      unitRef="usd">71469000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE3LTEtMS0xLTI5NzUwMA_f407eb66-a23f-4004-97e5-639b33b2c37f"
      unitRef="usd">71315000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE3LTMtMS0xLTI5NzUwMA_c4f9edc9-d122-4b27-9cfa-ba7878986e62"
      unitRef="usd">454000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE3LTUtMS0xLTI5NzUwMA_4ed78df6-4c1a-48de-8d97-b8ad5e183f9d"
      unitRef="usd">71769000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i3c93d574c339401191a45224c5b9c45a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE4LTEtMS0xLTI5NzUwMA_1b1d999d-8bad-4c15-9586-0682acf7ed2d"
      unitRef="usd">228275000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="icbfd8fdbe44c49b28f953090bd798dc8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE4LTMtMS0xLTI5NzUwMA_237f824c-84e9-4a16-b4f8-83504b3d285b"
      unitRef="usd">0</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTplYmQ1YmRjZGNkMjc0YmNiYjNmMmZhNDVkMzlkYmRlNi90YWJsZXJhbmdlOmViZDViZGNkY2QyNzRiY2JiM2YyZmE0NWQzOWRiZGU2XzE4LTUtMS0xLTI5NzUwMA_928d6d5d-42d2-486b-af29-4ada5beea460"
      unitRef="usd">228275000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:OtherAssetsCurrent
      contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzMtMS0xLTEtMjk3NTAw_b5c33c7c-2210-48bf-a8e3-ce7fcc1d3a4e"
      unitRef="usd">5292000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzMtMy0xLTEtMjk3NTAw_0258e8d5-f4c4-444e-b372-8f3afde92801"
      unitRef="usd">27000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzMtNS0xLTEtMjk3NTAw_7eff275a-aae5-4af5-8d81-1e4dedd4e10b"
      unitRef="usd">5319000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzQtMS0xLTEtMjk3NTAw_7357eb12-bdd3-4dc8-b7df-4339e52a551d"
      unitRef="usd">60008000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzQtMy0xLTEtMjk3NTAw_90c888e1-a631-4b65-9034-9d07e884ade8"
      unitRef="usd">27000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzQtNS0xLTEtMjk3NTAw_20bbb116-9211-4775-a59f-3b8fca077d82"
      unitRef="usd">60035000000</us-gaap:AssetsCurrent>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzUtMS0xLTEtMjk3NTAw_c6cc17b4-d5f7-4f04-8788-6c9dd44016ef"
      unitRef="usd">29026000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzUtMy0xLTEtMjk3NTAw_378a1157-6f72-4b24-a13d-2897427190df"
      unitRef="usd">26000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzUtNS0xLTEtMjk3NTAw_487d66c0-87be-4294-bc9f-ae6c0ecf6e8b"
      unitRef="usd">29052000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Assets
      contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzYtMS0xLTEtMjk3NTAw_6083fbee-aac6-4633-bbf1-51cebea93887"
      unitRef="usd">232999000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzYtMy0xLTEtMjk3NTAw_bafd1b1e-9bb1-4579-a25a-9c5173ee6721"
      unitRef="usd">53000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzYtNS0xLTEtMjk3NTAw_10704726-6f86-47e6-b67b-3c6561875ff4"
      unitRef="usd">233052000000</us-gaap:Assets>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzctMS0xLTEtMjk3NTAw_bb993a4c-7271-4659-8353-27aaa8125fbc"
      unitRef="usd">8808000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzctMy0xLTEtMjk3NTAw_72aba134-5057-4e03-b06b-3c91ecc8326a"
      unitRef="usd">-130000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzctNS0xLTEtMjk3NTAw_70f35154-f943-4ef1-9802-36a83133bae3"
      unitRef="usd">8678000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzgtMS0xLTEtMjk3NTAw_6091eb65-20ba-41ad-b040-0cd6bc47acf9"
      unitRef="usd">1303000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzgtMy0xLTEtMjk3NTAw_d688402d-fdf3-4c3f-88bf-4f3b44761c9a"
      unitRef="usd">42000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzgtNS0xLTEtMjk3NTAw_a16c4091-2012-455b-a2f8-976488c29cb2"
      unitRef="usd">1345000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzktMS0xLTEtMjk3NTAw_62020b44-b6bd-49c9-85a7-93ad3080017d"
      unitRef="usd">67807000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzktMy0xLTEtMjk3NTAw_59f8b5ef-ca23-4e5c-b714-7217f556b598"
      unitRef="usd">-88000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzktNS0xLTEtMjk3NTAw_438b91f1-9544-4bcc-8fdf-f096bc241bf4"
      unitRef="usd">67719000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzEwLTEtMS0xLTI5NzUwMA_888a0c01-bec8-4c73-8ffe-1cf443d4aa94"
      unitRef="usd">6270000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzEwLTMtMS0xLTI5NzUwMA_e629b36f-2624-4722-a747-b7eab21a6e23"
      unitRef="usd">-155000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzEwLTUtMS0xLTI5NzUwMA_e5da04a8-9287-4205-8d3b-22ecf6570948"
      unitRef="usd">6115000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzExLTEtMS0xLTI5NzUwMA_4b90ad4c-faa3-4966-8678-45da78916ddf"
      unitRef="usd">6402000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzExLTMtMS0xLTI5NzUwMA_9a2f1cfb-7eef-4bd0-a4b2-007471a69aaf"
      unitRef="usd">833000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzExLTUtMS0xLTI5NzUwMA_4cd25e39-ea2d-4f57-86f0-fc9fc19f8e71"
      unitRef="usd">7235000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzEyLTEtMS0xLTI5NzUwMA_3f50c889-a3e5-4fdc-a65a-f70230c334c4"
      unitRef="usd">1904000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzEyLTMtMS0xLTI5NzUwMA_92b9b957-5858-4dc5-8552-3887de9eb7ca"
      unitRef="usd">3000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzEyLTUtMS0xLTI5NzUwMA_8285ff39-2d37-4af5-a8ff-d93646532c28"
      unitRef="usd">1907000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzEzLTEtMS0xLTI5NzUwMA_19408cc9-8ce5-4bf5-bd23-e3a45ef45437"
      unitRef="usd">157618000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzEzLTMtMS0xLTI5NzUwMA_85505cc2-a3fa-4188-82ba-89f524d5213d"
      unitRef="usd">593000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzEzLTUtMS0xLTI5NzUwMA_c3afa34c-60cd-4ce6-83d6-d6a724ef2d0f"
      unitRef="usd">158211000000</us-gaap:Liabilities>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE0LTEtMS0xLTI5NzUwMA_d9540455-8e9f-49c2-a76e-7b5906e2ea35"
      unitRef="usd">54906000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE0LTMtMS0xLTI5NzUwMA_c36b6d08-55b0-4e13-aa49-4724fc884cb6"
      unitRef="usd">91000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE0LTUtMS0xLTI5NzUwMA_09ede65d-f480-4dd4-8e8b-42becd60de21"
      unitRef="usd">54997000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE1LTEtMS0xLTI5NzUwMA_e9e22355-353a-438f-bbe8-3cda17682eca"
      unitRef="usd">965000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE1LTMtMS0xLTI5NzUwMA_d721ef05-bd2d-459e-8bef-ca8b6e1b0911"
      unitRef="usd">-631000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE1LTUtMS0xLTI5NzUwMA_722820d5-ed09-4ab4-b9bf-b03fffd5e7f4"
      unitRef="usd">334000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE2LTEtMS0xLTI5NzUwMA_571f8703-53f0-453c-bce1-357b11f3fc89"
      unitRef="usd">75075000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE2LTMtMS0xLTI5NzUwMA_cfd5688e-ad20-4e4b-a79f-80aca9a7a4df"
      unitRef="usd">-540000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE2LTUtMS0xLTI5NzUwMA_c8a79c14-04c3-4482-a5e0-8f71bb85ef9f"
      unitRef="usd">74535000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE3LTEtMS0xLTI5NzUwMA_48c958f3-aae4-44c9-84ef-397e1fe5a9be"
      unitRef="usd">75381000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE3LTMtMS0xLTI5NzUwMA_705b64d1-97c3-4d14-b330-8243ae7ae9c1"
      unitRef="usd">-540000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE3LTUtMS0xLTI5NzUwMA_d084c9e4-b623-49c2-8698-3d2d92a279c8"
      unitRef="usd">74841000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i670b392d30e849e695e1cc46b056bb28_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE4LTEtMS0xLTI5NzUwMA_41f456f5-4785-42ee-82f2-cf690aa3ff9f"
      unitRef="usd">232999000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i786c656d006c45b9b0f0c5fcd6c9efbe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE4LTMtMS0xLTI5NzUwMA_099c9268-1451-49e7-8daf-e0851e319511"
      unitRef="usd">53000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpmMjFiY2QxYmY1N2I0MDk4OWY0YmMwYmMxODQxZWVjMi90YWJsZXJhbmdlOmYyMWJjZDFiZjU3YjQwOTg5ZjRiYzBiYzE4NDFlZWMyXzE4LTUtMS0xLTI5NzUwMA_ab9de21f-3136-49f1-af38-9a262d2195fa"
      unitRef="usd">233052000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzQtMS0xLTEtMjk3NTAw_a2653966-ab19-415a-845b-99d9fb7ab203"
      unitRef="usd">4165000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzQtMy0xLTEtMjk3NTAw_7e1bf1e5-28da-4813-a07c-726d6122db9b"
      unitRef="usd">162000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzQtNS0xLTEtMjk3NTAw_69ebb45a-a15c-4837-be60-c93b54d00b6e"
      unitRef="usd">4327000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzYtMS0xLTEtMjk3NTAw_804983cc-2b63-488c-b5e0-30f0a97c208f"
      unitRef="usd">4247000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzYtMy0xLTEtMjk3NTAw_21d3bbd4-3543-4d25-ba29-afd281034aa1"
      unitRef="usd">-23000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzYtNS0xLTEtMjk3NTAw_17e655f7-9fbc-4285-a278-e367edcaaa51"
      unitRef="usd">4224000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzctMS0xLTEtMjk3NTAw_68dbb637-5a6a-43ae-b47b-906dc8705bdc"
      unitRef="usd">-2075000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzctMy0xLTEtMjk3NTAw_d6778312-e489-4de0-b9d9-be00ce3ac691"
      unitRef="usd">46000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzctNS0xLTEtMjk3NTAw_1c2b03f8-d21f-4428-a5d8-2b0744103d84"
      unitRef="usd">-2029000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzktMS0xLTEtMjk3NTAw_a59cbf5d-da23-4d9b-bf57-e47aae3e3e0a"
      unitRef="usd">566000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzktMy0xLTEtMjk3NTAw_7abfc6bc-468a-4740-9fd8-4b3536127036"
      unitRef="usd">-75000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzktNS0xLTEtMjk3NTAw_ecef7c22-346a-49b1-8c45-b9b30e92e7fc"
      unitRef="usd">491000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzEwLTEtMS0xLTI5NzUwMA_527580fd-246a-4dc1-beea-9243a3a732bf"
      unitRef="usd">1247000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzEwLTMtMS0xLTI5NzUwMA_b189821c-9a85-4e21-b146-c31b7b65c897"
      unitRef="usd">-255000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzEwLTUtMS0xLTI5NzUwMA_d97ae6d8-52f2-4810-8392-7ba5f3cfca82"
      unitRef="usd">992000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzExLTEtMS0xLTI5NzUwMA_dace8f06-fb43-4179-8ed5-cc7819909669"
      unitRef="usd">6468000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i42df09f8a43746b39c7b3644b315a6d8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzExLTMtMS0xLTI5NzUwMA_d86db14f-841f-4573-aa56-bec5a09fdc6b"
      unitRef="usd">-5000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkMjk4ZGUxZWRkODI0NTQzOWE5N2U5MjQ2MTE5YTY5Ny90YWJsZXJhbmdlOmQyOThkZTFlZGQ4MjQ1NDM5YTk3ZTkyNDYxMTlhNjk3XzExLTUtMS0xLTI5NzUwMA_8bb833f2-72a1-4446-8de7-c472d02706ea"
      unitRef="usd">6463000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:ProfitLoss
      contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzQtMS0xLTEtMjk3NTAw_25d573cc-96ff-412b-824e-b1daec11b686"
      unitRef="usd">7898000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzQtMy0xLTEtMjk3NTAw_600a89a6-4968-42de-b208-7bb9923c9304"
      unitRef="usd">91000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzQtNS0xLTEtMjk3NTAw_261cd721-74ee-43f3-aef1-bd608cf07d63"
      unitRef="usd">7989000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzYtMS0xLTEtMjk3NTAw_9eb0efef-90b5-49d9-80cb-461200291320"
      unitRef="usd">4512000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzYtMy0xLTEtMjk3NTAw_d16ac3df-1ae2-448a-ada5-a0074dd97f58"
      unitRef="usd">-26000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzYtNS0xLTEtMjk3NTAw_a103f34e-29c1-4524-8ad8-b5ba7e0babfd"
      unitRef="usd">4486000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzctMS0xLTEtMjk3NTAw_a623f0e3-638a-432e-bd9d-f0e95a714186"
      unitRef="usd">-428000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzctMy0xLTEtMjk3NTAw_dcd0a5f6-33d8-4990-9037-315d1cc9f711"
      unitRef="usd">26000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzctNS0xLTEtMjk3NTAw_9a426cf4-2cdb-425f-9f37-ce101ea33af8"
      unitRef="usd">-402000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzktMS0xLTEtMjk3NTAw_72bba01b-b2ad-4108-8522-91b70d6f584b"
      unitRef="usd">3000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzktMy0xLTEtMjk3NTAw_cb84e529-2464-49b3-8ab1-12bb9fe7eac0"
      unitRef="usd">27000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzktNS0xLTEtMjk3NTAw_d57a9a83-e990-4eba-bd47-6fe86aa9fbdd"
      unitRef="usd">30000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzEwLTEtMS0xLTI5NzUwMA_71a7e55f-a4cb-4a68-8c77-4b782d469b98"
      unitRef="usd">169000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzEwLTMtMS0xLTI5NzUwMA_235a4346-7f23-405f-99b1-4084ecdf752d"
      unitRef="usd">-68000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzEwLTUtMS0xLTI5NzUwMA_53a780c7-1ea9-48af-a525-debd9fdf2591"
      unitRef="usd">101000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzExLTEtMS0xLTI5NzUwMA_06a74340-fea4-475a-9cd9-2a56aa9eaa23"
      unitRef="usd">2852000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="ie209165399db45729e89c8418744612e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzExLTMtMS0xLTI5NzUwMA_9ff2158a-bf9c-491b-9ff4-f47d8d61cb08"
      unitRef="usd">4000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTowMDliYThkNGFhZjY0ZDBkODc1OWVkODE2YTVlOWUzMC90YWJsZXJhbmdlOjAwOWJhOGQ0YWFmNjRkMGQ4NzU5ZWQ4MTZhNWU5ZTMwXzExLTUtMS0xLTI5NzUwMA_071f1bb8-616e-45b9-b903-8c499adf8fc6"
      unitRef="usd">2856000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:LiabilityForFuturePolicyBenefitActivityTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90ZXh0cmVnaW9uOjM3NzkzMGQ5MjBlYTRiOGE5ZTdjZDA4ODM0MzhhNjNhXzEwNDQ1MzYwNDc5MjAx_af2a0b98-bd59-4665-9118-e6bf67416808">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables show the components of the change in the liability for future policy benefits, which is included in other insurance liabilities and other long-term insurance liabilities on the consolidated balance sheets, during the years ended December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Large Case&lt;br/&gt;Pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-Term&lt;br/&gt;Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of expected net premiums &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, beginning of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in cash flow assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of actual variances from expected experience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted beginning liability for future policy benefits - original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accrual (using locked-in discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net premiums (actual)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, end of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of expected future policy benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, beginning of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in cash flow assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of actual variances from expected experience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted beginning liability for future policy benefits - original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accrual (using locked-in discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments (actual)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, end of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net liability for future policy benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net liability for future policy benefits, net of reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The present value of expected net premiums is equivalent to the present value of expected gross premiums for the long-term care insurance contracts as net premiums are set equal to gross premiums.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Large Case&lt;br/&gt;Pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-Term&lt;br/&gt;Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of expected net premiums &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, beginning of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in cash flow assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of actual variances from expected experience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted beginning liability for future policy benefits - original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accrual (using locked-in discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net premiums (actual)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, end of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of expected future policy benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, beginning of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in cash flow assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of actual variances from expected experience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted beginning liability for future policy benefits - original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accrual (using locked-in discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments (actual)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(313)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending liability for future policy benefits at original (locked-in) discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of changes in discount rate assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability for future policy benefits, end of period - current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net liability for future policy benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net liability for future policy benefits, net of reinsurance recoverable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The present value of expected net premiums is equivalent to the present value of expected gross premiums for the long-term care insurance contracts as net premiums are set equal to gross premiums.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of undiscounted expected gross premiums and expected future benefit payments for long-duration insurance liabilities as of December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Large case pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected future benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,539&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,882&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected gross premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected future benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,265&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,115&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected gross premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average interest rate used in the measurement of the long-duration insurance liabilities as of December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Large case pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accretion rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.24%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.53%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest accretion rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.11%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.11%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.39%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.88%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average durations (in years) of the long-duration insurance liabilities as of December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Large case pensions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LiabilityForFuturePolicyBenefitActivityTableTextBlock>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzMtMy0xLTEtMjcyNDIy_0f22826f-84e6-4aee-a27b-54508c800a15"
      unitRef="usd">389000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzQtMy0xLTEtMjcyNDIy_caf7fd55-2b81-46ca-8953-267ac77af45f"
      unitRef="usd">323000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzUtMy0xLTEtMjcyNDIy_69c74234-b670-4b51-8ee0-28d4594a4edd"
      unitRef="usd">-15000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzYtMy0xLTEtMjcyNDIy_84c387cd-b6f8-4e8b-8c9c-71a49a28783d"
      unitRef="usd">18000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzctMy0xLTEtMjcyNDIy_11d5ba5a-95be-46ee-b422-812465da20cf"
      unitRef="usd">326000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome
      contextRef="i614d4d469d8542ec8ffd5f8bf31e0bef_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzktMy0xLTEtMjcyNDIy_871cd501-0edf-4a55-9fb4-a35c5355f129"
      unitRef="usd">16000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected
      contextRef="i614d4d469d8542ec8ffd5f8bf31e0bef_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzEwLTMtMS0xLTI3MjQyMg_778510dc-1671-4145-b7d1-55ef4652f999"
      unitRef="usd">40000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzEyLTMtMS0xLTI3MjQyMg_f745d035-6947-490a-85f9-714ed20418b7"
      unitRef="usd">302000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax
      contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzEzLTMtMS0xLTI3MjQyMg_67c2a4b4-fde0-439f-9c11-83356240a007"
      unitRef="usd">-2000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange
      contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzE0LTMtMS0xLTI3MjQyMg_e86e1941-e5c6-49ce-984e-5bff620585ee"
      unitRef="usd">300000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzE3LTEtMS0xLTI3MjQyMg_9aa472e7-6b21-4d7c-a3de-d59d31927c40"
      unitRef="usd">3034000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzE3LTMtMS0xLTI3MjQyMg_37094bf3-43b0-45e2-883b-2d8ee12ecb02"
      unitRef="usd">1991000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzE4LTEtMS0xLTI3MjQyMg_2c653a8b-09c2-4fdb-aa62-63cb4a914e6b"
      unitRef="usd">2650000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzE4LTMtMS0xLTI3MjQyMg_526fbd6f-b93a-408c-9983-6c125b934782"
      unitRef="usd">1480000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzE5LTEtMS0xLTI3MjQyMg_ac7bc56f-34d0-422c-a572-44d87555cdfa"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzE5LTMtMS0xLTI3MjQyMg_0922297d-8a99-4f63-95d7-b7e96fecab5c"
      unitRef="usd">99000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience
      contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzIwLTEtMS0xLTI3MjQyMg_c3070f12-3c7b-4eec-b3a8-36dfe93919f1"
      unitRef="usd">-44000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzIwLTMtMS0xLTI3MjQyMg_fac2e2fa-ff49-4950-9fcb-592d567947bd"
      unitRef="usd">18000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange
      contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzIxLTEtMS0xLTI3MjQyMg_bd6a01ad-06b5-4d2d-af25-5ec4c6f85dd4"
      unitRef="usd">2606000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzIxLTMtMS0xLTI3MjQyMg_b2b23d7f-e68e-4adf-b1af-f6e90efbfc55"
      unitRef="usd">1597000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance
      contextRef="iba6736243aa54f7294406b62ff339374_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzIyLTEtMS0xLTI3MjQyMg_fcdb5bcd-474f-49d0-af45-819d4d2cf413"
      unitRef="usd">4000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance
      contextRef="i614d4d469d8542ec8ffd5f8bf31e0bef_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzIyLTMtMS0xLTI3MjQyMg_3dfb76a1-bc7a-4caa-b3c7-80718b3e5757"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense
      contextRef="iba6736243aa54f7294406b62ff339374_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzIzLTEtMS0xLTI3MjQyMg_9cab7718-25f6-4a5f-827c-7020fba7efa4"
      unitRef="usd">106000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense
      contextRef="i614d4d469d8542ec8ffd5f8bf31e0bef_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzIzLTMtMS0xLTI3MjQyMg_b3e449a4-4623-462b-bd0d-5a810a1eaef5"
      unitRef="usd">80000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense>
    <us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits
      contextRef="iba6736243aa54f7294406b62ff339374_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzI0LTEtMS0xLTI3MjQyMg_3b36508d-2e0b-4629-b2fe-2514b359a60e"
      unitRef="usd">291000000</us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits
      contextRef="i614d4d469d8542ec8ffd5f8bf31e0bef_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzI0LTMtMS0xLTI3MjQyMg_fad3793a-2fe2-4ee6-9725-7a7b816363e4"
      unitRef="usd">64000000</us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="i473c68aa9e4c42a8a8d365737c72ba29_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzI3LTEtMS0xLTI3MjQyMg_c8accf3e-4beb-4e86-8de5-039a9eaacf77"
      unitRef="usd">2425000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzI3LTMtMS0xLTI3MjQyMg_1b4f1d0b-6bf5-49cb-96c2-3ea75be4bee3"
      unitRef="usd">1613000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax
      contextRef="i473c68aa9e4c42a8a8d365737c72ba29_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzI4LTEtMS0xLTI3MjQyMg_5af67540-869a-460f-af63-fba55268431d"
      unitRef="usd">173000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax
      contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzI4LTMtMS0xLTI3MjQyMg_15b905ed-d3f2-451d-9487-14fc6151d950"
      unitRef="usd">47000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="i473c68aa9e4c42a8a8d365737c72ba29_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzI5LTEtMS0xLTI3MjQyMg_5736248f-df40-4188-be7c-df018ff161d5"
      unitRef="usd">2252000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzI5LTMtMS0xLTI3MjQyMg_1a19431c-2ee8-4a5a-b3bc-184973a7b6d1"
      unitRef="usd">1566000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="i473c68aa9e4c42a8a8d365737c72ba29_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzMxLTEtMS0xLTI3MjQyMg_1e5707a5-8c9a-4797-b583-c2d7d2a01708"
      unitRef="usd">2252000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzMxLTMtMS0xLTI3MjQyMg_9e8c3049-d06b-453f-8102-29a46fd4c2f0"
      unitRef="usd">1266000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="i473c68aa9e4c42a8a8d365737c72ba29_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzMyLTEtMS0xLTI3MjQyMg_9a2b0ca3-5977-45a2-ad24-a5d7f580c437"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzMyLTMtMS0xLTI3MjQyMg_ac69d4d2-629c-431f-91ef-75f1b93a0146"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="i473c68aa9e4c42a8a8d365737c72ba29_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzMzLTEtMS0xLTI3MjQyMg_e4a28838-64e0-4de5-b081-e8cc9a07a318"
      unitRef="usd">2252000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyODJlYzhhZWM3Y2E0M2Y4ODVlNTY2YjYwYmUyY2Q0MS90YWJsZXJhbmdlOjI4MmVjOGFlYzdjYTQzZjg4NWU1NjZiNjBiZTJjZDQxXzMzLTMtMS0xLTI3MjQyMg_82866a87-fca2-41cc-b631-d14c88ca3336"
      unitRef="usd">1266000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange
      contextRef="i644e02c89965481d980470106777aa5c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzMtMy0xLTEtMjcyNDIy_2b83daf8-6f3c-445c-9778-c2afedfa370d"
      unitRef="usd">417000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="i644e02c89965481d980470106777aa5c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzQtMy0xLTEtMjcyNDIy_91699316-7adf-4d3a-858c-c163799f1693"
      unitRef="usd">330000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="i644e02c89965481d980470106777aa5c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzUtMy0xLTEtMjcyNDIy_d7324041-890f-47b3-9801-52210ceed797"
      unitRef="usd">8000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience
      contextRef="i644e02c89965481d980470106777aa5c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzYtMy0xLTEtMjcyNDIy_54e69198-3cec-4f1b-9afa-92db7fbd1cc8"
      unitRef="usd">9000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange
      contextRef="i644e02c89965481d980470106777aa5c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzctMy0xLTEtMjcyNDIy_07defbe4-2188-4854-baa1-a6bfa9915774"
      unitRef="usd">347000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome
      contextRef="i516e66d0f707473d919c7b8251b39ca7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzktMy0xLTEtMjcyNDIy_8383acb6-e438-4a40-bf2f-887aa5cf7c2b"
      unitRef="usd">17000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected
      contextRef="i516e66d0f707473d919c7b8251b39ca7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzEwLTMtMS0xLTI3MjQyMg_56d9362d-38a3-4df3-bb69-18817660351c"
      unitRef="usd">41000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzEyLTMtMS0xLTI3MjQyMg_38cccfe2-fe7e-42a8-85cc-2781df378fb3"
      unitRef="usd">323000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzEzLTMtMS0xLTI3MjQyMg_d0e7628c-63ad-4f5f-8528-1a387296efc5"
      unitRef="usd">66000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzE0LTMtMS0xLTI3MjQyMg_e7c8ddcc-6600-4e18-91eb-7d24be723c89"
      unitRef="usd">389000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="i1263a7bd13e6441c90af49d5dde6fbc0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzE3LTEtMS0xLTI3MjQyMg_98bc37ff-f309-4bc4-93a3-26c94e43e911"
      unitRef="usd">3582000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="i644e02c89965481d980470106777aa5c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzE3LTMtMS0xLTI3MjQyMg_2a85beee-50a6-4865-9407-73747a5278e9"
      unitRef="usd">2051000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="i1263a7bd13e6441c90af49d5dde6fbc0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzE4LTEtMS0xLTI3MjQyMg_934d1174-ae3e-4f92-b511-011d9cb90ab9"
      unitRef="usd">2979000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="i644e02c89965481d980470106777aa5c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzE4LTMtMS0xLTI3MjQyMg_cf515781-b882-4698-abca-8ee03ffb0314"
      unitRef="usd">1430000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="i1263a7bd13e6441c90af49d5dde6fbc0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzE5LTEtMS0xLTI3MjQyMg_95b57691-6a6e-438c-a764-9ea202531fe5"
      unitRef="usd">-96000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange
      contextRef="i644e02c89965481d980470106777aa5c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzE5LTMtMS0xLTI3MjQyMg_bbb90261-08ac-4782-8115-7ceea55dfa5e"
      unitRef="usd">35000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience
      contextRef="i1263a7bd13e6441c90af49d5dde6fbc0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzIwLTEtMS0xLTI3MjQyMg_2b05b309-4b13-46cb-a6f3-71cc5c731a7e"
      unitRef="usd">-39000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience
      contextRef="i644e02c89965481d980470106777aa5c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzIwLTMtMS0xLTI3MjQyMg_4ab6c358-94cd-4b02-b778-55fba6d26f10"
      unitRef="usd">3000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange
      contextRef="i1263a7bd13e6441c90af49d5dde6fbc0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzIxLTEtMS0xLTI3MjQyMg_e1f927c3-488a-4b77-8d39-e6a4612a788a"
      unitRef="usd">2844000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange
      contextRef="i644e02c89965481d980470106777aa5c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzIxLTMtMS0xLTI3MjQyMg_387cac9e-b32c-4e70-9316-c5242db48d82"
      unitRef="usd">1468000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance
      contextRef="i6d569b44a37d470fadb0d1f07580eca6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzIyLTEtMS0xLTI3MjQyMg_7e3917a6-8f66-40b1-8532-4747739ef350"
      unitRef="usd">2000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance
      contextRef="i516e66d0f707473d919c7b8251b39ca7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzIyLTMtMS0xLTI3MjQyMg_06dac49e-ba9a-44f1-b8b9-df2903dc74e3"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense
      contextRef="i6d569b44a37d470fadb0d1f07580eca6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzIzLTEtMS0xLTI3MjQyMg_31127889-081e-4bcf-aef7-c27091587df3"
      unitRef="usd">117000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense
      contextRef="i516e66d0f707473d919c7b8251b39ca7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzIzLTMtMS0xLTI3MjQyMg_d411c45d-65f9-4535-8eb6-dad309db3d43"
      unitRef="usd">74000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense>
    <us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits
      contextRef="i6d569b44a37d470fadb0d1f07580eca6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzI0LTEtMS0xLTI3MjQyMg_4d46f0a7-66c6-4cc1-8bc3-b4404644c5fc"
      unitRef="usd">313000000</us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits
      contextRef="i516e66d0f707473d919c7b8251b39ca7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzI0LTMtMS0xLTI3MjQyMg_8d8697e5-f1f6-420e-8afe-3ba2b6f25a39"
      unitRef="usd">62000000</us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzI3LTEtMS0xLTI3MjQyMg_acc0c7b6-d30b-425f-966c-1f972b67d84b"
      unitRef="usd">2650000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzI3LTMtMS0xLTI3MjQyMg_de75d333-173f-40c5-85fe-8d9e5063e841"
      unitRef="usd">1480000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax
      contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzI4LTEtMS0xLTI3MjQyMg_9ad376ac-d5c6-42a9-bf74-701a336b7c4c"
      unitRef="usd">-384000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax>
    <us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzI4LTMtMS0xLTI3MjQyMg_11f9bf2f-6d4c-4e23-883e-10543589d3cb"
      unitRef="usd">-511000000</us-gaap:AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzI5LTEtMS0xLTI3MjQyMg_c50a3968-a917-4c6b-93fc-f55e118a30cf"
      unitRef="usd">3034000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzI5LTMtMS0xLTI3MjQyMg_e720956f-ef2a-478b-81a2-be8632af954a"
      unitRef="usd">1991000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzMxLTEtMS0xLTI3MjQyMg_94026e66-171a-476a-a800-f1e8626414f0"
      unitRef="usd">3034000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzMxLTMtMS0xLTI3MjQyMg_dc298f35-4cdb-4e73-b97a-24ff7125038a"
      unitRef="usd">1602000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzMyLTEtMS0xLTI3MjQyMg_d30877c7-1b84-4266-965d-9569047835b0"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzMyLTMtMS0xLTI3MjQyMg_6a61b687-7fb0-481d-8adc-f82e11c06799"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzMzLTEtMS0xLTI3MjQyMg_9dfec91e-b09a-48f0-9ebc-af12977505d2"
      unitRef="usd">3034000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo2MGJiZjAzYjZkMWE0ZDU5ODQ3ZGVhYzg3YjkxMDM0Mi90YWJsZXJhbmdlOjYwYmJmMDNiNmQxYTRkNTk4NDdkZWFjODdiOTEwMzQyXzMzLTMtMS0xLTI3MjQyMg_0576f7bf-db01-4966-9fea-126676ef63eb"
      unitRef="usd">1602000000</us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance
      contextRef="i473c68aa9e4c42a8a8d365737c72ba29_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo1M2ZlODhiOTUxYjc0MzkyOTFkZmQ0NzQ3OGI1YzQzNS90YWJsZXJhbmdlOjUzZmU4OGI5NTFiNzQzOTI5MWRmZDQ3NDc4YjVjNDM1XzItMS0xLTEtMjcyNDIy_d08e5f7c-4717-4dcd-bb37-02da33e96d0f"
      unitRef="usd">3539000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance
      contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo1M2ZlODhiOTUxYjc0MzkyOTFkZmQ0NzQ3OGI1YzQzNS90YWJsZXJhbmdlOjUzZmU4OGI5NTFiNzQzOTI5MWRmZDQ3NDc4YjVjNDM1XzItMy0xLTEtMjcyNDIy_7debdc9a-b47a-4aaf-ade6-46bf5ab77761"
      unitRef="usd">3882000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance
      contextRef="i473c68aa9e4c42a8a8d365737c72ba29_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo1M2ZlODhiOTUxYjc0MzkyOTFkZmQ0NzQ3OGI1YzQzNS90YWJsZXJhbmdlOjUzZmU4OGI5NTFiNzQzOTI5MWRmZDQ3NDc4YjVjNDM1XzMtMS0xLTEtMjcyNDIy_f2833f0b-f433-4892-9199-e1dea06b30df"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance
      contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo1M2ZlODhiOTUxYjc0MzkyOTFkZmQ0NzQ3OGI1YzQzNS90YWJsZXJhbmdlOjUzZmU4OGI5NTFiNzQzOTI5MWRmZDQ3NDc4YjVjNDM1XzMtMy0xLTEtMjcyNDIy_f75b13b9-6d26-4922-b435-af0d16a656ed"
      unitRef="usd">0</us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance
      contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo1M2ZlODhiOTUxYjc0MzkyOTFkZmQ0NzQ3OGI1YzQzNS90YWJsZXJhbmdlOjUzZmU4OGI5NTFiNzQzOTI5MWRmZDQ3NDc4YjVjNDM1XzYtMS0xLTEtMjcyNDIy_938d8f28-eb8b-4e02-8cda-25f83775eaea"
      unitRef="usd">3265000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo1M2ZlODhiOTUxYjc0MzkyOTFkZmQ0NzQ3OGI1YzQzNS90YWJsZXJhbmdlOjUzZmU4OGI5NTFiNzQzOTI5MWRmZDQ3NDc4YjVjNDM1XzYtMy0xLTEtMjcyNDIy_941eecb5-d98a-4e40-b444-6868774da0f0"
      unitRef="usd">3115000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance
      contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo1M2ZlODhiOTUxYjc0MzkyOTFkZmQ0NzQ3OGI1YzQzNS90YWJsZXJhbmdlOjUzZmU4OGI5NTFiNzQzOTI5MWRmZDQ3NDc4YjVjNDM1XzctMS0xLTEtMjcyNDIy_0c1b5789-4eb6-406d-9b3c-c347b06b1154"
      unitRef="usd">437000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTo1M2ZlODhiOTUxYjc0MzkyOTFkZmQ0NzQ3OGI1YzQzNS90YWJsZXJhbmdlOjUzZmU4OGI5NTFiNzQzOTI5MWRmZDQ3NDc4YjVjNDM1XzctMy0xLTEtMjcyNDIy_f89aa19d-a86c-445c-af85-73cf6ccb2cd0"
      unitRef="usd">478000000</us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate
      contextRef="i473c68aa9e4c42a8a8d365737c72ba29_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2Y4NmEzNDRkNDE0OWEyYjM3NmEyNzcxZjljNGU4YS90YWJsZXJhbmdlOmRjZjg2YTM0NGQ0MTQ5YTJiMzc2YTI3NzFmOWM0ZThhXzItMS0xLTEtMjcyNDIy_f195a017-0c0f-48dd-bfea-272eedfac4fe"
      unitRef="number">0.0420</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate
      contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2Y4NmEzNDRkNDE0OWEyYjM3NmEyNzcxZjljNGU4YS90YWJsZXJhbmdlOmRjZjg2YTM0NGQ0MTQ5YTJiMzc2YTI3NzFmOWM0ZThhXzItMy0xLTEtMjcyNDIy_80d5b0da-e4c6-449e-992b-1d5a8d36e0db"
      unitRef="number">0.0420</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate>
    <us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate
      contextRef="i473c68aa9e4c42a8a8d365737c72ba29_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2Y4NmEzNDRkNDE0OWEyYjM3NmEyNzcxZjljNGU4YS90YWJsZXJhbmdlOmRjZjg2YTM0NGQ0MTQ5YTJiMzc2YTI3NzFmOWM0ZThhXzMtMS0xLTEtMjcyNDIy_601c80c2-a0fd-4994-bd5e-81d64f923082"
      unitRef="number">0.0524</us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate>
    <us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate
      contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2Y4NmEzNDRkNDE0OWEyYjM3NmEyNzcxZjljNGU4YS90YWJsZXJhbmdlOmRjZjg2YTM0NGQ0MTQ5YTJiMzc2YTI3NzFmOWM0ZThhXzMtMy0xLTEtMjcyNDIy_43ba5482-b553-47bb-9394-7d8e3169c0e5"
      unitRef="number">0.0253</us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate
      contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2Y4NmEzNDRkNDE0OWEyYjM3NmEyNzcxZjljNGU4YS90YWJsZXJhbmdlOmRjZjg2YTM0NGQ0MTQ5YTJiMzc2YTI3NzFmOWM0ZThhXzYtMS0xLTEtMjcyNDIy_b97eb4db-e4be-4e28-b235-49540955a21c"
      unitRef="number">0.0511</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2Y4NmEzNDRkNDE0OWEyYjM3NmEyNzcxZjljNGU4YS90YWJsZXJhbmdlOmRjZjg2YTM0NGQ0MTQ5YTJiMzc2YTI3NzFmOWM0ZThhXzYtMy0xLTEtMjcyNDIy_d53e2d9e-942c-4e41-8843-c153e80dfb9d"
      unitRef="number">0.0511</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate>
    <us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate
      contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2Y4NmEzNDRkNDE0OWEyYjM3NmEyNzcxZjljNGU4YS90YWJsZXJhbmdlOmRjZjg2YTM0NGQ0MTQ5YTJiMzc2YTI3NzFmOWM0ZThhXzctMS0xLTEtMjcyNDIy_effa0957-0fdc-4548-9b6e-bc3375c4b50e"
      unitRef="number">0.0539</us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate>
    <us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2Y4NmEzNDRkNDE0OWEyYjM3NmEyNzcxZjljNGU4YS90YWJsZXJhbmdlOmRjZjg2YTM0NGQ0MTQ5YTJiMzc2YTI3NzFmOWM0ZThhXzctMy0xLTEtMjcyNDIy_dc863e6c-feb4-408e-a7a0-43953ec18b00"
      unitRef="number">0.0288</us-gaap:LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration
      contextRef="i473c68aa9e4c42a8a8d365737c72ba29_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTozZmFlNzQzMTc1N2E0OTFiOGJhM2MyN2FlZTA0MmZiMC90YWJsZXJhbmdlOjNmYWU3NDMxNzU3YTQ5MWI4YmEzYzI3YWVlMDQyZmIwXzEtMS0xLTEtMjcyNDIy_b0e0bfc1-94ad-4a42-a810-077009a842f2">P7Y4M24D</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration
      contextRef="i0b99c5b96c164850bc3f80f97475b0ae_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTozZmFlNzQzMTc1N2E0OTFiOGJhM2MyN2FlZTA0MmZiMC90YWJsZXJhbmdlOjNmYWU3NDMxNzU3YTQ5MWI4YmEzYzI3YWVlMDQyZmIwXzEtMy0xLTEtMjcyNDIy_9e0db425-74cc-4b1b-8eb3-a5401025d9bb">P7Y6M</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration
      contextRef="i44b1cfc235fa48afa1d4a8632b5f8d50_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTozZmFlNzQzMTc1N2E0OTFiOGJhM2MyN2FlZTA0MmZiMC90YWJsZXJhbmdlOjNmYWU3NDMxNzU3YTQ5MWI4YmEzYzI3YWVlMDQyZmIwXzItMS0xLTEtMjcyNDIy_9f6bba8c-fcb1-4841-9a86-6e8cb18f4427">P12Y7M6D</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration>
    <us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration
      contextRef="i1f0672fcd32945aca44585b9882b4499_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTozZmFlNzQzMTc1N2E0OTFiOGJhM2MyN2FlZTA0MmZiMC90YWJsZXJhbmdlOjNmYWU3NDMxNzU3YTQ5MWI4YmEzYzI3YWVlMDQyZmIwXzItMy0xLTEtMjcyNDIy_6bad26b1-2813-4011-98a7-5cd9254fe4a7">P13Y6M</us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageDuration>
    <us-gaap:PolicyholderAccountBalanceTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90ZXh0cmVnaW9uOjM3NzkzMGQ5MjBlYTRiOGE5ZTdjZDA4ODM0MzhhNjNhXzEwNDQ1MzYwNDc5MjA0_6b459c12-5f44-488f-8d39-158e807791f0">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in policyholders&#x2019; funds related to long-duration insurance contracts, which are included in policyholders&#x2019; funds and other long-term liabilities on the consolidated balance sheets, during the years ended December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except weighted average crediting rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Policyholders&#x2019; funds, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deposits received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Policy charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surrenders and withdrawals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest credited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in net unrealized gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Policyholders&#x2019; funds, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average crediting rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.72%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.81%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amount at risk&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PolicyholderAccountBalanceTableTextBlock>
    <us-gaap:PolicyholderFunds
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzItMS0xLTEtMjcyNDIy_faa663bb-f11b-4e3a-9dff-ad8271132ab4"
      unitRef="usd">522000000</us-gaap:PolicyholderFunds>
    <us-gaap:PolicyholderFunds
      contextRef="i501f291fb23d49e987222cf13c851afc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzItMy0xLTEtMjcyNDIy_e68127ba-31a7-4694-ad0b-613f071cef4a"
      unitRef="usd">568000000</us-gaap:PolicyholderFunds>
    <cvs:PolicyholderAccountBalanceDepositsReceived
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzQtMS0xLTEtMjcyNDIy_fbf513e2-dece-4e72-b4fd-3c2c1cab74ac"
      unitRef="usd">13000000</cvs:PolicyholderAccountBalanceDepositsReceived>
    <cvs:PolicyholderAccountBalanceDepositsReceived
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzQtMy0xLTEtMjcyNDIy_0093e463-7669-4145-a08c-54a01cd14426"
      unitRef="usd">20000000</cvs:PolicyholderAccountBalanceDepositsReceived>
    <us-gaap:PolicyholderAccountBalancePolicyCharge
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzUtMS0xLTEtMjcyNDIy_2959c897-25e1-42a1-89a9-a4927dd5fb6e"
      unitRef="usd">2000000</us-gaap:PolicyholderAccountBalancePolicyCharge>
    <us-gaap:PolicyholderAccountBalancePolicyCharge
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzUtMy0xLTEtMjcyNDIy_c9c004d8-99c8-4bdc-aa45-077c93cd1420"
      unitRef="usd">2000000</us-gaap:PolicyholderAccountBalancePolicyCharge>
    <us-gaap:PolicyholderAccountBalanceSurrenderAndWithdrawal
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzYtMS0xLTEtMjcyNDIy_9283ef9d-537b-4cbe-be5f-1c0ffecaaae6"
      unitRef="usd">31000000</us-gaap:PolicyholderAccountBalanceSurrenderAndWithdrawal>
    <us-gaap:PolicyholderAccountBalanceSurrenderAndWithdrawal
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzYtMy0xLTEtMjcyNDIy_6071c358-7245-4402-8bda-c7ac4d8e00ae"
      unitRef="usd">21000000</us-gaap:PolicyholderAccountBalanceSurrenderAndWithdrawal>
    <us-gaap:InterestCreditedToPolicyholdersAccountBalances
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzktMS0xLTEtMjcyNDIy_8b9932cb-4115-415d-99b8-16b00e7b85ab"
      unitRef="usd">11000000</us-gaap:InterestCreditedToPolicyholdersAccountBalances>
    <us-gaap:InterestCreditedToPolicyholdersAccountBalances
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzktMy0xLTEtMjcyNDIy_3ad01010-9612-4edf-83c2-afc063c47023"
      unitRef="usd">12000000</us-gaap:InterestCreditedToPolicyholdersAccountBalances>
    <cvs:PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzEwLTEtMS0xLTI3MjQyMg_356feda8-305d-4c70-a34a-b2ba0e1e7283"
      unitRef="usd">-148000000</cvs:PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses>
    <cvs:PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzEwLTMtMS0xLTI3MjQyMg_c24b58f1-dd38-4dec-8614-316d1cb3110f"
      unitRef="usd">-42000000</cvs:PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses>
    <us-gaap:PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzExLTEtMS0xLTI3MjQyMg_e0a095c5-7a56-489d-ad0d-121876cffa70"
      unitRef="usd">-20000000</us-gaap:PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange>
    <us-gaap:PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzExLTMtMS0xLTI3MjQyMg_e0848a0c-c084-4ddf-bf3a-7166c15bbba4"
      unitRef="usd">-13000000</us-gaap:PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange>
    <us-gaap:PolicyholderFunds
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzEyLTEtMS0xLTI3MjQyMg_3ed236fa-e5b2-45e4-be89-def9171e011b"
      unitRef="usd">345000000</us-gaap:PolicyholderFunds>
    <us-gaap:PolicyholderFunds
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzEyLTMtMS0xLTI3MjQyMg_70e0b8f2-e81f-4b28-b839-49c0f4d19042"
      unitRef="usd">522000000</us-gaap:PolicyholderFunds>
    <us-gaap:PolicyholderAccountBalanceWeightedAverageCreditingRate
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzEzLTEtMS0xLTI3MjQyMg_e966590e-fa0a-4b8b-a478-d27f4017c039"
      unitRef="number">0.0472</us-gaap:PolicyholderAccountBalanceWeightedAverageCreditingRate>
    <us-gaap:PolicyholderAccountBalanceWeightedAverageCreditingRate
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzEzLTMtMS0xLTI3MjQyMg_17f82ed9-1e7b-425a-98aa-0f222464fc46"
      unitRef="number">0.0481</us-gaap:PolicyholderAccountBalanceWeightedAverageCreditingRate>
    <us-gaap:PolicyholderAccountBalanceNetAmountAtRisk
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzE1LTEtMS0xLTI3MjQyMg_3fb9a5ca-3989-4f6e-b1f6-c50dad4e3f12"
      unitRef="usd">0</us-gaap:PolicyholderAccountBalanceNetAmountAtRisk>
    <us-gaap:PolicyholderAccountBalanceNetAmountAtRisk
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzE1LTMtMS0xLTI3MjQyMg_f041a4d0-3cb2-4f8a-a821-cc96aacc1d84"
      unitRef="usd">0</us-gaap:PolicyholderAccountBalanceNetAmountAtRisk>
    <us-gaap:CashSurrenderValueDuePolicyholdersAmount
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzE3LTEtMS0xLTI3MjQyMg_c2fbd735-156c-413a-9c6e-e90bededa80d"
      unitRef="usd">339000000</us-gaap:CashSurrenderValueDuePolicyholdersAmount>
    <us-gaap:CashSurrenderValueDuePolicyholdersAmount
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpiZGE0Y2IxMjBhNTg0YjlhYThlZWI1YTM5NTYxYWNlNi90YWJsZXJhbmdlOmJkYTRjYjEyMGE1ODRiOWFhOGVlYjVhMzk1NjFhY2U2XzE3LTMtMS0xLTI3MjQyMg_70ea13b3-5d57-40aa-81ec-7da23ec71bc8"
      unitRef="usd">346000000</us-gaap:CashSurrenderValueDuePolicyholdersAmount>
    <us-gaap:SeparateAccountAssets
      contextRef="i412d46651ee84600b71fc148cc986f29_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzItMS0xLTEtMjkyMjMw_c6e04a4e-63a2-4ee7-a654-3b28eab3ec41"
      unitRef="usd">156000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i8ce672bf30504e35921812d7a7fa7934_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzItMy0xLTEtMjkyMjM5_f87839c9-5b4c-4f64-b159-0a220545c7ec"
      unitRef="usd">188000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i36b9491833204d099e03fcc01e203119_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzQtMS0xLTEtMjkyMjMw_5bef150f-e3e0-486c-8b8b-8e299d549af6"
      unitRef="usd">717000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i4b4626daa8754d42a34f1edb762746ec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzQtMy0xLTEtMjkyMjQ1_cae4a7e4-4932-4852-8a15-e9e8f272b2e8"
      unitRef="usd">1234000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="idac6af1bd4cc4ca791c3b7491cdfee7d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzUtMS0xLTEtMjkyMjMw_3d911065-7b1d-489d-be41-56761f4cb065"
      unitRef="usd">27000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ib04e1d5c5dc2451c8c17187d5ff131f1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzUtMy0xLTEtMjkyMjQ1_80873ff8-4c97-4372-b100-0494e58729f8"
      unitRef="usd">48000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i8d1de373967241e5bf5de600e7c144af_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzYtMS0xLTEtMjkyMjMw_1c7da625-707b-4f61-8406-63d7e268e66c"
      unitRef="usd">1667000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="if6a5bdf13f3348caaae04f36dfdf1529_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzYtMy0xLTEtMjkyMjUz_eb14b41f-e1b8-48ad-bd65-9ec14d0d3d0a"
      unitRef="usd">2339000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ib1c08c444f6d46058bc3a4972bc57366_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzktMS0xLTEtMjkyMjMw_91e04cdd-a176-4306-ae47-cd166e6234ed"
      unitRef="usd">201000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i180b8e344c4c441c95dcb1988928fc19_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzktMy0xLTEtMjkyMjYx_0ca6e4e9-eb09-425e-b798-09db1c139456"
      unitRef="usd">325000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ie5496f38c2d14219bdf381b856591253_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzEwLTEtMS0xLTI5MjIzMA_dba24714-72ec-44be-9b7f-a3a12c5248b1"
      unitRef="usd">41000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ifadd8aac47504af7be902e13455b168c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzEwLTMtMS0xLTI5MjI2Nw_c5d52a01-0171-4995-9ad3-50817e1261db"
      unitRef="usd">144000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i5f100f6542cb4642be65ec9453938f5a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzExLTEtMS0xLTI5MjIzMA_7cc44a1d-689e-4451-ba6d-ba15fcb4d0b7"
      unitRef="usd">6000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i65d11629522144ccaf2eec93210bb7ba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzExLTMtMS0xLTI5MjI3Mw_a3072114-5461-448f-b7ae-b619b9c5ee40"
      unitRef="usd">57000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i3030957b790447e48affd8a2d4705582_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzEyLTEtMS0xLTI5MjIzMA_9d5fb77a-3d6d-42f2-b3cf-8cf3639cdd1b"
      unitRef="usd">18000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ia7cd37bb88ab41ed9c765b58f78429c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzEyLTMtMS0xLTI5MjI3OQ_1019e84a-0b4d-40c2-ab51-d62a33b0848b"
      unitRef="usd">134000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="iadbe70c5f2f243658fd3bcc5dd8c2d3d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzEzLTEtMS0xLTI5MjIzMA_24ca22b5-720f-4117-939e-5a668c384c6b"
      unitRef="usd">2677000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="iba813c84c6544fb990007eb39d2d1988_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzEzLTMtMS0xLTI5MjMxNQ_3bef1985-ac63-4520-ab0e-94939d102888"
      unitRef="usd">4281000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i565057424b24407abbffae1c71ea0c08_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzE1LTEtMS0xLTI5MjIzMA_e8a46063-e526-4c34-861b-d710f7e63a7c"
      unitRef="usd">480000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i9fed7c25098a4dd3957760b3fa0df1c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzE1LTMtMS0xLTI5MjI4NQ_22e2e9d0-ae26-423a-b558-57ba6701d660"
      unitRef="usd">548000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ibbd43a9242a0495591196ce21cc7a152_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzE3LTEtMS0xLTI5MjIzMA_152b64dc-08cf-4329-b474-3bfbf0c7afb7"
      unitRef="usd">3313000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="id7e14cbf58db473094f1a3a50e0e0423_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZToyZTNlMWQ1MTFkNDA0NzFjYjhjMmFiMGFjMDA2YmEzYS90YWJsZXJhbmdlOjJlM2UxZDUxMWQ0MDQ3MWNiOGMyYWIwYWMwMDZiYTNhXzE3LTMtMS0xLTI5MjMyOQ_1e56f097-4f01-46d6-8ed5-163b2fbc1bb8"
      unitRef="usd">5017000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountsLiability
      contextRef="i2cfae73c894b48b3adc8ba56219aaf76_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90ZXh0cmVnaW9uOjM3NzkzMGQ5MjBlYTRiOGE5ZTdjZDA4ODM0MzhhNjNhXzEwOTk1MTE2Mzc0OTA_86744857-0167-4543-9e9f-7fa4b874ec3b"
      unitRef="usd">85000000</us-gaap:SeparateAccountsLiability>
    <us-gaap:SeparateAccountAssets
      contextRef="i5f60137c965c405995e63ea19fbaacc4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90ZXh0cmVnaW9uOjM3NzkzMGQ5MjBlYTRiOGE5ZTdjZDA4ODM0MzhhNjNhXzEwOTk1MTE2Mzc1MTY_fc4559c1-f801-4eca-81b0-d6405308c871"
      unitRef="usd">70000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountLiabilityTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90ZXh0cmVnaW9uOjM3NzkzMGQ5MjBlYTRiOGE5ZTdjZDA4ODM0MzhhNjNhXzEwNDQ1MzYwNDc5MjA2_d1ea7777-a090-4533-877d-6a3b55a2d8dc">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in Separate Accounts liabilities during the years ended December&#160;31, 2022 and 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Separate Accounts liability, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums and deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surrenders and withdrawals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(581)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(984)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net transfers from general account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Separate Accounts liability, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SeparateAccountLiabilityTableTextBlock>
    <us-gaap:SeparateAccountsLiability
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzMtMS0xLTEtMjcyNDIy_b93dea82-dc9b-49e1-b16a-9868ffdd008b"
      unitRef="usd">5087000000</us-gaap:SeparateAccountsLiability>
    <us-gaap:SeparateAccountsLiability
      contextRef="i501f291fb23d49e987222cf13c851afc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzMtMy0xLTEtMjcyNDIy_f5a3666f-9455-4db8-af54-518302d6deac"
      unitRef="usd">4881000000</us-gaap:SeparateAccountsLiability>
    <us-gaap:SeparateAccountLiabilityPremiumAndDeposit
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzQtMS0xLTEtMjcyNDIy_e6b29af8-0c9f-444e-9a22-1b8f3c5b0455"
      unitRef="usd">853000000</us-gaap:SeparateAccountLiabilityPremiumAndDeposit>
    <us-gaap:SeparateAccountLiabilityPremiumAndDeposit
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzQtMy0xLTEtMjcyNDIy_2572c176-1e67-4594-b7f2-afa730773fb0"
      unitRef="usd">1118000000</us-gaap:SeparateAccountLiabilityPremiumAndDeposit>
    <us-gaap:SeparateAccountLiabilitySurrenderAndWithdrawal
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzYtMS0xLTEtMjcyNDIy_02243099-3b4f-40af-b1af-cc3de3d9c960"
      unitRef="usd">581000000</us-gaap:SeparateAccountLiabilitySurrenderAndWithdrawal>
    <us-gaap:SeparateAccountLiabilitySurrenderAndWithdrawal
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzYtMy0xLTEtMjcyNDIy_8e7d783f-ac9b-43e2-aa03-079b6947258f"
      unitRef="usd">42000000</us-gaap:SeparateAccountLiabilitySurrenderAndWithdrawal>
    <us-gaap:SeparateAccountLiabilityBenefitPayment
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzctMS0xLTEtMjcyNDIy_6b9d15d8-b278-4b02-b320-9161e65c2ed4"
      unitRef="usd">947000000</us-gaap:SeparateAccountLiabilityBenefitPayment>
    <us-gaap:SeparateAccountLiabilityBenefitPayment
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzctMy0xLTEtMjcyNDIy_46230d8b-f346-43c3-b6e0-fd9bcd1c01ec"
      unitRef="usd">984000000</us-gaap:SeparateAccountLiabilityBenefitPayment>
    <us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzgtMS0xLTEtMjcyNDIy_e5c908a5-0485-428b-9287-19fe8f2a9d4b"
      unitRef="usd">-1130000000</us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance>
    <us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzgtMy0xLTEtMjcyNDIy_b1913963-cfdd-4048-9185-c96f2b2d8f9c"
      unitRef="usd">53000000</us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance>
    <us-gaap:TransferToFromPolicyholderAccountBalanceToFromSeparateAccount
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzktMS0xLTEtMjcyNDIy_4e582f0c-f303-44c5-8714-38aeefffca87"
      unitRef="usd">9000000</us-gaap:TransferToFromPolicyholderAccountBalanceToFromSeparateAccount>
    <us-gaap:TransferToFromPolicyholderAccountBalanceToFromSeparateAccount
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzktMy0xLTEtMjcyNDIy_199253e9-bd77-4f95-890e-cb5bc6ef1aca"
      unitRef="usd">14000000</us-gaap:TransferToFromPolicyholderAccountBalanceToFromSeparateAccount>
    <us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromOtherChange
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzEwLTEtMS0xLTI3MjQyMg_b3319684-7660-48a6-9a96-60306b0e7481"
      unitRef="usd">-63000000</us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromOtherChange>
    <us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromOtherChange
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzEwLTMtMS0xLTI3MjQyMg_99699ebf-472d-4471-b7cc-98515a10665e"
      unitRef="usd">47000000</us-gaap:SeparateAccountLiabilityIncreaseDecreaseFromOtherChange>
    <us-gaap:SeparateAccountsLiability
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzExLTEtMS0xLTI3MjQyMg_0c0de8ce-b3e3-4ba2-ace3-1f764dd9f14a"
      unitRef="usd">3228000000</us-gaap:SeparateAccountsLiability>
    <us-gaap:SeparateAccountsLiability
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzExLTMtMS0xLTI3MjQyMg_dfead961-6507-4a15-ac5f-750515894f45"
      unitRef="usd">5087000000</us-gaap:SeparateAccountsLiability>
    <us-gaap:SeparateAccountLiabilityCashSurrenderValueAmount
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzEzLTEtMS0xLTI3MjQyMg_c73374b3-0f62-445c-9547-cd689be73269"
      unitRef="usd">2087000000</us-gaap:SeparateAccountLiabilityCashSurrenderValueAmount>
    <us-gaap:SeparateAccountLiabilityCashSurrenderValueAmount
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF81NDk3NTU4MTU3ODQvZnJhZzozNzc5MzBkOTIwZWE0YjhhOWU3Y2QwODgzNDM4YTYzYS90YWJsZTpkY2JiZDVkYzQ3NDM0MzE5YWQ0YzhiNzZlMDYyNWQ5MC90YWJsZXJhbmdlOmRjYmJkNWRjNDc0MzQzMTlhZDRjOGI3NmUwNjI1ZDkwXzEzLTMtMS0xLTI3MjQyMg_fafdd813-2c68-4268-b71e-27d797e717bf"
      unitRef="usd">3513000000</us-gaap:SeparateAccountLiabilityCashSurrenderValueAmount>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzY3NTk_5cad6010-9b53-4b8e-8f0a-6bf740482a59">Borrowings and Credit Agreements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s borrowings as of December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.452%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due July 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due November 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8% senior notes due June 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4% senior notes due December 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.375% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.625% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due November 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5% senior notes due December 2024 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1% senior notes due March 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due July 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.875% senior notes due June 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3% senior notes due August 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.625% senior notes due April 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.25% senior notes due June 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3% senior notes due August 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.3% senior notes due March 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.25% senior notes due August 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.75% senior notes due April 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.75% senior notes due August 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.875% senior notes due February 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.125% senior notes due September 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.875% senior notes due July 2035&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.625% senior notes due June 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.75% senior notes due December 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.78% senior notes due March 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.125% senior notes due September 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due April 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7% senior notes due August 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.75% senior notes due May 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5% senior notes due May 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due November 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3% senior notes due December 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due March 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.125% senior notes due July 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due August 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.05% senior notes due March 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.25% senior notes due April 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUyLTAtMS0xLTI2NTI0Nw_1b8d2063-d583-4908-be86-f25a8a8346c8"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUyLTAtMS0xLTI2NTI0Nw_d9e5828d-1d67-442b-bf21-ed9fd901073c"&gt;Finance lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total debt principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt discounts and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(786)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;__________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes long-term debt of $3&#160;million which has been accounted for as liabilities held for sale and is included in liabilities held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the Company&#x2019;s required repayments of debt principal due during each of the next five&#160;years and thereafter, as of December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt principal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;See Note 6 &#x2018;&#x2018;Leases&#x2019;&#x2019; for a summary of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;maturities of the Company&#x2019;s finance lease liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-term Borrowings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper and Back-up Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not have any commercial paper outstanding as of December 31, 2022 or 2021. In connection with its commercial paper program, the Company maintains a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 16, 2025, a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 11, 2026, and a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 16, 2027. The credit facilities allow for borrowings at various rates that are dependent, in part, on the Company&#x2019;s public debt ratings and require the Company to pay a weighted average quarterly facility fee of approximately 0.03%, regardless of usage. As of December&#160;31, 2022 and 2021, there were no borrowings outstanding under any of the Company&#x2019;s back-up credit facilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Federal Home Loan Bank of Boston (&#x201c;FHLBB&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A subsidiary of the Company is a member of the FHLBB. As a member, the subsidiary has the ability to obtain cash advances, subject to certain minimum collateral requirements. The maximum borrowing capacity available from the FHLBB as of December&#160;31, 2022 was approximately $915 million. At both December&#160;31, 2022 and 2021, there were no outstanding advances from the FHLBB.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-term Borrowings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Exercise of Par Call Redemptions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2022, the Company exercised the par call redemption on its outstanding 3.5% senior notes due July 2022 to redeem for cash on hand the entire $1.5&#160;billion aggregate principal amount. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2022, the Company exercised the par call redemption on its outstanding 2.75% senior notes due November 2022 (issued by Aetna Inc. (&#x201c;Aetna&#x201d;)) to redeem for cash on hand the entire $1.0&#160;billion aggregate principal amount.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2022, the Company exercised the par call redemptions on its outstanding 2.75% senior notes due December 2022 and 4.75% senior notes due December 2022 (including notes issued by Omnicare, Inc.) to redeem for cash on hand the entire aggregate principal amount of $1.25&#160;billion and $399&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2021 Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 18, 2021, the Company issued $1.0&#160;billion aggregate principal amount of 2.125% unsecured senior notes due September 15, 2031 for total proceeds of $987&#160;million, net of discounts, underwriting fees and offering expenses. The net proceeds of this offering were used for the purchase of senior notes in connection with the Company&#x2019;s cash tender offer in August 2021 as described below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During March 2020, the Company entered into several interest rate swap transactions to manage interest rate risk. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;resulting from changes in interest rates related to the anticipated issuance of $750&#160;million aggregate principal amount of 3.625% unsecured senior notes due April 1, 2027, $1.5&#160;billion aggregate principal amount of 3.75% unsecured senior notes due April 1, 2030, $1.0&#160;billion aggregate principal amount of 4.125% unsecured senior notes due April 1, 2040 and $750&#160;million aggregate principal amount of 4.25% unsecured senior notes due April 1, 2050 (collectively, the &#x201c;March 2020 Notes&#x201d;). In connection with the issuance of the March 2020 Notes on March 31, 2020, the Company terminated all outstanding cash flow hedges. The Company paid a net amount of $7&#160;million to the hedge counterparties upon termination, which was recorded as a loss, net of tax, of $5&#160;million in accumulated other comprehensive income and will be reclassified as interest expense over the life of the March 2020 Notes. See Note 14 &#x2018;&#x2018;Other Comprehensive Income (Loss)&#x2019;&#x2019; for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Early Extinguishments of Debt&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, the Company redeemed for cash the remaining $2.3&#160;billion of its outstanding 3.7% senior notes due 2023. In connection with the early redemption of such senior notes, the Company paid a make-whole premium of $80 million in excess of the aggregate principal amount of the senior notes that were redeemed, wrote-off $8 million of unamortized deferred financing costs and incurred $1 million in fees, for a total loss on early extinguishment of debt of $89&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2021, the Company purchased approximately $2.0&#160;billion of its outstanding 4.3% senior notes due 2028 through a cash tender offer. In connection with the purchase of such senior notes, the Company paid a premium of $332 million&#160;in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $26&#160;million of unamortized deferred financing costs and incurred $5&#160;million in fees, for a total loss on early extinguishment of debt of $363&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2020, the Company purchased $4.5&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $113&#160;million of its 4.0% senior notes due 2023, $1.4&#160;billion of its 3.7% senior notes due 2023, $1.0&#160;billion of its 4.1% senior notes due 2025 and $2.0&#160;billion of its 4.3% senior notes due 2028. In connection with the purchase of such senior notes, the Company paid a premium of $619&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $45&#160;million of unamortized deferred financing costs and incurred $10&#160;million in fees, for a total loss on early extinguishment of debt of $674&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the Company purchased $6.0&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $723&#160;million of its 4.0% senior notes due 2023, $2.3&#160;billion of its 3.7% senior notes due 2023 and $3.0&#160;billion of its 4.1% senior notes due 2025. In connection with the purchase of such senior notes, the Company paid a premium of $706&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $47&#160;million of unamortized deferred financing costs and incurred $13&#160;million in fees, for a total loss on early extinguishment of debt of $766&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Covenants&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s back-up revolving credit facilities and unsecured senior notes contain customary restrictive financial and operating covenants. These covenants do not include an acceleration of the Company&#x2019;s debt maturities in the event of a downgrade in the Company&#x2019;s credit ratings. The Company does not believe the restrictions contained in these covenants materially affect its financial or operating flexibility. As of December&#160;31, 2022, the Company was in compliance with all of its debt covenants.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzY4MDE_972acc2d-106a-4921-833a-59480a4506c6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s borrowings as of December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.452%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due July 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due November 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8% senior notes due June 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4% senior notes due December 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.375% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.625% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due November 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5% senior notes due December 2024 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1% senior notes due March 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due July 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.875% senior notes due June 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3% senior notes due August 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.625% senior notes due April 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.25% senior notes due June 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3% senior notes due August 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.3% senior notes due March 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.25% senior notes due August 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.75% senior notes due April 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.75% senior notes due August 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.875% senior notes due February 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.125% senior notes due September 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.875% senior notes due July 2035&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.625% senior notes due June 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.75% senior notes due December 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.78% senior notes due March 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.125% senior notes due September 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due April 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7% senior notes due August 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.75% senior notes due May 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.5% senior notes due May 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due November 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3% senior notes due December 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due March 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.125% senior notes due July 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due August 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.05% senior notes due March 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.25% senior notes due April 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUyLTAtMS0xLTI2NTI0Nw_1b8d2063-d583-4908-be86-f25a8a8346c8"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUyLTAtMS0xLTI2NTI0Nw_d9e5828d-1d67-442b-bf21-ed9fd901073c"&gt;Finance lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total debt principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt discounts and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(786)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;__________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes long-term debt of $3&#160;million which has been accounted for as liabilities held for sale and is included in liabilities held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i46d398142bc14090b6efa835576c60fe_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzEyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmI3ZGI0OWQ0ZGU4ZTRjYzI5MTJhMzc1NTEyY2MxYjFiXzQ_6c391758-d492-4519-bd4e-44d34f75e130"
      unitRef="number">0.035</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i46d398142bc14090b6efa835576c60fe_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzEyLTEtMS0xLTI2NTI0Nw_bbf92f4b-5bc9-44ad-af9c-aa8e33022bdf"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6dc40fd3418e432b9e325f5ecd1b6217_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzEyLTMtMS0xLTI2NTI0Nw_627d31f5-e871-4dde-b443-757620cc232f"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3af420d8300b4f17a1fa385f41425a8c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzEzLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjlmYWNiOWZkNmZhYzQ4ZmY4N2EzODkwZTE0MzI3ZGMxXzQ_568484ce-4844-4bcb-8096-4e3f604958bf"
      unitRef="number">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3af420d8300b4f17a1fa385f41425a8c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzEzLTEtMS0xLTI2NTI0Nw_47d19e0e-4be4-4862-b5cd-b6a5fd303aad"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i12e6f7addf034c2eb5edf2df1a607732_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzEzLTMtMS0xLTI2NTI0Nw_b35410a6-c35a-48ce-ae11-698b4212ad5b"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if443d252b4df496d80927ef019eadf74_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE0LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjM0OGI4MDAzMDI4ODQ5MjU5MmQwZmY4YWY3M2I4ZGRkXzQ_75c0de00-a446-4205-a576-71304734ae45"
      unitRef="number">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if443d252b4df496d80927ef019eadf74_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE0LTEtMS0xLTI2NTI0Nw_5b731118-8cae-4848-9304-439b17ec7800"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iaabe5773025f4c2cabd69d7914e764b7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE0LTMtMS0xLTI2NTI0Nw_dfb72fcc-1b26-4e5a-a0e3-a7696ef8df9b"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3e95a5abc36e4381a98f975d83721a1c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE1LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjVhYzAyOTI0NTlkNzRmMGU5ZGNhMWZmODkxMTBkMzEwXzQ_8c830820-1f6a-4bc9-9e1b-630685090408"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3e95a5abc36e4381a98f975d83721a1c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE1LTEtMS0xLTI2NTI0Nw_6cdc6b8a-9744-49b8-959f-ad9c92f17df2"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic62f6a9337b643efa667a4246f23f5a3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE1LTMtMS0xLTI2NTI0Nw_6ef58819-9f27-4b64-802f-8e62f5e7e3d9"
      unitRef="usd">399000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0bfa33d6699f4a16a614e7bb4af6003b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE3LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjVmNzJmOThhNTYxYzQ0NDNiNThkOTYxYzlkNjBmNjc2XzQ_f7abb898-87d4-4058-84a9-fc43a8ae3ab2"
      unitRef="number">0.028</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0bfa33d6699f4a16a614e7bb4af6003b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE3LTEtMS0xLTI2NTI0Nw_15d4bcc5-8098-467b-a293-10c859869b7f"
      unitRef="usd">1300000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id32712eeb9e24f4293e053682e64d0c0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE3LTMtMS0xLTI2NTI0Nw_0a9d5d36-7716-41d1-a8fe-b3b50fa65d31"
      unitRef="usd">1300000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6556efb47077422bb88b269c462914c5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE4LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjBjZmU1MTg3M2Q0ZDQ4ZmE4NjgyOGY3ZjhlMTVjMTRjXzQ_6e1da833-b46d-4e41-8021-bdc38fd96ceb"
      unitRef="number">0.04</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6556efb47077422bb88b269c462914c5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE4LTEtMS0xLTI2NTI0Nw_fc611127-8d30-4332-b77e-25d363c2bd95"
      unitRef="usd">414000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic7f8bc3f2aea4b8490a2c00543939418_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE4LTMtMS0xLTI2NTI0Nw_607f990a-251e-4bf0-897a-5e07a1fab185"
      unitRef="usd">414000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i095b5e69420d48439f08a7fd6032e39f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE5LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmY4NmY4NWMxZGI1ZTQ2Yjg5NjYwYWQ1NDEzMjljZWI0XzQ_50e7db4d-43e6-4498-bb01-c666a48e1b85"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i095b5e69420d48439f08a7fd6032e39f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE5LTEtMS0xLTI2NTI0Nw_8ef6a138-1b67-4e6b-848f-8c1614cad187"
      unitRef="usd">650000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i788e48585b7d4fb18382daa954eec2a2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzE5LTMtMS0xLTI2NTI0Nw_c55fe9d0-3df9-425f-8b81-f295701b40ea"
      unitRef="usd">650000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i412829e3534d4fc095e6237114df2eaf_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIwLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjdmZDZlMWUwZWIwZTQxOTA4ODE2NmQwMjhmMzQ3MDUxXzQ_529792ac-31bf-4797-a34e-f44039aa27e7"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i412829e3534d4fc095e6237114df2eaf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIwLTEtMS0xLTI2NTI0Nw_8292e42c-f60c-4a6f-8eb6-2c989589b7f5"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4dd41a67d29a43c5ada1608f1dbdcca9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIwLTMtMS0xLTI2NTI0Nw_48ef9845-7aab-42aa-9900-161d0372096d"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iee8c1ff2a84748f8b1e708329c8b5afa_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmUwN2NiOWQ1YTUyYjQzZTNiY2UzMjE2NmJiZmUwNzhhXzQ_a4843f53-98b7-4299-b492-6764b27d7594"
      unitRef="number">0.035</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iee8c1ff2a84748f8b1e708329c8b5afa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIxLTEtMS0xLTI2NTI0Nw_c5d2d06d-10fc-41ba-9f1d-bbb2198ae37f"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i79ee0b15e57241c5911bf2f116f391e5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIxLTMtMS0xLTI2NTI0Nw_f837df1e-ba8d-428d-af98-34d7e35324e2"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2e6d6e97c2644b418692bbab3d848bbc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmI5NDRiYjA4ZjlmNTQ5MzQ4MzkwNDllMWM0M2NiMGNiXzQ_0abe4d85-8766-4289-9a01-cc7909a4b45f"
      unitRef="number">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2e6d6e97c2644b418692bbab3d848bbc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIyLTEtMS0xLTI2NTI0Nw_e38c46c1-fca9-40ee-b16a-03d45de49883"
      unitRef="usd">299000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iffb22ad240ec40d99c5b5c11c4fe3c23_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIyLTMtMS0xLTI2NTI0Nw_30318247-77da-4d69-8bd5-cdcb810994c0"
      unitRef="usd">299000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4ba50b36e4af4b1aac05a10e19f622f0_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIzLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjUyZTEwNzlhMDU4ZDRkN2E4MWM1ODA5YWRkNTZhZmIxXzQ_7d3763e9-db63-486c-aef3-4e9a22f3fee4"
      unitRef="number">0.041</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4ba50b36e4af4b1aac05a10e19f622f0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIzLTEtMS0xLTI2NTI0Nw_659790f2-bd33-46ce-82a3-9ae1d22b9088"
      unitRef="usd">950000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i533be9b87ab747d18146404b355d4dc7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzIzLTMtMS0xLTI2NTI0Nw_0e2e43f6-3f24-4c35-94f8-b4142dc3d57a"
      unitRef="usd">950000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2a9a8b0623524068af6014036c34e60f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI0LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmE5ZTE5ODE4YTU1ODQ3NDc4YWRkZjljODIzNmUxZTA5XzQ_0147a3c8-9068-465a-9eab-e002473988c6"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2a9a8b0623524068af6014036c34e60f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI0LTEtMS0xLTI2NTI0Nw_f680982e-187b-4273-8a36-c01cf514c2e3"
      unitRef="usd">2828000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8b4b00758ca84efebf14e070000ab9e3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI0LTMtMS0xLTI2NTI0Nw_142245c1-40e0-45cb-ae8b-d4b4126cec3c"
      unitRef="usd">2828000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie19828a34e7c48c894138597b0f024aa_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI1LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmQxN2Q1MGMzNGUwNzQ2OTM5NzUwMWM5ZTFhNDM5NDEwXzQ_6332999d-1cb9-4547-bdca-ff67bd814660"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie19828a34e7c48c894138597b0f024aa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI1LTEtMS0xLTI2NTI0Nw_d8ac6919-443f-415d-992c-40d1cd596c3f"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i096820313ad94c9eaf41e3a34195cf2c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI1LTMtMS0xLTI2NTI0Nw_83c1535d-fb39-4c60-a3b2-825a5d8d1ed9"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie696efac889145fabb06c27642b8faab_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI2LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjVlNGU2ODU2NjNhMTRhMmNhNTA4OGUyZmI5ZjNlOWZiXzQ_38941ffa-5c2d-45c7-8da9-7d477f3958f8"
      unitRef="number">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie696efac889145fabb06c27642b8faab_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI2LTEtMS0xLTI2NTI0Nw_62405f6e-16d6-405b-a2de-f18cffa4e890"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6a9abfe3905e466f9226a7fba19a5d61_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI2LTMtMS0xLTI2NTI0Nw_06931980-4811-4011-8220-27febc821e51"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i75b0bb3f7a324df2b692b9a2d398518e_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI3LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjhiODY2MTcyZWM1YTQ0NmM5OTlmZjZmZTVhYjZhZjI5XzQ_4c2e0a43-53a5-4a27-861b-0b2c4743f43c"
      unitRef="number">0.03625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i75b0bb3f7a324df2b692b9a2d398518e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI3LTEtMS0xLTI2NTI0Nw_06bc36ee-4936-4a7d-b84c-d55e52d024d4"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie0f1d199662c4aa1addebeb3b5240b80_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI3LTMtMS0xLTI2NTI0Nw_10cedc22-fff4-4c6e-9ef5-1d138049d2ef"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9d39dacca1a042f6b353bda666b8bda1_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI4LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjgzNzRmNzZkMTI3MDQzYTdiZDMwYWYzY2I1MzQ1ODIzXzQ_a7345b72-9457-438c-8c9b-2c458dee1cd7"
      unitRef="number">0.0625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9d39dacca1a042f6b353bda666b8bda1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI4LTEtMS0xLTI2NTI0Nw_48171cd1-9876-4861-ae6d-b14cd731ea8e"
      unitRef="usd">372000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5c95f5eb8a5e43e6b03486361d0edd35_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI4LTMtMS0xLTI2NTI0Nw_06038131-e7ee-484c-8f21-52ab4cecff34"
      unitRef="usd">372000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0a911574fd4e42ccbf711bfad6c77ba7_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI5LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjNiOGNiYjU3MzAzMDQ5YmRiZjUwM2MyNTg2YTczYzFmXzQ_be65fab1-79fe-4fed-ab1f-3a165e720388"
      unitRef="number">0.013</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0a911574fd4e42ccbf711bfad6c77ba7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI5LTEtMS0xLTI2NTI0Nw_f3f13b37-592f-487e-afe6-1953b70c44a8"
      unitRef="usd">2250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib0f77ee954bb4d2db587828489c53759_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzI5LTMtMS0xLTI2NTI0Nw_32615232-e3ed-4b80-81e2-6bce5cd8da13"
      unitRef="usd">2250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0eb3702b560245409a4fb90d58b8cbee_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMwLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmZlNDk5ZmRmZjRiMzQ1MDc5YjY0M2MwZjlhNmU5NjJjXzQ_09293d41-5085-4d0b-900a-2318e914096b"
      unitRef="number">0.043</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0eb3702b560245409a4fb90d58b8cbee_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMwLTEtMS0xLTI2NTI0Nw_a8d975e0-cf6a-4cb5-8278-ac46a32a5dfc"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8c0858694d0545f4b143004f36109ead_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMwLTMtMS0xLTI2NTI0Nw_916561df-b8cb-4dbc-a74d-9698def82a79"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5f8491428a0e48e7b0b3ef58c6387fb3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjBiZjMxNzNhODI3NzQwM2I5MDZjODVmZGMwY2NjMmEyXzQ_ed63d818-b5b4-4f44-a619-ce9a0b608004"
      unitRef="number">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5f8491428a0e48e7b0b3ef58c6387fb3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMxLTEtMS0xLTI2NTI0Nw_f86a17ec-d67c-4cfb-ab90-2473704359ae"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8b1061d1cca14c27a643cc1dd4680a00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMxLTMtMS0xLTI2NTI0Nw_786cbb7c-9d74-4f89-925d-fb6efdb329f7"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6973def3f8764f29984b67e00ced9e10_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmM1N2UyNGMxN2NmYTRkYjZhOTZiMzRkODNhY2YyYzlhXzQ_01f45c79-e434-4242-a887-78932c8231bb"
      unitRef="number">0.0375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6973def3f8764f29984b67e00ced9e10_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMyLTEtMS0xLTI2NTI0Nw_2219cc6d-d101-451d-8bd5-45e2fe2e4426"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8970f954df4441f4b7ea8363b24cff7b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMyLTMtMS0xLTI2NTI0Nw_4bc10cf8-48de-485c-9331-9798ce71bfb2"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifb4028e415d14620a23a814353bd620f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMzLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjRjZjViMzk0MDUyZDQ1MGNhZGYwYTk4MzVjNGQ3ZDc2XzQ_c283137c-9545-485d-9139-0b8dfb2d7fae"
      unitRef="number">0.0175</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifb4028e415d14620a23a814353bd620f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMzLTEtMS0xLTI2NTI0Nw_26d27ea2-ce5b-482a-9c36-89db29152218"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i88ba47fdbaa24d6183f12124cf69ae33_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzMzLTMtMS0xLTI2NTI0Nw_fedbeabb-af84-435f-bbd7-0917c0736d92"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibdfec9e9766a4ff5bcabe5606e8aeec1_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM0LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjBiMjJjY2VmOWRiZjQwMzVhY2Y5MjQxMGY1Y2Q5MGY5XzQ_6c957266-6914-4c7d-ab23-e70ea262ef9a"
      unitRef="number">0.01875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ibdfec9e9766a4ff5bcabe5606e8aeec1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM0LTEtMS0xLTI2NTI0Nw_e1578a80-0062-438c-b982-7e833494330e"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i782152e0441e4c2a8aa5248aacc1d97e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM0LTMtMS0xLTI2NTI0Nw_0da33f14-7cdb-4eb8-a11a-729c0f0f573d"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i363e35471111481bb74f8fba9324ea53_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM1LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjlkZmQyNmU5MWY3ODRmNjNiNzU2MGRmMmYzN2RkMjA3XzQ_39e812aa-86d5-4e97-89d9-f26c0899fa99"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i363e35471111481bb74f8fba9324ea53_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM1LTEtMS0xLTI2NTI0Nw_36bb6bbe-5f99-40d8-9ff6-7b3a1c48de9b"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iae612530eaf9406ca68bdc6076595a22_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM1LTMtMS0xLTI2NTI0Nw_df1eaac3-ceaa-428e-8c48-7c4b94be43cb"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i13ffe568d3ed4a168945f8b506bb89d5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM2LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjliMmM2YmQ2YjlkOTRkYzE4M2Q3ZGJjOTQxNGIzMzViXzQ_7b8b9f76-f038-4c1f-a058-46c90055f650"
      unitRef="number">0.04875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i13ffe568d3ed4a168945f8b506bb89d5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM2LTEtMS0xLTI2NTI0Nw_60aa1d09-72f2-4419-9114-778ddc09a742"
      unitRef="usd">652000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i654327bfda6446f7a000b137efb56172_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM2LTMtMS0xLTI2NTI0Nw_15e314a8-d4a6-4bd6-8a16-a2e4be69cbe0"
      unitRef="usd">652000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i26367f6403b04922b185cd41633e004b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM3LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmY0OWVhMGUwOGIzMzQ4YmNhNjM5ZDhjMGNiODljN2JlXzQ_cbba5636-8f07-45fc-9315-df87ee60ce57"
      unitRef="number">0.06625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i26367f6403b04922b185cd41633e004b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM3LTEtMS0xLTI2NTI0Nw_dca4cbab-a36a-41a7-8538-31e320fb4bd9"
      unitRef="usd">771000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i84ed8c55fc0643daa63fac8671ac1c47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM3LTMtMS0xLTI2NTI0Nw_f595d936-3636-46cf-bbf8-bf19413eb3b3"
      unitRef="usd">771000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i06aeda9941724578b3400960ab91b49b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM4LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjgwYTQxYTIyYzI4ZjQwNjhiNjFmNjFmMGVmZjQ0MTVhXzQ_67c39916-e6ac-47d9-9401-0c642093146c"
      unitRef="number">0.0675</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i06aeda9941724578b3400960ab91b49b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM4LTEtMS0xLTI2NTI0Nw_71fbad10-90bc-4b41-9f8f-c5c8e3791eba"
      unitRef="usd">533000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i55522731fb6f4d858d93159da79516a7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM4LTMtMS0xLTI2NTI0Nw_85c3affd-845f-44e5-9615-cced04c1eb80"
      unitRef="usd">533000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iab7177b9be24447698af5c299280e476_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM5LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjM3YmZiYzQ3MDc2YzQ3NmU4YWY4ZTMxZWVlMjkyNDgwXzQ_83e80bdd-9b40-450c-86cc-c203c187417a"
      unitRef="number">0.0478</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iab7177b9be24447698af5c299280e476_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM5LTEtMS0xLTI2NTI0Nw_8a0fcfcc-7075-47e6-a9c6-20317c25e742"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i37a3a6af561f47c5852d985e16ed71d3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzM5LTMtMS0xLTI2NTI0Nw_3aca2313-ee7f-4d14-8514-15f32d7173b5"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia814b2597f3d40c3aa4b441a58f72382_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQwLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmM5YzJiOWI3ZGJkZjQwMWI5NDZhZTVkYWEzNWEzMzQ1XzQ_250f7ddf-73c7-4816-ac6a-48c32a5806f5"
      unitRef="number">0.06125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia814b2597f3d40c3aa4b441a58f72382_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQwLTEtMS0xLTI2NTI0Nw_7522542b-8468-45fd-8219-cde6599514a4"
      unitRef="usd">447000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic986abeb083b454c96d3dc4609ec7e06_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQwLTMtMS0xLTI2NTI0Nw_460e114d-b6b7-47a9-9936-215b657842f1"
      unitRef="usd">447000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6bd24d3fc7ac43f298c824109beb8c10_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjFlNTYyNmZjMmE5YjQ4ZmI5YmNkYTk0ODNhYmYwZjEzXzQ_649ae688-a4a8-4780-855a-4420b86bb7bd"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6bd24d3fc7ac43f298c824109beb8c10_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQxLTEtMS0xLTI2NTI0Nw_20179c0e-6938-4ec2-9b03-f1a6cedf1e84"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7bd579c48c854055ae2e0ed5e2761764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQxLTMtMS0xLTI2NTI0Nw_eb4ab346-5bb3-496c-ba8e-00b173ff4df7"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i170dc9d394554411a59b342f34d93d1a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQyLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjhiZGRhYzZlZGRiOTRlNmE4ZmFkYzBmMzQ0ZjQxNzkyXzQ_44f8be66-2762-4376-9dd6-0f4cb3724ebf"
      unitRef="number">0.027</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i170dc9d394554411a59b342f34d93d1a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQyLTEtMS0xLTI2NTI0Nw_ab19efcd-2d29-4e92-9f03-9901f32942cb"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8f7debdac94840a4bf5279ec76e1bc30_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQyLTMtMS0xLTI2NTI0Nw_56ff157e-235b-43f0-bbd5-a439a12641b2"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2c6a0d7374684e1c95b28bb2666b8bdd_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQzLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjFjNGZhZjMzNTVhNjQ3Y2FiZjU0NTA3MmM1NGY0YzdjXzQ_f9e87511-3eb8-4184-9afe-9aeaeecd2099"
      unitRef="number">0.0575</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2c6a0d7374684e1c95b28bb2666b8bdd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQzLTEtMS0xLTI2NTI0Nw_ec87dd9a-2551-4718-baee-2883c3841ffd"
      unitRef="usd">133000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7921747c0542413d82061a71fe1c0e43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQzLTMtMS0xLTI2NTI0Nw_78ff36b3-6522-4fe1-8e21-3cc331eaa77b"
      unitRef="usd">133000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7c5ea867903e4bd98992266582152be7_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ0LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjVhZTdiZWUxZmU1NzQ2YmFhNWJjMDFhYWZjODdjOGJlXzQ_7bc9ae5b-6121-41a0-9970-aecc49ad07d3"
      unitRef="number">0.045</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7c5ea867903e4bd98992266582152be7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ0LTEtMS0xLTI2NTI0Nw_bbd9e162-1753-4ecf-beec-6e275728c8a3"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i936efdc2f58c43ab85e5eb2d3d14283a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ0LTMtMS0xLTI2NTI0Nw_a52f520d-234b-450c-a03f-07132b16ede4"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iade73b7bf7a9412cabfa7e66daa3a170_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ1LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmVlZTUyZTI4ZDZiMTQ1YWU4NzUxYjExOTI5ZWIyNGJmXzQ_e82dc584-3596-4410-a5db-b8fda1480172"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iade73b7bf7a9412cabfa7e66daa3a170_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ1LTEtMS0xLTI2NTI0Nw_e4b9d1a8-d190-4b4c-ab96-1386091b533f"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i96cf2b69c10d4cb7bbeea0f0473d095c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ1LTMtMS0xLTI2NTI0Nw_b24ab080-13d1-405a-8657-7e3f5a264e25"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibfef3a2b0e55448e81cc7fd8cdcefa84_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ2LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjVhMTUxZGI2MTU1NTQwZTRiNjc4MGEyM2I3YmJiZGE0XzQ_6c16bc2c-d425-4ef2-b9bf-2f7d9ae4f7da"
      unitRef="number">0.053</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ibfef3a2b0e55448e81cc7fd8cdcefa84_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ2LTEtMS0xLTI2NTI0Nw_c5399daa-df1f-4505-ab4e-0fe7b0d766f9"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9023482dafe64c8487415d9d977873b9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ2LTMtMS0xLTI2NTI0Nw_69568cda-6f01-4909-bd2d-c8250e32b5cc"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i30e9474ca99f4c96bd9f16e412ac3108_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ3LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjNmNjU2NjNhNDBiNDQyY2Q5MDlkOTg5YmFiOWY5MjkxXzQ_a5cdb2e0-d6e0-4bf6-9405-588f2ad2b755"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i30e9474ca99f4c96bd9f16e412ac3108_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ3LTEtMS0xLTI2NTI0Nw_4ef7a603-5927-4a97-b7b3-e299181057d8"
      unitRef="usd">375000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id71a7150882a412185e3bc50665a4eb0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ3LTMtMS0xLTI2NTI0Nw_d25950bd-5e35-4a78-85d0-3e4fb5e72e74"
      unitRef="usd">375000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i45407f38c46c4bccad465eebd0e1c1a0_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ4LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjhhNzMxZjMyYjhmYTQ2ZGE4MDE4OWYxNDIwNjNjYmU0XzQ_d827f7f0-8290-4bd6-b419-6e194bb4aa34"
      unitRef="number">0.05125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i45407f38c46c4bccad465eebd0e1c1a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ4LTEtMS0xLTI2NTI0Nw_815c9054-9ccf-4b2d-8441-f4d77883373d"
      unitRef="usd">3500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3d8773a95fa54a4c955ee222946850f1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ4LTMtMS0xLTI2NTI0Nw_4b28c866-bc4c-4ad2-b205-879b31673b3c"
      unitRef="usd">3500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6861e988cc904169ad4ce04f9a698dfb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ5LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjM3ZjNiYjViNTJjYjRiYTFhNDRiOGZkYjU1NjNmZDE1XzQ_ada2e5f3-b9ff-4693-a3c5-c47c8848c1fd"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6861e988cc904169ad4ce04f9a698dfb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ5LTEtMS0xLTI2NTI0Nw_6a6fc720-f7d4-4f24-839a-d2508c94ee2e"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i595551a12fa549a4b9bf4bb76c4cd9b6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzQ5LTMtMS0xLTI2NTI0Nw_4787351b-c483-4c5a-a299-a61d822fb171"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i84d217e379554fdc8044f794cb43db4a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUwLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmE4ZGUwYjRmYzI2YjQyNTQ5MzJlMTNlNzdlOWMwNGZlXzQ_1ec7b93a-1442-457f-83d3-bd0078bc62ed"
      unitRef="number">0.0505</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i84d217e379554fdc8044f794cb43db4a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUwLTEtMS0xLTI2NTI0Nw_d96f4eb3-3223-470f-b298-cf15d5d27108"
      unitRef="usd">8000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5c83f742d5604d34bf2d877385d1f1bf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUwLTMtMS0xLTI2NTI0Nw_fed57a41-b664-4a35-bb70-896578b67ddf"
      unitRef="usd">8000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idb3abfe6fdc34a699fc61058a8ebf7fd_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUxLTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjg0MjZiZmU0NTM5ZTRkMDg5MDg3NTNhOTFmZTFiNmJiXzQ_766d5bd9-6176-4c0e-8247-5cf71ef4fe77"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="idb3abfe6fdc34a699fc61058a8ebf7fd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUxLTEtMS0xLTI2NTI0Nw_dd95886c-16c3-4796-a69b-46a6314f4b6f"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7d36c8bfa1e04bd1a278e34c22872187_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUxLTMtMS0xLTI2NTI0Nw_749d261b-1978-496a-a1f7-e42b37077588"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUyLTEtMS0xLTI2NTI0Nw_666b1ed8-21eb-451c-be43-f57c5070a769"
      unitRef="usd">1465000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUyLTMtMS0xLTI2NTI0Nw_fb2ce339-1c56-4b5b-8e75-dca57b038a27"
      unitRef="usd">1300000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3e5f05c48e5f410f832224ee5b84dc43_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUzLTEtMS0xLTI2NTI0Nw_845e91b3-ac7c-470a-b053-985671a5eaec"
      unitRef="usd">314000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1b89c9ecfa1844e19052dc3ccefa9571_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzUzLTMtMS0xLTI2NTI0Nw_aeebd652-202b-40b3-bc49-6245f71376ba"
      unitRef="usd">320000000</us-gaap:DebtInstrumentCarryingAmount>
    <cvs:LongtermDebtGrossAndLeaseObligation
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzU0LTEtMS0xLTI2NTI0Nw_44312cdc-4ba0-4697-9f96-7a9f03c9a500"
      unitRef="usd">52753000000</cvs:LongtermDebtGrossAndLeaseObligation>
    <cvs:LongtermDebtGrossAndLeaseObligation
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzU0LTMtMS0xLTI2NTI0Nw_40f6c619-333c-4902-bab1-48400cb43d3f"
      unitRef="usd">56743000000</cvs:LongtermDebtGrossAndLeaseObligation>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzU1LTEtMS0xLTI2NTI0Nw_6f8a6a1d-a78e-4f01-8e0e-16dd1f3fbe05"
      unitRef="usd">200000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzU1LTMtMS0xLTI2NTI0Nw_143d4cca-88a8-413d-b09e-9f2d019ffb1a"
      unitRef="usd">219000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <cvs:DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzU2LTEtMS0xLTI2NTI0Nw_21eddf5b-c5f1-4a68-83ea-9b2e6bcd049e"
      unitRef="usd">696000000</cvs:DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet>
    <cvs:DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzU2LTMtMS0xLTI2NTI0Nw_e6e16884-7f24-4c9a-8dfe-dc495ff4f2a5"
      unitRef="usd">786000000</cvs:DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzU3LTEtMS0xLTI2NTI0Nw_f3d2c110-a75e-4af1-911a-54df508315d9"
      unitRef="usd">52257000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzU3LTMtMS0xLTI2NTI0Nw_6511ecde-ec88-43f1-84a9-05385138d91b"
      unitRef="usd">56176000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzYwLTEtMS0xLTI2NTI0Nw_3b283fb8-61d1-4073-8a0c-29b9a28a4186"
      unitRef="usd">1778000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzYwLTMtMS0xLTI2NTI0Nw_948b807e-96f2-40f9-9508-61ebbf75fa16"
      unitRef="usd">4205000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <cvs:LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzYxLTEtMS0xLTI2NTI0Nw_1d4c7952-08c6-4a00-8b33-fd71e7935ab2"
      unitRef="usd">50479000000</cvs:LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale>
    <cvs:LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTozMzNhNmI5YjVjNTg0NTBiODdjYTQ2MmYwNWJiMDJhZi90YWJsZXJhbmdlOjMzM2E2YjliNWM1ODQ1MGI4N2NhNDYyZjA1YmIwMmFmXzYxLTMtMS0xLTI2NTI0Nw_bfb148b0-f989-47f3-b42e-49e6faa12724"
      unitRef="usd">51971000000</cvs:LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id47f5a8f599c4b868d0305b2456c6b4f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzE5MA_79791f6e-51f0-4041-903a-2be0133c348b"
      unitRef="usd">3000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzY4MDI_f89f9692-2e6a-4bc4-8bf1-96917cbf3c28">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the Company&#x2019;s required repayments of debt principal due during each of the next five&#160;years and thereafter, as of December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt principal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;See Note 6 &#x2018;&#x2018;Leases&#x2019;&#x2019; for a summary of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;maturities of the Company&#x2019;s finance lease liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTo1YWY5MTQ0ZmE0NmQ0NjA1OWYwOTM4MDI1ZDQ4NWZiZi90YWJsZXJhbmdlOjVhZjkxNDRmYTQ2ZDQ2MDU5ZjA5MzgwMjVkNDg1ZmJmXzEtMS0xLTEtMjY1MjQ3_9314c789-aa72-46b9-bf4c-cb873ca40613"
      unitRef="usd">1719000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTo1YWY5MTQ0ZmE0NmQ0NjA1OWYwOTM4MDI1ZDQ4NWZiZi90YWJsZXJhbmdlOjVhZjkxNDRmYTQ2ZDQ2MDU5ZjA5MzgwMjVkNDg1ZmJmXzItMS0xLTEtMjY1MjQ3_6d7f5413-da5d-495e-ae67-3f5799c32d1b"
      unitRef="usd">2706000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTo1YWY5MTQ0ZmE0NmQ0NjA1OWYwOTM4MDI1ZDQ4NWZiZi90YWJsZXJhbmdlOjVhZjkxNDRmYTQ2ZDQ2MDU5ZjA5MzgwMjVkNDg1ZmJmXzMtMS0xLTEtMjY1MjQ3_c489e80d-fa0d-4c51-ae87-068a5f6e0bc5"
      unitRef="usd">3785000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTo1YWY5MTQ0ZmE0NmQ0NjA1OWYwOTM4MDI1ZDQ4NWZiZi90YWJsZXJhbmdlOjVhZjkxNDRmYTQ2ZDQ2MDU5ZjA5MzgwMjVkNDg1ZmJmXzQtMS0xLTEtMjY1MjQ3_e00e1a89-bae1-4618-82fc-8dc5016a69a7"
      unitRef="usd">2507000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTo1YWY5MTQ0ZmE0NmQ0NjA1OWYwOTM4MDI1ZDQ4NWZiZi90YWJsZXJhbmdlOjVhZjkxNDRmYTQ2ZDQ2MDU5ZjA5MzgwMjVkNDg1ZmJmXzUtMS0xLTEtMjY1MjQ3_1d69efaa-d974-4b81-a7d1-a4853f512f91"
      unitRef="usd">3379000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTo1YWY5MTQ0ZmE0NmQ0NjA1OWYwOTM4MDI1ZDQ4NWZiZi90YWJsZXJhbmdlOjVhZjkxNDRmYTQ2ZDQ2MDU5ZjA5MzgwMjVkNDg1ZmJmXzYtMS0xLTEtMjY1MjQ3_82fecbe2-4472-4d71-9bcc-f2b5da32b5c8"
      unitRef="usd">37192000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTo1YWY5MTQ0ZmE0NmQ0NjA1OWYwOTM4MDI1ZDQ4NWZiZi90YWJsZXJhbmdlOjVhZjkxNDRmYTQ2ZDQ2MDU5ZjA5MzgwMjVkNDg1ZmJmXzctMS0xLTEtMjY1MjQ3_8f499045-cccd-42fd-a977-1227b733138f"
      unitRef="usd">51288000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTo1YWY5MTQ0ZmE0NmQ0NjA1OWYwOTM4MDI1ZDQ4NWZiZi90YWJsZXJhbmdlOjVhZjkxNDRmYTQ2ZDQ2MDU5ZjA5MzgwMjVkNDg1ZmJmXzgtMS0xLTEtMjY1MjQ3_666b1ed8-21eb-451c-be43-f57c5070a769"
      unitRef="usd">1465000000</us-gaap:FinanceLeaseLiability>
    <cvs:LongtermDebtGrossAndLeaseObligation
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90YWJsZTo1YWY5MTQ0ZmE0NmQ0NjA1OWYwOTM4MDI1ZDQ4NWZiZi90YWJsZXJhbmdlOjVhZjkxNDRmYTQ2ZDQ2MDU5ZjA5MzgwMjVkNDg1ZmJmXzktMS0xLTEtMjY1MjQ3_ab56438d-450a-4a0b-9d35-8c3b5cdfad2a"
      unitRef="usd">52753000000</cvs:LongtermDebtGrossAndLeaseObligation>
    <us-gaap:ShortTermBorrowings
      contextRef="ia5d25fae6d644b13b9d7d803b1a2d336_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3Xzc1MA_788045c6-44ba-4fd0-a42b-a9c08db857f0"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="iab1819ee2b2c48beb7a3d3480b4d3018_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3Xzc1MA_ba06b9e5-918b-4741-a6e3-02c970bf4d02"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i7725a00fc4434458820e5285675db777_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3Xzg5OA_7c894714-4de4-4155-8b1d-aa51c8b03f2a"
      unitRef="usd">2000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="if5314895b87347ca95eb2d88cacc462b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzY3MzE_a74e437a-3b71-4ccb-bd16-984e1df1124e">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ide893c421b8b4a6bb460e90ff3db6be6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3Xzk4OA_21a11720-d81a-4dc7-842f-6601cc4d2c7f"
      unitRef="usd">2000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i9b7205dfebbd4f39b3d90a92a474a62c_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzY3NjU_be96d83d-af2a-40b8-b34d-dc4f35e44068">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i4f2daf0d0e1b46beb6977fe725dd8568_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzEwODI_6c14daf3-4352-4169-8e5f-7f16e91ee291"
      unitRef="usd">2000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i58ff8eedba304dc89f24ce5bfd8071d0_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzY3OTU_384f3c34-ebde-41e9-bb52-3fc3d56fd6f6">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i53a3dea184cf43989b62efd3b338a4e4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzEzODY_5229e210-e72b-4da7-a912-a7fc1f0b3833"
      unitRef="number">0.0003</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:ShortTermBorrowings
      contextRef="i296638e184854141a99df90a77e2a441_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzE0Mzk_21d1aa6b-990b-4fcf-87da-0c9f9ad355d1"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i096d8d3381b14ad1aa6e9c2bb706e0cd_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzE0Mzk_eb002587-d4b6-4ede-ab9d-8f662806b0a0"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzE4MjE_be3a6f5d-ee9d-40e4-b460-e2f9098e6c93"
      unitRef="usd">915000000</us-gaap:FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable>
    <us-gaap:ShortTermBorrowings
      contextRef="ie9b65b8aa3934b9e926bf1519bff738d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzE4NTU_170aaae5-5df1-4f9e-ba4e-0c50b4d33780"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="iadf9ac334c4b4658ad05a02180f0b8c5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzE4NTU_82bd68a9-817a-4067-aa6d-40e827b0fcde"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i364fd8c191ee4a44ba567c6975b7a46b_I20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzIwMjk_1c4e88ec-bf66-48cb-8aa7-31434139c896"
      unitRef="number">0.035</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i70894237af7b4390b3fb413977da682d_D20220501-20220531"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzIwOTc_bd5e8c1d-10bc-404d-b915-1a57eacc553e"
      unitRef="usd">1500000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i51ef9d9ca64a4f4287885afe3f594d9e_I20220831"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzIyMTE_47e72464-57a1-47e4-8bef-fc1a1b099236"
      unitRef="number">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i8fbfb24ea6744e208cb848ccde2da9e1_D20220801-20220831"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzIzMTY_22ee5e4b-be4f-412b-a339-b49dace59c58"
      unitRef="usd">1000000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9aa5250b8a554547a64d644fea28511e_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzI0MzM_4a38daf7-a3d5-41be-a685-7a24ee91db5f"
      unitRef="number">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6b6fb40f4dca4685b9a5bbb62b5bc3c2_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzI0NzE_2afd57b5-9033-4fb5-8942-2e9214ea6fd7"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="id3d628c3b8c14ac6864d45ff3df48167_D20220901-20220930"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzI2MTY_9732e853-6b7a-4330-a944-529588f49427"
      unitRef="usd">1250000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ib7e2b901e8f64b298c94032d51d86694_D20220901-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzI2MjM_4b7e2b89-2a3b-474c-ae93-291f8c8c02c4"
      unitRef="usd">399000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i37ff025b209247ed83d75720f35ca078_I20210818"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzI2OTI_ffe7cbd4-e196-4dfe-b299-9f73d4132db3"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i37ff025b209247ed83d75720f35ca078_I20210818"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzI3MjU_0e675001-ce53-4940-abe1-afb03300c2bb"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="ifde94c7f37464b33b3e1498967849d4c_D20210818-20210818"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzI3OTY_ff453c2e-8a1a-4d8e-be4a-4fc75a892e02"
      unitRef="usd">987000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib92c96bdb7a54505966770b11a97675d_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzMzNTk_9c356ef2-b8fa-4bb8-b36b-22bff9c18395"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib92c96bdb7a54505966770b11a97675d_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzMzOTI_09fa5019-0062-4e91-92e3-9e442b8fe04c"
      unitRef="number">0.03625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i1cd70718cc1343babbfe7bdcef36bd9a_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzM0Mzc_0e780bd0-3eb2-4d31-86b8-2c4daea7ab6e"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1cd70718cc1343babbfe7bdcef36bd9a_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzM0NzA_9dbba6f3-351a-49d9-9095-e583ccce2b6d"
      unitRef="number">0.0375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9544c22127144ed0964d5a4436da8785_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzM1MTU_07389143-93c0-4480-b405-c9b0060b2e50"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9544c22127144ed0964d5a4436da8785_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzM1NDg_8ca829b8-6206-4098-bffa-22ee150b2e3e"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id0e311329095472ab7b183da066396c8_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzM1OTY_9e62460b-c29e-4e39-9bfa-533fc34f6d32"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id0e311329095472ab7b183da066396c8_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzM2Mjk_4c6ffab9-caaf-4eb1-b961-d52d8baaceb8"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:PaymentsForDerivativeInstrumentFinancingActivities
      contextRef="i60425698f8a3418da11bdd624d74fae8_D20200301-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzM4Nzg_337cd6fd-95e7-44db-885d-a635d83d3db9"
      unitRef="usd">7000000</us-gaap:PaymentsForDerivativeInstrumentFinancingActivities>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i60425698f8a3418da11bdd624d74fae8_D20200301-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzM5NzI_61ab11a1-ce9c-46f7-972f-de9f48fb0222"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ieab996d7d0884ceab3cf45494319270b_D20211201-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzQyMzA_7a74ba8c-7032-4220-ac1c-2a16267d60b1"
      unitRef="usd">2300000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ied3ea35dfc6c47b7b9f3cc1126a9a800_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzQyNTI_07ba30a4-838b-4584-8fb7-9a192a3afbca"
      unitRef="number">0.037</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="ie2ed035e89ea4208b36e5c0321f9ff7f_D20211201-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzQzODE_ff9ef787-d94d-4946-98a2-400894eaa0da"
      unitRef="usd">-80000000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="ie2ed035e89ea4208b36e5c0321f9ff7f_D20211201-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzQ0Nzg_8114239e-b039-46c7-9d92-c160d8e198ed"
      unitRef="usd">8000000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <cvs:DebtExtinguishmentFees
      contextRef="ie2ed035e89ea4208b36e5c0321f9ff7f_D20211201-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzQ1MzQ_59000593-0ace-4b32-935d-922762eef1dc"
      unitRef="usd">1000000</cvs:DebtExtinguishmentFees>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ie2ed035e89ea4208b36e5c0321f9ff7f_D20211201-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzQ1OTg_265846f8-b973-4d2d-8842-dfd043f81182"
      unitRef="usd">-89000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i83224dff234f476ba7ed0ccd21116967_D20210801-20210831"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzQ2NTU_27cab97d-8123-4532-bb89-3c8c155808df"
      unitRef="usd">2000000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i485c3eb16ae24960b7e3cac5ed2c512b_I20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzQ2Nzc_07cefd6f-6319-4e86-9af5-841575d9c5eb"
      unitRef="number">0.043</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="ia34bc950bc544c9382c1522adba2fb40_D20210801-20210831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzQ4MTU_ffb82561-9838-486c-9966-8431bc3da9a3"
      unitRef="usd">-332000000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="ia34bc950bc544c9382c1522adba2fb40_D20210801-20210831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzQ5MTM_e5b17402-0b7b-4774-a19c-94d64c7ea91e"
      unitRef="usd">26000000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <cvs:DebtExtinguishmentFees
      contextRef="ia34bc950bc544c9382c1522adba2fb40_D20210801-20210831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzQ5Njk_088e5470-fc80-4c0a-a6c0-73eb4922c6cb"
      unitRef="usd">5000000</cvs:DebtExtinguishmentFees>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ia34bc950bc544c9382c1522adba2fb40_D20210801-20210831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzUwMzM_d84b9bdb-e69d-4db1-a408-268e9e03f366"
      unitRef="usd">-363000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i80466863c1954a5995d8cb88bd23d373_D20201201-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzUwNzg_202be032-0444-4a28-a041-7e5e8c53c20e"
      unitRef="usd">4500000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i7385c90f6eec42dbafb7d0cc760c4687_D20201201-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzUxOTI_da81853f-16c9-44d7-9604-05947671971a"
      unitRef="usd">113000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ief5a743376c14f51b6a0e836c4b51640_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzUyMDI_b9e8d41a-82f1-4a12-800a-1b31bafcfec8"
      unitRef="number">0.040</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="icf67de8907724398ac7599821631c87e_D20201201-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzUyMjg_31385627-6cac-446d-988b-3f6c778b490d"
      unitRef="usd">1400000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i74057c0c3792479e937638290c160b1c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzUyMzg_83e6c859-1c49-4abe-9036-81dd9570a8fc"
      unitRef="number">0.037</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i7d58decd879f498a93452c94fc35e626_D20201201-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzUyNjQ_f1d26e80-434b-4ce9-b2eb-5eca33925ec8"
      unitRef="usd">1000000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iea5790297968453b80af10c825264b1a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzUyNzQ_37d02763-7ff9-4c3d-b071-9885a8515b95"
      unitRef="number">0.041</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i7f44b18f700943b2a98a19f48efe6062_D20201201-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzUzMDM_1d36d63d-65f8-4724-8b14-510f9d4f09f3"
      unitRef="usd">2000000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i63e27afb0d604706bcc006002a4c8301_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzUzMTM_3adc2ad0-5bf4-4c49-a954-e7d7030da520"
      unitRef="number">0.043</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="i36384f97305a4feabdce46713990833c_D20201201-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU0MjM_125ba43a-8ec2-4e72-9907-1bd6bf76d302"
      unitRef="usd">-619000000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="i36384f97305a4feabdce46713990833c_D20201201-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU1MjE_5356c4ce-a154-4362-8c18-3a1a7e6d03d1"
      unitRef="usd">45000000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <cvs:DebtExtinguishmentFees
      contextRef="i36384f97305a4feabdce46713990833c_D20201201-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU1Nzc_fa5dad77-a135-42a8-ae0b-baa6da5d6824"
      unitRef="usd">10000000</cvs:DebtExtinguishmentFees>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i36384f97305a4feabdce46713990833c_D20201201-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU2NDE_82c96ff6-ee95-4bb1-9fb6-e4b15d861adc"
      unitRef="usd">-674000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i0d45c5eeb3784063b1f6c2bd8750adc3_D20200801-20200831"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU2ODQ_1bbf2620-de0c-474c-883e-583758617df1"
      unitRef="usd">6000000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i335a47dd1b0d4b048c9088e555d579ec_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU3OTg_66cd5115-5f40-4dc1-bd0e-6c72f2a4155f"
      unitRef="usd">723000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3b98834372be433bb753acc0051b6968_I20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU4MDg_ab830396-41ed-4ff0-9ec9-a780daa1134f"
      unitRef="number">0.040</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i5b2c782f0ddb4f47b2267b9624558fbc_D20200801-20200831"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU4MzQ_1f1a11f5-3f31-4c55-80ec-6535f1213544"
      unitRef="usd">2300000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia13f558316964fe4aba42d03ed32c28a_I20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU4NDQ_86bb247e-7725-497d-9b2c-2b74fe777d1f"
      unitRef="number">0.037</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="iac13c74e53a64777a3a5d7e4fe3b2046_D20200801-20200831"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU4NzM_c7a5104e-9abc-467a-a01e-dab6e6af2602"
      unitRef="usd">3000000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4f514b120f594513be910dc9973e11be_I20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU4ODM_0260577d-ceec-4506-baa8-f68a704c255c"
      unitRef="number">0.041</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="i2b7fcc349cf541ddb6fa797410c0ffa1_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzU5OTM_ff89a8b0-5e0a-4055-8ac2-42a7ad7ce829"
      unitRef="usd">-706000000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="i2b7fcc349cf541ddb6fa797410c0ffa1_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzYwOTE_ec20795a-c7b5-4faa-af4d-fab02ab1710a"
      unitRef="usd">47000000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <cvs:DebtExtinguishmentFees
      contextRef="i2b7fcc349cf541ddb6fa797410c0ffa1_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzYxNDc_9193aa96-b77d-416f-ac14-d3539041a742"
      unitRef="usd">13000000</cvs:DebtExtinguishmentFees>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i2b7fcc349cf541ddb6fa797410c0ffa1_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDUvZnJhZzphMzE0NzZlZWYxMzI0N2QxODZiNmM0OGI0MDg5OTNmNy90ZXh0cmVnaW9uOmEzMTQ3NmVlZjEzMjQ3ZDE4NmI2YzQ4YjQwODk5M2Y3XzYyMTE_76619254-1e84-4b19-b0c9-7b9768b3c57a"
      unitRef="usd">-766000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMzIz_b9a7c62d-ad64-4b60-b535-393965828051">Pension Plans and Other Postretirement Benefits&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Defined Contribution Plans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the Company sponsors several active 401(k) savings plans that cover all employees who meet plan eligibility requirements. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company makes matching contributions consistent with the provisions of the respective plans. At the participant&#x2019;s option, account balances, including the Company&#x2019;s matching contribution, can be invested among various investment options under each plan. The CVS Health Future Fund 401(k) Plan offers CVS Health Corporation&#x2019;s common stock fund as an investment option. The Company also maintains nonqualified, unfunded deferred compensation plans for certain key employees. The plans provide participants the opportunity to defer portions of their eligible compensation and for certain nonqualified plans, participants receive matching contributions equivalent to what they could have received under the CVS Health Future Fund 401(k) Plan absent certain restrictions and limitations under the Internal Revenue Code. The Company&#x2019;s contributions under its defined contribution plans were $567 million, $552 million and $520 million in the years ended December&#160;31, 2022, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Defined Benefit Pension Plans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sponsors a tax-qualified defined benefit pension plan that was frozen in 2010 and a nonqualified supplemental pension plan that was frozen in 2007. The Company also sponsors several other defined benefit pension plans that are unfunded nonqualified supplemental retirement plans.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pension Benefit Obligation and Plan Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables outline the change in pension benefit obligation and plan assets over the specified periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in benefit obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,011)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the pension benefit obligation during the years ended December&#160;31, 2022 and 2021 was primarily driven by the change in the discount rate during each respective period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assets (liabilities) recognized on the consolidated balance sheets at December&#160;31, 2022 and 2021 for the defined benefit pension plans consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets reflected in other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities reflected in accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities reflected in other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Periodic Benefit Cost (Income)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of net periodic benefit cost (income) for the years ended December&#160;31, 2022, 2021 and 2020 are shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Components of net periodic benefit cost (income):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(309)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost (income)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pension Plan Assumptions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a series of actuarial assumptions to determine its benefit obligation and net periodic benefit income, the most significant of which include discount rates and expected return on plan assets assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Discount Rates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The discount rate is determined using a yield curve as of the annual measurement date. The yield curve consists of a series of individual discount rates, with each discount rate corresponding to a single point in time, based on high-quality bonds. Projected benefit payments are discounted to the measurement date using the corresponding rate from the yield curve that is consistent with the maturity profile of the expected liability cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Return on Plan Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The expected long-term rate of return on plan assets is determined by using the plan&#x2019;s target allocation and return expectations based on many factors including forecasted long-term capital market real returns and the inflationary outlook on a plan by plan basis. See &#x201c;Pension Plan Assets&#x201d; below for additional details regarding the pension plan assets as of December 31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also considers other assumptions including mortality, interest crediting rate, termination and retirement rates and cost of living adjustments. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined its benefit obligation based on the following weighted average assumptions as of December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined its net periodic benefit cost (income) based on the following weighted average assumptions for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term rate of return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pension Plan Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s pension plan assets primarily include debt and equity securities held in separate accounts, common/collective trusts and real estate investments. The valuation methodologies used to value these debt and equity securities and common/collective trusts are similar to the methodologies described in Note 4 &#x201c;Fair Value.&#x201d; Pension plan assets also include investments in other assets that are carried at fair value. The following is a description of the valuation methodologies used to value real estate investments and these additional investments, including the general classification pursuant to the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Real Estate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Real estate investments are valued by independent third party appraisers. The appraisals comply with the Uniform Standards of Professional Appraisal Practice, which include, among other things, the income, cost, and sales comparison approaches to estimating property value. Therefore, these investments are classified in Level 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Private equity and hedge fund limited partnerships&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Private equity and hedge fund limited partnerships are carried at fair value which is estimated using the NAV per unit as reported by the administrator of the underlying investment fund as a practical expedient to fair value. Therefore, these investments have been excluded from the fair value table below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2022 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Domestic real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Common/collective trusts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total pension investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The assets in the underlying funds of common/collective trusts consist of $104 million of equity securities and $203 million of debt securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $390 million of other receivables as well as $432 million of private equity limited partnership investments and $225 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2021 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Domestic real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Common/collective trusts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total pension investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The assets in the underlying funds of common/collective trusts consist of $261 million of equity securities and $149 million of debt securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $76 million of other receivables as well as $583 million of private equity limited partnership investments and $237 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balances of Level 3 pension plan assets during the year ended December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, sales and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balances of Level 3 pension plan assets during the year ended December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.036%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, sales and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s pension plan invests in a diversified mix of assets designed to generate returns that will enable the plan to meet its future benefit obligations. The risk of unexpected investment and actuarial outcomes is regularly evaluated. This evaluation &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;is performed through forecasting and assessing ranges of investment outcomes over short- and long-term horizons and by assessing the pension plan&#x2019;s liability characteristics. Complementary investment styles and strategies are utilized by professional investment management firms to further improve portfolio and operational risk characteristics. Public and private equity investments are used primarily to increase overall plan returns. Real estate investments are viewed favorably for their diversification benefits and above-average dividend generation. Fixed income investments provide diversification benefits and liability hedging attributes that are desirable, especially in falling interest rate environments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, target investment allocations for the Company&#x2019;s pension plan were: 12% in equity securities, 77% in fixed income and debt securities, 5% in real estate, 3% in private equity limited partnerships and 3% in hedge funds. Actual asset allocations may differ from target allocations due to tactical decisions to overweight or underweight certain assets or as a result of normal fluctuations in asset values. Asset allocations are consistent with stated investment policies and, as a general rule, periodically rebalanced back to target asset allocations. Asset allocations and investment performance are formally reviewed periodically throughout the year by the pension plan&#x2019;s Investment Subcommittee. Forecasting of asset and liability growth is performed at least annually.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally contributes to its tax-qualified pension plan based on minimum funding requirements determined under applicable federal laws and regulations. Employer contributions related to the nonqualified supplemental pension plans generally represent payments to retirees for current benefits. The Company contributed $27 million, $78 million and $25 million to its pension plans during 2022, 2021 and 2020, respectively. No contributions are required for the tax-qualified pension plan in 2023. The Company expects to make an immaterial amount of contributions for all other pension plans in 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the pension benefit obligation as of December&#160;31, 2022: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028-2032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Multiemployer Pension Plans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also contributes to a number of multiemployer pension plans under the terms of collective-bargaining agreements that cover its union-represented employees. The risks of participating in these multiemployer plans are different from single-employer pension plans in the following respects: (i) assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers, (ii) if a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers, and (iii) if the Company chooses to stop participating in some of its multiemployer plans, the Company may be required to pay those plans an amount based on the underfunded status of the applicable plan, which is referred to as a withdrawal liability. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;None of the multiemployer pension plans in which the Company participates are individually significant to the Company. The Company&#x2019;s contributions to multiemployer pension plans were $20 million, $19 million and $19 million in 2022, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Postretirement Benefits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides postretirement health care and life insurance benefits to certain retirees who meet eligibility requirements. The Company&#x2019;s funding policy is generally to pay covered expenses as they are incurred. For retiree medical plan accounting, the Company reviews external data and its own historical trends for health care costs to determine the health care cost trend rates. As of December&#160;31, 2022 and 2021, the Company&#x2019;s other postretirement benefits had an accumulated postretirement benefit obligation of $159 million and $207 million, respectively. Net periodic benefit costs related to these other postretirement benefits were $4 million, $4 million and $12 million in 2022, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the accumulated other postretirement benefit obligation as of December&#160;31, 2022: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028-2032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Pursuant to various collective bargaining agreements, the Company also contributes to multiemployer health and welfare plans that cover certain union-represented employees. The plans provide postretirement health care and life insurance benefits to certain employees who meet eligibility requirements. The Company&#x2019;s contributions to multiemployer health and welfare plans totaled $62 million, $60 million and $54 million in 2022, 2021 and 2020, respectively.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMDU_8448054a-5749-4e40-bc01-2a77d27b383d"
      unitRef="usd">567000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMDk_02910467-9b13-412f-b1ad-c3135a7649ba"
      unitRef="usd">552000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMTY_d1cd6839-fdcb-4228-a251-8b5141e7cde2"
      unitRef="usd">520000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMzE4_a27052b8-88c3-4231-a3a8-653e5ad7d4cd">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables outline the change in pension benefit obligation and plan assets over the specified periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in benefit obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,011)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock>
    <us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMzI3_3fa95115-9aa4-4abe-aa88-a3df904989e2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables outline the change in pension benefit obligation and plan assets over the specified periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in benefit obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,011)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i6ae60f8a88824bf889f05cc3b51730b3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzItMS0xLTEtMjY1MjQ3_db7cab97-e263-4a9b-a296-2985368ab33c"
      unitRef="usd">6009000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="idb014b08ea1a43c8bfc4d9fe2fe4cb7b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzItMy0xLTEtMjY1MjQ3_c9445336-9249-46fc-8d9b-50fc5cc70c2c"
      unitRef="usd">6462000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzQtMS0xLTEtMjY1MjQ3_33fcad75-fc5d-498d-8ce8-22ffb533641a"
      unitRef="usd">132000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzQtMy0xLTEtMjY1MjQ3_0afcfdb8-e7ff-4313-9f91-38f8da344229"
      unitRef="usd">110000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzUtMS0xLTEtMjY1MjQ3_6252189e-e73a-4f43-b480-10ad2111ee32"
      unitRef="usd">1011000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzUtMy0xLTEtMjY1MjQ3_b56de137-1ec1-46f8-975f-a159071fe582"
      unitRef="usd">102000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzYtMS0xLTEtMjY1MjQ3_0cc431a4-92a2-424a-9734-f8e932c2b308"
      unitRef="usd">387000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzYtMy0xLTEtMjY1MjQ3_2c35633e-8d99-4c86-ab42-ea3d3cf6283b"
      unitRef="usd">408000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement
      contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzctMS0xLTEtMjY1MjQ3_f600f3e7-1632-4369-830d-cb796d667045"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement>
    <us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement
      contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzctMy0xLTEtMjY1MjQ3_312108d4-2dd7-4ab0-8f5f-967a117c76b4"
      unitRef="usd">53000000</us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzctMy0xLTEtMjY1MjQ3_33027307-2ca2-4570-a210-d176e16a3626"
      unitRef="usd">53000000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzgtMS0xLTEtMjY1MjQ3_e0fa3905-eebd-4ab5-93f5-2695a2aefd55"
      unitRef="usd">4740000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i6ae60f8a88824bf889f05cc3b51730b3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzgtMy0xLTEtMjY1MjQ3_6b2e00d7-fc3c-4065-aeac-166207d43153"
      unitRef="usd">6009000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6ae60f8a88824bf889f05cc3b51730b3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzExLTEtMS0xLTI2NTI0Nw_d31dda76-fe10-43c3-9381-e2aa841c6b79"
      unitRef="usd">6677000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idb014b08ea1a43c8bfc4d9fe2fe4cb7b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzExLTMtMS0xLTI2NTI0Nw_809e8766-4590-474a-8cce-8cf0e7649e54"
      unitRef="usd">6845000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzEzLTEtMS0xLTI2NTI0Nw_42ef671b-13fa-4d64-82ff-3f504cdd67d1"
      unitRef="usd">-968000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzEzLTMtMS0xLTI2NTI0Nw_82fe206d-dc61-4f83-985b-d6f23a867a95"
      unitRef="usd">215000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzE0LTEtMS0xLTI2NTI0Nw_2871ed69-f457-4eaa-88fc-1352b72a751a"
      unitRef="usd">27000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzE0LTMtMS0xLTI2NTI0Nw_86882918-c0b0-4a1b-bc59-039f654e31cb"
      unitRef="usd">78000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzE1LTEtMS0xLTI2NTI0Nw_d3698ce0-6870-4782-9993-fb06e2a138a2"
      unitRef="usd">387000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzE1LTMtMS0xLTI2NTI0Nw_70033b54-0cc3-417b-834a-3f6b3780dd37"
      unitRef="usd">408000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzE2LTEtMS0xLTI2NTI0Nw_71a4dadd-4cc5-4d08-958c-0cc0fa9474f7"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement
      contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzE2LTMtMS0xLTI2NTI0Nw_312108d4-2dd7-4ab0-8f5f-967a117c76b4"
      unitRef="usd">53000000</us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzE2LTMtMS0xLTI2NTI0Nw_33027307-2ca2-4570-a210-d176e16a3626"
      unitRef="usd">53000000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzE3LTEtMS0xLTI2NTI0Nw_7567d22c-0f09-4db1-a689-5bbec313f86d"
      unitRef="usd">5346000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6ae60f8a88824bf889f05cc3b51730b3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzE3LTMtMS0xLTI2NTI0Nw_7f5e8700-9e2e-4cdb-b52a-bc5abcc1e0c5"
      unitRef="usd">6677000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzE5LTEtMS0xLTI2NTI0Nw_0f7d4085-bbb3-4ef8-8fda-1746eb5cf2da"
      unitRef="usd">606000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i6ae60f8a88824bf889f05cc3b51730b3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyZThjNDQ1MGU5N2M0OWZiODM1OWJjZWVlOTE0NmFkYi90YWJsZXJhbmdlOjJlOGM0NDUwZTk3YzQ5ZmI4MzU5YmNlZWU5MTQ2YWRiXzE5LTMtMS0xLTI2NTI0Nw_c06eb23b-1afb-4a52-b261-ae0d0b9998ad"
      unitRef="usd">668000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMzI4_f49e799a-3020-44ca-ba3b-a4ea57a2a5c8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assets (liabilities) recognized on the consolidated balance sheets at December&#160;31, 2022 and 2021 for the defined benefit pension plans consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets reflected in other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities reflected in accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities reflected in other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo3OGYzYzUwYzk1YjI0MmE1OWY2Y2FlZWMyOTMyNjkxZi90YWJsZXJhbmdlOjc4ZjNjNTBjOTViMjQyYTU5ZjZjYWVlYzI5MzI2OTFmXzEtMS0xLTEtMjY1MjQ3_e41a8eff-0386-4bc5-bfe5-7606d5edeb9c"
      unitRef="usd">827000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i6ae60f8a88824bf889f05cc3b51730b3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo3OGYzYzUwYzk1YjI0MmE1OWY2Y2FlZWMyOTMyNjkxZi90YWJsZXJhbmdlOjc4ZjNjNTBjOTViMjQyYTU5ZjZjYWVlYzI5MzI2OTFmXzEtMy0xLTEtMjY1MjQ3_f9efaead-b555-441c-b635-730486fc55df"
      unitRef="usd">946000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo3OGYzYzUwYzk1YjI0MmE1OWY2Y2FlZWMyOTMyNjkxZi90YWJsZXJhbmdlOjc4ZjNjNTBjOTViMjQyYTU5ZjZjYWVlYzI5MzI2OTFmXzItMS0xLTEtMjY1MjQ3_2926e26c-c812-42bc-87bd-fcb9abf60538"
      unitRef="usd">24000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i6ae60f8a88824bf889f05cc3b51730b3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo3OGYzYzUwYzk1YjI0MmE1OWY2Y2FlZWMyOTMyNjkxZi90YWJsZXJhbmdlOjc4ZjNjNTBjOTViMjQyYTU5ZjZjYWVlYzI5MzI2OTFmXzItMy0xLTEtMjY1MjQ3_10c4ed36-532a-438f-adc1-810de2ce34ca"
      unitRef="usd">28000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo3OGYzYzUwYzk1YjI0MmE1OWY2Y2FlZWMyOTMyNjkxZi90YWJsZXJhbmdlOjc4ZjNjNTBjOTViMjQyYTU5ZjZjYWVlYzI5MzI2OTFmXzMtMS0xLTEtMjY1MjQ3_12da545b-92f0-417e-b9be-42982df1c543"
      unitRef="usd">197000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i6ae60f8a88824bf889f05cc3b51730b3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo3OGYzYzUwYzk1YjI0MmE1OWY2Y2FlZWMyOTMyNjkxZi90YWJsZXJhbmdlOjc4ZjNjNTBjOTViMjQyYTU5ZjZjYWVlYzI5MzI2OTFmXzMtMy0xLTEtMjY1MjQ3_233817cc-ac24-41e0-a385-384c27799541"
      unitRef="usd">250000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo3OGYzYzUwYzk1YjI0MmE1OWY2Y2FlZWMyOTMyNjkxZi90YWJsZXJhbmdlOjc4ZjNjNTBjOTViMjQyYTU5ZjZjYWVlYzI5MzI2OTFmXzQtMS0xLTEtMjY1MjQ3_77385d0c-0494-4a62-9fd3-6db79e6c0465"
      unitRef="usd">606000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i6ae60f8a88824bf889f05cc3b51730b3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo3OGYzYzUwYzk1YjI0MmE1OWY2Y2FlZWMyOTMyNjkxZi90YWJsZXJhbmdlOjc4ZjNjNTBjOTViMjQyYTU5ZjZjYWVlYzI5MzI2OTFmXzQtMy0xLTEtMjY1MjQ3_c341e892-4a03-445d-9206-59d1640aeda4"
      unitRef="usd">668000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMzI5_6826b17b-570b-4b9d-b1ce-6d4c40c0792b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of net periodic benefit cost (income) for the years ended December&#160;31, 2022, 2021 and 2020 are shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Components of net periodic benefit cost (income):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(309)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost (income)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzItMS0xLTEtMjY1MjQ3_82cab2de-bcda-4080-b9e0-c67ccdb1801e"
      unitRef="usd">132000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzItMy0xLTEtMjY1MjQ3_daac5459-c3bf-4337-9765-5256cad72e35"
      unitRef="usd">110000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="idf18a7ebe0824b4c9cc0c9a8db021e64_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzItNS0xLTEtMjY1MjQ3_8a085ed1-b089-49b0-b1bd-611eea8bbe3f"
      unitRef="usd">168000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzMtMS0xLTEtMjY1MjQ3_f4c599b6-247c-4c86-97eb-d4b9ba8df27c"
      unitRef="usd">309000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzMtMy0xLTEtMjY1MjQ3_a7bd3cb6-f498-4241-8318-de82d5bd6aba"
      unitRef="usd">317000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="idf18a7ebe0824b4c9cc0c9a8db021e64_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzMtNS0xLTEtMjY1MjQ3_6bf2944a-67ef-451f-8da1-c6d8441b0ce0"
      unitRef="usd">388000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzQtMS0xLTEtMjY1MjQ3_fdb0aa84-8b35-456d-a3e4-ed6d9f83e1bf"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzQtMy0xLTEtMjY1MjQ3_212aa6d8-1316-4f22-b083-35db13517407"
      unitRef="usd">-5000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="idf18a7ebe0824b4c9cc0c9a8db021e64_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzQtNS0xLTEtMjY1MjQ3_2b3c3cf4-b890-4ebe-8a99-39612c3ef92d"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzUtMS0xLTEtMjY1MjQ3_3f7dc3b9-70f2-4958-88b6-e6a1c7408c6b"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzUtMy0xLTEtMjY1MjQ3_12aa0658-0400-44d2-be7d-e8b4cd64f747"
      unitRef="usd">-16000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="idf18a7ebe0824b4c9cc0c9a8db021e64_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzUtNS0xLTEtMjY1MjQ3_463f5777-399f-468e-8a05-c73d214d3a36"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzYtMS0xLTEtMjY1MjQ3_122ba9b1-01bf-45f4-80c6-613bd14ee2e0"
      unitRef="usd">-173000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzYtMy0xLTEtMjY1MjQ3_cfebd8cf-718d-4913-b62e-8b8d1fffd76b"
      unitRef="usd">-186000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="idf18a7ebe0824b4c9cc0c9a8db021e64_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTowOGY3ZmJiNWVhZTY0MzdmOGFjM2QwNWIyZmM3MTc4YS90YWJsZXJhbmdlOjA4ZjdmYmI1ZWFlNjQzN2Y4YWMzZDA1YjJmYzcxNzhhXzYtNS0xLTEtMjY1MjQ3_ec2bbbb6-c898-47f8-a5ba-80e14d02343a"
      unitRef="usd">-218000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMzE3_b2a0f9be-0e7b-4c27-9390-5050613fce4b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined its benefit obligation based on the following weighted average assumptions as of December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined its net periodic benefit cost (income) based on the following weighted average assumptions for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term rate of return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToxYjM4ODdhZTgwNTA0YmFiYjYxNmI0MWNlMWU0NTQ2YS90YWJsZXJhbmdlOjFiMzg4N2FlODA1MDRiYWJiNjE2YjQxY2UxZTQ1NDZhXzEtMS0xLTEtMjY1MjQ3_5da625d3-16c7-47ac-99f8-bce39bdcece7"
      unitRef="number">0.052</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToxYjM4ODdhZTgwNTA0YmFiYjYxNmI0MWNlMWU0NTQ2YS90YWJsZXJhbmdlOjFiMzg4N2FlODA1MDRiYWJiNjE2YjQxY2UxZTQ1NDZhXzEtMy0xLTEtMjY1MjQ3_88d9042f-55ce-4ca0-ae41-e1f8172bcdef"
      unitRef="number">0.028</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTphOWU1ZmEwNDA2OWM0OGY0OGRjNTM0NzA5YjU5NmVkZC90YWJsZXJhbmdlOmE5ZTVmYTA0MDY5YzQ4ZjQ4ZGM1MzQ3MDliNTk2ZWRkXzEtMS0xLTEtMjY1MjQ3_4a9ca28c-803d-481a-bc06-db622f463ef8"
      unitRef="number">0.023</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTphOWU1ZmEwNDA2OWM0OGY0OGRjNTM0NzA5YjU5NmVkZC90YWJsZXJhbmdlOmE5ZTVmYTA0MDY5YzQ4ZjQ4ZGM1MzQ3MDliNTk2ZWRkXzEtMy0xLTEtMjY1MjQ3_38442119-3c66-4d90-a0b3-33f3d0ef5809"
      unitRef="number">0.018</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTphOWU1ZmEwNDA2OWM0OGY0OGRjNTM0NzA5YjU5NmVkZC90YWJsZXJhbmdlOmE5ZTVmYTA0MDY5YzQ4ZjQ4ZGM1MzQ3MDliNTk2ZWRkXzEtNS0xLTEtMjY1MjQ3_b9551766-53c8-48a4-8d67-647643fcf9e8"
      unitRef="number">0.029</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTphOWU1ZmEwNDA2OWM0OGY0OGRjNTM0NzA5YjU5NmVkZC90YWJsZXJhbmdlOmE5ZTVmYTA0MDY5YzQ4ZjQ4ZGM1MzQ3MDliNTk2ZWRkXzItMS0xLTEtMjY1MjQ3_070befaf-b26f-49c6-bac7-a45f0da6f76a"
      unitRef="number">0.048</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTphOWU1ZmEwNDA2OWM0OGY0OGRjNTM0NzA5YjU5NmVkZC90YWJsZXJhbmdlOmE5ZTVmYTA0MDY5YzQ4ZjQ4ZGM1MzQ3MDliNTk2ZWRkXzItMy0xLTEtMjY1MjQ3_079f237b-2d93-4ea0-9c8a-2be3fce57e03"
      unitRef="number">0.048</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTphOWU1ZmEwNDA2OWM0OGY0OGRjNTM0NzA5YjU5NmVkZC90YWJsZXJhbmdlOmE5ZTVmYTA0MDY5YzQ4ZjQ4ZGM1MzQ3MDliNTk2ZWRkXzItNS0xLTEtMjY1MjQ3_67233d17-7a42-4d8b-b640-227d87ef4c70"
      unitRef="number">0.063</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMzEy_dc7b69bd-cbfb-4b90-b242-2f985ee252c4">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2022 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Domestic real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Common/collective trusts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total pension investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The assets in the underlying funds of common/collective trusts consist of $104 million of equity securities and $203 million of debt securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $390 million of other receivables as well as $432 million of private equity limited partnership investments and $225 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2021 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Domestic real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Common/collective trusts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total pension investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The assets in the underlying funds of common/collective trusts consist of $261 million of equity securities and $149 million of debt securities. &lt;/span&gt;&lt;/div&gt;(2)Excludes $76 million of other receivables as well as $583 million of private equity limited partnership investments and $237 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy.</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib1c28ec013bc4526b9794acd9746c77a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEtMS0xLTEtMjY1MjQ3_964ad5e7-d54e-44d1-bbf6-ad9ed1371d10"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i76a4faa3d2d7408ba85519e8aa053ec1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEtMy0xLTEtMjY1MjQ3_3487f981-3f8b-435d-a292-8774f519f4b9"
      unitRef="usd">81000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib6f2f249637c4a7b939be9fe6d0553f0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEtNS0xLTEtMjY1MjQ3_b2712e86-48d8-4854-a16e-1c5d6f852ca5"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i15f18808419f492daac9928c78dfe207_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEtNy0xLTEtMjY1MjQ3_1fa55897-136d-4aee-99c2-73b37c00de5c"
      unitRef="usd">88000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5165fa288fc140b58b3e2eb13b880dad_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzMtMS0xLTEtMjY1MjQ3_afabab94-e261-45db-a265-8c2ab76e5fcc"
      unitRef="usd">566000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i437030cc5ae74594bd99c673acc0141d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzMtMy0xLTEtMjY1MjQ3_811e2a0a-68d2-4238-ba11-35ce9d0af81f"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9f1345bbf71048cab8ec53160a98d6e0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzMtNS0xLTEtMjY1MjQ3_f587f1bd-d6a0-4495-9116-715f6e34dcc1"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iafecfb17bf3847a289eb418831589dd0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzMtNy0xLTEtMjY1MjQ3_1e0885e1-d1a1-4558-8bab-eaa297f45f9b"
      unitRef="usd">570000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i393269929aa54f8d841281c28c513489_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzQtMS0xLTEtMjY1MjQ3_a176d079-a6e1-431c-a19a-91aab996e9dd"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i71ffeabd45b047f7aa8093796c73ce64_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzQtMy0xLTEtMjY1MjQ3_46ba3a6e-6f4e-42ac-b367-1026dbcabf7b"
      unitRef="usd">102000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i19f2f4c671e34716acf9fd0f2b572d66_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzQtNS0xLTEtMjY1MjQ3_c3b76664-d75a-4275-be9f-979e3921192b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i102010332f0b40f2a4057d6bf03e8a1f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzQtNy0xLTEtMjY1MjQ3_938dfac4-c806-4e08-86c8-89d46868959f"
      unitRef="usd">102000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie97efbadc22e498ab09fa57a7f7a0ece_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzUtMS0xLTEtMjY1MjQ3_50d31d11-baa5-4a64-82a8-37705bdf8fc7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ide1653ba45f64f029e277348c07102cf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzUtMy0xLTEtMjY1MjQ3_02e39bc2-f7e5-4a40-9627-b0911f4cf80b"
      unitRef="usd">2611000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib74558535ca347569c43f5b77d45f6c5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzUtNS0xLTEtMjY1MjQ3_c8ba22b7-5439-492e-89c2-24f7b6297029"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic3055783102048978188614bf9c92f67_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzUtNy0xLTEtMjY1MjQ3_b3873178-e992-4508-8bba-996136ef2357"
      unitRef="usd">2611000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9f0b29ec64ee405b9f397e174b416349_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzYtMS0xLTEtMjY1MjQ3_2eac9705-645f-4576-a056-10df957b1fe2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8f22f16c5656496881261f222143a65c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzYtMy0xLTEtMjY1MjQ3_4b470237-cde9-49da-b9a4-8bd758eaae66"
      unitRef="usd">101000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i80aed82dcefc4d2c8a1b6d1666a62cc5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzYtNS0xLTEtMjY1MjQ3_5c6a9e26-ba22-44a0-8f67-6ebc61ab7161"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idecaa5de548e46198a7835338a65cfc9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzYtNy0xLTEtMjY1MjQ3_91930c64-4b3d-43a3-a1de-10f2d079c7de"
      unitRef="usd">101000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifb3e587df0ce4e58832ac7d14ef31287_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzctMS0xLTEtMjY1MjQ3_4e2ad15c-96ba-4f86-9965-37a00d048872"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i81a129fd9ac642898dfe6c3dbf7c13d3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzctMy0xLTEtMjY1MjQ3_4e42f791-448f-45f0-8056-f5d29b55666c"
      unitRef="usd">6000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i07cf02d634944cfe8dec224d5af50138_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzctNS0xLTEtMjY1MjQ3_63124268-284e-45e9-a940-92c0b29ee22e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icedecd6a5d6c4cd6932eb56e5297820a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzctNy0xLTEtMjY1MjQ3_d65e7e7d-ad1c-4934-b80a-dad6995cb280"
      unitRef="usd">6000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i67ed1aa4b0994e08a75a11aabef0ca61_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzgtMS0xLTEtMjY1MjQ3_3b449831-a27c-4e8e-9a1d-fd8f86169efb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2d4ba1b4e5fd46a59de47cb57daebd43_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzgtMy0xLTEtMjY1MjQ3_ac08ab17-adc0-434a-b1ce-33764e175058"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i53d2e727f536476fb8cadfd6668d3f36_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzgtNS0xLTEtMjY1MjQ3_a01ab5e9-49eb-4fbc-ba81-ec0c07a19bb0"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if42d8de426004e0aa3dd6333ac3a65bd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzgtNy0xLTEtMjY1MjQ3_8d20b6cd-19a9-4425-a5ca-402d0cc8bc17"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i06bd54c2ec1749b6bfe532accaddeb19_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzktMS0xLTEtMjY1MjQ3_08fc3d2b-64c6-49b3-aa8c-ab0ab287d838"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i15075758aefe43d2bf31d3cc52dcb868_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzktMy0xLTEtMjY1MjQ3_c7178d9d-4074-418a-ad4e-1d0c9c8773f5"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i75cf4995d769495181bc451a1291d416_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzktNS0xLTEtMjY1MjQ3_03a3bef4-c323-4f7c-a299-586b2d07d7eb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6964724f64da443a8d85ef14ba9b207f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzktNy0xLTEtMjY1MjQ3_d0f8b758-d9a9-40e4-af81-3ee388a5b8e1"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibc8d04d5adea4cc4950dd1f1163a8c24_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEwLTEtMS0xLTI2NTI0Nw_4facc99c-13e1-4656-968a-713f5d47a821"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i467dc11c176c49a494b2bfbc4ecd8d40_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEwLTMtMS0xLTI2NTI0Nw_641e5425-960f-4e6a-8260-ec33b094fbdb"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4561999a767a47c9b145429b6871dada_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEwLTUtMS0xLTI2NTI0Nw_9fd45178-053b-4ad1-ab63-5115c7554c99"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i49acfce007b84f6a8ed646d3879a295e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEwLTctMS0xLTI2NTI0Nw_d1b38e6b-9c8a-4402-8328-57892f518f86"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i47f6d39a48124eada9253e73f5eb298d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzExLTEtMS0xLTI2NTI0Nw_f59f51fe-7f20-4e41-b635-783bf73a99fa"
      unitRef="usd">566000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i425da7be65a34eadaf6d0d7d246f41ac_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzExLTMtMS0xLTI2NTI0Nw_f7272b80-a1a6-4fe5-97a2-5c1c00cefbaf"
      unitRef="usd">2837000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6dea2df573724790a05410f34ffcaa89_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzExLTUtMS0xLTI2NTI0Nw_0c0c109c-c5f0-4ec2-9a9e-d3e45e2b295f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iaceec8e969924b699be4f035e5a5f056_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzExLTctMS0xLTI2NTI0Nw_0f4708ae-e7d3-45e8-a268-df7445a3bc55"
      unitRef="usd">3403000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if4bcbef4b6154d14993eefedb06e445c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEzLTEtMS0xLTI2NTI0Nw_4a7afb81-8dc3-4ffa-9621-f3912ff25da9"
      unitRef="usd">133000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1d3a7dadc46046679f4259f0c2cf607b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEzLTMtMS0xLTI2NTI0Nw_efbeaf0e-dd8e-4358-94eb-f135cc7b1608"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3bb67485d5704379b1a6d4da590cf813_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEzLTUtMS0xLTI2NTI0Nw_c1eae762-1dcd-4d74-a886-6f98ebec3ec5"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i25c01da9448541d9a4bbe6f5bf974426_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzEzLTctMS0xLTI2NTI0Nw_9ddb3527-8b22-4690-ae7f-7000b40251a7"
      unitRef="usd">133000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icff5a9de270b47439f9f2e3164cdbaf1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE0LTEtMS0xLTI2NTI0Nw_d50caba2-fe48-476f-9993-7ca8653c032b"
      unitRef="usd">43000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idce9aa4064f649998284ca968ead9aeb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE0LTMtMS0xLTI2NTI0Nw_c052b888-5ad1-4f21-a8ec-38dffed62ec2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id88dc572d4a4463a87db8a149bc97af6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE0LTUtMS0xLTI2NTI0Nw_29d01f3f-aafb-42dc-9303-eea6117779ad"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia48873c4be084823ac547c96b29588bf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE0LTctMS0xLTI2NTI0Nw_e7de78bf-4c9c-4c41-9be8-cfb20147bcb2"
      unitRef="usd">43000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i361bca717f0145f392b30b6c5842a5fb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE1LTEtMS0xLTI2NTI0Nw_7d3b83e4-2962-4230-b50b-81c9834be427"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ieb37318a487b4f68b2cff4e55df4fae8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE1LTMtMS0xLTI2NTI0Nw_76271def-0a67-4f10-b8f5-9924d2743276"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i458d0bce582548dabb9da928f9be1723_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE1LTUtMS0xLTI2NTI0Nw_1dd17caa-0073-4b18-9437-e57dc7eba110"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2f36bf1575754528b65dba20e88e4417_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE1LTctMS0xLTI2NTI0Nw_4666acbc-d8d2-4064-8904-e46a2e1efe30"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i34cb265be9104204aa213bd1c51fcdbb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE2LTEtMS0xLTI2NTI0Nw_6637990e-0360-4da5-9b43-f7d3e1e8eb15"
      unitRef="usd">176000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i859f79ed7f81424ea30511713f0e5fd7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE2LTMtMS0xLTI2NTI0Nw_6c367825-3787-42d0-819c-18e775ec498d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icd55208234184797b8bc48b1ab33f4f2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE2LTUtMS0xLTI2NTI0Nw_c6774677-08e0-4f00-8c50-bee1d4ab1c3e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i047b2e5d175948e28dc1326800198805_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE2LTctMS0xLTI2NTI0Nw_b3b7bc6b-f966-4068-a67a-541b0e40f4fd"
      unitRef="usd">176000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3a9722f65b7649a0af5a40118df4c83a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE4LTEtMS0xLTI2NTI0Nw_eb480895-16ba-44f3-98e6-4ed3ae9ad7d9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0fb1ff4cb6bd4a5f987eb066e1579632_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE4LTMtMS0xLTI2NTI0Nw_f77bd6e4-7dce-4f12-b020-1193b822d13b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3d10279e4e4240e58c58b67195918c98_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE4LTUtMS0xLTI2NTI0Nw_a3d77751-f5b9-4664-9119-2308a60d5004"
      unitRef="usd">325000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icdeaeb4835884f6087e9025f4a721a0e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE4LTctMS0xLTI2NTI0Nw_3a31aeb8-eda1-4438-82d3-b838792fc0f5"
      unitRef="usd">325000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic03a2021968d469cafd277b1d48aeec0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE5LTEtMS0xLTI2NTI0Nw_3f3aab9a-73ce-468d-8fd3-3d02b11857de"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4e96192e9c994cc3a7cd9d3198afec11_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE5LTMtMS0xLTI2NTI0Nw_1b0bfb3f-776c-441c-a37b-7c9b972c9c93"
      unitRef="usd">307000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1b84bbaf70a647149bd4230fec93c00e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE5LTUtMS0xLTI2NTI0Nw_75d68c45-fc31-4365-9843-653932397f4c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i434d9033c59345d994a83769698d5f43_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzE5LTctMS0xLTI2NTI0Nw_64f74771-7afa-4a7c-90c3-7fbc80c5622d"
      unitRef="usd">307000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8553b3aff6d249b18a9cd384b6c1a55b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzIxLTEtMS0xLTI2NTI0Nw_057c061a-8a27-4892-bc42-301e6fdd511d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i82cdd943a4d64fa6817835bd3971c780_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzIxLTMtMS0xLTI2NTI0Nw_4f89eee2-24e2-46bf-8e06-37d8742cc3f1"
      unitRef="usd">307000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i293cf1a1995d4e29b26bc330b1666507_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzIxLTUtMS0xLTI2NTI0Nw_3b0aa5bb-8d42-4459-9b19-6a00b1b7ed3b"
      unitRef="usd">325000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6ceb26b60fcb4903b42e2e7063f9ec62_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzIxLTctMS0xLTI2NTI0Nw_4eefb0cb-22a4-4078-83d6-963d22600e4e"
      unitRef="usd">632000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1b1cda680d3d4f8696d51e3ed6642658_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzIyLTEtMS0xLTI2NTI0Nw_153c7f8e-5529-4e32-8aeb-1b0025a33126"
      unitRef="usd">749000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i10542d46becc44c5967969f7f85f3589_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzIyLTMtMS0xLTI2NTI0Nw_4fed6903-a7dd-4128-8ee7-f991f2f4d43c"
      unitRef="usd">3225000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i292b96aad4ec49cdbd305facd2f76542_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzIyLTUtMS0xLTI2NTI0Nw_d8d999c4-ac6e-4751-9aca-9978fd6c7ec3"
      unitRef="usd">325000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5f6a83783837419fbce160a80bfc2d32_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmMGM0MzM3ODkzMDk0NjEyYmM1MWI3MzdlNjUzZDdkZC90YWJsZXJhbmdlOmYwYzQzMzc4OTMwOTQ2MTJiYzUxYjczN2U2NTNkN2RkXzIyLTctMS0xLTI2NTI0Nw_fd870022-4dd9-4be4-8f24-b2ed3f4418a2"
      unitRef="usd">4299000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount
      contextRef="ie6ba387bd5784b3588f79042c1627c7c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzUyNTc_e7271f09-a965-46c0-8dcf-591b86e78eb9"
      unitRef="usd">104000000</us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount>
    <us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount
      contextRef="i7b3fb67b13b4433fb27cf39843018e90_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzUyODU_0fe4a312-240f-4624-a5ba-3570f7a5cea4"
      unitRef="usd">203000000</us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1ba4905b6b0747a79b11529e76f3525a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzUzMTg_b5036d2a-dded-4240-a958-9c477c70bdc2"
      unitRef="usd">390000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id34b6ff6eb5d4ff8b7d64f102c051a4f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzUzNTM_32eea42e-bd9d-4709-8f4e-868297d98e32"
      unitRef="usd">432000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2f8b8e5367b4480ea7d27890901e6247_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzU0MTA_71f6cb4a-0d3a-4753-8e4d-6d43e2f14b2e"
      unitRef="usd">225000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2483b2d9ed46464386b90249127712ec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEtMS0xLTEtMjY1MjQ3_c10fb62e-d0e4-4269-b377-31fa4032c355"
      unitRef="usd">60000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5a89dc1177b443eebe04b19998c03509_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEtMy0xLTEtMjY1MjQ3_9d078728-4559-4044-b957-4bf970c59fb3"
      unitRef="usd">97000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibf9ceb18ea574327a935ba6e88f2287e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEtNS0xLTEtMjY1MjQ3_cce9ecc9-c3da-4a14-8a15-5c6a395d8bf3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie38b76b68c8f4324b3b7de80321c3a38_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEtNy0xLTEtMjY1MjQ3_7bb4cd7c-7c64-4eea-8943-328c1699ad9b"
      unitRef="usd">157000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib4c7e5e536ab42b8b050fbde07b7944b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzMtMS0xLTEtMjY1MjQ3_80038c60-1e5b-42b1-937c-8526cd2c04c5"
      unitRef="usd">1223000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib321cf5df709449c9ceca7c03a1a464a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzMtMy0xLTEtMjY1MjQ3_4243e7fb-13e1-4eb9-b57f-18a39a77dab3"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie5115a8b317f4f088dd39cf66bd37168_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzMtNS0xLTEtMjY1MjQ3_8344a1cc-7b89-4e6e-924e-83f8fffe464e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia7ca09ccbe954fe782f927e64956c241_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzMtNy0xLTEtMjY1MjQ3_c1bade75-bb2a-4419-84e7-3e94b1c003ba"
      unitRef="usd">1224000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia6de203a7cbb4d628006e35c743071f4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzQtMS0xLTEtMjY1MjQ3_d1c2db29-1208-4678-b271-8bd3be8f90af"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibe3ca3dba18c491a9e22b5dec78052d1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzQtMy0xLTEtMjY1MjQ3_cc8b2e23-25bd-42e0-a2b8-a1fe474dd00c"
      unitRef="usd">150000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4f8b8023230e41f1a277473b8be2f39c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzQtNS0xLTEtMjY1MjQ3_36c7ffa8-7ce8-4244-b750-4189304aaab3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iaac68e1f017c44aa9dd4c8012dbc3c27_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzQtNy0xLTEtMjY1MjQ3_f9f850b7-b277-47cf-9a29-d99d39720f98"
      unitRef="usd">150000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i422a5afe8aab4de28a6a361f067c59ff_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzUtMS0xLTEtMjY1MjQ3_621b2a20-3953-4871-8996-61054942eafc"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i55f94c0a8c604d198a8060e3981590d2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzUtMy0xLTEtMjY1MjQ3_4b1e2477-8396-422a-8893-6f07283ed42f"
      unitRef="usd">2458000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3f4a9f967aaa4491ac8ac4bb55abdd08_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzUtNS0xLTEtMjY1MjQ3_443916d4-180b-43b0-a44b-8a56039d72a9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4c682f38539f4aea97612b5c8fd96801_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzUtNy0xLTEtMjY1MjQ3_1e42208b-3a49-4af6-8075-11d292c96cf8"
      unitRef="usd">2458000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iad6319eb9e074402bd329fc00b71a0d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzYtMS0xLTEtMjY1MjQ3_52e8a6f2-5a0d-4921-a94c-69930a632a1b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i225a548f115e4e4cbc128578264d598f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzYtMy0xLTEtMjY1MjQ3_6f68e7a1-48dc-41db-a7c5-61dc67fb8c21"
      unitRef="usd">202000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1b7f7de16d6f455b9b95fe42c0e7ddf4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzYtNS0xLTEtMjY1MjQ3_5f9df607-d311-4abb-a581-f5926769edc4"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic622298e7e1042bab9e914624480e3f3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzYtNy0xLTEtMjY1MjQ3_668aa60c-e11f-4afc-b5e2-ea8ebfef142c"
      unitRef="usd">202000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ice305fd722c144a8a3962bcd2d78808d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzctMS0xLTEtMjY1MjQ3_65bc78f9-1525-498f-b4ad-96dd3594b964"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic6fff6d946ac4c55bcd073422901fa74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzctMy0xLTEtMjY1MjQ3_0b7209f3-f7e8-49ba-b956-0df6d1133739"
      unitRef="usd">277000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idec237e4913a4141abffa54109b01c5b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzctNS0xLTEtMjY1MjQ3_16cbf4c3-020a-4e5d-921b-98b34d411ec0"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i424cf2f1fe794bf8b9685e626e4b60eb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzctNy0xLTEtMjY1MjQ3_5d7ba3de-034b-46d5-832f-5459b6efcb7e"
      unitRef="usd">277000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i92dad2a6cdd147b4a4bab53cde589c29_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzgtMS0xLTEtMjY1MjQ3_6128fcff-93d0-41ae-8052-27804172f24b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i841e9a2db5bb4870b1acecc87843ca11_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzgtMy0xLTEtMjY1MjQ3_c153db2e-65e3-488a-89b4-35c3b35d1a8e"
      unitRef="usd">76000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i323adde47a404de6a429ebcdc6d4a624_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzgtNS0xLTEtMjY1MjQ3_772204c9-e03f-452e-bf0c-a76a0d638d9b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i66bfc1b58bee484ca8439711f02fc588_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzgtNy0xLTEtMjY1MjQ3_2e0a3c02-f898-4672-8a1a-18cdf82c005b"
      unitRef="usd">76000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6febefab642d465386af8f7ad424e1d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzktMS0xLTEtMjY1MjQ3_5be4ad14-a676-48a1-8fd1-f2fc40717eae"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia8b7ecb5ef6b4772b3207c0af0378129_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzktMy0xLTEtMjY1MjQ3_377c6a8a-d9fa-40da-8395-f3ceda3b4715"
      unitRef="usd">162000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5d7062cfce4d47d4950a86d0fe1a51be_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzktNS0xLTEtMjY1MjQ3_3f772f61-9d20-421b-ab25-462ac6f85a6d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icc0351d4a2c042f8ad934772134cdbd5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzktNy0xLTEtMjY1MjQ3_b60f35d7-3bbc-4884-9ccb-6ed9a50b8a35"
      unitRef="usd">162000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i588df02460dd45ebac24745a67831e0b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEwLTEtMS0xLTI2NTI0Nw_32a9bd21-b6a6-436b-992a-78d9a2a0f35d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iaa15814eab354d1da0577719608c58a7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEwLTMtMS0xLTI2NTI0Nw_79c30ec9-982e-440c-b25d-285cce382917"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie93d0f38ac78460a8408e52712b8a9e0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEwLTUtMS0xLTI2NTI0Nw_9d508c4c-0b6b-4899-9e11-00cf50d25efb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i62058f08b95b41b29a2bd7105c86068a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEwLTctMS0xLTI2NTI0Nw_cd9ca3dc-254e-4429-921a-e81ede428c23"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib0978cb2beb54ca08a64c48351e6340d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzExLTEtMS0xLTI2NTI0Nw_ef4c437e-82be-4609-96bb-60354c0e1989"
      unitRef="usd">1223000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9283234f91734e7f8067245dffa66546_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzExLTMtMS0xLTI2NTI0Nw_5475d582-e3e2-4152-82d9-b4bceb9ea0e7"
      unitRef="usd">3330000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4a65013be1484144aa7390d6ce8685f1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzExLTUtMS0xLTI2NTI0Nw_f8d818e7-90d0-4807-ad92-f3dc7c8516b7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0dd96e63a05b477c81a74ccccae0af1a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzExLTctMS0xLTI2NTI0Nw_cda26cdc-88bb-49fe-a66a-3ea2a9bb8669"
      unitRef="usd">4553000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7d58e5df6a4d4dc2b2d2020abf96dab7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEzLTEtMS0xLTI2NTI0Nw_57a55a8d-3de7-4360-aa77-5152d2a6a2d3"
      unitRef="usd">201000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i30951550eb89447faeb8aed509f96d7a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEzLTMtMS0xLTI2NTI0Nw_c8afafd4-979f-4abd-a2ff-33f6e1c69e17"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib5e498c9e0e949d295170b34d02f42b1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEzLTUtMS0xLTI2NTI0Nw_e4361128-b4c7-4126-80d9-8d94a6b4449d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iecf6ed88f0704ea1b5a17c05fba15357_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzEzLTctMS0xLTI2NTI0Nw_6e090a28-0bf6-4636-b8c2-8e1f11e85371"
      unitRef="usd">201000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie5a4161ee999468695164764689d0456_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE0LTEtMS0xLTI2NTI0Nw_d3de1d0d-a36d-483d-93f7-1cb3e8082f63"
      unitRef="usd">81000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4b5516f1d83549df8e3672acb28d4018_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE0LTMtMS0xLTI2NTI0Nw_249a566d-b695-413c-a240-6d86875ffbe9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i57859501e60645cb9752e9e1f0aaca52_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE0LTUtMS0xLTI2NTI0Nw_d8ff98bb-b6d2-44ea-8d3a-fd15d1265a83"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4691f1cc92b841bebd9eb3e713080db4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE0LTctMS0xLTI2NTI0Nw_d028722f-f105-482b-8d8b-b8325bb6dc07"
      unitRef="usd">81000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if380f772d15949968faea35f6c392908_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE1LTEtMS0xLTI2NTI0Nw_358422c7-d1d5-4900-8b91-91637b65da13"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9a39f01aeb134cdc96203f9fb9113b29_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE1LTMtMS0xLTI2NTI0Nw_124ba9f6-5b92-4dc2-82b7-6cb561708883"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib12ac2d182de47eabc00a82a798699f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE1LTUtMS0xLTI2NTI0Nw_c192a536-d0b7-4655-ab61-331886832f33"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia432ea4fe3664eda9ea74cb9f5d6541e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE1LTctMS0xLTI2NTI0Nw_af4fa547-9a8a-4c5a-98bc-8de517335d52"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id85fcc73165340dca7de806a6adfdfbd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE2LTEtMS0xLTI2NTI0Nw_83b4bd6f-d753-4559-9397-f90e6568b603"
      unitRef="usd">283000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i06c3b035437e4295b67d73728537c87e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE2LTMtMS0xLTI2NTI0Nw_340b6dbd-29ef-4b46-b012-f7364cced0fd"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7760d59224714c619f74107d44fec8a9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE2LTUtMS0xLTI2NTI0Nw_cba0d5e9-b417-4635-9ab1-41e4c4b41de3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9b273fdc1bd847ed8bc54eda0343fb49_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE2LTctMS0xLTI2NTI0Nw_b586b9bb-ba0e-4950-b4e0-cd50d07fd617"
      unitRef="usd">283000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1f27f3a0ddaa4943a0a01af080cffc48_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE4LTEtMS0xLTI2NTI0Nw_e71fa8ad-d500-403d-a27b-6dc8fc74a3c8"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9c0c1b4aba8442ebb3315909595081fb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE4LTMtMS0xLTI2NTI0Nw_c51fce36-cbb0-42fc-ae36-6e23998dea72"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i606a32f530d0485e9489b153aae2186a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE4LTUtMS0xLTI2NTI0Nw_ff137889-4bbe-4dbe-821a-c8e7117cc388"
      unitRef="usd">378000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ied58211431b74500ad5aa97b2eb41a6b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE4LTctMS0xLTI2NTI0Nw_907b8d64-435f-4cf5-a8b4-8437430b9cef"
      unitRef="usd">378000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i626787e8dd8a4a428e915960b4c68a35_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE5LTEtMS0xLTI2NTI0Nw_ba6a3807-bbe0-413c-a76e-5da151e77523"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4ffe6c35b7494418ac8c422fd3541f2b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE5LTMtMS0xLTI2NTI0Nw_42318a78-7225-4821-bd2a-d8ffc9b19ae1"
      unitRef="usd">410000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i63c0c51144c74ed59e090814aedeff5e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE5LTUtMS0xLTI2NTI0Nw_54b8c3f5-de60-4783-8901-6bd3bf380b70"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i63529787efd54319893b4e048ab45752_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzE5LTctMS0xLTI2NTI0Nw_1cd00c85-5082-4814-9410-f96a2264b088"
      unitRef="usd">410000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic094ef4183de49abb0d6149a76f6e4e4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzIxLTEtMS0xLTI2NTI0Nw_d9738cbd-0f99-461b-ba69-c54c3fecc25a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i72861e7450344b1abe5a17aa6d5da491_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzIxLTMtMS0xLTI2NTI0Nw_ddc0676d-aa66-4da2-b1ec-65b09fd55c40"
      unitRef="usd">410000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2fb5d20c5bdd4e3c88101cecdc5afb9b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzIxLTUtMS0xLTI2NTI0Nw_e07221c3-611a-45bd-8b8c-b9f803c72fc2"
      unitRef="usd">378000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i391c77fcea114168adcefd3a368e933a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzIxLTctMS0xLTI2NTI0Nw_855393ae-3dd9-47d6-bd93-5d909fc96ea5"
      unitRef="usd">788000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8291bfbd551444d08280efa65d088b0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzIyLTEtMS0xLTI2NTI0Nw_d6d6198d-de0b-4623-a894-1cf8c4146e59"
      unitRef="usd">1566000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i16285192a2914c1f825e830eeb4eeb4f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzIyLTMtMS0xLTI2NTI0Nw_85893026-d281-4908-bb07-a189da6b5788"
      unitRef="usd">3837000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9d3917a82295412f9c9275a317a05f05_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzIyLTUtMS0xLTI2NTI0Nw_57e2e3e3-4b05-4f2d-b598-d99c235388af"
      unitRef="usd">378000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idfd78e27e7c6482c9fc4edcc25879cfc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZToyNGUwMTk0N2VhZGM0MjNlODU1YjI4ZGVjOTA2YTExZC90YWJsZXJhbmdlOjI0ZTAxOTQ3ZWFkYzQyM2U4NTViMjhkZWM5MDZhMTFkXzIyLTctMS0xLTI2NTI0Nw_e34b01ff-e8ee-44e7-974d-af2b0222f661"
      unitRef="usd">5781000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount
      contextRef="ief0525a09e3740098895f800adaf9574_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzU4MTM_59c54be4-75e2-4fdc-83c6-bdc897ff2c8b"
      unitRef="usd">261000000</us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount>
    <us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount
      contextRef="ib3fd8796636345479f329fc227aac5b9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzU4NDE_d7b3a188-d441-4585-b037-f45f9c1feb4f"
      unitRef="usd">149000000</us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id74fa3142e884619b01040d54d501710_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzU4NzQ_0b184a9f-a99c-4c51-8940-a1251d0d6a2b"
      unitRef="usd">76000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icc02cf1426314af28563a5e9e8a9a5e1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzU5MDk_93cc5b50-ec13-406e-b99e-0c8776437cf7"
      unitRef="usd">583000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2cdf7726148d4d678b6d37597a2aac70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzU5NjY_64491baa-e4f9-4325-8af1-c30630434efe"
      unitRef="usd">237000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsCategoryTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMzMw_6485ba20-02d2-40d1-9dce-cee9bb6744cf">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balances of Level 3 pension plan assets during the year ended December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, sales and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balances of Level 3 pension plan assets during the year ended December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.036%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, sales and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DefinedBenefitPlanPlanAssetsCategoryTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i606a32f530d0485e9489b153aae2186a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmOWJhZDZiZDg3MWY0M2FhOWMwZTRhMjkzNzgzYTg3MC90YWJsZXJhbmdlOmY5YmFkNmJkODcxZjQzYWE5YzBlNGEyOTM3ODNhODcwXzEtMS0xLTEtMjY1MjQ3_75cd2aff-7492-4b29-a542-eb348d0806eb"
      unitRef="usd">378000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9d3917a82295412f9c9275a317a05f05_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmOWJhZDZiZDg3MWY0M2FhOWMwZTRhMjkzNzgzYTg3MC90YWJsZXJhbmdlOmY5YmFkNmJkODcxZjQzYWE5YzBlNGEyOTM3ODNhODcwXzEtNS0xLTEtMjY1MjQ3_96e0d96d-c7c6-4520-8242-d40fa03487e5"
      unitRef="usd">378000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld
      contextRef="i92b4331fe0364273803356e287d2561b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmOWJhZDZiZDg3MWY0M2FhOWMwZTRhMjkzNzgzYTg3MC90YWJsZXJhbmdlOmY5YmFkNmJkODcxZjQzYWE5YzBlNGEyOTM3ODNhODcwXzItMS0xLTEtMjY1MjQ3_9fd431cb-e519-4114-9ba3-25b9cc1413ff"
      unitRef="usd">21000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld
      contextRef="ic928117af54f4c0892def0fc4bb4ca6f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmOWJhZDZiZDg3MWY0M2FhOWMwZTRhMjkzNzgzYTg3MC90YWJsZXJhbmdlOmY5YmFkNmJkODcxZjQzYWE5YzBlNGEyOTM3ODNhODcwXzItNS0xLTEtMjY1MjQ3_fb2414db-9d8b-4c98-9dfe-3c412453e5a6"
      unitRef="usd">21000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld>
    <us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements
      contextRef="i92b4331fe0364273803356e287d2561b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmOWJhZDZiZDg3MWY0M2FhOWMwZTRhMjkzNzgzYTg3MC90YWJsZXJhbmdlOmY5YmFkNmJkODcxZjQzYWE5YzBlNGEyOTM3ODNhODcwXzMtMS0xLTEtMjY1MjQ3_9d1fab41-8c87-45ff-b77c-3ebc81bc3ec9"
      unitRef="usd">-74000000</us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements>
    <us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements
      contextRef="ic928117af54f4c0892def0fc4bb4ca6f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmOWJhZDZiZDg3MWY0M2FhOWMwZTRhMjkzNzgzYTg3MC90YWJsZXJhbmdlOmY5YmFkNmJkODcxZjQzYWE5YzBlNGEyOTM3ODNhODcwXzMtNS0xLTEtMjY1MjQ3_23f59ece-906c-4151-83b7-9abcd2820ef7"
      unitRef="usd">-74000000</us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements>
    <us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels
      contextRef="i92b4331fe0364273803356e287d2561b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmOWJhZDZiZDg3MWY0M2FhOWMwZTRhMjkzNzgzYTg3MC90YWJsZXJhbmdlOmY5YmFkNmJkODcxZjQzYWE5YzBlNGEyOTM3ODNhODcwXzQtMS0xLTEtMjY1MjQ3_4014ee79-fb55-4411-b7f0-7c73862204f6"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels>
    <us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels
      contextRef="ic928117af54f4c0892def0fc4bb4ca6f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmOWJhZDZiZDg3MWY0M2FhOWMwZTRhMjkzNzgzYTg3MC90YWJsZXJhbmdlOmY5YmFkNmJkODcxZjQzYWE5YzBlNGEyOTM3ODNhODcwXzQtNS0xLTEtMjY1MjQ3_03ece846-d968-4507-a7d4-2d7316d30e88"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3d10279e4e4240e58c58b67195918c98_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmOWJhZDZiZDg3MWY0M2FhOWMwZTRhMjkzNzgzYTg3MC90YWJsZXJhbmdlOmY5YmFkNmJkODcxZjQzYWE5YzBlNGEyOTM3ODNhODcwXzUtMS0xLTEtMjY1MjQ3_06c32dc7-2917-4127-830c-4480d4fdb2e7"
      unitRef="usd">325000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i292b96aad4ec49cdbd305facd2f76542_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmOWJhZDZiZDg3MWY0M2FhOWMwZTRhMjkzNzgzYTg3MC90YWJsZXJhbmdlOmY5YmFkNmJkODcxZjQzYWE5YzBlNGEyOTM3ODNhODcwXzUtNS0xLTEtMjY1MjQ3_c6b7cde6-b0fb-4d78-b013-cb60d17c9af0"
      unitRef="usd">325000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i535c834eab7441c89aa3908b303c0da7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmZTBhMmM4YjQ2MjM0YmQyOTdiMGMwNjFmNjQzMzBkZS90YWJsZXJhbmdlOmZlMGEyYzhiNDYyMzRiZDI5N2IwYzA2MWY2NDMzMGRlXzEtMS0xLTEtMjY1MjQ3_8d087cc0-e021-4ee6-aee9-394ae3575612"
      unitRef="usd">343000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6621e945d6764a88aa47982bd5644a44_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmZTBhMmM4YjQ2MjM0YmQyOTdiMGMwNjFmNjQzMzBkZS90YWJsZXJhbmdlOmZlMGEyYzhiNDYyMzRiZDI5N2IwYzA2MWY2NDMzMGRlXzEtNS0xLTEtMjY1MjQ3_5510ac4b-c6ee-42ad-8e61-eb9a1adf86d9"
      unitRef="usd">343000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld
      contextRef="if24037d3545b44d7b17124b131dcad75_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmZTBhMmM4YjQ2MjM0YmQyOTdiMGMwNjFmNjQzMzBkZS90YWJsZXJhbmdlOmZlMGEyYzhiNDYyMzRiZDI5N2IwYzA2MWY2NDMzMGRlXzItMS0xLTEtMjY1MjQ3_0a9dc0c7-42de-4e3f-a0f2-40298e3bd3f7"
      unitRef="usd">43000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld
      contextRef="i397591891c3b446b8fe2edeab28e0a83_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmZTBhMmM4YjQ2MjM0YmQyOTdiMGMwNjFmNjQzMzBkZS90YWJsZXJhbmdlOmZlMGEyYzhiNDYyMzRiZDI5N2IwYzA2MWY2NDMzMGRlXzItNS0xLTEtMjY1MjQ3_2ed4c39b-24c7-4afa-8b20-aaaea251cd39"
      unitRef="usd">43000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld>
    <us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements
      contextRef="if24037d3545b44d7b17124b131dcad75_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmZTBhMmM4YjQ2MjM0YmQyOTdiMGMwNjFmNjQzMzBkZS90YWJsZXJhbmdlOmZlMGEyYzhiNDYyMzRiZDI5N2IwYzA2MWY2NDMzMGRlXzMtMS0xLTEtMjY1MjQ3_93e1183d-daf2-4198-b209-13bbdbbd3ce7"
      unitRef="usd">-8000000</us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements>
    <us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements
      contextRef="i397591891c3b446b8fe2edeab28e0a83_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmZTBhMmM4YjQ2MjM0YmQyOTdiMGMwNjFmNjQzMzBkZS90YWJsZXJhbmdlOmZlMGEyYzhiNDYyMzRiZDI5N2IwYzA2MWY2NDMzMGRlXzMtNS0xLTEtMjY1MjQ3_f0a968b3-dc59-4e73-953d-45104555acf9"
      unitRef="usd">-8000000</us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements>
    <us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels
      contextRef="if24037d3545b44d7b17124b131dcad75_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmZTBhMmM4YjQ2MjM0YmQyOTdiMGMwNjFmNjQzMzBkZS90YWJsZXJhbmdlOmZlMGEyYzhiNDYyMzRiZDI5N2IwYzA2MWY2NDMzMGRlXzQtMS0xLTEtMjY1MjQ3_646074de-4cac-42e6-a920-6fc1b33e1fa7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels>
    <us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels
      contextRef="i397591891c3b446b8fe2edeab28e0a83_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmZTBhMmM4YjQ2MjM0YmQyOTdiMGMwNjFmNjQzMzBkZS90YWJsZXJhbmdlOmZlMGEyYzhiNDYyMzRiZDI5N2IwYzA2MWY2NDMzMGRlXzQtNS0xLTEtMjY1MjQ3_a1518ac6-1730-42a5-8eb3-e9d1b117fc2b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i606a32f530d0485e9489b153aae2186a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmZTBhMmM4YjQ2MjM0YmQyOTdiMGMwNjFmNjQzMzBkZS90YWJsZXJhbmdlOmZlMGEyYzhiNDYyMzRiZDI5N2IwYzA2MWY2NDMzMGRlXzUtMS0xLTEtMjY1MjQ3_5cbd1897-f154-44a7-91c3-d91c7bf1c593"
      unitRef="usd">378000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9d3917a82295412f9c9275a317a05f05_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTpmZTBhMmM4YjQ2MjM0YmQyOTdiMGMwNjFmNjQzMzBkZS90YWJsZXJhbmdlOmZlMGEyYzhiNDYyMzRiZDI5N2IwYzA2MWY2NDMzMGRlXzUtNS0xLTEtMjY1MjQ3_3d202e6d-80bc-45bb-99ae-429cea6586ec"
      unitRef="usd">378000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="idd0c449a45b5463791a11ad8fb885a7f_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzc0MDU_8acc3181-a326-47d7-8643-d2a5599a54c6"
      unitRef="number">0.12</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="ibab30eb09068437faeb20a15dacc2fac_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzc0MzA_82c1ef8d-8fc1-4b36-a297-f7e50efb757a"
      unitRef="number">0.77</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i534f8d2a6659488381539213487bbba7_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzc0NzA_ac2eb68f-0971-42c1-9a96-78ac2de18e67"
      unitRef="number">0.05</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="ib6f3a72a51a14616b3c062670d5dc4fa_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzc0ODk_426da5ac-51bd-4309-83cc-0ba2455ef938"
      unitRef="number">0.03</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i8dbb3cd21e554ebcb4cf9e874172fbff_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzc1MzU_38a9cb28-3eee-4e0f-b8c7-7247db38d8fd"
      unitRef="number">0.03</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzg0NDg_f86797be-17e9-4422-9556-9493826d1f12"
      unitRef="usd">27000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzg0NTI_118fc5e3-f2b2-4509-932a-68ead841fc0f"
      unitRef="usd">78000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="idf18a7ebe0824b4c9cc0c9a8db021e64_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzg0NTk_a08562f5-0c7b-4aa5-a764-19d33b0e0bde"
      unitRef="usd">25000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMzE0_031fd6d4-3fb7-4c6d-ad43-ac93790a42da">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the pension benefit obligation as of December&#160;31, 2022: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028-2032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the accumulated other postretirement benefit obligation as of December&#160;31, 2022: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028-2032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo0NTAzMzM0MmYyZDA0MjE4OTE4M2IwYmRhZjA0MmE5ZS90YWJsZXJhbmdlOjQ1MDMzMzQyZjJkMDQyMTg5MTgzYjBiZGFmMDQyYTllXzEtMS0xLTEtMjY1MjQ3_e83c9dd4-cccb-4ebd-87e1-de2f3e896a5e"
      unitRef="usd">368000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo0NTAzMzM0MmYyZDA0MjE4OTE4M2IwYmRhZjA0MmE5ZS90YWJsZXJhbmdlOjQ1MDMzMzQyZjJkMDQyMTg5MTgzYjBiZGFmMDQyYTllXzItMS0xLTEtMjY1MjQ3_62ecc2e5-d32a-4566-b50f-d0e5ccfb072b"
      unitRef="usd">369000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo0NTAzMzM0MmYyZDA0MjE4OTE4M2IwYmRhZjA0MmE5ZS90YWJsZXJhbmdlOjQ1MDMzMzQyZjJkMDQyMTg5MTgzYjBiZGFmMDQyYTllXzMtMS0xLTEtMjY1MjQ3_d0764f77-b856-45cb-b33e-7fffdfc41c18"
      unitRef="usd">372000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo0NTAzMzM0MmYyZDA0MjE4OTE4M2IwYmRhZjA0MmE5ZS90YWJsZXJhbmdlOjQ1MDMzMzQyZjJkMDQyMTg5MTgzYjBiZGFmMDQyYTllXzQtMS0xLTEtMjY1MjQ3_7074428a-81d4-4a21-a04b-28b6b98c6001"
      unitRef="usd">369000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo0NTAzMzM0MmYyZDA0MjE4OTE4M2IwYmRhZjA0MmE5ZS90YWJsZXJhbmdlOjQ1MDMzMzQyZjJkMDQyMTg5MTgzYjBiZGFmMDQyYTllXzUtMS0xLTEtMjY1MjQ3_cf8063cd-991b-4f07-b188-3f3d7e73985d"
      unitRef="usd">367000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i386090869fc94797bcda9d9bd6beaaf4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo0NTAzMzM0MmYyZDA0MjE4OTE4M2IwYmRhZjA0MmE5ZS90YWJsZXJhbmdlOjQ1MDMzMzQyZjJkMDQyMTg5MTgzYjBiZGFmMDQyYTllXzYtMS0xLTEtMjY1MjQ3_fea4fea8-5adc-40d5-81e7-a5dc3bf5d252"
      unitRef="usd">1776000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:MultiemployerPlanPensionInsignificantPlanContribution
      contextRef="iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzk5NDM_5c94be2d-76bf-422d-a0bb-d1f59cb09b82"
      unitRef="usd">20000000</us-gaap:MultiemployerPlanPensionInsignificantPlanContribution>
    <us-gaap:MultiemployerPlanPensionInsignificantPlanContribution
      contextRef="i3db08081201f432393b01ebf39aae1e5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzk5NDc_89825b0f-b81f-44ab-9f0e-4378a73fbee9"
      unitRef="usd">19000000</us-gaap:MultiemployerPlanPensionInsignificantPlanContribution>
    <us-gaap:MultiemployerPlanPensionInsignificantPlanContribution
      contextRef="idf18a7ebe0824b4c9cc0c9a8db021e64_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzk5NTQ_ac5dae02-372a-4786-8902-b1b67f6e9718"
      unitRef="usd">19000000</us-gaap:MultiemployerPlanPensionInsignificantPlanContribution>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i384b40a0741e4d28b9e0484a44c098d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzEwNTI4_29d66009-ef52-4365-8317-07b37396361c"
      unitRef="usd">159000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ib0d860116b5a468e8949760638176508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzEwNTM1_c081afdf-779c-4d21-bafd-9f35ff1346f0"
      unitRef="usd">207000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ie948ccd30d67420f85d943d80b28ab90_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzEwNjMy_86607dab-1be1-4cfd-91c4-3179a89b83c8"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="iad4db4c6c00f4fadb397e0b96255d42c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzEwNjM2_1d984062-2990-4420-9632-9625507d5aff"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="idb4cca5b0ebf4f3aaa50ec243577cbda_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzEwNjQz_ac50a8bd-01af-49e3-82dd-77f0dee9f7ca"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i384b40a0741e4d28b9e0484a44c098d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo1ZTQ2ODg0OGU0OTg0NzBmOThmMDYwYWM3NzY2YzlkZC90YWJsZXJhbmdlOjVlNDY4ODQ4ZTQ5ODQ3MGY5OGYwNjBhYzc3NjZjOWRkXzEtMS0xLTEtMjY1MjQ3_ab154320-040a-4448-b9ec-920dd7274fa9"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i384b40a0741e4d28b9e0484a44c098d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo1ZTQ2ODg0OGU0OTg0NzBmOThmMDYwYWM3NzY2YzlkZC90YWJsZXJhbmdlOjVlNDY4ODQ4ZTQ5ODQ3MGY5OGYwNjBhYzc3NjZjOWRkXzItMS0xLTEtMjY1MjQ3_4477f9ac-e594-45f8-9c02-4a6c6242b210"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i384b40a0741e4d28b9e0484a44c098d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo1ZTQ2ODg0OGU0OTg0NzBmOThmMDYwYWM3NzY2YzlkZC90YWJsZXJhbmdlOjVlNDY4ODQ4ZTQ5ODQ3MGY5OGYwNjBhYzc3NjZjOWRkXzMtMS0xLTEtMjY1MjQ3_0a7aaac2-50d5-49d7-9587-2cd616a2266a"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i384b40a0741e4d28b9e0484a44c098d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo1ZTQ2ODg0OGU0OTg0NzBmOThmMDYwYWM3NzY2YzlkZC90YWJsZXJhbmdlOjVlNDY4ODQ4ZTQ5ODQ3MGY5OGYwNjBhYzc3NjZjOWRkXzQtMS0xLTEtMjY1MjQ3_3b7cd1d3-8272-45ad-af81-809a69d32cfc"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i384b40a0741e4d28b9e0484a44c098d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo1ZTQ2ODg0OGU0OTg0NzBmOThmMDYwYWM3NzY2YzlkZC90YWJsZXJhbmdlOjVlNDY4ODQ4ZTQ5ODQ3MGY5OGYwNjBhYzc3NjZjOWRkXzUtMS0xLTEtMjY1MjQ3_caaf8386-3f33-4a80-8ce0-10bf364348f3"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i384b40a0741e4d28b9e0484a44c098d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90YWJsZTo1ZTQ2ODg0OGU0OTg0NzBmOThmMDYwYWM3NzY2YzlkZC90YWJsZXJhbmdlOjVlNDY4ODQ4ZTQ5ODQ3MGY5OGYwNjBhYzc3NjZjOWRkXzYtMS0xLTEtMjY1MjQ3_cd166acd-63de-47f7-983d-e4250dc9be41"
      unitRef="usd">59000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:MultiemployerPlanPensionInsignificantPlanContribution
      contextRef="ie948ccd30d67420f85d943d80b28ab90_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMjY2_f204d1da-32ee-43c5-b7d3-365f0019160e"
      unitRef="usd">62000000</us-gaap:MultiemployerPlanPensionInsignificantPlanContribution>
    <us-gaap:MultiemployerPlanPensionInsignificantPlanContribution
      contextRef="iad4db4c6c00f4fadb397e0b96255d42c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMjcw_1175fcee-c2e2-493c-8e2d-c41ed419a33e"
      unitRef="usd">60000000</us-gaap:MultiemployerPlanPensionInsignificantPlanContribution>
    <us-gaap:MultiemployerPlanPensionInsignificantPlanContribution
      contextRef="idb4cca5b0ebf4f3aaa50ec243577cbda_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNDgvZnJhZzo1YmM1YTc0YzQ5ZDM0ZjcxOTkxM2Q3NTEwYzg3MWNmMi90ZXh0cmVnaW9uOjViYzVhNzRjNDlkMzRmNzE5OTEzZDc1MTBjODcxY2YyXzExMjc3_efdbcb8a-858c-4c69-8fcc-c6b4c3000038"
      unitRef="usd">54000000</us-gaap:MultiemployerPlanPensionInsignificantPlanContribution>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzM4MjU_0271e2b4-8b2f-48e9-b45c-e2f5dd013110">Income Taxes&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax provision for continuing operations consisted of the following for the&#160;years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(450)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,029)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(564)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a reconciliation of the statutory income tax rate to the Company&#x2019;s effective income tax rate for continuing operations for the&#160;years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statutory income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health insurer fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basis difference upon disposition of subsidiary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior year refunds and unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the components of the Company&#x2019;s deferred income tax assets and liabilities as of December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and rents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad debts and other allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss and capital loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll tax deferral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(532)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(340)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and rents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,870)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,773)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes deferred income tax assets of $131&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When evaluating the realizability of deferred tax assets, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and the Company&#x2019;s recent operating results. The Company established valuation allowances of $532 million and $325 million as of December&#160;31, 2022 and 2021, respectively, because it does not consider it more likely than not that certain deferred tax assets will be recovered.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the Company had net operating and capital loss carryovers of $266 million, which expire between 2023 and 2042.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending balance of unrecognized tax benefits in 2022, 2021 and 2020 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expiration of statutes of limitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CVS Health Corporation and most of its subsidiaries are subject to U.S. federal income tax as well as income tax of numerous state and local jurisdictions. CVS Health Corporation participated in the Compliance Assurance Process through 2019, which is &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a program made available by the U.S. Internal Revenue Service (&#x201c;IRS&#x201d;) to certain qualifying large taxpayers, under which participants work collaboratively with the IRS to identify and resolve potential tax issues through open, cooperative and transparent interaction prior to the annual filing of their federal income tax returns. The IRS has completed its examinations of the Company&#x2019;s consolidated U.S. federal income tax returns for tax years through and including 2013 and 2018 through 2019. The IRS has substantially completed its examinations of the Company&#x2019;s consolidated U.S. federal income tax returns for tax years 2014 through 2017.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CVS Health Corporation and its subsidiaries are also currently under income tax examinations by a number of state and local tax authorities. As of December&#160;31, 2022, no examination has resulted in any proposed adjustments that would result in a material change to the Company&#x2019;s operating results, financial condition or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all material state and local income tax matters have been concluded for fiscal years through 2015. Certain state exams are likely to be concluded and certain state statutes of limitations will lapse in 2023, but the change in the balance of the Company&#x2019;s uncertain tax positions is projected to be immaterial. In addition, it is reasonably possible that the Company&#x2019;s unrecognized tax benefits could change within the next twelve months due to the anticipated conclusion of various examinations with the IRS for certain previous years. An estimate of the range of the possible change cannot be made at this time.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records interest expense related to unrecognized tax benefits and penalties in the income tax provision. The Company accrued interest expense of approximately $29 million, $40 million and $34 million in 2022, 2021 and 2020, respectively. The Company had approximately $112 million and $151 million accrued for interest and penalties as of December&#160;31, 2022 and 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the total amount of unrecognized tax benefits that, if recognized, would affect the Company&#x2019;s effective income tax rate is approximately $336 million, after considering the federal benefit of state income taxes.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzM4MjY_a20519e4-5e20-4dce-bf02-7660b95fc6f4">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax provision for continuing operations consisted of the following for the&#160;years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(450)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,029)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(564)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzItMS0xLTEtMjY1MjQ3_97461a4f-c6d6-4bd3-a6b8-c3e7b5b0727c"
      unitRef="usd">2803000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzItMy0xLTEtMjY1MjQ3_f65eac0d-7e9d-4ba9-91a7-fe8246aa75c6"
      unitRef="usd">2285000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzItNS0xLTEtMjY1MjQ3_be673fe5-f21b-4ea7-850d-6352111ea6bd"
      unitRef="usd">2615000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzMtMS0xLTEtMjY1MjQ3_d7fc216e-bc62-4fcb-b3fb-1c1272c1e9d5"
      unitRef="usd">735000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzMtMy0xLTEtMjY1MjQ3_71c9598f-851d-455c-8c22-637a1f9c273e"
      unitRef="usd">665000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzMtNS0xLTEtMjY1MjQ3_0630a34a-3fa7-40dc-a45f-81a5a1790c0e"
      unitRef="usd">518000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzQtMS0xLTEtMjY1MjQ3_72c0cae2-3028-46e5-bef8-a7b81e5ea7d5"
      unitRef="usd">3538000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzQtMy0xLTEtMjY1MjQ3_82df58f5-f642-4396-87f3-0d8631d39e44"
      unitRef="usd">2950000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzQtNS0xLTEtMjY1MjQ3_399c9147-8669-437e-8fea-95ac79d9c754"
      unitRef="usd">3133000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzYtMS0xLTEtMjY1MjQ3_ea7bc235-b71b-4757-b645-e8a2e5078306"
      unitRef="usd">-1526000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzYtMy0xLTEtMjY1MjQ3_1097ad0a-26e2-4f5d-9cc4-f59c9b2b6e53"
      unitRef="usd">-282000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzYtNS0xLTEtMjY1MjQ3_bd188871-0c5f-423f-96a3-759205fbcd4d"
      unitRef="usd">-450000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzctMS0xLTEtMjY1MjQ3_3c9a9377-537f-4124-a2c7-d4e4678bd642"
      unitRef="usd">-503000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzctMy0xLTEtMjY1MjQ3_d0f28f05-0090-424c-b43a-81d1a03a3934"
      unitRef="usd">-120000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzctNS0xLTEtMjY1MjQ3_0d4081d9-9422-4513-a7d3-c39213491c40"
      unitRef="usd">-114000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzgtMS0xLTEtMjY1MjQ3_e54ce502-4be5-4af1-8fec-71f1eb0fe667"
      unitRef="usd">-2029000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzgtMy0xLTEtMjY1MjQ3_9d961814-59f7-44e1-91b6-add1b71124dd"
      unitRef="usd">-402000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzgtNS0xLTEtMjY1MjQ3_ac709231-6ca2-4c93-9c9f-76a48b8d0037"
      unitRef="usd">-564000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzktMS0xLTEtMjY1MjQ3_b491bf1a-2ca0-40d7-b5be-b1d348e745bb"
      unitRef="usd">1509000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzktMy0xLTEtMjY1MjQ3_d320a149-0619-4271-90fe-624ceaedab0d"
      unitRef="usd">2548000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZToyMDc3MzQxZTQ4ZTg0MWMzOTg1Y2JhODk4ZGE1NmQyZi90YWJsZXJhbmdlOjIwNzczNDFlNDhlODQxYzM5ODVjYmE4OThkYTU2ZDJmXzktNS0xLTEtMjY1MjQ3_a5eda19e-3c81-40d2-ab4d-8368f3996599"
      unitRef="usd">2569000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzM4MjA_53d0acab-82b8-48fd-aab3-62c6e8190ca5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a reconciliation of the statutory income tax rate to the Company&#x2019;s effective income tax rate for continuing operations for the&#160;years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statutory income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health insurer fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basis difference upon disposition of subsidiary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior year refunds and unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzEtMS0xLTEtMjY1MjQ3_12ff5ea0-d5ee-4abb-a8bc-2adada387fc8"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzEtMy0xLTEtMjY1MjQ3_d2ba9324-0ba5-4471-ae07-1a7a72011c07"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzEtNS0xLTEtMjY1MjQ3_d80fdb8b-453c-4d59-bbb5-816cead2ad16"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzItMS0xLTEtMjY1MjQ3_c853fde6-0ce0-45fe-acac-c4a3d4b42eec"
      unitRef="number">0.032</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzItMy0xLTEtMjY1MjQ3_904888b4-1404-4bc1-8ea8-9e3a8edfc521"
      unitRef="number">0.041</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzItNS0xLTEtMjY1MjQ3_e69ae2c1-5df1-4c40-adf6-445e86e3a021"
      unitRef="number">0.032</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <cvs:HealthInsurerFeeTaxEffectPercent
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzMtMS0xLTEtMjY1MjQ3_4b77e82f-d35d-4c46-9d36-7304fcaa2441"
      unitRef="number">0</cvs:HealthInsurerFeeTaxEffectPercent>
    <cvs:HealthInsurerFeeTaxEffectPercent
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzMtMy0xLTEtMjY1MjQ3_e8a01ac8-cd15-49f8-9e53-161f314b677d"
      unitRef="number">0</cvs:HealthInsurerFeeTaxEffectPercent>
    <cvs:HealthInsurerFeeTaxEffectPercent
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzMtNS0xLTEtMjY1MjQ3_f72d6094-d9f1-4501-a9c3-8ddbc3aa109b"
      unitRef="number">0.022</cvs:HealthInsurerFeeTaxEffectPercent>
    <cvs:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzQtMS0xLTEtMjY1MjQ3_de6e24b2-89a5-4fe9-83de-837acf32caa7"
      unitRef="number">0.034</cvs:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent>
    <cvs:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzQtMy0xLTEtMjY1MjQ3_ecf1fbd2-29de-4827-8e1c-2066d0e206fe"
      unitRef="number">0</cvs:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent>
    <cvs:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzQtNS0xLTEtMjY1MjQ3_f48fb06b-e945-437a-a7ea-2485d332eac5"
      unitRef="number">0</cvs:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzUtMS0xLTEtMjY1MjQ3_ea0e7cd1-1fc5-4f41-b977-13e4cd05c9f6"
      unitRef="number">0.016</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzUtMy0xLTEtMjY1MjQ3_d9422d91-9850-45f6-a95c-9319a65a91c7"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzUtNS0xLTEtMjY1MjQ3_ec15b184-4708-4b54-aeec-9329a824768b"
      unitRef="number">-0.012</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzYtMS0xLTEtMjY1MjQ3_41771e4b-e831-477e-8f41-0d922d197627"
      unitRef="number">-0.026</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzYtMy0xLTEtMjY1MjQ3_64295b5b-de77-47cb-af75-dd28de208d08"
      unitRef="number">-0.012</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzYtNS0xLTEtMjY1MjQ3_9100aa5e-a688-48cd-bc77-7a3123f3ce4e"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzctMS0xLTEtMjY1MjQ3_356c7d2d-c5f7-4baf-8b49-100e649dbbb7"
      unitRef="number">-0.007</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzctMy0xLTEtMjY1MjQ3_193a738f-bc92-4c9e-b9f7-198df7eb1c09"
      unitRef="number">0.003</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzctNS0xLTEtMjY1MjQ3_79b4e352-a49a-4ec7-b06b-d5e034400353"
      unitRef="number">0.011</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzgtMS0xLTEtMjY1MjQ3_0f6420c9-fc77-4885-91f9-0b1fea9e00ce"
      unitRef="number">0.259</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzgtMy0xLTEtMjY1MjQ3_10651b68-f24a-4b67-8ea9-da2b5d5ad965"
      unitRef="number">0.242</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo4ZTc2MzlhZjY1MTY0Mjg2YjNjZTE2MTc2N2I3ZGU4OC90YWJsZXJhbmdlOjhlNzYzOWFmNjUxNjQyODZiM2NlMTYxNzY3YjdkZTg4XzgtNS0xLTEtMjY1MjQ3_90379eed-08dc-4ab4-ac59-6481bfd35803"
      unitRef="number">0.263</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzM4MjE_753debfd-82cb-4189-91b8-0d29aaa2929c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the components of the Company&#x2019;s deferred income tax assets and liabilities as of December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and rents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad debts and other allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss and capital loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll tax deferral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(532)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(340)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and rents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,870)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,773)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes deferred income tax assets of $131&#160;million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 &#x2018;&#x2018;Acquisitions, Divestitures and Asset Sales&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzItMS0xLTEtMjY1MjQ3_717eccf6-93cf-4ee1-8e8d-acccfc93afec"
      unitRef="usd">5242000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzItMy0xLTEtMjY1MjQ3_b6680811-d82b-45bb-b9f3-4072590a9d2f"
      unitRef="usd">5563000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzMtMS0xLTEtMjY1MjQ3_c39c5905-591d-4c0f-bf3e-d76f85f0e66a"
      unitRef="usd">1260000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzMtMy0xLTEtMjY1MjQ3_4f62eaa7-e602-4fbc-8c27-4b7797a2ff60"
      unitRef="usd">19000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzQtMS0xLTEtMjY1MjQ3_ac00527e-fdf0-48b6-873c-73b4c5f2ca11"
      unitRef="usd">103000000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzQtMy0xLTEtMjY1MjQ3_9140b92d-5ef9-4eee-ac54-9cde71a78fe1"
      unitRef="usd">99000000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzUtMS0xLTEtMjY1MjQ3_98e22f49-9100-42f8-a200-9ea40f07da4b"
      unitRef="usd">153000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzUtMy0xLTEtMjY1MjQ3_e2fc95b6-3eea-4fa1-9a3e-d49081b14abb"
      unitRef="usd">193000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <cvs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzYtMS0xLTEtMjY1MjQ3_0200e4a8-7705-417e-9744-a5031bb30e4c"
      unitRef="usd">480000000</cvs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances>
    <cvs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzYtMy0xLTEtMjY1MjQ3_efc538a3-c49a-4ef3-a910-865d5ba1d1e0"
      unitRef="usd">489000000</cvs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzgtMS0xLTEtMjY1MjQ3_68a03581-35bd-4c7d-84a9-0a3856dde6da"
      unitRef="usd">266000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzgtMy0xLTEtMjY1MjQ3_0592eaad-104e-4108-a3a6-44aa525e7cc3"
      unitRef="usd">416000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzktMS0xLTEtMjY1MjQ3_ba0d46e4-d9f0-485a-b289-236422e4a8dd"
      unitRef="usd">66000000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzktMy0xLTEtMjY1MjQ3_2374bc94-fffc-431e-8185-f020a028cf3c"
      unitRef="usd">78000000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzEwLTEtMS0xLTI2NTI0Nw_9e43bb2e-97fe-4e4a-9505-128e4879e760"
      unitRef="usd">319000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzEwLTMtMS0xLTI2NTI0Nw_56a7664b-5505-4624-bff9-ef3e57ed317d"
      unitRef="usd">662000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <us-gaap:DeferredTaxAssetsInvestments
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzExLTEtMS0xLTI2NTI0Nw_91a21204-59a0-473f-819b-159266bf1003"
      unitRef="usd">293000000</us-gaap:DeferredTaxAssetsInvestments>
    <us-gaap:DeferredTaxAssetsInvestments
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzExLTMtMS0xLTI2NTI0Nw_f40f00a0-7268-421d-ad21-1f91ddd3ed5f"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsInvestments>
    <cvs:DeferredTaxAssetsPayrollTaxDeferral
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzEyLTEtMS0xLTI2NTI0Nw_84c33cbd-e438-4a15-b60e-f7d7cf285e03"
      unitRef="usd">0</cvs:DeferredTaxAssetsPayrollTaxDeferral>
    <cvs:DeferredTaxAssetsPayrollTaxDeferral
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzEyLTMtMS0xLTI2NTI0Nw_07e8498e-47c5-47a5-b9c9-24ef7c356d81"
      unitRef="usd">87000000</cvs:DeferredTaxAssetsPayrollTaxDeferral>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzEzLTEtMS0xLTI2NTI0Nw_f3680f81-8ae7-4ce3-a164-c0c35cfb9980"
      unitRef="usd">335000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzEzLTMtMS0xLTI2NTI0Nw_50949a09-3d3c-4987-a810-10041f7a855d"
      unitRef="usd">377000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzE0LTEtMS0xLTI2NTI0Nw_93878fa0-f400-4ef2-9477-101f4fdcaadb"
      unitRef="usd">532000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzE0LTMtMS0xLTI2NTI0Nw_4c5328c7-f457-4677-9457-b1bccbb00d17"
      unitRef="usd">325000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzE1LTEtMS0xLTI2NTI0Nw_3b805a77-5d33-44a3-b174-ac61093d47f9"
      unitRef="usd">7985000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzE1LTMtMS0xLTI2NTI0Nw_54ec92ea-2d7b-442e-bdd0-e63686664b5f"
      unitRef="usd">7658000000</us-gaap:DeferredTaxAssetsNet>
    <cvs:DeferredTaxLiabilitiesRetirementBenefits
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzE3LTEtMS0xLTI2NTI0Nw_c87b87fa-61e6-4518-9942-8ef23bc73259"
      unitRef="usd">92000000</cvs:DeferredTaxLiabilitiesRetirementBenefits>
    <cvs:DeferredTaxLiabilitiesRetirementBenefits
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzE3LTMtMS0xLTI2NTI0Nw_5cba3ac1-d2f8-4641-8a8e-a63b926bbdf6"
      unitRef="usd">105000000</cvs:DeferredTaxLiabilitiesRetirementBenefits>
    <us-gaap:DeferredTaxLiabilitiesInvestments
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzE4LTEtMS0xLTI2NTI0Nw_a2129ec7-18e8-4dc8-ac63-313501c1deb7"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesInvestments>
    <us-gaap:DeferredTaxLiabilitiesInvestments
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzE4LTMtMS0xLTI2NTI0Nw_58e0c6d0-58e4-4e52-963e-425c97fe3d1d"
      unitRef="usd">340000000</us-gaap:DeferredTaxLiabilitiesInvestments>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzE5LTEtMS0xLTI2NTI0Nw_9e999f30-eff6-4588-9eda-6c593cd3b8df"
      unitRef="usd">4639000000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzE5LTMtMS0xLTI2NTI0Nw_04c1702b-6dfa-41f6-bce4-54eeeca3bb76"
      unitRef="usd">4947000000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <cvs:DeferredTaxLiabilitiesDepreciationAndAmortization
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzIwLTEtMS0xLTI2NTI0Nw_7c406296-a718-47cc-ab96-cdac1c374e40"
      unitRef="usd">7139000000</cvs:DeferredTaxLiabilitiesDepreciationAndAmortization>
    <cvs:DeferredTaxLiabilitiesDepreciationAndAmortization
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzIwLTMtMS0xLTI2NTI0Nw_7f20dbf4-d0ea-441b-a231-972ff0fbcc11"
      unitRef="usd">8381000000</cvs:DeferredTaxLiabilitiesDepreciationAndAmortization>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzIxLTEtMS0xLTI2NTI0Nw_c6e100b3-e58d-420e-9b78-e6b09cdadf8a"
      unitRef="usd">11870000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzIxLTMtMS0xLTI2NTI0Nw_52d1c087-7c11-439f-8762-f88409795a1e"
      unitRef="usd">13773000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzIyLTEtMS0xLTI2NTI0Nw_49cf5300-6738-466e-8345-efcff1ba3fc7"
      unitRef="usd">3885000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTo0MTdmYmM4ODVjOTE0ZTIxOGE3MzAyNDUwY2Q0ZjAwZC90YWJsZXJhbmdlOjQxN2ZiYzg4NWM5MTRlMjE4YTczMDI0NTBjZDRmMDBkXzIyLTMtMS0xLTI2NTI0Nw_deed6f42-3bd9-4056-8720-49e0c8459560"
      unitRef="usd">6115000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i44db5359c9524cc6b84b1886a5fa9bb7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzUzMQ_7b07d3ed-b143-4d74-8ce2-452502c82bce"
      unitRef="usd">131000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzEwNjY_93878fa0-f400-4ef2-9477-101f4fdcaadb"
      unitRef="usd">532000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzEwNzM_4c5328c7-f457-4677-9457-b1bccbb00d17"
      unitRef="usd">325000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzEyODQ_68a03581-35bd-4c7d-84a9-0a3856dde6da"
      unitRef="usd">266000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzM4MjM_22b10698-e5d4-4373-a9e1-2406c141b063">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending balance of unrecognized tax benefits in 2022, 2021 and 2020 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expiration of statutes of limitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzEtMS0xLTEtMjY1MjQ3_081e06ed-8c21-4ff7-8d82-4a76f6fc29da"
      unitRef="usd">782000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i501f291fb23d49e987222cf13c851afc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzEtMy0xLTEtMjY1MjQ3_e677ea51-003e-4fdf-9d7a-cbe7e974546f"
      unitRef="usd">768000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i68e253af6bf3467aade09b572c1b73a6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzEtNS0xLTEtMjY1MjQ3_617de75b-e7d4-4fa1-8296-9ecabef10af3"
      unitRef="usd">655000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzItMS0xLTEtMjY1MjQ3_4bf2d8b8-f2ee-425a-ab40-4b9c53267933"
      unitRef="usd">5000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzItMy0xLTEtMjY1MjQ3_0dcc0e11-b1f1-4958-912d-21c13ee2df15"
      unitRef="usd">3000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzItNS0xLTEtMjY1MjQ3_2810c34f-1e36-4b14-8c7b-6d906d5adac1"
      unitRef="usd">3000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzMtMS0xLTEtMjY1MjQ3_490278f2-6169-446a-888c-22bf88276cb4"
      unitRef="usd">42000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzMtMy0xLTEtMjY1MjQ3_88ea395b-837b-42c3-bda4-9a25a250a780"
      unitRef="usd">52000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzMtNS0xLTEtMjY1MjQ3_634cad33-3a3f-4067-93b0-839353b01cb2"
      unitRef="usd">182000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzQtMS0xLTEtMjY1MjQ3_2a0d7ac3-6852-4f51-a086-8fe6b684a909"
      unitRef="usd">166000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzQtMy0xLTEtMjY1MjQ3_cfdcfffb-a09f-42c5-a558-2287c2ad5b45"
      unitRef="usd">33000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzQtNS0xLTEtMjY1MjQ3_cfb6434a-30f2-4a18-9433-3a6e3860f617"
      unitRef="usd">56000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzUtMS0xLTEtMjY1MjQ3_820fea0d-ca2d-40c3-93d2-3432254c496c"
      unitRef="usd">4000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzUtMy0xLTEtMjY1MjQ3_92b53e02-9bec-4af0-a9d3-4fba115c5f65"
      unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzUtNS0xLTEtMjY1MjQ3_fb5a58fa-aac7-4797-bf9c-ab584f5c97aa"
      unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzYtMS0xLTEtMjY1MjQ3_54983355-b168-474b-8ed0-a7bf1ec4e856"
      unitRef="usd">213000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzYtMy0xLTEtMjY1MjQ3_29d29637-f40c-4714-8f42-eb4cd4d896b1"
      unitRef="usd">7000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzYtNS0xLTEtMjY1MjQ3_23a222d8-182f-4c61-821a-0e3249f3572f"
      unitRef="usd">14000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzctMS0xLTEtMjY1MjQ3_900f4175-8c77-4143-b004-a785656e49b0"
      unitRef="usd">446000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzctMy0xLTEtMjY1MjQ3_1b671309-1a22-4380-ab0f-a0bafad60d9f"
      unitRef="usd">782000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i501f291fb23d49e987222cf13c851afc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90YWJsZTplNmNjMjFjYjA1ZjU0NTdkYjI5YzRjYjViYzA0MjIxZS90YWJsZXJhbmdlOmU2Y2MyMWNiMDVmNTQ1N2RiMjljNGNiNWJjMDQyMjFlXzctNS0xLTEtMjY1MjQ3_d08a4bd9-ae77-4b88-97b6-fb1ba234336f"
      unitRef="usd">768000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzM0NTQ_4053a5b4-7e4a-441a-9ac6-858a7e80e3e0"
      unitRef="usd">29000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzM0NTg_d6a1a8bd-0dfe-4208-8b2b-4d4790f83548"
      unitRef="usd">40000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzM0NjU_bfe6bb52-5e2c-4bf3-ae72-d15437638d8b"
      unitRef="usd">34000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzM1MzA_bd5a3863-84df-42fa-8e3b-5e8b44cb68a2"
      unitRef="usd">112000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzM1Mzc_fbf286c5-48b3-4c52-b279-32d6134e1e82"
      unitRef="usd">151000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTQvZnJhZzo5NjNhNjQzNjEzNDU0YWI2Yjk5ZjhjNTM0ODhmYTBjNy90ZXh0cmVnaW9uOjk2M2E2NDM2MTM0NTRhYjZiOTlmOGM1MzQ4OGZhMGM3XzM3NTU_adf843b8-822c-47a2-bf02-73be4b6e7673"
      unitRef="usd">336000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzg0NDY_5aadccae-354c-435d-8c46-23514e5f4bb2">Stock Incentive Plans&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The terms of the CVS Health 2017 Incentive Compensation Plan (&#x201c;ICP&#x201d;) provide for grants of annual incentive and long-term performance awards to executive officers and other officers and employees of the Company or any subsidiary of the Company, as well as equity compensation to outside directors of CVS Health Corporation. Payment of such annual incentive and long-term performance awards will be in cash, stock, other awards or other property, at the discretion of the Management Planning and Development Committee (the &#x201c;MP&amp;amp;D Committee&#x201d;) of the Board. The ICP allows for a maximum of 58 million shares of CVS Health Corporation common stock to be reserved and available for grants. As of December&#160;31, 2022, there were approximately 21 million shares of CVS Health Corporation common stock available for future grants under the ICP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the acquisition of Aetna (the &#x201c;Aetna Acquisition&#x201d;) on November 28, 2018, approximately 22 million shares of Aetna common stock subject to awards outstanding under the Amended Aetna Inc. 2010 Stock Incentive Plan (&#x201c;SIP&#x201d;) were assumed by CVS Health Corporation. In addition, in accordance with the merger agreement, shares which were available for future issuance under the SIP were converted into approximately 32 million shares of CVS Health Corporation common stock reserved and available for issuance pursuant to future awards. Subsequent to the expiration of the SIP on May 21, 2020, the ICP was the only compensation plan under which the Company grants stock options, restricted stock and other stock-based awards to its employees.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzE3Nzg_6fb0217d-b4b8-4272-817b-3803971eadab"&gt;three&lt;/span&gt; to five years) using the straight-line method. The following table is a summary of stock-based compensation for the&#160;years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units and performance stock units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and stock appreciation rights (&#x201c;SARs&#x201d;) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Units and Performance Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s restricted stock units and performance stock units are considered nonvested share awards and require no payment from the employee. The fair value of the restricted stock units is based on the market price of CVS Health Corporation common stock on the grant date and is recognized on a straight-line basis over the vesting period. For each restricted stock unit granted, employees receive one share of common stock, net of taxes, at the end of the vesting period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s performance stock units contain performance vesting conditions in addition to a service vesting condition. Vesting of the Company&#x2019;s performance stock units is dependent upon the degree to which the Company achieves its performance goals, which are generally set for a three-year performance period and are approved at the time of grant by the MP&amp;amp;D Committee. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of performance stock units granted with service and performance vesting conditions is based on the market price of CVS Health Corporation common stock on the grant date and is recognized over the vesting period. Certain of the performance stock units also contain a market vesting condition based on the performance of CVS Health Corporation common stock relative to a comparator group. The fair value of these performance stock units is determined using a Monte Carlo simulation as of the grant date and is recognized over the vesting period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, there was $619 million of total unrecognized compensation cost related to the Company&#x2019;s restricted stock units and performance stock units that are expected to vest. These costs are expected to be recognized over a weighted-average period of 2.1 years. The total fair value of restricted stock units vested during 2022, 2021 and 2020 was $328 million, $406 million and $229 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the restricted stock unit and performance stock unit activity for the&#160;year ended December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In thousands, except weighted average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year, nonvested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,626)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,421)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of year, nonvested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Vested performance stock units have been included at target level performance. Based on actual performance, the number of restricted stock units and performance stock units vested during the year ended December 31, 2022 was 8.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options and SARs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All stock option grants are awarded at fair value on the date of grant. The fair value of stock options is estimated using the Black-Scholes option pricing model, and stock-based compensation is recognized on a straight-line basis over the requisite service period. Stock options granted generally become exercisable over a four-year period from the grant date. Stock options granted through 2018 generally expire seven years after the grant date. Stock options granted subsequent to 2018 generally expire ten years after the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All unvested Aetna SARs outstanding upon the acquisition of Aetna were converted into replacement CVS Health Corporation SARs. The replacement SARs granted are settled in CVS Health Corporation common stock, net of taxes, based on the appreciation of the stock price on the exercise date over the market price on the date of grant. The fair value of SARs is estimated using the Black-Scholes option pricing model, and stock-based compensation is recognized on a straight-line basis over the requisite service period. SARs generally become exercisable over a three-year period from the grant date. SARs generally expire ten years after the grant date. No SARs have been granted subsequent to the Aetna Acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of stock option and SAR activity that occurred for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received from stock options exercised (including ESPP)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for taxes for net share settlement of equity awards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intrinsic value of stock options and SARs exercised &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of stock options and SARs vested &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each stock option is estimated using the Black-Scholes option pricing model based on the following assumptions at the time of grant:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The dividend yield is based on annual dividends paid and the fair market value of CVS Health Corporation stock at the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected volatility is estimated based on the historical volatility of CVS Health Corporation&#x2019;s daily stock price over a period equal to the expected life of each option grant after adjustments for infrequent events such as stock splits.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The risk-free interest rate is selected based on yields from U.S. Treasury zero-coupon issues with a remaining term equal to the expected term of the options being valued.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected life represents the number of&#160;years the options are expected to be outstanding from grant date based on historical option or SAR holder exercise experience.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, unrecognized compensation expense related to unvested stock options totaled $41 million, which the Company expects to be recognized over a weighted-average period of 1.9 years. After considering anticipated forfeitures, the Company expects approximately 7 million of the unvested stock options to vest over the requisite service period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s stock option and SAR activity for the&#160;year ended December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;thousands, except weighted average exercise price and remaining contractual term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,921)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(478)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.52&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.76&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at end of year and expected to vest in the future&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.47&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ESPP&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;) provides for the purchase of up to 60&#160;million shares of CVS Health Corporation common stock. Under the ESPP, eligible employees may purchase common stock at the end of each six&#160;month offering period at a purchase price equal to 90% of the lower of the fair market value on the first day or the last day of the offering period. During 2022, approximately 2 million shares of common stock were purchased under the provisions of the ESPP at an average price of $78.55 per share. As of December&#160;31, 2022, approximately 29 million shares of common stock were available for issuance under the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of stock-based compensation associated with the ESPP is estimated on the date of grant (the first day of the six&#160;month offering period) using the Black-Scholes option pricing model.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the assumptions used to value the ESPP awards for the&#160;years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The dividend yield is calculated based on semi-annual dividends paid and the fair market value of CVS Health Corporation stock at the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected volatility is estimated based on the historical volatility of CVS Health Corporation&#x2019;s daily stock price over the previous six&#160;month period.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The risk-free interest rate is selected based on the Treasury constant maturity interest rate whose term is consistent with the expected term of ESPP purchases (i.e., six&#160;months).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected life is based on the semi-annual purchase period.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ia298adcd58b540f39bbb027f8433e7d2_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzYxNQ_4695b22c-d32c-4696-9f97-f576395f3c6e"
      unitRef="shares">58000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ia298adcd58b540f39bbb027f8433e7d2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzc0MA_12080a8d-45c5-4d8b-b73f-aa4ff4289996"
      unitRef="shares">21000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i4a56dcd6eefa4635ba2a3f12f2cf62af_I20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzkyNQ_d44e8542-9180-4ef4-bc12-ff9ec232287a"
      unitRef="shares">22000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i4a56dcd6eefa4635ba2a3f12f2cf62af_I20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzEyNDA_dfbd30d4-73a1-4d43-9e8b-df243ed8f191"
      unitRef="shares">32000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ib01e468dcb8f4ca98e9b64ffb83ffbe0_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzg0NDc_f9f13996-e37e-424f-8cae-967347af9248">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzg0NDg_2734ac05-1a69-43a0-b9a2-bbf1ad901202">The following table is a summary of stock-based compensation for the&#160;years ended December&#160;31, 2022, 2021 and 2020:&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units and performance stock units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and stock appreciation rights (&#x201c;SARs&#x201d;) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes the ESPP.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8a7879ca683449ffa5da3418bf44e68d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTowMjJhZmFjNGVhNTQ0ZDk4YThiODIwYjM0NzEyNzYyMS90YWJsZXJhbmdlOjAyMmFmYWM0ZWE1NDRkOThhOGI4MjBiMzQ3MTI3NjIxXzEtMS0xLTEtMjY1MjQ3_68ba624d-c3c4-4f33-bc59-ab488d993160"
      unitRef="usd">369000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id4b79b50a55d4d81bf3f34a3889c23df_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTowMjJhZmFjNGVhNTQ0ZDk4YThiODIwYjM0NzEyNzYyMS90YWJsZXJhbmdlOjAyMmFmYWM0ZWE1NDRkOThhOGI4MjBiMzQ3MTI3NjIxXzEtMy0xLTEtMjY1MjQ3_6d0851fd-dded-47a3-9720-cd54d8270a8e"
      unitRef="usd">404000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if240ee4b0e0f42d0b398179a94077c59_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTowMjJhZmFjNGVhNTQ0ZDk4YThiODIwYjM0NzEyNzYyMS90YWJsZXJhbmdlOjAyMmFmYWM0ZWE1NDRkOThhOGI4MjBiMzQ3MTI3NjIxXzEtNS0xLTEtMjY1MjQ3_f49d7d92-54fa-415a-af75-747f677af70b"
      unitRef="usd">329000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTowMjJhZmFjNGVhNTQ0ZDk4YThiODIwYjM0NzEyNzYyMS90YWJsZXJhbmdlOjAyMmFmYWM0ZWE1NDRkOThhOGI4MjBiMzQ3MTI3NjIxXzItMS0xLTEtMjY1MjQ3_d9f0a005-e526-4b34-95ad-c318fc96197f"
      unitRef="usd">78000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i983d904f9748498597906f71baf2d240_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTowMjJhZmFjNGVhNTQ0ZDk4YThiODIwYjM0NzEyNzYyMS90YWJsZXJhbmdlOjAyMmFmYWM0ZWE1NDRkOThhOGI4MjBiMzQ3MTI3NjIxXzItMy0xLTEtMjY1MjQ3_e35c4086-0376-4257-b19b-09b29af56cd4"
      unitRef="usd">80000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iadd17fda7e474b46b4ac5a0ddb578ebe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTowMjJhZmFjNGVhNTQ0ZDk4YThiODIwYjM0NzEyNzYyMS90YWJsZXJhbmdlOjAyMmFmYWM0ZWE1NDRkOThhOGI4MjBiMzQ3MTI3NjIxXzItNS0xLTEtMjY1MjQ3_08343b28-7ba7-40b1-a9b1-8b91c0cb16b7"
      unitRef="usd">71000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTowMjJhZmFjNGVhNTQ0ZDk4YThiODIwYjM0NzEyNzYyMS90YWJsZXJhbmdlOjAyMmFmYWM0ZWE1NDRkOThhOGI4MjBiMzQ3MTI3NjIxXzMtMS0xLTEtMjY1MjQ3_b5c1c0da-84ea-4321-8af1-807b3326754c"
      unitRef="usd">447000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTowMjJhZmFjNGVhNTQ0ZDk4YThiODIwYjM0NzEyNzYyMS90YWJsZXJhbmdlOjAyMmFmYWM0ZWE1NDRkOThhOGI4MjBiMzQ3MTI3NjIxXzMtMy0xLTEtMjY1MjQ3_a20e2d9b-ec15-46ac-aad2-5fadb272bf5a"
      unitRef="usd">484000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTowMjJhZmFjNGVhNTQ0ZDk4YThiODIwYjM0NzEyNzYyMS90YWJsZXJhbmdlOjAyMmFmYWM0ZWE1NDRkOThhOGI4MjBiMzQ3MTI3NjIxXzMtNS0xLTEtMjY1MjQ3_ed19b41c-8c4a-4242-9cab-f2ee65e9b385"
      unitRef="usd">400000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i70ba7d8cc22e4bd9aed774540fbc5a2a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzM0Nzk_8f9619b6-e6a1-4208-918e-83c329d59a6e"
      unitRef="usd">619000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i8a7879ca683449ffa5da3418bf44e68d_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzM3MDE_c9fd6a44-602f-4273-a201-d20c25740c9e">P2Y1M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i8a7879ca683449ffa5da3418bf44e68d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzM3ODQ_347cd0af-abf3-4261-9251-9d1426f128a4"
      unitRef="usd">328000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="id4b79b50a55d4d81bf3f34a3889c23df_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzM3ODg_76b1cbc3-2c2c-4815-8341-fa18959a0341"
      unitRef="usd">406000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="if240ee4b0e0f42d0b398179a94077c59_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzM3OTU_c0e1e199-8807-4649-aa03-db5efdbe75fa"
      unitRef="usd">229000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzg0NDk_b2753a64-9b90-4d85-9ddd-6d69c0501fab">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the restricted stock unit and performance stock unit activity for the&#160;year ended December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In thousands, except weighted average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year, nonvested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,626)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,421)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of year, nonvested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Vested performance stock units have been included at target level performance. Based on actual performance, the number of restricted stock units and performance stock units vested during the year ended December 31, 2022 was 8.0&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i84d934c3f64d4e02a86157aaa7bdff55_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxZjFhYmNiYTZlOWU0MTBlYmY0ZDk4YzA4ZGUzNDg5ZC90YWJsZXJhbmdlOjFmMWFiY2JhNmU5ZTQxMGViZjRkOThjMDhkZTM0ODlkXzEtMS0xLTEtMjY1MjQ3_60c2a7b5-a187-44df-b59b-7cbb5b80d67f"
      unitRef="shares">14330000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i84d934c3f64d4e02a86157aaa7bdff55_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxZjFhYmNiYTZlOWU0MTBlYmY0ZDk4YzA4ZGUzNDg5ZC90YWJsZXJhbmdlOjFmMWFiY2JhNmU5ZTQxMGViZjRkOThjMDhkZTM0ODlkXzEtMy0xLTEtMjY1MjQ3_2034317c-02c6-4af9-9385-5e0388e5fa53"
      unitRef="usdPerShare">63.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i8a7879ca683449ffa5da3418bf44e68d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxZjFhYmNiYTZlOWU0MTBlYmY0ZDk4YzA4ZGUzNDg5ZC90YWJsZXJhbmdlOjFmMWFiY2JhNmU5ZTQxMGViZjRkOThjMDhkZTM0ODlkXzItMS0xLTEtMjY1MjQ3_1402b9f3-2739-4c3b-a7b8-90f202bbf3a6"
      unitRef="shares">5398000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8a7879ca683449ffa5da3418bf44e68d_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxZjFhYmNiYTZlOWU0MTBlYmY0ZDk4YzA4ZGUzNDg5ZC90YWJsZXJhbmdlOjFmMWFiY2JhNmU5ZTQxMGViZjRkOThjMDhkZTM0ODlkXzItMy0xLTEtMjY1MjQ3_36332089-f797-4f16-be43-c5b8ae68a2c6"
      unitRef="usdPerShare">101.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i8a7879ca683449ffa5da3418bf44e68d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxZjFhYmNiYTZlOWU0MTBlYmY0ZDk4YzA4ZGUzNDg5ZC90YWJsZXJhbmdlOjFmMWFiY2JhNmU5ZTQxMGViZjRkOThjMDhkZTM0ODlkXzMtMS0xLTEtMjY1MjQ3_1b78ea89-4836-4368-a96e-0ac8ac5d400e"
      unitRef="shares">5626000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8a7879ca683449ffa5da3418bf44e68d_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxZjFhYmNiYTZlOWU0MTBlYmY0ZDk4YzA4ZGUzNDg5ZC90YWJsZXJhbmdlOjFmMWFiY2JhNmU5ZTQxMGViZjRkOThjMDhkZTM0ODlkXzMtMy0xLTEtMjY1MjQ3_60c8d0a3-e2fe-4dc8-98ed-27c50baae962"
      unitRef="usdPerShare">58.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i8a7879ca683449ffa5da3418bf44e68d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxZjFhYmNiYTZlOWU0MTBlYmY0ZDk4YzA4ZGUzNDg5ZC90YWJsZXJhbmdlOjFmMWFiY2JhNmU5ZTQxMGViZjRkOThjMDhkZTM0ODlkXzQtMS0xLTEtMjY1MjQ3_070a2e5d-3727-4c1f-bad5-3101d720ddd8"
      unitRef="shares">1421000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i8a7879ca683449ffa5da3418bf44e68d_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxZjFhYmNiYTZlOWU0MTBlYmY0ZDk4YzA4ZGUzNDg5ZC90YWJsZXJhbmdlOjFmMWFiY2JhNmU5ZTQxMGViZjRkOThjMDhkZTM0ODlkXzQtMy0xLTEtMjY1MjQ3_ed99783d-5ff0-441e-a157-b5f8124c485e"
      unitRef="usdPerShare">72.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i70ba7d8cc22e4bd9aed774540fbc5a2a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxZjFhYmNiYTZlOWU0MTBlYmY0ZDk4YzA4ZGUzNDg5ZC90YWJsZXJhbmdlOjFmMWFiY2JhNmU5ZTQxMGViZjRkOThjMDhkZTM0ODlkXzUtMS0xLTEtMjY1MjQ3_51d3238b-89e9-4c1f-8897-6172058d9ba2"
      unitRef="shares">12681000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i70ba7d8cc22e4bd9aed774540fbc5a2a_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxZjFhYmNiYTZlOWU0MTBlYmY0ZDk4YzA4ZGUzNDg5ZC90YWJsZXJhbmdlOjFmMWFiY2JhNmU5ZTQxMGViZjRkOThjMDhkZTM0ODlkXzUtMy0xLTEtMjY1MjQ3_4fc74096-3377-4cfb-ae3a-3500c3cfef77"
      unitRef="usdPerShare">80.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates
      contextRef="i8a7879ca683449ffa5da3418bf44e68d_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzQyMDg_3a997f62-9526-4db6-84b0-fa7882238103"
      unitRef="shares">8000000</cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i1ff8661ca2c148108297d7a193977a4b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzg0NTg_02d99038-f5d0-41b9-a99e-8be827a74cae">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ib929cd58d3cb4a4096643aeea5fb40bb_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzQ2NDk_cf22045a-d9ca-4c77-9686-097d77e08b59">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i73e8856343074dedba7db4a6c8fffe3a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzQ3MzI_90a7e2a2-1589-4f27-b765-10e85766b8e4">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="idc7553fd8525450491acaa6901e0117c_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzg0NDQ_fae2bcc4-b7ac-4b37-934b-9d0f9edcc022">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="idc7553fd8525450491acaa6901e0117c_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzUzNzQ_b48862fd-4b76-4f76-baef-fd29683bb3cc">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzg0NDE_d26d2760-a2b6-4752-937f-3b80b06ac5f6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of stock option and SAR activity that occurred for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received from stock options exercised (including ESPP)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for taxes for net share settlement of equity awards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intrinsic value of stock options and SARs exercised &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of stock options and SARs vested &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzEtMS0xLTEtMjY1MjQ3_176946e1-3977-4d68-856b-43f90714daff"
      unitRef="usd">551000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i983d904f9748498597906f71baf2d240_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzEtMy0xLTEtMjY1MjQ3_5048b118-e6f2-4e06-add5-1f7e21b31634"
      unitRef="usd">549000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="iadd17fda7e474b46b4ac5a0ddb578ebe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzEtNS0xLTEtMjY1MjQ3_64d02739-b71c-444a-86d5-be1d3e67a463"
      unitRef="usd">264000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzItMS0xLTEtMjY1MjQ3_7e22ca14-44f2-4046-8357-7a8b84108b91"
      unitRef="usd">370000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i983d904f9748498597906f71baf2d240_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzItMy0xLTEtMjY1MjQ3_c10885ab-d9a9-46e1-aceb-c6d16479505d"
      unitRef="usd">168000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iadd17fda7e474b46b4ac5a0ddb578ebe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzItNS0xLTEtMjY1MjQ3_aef18a5b-4433-438f-9b92-4209e61ce766"
      unitRef="usd">88000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzMtMS0xLTEtMjY1MjQ3_e67cf68c-3982-484f-b62d-55a68e67e63f"
      unitRef="usd">118000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i983d904f9748498597906f71baf2d240_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzMtMy0xLTEtMjY1MjQ3_ac051961-0581-4cc6-81dc-4e23a6e1ab0a"
      unitRef="usd">105000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="iadd17fda7e474b46b4ac5a0ddb578ebe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzMtNS0xLTEtMjY1MjQ3_f9571e08-cf9f-4ca0-bf83-6bcd44908347"
      unitRef="usd">24000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue
      contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzQtMS0xLTEtMjY1MjQ3_dfdcd76e-1160-4e6a-93c7-0bfed918c1a7"
      unitRef="usd">219000000</cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue>
    <cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue
      contextRef="i983d904f9748498597906f71baf2d240_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzQtMy0xLTEtMjY1MjQ3_619762dd-1cf6-4a48-8f95-dbbb4f70fdf5"
      unitRef="usd">224000000</cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue>
    <cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue
      contextRef="iadd17fda7e474b46b4ac5a0ddb578ebe_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTpmMGQ4ZWZjYzkxZDA0OWNjODFjOGMzMTI1NTk3OTllZi90YWJsZXJhbmdlOmYwZDhlZmNjOTFkMDQ5Y2M4MWM4YzMxMjU1OTc5OWVmXzQtNS0xLTEtMjY1MjQ3_6b0fcc36-8698-44e0-90d6-702336520212"
      unitRef="usd">252000000</cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzg0NDI_6d87d586-8829-4f23-9395-72da7bf6189e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each stock option is estimated using the Black-Scholes option pricing model based on the following assumptions at the time of grant:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The dividend yield is based on annual dividends paid and the fair market value of CVS Health Corporation stock at the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected volatility is estimated based on the historical volatility of CVS Health Corporation&#x2019;s daily stock price over a period equal to the expected life of each option grant after adjustments for infrequent events such as stock splits.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The risk-free interest rate is selected based on yields from U.S. Treasury zero-coupon issues with a remaining term equal to the expected term of the options being valued.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected life represents the number of&#160;years the options are expected to be outstanding from grant date based on historical option or SAR holder exercise experience.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i1ff8661ca2c148108297d7a193977a4b_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzEtMS0xLTEtMjY1MjQ3_8681f5d9-e4a1-4c94-bee5-6f130f3f69ab"
      unitRef="number">0.0218</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ie6f1a0aed7b14023be37031ee7e6081d_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzEtMy0xLTEtMjY1MjQ3_9386cf1a-aeb6-4ff8-9afa-8b998781b7c6"
      unitRef="number">0.0268</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i6f45fbcf1c62442cb073a0677f6e9707_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzEtNS0xLTEtMjY1MjQ3_48195037-356a-4637-baf3-ac691186b7e9"
      unitRef="number">0.0342</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i1ff8661ca2c148108297d7a193977a4b_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzItMS0xLTEtMjY1MjQ3_8c5b67fa-d701-4aa3-bd5a-1094d06af152"
      unitRef="number">0.2734</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ie6f1a0aed7b14023be37031ee7e6081d_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzItMy0xLTEtMjY1MjQ3_9506d7c5-43df-433d-9c4a-778d82e311db"
      unitRef="number">0.2710</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i6f45fbcf1c62442cb073a0677f6e9707_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzItNS0xLTEtMjY1MjQ3_36ba0d25-6072-4bcb-806f-24849e02420d"
      unitRef="number">0.2522</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i1ff8661ca2c148108297d7a193977a4b_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzMtMS0xLTEtMjY1MjQ3_b22af4b2-c5e6-4856-a5c3-436658fc5ad2"
      unitRef="number">0.0246</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ie6f1a0aed7b14023be37031ee7e6081d_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzMtMy0xLTEtMjY1MjQ3_92f1de93-cfe5-4037-8c19-e9a69105ee68"
      unitRef="number">0.0113</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i6f45fbcf1c62442cb073a0677f6e9707_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzMtNS0xLTEtMjY1MjQ3_5f06d851-1bc0-4ea1-9454-ed6722bef160"
      unitRef="number">0.0061</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i1ff8661ca2c148108297d7a193977a4b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzQtMS0xLTEtMjY1MjQ3_ea089685-cae6-4989-8945-d54ff1952aa4">P6Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ie6f1a0aed7b14023be37031ee7e6081d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzQtMy0xLTEtMjY1MjQ3_3d72d396-2587-4519-b815-f5742b6b44a2">P6Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i6f45fbcf1c62442cb073a0677f6e9707_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzQtNS0xLTEtMjY1MjQ3_7af383a5-a83f-417b-99d6-a71b7ccd0b68">P6Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i1ff8661ca2c148108297d7a193977a4b_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzUtMS0xLTEtMjY1MjQ3_62798dbb-c1be-4fc7-90a6-dde8951509c7"
      unitRef="usdPerShare">24.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie6f1a0aed7b14023be37031ee7e6081d_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzUtMy0xLTEtMjY1MjQ3_ac684436-cc1e-48f1-954e-4701075c2cce"
      unitRef="usdPerShare">14.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6f45fbcf1c62442cb073a0677f6e9707_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTo0ZThhM2M2ODVkODY0NTNhYTdmZjVjYTJlZTMxNWM5MS90YWJsZXJhbmdlOjRlOGEzYzY4NWQ4NjQ1M2FhN2ZmNWNhMmVlMzE1YzkxXzUtNS0xLTEtMjY1MjQ3_44ee2f5e-a4da-4a30-bd79-fbd02a2c628f"
      unitRef="usdPerShare">8.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i2310964202714b25bc144cf465c755a8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzY1ODE_fec1611e-e29c-4444-9c1b-3da802a0457d"
      unitRef="usd">41000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzY2NjI_913a1bea-4aae-4566-886e-af5ea1acc88a">P1Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber
      contextRef="i2310964202714b25bc144cf465c755a8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzY3NDM_5a90d6db-207c-4f05-baba-e23307e1f1c1"
      unitRef="shares">7000000</cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzg0NTE_2e4bf05d-2e33-4703-aac5-578cce8e8574">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s stock option and SAR activity for the&#160;year ended December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;thousands, except weighted average exercise price and remaining contractual term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,921)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(478)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.52&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.76&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at end of year and expected to vest in the future&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.47&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i1075aa911329487a922a9ba44f7a262d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzEtMS0xLTEtMjY1MjQ3_ebb85acd-6307-455e-a958-7793cdc395df"
      unitRef="shares">19061000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i1075aa911329487a922a9ba44f7a262d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzEtMy0xLTEtMjY1MjQ3_3ec1a6d7-0fa8-4cfe-83e5-27e041a2a9ea"
      unitRef="usdPerShare">71.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzItMS0xLTEtMjY1MjQ3_524ca5db-caaf-4b39-83d1-eb37bb916114"
      unitRef="shares">1993000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzItMy0xLTEtMjY1MjQ3_d03eddbd-b70f-4445-bee2-0a6969d98f0c"
      unitRef="usdPerShare">101.04</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzMtMS0xLTEtMjY1MjQ3_68942663-a63c-480d-8e9f-528f668f3f63"
      unitRef="shares">4921000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzMtMy0xLTEtMjY1MjQ3_47cc441d-293f-4a0f-ac01-9cf3f57a4f34"
      unitRef="usdPerShare">75.91</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzQtMS0xLTEtMjY1MjQ3_d26b7e8f-0553-4727-91b9-f227cad0306d"
      unitRef="shares">478000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzQtMy0xLTEtMjY1MjQ3_60ff6d79-f317-470d-820d-ec8f4713d369"
      unitRef="usdPerShare">70.78</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzUtMS0xLTEtMjY1MjQ3_1b8de2ce-24ea-43d8-920e-5625a4f98bff"
      unitRef="shares">615000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzUtMy0xLTEtMjY1MjQ3_fe9d53f1-e8c1-4f38-a130-dfddf5a6e592"
      unitRef="usdPerShare">99.78</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i2310964202714b25bc144cf465c755a8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzYtMS0xLTEtMjY1MjQ3_839f95d0-4e51-43ff-b42d-45c61b64ce94"
      unitRef="shares">15040000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i2310964202714b25bc144cf465c755a8_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzYtMy0xLTEtMjY1MjQ3_797efe75-6252-47f1-9bca-69253b8ede8a"
      unitRef="usdPerShare">73.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzYtNS0xLTEtMjY1MjQ3_4536a8bb-3fd5-4a74-a8dd-ebe204c2269d">P4Y6M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i2310964202714b25bc144cf465c755a8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzYtNy0xLTEtMjY1MjQ3_fa5ba686-ee0f-4b53-a460-c05539301ca5"
      unitRef="usd">340507000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i2310964202714b25bc144cf465c755a8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzctMS0xLTEtMjY1MjQ3_355d10b0-131f-4a54-8b27-926da77bdb2c"
      unitRef="shares">7730000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i2310964202714b25bc144cf465c755a8_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzctMy0xLTEtMjY1MjQ3_f1282418-c3d4-4ceb-bd1a-151c2324d9a1"
      unitRef="usdPerShare">72.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzctNS0xLTEtMjY1MjQ3_614ee1b8-87f2-4386-bb7a-bc8f66a54563">P2Y9M3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i2310964202714b25bc144cf465c755a8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzctNy0xLTEtMjY1MjQ3_5121100f-067e-4e91-aefa-2ed0459ba6e6"
      unitRef="usd">184904000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i2310964202714b25bc144cf465c755a8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzgtMS0xLTEtMjY1MjQ3_64b033c5-22cb-4734-aefd-67daef038753"
      unitRef="shares">14757000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i2310964202714b25bc144cf465c755a8_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzgtMy0xLTEtMjY1MjQ3_b5da0fb9-c364-4bd0-a281-a66bf451e90c"
      unitRef="usdPerShare">72.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i85d4f2d2a0394b3ebd0700e20f040c1e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzgtNS0xLTEtMjY1MjQ3_3b719882-22b5-4f4d-900a-8d4f70bca27c">P4Y5M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i2310964202714b25bc144cf465c755a8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZTplNjhhYmUyNThiNjY0NTZhYmRmODg2ZDExNzcxYTViZi90YWJsZXJhbmdlOmU2OGFiZTI1OGI2NjQ1NmFiZGY4ODZkMTE3NzFhNWJmXzgtNy0xLTEtMjY1MjQ3_8e874963-6100-4c1b-84d7-432c1ac936f9"
      unitRef="usd">336664000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i282e236db6f547ceac0cbccfa36c5851_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzcwMTg_94fc7fcd-8a2a-4950-a4f3-7dca563c684c"
      unitRef="shares">60000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i5c6c53ae9a7745a09f19b70ba79aa0c2_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzcyMDI_0c7aaa00-aeba-4610-b05d-1867fc4ffc3c"
      unitRef="number">0.90</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4XzczMjU_9f8b6540-3968-4a1e-95b2-6f41328f325b"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <cvs:StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzc0MjI_02691822-a4fc-4f4a-a0b2-ce3d288dc9bd"
      unitRef="usdPerShare">78.55</cvs:StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i282e236db6f547ceac0cbccfa36c5851_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzc0NjA_4db07f7d-01be-4685-a378-3cfe7ad65afa"
      unitRef="shares">29000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90ZXh0cmVnaW9uOjhlZDliNDZkYjEzNzQyM2E5MzdkNDg3NDNjMWZjNWY4Xzg0Mzc_4854b19f-8c09-49dd-99ee-a99cd1410619">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the assumptions used to value the ESPP awards for the&#160;years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The dividend yield is calculated based on semi-annual dividends paid and the fair market value of CVS Health Corporation stock at the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected volatility is estimated based on the historical volatility of CVS Health Corporation&#x2019;s daily stock price over the previous six&#160;month period.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The risk-free interest rate is selected based on the Treasury constant maturity interest rate whose term is consistent with the expected term of ESPP purchases (i.e., six&#160;months).&lt;/span&gt;&lt;/div&gt;(4)The expected life is based on the semi-annual purchase period</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i5c6c53ae9a7745a09f19b70ba79aa0c2_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzEtMS0xLTEtMjY1MjQ3_e0e40cba-18c2-49f0-aa4b-30d7b2cbf9eb"
      unitRef="number">0.0112</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i0c6f50abab644dc7a7aa89e157fa28d7_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzEtMy0xLTEtMjY1MjQ3_dff7497c-e212-4ac4-8ab8-eb5ffd92ab1b"
      unitRef="number">0.0134</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i3754a0a6a19e4cec89a94c39d17cded7_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzEtNS0xLTEtMjY1MjQ3_e5ed53a0-6a5e-47eb-8c13-3882bb8d05e9"
      unitRef="number">0.0146</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i5c6c53ae9a7745a09f19b70ba79aa0c2_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzItMS0xLTEtMjY1MjQ3_5f4646df-fb9c-4299-b34e-6ef4682d041f"
      unitRef="number">0.2354</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i0c6f50abab644dc7a7aa89e157fa28d7_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzItMy0xLTEtMjY1MjQ3_710db793-88d6-4ea4-8117-96b21ddc800a"
      unitRef="number">0.2527</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i3754a0a6a19e4cec89a94c39d17cded7_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzItNS0xLTEtMjY1MjQ3_cf23dbda-2349-428b-8928-00c8dc188534"
      unitRef="number">0.3721</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i5c6c53ae9a7745a09f19b70ba79aa0c2_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzMtMS0xLTEtMjY1MjQ3_70bb058d-5031-4637-bae4-4ed2699a56b3"
      unitRef="number">0.0142</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i0c6f50abab644dc7a7aa89e157fa28d7_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzMtMy0xLTEtMjY1MjQ3_b3449e4d-30fd-45f6-8741-f775c715651d"
      unitRef="number">0.0008</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i3754a0a6a19e4cec89a94c39d17cded7_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzMtNS0xLTEtMjY1MjQ3_0f78ab30-28f3-4426-b237-6c653f36381d"
      unitRef="number">0.0081</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i5c6c53ae9a7745a09f19b70ba79aa0c2_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzQtMS0xLTEtMjY1MjQ3_978ecb92-1090-40b0-ad13-128f19cdf7d8">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i0c6f50abab644dc7a7aa89e157fa28d7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzQtMy0xLTEtMjY1MjQ3_37abc527-34a2-42b1-b914-eec760ced2d5">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i3754a0a6a19e4cec89a94c39d17cded7_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzQtNS0xLTEtMjY1MjQ3_ab424b14-f18c-4545-b61b-dcdd55fad4fd">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5c6c53ae9a7745a09f19b70ba79aa0c2_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzUtMS0xLTEtMjY1MjQ3_fbd82b8a-ba5a-4df1-9eba-66bda944a4de"
      unitRef="usdPerShare">16.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0c6f50abab644dc7a7aa89e157fa28d7_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzUtMy0xLTEtMjY1MjQ3_3ce9c498-ff5a-484c-836e-7a9f2a801046"
      unitRef="usdPerShare">12.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3754a0a6a19e4cec89a94c39d17cded7_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNTcvZnJhZzo4ZWQ5YjQ2ZGIxMzc0MjNhOTM3ZDQ4NzQzYzFmYzVmOC90YWJsZToxMGM1Y2MxZmI0M2M0NDc4YjFhZjZiYWNjNTc0ZDQzYS90YWJsZXJhbmdlOjEwYzVjYzFmYjQzYzQ0NzhiMWFmNmJhY2M1NzRkNDNhXzUtNS0xLTEtMjY1MjQ3_b77781a6-fe81-4075-8aeb-5332326bde70"
      unitRef="usdPerShare">13.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzUyMzg_0511226e-2156-4013-94a3-db0e1454b14d">Shareholders&#x2019; Equity&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following share repurchase programs have been authorized by the Board:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In billions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Authorization&#160;Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Remaining as of&lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 17, 2022 (&#x201c;2022 Repurchase Program&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 9, 2021 (&#x201c;2021 Repurchase Program&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each of the share Repurchase Programs was effective immediately and permit the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase (&#x201c;ASR&#x201d;) transactions, and/or other derivative transactions. Both the 2022 and 2021 Repurchase Programs can be modified or terminated by the Board at any time.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2022, the Company repurchased an aggregate of 34.1&#160;million shares of common stock for approximately $3.5&#160;billion pursuant to the 2021 Repurchase Program, including share repurchases under the $1.5&#160;billion fixed dollar ASR transaction described below. During the years ended December&#160;31, 2021 and 2020, the Company did not repurchase any shares of common stock.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $2.0&#160;billion fixed dollar ASR with Citibank, N.A. (&#x201c;Citibank&#x201d;). Upon payment of the $2.0&#160;billion purchase price on January 4, 2023, the Company received a number of shares of CVS Health Corporation&#x2019;s common stock equal to 80% of the $2.0&#160;billion notional amount of the ASR or approximately 17.4 million shares at a price of $92.19 per share, which were placed into treasury stock in January 2023. At the conclusion of the ASR, the Company may receive additional shares representing the remaining 20% of the $2.0&#160;billion notional amount. The ultimate number of shares the Company may receive will depend on the daily volume-weighted average price of the Company&#x2019;s stock over an averaging period, less a discount. It is also possible, depending on such weighted average price, that the Company will have an obligation to Citibank which, at the Company&#x2019;s option, could be settled in additional cash or by issuing shares. Under the terms of the ASR, the maximum number of shares that could be delivered to the Company is 43.4 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $1.5&#160;billion fixed dollar ASR with Barclays Bank PLC. Upon payment of the $1.5&#160;billion purchase price on January 4, 2022, the Company received a number of shares of CVS Health Corporation&#x2019;s common stock equal to 80% of the $1.5&#160;billion notional amount of the ASR or approximately 11.6&#160;million shares at a price of $103.34 per share, which were placed into treasury stock in January 2022. The ASR was accounted for as an initial treasury stock transaction for $1.2&#160;billion and a forward contract for $0.3&#160;billion. The forward contract was classified as an equity instrument and was recorded within capital surplus. In February 2022, the Company received approximately 2.7&#160;million shares of CVS Health Corporation&#x2019;s common stock, representing the remaining &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20% of the $1.5&#160;billion notional amount of the ASR, thereby concluding the ASR. These shares were placed into treasury stock and the forward contract was reclassified from capital surplus to treasury stock in February 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the time they were received, the initial and final receipt of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted average common shares outstanding for basic and diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The quarterly cash dividend declared by the Board was $0.55 and $0.50 per share in 2022 and 2021, respectively. In December 2022, the Board authorized a 10% increase in the quarterly cash dividend to $0.605 per share effective in 2023. CVS Health Corporation has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#x2019;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Regulatory Requirements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s insurance business operations are conducted through subsidiaries that principally consist of health maintenance organizations (&#x201c;HMOs&#x201d;) and insurance companies. The Company&#x2019;s HMO and insurance subsidiaries report their financial statements in accordance with accounting practices prescribed by state regulatory authorities which may differ from GAAP. The combined statutory net income for the years ended and estimated combined statutory and capital surplus at December&#160;31, 2022, 2021 and 2020 for the Company&#x2019;s insurance and HMO subsidiaries were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statutory net income &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated statutory capital and surplus&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s insurance and HMO subsidiaries paid $3.2 billion of gross dividends to the Company for the year ended December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to general state law restrictions on payments of dividends and other distributions to stockholders applicable to all corporations, HMOs and insurance companies are subject to further regulations that, among other things, may require those companies to maintain certain levels of equity and restrict the amount of dividends and other distributions that may be paid to their equity holders. In addition, in connection with the Aetna Acquisition, the Company made certain undertakings that require prior regulatory approval of dividends by certain of its HMOs and insurance companies. At December&#160;31, 2022, these amounts were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated minimum statutory surplus required by regulators&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments on deposit with regulatory bodies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated maximum dividend distributions permitted in 2023 without prior regulatory approval&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022 and 2021, noncontrolling interests were $300 million and $306 million, respectively, primarily related to third party interests in the Company&#x2019;s operating entities.&#160;The noncontrolling entities&#x2019; share is included in total shareholders&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; equity on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzUyNTc_4838adae-94d5-44bd-ac55-f80b33acc48e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following share repurchase programs have been authorized by the Board:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In billions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Authorization&#160;Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Remaining as of&lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 17, 2022 (&#x201c;2022 Repurchase Program&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 9, 2021 (&#x201c;2021 Repurchase Program&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ibad8baec27da4cd58b6724ab5ca623d2_I20221117"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZTo2MGFmMTE4MWM5YTM0M2UzYTM5Njg1YjgwZmMwNjg3Zi90YWJsZXJhbmdlOjYwYWYxMTgxYzlhMzQzZTNhMzk2ODViODBmYzA2ODdmXzEtMS0xLTEtMjY1MjQ3_01bb9a25-c8c6-4944-84a6-f70f169ec1cf"
      unitRef="usd">10000000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="ia92776d15fb0441ab7ac651bee86eba1_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZTo2MGFmMTE4MWM5YTM0M2UzYTM5Njg1YjgwZmMwNjg3Zi90YWJsZXJhbmdlOjYwYWYxMTgxYzlhMzQzZTNhMzk2ODViODBmYzA2ODdmXzEtMy0xLTEtMjY1MjQ3_ff7ac19b-5da6-4044-8579-c75d622300fc"
      unitRef="usd">10000000000.0</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i7008e24144824bc0af76d8c285ae7f14_I20211209"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZTo2MGFmMTE4MWM5YTM0M2UzYTM5Njg1YjgwZmMwNjg3Zi90YWJsZXJhbmdlOjYwYWYxMTgxYzlhMzQzZTNhMzk2ODViODBmYzA2ODdmXzItMS0xLTEtMjY1MjQ3_79852f7b-119e-4841-a0c7-fb5e3813241a"
      unitRef="usd">10000000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i5a3166170d724c7b97874fd6a4dd3558_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZTo2MGFmMTE4MWM5YTM0M2UzYTM5Njg1YjgwZmMwNjg3Zi90YWJsZXJhbmdlOjYwYWYxMTgxYzlhMzQzZTNhMzk2ODViODBmYzA2ODdmXzItMy0xLTEtMjY1MjQ3_44f281aa-1443-484a-a62c-b8d068bdc9a1"
      unitRef="usd">6500000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i8e288b240a5b4df481e15c83675a98b4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzU5Mg_fc0d1b8a-22f0-4021-91b1-2598bcccf6f2"
      unitRef="shares">34100000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i8e288b240a5b4df481e15c83675a98b4_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzYzNg_ad26d6f8-3678-4b72-b3f1-13a5e03740f9"
      unitRef="usd">3500000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <cvs:PaymentsForAcceleratedShareRepurchasesAmount
      contextRef="i1bffae2ffcf645319842b632734137ce_D20220104-20220104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzcxOA_aa174b4b-db2e-4155-a5ba-027e9f71acc7"
      unitRef="usd">1500000000</cvs:PaymentsForAcceleratedShareRepurchasesAmount>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzgxNw_bfaad557-12eb-44cb-951e-3ff482c56454"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzgxNw_dc217d1f-9693-4b28-b959-562645bcdf43"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <cvs:AcceleratedShareRepurchasesAgreementAmount
      contextRef="i84ac2198cd22435ba1570e2db00d59e9_I20230104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzk1Mw_8d53bbcc-d2fd-4c9d-a881-af64e8a2cf13"
      unitRef="usd">2000000000</cvs:AcceleratedShareRepurchasesAgreementAmount>
    <cvs:PaymentsForAcceleratedShareRepurchasesAmount
      contextRef="i25c547443c724d349e0e7af7c9e93168_D20230104-20230104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzEwMjc_ed53e341-f4c6-4753-9f9a-71f4370d5921"
      unitRef="usd">2000000000</cvs:PaymentsForAcceleratedShareRepurchasesAmount>
    <cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares
      contextRef="i84ac2198cd22435ba1570e2db00d59e9_I20230104"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzExNTU_fdd56c26-ce83-48f0-a901-49da6fd39c89"
      unitRef="number">0.80</cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares>
    <cvs:AcceleratedShareRepurchasesAgreementAmount
      contextRef="i84ac2198cd22435ba1570e2db00d59e9_I20230104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzExNjU_37d539a4-d975-4daf-ad1c-f36dfc0e1f4a"
      unitRef="usd">2000000000</cvs:AcceleratedShareRepurchasesAgreementAmount>
    <cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased
      contextRef="i84ac2198cd22435ba1570e2db00d59e9_I20230104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzEyMTI_aa61363c-7c90-4284-b0b5-d9ff30396057"
      unitRef="shares">17400000</cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased>
    <us-gaap:SharePrice
      contextRef="i84ac2198cd22435ba1570e2db00d59e9_I20230104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzEyMzY_a3d1f79a-8362-42e8-82dd-651d711fd020"
      unitRef="usdPerShare">92.19</us-gaap:SharePrice>
    <cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram
      contextRef="i84ac2198cd22435ba1570e2db00d59e9_I20230104"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzEzOTQ_a71e94f4-3d59-415b-9d76-709b62366367"
      unitRef="number">0.20</cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram>
    <cvs:AcceleratedShareRepurchasesAgreementAmount
      contextRef="i84ac2198cd22435ba1570e2db00d59e9_I20230104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzE0MDQ_b8bfe709-39a3-4102-a218-45f9ffd01c2e"
      unitRef="usd">2000000000</cvs:AcceleratedShareRepurchasesAgreementAmount>
    <cvs:AcceleratedShareRepurchaseProgramMaximumNumberOfShares
      contextRef="i84ac2198cd22435ba1570e2db00d59e9_I20230104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzE5MDQ_fca64a1c-a918-4f23-81df-3ef6a6672780"
      unitRef="shares">43400000</cvs:AcceleratedShareRepurchaseProgramMaximumNumberOfShares>
    <cvs:AcceleratedShareRepurchasesAgreementAmount
      contextRef="i3d0b0cadc79d4115ba44a2ff3d97605e_I20220104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzIwMDE_144d1258-863d-4bef-b08a-b30f4b0777a6"
      unitRef="usd">1500000000</cvs:AcceleratedShareRepurchasesAgreementAmount>
    <cvs:PaymentsForAcceleratedShareRepurchasesAmount
      contextRef="i1bffae2ffcf645319842b632734137ce_D20220104-20220104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzIwNjU_aa174b4b-db2e-4155-a5ba-027e9f71acc7"
      unitRef="usd">1500000000</cvs:PaymentsForAcceleratedShareRepurchasesAmount>
    <cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares
      contextRef="i3d0b0cadc79d4115ba44a2ff3d97605e_I20220104"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzIxOTM_39472dde-7550-4adc-8ae9-24236514406f"
      unitRef="number">0.80</cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares>
    <cvs:AcceleratedShareRepurchasesAgreementAmount
      contextRef="i3d0b0cadc79d4115ba44a2ff3d97605e_I20220104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzIyMDM_6cc3545a-9d1b-4371-b1d6-1c3decfef1c8"
      unitRef="usd">1500000000</cvs:AcceleratedShareRepurchasesAgreementAmount>
    <cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased
      contextRef="i3d0b0cadc79d4115ba44a2ff3d97605e_I20220104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzIyNTA_4ab4bbe9-0b05-43ae-8f5c-201a35a7bab4"
      unitRef="shares">11600000</cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased>
    <us-gaap:SharePrice
      contextRef="i3d0b0cadc79d4115ba44a2ff3d97605e_I20220104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzIyNzQ_bad6ba74-3e7b-4192-b062-e97a19e7c9a2"
      unitRef="usdPerShare">103.34</us-gaap:SharePrice>
    <cvs:TransferOfSharesToTreasuryStockValue
      contextRef="i3d0b0cadc79d4115ba44a2ff3d97605e_I20220104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzI0MTQ_f265e838-6844-404e-a929-a6902a9cf73d"
      unitRef="usd">1200000000</cvs:TransferOfSharesToTreasuryStockValue>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i094abc0cc72e4a7b9ea560f3aa3450de_I20220104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzI0NDQ_722670a3-f82f-4374-b6ca-814ce4d12a13"
      unitRef="usd">300000000</us-gaap:DerivativeNotionalAmount>
    <cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased
      contextRef="i17d6d14c27bd46188dd9e2556640612b_I20220228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzI2MDI_d864120b-d29e-4ba5-844e-eeb91ec718cf"
      unitRef="shares">2700000</cvs:AcceleratedShareRepurchasesNumberOfSharesRepurchased>
    <cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram
      contextRef="i17d6d14c27bd46188dd9e2556640612b_I20220228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzI2ODE_7eb0d377-cdbd-4b8e-8733-79d73d24f39b"
      unitRef="number">0.20</cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram>
    <cvs:AcceleratedShareRepurchasesAgreementAmount
      contextRef="i17d6d14c27bd46188dd9e2556640612b_I20220228"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzI2OTE_72eb6a45-5349-437e-a45a-c8a2a57d69ab"
      unitRef="usd">1500000000</cvs:AcceleratedShareRepurchasesAgreementAmount>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i12bf05eff52b4dc7a2761da3f17bd087_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzMyMDE_243d068d-1828-4aed-b21f-8f5d9fd0cc1c"
      unitRef="usdPerShare">0.55</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzMyMDE_a7d0b29e-84fd-4311-8377-30a50f03e45f"
      unitRef="usdPerShare">0.55</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i3549637e3aa64b7ca86fda506d366817_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzMyMDE_a9d7369a-c8bc-4203-99da-cc23c0f04a60"
      unitRef="usdPerShare">0.55</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="id5d6daa4ca684089955a31c220b36c14_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzMyMDE_f10bff9a-95c0-4c89-94d5-a3cfcc01d171"
      unitRef="usdPerShare">0.55</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzMyMDg_30abf26d-65ea-496d-9b56-79c434802fcc"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i59704ef4a59040dea06f0021fcb06568_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzMyMDg_69c38f2f-8550-4f15-a2bf-372278244228"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="ifc442e76415641328a8c0780c2b0fd3b_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzMyMDg_97a88e9b-afb1-4ba0-9de5-450256ac4078"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i52430d6ae75d4b3fae0b76f1ae95568c_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzMyMDg_d934200d-f7ab-4572-a15d-94037b761dd6"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <cvs:DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzMyOTA_f649ce7a-f823-49f0-9b5c-6e9ac68fa430"
      unitRef="number">0.10</cvs:DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i500357364f0b4a8aa0660969b4e7e47e_I20230101"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzMzMzY_fe9ef4f2-349b-4b8f-bda6-c95a2d34add3"
      unitRef="usdPerShare">0.605</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:ScheduleOfRegulatoryAssetsTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzUyNTU_ea8d003f-3a76-4d98-8d4e-969513588a15">The combined statutory net income for the years ended and estimated combined statutory and capital surplus at December&#160;31, 2022, 2021 and 2020 for the Company&#x2019;s insurance and HMO subsidiaries were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statutory net income &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated statutory capital and surplus&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRegulatoryAssetsTextBlock>
    <us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount
      contextRef="i2861b22f2af148719342305921a4f8a9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZTowOGQ2ZTNiZWE2ZGI0ZjEwYWViNTdiMTY4M2U0MGYwNi90YWJsZXJhbmdlOjA4ZDZlM2JlYTZkYjRmMTBhZWI1N2IxNjgzZTQwZjA2XzEtMS0xLTEtMjY1MjQ3_9f399dd4-a6b4-4fed-81aa-e8f7a2a573d3"
      unitRef="usd">2851000000</us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount>
    <us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount
      contextRef="ib3c08b2b0c4e47d4803766dfaa373def_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZTowOGQ2ZTNiZWE2ZGI0ZjEwYWViNTdiMTY4M2U0MGYwNi90YWJsZXJhbmdlOjA4ZDZlM2JlYTZkYjRmMTBhZWI1N2IxNjgzZTQwZjA2XzEtMy0xLTEtMjY1MjQ3_96e25a39-c991-4b39-8c76-ac36908022f3"
      unitRef="usd">3302000000</us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount>
    <us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount
      contextRef="i55bbfd8a1ccf4503a274fb9d768bf153_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZTowOGQ2ZTNiZWE2ZGI0ZjEwYWViNTdiMTY4M2U0MGYwNi90YWJsZXJhbmdlOjA4ZDZlM2JlYTZkYjRmMTBhZWI1N2IxNjgzZTQwZjA2XzEtNS0xLTEtMjY1MjQ3_87c5089c-79e1-47a6-91a9-a03ff638ada3"
      unitRef="usd">3667000000</us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
      contextRef="i10dc16dcaa2a4ba381f65a9a4a83824e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZTowOGQ2ZTNiZWE2ZGI0ZjEwYWViNTdiMTY4M2U0MGYwNi90YWJsZXJhbmdlOjA4ZDZlM2JlYTZkYjRmMTBhZWI1N2IxNjgzZTQwZjA2XzItMS0xLTEtMjY1MjQ3_0b7f93f2-0eb3-40db-8e97-3b9493ccf0ef"
      unitRef="usd">15503000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
      contextRef="i3172ad2aca194783adc959bfa45cb532_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZTowOGQ2ZTNiZWE2ZGI0ZjEwYWViNTdiMTY4M2U0MGYwNi90YWJsZXJhbmdlOjA4ZDZlM2JlYTZkYjRmMTBhZWI1N2IxNjgzZTQwZjA2XzItMy0xLTEtMjY1MjQ3_be803549-2be6-452c-b522-fc5892c1ebbf"
      unitRef="usd">14879000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
      contextRef="ice175d1759f24588b3cf0829061e9e44_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZTowOGQ2ZTNiZWE2ZGI0ZjEwYWViNTdiMTY4M2U0MGYwNi90YWJsZXJhbmdlOjA4ZDZlM2JlYTZkYjRmMTBhZWI1N2IxNjgzZTQwZjA2XzItNS0xLTEtMjY1MjQ3_381663f2-a488-48b9-a8c1-d05e092bbbff"
      unitRef="usd">13238000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance>
    <us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries
      contextRef="i2861b22f2af148719342305921a4f8a9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzQyNTM_ab4badd1-bbfe-453d-8c78-aed5d5d6d615"
      unitRef="usd">3200000000</us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries>
    <us-gaap:StatutoryAccountingPracticesDisclosureTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzUyNDk_6f02bfe7-8db0-41bf-8915-6d25234265e8">At December&#160;31, 2022, these amounts were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated minimum statutory surplus required by regulators&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments on deposit with regulatory bodies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated maximum dividend distributions permitted in 2023 without prior regulatory approval&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:StatutoryAccountingPracticesDisclosureTextBlock>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZToxMDdkMDk1NTJiNzU0NjlhYjhkNzNhODQ5MTZiODI3Yy90YWJsZXJhbmdlOjEwN2QwOTU1MmI3NTQ2OWFiOGQ3M2E4NDkxNmI4MjdjXzEtMS0xLTEtMjY1MjQ3_582bb818-e250-4d8c-89e0-cc015f0a8dab"
      unitRef="usd">7741000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired>
    <us-gaap:AssetsHeldByInsuranceRegulators
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZToxMDdkMDk1NTJiNzU0NjlhYjhkNzNhODQ5MTZiODI3Yy90YWJsZXJhbmdlOjEwN2QwOTU1MmI3NTQ2OWFiOGQ3M2E4NDkxNmI4MjdjXzItMS0xLTEtMjY1MjQ3_65eec683-6074-463a-8c15-4045b91aafb9"
      unitRef="usd">652000000</us-gaap:AssetsHeldByInsuranceRegulators>
    <us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90YWJsZToxMDdkMDk1NTJiNzU0NjlhYjhkNzNhODQ5MTZiODI3Yy90YWJsZXJhbmdlOjEwN2QwOTU1MmI3NTQ2OWFiOGQ3M2E4NDkxNmI4MjdjXzMtMS0xLTEtMjY1MjQ3_81ff9ac2-04b3-47f4-aef4-e02a9b9cc23e"
      unitRef="usd">2706000000</us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval>
    <us-gaap:MinorityInterest
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzUwMTk_b30dc2c8-dd1f-4248-a047-41f521acbd2d"
      unitRef="usd">300000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjAvZnJhZzpjMDEyZmYzMjY3ZGM0N2RlOWI5YjFiZDYyMjc4OGI3Mi90ZXh0cmVnaW9uOmMwMTJmZjMyNjdkYzQ3ZGU5YjliMWJkNjIyNzg4YjcyXzUwMjY_c8d84b3a-8a82-42dc-bf67-c9e7830fb565"
      unitRef="usd">306000000</us-gaap:MinorityInterest>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90ZXh0cmVnaW9uOjVhNmRjNDE2NzM1ZjQyNzU5YTA4YzU4MTdkYzg3ZTljXzk0Mg_376c65d2-e105-4444-901b-f586f3f7192c">Other Comprehensive Income (Loss)&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shareholders&#x2019; equity included the following activity in accumulated other comprehensive income (loss) in 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.169%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.089%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;At December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net unrealized investment gains (losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption of new accounting standard (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;$0, $181 and $0 pretax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(3,021), $(644) and $497 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($315, $(32) and $31 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in discount rate on long-duration insurance reserves:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption of new accounting standard &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($0, $(1,166) and $0 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(906)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($1,126, $328, and $0 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($38, $0 and $(7) pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(15), $(34) and $(35) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension and other postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(229), $20 and $(30) pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($3, $6 and $7 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total beginning of year accumulated other comprehensive income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption of new accounting standard &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(766)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(314)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total end of year accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt; Reflects the adoption of ASU 2018-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; (Topic 944) during the year ended December 31, 2021. See Note 8 &#x2018;&#x2018;Other Insurance Liabilities and Separate Accounts&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included within interest expense in the consolidated statements of operations. The Company expects to reclassify $11 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90ZXh0cmVnaW9uOjVhNmRjNDE2NzM1ZjQyNzU5YTA4YzU4MTdkYzg3ZTljXzk0NA_7a66b6cf-e809-4e49-a866-68c3bf6b30bd">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shareholders&#x2019; equity included the following activity in accumulated other comprehensive income (loss) in 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.169%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.089%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;At December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net unrealized investment gains (losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption of new accounting standard (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;$0, $181 and $0 pretax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(3,021), $(644) and $497 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($315, $(32) and $31 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in discount rate on long-duration insurance reserves:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption of new accounting standard &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($0, $(1,166) and $0 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(906)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($1,126, $328, and $0 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($38, $0 and $(7) pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(15), $(34) and $(35) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension and other postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(229), $20 and $(30) pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($3, $6 and $7 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total beginning of year accumulated other comprehensive income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption of new accounting standard &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(766)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(314)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total end of year accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt; Reflects the adoption of ASU 2018-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; (Topic 944) during the year ended December 31, 2021. See Note 8 &#x2018;&#x2018;Other Insurance Liabilities and Separate Accounts&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included within interest expense in the consolidated statements of operations. The Company expects to reclassify $11 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic9ccb78a44d7465982d030ff243bbb22_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMtMS0xLTEtMjY1MjQ3_dd530374-e41d-4384-944e-6e698dc1d085"
      unitRef="usd">798000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i771fadc404fa4b92b4c5f7223f25415c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMtMy0xLTEtMjY1MjQ3_4cb80f1b-4c34-4344-aa9b-5849c415bc43"
      unitRef="usd">1214000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i88fc675ce48b4c548ef81361fcc6c9d6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMtNS0xLTEtMjY1MjQ3_912f99cb-a945-4472-a198-a7a4245b501d"
      unitRef="usd">774000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax
      contextRef="i1dc4dc90c6c14d12b12e609426ef8a6e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtMC0xLTEtMjk3Mjg2L3RleHRyZWdpb246ZjFmMTU0NTM4ZDJkNDMzOGE1ZTQ2YzczMDBhZDk1N2FfNTQ5NzU1ODEzOTcw_31571511-59db-48ba-a672-9784adb814ab"
      unitRef="usd">0</cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax>
    <cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax
      contextRef="ibcd29ef153c04215b9cfa268ba78b5f0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtMC0xLTEtMjk3Mjg2L3RleHRyZWdpb246ZjFmMTU0NTM4ZDJkNDMzOGE1ZTQ2YzczMDBhZDk1N2FfNTQ5NzU1ODEzOTU1_bf29248d-72b6-4a6e-bb9a-08aa20c79883"
      unitRef="usd">181000000</cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax>
    <cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax
      contextRef="i7f0ef44e552b4f5b981adaa9006f01dc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtMC0xLTEtMjk3Mjg2L3RleHRyZWdpb246ZjFmMTU0NTM4ZDJkNDMzOGE1ZTQ2YzczMDBhZDk1N2FfNTQ5NzU1ODEzOTcz_bc3cd0a1-5d2f-4c7d-85e4-1adaf294e61e"
      unitRef="usd">0</cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1dc4dc90c6c14d12b12e609426ef8a6e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtMS0xLTEtMjk1MDE2_7229370e-2671-4196-83a7-3d51c2cfe491"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibcd29ef153c04215b9cfa268ba78b5f0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtMy0xLTEtMjk1MDE2_a2deda40-75a6-4158-b487-920e6149f8b7"
      unitRef="usd">140000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7f0ef44e552b4f5b981adaa9006f01dc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtNS0xLTEtMjk1MDE2_81fb6c61-1616-4078-9024-143c45619891"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i023f6f414fc44282a2cc8132892a707c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtMC0xLTEtMjY1MjQ3L3RleHRyZWdpb246MDE2MjhlNGE4OTYzNDYwZjk5YzA4OWVmNjkzZmVlZmRfNjQ_02af8aff-78b9-4b14-8284-9eb2ba7b2b33"
      unitRef="usd">-3021000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="iee8d0bfbbe9b491fb9bfa6c2b789c080_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtMC0xLTEtMjY1MjQ3L3RleHRyZWdpb246MDE2MjhlNGE4OTYzNDYwZjk5YzA4OWVmNjkzZmVlZmRfNjg_0f87383d-1999-4665-a1a8-18be797f0b6a"
      unitRef="usd">-644000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i07377a7640384b77a5031acac5ac0cff_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtMC0xLTEtMjY1MjQ3L3RleHRyZWdpb246MDE2MjhlNGE4OTYzNDYwZjk5YzA4OWVmNjkzZmVlZmRfNzU_b4944240-fa47-4bd5-a1a8-1f538e2108aa"
      unitRef="usd">497000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i023f6f414fc44282a2cc8132892a707c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtMS0xLTEtMjY1MjQ3_931d08d6-4a29-4e56-b92b-7b138861d192"
      unitRef="usd">-2556000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iee8d0bfbbe9b491fb9bfa6c2b789c080_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtMy0xLTEtMjY1MjQ3_efdd8ea6-a185-4fd7-8a65-491dedb6cd0d"
      unitRef="usd">-530000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i07377a7640384b77a5031acac5ac0cff_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzQtNS0xLTEtMjY1MjQ3_8072a27b-d865-4fd2-a6ba-e71bb9822465"
      unitRef="usd">415000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i023f6f414fc44282a2cc8132892a707c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzUtMC0xLTEtMjY1MjQ3L3RleHRyZWdpb246ZmQ1OWVkNjFlYjg0NDM0ZDk2OTBiNmNiYWUzMDU1YzJfNzA_3c8f24b8-6e27-4f6f-ac4f-2b5503157223"
      unitRef="usd">315000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="iee8d0bfbbe9b491fb9bfa6c2b789c080_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzUtMC0xLTEtMjY1MjQ3L3RleHRyZWdpb246ZmQ1OWVkNjFlYjg0NDM0ZDk2OTBiNmNiYWUzMDU1YzJfNzQ_058032b3-b971-4378-847a-91c6d0225b20"
      unitRef="usd">-32000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i07377a7640384b77a5031acac5ac0cff_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzUtMC0xLTEtMjY1MjQ3L3RleHRyZWdpb246ZmQ1OWVkNjFlYjg0NDM0ZDk2OTBiNmNiYWUzMDU1YzJfODE_705c6e97-071f-4b3d-a021-e36979377945"
      unitRef="usd">31000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i023f6f414fc44282a2cc8132892a707c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzUtMS0xLTEtMjY1MjQ3_25ce6884-8281-4139-bc0d-0205c9bd8f2a"
      unitRef="usd">-239000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iee8d0bfbbe9b491fb9bfa6c2b789c080_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzUtMy0xLTEtMjY1MjQ3_6d659004-977c-44bf-80b3-fe538745d1b8"
      unitRef="usd">26000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i07377a7640384b77a5031acac5ac0cff_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzUtNS0xLTEtMjY1MjQ3_03014cce-2c3d-41e2-99d3-77d55701816b"
      unitRef="usd">-25000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i023f6f414fc44282a2cc8132892a707c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzYtMS0xLTEtMjY1MjQ3_cf1d55fe-cfb3-48b5-b93d-c9a8e10a28f6"
      unitRef="usd">-2317000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iee8d0bfbbe9b491fb9bfa6c2b789c080_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzYtMy0xLTEtMjY1MjQ3_a3bddcb0-c15d-44bf-afb5-2f21e8b2bf17"
      unitRef="usd">-556000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i07377a7640384b77a5031acac5ac0cff_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzYtNS0xLTEtMjY1MjQ3_a88d176f-ed14-4265-ae26-b1cf777b49f9"
      unitRef="usd">440000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idfb87a5b2adf46d8a1cc7648916f9ec9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzctMS0xLTEtMjY1MjQ3_150a0618-4c19-46e6-80bd-b117d0b761de"
      unitRef="usd">-1519000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic9ccb78a44d7465982d030ff243bbb22_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzctMy0xLTEtMjY1MjQ3_5b6423e3-997b-4daa-aa45-e482569c1842"
      unitRef="usd">798000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i771fadc404fa4b92b4c5f7223f25415c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzctNS0xLTEtMjY1MjQ3_eaacee8b-e003-46ef-9ac5-8060ae974316"
      unitRef="usd">1214000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifea16681bcf147688ca4766b0691becd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzExLTEtMS0xLTI5NDk3Nw_6e86c8e1-3a6f-4206-a809-cc412ee567bf"
      unitRef="usd">-651000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0883ba92f0894b389a5662952ea59782_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzExLTMtMS0xLTI5NDk3Nw_43d68263-3b2d-4eff-823c-b2c8b9844180"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i25433e213492429485a961cd63705c7d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzExLTUtMS0xLTI5NDk3Nw_b6eab1ee-06dd-4acd-9f0c-3cf5c994ef05"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax
      contextRef="ib0cc3bef65884acf9911dabdba462d4a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEyLTAtMS0xLTI5NDUzNy90ZXh0cmVnaW9uOmVkZjAzMTZiMDJjNDRmOGJhY2I0YmM0YTlhYmIzMGY3XzU0OTc1NTgxMzk3NA_bdadc43d-2349-4444-b087-d01b9d2944ec"
      unitRef="usd">0</cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax>
    <cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax
      contextRef="i766e456db6b04cc6983552df4d2bd677_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEyLTAtMS0xLTI5NDUzNy90ZXh0cmVnaW9uOmVkZjAzMTZiMDJjNDRmOGJhY2I0YmM0YTlhYmIzMGY3XzU0OTc1NTgxMzk4MA_39071e68-86bc-4c79-8740-981fcef88c8e"
      unitRef="usd">-1166000000</cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax>
    <cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax
      contextRef="i5e7b828a30914b35b0be92961fa877cb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEyLTAtMS0xLTI5NDUzNy90ZXh0cmVnaW9uOmVkZjAzMTZiMDJjNDRmOGJhY2I0YmM0YTlhYmIzMGY3XzU0OTc1NTgxMzk4OA_b0e315e9-ccc1-428a-8511-c778e0462dff"
      unitRef="usd">0</cvs:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib0cc3bef65884acf9911dabdba462d4a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEyLTEtMS0xLTI5NDk3Nw_78ebd73e-9e18-4553-bf01-e84287137c4b"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i766e456db6b04cc6983552df4d2bd677_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEyLTMtMS0xLTI5NDk3Nw_52cd2cde-7e15-4f35-b5a6-5c72bebadd16"
      unitRef="usd">-906000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5e7b828a30914b35b0be92961fa877cb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEyLTUtMS0xLTI5NDk3Nw_05e574b1-0d9d-4f89-b79d-dbe624e5c732"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i3a4812ee71224d53b0a6f7e8aee63c1c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEzLTAtMS0xLTI5NDUzNy90ZXh0cmVnaW9uOmQ2OWU3MGMxNTI5YjQ3MjhiNmQ4ZGViMGYyYmNkYjdjXzU0OTc1NTgxMzk5Ng_0bfa342a-93bd-452b-8086-07276a99194b"
      unitRef="usd">1126000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i598ca408d2d84a49a1bce5601d7579a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEzLTAtMS0xLTI5NDUzNy90ZXh0cmVnaW9uOmQ2OWU3MGMxNTI5YjQ3MjhiNmQ4ZGViMGYyYmNkYjdjXzU0OTc1NTgxNDAwMQ_a9254fc8-ffc7-4d8b-9cea-62a97297f31e"
      unitRef="usd">328000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i811c61381d624e819e35527aea6e070f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEzLTAtMS0xLTI5NDUzNy90ZXh0cmVnaW9uOmQ2OWU3MGMxNTI5YjQ3MjhiNmQ4ZGViMGYyYmNkYjdjXzU0OTc1NTgxNDAxMA_c82d1415-cbd4-4ce8-b5bf-bcb226580ce3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3a4812ee71224d53b0a6f7e8aee63c1c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEzLTEtMS0xLTI5NDk3Nw_599315ac-31af-4a88-af7f-468f710e8397"
      unitRef="usd">870000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i598ca408d2d84a49a1bce5601d7579a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEzLTMtMS0xLTI5NDk3Nw_6e37657a-323e-4c73-aac1-632d320aa580"
      unitRef="usd">255000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i811c61381d624e819e35527aea6e070f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEzLTUtMS0xLTI5NDk3Nw_d64af2f8-d142-44a8-bef4-a9f872ef1f94"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3a4812ee71224d53b0a6f7e8aee63c1c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE0LTEtMS0xLTI5NDk3Nw_5ca49cbd-ed3a-4de0-bd6f-4840f279ca7a"
      unitRef="usd">870000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i598ca408d2d84a49a1bce5601d7579a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE0LTMtMS0xLTI5NDk3Nw_f14fcea7-41b8-4853-af8d-83df46b39c46"
      unitRef="usd">255000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i811c61381d624e819e35527aea6e070f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE0LTUtMS0xLTI5NDk3Nw_17f7c8a5-e715-417d-ab7c-9f6ef1decd82"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia514adc5b997452badcc59a3cef31271_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE1LTEtMS0xLTI5NDk3Nw_ffd42404-a6cd-4e34-82b7-44561030b166"
      unitRef="usd">219000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifea16681bcf147688ca4766b0691becd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE1LTMtMS0xLTI5NDk3Nw_325a6951-8ad8-4377-9076-47c0d59ddf96"
      unitRef="usd">-651000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0883ba92f0894b389a5662952ea59782_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE1LTUtMS0xLTI5NDk3Nw_78b9d122-7fa3-4a8d-b3bf-469d2e3c7fa9"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i01610c9c48964170846a9803dfaae808_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEwLTEtMS0xLTI2NTI0Nw_223d46d1-36c5-4012-9010-9125ed03fe43"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic5ca31cddc0e4d939c02b38a65d9a6dd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEwLTMtMS0xLTI2NTI0Nw_8fd74e9e-a1b9-49a8-a8ae-cd13a470cefe"
      unitRef="usd">7000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8c92e83572bf462c88118f40349b2650_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEwLTUtMS0xLTI2NTI0Nw_a2387ffe-b039-4730-a420-321841e70a3d"
      unitRef="usd">4000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="icb9f09a01d4b4d99b74e89116f65644f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzExLTEtMS0xLTI2NTI0Nw_f31bef0f-a484-4c7d-bd37-f29e8e582bf0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i22d7007c61d0497e98e462fffb60e872_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzExLTMtMS0xLTI2NTI0Nw_099d21ec-d7b8-4a57-a5c7-0856794965ca"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if125eb5e1f404115a1ed0d00ee58b816_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzExLTUtMS0xLTI2NTI0Nw_8aac507e-d538-4de1-a595-56e3c46d591a"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icb9f09a01d4b4d99b74e89116f65644f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEzLTEtMS0xLTI2NTI0Nw_ad4bd4c1-333b-48ec-8466-53e2418b7257"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i22d7007c61d0497e98e462fffb60e872_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEzLTMtMS0xLTI2NTI0Nw_33001b78-4ccb-4d8a-8408-a0ba3b69d34c"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if125eb5e1f404115a1ed0d00ee58b816_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzEzLTUtMS0xLTI2NTI0Nw_594153e4-65bc-4378-b230-692987217edd"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2aee76db1bb748378d6caddd4053ea53_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE0LTEtMS0xLTI2NTI0Nw_c869dfd8-fc48-4b2d-b2c7-4357b3b71779"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i01610c9c48964170846a9803dfaae808_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE0LTMtMS0xLTI2NTI0Nw_e0c409c2-25fc-4551-965e-fe597a8ed185"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic5ca31cddc0e4d939c02b38a65d9a6dd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE0LTUtMS0xLTI2NTI0Nw_06cd4ea6-a32c-4a6e-b561-b9e9e7098cce"
      unitRef="usd">7000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i90400ed7cb0a406798d26f08b8d43428_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE3LTEtMS0xLTI2NTI0Nw_c9aadbfe-0f85-4f12-b395-89f2d634b012"
      unitRef="usd">222000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i82369985b1244530ab5a13db891d7cb5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE3LTMtMS0xLTI2NTI0Nw_e766dc4b-4c5f-43d4-bed1-5413b73d2a72"
      unitRef="usd">248000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iec1de78285984edda41f8718f4ee9eae_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE3LTUtMS0xLTI2NTI0Nw_9e9ad5e1-e261-4ece-aa5f-6972187e31a4"
      unitRef="usd">279000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ifb77c13970ba4503946c83a942f0b97b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE4LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmI4NDFkYzExM2M1ZTRhODdhYjdkZjQ4MDZlZTY4MjdlXzY0_522ad5ef-53bc-4bd9-8df5-61122d9064cd"
      unitRef="usd">38000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i7f3a20682c0f4c82a18c98153f67cbfd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE4LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmI4NDFkYzExM2M1ZTRhODdhYjdkZjQ4MDZlZTY4MjdlXzY4_45c0424e-2546-4e60-9325-c452621bde9e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i1c4a15704cee48ee8522b657c8eb6247_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE4LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmI4NDFkYzExM2M1ZTRhODdhYjdkZjQ4MDZlZTY4MjdlXzc1_c1dbaed8-b1eb-4e4d-807d-95cf3ed16a1f"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ifb77c13970ba4503946c83a942f0b97b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE4LTEtMS0xLTI2NTI0Nw_209efeef-df8d-43f0-b0c7-7594066178e7"
      unitRef="usd">28000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7f3a20682c0f4c82a18c98153f67cbfd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE4LTMtMS0xLTI2NTI0Nw_71b1a0b4-a602-4c30-825a-86e55ac3b9d1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i1c4a15704cee48ee8522b657c8eb6247_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE4LTUtMS0xLTI2NTI0Nw_e86bef32-0aa0-4cee-8ca1-bcb8f61cd0d1"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ifb77c13970ba4503946c83a942f0b97b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE5LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjYwOWJmMWYwOWNhNTQzMTlhY2Q4NDdlZjgzNDA2NjQxXzcw_c02e6412-6d6d-41a1-936c-ba93588ed022"
      unitRef="usd">-15000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i7f3a20682c0f4c82a18c98153f67cbfd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE5LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjYwOWJmMWYwOWNhNTQzMTlhY2Q4NDdlZjgzNDA2NjQxXzc0_396b68d8-0c5a-4c47-8bbc-10e5a6dbf75d"
      unitRef="usd">-34000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i1c4a15704cee48ee8522b657c8eb6247_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE5LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjYwOWJmMWYwOWNhNTQzMTlhY2Q4NDdlZjgzNDA2NjQxXzgx_54134e58-dc4a-4df1-9241-63cd5bd15fcf"
      unitRef="usd">-35000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ifb77c13970ba4503946c83a942f0b97b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE5LTEtMS0xLTI2NTI0Nw_0b9f2efb-1859-4752-be85-6817accff4b5"
      unitRef="usd">11000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7f3a20682c0f4c82a18c98153f67cbfd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE5LTMtMS0xLTI2NTI0Nw_d2f24195-cc21-4dc6-9437-9b0c7d1530f9"
      unitRef="usd">26000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i1c4a15704cee48ee8522b657c8eb6247_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzE5LTUtMS0xLTI2NTI0Nw_09db0ece-2828-42f8-869b-bb15138e5efe"
      unitRef="usd">26000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifb77c13970ba4503946c83a942f0b97b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzIwLTEtMS0xLTI2NTI0Nw_6a5858e8-c164-4cc6-877e-f098bc986c2f"
      unitRef="usd">17000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7f3a20682c0f4c82a18c98153f67cbfd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzIwLTMtMS0xLTI2NTI0Nw_ef812152-8bc8-4ff4-8bc2-a62a08c1d3e1"
      unitRef="usd">-26000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1c4a15704cee48ee8522b657c8eb6247_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzIwLTUtMS0xLTI2NTI0Nw_c2522340-2c5e-4528-b13f-cef1222f301f"
      unitRef="usd">-31000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if5be5c21fc6b47318e20171c1f0a645b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzIxLTEtMS0xLTI2NTI0Nw_1ca437bb-5897-41fd-9983-cd415880510a"
      unitRef="usd">239000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i90400ed7cb0a406798d26f08b8d43428_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzIxLTMtMS0xLTI2NTI0Nw_ac9a60cd-2809-4121-be46-63de0e4f3e15"
      unitRef="usd">222000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i82369985b1244530ab5a13db891d7cb5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzIxLTUtMS0xLTI2NTI0Nw_4575f35d-0b32-45f2-b99d-cc6ecfa5a483"
      unitRef="usd">248000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6b84989b019a41baa48fa485b7f433eb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI0LTEtMS0xLTI2NTI0Nw_146b6372-30c1-4795-9361-6d5428eca56d"
      unitRef="usd">-35000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1aeff9cdec2548d19148b1b223aae8c8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI0LTMtMS0xLTI2NTI0Nw_238b2e1e-5b72-4b8d-b8f5-3d07921a10e8"
      unitRef="usd">-55000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6f4df77c750240e3a41b042b6e64fc43_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI0LTUtMS0xLTI2NTI0Nw_108d45f9-cfd1-4578-a614-61143cfb11fc"
      unitRef="usd">-38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i0b83d8d8e7104451a4bcacd3638e07ca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI1LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmZmOTU2ODE5MmZmZDRkZTY4MmVjODFlM2E5YTg2M2RiXzY0_de731057-1cc2-4c1b-8b16-666877904416"
      unitRef="usd">-229000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="if885d6ab9e204495a3e6ef113c294079_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI1LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmZmOTU2ODE5MmZmZDRkZTY4MmVjODFlM2E5YTg2M2RiXzY4_e907c823-6791-4a5d-9df9-5fd841a8d94a"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i72d609617ef245bab1355fa62da5e409_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI1LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOmZmOTU2ODE5MmZmZDRkZTY4MmVjODFlM2E5YTg2M2RiXzc1_e4748540-584f-444d-bccc-27928b6fe836"
      unitRef="usd">-30000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i0b83d8d8e7104451a4bcacd3638e07ca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI1LTEtMS0xLTI2NTI0Nw_ce840fd8-0b34-4b00-9f0c-f8417407b528"
      unitRef="usd">-170000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if885d6ab9e204495a3e6ef113c294079_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI1LTMtMS0xLTI2NTI0Nw_d6c7b091-2624-4109-9e4b-6350b93e816b"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i72d609617ef245bab1355fa62da5e409_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI1LTUtMS0xLTI2NTI0Nw_5bdf208b-5eef-46ba-9be5-dc2c96bc10c0"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i0b83d8d8e7104451a4bcacd3638e07ca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI2LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjZhNzA3YjE4OTJiNjRmMzE4Njc4YTQ1YjUwMzRjMjcyXzY4_cd18eeda-294c-4ed4-8648-2e161ff7a0a9"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="if885d6ab9e204495a3e6ef113c294079_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI2LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjZhNzA3YjE4OTJiNjRmMzE4Njc4YTQ1YjUwMzRjMjcyXzcy_078097cc-8f4d-4fd0-b80a-762c28e00560"
      unitRef="usd">6000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i72d609617ef245bab1355fa62da5e409_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI2LTAtMS0xLTI2NTI0Ny90ZXh0cmVnaW9uOjZhNzA3YjE4OTJiNjRmMzE4Njc4YTQ1YjUwMzRjMjcyXzc5_9d9b4ee7-d7b4-49d7-ae29-46799e6331fc"
      unitRef="usd">7000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i0b83d8d8e7104451a4bcacd3638e07ca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI2LTEtMS0xLTI2NTI0Nw_92f172d6-3eef-4be3-8ba5-23b681e848b9"
      unitRef="usd">-2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if885d6ab9e204495a3e6ef113c294079_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI2LTMtMS0xLTI2NTI0Nw_30dd1797-726b-47c2-9c97-90a6c5638f41"
      unitRef="usd">-5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i72d609617ef245bab1355fa62da5e409_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI2LTUtMS0xLTI2NTI0Nw_26266acb-6127-4a84-adcf-8661f78469ac"
      unitRef="usd">-5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0b83d8d8e7104451a4bcacd3638e07ca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI3LTEtMS0xLTI2NTI0Nw_896c55d2-df88-41c5-bbde-807880bfecc3"
      unitRef="usd">-168000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if885d6ab9e204495a3e6ef113c294079_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI3LTMtMS0xLTI2NTI0Nw_0f09f4ec-7ee6-408f-9f1d-309e98241aea"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i72d609617ef245bab1355fa62da5e409_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI3LTUtMS0xLTI2NTI0Nw_526e2fee-7d60-4288-b988-87a29608a8e5"
      unitRef="usd">-17000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7a3276638fa043e8b7afa530e1d05bb2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI4LTEtMS0xLTI2NTI0Nw_8c153557-d948-40bd-a5ce-b926ec411369"
      unitRef="usd">-203000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6b84989b019a41baa48fa485b7f433eb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI4LTMtMS0xLTI2NTI0Nw_2ad8afda-0455-4d60-a1e4-649444566d72"
      unitRef="usd">-35000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1aeff9cdec2548d19148b1b223aae8c8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzI4LTUtMS0xLTI2NTI0Nw_9c59bb95-cc35-404f-b600-0dd1258b6c72"
      unitRef="usd">-55000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4fb000b6c98f4852bdadc304be11feb1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMwLTEtMS0xLTI2NTI0Nw_9f08eb71-89df-4e78-b429-9878aaec5478"
      unitRef="usd">334000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8cf1c76c42274016b31466d614be3e9d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMwLTMtMS0xLTI2NTI0Nw_d5ace3fb-97d4-432a-a2b4-6be79ab68e4e"
      unitRef="usd">1414000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i351a28ebc5774422943a9b3793f826c0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMwLTUtMS0xLTI2NTI0Nw_88b2ca44-ffd2-43d8-8104-5d2fe4649708"
      unitRef="usd">1019000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9e58ede6136947f8b425e9c08cd2ab43_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzM5LTEtMS0xLTI5NTAyOQ_8bc8fb9e-6080-436c-8b3a-8eb7ce88ee89"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iba7e0b37b090469783d9d2507887d647_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzM5LTMtMS0xLTI5NTAyOQ_ae7ef70d-e1e4-4a64-a655-4b439e017d6c"
      unitRef="usd">-766000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i45396cadefb0439195f503c88cc4379c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzM5LTUtMS0xLTI5NTAyOQ_223a7454-860c-4c64-b75e-107716448a97"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMxLTEtMS0xLTI2NTI0Nw_62615017-20b8-477a-a5f6-f1be1a9cdfd0"
      unitRef="usd">-1598000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMxLTMtMS0xLTI2NTI0Nw_08a4bb3c-d248-4268-a182-3a3d9b8cebd6"
      unitRef="usd">-314000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMxLTUtMS0xLTI2NTI0Nw_75934af2-c65c-4634-a557-bf829d2729ba"
      unitRef="usd">395000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic2b7c36808c049e6bacef0812147f213_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMyLTEtMS0xLTI2NTI0Nw_c1363ea5-aae0-42ff-a242-2b08be224026"
      unitRef="usd">-1264000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4fb000b6c98f4852bdadc304be11feb1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMyLTMtMS0xLTI2NTI0Nw_4ad050a5-fc61-45f5-af40-a4ee32d2205d"
      unitRef="usd">334000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8cf1c76c42274016b31466d614be3e9d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90YWJsZTplYTk2NDg3Njc5MDQ0Mzg3YTc3YzJlYTc0ZmY1NWVkMy90YWJsZXJhbmdlOmVhOTY0ODc2NzkwNDQzODdhNzdjMmVhNzRmZjU1ZWQzXzMyLTUtMS0xLTI2NTI0Nw_44b0118f-51e2-441e-8830-7439a2628dbf"
      unitRef="usd">1414000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="if5be5c21fc6b47318e20171c1f0a645b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjMvZnJhZzo1YTZkYzQxNjczNWY0Mjc1OWEwOGM1ODE3ZGM4N2U5Yy90ZXh0cmVnaW9uOjVhNmRjNDE2NzM1ZjQyNzU5YTA4YzU4MTdkYzg3ZTljXzYyNQ_5a4d5c89-01bb-4718-b5b0-d26fd684162d"
      unitRef="usd">11000000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90ZXh0cmVnaW9uOjlhMTYzNDUyMjI0ODQxZTE4ZDFkMDY2ODhjZTQ2YTljXzU4Ng_426c207a-9c77-4044-9a66-45daedd6746f">Earnings Per Share&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share is computed using the treasury stock method. Stock options and SARs to purchase 4 million, 7&#160;million, and 15&#160;million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the years ended December&#160;31, 2022, 2021 and 2020, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of basic and diluted earnings per share from continuing operations for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (income) loss attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units and performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and SARs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share from continuing operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibeb7c35ad88b4db086fed358829f1fca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90ZXh0cmVnaW9uOjlhMTYzNDUyMjI0ODQxZTE4ZDFkMDY2ODhjZTQ2YTljXzEyNQ_1b922398-1f83-44a4-bf92-6a25d80dcb9c"
      unitRef="shares">4000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iac8347b945e247b7ba7d5c565f033409_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90ZXh0cmVnaW9uOjlhMTYzNDUyMjI0ODQxZTE4ZDFkMDY2ODhjZTQ2YTljXzEyOQ_867415fd-11e8-4257-8fd7-2455a01c8944"
      unitRef="shares">7000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5695caba25e84d32ab05654a2de0b06a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90ZXh0cmVnaW9uOjlhMTYzNDUyMjI0ODQxZTE4ZDFkMDY2ODhjZTQ2YTljXzEzNw_a5a184b8-69f5-430b-807c-93659ba77fa1"
      unitRef="shares">15000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90ZXh0cmVnaW9uOjlhMTYzNDUyMjI0ODQxZTE4ZDFkMDY2ODhjZTQ2YTljXzU4Mw_5189cb9f-d521-4984-a2d3-e49552dc9d97">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of basic and diluted earnings per share from continuing operations for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (income) loss attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units and performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and SARs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share from continuing operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzItMS0xLTEtMjY1MjQ3_084cce72-b6ad-4ba2-a7ab-1d1ef2a5d92b"
      unitRef="usd">4327000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzItMy0xLTEtMjY1MjQ3_4f5ed495-9df5-4082-8b65-2634354f12b7"
      unitRef="usd">7989000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzItNS0xLTEtMjY1MjQ3_c8393fa4-7981-48af-996e-e16f32e7611e"
      unitRef="usd">7201000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzQtMS0xLTEtMjY1MjQ3_62aba313-32c8-468b-8b2c-e8459e3d521c"
      unitRef="usd">16000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzQtMy0xLTEtMjY1MjQ3_343cbf7e-1077-45f6-aad0-3a648d46de03"
      unitRef="usd">-12000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzQtNS0xLTEtMjY1MjQ3_85bea384-405d-423e-b5a5-31b3313c7aa4"
      unitRef="usd">13000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzUtMS0xLTEtMjY1MjQ3_8e1dea99-1f38-4f92-ad23-fd3b2e9afcc4"
      unitRef="usd">4311000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzUtMy0xLTEtMjY1MjQ3_a6987219-7d26-4304-93b4-67eb8ded7bdc"
      unitRef="usd">8001000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzUtNS0xLTEtMjY1MjQ3_7eebebdf-059b-45b8-9d48-00ab4fb34414"
      unitRef="usd">7188000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzgtMS0xLTEtMjY1MjQ3_450b527a-f5ed-47f0-ad58-658222a5332e"
      unitRef="shares">1312000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzgtMy0xLTEtMjY1MjQ3_410cb901-a276-4540-a05f-adaca966e7e2"
      unitRef="shares">1319000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzgtNS0xLTEtMjY1MjQ3_adbe30b1-2815-4882-b25e-662916e1ac03"
      unitRef="shares">1309000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i54d9d35ededb400290c122b74d7762fb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzktMS0xLTEtMjY1MjQ3_61f7244f-0aa6-470f-9d51-ccf96bd9fdbe"
      unitRef="shares">6000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i10fcd8594c7341938f00b2bcb419f4c9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzktMy0xLTEtMjY1MjQ3_61655990-bd61-4a7f-a489-64b89cd0f6e5"
      unitRef="shares">6000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic788c95fb5c54497bda6d70714f8f38b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzktNS0xLTEtMjY1MjQ3_cd6db099-b06b-447b-8d22-c078b3636a20"
      unitRef="shares">4000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ibeb7c35ad88b4db086fed358829f1fca_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzEwLTEtMS0xLTI2NTI0Nw_c2a79a7b-442f-4e30-a8b1-02942cb2d22f"
      unitRef="shares">5000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="iac8347b945e247b7ba7d5c565f033409_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzEwLTMtMS0xLTI2NTI0Nw_6ca5a660-4e97-4712-9de9-85b6d50f0514"
      unitRef="shares">4000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i5695caba25e84d32ab05654a2de0b06a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzEwLTUtMS0xLTI2NTI0Nw_5177bc5b-ceb8-4e93-812c-f07fc7e97681"
      unitRef="shares">1000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzExLTEtMS0xLTI2NTI0Nw_395a1153-9e73-4037-aeaf-dd666d379c16"
      unitRef="shares">1323000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzExLTMtMS0xLTI2NTI0Nw_695da984-98fb-40be-b2e7-0d2ade8c92bf"
      unitRef="shares">1329000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzExLTUtMS0xLTI2NTI0Nw_494a15a6-6368-45e7-85a4-57544ca0d5cd"
      unitRef="shares">1314000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzE0LTEtMS0xLTI2NTI0Nw_17352da6-8dc3-4041-a55d-f6cafb0121f0"
      unitRef="usdPerShare">3.29</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzE0LTMtMS0xLTI2NTI0Nw_4cf1a58c-40ee-4fca-9b61-2ea61f9a6d4a"
      unitRef="usdPerShare">6.07</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzE0LTUtMS0xLTI2NTI0Nw_c4e86d90-c873-4bee-84c8-b7f0b09deeaa"
      unitRef="usdPerShare">5.49</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzE1LTEtMS0xLTI2NTI0Nw_0ca71b3a-065a-4e4b-a425-715742ca2db1"
      unitRef="usdPerShare">3.26</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzE1LTMtMS0xLTI2NTI0Nw_487af642-d496-4258-bb02-d74f470e7956"
      unitRef="usdPerShare">6.02</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjYvZnJhZzo5YTE2MzQ1MjIyNDg0MWUxOGQxZDA2Njg4Y2U0NmE5Yy90YWJsZTo0ZjExMDVjYjBjMTE0MWRmODdjYjM2MGY1NzM3NTVhOS90YWJsZXJhbmdlOjRmMTEwNWNiMGMxMTQxZGY4N2NiMzYwZjU3Mzc1NWE5XzE1LTUtMS0xLTI2NTI0Nw_05aa4ad9-acad-4e1e-afad-ab5d45e04233"
      unitRef="usdPerShare">5.47</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:ReinsuranceTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90ZXh0cmVnaW9uOjBjMzVkODgxNjEwMjQwYmZhMGNkODlmOWU4YzZhN2M1XzE2NDA_5ccaf8ba-2295-427a-b058-db8eb5dbee91">Reinsurance&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#x2019;s primary liability as the direct insurer of the risks reinsured.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2023, the Company entered into two four-year reinsurance agreements with an unrelated reinsurer that allow it to reduce required capital and provide collateralized excess of loss reinsurance coverage on a portion of the Health Care Benefits segment&#x2019;s group Commercial Insured business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reinsurance recoverables (recorded as other current assets or other assets on the consolidated balance sheets) at December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reinsurer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hartford Life and Accident Insurance Company&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lincoln Life &amp;amp; Annuity Company of New York&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VOYA Retirement Insurance and Annuity Company &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fresenius Medical Care Reinsurance Company (Cayman) Ltd. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Direct, assumed and ceded premiums earned for the years ended December&#160;31, 2022, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(772)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(680)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(825)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net premiums&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impact of reinsurance on benefit costs for the years ended December&#160;31, 2022, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net benefit costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There is not a material difference between premiums on a written basis versus an earned basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has various agreements with unrelated reinsurers that do not qualify for reinsurance accounting under GAAP, and consequently are accounted for using deposit accounting. The Company entered into these contracts to reduce the risk of catastrophic loss which in turn reduces the Company&#x2019;s capital and surplus requirements. Total deposit assets and liabilities related to reinsurance agreements that do not qualify for reinsurance accounting under GAAP were not material as of December&#160;31, 2022 or 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReinsuranceTextBlock>
    <cvs:NumberofReinsuranceContractsEnteredInto
      contextRef="if8b5128a2a36428d980c81abdc2d74c7_D20230101-20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90ZXh0cmVnaW9uOjBjMzVkODgxNjEwMjQwYmZhMGNkODlmOWU4YzZhN2M1XzQzOQ_65a04a9f-3c2e-4770-afcd-d17262fc8d1d"
      unitRef="reinsurance_agreement">2</cvs:NumberofReinsuranceContractsEnteredInto>
    <cvs:FourYearsReinsuranceAgreementWithUnrelatedInsurer
      contextRef="if8b5128a2a36428d980c81abdc2d74c7_D20230101-20230131"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90ZXh0cmVnaW9uOjBjMzVkODgxNjEwMjQwYmZhMGNkODlmOWU4YzZhN2M1XzE2MzA_c78a2a14-c43e-4dc7-8e63-982faaf6bf35">P4Y</cvs:FourYearsReinsuranceAgreementWithUnrelatedInsurer>
    <us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90ZXh0cmVnaW9uOjBjMzVkODgxNjEwMjQwYmZhMGNkODlmOWU4YzZhN2M1XzE2MzE_0c2e5801-8bd2-4fce-ab81-0f27f3e26cc0">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reinsurance recoverables (recorded as other current assets or other assets on the consolidated balance sheets) at December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reinsurer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hartford Life and Accident Insurance Company&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lincoln Life &amp;amp; Annuity Company of New York&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VOYA Retirement Insurance and Annuity Company &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fresenius Medical Care Reinsurance Company (Cayman) Ltd. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="icfc7256b949f40db867c30ba258ef319_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzItMS0xLTEtMjY1MjQ3_dcceaed2-a3e8-45d3-9382-d8c839089e92"
      unitRef="usd">1549000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i31cd59a8c7b74ded8d867dc5a415def7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzItMy0xLTEtMjY1MjQ3_dcd432b7-860a-4989-bbbf-0274c44363c1"
      unitRef="usd">1902000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i17e2ab802dda4aed8d1d06c6ae11e2f6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzMtMS0xLTEtMjY1MjQ3_0a46f51d-75c8-4a72-9ba4-8243fb41925f"
      unitRef="usd">385000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i67df86d1566f40d3984c59da72c03ce0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzMtMy0xLTEtMjY1MjQ3_6bec00c9-1bd5-4430-9ff7-d1943276de6f"
      unitRef="usd">395000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="ibc5740783a6940949d69470ccd32d19e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzQtMS0xLTEtMjY1MjQ3_9270201c-ccfc-4e8e-803d-cb6aa974c8da"
      unitRef="usd">159000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i20f471f240524ef8b98dd7b01be1b787_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzQtMy0xLTEtMjY1MjQ3_2ee32f4c-25c2-448e-9e55-4bdba93b85fc"
      unitRef="usd">167000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i0162c987e7634f4fae5ee04958939adf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzUtMS0xLTEtMjY1MjQ3_5aa6996f-742b-47df-b447-121939e85e48"
      unitRef="usd">102000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i30bb205b44d94d42bbc0af842bfe1376_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzUtMy0xLTEtMjY1MjQ3_103dda1c-79d6-481c-bd3d-1147784f5443"
      unitRef="usd">46000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i2253b0fadbb64b758c7a25f141c58162_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzYtMS0xLTEtMjY1MjQ3_5557d051-835b-47ef-8630-b1715bcfe2a9"
      unitRef="usd">55000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i91b1f9bf665d415c9bc2b9f98030d772_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzYtMy0xLTEtMjY1MjQ3_ac11718b-156b-492e-b1d1-4f66b8046b12"
      unitRef="usd">54000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzctMS0xLTEtMjY1MjQ3_938f3e29-73a4-479d-a8da-e7a4baa96233"
      unitRef="usd">2250000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo2NjU4YjEzMTg3MjI0NjYyOTJmZTQ3Yjg4NTVjMjk3My90YWJsZXJhbmdlOjY2NThiMTMxODcyMjQ2NjI5MmZlNDdiODg1NWMyOTczXzctMy0xLTEtMjY1MjQ3_f231c935-13d4-4a93-a289-c4297e6c1e77"
      unitRef="usd">2564000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90ZXh0cmVnaW9uOjBjMzVkODgxNjEwMjQwYmZhMGNkODlmOWU4YzZhN2M1XzE2Mzc_471454a3-b9ed-4d20-8c32-bc1e96f9c80e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Direct, assumed and ceded premiums earned for the years ended December&#160;31, 2022, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(772)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(680)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(825)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net premiums&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock>
    <us-gaap:DirectPremiumsEarned
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzEtMS0xLTEtMjY1MjQ3_ae1230f3-754a-4b12-bffa-315abc9e3139"
      unitRef="usd">85670000000</us-gaap:DirectPremiumsEarned>
    <us-gaap:DirectPremiumsEarned
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzEtMy0xLTEtMjY1MjQ3_f6abc7fe-a20f-4aa2-840b-eb9af1a73e54"
      unitRef="usd">76320000000</us-gaap:DirectPremiumsEarned>
    <us-gaap:DirectPremiumsEarned
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzEtNS0xLTEtMjY1MjQ3_9b7b83af-f25d-42a7-a571-ae265aa2f3f0"
      unitRef="usd">69711000000</us-gaap:DirectPremiumsEarned>
    <us-gaap:AssumedPremiumsEarned
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzItMS0xLTEtMjY1MjQ3_f146b953-ef1c-4233-88c8-00d908a3972e"
      unitRef="usd">432000000</us-gaap:AssumedPremiumsEarned>
    <us-gaap:AssumedPremiumsEarned
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzItMy0xLTEtMjY1MjQ3_22c41934-8cff-4f3d-a15a-a277324ab242"
      unitRef="usd">492000000</us-gaap:AssumedPremiumsEarned>
    <us-gaap:AssumedPremiumsEarned
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzItNS0xLTEtMjY1MjQ3_d8a4af36-9347-4ff1-a2c3-7739cf8fa6ce"
      unitRef="usd">478000000</us-gaap:AssumedPremiumsEarned>
    <us-gaap:CededPremiumsEarned
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzMtMS0xLTEtMjY1MjQ3_cb89cc1c-7618-4750-992e-feb08867807e"
      unitRef="usd">772000000</us-gaap:CededPremiumsEarned>
    <us-gaap:CededPremiumsEarned
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzMtMy0xLTEtMjY1MjQ3_d7f2a736-92ab-4fa7-8774-a007fd730205"
      unitRef="usd">680000000</us-gaap:CededPremiumsEarned>
    <us-gaap:CededPremiumsEarned
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzMtNS0xLTEtMjY1MjQ3_b6877afe-7643-4c3b-8394-2ee3e1a4a9d1"
      unitRef="usd">825000000</us-gaap:CededPremiumsEarned>
    <us-gaap:PremiumsEarnedNet
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzQtMS0xLTEtMjY1MjQ3_e9a73867-5ec7-4290-9518-b9ea5508e89e"
      unitRef="usd">85330000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzQtMy0xLTEtMjY1MjQ3_489b9bac-1890-42f7-9d5f-c8e7ff943d90"
      unitRef="usd">76132000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTowM2FmNTQzM2Y1ODg0MzE3YmQ4Zjk1NDYwOGRmNzM5Zi90YWJsZXJhbmdlOjAzYWY1NDMzZjU4ODQzMTdiZDhmOTU0NjA4ZGY3MzlmXzQtNS0xLTEtMjY1MjQ3_a26a4cee-b47a-4877-b95a-6c7e507b5553"
      unitRef="usd">69364000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:EffectsOfReinsuranceTableTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90ZXh0cmVnaW9uOjBjMzVkODgxNjEwMjQwYmZhMGNkODlmOWU4YzZhN2M1XzE2NDE_958390a5-d922-4108-9cdd-41cf6be436a8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impact of reinsurance on benefit costs for the years ended December&#160;31, 2022, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net benefit costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EffectsOfReinsuranceTableTextBlock>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredGross
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzEtMS0xLTEtMjY1MjQ3_aadb0066-0949-4844-a063-5f5d4e275ea8"
      unitRef="usd">71357000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredGross>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredGross
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzEtMy0xLTEtMjY1MjQ3_98360cb9-1afe-4619-bd5f-29818807357b"
      unitRef="usd">64339000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredGross>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredGross
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzEtNS0xLTEtMjY1MjQ3_9960c023-d871-4f89-b74a-c1f0725118e4"
      unitRef="usd">56077000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredGross>
    <us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzItMS0xLTEtMjY1MjQ3_0b285fad-e653-4916-b259-e6deb7836012"
      unitRef="usd">379000000</us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed>
    <us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzItMy0xLTEtMjY1MjQ3_8c670be9-75e1-4a1c-93b6-5a6f08e96b01"
      unitRef="usd">398000000</us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed>
    <us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzItNS0xLTEtMjY1MjQ3_d0809bf3-0cea-4c31-bcc2-0628ee96b2dc"
      unitRef="usd">329000000</us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed>
    <us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzMtMS0xLTEtMjY1MjQ3_475d751e-89bd-4b02-b40d-6a4ffe6dbe1a"
      unitRef="usd">663000000</us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded>
    <us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzMtMy0xLTEtMjY1MjQ3_cbdef83c-8519-4c4c-a873-ea880c7f681a"
      unitRef="usd">549000000</us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded>
    <us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzMtNS0xLTEtMjY1MjQ3_e6d09eeb-e6ba-4bda-b853-ee453fe6cfd0"
      unitRef="usd">727000000</us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzQtMS0xLTEtMjY1MjQ3_b124332c-e362-4077-a62a-d7ef1637b987"
      unitRef="usd">71073000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzQtMy0xLTEtMjY1MjQ3_57df6b2c-473b-4c93-b125-2c6b64a85de9"
      unitRef="usd">64188000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNjkvZnJhZzowYzM1ZDg4MTYxMDI0MGJmYTBjZDg5ZjllOGM2YTdjNS90YWJsZTo1MDRjYjJmZjJmMzA0MGY5OTk1ZjI3ZjJlZTlhZDhhOC90YWJsZXJhbmdlOjUwNGNiMmZmMmYzMDQwZjk5OTVmMjdmMmVlOWFkOGE4XzQtNS0xLTEtMjY1MjQ3_c4413009-8188-4719-8784-92ecddc074d7"
      unitRef="usd">55679000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzM4NjI0_2039491c-4701-4470-819c-f55b5f4c2c07">Commitments and Contingencies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;COVID-19&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The COVID-19 pandemic continues to evolve. The Company believes COVID-19&#x2019;s impact on its businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#x2019;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond the Company&#x2019;s knowledge and control. As a result, the impact COVID-19 will have on the Company&#x2019;s businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has the following significant guarantee arrangements at December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;ASC Claim Funding Accounts - The Company has arrangements with certain banks for the processing of claim payments for its ASC customers. The banks maintain accounts to fund claims of the Company&#x2019;s ASC customers. The customer is responsible for funding the amount paid by the bank each day. In these arrangements, the Company guarantees that the banks will not sustain losses if the responsible ASC customer does not properly fund its account. The aggregate maximum exposure under these arrangements is generally limited to $250 million. The Company can limit its exposure to these guarantees by suspending the payment of claims for ASC customers that have not adequately funded the amount paid by the bank. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Separate Accounts Assets - Certain Separate Accounts assets associated with the large case pensions business in the Corporate/Other segment represent funds maintained as a contractual requirement to fund specific pension annuities that the Company has guaranteed. Minimum contractual obligations underlying the guaranteed benefits in these Separate Accounts were approximately $941&#160;million and $1.3 billion at December&#160;31, 2022 and 2021, respectively. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for additional information on Separate Accounts. Contract holders assume all investment and mortality risk and are required to maintain Separate Accounts balances at or above a specified level. The level of required funds is a function of the risk underlying the Separate Account&#x2019;s investment strategy. If contract holders do not maintain the required level of Separate Accounts assets to meet the annuity guarantees, the Company would establish an additional liability. Contract holders&#x2019; balances in the Separate Accounts at December&#160;31, 2022 exceeded the &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;value of the guaranteed benefit obligation. As a result, the Company was not required to maintain any additional liability for its related guarantees at December&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lease Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#x2019;s Stores and Linens &#x2018;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#x2019;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#x2019;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations, and any significant adverse impact of COVID-19 on such purchasers and/or former subsidiaries increases the risk that the Company will be required to satisfy those obligations. As of December&#160;31, 2022, the Company guaranteed 67 such store leases (excluding the lease guarantees related to Linens &#x2018;n Things, which have been recorded as a liability on the consolidated balance sheets), with the maximum remaining lease term extending through 2034.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#x2019;s assessments generally are based on a formula relating to the Company&#x2019;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the ACA.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#x201c;Penn Treaty&#x201d;) in rehabilitation, an intermediate action before insolvency, and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#x2019;s operating results, financial condition and cash flows, and the risk is heightened by any significant adverse impact of the COVID-19 pandemic on the solvency of other insurers, including long-term care and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#x2019;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s total guaranty fund assessments liability was immaterial at both December&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation and Regulatory Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has been involved or is currently involved in numerous legal proceedings, including litigation, arbitration, government investigations, audits, reviews and claims. These include routine, regular and special investigations, audits and reviews by&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; CMS, state insurance and health and welfare departments, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the U.S. Department of Justice (the &#x201c;DOJ&#x201d;), &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;state Attorneys General, the U.S. Drug Enforcement Administration (the &#x201c;DEA&#x201d;), the U.S. Federal Trade Commission (the &#x201c;FTC&#x201d;) and other governmental authorities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legal proceedings, in general, and securities, class action and multi-district litigation, in particular, and governmental special investigations, audits and reviews can be expensive and disruptive. Some of the litigation matters may purport or be determined &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years. The Company also may be named from time to time in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; actions initiated by private third parties that could also be separately pursued by a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs incurred in these matters can be substantial, regardless of the outcome.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. None of the Company&#x2019;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#x2019;s financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses and assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and rights to indemnification, will have a material adverse effect on the Company&#x2019;s financial position. Substantial unanticipated verdicts, fines and rulings, however, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on its results of operations. In addition, as a result of governmental investigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or loss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be material to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Usual and Customary Pricing Litigation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and certain current and former directors and officers are named as a defendant in a number of lawsuits that allege that the Company&#x2019;s retail pharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions are brought by a number of different types of plaintiffs, including plan members, private payors, government payors, and shareholders based on different legal theories. Some of these cases are brought as putative class actions, and in some instances, classes have been certified. In October 2022, one of the litigating shareholders made a litigation demand to the Board related to these and other issues after his amended derivative complaint was dismissed for failing to demonstrate demand futility. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;PBM Litigation and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is facing multiple lawsuits, including by state Attorneys General, governmental subdivisions and several putative class actions, regarding drug pricing and its rebate arrangements with drug manufacturers. These complaints, brought by a number of different types of plaintiffs under a variety of legal theories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is defending itself against these claims. The Company has also received subpoenas, civil investigative demands (&#x201c;CIDs&#x201d;), and other requests for documents and information from, and is being investigated by, the FTC and Attorneys General of several states and the District of Columbia regarding its PBM practices, including pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs, and requests for information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Behnke v. CVS Caremark Corporation, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#x2019;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#x2019;s PBM. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Controlled Substances Litigation, Audits and Subpoenas&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims beginning as far back as the early 2000s generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned In re National Prescription Opiate Litigation (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs, and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas, CIDs, and other requests for information. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, the Company was among the chain pharmacies found liable by a jury in a trial in federal court in Ohio; in August 2022, the court issued a judgment jointly against the three defendants in the amount of $651&#160;million to be paid over 15 years, and also ordered certain injunctive relief. The Company is appealing the judgment and has not accrued a liability for this matter. In March 2022, CVS Health Corporation and CVS Pharmacy, Inc. entered into a settlement agreement with the State of Florida to resolve claims related to opioid medications dating back more than a decade. Under the terms of the settlement agreement, CVS Health Corporation settled all opioid claims against it and its subsidiaries by the State of Florida for $484&#160;million, which is to be paid over a period of 18 years. During the three months ended March 31, 2022, the Company recorded a $484&#160;million liability associated with this legal settlement. In August 2022, CVS Pharmacy, Inc. entered into an agreement with the State of New Mexico to settle all opioid claims against it and its parents and subsidiaries by the State of New Mexico and participating subdivisions. In September 2022, CVS Pharmacy, Inc. entered into an agreement with the State of West Virginia to settle all opioid claims against it and its parents and subsidiaries by the State of West Virginia and participating subdivisions. Also in September 2022, CVS Pharmacy, Inc. entered into an agreement with the Cherokee Nation to settle all opioid claims against it and its parents and subsidiaries by the Cherokee Nation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2022, the Company agreed to a formal settlement agreement, the financial amounts of which were agreed to in principle in October 2022, with a leadership group of a number of state Attorneys General and the Plaintiffs&#x2019; Executive Committee (&#x201c;PEC&#x201d;). The agreement would resolve substantially all opioid claims against Company entities by states and political subdivisions, but not private plaintiffs. The maximum amount payable by the Company under the settlement would be approximately $4.3&#160;billion in opioid remediation and $625&#160;million in attorneys&#x2019; fees and costs and additional remediation. The amounts would be payable over 10 years, beginning in 2023. The agreement also contains injunctive terms relating to the dispensing of opioid medications. The settlement agreement is available at nationalopioidsettlement.com.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the settlement agreement, before the Company determines whether to enter into any final settlement, it will assess the number and identities of the governmental entities that will participate in any such settlement. The settlement agreement contemplates that if certain governmental entities do not agree to the settlement, but the Company nonetheless concludes that there is sufficient participation to warrant going forward with the settlement, there would be a corresponding reduction in the amount due from the Company to account for the governmental entities that did not agree. Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants. Private plaintiff litigation will also continue.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has been informed that 45 states, the District of Columbia, and all eligible United States territories have elected to join the settlement. Three states were the subject of earlier settlements. The Company has elected to proceed with the settlement process based on that level of participation. The settlement process will progress to the period during which subdivisions may elect to join.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2022, the Company also agreed to a formal settlement agreement with a leadership group representing tribes throughout the United States. The agreement would resolve substantially all opioid claims against Company entities by such tribes. The maximum amount payable by the Company under the settlement would be $113&#160;million in opioid remediation and $18&#160;million in attorneys&#x2019; fees and costs. The amounts would be payable over 10 years, beginning in 2023. The agreement is contingent upon sufficient participation by tribes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has concluded that settlement of opioid claims by governmental entities and tribes is probable, and the loss related thereto could be reasonably estimated. As a result of that conclusion, and its assessment of certain other opioid-related claims including those for which the Company reached agreement in August and September 2022, the Company recorded pre-tax charges of $5.2&#160;billion and $99 million during the three months ended September 30, 2022 and the three months ended December&#160;31, 2022, respectively, of which $4.8&#160;billion was recorded in other long-term liabilities on the consolidated balance sheet. In addition, the Company expects the cash impact in 2023 and 2024 to be less than $500&#160;million in each year. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment requires judgments about future events. Moreover, the settlement is in its early phases, and there is no assurance that contingencies will be satisfied. The amount of ultimate loss may differ materially from this accrual.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because of the many uncertainties associated with any settlement arrangement or other resolution of all opioid-related litigation matters, including the uncertain scope of participation by governmental entities, and given that the Company continues to actively defend ongoing litigation for which it believes it has defenses and assertions that have merit, the Company is not able to reasonably estimate the range of ultimate possible loss for all opioid-related litigation matters at this time. The outcome of these legal matters could have a material effect on the Company&#x2019;s business, financial condition, operating results and/or cash flows.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the DOJ served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS pharmacy locations concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. In January 2022, the DOJ served the Company with a CID regarding similar subjects, and the Company is providing documents and information in response to these matters.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Prescription Processing Litigation and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its prescription processing practices, including the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ex rel.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Bassan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; v. Omnicare, Inc. and CVS Health Corp. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#x2019;s Office for the Southern District of New York (the &#x201c;SDNY&#x201d;) filed a complaint-in-intervention in this previously sealed &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; case. The complaint alleges that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. ex rel. Gill et al. v. CVS Health Corp. et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (U.S. District Court for the Northern District of Illinois). In July 2022, the Delaware Attorney General&#x2019;s Office moved for partial intervention as to allegations under the Delaware false claims act related to not escheating alleged overpayments in this previously sealed &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; case. The federal government and the remaining states declined to intervene on other additional theories in the relator&#x2019;s complaint. The Company is defending itself against all of the claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#x2019;s Omnicare pharmacies&#x2019; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2016, the Company received a CID from the U.S. Attorney&#x2019;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#x2019;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Provider Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by providers with whom the Company has a contract and with whom the Company does not have a contract (&#x201c;out-of-network providers&#x201d;).&#160;Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for out-of-network services (including COVID-19 testing) and/or otherwise allege that the Company failed to timely or appropriately pay or administer claims and benefits (including the &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company&#x2019;s post payment audit and collection practices). Other major health insurers are the subject of similar litigation or have settled similar litigation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;CMS Actions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CMS regularly audits the Company&#x2019;s performance to determine its compliance with CMS&#x2019;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#x2019;s and other companies&#x2019; Medicare plans by considering the applicable health status of Medicare members as supported by information prepared, maintained and provided by providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#x2019; medical records to determine whether those records support the related diagnosis codes that determine the members&#x2019; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#x201c;RADV&#x201d;) audits of various Medicare Advantage plans, including certain of the Company&#x2019;s plans, to validate coding practices and supporting medical record documentation maintained by providers and the resulting risk-adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#x2019;s risk-adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of the HHS (the &#x201c;OIG&#x201d;) also is auditing the Company&#x2019;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2012, in the &#x201c;Notice of Final Payment Error Calculation for Part C Medicare Advantage Risk Adjustment Validation Data (RADV) Contract-Level Audits,&#x201d; CMS revised its audit methodology for RADV contract-level audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS announced extrapolation of the error rate identified in the audit sample along with the application of a process to account for errors in the government&#x2019;s traditional fee-for-service Medicare program (&#x201c;FFS Adjuster&#x201d;). For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract, nor did CMS propose to apply a FFS adjuster. By applying the FFS Adjuster, Medicare Advantage organizations would have been liable for repayments only to the extent that their extrapolated payment errors exceeded the error rate in Original Medicare, which could have impacted the extrapolated repayments to which Medicare Advantage organizations are subject. This revised contract-level audit methodology increased the Company&#x2019;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. In the RADV audit methodology CMS used from 2011-2013, CMS selected only a few of the Company&#x2019;s Medicare Advantage contracts for various contract years for contract-level RADV audits. In October 2018, CMS in the proposed rule (&#x201c;Proposed Rule&#x201d;) announced a new methodology for RADV audits targeting certain health conditions and members with many diagnostic conditions along with extrapolation for the error rates identified without use of a FFS Adjuster. While the rule was under proposal, CMS initiated contract-level RADV audits for the years 2014 and 2015 with this new RADV methodology without a final rule. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 30, 2023, CMS released the final rule (&#x201c;RADV Audit Rule&#x201d;), announcing it may use extrapolation for payment years 2018 forward, for both RADV audits and OIG audits and eliminated the application of a FFS Adjuster in Part C contract-level RADV audits of Medicare Advantage organizations. In the RADV Audit Rule, CMS indicated that it will use more than one audit methodology going forward and indicated CMS will audit contracts it believes are at the highest risk for overpayments based on its statistical modeling, citing a 2016 Governmental Accountability Office report that recommended selection of contract-level RADV audits with a focus on contracts likely to have high rates of improper payment, the highest coding intensity scores, and contracts with high levels of unsupported diagnoses from prior RADV audits.   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive refunds for years prior to 2018 or prospective adjustments to Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#x2019;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#x2019;s bids &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of RADV, Public Exchange related or other audits by CMS, the OIG or otherwise, including audits of the Company&#x2019;s MLR rebates, methodology and/or reports, could be material and could adversely affect the Company&#x2019;s operating results, cash flows and/or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The RADV Audit Rule does not apply to the CMS Part C Improper Payment Measures audits nor the HHS-RADV programs. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Medicare and Medicaid CIDs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#x2019;s patient chart review processes related to risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2017, the Company received a CID from the SDNY requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Stockholder Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in February 2019, multiple class action complaints, as well as a derivative complaint, were filed by putative plaintiffs against the Company and certain current and former officers and directors. The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#x2019;s LTC business unit. The Company and its current and former officers and directors are defending themselves against these claims. Since filing, several of the cases have been consolidated, and the first-filed federal case, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;City of Miami Fire Fighters&#x2019; and Police Officers&#x2019; Retirement Trust, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. (formerly known as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Anarkat&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), was dismissed with prejudice in February 2021. Plaintiffs appealed that decision to the First Circuit after their motion for reconsideration was denied, and in August 2022 the First Circuit affirmed the dismissal. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re CVS Health Corp. Securities Act Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (formerly known as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Waterford&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re CVS Health Corp. Securities Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (formerly known as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;City of Warren&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Freundlich&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) have been stayed pending the outcome of the First Circuit appeal. Plaintiffs in both cases have since filed amended complaints, which the Company has moved to dismiss. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August and September 2020, two class actions under the Employee Retirement Income Security Act of 1974 (&#x201c;ERISA&#x201d;) were filed in the U.S. District Court for the District of Connecticut against CVS Health, Aetna, and several current and former executives, directors and/or members of Aetna&#x2019;s Compensation and Talent Management Committee: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Radcliffe v. Aetna Inc., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Flaim v. Aetna Inc., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. The plaintiffs in these cases assert a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) Plan&#x2019;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#x2019;s LTC business unit. The district court consolidated the actions, and in October 2021, dismissed the consolidated action without prejudice. Plaintiffs filed an amended consolidated complaint, which the Company moved to dismiss. In October 2022, the court granted the Company&#x2019;s motion to dismiss with prejudice. Plaintiffs have appealed this decision to the Second Circuit.&lt;/span&gt;&lt;span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also received a related document request pursuant to ERISA &#xa7; 104(b), to which the Company has responded. The Company and its current and former officers and directors are defending themselves against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, the Company received a demand for inspection of books and records pursuant to Delaware Corporation Law Section 220 (the &#x201c;Demand&#x201d;). The Demand purports to be related to potential breaches of fiduciary duties by the Board in relation to certain matters concerning opioids.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other Legal and Regulatory Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas, or similar process from various governmental agencies requesting information. These other legal proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, breach of fiduciary duty, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, denial of or failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, product liability, intellectual property litigation, and employment litigation. Some of &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#x2019;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed, or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#x2019;s operating results. The Company will continue to defend contract awards it receives.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#x2019;s and the rest of the health care and related benefits industry&#x2019;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#x2019; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight, and claim payment practices (including payments to out-of-network providers).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a leading national health solutions company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#x2019;s businesses, changes to or clarifications of the Company&#x2019;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the federal government, withholding of premium payments to the Company by government agencies,&#160;assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i)&#160;future enactment of new health care or other laws or regulations; (ii)&#160;the interpretation or application of existing laws or regulations as they may relate to one or more of the Company&#x2019;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii)&#160;pending or future federal or state government investigations of one or more of the Company&#x2019;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv)&#160;pending or future government audits, investigations or enforcement actions against the Company; (v)&#160;adverse developments in any pending &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lawsuit against the Company, whether sealed or unsealed, or in any future &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lawsuit that may be filed against the Company; or (vi)&#160;adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:GuaranteeObligationsMaximumExposure
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE1Mjg_0cfdb3c8-178f-491a-b4dc-08ce4ddc767b"
      unitRef="usd">250000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <cvs:ContractualObligationsToMaintainLevelsOfSeparateAccounts
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzIwODA_73d178d2-3ba3-4d6b-834a-a7e0ca00c863"
      unitRef="usd">941000000</cvs:ContractualObligationsToMaintainLevelsOfSeparateAccounts>
    <cvs:ContractualObligationsToMaintainLevelsOfSeparateAccounts
      contextRef="i69eed5106b194cac81e8857cca41692b_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzIwODc_df6f9e64-0621-4d13-b181-e6b33b195f13"
      unitRef="usd">1300000000</cvs:ContractualObligationsToMaintainLevelsOfSeparateAccounts>
    <cvs:GuarantorObligationsNumberOfLeases
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzM5NTE_26d38a46-b29d-47ec-a30f-78eb2008ab0b"
      unitRef="lease">67</cvs:GuarantorObligationsNumberOfLeases>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i89589b4e8c2b4f25b791df1123f534f7_D20220801-20220831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE0NzE3_ea8b2669-700f-479a-aeeb-628ea041f654"
      unitRef="usd">651000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <cvs:LegalSettlementPeriodOfPayment
      contextRef="i03d4640633404e31a33fb826637ad08a_I20220831"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzM4NjI2_72a23869-fdd2-4f82-8bf8-cb8747c2edd4">P15Y</cvs:LegalSettlementPeriodOfPayment>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i3b026ed44ce7463faf26ee5548ce9d7d_D20220301-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE1MjM0_188da8bb-3524-4392-8e26-b2e0f8a01abf"
      unitRef="usd">-484000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <cvs:LegalSettlementPeriodOfPayment
      contextRef="ibaa8af588ffe417797fab6c210df9c5b_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzM4NjI4_97bc8789-3167-442f-9031-2e9f164d43bc">P18Y</cvs:LegalSettlementPeriodOfPayment>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="ibaa8af588ffe417797fab6c210df9c5b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE1MzU0_be71a958-4680-40f6-b29e-dfe86334eac7"
      unitRef="usd">484000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i8f9313db581d4747bb5036854512069d_D20221201-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE2NTQ0_d002ffaa-9eaf-4b16-a887-8b33b93db8a1"
      unitRef="usd">4300000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LegalFees
      contextRef="i8f9313db581d4747bb5036854512069d_D20221201-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE2NTcz_b261039a-ba48-451c-8b4d-982f9222e94b"
      unitRef="usd">625000000</us-gaap:LegalFees>
    <cvs:LegalSettlementPeriodOfPayment
      contextRef="id48716cf9312414a9271423a5fd71f20_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzM4NjQw_44169448-63b9-48cf-9e0d-afaeed512a92">P10Y</cvs:LegalSettlementPeriodOfPayment>
    <cvs:LitigationSettlementNumberOfStatesElectedToJoin
      contextRef="id48716cf9312414a9271423a5fd71f20_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE3NjY5_ce695466-45a6-4890-8934-4070ffb8e188"
      unitRef="state">45</cvs:LitigationSettlementNumberOfStatesElectedToJoin>
    <cvs:LitigationSettlementNumberOfStatesSubjectToEarlierSettlements
      contextRef="i656c8f23bf884eb99730c0e0ceed03bb_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE3Nzg2_81c3e2b1-0821-485a-8cc3-a2ff9d87e388"
      unitRef="state">3</cvs:LitigationSettlementNumberOfStatesSubjectToEarlierSettlements>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ie67a9c6077ac426d83b2d281de921897_D20221201-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE4MzU3_acace28d-5c38-4427-836a-80dc1f21abee"
      unitRef="usd">113000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LegalFees
      contextRef="ie67a9c6077ac426d83b2d281de921897_D20221201-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE4Mzg2_88faac5d-395f-4cd2-b7de-cb7f4e200dfe"
      unitRef="usd">18000000</us-gaap:LegalFees>
    <cvs:LegalSettlementPeriodOfPayment
      contextRef="i0711d6880304457da9bc46c7f815c64f_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzM4NjI3_5c1cb053-f7e9-4462-84b4-12990b1b091b">P10Y</cvs:LegalSettlementPeriodOfPayment>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i429b564fb66a4c4db88cad8833594b8a_D20220701-20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE4OTM2_049147f0-4827-45a0-9f06-ea744365c17f"
      unitRef="usd">-5200000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i939712c24e004976bf4f03ca8692f893_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE4OTQz_ab58e063-0baa-451b-a8de-8601dc7da5f9"
      unitRef="usd">-99000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:LossContingencyAccrualCarryingValueNoncurrent
      contextRef="iaca84de086504e58ba6e3854de871467_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE5MDQ5_4a3533ff-a787-4655-b82c-2f8e273a1c8c"
      unitRef="usd">4800000000</us-gaap:LossContingencyAccrualCarryingValueNoncurrent>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="i64d6b9d0c0594df5bccc5dbc7ec5cfa6_D20230101-20231231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE5MjEz_3aab4bfc-ebc7-4880-a1a6-e2251de55573"
      unitRef="usd">500000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="if13a1b08fb134bc2819e0fbde58e3608_D20240101-20241231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzE5MjEz_ef2dc150-cf26-40fb-ae4e-756d55ec9a79"
      unitRef="usd">500000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i51647e75bc724c0097093f48fc959e1c_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzIvZnJhZzo1NmJlMGZlYmI3OTU0ZjFlYTEwMjc4MWQ4MTc1YjkwZS90ZXh0cmVnaW9uOjU2YmUwZmViYjc5NTRmMWVhMTAyNzgxZDgxNzViOTBlXzMyMTA2_95fa4004-948c-4d70-baf2-a3799aa5b9bd"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzk1Nzg_8987fe4e-3aaa-4000-8299-81db8f619f5e">Segment Reporting&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has three operating segments, Health Care Benefits, Health Services and Pharmacy &amp;amp; Consumer Wellness, as well as a Corporate/Other segment. The Company&#x2019;s segments maintain separate financial information, and the CODM evaluates the segments&#x2019; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#x2019;s segments based on adjusted operating income. Adjusted operating income is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#x2019;s business nor reflect the Company&#x2019;s underlying business performance. Effective for the first quarter of 2023, adjusted operating income also excludes the impact of net realized capital gains or losses. See the reconciliation of consolidated operating income (GAAP measure) to consolidated adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#x2019;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment financial information for the years ended December 31, 2022, 2021 and 2020 has been recast, as applicable, to reflect the following items, the impact of which are reflected in the &#x201c;Adjustments&#x201d; lines of the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The realignment of the Company&#x2019;s segments to correspond with changes made to its operating model as described in Note 1 &#x201c;Significant Accounting Policies,&#x201d; including the discontinuance of the former Maintenance Choice segment reporting practice as described in Note (1) of the table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The exclusion of the impact of net realized capital gains or losses from adjusted operating income, as described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The impact of the adoption of the long-duration insurance accounting standard, which the Company adopted on January 1, 2023 using a modified retrospective transition method as of January 1, 2021, as described in Note 8 &#x201c;Other Insurance Liabilities and Separate Accounts.&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care &lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy &amp;amp; &lt;br/&gt;Consumer &lt;br/&gt;Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues, as previously reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues, as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 1.75pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss), as previously reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(728)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss), as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,613)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care &lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy &amp;amp; &lt;br/&gt;Consumer &lt;br/&gt;Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues, as previously reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,318)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues, as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 1.75pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss), as previously reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,471)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss), as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,635)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care &lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy &amp;amp; &lt;br/&gt;Consumer &lt;br/&gt;Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues, as previously reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues, as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 1.75pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss), as previously reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(708)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(560)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss), as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy &amp;amp; Consumer Wellness segment. Prior to January 1, 2023, intersegment adjusted operating income eliminations occurred when members of the Health Services segment's clients enrolled in Maintenance Choice elected to pick up maintenance prescriptions at one of the Company&#x2019;s retail pharmacies instead of receiving them through the mail. When this occurred, both the Health Services and Pharmacy &amp;amp; Consumer Wellness segments recorded the adjusted operating income on a stand-alone basis.&#160;Effective January 1, 2023, the adjusted operating income associated with such transactions is reported only in the Pharmacy &amp;amp; Consumer Wellness segment, therefore no adjusted operating income elimination is required. Segment financial information has been recast to reflect this change. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2022, 2021 and 2020, revenues from the federal government accounted for 18%, 17% and 16%, respectively, of the Company&#x2019;s consolidated total revenues, primarily related to contracts with CMS for coverage of Medicare-eligible individuals within the Health Care Benefits segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of financial measures of the Company&#x2019;s segments to the consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.092%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Services &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy &amp;amp;&lt;br/&gt;Consumer&lt;br/&gt;Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Adjusted operating income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,613)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Adjusted operating income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,635)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Adjusted operating income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total revenues of the Health Services segment include approximately $12.6 billion, $11.6 billion and $10.9 billion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;of retail co-payments for 2022, 2021 and 2020, respectively. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for additional information about retail co-payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy &amp;amp; Consumer Wellness segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of consolidated operating income to adjusted operating income for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (GAAP measure)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized capital (gains) losses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office real estate optimization charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on divestiture of subsidiaries &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(475)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Opioid litigation charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on assets held for sale &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related integration costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Store impairments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(8)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(9)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition purchase price adjustment outside of measurement period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(10)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receipt of fully reserved ACA risk corridor receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(11)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company&#x2019;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#x2019;s GAAP consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#x2019;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#x2019;s insurance products, the services performed for the Company&#x2019;s customers or the sale of the Company&#x2019;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#x2019;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#x2019;s and investors&#x2019; ability to compare the Company&#x2019;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#x2019;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company&#x2019;s net realized capital gains and losses arise from various types of transactions, primarily in the course of managing a portfolio of assets that support the payment of insurance liabilities. Net realized capital gains and losses are reflected in the consolidated statements of operations in net investment income within each segment. These capital gains and losses are the result of investment decisions, market conditions and other economic developments that are unrelated to the performance of the Company&#x2019;s business, and the amount and timing of these capital gains and losses do not directly relate to the underwriting of the Company&#x2019;s insurance products, the services performed for the Company&#x2019;s customers or the sale of the Company&#x2019;s products or services. Accordingly, the Company believes excluding net realized capital gains and losses enhances the Company&#x2019;s and investors&#x2019; ability to compare the Company&#x2019;s past financial performance with its current performance and to analyze underlying business performance and trends. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In 2022, the office real estate optimization charges primarily relate to the abandonment of leased real estate and the related right-of-use assets and property and equipment in connection with the planned reduction of corporate office real estate space in response to the Company&#x2019;s new flexible work arrangement. The office real estate optimization charges are reflected in the Company&#x2019;s GAAP consolidated statement of operations in operating expenses within the Health Care Benefits, Corporate/Other and Health Services segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In 2022, the gain on divestiture of subsidiaries represents the pre-tax gain on the sale of bswift, which the Company sold in November 2022, and the pre-tax gain on the sale of PayFlex, which the Company sold in June 2022. In 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#x2019; Compensation business, which the Company sold in July 2020. The gains on divestitures are reflected as a reduction of operating expenses in the Company&#x2019;s GAAP consolidated statements of operations within the Health Care Benefits segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In 2022, the opioid litigation charges relate to agreements to resolve substantially all opioid claims against the Company by certain states and governmental entities. The opioid litigation charges are reflected within the Corporate/Other segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In 2022, the loss on assets held for sale relates to the LTC reporting unit within the Pharmacy &amp;amp; Consumer Wellness segment. The Company continually evaluates its portfolio for non-strategic assets. The Company determined that its LTC business was no longer a strategic asset and during the third quarter of 2022 committed to a plan to sell the LTC business. As of September 30, 2022, the LTC business met the criteria for held-for-sale accounting and its net assets were accounted for as assets held for sale. The carrying value of the LTC business was determined to be greater than its estimated fair value less costs to sell and a loss on assets held for sale was recorded during the third quarter of 2022. As of December 31, 2022, the net assets of the LTC business continued to meet the criteria for held-for-sale accounting and during the fourth quarter of 2022, an incremental loss on assets held for sale was recorded to write down the carrying value of the LTC business to its estimated fair value less costs to sell. During 2022, the loss on assets held for sale also relates to the Commercial Business reporting unit within the Health Care Benefits segment. In March 2022, the Company reached an agreement to sell its Thailand business, which was included in the Commercial Business reporting unit. At that time, a portion of the Commercial Business goodwill was specifically allocated to the Thailand business. The net assets of the Thailand business were accounted for as assets held for sale at March 31, 2022. The carrying value of the Thailand business was determined to be greater than its estimated fair value less costs to sell and a loss on assets held for sale was recorded during the first quarter of 2022. The sale of the Thailand business closed in the second quarter of 2022, and the ultimate loss on the sale was not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In 2021 and 2020, acquisition-related integration costs relate to the acquisition of Aetna. The acquisition-related integration costs are reflected in the Company&#x2019;s GAAP consolidated statements of operations in operating expenses within the Corporate/Other segment.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(8)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In 2021, the store impairment charge relates to the write down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately 900 retail stores between 2022 and 2024. The store impairment charge is reflected within the Pharmacy &amp;amp; Consumer Wellness segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(9)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In 2021, the goodwill impairment charge relates to an impairment of the remaining goodwill of the LTC reporting unit within the Pharmacy &amp;amp; Consumer Wellness segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(10)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt"&gt;In 2021, the Company received $61&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#x2019;s GAAP consolidated statement of operations as a reduction of operating expenses within the Health Care Benefits segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(11)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt"&gt;In 2020, the Company received $313&#160;million owed to it under the ACA&#x2019;s risk corridor program that was previously fully reserved for as payment was uncertain. After considering offsetting items such as the ACA&#x2019;s minimum MLR rebate requirements and premium taxes, the Company recognized pre-tax income of $307&#160;million in the Company&#x2019;s GAAP consolidated statement of operations within the Health Care Benefits segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzQx_fa859048-6363-4a0c-95fe-87f634745abb"
      unitRef="segment">3</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzEwNDQ1MzYwNDc4NTYw_1e39b294-8494-45c5-8d44-7d39cfaedd65">Segment financial information for the years ended December 31, 2022, 2021 and 2020 has been recast, as applicable, to reflect the following items, the impact of which are reflected in the &#x201c;Adjustments&#x201d; lines of the table below:&lt;div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The realignment of the Company&#x2019;s segments to correspond with changes made to its operating model as described in Note 1 &#x201c;Significant Accounting Policies,&#x201d; including the discontinuance of the former Maintenance Choice segment reporting practice as described in Note (1) of the table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The exclusion of the impact of net realized capital gains or losses from adjusted operating income, as described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The impact of the adoption of the long-duration insurance accounting standard, which the Company adopted on January 1, 2023 using a modified retrospective transition method as of January 1, 2021, as described in Note 8 &#x201c;Other Insurance Liabilities and Separate Accounts.&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care &lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy &amp;amp; &lt;br/&gt;Consumer &lt;br/&gt;Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues, as previously reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues, as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 1.75pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss), as previously reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(728)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss), as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,613)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care &lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy &amp;amp; &lt;br/&gt;Consumer &lt;br/&gt;Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues, as previously reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,318)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues, as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 1.75pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss), as previously reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,471)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss), as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,635)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care &lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy &amp;amp; &lt;br/&gt;Consumer &lt;br/&gt;Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues, as previously reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues, as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 1.75pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss), as previously reported&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(708)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(560)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss), as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy &amp;amp; Consumer Wellness segment. Prior to January 1, 2023, intersegment adjusted operating income eliminations occurred when members of the Health Services segment's clients enrolled in Maintenance Choice elected to pick up maintenance prescriptions at one of the Company&#x2019;s retail pharmacies instead of receiving them through the mail. When this occurred, both the Health Services and Pharmacy &amp;amp; Consumer Wellness segments recorded the adjusted operating income on a stand-alone basis.&#160;Effective January 1, 2023, the adjusted operating income associated with such transactions is reported only in the Pharmacy &amp;amp; Consumer Wellness segment, therefore no adjusted operating income elimination is required. Segment financial information has been recast to reflect this change. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of financial measures of the Company&#x2019;s segments to the consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.092%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Services &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy &amp;amp;&lt;br/&gt;Consumer&lt;br/&gt;Wellness&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Adjusted operating income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,613)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Adjusted operating income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,635)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Adjusted operating income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total revenues of the Health Services segment include approximately $12.6 billion, $11.6 billion and $10.9 billion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;of retail co-payments for 2022, 2021 and 2020, respectively. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for additional information about retail co-payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy &amp;amp; Consumer Wellness segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="ic57ff1de57e040e09c97cab45478a2d9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzItMS0xLTEtMjk1NzYw_94e5483a-aa39-4b0f-946e-b0708285f2c5"
      unitRef="usd">91409000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibe58c09ac79e451fbfad93b9169958d4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzItMy0xLTEtMjk1Nzcw_b5c6e16b-fffc-49c3-802a-cc4d5f8ca2e0"
      unitRef="usd">169236000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i12151a132ac84f09952fa59e048adb99_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzItNS0xLTEtMjk1Nzcw_1422e17c-e173-490e-bd0f-cc126af141f6"
      unitRef="usd">106594000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie15ff7b3ed9249059a31d87e8221ef8d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzItNy0xLTEtMjk1Nzgz_c3bdf2d4-ac61-4d51-b4eb-de3d6f651a6d"
      unitRef="usd">530000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib242b2a53204442293d0e613aa093688_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzItOS0xLTEtMjk1Nzgz_e27f4b53-227f-46be-b783-165b4cdc8f02"
      unitRef="usd">-45302000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzItMTEtMS0xLTI5NTc4Mw_b5e11396-7468-4606-8fd7-d89705dd6d09"
      unitRef="usd">322467000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i83a2435cc9ab448c913552eb356f4039_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzMtMS0xLTEtMjk1NzYw_a00a2747-305c-427b-9793-c3e86365497f"
      unitRef="usd">-59000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia379beb5856c4694ac66b32c06bf2386_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzMtMy0xLTEtMjk1Nzcw_574276d1-f013-4812-ade6-1b5533380cc0"
      unitRef="usd">340000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1707f9f5c214463ebc3f072c05afa26e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzMtNS0xLTEtMjk1Nzcw_b5779d15-c3aa-4e1b-af8c-53423b6cb758"
      unitRef="usd">2002000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0a2425da88d34b11a7d4ed0662f4e0c0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzMtNy0xLTEtMjk1Nzgz_c174b722-28ba-43d3-8983-e47982d43403"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5da73c1ec8f946c9afb45f207ff36c25_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzMtOS0xLTEtMjk1Nzgz_ac169bb0-039f-41b3-8ff9-b81c335d58ed"
      unitRef="usd">-2283000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3bddb95b4cf348ec83e4a333d7575820_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzMtMTEtMS0xLTI5NTc4Mw_59a71902-cee6-474b-85a7-d332949fa3b0"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2a07c8633b37492ba109c7cd9a92299a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzQtMS0xLTEtMjk1NzYw_b4632974-bdf8-49e3-b3bf-f198b0714633"
      unitRef="usd">91350000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzQtMy0xLTEtMjk1Nzcw_4a1f46f9-5a9a-4170-b540-32bfada031a3"
      unitRef="usd">169576000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icd57b0b73c1b4e1aa835dde2abf6925c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzQtNS0xLTEtMjk1Nzcw_ff52248b-d569-4f83-870d-3c71263c4507"
      unitRef="usd">108596000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie1d5e5a55e6f4909a1d1c3d2003ec720_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzQtNy0xLTEtMjk1Nzgz_940d306d-fb3e-4f9d-a9d7-00164ebeda74"
      unitRef="usd">530000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib085c0543c9d4988b6b20b9b427998b0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzQtOS0xLTEtMjk1Nzgz_d02050ad-68b5-45d7-8fd2-15934b7d7d75"
      unitRef="usd">-47585000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzQtMTEtMS0xLTI5NTc4Mw_1a4e248d-d54a-4278-9f3a-aa0049c7baf7"
      unitRef="usd">322467000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ic57ff1de57e040e09c97cab45478a2d9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzYtMS0xLTEtMjk1NzYw_7f4ce0f1-7c3c-4b9f-92a5-d9062c02a666"
      unitRef="usd">5984000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ibe58c09ac79e451fbfad93b9169958d4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzYtMy0xLTEtMjk1Nzcw_13787311-09cd-46d8-b351-17ed06349887"
      unitRef="usd">7356000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i12151a132ac84f09952fa59e048adb99_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzYtNS0xLTEtMjk1Nzcw_b1f56496-616c-47c3-8642-fa8f35835f7d"
      unitRef="usd">6705000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ie15ff7b3ed9249059a31d87e8221ef8d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzYtNy0xLTEtMjk1Nzgz_12bbc945-a475-4d83-94af-4507857ec16b"
      unitRef="usd">-1785000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ib242b2a53204442293d0e613aa093688_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzYtOS0xLTEtMjk1Nzgz_dffe3e8c-dbfb-4799-bbe3-caa3a3542ce9"
      unitRef="usd">-728000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzYtMTEtMS0xLTI5NTc4Mw_3f8e58a1-fc46-40a3-b287-1a8feb8610e5"
      unitRef="usd">17532000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i83a2435cc9ab448c913552eb356f4039_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzctMS0xLTEtMjk1NzYw_abc7a159-17ac-4f94-b3b2-b24163d0c958"
      unitRef="usd">354000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ia379beb5856c4694ac66b32c06bf2386_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzctMy0xLTEtMjk1Nzcw_6b5ef661-f8b9-4154-b0f2-38414eba5a2e"
      unitRef="usd">-575000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i1707f9f5c214463ebc3f072c05afa26e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzctNS0xLTEtMjk1Nzcw_d1d10fa2-b1d9-4778-8cd6-62d1a72fa0df"
      unitRef="usd">-174000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i0a2425da88d34b11a7d4ed0662f4e0c0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzctNy0xLTEtMjk1Nzgz_1ad54460-15df-4c5b-a49b-0dc1a622704d"
      unitRef="usd">172000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i5da73c1ec8f946c9afb45f207ff36c25_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzctOS0xLTEtMjk1Nzgz_bd2c3f4a-01c5-408c-8a2c-65efc5d9eda8"
      unitRef="usd">728000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i3bddb95b4cf348ec83e4a333d7575820_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzctMTEtMS0xLTI5NTc4Mw_4a7206c4-335a-4336-8f88-7755d68faf33"
      unitRef="usd">505000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i2a07c8633b37492ba109c7cd9a92299a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzgtMS0xLTEtMjk1NzYw_3f8d027a-f539-476e-9290-6b6c5ace2e87"
      unitRef="usd">6338000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzgtMy0xLTEtMjk1Nzcw_a1d3240a-4f86-413b-9130-37ecb0ae6924"
      unitRef="usd">6781000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="icd57b0b73c1b4e1aa835dde2abf6925c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzgtNS0xLTEtMjk1Nzcw_ae299878-0b27-42bc-a94b-a3d57ba6e723"
      unitRef="usd">6531000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ie1d5e5a55e6f4909a1d1c3d2003ec720_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzgtNy0xLTEtMjk1Nzgz_f6f2d0c2-ae1c-475a-9368-dd0c5dd4a931"
      unitRef="usd">-1613000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ib085c0543c9d4988b6b20b9b427998b0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzgtOS0xLTEtMjk1Nzgz_235c4daf-1d99-4f94-91ed-5e3515d76ca7"
      unitRef="usd">0</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxYTAyZDMzYTMzYzE0ZTIyODJlY2U3MGE2MGEwODhlZi90YWJsZXJhbmdlOjFhMDJkMzNhMzNjMTRlMjI4MmVjZTcwYTYwYTA4OGVmXzgtMTEtMS0xLTI5NTc4Mw_57c2ee37-a64b-4ea2-8917-c01289584621"
      unitRef="usd">18037000000</cvs:AdjustedOperatingIncomeLoss>
    <us-gaap:Revenues
      contextRef="i2b1171c68bbe4af1819c9145310c6fb8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzItMS0xLTEtMjk1ODIz_79e29adc-d64c-49ad-a48a-720a5380f794"
      unitRef="usd">82186000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iff2a6e509d3c452fbb34c09f2c1f55ea_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzItMy0xLTEtMjk1ODMx_07842be9-d22c-48fc-b772-169cec94cc86"
      unitRef="usd">153022000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaf761e93be114754a9786359d43f61dd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzItNS0xLTEtMjk1ODMx_8b748aff-4925-4ccb-8efc-18b4751de963"
      unitRef="usd">100105000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8708367e0d6148a297ee5ca38d90794b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzItNy0xLTEtMjk1ODQx_959e27a0-347d-4d60-95bf-44219312fdb1"
      unitRef="usd">721000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if5e992bf9c2a499eaf6476b15ef7c5f5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzItOS0xLTEtMjk1ODQx_4fe7bdb8-e38b-4dff-948c-178958ac6b6b"
      unitRef="usd">-43923000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzItMTEtMS0xLTI5NTg0MQ_dfb38e1a-1e95-4dd3-b305-2f67fe38ee38"
      unitRef="usd">292111000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifc4a75422af949c2a32932d3412701db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzMtMS0xLTEtMjk1ODIz_66cd9efe-7037-4514-b308-1cac8693bb04"
      unitRef="usd">-67000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i93f387cc7da9423da81f99d85943fc07_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzMtMy0xLTEtMjk1ODMx_ab0bb960-5198-4691-a4b6-529ecb1deba3"
      unitRef="usd">870000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia738f2f875064e3b9b39a81213de4404_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzMtNS0xLTEtMjk1ODMx_bdf0db85-7d48-426f-b0b1-519fda520105"
      unitRef="usd">1515000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i57299b3f0d29410bbd43971727bf7de2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzMtNy0xLTEtMjk1ODQx_9016e7b5-93c4-44a4-98c6-35ba5e9fa193"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5cfee834f48c44269e6203285ea53742_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzMtOS0xLTEtMjk1ODQx_f58b821f-b6ee-4986-982d-259b4c5b6368"
      unitRef="usd">-2318000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icf605eb33300435fa4bb68398ee8e8db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzMtMTEtMS0xLTI5NTg0MQ_14114d2a-e488-40a4-99bd-15d62868ac45"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1edd8caecae44ce995f38b9edd410db7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzQtMS0xLTEtMjk1ODIz_72d024ba-d546-496b-ac77-c6c183485969"
      unitRef="usd">82119000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie123d487288b460289e6aaf6ae104852_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzQtMy0xLTEtMjk1ODMx_6a78d5b1-6570-429f-b4fd-f6d69bc86aa6"
      unitRef="usd">153892000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0d2a7ac149f64c73a8f3b978546f2741_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzQtNS0xLTEtMjk1ODMx_0e15b6f1-985c-47fa-8a1c-60faac40b302"
      unitRef="usd">101620000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia0cc9849a9ff470b935a370313045788_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzQtNy0xLTEtMjk1ODQx_dcb65765-0133-43e3-bcc9-3bbb056671c0"
      unitRef="usd">721000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i977f19fae3bf4bc8963ec72c8c49ebdc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzQtOS0xLTEtMjk1ODQx_7ce39c46-1dc3-4889-ad00-624ec8e4ad39"
      unitRef="usd">-46241000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzQtMTEtMS0xLTI5NTg0MQ_73fc4a3f-16f5-42cf-90c4-6bfe13cacb48"
      unitRef="usd">292111000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i2b1171c68bbe4af1819c9145310c6fb8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzYtMS0xLTEtMjk1ODIz_accc191b-c311-4360-9be9-b6058f38a3aa"
      unitRef="usd">5012000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="iff2a6e509d3c452fbb34c09f2c1f55ea_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzYtMy0xLTEtMjk1ODMx_cdd6efd8-6974-40ec-bbf4-a0e2a9f125ca"
      unitRef="usd">6859000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="iaf761e93be114754a9786359d43f61dd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzYtNS0xLTEtMjk1ODMx_3775962f-1127-4b6c-be94-a944a120e8fe"
      unitRef="usd">7623000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i8708367e0d6148a297ee5ca38d90794b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzYtNy0xLTEtMjk1ODQx_6494723f-1d99-4962-9cc8-d0bef6266497"
      unitRef="usd">-1471000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="if5e992bf9c2a499eaf6476b15ef7c5f5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzYtOS0xLTEtMjk1ODQx_f5996a34-9cdb-45a5-9d42-ecd3a0efa2c9"
      unitRef="usd">-711000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ib1b874ae66ad400991b82de7c7e71228_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzYtMTEtMS0xLTI5NTg0MQ_04696530-3f8e-4720-b15e-8f8a58b5c6f2"
      unitRef="usd">17312000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ifc4a75422af949c2a32932d3412701db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzctMS0xLTEtMjk1ODIz_03ef32f2-1cbc-4375-b9f3-6bb3967bfb03"
      unitRef="usd">98000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i93f387cc7da9423da81f99d85943fc07_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzctMy0xLTEtMjk1ODMx_7e9074e8-398c-456d-b32f-cf97363c9af0"
      unitRef="usd">-367000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ia738f2f875064e3b9b39a81213de4404_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzctNS0xLTEtMjk1ODMx_8970a4e1-8c4a-4188-982f-809fdb6bb671"
      unitRef="usd">-363000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i57299b3f0d29410bbd43971727bf7de2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzctNy0xLTEtMjk1ODQx_c39abcc4-9876-41e6-89cc-3f2cf0b8951d"
      unitRef="usd">-164000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i5cfee834f48c44269e6203285ea53742_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzctOS0xLTEtMjk1ODQx_be791f1f-e195-4a30-a0cf-ea9cb3ba6410"
      unitRef="usd">711000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="icf605eb33300435fa4bb68398ee8e8db_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzctMTEtMS0xLTI5NTg0MQ_9a50a34b-cdf4-4359-a0b6-a81e328fcb64"
      unitRef="usd">-85000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i1edd8caecae44ce995f38b9edd410db7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzgtMS0xLTEtMjk1ODIz_a11daad6-ee3f-4ea1-ab34-3c6176598ddb"
      unitRef="usd">5110000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ie123d487288b460289e6aaf6ae104852_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzgtMy0xLTEtMjk1ODMx_2be06524-e985-467e-a272-2d0c3bb004da"
      unitRef="usd">6492000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i0d2a7ac149f64c73a8f3b978546f2741_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzgtNS0xLTEtMjk1ODMx_2d0be0f4-cd98-472d-b1a4-13ea6a6926ba"
      unitRef="usd">7260000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ia0cc9849a9ff470b935a370313045788_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzgtNy0xLTEtMjk1ODQx_bb0cd847-650d-4384-acaf-3b76b589c488"
      unitRef="usd">-1635000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i977f19fae3bf4bc8963ec72c8c49ebdc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzgtOS0xLTEtMjk1ODQx_762ab4ee-9863-4988-b1a6-9652b02471b3"
      unitRef="usd">0</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTo2YmY5OTUyNmUwODk0MDVmOWUyMzM5Y2Q3YjA3OTFmMi90YWJsZXJhbmdlOjZiZjk5NTI2ZTA4OTQwNWY5ZTIzMzljZDdiMDc5MWYyXzgtMTEtMS0xLTI5NTg0MQ_ac4061b5-720d-4b3e-8c3c-0f78589ce781"
      unitRef="usd">17227000000</cvs:AdjustedOperatingIncomeLoss>
    <us-gaap:Revenues
      contextRef="i3b8dd9bca2d845c5a94bae3567479a9e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzItMS0xLTEtMjk1ODUw_b9ed6b01-9a4c-4953-8694-7d6557da1318"
      unitRef="usd">75467000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4bb91f8d55eb47ff966a699f6afb0276_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzItMy0xLTEtMjk1ODU4_49aeacc2-cd67-4564-9665-65ce40f12247"
      unitRef="usd">141938000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic8b4d98a4ab443d1864e4785b87c3333_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzItNS0xLTEtMjk1ODU4_72b88bfb-e5ec-4711-9102-aade4e267c27"
      unitRef="usd">91198000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iebc232da670a4ceabcfa09b1f0849657_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzItNy0xLTEtMjk1ODY2_e0bd79c2-cf05-4970-9d96-7e5bbd49dc7c"
      unitRef="usd">426000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8104c5fdfe0c4205a5f07c99c7cede7b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzItOS0xLTEtMjk1ODY2_a6a48410-9d3d-4a25-b4d3-32364f1ea915"
      unitRef="usd">-40323000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i90b72ec258964345839ac8de15529de0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzItMTEtMS0xLTI5NTg2Ng_e660498b-1899-449d-aef6-dec11e8d0837"
      unitRef="usd">268706000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i677074299da14bd2b078357e93653928_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzMtMS0xLTEtMjk1ODUw_3dbbd5a4-8e0e-4cad-9329-e87ca4c8480d"
      unitRef="usd">-58000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i114930f0b44c4d1a9f07a0c3d6dd2dd5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzMtMy0xLTEtMjk1ODU4_a8b5b16c-ebd2-49fa-a86d-e4e484723fca"
      unitRef="usd">-584000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia1b5e13d39f046e3b93ecd36eeb5ee63_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzMtNS0xLTEtMjk1ODU4_0ac919b0-82aa-4868-b12a-e1bf013c6ce0"
      unitRef="usd">2381000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib4d84170ec8e498b9520974828e0c142_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzMtNy0xLTEtMjk1ODY2_06b4a680-3106-4401-9af3-6f3baea0065f"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i948f596e14ee4a9d9806fb733eb3ebcd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzMtOS0xLTEtMjk1ODY2_e66a0018-21a7-430c-8134-0a21f79fed9d"
      unitRef="usd">-1739000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i782729dd554e4d80bb426bea495446dd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzMtMTEtMS0xLTI5NTg2Ng_cbc1ec5c-99b7-4169-874f-9afb13f055bd"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia95a883374f34cadb8aba20153008269_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzQtMS0xLTEtMjk1ODUw_c99c2156-d325-41ad-8a4b-9ee6f093a4ab"
      unitRef="usd">75409000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzQtMy0xLTEtMjk1ODU4_07694566-f2bf-47a8-baae-98940a1481ef"
      unitRef="usd">141354000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if7a2e3c175d84b5aa44a7a859d45ad5d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzQtNS0xLTEtMjk1ODU4_47bd928a-20ba-4008-ba57-444d42ad8cf5"
      unitRef="usd">93579000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2ce5e18976c2489a9a964cdebbae85ac_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzQtNy0xLTEtMjk1ODY2_9e9a751f-fc60-4be5-afef-f9cce3e88a15"
      unitRef="usd">426000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i37c56e2626d741fc89c81191ac507cb5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzQtOS0xLTEtMjk1ODY2_15dbc8a3-8df9-40bb-9aac-6bf3ccb75277"
      unitRef="usd">-42062000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzQtMTEtMS0xLTI5NTg2Ng_46a0fffd-116f-4ab2-b31a-815ddfd4a2f5"
      unitRef="usd">268706000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i3b8dd9bca2d845c5a94bae3567479a9e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzYtMS0xLTEtMjk1ODUw_4a9fd6b9-8901-401d-85fc-adef684ef22c"
      unitRef="usd">6188000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i4bb91f8d55eb47ff966a699f6afb0276_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzYtMy0xLTEtMjk1ODU4_55a38be8-b077-44cc-a4e4-d8929036d36d"
      unitRef="usd">5688000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ic8b4d98a4ab443d1864e4785b87c3333_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzYtNS0xLTEtMjk1ODU4_9812415e-65a4-452f-9ea1-c3063a5e2eac"
      unitRef="usd">6146000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="iebc232da670a4ceabcfa09b1f0849657_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzYtNy0xLTEtMjk1ODY2_ec6099b5-143f-47c2-8b6c-2c5b0d8b3fab"
      unitRef="usd">-1306000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i8104c5fdfe0c4205a5f07c99c7cede7b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzYtOS0xLTEtMjk1ODY2_784afe5e-8212-4392-8b98-f08c85d5cc2d"
      unitRef="usd">-708000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i90b72ec258964345839ac8de15529de0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzYtMTEtMS0xLTI5NTg2Ng_6138cc6d-999a-40b3-b81d-a0026abf030f"
      unitRef="usd">16008000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i677074299da14bd2b078357e93653928_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzctMS0xLTEtMjk1ODUw_25a059d8-a31a-4180-bc04-47b7b662fa82"
      unitRef="usd">-53000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i114930f0b44c4d1a9f07a0c3d6dd2dd5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzctMy0xLTEtMjk1ODU4_b6779e6e-04cc-4e81-851e-4fcc050da882"
      unitRef="usd">-560000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ia1b5e13d39f046e3b93ecd36eeb5ee63_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzctNS0xLTEtMjk1ODU4_e9192310-c83f-4600-bfd6-b6a50b067f55"
      unitRef="usd">-134000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ib4d84170ec8e498b9520974828e0c142_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzctNy0xLTEtMjk1ODY2_3f1be299-6603-4fae-bfc3-eeb5660baaea"
      unitRef="usd">-13000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i948f596e14ee4a9d9806fb733eb3ebcd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzctOS0xLTEtMjk1ODY2_5c9a290c-861c-4eab-95e6-589b6d35fa77"
      unitRef="usd">708000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i782729dd554e4d80bb426bea495446dd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzctMTEtMS0xLTI5NTg2Ng_10977b12-d8ab-405c-a538-f1b056be7ac3"
      unitRef="usd">-52000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ia95a883374f34cadb8aba20153008269_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzgtMS0xLTEtMjk1ODUw_0866585c-1373-4afb-aa8b-18c1b96e3332"
      unitRef="usd">6135000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzgtMy0xLTEtMjk1ODU4_1bf9af24-1f84-4a9b-916f-62a480c2425a"
      unitRef="usd">5128000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="if7a2e3c175d84b5aa44a7a859d45ad5d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzgtNS0xLTEtMjk1ODU4_5413fd0f-49d3-4b7d-b823-665ca72fd032"
      unitRef="usd">6012000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i2ce5e18976c2489a9a964cdebbae85ac_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzgtNy0xLTEtMjk1ODY2_14df488e-b533-45c3-b5e2-d07e238dc73c"
      unitRef="usd">-1319000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i37c56e2626d741fc89c81191ac507cb5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzgtOS0xLTEtMjk1ODY2_fbfa57e5-c630-4b58-9f1a-46796686b630"
      unitRef="usd">0</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToyZTQ1NWY5NjMxZDM0Njc4OTczNmE4MTBiNTMyM2VjNS90YWJsZXJhbmdlOjJlNDU1Zjk2MzFkMzQ2Nzg5NzM2YTgxMGI1MzIzZWM1XzgtMTEtMS0xLTI5NTg2Ng_b39326a1-72ae-4102-b4ec-f366a29560ab"
      unitRef="usd">15956000000</cvs:AdjustedOperatingIncomeLoss>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i963c0343d69a42caadc378204229b722_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzE1NzY_bf2a85fd-807e-4289-aaa0-27a8089f4a18"
      unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i03d09415d2bf43b384994476ca92e168_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzE1ODA_293e98f6-d25f-400f-85d5-274b03dcb1e7"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i75dd5be1e137424fa4519c29f0daa19d_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzE1ODc_69f3e2ff-2c23-436d-877b-8eb977508a61"
      unitRef="number">0.16</us-gaap:ConcentrationRiskPercentage1>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a07c8633b37492ba109c7cd9a92299a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzItMS0xLTEtMjY1MjQ3_83f44f28-d971-43ec-b9ff-00ff4dfb251f"
      unitRef="usd">90798000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzItMy0xLTEtMjY1MjQ3_454e0810-8529-45f0-816a-1bd9503dd715"
      unitRef="usd">157968000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd57b0b73c1b4e1aa835dde2abf6925c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzItNS0xLTEtMjY1MjQ3_0159e2c6-9b83-4b75-8e2a-136f2c0d6f42"
      unitRef="usd">72739000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie1d5e5a55e6f4909a1d1c3d2003ec720_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzItNy0xLTEtMjY1MjQ3_b1a60eee-503a-48d6-a7ae-5c835c26594c"
      unitRef="usd">124000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzItMTEtMS0xLTI2NTI0Nw_7010ea6e-6c19-4f10-b520-e3cadc44f24f"
      unitRef="usd">321629000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic42863604ce54004b9083c8738b254f9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzMtMS0xLTEtMjY1MjQ3_b6838953-4ddf-4779-a8fc-9c15ccc9c43d"
      unitRef="usd">76000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a109a847174412e8d5696bab1036d5c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzMtMy0xLTEtMjY1MjQ3_5b1cfc3c-b36f-4106-ab53-3dcc3d022f8f"
      unitRef="usd">11608000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i94f2ff5e331c4b7687981a263ec1c30d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzMtNS0xLTEtMjY1MjQ3_d4ff09b7-dc0a-4a9d-8c67-1f5b5326e5c2"
      unitRef="usd">35901000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib085c0543c9d4988b6b20b9b427998b0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzMtOS0xLTEtMjY1MjQ3_af9af881-8372-444c-82a2-3f568ea64951"
      unitRef="usd">-47585000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i2a07c8633b37492ba109c7cd9a92299a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzQtMS0xLTEtMjY1MjQ3_4199b1d4-a58e-4849-b686-f786c63f3e32"
      unitRef="usd">476000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzQtMy0xLTEtMjY1MjQ3_da508278-e23d-49e3-8bdf-38a5a1a6a50c"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="icd57b0b73c1b4e1aa835dde2abf6925c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzQtNS0xLTEtMjY1MjQ3_a225e3ce-b253-4697-b06f-3968e8eab82a"
      unitRef="usd">-44000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ie1d5e5a55e6f4909a1d1c3d2003ec720_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzQtNy0xLTEtMjY1MjQ3_b10ae807-4e93-44db-92b8-832665f6d4da"
      unitRef="usd">406000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ib085c0543c9d4988b6b20b9b427998b0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzQtOS0xLTEtMjY1MjQ3_c5021afd-7fe8-4a3b-9b4e-72a70d70dfba"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzQtMTEtMS0xLTI2NTI0Nw_e8d0088c-4b52-446c-baa7-ff7671ed649c"
      unitRef="usd">838000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i2a07c8633b37492ba109c7cd9a92299a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzUtMS0xLTEtMjY1MjQ3_a966812f-fa43-45c0-b10b-4b9f9f8e6d4b"
      unitRef="usd">91350000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzUtMy0xLTEtMjY1MjQ3_c793c5ad-79cc-4a81-b609-1e3fb46a68d1"
      unitRef="usd">169576000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icd57b0b73c1b4e1aa835dde2abf6925c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzUtNS0xLTEtMjY1MjQ3_42c34c0f-1f54-4f1e-af5a-ac578e3a402e"
      unitRef="usd">108596000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie1d5e5a55e6f4909a1d1c3d2003ec720_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzUtNy0xLTEtMjY1MjQ3_85809ee1-905d-46b9-8f9a-addf2bff5e8b"
      unitRef="usd">530000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib085c0543c9d4988b6b20b9b427998b0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzUtOS0xLTEtMjY1MjQ3_fe8f76a5-0cef-4b44-80c8-3054d81a0841"
      unitRef="usd">-47585000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzUtMTEtMS0xLTI2NTI0Nw_9d8fd173-e13b-4998-9eb4-3137136a367e"
      unitRef="usd">322467000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i2a07c8633b37492ba109c7cd9a92299a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzYtMS0xLTEtMjY1MjQ3_8c306227-28a1-4912-9795-8009b965e1a0"
      unitRef="usd">6338000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzYtMy0xLTEtMjY1MjQ3_8de61937-951c-469f-b7e4-0e4677a1913a"
      unitRef="usd">6781000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="icd57b0b73c1b4e1aa835dde2abf6925c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzYtNS0xLTEtMjY1MjQ3_9ae65da4-1e5a-4d20-8517-54089a73a16e"
      unitRef="usd">6531000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ie1d5e5a55e6f4909a1d1c3d2003ec720_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzYtNy0xLTEtMjY1MjQ3_a99bafa5-e796-4b7c-a564-2080f3cbfcd0"
      unitRef="usd">-1613000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ib085c0543c9d4988b6b20b9b427998b0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzYtOS0xLTEtMjY1MjQ3_0ce4d25b-3969-4424-8981-f781720561ae"
      unitRef="usd">0</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzYtMTEtMS0xLTI2NTI0Nw_236f6fc2-2e5c-433d-94db-28c0739ef699"
      unitRef="usd">18037000000</cvs:AdjustedOperatingIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2a07c8633b37492ba109c7cd9a92299a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzctMS0xLTEtMjY1MjQ3_53da3428-e994-4e2d-bcce-4bf5bf252532"
      unitRef="usd">1579000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzctMy0xLTEtMjY1MjQ3_b390faed-f41f-4ec2-9d00-920019dce87d"
      unitRef="usd">519000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="icd57b0b73c1b4e1aa835dde2abf6925c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzctNS0xLTEtMjY1MjQ3_143480b3-5016-4b3f-b1ef-401d739cfea4"
      unitRef="usd">1889000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ie1d5e5a55e6f4909a1d1c3d2003ec720_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzctNy0xLTEtMjY1MjQ3_66af34ff-43e9-42b3-8bb1-2618efeb6e86"
      unitRef="usd">237000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib085c0543c9d4988b6b20b9b427998b0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzctOS0xLTEtMjY1MjQ3_aef69d73-46a6-42f8-8e9e-41cd2f2268ff"
      unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzctMTEtMS0xLTI2NTI0Nw_b4236dfc-78bb-4349-bf44-65c59fbc7d89"
      unitRef="usd">4224000000</us-gaap:DepreciationDepletionAndAmortization>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1edd8caecae44ce995f38b9edd410db7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzktMS0xLTEtMjY1MjQ3_a954d703-eb51-475d-8893-090990d22cb5"
      unitRef="usd">81457000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie123d487288b460289e6aaf6ae104852_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzktMy0xLTEtMjY1MjQ3_fde97451-b1d5-4c39-968f-0fda8b82b19b"
      unitRef="usd">143912000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0d2a7ac149f64c73a8f3b978546f2741_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzktNS0xLTEtMjY1MjQ3_f618da02-2829-4ee8-9134-87c4be01fcef"
      unitRef="usd">65418000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia0cc9849a9ff470b935a370313045788_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzktNy0xLTEtMjY1MjQ3_daaf8a90-5235-4d45-af31-03735ac1cc0c"
      unitRef="usd">125000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzktMTEtMS0xLTI2NTI0Nw_238d4908-b682-478e-a822-2ef48fe4efc9"
      unitRef="usd">290912000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7643d22e2ea64b119f44152086b5ef19_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEwLTEtMS0xLTI2NTI0Nw_a1cce818-1f8e-4ebc-98e1-d388feb7d60e"
      unitRef="usd">76000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i28a3b9441e5e432f912162e86ac57adc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEwLTMtMS0xLTI2NTI0Nw_cfeb8964-e3e5-4629-aa6a-833322d400ce"
      unitRef="usd">9980000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i38f3804941744661bf9c3ad58fc2aad2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEwLTUtMS0xLTI2NTI0Nw_64faa80c-e321-40bf-abc0-a8bff0951dbc"
      unitRef="usd">36185000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i977f19fae3bf4bc8963ec72c8c49ebdc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEwLTktMS0xLTI2NTI0Nw_52c8b0a0-3603-4784-81a9-b9ed8675d19a"
      unitRef="usd">-46241000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i1edd8caecae44ce995f38b9edd410db7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzExLTEtMS0xLTI2NTI0Nw_2d1bbab6-861a-4579-8855-c6e504080318"
      unitRef="usd">586000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ie123d487288b460289e6aaf6ae104852_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzExLTMtMS0xLTI2NTI0Nw_f16c3334-85bc-44bc-8fa0-46101fa00710"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i0d2a7ac149f64c73a8f3b978546f2741_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzExLTUtMS0xLTI2NTI0Nw_292422b6-44e0-4d3b-b617-01c416f7b832"
      unitRef="usd">17000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ia0cc9849a9ff470b935a370313045788_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzExLTctMS0xLTI2NTI0Nw_aa162488-fa95-406e-896a-6cede36fbd2d"
      unitRef="usd">596000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i977f19fae3bf4bc8963ec72c8c49ebdc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzExLTktMS0xLTI2NTI0Nw_2371b9d7-fa30-4a05-8f46-7ba8c2a16799"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzExLTExLTEtMS0yNjUyNDc_b89f3cd6-4318-411b-ad9c-7f8f271c4974"
      unitRef="usd">1199000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i1edd8caecae44ce995f38b9edd410db7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEyLTEtMS0xLTI2NTI0Nw_5c609e77-78dc-4852-bbcf-cddfa4a0b730"
      unitRef="usd">82119000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie123d487288b460289e6aaf6ae104852_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEyLTMtMS0xLTI2NTI0Nw_2d21931a-f463-475d-a68f-073ff92b7f07"
      unitRef="usd">153892000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0d2a7ac149f64c73a8f3b978546f2741_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEyLTUtMS0xLTI2NTI0Nw_b26a61d9-f108-4651-a90b-00dd4d7d1dcd"
      unitRef="usd">101620000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia0cc9849a9ff470b935a370313045788_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEyLTctMS0xLTI2NTI0Nw_1a3b1900-5e7a-42ce-8a46-622f7e97c1e2"
      unitRef="usd">721000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i977f19fae3bf4bc8963ec72c8c49ebdc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEyLTktMS0xLTI2NTI0Nw_be8cf1f0-1099-4bbb-a78b-94477fcea6b6"
      unitRef="usd">-46241000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEyLTExLTEtMS0yNjUyNDc_4665fbb6-7a9e-443a-8c21-7257eea39848"
      unitRef="usd">292111000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i1edd8caecae44ce995f38b9edd410db7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEzLTEtMS0xLTI2NTI0Nw_b183d0ea-65ad-4b5b-beb8-bf65bc06488e"
      unitRef="usd">5110000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ie123d487288b460289e6aaf6ae104852_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEzLTMtMS0xLTI2NTI0Nw_d270c999-9ac4-41a6-ba30-fe1f8533b4ea"
      unitRef="usd">6492000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i0d2a7ac149f64c73a8f3b978546f2741_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEzLTUtMS0xLTI2NTI0Nw_65418399-d39d-401c-b4ba-c4b57d8f0101"
      unitRef="usd">7260000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ia0cc9849a9ff470b935a370313045788_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEzLTctMS0xLTI2NTI0Nw_0de8703d-439e-449b-908e-bb200ca69aea"
      unitRef="usd">-1635000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i977f19fae3bf4bc8963ec72c8c49ebdc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEzLTktMS0xLTI2NTI0Nw_a3c7e330-a6d2-497d-8452-445d6f92b046"
      unitRef="usd">0</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzEzLTExLTEtMS0yNjUyNDc_ea3a5053-80de-4d77-8607-996f141fd88d"
      unitRef="usd">17227000000</cvs:AdjustedOperatingIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i1edd8caecae44ce995f38b9edd410db7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE0LTEtMS0xLTI2NTI0Nw_790838dd-9a41-4ce1-ab3b-e38eef5257c0"
      unitRef="usd">1811000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ie123d487288b460289e6aaf6ae104852_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE0LTMtMS0xLTI2NTI0Nw_ff651c09-0cbc-4033-8753-77ada7047805"
      unitRef="usd">505000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0d2a7ac149f64c73a8f3b978546f2741_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE0LTUtMS0xLTI2NTI0Nw_72d05b06-4127-4a5c-92f8-0be6d69a1dd8"
      unitRef="usd">1955000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia0cc9849a9ff470b935a370313045788_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE0LTctMS0xLTI2NTI0Nw_65ebf1e8-b9dc-486e-89b3-e4bc990b981a"
      unitRef="usd">215000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i977f19fae3bf4bc8963ec72c8c49ebdc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE0LTktMS0xLTI2NTI0Nw_aab4346a-1665-4075-a3d3-8d16fa8bb563"
      unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE0LTExLTEtMS0yNjUyNDc_6d1d1ceb-4185-4e99-8d6e-8effd335dbaf"
      unitRef="usd">4486000000</us-gaap:DepreciationDepletionAndAmortization>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia95a883374f34cadb8aba20153008269_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE2LTEtMS0xLTI2NTI0Nw_f6366d0a-3ec3-4834-94cd-ecefb6ff9976"
      unitRef="usd">74871000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE2LTMtMS0xLTI2NTI0Nw_5f55cebe-0aa7-48d7-b638-456b5d94f9cb"
      unitRef="usd">131936000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if7a2e3c175d84b5aa44a7a859d45ad5d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE2LTUtMS0xLTI2NTI0Nw_a7ee22bc-d95d-480f-90b4-d15e1cc81754"
      unitRef="usd">60990000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ce5e18976c2489a9a964cdebbae85ac_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE2LTctMS0xLTI2NTI0Nw_59cffc73-04cc-4b21-b614-d1c92d2860f9"
      unitRef="usd">111000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE2LTExLTEtMS0yNjUyNDc_e3c4c5ae-4177-4f55-aed3-d49d0e8e95ba"
      unitRef="usd">267908000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d20d05e0c4b4f8688a601a6a2a0b0df_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE3LTEtMS0xLTI2NTI0Nw_0f5b715e-4fa2-453a-9889-949d36fca3af"
      unitRef="usd">55000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i940aaafcbe33455889e57c5de95674de_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE3LTMtMS0xLTI2NTI0Nw_623b36ce-a6c2-43c1-94a2-df71a93a7ec0"
      unitRef="usd">9418000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i94f36228e56d4a5e93aeacea94e8a9c3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE3LTUtMS0xLTI2NTI0Nw_bf9004dc-e05d-44bf-8ec4-1f241a67d087"
      unitRef="usd">32589000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37c56e2626d741fc89c81191ac507cb5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE3LTktMS0xLTI2NTI0Nw_472a38b0-dfd0-4ca4-ae1a-7d500c3d5bdd"
      unitRef="usd">-42062000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="ia95a883374f34cadb8aba20153008269_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE4LTEtMS0xLTI2NTI0Nw_8c20b6f3-f2d7-45d0-af3b-b337f9332654"
      unitRef="usd">483000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE4LTMtMS0xLTI2NTI0Nw_0c99b574-2d6b-4ea4-9ab0-93c55bc8ba8b"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if7a2e3c175d84b5aa44a7a859d45ad5d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE4LTUtMS0xLTI2NTI0Nw_5ab983c6-304f-419c-87bd-62b5cd66d3ef"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i2ce5e18976c2489a9a964cdebbae85ac_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE4LTctMS0xLTI2NTI0Nw_8360eb67-b26d-43bb-bb16-48a085fe10ab"
      unitRef="usd">315000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i37c56e2626d741fc89c81191ac507cb5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE4LTktMS0xLTI2NTI0Nw_4b205542-4732-48c4-b0ac-e40c7293c65e"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE4LTExLTEtMS0yNjUyNDc_af174843-df5a-4290-a9c3-3a2fbcf08593"
      unitRef="usd">798000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="ia95a883374f34cadb8aba20153008269_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE5LTEtMS0xLTI2NTI0Nw_30cd394c-46bd-4dff-bf47-827a46e2daf4"
      unitRef="usd">75409000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE5LTMtMS0xLTI2NTI0Nw_134a29de-b74d-4ba1-bcab-22f3dc2d27b3"
      unitRef="usd">141354000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if7a2e3c175d84b5aa44a7a859d45ad5d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE5LTUtMS0xLTI2NTI0Nw_d336e130-059b-45f7-9611-d8beec75e9a8"
      unitRef="usd">93579000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2ce5e18976c2489a9a964cdebbae85ac_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE5LTctMS0xLTI2NTI0Nw_75a896ee-a486-4bf8-9cdb-d4211c2b8f00"
      unitRef="usd">426000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i37c56e2626d741fc89c81191ac507cb5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE5LTktMS0xLTI2NTI0Nw_28d5d323-2833-4b07-8491-7257e91ec63e"
      unitRef="usd">-42062000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzE5LTExLTEtMS0yNjUyNDc_5a53774a-2ca1-4dd3-b693-01f3d4f459e6"
      unitRef="usd">268706000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ia95a883374f34cadb8aba20153008269_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIwLTEtMS0xLTI2NTI0Nw_a46619f2-3594-4fd5-91c1-95ffdf4b31eb"
      unitRef="usd">6135000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIwLTMtMS0xLTI2NTI0Nw_3ca3a510-f3f6-4f49-ba9c-1ef705f4202e"
      unitRef="usd">5128000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="if7a2e3c175d84b5aa44a7a859d45ad5d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIwLTUtMS0xLTI2NTI0Nw_dc007215-5452-4d55-aea7-cbfb22c71de5"
      unitRef="usd">6012000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i2ce5e18976c2489a9a964cdebbae85ac_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIwLTctMS0xLTI2NTI0Nw_c1b1eac3-b38b-492f-865a-34be428b0dea"
      unitRef="usd">-1319000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i37c56e2626d741fc89c81191ac507cb5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIwLTktMS0xLTI2NTI0Nw_5593b242-e5aa-48f2-a3fb-545f51501dca"
      unitRef="usd">0</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIwLTExLTEtMS0yNjUyNDc_734f096a-f5f0-44d8-a386-186e90a6aafe"
      unitRef="usd">15956000000</cvs:AdjustedOperatingIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia95a883374f34cadb8aba20153008269_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIxLTEtMS0xLTI2NTI0Nw_84188b74-5dae-44a7-b0f7-288eadfd4267"
      unitRef="usd">1832000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIxLTMtMS0xLTI2NTI0Nw_2642a680-384b-4362-b42b-b2dd4729cf06"
      unitRef="usd">532000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if7a2e3c175d84b5aa44a7a859d45ad5d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIxLTUtMS0xLTI2NTI0Nw_0887fa46-c859-4b04-9dc9-9bf80d1a60cd"
      unitRef="usd">1881000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2ce5e18976c2489a9a964cdebbae85ac_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIxLTctMS0xLTI2NTI0Nw_9a01ff3c-752d-4b1b-be91-d2eca412f82e"
      unitRef="usd">196000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i37c56e2626d741fc89c81191ac507cb5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIxLTktMS0xLTI2NTI0Nw_fd036ece-cc7b-4cf0-b662-c396310c0afe"
      unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZTozODMwYmZiY2QwNjk0ZjA5OTBiMTQ1ZmNjYTAxZGU1Mi90YWJsZXJhbmdlOjM4MzBiZmJjZDA2OTRmMDk5MGIxNDVmY2NhMDFkZTUyXzIxLTExLTEtMS0yNjUyNDc_dd413ea3-449b-499a-9fe9-685d42ba1c79"
      unitRef="usd">4441000000</us-gaap:DepreciationDepletionAndAmortization>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="if1c299109ff140ef8ff565f728a5e798_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzIwMDg_7b7be722-e1b8-4b01-b8bb-f1e09ead5386"
      unitRef="usd">12600000000</cvs:NetRevenuesRetailCoPayments>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="ie123d487288b460289e6aaf6ae104852_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzIwMTI_a7484713-5069-42fb-adee-2eadfa6611f7"
      unitRef="usd">11600000000</cvs:NetRevenuesRetailCoPayments>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="ic8e040e9919b4e0c89af15e59a55694e_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzIwMTk_e50e172c-fac4-4728-bb9f-8dd24b8baea9"
      unitRef="usd">10900000000</cvs:NetRevenuesRetailCoPayments>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzk1NzA_af936993-fbf4-46ee-89f9-a02684560912">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of consolidated operating income to adjusted operating income for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (GAAP measure)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized capital (gains) losses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office real estate optimization charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on divestiture of subsidiaries &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(475)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Opioid litigation charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on assets held for sale &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related integration costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Store impairments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(8)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(9)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition purchase price adjustment outside of measurement period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(10)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receipt of fully reserved ACA risk corridor receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(11)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company&#x2019;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#x2019;s GAAP consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#x2019;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#x2019;s insurance products, the services performed for the Company&#x2019;s customers or the sale of the Company&#x2019;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#x2019;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#x2019;s and investors&#x2019; ability to compare the Company&#x2019;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#x2019;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company&#x2019;s net realized capital gains and losses arise from various types of transactions, primarily in the course of managing a portfolio of assets that support the payment of insurance liabilities. Net realized capital gains and losses are reflected in the consolidated statements of operations in net investment income within each segment. These capital gains and losses are the result of investment decisions, market conditions and other economic developments that are unrelated to the performance of the Company&#x2019;s business, and the amount and timing of these capital gains and losses do not directly relate to the underwriting of the Company&#x2019;s insurance products, the services performed for the Company&#x2019;s customers or the sale of the Company&#x2019;s products or services. Accordingly, the Company believes excluding net realized capital gains and losses enhances the Company&#x2019;s and investors&#x2019; ability to compare the Company&#x2019;s past financial performance with its current performance and to analyze underlying business performance and trends. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In 2022, the office real estate optimization charges primarily relate to the abandonment of leased real estate and the related right-of-use assets and property and equipment in connection with the planned reduction of corporate office real estate space in response to the Company&#x2019;s new flexible work arrangement. The office real estate optimization charges are reflected in the Company&#x2019;s GAAP consolidated statement of operations in operating expenses within the Health Care Benefits, Corporate/Other and Health Services segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In 2022, the gain on divestiture of subsidiaries represents the pre-tax gain on the sale of bswift, which the Company sold in November 2022, and the pre-tax gain on the sale of PayFlex, which the Company sold in June 2022. In 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#x2019; Compensation business, which the Company sold in July 2020. The gains on divestitures are reflected as a reduction of operating expenses in the Company&#x2019;s GAAP consolidated statements of operations within the Health Care Benefits segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In 2022, the opioid litigation charges relate to agreements to resolve substantially all opioid claims against the Company by certain states and governmental entities. The opioid litigation charges are reflected within the Corporate/Other segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In 2022, the loss on assets held for sale relates to the LTC reporting unit within the Pharmacy &amp;amp; Consumer Wellness segment. The Company continually evaluates its portfolio for non-strategic assets. The Company determined that its LTC business was no longer a strategic asset and during the third quarter of 2022 committed to a plan to sell the LTC business. As of September 30, 2022, the LTC business met the criteria for held-for-sale accounting and its net assets were accounted for as assets held for sale. The carrying value of the LTC business was determined to be greater than its estimated fair value less costs to sell and a loss on assets held for sale was recorded during the third quarter of 2022. As of December 31, 2022, the net assets of the LTC business continued to meet the criteria for held-for-sale accounting and during the fourth quarter of 2022, an incremental loss on assets held for sale was recorded to write down the carrying value of the LTC business to its estimated fair value less costs to sell. During 2022, the loss on assets held for sale also relates to the Commercial Business reporting unit within the Health Care Benefits segment. In March 2022, the Company reached an agreement to sell its Thailand business, which was included in the Commercial Business reporting unit. At that time, a portion of the Commercial Business goodwill was specifically allocated to the Thailand business. The net assets of the Thailand business were accounted for as assets held for sale at March 31, 2022. The carrying value of the Thailand business was determined to be greater than its estimated fair value less costs to sell and a loss on assets held for sale was recorded during the first quarter of 2022. The sale of the Thailand business closed in the second quarter of 2022, and the ultimate loss on the sale was not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In 2021 and 2020, acquisition-related integration costs relate to the acquisition of Aetna. The acquisition-related integration costs are reflected in the Company&#x2019;s GAAP consolidated statements of operations in operating expenses within the Corporate/Other segment.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(8)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In 2021, the store impairment charge relates to the write down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately 900 retail stores between 2022 and 2024. The store impairment charge is reflected within the Pharmacy &amp;amp; Consumer Wellness segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(9)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;In 2021, the goodwill impairment charge relates to an impairment of the remaining goodwill of the LTC reporting unit within the Pharmacy &amp;amp; Consumer Wellness segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(10)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt"&gt;In 2021, the Company received $61&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#x2019;s GAAP consolidated statement of operations as a reduction of operating expenses within the Health Care Benefits segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(11)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt"&gt;In 2020, the Company received $313&#160;million owed to it under the ACA&#x2019;s risk corridor program that was previously fully reserved for as payment was uncertain. After considering offsetting items such as the ACA&#x2019;s minimum MLR rebate requirements and premium taxes, the Company recognized pre-tax income of $307&#160;million in the Company&#x2019;s GAAP consolidated statement of operations within the Health Care Benefits segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzEtMS0xLTEtMjY1MjQ3_0fc638b5-85e0-4e33-8ef8-f5559a5652ca"
      unitRef="usd">7954000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzEtMy0xLTEtMjY1MjQ3_4ba1f4ec-ae63-42cc-a03e-9edbec336961"
      unitRef="usd">13310000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzEtNS0xLTEtMjY1MjQ3_4a80a8a5-f6b7-484c-a5dc-8a650c5c4813"
      unitRef="usd">13911000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzItMS0xLTEtMjY1MjQ3_ad46c72b-5d76-4812-9147-c36626c420f4"
      unitRef="usd">1785000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzItMy0xLTEtMjY1MjQ3_a703a58b-a512-453f-a0f1-09ed7e1ac324"
      unitRef="usd">2233000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzItNS0xLTEtMjY1MjQ3_d96f76e2-dcc3-4ef8-bde7-29b94f297fd2"
      unitRef="usd">2341000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzMtMS0xLTEtMjc0MjU2_3e50b947-6017-408b-8225-bf4fe7bd214d"
      unitRef="usd">-320000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzMtMy0xLTEtMjk3ODI2_7745deb5-f038-4b21-b432-ae275be42a0c"
      unitRef="usd">176000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzMtNS0xLTEtMjk3Nzcw_98113fc6-5c92-4c5f-9b77-3ea31a5c74dd"
      unitRef="usd">52000000</us-gaap:RealizedInvestmentGainsLosses>
    <cvs:OfficeRealEstateOptimizationCharges
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzMtMS0xLTEtMjY1MjQ3_19f1ac17-e6b4-4e12-a2b5-07e6f1ed8493"
      unitRef="usd">117000000</cvs:OfficeRealEstateOptimizationCharges>
    <cvs:OfficeRealEstateOptimizationCharges
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzMtMy0xLTEtMjY1MjQ3_61c1e153-7bdd-4253-881a-16c163e73e2d"
      unitRef="usd">0</cvs:OfficeRealEstateOptimizationCharges>
    <cvs:OfficeRealEstateOptimizationCharges
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzMtNS0xLTEtMjY1MjQ3_688faa29-f2e5-4b18-8116-6a0cf90348ef"
      unitRef="usd">0</cvs:OfficeRealEstateOptimizationCharges>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzQtMS0xLTEtMjY1MjQ3_326428dc-1c19-4089-a22e-ff42f612e48e"
      unitRef="usd">475000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzQtMy0xLTEtMjY1MjQ3_04567596-4a66-48cb-b0eb-a59f2d1ef15a"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzQtNS0xLTEtMjY1MjQ3_d1d14fc3-e6c9-4fb7-9422-ab4dad947f3e"
      unitRef="usd">269000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzUtMS0xLTEtMjY1MjQ3_631aa56e-bff9-459e-81fe-1b1393ecf5e3"
      unitRef="usd">-5803000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzUtMy0xLTEtMjY1MjQ3_a52bc16d-b09c-4881-b826-2647b857b69c"
      unitRef="usd">0</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzUtNS0xLTEtMjY1MjQ3_595aab16-3468-4d44-b2fd-8d5f6793cebf"
      unitRef="usd">0</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzYtMS0xLTEtMjY1MjQ3_c8490829-e4b9-4b6f-82e8-9ef00b0865f5"
      unitRef="usd">2533000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzYtMy0xLTEtMjY1MjQ3_e1f5f709-af58-409e-848e-72cec6ca5fed"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzYtNS0xLTEtMjY1MjQ3_2e69e937-6b61-4c8e-b037-007ff9782271"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzctMS0xLTEtMjY1MjQ3_d3892c31-4ee3-444b-b4b1-73b94b511fcc"
      unitRef="usd">0</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzctMy0xLTEtMjY1MjQ3_9ad8b749-384b-4af6-9d5c-c4de9f18cb6e"
      unitRef="usd">132000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzctNS0xLTEtMjY1MjQ3_0d015b13-4e66-4bd3-a689-d385c10d7b74"
      unitRef="usd">332000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <cvs:StoreImpairmentCharges
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzgtMS0xLTEtMjY1MjQ3_796e4153-9d26-4171-ab3d-f8d1801cac1c"
      unitRef="usd">0</cvs:StoreImpairmentCharges>
    <cvs:StoreImpairmentCharges
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzgtMy0xLTEtMjY1MjQ3_c6534885-8d45-4e30-a29b-59019cbee4b7"
      unitRef="usd">1358000000</cvs:StoreImpairmentCharges>
    <cvs:StoreImpairmentCharges
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzgtNS0xLTEtMjY1MjQ3_8bb40884-79f4-417e-8cbc-05532ee71525"
      unitRef="usd">0</cvs:StoreImpairmentCharges>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzktMS0xLTEtMjY1MjQ3_5d1acc0a-8e6b-499f-a799-66572fe7c1ce"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzktMy0xLTEtMjY1MjQ3_a352766a-a78c-498a-b126-8e88fe7fd900"
      unitRef="usd">431000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzktNS0xLTEtMjY1MjQ3_5b22d887-fcc6-46e6-b30b-426fe89b87ff"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzEwLTEtMS0xLTI2NTI0Nw_3e37eb22-ee2b-4e08-8094-dbc8591168b3"
      unitRef="usd">0</cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzEwLTMtMS0xLTI2NTI0Nw_6025ff19-8f73-44c5-9d1e-2991d83fa4b7"
      unitRef="usd">61000000</cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzEwLTUtMS0xLTI2NTI0Nw_b7c2afee-485e-44b8-91ca-34ec4f9327b3"
      unitRef="usd">0</cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzExLTEtMS0xLTI2NTI0Nw_77488797-5e19-4b8a-afbd-e1660beb1382"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzExLTMtMS0xLTI2NTI0Nw_49fbc226-0003-4bee-804a-b5b49836be68"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzExLTUtMS0xLTI2NTI0Nw_6f9496b1-6af6-4c0b-9475-451e301556cd"
      unitRef="usd">307000000</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzEyLTEtMS0xLTI2NTI0Nw_435e2fce-aa36-4101-a927-4896e595c2f1"
      unitRef="usd">18037000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzEyLTMtMS0xLTI2NTI0Nw_ea3a5053-80de-4d77-8607-996f141fd88d"
      unitRef="usd">17227000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90YWJsZToxMjJlOGY3ZWYyZTQ0NDJmYThlNmFiYTcxMzFlMDE2Ni90YWJsZXJhbmdlOjEyMmU4ZjdlZjJlNDQ0MmZhOGU2YWJhNzEzMWUwMTY2XzEyLTUtMS0xLTI2NTI0Nw_734f096a-f5f0-44d8-a386-186e90a6aafe"
      unitRef="usd">15956000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:NumberOfStoresPlannedClosure
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzg1MDM_cf9d7259-6aa8-460d-838a-eab44dda9e56"
      unitRef="store">900</cvs:NumberOfStoresPlannedClosure>
    <cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzg3OTU_94d7866e-eb05-41be-8efe-af9d6fd259e2"
      unitRef="usd">61000000</cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <us-gaap:GainContingencyUnrecordedAmount
      contextRef="i8b77d3d696ee47dba7d85700d9f05fd1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzkyMDA_63329f75-33bb-4970-9d66-d63bc8b0ae47"
      unitRef="usd">313000000</us-gaap:GainContingencyUnrecordedAmount>
    <cvs:FormerGainContingencyRecognizedInCurrentPeriodBeforeTax
      contextRef="ife99c731f49c491f9dbcec868c83f01f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xNzUvZnJhZzoxYTMyNzI4ZjZhNjM0YWJiYTljNjY5NDRmYzQwNDlhZi90ZXh0cmVnaW9uOjFhMzI3MjhmNmE2MzRhYmJhOWM2Njk0NGZjNDA0OWFmXzk0NjI_93ada995-7177-4e84-8740-f29ab2ea93f2"
      unitRef="usd">307000000</cvs:FormerGainContingencyRecognizedInCurrentPeriodBeforeTax>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTctMS0xLTI5MjkwOQ_c6eb65b0-97a6-4658-b684-153587943450"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTctMS0xLTI5MjkwOQ_c6eb65b0-97a6-4658-b684-153587943450"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTEwLTEtMS0yOTI5MDk_54b1200e-622f-43b1-bc66-26023b61255a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTEwLTEtMS0yOTI5MDk_54b1200e-622f-43b1-bc66-26023b61255a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTgtMS0xLTI5MjkwOQ_c7c47afe-7c09-404c-8eab-bfc84e73f762"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTgtMS0xLTI5MjkwOQ_c7c47afe-7c09-404c-8eab-bfc84e73f762"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzk4OTU2MDQ2NTA5OTI_0918e7e7-e2f8-48f2-b797-be453d0ca700" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzk4OTU2MDQ2NTA5OTI_0918e7e7-e2f8-48f2-b797-be453d0ca700" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of <xhtml:span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzk4OTU2MDQ2NTA5OTM_e949208d-ec5c-442c-bfb1-60608d2297f0">ASU 2018-12</xhtml:span>, </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Topic 944) during the year ended December 31, 2021. See Note 8 &#x2018;&#x2018;Other Insurance Liabilities and Separate Accounts&#x2019;&#x2019; for additional information.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTctMS0xLTI5MjkwOQ_c6eb65b0-97a6-4658-b684-153587943450"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzk4OTU2MDQ2NTA5OTI_0918e7e7-e2f8-48f2-b797-be453d0ca700"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTEwLTEtMS0yOTI5MDk_54b1200e-622f-43b1-bc66-26023b61255a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzk4OTU2MDQ2NTA5OTI_0918e7e7-e2f8-48f2-b797-be453d0ca700"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE0LTgtMS0xLTI5MjkwOQ_c7c47afe-7c09-404c-8eab-bfc84e73f762"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzk4OTU2MDQ2NTA5OTI_0918e7e7-e2f8-48f2-b797-be453d0ca700"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTQtMS0xLTI2NTI0Nw_8f1bb28a-c8a4-4c78-9ea3-af61cd28b62f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTQtMS0xLTI2NTI0Nw_8f1bb28a-c8a4-4c78-9ea3-af61cd28b62f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzgtNC0xLTEtMjY1MjQ3_b3517f08-7282-4c85-8f1c-6e22b84fa874"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzgtNC0xLTEtMjY1MjQ3_b3517f08-7282-4c85-8f1c-6e22b84fa874"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTQtMS0xLTI2NTI0Nw_c2b5caaf-e724-468f-87e1-a662ef57b586"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTQtMS0xLTI2NTI0Nw_c2b5caaf-e724-468f-87e1-a662ef57b586"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtNC0xLTEtMjY1MjQ3_335a7aa8-8c30-4b17-a5c7-4da78b6cf53b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtNC0xLTEtMjY1MjQ3_335a7aa8-8c30-4b17-a5c7-4da78b6cf53b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI2LTQtMS0xLTI2NTI0Nw_69e345b2-8fd2-495b-b6c2-569e13e37943"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI2LTQtMS0xLTI2NTI0Nw_69e345b2-8fd2-495b-b6c2-569e13e37943"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTQtMS0xLTI2NTI0Nw_1b6f591b-bd17-46c4-9673-7791614c2538"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTQtMS0xLTI2NTI0Nw_1b6f591b-bd17-46c4-9673-7791614c2538"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE3LTQtMS0xLTI2NTI0Nw_b087569e-b95a-47ca-9bcc-80b7e4472a6a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE3LTQtMS0xLTI2NTI0Nw_b087569e-b95a-47ca-9bcc-80b7e4472a6a"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3Nw_ad8b6184-2d5f-4358-aca0-fe4aae4db63a" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3Nw_ad8b6184-2d5f-4358-aca0-fe4aae4db63a" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Common stock and capital surplus includes the par value of common stock of $18&#160;million as of December 31, 2022 and $17 million as of December 31, 2021 and 2020.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTQtMS0xLTI2NTI0Nw_8f1bb28a-c8a4-4c78-9ea3-af61cd28b62f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3Nw_ad8b6184-2d5f-4358-aca0-fe4aae4db63a"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzgtNC0xLTEtMjY1MjQ3_b3517f08-7282-4c85-8f1c-6e22b84fa874"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3Nw_ad8b6184-2d5f-4358-aca0-fe4aae4db63a"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTQtMS0xLTI2NTI0Nw_c2b5caaf-e724-468f-87e1-a662ef57b586"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3Nw_ad8b6184-2d5f-4358-aca0-fe4aae4db63a"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtNC0xLTEtMjY1MjQ3_335a7aa8-8c30-4b17-a5c7-4da78b6cf53b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3Nw_ad8b6184-2d5f-4358-aca0-fe4aae4db63a"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI2LTQtMS0xLTI2NTI0Nw_69e345b2-8fd2-495b-b6c2-569e13e37943"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3Nw_ad8b6184-2d5f-4358-aca0-fe4aae4db63a"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTQtMS0xLTI2NTI0Nw_1b6f591b-bd17-46c4-9673-7791614c2538"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3Nw_ad8b6184-2d5f-4358-aca0-fe4aae4db63a"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE3LTQtMS0xLTI2NTI0Nw_b087569e-b95a-47ca-9bcc-80b7e4472a6a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3Nw_ad8b6184-2d5f-4358-aca0-fe4aae4db63a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzQtOC0xLTEtMjY1MjQ3_a032804d-c9e5-4ea5-8b30-43a8d7915f00"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzQtOC0xLTEtMjY1MjQ3_a032804d-c9e5-4ea5-8b30-43a8d7915f00"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzQtNi0xLTEtMjY1MjQ3_ff0587d7-da99-4ddb-8c92-ab01066108c2"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzQtNi0xLTEtMjY1MjQ3_ff0587d7-da99-4ddb-8c92-ab01066108c2"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzQtMTAtMS0xLTI2NTI0Nw_8ae1937e-aba3-4db1-b06b-6ea47c9a06f8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzQtMTAtMS0xLTI2NTI0Nw_8ae1937e-aba3-4db1-b06b-6ea47c9a06f8"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3Mw_981c78eb-618a-44f0-9a9d-80b97609c9e3" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3Mw_981c78eb-618a-44f0-9a9d-80b97609c9e3" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of <xhtml:span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3OA_50a38f39-24c9-439d-81f9-601a8eefa8a4">Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-13</xhtml:span>, </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Topic 326), which resulted in a reduction to retained earnings of $3&#160;million during the year ended December 31, 2020.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzQtOC0xLTEtMjY1MjQ3_a032804d-c9e5-4ea5-8b30-43a8d7915f00"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3Mw_981c78eb-618a-44f0-9a9d-80b97609c9e3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzQtNi0xLTEtMjY1MjQ3_ff0587d7-da99-4ddb-8c92-ab01066108c2"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3Mw_981c78eb-618a-44f0-9a9d-80b97609c9e3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzQtMTAtMS0xLTI2NTI0Nw_8ae1937e-aba3-4db1-b06b-6ea47c9a06f8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3Mw_981c78eb-618a-44f0-9a9d-80b97609c9e3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtMi0xLTEtMjY1MjQ3_73897469-4aee-4b20-b92f-d8b722c9d81b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtMi0xLTEtMjY1MjQ3_73897469-4aee-4b20-b92f-d8b722c9d81b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTItMS0xLTI2NTI0Nw_8860a665-734e-4981-ad73-7ff28eb0e6f2"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTItMS0xLTI2NTI0Nw_8860a665-734e-4981-ad73-7ff28eb0e6f2"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI3LTItMS0xLTI2NTI0Nw_7bb20a0c-dae7-400a-932d-6273537cbc05"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI3LTItMS0xLTI2NTI0Nw_7bb20a0c-dae7-400a-932d-6273537cbc05"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTUtMS0xLTI2NTI0Nw_b1a6a773-e6f4-4300-9d66-479c354994aa"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTUtMS0xLTI2NTI0Nw_b1a6a773-e6f4-4300-9d66-479c354994aa"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzktMi0xLTEtMjY1MjQ3_5d0ba310-3d35-4b81-a47c-81bd2313b35e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzktMi0xLTEtMjY1MjQ3_5d0ba310-3d35-4b81-a47c-81bd2313b35e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzgtMi0xLTEtMjY1MjQ3_3f1718f0-be4b-46c6-92b0-3211aa793753"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzgtMi0xLTEtMjY1MjQ3_3f1718f0-be4b-46c6-92b0-3211aa793753"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE4LTItMS0xLTI2NTI0Nw_fdb2753c-df7b-47ab-ac9e-0dd3d25a3a1f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE4LTItMS0xLTI2NTI0Nw_fdb2753c-df7b-47ab-ac9e-0dd3d25a3a1f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTUtMS0xLTI2NTI0Nw_fcbd8ce3-30b8-4171-8a70-7b62caa5b56e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTUtMS0xLTI2NTI0Nw_fcbd8ce3-30b8-4171-8a70-7b62caa5b56e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzktNS0xLTEtMjY1MjQ3_d4b1cd72-a297-42b8-809c-b1f8f1c69c9f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzktNS0xLTEtMjY1MjQ3_d4b1cd72-a297-42b8-809c-b1f8f1c69c9f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE4LTUtMS0xLTI2NTI0Nw_b5044474-ff72-4143-a8b9-3c5839978fa9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE4LTUtMS0xLTI2NTI0Nw_b5044474-ff72-4143-a8b9-3c5839978fa9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI3LTUtMS0xLTI2NTI0Nw_07c936c0-f94c-4c22-955f-5b8f2c82a300"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI3LTUtMS0xLTI2NTI0Nw_07c936c0-f94c-4c22-955f-5b8f2c82a300"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtNS0xLTEtMjY1MjQ3_bf3567bd-5dff-4143-aed8-f6311896e895"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtNS0xLTEtMjY1MjQ3_bf3567bd-5dff-4143-aed8-f6311896e895"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTItMS0xLTI2NTI0Nw_acd205b2-ef06-4bc4-9857-1dae880fab11"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTItMS0xLTI2NTI0Nw_acd205b2-ef06-4bc4-9857-1dae880fab11"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTUtMS0xLTI2NTI0Nw_6963df9f-0ea1-4ac6-b0b5-ec498ce9787e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTUtMS0xLTI2NTI0Nw_6963df9f-0ea1-4ac6-b0b5-ec498ce9787e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTItMS0xLTI2NTI0Nw_8027cace-077c-4657-b8a5-343955af68fd"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTItMS0xLTI2NTI0Nw_8027cace-077c-4657-b8a5-343955af68fd"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3NQ_df308064-6268-4ba8-aef5-0aa63fa331d2" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3NQ_df308064-6268-4ba8-aef5-0aa63fa331d2" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Treasury shares include 1 million shares held in trust for each of the years ended December 31, 2022, 2021 and 2020. Treasury stock includes $29 million related to shares held in trust for each of the years ended December 31, 2022, 2021 and 2020. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for additional information.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtMi0xLTEtMjY1MjQ3_73897469-4aee-4b20-b92f-d8b722c9d81b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3NQ_df308064-6268-4ba8-aef5-0aa63fa331d2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTItMS0xLTI2NTI0Nw_8860a665-734e-4981-ad73-7ff28eb0e6f2"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3NQ_df308064-6268-4ba8-aef5-0aa63fa331d2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI3LTItMS0xLTI2NTI0Nw_7bb20a0c-dae7-400a-932d-6273537cbc05"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3NQ_df308064-6268-4ba8-aef5-0aa63fa331d2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTUtMS0xLTI2NTI0Nw_b1a6a773-e6f4-4300-9d66-479c354994aa"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3NQ_df308064-6268-4ba8-aef5-0aa63fa331d2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzktMi0xLTEtMjY1MjQ3_5d0ba310-3d35-4b81-a47c-81bd2313b35e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3NQ_df308064-6268-4ba8-aef5-0aa63fa331d2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzgtMi0xLTEtMjY1MjQ3_3f1718f0-be4b-46c6-92b0-3211aa793753"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3NQ_df308064-6268-4ba8-aef5-0aa63fa331d2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE4LTItMS0xLTI2NTI0Nw_fdb2753c-df7b-47ab-ac9e-0dd3d25a3a1f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3NQ_df308064-6268-4ba8-aef5-0aa63fa331d2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMwLTUtMS0xLTI2NTI0Nw_fcbd8ce3-30b8-4171-8a70-7b62caa5b56e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3NQ_df308064-6268-4ba8-aef5-0aa63fa331d2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzktNS0xLTEtMjY1MjQ3_d4b1cd72-a297-42b8-809c-b1f8f1c69c9f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3NQ_df308064-6268-4ba8-aef5-0aa63fa331d2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzE4LTUtMS0xLTI2NTI0Nw_b5044474-ff72-4143-a8b9-3c5839978fa9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3NQ_df308064-6268-4ba8-aef5-0aa63fa331d2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzI3LTUtMS0xLTI2NTI0Nw_07c936c0-f94c-4c22-955f-5b8f2c82a300"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3NQ_df308064-6268-4ba8-aef5-0aa63fa331d2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzMtNS0xLTEtMjY1MjQ3_bf3567bd-5dff-4143-aed8-f6311896e895"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3NQ_df308064-6268-4ba8-aef5-0aa63fa331d2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTItMS0xLTI2NTI0Nw_acd205b2-ef06-4bc4-9857-1dae880fab11"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3NQ_df308064-6268-4ba8-aef5-0aa63fa331d2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzEzLTUtMS0xLTI2NTI0Nw_6963df9f-0ea1-4ac6-b0b5-ec498ce9787e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3NQ_df308064-6268-4ba8-aef5-0aa63fa331d2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90YWJsZTo2ZmYzM2UwOGFhYjA0NzI2YjMwODQ0NzI5NjcxNjUyYi90YWJsZXJhbmdlOjZmZjMzZTA4YWFiMDQ3MjZiMzA4NDQ3Mjk2NzE2NTJiXzIyLTItMS0xLTI2NTI0Nw_8027cace-077c-4657-b8a5-343955af68fd"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjM2MDM4OTA3OTM1ZTQxZWVhNWU5Y2Y3Y2FjOTE1ZDQ0L3NlYzozNjAzODkwNzkzNWU0MWVlYTVlOWNmN2NhYzkxNWQ0NF8xMTUvZnJhZzpiN2I1YWE0NDdlMGE0ZWMxYTQ1NGU0OTc3ZGJiMDU2Yi90ZXh0cmVnaW9uOmI3YjVhYTQ0N2UwYTRlYzFhNDU0ZTQ5NzdkYmIwNTZiXzc3NQ_df308064-6268-4ba8-aef5-0aa63fa331d2"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>142
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M-13597(H?+$]09,P3HR5M@1@41![U)@& "RD28SA:9 <R21.,G>L8NM"=I,
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M^T)]X<=/M"84:;R$%]+\HF,E&V,')7NI>%DK@P5ESJHK>:X=<:;@CWH4<*V
MVPIACT)0*P1O50AK!>-JMZ)B_+ DBLRG@A^1T-* IF^,,XTVT,^9COM*"?B:
M@YZ:+SB3O,A3HFB*5@HN$%0E$=^@!2\AE3(=XP-%GUG"2XINT-?5$EU]N$8?
M4,[08UX4$#XY=148HR'=I#[XH3H8]QSL8_3(F<HD^I6E-+T$<(%%0P6_4'G
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MQP>.CV)RHY#8D&^RA/(I <5<^H3B;4+C^%7&'(I3,H@^D3B,XST!3=X.C_;
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;.U=>6_<QI+_*H0V>+
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M&@HWDF"$<R6SC2EVUO"#22-V4=$F7L;3&'G= X>@6!$JV:Z"?4I"5DPZF8J
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MS<D6#9]8Q)?/+NGGQ=DS#5Z'=\_B\_,K^GGV_$KKP9-#.'@R/R;0%L_BBU/
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M6D:=UY+![+5%UYHSE$&T'2KL=G7]TS[%9O>6>7'I1.L6-IHDM*MED:]]Q.L
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M6KI_5EW=RAF']MM_1"O:X..RX:X&Y@?D4GX@5:B^IST[VWXPT%'-Q8!JW*J
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M!/^Z,61;U'B [J\J$D+Z!R9@NP#@O?X?4$L#!!0    ( ,4SN5:R7RSJ!PP
M *TG   9    >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;-U:6W/;-A;^*QC5
MT\G.R+(DWY2;9VQG.TTG77OBM'W8V0>(A"34),$ H&7MK]_O'( TJ5O2-,W.
M[D,<B@3.]3LWD*^6QMZ[A5)>/.99X5[W%MZ7+XZ.7+)0N70#4ZH"3V;&YM+C
MIYT?N=(JF?*F/#L:#X=G1[G41>_B%=^[M1>O3.4S7:A;*UR5Y]*NKE1FEJ][
MHUY]X[V>+SS=.+IX5<JYNE/^E_+6XM=10R75N2J<-H6P:O:Z=SEZ<75"ZWG!
MKUHM7>M:D"938^[IQ]OT=6]( JE,)9XH2/SWH*Y5EA$AB/$QTNPU+&EC^[JF
M_@/K#EVFTJEKD_VF4[]XW9OT1*IFLLK\>[/\445]3HE>8C+'?\4RK#T]Z8FD
M<M[D<3,DR'41_I>/T0ZM#9/AC@WCN&',<@=&+.4;Z>7%*VN6PM)J4*,+5I5W
M0SA=D%/NO,53C7W^XC+Y6&FGR4*N+][ 0LYK7UGEA"Q2<>D<@'$G,^5>'7GP
MHUU'2:1]%6B/=] >C<7/IO +)_Y>I"KM$CB"H(VTXUK:J_%>BF]4,A#'H[X8
M#\?C/?2.&^V/F=[Q#GI7E<,=Y\2UR:>ZD $HC=XMXXA_7DZ=MP#1O[89(K Y
MV<Z& NN%*V6B7O<0.4[9!]6[^/Z[T=GPY1XE3AHE3O91_Y,N_%JTQ:TUI7$J
M%3?R7H &990?E<S\HF/'FT+\H*:V0@80Y^S(X[[P"T4N*&6Q$JKPRH*,+KP1
MDB),%YI"5^3*SI45<@[:R M>T (B;96062;,C DA]3@/Z70Q%VXA258\V9"J
M+]X60-.S[[^;C,?#EQO/^?[HY=\$,I](I%L,Q"^ L64>$#%W-<-UN?I;3(!
M3NX7)@,!AQ"'M%8EBK0Z.'X^& Y%"0HL+12/[#X0(^-E)AYD5JF:'5!8.!F2
MFH8?RM*:1XT$I;*5.!@-!V=B"@9X'$B4M6-DRPU+&7<^X,%TQ82OC+0I<7D#
MBR;>0%+IA9+)HF8-6Y:*\ZA(V%TZ @%RN&KZ.YZQ4Y@PY 9AB6SUN[':K[9Z
MH6.8?C!*Z6FI5?,JDY!B]42/6#E$J9M%_;'.0# ;4R6!*LF,(]<G!A"(P-5%
MDE4,"-)"/9;:RGH_W5E*K,13.$&;5%2-GV<*5V#\H[3^\"XQWA^^-R!DQ&6!
M0+#@*M[F;$;RO /46?C1\_.SZ,"NM\ ;1H+-82:2E-U-03 0;[>CB781W"@]
MJ5JV1%F/BBO('7JF<3_1-JER GX2??()6RZ @,)X,54*=I@2N0 %5\'A'I6W
M&Y<,VBEA@"..-2CE:HM+92,O*3U3C-PUF)X"\GF-TC^B>73W?OW;'D\KBJ)M
M8B:)*MGM$CJSZVT,%IEMB^%=%FA;Z7-T/V[K?JM"IKK3\T+/5CM2YATD5?D4
MFH]#\?LF.;,KTUK"[#[\,]ER3?5]J7(X./UZJ7*REB>C)_["-$D/]VD;PI9Z
MZ4X^_4NRXH!P=0/Y"56CYS6LUL0CVM>_WM4_6<OH#A04#@6T!.QUF0;*D$@7
M85P@89[)S!EQ7Y@E6BNH*")^G")9:@I/^+$F9SO],K@;B#>J1.9EX$*IGZ".
M3I1X1L\CF3<W/S5["0ZF*&+#O]00.+CC@<:#34PX6HZX*C-.,-&_&R$3[X/3
M-Z\,Q"D:ZB-:)D\)</:_72_6 ;:1,#6UX$+FIH(RV S>V'IP//G&%6-=T/WE
M8FWUE]6*':J/QY,GU;GG=N"3I0*#*7??C*>:+&%:%]B+'*<H'<(63FCL*8WU
M,P,R'*^%*0YII/%JKA.$)I$=="BE*@A(XB^0XXC&35[HA'(OYI?SDY<B,\7\
MD)8)OCNM)ZJZ3+S[<-W<K .U+Y8+#=# 6\'J8$#1&@%_B]R>RV0EOI=Y^1+2
M%*Z"I\5OF-V9ME/S4#F6C$F6@6 @UM1A6*>5K1L_<+#K@32F%)UK'R-/"B2#
M@JX<N/&NM@9D?JZ,33T^'K8+<GLMT.GY9H+N%W"11!602#((%R (\1?D1W*'
M(S_610*VM"L2NU/..M1)][:#F#8"07K.4%""W$7S6L[!,)/:1G(9[4^,P_.H
M*/1*$F,)_MFJ&\=("WC V1Y9"=H7$2MKHD/&@_'@M*ZIG[1[;4K,]-&2H[8E
M"W)?X+--^PCRH'BNUBU-4I%XA[@X#):%?E41XK>+BIFI+"(VBM>G" 0J+2<4
M!. GE1Z-Z^!DGS3V@F!+DD>D5/H^TZO8](?<1N&Z5T*K^,B!*A!/.B31(4L$
M]L0J] B4(6%2.N!P1U9EG)/<0I<4HDB1<STE(P8.9,".JC%P(V0HS$?G+]E)
M#NDF9460:+VJ*[E!_@PLOB3P@]H=NT6"L"U\!W5B:O""K A$9&P18K)2$IV6
MHA.I;=C#WQ$KB(OA%D9?$M1^&Z-IY46JTR#D!H"W44VU>X+]DP4YD*@5<U7F
M^['C"1U-RU^9EHA,-&BH!4O%O7/,O%04J<W"CK68H=,@8$0]->]/:;6FMZ+^
M)'@RKNEX?2HSJJ^"3RA9TH;,AIDL%73I*BJ7L%D+^01NJE< 7&4Y<*?2H7J4
M%E%B-0I=Q=UM59@I':]) JLNRHJ4;TT>3)PQ2-*QK5;,MV5HF..=>E"9.*[W
MM019:%C=)HM50 :*:6:6G$B893C:UO]6'377S?]I=+S J%4G%==]',K_"\[7
M%45UZ,:)?9^3YH$8C\^Q_P%J&DO\1I,)G\ZA UJQ,-23E*&"TH[QR0EXS)0-
M(R2'CY>/M/-X)&ZX?1J-)N(##UA;?7<@G@\GXMV3DBT!T?:P<0[$Y(SN6H(O
M=;N% XOSF@,N H/=IB+5)NU32/+0U"WUS)/!_D&]-L_(&P,R )ERMEMBU,I6
MA\A_E)*JJ=.IIODH4GGW[KKI7,*MSF"[-D">'Y\^]661@IG-:))S9N:7A"P>
MS@!)G3 HX&TT*4KF'%M356!4CQ!95+FD%QT.]0@1(U,4=LT=33.BAAB/@ ;^
MFZRTD \$3D<>3[CSXS:]2="M)!L;U&L2[JKFWTFL6RH_:L@A("'FU$*;0"CM
M^N%@?-HTZ'5!H%R[.]4V3:!5LRS,/C)DLK1Z&F2;Q-Y YBM5F_V&6$/9K5S]
MD*E'@ME/%3RW V+ULFU@.6^!I5Y'LY5.E6M!Q @:2,V*ST/! +DGWJ I)3:(
MN$D3MFH]J\T"=6+*DX^',GV0*-]S/OWE>(1U=3ZMK O6Z:),/(,C'KG4NW@<
MTD<,LITZ^YJ[3CY@$4E*TZP.M0'%Y!YWT>=?MWU"HP,0*ZZJ=(ZT\Y[FV@21
M'EC3?%R'WO7-U?O+)O+69.2(HBE.9H=YP!3WG-39?968H3'I6\7,^/3_-V8^
M+*3.R%N=7;7Y$4D_4RG=$DJ6CIE(LZ)[<,DC&7'4=-X9YF8ZF0CDN_-G:G(-
M<(6"WDA2 ZRYL3F:THF=U?2^9./D=GQVUA_2X:U*"3$BH,_57J&6L]U51940
MI835)\T#PD*_@HCY;/->^E! PEF+Y'&^]1)C&ZNY,2D?19!L\>@C8!U_3"+C
MU$O;-TP2@+TYAVTL#/UDS"\JU&L"Y=8FST>OUY .7+9/1ELX?<VAES))G^7^
MU.![<#)JPG3OM/69ONR,G]HZOSD<DU7J$7.[+?B0,-U[2CCN/YTH())U&F.Z
M=82+QTB/;*Y&-5_S9L>VIZB-&/_-V'N$0$PH;#LDG,"D0>$-%4U@+OI\N*,W
MVT>KT7I+99V<MDX&]Z9\UN?;)OBSYW\@P0\_)\$3L_]2@G_;R;M;U[['Q1(/
M^?,>U_I"("3\U:[.*8RM8:\->S?S[W#(^;>;_M>R,;_+ M+KP+E$4L1S9.DF
MA.C?6W0W<ML; ^20(/0MVO"%=*!0UR">7^F%1(.LUENLC;-O2&D-G!9F .2)
M$DB8\YB-M8[>0Z/Y"$<6^_2)^;F,XEA1E1S!;*LN.,,[A#!\!EZD%DR8Q+,E
MDV" 1L[T2VIU."CY#)0D;(]/QUVZ"5I*"ABKXP':"G5A*1"*M<LZ\?E%_ME]
M)-=-BCL267WDP=9J>V;C)&BP[9N;H]8G5/Q6@3X4H_!!20M?4S5WFV_1+L,G
M6$_+PX=LJ&]S>H&7J1FV#@?GI[V Z/J'-R5_D#4UWIN<+]'"0"5:@.<S8WS]
M@Q@T7^A=_ =02P,$%     @ Q3.Y5FIZI049$@  GS<  !D   !X;"]W;W)K
M<VAE971S+W-H965T,3(N>&ULQ5O[;^/(#?Y7!NFB2 #%T?NQ+R"[UVL7N.XM
M+KT615$4LCRVU94EWTA*SOWK^Y$S>MB6'6>O0/.#+8WGP2$YY$<.\_:I4E_K
MM92-^'53E/6[JW73;%_?W=796F[2>E9M98E?EI7:I U>U>JNWBJ9+GC0IKAS
M;3N\VZ1Y>?7^+;=]4>_?5FU3Y*7\HD3=;C:IVGV01?7T[LJYZAI^RE?KAAKN
MWK_=IBOY()N?MU\4WN[Z61;Y1I9U7I5"R>6[JWOG]0>?^G.'O^;RJ1X]"]K)
MO*J^TLNGQ;LKFPB2A<P:FB'%UZ/\*(N")@(9OY@YK_HE:>#XN9O]>]X[]C)/
M:_FQ*OZ6+YKUNZOX2BSD,FV+YJ?JZ4_2[">@^;*JJ/E3/.F^KG<ELK9NJHT9
M# HV>:F_TU\-'T8#8OO$ -<,<)ENO1!3^5W:I._?JNI)*.J-V>B!M\JC05Q>
MDE >&H5?<XQKWG\J'V7=@,M-_?:NP834?)>9P1_T8/?$8,<5?Z[*9EV+/Y0+
MN=B?X Z4].2X'3D?W+,S?B>SF? <2[BVZYZ9S^NWY_%\WO/;$_^XG]>-@AK\
M<VJG>AY_>AXZ&J_K;9K)=U?0_5JJ1WGU_O>_<T+[S1DJ_9Y*_]SLSPGA[.!I
MTL;[_DO5I(7(1RUI(\!HN9E+U3-;I.6"'ASQ))44:2V658$C6[_6/_-/GTKH
M8%'@.-7B8ZL49A,_5.7JMI%J8Q8ZU?Z=G#>BEEFK\B:7(.(QS8MT7D@L!"N1
MXN&5<*W(B?'M1%80NM1@6VYLX\&S;#LQ#9Y##Y[E^C844#4KF ]15"FH"@*1
MQ(EP+-OW11"+&%^)[8H?FS4V.V9"@,5H#?J,1&!C3()/%^O8$SR[=FXT?1'1
MYSJ6XWB:BCAQF#['B72#[0;T$%J.[XI_O>2/5_E49D6[ (>*GH-C0JJE>(65
MC!S$TSK/UF*=/DHQEY+,7%:U92,7S%:(,:UKB6%K62P&3I.P4X@YUVLM\##=
M$2N <R*#Q*LB7Z0T\3PMTC*30GN-*66:B0<IQ>>JD<(5O_]=[#KA&_-UG_W2
MYG5.)KFVQ'<Y;2QO6D4: :+NB0CQ@*5K'A"],5]Z.XL%CV39:(^$MYFX/Z?0
M%N_@8[79IN5.;^^0GQXTJF,H#7OE0Q-,@P7?4V\E>X]B1V\%<Z&I>%[7AA4$
M>QZE8D>%Z=)2R%]S;*M<B96JVBU:RC9O=M2/+9!8JFHC4K%-59-G^3;EOI@Q
M%655WNXW=X-FXB]KG._]DWP@0Z*H.=)=T%2D"F<D@_\26^U2:SCB[1:GA]:@
M5>6O6ZER"<G>*M[A5E6+-H//%_=%LZ[:U9KFGZ"@K)ICO7N0V ;F$??ZETX3
M61P['E?(55H4.UB%E<(C#>X4DZ:LV_F_P7?B2U:D^:;&2&A;JG+0 (!!^QJ)
MUBA*+>9M#1M9:X6J2EI [U0L6](TL84J9SN<EU(N<^+/O,A7K$JU:.')E%YH
M6G8S;<D>!DMV@65[H<4=V]D_J@I;N:=?^-1]QOG0;?KS^S17$Y,?$/5:_#Q[
MF(E5!3TM27)C@LFNV9&/;^:A^V:RY=J)7;*!#BR>*QX:R O"W+0EJVIA]HX]
M$7NAOU!"2'"1/^9:W5S+2[Q^/OT68U8WN<&;&[F:Q*Q2D!4ISHC"Q(H]]/5N
M^ FF.Q37B8W7&$8[%@!H@%_E> 0L-?P&V5.RV? (@;AV?9]> QSNGV2=+\"&
M'%1NC NYG:?95^C@:);8#WJ*Z=D1US'(C8*(M&XC5?;,!/ 3D=M/H=\PB1,$
M-^2DX.RT9^*S,3'>M1(XN8%I](:].UY(.XD=VLE" JB3NL'_+R6\[_X,PPY&
MC]<0I>L9/[<X4&#CZZ "(;FT:[]_)9<7<!NTP+=O!@]]J('.BS70\Y,##=0M
M$;E_$CTU^4[X3:J7^-$>%R/A^#'O#/X:#OR<ZMDCM=5O8>QBK$W:&$$;)]4/
M_4<KTIN3A*2#)+@$DURJ@M$@?WHF17:P=!P%%^N@"] RZ""] 1;AY)$.>M"A
MYW0P2L9[H3>'QGM\N& ,7J:#(R,0/Z>!SJ%9ZIKT42)%M,.; 0Y^"]SJG)F
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M1K("Q,HW((<*83(*Y\EMOQ%K$ MF=AD6/8&^9ZBW!;YK@G=U6].0W.1K2&O
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M!_R^K(#FS0LMT/]/WOO_ E!+ P04    " #%,[E6%I6Q,TT2   40   &0
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M9N(CD\/G/>A15DA(E&"&..5]H7Q2P,GGUM@ #A0A\29S[3]1&7!G.[N190Z
MK#/3 :3'2\$RP1&O)$V/9>S_L)<@'YQ+O.?Y3@ !OXD$'F(@E8-7EWE<9"#]
MJBKEIJ[X)A4H_]LO=^SO@J?5G@$]+7MH"&SOT>7>"]OQ&5B->LZ41I-(CVQ;
M%IGI\9CLKM@'U^*C-\<?O*EYN#7ZN?5Q^9:G0$"P._1QBMT:((Y >EBD)Z1I
MAFR9PL8,26[5Z-53M!E;B=X8&!\(S=B0M&W4";),ZP0['&JKXABP#580IR Z
MN970\4$"6&!JN=!#E$*P5-R+E(;D8 "BY&6\/S*A4)$2& 1NC^QO-S>?#)M%
M"G%6YCOB!V?6$,"GA@1JBK--*<468*WB4AY\7U$=#\2%FTD+P\]0X-'DI?\K
MSHQ>AR^?ZQG^5O,49P;"Z2(%06=Q<B1("PZ()F9?,"*S>,F^QT<6TG,8OF2_
MY,X9_%87>#F /P#Z2  L/:_(.Q@L>D,@#]+F ! _RZ^DV/8XD1OG2V=:!NTP
MJ=SQY,S4*;W88#@@ ],C,( 3)[T05@@"+P8X5S*3*2\MWSU&@W-F*Y'9;K^N
M?AJN/6;=._"@=HAGU@'+'#P>P(VA\6O[CL&*P!>64GT%QX!OQH=)1 D,)<9G
MH(LIRV)3E-K.CGV9];0R=5IYA\^0CAIJ=>YU1DD'-J(@_(>< TBJS@CE+<<T
MYO;+EG%J-=<'XS# RE J!%BT$YJX,78%&MWET U,O$)GBQV<C*[8K^!B.RKM
MZ7Q8R4,\\GN(;2B$=O"K%04IA)X9RH#2C ALN6CV>Z.B$X\=::2M=&9#X=I$
M&XX</L M]!OB\3P1H.0ZPD,-"$F#(*2=@!" ^*+!35MDH%"9$<P]6=0*X=0@
M/!,0O),B+78XNC/^9A#*<WJNP/>>P,;F: AS: "1^1M-&5]D12)2ZS0>UT(;
MI$[0$0AZ.ZQX:^DCN/%2G)X4-F7Q%81*9,F_\EP[B!PYA#]'R,@0/>3,97X/
M$L7H.!">#Z(D@6"<)2AQM6=;L"K,VOZE:S8*O36XL4?%D/%C)Y8Z24P97-!F
MBWI'*1/F KJYPOS&-U7?>YDVC2:[ 59B6!N(G&-0J1$I.OD[E;>,9=BGL\+
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MGCSIX<1\,(-[] +G@6?!#@48!.@$T]JDY \<SS7EHR(YKT8Z5U1F*LUW/7+
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M%."V)D J--IW2%J\LA!BD\LT;UV'W VE6$$0(]>57,$;H#.2(K4;K@M0:=J
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MX31*@C">TUP\#N:(4.BP\%GH3P5X$H3SL0-X0DI$XV""&AM-H.!_#O!T$A'
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M('*\:7?"52WK'C>C3C'3B:)O[RA$&8;>)[CF#3Q'_ ZS)CGG< INMG;VO-W
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ML4@S*H,_]2:]6D]3P+RXO(;!.F,IV1J,,=PVTSP=_KIAI'TV0+NUSC*B&@!
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M2&/H+C?Y(YDQM'%(%=SV]I447?> [92A[93!#9\0Q<>O6R/5 \@P'EU!F..
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MSQ@*OB(JXGHVN$EC7"]SCO.@V.O)^_S85.V&N^T)T+@E=4Y/6;;>(D3L^&Q
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M RE&#_--#HEM!,1]SFI-P)[Z<'!!KDK)- #PTG+"F][H>;I\"F #_1>3>-X
M)SR,2DY==<CW:DXFM;%*@3L.\/P-F=^L(10P-+#<9XXVBD,:UH+.U8]64)_1
MUP,'K(B95>2G''Y#%]7!!TD8,PQ.;0UGA>V;;X!Y5XCR6J&"K18).Z!4A!](
MFZ.DZ9H"]B*-)HUN<=V+))FWM^$DE 2<JWQPCB2Q%\,##&%0,#/WH[>#U>N
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M6)1O.;C;_K,+[KJU[\9!B?GK9^J0R7,LU3^C*$"#'J?3DYXBO6&LK-N4_=F
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M_/Q-V?>F:_W+ &=O00\L9X6O $_TK3Y]431F:7W#=Y:^N -MA_\ZN \P9FK
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MS(HU'4D$FA/X%J$SM:44'T<"<[-P#"PSN;A6F0>V,3TY$N(X,>\,'?DJ@&9
M;R]&,7TD/LZ1Q@7S48O_FR(##;6@#I,<\3+\"/JQ0C5Z^MW13F(I:O0)5Q@3
M9VM2YN ;=H3(Q=!CZB%EU_D6XU%0.B6F4?ZD=@$6Z3E'5'IPR.>((N<Y(T-J
M1<1,GINJ(,X$(O@9\/AL\P7C=I,Q?1##J(%8K;$S01)3AK1C< _,8F%BRGFL
M&282HE/I3]+"(5$Z"SEF<A8L*ABL:AGD"L3F5SV5?K)((# J]^WJGC2H&$G8
MCL9%3Q>BA6)ET:D 0%!_CM,>L&--0D1UM79$*! 2""@6"$5N6C-5)S8>)6'
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M4U(^LFSV+"MRPRN#P;CX<*W5QFAN$QN,?X+WO! ! >9(BBA41;T,WR(?_3S
M,V&)1_B[N$:7GWY6ETB?==X#*5H#DO<C>]CI@MVP+-YBWK=BCC^OUQ#K><%=
MOO3;\[AT6.$=EU'!PP$>39S$[-9WOUX$1RVJK*S06@X0DW4DU)BSFZ"S!@CB
MKAG@%;I\AA1#'5X%#ERCH![6N ];]1EG8&Z&Q Z)R$ME</P)DDK<R%Z,&"U,
M'F'"SF+EGUQ]T1$1!G1>>@R6T#/:#%@9H20WUN<-FGK*(7%TD>XLQ (B&KP/
MU('&W)  4"4F7*2+17V5B<MFP&P4%I1!G7XQ:_!+L8Q=KLNE$=^'73>,_B%@
M ,W# HG&@[H# $M;4XYM3BC_ OAMN<8;.K?FP BU-/X+"X+K"P[#.NR-<V,]
MNU:;SMXBV/W*=G78)UE^=AGH(7/L4N#D=;/E=*)X9CE)YZ[>,HSB_4EOP'Y5
M<I_&((<#G,!8*1>Z+Q;(5+V$?#4P7K1!E?-4+Q++'@I'R@K"2AB#]*"@+7(Y
M5BR[ND'W1'@(5!!$L*.6$O:MJ>#9#8 7H@]<B0NQ7J2=ZI,H3PQ6);4PH'@!
M$?,R>/,E%6!#.BS K=L1\R=0)T%!"$5&?@@6#-A/H(@>;%G74[T6? Y++@X$
M>&XCE==V!'-*>/;S$R <YSAE^TR+=#6ZF:LFE,N4O56AKV?+!BY@@$5\M"7X
M@=.INW>+,_&P16:[3BC>G-=S<"N49@K%G(\2($\Y2@\D/#)NL.J@'>RMK0<*
M%V*&/=;)]Z18)J*FH^+ME\IL^M!9<V<]%:A-/<H&ERV7ZDDVLO:(?IOT\A2\
MC2I5GME.ZI"(FV,;992RQ+T>6N9F-\6=0,40O1(Y,=+ RC\^+_\%$(.5+Y9!
MT:*@?;#C<QL(%=UI 7%/TQ='RCWN8&&HJ:@4-ZP+.3SM"=C13QSZ8A:%"ZR!
M=V1YD=R0U>=ZO,0M!!4@"A171WDB6YO8TI7X^\&_) ;&<->GU0FXBLUH[$?Z
MT\%XY*%8KKF.B@])UVK2LBY@1607CM@5KJ%AC;UR=VB(9EB ]< O:%R 4A6H
MJUF6-HBM2'\,]5+Z?G8;BV886'1;SN- 3-DWT@R"]1*R^US!<MKA =N4]"MK
M:\WB)_RK1B(2@9)-V#>3JJF'IC>X]AG,6"Q/452F)=,9I_YEVQC;IP9QU&P%
MF\OLX#A[,\]BX^ A5*!!&KP9A!'=C$8HA,L9^,B^6<A=^K(-IC[X("IKW Q#
MR(4;6";!1H-W2WD.=6JH5$)7D4\1L]N2_4_L-NP(8F;QXU-Z$.KO1<<B$[M0
MQ I$R77C4?$/KX;G@EIU2@I\ #  *@F-,B<)XPQA#(EYZ#LI7-46K#J&\^PM
MHV>A*IQ=*J(N:9&:$RQ9A1J#]L&J[0,=;Y9FI]@5Y+$S/=;Z-JNR6Y><\@?D
M<%J"=9N4/K@R6T/(0.$,]VO-,0FD; ^>" )># $C5< (^'00J]1#%RZ6_KX:
M1%+TBC;&:? 5'%\L"% *JF?_+NX5_2Y#^.NW&RY7@"<+ @S?Y_YN Z95TB>S
MX&%R1CV+$?4KDE-,J&J1)N1'XC-92\-N7&=#<C_H7RK-9\!C_G?H.9F1^?;\
M.,RG./*/41M6(;;14@&%S,@WU 1#$O\)^ 11P87'Q$W0@ .;(--=K#%.*]-X
M!%1[V8::R!L'>BRM.DJB*(1M$-]AAS/;DA6FLM:&VL]@>40J[<VMF0J43H"8
M"*-"X2:L+$NR%S-;+;?6*!0+:O?MM[D)M6(SB9+ V1 EI_K;FQ"U7[WY,,Y'
MO,_E>[3NGQ(H(E*6=4HO&RD2L+- JU9 )L@VV)$#<N!WMK<H25]0Y+J1Q-M@
M\Y -NP;WA?1Y$#O,T;_SH9=6X[5]S!>M%XHWR2I^**69LC-S<IMVVEOI:J#;
M@.G'6.?S"0? ZG]%=$-WP2U6@OIMC-E4VF9IQ3#1<0HLME9(8E,Z?JA+9 =B
MVB40!Z.PP5-TMF#F)Y7ELS*OH,?50]7O$O&!/#K.A%$T"XK36(RO@7@;!P8T
MF-B$K6Y53GSQ2'(K%^\O?<S+)-EH+&9YZ2>N737$,PUIHQ\:TIGR]=RP(=7G
M43C-#L&[7R_HJAW6(YLJ[*6U4O''+S4!@UT;K@'"VS)AM1VAR-1UPH),T0G$
MD3[D5B'BW;V[I.H@=_)'E98@&I$XDV<E:$N6 #/?4@OP->_1?$$=>52\,:L6
MHLK;H^+BM^OBHL1\27<3.E[)%S-HA(^*1YQR4Z1<4$%16Z?>EAY/-F0X2RNQ
MCTG;GP-:&JP1/E<W#=<88%ME0]7!J'BYB0PV_L[,(3X$"PRW/64<)M8.T5B;
MJM&D$U5,;X&T'!-B3A:LF*9/**TKTC;18RON $9^*#,L3IS)2GZ"+Z[ <RLN
MU51]P(B0J_;DM('WE#@<G*.\E7Q\J;[@)?E(HN#982H^F_70:F#3&<RL"91@
M?T*S,<($<9N*=]HJ/?:-D#TQGQ-](Y(F<H&PCPRCN#K9$#= 5MIN9BDED.PE
MM Z7DF>E4MS^A_]5#7/!!TN0 R2TPIW^DN1!SV,^\UKE #DLY/FQ$)WD>7]&
M)PV]WZNRQ7;6MOB IBKD6!.;F_47A=P].T/,E0HTZG;\+1A><BP3(Z"=#MS)
MS%$'_[MR?F/!UL&?2'[P[7K,":CRL5U]B.'!-KISR+2(./$[Y_B)C'.)UA=[
M+:N;0@Z0F!*34V<G)R=I7TIBT/$B+O22W;J#>)K/@>;T=AOK@+O*^: RE"%G
MG:$P<<FJ<B/M!^^1D8N/I33"9I+Q:4-]#0GJ'WVX_*7XZ(Z*L^<G3Q]38D_9
M)3F,M4<%?01Q68UUT*>5=0@Y++476MSRL-YPEX963,!E!1,.[.VY-[LQM^A9
MR;$K::>HI"$/)!3]L$R9Y"[947&>U923?ESIGWGX6L'/!C2#5/?<<91@*NGX
M&,?5X]HZF:!]/F0.6N(&9=7379OZ<+&G?C<4$I7\\] TW6QWH9UR,H+MBWU&
M^XQ@8KR9LST'XGNV(68X+77I^E(A]*GW0+SY!P2('C,^G-.8M/B5BPT=H5TQ
ML6GTG9R8^(JYOW^_1/N/L+!H1#R)D:(4@YL20A@):%=(TLQ64(^BI<P:.;^P
MNRT'%[WD84<" 5^@Q+W$/\Z')43/24NI7.*ISE&&5%;QA[-4,TTS6OT*W-]4
ML6J*-V3-O_GV63R/PD::3"%5E4^?<6U'FG+10<4&)&I+$-ZU[1]TN.*6' -K
M%CM<6VXVX)>HN@S@4LE3FO\UA3KN:R+/@U-F1 1MCD)4H*/U$Y=,$S>+$S#P
MTQ438(N&H3K"C)[AF@M%:S&K%R.$R$3DW"%RWC408]0E)Y"I\*5V(XF,1;NO
MC>8O/'HH%*FA+8D=-J@6*HB[CZ2)E0ADNGA4;PJJO1OEBVN2?0%A=%924L0[
M[73B:.SL$C'^S=/G3Y4=-'EJ_0YCE-CX8QUUSY\^UP+@94SK,..M^=P[)P:8
M>-/MT4EG6PI!VBFV<^C,:B= 1!M[QZG ?)45VGL9X*.Y [_TBZU<$7+!#\,X
M=IAJ#'(O]I-'X+5Y-C,-X6ESUV;3!SWT[^_O=]!WQ6^V R?(EO]K6\R?\K5=
MGJ.:L7_75B] L[L;H\[3W[W'T?)'(^=YS.?QI <W-&?<FPI]WHND):=P4(@/
M%B;'1C",@6LQ9V3'Z4#"14D-=M(TM@0?9$,UG]2#NL=\(SA7P2'70V1OOYAJ
M(-7/\Q+PW) F)*[>AF8//7T;:*/%&%*H2;6;4SA[B!*JR-KTI7DP)@YVTO?8
M^9AQ$Q]?YX*CI'K#+A@L/=\03LQNU4ZG=(N=T@FY[L)1^/R$Y]/D0*<-WC\>
M6JUM-%+??'OV+.@Y= 84\>%<I@G#$;QP8'(6+EE.\"L\$J#2K; E/U%+'B,>
MB_W>9T_&Y"$SCZ5MQ'MJW]E6C?OO)0"64^R[QI"7GS2XZ!S<EN ;4ZT<'7;>
MG'B54:U7;IT:S6F1D8[NK+*NG334\4!.'H[D0*VA.F-+8I:*X0SEGRJ;W!I'
M*XJ8D%JH POJV<<TZQI^Y)8#7"<Y?U'(J48^ 908KKU(0DI07TXXO&%C.7'Z
MR7(0E=90,J7[TY$.BJ868DSX3$TF&-URX*9Y'>R21P\"ZT^62R-!>;-"O:.4
M< _0(!< %>ZP>!!4</IH7B]*#A>+Z,P)-V9C2E4D(G%4Z\%( U$"-M*/3^V%
MX/4>2M3 E@$K.K<#=GZ8VZ+I%0+ ]$W#6I=[C?"YMKMG3D42841'_ AK@[E"
M2F-I9C\51#R#N"<(XC"%#N3"'I\^RSIQIS*OZLK#YAJ[I+)KGM($V>AL3[EU
M+C?1M"C>,888(Y(B7,AFHHK),-$54AR!1V,:Q=)Y_U!*W]U-\A2INTXQD)8&
M8Q6.&\'U<'7&FCM"I3>S4&*6D<1;3@&Q0RNER7 >-U90L A.4"HFOFKLD7X/
MM/A[C73(5Y+*Y>26-.([$>.,?O^+QA95%D/P]YG.;TY/GZ16<)^QA"#CX;;R
M;S:(-NGTDG;NO=H0-Y^@*.5PU:PBJPDVHMW4K.1VCQXB7XR9(&G7B[U/U#,1
M8E/4M=0A'@[@3K7H)4?SV:!1FUTK/1:SX HG_>U)0PLK-@;_4)\LVXAU'#YI
M.7T,HL-3T90.#@@/01PEID=QP&3<"$)RB"=/]!P%9C:>'9W%P1K(1"]>!":J
M[PU5XR.?G"1][GNNGCCZFP[JF$6W'5S#YP&DN_1$5\!D/.J3'M7XZIG=>_*3
MW*#$;@R=:Y*C2<+MVL'_5(+\AET>B*:^>79RDDH=G5Y'H<%Z%Y5UQFV05AH=
M;+LRTL$_M-+J%QHBAW91WKJ./F?-3W32!_8W2.$<0) F+O($(OO)P6R?MG'-
M41O*42!SRS;F _B#CCK#1NK'4B*,NK<HQ;]9\?@$(3)[/"V= )*LI4I%LE'M
MB^6CX5:[76-J+1XY02RA^>!:=^@APB$/[-38T, 9<2O.Y9J5J/9($HI'N1!R
M*!.C$@OT19+,5<SJX9.1S.ZVIL\R 39)JS./61O;V[UJ2QKL:>K<3K4PFY97
MBLR(IP1\SSYE EQ4(J/^9:YA3K=4QIE)U#J9"XBT[M[7*HJ7A][00->\273!
M-=&OXY7/&F%6S6H;=][IZL>]KM-M@?<W6.JIMLE#CA/3X33W'X\^DD[YN6RE
M;'QV(E[EIY\+:@_-VVW%@;E\>Q[*FAWW*FC*7?PQ^40'%GQ2K4\#R] ,L)/%
MGRBL^<3#KF+)T\>2)R <LT>2E-_2B+^=[IR-ZPWWGMY:U\0V0$K%2'I^NJ)Z
M+A7H],IWX/T9GAE'%XR1>?809%Z\OTR*+5I'$M?:3[8\_^4^B-"TG!47K^*,
MNO\_^ZDR?D@FZDVVDQ"!="K@]UQJ"BT<H"[ XDB7QNU1\6G=4C^"Y!JUL)"D
MXK_2S'$-4KU32<5T[W^Y[N;Q.'HX?9'4V34+%Z3Y$W5_/FSI[-#5]>7'_PJG
MKJ3N'OM##FU[J+T>,>PF-C*W6)1OT+)05XD>U8F-(+'+)&L%21NE,+[V-Y8$
MIH5PF?(#925NS2S@&'V2,+R/+T\)ZW68)G8VH@>"Z1S,@.(,*CNJMFN@3P-!
M1$1*;8U(LE7L)8BPFZ])[T-+L7W6@9%QV(_H,$3^VF&FAS0(35;GWX.+UCKK
MF:=^'II,PX!:O4,4*T]I8G?,6VNGY[K(JE-=,N&,D@TT4CJ=C9<_8T%XTV"R
MZM,Z&9]P 5>?M3SS#->3PC"A/\-^2JNDY!N.ZH=A-9*6F.YM<NIT)WG57OH*
M-0$EW4X!68'I_UQU7NR(\D4DT^EW$TF#4* OH[F,Z2]@>: 2EE+RDZ!QJ(94
MLG,K,.I;&?L+011CZ5JCZVI;X310R9I0"H6'9'GL74(7YS87[#]3L7_ =BB_
M_U?L&AL5<3Y&ZO;;G4A248Y6-V#[0>IX4BJ#.IZDQ@3L0*!6!K.+_=^GCG*;
MF%(VI+DG*+S;XI]HW="9EU3V/9ZP46G^>K\>4)8?#6:4+GVS[]*_V-'Q[_ !
M$!5=&YHGU^T]D7Z/YR)G=#F[D1_'30[2)4Y-9[DH,O0ZU"9ZM7EC_9ZQK^@7
MRM4M-UW(D2,YO\!G9'E'XBC?K48Y\E4V094/ET]>& Z22901;M&"'NSCT"T.
M6YGD$QX<JWSGU /CA G"*2)O$J1,GT+ASH+>.8R6>@[#\/)D<E'8M(0I<>-R
MX#$%+F#N4?3]P@B6GF7Q<=;L1,<5]T&'9Q6$6!"Q\5E)JOEM.BO'CDO^,O1S
M!AO8)I-B'^6>Z%@^-SAM3%F!3II+2K/1]S4$!@)L\[RT=?D'/'<T98MR,*,D
M?)@O%;UXO)%&3TDGR>XE$V>ZI_O'XJ26O>WF.MUFJNE<AT#D#>?W%:3E-)D.
M;:=Q?Z(L8UO9+ R3T4-4I29ODF!S,HQ*!T](8BXB+H1D,^+2$?/I^-- 22K<
M9@,5D@,@7YFH1,_6!(">CL]GHJ;TS K$HZ$YD[6I<7C]L/T<)[R^NZ6+#]=H
MI$@[XM\R*P,+#MQN/,G\IB/.H&2;BY5;@HB<+DN_$<"P:F+5PDB:D*I6Y>7#
MY86<;4I*NO\<>#(Q]1Z*OK"]*A8R>,%N91W=O,,!TTS:NJRX69L*K)_U:W66
M,=%@A 7^P(RVCDD*+N^>,]9I2D,&!JH[%JTI372;;\-9WC"H/1[E%=5 ,YLH
MG1'N#@H5G:2-V+;Y-A-1@)9&Y<VRH=S!#.N<!E'%HT'HK+>\3+;'NT#X:,AJ
MQSW\?'PS*')*$H8V:^HFI,QWO )QFNG=RM5:@"4'QG.I+L>I')1F9217<X-"
MHW,3QDF"VI;+UGGK&=#H'(U6YN/KVFX/7$&SC73251B*E3/3>8T]T*"*A( (
M7OCQZO)*OD85JC0"<\VZ.IPC%OA#1L]+7P+-Q2:PPECTN!E$EX_36I(&7)YF
MPHQ*EH?<DM3&(^>-L)8+:G0]G3?A$F&M&$OA$<$<(*G/AX4HZ\T;UP?G7!S#
M/,Q<4@X3AVZQA"6CR/;(F+RF@ Z)H2*?$>70L*%ZM/V :_"\<EI1AT!)MD%Z
M[,4M^GQ^^5N<:L/Z#:1,%<,^HJ<,%TIITY,=Y'K8@SP>,R]UEN.2]C3"-)T?
MS.@4>%^ST$&2,P?RKV*5X&/NYU$Q5)P9=VITAJ9-[2QBIS<]^6@Y^YR^Z2'3
M7.-M \E8)4FX)@B&P')#!ZO3PVOXPT\_76>YLT_O?XRDI:Y$SR3>Y\&-F";4
M /3$DMCTQ5BSC^:D2,$NF"W<P?L?9>HD%4O$KPXG)IGQ9(3GZ=E,LQ>RD8^N
ME_V_HV:G*S%7;[L.L  1>"4FE)0.Q6X74ZQ+\WC/HU#\%N4!W[15/$)I>!R&
MSA_^0GT9?,AH)J@4E^#6TB'+7C *M .]4;O&+;GU&U<*=OR0&SS4?4BU#O.5
M3[L/]BI:RDQJ7$-I1$#6J1ZYQZ:EM,M,84P@FTF??Q[C,)U:A_4Q'&<)ZV^D
M@*"<90C1=,(Y4=/:XT0(\.5Z0UVI+HU^Q9*'NEU(P(R:G^@!(6D58^8X^JTK
M@VNX,(8FQHK;LQO)JW)[]^Y:R&VZ&.>]&Z/1QW'LB%#&2$S#*CZ,[C%B(R@1
MQ$EGPK(SN+6C)<BH@K0[CN41'WB$ B$3]8#E:)YJ&M[ED,(]F^('URU!\/XE
M;N-=+*]1)")G-184T 1-Y=IF&\#%P==]B!1MEVXS#$=7JF1O34A9H2T^=79)
M(JE SG8'G8:W<LF3XW,2Z+ -CV[\ZFZ3*9=RI$LY?4K<,L&,CLV4]DO?=:-Z
M7L43OD)*IN,MT:<W^#*>D5.QQS[IRX58,^S")CZY#!I#/CR$_SUA9O3:7D9$
MQ,3:W3YS.X&_&$X@2ZAI'XE JEP$@1%2/YK2@"=W$2Z15V%PFFF3M%#KMY_A
MVV1RGFJ:LFAA&Y.*4S4E-L/TJ8^AT[&CVT@CWM3-1+5##0?BHO7\.KMP;51.
MN9K31&@JV2-_%/-@TM909@*:CM:D_6-C#-<6&"\XV("1I</A]N,Y0,)$P</.
MTN!R^BPY.(*(H[M2["F4I;0$(S!'Q:=8MI5F(.$I/,P89"'>D7F&;/LR LZ4
M@EPI()\)\;*+4-4B82O/U4SQ1%F:-9;N'3>*CD+RT326A__5T^8D)01RH]C^
M>Q"<AI![5$PNJA$%2D;J#=<^.&VV1AS$LU)8Z-N5\;S!6#.OO!@NS6VS=%N4
MV;1-A*8G<S"RLLL5GDLAGXURB&DA*BHJ/#V%GK/GTP5KB%@:2OU4[ >65$PH
M?DP;7^0E.GIV2=Q//HJND0?H/YF8$M_'ZA;W85Z+ N#-4UP<M]C8&\/&B0P&
M;DV$$#//DN17?IIEVY=0 HMBK4=@?84OK9E)ZC'+H]"Z!!<M/+31^Q9]8;P&
M]39713O5LCCC-0YI"T/AR)!)TOQ>?1QZL%2_\ROK>.PY/EAZQ^+Y&:[U])TK
M]= B&RB\<=>7>2YCL;2;+W'N]\;TXPB'1NWD$2A#I?T[BW@B0*&A_%I\DK3X
MT/O)J/7'XYG2-AD*^0 K-K<U3^+20!V?FAC3A6VY(*(MPY-Q'.:WED;*$"B9
MU.'-?5(DG(S\:/]O#<8K>,25?P$PQKD:%%W'X1 PC_7Q=GJSF+0 $![MGF8G
M*R1DXN6F68[-RH"M/ "([)+?<U2<TYN1& S*+IM]U(D!,_%^FGB5P<(!XWFK
M+2)_5EP-<]#).#^14:M!8VC=$_'7V<$:#J:EBS2=$/7T)&/\\EDGJ<PRW1HR
M^#0O8S8Q\8PU LW?Y(%TZ$K%29P/&+?_H/>/LJH8F8Y8G^((0.4).$=,UGM5
M<QK<?@#K/-#[MQ@AK7@&$.4?TNIQ.%R0EIB*P]#C_>7NO.I0^Z!?8U&>9O1<
MRF$!13YV=TT6=I49\SKNO@00_$J<N\*=2J9.XL"\ECB9M$J%C=TJQ)@O>)+/
MWG+N_^T:+>8S$*=RT'NJ-V)?C1Y[G!Y69<_:_:3.DO6L9)G>@)()&G;&KN<#
M" $_:,^ O-@B$Q.\7$3_?UP)O^Y==</#X #9W&7Z)CT(D<X+>C&+$\FR*=OI
M>*_DI3_EY!"X&1\.XAXTC.QT"EDRZ67?\:E[IB3&N8B8Y=>1B8S79.4P;%G&
M\5%O<#Y8C-JNV4G@[3'UM*X89XWS^Q!XK*+:.GUI0M(?%>K(R?P%,F(AX1OD
MDH*P9#A1&">:G[5,BV1[E,4OOU[$%UK@<.]1#5<K9 ]%I+RH81%?4KL&Q4^^
M]&3'V[5%X!:6?60=ZJ'M3^5HB&%RGB&681>V\_VAO/Y0YV+0:^4NI%[WP99K
M6[Q#]^0=O8PE5@IHC!N^54NSOO&GSZ;75\?^VH&*C".Y& -@5N1=$!ZL?]G=
M /GP56C9[$*=YD3C*LU(4O U"%<)-]/D"PUT:E.%P;&4I,)MPI:Z:L!*/PU2
ME.*4"S$@Q@GIG%X"QK16\94/")E<%]"YEO!/MH%[YHE".SV(UY')S_-Y3A-(
M^AT]@P6FVA]+2_#7UKQ_/27O[R4R)RWYKC,@A0W& X\3QH&(;(MYMN35R:-A
MT2,L$"4RX@#F*(!.>-(K[Z*)D> L57&[9Y=087/?)":E&;OI$(J=\TO80W_G
M1BU$T4J\A8>Y+;B:":^^;VE?@L4MT07';KSX[FG(-;S]_/XZO)<AU;,/&/B4
MGQ)E*U=A&D3/ @9ZSHIST[>EOGJ!17M"DQB="X SW=,AML=)21.>1JL%S84X
MA1@T=IC_"K*#?ES9EG*:)8P9^+[X7-95@\=IL)66%J(V[2#3Q#Q4>)[^_6\P
M#YONU7'_^M6Q]?"_"O[KW!W\G\YC83GD]2M QM)<@%64V64_')P>)-]B0/'#
MP?GI]^=G!\=P9[S\]:L-[/E#B2,S<,S) FX].?KNV0%/X]8/O=O@DLC(O5O3
MGRLZ0(H7P.\+YWK]@ _ ?@X"[_7_ %!+ P04    " #%,[E6.JFT$D(4  #M
M10  &0   'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6S=7'EOW$:6_RH%39*5
M $KBT:<O0)8S,QG$L6%[)E@L%HMJLKJ[UFRRPT-MY=//[[TJGLT^9,\?00Q8
M8C>+K]Y]%O5BEV:?\[52A?BRB9/\Y<6Z*+;/;F_S<*TV,K])MRK!G66:;62!
MC]GJ-M]F2D;\T":^]5UW<KN1.KEX]8*_>Y^]>I&61:P3]3X3>;G9R.SQM8K3
MW<L+[Z+ZXH->K0OZXO;5BZU<J8^J^.?V?89/MS642&]4DNLT$9E:OKRX\YZ]
M'M%Z7O OK79YZUH0)8LT_4P??HI>7KB$D(I56! $B5\/ZE[%,0$"&K]9F!?U
MEO1@^[J"_E>F';0L9*[NT_A7'17KEQ>S"Q&II2SCXD.Z^[NR](P)7IC&.?\4
M.[/6GU^(L,R+=&,?!@8;G9C?\HOE0^N!F7O@ =\^X#/>9B/&\HTLY*L76;H3
M&:T&-+I@4OEI(*<3$LK'(L-=C>>*5Q_5"BPNQ >U3;-")ZL7MP7 TLW;T()X
M;4#X!T!XOGB;)L4Z%S\FD8JZ &Z!3XV47R'UVC\*\8T*;T3@.<)W??\(O* F
M,F!XP;E$BO^Y6^1%!I7XWR%Z#;31,#0RDV?Y5H;JY07L(%?9@[IX]<-?O(G[
M_ BNHQK7T3'HYPGDB2#$I[42]^EF*Y-'L9:Y*-:94@*6G4F^GYLG<D?\7<FX
M6(M[F2GQ6B5JJ5O??@2M.E2YD$DDWJ\EK")\%#_(S?8YP"<P;)6)7V%AB<KQ
M%#;:X0/]EKB? 1M9J-MWQ1K+[)8W;=Q^^,O,]Z;/\QH?06ZEP']\LY7TM%CJ
M1":AEK'0B?%),&Z',2H(TKLW;X5ZD'&)Q3E_50&ST%MD0WHPWER0=\"'51E+
MMG&= SAL.]01+5M#@D4J9!RG(:& Q](R8SYL4MQO;\*(X&&9Y^!!B[<"NS*^
M2:@LT?NHMM:(=&D(.L0:\D41HQ[]/_P$7=>$Z21,-]CF[M M 1+ANZ X$8EG
M[_;EW^[NWHN-DGF9J2NAOH1QR;P@E#0P"@M"$/1#P7YG&=!G$E:RTHM8,0,L
M.U(6N"[4!DJA\53RZ "0+$2B--_+5$R,!9,)?IIA*T0($8+-^4%.+$KP%TP6
M24H0EN3H!Q>6<$M9_$CHU\]TI/'C<JDX.@A\QR"6.LL+\5LILP+H 0%XHL Y
MS&HH1YY:-EE9-EQ*$%L1,&/].YX,Y587T-X5M!J,ST2<DJK<P+@4/Y>I,(6"
MQ[KF*C[G::PC.;AS3U3@86?]8907%)&9XF69L1CP8*&^$+(KF37B)L%5M$5B
MF:6; 7TB>P&O$*+HVR,ZV?9%94Y&=)BIL$/HT#;#9[T%TRR5Q)0!LS+KA4K6
M]"D?U 6Y &>+1\,FW *PK82H&[?2!KB#>B(*9]G>3E!KF<CX\7=U2KV,:P*$
M"$+^)4VN65[-?I:F#KHBTGD(Q5 PF+P,UT39>5+%^G5:QA&,HH"$^2D-_.@9
M@$+4TT59L*([I'UY"0":M#YUAI"JA$I;04%D')8Q8T ^+@QAJ@VCB##28R.8
M04==&]BCDAF4BA(&@7"O-@OH7Q7R^:?'C,.%RR%KH11E@2&$Q9%%;K>Q#B5<
MC4/";-O_,H6GWC%/C,_IFN-NK8FCF:H>,M30(E(3WWUNW&8=-'SON: 8FU>>
MJ*!MC?T\,\],GK->LY6O$J;_E/]F#81FY=L4=!I-@^*N%$6]B)TA*7\CX$T:
M*0ZF\#!AIA<&[5]22-.K,/^(W?42? $"=Q!/F?"C[Z$XH88V5>1 65H.G;0M
MI95E._*0T""4MQ2"5<)W[M<IXG]M>UF=8&PIE]+&!/?1N_2N!EAWTV$=^Y?<
M>KRG^T_CEHZ810<QN4@?5'?_9CO:7$;IMF@A$R/.7T=E9I08.^.2;;OA<8[0
M%\%M.E;!VN;,X$RT_H<$EQ';C*H'HN0D09)T(3BLR521I?G6!B0DJ3!@WG6C
MBG5JPO6R!\9SAAD_J_3"Y%P_U7C_K(TCU#:9^UBE5U9I\IM*4_X;AFH2^WT[
M!4#4)'$,[/).YFBO]U+$*@7$@W KE1K]&&MX&&9MSKIRWW9U']2#2DIE\DDD
MW \Z+?/XT2H?%GPGYIXS<N>X\"9SQP\F=.5.G/%\A*MQX.+GY6CL!*Y_A<L
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M22O/U-BT]1![?OX8<5'Z)XF;3PA2Y]G.GRE(42U:CT/XE.Z916Q_2%$IAEP
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MH:57^GEX>A$EM+I12'Z;!X+5 E$F*'MA4]U73;?7I EY\J17.!LJ.9G-AIF
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MF-5& \CAY3Q&X9^[;H/%$EEE\[R?QC7!GH(M<Q9V<Z6A:V?6>2L\5RZEA&'
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MG*K &9PT1"_G_:(?O+F*]#&9ZE>AZXNXWC1#$6F/7@)_?$KWOL><4E),7)N
M=#=2K\V4WV_..H87#E_W\P1?E[U0YV/K6@_5G'=.IJV0= &*RD0W-5(S\)JP
MXC1YVS&^V/[E#"LM0*&>DT($L>F0L,NTA> ,''#N#0HQY<Q_CA8%+A28DWH
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M4+K8F@PA]B(AU$KNQ]_:22ZV7$Q-]$B** .*LQ/W)%PH=PA?\ZQ^[@FQM4J
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MMB\/$FA1+T!\3N0:C0_(;U.*$7*.>N,N(BOJ@HRF$5PU:Z?BHV6E@L!--QC
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M6@KR(OODPE5 -,=3T[Z<G?:KEY^FTW[U?WC:-Y.8'%$+@9@%,9E_:2"=[8%
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M'8T#9=UW'SQ:9,D9:@25*,2>K!R3(YU9K$*\:-Q^&O2,%>/$D+[/1:;:G3Q
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M)F] M^VY&ZW N@1H+@K-YCN06_92-+8PR%6%7&K@A:5^[RTW/AI]^HNF<7$
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M'(R9DKE@+U=B.,&,0EZF$-#I35V<\)@&G0V%I#:2BJ77A'6B*TJ'$]D*&WS
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MTP&XSEWA%F+F],4P5GNM8N;H$J@&SRZ?)SF PAH&JS[C$KO3*]"+%-ZOTQ]
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M*I!@.W^D%FV4J1-:5&YN60UAEMG7]Z@F:]\H]QZ'-*9 U17"QW/V/;KN6ZX
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MZ4]@ Z SX@/P_;;K1OT'O@#U")K>M_\;4$L#!!0    ( ,4SN5:7= <G3 L
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M?\S<*&2?GZM-\1QM0F#/\NR@E3Q,'#IQ+-OWV(RS!X.S!T<[>]J&J2*'XQ
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M"_:.$ROR[</V]O'<\3HY6@D&>W<<'@5:GH"777XWNYQAAX']!+PE)VB2%:F
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M5.;C1]-HRB5_<#@IFZ9<\.U<QZFNZ 4\GY9ETS5H@OX3U)O_ 5!+ P04
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M7Y!?SN_/R;IXX#('W]1]1QPK"FSBTH8*#"PHN2]!",HBV2X7L=BR2F7(U;;
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MP/M5 <&Z>L -FM]F7/\74$L#!!0    ( ,4SN59_'WT^= 4  *\-   9
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M*A@F-J:WG0A=G82KQ3[M!F#'];[Q6.T!C^N]8Y?,@G2 4(HYBIH&^>ES7TH
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M9 @6J '>S_*\:BHT0?M9^]E_ %!+ P04    " #%,[E60)\#7/D%   M$0
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M&8/$ Z@2RK%U!=L>?>8@%H<>;N?<D0/CAV;6$'94SG1*_O6:?X;?5I'.2XC
M78E,GC&]+*%M$"P^)G)56..8H6UY=8;!YT,[8$ /'7"=UJ@];QL;$>^^Q$FQ
M@!E#=VJU1Y?Z@_S'("6973EDN U+$KP//=!=:W N81#8L6(DX2E'M,FIU!F3
M:LWS'=V6W($R6R0 &P 940TO3U>H/07:3!'TE*DNF[P-*?K7ZT\(U5!QXAL
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M%]Z,IPMRXQPF8DG \.T!]"<]^I.O1G^7O [U%\9(Z\WZ28DE &J5-+N ?_B
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MKM?N<2T%YCLBP/M5@TQMO] !_2\DY_\ 4$L#!!0    ( ,4SN5:_+.Y8,P@
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MY?E'Y'D^^[VN]$JQ#U4N\GT!,QC76^AW%E[[HQ+?B\QA@3=EONO[(_*"WN/
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MS:.68G6=Z5[0)I/<W#%H_?@_@9'"S!9R<W\8VX$P%$?M=J>OAGA6#RB)\6F
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M(M&\'PJT3::*1U#;"A(LSWCEZ">9_;1'0Z5NI!$N5+WQ;4_"=E6C%9M62_G
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MN(]<@V#($0F6X6<*72_G/I[ IY!Z2?@9!:<9=GJ5F0WR1B8"$8N#:-3OP5]
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MPY4$C<MQ,(TO9[G3]PI?..[,P1I<)@NEOCGANAH'D0L(!9;6(3!Z/.(<A7!
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M9/X "83[?D,]"\S;O'0CWA>:WC&'&,;K\_(@".M+@ODI,&RW4@1NR&<;A/T
MX?]1BB33;!XJ+P#S+=89@*C* 7M0N]')9['=B'5G%%55P$H;2PI)-U</(78
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MP#'V@?7J56ALO08$V$"Q;.\=<=H7A5.%J/8;6!/%K$6&&;=@O.13([RKR'3
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M;M[>W9*?D_(W<I<713+/"Y5RS63R5 \DMLO>JBI50]\O294\'A\X0+U(*"V
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M8/*X9"O*01A]3&Y &\5R \7K*'(X!D,9UT>H=7<[)H<'1^2 ,$&N&.=X5O3
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M=8QDU+;NVW:,+*K2Z4D:+,2JY@IK95#6 .<7$G="W;'56%-])_\#4$L#!!0
M   ( ,4SN5:$,!,(Z (   0(   9    >&PO=V]R:W-H965T<R]S:&5E=#0Y
M+GAM;*U576_:,!3]*U963:W4-B1 Z#J(Q,>F[0$)%75[F/9@DAMBU;%3VQ"Z
M7S_;"6D*@4W37A)_W'ONN<?VO<."BR>9 BBTRRB3(R=5*K]W71FED&%YRW-@
M>B?A(L-*3\7:E;D '%NGC+I^IQ.X&2;,"8=V;2'"(=\H2A@L!)*;+,/B90*4
M%R/'<_8+#V2=*K/@AL,<KV$)ZC%?"#US:Y289, DX0P)2$;.V+N?#HR]-?A&
MH)"-,3*9K#A_,I.O\<CI&$) (5(& >O?%J9 J0'2-)XK3*<.:1R;XSWZ9YN[
MSF6%)4PY_4YBE8Z<.P?%D. -50^\^ )5/GV#%W$J[1<5E6W'0=%&*IY5SII!
M1ECYQ[M*AX:#%YQP\"L'_]"A=\*A6SET;:(E,YO6#"L<#@4OD##6&LT,K#;6
M6V=#F#G%I1)ZEV@_%2[)FI&$1)@I-(XBOF&*L#5:<$HB A+=H!DD( 3$>OMY
M0R2QZD^Y5!)=SD!A0N65-GM<SM#EQ16Z0(2A.:%4F\FAJS1'$\F-*CZ3DH]_
M@H_GHSEG*I7H$XLA?@O@ZN3J#/U]AA/_+.(,HEO4]:Z1W_']%D+3OW?WSM#I
MUH)W+5[W!-Z<;T&_ JTVP_1%$HEX\JJQU?VE1>H?#YQ2I&]N@47\LTW7,FRO
M/:PI!O<RQQ&,'/W:)8@M..'[=U[0^=BFR7\">Z-0KU:H=PX]K,7 #14BH\(U
M6L&:,&9NJ%9-I8!R$(3';7J40?HVB*EEV_!N\&'H;IMI'MOTO5>;-^S[-?O^
M6?93G!.%*?F%U:D74 ($S:A![X!9BXU_@EE0,PO.,AMG7*B*%X*=[@,2VN@%
M1Z%O?/^07XN1%YP@.*@)#O[YX('%?S[RP=%Q>KYW>.;'1LU[41)W&P4U [&V
M?48B6Q[+RE.OUJUL;"OXP?I$M[BR([W"E/UQCH6^RA)12#1DYW:@&8FRYY03
MQ7-;ME=<Z29@AZENTR",@=Y/.%?[B0E0-_[P-U!+ P04    " #%,[E6BJAF
ML#P$  #7%@  &0   'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6RU6&MOVS84
M_2N$5@PMX$0B];"=V0::9'T :6LTZ_9AV =&IFVBE*B25)SNUX^4%3T<1H@'
M^HNMQ[U'YQY>40=WMN/BN]P2HL!#QG(Y][9*%1>^+],MR; \YP7)]9TU%QE6
M^E1L?%D(@E=54L9\% 2)GV&:>XM9=6TI%C->*D9SLA1 EEF&Q<]+POAN[D'O
M\<)7NMDJ<\%?S J\(;=$?2N60I_Y#<J*9B27E.= D/7<>PLOKE!H$JJ(/RG9
MR<XQ,*7<<?[=G'Q<S;W ,"*,I,I 8/UW3ZX(8P9)\_A1@WK-,TUB]_@1_5U5
MO"[F#DMRQ=E?=*6V<V_B@159XY*IKWSW@=0%Q08OY4Q6OV!7QP8>2$NI>%8G
M:P89S??_^*$6HI, HV<24)V 7IH0U@F5<OZ>6576-59X,1-\!X2)UFCFH-*F
MRM;5T-PLXZT2^B[5>6IQ2S<Y7=,4YPJ\35->YHKF&[#DC*:42' &ED+WC% _
M <Y7X/<?)2WT*BKP^IHH3)E\HT.^W5Z#UZ_>@%> YN 394POD)SY2O,S3_'3
MFLOEG@MZALLU2<]!"$< !0A9TJ]>G@[[Z;Y6I9$&-=*@"B]\!N^Q\!%8,B-/
MO_Z_;W0X^*A()O^QE;K'CNS8YN6\D 5.R=S3;Y\DXIYXBU]_@4GPFZUP1V ]
M&<)&AG (??$'5YB!HML%Y%$%6^%[M+A",YO(_2*,DB"8^??=BBQ181RW43VJ
M44,U&J2J&[C,2H856>E766N14KS?+#1IG'&AZ+_5!1OO/732872&8#0)#XC;
MPH(DCNS,XX9Y/,A\:95W!')BU3A^0@*&$(X/J%JBT&2:V)DF#=-DD.DUE067
MNB/>"UX6(_"!L-69_IR<Z6MD!#YS!71(RLT^4NIU^*+KJC2W;@B#SSKV+7$$
MUI-EW,@R/N%F,78I@R.PG@R31H:)RSZ>/.E0%$4'73SXP/]9SK0I9SI8SHTN
MP\9[,.O8]7($UBL0!NWW/SAAX];@CI1PA=:7HF.%H-,O70W7VV"GG?VU+NII
M% K"B7T7AJTY@8,?_<5E2=G*6#5#DV::]3TQ1.V^RZD;<876K[SU(S \9<<.
MNIVCI7"$UI>B]3MPV/ <W;%/W4L41_%AQUJB$(J?Z=C6XL!AC_../JA2J_ "
MFH- 1Z^1([1^V:U?@LDIV]6I0W*%UI>B]4APT'L<WZYCBX.=CB>'_6H)"Q,X
M?:9A6R\#A\W,#<&2;#E[P?[JR*34]9S"\L#6\\#I*1O6J3=RA=8? +3F" TZ
MCJ,;MH;K=F*"PL-^M49%R-ZNJ+4O:-B^W/*UVF%!K,0&4X\>1SA"ZQ?:F<N<
M=##C=C)S"B^$6B^$W YGT-.YRV02'<XX+%'C"!T.#OS.U-&,?#]AL:&Y!(RL
M=5IP/M;Y8C]%W9\H7E2#R#NN%,^JPRW!*R),@+Z_YEP]GIC99C/+7OP'4$L#
M!!0    ( ,4SN5:(A$X6= P  ,U\   9    >&PO=V]R:W-H965T<R]S:&5E
M=#4Q+GAM;+5=76_;1A;]*X2V*%I@$W&^.:EM(,FT:(!F:\3;[<-B'QAY;!.5
M1"])VRVP/WXI6=9P/C@4Z<N71)+/',Y<\I*'A\.Y9T]E]4=]IW63_+E9;^OS
MQ5W3W+];+NO5G=[D]=OR7F_;O]R4U29OVJ_5[;*^KW1^O6^T62]QFO+E)B^V
MBXNS_6^7U<59^="LBZV^K)+Z8;/)J[\^Z'7Y=+Y BY<?OA2W=\WNA^7%V7U^
MJZ]T\]O]9=5^6QY9KHN-WM9%N4TJ?7.^>(_>*83V+?:0?Q7ZJ>Y\3G9C^5J6
M?^R^?+H^7Z2[+NFU7C4[CKS][U%_U.OUCJKMR'\/K(OC1G<-NY]?V'_:C[X=
MS=>\UA_+]>_%=7-WOL@6R;6^R1_6S9?RZ6=]&!';\:W*=;W_-WDZ8--%LGJH
MFW)S:-SV8%-LG__/_SQ$HM, \9X&^-  NPUH3P-R:$!.;4 /#>@^,L]#V<=!
MY4U^<5:53TFU0[=LNP_[8.Y;M\,OMKL=?]54[5^+MEUS<57<;HN;8I5OF^3]
M:E4^;)MB>YM<ENMB5>@Z>9.HHLYO;RM]F^]W5'F3?-&/>ON@D^^4;O)B77_?
MHGZ[4LEWWWR??),4V^1SL5ZWV/ILV;1=W&UHN3ITY\-S=W!/=Q!./I?;YJY.
M?MQ>ZVN;8-F.[3A _#+ #SC*J/3J;4+0WQ.<8ASHT,?3FZ- <W5Z\S0R&G+<
M763/1_KX>G?&OW]IH<FG1F_J_X3B_LQ+P[R[T\N[^CY?Z?-%>_ZH=?6H%Q??
M_@WQ](=0S"#)%!"9%4]ZC">-L5\<HA<\4I];LGW+W?GS\8)@Q+$\6SYV8^'#
ML$PEPC9,!6!<R#0[PJS^LV/_6;3__V@O#<7V4==->S+>?5R5FS8QUV5=?Q\:
MTS,;[_0B(YDS(!^#D'1&K7R0D#UCX<>Q\.A8_EDV^;J]F/3O$>YME&!,N7 &
MX,.PQ.VUR1E" ,8SD?+P*,1Q%"(ZBLN[O+T<K?X*]3_:<FP.0I(I(#(K8MDQ
M8ME,Y[0,,IZ09 J(S(JG/,933CZG2?^83UF;WDX&^3"44>["5  F4)J)< :A
MU&B2-#J"GZI6 R1735GIH(2(MAZ[WT'9%!2;';F.FD,SY=*!&"JHD&P*BLT.
M*C9!Q9,3ZM#4RB@LLM1)J! ,$<2<A K D.2,]22448TH*J(N+BN]*1XVX1&
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MS3OJ3_[!@KBO6@=@G%&4N9D7@*52]ESIN!'"''8!">[+VC?4G?<4 "'W+8<
MIF\PG04D7KV"A&_YHC1CTGV*&L0ACEWQ$<!)PD3/.P'<:%$^P4(>.B,.V%OQ
M38[.8U"5"L5FA]NH5#Z7K<Q!;650-@7%9@?5B&@^?;HR]TW@C%#OM?D 3(C,
M>[\H!$,RZYG*((Q6%1,\Y1.R<,#LBF]U]#HPH$(6BLV.N!&R8BZ?68#ZS*!L
M"HK-#JJ1UV*ZSRQ.6[\B! NL7Q& 1=:O$$:\B@DF\RF7PX@3%M_DZ ,&5-9"
ML=GA-K)6S&4Y"U#+&91-0;'9035*6TRWG,6PY3P,45&(W6LCJ<4$R_F$S.NU
MQN+;&WV$@!K04&QVK#LKQ\UE0 O8E>5@EY:;0]H+(^W%= -:^-8Q)OZU+X"B
MJ3N9*(!"LF\FGS B6L1%],>RNB_;#-3+2$J!NLV@; J*S5Y9T"CX;"ZW.0,5
MZ:!L"HK-#JH1Z=ETMSD+.,38]8>"(%=+AD"HQVK.C!;.8!?!R )+5Z2N6Q0
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MX4LYE?87K5M?ST'I4BI>M6 =0458\\4/K0Y; #_: 0A:0/ 4,-@!"%M ^%+
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M:@&JA:@645HWI)\4) V^;]WPAQ84U2<]=-:/:B:J6:AFHYJ#:BZJ>:CFHUJ
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M][-;KO&+")0UP/<K*<WKQE[2Y3?6] ]02P,$%     @ Q3.Y5IZZFPX.!
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MK]4UN$(?F40J9,,2&29'V*)/*7 JA[K6.-9+RWHDL-:T^-6T^"-WM#^F])'
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MV?O'0KP2,R&"CEGR3SR3RZ$3.6!&YV2=R'NV_8N6@H+<WY0EHO@%VUW9L.>
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M3[69+=L$AYL1,U$3 ]@(<-C8-:-Y H2[3MX!&V./ - EL*G>!*1P0Q5-+07
M33!7P0ET"4=K1LQ$30Q0(\!1HVM&XPP(=YV\ S9X)  >"6P*- $IL5!%4TL!
MQ!+,%6D"78'1FA$S4=5LX >&\T/3C*-3(-QWLJIM8_3! $B839V&D2(+532U
M%( L;*Y.PW0-1OOL;; 9^^S- "'8 9W&J7*'&5,BG7Y015.7V;N*Q*92PVBO
M-K&!+ R0A<U5:IA!J6G',VH[ZE91Z(WT(U $.R#6M/V(#(1P_\E[86,*P@!-
MF$W5AI'""U4TM10 +VRN:L-T14:_ @A_EM>N KB#X=S1;U_C7 CWG[QG-H8A
M'&"&VQ1Z."GM4$532P&TP^<*/5S7</3+@DQ&8]<%<> /CO-'ORN- R+<?_)6
MV)B*<$ :;E/TX:380Q5-+05@#Y\K^G!=T-$N$#+8C%T@Q'N7O>(8TNM)\YP(
M]Y^\$3:&(QRPAMM4?C@I\U!%4TL!S,/G*C]<5WZT*X4,-F-7"G%@$(XS2+\G
MC>,BW'_R1MA@%0ZLPFVJ.IP49*BBJ=>> \B$<U6=4)=L^/ 3D<%&C-S^$ )8
MA#A8['MR=&J$!YBZ$U31U.4"JH0VU9V0E&.HHJFE (X)YZH[H2[=!'PXQ308
M,1:.M"6018B3!7>2[=H)C5F13DNHHJGK!$P);0H\(2G#4$532]&[0V?V+3JZ
M>C/\@&,P\8*19@2D"'&DZ)H1F1KA 29OA(U120B8$MK4>4)2AJ&*II8"&":<
MJ_.$AW4>_#E>>]L8P(? X4/I7O,M9*23$JIHZG(!:(1-74B0P@Y5-+44 #MB
MKBXD=,UGV+VHB9H8H(? T4-I2>/$" \P>1]LC$D$P(RPJ0X)4MZABJ:6 GA'
MS%6'A*[[:"V)F:B) 7T(G#[Z+6D>&.$!)N^#E7N)>S<3VU2&!.U-QS9P1P#N
MB+G*D-"5(:TE,1,U,8 /@<.'TI+&>1$>8/(^V."4"#@ELJGV1*0,0Q5-+04P
M3#17[8D,M_4,6A(U41,#HHAPHH"6'!T7X1$F;X2-&4D$H!+9U'HB4HBABJ:6
M B FFJOU1 8=9]B3NHDW\CH9 5-$.%,(8S*DHQ&J:.H* 4XBF_).1 HN5-'4
M4@"X1'/EG>CPC3VHB9I8[_02'",$,A["72?O@(V92 18$MG4=2)29*&*II[4
M L@2S]5UXL-WZ^#/\=HU &O$.&L(9#"$NT[=+*IHZD*!76*;TD],BC54T=12
M -;$<Z6?^/"-/:B)FAA 1HQ#AD!&0KCKY!VP,0>)@5EBF[I/3 HW5-'44@#<
MQ'-UG_CPC3VHB9H8H$:,HX9 AD&XZ^0=L#$!B0%=8IN"3TP*-U31U%+T#E^;
M??K:8<$'-1F<O=8_? V'#8$,@@[X3C^"S<H9;&[O$#;7ZBEL+NTQ;%3A!N7P
M>^68?1*;>UC*P6T&R?6.8G-QFA#8..B \_2ML'(DF]L[D\VU*>:\1"<KAPV,
M:0[:AG+,/IBMB\#1SL1L=LDM>^=6-Z>&?TR*N[3>@4S>UC[NNT85*G;G<.\>
M5/E#>Y3UE[RJ\DW[X[U,UK)H#.J_W^9Y]?*@.1U[?QSZV?]02P,$%     @
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MS=+ -5R=OB J?_0RE*\O,('5,,#,7 [SI6H=OA#USR9\]5]]??3U(,91MX>
M490:^B? PL?!XE]%G:W!/NF@X/N!V_TR")DUV!$;^B6 PN\#BN/E\3_G*J]V
M1=5<6S^5Q</NE?,S7]^\OBW*U\WOFLGJUZ)N35;%MLZW#\W5]MN.EUEMJLC@
M#=O..U3>U# )[O#GQ1T^*7=0>5.#)[C#Q[G#;J+3Z4*[0J=8W_$%JO@#4:6Y
M9#[P1[YV&'@BI-!"Y4T]9P$M_KR@Q2>%%BIOZE8- 2T!#BU6^1_HI!&E;K=(
M"5@%:1@8-I4() E&K^P$ (@D4?<V#UAY?FSX^AL(#@EP#AETEP]TQ&"L.X>
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M#ZCBHC:=WDD0UJ/>_Y+$A_D>;\A^W"99?Y->%L""F55R\;<7V =P$D:4WF7
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MPP*[@S+;U._FWV5EF:WK/U>"+T1>&<CO[[.L?#JH3M#\O,/L?U!+ P04
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MEZI&!ZX'J/<+QN1]0T_05/W3?U!+ P04    " #%,[E6Y#3(=C )  !E4
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M'(59H.?7G*NGCKE>^C^'Y"]02P,$%     @ Q3.Y5O9(F#?(!P  2$\  !D
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MWJI>MJW>*/)9M<S8;5X4>5I]O)?11*KR //]-,^+IXTRP'+QO-%_4$L#!!0
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MUEL23??>#!3?V7YVQ97NCNUEJ;]X0!B!OK_A7#T/S +=-U3V/U!+ P04
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MHQF[L1D/X0PA'LSK<^ 9:SYC-T#C(:$!1] 7?PY&8PUI[$9I;,#T9#P8-N<
M-=:DQK^":FQ@-408]SV<@]98XQJ?AM?8 .PH&+P9V&MS= ,:V7 J9(,!V7$<
M]'O'7I^K'\UL.(;9O"/A4=0& [7'<=A?7($!VY/]5<NAYKU7:#NW&\U&7:=]
M=SX'K$'#&MQ@#098CP<O&/;DKN(UK,$-UF" =0+].6Y/[BI>PQK<8 T&6$?1
M8$*? ]:@80UNL 8#K"$9M/PY8 T:UN &:QC"&O!@F61/[BI>PQI^!=9@@'44
MQ(/1<PY8@X8UG ;68(!U$@X^S]AK<_W^J&$=G@K6H0'6TD__J6JOS]6/AG5X
M#*R/0G0X1#0$0="?,O8*70UIDH=6ALYO:E&7%!6\2-4W@XPL,HJJ>M%8K#ZB
MU>YZS@J6U[EU1+8U'1B>]+];V>6XVMW[(&Y'^FUKB^2\+@1:UE3M;=#G5(Y3
MM4U24K53II9A<IBRG*A12U->\)RELL-7U&A\^#T=XF#@_*3K 7]OATAMS]V1
M\I$5E1R:*YD^N!A)->5NQVM7$'S3;!HMN! \;P[7E"QIJ6Z0UU><BY>"VH?J
M]AWG_P-02P,$%     @ Q3.Y5I%R?7>  P  P \  !D   !X;"]W;W)K<VAE
M971S+W-H965T.#0N>&ULO9=M;YLP$,>_BL6F:9.Z@DD@H4N0UD13*VU3U.[A
MQ;07#EP2JP8SVR3MMY\-E(8D95U$^R;!#W>^WQ_[.(\V7-S(%8!"MPE+Y=A:
M*96=V;:,5I 0><HS2/7(@HN$*-T42UMF DA<&"7,=AW'MQ-"4RL<%7TS$8YX
MKAA-82:0S).$B+MS8'PSMK!UWW%%ERME.NQPE)$E7(/ZGLV$;MFUEY@FD$K*
M4R1@,;8^XK,)[AN#8L8/"ANY]8P,RISS&].XC,>68R("!I$R+HC^6\,$&#.>
M=!Q_*J=6O:8QW'Z^]_ZI@-<P<R)APME/&JO5V!I:*(8%R9FZXIL+J( \XR_B
M3!:_:%/-=2P4Y5+QI#+6$20T+?_);27$EH$&/6S@5@;N4PUZE4&O "TC*["F
M1)%P)/@&"3-;>S,/A3:%M::AJ7F-UTKH4:KM5'@!A*D5FA !:,*EDFA&[LB<
M 7J/+M,H%P)B1-)8=],8-68S0A.)IK#6>R'3;U:AMU-0A#+Y3AM74R]3F0N2
M1H!F@L=YI-!G'8$>_WX]16]?OT.O$4W1%\J8?JER9"O-9"*SHRK^\S)^]Y'X
MIQ"=HAX^0:[CN@?,)T\WQTUS6RM9R^G6<KJ%O]XC_@Z(\JL OE20R-^'^$J'
M_<,.S2D^DQF)8&SI8RI!K,$*W[S"OO/A$&U'SAKLO9J]U^8]K+?+_BXY05]U
M1N(+= 7T?D,<TJ)<P"L6, EH'>(>[O?[(WN]3=D:QY&4_9JRWTHYR9.<$9-[
M'CL23X4MU_&W85T\P+NPK>$<">O5L%XK[$?&D,[]4ND,0-,E8I3,*:.*@D3Z
M$X)6)7QDX*,B>V15]L@$U>.*%P?K!*6E(J)=$6]?D<#?D:,UX"/E\&LY_%8Y
MOG%%CA3DJ1+X>Q($@;NK06N41VHPJ#48M&JPGRC+P%NM_C>-=>2L 3BL 8==
MI_!AE^P=.6NP!S5[\-PI/-C;P+[K>L'.#@[V$KWO#GM./:L1/78>BAGGA9)S
MM5"3 ^]]B:IIVR!>WW<> ]FJRO"_3MFA:N:\W>Q_MUI7WIJ0#[42[KQ8PIU6
M2UUY:_(_U$OXV0NF:H7&-@WPT-O=IL]1,>&'D@F_5,U4+=0X;X$W<'9Y.RV:
M[*WKE;G;?B%BJ:-$#!;:O7,ZT.&(\KI8-A3/BAO7G"M]?RL>=6$0@S 3]/B"
M<W7?,)>X^M(>_@502P,$%     @ Q3.Y5A\QN/-H @  -P4  !D   !X;"]W
M;W)K<VAE971S+W-H965T.#4N>&ULM53O;]HP$/U73EDUM5)+(- ?ZB!2@4U%
MZBH$ZO9AV@>3',2K8V?V!>A_OW,2(B:UU;[L2WRV[SV_Y]QYN#/VV66(!/M<
M:3<*,J+B-@Q=DF$N7,<4J'EG;6PNB*=V$[K"HD@K4*["J-N]"G,A=1 /J[6Y
MC8>F)"4USBVX,L^%?1FC,KM1T L."PNYR<@OA/&P$!M<(CT5<\NSL&5)98[:
M2:/!XGH4W/5NQP.?7R5\D[AS1S%X)RMCGOUDEHZ"KA>$"A/R#(*'+4Y0*4_$
M,GXWG$%[I <>QP?V+Y5W]K(2#B=&?9<I9:/@)H 4UZ)4M#"[>VS\7'J^Q"A7
M?6'7Y'8#2$I')F_ K""7NA[%OKF'(T 4O0&(&D!4Z:X/JE1.!8EX:,T.K,]F
M-A]45BLTBY/:_Y0E6=Z5C*/X'H6B#";"(DR,(P=S\2)6"N$"'H6UPE\:G$Z1
MA%3N#$Y :AA+I?A*W3 DEN")PJ0Y;EP?%[UQW!23#O1[YQ!UHPB>EE,X/3G[
MFR9D!ZV-J+415;R#?[ Q1HUK2:^J>Y?%-\"M*T2"HX KW*'=8A!__-"[ZGYZ
M1V._U=BOV/MO:'R08B65I!?@7H*)$C)W('1Z"._27_R_N> )/N^YZ1S"CP?F
M@!EA[GZ^9J?_'^P,6CN#=Z]\F1E+%VGI2X3;:Z8=ASKQ9:3)<K>Y<UY,2FLQ
MA55)\&@(%E@PBA=.9^/'Q1DDM75UN)IST$BO.:VU].HR]B_--K[NW S#[;&#
M\*@/_)/R5=B-U$R/:T9U.]>7 =BZ3>L)F:)JC94A;K0JS/AE0^L3>']M#!TF
MOMO:MS+^ U!+ P04    " #%,[E6?%>85I4#  #N#P  &0   'AL+W=O<FMS
M:&5E=',O<VAE970X-BYX;6S-5]MNVS@0_96!MEBT0!I=?,_: EI+10.T@)%L
MVH?%/M#2..*6$K4D;2=_OZ0D*Y:M" Z@AWVQ26G.X<R<X8B<[[GX)1-$!4\I
MR^3"2I3*;VQ;1@FF1%[S'#/]9L-%2I2>BD=;Y@))7(!29GN.,[930C/+GQ?/
M5L*?\ZUB-,.5 +E-4R*>/R/C^X7E6H<'=_0Q4>:![<]S\HCWJ![RE= SNV:)
M:8J9I#P#@9N%]<F]"6?&OC#X07$OC\9@(EES_LM,;N.%Y1B'D&&D# /1?SM<
M(F.&2+OQ;\5IU4L:X/'XP/ZEB%W'LB82EYS]I+%*%M;4@A@W9,O4'=]_Q2J>
MD>&+.)/%+^PK6\>":"L53RNP]B"E6?E/GJH\' '<X2L KP)XEP(&%6!P*6!8
M 8:7 D85H C=+F,O$A<01?RYX'L0QEJSF4&1_0*M\T4S4R?W2NBW5..4_Q4)
M4PDLB4!8<JDDK,@S63.$C_"-DC5E5#V#KD=XR')"8U@R0E,))*N'G^)_M)^Z
M=A2$3[I^)<+[ !6A3'[0+ _W ;Q_]P'> <W@.V5,UX><VTH[;URPH\K1SZ6C
MWBN.!AA=P\"] L_QO!;X\G*XVP(/+H<[+?#P8K@[:\)M+5BMFE>KYA5\@U?X
M[A,NU,=X*TBQVVXSJ8=99"3,E-";3U[!'48\B[1^I0W?'/0*<*?;0UX(IOB1
MRG]]T\O K<)4_MTF4.G3L-TGT]!N9$XB7%BZ8TD4.[3\WW]SQ\X?;7+U21;T
M21;V1-80=E +.^AB]__DBC!(RDT9F4T9%9LR+S=EFRHEX:@@-%^%G>\Z[E!O
MD=UQNL^MIN/)M&D4=/KVUC3V1-9(X[!.X[ SC557>]D7*\'C;:3 5'A;$COI
MWEK:?9(%?9*%/9$U-!G5FHS^ASUKU*>P?9(%?9*%/9$UA!W7PHX[-]N)L*\V
MKRO(]+E7:RJ0'L1ODZQ<;7S4JF8S;WS2SSI=>JL4?9*%/9$UI)C44DPZI;A[
MR:S.<L1W*$SF6X];D[,TCTYR?&YQ^L&8M'Q[FB;AN<G+,HT8IW6,T\X87QJ'
M>2.!JP0%J(1D($TEPJ$2VX*>GH7DN>Y)V)W+O[6T^B0+>R)KI'U6IWW6]\ED
M=M')Y-RJY61R;C29#4YZ0GAN-)Y.9B?59A_=E<Q-^#L1CWK3 ,.-ACG7$XT7
MY>VRG"B>%]>G-5?Z,E8,=19B%,9 O]]PK@X3<R.KK_C^?U!+ P04    " #%
M,[E6H :5K5T&  #,(P  &0   'AL+W=O<FMS:&5E=',O<VAE970X-RYX;6S%
M6EUOVS84_2N$5PPMD-8B]65GB8'$ZM "+1:DZ_8P[(&1&)NK)+H4G33_?J0D
M2Y9(,4E+;"^))!\>\5S>2QY*.KMG_$NU)42 ;T5>5N>SK1"[T_F\2K>DP-4;
MMB.E_.66\0(+><HW\VK'"<[J1D4^1YX7S0M,R]GJK+YVQ5=G;"]R6I(K#JI]
M46#^<$ER=G\^@[/#A6NZV0IU8;XZV^$-^43$Y]T5EV?SCB6C!2DKRDK R>WY
M[ *>)KZO&M2(/RBYKXZ.@9)RP]@7=?(^.Y]YJD<D)ZE0%%C^NR-KDN>*2?;C
M:TLZZ^ZI&AX?']A_K<5+,3>X(FN6_TDSL3V?+68@([=XGXMK=O^.M()"Q9>R
MO*K_@OL6Z\U NJ\$*]K&L@<%+9O_^%L;B*,&,)IH@-H&:-P@F&C@MPW\IS8(
MV@9!'9E&2AV'! N\.N/L'G"%EFSJH YFW5K*IZ4:]T^"RU^I;"=6[PC.Q1:L
M,2=@S2I1@2O\@&]R E[+\V+'2E+*B^P6K+>XW!! 2S#=YF5"!*9Y]4JV_OPI
M 2]?O (O5)./-,_E,%=G<R$[K6X]3]L.7C8=1!,=A A\9*785N!MF9%L2#"7
M:CO)Z"#Y$ED9$Y*^ 3X\ <A#R-"A]=.;0T/SY.G-/8L:OQM O^;S)_@^4'Q#
M<RH>@)P$P.=RAVD&UCFF105PV1U>9/_(9)(%*\#;;W+2J CXZYKE.9#5<X]Y
M]K=I9)H[!^8[JQGIM-KAE)S/Y)13$7Y'9JN??X*1]XLIJB[)$D=D@X@'7<0#
M&_NA9%*5_FF=_KLF_4_ #=G0LJ3E1A7,CG#*,E-<&_ZPYE<3\]UJ$<6+L_G=
M<;RLG7ANO!R1#>(5=O$*[1E*JNKTD(<J/4TA"5VFFDNRQ!'9('11%[KH>U.-
MR-JV)EG#'!TE&?1@@$99%CTA%1-K)[\S!'$7@O@I(:@7FTM2DELJC*N(E>6Y
M">22+'%$-HC>HHO>XL=K;^$R="[)$D=D@] MN] MK8G7)EM;=YRDC$O_H<P,
M$UO"Y4&UY[A,"<C;)9@28V8NM4*,EZ,JU"'AN :76J$&L(,,!$*O]WZ>5>*:
M\1WC6) Y^$UI,KHS*\5SL\,I6^**;1B^(^L,?[RX6@Y7\7/)EKAB&\8/]?%#
M_TV%M?<YKA\4C&O,!(KAJ,I,(#159[U%AU8_>EC#WG=ZKCC+]JD 'R30*,BI
M\W;*EKAB&\:R-]\P^-_V.]"EYUX[94M<L0W#WGMX:/6Y#C8][0V.2\NPZS&@
MXJ4?C<M41T6+HU5U*+)WV]!NMYL)_9KT$X^:E.X(5T+-,X_NLC5%)B,^UJ-C
MP@DQO6^&=N/<B'E?R*00:F0R6J5L+^M!+?B E2!GY>9U)H76#^".-=?I8]8;
M:QWUQGH?A216R%!N;W2AU0P^,T%/0$F$4>#"E*6:1AT5+Y&6I3I*9FDPH;3W
MI=!N3"_2KWM:435JU;0.W5)J(AZ%) 9( "<$H-YV(L\ZA5]DV>GHX2(MTSWG
M<O'?CH?1) XY]:1.V1)7;,/8]IX463W;:JW"*(O\@6"CG6^;#S(7^LNQ63+
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M    >&PO=V]R:W-H965T<R]S:&5E=#DP+GAM;,U=:W/;-A;]*QRWTTEG:HL
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M;,I%8:"^GV69?'E37*!ZEN?J?U!+ P04    " #%,[E6)XD6BP,#  !O"@
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M7!3C3;%1/+,3PI0K/6_8Y4)/A"!,@'X^XUQM-F;HJ&;,Z"]02P,$%     @
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M5E6>CI*8;7FIYBS"GD/[3J%<H--__\YO>I^K')Z);,=O6/H-+7MXR&^Q%E9
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M]!6 TA30\XD0>C,PY\SRNZ+_%U!+ P04    " #%,[E6"8MM(N<#  !Z#
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M'6@B43:ZY4#QK>T55USISM,^YOKC (01T._7G*OCP"Q0?VY,?P!02P,$%
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M[J+IH]J2G;0MT4E;5&M13:":1#6%:AK5#*I92G.71Q\$E\2D[0'QKP'RW3]
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M>&I\WH;]@(QNEC(=W2PE7BZYX='X&-4DJBE4TZAF4,U2FMOP?<Y<QW/FTU<
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M;5%-H)H\:">V]V@:BVH&U2REN>W;I[%-TDQN?1'<W1\_WA/>W*,SN:C6HII
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M"Z((2'0Z 84)E6=Z['$Z0:<G9^@$$8;N"*7ZU<BAK329\;>3DN*FH/!>H9A
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MD3801:%5=!3/\EIEQI6N?/+F2A>G(,P$/;[@7.TZIORIRMWX+U!+ P04
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MHX'@&R3,:(UF=M+<I-::#4O,-#XJH:\R;:=&8RZT!4OF$M$D1!,!(5/H>BX
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M"51+44VVVCO;2F7HHCFJ%:BF4$V_^^4U"[8+HTV=&9>?:]#18!JJQ:B6H)I
MM1359*OUV2\J0U?.4:U -85JFM*>2_ZL*<^RCF?U[.IR659WY77Y\+#Q;K;W
M4-M>L;_YK%>5M\TIP?_P*3@Y._C\M?\A]RV?+_P/>O?YLXZ_NGR<W95Z5MTM
M5AOOH;QMEAJ=3IN73;6XNW_]H%X_?CQI6I.OZ[I>+W=_O2]G\[+:#FC^_7:]
MKE\^V"[P?5W]MGLX5_\'4$L#!!0    ( ,4SN5;<+#J39@4  -TD   :
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M<8I=W$BVR\]UETQ*EN676XQ6F&L#]?V:,7F\T3]0_2]A]C]02P,$%     @
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MLXP+**Y)&K\G290D'D'SMX?'GO#%V\.C,V[2KJRIXTM/\,UE54N!E=-$KHC
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M#5[50%D OE]):?8#NT!W^<M_ %!+ P04    " #%,[E6D",91/("  #C"0
M&@   'AL+W=O<FMS:&5E=',O<VAE970Q,#0N>&ULK59K;]HP%/TK5B9-F[22
M%X^V@TA .FT?JJ%673^;Y$*L)G9FF\?^_:Z=D $*"*U\(;%SS_$]UP=?#S="
MOJD,0)-MD7,U<C*MRWO754D&!54=40+'+PLA"ZIQ*)>N*B70U(**W T\K^\6
ME'$G&MJYF8R&8J5SQF$FB5H5!95_)I"+S<CQG=W$$UMFVDRXT;"D2W@&_5+.
M)([<AB5E!7#%!"<2%B-G[-_' Q-O WXQV*B]=V*4S(5X,X,?Z<CQ3$*00Z(-
M \7'&J:0YX8(T_A=<SK-D@:X_[YC_V:UHY8Y53 5^2M+=39R;AV2PH*N<OTD
M-M^AUM,S?(G(E?TEFSK6<TBR4EH4-1@S*!BOGG1;UV$/X/=/ ((:$!P#NB<
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M,[R%@30!^'TAA-X-S +-O2[Z"U!+ P04    " #%,[E6G(QS"_ 5  ""(@$
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M7]^K[[[4ZU^'&PPH3_E5!-]SV,"%&&JBTFJBBNM?JJ#J HHF46C3, NM+E9
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MY5Z/-&%/&:*D<@L2RRW*R+8F; HW%D["X Q^B>S@XZA#&_4,6Y.CQF[4*&J
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MLSM=Q#4]I=@T;BR<A,$9_ K"+]#T-()QTO6,&NE9U.QMIV3;O!9P]:=3M'J
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MN#90]W/&Y-M".^B_4I+O4$L#!!0    ( ,4SN58C3-ZMQP0  (H4   :
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MNL;.&Y0%X/I22O,\L!MTO?SL?U!+ P04    " #%,[E6*75C.RP(  #J1@
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M?7\ ZOM!:1$HC4#13"D;WQ_ ^/X#F)XCEX'Z?E :@:*9P6]\?W!@:?[+ _K
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M)<O*QQAH!%PW4._7C,F7@NZ@N9%;_ M02P,$%     @ Q3.Y5D>9I+X7!0
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M76^;2!2&_\J(KK:MU)H/VSA-;:36^ /42ME:W;U8[<4$C@,J,&1F;#?_OC-
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MBI:@HJ58:&HKD H#'3[3Y -5A4!%BU'1$E2T% M-;0]2_:!V]<-M\H&J@5!
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MV=P2]VR85OQ( OH /E]82[N%%^B>W?P/4$L#!!0    ( ,4SN5:O22R=O ,
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M$#:9:4-I\I!AA1<SP0] &+16,Q=-,ANV#I\RL^\/2NB[5//4XIY0)O<"LYR
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M:@'J\^NR;+Z]:;]@_W3<XG]02P,$%     @ Q3.Y5FI7JS6"!@  QB,  !H
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MU7'(DI!0@O+DKSF+P>\IYBB_?Y^$+,9 ,C"/_E$!XJA]\ZV/)2)4O -O $G
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M',$<@ <,B:+Z/;CS/@I6[ZE@_1_:X5]02P,$%     @ Q3.Y5I>*NQS
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MJG<$Z!U5[PC0.ZK>$:!W5+TC0.^H>D> WDGU3@"]D^J= 'HGU3L!]$[N9@E
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MJG<'Z-U5[P[0N[N'O0%Z=]6[ _0>JO< Z#U4[P'0>ZC> Z#W4+T'0.^A>@^
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M^=WY[?-?+_^^Z;^&5ZZG]S.6RS]02P,$%     @ Q3.Y5BS[_2J[ @  >4D
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( ,4SN58\#;]1.P0  '(0   8
M          " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " #%,[E6O=28/18(  !V*P  &               @(%^#   >&PO=V]R
M:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ Q3.Y5G( J[,_!   F0\
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M965T-RYX;6Q02P$"% ,4    " #%,[E6>>#<2< %  #"&P  &
M    @(&Y0   >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @
MQ3.Y5HWVP:9] @  I 8  !@              ("!KT8  'AL+W=O<FMS:&5E
M=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( ,4SN5:+W^)*9R@  -:'   9
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M970Q-"YX;6Q02P$"% ,4    " #%,[E6"2G?:LT.   I4   &0
M    @('9JP  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (
M ,4SN58*1TLZ-@D  !P;   9              " @=VZ  !X;"]W;W)K<VAE
M971S+W-H965T,38N>&UL4$L! A0#%     @ Q3.Y5@<M-2U:$0  -D0  !D
M             ("!2L0  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"
M% ,4    " #%,[E6_A,=TK ,  #C*@  &0              @(';U0  >&PO
M=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( ,4SN59#U'#=Q!,
M "9    9              " @<+B  !X;"]W;W)K<VAE971S+W-H965T,3DN
M>&UL4$L! A0#%     @ Q3.Y5B:HN,F""@  @AL  !D              ("!
MO?8  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " #%,[E6
M#0&'..D-  ",+0  &0              @(%V 0$ >&PO=V]R:W-H965T<R]S
M:&5E=#(Q+GAM;%!+ 0(4 Q0    ( ,4SN59,310^60H  -8<   9
M      " @98/ 0!X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%
M  @ Q3.Y5J1[:P0=!@  %A(  !D              ("!)AH! 'AL+W=O<FMS
M:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " #%,[E60IOF3@D$  "H"0
M&0              @(%Z( $ >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+
M 0(4 Q0    ( ,4SN5;@*LLZT04  ( -   9              " @;HD 0!X
M;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ Q3.Y5NW-GWKT
M*0  XX8  !D              ("!PBH! 'AL+W=O<FMS:&5E=',O<VAE970R
M-BYX;6Q02P$"% ,4    " #%,[E6.JFT$D(4  #M10  &0
M@('M5 $ >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( ,4S
MN59:T\X4C%8  &]& 0 9              " @69I 0!X;"]W;W)K<VAE971S
M+W-H965T,C@N>&UL4$L! A0#%     @ Q3.Y5I=T!R=,"P  +R,  !D
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M=#,S+GAM;%!+ 0(4 Q0    ( ,4SN59KH.@P?0<  &(9   9
M  " @?#K 0!X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @
MQ3.Y5IUF(3V8!@  Y!(  !D              ("!I/,! 'AL+W=O<FMS:&5E
M=',O<VAE970S-2YX;6Q02P$"% ,4    " #%,[E64@W71TX/  #B/@  &0
M            @(%S^@$ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4
M Q0    ( ,4SN59 GP-<^04  "T1   9              " @?@) @!X;"]W
M;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ Q3.Y5H*#7_*\"0
M_2,  !D              ("!*! " 'AL+W=O<FMS:&5E=',O<VAE970S."YX
M;6Q02P$"% ,4    " #%,[E6S4]@J;(&   M$0  &0              @($;
M&@( >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( ,4SN5:_
M+.Y8,P@  (\8   9              " @00A @!X;"]W;W)K<VAE971S+W-H
M965T-# N>&UL4$L! A0#%     @ Q3.Y5I#?MYWT P  CPD  !D
M     ("!;BD" 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,4SN59C-[_8:A4  !D; 0 9              "
M@;U. @!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ Q3.Y
M5OU(!Z8= P  RPH  !D              ("!7F0" 'AL+W=O<FMS:&5E=',O
M<VAE970T-RYX;6Q02P$"% ,4    " #%,[E6O*Q5D5@#  ")"P  &0
M        @(&R9P( >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0
M   ( ,4SN5:$,!,(Z (   0(   9              " @4%K @!X;"]W;W)K
M<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ Q3.Y5HJH9K \!   UQ8
M !D              ("!8&X" 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q0
M2P$"% ,4    " #%,[E6B(1.%G0,  #-?   &0              @('3<@(
M>&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( ,4SN5;VXDLQ
MD (  #T'   9              " @7Y_ @!X;"]W;W)K<VAE971S+W-H965T
M-3(N>&UL4$L! A0#%     @ Q3.Y5FTJNHWQ @  \P<  !D
M ("!18(" 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " #%
M,[E6:^_9KB<%  "F)   &0              @(%MA0( >&PO=V]R:W-H965T
M<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( ,4SN59F=PQZQ (  .\(   9
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M970U.2YX;6Q02P$"% ,4    " #%,[E6B!3OA4L(   ].P  &0
M    @(';I0( >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    (
M ,4SN59QLX2/_ 0  . >   9              " @5VN @!X;"]W;W)K<VAE
M971S+W-H965T-C$N>&UL4$L! A0#%     @ Q3.Y5LY56G2)"P  !ET  !D
M             ("!D+," 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"
M% ,4    " #%,[E6D8H?E>D(   Q4P  &0              @(%0OP( >&PO
M=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( ,4SN59O'/(9J (
M !,'   9              " @7#( @!X;"]W;W)K<VAE971S+W-H965T-C0N
M>&UL4$L! A0#%     @ Q3.Y5JQTIF0""0  &ET  !D              ("!
M3\L" 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4    " #%,[E6
MC] +>X@"  #3!@  &0              @(&(U ( >&PO=V]R:W-H965T<R]S
M:&5E=#8V+GAM;%!+ 0(4 Q0    ( ,4SN584LVY/S@0  +T9   9
M      " @4?7 @!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%
M  @ Q3.Y5MQ29=:[ @  %P@  !D              ("!3-P" 'AL+W=O<FMS
M:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " #%,[E6")PVZ)$-  !8D0
M&0              @($^WP( >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+
M 0(4 Q0    ( ,4SN59%;[,8#0D  .I!   9              " @0;M @!X
M;"]W;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ Q3.Y5KZ7X;D!
M P  +0H  !D              ("!2O8" 'AL+W=O<FMS:&5E=',O<VAE970W
M,2YX;6Q02P$"% ,4    " #%,[E6;;$4B&$%  ##(@  &0
M@(&"^0( >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( ,4S
MN59]9$8G*0@  +E7   9              " @1K_ @!X;"]W;W)K<VAE971S
M+W-H965T-S,N>&UL4$L! A0#%     @ Q3.Y5OGWL_T7 P  NPL  !D
M         ("!>@<# 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q02P$"% ,4
M    " #%,[E6U(::58<%  #U)P  &0              @('("@, >&PO=V]R
M:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    ( ,4SN5;NC&*L70,   $0
M   9              " @880 P!X;"]W;W)K<VAE971S+W-H965T-S8N>&UL
M4$L! A0#%     @ Q3.Y5N0TR'8P"0  95   !D              ("!&A0#
M 'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6Q02P$"% ,4    " #%,[E6ZV##
MP8$"   H!@  &0              @(&!'0, >&PO=V]R:W-H965T<R]S:&5E
M=#<X+GAM;%!+ 0(4 Q0    ( ,4SN5;V2)@WR <  $A/   9
M  " @3D@ P!X;"]W;W)K<VAE971S+W-H965T-SDN>&UL4$L! A0#%     @
MQ3.Y5D50TX6E P  3PT  !D              ("!."@# 'AL+W=O<FMS:&5E
M=',O<VAE970X,"YX;6Q02P$"% ,4    " #%,[E6" Z%86L#  "@"P  &0
M            @($4+ , >&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4
M Q0    ( ,4SN5:Z0T,VM 0  .45   9              " @;8O P!X;"]W
M;W)K<VAE971S+W-H965T.#(N>&UL4$L! A0#%     @ Q3.Y5N]W8O72!
M@QP  !D              ("!H30# 'AL+W=O<FMS:&5E=',O<VAE970X,RYX
M;6Q02P$"% ,4    " #%,[E6D7)]=X #  # #P  &0              @(&J
M.0, >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+ 0(4 Q0    ( ,4SN58?
M,;CS: (  #<%   9              " @6$] P!X;"]W;W)K<VAE971S+W-H
M965T.#4N>&UL4$L! A0#%     @ Q3.Y5GQ7F%:5 P  [@\  !D
M     ("! $ # 'AL+W=O<FMS:&5E=',O<VAE970X-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,4SN5;[DHXMF@<  -<S   9              "
M@:-F P!X;"]W;W)K<VAE971S+W-H965T.3$N>&UL4$L! A0#%     @ Q3.Y
M5B>)%HL# P  ;PH  !D              ("!=&X# 'AL+W=O<FMS:&5E=',O
M<VAE970Y,BYX;6Q02P$"% ,4    " #%,[E6-J]QLCT#  !C#   &0
M        @(&N<0, >&PO=V]R:W-H965T<R]S:&5E=#DS+GAM;%!+ 0(4 Q0
M   ( ,4SN58)BVTBYP,  'H,   9              " @2)U P!X;"]W;W)K
M<VAE971S+W-H965T.30N>&UL4$L! A0#%     @ Q3.Y5@/2>9]K!@  KS<
M !D              ("!0'D# 'AL+W=O<FMS:&5E=',O<VAE970Y-2YX;6Q0
M2P$"% ,4    " #%,[E6HOX&()0#  !)"P  &0              @('B?P,
M>&PO=V]R:W-H965T<R]S:&5E=#DV+GAM;%!+ 0(4 Q0    ( ,4SN59P;T>6
MOAP  "D+ @ 9              " @:V# P!X;"]W;W)K<VAE971S+W-H965T
M.3<N>&UL4$L! A0#%     @ Q3.Y5HNX&2,= P  ^@H  !D
M ("!HJ # 'AL+W=O<FMS:&5E=',O<VAE970Y."YX;6Q02P$"% ,4    " #%
M,[E6+JZEMX<$  #^&0  &0              @('VHP, >&PO=V]R:W-H965T
M<R]S:&5E=#DY+GAM;%!+ 0(4 Q0    ( ,4SN5;^- F!&A$   4@ 0 :
M          " @;2H P!X;"]W;W)K<VAE971S+W-H965T,3 P+GAM;%!+ 0(4
M Q0    ( ,4SN5;<+#J39@4  -TD   :              " @0:Z P!X;"]W
M;W)K<VAE971S+W-H965T,3 Q+GAM;%!+ 0(4 Q0    ( ,4SN58"QYJR) 4
M %<8   :              " @:2_ P!X;"]W;W)K<VAE971S+W-H965T,3 R
M+GAM;%!+ 0(4 Q0    ( ,4SN58YO772/ ,   @*   :              "
M@0#% P!X;"]W;W)K<VAE971S+W-H965T,3 S+GAM;%!+ 0(4 Q0    ( ,4S
MN5:0(QE$\@(  .,)   :              " @73( P!X;"]W;W)K<VAE971S
M+W-H965T,3 T+GAM;%!+ 0(4 Q0    ( ,4SN5:<C',+\!4  ((B 0 :
M          " @9[+ P!X;"]W;W)K<VAE971S+W-H965T,3 U+GAM;%!+ 0(4
M Q0    ( ,4SN5;_F>\GW ,  +(0   :              " @<;A P!X;"]W
M;W)K<VAE971S+W-H965T,3 V+GAM;%!+ 0(4 Q0    ( ,4SN5:D:DYF\@(
M !@+   :              " @=KE P!X;"]W;W)K<VAE971S+W-H965T,3 W
M+GAM;%!+ 0(4 Q0    ( ,4SN5;X5A]^0P,  !\,   :              "
M@03I P!X;"]W;W)K<VAE971S+W-H965T,3 X+GAM;%!+ 0(4 Q0    ( ,4S
MN594U +$H ,  +$,   :              " @7_L P!X;"]W;W)K<VAE971S
M+W-H965T,3 Y+GAM;%!+ 0(4 Q0    ( ,4SN58C3-ZMQP0  (H4   :
M          " @5?P P!X;"]W;W)K<VAE971S+W-H965T,3$P+GAM;%!+ 0(4
M Q0    ( ,4SN5; [TF?20,  ,\*   :              " @5;U P!X;"]W
M;W)K<VAE971S+W-H965T,3$Q+GAM;%!+ 0(4 Q0    ( ,4SN5;%@I0-F@,
M -<+   :              " @=?X P!X;"]W;W)K<VAE971S+W-H965T,3$R
M+GAM;%!+ 0(4 Q0    ( ,4SN58I=6,[+ @  .I&   :              "
M@:G\ P!X;"]W;W)K<VAE971S+W-H965T,3$S+GAM;%!+ 0(4 Q0    ( ,4S
MN591LPW_D ,  -,+   :              " @0T%! !X;"]W;W)K<VAE971S
M+W-H965T,3$T+GAM;%!+ 0(4 Q0    ( ,4SN58=I5DM80@  )([   :
M          " @=4(! !X;"]W;W)K<VAE971S+W-H965T,3$U+GAM;%!+ 0(4
M Q0    ( ,4SN5;G&!OZ200  /H2   :              " @6X1! !X;"]W
M;W)K<VAE971S+W-H965T,3$V+GAM;%!+ 0(4 Q0    ( ,4SN5:4$3E4#@0
M )T;   :              " @>\5! !X;"]W;W)K<VAE971S+W-H965T,3$W
M+GAM;%!+ 0(4 Q0    ( ,4SN59'F:2^%P4  )<=   :              "
M@34:! !X;"]W;W)K<VAE971S+W-H965T,3$X+GAM;%!+ 0(4 Q0    ( ,4S
MN59ZPP77B@,  '(7   :              " @80?! !X;"]W;W)K<VAE971S
M+W-H965T,3$Y+GAM;%!+ 0(4 Q0    ( ,4SN5:V3;KVU ,  /P.   :
M          " @48C! !X;"]W;W)K<VAE971S+W-H965T,3(P+GAM;%!+ 0(4
M Q0    ( ,4SN59$,AA])0(   \%   :              " @5(G! !X;"]W
M;W)K<VAE971S+W-H965T,3(Q+GAM;%!+ 0(4 Q0    ( ,4SN59U UC?40T
M $AZ   :              " @:\I! !X;"]W;W)K<VAE971S+W-H965T,3(R
M+GAM;%!+ 0(4 Q0    ( ,4SN59?-,1?#P4  +$8   :              "
M@3@W! !X;"]W;W)K<VAE971S+W-H965T,3(S+GAM;%!+ 0(4 Q0    ( ,4S
MN59Z\/]U:0(  ((%   :              " @7\\! !X;"]W;W)K<VAE971S
M+W-H965T,3(T+GAM;%!+ 0(4 Q0    ( ,4SN5:O22R=O ,  (P2   :
M          " @2 _! !X;"]W;W)K<VAE971S+W-H965T,3(U+GAM;%!+ 0(4
M Q0    ( ,4SN5:^\+.LE0,  !L-   :              " @11#! !X;"]W
M;W)K<VAE971S+W-H965T,3(V+GAM;%!+ 0(4 Q0    ( ,4SN59>7FT(\PH
M %&.   :              " @>%&! !X;"]W;W)K<VAE971S+W-H965T,3(W
M+GAM;%!+ 0(4 Q0    ( ,4SN59K"JZ@<0D  ,51   :              "
M@0Q2! !X;"]W;W)K<VAE971S+W-H965T,3(X+GAM;%!+ 0(4 Q0    ( ,4S
MN59VJHTHYP(  %4*   :              " @;5;! !X;"]W;W)K<VAE971S
M+W-H965T,3(Y+GAM;%!+ 0(4 Q0    ( ,4SN5:ED1>W(0@  "DW   :
M          " @=1>! !X;"]W;W)K<VAE971S+W-H965T,3,P+GAM;%!+ 0(4
M Q0    ( ,4SN59J5ZLU@@8  ,8C   :              " @2UG! !X;"]W
M;W)K<VAE971S+W-H965T,3,Q+GAM;%!+ 0(4 Q0    ( ,4SN5;"V*K\4P,
M *X5   -              "  >=M! !X;"]S='EL97,N>&UL4$L! A0#%
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K! !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    "+ (L 9"8  ->!!     $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1080</ContextCount>
  <ElementCount>782</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>246</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>15</UnitCount>
  <MyReports>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Statements of Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity</Role>
      <ShortName>Consolidated Statements of Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Consolidated Statements of Shareholders' Equity (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals</Role>
      <ShortName>Consolidated Statements of Shareholders' Equity (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - Consolidated Statements of Cash Flows (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlowsParenthetical</Role>
      <ShortName>Consolidated Statements of Cash Flows (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Acquisitions, Divestitures and Asset Sales</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSales</Role>
      <ShortName>Acquisitions, Divestitures and Asset Sales</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Fair Value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValue</Role>
      <ShortName>Fair Value</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Goodwill and Other Intangibles</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/GoodwillandOtherIntangibles</Role>
      <ShortName>Goodwill and Other Intangibles</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Health Care Costs Payable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayable</Role>
      <ShortName>Health Care Costs Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Other Insurance Liabilities and Separate Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccounts</Role>
      <ShortName>Other Insurance Liabilities and Separate Accounts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Borrowings and Credit Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsandCreditAgreements</Role>
      <ShortName>Borrowings and Credit Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Pension Plans and Other Postretirement Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Stock Incentive Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/StockIncentivePlans</Role>
      <ShortName>Stock Incentive Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Other Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncomeLoss</Role>
      <ShortName>Other Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Reinsurance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/Reinsurance</Role>
      <ShortName>Reinsurance</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Acquisitions, Divestitures and Asset Sales (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesTables</Role>
      <ShortName>Acquisitions, Divestitures and Asset Sales (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSales</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/Investments</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Fair Value (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueTables</Role>
      <ShortName>Fair Value (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/FairValue</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Goodwill and Other Intangibles (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables</Role>
      <ShortName>Goodwill and Other Intangibles (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/GoodwillandOtherIntangibles</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/Leases</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Health Care Costs Payable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableTables</Role>
      <ShortName>Health Care Costs Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/HealthCareCostsPayable</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Other Insurance Liabilities and Separate Accounts (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsTables</Role>
      <ShortName>Other Insurance Liabilities and Separate Accounts (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccounts</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Borrowings and Credit Agreements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsandCreditAgreementsTables</Role>
      <ShortName>Borrowings and Credit Agreements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/BorrowingsandCreditAgreements</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Pension Plans and Other Postretirement Benefits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/IncomeTaxes</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Stock Incentive Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/StockIncentivePlansTables</Role>
      <ShortName>Stock Incentive Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/StockIncentivePlans</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/ShareholdersEquity</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Other Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncomeTables</Role>
      <ShortName>Other Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/OtherComprehensiveIncomeLoss</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/EarningsPerShare</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Reinsurance (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ReinsuranceTables</Role>
      <ShortName>Reinsurance (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/Reinsurance</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SegmentReporting</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails</Role>
      <ShortName>Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails</Role>
      <ShortName>Significant Accounting Policies - Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Significant Accounting Policies - Deferred Acquisition Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesDeferredAcquisitionCostsDetails</Role>
      <ShortName>Significant Accounting Policies - Deferred Acquisition Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Significant Accounting Policies - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails</Role>
      <ShortName>Significant Accounting Policies - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails</Role>
      <ShortName>Significant Accounting Policies - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Significant Accounting Policies - Receivables and Contracted Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails</Role>
      <ShortName>Significant Accounting Policies - Receivables and Contracted Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Significant Accounting Policies - Contract Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails</Role>
      <ShortName>Significant Accounting Policies - Contract Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Significant Accounting Policies - Variable Interest Entities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails</Role>
      <ShortName>Significant Accounting Policies - Variable Interest Entities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Significant Accounting Policies - Discontinued Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails</Role>
      <ShortName>Significant Accounting Policies - Discontinued Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Acquisitions, Divestitures and Asset Sales - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails</Role>
      <ShortName>Acquisitions, Divestitures and Asset Sales - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Acquisitions, Divestitures and Asset Sales - Summary of Assets and Liabilities Held for Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails</Role>
      <ShortName>Acquisitions, Divestitures and Asset Sales - Summary of Assets and Liabilities Held for Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Investments - Schedule of Total Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails</Role>
      <ShortName>Investments - Schedule of Total Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Investments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsNarrativeDetails</Role>
      <ShortName>Investments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Investments - Debt Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails</Role>
      <ShortName>Investments - Debt Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Investments - Debt Securities by Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails</Role>
      <ShortName>Investments - Debt Securities by Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Investments - Unrealized Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails</Role>
      <ShortName>Investments - Unrealized Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails</Role>
      <ShortName>Investments - Unrealized Loss Position Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Investments - Mortgage Loans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails</Role>
      <ShortName>Investments - Mortgage Loans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails</Role>
      <ShortName>Investments - Mortgage Loans Credit Ratings Indicator (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Investments - Mortgage Loan Principal Repayments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails</Role>
      <ShortName>Investments - Mortgage Loan Principal Repayments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Investments - Net Investment Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails</Role>
      <ShortName>Investments - Net Investment Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Investments - Realized Gains (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails</Role>
      <ShortName>Investments - Realized Gains (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Fair Value - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails</Role>
      <ShortName>Fair Value - Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Fair Value - Changes in Level 3 Financial Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails</Role>
      <ShortName>Fair Value - Changes in Level 3 Financial Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Fair Value - Gross Transfers Into (Out Of) Level 3 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details</Role>
      <ShortName>Fair Value - Gross Transfers Into (Out Of) Level 3 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails</Role>
      <ShortName>Fair Value - Carrying Value and Fair Value Classified by Level (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails</Role>
      <ShortName>Fair Value - Separate Accounts Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Fair Value - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueNarrativeDetails</Role>
      <ShortName>Fair Value - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Goodwill and Other Intangibles - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails</Role>
      <ShortName>Goodwill and Other Intangibles - Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Goodwill and Other Intangibles - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails</Role>
      <ShortName>Goodwill and Other Intangibles - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Goodwill and Other Intangibles - Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangibles - Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Goodwill and Other Acquired Intangibles - Future Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails</Role>
      <ShortName>Goodwill and Other Acquired Intangibles - Future Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - Leases - Summary of the Components of Net Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails</Role>
      <ShortName>Leases - Summary of the Components of Net Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - Leases - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails</Role>
      <ShortName>Leases - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Leases - Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - Leases - Maturities of Operating and Finance Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturities of Operating and Finance Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - Health Care Costs Payable - Incurred and Paid Health Care Claims Development (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails</Role>
      <ShortName>Health Care Costs Payable - Incurred and Paid Health Care Claims Development (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0000085 - Disclosure - Health Care Costs Payable - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails</Role>
      <ShortName>Health Care Costs Payable - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0000086 - Disclosure - Health Care Costs Payable - Liability for Unpaid Claims and Claims Adjustment Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails</Role>
      <ShortName>Health Care Costs Payable - Liability for Unpaid Claims and Claims Adjustment Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>0000087 - Disclosure - Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails</Role>
      <ShortName>Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>0000088 - Disclosure - Other Insurance Liabilities and Separate Accounts - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails</Role>
      <ShortName>Other Insurance Liabilities and Separate Accounts - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>0000089 - Disclosure - Other Insurance Liabilities and Separate Accounts - Changes in Balances of Long-Duration Insurance Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails</Role>
      <ShortName>Other Insurance Liabilities and Separate Accounts - Changes in Balances of Long-Duration Insurance Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>0000090 - Disclosure - Other Insurance Liabilities and Separate Accounts - Adjustments Resulting From Applying New Accounting Standard (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails</Role>
      <ShortName>Other Insurance Liabilities and Separate Accounts - Adjustments Resulting From Applying New Accounting Standard (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>0000091 - Disclosure - Other Insurance Liabilities and Separate Accounts - Changes in Liability for Future Policy Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails</Role>
      <ShortName>Other Insurance Liabilities and Separate Accounts - Changes in Liability for Future Policy Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>0000092 - Disclosure - Other Insurance Liabilities and Separate Accounts - Undiscounted Expected Gross Premiums and Expected Future Benefit Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails</Role>
      <ShortName>Other Insurance Liabilities and Separate Accounts - Undiscounted Expected Gross Premiums and Expected Future Benefit Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>0000093 - Disclosure - Other Insurance Liabilities and Separate Accounts - Weighted-average Interest Rates and Durations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails</Role>
      <ShortName>Other Insurance Liabilities and Separate Accounts - Weighted-average Interest Rates and Durations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>0000094 - Disclosure - Other Insurance Liabilities and Separate Accounts - Roll Forward of Policyholders' Funds (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails</Role>
      <ShortName>Other Insurance Liabilities and Separate Accounts - Roll Forward of Policyholders' Funds (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>0000095 - Disclosure - Other Insurance Liabilities and Separate Accounts - Separate Account Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails</Role>
      <ShortName>Other Insurance Liabilities and Separate Accounts - Separate Account Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>0000096 - Disclosure - Other Insurance Liabilities and Separate Accounts - Roll Forward of Separate Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails</Role>
      <ShortName>Other Insurance Liabilities and Separate Accounts - Roll Forward of Separate Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>0000097 - Disclosure - Borrowings and Credit Agreements - Schedule of Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails</Role>
      <ShortName>Borrowings and Credit Agreements - Schedule of Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>0000098 - Disclosure - Borrowings and Credit Agreements - Debt Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails</Role>
      <ShortName>Borrowings and Credit Agreements - Debt Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>0000099 - Disclosure - Borrowings and Credit Agreements - Short-term Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails</Role>
      <ShortName>Borrowings and Credit Agreements - Short-term Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>0000100 - Disclosure - Borrowings and Credit Agreements - Long-term Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails</Role>
      <ShortName>Borrowings and Credit Agreements - Long-term Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>0000101 - Disclosure - Pension Plans and Other Postretirement Benefits - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>0000102 - Disclosure - Pension Plans and Other Postretirement Benefits - Benefit Obligations and Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits - Benefit Obligations and Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>0000103 - Disclosure - Pension Plans and Other Postretirement Benefits - Net Periodic Benefit Cost (Income) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits - Net Periodic Benefit Cost (Income) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>0000104 - Disclosure - Pension Plans and Other Postretirement Benefits - Weighted Average Assumptions Used (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits - Weighted Average Assumptions Used (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>0000105 - Disclosure - Pension Plans and Other Postretirement Benefits - Fair Value of Pension Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits - Fair Value of Pension Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>0000106 - Disclosure - Pension Plans and Other Postretirement Benefits - Changes in Level 3 Pension Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits - Changes in Level 3 Pension Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>0000107 - Disclosure - Pension Plans and Other Postretirement Benefits - Defined Benefit Plans Expected Benefit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits - Defined Benefit Plans Expected Benefit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>0000108 - Disclosure - Income Taxes - Income Tax Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails</Role>
      <ShortName>Income Taxes - Income Tax Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>0000109 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails</Role>
      <ShortName>Income Taxes - Effective Tax Rate Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>0000110 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>0000111 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>0000112 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>0000113 - Disclosure - Stock Incentive Plans - Stock-Based Compensation Expense and ESPP (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails</Role>
      <ShortName>Stock Incentive Plans - Stock-Based Compensation Expense and ESPP (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>0000114 - Disclosure - Stock Incentive Plans - Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails</Role>
      <ShortName>Stock Incentive Plans - Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>114</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>0000115 - Disclosure - Stock Incentive Plans - Stock Option and SAR Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails</Role>
      <ShortName>Stock Incentive Plans - Stock Option and SAR Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>115</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>0000116 - Disclosure - Stock Incentive Plans - Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/StockIncentivePlansValuationAssumptionsDetails</Role>
      <ShortName>Stock Incentive Plans - Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>116</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>0000117 - Disclosure - Shareholders' Equity - Share Repurchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails</Role>
      <ShortName>Shareholders' Equity - Share Repurchases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>117</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>0000118 - Disclosure - Shareholders' Equity - Accelerated Share Repurchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails</Role>
      <ShortName>Shareholders' Equity - Accelerated Share Repurchases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>118</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>0000119 - Disclosure - Shareholders' Equity - Dividends (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails</Role>
      <ShortName>Shareholders' Equity - Dividends (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>119</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>0000120 - Disclosure - Shareholders' Equity - Regulatory Requirements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails</Role>
      <ShortName>Shareholders' Equity - Regulatory Requirements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>120</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R121.htm</HtmlFileName>
      <LongName>0000121 - Disclosure - Shareholders' Equity - Noncontrolling Interests (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityNoncontrollingInterestsDetails</Role>
      <ShortName>Shareholders' Equity - Noncontrolling Interests (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>121</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R122.htm</HtmlFileName>
      <LongName>0000122 - Disclosure - Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/OtherComprehensiveIncomeTables</ParentRole>
      <Position>122</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R123.htm</HtmlFileName>
      <LongName>0000123 - Disclosure - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/EarningsPerShareTables</ParentRole>
      <Position>123</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R124.htm</HtmlFileName>
      <LongName>0000124 - Disclosure - Reinsurance - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ReinsuranceNarrativeDetails</Role>
      <ShortName>Reinsurance - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>124</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R125.htm</HtmlFileName>
      <LongName>0000125 - Disclosure - Reinsurance - Reinsurance Recoverables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails</Role>
      <ShortName>Reinsurance - Reinsurance Recoverables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>125</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R126.htm</HtmlFileName>
      <LongName>0000126 - Disclosure - Reinsurance - Effects of Reinsurance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails</Role>
      <ShortName>Reinsurance - Effects of Reinsurance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>126</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R127.htm</HtmlFileName>
      <LongName>0000127 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/CommitmentsandContingencies</ParentRole>
      <Position>127</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R128.htm</HtmlFileName>
      <LongName>0000128 - Disclosure - Segment Reporting - Retrospective Adjustments to Segment Composition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails</Role>
      <ShortName>Segment Reporting - Retrospective Adjustments to Segment Composition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>128</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R129.htm</HtmlFileName>
      <LongName>0000129 - Disclosure - Segment Reporting - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingNarrativeDetails</Role>
      <ShortName>Segment Reporting - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>129</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R130.htm</HtmlFileName>
      <LongName>0000130 - Disclosure - Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails</Role>
      <ShortName>Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>130</Position>
    </Report>
    <Report instance="cvs-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R131.htm</HtmlFileName>
      <LongName>0000131 - Disclosure - Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails</Role>
      <ShortName>Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>131</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept TreasuryStockShares in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. cvs-20230525_d2.htm 4</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty in us-gaap/2022 used in 3 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. cvs-20230525_d2.htm 4</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty in us-gaap/2022 used in 3 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. cvs-20230525_d2.htm 4</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 4 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 -  cvs-20230525.htm 4</Log>
    <Log type="Warning">[dqc-0005-Context-Dates-After-Period-End-Date] The date of 2023-01-04 used for SharePrice with a value of 92.190000 and the SubsequentEventTypeAxis is earlier than or the same as the reporting period end date 2023-05-25.  The properties of this SharePrice fact are Context: i84ac2198cd22435ba1570e2db00d59e9_I20230104, Unit: usdPerShare, Rule Element Id: 48. cvs-20230525_d2.htm 4</Log>
    <Log type="Warning">[dqc-0005-Context-Dates-After-Period-End-Date] The date of 2023-02-07 used for BusinessAcquisitionSharePrice with a value of 39.000000 and the SubsequentEventTypeAxis is earlier than or the same as the reporting period end date 2023-05-25.  The properties of this BusinessAcquisitionSharePrice fact are Context: i8941690cb4944d199bf33e6da1cee933_I20230207, Unit: usdPerShare, Rule Element Id: 48. cvs-20230525_d2.htm 4</Log>
    <Log type="Warning">[dqc-0005-Context-Dates-After-Period-End-Date] The date of 2023-01-04 used for AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram with a value of 0.200000 and the SubsequentEventTypeAxis is earlier than or the same as the reporting period end date 2023-05-25.  The properties of this AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram fact are Context: i84ac2198cd22435ba1570e2db00d59e9_I20230104, Unit: number, Rule Element Id: 48. cvs-20230525_d2.htm 4</Log>
    <Log type="Warning">[dqc-0005-Context-Dates-After-Period-End-Date] The date of 2023-02-07 used for BusinessCombinationTerminationFee with a value of 500000000.000000 and the SubsequentEventTypeAxis is earlier than or the same as the reporting period end date 2023-05-25.  The properties of this BusinessCombinationTerminationFee fact are Context: i8941690cb4944d199bf33e6da1cee933_I20230207, Unit: usd, Rule Element Id: 48. cvs-20230525_d2.htm 4</Log>
    <Log type="Warning">[dqc-0005-Context-Dates-After-Period-End-Date] The date of 2023-01-04 used for AcceleratedShareRepurchasesAgreementAmount with a value of 2000000000.000000 and the SubsequentEventTypeAxis is earlier than or the same as the reporting period end date 2023-05-25.  The properties of this AcceleratedShareRepurchasesAgreementAmount fact are Context: i84ac2198cd22435ba1570e2db00d59e9_I20230104, Unit: usd, Rule Element Id: 48. cvs-20230525_d2.htm 4</Log>
    <Log type="Warning">[dqc-0005-Context-Dates-After-Period-End-Date] The date of 2023-01-31 used for NumberofReinsuranceContractsEnteredInto with a value of 2 and the SubsequentEventTypeAxis is earlier than or the same as the reporting period end date 2023-05-25.  The properties of this NumberofReinsuranceContractsEnteredInto fact are Context: if8b5128a2a36428d980c81abdc2d74c7_D20230101-20230131, Unit: reinsurance_agreement, Rule Element Id: 48. cvs-20230525_d2.htm 4</Log>
    <Log type="Warning">[dqc-0005-Context-Dates-After-Period-End-Date] The date of 2023-01-04 used for AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares with a value of 0.800000 and the SubsequentEventTypeAxis is earlier than or the same as the reporting period end date 2023-05-25.  The properties of this AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares fact are Context: i84ac2198cd22435ba1570e2db00d59e9_I20230104, Unit: number, Rule Element Id: 48. cvs-20230525_d2.htm 4</Log>
    <Log type="Warning">[dqc-0005-Context-Dates-After-Period-End-Date] The date of 2023-01-04 used for AcceleratedShareRepurchasesAgreementAmount with a value of 2000000000.000000 and the SubsequentEventTypeAxis is earlier than or the same as the reporting period end date 2023-05-25.  The properties of this AcceleratedShareRepurchasesAgreementAmount fact are Context: i84ac2198cd22435ba1570e2db00d59e9_I20230104, Unit: usd, Rule Element Id: 48. cvs-20230525_d2.htm 4</Log>
    <Log type="Warning">[dqc-0005-Context-Dates-After-Period-End-Date] The date of 2023-01-04 used for AcceleratedShareRepurchaseProgramMaximumNumberOfShares with a value of 43400000.000000 and the SubsequentEventTypeAxis is earlier than or the same as the reporting period end date 2023-05-25.  The properties of this AcceleratedShareRepurchaseProgramMaximumNumberOfShares fact are Context: i84ac2198cd22435ba1570e2db00d59e9_I20230104, Unit: shares, Rule Element Id: 48. cvs-20230525_d2.htm 4</Log>
    <Log type="Warning">[dqc-0005-Context-Dates-After-Period-End-Date] The date of 2023-02-07 used for BusinessCombinationConsiderationTransferred1 with a value of 10600000000.000000 and the SubsequentEventTypeAxis is earlier than or the same as the reporting period end date 2023-05-25.  The properties of this BusinessCombinationConsiderationTransferred1 fact are Context: ieaa2442b4a1b43c1a1e9635e5d302668_D20230207-20230207, Unit: usd, Rule Element Id: 48. cvs-20230525_d2.htm 4</Log>
    <Log type="Warning">[dqc-0005-Context-Dates-After-Period-End-Date] The date of 2023-02-07 used for BusinessCombinationTerminationFee with a value of 300000000.000000 and the SubsequentEventTypeAxis is earlier than or the same as the reporting period end date 2023-05-25.  The properties of this BusinessCombinationTerminationFee fact are Context: icc5a99c2de364d84899668bcf7f91a6d_I20230207, Unit: usd, Rule Element Id: 48. cvs-20230525_d2.htm 4</Log>
    <Log type="Warning">[dqc-0005-Context-Dates-After-Period-End-Date] The date of 2023-01-04 used for PaymentsForAcceleratedShareRepurchasesAmount with a value of 2000000000.000000 and the SubsequentEventTypeAxis is earlier than or the same as the reporting period end date 2023-05-25.  The properties of this PaymentsForAcceleratedShareRepurchasesAmount fact are Context: i25c547443c724d349e0e7af7c9e93168_D20230104-20230104, Unit: usd, Rule Element Id: 48. cvs-20230525_d2.htm 4</Log>
    <Log type="Warning">[dqc-0005-Context-Dates-After-Period-End-Date] The date of 2023-01-04 used for AcceleratedShareRepurchasesAgreementAmount with a value of 2000000000.000000 and the SubsequentEventTypeAxis is earlier than or the same as the reporting period end date 2023-05-25.  The properties of this AcceleratedShareRepurchasesAgreementAmount fact are Context: i84ac2198cd22435ba1570e2db00d59e9_I20230104, Unit: usd, Rule Element Id: 48. cvs-20230525_d2.htm 4</Log>
    <Log type="Warning">[dqc-0005-Context-Dates-After-Period-End-Date] The date of 2023-01-31 used for FourYearsReinsuranceAgreementWithUnrelatedInsurer with a value of P4Y and the SubsequentEventTypeAxis is earlier than or the same as the reporting period end date 2023-05-25.  The properties of this FourYearsReinsuranceAgreementWithUnrelatedInsurer fact are Context: if8b5128a2a36428d980c81abdc2d74c7_D20230101-20230131, Unit: (none), Rule Element Id: 48. cvs-20230525_d2.htm 4</Log>
    <Log type="Warning">[dqc-0005-Context-Dates-After-Period-End-Date] The date of 2023-01-04 used for AcceleratedShareRepurchasesNumberOfSharesRepurchased with a value of 17400000.000000 and the SubsequentEventTypeAxis is earlier than or the same as the reporting period end date 2023-05-25.  The properties of this AcceleratedShareRepurchasesNumberOfSharesRepurchased fact are Context: i84ac2198cd22435ba1570e2db00d59e9_I20230104, Unit: shares, Rule Element Id: 48. cvs-20230525_d2.htm 4</Log>
    <Log type="Warning">[dqc-0005-Context-Dates-After-Period-End-Date] The date of 2023-01-01 used for DividendsPayableAmountPerShare with a value of 0.605000 and the StatementScenarioAxis member ScenarioForecastMember is earlier than or the same as the reporting period end date 2023-05-25.  The properties of this DividendsPayableAmountPerShare fact are Context: i500357364f0b4a8aa0660969b4e7e47e_I20230101, Unit: usdPerShare, Rule Element Id: 49. cvs-20230525_d2.htm 4</Log>
    <Log type="Warning">[dqc-0005-Context-Dates-After-Period-End-Date] The date of 2023-01-31 used for IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates with a value of 4 and the StatementScenarioAxis member ScenarioForecastMember is earlier than or the same as the reporting period end date 2023-05-25.  The properties of this IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates fact are Context: ie19a1ad3f0604084922f302641035795_D20230101-20230131, Unit: state, Rule Element Id: 49. cvs-20230525_d2.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="cvs-20230525.htm">cvs-20230525.htm</File>
    <File doctype="8-K" original="cvs-20230525_d2.htm">cvs-20230525_d2.htm</File>
    <File>cvs-20230525.xsd</File>
    <File>cvs-20230525_cal.xml</File>
    <File>cvs-20230525_def.xml</File>
    <File>cvs-20230525_lab.xml</File>
    <File>cvs-20230525_pre.xml</File>
    <File>exhibit231-2022restated.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>cvs-20230525_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2022</BaseTaxonomy>
    <BaseTaxonomy items="3060">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>148
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cvs-20230525.htm cvs-20230525_d2.htm": {
   "axisCustom": 2,
   "axisStandard": 48,
   "baseTaxonomies": {
    "http://fasb.org/srt/2022": 1,
    "http://fasb.org/us-gaap/2022": 3060,
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1080,
   "dts": {
    "calculationLink": {
     "local": [
      "cvs-20230525_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cvs-20230525_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cvs-20230525.htm",
      "cvs-20230525_d2.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cvs-20230525_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cvs-20230525_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cvs-20230525.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 1291,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 11,
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 13
   },
   "keyCustom": 139,
   "keyStandard": 643,
   "memberCustom": 126,
   "memberStandard": 103,
   "nsprefix": "cvs",
   "nsuri": "http://www.cvshealth.com/20230525",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525.htm",
      "contextRef": "i3fdad821325f486399d0038fd579bc16_D20230525-20230525",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.cvshealth.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525.htm",
      "contextRef": "i3fdad821325f486399d0038fd579bc16_D20230525-20230525",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RepaymentsOfLongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000100 - Disclosure - Borrowings and Credit Agreements - Long-term Borrowings (Details)",
     "menuCat": "Details",
     "order": "100",
     "role": "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
     "shortName": "Borrowings and Credit Agreements - Long-term Borrowings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "ifde94c7f37464b33b3e1498967849d4c_D20210818-20210818",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDebtNetOfIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000101 - Disclosure - Pension Plans and Other Postretirement Benefits - Narrative (Details)",
     "menuCat": "Details",
     "order": "101",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
     "shortName": "Pension Plans and Other Postretirement Benefits - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i6ae60f8a88824bf889f05cc3b51730b3_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000102 - Disclosure - Pension Plans and Other Postretirement Benefits - Benefit Obligations and Plan Assets (Details)",
     "menuCat": "Details",
     "order": "102",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
     "shortName": "Pension Plans and Other Postretirement Benefits - Benefit Obligations and Plan Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActuarialGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanInterestCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000103 - Disclosure - Pension Plans and Other Postretirement Benefits - Net Periodic Benefit Cost (Income) (Details)",
     "menuCat": "Details",
     "order": "103",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails",
     "shortName": "Pension Plans and Other Postretirement Benefits - Net Periodic Benefit Cost (Income) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "iafd79fc959e44536924c6a9df3de3ae1_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000104 - Disclosure - Pension Plans and Other Postretirement Benefits - Weighted Average Assumptions Used (Details)",
     "menuCat": "Details",
     "order": "104",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails",
     "shortName": "Pension Plans and Other Postretirement Benefits - Weighted Average Assumptions Used (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i386090869fc94797bcda9d9bd6beaaf4_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000105 - Disclosure - Pension Plans and Other Postretirement Benefits - Fair Value of Pension Plan Assets (Details)",
     "menuCat": "Details",
     "order": "105",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
     "shortName": "Pension Plans and Other Postretirement Benefits - Fair Value of Pension Plan Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i5f6a83783837419fbce160a80bfc2d32_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i6ae60f8a88824bf889f05cc3b51730b3_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000106 - Disclosure - Pension Plans and Other Postretirement Benefits - Changes in Level 3 Pension Plan Assets (Details)",
     "menuCat": "Details",
     "order": "106",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
     "shortName": "Pension Plans and Other Postretirement Benefits - Changes in Level 3 Pension Plan Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DefinedBenefitPlanPlanAssetsCategoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "ic928117af54f4c0892def0fc4bb4ca6f_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i386090869fc94797bcda9d9bd6beaaf4_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000107 - Disclosure - Pension Plans and Other Postretirement Benefits - Defined Benefit Plans Expected Benefit (Details)",
     "menuCat": "Details",
     "order": "107",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails",
     "shortName": "Pension Plans and Other Postretirement Benefits - Defined Benefit Plans Expected Benefit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i386090869fc94797bcda9d9bd6beaaf4_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000108 - Disclosure - Income Taxes - Income Tax Provision (Details)",
     "menuCat": "Details",
     "order": "108",
     "role": "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails",
     "shortName": "Income Taxes - Income Tax Provision (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000109 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details)",
     "menuCat": "Details",
     "order": "109",
     "role": "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails",
     "shortName": "Income Taxes - Effective Tax Rate Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Acquisitions, Divestitures and Asset Sales",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSales",
     "shortName": "Acquisitions, Divestitures and Asset Sales",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000110 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "110",
     "role": "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000111 - Disclosure - Income Taxes - Narrative (Details)",
     "menuCat": "Details",
     "order": "111",
     "role": "http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i69eed5106b194cac81e8857cca41692b_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000112 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)",
     "menuCat": "Details",
     "order": "112",
     "role": "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i68e253af6bf3467aade09b572c1b73a6_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000113 - Disclosure - Stock Incentive Plans - Stock-Based Compensation Expense and ESPP (Details)",
     "menuCat": "Details",
     "order": "113",
     "role": "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
     "shortName": "Stock Incentive Plans - Stock-Based Compensation Expense and ESPP (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i84d934c3f64d4e02a86157aaa7bdff55_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000114 - Disclosure - Stock Incentive Plans - Restricted Stock Activity (Details)",
     "menuCat": "Details",
     "order": "114",
     "role": "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails",
     "shortName": "Stock Incentive Plans - Restricted Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i84d934c3f64d4e02a86157aaa7bdff55_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R115": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromStockOptionsExercised",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000115 - Disclosure - Stock Incentive Plans - Stock Option and SAR Activity (Details)",
     "menuCat": "Details",
     "order": "115",
     "role": "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails",
     "shortName": "Stock Incentive Plans - Stock Option and SAR Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "ib929cd58d3cb4a4096643aeea5fb40bb_D20220101-20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R116": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i5c6c53ae9a7745a09f19b70ba79aa0c2_D20220101-20221231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000116 - Disclosure - Stock Incentive Plans - Valuation Assumptions (Details)",
     "menuCat": "Details",
     "order": "116",
     "role": "http://www.cvshealth.com/role/StockIncentivePlansValuationAssumptionsDetails",
     "shortName": "Stock Incentive Plans - Valuation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i5c6c53ae9a7745a09f19b70ba79aa0c2_D20220101-20221231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R117": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000117 - Disclosure - Shareholders' Equity - Share Repurchases (Details)",
     "menuCat": "Details",
     "order": "117",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails",
     "shortName": "Shareholders' Equity - Share Repurchases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i6ef83537787945f98e2064fc26ab7c59_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R118": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i84ac2198cd22435ba1570e2db00d59e9_I20230104",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "cvs:AcceleratedShareRepurchasesAgreementAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000118 - Disclosure - Shareholders' Equity - Accelerated Share Repurchases (Details)",
     "menuCat": "Details",
     "order": "118",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails",
     "shortName": "Shareholders' Equity - Accelerated Share Repurchases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i84ac2198cd22435ba1570e2db00d59e9_I20230104",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "cvs:AcceleratedShareRepurchasesAgreementAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R119": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DividendsPayableAmountPerShare",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendsPayableAmountPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000119 - Disclosure - Shareholders' Equity - Dividends (Details)",
     "menuCat": "Details",
     "order": "119",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails",
     "shortName": "Shareholders' Equity - Dividends (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DividendsPayableAmountPerShare",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendsPayableAmountPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Investments",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.cvshealth.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R120": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000120 - Disclosure - Shareholders' Equity - Regulatory Requirements (Details)",
     "menuCat": "Details",
     "order": "120",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails",
     "shortName": "Shareholders' Equity - Regulatory Requirements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R121": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000121 - Disclosure - Shareholders' Equity - Noncontrolling Interests (Details)",
     "menuCat": "Details",
     "order": "121",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityNoncontrollingInterestsDetails",
     "shortName": "Shareholders' Equity - Noncontrolling Interests (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R122": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i69eed5106b194cac81e8857cca41692b_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000122 - Disclosure - Other Comprehensive Income (Loss) (Details)",
     "menuCat": "Details",
     "order": "122",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails",
     "shortName": "Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i88fc675ce48b4c548ef81361fcc6c9d6_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R123": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000123 - Disclosure - Earnings Per Share (Details)",
     "menuCat": "Details",
     "order": "123",
     "role": "http://www.cvshealth.com/role/EarningsPerShareDetails",
     "shortName": "Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R124": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "if8b5128a2a36428d980c81abdc2d74c7_D20230101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cvs:FourYearsReinsuranceAgreementWithUnrelatedInsurer",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000124 - Disclosure - Reinsurance - Narrative (Details)",
     "menuCat": "Details",
     "order": "124",
     "role": "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails",
     "shortName": "Reinsurance - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "if8b5128a2a36428d980c81abdc2d74c7_D20230101-20230131",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cvs:FourYearsReinsuranceAgreementWithUnrelatedInsurer",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R125": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000125 - Disclosure - Reinsurance - Reinsurance Recoverables (Details)",
     "menuCat": "Details",
     "order": "125",
     "role": "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails",
     "shortName": "Reinsurance - Reinsurance Recoverables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R126": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DirectPremiumsEarned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000126 - Disclosure - Reinsurance - Effects of Reinsurance (Details)",
     "menuCat": "Details",
     "order": "126",
     "role": "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails",
     "shortName": "Reinsurance - Effects of Reinsurance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DirectPremiumsEarned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R127": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GuaranteeObligationsMaximumExposure",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000127 - Disclosure - Commitments and Contingencies (Details)",
     "menuCat": "Details",
     "order": "127",
     "role": "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i69eed5106b194cac81e8857cca41692b_I20211231",
      "decimals": "-8",
      "lang": "en-US",
      "name": "cvs:ContractualObligationsToMaintainLevelsOfSeparateAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R128": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000128 - Disclosure - Segment Reporting - Retrospective Adjustments to Segment Composition (Details)",
     "menuCat": "Details",
     "order": "128",
     "role": "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
     "shortName": "Segment Reporting - Retrospective Adjustments to Segment Composition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R129": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000129 - Disclosure - Segment Reporting - Narrative (Details)",
     "menuCat": "Details",
     "order": "129",
     "role": "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails",
     "shortName": "Segment Reporting - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Fair Value",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.cvshealth.com/role/FairValue",
     "shortName": "Fair Value",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R130": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000130 - Disclosure - Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)",
     "menuCat": "Details",
     "order": "130",
     "role": "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
     "shortName": "Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i2a07c8633b37492ba109c7cd9a92299a_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R131": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000131 - Disclosure - Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)",
     "menuCat": "Details",
     "order": "131",
     "role": "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
     "shortName": "Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationIntegrationRelatedCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Goodwill and Other Intangibles",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.cvshealth.com/role/GoodwillandOtherIntangibles",
     "shortName": "Goodwill and Other Intangibles",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.cvshealth.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Health Care Costs Payable",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayable",
     "shortName": "Health Care Costs Payable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InsuranceContractAcquisitionCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Other Insurance Liabilities and Separate Accounts",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccounts",
     "shortName": "Other Insurance Liabilities and Separate Accounts",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InsuranceContractAcquisitionCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Borrowings and Credit Agreements",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.cvshealth.com/role/BorrowingsandCreditAgreements",
     "shortName": "Borrowings and Credit Agreements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Pension Plans and Other Postretirement Benefits",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits",
     "shortName": "Pension Plans and Other Postretirement Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Consolidated Statements of Operations",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.cvshealth.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Stock Incentive Plans",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.cvshealth.com/role/StockIncentivePlans",
     "shortName": "Stock Incentive Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Shareholders' Equity",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.cvshealth.com/role/ShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Other Comprehensive Income (Loss)",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncomeLoss",
     "shortName": "Other Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Earnings Per Share",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.cvshealth.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReinsuranceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Reinsurance",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.cvshealth.com/role/Reinsurance",
     "shortName": "Reinsurance",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReinsuranceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://www.cvshealth.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Segment Reporting",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://www.cvshealth.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "28",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Consolidated Statements of Comprehensive Income",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Acquisitions, Divestitures and Asset Sales (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesTables",
     "shortName": "Acquisitions, Divestitures and Asset Sales (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfLongLivedAssetsHeldForSaleTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cvs:TotalInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Investments (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.cvshealth.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cvs:TotalInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Fair Value (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.cvshealth.com/role/FairValueTables",
     "shortName": "Fair Value (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Goodwill and Other Intangibles (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables",
     "shortName": "Goodwill and Other Intangibles (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.cvshealth.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Health Care Costs Payable (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableTables",
     "shortName": "Health Care Costs Payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Other Insurance Liabilities and Separate Accounts (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsTables",
     "shortName": "Other Insurance Liabilities and Separate Accounts (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Borrowings and Credit Agreements (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsTables",
     "shortName": "Borrowings and Credit Agreements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Pension Plans and Other Postretirement Benefits (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables",
     "shortName": "Pension Plans and Other Postretirement Benefits (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.cvshealth.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Stock Incentive Plans (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.cvshealth.com/role/StockIncentivePlansTables",
     "shortName": "Stock Incentive Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Shareholders' Equity (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityTables",
     "shortName": "Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Other Comprehensive Income (Tables)",
     "menuCat": "Tables",
     "order": "42",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncomeTables",
     "shortName": "Other Comprehensive Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Earnings Per Share (Tables)",
     "menuCat": "Tables",
     "order": "43",
     "role": "http://www.cvshealth.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Reinsurance (Tables)",
     "menuCat": "Tables",
     "order": "44",
     "role": "http://www.cvshealth.com/role/ReinsuranceTables",
     "shortName": "Reinsurance (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Segment Reporting (Tables)",
     "menuCat": "Tables",
     "order": "45",
     "role": "http://www.cvshealth.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:NumberOfPharmacyPlanMembers",
      "reportCount": 1,
      "unitRef": "people",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Significant Accounting Policies - Narrative (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails",
     "shortName": "Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i501f291fb23d49e987222cf13c851afc_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails",
     "shortName": "Significant Accounting Policies - Accounts Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:VendorandManufacturerReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i69eed5106b194cac81e8857cca41692b_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredPolicyAcquisitionCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Significant Accounting Policies - Deferred Acquisition Costs (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesDeferredAcquisitionCostsDetails",
     "shortName": "Significant Accounting Policies - Deferred Acquisition Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DeferredPolicyAcquisitionCostsAdditions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Significant Accounting Policies - Property and Equipment (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails",
     "shortName": "Significant Accounting Policies - Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
     "shortName": "Significant Accounting Policies - Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "iff2a00c33afd4f03b1e2f8fd84299373_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Significant Accounting Policies - Receivables and Contracted Balances (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails",
     "shortName": "Significant Accounting Policies - Receivables and Contracted Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i69eed5106b194cac81e8857cca41692b_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Significant Accounting Policies - Contract Balances (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails",
     "shortName": "Significant Accounting Policies - Contract Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ConsolidationVariableInterestEntityPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:ProceedsFromVariableInterestEntity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Significant Accounting Policies - Variable Interest Entities (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails",
     "shortName": "Significant Accounting Policies - Variable Interest Entities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ConsolidationVariableInterestEntityPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:ProceedsFromVariableInterestEntity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Significant Accounting Policies - Discontinued Operations (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails",
     "shortName": "Significant Accounting Policies - Discontinued Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Acquisitions, Divestitures and Asset Sales - Narrative (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails",
     "shortName": "Acquisitions, Divestitures and Asset Sales - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i8941690cb4944d199bf33e6da1cee933_I20230207",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionSharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i44db5359c9524cc6b84b1886a5fa9bb7_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Acquisitions, Divestitures and Asset Sales - Summary of Assets and Liabilities Held for Sale (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails",
     "shortName": "Acquisitions, Divestitures and Asset Sales - Summary of Assets and Liabilities Held for Sale (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i44db5359c9524cc6b84b1886a5fa9bb7_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Investments - Schedule of Total Investments (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails",
     "shortName": "Investments - Schedule of Total Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:TotalInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:LongTermInvestmentsIncludingAssetsHeldForSale",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedInvestmentsAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Investments - Narrative (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
     "shortName": "Investments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedInvestmentsAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Investments - Debt Securities (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
     "shortName": "Investments - Debt Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Investments - Debt Securities by Maturity (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
     "shortName": "Investments - Debt Securities by Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Investments - Unrealized Loss Position (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
     "shortName": "Investments - Unrealized Loss Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
     "shortName": "Investments - Unrealized Loss Position Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ActivityInMortgageLoanPortfolioTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "ia4afa3728f7a4abe948e80bf8d977e54_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstateNewMortgageLoans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Investments - Mortgage Loans (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails",
     "shortName": "Investments - Mortgage Loans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ActivityInMortgageLoanPortfolioTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "ia4afa3728f7a4abe948e80bf8d977e54_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstateNewMortgageLoans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i9ad5913b793d42b68d0dc23a03aeccd7_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
     "shortName": "Investments - Mortgage Loans Credit Ratings Indicator (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i9ad5913b793d42b68d0dc23a03aeccd7_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i9ad5913b793d42b68d0dc23a03aeccd7_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Investments - Mortgage Loan Principal Repayments (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails",
     "shortName": "Investments - Mortgage Loan Principal Repayments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i9ad5913b793d42b68d0dc23a03aeccd7_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentIncomeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Investments - Net Investment Income (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
     "shortName": "Investments - Net Investment Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentIncomeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Investments - Realized Gains (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails",
     "shortName": "Investments - Realized Gains (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Fair Value - Fair Value Measurements (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
     "shortName": "Fair Value - Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FinancialLiabilitiesFairValueDisclosure",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "ibbd43a9242a0495591196ce21cc7a152_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "ic2993c1ba25f447ab89c08c88e66aa96_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated Statements of Shareholders' Equity",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
     "shortName": "Consolidated Statements of Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "ic2993c1ba25f447ab89c08c88e66aa96_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Fair Value - Changes in Level 3 Financial Assets (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
     "shortName": "Fair Value - Changes in Level 3 Financial Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "ia4ddc4dc69fa45d7b4aabcb366bedfb2_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Fair Value - Gross Transfers Into (Out Of) Level 3 (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
     "shortName": "Fair Value - Gross Transfers Into (Out Of) Level 3 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "if12cdf7fc62645698e90b515b611256b_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "ib998634049ce4ca88cef9c730f1a8c88_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgagesHeldForSaleFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
     "shortName": "Fair Value - Carrying Value and Fair Value Classified by Level (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "ib998634049ce4ca88cef9c730f1a8c88_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgagesHeldForSaleFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
     "shortName": "Fair Value - Separate Accounts Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i5e061b66c25d4fd5ac6440b36c42c982_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "ia4ddc4dc69fa45d7b4aabcb366bedfb2_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Fair Value - Narrative (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.cvshealth.com/role/FairValueNarrativeDetails",
     "shortName": "Fair Value - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i4ecc8bd5e850436fa0683a5a0e40c8c0_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i69eed5106b194cac81e8857cca41692b_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Goodwill and Other Intangibles - Goodwill (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
     "shortName": "Goodwill and Other Intangibles - Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "ic9bbc9d820604ed98ed4729f6b0aa8f3_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Goodwill and Other Intangibles - Narrative (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
     "shortName": "Goodwill and Other Intangibles - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillImpairedAccumulatedImpairmentLoss",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairedAccumulatedImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Goodwill and Other Intangibles - Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangibles - Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i69eed5106b194cac81e8857cca41692b_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Goodwill and Other Acquired Intangibles - Future Amortization Expense (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails",
     "shortName": "Goodwill and Other Acquired Intangibles - Future Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Leases - Narrative (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.cvshealth.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i4a8283341305437cbb2e2a1b13edca69_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SaleAndLeasebackTransactionGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "cvs:TreasuryStockSharesHeldinTrust",
       "cvs:TreasuryStockSharesHeldinTrust",
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i501f291fb23d49e987222cf13c851afc_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:TreasuryStockSharesHeldinTrust",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Consolidated Statements of Shareholders' Equity (Parentheticals)",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
     "shortName": "Consolidated Statements of Shareholders' Equity (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "cvs:TreasuryStockValueSharesHeldInTrust",
       "cvs:TreasuryStockValueSharesHeldInTrust",
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i501f291fb23d49e987222cf13c851afc_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:TreasuryStockValueSharesHeldInTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - Leases - Summary of the Components of Net Lease Cost (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails",
     "shortName": "Leases - Summary of the Components of Net Lease Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - Leases - Supplemental Cash Flow Information (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails",
     "shortName": "Leases - Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:LesseeLeaseTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails",
     "shortName": "Leases - Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:LesseeLeaseTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - Leases - Maturities of Operating and Finance Lease Liabilities (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails",
     "shortName": "Leases - Maturities of Operating and Finance Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "ibd901a0e46c140848ccfebccd9919a95_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - Health Care Costs Payable - Incurred and Paid Health Care Claims Development (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails",
     "shortName": "Health Care Costs Payable - Incurred and Paid Health Care Claims Development (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "ibd901a0e46c140848ccfebccd9919a95_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "ibb1ed30851ad423db47b88e42b33cf8f_I20221231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - Health Care Costs Payable - Narrative (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
     "shortName": "Health Care Costs Payable - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "ibb1ed30851ad423db47b88e42b33cf8f_I20221231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - Health Care Costs Payable - Liability for Unpaid Claims and Claims Adjustment Expense (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails",
     "shortName": "Health Care Costs Payable - Liability for Unpaid Claims and Claims Adjustment Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "ibd901a0e46c140848ccfebccd9919a95_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i69eed5106b194cac81e8857cca41692b_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000087 - Disclosure - Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
     "shortName": "Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "if07e27d83137497c9009bcc13d88e451_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000088 - Disclosure - Other Insurance Liabilities and Separate Accounts - Narrative (Details)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails",
     "shortName": "Other Insurance Liabilities and Separate Accounts - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "cvs:AccumulatedOtherComprehensiveIncomeLossBeforeTax",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i5bb58d471a7046db9c3cc65f4971e64f_I20210101",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LiabilityForFuturePolicyBenefitActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i473c68aa9e4c42a8a8d365737c72ba29_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitAfterReinsurance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000089 - Disclosure - Other Insurance Liabilities and Separate Accounts - Changes in Balances of Long-Duration Insurance Liabilities (Details)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails",
     "shortName": "Other Insurance Liabilities and Separate Accounts - Changes in Balances of Long-Duration Insurance Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i1263a7bd13e6441c90af49d5dde6fbc0_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashDivestedFromDeconsolidation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000009 - Statement - Consolidated Statements of Cash Flows (Parenthetical)",
     "menuCat": "Statements",
     "order": "9",
     "role": "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlowsParenthetical",
     "shortName": "Consolidated Statements of Cash Flows (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashDivestedFromDeconsolidation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000090 - Disclosure - Other Insurance Liabilities and Separate Accounts - Adjustments Resulting From Applying New Accounting Standard (Details)",
     "menuCat": "Details",
     "order": "90",
     "role": "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails",
     "shortName": "Other Insurance Liabilities and Separate Accounts - Adjustments Resulting From Applying New Accounting Standard (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i1fdaf8f10b1148d5a53af4de5a2e85e1_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i0b99c5b96c164850bc3f80f97475b0ae_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000091 - Disclosure - Other Insurance Liabilities and Separate Accounts - Changes in Liability for Future Policy Benefits (Details)",
     "menuCat": "Details",
     "order": "91",
     "role": "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails",
     "shortName": "Other Insurance Liabilities and Separate Accounts - Changes in Liability for Future Policy Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i1263a7bd13e6441c90af49d5dde6fbc0_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i473c68aa9e4c42a8a8d365737c72ba29_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000092 - Disclosure - Other Insurance Liabilities and Separate Accounts - Undiscounted Expected Gross Premiums and Expected Future Benefit Payments (Details)",
     "menuCat": "Details",
     "order": "92",
     "role": "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails",
     "shortName": "Other Insurance Liabilities and Separate Accounts - Undiscounted Expected Gross Premiums and Expected Future Benefit Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i473c68aa9e4c42a8a8d365737c72ba29_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i473c68aa9e4c42a8a8d365737c72ba29_I20221231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000093 - Disclosure - Other Insurance Liabilities and Separate Accounts - Weighted-average Interest Rates and Durations (Details)",
     "menuCat": "Details",
     "order": "93",
     "role": "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails",
     "shortName": "Other Insurance Liabilities and Separate Accounts - Weighted-average Interest Rates and Durations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i473c68aa9e4c42a8a8d365737c72ba29_I20221231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PolicyholderAccountBalanceTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i69eed5106b194cac81e8857cca41692b_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PolicyholderFunds",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000094 - Disclosure - Other Insurance Liabilities and Separate Accounts - Roll Forward of Policyholders' Funds (Details)",
     "menuCat": "Details",
     "order": "94",
     "role": "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails",
     "shortName": "Other Insurance Liabilities and Separate Accounts - Roll Forward of Policyholders' Funds (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PolicyholderAccountBalanceTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i501f291fb23d49e987222cf13c851afc_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PolicyholderFunds",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000095 - Disclosure - Other Insurance Liabilities and Separate Accounts - Separate Account Assets (Details)",
     "menuCat": "Details",
     "order": "95",
     "role": "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails",
     "shortName": "Other Insurance Liabilities and Separate Accounts - Separate Account Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i412d46651ee84600b71fc148cc986f29_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SeparateAccountLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i69eed5106b194cac81e8857cca41692b_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountsLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000096 - Disclosure - Other Insurance Liabilities and Separate Accounts - Roll Forward of Separate Accounts (Details)",
     "menuCat": "Details",
     "order": "96",
     "role": "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails",
     "shortName": "Other Insurance Liabilities and Separate Accounts - Roll Forward of Separate Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SeparateAccountLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "idb6445eca93841a3b69baabdc7b0d859_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountLiabilityPremiumAndDeposit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000097 - Disclosure - Borrowings and Credit Agreements - Schedule of Borrowings (Details)",
     "menuCat": "Details",
     "order": "97",
     "role": "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails",
     "shortName": "Borrowings and Credit Agreements - Schedule of Borrowings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedPremium",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000098 - Disclosure - Borrowings and Credit Agreements - Debt Maturities (Details)",
     "menuCat": "Details",
     "order": "98",
     "role": "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails",
     "shortName": "Borrowings and Credit Agreements - Debt Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000099 - Disclosure - Borrowings and Credit Agreements - Short-term Borrowings (Details)",
     "menuCat": "Details",
     "order": "99",
     "role": "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails",
     "shortName": "Borrowings and Credit Agreements - Short-term Borrowings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20230525_d2.htm",
      "contextRef": "i656c8f23bf884eb99730c0e0ceed03bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 246,
   "tag": {
    "cvs_A2021RepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Repurchase Program",
        "label": "2021 Repurchase Program [Member]",
        "terseLabel": "2021 Repurchase Program"
       }
      }
     },
     "localname": "A2021RepurchaseProgramMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_A2022RepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 Repurchase Program",
        "label": "2022 Repurchase Program [Member]",
        "terseLabel": "2022 Repurchase Program"
       }
      }
     },
     "localname": "A2022RepurchaseProgramMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_AOCIChangeInDiscountRateOnInsuranceReservesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AOCI, Change In Discount Rate On Insurance Reserves",
        "label": "AOCI, Change In Discount Rate On Insurance Reserves [Member]",
        "terseLabel": "Change in discount rate on long-duration insurance reserves"
       }
      }
     },
     "localname": "AOCIChangeInDiscountRateOnInsuranceReservesMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchase Program, Maximum Number Of Shares",
        "label": "Accelerated Share Repurchase Program, Maximum Number Of Shares",
        "terseLabel": "ASR, maximum amount of shares received or delivered"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseProgramMaximumNumberOfShares",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_AcceleratedShareRepurchasesAgreementAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases Agreement, Amount",
        "label": "Accelerated Share Repurchases Agreement, Amount",
        "terseLabel": "ASR agreement, amount"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesAgreementAmount",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_AcceleratedShareRepurchasesNumberOfSharesRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Number Of Shares Repurchased",
        "label": "Accelerated Share Repurchases, Number Of Shares Repurchased",
        "terseLabel": "Shares repurchased under ASR agreement (in shares)"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesNumberOfSharesRepurchased",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Percent Of Notional Amount In Shares To Be Received At End Of Program",
        "label": "Accelerated Share Repurchases, Percent Of Notional Amount In Shares To Be Received At End Of Program",
        "terseLabel": "ASR, shares to be received at the end of program as a percent of notional amount"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Percent Of Notional Amount Received In Shares",
        "label": "Accelerated Share Repurchases, Percent Of Notional Amount Received In Shares",
        "terseLabel": "ASR percent of notional amount received in shares"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, After Allowance For Credit Loss, Current, Including Assets Held For Sale",
        "label": "Accounts Receivable, After Allowance For Credit Loss, Current, Including Assets Held For Sale",
        "totalLabel": "Total accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_AccumulatedOtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income (Loss), Before Tax",
        "label": "Accumulated Other Comprehensive Income (Loss), Before Tax",
        "negatedTerseLabel": "Reduction to accumulated other comprehensive income (loss), before tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_ActivityInMortgageLoanPortfolioTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table representing activities in mortgage loan portfolio during the period.",
        "label": "Activity In Mortgage Loan Portfolio [Table Text Block]",
        "verboseLabel": "Schedule of Activity in Mortgage Loan Portfolio"
       }
      }
     },
     "localname": "ActivityInMortgageLoanPortfolioTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_AdjustedOperatingIncomeLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted Operating Income (Loss)",
        "label": "Adjusted Operating Income (Loss)",
        "terseLabel": "Adjusted operating income",
        "verboseLabel": "Adjusted operating income (loss)"
       }
      }
     },
     "localname": "AdjustedOperatingIncomeLoss",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_AetnaInc2010StockIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aetna Inc 2010 Stock Incentive Plan [Member]",
        "label": "Aetna Inc 2010 Stock Incentive Plan [Member]",
        "terseLabel": "Aetna Inc 2010 Stock Incentive Plan"
       }
      }
     },
     "localname": "AetnaInc2010StockIncentivePlanMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_AllOtherReinsurersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All Other Reinsurers [Member]",
        "label": "All Other Reinsurers [Member]",
        "terseLabel": "All Other"
       }
      }
     },
     "localname": "AllOtherReinsurersMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_BackUpCreditFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Back-Up Credit Facilities [Member]",
        "label": "Back-Up Credit Facilities [Member]",
        "terseLabel": "Back-Up Credit Facilities"
       }
      }
     },
     "localname": "BackUpCreditFacilitiesMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_BarclaysBankMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Barclays Bank",
        "label": "Barclays Bank [Member]",
        "terseLabel": "Barclays Bank"
       }
      }
     },
     "localname": "BarclaysBankMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_BswiftLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "bswift LLC",
        "label": "bswift LLC [Member]",
        "terseLabel": "bswift LLC"
       }
      }
     },
     "localname": "BswiftLLCMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Purchase Price Adjustment, Outside Of Measurement Period",
        "label": "Business Combination, Purchase Price Adjustment, Outside Of Measurement Period",
        "negatedTerseLabel": "Acquisition purchase price adjustments outside of measurement period"
       }
      }
     },
     "localname": "BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_BusinessCombinationTerminationFee": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Termination Fee",
        "label": "Business Combination, Termination Fee",
        "terseLabel": "Termination fee"
       }
      }
     },
     "localname": "BusinessCombinationTerminationFee",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_CVSHealth2017IncentiveCompensationPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CVS Health 2017 Incentive Compensation Plan [Member]",
        "label": "CVS Health 2017 Incentive Compensation Plan [Member]",
        "terseLabel": "CVS Health 2017 Incentive Compensation Plan"
       }
      }
     },
     "localname": "CVSHealth2017IncentiveCompensationPlanMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_CashFlowLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flow, Lessee [Abstract]",
        "label": "Cash Flow, Lessee [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "localname": "CashFlowLesseeAbstract",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_Categories5And6Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage loan credit quality indicator - Categories 5 and 6",
        "label": "Categories 5 And 6 [Member]",
        "terseLabel": "5 and 6"
       }
      }
     },
     "localname": "Categories5And6Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loan Credit Quality Indicator - Category 1 [Member].",
        "label": "Category 1 [Member]",
        "terseLabel": "1"
       }
      }
     },
     "localname": "Category1Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category2To4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loan Credit Quality Indicator - Category 2 to 4 [Member].",
        "label": "Category 2 To 4 [Member]",
        "terseLabel": "2 to 4"
       }
      }
     },
     "localname": "Category2To4Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category7Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage loan credit quality indicator - Category 7",
        "label": "Category 7 [Member]",
        "terseLabel": "7"
       }
      }
     },
     "localname": "Category7Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ChangeInContractWithCustomerLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Contract With Customer, Liability",
        "label": "Change In Contract With Customer, Liability [Roll Forward]",
        "terseLabel": "Change in Contract with Customer, Liability [Roll Forward]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityRollForward",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in operating assets and liabilities, net of effects from acquisitions:",
        "label": "Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]",
        "terseLabel": "Change in operating assets and liabilities, net of effects from acquisitions:"
       }
      }
     },
     "localname": "ChangeInOperatingAssetsAndLiabilitiesNetOfEffectsFromAcquisitionsAbstract",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_CitibankNAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Citibank, N.A.",
        "label": "Citibank, N.A. [Member]",
        "terseLabel": "Citibank, N.A."
       }
      }
     },
     "localname": "CitibankNAMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_CommonAndCollectiveTrustsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of Common/Collective Trusts held by the company, primarily related to investment funds otherwise known as underlying funds.",
        "label": "Common And Collective Trusts [Member]",
        "terseLabel": "Common/collective trusts"
       }
      }
     },
     "localname": "CommonAndCollectiveTrustsMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.",
        "label": "Contract With Customer Liability Loyalty Program Earnings And Gift Card Issuance",
        "terseLabel": "Rewards earnings and gift card issuances"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_ContractWithCustomerLiabilityRedemptionAndBreakage": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer Liability Redemption And Breakage",
        "label": "Contract With Customer Liability Redemption And Breakage",
        "negatedTerseLabel": "Redemption and breakage"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRedemptionAndBreakage",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the contractual obligation to maintain the required level of funding in Separate Accounts necessary to fund specific guaranteed pensions annuities.",
        "label": "Contractual Obligations To Maintain Levels Of Separate Accounts",
        "terseLabel": "Contractual obligations underlying the guaranteed benefits"
       }
      }
     },
     "localname": "ContractualObligationsToMaintainLevelsOfSeparateAccounts",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_CoventryHealthCareWorkersCompensationBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coventry Health Care Workers Compensation Business",
        "label": "Coventry Health Care Workers Compensation Business [Member]",
        "terseLabel": "Coventry Health Care Workers Compensation Business"
       }
      }
     },
     "localname": "CoventryHealthCareWorkersCompensationBusinessMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings",
        "label": "Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings",
        "terseLabel": "Credit-related impairment loss"
       }
      }
     },
     "localname": "CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtAndEquitySecuritiesAvailableForSaleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt and equity securities which are categorized neither as trading securities nor held-to-maturity securities. Such securities are reported at fair value; unrealized gains and losses related to Available-for-sale securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income)",
        "label": "Debt And Equity Securities Available For Sale [Member]",
        "terseLabel": "Debt securities available for sale"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesAvailableForSaleMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_DebtExtinguishmentFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Extinguishment Fees",
        "label": "Debt Extinguishment Fees",
        "terseLabel": "Debt extinguishment fees"
       }
      }
     },
     "localname": "DebtExtinguishmentFees",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Unamortized Discount And Debt Issuance Costs, Net",
        "label": "Debt Instrument, Unamortized Discount And Debt Issuance Costs, Net",
        "negatedTerseLabel": "Debt discounts and deferred financing costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountAndDebtIssuanceCostsNet",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Without Single Maturity Date, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Without Single Maturity Date, Accumulated Loss",
        "terseLabel": "Debt securities, maturity, without single maturity date, unrealized losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Without Single Maturity Date, Fair Value",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Without Single Maturity Date, Fair Value",
        "terseLabel": "Debt securities, maturity, without single maturity date, fair value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionWithoutSingleMaturityDateFairValue",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]",
        "label": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Weighted Average Duration Of Securities",
        "label": "Debt Securities, Available-For-Sale, Weighted Average Duration Of Securities",
        "terseLabel": "Weighted average duration of securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_DeferredTaxAssetsPayrollTaxDeferral": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Payroll Tax Deferral",
        "label": "Deferred Tax Assets, Payroll Tax Deferral",
        "terseLabel": "Payroll tax deferral"
       }
      }
     },
     "localname": "DeferredTaxAssetsPayrollTaxDeferral",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Bad Debts And Other Allowances",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Bad Debts And Other Allowances",
        "terseLabel": "Bad debts and other allowances"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DeferredTaxLiabilitiesDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Depreciation and Amortization - Amount of deferred tax liability attributable to taxable temporary differences from depreciation and amortization",
        "label": "Deferred Tax Liabilities, Depreciation And Amortization",
        "negatedTerseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDepreciationAndAmortization",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DeferredTaxLiabilitiesRetirementBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Retirement Benefits",
        "label": "Deferred Tax Liabilities, Retirement Benefits",
        "negatedTerseLabel": "Retirement benefits"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesRetirementBenefits",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Common Collective Trust, Debt Securities [Member]",
        "label": "Defined Benefit Plan, Common Collective Trust, Debt Securities [Member]",
        "terseLabel": "Common/collective trusts, Debt Securities"
       }
      }
     },
     "localname": "DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Common Collective Trust, Equity Securities [Member]",
        "label": "Defined Benefit Plan, Common Collective Trust, Equity Securities [Member]",
        "terseLabel": "Common/collective trusts, Equity Securities"
       }
      }
     },
     "localname": "DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_DenominatorForEarningsPerShareCalculationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Denominator For Earnings Per Share Calculation [Abstract]",
        "label": "Denominator For Earnings Per Share Calculation [Abstract]",
        "terseLabel": "Denominator for earnings per share calculation:"
       }
      }
     },
     "localname": "DenominatorForEarningsPerShareCalculationAbstract",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operation, Number Of International Health Care Members, Renewal Rights Sold",
        "label": "Disposal Group, Not Discontinued Operation, Number Of International Health Care Members, Renewal Rights Sold",
        "terseLabel": "Number of international health care members, renewal rights sold"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationNumberOfInternationalHealthCareMembersRenewalRightsSold",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividends Payable, Quarterly Dividends Declared, Increase Amount, Percent",
        "label": "Dividends Payable, Quarterly Dividends Declared, Increase Amount, Percent",
        "terseLabel": "Quarterly dividends declared, percent increase"
       }
      }
     },
     "localname": "DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ESPP Issuance, Net Of Treasury Stock, Shares, Acquired, Cost Method",
        "label": "ESPP Issuance, Net Of Treasury Stock, Shares, Acquired, Cost Method",
        "terseLabel": "ESPP issuances, net of purchase of treasury shares (in shares)"
       }
      }
     },
     "localname": "ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ESPP Issuance, Net Of Treasury Stock, Value, Acquired, Cost Method",
        "label": "ESPP Issuance, Net Of Treasury Stock, Value, Acquired, Cost Method",
        "terseLabel": "ESPP issuances, net of purchase of treasury shares"
       }
      }
     },
     "localname": "ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_EarningsPerShareBasicAndDilutedEPSAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share, Basic And Diluted EPS",
        "label": "Earnings Per Share, Basic And Diluted EPS [Abstract]",
        "terseLabel": "Earnings per share from continuing operations:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedEPSAbstract",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effect Of Application Of Accounting Standards Update 2018-12, Adjustments For Change In Discount Rate Assumptions",
        "label": "Effect Of Application Of Accounting Standards Update 2018-12, Adjustments For Change In Discount Rate Assumptions [Member]",
        "terseLabel": "Change in discount rate assumptions"
       }
      }
     },
     "localname": "EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForChangeInDiscountRateAssumptionsMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effect Of Application Of Accounting Standards Update 2018-12, Adjustments For Removal Of Shadow Adjustments In Accumulated Other Comprehensive Income",
        "label": "Effect Of Application Of Accounting Standards Update 2018-12, Adjustments For Removal Of Shadow Adjustments In Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Removal of shadow adjustments in accumulated other comprehensive income"
       }
      }
     },
     "localname": "EffectOfApplicationOfAccountingStandardsUpdate201812AdjustmentsForRemovalOfShadowAdjustmentsInAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal Charges, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Legal Charges, Percent",
        "terseLabel": "Legal charges"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLegalChargesPercent",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvs_EmployeeStockOptionsAndStockAppreciationRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Options and Stock Appreciation Rights [Member]",
        "label": "Employee Stock Options And Stock Appreciation Rights [Member]",
        "terseLabel": "Employee Stock Options and Stock Appreciation Rights"
       }
      }
     },
     "localname": "EmployeeStockOptionsAndStockAppreciationRightsMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_EquitySecuritiesAndCommonAndCollectiveTrustsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities And Common And Collective Trusts",
        "label": "Equity Securities And Common And Collective Trusts [Member]",
        "terseLabel": "Equity securities and common/collective trusts"
       }
      }
     },
     "localname": "EquitySecuritiesAndCommonAndCollectiveTrustsMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_EquitySecuritiesDomesticRealEstateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about ownership interests or the right to acquire ownership interests in domestic real estate whose ownership interest is represented by shares of common or preferred stock (which is neither mandatorily redeemable no redeemable at the option of the holder), convertible securities, stock rights, or stock warrants categorized by other type.",
        "label": "Equity Securities Domestic Real Estate [Member]",
        "terseLabel": "Domestic real estate"
       }
      }
     },
     "localname": "EquitySecuritiesDomesticRealEstateMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Assets Measured On Recurring Basis, Unobservable Unput Reconciliation, Net Realized And Unrealized Capital Gaines (Losses) [Abstract]",
        "label": "Fair Value, Assets Measured On Recurring Basis, Unobservable Unput Reconciliation, Net Realized And Unrealized Capital Gaines (Losses) [Abstract]",
        "terseLabel": "Net realized and unrealized capital gains (losses):"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_FederalCourtInOhioJudgmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal Court In Ohio Judgment",
        "label": "Federal Court In Ohio Judgment [Member]",
        "terseLabel": "Federal Court in Ohio Judgment"
       }
      }
     },
     "localname": "FederalCourtInOhioJudgmentMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Assets And Liabilities, Lessee [Abstract]",
        "label": "Finance Lease, Assets And Liabilities, Lessee [Abstract]",
        "terseLabel": "Finance leases:"
       }
      }
     },
     "localname": "FinanceLeaseAssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_FinanceLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Cost",
        "label": "Finance Lease Cost",
        "totalLabel": "Total finance lease costs"
       }
      }
     },
     "localname": "FinanceLeaseCost",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "cvs_FinanceLeaseRightOfUseAssetNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Right-Of-Use Asset, Accumulated Depreciation",
        "label": "Finance Lease, Right-Of-Use Asset, Accumulated Depreciation",
        "negatedTerseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAccumulatedDepreciation",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FinanceLeaseRightOfUseAssetGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "cvs_FinanceLeaseRightOfUseAssetNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Right-Of-Use Asset, Gross",
        "label": "Finance Lease, Right-Of-Use Asset, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetGross",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FinanceLeaseRightOfUseAssetNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Right-Of-Use Asset, Net",
        "label": "Finance Lease, Right-Of-Use Asset, Net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetNet",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the cost, accumulated amortization and net balance of intangibles assets and amortization period, in total and by major class. Finite-lived intangible assets have a stated useful life over which their gross carrying value is amortized. Indefinite intangible assets have a projected indefinite period of benefit (hence are not amortized).",
        "label": "Finite Lived And Indefinite Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Summary of Intangible Assets"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixtures, Equipment And Internally Developed Software [Member]",
        "label": "Fixtures, Equipment And Internally Developed Software [Member]",
        "terseLabel": "Fixtures, equipment and internally developed software"
       }
      }
     },
     "localname": "FixturesEquipmentAndInternallyDevelopedSoftwareMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Gain Contingency, Recognized In Current Period, Before Tax",
        "label": "Former Gain Contingency, Recognized In Current Period, Before Tax",
        "terseLabel": "Former gain contingency, recognized in current period, before tax"
       }
      }
     },
     "localname": "FormerGainContingencyRecognizedInCurrentPeriodBeforeTax",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Gain Contingency, Recognized In Current Period, Net of Tax",
        "label": "Former Gain Contingency, Recognized In Current Period, Net of Tax",
        "terseLabel": "Former gain contingency, recognized in current period, net of tax"
       }
      }
     },
     "localname": "FormerGainContingencyRecognizedInCurrentPeriodNetOfTax",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This line item represents the four years of a reinsurance agreement with an unrelated insurer.",
        "label": "Four Years Reinsurance Agreement With Unrelated Insurer",
        "terseLabel": "Term of reinsurance agreements with unrelated issuer"
       }
      }
     },
     "localname": "FourYearsReinsuranceAgreementWithUnrelatedInsurer",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fresenius Medical Care Reinsurance Company (Cayman) Ltd.",
        "label": "Fresenius Medical Care Reinsurance Company (Cayman) Ltd. [Member]",
        "terseLabel": "Fresenius Medical Care Reinsurance Company (Cayman) Ltd."
       }
      }
     },
     "localname": "FreseniusMedicalCareReinsuranceCompanyCaymanLtdMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_FrontStoreRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Front Store Revenue [Member]",
        "label": "Front Store Revenue [Member]",
        "terseLabel": "Front Store"
       }
      }
     },
     "localname": "FrontStoreRevenueMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_GuarantorObligationsNumberOfLeases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantor Obligations, Number Of Leases",
        "label": "Guarantor Obligations, Number Of Leases",
        "terseLabel": "Guarantor obligations, number of leases"
       }
      }
     },
     "localname": "GuarantorObligationsNumberOfLeases",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_HartfordLifeAndAccidentInsuranceCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hartford Life And Accident Insurance Company [Member]",
        "label": "Hartford Life And Accident Insurance Company [Member]",
        "terseLabel": "Hartford Life and Accident Insurance Company"
       }
      }
     },
     "localname": "HartfordLifeAndAccidentInsuranceCompanyMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_HealthCareAndOtherInsuranceLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care and Other Insurance Liabilities",
        "label": "Health Care and Other Insurance Liabilities [Abstract]"
       }
      }
     },
     "localname": "HealthCareAndOtherInsuranceLiabilitiesAbstract",
     "nsuri": "http://www.cvshealth.com/20230525",
     "xbrltype": "stringItemType"
    },
    "cvs_HealthCareBenefitsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Benefits Segment [Member]",
        "label": "Health Care Benefits Segment [Member]",
        "terseLabel": "Health Care Benefits"
       }
      }
     },
     "localname": "HealthCareBenefitsSegmentMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Costs Payable, Period After Date Of Services Claims Are Paid",
        "label": "Health Care Costs Payable, Period After Date Of Services Claims Are Paid",
        "terseLabel": "Period after date of service a claim is paid"
       }
      }
     },
     "localname": "HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_HealthInsurerFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the estimated amount of the health insurer fee accrued during the reporting period, as required by Health Care Reform.",
        "label": "Health Insurer Fee",
        "terseLabel": "Health insurer fee"
       }
      }
     },
     "localname": "HealthInsurerFee",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_HealthInsurerFeeTaxEffectPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the tax effect of the health care reform's non-tax deductible health insurer fee.",
        "label": "Health Insurer Fee Tax Effect, Percent",
        "terseLabel": "Health insurer fee"
       }
      }
     },
     "localname": "HealthInsurerFeeTaxEffectPercent",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvs_HealthServicesSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Services Segment",
        "label": "Health Services Segment [Member]",
        "terseLabel": "Health Services"
       }
      }
     },
     "localname": "HealthServicesSegmentMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_HeartlandHealthcareServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Heartland Healthcare Services [Member]",
        "label": "Heartland Healthcare Services [Member]",
        "terseLabel": "Heartland Healthcare Services"
       }
      }
     },
     "localname": "HeartlandHealthcareServicesMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_HeathSavingsAccountBalance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Heath Savings Account Balance",
        "label": "Heath Savings Account Balance",
        "terseLabel": "HSA balances"
       }
      }
     },
     "localname": "HeathSavingsAccountBalance",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual Public Health Insurance Exchanges, Number Of Additional States",
        "label": "Individual Public Health Insurance Exchanges, Number Of Additional States",
        "terseLabel": "Additional number of states in which the Company entered the individual public health insurance exchange"
       }
      }
     },
     "localname": "IndividualPublicHealthInsuranceExchangesNumberOfAdditionalStates",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_IndividualPublicHealthInsuranceExchangesNumberOfStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual Public Health Insurance Exchanges, Number Of States",
        "label": "Individual Public Health Insurance Exchanges, Number Of States",
        "terseLabel": "Number of states in which the Company has entered the individual public health insurance exchange"
       }
      }
     },
     "localname": "IndividualPublicHealthInsuranceExchangesNumberOfStates",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_InitialContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entity, Initial Contractual Term",
        "label": "Initial Contractual Term",
        "terseLabel": "Initial contractual term (in years)"
       }
      }
     },
     "localname": "InitialContractualTerm",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_InsuranceAndHMOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance and HMO subsidiaries [Member].",
        "label": "Insurance And HMO [Member]",
        "terseLabel": "Insurance and HMO"
       }
      }
     },
     "localname": "InsuranceAndHMOMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_InsurancePremiumDeficiencyReservePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance Premium Deficiency Reserve [Policy Text Block]",
        "label": "Insurance Premium Deficiency Reserve [Policy Text Block]",
        "terseLabel": "Premium Deficiency Reserves"
       }
      }
     },
     "localname": "InsurancePremiumDeficiencyReservePolicyTextBlock",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets, Net (Excluding Goodwill), Including Assets Held For Sale",
        "label": "Intangible Assets, Net (Excluding Goodwill), Including Assets Held For Sale",
        "totalLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_InternationalHealthCareRenewalRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Health Care Renewal Rights",
        "label": "International Health Care Renewal Rights [Member]",
        "terseLabel": "International Health Care Renewal Rights"
       }
      }
     },
     "localname": "InternationalHealthCareRenewalRightsMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Contracts With Fixed Maturity, Fair Value Disclosure.",
        "label": "Investment Contracts With Fixed Maturity, Fair Value Disclosure",
        "terseLabel": "Investment contract liabilities with a fixed maturity"
       }
      }
     },
     "localname": "InvestmentContractsWithFixedMaturityFairValueDisclosure",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.",
        "label": "Investment Contracts Without A Fixed Maturity, Fair Value Disclosure",
        "terseLabel": "Investment contracts liabilities without a fixed maturity"
       }
      }
     },
     "localname": "InvestmentContractsWithoutFixedMaturityFairValueDisclosure",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_InvestmentIncomeExcludingCapitalGainsOrLosses": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Income, Excluding Capital Gains Or Losses",
        "label": "Investment Income, Excluding Capital Gains Or Losses",
        "totalLabel": "Net investment income (excluding net realized capital gains or losses)"
       }
      }
     },
     "localname": "InvestmentIncomeExcludingCapitalGainsOrLosses",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LargeCasePensionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Large Case Pensions",
        "label": "Large Case Pensions [Member]",
        "terseLabel": "Large Case Pensions"
       }
      }
     },
     "localname": "LargeCasePensionsMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_LeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability",
        "label": "Lease, Liability",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "LeaseLiability",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LeasesWeightedAverageDiscountRateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases, Weighted Average Discount Rate [Abstract]",
        "label": "Leases, Weighted Average Discount Rate [Abstract]",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "LeasesWeightedAverageDiscountRateAbstract",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_LegalSettlementPeriodOfPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal Settlement, Period Of Payment",
        "label": "Legal Settlement, Period Of Payment",
        "terseLabel": "Legal settlement, period of payment"
       }
      }
     },
     "localname": "LegalSettlementPeriodOfPayment",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_LesseeLeaseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Lease [Table Text Block]",
        "label": "Lessee, Lease [Table Text Block]",
        "terseLabel": "Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "LesseeLeaseTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Leases Liabilities Payments Due [Abstract]",
        "label": "Lessee, Leases Liabilities Payments Due [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "LesseeLeasesLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_LesseeLiabilityPaymentsDue": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Payments, Due",
        "label": "Lessee, Liability, Payments, Due",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeLiabilityPaymentsDue",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 6.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Payments, Due After Year Five",
        "label": "Lessee, Liability, Payments, Due After Year Five",
        "totalLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeLiabilityPaymentsDueYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 5.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Payments, Due Year Five",
        "label": "Lessee, Liability, Payments, Due Year Five",
        "totalLabel": "2027"
       }
      }
     },
     "localname": "LesseeLiabilityPaymentsDueYearFive",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeLiabilityPaymentsDueYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Payments, Due Year Four",
        "label": "Lessee, Liability, Payments, Due Year Four",
        "totalLabel": "2026"
       }
      }
     },
     "localname": "LesseeLiabilityPaymentsDueYearFour",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeLiabilityPaymentsDueYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Payments, Due Year Three",
        "label": "Lessee, Liability, Payments, Due Year Three",
        "totalLabel": "2025"
       }
      }
     },
     "localname": "LesseeLiabilityPaymentsDueYearThree",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeLiabilityPaymentsDueYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Payments, Due Year Two",
        "label": "Lessee, Liability, Payments, Due Year Two",
        "totalLabel": "2024"
       }
      }
     },
     "localname": "LesseeLiabilityPaymentsDueYearTwo",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeLiabilityPaymentsYearOne": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Payments, Year One",
        "label": "Lessee, Liability, Payments, Year One",
        "totalLabel": "2023"
       }
      }
     },
     "localname": "LesseeLiabilityPaymentsYearOne",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Undiscounted Excess Amount",
        "label": "Lessee, Liability, Undiscounted Excess Amount",
        "negatedTotalLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeLiabilityUndiscountedExcessAmount",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeOperatingAndFinanceLeasesRenewalTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating And Finance Leases, Renewal Term",
        "label": "Lessee, Operating And Finance Leases, Renewal Term",
        "terseLabel": "Lease renewal term"
       }
      }
     },
     "localname": "LesseeOperatingAndFinanceLeasesRenewalTerm",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Future Policy Benefit, After Reinsurance, Net Of Tax",
        "label": "Liability For Future Policy Benefit, After Reinsurance, Net Of Tax",
        "terseLabel": "Liability for future policy benefits, after tax"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitAfterReinsuranceNetOfTax",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Future Policy Benefit, Expected Future Policy Benefit, Before Reinsurance, Before Discount Rate Change",
        "label": "Liability For Future Policy Benefit, Expected Future Policy Benefit, Before Reinsurance, Before Discount Rate Change",
        "terseLabel": "Liability for future policy benefits, beginning of period - current discount rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceBeforeDiscountRateChange",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Future Policy Benefit, Including Deferred Profit Liability, Expected Future Policy Benefit, Before Reinsurance, After Discount Rate Change",
        "label": "Liability For Future Policy Benefit, Including Deferred Profit Liability, Expected Future Policy Benefit, Before Reinsurance, After Discount Rate Change",
        "terseLabel": "Liability for future policy benefits, end of period - current discount rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitIncludingDeferredProfitLiabilityExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LiabilityForUnpaidClaims": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the total liability on the balance sheet for unpaid claims for both short-duration and long-duration insurance contracts after reinsurance.",
        "label": "Liability For Unpaid Claims",
        "terseLabel": "Liability for unpaid claims"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaims",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs",
        "label": "Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs",
        "terseLabel": "Benefit costs recorded in other insurance liabilities"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LincolnLifeAnnuityCompanyOfNewYorkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lincoln Life &amp; Annuity Company Of New York [Member]",
        "label": "Lincoln Life &amp; Annuity Company Of New York [Member]",
        "terseLabel": "Lincoln Life &amp; Annuity Company of New York"
       }
      }
     },
     "localname": "LincolnLifeAnnuityCompanyOfNewYorkMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_LitigationSettlementNumberOfStatesElectedToJoin": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Number Of States Elected To Join",
        "label": "Litigation Settlement, Number Of States Elected To Join",
        "terseLabel": "Number of states that elected to join the settlement"
       }
      }
     },
     "localname": "LitigationSettlementNumberOfStatesElectedToJoin",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_LitigationSettlementNumberOfStatesSubjectToEarlierSettlements": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Number Of States Subject To Earlier Settlements",
        "label": "Litigation Settlement, Number Of States Subject To Earlier Settlements",
        "terseLabel": "Number of states subject to earlier settlements"
       }
      }
     },
     "localname": "LitigationSettlementNumberOfStatesSubjectToEarlierSettlements",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_LongTermCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Care",
        "label": "Long Term Care [Member]",
        "terseLabel": "Long-Term Care"
       }
      }
     },
     "localname": "LongTermCareMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_LongTermCareReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Care Reporting Unit [Member]",
        "label": "Long-Term Care Reporting Unit [Member]",
        "terseLabel": "Long-Term Care Reporting Unit"
       }
      }
     },
     "localname": "LongTermCareReportingUnitMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, including liabilities held for sale, classified as noncurrent.",
        "label": "Long-Term Debt And Lease Obligation, Including Liabilities Held For Sale",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndLeaseObligationIncludingLiabilitiesHeldForSale",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LongTermInvestmentsIncludingAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Investments, Including Assets Held For Sale",
        "label": "Long-Term Investments, Including Assets Held For Sale",
        "terseLabel": "Long-term"
       }
      }
     },
     "localname": "LongTermInvestmentsIncludingAssetsHeldForSale",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LongtermDebtGrossAndLeaseObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Debt, Gross And Lease Obligation",
        "label": "Long-term Debt, Gross And Lease Obligation",
        "totalLabel": "Total debt principal"
       }
      }
     },
     "localname": "LongtermDebtGrossAndLeaseObligation",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents mortgage loans for the reporting period measured at carrying value. We carry the value of our mortgage loan investments on our balance sheet at the unpaid principal balance, net of impairment reserves.",
        "label": "Mortgage Loans [Member]",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Collections Of Principal After Year Five",
        "label": "Mortgage Loans On Real Estate Collections Of Principal After Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Collections Of Principal In Next Twelve Months",
        "label": "Mortgage Loans On Real Estate Collections Of Principal In Next Twelve Months",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Collections Of Principal In Year Five",
        "label": "Mortgage Loans On Real Estate Collections Of Principal In Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Collections Of Principal In Year Four",
        "label": "Mortgage Loans On Real Estate Collections Of Principal In Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Collections Of Principal In Year Three",
        "label": "Mortgage Loans On Real Estate Collections Of Principal In Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Collections Of Principal In Year Two",
        "label": "Mortgage Loans On Real Estate Collections Of Principal In Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateLoansFullyRepaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pertains to amount of mortgage loans fully repaid.",
        "label": "Mortgage Loans on Real Estate, Loans Fully Repaid",
        "terseLabel": "Mortgage loans fully repaid"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateLoansFullyRepaid",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateYearOfOriginationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Year Of Origination",
        "label": "Mortgage Loans On Real Estate Year Of Origination [Axis]",
        "terseLabel": "Mortgage Loans On Real Estate Year Of Origination [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateYearOfOriginationAxis",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_MortgageLoansOnRealEstateYearOfOriginationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Year Of Origination",
        "label": "Mortgage Loans On Real Estate Year Of Origination [Domain]",
        "terseLabel": "Mortgage Loans On Real Estate Year Of Origination [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateYearOfOriginationDomain",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_NetRevenuesRetailCoPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Revenues, Retail CoPayments",
        "label": "Net Revenues, Retail CoPayments",
        "terseLabel": "Copayments"
       }
      }
     },
     "localname": "NetRevenuesRetailCoPayments",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_NoncontrollingInterestOtherPeriodIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Other Period Increase (Decrease)",
        "label": "Noncontrolling Interest, Other Period Increase (Decrease)",
        "terseLabel": "Other increases (decreases) in noncontrolling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestOtherPeriodIncreaseDecrease",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_NumberOfMedicalMembers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Medical Members",
        "label": "Number Of Medical Members",
        "terseLabel": "Number of medical members"
       }
      }
     },
     "localname": "NumberOfMedicalMembers",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberOfPatientsServedPerYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Patients Served Per Year",
        "label": "Number Of Patients Served Per Year",
        "terseLabel": "Number of patients served per year (more than)"
       }
      }
     },
     "localname": "NumberOfPatientsServedPerYear",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberOfPeopleServed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of People Served",
        "label": "Number Of People Served",
        "terseLabel": "Number of people served"
       }
      }
     },
     "localname": "NumberOfPeopleServed",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberOfPharmacyPlanMembers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Pharmacy Plan Members",
        "label": "Number Of Pharmacy Plan Members",
        "terseLabel": "Number of pharmacy plan members"
       }
      }
     },
     "localname": "NumberOfPharmacyPlanMembers",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Stores, Annual Planned Closures For Closure Period",
        "label": "Number Of Stores, Annual Planned Closures For Closure Period",
        "terseLabel": "Number of stores, annual planned closures for closure period"
       }
      }
     },
     "localname": "NumberOfStoresAnnualPlannedClosuresForClosurePeriod",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberOfStoresPlannedClosure": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Stores, Planned Closure",
        "label": "Number Of Stores, Planned Closure",
        "terseLabel": "Number of stores, planned closure"
       }
      }
     },
     "localname": "NumberOfStoresPlannedClosure",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberOfWalkInMedicalClinics": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Walk In Medical Clinics",
        "label": "Number Of Walk In Medical Clinics",
        "terseLabel": "Number of walk-in medical clinics (more than)"
       }
      }
     },
     "localname": "NumberOfWalkInMedicalClinics",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberofReinsuranceContractsEnteredInto": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reinsurance contracts entered into with an unrelated insurer.",
        "label": "Number of Reinsurance Contracts Entered Into",
        "terseLabel": "Number of reinsurance contracts entered into"
       }
      }
     },
     "localname": "NumberofReinsuranceContractsEnteredInto",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumeratorForEarningsPerShareCalculationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Numerator For Earnings Per Share Calculation [Abstract]",
        "label": "Numerator For Earnings Per Share Calculation [Abstract]",
        "terseLabel": "Numerator for earnings per share calculation:"
       }
      }
     },
     "localname": "NumeratorForEarningsPerShareCalculationAbstract",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_OakStreetHealthIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oak Street Health Inc.",
        "label": "Oak Street Health Inc. [Member]",
        "terseLabel": "Oak Street Health Inc."
       }
      }
     },
     "localname": "OakStreetHealthIncMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_OfficeRealEstateOptimizationCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office Real Estate Optimization Charges - Related to the abandonment of leased real estate and the related right-of-use assets and property and equipment",
        "label": "Office Real Estate Optimization Charges",
        "terseLabel": "Office real estate optimization charges"
       }
      }
     },
     "localname": "OfficeRealEstateOptimizationCharges",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OmnicareLongTermCareBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Omnicare Long-Term Care Business",
        "label": "Omnicare Long-Term Care Business [Member]",
        "terseLabel": "Omnicare Long-Term Care Business"
       }
      }
     },
     "localname": "OmnicareLongTermCareBusinessMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Capital Leases, Amount Due In Excess Of Remaining Estimated Economic Life",
        "label": "Operating And Capital Leases, Amount Due In Excess Of Remaining Estimated Economic Life",
        "terseLabel": "Leases, amount due in excess of remaining estimated economic life"
       }
      }
     },
     "localname": "OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Expenses, Excluding Store Impairments, Goodwill Impairments, Loss On Assets Held For Sale, And Loss On Litigation Settlement",
        "label": "Operating Expenses, Excluding Store Impairments, Goodwill Impairments, Loss On Assets Held For Sale, And Loss On Litigation Settlement",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesExcludingStoreImpairmentsGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Assets And Liabilities, Lessee [Abstract]",
        "label": "Operating Lease, Assets And Liabilities, Lessee [Abstract]",
        "terseLabel": "Operating leases:"
       }
      }
     },
     "localname": "OperatingLeaseAssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Liability, Current, Including Liabilities Held For Sale",
        "label": "Operating Lease, Liability, Current, Including Liabilities Held For Sale",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentIncludingLiabilitiesHeldForSale",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Liability, Noncurrent, Including Liabilities Held For Sale",
        "label": "Operating Lease, Liability, Noncurrent, Including Liabilities Held For Sale",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentIncludingLiabilitiesHeldForSale",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease, Right-of-Use Asset, Fair Value Disclosure",
        "label": "Operating lease, Right-of-Use Asset, Fair Value Disclosure",
        "terseLabel": "Operating lease, right-of-use asset, fair value"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetFairValueDisclosure",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right-Of-Use Asset, Including Assets Held For Sale",
        "label": "Operating Lease, Right-Of-Use Asset, Including Assets Held For Sale",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetIncludingAssetsHeldForSale",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OtherAcquiredIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Other Acquired Intangible Assets [Line Items]",
        "terseLabel": "Other Intangible Assets[Line Items]"
       }
      }
     },
     "localname": "OtherAcquiredIntangibleAssetsLineItems",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_OtherAcquiredIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Other Acquired Intangible Assets [Table]",
        "terseLabel": "Other Intangible Assets [Table]"
       }
      }
     },
     "localname": "OtherAcquiredIntangibleAssetsTable",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_OtherAssetBackedSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by a variety of assets such as automobile loans, credit card receivables, home equity loans, etc.",
        "label": "Other Asset-Backed Securities [Member]",
        "terseLabel": "Other asset-backed securities"
       }
      }
     },
     "localname": "OtherAssetBackedSecuritiesMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_OtherInsuranceLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Insurance Liabilities, Current",
        "label": "Other Insurance Liabilities, Current",
        "terseLabel": "Other insurance liabilities"
       }
      }
     },
     "localname": "OtherInsuranceLiabilitiesCurrent",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OtherInsuranceLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Insurance Liabilities [Member]",
        "label": "Other Insurance Liabilities [Member]",
        "terseLabel": "Other Insurance Liabilities"
       }
      }
     },
     "localname": "OtherInsuranceLiabilitiesMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_OtherInsuranceLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Insurance Liabilities, Noncurrent",
        "label": "Other Insurance Liabilities, Noncurrent",
        "terseLabel": "Other long-term insurance liabilities"
       }
      }
     },
     "localname": "OtherInsuranceLiabilitiesNoncurrent",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OtherLongTermInsuranceLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Long-Term Insurance Liabilities [Member]",
        "label": "Other Long-Term Insurance Liabilities [Member]",
        "terseLabel": "Other Long-Term Insurance Liabilities"
       }
      }
     },
     "localname": "OtherLongTermInsuranceLiabilitiesMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_OutstandingSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding Senior Notes [Member]",
        "label": "Outstanding Senior Notes [Member]",
        "terseLabel": "Outstanding Senior Notes"
       }
      }
     },
     "localname": "OutstandingSeniorNotesMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PayflexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payflex",
        "label": "Payflex [Member]",
        "terseLabel": "Payflex"
       }
      }
     },
     "localname": "PayflexMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PaymentsForAcceleratedShareRepurchasesAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Accelerated Share Repurchases, Amount",
        "label": "Payments For Accelerated Share Repurchases, Amount",
        "terseLabel": "Payments for ASR, amount"
       }
      }
     },
     "localname": "PaymentsForAcceleratedShareRepurchasesAmount",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PaymentsForInsuranceBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Insurance Benefits",
        "label": "Payments For Insurance Benefits",
        "negatedTerseLabel": "Insurance benefits paid"
       }
      }
     },
     "localname": "PaymentsForInsuranceBenefits",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Inventory And Prescriptions Dispensed By Retail Network Pharmacies",
        "label": "Payments For Inventory And Prescriptions Dispensed By Retail Network Pharmacies",
        "negatedTerseLabel": "Cash paid for inventory and prescriptions dispensed by retail network pharmacies"
       }
      }
     },
     "localname": "PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PensionAndAnnuityInvestmentContractsInterest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pension And Annuity Investment Contracts Interest",
        "label": "Pension And Annuity Investment Contracts Interest",
        "terseLabel": "Interest rate for pension and annuity investment contracts"
       }
      }
     },
     "localname": "PensionAndAnnuityInvestmentContractsInterest",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvs_PharmacyAndConsumerHealthSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy And Consumer Health Segment",
        "label": "Pharmacy And Consumer Health Segment [Member]",
        "terseLabel": "Pharmacy &amp; Consumer Wellness"
       }
      }
     },
     "localname": "PharmacyAndConsumerHealthSegmentMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PharmacyClaimsAndDiscountsPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Claims And Discounts Payable, Current",
        "label": "Pharmacy Claims And Discounts Payable, Current",
        "terseLabel": "Pharmacy claims and discounts payable"
       }
      }
     },
     "localname": "PharmacyClaimsAndDiscountsPayableCurrent",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PharmacyRebatePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Rebate Period",
        "label": "Pharmacy Rebate Period",
        "terseLabel": "Pharmacy rebate period"
       }
      }
     },
     "localname": "PharmacyRebatePeriod",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_PharmacyRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Revenue [Member]",
        "label": "Pharmacy Revenue [Member]",
        "terseLabel": "Pharmacy"
       }
      }
     },
     "localname": "PharmacyRevenueMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Policyholder Account Balance, Change In Net Unrealized Gains (Losses)",
        "label": "Policyholder Account Balance, Change In Net Unrealized Gains (Losses)",
        "terseLabel": "Change in net unrealized gains (losses)"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceChangeInNetUnrealizedGainsLosses",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PolicyholderAccountBalanceDepositsReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Policyholder Account Balance, Deposits Received",
        "label": "Policyholder Account Balance, Deposits Received",
        "terseLabel": "Deposits received"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceDepositsReceived",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PremiumDeficiencyReserveLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.",
        "label": "Premium Deficiency Reserve Liability",
        "terseLabel": "Add: Premium deficiency reserve",
        "verboseLabel": "Premium deficiency reserve"
       }
      }
     },
     "localname": "PremiumDeficiencyReserveLiability",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax",
        "label": "Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax",
        "terseLabel": "Revenues from external customers",
        "verboseLabel": "Revenues"
       }
      }
     },
     "localname": "PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PremiumsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premiums [Member]",
        "label": "Premiums [Member]",
        "terseLabel": "Premiums"
       }
      }
     },
     "localname": "PremiumsMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.",
        "label": "Proceeds And Related Gross Realized Capital Gains Losses From Sale Of Debt Securities [Table Text Block]",
        "verboseLabel": "Schedule of Proceeds and Related Gross Realized Capital Gains and Losses From the Sale of Debt Securities"
       }
      }
     },
     "localname": "ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_ProceedsFromVariableInterestEntity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Variable Interest Entity",
        "label": "Proceeds From Variable Interest Entity",
        "terseLabel": "Proceeds from VIE"
       }
      }
     },
     "localname": "ProceedsFromVariableInterestEntity",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property, Plant And Equipment, Net, Including Assets Held For Sale",
        "label": "Property, Plant And Equipment, Net, Including Assets Held For Sale",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_ProviderNetworksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired in a business combination or other transaction. This item represents the value ascribed to the relationships with the acquiree's physicians, hospitals and other health care providers network.",
        "label": "Provider Networks [Member]",
        "terseLabel": "Provider networks"
       }
      }
     },
     "localname": "ProviderNetworksMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RadcliffAndFlaimVAetnaIncEtAlMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Radcliff and Flaim v Aetna Inc., et al",
        "label": "Radcliff and Flaim v Aetna Inc., et al [Member]",
        "terseLabel": "Radcliff and Flaim v Aetna Inc., et al"
       }
      }
     },
     "localname": "RadcliffAndFlaimVAetnaIncEtAlMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RedOakMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Red Oak",
        "label": "Red Oak [Member]",
        "terseLabel": "Red Oak"
       }
      }
     },
     "localname": "RedOakMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RedeemablePreferredSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Preferred Securities [Member]",
        "label": "Redeemable Preferred Securities [Member]",
        "terseLabel": "Redeemable preferred securities"
       }
      }
     },
     "localname": "RedeemablePreferredSecuritiesMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party Transaction, Charitable Contribution To Non-Profit Entity",
        "label": "Related Party Transaction, Charitable Contribution To Non-Profit Entity",
        "terseLabel": "Charitable contribution to CVS Health Foundation"
       }
      }
     },
     "localname": "RelatedPartyTransactionCharitableContributionToNonProfitEntity",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_RestrictedStockUnitsAndPerformanceShareUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units and Performance Share Units [Member]",
        "label": "Restricted Stock Units And Performance Share Units [Member]",
        "terseLabel": "Restricted Stock Units and Performance Share Units"
       }
      }
     },
     "localname": "RestrictedStockUnitsAndPerformanceShareUnitsMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units (RSUs) And Performance Stock Units (PSUs)",
        "label": "Restricted Stock Units (RSUs) And Performance Stock Units (PSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs) and Performance Stock Units (PSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RetailLongTermCareSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retail Long-Term Care Segment [Member]",
        "label": "Retail Long-Term Care Segment [Member]",
        "terseLabel": "Retail LTC"
       }
      }
     },
     "localname": "RetailLongTermCareSegmentMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RevolvingCreditFacilityExpiringMay112026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility, Expiring May 11, 2026",
        "label": "Revolving Credit Facility, Expiring May 11, 2026 [Member]",
        "terseLabel": "Revolving Credit Facility, Expiring May 11, 2026"
       }
      }
     },
     "localname": "RevolvingCreditFacilityExpiringMay112026Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RevolvingCreditFacilityExpiringMay162025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility, Expiring May 16, 2025",
        "label": "Revolving Credit Facility, Expiring May 16, 2025 [Member]",
        "terseLabel": "Revolving Credit Facility, Expiring May 16, 2025"
       }
      }
     },
     "localname": "RevolvingCreditFacilityExpiringMay162025Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RevolvingCreditFacilityExpiringMay162027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility, Expiring May 16, 2027",
        "label": "Revolving Credit Facility, Expiring May 16, 2027 [Member]",
        "terseLabel": "Revolving Credit Facility, Expiring May 16, 2027"
       }
      }
     },
     "localname": "RevolvingCreditFacilityExpiringMay162027Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "label": "Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "terseLabel": "Right-of-use assets obtained in exchange for lease obligations:"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_SalesChannelOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Channel, Other [Member]",
        "label": "Sales Channel, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "SalesChannelOtherMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.",
        "label": "Schedule Of Mortgage Loan Internal Credit Ratings [Table Text Block]",
        "verboseLabel": "Schedule of Mortgage Loan Amortized Cost and Credit Quality Indicator"
       }
      }
     },
     "localname": "ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_SeniorNotes1Point3PercentAugust2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1 Point 3 Percent, August 2027",
        "label": "Senior Notes, 1 Point 3 Percent, August 2027 [Member]",
        "terseLabel": "1.3% senior notes due August 2027"
       }
      }
     },
     "localname": "SeniorNotes1Point3PercentAugust2027Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes1Point75PercentAugust2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1 Point 75 Percent, August 2030",
        "label": "Senior Notes, 1 Point 75 Percent, August 2030 [Member]",
        "terseLabel": "1.75% senior notes due August 2030"
       }
      }
     },
     "localname": "SeniorNotes1Point75PercentAugust2030Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes1Point875PercentFebruary2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1 Point 875 Percent, February 2031",
        "label": "Senior Notes, 1 Point 875 Percent, February 2031 [Member]",
        "terseLabel": "1.875% senior notes due February 2031"
       }
      }
     },
     "localname": "SeniorNotes1Point875PercentFebruary2031Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.625DueAugust2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.625%, Due August 2024 [Member]",
        "label": "Senior Notes, 2.625%, Due August 2024 [Member]",
        "terseLabel": "2.625% senior notes due August 2024"
       }
      }
     },
     "localname": "SeniorNotes2.625DueAugust2024Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.75DueDecember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.75%, Due December 2022 [Member]",
        "label": "Senior Notes, 2.75%, Due December 2022 [Member]",
        "terseLabel": "2.75% senior notes due December 2022"
       }
      }
     },
     "localname": "SeniorNotes2.75DueDecember2022Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.75DueNovember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.75%, Due November 2022 [Member]",
        "label": "Senior Notes, 2.75%, Due November 2022 [Member]",
        "terseLabel": "2.75% senior notes due November 2022"
       }
      }
     },
     "localname": "SeniorNotes2.75DueNovember2022Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.875DueJune2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.875%, Due June 2026 [Member]",
        "label": "Senior Notes, 2.875%, Due June 2026 [Member]",
        "terseLabel": "2.875% senior notes due June 2026"
       }
      }
     },
     "localname": "SeniorNotes2.875DueJune2026Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.8DueJune2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.8%, Due June 2023 [Member]",
        "label": "Senior Notes, 2.8%, Due June 2023 [Member]",
        "terseLabel": "2.8% senior notes due June 2023"
       }
      }
     },
     "localname": "SeniorNotes2.8DueJune2023Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2Point125PercentDueSeptember2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2 Point 125 Percent, Due September 2031",
        "label": "Senior Notes, 2 Point 125 Percent, Due September 2031 [Member]",
        "terseLabel": "2.125% senior notes due September 2031"
       }
      }
     },
     "localname": "SeniorNotes2Point125PercentDueSeptember2031Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2Point7PercentAugust2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2 Point 7 Percent, August 2040",
        "label": "Senior Notes, 2 Point 7 Percent, August 2040 [Member]",
        "terseLabel": "2.7% senior notes due August 2040"
       }
      }
     },
     "localname": "SeniorNotes2Point7PercentAugust2040Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.25DueAugust2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.25%, Due August 2029 [Member]",
        "label": "Senior Notes, 3.25%, Due August 2029 [Member]",
        "terseLabel": "3.25% senior notes due August 2029"
       }
      }
     },
     "localname": "SeniorNotes3.25DueAugust2029Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.375DueAugust2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.375%, Due August 2024 [Member]",
        "label": "Senior Notes, 3.375%, Due August 2024 [Member]",
        "terseLabel": "3.375% senior notes due August 2024"
       }
      }
     },
     "localname": "SeniorNotes3.375DueAugust2024Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.5DueJuly2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.5%, Due July 2022 [Member]",
        "label": "Senior Notes, 3.5%, Due July 2022 [Member]",
        "terseLabel": "3.5% senior notes due July 2022"
       }
      }
     },
     "localname": "SeniorNotes3.5DueJuly2022Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.5DueNovember2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.5%, Due November 2024 [Member]",
        "label": "Senior Notes, 3.5%, Due November 2024 [Member]",
        "terseLabel": "3.5% senior notes due November 2024"
       }
      }
     },
     "localname": "SeniorNotes3.5DueNovember2024Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.7DueMarch2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.7%, Due March 2023 [Member]",
        "label": "Senior Notes, 3.7%, Due March 2023 [Member]",
        "terseLabel": "3.7% senior notes due March 2023"
       }
      }
     },
     "localname": "SeniorNotes3.7DueMarch2023Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.875DueAugust2047Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.875%, Due August 2047 [Member]",
        "label": "Senior Notes, 3.875%, Due August 2047 [Member]",
        "terseLabel": "3.875% senior notes due August 2047"
       }
      }
     },
     "localname": "SeniorNotes3.875DueAugust2047Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.875DueJuly2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.875%, Due July 2025 [Member]",
        "label": "Senior Notes, 3.875%, Due July 2025 [Member]",
        "terseLabel": "3.875% senior notes due July 2025"
       }
      }
     },
     "localname": "SeniorNotes3.875DueJuly2025Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3DueAugust2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3%, Due August 2026 [Member]",
        "label": "Senior Notes, 3%, Due August 2026 [Member]",
        "terseLabel": "3% senior notes due August 2026"
       }
      }
     },
     "localname": "SeniorNotes3DueAugust2026Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3Point625PercentApril2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3 Point 625 Percent, April 2027",
        "label": "Senior Notes, 3 Point 625 Percent, April 2027 [Member]",
        "terseLabel": "3.625% senior notes due April 2027"
       }
      }
     },
     "localname": "SeniorNotes3Point625PercentApril2027Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3Point70PercentDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3 Point 70 Percent, Due 2023",
        "label": "Senior Notes, 3 Point 70 Percent, Due 2023 [Member]",
        "terseLabel": "3.7% senior notes due 2023"
       }
      }
     },
     "localname": "SeniorNotes3Point70PercentDue2023Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3Point75PercentApril2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3 Point 75 Percent, April 2030",
        "label": "Senior Notes, 3 Point 75 Percent, April 2030 [Member]",
        "terseLabel": "3.75% senior notes due April 2030"
       }
      }
     },
     "localname": "SeniorNotes3Point75PercentApril2030Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.125DueNovember2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents senior notes due 2042 with a coupon rate of 4.125%.",
        "label": "Senior Notes, 4.125%, Due November 2042 [Member]",
        "terseLabel": "4.125% senior notes due November 2042"
       }
      }
     },
     "localname": "SeniorNotes4.125DueNovember2042Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.1DueMarch2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.1%, Due March 2025 [Member]",
        "label": "Senior Notes, 4.1%, Due March 2025 [Member]",
        "terseLabel": "4.1% senior notes due March 2025"
       }
      }
     },
     "localname": "SeniorNotes4.1DueMarch2025Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.3DueMarch2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.3%, Due March 2028 [Member]",
        "label": "Senior Notes, 4.3%, Due March 2028 [Member]",
        "terseLabel": "4.3% senior notes due March 2028"
       }
      }
     },
     "localname": "SeniorNotes4.3DueMarch2028Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.5DueMay2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.5%, Due May 2042 [Member]",
        "label": "Senior Notes, 4.5%, Due May 2042 [Member]",
        "terseLabel": "4.5% senior notes due May 2042"
       }
      }
     },
     "localname": "SeniorNotes4.5DueMay2042Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.75DueDecember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.75%, Due December 2022 [Member]",
        "label": "Senior Notes, 4.75%, Due December 2022 [Member]",
        "terseLabel": "4.75% senior notes due December 2022"
       }
      }
     },
     "localname": "SeniorNotes4.75DueDecember2022Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.75DueMarch2044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.75%, Due March 2044 [Member]",
        "label": "Senior Notes, 4.75%, Due March 2044 [Member]",
        "terseLabel": "4.75% senior notes due March 2044"
       }
      }
     },
     "localname": "SeniorNotes4.75DueMarch2044Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.78DueMarch2038Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.78%, Due March 2038 [Member]",
        "label": "Senior Notes, 4.78%, Due March 2038 [Member]",
        "terseLabel": "4.78% senior notes due March 2038"
       }
      }
     },
     "localname": "SeniorNotes4.78DueMarch2038Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.875DueJuly2035Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.875%, Due July 2035 [Member]",
        "label": "Senior Notes, 4.875%, Due July 2035 [Member]",
        "terseLabel": "4.875% senior notes due July 2035"
       }
      }
     },
     "localname": "SeniorNotes4.875DueJuly2035Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes43Due2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.3%, Due 2028",
        "label": "Senior Notes, 4.3%, Due 2028 [Member]",
        "terseLabel": "4.3% senior notes due 2028"
       }
      }
     },
     "localname": "SeniorNotes43Due2028Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4DueDecember2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4%, Due December 2023 [Member]",
        "label": "Senior Notes, 4%, Due December 2023 [Member]",
        "terseLabel": "4% senior notes due December 2023"
       }
      }
     },
     "localname": "SeniorNotes4DueDecember2023Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4Point125PercentApril2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4 Point 125 Percent, April 2040",
        "label": "Senior Notes, 4 Point 125 Percent, April 2040 [Member]",
        "terseLabel": "4.125% senior notes due April 2040"
       }
      }
     },
     "localname": "SeniorNotes4Point125PercentApril2040Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4Point25PercentApril2050Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4 Point 25 Percent, April 2050",
        "label": "Senior Notes, 4 Point 25 Percent, April 2050 [Member]",
        "terseLabel": "4.25% senior notes due April 2050"
       }
      }
     },
     "localname": "SeniorNotes4Point25PercentApril2050Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4PointThreePercentDue2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4 Point Three Percent, Due 2028",
        "label": "Senior Notes, 4 Point Three Percent, Due 2028 [Member]",
        "terseLabel": "4.3% senior notes due 2028"
       }
      }
     },
     "localname": "SeniorNotes4PointThreePercentDue2028Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.05DueMarch2048Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.05%, Due March 2048 [Member]",
        "label": "Senior Notes, 5.05%, Due March 2048 [Member]",
        "terseLabel": "5.05% senior notes due March 2048"
       }
      }
     },
     "localname": "SeniorNotes5.05DueMarch2048Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.125DueJuly2045Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.125%, Due July 2045 [Member]",
        "label": "Senior Notes, 5.125%, Due July 2045 [Member]",
        "terseLabel": "5.125% senior notes due July 2045"
       }
      }
     },
     "localname": "SeniorNotes5.125DueJuly2045Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.3DueDecember2043Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.3%, Due December 2043 [Member]",
        "label": "Senior Notes, 5.3%, Due December 2043 [Member]",
        "terseLabel": "5.3% senior notes due December 2043"
       }
      }
     },
     "localname": "SeniorNotes5.3DueDecember2043Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.75DueMay2041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.75%, Due May 2041 [Member]",
        "label": "Senior Notes, 5.75%, Due May 2041 [Member]",
        "terseLabel": "5.75% senior notes due May 2041"
       }
      }
     },
     "localname": "SeniorNotes5.75DueMay2041Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5DueDecember2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5%, Due December 2024 [Member]",
        "label": "Senior Notes, 5%, Due December 2024 [Member]",
        "terseLabel": "5% senior notes due December 2024"
       }
      }
     },
     "localname": "SeniorNotes5DueDecember2024Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.125DueSeptember2039Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.125%, Due September 2039 [Member]",
        "label": "Senior Notes, 6.125%, Due September 2039 [Member]",
        "terseLabel": "6.125% senior notes due September 2039"
       }
      }
     },
     "localname": "SeniorNotes6.125DueSeptember2039Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.25DueJune2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.25%, Due June 2027 [Member]",
        "label": "Senior Notes, 6.25%, Due June 2027 [Member]",
        "terseLabel": "6.25% senior notes due June 2027"
       }
      }
     },
     "localname": "SeniorNotes6.25DueJune2027Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.625DueJune2036Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.625%, Due June 2036 [Member]",
        "label": "Senior Notes, 6.625%, Due June 2036 [Member]",
        "terseLabel": "6.625% senior notes due June 2036"
       }
      }
     },
     "localname": "SeniorNotes6.625DueJune2036Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.75DueDecember2037Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.75%, Due December 2037 [Member]",
        "label": "Senior Notes, 6.75%, Due December 2037 [Member]",
        "terseLabel": "6.75% senior notes due December 2037"
       }
      }
     },
     "localname": "SeniorNotes6.75DueDecember2037Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeparateAccountFinancialAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Separate Account, Financial Assets",
        "label": "Separate Account, Financial Assets [Member]",
        "terseLabel": "Separate Accounts, financial assets"
       }
      }
     },
     "localname": "SeparateAccountFinancialAssetsMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeparateAccountOtherAssetBackedSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Separate Account, Other Asset-Backed Securities",
        "label": "Separate Account, Other Asset-Backed Securities [Member]",
        "terseLabel": "Other asset-backed securities"
       }
      }
     },
     "localname": "SeparateAccountOtherAssetBackedSecuritiesMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SettlementFrameworkAndOtherOpioidRelatedClaimsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settlement Framework And Other Opioid-Related Claims",
        "label": "Settlement Framework And Other Opioid-Related Claims [Member]",
        "terseLabel": "Settlement Framework and Other Opioid-Related Claims"
       }
      }
     },
     "localname": "SettlementFrameworkAndOtherOpioidRelatedClaimsMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SettlementFrameworkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settlement Framework",
        "label": "Settlement Framework [Member]",
        "terseLabel": "Settlement Framework"
       }
      }
     },
     "localname": "SettlementFrameworkMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested In Period, Actual Payout Rates",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested In Period, Actual Payout Rates",
        "terseLabel": "Restricted stock units and performance stock units vested if actual payout rates are applied (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodActualPayoutRates",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Equity Instruments Other Than Options, Vested In Period, Fair Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Equity Instruments Other Than Options, Vested In Period, Fair Value",
        "terseLabel": "Fair value of stock options and SARs vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Number",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Number",
        "terseLabel": "Expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Payment Arrangement, Option, Granted Prior Through 2018",
        "label": "Share-Based Payment Arrangement, Option, Granted Prior Through 2018 [Member]",
        "terseLabel": "Stock options granted through 2018"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Payment Arrangement, Option, Granted Subsequent to 2018",
        "label": "Share-Based Payment Arrangement, Option, Granted Subsequent to 2018 [Member]",
        "terseLabel": "Stock options granted subsequent to 2018"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SharesHeldInTrustPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares Held In Trust [Policy Text Block]",
        "label": "Shares Held In Trust [Policy Text Block]",
        "terseLabel": "Shares Held in Trust"
       }
      }
     },
     "localname": "SharesHeldInTrustPolicyTextBlock",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_SignifyHealthIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Signify Health, Inc.",
        "label": "Signify Health, Inc. [Member]",
        "terseLabel": "Signify Health, Inc."
       }
      }
     },
     "localname": "SignifyHealthIncMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_StateOfFloridaSettlementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State Of Florida Settlement",
        "label": "State Of Florida Settlement [Member]",
        "terseLabel": "State of Florida Settlement"
       }
      }
     },
     "localname": "StateOfFloridaSettlementMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Employee Stock Purchase Plan, Average Purchase Price of Shares Purchased",
        "label": "Stock Issued During Period, Employee Stock Purchase Plan, Average Purchase Price of Shares Purchased",
        "terseLabel": "Average purchase price of shares purchased (in dollars per share)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cvs_StockOptionsAndStockAppreciationRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Options And Stock Appreciation Rights",
        "label": "Stock Options And Stock Appreciation Rights [Member]",
        "terseLabel": "Stock Options and Stock Appreciation Rights"
       }
      }
     },
     "localname": "StockOptionsAndStockAppreciationRightsMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stockholders' Equity, Including Portion Attributable To Noncontrolling Interest, Pretax",
        "label": "Stockholders' Equity, Including Portion Attributable To Noncontrolling Interest, Pretax",
        "terseLabel": "Adoption of new accounting standard, pre-tax"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestPretax",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_StoreImpairmentCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Store Impairment Charges",
        "label": "Store Impairment Charges",
        "terseLabel": "Store impairments",
        "verboseLabel": "Store impairment charges"
       }
      }
     },
     "localname": "StoreImpairmentCharges",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_SupportingExperienceRatedProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supporting discontinued and experience-rated products.",
        "label": "Supporting Experience Rated Products [Member]",
        "terseLabel": "Supporting experience- rated products"
       }
      }
     },
     "localname": "SupportingExperienceRatedProductsMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SupportingRemainingProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities in an unrealized capital loss position supporting remaining products.",
        "label": "Supporting Remaining Products [Member]",
        "terseLabel": "Supporting remaining products"
       }
      }
     },
     "localname": "SupportingRemainingProductsMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ThailandBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Thailand Business",
        "label": "Thailand Business [Member]",
        "terseLabel": "Thailand Business"
       }
      }
     },
     "localname": "ThailandBusinessMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_TotalInvestmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Axis]",
        "terseLabel": "Total Investments [Axis]"
       }
      }
     },
     "localname": "TotalInvestmentsAxis",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Domain]",
        "terseLabel": "Total Investments [Domain]"
       }
      }
     },
     "localname": "TotalInvestmentsDomain",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_TotalInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Line Items]",
        "terseLabel": "Total Investments [Line Items]"
       }
      }
     },
     "localname": "TotalInvestmentsLineItems",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Table]",
        "terseLabel": "Total Investments [Table]"
       }
      }
     },
     "localname": "TotalInvestmentsTable",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item includes total investments, both current and long-term.",
        "label": "Total Investments [Table Text Block]",
        "verboseLabel": "Schedule of Total Investments"
       }
      }
     },
     "localname": "TotalInvestmentsTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_TransferOfSharesToTreasuryStockValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transfer Of Shares To Treasury Stock Value",
        "label": "Transfer Of Shares To Treasury Stock Value",
        "terseLabel": "Transfer of shares to treasury stock value"
       }
      }
     },
     "localname": "TransferOfSharesToTreasuryStockValue",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance",
        "label": "Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance",
        "negatedTerseLabel": "Purchase of treasury shares, net of ESPP issuances (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_TreasuryStockSharesHeldinTrust": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Shares, Held in Trust",
        "label": "Treasury Stock, Shares, Held in Trust",
        "terseLabel": "Treasury shares held in trust (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesHeldinTrust",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance",
        "label": "Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance",
        "negatedTerseLabel": "Purchase of treasury shares, net of ESPP issuances"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_TreasuryStockValueSharesHeldInTrust": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Value, Shares Held In Trust",
        "label": "Treasury Stock, Value, Shares Held In Trust",
        "terseLabel": "Treasury shares held in trust"
       }
      }
     },
     "localname": "TreasuryStockValueSharesHeldInTrust",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_TribalEntitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tribal Entities",
        "label": "Tribal Entities [Member]",
        "terseLabel": "Tribal Entities"
       }
      }
     },
     "localname": "TribalEntitiesMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Department Of Health And Human Services, ACA Risk Corridor Receivables",
        "label": "U.S. Department Of Health And Human Services, ACA Risk Corridor Receivables [Member]",
        "terseLabel": "U.S. Department of Health and Human Services, ACA Risk Corridor Receivables"
       }
      }
     },
     "localname": "USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_USFederalGovernmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Federal Government",
        "label": "US Federal Government [Member]",
        "terseLabel": "US Federal Government"
       }
      }
     },
     "localname": "USFederalGovernmentMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_VOYARetirementInsuranceAndAnnuityCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "VOYA Retirement Insurance And Annuity Company [Member]",
        "label": "VOYA Retirement Insurance And Annuity Company [Member]",
        "terseLabel": "VOYA Retirement Insurance and Annuity Company"
       }
      }
     },
     "localname": "VOYARetirementInsuranceAndAnnuityCompanyMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ValueOfBusinessAcquiredMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value Of Business Acquired [Member]",
        "label": "Value Of Business Acquired [Member]",
        "terseLabel": "Value of Business Acquired"
       }
      }
     },
     "localname": "ValueOfBusinessAcquiredMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_VariableInterestEntityAmendedContractExtensionTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entity, Amended Contract Extension Term",
        "label": "Variable Interest Entity, Amended Contract Extension Term",
        "terseLabel": "Amended contract extension term"
       }
      }
     },
     "localname": "VariableInterestEntityAmendedContractExtensionTerm",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_VariableInterestEntityAmendedContractTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entity, Amended Contract Term",
        "label": "Variable Interest Entity, Amended Contract Term",
        "terseLabel": "Amended contract term (in years)"
       }
      }
     },
     "localname": "VariableInterestEntityAmendedContractTerm",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vendor Allowances And Purchase Discounts",
        "label": "Vendor Allowances And Purchase Discounts [Policy Text Block]",
        "terseLabel": "Vendor Allowances and Purchase Discounts"
       }
      }
     },
     "localname": "VendorAllowancesAndPurchaseDiscountsPolicyTextBlock",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_VendorandManufacturerReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 1.0,
       "parentTag": "cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vendor and Manufacturer Receivables",
        "label": "Vendor and Manufacturer Receivables",
        "terseLabel": "Vendor and manufacturer receivables"
       }
      }
     },
     "localname": "VendorandManufacturerReceivables",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_WeightedAverageRemainingLeaseTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Lease Term [Abstract]",
        "label": "Weighted Average Remaining Lease Term [Abstract]",
        "terseLabel": "Weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "WeightedAverageRemainingLeaseTermAbstract",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_YearOfOriginationPeriodFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination Period Five",
        "label": "Year Of Origination Period Five [Member]",
        "terseLabel": "2018"
       }
      }
     },
     "localname": "YearOfOriginationPeriodFiveMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination Period Four",
        "label": "Year Of Origination Period Four [Member]",
        "terseLabel": "2019"
       }
      }
     },
     "localname": "YearOfOriginationPeriodFourMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination Period One",
        "label": "Year Of Origination Period One [Member]",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "YearOfOriginationPeriodOneMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination Period Three",
        "label": "Year Of Origination Period Three [Member]",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "YearOfOriginationPeriodThreeMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination Period Two",
        "label": "Year Of Origination Period Two [Member]",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "YearOfOriginationPeriodTwoMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPriorToPeriodFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination Prior To Period Five",
        "label": "Year Of Origination Prior To Period Five [Member]",
        "terseLabel": "Prior"
       }
      }
     },
     "localname": "YearOfOriginationPriorToPeriodFiveMember",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yield Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings",
        "label": "Yield Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings",
        "terseLabel": "Yield-related impairment loss"
       }
      }
     },
     "localname": "YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "nsuri": "http://www.cvshealth.com/20230525",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r1200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r1201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r1202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r1203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r421",
      "r825",
      "r826",
      "r831",
      "r832",
      "r920",
      "r1096",
      "r1101",
      "r1283",
      "r1286",
      "r1287",
      "r1384",
      "r1387",
      "r1388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by consolidated entity or group of entities.",
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r421",
      "r825",
      "r826",
      "r831",
      "r832",
      "r920",
      "r1096",
      "r1101",
      "r1283",
      "r1286",
      "r1287",
      "r1384",
      "r1387",
      "r1388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity or group of entities consolidated into reporting entity.",
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r421",
      "r467",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r491",
      "r495",
      "r584",
      "r585",
      "r586",
      "r587",
      "r589",
      "r590",
      "r592",
      "r594",
      "r595",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1284",
      "r1285",
      "r1385",
      "r1386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r421",
      "r467",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r491",
      "r495",
      "r584",
      "r585",
      "r586",
      "r587",
      "r589",
      "r590",
      "r592",
      "r594",
      "r595",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1284",
      "r1285",
      "r1385",
      "r1386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r418",
      "r419",
      "r600",
      "r627",
      "r1122",
      "r1126",
      "r1128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r355",
      "r426",
      "r434",
      "r441",
      "r531",
      "r773",
      "r774",
      "r775",
      "r806",
      "r807",
      "r839",
      "r842",
      "r844",
      "r845",
      "r917"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r355",
      "r426",
      "r434",
      "r441",
      "r531",
      "r773",
      "r774",
      "r775",
      "r806",
      "r807",
      "r839",
      "r842",
      "r844",
      "r845",
      "r917"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r355",
      "r426",
      "r434",
      "r441",
      "r531",
      "r773",
      "r774",
      "r775",
      "r806",
      "r807",
      "r839",
      "r842",
      "r844",
      "r845",
      "r917"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.",
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.",
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r500",
      "r1150",
      "r1292",
      "r1369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r580",
      "r581",
      "r582",
      "r583",
      "r731",
      "r955",
      "r1025",
      "r1097",
      "r1098",
      "r1147",
      "r1165",
      "r1188",
      "r1288",
      "r1352",
      "r1353",
      "r1354",
      "r1355",
      "r1356",
      "r1357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r580",
      "r581",
      "r582",
      "r583",
      "r731",
      "r955",
      "r1025",
      "r1097",
      "r1098",
      "r1147",
      "r1165",
      "r1188",
      "r1288",
      "r1352",
      "r1353",
      "r1354",
      "r1355",
      "r1356",
      "r1357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": {
     "auth_ref": [
      "r1075",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1100",
      "r1102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of real estate property.",
        "label": "Real Estate, Type of Property [Axis]",
        "terseLabel": "Real Estate, Type of Property [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MortgageLoansOnRealEstateLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]",
        "terseLabel": "Mortgage Loans on Real Estate [Line Items]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateLineItems",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": {
     "auth_ref": [
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1100",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Land and any structures permanently fixed to it.",
        "label": "Real Estate [Domain]",
        "terseLabel": "Real Estate [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MortgageLoansOnRealEstateScheduleTable": {
     "auth_ref": [
      "r1077",
      "r1112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table]",
        "terseLabel": "Mortgage Loans on Real Estate [Table]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateScheduleTable",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r500",
      "r1150",
      "r1292",
      "r1369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r497",
      "r957",
      "r1148",
      "r1176",
      "r1279",
      "r1280",
      "r1292",
      "r1365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r497",
      "r957",
      "r1148",
      "r1176",
      "r1279",
      "r1280",
      "r1292",
      "r1365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r580",
      "r581",
      "r582",
      "r583",
      "r681",
      "r731",
      "r764",
      "r765",
      "r766",
      "r928",
      "r955",
      "r1025",
      "r1097",
      "r1098",
      "r1147",
      "r1165",
      "r1188",
      "r1275",
      "r1288",
      "r1353",
      "r1354",
      "r1355",
      "r1356",
      "r1357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r580",
      "r581",
      "r582",
      "r583",
      "r681",
      "r731",
      "r764",
      "r765",
      "r766",
      "r928",
      "r955",
      "r1025",
      "r1097",
      "r1098",
      "r1147",
      "r1165",
      "r1188",
      "r1275",
      "r1288",
      "r1353",
      "r1354",
      "r1355",
      "r1356",
      "r1357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r418",
      "r419",
      "r600",
      "r627",
      "r1127",
      "r1128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAdjustmentMember": {
     "auth_ref": [
      "r423",
      "r424",
      "r425",
      "r436",
      "r437",
      "r455",
      "r844",
      "r845",
      "r1228",
      "r1229",
      "r1231",
      "r1232",
      "r1234",
      "r1238",
      "r1239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative increase (decrease) for adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.",
        "label": "Revision of Prior Period, Adjustment [Member]",
        "terseLabel": "Adjustments"
       }
      }
     },
     "localname": "RestatementAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r356",
      "r423",
      "r424",
      "r425",
      "r427",
      "r428",
      "r431",
      "r432",
      "r433",
      "r434",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r455",
      "r532",
      "r533",
      "r807",
      "r840",
      "r844",
      "r845",
      "r846",
      "r889",
      "r918",
      "r919",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.",
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r356",
      "r423",
      "r424",
      "r425",
      "r427",
      "r428",
      "r431",
      "r432",
      "r433",
      "r434",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r455",
      "r532",
      "r533",
      "r807",
      "r840",
      "r844",
      "r845",
      "r846",
      "r889",
      "r918",
      "r919",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.",
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember": {
     "auth_ref": [
      "r356",
      "r427",
      "r428",
      "r434",
      "r441",
      "r532",
      "r533",
      "r807",
      "r840",
      "r846",
      "r889",
      "r918",
      "r919",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative increase (decrease) to previously issued financial statements for retrospective application of amendment to accounting standards and adjustment for reclassification from amendment to accounting standards.",
        "label": "Revision of Prior Period, Accounting Standards Update, Adjustment [Member]",
        "terseLabel": "Adjustments"
       }
      }
     },
     "localname": "RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r732",
      "r1235",
      "r1383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.",
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r356",
      "r423",
      "r425",
      "r427",
      "r428",
      "r431",
      "r432",
      "r440",
      "r455",
      "r807",
      "r840",
      "r844",
      "r845",
      "r889",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1233",
      "r1234",
      "r1236",
      "r1237",
      "r1238",
      "r1258",
      "r1259",
      "r1339",
      "r1348",
      "r1349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount as previously reported before adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.",
        "label": "Previously Reported [Member]",
        "terseLabel": "As Reported"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r441",
      "r732",
      "r1204",
      "r1235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r441",
      "r732",
      "r1204",
      "r1205",
      "r1235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock": {
     "auth_ref": [
      "r1001",
      "r1111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the supplemental schedule of reinsurance information. Reinsurance schedule includes, but is not limited to, the type of insurance, gross amount of premiums, premiums ceded to other entities, premiums assumed from other entities, net amount of premium revenue, and the percentage of the premiums assumed to net premium revenue.",
        "label": "SEC Schedule, 12-17, Insurance Companies, Reinsurance [Text Block]",
        "terseLabel": "Schedule of Direct, Assumed and Ceded Premiums Earned"
       }
      }
     },
     "localname": "SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201613Member": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.",
        "label": "Accounting Standards Update 2016-13 [Member]",
        "terseLabel": "ASU 2016-13"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201613Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201812Member": {
     "auth_ref": [
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2018-12 Financial Services-Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts.",
        "label": "Accounting Standards Update 2018-12 [Member]",
        "terseLabel": "Accounting Standards Update 2018-12"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201812Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r427",
      "r428",
      "r429",
      "r505",
      "r506",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r773",
      "r774",
      "r775",
      "r806",
      "r807",
      "r821",
      "r822",
      "r823",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r882",
      "r883",
      "r886",
      "r887",
      "r888",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableMember": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations incurred and payable to vendors for goods and services received.",
        "label": "Accounts Payable [Member]",
        "terseLabel": "Other payables"
       }
      }
     },
     "localname": "AccountsPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r23",
      "r40"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r1081"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r502",
      "r503"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r58",
      "r63",
      "r231",
      "r392",
      "r1210",
      "r1211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Pension and other postretirement benefits"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r157",
      "r367"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r57",
      "r63",
      "r231",
      "r392",
      "r1210",
      "r1211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember": {
     "auth_ref": [
      "r385",
      "r392",
      "r829",
      "r1210",
      "r1211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, including portion attributable to noncontrolling interest.",
        "label": "Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]",
        "terseLabel": "Net cash flow hedges"
       }
      }
     },
     "localname": "AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r380",
      "r381",
      "r382",
      "r385",
      "r392",
      "r1210",
      "r1211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member]",
        "terseLabel": "Net unrealized investment gains (losses)"
       }
      }
     },
     "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r61",
      "r62",
      "r63",
      "r373",
      "r987",
      "r1033",
      "r1037"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "negatedTerseLabel": "Reduction to accumulated other comprehensive income (loss)",
        "verboseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r60",
      "r63",
      "r231",
      "r919",
      "r1028",
      "r1029",
      "r1209",
      "r1210",
      "r1211",
      "r1225",
      "r1226",
      "r1227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Condensed Consolidated Statement of Cash Flows:"
       }
      }
     },
     "localname": "AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r427",
      "r428",
      "r429",
      "r430",
      "r441",
      "r505",
      "r506",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r773",
      "r774",
      "r775",
      "r804",
      "r805",
      "r806",
      "r807",
      "r821",
      "r822",
      "r823",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r882",
      "r883",
      "r886",
      "r887",
      "r888",
      "r889",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r959",
      "r960",
      "r961",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments required to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising Costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r779"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising costs"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r768"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocationsToPolicyholdersPolicies": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining amounts of income and expenses allocated to policyholders and contract holders, excluding the method for determining dividends payable to policyholders and accounting policies pertaining to separate accounts for variable annuity contracts.",
        "label": "Allocations to Policyholders, Policies [Policy Text Block]",
        "terseLabel": "Policyholders' Funds"
       }
      }
     },
     "localname": "AllocationsToPolicyholdersPolicies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r374",
      "r504",
      "r534",
      "r536",
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries": {
     "auth_ref": [
      "r537"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in allowance for credit loss on accounts receivable, from recovery.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Recovery",
        "negatedTerseLabel": "Receipt of fully reserved ACA risk corridor receivable"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRecoveries",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r93",
      "r140",
      "r146"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Antidilutive securities excluded from computation of EPS (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r60",
      "r63",
      "r231",
      "r1209",
      "r1210",
      "r1211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax": {
     "auth_ref": [
      "r1183",
      "r1187",
      "r1366",
      "r1371"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) (AOCI) from (increase) decrease in expected future policy benefit component of liability for future policy benefit from change in discount rate.",
        "label": "AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax",
        "negatedPeriodEndLabel": "Add: Impact of discount rate on long-duration insurance reserves",
        "negatedPeriodStartLabel": "Less: Impact of discount rate on long-duration insurance reserves",
        "negatedTerseLabel": "Effect of changes in discount rate assumptions"
       }
      }
     },
     "localname": "AociLiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax": {
     "auth_ref": [
      "r1183",
      "r1187",
      "r1366",
      "r1371"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) (AOCI) from increase (decrease) in expected net premium component of liability for future policy benefit from change in discount rate.",
        "label": "AOCI, Liability for Future Policy Benefit, Expected Net Premium, before Tax",
        "terseLabel": "Effect of changes in discount rate assumptions"
       }
      }
     },
     "localname": "AociLiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r1155",
      "r1251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-Backed Securities [Member]",
        "terseLabel": "Other asset-backed securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r277",
      "r304",
      "r371",
      "r415",
      "r475",
      "r487",
      "r493",
      "r526",
      "r584",
      "r585",
      "r587",
      "r588",
      "r589",
      "r591",
      "r593",
      "r595",
      "r596",
      "r825",
      "r831",
      "r864",
      "r1173",
      "r1284",
      "r1285",
      "r1350"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r361",
      "r378",
      "r415",
      "r526",
      "r584",
      "r585",
      "r587",
      "r588",
      "r589",
      "r591",
      "r593",
      "r595",
      "r596",
      "r825",
      "r831",
      "r864",
      "r1173",
      "r1284",
      "r1285",
      "r1350"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "terseLabel": "Total current assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r256"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsHeldByInsuranceRegulators": {
     "auth_ref": [
      "r1054"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of cash and investment securities on deposit with state regulatory authorities in connection with capital requirements.",
        "label": "Assets Held by Insurance Regulators",
        "terseLabel": "Investments on deposit with regulatory bodies"
       }
      }
     },
     "localname": "AssetsHeldByInsuranceRegulators",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r15",
      "r159",
      "r359",
      "r360"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "totalLabel": "Total assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Assets [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r15",
      "r154",
      "r159",
      "r359",
      "r360"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssumedPremiumsEarned": {
     "auth_ref": [
      "r317",
      "r999",
      "r1042",
      "r1045"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PremiumsEarnedNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of earned premiums assumed from other entities.",
        "label": "Assumed Premiums Earned",
        "terseLabel": "Assumed"
       }
      }
     },
     "localname": "AssumedPremiumsEarned",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r508",
      "r543"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "terseLabel": "Gross Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]",
        "terseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r129",
      "r512",
      "r975"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r131"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r129",
      "r511",
      "r974"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r129",
      "r513",
      "r976"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r129",
      "r510",
      "r973"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": {
     "auth_ref": [
      "r514"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost",
        "terseLabel": "Debt securities, maturity, without single maturity date"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
     "auth_ref": [
      "r134",
      "r977"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value",
        "terseLabel": "Debt securities, maturity, without single maturity date"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r126",
      "r507",
      "r543",
      "r964"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Debt securities",
        "totalLabel": "Total",
        "verboseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Number of Positions [Abstract]",
        "terseLabel": "Number of Securities"
       }
      }
     },
     "localname": "AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r739",
      "r740",
      "r741",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r248",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Condensed Consolidated Balance Sheet:"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "verboseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Buildings, building improvements and leasehold improvements",
        "verboseLabel": "Building and improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Distribution centers and Corporate offices"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r820",
      "r1159",
      "r1162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r217",
      "r218",
      "r820",
      "r1159",
      "r1162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Cash to be received by shareholders in proposed/pending acquisition (in dollars per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r220",
      "r221",
      "r222"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Total value of proposed/pending acquisition"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "verboseLabel": "Acquisition-related integration costs"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferred policy acquisition costs, including the nature, type, and amount of capitalized costs incurred to write or acquire insurance contracts, and the basis for and methodologies applied in capitalizing and amortizing such costs.",
        "label": "Deferred Policy Acquisition Costs, Policy [Policy Text Block]",
        "terseLabel": "Health Care Contract Acquisition Costs"
       }
      }
     },
     "localname": "CapitalizationOfDeferredPolicyAcquisitionCostsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r261",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r95",
      "r364",
      "r1123"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r96",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r88",
      "r95",
      "r99"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at the end of the period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at the beginning of the period",
        "totalLabel": "Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r88",
      "r267"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashDivestedFromDeconsolidation": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction in cash due to no longer including the former subsidiary's cash in the consolidated entity's cash.",
        "label": "Cash Divested from Deconsolidation",
        "terseLabel": "Cash and restricted cash sold"
       }
      }
     },
     "localname": "CashDivestedFromDeconsolidation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlowsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries": {
     "auth_ref": [
      "r422"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents disclosure of the aggregate cash dividends paid to the entity by consolidated subsidiaries.",
        "label": "SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Consolidated Subsidiaries",
        "terseLabel": "Dividends paid"
       }
      }
     },
     "localname": "CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash received from exercise of stock options and similar instruments granted under share-based payment arrangements and tax benefit from exercise of stock options.",
        "label": "Cash Proceeds Received and Tax Benefit from Share-Based Payment Awards [Table Text Block]",
        "terseLabel": "Summary of Stock Option and SAR Activity"
       }
      }
     },
     "localname": "CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashSurrenderValueDuePolicyholdersAmount": {
     "auth_ref": [
      "r1023",
      "r1188"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash to be paid to policyholder upon termination and surrender of long-duration contract issued by insurance entity.",
        "label": "Policyholder Account Balance, Cash Surrender Value",
        "terseLabel": "Cash surrender value"
       }
      }
     },
     "localname": "CashSurrenderValueDuePolicyholdersAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CededCreditRiskAxis": {
     "auth_ref": [
      "r1359",
      "r1375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of reinsurer or group of reinsurers in reinsurance contract.",
        "label": "Reinsurer, Name [Axis]",
        "terseLabel": "Ceded Credit Risk, Reinsurer [Axis]"
       }
      }
     },
     "localname": "CededCreditRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CededCreditRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Ceded Credit Risk [Line Items]",
        "terseLabel": "Ceded Credit Risk [Line Items]"
       }
      }
     },
     "localname": "CededCreditRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails",
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CededCreditRiskReinsurerDomain": {
     "auth_ref": [
      "r1359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of reinsurer or group of reinsurers in reinsurance contract.",
        "label": "Reinsurer, Name [Domain]",
        "terseLabel": "Ceded Credit Risk, Reinsurer [Domain]"
       }
      }
     },
     "localname": "CededCreditRiskReinsurerDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CededCreditRiskTable": {
     "auth_ref": [
      "r1056"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about reinsurer or group of reinsurers for whom the entity has a concentration of credit risk.",
        "label": "Ceded Credit Risk [Table]",
        "terseLabel": "Ceded Credit Risk [Table]"
       }
      }
     },
     "localname": "CededCreditRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails",
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CededPremiumsEarned": {
     "auth_ref": [
      "r317",
      "r998",
      "r1039",
      "r1040",
      "r1043",
      "r1045"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PremiumsEarnedNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of earned premiums ceded to other entities.",
        "label": "Ceded Premiums Earned",
        "negatedTerseLabel": "Ceded"
       }
      }
     },
     "localname": "CededPremiumsEarned",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Contract with Customer, Liability [Abstract]",
        "terseLabel": "Change in Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClaimsDevelopmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Claims Development [Line Items]",
        "terseLabel": "Claims Development [Line Items]"
       }
      }
     },
     "localname": "ClaimsDevelopmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r179",
      "r180",
      "r181",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r134",
      "r1296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by commercial real estate mortgage loans.",
        "label": "Commercial Mortgage-Backed Securities [Member]",
        "terseLabel": "Commercial mortgage-backed securities"
       }
      }
     },
     "localname": "CommercialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialRealEstateMember": {
     "auth_ref": [
      "r1136",
      "r1296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property that is solely used for business purposes.",
        "label": "Commercial Real Estate [Member]",
        "terseLabel": "Commercial Real Estate"
       }
      }
     },
     "localname": "CommercialRealEstateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r50",
      "r286",
      "r311"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 17)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r162",
      "r577",
      "r578",
      "r1083",
      "r1282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Capital shares reserved for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock held by shareholders with par value plus amounts in excess of par value or issuance value (in cases of no-par value stock).",
        "label": "Common Stock Including Additional Paid in Capital [Member]",
        "terseLabel": "Common Stock and Capital Surplus"
       }
      }
     },
     "localname": "CommonStockIncludingAdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r1225",
      "r1226",
      "r1338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Shares"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r34",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r34",
      "r1173"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStocksIncludingAdditionalPaidInCapital": {
     "auth_ref": [
      "r34",
      "r35",
      "r178"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of par value plus amounts in excess of par value or issuance value for common stock issued.",
        "label": "Common Stocks, Including Additional Paid in Capital",
        "terseLabel": "Common stock, par value $0.01: 3,200 shares authorized; 1,758 shares issued and 1,300 shares outstanding at December\u00a031, 2022 and 1,744 shares issued and 1,322 shares outstanding at December\u00a031, 2021 and capital surplus"
       }
      }
     },
     "localname": "CommonStocksIncludingAdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred income tax assets:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]",
        "terseLabel": "Components of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Liabilities [Abstract]",
        "terseLabel": "Deferred income tax liabilities:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r64",
      "r388",
      "r390",
      "r399",
      "r968",
      "r993"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to CVS Health"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r227",
      "r243",
      "r388",
      "r390",
      "r398",
      "r967",
      "r992"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r77",
      "r397",
      "r966",
      "r990"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r109",
      "r110",
      "r263",
      "r264",
      "r500",
      "r1081"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r109",
      "r110",
      "r263",
      "r264",
      "r500",
      "r1056",
      "r1081"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r109",
      "r110",
      "r263",
      "r264",
      "r500",
      "r1081",
      "r1375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r109",
      "r110",
      "r263",
      "r264",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percent"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r107",
      "r109",
      "r110",
      "r111",
      "r263",
      "r265",
      "r1081"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r109",
      "r110",
      "r263",
      "r264",
      "r500",
      "r1081"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "auth_ref": [
      "r232",
      "r234",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "terseLabel": "Variable Interest Entities"
       }
      }
     },
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r1291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Schedule of receivables and contract liabilities from contracts with customers"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r641",
      "r643",
      "r654"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 4.0,
       "parentTag": "cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Trade receivables (included in accounts receivable, net)",
        "verboseLabel": "Trade receivables"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r641",
      "r642",
      "r654"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "periodEndLabel": "Contract liabilities, end of period",
        "periodStartLabel": "Contract liabilities, beginning of period",
        "terseLabel": "Contract liabilities (included in accrued expenses)"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "auth_ref": [
      "r1154",
      "r1292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by sales channel for delivery of good or service in contract with customer.",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "terseLabel": "Contract with Customer, Sales Channel [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "auth_ref": [
      "r1154",
      "r1292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "terseLabel": "Contract with Customer, Sales Channel [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateAndOtherMember": {
     "auth_ref": [
      "r1242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that provides financial and operational oversight and administrative support for other segments and other segments not separately reported due to size or nature of business activities. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate and Other [Member]",
        "terseLabel": "Corporate/ Other"
       }
      }
     },
     "localname": "CorporateAndOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r121",
      "r486",
      "r487",
      "r488",
      "r489",
      "r495",
      "r1244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate/ Other"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r72",
      "r957"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r1294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Cost of Products Sold"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "terseLabel": "Total operating costs",
        "totalLabel": "Total operating costs"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r1223",
      "r1331",
      "r1333"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r216",
      "r801",
      "r811",
      "r1223"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current taxes"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r1223",
      "r1331",
      "r1333"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r108",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelatedIntangibleAssetsMember": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships.",
        "label": "Customer-Related Intangible Assets [Member]",
        "terseLabel": "Customer contracts/relationships and covenants not to compete"
       }
      }
     },
     "localname": "CustomerRelatedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r171",
      "r413",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r613",
      "r620",
      "r621",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Borrowings and Credit Agreements"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r278",
      "r280",
      "r300",
      "r421",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r603",
      "r609",
      "r610",
      "r611",
      "r612",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r885",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r29",
      "r280",
      "r300",
      "r624"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails": {
       "order": 1.0,
       "parentTag": "cvs_LongtermDebtGrossAndLeaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Long-term debt",
        "totalLabel": "Subtotal"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r269",
      "r271",
      "r597",
      "r885",
      "r1143",
      "r1144"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r611",
      "r863",
      "r1143",
      "r1144"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r47",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r48",
      "r421",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r603",
      "r609",
      "r610",
      "r611",
      "r612",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r885",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r48",
      "r174",
      "r175",
      "r176",
      "r177",
      "r268",
      "r269",
      "r271",
      "r295",
      "r421",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r603",
      "r609",
      "r610",
      "r611",
      "r612",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r622",
      "r885",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r268",
      "r271",
      "r1289"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "terseLabel": "Debt premiums"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r509",
      "r543",
      "r550",
      "r551"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss",
        "negatedTerseLabel": "Allowance for Credit Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss": {
     "auth_ref": [
      "r1250"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, after Allowance for Credit Loss",
        "totalLabel": "Net Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r520",
      "r548",
      "r1139"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "Fair Value, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r520",
      "r548"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "terseLabel": "Unrealized Losses, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions": {
     "auth_ref": [
      "r1262"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions",
        "terseLabel": "Number of Securities, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r520",
      "r548",
      "r1139"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "verboseLabel": "Fair Value, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r520",
      "r548"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "verboseLabel": "Unrealized Losses, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions": {
     "auth_ref": [
      "r1262"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions",
        "terseLabel": "Number of Securities, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGain": {
     "auth_ref": [
      "r521"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Realized Gain",
        "terseLabel": "Gross realized capital gains"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss": {
     "auth_ref": [
      "r521"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Realized Loss",
        "terseLabel": "Gross realized capital losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r1253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "terseLabel": "Schedule of Debt Securities Available For Sale"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r517",
      "r544",
      "r1139"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position",
        "totalLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r518",
      "r545"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss",
        "totalLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r519",
      "r546"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions",
        "totalLabel": "Number of Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r1223",
      "r1332",
      "r1333"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r93",
      "r216",
      "r802",
      "r810",
      "r811",
      "r1223"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r31",
      "r32",
      "r279",
      "r299",
      "r797"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r783",
      "r784"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense": {
     "auth_ref": [
      "r980",
      "r995",
      "r1002",
      "r1003",
      "r1031",
      "r1175",
      "r1219"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense (reversal of expense) for deferred policy acquisition costs.",
        "label": "Deferred Policy Acquisition Costs, Amortization Expense",
        "negatedTerseLabel": "Amortization expense"
       }
      }
     },
     "localname": "DeferredPolicyAcquisitionCostAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDeferredAcquisitionCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredPolicyAcquisitionCosts": {
     "auth_ref": [
      "r988",
      "r1003",
      "r1004",
      "r1031",
      "r1053",
      "r1175"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred policy acquisition cost capitalized on contract remaining in force.",
        "label": "Deferred Policy Acquisition Cost",
        "periodEndLabel": "Deferred acquisition costs, end of the period",
        "periodStartLabel": "Deferred acquisition costs, beginning of the period",
        "terseLabel": "Deferred acquisition costs"
       }
      }
     },
     "localname": "DeferredPolicyAcquisitionCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDeferredAcquisitionCostsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredPolicyAcquisitionCostsAdditions": {
     "auth_ref": [
      "r1175",
      "r1363",
      "r1371"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred policy acquisition cost capitalized.",
        "label": "Deferred Policy Acquisition Cost, Capitalization",
        "terseLabel": "Capitalizations"
       }
      }
     },
     "localname": "DeferredPolicyAcquisitionCostsAdditions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDeferredAcquisitionCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock": {
     "auth_ref": [
      "r326",
      "r1005",
      "r1031",
      "r1175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the movement in deferred policy acquisition costs.",
        "label": "Deferred Policy Acquisition Costs [Table Text Block]",
        "terseLabel": "Rollforward of deferred acquisition costs"
       }
      }
     },
     "localname": "DeferredPolicyAcquisitionCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r1223",
      "r1332",
      "r1333"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r214",
      "r1330"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred Tax Assets, Deferred Income",
        "terseLabel": "Deferred income"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r214",
      "r1330"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments).",
        "label": "Deferred Tax Assets, Investments",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "DeferredTaxAssetsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r1329"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred income tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r214",
      "r1330"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss and capital loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r214",
      "r1330"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation": {
     "auth_ref": [
      "r214",
      "r1330"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation",
        "terseLabel": "Employee benefits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent": {
     "auth_ref": [
      "r214",
      "r1330"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred rent.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent",
        "terseLabel": "Lease and rents"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements": {
     "auth_ref": [
      "r214",
      "r1330"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the estimated loss from legal settlements.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Legal Settlements",
        "terseLabel": "Legal charges"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves": {
     "auth_ref": [
      "r214",
      "r1330"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves",
        "terseLabel": "Insurance reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r798"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Valuation allowance",
        "verboseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r210",
      "r1329"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments).",
        "label": "Deferred Tax Liabilities, Investments",
        "negatedLabel": "Investments"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r214",
      "r1330"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedTerseLabel": "Lease and rents"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r672",
      "r1157"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld": {
     "auth_ref": [
      "r686",
      "r1157"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan from actual return (loss) on assets still held.",
        "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r665"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "negatedTerseLabel": "Actuarial gain"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r658",
      "r697",
      "r719",
      "r1157",
      "r1158"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedTerseLabel": "Amortization of net actuarial loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet": {
     "auth_ref": [
      "r186",
      "r189"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.",
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position",
        "totalLabel": "Net assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract]",
        "terseLabel": "Assets (liabilities) recognized on the consolidated balance sheet"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "auth_ref": [
      "r276",
      "r303",
      "r656",
      "r657",
      "r680",
      "r1157"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "terseLabel": "Noncurrent assets reflected in other assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r705",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets",
        "terseLabel": "Expected long-term rate of return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r660"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "periodEndLabel": "Benefit obligation, end of year",
        "periodStartLabel": "Benefit obligation, beginning of year",
        "terseLabel": "Benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r667",
      "r727"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedTerseLabel": "Benefit payments"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement": {
     "auth_ref": [
      "r1295"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases benefit obligation of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract. Excludes decreases to benefit obligation for remeasurement due to settlement.",
        "label": "Defined Benefit Plan, Benefit Obligation, Payment for Settlement",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationPaymentForSettlement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r681",
      "r682",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r708",
      "r1155",
      "r1156",
      "r1157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r1155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and cash equivalent in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DefinedBenefitPlanCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Change in benefit obligation:"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Change in plan assets:"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember": {
     "auth_ref": [
      "r1296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulated trust, responsible for collective investment and reinvestment of asset from employee benefit plan maintained by more than one employer, in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Common Collective Trust [Member]",
        "verboseLabel": "Common/collective trusts"
       }
      }
     },
     "localname": "DefinedBenefitPlanCommonCollectiveTrustMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r674",
      "r684",
      "r723",
      "r1155",
      "r1156",
      "r1157",
      "r1158"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Employer contributions",
        "verboseLabel": "Employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember": {
     "auth_ref": [
      "r1155",
      "r1156",
      "r1157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security representing ownership in corporation or other legal entity, not domiciled in United States of America (US), for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.",
        "label": "Defined Benefit Plan, Equity Securities, Non-US [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "DefinedBenefitPlanEquitySecuritiesNonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember": {
     "auth_ref": [
      "r1155",
      "r1156",
      "r1157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security representing ownership in corporation or other legal entity, domiciled in United States of America (US), for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.",
        "label": "Defined Benefit Plan, Equity Securities, US [Member]",
        "terseLabel": "U.S. domestic"
       }
      }
     },
     "localname": "DefinedBenefitPlanEquitySecuritiesUsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r691"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "2028-2032"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r691"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r691"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r691"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r691"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r691"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r658",
      "r696",
      "r718",
      "r1157",
      "r1158"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r671",
      "r682",
      "r684",
      "r685",
      "r1155",
      "r1156",
      "r1157"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r656",
      "r680",
      "r1157"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "totalLabel": "Funded status"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r658",
      "r663",
      "r695",
      "r717",
      "r1157",
      "r1158"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r693",
      "r715",
      "r1157",
      "r1158"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "terseLabel": "Net periodic benefit cost",
        "totalLabel": "Net periodic benefit cost (income)"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]",
        "terseLabel": "Components of net periodic benefit cost (income):"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r676",
      "r1298"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedTerseLabel": "Benefit payments"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock": {
     "auth_ref": [
      "r1296",
      "r1297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of defined benefit plan asset investment. Includes, but is not limited to, fair value of category of plan asset and its level within fair value hierarchy.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Table Text Block]",
        "terseLabel": "Schedule of Change in Level 3 Plan Assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsCategoryTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount": {
     "auth_ref": [
      "r1296"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment within defined benefit plan asset category.",
        "label": "Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount",
        "terseLabel": "Plan assets, investment within plan asset category, amount"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": {
     "auth_ref": [
      "r681",
      "r1157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage",
        "terseLabel": "Target investment allocations"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements": {
     "auth_ref": [
      "r687",
      "r1157"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, measured using unobservable input, of increase (decrease) in plan asset of defined benefit plan from purchase, sale and settlement of trade associated with underlying investment.",
        "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement",
        "verboseLabel": "Purchases, sales and settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanPurchasesSalesAndSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRealEstateMember": {
     "auth_ref": [
      "r1155",
      "r1157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property composed of building, land and land improvement; in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Real Estate [Member]",
        "terseLabel": "Real estate"
       }
      }
     },
     "localname": "DefinedBenefitPlanRealEstateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "auth_ref": [
      "r659",
      "r700",
      "r722"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "negatedTerseLabel": "Settlement losses"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "auth_ref": [
      "r679"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels": {
     "auth_ref": [
      "r688",
      "r1157"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan, for assets transferred into (out of) Level 3 of fair value hierarchy. Includes, but is not limited to, transfer due to change in observability of significant inputs.",
        "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Assets Transferred into (out of) Level 3",
        "terseLabel": "Transfers out of Level 3"
       }
      }
     },
     "localname": "DefinedBenefitPlanTransfersBetweenMeasurementLevels",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]",
        "terseLabel": "Assumptions used to determine benefit obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]",
        "terseLabel": "Assumptions used to determine net benefit costs"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r193",
      "r194",
      "r195",
      "r196",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Defined contribution plan, employer contributions"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r93",
      "r155"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r93",
      "r470"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r249",
      "r250",
      "r252",
      "r253",
      "r1128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r1335",
      "r1336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Forward contract, notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r244",
      "r245",
      "r246",
      "r247",
      "r254",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DirectPremiumsEarned": {
     "auth_ref": [
      "r317",
      "r997",
      "r1041",
      "r1044"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PremiumsEarnedNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before premiums ceded to other entities and premiums assumed by the entity, of premiums earned.",
        "label": "Direct Premiums Earned",
        "terseLabel": "Direct"
       }
      }
     },
     "localname": "DirectPremiumsEarned",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r653",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1153",
      "r1154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r1292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of disaggregation of revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r738",
      "r769",
      "r770",
      "r772",
      "r777",
      "r1166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock Incentive Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfLongLivedAssetsHeldForSaleTextBlock": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long lived assets held for sale. Disclosure may include the description of the facts and circumstances leading to the expected disposal, manner and timing of disposal, the carrying value of the assets held for sale, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss).",
        "label": "Disclosure of Long-Lived Assets Held-for-sale [Table Text Block]",
        "terseLabel": "Summary of Assets and Liabilities Held for Sale"
       }
      }
     },
     "localname": "DisclosureOfLongLivedAssetsHeldForSaleTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r14",
      "r68",
      "r319"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax",
        "terseLabel": "Loss from discontinued operations"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share",
        "terseLabel": "Loss from discontinued operations attributable to CVS Health (in dollars per share)"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share",
        "terseLabel": "Loss from discontinued operations attributable to CVS Health (in dollars per share)"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": {
     "auth_ref": [
      "r4",
      "r5",
      "r6",
      "r7",
      "r14",
      "r17",
      "r785",
      "r809",
      "r815"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Tax Effect of Discontinued Operation",
        "negatedTerseLabel": "Income tax benefit"
       }
      }
     },
     "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationsDisposedOfBySaleMember": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results.",
        "label": "Discontinued Operations, Disposed of by Sale [Member]",
        "terseLabel": "Discontinued Operations, Disposed of by Sale"
       }
      }
     },
     "localname": "DiscontinuedOperationsDisposedOfBySaleMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DiscontinuedOperationsPolicyTextBlock": {
     "auth_ref": [
      "r8",
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation.",
        "label": "Discontinued Operations, Policy [Policy Text Block]",
        "terseLabel": "Discontinued Operations"
       }
      }
     },
     "localname": "DiscontinuedOperationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails",
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails",
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails",
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails",
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails",
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails",
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails",
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails",
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r153",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r151",
      "r160",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Held-for-sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails",
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails",
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails",
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails",
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r0",
      "r1",
      "r15",
      "r159"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable": {
     "auth_ref": [
      "r0",
      "r1",
      "r15",
      "r159"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities": {
     "auth_ref": [
      "r0",
      "r1",
      "r15",
      "r159"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r15",
      "r159"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as deferred tax assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Tax Assets",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1": {
     "auth_ref": [
      "r0",
      "r1",
      "r15",
      "r159"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventory1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r15",
      "r159"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities": {
     "auth_ref": [
      "r0",
      "r1",
      "r15",
      "r159"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r0",
      "r1",
      "r15",
      "r159"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r1159",
      "r1162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r178",
      "r293"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "negatedTerseLabel": "Common stock dividends"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableAmountPerShare": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.",
        "label": "Dividends Payable, Amount Per Share",
        "terseLabel": "Cash dividend declared (USD per share)"
       }
      }
     },
     "localname": "DividendsPayableAmountPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DividendsPayableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Dividends Payable [Line Items]",
        "terseLabel": "Dividends Payable [Line Items]"
       }
      }
     },
     "localname": "DividendsPayableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsPayableTable": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table that contains information regarding dividends that have been declared but not paid as of the financial reporting date. This information may contain the amount, amount per share, declared date, and date to be paid.",
        "label": "Dividends Payable [Table]",
        "terseLabel": "Dividends Payable [Table]"
       }
      }
     },
     "localname": "DividendsPayableTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r125",
      "r1157",
      "r1296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by corporation domiciled in United States of America (US).",
        "label": "Debt Security, Corporate, US [Member]",
        "terseLabel": "U.S. corporate securities"
       }
      }
     },
     "localname": "DomesticCorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per share attributable to CVS Health:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r400",
      "r431",
      "r432",
      "r434",
      "r435",
      "r436",
      "r442",
      "r444",
      "r449",
      "r450",
      "r451",
      "r455",
      "r845",
      "r846",
      "r969",
      "r994",
      "r1133"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net income attributable to CVS Health (in dollars per share)",
        "totalLabel": "Net income attributable to CVS Health (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "verboseLabel": "Basic earnings per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r400",
      "r431",
      "r432",
      "r434",
      "r435",
      "r436",
      "r444",
      "r449",
      "r450",
      "r451",
      "r455",
      "r845",
      "r846",
      "r969",
      "r994",
      "r1133"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net income attributable to CVS Health (in dollars per share)",
        "totalLabel": "Net income attributable to CVS Health (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted earnings per share:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r103",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r452",
      "r453",
      "r454",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r786"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r416",
      "r786",
      "r812"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Statutory income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness": {
     "auth_ref": [
      "r1327",
      "r1334"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to disposition of a business not qualifying as a discontinued operation.",
        "label": "Effective Income Tax Rate Reconciliation, Disposition of Business, Percent",
        "terseLabel": "Basis difference upon disposition of subsidiary"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDispositionOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r1327",
      "r1334"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r1327",
      "r1334"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal tax benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic": {
     "auth_ref": [
      "r1327",
      "r1334"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to domestic income tax settlement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Settlement, Domestic, Percent",
        "terseLabel": "Prior year refunds and unrecognized tax benefits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectsOfReinsuranceTableTextBlock": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effects of reinsurance, for example, but not limited to, disclosure of direct, assumed, and ceded insurance.",
        "label": "Effects of Reinsurance [Table Text Block]",
        "terseLabel": "Schedule of Impact of Reinsurance on Benefit Costs"
       }
      }
     },
     "localname": "EffectsOfReinsuranceTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Compensation not yet recognized, period for recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r1326"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Compensation not yet recognized, other than options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r1326"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Compensation not yet recognized, options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Employee Stock Option",
        "verboseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r173",
      "r355",
      "r392",
      "r393",
      "r394",
      "r423",
      "r424",
      "r425",
      "r428",
      "r437",
      "r440",
      "r458",
      "r531",
      "r640",
      "r773",
      "r774",
      "r775",
      "r806",
      "r807",
      "r844",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r879",
      "r919",
      "r1028",
      "r1029",
      "r1030"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r87",
      "r137",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r372",
      "r861",
      "r1125"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r136",
      "r301",
      "r1194",
      "r1195",
      "r1196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r523"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r611",
      "r863",
      "r1143",
      "r1144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "verboseLabel": "Aggregate principal of debt extinguished"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci": {
     "auth_ref": [
      "r856"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3) and still held.",
        "label": "Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI",
        "negatedTerseLabel": "Change in unrealized capital losses included in OCI associated with Level 3 financial assets"
       }
      }
     },
     "localname": "FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r849",
      "r850",
      "r859"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r257",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Changes in Level 3 Financial Assets"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r256",
      "r261",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r256",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of Carrying Value and Fair Value By Level of Fair Value Hierarchy"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r611",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r850",
      "r925",
      "r926",
      "r927",
      "r1143",
      "r1144",
      "r1155",
      "r1156",
      "r1157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueNarrativeDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r256",
      "r260",
      "r611",
      "r1143",
      "r1144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r849",
      "r850",
      "r851",
      "r852",
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueNarrativeDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r611",
      "r1143",
      "r1144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r858"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair Value"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel12And3Member": {
     "auth_ref": [
      "r1297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measurement input including quoted price in active market for identical asset or liability reporting entity can access at measurement date (level 1), input other than quoted price included within level 1 either directly or indirectly observable for asset or liability (level 2) and unobservable input reflecting entity's own assumption (level 3).",
        "label": "Fair Value, Inputs, Level 1, Level 2, and Level 3 [Member]",
        "terseLabel": "Total Fair Value, Inputs, Level 1, 2 and 3"
       }
      }
     },
     "localname": "FairValueInputsLevel12And3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r611",
      "r684",
      "r689",
      "r850",
      "r925",
      "r1155",
      "r1156",
      "r1157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r611",
      "r684",
      "r689",
      "r850",
      "r926",
      "r1143",
      "r1144",
      "r1155",
      "r1156",
      "r1157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r611",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r850",
      "r927",
      "r1143",
      "r1144",
      "r1155",
      "r1156",
      "r1157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueNarrativeDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": {
     "auth_ref": [
      "r684",
      "r848",
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Measured at Net Asset Value Per Share [Member]",
        "terseLabel": "Fair Value Measured at Net Asset Value Per Share"
       }
      }
     },
     "localname": "FairValueMeasuredAtNetAssetValuePerShareMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueNarrativeDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": {
     "auth_ref": [
      "r853"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings",
        "terseLabel": "Included in earnings"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss": {
     "auth_ref": [
      "r854"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "terseLabel": "Included in other comprehensive income (loss)"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases",
        "terseLabel": "Purchases"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales",
        "negatedTerseLabel": "Sales"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": {
     "auth_ref": [
      "r855"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details": {
       "order": 1.0,
       "parentTag": "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3",
        "terseLabel": "Gross transfers into Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net",
        "terseLabel": "Transfers into (out of) Level 3, net",
        "totalLabel": "Net transfers into (out of) Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": {
     "auth_ref": [
      "r855"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details": {
       "order": 2.0,
       "parentTag": "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3",
        "negatedTerseLabel": "Gross transfers out of Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "auth_ref": [
      "r257"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r611",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r925",
      "r926",
      "r927",
      "r1143",
      "r1144",
      "r1155",
      "r1156",
      "r1157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueNarrativeDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r849",
      "r850",
      "r851",
      "r852",
      "r857",
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r858",
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueNarrativeDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable": {
     "auth_ref": [
      "r46",
      "r285",
      "r294"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of maximum advances or credit lines available from the Federal Home Loan Bank (FHLB).",
        "label": "Federal Home Loan Bank, Advances, General Debt Obligations, Maximum Amount Available",
        "terseLabel": "Federal home loan bank advances maximum amount available"
       }
      }
     },
     "localname": "FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FederalHomeLoanBankAdvancesMember": {
     "auth_ref": [
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowings from the Federal Home Loan Bank, which are primarily used to cover shortages in the required reserve balance and also in times of liquidity shortages. The member institution executes a promissory note, which is generally collateralized by government securities to the Federal Reserve or loans.",
        "label": "Federal Home Loan Bank Advances [Member]",
        "terseLabel": "Federal Home Loan Bank Advances"
       }
      }
     },
     "localname": "FederalHomeLoanBankAdvancesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r893",
      "r899",
      "r1172"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": 1.0,
       "parentTag": "cvs_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r895",
      "r905"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows paid for interest portion of finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r891",
      "r910"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails": {
       "order": 2.0,
       "parentTag": "cvs_LongtermDebtGrossAndLeaseObligation",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Total finance lease liabilities",
        "totalLabel": "Total finance lease liabilities",
        "verboseLabel": "Finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails",
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails",
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r891"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r1347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Maturities of Finance Lease Liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r891"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r910"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r910"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDueAfterYearFive",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r910"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsYearOne",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r910"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDueYearFive",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r910"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDueYearFour",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r910"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDueYearThree",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r910"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDueYearTwo",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r892"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease liability.",
        "label": "Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r910"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r894",
      "r905"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash flows paid for principal portion of finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r893",
      "r899",
      "r1172"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "cvs_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r908",
      "r1172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r907",
      "r1172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r515",
      "r516",
      "r535",
      "r539",
      "r540",
      "r541",
      "r542",
      "r547",
      "r549",
      "r552",
      "r622",
      "r638",
      "r834",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r1139",
      "r1254",
      "r1255",
      "r1256",
      "r1376",
      "r1377",
      "r1378",
      "r1379",
      "r1380",
      "r1381",
      "r1382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.",
        "label": "Financial Liabilities Fair Value Disclosure",
        "terseLabel": "Financial liabilities measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average period before the next renewal or extension (both explicit and implicit) for intangible assets that have been renewed or extended, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Weighted Average Period before Next Renewal or Extension",
        "terseLabel": "Weighted Average Life (years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r369",
      "r572"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Finite-lived intangible assets, accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r570",
      "r571",
      "r572",
      "r573",
      "r958",
      "r962"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r145",
      "r962"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Finite-lived intangible assets, gross carrying amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r141",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r145",
      "r958"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Finite-lived intangible assets, net carrying amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r125",
      "r1296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by corporation not domiciled in United States of America (US).",
        "label": "Debt Security, Corporate, Non-US [Member]",
        "terseLabel": "Foreign securities"
       }
      }
     },
     "localname": "ForeignCorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r881"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation and Transactions"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term debt securities issued by a national, local, or municipal government not within the country of domicile of the reporting entity.",
        "label": "Foreign Government Short-Term Debt Securities [Member]",
        "terseLabel": "Foreign securities"
       }
      }
     },
     "localname": "ForeignGovernmentShorttermDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForwardContractsMember": {
     "auth_ref": [
      "r1337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts negotiated between two parties to purchase and sell a specific quantity of a financial instrument, foreign currency, or commodity at a price specified at origination of the contract, with delivery and settlement at a specified future date.",
        "label": "Forward Contracts [Member]",
        "terseLabel": "Forward Contracts"
       }
      }
     },
     "localname": "ForwardContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Fixtures and equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainContingencyUnrecordedAmount": {
     "auth_ref": [
      "r1281"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount or range of possible amounts of gain that could be realized upon the resolution of a contingency.",
        "label": "Gain Contingency, Unrecorded Amount",
        "terseLabel": "Gain contingency, unrecorded amount"
       }
      }
     },
     "localname": "GainContingencyUnrecordedAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r830",
      "r1219"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedLabel": "Gain on divestiture of subsidiaries",
        "negatedTerseLabel": "Gain on sale of subsidiaries",
        "terseLabel": "Gain (loss) on sale of subsidiaries"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r1276"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedTerseLabel": "Opioid litigation charges"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r93",
      "r169",
      "r170"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on early extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r169",
      "r170"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs.",
        "label": "Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost",
        "negatedTerseLabel": "Premium paid in excess of debt principal"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r368",
      "r556",
      "r963",
      "r1140",
      "r1173",
      "r1263",
      "r1270"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Balance, end of the period",
        "periodStartLabel": "Balance, beginning of the period",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "Goodwill and Other Intangibles"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangibles"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r568",
      "r569",
      "r1140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r558",
      "r565",
      "r1140"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "terseLabel": "Cumulative goodwill impairments"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r93",
      "r557",
      "r562",
      "r568",
      "r1140"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedTerseLabel": "Impairment",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r561",
      "r1140"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "negatedTerseLabel": "Divestitures"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsMaximumExposure": {
     "auth_ref": [
      "r165"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.",
        "label": "Guarantor Obligations, Maximum Exposure, Undiscounted",
        "terseLabel": "Guarantor obligations, maximum exposure"
       }
      }
     },
     "localname": "GuaranteeObligationsMaximumExposure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HealthCareCostsPolicyPolicyTextBlock": {
     "auth_ref": [
      "r1082",
      "r1084"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accruing health care costs for a prepaid health care service provider.",
        "label": "Health Care Costs, Policy [Policy Text Block]",
        "terseLabel": "Health Care Costs Payable"
       }
      }
     },
     "localname": "HealthCareCostsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_HealthCareEntitiesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for all health care policies.",
        "label": "Health Care Entities, Policy [Policy Text Block]",
        "terseLabel": "Health Care Reform"
       }
      }
     },
     "localname": "HealthCareEntitiesPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_HealthInsuranceProductLineMember": {
     "auth_ref": [
      "r1370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product line consisting of insurance against loss by illness or injury.",
        "label": "Health Insurance Product Line [Member]",
        "terseLabel": "Health Insurance Product Line"
       }
      }
     },
     "localname": "HealthInsuranceProductLineMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgeFundsMember": {
     "auth_ref": [
      "r1296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in registered hedge funds.",
        "label": "Hedge Funds [Member]",
        "verboseLabel": "Hedge fund investments"
       }
      }
     },
     "localname": "HedgeFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r1219",
      "r1274"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)",
        "terseLabel": "Impairment of intangible assets, indefinite-lived"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r93",
      "r152"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 7.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Loss on assets held for sale"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Recoverability of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r71",
      "r94",
      "r226",
      "r431",
      "r432",
      "r434",
      "r435",
      "r448",
      "r451"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "totalLabel": "Income from continuing operations attributable to CVS Health"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r67",
      "r273",
      "r288",
      "r322",
      "r475",
      "r486",
      "r492",
      "r495",
      "r971",
      "r1135"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income before income tax provision",
        "totalLabel": "Income before income tax provision"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r227",
      "r415",
      "r427",
      "r475",
      "r486",
      "r492",
      "r495",
      "r526",
      "r584",
      "r585",
      "r587",
      "r588",
      "r589",
      "r591",
      "r593",
      "r595",
      "r596",
      "r846",
      "r864",
      "r1135",
      "r1284"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Income from continuing operations",
        "totalLabel": "Income from continuing operations",
        "verboseLabel": "Income from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/EarningsPerShareDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r66",
      "r287",
      "r289",
      "r318",
      "r400",
      "r427",
      "r431",
      "r432",
      "r434",
      "r435",
      "r444",
      "r449",
      "r450",
      "r846",
      "r969"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Income from continuing operations attributable to CVS Health (in dollars per share)",
        "verboseLabel": "Earnings per share from continuing operations, basic (USD per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/EarningsPerShareDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r66",
      "r318",
      "r321",
      "r400",
      "r427",
      "r431",
      "r432",
      "r434",
      "r435",
      "r444",
      "r449",
      "r450",
      "r451",
      "r846",
      "r969",
      "r994"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Income from continuing operations attributable to CVS Health (in dollars per share)",
        "verboseLabel": "Earnings per share from continuing operations, diluted (USD per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/EarningsPerShareDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r17",
      "r319",
      "r360",
      "r816"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Loss from discontinued operations, net of tax",
        "totalLabel": "Loss from discontinued operations, net of tax"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r1159",
      "r1162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails",
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r416",
      "r787",
      "r795",
      "r800",
      "r808",
      "r813",
      "r817",
      "r818",
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r417",
      "r439",
      "r440",
      "r473",
      "r785",
      "r809",
      "r814",
      "r996"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      },
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "totalLabel": "Total",
        "verboseLabel": "Income tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Amount [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r391",
      "r781",
      "r782",
      "r795",
      "r796",
      "r799",
      "r803"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "negatedTerseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable and pharmacy claims and discounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInsuranceLiabilities": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in insurance liability balances during the period.",
        "label": "Increase (Decrease) in Insurance Liabilities",
        "terseLabel": "Health care costs payable and other insurance liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInInsuranceLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r445",
      "r446",
      "r447",
      "r451",
      "r737"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Effect of dilutive securities (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r148"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "cvs_IntangibleAssetsNetExcludingGoodwillIncludingAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived intangible assets, Trademarks"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InsuranceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance [Abstract]",
        "terseLabel": "Insurance [Abstract]"
       }
      }
     },
     "localname": "InsuranceAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InsuranceContractAcquisitionCostTextBlock": {
     "auth_ref": [
      "r1006"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for cost related directly to successful acquisition of new and renewal of insurance contract. Includes, but is not limited to, deferred policy acquisition cost, deferred sale inducement cost, and present value of future profit of insurance contract acquired in business combination.",
        "label": "Insurance Contract, Acquisition Cost [Text Block]",
        "terseLabel": "Other Insurance Liabilities and Separate Accounts"
       }
      }
     },
     "localname": "InsuranceContractAcquisitionCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r368"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Intangible assets, gross"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r139",
      "r143"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestCreditedToPolicyholdersAccountBalances": {
     "auth_ref": [
      "r979",
      "r1186",
      "r1188",
      "r1362",
      "r1367"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense for allocation to policyholder account balance.",
        "label": "Policyholder Account Balance, Interest Expense",
        "terseLabel": "Interest credited"
       }
      }
     },
     "localname": "InterestCreditedToPolicyholdersAccountBalances",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r270",
      "r291",
      "r395",
      "r469",
      "r884"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "verboseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r406",
      "r411",
      "r412"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "negatedTerseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r255"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Amount expected to be reclassified"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InternalCreditAssessmentAxis": {
     "auth_ref": [
      "r122",
      "r833",
      "r1137",
      "r1138",
      "r1141",
      "r1260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by entity-defined rating.",
        "label": "Internal Credit Assessment [Axis]",
        "terseLabel": "Internal Credit Assessment [Axis]"
       }
      }
     },
     "localname": "InternalCreditAssessmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InternalCreditAssessmentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity defined credit risk rating.",
        "label": "Internal Credit Assessment [Domain]",
        "terseLabel": "Internal Credit Assessment [Domain]"
       }
      }
     },
     "localname": "InternalCreditAssessmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r467",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r491",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r376",
      "r1124",
      "r1173"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r363",
      "r375",
      "r457",
      "r553",
      "r554",
      "r555",
      "r956",
      "r1130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 1.0,
       "parentTag": "cvs_InvestmentIncomeExcludingCapitalGainsOrLosses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Interest and Dividend",
        "terseLabel": "Gross investment income"
       }
      }
     },
     "localname": "InvestmentIncomeInterestAndDividend",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInvestmentExpense": {
     "auth_ref": [
      "r76",
      "r323"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 2.0,
       "parentTag": "cvs_InvestmentIncomeExcludingCapitalGainsOrLosses",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses related to the generation of investment income.",
        "label": "Investment Income, Investment Expense",
        "negatedLabel": "Investment expenses"
       }
      }
     },
     "localname": "InvestmentIncomeInvestmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r74",
      "r75"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "totalLabel": "Net investment income"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeTextBlock": {
     "auth_ref": [
      "r74",
      "r75",
      "r76",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.",
        "label": "Investment Income [Table Text Block]",
        "verboseLabel": "Schedule of Net Investment Income"
       }
      }
     },
     "localname": "InvestmentIncomeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r525",
      "r1361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r314"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "verboseLabel": "Schedule of Amortized Cost and Fair Value of Debt Securities by Contractual Maturity"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r136",
      "r274",
      "r292",
      "r348",
      "r1099"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r1293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r909",
      "r1172"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Net lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Finance lease cost:"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r1346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Summary of the Components of Net Lease Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LegalFees": {
     "auth_ref": [
      "r73"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.",
        "label": "Legal Fees",
        "terseLabel": "Attorneys' fees and costs"
       }
      }
     },
     "localname": "LegalFees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeFinanceLeaseTermOfContract1": {
     "auth_ref": [
      "r1345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Finance Lease, Term of Contract",
        "terseLabel": "Finance lease term (in years)"
       }
      }
     },
     "localname": "LesseeFinanceLeaseTermOfContract1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r911"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r898"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r897"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Right-of-Use Assets and Lease Liabilities"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r1347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Maturities of Operating Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r910"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r910"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDueAfterYearFive",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r910"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsYearOne",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r910"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDueYearFive",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r910"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDueYearFour",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r910"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDueYearThree",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r910"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDueYearTwo",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r910"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r1345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease term (in years)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r911"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceived": {
     "auth_ref": [
      "r912"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payments to be received by lessor for operating lease.",
        "label": "Lessor, Operating Lease, Payments to be Received",
        "terseLabel": "Future noncancelable subleases, future minimum payments"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r43",
      "r415",
      "r526",
      "r584",
      "r585",
      "r587",
      "r588",
      "r589",
      "r591",
      "r593",
      "r595",
      "r596",
      "r826",
      "r831",
      "r832",
      "r864",
      "r1134",
      "r1284",
      "r1350",
      "r1351"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "Total liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r39",
      "r282",
      "r309",
      "r1173",
      "r1222",
      "r1257",
      "r1342"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r45",
      "r362",
      "r415",
      "r526",
      "r584",
      "r585",
      "r587",
      "r588",
      "r589",
      "r591",
      "r593",
      "r595",
      "r596",
      "r826",
      "r831",
      "r832",
      "r864",
      "r1173",
      "r1284",
      "r1350",
      "r1351"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "terseLabel": "Total current liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r15",
      "r159",
      "r359",
      "r360"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "totalLabel": "Total liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Liabilities [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r15",
      "r154",
      "r159",
      "r359",
      "r360"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r327",
      "r330"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Liability for Claims and Claims Adjustment Expense",
        "periodEndLabel": "Health care costs payable, end of period",
        "periodStartLabel": "Health care costs payable, beginning of period",
        "terseLabel": "Health care costs payable",
        "totalLabel": "Total health care costs payable",
        "verboseLabel": "Health care costs payable"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Liability for Claims and Claims Adjustment Expense [Line Items]",
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Line Items]"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the liability for claims and claims adjustment expense.",
        "label": "Liability for Claims and Claims Adjustment Expense [Table]",
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Table]"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitActivityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Liability for Future Policy Benefit, Activity [Line Items]",
        "terseLabel": "Liability for Future Policy Benefit, Activity [Line Items]"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitActivityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitActivityTable": {
     "auth_ref": [
      "r1013",
      "r1187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about activity for liability for future policy benefit. Includes, but is not limited to, beginning and ending balance, issuance, interest income (expense), net premium collected, benefit payment, derecognition, experience adjustment, change in cash flow assumption, and change in discount rate assumption.",
        "label": "Liability for Future Policy Benefit Activity [Table]",
        "terseLabel": "Liability for Future Policy Benefit Activity [Table]"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitActivityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock": {
     "auth_ref": [
      "r1013",
      "r1031",
      "r1187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of beginning balance to ending balance for liability for future policy benefit, with separate presentation of expected future net premium and expected future benefit.",
        "label": "Liability for Future Policy Benefit, Activity [Table Text Block]",
        "terseLabel": "Schedule of Changes in Liability for Future Policy Benefits"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance": {
     "auth_ref": [
      "r1187",
      "r1366",
      "r1371"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effect of reinsurance, of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, after Reinsurance",
        "periodEndLabel": "Adjusted balance at January 1, 2021, net of reinsurance",
        "terseLabel": "Liability for future policy benefits",
        "totalLabel": "Net liability for future policy benefits, net of reinsurance recoverable"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitAfterReinsurance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate": {
     "auth_ref": [
      "r1018",
      "r1187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current weighted-average discount rate used to measure liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Current Weighted-Average Discount Rate",
        "terseLabel": "Current discount rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitCurrentWeightedAverageDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange": {
     "auth_ref": [
      "r1187",
      "r1366",
      "r1371"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance and after current period update of cash flow assumption, of expected future benefit and expense component for liability for future policy benefit, discounted at original rate.",
        "label": "Liability for Future Policy Benefit, Expected Future Benefit, Original Discount Rate, before Reinsurance, after Cash Flow Change",
        "totalLabel": "Adjusted beginning liability for future policy benefits - original (locked-in) discount rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance": {
     "auth_ref": [
      "r1014",
      "r1187"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance, of undiscounted balance for expected future gross premium component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Future Gross Premium, Undiscounted, before Reinsurance",
        "terseLabel": "Expected gross premiums"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumUndiscountedBeforeReinsurance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange": {
     "auth_ref": [
      "r1013",
      "r1014",
      "r1031",
      "r1187"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefits",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance and after current period update of cash flow assumption and discount rate change, of expected future policy benefit and expense component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change",
        "periodEndLabel": "Liability for future policy benefits, end of period - current discount rate",
        "periodStartLabel": "Liability for future policy benefits, beginning of period - current discount rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeReinsuranceAfterDiscountRateChange",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange": {
     "auth_ref": [
      "r1182",
      "r1187",
      "r1366",
      "r1371"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative increase (decrease) in expected future policy benefit and expense component for liability of future policy benefit from cash flow assumption change for future cash flows.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) from Cash Flow Change",
        "terseLabel": "Effect of changes in cash flow assumptions"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseFromCashFlowChange",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience": {
     "auth_ref": [
      "r1015",
      "r1181",
      "r1187",
      "r1366",
      "r1371"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative increase (decrease) in expected future policy benefit and expense component for liability of future policy benefit from effect of variance from cash flow assumption change for actual experience.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) of Actual Variance from Expected Experience",
        "terseLabel": "Effect of actual variances from expected experience"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense": {
     "auth_ref": [
      "r1178",
      "r1187",
      "r1366",
      "r1371"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense for expected future policy benefit and expense component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Interest Expense",
        "terseLabel": "Interest accrual (using locked-in discount rate)"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance": {
     "auth_ref": [
      "r1177",
      "r1187",
      "r1366",
      "r1371"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in expected future policy benefit and expense component of liability for future policy benefit from contract issuance.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Issuance",
        "terseLabel": "Issuances"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance": {
     "auth_ref": [
      "r1187",
      "r1366",
      "r1371"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedFutureBenefitOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance and current period update of cash flow assumption, of expected future policy benefit and expense component of liability for future policy benefit, discounted at original rate.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Original Discount Rate, before Cash Flow and Reinsurance",
        "periodEndLabel": "Ending liability for future policy benefits at original (locked-in) discount rate",
        "periodStartLabel": "Beginning liability for future policy benefits at original (locked-in) discount rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitOriginalDiscountRateBeforeCashFlowAndReinsurance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]",
        "terseLabel": "Present value of expected future policy benefits"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance": {
     "auth_ref": [
      "r1014",
      "r1187"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance, of undiscounted balance for expected future policy benefit and expense component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted, before Reinsurance",
        "terseLabel": "Expected future benefit payments"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitUndiscountedBeforeReinsurance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsUndiscountedExpectedGrossPremiumsandExpectedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange": {
     "auth_ref": [
      "r1013",
      "r1014",
      "r1031",
      "r1187"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefits",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance and after current period update of cash flow assumption and discount rate change, of expected net premium component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, before Reinsurance, after Discount Rate Change",
        "periodEndLabel": "Liability for future policy benefits, end of period - current discount rate",
        "periodStartLabel": "Liability for future policy benefits, beginning of period - current discount rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange": {
     "auth_ref": [
      "r1182",
      "r1187",
      "r1366",
      "r1371"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative increase (decrease) in expected net premium component of liability for future policy benefit from cash flow assumption change for future cash flows.",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) from Cash Flow Change",
        "terseLabel": "Effect of changes in cash flow assumptions"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseFromCashFlowChange",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience": {
     "auth_ref": [
      "r1015",
      "r1181",
      "r1187",
      "r1366",
      "r1371"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative increase (decrease) in expected net premium component for liability of future policy benefit from effect of variance from cash flow assumption change for actual experience.",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) of Actual Variance from Expected Experience",
        "terseLabel": "Effect of actual variances from expected experience"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumCumulativeIncreaseDecreaseOfActualVarianceFromExpectedExperience",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome": {
     "auth_ref": [
      "r1178",
      "r1187",
      "r1366",
      "r1371"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest income for expected net premium component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, Interest Income",
        "terseLabel": "Interest accrual (using locked-in discount rate)"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumInterestIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected": {
     "auth_ref": [
      "r1179",
      "r1187",
      "r1366",
      "r1371"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of premium collected from policyholder to fund expected benefit payment for expected net premium component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, Net Premium Collected",
        "negatedTerseLabel": "Net premiums (actual)"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumNetPremiumCollected",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance": {
     "auth_ref": [
      "r1187",
      "r1366",
      "r1371"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance and current period update of cash flow assumption, of expected net premium component of liability for future policy benefit, discounted at original rate.",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Cash Flow and Reinsurance",
        "periodEndLabel": "Ending liability for future policy benefits at original (locked-in) discount rate",
        "periodStartLabel": "Beginning liability for future policy benefits at original (locked-in) discount rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange": {
     "auth_ref": [
      "r1187",
      "r1366",
      "r1371"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance and after current period update of cash flow assumption, of expected net premium component for liability for future policy benefit, discounted at original rate.",
        "label": "Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Reinsurance, after Cash Flow Change",
        "totalLabel": "Adjusted beginning liability for future policy benefits - original (locked-in) discount rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeReinsuranceAfterCashFlowChange",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]",
        "terseLabel": "Present value of expected net premiums"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance": {
     "auth_ref": [
      "r1013",
      "r1016",
      "r1031",
      "r1187"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, recoverable under reinsurance of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Reinsurance Recoverable, after Allowance",
        "periodEndLabel": "Less: Reinsurance recoverable",
        "terseLabel": "Less: Reinsurance recoverable",
        "verboseLabel": "Add: Reinsurance recoverable"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageDuration": {
     "auth_ref": [
      "r1017"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average duration of liability for future policy benefit, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Liability for Future Policy Benefit, Weighted-Average Duration",
        "terseLabel": "Weighted-average duration of long-duration insurance liabilities"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitWeightedAverageDuration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate": {
     "auth_ref": [
      "r1018",
      "r1187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Original weighted-average discount rate at contract issue date used to measure liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Weighted-Average Interest Accretion Rate",
        "terseLabel": "Interest accretion rate"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsWeightedaverageInterestRatesandDurationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefits": {
     "auth_ref": [
      "r984",
      "r1013",
      "r1019",
      "r1031",
      "r1187"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForFuturePolicyBenefitAfterReinsurance",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance, of present value of future benefit to be paid to or on behalf of policyholder and related expense less present value of future net premium receivable under insurance contract.",
        "label": "Liability for Future Policy Benefit, before Reinsurance",
        "totalLabel": "Net liability for future policy benefits",
        "verboseLabel": "Liability for future policy benefits"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock": {
     "auth_ref": [
      "r1038"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments.",
        "label": "Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]",
        "terseLabel": "Health Care Costs Payable"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits": {
     "auth_ref": [
      "r1180",
      "r1187",
      "r1218",
      "r1366",
      "r1371"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to policyholder from benefit payment for expected future policy benefit and expense component of liability for future policy benefit.",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment",
        "negatedTerseLabel": "Benefit payments (actual)"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefitsPaymentForBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinLiabilityforFuturePolicyBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions",
        "verboseLabel": "Acquisitions, net"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]",
        "terseLabel": "Less: Claims paid"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
     "auth_ref": [
      "r329"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
     "auth_ref": [
      "r329"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
        "terseLabel": "Prior years"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
     "auth_ref": [
      "r328"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
        "totalLabel": "Total incurred health care costs"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]",
        "terseLabel": "Add: Components of incurred health care costs"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet": {
     "auth_ref": [
      "r298",
      "r327",
      "r330"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Net",
        "periodEndLabel": "Health care costs payable, end of period, net",
        "periodStartLabel": "Health care costs payable, beginning of period, net"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]",
        "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedFromOtherParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded from other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded from Other Party",
        "terseLabel": "Amount awarded from other party"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedFromOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Legal settlement awarded to other party"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [
      "r1276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [
      "r1276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-Term Debt and Lease Obligation",
        "terseLabel": "Long-term debt (1)"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-Term Debt and Lease Obligation, Current",
        "negatedTerseLabel": "Current portion of long-term debt",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails",
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.",
        "label": "Long-Term Debt and Lease Obligation, Including Current Maturities",
        "totalLabel": "Long-term debt and lease obligation"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtByMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Long-term Debt, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "LongTermDebtByMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r167",
      "r421",
      "r1290"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r167",
      "r421",
      "r615"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r167",
      "r421",
      "r615"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r167",
      "r421",
      "r615"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r167",
      "r421",
      "r615"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r167",
      "r421",
      "r615"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r365"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long-Term Investments",
        "verboseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r48",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r163",
      "r164",
      "r579",
      "r580",
      "r581",
      "r1277",
      "r1278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r579",
      "r1204"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Liability recorded in association with legal settlement"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValueNoncurrent": {
     "auth_ref": [
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.",
        "label": "Loss Contingency, Accrual, Noncurrent",
        "terseLabel": "Long-term liability recorded in association with legal settlement"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r1277",
      "r1278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Number of claims"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r22",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "verboseLabel": "Acquisitions, Divestitures and Asset Sales"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSales"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r55",
      "r281",
      "r308",
      "r415",
      "r526",
      "r584",
      "r587",
      "r588",
      "r589",
      "r595",
      "r596",
      "r864"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/ShareholdersEquityNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstate": {
     "auth_ref": [
      "r1074"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet": {
     "auth_ref": [
      "r313"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio.",
        "label": "Mortgage Loans on Real Estate, Commercial and Consumer, Net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCommercialAndConsumerNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstateForeclosures": {
     "auth_ref": [
      "r1076"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from foreclosure.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Foreclosure",
        "terseLabel": "Mortgage loans foreclosed"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateForeclosures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstateNewMortgageLoans": {
     "auth_ref": [
      "r1076"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from new investment.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, New Mortgage Loan",
        "terseLabel": "New mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateNewMortgageLoans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgagesHeldForSaleFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of mortgage loans held-for-sale.",
        "label": "Mortgages Held-for-sale, Fair Value Disclosure",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgagesHeldForSaleFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]",
        "terseLabel": "Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]"
       }
      }
     },
     "localname": "MovementAnalysisOfDeferredPolicyAcquisitionCostsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDeferredAcquisitionCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MultiemployerPlanPensionInsignificantPlanContribution": {
     "auth_ref": [
      "r1299"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by multiemployer pension plan from all employers participating in multiemployer pension plan determined to be individually insignificant.",
        "label": "Multiemployer Plan, Pension, Insignificant, Plan Contribution",
        "terseLabel": "Multiemployer plans, plan contributions"
       }
      }
     },
     "localname": "MultiemployerPlanPensionInsignificantPlanContribution",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r408"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r408"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r88",
      "r91",
      "r94"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
        "terseLabel": "Reconciliation of net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r69",
      "r94",
      "r290",
      "r320",
      "r360",
      "r386",
      "r389",
      "r394",
      "r415",
      "r427",
      "r431",
      "r432",
      "r434",
      "r435",
      "r439",
      "r440",
      "r448",
      "r475",
      "r486",
      "r492",
      "r495",
      "r526",
      "r584",
      "r585",
      "r587",
      "r588",
      "r589",
      "r591",
      "r593",
      "r595",
      "r596",
      "r846",
      "r864",
      "r1135",
      "r1284"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income attributable to CVS Health",
        "totalLabel": "Net income attributable to CVS Health"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r229",
      "r242",
      "r386",
      "r389",
      "r439",
      "r440",
      "r1211"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      },
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Net (income) loss attributable to noncontrolling interests",
        "negatedTerseLabel": "Comprehensive (income) loss attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentIncome": {
     "auth_ref": [
      "r991"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.",
        "label": "Net Investment Income",
        "terseLabel": "Net investment income",
        "verboseLabel": "Net investment income (loss)"
       }
      }
     },
     "localname": "NetInvestmentIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "verboseLabel": "Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r101",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r434",
      "r441",
      "r455",
      "r505",
      "r506",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r773",
      "r774",
      "r775",
      "r804",
      "r805",
      "r806",
      "r807",
      "r821",
      "r822",
      "r823",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r882",
      "r883",
      "r886",
      "r887",
      "r888",
      "r889",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r959",
      "r960",
      "r961",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]",
        "verboseLabel": "Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r224",
      "r640",
      "r1225",
      "r1226",
      "r1227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r1243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r1243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStatesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of states the entity operates in as of the balance sheet date.",
        "label": "Number of States in which Entity Operates",
        "terseLabel": "Number of states in which entity operates"
       }
      }
     },
     "localname": "NumberOfStatesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStores": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of stores.",
        "label": "Number of Stores",
        "terseLabel": "Number of retail locations (more than)"
       }
      }
     },
     "localname": "NumberOfStores",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax": {
     "auth_ref": [
      "r383",
      "r384"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of unrealized gain (loss) from (increase) decrease in liability for future policy benefit from change in discount rate.",
        "label": "OCI, Liability for Future Policy Benefit, Gain (Loss), after Reclassification Adjustment and Tax",
        "terseLabel": "Change in discount rate on insurance reserves"
       }
      }
     },
     "localname": "OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating costs:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r475",
      "r486",
      "r492",
      "r495",
      "r1135"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "netLabel": "Operating income (GAAP measure)",
        "totalLabel": "Operating income",
        "verboseLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r900",
      "r1172"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r891"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LeaseLiability",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total operating lease liabilities",
        "totalLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails",
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r891"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "verboseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r891"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "verboseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r896",
      "r905"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows paid for operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r890"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r908",
      "r1172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r907",
      "r1172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Leased Assets [Line Items]",
        "terseLabel": "Operating Leased Assets [Line Items]"
       }
      }
     },
     "localname": "OperatingLeasedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r377",
      "r1173"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r227",
      "r228",
      "r230"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Net unrealized investment gains (losses)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r63",
      "r393",
      "r873",
      "r875",
      "r879",
      "r1209"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "OCI before reclassifications, pre-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r63",
      "r65",
      "r393",
      "r873",
      "r875",
      "r879",
      "r1209"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "negatedTerseLabel": "Loss on net cash flow hedges",
        "verboseLabel": "Other comprehensive income (loss) before reclassifications, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r379",
      "r384"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Net cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r65",
      "r173",
      "r387",
      "r390",
      "r397",
      "r873",
      "r878",
      "r879",
      "r966",
      "r990",
      "r1209",
      "r1210"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive income (loss)",
        "verboseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r59",
      "r61"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Pension and other postretirement benefits"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDebtSecuritiesMember": {
     "auth_ref": [
      "r1252",
      "r1261",
      "r1296",
      "r1341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt securities classified as other.",
        "label": "Other Debt Obligations [Member]",
        "terseLabel": "Other Debt Obligations"
       }
      }
     },
     "localname": "OtherDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other investments.",
        "label": "Other Investments [Member]",
        "terseLabel": "Other investments"
       }
      }
     },
     "localname": "OtherInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other noncash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPolicyholderFunds": {
     "auth_ref": [
      "r315"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due to policyholders for funds held that are returnable under the terms of insurance contracts, classified as other.",
        "label": "Other Policyholder Funds",
        "terseLabel": "Policyholders\u2019 funds"
       }
      }
     },
     "localname": "OtherPolicyholderFunds",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r185",
      "r656",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r704",
      "r705",
      "r706",
      "r708",
      "r711",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r728",
      "r729",
      "r730",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Other Postretirement Benefits"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 2.0,
       "parentTag": "cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total CVS Health Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForDerivativeInstrumentFinancingActivities": {
     "auth_ref": [
      "r404",
      "r1129"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.",
        "label": "Payments for Derivative Instrument, Financing Activities",
        "negatedTerseLabel": "Derivative settlements",
        "terseLabel": "Payments for derivative instruments"
       }
      }
     },
     "localname": "PaymentsForDerivativeInstrumentFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payments for Legal Settlements",
        "terseLabel": "Cash impact of litigation settlement"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
     "auth_ref": [
      "r90",
      "r329"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
        "totalLabel": "Total claims paid"
       }
      }
     },
     "localname": "PaymentsForLossesAndLossAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r1212",
      "r1213"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r403"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Payments for taxes related to net share settlement of equity awards",
        "terseLabel": "Payments for taxes for net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions (net of cash acquired)"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToSuppliersAndEmployees": {
     "auth_ref": [
      "r410",
      "r1216",
      "r1217"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payments to suppliers for goods and services provided and to employees for services provided.",
        "label": "Payments to Suppliers and Employees",
        "negatedTerseLabel": "Cash paid to other suppliers and employees"
       }
      }
     },
     "localname": "PaymentsToSuppliersAndEmployees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [
      "r1276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r681",
      "r683",
      "r689",
      "r707",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r725",
      "r726",
      "r728",
      "r734",
      "r1157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "verboseLabel": "Pension Plans and Other Postretirement Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": {
     "auth_ref": [
      "r28",
      "r656",
      "r657",
      "r680",
      "r1157"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.",
        "label": "Liability, Defined Benefit Plan, Current",
        "negatedTerseLabel": "Current liabilities reflected in accrued expenses"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r30",
      "r656",
      "r657",
      "r680",
      "r1157"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "negatedTerseLabel": "Noncurrent liabilities reflected in other long-term liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPolicy": {
     "auth_ref": [
      "r193",
      "r198",
      "r199",
      "r200",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]",
        "terseLabel": "Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r184",
      "r656",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r704",
      "r705",
      "r706",
      "r708",
      "r711",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r728",
      "r729",
      "r733",
      "r1157",
      "r1158",
      "r1162",
      "r1163",
      "r1164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plan"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r681",
      "r682",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r708",
      "r1155",
      "r1156",
      "r1157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r1300",
      "r1301",
      "r1302",
      "r1303",
      "r1304",
      "r1305",
      "r1306",
      "r1307",
      "r1308",
      "r1309",
      "r1310",
      "r1311",
      "r1312",
      "r1313",
      "r1314",
      "r1315",
      "r1316",
      "r1317",
      "r1318",
      "r1319",
      "r1320",
      "r1321",
      "r1322",
      "r1323",
      "r1324",
      "r1325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r1300",
      "r1301",
      "r1302",
      "r1303",
      "r1304",
      "r1305",
      "r1306",
      "r1307",
      "r1308",
      "r1309",
      "r1310",
      "r1311",
      "r1312",
      "r1313",
      "r1314",
      "r1315",
      "r1316",
      "r1317",
      "r1318",
      "r1319",
      "r1320",
      "r1321",
      "r1322",
      "r1323",
      "r1324",
      "r1325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange": {
     "auth_ref": [
      "r1188",
      "r1367"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in liability for policyholder account balance from change, classified as other.",
        "label": "Policyholder Account Balance, Increase (Decrease) from Other Change",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceIncreaseDecreaseFromOtherChange",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PolicyholderAccountBalanceNetAmountAtRisk": {
     "auth_ref": [
      "r1022",
      "r1188"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of guaranteed benefit in excess of current account balance of policyholder account balance.",
        "label": "Policyholder Account Balance, Net Amount at Risk",
        "terseLabel": "Net amount at risk"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceNetAmountAtRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PolicyholderAccountBalancePolicyCharge": {
     "auth_ref": [
      "r1184",
      "r1188",
      "r1367"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in liability for policyholder account balance from policy charge.",
        "label": "Policyholder Account Balance, Policy Charge",
        "negatedTerseLabel": "Policy charges"
       }
      }
     },
     "localname": "PolicyholderAccountBalancePolicyCharge",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PolicyholderAccountBalanceRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Policyholder Account Balance [Roll Forward]",
        "terseLabel": "Policyholder Account Balance [Roll Forward]"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PolicyholderAccountBalanceSurrenderAndWithdrawal": {
     "auth_ref": [
      "r1188",
      "r1367"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in liability for policyholder account balance from contract redemption and withdrawal of funds.",
        "label": "Policyholder Account Balance, Surrender and Withdrawal",
        "negatedTerseLabel": "Surrenders and withdrawals"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceSurrenderAndWithdrawal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PolicyholderAccountBalanceTableTextBlock": {
     "auth_ref": [
      "r1188",
      "r1368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about policyholder account balance, including, but not limited to change in liability and related cash surrender value.",
        "label": "Policyholder Account Balance [Table Text Block]",
        "terseLabel": "Roll Forward of Policyholders' Funds"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PolicyholderAccountBalanceWeightedAverageCreditingRate": {
     "auth_ref": [
      "r1021",
      "r1188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average crediting rate for liability for policyholder account balance, calculated at a point in time.",
        "label": "Policyholder Account Balance, Weighted Average Crediting Rate",
        "terseLabel": "Weighted average crediting rate"
       }
      }
     },
     "localname": "PolicyholderAccountBalanceWeightedAverageCreditingRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PolicyholderAccountsPolicy": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for contracts reported in separate accounts, including the extent and terms of minimum guarantees, basis of presentation for separate account assets and liabilities and related separate account activity, the liability valuation method and assumptions used in valuing each type of policyholder and contract holder account maintained by the entity.",
        "label": "Policyholder Accounts, Policy [Policy Text Block]",
        "terseLabel": "Separate Accounts"
       }
      }
     },
     "localname": "PolicyholderAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredGross": {
     "auth_ref": [
      "r325"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PolicyholderBenefitsAndClaimsIncurredNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred.",
        "label": "Policyholder Benefits and Claims Incurred, Direct",
        "terseLabel": "Direct"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare": {
     "auth_ref": [
      "r325"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.",
        "label": "Policyholder Benefits and Claims Incurred, Net, Health",
        "terseLabel": "Benefit costs",
        "verboseLabel": "Benefit costs"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredHealthCare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredNet": {
     "auth_ref": [
      "r296",
      "r325"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred.",
        "label": "Policyholder Benefits and Claims Incurred, Net",
        "totalLabel": "Net benefit costs"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Policyholder Benefits and Claims Incurred, Net [Abstract]",
        "terseLabel": "Policyholder Benefits and Claims Incurred, Net [Abstract]"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PolicyholderFunds": {
     "auth_ref": [
      "r1020",
      "r1024",
      "r1025",
      "r1188"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due to policyholder. Includes, but is not limited to, unpaid policy dividend, retrospective refund, and undistributed earnings on participating business. Excludes future policy benefit and claim expense.",
        "label": "Policyholder Account Balance",
        "periodEndLabel": "Policyholders\u2019 funds, end of the period",
        "periodStartLabel": "Policyholders\u2019 funds, beginning of the period"
       }
      }
     },
     "localname": "PolicyholderFunds",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofPolicyholdersFundsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r862"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r33",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r33",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r33",
      "r1173"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsEarnedNet": {
     "auth_ref": [
      "r965",
      "r989",
      "r1000",
      "r1046"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.",
        "label": "Premiums Earned, Net",
        "terseLabel": "Premiums",
        "totalLabel": "Net premiums"
       }
      }
     },
     "localname": "PremiumsEarnedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsReceivableAtCarryingValue": {
     "auth_ref": [
      "r312"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 3.0,
       "parentTag": "cvs_AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.",
        "label": "Premiums Receivable, Net",
        "terseLabel": "Premium receivables"
       }
      }
     },
     "localname": "PremiumsReceivableAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrivateEquityFundsMember": {
     "auth_ref": [
      "r1296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments held in private equity funds.",
        "label": "Private Equity Funds [Member]",
        "verboseLabel": "Private equity investments"
       }
      }
     },
     "localname": "PrivateEquityFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromCustomers": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash receipts from customers during the current period which are usually for sales of goods and services.",
        "label": "Proceeds from Customers",
        "terseLabel": "Cash receipts from customers"
       }
      }
     },
     "localname": "ProceedsFromCustomers",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r402"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from debt"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r79"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "verboseLabel": "Proceeds from divestiture of subsidiary"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.",
        "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
        "terseLabel": "Proceeds from sale of subsidiaries (net of cash and restricted cash sold of $2,854, $0 and $9)"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromInterestAndDividendsReceived": {
     "auth_ref": [
      "r405",
      "r409"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for dividends and interest on the entity's equity and debt investments during the current period.",
        "label": "Proceeds from Interest and Dividends Received",
        "terseLabel": "Interest and investment income received"
       }
      }
     },
     "localname": "ProceedsFromInterestAndDividendsReceived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Proceeds from issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity": {
     "auth_ref": [
      "r970"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from principal payment received from sales-type and direct financing leases classified as investing activity.",
        "label": "Proceeds from Lease Payment, Sales-Type and Direct Financing Leases, Investing Activity",
        "terseLabel": "Proceeds from sale-leaseback transactions"
       }
      }
     },
     "localname": "ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r1214",
      "r1215"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from sales and maturities of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r78",
      "r124",
      "r401"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-Sale",
        "terseLabel": "Proceeds from sales"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r83",
      "r208"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options",
        "verboseLabel": "Cash received from stock options exercised (including ESPP)"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r1293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsChangesinBalancesofLongDurationInsuranceLiabilitiesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r1148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Products"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r360",
      "r386",
      "r389",
      "r407",
      "r415",
      "r427",
      "r439",
      "r440",
      "r475",
      "r486",
      "r492",
      "r495",
      "r526",
      "r584",
      "r585",
      "r587",
      "r588",
      "r589",
      "r591",
      "r593",
      "r595",
      "r596",
      "r824",
      "r827",
      "r828",
      "r846",
      "r864",
      "r971",
      "r1135",
      "r1170",
      "r1171",
      "r1211",
      "r1284"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentFairValueDisclosure": {
     "auth_ref": [
      "r1340"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant, and Equipment, Fair Value Disclosure",
        "terseLabel": "Property and equipment, fair value"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r156",
      "r366"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "cvs_PropertyPlantAndEquipmentNetIncludingAssetsHeldForSale",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "verboseLabel": "Total property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment [Member]",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r158",
      "r310",
      "r978",
      "r1173"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r158",
      "r1085",
      "r1086"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Useful life of property plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_PropertySubjectToOperatingLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property subject to an operating lease.",
        "label": "Property Subject to Operating Lease [Member]",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "PropertySubjectToOperatingLeaseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by property that could be leased or is available for lease.",
        "label": "Property Subject to or Available for Operating Lease [Axis]",
        "terseLabel": "Property Subject to or Available for Operating Lease [Axis]"
       }
      }
     },
     "localname": "PropertySubjectToOrAvailableForOperatingLeaseAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A descriptive title of whether the property is subject to or available for operating lease.",
        "label": "Property Subject to or Available for Operating Lease [Domain]",
        "terseLabel": "Property Subject to or Available for Operating Lease [Domain]"
       }
      }
     },
     "localname": "PropertySubjectToOrAvailableForOperatingLeaseDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RealEstateFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in funds that invest in commercial or residential real estate.",
        "label": "Real Estate Funds [Member]",
        "verboseLabel": "Real estate partnerships"
       }
      }
     },
     "localname": "RealEstateFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RealEstateInvestmentMember": {
     "auth_ref": [
      "r1071",
      "r1072",
      "r1073",
      "r1193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents direct equity investments in real estate projects (Land, buildings and improvements owned for income production and capital accretion potential) and certain loans accounted for as real estate investments. For loans accounted for as real estate investments, the entity (lender) has virtually the same risks and rewards as those of owners or joint venture participants. Such arrangements are treated as if the entity actually has an ownership interest in the property. In such arrangements, the entity (lender) participates in expected residual profits, which may be in the form of an equity kicker or a higher than usual effective interest rate. At the outset and during the construction and development of the property, the borrower generally has little or no equity in the property and the entity's (lender's) only source of repayment is the property. The entity (lender) generally (a) agrees to provide substantially all funds to acquire, develop, and construct the property, (b) funds the commitment or origination fees or both, and (c) funds interest during the development and construction of the property.",
        "label": "Real Estate Investment [Member]",
        "terseLabel": "Real estate investment"
       }
      }
     },
     "localname": "RealEstateInvestmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "auth_ref": [
      "r324"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment.",
        "label": "Realized Investment Gains (Losses)",
        "negatedTerseLabel": "Net realized capital (gains) losses",
        "terseLabel": "Net realized capital gains (losses)"
       }
      }
     },
     "localname": "RealizedInvestmentGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r1245",
      "r1246",
      "r1247",
      "r1248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": {
     "auth_ref": [
      "r63",
      "r393",
      "r873",
      "r877",
      "r879",
      "r1209"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
        "terseLabel": "Amounts reclassified, pre-tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r63",
      "r65",
      "r393",
      "r873",
      "r877",
      "r879",
      "r1209"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "terseLabel": "Changes in Accumulated Other Comprehensive Income (Loss) by Component"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r117",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Reconciliation Of Consolidated Operating Income to Adjusted Operating Income"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r118",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of a significant segment item of information disclosed (for example, liabilities) other than profit (loss), revenues, or assets, between reportable segments in total and the entity's consolidated total for that significant segment item disclosed.",
        "label": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemablePreferredStockMember": {
     "auth_ref": [
      "r25",
      "r172",
      "r415",
      "r526",
      "r584",
      "r587",
      "r588",
      "r589",
      "r595",
      "r596",
      "r864"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of type or class of redeemable preferred stock. For instance, cumulative preferred stock, noncumulative preferred stock, convertible or series.",
        "label": "Redeemable Preferred Stock [Member]",
        "terseLabel": "Redeemable preferred securities"
       }
      }
     },
     "localname": "RedeemablePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReinsuranceAccountingPolicy": {
     "auth_ref": [
      "r1057",
      "r1189",
      "r1190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of reinsurance accounting policy, for example, but not limited to, description of the methodologies and assumptions underlying determination of reinsurance recoverables, reinsurance payables and retention policy.",
        "label": "Reinsurance Accounting Policy [Policy Text Block]",
        "terseLabel": "Reinsurance Recoverables"
       }
      }
     },
     "localname": "ReinsuranceAccountingPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReinsuranceDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reinsurance Disclosures [Abstract]",
        "terseLabel": "Reinsurance Disclosures [Abstract]"
       }
      }
     },
     "localname": "ReinsuranceDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed": {
     "auth_ref": [
      "r296"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PolicyholderBenefitsAndClaimsIncurredNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of policy benefits and costs incurred for policies assumed.",
        "label": "Policyholder Benefits and Claims Incurred, Assumed",
        "terseLabel": "Assumed"
       }
      }
     },
     "localname": "ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded": {
     "auth_ref": [
      "r296"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PolicyholderBenefitsAndClaimsIncurredNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reduction of provision for policy benefits and costs incurred for policies ceded.",
        "label": "Policyholder Benefits and Claims Incurred, Ceded",
        "negatedTerseLabel": "Ceded"
       }
      }
     },
     "localname": "ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Premiums Earned, Net [Abstract]",
        "terseLabel": "Premiums Earned, Net [Abstract]"
       }
      }
     },
     "localname": "ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments": {
     "auth_ref": [
      "r327",
      "r330",
      "r1360",
      "r1364"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
       "weight": -1.0
      },
      "http://www.cvshealth.com/role/HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.",
        "label": "Reinsurance Recoverable for Unpaid Claims and Claims Adjustments",
        "periodEndLabel": "Add: Reinsurance recoverables",
        "periodStartLabel": "Less: Reinsurance recoverables",
        "terseLabel": "Reinsurance recoverables"
       }
      }
     },
     "localname": "ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses": {
     "auth_ref": [
      "r983",
      "r1007",
      "r1008",
      "r1055"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, policy benefits and policy reserves. Excludes premiums paid under reinsurance contracts.",
        "label": "Reinsurance Recoverable for Paid and Unpaid Claims and Claims Adjustments",
        "terseLabel": "Total reinsurance recoverables"
       }
      }
     },
     "localname": "ReinsuranceRecoverablesOnPaidAndUnpaidLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsuranceTextBlock": {
     "auth_ref": [
      "r981",
      "r982",
      "r1057",
      "r1189",
      "r1190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure pertaining to the existence, magnitude and information about insurance that has been ceded to or assumed from another insurance company, including the methodologies and assumptions used in determining recorded amounts.",
        "label": "Reinsurance [Text Block]",
        "terseLabel": "Reinsurance"
       }
      }
     },
     "localname": "ReinsuranceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/Reinsurance"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r272"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Expenses from transactions with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.",
        "label": "Related Party Transaction, Other Revenues from Transactions with Related Party",
        "terseLabel": "Other revenues from transactions with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedLabel": "Repayments of long-term debt",
        "terseLabel": "Redeemed principal amount"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r567",
      "r568",
      "r1140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [
      "r567",
      "r568",
      "r1140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResidentialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r1249",
      "r1296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by residential real estate mortgage loans.",
        "label": "Residential Mortgage-Backed Securities [Member]",
        "terseLabel": "Residential mortgage-backed securities"
       }
      }
     },
     "localname": "ResidentialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r1206",
      "r1220"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash (included in other current assets)"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r1079",
      "r1207",
      "r1220"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash (included in other assets)"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedInvestmentsAtFairValue": {
     "auth_ref": [
      "r347",
      "r1067",
      "r1078",
      "r1080"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate value of all restricted investments.",
        "label": "Restricted Investments, at Fair Value",
        "terseLabel": "Investments related to 2012 contract conversion"
       }
      }
     },
     "localname": "RestrictedInvestmentsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r36",
      "r178",
      "r306",
      "r1032",
      "r1037",
      "r1173"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r355",
      "r423",
      "r424",
      "r425",
      "r428",
      "r437",
      "r440",
      "r531",
      "r773",
      "r774",
      "r775",
      "r806",
      "r807",
      "r844",
      "r1028",
      "r1030"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r184",
      "r185",
      "r656",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r704",
      "r705",
      "r706",
      "r708",
      "r711",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r728",
      "r729",
      "r730",
      "r733",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r184",
      "r185",
      "r656",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r704",
      "r705",
      "r706",
      "r708",
      "r711",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r728",
      "r729",
      "r730",
      "r733",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r466",
      "r467",
      "r485",
      "r490",
      "r491",
      "r497",
      "r498",
      "r500",
      "r652",
      "r653",
      "r957"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenues",
        "verboseLabel": "Intersegment revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r655",
      "r1131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r396",
      "r415",
      "r466",
      "r467",
      "r485",
      "r490",
      "r491",
      "r497",
      "r498",
      "r500",
      "r526",
      "r584",
      "r585",
      "r587",
      "r588",
      "r589",
      "r591",
      "r593",
      "r595",
      "r596",
      "r864",
      "r971",
      "r1284"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Total revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r906",
      "r1172"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r906",
      "r1172"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleAndLeasebackTransactionGainLossNet": {
     "auth_ref": [
      "r904",
      "r913",
      "r1172"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.",
        "label": "Sale and Leaseback Transaction, Gain (Loss), Net",
        "terseLabel": "Gains from sale-leaseback transactions"
       }
      }
     },
     "localname": "SaleAndLeasebackTransactionGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesChannelDirectlyToConsumerMember": {
     "auth_ref": [
      "r1154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred directly to consumer.",
        "label": "Sales Channel, Directly to Consumer [Member]",
        "terseLabel": "Mail choice"
       }
      }
     },
     "localname": "SalesChannelDirectlyToConsumerMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesChannelThroughIntermediaryMember": {
     "auth_ref": [
      "r1154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred through intermediary.",
        "label": "Sales Channel, Through Intermediary [Member]",
        "terseLabel": "Pharmacy network"
       }
      }
     },
     "localname": "SalesChannelThroughIntermediaryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r500",
      "r1241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of accounts receivable, net"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r63",
      "r1343",
      "r1344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Changes in Fair Value of Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.",
        "label": "Schedule of Amounts Recognized in Balance Sheet [Table Text Block]",
        "terseLabel": "Schedule of Assets (Liabilities) Recognized in Balance Sheet"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Weighted Average Assumptions Used in Determining Benefit Obligations and Net Benefit Costs"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r217",
      "r218",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails",
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesSummaryofAssetsandLiabilitiesHeldforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Schedule of reconciliation of cash and cash equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock": {
     "auth_ref": [
      "r1375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of reinsurer or group of reinsurers for whom the entity has a concentration of credit risk.",
        "label": "Ceded Credit Risk [Table Text Block]",
        "terseLabel": "Schedule of Reinsurance Recoverables"
       }
      }
     },
     "localname": "ScheduleOfCededCreditRiskByReinsurerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.",
        "label": "Schedule of Changes in Fair Value of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Changes in Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.",
        "label": "Schedule of Changes in Projected Benefit Obligations [Table Text Block]",
        "terseLabel": "Schedule of Changes in Benefit Obligations"
       }
      }
     },
     "localname": "ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Income Tax Provision"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r48",
      "r174",
      "r175",
      "r176",
      "r177",
      "r268",
      "r269",
      "r271",
      "r295",
      "r1143",
      "r1145",
      "r1224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Summary of Company's Borrowings"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r193",
      "r194",
      "r195",
      "r196",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r1",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r16",
      "r18",
      "r19",
      "r20",
      "r160",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Schedule of discontinued operations"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r1240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Reconciliation of Basic and Diluted Earnings (Loss) Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r206",
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Summary of Stock-Based Compensation"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of Expected Future Benefits Payments"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r849",
      "r850"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "verboseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Separate Account Investment [Line Items]",
        "terseLabel": "Fair Value, Separate Account Investment [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable": {
     "auth_ref": [
      "r1174",
      "r1191",
      "r1372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about fair value of asset supporting separate account.",
        "label": "Fair Value, Separate Account Investment [Table]",
        "terseLabel": "Fair Value, Separate Account Investment [Table]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock": {
     "auth_ref": [
      "r297",
      "r1191",
      "r1372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of asset supporting separate account.",
        "label": "Fair Value, Separate Account Investment [Table Text Block]",
        "terseLabel": "Summary of Separate Account Assets",
        "verboseLabel": "Schedule of Fair Value of Separate Accounts by Major Category of Investment"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r1140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r1140",
      "r1263",
      "r1264",
      "r1265",
      "r1266",
      "r1267",
      "r1268",
      "r1269",
      "r1270",
      "r1271",
      "r1272",
      "r1273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Summary of Changes in Carrying Amount of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Net Investment Income [Line Items]",
        "terseLabel": "Schedule of Investment Income, Reported Amounts, by Category [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable": {
     "auth_ref": [
      "r74",
      "r75",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.",
        "label": "Investment Income [Table]",
        "terseLabel": "Schedule of Investment Income, Reported Amounts, by Category [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "terseLabel": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense and Components of Change in Health Care Costs Payable"
       }
      }
     },
     "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of Net Periodic Benefit Cost (Income)"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r101",
      "r102",
      "r105",
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
        "terseLabel": "Schedule of Adjustments Resulting From Applying New Accounting Standard"
       }
      }
     },
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.",
        "label": "Schedule of Nonvested Share Activity [Table Text Block]",
        "terseLabel": "RSU and Performance Share Unit Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOperatingLeasedAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Schedule of Operating Leased Assets [Table]",
        "terseLabel": "Schedule of Operating Leased Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeasedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRegulatoryAssetsTextBlock": {
     "auth_ref": [
      "r349",
      "r350",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets that are created when regulatory agencies permit public utilities to defer certain costs included in rate-setting to the balance sheet.",
        "label": "Schedule of Regulatory Assets [Table Text Block]",
        "terseLabel": "Schedule of Regulatory Requirements"
       }
      }
     },
     "localname": "ScheduleOfRegulatoryAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r115",
      "r116",
      "r119",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r115",
      "r116",
      "r119",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summarized Financial Information Of Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r735",
      "r736",
      "r739",
      "r740",
      "r741",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.",
        "label": "Share-Based Payment Arrangement, Option and Stock Appreciation Rights, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Options and Stock Appreciation Rights Award Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule ESPP Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-Term Debt [Table]",
        "terseLabel": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r179",
      "r180",
      "r181",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Share Repurchase Programs"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value).",
        "label": "Schedule of Unrealized Loss on Investments [Table Text Block]",
        "verboseLabel": "Schedule of Debt Securities In An Unrealized Capital Loss Position"
       }
      }
     },
     "localname": "ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r1169",
      "r1328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Tax Benefits Rollforward"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r233",
      "r235",
      "r238",
      "r239",
      "r240",
      "r825",
      "r826",
      "r831",
      "r832",
      "r936",
      "r937",
      "r938"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "auth_ref": [
      "r233",
      "r235",
      "r238",
      "r239",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table Text Block]",
        "terseLabel": "Schedule of variable interest entities"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "verboseLabel": "Schedule of Projected Annual Amortization Expense for Intangible Assets for Next Five Years"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r463",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r495",
      "r500",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r575",
      "r576",
      "r1140",
      "r1365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r463",
      "r464",
      "r465",
      "r475",
      "r478",
      "r489",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r499",
      "r500",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Other Significant Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Other Significant Reconciling Item [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingOtherSignificantReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SelfInsuranceReserve": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.",
        "label": "Self Insurance Reserve",
        "terseLabel": "Self insurance liabilities"
       }
      }
     },
     "localname": "SelfInsuranceReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SelfInsuranceReservePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for self-insurance reserves, including, but not limited to incurred but not reported reserves (IBNR).",
        "label": "Self Insurance Reserve [Policy Text Block]",
        "terseLabel": "Self-Insurance Liabilities"
       }
      }
     },
     "localname": "SelfInsuranceReservePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsScheduleofBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeparateAccountAssetCategoryAxis": {
     "auth_ref": [
      "r1048",
      "r1191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by separate account asset investment.",
        "label": "Separate Account Asset Category [Axis]",
        "terseLabel": "Separate Account Asset Category [Axis]"
       }
      }
     },
     "localname": "SeparateAccountAssetCategoryAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueNarrativeDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeparateAccountAssetCategoryDomain": {
     "auth_ref": [
      "r1048",
      "r1191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Separate account asset investment.",
        "label": "Separate Account Asset Category [Domain]",
        "terseLabel": "Separate Account Asset Category [Domain]"
       }
      }
     },
     "localname": "SeparateAccountAssetCategoryDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueNarrativeDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeparateAccountAssets": {
     "auth_ref": [
      "r985",
      "r1047",
      "r1048",
      "r1191"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset at fair value held for benefit of separate account policyholder.",
        "label": "Separate Account Asset",
        "terseLabel": "Separate accounts assets"
       }
      }
     },
     "localname": "SeparateAccountAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeparateAccountCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r1191",
      "r1372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and cash equivalent in which separate account asset is invested.",
        "label": "Separate Account, Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "SeparateAccountCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeparateAccountDebtSecurityMember": {
     "auth_ref": [
      "r1372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporation, government, or governmental agency, municipality, and other institution; in which separate account asset is invested.",
        "label": "Separate Account, Debt Security [Member]",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "SeparateAccountDebtSecurityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeparateAccountLiabilityBenefitPayment": {
     "auth_ref": [
      "r1192",
      "r1373"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to separate account policyholder from benefit payment.",
        "label": "Separate Account, Liability, Benefit Payment",
        "negatedTerseLabel": "Benefit payments"
       }
      }
     },
     "localname": "SeparateAccountLiabilityBenefitPayment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeparateAccountLiabilityCashSurrenderValueAmount": {
     "auth_ref": [
      "r1050",
      "r1192"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of separate account liability payable to policyholder upon surrender of contract before maturity.",
        "label": "Separate Account, Liability, Cash Surrender Value, Amount",
        "terseLabel": "Cash surrender value, end of the period"
       }
      }
     },
     "localname": "SeparateAccountLiabilityCashSurrenderValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance": {
     "auth_ref": [
      "r1192",
      "r1373"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in separate account liability from performance of investment.",
        "label": "Separate Account, Liability, Increase (Decrease) from Invested Performance",
        "terseLabel": "Investment earnings"
       }
      }
     },
     "localname": "SeparateAccountLiabilityIncreaseDecreaseFromInvestedPerformance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeparateAccountLiabilityIncreaseDecreaseFromOtherChange": {
     "auth_ref": [
      "r1192",
      "r1373"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount increase (decrease) in separate account liability from change, classified as other.",
        "label": "Separate Account, Liability, Increase (Decrease) from Other Change",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "SeparateAccountLiabilityIncreaseDecreaseFromOtherChange",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeparateAccountLiabilityPremiumAndDeposit": {
     "auth_ref": [
      "r1192",
      "r1373"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow to separate account liability from premium and deposit from cash received.",
        "label": "Separate Account, Liability, Premium and Deposit",
        "terseLabel": "Premiums and deposits"
       }
      }
     },
     "localname": "SeparateAccountLiabilityPremiumAndDeposit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeparateAccountLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Separate Account, Liability [Roll Forward]",
        "terseLabel": "Separate Account, Liability [Roll Forward]"
       }
      }
     },
     "localname": "SeparateAccountLiabilityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeparateAccountLiabilitySurrenderAndWithdrawal": {
     "auth_ref": [
      "r1192",
      "r1373"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in separate account liability from contract redemption and withdrawal of funds.",
        "label": "Separate Account, Liability, Surrender and Withdrawal",
        "negatedTerseLabel": "Surrenders and withdrawals"
       }
      }
     },
     "localname": "SeparateAccountLiabilitySurrenderAndWithdrawal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeparateAccountLiabilityTableTextBlock": {
     "auth_ref": [
      "r1052",
      "r1192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about separate account liability, including, but not limited to change in liability and related cash surrender value.",
        "label": "Separate Account, Liability [Table Text Block]",
        "terseLabel": "Roll Forward of Separate Accounts"
       }
      }
     },
     "localname": "SeparateAccountLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeparateAccountMortgageBackedSecurityMember": {
     "auth_ref": [
      "r1372",
      "r1374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security collateralized by real estate mortgage loan, in which separate account asset is invested.",
        "label": "Separate Account, Mortgage-Backed Security [Member]",
        "terseLabel": "Mortgage-backed securities"
       }
      }
     },
     "localname": "SeparateAccountMortgageBackedSecurityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeparateAccountsLiability": {
     "auth_ref": [
      "r986",
      "r1047",
      "r1049",
      "r1051",
      "r1192"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.",
        "label": "Separate Account, Liability",
        "negatedTerseLabel": "Separate accounts liabilities",
        "periodEndLabel": "Separate Accounts liability, end of the period",
        "periodStartLabel": "Separate Accounts liability, beginning of the period",
        "terseLabel": "Separate accounts liabilities"
       }
      }
     },
     "localname": "SeparateAccountsLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r1148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Services"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SettledLitigationMember": {
     "auth_ref": [
      "r1276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.",
        "label": "Settled Litigation [Member]",
        "terseLabel": "Settled Litigation"
       }
      }
     },
     "localname": "SettledLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r1166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)",
        "verboseLabel": "Weighted-average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansValuationAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r751",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Unvested at end of period (in shares)",
        "periodStartLabel": "Unvested at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r751",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Unvested at end of year (in dollars per share)",
        "periodStartLabel": "Unvested at beginning of year (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r758"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Vested in period, fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "verboseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "verboseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "verboseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r1168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available for grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Shares exercisable at end of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price exercisable at end of year ($ per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r758"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value of stock options and SARs exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "negatedTerseLabel": "Shares expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Shares forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Shares granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r207"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic value outstanding at end of year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r743",
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Shares, Outstanding at end of year (in shares)",
        "periodStartLabel": "Shares, Outstanding at beginning of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r743",
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted average exercise price, outstanding at end of year ($ per share)",
        "periodStartLabel": "Weighted average exercise price, outstanding at beginning of year ($ per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r759"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value vested at end of year and expected to vest in the future"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Shares vested at end of year and expected to vest in the future (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price vested at end of year and expected to vest in the future ($ per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r739",
      "r740",
      "r741",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, exercised ($ per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, expired ($ per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, forfeited ($ per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, granted ($ per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r742",
      "r761",
      "r762",
      "r763",
      "r764",
      "r767",
      "r776",
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share price (in dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r1167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "verboseLabel": "Expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r207"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value exercisable at end of year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term exercisable at end of year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average contractual term, outstanding at end of year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term vested at end of year and expected to vest in the future"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price of common stock percent"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Shares outstanding, end of year balance (in shares)",
        "periodStartLabel": "Shares outstanding, beginning of year balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortDurationInsuranceContractAccidentYear2019Member": {
     "auth_ref": [
      "r1012"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year 2019 in which covered event occurs under terms of short-duration insurance contract.",
        "label": "Short-Duration Insurance Contract, Accident Year 2019 [Member]",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "ShortDurationInsuranceContractAccidentYear2019Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortDurationInsuranceContractAccidentYear2020Member": {
     "auth_ref": [
      "r1012"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year 2020 in which covered event occurs under terms of short-duration insurance contract.",
        "label": "Short-Duration Insurance Contract, Accident Year 2020 [Member]",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "ShortDurationInsuranceContractAccidentYear2020Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r26",
      "r278",
      "r305",
      "r1173"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "terseLabel": "Short-term debt"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-Term Debt [Line Items]",
        "terseLabel": "Short-term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-Term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-Term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r283",
      "r284",
      "r302",
      "r1208"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-Term Investments",
        "terseLabel": "Investments",
        "verboseLabel": "Current"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r901",
      "r1172"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-Term Lease, Cost",
        "terseLabel": "Short-term lease costs"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsAccidentYearAxis": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by accident year in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-Duration Insurance Contracts, Accident Year [Axis]",
        "terseLabel": "Short-duration Insurance Contracts, Accident Year [Axis]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsAccidentYearAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsAccidentYearDomain": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-Duration Insurance Contracts, Accident Year [Domain]",
        "terseLabel": "Short-duration Insurance Contracts, Accident Year [Domain]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsAccidentYearDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about undiscounted information about claims development by accident year for short-duration insurance contracts.",
        "label": "Short-Duration Insurance Contracts, Claims Development [Table]",
        "terseLabel": "Short-duration Insurance Contracts, Claims Development [Table]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsClaimsDevelopmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted information about claims development by accident year for short-duration insurance contracts.",
        "label": "Short-Duration Insurance Contracts, Claims Development [Table Text Block]",
        "terseLabel": "Information about Incurred and Paid Health Care Claims Development"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet": {
     "auth_ref": [
      "r333"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reinsurance, of paid claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-Duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net",
        "terseLabel": "Cumulative Paid Health Care Claims, Net of Reinsurance"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet": {
     "auth_ref": [
      "r336",
      "r337"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net",
        "verboseLabel": "Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) claims liability, net"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet": {
     "auth_ref": [
      "r332"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of incurred claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-Duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net",
        "terseLabel": "Incurred Health Care Claims, Net of Reinsurance"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet": {
     "auth_ref": [
      "r334",
      "r335"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net",
        "terseLabel": "Short-duration health care costs payable, net of reinsurance",
        "totalLabel": "Total outstanding liabilities for health care costs payable, net of reinsurance"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented": {
     "auth_ref": [
      "r334"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts for accident years not separately presented in claim development information. Excludes unallocated claim adjustment expense.",
        "label": "Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net, Not Separately Presented",
        "terseLabel": "All outstanding liabilities for health care costs payable prior to 2021, net of reinsurance"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reconciling item for the reconciliation of the liability in the disclosure of claims development (in excess of) less than the liability for unpaid claims and claims adjustment expense for short-duration insurance contracts, classified as other.",
        "label": "Short-Duration Insurance Contracts, Liability for Unpaid Claims and Claim Adjustment Expense, Other Reconciling Item",
        "terseLabel": "Insurance lines other than short duration"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]",
        "terseLabel": "Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the reconciliation of claims development to the liability for unpaid claims and claim adjustment expense for short-duration insurance contracts.",
        "label": "Short-Duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table]",
        "terseLabel": "Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]",
        "terseLabel": "Software"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r358",
      "r463",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r495",
      "r500",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r574",
      "r575",
      "r576",
      "r1140",
      "r1365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SegmentReportingRetrospectiveAdjustmentstoSegmentCompositionDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r53",
      "r173",
      "r355",
      "r392",
      "r393",
      "r394",
      "r423",
      "r424",
      "r425",
      "r428",
      "r437",
      "r440",
      "r458",
      "r531",
      "r640",
      "r773",
      "r774",
      "r775",
      "r806",
      "r807",
      "r844",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r879",
      "r919",
      "r1028",
      "r1029",
      "r1030"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r423",
      "r424",
      "r425",
      "r458",
      "r957"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatutoryAccountingPracticesDisclosureTextBlock": {
     "auth_ref": [
      "r316",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of how the entity's reporting under GAAP as of the balance sheet date differs from the results based on prescribed and permitted accounting practices of the state or country of domicile in which a relevant statutory filing is made, or differences in results based on the National Association of Insurance Commissioners (NAIC) prescribed practices, or a combination thereof. Describes the accounting practices used and the related monetary effect on statutory surplus, net income, and risk-based capital. If an insurance enterprise's risk-based capital would have triggered a regulatory event had it not used a permitted practice, that fact is disclosed in the financial statements. Permitted statutory accounting practices include practices not prescribed but allowed by the domiciliary state insurance department regulatory authority.",
        "label": "Statutory Accounting Practices Disclosure [Table Text Block]",
        "terseLabel": "Statutory Accounting Practices Disclosure"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatutoryAccountingPracticesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statutory Accounting Practices [Line Items]",
        "terseLabel": "Statutory Accounting Practices [Line Items]"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of dividends that can be declared or paid without approval of regulatory agency.",
        "label": "Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval",
        "terseLabel": "Estimated maximum dividend distributions permitted in 2023 without prior regulatory approval"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance": {
     "auth_ref": [
      "r307",
      "r339"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country.",
        "label": "Statutory Accounting Practices, Statutory Capital and Surplus, Balance",
        "terseLabel": "Estimated statutory capital and surplus"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired": {
     "auth_ref": [
      "r340"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices.",
        "label": "Statutory Accounting Practices, Statutory Capital and Surplus Required",
        "terseLabel": "Estimated minimum statutory surplus required by regulators"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount": {
     "auth_ref": [
      "r307"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net income for the period determined using accounting principles prescribed or permitted by insurance regulators.",
        "label": "Statutory Accounting Practices, Statutory Net Income Amount",
        "terseLabel": "Statutory net income"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryNetIncomeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatutoryAccountingPracticesTable": {
     "auth_ref": [
      "r316",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail by state, country, or other jurisdiction of domicile in which financial statements are filed reflecting statutory capital and surplus, net income and the differences between financial reports which are in conformity with generally accepted accounting principles and the statutory financial statements which also use state permitted or prescribed accounting practices.",
        "label": "Statutory Accounting Practices [Table]",
        "terseLabel": "Statutory Accounting Practices [Table]"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)"
       }
      }
     },
     "localname": "StockAppreciationRightsSARSMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r33",
      "r34",
      "r173",
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Shares issued employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r33",
      "r34",
      "r173",
      "r178",
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Shares exercised (in shares)",
        "verboseLabel": "Stock option activity, stock awards and other (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r53",
      "r173",
      "r178"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Stock option activity, stock awards and other"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r33",
      "r34",
      "r173",
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Stock repurchased during the period (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r33",
      "r34",
      "r173",
      "r178"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "terseLabel": "Stock repurchased during period, value"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r34",
      "r37",
      "r38",
      "r123",
      "r1173",
      "r1222",
      "r1257",
      "r1342"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "terseLabel": "Total CVS Health shareholders\u2019 equity",
        "totalLabel": "Total CVS Health shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r224",
      "r225",
      "r241",
      "r355",
      "r356",
      "r393",
      "r423",
      "r424",
      "r425",
      "r428",
      "r437",
      "r531",
      "r640",
      "r773",
      "r774",
      "r775",
      "r806",
      "r807",
      "r844",
      "r873",
      "r874",
      "r879",
      "r919",
      "r1029",
      "r1030",
      "r1222",
      "r1257",
      "r1342"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Reduction to retained earnings as a result of new accounting standard adoption",
        "periodEndLabel": "End of year balance",
        "periodStartLabel": "Beginning of year balance",
        "terseLabel": "Total shareholders\u2019 equity",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeLossDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r183",
      "r414",
      "r626",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r639",
      "r640",
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r903",
      "r1172"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "negatedTerseLabel": "Less: sublease income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r880",
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails",
      "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r880",
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails",
      "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r880",
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsDivestituresandAssetSalesNarrativeDetails",
      "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalIncomeStatementElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Income Statement Elements [Abstract]",
        "terseLabel": "Condensed Consolidated Statement of Operations:"
       }
      }
     },
     "localname": "SupplementalIncomeStatementElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsAdjustmentsResultingFromApplyingNewAccountingStandardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r1010"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.",
        "label": "Current Year Claims and Claims Adjustment Expense",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r1010"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.",
        "label": "Prior Year Claims and Claims Adjustment Expense",
        "negatedTerseLabel": "Decrease in prior years' healthcare costs payable",
        "verboseLabel": "Prior years"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferToFromPolicyholderAccountBalanceToFromSeparateAccount": {
     "auth_ref": [
      "r1185",
      "r1188",
      "r1192",
      "r1367",
      "r1373"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfer to (from) liability for policyholder account balance (to) from liability for separate account.",
        "label": "Transfer to (from) Policyholder Account Balance (to) from Separate Account",
        "terseLabel": "Net transfers from general account"
       }
      }
     },
     "localname": "TransferToFromPolicyholderAccountBalanceToFromSeparateAccount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsRollForwardofSeparateAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r515",
      "r516",
      "r622",
      "r638",
      "r834",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r1254",
      "r1255",
      "r1256",
      "r1376",
      "r1377",
      "r1378",
      "r1379",
      "r1380",
      "r1381",
      "r1382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Shares"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "negatedPeriodEndLabel": "Treasury shares outstanding, end of year balance (in shares)",
        "negatedPeriodStartLabel": "Treasury shares outstanding, beginning of year balance (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r52",
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r52",
      "r179",
      "r182"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost: 458 and 422 shares at December\u00a031, 2022 and 2021"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r427",
      "r428",
      "r429",
      "r430",
      "r441",
      "r505",
      "r506",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r773",
      "r774",
      "r775",
      "r804",
      "r805",
      "r806",
      "r807",
      "r821",
      "r822",
      "r823",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r882",
      "r883",
      "r886",
      "r887",
      "r888",
      "r889",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r959",
      "r960",
      "r961",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfCostGoodOrServiceExtensibleList": {
     "auth_ref": [
      "r1293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates type of cost from product sold and service rendered.",
        "label": "Cost, Product and Service [Extensible Enumeration]",
        "terseLabel": "Cost, Product and Service [Extensible List]"
       }
      }
     },
     "localname": "TypeOfCostGoodOrServiceExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r1132",
      "r1155",
      "r1358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. government securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USStatesAndPoliticalSubdivisionsMember": {
     "auth_ref": [
      "r1155",
      "r1372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bonds or similar securities issued by state, city, or local US governments or the agencies operated by state, city, or local governments. Debt securities issued by state governments may include bond issuances of US state authorities including, for example, but not limited to, housing authorities, dormitory authorities, and general obligations while debt securities issued by political subdivisions of US states would include, for example, debt issuances by county, borough, city, or municipal governments.",
        "label": "US States and Political Subdivisions Debt Securities [Member]",
        "terseLabel": "States, municipalities and political subdivisions",
        "verboseLabel": "States, municipalities and political subdivisions"
       }
      }
     },
     "localname": "USStatesAndPoliticalSubdivisionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/OtherInsuranceLiabilitiesandSeparateAccountsSeparateAccountAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "auth_ref": [
      "r972",
      "r1155",
      "r1372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Treasury and Government [Member]",
        "terseLabel": "U.S. government securities"
       }
      }
     },
     "localname": "USTreasuryAndGovernmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy": {
     "auth_ref": [
      "r1009",
      "r1011"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for estimating the ultimate cost of settling insurance claims relating to insured events that have occurred on or before a particular date (ordinarily, the statement of financial position date). The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claims adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Unpaid Policy Claims and Claims Adjustment Expense, Policy [Policy Text Block]",
        "terseLabel": "Other Insurance Liabilities"
       }
      }
     },
     "localname": "UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r780",
      "r789"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r790"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Reductions for tax positions of prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r792"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r788"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Income tax penalties and interest accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r788"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Income tax penalties and interest expense"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r791"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions based on tax positions related to the current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r790"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions based on tax positions related to prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r793"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Expiration of statutes of limitation"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r794"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r112",
      "r113",
      "r114",
      "r459",
      "r460",
      "r461",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Valuation Allowance [Line Items]",
        "terseLabel": "Valuation Allowance [Line Items]"
       }
      }
     },
     "localname": "ValuationAllowanceLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationAllowanceTable": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A listing of an entity's valuation allowances to reduce deferred tax assets to amounts which it is more likely than not will not be realized, including a description of the deferred tax assets for which the valuation allowance has been recorded and the amount of the valuation allowance.",
        "label": "Valuation Allowance [Table]",
        "terseLabel": "Valuation Allowance [Table]"
       }
      }
     },
     "localname": "ValuationAllowanceTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableInterestEntityOwnershipPercentage": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).",
        "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage",
        "terseLabel": "VIE, ownership percentage"
       }
      }
     },
     "localname": "VariableInterestEntityOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r902",
      "r1172"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease costs"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r443",
      "r451"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average diluted shares outstanding (in shares)",
        "totalLabel": "Weighted average shares, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r442",
      "r451"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average basic shares outstanding (in shares)",
        "verboseLabel": "Weighted average shares, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.",
        "label": "Write off of Deferred Debt Issuance Cost",
        "terseLabel": "Write off of deferred debt issuance cost"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditAgreementsLongtermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 15
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1000": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1001": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1002": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=35755530&loc=d3e11264-158415",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1003": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124505477&loc=SL117422543-158416",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1004": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124505477&loc=SL117422543-158416",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1005": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124505477&loc=SL117422543-158416",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1006": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "944",
   "URI": "https://asc.fasb.org/subtopic&trid=4737841",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1007": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99404803&loc=d3e21409-158489",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1008": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99404803&loc=d3e21412-158489",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1009": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14754-158437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1010": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1011": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14784-158437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1012": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1013": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1014": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1015": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1016": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(4)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1017": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(5)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1018": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(6)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1019": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1020": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1021": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1022": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1023": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)(3)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1024": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1025": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1026": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1027": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1028": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1029": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1030": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1031": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1032": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1033": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1034": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1035": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1036": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1037": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1038": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/subtopic&trid=2560295",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1039": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "605",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=84167274&loc=d3e27175-158546",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1040": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(a)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1041": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(b)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1042": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(b)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1043": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(b)(3)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1044": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1045": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1046": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(3)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1047": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6484091&loc=d3e19268-158472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1048": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1049": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e725-108305",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1050": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1051": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1052": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1053": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506110&loc=d3e32546-158582",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1054": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600598&loc=SL75763979-209797",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1055": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1056": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1057": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "944",
   "URI": "https://asc.fasb.org/topic&trid=2303980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1058": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1059": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e765-108305",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1060": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1061": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1062": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1063": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1064": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1065": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1066": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1067": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Footnote 11(c)))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1068": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1069": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1070": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1071": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1072": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1073": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1074": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Column G))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1075": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1076": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 6))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1077": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29)",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1078": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1079": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1080": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=127002003&loc=SL6242269-115581",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1081": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1082": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491204&loc=d3e4879-115612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1083": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1084": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "720",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=49178521&loc=d3e9162-115647",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1085": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1086": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1087": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1088": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1089": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1090": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1091": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1092": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1093": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1094": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1095": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1096": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1097": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1098": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1099": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1100": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1101": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1102": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1103": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1104": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1105": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1106": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1107": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1108": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1109": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1110": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1111": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1112": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1113": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1114": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1115": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1116": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1117": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1118": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1119": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1120": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1121": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1122": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(m)",
   "Publisher": "SEC",
   "Section": "4",
   "Subparagraph": "(1)(iii)",
   "Subsection": "08",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3505-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921842-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "79",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82922352-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124504833&loc=d3e7104-158389",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124504731&loc=d3e11522-158419",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783724-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783724-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783724-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783724-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783724-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(g)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783724-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(h)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783724-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783734-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783734-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(g)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783734-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819541-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "605",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99379264&loc=d3e27758-158548",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "605",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99379264&loc=d3e27830-158548",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124505678&loc=SL117422397-158474",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124505678&loc=SL117422401-158474",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1197": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1198": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1199": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1200": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1201": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1202": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1203": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r1205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r1206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953659-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6283291-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6283291-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1253": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1282": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1294": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "https://asc.fasb.org/topic&trid=2122478",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450678-114947",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6811-158387",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6824-158387",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(6))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124505477&loc=SL117422543-158416",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99404803&loc=d3e21412-158489",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=122147696&loc=SL65671395-207642",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124505678&loc=SL117422397-158474",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1376": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1377": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1378": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1379": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1380": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1381": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1382": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1383": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "11",
   "Subsection": "03",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1384": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1385": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1386": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1387": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1388": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2599-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2611-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=26872618&loc=d3e7436-122677",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2AA",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759068-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13(3)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6479118&loc=d3e64650-112822",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6811-158387",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124504833&loc=d3e7104-158389",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(13)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),5)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.14)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.23(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.3(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.5)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=35755530&loc=d3e11264-158415",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(cc)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671315-158438",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671317-158438",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671321-158438",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6483535&loc=d3e16392-158451",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486098&loc=d3e24746-158529",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486098&loc=d3e24790-158529",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "505",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=82848697&loc=d3e24938-158530",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "505",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=82848697&loc=d3e24959-158530",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12.6(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "980",
   "URI": "https://asc.fasb.org/extlink&oid=6499975&loc=d3e44250-110382",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "980",
   "URI": "https://asc.fasb.org/extlink&oid=6499975&loc=d3e44264-110382",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "715",
   "Topic": "980",
   "URI": "https://asc.fasb.org/extlink&oid=6501251&loc=d3e52485-110419",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123405975&loc=d3e41551-112718",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(m)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3337-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(b))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22 (b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL82887624-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5708775-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126972413&loc=SL7495116-110257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919396-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128295416&loc=SL77919786-209982",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r937": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r950": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r951": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r952": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r953": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r954": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r955": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r956": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r957": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r958": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r959": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r960": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r961": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r962": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r963": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r964": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r965": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(c))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r966": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r967": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r968": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r969": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r970": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123398031&loc=SL120154370-112784",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r971": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r972": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r973": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r974": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r975": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r976": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r977": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r978": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r979": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6480726&loc=d3e6691-158385",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r980": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6480726&loc=d3e6691-158385",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r981": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6811-158387",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r982": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6816-158387",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r983": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6824-158387",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r984": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(13)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r985": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r986": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r987": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r988": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(7))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r989": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r990": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r991": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r992": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r993": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r994": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r995": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(7)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r996": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r997": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r998": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r999": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>149
<FILENAME>0000064803-23-000021-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000064803-23-000021-xbrl.zip
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M4*LXXA;1A3$$EBDW&AZMQ-8@@4*0V  -DJVV^.J,\5*2VQ2=>T.R%C8Y%!/
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MC*U/^"0LD4++CE2GMWHNRL>-T[HSJ-6!I3:5<['1I.#!FHC4>[@54Z"F$,N
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MS 0N1AIR[V"$J:4V<>7JN>)VYS </SNR<I4P!RO!&_0)C$V9H3+EX$OSX,S
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MRX@YU"&WZ1XJ5VYLX0@A88MB $'_Y,8(I69VK:DCRC25/==-I?%4<2(8DAK
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M+VY>7M_(Y7\>KN]>?G,I-S?S;S2YG0_ZY#K<AP_\4USZN#[,#^-OU[?S2\M
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M9FW-%:P#UZ6R5T1G\PX-^](KM,U/GHX0/]6P/HD(U^4TU[$O^;,X-9@-S&:
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MV+"5Z22MGH0JX,>*?6(P'-$R]+'<E!I%0E ).4FQE"H" V/>P*GKV<-P1+_
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M(V0NTY:]<;&YO'G=5IU_\? %.+T/=>8?]6ME1K<@M)_8^EP>"%(^6DY?.(1
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MT!X!/A8]/\;-F[]>+O]Z?;A]+L_C:[%_A*]3GS?CFK/DPL-99@Q8B)=+)<W
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M %J\0>90CM014U&'PL-2TIXE^;[;_%CX?'=]B(OG5[MG/EZ:?JE2D4;.=6E
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M@O(C>4>45.-F/O.' 3HU#"0O!(M:"2KQ/\X,&$^T(9XYD@)W8PK,'0;H]##
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MAICY=36_/>::BXO:!]VU857%KC^[M./F+NXZQ91BZ7.E: B>Q'SRDO6$.6Y
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M2F%\M$&'L43A$XG"YP\67^)/G4.VG5YT>E4[P&X<##KQQRQL_O"%S:>SL!V
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MW*&;2Z.,@K-D*:,*=:$"+S4$OT15@Y7@;*HE3.*&""NR6:44S:T?. 1IDF<
M85DRM2!*<#:E](&10&3.?70B&64,*$)! 0/B2$@-"&LT URS4H(SVLLD )"\
M0\M=2&F,C5)[&:+--5ZA"05>34+5CU6",T)4XHHQ$Z4* F2T'"+X"%9$ Z@/
MEXA:#"4XFQ( IW7(>ZXJ1J&# QV,U(0$FXA,@8X.XYQ'3#WL,,[1<:OAQQS&
M^69W/9X@U_(,MM,(.PBF/X?'T)T(JM6UU1Q:7^M553OTJIWH8_L47"<^[I'8
M-Q#ST-,ZVY^>5_D\6IQJ_[!]4D#EJU[G.H_S+2N]ZN!7%$+\U_$5OR;P@S+U
M>H-N;Q"?%*GJ'>_$U$?(!?[/F5OOG;YB.Z?[?&L8CC9.W[VT1]M'6VQK?4ML
M[ZWR[;TM^F[O[T_OWOYSV'K[1NZS?;[/7AQM[VW0=^M_DU>\U=D_[YVWCE;/
MM]<_?&R=?SC'Z\C6VW\Z^WO_=+;?MHY;K'6X?_[A4^OMWZ3UPGS:VGMS^J[[
MU^&[\Y-VBVW2_;<;I+4>.ELO-\B[MUN?]O?^IJV7;\CVGN?O7O[5WEI_P_;;
MENR__:O_;J_'WAWOGV^Q-Q^W7[XXW#]:):WS3;9_M/5Q&\>#GV7KR']J';TY
MN[CGWW\=NN/0V3YZ=_SN:.O\W=ZJV'_[ I_[-]\Z>M?>.E\5K?KS!]8ZWV"M
MO;_:_S[?(*_V#@9;N^33J[U-B;]]W/[[O==>:$BQU)[84A#A2Q/!E2YY(Z+F
M22M6+ E[+V$W/N)_F;AGVYFXZQ_>2^$HXC:6J&%3*;BCI?-*E4P1QIVB3$I8
M4O9^ROI;D%71*>E(:36H4BAI2J>,**GDTFB;*X7(DZ+3[G[8^;) J:5)ONY)
M,>@U5(2\^_<A\<?_=.&M'6X?;_+]HW\.\5K20M[L[^W@.%X<MM;?$!RO;)V'
M#_O'FQ];>^^0MA]P+F]P3G\CK5<EHO8]L=1$'74963*E,(F53EM=NB@D#\0#
M:N\G1:\*L?K?)UEK_WI#B"^E^@R6R/FKO;\G2P3_MDE:']^;1)UC!DIO0)3"
M:U/:"+R$I*@/S#C%TE+V?)FP!X/66B8J2O6C?;IU]#=_[[BD.A%3:F88DM7(
M$BGM2Q49<T8D,%HLR?IELFZR._"J;$2I[1B2,R!AK40#1'E62OR!\LBS5%\2
M]LN$W?IX!V$]<](#I#)JAH) F50:'6D)2K&8I';2J"5A[R'L;4' N00-8$KC
M.2G1T-,E2*]+$4"C</5)<K<DZSV*B]^!5T>,SHN^=%9"*;2'TCJ//@EQ.@JA
M&:BET7R?A#V[@[#4J20M1;D:$*Q">5%:I7FIM:6*"L\D-TNC^5ZCV7.D)01<
MXQ0]#A9D]NS0 0$/I$Q1 $01G.*PM)/G;%7\/6BU;TCQE @ZC$&7 :Q%V1T<
MRG/+2G"$$J4H,7X9^[B7K%M[J[?<#XC4<AV1DNATX(*@I2/*H9T,*-(M$)7,
MDK#W$7;[IM4!N:<K$:'T-LI21$#WPV7[@X,)*,=E(LO QT-D^-;']]90](HC
M8I*BFRQ$(J4%&[*A8;4B%DG,ES)\SM;$AGBU]^:6R2B)0,M0E"EI]!VIX"48
M9TON<\,@JTT"NQ0V7R;LAT%K]X:P">C5^( 4S:<IE8(Y='9P692.IASS4+A"
MEB&D!UCBF[>4(V'HUOA8$JU]#E_KTAD4Y5QP*R4D]-'#DK#WQSIN"8+D73 ^
M\I(3!*N@FI8&-"FU4[GH5SJIXI*P]T>3;Q%66<5#LJDD$6@IP"LTYYPLHQ<6
M"8XB5B\)>V\T>>NF^\$30M2@X>&B<-DE5Z5ECI2<40J@T8"6RZ#G R3L;8L@
MIUIJS<NHDD#KF*!M%Y0JA;:>RUPO#<L@T@,D[&W5910!I62IN8@E+GY:0LA!
MI)08VM($Z;UTF.^/)M\TM5S*7?I=*&5(:6S!QF#*I#BEQJIHK%R2]1Y!P.\0
M!+GE+%>>E,D*-+4\8R6:6*F4SB3F#0,4#4O"WH?76XI+<V.U4!9-@8ABP#%4
M89:E,IC<3<7;8.AR]^,!AM8M^0H^,)*W06,BJ*Y<#M(;] ]H@&@,2> H71+V
M?D%PB[#:(4B!^!()B<XL(5#FDSE+Q3277'OGR5+"/B#X<HNP*3B&9BH2-FFT
M836X$KQ%WS8$'I@$#G09);@W^')+PLI ''"*OD#@$@5!-K2$]B4*UL XY8[+
MN(ST/F2W[N_W(7%BB!*XV)5!6H)!ZRK)D@ HGH!S&M@]D=[17_J]8>5C?_3U
M,$*H<Z=#^_3W_\'_C7M52I,4X9K%D#<#A1%1&<,!G%%&0'I?O^#BGO[@++/O
MN-TM#V/[X'#P7+ 5+4\&OWULA\'A<TK(_WU27_K[__1/H/O[_[CJ5WS Z//H
M.;>>EO.K2^BT#[K/<].56#T9W3SYW?<ZO>KY?]4Y\^2WU.L.R@3'[<[9\_^W
MUSZ._:(5/Q8[O6/H_K]G?>CVRWZLVFET8;]]'I]3@P.LOWX<#5KC<Q!D<3()
MRO*PW[0V]S;6B]V]U;V-W>MCGL/1[FZLO=G9W-O<V"U66^O%QK_7_EQMO=PH
MUK:WMC9W=S>W6S.< GO0%-X"PK5[,.AUGQ7K*VLK!1H3PMX:]N>A-(=L>;&]
MLU7DK99NK]O*=3-M7XQK"%"<Y4+>%" 81CF321C%K0TH^$P*4EOGZ>C,*$XD
MD^7DPY.B"[F:),3V\_6>'^:JA]R[Z,EH#7]6/AYOTNV7^UE&\JWC?SZ\V]O)
M<DB@S&+;ZP?G6=)OK^_C]Q?'(_F(<F[O\#C+R-;Y7YUW*-NRS-M>W^FTC@[$
M%LM:Y0#OW3E\US&?7K%W9_MOO4*YQK?R->=>;K_<XJWU%_B,#V?[+,NUU8\M
MMG6V]7:#[Q]OG(:7_XCP)SZ;=4[=48^_V_,?<3P<Y;'8/_<HC_?9]MY?1ZB]
MZ-;Z*M\_WT0Y&]K[_Z \/O?G[[G6P4K4V-IJU#0R;]I2;4HE'0?I28A>/_G=
ME/^JI=XE$WXOYA57#ULKN-AW-EI[Q<[&Z^V=O;D?[NMAU1]"=X!:O-B-/JNF
M@O)B>Z>@\FGXI>BE8N\PYI^&57O0QA=O?/*'T#V(Q:H?Y)^IY6)Z+!ODNJ+)
M!:Y6GB72H@,G_?A\\N&WT.Z?=.#L>;M;SZB^Z;=CJ Y0W[G>8- [?IYUW6FL
M!FT/G?%+ZO>-?AZK06M7--%9$PY0Y0["Y,5C);E2*\E?!^'V;YJN:,T_^S-9
MH9_][4N/96J%,/V@Q_Y:#WDT;"1,IO'_/N%/)C><0 @HLY^SDT\%15I<(78G
MIENT&9%EZB D-T H;H*PMD-R)6"&TNBDDN+IY'N$JH.0&Q2YI]V@J,8'F?SR
M_ )28R)]W?RK_.H9$>#6*AP98H^OAU[7Y7(;H[++)T7J5<<PP,=_&CP/^)?R
M&-]YF&]#5_:L/$/2E[';2,7UHNU>OE'[QVC ,[SG>(NV]MZPUDMT0HX^G+\[
M\F?9D=@Z\OA,CV[4UOB>?_!=LOMN[Z3][N4_1S@VMG_^!N_=)_OG^V?;>^AX
MG/^5G98S' <Z)H>'^]1,JK/J.J+6W@>ZM?J>,.E=SH@&X]!WM326AGM=4H<V
M>^)>F6B>_+X%9P63SXK,M)LZ\!J^ZX7^:RWC'BA$V\<'1;_RB-_3_@4HWA_0
ME:.3@R<%= ;U+X=UL2=P,_KS^'D37-J33]\B42D1)Y^>_#H3C2<>I/$><:UM
MU(6M._&@W1]4J%1;^$LCE]!WV7[DO4F)<JE=J6FV_2CSI4M&E209[O"30UJB
MI?3/;O'GQNJKO3_1%]IY?7,-;.^L[LW6.;I7>=5X>KKQ"= 2RBC(.JNZX'X!
M_:)_$GTN%@]%NUNT!_T";2=48=4OGYW6>,T->B?U@IN]C80::H6,M-37&DF<
MK3 ^?2/I,1\K'MGV&C'Q9S$^1@)QL^O'AX*,.Q[$M=ZP.ZC.UGKANBF"4_#/
MZ\,#3JK>:7Y.HVV0K9?OCO'=#,>$ML.+=FM]$\>S(5M'&R@P-\]:>YMBZ^CO
M,Q2P-VR0WL=WQSCFHW>=UDN<[=M-LG74PGE]8%M[+PZWCC;IUM'!66O]KTZK
MMD%6;]H@PM#("$FE%!1M$ )H@UBGRA0H84)IU-. AG?LP$>HXA?MCR7&'X#Q
M%^U.Q*<[%-!+O-Z/UULV,W/<&F9,*1)"54A#2DO0>B8A"J\HZ*!8;L>2V\T0
M2I> _5[ [L&GS7$K&U\+YB5Z'XS>S9OH18SFHT==R4E$:0LBE#8J40(*7LN-
M3#YH1*\L<V-((LC]_E[SC(N[0SM/:WU?]*JB-SB,57$TK-K]T!X%&M%<;E^U
M#7YYC&6,EO2LYK[6.SYN]W,3IJ*.A&8E48S6V:)-=7-GM]@X/NGTSI#)]62O
M2Y>BU5OYY2Z8WX@[H$ORY#YZD$R-)P\BW;=>>G?,Y8M1[1^N)WY,-&,UA"KV
M^^-_7N$ :"-UQ/>$- X^OH\,M$%"EDKR7)HK?&EUB%F@)P!IDA#^R>_;W5CD
ML,9ZU3Z]950_>\SMQFO,6L./VQ6JM68Z3]_%JD_O>=!*L,A+9FDHA;&HARWU
M)9J0R9G @C?JR>]O>[FYH_\0![/C4ZT;MZO7Z.NB'EQ05_B[N'GVGB5'H@UH
M]QN?LVS0OG(V!;2T*$V6$FZ%??+[SF$OQ&*SWX%NN,G/__XOJLAO#___C^+^
MZQZRM_.N?3(*@_QDK/7TO>#)$QYE2:4"7*A!E4ZR5%)A))5>&U7[?,Q8^= D
M@1\>_!WS,INR)Q4NXO8)=(KX*?KA %4 _CGE#IJ_?"T&/_?_IPB7(N/E=@#Y
M05ONU^._JC9X9D&WRSV2__XO7$[ZMWXQB)UX<MA##=JM+>1GV3?H#+-M5D 5
M 1=BB,^+KU[-8U+,PCA[^HBB).OX523+SRD\&.H%XH)&M>X"S_V1HBJMI*)$
M<>&5U5JZB :9(+="1;\\IGI_U4-O['5&<8/#*=_%&?X^-U-R4O 2I3AJ;&GK
M*@[ KZC)<R&"1YK]KE66^^16*.2V9)\WV?4"C31T<D<;?E5ML^%7&"D"E%JI
M&"5(A:*?K;JB _U)[LKS>912K5]7OTZ9S(;L:X?1?R@&A[& $S2)4=OFP)+K
M?2I<[/0^9KKG'S-W"E/^JTCM3E8=[3[JD4'L!N3'H(<L.1YV!M"-O6&_<U;T
M8=#NI[/ZSO$-/=<9=\K.2CW_<&5+=XC/05YWSR:_I5X'7Y[ORV9Z.\=Z^L\?
MB9RK..5.\:;;SIJPV-K]/GH^HA1\6[4'2/(<_AIVQP&@_O6<H]3^% /.K-/_
M^;37P?E[S[34D<=20BX@U+DQ70JZY"%J;;5(3) GZ+G@1_';YZ+%LUB%13%F
M+@+F*G>+DRN)I#O#3BP$D^/E,KB>0)KS1I]27:R]V"D0.RMXX5=:LXNW8G9[
M=>-\E"-;*-7RJ)?+I5XNY]OK?XO<GQN?+7",G]Y;L 9)+,O$0BJ%%;$$)5C)
M#$L>) L.YG7I7'*Y.!ZS^?:ZH0)*RJXLG6L)UQ<+1Y"5T94__=IY7<6L:2+:
M6G7!1=;UU79*V?I>KJ&Q62[><YX$#PH])(&X$8G3TE"62L>10TE:D KF=-T@
MATM_A<7WZAXJ0LF>NE\>MHI&UR[7T?5UM-GO#V.U7$WW::2S]TZ3F,\C*AEG
MZ/#ZX$N'*JKD27%429J2D.9R95WU0+]^C:'U*I[ZAZVQ\;6/M<:F2I4KINK(
M\XL5^HXG=Q5*U3)F[ GBG&\[?G.;U6O-BM7JFY)Z^8J6=NK9M]2L2"&G_E@A
M5KA5TTCJ';,D%T\]IR>#HCX9KIC <?QK9O#M'YN5LK/7'G3&Y5?^L/ =Z/<?
MD*SR\Y"G@GI/8O?LV/4Z3_L/R>1Y$'&JT4L6F7:M<9%$C:PXT18H23\>MO$O
ME^+V:Q+BQO092[_/TF_QD?F8\8F13CRCS-7BH9$FWRA-M/5R"QVB38'WG+T[
M1I-OO=/&WS^VU@^/6L<[G>V7&[E+R.$6>W,S393LGV^<;QT=H)GXUS&:C&3[
M[5_M_;U5@N]F.&:!)N('?-;Y.W2Z[DC*5R'XD*-^Q!-?"N%2/KG-EX@RRWRP
M03/^Y/=LA..2V!WT_(=GQ0E4Q2ETAK'X/V2%T.(DGUIY^&TY^\N5\O@K9:P>
M1MIAN4P>L$QNU0)$!=KFJEDK<UM8$6GI)'YU.AC/I*"&J[I\<%9+X"?0U#]
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M9T3L;O7%3?#S:FLKK4Y2B6"G9UX=P;N5DS<Q=#2_10QP"?Y#?(RV,J%"#-P
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MG"<U?5,+G&4SCMS.'EP^05]IY-$H@5)0>IX[TFT!705A);PUK50+O-5V"E?
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M\9,;Z@@Y[77M/+T+?5-FR1P7YKEK!DOQ9TK]1QB#]!6^=HRCF@$K"##BEVL
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MK23R\W0Y_Q=.(Q 7PE7QPSGQ0I?+#R(*IPA!K-)F;DQWVT=>'UVG;JB4&^@
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MC-VZA(WI_+1S_=>7,.[8NR<+][>__3]02P,$%     @ Q3.Y5OLM&K*_6
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MLY<7BR4A<'Z=\%>S,>A_N3HOALE81/1@K"J@E&)$<KU4T5F18R_("FQ=F'D
MF4,J#&Z"F*Y9M8&I?_]Q<^/>T/?-VZ^\G'T^G^,9F6'C+Y<ARKL$'=6'9=O3
M.VW(\N1R&G5FV?*>J^#"01X=.7)66(R0="*@8%80.%=D9Q46BLR)Q=;QHL9+
M:!@FE$QFC,@ &>- .EB!SSR#EP(U$S;*W#JB,<R\J%.B[)',JGWXT[9;P98-
MJ11=Q_6R5MD3=8!<"M+A&<%%YT"4()-#ZZ1N?3>_"UU#LIZ&A*GF/.T7;2%G
MKQBYQ"Y'!%6T@\@L$:IJ+P^;36Y^(;8_VMJM_<67,)Y4+)39?!$F^ '3Q7R\
M'./B1?X_%VO/Z3J%8AN"WH5Y+3+1,3.EK  3K2,CC)/)S4*$J&(RQ@ERL5K?
M G6\I"'IC.;(W?70G@(>O9SWEV%Q]FHR^_H/S)_PJE+P12'Y]Q[3)"P6XS)>
MMUU\,5U9_5P(9($;T(9;LOKKU:U3'@0&R9W.(>O6X>.6] ])6YT,S9TSOAUT
MT_C-.,3Q9+S\_FHV?W6QO)CCNAKZ\M[_<=*O#^?E(F**(EJTI&4+KGUDSY2#
MK%C6VN:D37,;JNT2AA1ZZ![ )V1_+^*7%D6,FKZL!?S3]/WC/$P7(5V=NOK=
M9&,E-]?\*3O!R3-12!:I\H77ZD4'3&.TRL;"7&M'LIN5#*F\^:0BN2<P] +L
M=_4'*\)7GWHW6RSGN!S/5[&LR[/[;D)+VK(8C%S**!-XTBV@1&;@HP^0%),Z
MTEJ4Z]/$.&(I>U95=WS1?4IL]X6'AH7[#X821B7:7(JF_6'5%$KHH<;7R8GG
MP1!)*:?699J/D'."LKZ<(]<Y @^UA6P6"4*PEM2HI:7[5+1NG0+>25E?;SDF
MK<#4H,AO#];U<98."LM9ATS6*G!1IQHH7;4=UPFL#SD8'J()K4V?3B\4!ALT
M/0J<I^1Z?_>-/X5)'53QX0QQ>>R4A[O/:GZ7^ BIC6X.KYRU,2[65NQR)+U7
M3A<-28L:\7()HLN>O@W"*>4M2ZU;PMZGXE@!=ML)73==N^Z^=F.O7/4AUD6&
MJ!U"DI%L\6 8!)\"H&.E1)%YY*WS1O>A;TCQW"/QLBEQ.F-3,TWX(J79Q72Y
M>!>^KV3=/&2\7GE.2:,QM35V(3-713*]N03&BDK:)>]SZUR^1\@9DH9J#)-6
M3&B)BOD%YBW++)E4;L@U3.4BN6,FD\XS%KR2(CA7#.<=8&([,4.*/+9'1 ,&
M-,/#+3K>EG6'HC#Y^WQV<7YM.&VM ;HBFC9"%,T9E%0K@))S$!2YSMDA9T46
M8WCKG.\C21Y2#+ CI=0',]O7P[S!L,!KO7I%$RK!/&$ --81=,&1[E0ZUQH=
M[S72>6G>R>QQBH;4OK Q?AJRHIV FDT_?<3YYSK?I9I8X7R\#),5@6_CY++U
MYO7J&<_D/I;:L3TR4$H;B(%6'UD4Z#/M36RMQ/8B<$@M$EL+G\X8U:8'<(T%
MOYXN+N;5,=VR=J&Y+-(7X,+0VC,/X# 8,$I)+IA1K&Q 9WO+WB?>,Z3NAXT0
MT'Q[FS#\W5F8?P[I^[5WME)]MXSQ:RB*D&66 :0U9'<Q%B!J)-EF$R>Q)E7A
M;@?&[_J^70#@GA\ .MGNMO>'MUO;O[J8YL4H(>;BE08RO(F6&!-XSC4$$;75
M*H0H.TFANT?)+J#PSPL4#;>^&0P^+&?I7VLJ%K_\]P79-H?U% G,V< 0%+(,
MRB4&T6<$H7T4)7)I6&O8M*&\_?Z-DK/>*E/ N5"3V!-]57M\^1@*B\%J[UN'
M(.]3,:1 XPDPMGGDCF13L^/VZW@ZFZ\VX')1&!DSF R$5$?RB10A8M*UEEDI
M@T6;31OK:+!LTC"D8., H'(4B]I%)5=-LD=9*NZ0<>!89\DH63-"3*ACY97S
MWF3=O!OI^LUM8QCO*W3>EM\7N'KZ**.,,>=8\U>KWQPS."D$.,64$B:)T'Q4
MX:,$#4E:'L#YQZ,6QVQ^N_E$EW-$1BCKF%%%QF[D6*<]% C,,-">YQ2B*1A;
M=QFX>O>0!%T#+A^TI>T,1SP/!#*\O,^Y7 ]G6*0D K"0*E4E9(B2)W)QI<M&
MEH*Y=07Y5D*&=%W2@-7';W;+0?1A^FE,VG=-Q6^XO"Y0OT&D9\)D2PZ,2RL1
M0_HW9@:HDK!HD7?1I.YINH9TT=$ %<U9T3:X<$G4;#TACWQFSLDMULR 7774
M9[QV92+;.PBO3#+%F-!)#>TF(4.ZKVBA[8_>[)8=.<GT6'ZOR<0UY%U-^//+
M=.*1M;845F>.6U]JFGP$KU6IP,S%VI"(X,;L?XR>(5T\-$!!LZUO?D]UT_UH
M,4I12X:<G*>4ZFBHZ,#7CK&(GG.I++EMK9-'MY QI!N'!JP_=J,;.ZW7EZ/)
M2.6<AT+RIH[\0_#",O!9*9LLT61;Q\'N$#"D:X4&7#Y\<[M(C:GC_.['U-!C
M+@H1F/0U78)\$B^PD">B9.W"J+AO;?<]15/#-8]X*L*)>CV3I *EG:KM!B-4
M&\HY)I037267CO=NW-G7C<CQ2'@D:6>O+6]9,O%YO!:D]=Y^E1WT":>I$A2D
M\$DI#M;6@U<3%5<]1 R74B0NBN.MRV\>(6=((8U.,=&*)4.[.'-2Z2 ] Y$#
MX9O%" YK*,<$P716(C;O<]S%Q=E@$E+;(^\$C.[(( N1;(7:4\M(5ALJ%0:N
MZ 2!)^]5%L6HUEV%'C'(CHHJ7"U)BZ@<CW3@5>&@I-9D4#D$;H44W(;,68<A
MA3T,S7YO#P[A^"-AA4-VNV' \0N]>S;_7AU9+VM#;QD 0ZT02$I"4&0=.$\K
MT4$H(=I/BKEY_Y#4;3M.'[S#C>7401G:*GJ/VM1;7NWH#U7 54E/BQ>*)RDS
M:UT.?CBU0U*:[?#3$_?:F?=A<;;*QUV<587^)4Q69N7R99C/OQ/%_PR3"QQQ
MZ4SP@0.B];0C"<&E)*!PRUPDIR3+UG?4.Q$VO$N,%AAJSY/F98/OZ75$&!EY
M)">O"T2<M3%H"5K7W$V/#EP,!FS4*5E3!&U :_'S"#W#N]IH(F!:<:"=]W=&
MIO]FS%5H6>]C-2!W"51$ 9&3)F6JH"<A)PUOG@2YA8[A76RTP,#1.]ZAYS]*
MV1>RFVS-VY:@K"4U%HJ$K%$S#.3[A;Y3/@^YO,."Q*BU [T6N#$KDK>F0%:^
M=O_AI<X*E."CL#(9;C)KW0UJ"QE#<K".Y/Z6:1%';7K3F.=LNJ+B9G38BYS'
M=4_"Y%T8Y]?3RQ*FD0LY,RP)?"@:5&8>@F$&=# FN9!**AWT@-F9OB&Y:8WQ
MTAF;F@'IXQS#XF+^_1:@:;U:!,%!U!&S2EH%$<G>#\%RYT7 *%IGL=ZG8D_?
MJ]N>5(U1<>2>-QPZLPSC*>:KV>MDN%U\KMN,^6<LXS1>C@PR9G@=-YMU'3RL
MD-2_QUHXXXJ)"H5J+3J>IFI(/E5C:#1F24NOZHJ.G7HC%JV5XMI#K@%(^I+,
M1ATRY."S,2HR9UIGENY)XI!\K\8@ZI)9760GC%@(QH5ZO:)X=0KKA4^T&J+S
MA5O/2!ZV1LN#-_5'K>3*=>+9)E:L!2=JYHA4M:*%F,D9R7/IE72E[TY>@\E
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MLJ5M6/X6%=61OYK!6ZP1/CN06"L.M"+ES8VO*;W.!<-B\*W3'Q^F9@B&UD#
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M\DP"*SR#\G3X@O<2//=*9LF<RJWK0 XB= AWD,\ G =R]A0@?#BXYA,W7-@
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MXXPVL769QJZT#>FV88!H;,+2$YFB\?NO85F__MY!V.C^P[LU39]8S+!,U$@
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MF<W7<"1RWLUGYSA??G\9%A=D-GR_MB=_)[M@_G5.@)TO;LFI)RU;5R?N:57
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M*DYR*))<.R4%26&D;WVQRB9;$%EKQ_@P2H?@.0\0;GLS\72 6TT/URX(KW0
M$X0#)0)1R05M%G+KBT-=1.O9#@<1.B3K;3APVYN%IT';;V2J?/R*DR_XZVRZ
M/%N,7,C9<FL G:PSZU,A6S-&*(5)%[S1CC6OM#R&X%W0I_Y4Z#N*I:= X>JZ
M\/K,I.QUT-9#L#S424D)O JU.:%F'GVT$D^H9N_0N@OV])\(>X<S\H2J=G8Q
M'R6934%IH&@D,S0[!%>2 :-Y,=X(YYI?B1U$Z"Z ,W\BP!W(PFXC(^]PNJ!G
MO)N$:0T?K)IUOIO11N%R/%^%$*[*!Z]R*F[B2O3Y^N]>+!9X3 O3YB0TB:IT
MNS'-8BYE/,5\2<'JG2M(+VK#J$_3&HQ[/?TI3&JD]\,9XG)DA>=%U4:ZR>1Z
M^6?!V5# D#LAI,M&QM:- /<F\EBQ>LFZ%UNY=I^:JWDDMUK3CNK8+<7(^#59
M"E E:(B9% ,JM$+4W!K56J\?3_6@JN^[A>:F&.Z9Y<TL@'WIOD7P;[/UC!)2
M8#(%)K06X'C-=*9]A.B= >]+3BR:)%+KF8%-"!_4E=VP 7L\XQM>VMW;J)6B
M>S6;UV^NU.(M,E-1W#B#@)Q;4+KZ="@X^(C.,,\2\ZU+VO8F<EB!H3ZAV"T_
M.X3=JXMJ0GU8DME=[6SZR<A%51)S# KMP3I$'VH'%1+N];8Q&)U;-UG8A:[V
M:[]G=(YX%*BC+:!E( @P3_I+)UE;0;$84#%N6D=@=R!KX#;)D1!Z^B@=QZ<N
M#T\8S_\9)A>X7O;ZR(]T4HDI0W)$UM[F2I)"R9:!,]XSG;+WKGM)O96T8=T3
M]8ZCX]DUE#A"+5O&^7B6Q^FJ[H$^]WI*CSIB7'O;]_<<0=A[2SH+'VRG9.02
MUX8'#\'Y"$IFTO6"!)?S*KCH F>R?1K6;K2UEXQ7%3KO<7DQG[Z=WCIO6+P3
MW-0K,MJ"VIL?G*8SC5E89$D$GUIW#=J'OH$KVP;@>EI0-N)>E][2.D]NM8=O
MR]_#F+R[U<#O43!&,VT=R%QJKF\U#;A%"+F65A1>.'8/KP?)&[BWW@NZVO"N
M0W#=>(BT'Y6^2M[/%_AQ]@&7R_48V@6G76'<Q>)!Z)J:69P [WPF?]%Y+5E.
M(;:^.#^4UCT=\S\D[#K@:H<8?#U=XAP7ZXVP(LL8D@49%*O%8@I\<!E$*:IH
M@:[$[CWRVQ0-*P?C)' ZF$'=^A!K@_=C^(:+ZR_?S6=?QM6,/MPUV.FQ32S^
M_1?0R)"_?MOEO,Q+7H\*Z1U=Z\,Q1%:+V35XFR*()#A+"6W(K2\&'B#E6"ES
M>6'ST$)E<LEB*8!&D6F'-5/26'*)DQ75#T?A6P>_'J=H2%G4+="Q*50:\J.E
M)D*B*C](%$LYI7I;$I-8-\L/TEC(-C!6L@E>M+[4?8*D(06UND!)2X[T!A,7
M>41,==;P2M>& "X8K#=KD@5'II7IP#;>'2:'K_@5$J)J(M+VA0<A7%&\@&:8
M03D>(# 1@'&."KV+,G5P@[ #94,2IBW1\]!Q:<BGYJ>FQKBQUBG3OWB00E,,
M%ZK>/X: 1"&1Z9)(8$U!)DO)A;7NP+@/?4,2NWW@J3G/FJ'J"3,";6(N6OG_
M=7=EO6WM1OB]_X4 ]^6E@+.U%VAO M\"]_& R]!1(4N!EMSFWW?FV$HL+[$L
MD?)!@"")9%GGX\QP-@YGF(G)HAM1/(N.%R945>A*"*]=:SEZB5MW]'IO-_@C
MQM8+Y4W)3&A#AX/&L:2-9U7S&D+*QO#6=P2?@30EW=M06I[P9YLPIO7NV-N^
M#Z')@&:@H$J(KJ*O'16U&L:U5^Y24"&@+^7ZR,S/@4U)R_:7G(9,.EN6Y7VM
MD*G?'+ZBWGB49ESDV7PV/J5)QN6P1[3.OARQL$:9F.]/_HYFG'"S7&QFB^UL
M<?7Q"^J7L4A\<,5QIP1G$@+=[C34/TD 0P%QB=N0=&D](^%P=*>JKL>?M,^'
MQ]T26 ^\R)*=MJQPZD4B56!>8/#IA,D@@C.I>?7U*7BG9"([R=]]I7<V]C:S
MI8<@?C=;?UFN9S>'>V^VZ]D"UNM!:B,H'<'H<(5I-/<L*GQ914*?(-MH;.O[
M5D>#G9+-G9 HGL[8L\KAQ<X/'0O*\/N^[7UX<)XKYT$QJ8MD&N,V%M"+8*HX
M#."D M>\2J\!["E56$](-ELRNTD#N$- _[XD7VF+'TMSN'5U_P57<?[V<UQ=
MP?H3K#)5BA=?G?8\,N^40\<Z6I8<'5[JX'E0PJ;DGW$F&T.:TO%O9RE\36:>
M55_BFW?J(-[AQ]:;61X :JPIT\3F6IDV@-$7SY%!=M;GC"(66@^E/Q[ME*[G
M3T@[-F!M$Z7XSS'8_(V:QL/J XPYA!'^;G-$$YVQB"A(*BZ,Z-F.%1I.%V^\
M,T$(=X"F>^XY4[I4?P;UU93L9]5)8[GW1?GO=KT917=(*CNP1C.KJD$[7A3S
M (C4%83M8];0NA;C&)R'")C[-03L;.P\6T)O=^"#+VYJGB.&WS]NCC;)Z!WX
MC-8IO6.6UNZ:Q/X1W=UKXZKH$$/TK$3NF4X"@TCJYV%23BEH;K5MG<7[&9[3
M.C]_)_$>9;^L(-_&*HMRMP)Z4+7B^E5A8.C^$4<R)%\C;CT)&)<8S>\GZIYH
M^?S"!T\IX]9,.O;;./=D1?.B@'V8U'^8NNNL5C2IYD9=HG*NUG/.<.&D+BT2
M0D-EWKB8DDTQU=8'FP>#FU+2K+DT]6559TGZ;?$5=@97RN2L\XZ!MAA]9NI,
MB%X^$P4\NOO<%W<>";H#:DHIK3-+SK&L:32CX#%(EP\N5@XN!J^"UZP*2S,@
M.;J%D9HC2)V3%PEL$4<;J(?/FU)RZ8QVZ43"]U B-SXB#39(/*/B0I$48 7U
M6J,>*4DRA3\HOA2O2J^JW[LXFJ]MG[]#*E9J;S$ TEX2P0,+U*+#A*)<MB&#
M:QU>/@-IBD[:T9+Q$Z5X,COZR3_^9_?>;5[W$M:P0LU-[F/.JVV<KW=O#<K8
MFGA!O:VH E 'RZ+5D2DG\0=:.%,[7#\] ?$4';=^$M:/F:UM\@OPOHGC.)KU
MKA'6Q7R^_(OZ&JT'(3Q4SRT5-P<D7C3H@FK/H@)N7/)>"_XRV]T$UQ1]OI.%
M[M49V$\'WB8)%U=T9W;L_%J7J[_BJJP'P  '8DT8WUBJK;8(4&+,HXP(.8=B
MDNZN\)Z&-T5GLI]V:\2F/JKL4_R&Y)I_WQ!Q/M2"TFND9091,"TU>M <)5RE
M5'T1JJ1TV+2S9Q\UI9/!O@KG1#)WU"&DV08+H+5#!%I)&I&F$O,.Q1(P7@I%
M1&/O'_%U4!>$9$J'@&?0#"\F?C]!H*S'@FIT!EVD#UQI)LFN:>"%A10MOI1"
M\*"T3!W34??03.G0KK] ',>$<T99;Y?7].\N4;_+BKR__C)??H.]'P\5)9N6
MSVRD$7Q2"18I<>)R4:KJI&/J=8#49@6'")__983O?,SN)[#42/ &[LY91U\=
MM:@!PY :J&-UY"R"L+B=#,_9.<]=K[N_/X%UB&B%,_;^Z2Q;)_+EE?-(8\G@
MG6*M(4JMC96>Y:0MVFWO6>#%,BYK3B[S+*"[B3P*^4&92_X+J[36W'UER=Q]
MXI(JQI+SP88J&12//H.CGJD95;"(+CKP7EO5^CK'Z:@/DLA?)YG>EZM]PX/=
MH6CTV5=1+9+!8L#BDF$)E&+HEAHGT$T-_?VZ%QY5BU\G67XL)SH7- RJ&)N,
M5LP W7V+1K-00F4*= [":*-]A_D[CR!IWD7G[BJUUUK1VAR-R]7:%N9YR:Q&
MAS%[4J8VG\MX>%'<9$XBCY6+9[LL'<N*O@?Q(G(E:*JH354Q+7"3)R,Y<RHK
M+[4T7'0_H7YP$/_Z;6Q[2</1M.];K3QF\R@F7L%G:I"^J[H>.YH>79]\R+<V
MJ4A^,?Q&-<@_>RXR^&-%=@^E5,C '7.&VE@H4QAZZ8!^.8!*U:=@3.,==@BN
M4[7))>1Y7*]G=99'EGW ;81.X/::6 CE*0BWC3ENVJE^IU&0)8L<@-DJ,M,\
M!Q844@O#:9^TJ#% :_>_)?Y)M7AO+I3W==FK<;Z9)?P9B=Y 7:[@_AI_4([K
M&,8QW+JB&ZQ3+"P$&1B8D"V7)KGF$<0)<*=4C--=,,_%UKZV^'U<+6:+*[K@
M^\?GN#IA_,I3W]3$YAX$LY&=_7,43R@77V$5K^#W[76"U<?Z;C;?XKOCX]<?
MMYOU)BX*8AIBR2I$'5BUG!K=CB6N&5@6*G*;@W.^]9GP"R&>JL%0L&]J>^,<
M!?YZN;AYPL5FLYJE[2:F.;6AI_?>Q#643S>#C_=N%!@A3!3 6>*&HSL;,_,A
M*PI)LC*)6QM;'RZ<CGI*06-/J;ROVL[,[V:6]@D:/2 .HI[E03FG,?Z-I'HQ
M(*HVLA@Q-*I('T2NM*FM.TN^"."4K.DYI:\?%YL)V@]+3^[HH[>1(R1-5\\1
MC<F$"UT+[QP3:/H%XM406A<6/H^J_[KQ$_,M<><374RDUC9W=08-$,5?H@HO
M_,AN!L4@9/ ^>$Y70PS3H1@6=:*68#(;HTQ%9IZ=5L>L9$H&H[&,/F(C7EL4
MFFUG],M_+.<@F!:"*LX&YK(/C'0,"^ $V3BM2@T85;;.;K\8Y*2RG)VEL2\'
M^X9@ES"CYB94ZW'3AF*]K'?>.SXB._"+FP1HQRRB4;SV"7W5V?9Z33'B.!UK
M2,%I82IG "E3=WR,Z%.V3#J1I"XA*FB].Q^ ./G\9+:B'C=[7SNX6&TU6K(2
M2KAIFYDB1 :!=&;E1K4?POD(CBF9N=.X_^#DY%2J-[-)%VND ,96^U"J2X5K
M.L6#C'ZU=9F%4A+SQ155(%3I6\<LCP*94FS25@).IWN[WN]0'@ )125+%^M+
MY*-_5&FJDF'"%Y53C2F(UJKM$1B3&LC8EO^G$KT9]S\MY[/\[?-RCM3<%11?
M+,K;>9Q=DV]-!QSC:J&@,E(\,"HL1K])>N:-U<QXJ[/7V@?=NA7LH=C.0H-_
MK-#G&S1W-E$#N,(EI^-M8"DIR="K5#S%8+UL;1H/1S<I@]E#KN[OHDZ,:[:Y
M'KBK'Q<WV.Y4[^]@7EPOMXO-K5T8 D@K:0RGT]0VP_+,O!(6M8R606F>(;3.
M]A\-=E)6^AQB=QZVOJ(4CM9IL"4Y:S%2MI$#;AEMF'?<L9P#PN26LNNO+H,C
MU&DY"M,4P9?SM&\^X@^XHC.<2_A">;O%U7X7S&7],%O@ZF9Q_F^(U)05(_W;
M7UEOEF^7BS62N5!MQG^6F[%&^]C\12<@3?(=YR!2H_S()7R%Q9:&;N2J>1".
M21-0Q(Q#-S9"8<8:%57))C6?8K%[=I,,[:Z<^[:_CM9*^<31*Z^X;30WD86,
MWH.RO)8:;,VFM<?W"(PIN79'<?K15.H)I&[2?N%!3(?:\W9UN_SQ*N;-G[/-
MY[=;W%'7L'K_O]OC!BIYQ3]E+/ 11D<;Z$I2**3)'49N2;,@)92$,1S/APP?
M: 1G2O[82;+R6BQJZ'F]'&@2I2J(F0D0U# O">:Y"\SDPB&97(UH75K;2<;.
MU9NHB3[JS:H#G:G;]^FO%-?P][_]'U!+ P04    " #%,[E6Q!C"I%EI!P!@
M[%4 $P   &-V<RTR,#(S,#4R-5]D,BYH=&WLO7EWV]9V-_Q_/P5>][U][+5
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MN&IQX,]B5F\>>@2'7W6#U,?BJ"YSH%LFEBG2\?.;']T7RR1-@:0&N9DVH.[
M+\2/,IATT3P?C)Y]SN.]]3#3!)^\T+GL H<)5VMT.#S"U7D/6[3$<UJV->P#
M$Q30 ZBSR-5)MX6C@CLI/,,>OMK,F'1A\R9E!:=@"2>-*8F)IHX626KP.M)L
MR<<-6,"B3$T> >V!GCRILC'3M5#*SV5CHA']-0+*/X=19--L N<P.IE,RK:@
M5[PM8<Y I#(:^4]P3C[^U/$<WIFF*NLE\];H)/V]K1MZRK+4Z3K;BV4(S!--
ME */*''(+>IUNI2H-<%Q?)-DJ)S0E=-YF4W,9R&8)[C5'T4Q94V,\WEE<F)Y
M+YIR^7QP0.\#FZB!;<E%_*.6CR] VA\]/=PITG_PK1*K$#CNSK)*8&=AY0,Z
MQ)T'VO$XU[D\J<)%=U_D&&[IGR>H_@!E#N\*8[WEUMXI5FL^ '.HA6R0R#+@
MJ1-BL85IF.O^"\APDBSQ6]$,.$2-NAOH&34,F'P*"6TXW.4X*C"=<F'B>UK>
M,5K^.BCW).6]A'U-K<X;A:3UQJ0@#>#G7Y8IB-<^Q?5.D%9$L@X&#%I+>$!)
MG)L)+IG.O6A)K8:+=OHGZ26H*C"Q:$$Z=XWW+O-$!Y7 %H-B+N<6GDR:*#=)
MW42'P[T[0]=?,X\.=SQ)RZ7RQ@28]%64."T4O75I4J5=HO%NF1+SAN^D+1,G
MT ,<']+Y4#-$+:16>\Q3L_G#R.2+Z!])08;52 PK-)1G,!K0HT$U)FW=IW1R
MS/$)69AF7J8H%F#XX6M&\58-_)G5P,_(^_#:COJG+!F#T6]-Q'.S3&!J1M7S
M^KJS_Z<IX\-H[3PQ\7W[]W'U^-L-%[\T91(5UD"'L"ZP05D:%643S1/T0(!!
MU<!78-V42H$156#EU\J2NE9:Y?ACZ?@C4B72 ) @W%XQY:(G>$B[6.')0'<2
MWI<ZIKS!$KSE-\#J-TYN?#XIT$>'?<._@3-E"D."6[;X5$9KCI17IX%7Y)A=
M+^LL_HZ09(8D9MW]Z/I;5N5EAFOAG#A+( 4VLR8HTM:MKJG=0/]EN(7.!43+
M5Q+72<;EI1G [P:(?(**,3L6.F0:>AC]-P/+2"YJ88#TWBH#00K?%\<E*BMZ
M+712Q5%:PI+BX=.!F4MV>,Q!:"^2%1_*<C)I*R1O],N:?[8X89$#?1^+:;;U
MO&SS-!H;U/F),D$8_-X6K(=;(NJ2*J\*OZT.:0UDPH1]K9NG-$1_GEDVEJZ1
MHZ)W)5@S,C+6'];-A9G"($S&VP;+ S_0/L4A![:KEP -I&C$D+P"R0;2C2>B
M6I7G2"6/D1S4SN!W_>3TAR9.3WYY__KLYY-W_Q.=OS]Y_^K-JY_?1Z=G/Y^^
M>O?SZY]_B+X_>_?;R;N7@Y_.SOX3_[8WG>_ E#;*I^AME5TBG7G^XI_@/S,F
MH7<&R0D.*>E1H^/CH\ ;["Y;![(P$SBJ>E.=3 V<L&I<5LK)D6SA_ZY Y1KD
M97DA.I@H$.A-)ET+C_O#T2.@H1+D:.UI&&BVH'[,:E-2=]_&A_/A_B,^'>&3
MJ-7A<<1'QRO0K>"?Q6S:YF"NMV0? 9OWGB$V(9];H< &'HANS"D([K*2ZQ/B
M _""&C_0L"!B809,!,X+L#XK]8')RN'$B8E@=H+-?GL8_6:BJT0847*!:JR:
M)7SF<%W<^O+JH\2M=_Z4;8B>&5A;#(YX? S5:_A-U\=C3=G:QOO.$ME8Y4X^
M+5?$:JLV1Q&T+A-9T0!"'+?T$>1^>;;(/-.@^]WP^=VSD4/ER:WA$"R"*!''
M '+^JFQG<PR"!2N-GR_;2O@]ZP&LZ<-96K0%&,T<@8NN3-2N!0NO0,:3_^LR
M ?KG<<-?A9F1/[IVU,QWDFB%!<]13_N  JOFN<Y-@5\@?SOMA3V7F_G)>BCJ
MV[\WR3@W2NYP<E)3#3 "FRQK\US_\0).)IC\J^><Y#"@AUZ$)GR/"YWL=[XL
M*0)@Q#S=>XI9 DT%_Y?JA_GJWG"$EQXWZ?JU_>'^\?[&J]N>' WW-E][,CPX
M?/91K_UJ!CL:'AT=WY7![MS*;GOM_O!P]'E6]NCP1J]]3*>,3QJ<93S\WSPX
M>* /B,?H^?[R0S12?YN7KM,]SXLL37.S"TZX/7;"C9X=6!^<+L;MYHG.LAV?
MY@FP]4FV!"9>_[&YWN_ISDSS.Y-G8'O?;^C7LJ&G27&_EU_+7G)^B[G?T*]F
M0]L\#69YKQA]!=OZJFZRQ;U:]#7MZ&62M["C]QOZM6SH!_3$W1_0KV@_X=/W
MY_-KV<_O2PYLWRM'7]O._M!F*68WW1_5KV1#7U.DYUZ4?BW[^5-V8?+5_79^
M)=OY)KG?RZ]F+_'?]RK1U[:M9VV#.1'WQ_0KV<^W6(1ROYM?RVZ6"&N2)?G]
MCGXM.UIA#5ESOY]?S7Z68TS\N]>,OL*=_?W>3_\5;>BY,1?WN_G5[.9\+8'A
M?COO[G;^FIFK^\W\2C;SMRS/UQ6BQU0A<==JCD[R//)+Q-*4ZDT$^6G:-HB2
MX3!:X!]4ZB,X4![>7UE13:16R^J?"O.'%9/I8RQ]XU=*%2J69L,_\W(IU6\.
M><H;%4,WX9BZ>!:3LBJ+Y#*K6JPRKTU28\7EZ-CBNYV>_?KZY6!T;&OTL+H&
M1X8H"%20(\.@=V Q3G]]]5B _0R-\=)PA5&$I4#3,L_*V%LDJ7V+HTE2SZ-I
M7E[5=O:VNFFBU4WQ>H&_DH6/M[F.8[4)@5.*<_;<(\FX+O.VV?S(GP^!V4^-
MO5"=_/_GE6,>,S,85R:Y&"13&.OS)+]*5O6#QY\2K[3OV.[<X=UP1"8"O8DU
M7OB?V2K>=)KD-%9X'%L3KZ$QT3G>#-5DDJJ@*FZX$M5S+##U'UB_'%MX4+SW
M.U.8*:&!"M?04P;C37+C0!GD]#!*1!PM"*@&SU#=K/THD#7S;!D[1)NW2=5$
M+X-K>O^8!T%H-J7]E,. L$,^-]5E-C&W'&W?"]_"4BR2R2KZCV2Q?(&%CG6+
M6'J_F3S'%_[Q+\ &58Q DOOLJE[" U0BC$6$\+8&*PQ-4>->3J>*O9)\P-4P
M6,^(U&;200(2&0MO>8\)(L5C;US0ZW\?@< 4_XN^ +P.2^/EH>0RR7*J0B1P
M#C,F>(5DA8-<IU4N/ 5N5F?P2(R%OO"'2>%?/!TD.BQKS@W5\4_^V6;,^>![
MOY<PU0BE#7_?K48MCXV!)W-5)A<[%Y=ECD  R0++L+GH$^MJ9S6#-#390KZ9
M8SPWFY=EBK*H,A.3+1O^YZR%@9<H]I98EYSDG8>G.F"2 +@;,X'6J5>%J6:9
MD56T?Y+D\F^LLOJ"?^4QXFFH0^Q&K+#VEC!$U&7<$&^Q<%0,5;F2V^+H=3$9
MTC?.DHOH' @.AN1? [I!2EI6")*+F)APXO^EJ+\!N'8<Y4:HB";02PJFF*-\
M1/&/E#8O<WACA"FBAK>NH$6M3-I.Y"-M51"UZC% E#DA7R8L8EFR_&NP*80"
M1+ ?24,X1KBOE:$Z[ EP,6!SE=3ZYID4Z,,0C*^VZ)=AI<N).P%72*@X3O]>
M+LX/E9BL2.%+K"+YI!-J1DD-QS$GR%'O@&B!,-+4$HFK7N ,EO@;_9$0J.^:
M(F?A;BI1Q6*"!]A<2'RCXO([6GC__>995P@*@R7H'DZ:T21TW!3@W$L^/;A[
M2_:JT=^@X4T,"<!0Z642P-4&[?AWPHHI@_?7'ERL.^0MO@WITH)6"9#*)T)B
M<).FDOV5*TN_^1A( 6@;4/D-5<P3.%B9WU4,*P5D4(@ 7,U;K85#)FL+9&0*
M'0(OB;[G^_HP"DA;>0T,EE#%3PB3JJTZ4#(O9'?P.XC10%@]!>(?;QCBE<&Q
M&<1\,"C$887'^"@1,<.B$0WY &YSX#8^V CP'[S,G[ 00@FI#A$"*IQ<OU0X
M6('A@=%>%.55H8:=?I:0?3I#(8 B>F0LE93XU!@9J044 S%;\HA2;'>"9U?&
MMMVF&T:OIY&E^=+2/(PC'+NP9(3,P$/+)TR/-3_I+-M)5DW:!7?#J.5H=B'0
M9*"B?=W$^MQJ9\9]%J;*)Q!<DPM8>E!B0^V&/U[?U6/Z/V6K6%1$6R#OX+BU
MI/ID[*HHMD@V(-IB"X2&PF_1V7(87-LPMY#FKP02*LD61%F$VL$@C,#DQ[FB
M# $9M4M^6:7-!K;! UW-N9-"@BA#3 &,O'OEP[#$79$3DG$I8"97\+7->)U_
M.??#_MUP/WRY9>M'!WM[\NY]]/IVO..FO6@.'OP9#&?K]+2WAVWN<0WJT*XH
MP5LG=7:)W@PO*+$38_U3N\K8ABD?V5/&ZTJSUE4F1N2L!$&1R1*'I</N:Z1#
M<1NPB%BBV FLX  SGR=+O%UN(<\5R(>YR9>@,5P8N9#!E.'.I2&I!E8W0C:#
MG8H60\V85@5[@)*:P"51%2A@)5"# ]&49C-RS%R559[&OA,?!KT "Y\]_>42
MC/(KU!4OR0-B5HP@5PB"9<](\6&\,T-X*Y,2OEBH3-)@0;<KHN,8J(9-[3SR
M#&=WQR@&?AE=)?G%("N<TP\())N@%667=ZG^M+$Z%!>$.2:44>+X1Z.]"&@S
M1YF+4-86VIIN 3,Z85<2H4G"I%;NK6ZKR' #)1!'@JL).FR&UK;>2>N@RAI<
MA2-&K4)T1F5AW"!@PJ0IHG,405G#Q2)5%M] QH6U.=/HX,B]@O=(<,O0WZ+*
M=QQ=PJ 9@)B!RMC%.$BSB@E!=LX!.8NSHA8O1"X39)^G[U9R:]4#&%ZBA4D^
M7UXKW2)&F<YQ ;I.6;0%P$IBA.JT:F>\/QK!>?ORK9ZJ<(6L&8 ;KHXQ-S/Z
M!'=ID;. *SF9X,X J?Z3FB#QEJ&G**<C"B]M&CQ>$M1J&W1T\V1 O\8[D)K0
M#O(_0ZZW'>/[_;ST=:',P&*TXO*A^KC6VT; N\7I,\VJNL%EJQIV4R",=^!5
MTX8[AAU<R-=$!20O5Q.VVU$\VGEY1==.@:]9;#\8Q$LXAX00^ 8X'ZO&YBK$
M*L1=X9->TQ?UY(%&'VK'!.?GM0,*ATV=;%)!1M_@[%=T<\\;P%C!B/C)2.;3
M%JBBHD93\,DN3Y*!DD5A2?N[-S8N:9E,S$??4J1/9WH<-Z% K_'(RZQ"$Q7E
M'[N/Z;&Y]ME0AZ( EZ+_%5VQ;/;H@-90$CV;7#J&\M+=-*SAUI*A)FG[11#P
M02MF R"R!4_:KJ2'R^WS*,>G+;/RIN:]>UJ5."]RW[IW"0:FAERNLES\"+(H
M[OVPP5.XRJNC.P%$4+=+0MW&E=E /J[AE!4O3+PP+ )@]&:I''08::N3?L!I
M%*=C TJ  %6'X--@1EJ<Z7-C(FY))8CX3U[(?_0+[Q3<>DLO*L:][V\X@7I(
MO6VT=X(Y?F\Q.PF)U@)_6[[A.?0L6G2HWTS14<<0H8RR*1SO>6_@<RVV>(/8
M(-*-JL'F,34VV+'%[;<XK/5T+D'IW1KT9I1HW=X:$RSYE($J-L,6*BSF9(=\
M1HTQ3S!"R*=:LNX.1P7U<73=X,E')I1,X7RD1"=P5T[]&3T=/\^F1K@31EQJ
ME0FD3UF=E!REK.L@LP21@0H@=F"*$486%,2*G$RU41G@&09J"M2EQ@]X,C6Y
MARFB>6EX2@@_&[,]0.]!N4U& 9P)4"J''3N"]==Y-F7(?(HS8#PP(<UC@*W6
M4FLW>&E'\S+/0->=Z')J!X_E?%6C;(LCLRA5R:U+Y#/P$XR[7,!#>K>TAD1>
MCAHH65&PK; 4OM[GU+H@I:!CMEA+#FX#-GAA5DZ/ 688F$"BB:/0 4X &J_X
MPIT#E_>@)FK2? V2HB1":V ?$X8$IJ G8G0[?9N<SH7YT$0S8" 2!IYPH($H
M@Z6*6IB6ITC3GED)(T%-;$&B#:D(7E%/>4LH/)MSRXMQ"0^H4E '%D2]10FW
M5@:ZH\ <M?DGO!-IA<14MS7Z(8GJG:2?5>45#A+-4YZ++  .)^$DM0N)!^^:
MIKT!,U\RSW9KK%O8G(PW0FHS>)B(4C'&O, ,!""7(&=.6D)R:TR.92,[_&5X
M/@R2$EHD!:3["@\$W4..AV%TUJ)3M<(X!-K_N42%)GPNL5F)X:82!++-8;9)
MA>%]YKOX9I:ZK+:FP.1(*<\Q H0N$,2P-L!SD-:J,G<]K_1<<L//FB:A"]"G
M&<-A2A8YZ;"B["%=4HC3)@F$KA+T?\!XGN,G\3[DCIZ7@P>25:2+2TC8*NL[
M$XBYL6PDI14F;(DHS9)941(C;]!W@192XWE"#F,X-;0H5O'U5H<D$>_Z2D2%
MO@4,2K9_**)*#A(*IB>U9%8X#OS.4'+(.V#=5MGXI OE-27]]"U(S]]$GV70
M-]Q=53 DY*6M@O[CWT=/]EYH#^9A]+(E=81[<35=_]78S'#D<)8H703F.H![
M!G1TX:"H'7SVWC5AQGV.+MBEXQMOECJ8N1 H?5<4X<>2= &V;]VPFF3I\3*9
M3&R>%[RY8V."#/3;@2'7D=B_>"YD%$*L% KFF=L>2M@5BAZVW9)X49#%."\T
MWL #Y<9L/%@1Y9A1K0,>ER5.0M)*0#M)2*+R/-SGN=5 6X'L#%TSHW!QU@YH
ML"#!T63';/_1O!DU;&C='=[=(1>[;2;U7<!'_)!Z/.WPD4QX;0KX$&BR^\\V
MW&E7C(0**!#>ZY\<A \!(3H"#!?0,*P=Y]<ZR<>R)DS9$4$3C)48(/)X'DUW
MY]7'1D%;\H_ .Q88KH7_8_>22$KDBQEG<V+21,^KS3];5'#'*\D(^Y>RS<X9
M:I)JQK[^LFV @9)'!LZ =*4@0P=_O&QS5#91AB[+)2:GL=OD/FZLO/+@SXL;
MWS@[?>=4!9?O: _&'\UV(3+N2WB1XX0\J-[0ZVY?.M[A*[BAG^\T]-QL%7!K
M:M)F10*S G2*T93J+7.B.*#K<;2IPTQ_/^!/$D!_\N4#Z+TI_^)YO"N*[M:R
M!292P]*QL&E!+%TM66\)!G/<4%]K#>_8AA"OB0!NE\K7CA]-*$I)[L16X,B)
M/\)&H3EH&DNS/SR12=#M+PO]8#"5*?<OH@QX<H21^.5/&;3V.<Q32Z;RVCMN
M,'Y2;M!+,Z[*)'4QF#\I("J^H]CJ2QA/I-(+UO;FR6565HD-&5(G9:]@Q06&
M)LG2]J6-^\*K^$+[L^LSJZ]\^_)M[=V3=8*A[D,ZC1LLKA\+2=%TOS"<M8KQ
M 8SQH8'-)./I-)=>L,JWR4Y+3$BK5L$W?PM?>NJ_U$;3U5BXR<U>1SZ,STMV
M*=;0V/"%?2_V)FY!@93SLG?]DM@3[6Q_B9-$9K',RQ5(F1E,>4E4 L<]2ULB
M?TI(P2J:IDTY+6\)*OL SK6Z5%M4966-XPZ]=,Z5^.9T6>PO+@5EA@97(55
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M /"Z!@;JG.JA+!P+,E:O:E/%22]]J'A16YKRQ[L"KFZ!6R>U"ABQF-9M>Z(
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M5CO8ZZ#IAHM J#<;<8 9!'F,2'V)=-O$6DY$>O;ALR^_+A?NJ0;[=F1.6P6
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MBE+/A09>;I(.H>,*Y2:\J#W_(RD4/[J#DDRZFK37\MZX;,>YZYCAY)#Y("V
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M)./J90+)6SFW3665(R^72M>3'21>Y?]=L0DW]$M9K_OH:40K#2O+M00.O]G
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MCC115(@J[GMBVU[,0%&NO>Z'%HZ6ZYZV]/2A]W3I+TBGZTF-ZD(A])EER'!
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M4<;$'&MPD!A+U_[;M?'"0=)AY/9/QO0#("-"3TK%"IA8FTR-&(2@/L$,)@Q
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MTNPH3);K:_%Q8TKO2:D[]B',;#)=  $N^<A=Y??*C"DM+(Z0.W2.1UD,\&(
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MQ_[00!#R.0D;!UT_DZ( UD$Y,'"']/7!W#9,C)$ 0XHMS<F#8]W4WN3\UH)
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M*W *.2BU:!*W*>NCJ)IR=CS!#< HX!#B5"BX%H*K6U0%/_D31H]5.,%O'B8
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M@9*5'%1K-=G N@6$Y=FH!H;C.;=LX*ZE22KY[/LNAU8+:VRC/OM^O72HIU:
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M#O;-ONL-L[O6O-U@NP2._?!4<2[CV^S3\7W@)[C86)JK\1F\,XFE3]J:;!K
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M;EO*74S*Z=_GQF1S.;7UV"MTJ'#C%02B6RWE*.1E3@"+<I(LV@X\^O@Y1:S
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M<::F[.LHB+TL@9?3WN1\>%S;-CRT$,<G8^Y\7I:K+6<]H<7<B25E'.W<@[*
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M!23%\15M,?9T^>W.#4^?AP,4OQ.)HG1)Y]?2>?.I<G WM"OC&X6E4_3"$M^
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M]#-[D;^6,V7746POS>)?-JNJ(9NR$P]_69#O.VM.L6/F70=[&?H7'$/V[C1
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MN>A#?7XD#8WXRU5[CJ9!D!;M[EK.?OI(86,+LDW2\28.SW.+3IM2QK=:,O%
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M8E7U5R(*O]\PH!NJH 2/J-"G";+2KD+%9;DOR)M1F>F=;"<F9@M_K^^!+Q3
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MV[E4.MC%+@!89>LCA!D5,&[Y_66RU+T036W)Q<CO&!EE)/\==N&_>'92IK!
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M$HA NY5."<5(<U+U*%(%),@*O<&S?$0IVD:1X:.#4E;:5W/.@%/:"?!WER4
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M*%^ZZ&/D=YG3]26^22XP-U>\>K#^C+G3B>L(A8,GBD9;@^(&<CNLV5WC7[H
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MY.@N@*OI\TM<*0)OV <J%N<ZE"YJD8=<SK\D.16D9"'?B-17H85JD?:V.\$
M@Z[79A1OH:GIJF+HFZ(^Y744=@NA<D..MEKCD+EAY]\&1\6B/O#4_ABN=+MJ
MDRD.3S*M!CG/1GD =K?34&J:<SG)#41/&^>>NCSUD514V$&-M;I"H2;GI8?*
MQXL4T-VQ?7L@K6+/^6>=D9,%R2AC8N/+IEBL0#I[DU;P[)F4ER<R'[EYCMT
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M?>$,6?_69?/HSNI80T2B_(P7CJ@/SP_\'15?#W]\T=Z_KTBJY5 R,-[M 9$
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MA6W@[JQ) AS&0:!(2I8"IUYSI?CVMKN>F.1L/L=&=R+I;8L!S4439W,GQ,!
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M\M?FAG%N:"A3C;%C5/56"$-GYY\*DTL).V>_9'3V6RR$G0K8L:PJ@W^O)7U
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MS58TSJBE?4@SPJ[+Y[JZQI:$)D(3H8G0M#>Z2#/"VAA?O"C:*;J(4Q]LQ]/
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MW/%>JAP.__X/8#F6ZB+<!Q"Z8*S45-BW49!2N#_!JT(=YC>XR9G@H-MY45+
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MI+#/[6[%9-('O#A M<U/C>BXA;_<<G1D$FE*ZZ&+)%'WS(+D$>G#H> OP*N
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MD6=KF8;/2E @'8@OWWO33B)8^$?J&5FI46I[;PVM5"K7V&=P-S+9.*HIE<J
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M1:;1N0R.+L_#QPSP&V;'K+O5_\7')G5RH..;XOSEYGHWQC ;&[K5OW@*X,J
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METN71-/E)5,;1@!]7#,<J>@M-/9MS;RPA6T#C9[>'QS6"*/M$5?#TL<F@>Y
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M$U#]*K^7,-&,FVKNO8>Z;08_6$U8$':T#[8'JW,M%^.$E@\__\%U;@C_$'L
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M8ZO/>@9C=I^-I_/AU)Z.C?ZLU_OGR'S7*/O\C+EU#F5)](F)^EG2^PW&S#"
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M;%0?VB_QV-8A]3"ECGO[:YBMN_"Y;V<PFAYB KP49V&+'?L)B];=W_ ;PC8
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MMDG)@C*(>Y<$F;CRXSORA"$70W?J?)L&&,%"_Z-P_H@SX?0I M<;7\L_WBU
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MJ,;MJNGTK3+[A(FF5>5]A6KA:+N>@SRFVD[[:=EEJ%!<=K R+$D-16\8P_Y
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MNA";S$KJ3A\+Q\X%-_I/3E0O%'!/SXU>*."ZCR'K7B)L7K48=034]AGD<9&
M:='I^]'IN>>_/;.7M6OW!'Z[#[[4'?C1$.DI1[NTFVPWV6[R63;Y2%/5:9+8
MA":C-YJ'?DK$.MBN2];C(<>MG!+7N).6M(J#CMCLF7"C\4G&(#_FQ-L+0#CC
M+3^,G4S.8S#A>/H4$ZI;O#A[O!BT>''I NIUSQIN?7["Z5@*/9/YN:][D\[X
MN>_G% <];G9NRXE>$"<:G;VF_,*9T:0S.\D5G9X?/9+/]EQ<#U]D2>M1ZO#Y
M#JL?3T\RJO[44\EM@Z7Q=S2:?$](X6+!-CS. [ OV%XF/^CU7@X_>*$W-.L,
M3G)'IU=)6@39!V:'*JPM!3\W!4\[I]&Z3D_!%Q;/_$-D5E/58AO?R["@A]WS
M#P<>BZIGHRN/9N.G<$:^>+@->J,GA=O+9 FO>[-N&X!I[O4,>IU9&X!ID:.R
M\F!ZJ(>@I=]GOJ+IK--O@Q;?';3H-=^^^"O7SNI[0A>UJ:GG2 "C0?<X^WH_
M*#3%._(]&<?GJ6Y/]BL7;"&ZOW7>/\[P>T0/WHMB/6#:]/97G<^2[5S<E?;'
MG5%S[O3T2E:+4-]I0LT.3?MJ^<097.OX<+/KY?.*1PKX--H*^Q"GLO5_[&]Q
MX A<H']I49[3>!S:8,4AP8KC\L@N'6S4!+5?PNS6$=EFMY_[!?4&G=/<T>D5
MDQ9!]A,9+0DW^X:HX_6%TO EM!5Z+V<4TD25"RM.Z0]?4"[K2RVSZ$].'I,Y
M3[@]<2SK9;*$U_T#2O<;S U>Z.U,.X='O\Y>#6EQ8R]GP)$Y&2WU/I]$ZAR:
MJO]22/@2PA1_;H(X\)TPR((;GINX6.$@NN.LBO.UF$?NM'MH!66#W1JMV[V%
M71NR:)G#!5W2)?L\6PPY@ &VA-Q>4Y/.>WGABS_U='7Q#<=(7UR#K9X[ZP]?
MCN?CQ7KCW>YPKQE>+>1*"#X='%<$?]G>MM>]WK0-933W>D:=9[^>TZLD+6[L
M)2RZAZ9%M>3[W%*I=[%=\BXCEJ',BC!.ORN \:)*D%Y/W.'T +%U$ R:X@K9
M8XT75J3]NN>.^^6./"U4OQNJ@W(?JN=VV[TL!C1RIZ/#>T>=%P.ZN$L=C&:=
M27,N]?0J5HM1WZF='^?Q;]E$DR^UVVG:M9Z>43QWB,</;D]S['?^/[=I)GPG
MKK3,'G5+X\YHCSU=;^(TP#2WMXD(84>WXAHQ[&I ORX"T$L%+O##WYS75@8S
M@?-"/":H#O<&+\(C_5)#+62QE%L1M;#;#W:#WI$V]&6[4OM'=K5I(F=XF3=T
MN;[N%C_V;.A]P$#5EGR?^WKZP\X!_?!?"NV2;?13YLU#H53MQS=?]K 5^D?;
M"O\XY']YHP+^H\XH+_(*#;NWO:G"UB#R192]O<)/'ON^IGO !%6F-T]BO^WS
M]NL<5*:=,4'ABQ .YHSVN]=?Q W-U'D7>>%]&J3T<>_:\>;QK7""R,E60>K\
M_O._>>O-]3MG&2>.YR1B$4>+( RX_BE>.A_B9!.#P2I^^C-;B<1)Y;)Y,]9Y
M_?=W[SXY:^&EVT2\<;+8\:H-7M>Y6P6+%;QIDX@45DIA(P)>LP8(WE.^Z^0Z
M=39) /O8>*%:$_>BW@T+PG8!?@O1*6$-W\7?_GV>_/2WFB^?@*QIQ;=!!A2P
MR-W=I!)SX+AX$B^Y=ZZ<?K??!Q8. $@ 7  Z^*#7]'-54\3G8J?U(BVOO>0F
MB*Z8R[X=P&M.0-T/<^.^2K[NCZ^?A,3WVD(!-D-DM@;&2", 3GBI0TQ9(.KH
M%HM(STQI%GDY40Q$&-T@'<=PHP$\B'0/$G,#?XU@TPL@VG@M$B#4= N_]E(G
MQ")(9P%<W<$,96 ,J>-%/JUTE8ED#=\ER%* 3I$F]2;*Q-FBP:.A07ZT@>.+
M10*<$AC(J]ZLY\ F0K@H%Z\7VS/_Z"++K^0T'><OP!#U>^?.LS'+3T#61\X<
M4$=D\#;@ _^"GRZ\#?($XNCP\JJE*Y^_\0!+Y.,]B41W@(U1U1PX9YG$:]S+
M+2*W^-]MD-U;3P&&PLNRP MAG_%RF<(:L,\5P U6]$ I\6Z$?!ZVX,%.,T;<
MI7<+(@W4JL)3].[[0(1^]9$(6N?)F!^N;6XXB1YXWH82[<_;!!4AQ"PWQYA1
M\4I\I-Y19^K,F7I1YXGK+J[CH++W1PRDT9N0TM<;7\L_4+T(F$@(X3_ 9N&]
M E0JD4H=2_Z!M!9N\<V \1\SL7:F^%I2#G_YM@KF0>;,9IT>*XAP)-P#4'(0
MD0J&_SI3DG@@(M,2Q',01,TE #VL052@Y !M(X G@#-[&<BVSEA3!R L7,:*
M^32B.4NS_2_PAYUXZ@3^?_P0#,;=P736G<P&(S'L">&-Q&RQG"R\Q:PW\H?#
M?\QZ/^R+^6HC$BI#M)W+AO5=X&<KZ1"P?R7WW34_\>:@Q6VS^I]8SHX%0% D
M)U*A1N-"Q-#Z[RHQ=OZ-N)J#SO#UREO"9M]ZX9UWG_[P4_X6X0IM -:=?7_B
MK+JMI^=6.^W#WP+0=GS4=XA]2^WILTCC;;*H$-H-8[@U1J^7KIQ?0>%KROYW
MXNQ?EG1&7I21ZNHY(6C<(8K(4-]1NETNP9A"'H6.CQ".Z 3T][5 Q1:D\ +/
M'@G!FB5*_G05)QF93QWG3U!#Z4,TJ1S\+*\=P&& -E*S$F*%TJG3+ %C"UTD
M^$+O6["&4\+RH+6NXM"'E1,!7X,MH(Y!ZRR#"(PUT)Z1Q;)8IV7U0\M0? /Q
M'^()4?@OM_02>!VHXS?! @X"OR*>E;(-H;:[('5C&V]3T,Q1[V8C(4.V?K,%
M-A<G]WK["2KVP.Y9H[^+DZ\H!-2W!#(7K)-YQN:"D!H[78/Z!O004*SP)A8K
MX6]#X>H%J*H6CH=;S[\*,"L 7N"#%7$?;\F<B%'.($@(>NBC G);>;A[LAL8
M I8)PM8SK,H<N0"'N0@#V"8?W0@XNL$ETH&+Y@48VW0-&P^>0-OY)O'@_L$<
M@VV#K8+NN ST-A=M\3L1AO@G+F^V*S<VCY,DOH-7("!!2,(&"KBYW,(Q +/
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M%I=;7&XB+H_<:8O++2Z_!%Q^W7>[A[0L/#,T/J1T]?M0NH%7V^MUAHVZV5-
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MD%YJDL [10;Y(.W;)'\\:0P*78 C)O#5%:B9)P9]LR&/48$(( MRY5] 9+X
MK1REL.ETM8A3V7<1+F*+7YX2GJ#"-!N@J(@*Y PD9*09AU(8M0EF*B+'I\F
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MC'5V?3TQRG#9P?3X1'0UZ8Z?F:XFCT)7@\>DJ\EX?'YTI3V2LX)#\KV5$PA
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M4<,O:3@^-/7TC"VC4P"XLO?(GM60,E=I .#UXRVV1U+[;0>"/0)TFDV9O?[
M'8V^K\O!]X+H/ K'CSAE2RF' JC9Q#)SN[/OZZ+P"#!JJ:51.-%22ZUHZ0W=
MX?C[.C6<D%YV34E[-%"..OT]&J/6V>[]SG27[?Z/0_Y7VT)S__:XCP:5Z5[-
M8JVV#<_^]NL<5*:=,4'ALUABT]G8^2/.A#-VR/DSOI9__(95R<HAI/Q"LNTK
MM8G_F(FU,^56K4'J_/)M%<R#S)G-.CT>QF!&FP01?+#FG$IL09OHOO_PX3;!
MX0BP3+DY!W=AC76C-M7!7K?R2'<T4VTN)O2;A@E_63,E&*ZJ12]/N%O ,L'"
M@=T"X&F< A>G=YPO0IP2?1AE<FUYK=KYCO..!E#@>(.0!^7%//UG%THY//QL
M&8I%9B9ST.B#'1T#2^ODOI4+<#M?;Q[?BH[S24%8'D)NU=]2EWKQ;8&3C>30
M!3-XPS23%HLXBM=P+6&PU..3YML@1.@43U'>@..EZ99:(F,CZELOQ"SG-(MQ
M-@,VFPZB+<TIY$.;485J"I%ZHPW\LZ3&0=.H,<^79P7">A\G"34<9YS[D B@
M$^>=3D]_)HX=\#P9*LO:)/"68..%.-+AX2HNCUJ@RU$AOK--<6E['(A,:^0#
M!FI%Q$*B)#E9,XYJFG^71QLT'PF'S4;"WJ2 A2 MUD%F&J%_((YQ(R)LZO[4
M*!CO5ZAQEMQHU#1$^&2U]H]WY">#P**) %_$QB.!\8Y'<Z7Y+.9E>6!I7\\3
M5<, N/=_3KQBE_[M9A,G<F8L2"],>:8!=_AE"!@2PGJIT$,.:)R7'!N0;N?_
M1*:!8P_D? +^99#22*.Z\8-SY$X@B,^1IXR;ADKD]L_-BEA6YN.ZH/A;F5$\
M9+D^3*UF4;R:=$=JA*&+8\D&CCW9[55OTC5?VY.(7-P*3CI+;H4<W1!S>Z;4
M1IQ$!%&Z35 T\60,/3WP&R[%$S&U5F4]C1,PDH#9*6Y9XG=NC =\NJ+!94IC
MXV>45DA?F05Q;AQ.U2)MCBGAX?J <\3A2=-P^,,6=.0US@8AW /@QPL>PDV&
M!WJ'-JR1TY7*"2@:G<K\K]>=Z/FR-&9T+D2DN*D<7E=4W16?)%N&-X(36.>"
M1[&!/H8S:' \N1PI*S>MV1J.2TV$FF,:+Y> 0IH8P=@(MDQV. @<Z0'0$M_B
MZJE[<IJ*-D]8E:/!-LLPOJ.AW\AW:>HH3VP1/MAC6KPCU47PTFV4 (QHSI<:
M=Q7&:<H%+Z0NIF*A%$XI <AH^8838$'?$%<\Z1R BI/J",2O1F-#Z7,!)T#X
M?7/W!7!3YLSMG)ST&93B).!Y[ BL#W*"CA+8S3I#-7U_-!-P$1%!?P2F%L(N
M4($(O3ODRKE#VL+#3&<SX\\ L>'Y^99_@.8^SG:48@-)#Z0(W3/.>0UQA)J>
M_0;8+<D5;>U,L"T?)S=>)*?*IGHR]G_^_F>JIF)+*T7S>A(*1F?1XF.Y36B+
MH)Z@Y<,;!"7$12:/M$3?HK,!9[_Q1&4:$06?Q:F],"Q&6\3;5G.3Y-PA (N<
M-OHZ00U>#OOU4C7XDK>KP,HB2T_IW .BJ#5)7D,BFJ?O!HEZK02U&N9I'U:/
M<((S+3+D3KGKJ)G(AR-4:56D>CE@SY43^&I^$O",*D!GN"<:6!N5+HC'#RKD
MHV%9P*4CP;,NB9?37%*111ZHLG"X5#Z9GWOMF]%5Y*W,O*]DFQ.@U 4"0X[U
MQ<?)/<N 6QSE90,=QZ+*M>!S4(1P_VD=?K$.8AE,.5A'?GX_>5A7J;H(JZI7
MW2,2IX$?@$@1YA99Z9'HQ19YU:JLPM\3*<HI6E6/(:<'I <U1<TQY"F'2!>6
MFH2SPP#Y-,A<_(1P6+X&Y6MT7SM,W#Y(?D> P21M8+T=&U"CN"UH6K>:&^E6
MO %WUZ@V>XAW%3F6R$Z.<BP>T-P=OAYO-'=D1&LT=A@?-1+.[W.XR9,W2>#2
M5,]^9Z(5:>E'U*/D*FSL!HJ9OW(DRYPS-?H&LTXX&I*<<?+FT9Y0@]6OC+S+
M;&'^1(1-]^X75^2Y>YJE2E6^Z-Q%2Y>?1[Z.%! &L)Z/Z)R?_!GD1B9;0\:U
MCTSI3/AF2_*9712X7LW$>J,>PDLS5"I3N5-6-I>:2C8@5>*45#-010%;\(%
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MR:+L#=5*7IJKVJK6"?*D\%T.4.-ES3D]\RWTK((+,RQ\P0+/(C%R^%+1%;N
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M9AU;ND:OD4#7E]7U4@4Q9!9Y;NP"!D)XAH1G,5QJ.NN#A9R0K^I&H#Y$_9)
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M )32K8"@/+WR=L%4R[G_<PISV>N%0JZLQODFY$ ^8##4A6"3A$(038'<H6F
M2MHT9/L/Y)[P9E738Y(,.HL4+I"S*)@%)Y1MQ'%FXCTL1TPS6WX5_E[.KJ+?
MG4U[6^:X6CC*ZM.<%L@BR2^,FS>/R-"6Z82HDQPL;*=X.L["96-097AO5O<I
M,6*SW$)F=W^J^XHE)W7"(H$HLS:E*$3]R2-'-;FZJ"L1\???_OJ@'5]JC"&*
MQB#:TNCG^P4EYZ(G3'905T,5U<P5G:T+U\],%> 6< Z\3&K@?<IY\>1;7?$$
M*=X4%M(D 4@G*IHACY7IR"W3]2EE1]!(=!.]5YS;5(.J48U[Y:SK_'SZW*\>
M2>7EAWK:8(\P+1M-;)FA#9L$ EA03UU/=EE:@TQ#P#C_W/K:7:M] 7D /1'*
M_,_*- R2JZ1"O@Q=G=&6XKI6HEAA4I1LPR]#E9:>4/%2+0(1!ZE:F"I8[Z_4
MWU4%(GIR5+2NO REN+$:<C;L0M59H(TF'N(+E"JBC%WT^&!$<F&2XRGFB!,W
M[JEMZ:O1:)9/'ACUK6R"PR-98&^IT=,6MLH,334=#0VT[1)GJU*E@Y6+9"%!
M$%'E'&<#ZZ;/')3 # #,'0*+%C\T';)V0\>5N3O8!"V@U<CD8)-/81B *50%
M,N22XM[]\.*5"#<RF8JPF<+:S#!N;H O(N5AO-Q%]Q?5]14+-W)TJ1,7#*&C
MD$3U99N2^W4.EXF4E(F(@2\'<SNO>]T?9?ABDXBKS/MF.0=WG5]/OO ,_.Y5
M&A,O 0\1!&1ZEJ#&]4+^/3L4'S%A<0,,\9NJSWDU&N^%7V=!G@_@NIIKJM&S
M<+?23Z+Q6"==*%O2GJ\*C),FNP(B&G\\4+78D#YDD;?*,D4N7(_;LN03/2-Z
M@ZZLK"EXG_EG<Z&U]:9<SH&*\V>RY./EU7\!*K^#>Y"NWM\(MW\STX\;<KR]
M;7<KH9%83ZXAHU8HL.@6#RK1$E6*C7;(&<>%H\&$^H7'8#(];*I,U01_@9A)
MOX@X.A!R2B#^7H<Y> .4:XJ YW_:8Z=WOR??5H4RK7D)4RJ7L#M06^WT??69
MJG=0/5$(G4](# 114D*EWZ<-R^JP[*0-RQX$,,(]5)\B<8?!-0NK0B5Y[2K^
M1*QC++(T=0'\&.Q]41B5H8@HER(.OP<^0-3!K3_42-H\#8$*9VK9=%8V9K'A
MH#:=O5ZD35J$K#A.T_3\(#2<B2<XVQX='F BN.K/CEO,XR21X^+@O:Z=9DY3
M##WVUA=YC"O3)A:R.T21-; 99IQJ_&U2Q1?L >\%_K+V?*'JPG(\P<2!V'Z'
MK?)/D<U&2//%22Q<\B!+Q&22MVK[*2O-*G=G)WC!7<A!C9]+"U"/D-_(&<NR
M+C>:LN,<F I;/5/L=//"JHQJ]!R1(SL3"A]-*;.4@X "<BKYBH?'K"G7G6A0
M18KMGEZ4*XKXMJ&4=8P%R_QE;['BTHCR:QG5]9MB+HKRK7)J;05;>KBJR/8R
MB3LY#+-:O%EIV0:-R.<A&4?94\,%%/125DKA7_$:*Z%0X\,HM[B!?QEL)0?5
M-S X NU]4YPJMH:0FBK>&.-T5 X NC\&Z[E%-88)43B9V<6&!N5[P6K\NU)I
MW8HWY5)V<TU5K7A 0;4@L\R87Y:"4.[+2LF7\/-MH@.IG/M<I+X*E0'V_B4
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MQ]L4>S"863VY*2<U<@'OVTIUV&Y\R<:0C\@@/XD%Y5B1/1GF:QR>HQXTV]R
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M\K90,YT;9+HP@'QQ\ONTH7+^LN*E]/67:J'*ZTO6W0<]<OVJ*;V^EE)IO+S
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M&[9CJK%=2U],78:URDO%\5X0YBC%E-::PW48<[S@1%WB.E7[D!Y;<UJAY;C
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MH(<L) 8:A8EEE$"BI:>..P,U#Y"(\,^+9$%"!!%(?T&8H)VDC=8[U?WQ_^P
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M;=DO=^7P_-3XT5$H^&E\--N5BJMR_U=C1+9N!"=ET# L-$@3]*(Y%2#0CDG
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M4S!-EK]CSVXNHFY'SVZ.=K:0H5O@5R_WJ50DF_GU9ORZ;G";# A;3@EP.%A
M??2(C8Y,ZSB5DD/%HS.<\\*9AQ[^WEK@!&<>:HJ'5IQ6IC51FB'@45)J9LR
MZ*L2@$T2DC<H[AW*V=_,0P]_;RW(_F8>:HJ'5@>>!<,0HP)PZE->0"A@#$N-
MO,Y&BQ;K8$61XVV3/?3$<KPKG;NNJIQOJ'?WNH'"+>*F!^W=G8^)S3?\Y%Z?
M!LF,KA,E5DPCQ A0/LG+0R* ]CH YSCGC@AE$2]Z?3!Y?'F #/4'Z-[-4+\?
MJ*_X3UPQIY6D0$4+)D+=>!"-S&BW.*R=EU9A$TJH/T+YM0SU!^C?S5"_'ZBO
MN"A448V8YH 3+M.\ 0$DTQ0PP2BU&CIF7=FJ3UL$]:<P9_=%[W//^8$;)SSU
M(R[<K(<W)\&>6-#GCM[5Z\-7RT3\?'AZ.AR\G0SMI^E)FX: J@.78T W(UBV
M+B?&+!=&.J 4H]&6TAXH'2RPG!-K B30D9T]O(MABV) .1:=:>D><F*9ENZ+
MEE939)X*S R.)A]G@'(<:4DB"QAW<7\8\HS01$LPTU*FI6VCI3MZK9F6[HN6
M5MQ1QH0(-!@075(5:<DAH"4/P&E!O%'17&*A=;14>*,_%;6*\;^N]WGOW\4?
MY968T4][TZM:?/$>H803E-YZW]'6#D_C=U\DC9[!<!(_?3),\!D/^SVG4^8K
M] 9Z8'NZ'Z\O_N#4#R;CW95;J"^^^@::$GUGPW$O;<:SD>_K2>^S__E+STU.
M:B3/O:M<P6=P]A9MXA6<3RY_R]RFV'A)?G3_A%2LHN"+:S'_9[K< ON$0R(5
M%(K$)RWR7C.O;!!66X68H_0?E*3CJW>=C.I[.-,?/# CKS\!'>(M/M/]+_IB
MO//3PDJ<]@9@?MDO6['J<(/B##_C13+V\D4+86.+5@(J,NRPK'%_%H'H1^FW
MXN7HUEQ+YV24GA__YSJ[!Y/PE?-?B^KD>?2\FJ+G[10]__Y)7\8!ZPAB!6/W
M?_3%VJ._<*.SV^L,0UR#T[.1/_&#<81]I^QSN)0S3O7H0SS#D^'9L_)(EH7>
M4VX8Q1U)1-W79V/_K/[+SZXW/NOKBV>]07%IQ9M^KCZK(I0$AR6R+A:O?'F&
ME/@$*=!2!1&K;ZY>WBU>6GJ$E*]QNDN4N/1EN(LN?>VJCT6IZ>#RMU[UL5>_
M1B3-%XO(M3[V.U'E[R:,$%OYW37.0PG@^S&QU?=078#@U7#4F9SXSCNO1^/.
MR\AJKA.-6I]2,QV"N@LVU347Z4&]INEM%Q_XK#>)7V:_NQ!7/:1>#SKQ OI)
M\^$Z\IDE@25Z2S9E09F=^GZVZFBD8')3-WP=G<W'M' H+]SM%@[>A' >A5KO
MK//MIMG4:V_\8PMDW?C^MS?*M>E*R]]'P]";I*;D;2FW>%?%M\YZ!_'SWQU_
M^G+TZVM\</P2OC]]38Y^?1,_>Y\=?-N'!Q]?TO?'?YP>S.);%^^/W\&#7]]\
M._SU3WKP\0 >O7C'CH[?P/<?/UV\^_L-*=YW;/'AQ7)\Z[_]PX]OOKQ_<0#?
M'W^X./CVAAY^_,0.7_QQ>G0<K^>%_7;PXLW7PV_OR/]^>UW%MEY.#CZ^0P<?
MWY!_O#2.*@*!Y10"J@P#QA@$O$&>*H\#4V%GCW8);FJ@W$V>"VW66<@T]^1H
MKO$JTTQS&Z*YBR6:,]Q$;J,<<*4-H,9)8 +3 'G,)(52LR2S(+I*-E4^FFDN
MTUR;;OP&--=XA6VFN<W0W.&R-:>CN:V5D2":WQS0Q'":J6C2*<$1LXHX31+-
M(77G-N/[HKFG4%=[-#GQHXY=2%=4JC,_]"-J?NQV!M$='X;.1'^]W;"<[]2?
MY,^XR["<[6XW39&>\\'(QTOYYET\>)_]>)*2:)T/NC<8ET?0CU?DIAYY5\J5
MRFW-QS\ND6PKJ&$AD5GF,?<_ZUX_)1OC\W0<'YIOO3T?]28]/]YW'\_+_9O*
MM@U'Z0;VYP2LCH>_ZU'\E?P\;NYY_&8UNF(PYS8ZB  F@4KJ$ 32" 1L]!^U
M<CJ>%;RSA[L$K497'D3>+3>L-4T-#<0,'HH:,OIOAO[EH(.ST!DM& @&*D"U
MH, @+8%D%FK! Z)"[^PQMBJUD;'?6NP_I!^=$=\NQ*_XWP@KPQ U (N(<ZJD
M 49$_QM%XQ!A9GP\$CM[E-ZY5+A]C:O;XNT\/]&##\F]+@>HG$<W9Z0GOA.A
M')V=\Y$>6-\9^?CIT0VZE<MSW9:-K>:VQC.^1[;W6T^;7K\WN7@U'+TZGYR/
M_._#?L]>_.('/O0FOT9O-,40]U,5\A^IPV$\[H6X=@6?38EN?^ BS64NNQ&7
M_3GGNWRZ./SVYNL_G&-O2;1>4GUQM%Z(!MI)!;#QT,0]MU28G3TIVM3VT'0$
MZ<G#O/&,9X;Y \/\8@GF$KI "2< 21MA+K4#*J  M'2,41J,M6IG#S.68?YX
M8=Z\I](TS+\S3B?#_WKP/UQ^RB/.X]:+"']"+: H&* HPL!Z;0UV@6A(&QNF
MDR5!;XOEB*'XST$G^O714[<7G4ET5,;] BP=/47+[1R6)Q&,:=YAN2084TS2
M*;?K>;5;QVFSRDM,?#;;NM7P3&:ZQOV9*C9C7=Q6QSUPD'A L:= FJ" ,D$(
MPYS@7#WBL6&/G G:G9*Y*R=D[-_2R:FP3S"%G$D"A(<F8A];H*E :>@6C@8O
MP9:ENJB<A]D>P+<Q#Y-A_D#.3 5SZC$.<5^!9(Y$F#L*E.8D85U%G!L)D=S9
M:Y,6^!-+OJ12,ZO')YW0'W[IG'CW(>=86N*R/(_;\BKNRG_2IEP=G,F1UYNS
MU;M5AT0A[Y2W"A#*(EL9Z8'Q6*3^.P,UUY+XZ)"LJ0S+@==V0[S]OD@&^Z;!
MON*!($(]YQ1X)2&@2=?2",V 4"QXRFWT0=S.WIHIE-=W03+.6XSS!GR0C//V
MX7RU BP(1 B$@) 49;1: .F4 M PY[UQ:5A)=$'N,LT[9U%N"]C?$SY2PF3@
M.L.BY^IL.)Z,_*0W*E3C.J;,38X[3RR/<L^]+M<GL&K'(CL5O_7[PG95F>3?
M^_'.<SCECEQFUVB#**1M"!RP(!F@A'(@A0U 2*BM))@I3*.#PF6.FVX/U%OO
MFV3(WR/D5]T4K[73-#HG$>TT;C*0F,GX-\HY02(([9,@6HM"J!GV+?15,MS;
M"/=5;P4Q&GBP(,0'.Z!(42"M<8 C(Z0V%FE,UH8@'^0!GZ4@QK?LPJ\6XFY:
M/MM-:O??HI_8;7U95^ZSOPN/?5CU5#CFB$$DXM:9:*P(D71OHN,2D/%(*^N"
M@VED)%-W\55NBJ(MBKX^969X&#<G&S&W!?^RSP*EIL80"QRF$?R82Z"1Q(!H
MXI21UAO'4\AU=5ILAOXCA'Y;'9T,^%L"?L5K$4P1J@,&EK/HM7!"X].>"6""
MQ,IA@:-E%P&OFFI9:Y_&W1;JR3]?X]+<)<ORA&FK\0S,&L:JV2K^JW^>UG*M
M;LCA<)"N;#3LQQOZ\#H-;O#C+"K6(/U]6G5VI"66IWG-V*, J+$!&$X(L,Y[
MPEEPUL@D*A9Y<%M$/A\@AON$^:/QIO[,'VWFCV5_R</($H8P0"!,YI-S0&NL
M@!=<6F@$X2G'([I<W-F ROSQ&/FC<;<I\T>+^6/%_<+4>(2,!\(H!6A\>B3)
M  4X)@H2:I3P(?$'DULS,N8I9)86'; ?2@_LQTY**G7T'*K2]-C! JZBMU8"
MZTZ].H^-,!^T9B[2XRRR=#U.S+1W ]I[^:6@O,5)\%(&"172@'$L :4< Z.Q
MB":48B'0 (5%J1XNQYF? OY;D6'*/+!Y'CA8Y@%#*>&!.R "8A']@0+M @*(
M,*4EDL$@''G@SB-6,AEL#1D\:'E=)H'-D\"?*R3@B,!4:X!<&K6DE =:2A+]
M(2$"(4$RFKIW5\4&VF<,/-7TTXK;\_ROMYW_>-V?G-S20RUO\1F)&^&&Y^E3
MZSO+8_0:6Z!V/PE:FL?+,;$&GP=?USB'VLFX488#HRR*SJ&.SB&"%, @4D[.
M6<ILD95;\TBX4U2L 4AMQPC23*Z97-N9Y,SDVBRYKGC<,)! B30 >2D 99@#
M)1 $-"#%A:1*(END+)M..61RS>2:R?5!,\"97)LEUY5(A@Q""Z\M8$&;:+E*
M!A0V"BA/!;6*Q2>I+O*Y8K6"?EO)M0AY_%0X_O&_KO=Y[]_%'^5]F-%/>]-[
M6GSQ'D&)$RC?>M_1-O4#ZL%%RL4.AI/XZ9-A F2Q+GKB72?T!GI@>[H?KR_^
MH-""WUVYA?KBJV^@2:_E;#CNI:U\-O))F/2S__E+STU.:DZ8>U>U77#V%FWB
M%9Q/+G_+W*98GX*/]T]MQ2H*L;@6\W^FRRVH@W!(I()"$>8I\EXSKVP05MLT
M 8G2?Q!4._6[3D;U/9SI#QZ8D=>?@$[*2L]T_XN^&._\M+ 2I[T!F%_VRU:L
M.MR@.,//>*&I<_FBA;"Q12L!%6EV."H$HIY%&/M1^JUX.;HUU](Y&:4GTO^Y
MSN[!G;W7\8U?BU#?/'I>3='S=HJ>?_^D+^. =02Q@K'[/_IB[=%?N-%?=+^8
M;_?VQ/NY:H[E:S_5HP_QO";Z+8]?&2&=\D!!SO$&^OIL[)_5?_G9]<9G?7WQ
MK#<H+J-XT\_59U7DD8[^$C$7"U6^/$/%+BR1446EJV^N7MXM7EIZV)2O";S+
M)+WT9;B++GWMJH]%:%=P=JN/O?HULJF+%=?ZV.]$_K^;Z5,KO[K&!2B/__V8
MNNI[F"B.U?ZD\\);?VK\J$-0=\%\N>:2/*BK,[W+X@.?]2;QR^QW[_LJ1G\]
MZ,0+Z,>?CKL=_]7Z:%>=Q=49G^A1-$!.TYS,RZN_YMS3&QAN[3XC*>+>U U?
MBI]'NG#H)HAZ%.G%_?$X/E"?7>? W*G(]3HGZ=95[TU=Y#9LV!K']8EI\2=M
MV$()LQ#D]__OO/=9]]?-$+NS<F_K;OWZ,<!UM_AHHGB<<2L#)B9(2;U12A!H
MH8<1Z@X28_YY?<VT<SQ ^P.7_O-R=HSV)\_U:)1B%G_I_KG?EC#>IVD8[^CX
M$WGW[1T^.G[_\=W?!_#@A?WV[O15__WQ^]/WQ_O?#CY^BK_O3HZ>UV&\LX^'
M+SY\._CV#AV<OO]T].L;>/ Q?L+QRV]'QR?Q6N)G'+_ZE,)Y[]\NA?%.4\CO
M(%[KGQ?O3]_0>/T7AQ\/3PZ.#]C1KW]]//CVYNO!WW^<O'_A^O_[[6"- HYW
MDE&F@7,^*> 8!;2G 4ABG \$"Q5LJDGL*OH()[EFBGJL%*4B%S$$N4&*6FTE
M\E(R8:VFB"M<4M1UDK>9HNZ=HI;[3JWB0@25NL4@ =19!$R(?^,!(4HHTE*3
MG3W5I7!5I"L/FKTG;+X>?/9YENP]&4YO3X:CR;$?G<ZM>B:AYDCHS:J=I 61
MB#@'D!,04"5"M)-\M).X=1Q9AX0A19F>N#,)98WC%B.X(;LB(WCC"%XV(QPE
MT8SP#$""=30CTM@T%@&-@V:.B4",$CM[I(ON/CFM?=K%VV)&[%M;I PZ(V]]
M-+=-WW<[ S_)PQXW;5/4*__'=.$/_:2<1KLUPAC;P$QK)LQ+[B%27 -&/ :4
MD0"4UAXPJH(G4(9 =+0M1!>+U1[QK8_!9"@W;5QD*-\;E%<TL@S!2@4#,#<1
MREX3H"@E "./M+64.VDBE&F7KAGEEH,5]QBL&$R&H]XMIT@_#5>G(<.B7NR+
M2$*9?9ICGS63H870"&(E0!"I(EMK!:2@$BCL!.;($Q?<SAY27:CR)*;'#-V&
M#(D,W8U!=]EP8-83['$ /(U^I5I*H"UE0 <8K$88BR#21*6NX&V"[E,+3Q3E
M6IT3WW<)#IUQ//0Y-+'QT$2QZD?A16]\-HQ+_FM<RK.IP&?\:?K6WN#<NZ,S
M7]:H3KV=S$LWX*4ULUPUA5H[;@&V/O*2LA(831A@F!'',7&(1EY2K4J]YL!$
M2^V)NP!YWOH(O:_>@6]^-,P ORG 5R:W2F0(#A+8H"B@F#I@B+= DI34#$D%
M0:6R5QF)^N<6@?R)A2RJ^8XE&CJZ %*.76S:\BA6O62M'#]MG(W6#&04F&&O
MHGW!*9> >AM ?/8HP(2AP07$.$KQTRXG=\Z$Y !&B_';D,&1\;MA_*[.@3?8
M!TA!Q'": ^\1D# 00+ D,@0C#&([>ZQ+4%,SAMH6Q4!X%[?=F#@>3G2_"6/B
MD:KR/EB,(Y-4XR2U9A":-T@Z(3C@*9Q!-;) .1$ 08%@XP+3&N[L<1:MC#MK
M+F8M[D>)^D8#(AGUFT#]2H8%6<@COH$RR32AW ##D09*QDU3QFEH=40][$+R
MU ; ;DL0Y+?AX .8^-%II]=,N\E3IK"&#)>T)[F0?6-$MG:@$#7:"XPDP$8Y
M0%W!8I( ;[U,/;M<4+JSAU$7JJ;")*TQ8/(HQC89,!G]&T?_BJBQ)M)J%@T9
M P..[@M$0&IF 3+<."@8L4)%]),NQ%LSB/6)U9'\/AJ>Q<NY*'14DH3*68).
M[G2Y%XNE7OS?^WHPV1^XE_7ZYRJW9LEKW;@+@4G<,QL UMP#2C0%AI'$8$0K
M$]+\"U;HC4C15.QE2\,KCQS,#1D@&<SW!^852P0CP0/B&DB&#*#86:"A<\!(
MJPC6E@<62C#?W0_)I2.W+ATI:ZD&'SI]K\>^4ZP0& 9P'O^1*TGNJ9*DWH3?
MTA[\D2[F*/PY]D4$.!-5@T1UL2Y@XA"12/,4(8& <L> 2:,*A#8!.F4Y5+RH
MKI?BSM-7<UU)B]'<5%U)1O/]H7G%[/"8::6Q!C 42A[& RTP!U(PIC$5D:]%
MT>:&<)O0_,1B'+\.A^Y+K]_/ 8U-VQ;U2F?B:9!XOJTQ(R"1TM)H1C"*/*!2
M(J#CDP00S)!SG'*:FF&$[")VYR:]'+QH,7 ;,B,R<#<#W!6+(>X.%4(Z@! *
M@ J'@80N !9(= PTDUK!"-QD,619C@>4Y9CHP8=>&AE4AB5NGQ!Y&MY,8PH=
M];J7]6B'?O+R:]64EREJ Q0%UR5&?+!2: J@Y"0E1AC0)/Y-:T:@(0H3ZPOE
M( F;&@2>0Q1M!'5CVAT9U/<-ZA6[(RC.','180@V.@P..Q"=!@8<400CQK24
M,H):=2'+D8H'0^=;?Z9'>E(.3"W41^_>$O/(2:HI(?-JY2O%PI*I,BLUR$IH
MC:G!A#,:IVY_!EWTAB@&*C *G$38Q8W55)NDA(QQ5O5XS"!N2LL\@WCS(%X-
M:5C" O8<.$RBOX!ETOJ#""B.F2+<"15\ZK2%\LYRYCFB<3?5CEQC<>]J'8?#
M@<U==8T3$5YC35CC1:KU D%1!JCF#&B+%6!<"(8%53RHG3W:Y;A-PH4Y;M%2
M:R*#^!Y O"90X8C05@%N?5(!,QR8@#D@7B!F*$<NE530KD"T12!N*$[1:A.B
MU.I8;T)LMD._=4MQX]F6U[__QT/#C>J19-YMD'?)&N/)4&$TH@&X-'F7*B&!
M#*D[AD*FL/048[BSA['L8K$UJ@3W-)PWL]O38[=&=5<RNS7+;BM6I>&"R22Y
M$G0P@#(!@?*& LX-03A2FU8X=2J3)O)?]ZRY4E](?91QP5U-NY77^(RY&R;Q
MEMSP/!70+-_Q7;[A@:[R*5CWO_6TZ?5[DYX?/[LT0-A$MN,A/^.)!7VG,RS/
M]$4:OG87S_BQF2[K;O'Q6"<-C^+\O3P_QR/M?-:(:]QD>;U.6@D:"A63 @AN
MHT/&+0+102, \: =,=YSG3H%:5>21SCH.U/38Z6FAD>+9FK:.#6MQNAQI*,T
M(LPP*",U:0HDY!!8IJ1R/@@K8:&VP.@C#-)OB_7W^XF.*+ 7'=O7O=-QH?#D
MTF2;JTS"7)34E UE/X^?U5OPO-B!_8%[4:]_15N9L9IGK'5B3T$YJC 3 !$7
M(F,I"13DJ5+ 1.*2+GA1-FI3G,6>'C.H[VA]9% _'*A7S!!GD6+:.D"$B69(
M\-%#LBXIN%E!M%0*4UAHJ1#2IB;H)Q:$^H_7_<E)Q^J1C[<[GID>G5R'N'%)
M["JH>_%J.)K25?47]_&\U,E]^?7,#\8^TU6#=+5.^@EA&!06!!AN(: 2"6 \
MMP J18*7WF&/(EW!+J)M:L'*]8DMLT$RN!\>W"NV2/0FO$)4 TJ9!11[#(PD
M 0C"N8L43JR*#H;L<M&F8.U3BX@,^SU[<3+L.S\:%X-DQ<^=$&\O-UC>3TO$
M_ :\2NN>>:E!7EHG%$5E<$JI )3S#E!$&)#2!J"EQ@)3QQQ-PKA=!MOD(N6X
M1TMMCHSB^T#Q:OE:A+ (D@'J(I2I<P1HA"1P'#NM%;.*\]0406 6C7K(:IO1
MN7<=7YK<N<WR/LI3THK/E:[ET&OSA+1.(TH*':B"$*@@/* FN3LN"*"$L4$@
MB'0A8RV[@C8U^2?',MJ(Y.:J.3*2[P/)*Z8%I<88P2B07EL0]] !F9!L!60&
M*Z,H=T42A8LV=4T_L<A%*=_0&XS/1WI@?:<_ TH.76RR@J-8^-?UNF=^VB@_
MK9.(XII!QXP$N!B8$8P'DE(! G3!&^TQEBH%,*!4+7)]<@"C989&QO+]8WE-
MW2B7 08.#+'1UHB^ C!!$$"8=IY8136A"<OD[DY##F/<%I05&#IGPU$!RF'H
M#)?F=MW5^G@:KM%&YG5-D[Z9LYKGK+6B4CP^8+0.@'O,$V=!H"@R(#I-4L/X
M!X<ITM&RQ&X.=+3,_LAH?@@TKR92K.,!,@6,TRJB60I@4'0NE"-$*8P@\[Y
M,[WSF-#["W:XWOBLKR_2Q?JK">"^?O.)16?6F$S]X> #F/C1:60#DT>I;[[2
M-:[W<5SN%W&U4QF</NM-=+\@V2,35T2G"\F.W@9HEJX;(4*-#(0'H(,Q@(:B
MX$2FN8A&JT LA[IP],3=C:8<M&DQN)NJ=,W@?CAPK[;=0(2IQPR(I,M)J>-
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M+X2Q")&=/9YD2)HJY+\>2K8H9'(WL>WM1G[S%DU&_D:0OVJI8"IT*J[E'!E
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M?)!.1*^!=:&\<WXE1S3N)MDVZP-N3KSM:;A$FQ1OR\G@C7#5.OTV)E4@/A!
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MUK&WXOP.<-[N]Y$*1Y, A'E=.G)GQ =M2A%;X)$ZM,@JSN\KSGO1V'<9H%=
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MDAI,*5<,@<<8.#/6-3B6K-T-M.)X*W"\-KE0<;PV'+=%0K0H%(O@8AG=Q%,
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M-Y:P2*(BWG.?9*KAS7M,JL^OAS=9R*L:(X+3F4\Q4RQHPQ XBY0QQX169.]
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M1>C.-SD9D^:"*U4RFR(9'1F1F/*>9YWRPM1-KC>X:]?=*A\YD9Y \"$#SY
M6@8+^=$E.GCC,_CV#M2^Z>S,S'VLK+T3",Z'H/CQZ=DD'L?1=/@F#DXR* 9_
M/QK/XH!BB_NV/8]5<X4[9N-:E7H_UJG:N-JXVKBW-EZJ_H,R8G1VVY.4:)2P
M49"LHH.WFK@@^+<KYL:?>?RI.W/8Y+V+HW\49\_32_NN^O3+^?1T0=,+00(7
M1"A(483LTCN?77J?_U-)XUT*4C-7CLVN,J>RXF]=^.L@9%SQMTG\M?M0>!J(
MIP84U1(P4 8F*0$F8@K42,.8J/BK/L9VV7BI+INK1PPKQVV2X]IQ0R>C)#$)
M2#0IP&0E."0"B'&*F."%XZQ')%>'86_E.W>B0K@IH!]<-E@H('HSG%WLY\LH
M/[9O[21,!W84!N/"?;M61+S<M 9'HS;"\$2\1A.)$SY[9-DYD$D10L72J:IF
M;0ZGT_,8GIQ/RI&&9A[4?'1#\^+S9MVF3]_%B1].8ZB[SW*[#U\P=B7K6Y-D
MB! 31T"-"(9R!]'9P U7-*#=.Z"U+N,>>-FUUKPWE+F@?$8SY"(F*I5 FI+C
M0G"/B83$F1.V*[[\ESTYCY4NNZ'+UE +1[02TD1P1EA Y2T8YSUHXE1$5,S*
M3)=:=M4#M_+E_>/+:N-JXVKCWMKX+FO.ZYZ]_CV[E40PS#D3T8,D/._9+!HP
M00JP1DH4DKJF<WW=LRO7;9V-[[+TN'+=!L(YK60"=2IHKCD$2P*@EPC::@9Y
M!0,2;4N_[[Z1W4Z4(#_]]<6+P3##H8S]GNX/1G%66OR>G4_\L9W&\OWL<G#M
M8!YPK27)-;5\MS%^KPE2X=&)P%!$M 314!:(0.6,2[?>$_R;Z<,"@,/+YW^>
M/_YT3O,\S/_(__=\.(GA\7@Z>Q9GQ^.Z*2RY*>""F<TI.*8$]Q"2<H"JM(;W
M)@()@0<FBI1)>P<KA_AKX7IES.VS\1(N] ;ILO&B*UMVP):M^;5.Y&5#A9"2
M8H 4.5CM#' O-#=&Z63-WH'H*5MN*0HKTU4;;X.-[R+X7'>3S>TFK>"SHI9'
M8C1$*C2@T18<%Q*"$MYP1!Y%W4TJTVV?C>\B]%R9;G-,UPX](T$3B/= 5,I4
M1[0!&PT!BHXHAC)02_I%=3M1\_QX?'HZ'EW6.(?AFV&(H_!MP>5[G FKV<8=
MLW&M6KT?ZU1M7&V\B7.2J>,6R4^N=M+Y_MIXE[7'6H<^IEC0+-DD%#3&9M)0
M@*R>$4SIG2PLTP$C]\C8W@';E[C*8<F*PLIT_;+QAKM>5*;;--.UXH;H@O$L
M<6 >+:!-#!PU'J3AP5MC4J"\,EUENFVS\89[7U2FVS33M>.&'*,/02,$6_I?
ME"/(.I($S"63&(9H,/2*ZFH'C*U\YTZ4(<\[(0]'OF1%\N<.1X/19U,B\T_F
M8R)K_7'-"FZWC6MEZ?U8IVKC:N-JXVKC:N-JXWY4+'4P"^MCQ=+B*>V-HSX_
M,GMXZ:T_B?-_:]1AJ:C#X;L%4[(4,4QRXT!H6YIN1@U:)@8Q)$:Y-@%MV#MH
M3V^O".P' CNM&:P(7#\"VW$_0E2(02"0P!F@9@H<U1ILI#KYR)E#T2\(;EF]
MH%H(PA_L2:F='=C9(#_N\=3%R8#3_4&!T2I5@VX\"7$"L_'9PV+_Z?AD& 97
M][-5;+7P+'4R(4@O'8_>(1=&"R8D<A5"-%QZ\<?A+=MJ-!_^_'PVG=E1L5E-
M4'1(5!<+6J0R+U!&5Z9^9 <!133@\EX#+JF(C 1G:-P[H/MJ07[BVW*%MX;*
MAA*)6P?=F[.,"[%K:. A6IV,<^BU=))P)6U@47M*O+HM=C\[BG"98[S\>Q6F
M2\*TU>5 $Z:\]1&(4AY0BNQ.:"N (S="V"1URAX]L@X&WVX4GQLJ9-XZC"_7
MF]<($SW5AJ"6VJ6@&454GG :*+_UWEQP?3P^R8:</OWO^7!VD87#R7DQW8OQ
MI%S%H]EL,G3G,^M.XLOQ8MU1-_1NF:+5Q)<ZF82A#ER@6?M+CV"DXJ"4H9*B
M9X+KS!1J/\O+NJ/?#[0O4S?T[=OY#:-R*N[[B/MV9P]JI549Z%$F!.2$E$:@
M$E 9SP4:@];N'3"]3Q6_9T["+D)^"<0[&4W2&#1Q$1&ETXXPG=5X<%YX)'6#
MO\] ;Q\3$8(*%A5X34O3!>%!&T\@4)KRC_*R\])T ?>-J1O\]J'=9I!K9RQW
M)"*WQ$DDB6:OCI(HC/*;1GL%])* ;LWA=:5G2O;,P2C!  .)8 ,1@-KS3.4Q
M<E+F\/(:@-L^-&MC='!6,9EW[AB-#<*EB-(:I;6EMN[=]QGJK8-/@0;4BE!(
M+GA U C.*0)6FJS8/%*7V-Z!PGW!5VXE4M'>.[0[&YTAC B"'H6)6GGC3++(
M1#*,;QSM%=!+ KI5:2.8TDVE#4TA[]B9O\'(I, P:RE/@N:]/>_=9.5$?T5S
M[] L38Q!4"(=->AMUEY1:Z&\MTBE8:[NW?<9ZNV2'ATQ.H("2@M=0.4LN.R\
M :4.K<OKS)5K-F^-74T473O<ZVF_K7SG3ISV.XJS<M9O?!H']31?K=?=:AO7
MTWSW8YVJC:N-UZ\\B%(AHN.EDAQ%"HXC"O11Z622<:PY'\"NS@>PKTN0%Y-Q
M&LY^'D^G549T*"/(@O2=XX$%(0@H7@9V^B3!BA(1#$%['4P4PN\=X#ZG?9U9
MM*7XJQS7*XZC1B89C90$6>F%Z K%,<>H#(XP12K']8;C%LR%,!R5*4$2$P #
M8V"C0,@/ 5&\#";6K')<O_'G"M8L3T'SA&B94=%:E=T-RYQ%$5?"7X78DA!K
M)QZ,8,%[#=3[C+.8!%@;/0A!G58F*O39C:!].F!8\?4IOH*3>4>+WAJN,0/-
M2>.L=<$K1X*^/.-;][<^@*^="A V$6Z" N=T.37''.A$!"A43B6M2:2RV>#8
MRB5X]83OM_2 \^/3LTD\CJ/I\$T<G&10#/Y^-)[% <56K?,R^<[[2$JUL^N.
MV;A.![D?ZU1M7&U<;=Q;&R]SZLXGQ_/-AR19PJ2-%MH:BI0%@XE)?@MO_H;C
M=XT_\_A3=^:PR7D71W\^ M"^JPY_APX_75"B+Y.*)F#6V-I;0%06;#(&?))*
MLV08Y;)TR1!&]Z.+=X5GU\'D"L_>P+,5;Q9%;\=DP-HRG-/(#$]M)42?;/2>
M.:=8A6?U4+;-QLM08 ?QQDJ!O:' !8-&B"$R_W]>/6L *?%@0K(@(@W*A" P
MTEYQX$[4J#:U_8/Q68/.8NTWP]G%_F ^K]B^M9,P'=A1&(P+AG:MBG6Y/F4V
ME$-RVI,@6<E"&FN80!.S\YU$Q.4+ IJU*=/48WAR/BFG+9IVJ/.F9<V+SYMU
MFSY]%R=^.(UUDOJ21,46-!RT/' 2(P-!12JGG0V89!0P):A-Z!4)(?/4RH>=
M:^+RWA8_U6+G+A+,W(5 &77)*U\RE)91P0D5V0E,D2??%5_^RYZ<QTJ7W=!E
MJYV;-)&C< QT"JQT>W'@I,_LF5^@/')ED.\=Z%KHL<-\66U<;5QMW%L;WV71
M<]VSU[]GM\+17B65-^J8UTAP0$M#WKVSXE%")4I<))A<W;,KUVVAC>^R +9R
MW0;".:VXLS>8%TYEGI.E9YWD'$S^&43'HU(1J;.R;V2W$X6P+\XG_MA.XV"<
M!K/+V0R#>61U?S"*L_+SI[^^>#$89LB4H3C?-A/Y'J?/:HKR+E.4"X/\P7A=
MDE7"J>P *VZ$3YJSS"+&2L'3K3>%,OGLLXDD\[#^(__?\^$DAL?CZ>Q9G!V/
M0Y.A+#@XO(1!W166VQ7X@G$ERCE&+/$0;%20GPP+AK, DJDRU\X[3TI;M/:>
M<.?5&+5VNM)E+^ER@0.]-JYL7.9;466MZNB21UM#'8CR97X>@630 WK&P B1
M0#B=F-?,<D(RC^Y+W6X7>^=4NJ40K318;;P--MYP_73=:GJUU;2"UB3ZF#@R
MH,([P" T&$\,"!:UTU81QT/=:BH-;IN--UQ#76FP5S38CF>SA,2@$)""H8"*
M"3!.*O!&&,U2XHKWR^7>B3KJ^3SAR[KI,'PS#'$4OBU@?8^S:S6#N6,VKI6P
M]V.=JHVKC3?@?W;>]_?)U4XZWU\;5[2ZF!VZF+B@ W!,6D5A.&C?5$P$#T8X
M =(GPGG26E.^=\#V#24K>)@5A97I^F7C.PDX5J;;'-.U8HHH"9/(**3$%&#B
M$C2A"4RP)B2)1CM3F:XRW;;9^$YBBI7I-L=T[;!A4L&S: (HJ25@=!I<4@FT
M-":BC"E0UBNJVXD:V'DSV/R<EUA[_MSA:##Z;'IB_LE\?&(M?JVYI>VV<:UL
MO!_K5&U<;5QM7&U<;5QMW!.-VL$LH&N] TL!S.(YYHW+/C^Y>3B:^^U/+OWW
M*E27$ZIBP=P@Q?-"&8M@1)2EO"6 H8Z ]DH0E:P2I54J8_VH;:DX7',/SXK#
MS>"P'3 B-'*25RX#D3G &#PXYR0X3!$#T4Z*'@%QRXK,U$(H_F!/2HWEP,X&
M^5&/IRY.!ISN#PJ65BDU<^-)B!.8W]Q#GI<@C,_=21Q<W=/E&V;CLX=E@:;C
MDV'X\&*_26VQ)9<[],M1*9,<HO,1DW26ANQ9"$Z1)IZH^^/PE@T@F@]_?CZ;
MSNRHV*R&O;MCL6=O%S3S1&*H99*!#]$ )I8RB='\17+#1%Y1:YJY"$JTFPY?
M(>J.%,:WI+^Z _*&DF>[QSQ+]AN@T2;AH[1E/JU@:!T7-%%!/7JAC+HM]7Q6
MS'^9>+O\>Y5EEF295C<!K26Q4@I0'".@T11L4!Q42DQ'1Z),99SP HY9.K/6
M+X2O4/Y[Q\S0/^?N;W?W*"SQ"/3+6VLK4$,Y)FMU]M8BJJ TH2S[:C8JI-)*
M>VM7K?#D\?@D&W#Z]+_GP]E%%IDGY\5D+\:3<A6/9K/)T)W/;#;YR_%BC5K]
MNVZ9M]5]V#,GO+4)HF((*'4"K6*F7RE93$(YH<N<6[U/#:\.7D?T7ZF[4O?J
M[NZ"FMIO]G5O&/Q32;R/)-YJ(I.\"]I'#IPX#4@5A7*>'Y23+).[<$+&O0-.
M]_76>-"50BN%KL'[I<YG^#CE/2(*(BTWACJ>O!:FC!JLWN]])L[602WO+)%9
MX( TQ ,&)Z$('4!F+3*E*,\+?2#D/E\P4ZUZOY6Z*W7WQ_MU&)))R5FE-#HE
MK;%&$!M<]H"$LK)ZOUM!XJW1W5S]?_;>M+F)9&D;_BL=//?S!$2H/+U4;W"_
M1'CP+#XQ-C.#.7/@BZ-6JT';44L8\^O?S*KJ59)M@0$9:^(<;*M;W;5D77EE
M5E9F+O(LYR0(<I]0H37)(YV0B&4LSC+0Y2G6FQN$R6K)N3WYW2/HCXV@6P!H
M&-(@""1-$IY1GRDN5)[P)%!"YK"*HCWYO<^XN7)V%PP;F.58$5^RD%!-0Y+E
MB20R93*)8JE]G3]ZG@8#FN1[\KN'[CUT[RYTRRC.<RX#QG-* Y5D2D29S*G/
M_5RG^O8!5G<$W7MTWA*=5\*X<PR]YT%*PH &A%*)/EU 9Z:8+Z*4QS"UCYY'
M_NIAXSTT[Z%Y#\T[ \U)G(A,AQ'76485S_,T\H6O?*&4]"/^S:%YSZKO-&!V
M)>Q?!GFNI50DXKD&6JTUX8%,2,)BGD=9$C)I:76ZI]5W@]WFZ,)/1NSAIRP^
M//]?\\^=#F)R\R"&_O]]-IN6!<[DT[D:L47Q03W#?I/(?+O?"U8J?,"CY^?;
M_%=/4-73JH]N+ EJDJ=!5JF78B+59/&4X"=WC9?9+<;DT?/'P9.O(MBW>?NS
MSJAD!XD=!5AW>CI=3*8+=3^A[NU_AKX8_WO"_LF7+\?'T9MW_Q["O?XIP-Z;
ML[^A';\.3X]>^]#>^/23?/]F?'QY>O868$M$IW^=2QWYF9]0DH1)1BAG&3!+
M'1.?L232+(H"&:*NL$/T]Q3G:[A8S)[^]-/EY>7!1SX?'4SG%S^%OA_]!#I&
M_53=^^CY6;<6H5<8/:6\[0*WDQP49!SX"0]R*IC( I5E<2H$HT&2AU9O!EO7
MA_M=C4 <SN;+'UT7?KZ _')U>G'N1W&0:982$4<QH2%7)!,QR(OP>2Y"F(U0
M;7L,Z$NIT'Y*OVA*PU1&N?0#PD4D<$H%84Q'),H9]8,$ICM.MIW2V ]TF >:
MAY&DN<JS- Q#H8-(9'' M#!3ZN^G]"M-J60!#524DCP*T$O ,Y*S/"0B8[E@
M&2PQ%3YZ'JSAF3=]X($B'N'\.Q ?PHQ@=JT%S@E.B:>8&)K2LT/E72DV+ST%
M3$.NGJPT_P8>FTC\Q3_P&@5ALOT[_5!Z_[.-6777ZL%6D:ZE[W@O?==)W_&G
MDT/0$;X.-0"*R+EV.L)/8N 46<I"K85.\F]J*^\G]<LG-0\43Y(\ BZ>,4+3
M."=<*DI8+'0<)LJ7E&\UJ7>N(O:3NO6D\C2. \D#X@,V$BHUK-1 Y42"_E=1
M(O)(^H^>A^L<$K=6%,;B!?Q?3+^&SGBEE'>*UEK@F>1!R3/WXQ68TH4&LWJR
M\ Z%F"XG"TS[^.=T5(A"E>:N])G[81J!!B$VG8V@<59HX*\#T[/*BGE^#ZWL
M<&]E[\ZR RO[\IS)C .OIB24,2C(* 8K6S"?:$494QAO&K'/M;([!9-PG0@V
M*Q8@TX"3L]&R;&@5+K89FWL?$#=Q]8GV5^'OK7C7';FS6[F+#9[OX7N]'/WU
MZ>2O<Q')7$8L(I)F.:%!R$B69:"B0P9V6YJSD"+-7XU1MB[="J%9B;.]@K5&
M>KXE]][+P)8R$((*IY118->*2,E](-M4$ZXD)TJ$4F>^!MIVG4/F[GG9?A8_
M8Q:9B,$V H,]BC'302A]DNL@(9R%N<_33/@B@I6<;L&[UJ_J%G>Z]\0FJHG-
M@R84)Y?G>1:(-%.< *L XXQJ'_T]$LQNGJ>)GXM<19]+*':%-0(ZC9186-["
MY'1F@ Q$O-- >*$@Q4<R+"3(Y],')0@O#\]CGT69CG(24@&,($(9"'1.$C]@
MF5)HN]-'SUOVT"O,F,7FLO1>SR38:=YC-(E"_]GAJ]?FM^#9$X +@*(@<JMM
MX'U=>\(\\"ERUD+< @9^+29L(@I@N,>3$DS*,<!2Z1'OQ5R!/>?],2VQ ,!W
M,X$ I\ZFLT)X49@\&7B7PP),7;""ER,TBL$*9O"77%JU##;R7"T8/$*"33R?
MP R5VS)Q,"%RL"B"W(\TU31EH,.-*0]&ME#4G'<)\OUYEQU9MF]"7+99EH1*
MIB1,_= ZUW*:QR2A4OL!SWT_P!KL-_!XN9SCDJZ<*!M\**CXG:KOZO_[H_CI
M7O'_Y]-[Z,MKZ--?X>G98?SR[/C<SX-,I2HE*M09H6".$Y[F*=@#-(ZD+UCJ
M^WL6\+"DXN1< 9*$?B;!(HP%<,-0$*YY )0@@4_#,$^U#Y3@U6M4\QD)PMU4
M\V=L?J%091Z/9_/I!V75/"A,%(06H4%/[A]3$)NCY=PX<+T7J(P8RLSW)P$Y
MI4]NB=-!R[F=]9S;MKP1\!WH(R:N_:-@O!@5BP+:B_;=*S5C<V1S;F"V<G??
M2CF,83J*22N\KZ,<DH,TKK7#\__E\Y]6[<L[GH; O]4\X) "#YJ.X=U7. O8
M/R-'P%E,#*+9K- UJ2P7\($1MH.-)K)[ \5@OM5(O\M"+H95@'#K6V[L_.8K
MC$,+EHO-7VD%0 J%Q.JN@?F6HY@%W;%H_XO--:HX2OPHR_T4V*BB@5(L5KG0
MJ6 B#V))Z7D09(^J;PWG#>VX4(3/%7M/F(8N/F6C2W95/OJI*W\@?.UAWS1B
ME1(Q\:)=N5PS:%I_M4&SZP/X[M3"TM,E+)6YC?/\7[8S;?&&<[0B_L\M9@_(
MQ/-C^.)'7#TOVJNG,<E>U:OG?W]BFS!@'4!\,YA8">0W GY:H<(M^G7K/FVQ
M,L+@T4V,/$S[C!P_^>J L'Z\@H.OHEMO]?8N40SR@[C:9 13Z70YAF>*.RBG
MT#6*?V9E4;[4?X)I"V-O5M'A1+8VG1M*4FTYG\'[?QZ9HIS?UU3!]QA2.O5/
MSOX*3][]/'QY-GJ')R+>OCN^>OG;FZNW9V_B-V<_%T RK]X>G40G?5+Z[J^/
MIT=OKH#(QO .(*Y_CT_>'=.W[_XU.GTW&I[\=NR?GOWK_<DG<?6?3Q?AR=D)
M/<^B1-"4^23/%>8CHX*P*/")SI1F.0\"GW/KS"@F2R4/T5? (S^1<1BQS(\H
M"V4>*OC/SV6:YRP+DD>>*@6;H6Z<+P%*;]CV]RH3VLG%-I $7W1ML[S23.+-
M[>OV)PWC.,D"%G.N::AXGN@@B4(!(Z+3'+?KOBKH;23=ZY?U$0SNO*AMK)^7
M)=Q2EM;MX&T'?=^'J;SX]ROO=\5&BR% ^7SF%-X H!VL"231EP5<*L X*)>\
M+&3!YB@FCZ%]:&<"?QM=#3SG$VT>YERC'O!HI/'5=4LK*[_IP!NRTAM/YPIN
M@JYO#J%=P#W]H[M!0*5BW*>IHCF/6<;3- CRF%,6@Z1MV% /^T %@@Y&Q4O]
M"M]1WLX+YS\XA/J%GER>)S&+A. Y85F4X59J3G(641)SH4.5*.TS(*SYP%]S
MNM;Z;4<>X+N1L')PFXD7(+"%Z,U\%N4,@%(+QB35L69AE*<YS+5((N5'F])U
MAIW2/F[6_V&C]\>3$R7Q?-$+\[:]#&R0@>./IX?GJ<\""J2,:.5K0ID("(LU
M"$*,H?! V$(_PZQ!P3H9N(31!C;FC>UX>W9Z0128-U(,.8HW&S(8>W'E<351
M&G$'( XL'@=$TP_PVT9QF:GI;-0'BKL(CJW$Y4_7NC]'#(0&/[NEM'QWO_VW
MEQ;Z\O <9$3X2<A('.J84!Z'A$N?DQ2F@PN>J3S!;?LUI;_K;?H9##4(C!EK
M*P/JX\Q6L?'*F4)K8W'5B(UQ$""^&#\/@QE%44/C!'AH >JHOE,P@!_N-#9<
MG7_ 1]X"E&8 8,!I[T3,CD]_72MG]A7E*VB5DG^J^1O%YAU)0P\N2MOE="ZA
M9P\8EO[Z>')Q'H4R3$#O$#^3.3IQ$Y+E4A*>AGF:,1G!Y4?/IQ-5R=6JP+EI
M+;T90 SZ'0^\,Z NCK-X,%U3(R7&A0BL>@%3B'+U'='(O,#*R!Z&-DA'=/+7
M.>5Y&B9 7"(@" 3#P<#$2C*21#XP"<&B5--'SZ/X&A0R0PW ,)\N+X;>8LXJ
MY_# ^P"0 R;N_,J&DP+VH.U$9#$'@@P",K3TNJB]T;/Y%#>T+415X=\&@(0"
M95A4N\<MI+,,!:#I4'X TPT4(M@;6LW-!KA%NDJ#FAI?;(2R7G_K3S9?>$?P
MXI:](N?+"XNN54C#GT=_5M2\*_M<C0J%@H_ZN !IOIBS5L_,*\93J=!3;BLA
MENA$1EQ=3+W_+L&:6EC '8!0C\!H "SG:K& E>:>,5TNQ'3LW/.CZ27>@<J>
MC4:=UXAIN<[3O(.6%0Z@F,Y!1CX4\V7IR:+$D<%=I+P>\A<O_WU\1(*\#B7!
M[N,H*Q"A"^-_A]9\ *.+(315MC(.:P%S(Q;&O%+P^72,=ID[(_#ZX-6!>=34
MV'#&S#=V&S.I",P]H#E&TLZS>Q1\N6J/A\$6C02X?9&RUI<HIU, 2F:\!S9<
M SX2K!QZ&J;/SF.S2P -M O&G&O8\A3# &/U+A5( BO;>S'PW@LV-T(OU!S#
M0G#%V$5GNU1>TR=8:&92Q!*Z(ZNE#7((O\*57SX."UXLO#P_".Z%O!U/<)0G
MRFJAVFQ'^6EFRJY2LR]LHVMP0'0Q+Q>X3.>X(&'$8-"C07NL8*3-KHJRHH/;
M0VY/!F\WW@%U4>\XSNT>M#><7IIK+X:%TM[+NA$PWT6)WSUA[^&%C]L>@I='
M)_5:F*L/A;KL3CG*A+4([!9W)9 'WF%I0H50$NTR@$ETS<:6=?N##U2(FC@\
MSO_QRB%PU9<J& ECD-Q>(/8.=U<+(W3,TTL02@!U \<KMHMK*#ZKP=B?F_[5
M7'5@V44-C6W J_1"-5G]%;EB2P':+ !QT2UCP,1^;0C@VEE'MAL*=U<Q+,DT
MLF[0@7?<=+H[<HCOBWKH*H/(^W]L/'MF=@-0^7G_P%L<K^Z-I3M<@7+A7 (6
M\2<7!*1O;#M=CZ23W(K/5\JRH?NUUFQ#1/-L#?B[\(S_J/4L1+VB;ANL%?P>
MSH ;E.;Y,,$:KMK1J68"3VHM9[/IW*+O!O&I9ZBQ4JSP0K-,:I=6+RM5CEO:
MMDT-=+:E'_UE7"E$/H#:17NQ04M N8@A"N-6"O+K[@.X_ORM<+@J9_^5_?=!
M._R/WE^=J\S7/!,4Z_=)0M,T(#QC.8EE&.5*Y4!,T[Z#/ IDKK74(LA@<G+)
M92BD9HE*M9 RIGV'__=32+].1\ $JDB.:K&U(!D #^DH1S3A0/8&:P%NLU?8
M/O%N2X&W#/*^A]C*,(*E$^IR;Y&O=Q9_@I_G$<MDAO:6B#&_>*0I85SDQ!>A
M\A,I5*2R1\_U=#E?YRRNAKHA%J@7 /ZTD:KR:;UK@9__[)R%@SX8#V[64 C*
MU=:'^LE$#E7:"A_=R"A80=/+@UW9U=DR/&S=:%7*9D<([%FC2[O-K*##*G"T
M8H#73U1E[$R,;JSQHK*#I>%2A2YZAFKM6*X84&F-H&M?C8H7W]6GHL W08 =
M*1BJT:QR5:(9;WT!([O[;1DY/*.8=YH#K= @AL:7@)LB0(FM$]*^"AHO'5TN
M$26->=)[QBW:;Q@&$F0^GS+94-9OY,AP)'504Q[T TSPU"U^DZLAV,BP_FI3
M']T2.!B.V[9X-*BV.I1OL,XM@@^L/WX%-,UQ6_?(/X_^+%OW%#TG1O.BJANW
M&-PV=91H5X-54T44&EM)34HG,G(,++U<S$WD6XM1.K^2L99 $X*U?M5YYS_=
MA[YH/[3V85<VQFUNKHV0V1R]XBY.M 2-51M/]7/A:_]:CJZ: /D;AZ1>C&!<
M+\#RF#?9S-1X-II> 0!C5L29D1)8J85<&O$WV\HPB^5BB0("G\S *B4+P!DS
M:V"?SZ$E;HP'/7GIK2N[NNMAJ3]I]I\OT,5DN A(&1*+LOT9*6<8W31'@\.^
M8 0KL&JY:0]ZZ!;S E&IZS(#6H[O1C_-ZG)Y? E*!E8XB$Z):PR>-4*C -;G
MF+V;SM%;YL!M7I3O33AJM1;PK6[M- ZQ)PB)KILFZE7):@?>. <WB)UPD;\K
M+3-'W]$UZ$;@:[3S\-6+@ZJ1'6M3 5:9R +O7VRR1#BR/J&V%6J".YTWHA$@
M;[;DH Y7@4I]=(918X?;.W^I+M3KH;@V#@$FNL<WM9^J, 6F$T0IS5.1^W[.
MA0@BF66*QL'M^2:Z]H_KOM@&VD56!S+7S6VB%E#T]CQT+0\]@7=>G.M,TBB-
M@'C&4A$J!2/,AS\%%4*FOJ]C$3]Z;HC(*A$U,][@LW-BH'88C4K/+36+#I[5
MDX!.9M'7,EGIT1Y 5!+<%\2M!5 %.0N8C+2?^-3/:!Z&.O+#A 9^%*=Y; 0P
MJ@00?KE3 3RLH^3WHGB=*%Z='KT_!YL^]JGD1/ P(#3,-<DSWR>ADB',% 4I
MS3>91*WC"$XHU^)D=,\-E-J+MK.V2=_/5S&-<L4?_.?/)VT?[XWN71/MLI4[
M%W=X++._P9W;:4K-Q8R*AY87%Y/^=F*+,:!.QD6]'*&,-11Y4#E9:S_F1"V0
MF:VCT;:Q-[M"&]J]T0-=C[<=(UP0]4NJ3;:U+:C&%EI1[R)8 C]IN93ACY^
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ME /?XLIB#O^7U9O=Y0-SZ:>%7+V6I >Y'V^\[!\$&Z]=]]CL /#BLYYZ_36
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MJ=M HQ1L;5^3J%\M3.^PZBQ6IJSS<SXUWP(@=$/=).AO"02,N4-9-MDH:,\
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MM2[]8#-ZXN#*^V/*)KLRG76C1M..%^)6J8-Q6LU4F4G%NY>3&=:P;SBI^\;
M3!\2Z6LUVH'7:8^3+5:Y4ZXLF$V-F3$=C]%&;..PO5SY3]INDW4E*+;PDK0+
M:*!N,4RV,GE,B433VG)H"FV#+AZQN3<ORO<HV>@3@LG!$N=&40R\0GOE=-#3
ML[?*8_]PT\;3'4\;?V,:^)[?7',N I]1$:0)Y5&:18%6>4JC)($/E-Q4O^IF
M?WOW/2K(<^;'*HQC285(,P6Z-PMX"JWC6B??,[DY;GS.7*U1NX),(0NS<&;3
MZ<B97T9Q(#.K*7</--K+LW$K+#JIT_L+T3QZC0-CF]7\U&[MXNUD,25.:^%D
M =6<S;%<,)KO5S.P/=7!Q<$ $% 7B(:VG#C8NU6IWD'E4RC8Z,F@[52HZIH/
M &H%0P?YO"X@5K^C=FC<#_;^HID_W.A4\P^.)+1L34?&W4T([&.8H:FT#'.\
M'"T*)(SEM7K'%&)F3KPJS="6,"."Q@,R:9'WYITPO(A[@"M6S-9=:<D<(.S0
M^:N<J)H7FV^5ZH,R2JPR%F#V>,M@-7=*I1ET[<!# P=>44RED=6YZM>D9*Z0
MD7$-P<U3;@JOU):S)?VNK'7EOP>SH:S*4[L&UH9*RRGFI!4&!]HM@7*AN%=E
M?0>>&L]&4Z-QGW1-*LO';=7@U@BX(2O;EHHKW.2:M+X=W5'@Z@JNK"_0^14'
MHV\T8LR$Z<D00&"*]4Y'[2X6DUJ(KX.L^[!*&S^9-8_1_H55@XY84Q0,Q'>D
MQE9N'Q<'"B3&E$+JR;43Z2<X+R84PWI$W=(HRMK_Y@Q)Y^HMG/-)C?L^EJ*:
MS\70\=9*Y9EY 7E!/Y%GDM9[MLIU<5'@QE*_!3A/9=LA6'>TW;FRZIUQZQO'
M2>(#U[S"YL&P_7?I !Q09_)^OIPMA/$,%^8Q KTMZ-A&@;.56)[T=BO,P!K7
MDO/ F(S<M1$_G33:T>'&FH<:_%R Q"^<'Q:5S'(^L9X%AXOWU'1Z:53SS=OU
MWWJ%V':UK::U6]T=)K):X^16A:*Z14LBY/V=$O!9%6L*/ ):\I3@)]^)K)OX
MHZ0.>?OV3>B-#3TP-6/^G!<?4',KZ\) !!DJ>6'+!]8N5&1D$]#EPV)6>UAQ
M:;FZ<,J$&CAV8N#*/LV1$S1QZS+:!]YK@T' .DIW@]4FPJ6X[.Q;=_QMW>B"
M[GU]/YUK 1;!-LVN[K-5.\Q[6H^V\6> (1\*V7B,797OJO<(7W;;8[[:.J<2
M-Q4CMT/6*AN.@[>4.+@'WN%J;-L"BV#7NU* 9ZJ8U1<=04?KI^7][[?>3*!K
MKVU=-PC M*%I45U;%R-[9S9,KU5(TQNQBZY1 5J_4)=EYY$H!:U=5>"D(V ;
M"^^_2QA"'/>J?%UA]C-MC(C33<RZ.(%[7@RG2^LZN5)L7GWFR:(4R[(T9*S9
MNI!(*D!],7SBH.XPON@GLQ/9F<.RWL:H]X05JC>X_Y+934?4OTT7S#[GFF6P
MQB%<UBTMC.L5A\=M1L*_AN;!-'ZHULAU#UU?PWBQ2<2,CV?0:[G92><=CR&O
M=E&L%3&WY1F-'%VS!-<TM/)!P;- ;F?("YTY>6$HI_5+MCSE-N1@#^1?#\@;
M(H ,?X2&FQ&*>CNL"DRZC0]S@?4F050*M_-9+MK%006;(4NIHY/*VI.)(2J*
M8("*Q0*S\T20'9*F>J\$=@9=ZGFV,>S*O=)()#:XWLUI- NN=!P)@H^H%$Q'
M+306Z[)4>CFJ-YN,S6MVP6SPB\&P>J1ZFJ8R7W&7!L,]H#<$X[P&5719$^9E
M&?>EU0JX]/O+:-YVX)N-QJ:-&-YB:_J6?:=J@\W-CECK079,S, #@EJ'C>/J
M9F=K-K-JCE7S57QRV\2VM]C%=\N)!0"[XV"VL6T-.8QR;JL7T%*+2C,U6W=F
M0'I!1UPM+G'OJKK!!("+QCCIC4X_4L*K(X\J,;M J]4$');KC,1>3:4]8FQ)
M_4979#9B @W]_C96F^IM!Q]FZ]R(>J.1T/\W6IJ*W*"SE^CCY*4RAF)GT](
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MP 5HUGW#U58NQZH3!-'$EZ#_&)8X+*)WQI<Y'6#X QHQKOOV; [2]?%R[%V
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M&<;*I0^VN=7+)]X"8W5@]K9!CR^M3YRM%D)J>GT[@,@?'D#X)^_$Y;GT*4"
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MHLC^+8/-JS3WURDK-KRKU_2'/,%7<_^W.+VA 4'??8K3O#X@*P4W*( H?AM
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M/Y/L^+\\ORP^Q<@#2A/($L"QW@BR]$RL(F@;*V&CH#@N,93Q#Z5:6W;P=U$
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M"5C=IQ+ F7V:X]J%J=6&*OQ^K;A?#E](BD./-T8"RY)N3[=89Y>MKMRFWZ5
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M'OU[-ZE;PCS&7FL=J%%"44HT-5AY&YS!9B#]@R?]=3N!",HQI!CPCF) E;9
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MP D50)X$0[GFTJ'49%X=LWO+R1J ;@"Z_5KY[YOQ,@#=PP/=AL>,XM2?&P:
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M!F*/J=5'^G-4"BREH1SB5+]1Z\"U1Y!*=G/1XUIJ'92(>Z+BS5Z?43544CN
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M!) "84"Y)4 3Z@ TV-)@@Q(TE1,\)G@SE>>0VSD\=02X36\J8X)62$:U7D4
M0!*F7GM!1Y&?0B_VH 7R0/=WMNIM>"2$B)0O# '<<0\HC.I]ZD\&@E&0I7A*
MX_C1J3R6>Z79WV<H/\(G>.]=$N]G2SVYK>_'S.;.S\%R=O$B+78QFXS=J)GL
MDVY4<^L->#HP?N]9#!6V%P,6WR,6_[;%PZ("Y<9C!H)3#%"E&5!>1#Q&2"BE
M*8421RC&Q^CNC6AN2R"/' @R(-V = ^? 3(@W<,@W:8["2JGN$7 .N= *AD
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M7CAC4C&FH(OB&(SLF2F6&BLH*Z"ATGOZ^,+9 &1W=@1L%.R#&$L?^17@"!M
MK=&I(C,$5%"NB3(<4W=TBJ*R">6=^[;>(YX]MTS"2#73Y>C=<C;W.P,Q#BV/
M[_XQS!"EG/9"X("B5&:DQ!(3SB$3&*K!CWG(\ 6W^#%E5"^IC+HEQ%0#JBP&
MD@H-=)2[A$$&$<WN3<&\!D$>.P-PH'S%9>H=3U&@AFJ&#57&".&8#R80MP?2
MRT#Y=Z#\#9>?DM():RP0,$2Y)0JNP&#K@'<4(11%&L;\0/G/@?))@!'MG7,,
M2AIOA218!*\09II#@=7C4_Z@M]R5_#=<9(;"H*.$!SQW&% I C#!.:"]I<);
MCSA*??_4,6=LH/XG3/W0$.2M"$@20ZWCRG%"@Z1.>AK% ?_XU#_P_3L0_H9+
M*2C,(146($$%H(198(2G +D@'#2".@4'OO\<*-\[*SQ!6E-J*>10ZBCS0\^T
M\88K* ;*/VC*W_"Y$(HEHU #QAV-E$\]D)9I8)1B-GYBA24#Y3\'RG<<&6@D
MT8PH2C2,FC[4"&'J8(">[@'E#Q+_G4U]&YX*'@QA1D61'W,$J-88:(8ML"S)
M_ PB@M$>BOS/+GNLTM,W>2GVL2CO T@N6ID0<<KHQ,6XT$' H+2BR"H&W6"Q
M.'3\0EM<%98RQ*VFP!+H(WPQ 712813A0<9+X"771Z=<'1-X7XW1]BAN9*#^
M+@@VZBO6*RPACC\9(PVC!@M&,48^"C2/3_V#WG('PM_P5#@-K0A: V1-)'RE
M.3"68,"<Q)99[KC73S@(=J#\+F;4&F>DTYXK3:VGQAK*().>"0Z)W(-DGH'R
M[T#Y&TX*Y;BVG@?@A8L:BR((&"XAD"(8PZ3C[AXM%@/E[S'E<TT%#XGP@Z66
M4PF5@E@S9;QWENO'H?R!PF])X1O>",:)(9Q3P"WG*?M8 4V@ %YJH@U6@@4?
MA?HGF',\$'=7/$4B$R+4>Q>)VV-EF,'8<2-Y_,W;0: _;*+?=$1 K;1##$#-
M**#,2* MCY3/ Z50:$Z-&]CZ<Z!\'(*U$$HC6: (&^V%,DBF CHD"+@'X<:#
M(>_.AKP-1X2.^IK#W@#)(ZM/2<Q 2\N -PQ9A1RU3!1+'M^G]/SGEC$1*6@T
MGG[RB^6YGZ8?;229(7=BMUU2,2TE(8(&0JUV1FJC(V@Q$A$.\YM[)9K&!O$
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M'EHMKWOOC,LMDLH+BZRC(2B%:7#6$:L99-;?Q0$^2 +W)@E<;>MRR35'41H
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M[O:O];@%B-,:_G,#)@0S&AUW3T]QA/C$8_A/#__ .8[2%7")\2?=?G<T'B8
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MYJB1A-(<"TH9)QB"(\P'Y6EFI)-J2>,N0,,6O/#*6Q$SJPOK-65& UW )TN
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MTM2>WUL\O^\N"/6NYW&M<V N"E WH[!5A6\9ONR/QD.0NAO)P9(<&J:/V>'
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M=%M,41S8*@\1#M5H@@V]86;SRDJ2Y M9=Z?F?,6I,]/QIK*SD 3 ]W/[[],
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MLEIF20"AP0GV)IJ;C[N09O]0<V%YL#GQUA4$9#[H5%8)PD.(WBL0/50L9C:
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M3YE3;02_C>#?=03_37G66O%[(_'[HA2]202_YCM[K^G.V:&STK*"1<*#%2"
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M5GLPQ3FLN0E@"#-A<E&@_^@*%M J'NNC>.P=FVX/N<K<5"MJ6),97J6-;",
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MJQ=_QW:M?_WU'X?U7N2/_WPI?CS^3OWKQ5OSWQ^^??_JS8\_1:FBE20@:R9
MXQF"10<AY*)=4H%BWCNP(@SH>U*A<U3_LC]YVSR8.N77+LPDT>FT*=C>TO3D
M;"SKHQ^ K73QO'[S]Y]TT,8*\A"R+8#!$03/"HA,MM:33"+=ENYQO70F=)+O
M7CU']75>+)\;(L++J[VZ.*[TF"[_W5;0].2"%I?_>).ZHF9L^^%PLWPWS>>'
MUX;L1]^ZLB[$'U^A6%GTXOSNKWQD0Z3*\SQ_>GM\L?E)@3>&ZZ,_#^=_;-ZM
M<6@=\U^ 6N#M.1V]H_=G>__QR4,=3T_@XQ&\^?"7CWCPO^.\?N^67[TQ,Y<H
MB<6ADJ$2C@A(-L4H4E$9H]1(F.,E']3O</ZZ 4\*PSXX83 3IFB#<RRS5:R,
MS*45'OZL5;(>&^3V1T^Y$I?)2E,@M,:'Z@"IE$4T%')HZ1*;Q)2?2;7I3/D[
M4WYX^>''G[)C6[*)X'72@-$KB*P]2&*E?%VRVM#>@?G<+MNXDNZPT^0CV&DA
M2%GAZ%%SK+"K-H*H"+5"FV($"]V]]:=:0*]?O/W)ZL26E <O6KH&>@,QZ@QU
M/B+%X&0H;N_ VV%X_K'LM,=:']U.6^7B$2]__O$G42>(?8S5)X\6L 2$*$L!
M1=(E&PQ+KHLGW+UV[FNH;=+ZZ;O7O=;/JY_?_I2Y^H(^$R1;8K7SLZM&(Q60
MF%ST7FC+K4[TW<OG'<]Y,CU)1Q>YKIOIR>3\M@RG_4F\J/^^.#V=S<_O/OYX
M-OGFD$[>UA57+W3"YW<SVK]?KLS_-:FW<'[(9_SQ!DGUEMK9R9S+$:?SR_NB
M/Y;+9+9H5I-FQZ=S/N23L^HPM&>8'?/EA?_7LUM<CYN'97=;R)]X,9]"(T>+
MU8!+%+1'2;K:O)&J(UY'6V1OPD\OFF$G9*N,\[N%]RDJ_CAQ.OOFB,[.IF7*
M^3_??U-_ILW.!1V]I/,V%.]?U(=]T_#SIO[^?Q[-TB\[M\K3NY<?TD^"D^6Z
MGB&'%B?T#L&3D1 *H1>VJ!#*WH0K%YPV?V]^P6O*$5PX&&\.>4+7^LFZ?,[.
M%R3]J;UWTRB\RWY4"S2<'<[>G4PB'\W>3>+[Q9*\6BN3XZO%<GU>^,FK[<K'
M]'Z2IZ54Q)3Y[/BV+[>/Q;JH+S[%8?MFY'8@68>T?F'.>;_B^.BH07#>*BZ>
MTK2^5/_^T?EF1>(YG^2SRB3U8D='U=2]NN;[^I5I^_#LC[N^\PS[F.9OJX_;
M#LW-PE5<'.O_<0RP""74*3VBTS-^?OV7KZ[3!:<GBXE9?.FKJVM=G1W<<@"_
M."*X?/L/3_J9N/2FK_):KW[YZNUGB[=NA$8NWW/X+"A]Y]OBF;SSO<]=5HIG
M)I@ONNSGWZM,]C@WZ^]UV3_)'?[2%.&5(C]< W]QP>=M(YNF3ZC W9:;N[C7
M:JK,YHL]Z/G%25VTEX&>[TZNM^#[5"G]S"!<'FD]\3!\YJ'WKJ*'ORO(%QML
MDY$_X#GOK.BPH4/RE\;]BX'XK[8!?#(23YT[OPXIPHNZZ5VS/C^_QT+XLR#S
MYV/(]U@^7U[L?%4WN0GS=HL08)4EIMTS-_8*TW_CZEF?5Z^F>BH\><\T7Z:^
MQK9)JFY[Q.T111F;?%$Z%N^18PA.BR185(QGH6-<33C\Y>\F^#^GYX?3D]<G
M_&-=99\D8&WW&<B57.JWU__\O[_4SWUX]>8OAR^/OQ.O_OEJ^OK-+^KUF\/#
MEW^MGWWQPV__^NO+=Z^^ORF7^M;\>-R\R)?RY3^_??_CSTU6]9UY_>9'\_JO
MW[ZKGB36:_[RXX>OY7]_^.XJP^K;\Y<__RA?_OQW_9//@3(+!QY- 8Q)08P^
M@#6F>!4X,E]U*-["HI>=OCI]K9Z^FL&[,'4[=:V4NM[?H*Z<.6HE/)#BU)*4
M&&+2#%H45=B3E<$LJ$N,B;I6V5Q] VS(UU>68[4CZU.]/9R4=F#=7KG;]]_Y
MEDI/35^+)/<Z4V\NY^@O=8H:D9UU0^R1V.SET! KQMF<=82B*0"ZZ"!J;<!)
M1T)2D4[;O0.[;\(P(ZCW1^S07S'TNQ'S.+"_:<1HY=A&,B!L:W+>(MG!EPS2
MLD4,T93@&^S5+8F V]%K;0.,F 5(/K)<?C=FSOED"5MF)\HPKX70&HU=,=H;
M/NFVS&.2VM^'M@Q%H7.=9/"M1!JF8B$(H2K',=FDZ^PC[QW@O@]#:>G&'RIU
MZ(\-^MV6>1S8W[1ER#B5"R*PR09020ODN%HUSMD40K$E+V"/0HX(]CMV(//7
M.5.S9A9QO>7LE^Z0/1:)=:/ED=GKAZ'1PNQ,M5(*%"L+H*_L%8L*H*TU*7K6
M6:;&7JH?P'2\/Q+>NZ7R.%B_::FD[%!%$8&BS("9$I","0*K$(BT"DA[!WK?
M^:6[PHWOU&74YLD_^&S:*G5,FT*[;GYO%QG!]<GNU]Q^YWVNP%$$3(HH1$PZ
M^F38^!*+R3H[ZQ\C\CV[./^^CN@1?YR\<<-TZ8SU ,;Z<6B=&%ML4)*J,R4T
MH)05%3%GT+*=(&,)GBMC>1Q3J+L?J&PKN#^R4SJP'P;LFZ:(9%7GSC$4V8J<
MD_9 @@HDAR):HVR=TKT#9]R(@+T+LOUO9L?'/$^/8(?LA!N5BC!>IM891:&H
MW)1]%%B2XTA$0JS+#NENU:JX+ V-E-#2Y9/)8%6IEDI3LT3=9'F84WW+6"?B
M:LN&]R.4COU[F2D=]RO$_4T;1@AO<RLAU,[- (,T0"4$$*5DH0O98'+#O9!+
M-^[MQRD/D]\NJD70V1F?]U.4!S!8]-:SBYEC0.U\]*JZ6"*S\]I33-UZV706
M>SNT7I(S06<4X%0K9I5+@B!C*R\3?0[&)M>D>&H_+%\UNA^R=.QWZV5-N+]I
MO?ALG76)H;!R@$5&\"XBB%B-#>%2K"9,P[V78\+]+IS!O&GUN-;8XV++4CY[
M$Y!'C_KWSJ)C(_Q?AH:>TZXH+DV/K J@- JBE *"]]%YYPP6L>@K*NRJPO_K
M[P_26S!U]MUV]NU%G=?"KS<-:N.XM![-(&54E5^] /*Z&M144).V2J;&KV)?
M^:WNOW2S)<1G"Z\^9LG..ROWW5[$\^5UO/,_+T\,6P7/RX/$KQ<'B5<O?S\\
M2'ST)_GL?5=CJI47O:W?T/Q>LK+/5"*]K!5\=G91OQ#?+W[CK[.Z($X6[9->
M+6H<UFM?#UT;J44KI46)\_;IOW!NW9$^_]'K<J+7'_X_K:SOWV9U*'__]#>S
M^>E53<7%Q"2:S]]/ZCLGZ?WD[07-J1)K>Y3Z'O]V6F=\>MXN.SV^^OM'G[EZ
MD!^>??_LHZ?Y\^Y+2XSP(;7U-*'Z8^UITL+FG?S/15V:Y^\G5VV@ZB1^_?77
ME[T%)I=3WI;AU7?RQ=7CMQXLGZE7+&.Q.:M*0JX@AQ#)*:M2$447D>3GZA6G
M7\_^Q)3_Y]5=?7UY4R^N[NEUN6.7J6LZ/:]WWK(M-G1?^?)*QG7O>?/+3YSK
M/H]L0>9F=ENMP7MVD+6N>WR(DEW>.S#/W$WBO$Q1&9;+70^9_FG]XV&OLWLH
M22HP?N7)99'4]PT#1Q7UB^I[YXLJR*VV+\_/ZG>N<H]G%Y>=U7ZH9E4CXW,Z
MY[-GD^_KSC0M=9>JK'1,\U^X@C_6A_EU44%X>G)Z<7XVN5A<9W95D7E0@_RJ
M)/JB@GY]O:[PALV&QM/Y+%*<+K"Z*.1<Z.+H?H3QZ4\\(0UP+,9HGZRGC$$Y
MKXJW+ /)A,D$V6G@R6@ 7[Y(/R6C7$!MJ[TM$F".!4@C@RB"=/&I5/NPT8#=
M,AJ8?2X4>PE_JHB<3_D27!]Q06H5OL\7%L&_\[.WS_8G=%%-SUE%(E\2Q?XU
MA*HYD.M>G'BZ0'Q]X[#9$/P_%PU8EZ2R,!O^(*7%B_]KM=31F.GBA*O-,7M_
MV6"RWO_^.!AE64(1)D6;C$BQKEM%1)D8J=1_EOJJMYU0GHI07KY_^>'KG]BZ
M%#P+R,4R8"D&2&:$3-E*9&=#:NJ39^)60KG!)[>V[?LLP^QP3S\S\IY^?]JC
M[T9/OXBJ8IM$D%JB5$PI^RPHFVB$<]GO/79_E._3(>>+(WY=/NT(]/KDH\XI
M.]\6Y=6;ES]%89S32@.IX@!)F;:I9E#5Z=-.Z6*%O3F]1!R-:4W!)2):21YM
M+"G9.N.:I1]/&Y7O+X[K#KSHH7+9^*2Y &U/O=DZY>/>(X=\='<O/K78]5KO
MJDN?XJKW4=LR[^B=-;EFI&IMO'T[Y[>+]D-71P9'?/+V_'!QVE*?>_'2](\5
M>FG-1.:315>E]GN_T]L6-CU1ZIG3=[_]I7U$[+. 7W;5I^]Y8I]I8S?D7MTS
MHS:EE\PFK0'SS+DOO9^^!K9C#=AGPGY9^Z>UK &]TC9-=VHJI=G,UCU_- "1
M:G)</W[XD(9-6S<<GY1.ZB-RJT!OYSN:[4_XM\2GYY.3BV:$-Q/Y'AD7'RER
MOK!_TE,NCIO-YF]?'*\6 [#PV&=E\7^7'LDM<>,EA^,^_:JV9EB;+/R.=FI]
M".\WA'\<KBP&\F^+?KRK;=&W/8/58=QA/,XA[##N,%[WL'88/P&,MRO7Z?91
MN#ZUGUP?V/=.L?TF^TWVF^PW.::;W(6B(2\^#3)_6<_R^]8;>.)K;,+XWYX"
MTT=L4T:L7Z-?8^.NL6-M4!8Y3V__R.#J-3UOINE>C<C[FS6(E97>%>5*D*BC
M\)%CC,4G*='JNXK[???J+P\KE?#-I7)O=G'VJ1+R_[O2D;70])M#.I'JY2(*
M>WF\];I<OW_V>QJOV%"%Y&4:[^EA?4__^.'MAY<?_O[N]8NOQ:OCE[_]^.8E
M_FOQW^&T_G?T\DU2/]Y,XSW^R^&KG_//KU^\_/#JQ=?X\L7?U8\?_G+X\D/]
M?/WO]5__;_WOAWH?_SJ\M8N;(6$"60T840#FG,&380@^A1P%^\QA[\#(I7NX
MC:^6Y](X'QW?/;A.P796&O@R]GIHG9>'DM<NU"-X0B*[68^ HY<)HX. 7-G,
MA  ^(T.VJ=0UD&26U,J36K6J<@2=RCJ5[2:5?9W2Q?%%RU;,EY6L.GD]B+Q>
M#7KI<M%DHP!==  47*TPY208D9)5*1.;5E/=XO915_>\QNAY72/]]?QOLY.W
M/.^>U]*8OVFP9&D*8W$08[55$$-K3U<,M-D-1BHJR>\=Z*5[/8T/\MU:Z=;*
M(UHK-[FKFR</I*K7@UJ:2B=*P4%*>M'R!2$D+\ %R8HH6R%<-4_"TAV_.U=U
MKMIIKNJ>U9+'0HVV%O3UG7KUYCOQZMU/7B=1B PPD88ZU1*\21H<%8'%&_:I
M'0R-J6E-=ZTVV+6Z'>C=@5H>VB]O0MN0+TH5"1:S >2,X+-.X%4JRN;LBS1[
M!\9LX;%)MTNZ7;*$77([2?40U6H)ZX>;A*6B#M9H \JJ=N;C/7@L!"8*&4I.
M2-JV()67W97JE-4IZ\\IJSM,RY)4NDE2R6/UC9C!L:L.4V:"F!.#)Q>]C$;&
M(IO#-*;VOBM2[&^*L/&R$/3^Y+BB,DU/6_G3Z54Y^--9^T>]S\G91<S37Z=G
MS=OH74 _ZQHZTM)F#D1&(LH8='$R4Q;UY10%=;WC1M+;#T.](X;HDD\!% 6L
MY!8MM",@<-DZ5ZR(WH:] V^6UCOV[I]CP?S08/DRN'>!X$8A_V:\W7HT6A0)
M2?MV#LRA(E_G)GQ6-@7KC%3-]])N3!U ._9W OO=C5D.[0-%G::83% !,HK6
MA\89\([J9I^"4L%7,T#5?3XLK:[I4!\+U,=MVG=!W<HA?W.#+U;'8,A#S*@
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MK#!%(M]'SJ_J#)[&O8U[&_?>U,DG3=-='[+]L$BV$JP5GG,61:Z%PB-G08;
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M< @.2_*:IZ!Y5!IR\)GT!0@:0@H^*=L1G)@3W"5R2QO!W0#!'2\0'!89I#/
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M2[*D]P5?"^BO[*B1-7*A-NB>*/N!5,,<->D-26NA2(?D)G7G;QI!*Z$I^^L
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MD:XFJ*^)ZT5!3<:32(;$,[B:%Z !69 %&)1:PAF=#=&MGZ!^:"$"+P^V<3R
MR00/6F3 %>H4(5F10BFON@/TH@^8BH"ZJY@-:2)-_5A+FOKYJ*.H3@5Y+K=>
M4YN._L[<H; "R8[(FFG#"POT!K,29$H*K(^MRO%# #4"K0+CHD9K-$92/VQV
M!F(PD OW+45QS9']8A'9&"T4J0S+W-23YZ)EP5C#DH_"V6Q#1E>C%+UHQXC<
M8UR'9#-/1DLIH];<1%?=@&@ (@EPO/29MTU8WSJD_UB$M(O)91L5"S$&I@,
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MMS7!S9<@@K!I?3WL&S-TEQF2U%[(Y(I1%DA-] H*9*&*<2X77CK+#(T!KL0
M2YE=V7EI$B>U0",Q@(S(G(MD-4COC(XZQ )[!^LZ'M6PWT'L*Q5#,"$)63)I
M@M*KC"HE^MO:;)QMV-\.[*]*:;*)HP1@OO9J L'),O!9L=IG5EAK@\YZ[T"H
M!O_MA;^V0J1L7=8I0@[%!XLF.NU1*$C9-?AO"_R7<GD\%PZ3"RP*XQE C"R(
M1&Q@5'91V)P=WSO0G4=_]Z*WG8@(?R5;9],BPJMJN/>'].^E D>7(O85*[-]
MQ+Y9,>)9^;]?/G_ #V?/M[ZK.8#6(@,>+X>-R<@/+CC."K>!08Z%^90+"]Y[
MG8(6$>/:'$!?X:.;T@(OFUVTG62Q V'CK]-&HX>KT<-Y_S"8VE\N(O.J^H=-
MU/17#,QY"T;&6(@G]@Z6S</+!Y(;)W17@=BL0')3(&Z!(99KR B7BDN>.6X3
M@Q X\SXH)KTW06=CE)5-@=@!LMBLV'(CB]L@B_/J1%;6!:N E1SE6;"I2):D
MRNA+,2:NK^!4(XL.6QMKB#<W:V/#Z6$I%JTBMSE;QRS6<L4"-7/:9<8#MTH'
M6WS-1EFN,M*LC<YRPM:&H9L"<1O^B.6(->T0YX3)K"A4#'1&%CP/+'+%0?$0
MBA5-A=A4NKB*"K&&N'53(3:>()9BVA&M5 X3/705&$1AF3,HF57.(_>*[%2R
M,9;+4W1(B>A>Z+D3X>ROI!%TO?C$_YV.XS%.OM*,:N?3D+H<K?[X^)IFMQ;B
M_GTY$*VU)[ZNQQ4S*7>0>&)>R,B$54%R\"9#.[^\"SRPACCT;?! P_O5\'[>
M%6R++$F0AI:S)#M.>6#(HV>:['YKN#<:^?HJRC:D=Q#I70XO-XF_;@98$3G6
M.7%C6'"A=F8"^LNJR @--AE#C%#67ER_\4 '>:#+D>,F\;\9[^<E?BE%@T'!
M2HDD\9V#&MV)I.8+:X,#KQ6LRB5K2-\:I'?YE'&3^.MF@*7XKC%)Y^@*4U@-
M?9TU\\F2Q+=@M5/.T1N:Q-\!'NARJ+=)_&^V\9>CM9)$?9#%,ZYCKB4&. NQ
M)*; B^K<==RG=KYXN\'>Y?/%#>S?#O:ER*O$;+24F>F@"@,1"O-> _/UP1>?
M,,5(8+>=!WOW8J6=B+]^)>[=]?CK$\+VM\5>=R.7ILO!U]FS:_Q\)7Y^OAQ@
M1:$+B=W$G*V%GC(FYB-&IE4.!H(HQ<B67+NU".]R6+4A_)L0OG2ZQH$JJ4@F
MBS0,DE,L!(4,2\8L'/(4L2%\HQ"^)='4!<";7W4MP%^*I&I40L3,F1&>1'NH
M,=4<+2.;BV<@@A=R??6=&P=TEP.Z'$EM'+!6#C@O_$WVM92;9BDXRT#QS$(J
MCCE4/I5HDO;KRZ9H'-!A3;_+0=:FZ7\+V)<#J=F:H&-A*@5)MKP+#$TH+,3H
MHH["6^=6%6UNFOY6(+S+X=.&\&^RY9=#I]Q*H8F\F?$ #$H %D!XYJ31@=M
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M)'#>AQNC4MH)8'QV7H8L-X;":F8B*(DF\9):'YE=H((NQW6;W+\&Y)<"N&#
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MAFB7$^UR*L7'Q!1IMPQ44LQ+SEF*6!!!ZVRJ[U8L5TK9+J;M7D[==\C3Z]Z
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M*HE%;?5"]C-SH2BNLM:\E&XAN/66:[WEOIM;K]7#7SLKZ16>/2L]:EVM?K3
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M]HFG][\48 LJN7 ;#":CC[/\7/>G;Z.-=S(:_D /83 GJQYI7!.Z-CW&Z5=
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MWW!\A:X+A?_8^?A^6VQOX3</WHD_S\+9SM;73T9;D:3AA 6%5J5VG$"(F=B
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M!5E)E.X6?_,J$1V9,9"-8"I,>;X?U ,X/*C6U/%HH%N.K[4&QP<'T#\=[^"
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M6R>I7RKUCAI*#FIWQ[DO^^@:)CZJP=;NCK6[8^WN6+L[UNZ.*V-H_%24D4-
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MQXPG1BF&BZJCY6+QGBVUQL-* '@(HLLLC<-^&]\\A,ZM3(VGS6MW:E'\>[P
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M-Y)M]D9?S"J]5,+]86M<K5]?^[\ :<U4VA'YZ=9761-9<S5L?\HD*,<\92@
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MC#A6''$78,\()E'@C.-(*1B386.;SROL/F//5(Z1TCF1M?59J4PS\ZYTW/_
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M,X>TPQ$I3BWL<^.CMQO;1<DB^NL:'2VI>W.L*9.J)7[-)/YB4N(3Q\1YB73
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M++3%!UJR@XG1S4]9+H-EQ6.'_=*%?36868QD%(J[J%*,BU4Y*XI?C"* 0"N
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MA:(F:N,U)P!"7!(:%\";/DP8?GHP\-38<G]LF>HQ+I(.4FM$DA"(&\,0O-:
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MDT?9Z[9:!1@-8B_VZ^C3(T'1\;0YK3"-@8B(G T><6T9<C)(E*()1HED'2<
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M+$OB6;KQ/SH]]W$+P/+]?\Z1Z_Y^:?[0U^EY:;YO CM^<O&/=-^W[=>_O$Q
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M,K(:.VY0J,1RJ,3)M$I7.'")I.&@7-X>D%J"Y8J"(UYZ8A"62"W6"ML@6ZM
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MV9$D/2=(3H'X9"R)*5NF6:*,^=4W N2C% Q4NU+M2JW8?H)V98J)Z=(^'3T
M289E KX,AC3"$K"!9HC,4N SU&S_9)2RG&N4\L,T5Q<(KGAP7%H-70+>LD?S
MSGN*+X'L?NL^>_=^.<]+Z9YO*MG=R-S45+*?1\E7F@/__FUQGNTHLL>RS&?7
M*516*6EIPB>+.K3,QA,'VI#(=0;*=*#"KKZ!UWK:-->1O8\ MCLQG JV1H!M
MB@8QG0U/T1*62MXYEZZTX':$9LXY%/415 &;F7%.;V.(4*./\1(H33L=K;C1
M9)RQ.UH9]P_WYA7IGD'(/-<E/E$O\3CBVF4?@0_7V\FS]?;H SY9EZ8T_)+[
M7U,D9VE\4(/FNWL+=IT8ETL'[N"(L 9#Y5P&,[.L2) TN@A)9(9!\T2LY[].
M.8SSQKGW@0B;7R]Z3/6O&JPF7=N25;MJL![?8$W1VTR!.8B4B%!V#[)QQ*%Q
M(B%8Y5P(+!IHHL&J;+JRZ<OIZ.YP=^7P6WGHRE]N>#RE"E;W]%S=TX+X='F(
MOI<8?RR/T-IQNER$,_%1U0O=W0N):VASX-E'+21AN) $6.D/') [)TM]BB6#
MGL;5-T+8!GF@2IFK37H,REQMTJ/8I.OVOQT37A 9I29 G2.XA('HZ+A(03,?
M3,FK40VR2<^MA4$]X1=ZPM/#2G^<;;JT4:63(\X^J.[/],65[(25"ZECSOET
MT^/^(J=. 609*<>/UH&04FD7=&1A4L_4U&%HV?4O@K*2E^P.#R>#Q'R9X3HX
M&*_T]_]*AT>CM'^T$O"&?3X8G[[":.[+EX/Q),=CZD[B(<J!ZLBQ.G+LYL.^
M^)%C=938BQXEUE '_\QGGTW4R.*%0ODB_<]Q'WU?^I$!W'<6T3-)F5_<]3\;
MX0 8CZ"49"D94)1ZS7)@8$*P1F5N9Q4SOW&F"\KT=L*YGJ%*<'#:Z[2'K9TM
MUNJ\WVNOO:7ML_<8^>\.6J/W_=;Z^T%K[2WOCM[]_9IO*L'@CV&+;W_MK6U_
MQ=?3UMJ6:.VT^YOKK=/NSL9)=Z=UTEKK];N=,J[XQ[EF>Z>M0>OD4U")@H-$
ME'"E:U#2Q"D)1'ANDO,B!6"K;YB\MT8P+QH>6M1\J EKU:H]5ZMF0E*:^RRH
MI)"$M)P9-'3:Z>RT%3"K'%JMVL*MVNDEJR8_9:.-L,$2Z2&4)"8@GDE+J..<
M2I!!IS*!R$QW+6JH57L)^]]KR>.M2^%X/)GC_DM3$OT7?HR7U)!G^_6?KU<^
M'^ I[4^TL;_7]SYC/6]UL$_:T0CE+5AFA. 4(K4V49%#H"QQ*ABK]'E)CF9K
MFCY+GS*3-),D$B5@5""F5#.9Q*V-$JS+:O6-9GI!CJ9!#+GB]7NXZT%Q%9TS
M6D($[@1DEJ+7BFM0*=R3&/Z81KI_/"+Q8**9EL-4,-\'S)=8XQ;[%%P"IQ,0
ML )C82,Y,8Y)DFPRF2/UY\D@:WS%!30(SB^I8^^?1PB/PU<K(T1CZ'_!,RI,
M8B)3?CDHW^!YKAP>^]C_JW]XX];!#/TMGK?1BBXHEYF/$ ($#&!9$%XC[0@Q
MIZ1C)1G+L4O;TR1#1,L859)HS^)Y/S^?@!&IM&(9@L??K;[A]^88S4LMK'#]
M!E=/(;$H@XR!@V3!!*:9T5'FS 3+K(I/2X/K51IAJ-$B9T,@6$U E/'7N-Z$
M@H4DC>8V(XVXIF-V8[/NGI\B$0[&7PXFZ3A5D)A!^8XL)J&%59H#2])G&9,J
MLUL" W#YGERA!C@/89FZTT2"!1V=XD@D:.D$D14C!J@B2D2=N#))J2*+OU*J
MZA7/&,Y9.>DC\H8L!)C)X$D*6:B8\8?R8GN^ZA6-@_,EHK%]]BEY!AY8)HEY
M9!O&85P0,4RP"<URI%%$ZC N>+6 JJ/'TRN>7+;7DSOA9Z4(O3\8X[?[]Z5Q
M+R.&9(&: ("./X*BTO@@'%C-?9!:*%4EG^68]KUIIF89NN00(W%,*XPAD:2Y
M!)J$R)1*B@M(L6323K?LJIK/L\$K,]2;)  "_@]8L#(&SZPQEIL<V'UY6L7K
MW?%ZB8IUOWZBP:D$R9+DJ2T]]A+QVAI";42KRX0%66:[\^D6YE7T>0S4?4B'
M_9CVC_INN#(Z&!]]=I]QA? *4ZP*T RF*$FP*@L3>&3 F<7P41B,.J22EG$I
M*G58CBFZ-+-1M@8;9ZVWGZ)W'#0#HGD*!, G8KW.Q G'>) <C&>K;^#>W*%J
M/,T%;,:K,\X%T)*"R]HG2WEB J3T3)G[YJ14P-X#L*T? <O;)Y^"C)([R@AE
MFA&P5A+KHB"2&J83XXK%,B =:MK)DFKA#D:C- X/0!Y>1!PC,[XD*PD\>%#
M?5(R!:3$P@J3I:OD84FVZ.LUY$$'C#4=BT09FY \2(:/NHKX@<F,ZQ>IUZMO
MFM0R9LDS )X34I6,C"EN)<(1( 27>4*D"LZH]]J[RAJ6A]1+K$&T3CXY034N
M!A )"ED#F$R\=NB9%,9G-LB4@*Z^D=-;N2][.O1YZY8:_,]1CT(%M5)[;2F
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MS5;?Z)_)Y5//QCB%U/_KXO$XNFTRXRO\^\,OY_M0P]/75Q20*\,OK_O);3-
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M9JW.9]'B6Q3O!_1&[Z ]^'RZN=X5O<'NL-7Y.&AU/@PFI8F)16>$(!Y4))"
ME6B;$1^#,#E:%9)??3,]7?,64?D^'/<EB%%WPUH5HQX86U,T-@?%D)]H8J*@
M!(3@Q&N=""\.403NHY4(C_N/GZW"<6.Q&G0V/HC,77+@#5CJ>*!4@K#" C-5
M.%X*5J>%8ZJSQ<5!<+*2M9\I,58[(A.=%%]X9AJ'U:K#SJW#6NEE4K;4UH!!
M#&9JG,Y14<$3?E=9ZO+1*6]OH-&%=OEOI_6UM[Y1[A,>^[-L#[HGW9TMUEXK
M'5B'@][.!IU4L=&DHP<DJ")A" K6$.\I(T$IY< DY@NTQ6LQ6_K#V^//QX='
MA:="U6)OUF+OA+;J^QX875,\U:2L'!.&,*\TAG'*$P,F$Q.8PGC"16;TZAO5
MJ,R_*K8N%JO:F 1&&NEUA(QL1Q@>G;,24@K<+:A0K6)U3JQ.\=0@94XV4B)B
MM@2X1)AZPTCF5FK*/-#DFH;5JJ;.W>B-<<-M$E( HC&@(TV*"\T8Q,R3JSQU
M^>C<.+E=38VCWEIOV-K9/D$N>E+N$]XSV%Q[Q]NCK9/68'?4.ML2K;7M\VX+
MW&K+72""^4Q 6TV<@$0R !76.:Z3+OD"BC\B3WT)&LW=T%8W&I<)O6D2RRU/
MP /)B@8"3I6D/Z\(#]98:4K*@&Q>D7:56Q<,Y1B!.:4CMPY$D"XZ7%J36?0Q
M!&=KSD#SH#S%<0$#4FM $NV<1X[K'+&64H+1:*1"<VI5;!Z4JQH[+\M-R026
M,W<&-)AL/$N:&L%M,%ZZ["K+73X^O]ZNQFZ?X&O[FSM;K-O9/NT.MLYZG7:_
MR[?/6H/"=/_H]\K?G.WN%I;KBA*8I2#6>(W@MI;XTMA8E5KA,K=46IBYG?&/
M+<6J&GNS:[P;VJK"\\#HFB*R048>J2J#X3(26>;1^R%_(=Y[SFS)&R_)K[I1
M"D]58Q>LQMJ4J&<R2<V!!6D9\YEGQE06EB59U=BE8'6*J68C=,PL$>],1&=F
M)HVY#1$0==$3."3>-*Q6-79>GLJ3BBI9';@"\,",LMQ[YT4T8+RO/1,:@,Y9
MQF[(]MJ'?G?P%GJ#X:C=V9*MLRUHG>%]6!L.6SLMVD(>VUIO3\9N4.<31".)
MT:KT!3.66%>R!H*VU#I\#B2ZX;D;)L#WF>H+?>SE:R-G&<,V/52]S"$CXC6[
M9@JJ=X?I?$3;?[-_5 WY1H]]-QM1/?8#VX0I=IV$": "(SDX2X F]-U,.4)%
M!!D36&/$ZAO>J +Q*A(ON/%@]IR[R''U ]!H;9!>!L8"Y"0"K\T<EH/5*78M
MJ&"&@R9:1T<@*DN,CY*$&+QADXGWM&E8K2KPW+D.WDGJ2W\DE\$SYP*5CM'$
M;%:<9UK9]?+1.<-DB>W37N<=7O-PM[6V#;VU#WMM_@Y:DV._E=T=_+[3V^V-
M-B:Y#CH*K42R)'HE2G_\0%S*^%6R#A==Y)2@="1CL_#KEAN'W4*N996 ;]X=
MO1/4JN-[8&A-=QV3%H/,S(F/ C&A0B*&.X$!:&*1<V^I,:MO;*-DI2H!+Q:K
M4@B?K#?:>5VFB1@&"BAX(66$&!;45;=B=4ZL3C<X2#R!R(J(S(% $))8R(;X
M,JHG!A&E=DW#:I6 YY: G77&4\6%Q+!1F=)-B $5*@A(BM:$W :@\_;1$*-W
M$DFJW%Q[!]W.=CF>:*\%*.2T-Q@.-M<VSMJC[:^]SELYD8 9:">"(197'-VP
M=,0FYTFB%*-288T)JJ0JF-D*Q[[-7KX/2WT)\LS=L%9S^)8)O.G>!ZKT[N*)
M,*-+#I\6Q#BA2* L9,G*+*RBL[XR?+K]755:GPN4C0=/J98F. ,I)Y\9)*K+
M^;DR[[>FXS8/RE,,%WDL!QE8V2VA!+_RQ"7C22S[7!R#TR!"\Z!<A=BYTW$9
M&FQ32HYT !.,!2:,M-K3C'S'U73<!N#S]M$0HZVO>+YX##RC]9)VN\7Q?LGV
MV?9):Z>%_/<]'A>_7SL?#:&$X-;:2%CP%L$-NG3O<B1GI7TLHH.BDR:ULW+<
M\S:UJBJQ-R?CW@EKU3$N$WA3'#<:%Y1E"!L0F0"3D5C+ _K)R$*4%@.629O:
M9N7_5:%VT5U.E.%4,.&BA6"3R\"20&@S*T/FH7+<YD%YBN,:$9@4".#L!>(Y
M*$J<\)P8+IV,)K)4YD8T#<I5QYV;XTZFV;E@C&4@L_.>JL"U NY-=JX.8F@
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MN[0 Z34G%J0F($P@)EA/T"!+$U-B(996\:]G8ZG?L@7N0U)?@CYS-ZA5Q_?
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MK,D;XAAS1',;:*99:A&;!^4JYL[+<X4224C0#/^!8=YKR"9[9P6'Y&3-RFT
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M&Y3SVEP_;Z6E?4 ZBK&G8@AH8(X2:S4E+H4 UD6JHRC)!O-05%Y%V)O=WIV
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M>[/[64"$OON4KW.-Q1>YL$Q,Q^7>)YGX>4X2GI!TD!EN1NH.2Q,W.B\;BSP
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MF/67[PQ]IW[_D?[[=5VL'_VNUE\.^AM;G^3[O__X=&%\1$-(('UBGJO,M!?
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MSF;N @-+0*:52 Q$ *(@ #$$2^Y$7AK[6$Y_C*XUSHVD1HE2$&(FGX)K5QR
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MI#<*G)$QHB^1.\%S] G$Q=;BJJ@D50K<< _"Z>"==46:0!JB(7[:N$=$]BL
MA]6W4]&T0V3W8:>Z>C"%T;C:OIVD$^I&H_JOX21MEG!Q!@RGXC_XW'5H'0S'
MK/O=WN#@ Z.UV>_1>_UCPE;W=CPZ<\4.G&<HX)07]OHA]O=JJ^&T$RI=TP/2
MD!+ALU+(Y)@M#(_.CJ2;O&DHQ;B2PH<^3GK)'H[I6L?8W?S3<%#JW0<'A-TS
MOZ;))*'J7I;^<']4^:(<#KN>V/U]^M5G&BH]7"$V'W0W&7S"259BC4*MA#$S
MU'_3MM!/W9<O-% ^U_ZVCG"$W7?VB5.(/>C>_8-$\CW";EX#\5E'8E.:>]H[
MDR(X<['/??Q"EROA\V!(''A4E[1.=7_XE5731*2G##B9M1#I7BS4^WW ^M5^
M1GI[RK'T]:>]GZOOKXZ-EOS<?>L$T=>_?8.OJUJ[ W<"-AX/^Y&8:<K<=?B5
MW^NX\0D](+$OD>Q>G3%ZH+VNGV^_$A3=N=<Q/QY\[@\'!]TPGBZ:9GT?J'LQ
MOJ19ZY,>B?2'ND6=V6OV]@:3J1R=+..W-]&:>/ZL=ZF^>W!8[WM!Y<V9)P ?
M2'?28)3U(@@1LBO1$6'9,K_ A%RD5_%V]V0O3I_FWSBL&PT)VJD"S.0#U8"O
MW[HX\<V7?[QW(24EG&!!2</ 9LN< <6R#%J3*JLA&=H:Y8S^^E\5%5-&&6$Z
M'-)N7V/*%EO]&*+B&+GGQH&R)6"4/ B=:5BRA-16__96__C%>R>3P.+(?"E)
M,(C*L""K7\FBYEBBU9:4!#O;;;U;_7*6D"O'9HSC&PB#5D!CD<$8[<$YY816
M7HK:C2K&.$W[;,)P&\*P1<(0DL1H7&'<6Q(&$@WF@S?,$D?(C,*AL1O/9^O&
M=+(P_*H3+,P!IJA@B6^(^<$($U7B1AK+L\X)2FC+?FO+3F-[#]+DH$-B6L3,
M0''/G$J)\1@D:(W%*[?Q?#9@NUOV"ZKE7G^_7PW63V$X)L5MM-/_--&^%I,(
MER,)098"M0:,*4(J'IT%866)I>D$MR818O/XC_?*!9^B=$QAS4Y$7EATR3(K
M23^(RI%REB^5B*I=(UDO!YDLA6F>7.<\.:=.[H<C4M=+(0.G# ?[)\KGV:_D
M0ZRVR+A>G!:D6^A1]PF]6PV3B:+;(\6TJ\PR_6?"X3CT3PLGT:>!1)#X:72X
MUP6,'=1P@KU>V3NL@YO<Z^3[O>HIP3KPF1%7ZX"$=$3V5=6-O_3'.[V.[LZY
M9SZ1A9;Z$TOPR>3.$Q.&S+3#:E60W=8?Y/I 9%<,<7K 2]9A2!\GCSN9B(OW
MGSND@_/WGIC3]7K=:+M_3&XSM<K.W7QJ<]<PNM.R4O'H<K/X]=<[_7X8:<\G
MJ(\1R2X[8[2?>,HNF%P?AH,O-%_G;'ZRN/;(R*Q?/3BL(UH5 ^K2*D'S3:J?
MPFBG]W,MM+4B-MX97^>)\-%R5X(]-7<'G2=R'/YF_X^F?N+H/&?)Q5"= H-:
MYNB@OW^XWP&Z\\-4II_$YU1O:/6Q5(Z=0+ 7/GVB2>M\GP5S)_9[X<M$4B?^
MR:DPO]K_M#<XHE^<#JN3Z,Z]./&N5CDD<ODZOM'AIQ/?R]ZYP8[./.40/Q'2
M.S2$H\D@Z5I#'-.8<6+%DG8ZK%\X\0Y,O*XG$_9UFG+O'PN<W(22K2_):X\
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M\Q: !<V5B%'1AVGC.;@;GXPTW\8*0_N&VDB#]BI >T87*4DK%Q1+DSHW1;%
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M##NB#?MG+8+<HN5>I0MV>)LS#S3Y,.,GNS7O4.E3E4J45_ L'%;00'8OSA=
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MK<[IU3F]9^)$57!T 9A:>U K!Z,9!OA@C-(L()$21IR3B"S)-/ B:4*YYUI
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MS#MNLVLM.;,Q9GYJCMVMI<G=+$UNQI[FVRL.GK,&^-)%Z3W-'"0^P>!S85$
M[P?B'0AZC,R]4[/.JXBU$V9KIP\.7Z<D<IL1IH+S_)9BU+]P?4"S3-X[Z-Y!
MF!2+6@O).,.* \[GP!VD2GJ=4H(PK1:FIQ(FMO_S[9'!5D5J*2(BE^PEJI!3
M4B""HQ9*2J<CW]H9+"=*F^*27 P)V'?CH&,+;ZK1'5L'&;%56U_:\XH3M#S\
M>RSYW'. #.=H=4 _>O$<?(U"*!?Q!N>KE)[,^,'%M8<ZE]VB?AP,VL5I;T-
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M,5RTX[LT7^K'ZS&S$)?:TN]?G)6?U;O_]]X>R:!5$!K$4M."5(N!TPI62E$
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MZ=LC0Y@E+N8(V$;$A<R4[Q*B8@B-+;'>:YT;-3;--#J719/-QF[AX(%0]"&
MZ!7$Z!T(_5KG!<C!8*?8&ER !=J>*X_V_+S7_5%XL.!W+@2\?I:*_HHQ;Q7-
M,T8E#]W<(N/=E:$\J*K1:Z2;*WSP?O](V-SK(CC !@5(E[! SCH+P,<85I$D
MXLG6SFSB>0AT0V]RH1TMNM65$)>/RS%'J]\"KZ5?@DV%<K.>YSHUKQ@7S'$K
MNMLIC>HNJ! (5/']AXSB_4) =V&LOD'05_>S.'Q]1"-W(%X!T<A87MQ@R%HO
MD%#:^ZBC%HJO63^+4:.)LCL$Q&H6HN2S,]N[',I]!::CX'VBX475L;%A*SDH
M F_XU97?WX@00(4%KNQS;%\A6%/1AVBSP#'=H)80F]*^@L"7[&ZG?8*;Q4W%
MU2J;;3SI>N.H@\+";2OS>BJ4]PKN3956?'4!"-,K,_]O.R7 #$ZZ%W#)  YA
M_.'C^6 4>S2&L<<H55!F(#.27668LLG-CD"18HJ]LR5J@S>B*T5A^/LON"W'
M</&S<+ZJ%=#B];!]=_&F%*:_LH#48S4[5A^&^E*\^^-*9XKWA\OIS7,;M=WC
MXUX\AI"S&(Q1__?BW=\SI<$OH6)Z+'#-2W@N@E=6H"UXFME57"@L-</W#4F*
M7$5EK2&$4<.ULH92"V$AYTE9*FDHDA2S#7_9RDI/JFCQCJD)MJ$!8]78LWUP
M>G+R^>S3Y<'A2>O@-->7?('W'\[>[1W3+WNO?QS\]#_@VJW9QIZ?Z+L_W[2^
M'+XE[_Y\2W-]R<$9O/_S,W\'@>?^X6MV\/,-/.>_S^9V4XG.:6%]0)+AO-<I
M5YH8H9%2AOG@F1$A;>T0LXU7M@W](7F^'[/L[GZ L7;8NG1-WNV??T.!\IHM
M&G="R]75Z<V"Y50IWM '+1S/9U*%]X@H.;,C-'IB95 ()ZL1]RDBS:) 5$7,
MB87)CW9K1Q&(K5\82"YSCEL]TWTN\#0WN5R>I)@LU51BS<U!4<P+$=O-'O6S
M]XWOM'K\D$[R9!7VG[UN_Y:U"K6;?!L#,*</@J#<6Q$<\M8F!$)@P  $@J)C
MRCF3"R$XN,G;QBQ)$_=P4'Z#6_M\'-3G[6K>$WR6]SG[2X%/[7>N$G:F_<Z
M60S!!>043KG&2N1>IQ1A*XTTP>B$/< .)DW\N/U75IN-?81#5Y0=W13O;:B'
MM_'?GA/KYB]/[=GETH:WN>@\[%WD,K,2)<O%LO&JF-$$U8[;ZA!T#K&XU(93
M*1FRDGG$-0Y(1Y.0H#I)J7._:+:UP[<-G4UO_EKO&5XCU:[W#*^W7SA$M-HU
M?!!@FW8-N?*><Q(0-9EFRX)_:#U,MO& :4)9GAA$I$HTS9K0!S]50F^MS_$\
M<X=ORG+ZYYH]?'(G\Y[IPS=7NQV&6%T[FDOA\1S*W4!S1VR=$!8BEVY3A0QQ
M!B5*E;<0R&.9MT/-X6E8Y&;6J<$Z-;A9+N <8*F=P%6"SK03*'%*LJ"#843E
M_2(0W5+X$[U.7!$6F#3@!.*EZ6'J]. S3P^>MWIU<G##_+9BUHK?U'[;W2!T
M#J4J<3I$ZB.B/&\O9D$C0W%$0E(!0;31+J6M'3F'4+5.#ZZ3<M?IP?7V#>>
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M"^[OB >'55(!8>(B6%<MD&5*(^935#9(89,%4)LM8+L5JMGA9!0Q2@O P78
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M_-3*XC<B7AYCKGOS\,R2E6&04VP+[*6%IXBH+:S5BK"RK=I8'[9:#TR]N;?
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MW%+Z-NO%Q!E*F=&(),T0YY8CEPQ%TE(1- [>&;^Q/1EN^*86S[9%K->,*V<
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MVD^#C.>?!ZG5]A9\Y%2S]AT N:GON-]_O^JL[DM!27SW$(!5^G8.K!C3RBI
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MVRNMO1')"2\X-\H%*X/"BO"D$]/N,6':(MK/*]J3U:Q!!H>-00Y+ASA7#NE
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MRY3/N=1X51@3GMMRO176&H2Z]MH#K +0&N'7"+9VSF"^^\,U*@@U$T)-857
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MF?L)Y$-9S4#>H"2!,>C*'IG3!=@+"Y@[Z >3"7SW2"^J,]2+SJW@/#;SXX4
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M5;T!Z@)KEP%U\0Q=!/!2"";*C+&R-#0I"EZ40N8J36)=<I5Y(B5W/ : _R2
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M$?^"YKTG_/6$Q#T<NA4,O?A$7@A'6QD*GT_@,?.J=G#TZVK2TZ#!;'B/9S+
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MOO1;],QRJ_D\]-'3Q0(VZK&8*"_E+2Y:A^+C;;?K3]R"1^V]_;N]LD]P%W[
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M/MT[6>Y$4_F+@J6-8&Q#+.BO>?[D3L1.U[,BF[0&G$ G>[DZJR:C)Y[T.5Q
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MMA0ZI3I.J121SF@.>E0N(Z&*(E*Y2D _9AG/N2MT2OB=B%8.V1@#N-TTN!F
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ML4D%+Y,T4P!.^9AE-Y5V-H#3 $YWAC-V *=;!*>-S I2%!G/TS*"'2HB*G,
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MM2K4O8<TS0?P&L#KVP&O:[6N2F*JLE*7)E8TC3.1E7&A.(>;8;0IY!70:ZW
M:=#1OB3&]9/O >-$+BBC"2(;T1$5:1:!LDTBDI*<EHD1/,D X^(QV=)3[U-+
MF@:$VY>[_GTBW'7*BV)9I$:E&>,Y)31CA O%M$FR+.7:Q(/MN1>XMI8-GQX=
MOS%Y'E/.9)0P[,('ZEHD3)GC$B>)83IF!*S/-&?C(KX;&MS0@V:@ MVLWBF*
MN* IYUHD5.I4Q@4C66$XR3/"?6.LS]3 !C"Z!A@=;L8PB09[,1,T8B8V$55"
M1YRD/#*L4&#T,\IB?>]AMND$&]BUOXD[FB24D[B,):6*ZD1P,))$K(C.M4ZU
MSH8[>OMW=#T4)YC,9)*KR "(1I27(A(LUY&A!@PD;.>K!-[1@0+_#EW2ZU"U
M)#(S"=$$+B?-L=4,P5:IN3'P=Y,/0:;]N+<;0:98*)YP&4<L%2*B+$?V@%1$
M)I%EG!"5*Q.#FC\F;*#$_X:OKZ2:T:2(C6+_?WMOWMS&C:T/?Q66WKGW3:H(
M!7L#SI2J'#N9ZZG(SB3.9))_7%@EVA2IX6);_O2_ W1S$9NR):LE41)FL661
MW8T&\#QG/PC)ZM."8EUQ14'E<J0YP>+Z\'UX?3]N#[F;X14L+3=28<0(EF"@
MYQR_="AC9-8$@[$4L;.^'P6[.ZP?:ZZBT#(0'@(WVFN%9;058\'"_YPO483=
M@G(KBI".Y8;U48@24R'.L$.*,(ZPH216.@:OT_E1_8KIHC[?'PQ? <*5HA75
M8,L*L)>\PM9R*FTP7 O.P<PM\O>N0;O%1>ZL(\$)A[2V %LB-5(5CTD,6\(B
M%L+Z793 C[GNZ9IGT)2HY6.(6AHMC%*, 9A9<C=;9:P!UA4,8T6E+LZ,':#D
M?[4#!2ESAA(AD6=4 "$;CY3A%ND09,2:I13HNM@)MQ6I70Q9EI2,0F[=EP,$
MS''0R>W' W8*U!4B@M!&"*EYJ>3<$7+;C+#@"E9'2(DBM1'QRBADC4EM7S7'
MAG!%0JR+G9AH1UD*NQ5V>PSL%BM# W.D$EYQ*XSAW !4A/9<&"^Z,J0+NUV/
MW5IQ*%Y9KZDRL"K6(-@&B=T$6-6<>TZ-5RZ*O0/-^J(JJELAM\=);M0%$8C2
ME724@]X&_Y7<^6"M"4H85XJ=;HV_-J-Q.FA3"1)1=!(C;H- )@;XIX:]RH)2
M)A<"E&*G0EX/B;RN$J9DE1,R4$FEKSB)8'@Z18@FQ@E<.=M)&E_1T;KCN%:8
MD@AOG3(,*1\UZ&C6(FV,0])&YIRM!*VJQ'%]+-MGBI9BI\)P]Y'AKM)&R"BJ
M&..$8<&![:RE@1IB"0O>F1(VV!%>VQ+)Y=+@&*-'A,B(N+$4648,4D!Y/GIN
M:+(^[V&QTV(4BRW=G.5QC?0-(*LZYGO]_J*;YYUTT;ZTXQ:H98AEB/=JB(\L
MMV-Q7E9OO#@PJS?()V;UOAF.I]-ON^IU^PBTM8>IDW76M[:<SG9K*MJ?[<P.
M;G3TTFJD-*P4Q\0C):)#QH<H%0^14K=W(/M$==4*[1X9F86<=NG=[J+O;"&G
MVR2GS<P,(0Q3-BAD<94BE@YXB0>.O-)48R8]_&_O0/1E(:="3O>&G#IK&UO(
MZ1;)J958H16AG(B 9.J@P06-2 =#D&-8,B,"#:;6G'A7CJU"3H6<;CR8V$'?
MUXU@8J&IVZ2I5K-8)['65B#"6<IN=10I*QVB3ECLE64QI>Z3/MOB?[]R:+$P
M5&&H>]C;]8L,54CH2B342G"H%#<Q@*Z4*C819SJ1D%8(A(I3P@OG*!AR%;Y.
MI[%"086"[EOSU:(:W:9[J9V>( E3SDF/M-8I.=XR9!7QR&!,I;$1,YQ*?V0?
M;Z&FNS/B2L/51]+HXFX;KA:UJ$L"<NW@&Q4&"^T5,BDGBA.%D768@Y5F*RLE
MC4;1O0-QG0;WI3?-#D.V^_ZK!;(=0W8S)&6!9G60 >$4C>)!$:0$"8A'Y[#
MWJ@,68D+9A\F9COHQUHP>Z.8;45J@B8:E@$CIY(+5&(0L]%+9*41V&)912%
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MPG-_('T7=0%7 G*I#?AJ#+>\_M@%$,C"IJ([C3BG'"FM2*I_)T#)0A(32FW
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M@QBW@5-EL0\FG:/,2#LV>'G/80'U[@KISHH%K@3E4C!P#12W @!":&8IIRB
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M3-\?A6#[9OEN^EWOQTDJLZU3^?X$DCGJ_?SS+_?\O7X83V>)( X!]L8=SU.
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MA/Q\61S?G)Z0'IY-9C]?U=QOS&TSK_V;QM\5Z>!U*LM,,_3B)'E'5TW1<JG
M^;?_.;W]\\7;/UN\_5T2R@,&YWW-G)EN]U2O=Z1>3Q2YH&'RRK??27K)UA&U
M,TFF)97DH:22; UC[4(NR46AG+QW8N/_7]J.ZR&-_O(>C9P!@S=E TR2"C3W
M-5"6+]^D::SE+:R'0<=-CL,RG#&]\+&+>=HN0S\[I%;JQ&8DMH9UTPUL/&V&
MLM_[+:58K'UY^3KAHSG)62?]W#PK)X+4F1&@T:7@7CON77>87P9@F^XB2XMW
M:UAM?2JSI;<:P/ELDZWV;8H"UK7 *5"?FY_!-"[Z@TWK."<HP2N2Z]?I(ZD[
MV'3S$?DD(OBD<3.8=9?!]L%?F%DR789 .\\LN1LA^2RQF8/7?YJ!>)A+N>^%
M:S#WGUN,OJ:1IA ]==6<CP9UFSQ8Q_&'.OVC^3@=CY&ET>*HEK6V^[D$/=_K
M,_MC57%Z[DGCR:;D.O?Q0JW-=W=+RVT1[G^2DRK6VWO4P)@VP? EZI;'1RRY
MIKGS=DY,D7OZ;3JV(+7HK?D]R\^Z22_(K^$PC(XR(31!VL'[.@1?MP;XV'L[
M]TV_\[KIW_*MUF/S6U=B><25&:9_)H$"@CH9H6LX6:@<E[$WS+LPJBOZ/QR/
MAZ&FQP^UQ@'/Z>=VPJOQ-02P?7!Y9RS.8,MI:75F1U@,;-FY;_OU">VC=0YK
M+]6X:1TYF"U6]F)]>R,X]4CB@N1F&OIU&N%;F3'YC,O5O.=#-9,3W9Q.PY/%
M#]^GU)6A.7LR&.4WSA=]?P)V(@RP6:PMIU'F!]8?K\:]C^NQIQ,V5P>!-A_O
MYX\V#@E=7+HOM+CP8[Q/ONHSLE_ABQ_Z^2LOODZ)?88O-]A\U&@S&5L.<;[H
MK.9NOKHC!S%?Z*!H2?B*P\3]>SU5Y[B.A;G$EW5KPE-SEO;GN2-G+SG+EYR/
MV?CT#B9C^X',S\,4R/QT77+5*L]Y2KB+;5-/T]WY F<7M;X&I;SNZV/!"$O"
MO'8.PR^^:0*$+WYX^>LB!KA^YM?J-(O4UJ7:5SV[:/41>W\#CB+KO[AP;^;6
MW&U')?DZ1^72I;%*YJW;<U_P]%5B[*H_<=-(I%;YD]ZV//8J';T4)HL^X&DV
MI\MY.PMK<[=0S)JC$;)6EZ-A^9C"Y=?6KSTU S (<_S13#^CH&:W_?GH;K^W
M9:EJ=6[U5NFSM5D93!?GEJ43 &?PRT\Y]I4.Z\QZYYJ]EETW8*^?G-;NDKIG
M?CUQO>-!ZCU8*U!U,O';NK=3?O>D=:[[3IHD[6P09FBF0/K&+?*CX ;P__R[
MM&#-L5?GOEN/>LE^BZ\O5JO?C""=Z36":\YZP_3"Z?>K7,-F%8\'IXOA)4\)
M&/@?06&N3<#A(G1?US2 Q@86:(YGU_DG^8B,Y$AIM,7%!-ID>R_F_PL0>)V"
M*6E-UBWB91.;M%R+K% 8\Z+7=IWMV:I1^[H1O!BM'2M90VIY91I7RG+()3X+
M2Z=9I*;#6%J#Q80LW6[-5S:?6J]E;Y(UYGM1WY/-YZM/=X9<TZ9H^@4>6I0W
M+H_"R_Z1!?$L#3P# #@Z7DN%75IU&=2C=>_(ML&NH7B^UO)\E?'; '2S0<S#
M5AS^;_PA>86>>M_$/%>J0YJAY.W*6^#1ZQ$P2;4K=Q$77JMKZR\/9?&;E6;-
M\>/977=QT=DR67QQKOFRI"=GYM3 2E>>PU4BS\'*!=I/#LU49)?(.B=I;=YT
MT1.Q/GM]Y)M*%9>#+2!<S3EDK O$9:9\?U6_$NL6BOFZ17_>M6,<I^/Y).6L
MG4U3I[%SAQT/8$GRXU,3Y_?U ]+;+KQ :_4;Q_EPBN1C=V%YXN:E1/7B5=9F
M+UU[L2"X#W2<$D03UY[;!_WS%8*;KO'-?;$HD?SBCDA?6%O06J=(7UI3'5J[
M!@#KFNA22Q!D!_2*T)>KV+CM!LUA&+"*\&,=F-GV9HN#2RYZP0TW>1VTAP4Z
MRN&M%!$[EVJR"+*M*Q?G=MGPW+%)2T6R_R6)<Y5="@\<3.K34)/+?1F!7%/Z
MZOE/!5.308IF])MS6Y=1Q.3V7,Q^/N X'UA95ZWE!5B+-,3&#YJ<QN-<['8U
M 9\FZ)*&QGZ2+MF!EZ:RGT-FRT-TS8(/FGN>IFJ5A<=ZW>3*6L*FQ98LAZ6E
M,5YOT-K\<NV X@OE^G?9D;7;N.^H^.5NDYV;II7F@D.($\K3.3>#%*FC&%?W
M@I'O7?E.2G!+.;@944UF5"*2VO>@<L!QZ>#/VDQC"!V:LQX5]4V^KL[B<88"
MZ,6A@._LV)_!7\>SD^'!_P-02P,$%     @ QC.Y5FF,?(C?.P$ >V0. !0
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M3=+ (FWT*AM>$W\*^6/)$::@&&OM'&\$\IAH<[BD>[C0_#?6ABF8GWTFDG[
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M6/W+V>P<\R_GT[K3X70X6>4/+'[X^M,BJ>[7+SA-PUE-3"&'5:#((%0JH%)
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M(Z64(EYZPS1M7(%VL<:;>%=LAYY9BPD?(<WK')GGY[/YY RGSV8SG/^&\]7
M4UJ^"5R$2*Z9+K6]16UT410(Z776!A4V[T/= =;Q][Y>^'+]G&NMD,;YZ?^B
MUWHR#>/\SS ^+X3S?(J7;VP')8ILC0K ?<WQ6EP41U&O;I44FF#ZZZ/7-QY\
MVY[SR+3?7+2]E+WBV?#\[-*:G\WIZ)Y^I:WZ7V%T3OZ<8<%K8X 9DXB7B_P
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M_&N8CC'_AM5877W^"]HF-C4J^/7+I2P"^B>_#U\&02!SBB\*3#DHQ6L;EUP
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MZ'!SJG@SM?20<W8'O-7]9A> /66P;P5WF@3VIBKM3I<#]'$2XEAF([<90?I
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M6//F%+?*E>RXY4P5LE)=D=WF+>R*Z+[7^;[ZUC0K9<N2-8O>I1Z4-W4F<U+
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MC.LJA/G7=YC.IXN+P6>?Z[0BVH%61MRZJR#3A0[W C'7LT@)#HXY"UHP$H)
MYJ]G%FY4[4X//:W5M(^&)L<0;V.GZ9_DPWT('W!1OK?NB.4$N7!U\EBIT<ZD
M#026(F0F>%2:,2>[- _;\-$/6J>'BJH''V>1-7)IA>O.6"D4I@,2(%ZW*1O
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M+R%J+XJW"8**!103$J)D!2(/!8WS3N76'0@;P'ZC];2:[V"5#ZD(L>B3-46
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MNU(LH&>U)VNT$&-)(*5-0EO#?<J-B?9*^@X=PK,NZFL<%'BR\8U'Z:5B JQ
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MR13#M?(NY-9M0QY&\HJ)TT U/:_0'QF?9S%A4C6=. A5;_DE.&,#\!*M)>^
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MV)-"(_%.;\<T5O]CY.JIN_F3/!JT9!GSZ9W3/,:U;?'."5=B+%XJG8//J?#
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MW>)J;&DS!R&1&VAK.D'@F<RPJ)5N[2_? W%LD;=1FEVVE'"'4^0G0-?-$09
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M>'*#.DII-.#GDJ,ZAGV/A3WZ:K3#/<JHF V/+FRR$CB)J::P< @IU+Y$DJ?
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ML2/0>X[=;)++)4@(:'7+QEUES4:P#EWFET'=Z0J[U=S8"\1+/WJF9:'C%<L
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MK,_OC'E 23:C)===<I9%<#WT!WR(I!<!F .D<!<D!P^^W4][KC\:96MR5$X
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M?'T,-98H-UR;P+5+7!Z&I'O7?C'8:</]OBJZ5K,)HDLEH&!0N*SQ@:C!T_*
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M"I3E@1?)'5.=.@ ^\@J^=?%CA4$:R'/:DJ^-4R#6=/Q],O^>X[B,<UJW!^M
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M+("[$/%M(4(;OVSUY*)6IM0I>K$:4$;5*>D*)$JTF;/$?.O<Z>V4#)4>.@@
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MY@&B+U*ZX),1K:OP[R'E"*\R#22U^5K7@,T-_?9J\;RIB<]Y]KTF.]<NT4N
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MBQ:,U\9[C)22J+L4!IQQ&81+*EM4VO@6[V./T3%TAL)!(MH2RFG"W]99"3<
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M!ZBXZIQ:"Z@MTM4E:_\F(PIK'07H,T'X3FSN1J)(-I$I+3Q1Q$EUN,# .Z4
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M3GR[5VO?<VXO/ZZ_!/K&__W__3]02P,$%     @ QC.Y5D?_\BG$#@  ?@\
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MAA2N[UP([4?<&].);3,Y'#0#J4$XS&#519[V?(<W4%;*N5=01 7KR'DA0$@
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M5LW<L1[> :Z"QU*\[NIP5!UMU:S,6"ZT\V9NV+O)EEQX6 9\]'N+G?*FERV
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MXRS,HD!&/,JBV&63UUN22Z/]5A'0:0(V9 =T+L"F:FZ[P_ZS9;=I'&4.!EY
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M&@<,$I$(E(4HQJER.RG</]BE&3X?B_D=U ,] *&E=CTF/  J$E&(.>$PT3]
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M=HJY_FME[G5='\B;\_B_ZK5L<0^N]6-0GPE4FJR>S:/AMH2=] 38K4]CS>O
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M_V 24RBTB<81#V60B7:"K!N)##L]P[<).3 Y>ET995HX30CG,889BIEI[Y-
MIIC^E>C98D()E3H591Z,O48PE,^Q>K@["?Y 54!>.@AL2GX,XQ@8N9Z'T]!G
M<PCTK=?1ZQX]ZP0>[;KQ%YK/33&S*Z4)XHOD,UI5N<J;:M-K<;2$I@].J@VR
M1(D($J("37:A@#B5%$99A*(T3$DJ8Z>Z@'[ENS0^7-=/VFI@=6K+*M\S:T>C
M9YRO@9G6OM&1T7!5 ) :-<%K/3=YV;"UUZ9' \V!KRI^GJ4;MVK?,-!N5>D;
M:)B30I_BG\R9_O]>SI[-G'8U74C 9<03&"*L])Y#99 @9 K\BR#,(D$"957;
MWV*L2^-N+>..J"<C,S!"]PK7V8GQ8>;UC-S +/HR-,= V$3FK& [+=QI)WZ]
M@IU.Q?$LH4Z]\.P;Z'0((;LPIYUW.$>0TR%5]H0X';RD9X.GK@:K"6%_48/5
MA+3^0A==15;#^>_S)_GUOBR6=_=?Y?P_)2VK=5"UZ:H2I3R&&4D81$(DD(HD
MA1S'E",I69 X5>?V)MFE<7@M,%"F</.S$10L&L'!0LZ;OS@VC_(VA7;F]EDF
M9N EHHZD7RNRJX;V9G3]!+1J/NMO-FV0I*B-ZMM\?C>3JX_!6_U)9Y ;[4$"
M6CA &'AL8^5[3GQUN_(FU[A-L7S#N=4[R_L /6M<=?=9IXN84(^K!^,6J-X6
M#]KDGQ*1D3B6B3:UZQJ*/((L2T-(HXC(+&(Q4L*I-)/%H)=&VAN9-;](:D1N
M:H<VTCK&G%FA;D?&OK$<F&?[PNA>>,@!%U]UB&R&'+<LD0,(6U6*7*[M1SY?
M2SJOE'YYK^;B5I9/.3?MKU13'RFGLW5"5?55CU#M_JA]762&A R8@I*'PC@%
M.&0A2J$4-& R% (G@0M)^13NXLBLDW0C>;#JR65>)]&.\\XU-4-S8[]9<:;&
M(>#S1*%>11N5:H< ]34E#S)&C^)0>DMS5Y3/6>>.U=PJA)*0H8B8S(488HH1
M3&*,11@R@4.KS(4=][XTXLP<R@>]0NFX0_4$W0=FIDXRD/7PE+X&PJ%(4G]
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MYL^J]HNT)Q/<DU"CVNM^@7QMW'N^NQNS5^6BC0CX12[N"]%$!$GY23_PG;=
M1!D2/(%24 Z1BCFD41+ .*8*\T@E.+)J3GY\J$MCX'5XU 08*1T]!1;8'J9,
MOX@-3(/N8%D3FCT.ATA*WV6#H/1O:W*R&& 4PK%7M",1ARM.[TGQ);^[7]RH
M;U73'./JH2@7^3^;'1&)M"W'H@C&,E80I8)"(I2 +$TD"8,X2]+>'2D.C'MI
ME+$IF\EF*HWHL%!P675ME?JWJSB$O^4!AW]4AS[@>-FJXDN'IQ:[J?%6U[Q<
M23Y,IPH+J ;H4W%HU+-UJ;" XE"/"IO+>\8@=N%S>B?\?KE8EO)S,<OY<VM/
MU2FR7V0^KY:ED6::141&B*60)"F!*$XB2&.EJ0L+F3(A,A93IRA$M_$OC;A6
MXM<^354KH/>:1@/ 6I/4,=30<4*X,N5C @DC@21$4L:0J"B :1K',HD$9YA-
M'VO#]]U<G'U27DHRI!O 5+K06TM&9S43T@7XWW2^I.4S:&))PKI17[W:K%49
M=JX"S-,@-*T80AQ#%""A7Z,DA!&E(DK",$Q5:M-%<8R79X36B29O96;Q NV:
MJ#K:]TF6IM/&L)-F9R(,.!4#FPHO*:R1'33"=SZ9KC[&%XL7Q3W MQ]ROD)\
M'4<?-\BW'S1;8;X];^.SY]7'57,2'-.,!*:G=4)2<R)*($,Q@:$D.%&$A8+*
MT_M>?;S4-C.'>CA][-LYYACFEASF#\FA.>M$$#UUP]J"9M".6!_/TVC%4G6[
MSEC;E_6,TI*/U%3+N.+<E.&O5A0WY3Q.)$YC*!/&(.+8-#W!""HB(BIP&B*W
MMGI[1[HT8ND$!;25=&5;Y:[E=/:C&Z<)IXJ9]C%8[S9BK"!&,849(1KTT*2F
M!3T:$9P&\CE:#XR M<E^P5&$890%%"(5F:UVRF":A!F*,].P%K4[N]L%+1<C
M/L^O1QT!Z:O72#]/] ;A+I^;PWNS.3"'N8U<OB8@41PQ9=HDQ331#SL)(3%=
M-T*E-]@X)2&/(]>MM4?XA]]$'P1?SL4PL-L9*UZ '-A,>8W?1OE!CU&@QX#P
M%06Z=YQQHT"/J;L5!7KT@IZ=V9YH/C/NA[:+^;J'T%O)%NO?IDC(C'*B8!S+
M&"(F,"2,(RBB* UXB/7_E&/S-<NA75Z%<8JYK!,O'+NDV8(M2(0CLYV,,FF"
MI(B %#$.,:,R1#P1$CNYV(: >@S?VE<SQD 8RY3@+-'/LE"FFZ *];J(< @3
MRDA 8XXQ<C*Q!\%X!"O02+?1)' @M.V6PR$P''AUK.%;2S8!*QV@*DIHM/#8
MD<\1'U]-]VR'';>OGB,86ZWS7*_OM\*^65;Y7%;5%?_',F\"MNH(W<]ESN54
MX8 D,@PT"Z5FHQ\SR%1*(6-)$B>$1Y@ZA<,>'.W2J.>:5O=M >M2<ID_F9.N
MYR:/XKZ8:8SK6K"/9?&H%W6A=PQS8?9)=*U<W;)4%+,9+3>2,!Q+JAV>(COJ
M\@;\P'S5R0DV!)VTH?VUK/[8R@H23Q1U>*Q1><E*[==D9'>1>Z;7.C+/E$@Q
M:0#5W_+%?;%<O,^_2_$+71B6>UYEI;[-*SXK3&+J5(1"4!(:?XW0U"12#FF0
MQI ))@+"4VW^*]NDK_YB7!IG;90HY)TJFWZSNE"3U@M0H(QJX*'5S3X]Z80Y
M.\Q5X\W$P"2V,0DK+4"K!K@"M2:@4V4"UOLUL%9GE/FPSQP;9UY&2B+S,3\_
M^4DI.QW7 ]EE)]Q\M$2STP'8S#GS<#=?3:978]RHC7;'&8IH%E("4Z:HZ5)&
M(*,H@5P$*I292#/&W<\;+$>_S-.'-ZL#AC:,[-1&T[N1#P-$>"!3R&*]GT%$
M*&TO1!@F<4QD'(@XXXGK0<-@N ]_[/"NV:L,"CE7A"<)EI!*9'H4TQ 2R:G)
MT0E%AJ@VX9P"[P> >PR;K%X_GNKUHU#@T;0 [Q-N;XNZW89P "P'=V4=[:A^
M]6!.'X;LH'X0I,$ZJ.\>]<P=U ]"<;R#^N'+W59A(?/IW_3"OI#SZ^+A83G/
M.6T2?WG,&4XR"<.HWB4F,<0RCJ$*$L5QFH7*KJ#OWA$NC6Q:(<%+*>V89C^,
MASG%"S@#LX<C+M94<53W':102?[37?'TL[ZVX0/]PYH&]M]QE!?^J$+=JWW\
MBR>T#W]CZ@J82N!R7C5E(LI23V=3C^S-\_H[;:NYJ]]I*6[J\+?J?5$JF9L0
MW.K#O$E'_ILTR3U27)EH]COY[KLL>5ZU'E0D@X1&#$'"E(0HT48A9:$):>,Q
MU1:YD-@JB_A<"EP<!;6R MH("V0K+7@TXDY,#+S13W_CA__1VRL^^F-B9U==
M\N0/3+&U6K#6"VPJ#S:U-R<HFU]L$0 U!*:7: W"!&S 8 Y9&B F8/5LM5B
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ML(0L0#'DB2 )ST2,5.1"HKN'N32>;.IMY&LQW:AN#Y9V;'8Z0@,35@/.BU0
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M/=%\9G:_;<_R>B<\95D4"<(#B+-00)3$#.(4$QA%0:@?\XP$@6,2W-$Q+\V
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MUP6WQ3(F,952;T:H@BA-8L@PUHMOP#C#"<7(K8WU_J$N;6.REA1THO:.'#P
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M)J"#/Z_+/JUB.SX7I6&'JT633%<W*BL^:=U,>ETQT\/<?6C;I7=!XQ0+8V1
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MM;D)6D44]8)6%:!T 4:9?;=TYS"6@2MB?S,QS<I,=%<Q\@HY75T,!_;,9<:
MP2>[WA@.0/?"P\-H[KO9WW5)BZ]BJ7VR'^\?2%'JAUB?19[7LWX9,?A5L/7M
MJOA?(U_C45TDB,4RR=51(4<2HBC+(*%A"F7*,0V9VNOLO)6^!9O;CF=T@V6M
M'"AVVIEK$WOV]+IVEW>XUUJ1D?<\HQ9H] )[Q>K+E1?1U_O@:\.P6CVPU\\P
M<*/A*RVC_;;X6LLYT48Y];(Z[9QC8']F+_4ZW62[ZQ@@=??;4<;OF35:KID0
MO/J@ -"3?U;;O^RV'JP6D@NL-E-U=B2YVEOSC$,2AA*F/,J03$/"8J=JY9>G
MG-NNV4H,]&-BFK,Z)GI>!MGN<LTO="-O;\]1JSNF-O43GO5']7A+9H^/KWS-
MRQ-.FYEI#<!!#J;]-]UM_=_6Y>:6W(I/:[*J;E9?!5F^K]0^K 9>+H6)E*QN
MY)>VX?''E>[5\/W'>A$'D9 \PC"D::BXAR>02!3JN.\L1B%6YKYUI$M?(>;&
M1NHA1/8V7F_H+YOE4P Z,D>U*@"C [A9 :T%J-4 '3UT',9.$VV6F4XR2ID)
M5L+>LIYB12:RHD=<&2>#>2BD9XSCWD-/9@@/5;YK] X>JT= Y7IU^UV4]Q]7
MCZ*NME+MW#6U#_Q798@WQO4BQ6$FPXA $>2Z+02+(<DR 2,U+H])RM+4JG>9
M\\QSVV"T\%!-=.\0UN>$].6M933\1MY/#'1:<-"1O.L\KH4'6OK=@7\LF!U"
M*,>">ZHX2J^PNT51]H'N7"BETWC3Q5/V4?-94&6O =PXORHWB]^*57&_O6^B
MB!.*$LIR B.=MX8DY9 F,8$ZV3<*,B*X#&TX_6#DN7%V(YP=E1SB=)Z1!VD_
MM@5?R^4Q-OJDMN?N#-27.O<%ZE_[NX+#\29Y:T^JT;Z5IS\P?CFE8G6S$MK
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MP4[T*ZOZ.;V]RGV1].Q*=A;C5?S'?<$ZY33N/5X_ZOPL?G0:])7KE?J1B9K
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MH#3P@;-S6_[K/$8CFYT^VRW]M7G:5G4UJ_;QTK]6G]I#\R_4B\G/.L^D1=-
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M7Q5(!*L^5=POXQXIE85QDL DH HBE6HS-6-ZU8A#$N$HH%0(MQ($7I$?I_)
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M%I]6A9%]SDC""4,!)*FB$$4<04Q% (,$AS(*TP!)JQUHG\&GMF[7\IMUMM4
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MW_5W7+ZX;WO#IT+R)FQ)/BUDQ3I+<6-JB.;_4[OA<(I%F$4!E#@2$&F3$]*
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M;4+F6!A& N$$)D)D$&4Q@I@( AF- BIYIKA=?+?SR%,S$JO]:+D5&M!6ZHH
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M/(Q,&2U,(&(JA2SB"B8IQ4% ,<IBMT-*1P&F9A*V\INM5*L!Z*HP,\'2G5^
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M7;_<3I/A)\'> !YA,D:RB:^<E+=^+.8K\3QC1/=]\FAV]96J=TWM:Q_5MP[
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M::,,V.SE[A&M/V2AW)AF(OA'9J0N\JT>%VT E]7%WAKNM0$'=< WVW4=&+6
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M@-O-NJI,"L;FI]FAOYM*VJ"L6IFD^*W[4+XXU<-F_8_ZM'@PQ-J+ JUX<X<
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M!;9R95LI>\3UO-K#<-X:_RLL\<B$;R  !PPN#OT8H(8!&APNP $)<( "&$U
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MQAFEG+F:V0[SS8U/:Z_%<I\BLN__#I8'\=V-01?$S]O7@7&<Q/&S%Q=TY+T
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MK AD481A'B6X*'!B@H>] OJ'2#,W2C+W"9[Q_H,6PXVB)H-X9 (S>D"CB U
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M=N\WT@,K?I=6NQJ O0H7H*-\4%=S:' #1WKV%N=5 CJ'@O=2W.;@<?N&9YH
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MN'N+J[S2 G[#*UXM:4@3#V,?^@FA$.&$0,S]$,:ICV*?BR@,R++@=RI,XG:
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M D/W$K>53-T?$%J!Y(CAS,:<E+^L8'C)3G8W.ZYANL\7C+A(HRP@,,F$(IX
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MZ'V5/K>J.DA67 [U1_&(<_9NA?,'M?'?_,#^>]L6A J$\ -!4^D[JYYZ\O_
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M2B+>@*Y2G:QCRP#52Z;1S'B>:G)&7DLNG9<1-M-<(.LJ,/824:8-FG4 VD%
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MLAPEU^-"<CX'3U)@\P2&5WL1^E>%O\OTCKZ@D$VGT:]<2UH4H(0!UI'&>R3
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ME?YJ&,,LS3@,L)^D22:8GQAU&.\;9&[,*N4$6E!S;^ D?N>=/A>HC,QX.T#
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M\^UTAQ!.M$5^>R]?-1U;U&0\J;#'^F4\A/:>KYC*#569P-+"?,3%TT)5WW_
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M'FHIP:,4TS90Y#F.9J0P!):I0D :*)1H"_#A)UUM=4;'._R8;YJMI_:B12>
M[4K%:>K]!9>1'T=A<A;F\?SI$\=T'%7M,(#C^&6N&L&^S*'XLB[^:$/&0^1G
M-/$#**0W(JV*2#>J$JIE%1+<YS0,R&4M8'M&GYN=H2>BT*8=MK0A[% W/DP<
M!\OQ3Q./='@]2"K3Q6SD#2,$Q Y";K2>K'UCOW(W5@-8SO=A-7G(,"[[S*57
MQ9]'XG[.,<E7<L"F05+U?LO_B^/R5LX?7P:)GP@6>3!F@?22LCB#!/$0JA-#
M03%.,+.JS&XMP=PX3;Z?D1V5V8-N1F>C0CDRI=6R+U[&\B_ 3H&%BHHEO#&I
ME Y *^&.U ;CYXC8[,>?E-P&P_.2X(8_R([D&,^7-R57B5!<:J@>>\M5JMFU
M$-)&B 4)$P]A&(4\A2B,.,R((# +X\!+XP1C;)1DVC_,W.A*2@II1U10RPJT
ML&8\=@;7?K)RA];(C#0,*&/2,</A"+-4G/YZM_[^'_(!-:G('_9<<N:QDQ"&
MF6HM*QA>[<I7VR>R?Y9_^;3A#]62^"2-8I_".! >1$F4P2SF/@PI0CRA/B'I
MA3[:D5'G1@S'G(IGE2>4Y$"+;IA1;3<)0UVV"Z%]!5?-&E4'[ED/2J.Y9<?&
M?&5WK >&\VY8W\T#S[?K7NR5-'K4(4&S>1%$B 8D#&$48 11[&-(0E] +TFS
MD%.:"F;5R>3H*'.CG[J:_F,MHNW1]5$8#4^L+P5G[(/J1C[0"#C"9DXO!*[.
MI8^.,>UQ=)^:!Z?0O1</J'CSSV]U!FW@^<FG0E4*SK_S;I=JQ3#-FYL)/R4T
M2F$0H "BR$]@RD4$61KS2#HJ'F=&)]&V \^-$_9YQT!)#W;B/^]7KQ2PJ/%B
M,Q/]'#(FOB/3B@6T0^KHV&!L451G)*PG"C)TBKE=)9P!P/65Q;%YW'0U<@8H
M^:Q@SI#[AY?3+.1T/=VL5SE]VD?#A&' 4)2$TN!CDOG3Q(.92!+H4X(%$4)@
MAFW+81X;:&Y,W\K9=_!MAZ29]><"GY&9>B?B M1"@C^;_XY6"K(/$8>E'(\.
M,WDIQCYECY52[+U^8%/WM6:;NIC$U[SZZU8^Y_WZ >?%$B&<H(1RF'"N>H"&
M#&8A"F' 4<Q)$/H!M6*$GK'F1@K/1 5*5J"$!7_6XEKN0O6!;$86CJ ;V[(;
MBII]3_;S>+CJPMXSTK1]U\^K?-!IW> 6.]JHRLWR*W^4+\P]KOC57<GUKOD[
MY;#R\A&7FZ<O\@5IWFV6Q"1)< B9SSA$&"72I%#E9+ GN,!I2M/(A$"L1IT?
ME>RE!$I,2Q*Q@[R?3D8#<G1BL<;0F%(&8=)'+O*!'6*1_]J3BMU8D]#+(/5;
MHAEV\\#\B8VT=N[7*WE'54<E+4.2,>$G!&*6J"0L'D 2Q1'T),OXC$4,"V13
M4.]P""LRF:Q=><>;K^YQR1N1____+PW\Y/_H:E6;)\L\B4-T/9&0E'$/)CB-
MI4,H?R+2083<DV9AX&<A3ZV:(U^([F3]S:=!U\SNNPRSD5FY*]R_MS&@8Q<3
M/(V(JW23PP&FS3(YJ>!!<LGI*X=1;/W6OY,S]J'8Z'#/VMD\V"I"/)4>8 0Y
M59UT:>I#9<Q)/Y&*1" :)7:GA(;CSHTN&I)0<H.O7*S+!SM6,(7;C"I& '%D
M_NCBU\H\S4Z3)5:.F,5TU$GIQA**EQQD>_LP8GI1C.^:J"8AG'TJ/ORD.FGT
MX[KL%N_;A70N$YK&7N3'$',20A1)TL)!)&T:WTNS.,!>G%C5FAHLR=S(JRTM
MJ0O#6^Y\#Y\.,RJ;!.21R>UK6VI_5ZL3M'JH!.=6$R"7#?"LS.<^[-P=WUT,
MJ",&'"['I)QX,5PO6?+R!P[TF97_\E8^D'7/$J_*4HVI//6W3_M+FO#WJQ^X
M9+4Y^:FH-J4^GJYTC-2ME/7Z49>=E@(+GF^V\I/Y3ZZTX^SJ.R_Q'?]-/GSS
M'F^X*ERGZ]8MHY2@A,<Q#&.62GLQP#!-!8(>RKS8]SQ/!$;A[O-2:W:,7LLN
M^>6-)!BV7JUP68%'7M9N[.F:GG-^=0S=Y%D(.Z/51VL+M;K/(SPZF*@F2MWK
M&ER !F:7T]G!!M2!DKKX9 //_^/N77<CQ[4UP5<A,-.-*L#<+8F41';_<MZJ
M<Y"5F9.9=0X:]2/ JZVSPQ$^<<DJGZ<?DI(B9,>-5%"R]@ ;NYRV)*[U4?JX
M%KDN-Z #T UH(0(-1L"!!"Q*8%_',N)FP*3F/=8&Q#24&G?38QHZG]IHF99T
M/?-1JI^55 NYKKMSN<VCF>!8:&[68Z1M2FTJ-*0Z4; D">.\Y*7B?:J&'!O+
MBQW'+QW2M/%;6Q&!;.4.S#(Y!JW?RM4;J9%R2%KQ;IJ&?,!)&#%=Y(S^L;)#
MC@TQ;C+(&24/<C_.7=OWY(QMMC9TJ(DLKQ9W7U=,;"JAUI]V25 I,89YR2A4
MB%.(=8X@3\H"2H&H+*0N&0[:U/4:=6HV]$YHL)<:[,2^(A'-;PY\#X4B(SOX
M.='UH/8X)PH *=K1D<^8(Y\F!<!P>, 4<O-U35%^L+_K,HO.1)J519H44A7&
M$LD0Q)@C2!.=0\1Q(7169FGI55'Z_#!3HQ\G5+]&)R_P\[0^KD9E:/NC;5YB
MNY34(MZ \RCU[E!R'(3(O4A>#/(J74>.*WJJO\B)J\/ST+YL-^L-6]AB=-_5
MHEJN/B\WJJV:I1,B4^V:'.4<8LHR2(N$0LV0+AA#*O/+/K@TT.2^^+VLH!86
M.&G]$Y[.PGJ>!F*"-3 1G,*I1X;86<#\,\)B 3=2!EA_ (/2O7Q0.9/>=?;V
MT=*Y?)3HIF]Y7=\W/^/A0:U$Q>:_+U>;.W:GWC#Q3R7W%=F:%U<9]B0E)Y 5
M96H,IC2!G"4)9+C,-!:2)5R%)6OX#3PU0MW+#1X:P0T05G*PWHD>FK[A.0=^
M1M<0R [,OAU06YEA+72GYN, Y0%"H8J6\^$Y[,@)(&%@'&:#!-X?;N+9)+7U
MQJYF=2.Z7?7AIOCP;ZQ:N#9$QJ!<SPJ!BS17K@&Z[1IDR(MD!849IU@K0I,\
M03[AV\$C!W'6"%'=MAEWM5/ _%AW\5:[VLT+<\&N;YBH-0)W5B7;+&SNE/(\
MWPV?ILLVY&#@#TQK>[F;9IA'ZF4#)SSXL@*U^$.A[&]X#H;V2)9H5-2#C-->
MR)VQ5L.>-YKYVDO-KCW;[P$]#5RVOO^Z6@JEY/J;$JKZJ>3MPNXZ-.6O;./[
MXZ>K:]?>8A\GK8DBG& ..4+")JR4QA@6""(FLR+1M%0)#C*!HXDV-2.YTW3%
M'3 UX1RN.?#WVV]M+X# +)>(4^EI2;_*! UM:QNE0*L5:-5R4V,W0=MJ?O:3
M/QV^LQZT]TM\W&,9[O$$&]>TCP[H@?$??X1^?/^A6E0;]<F._[+!UJTP]L=V
M;B,_NIVX9KS,1,$* D6ND>%UPB'A"8,HH5FIF. %Q3V"5,(EF6@(2ZT(G#N>
M.&C%=P/87AO .NJ$L7N/B?-C\8'F81RV;K!WTA]V\KL!'0W K0_VP63<'[Y(
MI-M#@%')M3] +TGTBB?%)\O.*.__MD&)G:8-9<E+S"6#W#4#2PB!E"L*)<XQ
M8IFBN Q*W>XIQ]3,WO!^&7TGX'KFBP3K:]*?]>L?E7A)?<-TT+@2RQ&X\)P4
MDR%$#ZA"6-'G<3V#&M4C6QFZ;4*3=AE3;='LVH"=I8H4N=(4BI0+B!4V3%@6
M"4RY,1Q%HE%1E#UL1[_1)VHOMB[D8]/O)#"2T0]X/P:,B.-(L8R-P&THX[,N
M0;M*^[78$8,9@V"*%<WH-^BXX8Q!0!S$,X;=W;.OV7)Q9[[BAW>*;WYGF^9H
M[9MJO[8O^NNJ6HCJD<T_+BP;?C#,.<,L-72$"JA9KHW%QDK("150(4&R%$O&
MTJ .T+VDF*"]5@;V-^L%OA]7#0[IP-1EY8=6 6 UN &-#D^-/6:EC=C0[!JP
M8C4UZR7#N(W-KH'IH+G950_KQW;MGJ+;/F2VT?7M3U;-[8[AA^7*_F8?7F#E
MFC&12\K2#/(B30S1E01RE26V]9DF5/%"J*!<\% !IL9QNYU^MZ&_9L$=2()G
MP(_MAL1U8*)[#JD5U1YT62&?=:C=Z0/U<@7M9?'HKR]ZD9@O>/A12:\O."_Y
MKO=SP@.;ZKZ1ISI%.B,"4842BCC4*480:X4@S8V[F6-6ZC3+"U8HWVBFR\--
M+83)WU3SA/,\2\4':6CCJVDRV_$66X%O@!'9PP;K@Z)_5%%<-$<*)8J :E
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M"4<?-LJ'?DZ-]O,]>TWXGM,'EQ);;=>_*UF9I[YE*_5-5?M\D8='MGAZ:TB
M+3YM9./RYUCC5. 28AN,@<WW"KE4Q.Z>HZPHRJR07L77>TLPM<][IP1HM !6
M#=#1 S2*@%]J57X%1IE_^&_$])NHRQM<@\,_,)WT1;['7EB_*?#?'AM\*D;:
M,8O^,03MI%V%XIG-M7[/'6V_[2JUNUMPUSTH? 7Z>L]6#TP\V>*'2S/*@UK]
M;\7FF_NF;4GS&:F<L=0VOLYR;=:=C"=FR6$8)EQE68ZS7*+<=\GQ&W)J:TPK
M-?CO[.'Q?X%6<O#O:CY?J#-E8OI"?GGQB _DP*O%#L-;6S:U1;"6&;0MCL)7
M!D] _9>"^,".Q/T^ ,?A^3"(SA"[YX-&8_(PQ;K4'7CGE5D@]7[I)U?>FJ4X
M$R*':9$FQA\0*:3"<#73:2($+21.U&RSW+"YWX[ED3&"V'@WTH#G)+N$A<K)
MV#.UHP,BY:FFV/A3.3+K&L861)86$$M<E)1H0G/=,X&F'XQCI\W$ E+G*4(%
M+2#/$F,J,"PAS[7Q3A'1%$F5"41G"^59?[@OB+O\SJ$K!+\$$/SRV^WM5_"@
MF#'90EMT'</3;T/\RI=MX(5_#Y+?86;_G*)#]6-G$G5&>)W\H4,53V8-';FT
M]UF:LB71?["_Z]I['Q<_S9*V7#W-BE1+@A,,,TS,ZL-Q"4E6$B@3BDA>XIPG
M)/"\[,104W,)=H(%'XR=PM+[\"L"0L,?<#DA;;+TKJ#F9<3ZG%]= "/>&=6I
M@<8^A[J@\)&SIDMWA&\<_%A5G,W?+S8N!;IQL;3,>8%+"1F3TNY'YY!JED%M
MUGQ,52JD]$H8/#7 U!B@EA&T0OJ[K$?1N^SQ7XO)P-_\"SAZN/)'<?%WW*_%
M9R0WW?>U"?+(S^E^QO\^>MMHWO8YH;N^]=GK>IHTU=H(:*RDK9*-P62\=O/;
M1^-UR2_ZS9.M]- 2FZ )*E0"59HCX]1P!5DI$TAQ25.F<5GJH*9Q(8-/C?2Z
MLH.]\+;O42V^K>UK&R48#0(MHY I\;25!@)Z:.LI .,!\E?ZH!;+S H9>ES#
MJP<H!Z98GV?TSL&S/0",%_A]PQ:2K>3ZCT?)-BI+4I)F;4H+PI3;[D!)?; C
M%>2,"EB4A:1Y0B41.C#_[O*H4V.TO=!@)S6HQ;8560E,L^",.P_L_1@L.J(#
M4Y<'F,-DW/FC%"_;SF/,L3/M_&$XDF47<'//HC-J];,2[1J><"XUUP+*$N40
M*YQ#3BB%,D4%I1G/*?**9#KZ]*FQ3"-<8!FJYX#Y449O& :FAD:N(0I<'],X
M5G&79\\>MY#+,;4.BK8<O2BB4_2#_?U>:R4V7_31O\^T*H1*C3NDLY1#G%+C
M'1&N(5-)6N0D*Y(B:0N!_KC22;HD3-CIT N1AMPK=N<>&_9WV]\D@FMT<6*N
M\)&BX/R:SM*-VWFN=;#>TO&K!O:9?%$<TGFZ*,/K>U&^,'FY4]X/"]_T_E1M
MJCOWD.]JLYF[#GIU$/@7[1J<K[]O^7^8H7\LW[/5O%*K_77K&4.)(BG&L,1)
M 7&!C*^5J!PFC*5IC@U/9EXG95=+,C7+J!;<?J2NXO4:K&O9;8T.54L/UGOQ
M_;>3KYNOR_OQH\W"P RZUP/L!6R[D]KT^UH9T&@#?BQ!HT_G^M'FQ?\\8+3Y
M&>G@8.!Y"CIOB(+MF8.)ZYX_V@E&%!BZ1QUQ'AB_)*SK$[N>9=)8] *EL-2)
M@)B7S-CZA8224)63)&&R#&IU>'G(J:U6)XO";N[5]9W +\^ YQY 5%R'WABX
M5!^VEGB< K'/T1FA0FPSX&1*Q#X'(*1&[(L[PPWLMD/6OU>;^[?;]<;XS*M=
M=\%/RR<VWSQ]72WO5NS!D-_"#+R^7<C?*KUYRU;RXWJ]M5DR,YDEN%"*P;0T
M_(33)(4T)<;F3@0VRXS J?).5XDCTM1([)OZRVW,JT9DP!82W!FA;0]I":I&
M[ ";+M+473:ZQY^0@=FO50A8C4"K$MAW96V4 HU6H%7+I7E8Q6R*GP2M:J//
MF;]!/O[<C629W[J&Z]:%K19BY3I0_")5_=.OYG= M),\WTWK2HGEW<*UE[%]
M=^?-+#\VLWSATXR4L!EW1L[8\Y$&&LVPCPM,U\*/_.2>X0'R/\S0SFGXL?RF
M+"#57'U6FWW,^(_E6[:^-Y+\K*22;Y[^6-L>[+O@\ENQJ7[6#7#XVBDT8UE"
M;'4"6!;4K+N)%) SQ* 299X@QJ5&0<[!$$).;27NZ&@8X3^WE0V:WBP=.SAU
MP4)MVN02\WO[+V%4MCSA=+9Q0,M=@@7;*?P_ V,6AG@A/$,<7GF:AXZ(Z,RP
MF<"=@L!H^*)$G?FSU1-\[<SM+U97\P+\"G;J@KV^X,]6XYC1% -.2*S@BR%$
M'#=68T"0#T([AARKWP+TVW(I_ZKF<[.T?33FV>*NXO.ZKY&-AQ/SI<V?VU>J
MY!EEJBQ3F!&<0XP* FFN$2PTH9CP$A.BPO(SPP0(X9-Q4C=;^9U]6!<.W>L1
M&&42.!E^M#X<P ,3]C-D]Z(W:4Q@+_Q U43[ 1>)6 ,''Y4R^P'SD@Q[/J4?
MS1E"-11J#'KSAFW,B.^-A?=HB?CK<EZ)I_TWE6,B4I$I2$M;^IA+!@EB"DI4
M9(5QI#3+O)JRAPX\-7NXE=M]?#NAP^C,&W0_(AL"RH$IK!7YQE46W3P'T_S2
M"0[^;/X["(N%HA:)O[R''96Y0L%XR5G!]_=EJR97U.WR?V6K+RMWYEAW?_NJ
M5FZ'?Y:70JD2"9BAG$-<E+GAJ@)#E4M5Y(G4*4-A7.4S[/28JLUQ7ENQ;\ C
M6]4=(=WYGUS.YVRUMD>"]5E@X%&@YUSX4EALA <GL!;<[S6X1F;S*M<1#K)N
M&&F/!^NCP9BL%0)4-,[R&G1DQ@H!XI"O@N[NQU:?E#':U/,>N;N-U+9T\KNM
MLM63/Y@W<X8S0C.2&,NJL+R5,0:IR#+(9$[*-,L+F?(0W@H58&H,9E[$(HR4
M@B'WHZ<A@1R8J&K1;SJ;<TT/[9W\-W9;CQNV8I5L2KA;'>)Q5E_T(K%7\/"C
M\EA?<%XR6N_G]..V>F/.<:9]\FY'/5%(Y2HEL+"^(DX+"3DSIE<F4X1HDJ6$
M!&6BGQAG:DS5;)/OY/39]@["U8^G(J U,!WU 2J8<"[ $(E73HTR*GU<4/4E
M2URZO&=<IC66WMAH*UL 6"W6+IKA=K4R,^_&>?.TOZ3AHEL;X//ET268_V8N
MM&5_ZBBMWU9UU4A<\(1+F&E;IT\E">0:2TC+C%%"-$(HJ-76 #).C83J\#9P
M9R55UP1Y#C"=?OSURI,T,/<YT:&3'73U QT%7=6,SG6-DL!I::VXIM!&K:F-
MW&EC4)VV$4-0AYN*6#&K T@X;I#K<! ?1,4..%1/Y[BU33\L5W5/H7JKL.DL
MU+8;^JPVQE=_J+8/3=_'N4N:VRXVW\P:]D;IY;,"]+?:$*T]*/XP7_[U]MYJ
M-\M*7; $%9!IS""F16*/9BE$*E%2%F6A&0FI/SR:Y$'KRPA5C>M3>AOUH8P^
M-O"K$RUH0P1UW1;LL=ZU;Q*)UP":%Z-& /QB-X&5A#9<1#9P ..Q!%9B&N_E
M\=P?F.(K,?3&PK.I;SK"-0<VC=Z=CG$VEJC1_:;MECL'K?K ZG]CWAB+0+<7
MR U@%H0ZZLC" &H<(FY.C#UUL78U1I-[W.V0L:?C8!]E= %Z^ESB7LGM7'W1
MQ]=VM['=K-ZWBWJ?^_;Q<:5$Y?[^K;J[WZS=&M_$3CW]8'S>B:*1*F,9)\8#
M*[" 6#(%J4PI+!A+4IPIQ670*=K@$D_.'VL4MF'W=0I9HYT[[JY_TU40U!K6
MMGX;0QE8O7GXU\+3DYO29(_HU^W\M;UIW7IMYV?]9C?AX$^GZ3!1#Z/-2RPG
M;W!YQW7YQH+_P $<;>#K*OA_4.8>-J_W*6VIE+^MB&V_V9E9A9! !$&=X:0.
MLV5ID4):%ARA N49+_M4\S\_[-06ED;:?G7]+R#L1^_Q<1N8HW?U_AN)V\0&
M5X2I%AK\TH@=L?%'&$Z16P%<&/15V@+X 7&J18#GW8/L2)TPAU2>,8IQ!LM"
M,(A)4AI&RC#4><%H)C7&*LA*[B7%U BJ:_G6WH[;JO;8,@A,#.@W9U$V=29O
MEGIMT(QB=%Z%Y#C[)5,P#J^"*7 ?(ZH15]<%VH_WQ^*15?+MG%4/ZQD7*%>$
MEU 8TPUBS6W#-6/!49H+D9>YQ,3K(/?<(%/CO^>?WM9)"H03-:0*V0E$S]-7
M+)Q&8R<C(ZB%!&]C0112@^UZJ$8JXO!-/;KVRS9/]]XF6V^,';L_@5DNW*\Y
MF[LNVNM[I3:'[Y_[#5]N[LT%R]4&RFU==M+M3LR7B[O];_8=N=OJ$.MF.WZU
MW]F,5.?ATC2<K<1VXM81BZR=%_YY_;0+U_8S7K^I]695V9UIN\O\V<B\-0;S
M8C-+4Z:(1 E,<6)K#2%:M\96J4A2PB4G91%BGYX::&H4O)>S+D?P2[40\ZUT
MJ>I@Z=)1F<NI"PR..0FTGU$9 [Z!F;F#G)7Q!NREC&<27L(ADM5W<IA1#;M+
MRKZTW2Y>WX\CVFHM;7K#&[:NQ"["%+%$,(DXY(KD$!NW%M(B+6"9I$+Q5.@B
MDV$9[&?'"WGAQTE8=^+MRQKM\J(""Y6<1]F/):(A-S!5["I][3*=;D -XQ!A
MO5ZH1"*.\V.-RAY>:K^D$+^;7B?<]_W?:B6JM=K%D_VPENQ'8V(:J[(2+@5K
M5JBBY AKR$AF<Z%$!AG/,EAR3-.L+'*9AA5R'4'HJ=E .^F:M$]7P=R>/RZ[
MY]"WW]9 -=K)<2.%O=X$SP/GB<WOB&?.U\82[U3OAA/OWQVG^G0"BT,F:B*1
MQEXB_TN%'H=,0NQ8Y*"Q^ZUP_Z[L<;>2M\;R9'>JK6_^KIIOS6_K/(LOV\W:
M]B$SJ^P,$ZYHPC7$A::VX("&-$LH3&F!,:*:YCD+6:P"QY_:NM.*#U@M/Y"U
MX$TZ"ECN1>^?I1(Z1S11:4DUAD((8U 0X]JPDBM("L7S/.>,%45(&/B0<S1"
M,/?!'-63<+.;J]$FQF]]'Q#N@9?J'=*-Z&#?3Z;)V.K(;5OH.HWB+;@]D8NT
M=H:./NHRV!.:ERM:W\=$KTSX\M_UD=\L*U2:YV910@RG$*<9@QPC##.1ECHK
M-4$\J'97L 136Z .BN9%*T=X8@;\.&Y07 =FN?-%"6^._6J,*E^](1V^7.&)
M\:=2L? \/ %%"R\\Z(H]*'[9B> OG8@/K%HY%\$(LWUH/8HZJ>.'6CVD,TQS
MPE IC:&H%<0V:H')TACS,J>B+/*RT%G81OAPPDYO%WV7\36O=%UH[$FQ5:\4
M]&&F-V [Z=6G;/J;2%;=IMI91^%.XI_5.?+FT:#3$G/+:!A!Q]\H&A3PH]M#
MPX[8;\FQXBP7-OSFBSX1@?RV[N9J;/Q=.]=]LP&2EC+!V*PKBE"(<Y%#SF4!
MM4!,%A1A(;,0*_Q*>:9FD^_5L9[QN?#\&[#7:]\JV:O5P" 3Z[>BC#A= R\;
MH\Q4\-(0"=](_'^M-*.2?"3H7C)YK,=>FR#]6?UU*UQNMNT$N%HNS(^B;DAJ
MW)4F/^'CHGM-M1#5XURM]SD#)$-8,RQ@HG0),4H+2*6@L% Z23 M#'VK?MG0
M,<2;&IEW$T"Z_66^J?5V[JI0?C!OH<V#G3_9?QD,P%Y!6QYN(<V2WC?W.<J,
M>SH*KS:/ [/\D>E8@S\>)=LHM\=3*V2/C#M7[E0:*8DY)N;1,Y:C"/=*Z<DQ
M@3V=BQQUE&N7B=N?K)K;E_;#<O6=S=5W);8KUU+H4[50'S?J83W+=*(+@0CD
M*,$04X0@3[/<O 54TJ1$W!CQ_58!C]&G1O+O%-^ O9PW8*<#U,L57#-+ U9Z
MX,0/M,K#)B:4K"/#/3 77T#ZNS?25U!M &+1F=1G[%<BR@!83O-@R$/ZT=R;
M;36W9X^&5ML?/S[8%HTUV_ZN[)'E3)2<D42F4%*N#+WA#)*\E! QPK -!.<J
MB-Z\1IT:K;62FL^,-S^"JB-UG2EEZVO?+^?RV9_"&,YO3I(R)XQH E.L;2!L
MB2'5-LH(9<+\I<R0PF''$=%G9:3X_'8R+/Y#H^ZWGD1'<N!UY!F$NW]T109_
MUD)'7$*"0(JT=/B-.>J2$03#RZ4B[.;P[.UW2IN%1C:[,K:+T]OEP\/2_/]\
MKFRJN/JQ,DZ\M4/V:U/SJ91:$E5(!65*$<18,,@81Y!DFE.:%2(IB6^"]Q5R
M3&T9J04W;T<K.=A8T<VJ\L*:\T]WOF:6SA/:B-@/;BH[+4"CANLO9[>AK29@
MKPIPNAS,Q67ZBSHI_FGJ(TW.2)GL0T]24.IY!&C/9*=?\_31$M@C0-#-<8_Q
MN/ U[#!I8']F7*<._%9W1OB^Y6OUGUOSZQ_++$E)Z_P@76J:)# O>6K6L<1F
MRF,&!2U3RBC*:9;[KF-7RC*UM>S[LZRQML'$>B>[[2!EI?=GS6LGZ_)R-N(4
M#+RD>=87;9I"V):$!Q/38UV[=H;\U[819VJD]2W"C,59VR)!>V9]NW:$T=:X
M2%!TU[E8C^P9C\16*WMX^DT]+E<V^^#!'I+LHJ#VO<*;#[+(4)%CF<)"%1KB
MO!20\Y)")+362<ES5@9M[@6./[4UK17_0GYK%.C]=I,&!'3@%:J5N(D$_5TQ
M*V;=WRWZ?E)/F&(%]@2./FX@3S]H#@)W>CXFW&9O4Z6^&B9]8,+U#Z\?NI[E
M3)1YCA0L-2L@YEI"(BF#DE.=*2%RA+SM\3/C3(V7]MF!CXVPX-%< !YJ<?T-
MN'/87C:?(R$V,/$T8'W1H)73[26 WV."Y6_)1@)M)"NU+WA!%J@')&>LRW-W
MCV8Y>JC0M0I]+@]GRK=LH^Z6JZ>T,2E8D;%,9Q@2QFQ.9\(@)UQ"E%"F58ZX
M3+UWW5\\>VJ,F/I_QB]1NLQS5^@^,+>UDH&TA_?^$@A_#KL"D)%XZW=CE-S9
M1/I/2\-6;U=*5AOP_VZ9JX+Z<2$KQT< @B,(1BI7>@*D,TSV\H[1V.N$J%W&
M.G7)R.7!WO_GULS@Q\5ZLW*OT?J++=/YXYXMCG:A?)%U[_[XSFBRLU-GPC8(
M8<;%92G/(!:9ABQ7!2QQ03*L.&,X&:6&6&S-IL;0[3:63?>4R_F<K3KU$\?J
M/AS]]6&2IU(1!G--;.1-+J!953&4%">IS!(B)>V1"#P%W:87W=.*#-MZ-.Z4
M ;AP<VV33.L2=O__>L/\]H4F(^^$C*,(J<LU.J ##W#X@(T!Z%RG[8."/NX2
M8*'JY$-/H&+>4//_VF7UHNOUKU%[;ZCIC%:@;S !^QJBQE&PF=\VT.#3+E6
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M5:;EY<KV.D*,W*'W2]NZ4:U$M;9R&KF,7;^NA/,"TIGD:9ZE$L&2,0$Q0<8
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M6X<0<&H4=OO]VXZV-DO E4U:=W+;#=#-O6HW01]K^0$S]&:+#EKU[>\7#0"
M.03\_:]!IO^R8_S:DSK\$6"K7N.8=12\ 8V*MMQYJR2HM00?%RWI_EB"-_:^
MYCVXW0"CK*N07JO[RG/L[X6_]ER/Y*>_ZIP'.?1#3L@9EW^084?;%!@2M.ZV
MP:#C]/,^/BLSAE@^*'N(ZW-H.].<%XHG"E*F&,0J)Y"A+(&8<V%^+0E&95M=
MR\\E"9;!BR&>%]L:>)&WD1[&$;%*U'6US-K^/+)C\3RRHVI4"=R^")^N'&4Y
M$06!W+B-$%-60)*F)40Y406A6J@BZ5$,;8PY&Z- FCU"6JE[&[GU4TUT"OT\
MT6%F9*3^.LJNE%;X-E3*,S JGL_:&[Y(;FSX^*-ZMKWA>>GL]G]0S_:%RX>'
MRD4KN?(LYOGFV6HA*K7>-QC;Y]ND6FFSG%%(L2%)K'D*.2X8U*GB99E1I8LR
M+,TJ3("0CW*</*J._.Y@ZID&@?T,P^;"C_>&PW=@TCL++-C+#OX<)&FI'VZQ
MVAN&#3YN=\->P!PT-^SWE'XD]]MR*?^JYO./#X^L6AD781_ 6?_*RF$)=Y;S
M-,VS$D%:),3P&^/0[MI!1&6"K.U.A%>WP^"1I[8M][86TUI]=XT.H-I)'$AL
M_OC[<=H@J Y,9ZW,-Z"5^@9TP^7W@@,K>3PB"P8K$H?YCSLJ?07#\9*YPA_0
M]^!S*922:UL)[^-ZO;5A$U_TI^7BKBW-/BMT8:PNDD-!!8<X9\8N*U0."UP:
MOB(V\B&(K2X/.36::B4&=J)!U<ALCP7F1NHZ&$(:N4.//B]"[WO\&1/0P8]
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MW=MAAXA?.&ND*8M58FMH<<<MQC42^ =EN\8:MV>!+[:^MSM"YC]VQ^@GF]N
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M/5LMW-[_+!<Y1Z7M?L2Y,46)8)"G10I%BD1.<XQ5'A1K?C#"U$BW%3 PW?<
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M",,)J'(,#.W<?)<@,SHW5DT#UE8XGVU$CJOMK67(B]M/W![DN'*O6X&<^-Y
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M.MC68@,MMWU]D$NGJ9^4)P9_9"X^LW->@%J=!6@4 D8C<->9F/.1P=YGR+Z
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M$,PE,+VJ%'/1S0:F.9%2%T^H/HNZL=?[8J7?["6+N$0!4MR792E$2<0@EJ&
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M+L+9FN(NAZJ/Y]3=.QRG?COPVP4#3T)REP/3,IV'.[D[1OY;D/)6WI;%?6M
M&JOP8_%--$>H##&4I!C#()$Y1#'%D."80A8G*26Y"&1FG<I^=K2YD5@4A+G]
MMO8\F.<]#%XA&IEZM*QZ,]F1MME, BWO@!/]\PC:[_J](CG1EOX,HG[VZ-;
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MAW@2."/>HL$-25CF _79]5)=?PB1 W7O[@E=_>KHU/"Y/@Q'.@G)RMA-9X+
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M:4ETPAL!47E1^\BZ,@L#=_P<>'4,"(<65L,3TD=QP/AR^JIT1YW&'Y_G?KI
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MT85(JP\:NGGWP",-*H+C*&DV8$S>H;RGE^5V_$H8: ]O)SC?\J0 3 P^EN[
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M?2"?I&C8VIKJVU,]Z3?AW-P4A+R&L.QN9WP=ER138>Y#F(PO5Z-G;MC+SO.
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MJ3$JX'M)@E2Z**)3& 0-Q-$H<_14\NU[T(<E0P]UCYK/E?<AV :L3,?2;D[
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MJY]$/T?4, <W+4/R%*TUZ3S>3IG<D.M(Z<R9UX)HQRQN -P06[8"SU5*V8:
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M83X8X2/2D%UEI![84KZW4Z%SHNU(B3?@OCUV*%%XZ2XW?/;?1SX:!EY2DKF
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MCZRI'7PZI2G^GRC!2ZD7NL$^2$XR2EAK37&1Y4,AN._+]T/@3WTF<A[%# _
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M5I.)IAF\3D+*7-L,/"#B]).7]0-?E6II?.#&66+9:C82ZS;B.@!/-+== _I
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M!M20*+4CDBDT\([A$LS, AIZ5K]'T&$4[@?'G^WHHT<M-8#!$IM_R)_\CN)
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MDNZ/N;@I8<"XI73I)]HZ0:2'4F&?.3'(G=61QE3]FM419.X'OY_M *%O?34
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M.>@8V=[!,W<R /J.N%>7V9^,..\LR5PY)[GUV>YSJ/OH"X;UH"J@H)[X&G"
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M\](\M[49]</Z9@/">R  C #ZMQM[/WMK._3C)@FAI@]NT'";F/ @@[!DQ9(
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MOJK[\F/Y0G^&M1F5D4F$ L5: 8I.?XA.,J ;@K:^2(S\E=9P_8F"E]G<]$@
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M@O=)@.2H>/8VY$X]UCLLU0U"KS#.WUH- Z-J_<#U_O)[F"ZJ]'8<6"?0&:>
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M)3)17!+*L !CGI,3+@3$@ QX0562X$RPUA=P-\J&'7U[EI.R!Q6]S,S0W>C
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M.SX-BV=2QLOL $IV<?CZ=8&;&<KSLIT7TE=)V=.KG:.B[ !^^\]_RY(I^B<
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M5$8H!*9\;4BG W@1$I3L16:,CKC2^MGZ'"/ 'Y/R)MO&<U9R$9RLWMJ%3]M
M9[SCP)FUZ)4H[1]?.Y(VVHC+(3AY? !X.[6,IO4EYAT3ZR1YE54NJ"P@70>@
MN$IUD*L$H;W.GD[QJ&T7:'5N??GS^F.9[-U0T7O[89X@]1$B9YM26HR/MKHS
MUM='E?ITXVU]8Q&ZA)KV(+L-SSH".T-7W+?1[#-0.4+,(PBU[=U*U[_/5Y\6
MT\NPN-[T-4IW*AI8P*2Y1 AL/;DP%;)-(X*U441GI*"SO/'U=C"1XX+:,<B8
MGU--(\#A;?)='<6YV9Q1DR^BR0D*FL[Q5,]Q9!JR0IY3%L:;]CTT[U,QEC&2
M[:^\1I(?'7;>T=;[.E]LA\YL=X/QPM3>GV"T*:!,RA!=9F"9B1;1BX2M0Q+/
M4S6L.76JWI^$T<E*& &L_A/S5_SM:I9O^EOGX'Q]J<LYQ5IT[\&C13 1K2G)
MJ*Q;WWSW:1@39$[7\;RAP$>1@$VW\0^22AU M+K^B9.@(CFR!9RN93C*,=I9
MQ9"_&U,JS*4^)NGMIV78&ZUG"#51P"B@]!G#Q:_+VKSV+AN&,5_3+($N>Y*-
MM05\]!QDH>N^1!<L;WV/[25DV"S_GD%TNN@'15!U0VX-Q\U6^#NNOLWSK=P>
M_A3Q]W"Y,0,$<83<"V#<U!)B3EYQ80I<3JB$*L+&3O-EGXD4G$+C6*;-]A.)
M.IOV!HY6/<;'UF&.UB02H-HT657:2/!,97!6QQ@2EJ):1#N?IF*X4,+Y4##O
M124#ITA\QOPQ_&O751>-=<I&2*J^=RJ/$+C78$WF:(SAJ.X]1.U-?KC[F<,!
MHZ6.Y@T$-@)?;7]\[,--V9^*'EF2"$(: 2I[":'>Y>BT5+Z6%>36]O<S) W;
M_>L<@:66.ADMQ#[^.:,5ODV_?\)%JAK\BI.B;69*%] J,1):+A"LK4-HM-?)
M.MI [BQ@VT/<L &$II#H!+=3]3/P)?9^1ILQ7.QR>J["Q1^XN)QPAID$XVI/
M@T"G<ZI]?4,&4R<?V3I1P'89R+#_TX<-$/0!D4:2'!@+^R7SYG*=P[/CZ]>:
MT[,D7:VYTZS>]M)!-KG.5*M/3HJX6\]3<XF)V*E1R>$K#^N?]86AGC7P$O"U
M9LH;)4+6&H1BM&DX"=&;PHD]A2F04#U_+I'NH 6'M94&1=/!\AZ\Q=(\(>9E
M;=&SG\%)9!X)_@9$B@BJA !1T?4;L[?2).[8_4241[HG/;?2L!VY^H)-8PF/
MP++^,)]]K3B_#6TL)Y%\3%%< !=9JKUWZ%ZN#0V3,0FM+%G(UCTF]Y#1"4'F
M)2&HE<P;1KC/FA+^RW29YO4G5YBW<XSGL[X2PI]>[ SIX =PVW\R./,^<%$,
M6%Y'%"3OP$M9P+!DG"QD?S?OCMU?,OA>R6[ZAGV8+]>'\]X_>8MEOL#-'];N
M=*A,E$XA1.TR7>@VTRE==Q^G.]_IA#ZT#DPU(GVTR>2'X&Q/M\NSJW4$-_!>
MGHB/7TO!M/I8]OY^8HI,Q5D'Q57?.;L$P:L$F142./G..;2.<QU%Z&@;Z31'
M:E.5C:?JL,,&7/Z.Q/1ZZPGT+(H()N3:M9%K<$DJ< 8Y\^2+AX"-47D(?<-&
M1GH"8V\*&FWWQ#?IOZ^FR^G&GII6&WJZNEJL>P6N6Z:M&W'_'A:5^1]XO'UY
MW#IM3,L&/#:R*G>SN]_-+^-T%K:UU&LB[A!Y ^7"K%#KV'Y0'.J%"\%E!&F]
MU3';Q'+K(^ P"MN5(N[6O:NKM]=WOMN\XW'.F WDVF%6M.>,9! 8JX>_,\H4
MI=NWC3R4QF'MR1X1]GC!8@_*&X<Q^7V^#!=_6\ROOK^[",OEVC]=RZ^FIB19
MK6,>(<HZF5*3[**7 3@+GB<E9>"LO=GX%$ECJ6OL P\/S<9FRADWUK;9,);9
MR&W=FCXH4+6-I N% ?<I:R:=E:)UFZAGB1J\8W\["'2'UQ'Z&!O _A,O,OGY
M]"W^/E_M-W-W^>8&)>.> S*R=)4BDSIF@:!],%(H9[+KP3<^AM31@O$8P#P%
MQYZT-S:0;KXAILK;ZR\=> TH(FI#FYREL)D1[%!F$-9[Y40NYGZ.0%ND'DCO
MX#,HS@77/O4X#LSN>YJXQ_26-X>V9!,*6*9B[3H>@*ZB "4)8[A(SO!.%0FG
M1AH?H6_PF1?]8K(?/8T @YNPU9=:Z5-?0+>MJK]\P_6PH3<YKXWN<%%E<#%?
MUMC'V^N?Q+VDC]B,'-HOI[5!%1TOB<4"W#ER%J/RX!,9[0)]#"5BD+IU%Z3S
M<#:6XO@S^$TCA,H(-M!!#-XI4=!:J^"U@.P2L4GG#P09Z6@R4= M)HW"UD_!
M1Y(Z=,'U^%#WE,W2$P0&SFG[>#FC^W2!NYR9=_3U[LC9%8=&KIW09&UAT*!\
M'16&LCZCI*BS*MSD>^E*>W/:GE]I1-Y:7\J>]R;Y@7'T=OGGM*P^?'BW)3TE
MX6+-LLK&F-KU+H,K>EVCG(0W*3G5I4/^O8\=D8-T!H2<(M.A4V7#=;G OW9S
MFXM)' 6'$A01+C@'+YF#5!3S-AF;<I<*Q9\^=$1^R1F@<+P\!P;"']_"E"[V
M?.]D(RJ+,DR1N>IJYA J\-K&*@R>='#"^]0!$?L_?=B4^G-#HX&$!R\$H\_9
MO$N&B_]</]37R_ SSO#/</%Y^O7;ZB9XR;U,(C'P&,G-<:[V=F8:M'/DG$LK
M#>MBBW1?<?#)UV?%4D^:&'R@P ^2]>+ZEJ%_SA?_HH]^-[_\CK/E)LOQY^V#
M$17/D2Y767NL^-IB$%,$$VV@VU9ER[L [8BEA\W+/S?B^M;-" ()MR[NEHTO
M^'5=E+#U3Y7(1G.(,M30MDADU.4 S!C%I)(.4^LWW"<)&DOWF3/$O=HI9@PH
MV]"^W8X!G;,Q6R &Z@0.7LO 23;6,[0I!"E2ZT>%GP@8..NDG6+O0^9H*0_M
MD'T+B\N0KM^LYSTOKRYQL3ERMQQMCU8M5$3/.&1% E*:OG)661)55%KE:)GM
MXK9W6VU@D!RORGFO<AT8*;<W\:;Q\FKY,RL832HZ)F#<.V(E& @F&L@\5:M/
M<:&[6$;/+#/P\TL3;+24Y ANF#TW\OH\=3P8Y14C'==&\UG6TLK,H=3VDRKQ
MR&SK_-M'2!E+WZ$SV"XME#%23-4O%WCC6"A7 E,)(FU!4*)PDD_DH)%VC>8!
MLVG]G/8L4>-(YSY)]1W@=+P>AG[3"O_ZLB+*5YL#F)S8[8'+E8@Z\@P&B]_$
M35WVBB1$EI\('-%VB4,_]OGC@\4)*IPWEN? F-B4DE_?YX!ERP73!4H*%I0L
M$9QT'$RL8RL<Z3W(#HC8_^G#VC#]X:&!+ =$0\;IY -^#1?;GC3KHQ.]30XE
M6,RN=LJ2$.AV!A7):M<>I8]/!6&6F/[7U_F/_Z"/WMPO],7MM;)GP6&CRF<Q
M5$X5\\ (V5"]W2A.TOD6<@ N;*2;E4CV]2NNM4MDP*/W3S7K?1X>=U<;YA8Y
M65WS!K(;J]U@K8N":X0B1"V+(V_-(2?OG=6"$2]E$N+%V0VG::J+>7"(V,9I
M'G#D*F=1I\20E:.(\)I<G$!8FQ.7EEF?7YAYT$SM#40V @?TRU5<XG]?D<!^
MK0]1-^.".'>BU+:&.EF[.?N\SL1&-*Q:1JHT;^CS""G#O@>>]T&F@3+&B:GM
M7L.85#1&0[(H2#@82"X^0BH<C4"M.&L]XN118@:.OK=0]?/P.4+NXP/0+ES,
MM13:"T@H YVL-H.WL@ WR0@CDM#-VVGM)61TP#E&R4]#YPB)CP V_6?4?[CI
MSRB<T4;H!&G=!$P) 5[169]MC%*E''1L/W3P;.QU@KA]%7?N6$$S@OVT1_I?
MOI$&/RVF"2?%I\A"]8ZS]: <G3FAV 1.,8%2LU!; _7^,'%+T&NOYCD21L\_
M=!RITQ$!]$YCGYJ$,,V[EGF+,%MN*.-U2J#-.AJPT3A0)"L(N8[.J4%\;[SD
MIG6EYB'T#3VZ\67!M[G&ARX?>LA7K8G:?OD;XB2+Q(1- JS%*C67( KO(>BL
M$K&#S-\+T>\O*'INH:&G/XX;A^UU-8)C]/WE]S!=5'E_++4:[\/T!V[:HRW_
MF+_%VWX $ZUSY P=:%V3WI,2X%)]\/0.7<"D?&X]);DS<<,FOXP=N/WJ>@0@
MOCLZX4Y#RUL? I<3SRSGD67:B)Z#*@(A!/(80F0I*V$YW0R-X=N!K&$?0U\*
M<%OK=Q2#H/\6IK/:6??CK#9:N>5EPG@.SB0&K A%ACCG$'CRD(3TNFB#I;0.
M+SQ&R[#Q]Y<"SR::'-@(_?VJ1OT^EK]CGJ9PL0D"DE@$E\E*1]NHYK4821R8
M9* P@A#9T,BD[6!Y[O_T82--8T=7(ZT,C*N?!/98J[,=FX^48&[9_JD2\\O\
M(D\D<BN)8)#1%E"R^G<^&Y!87(HF96.[^$5]TM@)X^[?&>.C04BSG3)(3_HO
M5Y>787$]+QN#GG[W81KB]&(]]'?;(K/^8<\MZP\EXXP=[4^2T# -[TWA+BNE
M 46I!WU1$.NT;LY$]"D4975KGWOD#>]-$ P5:@A":U L!' F*Y D$851!I]:
M-QE_U0WO#T'8R0WO#U'>",(*SS74CCZD%)V E+'&F$,$[Q"!9970>1]1I\98
M?%T-[P_"PX$-[P]1SKBQMDOQ\,8BN8P0BJA-;;0G^XHL+<V,4EX5RWSKR9DO
MO.']01 XN.'](?H8&\ .:)DNI58:/8))Q*MRR0+)-4,N!8M,23#>V@1YI0WO
M#P),HX;WAVAO!" ]I[^:LF7)FG7 V(/RAH.W20&+4: NQJ70NOG,V+*XQM/"
M^11+8*R@&<%^VGBZZZ&1M]P^S>R-9Z!-D,9X UEEK _9"KQ@$C@O27MI99"M
MV^B<0.Z_3P;801"<#X.'$4#_$!8WPS.7=)GBDO3U81YFR\^8</JC'DZ_XVH2
M4]3*$_-!Q<I\RN#)=8:,B>?,)4KL85!%.P8&'NI\+M@]936=%0,O:P.\G]7$
M__GBFD^*2\)&RX&EVF?9D,QC* &8+,))9J-.O7;P[TKHP+.?QP_H(W7ZLH#[
M:3&G+U?7G^B^K3?MKV16?J\W\,0J:>DV=!!LK 4QM$^]$PZ<UUA,)#&[UDD4
M+>@>>(KT^&'=1N,O"^6_;"G\(_RUT=!$J74G:P6:_'A0A2$XC-7!)V>))4UZ
MZ'74ZH'T#IN>^0)0?9J&7Q::/ZZ^X6++I90B2D.\A<@EN?TR@>-, 2=S2JV]
M&=EK3+LSI</F:;X !!^KU1%@]PCIDB]@@RU5H$AVE>)*@0NH0$BZ<H01.<K6
M!45'D#EL^N90J.U;G\=#=KX*%TT@>R=QY3CY(FW/Y$T J3#1]5(8Q.02,!>S
M\\Q8ZUN[>:?2_.]3)'=*A.^LR!C!X7U$B.=3N%Z_.6!QF%0D/YCK7)^'6>T9
M*B!J)\@_]LC]@"[B/6J'#>"=%U6G1_&.4?&+ _."OK^CF$G2LF#*#JPA02O#
M+#B9/=V93G,6>69LV!CU/8*'/=!?$*1/4?3+0O7:B[C+*H\E<:]JPD*=<)U]
M@4CF'\@L2 (V299:V]DGD#ML].ZE(/HD)8\ S\?*>:*$TXH; 3HRDJ]VC/QB
M%2 8KHV//O/H1F)T#QNQ&Q3)9U%O,Q^R=:U)?39:KM8#@W9)///R1UWTSF^.
MKR$YZ./;U(8<SU&CFH\[R]P 5$JI(EW3(#1&4+%.-RY:@F9)D8>'#DOS9@H/
MR3AIN.D]"6[RN%PHTGIAP2/6^5+90%1U,B*W3,M@L_3N&8@\^N%#I_B<IL6?
MQI:>++NA)]O>8V"=;FV5"#IXLD-9[4&(48&/ML['S%B*ML[K+@V#]WWV,*IO
MI*HG%'^PW$:F]]V0*!^LM1E!DK=-^T!$"(%K$,(FHB!QQKK4X>[_]/'H_G!M
M/:'Z(T0W="DWQMV+^^KZ"Z:KQ=I(>O.CSF"F7?';IGQR-Q&#Z6*U(U,^%UG+
M@3DXYBQHP4AH IF_'V'>7YM]R*+C@<HQVIV?0]0#8^CO\\7J:_B*Z_2Z7:M\
M)P*3=8Y[J64Z21L(Y/%!9H)'I1ESLLN$@3T?/4R$J0<\G"JV$7C-:Z__CD1V
M+?-3*$P') 9X/4YM !=R!A]",01?C=@Z"+^?DF%B-XVQTE#8(X#,L_5]BHZY
M[#D4R\GAMF@A>$E./]=:"L]LPC'6WY[EP#G>3NU#^N,&TVX8B.,Y.^,A6$<,
M(6<0>(D@Z9YQH8Y-MJT[Q+WT MM#('!P@>TA^A@;P XHT32.NZ1K,6B,%A2S
M=,Z+*$ 89IP2*@;6:R[GZRFP/0@PC0IL#]'>R)SW#S<))X%QIVSU';S0H()3
M$-!QB,EJ%0I7DA\3N?EP4#'J66RKMN&;XR0X@K/JRS=R*&KCXCO,3&)!21Y%
M /(E#2CA(SBC"K@BM>"2>V:P\4&TCX[Q./%'JO=^EYQ393UHM](JE]HK^!X#
M-T]AFV3+>F!N8Q*3C+6;@2Q0$]AKF1QQ95$#%SX%Z55)KG0X3 Y:=#QV]VF8
MZ5?:(SAX[NX!E[ $%S3M >%KP8XE^-<2!]H3MF".XOZ P99O8..YD]H<,\=*
M]B6\1/\>%M7J^G%"\\*G/JWY._/3]/;XK*R2"&3D:A"\#J 45H-#C1!90B,R
M-SR-^%GYQA;'N'H\Z+TQX8*QQ1CFH$8Z04E=:K6)!1Y8B5$KX53SQ+#GR1K?
M$_4AB'C@$S76PPCNG]^FLS!+TWK^DH"NJJPVKWK&)*^)>)GK./BB-$E(&:A-
M;;.3V0K>.C7K$5(&=K);JWS>7OXC@-%NU%#M%/$%%S^FB8RSCV4/=\LZI'&Y
M_U?;L(61B>Q])2 BTM5?;*U9+@*"#(8\ QM-:'UHMZ1_6, V =1\)-H= ;(_
M8QVH-5L1+[M'Q[<A_0OS[:FP:RV'EAGM-/BD%"@T$:+) HPQU>P*3C9/8>M,
MW+"8' X_\W,H<P0H?3>_O,1%>IXO[=&BQ #&>D%W55 0%3=@$_V"NV19:ET3
MTY6V8<M?1H/17E0Y<*3]MAC^$5[(1F)110E,:D[>?E3@' M@"V?<:U:2YC_#
M<F^,[+EUAJU'&1QBS54Q@I/OMK/F?>/\EK/;@!)'6033#)+49*]S1'#&9XB"
M><MS8*9YB.T@ H<] _MV=OK3U0B 2+;%:C%-*\QWPPZKW\)T\5_AX@HGG 2G
M$JM92Z60^(*'X%@!)Z/19(K;$ENW&'B.IK&TQV\.AX=V7SO=C"#K^/%-^D^L
MLWXPO_F!"S(=?KG:EAB6V_]EPAQG0=5.8"[(VMNCD.& !;B*3* (*L?GHL=-
M"!E+2^:^T'=^;8UV8M-/E65W)=+D 6/_1S9_Q>A >8]/&<ZFR%2(X-":V@$(
MP5LIUW6<4>9BG.6-KX^!GC)<E,+E3,:G](3XP#Q$7VCK.<*\"DF;U-I(>Y%/
M&8<@XIBGC$/T,."EN%RLZD#<?)56'Q<;OPK7(<]@E7.*?")M9:YM(1""$ D*
M%TY(2]:JZ?0D1@O<P1!]=XN?Q]8>_Z/%0<J=-Y3T.)!RZX/CSJ/VPEANR/S+
MP410UI!O;0PQ8;,PZ+U,P;:#RT,"AL%,&YT^!,B) A[8R/YR]?W[?+&:SK[^
M^M=W7$QQEO!S($MMQ]TV6.(0)8KU0&.IZ0CFO+H,Y!*C\MGY6(3L$K?JN-S@
M"#E5J?-^)3R"*,!CSV\B):.D\L"\J_-<B@)O8@;T6234-F<]IO?T04-,QUQ-
M+>4_ ABU#16G%)5U$M"P=1F @&!D@!RCI5VEL'WK]]?_GGX0H'I]3S] NR-
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M>6[M=!Y#YTM*F3X%H[WK\'"<^@U.9_BU9JG\<2ZXWMV.;PKMDD>8E]$5)TJ
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M,0=9YRQU).Y<ZP?;ES'S;3CT'#LK[A!5C@*BG8:3!8%T$WD2G><(*A6$J*4
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M>,549?&RN(UGRXP."6RH331L;5-8R UT7"=C&(M<M.A^-)*L#@'8$"%# -E
M71UX'S<5MC><718_QAB"+DJ CMZ",CI#5#) +C%END"$%ZT'ICU.38=X:P&
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MQD$6E5)VRJ0\.MK?1^^@2:#00HP='"$?SK[B^G9"\@47P1:>A1$@@O$D$>1
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M[:F?GF#W]#-ES-DQ&RQ(K-T:A#7@9.;D&"6=K$;ZSX29?_TG(QS@3FVEGIY
M-^S-4C-O0B#Y*54[A0@$[T,!+ZP,,ALKIW.37DR>P2B$[)=G,$)=/6'QUJLV
MOSS+E359!100&6>U5:$%GY,"DS2/GFM_:R+WA'D&O-?[M1$(!N09[**13L$E
MKCJ0&\.9SPR0N]H,LQ!3Y,I#M#)%6_L+V<F*Z.Z3T\D].@NX=M%(I^"ZRL=Q
M.07KF0>A:Q5JH9\<YQ*X+;IX%56XVSET]@RIZ=\I9@'7+AKI"5R_>/ 7[R3;
M"H+ 0K5?(;E4GVN$ 8_!0S#D_P2;C)[2(7B(I$Y =MCHVFX*Z0E?-R'O^@[X
MZMOJ_&;"ELI%F5KDC)YA?7]+X$)T8*,H1L10PG2SHYZ@JQ-#K 40'@-9*ZUT
M@+2/J_56-6?7S#W Y>4A78JT-MM:.L)XK22ARS^2E\1MXKR4+(UO#;@1Y'6"
MNV;86!U&41U@\.HQ^A-^)R8Q7PCM<?9RKOR5"$8P"RKEVB^11V#6)W1)^.);
MUYJ-)'%>+$X&E=7A]-8!+/_8G"V^A3/\4 ;(D8=BN>.TEYW.=*\0@U&R &B)
MY1 D3Z+UF^H8^N9U8 \%R,DTU@$:B?[OJTTXW=K,5UDZZ4*%U; QTF&1A?:5
MLAJ4361'&UM ,68E*]IB\^X#SY#424_4J5R.E@KI&U]7OG_.*DH48*IGKC*9
MSLX$!4HH(9TTB<76A3S/$C7O1=L4 L/AM8,^>@-8[:955FOZB.]79_5L7BW/
M%LMSS!^^XWK+Y?749U_H/)8>3!:T1[D*Y+$9!"F]BL4X2WMX2M@-)[5;,.X"
MF*?@.)'V.@#IS:WQP)UQ/>W\,VEU&U=X';YOF7UWG:AM8S+,& D)ZXV2:FR4
MZ0+::52&!\7+='T)=J.YD^[+TX<&#Z#2'B!\Q=+;Y>9L?7X1S[_ZW44QPD.2
MN$FIY8%Y&VJM@2N);BUI(##ZF(4/*80HC6C^.K(GS9W$?@Z"L+OP/J2Z.X#W
MO\B7_!*^X*9>0F]6ZSH7X $G[\3*J 3:!(X)<N^$KL4RWH(,UEBA4TBI=?.K
M@:3-#-:#XF4UO?(ZP.0?_WV^./OYN>8Z;LN[:G75JC9J#GEQ^O-WI)6^D8CC
M+68O8F4GGL?:@\E"DIZ$J<@RBDR2K^"9<,*A4KFU<;LSL3,G0<R)V\,HN ,D
M/RGE6P6,3XO:BRPR+^3H8@VMT3+@"U>@,\OD@QBGL/G+9 O".TGSZ<Z,F$3Q
M,Z*]SO9[N_R!F[.M(,EYK=1O=_6;Q=^8_Q7.ZD;_^=#5Q)A'E-J YXZ!DI@A
M**>!YZB#Q!*"OU.B]^#4X1V7[]AVF 8DJ\-JK$]0TE7S+)<HO=.5RY2JR:1X
MH,UO P@2L+26N:C8[K@<0$''YL%<T&RMMPX,A-\QGMV(^)JA$\.)"98]Y.!J
MA":P^K9KP6HI9<!27&S]_OD(*3-GNLV&PY8::@:TR=HU?$;2!UE"KU+:9MC<
M;*W]NS,\^]V-FS&,X^40O1<B2M32)1!)U#$]6" &;L 12JPQP2AV@-3"9KT7
M/J>OF,]/;^<%?"AWI?[;SW^%_URM7].OOJS6/S^4FT/],@BMF3;1D\<8E >E
M8P"G;((H774L:3/EULT9FA#>27!T7YS=/><.K]0.KM\AI>/!BH)"*RB6/$"E
MF(60D<[]'&/)QCCF)^O@U&M[AQG LD/_AS&:ZPF,3Q25ZZQ\-$5"+'5@;V'5
MO-4"="!;1OF2BCA$.[&CZ_\P"@H[]'\8HY=.H79OT@$O]'\TFH%F8KL]/02&
M EB67AJ!2IE#M( \OAD4H\"PRPR*,9KI"6U/5XU[E[E!58=H:;)>@HO@3)*0
MO2Q<VSH(=K+.UAVW?>CJKFVEOYY0.:A2,RBGR-]W=(%L&Z-%ND"J.'4)RCJG
M,(=RB,/PJ/M"C$+(7GTAQJBK)RP^T(5 :MJ;J>0ZM(,D5VC3!A\%2%X8,W3-
M9'6(TOTC[ LQ"@0C^D*,T4BGX+KJ0B!D#C;%3-<",Z $B^!]UF"\*,DPKV2>
M++_RN/M"M ;7+AKI%%Q770AR\I')D$$Z(4!QR\D.]A&DTH+VC_9:3^9 ''=?
MB-;@VD4C'8#KCI6[34NZ,G$O&DU%(9FJV1DQDZ>E$2%RE0!+R%$G4ZQOG5O[
M'$WSPFQ^9Z&ISCK'X.5NY;:D9$N $K>I:(E#5,26)4,A!#(&6&D](>QYJF8.
M$#=%P0B([:"2#D#V.FR^OEKF^I^:&_DCG-;KX6KBJ+?:2D>6IHFUF4]4X!)M
M3D1K5"B,HVS]>O@4/?T":Q?=WZO!;Z2(#D!5,Q=N<FRO0H?."!>% X7DL2@K
M:RI$2L"3T24I(TMJ'<=XB(Z90VK3@FAOP7< GKLIVM=<\,!C8F!9;6IL= :7
M'0-&6\*A*B;)UKU"'J9D9C-K6@ U$/[,F9>O5]^^D2KH)%V=GF(Z6_S /]?G
MF^NC-!LCG;0,?&!U-*A&",G6][B29.U;7<QS^44#EIFW9<)$(&DMW@X.F]O9
M>^]6MRK^B_0N%^%!BE)GB=D $4,"AR85'YR)S=,@'Z-E9BS-[M<UT5&G6+O<
MC8;\CF ]AV YB<>D""[&#,PDHV0L1?#6P=#'J9G7S&ZC[0$0VD'T'8#H:L=]
M##_KQKH\=4U6618F@;Q95H>,D%@R=\ 22A12!(RM,QH?)*0_Z.RBY55KD7>$
MFT^8</'C%A^<<RT*MQ CJT]*.I*,#((*GHF<DT[-DV$?HV5>UVQB].PE^ X
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MRN;UU[#^@IL3+(49)178Z#69S8Y#\&1 :\N2,87^H^ZDT3W<L_[YI>;U(28
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M!E+8XJ,3AA<VX% ;MVJ/_NC^;L2$DN^H<O2.I?J/]6JS.?$ETQ[(#AS'.IN
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MH;5,N3$B'Z=FWFJ8P]N;C?32 <*>D=U5>/^"87(C7YUNO_/R-Z_R?YYOSJH
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MW)KD6S\5M*#[(+S;?O ^G6]RHLX[,)E.X?F>)<FO'!IKI#%@O*/]'26#X$L
MR0TJEI318LR7W%-HOS2?XE34-83]T1"X<.C?V7ATLPDL-3G$0D@UE3+8#('K
M!.A48,(DZ_F826,GD'YIMGY'P#\6 !W@_FWXNGGK)J[_6*Q66/FM7^S)[)!9
M8E (=<(=*)?(_8^\]EG0FA?CF"JM6SL=3-RE&>6-L3N.$B<TO&O2^MLE?IK=
M?/H%RRS-<)Z^OB.M+K]\:Y%])5R2PG /T:<-,PHB1P-1HBMT__!0'@RQW5L
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M]=4!()\0WE7*7CLI.$BL]8&H.+DX(@!R*^N8 )\?]@X>Z\#KZ]YL":X6LN\
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MPQ@$RS@D9);<%IE4:7V2/47+M(AJH><7H7.$T#L SWVCY?OMMBM<I5.\2.5
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MPF9FF >AD@:5O0>G# .-Y-ZQ@IC9^"W3]M/6:T#IS)ALH+B>G?%O\875O4M
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M=B)PW$38$ AY#(3-U=43%G^;?5NOEAN)<7$VR_+J;#<N,^$M"%[-EWD')+T
MPAN#409I9!X*?H_0U GBVL/A,>"UT$VO6+M*+1?K%44D9)&F&J@U$%7.($QQ
M48O@2V[>(?\X.9T@K(G>MP'5'DKH%$_BJAN6\QRD8Z *)A)1YD !3 1?I-)&
M1R%RZSF^3Y S;N[^Z'C:1PF=XNE*1#(@1SJK00J.%"\Q!9%)#9XE^@93*LG6
M?39/D#.N_W]T/.VCA)[P=.DIY+/56UQMXO'-M]_CXN,7DOA5GYK)4CJ*HE-=
MYT7GKH>0#0-C4[(>C338.L^U&X6=G&+'\[O:ZZT#5&ZY499GQ[(I8"EB!\6C
M)='Y ++(Q&4N)N;ANUGW70\]6"//F/.4#M52E]"[-K5WY=:632*?<29CG:>'
M-9](Y[SV#- PZW*,"N]V& X O@=)&WND1'-0/ N[PS74)?!N>+EI:OGG=/5E
M.KN;,_]Q]K76UR:F9)9(L!07J4 LRUS;R!&R+KGDJ")SPW>A[4SVV',JC@_8
M837[ J:LO_H29I]Q.9U=^-:C3%K?EH9C3UO?2S8C3%S/D5MR<24(5TW&I%+G
M8T2PPF8*NBW+L76L,.KROSJ8YG&U/>Q^B5P/#M3@-O-YI2<9)>W A.1]E*5@
M\Y"]">&G,Z%]%Q0^?W /K>,N_9#'QV1R[R6K3W?M9B-6*0KJ@S7@08?(-&/$
M\N#P/6RN[1$=X<'!<\"\VUTTV0%('V\:$=[PP',D4\\DL"@U!!\L,5(BLR86
M6UJ?J"]@WNU.ZM]ZWNTNNN@ 5%N\+N':I"A# JZ2N5H!F!4PNDR""UFF(SR@
M[NN93R/U[_[29Q===("N+;M @F*9H4A0DM D.6? 9T&!)G.*)*:LDZU79C?L
MYSIBE'[LVW0 _?6$RJTJ%EQS[8VR4,)FW1$S$&*0P((RDGZD4FJ]1.OE]7GM
MA)"#^KQV45=/6'R@K&JTYKG0-5)2%J"L"C69JR!D)*-&ATFT?J!Q:&V[D^ZN
MG4"P0Z%[%XUT *Y'%B0I^BSN9*I> Y*/$I#NANP C1;<E:04:]T^?<!"L@'G
MZ(Y]O3;03Y<HN[1"1B9(-I(@&EF?-SD.@;D(D3FC D9!_SLXSGJX)%OH>=M%
M9;L(O0/P/+LA*Q0CDJJFE2U%/)H.7^>E \MJD,Z=,KKUJO,3752VD^9W752V
MBQHZ@-5>9_OF0/^$?ZQ^H5_U[YLZ:'#.BQ(IIK<U4>1LAE#W)!5/AANY=84-
MO^1G?_K'GB8^]BT[&A:ZM(.+2NIO#_>/?)B?G[^9+_X3%GE27!"%N0PV61)Y
M8+9.65 D=VD9+[*.EAD<]=M2VUO6^5@(>WYTRQ#J[A+8#S=$L2)0AZ A"0H"
ME><>O'<6+)?"F8Q%AN&W4)Y$R]HP2-FSCVT7M>V-QF^XF,[SQU58K ;"Y%E:
MK<,Y>6SKQ>S=K7:5CZOI^?E?\3Q/DA!*T/^G&,#7&4H>P7-%]UPN$=%X$\7P
MTZV>);.W//A(6&VKSBY/T??K1?H2EKC\&,XW:Z<^XFIU?I%NFS"G'5<8@5BA
MJZF*U*'G$+W(!9T6LK1^O+4;A;TEE$;":3,E=C$4XCY_GQ;D/Q$URU]P]1_$
MV:V<\"9=2TQ&)=&; %BGOZJB(H6K D'H$KEP9(YW1[4-@-1GR>PM,AL)KFW5
MV>6Q^K"78PRR:"B,]4Q5+T=+DF"48)4.V6M;1]MU[)P.N!BJ$V0>KK8#G=/7
ML]Q%;_H#$>[K/[YA6EU_[QC=Z=M3<>S^]#WE,T*'.B*OV6 'W)JZ(H;^B!XU
M!)19.AZ3%JV[N8[8H;[;0T!RU4TJJ?9)%[I6I.;@;.007/"Q%F=D\R4-.Q%X
M.AWGNZ#J[K$[G,XZ< 4>*?TYHV(./@'G=2LTYW2%<!L@2)\-B2MHT5$)?C"(
M#:CZ[4KMN^BA2S1=CPW,,;L2@255,\<D&B]8@611)F:LL*9UD]I)E=IWTO.V
MI?9=A-X!>)ZM\<K,DX^,0\E)4Y0E$1SYLO4DQ^2DM3FWKOB<:*E])\WO6FK?
M10T=P.JY4NY#+*)QGM=95M*A!R4HC')*.7"Q)*>UEJ[Y%*@]R!PWZST(^(96
M5@=XW.YM.T:74=3<)Z\+P*2S$'10P(K(D:.(/@S_BF_?.2J#8>YX_EA[+74)
MO:LDP)OUBAB[^D'XL4G%OZ7P_]-_\/P[_FT^6WU93C*2Z+2IDVCJ9'@I-K+,
M-4G/$N/*Q=2ZU^U DGLK8A\,HN>W"@ZFT=,#\+\P+#[]9SZ1RD@MA(5H,G$9
ML6[R= HTY]$J#)(U7R>W'Z6]U;%'ANL^^CM1E!+L<!)MM-9X SSI!)M>V;K+
M!;BV-2[,G 31 4XKK;U5LGM ZLXZ/$VLOIFO%Q/KL@M,1#"J;HDW=4L\)UZ9
MDYF59'.)P_NG6Y':6Q&[ Z3NK,$3!>KT.TZ*Y)F%PD 'KT'E&HTFHR 7A:ID
MKR@>[0"H1&IO->T>@+JK!D\/J)7%-R3I<%X97G[Z@@L,955G*10?9*GI8.OJ
M\D ,$%)!(+@)2Z!+K/G#[E:TC[N.KSLHM]%QMR,$?YO1E_@I_('+ZR_?+^;?
MIS6/O'_?Q5:_MDTCQ>X<-.J,N/ZT!VK6(CB)"3,4Q0F@)CIPI@ZESC$;6ZPM
MHG6YXPER#CT6:[5^/JO6\*Y<?TRUFMGRREQ>S6>KZ6P]G7U^]PT7&STNKZ41
M(]=>A Q9)D$QH'(U4Y' >":UB\:*0?I"#B!YW-Q3*V3=/?J.J<<.;O-7ZT65
M]CZ<6@S2"J,AY^1 L9J_<,Z#"R1A8[G!YF,,]J=V_%:>HX'J+J"/H^%^L/P&
M29GA_!ZKDT)2M(+H5TD$4+X0)]$%,,F3HY2SMC=SY]L"]C&21D;ED9#Q,"";
MJ*D?U'VL4^+.9OEW^@\>8$H'EY3P"F1FM1!!]Y*7Y(T'@HSRV6OE6I>6MB)L
MW(S\N ALJ+)^</B(+">H<^9"U36THBZ>,B0JC!XT#SF::%+[MV-/4S1NAGU<
MY+50TOZ0FZ_">:M4T.9C]Y&B$#X%=I'P(GXY<HBU@3D$IES03F<W0/9G7W)'
M/B9'=!^/I>,.3M K5B\]D\>,-*+-CL<"5HJ:V$KU :=F8%26&546,@PPCF8+
MRD9O!CD.4!X!:$.M=83%GWR4QW@31AFOL4I.(2B5D"XCNI:,"!AC,"JE 5;P
M;$W?Z%T?H^*RN08[0N=C[(12,!?M(29>:Z_D.D=?QW9R%=!SE8T?8&3Y4R2-
MWL\Q*@9;Z*D#?_,Q-K12;M,P)0/W%*G)3 PA@I%1.B,0A6_]CK!+F(WI)[;0
M33.(#5@!?$TFDU;3[_5O'^AD_X!I/DO3\^GF4YI4 [?[B.:5P3TX.T*5T%@4
M6DL)*051=RDYBK;I>@S(95(2+8'R=*J$.UCE]3_]60\WQIJ3\YPC"(.Q&JL'
M)\FKI;\&R[E1MGG3;SOJ^ZT=[H*W+<_ H;7;@4-X?7;<\'7O!#F[2OE7CWA-
MO^_'3_^XOJORMK!,N).*?. 8@#R?!$45+8PQWC;O!VI =B=(/C+BYN.J_T00
M_W#HA\M)84JA)@G+VI&JD!PM7Y_T12XX5S%:EUM/'3R$WG$#^!/">!.%CPAN
M<A G?]UXB+_-ZJVX>(,;P6]8?X^+1.J:2!$DA8L&&$H*2(.@\%&[NAM8VH"Q
MF.+\,\[N-I\S;B@U,NB:*V)D4&UC/&_G-918TS^+YW@I]M_Q<SA_]24L/N/R
MBNT4C?>N".!.AUJ7->#K\D 1!#<H."LI;X&_AB2-^P2C ZB.I=X3\0,HS/@V
M7T[KE^_*+^OE=(;+Y40DK0V7==^(=:!LL!!K1<)A,<K%:$1LG;7:F]AQWVZ<
MD =PN*I/!-/TS5M3;7^E?[9<3=/$.L>M#PIT"G5!)H7/GHL,QF=92.ZEV-;I
MFOVI'?<9QPFANH&R3P36FP$M9_G_K9>KBW'-T>4LM0P0K.>@G#004XF@)6>"
M' K!0NN^J7WHW K*]K]0/DS!W8+X(4E/M+(Q*(.0G;;U\54$+[  H_LF1>[I
MULE'@>Y#U&T%6/>G!.S!RCR%.MI5:9K^<C'6.<SR[],02;ZKNLZ[12%MR\]H
M7DG;A[<CE-)41"8,*Q!X?1;EDB&D:@JO;"C"IBA-\UTG1WIP=T_@9S\)_*:X
MHW7TUGHHQF'=2VO!F?HP-N9")N2E:K[,< \R.RDI'(B@IQ[6#:&O#N[F.JK^
M0D_GY_/_A%G"BT%MFFE&Y#(HDF5062EPQ=(!'J--*HI<;.M2[2.D]/,,;A (
MS-OKHP-87>04POE?%O/UMU?G8;F<EFFZ8*P.UXW"<<ZS@1PDB4@;!RZ1:Y#1
MJU B3\$UGU7S-$GCPJR)VN]VTC740=^0NIQR*K,,+F("7M=^*N5J:V HD!+C
M(@K!A3DBJ'H8;=T4 MO#:P]]] :PNIJMS!?T5WP[WZPON(AP,-\$.-?#;J.1
MLN3:AUJ?044%WE@+LBA6"I,15?.MI_N1VBT8]P',4W <2'L=@/3^1?'[]?@<
M6TPNN8[/*3G5#9AT3P229BXI!,Y\?><WN,]V3<ZX'1A#7*BM9-\!C)YV:Z_[
M^+G%6((&)S@)RX@,GA7R:X613OIL!QB7L0UAO?EJ>\)@IVAS'YUT +1[C-0H
M_?)[EXG,#Z2^Q??-TLFSE!;K<'Z=C?I0J^M.AF0H3 =N:CN^K<L-:MX;41:'
MH0Z3'V#?[8%4]QRU[@6E1Y[I'$FO)XOD3;O([5VJ6N@0+4I(HG9 Z3J,-M%9
M(5![&YTK7 ^P7;P!Y?V\)^\)T0?IMT=4_S;[3GS,%S\FRH>8/&,0.+&CF#00
MZ!XC82:7E<Q1RZ$>C=^GII]7:D="WWYZZ!%1]^WHSIK JXV8K[]^.Y__P)]^
M/$D^<"N$@9Q]S=]K!<': "JYY+/T(N<!%@4TY&#<3LLNSLVA]#URA_!^-\8O
M(?^*<5,\N&CLN(HBEA.&J)T)!8326/M( P11.TJ-B\JIX.3=@9H/M@FWIFO<
M3LKA$#RZ#GL\K2\39+//O\^7RU=AL?A1+O9D+R?2Z2C09G+3>:G/G1)$;S0P
M'I3()NO<?!CA#N2-VQDYPCG;2%,]@O#G(1 33Q;$7:K#[.I<<,8\!$D^M0V<
M2<Y01->Z[?P9DL;M71P!; =HI$> ;77*7WUK@M9@4DX 4XC5 [?@ QWQTGG#
MN5<\B\'QMQ/%XW8J=N%SMM)GC^BML>%5+[#T1A0F/2BMZVC':,!AL"!]XL7H
MB%H/L/7G47JV0IY_0<C;5Q>]Q2[OPP_Z]>?7AA3.)RDANF =^%@LU.(8!!XB
M>$]A69 .N>7[A"/W/VJ[;#D[/=@,(>H>3Z1-%#110D5NE0%,UE#L$\@_0#("
M'3#XX+QW[1MP'J1D.SR]I/++[@KH$4;W2ZL3$Q4=JTK4J<6N/B(HX'@)0*++
M)G$=K!]@P>US9&T'L)=4#3E0-;NCS5^@;8:?PXKH& YT;W$UD:IH96*NPR[J
MLT"ZM+WQ"FS2-B=I6?#->[@>H&,[6+VD,L>NPN]@I.,C4GJH$]PJS")(LA ?
MR4)2IAN=I0!2*9*AU88W+UYL3UUO#5J#=M$<JIU^W/5;G'S U72QJ3M?E50H
M!)$H7,Z0>"T_VRPALJ)!"(I)3)':B;B;S_[DYW79YG*PKA]VWML)OLO+\!9[
MMV-:QED1Z!&RL(IN^A# :^+0*,84]XB^#-A]]3!17;:BM$+=,*HY%'(#HNUW
M#,OI[/,9!<*SSY==-"RGE&U!X-;6APFN=N@B@R EA<.Z:)$&C"2?)J[+5I3C
MH.]058U_\#U^IO^*1%*:7C4IG'V=+U;3_[UH2N ILQCH<$<DOW>S8<D)S) I
MVO;(C?#:['VK/O'!7?:.#'^]ME+%^'"[:T[7+Y5O<3MA0@MF.3D,P05BR1EP
MIC! [Q6/Y#Y$.]0NC(?H&?=\&RHN:*:!@T'5?)?5'69D-JR@E&"8\: H+"=/
M5-8!'"Q$%WV*9< VC5V!--CI-320#I!Z:P@-.//D;5C4)I/OV&2ZR;W?UGR.
MR=/T'F-%N+3!\'HK&5;=H5+J\@@)2H5LG>#!F,$6>[2?6+)-&E@;6:SQ#I@O
MM1>$(E\G@@=4#K,ID0<V>'?$OAGZH0Z?5@C9)RV_BS[V3FM]QT6<C]"#R(D5
MCHD.5Q-5?5[AP L;0$27,E>)L>9O7%OW( X_=7QHT#723P<5R+_/*-"8?YY-
M_W?#WE4V[UJ2[W%&5\UTTT;TVXP^%Y>KRP:CB<9 5[M@(%(=\Q(3!Y>B)%8Q
MAB 44\US% >0V\EL\L;0/);^3A2JF\XWS!,GG$9F"U <7E^]ITA7 @M  LB:
MN.<RMCXU#R"WD]GD'4!U'_WU"]5/7\+JG_/U>?[MZS>2YMWE71.7O(Z"+- [
M),>E>B^!.TU,>YF=\@P+/PY*GZ&TD]'BQP%H2ZTUP^: $>\C8F@2_S[SNYM'
MP[OP<H38V'LOLHL>3)&1H)(]A!#H C8A2%FXY+KUB^(!8^,[0YK+(\)^_4<Z
M7^=:-?DZ7\]6=6D$27]&W_@T?_U'^#J=;?[Y!URM%[/EA_GY^9L+9WH2F,Z6
M,PZ<<PV*YU2?0B)H(U1RVJHB36-Q#<U3OU'Y+MB\>W)VA81^[_^)Q<)<9@DL
MYD"WD]3@-7<0O36>;JW$FD]]?(24<7'8%UZV<P-V4M[>&/R&B^F\[A]?K 8.
MFA88EK619[D^KYF,-Z2D5^M%U=[[#0W5([_<BK*<&!$CA88"2@F<G"DA($8Z
M(8R+S(?B2*ZMEX.WH7S<A-0IXGQ(:/1[-#_,]7OB=O$ SZPDE=%;$#+4URH4
MDT:3B'%DQ2$%'<:U7GO:@NYQ4V OQQA:P*)?4_@5=^'91<=YX0C6U/'R20<(
M#ND@D+[H4)?2ZR-EUG:B>]P4VRF:PG"PZ*=+Z1'6/USL0"2^?N+]]_!MB>_*
MV;=OY]-4AZM>;$FF;_T^_3I=72Z!09)U+&A <RE!A?I(J+Y0RS*70+H(JOG0
MD '8&#?C=XKV<C30=&\^#Y\<MV8&_G.Z^D+_OBINO?HR7UPT%'%MI!*.@W4R
M@1*)=!*%!LFB<<JC"<UW;39E8-QY/*=H,D< 2O?&,O'!BIS(]&.,MK83DQ.)
MSD-D3$O%K9>^]?+"0W)$@\WX.44 [Z2\ W-$KV=YP'K0Q]4\_9NB'_IET^_X
M_CS,EIMO_4+FF6_/*[QL)@BS_/KC^_?[%XD._, VE:.67#<J)]UDZM^5VQ1\
MP/-Z'KV:+U?+CU_(HF*E\7WXL3DHK[/ZS&;I,7D06=1IDH&@:;,&CTJZ8J5/
MIG4)Y3"*#SU6/Z8OY'B=TV=?3=?\B(OOTX2;C[RGR-HUF"Y/F _7)GT1T&PH
MO=B:4&1"'4AXK$02HTD*'/.F/O<74B(37+=VX@=A9/0%*,?"\MT#>WQ8=)#P
MJ0?:V_ 5-ZN/0D[>!NX@^_IL*9!<'5*<87,43CH?%&^=N+G]^>,BL0,XS!OI
MIB-<76XQ8E%4=QQ!>$/!J_$27#(6@A#HBY3%R]:!V\\4C(NM_37Y""3V$.O(
MTQI>_>/C7S>NE6#<7OM3MRVJ\G:Y@"K'F!DCQ]NJS7.A$B&6I,&5J#W:X+W9
M9NCS+I_9!T#VT>O\"$(>&3QGN)H%XH?88O<=\DM^1$%BQW,(1050UC-BA8Y:
M#!9US"(IW 8TVWS6N"7D1F!I+M010;)<K"8?ZOO[S0DKE(O"* /2)0Z*?$-P
M#@-$@<(XD<*6,_?HM]ZZ:>AO-[?,3Q\X+ASZ<5SVUT(/T+DZ%D/D.DK">6U9
M4$DGB,868%RX' HZ5;9R@K<!SYA7SP'*NJON/20WLL+_-IU-OZZ_7A)NBC Y
MYKI#1A/6LY/@%7-0]UP6S84U9:O>C6=4_M.'CJST?50V;R&_L14?_KA%N'):
M%VT*H--U0G$DP)=<(&PFS*(J/C11_.T/'>>R:*;XO>7705!Z5I/\G^@?;XX\
MK/V90>N:.R*_218.7NL(IB3)0Y*Y_0[%GP@8M_6J'Z_A<.UT *U'I'9K*-0O
M/V[^S64><\/Q#=NS?,^S#UK55>1%D%-/%IFK#!08$40D RLH6\_Y'8*/<4/K
M V!U-V$\MHY'CL(_X'*UF*85YDVX^/?9=+/MB0Z!,E]\K7,6-MQOOG]Y04C-
MLL>L04=R)I5T%F*NV\OIALDV)6GN9I0?C,EW_^21<\FC(V5^-+6-#,KKVZOR
M]N[;IE>*N-O\]>S;S<RT#]//7Z[Y,XSS;'4&##Z!4IE. 55?<*3DN*3+RC&[
M!2SW^>R1<P4] 7-PU77@%_S$XR4+(><LE!2@0\8ZKJ]&2DY#T38P;DPLV+H8
M\@ 9([N?O0"QE:)ZP]J%/5TRXC03ME;(F>&V/LBA4-U1R&>D#KP$&4)JW:OP
M*#'CMMGWC;N]E=8!^AXYMC^>??AX54M(RDOC.5C!#9F32>!M=A"$U#%A=D(U
M#V>>(VK<)O;NT-A6B1V@LDURX_?K*9G9N>RYR4!W0R3ADB \:@0*&W.466C9
M?)U38Q9&/G^[2SN-B9 .#.39(^BQ$^CMNIX'[\KFI\O+YGL2RL0*<HXTW5NR
M/G14=1B_M]X#E]'G;%W.VR756V:M=F5BW/3!J)#<->DU*#Y>D(%\#]/S>EB]
MF2_^0O_M:F(+*\K42]1Q4=^H2/#)1M!91&&34C&V?M4Q%"_C)C5>HKD<A)8.
MK(:X_SJ?;=S)5^';=!7.+QB[W#><B:\WZ]5Z@;\ME^O-B-[,E6";84-.!U!<
M:HB"PAWF@S(R,I&S:FP..Q,Y;LZD)YP/J]\. +RW(6_^^ <NZUO%"['S20G*
MZV04)%FK3J8.PD>&@(GG$C"PG(Y>R-N!_G%#AIY@/QHJ.K"(2Q%C?E@(5R.$
MG2:73AL&.C%9E[XAA.(*2"^D4C[)D%NO#=V.LG%3/3VA> !-=H#/K23\=KY9
M%H<7!KG<; VY_?,JY;?SU;]P=2/_F]]T\1]M]DI_^A)FES6K2<RL8.0)E)2.
M!,4]>%4CFBBDL2J(]A'O:,R..\*@)RLZ#;R]9,.\4"FYFI??JO^.3UQ@WF"T
M@+)D4)%.+&^$!NV8<FA$4<W[^H[+X;A#&/X4)G@XLCJPN[V=U=?_LYZN?OPV
M6ZX6ZTT5ZNX)](^-/'^;74[YJA)]$Z:+NG@'R:V-S@F/8(SWEPJE$PE0<Z>R
MQ&!E-_G?@SC=R@[=G\$.3P!IO=AC?%Y*\9Z4_O@V75P\W]R(86)BI+C1"8B)
M66*<!_ L<@C<*BZ4DV0@0YA8"^*WLAK_I[&:H^.A T,8SG.^U4DX23R8J"EH
M348H4-F2:B138! Q670Q^-8#JH_"V':U2?9GL*#^@#1R-_3>%_$EKS7UDS;;
M5.O%^VZ]6J["K(Y2NRA/39*20<:40$M9ERXY#C$CJ8T9%S4C(?D[C80/-DX/
M3.9V%O*BR_>]@:&#6V?OZ_;]>I&^T#??+TB;FS%55Z4O4E<=F3"AN% *1S%A
M%-: DH9!+"+4K63,Q%)\UJUKE\-QLYWU_'FJ^>-#I@?CV0P(62[7F']=+ZZ+
M6!=%WY]ZF*]9KZ,2)XIYB]P9P&P=*-09'!<.3& E2XO1FT%Z?G<G=3O8_RF*
M^\=0]MB.TL,L/LK<V7=<A,_XDUW/+YMUKKZ9)R(;[AT3('V]![E3==,OR<,6
M%701)<FMW*,AB-L.WR^ZBM^'XKM=^/C J-L[;T?/ZI;+Z>I'TYF^SWS&8&-\
M=^&MC\F]+NO $LN G/E:_#/D,Y#C0/!*+I7$A&V=T>AE<N_^+V4N7@@(\JUD
M"12K>)M 6500,4OROEA&J8U-OO70XV;$G_2$WETP^_B$WF.JOP-O^^>9%1F-
M-$%(2+P..;:10?!> 2\Z!!D*MZ5UH_CN@VJ.,)?WJ"!X<CC-+AKI $Z#/#-,
M,J40C(&2B7.ER=F/RF;0SOJ2A,H^-)]__L*'T^P$JV,,I]E%QZ<WG"8D%;5C
M$30S]2EK3<9X&8$'YC%)'\I==^J_PVF:(.6PX32[J.T4#M_'I'T3ZUK.LXDN
M@T](/I2('D(*'A+=7+9(87WSC1V'4]W+4-PQO88CZ_Z4T?YL)]!U&??VPJ:H
M<MWTI<"ZE#:%)PC<,;#&V6B5JHUYO5C&7AQV?E4TQN_1VLH.!M.?P]0N"[U!
M&Q>L*L#1!5"1U;G0W()+D@03)0;7>B_,T9@[40,[ L*/;XQ[P.W C7D?5V&Q
MZMP:-^^_EU<ML!..AOAD#K@S$136L5 ^.TC"QD*^BBF83\88?^:M\]F(?P9;
M/ !L+_I*_+D/?<*3YDXR"X8A@DH4'KC,)5#L*5702B9S.G[GS[QU/A?RSV"$
M!X"MGV7&PXF'E%=P>EM"PFJ'F^$HQ@KR&(P"YZ2K:R!#B3*IX+I)D.S.7N<3
M,_\,%GD8Y/X,1GG7B3=>%_0I0RJ6@W(BU+>2"KQ-F>F<E&S^"K>OF'&\H:%_
M!H,\!&Y-MZQW;8O_Q#J^%?-E$]O&N?^53I3K)Y2W%6U\X#+Y#%D+.M$VV[^<
M<W5*DPZYF.#9Z?BT>XG@1.//DTFV#@;'%QUZ;B^^B4:2B[ %G/ 65$8!3JDZ
M<HT<E!2Y%J%U@V /?+_X'.YPAM/A(; 3BO]T^=_GQ>>53$&Q""'6Z4#9DBL4
M/8=8-(O>D3,D3Z=:LR/S)WJ#_ZE.@B'Q_*(=@9_3@L\++EEKDI8).&<(*J@(
MT1<&P8K$O40NP^DX]#LR_^*SV"_@(!@2SR_Z(+C,1JX)U<]+C?ED$F<!TB9_
MHS#772T)(FKD,9620S>SAYMR_N+3YB_@"!@,R2_:_G>(I;B)(L>@2,]>@_*.
MCLNH/11C2E(Q&EGXR5A_XXS *6?H7X#M#X3BD;/[!PW>V=%E.DNK=3BG7S!?
MKSZ0P)83H7-,J1AP3!10,6D(3DGPRLC$"V8N[S2'M9W/="@#)^JV'Y:!/QW(
MG-+H@ELCW,(L?SS[,,CP@F<_9;#Q!;OQU\<  YY%M%E+,*+N%0]J,[C<0DHN
M*NV3=MCZ)?-+&6 0C=!<R (F1 XJ.3I8M)&05-)!6"E5:3YB[+\##';$[' #
M#'91?P>QS\_OFNM\=)OI*O2&2Q*AU>!9UB"9\T4Z)T/SEO47.<!@)Q \.<!@
M%XUT *=!GBQSQ,**5B!X222#5" 8+\$9;5!YE>C__CO 8*<!!CO!ZA@##';1
M\=@3Z>[Q=L/ZA9NW"8SIQ^3'DX._F*\_?Q&,NZMG\4I(BN8]&,OJ"#+%(7A.
MQP23TI#@HXQNI]!O+S(Z;\48'$,/AG3#*_14L/MQ'9?X/VOZ]J?Y+5:%24X6
M+#6U0U%SK(V;=66]RH5;9KU(UK3$[L-D=-X\T"5V&RBT!_]B,P#P&WU\FE[$
M!C4CN:2@^N,E0UXI+((G""K6(;VH(*2DH&C&O2-N,)36SL)S1'6>+#L67H=1
MXL@GZD_S2"\S>22N1WB\Y$^ER(.A*X*X$J"4<Q#J:E'T-B2*7K,UVPPTVN>S
M.R^V'O/L'%QU/1R8AV?*(T/O1-)@BF0D7FF@=GJ!]#HH+9T-I?6>V,.I?BE#
MC0[))!Q9][V@/3[/<;S+\;U%3:K4QTATICCR[4&5.K]:!@Y9!,.T,;'D05KR
M6A#?>6C7&'6#[>K:!0(=8/_]8IX0\_(-:>3VC?;Z#URD*3$[X2Z:' 2#4IMQ
M%#?D7W%A0(;"C)$^)][Z\?6S1'4>R@V+U;8JVQN#WW$1YZU0>%F5N:S9?)I_
M"G_\<[KZ\F5^7A<2O9DO'I;Y)+$02HSD4@6T0&Y5!)=B!!$8<L4B3ZEU]^.^
MM'8>S@V,V6,HN(/C=&\QW['AY4\K47^;K1;3V7*:+MJE%%<AL(!0BD *)J*&
MX-%!HI"EI$SNG>EF1-0.?'4>8Q[! >D).-VDG/>3!T7D.[9.W;0C8K3%"9_!
MN^#H^K0)O+867 SH?:UTQ=W2U4=GX43[8P\SI5."S0NXJFXMC+S=C,R#4$EE
M#P*1@Y)60ZSM-1:=)3:R"]C-8)@G.=G*ALP+LZ&.P/&R3.1JCHWT*A;&()I(
M9X25$:+U 62QOCB'3LB.K>.D1^HV1.9PQK('3$Y_1,*##\?_LI@OEY-01.)H
M)?A2.XYT2D"GE@4IZ&M?T*#MYG7CXVR<:+JJ7XLY%"H]W"U/+6%].*W'<K8<
M-0>1;.VZJ ^DI69@N&(J^&Q$:A[W[TSEB::Y!L3ZL(I^ <,G[S\6OA[#&14*
M84@2C$0!R@<$;P7%5,8X*W40* ;9O-Z6C1/-;/5[_A\*E9=C-#?UQUN2P!QU
M]HQ486K@9Q+X8,E[C%S9;$..O)L)48^S<:(YK'Z-YE"HO!RCN1]PN9AMSJR
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MKK[,UZN;FLO9MV^+^?=P/BD:/1H30=I:MHV"@;=*@,^\\,P5"W<?;1WG #V
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M+0O_B<)CKW\Z</A^ #N_D_J7LLCI7\-N?E'_BI2#_.___#]02P,$%     @
MQC.Y5D\R_^-H P  )0H  !L   !E>&AI8FET,C,Q+3(P,C)R97-T871E9"YH
M=&W=5FUOVS80_KY?<76PO@"6]4+9DATWP.HD:+$D"Q)O03\-M'2RN,JD05)Q
MO%^_HR2W#AIOZ8>AV/2!.)+'N^>>NZ,X?7'ZRVS^\?H,2KNJX/K7=Q<?9M#S
M?/^.S7S_='X*[^>7%Q /@A#FFDLCK%"25[Y_=M6#7FGM>N+[F\UFL&$#I9?^
M_,9WIF*_4LK@(+=Y[V3J5FA$GI_\,'WA>7"JLGJ%TD*FD5O,H39"+N$N1_,)
M/*_3FJGU5HME:2$*(@9W2G\2][S=M\)6>+*S,_7;^=1OG$P7*M^>3'-Q#R)_
MVQ,\'F/ TB N$HRS,.'C)(VBF'.&"QRRZ/>00/JDWIXQ=EOAV]Y*2*]$YW^2
M1&M[O!&Y+2=A$/S8>Z2WYGE.Z+T*"SL)4]*T^& ]7HFEG#3X2;]0TA(N37Y:
M\2MWSS:S.Y"I2NG)4=!\QV['*_A*5-O)J[E8H8$KW,"-6G'YJF\H=9Y!+8I6
MT8@_D4(A)\UTTX5)=BHA<1=V&+E8SQY*L1"4!#8('Z/_^QC&9'VWT.!O5O:"
MRBASJ+]35#,EC:M 5< 'F>,:::#I#2Z%(514D]?UHA(9_)1EJI;6U>>YT*OG
MY^]96=^CXX_:6%%L_W4^XB?YN$/(.DJL ELB")DIO5::NY:'Q18T%D2,S-Q6
MH]&2U2G<6NIDUXP&7I\KO8);+X4K90; &/.B)!RF4;^3@S$;=3)+AT&RDX.
M#3LY2D=1IQ^.DB3>Z8=).F2='*1IT.F'<1BG82>S<9P$K3QBHU'<BN,PVIV,
MQ_'.*8O'$8E<YJU-NB78&U<5L]]NX3WRRI9T$7WA@794K8D+6K&0-[?7.2YT
MS?46TGY[5;W&APS7%@JEB0*+D#8.&C$D)6X<R9M29&5#I#,#PL EWT(T;(V\
MZ<-&D'.-9HW9YZRX)*E*M(X+(;G,!*^H6CZS?QB[P_"/X)]VBT5!,W&/$DWC
M0KC>I3^! V2UJD#=H]X#U/IP77,03]^56%7G!*(I*")@5FO=MF&#D# WI91Z
M/P^^O87^(YWW\BA.CDTSPIF6QL++(Y8>PT>Z=I9P<7']OXW\G3+6E<$E-X9G
M96W06O,5[.^#;;\5#T!ZFN7G9&#_6;%6[:-JHK'BKL,./C06REJUF@1?CO %
MW06U/7SD&WY*C\;V =4\Y4[^ E!+ 0(4 Q0    ( ,4SN59D_#_J<[P  #Z$
M"@ 0              "  0    !C=G,M,C R,S U,C4N:'1M4$L! A0#%
M  @ Q3.Y5L$-#K,_+0  72$" !               ( !H;P  &-V<RTR,#(S
M,#4R-2YX<V102P$"% ,4    " #%,[E6^RT:LK]8  "HP@, %
M    @ $.Z@  8W9S+3(P,C,P-3(U7V-A;"YX;6Q02P$"% ,4    " #%,[E6
MQ!C"I%EI!P!@[%4 $P              @ '_0@$ 8W9S+3(P,C,P-3(U7V0R
M+FAT;5!+ 0(4 Q0    ( ,8SN59IC'R(WSL! 'MD#@ 4              "
M 8FL" !C=G,M,C R,S U,C5?9&5F+GAM;%!+ 0(4 Q0    ( ,8SN59'__(I
MQ X  'X/   3              "  9KH"0!C=G,M,C R,S U,C5?9S$N:G!G
M4$L! A0#%     @ QC.Y5JB-,*I,E ( B-P: !0              ( !C_<)
M &-V<RTR,#(S,#4R-5]L86(N>&UL4$L! A0#%     @ QC.Y5M+YR-[1I0$
MFJ83 !0              ( !#8P, &-V<RTR,#(S,#4R-5]P<F4N>&UL4$L!
M A0#%     @ QC.Y5D\R_^-H P  )0H  !L              ( !$#(. &5X
M:&EB:70R,S$M,C R,G)E<W1A=&5D+FAT;5!+!08     "0 ) $\"  "Q-0X
"   !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
